originalID_label,originalID,gene_label,geneSymbol,funcType,Size,Z.Pos.Vs.Neg_DA,AveExpr.Pos.Vs.Neg_DA,Ave.Negative.Pos.Vs.Neg_DA,Ave.Positive.Pos.Vs.Neg_DA,logFC.Pos.Vs.Neg_DA,adj.P.Val.Pos.Vs.Neg_DA,Z.Pos.Vs.Neg_DE,AveExpr.Pos.Vs.Neg_DE,Ave.Negative.Pos.Vs.Neg_DE,Ave.Positive.Pos.Vs.Neg_DE,logFC.Pos.Vs.Neg_DE,adj.P.Val.Pos.Vs.Neg_DE,ensembl_gene_id,external_gene_name,gene_biotype,chromosome_name,strand,start_position,end_position,band,description,phenotype_description,hgnc_symbol,entrezgene,refseq_mrna
GLI2_TF,GLI2,GLI2_TF,GLI2,TF,231,12.739456985175,-0.00426204883562653,-0.0148928378672611,0.03066768655403,0.0455605244212912,2.95666802011523e-33,9.98168217723865,0.644080576194708,0.297493572545011,1.78286644532943,1.48537287278442,5.98107276953505e-20,ENSG00000074047,GLI2,protein_coding,2,1,120735623,120992653,q14.2,GLI family zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:4318],Alobar holoprosencephaly;Combined pituitary hormone deficiencies genetic forms;CULLER-JONES SYNDROME;GLI2-Related Holoprosencephaly;HOLOPROSENCEPHALY 9;Lobar holoprosencephaly;Microform holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Post-axial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome;Semilobar holoprosencephaly;Septopreoptic holoprosencephaly,GLI2,2736,NM_005270
CFH_SIG,CFH,CFH_SIG,CFH,SIG,76,12.598233355514,0.0121008347944544,-0.00667782545610763,0.0738021470463013,0.0804799725024089,8.94476762830528e-33,10.2614412815272,2.52817281104117,2.04215936687038,4.12507412760234,2.08291476073196,4.80151621862306e-21,ENSG00000000971,CFH,protein_coding,1,1,196651878,196747504,q31.3,complement factor H [Source:HGNC Symbol;Acc:HGNC:4883],Atypical hemolytic uremic syndrome with H factor anomaly;BASAL LAMINAR DRUSEN;COMPLEMENT FACTOR H DEFICIENCY;De novo thrombotic microangiopathy after kidney transplantation;Dense deposit disease;Familial drusen;HELLP syndrome;HEMOLYTIC UREMIC SYNDROME ATYPICAL SUSCEPTIBILITY TO 1;Immunodeficiency with factor H anomaly;Immunoglobulin-mediated membranoproliferative glomerulonephritis;MACULAR DEGENERATION AGE-RELATED 4,CFH,3075,NM_000186;NM_001014975
ENPP2_SIG,ENPP2,ENPP2_SIG,ENPP2,SIG,15,12.2301789878455,0.0334009994560692,0.0155899083875026,0.0919231558242166,0.076333247436714,5.92282341042387e-31,7.48889253472254,2.61954798458174,2.33263518561355,3.56226146690579,1.22962628129223,2.05999173790681e-11,ENSG00000136960,ENPP2,protein_coding,8,-1,119557086,119673453,q24.12,ectonucleotide pyrophosphatase/phosphodiesterase 2 [Source:HGNC Symbol;Acc:HGNC:3357],NA,ENPP2,5168,NM_001040092;NM_001130863;NM_001330600;NM_006209
CYSLTR2_SIG,CYSLTR2,CYSLTR2_SIG,CYSLTR2,SIG,51,12.0713898127362,0.0501287498929636,0.0236930966493909,0.13698875340756,0.113295656758169,3.09830817226097e-30,9.91669219720242,2.72148094763742,2.3860694473948,3.82354730557745,1.43747785818265,1.00550245937889e-19,ENSG00000152207,CYSLTR2,protein_coding,13,1,48653711,48711226,q14.2,cysteinyl leukotriene receptor 2 [Source:HGNC Symbol;Acc:HGNC:18274],Uveal melanoma,CYSLTR2,57105,NM_001308465;NM_001308467;NM_001308468;NM_001308469;NM_001308470;NM_001308471;NM_001308476;NM_020377
CLEC3B_SIG,CLEC3B,CLEC3B_SIG,CLEC3B,SIG,35,11.8614524407761,-0.0950433346439559,-0.112801373751995,-0.0366954918604,0.0761058818915948,3.11003495432869e-29,7.72988645234232,0.383905468539356,0.243097511673535,0.846560183955628,0.603462672282093,3.84098902924501e-12,ENSG00000163815,CLEC3B,protein_coding,3,1,45001548,45036071,p21.31,C-type lectin domain family 3 member B [Source:HGNC Symbol;Acc:HGNC:11891],NA,CLEC3B,7123,NM_001308394;NM_003278
SOCS2_SIG,SOCS2,SOCS2_SIG,SOCS2,SIG,59,11.81085787801,-0.0122455200680235,-0.0331596004392949,0.0564721725804396,0.0896317730197345,4.73685367328412e-29,8.65577729214332,4.68886492960418,4.22049018310859,6.22781052523255,2.00732034212396,4.47206680872686e-15,ENSG00000120833,SOCS2,protein_coding,12,1,93569814,93583487,q22,suppressor of cytokine signaling 2 [Source:HGNC Symbol;Acc:HGNC:19382],NA,SOCS2,8835,NM_001270467;NM_001270468;NM_001270469;NM_001270470;NM_001270471;NM_003877
PTBP3_SIG,PTBP3,PTBP3_SIG,PTBP3,SIG,38,11.5583139848241,0.0601142975454657,0.0459860507586718,0.106535679844932,0.06054962908626,7.9312985471666e-28,7.58190229697925,8.38596730701272,8.30202973788735,8.66176217699606,0.359732439108711,1.08007807918783e-11,ENSG00000119314,PTBP3,protein_coding,9,-1,112217716,112333667,q32,polypyrimidine tract binding protein 3 [Source:HGNC Symbol;Acc:HGNC:10253],NA,PTBP3,9991,NM_001163788;NM_001163790;NM_001244896;NM_001244897;NM_001244898;NM_005156
GGT5_SIG,GGT5,GGT5_SIG,GGT5,SIG,37,11.0933761488196,0.000600325245433667,-0.02149646429613,0.0732040623105715,0.0947005266067017,1.39903663434892e-25,8.38828010028229,2.94948210923126,2.55494762035561,4.24580971553694,1.69086209518132,3.12933982437082e-14,ENSG00000099998,GGT5,protein_coding,22,-1,24219654,24245142,q11.23,gamma-glutamyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:4260],NA,GGT5,2687,NM_001099781;NM_001099782;NM_001302464;NM_001302465;NM_004121
TRIM15_SIG,TRIM15,TRIM15_SIG,TRIM15,SIG,43,11.0161695959881,-0.0443887447017425,-0.0679700633839279,0.033092730968295,0.101062794352223,2.93990096556754e-25,8.42465697811648,0.419520656624098,0.251032154133811,0.97312573623504,0.722093582101229,2.43018344632109e-14,ENSG00000204610,TRIM15,protein_coding,6,1,30163206,30172693,p22.1,tripartite motif containing 15 [Source:HGNC Symbol;Acc:HGNC:16284],NA,TRIM15,89870,NM_033229
MAGED1_SIG,MAGED1,MAGED1_SIG,MAGED1,SIG,38,10.9145410291722,0.0933951892739386,0.0640382148290016,0.189853819593017,0.125815604764016,8.13787279722728e-25,8.61797244889091,5.74926394965214,5.5045382276819,6.55336275041151,1.04882452272962,5.98593546464487e-15,ENSG00000179222,MAGED1,protein_coding,X,1,51803007,51902357,p11.22,MAGE family member D1 [Source:HGNC Symbol;Acc:HGNC:6813],NA,MAGED1,9500,NM_001005332;NM_001005333;NM_006986
HEATR6_SIG,HEATR6,HEATR6_SIG,HEATR6,SIG,22,10.6427505971249,0.14856581429653,0.127972068370122,0.2162309794833,0.0882589111131777,1.41960917350214e-23,9.01828273774553,4.60025133535222,4.47556679612889,5.00992910708604,0.534362310957147,2.29644881483046e-16,ENSG00000068097,HEATR6,protein_coding,17,-1,60043194,60078931,q23.1,HEAT repeat containing 6 [Source:HGNC Symbol;Acc:HGNC:24076],NA,HEATR6,63897,NM_022070
HOXB2_TF,HOXB2,HOXB2_TF,HOXB2,TF,275,10.3546052586657,-0.00303712560194452,-0.0187569975366085,0.0486138821833799,0.0673708797199884,2.75357714346839e-22,5.43481480164327,3.79460946510175,3.49715861116968,4.77194798516429,1.27478937399461,2.19303235670352e-06,ENSG00000173917,HOXB2,protein_coding,17,-1,48540894,48544989,q21.32,homeobox B2 [Source:HGNC Symbol;Acc:HGNC:5113],NA,HOXB2,3212,NM_002145
DCUN1D3_SIG,DCUN1D3,DCUN1D3_SIG,DCUN1D3,SIG,59,10.3333561191167,0.108169617717854,0.0863491697577667,0.179865375300997,0.0935162055432303,3.17299634883218e-22,9.15388645703746,3.92001996418176,3.73437855360501,4.52998459893394,0.795606045328924,7.61689045400426e-17,ENSG00000188215,DCUN1D3,protein_coding,16,-1,20854925,20900358,p12.3,defective in cullin neddylation 1 domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28734],NA,DCUN1D3,123879,NM_173475
CISH_SIG,CISH,CISH_SIG,CISH,SIG,9,10.2340644713146,0.081753355304876,0.0652677446587657,0.135920361713524,0.0706526170547587,8.25761425753512e-22,4.59229376979136,4.23307612973909,4.10075345076025,4.66785064638384,0.567097195623588,7.05533920186512e-05,ENSG00000114737,CISH,protein_coding,3,-1,50606490,50611831,p21.2,cytokine inducible SH2 containing protein [Source:HGNC Symbol;Acc:HGNC:1984],BACTEREMIA SUSCEPTIBILITY TO 2;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,CISH,1154,NM_013324;NM_145071
CES3_SIG,CES3,CES3_SIG,CES3,SIG,16,10.0506771052432,-0.0629817518476204,-0.0777460410811162,-0.0144705157947057,0.0632755252864106,5.03939776393235e-21,3.64205167339425,0.900256350873901,0.825639151625339,1.14542714840489,0.319787996779549,0.0017532810961149,ENSG00000172828,CES3,protein_coding,16,1,66961245,66975149,q22.1,carboxylesterase 3 [Source:HGNC Symbol;Acc:HGNC:1865],NA,CES3,23491,NM_001185176;NM_001185177;NM_024922
SCD5_SIG,SCD5,SCD5_SIG,SCD5,SIG,29,10.0028008724679,0.0118799870956742,-0.00949295143285991,0.0821053565465718,0.0915983079794317,7.6712136314869e-21,7.85865777255922,2.37436750287222,2.11471716711471,3.22750432036119,1.11278715324649,1.52878535619148e-12,ENSG00000145284,SCD5,protein_coding,4,-1,82629539,82798796,q21.22,stearoyl-CoA desaturase 5 [Source:HGNC Symbol;Acc:HGNC:21088],NA,SCD5,79966,NM_001037582;NM_024906
IL2RA_SIG,IL2RA,IL2RA_SIG,IL2RA,SIG,39,9.96693903795921,0.0110178912566536,-0.00377094153517352,0.0596097704297999,0.0633807119649733,1.03651467604977e-20,8.04918811638262,2.76011934736021,2.39954351704119,3.94486850412272,1.54532498708153,3.9653148303683e-13,ENSG00000134460,IL2RA,protein_coding,10,-1,6010689,6062370,p15.1,interleukin 2 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:6008],DIABETES MELLITUS INSULIN-DEPENDENT 10;IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY;Immunodeficiency due to CD25 deficiency;Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,IL2RA,3559,NM_000417;NM_001308242;NM_001308243
HOXB3_TF,HOXB3,HOXB3_TF,HOXB3,TF,266,9.87936361586685,0.0188416010343254,-0.00180946126505768,0.0866950914465841,0.0885045527116417,2.35463141789947e-20,6.67067633234077,4.24365251541754,3.77550752559292,5.78184319626986,2.00633567067694,4.15351575949834e-09,ENSG00000120093,HOXB3,protein_coding,17,-1,48548870,48604912,q21.32,homeobox B3 [Source:HGNC Symbol;Acc:HGNC:5114],NA,HOXB3,3213,NM_001330322;NM_001330323;NM_002146
CCL1_SIG,CCL1,CCL1_SIG,CCL1,SIG,21,9.78584923014793,-0.0156095959980438,-0.0393850023412014,0.0625095962723313,0.101894598613533,5.64703460160925e-20,6.920999957864,0.592287191207882,0.373376427530034,1.31156541472081,0.938188987190777,9.06339138401044e-10,ENSG00000108702,CCL1,protein_coding,17,-1,34360328,34363231,q12,C-C motif chemokine ligand 1 [Source:HGNC Symbol;Acc:HGNC:10609],NA,CCL1,6346,NM_002981
HOXB4_TF,HOXB4,HOXB4_TF,HOXB4,TF,124,9.63395579867341,0.00953887935679886,-0.00832391136629859,0.0682309060184048,0.0765548173847035,2.38083321757316e-19,6.57255448367412,3.18524340406815,2.84336762224376,4.3085495443483,1.46518192210454,7.14874419343859e-09,ENSG00000182742,HOXB4,protein_coding,17,-1,48575507,48578350,q21.32,homeobox B4 [Source:HGNC Symbol;Acc:HGNC:5115],NA,HOXB4,3214,NM_024015
PITRM1_SIG,PITRM1,PITRM1_SIG,PITRM1,SIG,44,9.62104637739162,0.222602242980926,0.198009513214194,0.303406926500185,0.105397413285991,2.57090821064477e-19,7.69986479858403,6.52278128340325,6.42791622991971,6.83448074484915,0.406564514929433,4.71308179936235e-12,ENSG00000107959,PITRM1,protein_coding,10,-1,3137728,3172841,p15.2,pitrilysin metallopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:17663],NA,PITRM1,10531,NM_001242307;NM_001242309;NM_001347725;NM_001347726;NM_001347727;NM_001347728;NM_001347729;NM_001347730;NM_014889
SCN2A_SIG,SCN2A,SCN2A_SIG,SCN2A,SIG,35,9.61053167400543,-0.017995245358828,-0.0341131332314307,0.0349635290797238,0.0690766623111546,2.71805729868861e-19,5.95365983734804,0.599891047773109,0.419129909826744,1.19382050102545,0.774690591198707,1.8145831746482e-07,ENSG00000136531,SCN2A,protein_coding,2,1,165194993,165392310,q24.3,sodium voltage-gated channel alpha subunit 2 [Source:HGNC Symbol;Acc:HGNC:10588],Benign familial infantile epilepsy;Benign familial neonatal-infantile seizures;DRAVET SYNDROME;Early infantile epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 11;Generalized epilepsy with febrile seizures-plus;INFANTILE EPILEPTIC ENCEPHALOPATHY;Nonspecific severe ID;SEIZURES BENIGN FAMILIAL INFANTILE 3;West syndrome,SCN2A,6326,NM_001040142;NM_001040143;NM_021007
TRPC2_SIG,TRPC2,TRPC2_SIG,TRPC2,SIG,62,9.46206860062588,-0.0207012882996923,-0.0438236446574333,0.055272168304314,0.0990958129617471,1.0875337370206e-18,8.09190854360265,2.26729462330371,2.02586968798572,3.06054798220569,1.03467829421997,2.91603703302653e-13,ENSG00000182048,TRPC2,transcribed_unprocessed_pseudogene,11,1,3609901,3637559,p15.4,transient receptor potential cation channel subfamily C member 2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:12334],NA,TRPC2,NA,NA
KITLG_SIG,KITLG,KITLG_SIG,KITLG,SIG,29,9.44664300277199,-0.126290597262256,-0.141328742269959,-0.0768795493798037,0.0644491928901554,1.20778602346804e-18,5.60443159609979,0.896876866419205,0.75274461184111,1.37045427431866,0.617709662477549,1.00878456581042e-06,ENSG00000049130,KITLG,protein_coding,12,-1,88492793,88580851,q21.32,KIT ligand [Source:HGNC Symbol;Acc:HGNC:6343],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 69;Familial progressive hyper- and hypopigmentation;Familial progressive hyperpigmentation;HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION FAMILIAL PROGRESSIVE;Non-seminomatous germ cell tumor of testis;SKIN/HAIR/EYE PIGMENTATION VARIATION IN 7;Waardenburg syndrome type 2,KITLG,4254,NM_000899;NM_003994
UNC5B_SIG,UNC5B,UNC5B_SIG,UNC5B,SIG,21,9.40861316493149,-0.0216674417263782,-0.0320904716731751,0.0125796566702402,0.0446701283434152,1.60890005456673e-18,5.79456225550872,1.68823687146959,1.525073529223,2.22434499599408,0.699271466771075,3.93046637250853e-07,ENSG00000107731,UNC5B,protein_coding,10,1,71212570,71302864,q22.1,unc-5 netrin receptor B [Source:HGNC Symbol;Acc:HGNC:12568],NA,UNC5B,219699,NM_001244889;NM_170744
CNTN1_SIG,CNTN1,CNTN1_SIG,CNTN1,SIG,64,9.40815844127539,-0.136896223489398,-0.160854596955006,-0.0581758535309734,0.102678743424032,1.60890005456673e-18,7.47482161021194,0.626839429094497,0.367397107437299,1.47929277168244,1.11189566424514,2.26345863822527e-11,ENSG00000018236,CNTN1,protein_coding,12,1,40692439,41072415,q12,contactin 1 [Source:HGNC Symbol;Acc:HGNC:2171],Congenital lethal myopathy Compton-North type;MYOPATHY CONGENITAL COMPTON-NORTH,CNTN1,1272,NM_001256063;NM_001256064;NM_001843;NM_175038
MMP2_SIG,MMP2,MMP2_SIG,MMP2,SIG,106,9.40294033283338,-2.70404442262827e-05,-0.026992160228645,0.0885726388474352,0.11556479907608,1.62813062567822e-18,7.79673306928248,3.83285434145047,3.32413310711219,5.50436696856193,2.18023386144974,2.34007159866205e-12,ENSG00000087245,MMP2,protein_coding,16,1,55389700,55506691,q12.2,matrix metallopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:7166],Multicentric osteolysis nodulosis and arthropathy;Nodulosis-arthropathy-osteolysis syndrome;TORG-WINCHESTER SYNDROME,MMP2,4313,NM_001127891;NM_001302508;NM_001302509;NM_001302510;NM_004530
MMP15_SIG,MMP15,MMP15_SIG,MMP15,SIG,59,9.34684840711537,-0.0457315268498596,-0.0605391424411919,0.00292206723594653,0.0634612096771383,2.67186026879394e-18,7.53206883728888,1.92633946234518,1.64197766227649,2.86067109114234,1.21869342886586,1.52071934177227e-11,ENSG00000102996,MMP15,protein_coding,16,1,58025754,58046901,q21,matrix metallopeptidase 15 [Source:HGNC Symbol;Acc:HGNC:7161],NA,MMP15,4324,NM_002428
FBXL2_SIG,FBXL2,FBXL2_SIG,FBXL2,SIG,35,9.26465575968613,-0.105808951077717,-0.123880868168367,-0.0464297949227234,0.0774510732456438,5.59116361946164e-18,6.56575644933893,0.408040129859915,0.305088076824223,0.746311161262906,0.441223084438683,7.43557959282441e-09,ENSG00000153558,FBXL2,protein_coding,3,1,33277025,33403662,p22.3,F-box and leucine rich repeat protein 2 [Source:HGNC Symbol;Acc:HGNC:13598],NA,FBXL2,25827,NM_001171713;NM_001349316;NM_001349319;NM_001349320;NM_001349321;NM_001349322;NM_001349323;NM_001349324;NM_001349325;NM_001349326;NM_012157
RUNX1_TF,RUNX1,RUNX1_TF,RUNX1,TF,120,9.24231111748672,0.0895667881700606,0.0690789190421236,0.156884072447568,0.0878051534054443,6.66195520391395e-18,5.40597514779831,8.65594347112155,8.52788385851516,9.0767107696854,0.548826911170243,2.47394695352817e-06,ENSG00000159216,RUNX1,protein_coding,21,-1,34787801,36004667,q22.12,runt related transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471],Acute myeloid leukemia with t(8;21)(q22;q22) translocation;Chronic myeloid leukemia;Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome;Isolated delta-storage pool disease;LEUKEMIA ACUTE MYELOID;PLATELET DISORDER FAMILIAL WITH ASSOCIATED MYELOID MALIGNANCY;Precursor B-cell acute lymphoblastic leukemia,RUNX1,861,NM_001001890;NM_001122607;NM_001754
HCAR1_SIG,HCAR1,HCAR1_SIG,HCAR1,SIG,18,9.13176542725051,0.0379610727486262,0.0258203935448726,0.0778518758466736,0.052031482301801,1.80108440219729e-17,5.60998536826693,0.461013705273668,0.356450958422499,0.804577016356079,0.44812605793358,9.87376833750288e-07,ENSG00000196917,HCAR1,protein_coding,12,-1,122726076,122730843,q24.31,hydroxycarboxylic acid receptor 1 [Source:HGNC Symbol;Acc:HGNC:4532],NA,HCAR1,27198,NM_032554
BMP1_SIG,BMP1,BMP1_SIG,BMP1,SIG,91,9.11526388313045,0.213869725396976,0.192367414875933,0.284520174251833,0.0921527593759001,2.03187688066759e-17,7.92730504645548,4.82962573412995,4.64570662835595,5.4339313673874,0.788224739031448,9.77468561536962e-13,ENSG00000168487,BMP1,protein_coding,8,1,22165140,22212326,p21.3,bone morphogenetic protein 1 [Source:HGNC Symbol;Acc:HGNC:1067],High bone mass osteogenesis imperfecta;Osteogenesis imperfecta type 3;OSTEOGENESIS IMPERFECTA TYPE XIII,BMP1,649,NM_001199;NM_006129
FGFR2_SIG,FGFR2,FGFR2_SIG,FGFR2,SIG,11,-9.10000031633019,-0.108135100420089,-0.0918142219383747,-0.161760844002865,-0.0699466220644906,2.2678697889891e-17,-2.49055863438863,0.384831661191127,0.428490855485361,0.241380022795785,-0.187110832689576,0.0360078425741976,ENSG00000066468,FGFR2,protein_coding,10,-1,121478334,121598458,q26.13,fibroblast growth factor receptor 2 [Source:HGNC Symbol;Acc:HGNC:3689],ACROCEPHALOSYNDACTYLY TYPE V;Antley-Bixler syndrome;Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis;APERT SYNDROME;Beare-Stevenson Cutis Gyrata syndrome;BENT BONE DYSPLASIA SYNDROME;Crouzon disease;CROUZON SYNDROME;Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome;FAMILIAL SCAPHOCEPHALY SYNDROME;Familial scaphocephaly syndrome McGillivray type;FGFR2-related bent bone dysplasia;GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;JACKSON-WEISS SYNDROME;LACRIMO-AURICULO-DENTO-DIGITAL SYNDROME;LACRIMOAURICULODENTODIGITAL SYNDROME;PFEIFFER SYNDROME;Pfeiffer syndrome type 1;Pfeiffer syndrome type 2;Pfeiffer syndrome type 3;SAETHRE-CHOTZEN SYNDROME;Scaphocephaly maxillary retrusion and mental retardation,FGFR2,2263,NM_000141;NM_001144913;NM_001144914;NM_001144915;NM_001144916;NM_001144917;NM_001144918;NM_001144919;NM_001320654;NM_001320658;NM_022970;NM_023029
PLAG1_SIG,PLAG1,PLAG1_SIG,PLAG1,SIG,51,-9.01377457445903,-0.127877484593499,-0.107038212033077,-0.196349380149171,-0.089311168116094,4.85120072056982e-17,-4.76065185420896,1.93300867305215,2.12179667621941,1.31270523407403,-0.809091442145379,3.7094492054815e-05,ENSG00000181690,PLAG1,protein_coding,8,-1,56160909,56211324,q12.1,PLAG1 zinc finger [Source:HGNC Symbol;Acc:HGNC:9045],Pleomorphic salivary gland adenoma;SALIVARY GLAND ADENOMA PLEOMORPHIC,PLAG1,5324,NM_001114634;NM_001114635;NM_002655
LGALS3BP_SIG,LGALS3BP,LGALS3BP_SIG,LGALS3BP,SIG,29,8.99951039069763,-0.0360643924531323,-0.0581684155785293,0.0365631121017437,0.0947315276802729,5.36694054721378e-17,4.6635613622071,5.24230678616821,4.97823189282717,6.10998143571733,1.13174954289016,5.3808656707967e-05,ENSG00000108679,LGALS3BP,protein_coding,17,-1,78971238,78979947,q25.3,galectin 3 binding protein [Source:HGNC Symbol;Acc:HGNC:6564],NA,LGALS3BP,3959,NM_005567
MFGE8_SIG,MFGE8,MFGE8_SIG,MFGE8,SIG,9,8.98761118935874,-0.0429946949536182,-0.0598666557239291,0.0124417475774035,0.0723084033013326,5.81473696229546e-17,6.39517690174804,4.26873928180962,4.05816205695692,4.96063587775423,0.902473820797312,1.94796681573447e-08,ENSG00000140545,MFGE8,protein_coding,15,-1,88898683,88913381,q26.1,milk fat globule-EGF factor 8 protein [Source:HGNC Symbol;Acc:HGNC:7036],NA,MFGE8,4240,NM_001114614;NM_001310319;NM_001310320;NM_001310321;NM_005928
GALNTL6_SIG,GALNTL6,GALNTL6_SIG,GALNTL6,SIG,10,-8.9743297484434,-0.120872477619046,-0.111426872702305,-0.151908036631194,-0.0404811639288886,6.38352890601467e-17,-2.60738016914908,0.321555937510904,0.365232188020598,0.178048257264765,-0.187183930755833,0.0276817083338563,ENSG00000174473,GALNTL6,protein_coding,4,1,171812254,173041559,q34.1,polypeptide N-acetylgalactosaminyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:33844],NA,GALNTL6,442117,NM_001034845
AGPAT4_SIG,AGPAT4,AGPAT4_SIG,AGPAT4,SIG,31,8.96119166281969,0.0360200750896788,0.0215813559245729,0.0834615809178841,0.0618802249933112,7.00274843183241e-17,3.6868403690168,4.42318527015207,4.31632517237582,4.77429701998833,0.457971847612519,0.00153195986201272,ENSG00000026652,AGPAT4,protein_coding,6,-1,161129967,161274061,q26,1-acylglycerol-3-phosphate O-acyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:20885],NA,AGPAT4,56895,NM_020133
ADCY2_SIG,ADCY2,ADCY2_SIG,ADCY2,SIG,52,8.93287257316191,-0.0678221445260214,-0.0963437183356928,0.0258915979914707,0.122235316327163,8.81795222451584e-17,6.43074806183679,1.08008452673527,0.821324536681237,1.93029592262709,1.10897138594585,1.61099140626521e-08,ENSG00000078295,ADCY2,protein_coding,5,1,7396208,7830081,p15.31,adenylate cyclase 2 [Source:HGNC Symbol;Acc:HGNC:233],NA,ADCY2,108,NM_020546
LCT_SIG,LCT,LCT_SIG,LCT,SIG,73,8.92951531800396,0.0185353940705766,-0.00621307032870052,0.099851777096773,0.106064847425473,8.86244934980991e-17,8.47878407072047,1.00743196031971,0.74835715771117,1.85867774031918,1.11032058260801,1.67637987245759e-14,ENSG00000115850,LCT,protein_coding,2,-1,135787850,135837184,q21.3,lactase [Source:HGNC Symbol;Acc:HGNC:6530],Congenital lactase deficiency;LACTASE DEFICIENCY CONGENITAL,LCT,3938,NM_002299
VANGL1_SIG,VANGL1,VANGL1_SIG,VANGL1,SIG,46,8.92159948798689,0.0262633853771691,0.00281260086334026,0.103315963065464,0.100503362202124,9.28731646244111e-17,5.19487922736465,4.30882508558112,4.11986109757241,4.9297067604669,0.809845662894496,6.37360087485599e-06,ENSG00000173218,VANGL1,protein_coding,1,1,115641970,115698224,p13.1,VANGL planar cell polarity protein 1 [Source:HGNC Symbol;Acc:HGNC:15512],Caudal regression sequence;Cervical spina bifida aperta;Cervical spina bifida cystica;Cervicothoracic spina bifida aperta;Cervicothoracic spina bifida cystica;Lumbosacral spina bifida aperta;Lumbosacral spina bifida cystica;NEURAL TUBE DEFECTS;Neural tube defects susceptibility to;SACRAL DEFECT WITH ANTERIOR MENINGOCELE;Thoracolumbosacral spina bifida aperta;Thoracolumbosacral spina bifida cystica;Total spina bifida aperta;Total spina bifida cystica;Upper thoracic spina bifida aperta;Upper thoracic spina bifida cystica,VANGL1,81839,NM_001172411;NM_001172412;NM_138959
SGPP1_SIG,SGPP1,SGPP1_SIG,SGPP1,SIG,24,-8.87769956866273,-0.0198638365581062,0.00244017732832468,-0.0931484536135219,-0.0955886309418465,1.34645649753868e-16,-6.18847088158847,2.9176218195792,3.15433016890694,2.13986581464518,-1.01446435426176,5.59420185945397e-08,ENSG00000126821,SGPP1,protein_coding,14,-1,63684216,63728065,q23.2,sphingosine-1-phosphate phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:17720],NA,SGPP1,81537,NM_030791
RASGRF1_SIG,RASGRF1,RASGRF1_SIG,RASGRF1,SIG,49,8.87495527071554,-0.0702038108502271,-0.0843112011538713,-0.0238509569953961,0.0604602441584751,1.34797961942136e-16,6.81981742163727,0.70749259554422,0.558309175841148,1.19766668885431,0.639357513013166,1.7204430818846e-09,ENSG00000058335,RASGRF1,protein_coding,15,-1,78959947,79090773,q25.1,Ras protein specific guanine nucleotide releasing factor 1 [Source:HGNC Symbol;Acc:HGNC:9875],NA,RASGRF1,5923,NM_001145648;NM_002891;NM_153815
PTGFR_SIG,PTGFR,PTGFR_SIG,PTGFR,SIG,59,8.83593109729597,-0.0714176726852858,-0.0860790788355309,-0.0232444810487664,0.0628345977867645,1.8691704127447e-16,6.66433710638532,0.495225349134573,0.321312195743619,1.06665428170485,0.74534208596123,4.27570705252545e-09,ENSG00000122420,PTGFR,protein_coding,1,1,78303884,78540701,p31.1,prostaglandin F receptor [Source:HGNC Symbol;Acc:HGNC:9600],NA,PTGFR,5737,NM_000959;NM_001039585
DLG5_SIG,DLG5,DLG5_SIG,DLG5,SIG,56,8.8185305122133,-0.0616838841564084,-0.0792079320761837,-0.00410486956286089,0.0751030625133227,2.13516610047982e-16,6.377437115015,4.06691172537814,3.89156677284261,4.64304514085201,0.751478368009404,2.12083673968271e-08,ENSG00000151208,DLG5,protein_coding,10,-1,77790791,77926755,q22.3,discs large MAGUK scaffold protein 5 [Source:HGNC Symbol;Acc:HGNC:2904],NA,DLG5,9231,NM_004747
TNFRSF4_SIG,TNFRSF4,TNFRSF4_SIG,TNFRSF4,SIG,70,8.79400086280084,-0.00465545532516447,-0.0269188446129342,0.0684956809060791,0.0954145255190134,2.59944516611434e-16,7.96562148319449,1.98562327488848,1.69171296290803,2.95132858568137,1.25961562277333,7.508597273813e-13,ENSG00000186827,TNFRSF4,protein_coding,1,-1,1211340,1214153,p36.33,TNF receptor superfamily member 4 [Source:HGNC Symbol;Acc:HGNC:11918],Combined immunodeficiency due to OX40 deficiency;IMMUNODEFICIENCY 16,TNFRSF4,7293,NM_003327
HOXB4_SIG,HOXB4,HOXB4_SIG,HOXB4,SIG,165,8.77718147240285,-0.0300830936840499,-0.0547360808407374,0.0509195784022092,0.105655659242946,2.95479084957862e-16,6.57255448367412,3.18524340406815,2.84336762224376,4.3085495443483,1.46518192210454,7.14874419343859e-09,ENSG00000182742,HOXB4,protein_coding,17,-1,48575507,48578350,q21.32,homeobox B4 [Source:HGNC Symbol;Acc:HGNC:5115],NA,HOXB4,3214,NM_024015
COL4A5_SIG,COL4A5,COL4A5_SIG,COL4A5,SIG,85,8.76279343185544,-0.0517162005732354,-0.0775957389276086,0.0333165683054193,0.110912307233028,3.28760017976913e-16,6.00736122573132,2.76697646686942,2.3541556388082,4.12338775907057,1.76923212026237,1.36275522294594e-07,ENSG00000188153,COL4A5,protein_coding,X,1,108439844,108697545,q22.3,collagen type IV alpha 5 chain [Source:HGNC Symbol;Acc:HGNC:2207],ALPORT SYNDROME X-LINKED;X-linked Alport syndrome;X-linked diffuse leiomyomatosis -  Alport syndrome,COL4A5,1287,NM_000495;NM_033380
DEGS2_SIG,DEGS2,DEGS2_SIG,DEGS2,SIG,35,8.75045379218691,0.0369692964593292,0.00920494219612271,0.128195031895579,0.118990089699457,3.56726741623993e-16,6.22123542131466,1.31823356602886,1.17937496911846,1.77448324159161,0.595108272473154,4.6547410356659e-08,ENSG00000168350,DEGS2,protein_coding,14,-1,100143957,100159645,q32.2,delta 4-desaturase, sphingolipid 2 [Source:HGNC Symbol;Acc:HGNC:20113],NA,DEGS2,123099,NM_206918
QPRT_SIG,QPRT,QPRT_SIG,QPRT,SIG,83,8.74898268168763,0.105006480650752,0.0763739396461071,0.199084829666012,0.122710890019905,3.56726741623993e-16,7.18939320298921,3.79376723975676,3.55128948270449,4.59047987007137,1.03919038736688,1.65136635468243e-10,ENSG00000103485,QPRT,protein_coding,16,1,29679008,29698699,p11.2,quinolinate phosphoribosyltransferase [Source:HGNC Symbol;Acc:HGNC:9755],NA,QPRT,23475,NM_001318249;NM_001318250;NM_014298
PFKFB2_SIG,PFKFB2,PFKFB2_SIG,PFKFB2,SIG,44,-8.73575474142557,0.074470278250581,0.0977175526935493,-0.00191362349060063,-0.0996311761841501,3.93187587382204e-16,-6.59857922092016,3.96863892095587,4.22146522004944,3.13792393821985,-1.08354128182959,6.15585637493369e-09,ENSG00000123836,PFKFB2,protein_coding,1,1,207034366,207081024,q32.1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 [Source:HGNC Symbol;Acc:HGNC:8873],NA,PFKFB2,5208,NM_001018053;NM_006212
USP54_SIG,USP54,USP54_SIG,USP54,SIG,116,8.68754119261379,-0.0248791774112464,-0.0502280413262186,0.0584099468808049,0.108637988207023,5.90096164964701e-16,6.92791963730404,3.71566889844984,3.52021449043693,4.35787623906369,0.837661748626757,8.70811952762586e-10,ENSG00000166348,USP54,protein_coding,10,-1,73497538,73625953,q22.2,ubiquitin specific peptidase 54 [Source:HGNC Symbol;Acc:HGNC:23513],NA,USP54,159195,NM_001320437;NM_001350995;NM_152586
CRADD_SIG,CRADD,CRADD_SIG,CRADD,SIG,12,8.66200802010088,0.135970779450419,0.119518842258985,0.190027144507991,0.0705083022490063,7.24586926154962e-16,1.93239098913347,2.58007073130497,2.54654524368233,2.69022590492222,0.143680661239888,0.109770928470171,ENSG00000169372,CRADD,protein_coding,12,1,93677375,93894840,q22,CASP2 and RIPK1 domain containing adaptor with death domain [Source:HGNC Symbol;Acc:HGNC:2340],Autosomal recessive non-syndromic intellectual disability;Megalencephaly with Variant Lissencephaly;MENTAL RETARDATION AUTOSOMAL RECESSIVE 34 WITH VARIANT LISSENCEPHALY;MENTAL RETARDATION NON-SYNDROMIC,CRADD,8738,NM_001320099;NM_001320100;NM_001320101;NM_001330126;NM_003805
CYP4F11_SIG,CYP4F11,CYP4F11_SIG,CYP4F11,SIG,10,8.65474006480611,-0.0952766140651175,-0.108812983360995,-0.0507999720929488,0.0580130112680462,7.57979742037983e-16,5.2382844055168,0.276803931672836,0.208323500983864,0.501811061079457,0.293487560095594,5.2058134588686e-06,ENSG00000171903,CYP4F11,protein_coding,19,-1,15912367,15934867,p13.12,cytochrome P450 family 4 subfamily F member 11 [Source:HGNC Symbol;Acc:HGNC:13265],NA,CYP4F11,57834,NM_001128932;NM_021187
NEK5_SIG,NEK5,NEK5_SIG,NEK5,SIG,96,8.6359684276772,0.0871663152913516,0.0574095311932021,0.184938605899557,0.127529074706355,8.77179560812977e-16,8.61326399209772,0.686888233468711,0.545439463841885,1.15164847652828,0.606209012686398,6.00607374586587e-15,ENSG00000197168,NEK5,protein_coding,13,-1,52033611,52129092,q14.3,NIMA related kinase 5 [Source:HGNC Symbol;Acc:HGNC:7748],NA,NEK5,341676,NM_199289
NFIX_TF,NFIX,NFIX_TF,NFIX,TF,166,8.61502263964475,0.0141932181625533,-0.00314576146873182,0.0711641512367757,0.0743099127055076,1.03455647804755e-15,8.08370832275222,5.69664504065981,5.40374814616291,6.65902055114965,1.25527240498675,3.05269912403244e-13,ENSG00000008441,NFIX,protein_coding,19,1,12995608,13098796,p13.13,nuclear factor I X [Source:HGNC Symbol;Acc:HGNC:7788],19p13.3 microduplication syndrome;Malan overgrowth syndrome;MARSHALL-SMITH SYNDROME;Sotos-Like syndrome;SOTOS SYNDROME 2,NFIX,4784,NM_001271043;NM_001271044;NM_001365982;NM_002501
RNF220_SIG,RNF220,RNF220_SIG,RNF220,SIG,124,8.57921086885935,0.127534993657924,0.103824730753678,0.205440143200446,0.101615412446768,1.38848190862787e-15,7.04722807710903,7.3684605817156,7.24773662934176,7.76512499665823,0.517388367316466,4.04673917332453e-10,ENSG00000187147,RNF220,protein_coding,1,1,44405194,44651724,p34.1,ring finger protein 220 [Source:HGNC Symbol;Acc:HGNC:25552],NA,RNF220,55182,NM_001319956;NM_001319957;NM_018150
NEDD4L_SIG,NEDD4L,NEDD4L_SIG,NEDD4L,SIG,45,-8.56982334527856,-0.0930575752293199,-0.078234535459218,-0.141761848759654,-0.0635273133004365,1.48049962655363e-15,-5.54019207333955,2.4006376696722,2.5899840109754,1.77849969110452,-0.811484319870885,1.32691785605845e-06,ENSG00000049759,NEDD4L,protein_coding,18,1,58044226,58401540,q21.31,neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:7728],Periventricular nodular heterotopia;PERIVENTRICULAR NODULAR HETEROTOPIA 7;Periventricular nodular heterotopia with ID cleft palate and 2.3 toe syndactyly,NEDD4L,23327,NM_001144964;NM_001144965;NM_001144966;NM_001144967;NM_001144968;NM_001144969;NM_001144970;NM_001144971;NM_001243960;NM_015277
FOXC1_TF,FOXC1,FOXC1_TF,FOXC1,TF,241,8.55666438874131,-0.0185511848731377,-0.0312529179423885,0.0231830809258289,0.0544359988682173,1.63144464260758e-15,6.17473602081735,2.83108472301879,2.40634508739332,4.22665781150248,1.82031272410916,5.97276706295042e-08,ENSG00000054598,FOXC1,protein_coding,6,1,1609915,1613897,p25.3,forkhead box C1 [Source:HGNC Symbol;Acc:HGNC:3800],ANTERIOR SEGMENT DYSGENESIS 3;Axenfeld-Rieger syndrome;Axenfeld-Rieger syndrome type 3;Axenfeld anomaly;IRIDOGONIODYSGENESIS ANOMALY;Isolated aniridia;PETERS ANOMALY;RIEGER ANOMALY,FOXC1,2296,NM_001453
HOXA7_TF,HOXA7,HOXA7_TF,HOXA7,TF,314,8.53972346789373,0.0358652202976462,0.0207684771173466,0.0854688050329164,0.0647003279155698,1.85782047533978e-15,6.4475892815624,3.30372431479251,2.93491834182328,4.51551536883425,1.58059702701097,1.47458545596144e-08,ENSG00000122592,HOXA7,protein_coding,7,-1,27153716,27157936,p15.2,homeobox A7 [Source:HGNC Symbol;Acc:HGNC:5108],NA,HOXA7,3204,NM_006896
SEMA3A_SIG,SEMA3A,SEMA3A_SIG,SEMA3A,SIG,38,8.50937208772236,-0.0756271059680348,-0.089085922717857,-0.0314052795043334,0.0576806432135237,2.37518448888019e-15,6.39016026460652,0.753770968237277,0.61507341192116,1.2094915104188,0.594418098497642,1.99177082787012e-08,ENSG00000075213,SEMA3A,protein_coding,7,-1,83955777,84492724,q21.11,semaphorin 3A [Source:HGNC Symbol;Acc:HGNC:10723],Hypogonadotropic hypogonadism 16 with or without anosmia;Kallmann Syndrome,SEMA3A,10371,NM_006080
ST8SIA6_SIG,ST8SIA6,ST8SIA6_SIG,ST8SIA6,SIG,81,8.49472360671055,-0.0366165054485479,-0.062311318996336,0.0478093104941845,0.11012062949052,2.63744143657009e-15,5.76699232649029,3.3651869351258,3.08952708432059,4.27092644491434,1.18139936059375,4.4949189924419e-07,ENSG00000148488,ST8SIA6,protein_coding,10,-1,17315421,17454595,p12.33,ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:23317],NA,ST8SIA6,338596,NM_001004470;NM_001345961
MDH1B_SIG,MDH1B,MDH1B_SIG,MDH1B,SIG,18,8.49347201163974,-0.0552788223206597,-0.0747128815335134,0.00857594366443119,0.0832888251979447,2.63744143657009e-15,7.08051338059981,0.303832999688752,0.253560439977838,0.469014267310327,0.215453827332489,3.27988181371454e-10,ENSG00000138400,MDH1B,protein_coding,2,-1,206737763,206765328,q33.3,malate dehydrogenase 1B [Source:HGNC Symbol;Acc:HGNC:17836],NA,MDH1B,130752,NM_001039845;NM_001282940;NM_001330223;NM_001330224;NM_001330225;NM_001330226
LRGUK_SIG,LRGUK,LRGUK_SIG,LRGUK,SIG,35,8.4353324178306,-0.0506205537215537,-0.0610295026161824,-0.0164197216392023,0.0446097809769802,4.22920287399321e-15,4.47138421535526,0.612987495747169,0.558535707944615,0.791900512812702,0.233364804868087,0.00011009776063823,ENSG00000155530,LRGUK,protein_coding,7,1,134127299,134264591,q33,leucine rich repeats and guanylate kinase domain containing [Source:HGNC Symbol;Acc:HGNC:21964],NA,LRGUK,136332,NM_144648
HOXA5_TF,HOXA5,HOXA5_TF,HOXA5,TF,92,8.43478850620838,-0.0728400365537108,-0.0882055184213397,-0.0223534532743588,0.065852065146981,4.22920287399321e-15,6.26694536476768,3.63341471461351,3.24654742746487,4.90455008667335,1.65800265920848,3.74006927271106e-08,ENSG00000106004,HOXA5,protein_coding,7,-1,27141052,27143681,p15.2,homeobox A5 [Source:HGNC Symbol;Acc:HGNC:5106],NA,HOXA5,3202,NM_019102
ADRB1_SIG,ADRB1,ADRB1_SIG,ADRB1,SIG,30,8.42901404391658,0.0537048009768401,0.0409641543379573,0.0955669256474547,0.0546027713094972,4.37585773254926e-15,3.73209716588793,1.77565270039762,1.62398962163971,2.27397424488788,0.649984623248175,0.00132901276762893,ENSG00000043591,ADRB1,protein_coding,10,1,114044056,114046908,q25.3,adrenoceptor beta 1 [Source:HGNC Symbol;Acc:HGNC:285],RESTING HEART RATE VARIATION IN,ADRB1,153,NM_000684
HOXB6_SIG,HOXB6,HOXB6_SIG,HOXB6,SIG,127,8.42214433920069,-0.0440266867212153,-0.0691729524656803,0.038596757867741,0.107769710333421,4.50455149104669e-15,6.34352703916431,2.44846615554767,2.06158225084075,3.71965612815609,1.65807387731534,2.53879082934202e-08,ENSG00000108511,HOXB6,protein_coding,17,-1,48595751,48604992,q21.32,homeobox B6 [Source:HGNC Symbol;Acc:HGNC:5117],NA,HOXB6,3216,NM_018952
USP40_SIG,USP40,USP40_SIG,USP40,SIG,68,8.42212517032397,0.106624266532968,0.0815515263368278,0.189006127177429,0.107454600840601,4.50455149104669e-15,5.34216848785457,4.59846344424019,4.47566011379988,5.00196010140121,0.526299987601338,3.30675185006628e-06,ENSG00000085982,USP40,protein_coding,2,-1,233475520,233566782,q37.1,ubiquitin specific peptidase 40 [Source:HGNC Symbol;Acc:HGNC:20069],NA,USP40,55230,NM_001365479;NM_018218
SFRP4_SIG,SFRP4,SFRP4_SIG,SFRP4,SIG,21,8.39887727274283,0.0540978617321198,0.0311219145684163,0.129590259555717,0.098468344987301,5.41247791284684e-15,5.2450122514988,0.323060633704722,0.258918607040033,0.533813007031558,0.274894399991525,5.07650405932999e-06,ENSG00000106483,SFRP4,protein_coding,7,-1,37905932,38025695,p14.1,secreted frizzled related protein 4 [Source:HGNC Symbol;Acc:HGNC:10778],PYLE DISEASE,SFRP4,6424,NM_003014
AKT3_SIG,AKT3,AKT3_SIG,AKT3,SIG,50,-8.39701473556035,-0.0380920938155327,-0.0222313095764204,-0.090206099172616,-0.0679747895961958,5.42043278403123e-15,-4.28855648155267,3.50791688349565,3.69427106094742,2.89561030043984,-0.798660760507584,0.000213459564272927,ENSG00000117020,AKT3,protein_coding,1,-1,243488233,243851079,q44,AKT serine/threonine kinase 3 [Source:HGNC Symbol;Acc:HGNC:393],Hemimegalencephaly;Hemimegalencephaly AKT3;MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,AKT3,10000,NM_001206729;NM_005465;NM_181690
GNG2_SIG,GNG2,GNG2_SIG,GNG2,SIG,59,-8.39072187775143,0.0150348217323501,0.0409360771403423,-0.0700693031796242,-0.111005380319967,5.63807239185635e-15,-8.0220244284453,6.36918357384608,6.63726146530623,5.48835621619129,-1.14890524911493,4.84780331677996e-13,ENSG00000186469,GNG2,protein_coding,14,1,51826195,51979342,q22.1,G protein subunit gamma 2 [Source:HGNC Symbol;Acc:HGNC:4404],NA,GNG2,54331,NM_001243773;NM_001243774;NM_053064
PLAG1_TF,PLAG1,PLAG1_TF,PLAG1,TF,142,-8.3724489739836,-0.103610788045744,-0.089577035845774,-0.14972168813136,-0.0601446522855863,6.49370963660091e-15,-4.76065185420896,1.93300867305215,2.12179667621941,1.31270523407403,-0.809091442145379,3.7094492054815e-05,ENSG00000181690,PLAG1,protein_coding,8,-1,56160909,56211324,q12.1,PLAG1 zinc finger [Source:HGNC Symbol;Acc:HGNC:9045],Pleomorphic salivary gland adenoma;SALIVARY GLAND ADENOMA PLEOMORPHIC,PLAG1,5324,NM_001114634;NM_001114635;NM_002655
HOXA6_TF,HOXA6,HOXA6_TF,HOXA6,TF,209,8.36981857667326,-0.0213875211156982,-0.0393779266156021,0.0377238112411291,0.0771017378567312,6.5493504728145e-15,6.97464667691206,2.40840874568538,2.06944518271268,3.52214616688141,1.45270098416873,6.54462479277416e-10,ENSG00000106006,HOXA6,protein_coding,7,-1,27145396,27150603,p15.2,homeobox A6 [Source:HGNC Symbol;Acc:HGNC:5107],NA,HOXA6,3203,NM_024014
HOXB6_TF,HOXB6,HOXB6_TF,HOXB6,TF,94,8.36802199927211,0.0143940426059327,-0.000307160752494288,0.0626979964979069,0.0630051572504013,6.56009169353156e-15,6.34352703916431,2.44846615554767,2.06158225084075,3.71965612815609,1.65807387731534,2.53879082934202e-08,ENSG00000108511,HOXB6,protein_coding,17,-1,48595751,48604992,q21.32,homeobox B6 [Source:HGNC Symbol;Acc:HGNC:5117],NA,HOXB6,3216,NM_018952
ORAI1_SIG,ORAI1,ORAI1_SIG,ORAI1,SIG,62,8.35756693065688,0.135165528483374,0.117447732556792,0.193381143670714,0.0759334111139219,7.07262645504401e-15,6.42681469530007,5.87314953811208,5.74654999433102,6.28911946767843,0.542569473347406,1.64408110479555e-08,ENSG00000276045,ORAI1,protein_coding,12,1,121626550,121642677,q24.31,ORAI calcium release-activated calcium modulator 1 [Source:HGNC Symbol;Acc:HGNC:25896],Combined immunodeficiency due to ORAI1 deficiency;IMMUNODEFICIENCY 9;Myopathy tubular aggregate 2;Stormorken-Sjaastad-Langslet syndrome;Tubular-Aggregate Myopathy,ORAI1,84876,NM_032790
WT1_TF,WT1,WT1_TF,WT1,TF,181,8.32926694135728,0.0339498257260265,0.0101108031551597,0.112278042744589,0.102167239589429,8.86761677894139e-15,5.73065065737986,2.97849573209965,2.6975938194225,3.90145915946745,1.20386534004495,5.43988883171934e-07,ENSG00000184937,WT1,protein_coding,11,-1,32387775,32435885,p13,Wilms tumor 1 [Source:HGNC Symbol;Acc:HGNC:12796],46XY complete gonadal dysgenesis;46XY partial gonadal dysgenesis;ANIRIDIA 1;DENYS-DRASH SYNDROME;Desmoplastic small round cell tumor;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;FRASIER SYNDROME;Frasier Syndrome Frasier syndrome Frasier syndrome;MEACHAM SYNDROME;MESOTHELIOMA MALIGNANT;Nephroblastoma;NEPHROTIC SYNDROME TYPE 4;Sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;WAGR syndrome;WILMS TUMOR 1;WILMS TUMOR ANIRIDIA GENITOURINARY ANOMALIES AND MENTAL RETARDATIONSYNDROME,WT1,7490,NM_000378;NM_001198551;NM_001198552;NM_024424;NM_024426
NPHP1_SIG,NPHP1,NPHP1_SIG,NPHP1,SIG,52,8.27018423480748,-0.0460738500270609,-0.0677719188141334,0.0252198045590346,0.0929917233731679,1.43913856331797e-14,5.6611090661208,0.532190378641926,0.456227897118811,0.781781389360734,0.325553492241923,7.71827974711999e-07,ENSG00000144061,NPHP1,protein_coding,2,-1,110122311,110205066,q13,nephrocystin 1 [Source:HGNC Symbol;Acc:HGNC:7905],Bardet-Biedl syndrome;JOUBERT SYNDROME 4;JOUBERT SYNDROME TYPE 4;Joubert syndrome with renal defect;Juvenile nephronophthisis;NEPHRONOPHTHISIS 1;NEPHRONOPHTHISIS TYPE 1;Senior-Loken syndrome;SENIOR-LOKEN SYNDROME 1;SENIOR-LOKEN SYNDROME TYPE 1,NPHP1,4867,NM_000272;NM_001128178;NM_001128179;NM_207181
HOXA9_TF,HOXA9,HOXA9_TF,HOXA9,TF,195,8.2617244595234,-0.01913850565247,-0.0355570539071853,0.0348081528987375,0.0703652068059226,1.52510750062603e-14,5.11060268472396,4.76336388729663,4.42921511973099,5.86128126644085,1.43206614670986,9.07637087829975e-06,ENSG00000078399,HOXA9,protein_coding,7,-1,27162438,27175180,p15.2,homeobox A9 [Source:HGNC Symbol;Acc:HGNC:5109],NA,HOXA9,3205,NM_152739
RHPN1_SIG,RHPN1,RHPN1_SIG,RHPN1,SIG,49,8.25014177230628,0.0638813817238046,0.0410144313853277,0.139015647121657,0.0980012157363298,1.6591680191101e-14,6.61958341476681,5.16696589393149,4.90930778131922,6.01355683537183,1.10424905405262,5.48411579084716e-09,ENSG00000158106,RHPN1,protein_coding,8,1,143368876,143384221,q24.3,rhophilin Rho GTPase binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19973],NA,RHPN1,114822,NM_052924
IL12A_SIG,IL12A,IL12A_SIG,IL12A,SIG,54,8.23912639166853,-0.0370410431783501,-0.0609205007103333,0.0414200315695947,0.102340532279928,1.79369613586914e-14,6.40168008022984,2.22392332962847,2.04935294160781,2.79751174741063,0.748158805802823,1.89703150239722e-08,ENSG00000168811,IL12A,protein_coding,3,1,159988835,159996019,q25.33,interleukin 12A [Source:HGNC Symbol;Acc:HGNC:5969],Behcet disease;Primary biliary cholangitis,IL12A,3592,NM_000882;NM_001354582;NM_001354583
PDGFD_SIG,PDGFD,PDGFD_SIG,PDGFD,SIG,90,8.2378284546918,-0.0650849051024755,-0.0877627814419262,0.00942811715571991,0.0971908985976463,1.79369613586914e-14,5.8505346397763,2.50374382672802,2.27350715165433,3.26023575911299,0.986728607458663,3.01617921897979e-07,ENSG00000170962,PDGFD,protein_coding,11,-1,103907189,104164379,q22.3,platelet derived growth factor D [Source:HGNC Symbol;Acc:HGNC:30620],NA,PDGFD,80310,NM_025208;NM_033135
IGF2BP2_SIG,IGF2BP2,IGF2BP2_SIG,IGF2BP2,SIG,35,8.22944843942881,0.102990749286487,0.0765995626705857,0.189704648167305,0.113105085496719,1.90027012739798e-14,3.12197991775792,6.35441265308085,6.25284845107491,6.68812360252894,0.435275151454023,0.00785874743846464,ENSG00000073792,IGF2BP2,protein_coding,3,-1,185643739,185825056,q27.2,insulin like growth factor 2 mRNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:28867],DIABETES MELLITUS NONINSULIN-DEPENDENT,IGF2BP2,10644,NM_001007225;NM_001291869;NM_001291872;NM_001291873;NM_001291874;NM_001291875;NM_006548
COL6A3_SIG,COL6A3,COL6A3_SIG,COL6A3,SIG,37,-8.19096958327857,-0.17419106428391,-0.157250441507156,-0.229853110550389,-0.0726026690432337,2.5866177097706e-14,-5.09935857116858,1.15228599869,1.3036498446734,0.654947647601689,-0.648702197071714,9.43345968948034e-06,ENSG00000163359,COL6A3,protein_coding,2,-1,237324003,237414375,q37.3,collagen type VI alpha 3 chain [Source:HGNC Symbol;Acc:HGNC:2213],BETHLEM MYOPATHY;Bethlem myopathy 1;Congenital muscular dystrophy Ullrich type;DYSTONIA 27;Primary dystonia DYT27 type;ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1,COL6A3,1293,NM_004369;NM_057164;NM_057165;NM_057166;NM_057167
PROC_SIG,PROC,PROC_SIG,PROC,SIG,29,8.18716801036243,0.0357199568107856,0.016691091585977,0.0982433711208709,0.0815522795348938,2.63783256658299e-14,7.89294173618454,0.547919222435699,0.43394988078413,0.922389916433713,0.488440035649583,1.20361359126998e-12,ENSG00000115718,PROC,protein_coding,2,1,127418427,127429246,q14.3,protein C, inactivator of coagulation factors Va and VIIIa [Source:HGNC Symbol;Acc:HGNC:9451],Severe hereditary thrombophilia due to congenital protein C deficiency;THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY AUTOSOMAL DOMINANT;THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY AUTOSOMAL RECESSIVE,PROC,5624,NM_000312
NEK10_SIG,NEK10,NEK10_SIG,NEK10,SIG,45,8.17145754844756,-0.0703563212354038,-0.0896193602913989,-0.00706347862284847,0.0825558816685502,2.96978962491617e-14,4.74148135810826,0.848402841923046,0.684683335937693,1.3863383615892,0.701655025651509,4.00092892176948e-05,ENSG00000163491,NEK10,protein_coding,3,-1,27110085,27369460,p24.1,NIMA related kinase 10 [Source:HGNC Symbol;Acc:HGNC:18592],NA,NEK10,152110,NM_001031741;NM_001304384;NM_152534;NM_199347
FADS3_SIG,FADS3,FADS3_SIG,FADS3,SIG,28,8.15557357910026,-0.0381399980572839,-0.0499236219491393,0.000577623301669834,0.0505012452508092,3.31969169143523e-14,5.98551251447476,3.85877811218393,3.71727687069637,4.32371076278592,0.606433892089548,1.52986293661824e-07,ENSG00000221968,FADS3,protein_coding,11,-1,61873519,61892051,q12.2,fatty acid desaturase 3 [Source:HGNC Symbol;Acc:HGNC:3576],NA,FADS3,3995,NM_021727
SDSL_SIG,SDSL,SDSL_SIG,SDSL,SIG,56,8.15520167571773,-0.0214290572454498,-0.0508968182308465,0.075393585992282,0.126290404223129,3.31969169143523e-14,6.64375263480033,2.77675139900002,2.58814866560322,3.39644609444663,0.808297428843408,4.80226844674853e-09,ENSG00000139410,SDSL,protein_coding,12,1,113422380,113438276,q24.13,serine dehydratase like [Source:HGNC Symbol;Acc:HGNC:30404],NA,SDSL,113675,NM_001304993;NM_138432
AGTPBP1_SIG,AGTPBP1,AGTPBP1_SIG,AGTPBP1,SIG,47,-8.1481411260601,0.124400198515908,0.143767844623649,0.0607636470190428,-0.083004197604606,3.47933209174767e-14,-6.05134409041185,6.91770887337932,7.04898715660535,6.48636594277949,-0.562621213825855,1.08621137364387e-07,ENSG00000135049,AGTPBP1,protein_coding,9,-1,85546539,85742029,q21.33,ATP/GTP binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17258],NA,AGTPBP1,23287,NM_001286715;NM_001286717;NM_001330701;NM_015239
AQP3_SIG,AQP3,AQP3_SIG,AQP3,SIG,45,8.12745586128344,-0.0577197679807838,-0.0683059773134775,-0.0229365087447901,0.0453694685686876,4.08100649007137e-14,5.60014965898251,3.39732555163079,3.20336382734368,4.0346283600027,0.831264532659013,1.02966901047149e-06,ENSG00000165272,AQP3,protein_coding,9,-1,33441156,33447596,p13.3,aquaporin 3 (Gill blood group) [Source:HGNC Symbol;Acc:HGNC:636],GIL BLOOD GROUP,AQP3,360,NM_001318144;NM_004925
ARHGAP22_SIG,ARHGAP22,ARHGAP22_SIG,ARHGAP22,SIG,104,8.12164815633495,-0.027170208938025,-0.0535790681849525,0.0596017571590226,0.113180825343975,4.23358859683055e-14,6.37773686814723,3.47032082117424,3.19789021168077,4.36544996665277,1.167559754972,2.12083673968271e-08,ENSG00000128805,ARHGAP22,protein_coding,10,-1,48446034,48656265,q11.23,Rho GTPase activating protein 22 [Source:HGNC Symbol;Acc:HGNC:30320],NA,ARHGAP22,58504,NM_001256024;NM_001256025;NM_001256026;NM_001347735;NM_001347738;NM_021226
NRGN_SIG,NRGN,NRGN_SIG,NRGN,SIG,23,-8.11576539455634,0.0177967133859354,0.0477560619638566,-0.0806411462272342,-0.128397208191091,4.3949875313767e-14,-5.0691086825855,4.72095454739211,4.96013790931214,3.93506635822629,-1.02507155108585,1.06381817249296e-05,ENSG00000154146,NRGN,protein_coding,11,1,124739942,124747210,q24.2,neurogranin [Source:HGNC Symbol;Acc:HGNC:8000],NA,NRGN,4900,NM_001126181;NM_006176
HOXA4_TF,HOXA4,HOXA4_TF,HOXA4,TF,58,8.11181923806952,-0.0497071263128378,-0.0698919064467334,0.0166142941271052,0.0865062005738385,4.47926744368031e-14,6.28223743103136,1.43295655097186,1.24310518084615,2.05675390995634,0.813648729110192,3.46431711914993e-08,ENSG00000197576,HOXA4,protein_coding,7,-1,27128507,27130799,p15.2,homeobox A4 [Source:HGNC Symbol;Acc:HGNC:5105],NA,HOXA4,3201,NM_002141
SLC47A1_SIG,SLC47A1,SLC47A1_SIG,SLC47A1,SIG,29,-8.11046380219545,-0.0134457651955957,0.00656531184697852,-0.0791964469069111,-0.0857617587538896,4.47926744368031e-14,-4.39549748237533,0.847981139747088,0.963686269058373,0.467807143438579,-0.495879125619794,0.000145303988656873,ENSG00000142494,SLC47A1,protein_coding,17,1,19495385,19579034,p11.2,solute carrier family 47 member 1 [Source:HGNC Symbol;Acc:HGNC:25588],NA,SLC47A1,55244,NM_018242
PRDM16_SIG,PRDM16,PRDM16_SIG,PRDM16,SIG,130,8.10951812864094,-0.0316167650261438,-0.0524508999877377,0.036838249847665,0.0892891498354026,4.47926744368031e-14,4.55821766210588,2.24869631855911,1.95650508301276,3.20875323535426,1.2522481523415,8.05297823437726e-05,ENSG00000142611,PRDM16,protein_coding,1,1,3069168,3438621,p36.32,PR/SET domain 16 [Source:HGNC Symbol;Acc:HGNC:14000],1p36 deletion syndrome;Familial isolated dilated cardiomyopathy;Left ventricular noncompaction;LEFT VENTRICULAR NONCOMPACTION 8,PRDM16,63976,NM_022114;NM_199454
SCN9A_SIG,SCN9A,SCN9A_SIG,SCN9A,SIG,103,8.09317858562726,-0.0471870103861514,-0.0593701914575584,-0.00715655829438535,0.052213633163173,5.06933369593366e-14,6.37579003696612,2.20383227621028,1.82766649586542,3.43980555448626,1.61213905862084,2.12083673968271e-08,ENSG00000169432,SCN9A,protein_coding,2,-1,166195185,166376001,q24.3,sodium voltage-gated channel alpha subunit 9 [Source:HGNC Symbol;Acc:HGNC:10597],Channelopathy-associated congenital insensitivity to pain;DRAVET SYNDROME;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 6;ERYTHERMALGIA PRIMARY;Erythromelalgia;Generalized epilepsy with febrile seizures-plus;GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS TYPE 7;Hereditary sensory and autonomic neuropathy type 2;Indifference to pain congenital autosomal recessive;NEUROPATHY HEREDITARY SENSORY AND AUTONOMIC TYPE IIA;PAROXYSMAL EXTREME PAIN DISORDER;Primary erythromelalgia;Sodium channelopathy-related small fiber neuropathy,SCN9A,6335,NM_001365536;NM_002977
MRPL41_SIG,MRPL41,MRPL41_SIG,MRPL41,SIG,39,8.09017426061517,0.130446407179391,0.117051975944049,0.174456681238374,0.0574047052943254,5.14182892931587e-14,4.92817264813757,4.32687682014958,4.23866999967861,4.61669923026852,0.37802923058991,1.89932120254556e-05,ENSG00000182154,MRPL41,protein_coding,9,1,137551879,137552555,q34.3,mitochondrial ribosomal protein L41 [Source:HGNC Symbol;Acc:HGNC:14492],NA,MRPL41,64975,NM_032477
NRG4_SIG,NRG4,NRG4_SIG,NRG4,SIG,103,8.07706200115843,-0.0098367325357663,-0.0338304540461448,0.0689997809983346,0.102830235044479,5.66675364337021e-14,4.93222749261799,2.54448177749947,2.31635449217017,3.29404285786717,0.977688365697003,1.86626468511567e-05,ENSG00000169752,NRG4,protein_coding,15,-1,75935969,76059795,q24.2,neuregulin 4 [Source:HGNC Symbol;Acc:HGNC:29862],NA,NRG4,145957,NM_138573
TAOK3_SIG,TAOK3,TAOK3_SIG,TAOK3,SIG,39,8.07125972257302,0.174757518050898,0.16091431432268,0.220242330300759,0.0593280159780787,5.88205702130369e-14,3.29342914162481,7.45447253850556,7.41168607144805,7.59505664455167,0.183370573103626,0.00489833683986964,ENSG00000135090,TAOK3,protein_coding,12,-1,118149801,118372907,q24.23,TAO kinase 3 [Source:HGNC Symbol;Acc:HGNC:18133],NA,TAOK3,51347,NM_001346487;NM_001346488;NM_001346489;NM_001346490;NM_001346491;NM_001346492;NM_001346493;NM_001346494;NM_001346495;NM_001346496;NM_001346497;NM_016281
RORB_TF,RORB,RORB_TF,RORB,TF,108,-8.05123026409016,-0.095278907116156,-0.0868499874053688,-0.122973929023028,-0.0361239416176593,6.85946893355288e-14,-3.98991575001187,0.374996461225102,0.459763858650911,0.0964750125403012,-0.36328884611061,0.000587291869055862,ENSG00000198963,RORB,protein_coding,9,1,74497335,74693177,q21.13,RAR related orphan receptor B [Source:HGNC Symbol;Acc:HGNC:10259],NA,RORB,6096,NM_001365023;NM_006914
ELOVL5_SIG,ELOVL5,ELOVL5_SIG,ELOVL5,SIG,23,-8.04551869936026,0.11853371810721,0.133753271579374,0.0685266138415266,-0.0652266577378476,7.11523148381809e-14,-4.86086806309676,7.0540037997577,7.13443555602308,6.78972802917144,-0.344707526851638,2.52507930743427e-05,ENSG00000012660,ELOVL5,protein_coding,6,-1,53267398,53349179,p12.1,ELOVL fatty acid elongase 5 [Source:HGNC Symbol;Acc:HGNC:21308],Spinocerebellar ataxia 38;Spinocerebellar ataxia type 38,ELOVL5,60481,NM_001242828;NM_001242830;NM_001242831;NM_001301856;NM_021814
IKZF4_TF,IKZF4,IKZF4_TF,IKZF4,TF,64,8.01495657684171,0.0101669716611808,0.00333488566476501,0.0326152542208325,0.0292803685560674,9.03769912244662e-14,5.05460760183654,3.7847409410456,3.71663904338628,4.00850431906909,0.291865275682809,1.13207617074497e-05,ENSG00000123411,IKZF4,protein_coding,12,1,56007659,56038435,q13.2,IKAROS family zinc finger 4 [Source:HGNC Symbol;Acc:HGNC:13179],NA,IKZF4,64375,NM_001351089;NM_001351090;NM_001351091;NM_001351092;NM_022465
ZDHHC14_SIG,ZDHHC14,ZDHHC14_SIG,ZDHHC14,SIG,8,8.0042911296509,-0.0305498886348318,-0.0458043862225738,0.0195720320106063,0.06537641823318,9.75979621477896e-14,4.15694816659676,3.58360258378992,3.48583366718033,3.90484330979286,0.419009642612529,0.000333909790729604,ENSG00000175048,ZDHHC14,protein_coding,6,1,157381133,157678157,q25.3,zinc finger DHHC-type containing 14 [Source:HGNC Symbol;Acc:HGNC:20341],NA,ZDHHC14,79683,NM_024630;NM_153746
NRP2_SIG,NRP2,NRP2_SIG,NRP2,SIG,43,-8.00005563780522,-0.125600326357934,-0.109393798626284,-0.178850346047642,-0.0694565474213581,1.00033737147321e-13,-4.40450706666984,1.21285378103203,1.34845758182792,0.767298435559824,-0.581159146268094,0.000140772426225274,ENSG00000118257,NRP2,protein_coding,2,1,205681990,205798133,q33.3,neuropilin 2 [Source:HGNC Symbol;Acc:HGNC:8005],NA,NRP2,8828,NM_003872;NM_018534;NM_201264;NM_201266;NM_201267;NM_201279
RASSF8_SIG,RASSF8,RASSF8_SIG,RASSF8,SIG,52,7.9985239773338,-0.0380424653617326,-0.0520478949776735,0.0079753748049303,0.0600232697826037,1.00311836199274e-13,5.1443720654852,1.94937501258092,1.78187878798167,2.49971975054987,0.717840962568197,7.94020882974806e-06,ENSG00000123094,RASSF8,protein_coding,12,1,25959029,26079892,p12.1,Ras association domain family member 8 [Source:HGNC Symbol;Acc:HGNC:13232],NA,RASSF8,11228,NM_001164746;NM_001164747;NM_001164748;NM_007211
CTIF_SIG,CTIF,CTIF_SIG,CTIF,SIG,18,7.9653459573045,0.0246374468461012,0.0127923772811136,0.0635569611310605,0.0507645838499468,1.30005194262602e-13,4.0129540407152,4.56926888354803,4.50419157334484,4.78309433135852,0.278902758013685,0.000544921822850803,ENSG00000134030,CTIF,protein_coding,18,1,48539031,48863217,q21.1,cap binding complex dependent translation initiation factor [Source:HGNC Symbol;Acc:HGNC:23925],NA,CTIF,9811,NM_001142397;NM_014772
NKX2-3_TF,NKX2-3,NKX2-3_TF,NKX2-3,TF,42,7.96061025893388,0.0206592316981275,-0.00231902457647967,0.0961592166004084,0.098478241176888,1.3380495889972e-13,6.40965847106294,1.89770915271919,1.5294067069789,3.10784576015156,1.57843905317266,1.83004651256171e-08,ENSG00000119919,NKX2-3,protein_coding,10,1,99532942,99536524,q24.2,NK2 homeobox 3 [Source:HGNC Symbol;Acc:HGNC:7836],NA,NKX2-3,159296,NM_145285
PLXNA3_SIG,PLXNA3,PLXNA3_SIG,PLXNA3,SIG,34,7.95867723274225,0.126527178262163,0.110566486626367,0.178969450779781,0.0684029641534139,1.3464146072649e-13,4.89982042244732,4.9008221921714,4.77460105542898,5.31554878432505,0.540947728896065,2.13095624475294e-05,ENSG00000130827,PLXNA3,protein_coding,X,1,154458281,154477779,q28,plexin A3 [Source:HGNC Symbol;Acc:HGNC:9101],NA,PLXNA3,55558,NM_017514
ATP1B1_SIG,ATP1B1,ATP1B1_SIG,ATP1B1,SIG,51,7.95579019592443,0.0789420056668245,0.053183476206852,0.163577173892448,0.110393697685597,1.36542784434924e-13,7.9238738505052,4.26300864941002,3.98935596126141,5.16215319618405,1.17279723492265,9.77468561536962e-13,ENSG00000143153,ATP1B1,protein_coding,1,1,169105697,169132722,q24.2,ATPase Na+/K+ transporting subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:804],HYPERTENSION ESSENTIAL,ATP1B1,481,NM_001677
ST3GAL4_SIG,ST3GAL4,ST3GAL4_SIG,ST3GAL4,SIG,51,7.9466400513886,0.111657863296126,0.0914034893726283,0.178207949044762,0.0868044596721339,1.45662613848605e-13,5.15558150457288,5.20659524076312,5.07147620438747,5.65055778885454,0.579081584467071,7.61770709412555e-06,ENSG00000110080,ST3GAL4,protein_coding,11,1,126355640,126440344,q24.2,ST3 beta-galactoside alpha-2,3-sialyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:10864],NA,ST3GAL4,6484,NM_001254757;NM_001254758;NM_001254759;NM_001348396;NM_001348397;NM_001348398;NM_001348399;NM_001348400;NM_006278
TMEM67_SIG,TMEM67,TMEM67_SIG,TMEM67,SIG,90,7.94193835374311,-0.0355847099636013,-0.0583383431729674,0.0391772277243157,0.097515570897283,1.49917727203129e-13,6.26477053236794,2.42805260863757,2.28429008247875,2.90041519458799,0.616125112109242,3.76324349824848e-08,ENSG00000164953,TMEM67,protein_coding,8,1,93754844,93819234,q22.1,transmembrane protein 67 [Source:HGNC Symbol;Acc:HGNC:28396],Bardet-Biedl syndrome 14;COACH SYNDROM;COACH syndrome;Joubert Syndrome;JOUBERT SYNDROME 6;Joubert syndrome type 6;Joubert syndrome with hepatic defect;Meckel syndrome;Meckel syndrome type 3;MECKEL SYNDROME TYPE 3;NEPHRONOPHTHISIS 11;NEPHRONOPHTHISIS TYPE 11;RHYNS syndrome;Senior-Boichis syndrome,TMEM67,91147,NM_001142301;NM_153704
SPTLC3_SIG,SPTLC3,SPTLC3_SIG,SPTLC3,SIG,26,7.9379143883731,-0.0533302926149659,-0.0777559833094558,0.026925548238358,0.104681531547814,1.53465944045491e-13,5.96354829283429,1.76107360148351,1.54934147488725,2.45676487458551,0.907423399698259,1.73433636160221e-07,ENSG00000172296,SPTLC3,protein_coding,20,1,13008972,13169103,p12.1,serine palmitoyltransferase long chain base subunit 3 [Source:HGNC Symbol;Acc:HGNC:16253],NA,SPTLC3,55304,NM_001349945;NM_018327
ZNF358_TF,ZNF358,ZNF358_TF,ZNF358,TF,132,7.91242360987817,0.0114534528557403,-0.000109638491691262,0.0494464672830156,0.0495561057747069,1.86727450300772e-13,5.05543410031513,3.16511398223544,3.03174840612981,3.60331516086822,0.571566754738412,1.12848126300688e-05,ENSG00000198816,ZNF358,protein_coding,19,1,7515292,7521025,p13.2,zinc finger protein 358 [Source:HGNC Symbol;Acc:HGNC:16838],NA,ZNF358,140467,NM_018083
RUNX1_SIG,RUNX1,RUNX1_SIG,RUNX1,SIG,42,7.8815177770856,0.174221574505781,0.152844052479724,0.24446200401997,0.0916179515402462,2.37132895268304e-13,5.40597514779831,8.65594347112155,8.52788385851516,9.0767107696854,0.548826911170243,2.47394695352817e-06,ENSG00000159216,RUNX1,protein_coding,21,-1,34787801,36004667,q22.12,runt related transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471],Acute myeloid leukemia with t(8;21)(q22;q22) translocation;Chronic myeloid leukemia;Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome;Isolated delta-storage pool disease;LEUKEMIA ACUTE MYELOID;PLATELET DISORDER FAMILIAL WITH ASSOCIATED MYELOID MALIGNANCY;Precursor B-cell acute lymphoblastic leukemia,RUNX1,861,NM_001001890;NM_001122607;NM_001754
MEIS1_TF,MEIS1,MEIS1_TF,MEIS1,TF,251,7.85619289560931,-0.0101334939202442,-0.0256250902079068,0.0407674653106474,0.0663925555185543,2.87783902996245e-13,3.89921233811783,4.88161681099855,4.6491273239814,5.64551083976919,0.996383515787784,0.000782916578194669,ENSG00000143995,MEIS1,protein_coding,2,1,66433452,66573869,p14,Meis homeobox 1 [Source:HGNC Symbol;Acc:HGNC:7000],NA,MEIS1,4211,NM_002398
BLVRA_SIG,BLVRA,BLVRA_SIG,BLVRA,SIG,31,-7.84006650283487,0.0161223055764136,0.0405996634561257,-0.0643032988854976,-0.104902962341623,3.24417459073708e-13,-6.58724582743951,3.86550629011713,4.07928962248744,3.1630753409004,-0.916214281587038,6.60151516209433e-09,ENSG00000106605,BLVRA,protein_coding,7,1,43758680,43807342,p13,biliverdin reductase A [Source:HGNC Symbol;Acc:HGNC:1062],HYPERBILIVERDINEMIA,BLVRA,644,NM_000712;NM_001253823
RDH13_SIG,RDH13,RDH13_SIG,RDH13,SIG,24,7.83776093236129,0.0057885332835453,-0.00304895409711352,0.0348259918199957,0.0378749459171093,3.27579734270866e-13,6.03730439946131,2.88224539062222,2.76483032068888,3.26803776326032,0.503207442571441,1.16651313783957e-07,ENSG00000160439,RDH13,protein_coding,19,-1,55039108,55071291,q13.42,retinol dehydrogenase 13 [Source:HGNC Symbol;Acc:HGNC:19978],NA,RDH13,112724,NM_001145971;NM_138412
IRX3_TF,IRX3,IRX3_TF,IRX3,TF,119,7.80708031608199,-0.0505743667169786,-0.0635060373913283,-0.00808459164411533,0.0554214457472132,4.14448099151454e-13,5.16498239933933,1.53921436809393,1.27569760419203,2.40505516377158,1.12935755957955,7.31396709243775e-06,ENSG00000177508,IRX3,protein_coding,16,-1,54283304,54286787,q12.2,iroquois homeobox 3 [Source:HGNC Symbol;Acc:HGNC:14360],NA,IRX3,79191,NM_024336
NAALADL2_SIG,NAALADL2,NAALADL2_SIG,NAALADL2,SIG,77,7.79507660315718,0.00572658874781619,-0.0160669633032173,0.0773339740583547,0.0934009373615721,4.51949678547686e-13,6.519111048126,0.966011428687742,0.825977712690799,1.42612220982055,0.600144497129755,9.58040174395565e-09,ENSG00000177694,NAALADL2,protein_coding,3,1,174438573,175810548,q26.31,N-acetylated alpha-linked acidic dipeptidase like 2 [Source:HGNC Symbol;Acc:HGNC:23219],NA,NAALADL2,254827,NM_207015
OCLN_SIG,OCLN,OCLN_SIG,OCLN,SIG,82,7.79080381417978,-0.020575508087456,-0.0440578686281695,0.0565808194034599,0.10063868803163,4.63571727968182e-13,4.41430819973388,2.05620878726753,1.89964055720302,2.57064725747948,0.671006700276463,0.000135647911894763,ENSG00000197822,OCLN,protein_coding,5,1,69492292,69558104,q13.2,occludin [Source:HGNC Symbol;Acc:HGNC:8104],Congenital intrauterine infection-like syndrome;PSEUDO-TORCH SYNDROME 1,OCLN,100506658,NM_001205254;NM_001205255;NM_002538
CBR3_SIG,CBR3,CBR3_SIG,CBR3,SIG,20,-7.7869419418086,0.00516697738863019,0.0190874304205355,-0.0405716540019159,-0.0596590844224514,4.73974341001663e-13,-1.72598117361576,0.675905054540107,0.698327012404244,0.602232907272227,-0.0960941051320177,0.156369771392936,ENSG00000159231,CBR3,protein_coding,21,1,36135079,36146562,q22.12,carbonyl reductase 3 [Source:HGNC Symbol;Acc:HGNC:1549],NA,CBR3,874,NM_001236
WT1_SIG,WT1,WT1_SIG,WT1,SIG,68,7.77566187798992,0.0972991091012464,0.0689026154132345,0.190601874076143,0.121699258662908,5.13902344232836e-13,5.73065065737986,2.97849573209965,2.6975938194225,3.90145915946745,1.20386534004495,5.43988883171934e-07,ENSG00000184937,WT1,protein_coding,11,-1,32387775,32435885,p13,Wilms tumor 1 [Source:HGNC Symbol;Acc:HGNC:12796],46XY complete gonadal dysgenesis;46XY partial gonadal dysgenesis;ANIRIDIA 1;DENYS-DRASH SYNDROME;Desmoplastic small round cell tumor;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;FRASIER SYNDROME;Frasier Syndrome Frasier syndrome Frasier syndrome;MEACHAM SYNDROME;MESOTHELIOMA MALIGNANT;Nephroblastoma;NEPHROTIC SYNDROME TYPE 4;Sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;WAGR syndrome;WILMS TUMOR 1;WILMS TUMOR ANIRIDIA GENITOURINARY ANOMALIES AND MENTAL RETARDATIONSYNDROME,WT1,7490,NM_000378;NM_001198551;NM_001198552;NM_024424;NM_024426
FAM13B_SIG,FAM13B,FAM13B_SIG,FAM13B,SIG,37,7.7594782211835,0.260085294525891,0.247239482876678,0.302292961373304,0.0550534784966254,5.79131742576558e-13,3.32045206007978,6.30207982681694,6.256949706923,6.45036450646845,0.193414799545451,0.00453669790072811,ENSG00000031003,FAM13B,protein_coding,5,-1,137937960,138051961,q31.2,family with sequence similarity 13 member B [Source:HGNC Symbol;Acc:HGNC:1335],NA,FAM13B,51306,NM_001101800;NM_001101801;NM_016603
NRCAM_SIG,NRCAM,NRCAM_SIG,NRCAM,SIG,19,-7.75640527247136,-0.0997754182351381,-0.0895086634075147,-0.133509041240186,-0.0440003778326717,5.88507900093571e-13,-3.96420789373205,0.450807131653589,0.518700289109819,0.227729614297406,-0.290970674812413,0.000636197624012573,ENSG00000091129,NRCAM,protein_coding,7,-1,108147623,108456717,q31.1,neuronal cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:7994],NA,NRCAM,4897,NM_001037132;NM_001193582;NM_001193583;NM_001193584;NM_005010
ADAMTS14_SIG,ADAMTS14,ADAMTS14_SIG,ADAMTS14,SIG,37,7.75512196191329,-0.00232229431497418,-0.0224403193395365,0.0637797879085878,0.0862201072481244,5.89695655818056e-13,7.81240592095306,2.16097904209542,1.84072556936192,3.21324045250549,1.37251488314357,2.10049938478944e-12,ENSG00000138316,ADAMTS14,protein_coding,10,1,70672506,70762441,q22.1,ADAM metallopeptidase with thrombospondin type 1 motif 14 [Source:HGNC Symbol;Acc:HGNC:14899],NA,ADAMTS14,140766,NM_080722;NM_139155
TCTN1_SIG,TCTN1,TCTN1_SIG,TCTN1,SIG,117,7.74675819371925,0.0184621773226622,-0.0036998355776808,0.0912802197095035,0.0949800552871844,6.24809793942426e-13,5.41747560085648,3.60781684085599,3.47586010555412,4.04138897113355,0.565528865579432,2.3677775779324e-06,ENSG00000204852,TCTN1,protein_coding,12,1,110614027,110649430,q24.11,tectonic family member 1 [Source:HGNC Symbol;Acc:HGNC:26113],Joubert Syndrome;JOUBERT SYNDROME 13;Joubert Syndrome and Related Disorders,TCTN1,79600,NM_001082537;NM_001082538;NM_001173975;NM_001173976;NM_001319680;NM_001319681;NM_001319682;NM_024549
ENDOD1_SIG,ENDOD1,ENDOD1_SIG,ENDOD1,SIG,63,-7.74273226139093,-0.0139969760081038,-0.00290733540039595,-0.0504343665762866,-0.0475270311758907,6.39804530950511e-13,-6.10129396046006,4.2044929595639,4.39713502917591,3.57152615941015,-0.825608869765758,8.76917488707901e-08,ENSG00000149218,ENDOD1,protein_coding,11,1,95089846,95132645,q21,endonuclease domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29129],NA,ENDOD1,23052,NM_015036
DGKH_SIG,DGKH,DGKH_SIG,DGKH,SIG,21,-7.73609306365916,0.0427700596106864,0.0586192917433017,-0.00930598882504969,-0.0679252805683515,6.68791502046116e-13,-1.12607492191358,3.13328044315209,3.17133648678253,3.00823915693778,-0.163097329844753,0.370076538166263,ENSG00000102780,DGKH,protein_coding,13,1,42040036,42256578,q14.11,diacylglycerol kinase eta [Source:HGNC Symbol;Acc:HGNC:2854],NA,DGKH,160851,NM_001204504;NM_001204505;NM_001204506;NM_001297429;NM_152910;NM_178009
IL1RAP_SIG,IL1RAP,IL1RAP_SIG,IL1RAP,SIG,38,7.73326962441786,0.267911243563672,0.257942871980227,0.300664464480703,0.0427215925004757,6.78457150733702e-13,5.88291546086011,6.2264173978443,6.06451997316344,6.75836607893854,0.693846105775103,2.55003793781569e-07,ENSG00000196083,IL1RAP,protein_coding,3,1,190514051,190659750,q28,interleukin 1 receptor accessory protein [Source:HGNC Symbol;Acc:HGNC:5995],NA,IL1RAP,3556,NM_001167928;NM_001167929;NM_001167930;NM_001167931;NM_001364879;NM_001364881;NM_002182;NM_134470
PRDM16_TF,PRDM16,PRDM16_TF,PRDM16,TF,172,7.7308790097272,0.00676742199995974,-0.00706705192980712,0.0522235506263366,0.0592906025561438,6.85962667108255e-13,4.55821766210588,2.24869631855911,1.95650508301276,3.20875323535426,1.2522481523415,8.05297823437726e-05,ENSG00000142611,PRDM16,protein_coding,1,1,3069168,3438621,p36.32,PR/SET domain 16 [Source:HGNC Symbol;Acc:HGNC:14000],1p36 deletion syndrome;Familial isolated dilated cardiomyopathy;Left ventricular noncompaction;LEFT VENTRICULAR NONCOMPACTION 8,PRDM16,63976,NM_022114;NM_199454
ZNF334_TF,ZNF334,ZNF334_TF,ZNF334,TF,165,7.72606897436244,-0.0659007770934636,-0.0806099340780124,-0.0175706898585178,0.0630392442194947,7.06892418522078e-13,4.96857622424263,1.90894993131769,1.72238309957947,2.5219552356004,0.799572136020932,1.61623385940386e-05,ENSG00000198185,ZNF334,protein_coding,20,-1,46499630,46513559,q13.12,zinc finger protein 334 [Source:HGNC Symbol;Acc:HGNC:15806],NA,ZNF334,55713,NM_001270497;NM_001353813;NM_001353814;NM_001353815;NM_001353816;NM_001353817;NM_001353818;NM_001353819;NM_001353820;NM_001353821;NM_001353822;NM_001353823;NM_001353824;NM_001353825;NM_001353826;NM_018102;NM_199441
ITPR2_SIG,ITPR2,ITPR2_SIG,ITPR2,SIG,74,7.71284248988913,0.163108507628373,0.139292371104701,0.241361527634725,0.102069156530024,7.78194951883295e-13,6.83416762219828,6.78596988927163,6.61263441449763,7.35550073495765,0.742866320460023,1.56971139688001e-09,ENSG00000123104,ITPR2,protein_coding,12,-1,26335352,26833194,p11.23,inositol 1,4,5-trisphosphate receptor type 2 [Source:HGNC Symbol;Acc:HGNC:6181],ANHIDROSIS ISOLATED WITH NORMAL SWEAT GLANDS;Isolated generalized anhidrosis with normal sweat glands,ITPR2,3709,NM_002223
PTPRB_SIG,PTPRB,PTPRB_SIG,PTPRB,SIG,28,-7.70882818854023,-0.105239451812324,-0.094982393844635,-0.138941213706161,-0.0439588198615256,7.96980728380824e-13,-4.08123443434777,0.618147275314936,0.718762870540127,0.287553176717879,-0.431209693822247,0.000431690838719533,ENSG00000127329,PTPRB,protein_coding,12,-1,70515866,70637440,q15,protein tyrosine phosphatase, receptor type B [Source:HGNC Symbol;Acc:HGNC:9665],NA,PTPRB,5787,NM_001109754;NM_001206971;NM_001206972;NM_001330204;NM_002837
GMDS_SIG,GMDS,GMDS_SIG,GMDS,SIG,44,7.68595371659412,0.182243093814434,0.161228654847891,0.251290536133075,0.0900618812851839,9.45993790394077e-13,5.99023497560936,4.67061534988615,4.55738505373219,5.04265775153489,0.485272697802701,1.49072304118576e-07,ENSG00000112699,GMDS,protein_coding,6,-1,1623806,2245605,p25.3,GDP-mannose 4,6-dehydratase [Source:HGNC Symbol;Acc:HGNC:4369],NA,GMDS,2762,NM_001253846;NM_001500
USP48_SIG,USP48,USP48_SIG,USP48,SIG,16,7.68340064453073,0.0710039000782043,0.0512493686104254,0.135911646329478,0.0846622777190528,9.57845694578335e-13,5.95819482763872,6.940315875731,6.86010044420045,7.20388086504565,0.3437804208452,1.78114186199433e-07,ENSG00000090686,USP48,protein_coding,1,-1,21678298,21783606,p36.12,ubiquitin specific peptidase 48 [Source:HGNC Symbol;Acc:HGNC:18533],NA,USP48,84196,NM_001032730;NM_001330394;NM_001350164;NM_001350166;NM_001350167;NM_001350168;NM_032236
WNT7B_SIG,WNT7B,WNT7B_SIG,WNT7B,SIG,51,7.6803056054896,-0.0983362795976557,-0.122616219905876,-0.0185593328706476,0.104056887035228,9.74006162419238e-13,3.84826247994955,0.415045088080822,0.329548478617095,0.695962519175926,0.366414040558831,0.000926554087769031,ENSG00000188064,WNT7B,protein_coding,22,-1,45920366,45977162,q13.31,Wnt family member 7B [Source:HGNC Symbol;Acc:HGNC:12787],NA,WNT7B,7477,NM_058238
GPR146_SIG,GPR146,GPR146_SIG,GPR146,SIG,53,7.67787531445391,0.0550796346646838,0.0351281685691528,0.120634451835714,0.0855062832665615,9.85359458503119e-13,7.68188431714718,2.25952430423553,2.0442065782899,2.96699683234259,0.922790254052688,5.34335943014426e-12,ENSG00000164849,GPR146,protein_coding,7,1,1044546,1059261,p22.3,G protein-coupled receptor 146 [Source:HGNC Symbol;Acc:HGNC:21718],NA,GPR146,115330,NM_001303473;NM_001303474;NM_138445
MAP4K4_SIG,MAP4K4,MAP4K4_SIG,MAP4K4,SIG,21,-7.64740677868013,0.0726603885980548,0.0892138164575565,0.0182705542025493,-0.0709432622550072,1.24016660349788e-12,-4.46917704262713,7.78154371288895,7.85490282279255,7.54050663749141,-0.314396185301147,0.000111033238432981,ENSG00000071054,MAP4K4,protein_coding,2,1,101696850,101894689,q11.2,mitogen-activated protein kinase kinase kinase kinase 4 [Source:HGNC Symbol;Acc:HGNC:6866],NA,MAP4K4,9448,NM_001242559;NM_001242560;NM_004834;NM_145686;NM_145687
AGXT_SIG,AGXT,AGXT_SIG,AGXT,SIG,54,7.64293056352553,-0.0721263768976739,-0.0852003317014287,-0.0291690968281939,0.0560312348732347,1.27476439940157e-12,5.57770043902353,0.467159777402101,0.325922345103555,0.931225626383035,0.60530328127948,1.12213873934561e-06,ENSG00000172482,AGXT,protein_coding,2,1,240868824,240880502,q37.3,alanine--glyoxylate and serine--pyruvate aminotransferase [Source:HGNC Symbol;Acc:HGNC:341],Hyperoxaluria Primary Type 1;HYPEROXALURIA PRIMARY TYPE I;Primary hyperoxaluria type 1,AGXT,189,NM_000030
ZSCAN9_TF,ZSCAN9,ZSCAN9_TF,ZSCAN9,TF,48,7.61943495700721,0.0993477258066967,0.084109205883605,0.149417148411141,0.0653079425275358,1.51864977746077e-12,5.82316802079703,3.70546387071606,3.57863394087663,4.12219078304563,0.543556842169005,3.46106130073593e-07,ENSG00000137185,ZSCAN9,protein_coding,6,1,28224886,28233482,p22.1,zinc finger and SCAN domain containing 9 [Source:HGNC Symbol;Acc:HGNC:12984],NA,ZSCAN9,7746,NM_001199479;NM_001199480;NM_006299
NT5C_SIG,NT5C,NT5C_SIG,NT5C,SIG,52,7.61248008615205,0.116332259346318,0.0971305218665691,0.179423682494063,0.0822931606274941,1.59122677009683e-12,6.09160671918215,4.83161805277504,4.73516815853131,5.14852484814729,0.413356689615982,9.1905719976298e-08,ENSG00000125458,NT5C,protein_coding,17,-1,75130225,75131757,q25.1,5', 3'-nucleotidase, cytosolic [Source:HGNC Symbol;Acc:HGNC:17144],NA,NT5C,30833,NM_001252377;NM_014595
PBX3_TF,PBX3,PBX3_TF,PBX3,TF,222,7.60984390626681,-0.00922205649954238,-0.0220085696878392,0.0327907725477185,0.0547993422355577,1.61250281326932e-12,5.48839278125779,5.04915071207555,4.82557663773856,5.78375124203992,0.958174604301356,1.68891246619882e-06,ENSG00000167081,PBX3,protein_coding,9,1,125747345,125967377,q33.3,PBX homeobox 3 [Source:HGNC Symbol;Acc:HGNC:8634],NA,PBX3,5090,NM_001134778;NM_001330782;NM_006195
ZSWIM1_TF,ZSWIM1,ZSWIM1_TF,ZSWIM1,TF,32,7.59557653990751,0.0787271086788546,0.0678642265449899,0.114419435690124,0.0465552091451345,1.78783909170835e-12,4.41066154621466,3.77690540435432,3.7122655442859,3.98929351600769,0.277027971721786,0.000137515118226639,ENSG00000168612,ZSWIM1,protein_coding,20,1,45881227,45885266,q13.12,zinc finger SWIM-type containing 1 [Source:HGNC Symbol;Acc:HGNC:16155],NA,ZSWIM1,90204,NM_080603
IRS1_SIG,IRS1,IRS1_SIG,IRS1,SIG,31,-7.58920465115865,-0.137838634218673,-0.123149692640163,-0.186102299405206,-0.062952606765043,1.86484949445247e-12,-4.01453224973128,1.47664445083213,1.58555292047542,1.11880233628991,-0.466750584185513,0.000542151650376765,ENSG00000169047,IRS1,protein_coding,2,-1,226731317,226799759,q36.3,insulin receptor substrate 1 [Source:HGNC Symbol;Acc:HGNC:6125],DIABETES MELLITUS NONINSULIN-DEPENDENT,IRS1,3667,NM_005544
DTD1_SIG,DTD1,DTD1_SIG,DTD1,SIG,61,7.57909796931098,-0.00933474199384515,-0.0223672715025215,0.0334864263918057,0.0558536978943273,2.00201092156243e-12,3.09612062325279,4.43032354353861,4.35878486441732,4.66537920350856,0.306594339091248,0.00837259517414716,ENSG00000125821,DTD1,protein_coding,20,1,18587893,18766644,p11.23,D-tyrosyl-tRNA deacylase 1 [Source:HGNC Symbol;Acc:HGNC:16219],NA,DTD1,92675,NM_001318043;NM_080820
KCNA3_SIG,KCNA3,KCNA3_SIG,KCNA3,SIG,38,-7.57761634236466,0.0743468803009292,0.103128395314578,-0.020220954743916,-0.123349350058494,2.01103440248501e-12,-6.25638446002752,3.53926943485354,3.7700267965926,2.78106667485376,-0.988960121738841,3.8930045337053e-08,ENSG00000177272,KCNA3,protein_coding,1,-1,110672465,110674940,p13.3,potassium voltage-gated channel subfamily A member 3 [Source:HGNC Symbol;Acc:HGNC:6221],NA,KCNA3,3738,NM_002232
PAG1_SIG,PAG1,PAG1_SIG,PAG1,SIG,33,-7.57250476607505,0.275755447115172,0.292473984162621,0.220823111102127,-0.071650873060494,2.07746817976586e-12,-5.15471098888336,6.25424985560351,6.40277433541354,5.76624085051341,-0.636533484900121,7.64309565484066e-06,ENSG00000076641,PAG1,protein_coding,8,-1,80967810,81112068,q21.13,phosphoprotein membrane anchor with glycosphingolipid microdomains 1 [Source:HGNC Symbol;Acc:HGNC:30043],NA,PAG1,55824,NM_018440
SHC1_SIG,SHC1,SHC1_SIG,SHC1,SIG,25,-7.54669006758188,0.0221258570801262,0.0334059201062734,-0.0149372071486432,-0.0483431272549167,2.51626913682665e-12,-4.06571471593786,6.23774998277602,6.27496043343957,6.11548707345291,-0.159473359986659,0.000455840264043239,ENSG00000160691,SHC1,protein_coding,1,-1,154962298,154974395,q21.3,SHC adaptor protein 1 [Source:HGNC Symbol;Acc:HGNC:10840],NA,SHC1,6464,NM_001130040;NM_001130041;NM_001202859;NM_003029;NM_183001
ACVR1_SIG,ACVR1,ACVR1_SIG,ACVR1,SIG,79,7.54336773221231,0.110843636715788,0.100732822501377,0.144064883420284,0.0433320609189068,2.56380069457599e-12,5.68355102278349,4.00112984272862,3.87371365447675,4.41978303269903,0.546069378222278,6.91009598273229e-07,ENSG00000115170,ACVR1,protein_coding,2,-1,157736444,157875862,q24.1,activin A receptor type 1 [Source:HGNC Symbol;Acc:HGNC:171],FIBRODYSPLASIA OSSIFICANS PROGRESSIVA,ACVR1,90,NM_001105;NM_001111067;NM_001347663;NM_001347664;NM_001347665;NM_001347666;NM_001347667
COL4A6_SIG,COL4A6,COL4A6_SIG,COL4A6,SIG,14,7.51638351409277,-0.0833325862456067,-0.105245722571383,-0.011332281175199,0.0939134413961839,3.13118550968257e-12,1.50485257030841,0.361756028930714,0.336472326755671,0.444831050362999,0.108358723607328,0.220268938443407,ENSG00000197565,COL4A6,protein_coding,X,-1,108155607,108439497,q22.3,collagen type IV alpha 6 chain [Source:HGNC Symbol;Acc:HGNC:2208],DEAFNESS X-LINKED 6;X-linked diffuse leiomyomatosis -  Alport syndrome;X-linked nonsyndromic sensorineural deafness type DFN,COL4A6,1288,NM_001287758;NM_001287759;NM_001287760;NM_001847;NM_033641
HMGXB3_SIG,HMGXB3,HMGXB3_SIG,HMGXB3,SIG,22,7.51132239280423,0.194635240397434,0.176014433536914,0.255817891510571,0.0798034579736564,3.23297513982028e-12,5.64626150066684,6.08727757513269,6.01615926241617,6.32095203120127,0.304792768785108,8.30306597970319e-07,ENSG00000113716,HMGXB3,protein_coding,5,1,150000046,150053142,q32,HMG-box containing 3 [Source:HGNC Symbol;Acc:HGNC:28982],NA,HMGXB3,22993,NM_014983
CPXM1_SIG,CPXM1,CPXM1_SIG,CPXM1,SIG,89,7.50840327120319,0.119603054089382,0.0947620605028362,0.201223461588033,0.106461401085197,3.28398122459479e-12,5.32175001993395,6.192361322371,5.93923617174282,7.02405824586357,1.08482207412075,3.59976046039779e-06,ENSG00000088882,CPXM1,protein_coding,20,-1,2794074,2800627,p13,carboxypeptidase X, M14 family member 1 [Source:HGNC Symbol;Acc:HGNC:15771],NA,CPXM1,56265,NM_001184699;NM_019609
TLE4_TF,TLE4,TLE4_TF,TLE4,TF,172,-7.50518330800076,0.100380732759074,0.110178511040975,0.0681880326899689,-0.0419904783510063,3.3435807153337e-12,-3.92589142838136,6.2390951057883,6.32053665855172,5.97150143242277,-0.349035226128956,0.000721508314545694,ENSG00000106829,TLE4,protein_coding,9,1,79571773,79726882,q21.31,TLE family member 4, transcriptional corepressor [Source:HGNC Symbol;Acc:HGNC:11840],NA,TLE4,7091,NM_001282748;NM_001282749;NM_001282753;NM_001282760;NM_001351541;NM_001351542;NM_001351543;NM_001351546;NM_001351547;NM_001351550;NM_001351552;NM_001351556;NM_001351558;NM_001351560;NM_001351562;NM_001351563;NM_001351564;NM_007005
TSLP_SIG,TSLP,TSLP_SIG,TSLP,SIG,42,7.48888015230091,-0.00936680406261434,-0.032527699436441,0.0667332807371018,0.0992609801735428,3.76148384221291e-12,1.4070414992369,0.780849083762421,0.743303719259942,0.904212424270566,0.160908705010624,0.253927757644233,ENSG00000145777,TSLP,protein_coding,5,1,111070062,111078026,q22.1,thymic stromal lymphopoietin [Source:HGNC Symbol;Acc:HGNC:30743],NA,TSLP,85480,NM_033035;NM_138551
PIAS3_SIG,PIAS3,PIAS3_SIG,PIAS3,SIG,56,7.48597546596277,0.142518156826506,0.131506836416122,0.178698209603479,0.0471913731873563,3.82065801555401e-12,5.76989830076364,4.77713309450013,4.69975509369945,5.03137509713093,0.331620003431477,4.43974716719877e-07,ENSG00000131788,PIAS3,protein_coding,1,-1,145848522,145859836,q21.1,protein inhibitor of activated STAT 3 [Source:HGNC Symbol;Acc:HGNC:16861],NA,PIAS3,10401,NM_006099
SLC39A6_SIG,SLC39A6,SLC39A6_SIG,SLC39A6,SIG,28,7.48096929542529,0.125871216789424,0.110863555806354,0.175182102876655,0.0643185470703013,3.94346844403823e-12,3.6007294569778,5.36271749758755,5.30780609065213,5.54314069180395,0.235334601151818,0.00199196416263357,ENSG00000141424,SLC39A6,protein_coding,18,-1,36108531,36129385,q12.2,solute carrier family 39 member 6 [Source:HGNC Symbol;Acc:HGNC:18607],NA,SLC39A6,25800,NM_001099406;NM_012319
MBOAT7_SIG,MBOAT7,MBOAT7_SIG,MBOAT7,SIG,53,7.477460342395,0.300358093226247,0.287802150141516,0.341613334790365,0.0538111846488485,4.02420626686674e-12,4.544611859758,8.05915069940148,7.97274784411316,8.3430457953488,0.370297951235634,8.44670864577781e-05,ENSG00000125505,MBOAT7,protein_coding,19,-1,54173412,54189882,q13.42,membrane bound O-acyltransferase domain containing 7 [Source:HGNC Symbol;Acc:HGNC:15505],Autosomal recessive non-syndromic intellectual disability;Intellectual Disability Accompanied by Epilepsy and Autistic Features;MENTAL RETARDATION AUTOSOMAL RECESSIVE 57,MBOAT7,79143,NM_001146056;NM_001146082;NM_001146083;NM_024298
STARD13_SIG,STARD13,STARD13_SIG,STARD13,SIG,34,7.45744858102403,-0.0936627080128511,-0.10165363862095,-0.06740679315767,0.0342468454632797,4.65511304713515e-12,2.85681776224669,1.36363600430984,1.29799495691736,1.57931373145655,0.281318774539196,0.0154330600751155,ENSG00000133121,STARD13,protein_coding,13,-1,33103137,33350630,q13.1,StAR related lipid transfer domain containing 13 [Source:HGNC Symbol;Acc:HGNC:19164],NA,STARD13,90627,NM_001243476;NM_052851;NM_178006;NM_178007
INSRR_SIG,INSRR,INSRR_SIG,INSRR,SIG,32,7.45340823187788,-0.0295713770411345,-0.0420979186866439,0.0115872597941109,0.0536851784807549,4.76960498740472e-12,4.76480719794425,0.313574431962572,0.251800448216213,0.516546092843465,0.264745644627252,3.65845478262072e-05,ENSG00000027644,INSRR,protein_coding,1,-1,156840063,156859117,q23.1,insulin receptor related receptor [Source:HGNC Symbol;Acc:HGNC:6093],NA,INSRR,3645,NM_014215
YBEY_SIG,YBEY,YBEY_SIG,YBEY,SIG,32,7.45255100868411,-0.057487736072646,-0.071425387311429,-0.0116925962880735,0.0597327910233557,4.7705156121656e-12,5.21947123424296,2.84840985453885,2.76553539435834,3.12071165227482,0.355176257916488,5.68342552128806e-06,ENSG00000182362,YBEY,protein_coding,21,1,46286342,46297751,q22.3,ybeY metalloendoribonuclease [Source:HGNC Symbol;Acc:HGNC:1299],NA,YBEY,54059,NM_001006114;NM_001314022;NM_001314023;NM_001314024;NM_001314025;NM_001314026;NM_058181
HOXA3_TF,HOXA3,HOXA3_TF,HOXA3,TF,254,7.44490603534815,-0.0202975179488759,-0.0318353576264608,0.017612526706046,0.0494478843325068,5.02347745721104e-12,6.12736264254065,3.18533681951919,2.83032062275039,4.35181860890238,1.52149798615199,7.58525213369721e-08,ENSG00000105997,HOXA3,protein_coding,7,-1,27106184,27152581,p15.2,homeobox A3 [Source:HGNC Symbol;Acc:HGNC:5104],NA,HOXA3,3200,NM_030661;NM_153631
NAV2_SIG,NAV2,NAV2_SIG,NAV2,SIG,35,-7.42999716918671,-0.139215676476457,-0.12503168314992,-0.185820225977935,-0.0607885428280154,5.58851570677184e-12,-3.48475488803253,1.09310779918072,1.18183754067073,0.801567219999268,-0.380270320671464,0.00282147814777572,ENSG00000166833,NAV2,protein_coding,11,1,19350724,20121601,p15.1,neuron navigator 2 [Source:HGNC Symbol;Acc:HGNC:15997],NA,NAV2,89797,NM_001111018;NM_001111019;NM_001244963;NM_145117;NM_182964
QRFP_SIG,QRFP,QRFP_SIG,QRFP,SIG,19,7.41828479588488,0.0012086003577735,-0.0126091836604497,0.046609890703364,0.0592190743638139,6.06782986937835e-12,2.08842310586993,0.220245768160566,0.207719039867035,0.261405018267882,0.0536859784008474,0.0821490289107949,ENSG00000188710,QRFP,protein_coding,9,-1,130892702,130896812,q34.12,pyroglutamylated RFamide peptide [Source:HGNC Symbol;Acc:HGNC:29982],NA,QRFP,347148,NM_198180
PBX1_TF,PBX1,PBX1_TF,PBX1,TF,319,-7.41293937192059,-0.130510772703528,-0.119840104977194,-0.165571538090052,-0.0457314331128576,6.25454543802929e-12,-5.33761278208593,1.13140485546894,1.34134887261947,0.441588799117224,-0.899760073502242,3.36580644845805e-06,ENSG00000185630,PBX1,protein_coding,1,1,164555584,164899296,q23.3,PBX homeobox 1 [Source:HGNC Symbol;Acc:HGNC:8632],CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH ORWITHOUT HEARING LOSS ABNORMAL EARS OR DEVELOPMENTAL DELAY;Precursor B-cell acute lymphoblastic leukemia;Renal hypoplasia bilateral,PBX1,5087,NM_001204961;NM_001204963;NM_001353130;NM_001353131;NM_002585
SLC50A1_SIG,SLC50A1,SLC50A1_SIG,SLC50A1,SIG,49,7.41264225297185,0.21162911888631,0.195234183007154,0.265498193917822,0.0702640109106671,6.25454543802929e-12,4.83819050650683,5.05652357713984,4.98964358059829,5.27627213720492,0.286628556606632,2.7578366289929e-05,ENSG00000169241,SLC50A1,protein_coding,1,1,155135344,155138857,q22,solute carrier family 50 member 1 [Source:HGNC Symbol;Acc:HGNC:30657],NA,SLC50A1,55974,NM_001122837;NM_001122839;NM_001287586;NM_001287587;NM_001287588;NM_001287589;NM_001287590;NM_001287591;NM_001287592;NM_018845
ZNF19_TF,ZNF19,ZNF19_TF,ZNF19,TF,14,7.40765711295117,0.0457861152389324,0.031701988880213,0.0920625304175819,0.0603605415373689,6.45477568125236e-12,5.29999636970888,1.09309968198013,1.03428798421467,1.28633811749523,0.252050133280565,3.97689985869802e-06,ENSG00000157429,ZNF19,protein_coding,16,-1,71464555,71565089,q22.2,zinc finger protein 19 [Source:HGNC Symbol;Acc:HGNC:12981],NA,ZNF19,7567,NM_006961
SIK3_SIG,SIK3,SIK3_SIG,SIK3,SIG,34,7.40667092359647,0.176378644834674,0.168783784203123,0.20133318690977,0.0325494027066469,6.46376200682183e-12,4.10761883212504,6.77436929757687,6.7308595354078,6.91732994470382,0.186470409296025,0.000395893274618504,ENSG00000160584,SIK3,protein_coding,11,-1,116843402,117098437,q23.3,SIK family kinase 3 [Source:HGNC Symbol;Acc:HGNC:29165],SPONDYLOEPIMETAPHYSEAL DYSPLASIA KRAKOW TYPE,SIK3,23387,NM_001281748;NM_001281749;NM_001366686;NM_025164
CARHSP1_TF,CARHSP1,CARHSP1_TF,CARHSP1,TF,85,-7.39155823096217,0.0219043335336452,0.0299384778575772,-0.00449356924498876,-0.034432047102566,7.19941616070527e-12,-2.98202950511597,4.91498474531722,4.97249048583623,4.72603731218332,-0.246453173652911,0.0112842917815632,ENSG00000153048,CARHSP1,protein_coding,16,-1,8852942,8869012,p13.2,calcium regulated heat stable protein 1 [Source:HGNC Symbol;Acc:HGNC:17150],NA,CARHSP1,23589,NM_001042476;NM_001278260;NM_001278261;NM_001278262;NM_001278263;NM_001278264;NM_001278265;NM_001278266;NM_014316
LAMB2_SIG,LAMB2,LAMB2_SIG,LAMB2,SIG,37,7.38382873859865,-0.00317657928615263,-0.018352494438616,0.0466871419290841,0.0650396363676999,7.57921124792861e-12,3.20964987452213,3.90199042762998,3.68618319683537,4.61107132881228,0.924888131976911,0.00618496622968778,ENSG00000172037,LAMB2,protein_coding,3,-1,49121114,49133118,p21.31,laminin subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:6487],LAMB-2-related infantile-onset nephrotic syndrome;Nephrotic syndrome type 5 with or without ocular abnormalities;PIERSON SYNDROME;Synaptic congenital myasthenic syndromes,LAMB2,3913,NM_002292
PROX2_TF,PROX2,PROX2_TF,PROX2,TF,47,7.38313673577932,-0.0547912057627197,-0.0652578254112685,-0.0204008840603453,0.0448569413509232,7.57921124792861e-12,3.04491891953353,0.483806722390574,0.453388124402313,0.583753544352002,0.130365419949689,0.00957857800398591,ENSG00000119608,PROX2,protein_coding,14,-1,74852871,74871940,q24.3,prospero homeobox 2 [Source:HGNC Symbol;Acc:HGNC:26715],NA,PROX2,283571,NM_001080408;NM_001243007
NEK11_SIG,NEK11,NEK11_SIG,NEK11,SIG,69,7.36749352902582,0.10852045716695,0.0901992978995927,0.168718551902552,0.0785192540029591,8.47340442284724e-12,6.60416786859006,1.98676575731274,1.82617218716044,2.51443034495603,0.688258157795591,6.00607614595706e-09,ENSG00000114670,NEK11,protein_coding,3,1,131026850,131350465,q22.1,NIMA related kinase 11 [Source:HGNC Symbol;Acc:HGNC:18593],NA,NEK11,79858,NM_001146003;NM_001321220;NM_001321221;NM_001321222;NM_001321223;NM_001321224;NM_001353022;NM_001353023;NM_001353024;NM_001353025;NM_001353026;NM_001353027;NM_001353028;NM_001353029;NM_001353030;NM_001353031;NM_001353032;NM_001353033;NM_001353034;NM_001353036;NM_001353037;NM_001353038;NM_001353039;NM_001353040;NM_001353041;NM_001353042;NM_001353043;NM_001353044;NM_001353045;NM_001353046;NM_001353048;NM_024800;NM_145910
TRIB2_SIG,TRIB2,TRIB2_SIG,TRIB2,SIG,27,-7.34187963593618,-0.00775340143005294,0.0171723910724604,-0.0896524339383111,-0.106824825010772,1.02043470590025e-11,-6.58019927100227,3.74031260982546,3.98389021934227,2.93998617855594,-1.04390404078632,6.87771644168949e-09,ENSG00000071575,TRIB2,protein_coding,2,1,12716889,12742734,p24.3,tribbles pseudokinase 2 [Source:HGNC Symbol;Acc:HGNC:30809],NA,TRIB2,28951,NM_021643
DPYSL3_SIG,DPYSL3,DPYSL3_SIG,DPYSL3,SIG,69,7.34066635080676,0.005038304118976,-0.0108509064529674,0.0572457102839327,0.0680966167369,1.02374195119436e-11,3.66061509705936,3.29877213604964,3.08994533752751,3.9849173311938,0.894971993666296,0.00165830559958733,ENSG00000113657,DPYSL3,protein_coding,5,-1,147390808,147510068,q32,dihydropyrimidinase like 3 [Source:HGNC Symbol;Acc:HGNC:3015],NA,DPYSL3,1809,NM_001197294;NM_001387
ROBO1_SIG,ROBO1,ROBO1_SIG,ROBO1,SIG,54,-7.334896624222,-0.157044664030671,-0.14501228395616,-0.196579627132635,-0.0515673431764752,1.06264795106071e-11,-3.64260440753885,0.828223013836739,0.977585344976709,0.337461068662549,-0.64012427631416,0.00175101043627372,ENSG00000169855,ROBO1,protein_coding,3,-1,78597239,79767998,p12.3,roundabout guidance receptor 1 [Source:HGNC Symbol;Acc:HGNC:10249],Pituitary stalk interruption syndrome,ROBO1,6091,NM_001145845;NM_002941;NM_133631
SEMA5A_SIG,SEMA5A,SEMA5A_SIG,SEMA5A,SIG,44,7.33046294085027,-0.0858741695444331,-0.0976202881683571,-0.0472797797801111,0.0503405083882461,1.08908319257114e-11,5.25659596424436,0.635145092392106,0.489460947732412,1.11382156770253,0.624360619970117,4.80809670010933e-06,ENSG00000112902,SEMA5A,protein_coding,5,-1,9035033,9546075,p15.31,semaphorin 5A [Source:HGNC Symbol;Acc:HGNC:10736],Monosomy 5p,SEMA5A,9037,NM_003966
CD48_SIG,CD48,CD48_SIG,CD48,SIG,41,-7.33006466132019,0.0597315486530598,0.0859995424381912,-0.0265775737838005,-0.112577116221992,1.08908319257114e-11,-5.03751913481022,5.35874075684171,5.56961339636464,4.66587351269496,-0.903739883669678,1.22247790212769e-05,ENSG00000117091,CD48,protein_coding,1,-1,160678746,160711831,q23.3,CD48 molecule [Source:HGNC Symbol;Acc:HGNC:1683],NA,CD48,962,NM_001256030;NM_001778
ARHGAP42_SIG,ARHGAP42,ARHGAP42_SIG,ARHGAP42,SIG,70,-7.31603305950524,-0.154428962332706,-0.143677801543502,-0.189754204925803,-0.0460764033823012,1.20230773902478e-11,-2.7706357805135,0.713523100819552,0.77292243295178,0.518353866670802,-0.254568566280979,0.0189479596833068,ENSG00000165895,ARHGAP42,protein_coding,11,1,100687288,100993941,q22.1,Rho GTPase activating protein 42 [Source:HGNC Symbol;Acc:HGNC:26545],NA,ARHGAP42,143872,NM_152432
STRN3_TF,STRN3,STRN3_TF,STRN3,TF,84,7.2972304084877,0.104065009456568,0.0924116469364121,0.142354629165653,0.049942982229241,1.37498945433471e-11,4.96083609336337,4.67888843360834,4.6119770779805,4.89874003067125,0.286762952690754,1.66625591572154e-05,ENSG00000196792,STRN3,protein_coding,14,-1,30893799,31026401,q12,striatin 3 [Source:HGNC Symbol;Acc:HGNC:15720],NA,STRN3,29966,NM_001083893;NM_014574
FAHD2B_SIG,FAHD2B,FAHD2B_SIG,FAHD2B,SIG,65,7.29321983503749,0.000265423806923873,-0.0199080108736216,0.0665495663287162,0.0864575772023378,1.40860673505296e-11,5.82919000115282,2.6752173020009,2.55406285120589,3.07329621175595,0.519233360550059,3.37388261366029e-07,ENSG00000144199,FAHD2B,protein_coding,2,-1,97083583,97094882,q11.2,fumarylacetoacetate hydrolase domain containing 2B [Source:HGNC Symbol;Acc:HGNC:25318],NA,FAHD2B,151313,NM_001320848;NM_001320849;NM_199336
AFF1_TF,AFF1,AFF1_TF,AFF1,TF,47,7.27406554218536,0.222089127838038,0.210227223652923,0.261063955874843,0.0508367322219197,1.61454101881716e-11,4.50440661793516,7.92365379963202,7.84705527753825,8.17533465794013,0.328279380401872,9.71246042255422e-05,ENSG00000172493,AFF1,protein_coding,4,1,86935002,87141054,q21.3,AF4/FMR2 family member 1 [Source:HGNC Symbol;Acc:HGNC:7135],Precursor B-cell acute lymphoblastic leukemia,AFF1,4299,NM_001166693;NM_001313959;NM_001313960;NM_005935
TMSB4X_SIG,TMSB4X,TMSB4X_SIG,TMSB4X,SIG,29,-7.27321262524633,0.284083044097254,0.309306549000834,0.201205813699776,-0.108100735301058,1.61574585525149e-11,-6.49105810237144,8.94849022057189,9.06397785491455,8.56903085058888,-0.49494700432567,1.13170076464845e-08,ENSG00000205542,TMSB4X,protein_coding,X,1,12975110,12977227,p22.2,thymosin beta 4 X-linked [Source:HGNC Symbol;Acc:HGNC:11881],NA,TMSB4X,7114,NM_021109
SULT1C4_SIG,SULT1C4,SULT1C4_SIG,SULT1C4,SIG,59,7.26875124486576,0.0407680274024488,0.0138765804407112,0.129125638848158,0.115249058407447,1.65260990414984e-11,5.15817651544896,1.62144908530605,1.45109148592972,2.18119548325688,0.73010399732716,7.52282992363466e-06,ENSG00000198075,SULT1C4,protein_coding,2,1,108377911,108388989,q12.3,sulfotransferase family 1C member 4 [Source:HGNC Symbol;Acc:HGNC:11457],NA,SULT1C4,27233,NM_001321770;NM_006588
PGM5_SIG,PGM5,PGM5_SIG,PGM5,SIG,6,-7.26867314869144,-0.156115765389535,-0.134490374656539,-0.227170620655093,-0.092680245998554,1.65260990414984e-11,-2.92308944516558,0.638822321702466,0.713926665694361,0.392050905729097,-0.321875759965264,0.0130995988328326,ENSG00000154330,PGM5,protein_coding,9,1,68328308,68531061,q21.11,phosphoglucomutase 5 [Source:HGNC Symbol;Acc:HGNC:8908],NA,PGM5,5239,NM_021965
LGMN_SIG,LGMN,LGMN_SIG,LGMN,SIG,63,-7.26181415197312,-0.184741205426696,-0.16957260922526,-0.234580878659985,-0.0650082694347252,1.72913262687274e-11,-4.55409532422338,1.8851116093783,2.05142650397684,1.33864838426883,-0.712778119708005,8.17895678735161e-05,ENSG00000100600,LGMN,protein_coding,14,-1,92703807,92748679,q32.12,legumain [Source:HGNC Symbol;Acc:HGNC:9472],NA,LGMN,5641,NM_001008530;NM_005606
CHRNA7_SIG,CHRNA7,CHRNA7_SIG,CHRNA7,SIG,25,7.24837896927564,-0.0467923669915828,-0.0556399387982724,-0.0177217739124597,0.0379181648858126,1.89919707163975e-11,4.93262029224833,1.4077097352436,1.3137813212012,1.7163316670972,0.402550345896004,1.86591356592627e-05,ENSG00000175344,CHRNA7,protein_coding,15,1,31923438,32173018,q13.3,cholinergic receptor nicotinic alpha 7 subunit [Source:HGNC Symbol;Acc:HGNC:1960],15q13.3 microdeletion syndrome;CHROMOSOME 15q13.3 DELETION SYNDROME,CHRNA7,1139,NM_000746;NM_001190455
ZNF423_TF,ZNF423,ZNF423_TF,ZNF423,TF,103,7.24058091149707,-0.111456005590676,-0.121076824261634,-0.0798447442432415,0.0412320800183924,2.00079147952098e-11,3.06295844182189,0.363304460812813,0.319734583703479,0.506462628457767,0.186728044754288,0.0091448349954983,ENSG00000102935,ZNF423,protein_coding,16,-1,49487524,49857919,q12.1,zinc finger protein 423 [Source:HGNC Symbol;Acc:HGNC:16762],Infantile nephronophthisis;Joubert syndrome with oculorenal defect;Nephronophthisis 14,ZNF423,23090,NM_001271620;NM_001330533;NM_015069
ITGAE_SIG,ITGAE,ITGAE_SIG,ITGAE,SIG,26,7.2280554033104,0.0484533438395876,0.0367519385457438,0.0869008183765028,0.0501488798307591,2.18242425482738e-11,4.04890947122539,4.37202305215068,4.25857105971069,4.74479388445353,0.486222824742845,0.000484385786057761,ENSG00000083457,ITGAE,protein_coding,17,-1,3714628,3801188,p13.2,integrin subunit alpha E [Source:HGNC Symbol;Acc:HGNC:6147],NA,ITGAE,3682,NM_002208
GPR107_SIG,GPR107,GPR107_SIG,GPR107,SIG,41,7.22708058245013,0.242218181146237,0.234405359942514,0.267888879387038,0.0334835194445237,2.18638629995003e-11,4.72548410364814,6.37260501891791,6.32834653300338,6.51802575835137,0.189679225347989,4.24161788084322e-05,ENSG00000148358,GPR107,protein_coding,9,1,130053426,130140169,q34.11,G protein-coupled receptor 107 [Source:HGNC Symbol;Acc:HGNC:17830],NA,GPR107,57720,NM_001136557;NM_001136558;NM_001287346;NM_020960
TNFRSF14_SIG,TNFRSF14,TNFRSF14_SIG,TNFRSF14,SIG,42,-7.22472655913772,-0.0602706550394126,-0.0447368184711322,-0.111310403763762,-0.0665735852926303,2.21276095611845e-11,-5.67318295461334,6.32365083646792,6.46552859177027,5.85748106904593,-0.608047522724331,7.20951700104917e-07,ENSG00000157873,TNFRSF14,protein_coding,1,1,2555639,2565382,p36.32,TNF receptor superfamily member 14 [Source:HGNC Symbol;Acc:HGNC:11912],NA,TNFRSF14,8764,NM_001297605;NM_003820
UGCG_SIG,UGCG,UGCG_SIG,UGCG,SIG,42,-7.22250043557786,0.0487704611169772,0.0786193613244775,-0.0493044967076667,-0.127923858032144,2.22907218419054e-11,-5.50650637691333,5.28829483851537,5.48714451581216,4.63493161311161,-0.852212902700547,1.55659335678164e-06,ENSG00000148154,UGCG,protein_coding,9,1,111896814,111935369,q31.3,UDP-glucose ceramide glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:12524],NA,UGCG,7357,NM_003358
ABCB4_SIG,ABCB4,ABCB4_SIG,ABCB4,SIG,23,-7.22228992731985,-0.0351038821768027,-0.0203963758047318,-0.0834285459707501,-0.0630321701660183,2.22907218419054e-11,-4.32049709156727,0.73984866615693,0.81004391980929,0.509207118442032,-0.300836801367259,0.000190017154384784,ENSG00000005471,ABCB4,protein_coding,7,-1,87401697,87480435,q21.12,ATP binding cassette subfamily B member 4 [Source:HGNC Symbol;Acc:HGNC:45],Cholestasis intrahepatic of pregnancy 3;CHOLESTASIS PROGRESSIVE FAMILIAL INTRAHEPATIC 3;GALLBLADDER DISEASE 1;Intrahepatic cholestasis of pregnancy;Low phospholipid associated cholelithiasis;Progressive familial intrahepatic cholestasis type 3,ABCB4,5244,NM_000443;NM_018849;NM_018850
OTUD7B_SIG,OTUD7B,OTUD7B_SIG,OTUD7B,SIG,36,-7.20788800402226,-0.123728064817737,-0.113133260836132,-0.158539563614437,-0.0454063027783052,2.46495391928478e-11,-3.98450506988818,2.03515445826933,2.14884626773149,1.66159565575079,-0.487250611980707,0.000596469216798536,ENSG00000264522,OTUD7B,protein_coding,1,-1,149937812,150010726,q21.2,OTU deubiquitinase 7B [Source:HGNC Symbol;Acc:HGNC:16683],NA,OTUD7B,56957,NM_020205
PABPC1L_SIG,PABPC1L,PABPC1L_SIG,PABPC1L,SIG,25,7.20566613672525,0.0363626868394672,0.0202712969773665,0.0892343963863696,0.0689630994090033,2.49243739892073e-11,6.19697149541299,5.03850283686352,4.8871339274412,5.53585782496544,0.648723897524236,5.34347925716412e-08,ENSG00000101104,PABPC1L,protein_coding,20,1,44910062,44959035,q13.12,poly(A) binding protein cytoplasmic 1 like [Source:HGNC Symbol;Acc:HGNC:15797],NA,PABPC1L,80336,NM_001124756
IFT81_SIG,IFT81,IFT81_SIG,IFT81,SIG,116,7.19084095655106,0.0970665413881665,0.0733272028308487,0.175067225219354,0.101740022388505,2.7642476311515e-11,5.34893725574588,2.6257596291019,2.49724247004784,3.04803029456524,0.5507878245174,3.21726073415317e-06,ENSG00000122970,IFT81,protein_coding,12,1,110124335,110218793,q24.11,intraflagellar transport 81 [Source:HGNC Symbol;Acc:HGNC:14313],SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY,IFT81,28981,NM_001143779;NM_001347946;NM_001347947;NM_001347948;NM_014055;NM_031473
GLI3_TF,GLI3,GLI3_TF,GLI3,TF,134,-7.18821827856129,-0.141496442184579,-0.133941359207456,-0.16632028625227,-0.0323789270448141,2.80333062860771e-11,-3.81587190302644,0.495106789696213,0.581304168983689,0.211886829180217,-0.369417339803472,0.00102447834994233,ENSG00000106571,GLI3,protein_coding,7,-1,41960949,42237870,p14.1,GLI family zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:4319],Acrocallosal syndrome;GREIG CEPHALOPOLYSYNDACTYLY SYNDROME;HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME INCLUDED;PALLISTER-HALL SYNDROME;POLYDACTYLY POSTAXIAL TYPE A1;POLYDACTYLY PREAXIAL IV;Polysyndactyly;Postaxial Polydactyly Type A;Postaxial polydactyly type B;Preaxial Polydactyly Type IV;Tibial hemimelia,GLI3,2737,NM_000168
MCC_SIG,MCC,MCC_SIG,MCC,SIG,46,-7.1857016935763,-0.225019605058139,-0.208248630815828,-0.280124234711446,-0.0718756038956183,2.84081553480976e-11,-3.46692057532728,0.568309520942116,0.617917182747795,0.40531291786631,-0.212604264881485,0.00297099352542891,ENSG00000171444,MCC,protein_coding,5,-1,113022099,113488823,q22.2,MCC, WNT signaling pathway regulator [Source:HGNC Symbol;Acc:HGNC:6935],NA,MCC,4163,NM_001085377;NM_002387
CALM3_SIG,CALM3,CALM3_SIG,CALM3,SIG,48,-7.17251923750595,-0.00707740152628042,0.00439147123510828,-0.0447608405994147,-0.0491523118345229,3.11237288096043e-11,-6.17582053391479,8.42119734478474,8.50546534114576,8.1443167853128,-0.361148555832962,5.97276706295042e-08,ENSG00000160014,CALM3,protein_coding,19,1,46601074,46610793,q13.32,calmodulin 3 [Source:HGNC Symbol;Acc:HGNC:1449],Catecholaminergic polymorphic ventricular tachycardia,CALM3,808,NM_001329921;NM_001329922;NM_001329923;NM_001329924;NM_001329925;NM_001329926;NM_005184
CBX6_SIG,CBX6,CBX6_SIG,CBX6,SIG,11,-7.1682083955274,0.21782614306605,0.233122954479647,0.167565191278517,-0.0655577632011297,3.19563708385213e-11,-2.42100111260716,5.92183051071112,5.97226029311525,5.75613265424039,-0.216127638874859,0.0418800001920136,ENSG00000183741,CBX6,protein_coding,22,-1,38861450,38872314,q13.1,chromobox 6 [Source:HGNC Symbol;Acc:HGNC:1556],NA,CBX6,23466,NM_001303494;NM_014292
CNNM4_SIG,CNNM4,CNNM4_SIG,CNNM4,SIG,57,7.16580382160425,0.152232738422187,0.133235976939254,0.214650669008967,0.0814146920697138,3.23581335966804e-11,5.03478057544771,4.8114066956378,4.73974251201621,5.04687472753727,0.307132215521055,1.23447919546076e-05,ENSG00000158158,CNNM4,protein_coding,2,1,96760902,96811874,q11.2,cyclin and CBS domain divalent metal cation transport mediator 4 [Source:HGNC Symbol;Acc:HGNC:105],JALILI SYNDROME,CNNM4,26504,NM_020184
ADAM28_SIG,ADAM28,ADAM28_SIG,ADAM28,SIG,30,7.14930597145978,0.022885706946508,0.00962809277425768,0.066446439226759,0.0568183464525012,3.63115026758711e-11,3.9186646939939,5.4210271385753,5.27482280013332,5.90141282202753,0.626590021894205,0.000735682549622331,ENSG00000042980,ADAM28,protein_coding,8,1,24294040,24359018,p21.2,ADAM metallopeptidase domain 28 [Source:HGNC Symbol;Acc:HGNC:206],NA,ADAM28,10863,NM_001304351;NM_014265;NM_021777
SLC16A10_SIG,SLC16A10,SLC16A10_SIG,SLC16A10,SIG,39,-7.14444163355965,-0.146653454216699,-0.133118739689818,-0.191124659090737,-0.0580059194009195,3.74326418051624e-11,-4.07149206529603,1.05720668800538,1.15441290289394,0.737814839085848,-0.416598063808087,0.000446353023767032,ENSG00000112394,SLC16A10,protein_coding,6,1,111087503,111231194,q21,solute carrier family 16 member 10 [Source:HGNC Symbol;Acc:HGNC:17027],NA,SLC16A10,117247,NM_018593
PMM1_SIG,PMM1,PMM1_SIG,PMM1,SIG,42,-7.13813381303414,0.14437291467859,0.170439401178622,0.0587258876070565,-0.111713513571565,3.89957687605448e-11,-5.75692409692987,3.02037000253764,3.1769398549912,2.50592620161879,-0.671013653372411,4.74812287365408e-07,ENSG00000100417,PMM1,protein_coding,22,-1,41576900,41589871,q13.2,phosphomannomutase 1 [Source:HGNC Symbol;Acc:HGNC:9114],NA,PMM1,5372,NM_002676
SLC37A3_SIG,SLC37A3,SLC37A3_SIG,SLC37A3,SIG,31,-7.12898833703999,0.0539959015266001,0.081376937457062,-0.0359703593877748,-0.117347296844837,4.14698293424325e-11,-4.83980648728894,2.88165118172984,3.03852844563938,2.36619731459848,-0.672331131040908,2.748171093025e-05,ENSG00000157800,SLC37A3,protein_coding,7,-1,140293693,140404433,q34,solute carrier family 37 member 3 [Source:HGNC Symbol;Acc:HGNC:20651],NA,SLC37A3,84255,NM_001287498;NM_032295;NM_207113
ZNF580_TF,ZNF580,ZNF580_TF,ZNF580,TF,140,7.12436521908794,-0.0208511408130575,-0.0306844322208074,0.0114582452409777,0.042142677461785,4.24501652679165e-11,3.75618859233486,4.61555031594694,4.56960819417624,4.76650300176494,0.196894807588704,0.001233602567849,ENSG00000213015,ZNF580,protein_coding,19,1,55635016,55643470,q13.42,zinc finger protein 580 [Source:HGNC Symbol;Acc:HGNC:29473],NA,ZNF580,51157,NM_001163423;NM_016202;NM_207115
LMLN_SIG,LMLN,LMLN_SIG,LMLN,SIG,42,7.1242448136898,0.0613574874641235,0.0416296346588332,0.126177575252934,0.0845479405941014,4.24501652679165e-11,5.29405142867021,2.99478281897568,2.86044573891137,3.43617608204409,0.575730343132718,4.09613484315307e-06,ENSG00000185621,LMLN,protein_coding,3,1,197960200,198043720,q29,leishmanolysin like peptidase [Source:HGNC Symbol;Acc:HGNC:15991],NA,LMLN,89782,NM_001136049;NM_033029
GCHFR_SIG,GCHFR,GCHFR_SIG,GCHFR,SIG,26,-7.12374063371853,-0.0442429473084187,-0.0293443288385156,-0.0931955508523862,-0.0638512220138705,4.24501652679165e-11,-3.34906182172586,2.35248847942999,2.43738699531496,2.07353621295081,-0.363850782364144,0.00418380964640037,ENSG00000137880,GCHFR,protein_coding,15,1,40764068,40767708,q15.1,GTP cyclohydrolase I feedback regulator [Source:HGNC Symbol;Acc:HGNC:4194],NA,GCHFR,2644,NM_005258
ZNF595_TF,ZNF595,ZNF595_TF,ZNF595,TF,58,-7.11543447728238,0.0199538235398755,0.0316881342593254,-0.0186017688240313,-0.0502899030833566,4.48680353845648e-11,-2.2867664210847,1.56455974967523,1.65041532370667,1.2824628635719,-0.367952460134775,0.0554835497233186,ENSG00000272602,ZNF595,protein_coding,4,1,53286,88208,p16.3,zinc finger protein 595 [Source:HGNC Symbol;Acc:HGNC:27196],NA,ZNF595,152687,NM_001286052;NM_001286053;NM_001286054;NM_182524
IMMP2L_SIG,IMMP2L,IMMP2L_SIG,IMMP2L,SIG,32,7.1136674977293,0.134020652245208,0.114119146999265,0.199411312339022,0.0852921653397571,4.51349372554537e-11,5.24902913522266,2.24341449852126,2.14533137138094,2.56568763055375,0.420356259172806,4.98123165782383e-06,ENSG00000184903,IMMP2L,protein_coding,7,-1,110663051,111562517,q31.1,inner mitochondrial membrane peptidase subunit 2 [Source:HGNC Symbol;Acc:HGNC:14598],NA,IMMP2L,83943,NM_001244606;NM_001350959;NM_001350960;NM_001350961;NM_001350962;NM_001350963;NM_001350964;NM_032549
CDX2_TF,CDX2,CDX2_TF,CDX2,TF,28,7.11328368897729,-0.0335544789934617,-0.0444438435274109,0.00222486161808557,0.0466687051454963,4.51349372554537e-11,1.52274734709025,0.269870132817749,0.254765563129975,0.319499433220432,0.064733870090457,0.214479747087248,ENSG00000165556,CDX2,protein_coding,13,-1,27962137,27971139,q12.2,caudal type homeobox 2 [Source:HGNC Symbol;Acc:HGNC:1806],NA,CDX2,1045,NM_001265;NM_001354700
ITGB8_SIG,ITGB8,ITGB8_SIG,ITGB8,SIG,61,7.10713091303317,-0.0201904187286338,-0.0349788247487451,0.0284000581945889,0.063378882943334,4.69668496344297e-11,4.57712893036458,1.69322298114491,1.51297655870472,2.28546122630554,0.772484667600819,7.50724088992644e-05,ENSG00000105855,ITGB8,protein_coding,7,1,20330702,20415754,p21.1,integrin subunit beta 8 [Source:HGNC Symbol;Acc:HGNC:6163],NA,ITGB8,3696,NM_002214
ASAH1_SIG,ASAH1,ASAH1_SIG,ASAH1,SIG,13,-7.10206835854231,0.442830344451227,0.46136623933026,0.381926689848692,-0.0794395494815676,4.84883207610381e-11,-5.36377911412845,7.68826204029951,7.78674433205538,7.36467736738737,-0.422066964668009,3.00675697823088e-06,ENSG00000104763,ASAH1,protein_coding,8,-1,18055992,18084998,p22,N-acylsphingosine amidohydrolase 1 [Source:HGNC Symbol;Acc:HGNC:735],Farber disease;Farber lipogranulomatosis;Spinal muscular atrophy-progressive myoclonic epilepsy syndrome;Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy;SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,ASAH1,427,NM_001127505;NM_001363743;NM_004315;NM_177924
SCN4A_SIG,SCN4A,SCN4A_SIG,SCN4A,SIG,40,7.09958600408321,0.0121269652125478,-0.00247448210158713,0.0601031492447055,0.0625776313462927,4.91332527895917e-11,5.39381963953415,0.694531493264434,0.60259930227339,0.996594406520724,0.393995104247335,2.60793456137952e-06,ENSG00000007314,SCN4A,protein_coding,17,-1,63938554,63972918,q23.3,sodium voltage-gated channel alpha subunit 4 [Source:HGNC Symbol;Acc:HGNC:10591],Acetazolamide-responsive myotonia;HYPERKALEMIC PERIODIC PARALYSIS;Hyperkalemic Periodic Paralysis Type 1;Hypokalemic periodic paralysis;HYPOKALEMIC PERIODIC PARALYSIS TYPE 1;HYPOKALEMIC PERIODIC PARALYSIS TYPE 2;MYASTHENIC SYNDROME CONGENITAL 16;MYOTONIA FLUCTUANS;MYOTONIA PERMANENS;MYOTONIA POTASSIUM-AGGRAVATED;PARAMYOTONIA CONGENITA OF VON EULENBURG;Postsynaptic congenital myasthenic syndromes,SCN4A,6329,NM_000334
PTGER1_SIG,PTGER1,PTGER1_SIG,PTGER1,SIG,24,7.09797913550167,0.0228936757243328,0.00891068439352468,0.0688377900969882,0.0599271057034635,4.94732874576337e-11,2.6272512056761,0.397754085568948,0.359079592950792,0.524827418457175,0.165747825506384,0.0264001860634953,ENSG00000160951,PTGER1,protein_coding,19,-1,14472466,14475354,p13.12,prostaglandin E receptor 1 [Source:HGNC Symbol;Acc:HGNC:9593],NA,PTGER1,5731,NM_000955
HOXB5_TF,HOXB5,HOXB5_TF,HOXB5,TF,39,7.09691788616068,-0.00313390034130634,-0.0241138470511635,0.0658002102767958,0.0899140573279593,4.96204602169564e-11,5.52762414023071,2.26894448037251,1.9631363607448,3.27374258772071,1.31060622697591,1.40394148701845e-06,ENSG00000120075,HOXB5,protein_coding,17,-1,48591257,48593961,q21.32,homeobox B5 [Source:HGNC Symbol;Acc:HGNC:5116],NA,HOXB5,3215,NM_002147
MOK_SIG,MOK,MOK_SIG,MOK,SIG,15,7.09165028179055,-0.0491891084511231,-0.0655024060194212,0.00441172641614216,0.0699141324355635,5.13058540746377e-11,4.0909849536525,3.02062070185958,2.89304924200151,3.43978406996467,0.546734827963163,0.000417426349628332,ENSG00000080823,MOK,protein_coding,14,-1,102224500,102305190,q32.31,MOK protein kinase [Source:HGNC Symbol;Acc:HGNC:9833],NA,MOK,5891,NM_001272011;NM_001330234;NM_001353827;NM_001353828;NM_001353829;NM_001353830;NM_001353831;NM_014226
MICAL1_SIG,MICAL1,MICAL1_SIG,MICAL1,SIG,28,-7.08877730170399,0.0354711701832192,0.0551613093713091,-0.0292250014347904,-0.0843863108060995,5.21384863172063e-11,-4.5469321014213,7.64006205716552,7.74709204057929,7.28839211166312,-0.458699928916166,8.36647695065347e-05,ENSG00000135596,MICAL1,protein_coding,6,-1,109444062,109465968,q21,microtubule associated monooxygenase, calponin and LIM domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20619],NA,MICAL1,64780,NM_001159291;NM_001286613;NM_022765
GNG11_SIG,GNG11,GNG11_SIG,GNG11,SIG,67,-7.08771023967192,-0.0533415913685249,-0.0371760278466266,-0.106457014369048,-0.0692809865224216,5.22313300911768e-11,-4.30310627391417,1.54729984555585,1.72101100087841,0.976534620924601,-0.744476379953808,0.000202219129382499,ENSG00000127920,GNG11,protein_coding,7,1,93921699,93928610,q21.3,G protein subunit gamma 11 [Source:HGNC Symbol;Acc:HGNC:4403],NA,GNG11,2791,NM_004126
TRIM45_SIG,TRIM45,TRIM45_SIG,TRIM45,SIG,32,7.08724926971196,0.0503130958211968,0.0330977341144122,0.106877855714918,0.0737801216005054,5.22313300911768e-11,5.59304425656492,2.24998171773898,2.1237975875678,2.66458671687285,0.540789129305041,1.05342594720745e-06,ENSG00000134253,TRIM45,protein_coding,1,-1,117111060,117122587,p13.1,tripartite motif containing 45 [Source:HGNC Symbol;Acc:HGNC:19018],NA,TRIM45,80263,NM_001145635;NM_025188
COLGALT2_SIG,COLGALT2,COLGALT2_SIG,COLGALT2,SIG,46,-7.08219502975963,-0.0238190802606721,-0.0113638431830136,-0.0647434306586929,-0.0533795874756793,5.39242421021724e-11,-4.20518801019959,1.44622629759084,1.5731249690959,1.02927351978853,-0.543851449307363,0.000283010873042635,ENSG00000198756,COLGALT2,protein_coding,1,-1,183929854,184037729,q25.3,collagen beta(1-O)galactosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:16790],NA,COLGALT2,23127,NM_001303420;NM_001303421;NM_015101
FLT4_SIG,FLT4,FLT4_SIG,FLT4,SIG,43,-7.08090980051773,-0.0840133766939642,-0.0713388361160476,-0.12565829573569,-0.0543194596196424,5.4178262770796e-11,-4.71788900869453,1.54088458008039,1.72273401350094,0.943379298841455,-0.779354714659486,4.36070385088322e-05,ENSG00000037280,FLT4,protein_coding,5,-1,180601506,180649624,q35.3,fms related tyrosine kinase 4 [Source:HGNC Symbol;Acc:HGNC:3767],HEMANGIOMA CAPILLARY INFANTILE;LYMPHATIC MALFORMATION 1;Milroy Disease,FLT4,2324,NM_001354989;NM_002020;NM_182925
KRT18_SIG,KRT18,KRT18_SIG,KRT18,SIG,66,7.04699593371837,-0.0400366958393976,-0.0577113162843693,0.0180370570512237,0.0757483733355929,6.8848975010373e-11,5.35643124407591,2.8153336241572,2.54386418444272,3.70730464036191,1.16344045591918,3.10648268354275e-06,ENSG00000111057,KRT18,protein_coding,12,1,52948871,52952906,q13.13,keratin 18 [Source:HGNC Symbol;Acc:HGNC:6430],CIRRHOSIS FAMILIAL;CIRRHOSIS FAMILIALCIRRHOSIS FAMILIAL WITH PULMONARY HYPERTENSION INCLUDED,KRT18,3875,NM_000224;NM_199187
PTPRK_SIG,PTPRK,PTPRK_SIG,PTPRK,SIG,34,-7.04150730119532,-0.242200391215807,-0.231175495360497,-0.27842504902611,-0.0472495536656138,7.12927057177472e-11,-3.78741400901459,0.626346871387742,0.692146548227641,0.410147933199505,-0.281998615028136,0.0011188685072841,ENSG00000152894,PTPRK,protein_coding,6,-1,127968779,128520674,q22.33,protein tyrosine phosphatase, receptor type K [Source:HGNC Symbol;Acc:HGNC:9674],NA,PTPRK,5796,NM_001135648;NM_001291981;NM_001291982;NM_001291983;NM_001291984;NM_002844
DOCK1_SIG,DOCK1,DOCK1_SIG,DOCK1,SIG,169,7.0402641501951,-0.0240221636658286,-0.0384738703191813,0.0234620153380444,0.0619358856572256,7.16076769706312e-11,6.13599707945693,3.36773849141867,2.98649768645717,4.62038685057789,1.63388916412072,7.26548951975273e-08,ENSG00000150760,DOCK1,protein_coding,10,1,126905409,127452517,q26.2,dedicator of cytokinesis 1 [Source:HGNC Symbol;Acc:HGNC:2987],NA,DOCK1,1793,NM_001290223;NM_001380
CHD5_SIG,CHD5,CHD5_SIG,CHD5,SIG,23,7.03105021120416,0.0350842796710092,0.0164051613680127,0.0964585255237117,0.0800533641556989,7.61568766654371e-11,6.57893996546863,1.36145571051524,1.16385637155006,2.01071068140084,0.846854309850781,6.89203230443798e-09,ENSG00000116254,CHD5,protein_coding,1,-1,6101787,6180321,p36.31,chromodomain helicase DNA binding protein 5 [Source:HGNC Symbol;Acc:HGNC:16816],NA,CHD5,26038,NM_015557
NR1H3_TF,NR1H3,NR1H3_TF,NR1H3,TF,150,7.02779648102889,0.0844892383528916,0.0687329532489439,0.13625988940872,0.067526936159776,7.74285731136474e-11,4.72101690497872,4.11022140928671,3.97027519734352,4.57004467710004,0.599769479756518,4.31182841721762e-05,ENSG00000025434,NR1H3,protein_coding,11,1,47248300,47269033,p11.2,nuclear receptor subfamily 1 group H member 3 [Source:HGNC Symbol;Acc:HGNC:7966],NA,NR1H3,10062,NM_001130101;NM_001130102;NM_001251934;NM_001251935;NM_005693
IL3RA_SIG,IL3RA,IL3RA_SIG,IL3RA,SIG,33,7.02749339956384,0.298663450830013,0.286596426966939,0.338312243522969,0.0517158165560293,7.74285731136474e-11,4.84979504215735,5.13268090819861,4.97481999330377,5.65136677142453,0.67654677812076,2.64517762234894e-05,ENSG00000185291,IL3RA,protein_coding,X,1,1336616,1382689,p22.33,interleukin 3 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:6012],NA,IL3RA,3563,NM_001267713;NM_002183
PRDM5_SIG,PRDM5,PRDM5_SIG,PRDM5,SIG,34,-7.00332519565877,-0.149351258985959,-0.129113982220002,-0.21584516835982,-0.0867311861398177,9.16327339198565e-11,-4.57134279582299,0.738704481679867,0.858433741362352,0.345308342723133,-0.513125398639218,7.64824502298383e-05,ENSG00000138738,PRDM5,protein_coding,4,-1,120684919,120922870,q27,PR/SET domain 5 [Source:HGNC Symbol;Acc:HGNC:9349],Brittle cornea syndrome;BRITTLE CORNEA SYNDROME 2,PRDM5,11107,NM_001300823;NM_001300824;NM_018699
AHDC1_TF,AHDC1,AHDC1_TF,AHDC1,TF,148,6.98849397647578,0.151110774571853,0.129372531705913,0.222536429702799,0.0931638979968861,1.01410079901068e-10,5.700142514726,5.28017760444635,5.13065266055691,5.77147384865451,0.6408211880976,6.38728002961312e-07,ENSG00000126705,AHDC1,protein_coding,1,-1,27534035,27604431,p35.3,AT-hook DNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25230],AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome;Xia-Gibbs syndrome,AHDC1,27245,NM_001029882
ST6GALNAC4_SIG,ST6GALNAC4,ST6GALNAC4_SIG,ST6GALNAC4,SIG,38,6.9876851512572,-0.00704402337901867,-0.017305419963726,0.0266719939707338,0.0439774139344597,1.01548899574614e-10,4.98407436882801,4.12455129905356,4.0149030957921,4.48482396691266,0.469920871120561,1.51095833522611e-05,ENSG00000136840,ST6GALNAC4,protein_coding,9,-1,127907886,127917041,q34.11,ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:17846],NA,ST6GALNAC4,27090,NM_175039;NM_175040
CPT1A_SIG,CPT1A,CPT1A_SIG,CPT1A,SIG,38,6.98086769364725,0.330551389613489,0.315585495380452,0.379725042093467,0.0641395467130151,1.06135731253312e-10,5.02330308618689,7.96420211326651,7.87942269274139,8.24276306642051,0.363340373679124,1.29713838979372e-05,ENSG00000110090,CPT1A,protein_coding,11,-1,68754620,68844410,q13.3,carnitine palmitoyltransferase 1A [Source:HGNC Symbol;Acc:HGNC:2328],Carnitine palmitoyl transferase 1A deficiency;CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY,CPT1A,1374,NM_001031847;NM_001876
TP53BP1_SIG,TP53BP1,TP53BP1_SIG,TP53BP1,SIG,66,6.97684760946456,0.275398113188516,0.254256843273417,0.3448622857667,0.0906054424932822,1.08741287273856e-10,5.5964029407964,5.98371114774578,5.87430871840038,6.34317627273778,0.468867554337397,1.04555595415961e-06,ENSG00000067369,TP53BP1,protein_coding,15,-1,43403061,43510728,q15.3,tumor protein p53 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11999],NA,TP53BP1,7158,NM_001141979;NM_001141980;NM_001355001;NM_005657
MGAT4A_SIG,MGAT4A,MGAT4A_SIG,MGAT4A,SIG,38,-6.97405329337792,0.160065576554989,0.177998200177487,0.101144098938208,-0.0768541012392787,1.10444194272899e-10,-4.10110977917256,5.03925362985156,5.13841095315694,4.71345099613388,-0.424959957023058,0.000404217283604421,ENSG00000071073,MGAT4A,protein_coding,2,-1,98619106,98731132,q11.2,alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A [Source:HGNC Symbol;Acc:HGNC:7047],NA,MGAT4A,11320,NM_001160154;NM_012214
ZDHHC21_TF,ZDHHC21,ZDHHC21_TF,ZDHHC21,TF,133,6.96961900765518,0.149951573329602,0.135104767158996,0.19873393646159,0.0636291693025936,1.134903739203e-10,4.36511806213791,4.52982016221382,4.43919043646008,4.82760354683327,0.388413110373195,0.000161645397372826,ENSG00000175893,ZDHHC21,protein_coding,9,-1,14611071,14693471,p22.3,zinc finger DHHC-type containing 21 [Source:HGNC Symbol;Acc:HGNC:20750],NA,ZDHHC21,340481,NM_001354118;NM_001354119;NM_001354120;NM_001354121;NM_001354122;NM_001354123;NM_001354124;NM_001354125;NM_001354126;NM_001354127;NM_001354128;NM_001354129;NM_001354130;NM_178566
XPNPEP2_SIG,XPNPEP2,XPNPEP2_SIG,XPNPEP2,SIG,26,-6.95585839656377,-0.056985752905979,-0.0413398624279181,-0.108393678762465,-0.0670538163345466,1.24602740481489e-10,-4.16811982214162,0.657293551742473,0.727339866366455,0.427141375120817,-0.300198491245638,0.00032148189542402,ENSG00000122121,XPNPEP2,protein_coding,X,1,129738974,129769536,q26.1,X-prolyl aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:12823],ANGIOEDEMA INDUCED BY ACE INHIBITORS SUSCEPTIBILITY TO;Renin-angiotensin-aldosterone system-blocker-induced angioedema,XPNPEP2,7512,NM_003399
PTK2_SIG,PTK2,PTK2_SIG,PTK2,SIG,121,-6.9442215425672,-0.0490528390613778,-0.032475115021896,-0.103522503762532,-0.0710473887406362,1.34738494629965e-10,-5.02739687939936,3.05852110168456,3.30140145021193,2.26048567080889,-1.04091577940304,1.2757484309571e-05,ENSG00000169398,PTK2,protein_coding,8,-1,140657900,141002216,q24.3,protein tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:9611],NA,PTK2,5747,NM_001199649;NM_001316342;NM_001352694;NM_001352695;NM_001352696;NM_001352697;NM_001352698;NM_001352699;NM_001352700;NM_001352701;NM_001352702;NM_001352703;NM_001352704;NM_001352705;NM_001352706;NM_001352707;NM_001352708;NM_001352709;NM_001352710;NM_001352711;NM_001352712;NM_001352713;NM_001352714;NM_001352715;NM_001352716;NM_001352717;NM_001352718;NM_001352719;NM_001352720;NM_001352721;NM_001352722;NM_001352723;NM_001352724;NM_001352725;NM_001352726;NM_001352727;NM_001352728;NM_001352729;NM_001352730;NM_001352731;NM_001352732;NM_001352733;NM_001352734;NM_001352735;NM_001352736;NM_001352737;NM_001352738;NM_001352739;NM_001352740;NM_001352741;NM_001352742;NM_001352743;NM_001352744;NM_001352745;NM_001352746;NM_001352747;NM_001352749;NM_001352750;NM_001352751;NM_001352752;NM_005607;NM_153831
PFKP_SIG,PFKP,PFKP_SIG,PFKP,SIG,35,6.93668492658511,0.251164773920407,0.234338482510469,0.306451159981633,0.0721126774711644,1.41517564810375e-10,3.99107445424605,6.58114356201357,6.47720979405194,6.92264022817321,0.445430434121263,0.000585383912048164,ENSG00000067057,PFKP,protein_coding,10,1,3066333,3137718,p15.2,phosphofructokinase, platelet [Source:HGNC Symbol;Acc:HGNC:8878],NA,PFKP,5214,NM_001242339;NM_001323067;NM_001323068;NM_001323069;NM_001323070;NM_001323071;NM_001323072;NM_001323073;NM_001323074;NM_001345944;NM_002627
BACE1_SIG,BACE1,BACE1_SIG,BACE1,SIG,49,6.92774687431525,0.0993648765672487,0.0845548325133032,0.148026449887355,0.063471617374052,1.50111538944915e-10,4.41962710929688,4.74563570139591,4.60455109711514,5.20919940117559,0.60464830406045,0.000132975566133839,ENSG00000186318,BACE1,protein_coding,11,-1,117285207,117316259,q23.3,beta-secretase 1 [Source:HGNC Symbol;Acc:HGNC:933],NA,BACE1,23621,NM_001207048;NM_001207049;NM_012104;NM_138971;NM_138972;NM_138973
PVR_SIG,PVR,PVR_SIG,PVR,SIG,69,6.92471983349049,-0.0108396103792689,-0.0228400728750033,0.0285904806781441,0.0514305535531474,1.52709395381668e-10,4.18511178946666,3.84526174831852,3.71288962970761,4.28019870946865,0.567309079761039,0.000304023078214459,ENSG00000073008,PVR,protein_coding,19,1,44643798,44666162,q13.31,poliovirus receptor [Source:HGNC Symbol;Acc:HGNC:9705],NA,PVR,5817,NM_001135768;NM_001135769;NM_001135770;NM_006505
AOX1_SIG,AOX1,AOX1_SIG,AOX1,SIG,50,-6.92107489239811,0.0484939146612293,0.0599236167048307,0.0109391793751104,-0.0489844373297203,1.56032807312319e-10,-4.71367743201308,1.06135725170912,1.188875972582,0.64236716884108,-0.54650880374092,4.42702410432045e-05,ENSG00000138356,AOX1,protein_coding,2,1,200586014,200677064,q33.1,aldehyde oxidase 1 [Source:HGNC Symbol;Acc:HGNC:553],NA,AOX1,316,NM_001159
SERPINB2_SIG,SERPINB2,SERPINB2_SIG,SERPINB2,SIG,20,-6.91876288840039,0.205029690679959,0.234534002697334,0.1080869511943,-0.126447051503033,1.57936604090082e-10,-5.43064750599304,3.27634158040033,3.59999678070505,2.21290306511339,-1.38709371559166,2.22933983397949e-06,ENSG00000197632,SERPINB2,protein_coding,18,1,63871692,63903888,q21.33,serpin family B member 2 [Source:HGNC Symbol;Acc:HGNC:8584],NA,SERPINB2,5055,NM_001143818;NM_002575
ENOSF1_SIG,ENOSF1,ENOSF1_SIG,ENOSF1,SIG,25,6.90801558966834,0.0944053450444132,0.0806589385811808,0.139572109137891,0.0589131705567101,1.69662986050257e-10,5.26065788696704,5.0271840975289,4.90007216630436,5.44483758583812,0.544765419533755,4.72340526427952e-06,ENSG00000132199,ENOSF1,protein_coding,18,-1,670318,712662,p11.32,enolase superfamily member 1 [Source:HGNC Symbol;Acc:HGNC:30365],NA,ENOSF1,55556,NM_001318760;NM_001354065;NM_001354066;NM_001354067;NM_001354068;NM_017512;NM_202758
HESX1_TF,HESX1,HESX1_TF,HESX1,TF,81,6.90566353146247,0.144865417566442,0.132142588460157,0.186668998915663,0.0545264104555063,1.71782454725857e-10,3.77457532438928,1.70452550281979,1.63035887924591,1.94821583741966,0.317856958173752,0.00116311572695111,ENSG00000163666,HESX1,protein_coding,3,-1,57197838,57227606,p14.3,HESX homeobox 1 [Source:HGNC Symbol;Acc:HGNC:4877],Combined pituitary hormone deficiencies genetic forms;HESX1-Related Combined Pituitary Hormone Deficiency;Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Kallmann Syndrome;Pituitary stalk interruption syndrome;Septo-optic dysplasia spectrum;SEPTOOPTIC DYSPLASIA,HESX1,8820,NM_003865
GRK4_SIG,GRK4,GRK4_SIG,GRK4,SIG,28,6.8977461382985,0.18214507495297,0.160962202796364,0.251745940610389,0.090783737814026,1.80880210678533e-10,5.56105726846917,2.67334868223004,2.5658422926924,3.02658396213942,0.460741669447021,1.2030710167125e-06,ENSG00000125388,GRK4,protein_coding,4,1,2963571,3040760,p16.3,G protein-coupled receptor kinase 4 [Source:HGNC Symbol;Acc:HGNC:4543],NA,GRK4,2868,NM_001004056;NM_001004057;NM_001350173;NM_005307;NM_182982
PGBD1_TF,PGBD1,PGBD1_TF,PGBD1,TF,145,6.8966924663924,-0.0074789346820714,-0.0275919190386225,0.0586065853465964,0.0861985043852189,1.81476399297016e-10,5.84550586633851,2.95313843040649,2.82463699418658,3.37535743512905,0.550720440942476,3.08379574817903e-07,ENSG00000137338,PGBD1,protein_coding,6,1,28281572,28302549,p22.1,piggyBac transposable element derived 1 [Source:HGNC Symbol;Acc:HGNC:19398],NA,PGBD1,84547,NM_001184743;NM_032507
ZDHHC15_TF,ZDHHC15,ZDHHC15_TF,ZDHHC15,TF,252,6.89497070928591,-0.0225683052033503,-0.0338616338569648,0.0145383460870973,0.0483999799440621,1.82935186641601e-10,5.99314890824886,0.88607171247414,0.733689103693669,1.38675742703854,0.653068323344874,1.46882038043476e-07,ENSG00000102383,ZDHHC15,protein_coding,X,-1,75368427,75523502,q13.3,zinc finger DHHC-type containing 15 [Source:HGNC Symbol;Acc:HGNC:20342],MENTAL RETARDATION X-LINKED 91;MENTAL RETARDATION X-LINKED TYPE 91,ZDHHC15,158866,NM_001146256;NM_144969
HDAC8_SIG,HDAC8,HDAC8_SIG,HDAC8,SIG,22,6.88723984178575,0.153726102460661,0.135263292448029,0.214389621073592,0.0791263286255632,1.92365093291728e-10,5.14029998013175,4.09466307489841,4.03558199883479,4.28878661053603,0.253204611701243,8.09327305367128e-06,ENSG00000147099,HDAC8,protein_coding,X,-1,72329516,72573101,q13.1,histone deacetylase 8 [Source:HGNC Symbol;Acc:HGNC:13315],CORNELIA DE LANGE-LIKE SYNDROME HDAC8 XLR;Cornelia de Lange syndrome;CORNELIA DE LANGE SYNDROME 5;Cornelia de Lange Syndrome HDAC8 X-linked dominant;Wilson-Turner syndrome,HDAC8,55869,NM_001166418;NM_001166419;NM_001166420;NM_001166422;NM_001166448;NM_018486
MTA1_TF,MTA1,MTA1_TF,MTA1,TF,389,6.87418486909472,0.103613795439995,0.0848387978550425,0.165303073219125,0.0804642753640826,2.09971921873318e-10,5.61654204077008,6.61242613402477,6.53602700262864,6.86345185146922,0.327424848840582,9.62994104623954e-07,ENSG00000182979,MTA1,protein_coding,14,1,105419820,105470729,q32.33,metastasis associated 1 [Source:HGNC Symbol;Acc:HGNC:7410],NA,MTA1,9112,NM_001203258;NM_004689
ARHGAP24_SIG,ARHGAP24,ARHGAP24_SIG,ARHGAP24,SIG,20,-6.86904213057567,0.237081431781807,0.284356329334956,0.0817496255357466,-0.202606703799209,2.16698493229895e-10,-5.21114086702778,2.72808737051626,2.93668322696287,2.04270098504883,-0.89398224191404,5.87944271238479e-06,ENSG00000138639,ARHGAP24,protein_coding,4,1,85475150,86002668,q21.23,Rho GTPase activating protein 24 [Source:HGNC Symbol;Acc:HGNC:25361],Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,ARHGAP24,83478,NM_001025616;NM_001042669;NM_001287805;NM_001346093;NM_031305
CYB5D1_SIG,CYB5D1,CYB5D1_SIG,CYB5D1,SIG,5,6.86822712187044,0.0243244845181211,0.00120877451831653,0.100276103088908,0.0990673285705914,2.16698493229895e-10,4.42312828170935,3.79984418192875,3.72921899276276,4.03189837490272,0.302679382139953,0.000131146850226508,ENSG00000182224,CYB5D1,protein_coding,17,1,7857746,7862282,p13.1,cytochrome b5 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26516],NA,CYB5D1,124637,NM_001330110;NM_144607
FNBP1_SIG,FNBP1,FNBP1_SIG,FNBP1,SIG,61,6.86747239680318,0.124731145157629,0.108783880614306,0.17712930008569,0.0683454194713835,2.16698493229895e-10,3.85019191564476,8.24415158509109,8.18463874671453,8.43969376832834,0.255055021613803,0.000920540962482852,ENSG00000187239,FNBP1,protein_coding,9,-1,129887187,130043194,q34.11,formin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17069],NA,FNBP1,23048,NM_015033
UCKL1_SIG,UCKL1,UCKL1_SIG,UCKL1,SIG,31,6.86738635939563,0.273473320426952,0.25303402061109,0.340631019821928,0.0875969992108379,2.16698493229895e-10,4.53350711312432,5.26623474491153,5.2190722416175,5.42119725573478,0.202125014117279,8.79115568208631e-05,ENSG00000198276,UCKL1,protein_coding,20,-1,63939829,63956416,q13.33,uridine-cytidine kinase 1 like 1 [Source:HGNC Symbol;Acc:HGNC:15938],NA,UCKL1,54963,NM_001193379;NM_001353475;NM_001353476;NM_001353477;NM_001353478;NM_001353479;NM_001353480;NM_001353481;NM_001353482;NM_017859
TOX2_TF,TOX2,TOX2_TF,TOX2,TF,196,-6.86596020450884,-0.104139738078863,-0.0940854656150317,-0.137175204745735,-0.0430897391307037,2.18002726116967e-10,-3.34256378944565,0.989900670584302,1.06246973490695,0.75145945923845,-0.311010275668502,0.00426374258699918,ENSG00000124191,TOX2,protein_coding,20,1,43914852,44069616,q13.12,TOX high mobility group box family member 2 [Source:HGNC Symbol;Acc:HGNC:16095],NA,TOX2,84969,NM_001098796;NM_001098797;NM_001098798;NM_032883
ZNHIT1_TF,ZNHIT1,ZNHIT1_TF,ZNHIT1,TF,189,6.85900732143713,0.0879246883923118,0.082136870711974,0.106941803627707,0.0248049329157333,2.27971262582036e-10,3.86336756959909,5.37283766168258,5.33662092640731,5.4918355061585,0.155214579751194,0.000881589660432261,ENSG00000106400,ZNHIT1,protein_coding,7,1,101218165,101224190,q22.1,zinc finger HIT-type containing 1 [Source:HGNC Symbol;Acc:HGNC:21688],NA,ZNHIT1,10467,NM_006349
SLC12A2_SIG,SLC12A2,SLC12A2_SIG,SLC12A2,SIG,21,6.85271111671988,0.248779313269923,0.227413662499018,0.318980737231467,0.0915670747324488,2.37295920671259e-10,4.83286487610619,4.60704113694747,4.49614997397197,4.97139781529555,0.475247841323582,2.80937137865273e-05,ENSG00000064651,SLC12A2,protein_coding,5,1,128083766,128189677,q23.3,solute carrier family 12 member 2 [Source:HGNC Symbol;Acc:HGNC:10911],NA,SLC12A2,6558,NM_001046;NM_001256461
NT5DC3_SIG,NT5DC3,NT5DC3_SIG,NT5DC3,SIG,54,6.85113212719499,-0.0117067291189699,-0.0233050954095007,0.0264021886927739,0.0497072841022745,2.38985729880302e-10,4.33561436368821,4.56528973184502,4.42565778966368,5.02408039901228,0.598422609348608,0.000179534863838886,ENSG00000111696,NT5DC3,protein_coding,12,-1,103770453,103841234,q23.3,5'-nucleotidase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:30826],NA,NT5DC3,51559,NM_001031701
DNM1_SIG,DNM1,DNM1_SIG,DNM1,SIG,25,6.84744157198014,0.144007550009918,0.123098360176062,0.212709173749731,0.0896108135736692,2.44269033258768e-10,3.11424081545397,4.10893295353451,3.97727586256151,4.5415205381601,0.564244675598585,0.00802357496316675,ENSG00000106976,DNM1,protein_coding,9,1,128191655,128255248,q34.11,dynamin 1 [Source:HGNC Symbol;Acc:HGNC:2972],Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 31;Lennox-Gastaut syndrome;Undetermined early-onset epileptic encephalopathy,DNM1,1759,NM_001005336;NM_001288737;NM_001288738;NM_001288739;NM_004408
IRX5_TF,IRX5,IRX5_TF,IRX5,TF,198,6.84326715816599,-0.0974732863108255,-0.109996928838801,-0.056324175147478,0.0536727536913226,2.50514763699232e-10,4.40727428320586,1.31568042695922,1.12409685565558,1.94516930409972,0.821072448444134,0.000139310485019562,ENSG00000176842,IRX5,protein_coding,16,1,54930862,54934485,q12.2,iroquois homeobox 5 [Source:HGNC Symbol;Acc:HGNC:14361],Craniofacial dysplasia-osteopenia syndrome;HAMAMY SYNDROME;HYPERTELORISM SEVERE WITH MIDFACE PROMINENCE MYOPIA MENTAL RETARDATION AND BONE FRAGILITY,IRX5,10265,NM_001252197;NM_005853
TIE1_SIG,TIE1,TIE1_SIG,TIE1,SIG,86,6.84135950889497,0.0166233086928956,-0.0051859599509725,0.0882823342370335,0.093468294188006,2.52886290979216e-10,4.52866960403512,3.66590744226259,3.45713050957145,4.35188879253348,0.894758282962029,8.94141261657605e-05,ENSG00000066056,TIE1,protein_coding,1,1,43300982,43323108,p34.2,tyrosine kinase with immunoglobulin like and EGF like domains 1 [Source:HGNC Symbol;Acc:HGNC:11809],NA,TIE1,7075,NM_001253357;NM_005424
FGGY_SIG,FGGY,FGGY_SIG,FGGY,SIG,6,6.83173621674611,0.113028170837689,0.102691139378968,0.146992702773487,0.0443015633945197,2.69400608934645e-10,2.8780968583176,2.46276885282794,2.41822642228712,2.60912255317634,0.190896130889225,0.0146491566552592,ENSG00000172456,FGGY,protein_coding,1,1,59296638,59810647,p32.1,FGGY carbohydrate kinase domain containing [Source:HGNC Symbol;Acc:HGNC:25610],NA,FGGY,55277,NM_001113411;NM_001244714;NM_001278224;NM_001350790;NM_001350791;NM_001350792;NM_001350793;NM_001350794;NM_001350795;NM_001350796;NM_001350797;NM_001350798;NM_001350799;NM_018291
ZBTB7C_TF,ZBTB7C,ZBTB7C_TF,ZBTB7C,TF,133,6.81067497236603,-0.03786916675207,-0.0442464225455825,-0.016915326287672,0.0273310962579104,3.10741504420333e-10,4.62170284317688,0.353098851830648,0.282645540150193,0.584588304495001,0.301942764344808,6.31673634202048e-05,ENSG00000184828,ZBTB7C,protein_coding,18,-1,48026672,48410752,q21.1,zinc finger and BTB domain containing 7C [Source:HGNC Symbol;Acc:HGNC:31700],NA,ZBTB7C,201501,NM_001039360;NM_001318841
CEL_SIG,CEL,CEL_SIG,CEL,SIG,49,6.80172905737051,0.0701693846014875,0.0481110134423509,0.142646889838651,0.0945358763962998,3.29395272461262e-10,4.97138505540418,1.72237150864537,1.59787763240578,2.13142281628975,0.533545183883967,1.59801960910934e-05,ENSG00000170835,CEL,protein_coding,9,1,133061978,133071861,q34.13,carboxyl ester lipase [Source:HGNC Symbol;Acc:HGNC:1848],MATURITY-ONSET DIABETES OF THE YOUNG TYPE 8 WITH EXOCRINE DYSFUNCTION;MODY,CEL,1056,NM_001807
FGF18_SIG,FGF18,FGF18_SIG,FGF18,SIG,11,6.79498956561724,-0.0230474126235747,-0.0409301658735212,0.0357102051976782,0.0766403710711992,3.4384454097859e-10,2.10550530430807,0.255954073595613,0.235807592208838,0.322149655295019,0.0863420630861812,0.0795870716322563,ENSG00000156427,FGF18,protein_coding,5,1,171419647,171457626,q35.1,fibroblast growth factor 18 [Source:HGNC Symbol;Acc:HGNC:3674],NA,FGF18,8817,NM_003862
MAPRE2_SIG,MAPRE2,MAPRE2_SIG,MAPRE2,SIG,68,6.79262485217564,0.140581490979148,0.118796509277808,0.212160716569265,0.0933642072914564,3.48195934799224e-10,5.34509658914078,6.64117448694069,6.54876897775616,6.94479258854697,0.396023610790808,3.27579912449121e-06,ENSG00000166974,MAPRE2,protein_coding,18,1,34976928,35143470,q12.1,microtubule associated protein RP/EB family member 2 [Source:HGNC Symbol;Acc:HGNC:6891],Circumferential Skin Creases Kunze Type;Multiple benign circumferential skin creases on limbs;Skin creases congenital symmetric circumferential 2,MAPRE2,10982,NM_001143826;NM_001143827;NM_001256420;NM_014268
L3MBTL4_SIG,L3MBTL4,L3MBTL4_SIG,L3MBTL4,SIG,53,-6.79030359960865,-0.0289910594032477,-0.0174087846462978,-0.0670471050332259,-0.0496383203869282,3.52499388920855e-10,-3.65306332970313,1.67960142620055,1.81958445528011,1.21965718779626,-0.599927267483853,0.00169838218500099,ENSG00000154655,L3MBTL4,protein_coding,18,-1,5954706,6415237,p11.31,L3MBTL4, histone methyl-lysine binding protein [Source:HGNC Symbol;Acc:HGNC:26677],NA,L3MBTL4,91133,NM_001330559;NM_001365765;NM_001365767;NM_001365770;NM_173464
CTNS_SIG,CTNS,CTNS_SIG,CTNS,SIG,18,6.78580667672645,0.151833444331265,0.136675854023387,0.201636955342863,0.0649611013194751,3.6227935097532e-10,5.60544196347277,3.93645141723654,3.82789658700352,4.29313157371647,0.465234986712947,1.00504195115882e-06,ENSG00000040531,CTNS,protein_coding,17,1,3636468,3661542,p13.2,cystinosin, lysosomal cystine transporter [Source:HGNC Symbol;Acc:HGNC:2518],CYSTINOSIS ADULT NON-NEPHROPATHIC TYPE;CYSTINOSIS ADULT NONNEPHROPATHIC;CYSTINOSIS LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;CYSTINOSIS NEPHROPATHIC;CYSTINOSIS NEPHROPATHIC TYPE;Juvenile nephropathic cystinosis;Nephropathic infantile cystinosis;Ocular cystinosis,CTNS,1497,NM_001031681;NM_004937
ETV1_TF,ETV1,ETV1_TF,ETV1,TF,213,-6.77830122492354,-0.109026978130529,-0.100334661389826,-0.13758744742141,-0.0372527860315836,3.80163085039963e-10,-3.88609295732901,0.287457135147949,0.336826457312907,0.125243648034515,-0.211582809278393,0.000819025302143088,ENSG00000006468,ETV1,protein_coding,7,-1,13891229,13991425,p21.2,ETS variant 1 [Source:HGNC Symbol;Acc:HGNC:3490],Ewing sarcoma,ETV1,2115,NM_001163147;NM_001163148;NM_001163149;NM_001163150;NM_001163151;NM_001163152;NM_004956
DPF1_TF,DPF1,DPF1_TF,DPF1,TF,132,6.7713105582252,-0.0273258804004017,-0.0374028006180535,0.00578400031473988,0.0431868009327935,3.97496209607891e-10,4.80350119235529,0.735244656125287,0.633493195383471,1.06957088427697,0.436077688893498,3.14265661734384e-05,ENSG00000011332,DPF1,protein_coding,19,-1,38211006,38229714,q13.2,double PHD fingers 1 [Source:HGNC Symbol;Acc:HGNC:20225],NA,DPF1,8193,NM_001135155;NM_001135156;NM_001289978;NM_001363579;NM_004647
CMBL_SIG,CMBL,CMBL_SIG,CMBL,SIG,83,6.75730150869581,0.0782527824200086,0.0530037390685978,0.161213924860358,0.108210185791761,4.36236099068765e-10,5.93632573100343,3.35606253623535,3.13641722444075,4.07775427498906,0.941337050548314,1.97670296584982e-07,ENSG00000164237,CMBL,protein_coding,5,-1,10275875,10307902,p15.2,carboxymethylenebutenolidase homolog [Source:HGNC Symbol;Acc:HGNC:25090],NA,CMBL,134147,NM_138809
EZR_SIG,EZR,EZR_SIG,EZR,SIG,27,-6.7546347721067,-0.00955254832314005,0.00283245199825083,-0.0502461208077101,-0.053078572805961,4.42677157320773e-10,-4.24797488140279,7.2360856951042,7.32334742532277,6.94936858152893,-0.373978843793843,0.000243389584910139,ENSG00000092820,EZR,protein_coding,6,-1,158765741,158819368,q25.3,ezrin [Source:HGNC Symbol;Acc:HGNC:12691],Autosomal recessive non-syndromic intellectual disability,EZR,7430,NM_001111077;NM_003379
TRIM46_SIG,TRIM46,TRIM46_SIG,TRIM46,SIG,22,6.75094159933103,0.0553761136161903,0.038860605085256,0.109641355932117,0.0707807508468611,4.52406337553316e-10,4.95098996444339,2.49140633039532,2.36343769243738,2.9118747122571,0.548437019819717,1.72826206565342e-05,ENSG00000163462,TRIM46,protein_coding,1,1,155173787,155184971,q22,tripartite motif containing 46 [Source:HGNC Symbol;Acc:HGNC:19019],NA,TRIM46,80128,NM_001256599;NM_001256600;NM_001256601;NM_001282378;NM_001282379;NM_025058
TEC_SIG,TEC,TEC_SIG,TEC,SIG,70,6.74933865759614,0.184999386030122,0.165518386903847,0.24900838315931,0.083489996255463,4.55738093711757e-10,6.09593472057879,5.38656104412646,5.21883676591376,5.93765510111106,0.7188183351973,9.00239581810695e-08,ENSG00000135605,TEC,protein_coding,4,-1,48135783,48269838,p11,tec protein tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:11719],NA,TEC,7006,NM_003215
SLC11A2_SIG,SLC11A2,SLC11A2_SIG,SLC11A2,SIG,27,-6.74662103266362,0.162729475784194,0.168326536441989,0.144339133622865,-0.0239874028191242,4.61958616973183e-10,-4.35019667255664,5.10991396407594,5.1803766154728,4.87839382377196,-0.301982791700842,0.000170295264033857,ENSG00000110911,SLC11A2,protein_coding,12,-1,50979401,51028566,q13.12,solute carrier family 11 member 2 [Source:HGNC Symbol;Acc:HGNC:10908],ANEMIA HYPOCHROMIC MICROCYTIC WITH IRON OVERLOAD 1;Microcytic anemia with liver iron overload,SLC11A2,4891,NM_000617;NM_001174125;NM_001174126;NM_001174127;NM_001174128;NM_001174129;NM_001174130
A2M_SIG,A2M,A2M_SIG,A2M,SIG,37,-6.74629994134833,-0.218568593385771,-0.200893042506922,-0.276645403416274,-0.0757523609093516,4.61958616973183e-10,-3.92731173004249,1.13353796685815,1.26008543313421,0.717739149093963,-0.542346284040248,0.000718839260236636,ENSG00000175899,A2M,protein_coding,12,-1,9067664,9116229,p13.31,alpha-2-macroglobulin [Source:HGNC Symbol;Acc:HGNC:7],ALPHA-2-MACROGLOBULIN DEFICIENCY;Alzheimer disease,A2M,2,NM_000014;NM_001347423;NM_001347424;NM_001347425
ANK2_SIG,ANK2,ANK2_SIG,ANK2,SIG,28,-6.73767291998481,-0.186873113082245,-0.177084110440197,-0.219036978906118,-0.041952868465921,4.88430649133091e-10,-3.26536925638681,0.256407164720038,0.302116211404856,0.10622029704135,-0.195895914363506,0.00530058216008896,ENSG00000145362,ANK2,protein_coding,4,1,112818109,113383740,q25,ankyrin 2 [Source:HGNC Symbol;Acc:HGNC:493],Cardiac arrhythmia ankyrin B-related;Romano-Ward syndrome,ANK2,287,NM_001127493;NM_001148;NM_001354225;NM_001354228;NM_001354230;NM_001354231;NM_001354232;NM_001354235;NM_001354236;NM_001354237;NM_001354239;NM_001354240;NM_001354241;NM_001354242;NM_001354243;NM_001354244;NM_001354245;NM_001354246;NM_001354249;NM_001354252;NM_001354253;NM_001354254;NM_001354255;NM_001354256;NM_001354257;NM_001354258;NM_001354260;NM_001354261;NM_001354262;NM_001354264;NM_001354265;NM_001354266;NM_001354267;NM_001354268;NM_001354269;NM_001354270;NM_001354271;NM_001354272;NM_001354273;NM_001354274;NM_001354275;NM_001354276;NM_001354277;NM_001354278;NM_001354279;NM_001354280;NM_001354281;NM_001354282;NM_020977
RHOBTB1_SIG,RHOBTB1,RHOBTB1_SIG,RHOBTB1,SIG,25,6.7331692952575,0.14191398538476,0.12381712656955,0.20137509292045,0.0775579663508998,5.01958260844495e-10,3.51511883339104,3.12112792858194,2.9803092247655,3.58381795540739,0.603508730641893,0.00258449252311975,ENSG00000072422,RHOBTB1,protein_coding,10,-1,60869438,61001440,q21.2,Rho related BTB domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18738],NA,RHOBTB1,9886,NM_001242359;NM_001350902;NM_001350903;NM_001350904;NM_001350905;NM_001350906;NM_001350907;NM_001350908;NM_001350909;NM_001350910;NM_001350911;NM_014836
EYA1_SIG,EYA1,EYA1_SIG,EYA1,SIG,20,-6.73131714497542,-0.0999640134548229,-0.0924634496540519,-0.124608723085928,-0.0321452734318758,5.06442521828039e-10,-1.44503045783708,0.347906685880022,0.378639220506546,0.246928357821442,-0.131710862685104,0.240281902577018,ENSG00000104313,EYA1,protein_coding,8,-1,71197433,71592025,q13.3,EYA transcriptional coactivator and phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:3519],BOR syndrome;Branchiootic syndrome;BRANCHIOOTIC SYNDROME 1;BRANCHIOOTORENAL SYNDROME 1;BRANCHIOOTORENAL SYNDROME TYPE 1;OTOFACIOCERVICAL SYNDROME;OTOFACIOCERVICAL SYNDROME 1,EYA1,2138,NM_000503;NM_001288574;NM_001288575;NM_172058;NM_172059
PCCA_SIG,PCCA,PCCA_SIG,PCCA,SIG,25,6.73081765193742,0.195394082579536,0.182594155039904,0.237450987352613,0.0548568323127093,5.06442521828039e-10,3.95625946084126,3.38283785703632,3.27983975255245,3.72126020034046,0.441420447788014,0.000653471892828044,ENSG00000175198,PCCA,protein_coding,13,1,100089015,100530437,q32.3,propionyl-CoA carboxylase subunit alpha [Source:HGNC Symbol;Acc:HGNC:8653],PROPIONIC ACIDEMIA,PCCA,5095,NM_000282;NM_001127692;NM_001178004;NM_001352605;NM_001352606;NM_001352607;NM_001352608;NM_001352609;NM_001352610;NM_001352611;NM_001352612
HS3ST1_SIG,HS3ST1,HS3ST1_SIG,HS3ST1,SIG,42,-6.7292969242874,-0.0214663805202836,-0.0063488672367489,-0.0711382098804692,-0.0647893426437202,5.09915851363258e-10,-5.12935483154054,0.717677674664877,0.837117619820513,0.325232140582076,-0.511885479238437,8.40450376820957e-06,ENSG00000002587,HS3ST1,protein_coding,4,-1,11393150,11429564,p15.33,heparan sulfate-glucosamine 3-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:5194],NA,HS3ST1,9957,NM_005114
CUX2_TF,CUX2,CUX2_TF,CUX2,TF,166,-6.72589590349984,-0.0724468302440353,-0.0620495059375033,-0.106609467251212,-0.0445599613137086,5.20093253471437e-10,-4.09231754940266,0.729823607298354,0.832192618121001,0.393468286023943,-0.438724332097058,0.000416096422769778,ENSG00000111249,CUX2,protein_coding,12,1,111034165,111350554,q24.11,cut like homeobox 2 [Source:HGNC Symbol;Acc:HGNC:19347],Developmental epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 67;Lennox-Gastaut syndrome,CUX2,23316,NM_015267
NQO1_SIG,NQO1,NQO1_SIG,NQO1,SIG,65,6.72521959290281,0.161817016991588,0.148647702560429,0.20508762155111,0.0564399189906809,5.20641947015646e-10,5.79239193412149,1.98058170893719,1.85108837966146,2.40605979084315,0.554971411181696,3.96170423634964e-07,ENSG00000181019,NQO1,protein_coding,16,-1,69706996,69726668,q22.1,NAD(P)H quinone dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:2874],NA,NQO1,1728,NM_000903;NM_001025433;NM_001025434;NM_001286137
ZNF713_TF,ZNF713,ZNF713_TF,ZNF713,TF,61,6.71965976867674,0.160935480000748,0.145937539847554,0.210214426218385,0.0642768863708308,5.3896696320027e-10,5.81060495866692,2.25403566831389,2.15796650517419,2.56969149005861,0.411724984884417,3.62928033537174e-07,ENSG00000178665,ZNF713,protein_coding,7,1,55887456,55942530,p11.2,zinc finger protein 713 [Source:HGNC Symbol;Acc:HGNC:22043],Autism,ZNF713,349075,NM_182633
ZNF474_TF,ZNF474,ZNF474_TF,ZNF474,TF,28,6.71906900887098,-0.068806622006144,-0.0832485999676319,-0.0213544087041124,0.0618941912635193,5.3923050768818e-10,3.1058808720151,0.335550857932301,0.298102924060714,0.458594069224659,0.160491145163945,0.00819152754487594,ENSG00000164185,ZNF474,protein_coding,5,1,122129546,122153569,q23.2,zinc finger protein 474 [Source:HGNC Symbol;Acc:HGNC:23245],NA,ZNF474,133923,NM_207317
NEO1_SIG,NEO1,NEO1_SIG,NEO1,SIG,34,-6.71835461298099,-0.132552131840384,-0.120394631824272,-0.172498203321895,-0.0521035714976235,5.39958683779797e-10,-4.43346087619137,2.45383070271253,2.62431691567047,1.89366171727932,-0.730655198391147,0.000126734200119558,ENSG00000067141,NEO1,protein_coding,15,1,73051710,73305205,q24.1,neogenin 1 [Source:HGNC Symbol;Acc:HGNC:7754],NA,NEO1,4756,NM_001172623;NM_001172624;NM_002499
GRB10_SIG,GRB10,GRB10_SIG,GRB10,SIG,52,6.71729265577258,0.103308372655225,0.0861901719343324,0.159553889309587,0.073363717375255,5.4198514047301e-10,4.97714064017057,5.15895779818611,4.98579631397289,5.72791696060098,0.742120646628084,1.55780291195128e-05,ENSG00000106070,GRB10,protein_coding,7,-1,50590063,50793462,p12.1,growth factor receptor bound protein 10 [Source:HGNC Symbol;Acc:HGNC:4564],NA,GRB10,2887,NM_001001549;NM_001001550;NM_001001555;NM_001350814;NM_001350815;NM_001350816
RFX2_TF,RFX2,RFX2_TF,RFX2,TF,115,6.71557202317605,0.027731165576376,0.0202383413013794,0.0523504453370794,0.0321121040357,5.46488720989965e-10,1.63776061698705,5.04981640301894,5.01203229558327,5.17396418459328,0.16193188901001,0.179971096889241,ENSG00000087903,RFX2,protein_coding,19,-1,5993164,6199572,p13.3,regulatory factor X2 [Source:HGNC Symbol;Acc:HGNC:9983],NA,RFX2,5990,NM_000635;NM_134433
STK36_SIG,STK36,STK36_SIG,STK36,SIG,100,6.71324549231956,0.114567941661256,0.0944988436570655,0.180509263675026,0.0860104200179605,5.53328913507746e-10,6.25837225423329,4.19920858625482,4.05607460327977,4.66950595888712,0.613431355607345,3.86259417971316e-08,ENSG00000163482,STK36,protein_coding,2,1,218672069,218702716,q35,serine/threonine kinase 36 [Source:HGNC Symbol;Acc:HGNC:17209],Primary ciliary dyskinesia,STK36,27148,NM_001243313;NM_015690
PELI2_SIG,PELI2,PELI2_SIG,PELI2,SIG,13,-6.70697016813432,0.104322928619044,0.114299746090101,0.0715419569284274,-0.0427577891616739,5.75624606647869e-10,-3.63691950444137,5.71883795368676,5.80684800904724,5.42966205750236,-0.377185951544873,0.00178300562626893,ENSG00000139946,PELI2,protein_coding,14,1,56117814,56301524,q22.3,pellino E3 ubiquitin protein ligase family member 2 [Source:HGNC Symbol;Acc:HGNC:8828],NA,PELI2,57161,NM_021255
L3MBTL4_TF,L3MBTL4,L3MBTL4_TF,L3MBTL4,TF,123,-6.70332296020792,-0.0259172291529375,-0.0176804159991098,-0.0529810438012286,-0.0353006278021187,5.88126728974527e-10,-3.65306332970313,1.67960142620055,1.81958445528011,1.21965718779626,-0.599927267483853,0.00169838218500099,ENSG00000154655,L3MBTL4,protein_coding,18,-1,5954706,6415237,p11.31,L3MBTL4, histone methyl-lysine binding protein [Source:HGNC Symbol;Acc:HGNC:26677],NA,L3MBTL4,91133,NM_001330559;NM_001365765;NM_001365767;NM_001365770;NM_173464
USP27X_SIG,USP27X,USP27X_SIG,USP27X,SIG,70,6.70145670759483,0.048425675739999,0.0368246434056685,0.0865433534099421,0.0497187100042737,5.9362023416765e-10,4.64843457462279,2.20542597346471,2.12330400048075,2.47525531326916,0.35195131278841,5.68737668895336e-05,ENSG00000273820,USP27X,protein_coding,X,1,49879948,49882565,p11.23,ubiquitin specific peptidase 27 X-linked [Source:HGNC Symbol;Acc:HGNC:13486],Intellectual disability;MENTAL RETARDATION X-LINKED 105;X-linked non-syndromic intellectual disability,USP27X,389856,NM_001145073
KCNK17_SIG,KCNK17,KCNK17_SIG,KCNK17,SIG,56,6.69817398662864,0.0519432962838308,0.030830072981257,0.121315315706574,0.0904852427253167,6.05005430891138e-10,5.25673971458568,2.74763452251774,2.49461892935261,3.57897147148892,1.08435254213631,4.80809670010933e-06,ENSG00000124780,KCNK17,protein_coding,6,-1,39299001,39314461,p21.2,potassium two pore domain channel subfamily K member 17 [Source:HGNC Symbol;Acc:HGNC:14465],NA,KCNK17,89822,NM_001135111;NM_031460
RNF40_SIG,RNF40,RNF40_SIG,RNF40,SIG,7,6.69096373364536,0.320796435823682,0.311717912568008,0.350625869378041,0.0389079568100333,6.33389989517414e-10,4.27526042583654,7.18646316784083,7.15384527277623,7.29363625162449,0.139790978848254,0.000222832253404873,ENSG00000103549,RNF40,protein_coding,16,1,30761745,30776307,p11.2,ring finger protein 40 [Source:HGNC Symbol;Acc:HGNC:16867],NA,RNF40,9810,NM_001207033;NM_001207034;NM_001286572;NM_014771
ENDOV_SIG,ENDOV,ENDOV_SIG,ENDOV,SIG,123,6.68687596147576,0.0423118782217805,0.0254532158575974,0.0977046259898107,0.0722514101322132,6.49091185149115e-10,6.05715247845475,3.33409746005505,3.23834829030278,3.64870187495539,0.410353584652606,1.06535946039663e-07,ENSG00000173818,ENDOV,protein_coding,17,1,80415165,80438086,q25.3,endonuclease V [Source:HGNC Symbol;Acc:HGNC:26640],NA,ENDOV,284131,NM_001164637;NM_001164638;NM_001352760;NM_001352761;NM_173627
DNAJC10_SIG,DNAJC10,DNAJC10_SIG,DNAJC10,SIG,21,6.68096645602416,0.286428927328917,0.269528142344857,0.341960077990828,0.0724319356459712,6.73501160913249e-10,4.1441280749169,6.73180108781191,6.65762128115571,6.97553473825369,0.317913457097974,0.000349166649100033,ENSG00000077232,DNAJC10,protein_coding,2,1,182716041,182794464,q32.1,DnaJ heat shock protein family (Hsp40) member C10 [Source:HGNC Symbol;Acc:HGNC:24637],NA,DNAJC10,54431,NM_001271581;NM_018981
SLC41A1_SIG,SLC41A1,SLC41A1_SIG,SLC41A1,SIG,70,-6.67455793089061,-0.10927625529824,-0.0949621726354301,-0.15630824119033,-0.0613460685549003,7.01195209580218e-10,-5.52816859269697,3.55027755229197,3.75287603399129,2.88459682670848,-0.868279207282803,1.40224816916175e-06,ENSG00000133065,SLC41A1,protein_coding,1,-1,205789094,205813748,q32.1,solute carrier family 41 member 1 [Source:HGNC Symbol;Acc:HGNC:19429],NA,SLC41A1,254428,NM_173854
PRDM5_TF,PRDM5,PRDM5_TF,PRDM5,TF,230,-6.67009257557789,-0.108072075287221,-0.0947873124199083,-0.151722010422679,-0.0569346980027706,7.2040643669337e-10,-4.57134279582299,0.738704481679867,0.858433741362352,0.345308342723133,-0.513125398639218,7.64824502298383e-05,ENSG00000138738,PRDM5,protein_coding,4,-1,120684919,120922870,q27,PR/SET domain 5 [Source:HGNC Symbol;Acc:HGNC:9349],Brittle cornea syndrome;BRITTLE CORNEA SYNDROME 2,PRDM5,11107,NM_001300823;NM_001300824;NM_018699
ADAM23_SIG,ADAM23,ADAM23_SIG,ADAM23,SIG,16,-6.66764346401411,-0.16730443650053,-0.149302097448329,-0.226454979100617,-0.0771528816522878,7.30044208588327e-10,-3.08705642460543,0.731325213971722,0.832030952501471,0.40043493023112,-0.431596022270351,0.00857444608193384,ENSG00000114948,ADAM23,protein_coding,2,1,206443532,206621127,q33.3,ADAM metallopeptidase domain 23 [Source:HGNC Symbol;Acc:HGNC:202],NA,ADAM23,8745,NM_003812
RASSF6_SIG,RASSF6,RASSF6_SIG,RASSF6,SIG,57,6.6590938482548,-0.0303458727486983,-0.0419238434477345,0.00769603097670645,0.0496198744244409,7.71179473972849e-10,3.81986879751526,0.518880437305939,0.450097899565262,0.744880204168164,0.294782304602901,0.00101136233216808,ENSG00000169435,RASSF6,protein_coding,4,-1,73571550,73620631,q13.3,Ras association domain family member 6 [Source:HGNC Symbol;Acc:HGNC:20796],NA,RASSF6,166824,NM_001270391;NM_001270392;NM_177532;NM_201431
CSNK1G1_SIG,CSNK1G1,CSNK1G1_SIG,CSNK1G1,SIG,22,6.65707660519326,0.190746570277762,0.180035064067758,0.225941519253492,0.045906455185734,7.79201794210213e-10,5.27233627211907,5.39185298895747,5.32701791686337,5.60488251155236,0.277864594688987,4.49721915424759e-06,ENSG00000169118,CSNK1G1,protein_coding,15,-1,64165525,64356173,q22.31,casein kinase 1 gamma 1 [Source:HGNC Symbol;Acc:HGNC:2454],EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY AND MICROCEPHALY,CSNK1G1,53944,NM_001329605;NM_001329606;NM_001329607;NM_022048
FUT6_SIG,FUT6,FUT6_SIG,FUT6,SIG,46,6.65499816923175,-0.018597279232827,-0.0381970926400627,0.0458021076766617,0.0839992003167244,7.87640992003244e-10,2.95080736805309,0.342633058394114,0.302555943042599,0.474315008834804,0.171759065792204,0.012214076834196,ENSG00000156413,FUT6,protein_coding,19,-1,5830610,5839731,p13.3,fucosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:4017],FUCOSYLTRANSFERASE 6 DEFICIENCY,FUT6,2528,NM_000150;NM_001040701
ITGA11_SIG,ITGA11,ITGA11_SIG,ITGA11,SIG,53,6.65352302715334,-0.0923211641519004,-0.101988255652157,-0.0605578635082017,0.0414303921439548,7.9291888697913e-10,5.88358905304628,0.497180802125663,0.407706425908554,0.791168038267593,0.383461612359039,2.55003793781569e-07,ENSG00000137809,ITGA11,protein_coding,15,-1,68296532,68432163,q23,integrin subunit alpha 11 [Source:HGNC Symbol;Acc:HGNC:6136],NA,ITGA11,22801,NM_001004439
HOXA11_TF,HOXA11,HOXA11_TF,HOXA11,TF,55,6.64518456848757,-0.0967780092043022,-0.110231568489107,-0.0525734572685134,0.057658111220594,8.3633580828709e-10,5.11898484755017,1.11442790903961,0.8724027367331,1.90965347518956,1.03725073845646,8.76896947141456e-06,ENSG00000005073,HOXA11,protein_coding,7,-1,27181510,27185223,p15.2,homeobox A11 [Source:HGNC Symbol;Acc:HGNC:5101],Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome;RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA;RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1,HOXA11,3207,NM_005523
CARHSP1_SIG,CARHSP1,CARHSP1_SIG,CARHSP1,SIG,21,-6.6420048322908,0.137090358880916,0.146461173577065,0.106300539165,-0.0401606344120649,8.517442882618e-10,-2.98202950511597,4.91498474531722,4.97249048583623,4.72603731218332,-0.246453173652911,0.0112842917815632,ENSG00000153048,CARHSP1,protein_coding,16,-1,8852942,8869012,p13.2,calcium regulated heat stable protein 1 [Source:HGNC Symbol;Acc:HGNC:17150],NA,CARHSP1,23589,NM_001042476;NM_001278260;NM_001278261;NM_001278262;NM_001278263;NM_001278264;NM_001278265;NM_001278266;NM_014316
AGBL2_SIG,AGBL2,AGBL2_SIG,AGBL2,SIG,31,6.64146545266586,0.115298134551521,0.102006252539155,0.158971461163582,0.0569652086244271,8.52036957050699e-10,5.57536310034088,1.46137089655318,1.35906441429282,1.79752076683724,0.438456352544424,1.13274315819239e-06,ENSG00000165923,AGBL2,protein_coding,11,-1,47659591,47715389,p11.2,ATP/GTP binding protein like 2 [Source:HGNC Symbol;Acc:HGNC:26296],NA,AGBL2,79841,NM_024783
ARL2BP_SIG,ARL2BP,ARL2BP_SIG,ARL2BP,SIG,34,6.63458159866334,0.182580067140273,0.175314804557664,0.206451644197417,0.0311368396397532,8.89815254665436e-10,3.6053975736726,5.81299154435364,5.77140505833767,5.94963285554895,0.17822779721128,0.00196568108329581,ENSG00000102931,ARL2BP,protein_coding,16,1,57245259,57253635,q13,ADP ribosylation factor like GTPase 2 binding protein [Source:HGNC Symbol;Acc:HGNC:17146],Retinitis pigmentosa;RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS,ARL2BP,23568,NM_012106
ZDHHC21_SIG,ZDHHC21,ZDHHC21_SIG,ZDHHC21,SIG,106,6.6315129560731,0.143915483969338,0.127828137287916,0.196773908779727,0.0689457714918109,9.05526981825956e-10,4.36511806213791,4.52982016221382,4.43919043646008,4.82760354683327,0.388413110373195,0.000161645397372826,ENSG00000175893,ZDHHC21,protein_coding,9,-1,14611071,14693471,p22.3,zinc finger DHHC-type containing 21 [Source:HGNC Symbol;Acc:HGNC:20750],NA,ZDHHC21,340481,NM_001354118;NM_001354119;NM_001354120;NM_001354121;NM_001354122;NM_001354123;NM_001354124;NM_001354125;NM_001354126;NM_001354127;NM_001354128;NM_001354129;NM_001354130;NM_178566
PECR_SIG,PECR,PECR_SIG,PECR,SIG,32,-6.63000202043467,0.0236470157131892,0.0555925973426396,-0.0813170382121481,-0.136909635554788,9.11845131960264e-10,-5.65342636165062,1.75937007937989,1.93923651303867,1.16838036878677,-0.770856144251901,8.05339696867106e-07,ENSG00000115425,PECR,protein_coding,2,-1,215996329,216082955,q35,peroxisomal trans-2-enoyl-CoA reductase [Source:HGNC Symbol;Acc:HGNC:18281],Autosomal Recessive Mental Retardation,PECR,55825,NM_018441
RAB43_SIG,RAB43,RAB43_SIG,RAB43,SIG,29,-6.62548202134742,0.253426531830533,0.279360355797421,0.16821539593933,-0.111144959858091,9.37117055117461e-10,-5.59115347173182,1.58812640880913,1.69509794157474,1.23664851543641,-0.458449426138326,1.05342594720745e-06,ENSG00000172780,RAB43,protein_coding,3,-1,129087569,129122801,q21.3,RAB43, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:19983],NA,RAB43,339122,NM_001204883;NM_001204884;NM_001204885;NM_001204886;NM_001204887;NM_001204888;NM_198490
ABL2_SIG,ABL2,ABL2_SIG,ABL2,SIG,62,6.62407766017151,0.361474722737882,0.35081435248238,0.396501653577389,0.0456873010950095,9.42986918854133e-10,5.25337491693443,5.49371566922005,5.41303899317131,5.75879617623733,0.345757183066019,4.87201649285989e-06,ENSG00000143322,ABL2,protein_coding,1,-1,179099330,179229684,q25.2,ABL proto-oncogene 2, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:77],NA,ABL2,27,NM_001136000;NM_001136001;NM_001168236;NM_001168237;NM_001168238;NM_001168239;NM_005158;NM_007314
PHC1_SIG,PHC1,PHC1_SIG,PHC1,SIG,94,6.62345362254325,0.156259454274018,0.136864713486772,0.219985031146397,0.0831203176596249,9.43903742047129e-10,5.92437875616202,4.03569256847074,3.89729588219114,4.49042453767514,0.593128655483995,2.07505714335164e-07,ENSG00000111752,PHC1,protein_coding,12,1,8913896,8941467,p13.31,polyhomeotic homolog 1 [Source:HGNC Symbol;Acc:HGNC:3182],Autosomal recessive primary microcephaly;MICROCEPHALY 11 PRIMARY AUTOSOMAL RECESSIVE;Primary microcephaly,PHC1,1911,NM_004426
TRIM37_SIG,TRIM37,TRIM37_SIG,TRIM37,SIG,17,6.60268676933343,0.399142127264783,0.38466197877194,0.446719758026981,0.0620577792550408,1.08260574891744e-09,4.48269626627478,4.86345921254687,4.80504798701269,5.05538181073061,0.25033382371792,0.000105663488837836,ENSG00000108395,TRIM37,protein_coding,17,-1,58982638,59106921,q22,tripartite motif containing 37 [Source:HGNC Symbol;Acc:HGNC:7523],MULIBREY NANISM,TRIM37,4591,NM_001005207;NM_001320987;NM_001320988;NM_001320989;NM_001320990;NM_001353082;NM_001353083;NM_001353084;NM_001353085;NM_001353086;NM_015294
NIT2_SIG,NIT2,NIT2_SIG,NIT2,SIG,28,6.60168818819748,0.226205903711721,0.210587179051032,0.277524570453984,0.0669373914029525,1.0864088887202e-09,5.28673022069114,4.54123780284591,4.44454288363483,4.85894968025374,0.414406796618909,4.21787559350621e-06,ENSG00000114021,NIT2,protein_coding,3,1,100334739,100361635,q12.2,nitrilase family member 2 [Source:HGNC Symbol;Acc:HGNC:29878],NA,NIT2,56954,NM_020202
FOXO1_TF,FOXO1,FOXO1_TF,FOXO1,TF,350,-6.59956270667192,-0.0122757845965093,0.00282311681110247,-0.0618864606500907,-0.0647095774611931,1.09855451791499e-09,-5.94500227904661,4.37790350125397,4.58837788695014,3.68634480539512,-0.902033081555018,1.89590311627883e-07,ENSG00000150907,FOXO1,protein_coding,13,-1,40469953,40666641,q14.11,forkhead box O1 [Source:HGNC Symbol;Acc:HGNC:3819],Alveolar rhabdomyosarcoma;RHABDOMYOSARCOMA 2,FOXO1,2308,NM_002015
DNMT3B_SIG,DNMT3B,DNMT3B_SIG,DNMT3B,SIG,139,6.59753291970535,0.0492912105399577,0.0277548881169216,0.120053412787076,0.0922985246701545,1.11012596186666e-09,5.73959127701387,4.67574536831237,4.43532241278296,5.46570650790899,1.03038409512602,5.20998270952174e-07,ENSG00000088305,DNMT3B,protein_coding,20,1,32762385,32809356,q11.21,DNA methyltransferase 3 beta [Source:HGNC Symbol;Acc:HGNC:2979],ICF syndrome;IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1;IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME1,DNMT3B,1789,NM_001207055;NM_001207056;NM_006892;NM_175848;NM_175849;NM_175850
CD99_SIG,CD99,CD99_SIG,CD99,SIG,82,6.58843972733624,0.126679701168188,0.113635572140153,0.169538982260305,0.0559034101201518,1.17650339460852e-09,5.54738604129476,8.6587722443475,8.49656300760408,9.19174545079019,0.695182443186111,1.28335103641193e-06,ENSG00000002586,CD99,protein_coding,X,1,2691187,2741309,p22.33,CD99 molecule (Xg blood group) [Source:HGNC Symbol;Acc:HGNC:7082],NA,CD99,4267,NM_001122898;NM_001321367;NM_001321368;NM_001321369;NM_001321370;NM_002414
FOXJ1_TF,FOXJ1,FOXJ1_TF,FOXJ1,TF,71,-6.58230307284134,-0.0916398886592199,-0.0868237571830033,-0.107464320652503,-0.0206405634694994,1.22165984748464e-09,-2.15491096338387,0.419280996209288,0.450179889607684,0.317756060757415,-0.132423828850269,0.0724332897226394,ENSG00000129654,FOXJ1,protein_coding,17,-1,76136333,76141245,q25.1,forkhead box J1 [Source:HGNC Symbol;Acc:HGNC:3816],NA,FOXJ1,2302,NM_001454
LY9_SIG,LY9,LY9_SIG,LY9,SIG,58,-6.58189761446314,-0.037406937013067,-0.0213363662275652,-0.0902102410225729,-0.0688738747950079,1.22165984748464e-09,-5.59682395969326,2.87658414869931,3.08073425856761,2.2058052162749,-0.874929042292711,1.04520774918824e-06,ENSG00000122224,LY9,protein_coding,1,1,160796074,160828261,q23.3,lymphocyte antigen 9 [Source:HGNC Symbol;Acc:HGNC:6730],NA,LY9,4063,NM_001033667;NM_001261456;NM_001261457;NM_002348
SNAPC4_TF,SNAPC4,SNAPC4_TF,SNAPC4,TF,176,6.57408930408072,0.219434077815206,0.204826261410787,0.267431188858298,0.0626049274475105,1.28343685085827e-09,5.62774652286595,4.89681517416916,4.83091663536897,5.11333894451263,0.282422309143661,9.16386671250998e-07,ENSG00000165684,SNAPC4,protein_coding,9,-1,136375577,136400168,q34.3,small nuclear RNA activating complex polypeptide 4 [Source:HGNC Symbol;Acc:HGNC:11137],NA,SNAPC4,6621,NM_003086
PAM_SIG,PAM,PAM_SIG,PAM,SIG,27,-6.56834306911817,0.00351800158526123,0.0122689105696464,-0.0252349850777187,-0.0375038956473652,1.32973502342881e-09,-3.88746889850284,4.70266463963746,4.81404693114471,4.3366942532565,-0.477352677888215,0.00081564907442208,ENSG00000145730,PAM,protein_coding,5,1,102753981,103031105,q21.1,peptidylglycine alpha-amidating monooxygenase [Source:HGNC Symbol;Acc:HGNC:8596],NA,PAM,5066,NM_000919;NM_001177306;NM_001319943;NM_001364583;NM_001364584;NM_138766;NM_138821;NM_138822
SLC25A14_SIG,SLC25A14,SLC25A14_SIG,SLC25A14,SIG,22,6.56714639859214,0.160672679585936,0.145949342574003,0.209049358339427,0.0631000157654233,1.33280484200999e-09,4.39006639374059,3.12322013070121,3.07248030006306,3.28993671708373,0.217456417020677,0.000147789765871821,ENSG00000102078,SLC25A14,protein_coding,X,1,130339888,130373361,q26.1,solute carrier family 25 member 14 [Source:HGNC Symbol;Acc:HGNC:10984],NA,SLC25A14,9016,NM_001282195;NM_001282196;NM_001282197;NM_001282198
FGFRL1_SIG,FGFRL1,FGFRL1_SIG,FGFRL1,SIG,63,6.56706279405062,0.00279246431288777,-0.0097549120032151,0.0440195579229401,0.0537744699261553,1.33280484200999e-09,3.63604312378786,4.87857771018128,4.77095167337699,5.23220611682398,0.461254443446996,0.00178705659506793,ENSG00000127418,FGFRL1,protein_coding,4,1,1009936,1026898,p16.3,fibroblast growth factor receptor like 1 [Source:HGNC Symbol;Acc:HGNC:3693],Wolf-Hirschhorn syndrome,FGFRL1,53834,NM_001004356;NM_001004358;NM_021923
AFF1_SIG,AFF1,AFF1_SIG,AFF1,SIG,32,6.5643191203018,0.299493538063258,0.287970980434389,0.337353370272397,0.0493823898380078,1.35333277149762e-09,4.50440661793516,7.92365379963202,7.84705527753825,8.17533465794013,0.328279380401872,9.71246042255422e-05,ENSG00000172493,AFF1,protein_coding,4,1,86935002,87141054,q21.3,AF4/FMR2 family member 1 [Source:HGNC Symbol;Acc:HGNC:7135],Precursor B-cell acute lymphoblastic leukemia,AFF1,4299,NM_001166693;NM_001313959;NM_001313960;NM_005935
GLI3_SIG,GLI3,GLI3_SIG,GLI3,SIG,19,-6.55075180540552,-0.186990061377263,-0.177240316232476,-0.219024938281564,-0.0417846220490872,1.47757263771581e-09,-3.81587190302644,0.495106789696213,0.581304168983689,0.211886829180217,-0.369417339803472,0.00102447834994233,ENSG00000106571,GLI3,protein_coding,7,-1,41960949,42237870,p14.1,GLI family zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:4319],Acrocallosal syndrome;GREIG CEPHALOPOLYSYNDACTYLY SYNDROME;HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME INCLUDED;PALLISTER-HALL SYNDROME;POLYDACTYLY POSTAXIAL TYPE A1;POLYDACTYLY PREAXIAL IV;Polysyndactyly;Postaxial Polydactyly Type A;Postaxial polydactyly type B;Preaxial Polydactyly Type IV;Tibial hemimelia,GLI3,2737,NM_000168
NFATC1_SIG,NFATC1,NFATC1_SIG,NFATC1,SIG,44,6.5453696669103,0.132629247993302,0.124605991894152,0.158991375176223,0.0343853832820715,1.52702319934881e-09,3.27980461441145,5.09132554745563,5.01860290170551,5.33027138349172,0.311668481786212,0.0050885558624317,ENSG00000131196,NFATC1,protein_coding,18,1,79395856,79529325,q23,nuclear factor of activated T cells 1 [Source:HGNC Symbol;Acc:HGNC:7775],NA,NFATC1,4772,NM_001278669;NM_001278670;NM_001278672;NM_001278673;NM_001278675;NM_006162;NM_172387;NM_172388;NM_172389;NM_172390
UGT8_SIG,UGT8,UGT8_SIG,UGT8,SIG,19,-6.54264717408661,-0.172375257942991,-0.16660732331005,-0.191327043165509,-0.0247197198554588,1.55027758446215e-09,-2.39730008383013,0.374620729580897,0.407300632243016,0.267243906548222,-0.140056725694794,0.0441559413967548,ENSG00000174607,UGT8,protein_coding,4,1,114598770,114678225,q26,UDP glycosyltransferase 8 [Source:HGNC Symbol;Acc:HGNC:12555],NA,UGT8,7368,NM_001128174;NM_001322112;NM_001322113;NM_001322114;NM_003360
SYDE2_SIG,SYDE2,SYDE2_SIG,SYDE2,SIG,26,-6.53719878413836,-0.224422193696524,-0.206311468621968,-0.283928861798635,-0.0776173931766674,1.60283334812889e-09,-2.45604257036065,0.79390583992754,0.854907276110789,0.593472549611151,-0.261434726499638,0.0388667577190659,ENSG00000097096,SYDE2,protein_coding,1,-1,85156889,85201016,p22.3,synapse defective Rho GTPase homolog 2 [Source:HGNC Symbol;Acc:HGNC:25841],NA,SYDE2,84144,NM_032184
LRP6_SIG,LRP6,LRP6_SIG,LRP6,SIG,127,-6.53611601124137,-0.0412970820468479,-0.0259094138807325,-0.091856563164084,-0.0659471492833515,1.60950652432768e-09,-5.69475557940749,2.28474067840409,2.56690931790587,1.35761514861253,-1.20929416929334,6.51612839474703e-07,ENSG00000070018,LRP6,protein_coding,12,-1,12116025,12267044,p13.2,LDL receptor related protein 6 [Source:HGNC Symbol;Acc:HGNC:6698],Coronary Artery Disease Autosomal Dominant 2;Oligodontia;Tooth agenesis;Tooth agenesis selective 7,LRP6,4040,NM_002336
PHF2_TF,PHF2,PHF2_TF,PHF2,TF,104,-6.53072680837968,0.1010553289319,0.106823256943727,0.0821035654644664,-0.0247196914792609,1.66338629199187e-09,-2.69221695125165,6.16889184032523,6.19643078546748,6.07840673485785,-0.11802405060963,0.0228430363099463,ENSG00000197724,PHF2,protein_coding,9,1,93576584,93679587,q22.31,PHD finger protein 2 [Source:HGNC Symbol;Acc:HGNC:8920],NA,PHF2,5253,NM_005392
CSGALNACT1_SIG,CSGALNACT1,CSGALNACT1_SIG,CSGALNACT1,SIG,10,-6.5262518650743,0.3045717212016,0.328637946900572,0.225496979619264,-0.103140967281308,1.70858203602265e-09,-3.92130565155118,4.20642218660337,4.36123799996318,3.69774165699257,-0.663496342970615,0.000729247721687469,ENSG00000147408,CSGALNACT1,protein_coding,8,-1,19404161,19758029,p21.3,chondroitin sulfate N-acetylgalactosaminyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24290],NA,CSGALNACT1,55790,NM_001130518;NM_001354475;NM_001354476;NM_001354477;NM_001354480;NM_001354481;NM_001354483;NM_001354484;NM_001354485;NM_001354487;NM_001354488;NM_001354489;NM_001354490;NM_001354491;NM_001354492;NM_001354494;NM_001354495;NM_001354496;NM_001354497;NM_001354498;NM_001354499;NM_018371
NR5A1_SIG,NR5A1,NR5A1_SIG,NR5A1,SIG,33,6.5217114217837,-0.0333133161024966,-0.0484514807746004,0.01642636782013,0.0648778485947304,1.75575451976466e-09,3.45379775525756,0.556811678343856,0.482447857707963,0.801149946147504,0.31870208843954,0.00308139187841097,ENSG00000136931,NR5A1,protein_coding,9,-1,124481236,124507420,q33.3,nuclear receptor subfamily 5 group A member 1 [Source:HGNC Symbol;Acc:HGNC:7983],46XX gonadal dysgenesis;46XX ovotesticular disorder of sex development;46XX SEX REVERSAL 4;46XX testicular disorder of sex development;46XY complete gonadal dysgenesis;46XY partial gonadal dysgenesis;46XY SEX REVERSAL 3;Male infertility with azoospermia or oligozoospermia due to single gene mutation;Premature ovarian failure 7;Spermatogenic failure 8,NR5A1,2516,NM_004959
IDUA_SIG,IDUA,IDUA_SIG,IDUA,SIG,22,6.51497356792618,0.174157592347285,0.161534949663598,0.215631989736543,0.0540970400729449,1.83082029046009e-09,4.2608472376079,4.8669184195804,4.79517842698356,5.10263553811287,0.307457111129308,0.000232425425977851,ENSG00000127415,IDUA,protein_coding,4,1,986997,1004564,p16.3,iduronidase, alpha-L- [Source:HGNC Symbol;Acc:HGNC:5391],HURLER-SCHEIE SYNDROME;HURLER SYNDROME;MUCOPOLYSACCHARIDOSIS TYPE 1H;MUCOPOLYSACCHARIDOSIS TYPE 1H/S;MUCOPOLYSACCHARIDOSIS TYPE 1S;SCHEIE SYNDROME,IDUA,3425,NM_000203
B4GALT7_SIG,B4GALT7,B4GALT7_SIG,B4GALT7,SIG,17,6.51156832951392,0.294159363760378,0.283249442477074,0.330006247976948,0.046756805499874,1.8671423469517e-09,4.49805953229462,4.21763059934847,4.16980293333323,4.3747786448271,0.204975711493865,9.96869167627946e-05,ENSG00000027847,B4GALT7,protein_coding,5,1,177600132,177610330,q35.3,beta-1,4-galactosyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:930],Ehlers-Danlos syndrome progeroid type;EHLERS-DANLOS SYNDROME PROGEROID TYPE;EHLERS-DANLOS SYNDROME SPONDYLODYSPLASTIC TYPE 1;Reunion Island Larsen-like syndrome,B4GALT7,11285,NM_007255
MTA1_SIG,MTA1,MTA1_SIG,MTA1,SIG,157,6.50372701107955,0.240492751033339,0.220907550166126,0.304844125311321,0.0839365751451948,1.96121800315411e-09,5.61654204077008,6.61242613402477,6.53602700262864,6.86345185146922,0.327424848840582,9.62994104623954e-07,ENSG00000182979,MTA1,protein_coding,14,1,105419820,105470729,q32.33,metastasis associated 1 [Source:HGNC Symbol;Acc:HGNC:7410],NA,MTA1,9112,NM_001203258;NM_004689
DPF1_SIG,DPF1,DPF1_SIG,DPF1,SIG,21,6.50093435383093,-0.0260165678855613,-0.0378143417528754,0.0127475462498993,0.0505618880027747,1.99196009112427e-09,4.80350119235529,0.735244656125287,0.633493195383471,1.06957088427697,0.436077688893498,3.14265661734384e-05,ENSG00000011332,DPF1,protein_coding,19,-1,38211006,38229714,q13.2,double PHD fingers 1 [Source:HGNC Symbol;Acc:HGNC:20225],NA,DPF1,8193,NM_001135155;NM_001135156;NM_001289978;NM_001363579;NM_004647
RPS6KL1_SIG,RPS6KL1,RPS6KL1_SIG,RPS6KL1,SIG,50,-6.49526082429732,-0.0341321783445382,-0.0258356426324806,-0.0613922242555845,-0.0355565816231038,2.06228521495752e-09,-5.08992973127548,1.73438542611011,1.91345845142238,1.14600262865552,-0.767455822766861,9.80777874649842e-06,ENSG00000198208,RPS6KL1,protein_coding,14,-1,74903954,74923396,q24.3,ribosomal protein S6 kinase like 1 [Source:HGNC Symbol;Acc:HGNC:20222],NA,RPS6KL1,83694,NM_031464
HDAC11_SIG,HDAC11,HDAC11_SIG,HDAC11,SIG,66,6.49465027894673,0.0284166528609415,0.0181688756224687,0.0620879209302091,0.0439190453077404,2.06371643649385e-09,4.08280559580298,2.5150662095107,2.44387603792454,2.74897677329379,0.305100735369246,0.000429293566717247,ENSG00000163517,HDAC11,protein_coding,3,1,13479724,13506424,p25.1,histone deacetylase 11 [Source:HGNC Symbol;Acc:HGNC:19086],NA,HDAC11,79885,NM_001136041;NM_001330636;NM_024827
RTN4R_SIG,RTN4R,RTN4R_SIG,RTN4R,SIG,35,6.49425485780325,0.0233830725131852,0.0052585324456023,0.0829351327352434,0.077676600289641,2.06371643649385e-09,5.08278284453402,2.14764311267657,1.97675017055258,2.70914849394111,0.732398323388526,1.00760433672066e-05,ENSG00000040608,RTN4R,protein_coding,22,-1,20241415,20283246,q11.21,reticulon 4 receptor [Source:HGNC Symbol;Acc:HGNC:18601],Schizophrenia,RTN4R,65078,NM_023004
ZC3HAV1L_TF,ZC3HAV1L,ZC3HAV1L_TF,ZC3HAV1L,TF,99,6.49147385794527,0.209390037678688,0.192586886211962,0.26460039249793,0.0720135062859684,2.09592406773047e-09,5.85501994657267,2.14016588498342,2.00002821289426,2.6006182361335,0.600590023239236,2.9518076923756e-07,ENSG00000146858,ZC3HAV1L,protein_coding,7,-1,139025706,139036042,q34,zinc finger CCCH-type containing, antiviral 1 like [Source:HGNC Symbol;Acc:HGNC:22423],NA,ZC3HAV1L,92092,NM_080660
ARHGAP39_SIG,ARHGAP39,ARHGAP39_SIG,ARHGAP39,SIG,21,-6.49060609289829,-0.12164219790372,-0.108148850110461,-0.165977483510146,-0.0578286333996854,2.10177757512887e-09,-4.39746921847173,0.404409980792528,0.475682973963555,0.170227288944866,-0.305455685018689,0.000144406329445077,ENSG00000147799,ARHGAP39,protein_coding,8,-1,144529179,144605816,q24.3,Rho GTPase activating protein 39 [Source:HGNC Symbol;Acc:HGNC:29351],NA,ARHGAP39,80728,NM_001308207;NM_001308208;NM_025251
TCF15_TF,TCF15,TCF15_TF,TCF15,TF,108,6.48599581184214,-0.0490368209797899,-0.057312030706794,-0.0218468461624907,0.0354651845443032,2.16065972557149e-09,3.95501509797089,0.39118987405092,0.341092811599612,0.555794507819502,0.21470169621989,0.000655630982861313,ENSG00000125878,TCF15,protein_coding,20,-1,603797,610398,p13,transcription factor 15 [Source:HGNC Symbol;Acc:HGNC:11627],NA,TCF15,6939,NM_004609
APBB1_SIG,APBB1,APBB1_SIG,APBB1,SIG,45,-6.48272406988756,-0.165903009828948,-0.145519717878838,-0.232876683379312,-0.0873569655004743,2.20154094567656e-09,-6.01983195549937,2.42791957366135,2.63818143226688,1.73705918110031,-0.901122251166575,1.28622579887906e-07,ENSG00000166313,APBB1,protein_coding,11,-1,6395124,6419414,p15.4,amyloid beta precursor protein binding family B member 1 [Source:HGNC Symbol;Acc:HGNC:581],NA,APBB1,322,NM_001164;NM_001257319;NM_001257320;NM_001257321;NM_001257323;NM_001257325;NM_001257326;NM_145689
KCNC4_SIG,KCNC4,KCNC4_SIG,KCNC4,SIG,12,6.48154800621675,0.0673728532080329,0.0543519006518591,0.110155983035461,0.0558040823836018,2.2122478255602e-09,5.81201513760305,2.6235376318478,2.50970419393528,2.99756178498893,0.487857591053657,3.62675602156466e-07,ENSG00000116396,KCNC4,protein_coding,1,1,110211343,110283100,p13.3,potassium voltage-gated channel subfamily C member 4 [Source:HGNC Symbol;Acc:HGNC:6236],NA,KCNC4,3749,NM_001039574;NM_004978
BMP2_SIG,BMP2,BMP2_SIG,BMP2,SIG,23,-6.47910686233324,-0.0982871874496509,-0.0835991310680978,-0.146547944131897,-0.0629488130637992,2.2417397841422e-09,-3.82941269011028,1.23014386951353,1.35518007390621,0.819310626508995,-0.535869447397215,0.000979432375727136,ENSG00000125845,BMP2,protein_coding,20,1,6767686,6780246,p12.3,bone morphogenetic protein 2 [Source:HGNC Symbol;Acc:HGNC:1069],20p12.3  microdeletion syndrome;Brachydactyly type A2;BRACHYDACTYLY TYPE A2;HEMOCHROMATOSIS TYPE 1;SHORT STATURE FACIAL DYSMORPHISM AND SKELETAL ANOMALIES WITH ORWITHOUT CARDIAC ANOMALIES;Short stature palatal anomalies congenital heart disease and skeletal malformations,BMP2,650,NM_001200
UPF3A_SIG,UPF3A,UPF3A_SIG,UPF3A,SIG,37,6.47385682714938,0.082867000712446,0.066194580085425,0.137647811344086,0.071453231258661,2.31428705087584e-09,4.57181380533766,4.90193378930337,4.84282938616085,5.09613397105738,0.253304584896529,7.63634690733848e-05,ENSG00000169062,UPF3A,protein_coding,13,1,114281601,114305817,q34,UPF3A, regulator of nonsense mediated mRNA decay [Source:HGNC Symbol;Acc:HGNC:20332],NA,UPF3A,65110,NM_001353644;NM_001353645;NM_001353646;NM_001353647;NM_001353648;NM_001353649;NM_001353650;NM_023011;NM_080687
EBF1_TF,EBF1,EBF1_TF,EBF1,TF,190,-6.47326149857772,-0.121776234539013,-0.11189361514215,-0.154247698271562,-0.042354083129412,2.31665393993413e-09,-3.60231654370594,0.981818100069419,1.07748189890657,0.6674941896045,-0.409987709302068,0.00198338266275085,ENSG00000164330,EBF1,protein_coding,5,-1,158695916,159099916,q33.3,EBF transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:3126],NA,EBF1,1879,NM_001290360;NM_001324101;NM_001324103;NM_001324106;NM_001324107;NM_001324108;NM_001324109;NM_001324111;NM_024007;NM_182708
APP_SIG,APP,APP_SIG,APP,SIG,101,-6.46769765511986,0.0169848192942001,0.0318712673338588,-0.03192779569325,-0.0637990630271088,2.3965648550316e-09,-3.15824054240915,6.24108794247387,6.46646605905266,5.50055984514358,-0.965906213909074,0.0070949150179256,ENSG00000142192,APP,protein_coding,21,-1,25880550,26171128,q21.3,amyloid beta precursor protein [Source:HGNC Symbol;Acc:HGNC:620],ABeta amyloidosis Arctic type;ABeta amyloidosis Dutch type;ABeta amyloidosis Iowa type;ABeta amyloidosis Italian type;ABetaA21G amyloidosis;ABetaL34V amyloidosis;Alzheimer disease;CEREBRAL AMYLOID ANGIOPATHY APP-RELATED;Early-onset autosomal dominant Alzheimer disease,APP,351,NM_000484;NM_001136016;NM_001136129;NM_001136130;NM_001136131;NM_001204301;NM_001204302;NM_001204303;NM_201413;NM_201414
SCML1_TF,SCML1,SCML1_TF,SCML1,TF,135,-6.4607764982793,-0.111810333540391,-0.0998234543537213,-0.151195793725162,-0.0513723393714408,2.50151943435375e-09,-4.09377663422268,1.87679085062157,2.00429517059527,1.45784808499369,-0.546447085601583,0.000413896000277351,ENSG00000047634,SCML1,protein_coding,X,1,17737449,17754988,p22.13,Scm polycomb group protein like 1 [Source:HGNC Symbol;Acc:HGNC:10580],NA,SCML1,6322,NM_001037535;NM_001037536;NM_001037540;NM_006746
OR14L1P_SIG,OR14L1P,OR14L1P_SIG,OR14L1P,SIG,40,6.4547348526288,0.103589506628104,0.078241286728655,0.186876514869151,0.108635228140496,2.59177675285143e-09,5.17270709668557,0.295256987218649,0.241516265479738,0.471833644360784,0.230317378881046,7.0536842837961e-06,ENSG00000198452,OR14L1P,transcribed_unprocessed_pseudogene,1,1,247617143,247622372,q44,olfactory receptor family 14 subfamily L member 1 pseudogene [Source:HGNC Symbol;Acc:HGNC:15023],NA,OR14L1P,NA,NA
STK24_SIG,STK24,STK24_SIG,STK24,SIG,68,-6.45449675526318,0.00934389731190459,0.02641557339853,-0.0467487526870075,-0.0731643260855374,2.59177675285143e-09,-2.86760251841694,6.96348279049541,7.01872947413988,6.78195797280641,-0.236771501333472,0.0150258734774159,ENSG00000102572,STK24,protein_coding,13,-1,98445185,98577940,q32.2,serine/threonine kinase 24 [Source:HGNC Symbol;Acc:HGNC:11403],NA,STK24,8428,NM_001032296;NM_001286649;NM_003576
KATNB1_SIG,KATNB1,KATNB1_SIG,KATNB1,SIG,21,6.45409986413498,0.246778503616457,0.227603514790021,0.309782038331892,0.0821785235418715,2.59177675285143e-09,6.01167811136593,5.1933140202156,5.10163374764895,5.49454920150603,0.392915453857077,1.33116240381414e-07,ENSG00000140854,KATNB1,protein_coding,16,1,57735739,57757244,q21,katanin regulatory subunit B1 [Source:HGNC Symbol;Acc:HGNC:6217],Lissencephaly 6 with microcephaly;Microlissencephaly,KATNB1,10300,NM_005886
FSCN1_SIG,FSCN1,FSCN1_SIG,FSCN1,SIG,65,6.44984095945886,0.0907682305920146,0.072988097111749,0.14918866917003,0.076200572058281,2.65802712200985e-09,4.87872778249822,5.89668289221839,5.70448701973034,6.52818361610771,0.82369659637737,2.33721965883465e-05,ENSG00000075618,FSCN1,protein_coding,7,1,5592816,5606655,p22.1,fascin actin-bundling protein 1 [Source:HGNC Symbol;Acc:HGNC:11148],NA,FSCN1,6624,NM_003088
ZDHHC8_SIG,ZDHHC8,ZDHHC8_SIG,ZDHHC8,SIG,76,6.44850148542924,0.269838158648443,0.252958803530367,0.325298896893549,0.0723400933631823,2.67395905041541e-09,4.68178757730281,5.42454897975516,5.33803518642656,5.70880858640627,0.370773399979712,5.02432358292968e-05,ENSG00000099904,ZDHHC8,protein_coding,22,1,20129456,20148007,q11.21,zinc finger DHHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:18474],NA,ZDHHC8,29801,NM_001185024;NM_013373
ZBTB46_TF,ZBTB46,ZBTB46_TF,ZBTB46,TF,150,6.44774364848316,0.128108177149299,0.108816952750481,0.191493628745414,0.082676675994933,2.67970356092737e-09,5.11490100509608,3.40033716879393,3.2055482758474,4.0403578170468,0.834809541199402,8.938479859048e-06,ENSG00000130584,ZBTB46,protein_coding,20,-1,63743666,63832038,q13.33,zinc finger and BTB domain containing 46 [Source:HGNC Symbol;Acc:HGNC:16094],NA,ZBTB46,140685,NM_025224
HLCS_SIG,HLCS,HLCS_SIG,HLCS,SIG,14,6.44603235129973,0.152023461307394,0.140765604989109,0.189013560638902,0.0482479556497934,2.70242022365227e-09,3.82078986654919,4.01203544705062,3.93307062676858,4.2714912851202,0.338420658351617,0.00100826118774084,ENSG00000159267,HLCS,protein_coding,21,-1,36750888,36990236,q22.13,holocarboxylase synthetase [Source:HGNC Symbol;Acc:HGNC:4976],HOLOCARBOXYLASE SYNTHETASE DEFICIENCY,HLCS,3141,NM_000411;NM_001242784;NM_001242785;NM_001352514;NM_001352515;NM_001352516;NM_001352517;NM_001352518
NAA35_SIG,NAA35,NAA35_SIG,NAA35,SIG,60,6.43440653634609,0.43616377118142,0.422045814450616,0.482551343296919,0.0605055288463028,2.9092949674734e-09,5.74151708591318,4.26309015832257,4.19366375507005,4.49120548329514,0.297541728225093,5.16347812036485e-07,ENSG00000135040,NAA35,protein_coding,9,1,85941146,86022298,q21.33,N(alpha)-acetyltransferase 35, NatC auxiliary subunit [Source:HGNC Symbol;Acc:HGNC:24340],NA,NAA35,60560,NM_001321881;NM_001321882;NM_024635
ZNF768_TF,ZNF768,ZNF768_TF,ZNF768,TF,231,6.43297804515252,0.0609677366102469,0.0438452028469006,0.117227490404099,0.0733822875571984,2.92848375747159e-09,4.31617073427854,5.44852210348645,5.37822263665976,5.67950606591703,0.301283429257277,0.000193261402327667,ENSG00000169957,ZNF768,protein_coding,16,-1,30524004,30526821,p11.2,zinc finger protein 768 [Source:HGNC Symbol;Acc:HGNC:26273],NA,ZNF768,79724,NM_024671
MYEF2_TF,MYEF2,MYEF2_TF,MYEF2,TF,167,-6.42784778558606,-0.0969091359690545,-0.0861590370122665,-0.132230889684215,-0.0460718526719485,3.02048319745486e-09,-3.95614289046781,2.71788519335991,2.91150737171121,2.08169803591992,-0.829809335791281,0.000653471892828044,ENSG00000104177,MYEF2,protein_coding,15,-1,48134632,48178353,q21.1,myelin expression factor 2 [Source:HGNC Symbol;Acc:HGNC:17940],NA,MYEF2,50804,NM_001301210;NM_016132
NAP1L3_SIG,NAP1L3,NAP1L3_SIG,NAP1L3,SIG,79,-6.42413997319407,-0.216957489957633,-0.19843086138999,-0.277830698108461,-0.0793998367184712,3.08632850883207e-09,-3.49267156893842,0.864189913203354,0.958932840179281,0.552891724568165,-0.406041115611116,0.00275991396219425,ENSG00000186310,NAP1L3,protein_coding,X,-1,93670930,93673568,q21.32,nucleosome assembly protein 1 like 3 [Source:HGNC Symbol;Acc:HGNC:7639],NA,NAP1L3,4675,NM_004538
EXOG_SIG,EXOG,EXOG_SIG,EXOG,SIG,26,6.42281635515178,0.280970250022498,0.271983472101457,0.310498234620205,0.0385147625187474,3.10457392699984e-09,4.80972279316709,3.51893230424103,3.45111616174063,3.74175677245664,0.290640610716006,3.06262512660872e-05,ENSG00000157036,EXOG,protein_coding,3,1,38496127,38542161,p22.2,exo/endonuclease G [Source:HGNC Symbol;Acc:HGNC:3347],NA,EXOG,9941,NM_001145464;NM_005107
ZDHHC8_TF,ZDHHC8,ZDHHC8_TF,ZDHHC8,TF,327,6.42149839929532,0.14564216370252,0.132003876718865,0.190453678077386,0.0584498013585208,3.12283017397946e-09,4.68178757730281,5.42454897975516,5.33803518642656,5.70880858640627,0.370773399979712,5.02432358292968e-05,ENSG00000099904,ZDHHC8,protein_coding,22,1,20129456,20148007,q11.21,zinc finger DHHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:18474],NA,ZDHHC8,29801,NM_001185024;NM_013373
INHA_SIG,INHA,INHA_SIG,INHA,SIG,41,6.418438264185,-0.0926757788496268,-0.104091175846056,-0.055168045861361,0.0489231299846945,3.17736484810594e-09,1.43284474289833,0.189048595901827,0.178270507608301,0.224462314580556,0.0461918069722551,0.244536219101622,ENSG00000123999,INHA,protein_coding,2,1,219569162,219575711,q35,inhibin subunit alpha [Source:HGNC Symbol;Acc:HGNC:6065],NA,INHA,3623,NM_002191
NCOA2_TF,NCOA2,NCOA2_TF,NCOA2,TF,179,-6.40982845510632,0.202512315919569,0.211726933046723,0.172235716787489,-0.0394912162592341,3.35274307227755e-09,-4.17823279686813,6.56806484824121,6.63589511242979,6.34519398019303,-0.290701132236765,0.00031075124913915,ENSG00000140396,NCOA2,protein_coding,8,-1,70109782,70403808,q13.3,nuclear receptor coactivator 2 [Source:HGNC Symbol;Acc:HGNC:7669],NA,NCOA2,10499,NM_001321703;NM_001321707;NM_001321711;NM_001321712;NM_001321713;NM_006540
MPG_SIG,MPG,MPG_SIG,MPG,SIG,29,6.40931755282059,0.221104577441405,0.210068291850162,0.257366658669773,0.0472983668196107,3.35467806319943e-09,3.36959159423351,5.66080838414225,5.60487669738163,5.84458392635574,0.23970722897411,0.00395027978769904,ENSG00000103152,MPG,protein_coding,16,1,77007,85853,p13.3,N-methylpurine DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:7211],NA,MPG,4350,NM_001015052;NM_001015054;NM_002434
ZDHHC9_TF,ZDHHC9,ZDHHC9_TF,ZDHHC9,TF,286,6.40205148025729,0.079212226963449,0.0584157320406233,0.147543567424162,0.0891278353835386,3.50494491563332e-09,4.55324829626639,4.40446996222267,4.30804303500919,4.72130129449553,0.413258259486341,8.18411530709312e-05,ENSG00000188706,ZDHHC9,protein_coding,X,-1,129803288,129843909,q26.1,zinc finger DHHC-type containing 9 [Source:HGNC Symbol;Acc:HGNC:18475],MENTAL RETARDATION SYNDROMIC X-LINKED ZDHHC9-RELATED;MENTAL RETARDATION X-LINKED SYNDROMIC RAYMOND TYPE;X-linked intellectual disability with marfanoid habitus,ZDHHC9,51114,NM_001008222;NM_016032
CCDC169_TF,CCDC169,CCDC169_TF,CCDC169,TF,177,6.40178971044741,-0.00875205781595048,-0.0228199603522434,0.0374710505175835,0.060291010869827,3.50494491563332e-09,4.40079302312925,1.13641272304528,1.05569003124451,1.40164442467639,0.345954393431881,0.000142706069022871,ENSG00000242715,CCDC169,protein_coding,13,-1,36222008,36297840,q13.3,coiled-coil domain containing 169 [Source:HGNC Symbol;Acc:HGNC:34361],NA,CCDC169,728591,NM_001144981;NM_001144982;NM_001144983;NM_001144984;NM_001144985;NM_001144986;NM_001198908
MYO10_SIG,MYO10,MYO10_SIG,MYO10,SIG,13,-6.39137998720152,-0.150432177943727,-0.135187493275445,-0.200521856139511,-0.0653343628640664,3.7417992350089e-09,-4.81943308842475,1.32687552560062,1.46550048277149,0.871393523467769,-0.594106959303719,2.94833521953382e-05,ENSG00000145555,MYO10,protein_coding,5,-1,16661907,16936288,p15.1,myosin X [Source:HGNC Symbol;Acc:HGNC:7593],NA,MYO10,4651,NM_012334
NME7_SIG,NME7,NME7_SIG,NME7,SIG,43,6.39020016154085,0.112571696508152,0.089098267275983,0.189698678270994,0.100600410995011,3.76045372968906e-09,4.6361936218709,3.09022832392061,2.99350891496207,3.40802066764155,0.414511752679487,5.96794987180279e-05,ENSG00000143156,NME7,protein_coding,1,-1,169132531,169367948,q24.2,NME/NM23 family member 7 [Source:HGNC Symbol;Acc:HGNC:20461],Situs inversus totalis,NME7,29922,NM_013330;NM_197972
GPR21_SIG,GPR21,GPR21_SIG,GPR21,SIG,53,6.3859465688188,-0.0112258790332277,-0.0277940271867466,0.0432123220426198,0.0710063492293663,3.85593123136192e-09,3.4980232205487,0.440996526838431,0.394643553665358,0.593299152978527,0.198655599313169,0.00272162877656401,ENSG00000188394,GPR21,protein_coding,9,1,123034527,123035696,q33.2,G protein-coupled receptor 21 [Source:HGNC Symbol;Acc:HGNC:4476],NA,GPR21,NA,NA
MSI2_SIG,MSI2,MSI2_SIG,MSI2,SIG,164,6.38140231265097,0.107144917974984,0.088143746825546,0.169577337465995,0.0814335906404486,3.96130553011196e-09,5.89379112762115,7.36336130242485,7.13524682793952,8.11288029001952,0.977633462080001,2.43487715101178e-07,ENSG00000153944,MSI2,protein_coding,17,1,57255851,57684689,q22,musashi RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:18585],NA,MSI2,124540,NM_001322250;NM_001322251;NM_138962;NM_170721
ZNF768_SIG,ZNF768,ZNF768_SIG,ZNF768,SIG,50,6.37921857738078,0.0842063313173091,0.0654929136491445,0.145693275084135,0.0802003614349907,4.00370623679902e-09,4.31617073427854,5.44852210348645,5.37822263665976,5.67950606591703,0.301283429257277,0.000193261402327667,ENSG00000169957,ZNF768,protein_coding,16,-1,30524004,30526821,p11.2,zinc finger protein 768 [Source:HGNC Symbol;Acc:HGNC:26273],NA,ZNF768,79724,NM_024671
CDK5R1_SIG,CDK5R1,CDK5R1_SIG,CDK5R1,SIG,16,-6.378939585388,-0.152568812859295,-0.135293745674022,-0.209329747896618,-0.074036002222596,4.00370623679902e-09,-3.03028812905505,1.88297006407254,1.95926566855403,1.63228450649048,-0.326981162063552,0.00994539537922801,ENSG00000176749,CDK5R1,protein_coding,17,1,32486993,32491253,q11.2,cyclin dependent kinase 5 regulatory subunit 1 [Source:HGNC Symbol;Acc:HGNC:1775],NA,CDK5R1,8851,NM_003885
PTP4A3_SIG,PTP4A3,PTP4A3_SIG,PTP4A3,SIG,70,6.3749116562329,0.0435372879182059,0.0307404597827005,0.0855840089348665,0.054843549152166,4.09924890374466e-09,5.13317830407996,4.1572395165324,3.95680544348723,4.81580861368081,0.859003170193577,8.28793351645295e-06,ENSG00000184489,PTP4A3,protein_coding,8,1,141391993,141432454,q24.3,protein tyrosine phosphatase type IVA, member 3 [Source:HGNC Symbol;Acc:HGNC:9636],NA,PTP4A3,11156,NM_007079;NM_032611
TM7SF2_SIG,TM7SF2,TM7SF2_SIG,TM7SF2,SIG,52,6.37303503723205,0.120319145204741,0.102240372811965,0.179720825923864,0.0774804531118988,4.13855904044284e-09,3.9765626408495,3.13215337817294,3.0538078072939,3.38957453963266,0.335766732338761,0.000612243396601393,ENSG00000149809,TM7SF2,protein_coding,11,1,65111845,65116384,q13.1,transmembrane 7 superfamily member 2 [Source:HGNC Symbol;Acc:HGNC:11863],NA,TM7SF2,7108,NM_001277233;NM_003273
ZNF500_TF,ZNF500,ZNF500_TF,ZNF500,TF,37,6.36624378314829,0.299100478091792,0.281781553214614,0.356005516973947,0.0742239637593326,4.31429041441312e-09,5.57304823043576,3.56368015202205,3.48022231995694,3.83789874309315,0.357676423136212,1.1433126306152e-06,ENSG00000103199,ZNF500,protein_coding,16,-1,4748239,4767624,p13.3,zinc finger protein 500 [Source:HGNC Symbol;Acc:HGNC:23716],NA,ZNF500,26048,NM_001303450;NM_021646
IFT57_TF,IFT57,IFT57_TF,IFT57,TF,76,6.35691615583928,0.00992524157528542,0.000640575832130148,0.0404320004456527,0.0397914246135225,4.57217100208146e-09,3.11247597984105,5.13447028302223,5.0824101582082,5.30552497883978,0.223114820631581,0.00806248706503071,ENSG00000114446,IFT57,protein_coding,3,-1,108160812,108222435,q13.13,intraflagellar transport 57 [Source:HGNC Symbol;Acc:HGNC:17367],Oral-facial-digital syndrome with short stature and brachymesophalangy;OROFACIODIGITAL SYNDROME XVIII,IFT57,55081,NM_018010
KAT2A_SIG,KAT2A,KAT2A_SIG,KAT2A,SIG,74,6.35343648876434,0.213698467849418,0.194957854747953,0.275274768039946,0.0803169132919926,4.66434744825739e-09,5.35912499046835,6.19956984921081,6.08361263626548,6.58057212031689,0.496959484051406,3.0703643843435e-06,ENSG00000108773,KAT2A,protein_coding,17,-1,42113111,42121367,q21.2,lysine acetyltransferase 2A [Source:HGNC Symbol;Acc:HGNC:4201],NA,KAT2A,2648,NM_021078
MCOLN2_SIG,MCOLN2,MCOLN2_SIG,MCOLN2,SIG,51,-6.35187046213125,-0.0826682675384598,-0.0662889991734876,-0.136485863594797,-0.0701968644213095,4.6995263352662e-09,-3.82483156244841,1.505723874033,1.63817966733164,1.07051198176603,-0.567667685565609,0.000995166373748377,ENSG00000153898,MCOLN2,protein_coding,1,-1,84925583,84997113,p22.3,mucolipin 2 [Source:HGNC Symbol;Acc:HGNC:13357],NA,MCOLN2,255231,NM_001330647;NM_153259
TKTL1_SIG,TKTL1,TKTL1_SIG,TKTL1,SIG,4,-6.34693681734685,-0.09708565133806,-0.0852968527199311,-0.135820275369055,-0.0505234226491237,4.83976831994029e-09,-1.79189147082935,1.24401061027934,1.31796593543241,1.00101454191924,-0.316951393513177,0.140192564603751,ENSG00000007350,TKTL1,protein_coding,X,1,154295795,154330350,q28,transketolase like 1 [Source:HGNC Symbol;Acc:HGNC:11835],NA,TKTL1,8277,NM_001145933;NM_001145934;NM_012253
E2F5_TF,E2F5,E2F5_TF,E2F5,TF,87,6.34448300347555,0.109713084333152,0.0901839957718547,0.173880089605988,0.0836960938341328,4.90449194897445e-09,4.84929740819558,1.94720275167708,1.82856500499467,2.33701249077644,0.508447485781775,2.64814355551986e-05,ENSG00000133740,E2F5,protein_coding,8,1,85177154,85217158,q21.2,E2F transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:3119],NA,E2F5,1875,NM_001083588;NM_001083589;NM_001951
SLC27A6_SIG,SLC27A6,SLC27A6_SIG,SLC27A6,SIG,63,6.34196527000448,-0.0056723710200689,-0.0183174955740654,0.0358758953716338,0.0541933909456992,4.97214989636473e-09,3.83285616094132,0.958941006393123,0.843218969707935,1.3391705555016,0.495951585793661,0.00097067995647094,ENSG00000113396,SLC27A6,protein_coding,5,1,128538013,129033642,q23.3,solute carrier family 27 member 6 [Source:HGNC Symbol;Acc:HGNC:11000],NA,SLC27A6,28965,NM_001017372;NM_001317984;NM_014031
CUX1_TF,CUX1,CUX1_TF,CUX1,TF,58,6.34056887939561,0.171637264199533,0.164251736264723,0.195903998842478,0.0316522625777546,5.00419024215349e-09,2.31103681766882,7.76146538811497,7.73356245895836,7.85314644105811,0.119583982099749,0.0527632505560714,ENSG00000257923,CUX1,protein_coding,7,1,101815904,102283958,q22.1,cut like homeobox 1 [Source:HGNC Symbol;Acc:HGNC:2557],NA,CUX1,1523,NM_001202543;NM_001202544;NM_001202545;NM_001202546;NM_001913;NM_181500;NM_181552
CTSW_SIG,CTSW,CTSW_SIG,CTSW,SIG,50,6.3398346290077,0.017688498849355,0.00240345632874392,0.067910781417077,0.0655073250883331,5.01486506070909e-09,3.38118178849653,6.35762287442426,6.22887557503608,6.78064971527114,0.551774140235056,0.00381805734727345,ENSG00000172543,CTSW,protein_coding,11,1,65879837,65883741,q13.1,cathepsin W [Source:HGNC Symbol;Acc:HGNC:2546],NA,CTSW,1521,NM_001335
MGAT4B_SIG,MGAT4B,MGAT4B_SIG,MGAT4B,SIG,35,6.33520978398332,0.100988104325514,0.0925940028006931,0.128568723621352,0.035974720820659,5.15406494079923e-09,2.65246400571886,6.62225483533078,6.58544186360725,6.74321174242235,0.157769878815095,0.0249225361948952,ENSG00000161013,MGAT4B,protein_coding,5,-1,179797597,179806952,q35.3,alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B [Source:HGNC Symbol;Acc:HGNC:7048],NA,MGAT4B,11282,NM_014275;NM_054013
SNTB2_SIG,SNTB2,SNTB2_SIG,SNTB2,SIG,42,-6.32746787846855,0.0746359431486191,0.0965793255727151,0.00253625804087515,-0.0940430675318399,5.4051346075662e-09,-4.82856684689767,2.65846700817372,2.80477380232547,2.17774468453226,-0.627029117793212,2.84982090510707e-05,ENSG00000168807,SNTB2,protein_coding,16,1,69187129,69309052,q22.1,syntrophin beta 2 [Source:HGNC Symbol;Acc:HGNC:11169],NA,SNTB2,6645,NM_006750
GRK5_SIG,GRK5,GRK5_SIG,GRK5,SIG,66,-6.31267104480301,0.0515360951346627,0.0707379327591903,-0.0115556570602139,-0.0822935898194042,5.93275369651181e-09,-4.81561853537282,3.46652340736715,3.61317924898263,2.9846542134877,-0.628525035494929,2.98681544293962e-05,ENSG00000198873,GRK5,protein_coding,10,1,119207589,119459742,q26.11,G protein-coupled receptor kinase 5 [Source:HGNC Symbol;Acc:HGNC:4544],NA,GRK5,2869,NM_005308
CALCRL_SIG,CALCRL,CALCRL_SIG,CALCRL,SIG,76,6.3048291899275,0.0317810977865094,0.0179939861814173,0.0770816073460979,0.0590876211646806,6.22479445855318e-09,6.50353256247326,2.49605243115621,2.20312458613808,3.45852963621576,1.25540505007768,1.04776996489004e-08,ENSG00000064989,CALCRL,protein_coding,2,-1,187341964,187448460,q32.1,calcitonin receptor like receptor [Source:HGNC Symbol;Acc:HGNC:16709],NA,CALCRL,10203,NM_001271751;NM_005795
SLC26A1_SIG,SLC26A1,SLC26A1_SIG,SLC26A1,SIG,11,6.29463629203766,0.116560432478036,0.105181993770332,0.153946731089065,0.0487647373187329,6.63061355250709e-09,0.927511807113911,0.534304925406344,0.526126184544145,0.561177931096427,0.0350517465522817,0.466987751314324,ENSG00000145217,SLC26A1,protein_coding,4,-1,979073,993440,p16.3,solute carrier family 26 member 1 [Source:HGNC Symbol;Acc:HGNC:10993],NEPHROLITHIASIS CALCIUM OXALATE,SLC26A1,10861,NM_022042;NM_134425;NM_213613
METTL8_SIG,METTL8,METTL8_SIG,METTL8,SIG,62,6.29327068282274,0.276254309242674,0.253629526791885,0.350592880152408,0.0969633533605235,6.67190600957327e-09,6.54086554060888,4.31980440671046,4.20757731087932,4.68855057872709,0.480973267847774,8.62220863235538e-09,ENSG00000123600,METTL8,protein_coding,2,-1,171317405,171434802,q31.1,methyltransferase like 8 [Source:HGNC Symbol;Acc:HGNC:25856],NA,METTL8,79828,NM_001321154;NM_001321155;NM_001321156;NM_001321157;NM_001321158;NM_001321159;NM_001321160;NM_001321161;NM_001321162;NM_024770
LTK_SIG,LTK,LTK_SIG,LTK,SIG,51,6.28902376501834,0.0204615924323382,0.0103130684210709,0.0538067427550735,0.0434936743340027,6.8328688116399e-09,1.72588571517273,3.75246971294322,3.66425020791351,4.04233380089797,0.378083592984454,0.156388916215072,ENSG00000062524,LTK,protein_coding,15,-1,41503637,41513887,q15.1,leukocyte receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6721],NA,LTK,4058,NM_001135685;NM_002344;NM_206961
TADA2B_TF,TADA2B,TADA2B_TF,TADA2B,TF,287,-6.28876844939389,0.106760508291692,0.124008328059682,0.050089100482583,-0.0739192275770987,6.8328688116399e-09,-5.41236252945303,5.02860476270991,5.15980527814563,4.59751735484971,-0.562287923295919,2.41797299912464e-06,ENSG00000173011,TADA2B,protein_coding,4,1,7041899,7057952,p16.1,transcriptional adaptor 2B [Source:HGNC Symbol;Acc:HGNC:30781],NA,TADA2B,93624,NM_152293
MLLT10_SIG,MLLT10,MLLT10_SIG,MLLT10,SIG,26,6.28808958762903,0.284907908225561,0.272249735353466,0.326499047662447,0.0542493123089819,6.84516570137875e-09,2.63803527038249,6.55116105181894,6.51324836452922,6.6757313100566,0.162482945527377,0.0257639424646615,ENSG00000078403,MLLT10,protein_coding,10,1,21524646,21743630,p12.31,MLLT10, histone lysine methyltransferase DOT1L cofactor [Source:HGNC Symbol;Acc:HGNC:16063],LEUKEMIA ACUTE MYELOID;Precursor T-cell acute lymphoblastic leukemia,MLLT10,8028,NM_001195626;NM_001195627;NM_001195628;NM_001195630;NM_001324296;NM_001324297;NM_004641
ARSG_SIG,ARSG,ARSG_SIG,ARSG,SIG,37,-6.28670301824698,0.0949426499485939,0.127581455343765,-0.012299139206969,-0.139880594550734,6.88884717770277e-09,-4.98542122701075,2.06439550678041,2.20864805352121,1.59042285320349,-0.618225200317717,1.50206639506631e-05,ENSG00000141337,ARSG,protein_coding,17,1,68259182,68422731,q24.2,arylsulfatase G [Source:HGNC Symbol;Acc:HGNC:24102],USHER SYNDROME TYPE IV,ARSG,22901,NM_001267727;NM_001352899;NM_001352900;NM_001352901;NM_001352902;NM_001352903;NM_001352904;NM_001352905;NM_001352906;NM_001352907;NM_001352909;NM_001352910;NM_014960
PPIP5K1_SIG,PPIP5K1,PPIP5K1_SIG,PPIP5K1,SIG,31,6.28382231040434,0.222448797139872,0.200922472920627,0.293178148145964,0.0922556752253367,6.99983481809982e-09,3.81039515121685,4.08520379660165,4.01543714992112,4.31443706426622,0.298999914345098,0.0010415897648603,ENSG00000168781,PPIP5K1,protein_coding,15,-1,43533462,43590253,q15.3,diphosphoinositol pentakisphosphate kinase 1 [Source:HGNC Symbol;Acc:HGNC:29023],NA,PPIP5K1,9677,NM_001130858;NM_001130859;NM_001190214;NM_001354382;NM_001354383;NM_001354384;NM_001354385;NM_001354386;NM_001354387;NM_001354388;NM_001354389;NM_001354390;NM_001354391;NM_001354392;NM_001354393;NM_001354394;NM_001354395;NM_001354396;NM_001354397;NM_001354398;NM_001354399;NM_001354400;NM_001354401;NM_001354402;NM_014659
USP43_SIG,USP43,USP43_SIG,USP43,SIG,30,6.28047938095464,0.208514728553702,0.194880222466507,0.253313819983056,0.058433597516549,7.13377908324838e-09,4.59681488619028,2.26643804444879,2.15965402745311,2.61729981457745,0.457645787124344,6.92859784566303e-05,ENSG00000154914,USP43,protein_coding,17,1,9644698,9729687,p13.1,ubiquitin specific peptidase 43 [Source:HGNC Symbol;Acc:HGNC:20072],NA,USP43,124739,NM_001267576;NM_153210
PRSS21_SIG,PRSS21,PRSS21_SIG,PRSS21,SIG,6,6.2758696402676,-0.200155634125009,-0.215401684343125,-0.150061469122626,0.0653402152205,7.3297037733217e-09,-0.137470743026677,2.67578968688377,2.68486515766511,2.64597028288796,-0.0388948747771486,0.92265697966202,ENSG00000007038,PRSS21,protein_coding,16,1,2817180,2826304,p13.3,serine protease 21 [Source:HGNC Symbol;Acc:HGNC:9485],NA,PRSS21,10942,NM_001270452;NM_006799;NM_144956;NM_144957
AEBP1_TF,AEBP1,AEBP1_TF,AEBP1,TF,98,6.27453305321943,0.056408607107948,0.0421330045588258,0.103314158340778,0.0611811537819524,7.37417844662788e-09,4.76463531090955,3.78695684069694,3.57298241545314,4.49001566649802,0.917033251044882,3.65847427653903e-05,ENSG00000106624,AEBP1,protein_coding,7,1,44104345,44114562,p13,AE binding protein 1 [Source:HGNC Symbol;Acc:HGNC:303],EHLERS-DANLOS SYNDROME CLASSIC-LIKE 2,AEBP1,165,NM_001129
FOLR3_SIG,FOLR3,FOLR3_SIG,FOLR3,SIG,6,-6.27076090111883,0.994885752663405,1.10282243798765,0.640236643740871,-0.462585794246784,7.53595157272447e-09,-5.40010441597793,2.31932181783263,2.58126546935536,1.45864981997222,-1.12261564938315,2.54052969921741e-06,ENSG00000110203,FOLR3,protein_coding,11,1,72114869,72139892,q13.4,folate receptor 3 [Source:HGNC Symbol;Acc:HGNC:3795],NA,FOLR3,2352,NM_000804;NM_001318045
CAMK2D_SIG,CAMK2D,CAMK2D_SIG,CAMK2D,SIG,57,-6.26117366420358,-0.0814192389392715,-0.0605702884902741,-0.149922933271692,-0.0893526447814175,7.99399389017499e-09,-6.52809851147973,3.09412861830634,3.35737065391934,2.22919050129221,-1.12818015262713,9.1636741938998e-09,ENSG00000145349,CAMK2D,protein_coding,4,-1,113451032,113761927,q26,calcium/calmodulin dependent protein kinase II delta [Source:HGNC Symbol;Acc:HGNC:1462],NA,CAMK2D,817,NM_001221;NM_001321566;NM_001321567;NM_001321568;NM_001321569;NM_001321570;NM_001321571;NM_001321572;NM_001321573;NM_001321574;NM_001321575;NM_001321576;NM_001321577;NM_001321578;NM_001321579;NM_001321580;NM_001321581;NM_001321582;NM_001321583;NM_001321584;NM_001321585;NM_001321586;NM_001321587;NM_001321588;NM_001321589;NM_001321590;NM_001321591;NM_001321592;NM_172114;NM_172115;NM_172127;NM_172128;NM_172129
MMP7_SIG,MMP7,MMP7_SIG,MMP7,SIG,9,6.25248724397289,-0.00164114183727345,-0.0141279309280609,0.0393868794610281,0.0535148103890888,8.43038920759983e-09,0.244534725112634,0.606902276399348,0.60178681419173,0.623710223652952,0.0219234094612222,0.861195290357679,ENSG00000137673,MMP7,protein_coding,11,-1,102520508,102530750,q22.2,matrix metallopeptidase 7 [Source:HGNC Symbol;Acc:HGNC:7174],NA,MMP7,4316,NM_002423
IRF4_TF,IRF4,IRF4_TF,IRF4,TF,180,-6.25180259161546,-0.0739900317238756,-0.0588619811356962,-0.123696483656465,-0.0648345025207688,8.43918897783081e-09,-2.21617486208453,2.87689638544113,2.9616663708324,2.59836643344125,-0.363299937391157,0.0642429775143799,ENSG00000137265,IRF4,protein_coding,6,1,391752,411443,p25.3,interferon regulatory factor 4 [Source:HGNC Symbol;Acc:HGNC:6119],Skin/hair/eye pigmentation variation in 8,IRF4,3662,NM_001195286;NM_002460
DPF3_SIG,DPF3,DPF3_SIG,DPF3,SIG,46,-6.25153974586624,-0.172568347543831,-0.157828054434694,-0.22100073918814,-0.063172684753446,8.43918897783081e-09,-4.19804870610873,0.750694640124706,0.839046494537368,0.460395689911671,-0.378650804625697,0.0002900134569424,ENSG00000205683,DPF3,protein_coding,14,-1,72619296,72894116,q24.2,double PHD fingers 3 [Source:HGNC Symbol;Acc:HGNC:17427],NA,DPF3,8110,NM_001280542;NM_001280543;NM_001280544;NM_012074
SUPT3H_SIG,SUPT3H,SUPT3H_SIG,SUPT3H,SIG,106,6.25098375799768,0.106214461114487,0.0858497235736799,0.173127170177141,0.0872774466034611,8.44811709951265e-09,4.58488650111703,3.55394601886506,3.44965261442886,3.89662434772688,0.446971733298024,7.2744190543869e-05,ENSG00000196284,SUPT3H,protein_coding,6,-1,44809317,45377953,p21.1,SPT3 homolog, SAGA and STAGA complex component [Source:HGNC Symbol;Acc:HGNC:11466],NA,SUPT3H,8464,NM_001261823;NM_001350324;NM_001350325;NM_001350326;NM_001350327;NM_001350329;NM_003599;NM_181356
FGF17_SIG,FGF17,FGF17_SIG,FGF17,SIG,49,6.24936595501194,0.0588256914834956,0.0383099961931452,0.126234404580361,0.0879244083872161,8.51479539153386e-09,5.05969994732485,1.27813412251447,1.14700855509242,1.7089752726155,0.561966717523082,1.10991187364001e-05,ENSG00000158815,FGF17,protein_coding,8,1,22042398,22048809,p21.3,fibroblast growth factor 17 [Source:HGNC Symbol;Acc:HGNC:3673],Hypogonadotropic hypogonadism 20 with or without anosmia;Hypogonadotropic hypogonadism 7 with or without anosmia;Kallmann Syndrome;Normosmic congenital hypogonadotropic hypogonadism,FGF17,8822,NM_001304478;NM_003867
MYRF_TF,MYRF,MYRF_TF,MYRF,TF,172,6.24713184137883,0.0178481212328835,0.0121741701527819,0.0364911033532173,0.0243169332004354,8.61595010014012e-09,5.1894187866416,2.35776110325228,2.13895021220217,3.0767111738455,0.937760961643323,6.52777643378155e-06,ENSG00000124920,MYRF,protein_coding,11,1,61752642,61788518,q12.2,myelin regulatory factor [Source:HGNC Symbol;Acc:HGNC:1181],ENCEPHALITIS/ENCEPHALOPATHY MILD WITH REVERSIBLE MYELINVACUOLIZATION,MYRF,745,NM_001127392;NM_013279
SMYD3_TF,SMYD3,SMYD3_TF,SMYD3,TF,141,6.24479353671908,0.140878473748117,0.128645233644544,0.181073405517002,0.0524281718724581,8.72413129996352e-09,4.32721972822516,4.49795929320457,4.35828266312499,4.95689679203746,0.598614128912471,0.000185401208838031,ENSG00000185420,SMYD3,protein_coding,1,-1,245749342,246507312,q44,SET and MYND domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15513],NA,SMYD3,64754,NM_001167740;NM_022743
CDC14B_SIG,CDC14B,CDC14B_SIG,CDC14B,SIG,40,-6.23988758120255,-0.152159014116614,-0.139043896711248,-0.195251542734244,-0.0562076460229953,8.97990394980809e-09,-5.21134513895016,1.60350835445705,1.76021123073812,1.08862747524784,-0.67158375549028,5.87944271238479e-06,ENSG00000081377,CDC14B,protein_coding,9,-1,96490241,96619830,q22.33,cell division cycle 14B [Source:HGNC Symbol;Acc:HGNC:1719],NA,CDC14B,8555,NM_001077181;NM_001351567;NM_001351568;NM_001351569;NM_001351570;NM_003671;NM_033331
GALC_SIG,GALC,GALC_SIG,GALC,SIG,47,-6.23427740424905,-0.0379463358920184,-0.0250262975974766,-0.08039789028837,-0.0553715926908935,9.28468626740725e-09,-3.95356339941748,5.44180393303985,5.5459963268253,5.09945749631621,-0.446538830509093,0.000659053309239183,ENSG00000054983,GALC,protein_coding,14,-1,87837820,87993665,q31.3,galactosylceramidase [Source:HGNC Symbol;Acc:HGNC:4115],Adult Krabbe disease;Infantile Krabbe disease;KRABBE DISEASE;Late-infantile/juvenile Krabbe disease,GALC,2581,NM_000153;NM_001201401;NM_001201402
SETD6_SIG,SETD6,SETD6_SIG,SETD6,SIG,124,6.23295234225278,0.14165052002426,0.122814175544608,0.203541366171688,0.0807271906270799,9.33423559806032e-09,5.49819259611165,3.71754393022518,3.62203505659074,4.03135880073834,0.409323744147599,1.61672360024386e-06,ENSG00000103037,SETD6,protein_coding,16,1,58515479,58521181,q21,SET domain containing 6, protein lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:26116],NA,SETD6,79918,NM_001160305;NM_024860
CDO1_SIG,CDO1,CDO1_SIG,CDO1,SIG,3,-6.23267268553867,-0.0246185380756544,-0.0109807157085188,-0.0694285258533857,-0.058447810144867,9.33423559806032e-09,-1.05904643817566,0.218763791418222,0.227313422820758,0.190672145381319,-0.0366412774394391,0.401743952547425,ENSG00000129596,CDO1,protein_coding,5,-1,115804733,115816659,q22.3,cysteine dioxygenase type 1 [Source:HGNC Symbol;Acc:HGNC:1795],NA,CDO1,1036,NM_001323565;NM_001323566;NM_001323567;NM_001801
USP44_SIG,USP44,USP44_SIG,USP44,SIG,82,6.23214529894071,-0.0942385503313254,-0.106919322314945,-0.0525731566708603,0.0543461656440851,9.3427676018163e-09,5.07422451290931,0.924872308751629,0.735106212736105,1.54838948137407,0.813283268637961,1.03801490880384e-05,ENSG00000136014,USP44,protein_coding,12,-1,95516560,95551476,q22,ubiquitin specific peptidase 44 [Source:HGNC Symbol;Acc:HGNC:20064],NA,USP44,84101,NM_001042403;NM_001278393;NM_001347936;NM_001347937;NM_032147
TIGD6_TF,TIGD6,TIGD6_TF,TIGD6,TF,109,6.2235591871442,0.0821306644916904,0.0744208150641531,0.107463026896456,0.0330422118323029,9.84479513241061e-09,4.30820508292666,2.45047149079791,2.38859952532641,2.65376509163283,0.265165566306423,0.000198658657569147,ENSG00000164296,TIGD6,protein_coding,5,-1,149993118,150000654,q32,tigger transposable element derived 6 [Source:HGNC Symbol;Acc:HGNC:18332],NA,TIGD6,81789,NM_001243253;NM_030953
IGFBP2_SIG,IGFBP2,IGFBP2_SIG,IGFBP2,SIG,85,6.22212380923865,0.0515014626414616,0.0375703942911145,0.0972749729354589,0.0597045786443445,9.91107757127063e-09,4.7506924581727,3.8020502335813,3.53975956166134,4.6638624413183,1.12410287965696,3.85474200182193e-05,ENSG00000115457,IGFBP2,protein_coding,2,1,216632828,216664436,q35,insulin like growth factor binding protein 2 [Source:HGNC Symbol;Acc:HGNC:5471],NA,IGFBP2,3485,NM_000597;NM_001313990;NM_001313992;NM_001313993
RGL1_SIG,RGL1,RGL1_SIG,RGL1,SIG,27,-6.22028710839461,-0.0414230968463001,-0.0194554912132398,-0.113602372497784,-0.0941468812845445,1.00034012391126e-08,-5.55562379790114,1.77679756395959,1.96827991672442,1.14764126201802,-0.820638654706406,1.23383171115671e-06,ENSG00000143344,RGL1,protein_coding,1,1,183636085,183928531,q25.3,ral guanine nucleotide dissociation stimulator like 1 [Source:HGNC Symbol;Acc:HGNC:30281],NA,RGL1,23179,NM_001297669;NM_001297670;NM_001297671;NM_001297672;NM_015149
AVPR1A_SIG,AVPR1A,AVPR1A_SIG,AVPR1A,SIG,40,6.21973689613674,-0.104059081210119,-0.116501903987602,-0.0631755206555337,0.0533263833320684,1.00141764712559e-08,4.09750069975985,0.375215776761922,0.2854479770421,0.670167118698483,0.384719141656384,0.000408984920573889,ENSG00000166148,AVPR1A,protein_coding,12,-1,63142759,63150942,q14.2,arginine vasopressin receptor 1A [Source:HGNC Symbol;Acc:HGNC:895],NA,AVPR1A,552,NM_000706
CYP2C8_SIG,CYP2C8,CYP2C8_SIG,CYP2C8,SIG,13,6.21914247738852,-0.0358547860248429,-0.0497274904900147,0.00972695721786458,0.0594544477078794,1.00278439307122e-08,4.53806969236313,0.72708104032664,0.643056695547319,1.00316103031584,0.360104334768516,8.65203890294816e-05,ENSG00000138115,CYP2C8,protein_coding,10,-1,95036772,95069497,q23.33,cytochrome P450 family 2 subfamily C member 8 [Source:HGNC Symbol;Acc:HGNC:2622],DRUG METABOLISM ALTERED CYP2C8-RELATED,CYP2C8,1558,NM_000770;NM_001198853;NM_001198854;NM_001198855
LPIN1_SIG,LPIN1,LPIN1_SIG,LPIN1,SIG,88,6.21810428889591,0.144397706032136,0.127592577343429,0.199614557437887,0.0720219800944581,1.00700190341498e-08,5.81047171734279,5.8060342074934,5.65390056830588,6.30590187910953,0.652001310803654,3.62928033537174e-07,ENSG00000134324,LPIN1,protein_coding,2,1,11677595,11827409,p25.1,lipin 1 [Source:HGNC Symbol;Acc:HGNC:13345],Genetic recurrent myoglobinuria;Myoglobinuria acute recurrent autosomal recessive,LPIN1,23175,NM_001261427;NM_001261428;NM_001349199;NM_001349200;NM_001349201;NM_001349202;NM_001349203;NM_001349204;NM_001349205;NM_001349206;NM_001349207;NM_001349208;NM_145693
COQ4_SIG,COQ4,COQ4_SIG,COQ4,SIG,69,6.21383941140819,0.264276790664076,0.24623152040501,0.323568392943861,0.0773368725388512,1.03223855824319e-08,5.85323122122122,4.72005708237517,4.62753009192915,5.0240743366978,0.396544244768649,2.97568033534958e-07,ENSG00000167113,COQ4,protein_coding,9,1,128322544,128334072,q34.11,coenzyme Q4 [Source:HGNC Symbol;Acc:HGNC:19693],COENZYME Q10 DEFICIENCY PRIMARY 7;Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,COQ4,51117,NM_001305942;NM_016035
MAPK11_SIG,MAPK11,MAPK11_SIG,MAPK11,SIG,82,6.20835536011203,0.13777249941066,0.119696850411246,0.19716391755159,0.0774670671403441,1.06633466435306e-08,6.25560982784982,3.13948232147639,2.9313531736926,3.82333523562316,0.891982061930565,3.8930045337053e-08,ENSG00000185386,MAPK11,protein_coding,22,-1,50263713,50270767,q13.33,mitogen-activated protein kinase 11 [Source:HGNC Symbol;Acc:HGNC:6873],NA,MAPK11,5600,NM_002751
RPS6KA2_SIG,RPS6KA2,RPS6KA2_SIG,RPS6KA2,SIG,64,-6.20576150000299,0.000995509449828331,0.0130735859056441,-0.038689598904995,-0.051763184810639,1.08147416117276e-08,-3.75452217933097,3.49754665414555,3.64005529537286,3.02930397582725,-0.610751319545607,0.00123865025842143,ENSG00000071242,RPS6KA2,protein_coding,6,-1,166409364,166906451,q27,ribosomal protein S6 kinase A2 [Source:HGNC Symbol;Acc:HGNC:10431],NA,RPS6KA2,6196,NM_001006932;NM_001318936;NM_001318937;NM_001318938;NM_021135
POMT1_SIG,POMT1,POMT1_SIG,POMT1,SIG,55,6.20287394187631,0.155716119270453,0.142381483522996,0.199529922440666,0.0571484389176702,1.09887735780893e-08,4.35730080781739,4.76582322097226,4.69642723139844,4.99383861528625,0.297411383887804,0.000166045849631143,ENSG00000130714,POMT1,protein_coding,9,1,131502902,131523806,q34.13,protein O-mannosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:9202],Autosomal recessive limb-girdle muscular dystrophy type 2K;Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Congenital muscular dystrophy without intellectual disability;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION) TYPE B 1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH BRAIN AND EYE ANOMALIES TYPE A1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH MENTAL RETARDATION TYPE B1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY LIMB-GIRDLE TYPE C1;Walker-Warburg syndrome,POMT1,10585,NM_001077365;NM_001077366;NM_001136113;NM_001136114;NM_001353193;NM_001353194;NM_001353195;NM_001353196;NM_001353197;NM_001353198;NM_001353199;NM_001353200;NM_007171
POC1B_SIG,POC1B,POC1B_SIG,POC1B,SIG,13,6.19101124590037,0.180252847473913,0.164248100532779,0.232839873137639,0.0685917726048604,1.18203506014352e-08,2.31128476672967,4.76338325198895,4.73447440960009,4.85836944840951,0.123895038809421,0.0527461242403617,ENSG00000139323,POC1B,protein_coding,12,-1,89419718,89526047,q21.33,POC1 centriolar protein B [Source:HGNC Symbol;Acc:HGNC:30836],Autosomal-Recessive cone-Rod dystrophy;CONE-ROD DYSTROPHY 20;Cone rod dystrophy,POC1B,282809,NM_001199777;NM_172240
MAPK12_SIG,MAPK12,MAPK12_SIG,MAPK12,SIG,35,6.18756489539422,0.242788240972677,0.221568084585917,0.312511611957746,0.0909435273718284,1.20528397308259e-08,5.26015833486413,4.20759726394096,4.01327336705995,4.84609006797855,0.832816700918607,4.72944116157412e-06,ENSG00000188130,MAPK12,protein_coding,22,-1,50245450,50261716,q13.33,mitogen-activated protein kinase 12 [Source:HGNC Symbol;Acc:HGNC:6874],NA,MAPK12,6300,NM_001303252;NM_002969
HOXA10_TF,HOXA10,HOXA10_TF,HOXA10,TF,251,6.18710489437608,0.0501877913916853,0.0400587938490461,0.0834687833174997,0.0434099894684537,1.20593373317404e-08,4.28592400882089,4.41277914737209,4.17104123957693,5.20706084441335,1.03601960483642,0.000215584002398343,ENSG00000253293,HOXA10,protein_coding,7,-1,27170592,27180261,p15.2,homeobox A10 [Source:HGNC Symbol;Acc:HGNC:5100],NA,HOXA10,3206,NM_018951
PIK3R6_SIG,PIK3R6,PIK3R6_SIG,PIK3R6,SIG,23,6.1857943466956,0.00163689879722873,-0.0122594604773074,0.0472963649849903,0.0595558254622976,1.21311483779464e-08,5.94425210598773,4.69883537647293,4.51542497329417,5.30146955834598,0.786044585051811,1.89890270100484e-07,ENSG00000276231,PIK3R6,protein_coding,17,-1,8802723,8867677,p13.1,phosphoinositide-3-kinase regulatory subunit 6 [Source:HGNC Symbol;Acc:HGNC:27101],NA,PIK3R6,146850,NM_001010855;NM_001290211
PLCL1_SIG,PLCL1,PLCL1_SIG,PLCL1,SIG,34,-6.18180155796412,-0.107203698750478,-0.0928120380006148,-0.154490584071458,-0.0616785460708435,1.24126456806237e-08,-5.26436487909465,2.29687455456437,2.4935209152551,1.65075079800914,-0.842770117245956,4.66268618220835e-06,ENSG00000115896,PLCL1,protein_coding,2,1,197804593,198572581,q33.1,phospholipase C like 1 (inactive) [Source:HGNC Symbol;Acc:HGNC:9063],NA,PLCL1,5334,NM_006226
PLCL2_SIG,PLCL2,PLCL2_SIG,PLCL2,SIG,49,-6.1772503023265,0.264454895451759,0.280490003734129,0.211768111095402,-0.0687218926387276,1.2745538449615e-08,-4.72619176897663,5.35922732989425,5.47381215593781,4.98273433003682,-0.491077825900993,4.23029285124706e-05,ENSG00000154822,PLCL2,protein_coding,3,1,16802651,17090604,p24.3,phospholipase C like 2 [Source:HGNC Symbol;Acc:HGNC:9064],NA,PLCL2,23228,NM_001144382;NM_015184
PTPN14_SIG,PTPN14,PTPN14_SIG,PTPN14,SIG,57,6.17634277360979,0.0322078723897806,0.0183514680176614,0.0777360581838868,0.0593845901662255,1.27888189083079e-08,2.72502577422438,3.22165844224167,3.05877394933347,3.75685034751148,0.698076398178006,0.0211076640916426,ENSG00000152104,PTPN14,protein_coding,1,-1,214348700,214552449,q41,protein tyrosine phosphatase, non-receptor type 14 [Source:HGNC Symbol;Acc:HGNC:9647],Choanal atresia and lymphedema;Lymphedema-posterior choanal atresia syndrome,PTPN14,5784,NM_005401
CAMK1D_SIG,CAMK1D,CAMK1D_SIG,CAMK1D,SIG,66,6.17537330259618,0.111128123496151,0.10049002653583,0.146081870651494,0.0455918441156638,1.28373393468039e-08,5.13085038987454,5.70803942139876,5.5404307177454,6.25875373340265,0.718323015657255,8.35915640096589e-06,ENSG00000183049,CAMK1D,protein_coding,10,1,12349482,12835545,p13,calcium/calmodulin dependent protein kinase ID [Source:HGNC Symbol;Acc:HGNC:19341],NA,CAMK1D,57118,NM_001351032;NM_020397;NM_153498
ANO7_SIG,ANO7,ANO7_SIG,ANO7,SIG,74,6.17448885924593,-0.0212328348779421,-0.0316631915907796,0.0130383371785238,0.0447015287693035,1.2879170546566e-08,3.31054353772924,2.19021224765332,2.03942923939058,2.68564213194519,0.646212892554611,0.00467458005662876,ENSG00000146205,ANO7,protein_coding,2,1,241188509,241225377,q37.3,anoctamin 7 [Source:HGNC Symbol;Acc:HGNC:31677],NA,ANO7,50636,NM_001001666;NM_001001891
NUDT11_SIG,NUDT11,NUDT11_SIG,NUDT11,SIG,64,-6.17350710757376,-0.187016178366372,-0.173584931043975,-0.231147419568535,-0.0575624885245595,1.29291579168878e-08,-3.78919130398135,0.537937580205854,0.623182468085809,0.257847234314576,-0.365335233771232,0.00111232671056888,ENSG00000196368,NUDT11,protein_coding,X,-1,51490011,51496592,p11.22,nudix hydrolase 11 [Source:HGNC Symbol;Acc:HGNC:18011],NA,NUDT11,55190,NM_018159
POMGNT1_SIG,POMGNT1,POMGNT1_SIG,POMGNT1,SIG,182,6.17277287210385,0.162148486527689,0.142877204767615,0.225468412310787,0.0825912075431718,1.29590873534808e-08,4.61987349781794,4.97455275990355,4.88224890398171,5.27783685793246,0.395587953950743,6.36805818689969e-05,ENSG00000085998,POMGNT1,protein_coding,1,-1,46188682,46220305,p34.1,protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) [Source:HGNC Symbol;Acc:HGNC:19139],Autosomal recessive limb-girdle muscular dystrophy type 2O;Congenital muscular dystrophy with cerebellar involvement;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 3;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION)TYPE B 3;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 3;muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH MENTAL RETARDATION TYPE B3;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY LIMB-GIRDLE TYPE C3;Retinitis pigmentosa;RETINITIS PIGMENTOSA 76;Walker-Warburg syndrome,POMGNT1,55624,NM_001243766;NM_001290129;NM_001290130;NM_017739
SEMA6A_SIG,SEMA6A,SEMA6A_SIG,SEMA6A,SIG,12,-6.16962440191203,0.0540654783397928,0.0915709270815165,-0.0691667103830136,-0.16073763746453,1.31890267210261e-08,-2.07942819368314,0.91972947083536,0.985975668004855,0.702063394421306,-0.28391227358355,0.0835363618970518,ENSG00000092421,SEMA6A,protein_coding,5,-1,116443616,116574934,q23.1,semaphorin 6A [Source:HGNC Symbol;Acc:HGNC:10738],NA,SEMA6A,57556,NM_001300780;NM_020796
ZDHHC1_TF,ZDHHC1,ZDHHC1_TF,ZDHHC1,TF,282,6.1670108257097,0.0514893221556159,0.0404514173152141,0.0877567237740792,0.0473053064588652,1.33776789365846e-08,3.16161996322262,2.14583616814858,2.0752288566529,2.37783162020583,0.30260276355293,0.00702961026673157,ENSG00000159714,ZDHHC1,protein_coding,16,-1,67394152,67416833,q22.1,zinc finger DHHC-type containing 1 [Source:HGNC Symbol;Acc:HGNC:17916],NA,ZDHHC1,29800,NM_001323627;NM_013304
ZNF33B_TF,ZNF33B,ZNF33B_TF,ZNF33B,TF,71,6.16378107862205,-0.00320784636562398,-0.0199518384411949,0.0518081275969662,0.0717599660381611,1.36219448424122e-08,4.62937045237754,4.70762247814032,4.59330865515008,5.08322503939395,0.489916384243867,6.12738425849282e-05,ENSG00000196693,ZNF33B,protein_coding,10,-1,42574185,42638570,q11.21,zinc finger protein 33B [Source:HGNC Symbol;Acc:HGNC:13097],NA,ZNF33B,7582,NM_001305033;NM_001305035;NM_001305036;NM_001305039;NM_001305040;NM_006955
SLC44A2_SIG,SLC44A2,SLC44A2_SIG,SLC44A2,SIG,68,-6.15691891669169,0.099278883106715,0.116805952648659,0.041689940326042,-0.0751160123226168,1.41923771753587e-08,-5.03069612337,6.42939390438178,6.58201413540492,5.92792743102001,-0.654086704384907,1.25539841351477e-05,ENSG00000129353,SLC44A2,protein_coding,19,1,10602457,10644557,p13.2,solute carrier family 44 member 2 [Source:HGNC Symbol;Acc:HGNC:17292],NA,SLC44A2,57153,NM_001145056;NM_020428
PDE2A_SIG,PDE2A,PDE2A_SIG,PDE2A,SIG,54,-6.15480640115986,-0.0588372852121279,-0.0421098368458373,-0.113798901272797,-0.0716890644269595,1.43497084452504e-08,-3.14899063585079,1.4027535550068,1.50629837471899,1.06253486166674,-0.443763513052242,0.00729054960657045,ENSG00000186642,PDE2A,protein_coding,11,-1,72576141,72674591,q13.4,phosphodiesterase 2A [Source:HGNC Symbol;Acc:HGNC:8777],NA,PDE2A,5138,NM_001143839;NM_001146209;NM_001243784;NM_002599
ZNF497_TF,ZNF497,ZNF497_TF,ZNF497,TF,184,6.14958543437713,0.0211872886887621,0.00364772933977629,0.0788172694068584,0.0751695400670823,1.47960066220358e-08,5.0135615756562,1.41727741447844,1.33493363921106,1.68783553321411,0.352901894003043,1.34830802634301e-05,ENSG00000174586,ZNF497,protein_coding,19,-1,58354357,58362848,q13.43,zinc finger protein 497 [Source:HGNC Symbol;Acc:HGNC:23714],NA,ZNF497,162968,NM_001207009;NM_198458
TYRO3_SIG,TYRO3,TYRO3_SIG,TYRO3,SIG,36,6.14636183450124,-0.0215030263350407,-0.0305493894512774,0.0082207381897368,0.0387701276410142,1.50650787360608e-08,4.81948114498101,1.15881311401018,1.05056508849581,1.51448519784311,0.463920109347306,2.94833521953382e-05,ENSG00000092445,TYRO3,protein_coding,15,1,41557675,41583589,q15.1,TYRO3 protein tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:12446],NA,TYRO3,7301,NM_001330264;NM_006293
B3GALT1_SIG,B3GALT1,B3GALT1_SIG,B3GALT1,SIG,65,6.14357208830793,-0.0871567423738803,-0.098682680170532,-0.0492858038991672,0.0493968762713649,1.52971107452095e-08,0.838498497422141,0.34076192704193,0.327681133085793,0.383741678612093,0.0560605455262993,0.514483419488984,ENSG00000172318,B3GALT1,protein_coding,2,1,167868948,167874041,q24.3,beta-1,3-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:916],NA,B3GALT1,8708,NM_020981
FZD3_SIG,FZD3,FZD3_SIG,FZD3,SIG,49,-6.14287016700156,-0.0895545182001888,-0.0796474855451841,-0.122106196923776,-0.0424587113785916,1.53298083752732e-08,-3.03479761610695,1.61364416109225,1.720335195602,1.26308790484592,-0.457247290756084,0.00982800049920872,ENSG00000104290,FZD3,protein_coding,8,1,28494205,28574267,p21.1,frizzled class receptor 3 [Source:HGNC Symbol;Acc:HGNC:4041],NA,FZD3,7976,NM_017412;NM_145866
EEF2K_SIG,EEF2K,EEF2K_SIG,EEF2K,SIG,23,6.14230993784327,0.256264755988094,0.237118254620755,0.319174689052206,0.0820564344314513,1.53489467705219e-08,6.33437574354866,5.39463521180511,5.28192220957629,5.76497793341409,0.483055723837801,2.6418210446847e-08,ENSG00000103319,EEF2K,protein_coding,16,1,22206278,22288738,p12.2,eukaryotic elongation factor 2 kinase [Source:HGNC Symbol;Acc:HGNC:24615],NA,EEF2K,29904,NM_013302
APLF_SIG,APLF,APLF_SIG,APLF,SIG,55,6.14044395929394,0.0458722449982648,0.0262301066781461,0.110410699478655,0.0841805928005087,1.54950519730149e-08,5.23401188354205,2.67327889864216,2.56783680912918,3.01973147847053,0.451894669341347,5.29785761900223e-06,ENSG00000169621,APLF,protein_coding,2,1,68467572,68655862,p13.3,aprataxin and PNKP like factor [Source:HGNC Symbol;Acc:HGNC:28724],NA,APLF,200558,NM_173545
SMYD2_SIG,SMYD2,SMYD2_SIG,SMYD2,SIG,8,6.13939138140435,0.0633031859182475,0.0486100517881087,0.111580626631561,0.062970574843452,1.55626947976272e-08,4.35892888923353,4.21594051800174,4.13900129446129,4.46874082392034,0.329739529459048,0.000165178205130522,ENSG00000143499,SMYD2,protein_coding,1,1,214281102,214337131,q32.3,SET and MYND domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20982],NA,SMYD2,56950,NM_020197
HOXB8_TF,HOXB8,HOXB8_TF,HOXB8,TF,23,6.13725379149507,-0.153171516381345,-0.170047141281504,-0.097723034566536,0.0723241067149683,1.57377883045365e-08,4.05853923688324,0.97138174766583,0.769038235345232,1.63622471671922,0.867186481373993,0.000467345882885734,ENSG00000120068,HOXB8,protein_coding,17,-1,48611377,48614939,q21.32,homeobox B8 [Source:HGNC Symbol;Acc:HGNC:5119],NA,HOXB8,3218,NM_024016
CAPN11_SIG,CAPN11,CAPN11_SIG,CAPN11,SIG,80,6.13613167178865,0.0319670379645123,0.0153001448458804,0.0867296867828744,0.071429541936994,1.58135183074305e-08,5.78334863118732,2.27929828544345,2.07345684364004,2.95563445136894,0.8821776077289,4.15997431160273e-07,ENSG00000137225,CAPN11,protein_coding,6,1,44158811,44184401,p21.1,calpain 11 [Source:HGNC Symbol;Acc:HGNC:1478],NA,CAPN11,11131,NM_007058
ERMP1_SIG,ERMP1,ERMP1_SIG,ERMP1,SIG,28,6.13049645913329,0.308888103701225,0.287242739719535,0.38000858535535,0.0927658456358157,1.63470639168558e-08,3.92374892285325,6.0498683032772,5.93703682020488,6.42060031908625,0.483563498881365,0.000725284256400585,ENSG00000099219,ERMP1,protein_coding,9,-1,5765076,5833117,p24.1,endoplasmic reticulum metallopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:23703],NA,ERMP1,79956,NM_024896
QPCT_SIG,QPCT,QPCT_SIG,QPCT,SIG,19,-6.12908500083484,0.297256320513168,0.360755010180141,0.0886177687502589,-0.272137241429882,1.64382481649835e-08,-5.79516021386844,3.66466034527675,3.9763629154588,2.64049475753572,-1.33586815792308,3.926352701122e-07,ENSG00000115828,QPCT,protein_coding,2,1,37342827,37373322,p22.2,glutaminyl-peptide cyclotransferase [Source:HGNC Symbol;Acc:HGNC:9753],NA,QPCT,25797,NM_012413
PITPNC1_SIG,PITPNC1,PITPNC1_SIG,PITPNC1,SIG,33,-6.12889634626169,0.128328015340327,0.144679516808123,0.0746016533747105,-0.0700778634334125,1.64382481649835e-08,-4.97857717005757,4.43393971079806,4.54079768059584,4.08283495289108,-0.457962727704759,1.54956312487937e-05,ENSG00000154217,PITPNC1,protein_coding,17,1,67377281,67697261,q24.2,phosphatidylinositol transfer protein cytoplasmic 1 [Source:HGNC Symbol;Acc:HGNC:21045],NA,PITPNC1,26207,NM_012417;NM_181671
SIRT3_SIG,SIRT3,SIRT3_SIG,SIRT3,SIG,36,6.12173241790721,0.234853309996263,0.221552789890545,0.278555018915053,0.0570022290245085,1.71563214481154e-08,5.07616922023012,3.97017803696868,3.90437149040999,4.18639954709006,0.282028056680071,1.02985867535256e-05,ENSG00000142082,SIRT3,protein_coding,11,-1,215030,236931,p15.5,sirtuin 3 [Source:HGNC Symbol;Acc:HGNC:14931],NA,SIRT3,23410,NM_001017524;NM_012239
GRHPR_SIG,GRHPR,GRHPR_SIG,GRHPR,SIG,31,6.12014429709175,0.182400302094554,0.16580060983528,0.236942148089311,0.0711415382540317,1.72895109962893e-08,4.76217606171677,6.0158857097818,5.94826070696835,6.23808214759742,0.289821440629073,3.6846350241345e-05,ENSG00000137106,GRHPR,protein_coding,9,1,37422666,37436990,p13.2,glyoxylate and hydroxypyruvate reductase [Source:HGNC Symbol;Acc:HGNC:4570],HYPEROXALURIA PRIMARY TYPE II;Primary hyperoxaluria type 2,GRHPR,9380,NM_012203
PDP2_SIG,PDP2,PDP2_SIG,PDP2,SIG,48,6.11941869850861,-0.0145943166467082,-0.030684891220009,0.0382747140941376,0.0689596053141467,1.73297349930009e-08,4.47753626783523,2.46388844975919,2.37608146959792,2.75239709886052,0.376315629262597,0.000107506747356423,ENSG00000172840,PDP2,protein_coding,16,1,66878589,66895754,q22.1,pyruvate dehyrogenase phosphatase catalytic subunit 2 [Source:HGNC Symbol;Acc:HGNC:30263],NA,PDP2,57546,NM_001329928;NM_001329929;NM_001329930;NM_001329931;NM_001329932;NM_001329933;NM_001329934;NM_020786
MYEF2_SIG,MYEF2,MYEF2_SIG,MYEF2,SIG,67,-6.11560575941678,-0.110397122079996,-0.0967420959270646,-0.155263636582484,-0.0585215406554196,1.77098066626834e-08,-3.95614289046781,2.71788519335991,2.91150737171121,2.08169803591992,-0.829809335791281,0.000653471892828044,ENSG00000104177,MYEF2,protein_coding,15,-1,48134632,48178353,q21.1,myelin expression factor 2 [Source:HGNC Symbol;Acc:HGNC:17940],NA,MYEF2,50804,NM_001301210;NM_016132
S100A12_SIG,S100A12,S100A12_SIG,S100A12,SIG,29,-6.10977929681294,0.124744138511282,0.192981828319513,-0.099465413715762,-0.292447242035275,1.82990650030959e-08,-6.38033224448207,5.6224911391939,6.0484482848893,4.22291766048044,-1.82553062440886,2.11277160084728e-08,ENSG00000163221,S100A12,protein_coding,1,-1,153373711,153375621,q21.3,S100 calcium binding protein A12 [Source:HGNC Symbol;Acc:HGNC:10489],NA,S100A12,6283,NM_005621
TMPRSS13_SIG,TMPRSS13,TMPRSS13_SIG,TMPRSS13,SIG,32,-6.109676711987,0.0779935361374694,0.0920099104499462,0.0319397348250458,-0.0600701756249004,1.82990650030959e-08,-3.539462548109,1.17955869967301,1.24303897688777,0.970980645967362,-0.272058330920405,0.00240134473013208,ENSG00000137747,TMPRSS13,protein_coding,11,-1,117900641,117929459,q23.3,transmembrane serine protease 13 [Source:HGNC Symbol;Acc:HGNC:29808],NA,TMPRSS13,84000,NM_001077263;NM_001206789;NM_001206790;NM_001244995
ZNF219_TF,ZNF219,ZNF219_TF,ZNF219,TF,104,6.10917396517035,-0.0124033272261367,-0.0255423319721961,0.0307676883680584,0.0563100203402545,1.8316272857558e-08,3.61395690226852,4.49562281438358,4.39748741683585,4.8180676920404,0.420580275204551,0.00191306346655395,ENSG00000165804,ZNF219,protein_coding,14,-1,21090077,21104722,q11.2,zinc finger protein 219 [Source:HGNC Symbol;Acc:HGNC:13011],NA,ZNF219,51222,NM_001101672;NM_001102454;NM_016423
ZNF609_TF,ZNF609,ZNF609_TF,ZNF609,TF,84,6.10834757453435,0.289506691626159,0.274786150164876,0.337874184998944,0.0630880348340679,1.83707897223156e-08,4.11962903070288,7.14884462777613,7.04919701855273,7.47625820093871,0.427061182385973,0.000380098698577525,ENSG00000180357,ZNF609,protein_coding,15,1,64460742,64686068,q22.31,zinc finger protein 609 [Source:HGNC Symbol;Acc:HGNC:29003],NA,ZNF609,23060,NM_015042
MXD3_TF,MXD3,MXD3_TF,MXD3,TF,263,-6.10637416947604,0.100487419242119,0.1198018652572,0.0370256680497081,-0.0827761972074919,1.85583850305751e-08,-4.16628869864097,4.29972084300838,4.37636572895054,4.04788764634125,-0.328478082609292,0.00032313998691201,ENSG00000213347,MXD3,protein_coding,5,-1,177301461,177312757,q35.3,MAX dimerization protein 3 [Source:HGNC Symbol;Acc:HGNC:14008],NA,MXD3,83463,NM_001142935;NM_031300
FEZ2_SIG,FEZ2,FEZ2_SIG,FEZ2,SIG,2,6.10390545298648,0.106363803969525,0.0966541721449413,0.138266879964587,0.0416127078196458,1.88061377908504e-08,2.47977897835494,4.86765925163619,4.83421472917456,4.97754839686724,0.143333667692678,0.0369052658515685,ENSG00000171055,FEZ2,protein_coding,2,-1,36531805,36646087,p22.2,fasciculation and elongation protein zeta 2 [Source:HGNC Symbol;Acc:HGNC:3660],NA,FEZ2,9637,NM_001042548;NM_005102
ASIC1_SIG,ASIC1,ASIC1_SIG,ASIC1,SIG,42,6.0987711592889,-0.0820539917367625,-0.0895023735844047,-0.0575807370945095,0.0319216364898952,1.93776467524045e-08,2.48801365791259,0.829623869881186,0.770572591272446,1.02364949959562,0.25307690832317,0.0362398222088249,ENSG00000110881,ASIC1,protein_coding,12,1,50057548,50083611,q13.12,acid sensing ion channel subunit 1 [Source:HGNC Symbol;Acc:HGNC:100],NA,ASIC1,41,NM_001095;NM_001256830;NM_020039
CAMK2B_SIG,CAMK2B,CAMK2B_SIG,CAMK2B,SIG,39,6.09616859656952,-0.005312119620461,-0.0147079241563131,0.0255598095687673,0.0402677337250804,1.96526047702152e-08,0.370356832461377,0.310141157694878,0.306109862397594,0.323386842243096,0.0172769798455022,0.786347896558634,ENSG00000058404,CAMK2B,protein_coding,7,-1,44217150,44334577,p13,calcium/calmodulin dependent protein kinase II beta [Source:HGNC Symbol;Acc:HGNC:1461],Autosomal dominant non-syndromic intellectual disability;Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 54,CAMK2B,816,NM_001220;NM_001293170;NM_172078;NM_172079;NM_172080;NM_172081;NM_172082;NM_172083;NM_172084
FLT3_SIG,FLT3,FLT3_SIG,FLT3,SIG,72,6.09364618128285,0.164915483489137,0.151228824697989,0.209885933802906,0.0586571091049173,1.99214460781485e-08,4.22966131693797,7.47265926568606,7.27960738651407,8.10697258296546,0.827365196451389,0.000260089981284139,ENSG00000122025,FLT3,protein_coding,13,-1,28003274,28100592,q12.2,fms related tyrosine kinase 3 [Source:HGNC Symbol;Acc:HGNC:3765],Acute biphenotypic leukemia;Acute myeloblastic leukemia with maturation;Acute myeloblastic leukemia without maturation;Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22);Acute myeloid leukemia with minimal differentiation;Acute myeloid leukemia with t(8;21)(q22;q22) translocation;LEUKEMIA ACUTE LYMPHOBLASTIC;LEUKEMIA ACUTE MYELOID;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,FLT3,2322,NM_004119
IRF4_SIG,IRF4,IRF4_SIG,IRF4,SIG,53,-6.09215508809549,-0.097415337677941,-0.0783531607820337,-0.160048204621636,-0.0816950438396026,2.00642310626427e-08,-2.21617486208453,2.87689638544113,2.9616663708324,2.59836643344125,-0.363299937391157,0.0642429775143799,ENSG00000137265,IRF4,protein_coding,6,1,391752,411443,p25.3,interferon regulatory factor 4 [Source:HGNC Symbol;Acc:HGNC:6119],Skin/hair/eye pigmentation variation in 8,IRF4,3662,NM_001195286;NM_002460
ZNF514_TF,ZNF514,ZNF514_TF,ZNF514,TF,61,6.07787143388296,0.135504011130237,0.118567538766483,0.191152420325427,0.0725848815589434,2.18875567523014e-08,4.42928997839104,4.22489091632549,4.11706391698902,4.57917962843105,0.46211571144203,0.000128517707310928,ENSG00000144026,ZNF514,protein_coding,2,-1,95145000,95165413,q11.1,zinc finger protein 514 [Source:HGNC Symbol;Acc:HGNC:25894],NA,ZNF514,84874,NM_001318005;NM_032788
CDC42EP4_SIG,CDC42EP4,CDC42EP4_SIG,CDC42EP4,SIG,23,-6.07353929014509,-0.0790648442582594,-0.0660633848554347,-0.121783925153255,-0.0557205402978203,2.24378902554772e-08,-5.43920452252594,3.76197894377172,3.92452781376784,3.22788979949875,-0.696638014269089,2.14800203951466e-06,ENSG00000179604,CDC42EP4,protein_coding,17,-1,73283624,73312005,q25.1,CDC42 effector protein 4 [Source:HGNC Symbol;Acc:HGNC:17147],NA,CDC42EP4,23580,NM_012121
TCEAL1_TF,TCEAL1,TCEAL1_TF,TCEAL1,TF,164,6.07006401926532,0.174363313164308,0.15683702879481,0.231949676092657,0.075112647297847,2.28793532164862e-08,5.00264131866208,3.24115913312855,3.15053458161339,3.53892551667838,0.388390935064989,1.40832562948272e-05,ENSG00000172465,TCEAL1,protein_coding,X,1,103628704,103630953,q22.2,transcription elongation factor A like 1 [Source:HGNC Symbol;Acc:HGNC:11616],NA,TCEAL1,9338,NM_001006639;NM_001006640;NM_004780
NRP1_SIG,NRP1,NRP1_SIG,NRP1,SIG,77,-6.0625453093703,-0.0557498138956232,-0.0451271849927008,-0.0906527374337967,-0.0455255524410959,2.39236599336647e-08,-4.54669445239188,1.81659184524663,2.01306913179095,1.17102361802959,-0.842045513761364,8.36921863311356e-05,ENSG00000099250,NRP1,protein_coding,10,-1,33177492,33336262,p11.22,neuropilin 1 [Source:HGNC Symbol;Acc:HGNC:8004],NA,NRP1,8829,NM_001024628;NM_001024629;NM_001244972;NM_001244973;NM_001330068;NM_003873
ABCD4_SIG,ABCD4,ABCD4_SIG,ABCD4,SIG,105,6.06158473417499,0.294592044468373,0.278326619660158,0.34803558312394,0.069708963463782,2.40152478977639e-08,4.73618840177627,5.35113846344364,5.28336622616188,5.57381867165516,0.29045244549328,4.0731763108674e-05,ENSG00000119688,ABCD4,protein_coding,14,-1,74285269,74303055,q24.3,ATP binding cassette subfamily D member 4 [Source:HGNC Symbol;Acc:HGNC:68],Methylmalonic acidemia with homocystinuria type cblJ;METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA cblJ TYPE,ABCD4,5826,NM_001353591;NM_001353592;NM_001353593;NM_001353594;NM_001353595;NM_001353596;NM_001353597;NM_001353598;NM_001353599;NM_001353600;NM_001353601;NM_001353602;NM_001353603;NM_001353604;NM_001353605;NM_001353606;NM_001353607;NM_001353608;NM_001353609;NM_001353610;NM_005050;NM_020324;NM_020325
SLC22A4_SIG,SLC22A4,SLC22A4_SIG,SLC22A4,SIG,35,-6.05911023951728,0.0853057803100528,0.10551151166964,0.0189155201285531,-0.0865959915410866,2.43352432712135e-08,-5.20545660750204,2.96244197492132,3.0909966784415,2.54004794906929,-0.550948729372212,6.03745905248897e-06,ENSG00000197208,SLC22A4,protein_coding,5,1,132294394,132344190,q31.1,solute carrier family 22 member 4 [Source:HGNC Symbol;Acc:HGNC:10968],Rheumatoid arthritis,SLC22A4,6583,NM_003059
SGSM2_TF,SGSM2,SGSM2_TF,SGSM2,TF,226,6.0575757834997,0.129010425954205,0.119199270046377,0.161247081079925,0.0420478110335476,2.45158373818532e-08,5.17608169085132,6.45421468626772,6.38559042655235,6.67969439676106,0.294103970208707,6.955896712883e-06,ENSG00000141258,SGSM2,protein_coding,17,1,2337498,2381058,p13.3,small G protein signaling modulator 2 [Source:HGNC Symbol;Acc:HGNC:29026],NA,SGSM2,9905,NM_001098509;NM_001346700;NM_014853
S100A9_SIG,S100A9,S100A9_SIG,S100A9,SIG,60,-6.05636342242633,0.379458978728792,0.439033959368468,0.183712613769858,-0.25532134559861,2.46484501265334e-08,-6.07386996197131,9.64216702265969,10.0528833040786,8.2926706694262,-1.76021263465237,9.93559524262673e-08,ENSG00000163220,S100A9,protein_coding,1,1,153357854,153361023,q21.3,S100 calcium binding protein A9 [Source:HGNC Symbol;Acc:HGNC:10499],NA,S100A9,6280,NM_002965
NPAS1_TF,NPAS1,NPAS1_TF,NPAS1,TF,73,6.04984058675169,-0.0211893163825143,-0.0295464493471158,0.00626983478689064,0.0358162841340065,2.56127033061036e-08,1.23076952878038,0.724862186875417,0.703633246270653,0.794614420291073,0.0909811740204197,0.32346355698483,ENSG00000130751,NPAS1,protein_coding,19,1,47019820,47045775,q13.32,neuronal PAS domain protein 1 [Source:HGNC Symbol;Acc:HGNC:7894],NA,NPAS1,4861,NM_001321086;NM_002517
GPR65_SIG,GPR65,GPR65_SIG,GPR65,SIG,37,-6.04946669549275,0.153347632987509,0.181781078019648,0.0599234564533399,-0.121857621566308,2.56175906625516e-08,-4.68659735115329,3.47158200027978,3.63785670887134,2.92525081490753,-0.712605893963803,4.94448133136517e-05,ENSG00000140030,GPR65,protein_coding,14,1,88005135,88014811,q31.3,G protein-coupled receptor 65 [Source:HGNC Symbol;Acc:HGNC:4517],NA,GPR65,8477,NM_003608
PLBD1_SIG,PLBD1,PLBD1_SIG,PLBD1,SIG,15,-6.04784378773484,0.287363171145682,0.348017208030556,0.0880713356668092,-0.259945872363747,2.58219674902839e-08,-4.41805807902165,5.25142864827742,5.55931311687114,4.23980825146946,-1.31950486540168,0.000133865496700995,ENSG00000121316,PLBD1,protein_coding,12,-1,14503661,14567883,p13.1,phospholipase B domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26215],NA,PLBD1,79887,NM_024829
SLC7A6_SIG,SLC7A6,SLC7A6_SIG,SLC7A6,SIG,39,6.04677427506128,0.136342616758716,0.125877845525311,0.170726865097045,0.0448490195717337,2.59388192291719e-08,5.311935364217,6.00368839740139,5.89021627113687,6.3765253836991,0.486309112562222,3.77026279258564e-06,ENSG00000103064,SLC7A6,protein_coding,16,1,68264516,68301823,q22.1,solute carrier family 7 member 6 [Source:HGNC Symbol;Acc:HGNC:11064],NA,SLC7A6,9057,NM_001076785;NM_003983
GCNT2_SIG,GCNT2,GCNT2_SIG,GCNT2,SIG,9,-6.04637156843703,-0.0388211898341566,-0.0235132962883948,-0.0891185543416596,-0.0656052580532648,2.59487288993157e-08,-2.2390444483851,2.47275061800708,2.53677976859202,2.26236912322798,-0.274410645364038,0.0612844995299558,ENSG00000111846,GCNT2,protein_coding,6,1,10492223,10629368,p24.3,glucosaminyl (N-acetyl) transferase 2 (I blood group) [Source:HGNC Symbol;Acc:HGNC:4204],BLOOD GROUP I SYSTEM;CATARACT 13 WITH ADULT i PHENOTYPE;Total early-onset cataract,GCNT2,2651,NM_001491;NM_145649;NM_145655
SPATS2_SIG,SPATS2,SPATS2_SIG,SPATS2,SIG,68,6.04495428874167,0.203531240409949,0.184682104018523,0.265464117124633,0.0807820131061095,2.6122634476049e-08,5.20750260889084,4.26281505558355,4.16122597484855,4.59660774942713,0.43538177457858,5.98764703964389e-06,ENSG00000123352,SPATS2,protein_coding,12,1,49366584,49527424,q13.12,spermatogenesis associated serine rich 2 [Source:HGNC Symbol;Acc:HGNC:18650],NA,SPATS2,65244,NM_001293285;NM_001293286;NM_023071
FAM98A_SIG,FAM98A,FAM98A_SIG,FAM98A,SIG,12,6.04399931324269,0.248383571364788,0.233168348267191,0.298376447256894,0.065208098989703,2.62224873750555e-08,5.90193398972194,4.71036600751653,4.60839463625702,5.04541479879777,0.437020162540749,2.33083321792222e-07,ENSG00000119812,FAM98A,protein_coding,2,-1,33583660,33599382,p22.3,family with sequence similarity 98 member A [Source:HGNC Symbol;Acc:HGNC:24520],NA,FAM98A,25940,NM_001304538;NM_015475
POMT2_SIG,POMT2,POMT2_SIG,POMT2,SIG,44,6.04335486180629,0.117566426100244,0.0996773581251288,0.176344792304192,0.0766674341790631,2.62721806391373e-08,4.60147269396124,3.84108372956897,3.76408325522108,4.09408528814062,0.33000203291955,6.8103722006354e-05,ENSG00000009830,POMT2,protein_coding,14,-1,77274956,77320884,q24.3,protein O-mannosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:19743],Autosomal recessive limb-girdle muscular dystrophy type 2N;Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 2;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION)TYPE B 2;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 2;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH BRAIN AND EYE ANOMALIES TYPE A2;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH MENTAL RETARDATION TYPE B2;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY LIMB-GIRDLE TYPE C2;Walker-Warburg syndrome,POMT2,29954,NM_013382
RBMS2_SIG,RBMS2,RBMS2_SIG,RBMS2,SIG,69,6.03816808320213,0.162855972114212,0.152292996494045,0.197562892009047,0.045269895515002,2.70736528985041e-08,5.21563358297423,3.63064803489484,3.50293932921101,4.05026235357027,0.547323024359267,5.78632044245333e-06,ENSG00000076067,RBMS2,protein_coding,12,1,56521820,56596193,q13.3,RNA binding motif single stranded interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:9909],NA,RBMS2,5939,NM_002898
ANGPT2_SIG,ANGPT2,ANGPT2_SIG,ANGPT2,SIG,37,6.03465399175102,-0.050397839984457,-0.0655837230490656,-0.000501367057885833,0.0650823559911799,2.76115224386004e-08,4.79074654389127,0.879168663280037,0.711050720692607,1.43155618892445,0.720505468231845,3.30255841193002e-05,ENSG00000091879,ANGPT2,protein_coding,8,-1,6499651,6563409,p23.1,angiopoietin 2 [Source:HGNC Symbol;Acc:HGNC:485],NA,ANGPT2,285,NM_001118887;NM_001118888;NM_001147
TAS1R3_SIG,TAS1R3,TAS1R3_SIG,TAS1R3,SIG,28,-6.03332178646739,-0.0754039917884345,-0.0688247562051806,-0.097021480133412,-0.0281967239282315,2.77820981392948e-08,-4.28319645476128,0.821338261509921,0.882782874489255,0.619448818863539,-0.263334055625716,0.000217201884777703,ENSG00000169962,TAS1R3,protein_coding,1,1,1331280,1335314,p36.33,taste 1 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:15661],NA,TAS1R3,83756,NM_152228
D2HGDH_SIG,D2HGDH,D2HGDH_SIG,D2HGDH,SIG,31,6.01845429960099,0.147775426157912,0.138275504129857,0.178989455678664,0.040713951548807,3.03939388071991e-08,5.34405974810127,5.26242883706256,5.16573455619023,5.58013861707166,0.414404060881426,3.2875837792954e-06,ENSG00000180902,D2HGDH,protein_coding,2,1,241734602,241768816,q37.3,D-2-hydroxyglutarate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:28358],D-2-hydroxyglutaric aciduria;D-2-hydroxyglutaric aciduria 1,D2HGDH,728294,NM_001287249;NM_001352824;NM_152783
DCTD_SIG,DCTD,DCTD_SIG,DCTD,SIG,28,6.01764879792837,0.308329574788594,0.296281872248117,0.347914883135877,0.0516330108877603,3.04820169550665e-08,4.53144544423882,5.88140637140738,5.82462871397239,6.0679615315509,0.243332817578511,8.85390440662944e-05,ENSG00000129187,DCTD,protein_coding,4,-1,182890060,182917936,q35.1,dCMP deaminase [Source:HGNC Symbol;Acc:HGNC:2710],NA,DCTD,1635,NM_001012732;NM_001351743;NM_001351744;NM_001351745;NM_001351747;NM_001351748;NM_001351750;NM_001351753;NM_001921
ZNF707_TF,ZNF707,ZNF707_TF,ZNF707,TF,81,6.01538287015233,0.0753980386567588,0.0644811098193486,0.111267947693964,0.0467868378746151,3.08064133561512e-08,3.45843249592031,3.48495821955097,3.43961506754261,3.63394286186415,0.19432779432154,0.00304341203835512,ENSG00000181135,ZNF707,protein_coding,8,1,143684452,143713898,q24.3,zinc finger protein 707 [Source:HGNC Symbol;Acc:HGNC:27815],NA,ZNF707,286075,NM_001100598;NM_001100599;NM_001288805;NM_001288806;NM_001288807;NM_001288808;NM_001288809;NM_173831
PPEF1_SIG,PPEF1,PPEF1_SIG,PPEF1,SIG,13,-6.01480702601703,0.211459050395808,0.260598942356046,0.0499994053835965,-0.210599536972449,3.08064133561512e-08,-3.4619171951131,0.347370525531133,0.391150697870656,0.20352138784413,-0.187629310026526,0.00301388915441303,ENSG00000086717,PPEF1,protein_coding,X,1,18675909,18827921,p22.13,protein phosphatase with EF-hand domain 1 [Source:HGNC Symbol;Acc:HGNC:9243],NA,PPEF1,5475,NM_006240;NM_152224;NM_152226
ZNF579_TF,ZNF579,ZNF579_TF,ZNF579,TF,175,6.01478020192308,0.0395323792341908,0.0235288319001619,0.0921154633317145,0.0685866314315526,3.08064133561512e-08,4.43146403765663,3.1566954097285,3.08427420068005,3.39465081088766,0.310376610207606,0.000127304271040082,ENSG00000218891,ZNF579,protein_coding,19,-1,55576774,55580848,q13.42,zinc finger protein 579 [Source:HGNC Symbol;Acc:HGNC:26646],NA,ZNF579,163033,NM_152600
GRIK5_SIG,GRIK5,GRIK5_SIG,GRIK5,SIG,32,6.01439491044013,0.128988444367785,0.105597446404202,0.205844580533846,0.100247134129644,3.08064133561512e-08,3.96574278579624,4.29239464168325,4.10685122458784,4.9020372978539,0.795186073266064,0.000633168436812112,ENSG00000105737,GRIK5,protein_coding,19,-1,41998321,42069498,q13.2,glutamate ionotropic receptor kainate type subunit 5 [Source:HGNC Symbol;Acc:HGNC:4583],NA,GRIK5,2901,NM_001301030;NM_002088
CUL1_SIG,CUL1,CUL1_SIG,CUL1,SIG,28,-6.01425923516909,0.100250303506388,0.106383584283581,0.0800980952384687,-0.026285489045112,3.08064133561512e-08,-1.07229035559609,5.85865765214738,5.87765486553765,5.79623823672218,-0.0814166288154786,0.395670610101314,ENSG00000055130,CUL1,protein_coding,7,1,148697914,148801110,q36.1,cullin 1 [Source:HGNC Symbol;Acc:HGNC:2551],NA,CUL1,8454,NM_003592
E2F2_TF,E2F2,E2F2_TF,E2F2,TF,185,-6.01281488301977,0.0577867661801299,0.0733727629311758,0.00657563399812191,-0.0667971289330537,3.10184285354394e-08,-5.39446149277239,4.20183388869218,4.38765636611395,3.59127432002066,-0.796382046093291,2.60293944452184e-06,ENSG00000007968,E2F2,protein_coding,1,-1,23506438,23531233,p36.12,E2F transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3114],NA,E2F2,1870,NM_004091
ERI1_SIG,ERI1,ERI1_SIG,ERI1,SIG,21,6.0103031808064,0.101746522229553,0.0920090918432598,0.133740936355945,0.0417318445126852,3.14382978337697e-08,4.73407295795114,4.66084530487571,4.5785988944892,4.93108351043137,0.352484615942171,4.10578224301398e-05,ENSG00000104626,ERI1,protein_coding,8,1,9002147,9116746,p23.1,exoribonuclease 1 [Source:HGNC Symbol;Acc:HGNC:23994],NA,ERI1,90459,NM_001354635;NM_001354636;NM_001354638;NM_153332
F3_SIG,F3,F3_SIG,F3,SIG,79,6.00835264567517,-0.0165354963920499,-0.0260523194860825,0.0147340652026284,0.040786384688711,3.17537185312203e-08,1.61256463549893,2.08266130789624,2.02272994017336,2.27957865898571,0.256848718812346,0.18706471975074,ENSG00000117525,F3,protein_coding,1,-1,94529173,94541759,p21.3,coagulation factor III, tissue factor [Source:HGNC Symbol;Acc:HGNC:3541],NA,F3,2152,NM_001178096;NM_001993
DTX4_SIG,DTX4,DTX4_SIG,DTX4,SIG,22,-6.00026149808734,0.30128181125636,0.33002342523555,0.206845079610448,-0.123178345625103,3.33090836308402e-08,-6.05886625566235,3.54394170689524,3.78300794504185,2.75843835298497,-1.02456959205688,1.06121844963681e-07,ENSG00000110042,DTX4,protein_coding,11,1,59171430,59208588,q12.1,deltex E3 ubiquitin ligase 4 [Source:HGNC Symbol;Acc:HGNC:29151],NA,DTX4,23220,NM_001300727;NM_015177
NAT14_TF,NAT14,NAT14_TF,NAT14,TF,117,5.99409902466434,0.0433079947664764,0.0266576658771229,0.0980162182600664,0.0713585523829437,3.45264580692904e-08,4.27247065111855,2.87273254589644,2.78392162970051,3.16453984196879,0.380618212268283,0.000224110310792818,ENSG00000090971,NAT14,protein_coding,19,1,55485188,55487568,q13.42,N-acetyltransferase 14 (putative) [Source:HGNC Symbol;Acc:HGNC:28918],NA,NAT14,57106,NM_020378
IDS_SIG,IDS,IDS_SIG,IDS,SIG,47,5.98410531635719,0.0278678792987125,0.0183198751585878,0.0592398929019793,0.0409200177433915,3.66174255781736e-08,3.94968964305789,7.5228973766251,7.45368770672569,7.75030057772315,0.29661287099746,0.000667309341789105,ENSG00000010404,IDS,protein_coding,X,-1,149476988,149521096,q28,iduronate 2-sulfatase [Source:HGNC Symbol;Acc:HGNC:5389],MUCOPOLYSACCHARIDOSIS TYPE 2;Mucopolysaccharidosis type 2 attenuated form;Mucopolysaccharidosis type 2 severe form;MUCOPOLYSACCHARIDOSIS TYPE II,IDS,3423,NM_000202;NM_001166550;NM_006123
CDA_SIG,CDA,CDA_SIG,CDA,SIG,70,-5.98387357314368,0.375657886876835,0.430350285391593,0.195954291756916,-0.234395993634677,3.66174255781736e-08,-5.88774562575781,4.22148944864944,4.52769372965293,3.21538966820943,-1.3123040614435,2.51142253467391e-07,ENSG00000158825,CDA,protein_coding,1,1,20589086,20618903,p36.12,cytidine deaminase [Source:HGNC Symbol;Acc:HGNC:1712],NA,CDA,978,NM_001785
USP20_SIG,USP20,USP20_SIG,USP20,SIG,74,5.97820107901127,0.0874496001802747,0.0750767389618008,0.128103287040974,0.0530265480791735,3.78384912228866e-08,4.93653108248835,6.18317216695958,6.09570799025297,6.47055446185272,0.374846471599753,1.8400182311628e-05,ENSG00000136878,USP20,protein_coding,9,1,129834698,129881838,q34.11,ubiquitin specific peptidase 20 [Source:HGNC Symbol;Acc:HGNC:12619],NA,USP20,10868,NM_001008563;NM_001110303;NM_006676
FOXP4_TF,FOXP4,FOXP4_TF,FOXP4,TF,203,5.97324554989492,0.00365137208070995,-0.00165830791308449,0.0210974634888917,0.022755771401976,3.89276874673143e-08,4.30890122702773,4.46158329311139,4.37674504914117,4.74033752329923,0.363592474158064,0.000198244028749048,ENSG00000137166,FOXP4,protein_coding,6,1,41546426,41602384,p21.1,forkhead box P4 [Source:HGNC Symbol;Acc:HGNC:20842],NA,FOXP4,116113,NM_001012426;NM_001012427;NM_138457
PTGES_SIG,PTGES,PTGES_SIG,PTGES,SIG,14,-5.96975843986829,0.0204370690850725,0.0511590842526893,-0.0805066950370968,-0.131665779289786,3.96886764011562e-08,-2.85598741274665,0.746790027303507,0.824877152234739,0.490218045386603,-0.334659106848135,0.0154637106097157,ENSG00000148344,PTGES,protein_coding,9,-1,129738331,129753042,q34.11,prostaglandin E synthase [Source:HGNC Symbol;Acc:HGNC:9599],NA,PTGES,9536,NM_004878
CD55_SIG,CD55,CD55_SIG,CD55,SIG,23,-5.9677828546454,0.143496117064205,0.168786359528937,0.0603996061086547,-0.108386753420282,4.00912544136783e-08,-6.74996986898476,6.81674650024197,6.95571585277378,6.36013291335174,-0.595582939422047,2.65908744585398e-09,ENSG00000196352,CD55,protein_coding,1,1,207321376,207386804,q32.2,CD55 molecule (Cromer blood group) [Source:HGNC Symbol;Acc:HGNC:2665],BLOOD GROUP CROMER SYSTEM;COMPLEMENT HYPERACTIVATION ANGIOPATHIC THROMBOSIS AND PROTEIN-LOSING ENTEROPATHY,CD55,1604,NM_000574;NM_001114752;NM_001300902;NM_001300903;NM_001300904
PHOSPHO2_SIG,PHOSPHO2,PHOSPHO2_SIG,PHOSPHO2,SIG,189,5.96548004715337,0.0280396118752463,0.0092765726692071,0.0896895978379464,0.0804130251687392,4.05791738611829e-08,5.81134356246915,1.36085134001042,1.27374215831161,1.64706722273506,0.373325064423448,3.62894156144085e-07,ENSG00000144362,PHOSPHO2,protein_coding,2,1,169694454,169701708,q31.1,phosphatase, orphan 2 [Source:HGNC Symbol;Acc:HGNC:28316],NA,PHOSPHO2,493911,NM_001008489;NM_001199285;NM_001199286;NM_001199287;NM_001199288
MAP2K5_SIG,MAP2K5,MAP2K5_SIG,MAP2K5,SIG,76,5.96483639768824,0.123285495440059,0.107817454328391,0.174109059092685,0.0662916047642942,4.06578112418599e-08,4.79328365593173,4.70799268516114,4.64999987746569,4.89854048187476,0.248540604409066,3.27816603549181e-05,ENSG00000137764,MAP2K5,protein_coding,15,1,67542703,67807117,q23,mitogen-activated protein kinase kinase 5 [Source:HGNC Symbol;Acc:HGNC:6845],NA,MAP2K5,5607,NM_001206804;NM_002757;NM_145160
DUSP13_SIG,DUSP13,DUSP13_SIG,DUSP13,SIG,14,-5.96348004816343,0.284578556153954,0.352265873929052,0.0621773691786352,-0.290088504750416,4.09149117282495e-08,-3.03681222328983,0.547876579982319,0.611134925029226,0.340027731971052,-0.271107193058175,0.0097747899393884,ENSG00000079393,DUSP13,protein_coding,10,-1,75094432,75109221,q22.2,dual specificity phosphatase 13 [Source:HGNC Symbol;Acc:HGNC:19681],NA,DUSP13,51207,NM_001007271;NM_001007272;NM_001007273;NM_001320842;NM_001320843;NM_001363514;NM_016364
PKD2_SIG,PKD2,PKD2_SIG,PKD2,SIG,67,5.96230186905875,0.0762208179015484,0.0583387168991379,0.134976292623754,0.0766375757246165,4.10772162584507e-08,4.37346402790507,5.33089508339994,5.22802149017986,5.66890831826593,0.440886828086071,0.000156895839250761,ENSG00000118762,PKD2,protein_coding,4,1,88007635,88077777,q22.1,polycystin 2, transient receptor potential cation channel [Source:HGNC Symbol;Acc:HGNC:9009],Autosomal dominant polycystic kidney disease;POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,PKD2,5311,NM_000297
CPA3_SIG,CPA3,CPA3_SIG,CPA3,SIG,107,5.96218132532571,0.0189494566481986,0.00414107461420306,0.0676055690456125,0.0634644944314094,4.10772162584507e-08,4.55539439656115,4.86539203620834,4.55304053102713,5.89168983894662,1.33864930791949,8.14520384326273e-05,ENSG00000163751,CPA3,protein_coding,3,1,148865296,148897203,q24,carboxypeptidase A3 [Source:HGNC Symbol;Acc:HGNC:2298],NA,CPA3,1359,NM_001870
CREB3L2_TF,CREB3L2,CREB3L2_TF,CREB3L2,TF,63,5.9617427959853,0.275757778460842,0.265392128158425,0.309816343740211,0.0444242155817855,4.11057479842451e-08,4.82477965859223,6.87554259413851,6.79487598334744,7.14059002959489,0.345714046247452,2.89141029232337e-05,ENSG00000182158,CREB3L2,protein_coding,7,-1,137874979,138002086,q33,cAMP responsive element binding protein 3 like 2 [Source:HGNC Symbol;Acc:HGNC:23720],Myxofibrosarcoma,CREB3L2,64764,NM_001253775;NM_001318246;NM_194071
GRHL1_TF,GRHL1,GRHL1_TF,GRHL1,TF,56,-5.95951851733558,-0.0867693140736101,-0.0749004202783435,-0.125767107972343,-0.0508666876939997,4.15770833013558e-08,-3.29423507288822,0.692586011057672,0.750867570518505,0.501089458543508,-0.249778111974997,0.00488889772944494,ENSG00000134317,GRHL1,protein_coding,2,1,9951693,10002277,p25.1,grainyhead like transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:17923],NA,GRHL1,29841,NM_198182
FAH_SIG,FAH,FAH_SIG,FAH,SIG,23,5.95923142008496,0.221944281290106,0.20623626301481,0.273556341337506,0.0673200783226962,4.15770833013558e-08,6.26379695328763,4.68595675672084,4.55184372142768,5.12661387268406,0.574770151256378,3.76324349824848e-08,ENSG00000103876,FAH,protein_coding,15,1,80152490,80186946,q25.1,fumarylacetoacetate hydrolase [Source:HGNC Symbol;Acc:HGNC:3579],Tyrosinemia type 1;TYROSINEMIA TYPE I,FAH,2184,NM_000137
DPF3_TF,DPF3,DPF3_TF,DPF3,TF,347,-5.95698897791784,-0.11582269601937,-0.105110796197415,-0.151018938291511,-0.0459081420940963,4.2068080320625e-08,-4.19804870610873,0.750694640124706,0.839046494537368,0.460395689911671,-0.378650804625697,0.0002900134569424,ENSG00000205683,DPF3,protein_coding,14,-1,72619296,72894116,q24.2,double PHD fingers 3 [Source:HGNC Symbol;Acc:HGNC:17427],NA,DPF3,8110,NM_001280542;NM_001280543;NM_001280544;NM_012074
MMP21_SIG,MMP21,MMP21_SIG,MMP21,SIG,15,5.95547415286599,-0.0577821824361571,-0.0679212858394452,-0.0244679855396389,0.0434533002998065,4.23758766941969e-08,0.921470351577749,0.235766192770041,0.231355698071511,0.250257818208068,0.0189021201365571,0.470296306701331,ENSG00000154485,MMP21,protein_coding,10,-1,125753580,125775821,q26.2,matrix metallopeptidase 21 [Source:HGNC Symbol;Acc:HGNC:14357],HETEROTAXY VISCERAL 7 AUTOSOMAL;MMP21-associated heterotaxy;Situs ambiguus;Situs inversus totalis,MMP21,118856,NM_147191
MCCC1_SIG,MCCC1,MCCC1_SIG,MCCC1,SIG,40,5.95501659114355,0.422355391511945,0.404655123295522,0.48051341565162,0.0758582923560985,4.24109554779581e-08,4.85917511110098,5.18020799506231,5.10064959555595,5.44161416486892,0.340964569312966,2.54195525102767e-05,ENSG00000078070,MCCC1,protein_coding,3,-1,183015218,183116075,q27.1,methylcrotonoyl-CoA carboxylase 1 [Source:HGNC Symbol;Acc:HGNC:6936],3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY;3-Methylcrotonyl-CoA Carboxylase Deficiency,MCCC1,56922,NM_001293273;NM_020166
MAP3K5_SIG,MAP3K5,MAP3K5_SIG,MAP3K5,SIG,60,5.95424253879791,0.0576532818547643,0.0515190578767733,0.0778085892110204,0.0262895313342473,4.25284328558789e-08,3.91258888761299,5.60117330902668,5.53645782507006,5.81380989916986,0.277352074099805,0.000749295764328247,ENSG00000197442,MAP3K5,protein_coding,6,-1,136557046,136792477,q23.3,mitogen-activated protein kinase kinase kinase 5 [Source:HGNC Symbol;Acc:HGNC:6857],NA,MAP3K5,4217,NM_005923
PTPN23_SIG,PTPN23,PTPN23_SIG,PTPN23,SIG,18,5.95304348225768,0.419237203159563,0.406863510332243,0.459893622449329,0.0530301121170857,4.26772136163117e-08,5.06873170232493,5.94052260174753,5.89693336428855,6.08374438196989,0.186811017681331,1.06468610066771e-05,ENSG00000076201,PTPN23,protein_coding,3,1,47381011,47413435,p21.31,protein tyrosine phosphatase, non-receptor type 23 [Source:HGNC Symbol;Acc:HGNC:14406],NA,PTPN23,25930,NM_001304482;NM_015466
SOHLH2_TF,SOHLH2,SOHLH2_TF,SOHLH2,TF,46,5.95302978520832,-0.0659130364180378,-0.0751929376791494,-0.0354219322743854,0.039771005404764,4.26772136163117e-08,1.93414083346672,0.407902098078248,0.388053671592575,0.473118356531174,0.0850646849385991,0.109465479624622,ENSG00000120669,SOHLH2,protein_coding,13,-1,36168217,36214588,q13.3,spermatogenesis and oogenesis specific basic helix-loop-helix 2 [Source:HGNC Symbol;Acc:HGNC:26026],NA,SOHLH2,54937,NM_001282147;NM_017826
P2RX6_SIG,P2RX6,P2RX6_SIG,P2RX6,SIG,14,5.94789978858308,-0.0343406734015001,-0.0476831269236259,0.00949881674262754,0.0571819436662534,4.39501098359601e-08,4.12354121055624,0.572807015209285,0.518076598881524,0.752635526000498,0.234558927118974,0.000375343370108525,ENSG00000099957,P2RX6,protein_coding,22,1,21009808,21028830,q11.21,purinergic receptor P2X 6 [Source:HGNC Symbol;Acc:HGNC:8538],NA,P2RX6,9127,NM_001159554;NM_001349874;NM_001349875;NM_001349876;NM_005446
B3GAT3_SIG,B3GAT3,B3GAT3_SIG,B3GAT3,SIG,36,5.94377866981027,0.324117938213225,0.314936299616672,0.354286179316183,0.0393498796995105,4.4924854546467e-08,4.69153580209124,4.9344225096154,4.88081312106284,5.11056764343095,0.229754522368114,4.84987146158479e-05,ENSG00000149541,B3GAT3,protein_coding,11,-1,62615296,62622154,q12.3,beta-1,3-glucuronyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:923],Larsen-like syndrome B3GAT3 type;MULTIPLE JOINT DISLOCATIONS SHORT STATURE AND CRANIOFACIAL DYSMORPHISMWITH OR WITHOUT CONGENITAL HEART DEFECTS,B3GAT3,26229,NM_001288721;NM_001288722;NM_001288723;NM_012200
ST6GALNAC3_SIG,ST6GALNAC3,ST6GALNAC3_SIG,ST6GALNAC3,SIG,6,-5.94366845879184,-0.0700739743284915,-0.0390899062315101,-0.171878769504287,-0.132788863272778,4.4924854546467e-08,-5.11936230593969,0.992439822867336,1.11586750997568,0.586891708082781,-0.528975801892898,8.7623912817992e-06,ENSG00000184005,ST6GALNAC3,protein_coding,1,1,76074746,76634603,p31.1,ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:19343],NA,ST6GALNAC3,256435,NM_001349106;NM_001349107;NM_001349108;NM_001349111;NM_152996
FGFR1_SIG,FGFR1,FGFR1_SIG,FGFR1,SIG,42,-5.94303617120204,-0.0561319872707459,-0.0469890060409992,-0.0861732113113422,-0.039184205270343,4.4976125639815e-08,-5.29582004908488,4.05300142661013,4.28489896108479,3.29105238476484,-0.993846576319945,4.06277345186884e-06,ENSG00000077782,FGFR1,protein_coding,8,-1,38400215,38468834,p11.23,fibroblast growth factor receptor 1 [Source:HGNC Symbol;Acc:HGNC:3688],Encephalocraniocutaneous lipomatosis;Giant cell glioblastoma;Gliosarcoma;HARTSFIELD SYNDROME;HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM;Isolated trigonocephaly;JACKSON-WEISS SYNDROME;Kallmann Syndrome;KALLMANN SYNDROME TYPE 2;Lobar holoprosencephaly;Microform holoprosencephaly;Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement;Normosmic congenital hypogonadotropic hypogonadism;Oligodontia;OSTEOGLOPHONIC DYSPLASIA;Osteoglosphonic dysplasia;PFEIFFER SYNDROME;Pfeiffer syndrome type 1;Pilomyxoid astrocytoma;Primary hypereosinophilic syndrome;Semilobar holoprosencephaly;Septo-optic dysplasia spectrum;TRIGONOCEPHALY 1,FGFR1,2260,NM_001174063;NM_001174064;NM_001174065;NM_001174066;NM_001174067;NM_001354367;NM_001354368;NM_001354369;NM_001354370;NM_015850;NM_023105;NM_023106;NM_023110
GLT1D1_SIG,GLT1D1,GLT1D1_SIG,GLT1D1,SIG,31,-5.94284525371136,0.244337659291317,0.300296916121412,0.0604715297067172,-0.239825386414695,4.4976125639815e-08,-5.53176666113131,3.41157114979467,3.71412501131198,2.41746560480923,-1.29665940650275,1.38164482323387e-06,ENSG00000151948,GLT1D1,protein_coding,12,1,128853427,128984968,q24.33,glycosyltransferase 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26483],NA,GLT1D1,144423,NM_001366886;NM_144669
SARDH_SIG,SARDH,SARDH_SIG,SARDH,SIG,29,5.93855378470797,-0.0604897671164466,-0.0702209075287026,-0.0285160200476056,0.0417048874810971,4.60798751561486e-08,3.90710679552864,1.8905291858825,1.7764107664197,2.26548970697455,0.489078940554853,0.000762385861171214,ENSG00000123453,SARDH,protein_coding,9,-1,133663560,133739955,q34.2,sarcosine dehydrogenase [Source:HGNC Symbol;Acc:HGNC:10536],SARCOSINEMIA,SARDH,1757,NM_001134707;NM_007101
ZBP1_SIG,ZBP1,ZBP1_SIG,ZBP1,SIG,38,-5.93735429791634,0.242797766699201,0.26618941238709,0.165939502296136,-0.100249910090955,4.62724157759934e-08,-3.92156628846002,2.71769671178413,2.86196602968873,2.24366895295474,-0.618297076733982,0.000728941229321185,ENSG00000124256,ZBP1,protein_coding,20,-1,57603846,57620576,q13.31,Z-DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:16176],NA,ZBP1,81030,NM_001160417;NM_001160418;NM_001160419;NM_001323966;NM_030776
HTRA4_SIG,HTRA4,HTRA4_SIG,HTRA4,SIG,19,-5.93723681684687,0.144374432218321,0.167873389823047,0.0671635715170755,-0.100709818305972,4.62724157759934e-08,-3.52059570138376,0.698801152087888,0.787370866832789,0.407786375068927,-0.379584491763862,0.00254020229717113,ENSG00000169495,HTRA4,protein_coding,8,1,38974228,38988663,p11.22,HtrA serine peptidase 4 [Source:HGNC Symbol;Acc:HGNC:26909],NA,HTRA4,203100,NM_153692
PCGF5_SIG,PCGF5,PCGF5_SIG,PCGF5,SIG,28,-5.93572145683619,0.00660193493338914,0.0208446016820837,-0.0401953986694644,-0.0610400003515481,4.66120678935824e-08,-6.17436261712323,5.77582865454957,5.88772440039143,5.40817120392633,-0.479553196465097,5.97276706295042e-08,ENSG00000180628,PCGF5,protein_coding,10,1,91163012,91284337,q23.32,polycomb group ring finger 5 [Source:HGNC Symbol;Acc:HGNC:28264],NA,PCGF5,84333,NM_001256549;NM_001257101;NM_032373
ECM1_SIG,ECM1,ECM1_SIG,ECM1,SIG,81,5.93387083443259,0.0640767909025061,0.0544324915279567,0.0957652031331683,0.0413327116052116,4.70503133246995e-08,4.09559951176649,3.04773201018199,2.88057047250781,3.59697706254,0.716406590032195,0.000411297794750304,ENSG00000143369,ECM1,protein_coding,1,1,150508062,150513789,q21.2,extracellular matrix protein 1 [Source:HGNC Symbol;Acc:HGNC:3153],Lipoid proteinosis;LIPOID PROTEINOSIS OF URBACH AND WIETHE,ECM1,1893,NM_001202858;NM_004425;NM_022664
SETD4_SIG,SETD4,SETD4_SIG,SETD4,SIG,88,5.93281561443224,0.176194897818499,0.161398351931727,0.224812120017892,0.063413768086165,4.72631016649161e-08,4.36848932286014,4.15834899280809,4.08760389519258,4.39079717068762,0.303193275495039,0.000159526113463871,ENSG00000185917,SETD4,protein_coding,21,-1,36034541,36079389,q22.12,SET domain containing 4 [Source:HGNC Symbol;Acc:HGNC:1258],NA,SETD4,54093,NM_001007259;NM_001007261;NM_001286752;NM_017438
ZDHHC1_SIG,ZDHHC1,ZDHHC1_SIG,ZDHHC1,SIG,51,5.93142905186941,0.0802758807768574,0.0681907615041523,0.119984129815745,0.0517933683115932,4.75729017462906e-08,3.16161996322262,2.14583616814858,2.0752288566529,2.37783162020583,0.30260276355293,0.00702961026673157,ENSG00000159714,ZDHHC1,protein_coding,16,-1,67394152,67416833,q22.1,zinc finger DHHC-type containing 1 [Source:HGNC Symbol;Acc:HGNC:17916],NA,ZDHHC1,29800,NM_001323627;NM_013304
S100A8_SIG,S100A8,S100A8_SIG,S100A8,SIG,48,-5.92836707039644,0.294523959752124,0.358163819661136,0.0854215629082298,-0.272742256752906,4.82494002343829e-08,-6.07576821276207,8.51279994163812,8.92740017326614,7.15054203771747,-1.77685813554867,9.88766305343061e-08,ENSG00000143546,S100A8,protein_coding,1,-1,153390032,153391073,q21.3,S100 calcium binding protein A8 [Source:HGNC Symbol;Acc:HGNC:10498],NA,S100A8,6279,NM_001319196;NM_001319197;NM_001319198;NM_001319201;NM_002964
SNRNP35_SIG,SNRNP35,SNRNP35_SIG,SNRNP35,SIG,4,5.92826472594317,0.390494103011332,0.384071416283935,0.411597216544208,0.0275258002602733,4.82494002343829e-08,4.90216627829149,4.28521519960687,4.24038774120235,4.4325054200789,0.192117678876549,2.11182207805326e-05,ENSG00000184209,SNRNP35,protein_coding,12,1,123457641,123473154,q24.31,small nuclear ribonucleoprotein U11/U12 subunit 35 [Source:HGNC Symbol;Acc:HGNC:30852],NA,SNRNP35,11066,NM_022717;NM_180699
ZDHHC9_SIG,ZDHHC9,ZDHHC9_SIG,ZDHHC9,SIG,98,5.9281712702526,0.156326879478999,0.134573751861283,0.227801441651494,0.0932276897902108,4.82494002343829e-08,4.55324829626639,4.40446996222267,4.30804303500919,4.72130129449553,0.413258259486341,8.18411530709312e-05,ENSG00000188706,ZDHHC9,protein_coding,X,-1,129803288,129843909,q26.1,zinc finger DHHC-type containing 9 [Source:HGNC Symbol;Acc:HGNC:18475],MENTAL RETARDATION SYNDROMIC X-LINKED ZDHHC9-RELATED;MENTAL RETARDATION X-LINKED SYNDROMIC RAYMOND TYPE;X-linked intellectual disability with marfanoid habitus,ZDHHC9,51114,NM_001008222;NM_016032
CACNA1F_SIG,CACNA1F,CACNA1F_SIG,CACNA1F,SIG,52,5.92707022262659,-0.0520615774514124,-0.0597325305757009,-0.0268570171858932,0.0328755133898077,4.84581829136897e-08,3.61333524633739,1.79617343751282,1.71718768390101,2.05569805652305,0.338510372622045,0.00191650396906413,ENSG00000102001,CACNA1F,protein_coding,X,-1,49205063,49233371,p11.23,calcium voltage-gated channel subunit alpha1 F [Source:HGNC Symbol;Acc:HGNC:1393],ALAND ISLAND EYE DISEASE;Aland Islands eye disease;CONE-ROD DYSTROPHY X-LINKED 3;Cone rod dystrophy;Congenital stationary night blindness;NIGHT BLINDNESS CONGENITAL STATIONARY TYPE 2A,CACNA1F,778,NM_001256789;NM_001256790;NM_005183
KCNK5_SIG,KCNK5,KCNK5_SIG,KCNK5,SIG,74,5.9268386106694,0.0589289829641022,0.0446989326355027,0.105684862615215,0.0609859299797118,4.84581829136897e-08,5.91449386555273,4.16138104759883,3.91587122887153,4.96805616627424,1.05218493740271,2.17833337918471e-07,ENSG00000164626,KCNK5,protein_coding,6,-1,39188971,39229475,p21.2,potassium two pore domain channel subfamily K member 5 [Source:HGNC Symbol;Acc:HGNC:6280],NA,KCNK5,8645,NM_003740
B4GALNT3_SIG,B4GALNT3,B4GALNT3_SIG,B4GALNT3,SIG,9,-5.92646104937032,-0.00456503127148021,0.030504869281587,-0.119794704517272,-0.150299573798859,4.84778625692822e-08,-4.07269400266625,1.12737001972946,1.2441046655326,0.743813326376294,-0.500291339156309,0.000444613165615312,ENSG00000139044,B4GALNT3,protein_coding,12,1,460364,563509,p13.33,beta-1,4-N-acetyl-galactosaminyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:24137],NA,B4GALNT3,283358,NM_173593
GPSM1_SIG,GPSM1,GPSM1_SIG,GPSM1,SIG,170,5.92300712489377,0.128962021879926,0.106802079948708,0.201773259653925,0.0949711797052173,4.94141071301431e-08,5.23799773261547,4.93329716663354,4.73953929806279,5.56993016336601,0.830390865303216,5.20658121581153e-06,ENSG00000160360,GPSM1,protein_coding,9,1,136327476,136359605,q34.3,G protein signaling modulator 1 [Source:HGNC Symbol;Acc:HGNC:17858],NA,GPSM1,26086,NM_001145638;NM_001145639;NM_001200003;NM_015597
TIAM1_SIG,TIAM1,TIAM1_SIG,TIAM1,SIG,23,-5.92145427699949,-0.0150260495973923,0.00809229602101263,-0.0909863280578655,-0.0990786240788783,4.97891102714078e-08,-3.88267809137245,2.63340592915789,2.78374295693206,2.1394414093285,-0.644301547603564,0.000826679384997107,ENSG00000156299,TIAM1,protein_coding,21,-1,31118416,31559977,q22.11,T cell lymphoma invasion and metastasis 1 [Source:HGNC Symbol;Acc:HGNC:11805],NA,TIAM1,7074,NM_001353684;NM_001353685;NM_001353686;NM_001353687;NM_001353688;NM_001353689;NM_001353690;NM_001353691;NM_001353692;NM_001353693;NM_001353694;NM_003253
NR6A1_TF,NR6A1,NR6A1_TF,NR6A1,TF,195,5.92048803371836,-0.0159875221160145,-0.0220870980561479,0.00405394168728125,0.0261410397434291,4.9988396428006e-08,5.57445339825054,3.27828457465813,3.08050245981842,3.92814009484576,0.847637635027343,1.13639594984627e-06,ENSG00000148200,NR6A1,protein_coding,9,-1,124517275,124771311,q33.3,nuclear receptor subfamily 6 group A member 1 [Source:HGNC Symbol;Acc:HGNC:7985],NA,NR6A1,2649,NM_001278546;NM_001489;NM_033334
NAA40_SIG,NAA40,NAA40_SIG,NAA40,SIG,43,5.91873061162666,0.175249695914557,0.15976203298764,0.226137731245857,0.0663756982582173,5.04306020413784e-08,4.83300121182505,5.10429343456831,5.02111771049982,5.3775850993648,0.356467388864978,2.80937137865273e-05,ENSG00000110583,NAA40,protein_coding,11,1,63938959,63957319,q13.1,N(alpha)-acetyltransferase 40, NatD catalytic subunit [Source:HGNC Symbol;Acc:HGNC:25845],NA,NAA40,79829,NM_001300800;NM_024771
MAN1C1_SIG,MAN1C1,MAN1C1_SIG,MAN1C1,SIG,59,-5.91552545935615,-0.0754496001562473,-0.0583088663228306,-0.131769154180331,-0.0734602878575001,5.13263089416454e-08,-3.85358577640408,2.11456021183463,2.23026131904912,1.734399430987,-0.495861888062117,0.000909420890300833,ENSG00000117643,MAN1C1,protein_coding,1,1,25617468,25786207,p36.11,mannosidase alpha class 1C member 1 [Source:HGNC Symbol;Acc:HGNC:19080],NA,MAN1C1,57134,NM_001289010;NM_020379
ADHFE1_SIG,ADHFE1,ADHFE1_SIG,ADHFE1,SIG,59,5.91205820184922,0.117148548758525,0.105387714527259,0.155791289804112,0.0504035752768525,5.23207979045383e-08,5.47525990924285,3.39074160828445,3.27201194313827,3.78085336519335,0.508841422055084,1.79762131113637e-06,ENSG00000147576,ADHFE1,protein_coding,8,1,66432492,66468907,q13.1,alcohol dehydrogenase, iron containing 1 [Source:HGNC Symbol;Acc:HGNC:16354],NA,ADHFE1,137872,NM_144650
MLLT10_TF,MLLT10,MLLT10_TF,MLLT10,TF,88,5.90672971122866,0.139669926559138,0.127538878205976,0.179529085433815,0.0519902072278392,5.39399236265997e-08,2.63803527038249,6.55116105181894,6.51324836452922,6.6757313100566,0.162482945527377,0.0257639424646615,ENSG00000078403,MLLT10,protein_coding,10,1,21524646,21743630,p12.31,MLLT10, histone lysine methyltransferase DOT1L cofactor [Source:HGNC Symbol;Acc:HGNC:16063],LEUKEMIA ACUTE MYELOID;Precursor T-cell acute lymphoblastic leukemia,MLLT10,8028,NM_001195626;NM_001195627;NM_001195628;NM_001195630;NM_001324296;NM_001324297;NM_004641
DHRS3_SIG,DHRS3,DHRS3_SIG,DHRS3,SIG,55,-5.90588858414155,-0.0395226039611782,-0.026044055356972,-0.083809263660713,-0.0577652083037412,5.41149314702756e-08,-5.30636872663309,2.86638705692912,3.08257042850214,2.15607026461777,-0.926500163884372,3.86365523414924e-06,ENSG00000162496,DHRS3,protein_coding,1,-1,12567910,12618210,p36.21,dehydrogenase/reductase 3 [Source:HGNC Symbol;Acc:HGNC:17693],DHRS3 related craniosynostosis,DHRS3,9249,NM_001319225;NM_001324370;NM_004753
DLG4_SIG,DLG4,DLG4_SIG,DLG4,SIG,94,5.90397568904102,0.1514170343014,0.141514571715286,0.183953697084349,0.0424391253690636,5.46447300612721e-08,4.51781426574403,5.27421874346354,5.16874273876902,5.6207827588884,0.452040020119379,9.25346550225063e-05,ENSG00000132535,DLG4,protein_coding,17,-1,7187169,7219841,p13.1,discs large MAGUK scaffold protein 4 [Source:HGNC Symbol;Acc:HGNC:2903],DLG4 related intellectual disability,DLG4,1742,NM_001128827;NM_001321074;NM_001321075;NM_001321076;NM_001321077;NM_001365
LIPN_SIG,LIPN,LIPN_SIG,LIPN,SIG,12,-5.9032467466341,0.472422929213391,0.529903431666094,0.283558421154509,-0.246345010511586,5.47849978740353e-08,-5.84677223211761,1.5004514135419,1.67646654613595,0.922115977875755,-0.754350568260191,3.0686255998963e-07,ENSG00000204020,LIPN,protein_coding,10,1,88761406,88778242,q23.31,lipase family member N [Source:HGNC Symbol;Acc:HGNC:23452],ICHTHYOSIS CONGENITAL AUTOSOMAL RECESSIVE 8;Ichthyosis lamellar 4;Lamellar ichthyosis,LIPN,643418,NM_001102469
PAX5_TF,PAX5,PAX5_TF,PAX5,TF,150,-5.8963819674865,-0.0592647818111561,-0.0499346297968516,-0.0899209955724424,-0.0399863657755908,5.70066790704845e-08,-4.11201692664672,2.68327035774468,2.85741722038021,2.11107352337082,-0.746343697009386,0.000389776842913855,ENSG00000196092,PAX5,protein_coding,9,-1,36833269,37034268,p13.2,paired box 5 [Source:HGNC Symbol;Acc:HGNC:8619],Leukemia acute lymphoblastic susceptibility to 3;Precursor B-cell acute lymphoblastic leukemia,PAX5,5079,NM_001280547;NM_001280548;NM_001280549;NM_001280550;NM_001280551;NM_001280552;NM_001280553;NM_001280554;NM_001280555;NM_001280556;NM_016734
ISG20_SIG,ISG20,ISG20_SIG,ISG20,SIG,48,-5.89348451162779,0.140677465741673,0.160408799767637,0.0758459396563629,-0.0845628601112739,5.79085602391165e-08,-3.28459905336532,4.10301601592102,4.20982368034236,3.75207654710804,-0.457747133234325,0.00502107173742197,ENSG00000172183,ISG20,protein_coding,15,1,88636153,88656483,q26.1,interferon stimulated exonuclease gene 20 [Source:HGNC Symbol;Acc:HGNC:6130],NA,ISG20,3669,NM_001303233;NM_001303234;NM_001303236;NM_001303237;NM_002201
METAP1D_SIG,METAP1D,METAP1D_SIG,METAP1D,SIG,46,5.89194058621348,0.107034963383313,0.0872424735122167,0.172067430102629,0.0848249565904122,5.83445018027064e-08,4.7596671519301,3.3184007254854,3.20505578352944,3.69081982048354,0.485764036954095,3.72132708738029e-05,ENSG00000172878,METAP1D,protein_coding,2,1,171999943,172082430,q31.1,methionyl aminopeptidase type 1D, mitochondrial [Source:HGNC Symbol;Acc:HGNC:32583],NA,METAP1D,254042,NM_001322278;NM_001322279;NM_199227
SOX12_TF,SOX12,SOX12_TF,SOX12,TF,209,5.89088465555068,0.15610297615477,0.138131537814265,0.215151987845002,0.0770204500307367,5.86104420200415e-08,4.67075599894254,4.81839364693073,4.69256872964589,5.23181837515234,0.53924964550645,5.25078746300656e-05,ENSG00000177732,SOX12,protein_coding,20,1,325595,330224,p13,SRY-box 12 [Source:HGNC Symbol;Acc:HGNC:11198],NA,SOX12,6666,NM_006943
RIPK4_SIG,RIPK4,RIPK4_SIG,RIPK4,SIG,18,-5.88949782449323,-0.253658587330765,-0.244396512350331,-0.284091119409333,-0.0396946070590022,5.89957345792943e-08,-2.44786225657475,0.271010821576951,0.308720825272839,0.147106523719036,-0.161614301553802,0.0395543838029877,ENSG00000183421,RIPK4,protein_coding,21,-1,41739369,41767089,q22.3,receptor interacting serine/threonine kinase 4 [Source:HGNC Symbol;Acc:HGNC:496],Bartsocas-Papas syndrome;CHAND SYNDROME;Popliteal pterygium syndrome lethal type,RIPK4,54101,NM_020639
RNF113A_SIG,RNF113A,RNF113A_SIG,RNF113A,SIG,18,5.88585049593504,0.137394392380309,0.13127880761325,0.157488456614931,0.0262096490016808,6.02011170913717e-08,1.9788024398606,4.77996810756023,4.75878627645226,4.84956555262928,0.0907792761770264,0.100980815167555,ENSG00000125352,RNF113A,protein_coding,X,-1,119870475,119871827,q24,ring finger protein 113A [Source:HGNC Symbol;Acc:HGNC:12974],Trichothiodystrophy;TRICHOTHIODYSTROPHY 5 NONPHOTOSENSITIVE;X-LINKED TRICHOTHIODYSTROPHY,RNF113A,7737,NM_006978
ADARB1_SIG,ADARB1,ADARB1_SIG,ADARB1,SIG,36,5.88136610264049,0.0739061125573925,0.0640289642678298,0.106359599794527,0.0423306355266975,6.17420717342537e-08,2.72106790761497,4.84064093052183,4.77595845233056,5.05316907315028,0.27721062081972,0.0213051669398724,ENSG00000197381,ADARB1,protein_coding,21,1,45073853,45226560,q22.3,adenosine deaminase, RNA specific B1 [Source:HGNC Symbol;Acc:HGNC:226],NA,ADARB1,104,NM_001112;NM_001160230;NM_001346687;NM_001346688;NM_015833;NM_015834
ABCC1_SIG,ABCC1,ABCC1_SIG,ABCC1,SIG,91,5.87987678530886,0.271856276616873,0.251085877571492,0.34010187348027,0.089015995908778,6.2186269625641e-08,5.24638551371889,7.44774245377293,7.32290294173999,7.85792942188117,0.535026480141189,5.04600628737877e-06,ENSG00000103222,ABCC1,protein_coding,16,1,15949577,16143074,p13.11,ATP binding cassette subfamily C member 1 [Source:HGNC Symbol;Acc:HGNC:51],NA,ABCC1,4363,NM_004996
SLC20A2_SIG,SLC20A2,SLC20A2_SIG,SLC20A2,SIG,17,5.87954736593012,0.283016918579957,0.268606097668486,0.330366758717647,0.0617606610491609,6.21964429611791e-08,4.43914651500556,4.61731454717167,4.55189496000557,4.83226461928887,0.280369659283307,0.000123877104332077,ENSG00000168575,SLC20A2,protein_coding,8,-1,42416475,42541926,p11.21,solute carrier family 20 member 2 [Source:HGNC Symbol;Acc:HGNC:10947],BASAL GANGLIA CALCIFICATION IDIOPATHIC 1;Bilateral striopallidodentate calcinosis,SLC20A2,6575,NM_001257180;NM_001257181;NM_006749
HNRNPLL_SIG,HNRNPLL,HNRNPLL_SIG,HNRNPLL,SIG,35,-5.87331087463756,0.0161989864422627,0.0305335614442914,-0.0309003314215458,-0.0614338928658372,6.43519957786957e-08,-4.90926720817799,4.11288107052407,4.2982424014301,3.50383669754714,-0.794405703882959,2.04877128008136e-05,ENSG00000143889,HNRNPLL,protein_coding,2,-1,38561969,38603586,p22.1,heterogeneous nuclear ribonucleoprotein L like [Source:HGNC Symbol;Acc:HGNC:25127],NA,HNRNPLL,92906,NM_001142650;NM_138394
LILRA2_SIG,LILRA2,LILRA2_SIG,LILRA2,SIG,43,-5.87330132501514,0.188964390358417,0.218016738853515,0.0935066738745207,-0.124510064978994,6.43519957786957e-08,-6.25049082222875,5.93241501365376,6.16922864112108,5.15431309483257,-1.01491554628851,3.97739868060069e-08,ENSG00000239998,LILRA2,protein_coding,19,1,54572920,54590287,q13.42,leukocyte immunoglobulin like receptor A2 [Source:HGNC Symbol;Acc:HGNC:6603],NA,LILRA2,11027,NM_001130917;NM_001290270;NM_001290271;NM_006866
DHDDS_SIG,DHDDS,DHDDS_SIG,DHDDS,SIG,17,5.871049112049,0.478612979361167,0.46540446907336,0.522012370306819,0.0566079012334589,6.50293590820536e-08,4.77955960608746,4.68291907125869,4.6319715163321,4.85031818030318,0.218346663971074,3.46160022606023e-05,ENSG00000117682,DHDDS,protein_coding,1,1,26432282,26471306,p36.11,dehydrodolichyl diphosphate synthase subunit [Source:HGNC Symbol;Acc:HGNC:20603],DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENTABNORMALITIES;Epilepsy and intellectual disability;Retinitis pigmentosa;Retinitis pigmentosa 59;Undetermined early-onset epileptic encephalopathy,DHDDS,79947,NM_001243564;NM_001243565;NM_001319959;NM_024887;NM_205861
FOXJ1_SIG,FOXJ1,FOXJ1_SIG,FOXJ1,SIG,13,-5.87096435575956,-0.0939504206812615,-0.0858192722256192,-0.120667051321229,-0.0348477790956096,6.50293590820536e-08,-2.15491096338387,0.419280996209288,0.450179889607684,0.317756060757415,-0.132423828850269,0.0724332897226394,ENSG00000129654,FOXJ1,protein_coding,17,-1,76136333,76141245,q25.1,forkhead box J1 [Source:HGNC Symbol;Acc:HGNC:3816],NA,FOXJ1,2302,NM_001454
PHF7_SIG,PHF7,PHF7_SIG,PHF7,SIG,43,5.86857362284694,0.110259144843596,0.0961458031515305,0.156631553260385,0.0604857501088541,6.58545447437096e-08,2.3420206312706,4.12918674093135,4.08989777628083,4.25827905335451,0.168381277073685,0.0496042778770168,ENSG00000010318,PHF7,protein_coding,3,1,52410660,52423641,p21.1,PHD finger protein 7 [Source:HGNC Symbol;Acc:HGNC:18458],NA,PHF7,51533,NM_001278221;NM_001321126;NM_001321127;NM_016483
CSF3R_SIG,CSF3R,CSF3R_SIG,CSF3R,SIG,34,-5.86775916167318,0.295072802664095,0.315669153473389,0.227399078576413,-0.0882700748969761,6.60593020541012e-08,-4.1699715644429,9.31247762437898,9.42401874030097,8.94598538634962,-0.47803335395135,0.000319568669975466,ENSG00000119535,CSF3R,protein_coding,1,-1,36466043,36483278,p34.3,colony stimulating factor 3 receptor [Source:HGNC Symbol;Acc:HGNC:2439],Atypical chronic myeloid leukemia;Autosomal recessive severe congenital neutropenia due to CSF3R deficiency;Chronic neutrophilic leukemia;Hereditary neutrophilia;Neutropenia severe congenital 7 autosomal recessive,CSF3R,1441,NM_000760;NM_156039;NM_172313
LTF_TF,LTF,LTF_TF,LTF,TF,424,-5.86261328233648,0.0659434270529992,0.0891496470441171,-0.0103055814892454,-0.0994552285333624,6.8017394436719e-08,-5.73332967447368,6.8596043699206,7.36769502721566,5.19016363880826,-2.1775313884074,5.39314401180222e-07,ENSG00000012223,LTF,protein_coding,3,-1,46435645,46485234,p21.31,lactotransferrin [Source:HGNC Symbol;Acc:HGNC:6720],NA,LTF,4057,NM_001199149;NM_001321121;NM_001321122;NM_002343
ZNF195_TF,ZNF195,ZNF195_TF,ZNF195,TF,165,5.86109778953624,0.165530955946984,0.151613558373583,0.211259547973872,0.0596459896002892,6.85177061704422e-08,4.54690508601094,4.66117813370065,4.58037173465571,4.92668487341975,0.34631313876404,8.36647695065347e-05,ENSG00000005801,ZNF195,protein_coding,11,-1,3339261,3379222,p15.4,zinc finger protein 195 [Source:HGNC Symbol;Acc:HGNC:12986],NA,ZNF195,7748,NM_001130519;NM_001130520;NM_001242841;NM_001242842;NM_001242843;NM_001256823;NM_001256824;NM_001256825;NM_007152
ZNF804A_TF,ZNF804A,ZNF804A_TF,ZNF804A,TF,99,5.86012784166135,0.0797016533243833,0.0679586153906588,0.118285920820907,0.0503273054302482,6.87556626471493e-08,3.58964708472859,2.86397230088732,2.72109330122716,3.33343187119929,0.612338569972132,0.00206271778493569,ENSG00000170396,ZNF804A,protein_coding,2,1,184598529,184939492,q32.1,zinc finger protein 804A [Source:HGNC Symbol;Acc:HGNC:21711],NA,ZNF804A,91752,NM_194250
ATP2C1_SIG,ATP2C1,ATP2C1_SIG,ATP2C1,SIG,85,5.85984540847788,0.261660222193626,0.242267707411521,0.325378485049112,0.0831107776375913,6.87556626471493e-08,3.53977042779972,6.85019749144601,6.79188644868599,7.0417909176575,0.24990446897151,0.00240134473013208,ENSG00000017260,ATP2C1,protein_coding,3,1,130850595,131016712,q22.1,ATPase secretory pathway Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:13211],BENIGN CHRONIC PEMPHIGUS;Familial benign chronic pemphigus,ATP2C1,27032,NM_001001485;NM_001001486;NM_001001487;NM_001199179;NM_001199180;NM_001199181;NM_001199182;NM_001199183;NM_001199184;NM_001199185;NM_014382
DEAF1_TF,DEAF1,DEAF1_TF,DEAF1,TF,107,5.85962856117986,0.208576260763644,0.196843282814447,0.247127474025293,0.0502841912108463,6.87556626471493e-08,4.30709432860765,5.32788973252003,5.25375758709925,5.57146678175975,0.317709194660502,0.000199342404290667,ENSG00000177030,DEAF1,protein_coding,11,-1,644233,706715,p15.5,DEAF1 transcription factor [Source:HGNC Symbol;Acc:HGNC:14677],Autism intellectual disability basal ganglia dysfunction and epilepsy;Autosomal dominant non-syndromic intellectual disability;DYSKINESIA SEIZURES AND INTELLECTUAL DEVELOPMENTAL DISORDER;Intellectual disability-epilepsy-extrapyramidal syndrome;Mental retardation autosomal dominant 24;SMITH-MAGENIS SYNDROME,DEAF1,10522,NM_001293634;NM_021008
ACACA_SIG,ACACA,ACACA_SIG,ACACA,SIG,26,5.85864327479959,0.49913803569464,0.481742928481641,0.556293387965924,0.0745504594842835,6.90412577658243e-08,5.04347954563788,5.69691709692038,5.60172483156678,6.00969168308222,0.407966851515437,1.19311359760802e-05,ENSG00000278540,ACACA,protein_coding,17,-1,37084992,37406836,q12,acetyl-CoA carboxylase alpha [Source:HGNC Symbol;Acc:HGNC:84],ACETYL-CoA CARBOXYLASE DEFICIENCY,ACACA,31,NM_198834;NM_198836;NM_198837;NM_198838;NM_198839
CAMKV_SIG,CAMKV,CAMKV_SIG,CAMKV,SIG,51,5.85740391665583,0.0513828699582833,0.0411101451398508,0.0851361086474188,0.0440259635075681,6.94343053069648e-08,3.32661191111356,1.00210346426772,0.905506092144504,1.31949482981542,0.413988737670919,0.00445631800848649,ENSG00000164076,CAMKV,protein_coding,3,-1,49857988,49869935,p21.31,CaM kinase like vesicle associated [Source:HGNC Symbol;Acc:HGNC:28788],NA,CAMKV,79012,NM_001320147;NM_024046
NCOA2_SIG,NCOA2,NCOA2_SIG,NCOA2,SIG,39,-5.85540533798433,0.375416988456145,0.386390712627778,0.33936046617792,-0.0470302464498583,7.0149478289447e-08,-4.17823279686813,6.56806484824121,6.63589511242979,6.34519398019303,-0.290701132236765,0.00031075124913915,ENSG00000140396,NCOA2,protein_coding,8,-1,70109782,70403808,q13.3,nuclear receptor coactivator 2 [Source:HGNC Symbol;Acc:HGNC:7669],NA,NCOA2,10499,NM_001321703;NM_001321707;NM_001321711;NM_001321712;NM_001321713;NM_006540
FCN1_SIG,FCN1,FCN1_SIG,FCN1,SIG,26,-5.84989879527003,0.527158577600156,0.586024996216011,0.333740345005205,-0.252284651210806,7.23829698360601e-08,-5.14593042132253,7.19029640869655,7.53134136043782,6.06972013868952,-1.4616212217483,7.89502028557757e-06,ENSG00000085265,FCN1,protein_coding,9,-1,134903232,134917912,q34.3,ficolin 1 [Source:HGNC Symbol;Acc:HGNC:3623],NA,FCN1,2219,NM_002003
KLHL9_SIG,KLHL9,KLHL9_SIG,KLHL9,SIG,51,5.84420346124976,0.208215495097036,0.198229417572871,0.241026892676437,0.0427974751035665,7.47703424106502e-08,5.48802937041979,5.43328746948106,5.34221275308257,5.73253296621896,0.390320213136394,1.68891246619882e-06,ENSG00000198642,KLHL9,protein_coding,9,-1,21329671,21335380,p21.3,kelch like family member 9 [Source:HGNC Symbol;Acc:HGNC:18732],KLHL9-related early-onset distal myopathy,KLHL9,55958,NM_018847
COL5A3_SIG,COL5A3,COL5A3_SIG,COL5A3,SIG,23,-5.84316166458508,-0.23783367709235,-0.225865176011058,-0.277158752073739,-0.0512935760626816,7.51064820581991e-08,-2.68450854126312,0.758421730348931,0.810989104420364,0.585700358399936,-0.225288746020428,0.0232455209418135,ENSG00000080573,COL5A3,protein_coding,19,-1,9959561,10010504,p13.2,collagen type V alpha 3 chain [Source:HGNC Symbol;Acc:HGNC:14864],NA,COL5A3,50509,NM_015719
RNF152_SIG,RNF152,RNF152_SIG,RNF152,SIG,13,-5.84283328233045,-0.0785312224755258,-0.0652492334428488,-0.122172043582893,-0.0569228101400442,7.51217826566314e-08,-4.08795840678871,0.639282157526238,0.726292901579383,0.353389712780189,-0.372903188799194,0.000421473544090714,ENSG00000176641,RNF152,protein_coding,18,-1,61808067,61894247,q21.33,ring finger protein 152 [Source:HGNC Symbol;Acc:HGNC:26811],NA,RNF152,220441,NM_173557
GEMIN8_SIG,GEMIN8,GEMIN8_SIG,GEMIN8,SIG,93,5.8399155774975,0.12155668293045,0.10452216032748,0.177527257197353,0.0730050968698737,7.63144660566636e-08,4.99219692041671,3.44859318845071,3.37805977550981,3.68034583097083,0.302286055461023,1.46275259383752e-05,ENSG00000046647,GEMIN8,protein_coding,X,-1,14008279,14029893,p22.2,gem nuclear organelle associated protein 8 [Source:HGNC Symbol;Acc:HGNC:26044],NA,GEMIN8,54960,NM_001042479;NM_001042480;NM_017856
ARNT2_TF,ARNT2,ARNT2_TF,ARNT2,TF,191,-5.83664606549412,-0.118693115845907,-0.112552919589652,-0.138868046402174,-0.0263151268125222,7.76077698765124e-08,-1.76579135312944,0.38274192422638,0.419193366811151,0.262972898590703,-0.156220468220448,0.146442115398098,ENSG00000172379,ARNT2,protein_coding,15,1,80404350,80597933,q25.1,aryl hydrocarbon receptor nuclear translocator 2 [Source:HGNC Symbol;Acc:HGNC:16876],Septo-optic dysplasia spectrum;WEBB-DATTANI SYNDROME,ARNT2,9915,NM_014862
ZNF629_TF,ZNF629,ZNF629_TF,ZNF629,TF,78,5.83652826624717,0.195371536896565,0.182908388316928,0.236321882229657,0.0534134939127295,7.76077698765124e-08,4.38511003128921,5.09911211097585,5.01605795819269,5.37200432726339,0.355946369070698,0.000150381140529113,ENSG00000102870,ZNF629,protein_coding,16,-1,30778456,30787205,p11.2,zinc finger protein 629 [Source:HGNC Symbol;Acc:HGNC:29008],NA,ZNF629,23361,NM_001080417;NM_001345970
NUDT6_SIG,NUDT6,NUDT6_SIG,NUDT6,SIG,42,5.83548419531475,0.0066682365759504,-0.0138741654473,0.0741647003666304,0.0880388658139304,7.79583337590518e-08,5.46252185413394,2.14541416795332,2.03803067574534,2.49824564235095,0.460214966605612,1.91772674980086e-06,ENSG00000170917,NUDT6,protein_coding,4,-1,122888697,122922968,q28.1,nudix hydrolase 6 [Source:HGNC Symbol;Acc:HGNC:8053],NA,NUDT6,11162,NM_007083;NM_198041
ADA_SIG,ADA,ADA_SIG,ADA,SIG,77,5.83286046538249,0.185899958609873,0.167881591776363,0.245103163919977,0.0772215721436148,7.90559203160479e-08,4.89887209997018,5.56760652040728,5.40318433210825,6.10785085338983,0.704666521281588,2.13716707140828e-05,ENSG00000196839,ADA,protein_coding,20,-1,44619522,44652233,q13.12,adenosine deaminase [Source:HGNC Symbol;Acc:HGNC:186],Adenosine Deaminase Deficiency;OMENN SYNDROME;SEVERE COMBINED IMMUNODEFICIENCY AUTOSOMAL RECESSIVE TCELL-NEGATIVE B CELL-NEGATIVE NK CELL-NEGATIVE DUE TO ADENOSINEDEAMINASE DEFICIENCY;Severe combined immunodeficiency due to adenosine deaminase deficiency,ADA,100,NM_000022;NM_001322050;NM_001322051
PNPLA1_SIG,PNPLA1,PNPLA1_SIG,PNPLA1,SIG,20,-5.83244884072498,0.578735549225397,0.643101347334272,0.367247926867664,-0.275853420466608,7.91018774001231e-08,-3.98615677731276,1.51849118887699,1.63672342580815,1.13001383896029,-0.506709586847861,0.000594391842023846,ENSG00000180316,PNPLA1,protein_coding,6,1,36243203,36312229,p21.31,patatin like phospholipase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21246],congenital ichthyosis;Congenital nonbullous ichthyosiform erythroderma;ICHTHYOSIS CONGENITAL AUTOSOMAL RECESSIVE 10,PNPLA1,285848,NM_001145716;NM_001145717;NM_173676
PRODH_SIG,PRODH,PRODH_SIG,PRODH,SIG,54,5.83218030189602,0.0828432686474797,0.0685229469358989,0.129895754271245,0.0613728073353463,7.91018774001231e-08,3.33048031359978,2.28036128958562,2.12405246764619,2.79394741881519,0.669894951168999,0.00440953955741335,ENSG00000100033,PRODH,protein_coding,22,-1,18912777,18936553,q11.21,proline dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:9453],Hyperprolinemia type 1;HYPERPROLINEMIA TYPE I;SCHIZOPHRENIA 4,PRODH,5625,NM_001195226;NM_016335
UBFD1_SIG,UBFD1,UBFD1_SIG,UBFD1,SIG,43,5.8312853585108,0.414604718684824,0.39984720878829,0.463093679773436,0.0632464709851457,7.93888186728233e-08,5.34153428085575,5.46007769994295,5.36981719244048,5.75664793887965,0.386830746439165,3.30675185006628e-06,ENSG00000103353,UBFD1,protein_coding,16,1,23557721,23574389,p12.2,ubiquitin family domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30565],NA,UBFD1,56061,NM_019116
SMAD7_TF,SMAD7,SMAD7_TF,SMAD7,TF,72,-5.82792349751546,0.000492332517844732,0.0156888557334101,-0.0494391009047271,-0.0651279566381373,8.08634634655438e-08,-4.35104171166252,3.24735488286542,3.40009208415434,2.74550407863038,-0.654588005523962,0.000169979295995131,ENSG00000101665,SMAD7,protein_coding,18,-1,48919853,48952052,q21.1,SMAD family member 7 [Source:HGNC Symbol;Acc:HGNC:6773],COLORECTAL CANCER SUSCEPTIBILITY TO 3,SMAD7,4092,NM_001190821;NM_001190822;NM_001190823;NM_005904
LRRC4_SIG,LRRC4,LRRC4_SIG,LRRC4,SIG,10,-5.82544983697336,0.249451479553416,0.304020061548493,0.07015471014102,-0.233865351407473,8.19279581513798e-08,-5.35434873484956,3.35230709135022,3.57763046155358,2.61195887496774,-0.965671586585834,3.12743487244848e-06,ENSG00000128594,LRRC4,protein_coding,7,-1,128027071,128032107,q32.1,leucine rich repeat containing 4 [Source:HGNC Symbol;Acc:HGNC:15586],NA,LRRC4,64101,NM_022143
KREMEN1_SIG,KREMEN1,KREMEN1_SIG,KREMEN1,SIG,16,-5.8233857206983,-0.0792255877724191,-0.0552471648679037,-0.158011834458684,-0.10276466959078,8.28029773138506e-08,-4.75871591423691,2.21221990583357,2.40196173608116,1.5887824635915,-0.813179272489667,3.73576530009914e-05,ENSG00000183762,KREMEN1,protein_coding,22,1,29073078,29168333,q12.1,kringle containing transmembrane protein 1 [Source:HGNC Symbol;Acc:HGNC:17550],ECTODERMAL DYSPLASIA 13 HAIR/TOOTH TYPE,KREMEN1,83999,NM_001039570;NM_032045
PCBD1_SIG,PCBD1,PCBD1_SIG,PCBD1,SIG,31,5.82293757140108,0.0920061351574525,0.0784931628755079,0.136405901226699,0.0579127383511913,8.28817619318575e-08,5.42204903624086,4.26207319241495,4.14491056473687,4.64703611192865,0.502125547191778,2.31991291369364e-06,ENSG00000166228,PCBD1,protein_coding,10,-1,70882280,70888565,q22.1,pterin-4 alpha-carbinolamine dehydratase 1 [Source:HGNC Symbol;Acc:HGNC:8646],HYPERPHENYLALANINEMIA BH4-DEFICIENT D;Pterin-4 alpha-carbinolamine dehydratase deficiency,PCBD1,5092,NM_000281;NM_001289797
ZNF69_TF,ZNF69,ZNF69_TF,ZNF69,TF,122,5.8211101101201,0.176694559348664,0.160680280053159,0.229312905605321,0.0686326255521624,8.36485071080647e-08,3.90875347482688,2.77899930957361,2.68686044902585,3.08174127994483,0.394880830918981,0.000759122730113664,ENSG00000198429,ZNF69,protein_coding,19,1,11887784,11914329,p13.2,zinc finger protein 69 [Source:HGNC Symbol;Acc:HGNC:13138],NA,ZNF69,7620,NM_001321163;NM_021915
FUT10_SIG,FUT10,FUT10_SIG,FUT10,SIG,9,5.81847942402974,0.139828884183656,0.121324864604389,0.200627805658389,0.0793029410539999,8.48289267402645e-08,5.52978559567466,2.91145105314102,2.7766909174827,3.35423435601837,0.57754343853567,1.39202549319029e-06,ENSG00000172728,FUT10,protein_coding,8,-1,33370824,33473422,p12,fucosyltransferase 10 [Source:HGNC Symbol;Acc:HGNC:19234],NA,FUT10,84750,NM_032664
ETV7_TF,ETV7,ETV7_TF,ETV7,TF,163,-5.81568280538678,0.0425102152994547,0.0532208303574833,0.00731819439450385,-0.0459026359629795,8.61110658353882e-08,-2.93611139848762,0.659531321769059,0.716936506961598,0.470914284707861,-0.246022222253737,0.0126795688353599,ENSG00000010030,ETV7,protein_coding,6,-1,36354091,36387800,p21.31,ETS variant 7 [Source:HGNC Symbol;Acc:HGNC:18160],NA,ETV7,51513,NM_001207035;NM_001207036;NM_001207037;NM_001207038;NM_001207039;NM_001207040;NM_001207041;NM_016135
ZNF664_TF,ZNF664,ZNF664_TF,ZNF664,TF,100,5.81039922227449,0.208474832973488,0.196114133659689,0.249088559290255,0.0529744256305654,8.87207353332808e-08,3.4298648134351,6.31307620041689,6.24538936597051,6.53547579931213,0.290086433341625,0.00329700715233951,ENSG00000179195,ZNF664,protein_coding,12,1,123971845,124015439,q24.31,zinc finger protein 664 [Source:HGNC Symbol;Acc:HGNC:25406],NA,ZNF664,144348,NM_001204298;NM_152437
NAT14_SIG,NAT14,NAT14_SIG,NAT14,SIG,31,5.8082686316635,0.191513313543605,0.172326016038496,0.254557291060392,0.0822312750218954,8.95962607854175e-08,4.27247065111855,2.87273254589644,2.78392162970051,3.16453984196879,0.380618212268283,0.000224110310792818,ENSG00000090971,NAT14,protein_coding,19,1,55485188,55487568,q13.42,N-acetyltransferase 14 (putative) [Source:HGNC Symbol;Acc:HGNC:28918],NA,NAT14,57106,NM_020378
CLEC5A_SIG,CLEC5A,CLEC5A_SIG,CLEC5A,SIG,28,-5.80818063015428,0.257116729761168,0.296418401913503,0.127982664117781,-0.168435737795722,8.95962607854175e-08,-5.54455441783578,4.07867677071396,4.38360928043477,3.07675566734559,-1.30685361308917,1.30176939592012e-06,ENSG00000258227,CLEC5A,protein_coding,7,-1,141927357,141947007,q34,C-type lectin domain containing 5A [Source:HGNC Symbol;Acc:HGNC:2054],NA,CLEC5A,23601,NM_001301167;NM_013252
LNX2_SIG,LNX2,LNX2_SIG,LNX2,SIG,56,5.80625648862712,0.290581434840068,0.278875225003364,0.329044695732096,0.0501694707287325,9.03403670515056e-08,3.98440178547487,3.95650602929742,3.88107878807717,4.20433839330681,0.323259605229641,0.000596498285754785,ENSG00000139517,LNX2,protein_coding,13,-1,27545913,27620529,q12.2,ligand of numb-protein X 2 [Source:HGNC Symbol;Acc:HGNC:20421],NA,LNX2,222484,NM_153371
TFDP2_TF,TFDP2,TFDP2_TF,TFDP2,TF,470,5.80622271590482,-0.000193763009944236,-0.0191654962934374,0.0621419320643903,0.0813074283578275,9.03403670515056e-08,5.69269665514137,6.54803713928159,6.39596403979812,7.04770589472725,0.651741854929123,6.56489933666168e-07,ENSG00000114126,TFDP2,protein_coding,3,-1,141944428,142149544,q23,transcription factor Dp-2 [Source:HGNC Symbol;Acc:HGNC:11751],NA,TFDP2,7029,NM_001178138;NM_001178139;NM_001178140;NM_001178141;NM_001178142;NM_006286
BBS1_SIG,BBS1,BBS1_SIG,BBS1,SIG,82,5.8041317045999,0.0575897760828343,0.0440651165030366,0.102027943273598,0.0579628267705614,9.13190573096504e-08,5.26288255777157,0.972463703970662,0.914526808178285,1.16282779014561,0.248300981967329,4.69363806430709e-06,ENSG00000174483,BBS1,protein_coding,11,1,66510606,66533613,q13.2,Bardet-Biedl syndrome 1 [Source:HGNC Symbol;Acc:HGNC:966],Bardet-Biedl syndrome;BARDET-BIEDL SYNDROME 1;BARDET-BIEDL SYNDROME TYPE 1,BBS1,582,NM_024649
MRPS30_SIG,MRPS30,MRPS30_SIG,MRPS30,SIG,42,5.80283253310014,0.362239634201439,0.343556342275217,0.423627593387597,0.0800712511123802,9.18731929604424e-08,4.69363169596251,5.32766785705341,5.26372943548306,5.53775124221315,0.274021806730088,4.82248923663409e-05,ENSG00000112996,MRPS30,protein_coding,5,1,44808947,44820428,p12,mitochondrial ribosomal protein S30 [Source:HGNC Symbol;Acc:HGNC:8769],NA,MRPS30,10884,NM_016640
VASP_SIG,VASP,VASP_SIG,VASP,SIG,31,-5.8013592955372,0.57409282048055,0.598375727928218,0.494306124581067,-0.104069603347151,9.25268249012585e-08,-6.24680735442737,7.67006791302518,7.7945974411507,7.26089946346988,-0.533697977680826,4.05383094157019e-08,ENSG00000125753,VASP,protein_coding,19,1,45506579,45526983,q13.32,vasodilator stimulated phosphoprotein [Source:HGNC Symbol;Acc:HGNC:12652],NA,VASP,7408,NM_003370
CDC42BPA_SIG,CDC42BPA,CDC42BPA_SIG,CDC42BPA,SIG,115,-5.79639597436323,-0.123484950567807,-0.1109827903132,-0.16456347711866,-0.0535806868054606,9.51443492131828e-08,-5.65081838972692,2.41561178813132,2.73730066071948,1.3586340639131,-1.37866659680638,8.14005157682466e-07,ENSG00000143776,CDC42BPA,protein_coding,1,-1,226989865,227318474,q42.13,CDC42 binding protein kinase alpha [Source:HGNC Symbol;Acc:HGNC:1737],NA,CDC42BPA,8476,NM_001366011;NM_001366019;NM_003607;NM_014826
DOCK9_SIG,DOCK9,DOCK9_SIG,DOCK9,SIG,43,-5.79337922914806,0.0331539927674272,0.0626877236072056,-0.0638854085632732,-0.126573132170479,9.67061328098392e-08,-3.54898575572201,2.7559184577955,2.89334169411933,2.30438496701721,-0.588956727102114,0.00233143583593925,ENSG00000088387,DOCK9,protein_coding,13,-1,98793429,99086625,q32.3,dedicator of cytokinesis 9 [Source:HGNC Symbol;Acc:HGNC:14132],NA,DOCK9,23348,NM_001130048;NM_001130049;NM_001130050;NM_001318849;NM_001366678;NM_015296
MTF1_TF,MTF1,MTF1_TF,MTF1,TF,382,-5.79247550322095,0.199503899878427,0.221569449569414,0.127002808036612,-0.0945666415328017,9.70638757963024e-08,-3.81811186950879,5.88293837946589,5.95087849016363,5.65970658717333,-0.291171902990299,0.00101681335417769,ENSG00000188786,MTF1,protein_coding,1,-1,37809574,37859592,p34.3,metal regulatory transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:7428],Intellectual disability,MTF1,4520,NM_005955
DPEP1_SIG,DPEP1,DPEP1_SIG,DPEP1,SIG,33,5.78790446357059,0.026493482869816,0.0169445835945324,0.0578684376314622,0.0409238540369298,9.95735786938957e-08,4.08707985430379,0.67254870557349,0.564478064494613,1.02763795483265,0.463159890338041,0.000422892829738133,ENSG00000015413,DPEP1,protein_coding,16,1,89613308,89638456,q24.3,dipeptidase 1 [Source:HGNC Symbol;Acc:HGNC:3002],NA,DPEP1,1800,NM_001128141;NM_004413
SMAD5_TF,SMAD5,SMAD5_TF,SMAD5,TF,48,5.78745571226013,0.200655990014972,0.190867894845681,0.232816874142642,0.0419489792969613,9.96717853230923e-08,4.42743286682496,4.78998738487248,4.70352933278344,5.07406384173648,0.370534508953034,0.000129233824734628,ENSG00000113658,SMAD5,protein_coding,5,1,136132845,136188747,q31.1,SMAD family member 5 [Source:HGNC Symbol;Acc:HGNC:6771],NA,SMAD5,4090,NM_001001419;NM_001001420;NM_005903
HOXB9_TF,HOXB9,HOXB9_TF,HOXB9,TF,25,5.78555459496411,-0.174097258543986,-0.185519242342855,-0.136567883204844,0.0489513591380112,1.00636269105277e-07,3.25692307112001,1.16313913684035,0.979592259490483,1.76622173384705,0.786629474356568,0.00541486675705405,ENSG00000170689,HOXB9,protein_coding,17,-1,48621156,48626358,q21.32,homeobox B9 [Source:HGNC Symbol;Acc:HGNC:5120],NA,HOXB9,3219,NM_024017
CYB5R2_SIG,CYB5R2,CYB5R2_SIG,CYB5R2,SIG,67,-5.78456088948285,-0.16239638660112,-0.148266804859225,-0.208822155181634,-0.0605553503224089,1.01063079935467e-07,-3.75066521271876,0.631577006288578,0.736882499666706,0.285573242331869,-0.451309257334838,0.00125394506457861,ENSG00000166394,CYB5R2,protein_coding,11,-1,7665100,7677222,p15.4,cytochrome b5 reductase 2 [Source:HGNC Symbol;Acc:HGNC:24376],NA,CYB5R2,51700,NM_001302826;NM_001302827;NM_016229
N4BP2_SIG,N4BP2,N4BP2_SIG,N4BP2,SIG,48,5.78374384319623,0.239073716204653,0.225632122139777,0.283238953846388,0.0576068317066111,1.01385309511526e-07,4.03789657480633,6.01004951366734,5.93383183582541,6.26047902657653,0.326647190751123,0.000502308012663058,ENSG00000078177,N4BP2,protein_coding,4,1,40056850,40158252,p14,NEDD4 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:29851],NA,N4BP2,55728,NM_001318359;NM_018177
MST1_SIG,MST1,MST1_SIG,MST1,SIG,25,5.78186535917914,-0.0294065628547896,-0.037588738366354,-0.00252227188822109,0.0350664664781329,1.02352760316904e-07,2.63940207539109,3.02360630759535,2.96393683209426,3.21966315567037,0.255726323576112,0.0256827076943853,ENSG00000173531,MST1,protein_coding,3,-1,49683947,49689501,p21.31,macrophage stimulating 1 [Source:HGNC Symbol;Acc:HGNC:7380],Primary sclerosing cholangitis,MST1,4485,NM_020998
PLAGL1_TF,PLAGL1,PLAGL1_TF,PLAGL1,TF,98,5.77992111781811,0.130115337157675,0.111891776606496,0.18999275039726,0.0781009737907637,1.03369771129297e-07,4.14314885332555,5.81568681937924,5.72103531100843,6.12668463259762,0.405649321589189,0.000350347432435521,ENSG00000118495,PLAGL1,protein_coding,6,-1,143940300,144064599,q24.2,PLAG1 like zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:9046],DIABETES MELLITUS TRANSIENT NEONATAL 1;Paternal uniparental disomy of chromosome 6;Transient neonatal diabetes mellitus,PLAGL1,5325,NM_001080951;NM_001080952;NM_001080953;NM_001080954;NM_001080955;NM_001080956;NM_001289037;NM_001289038;NM_001289039;NM_001289040;NM_001289041;NM_001289042;NM_001289043;NM_001289044;NM_001289045;NM_001289046;NM_001289047;NM_001289048;NM_001289049;NM_001317156;NM_001317157;NM_001317158;NM_001317159;NM_001317160;NM_001317161;NM_001317162;NM_006718
PNPLA7_SIG,PNPLA7,PNPLA7_SIG,PNPLA7,SIG,101,5.77661536601006,0.10025359337721,0.0873874467459083,0.142528075165773,0.0551406284198649,1.05244698837606e-07,5.1516489194704,3.66555949673081,3.5277799453355,4.11826373702967,0.590483791694167,7.71813092207436e-06,ENSG00000130653,PNPLA7,protein_coding,9,-1,137459952,137550402,q34.3,patatin like phospholipase domain containing 7 [Source:HGNC Symbol;Acc:HGNC:24768],NA,PNPLA7,375775,NM_001098537;NM_152286
TTN_SIG,TTN,TTN_SIG,TTN,SIG,18,-5.77152556627892,-0.0880074680355774,-0.0762902451245183,-0.126506914743343,-0.0502166696188248,1.08183628073532e-07,-4.10292717462379,2.32880530519182,2.46829979600456,1.87046626394999,-0.597833532054564,0.00040209253670794,ENSG00000155657,TTN,protein_coding,2,-1,178525989,178830802,q31.2,titin [Source:HGNC Symbol;Acc:HGNC:12403],Autosomal recessive centronuclear myopathy;Autosomal recessive limb-girdle muscular dystrophy type 2J;CARDIOMYOPATHY DILATED 1G;CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 9;CAUSE OF EARLY-ONSET MYOPATHY WITH FATAL CARDIOMYOPATHY;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Classic multiminicore myopathy;Early-onset myopathy with fatal cardiomyopathy;Familial isolated arrhythmogenic ventricular dysplasia biventricular form;Familial isolated arrhythmogenic ventricular dysplasia left dominant form;Familial isolated arrhythmogenic ventricular dysplasia right dominant form;Familial isolated dilated cardiomyopathy;Hereditary Myopathy with Early Respiratory Failure;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 10;SALIH MYOPATHY;Tibial muscular dystrophy;TIBIAL MUSCULAR DYSTROPHY TARDIVE,TTN,7273,NM_001256850;NM_001267550;NM_003319;NM_133378;NM_133379;NM_133432;NM_133437
PLA2R1_SIG,PLA2R1,PLA2R1_SIG,PLA2R1,SIG,41,5.77141678148243,-0.131066126189798,-0.139751817301584,-0.102527426822502,0.0372243904790813,1.08183628073532e-07,3.52692673632485,0.503628989667802,0.442494762239232,0.704498594075961,0.262003831836729,0.00249256999658607,ENSG00000153246,PLA2R1,protein_coding,2,-1,159932006,160062615,q24.2,phospholipase A2 receptor 1 [Source:HGNC Symbol;Acc:HGNC:9042],NA,PLA2R1,22925,NM_001007267;NM_001195641;NM_007366
SLC22A23_SIG,SLC22A23,SLC22A23_SIG,SLC22A23,SIG,50,-5.76920342408962,-0.199304301176576,-0.181938898337111,-0.256362053363389,-0.0744231550262784,1.09432228883322e-07,-4.9251573445537,1.52084277853206,1.68670854032689,0.975855275491898,-0.710853264834991,1.92306474175985e-05,ENSG00000137266,SLC22A23,protein_coding,6,-1,3268962,3457022,p25.2,solute carrier family 22 member 23 [Source:HGNC Symbol;Acc:HGNC:21106],NA,SLC22A23,63027,NM_001286455;NM_001286456;NM_015482;NM_021945
CACTIN_SIG,CACTIN,CACTIN_SIG,CACTIN,SIG,46,5.76784626096295,0.267002301411416,0.256283870332605,0.302220003527508,0.0459361331949028,1.09972247857253e-07,5.06643456765654,5.08778446873621,5.03615551806324,5.25742244951882,0.22126693145558,1.07385823661764e-05,ENSG00000105298,CACTIN,protein_coding,19,-1,3610645,3626815,p13.3,cactin, spliceosome C complex subunit [Source:HGNC Symbol;Acc:HGNC:29938],NA,CACTIN,58509,NM_001080543;NM_021231
FTCDNL1_SIG,FTCDNL1,FTCDNL1_SIG,FTCDNL1,SIG,14,5.76781555555301,0.0581449501881696,0.0449549094155722,0.101483655583847,0.0565287461682749,1.09972247857253e-07,4.1389421492676,1.60841995019926,1.53312993117323,1.85580144128477,0.32267151011154,0.000355717787544717,ENSG00000226124,FTCDNL1,protein_coding,2,-1,199760544,199851173,q33.1,formiminotransferase cyclodeaminase N-terminal like [Source:HGNC Symbol;Acc:HGNC:48661],NA,FTCDNL1,348751,NM_001350853;NM_001350854;NM_001350855
ZNF620_TF,ZNF620,ZNF620_TF,ZNF620,TF,86,5.75780821059992,0.124261421738917,0.109523936673737,0.172684586953078,0.063160650279341,1.16500074464935e-07,5.12137265753539,2.12482544469107,2.03609341125152,2.41637355456386,0.380280143312338,8.68033630793078e-06,ENSG00000177842,ZNF620,protein_coding,3,1,40477131,40518736,p22.1,zinc finger protein 620 [Source:HGNC Symbol;Acc:HGNC:28742],NA,ZNF620,253639,NM_001256167;NM_001256168;NM_175888
RNF112_SIG,RNF112,RNF112_SIG,RNF112,SIG,19,-5.75740076563053,-0.066491329081414,-0.0534126736645903,-0.109464054022406,-0.0560513803578159,1.16589129705024e-07,-3.94109917266745,0.451656120530358,0.49867730969189,0.29715792757104,-0.201519382120849,0.000688327047775762,ENSG00000128482,RNF112,protein_coding,17,1,19411125,19417276,p11.2,ring finger protein 112 [Source:HGNC Symbol;Acc:HGNC:12968],NA,RNF112,7732,NM_007148
NF1_SIG,NF1,NF1_SIG,NF1,SIG,34,5.75658865500917,0.419425806446576,0.407292843955933,0.459291254630119,0.0519984106741855,1.16958465943482e-07,3.77024230989008,6.27732761707031,6.21391793463008,6.48567371651677,0.271755781886686,0.00117914026597072,ENSG00000196712,NF1,protein_coding,17,1,31094927,31382116,q11.2,neurofibromin 1 [Source:HGNC Symbol;Acc:HGNC:7765],17q11 microdeletion syndrome;17q11.2 microduplication syndrome;Familial spinal neurofibromatosis;Juvenile myelomonocytic leukemia;Neurofibromatosis-Noonan syndrome;NEUROFIBROMATOSIS FAMILIAL SPINAL;NEUROFIBROMATOSIS TYPE 1;Neurofibromatosis type 1 due to NF1mutation or intragenic deletion;NEUROFIBROMATOSIS TYPE I;WATSON SYNDROME,NF1,4763,NM_000267;NM_001042492;NM_001128147
KCNMA1_SIG,KCNMA1,KCNMA1_SIG,KCNMA1,SIG,24,-5.75380516100446,-0.204660314267003,-0.193960680839676,-0.239816252671077,-0.0458555718314012,1.18706389754844e-07,-3.21149732644054,0.629207915349091,0.702783631406671,0.387459134017044,-0.315324497389626,0.00615788485784359,ENSG00000156113,KCNMA1,protein_coding,10,-1,76869601,77638369,q22.3,potassium calcium-activated channel subfamily M alpha 1 [Source:HGNC Symbol;Acc:HGNC:6284],CEREBELLAR ATROPHY DEVELOPMENTAL DELAY AND SEIZURES;Generalized epilepsy-paroxysmal dyskinesia syndrome;GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA;PAROXYSMAL NONKINESIGENIC DYSKINESIA 3 WITH OR WITHOUT GENERALIZED EPILEPSY,KCNMA1,3778,NM_001014797;NM_001161352;NM_001161353;NM_001271518;NM_001271519;NM_001271520;NM_001271521;NM_001271522;NM_001322829;NM_001322830;NM_001322832;NM_001322835;NM_001322836;NM_001322837;NM_001322838;NM_001322839;NM_002247
ZBTB3_TF,ZBTB3,ZBTB3_TF,ZBTB3,TF,28,5.75288261885526,0.083683908231179,0.0689115429752812,0.132221679786272,0.0633101368109906,1.19160581927719e-07,5.9567426154639,2.46769815868522,2.36997742118371,2.78878058190447,0.418803160720767,1.79155573198487e-07,ENSG00000185670,ZBTB3,protein_coding,11,-1,62748319,62754160,q12.3,zinc finger and BTB domain containing 3 [Source:HGNC Symbol;Acc:HGNC:22918],NA,ZBTB3,79842,NM_001363108;NM_001363109;NM_024784
JDP2_TF,JDP2,JDP2_TF,JDP2,TF,193,-5.7486443246569,0.18637687597971,0.204750434229332,0.126006613159526,-0.0787438210698059,1.21985894597431e-07,-2.77092773862865,5.54555502549914,5.6265533166238,5.27941778323241,-0.347135533391391,0.0189337868508403,ENSG00000140044,JDP2,protein_coding,14,1,75427716,75474111,q24.3,Jun dimerization protein 2 [Source:HGNC Symbol;Acc:HGNC:17546],NA,JDP2,122953,NM_001135047;NM_001135048;NM_001135049;NM_130469
ZSCAN21_TF,ZSCAN21,ZSCAN21_TF,ZSCAN21,TF,43,5.74575182635856,0.144001637433305,0.12757483397725,0.197975420217485,0.0704005862402351,1.23887076153715e-07,4.14461646823799,2.97979327993312,2.90855870695057,3.21384973401864,0.30529102706807,0.000348579587718508,ENSG00000166529,ZSCAN21,protein_coding,7,1,100049774,100065038,q22.1,zinc finger and SCAN domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13104],NA,ZSCAN21,7589,NM_001362779;NM_001362780;NM_001362781;NM_145914
TRIT1_SIG,TRIT1,TRIT1_SIG,TRIT1,SIG,10,5.73978889061816,0.276263989099749,0.263137109477274,0.319395165002165,0.0562580555248912,1.28088661249146e-07,5.04148858260796,4.01995613747756,3.94360213044778,4.27083358914681,0.327231458699026,1.20284697764035e-05,ENSG00000043514,TRIT1,protein_coding,1,-1,39838110,39883511,p34.2,tRNA isopentenyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:20286],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35;tRNA isopentenyltransferase deficiency,TRIT1,54802,NM_001312691;NM_001312692;NM_017646
MTHFR_SIG,MTHFR,MTHFR_SIG,MTHFR,SIG,32,-5.73955384623881,0.172129952463138,0.181607611316,0.140989073375163,-0.0406185379408366,1.28088661249146e-07,-3.64958140843575,5.72008592598732,5.77323149563003,5.54546476858984,-0.227766727040191,0.0017133815609374,ENSG00000177000,MTHFR,protein_coding,1,-1,11785723,11806920,p36.22,methylenetetrahydrofolate reductase [Source:HGNC Symbol;Acc:HGNC:7436],Cervical spina bifida aperta;Cervical spina bifida cystica;Cervicothoracic spina bifida aperta;Cervicothoracic spina bifida cystica;HOMOCYSTINURIA DUE TO DEFICIENCY OF N(510)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;Homocystinuria due to methylenetetrahydrofolate reductase deficiency;Isolated anencephaly/exencephaly;Lumbosacral spina bifida aperta;Lumbosacral spina bifida cystica;Methotrexate toxicity or dose selection;Methylenetetrahydrofolate reductase deficiency;Neural tube defects folate-sensitive;Schizophrenia;Thoracolumbosacral spina bifida aperta;Thoracolumbosacral spina bifida cystica;THROMBOPHILIA DUE TO THROMBIN DEFECT;Total spina bifida aperta;Total spina bifida cystica;Upper thoracic spina bifida aperta;Upper thoracic spina bifida cystica,MTHFR,4524,NM_001330358;NM_005957
CCL5_SIG,CCL5,CCL5_SIG,CCL5,SIG,18,-5.73923323410866,-0.0226398154211369,-0.00956082863144712,-0.0656136291586892,-0.056052800527242,1.28122695567959e-07,-3.55131256274043,5.34833300002657,5.47465549293059,4.93327338048482,-0.541382112445768,0.00231688524483672,ENSG00000271503,CCL5,protein_coding,17,-1,35871491,35880793,q12,C-C motif chemokine ligand 5 [Source:HGNC Symbol;Acc:HGNC:10632],NA,CCL5,6352,NM_001278736;NM_002985
OXTR_SIG,OXTR,OXTR_SIG,OXTR,SIG,5,5.73734884275201,0.0501406640131591,0.0359758358761788,0.0966822421775229,0.060706406301344,1.29230987294005e-07,4.96463292494111,0.71913610691301,0.658672434932048,0.917802457707599,0.259130022775552,1.63877758898147e-05,ENSG00000180914,OXTR,protein_coding,3,-1,8750408,8769628,p25.3,oxytocin receptor [Source:HGNC Symbol;Acc:HGNC:8529],NA,OXTR,5021,NM_000916;NM_001354653;NM_001354654;NM_001354655;NM_001354656
ATOH8_TF,ATOH8,ATOH8_TF,ATOH8,TF,130,-5.73722420196968,0.025691850230989,0.0402323549223055,-0.0220840937547652,-0.0623164486770706,1.29230987294005e-07,-3.50854111758329,0.499842917465946,0.549305278145818,0.337323732374939,-0.211981545770878,0.00263838543043462,ENSG00000168874,ATOH8,protein_coding,2,1,85751344,85791383,p11.2,atonal bHLH transcription factor 8 [Source:HGNC Symbol;Acc:HGNC:24126],NA,ATOH8,84913,NM_032827
RBMS3_SIG,RBMS3,RBMS3_SIG,RBMS3,SIG,27,-5.73629025588055,-0.141440671537394,-0.131429576894946,-0.174334268219722,-0.0429046913247763,1.29531406464279e-07,-2.46712183736693,0.433775093287746,0.479346626124547,0.284040056823972,-0.195306569300575,0.0379379085777684,ENSG00000144642,RBMS3,protein_coding,3,1,28574791,30010391,p24.1,RNA binding motif single stranded interacting protein 3 [Source:HGNC Symbol;Acc:HGNC:13427],NA,RBMS3,27303,NM_001003792;NM_001003793;NM_001177711;NM_001177712;NM_001330696;NM_014483
CPS1_SIG,CPS1,CPS1_SIG,CPS1,SIG,36,-5.73628241835575,-0.148683576340965,-0.141036420929445,-0.173809944121675,-0.0327735231922301,1.29531406464279e-07,-2.18883543326546,0.379900903575842,0.419382582608875,0.250175386753019,-0.169207195855855,0.0678582511015235,ENSG00000021826,CPS1,protein_coding,2,1,210477682,210679107,q34,carbamoyl-phosphate synthase 1 [Source:HGNC Symbol;Acc:HGNC:2323],CARBAMOYL PHOSPHATE SYNTHETASE 1 DEFICIENCY;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY HYPERAMMONEMIA DUE TO;PULMONARY HYPERTENSION NEONATAL SUSCEPTIBILITY TO,CPS1,1373,NM_001122633;NM_001122634;NM_001875
ATP7B_SIG,ATP7B,ATP7B_SIG,ATP7B,SIG,49,5.73590086175141,0.00425824565230458,-0.00918692434278493,0.0484352327790273,0.0576221571218121,1.29613998660171e-07,4.42572232406763,2.77027953369383,2.60392748533845,3.31686483543297,0.712937350094525,0.000129887265138917,ENSG00000123191,ATP7B,protein_coding,13,-1,51930436,52012125,q14.3,ATPase copper transporting beta [Source:HGNC Symbol;Acc:HGNC:870],WILSON DISEASE,ATP7B,540,NM_000053;NM_001005918;NM_001243182;NM_001330578;NM_001330579
ZDHHC14_TF,ZDHHC14,ZDHHC14_TF,ZDHHC14,TF,147,5.732764771532,0.128838978904818,0.12057391524854,0.15599561663259,0.0354217013840504,1.31821716069923e-07,4.15694816659676,3.58360258378992,3.48583366718033,3.90484330979286,0.419009642612529,0.000333909790729604,ENSG00000175048,ZDHHC14,protein_coding,6,1,157381133,157678157,q25.3,zinc finger DHHC-type containing 14 [Source:HGNC Symbol;Acc:HGNC:20341],NA,ZDHHC14,79683,NM_024630;NM_153746
ZNF846_TF,ZNF846,ZNF846_TF,ZNF846,TF,98,5.73191149045167,0.117020820169091,0.103247625920454,0.162275601271757,0.059027975351303,1.32222632711689e-07,4.19601799375649,3.31951487628192,3.25135627975165,3.54346455059564,0.292108270843984,0.000292211059357084,ENSG00000196605,ZNF846,protein_coding,19,-1,9751993,9793180,p13.2,zinc finger protein 846 [Source:HGNC Symbol;Acc:HGNC:27260],NA,ZNF846,162993,NM_001077624;NM_001353798;NM_001353799;NM_001353800
ADAMTS13_SIG,ADAMTS13,ADAMTS13_SIG,ADAMTS13,SIG,64,5.73170461330431,0.00627487264920381,-0.00639688380317588,0.0479106438498799,0.0543075276530557,1.32222632711689e-07,3.46735516407511,1.73742725292962,1.67409289307505,1.94552586388034,0.271432970805293,0.00296743757555219,ENSG00000160323,ADAMTS13,protein_coding,9,1,133414358,133459402,q34.2,ADAM metallopeptidase with thrombospondin type 1 motif 13 [Source:HGNC Symbol;Acc:HGNC:1366],Congenital thrombotic thrombocytopenic purpura;THROMBOTIC THROMBOCYTOPENIC PURPURA CONGENITAL,ADAMTS13,11093,NM_139025;NM_139026;NM_139027
SCN5A_SIG,SCN5A,SCN5A_SIG,SCN5A,SIG,9,-5.73100441906792,-0.152126603933051,-0.136909865043851,-0.20212446028328,-0.0652145952394291,1.32556900157517e-07,-2.57136558737082,0.460669906958998,0.521916664615387,0.259430560373722,-0.262486104241665,0.0300513112773831,ENSG00000183873,SCN5A,protein_coding,3,-1,38548057,38649673,p22.2,sodium voltage-gated channel alpha subunit 5 [Source:HGNC Symbol;Acc:HGNC:10593],ATRIAL FIBRILLATION FAMILIAL 10;Atrial standstill;Brugada syndrome;BRUGADA SYNDROME 1;CARDIOMYOPATHY DILATED 1E;Familial atrial fibrillation;Familial isolated dilated cardiomyopathy;Familial progressive cardiac conduction defect;Familial sick sinus syndrome;Idiopathic ventricular fibrillation non Brugada type;LONG QT SYNDROME 3;PROGRESSIVE FAMILIAL HEART BLOCK TYPE IA;Romano-Ward syndrome;Sick sinus syndrome 1;SUDDEN INFANT DEATH SYNDROME;VENTRICULAR FIBRILLATION PAROXYSMAL FAMILIAL 1,SCN5A,6331,NM_000335;NM_001099404;NM_001099405;NM_001160160;NM_001160161;NM_001354701;NM_198056
SUPT4H1_TF,SUPT4H1,SUPT4H1_TF,SUPT4H1,TF,42,-5.72527779806536,0.0371762297904746,0.0432776478567521,0.0171287132869914,-0.0261489345697607,1.36887585336665e-07,-3.62015512364513,6.45633037105974,6.48903863365887,6.34886036537689,-0.140178268281985,0.00187763663511969,ENSG00000213246,SUPT4H1,protein_coding,17,-1,58345175,58353093,q22,SPT4 homolog, DSIF elongation factor subunit [Source:HGNC Symbol;Acc:HGNC:11467],NA,SUPT4H1,6827,NM_003168
CNTNAP2_SIG,CNTNAP2,CNTNAP2_SIG,CNTNAP2,SIG,25,-5.71975143198258,-0.174362090051844,-0.165426448888029,-0.203722053875807,-0.0382956049877777,1.41189108899466e-07,-2.37006368123363,0.692639181318726,0.758528249862478,0.476146527532113,-0.282381722330365,0.0467383821514228,ENSG00000174469,CNTNAP2,protein_coding,7,1,146116002,148420998,q35,contactin associated protein like 2 [Source:HGNC Symbol;Acc:HGNC:13830],AUTISM SUSCEPTIBILITY TO 15;Cortical dysplasia-focal epilepsy syndrome;Pitt-Hopkins-like syndrome;Pitt-Hopkins-like syndrome 1,CNTNAP2,26047,NM_014141
ZBTB26_TF,ZBTB26,ZBTB26_TF,ZBTB26,TF,139,5.71798110417207,0.200811753288104,0.186311109341978,0.248456726253946,0.0621456169119677,1.42440062773288e-07,4.8686969013987,4.30934398821247,4.21496502964568,4.61944628064621,0.404481251000532,2.43630570326735e-05,ENSG00000171448,ZBTB26,protein_coding,9,-1,122915566,122931512,q33.2,zinc finger and BTB domain containing 26 [Source:HGNC Symbol;Acc:HGNC:23383],NA,ZBTB26,57684,NM_001304363;NM_001304364;NM_020924
ZNF469_TF,ZNF469,ZNF469_TF,ZNF469,TF,25,5.71766520494463,0.191017086712118,0.185814821065827,0.208110245264217,0.0222954241983904,1.42477803545495e-07,2.54017122549271,3.52959150902911,3.44763616907912,3.79887334029335,0.351237171214227,0.0323567612855215,ENSG00000225614,ZNF469,protein_coding,16,1,88427471,88440757,q24.2,zinc finger protein 469 [Source:HGNC Symbol;Acc:HGNC:23216],Brittle cornea syndrome;BRITTLE CORNEA SYNDROME 1,ZNF469,84627,NM_001127464;NM_001367624
SLC18A2_SIG,SLC18A2,SLC18A2_SIG,SLC18A2,SIG,89,-5.71679496658057,-0.0837009312536678,-0.0717873094252531,-0.122845688689888,-0.0510583792646345,1.42981400871548e-07,-4.95994739284704,1.76216764819827,1.99443201418147,0.99901330282492,-0.995418711356547,1.67042403314269e-05,ENSG00000165646,SLC18A2,protein_coding,10,1,117241073,117279430,q25.3,solute carrier family 18 member A2 [Source:HGNC Symbol;Acc:HGNC:10935],Brain dopamine-serotonin vesicular transport disease;PARKINSONISM-DYSTONIA INFANTILE 2,SLC18A2,6571,NM_003054
MAPK10_SIG,MAPK10,MAPK10_SIG,MAPK10,SIG,40,5.71645708709702,-0.0619540872816048,-0.0728900240566503,-0.0260217235921695,0.0468683004644809,1.43038449089199e-07,1.22882551910102,0.323030377609237,0.30583412854398,0.379532338823655,0.0736982102796753,0.324236865189289,ENSG00000109339,MAPK10,protein_coding,4,-1,85990007,86594625,q21.3,mitogen-activated protein kinase 10 [Source:HGNC Symbol;Acc:HGNC:6872],Epileptic encephalopathy Lennox-Gastaut type;Lennox-Gastaut syndrome,MAPK10,5602,NM_001318067;NM_001318068;NM_001318069;NM_001351624;NM_001351625;NM_002753;NM_138980;NM_138982
GPR84_SIG,GPR84,GPR84_SIG,GPR84,SIG,42,-5.71569858481777,0.338734285865768,0.37713911100647,0.212547003260606,-0.164592107745865,1.43450306688446e-07,-4.78275122673929,2.3099272177977,2.48988337061727,1.71864271567626,-0.771240654941008,3.41295850844235e-05,ENSG00000139572,GPR84,protein_coding,12,-1,54362445,54364487,q13.13,G protein-coupled receptor 84 [Source:HGNC Symbol;Acc:HGNC:4535],NA,GPR84,53831,NM_020370
ZNF605_TF,ZNF605,ZNF605_TF,ZNF605,TF,96,5.71495471868154,0.139736630002604,0.123113308322389,0.194356115523311,0.0712428072009221,1.43851249251366e-07,3.70258269880123,3.68785514595087,3.61511567371334,3.92685626901702,0.311740595303679,0.00145965131122522,ENSG00000196458,ZNF605,protein_coding,12,-1,132918306,132956306,q24.33,zinc finger protein 605 [Source:HGNC Symbol;Acc:HGNC:28068],NA,ZNF605,100289635,NM_001164715;NM_183238
NR1I2_SIG,NR1I2,NR1I2_SIG,NR1I2,SIG,35,5.71451224799215,0.0292004561192237,0.0113570557062692,0.0878287717617884,0.0764717160555191,1.43998175657833e-07,4.84990782345831,1.94008621720424,1.8033408320891,2.38939248258257,0.586051650493474,2.64517762234894e-05,ENSG00000144852,NR1I2,protein_coding,3,1,119780484,119818485,q13.33,nuclear receptor subfamily 1 group I member 2 [Source:HGNC Symbol;Acc:HGNC:7968],NA,NR1I2,8856,NM_003889;NM_022002;NM_033013
DGAT2_SIG,DGAT2,DGAT2_SIG,DGAT2,SIG,27,-5.71410475449367,0.0302567856775753,0.0659012004157425,-0.0868605770335455,-0.152761777449288,1.44075242417438e-07,-6.28787157524571,2.89103093984783,3.15146903741419,2.03530576212977,-1.11616327528442,3.38711627545917e-08,ENSG00000062282,DGAT2,protein_coding,11,1,75759512,75801535,q13.5,diacylglycerol O-acyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:16940],Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,DGAT2,84649,NM_001253891;NM_032564
GNPDA1_SIG,GNPDA1,GNPDA1_SIG,GNPDA1,SIG,54,-5.71388474267081,0.0691496119074186,0.0838792918126766,0.0207520922187139,-0.0631271995939626,1.44075242417438e-07,-4.41297019851504,4.0565281108276,4.19992439541958,3.5853688900254,-0.614555505394183,0.000136329450840911,ENSG00000113552,GNPDA1,protein_coding,5,-1,141991749,142013041,q31.3,glucosamine-6-phosphate deaminase 1 [Source:HGNC Symbol;Acc:HGNC:4417],NA,GNPDA1,10007,NM_005471
ZNF37A_TF,ZNF37A,ZNF37A_TF,ZNF37A,TF,66,5.71134382736221,0.209981088196193,0.19671287146706,0.253576657449059,0.0568637859819986,1.46013393187255e-07,3.10868393416165,5.195598004905,5.1410467709453,5.3748377736297,0.233791002684392,0.00813823634673006,ENSG00000075407,ZNF37A,protein_coding,10,1,38094334,38150293,p11.1,zinc finger protein 37A [Source:HGNC Symbol;Acc:HGNC:13102],NA,ZNF37A,7587,NM_001007094;NM_001178101;NM_001324245;NM_001324246;NM_001324247;NM_001324248;NM_001324249;NM_001324250;NM_001324251;NM_001324252;NM_001324253;NM_001324254;NM_001324256;NM_001324257;NM_001324258;NM_001324259;NM_001324260;NM_001324261;NM_001324262;NM_003421
PIK3CD_SIG,PIK3CD,PIK3CD_SIG,PIK3CD,SIG,47,-5.71080399505861,0.385426690157617,0.400359683721032,0.336361139877827,-0.0639985438432048,1.46081784188727e-07,-4.78658694345488,7.64829890303308,7.73079060744091,7.37725473140733,-0.353535876033586,3.3571076327065e-05,ENSG00000171608,PIK3CD,protein_coding,1,1,9651732,9729114,p36.22,phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [Source:HGNC Symbol;Acc:HGNC:8977],Activated PI3K-delta syndrome;Combined immunodeficiency with faciooculoskeletal anomalies;IMMUNODEFICIENCY 14,PIK3CD,5293,NM_001350234;NM_001350235;NM_005026
ZSCAN30_TF,ZSCAN30,ZSCAN30_TF,ZSCAN30,TF,208,5.71072988312696,0.0275697670588555,0.00953283780142658,0.0868339631904075,0.0773011253889808,1.46081784188727e-07,4.23613278700274,4.55126024413923,4.45538806816427,4.86626882234267,0.410880754178398,0.000254194175120614,ENSG00000186814,ZSCAN30,protein_coding,18,-1,35251058,35290245,q12.2,zinc finger and SCAN domain containing 30 [Source:HGNC Symbol;Acc:HGNC:33517],NA,ZSCAN30,100101467,NM_001112734;NM_001166012;NM_001288711
FXYD6_SIG,FXYD6,FXYD6_SIG,FXYD6,SIG,9,-5.70954683908745,0.461326770503084,0.498899261924182,0.337874298690907,-0.161024963233275,1.46870593457695e-07,-5.28651440507045,2.73033739881708,2.9286561452054,2.07871866068406,-0.849937484521338,4.21787559350621e-06,ENSG00000137726,FXYD6,protein_coding,11,-1,117836976,117877486,q23.3,FXYD domain containing ion transport regulator 6 [Source:HGNC Symbol;Acc:HGNC:4030],NA,FXYD6,53826,NM_001164831;NM_001164832;NM_001164836;NM_001164837;NM_022003
HSPG2_SIG,HSPG2,HSPG2_SIG,HSPG2,SIG,55,5.70756243814818,0.067779430913095,0.05204750319322,0.119470050564113,0.0674225473708927,1.48334684749865e-07,3.30230817625509,6.26184556391838,6.12068031893009,6.72567422602277,0.60499390709268,0.00478039834430492,ENSG00000142798,HSPG2,protein_coding,1,-1,21822244,21937310,p36.12,heparan sulfate proteoglycan 2 [Source:HGNC Symbol;Acc:HGNC:5273],Dyssegmental dysplasia Silverman-Handmaker type;DYSSEGMENTAL DYSPLASIA SILVERMAN-HANDMAKER TYPE;Schwartz-Jampel syndrome;Schwartz Jampel syndrome type 1,HSPG2,3339,NM_001291860;NM_005529
ACP6_SIG,ACP6,ACP6_SIG,ACP6,SIG,113,5.70732625119639,-0.0534792371847062,-0.0624241159433839,-0.0240889212633367,0.0383351946800474,1.48334684749865e-07,3.39060993669624,3.24780285462566,3.14738890217227,3.5777344126868,0.430345510514536,0.00371233153014599,ENSG00000162836,ACP6,protein_coding,1,-1,147629652,147670524,q21.2,acid phosphatase 6, lysophosphatidic [Source:HGNC Symbol;Acc:HGNC:29609],NA,ACP6,51205,NM_001323625;NM_016361
HP_SIG,HP,HP_SIG,HP,SIG,23,-5.70597672996628,0.307025259515989,0.353432778735691,0.154543410651254,-0.198889368084436,1.49211641787509e-07,-5.24196176484371,4.13103769954688,4.43359894596652,3.13690788988235,-1.29669105608417,5.11749460932419e-06,ENSG00000257017,HP,protein_coding,16,1,72054592,72061055,q22.2,haptoglobin [Source:HGNC Symbol;Acc:HGNC:5141],Anhaptoglobinemia,HP,3240,NM_001126102;NM_001318138;NM_005143
NFIA_TF,NFIA,NFIA_TF,NFIA,TF,243,-5.70579197439336,-0.119935955567274,-0.10982088053012,-0.153171202117921,-0.0433503215878005,1.49211641787509e-07,-3.8072512403561,2.10582087956559,2.27193808284875,1.56000721163523,-0.711930871213517,0.00105111515159994,ENSG00000162599,NFIA,protein_coding,1,1,60865259,61462788,p31.3,nuclear factor I A [Source:HGNC Symbol;Acc:HGNC:7784],1p31p32 microdeletion syndrome;BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS;Macrocephaly with intellectual disability,NFIA,4774,NM_001134673;NM_001145511;NM_001145512;NM_005595
MZF1_TF,MZF1,MZF1_TF,MZF1,TF,146,5.70381132271653,0.154039322768546,0.139429874801221,0.202041794661185,0.0626119198599646,1.5072236252603e-07,4.65973740724745,5.28818088725741,5.20459212162291,5.56282968862793,0.358237567005016,5.44464749476404e-05,ENSG00000099326,MZF1,protein_coding,19,-1,58561931,58573575,q13.43,myeloid zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13108],NA,MZF1,7593,NM_001267033;NM_003422;NM_198055
RBM45_SIG,RBM45,RBM45_SIG,RBM45,SIG,44,5.7034777095469,0.0585299001092758,0.0428956834134726,0.109899469252629,0.0670037858391568,1.50783654170914e-07,5.1129890938008,3.26457146664698,3.19950745734701,3.47835321148976,0.278845754142753,8.98464850520907e-06,ENSG00000155636,RBM45,protein_coding,2,1,178112424,178139011,q31.2,RNA binding motif protein 45 [Source:HGNC Symbol;Acc:HGNC:24468],NA,RBM45,129831,NM_001365579;NM_152945
ZNF48_TF,ZNF48,ZNF48_TF,ZNF48,TF,66,5.69928657484204,0.184463338387033,0.168346040667978,0.237420173749642,0.0690741330816635,1.54298297925827e-07,4.64878093392936,3.1450356366781,3.05572598015081,3.43848165098206,0.382755670831252,5.68630416760717e-05,ENSG00000180035,ZNF48,protein_coding,16,1,30378106,30400108,p11.2,zinc finger protein 48 [Source:HGNC Symbol;Acc:HGNC:13114],NA,ZNF48,197407,NM_001214906;NM_001214907;NM_001214909;NM_001324494;NM_152652
SETBP1_TF,SETBP1,SETBP1_TF,SETBP1,TF,365,-5.69887738080735,0.00576682103522942,0.0167372226288327,-0.0302787842008958,-0.0470160068297286,1.5442999799662e-07,-4.57616938267795,3.22880368201811,3.44557967411208,2.51653970799505,-0.929039966117031,7.53123493046815e-05,ENSG00000152217,SETBP1,protein_coding,18,1,44680173,45068510,q12.3,SET binding protein 1 [Source:HGNC Symbol;Acc:HGNC:15573],Developmental and expressive language delay;Intellectual disability-expressive aphasia-facial dysmorphism syndrome;MENTAL RETARDATION AUTOSOMAL DOMINANT 29;Schinzel-Giedion midface retraction syndrome;Schinzel-Giedion syndrome,SETBP1,26040,NM_001130110;NM_015559
PEX11A_SIG,PEX11A,PEX11A_SIG,PEX11A,SIG,47,5.69762272367614,-0.0026612868708052,-0.0225480520604028,0.0626809416093012,0.085228993669704,1.55330358174404e-07,6.23682748377566,1.7176014521779,1.58989229741561,2.13721724639682,0.547324948981209,4.28466220470018e-08,ENSG00000166821,PEX11A,protein_coding,15,-1,89677764,89690783,q26.1,peroxisomal biogenesis factor 11 alpha [Source:HGNC Symbol;Acc:HGNC:8852],NA,PEX11A,8800,NM_001271572;NM_001271573;NM_003847
ZNF891_TF,ZNF891,ZNF891_TF,ZNF891,TF,153,5.69666641400323,0.0601667188392657,0.0432412556185623,0.115778955135863,0.0725376995173006,1.55963067147803e-07,5.27552700102202,2.06014547002933,1.96106551236681,2.38569390234905,0.42462838998224,4.43913446569485e-06,ENSG00000214029,ZNF891,protein_coding,12,-1,133106817,133130473,q24.33,zinc finger protein 891 [Source:HGNC Symbol;Acc:HGNC:38709],NA,ZNF891,101060200,NM_001277291
DDX27_SIG,DDX27,DDX27_SIG,DDX27,SIG,21,5.69403752326891,0.407986236336524,0.3978215261159,0.441384569918576,0.0435630438026768,1.57966907299972e-07,5.29164136345908,6.41329771862443,6.36338523075443,6.57729589305442,0.21391066229999,4.13098514901958e-06,ENSG00000124228,DDX27,protein_coding,20,1,49219295,49244077,q13.13,DEAD-box helicase 27 [Source:HGNC Symbol;Acc:HGNC:15837],NA,DDX27,55661,NM_001348187;NM_017895
ZDBF2_TF,ZDBF2,ZDBF2_TF,ZDBF2,TF,158,-5.69396345188817,-0.123146699205478,-0.110969759375396,-0.163156644361464,-0.0521868849860679,1.57966907299972e-07,-4.14628005366236,1.45024658331834,1.57698963217208,1.03380513708464,-0.543184495087443,0.000346213096141186,ENSG00000204186,ZDBF2,protein_coding,2,1,206274663,206314427,q33.3,zinc finger DBF-type containing 2 [Source:HGNC Symbol;Acc:HGNC:29313],NA,ZDBF2,57683,NM_001285549;NM_020923
GJB6_SIG,GJB6,GJB6_SIG,GJB6,SIG,41,-5.69168327939806,-0.135032329672959,-0.11532128638764,-0.199797186181863,-0.0844758997942227,1.59845897973939e-07,-4.74093609285365,1.21771332640924,1.41244173914174,0.577891398859619,-0.834550340282119,4.00599322256452e-05,ENSG00000121742,GJB6,protein_coding,13,-1,20221962,20232365,q12.11,gap junction protein beta 6 [Source:HGNC Symbol;Acc:HGNC:4288],Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB;CLOUSTON SYNDROME;DEAFNESS AUTOSOMAL DOMINANT 3B;DEAFNESS AUTOSOMAL RECESSIVE 1A;DEAFNESS AUTOSOMAL RECESSIVE 1B;DEAFNESS X-LINKED 2;Hidrotic ectodermal dysplasia;KID syndrome,GJB6,10804,NM_001110219;NM_001110220;NM_001110221;NM_006783
INPP5E_SIG,INPP5E,INPP5E_SIG,INPP5E,SIG,50,5.69008325448644,0.18706426931416,0.173268621229053,0.232392827308084,0.0591242060790309,1.61103851392594e-07,4.43282912214567,4.37403263686907,4.30994998316718,4.58458992760385,0.274639944436672,0.000127030232839868,ENSG00000148384,INPP5E,protein_coding,9,-1,136428619,136439845,q34.3,inositol polyphosphate-5-phosphatase E [Source:HGNC Symbol;Acc:HGNC:21474],Joubert Syndrome;JOUBERT SYNDROME 1;JOUBERT SYNDROME TYPE 1;Joubert syndrome with hepatic defect;Joubert syndrome with ocular defect;MENTAL RETARDATION-TRUNCAL OBESITY-RETINAL DYSTROPHY-MICROPENIS;MENTAL RETARDATION TRUNCAL OBESITY RETINAL DYSTROPHY AND MICROPENISSYNDROME;MORM syndrome,INPP5E,56623,NM_001318502;NM_019892
HCN3_SIG,HCN3,HCN3_SIG,HCN3,SIG,24,5.68919731047475,0.145320171126863,0.128874827019617,0.199354873193528,0.070480046173911,1.6162035299586e-07,5.22369436874753,2.20377508087686,2.10748295546931,2.52016349293025,0.412680537460938,5.56730111494911e-06,ENSG00000143630,HCN3,protein_coding,1,1,155277463,155289848,q22,hyperpolarization activated cyclic nucleotide gated potassium channel 3 [Source:HGNC Symbol;Acc:HGNC:19183],NA,HCN3,57657,NM_020897
DHRS11_SIG,DHRS11,DHRS11_SIG,DHRS11,SIG,60,5.68901440582955,0.0598821277518514,0.0420553892917375,0.11845569697794,0.0764003076862025,1.6162035299586e-07,4.93631607873846,3.40205282032766,3.27268271093525,3.82712603690271,0.554443325967454,1.84018244540285e-05,ENSG00000278535,DHRS11,protein_coding,17,1,36591879,36600804,q12,dehydrogenase/reductase 11 [Source:HGNC Symbol;Acc:HGNC:28639],NA,DHRS11,79154,NM_024308
BCL6_TF,BCL6,BCL6_TF,BCL6,TF,397,-5.68868244759195,0.0943620669626742,0.118404520421713,0.0153654341686892,-0.103039086253024,1.61687942346535e-07,-5.42729350274518,6.5888520477934,6.81419272924062,5.84844695160968,-0.965745777630936,2.26450430614394e-06,ENSG00000113916,BCL6,protein_coding,3,-1,187721377,187745725,q27.3,BCL6, transcription repressor [Source:HGNC Symbol;Acc:HGNC:1001],Follicular lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Intravascular large B-cell lymphoma;Primary mediastinal large B-cell lymphoma,BCL6,604,NM_001130845;NM_001134738;NM_001706
DENR_SIG,DENR,DENR_SIG,DENR,SIG,52,5.68728324581036,0.434611365221486,0.418457870133646,0.487687134795816,0.06922926466217,1.62769700034075e-07,4.73917464760508,6.2839202303589,6.21953003418762,6.49548801777881,0.275957983591188,4.03356708113763e-05,ENSG00000139726,DENR,protein_coding,12,1,122752824,122771064,q24.31,density regulated re-initiation and release factor [Source:HGNC Symbol;Acc:HGNC:2769],NA,DENR,8562,NM_003677
TNFRSF18_SIG,TNFRSF18,TNFRSF18_SIG,TNFRSF18,SIG,53,5.68175394948777,0.043247953628794,0.0314669843164557,0.0819568527979054,0.0504898684814499,1.67866149974195e-07,5.64691986657755,1.5456694482985,1.35490221907159,2.17247605861548,0.817573839543888,8.30306597970319e-07,ENSG00000186891,TNFRSF18,protein_coding,1,-1,1203508,1206592,p36.33,TNF receptor superfamily member 18 [Source:HGNC Symbol;Acc:HGNC:11914],NA,TNFRSF18,8784,NM_004195;NM_148901;NM_148902
LPGAT1_SIG,LPGAT1,LPGAT1_SIG,LPGAT1,SIG,22,-5.67473040838106,0.480773692937555,0.501456619972764,0.412815504107582,-0.0886411158651815,1.74635276399545e-07,-6.37632656455216,6.89219198451394,6.99732326707758,6.54676062751914,-0.450562639558433,2.12083673968271e-08,ENSG00000123684,LPGAT1,protein_coding,1,-1,211743457,211830763,q32.3,lysophosphatidylglycerol acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:28985],NA,LPGAT1,9926,NM_001320808;NM_014873
CHI3L1_SIG,CHI3L1,CHI3L1_SIG,CHI3L1,SIG,7,-5.67413101814803,-0.00101690567114346,0.0639322165679193,-0.214421164456635,-0.278353381024555,1.74982237249974e-07,-4.45425686042198,3.75020044425263,4.04662972921676,2.77621850794194,-1.27041122127482,0.000117298116908397,ENSG00000133048,CHI3L1,protein_coding,1,-1,203178931,203186704,q32.1,chitinase 3 like 1 [Source:HGNC Symbol;Acc:HGNC:1932],ASTHMA-RELATED TRAITS SUSCEPTIBILITY TO 7;Schizophrenia,CHI3L1,1116,NM_001276
MAPK15_SIG,MAPK15,MAPK15_SIG,MAPK15,SIG,45,5.67215680230978,-0.00212844106353326,-0.0103714965098106,0.0249558839742351,0.0353273804840457,1.76743512359073e-07,3.10765368685247,0.608543801921395,0.540368986576442,0.832546766626238,0.292177780049796,0.00815793990036758,ENSG00000181085,MAPK15,protein_coding,8,1,143716340,143722458,q24.3,mitogen-activated protein kinase 15 [Source:HGNC Symbol;Acc:HGNC:24667],NA,MAPK15,225689,NM_139021
ZNF785_TF,ZNF785,ZNF785_TF,ZNF785,TF,302,5.67161422484208,0.132480818397414,0.114246711102412,0.192392885223849,0.0781461741214371,1.77036476354065e-07,5.35940475295805,3.81809085068168,3.69118867212468,4.23505515165467,0.543866479529993,3.0703643843435e-06,ENSG00000197162,ZNF785,protein_coding,16,-1,30573740,30585771,p11.2,zinc finger protein 785 [Source:HGNC Symbol;Acc:HGNC:26496],NA,ZNF785,146540,NM_152458
MBLAC1_SIG,MBLAC1,MBLAC1_SIG,MBLAC1,SIG,6,5.67036514695771,-0.106463747008668,-0.117560896815059,-0.0700016833590973,0.0475592134559616,1.78063134147203e-07,3.65204263083501,0.892483701661383,0.866438111687324,0.978062068719005,0.111623957031681,0.00170209626474715,ENSG00000214309,MBLAC1,protein_coding,7,1,100126785,100128495,q22.1,metallo-beta-lactamase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:22180],NA,MBLAC1,255374,NM_203397
SLC39A10_SIG,SLC39A10,SLC39A10_SIG,SLC39A10,SIG,57,5.66694739446274,0.385162642874965,0.372197269072964,0.427763156795826,0.0555658877228611,1.81178470417564e-07,4.20316476314197,4.93815095094991,4.84369946443718,5.24849154949173,0.404792085054543,0.000284876806758877,ENSG00000196950,SLC39A10,protein_coding,2,1,195575977,195737702,q32.3,solute carrier family 39 member 10 [Source:HGNC Symbol;Acc:HGNC:20861],NA,SLC39A10,57181,NM_001127257;NM_020342
TRPS1_TF,TRPS1,TRPS1_TF,TRPS1,TF,143,-5.66687673780914,0.116787210116501,0.126789727848567,0.0839217947111412,-0.0428679331374258,1.81178470417564e-07,-3.20586817536763,4.57409888437943,4.71782279247158,4.10186318636236,-0.615959606109221,0.00624803749444437,ENSG00000104447,TRPS1,protein_coding,8,-1,115408496,115809673,q23.3,transcriptional repressor GATA binding 1 [Source:HGNC Symbol;Acc:HGNC:12340],TRICHO-RHINO-PHALANGEAL SYNDROME TYPE 1;Trichorhinophalangeal syndrome type 1 and 3;Trichorhinophalangeal syndrome type 2;TRICHORHINOPHALANGEAL SYNDROME TYPE I;TRICHORHINOPHALANGEAL SYNDROME TYPE III,TRPS1,7227,NM_001282902;NM_001282903;NM_001330599;NM_014112
HSD17B1_SIG,HSD17B1,HSD17B1_SIG,HSD17B1,SIG,21,5.66510835421326,0.106417633713181,0.0907037730960896,0.158048890026479,0.0673451169303899,1.82609039677505e-07,2.59396007992917,1.29679017198466,1.25632912426412,1.42973361449502,0.173404490230898,0.0285846638988483,ENSG00000108786,HSD17B1,protein_coding,17,1,42549214,42555213,q21.2,hydroxysteroid 17-beta dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:5210],NA,HSD17B1,3292,NM_000413;NM_001330219
ORM1_SIG,ORM1,ORM1_SIG,ORM1,SIG,10,-5.66478243589226,0.125931844293589,0.195904015488537,-0.103976718204095,-0.299880733692631,1.82609039677505e-07,-3.98042758680361,2.00282476392301,2.19899336703463,1.35827078227055,-0.840722584764081,0.000604226776983583,ENSG00000229314,ORM1,protein_coding,9,1,114323056,114326475,q32,orosomucoid 1 [Source:HGNC Symbol;Acc:HGNC:8498],NA,ORM1,5004,NM_000607
YES1_SIG,YES1,YES1_SIG,YES1,SIG,55,5.66475662411278,0.0346636499141716,0.0167123839088409,0.0936463810745439,0.0769339971657029,1.82609039677505e-07,4.50159183397266,3.85154299908112,3.68027867323235,4.41426864115567,0.733989967923327,9.82317413285832e-05,ENSG00000176105,YES1,protein_coding,18,-1,721588,812546,p11.32,YES proto-oncogene 1, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:12841],NA,YES1,7525,NM_005433
MGAM_SIG,MGAM,MGAM_SIG,MGAM,SIG,28,-5.66370493552091,0.396220217555612,0.450383641356512,0.218254682209795,-0.232128959146717,1.83457708572032e-07,-5.29177047084875,5.3135565381723,5.61667358300977,4.31760053370632,-1.29907304930346,4.13098514901958e-06,ENSG00000257335,MGAM,protein_coding,7,1,141907813,142106747,q34,maltase-glucoamylase [Source:HGNC Symbol;Acc:HGNC:7043],NA,MGAM,8972,NM_001365693;NM_004668
ITGB4_SIG,ITGB4,ITGB4_SIG,ITGB4,SIG,44,-5.65700249329706,-0.0587962014631791,-0.0501658482781444,-0.0871530762140076,-0.0369872279358631,1.90233607490769e-07,-4.16513280256231,1.7970503129456,1.92600048002056,1.37335690684217,-0.552643573178392,0.000324336868023555,ENSG00000132470,ITGB4,protein_coding,17,1,75721328,75757818,q25.1,integrin subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:6158],EPIDERMOLYSIS BULLOSA JUNCTIONAL NON-HERLITZ TYPE;EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;EPIDERMOLYSIS BULLOSA SIMPLEX LOCALIZED;EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA;Junctional epidermolysis bullosa-pyloric atresia syndrome;Junctional epidermolysis bullosa generalized intermediate;Localized junctional epidermolysis bullosa non-Herlitz type,ITGB4,3691,NM_000213;NM_001005619;NM_001005731;NM_001321123
ADAM19_SIG,ADAM19,ADAM19_SIG,ADAM19,SIG,23,-5.65696885827264,0.107010175118561,0.12972007393695,0.0323919361438537,-0.0973281377930963,1.90233607490769e-07,-2.6625921350771,3.92245218205052,4.02674721209324,3.57976851191014,-0.446978700183104,0.0243980648120559,ENSG00000135074,ADAM19,protein_coding,5,-1,157395534,157575775,q33.3,ADAM metallopeptidase domain 19 [Source:HGNC Symbol;Acc:HGNC:197],NA,ADAM19,8728,NM_033274
GPR160_SIG,GPR160,GPR160_SIG,GPR160,SIG,44,-5.65150007209281,0.149819180235646,0.178315749731383,0.0561875947496526,-0.122128154981731,1.96095126275089e-07,-5.26874459811722,4.63461998843014,4.82147375998964,4.0206718818775,-0.800801878112141,4.56606774134049e-06,ENSG00000173890,GPR160,protein_coding,3,1,170037995,170085392,q26.2,G protein-coupled receptor 160 [Source:HGNC Symbol;Acc:HGNC:23693],NA,GPR160,26996,NM_014373
PCSK4_SIG,PCSK4,PCSK4_SIG,PCSK4,SIG,30,5.65058564892211,-0.00544326804409216,-0.0199486381254934,0.0422172336519404,0.0621658717774337,1.96848287209033e-07,4.02297211356237,2.13072616409372,2.0339373389906,2.44874658943255,0.41480925044195,0.000527281493471506,ENSG00000115257,PCSK4,protein_coding,19,-1,1481428,1490752,p13.3,proprotein convertase subtilisin/kexin type 4 [Source:HGNC Symbol;Acc:HGNC:8746],NA,PCSK4,54760,NM_017573
MMP9_SIG,MMP9,MMP9_SIG,MMP9,SIG,19,-5.65026530902487,-0.0113130716462191,0.046323055595894,-0.200688918298876,-0.24701197389477,1.96922881837834e-07,-4.51941295496123,5.2389445630595,5.54716153222384,4.22623166437666,-1.32092986784717,9.22575170977549e-05,ENSG00000100985,MMP9,protein_coding,20,1,46008908,46016561,q13.12,matrix metallopeptidase 9 [Source:HGNC Symbol;Acc:HGNC:7176],Metaphyseal anadysplasia;Metaphyseal anadysplasia 2,MMP9,4318,NM_004994
GSTT1_SIG,GSTT1,GSTT1_SIG,GSTT1,SIG,28,-5.64891103329843,-0.0870934131855807,-0.0772648570964704,-0.119387240335515,-0.0421223832390442,1.98186266776617e-07,-3.53352358489562,1.06716359135512,1.16804096648969,0.735709358770081,-0.43233160771961,0.0024450466962171,ENSG00000277656,GSTT1,protein_coding,CHR_HSCHR22_1_CTG7,-1,24033952,24042493,NA,glutathione S-transferase theta 1 [Source:HGNC Symbol;Acc:HGNC:4641],NA,GSTT1,2952,NM_000853;NM_001293807;NM_001293808;NM_001293809;NM_001293810;NM_001293811;NM_001293812;NM_001293813;NM_001293814
NPR2_SIG,NPR2,NPR2_SIG,NPR2,SIG,63,5.64829731935065,-0.011901161157513,-0.0244354452097012,0.0292829150139627,0.0537183602236638,1.98600701695428e-07,4.44842083267007,1.49768717449607,1.39832446232683,1.82416465733785,0.425840195011026,0.000119871968308465,ENSG00000159899,NPR2,protein_coding,9,1,35792154,35809732,p13.3,natriuretic peptide receptor 2 [Source:HGNC Symbol;Acc:HGNC:7944],Acromesomelic dysplasia Maroteaux type;Epiphyseal chondrodysplasia miura type;SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES;Tall stature-scoliosis-macrodactyly of the great toes syndrome,NPR2,4882,NM_003995
ITGA1_SIG,ITGA1,ITGA1_SIG,ITGA1,SIG,10,-5.645355523634,-0.00498170903771255,0.00824304705212604,-0.0484344790471822,-0.0566775260993083,2.01728429596644e-07,-3.70746885116441,1.55086385235533,1.66003848386307,1.19214720597275,-0.467891277890312,0.00143824427788128,ENSG00000213949,ITGA1,protein_coding,5,1,52787896,52959210,q11.2,integrin subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:6134],NA,ITGA1,3672,NM_181501
SHPK_SIG,SHPK,SHPK_SIG,SHPK,SIG,1,5.64340876202246,0.158727270097186,0.14271804940927,0.211328995214626,0.0686109458053565,2.03237953623834e-07,3.54524068481977,1.28502255977689,1.25210697079228,1.39317378072632,0.141066809934045,0.00236107574724508,ENSG00000197417,SHPK,protein_coding,17,-1,3608262,3636322,p13.2,sedoheptulokinase [Source:HGNC Symbol;Acc:HGNC:1492],Isolated sedoheptulokinase deficiency;SEDOHEPTULOKINASE DEFICIENCY,SHPK,23729,NM_013276
AGBL3_SIG,AGBL3,AGBL3_SIG,AGBL3,SIG,78,5.64332107406741,0.0361884026016235,0.0213415157787244,0.0849710307340061,0.0636295149552816,2.03237953623834e-07,4.96392469632889,1.53155117361259,1.44747089443617,1.8078149480494,0.360344053613227,1.64166751405593e-05,ENSG00000146856,AGBL3,protein_coding,7,1,134986508,135147963,q33,ATP/GTP binding protein like 3 [Source:HGNC Symbol;Acc:HGNC:27981],NA,AGBL3,340351,NM_001345850;NM_001345851;NM_178563
PIGZ_SIG,PIGZ,PIGZ_SIG,PIGZ,SIG,27,5.6433119920938,0.0991120653074218,0.0901249063015841,0.128641302040889,0.0385163957393046,2.03237953623834e-07,4.92591998160063,2.52830909540157,2.42511779435455,2.8673662274132,0.442248433058653,1.91749399092961e-05,ENSG00000119227,PIGZ,protein_coding,3,-1,196946356,196969060,q29,phosphatidylinositol glycan anchor biosynthesis class Z [Source:HGNC Symbol;Acc:HGNC:30596],NA,PIGZ,80235,NM_025163
PAPSS2_SIG,PAPSS2,PAPSS2_SIG,PAPSS2,SIG,13,-5.64094057221681,0.0626455322041418,0.0910227459462096,-0.030593884376938,-0.121616630323148,2.05754789554604e-07,-4.18562745113526,2.2162564788755,2.37579219087823,1.69206771086653,-0.683724480011697,0.000303617270554152,ENSG00000198682,PAPSS2,protein_coding,10,1,87659613,87747705,q23.2,3'-phosphoadenosine 5'-phosphosulfate synthase 2 [Source:HGNC Symbol;Acc:HGNC:8604],Autosomal recessive brachyolmia;BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES;SPONDYLOEPIMETAPHYSEAL DYSPLASIA PAKISTANI TYPE;Spondyloepimetaphyseal dysplasia PAPSS2 type,PAPSS2,9060,NM_001015880;NM_004670
NUAK2_SIG,NUAK2,NUAK2_SIG,NUAK2,SIG,39,-5.64018996953629,0.266125406753919,0.292969074604861,0.177924783815109,-0.115044290789752,2.06350746434884e-07,-4.47715633500276,3.26922716575395,3.44584157392188,2.68892268177359,-0.756918892148292,0.000107631076239569,ENSG00000163545,NUAK2,protein_coding,1,-1,205302059,205321791,q32.1,NUAK family kinase 2 [Source:HGNC Symbol;Acc:HGNC:29558],NA,NUAK2,81788,NM_030952
YBX2_SIG,YBX2,YBX2_SIG,YBX2,SIG,27,-5.63692664856337,-0.208048153634235,-0.194184531195092,-0.253600055934274,-0.0594155247391813,2.09989941269381e-07,-2.64226627559924,0.274890179311675,0.309571179131767,0.160938322759941,-0.148632856371826,0.0255010429350649,ENSG00000006047,YBX2,protein_coding,17,-1,7288263,7294639,p13.1,Y-box binding protein 2 [Source:HGNC Symbol;Acc:HGNC:17948],NA,YBX2,51087,NM_015982
NR5A1_TF,NR5A1,NR5A1_TF,NR5A1,TF,165,5.63442125451889,-0.00931162399899862,-0.0177812635051551,0.0185171915212298,0.0362984550263849,2.12753949494971e-07,3.45379775525756,0.556811678343856,0.482447857707963,0.801149946147504,0.31870208843954,0.00308139187841097,ENSG00000136931,NR5A1,protein_coding,9,-1,124481236,124507420,q33.3,nuclear receptor subfamily 5 group A member 1 [Source:HGNC Symbol;Acc:HGNC:7983],46XX gonadal dysgenesis;46XX ovotesticular disorder of sex development;46XX SEX REVERSAL 4;46XX testicular disorder of sex development;46XY complete gonadal dysgenesis;46XY partial gonadal dysgenesis;46XY SEX REVERSAL 3;Male infertility with azoospermia or oligozoospermia due to single gene mutation;Premature ovarian failure 7;Spermatogenic failure 8,NR5A1,2516,NM_004959
AMT_SIG,AMT,AMT_SIG,AMT,SIG,44,5.6338416738765,0.113449929860774,0.102905325687978,0.148096486428535,0.0451911607405571,2.13158936537724e-07,4.23993442476474,3.91010555419145,3.83177234090456,4.16748611213409,0.335713771229527,0.000250909718133374,ENSG00000145020,AMT,protein_coding,3,-1,49416775,49422753,p21.31,aminomethyltransferase [Source:HGNC Symbol;Acc:HGNC:473],Atypical glycine encephalopathy;GLYCINE ENCEPHALOPATHY;Infantile glycine encephalopathy;Neonatal glycine encephalopathy,AMT,275,NM_000481;NM_001164710;NM_001164711;NM_001164712
CD164_SIG,CD164,CD164_SIG,CD164,SIG,18,5.63308534674617,0.0802186521498746,0.0705669462894117,0.11193139997711,0.0413644536876983,2.1378415980288e-07,1.82397562538209,8.43007793293547,8.39557434121634,8.5434468771555,0.147872535939159,0.132702960977428,ENSG00000135535,CD164,protein_coding,6,-1,109366514,109382467,q21,CD164 molecule [Source:HGNC Symbol;Acc:HGNC:1632],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 66,CD164,8763,NM_001142401;NM_001142402;NM_001142403;NM_001142404;NM_001346500;NM_006016
ZFP92_TF,ZFP92,ZFP92_TF,ZFP92,TF,236,-5.62990501367093,0.113895361951735,0.129233144677104,0.0634997901398075,-0.0657333545372963,2.17446750550779e-07,-4.13681772741618,0.993504324648515,1.07089647491843,0.739215830904518,-0.331680644013909,0.000358308439329721,ENSG00000189420,ZFP92,protein_coding,X,1,153418322,153426481,q28,ZFP92 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:12865],NA,ZFP92,139735,NM_001136273
ZMYND12_TF,ZMYND12,ZMYND12_TF,ZMYND12,TF,232,5.62934546247837,0.0754603224584066,0.064362979049451,0.111923022230689,0.047560043181238,2.17836208892205e-07,4.84787839817672,0.94638540572991,0.881856817056105,1.15840791137241,0.276551094316308,2.66336726718262e-05,ENSG00000066185,ZMYND12,protein_coding,1,-1,42430329,42456253,p34.2,zinc finger MYND-type containing 12 [Source:HGNC Symbol;Acc:HGNC:21192],NA,ZMYND12,84217,NM_001146192;NM_032257
SYNE1_SIG,SYNE1,SYNE1_SIG,SYNE1,SIG,90,-5.62890421416436,0.028961939394817,0.0422645480968575,-0.0147466320547446,-0.0570111801516021,2.17942380739432e-07,-3.66690490983054,6.4915157559669,6.61306193429788,6.09214974145084,-0.52091219284704,0.00162808778754031,ENSG00000131018,SYNE1,protein_coding,6,-1,152121684,152637801,q25.2,spectrin repeat containing nuclear envelope protein 1 [Source:HGNC Symbol;Acc:HGNC:17089],Autosomal dominant Emery-Dreifuss muscular dystrophy;Autosomal recessive ataxia Beauce type;Autosomal recessive myogenic arthrogryposis multiplex congenita;Emery-Dreifuss muscular dystrophy 4 autosomal dominant;Emery-Dreifuss muscular dystrophy 4 autosomal recessive;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 8,SYNE1,23345,NM_001347701;NM_001347702;NM_033071;NM_182961
CR2_SIG,CR2,CR2_SIG,CR2,SIG,14,-5.62876066515197,-0.20809112423481,-0.189788566039027,-0.268228101163812,-0.0784395351247852,2.17942380739432e-07,-3.38585421701866,0.670332428816335,0.722589089781796,0.498631971358391,-0.223957118423405,0.00377023397657411,ENSG00000117322,CR2,protein_coding,1,1,207454230,207489895,q32.2,complement C3d receptor 2 [Source:HGNC Symbol;Acc:HGNC:2336],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 2;IMMUNODEFICIENCY COMMON VARIABLE 7;Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 9,CR2,1380,NM_001006658;NM_001877
DMAP1_TF,DMAP1,DMAP1_TF,DMAP1,TF,105,5.62815036551326,0.268254866471701,0.258231199041589,0.301189773742067,0.0429585747004776,2.18398201182228e-07,2.98666486624634,5.62970066826824,5.59673220413766,5.73802562184017,0.141293417702513,0.0111415294705804,ENSG00000178028,DMAP1,protein_coding,1,1,44213455,44220681,p34.1,DNA methyltransferase 1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18291],NA,DMAP1,55929,NM_001034023;NM_001034024;NM_019100
ACADVL_SIG,ACADVL,ACADVL_SIG,ACADVL,SIG,48,5.6268727201244,0.0295766646592448,0.0229694552917296,0.0512860668667944,0.0283166115750647,2.19703385779582e-07,2.12306433253772,8.36056197908251,8.33653200685016,8.43951760213168,0.102985595281517,0.0769789863787549,ENSG00000072778,ACADVL,protein_coding,17,1,7217125,7225266,p13.1,acyl-CoA dehydrogenase very long chain [Source:HGNC Symbol;Acc:HGNC:92],ACYL-CoA DEHYDROGENASE VERY LONG-CHAIN DEFICIENCY OF;Very long chain acyl-CoA dehydrogenase deficiency;Very Long Chain Acyl-Coenzyme A Dehydrogenase Deficiency,ACADVL,37,NM_000018;NM_001033859;NM_001270447;NM_001270448
LPAR6_SIG,LPAR6,LPAR6_SIG,LPAR6,SIG,35,-5.6245913667389,-0.0198188232599241,-0.00861625718984319,-0.0566272546330471,-0.0480109974432039,2.22305338984895e-07,-1.84505300362884,4.08849247837031,4.18380223268066,3.77533185706488,-0.408470375615778,0.127870345950631,ENSG00000139679,LPAR6,protein_coding,13,-1,48389567,48444704,q14.2,lysophosphatidic acid receptor 6 [Source:HGNC Symbol;Acc:HGNC:15520],HYPOTRICHOSIS 8;Hypotrichosis simplex;Woolly hair,LPAR6,10161,NM_001162497;NM_001162498;NM_005767
IL1RN_SIG,IL1RN,IL1RN_SIG,IL1RN,SIG,35,-5.62387602323503,0.314656224568153,0.355706644071975,0.179776274769882,-0.175930369302093,2.22693502342353e-07,-5.32564566482652,4.33145454507817,4.60353129973474,3.43748806549229,-1.16604323424245,3.5397372037356e-06,ENSG00000136689,IL1RN,protein_coding,2,1,113107214,113134016,q14.1,interleukin 1 receptor antagonist [Source:HGNC Symbol;Acc:HGNC:6000],GASTRIC CANCER HEREDITARY DIFFUSE;MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 4;Osteomyelitis sterile multifocal with periostitis and pustulosis;Sterile multifocal osteomyelitis with periostitis and pustulosis,IL1RN,3557,NM_000577;NM_001318914;NM_173841;NM_173842;NM_173843
ADAM9_SIG,ADAM9,ADAM9_SIG,ADAM9,SIG,31,-5.6237856062171,0.245263920183274,0.26464968296536,0.181567842470706,-0.0830818404946539,2.22693502342353e-07,-5.10521494199308,5.26770409381671,5.42604700872571,4.74743451625857,-0.67861249246714,9.25340813998865e-06,ENSG00000168615,ADAM9,protein_coding,8,1,38996869,39105261,p11.22,ADAM metallopeptidase domain 9 [Source:HGNC Symbol;Acc:HGNC:216],CONE-ROD DYSTROPHY 9;Cone rod dystrophy,ADAM9,8754,NM_003816
TBX1_TF,TBX1,TBX1_TF,TBX1,TF,116,5.62354438298595,-0.00786811829925364,-0.0160021512952239,0.0188579901160772,0.0348601414113012,2.22693502342353e-07,2.22476848563062,0.783881918443102,0.730638390923728,0.95882493743533,0.228186546511602,0.0631125973553268,ENSG00000184058,TBX1,protein_coding,22,1,19756703,19783593,q11.21,T-box 1 [Source:HGNC Symbol;Acc:HGNC:11592],22q11.2 Deletion Syndrome;22q11.2 microduplication syndrome;Conotruncal heart malformations;DIGEORGE SYNDROME;Tetralogy of Fallot;VELOCARDIOFACIAL SYNDROME,TBX1,6899,NM_005992;NM_080646;NM_080647
DPYSL4_SIG,DPYSL4,DPYSL4_SIG,DPYSL4,SIG,2,-5.62218542345615,-0.197489894053923,-0.181750683340927,-0.249204443539483,-0.0674537601985558,2.24130902427007e-07,-1.77070227300658,0.343161445811743,0.366556636575771,0.266291533301364,-0.100265103274407,0.145238891948025,ENSG00000151640,DPYSL4,protein_coding,10,1,132186948,132205759,q26.3,dihydropyrimidinase like 4 [Source:HGNC Symbol;Acc:HGNC:3016],NA,DPYSL4,10570,NM_006426
SCARB1_SIG,SCARB1,SCARB1_SIG,SCARB1,SIG,47,5.6214725501744,0.257937111824988,0.241670990452631,0.311382939191302,0.0697119487386713,2.24735475370525e-07,4.75705855950876,5.39648734568467,5.27041069242243,5.81073920640344,0.540328513981003,3.76024126350624e-05,ENSG00000073060,SCARB1,protein_coding,12,-1,124776856,124882668,q24.31,scavenger receptor class B member 1 [Source:HGNC Symbol;Acc:HGNC:1664],HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS6,SCARB1,949,NM_001082959;NM_005505
B3GNT7_SIG,B3GNT7,B3GNT7_SIG,B3GNT7,SIG,20,-5.617663428116,-0.0698185866169138,-0.0601076149156961,-0.101726065063772,-0.0416184501480755,2.29199096649819e-07,-3.75265672226421,2.71970986672489,2.88366180486178,2.18101064141799,-0.702651163443782,0.00124635012198725,ENSG00000156966,B3GNT7,protein_coding,2,1,231395710,231401164,q37.1,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:18811],NA,B3GNT7,93010,NM_145236
SGK2_SIG,SGK2,SGK2_SIG,SGK2,SIG,47,5.61758009566156,-0.00690483730691485,-0.0202028205411329,0.0367885361769446,0.0569913567180776,2.29199096649819e-07,3.79759973129117,0.773641863149227,0.723952929420994,0.936905502541994,0.212952573121,0.00108365607036792,ENSG00000101049,SGK2,protein_coding,20,1,43558968,43588237,q13.12,SGK2, serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:13900],NA,SGK2,10110,NM_001199264;NM_016276;NM_170693
TRMT61B_SIG,TRMT61B,TRMT61B_SIG,TRMT61B,SIG,75,5.61645633250023,0.283773530111283,0.269424640213044,0.330919882634067,0.0614952424210226,2.30364932744722e-07,4.93523054585178,3.46923750322797,3.40507978331779,3.68004144007569,0.274961656757895,1.84857633182364e-05,ENSG00000171103,TRMT61B,protein_coding,2,-1,28849821,28870309,p23.2,tRNA methyltransferase 61B [Source:HGNC Symbol;Acc:HGNC:26070],NA,TRMT61B,55006,NM_017910
HEYL_TF,HEYL,HEYL_TF,HEYL,TF,111,5.61399179336208,-0.0140419560552395,-0.0218260901486379,0.0115344845373552,0.0333605746859931,2.33177416433133e-07,2.16135016406037,1.60992628431351,1.55817462019023,1.77996746643285,0.221792846242623,0.0715907167473921,ENSG00000163909,HEYL,protein_coding,1,-1,39623435,39639643,p34.2,hes related family bHLH transcription factor with YRPW motif-like [Source:HGNC Symbol;Acc:HGNC:4882],NA,HEYL,26508,NM_014571
MSRB3_SIG,MSRB3,MSRB3_SIG,MSRB3,SIG,45,5.61386549526096,0.211047498328447,0.196357413686379,0.259314919295241,0.0629575056088614,2.33177416433133e-07,2.93845162105276,6.8378176388196,6.72821852881014,7.19792900027924,0.469710471469098,0.0126095154724315,ENSG00000174099,MSRB3,protein_coding,12,1,65278643,65491430,q14.3,methionine sulfoxide reductase B3 [Source:HGNC Symbol;Acc:HGNC:27375],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 74,MSRB3,253827,NM_001031679;NM_001193460;NM_001193461;NM_198080
CD226_SIG,CD226,CD226_SIG,CD226,SIG,29,-5.61341298473758,-0.148244077336052,-0.129213357207372,-0.210773586330287,-0.0815602291229155,2.33456212141271e-07,-5.12277184062946,2.22920946418624,2.39642702496045,1.67978033592815,-0.716646689032296,8.63779626570369e-06,ENSG00000150637,CD226,protein_coding,18,-1,69831158,69961803,q22.2,CD226 molecule [Source:HGNC Symbol;Acc:HGNC:16961],NA,CD226,10666,NM_001303618;NM_001303619;NM_006566
ZNF215_TF,ZNF215,ZNF215_TF,ZNF215,TF,152,-5.61161739646553,-0.13029383818872,-0.121777983555973,-0.158274503410604,-0.0364965198546306,2.35557513138783e-07,1.08964779194107,0.644242247184551,0.621381980543669,0.719354551861737,0.0979725713180678,0.387192235900327,ENSG00000149054,ZNF215,protein_coding,11,1,6926404,7001004,p15.4,zinc finger protein 215 [Source:HGNC Symbol;Acc:HGNC:13007],NA,ZNF215,7762,NM_001354853;NM_001354854;NM_001354855;NM_001354856;NM_001354857;NM_001354858;NM_001354859;NM_001354860;NM_013250
ZNF619_TF,ZNF619,ZNF619_TF,ZNF619,TF,30,5.60958182279949,0.298054395279306,0.286981811301295,0.334435742635627,0.0474539313343317,2.38007266854387e-07,5.10819894749328,3.40389381563527,3.33381310417202,3.63415901044306,0.300345906271043,9.14729005405598e-06,ENSG00000177873,ZNF619,protein_coding,3,1,40477113,40490236,p22.1,zinc finger protein 619 [Source:HGNC Symbol;Acc:HGNC:26910],NA,ZNF619,285267,NM_001145082;NM_001145083;NM_001145093
GATAD1_TF,GATAD1,GATAD1_TF,GATAD1,TF,78,5.6091033507269,0.220658240318911,0.209564839459789,0.257107985998886,0.0475431465390968,2.38328571291496e-07,3.72564455483022,5.51723917882889,5.46408639041339,5.69188405505125,0.227797664637858,0.00135641174813405,ENSG00000157259,GATAD1,protein_coding,7,1,92447482,92460075,q21.2,GATA zinc finger domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29941],Cardiomyopathy dilated 2b;Familial isolated dilated cardiomyopathy,GATAD1,57798,NM_021167
CLEC6A_SIG,CLEC6A,CLEC6A_SIG,CLEC6A,SIG,12,-5.6000746849413,0.0531811413203699,0.0982730487633739,-0.0949779831352144,-0.193251031898588,2.50725953145286e-07,-4.21134605475382,0.270737298710914,0.317890804260401,0.115804351905458,-0.202086452354943,0.000277115338162621,ENSG00000205846,CLEC6A,protein_coding,12,1,8455926,8478330,p13.31,C-type lectin domain containing 6A [Source:HGNC Symbol;Acc:HGNC:14556],NA,CLEC6A,93978,NM_001007033;NM_001317999
CLU_SIG,CLU,CLU_SIG,CLU,SIG,43,5.59981167741831,0.0122071450330243,0.00405061265547435,0.0390071799878314,0.0349565673323569,2.50752470154876e-07,3.94923667725676,5.52195818490194,5.30246192348099,6.24316018671363,0.940698263232639,0.000668131885520933,ENSG00000120885,CLU,protein_coding,8,-1,27596917,27615031,p21.1,clusterin [Source:HGNC Symbol;Acc:HGNC:2095],NA,CLU,1191,NM_001831
CLIC2_SIG,CLIC2,CLIC2_SIG,CLIC2,SIG,49,5.59926361840337,0.000803206086500155,-0.0104981073528887,0.0379360931016349,0.0484342004545236,2.51192143327886e-07,6.53294860149073,2.509167536329,2.25937320579775,3.32992033664596,1.07054713084821,8.9798537199133e-09,ENSG00000155962,CLIC2,protein_coding,X,-1,155276211,155334657,q28,chloride intracellular channel 2 [Source:HGNC Symbol;Acc:HGNC:2063],Chromosome Xq28 duplication syndrome;MENTAL RETARDATION X-LINKED SYNDROMIC 32;X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,CLIC2,1193,NM_001289
COL6A2_SIG,COL6A2,COL6A2_SIG,COL6A2,SIG,25,-5.59888006715514,-0.191644551574716,-0.177335845036936,-0.238658873055994,-0.0613230280190578,2.511929646922e-07,-1.6709874836074,2.96000864446169,3.04063466337498,2.695094582318,-0.345540081056979,0.170789153281052,ENSG00000142173,COL6A2,protein_coding,21,1,46098097,46132849,q22.3,collagen type VI alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2212],BETHLEM MYOPATHY;Bethlem myopathy 1;Congenital muscular dystrophy Ullrich type;Myosclerosis;MYOSCLEROSIS AUTOSOMAL RECESSIVE;ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1,COL6A2,1292,NM_001849;NM_058174;NM_058175
SLC25A29_SIG,SLC25A29,SLC25A29_SIG,SLC25A29,SIG,27,5.59854296729923,0.0791234038162913,0.0610317284458287,0.138567480033526,0.0775357515876969,2.511929646922e-07,3.80005705904675,5.98828427205933,5.88883475567562,6.31504696874866,0.42621221307304,0.00107607659682148,ENSG00000197119,SLC25A29,protein_coding,14,-1,100291116,100306547,q32.2,solute carrier family 25 member 29 [Source:HGNC Symbol;Acc:HGNC:20116],NA,SLC25A29,123096,NM_001039355;NM_001291813;NM_001291814;NM_001352820;NM_001352821;NM_001352822;NM_001352823;NM_152333
CUL7_SIG,CUL7,CUL7_SIG,CUL7,SIG,48,5.59853199268635,0.25805263157506,0.241381403191468,0.312829524835433,0.0714481216439648,2.511929646922e-07,3.44347377049724,5.13754722894213,5.08119344016849,5.32270967776978,0.241516237601287,0.00317019898549959,ENSG00000044090,CUL7,protein_coding,6,-1,43037617,43053945,p21.1,cullin 7 [Source:HGNC Symbol;Acc:HGNC:21024],3-M syndrome 1;3M syndrome;THREE M SYNDROME 1,CUL7,9820,NM_001168370;NM_014780
PHLDB2_SIG,PHLDB2,PHLDB2_SIG,PHLDB2,SIG,9,-5.59800191985425,-0.125140137353535,-0.10879757302902,-0.1788371344198,-0.0700395613907802,2.51609128284954e-07,-3.14310822661494,1.03757562397915,1.10463891542463,0.817224809229707,-0.287414106194922,0.00739771432135858,ENSG00000144824,PHLDB2,protein_coding,3,1,111732497,111976517,q13.2,pleckstrin homology like domain family B member 2 [Source:HGNC Symbol;Acc:HGNC:29573],NA,PHLDB2,90102,NM_001134437;NM_001134438;NM_001134439;NM_145753
ZNF138_TF,ZNF138,ZNF138_TF,ZNF138,TF,42,5.59570520518072,0.0777180775243475,0.059069632275829,0.138991540483765,0.0799219082079361,2.54606489517651e-07,5.73228802025881,3.39590990617419,3.28467610789622,3.76139238623039,0.476716278334176,5.4096898442727e-07,ENSG00000197008,ZNF138,protein_coding,7,1,64794388,64833681,q11.21,zinc finger protein 138 [Source:HGNC Symbol;Acc:HGNC:12922],NA,ZNF138,7697,NM_001160183;NM_001271637;NM_001271638;NM_001271639;NM_001271640;NM_001271649;NM_006524
C5AR1_SIG,C5AR1,C5AR1_SIG,C5AR1,SIG,50,-5.59503451695786,0.350362805232499,0.403980519078766,0.174190316880479,-0.229790202198287,2.55235718879885e-07,-5.50517384521288,5.6049623229417,5.94304668519025,4.49411370412504,-1.4489329810652,1.56549821510726e-06,ENSG00000197405,C5AR1,protein_coding,19,1,47290023,47322066,q13.32,complement C5a receptor 1 [Source:HGNC Symbol;Acc:HGNC:1338],NA,C5AR1,728,NM_001736
ZNF852_TF,ZNF852,ZNF852_TF,ZNF852,TF,128,5.59468798307529,0.175178320818666,0.158500012805226,0.229978475719967,0.0714784629147406,2.55389323108134e-07,4.55840978816136,3.42516418556263,3.33658647495949,3.71620523468722,0.379618759727728,8.05111954050968e-05,ENSG00000178917,ZNF852,protein_coding,3,-1,44494847,44510636,p21.31,zinc finger protein 852 [Source:HGNC Symbol;Acc:HGNC:27713],NA,ZNF852,285346,NM_001287349
SOCS4_SIG,SOCS4,SOCS4_SIG,SOCS4,SIG,82,5.59348558734162,0.284164299601882,0.27359552489357,0.31889027364348,0.0452947487499098,2.56709156439888e-07,5.28428646331996,5.30015055804678,5.22980105273424,5.53129893264512,0.301497879910879,4.25691295704662e-06,ENSG00000180008,SOCS4,protein_coding,14,1,55027230,55049489,q22.3,suppressor of cytokine signaling 4 [Source:HGNC Symbol;Acc:HGNC:19392],NA,SOCS4,122809,NM_080867;NM_199421
YLPM1_SIG,YLPM1,YLPM1_SIG,YLPM1,SIG,66,5.59331016369825,0.46143895331097,0.452491087824085,0.490839082767878,0.0383479949437932,2.56709156439888e-07,4.5289877993201,7.30298047274952,7.25079936523406,7.47443268315746,0.223633317923408,8.93975343111137e-05,ENSG00000119596,YLPM1,protein_coding,14,1,74763316,74859435,q24.3,YLP motif containing 1 [Source:HGNC Symbol;Acc:HGNC:17798],NA,YLPM1,56252,NM_019589
TRPM6_SIG,TRPM6,TRPM6_SIG,TRPM6,SIG,14,-5.59017975011711,-0.0559166343019675,-0.0173188209658668,-0.182738020977727,-0.16541920001186,2.61017400176237e-07,-4.15889263241275,1.30505523013207,1.45343204141534,0.817531421629892,-0.635900619785446,0.000332111837213514,ENSG00000119121,TRPM6,protein_coding,9,-1,74722495,74888094,q21.13,transient receptor potential cation channel subfamily M member 6 [Source:HGNC Symbol;Acc:HGNC:17995],HYPOMAGNESEMIA 1 INTESTINAL;Primary hypomagnesemia with secondary hypocalcemia,TRPM6,140803,NM_001177310;NM_001177311;NM_017662
CTSC_SIG,CTSC,CTSC_SIG,CTSC,SIG,29,5.58858110449298,0.367663471307928,0.357018367257129,0.402640241760552,0.0456218745034232,2.63065929506707e-07,5.32508799796473,7.3282534844702,7.22541155043485,7.66616269630063,0.440751145865788,3.54515187478388e-06,ENSG00000109861,CTSC,protein_coding,11,-1,88293592,88337761,q14.2,cathepsin C [Source:HGNC Symbol;Acc:HGNC:2528],Haim-Munk syndrome;Papillon-Lefevre syndrome;PERIODONTITIS AGGRESSIVE 1,CTSC,1075,NM_001114173;NM_001814;NM_148170
SMPDL3B_SIG,SMPDL3B,SMPDL3B_SIG,SMPDL3B,SIG,35,5.58761260369386,-0.0292878207477933,-0.0437380169918119,0.0181913954825537,0.0619294124743656,2.63936972722962e-07,3.9987190278659,2.1777570223698,2.05381715718797,2.58498800796726,0.531170850779287,0.000570801574947526,ENSG00000130768,SMPDL3B,protein_coding,1,1,27935000,27959157,p35.3,sphingomyelin phosphodiesterase acid like 3B [Source:HGNC Symbol;Acc:HGNC:21416],NA,SMPDL3B,27293,NM_001009568;NM_001304579;NM_014474
MAN1A2_SIG,MAN1A2,MAN1A2_SIG,MAN1A2,SIG,43,5.58752574740908,0.381256438637735,0.37316972666419,0.407827063693669,0.034657337029479,2.63936972722962e-07,4.44089646522684,6.43512013280728,6.38040989282076,6.61488234990582,0.234472457085051,0.000123169787406545,ENSG00000198162,MAN1A2,protein_coding,1,1,117367449,117528872,p12,mannosidase alpha class 1A member 2 [Source:HGNC Symbol;Acc:HGNC:6822],NA,MAN1A2,10905,NM_006699
TSHZ3_TF,TSHZ3,TSHZ3_TF,TSHZ3,TF,272,-5.57740821225745,0.0548709466629884,0.0695075455530335,0.00677926459569707,-0.0627282809573365,2.79365306312212e-07,-3.55600990330292,2.42396662992456,2.56714295162069,1.95353014435156,-0.613612807269128,0.00228802994031827,ENSG00000121297,TSHZ3,protein_coding,19,-1,31149979,31349547,q12,teashirt zinc finger homeobox 3 [Source:HGNC Symbol;Acc:HGNC:30700],NA,TSHZ3,57616,NM_020856
RNF215_SIG,RNF215,RNF215_SIG,RNF215,SIG,23,5.57673702475599,0.05874597693309,0.0519021910917824,0.0812327018402433,0.029330510748461,2.80058046363141e-07,3.2123258282986,3.00766000374714,2.95967757119917,3.16531656783329,0.205638996634119,0.00614391624108607,ENSG00000099999,RNF215,protein_coding,22,-1,30368811,30421771,q12.2,ring finger protein 215 [Source:HGNC Symbol;Acc:HGNC:33434],NA,RNF215,200312,NM_001017981
ZNF565_TF,ZNF565,ZNF565_TF,ZNF565,TF,45,5.57449647991341,0.10548774416227,0.0970621104923494,0.133171969077723,0.0361098585853735,2.83295447223286e-07,4.13615284374846,1.97490343218458,1.93046200901687,2.12092525116418,0.190463242147303,0.000359105213389836,ENSG00000196357,ZNF565,protein_coding,19,-1,36182060,36246257,q13.12,zinc finger protein 565 [Source:HGNC Symbol;Acc:HGNC:26726],NA,ZNF565,147929,NM_001042474;NM_152477
TNFAIP6_SIG,TNFAIP6,TNFAIP6_SIG,TNFAIP6,SIG,13,-5.57180516600826,0.172128228328095,0.212743023175091,0.038679616687966,-0.174063406487125,2.87312038401728e-07,-4.26897667060523,1.53037572252071,1.67209175405735,1.06473733318603,-0.607354420871319,0.000226346179658701,ENSG00000123610,TNFAIP6,protein_coding,2,1,151357592,151380046,q23.3,TNF alpha induced protein 6 [Source:HGNC Symbol;Acc:HGNC:11898],NA,TNFAIP6,7130,NM_007115
SRGAP3_SIG,SRGAP3,SRGAP3_SIG,SRGAP3,SIG,51,5.56920015788481,-0.0602629118627715,-0.0702436235176455,-0.027469144996757,0.0427744785208884,2.91239794633206e-07,1.76298491178935,2.49716956807325,2.42764239301482,2.72561600040811,0.297973607393286,0.14704286288191,ENSG00000196220,SRGAP3,protein_coding,3,-1,8980591,9363053,p25.3,SLIT-ROBO Rho GTPase activating protein 3 [Source:HGNC Symbol;Acc:HGNC:19744],Pilomyxoid astrocytoma;SLIT-ROBO RHO GTPASE-ACTIVATING PROTEIN 3,SRGAP3,9901,NM_001033117;NM_014850
AMACR_SIG,AMACR,AMACR_SIG,AMACR,SIG,7,5.56885042292317,0.013385046503673,-0.00648595447153979,0.0786754782793722,0.0851614327509119,2.91424581309348e-07,4.53671555305119,1.20826843242243,1.15169992991507,1.39413636923235,0.242436439317279,8.69313568149616e-05,ENSG00000242110,AMACR,protein_coding,5,-1,33986165,34008104,p13.2,alpha-methylacyl-CoA racemase [Source:HGNC Symbol;Acc:HGNC:451],ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY;BILE ACID SYNTHESIS DEFECT CONGENITAL 4;Congenital bile acid synthesis defect type 4,AMACR,23600,NM_001167595;NM_014324;NM_203382
ZDHHC15_SIG,ZDHHC15,ZDHHC15_SIG,ZDHHC15,SIG,118,5.5670828009126,-0.0532173478832091,-0.0651044952538007,-0.0141595779512652,0.0509449173025354,2.93991889580846e-07,5.99314890824886,0.88607171247414,0.733689103693669,1.38675742703854,0.653068323344874,1.46882038043476e-07,ENSG00000102383,ZDHHC15,protein_coding,X,-1,75368427,75523502,q13.3,zinc finger DHHC-type containing 15 [Source:HGNC Symbol;Acc:HGNC:20342],MENTAL RETARDATION X-LINKED 91;MENTAL RETARDATION X-LINKED TYPE 91,ZDHHC15,158866,NM_001146256;NM_144969
KDM7A_SIG,KDM7A,KDM7A_SIG,KDM7A,SIG,40,-5.56494273922784,0.0765314033048887,0.0972891422357947,0.00832740396048326,-0.0889617382753116,2.97215598978456e-07,-3.42457942293083,5.75551905499318,5.85538475757361,5.42738888937178,-0.427995868201835,0.00335089164106952,ENSG00000006459,KDM7A,protein_coding,7,-1,140084746,140176983,q34,lysine demethylase 7A [Source:HGNC Symbol;Acc:HGNC:22224],NA,KDM7A,80853,NM_030647
DGKD_SIG,DGKD,DGKD_SIG,DGKD,SIG,15,-5.56460409346882,0.281620203213616,0.29191299739901,0.247801022318751,-0.0441119750802595,2.9738650991501e-07,-3.8064659784045,7.10647016133905,7.16447422277823,6.91588538803887,-0.248588834739358,0.00105376626155502,ENSG00000077044,DGKD,protein_coding,2,1,233354507,233472104,q37.1,diacylglycerol kinase delta [Source:HGNC Symbol;Acc:HGNC:2851],NA,DGKD,8527,NM_003648;NM_152879
TAGAP_SIG,TAGAP,TAGAP_SIG,TAGAP,SIG,13,-5.56325191360594,0.243074259683194,0.269532348725811,0.156140538543168,-0.113391810182643,2.99292186660868e-07,-4.26037199798752,6.51477994493621,6.62472506185974,6.15353170361604,-0.471193358243697,0.000232803866087674,ENSG00000164691,TAGAP,protein_coding,6,-1,159034468,159045152,q25.3,T cell activation RhoGTPase activating protein [Source:HGNC Symbol;Acc:HGNC:15669],NA,TAGAP,117289,NM_001278733;NM_054114;NM_138810;NM_152133
GLS_SIG,GLS,GLS_SIG,GLS,SIG,65,5.56215001116402,0.298927181281575,0.283380496602312,0.350009145227723,0.0666286486254112,3.00778317635757e-07,4.96628049548296,6.58117230877978,6.49709586154132,6.8574234925633,0.36032763102198,1.62863894937753e-05,ENSG00000115419,GLS,protein_coding,2,1,190880827,190965552,q32.2,glutaminase [Source:HGNC Symbol;Acc:HGNC:4331],NA,GLS,2744,NM_001256310;NM_014905
SMAD5_SIG,SMAD5,SMAD5_SIG,SMAD5,SIG,30,5.55945199601665,0.240311507602259,0.22955639113038,0.275649747438432,0.046093356308052,3.05049208097519e-07,4.42743286682496,4.78998738487248,4.70352933278344,5.07406384173648,0.370534508953034,0.000129233824734628,ENSG00000113658,SMAD5,protein_coding,5,1,136132845,136188747,q31.1,SMAD family member 5 [Source:HGNC Symbol;Acc:HGNC:6771],NA,SMAD5,4090,NM_001001419;NM_001001420;NM_005903
PLSCR1_TF,PLSCR1,PLSCR1_TF,PLSCR1,TF,311,-5.5584905738745,0.148145844747723,0.163171121066402,0.0987770797006345,-0.064394041365768,3.06317220253694e-07,-2.06328825932055,5.58217444528555,5.62802498157576,5.43152268318915,-0.196502298386612,0.0861406898880205,ENSG00000188313,PLSCR1,protein_coding,3,-1,146515180,146544856,q24,phospholipid scramblase 1 [Source:HGNC Symbol;Acc:HGNC:9092],NA,PLSCR1,5359,NM_001363872;NM_021105
ANKAR_SIG,ANKAR,ANKAR_SIG,ANKAR,SIG,195,5.55068009211632,0.053187395504938,0.0384082548402983,0.101747429117326,0.0633391742770274,3.19889129259281e-07,4.6623101862425,2.44640256286556,2.37412472036224,2.68388690251933,0.309762182157088,5.39732445120732e-05,ENSG00000151687,ANKAR,protein_coding,2,1,189674290,189761193,q32.2,ankyrin and armadillo repeat containing [Source:HGNC Symbol;Acc:HGNC:26350],NA,ANKAR,150709,NM_144708
SCML4_TF,SCML4,SCML4_TF,SCML4,TF,292,-5.54980135487828,-0.0441915020446588,-0.0298898575013414,-0.0911826198298446,-0.0612927623285033,3.21065495951172e-07,-3.68498373859884,1.93947465124663,2.05434736281689,1.5620357418015,-0.492311621015393,0.00153940927497658,ENSG00000146285,SCML4,protein_coding,6,-1,107702154,107824317,q21,Scm polycomb group protein like 4 [Source:HGNC Symbol;Acc:HGNC:21397],NA,SCML4,256380,NM_001286408;NM_001286409;NM_198081
ZNF579_SIG,ZNF579,ZNF579_SIG,ZNF579,SIG,48,5.54635989860078,0.180730777646586,0.165878923044505,0.229529728481996,0.063650805437491,3.27003163461702e-07,4.43146403765663,3.1566954097285,3.08427420068005,3.39465081088766,0.310376610207606,0.000127304271040082,ENSG00000218891,ZNF579,protein_coding,19,-1,55576774,55580848,q13.42,zinc finger protein 579 [Source:HGNC Symbol;Acc:HGNC:26646],NA,ZNF579,163033,NM_152600
ALG10_SIG,ALG10,ALG10_SIG,ALG10,SIG,75,5.54589564382604,0.244067267276996,0.233924820449836,0.277392449709095,0.0434676292592588,3.27429047162647e-07,4.29870357353704,2.96835178836491,2.90637659406967,3.1719845696207,0.265607975551029,0.000205444675772038,ENSG00000139133,ALG10,protein_coding,12,1,34022468,34029694,p11.1,ALG10, alpha-1,2-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:23162],LONG QT SYNDROME 2,ALG10,84920,NM_032834
CYB5D2_SIG,CYB5D2,CYB5D2_SIG,CYB5D2,SIG,32,5.54468990028664,0.057392535301891,0.0451872063445212,0.0974957590189634,0.0523085526744422,3.28591651967714e-07,4.08400130898613,3.2144889317115,3.14713947529708,3.43578000278747,0.288640527490387,0.000427999331647505,ENSG00000167740,CYB5D2,protein_coding,17,1,4143168,4187310,p13.2,cytochrome b5 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28471],NA,CYB5D2,124936,NM_001254755;NM_001254756;NM_144611
RPH3A_SIG,RPH3A,RPH3A_SIG,RPH3A,SIG,5,-5.54457378534639,-0.205067344142311,-0.170061144422757,-0.320087714649416,-0.150026570226659,3.28591651967714e-07,-3.17292762041786,1.33522833164892,1.46442035232173,0.91074026372397,-0.553680088597756,0.00682172386795731,ENSG00000089169,RPH3A,protein_coding,12,1,112570380,112898881,q24.13,rabphilin 3A [Source:HGNC Symbol;Acc:HGNC:17056],NA,RPH3A,22895,NM_001143854;NM_001347952;NM_001347953;NM_001347954;NM_001347955;NM_014954
GDF10_SIG,GDF10,GDF10_SIG,GDF10,SIG,19,-5.54456760206125,-0.123755587035407,-0.115999823606446,-0.149238809730563,-0.033238986124117,3.28591651967714e-07,-3.06595787110133,0.346304453975765,0.39997494975874,0.169958539260277,-0.230016410498463,0.00907016766387616,ENSG00000266524,GDF10,protein_coding,10,1,47300197,47313577,q11.22,growth differentiation factor 10 [Source:HGNC Symbol;Acc:HGNC:4215],NA,GDF10,2662,NM_004962
LSS_SIG,LSS,LSS_SIG,LSS,SIG,35,5.54427337402885,0.249460884146956,0.238578618127676,0.285216901067448,0.0466382829397721,3.28702210724912e-07,3.93327941645184,5.20971779958927,5.12385577280211,5.4918358876042,0.367980114802087,0.000704832552034565,ENSG00000160285,LSS,protein_coding,21,-1,46188141,46228824,q22.3,lanosterol synthase [Source:HGNC Symbol;Acc:HGNC:6708],Cataract 44;Total early-onset cataract,LSS,4047,NM_001001438;NM_001145436;NM_001145437;NM_002340
CPA6_SIG,CPA6,CPA6_SIG,CPA6,SIG,17,5.54373342692703,0.0178712107344396,0.00746714956953286,0.0520559831334189,0.044588833563886,3.29275368275387e-07,2.29738251315103,0.677231220311478,0.636186375865515,0.812092852062499,0.175906476196984,0.0542227066750876,ENSG00000165078,CPA6,protein_coding,8,-1,67422038,67746385,q13.2,carboxypeptidase A6 [Source:HGNC Symbol;Acc:HGNC:17245],Benign familial mesial temporal lobe epilepsy;EPILEPSY FAMILIAL TEMPORAL LOBE 5;Familial mesial temporal lobe epilepsy with febrile seizures;FEBRILE SEIZURES FAMILIAL 11,CPA6,57094,NM_020361
FAT4_SIG,FAT4,FAT4_SIG,FAT4,SIG,38,-5.54222887349026,-0.24786465549917,-0.237067060105759,-0.283342468934666,-0.0462754088289072,3.31672760594653e-07,-3.75618220327116,0.544254362580878,0.627879719913364,0.269485331345568,-0.358394388567795,0.001233602567849,ENSG00000196159,FAT4,protein_coding,4,1,125316399,125492932,q28.1,FAT atypical cadherin 4 [Source:HGNC Symbol;Acc:HGNC:23109],Cerebro-facio-articular syndrome;HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2;Hennekam syndrome;periventricular neuronal heterotopia;Van Maldergem syndrome 2,FAT4,79633,NM_001291285;NM_001291303;NM_024582
STAC_SIG,STAC,STAC_SIG,STAC,SIG,21,-5.53939724119595,-0.184697721395209,-0.177316831891849,-0.208949215477678,-0.0316323835858285,3.36292871811246e-07,-0.934111673898653,0.633012435776346,0.659604181451524,0.545639557129334,-0.11396462432219,0.463819921246773,ENSG00000144681,STAC,protein_coding,3,1,36380344,36548007,p22.3,SH3 and cysteine rich domain [Source:HGNC Symbol;Acc:HGNC:11353],NA,STAC,6769,NM_001292049;NM_003149
NSUN6_SIG,NSUN6,NSUN6_SIG,NSUN6,SIG,121,5.53933782254604,0.0273624281432094,0.0125514672130924,0.0760270140564512,0.0634755468433588,3.36292871811246e-07,3.93227334426584,3.62069516840796,3.55876175335802,3.82419067500063,0.265428921642609,0.000706657055507359,ENSG00000241058,NSUN6,protein_coding,10,-1,18545561,18659285,p12.31,NOP2/Sun RNA methyltransferase family member 6 [Source:HGNC Symbol;Acc:HGNC:23529],NA,NSUN6,221078,NM_001351115;NM_001351116;NM_001351117;NM_001351118;NM_182543
SLCO4C1_SIG,SLCO4C1,SLCO4C1_SIG,SLCO4C1,SIG,24,-5.53770006708135,0.45334622977706,0.486754413617249,0.343576482873583,-0.143177930743665,3.38998654269978e-07,-5.41377422249983,3.61649458638281,3.82821321267054,2.92084767143741,-0.907365541233127,2.40489857175424e-06,ENSG00000173930,SLCO4C1,protein_coding,5,-1,102233986,102296284,q21.1,solute carrier organic anion transporter family member 4C1 [Source:HGNC Symbol;Acc:HGNC:23612],NA,SLCO4C1,353189,NM_180991
ARTN_SIG,ARTN,ARTN_SIG,ARTN,SIG,80,5.53451564941964,0.046689941358472,0.036008820870229,0.0817850515341278,0.0457762306638987,3.4475494162832e-07,3.51555924554094,2.01577458299837,1.8671490421874,2.504115645663,0.636966603475601,0.00258153893610301,ENSG00000117407,ARTN,protein_coding,1,1,43933320,43937240,p34.1,artemin [Source:HGNC Symbol;Acc:HGNC:727],NA,ARTN,9048,NM_001136215;NM_057090;NM_057091
PTPRJ_SIG,PTPRJ,PTPRJ_SIG,PTPRJ,SIG,66,-5.53209035031332,0.240407730530232,0.273265532008872,0.132446382814699,-0.140819149194174,3.49091757297105e-07,-4.66841226151413,5.76851762237344,5.95041274175062,5.17086223013412,-0.779550511616508,5.28745970644295e-05,ENSG00000149177,PTPRJ,protein_coding,11,1,47980558,48170841,p11.2,protein tyrosine phosphatase, receptor type J [Source:HGNC Symbol;Acc:HGNC:9673],NA,PTPRJ,5795,NM_001098503;NM_002843
SLC4A4_SIG,SLC4A4,SLC4A4_SIG,SLC4A4,SIG,10,-5.53077537747985,-0.0269358888991083,-0.0143627874528,-0.0682475079369785,-0.0538847204841784,3.50919737854783e-07,-1.44481431372679,1.17179127756646,1.21225668396346,1.03883351369059,-0.173423170272873,0.240346112897662,ENSG00000080493,SLC4A4,protein_coding,4,1,71062667,71572087,q13.3,solute carrier family 4 member 4 [Source:HGNC Symbol;Acc:HGNC:11030],Autosomal recessive proximal renal tubular acidosis;PROXIMAL RENAL TUBULAR ACIDOSIS WITH OCULAR ABNORMALITIES;RENAL TUBULAR ACIDOSIS PROXIMAL WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION,SLC4A4,8671,NM_001098484;NM_001134742;NM_003759
TIMP3_SIG,TIMP3,TIMP3_SIG,TIMP3,SIG,70,-5.53070796023077,-0.162638510086679,-0.151074496358576,-0.200634555193304,-0.0495600588347277,3.50919737854783e-07,-4.8183457929703,2.19562674327178,2.42415790362936,1.44473864495404,-0.979419258675313,2.95682648078295e-05,ENSG00000100234,TIMP3,protein_coding,22,1,32801701,32863043,q12.3,TIMP metallopeptidase inhibitor 3 [Source:HGNC Symbol;Acc:HGNC:11822],SORSBY FUNDUS DYSTROPHY;Sorsby pseudoinflammatory fundus dystrophy,TIMP3,7078,NM_000362
RNFT2_SIG,RNFT2,RNFT2_SIG,RNFT2,SIG,11,-5.53009315719454,-0.0617530218093508,-0.0519893935125064,-0.0938335147846969,-0.0418441212721904,3.51684814933615e-07,-1.78876363687262,0.996030122368425,1.03606245306201,0.864495321518081,-0.171567131543927,0.140865813584194,ENSG00000135119,RNFT2,protein_coding,12,1,116738178,116853631,q24.22,ring finger protein, transmembrane 2 [Source:HGNC Symbol;Acc:HGNC:25905],NA,RNFT2,84900,NM_001109903;NM_032814
AOC3_SIG,AOC3,AOC3_SIG,AOC3,SIG,27,-5.52917826664719,-0.0829649606108625,-0.0702778360789755,-0.12465122692992,-0.054373390850944,3.53055427229382e-07,-3.63664640267516,1.22105294260053,1.30263683079126,0.95299159568812,-0.349645235103139,0.00178388669881149,ENSG00000131471,AOC3,protein_coding,17,1,42851184,42858130,q21.31,amine oxidase, copper containing 3 [Source:HGNC Symbol;Acc:HGNC:550],NA,AOC3,8639,NM_001277731;NM_001277732;NM_003734
P2RY13_SIG,P2RY13,P2RY13_SIG,P2RY13,SIG,25,-5.52830063059253,0.568793118879359,0.630294326468854,0.366717722513873,-0.263576603954981,3.54356473103678e-07,-5.30913049878413,4.34356544750273,4.60779711825746,3.47537567216578,-1.13242144609168,3.82292240839224e-06,ENSG00000181631,P2RY13,protein_coding,3,-1,151326312,151329549,q25.1,purinergic receptor P2Y13 [Source:HGNC Symbol;Acc:HGNC:4537],NA,P2RY13,53829,NM_176894
CD58_SIG,CD58,CD58_SIG,CD58,SIG,15,-5.52430802358384,0.100856241206106,0.112854517595223,0.0614333330704329,-0.0514211845247902,3.62030092397905e-07,-4.65295067057666,4.78266321064869,4.86945239813591,4.49749873747638,-0.37195366065953,5.59333084677975e-05,ENSG00000116815,CD58,protein_coding,1,-1,116514534,116571039,p13.1,CD58 molecule [Source:HGNC Symbol;Acc:HGNC:1688],NA,CD58,965,NM_001144822;NM_001779
CIAO1_SIG,CIAO1,CIAO1_SIG,CIAO1,SIG,31,5.52378522020023,0.40407364621082,0.39213468549827,0.44330165998063,0.0511669744823599,3.62630518136371e-07,4.04458110139302,6.51881545844118,6.48048250613926,6.64476658743323,0.164284081293976,0.000491549810257677,ENSG00000144021,CIAO1,protein_coding,2,1,96266132,96273349,q11.2,cytosolic iron-sulfur assembly component 1 [Source:HGNC Symbol;Acc:HGNC:14280],NA,CIAO1,9391,NM_004804
MICB_SIG,MICB,MICB_SIG,MICB,SIG,22,-5.52353297835144,0.17755266675105,0.187236038289391,0.145735874553644,-0.0415001637357471,3.62673302871976e-07,-4.71751887560973,4.50017386153619,4.56668322881512,4.28164308333399,-0.285040145481135,4.36514457346086e-05,ENSG00000204516,MICB,protein_coding,6,1,31494881,31511124,p21.33,MHC class I polypeptide-related sequence B [Source:HGNC Symbol;Acc:HGNC:7091],NA,MICB,4277,NM_001289160;NM_001289161;NM_005931
S1PR3_SIG,S1PR3,S1PR3_SIG,S1PR3,SIG,11,-5.52273746648769,0.249171158885881,0.286934522944516,0.125091534121793,-0.161842988822723,3.6384041407839e-07,-4.10186959923971,0.901331544119176,0.994330421472159,0.595763804245086,-0.398566617227073,0.00040306540742496,ENSG00000213694,S1PR3,protein_coding,9,1,88990863,89005155,q22.1,sphingosine-1-phosphate receptor 3 [Source:HGNC Symbol;Acc:HGNC:3167],NA,S1PR3,1903;286223,NM_001001938;NM_001142413;NM_005226
PTDSS2_SIG,PTDSS2,PTDSS2_SIG,PTDSS2,SIG,35,5.52217641505258,0.469331087609214,0.454084626688569,0.519426602062764,0.0653419753741953,3.64524814245987e-07,4.20161214737371,4.44521986439182,4.38603583378675,4.63968167923702,0.25364584545027,0.000286430778594126,ENSG00000174915,PTDSS2,protein_coding,11,1,448268,491399,p15.5,phosphatidylserine synthase 2 [Source:HGNC Symbol;Acc:HGNC:15463],NA,PTDSS2,81490,NM_001329544;NM_001329545;NM_001329548;NM_030783
MAP4_SIG,MAP4,MAP4_SIG,MAP4,SIG,57,5.52186990906523,0.316131130808094,0.301460043181854,0.364336133008594,0.0628760898267397,3.64682208543936e-07,3.82439123517206,7.28170229149892,7.21862016127181,7.48897214795944,0.270351986687633,0.000996614603491246,ENSG00000047849,MAP4,protein_coding,3,-1,47850690,48089272,p21.31,microtubule associated protein 4 [Source:HGNC Symbol;Acc:HGNC:6862],NA,MAP4,4134,NM_001134364;NM_002375;NM_030885
ZNF660_TF,ZNF660,ZNF660_TF,ZNF660,TF,173,5.52101363388829,0.187727980135807,0.170856194303022,0.243163847872103,0.0723076535690811,3.65983765291165e-07,4.09375999800018,3.25921339286451,3.15207723748809,3.61123218910133,0.459154951613238,0.000413896000277351,ENSG00000144792,ZNF660,protein_coding,3,1,44578223,44599694,p21.31,zinc finger protein 660 [Source:HGNC Symbol;Acc:HGNC:26720],NA,ZNF660,285349,NM_173658
ZBTB32_TF,ZBTB32,ZBTB32_TF,ZBTB32,TF,76,-5.51988277874873,-0.0478655451656905,-0.0311430379621585,-0.102810925977296,-0.0716678880151371,3.67864712914034e-07,-3.08278620948319,0.590477116581112,0.638530191645998,0.432588441367917,-0.205941750278082,0.00866945380378691,ENSG00000011590,ZBTB32,protein_coding,19,1,35704558,35717038,q13.12,zinc finger and BTB domain containing 32 [Source:HGNC Symbol;Acc:HGNC:16763],NA,ZBTB32,27033,NM_001316902;NM_001316903;NM_014383
OPHN1_SIG,OPHN1,OPHN1_SIG,OPHN1,SIG,50,5.5194927860827,-0.0240344481351338,-0.032706867999913,0.00446064570628363,0.0371675137061966,3.68200074527649e-07,3.36239893531746,2.20619785877859,2.11678391257138,2.4999865391737,0.383202626602321,0.00403587066181984,ENSG00000079482,OPHN1,protein_coding,X,-1,68042344,68433913,q12,oligophrenin 1 [Source:HGNC Symbol;Acc:HGNC:8148],MENTAL RETARDATION X-LINKED OPHN1-RELATED;Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance;X-linked intellectual disability-cerebellar hypoplasia syndrome,OPHN1,4983,NM_002547
TNN_SIG,TNN,TNN_SIG,TNN,SIG,7,5.51849033352115,-0.0988853089523741,-0.108701282546753,-0.0666328242851293,0.0420684582616235,3.69822797169741e-07,-0.0520317761217108,0.438569532246824,0.43960531223273,0.435166255150277,-0.00443905708245349,0.971133165588649,ENSG00000120332,TNN,protein_coding,1,1,175067858,175148066,q25.1,tenascin N [Source:HGNC Symbol;Acc:HGNC:22942],NA,TNN,63923,NM_022093
EXTL2_SIG,EXTL2,EXTL2_SIG,EXTL2,SIG,133,5.51778649613401,0.190218854999815,0.168706638984473,0.260901850478794,0.092195211494321,3.70822493943843e-07,5.41451201629392,3.34839838927793,3.1989757825222,3.83935838290386,0.64038260038166,2.39909814979135e-06,ENSG00000162694,EXTL2,protein_coding,1,-1,100872372,100895179,p21.2,exostosin like glycosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:3516],NA,EXTL2,2135,NM_001033025;NM_001261440;NM_001261441;NM_001261442;NM_001439
LZTFL1_TF,LZTFL1,LZTFL1_TF,LZTFL1,TF,183,5.5147287319807,0.152275670026997,0.136528699676328,0.204015715464909,0.0674870157885813,3.76836244694072e-07,3.38361394052971,4.17918190127367,4.11274365429128,4.3974789985015,0.284735344210216,0.00379494799783135,ENSG00000163818,LZTFL1,protein_coding,3,-1,45823316,45916042,p21.31,leucine zipper transcription factor like 1 [Source:HGNC Symbol;Acc:HGNC:6741],Bardet-Biedl syndrome;BARDET-BIEDL SYNDROME 17,LZTFL1,54585,NM_001276378;NM_001276379;NM_020347
ZNF512B_TF,ZNF512B,ZNF512B_TF,ZNF512B,TF,218,5.51439546950614,0.0726565644521526,0.0565473207426587,0.12558693664049,0.0690396158978309,3.77059982228883e-07,5.29113726519378,5.59985011097422,5.50316456671844,5.91753118495751,0.414366618239068,4.13098514901958e-06,ENSG00000196700,ZNF512B,protein_coding,20,-1,63956704,63969930,q13.33,zinc finger protein 512B [Source:HGNC Symbol;Acc:HGNC:29212],NA,ZNF512B,57473,NM_020713
SLCO2B1_SIG,SLCO2B1,SLCO2B1_SIG,SLCO2B1,SIG,17,-5.51353687560765,-0.249187082193251,-0.224425156886184,-0.33054769391647,-0.106122537030286,3.78412862985211e-07,-3.3538565348057,0.661578742221409,0.745790447894234,0.384883137867841,-0.360907310026392,0.00412690330586451,ENSG00000137491,SLCO2B1,protein_coding,11,1,75100563,75206549,q13.4,solute carrier organic anion transporter family member 2B1 [Source:HGNC Symbol;Acc:HGNC:10962],NA,SLCO2B1,11309,NM_001145211;NM_001145212;NM_007256
ALOX5AP_SIG,ALOX5AP,ALOX5AP_SIG,ALOX5AP,SIG,19,-5.51222067230131,0.518919909262307,0.552004127881016,0.410214619515121,-0.141789508365895,3.80317969521578e-07,-4.87840157396432,6.05365506229507,6.26019381554237,5.37502773019678,-0.885166085345594,2.33721965883465e-05,ENSG00000132965,ALOX5AP,protein_coding,13,1,30713478,30764426,q12.3,arachidonate 5-lipoxygenase activating protein [Source:HGNC Symbol;Acc:HGNC:436],STROKE ISCHEMIC,ALOX5AP,241,NM_001204406;NM_001629
SLC27A5_SIG,SLC27A5,SLC27A5_SIG,SLC27A5,SIG,32,5.51219697797667,0.169557897861697,0.150880902764088,0.230925167468129,0.0800442647040411,3.80317969521578e-07,5.42002095561141,1.96726752216576,1.87960049958802,2.25531631063549,0.375715811047469,2.34234705489566e-06,ENSG00000083807,SLC27A5,protein_coding,19,-1,58479512,58512413,q13.43,solute carrier family 27 member 5 [Source:HGNC Symbol;Acc:HGNC:10999],Bile acid CoA ligase deficiency and defective amidation,SLC27A5,10998,NM_001321196;NM_012254
DSP_SIG,DSP,DSP_SIG,DSP,SIG,31,-5.51145383327065,-0.149296222761854,-0.143628301546108,-0.167919392470737,-0.0242910909246296,3.81433448391695e-07,-1.75682052890542,0.58427333271562,0.619051862815519,0.470001019530238,-0.149050843285281,0.148414942399967,ENSG00000096696,DSP,protein_coding,6,1,7541617,7586714,p24.3,desmoplakin [Source:HGNC Symbol;Acc:HGNC:3052],ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA FAMILIAL 8;Cardiomyopathy dilated with woolly hair and keratoderma;CARDIOMYOPATHY DILATED WITH WOOLLY HAIR KERATODERMA AND TOOTHAGENESIS;Carvajal syndrome;EPIDERMOLYSIS BULLOSA LETHAL ACANTHOLYTIC;Erythrokeratodermia-cardiomyopathy syndrome;Familial isolated arrhythmogenic ventricular dysplasia biventricular form;Familial isolated arrhythmogenic ventricular dysplasia left dominant form;Familial isolated arrhythmogenic ventricular dysplasia right dominant form;Idiopathic pulmonary fibrosis;KERATOSIS PALMOPLANTARIS STRIATA II;Lethal acantholytic epidermolysis bullosa;Severe dermatitis-multiple allergies-metabolic wasting syndrome;Skin fragility-woolly hair-palmoplantar keratoderma syndrome;SKIN FRAGILITY-WOOLLY HAIR SYNDROME;Striate palmoplantar keratoderma,DSP,1832,NM_001008844;NM_001319034;NM_004415
ZNF596_TF,ZNF596,ZNF596_TF,ZNF596,TF,15,5.50811730360793,0.126835761542048,0.116889514596484,0.15951628722033,0.0426267726238455,3.88230072244028e-07,3.35697046941435,1.93696222589969,1.89602404744198,2.07147338368933,0.175449336247347,0.00409742829762103,ENSG00000172748,ZNF596,protein_coding,8,1,232137,264703,p23.3,zinc finger protein 596 [Source:HGNC Symbol;Acc:HGNC:27268],NA,ZNF596,169270,NM_001042415;NM_001042416;NM_001287254;NM_001287255;NM_001287256;NM_001287399;NM_173539
SOX18_TF,SOX18,SOX18_TF,SOX18,TF,193,5.50483351784283,-0.0359706382237898,-0.0438106672366397,-0.0102105428958546,0.033600124340785,3.95025905501434e-07,3.21718212714578,0.706964614388914,0.625913020703881,0.973276993639738,0.347363972935857,0.00605446571180773,ENSG00000203883,SOX18,protein_coding,20,-1,64047582,64049639,q13.33,SRY-box 18 [Source:HGNC Symbol;Acc:HGNC:11194],HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME;HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME,SOX18,54345,NM_018419
VEGFA_SIG,VEGFA,VEGFA_SIG,VEGFA,SIG,20,-5.50412407542434,-0.0529465344151622,-0.0336670919353405,-0.116293273991719,-0.0826261820563787,3.96108626704555e-07,-2.01863101179793,5.29125727226498,5.37162681829273,5.02718590674522,-0.344440911547514,0.0938349656051058,ENSG00000112715,VEGFA,protein_coding,6,1,43770184,43786487,p21.1,vascular endothelial growth factor A [Source:HGNC Symbol;Acc:HGNC:12680],MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 1,VEGFA,7422,NM_001025366;NM_001025367;NM_001025368;NM_001025369;NM_001025370;NM_001033756;NM_001171622;NM_001171623;NM_001171624;NM_001171625;NM_001171626;NM_001171627;NM_001171628;NM_001171629;NM_001171630;NM_001204384;NM_001204385;NM_001287044;NM_001317010;NM_003376
PLAGL1_SIG,PLAGL1,PLAGL1_SIG,PLAGL1,SIG,75,5.50151235044683,0.127678080237372,0.110052365606075,0.185591142597348,0.075538776991273,4.0150499441836e-07,4.14314885332555,5.81568681937924,5.72103531100843,6.12668463259762,0.405649321589189,0.000350347432435521,ENSG00000118495,PLAGL1,protein_coding,6,-1,143940300,144064599,q24.2,PLAG1 like zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:9046],DIABETES MELLITUS TRANSIENT NEONATAL 1;Paternal uniparental disomy of chromosome 6;Transient neonatal diabetes mellitus,PLAGL1,5325,NM_001080951;NM_001080952;NM_001080953;NM_001080954;NM_001080955;NM_001080956;NM_001289037;NM_001289038;NM_001289039;NM_001289040;NM_001289041;NM_001289042;NM_001289043;NM_001289044;NM_001289045;NM_001289046;NM_001289047;NM_001289048;NM_001289049;NM_001317156;NM_001317157;NM_001317158;NM_001317159;NM_001317160;NM_001317161;NM_001317162;NM_006718
CACNA1E_SIG,CACNA1E,CACNA1E_SIG,CACNA1E,SIG,22,-5.50082363955443,-0.178257828399072,-0.161313012565256,-0.233933651853036,-0.0726206392877801,4.02558546312574e-07,-3.53230198823422,0.511264239992284,0.589030286884078,0.255747228776392,-0.333283058107686,0.00245125036296471,ENSG00000198216,CACNA1E,protein_coding,1,1,181317690,181808084,q25.3,calcium voltage-gated channel subunit alpha1 E [Source:HGNC Symbol;Acc:HGNC:1392],Epileptic Encephalopathy with Contractures Macrocephaly and Dyskinesia,CACNA1E,777,NM_000721;NM_001205293;NM_001205294
CXCR4_SIG,CXCR4,CXCR4_SIG,CXCR4,SIG,39,-5.50031750499787,0.150498610469748,0.16341610394636,0.108055417618023,-0.0553606863283368,4.03197613866971e-07,-3.1183792634284,8.08378680605567,8.20541241044873,7.68415982019277,-0.521252590255957,0.00793745641295397,ENSG00000121966,CXCR4,protein_coding,2,-1,136114349,136118165,q22.1,C-X-C motif chemokine receptor 4 [Source:HGNC Symbol;Acc:HGNC:2561],WHIM SYNDROME,CXCR4,7852,NM_001008540;NM_001348056;NM_001348059;NM_001348060;NM_003467
VIM_SIG,VIM,VIM_SIG,VIM,SIG,64,5.49935616424501,0.154560821407616,0.143573040855208,0.190663528936956,0.0470904880817473,4.04882106760679e-07,5.03939370789582,11.4451781619438,11.3187254606105,11.860665609182,0.541940148571474,1.21470186801571e-05,ENSG00000026025,VIM,protein_coding,10,1,17228241,17237593,p13,vimentin [Source:HGNC Symbol;Acc:HGNC:12692],CATARACT 30 MULTIPLE TYPES;Pulverulent cataract,VIM,7431,NM_003380
LILRA5_SIG,LILRA5,LILRA5_SIG,LILRA5,SIG,29,-5.49316808568704,0.55368386803961,0.616507443672565,0.347263548102758,-0.269243895569807,4.18797432077317e-07,-4.60277878890145,4.1346416607316,4.3879568505955,3.30232032260736,-1.08563652798813,6.78101053451742e-05,ENSG00000187116,LILRA5,protein_coding,19,-1,54307070,54313139,q13.42,leukocyte immunoglobulin like receptor A5 [Source:HGNC Symbol;Acc:HGNC:16309],NA,LILRA5,353514,NM_021250;NM_181879;NM_181985;NM_181986
C5AR2_SIG,C5AR2,C5AR2_SIG,C5AR2,SIG,20,-5.49281415321176,0.377934931680011,0.433761218516554,0.194505703502799,-0.239255515013754,4.18955952141387e-07,-4.82557448457142,2.79154984580149,2.98026452352499,2.17148733328142,-0.808777190243572,2.88511453545859e-05,ENSG00000134830,C5AR2,protein_coding,19,1,47332147,47347327,q13.32,complement component 5a receptor 2 [Source:HGNC Symbol;Acc:HGNC:4527],NA,C5AR2,27202,NM_001271749;NM_001271750;NM_018485
SLC16A6_SIG,SLC16A6,SLC16A6_SIG,SLC16A6,SIG,46,-5.49264977370738,0.117019346793092,0.147513771880795,0.0168233786477837,-0.130690393233011,4.18955952141387e-07,-4.97085984256906,2.22691108452479,2.42473180662012,1.57692871192586,-0.847803094694262,1.60067015787736e-05,ENSG00000108932,SLC16A6,protein_coding,17,-1,68267026,68291267,q24.2,solute carrier family 16 member 6 [Source:HGNC Symbol;Acc:HGNC:10927],NA,SLC16A6,9120,NM_001174166;NM_004694
SMPDL3A_SIG,SMPDL3A,SMPDL3A_SIG,SMPDL3A,SIG,29,-5.49065382967467,-0.0832979562070457,-0.055527954900985,-0.174542246212674,-0.119014291311689,4.23178080172746e-07,-5.11611963401711,1.76741164326381,1.96321562232816,1.12405571205235,-0.839159910275813,8.89204027531462e-06,ENSG00000172594,SMPDL3A,protein_coding,6,1,122789049,122809720,q22.31,sphingomyelin phosphodiesterase acid like 3A [Source:HGNC Symbol;Acc:HGNC:17389],NA,SMPDL3A,10924,NM_001286138;NM_006714
ERCC8_SIG,ERCC8,ERCC8_SIG,ERCC8,SIG,19,5.49017632572594,0.401552633611686,0.387708322193432,0.44704108541452,0.0593327632210876,4.23783223019531e-07,4.43147005247462,2.93253816390732,2.87407946786831,3.12461673660693,0.250537268738616,0.000127304271040082,ENSG00000049167,ERCC8,protein_coding,5,-1,60873831,60945073,q12.1,ERCC excision repair 8, CSA ubiquitin ligase complex subunit [Source:HGNC Symbol;Acc:HGNC:3439],Cockayne syndrome A;Cockayne syndrome type 1;Cockayne syndrome type 2;Cockayne syndrome type 3;Cockayne syndrome type A;UV-sensitive syndrome;UV-SENSITIVE SYNDROME 2,ERCC8,1161,NM_000082;NM_001007233;NM_001007234;NM_001290285
TNFRSF13C_SIG,TNFRSF13C,TNFRSF13C_SIG,TNFRSF13C,SIG,25,-5.48915332181362,-0.204913107395787,-0.187214596121465,-0.263065358725703,-0.0758507626042383,4.25187324945328e-07,-3.89836747086906,1.09315444505122,1.1769629108366,0.817783771756409,-0.359179139080194,0.000785094866380556,ENSG00000159958,TNFRSF13C,protein_coding,22,-1,41922023,41926818,q13.2,TNF receptor superfamily member 13C [Source:HGNC Symbol;Acc:HGNC:17755],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 2;IMMUNODEFICIENCY COMMON VARIABLE 4,TNFRSF13C,115650,NM_052945
PIK3C2B_SIG,PIK3C2B,PIK3C2B_SIG,PIK3C2B,SIG,96,5.4891425969551,0.167710168940357,0.153195587037004,0.215400938051376,0.0622053510143723,4.25187324945328e-07,5.35525895694944,4.77312418155577,4.60273865356951,5.33296234493922,0.730223691369706,3.121688935656e-06,ENSG00000133056,PIK3C2B,protein_coding,1,-1,204422628,204494724,q32.1,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta [Source:HGNC Symbol;Acc:HGNC:8972],NA,PIK3C2B,5287,NM_002646
DDX31_SIG,DDX31,DDX31_SIG,DDX31,SIG,23,5.4845538307336,0.247539398492438,0.228857331423246,0.308923333148354,0.0800660017251076,4.35818601639928e-07,5.80832480739976,3.91409349669925,3.78333968067481,4.3437131779224,0.560373497247594,3.66676278910136e-07,ENSG00000125485,DDX31,protein_coding,9,-1,132592997,132670401,q34.13,DEAD-box helicase 31 [Source:HGNC Symbol;Acc:HGNC:16715],NA,DDX31,64794,NM_001322340;NM_001322341;NM_001322342;NM_001322343;NM_001322344;NM_022779;NM_138620
NPC2_SIG,NPC2,NPC2_SIG,NPC2,SIG,17,-5.48361988207327,0.584015806880752,0.599903256759964,0.531814185849055,-0.0680890709109084,4.37571549269657e-07,-4.01180363486574,6.21485293957836,6.29178277073192,5.96208349435954,-0.329699276372383,0.000546714442557761,ENSG00000119655,NPC2,protein_coding,14,-1,74476192,74494177,q24.3,NPC intracellular cholesterol transporter 2 [Source:HGNC Symbol;Acc:HGNC:14537],Niemann-Pick disease type C adult neurologic onset;Niemann-Pick disease type C juvenile neurologic onset;Niemann-Pick disease type C late infantile neurologic onset;Niemann-Pick disease type C severe early infantile neurologic onset;Niemann-Pick disease type C severe perinatal form;NIEMANN-PICK DISEASE TYPE C2,NPC2,10577,NM_006432
PRMT7_SIG,PRMT7,PRMT7_SIG,PRMT7,SIG,60,5.48261543250821,0.279413670758736,0.262718421593899,0.3342694894432,0.0715510678493007,4.39507055674097e-07,4.1903388917673,5.114537075245,5.03848952500684,5.36440759745609,0.325918072449244,0.000298217310323481,ENSG00000132600,PRMT7,protein_coding,16,1,68310974,68358563,q22.1,protein arginine methyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:25557],Pseudohypoparathyroidism-like disorder;Short stature-brachydactyly-obesity-global developmental delay syndrome;SHORT STATURE BRACHYDACTYLY INTELLECTUAL DEVELOPMENTAL DISABILITY AND SEIZURES,PRMT7,54496,NM_001184824;NM_001290018;NM_001351143;NM_001351144;NM_019023
CHD1L_SIG,CHD1L,CHD1L_SIG,CHD1L,SIG,53,5.48130068522779,0.279091372770818,0.262883109793381,0.332347093982396,0.0694639841890145,4.42226485731426e-07,3.45581667113358,6.47755394012211,6.42533075042748,6.64914442054732,0.223813670119838,0.00306483001540919,ENSG00000131778,CHD1L,protein_coding,1,1,147242654,147295765,q21.1,chromodomain helicase DNA binding protein 1 like [Source:HGNC Symbol;Acc:HGNC:1916],NA,CHD1L,9557,NM_001256336;NM_001256337;NM_001256338;NM_001348451;NM_001348452;NM_001348453;NM_001348454;NM_001348455;NM_001348456;NM_001348457;NM_001348458;NM_001348459;NM_001348460;NM_001348461;NM_001348462;NM_001348463;NM_001348464;NM_001348465;NM_001348466;NM_004284;NM_024568
SPA17_SIG,SPA17,SPA17_SIG,SPA17,SIG,55,-5.48083255513788,-0.00384060758147351,0.00583263312804645,-0.0356241127698962,-0.0414567458979427,4.42838471835513e-07,-4.38063712432544,1.47266389174969,1.55773707328152,1.19313772385939,-0.364599349422124,0.000153021861412009,ENSG00000064199,SPA17,protein_coding,11,1,124673798,124697518,q24.2,sperm autoantigenic protein 17 [Source:HGNC Symbol;Acc:HGNC:11210],NA,SPA17,53340,NM_017425
ZNF70_TF,ZNF70,ZNF70_TF,ZNF70,TF,258,5.47885226082854,0.0592655065727109,0.0415825314723679,0.117366710473838,0.0757841790014698,4.47257955405125e-07,4.74214834802723,3.73495859760151,3.61451146754675,4.13071345349573,0.51620198594898,3.99107113298752e-05,ENSG00000187792,ZNF70,protein_coding,22,-1,23738682,23751112,q11.23,zinc finger protein 70 [Source:HGNC Symbol;Acc:HGNC:13140],NA,ZNF70,7621,NM_021916
LAMP3_SIG,LAMP3,LAMP3_SIG,LAMP3,SIG,17,-5.47760135623261,-0.067117769822501,-0.053503090631573,-0.11185171573555,-0.0583486251039768,4.49863043404857e-07,-3.24314187033673,0.674667305348314,0.729283119001009,0.495215346203744,-0.234067772797264,0.00563627310536421,ENSG00000078081,LAMP3,protein_coding,3,-1,183122215,183163839,q27.1,lysosomal associated membrane protein 3 [Source:HGNC Symbol;Acc:HGNC:14582],NA,LAMP3,27074,NM_014398
IL18_SIG,IL18,IL18_SIG,IL18,SIG,26,5.47516087018025,0.0316168534925219,0.0225905299447758,0.0612747737208307,0.0386842437760551,4.55190679054027e-07,3.4828061170536,4.91553782120137,4.83541903528246,5.17878526064921,0.343366225366744,0.00283640442526706,ENSG00000150782,IL18,protein_coding,11,-1,112143253,112164096,q23.1,interleukin 18 [Source:HGNC Symbol;Acc:HGNC:5986],NA,IL18,3606,NM_001243211;NM_001562
DCAKD_SIG,DCAKD,DCAKD_SIG,DCAKD,SIG,35,5.47507162736131,0.171775443271566,0.153174676804725,0.232892247376903,0.0797175705721779,4.55190679054027e-07,4.52694151464981,4.20981353301969,4.13354416716285,4.46041287797786,0.326868710815003,8.98244826720283e-05,ENSG00000172992,DCAKD,protein_coding,17,-1,45023340,45061109,q21.31,dephospho-CoA kinase domain containing [Source:HGNC Symbol;Acc:HGNC:26238],NA,DCAKD,79877,NM_001128631;NM_001288654;NM_001288655;NM_001321326;NM_024819
ARG1_SIG,ARG1,ARG1_SIG,ARG1,SIG,29,-5.47237251671108,0.282261695341702,0.343165207660003,0.0821501548672822,-0.261015052792721,4.6160047038747e-07,-4.83820766170751,3.7548766545623,4.05692993888008,2.76241586323243,-1.29451407564765,2.7578366289929e-05,ENSG00000118520,ARG1,protein_coding,6,1,131573144,131584332,q23.2,arginase 1 [Source:HGNC Symbol;Acc:HGNC:663],Argininemia,ARG1,383,NM_000045;NM_001244438
CTPS2_SIG,CTPS2,CTPS2_SIG,CTPS2,SIG,206,5.47098287805719,0.223822377300489,0.204623016279874,0.28690599208251,0.082282975802637,4.64652014818514e-07,4.36329641556257,4.46161236608983,4.3732853528521,4.7518296952995,0.378544342447399,0.00016272590108972,ENSG00000047230,CTPS2,protein_coding,X,-1,16587999,16712936,p22.2,CTP synthase 2 [Source:HGNC Symbol;Acc:HGNC:2520],NA,CTPS2,56474,NM_001144002;NM_019857;NM_175859
DDX42_SIG,DDX42,DDX42_SIG,DDX42,SIG,48,5.46889924750459,0.470565598916683,0.458477223811591,0.510284545690556,0.0518073218789645,4.69558394644753e-07,4.24768896595938,7.43465211071177,7.39130641310872,7.57707368855036,0.185767275441646,0.000243579970312168,ENSG00000198231,DDX42,protein_coding,17,1,63773603,63819317,q23.3,DEAD-box helicase 42 [Source:HGNC Symbol;Acc:HGNC:18676],NA,DDX42,11325,NM_007372;NM_203499
PDGFRB_SIG,PDGFRB,PDGFRB_SIG,PDGFRB,SIG,26,5.46806955934268,-0.101269661771017,-0.107192967886796,-0.0818073702477417,0.0253855976390542,4.71171417355612e-07,4.05295346912111,1.92555711130002,1.79078979950477,2.36836399291299,0.577574193408226,0.000477462896755468,ENSG00000113721,PDGFRB,protein_coding,5,-1,150113839,150155872,q32,platelet derived growth factor receptor beta [Source:HGNC Symbol;Acc:HGNC:8804],Acroosteolysis-keloid-like lesions-premature aging syndrome;BASAL GANGLIA CALCIFICATION IDIOPATHIC 1;BASAL GANGLIA CALCIFICATION IDIOPATHIC 4;Bilateral striopallidodentate calcinosis;Chronic myelomonocytic leukemia;Chronic myeloproliferative disease unclassifiable;Familial Infantile Myofibromatosis;Infantile myofibromatosis;Kosaki overgrowth syndrome;Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement;MYELOPROLIFERATIVE DISORDER CHRONIC WITH EOSINOPHILIA;MYOFIBROMATOSIS INFANTILE 1;PREMATURE AGING SYNDROME PENTTINEN TYPE;Primary hypereosinophilic syndrome;Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome,PDGFRB,5159,NM_001355016;NM_001355017;NM_002609
ITPR1_SIG,ITPR1,ITPR1_SIG,ITPR1,SIG,46,5.46729797456617,0.378667399083889,0.366493481588998,0.41866741370996,0.0521739321209625,4.72635505145338e-07,3.49193066288136,6.56935833597427,6.49719061844535,6.80648083642646,0.309290217981111,0.00276197741591233,ENSG00000150995,ITPR1,protein_coding,3,1,4493345,4847840,p26.1,inositol 1,4,5-trisphosphate receptor type 1 [Source:HGNC Symbol;Acc:HGNC:6180],Aniridia-cerebellar ataxia-intellectual disability syndrome;Gillespie Syndrome;SPINOCEREBELLAR ATAXIA 15;SPINOCEREBELLAR ATAXIA 29;Spinocerebellar ataxia 29 congenital nonprogressive;Spinocerebellar ataxia type 15/16;Spinocerebellar ataxia type 29;Spinocerebellar Ataxia Type15,ITPR1,3708,NM_001099952;NM_001168272;NM_002222
ZNF621_TF,ZNF621,ZNF621_TF,ZNF621,TF,44,5.46575116670233,0.245853372141017,0.23345163591824,0.286601934015854,0.0531502980976136,4.76181498347825e-07,3.96853608365488,5.1155962983084,5.05394166550539,5.31817580608972,0.264234140584326,0.000627696414953501,ENSG00000172888,ZNF621,protein_coding,3,1,40524878,40574685,p22.1,zinc finger protein 621 [Source:HGNC Symbol;Acc:HGNC:24787],NA,ZNF621,285268,NM_001098414;NM_001287245;NM_198484
ARAP3_SIG,ARAP3,ARAP3_SIG,ARAP3,SIG,23,-5.46473804575291,0.172118465702139,0.206572970845983,0.0589108059437947,-0.147662164902188,4.7831263846834e-07,-5.50083424290851,3.86307712158184,4.10461865039907,3.0694406697538,-1.03517798064527,1.59562856231461e-06,ENSG00000120318,ARAP3,protein_coding,5,-1,141653401,141682230,q31.3,ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [Source:HGNC Symbol;Acc:HGNC:24097],NA,ARAP3,64411,NM_022481
BST1_SIG,BST1,BST1_SIG,BST1,SIG,33,-5.46445820859195,0.589709593967852,0.620661264265471,0.488011248704246,-0.132650015561225,4.78471888988533e-07,-4.27423309828715,5.45459114323636,5.61682592308258,4.92153400945593,-0.695291913626646,0.000223069976194911,ENSG00000109743,BST1,protein_coding,4,1,15703065,15738313,p15.32,bone marrow stromal cell antigen 1 [Source:HGNC Symbol;Acc:HGNC:1118],NA,BST1,683,NM_004334
SMPD2_SIG,SMPD2,SMPD2_SIG,SMPD2,SIG,4,5.46296234671431,0.246669398198126,0.239011239503126,0.271831919624554,0.032820680121428,4.81923474957548e-07,1.59257425258172,3.83058131936494,3.81228627481436,3.89069360860257,0.0784073337882134,0.192758302354734,ENSG00000135587,SMPD2,protein_coding,6,1,109440724,109443919,q21,sphingomyelin phosphodiesterase 2 [Source:HGNC Symbol;Acc:HGNC:11121],NA,SMPD2,6610,NM_003080
ATP10A_SIG,ATP10A,ATP10A_SIG,ATP10A,SIG,88,-5.46222339687062,0.0727723951052158,0.0854002102364378,0.0312810025312004,-0.0541192077052374,4.83286117480324e-07,-5.30261135272698,3.90363736622522,4.1471299664441,3.1035902512203,-1.0435397152238,3.92623710438434e-06,ENSG00000206190,ATP10A,protein_coding,15,-1,25677273,25865172,q12,ATPase phospholipid transporting 10A (putative) [Source:HGNC Symbol;Acc:HGNC:13542],Angelman syndrome due to imprinting defect in 15q11-q13,ATP10A,57194,NM_024490
CA5B_SIG,CA5B,CA5B_SIG,CA5B,SIG,80,5.46202091757209,0.131141369525305,0.120506070713539,0.166085922763964,0.0455798520504249,4.83286117480324e-07,2.85980978804818,4.88871857135775,4.82031916393206,5.11345948147071,0.293140317538652,0.0153172375054468,ENSG00000169239,CA5B,protein_coding,X,1,15688830,15788411,p22.2,carbonic anhydrase 5B [Source:HGNC Symbol;Acc:HGNC:1378],NA,CA5B,11238,NM_007220
ZNF442_TF,ZNF442,ZNF442_TF,ZNF442,TF,19,5.46170862189048,-0.0246572100638971,-0.0356957170854673,0.0116121701498335,0.0473078872353008,4.83538067515244e-07,4.6932599377545,0.96340404804348,0.894484151167908,1.1898551377775,0.295370986609594,4.82746674868426e-05,ENSG00000198342,ZNF442,protein_coding,19,-1,12345944,12365905,p13.2,zinc finger protein 442 [Source:HGNC Symbol;Acc:HGNC:20877],NA,ZNF442,79973,NM_030824
CEBPD_TF,CEBPD,CEBPD_TF,CEBPD,TF,335,-5.46094186652156,0.177309500584458,0.199586966096392,0.104112113902388,-0.0954748521940035,4.84271634077994e-07,-5.48129879835099,5.69354303317403,5.93546662459572,4.8986512327885,-1.03681539180722,1.74676035787286e-06,ENSG00000221869,CEBPD,protein_coding,8,-1,47736909,47739086,q11.21,CCAAT enhancer binding protein delta [Source:HGNC Symbol;Acc:HGNC:1835],NA,CEBPD,1052,NM_005195
TRIM65_SIG,TRIM65,TRIM65_SIG,TRIM65,SIG,42,5.46085566024255,0.372887549985929,0.353648663293566,0.436101034832262,0.0824523715386957,4.84271634077994e-07,5.11317721610188,4.81142562335208,4.71715119537142,5.12118445814566,0.404033262774238,8.98464850520907e-06,ENSG00000141569,TRIM65,protein_coding,17,-1,75880335,75896951,q25.1,tripartite motif containing 65 [Source:HGNC Symbol;Acc:HGNC:27316],NA,TRIM65,201292,NM_001256124;NM_173547
KCNJ5_SIG,KCNJ5,KCNJ5_SIG,KCNJ5,SIG,26,-5.4607362075757,-0.074690010706767,-0.0658221571398798,-0.103827243855111,-0.0380050867152308,4.84271634077994e-07,-2.86732192839952,0.447810560141979,0.487074588544526,0.318800181105038,-0.168274407439488,0.0150296469865639,ENSG00000120457,KCNJ5,protein_coding,11,1,128891356,128921163,q24.3,potassium voltage-gated channel subfamily J member 5 [Source:HGNC Symbol;Acc:HGNC:6266],Andersen Tawil syndrome;Familial hyperaldosteronism type III;HYPERALDOSTERONISM FAMILIAL TYPE III;Long QT syndrome 13;Romano-Ward syndrome,KCNJ5,3762,NM_000890;NM_001354169
PTGR2_SIG,PTGR2,PTGR2_SIG,PTGR2,SIG,97,5.4605629649939,0.0353820149811804,0.0165357428012384,0.0973054807152757,0.0807697379140373,4.84271634077994e-07,3.82142142764987,2.19023196976535,2.1068862252176,2.46408227327938,0.357196048061781,0.00100701902613946,ENSG00000140043,PTGR2,protein_coding,14,1,73851844,73886827,q24.3,prostaglandin reductase 2 [Source:HGNC Symbol;Acc:HGNC:20149],NA,PTGR2,145482,NM_001146154;NM_001146155;NM_152444
FRS3_SIG,FRS3,FRS3_SIG,FRS3,SIG,15,5.45881309073205,0.189587243928121,0.178272268663096,0.226765019798916,0.0484927511358203,4.88466503546086e-07,5.21279275004562,3.07833856991046,3.00687269804043,3.31315500605484,0.306282308014414,5.84334059246651e-06,ENSG00000137218,FRS3,protein_coding,6,-1,41770176,41786542,p21.1,fibroblast growth factor receptor substrate 3 [Source:HGNC Symbol;Acc:HGNC:16970],NA,FRS3,10817,NM_006653
ZNF764_TF,ZNF764,ZNF764_TF,ZNF764,TF,34,5.45848702903345,0.243873181005384,0.23316615092506,0.279053422697879,0.0458872717728192,4.88763028525976e-07,5.05658590906653,3.39141904606253,3.32699107211207,3.60311096047117,0.276119888359101,1.12298221745186e-05,ENSG00000169951,ZNF764,protein_coding,16,-1,30553764,30558498,p11.2,zinc finger protein 764 [Source:HGNC Symbol;Acc:HGNC:28200],NA,ZNF764,92595,NM_001172679;NM_033410
MYLK4_SIG,MYLK4,MYLK4_SIG,MYLK4,SIG,19,5.45567611920632,0.0458252362333575,0.0320395421102301,0.0911210883522049,0.0590815462419748,4.95949738241497e-07,2.51870073534531,2.34011575564805,2.26722936904884,2.57959959733117,0.312370228282332,0.0339039706860644,ENSG00000145949,MYLK4,protein_coding,6,-1,2663629,2750966,p25.2,myosin light chain kinase family member 4 [Source:HGNC Symbol;Acc:HGNC:27972],NA,MYLK4,340156,NM_001012418;NM_001347872
PEG10_SIG,PEG10,PEG10_SIG,PEG10,SIG,17,-5.45431677253638,-0.257334363894624,-0.247421206179482,-0.289906167815805,-0.0424849616363234,4.99145830910755e-07,-2.77153521522815,0.64477736180734,0.694413290295975,0.481687882487543,-0.212725407808432,0.0189097128601121,ENSG00000242265,PEG10,protein_coding,7,1,94656325,94669695,q21.3,paternally expressed 10 [Source:HGNC Symbol;Acc:HGNC:14005],NA,PEG10,23089,NM_001040152;NM_001172437;NM_001172438;NM_001184961;NM_001184962;NM_015068
FGFR3_SIG,FGFR3,FGFR3_SIG,FGFR3,SIG,30,5.45333902549529,-0.0779210914532035,-0.0887845029139487,-0.0422270252250406,0.0465574776889079,5.01285042472454e-07,3.49707692377987,1.59314511559395,1.48477079955579,1.94923215400505,0.464461354449262,0.00272506571618243,ENSG00000068078,FGFR3,protein_coding,4,1,1793293,1808872,p16.3,fibroblast growth factor receptor 3 [Source:HGNC Symbol;Acc:HGNC:3690],Achondroplasia;ACHONDROPLASIA SEVERE WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS;Bladder Cancer;Camptodactyly-tall stature-scoliosis-hearing loss syndrome;CAMPTODACTYLY TALL STATURE AND HEARING LOSS SYNDROME;Cervical Cancer;Colorectal Cancer;Crouzon syndrome-acanthosis nigricans syndrome;CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS;Giant cell glioblastoma;Gliosarcoma;HYPOCHONDROPLASIA;Isolated brachycephaly;Isolated plagiocephaly;LACRIMO-AURICULO-DENTO-DIGITAL SYNDROME;LACRIMOAURICULODENTODIGITAL SYNDROME;MUENKE SYNDROME;NEVUS EPIDERMAL;SAETHRE-CHOTZEN SYNDROME;Severe achondroplasia-developmental delay-acanthosis nigricans syndrome;TESTICULAR GERM CELL TUMOR;Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA TYPE 2;THANATOPHORIC DYSPLASIA TYPE I;THANATOPHORIC DYSPLASIA TYPE II,FGFR3,2261,NM_000142;NM_001163213;NM_001354809;NM_001354810;NM_022965
SLC7A9_SIG,SLC7A9,SLC7A9_SIG,SLC7A9,SIG,18,5.45251417737744,-0.0463638717678256,-0.0592367074086271,-0.00406741180519212,0.0551692956034351,5.03000899356437e-07,4.01148314227195,0.22599558398139,0.206144621919706,0.291220173612639,0.0850755516929333,0.000547239876525694,ENSG00000021488,SLC7A9,protein_coding,19,-1,32830509,32869767,q13.11,solute carrier family 7 member 9 [Source:HGNC Symbol;Acc:HGNC:11067],CYSTINURIA;Cystinuria type B,SLC7A9,11136,NM_001126335;NM_001243036;NM_014270
NRG1_SIG,NRG1,NRG1_SIG,NRG1,SIG,6,-5.45103670379702,0.0791215886116027,0.108057929788401,-0.0159549609693061,-0.124012890757707,5.06579017941877e-07,-2.16060571711262,0.625571187516157,0.68509154123466,0.430004311012504,-0.255087230222156,0.0716968370384393,ENSG00000157168,NRG1,protein_coding,8,1,31639222,32855666,p12,neuregulin 1 [Source:HGNC Symbol;Acc:HGNC:7997],SCHIZOPHRENIA 6,NRG1,3084,NM_001159995;NM_001159996;NM_001159999;NM_001160001;NM_001160002;NM_001160004;NM_001160005;NM_001160007;NM_001160008;NM_001322197;NM_001322201;NM_001322202;NM_001322205;NM_001322206;NM_001322207;NM_004495;NM_013956;NM_013957;NM_013958;NM_013959;NM_013960;NM_013962;NM_013964
TRDMT1_SIG,TRDMT1,TRDMT1_SIG,TRDMT1,SIG,33,5.45046220424593,0.0959311769159928,0.0837985272489331,0.135795597250618,0.0519970700016846,5.0725262077046e-07,3.68183747396017,3.52021163390799,3.46705561756039,3.69486711619296,0.227811498632563,0.00155407143358496,ENSG00000107614,TRDMT1,protein_coding,10,-1,17137336,17202054,p13,tRNA aspartic acid methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:2977],NA,TRDMT1,1787,NM_001321006;NM_001321007;NM_001351219;NM_001351220;NM_001351221;NM_001351222;NM_001351223;NM_004412
DRG2_SIG,DRG2,DRG2_SIG,DRG2,SIG,27,5.4503666843734,0.376259554671028,0.368457853239714,0.401893716516775,0.0334358632770611,5.0725262077046e-07,3.74051366929467,4.95327792317429,4.9133432311527,5.08449191124523,0.171148680092532,0.00129641136581311,ENSG00000108591,DRG2,protein_coding,17,1,18087892,18107970,p11.2,developmentally regulated GTP binding protein 2 [Source:HGNC Symbol;Acc:HGNC:3030],NA,DRG2,1819,NM_001330144;NM_001388
CENPT_TF,CENPT,CENPT_TF,CENPT,TF,91,5.44939379923329,0.147417766542655,0.136314554161757,0.183899750079892,0.0475851959181348,5.09414536644701e-07,4.01488344555804,5.87018251464518,5.81690434407835,6.04523936079335,0.228335016715005,0.000541667447557814,ENSG00000102901,CENPT,protein_coding,16,-1,67828157,67847811,q22.1,centromere protein T [Source:HGNC Symbol;Acc:HGNC:25787],NA,CENPT,80152,NM_025082
GPT2_SIG,GPT2,GPT2_SIG,GPT2,SIG,60,5.44915232494886,0.133140013348715,0.118261113880321,0.182027825887723,0.0637667120074021,5.09486771071603e-07,3.60434972474122,4.0460257517371,3.915542847531,4.47475529412855,0.559212446597553,0.00197145016125355,ENSG00000166123,GPT2,protein_coding,16,1,46884362,46931289,q11.2,glutamic--pyruvic transaminase 2 [Source:HGNC Symbol;Acc:HGNC:18062],MENTAL RETARDATION AUTOSOMAL RECESSIVE 49;Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,GPT2,84706,NM_001142466;NM_133443
TRPV3_SIG,TRPV3,TRPV3_SIG,TRPV3,SIG,18,-5.44399291212233,-0.0903423907951833,-0.0817851144156047,-0.11845915604237,-0.0366740416267654,5.23423625352816e-07,-1.63626835550464,0.61309420404321,0.640887298237611,0.521774037404461,-0.11911326083315,0.180398007381983,ENSG00000167723,TRPV3,protein_coding,17,-1,3510502,3557995,p13.2,transient receptor potential cation channel subfamily V member 3 [Source:HGNC Symbol;Acc:HGNC:18084],Isolated focal non-epidermolytic palmoplantar keratoderma;Mutilating palmoplantar keratoderma with periorificial keratotic plaques;Olmsted syndrome;PALMOPLANTAR KERATODERMA MUTILATING WITH PERIORIFICIAL KERATOTICPLAQUES;PALMOPLANTAR KERATODERMA NONEPIDERMOLYTIC FOCAL 2,TRPV3,162514,NM_001258205;NM_145068
CECR2_SIG,CECR2,CECR2_SIG,CECR2,SIG,14,-5.44391792686718,0.0230729839163281,0.0421776354318561,-0.039699442491835,-0.0818770779236912,5.23423625352816e-07,-2.86022020927423,0.443338289683333,0.489450167681012,0.291827833405244,-0.197622334275768,0.0153046152583424,ENSG00000099954,CECR2,protein_coding,22,1,17359949,17558149,q11.1,CECR2, histone acetyl-lysine reader [Source:HGNC Symbol;Acc:HGNC:1840],NA,CECR2,27443,NM_001290046;NM_001290047
FUBP3_TF,FUBP3,FUBP3_TF,FUBP3,TF,124,5.4418711596264,0.286451107571527,0.276648024559532,0.318661237468081,0.042013212908549,5.28833797952326e-07,2.75792262903651,5.76262085670033,5.72980934696407,5.87043010297661,0.140620756012542,0.0195702338644671,ENSG00000107164,FUBP3,protein_coding,9,1,130578965,130638352,q34.11,far upstream element binding protein 3 [Source:HGNC Symbol;Acc:HGNC:4005],NA,FUBP3,8939,NM_003934
PYGO1_SIG,PYGO1,PYGO1_SIG,PYGO1,SIG,22,-5.44001355544316,-0.126543888341698,-0.118197930012969,-0.153966322850381,-0.0357683928374119,5.33731494913636e-07,-2.95225984288233,0.332784077806838,0.385761628547895,0.158714982514795,-0.2270466460331,0.0121731995528475,ENSG00000171016,PYGO1,protein_coding,15,-1,55538890,55588947,q21.3,pygopus family PHD finger 1 [Source:HGNC Symbol;Acc:HGNC:30256],NA,PYGO1,26108,NM_001330326;NM_001367806;NM_015617
ZNF133_TF,ZNF133,ZNF133_TF,ZNF133,TF,75,5.43940276898747,-0.0318035267426385,-0.0469462944603949,0.0179512814728466,0.0648975759332414,5.34917572788533e-07,3.53295438414226,3.20848975080019,3.13440854205384,3.45189943668106,0.317490894627228,0.00244865653324551,ENSG00000125846,ZNF133,protein_coding,20,1,18288283,18316996,p11.23,zinc finger protein 133 [Source:HGNC Symbol;Acc:HGNC:12917],NA,ZNF133,7692,NM_001083330;NM_001282995;NM_001282996;NM_001282997;NM_001282998;NM_001282999;NM_001283000;NM_001283001;NM_001283002;NM_001283003;NM_001283004;NM_001283005;NM_001283006;NM_001283007;NM_001283008;NM_001352450;NM_001352451;NM_001352452;NM_001352453;NM_001352454;NM_001352455;NM_001352456;NM_001352457;NM_001352458;NM_001352459;NM_001352460;NM_001352461;NM_001352462;NM_001352463;NM_001352464;NM_003434
RCBTB1_SIG,RCBTB1,RCBTB1_SIG,RCBTB1,SIG,17,5.43719074497159,-0.0058052785489056,-0.0201574040123543,0.0413517051167116,0.061509109129066,5.40945379121782e-07,3.02794023254823,5.74843291120831,5.69280289145312,5.9312172618325,0.238414370379376,0.0100111915435836,ENSG00000136144,RCBTB1,protein_coding,13,-1,49531946,49585558,q14.2,RCC1 and BTB domain containing protein 1 [Source:HGNC Symbol;Acc:HGNC:18243],Reticular dystrophy of the retinal pigment epithelium;RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES,RCBTB1,55213,NM_001352500;NM_001352501;NM_001352502;NM_001352503;NM_001352504;NM_001352505;NM_001352506;NM_018191
UCHL1_SIG,UCHL1,UCHL1_SIG,UCHL1,SIG,91,-5.43512196019532,-0.131622814869661,-0.122766409107812,-0.16072243380145,-0.0379560246936379,5.45916849107591e-07,-1.66012418947951,0.574793543686639,0.61576075998823,0.440186975838553,-0.175573784149677,0.173801340214349,ENSG00000154277,UCHL1,protein_coding,4,1,41256413,41268455,p13,ubiquitin C-terminal hydrolase L1 [Source:HGNC Symbol;Acc:HGNC:12513],Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome;PARKINSON DISEASE 5 AUTOSOMAL DOMINANT SUSCEPTIBILITY TO;SPASTIC PARAPLEGIA 79 AUTOSOMAL RECESSIVE;Young-onset Parkinson disease,UCHL1,7345,NM_004181
HIBCH_SIG,HIBCH,HIBCH_SIG,HIBCH,SIG,100,5.43502622718926,0.189012732808015,0.166237457290616,0.263845780936608,0.097608323645992,5.45916849107591e-07,4.56187057666148,3.43034677210598,3.33372200147839,3.74782816131089,0.414106159832493,7.94124518566137e-05,ENSG00000198130,HIBCH,protein_coding,2,-1,190189735,190344193,q32.2,3-hydroxyisobutyryl-CoA hydrolase [Source:HGNC Symbol;Acc:HGNC:4908],3-@HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY;HIBCH deficiency;Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,HIBCH,26275,NM_014362;NM_198047
POU2AF1_TF,POU2AF1,POU2AF1_TF,POU2AF1,TF,215,-5.43491582084216,-0.210562262828071,-0.194477265539193,-0.263412968205815,-0.0689357026666224,5.45916849107591e-07,-3.96826659673699,1.82613407004087,1.95226034322674,1.41171917243015,-0.540541170796586,0.000628167752602663,ENSG00000110777,POU2AF1,protein_coding,11,-1,111352255,111455630,q23.1,POU class 2 associating factor 1 [Source:HGNC Symbol;Acc:HGNC:9211],Primary biliary cholangitis,POU2AF1,5450,NM_006235
ZNF283_TF,ZNF283,ZNF283_TF,ZNF283,TF,62,5.43425035433487,0.0935081768935824,0.0761622174822264,0.150502043530895,0.0743398260486686,5.4730010934022e-07,5.23249252103647,2.13685456866595,2.03833267009825,2.46056937824553,0.422236708147283,5.33414340384556e-06,ENSG00000167637,ZNF283,protein_coding,19,1,43827321,43852017,q13.31,zinc finger protein 283 [Source:HGNC Symbol;Acc:HGNC:13077],NA,ZNF283,284349,NM_001297752;NM_181845
ZDHHC19_TF,ZDHHC19,ZDHHC19_TF,ZDHHC19,TF,151,-5.43401988507696,-0.0129163456553569,-0.000178832479910888,-0.0547681746603939,-0.0545893421804832,5.47350776894249e-07,-2.47407398017948,0.706481094873492,0.764699728493311,0.515191298694086,-0.249508429799225,0.0373758008366891,ENSG00000163958,ZDHHC19,protein_coding,3,-1,196197452,196211437,q29,zinc finger DHHC-type containing 19 [Source:HGNC Symbol;Acc:HGNC:20713],NA,ZDHHC19,131540,NM_001039617
ABHD5_SIG,ABHD5,ABHD5_SIG,ABHD5,SIG,48,-5.43236747777191,0.0808251495998842,0.0986582457995117,0.0222306906582509,-0.0764275551412608,5.51783492061571e-07,-3.14751391066063,4.42518702695263,4.5033561744323,4.16834554237656,-0.335010632055743,0.00731607157055004,ENSG00000011198,ABHD5,protein_coding,3,1,43690108,43734371,p21.33,abhydrolase domain containing 5 [Source:HGNC Symbol;Acc:HGNC:21396],CHANARIN-DORFMAN SYNDROME;Dorfman-Chanarin disease,ABHD5,51099,NM_001355186;NM_001365649;NM_016006
ZNF131_TF,ZNF131,ZNF131_TF,ZNF131,TF,240,5.42781950629875,0.116784223051662,0.101360214665625,0.167463107748641,0.0661028930830162,5.65349029123725e-07,4.76792441271687,6.03443209842389,5.98064006179635,6.21117736162866,0.230537299832308,3.62690507378685e-05,ENSG00000172262,ZNF131,protein_coding,5,1,43065176,43192021,p12,zinc finger protein 131 [Source:HGNC Symbol;Acc:HGNC:12915],NA,ZNF131,7690,NM_001297548;NM_001330704;NM_001330705;NM_001330706;NM_001330707;NM_001330708;NM_001330709;NM_001330710;NM_001330711;NM_001330712;NM_001330713;NM_001330714;NM_001330715;NM_001330716;NM_001330717;NM_003432
HHAT_SIG,HHAT,HHAT_SIG,HHAT,SIG,56,5.42557389976169,0.165564932935725,0.151131846772509,0.21298793032915,0.0618560835566415,5.71707387435903e-07,2.51797239974765,2.6930828098059,2.62721645505444,2.90950083256071,0.282284377506266,0.0339484861150584,ENSG00000054392,HHAT,protein_coding,1,1,210328252,210676296,q32.2,hedgehog acyltransferase [Source:HGNC Symbol;Acc:HGNC:18270],Chondrodysplasia-disorder of sex development syndrome,HHAT,55733,NM_001122834;NM_001170564;NM_001170580;NM_001170587;NM_001170588;NM_018194
CYP4F3_SIG,CYP4F3,CYP4F3_SIG,CYP4F3,SIG,46,-5.42539570498199,0.0895657527641725,0.14128589818333,-0.080371867898774,-0.221657766082104,5.71707387435903e-07,-4.86941663901321,3.76187535537274,4.04929399875096,2.81749981284429,-1.23179418590667,2.42975669754601e-05,ENSG00000186529,CYP4F3,protein_coding,19,1,15640897,15662825,p13.12,cytochrome P450 family 4 subfamily F member 3 [Source:HGNC Symbol;Acc:HGNC:2646],NA,CYP4F3,4051,NM_000896;NM_001199208;NM_001199209
IVNS1ABP_SIG,IVNS1ABP,IVNS1ABP_SIG,IVNS1ABP,SIG,33,-5.42397203418558,0.0730695162205167,0.0900353502700559,0.0173246329148879,-0.0727107173551679,5.75595244187782e-07,-4.43827895121723,7.00400639362821,7.12627121587385,6.60227912053537,-0.523992095338481,0.00012422813990575,ENSG00000116679,IVNS1ABP,protein_coding,1,-1,185296388,185317273,q25.3,influenza virus NS1A binding protein [Source:HGNC Symbol;Acc:HGNC:16951],NA,IVNS1ABP,10625,NM_006469
AKT1_SIG,AKT1,AKT1_SIG,AKT1,SIG,18,5.42327360056079,0.192374843597729,0.184629574827898,0.217823583841456,0.0331940090135582,5.77161885078053e-07,4.55192316639174,7.62693443449325,7.58306507455757,7.77107661713904,0.188011542581468,8.21911670241417e-05,ENSG00000142208,AKT1,protein_coding,14,-1,104769349,104795751,q32.33,AKT serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:391],Breast Cancer;Colorectal Cancer;COWDEN SYNDROME;COWDEN SYNDROME 6;OVARIAN CANCER OVARIAN CANCER EPITHELIAL INCLUDED;Proteus syndrome;Schizophrenia,AKT1,207,NM_001014431;NM_001014432;NM_005163
ZSWIM4_TF,ZSWIM4,ZSWIM4_TF,ZSWIM4,TF,35,5.42166460582923,0.124865125832043,0.117705099916329,0.148390925269391,0.0306858253530621,5.81689652719856e-07,2.37745997673199,3.79722504930769,3.75121403512089,3.94840409592149,0.1971900608006,0.0460353757655191,ENSG00000132003,ZSWIM4,protein_coding,19,1,13795460,13832230,p13.13,zinc finger SWIM-type containing 4 [Source:HGNC Symbol;Acc:HGNC:25704],NA,ZSWIM4,65249,NM_023072
RALGDS_SIG,RALGDS,RALGDS_SIG,RALGDS,SIG,51,5.41902235049467,0.0713162334821931,0.0588760442789757,0.112191140864193,0.0533150965852175,5.89061846084745e-07,3.763326594588,6.99687106663496,6.92118339549911,7.24555912893847,0.324375733439366,0.00120485656267619,ENSG00000160271,RALGDS,protein_coding,9,-1,133097720,133149334,q34.2,ral guanine nucleotide dissociation stimulator [Source:HGNC Symbol;Acc:HGNC:9842],Autosomal Recessive Mental Retardation,RALGDS,5900,NM_001042368;NM_001271774;NM_001271775;NM_001271776;NM_006266
ZNF318_TF,ZNF318,ZNF318_TF,ZNF318,TF,113,-5.41898862140748,0.0744927815579875,0.0890163558256835,0.0267724661069864,-0.062243889718697,5.89061846084745e-07,-3.48569361930034,6.15286138707538,6.21478889734314,5.94938528190987,-0.265403615433276,0.00281371358753506,ENSG00000171467,ZNF318,protein_coding,6,-1,43307134,43369647,p21.1,zinc finger protein 318 [Source:HGNC Symbol;Acc:HGNC:13578],NA,ZNF318,24149,NM_014345
GPR18_SIG,GPR18,GPR18_SIG,GPR18,SIG,37,-5.41778061648371,0.0175275786947958,0.0334408664366449,-0.0347589381712796,-0.0681998046079245,5.92351924447319e-07,-3.6523537232857,1.47338883926015,1.55901791551775,1.19203616012804,-0.366981755389708,0.00170178951292109,ENSG00000125245,GPR18,protein_coding,13,-1,99254714,99261744,q32.3,G protein-coupled receptor 18 [Source:HGNC Symbol;Acc:HGNC:4472],NA,GPR18,2841,NM_001098200;NM_005292
GIPR_SIG,GIPR,GIPR_SIG,GIPR,SIG,19,-5.41649949051557,-0.063001526299271,-0.0503053607638536,-0.104717498772785,-0.0544121380089317,5.95903907764804e-07,-2.91705010998632,1.32634134539634,1.4122640289301,1.04402395664254,-0.368240072287565,0.0132987136644616,ENSG00000010310,GIPR,protein_coding,19,1,45668221,45683722,q13.32,gastric inhibitory polypeptide receptor [Source:HGNC Symbol;Acc:HGNC:4271],NA,GIPR,2696,NM_000164;NM_001308418
PTCH2_SIG,PTCH2,PTCH2_SIG,PTCH2,SIG,30,5.41331202448174,0.060448350113583,0.0513201216179976,0.0904411008847922,0.0391209792667945,6.0589732668139e-07,3.33470418589958,1.6565627506744,1.60826876679856,1.81524298340932,0.206974216610766,0.00435766621575541,ENSG00000117425,PTCH2,protein_coding,1,-1,44819844,44843253,p34.1,patched 2 [Source:HGNC Symbol;Acc:HGNC:9586],BASAL CELL CARCINOMA SUSCEPTIBILITY TO 1;Basal cell nevus syndrome;Gorlin syndrome;Medulloblastoma;Tessier number 7 facial cleft,PTCH2,8643,NM_001166292;NM_003738
SIRPB1_SIG,SIRPB1,SIRPB1_SIG,SIRPB1,SIG,48,-5.41284033252491,0.449015727229592,0.498289498053634,0.287116194522024,-0.211173303531609,6.06746222706607e-07,-5.78246756327824,5.30422508522348,5.6007380501504,4.32996820046359,-1.27076984968681,4.17145097760436e-07,ENSG00000101307,SIRPB1,protein_coding,20,-1,1563521,1620061,p13,signal regulatory protein beta 1 [Source:HGNC Symbol;Acc:HGNC:15928],NA,SIRPB1,10326,NM_001083910;NM_001135844;NM_001329157;NM_001330639;NM_006065
SHOX2_TF,SHOX2,SHOX2_TF,SHOX2,TF,47,-5.41263877283816,-0.0142574307751162,-0.0099399866180365,-0.0284433187198065,-0.01850333210177,6.06746222706607e-07,-1.59575151834102,0.325136075145507,0.349944644326693,0.243622204978754,-0.10632243934794,0.191831288332691,ENSG00000168779,SHOX2,protein_coding,3,-1,158095954,158106503,q25.32,short stature homeobox 2 [Source:HGNC Symbol;Acc:HGNC:10854],NA,SHOX2,6474,NM_001163678;NM_003030;NM_006884
PHF2_SIG,PHF2,PHF2_SIG,PHF2,SIG,25,-5.41097692636663,0.180346508371076,0.186033510409184,0.161660644531579,-0.0243728658776044,6.11312938920479e-07,-2.69221695125165,6.16889184032523,6.19643078546748,6.07840673485785,-0.11802405060963,0.0228430363099463,ENSG00000197724,PHF2,protein_coding,9,1,93576584,93679587,q22.31,PHD finger protein 2 [Source:HGNC Symbol;Acc:HGNC:8920],NA,PHF2,5253,NM_005392
TNFRSF9_SIG,TNFRSF9,TNFRSF9_SIG,TNFRSF9,SIG,14,-5.41087459487421,0.0987793858023148,0.120259303162846,0.0282025144748566,-0.0920567886879889,6.11312938920479e-07,-2.66948049237746,0.912919373520347,0.967063672370654,0.735016677297911,-0.232046995072743,0.0240223882644517,ENSG00000049249,TNFRSF9,protein_coding,1,-1,7915894,7943165,p36.23,TNF receptor superfamily member 9 [Source:HGNC Symbol;Acc:HGNC:11924],NA,TNFRSF9,3604,NM_001561
GPR135_SIG,GPR135,GPR135_SIG,GPR135,SIG,136,5.40942269344877,0.0437783683943293,0.0272242315965141,0.098170532158579,0.070946300562065,6.15565146521479e-07,4.01867327090365,2.11759534982808,2.02360294133941,2.42642754914799,0.40282460780858,0.000534630264281196,ENSG00000181619,GPR135,protein_coding,14,-1,59429022,59465342,q23.1,G protein-coupled receptor 135 [Source:HGNC Symbol;Acc:HGNC:19991],NA,GPR135,64582,NM_022571
STK16_SIG,STK16,STK16_SIG,STK16,SIG,6,-5.40805246010088,-0.0228357534081732,-0.01510224567037,-0.0482458502609551,-0.033143604590585,6.18879598239774e-07,-0.805398125567095,4.85420245318353,4.86301964251335,4.82523168824269,-0.0377879542706551,0.532137050844379,ENSG00000115661,STK16,protein_coding,2,1,219245455,219250337,q35,serine/threonine kinase 16 [Source:HGNC Symbol;Acc:HGNC:11394],NA,STK16,8576,NM_001008910;NM_001330213;NM_001330214;NM_001330215
CALM1_SIG,CALM1,CALM1_SIG,CALM1,SIG,37,-5.40804032468301,0.0929142044582933,0.10804350473396,0.0432036464096753,-0.0648398583242843,6.18879598239774e-07,-2.20668448417929,8.28751686222964,8.31983005263253,8.18134495090588,-0.138485101726655,0.0655681906757589,ENSG00000198668,CALM1,protein_coding,14,1,90396502,90408268,q32.11,calmodulin 1 [Source:HGNC Symbol;Acc:HGNC:1442],Catecholaminergic polymorphic ventricular tachycardia;LONG QT SYNDROME 14;Romano-Ward syndrome;VENTRICULAR TACHYCARDIA CATECHOLAMINERGIC POLYMORPHIC 4,CALM1,801,NM_001363669;NM_006888
PNMT_SIG,PNMT,PNMT_SIG,PNMT,SIG,48,-5.40550943162089,-0.0399556115278858,-0.0285622063652269,-0.0773910856337649,-0.0488288792685381,6.26947971708836e-07,-3.58979293284181,0.712632960572581,0.80062647178065,0.423511423746069,-0.377115048034581,0.00206212654352717,ENSG00000141744,PNMT,protein_coding,17,1,39667981,39670475,q12,phenylethanolamine N-methyltransferase [Source:HGNC Symbol;Acc:HGNC:9160],NA,PNMT,5409,NM_002686
IL6ST_SIG,IL6ST,IL6ST_SIG,IL6ST,SIG,51,-5.40259875446561,0.0258306754433525,0.0433316905834172,-0.0316726600168601,-0.0750043506002771,6.36465082070706e-07,-4.75334626212005,6.0841125446087,6.22211261280487,5.63068374910699,-0.591428863697884,3.81717983452708e-05,ENSG00000134352,IL6ST,protein_coding,5,-1,55935095,55995022,q11.2,interleukin 6 signal transducer [Source:HGNC Symbol;Acc:HGNC:6021],NA,IL6ST,3572,NM_001190981;NM_001364276;NM_001364278;NM_001364279;NM_002184;NM_175767
NLK_SIG,NLK,NLK_SIG,NLK,SIG,77,5.40136228399584,0.108906685760355,0.0939394317982241,0.15808480592164,0.0641453741234162,6.40119841992118e-07,2.65075021315967,5.15352616218813,5.09626676274124,5.34166418894218,0.245397426200936,0.0250179975751983,ENSG00000087095,NLK,protein_coding,17,1,28041737,28196381,q11.2,nemo like kinase [Source:HGNC Symbol;Acc:HGNC:29858],NA,NLK,51701,NM_016231
ZFP36L1_TF,ZFP36L1,ZFP36L1_TF,ZFP36L1,TF,190,-5.39985801315316,0.0673790433676349,0.0834677059162138,0.0145162949937326,-0.0689514109224811,6.44757274897002e-07,-4.62447435503236,6.61675155358693,6.80779386680089,5.98904109588392,-0.818752770916974,6.26016417255657e-05,ENSG00000185650,ZFP36L1,protein_coding,14,-1,68787660,68796253,q24.1,ZFP36 ring finger protein like 1 [Source:HGNC Symbol;Acc:HGNC:1107],NA,ZFP36L1,677,NM_001244698;NM_001244701;NM_004926
CLYBL_SIG,CLYBL,CLYBL_SIG,CLYBL,SIG,12,5.39961277399406,0.132067733107924,0.119829196786173,0.172280066736533,0.0524508699503607,6.44886741014832e-07,4.03765413587056,2.39717450478616,2.32433522782717,2.63650355765142,0.312168329824254,0.000502622273618795,ENSG00000125246,CLYBL,protein_coding,13,1,99606669,99897134,q32.3,citrate lyase beta like [Source:HGNC Symbol;Acc:HGNC:18355],NA,CLYBL,171425,NM_206808
TCF12_TF,TCF12,TCF12_TF,TCF12,TF,95,5.3987791274607,0.38235739903162,0.37146045313235,0.418161649843506,0.0467011967111554,6.47135809247913e-07,3.77154751270873,6.63340272071693,6.58375455399832,6.79653241136379,0.212777857365469,0.00117359363036751,ENSG00000140262,TCF12,protein_coding,15,1,56918623,57299281,q21.3,transcription factor 12 [Source:HGNC Symbol;Acc:HGNC:11623],Coronal Craniosynostosis;Craniosynostosis 3;Extraskeletal myxoid chondrosarcoma;Isolated brachycephaly;Isolated plagiocephaly,TCF12,6938,NM_001306219;NM_001306220;NM_001322151;NM_001322152;NM_001322154;NM_001322156;NM_001322157;NM_001322158;NM_001322159;NM_001322161;NM_001322162;NM_001322164;NM_001322165;NM_003205;NM_207036;NM_207037;NM_207038;NM_207040
OR7E140P_SIG,OR7E140P,OR7E140P_SIG,OR7E140P,SIG,7,-5.39821606579052,-0.00453341144897019,0.0391105833212138,-0.147935108551003,-0.187045691872217,6.48414745328448e-07,-3.8879484654488,0.193621507276329,0.229615414141915,0.0753558132894008,-0.154259600852514,0.000814359232330199,ENSG00000238152,OR7E140P,unprocessed_pseudogene,12,-1,8414780,8415805,p13.31,olfactory receptor family 7 subfamily E member 140 pseudogene [Source:HGNC Symbol;Acc:HGNC:19561],NA,OR7E140P,NA,NA
ZNF300_TF,ZNF300,ZNF300_TF,ZNF300,TF,81,-5.39800677830026,-0.0866323328460921,-0.0786897859176807,-0.112729272753729,-0.0340394868360486,6.48417416592827e-07,-2.35939763560793,1.29846565556126,1.38434824377956,1.01628000855826,-0.368068235221305,0.0477685794736874,ENSG00000145908,ZNF300,protein_coding,5,-1,150894392,150904983,q33.1,zinc finger protein 300 [Source:HGNC Symbol;Acc:HGNC:13091],NA,ZNF300,91975,NM_001172831;NM_001172832;NM_052860
NUDT3_SIG,NUDT3,NUDT3_SIG,NUDT3,SIG,28,5.39677444777713,0.170152090196785,0.160552391986333,0.201693955745412,0.0411415637590787,6.52127482003976e-07,1.9482536405239,7.69793567399647,7.67272536919517,7.78076953262931,0.108044163434141,0.106785931104324,ENSG00000272325,NUDT3,protein_coding,6,-1,34279679,34392669,p21.31,nudix hydrolase 3 [Source:HGNC Symbol;Acc:HGNC:8050],NA,NUDT3,11165,NM_006703
ALDH1A2_SIG,ALDH1A2,ALDH1A2_SIG,ALDH1A2,SIG,8,-5.39452925189345,0.0623578037620887,0.0951287421405113,-0.045318136624157,-0.140446878764668,6.59568891244189e-07,-3.24501011325716,0.539954367550964,0.606073862687018,0.322704597818215,-0.283369264868803,0.00560879262939464,ENSG00000128918,ALDH1A2,protein_coding,15,-1,57953424,58497866,q21.3,aldehyde dehydrogenase 1 family member A2 [Source:HGNC Symbol;Acc:HGNC:15472],NA,ALDH1A2,8854,NM_001206897;NM_003888;NM_170696;NM_170697
DAPK2_SIG,DAPK2,DAPK2_SIG,DAPK2,SIG,24,-5.39115574439295,0.0684041711738493,0.100952614092877,-0.0385407127029567,-0.139493326795834,6.71295641940694e-07,-5.61167997277297,2.80364229832282,3.01322317964863,2.11501940253803,-0.898203777110607,9.79847876522798e-07,ENSG00000035664,DAPK2,protein_coding,15,-1,63907036,64072033,q22.31,death associated protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:2675],NA,DAPK2,23604,NM_014326
LIFR_SIG,LIFR,LIFR_SIG,LIFR,SIG,44,5.38965149494084,-0.180769936264188,-0.190394984575065,-0.149144777528449,0.0412502070466161,6.76156074499983e-07,3.4458613877827,0.681990734031088,0.582858978107193,1.00770936063817,0.424850382530978,0.00315361184227348,ENSG00000113594,LIFR,protein_coding,5,-1,38474668,38608354,p13.1,LIF receptor alpha [Source:HGNC Symbol;Acc:HGNC:6597],Stuve-Wiedemann syndrome,LIFR,3977,NM_001127671;NM_001364297;NM_002310
RPS6KC1_SIG,RPS6KC1,RPS6KC1_SIG,RPS6KC1,SIG,31,5.38760183812723,0.247030959208016,0.232686140002305,0.294163936598211,0.0614777965959058,6.83120428237236e-07,4.79819465827786,5.41153389398288,5.33190808832367,5.67316154114888,0.34125345282521,3.2128758116807e-05,ENSG00000136643,RPS6KC1,protein_coding,1,1,213051233,213274774,q32.3,ribosomal protein S6 kinase C1 [Source:HGNC Symbol;Acc:HGNC:10439],NA,RPS6KC1,26750,NM_001136138;NM_001287218;NM_001287219;NM_001287220;NM_001287221;NM_001349646;NM_001349647;NM_001349648;NM_001349649;NM_001349650;NM_001349651;NM_001349652;NM_001349653;NM_001349654;NM_001349657;NM_001349658;NM_001349659;NM_001349660;NM_001349661;NM_001349662;NM_001349663;NM_001349664;NM_001349665;NM_001349666;NM_001349667;NM_001349668;NM_001349669;NM_001349670;NM_001349671;NM_001349672;NM_012424
CDC42EP3_SIG,CDC42EP3,CDC42EP3_SIG,CDC42EP3,SIG,21,-5.38646623212009,0.497502737750063,0.527876967506091,0.397701697123112,-0.130175270382979,6.86655656532769e-07,-5.62658613544431,6.70896680414262,6.902095939463,6.07439964523281,-0.82769629423019,9.18532233139883e-07,ENSG00000163171,CDC42EP3,protein_coding,2,-1,37641882,37738468,p22.2,CDC42 effector protein 3 [Source:HGNC Symbol;Acc:HGNC:16943],NA,CDC42EP3,10602,NM_001270436;NM_001270437;NM_001270438;NM_006449
HEMK1_SIG,HEMK1,HEMK1_SIG,HEMK1,SIG,208,5.38517568481329,0.117335130725627,0.0986594313841044,0.178698142847773,0.0800387114636687,6.90804078347941e-07,5.01241485486227,4.80429222576229,4.70016302843339,5.1464310169858,0.446267988552407,1.35487338898945e-05,ENSG00000114735,HEMK1,protein_coding,3,1,50569152,50596168,p21.31,HemK methyltransferase family member 1 [Source:HGNC Symbol;Acc:HGNC:24923],NA,HEMK1,51409,NM_001317851;NM_016173
ZMYM6_TF,ZMYM6,ZMYM6_TF,ZMYM6,TF,98,5.38401763607347,0.196194375849098,0.188762833437502,0.220612300915771,0.0318494674782684,6.94465689264049e-07,3.25742083427663,4.65042094444222,4.61509785344026,4.76648252916296,0.151384675722699,0.0054076727320582,ENSG00000163867,ZMYM6,protein_coding,1,-1,34986165,35031945,p34.3,zinc finger MYM-type containing 6 [Source:HGNC Symbol;Acc:HGNC:13050],Intellectual disability,ZMYM6,9204,NM_007167
CDK10_SIG,CDK10,CDK10_SIG,CDK10,SIG,39,5.38199674196784,0.353020262096563,0.337723438866266,0.403281252710397,0.0655578138441312,7.00857876079534e-07,4.2835085852702,5.3442267685388,5.26778826025594,5.59538186718249,0.327593606926553,0.000217121445699538,ENSG00000185324,CDK10,protein_coding,16,1,89680737,89696354,q24.3,cyclin dependent kinase 10 [Source:HGNC Symbol;Acc:HGNC:1770],AL KAISSI SYNDROME;Severe Growth Retardation Spine Malformations and Developmental Delays,CDK10,8558,NM_001098533;NM_001160367;NM_052987;NM_052988
CLCF1_SIG,CLCF1,CLCF1_SIG,CLCF1,SIG,9,-5.38195541954065,-0.135182615961504,-0.117390027960221,-0.193643976537148,-0.0762539485769271,7.00857876079534e-07,-4.41311886023448,2.40262139680554,2.52909106570948,1.98707819897828,-0.542012866731203,0.000136315643631423,ENSG00000175505,CLCF1,protein_coding,11,-1,67364168,67374177,q13.2,cardiotrophin like cytokine factor 1 [Source:HGNC Symbol;Acc:HGNC:17412],Cold-induced sweating syndrome;CRISPONI SYNDROME;CRISPONI/COLD-INDUCED SWEATING SYNDROME 2,CLCF1,23529,NM_001166212;NM_013246
CERS5_TF,CERS5,CERS5_TF,CERS5,TF,120,5.3813788281219,0.184324058445497,0.180501766329317,0.196883018255805,0.0163812519264883,7.0230056530359e-07,1.3955126621447,5.30105697547299,5.28803781652315,5.34383421202245,0.0557963954993,0.258282186726838,ENSG00000139624,CERS5,protein_coding,12,-1,50129306,50167533,q13.12,ceramide synthase 5 [Source:HGNC Symbol;Acc:HGNC:23749],NA,CERS5,91012,NM_001281731;NM_001331069;NM_001331070;NM_001331071;NM_001331072;NM_001331073;NM_147190
PLA2G2D_SIG,PLA2G2D,PLA2G2D_SIG,PLA2G2D,SIG,35,-5.38046997444228,-0.123296699605098,-0.111077633054624,-0.163445061128086,-0.0523674280734624,7.04529948516291e-07,-2.52990833952759,0.333689997959152,0.372286613106418,0.206872548189566,-0.165414064916851,0.0330972190062448,ENSG00000117215,PLA2G2D,protein_coding,1,-1,20111939,20119566,p36.12,phospholipase A2 group IID [Source:HGNC Symbol;Acc:HGNC:9033],NA,PLA2G2D,26279,NM_001271814;NM_012400
COQ6_SIG,COQ6,COQ6_SIG,COQ6,SIG,18,5.3803959915061,0.371706132921074,0.361710222029383,0.404549840136631,0.0428396181072478,7.04529948516291e-07,3.99834588892319,4.03139893875438,3.98338109273394,4.18917186139297,0.205790768659025,0.000571477706461944,ENSG00000119723,COQ6,protein_coding,14,1,73949926,73963670,q24.3,coenzyme Q6, monooxygenase [Source:HGNC Symbol;Acc:HGNC:20233],COENZYME Q10 DEFICIENCY PRIMARY 6;Familial steroid-resistant nephrotic syndrome with sensorineural deafness;Neurofibromatosis type 3,COQ6,51004,NM_182476;NM_182480
ANAPC5_SIG,ANAPC5,ANAPC5_SIG,ANAPC5,SIG,25,5.37964743728961,0.262538683355317,0.248224907196835,0.309569662161757,0.0613447549649222,7.06502105466783e-07,3.56719813469762,7.19198355970967,7.14058492493758,7.36086478824653,0.220279863308956,0.00220616218002706,ENSG00000089053,ANAPC5,protein_coding,12,-1,121308245,121399896,q24.31,anaphase promoting complex subunit 5 [Source:HGNC Symbol;Acc:HGNC:15713],NA,ANAPC5,51433,NM_001137559;NM_001330489;NM_016237
CD177_SIG,CD177,CD177_SIG,CD177,SIG,8,-5.3794812698525,0.185494488874764,0.242384922298761,-0.00143122094694165,-0.243816143245702,7.06502105466783e-07,-4.36130963691395,2.7750907220997,3.05266465027708,1.86306210094546,-1.18960254933162,0.00016375541489526,ENSG00000204936,CD177,protein_coding,19,1,43353686,43363172,q13.31,CD177 molecule [Source:HGNC Symbol;Acc:HGNC:30072],NA,CD177,57126,NM_020406
IRGM_SIG,IRGM,IRGM_SIG,IRGM,SIG,47,5.37925123691208,0.197990515159601,0.182752995454332,0.248056651334055,0.0653036558797229,7.06598724726519e-07,4.10222245017239,2.09635940462437,1.97166125963572,2.50608188101563,0.534420621379909,0.000402797993539463,ENSG00000237693,IRGM,protein_coding,5,1,150846523,150900736,q33.1,immunity related GTPase M [Source:HGNC Symbol;Acc:HGNC:29597],INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 19;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,IRGM,345611,NM_001145805
ITGAD_SIG,ITGAD,ITGAD_SIG,ITGAD,SIG,4,-5.37898970707793,-0.0105759137113494,0.000455206224910886,-0.0468210220733475,-0.0472762282982584,7.06819872234453e-07,-2.93033487877068,1.00871018925031,1.06222640480577,0.832871195282363,-0.229355209523411,0.0128704605798396,ENSG00000156886,ITGAD,protein_coding,16,1,31393312,31426505,p11.2,integrin subunit alpha D [Source:HGNC Symbol;Acc:HGNC:6146],NA,ITGAD,3681,NM_001318185;NM_005353
RORC_TF,RORC,RORC_TF,RORC,TF,116,-5.37771812552885,-0.0037157765794156,0.0105905133399719,-0.0507221577431173,-0.0613126710830893,7.11018836122873e-07,-3.81322250106567,0.696487743210177,0.759883844081701,0.488186268918025,-0.271697575163676,0.00103381908468156,ENSG00000143365,RORC,protein_coding,1,-1,151806071,151831845,q21.3,RAR related orphan receptor C [Source:HGNC Symbol;Acc:HGNC:10260],Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency;IMMUNODEFICIENCY 42,RORC,6097,NM_001001523;NM_005060
DMPK_SIG,DMPK,DMPK_SIG,DMPK,SIG,28,-5.37565498193441,-0.0376936403301599,-0.0230282824830497,-0.0858798161135218,-0.062851533630472,7.18392199468573e-07,-3.91303368695089,2.31788475668144,2.43409129491896,1.936063273901,-0.498028021017967,0.000748694296447922,ENSG00000104936,DMPK,protein_coding,19,-1,45769717,45782552,q13.32,DM1 protein kinase [Source:HGNC Symbol;Acc:HGNC:2933],DYSTROPHIA MYOTONICA TYPE 1;MYOTONIC DYSTROPHY 1;Steinert myotonic dystrophy,DMPK,1760,NM_001081560;NM_001081562;NM_001081563;NM_001288764;NM_001288765;NM_001288766;NM_004409
MINK1_SIG,MINK1,MINK1_SIG,MINK1,SIG,32,-5.37355322620114,0.19163680791112,0.209184166611533,0.133981200752618,-0.0752029658589151,7.25995485134845e-07,-2.56920889176062,6.32725857259341,6.37137163174411,6.1823156639554,-0.189055967788706,0.0301997675721787,ENSG00000141503,MINK1,protein_coding,17,1,4833340,4898061,p13.2,misshapen like kinase 1 [Source:HGNC Symbol;Acc:HGNC:17565],NA,MINK1,50488,NM_001024937;NM_001321236;NM_015716;NM_153827;NM_170663
MBLAC2_SIG,MBLAC2,MBLAC2_SIG,MBLAC2,SIG,92,5.37308861757325,0.153523710342617,0.135571898747747,0.212508234154333,0.0769363354065858,7.27044123645191e-07,4.4780149661358,3.51247770981846,3.40531903144447,3.86457051019013,0.459251478745658,0.000107332932436866,ENSG00000176055,MBLAC2,protein_coding,5,-1,90458209,90474771,q14.3,metallo-beta-lactamase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:33711],NA,MBLAC2,153364,NM_203406
WDR5B_SIG,WDR5B,WDR5B_SIG,WDR5B,SIG,95,5.37265958616563,-0.0258449878973177,-0.0450063092066214,0.0371136392618232,0.0821199484684445,7.27951369678451e-07,4.93211839067434,3.33242616249569,3.21596802276085,3.71507433591013,0.499106313149278,1.86626468511567e-05,ENSG00000196981,WDR5B,protein_coding,3,-1,122412332,122416051,q21.1,WD repeat domain 5B [Source:HGNC Symbol;Acc:HGNC:17826],NA,WDR5B,54554,NM_019069
MMP19_SIG,MMP19,MMP19_SIG,MMP19,SIG,78,5.37202743668273,0.0781737196379632,0.0681315717060059,0.111169348557251,0.0430377768512454,7.29682245167772e-07,5.09784563656276,2.61344306844525,2.38522942999162,3.36328788050718,0.978058450515563,9.46374017836017e-06,ENSG00000123342,MMP19,protein_coding,12,-1,55835433,55842966,q13.2,matrix metallopeptidase 19 [Source:HGNC Symbol;Acc:HGNC:7165],CAVITARY OPTIC DISC ANOMALIES;Familial cavitary optic disc anomaly,MMP19,4327,NM_001272101;NM_002429
ZNF175_TF,ZNF175,ZNF175_TF,ZNF175,TF,28,5.36576769215272,0.14670748658073,0.130137452781346,0.201151883350138,0.0710144305687919,7.54230960082383e-07,4.39664805578416,3.44733449099281,3.32997533613949,3.83294314265373,0.502967806514238,0.000144766425007029,ENSG00000105497,ZNF175,protein_coding,19,1,51571283,51592510,q13.41,zinc finger protein 175 [Source:HGNC Symbol;Acc:HGNC:12964],NA,ZNF175,7728,NM_007147
GYG1_SIG,GYG1,GYG1_SIG,GYG1,SIG,43,-5.36551141809241,0.410844081714509,0.430110557661478,0.347539946460186,-0.0825706112012921,7.54230960082383e-07,-4.03467251181719,6.02802673840718,6.11491805009627,5.74252671428591,-0.372391335810358,0.000508218570576765,ENSG00000163754,GYG1,protein_coding,3,1,148991341,149027668,q24,glycogenin 1 [Source:HGNC Symbol;Acc:HGNC:4699],Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency;GLYCOGEN STORAGE DISEASE XV;POLYGLUCOSAN BODY MYOPATHY 2;Polyglucosan body myopathy type 2,GYG1,2992,NM_001184720;NM_001184721;NM_004130
SATB1_TF,SATB1,SATB1_TF,SATB1,TF,77,5.36544767850339,0.124774231562882,0.113685563237153,0.16120842749028,0.0475228642531279,7.54230960082383e-07,1.32716848205183,7.67403622845546,7.64799050498943,7.75961503412958,0.111624529140152,0.284157592592039,ENSG00000182568,SATB1,protein_coding,3,-1,18345377,18445588,p24.3,SATB homeobox 1 [Source:HGNC Symbol;Acc:HGNC:10541],NA,SATB1,6304,NM_001131010;NM_001195470;NM_001322871;NM_001322872;NM_001322873;NM_001322874;NM_001322875;NM_001322876;NM_002971
LTF_SIG,LTF,LTF_SIG,LTF,SIG,37,-5.36415909261717,0.0586931130173644,0.106122348207634,-0.0971458026078077,-0.203268150815442,7.58779117910536e-07,-5.73332967447368,6.8596043699206,7.36769502721566,5.19016363880826,-2.1775313884074,5.39314401180222e-07,ENSG00000012223,LTF,protein_coding,3,-1,46435645,46485234,p21.31,lactotransferrin [Source:HGNC Symbol;Acc:HGNC:6720],NA,LTF,4057,NM_001199149;NM_001321121;NM_001321122;NM_002343
TMEM231_SIG,TMEM231,TMEM231_SIG,TMEM231,SIG,30,5.36250311517422,-0.08604279254989,-0.0944829435762297,-0.0583108677490595,0.03617207582717,7.64909154085714e-07,4.48922677669511,1.39146086779753,1.30487666226473,1.67595182883389,0.371075166569167,0.000103384309768528,ENSG00000205084,TMEM231,protein_coding,16,-1,75536741,75556268,q23.1,transmembrane protein 231 [Source:HGNC Symbol;Acc:HGNC:37234],JOUBERT SYNDROME 20;Joubert syndrome with oculorenal defect;Meckel syndrome;Meckel syndrome type 11,TMEM231,79583,NM_001077416;NM_001077418
PRKCI_SIG,PRKCI,PRKCI_SIG,PRKCI,SIG,53,5.36178871957982,0.480652354572436,0.462623808270823,0.539889006706307,0.0772651984354839,7.67078235820331e-07,4.40132117659733,5.0338128023639,4.96284976574611,5.26697706553663,0.304127299790518,0.000142524236160226,ENSG00000163558,PRKCI,protein_coding,3,1,170222424,170305977,q26.2,protein kinase C iota [Source:HGNC Symbol;Acc:HGNC:9404],NA,PRKCI,5584,NM_002740
CA4_SIG,CA4,CA4_SIG,CA4,SIG,23,-5.35974230307827,-0.0252455928683454,0.0229783890559147,-0.183695819190914,-0.206674208246829,7.74947343324044e-07,-4.12043946467135,1.61619879208319,1.79063685183266,1.04304516719209,-0.747591684640576,0.000379429747699332,ENSG00000167434,CA4,protein_coding,17,1,60149942,60170899,q23.1,carbonic anhydrase 4 [Source:HGNC Symbol;Acc:HGNC:1375],Retinitis pigmentosa;RETINITIS PIGMENTOSA 17,CA4,762,NM_000717
FKRP_SIG,FKRP,FKRP_SIG,FKRP,SIG,15,5.35875287811809,0.27897052963317,0.273838158678001,0.295834034200154,0.021995875522153,7.78329156638801e-07,3.24200843382901,4.14686505692282,4.11164328261392,4.26259374393776,0.150950461323835,0.00565519544025683,ENSG00000181027,FKRP,protein_coding,19,1,46746046,46776988,q13.32,fukutin related protein [Source:HGNC Symbol;Acc:HGNC:17997],Autosomal recessive limb-girdle muscular dystrophy type 2I;Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Congenital muscular dystrophy without intellectual disability;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 5;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION) TYPE B 5;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 5;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH BRAIN AND EYE ANOMALIES TYPE A5;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH OR WITHOUT MENTAL RETARDATION TYPE B5;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY LIMB-GIRDLE TYPE C5;Walker-Warburg syndrome,FKRP,79147,NM_001039885;NM_024301
EPPK1_SIG,EPPK1,EPPK1_SIG,EPPK1,SIG,17,-5.35759566796314,-0.0401210257188779,-0.0282971502100396,-0.0789709023907749,-0.0506737521807353,7.82452042928922e-07,-2.81598654952539,0.966925880375574,1.04378305128525,0.714395175958075,-0.329387875327173,0.0170323748769996,ENSG00000261150,EPPK1,protein_coding,8,-1,143857324,143878464,q24.3,epiplakin 1 [Source:HGNC Symbol;Acc:HGNC:15577],NA,EPPK1,83481,NM_031308
ZNF445_TF,ZNF445,ZNF445_TF,ZNF445,TF,72,5.35721654838826,0.498384185908247,0.483932965974077,0.545866765691947,0.0619337997178702,7.82919519570064e-07,3.85311118461741,5.9041339922045,5.82394574478782,6.16760966228787,0.34366391750005,0.00091087450968237,ENSG00000185219,ZNF445,protein_coding,3,-1,44431705,44477670,p21.31,zinc finger protein 445 [Source:HGNC Symbol;Acc:HGNC:21018],NA,ZNF445,353274,NM_181489
PAX5_SIG,PAX5,PAX5_SIG,PAX5,SIG,29,-5.35708337715649,-0.0999597743097416,-0.0861971944954927,-0.145179679413702,-0.0589824849182095,7.82919519570064e-07,-4.11201692664672,2.68327035774468,2.85741722038021,2.11107352337082,-0.746343697009386,0.000389776842913855,ENSG00000196092,PAX5,protein_coding,9,-1,36833269,37034268,p13.2,paired box 5 [Source:HGNC Symbol;Acc:HGNC:8619],Leukemia acute lymphoblastic susceptibility to 3;Precursor B-cell acute lymphoblastic leukemia,PAX5,5079,NM_001280547;NM_001280548;NM_001280549;NM_001280550;NM_001280551;NM_001280552;NM_001280553;NM_001280554;NM_001280555;NM_001280556;NM_016734
FER_SIG,FER,FER_SIG,FER,SIG,8,5.3567056213538,0.303283784383869,0.284822022125629,0.363943860375228,0.0791218382495983,7.83681823616358e-07,3.50767695477095,4.29565996045286,4.2125390240092,4.56877160876775,0.356232584758557,0.00264407730282088,ENSG00000151422,FER,protein_coding,5,1,108747841,109196841,q21.3,FER tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:3655],NA,FER,2241,NM_001308028;NM_001308031;NM_001308038;NM_005246
LPIN3_SIG,LPIN3,LPIN3_SIG,LPIN3,SIG,32,-5.35610950856974,-0.123475460839693,-0.114409778122785,-0.153262704052389,-0.0388529259296033,7.85393835761387e-07,-2.77204182844647,0.440042426356583,0.496213069370001,0.255481742169638,-0.240731327200363,0.0188910743880633,ENSG00000132793,LPIN3,protein_coding,20,1,41340920,41360582,q12,lipin 3 [Source:HGNC Symbol;Acc:HGNC:14451],NA,LPIN3,64900,NM_001301860;NM_022896
HK3_SIG,HK3,HK3_SIG,HK3,SIG,66,-5.35447353015866,0.371681202254971,0.416638963797893,0.223962842899656,-0.192676120898238,7.91650019094299e-07,-5.49453191240937,5.91526875278471,6.2367897519625,4.85884261262911,-1.37794713933339,1.64454981950696e-06,ENSG00000160883,HK3,protein_coding,5,-1,176880869,176899346,q35.2,hexokinase 3 [Source:HGNC Symbol;Acc:HGNC:4925],NA,HK3,3101,NM_002115
CR1_SIG,CR1,CR1_SIG,CR1,SIG,18,-5.35118126528621,0.444237261164271,0.507020163840848,0.23795058094123,-0.269069582899618,8.05294058430666e-07,-5.22355039482203,5.06207344296192,5.33866921303902,4.15325876985144,-1.18541044318758,5.56730111494911e-06,ENSG00000203710,CR1,protein_coding,1,1,207496147,207641765,q32.2,complement C3b/C4b receptor 1 (Knops blood group) [Source:HGNC Symbol;Acc:HGNC:2334],KNOPS BLOOD GROUP SYSTEM;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED,CR1,1378,NM_000573;NM_000651
CTBS_SIG,CTBS,CTBS_SIG,CTBS,SIG,11,-5.34968585510538,0.390902899109725,0.405003641560811,0.344571888199012,-0.0604317533617987,8.11074224766303e-07,-5.06426548962057,5.58311574623507,5.64972272289881,5.36426425148277,-0.285458471416039,1.08489766800836e-05,ENSG00000117151,CTBS,protein_coding,1,-1,84549611,84574480,p22.3,chitobiase [Source:HGNC Symbol;Acc:HGNC:2496],NA,CTBS,1486,NM_004388
CHL1_SIG,CHL1,CHL1_SIG,CHL1,SIG,112,-5.34871465466781,-0.208873246000818,-0.192480964890861,-0.26273359821925,-0.0702526333283894,8.14532945082031e-07,-2.65869734042811,0.364062387930666,0.41384575171871,0.200488478341379,-0.213357273377331,0.0246108763970741,ENSG00000134121,CHL1,protein_coding,3,1,196763,409417,p26.3,cell adhesion molecule L1 like [Source:HGNC Symbol;Acc:HGNC:1939],NA,CHL1,10752,NM_001253387;NM_001253388;NM_006614
POLRMT_SIG,POLRMT,POLRMT_SIG,POLRMT,SIG,47,5.34672229263729,0.386246684880156,0.373717730867824,0.427413248063533,0.0536955171957088,8.22633165251088e-07,4.6102729611736,5.0516626256411,4.98770101421725,5.26182220603374,0.274121191816493,6.60696766322162e-05,ENSG00000099821,POLRMT,protein_coding,19,-1,617221,633537,p13.3,RNA polymerase mitochondrial [Source:HGNC Symbol;Acc:HGNC:9200],NA,POLRMT,5442,NM_005035
DNM1L_SIG,DNM1L,DNM1L_SIG,DNM1L,SIG,22,5.34203834272534,0.513675269346261,0.50577732718066,0.53962565074752,0.0338483235668591,8.43246088617956e-07,3.43792661384731,6.71424408816879,6.67924832528418,6.82923016621824,0.149981840934061,0.0032179668274315,ENSG00000087470,DNM1L,protein_coding,12,1,32679200,32745650,p11.21,dynamin 1 like [Source:HGNC Symbol;Acc:HGNC:2973],Autosomal dominant optic atrophy classic form;DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect;ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1;OPTIC ATROPHY 5,DNM1L,10059,NM_001278463;NM_001278464;NM_001278465;NM_001278466;NM_001330380;NM_005690;NM_012062;NM_012063
IFNLR1_SIG,IFNLR1,IFNLR1_SIG,IFNLR1,SIG,34,-5.3411561408637,-0.154544450246133,-0.137061430099668,-0.211988659298803,-0.0749272291991352,8.46423313635427e-07,-3.60601265413487,0.806568366448655,0.880666327435554,0.563103637491701,-0.317562689943852,0.00196157200532884,ENSG00000185436,IFNLR1,protein_coding,1,-1,24154168,24187959,p36.11,interferon lambda receptor 1 [Source:HGNC Symbol;Acc:HGNC:18584],NA,IFNLR1,163702,NM_170743;NM_173064;NM_173065
BCL11A_TF,BCL11A,BCL11A_TF,BCL11A,TF,133,5.33731273701046,0.146292674137673,0.130563457796122,0.197974384974198,0.0674109271780764,8.63601390769903e-07,3.78934450229467,5.56829977844916,5.44603477979272,5.97002763117746,0.52399285138474,0.00111199937736119,ENSG00000119866,BCL11A,protein_coding,2,-1,60450520,60555154,p16.1,BCL11A, BAF complex component [Source:HGNC Symbol;Acc:HGNC:13221],Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN;Intellectual disability,BCL11A,53335,NM_001365609;NM_018014;NM_022893;NM_138559
EML4_SIG,EML4,EML4_SIG,EML4,SIG,57,-5.33656769907104,0.0992581917215252,0.117582901769836,0.0390484301342193,-0.0785344716356165,8.66198718332958e-07,-2.78976992750375,6.00742034964256,6.07083954561591,5.79904299144441,-0.271796554171506,0.01812995265888,ENSG00000143924,EML4,protein_coding,2,1,42169353,42332548,p21,EMAP like 4 [Source:HGNC Symbol;Acc:HGNC:1316],Selection of therapeutic option in non-small cell lung carcinoma,EML4,27436,NM_001145076;NM_019063
PKIG_SIG,PKIG,PKIG_SIG,PKIG,SIG,34,5.3351065039801,-0.0216511210821121,-0.0411456136643614,0.0424022116881353,0.0835478253524966,8.72240531871103e-07,3.55253544697733,3.8705423142596,3.77708774690331,4.17760732128742,0.400519574384115,0.00230996139818588,ENSG00000168734,PKIG,protein_coding,20,1,44531785,44624247,q13.12,cAMP-dependent protein kinase inhibitor gamma [Source:HGNC Symbol;Acc:HGNC:9019],NA,PKIG,11142,NM_001281444;NM_001281445;NM_007066;NM_181804;NM_181805
IGF2R_SIG,IGF2R,IGF2R_SIG,IGF2R,SIG,35,-5.33171787905473,0.120268164222083,0.150312532799086,0.0215509531833595,-0.128761579615727,8.87699441553292e-07,-3.68005851573764,6.97569124665198,7.14295648799535,6.42610545366662,-0.716851034328726,0.00156254157547582,ENSG00000197081,IGF2R,protein_coding,6,1,159969099,160113507,q25.3,insulin like growth factor 2 receptor [Source:HGNC Symbol;Acc:HGNC:5467],Hepatocellular Carcinoma,IGF2R,3482,NM_000876
CAV1_SIG,CAV1,CAV1_SIG,CAV1,SIG,55,-5.33129625650893,-0.129500051596995,-0.121459976788662,-0.155917440252945,-0.034457463464283,8.88784402872482e-07,-1.25604077065839,1.57114875329612,1.62277481593323,1.40152026177418,-0.221254554159047,0.312837853961939,ENSG00000105974,CAV1,protein_coding,7,1,116525001,116561184,q31.2,caveolin 1 [Source:HGNC Symbol;Acc:HGNC:1527],Berardinelli-Seip congenital lipodystrophy;CONGENITAL GENERALIZED LIPODYSTROPHY TYPE 3;Diffuse cutaneous systemic sclerosis;Heritable pulmonary arterial hypertension;Limited cutaneous systemic sclerosis;LIPODYSTROPHY CONGENITAL GENERALIZED TYPE 3;PARTIAL LIPODYSTROPHY CONGENITAL CATARACTS AND NEURODEGENERATION SYNDROME;PULMONARY HYPERTENSION PRIMARY 3,CAV1,857,NM_001172895;NM_001172896;NM_001172897;NM_001753
ATP8B4_SIG,ATP8B4,ATP8B4_SIG,ATP8B4,SIG,57,5.33076906108843,0.229899050814993,0.217876688234995,0.269401099292133,0.0515244110571382,8.90389133182022e-07,2.87989738864773,7.40056567508548,7.30226377879385,7.72355762004369,0.421293841249835,0.0145761215055208,ENSG00000104043,ATP8B4,protein_coding,15,-1,49858238,50182817,q21.2,ATPase phospholipid transporting 8B4 (putative) [Source:HGNC Symbol;Acc:HGNC:13536],NA,ATP8B4,79895,NM_024837
FAHD2A_SIG,FAHD2A,FAHD2A_SIG,FAHD2A,SIG,118,5.3297741941033,0.118395503548312,0.102908285022745,0.169282078703748,0.0663737936810033,8.94297568781618e-07,3.89888619754747,4.23383898834804,4.17979704932982,4.41140535940789,0.231608310078061,0.000783693309555183,ENSG00000115042,FAHD2A,protein_coding,2,1,95402708,95416616,q11.1,fumarylacetoacetate hydrolase domain containing 2A [Source:HGNC Symbol;Acc:HGNC:24252],NA,FAHD2A,51011,NM_016044
REPS1_SIG,REPS1,REPS1_SIG,REPS1,SIG,44,5.32895541739836,0.278939280655015,0.267396777072453,0.316864649569146,0.0494678724966928,8.97353057301532e-07,2.62810888733873,5.94096159127439,5.9132265338589,6.03209106563957,0.118864531780669,0.0263514080845848,ENSG00000135597,REPS1,protein_coding,6,-1,138903493,138988261,q24.1,RALBP1 associated Eps domain containing 1 [Source:HGNC Symbol;Acc:HGNC:15578],NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7,REPS1,85021,NM_001128617;NM_001286611;NM_001286612;NM_031922
SNRPN_SIG,SNRPN,SNRPN_SIG,SNRPN,SIG,34,-5.32737688276182,-0.0273599798716705,-0.0143048915262324,-0.0702552701495385,-0.055950378623306,9.04192723498164e-07,-4.02896957704518,1.49965270067944,1.59692101077595,1.18005682464806,-0.416864186127885,0.00051880428801659,ENSG00000128739,SNRPN,protein_coding,15,1,24823637,24978723,q11.2,small nuclear ribonucleoprotein polypeptide N [Source:HGNC Symbol;Acc:HGNC:11164],Angelman syndrome due to imprinting defect in 15q11-q13;Autism;PRADER-WILLI SYNDROME;Prader-Willi syndrome due to imprinting mutation;Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Prader-Willi syndrome due to translocation,SNRPN,6638,NM_001349454;NM_001349455;NM_001349456;NM_001349457;NM_001349458;NM_001349459;NM_001349460;NM_001349461;NM_001349462;NM_001349463;NM_001349464;NM_001349465;NM_003097;NM_022805;NM_022806;NM_022807;NM_022808
PRKD3_SIG,PRKD3,PRKD3_SIG,PRKD3,SIG,78,-5.32712459895276,0.0112620297072195,0.0208217967106116,-0.0201486333039259,-0.0409704300145375,9.04458396128719e-07,-4.553060064408,5.31521030872047,5.47207181209703,4.79980822619746,-0.672263585899571,8.18589085886263e-05,ENSG00000115825,PRKD3,protein_coding,2,-1,37250502,37324808,p22.2,protein kinase D3 [Source:HGNC Symbol;Acc:HGNC:9408],NA,PRKD3,23683,NM_005813
ASMTL_SIG,ASMTL,ASMTL_SIG,ASMTL,SIG,26,5.32644227796666,0.412979929277429,0.398268081545468,0.461318857539589,0.0630507759941211,9.06162769609213e-07,4.67062718590349,5.22508808351471,5.15483037584652,5.45593483728163,0.301104461435115,5.25078746300656e-05,ENSG00000169093,ASMTL,protein_coding,X,-1,1403139,1453762,p22.33,acetylserotonin O-methyltransferase like [Source:HGNC Symbol;Acc:HGNC:751],NA,ASMTL,8623,NM_001173473;NM_001173474;NM_004192
PPA1_SIG,PPA1,PPA1_SIG,PPA1,SIG,28,5.32638530385015,0.0462352581478139,0.0354482398483658,0.0816783182745718,0.0462300784262059,9.06162769609213e-07,3.49094689087898,5.79758776173737,5.72201828047524,6.04588748588435,0.323869205409105,0.00276939287124656,ENSG00000180817,PPA1,protein_coding,10,-1,70202835,70233911,q22.1,pyrophosphatase (inorganic) 1 [Source:HGNC Symbol;Acc:HGNC:9226],NA,PPA1,5464,NM_021129
PADI2_SIG,PADI2,PADI2_SIG,PADI2,SIG,19,-5.32545258256876,0.142966112735111,0.189705796419876,-0.0106071336576893,-0.200312930077566,9.09831997762977e-07,-4.50982364835161,4.47276720080964,4.7077924299732,3.70054144784365,-1.00725098212955,9.52861547667358e-05,ENSG00000117115,PADI2,protein_coding,1,-1,17066761,17119451,p36.13,peptidyl arginine deiminase 2 [Source:HGNC Symbol;Acc:HGNC:18341],NA,PADI2,11240,NM_007365
NFE2L1_TF,NFE2L1,NFE2L1_TF,NFE2L1,TF,162,5.32313750972499,0.232450994107803,0.222755608946694,0.26430725963716,0.0415516506904661,9.20488634971057e-07,4.20075556324797,7.31227091618424,7.25541815042001,7.49907286083813,0.243654710418111,0.000287380730068753,ENSG00000082641,NFE2L1,protein_coding,17,1,48048329,48061545,q21.32,nuclear factor, erythroid 2 like 1 [Source:HGNC Symbol;Acc:HGNC:7781],NA,NFE2L1,4779,NM_001330261;NM_001330262;NM_003204
NCR1_SIG,NCR1,NCR1_SIG,NCR1,SIG,15,-5.32009425636058,0.113957226795138,0.139528714626206,0.0299366239216302,-0.109592090704576,9.35001512184221e-07,-0.867449570865547,1.08693657337629,1.10673009417917,1.02190071930966,-0.084829374869512,0.499227009115776,ENSG00000189430,NCR1,protein_coding,19,1,54906150,54916140,q13.42,natural cytotoxicity triggering receptor 1 [Source:HGNC Symbol;Acc:HGNC:6731],NA,NCR1,9437,NM_001145457;NM_001145458;NM_001242356;NM_001242357;NM_004829
NSUN5P1_SIG,NSUN5P1,NSUN5P1_SIG,NSUN5P1,SIG,131,5.3172027757732,0.135880004408481,0.120133119908396,0.187619767765905,0.0674866478575095,9.48944228810412e-07,4.64227079615919,4.35300145798263,4.2414565939666,4.71950601117814,0.47804941721154,5.82074611918226e-05,ENSG00000223705,NSUN5P1,transcribed_unprocessed_pseudogene,7,1,75410322,75416787,q11.23,NOP2/Sun RNA methyltransferase family member 5 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:19146],NA,NSUN5P1,NA,NA
HOXA2_TF,HOXA2,HOXA2_TF,HOXA2,TF,63,5.31648171629867,-0.00177635113074695,-0.0113417623264099,0.0296528570835743,0.0409946194099841,9.51676156876764e-07,4.52227105015154,1.0902381513344,0.971721916774831,1.47964863631584,0.50792671954101,9.13176194032527e-05,ENSG00000105996,HOXA2,protein_coding,7,-1,27100354,27102686,p15.2,homeobox A2 [Source:HGNC Symbol;Acc:HGNC:5103],Bilateral microtia-deafness-cleft palate syndrome;Microtia;MICROTIA HEARING IMPAIRMENT AND CLEFT PALATE MICROTIA WITH OR WITHOUT HEARING IMPAIRMENT INCLUDED,HOXA2,3199,NM_006735
NFIB_TF,NFIB,NFIB_TF,NFIB,TF,232,-5.31419213092886,-0.148873666955793,-0.142198520951473,-0.170806289541413,-0.0286077685899402,9.62673317768513e-07,-3.15993635003535,0.293410147760985,0.34948494873463,0.109164373133292,-0.240320575601338,0.00706758385380857,ENSG00000147862,NFIB,protein_coding,9,-1,14081843,14398983,p22.3,nuclear factor I B [Source:HGNC Symbol;Acc:HGNC:7785],Intellectual disability with macrocephaly,NFIB,4781,NM_001190737;NM_001190738;NM_001282787;NM_005596
PIGM_SIG,PIGM,PIGM_SIG,PIGM,SIG,66,5.31234067811838,0.0709518871951141,0.0524149203693055,0.131859063908485,0.0794441435391797,9.71454709156254e-07,4.48251796926098,3.82178743587772,3.72272907246649,4.14726491565744,0.424535843190951,0.000105685494111393,ENSG00000143315,PIGM,protein_coding,1,-1,160024953,160031991,q23.2,phosphatidylinositol glycan anchor biosynthesis class M [Source:HGNC Symbol;Acc:HGNC:18858],GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY;Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,PIGM,93183,NM_145167
ST8SIA1_SIG,ST8SIA1,ST8SIA1_SIG,ST8SIA1,SIG,17,-5.30951622599812,-0.123456536019666,-0.0973413770716153,-0.209263486848977,-0.111922109777362,9.85561708310886e-07,-4.30737159902308,0.824766654820187,0.924322298163123,0.497655255264828,-0.426667042898295,0.000199197888738041,ENSG00000111728,ST8SIA1,protein_coding,12,-1,22063773,22437041,p12.1,ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10869],NA,ST8SIA1,6489,NM_001304450;NM_003034
ATXN1_SIG,ATXN1,ATXN1_SIG,ATXN1,SIG,13,-5.30630026455914,0.185563537780917,0.201234225372321,0.134074135694874,-0.0671600896774467,1.00201584047399e-06,-4.95665512682691,5.37940659446319,5.53179889085012,4.87868904919185,-0.653109841658272,1.69369560961942e-05,ENSG00000124788,ATXN1,protein_coding,6,-1,16299112,16761491,p22.3,ataxin 1 [Source:HGNC Symbol;Acc:HGNC:10548],SPINOCEREBELLAR ATAXIA 1;Spinocerebellar ataxia type 1,ATXN1,6310,NM_000332;NM_001128164;NM_001357857
CHRNA6_SIG,CHRNA6,CHRNA6_SIG,CHRNA6,SIG,33,5.30517879508514,-0.0562083603089661,-0.0662774532329307,-0.023124197844511,0.0431532553884198,1.00639294752354e-06,3.09480811636448,0.394796687685805,0.327752625592215,0.615084320279031,0.287331694686816,0.00840187698885339,ENSG00000147434,CHRNA6,protein_coding,8,-1,42752620,42796392,p11.21,cholinergic receptor nicotinic alpha 6 subunit [Source:HGNC Symbol;Acc:HGNC:15963],NA,CHRNA6,8973,NM_001199279;NM_004198
NUDT19_SIG,NUDT19,NUDT19_SIG,NUDT19,SIG,24,-5.3051113212317,0.0767558457990484,0.0839191328208338,0.0532193312988965,-0.0306998015219374,1.00639294752354e-06,-2.27108201319771,3.70365820983204,3.74064969498785,3.58211475860578,-0.15853493638207,0.0573328450158606,ENSG00000213965,NUDT19,protein_coding,19,1,32691961,32713796,q13.11,nudix hydrolase 19 [Source:HGNC Symbol;Acc:HGNC:32036],NA,NUDT19,390916,NM_001105570
FPR1_SIG,FPR1,FPR1_SIG,FPR1,SIG,25,-5.30400613135002,0.179038667899911,0.229475858456201,0.0133164703578149,-0.216159388098386,1.01035869566382e-06,-5.0307166245871,4.90641137219405,5.2120172132599,3.90227789440626,-1.30973931885365,1.25539841351477e-05,ENSG00000171051,FPR1,protein_coding,19,-1,51745172,51804110,q13.41,formyl peptide receptor 1 [Source:HGNC Symbol;Acc:HGNC:3826],Susceptibility to localized juvenile periodontitis,FPR1,2357,NM_001193306;NM_002029
TMEM129_SIG,TMEM129,TMEM129_SIG,TMEM129,SIG,18,5.30400069535478,0.290323309031305,0.281357814974942,0.319781360930783,0.0384235459558402,1.01035869566382e-06,4.15405866046424,4.87043688651994,4.81945776538365,5.0379397131106,0.218481947726948,0.000337216780585327,ENSG00000168936,TMEM129,protein_coding,4,-1,1715952,1721358,p16.3,transmembrane protein 129 [Source:HGNC Symbol;Acc:HGNC:25137],NA,TMEM129,92305,NM_001127266;NM_138385
NAP1L2_SIG,NAP1L2,NAP1L2_SIG,NAP1L2,SIG,17,-5.30272587948402,-0.155683478503602,-0.135530748098657,-0.221899592691282,-0.086368844592625,1.01565132138264e-06,-2.57863455254735,0.84155846064524,0.908827142145907,0.620532792857336,-0.288294349288571,0.0295953670400115,ENSG00000186462,NAP1L2,protein_coding,X,-1,73212299,73214848,q13.2,nucleosome assembly protein 1 like 2 [Source:HGNC Symbol;Acc:HGNC:7638],NA,NAP1L2,4674,NM_021963
R3HDM1_SIG,R3HDM1,R3HDM1_SIG,R3HDM1,SIG,44,5.3026549462677,0.420029799420548,0.408261795829467,0.458696096934099,0.0504343011046328,1.01565132138264e-06,3.94123821668002,6.31162548046971,6.26116148857698,6.47743573954585,0.216274250968877,0.000688183840240565,ENSG00000048991,R3HDM1,protein_coding,2,1,135531455,135725270,q21.3,R3H domain containing 1 [Source:HGNC Symbol;Acc:HGNC:9757],NA,R3HDM1,23518,NM_001282798;NM_001282799;NM_001282800;NM_001354199;NM_001354200;NM_015361
BEST1_SIG,BEST1,BEST1_SIG,BEST1,SIG,5,-5.30222345353151,0.159881596964116,0.194883743302793,0.0448745447084634,-0.15000919859433,1.01640181244171e-06,-4.70912619779683,3.21288954245755,3.3489347221476,2.7658839520474,-0.583050770100192,4.49527994693274e-05,ENSG00000167995,BEST1,protein_coding,11,1,61950063,61965515,q12.3,bestrophin 1 [Source:HGNC Symbol;Acc:HGNC:12703],Adult-onset foveomacular vitelliform dystrophy;Autosomal dominant vitreoretinochoroidopathy;Autosomal recessive bestrophinopathy;Best vitelliform macular dystrophy;BESTROPHINOPATHY AUTOSOMAL RECESSIVE;MACULAR DYSTROPHY VITELLIFORM 2;MRCS syndrome;Retinitis pigmentosa;RETINITIS PIGMENTOSA 50;VITREORETINOCHOROIDOPATHY,BEST1,7439,NM_001139443;NM_001300786;NM_001300787;NM_004183
RAI1_SIG,RAI1,RAI1_SIG,RAI1,SIG,91,5.3021285138288,0.318078141036666,0.302447284744597,0.369436668853464,0.066989384108867,1.01640181244171e-06,3.82709472865442,5.86210723683954,5.7900966792164,6.09871335474417,0.308616675527773,0.000987708812998963,ENSG00000108557,RAI1,protein_coding,17,1,17681458,17811453,p11.2,retinoic acid induced 1 [Source:HGNC Symbol;Acc:HGNC:9834],17p11.2 microduplication syndrome;PMP22-RAI1 contiguous gene duplication syndrome;SMITH-MAGENIS SYNDROME,RAI1,10743,NM_030665
NLRC5_SIG,NLRC5,NLRC5_SIG,NLRC5,SIG,35,-5.30084301444767,0.1619666062055,0.179548138363042,0.104198714830719,-0.0753494235323234,1.02248941594837e-06,-3.42380192004006,6.82266208546273,6.90059721649867,6.5665895120589,-0.334007704439768,0.00335767047964598,ENSG00000140853,NLRC5,protein_coding,16,1,56989485,57083531,q13,NLR family CARD domain containing 5 [Source:HGNC Symbol;Acc:HGNC:29933],NA,NLRC5,84166,NM_001330552;NM_032206
ITGA5_SIG,ITGA5,ITGA5_SIG,ITGA5,SIG,60,5.29962479860848,0.227264427010886,0.217622003742403,0.258946674893043,0.0413246711506397,1.02823404008311e-06,2.41350614477388,7.70864693918509,7.66107166999572,7.86496568080728,0.203894010811562,0.0426049635526048,ENSG00000161638,ITGA5,protein_coding,12,-1,54395261,54419266,q13.13,integrin subunit alpha 5 [Source:HGNC Symbol;Acc:HGNC:6141],NA,ITGA5,3678,NM_002205
KHDC1_SIG,KHDC1,KHDC1_SIG,KHDC1,SIG,79,5.29942083370447,-0.0712936854066468,-0.0797548660308691,-0.0434926633556307,0.0362622026752384,1.02828350636354e-06,2.85665663188988,1.19965618729855,1.14851874453292,1.36767921352845,0.219160468995522,0.0154384578012048,ENSG00000135314,KHDC1,protein_coding,6,-1,73241314,73310365,q13,KH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21366],NA,KHDC1,80759,NM_001251874;NM_030568
COL17A1_SIG,COL17A1,COL17A1_SIG,COL17A1,SIG,34,-5.29821075895315,0.0222107975699892,0.0620363576697439,-0.108644614186348,-0.170680971856091,1.03374835496967e-06,-4.77378690194064,2.54389485678827,2.81047302836519,1.66799515017839,-1.1424778781868,3.54706645492716e-05,ENSG00000065618,COL17A1,protein_coding,10,-1,104031286,104085957,q25.1,collagen type XVII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2194],EPIDERMOLYSIS BULLOSA JUNCTIONAL NON-HERLITZ TYPE;Epithelial recurrent erosion dystrophy;Junctional epidermolysis bullosa generalized intermediate;Late-onset junctional epidermolysis bullosa;Localized junctional epidermolysis bullosa non-Herlitz type,COL17A1,1308,NM_000494
NSUN5P2_SIG,NSUN5P2,NSUN5P2_SIG,NSUN5P2,SIG,118,5.29806308768511,0.0723486938340467,0.0560504431368933,0.125900088981836,0.0698496458449431,1.03374835496967e-06,4.73607388138768,3.75249386432424,3.64311096854859,4.11189480758709,0.468783839038501,4.0731763108674e-05,ENSG00000106133,NSUN5P2,transcribed_unprocessed_pseudogene,7,-1,72947581,72954790,q11.23,NOP2/Sun RNA methyltransferase family member 5 pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:16609],NA,NSUN5P2,NA,NA
GTF2IRD2B_TF,GTF2IRD2B,GTF2IRD2B_TF,GTF2IRD2B,TF,38,5.29443199977605,0.141649249020207,0.133167465630863,0.169517965870908,0.0363505002400449,1.05326387925336e-06,1.8454237376298,2.84330610906488,2.81409536540396,2.93928426680787,0.125188901403903,0.12780836755519,ENSG00000174428,GTF2IRD2B,protein_coding,7,1,75092396,75149817,q11.23,GTF2I repeat domain containing 2B [Source:HGNC Symbol;Acc:HGNC:33125],NA,GTF2IRD2B,389524,NM_001003795
CXCL9_SIG,CXCL9,CXCL9_SIG,CXCL9,SIG,24,-5.29425700390209,-0.111505988371145,-0.101193572686405,-0.145389639906718,-0.0441960672203133,1.05326387925336e-06,-1.86733663735645,0.467239492307756,0.49987715222431,0.360001466867649,-0.139875685356661,0.123132262981102,ENSG00000138755,CXCL9,protein_coding,4,-1,76001275,76007488,q21.1,C-X-C motif chemokine ligand 9 [Source:HGNC Symbol;Acc:HGNC:7098],NA,CXCL9,4283,NM_002416
APOBEC3A_SIG,APOBEC3A,APOBEC3A_SIG,APOBEC3A,SIG,25,-5.2919966413044,0.149346480602959,0.195470248257996,-0.00220304169216216,-0.197673289950159,1.06523542253347e-06,-5.10042983150185,4.0751154251858,4.35244144987826,3.16390134405343,-1.18854010582483,9.4112615989482e-06,ENSG00000128383,APOBEC3A,protein_coding,22,1,38952741,38992778,q13.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3A [Source:HGNC Symbol;Acc:HGNC:17343],NA,APOBEC3A,200315;100913187,NM_001270406;NM_145699
PPARD_TF,PPARD,PPARD_TF,PPARD,TF,397,-5.29084368622675,-0.0268080682451552,-0.0130734748934979,-0.071936017829172,-0.0588625429356741,1.06971420069831e-06,-4.19496891009288,3.68105605673596,3.80319487339589,3.27974280199617,-0.523452071399718,0.000293290505975775,ENSG00000112033,PPARD,protein_coding,6,1,35342558,35428191,p21.31,peroxisome proliferator activated receptor delta [Source:HGNC Symbol;Acc:HGNC:9235],NA,PPARD,5467,NM_001171818;NM_001171819;NM_001171820;NM_006238;NM_177435
GPR174_SIG,GPR174,GPR174_SIG,GPR174,SIG,89,5.29084121680065,0.122595687219525,0.108569023865245,0.168683295383588,0.0601142715183436,1.06971420069831e-06,5.2897426588247,2.7460066946713,2.57197098537978,3.31783831091486,0.745867325535082,4.15642142840683e-06,ENSG00000147138,GPR174,protein_coding,X,1,79144663,79175315,q21.1,G protein-coupled receptor 174 [Source:HGNC Symbol;Acc:HGNC:30245],NA,GPR174,84636,NM_032553
OGT_SIG,OGT,OGT_SIG,OGT,SIG,149,5.29038438675484,0.160628300958078,0.147766284339028,0.202889212706385,0.0551229283673574,1.07024568924446e-06,4.33715375658007,9.09786285100242,9.01934145331843,9.35586172910697,0.336520275788548,0.000179079720919358,ENSG00000147162,OGT,protein_coding,X,1,71533104,71575892,q13.1,O-linked N-acetylglucosamine (GlcNAc) transferase [Source:HGNC Symbol;Acc:HGNC:8127],MENTAL RETARDATION X-LINKED 106,OGT,8473,NM_181672;NM_181673
MAPK13_SIG,MAPK13,MAPK13_SIG,MAPK13,SIG,37,-5.2903629153055,0.0438472379823628,0.0659823697777902,-0.0288824807740416,-0.0948648505518317,1.07024568924446e-06,-3.83448575074157,3.20144700211226,3.30074655327822,2.87517704828125,-0.42556950499697,0.000966537932317745,ENSG00000156711,MAPK13,protein_coding,6,1,36127809,36144524,p21.31,mitogen-activated protein kinase 13 [Source:HGNC Symbol;Acc:HGNC:6875],NA,MAPK13,5603,NM_002754
DVL2_SIG,DVL2,DVL2_SIG,DVL2,SIG,60,5.28836613364205,0.276339170038548,0.262476510478663,0.321887908592457,0.0594113981137947,1.08084882791842e-06,4.44363207148508,5.18900274441284,5.12757465026924,5.39083791088468,0.263263260615443,0.000121940408378896,ENSG00000004975,DVL2,protein_coding,17,-1,7225342,7234517,p13.1,dishevelled segment polarity protein 2 [Source:HGNC Symbol;Acc:HGNC:3086],NA,DVL2,1856,NM_004422
LYZ_SIG,LYZ,LYZ_SIG,LYZ,SIG,46,-5.28724378704754,0.333022774771644,0.357801937886309,0.251605524537744,-0.106196413348564,1.08635075916019e-06,-5.49639150408411,11.1667825378895,11.4979094147487,10.0787942282091,-1.41911518653966,1.63030694090588e-06,ENSG00000090382,LYZ,protein_coding,12,1,69348341,69354234,q15,lysozyme [Source:HGNC Symbol;Acc:HGNC:6740],ALys amyloidosis;AMYLOIDOSIS FAMILIAL VISCERAL,LYZ,4069,NM_000239
HMGB2_SIG,HMGB2,HMGB2_SIG,HMGB2,SIG,65,-5.28296021513707,0.0683646279622372,0.0839258515829832,0.0172348932083575,-0.0666909583746256,1.11089792954582e-06,-2.65750253318984,8.10114695333332,8.16315731036651,7.89739863736712,-0.265758672999391,0.0246642102782597,ENSG00000164104,HMGB2,protein_coding,4,-1,173331695,173335125,q34.1,high mobility group box 2 [Source:HGNC Symbol;Acc:HGNC:5000],NA,HMGB2,3148,NM_001130688;NM_001130689;NM_002129
PLA2G4A_SIG,PLA2G4A,PLA2G4A_SIG,PLA2G4A,SIG,31,5.2812745453069,0.0852784461337902,0.0707927427696913,0.132874328615829,0.0620815858461378,1.11887433367131e-06,3.71180903497911,3.48962305923266,3.38465311993393,3.83452428835704,0.449871168423111,0.00141915888900907,ENSG00000116711,PLA2G4A,protein_coding,1,1,186828949,186988981,q31.1,phospholipase A2 group IVA [Source:HGNC Symbol;Acc:HGNC:9035],Cryptogenic multifocal ulcerous stenosing enteritis;Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,PLA2G4A,5321,NM_001311193;NM_024420
RNF24_SIG,RNF24,RNF24_SIG,RNF24,SIG,69,5.28126382303133,0.118362795992075,0.110962277629441,0.142678784897874,0.0317165072684331,1.11887433367131e-06,2.30297491661132,7.49736886207627,7.45792400784359,7.62697338312649,0.169049375282892,0.0536339444302233,ENSG00000101236,RNF24,protein_coding,20,-1,3927309,4015558,p13,ring finger protein 24 [Source:HGNC Symbol;Acc:HGNC:13779],NA,RNF24,11237,NM_001134337;NM_001134338;NM_001321749;NM_007219
FBXW8_SIG,FBXW8,FBXW8_SIG,FBXW8,SIG,55,5.27945151834516,0.269500468072408,0.251601775670064,0.328310457394394,0.0767086817243306,1.1267349095427e-06,4.17903442448721,4.3478301890862,4.25475955698181,4.65363369457206,0.398874137590248,0.000310245843231888,ENSG00000174989,FBXW8,protein_coding,12,1,116910950,117031148,q24.22,F-box and WD repeat domain containing 8 [Source:HGNC Symbol;Acc:HGNC:13597],NA,FBXW8,26259,NM_012174;NM_153348
BTBD8_TF,BTBD8,BTBD8_TF,BTBD8,TF,48,5.27930046961179,0.116954266917779,0.100004553135374,0.172646183631397,0.0726416304960231,1.1267349095427e-06,3.97272092690734,2.40962826627167,2.32272124448337,2.69517990929037,0.372458664807004,0.000619592319608596,ENSG00000189195,BTBD8,protein_coding,1,1,92080305,92184725,p22.1,BTB domain containing 8 [Source:HGNC Symbol;Acc:HGNC:21019],NA,BTBD8,23285;284697,NM_015237;NM_183242
EGFL8_SIG,EGFL8,EGFL8_SIG,EGFL8,SIG,74,5.27928298336602,0.0122910152953854,-0.00216582159656616,0.0597920507975118,0.061957872394078,1.1267349095427e-06,3.58231924371172,1.15035686531261,1.09334529830381,1.33768058548439,0.244335287180583,0.00210748892111262,ENSG00000241404,EGFL8,protein_coding,6,1,32164595,32168281,p21.32,EGF like domain multiple 8 [Source:HGNC Symbol;Acc:HGNC:13944],NA,EGFL8,80864,NM_030652
HMG20B_TF,HMG20B,HMG20B_TF,HMG20B,TF,135,5.27908088819421,0.0087852119404908,-0.0042038819412491,0.0514636632662076,0.0556675452074567,1.1267349095427e-06,3.57057033070796,6.19330058235338,6.15553865758435,6.31737547802304,0.161836820438686,0.00218438476450953,ENSG00000064961,HMG20B,protein_coding,19,1,3572777,3579088,p13.3,high mobility group 20B [Source:HGNC Symbol;Acc:HGNC:5002],NA,HMG20B,10362,NM_006339
ESR2_TF,ESR2,ESR2_TF,ESR2,TF,87,-5.27901932589264,-0.113204144219202,-0.10723690449079,-0.132810789041128,-0.0255738845503386,1.1267349095427e-06,-1.42774973667658,0.267669429117248,0.283642415367436,0.215186760009487,-0.068455655357949,0.246316301739607,ENSG00000140009,ESR2,protein_coding,14,-1,64084232,64338112,q23.3,estrogen receptor 2 [Source:HGNC Symbol;Acc:HGNC:3468],Familial medullary thyroid carcinoma;OVARIAN DYSGENESIS 8,ESR2,2100,NM_001040275;NM_001214902;NM_001271876;NM_001271877;NM_001291712;NM_001291723;NM_001437
GNAL_SIG,GNAL,GNAL_SIG,GNAL,SIG,9,-5.27845787370982,-0.248675938974237,-0.235682537917432,-0.291368542446596,-0.0556860045291639,1.12825045468309e-06,-3.37163785011615,0.458465607000773,0.496175294562209,0.334562347870343,-0.161612946691866,0.00392696738626586,ENSG00000141404,GNAL,protein_coding,18,1,11689264,11885685,p11.21,G protein subunit alpha L [Source:HGNC Symbol;Acc:HGNC:4388],Autosomal dominant focal dystonia DYT25 type;DYSTONIA 25,GNAL,2774,NM_001142339;NM_001261443;NM_001261444;NM_182978
ARHGAP19_SIG,ARHGAP19,ARHGAP19_SIG,ARHGAP19,SIG,38,-5.27838957697226,0.0922287364094376,0.107431478035156,0.0422768710677907,-0.0651546069673655,1.12825045468309e-06,-5.15352333103281,4.88007208821598,4.96969261169762,4.58560465391917,-0.384087957778451,7.67146902760872e-06,ENSG00000213390,ARHGAP19,protein_coding,10,-1,97222173,97292673,q24.1,Rho GTPase activating protein 19 [Source:HGNC Symbol;Acc:HGNC:23724],NA,ARHGAP19,84986,NM_001204300;NM_001256423;NM_032900
FBXL5_SIG,FBXL5,FBXL5_SIG,FBXL5,SIG,39,-5.27754995545204,0.596636829037896,0.620639631136755,0.517770479284505,-0.10286915185225,1.13224747278684e-06,-4.04484091870236,7.47839714745091,7.54887147526301,7.24683864178257,-0.302032833480442,0.000491456981781222,ENSG00000118564,FBXL5,protein_coding,4,-1,15604539,15681679,p15.32,F-box and leucine rich repeat protein 5 [Source:HGNC Symbol;Acc:HGNC:13602],NA,FBXL5,26234,NM_001193534;NM_001193535;NM_012161
WWOX_SIG,WWOX,WWOX_SIG,WWOX,SIG,8,5.27479817324943,0.151962230170977,0.140606507383301,0.189273890759055,0.0486673833757541,1.14817028092628e-06,4.40809832039944,3.41861939540281,3.34879793335396,3.64803277070618,0.299234837352221,0.000138943567544351,ENSG00000186153,WWOX,protein_coding,16,1,78099430,79212667,q23.1,WW domain containing oxidoreductase [Source:HGNC Symbol;Acc:HGNC:12799],46XY partial gonadal dysgenesis;Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 28;ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA SUSCEPTIBILITY TO INCLUDED;Spinocerebellar ataxia autosomal recessive 12;Squamous cell carcinoma of the esophagus;Undetermined early-onset epileptic encephalopathy,WWOX,51741,NM_001291997;NM_016373;NM_130791
CDKL1_SIG,CDKL1,CDKL1_SIG,CDKL1,SIG,16,5.27430354396278,0.150069004971028,0.13932527423494,0.185369834532462,0.0460445602975216,1.15007177857021e-06,3.63694653427098,2.0179932548601,1.95687234372326,2.21881910573828,0.261946762015016,0.00178300562626893,ENSG00000100490,CDKL1,protein_coding,14,-1,50329404,50416461,q22.1,cyclin dependent kinase like 1 [Source:HGNC Symbol;Acc:HGNC:1781],NA,CDKL1,8814,NM_001282236;NM_004196
ISL2_TF,ISL2,ISL2_TF,ISL2,TF,118,-5.27211821814379,-0.0268984487256643,-0.013345510009547,-0.0714295330786212,-0.0580840230690741,1.16264294338555e-06,-0.134130279606457,0.389634005084101,0.391830178451567,0.382418006876714,-0.00941217157485285,0.924721543339557,ENSG00000159556,ISL2,protein_coding,15,1,76336773,76342475,q24.3,ISL LIM homeobox 2 [Source:HGNC Symbol;Acc:HGNC:18524],NA,ISL2,64843,NM_145805
RASGRP1_SIG,RASGRP1,RASGRP1_SIG,RASGRP1,SIG,36,-5.27166040541538,-0.131164345410847,-0.100178717974418,-0.232974264130539,-0.132795546156121,1.16433580388956e-06,-4.96704725391773,3.48261892900663,3.65724682830757,2.90884154558928,-0.74840528271829,1.6252109439167e-05,ENSG00000172575,RASGRP1,protein_coding,15,-1,38488103,38565575,q14,RAS guanyl releasing protein 1 [Source:HGNC Symbol;Acc:HGNC:9878],Autoimmune lymphoproliferative syndrome,RASGRP1,10125,NM_001128602;NM_001306086;NM_005739
ALG13_SIG,ALG13,ALG13_SIG,ALG13,SIG,65,5.27087787571761,0.0555260778297658,0.0404813009617961,0.104958916110238,0.0644776151484413,1.1680971598094e-06,4.32443663914046,5.55902634733207,5.49738601048589,5.76155888268382,0.264172872197928,0.000187053190258494,ENSG00000101901,ALG13,protein_coding,X,1,111665811,111760649,q23,ALG13, UDP-N-acetylglucosaminyltransferase subunit [Source:HGNC Symbol;Acc:HGNC:30881],ALG13-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Is;epileptic encephalopathies;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 36;X-linked non-syndromic intellectual disability,ALG13,79868,NM_001039210;NM_001099922;NM_001168385;NM_001257230;NM_001257231;NM_001257234;NM_001257235;NM_001257237;NM_001257239;NM_001257240;NM_001257241;NM_001324290;NM_001324291;NM_001324292;NM_001324293;NM_001324294;NM_018466
ENTPD1_SIG,ENTPD1,ENTPD1_SIG,ENTPD1,SIG,18,-5.26924426341953,0.626981359857247,0.679206108377502,0.455385757576407,-0.223820350801096,1.17731719739448e-06,-4.92121822890664,5.11681696758097,5.33783470332775,4.39061583584155,-0.947218867486196,1.95502489360688e-05,ENSG00000138185,ENTPD1,protein_coding,10,1,95711779,95877266,q24.1,ectonucleoside triphosphate diphosphohydrolase 1 [Source:HGNC Symbol;Acc:HGNC:3363],Autosomal Recessive Mental Retardation;Autosomal recessive spastic paraplegia type 64;Spastic paraplegia 64 autosomal recessive,ENTPD1,953,NM_001098175;NM_001164178;NM_001164179;NM_001164181;NM_001164182;NM_001164183;NM_001312654;NM_001320916;NM_001776
OSGEP_SIG,OSGEP,OSGEP_SIG,OSGEP,SIG,18,5.26870432416238,0.159734663758608,0.147658737902515,0.1994127058572,0.0517539679546851,1.17956126853482e-06,3.95146875026238,5.78790873993661,5.74135327450207,5.94087669779295,0.199523423290881,0.000663595799390067,ENSG00000092094,OSGEP,protein_coding,14,-1,20446401,20455089,q11.2,O-sialoglycoprotein endopeptidase [Source:HGNC Symbol;Acc:HGNC:18028],GALLOWAY-MOWAT SYNDROME;GALLOWAY-MOWAT SYNDROME 3;Nephrotic syndrome with primary microcephaly,OSGEP,55644,NM_017807
HSF4_TF,HSF4,HSF4_TF,HSF4,TF,139,5.26809875888936,0.0588615462442103,0.0532821760784027,0.0771937625032924,0.0239115864248897,1.1822330244603e-06,2.11178428051131,2.54693903188987,2.5082470214752,2.67406992325238,0.165822901777186,0.0785799211320213,ENSG00000102878,HSF4,protein_coding,16,1,67164681,67169945,q22.1,heat shock transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:5227],Cataract 5 multiple types;CATARACT MARNER TYPE;CATARACT ZONULAR HSF4-RELATED;Early-onset lamellar cataract;Total early-onset cataract,HSF4,3299,NM_001040667;NM_001538
TRIM66_SIG,TRIM66,TRIM66_SIG,TRIM66,SIG,33,5.2665732439909,0.0163210377300219,0.00283908301526746,0.0606188889356435,0.057779805920376,1.19086213571204e-06,3.23797607449401,5.01374019988933,4.93701126467722,5.26584955844342,0.328838293766199,0.00572260349028862,ENSG00000166436,TRIM66,protein_coding,11,-1,8612037,8682694,p15.4,tripartite motif containing 66 [Source:HGNC Symbol;Acc:HGNC:29005],NA,TRIM66,9866,NM_014818
CDKL3_SIG,CDKL3,CDKL3_SIG,CDKL3,SIG,36,5.26613605248108,-0.0524553620171456,-0.0668896540089156,-0.00502840261561537,0.0618612513933001,1.19246695652871e-06,4.03295762641929,0.561601004660565,0.53398988390439,0.652323258573713,0.118333374669322,0.000511318706482007,ENSG00000006837,CDKL3,protein_coding,5,-1,134286350,134371047,q31.1,cyclin dependent kinase like 3 [Source:HGNC Symbol;Acc:HGNC:15483],NA,CDKL3,51265,NM_001113575;NM_001300853;NM_001349363;NM_001349364;NM_001349366;NM_016508
EXD2_SIG,EXD2,EXD2_SIG,EXD2,SIG,62,5.26299948545714,0.196921014470109,0.177637438823018,0.26028133445341,0.0826438956303921,1.21174730247248e-06,4.12543742128784,3.54815218549407,3.44423511164984,3.88959399955369,0.445358887903847,0.000373187533923583,ENSG00000081177,EXD2,protein_coding,14,1,69191511,69244020,q24.1,exonuclease 3'-5' domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20217],NA,EXD2,55218,NM_001193360;NM_001193361;NM_001193362;NM_001193363;NM_018199
ERCC1_SIG,ERCC1,ERCC1_SIG,ERCC1,SIG,19,5.26023144993942,0.272428927620251,0.26100735690412,0.309956945687535,0.048949588783415,1.22886355792404e-06,3.61603034791179,6.09967342346019,6.05280298266822,6.2536763003481,0.200873317679874,0.0019024812120882,ENSG00000012061,ERCC1,protein_coding,19,-1,45407333,45478828,q13.32,ERCC excision repair 1, endonuclease non-catalytic subunit [Source:HGNC Symbol;Acc:HGNC:3433],CEREBROOCULOFACIOSKELETAL SYNDROME 4;Cockayne syndrome type 2;COFS syndrome;Fanconi anemia,ERCC1,2067,NM_001166049;NM_001983;NM_202001
PJA1_SIG,PJA1,PJA1_SIG,PJA1,SIG,23,5.25709920876814,0.114810783318994,0.103357076115377,0.152444392702307,0.0490873165869304,1.24868324452325e-06,3.3834299103286,3.64724390956524,3.58355104884688,3.85652045192558,0.272969403078701,0.00379572875964405,ENSG00000181191,PJA1,protein_coding,X,-1,69160851,69165793,q13.1,praja ring finger ubiquitin ligase 1 [Source:HGNC Symbol;Acc:HGNC:16648],NA,PJA1,64219,NM_001032396;NM_022368;NM_145119
PPP1R1B_SIG,PPP1R1B,PPP1R1B_SIG,PPP1R1B,SIG,10,-5.25624616239671,-0.0947440996929616,-0.0812882501189376,-0.138956176864755,-0.0576679267458169,1.2531954771506e-06,-3.25155364734809,0.240595824224382,0.28297933383737,0.10133572121028,-0.181643612627091,0.00550082284994805,ENSG00000131771,PPP1R1B,protein_coding,17,1,39626740,39636626,q12,protein phosphatase 1 regulatory inhibitor subunit 1B [Source:HGNC Symbol;Acc:HGNC:9287],NA,PPP1R1B,84152,NM_001242464;NM_032192;NM_181505
SRD5A3_SIG,SRD5A3,SRD5A3_SIG,SRD5A3,SIG,6,5.25556219012961,0.292374924131369,0.274458798549589,0.351242193900077,0.0767833953504884,1.25656946343014e-06,4.77764143202218,4.17513095818799,4.07493939874805,4.50433179634781,0.42939239759976,3.4887558557767e-05,ENSG00000128039,SRD5A3,protein_coding,4,1,55346242,55373100,q12,steroid 5 alpha-reductase 3 [Source:HGNC Symbol;Acc:HGNC:25812],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iq;Congenital Disorders of Glycosylation;KAHRIZI SYNDROME;SRD5A3-CDG,SRD5A3,79644,NM_024592
PPHLN1_SIG,PPHLN1,PPHLN1_SIG,PPHLN1,SIG,13,5.25463135425857,0.484793477617786,0.470708656588511,0.531072175285402,0.0603635186968908,1.26164437145997e-06,4.0593353529831,6.02395191724694,5.98381922316499,6.15581648351618,0.171997260351189,0.000466528851824494,ENSG00000134283,PPHLN1,protein_coding,12,1,42238447,42459715,q12,periphilin 1 [Source:HGNC Symbol;Acc:HGNC:19369],NA,PPHLN1,51535,NM_001143787;NM_001143788;NM_001143789;NM_001364823;NM_016488;NM_201438;NM_201439;NM_201440;NM_201515
GPR176_SIG,GPR176,GPR176_SIG,GPR176,SIG,5,-5.25049160871152,-0.159575578585815,-0.150167379008186,-0.190488234340881,-0.0403208553326948,1.2890084712249e-06,-1.62272231402557,0.378605607130697,0.39938173832953,0.310341176048816,-0.0890405622807139,0.184232513749668,ENSG00000166073,GPR176,protein_coding,15,-1,39799032,39920892,q15.1,G protein-coupled receptor 176 [Source:HGNC Symbol;Acc:HGNC:32370],NA,GPR176,11245,NM_001271854;NM_001271855;NM_007223
HTATSF1_SIG,HTATSF1,HTATSF1_SIG,HTATSF1,SIG,34,5.24961197618641,0.356461459360523,0.343457264908164,0.399189526846845,0.0557322619386802,1.2938515225492e-06,5.0586169623697,6.76275707539094,6.70386141937829,6.95627137371823,0.252409954339942,1.11399077379127e-05,ENSG00000102241,HTATSF1,protein_coding,X,1,136497079,136512346,q26.3,HIV-1 Tat specific factor 1 [Source:HGNC Symbol;Acc:HGNC:5276],NA,HTATSF1,27336,NM_001163280;NM_014500
UXS1_SIG,UXS1,UXS1_SIG,UXS1,SIG,11,5.24892122037406,0.113483371920042,0.100125858834477,0.1573723434869,0.0572464846524229,1.29738248910362e-06,2.42285887289484,5.72490471495973,5.69067813451101,5.83736347929123,0.146685344780221,0.0417059835275886,ENSG00000115652,UXS1,protein_coding,2,-1,106093303,106194339,q12.2,UDP-glucuronate decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:17729],NA,UXS1,80146,NM_001253875;NM_001253876;NM_025076
CHIT1_SIG,CHIT1,CHIT1_SIG,CHIT1,SIG,8,-5.24754521780987,0.11162460151352,0.162955505090231,-0.0570340816671011,-0.219989586757332,1.30577042783942e-06,-2.6674507157318,1.81492186596496,1.94439720288586,1.3895029017963,-0.55489430108956,0.024137087796971,ENSG00000133063,CHIT1,protein_coding,1,-1,203212827,203273641,q32.1,chitinase 1 [Source:HGNC Symbol;Acc:HGNC:1936],CHITOTRIOSIDASE DEFICIENCY,CHIT1,1118,NM_001256125;NM_003465
ZNF23_TF,ZNF23,ZNF23_TF,ZNF23,TF,44,5.2469326018503,0.165349863196723,0.155482051678501,0.197772672470879,0.0422906207923782,1.30877986272786e-06,3.10126549351449,1.02066136268598,0.986411258271472,1.13319742004792,0.146786161776448,0.00827488839250148,ENSG00000167377,ZNF23,protein_coding,16,-1,71447597,71463095,q22.2,zinc finger protein 23 [Source:HGNC Symbol;Acc:HGNC:13023],NA,ZNF23,7571,NM_001304492;NM_001304493;NM_001304494;NM_145911
SLC25A12_SIG,SLC25A12,SLC25A12_SIG,SLC25A12,SIG,19,5.24529912864153,0.20610991936754,0.191537674149894,0.253990153654089,0.0624524795041944,1.31908165876379e-06,4.47049406329106,4.16997744253955,4.10219781855801,4.39268192133606,0.290484102778045,0.000110420022334759,ENSG00000115840,SLC25A12,protein_coding,2,-1,171783405,171999859,q31.1,solute carrier family 25 member 12 [Source:HGNC Symbol;Acc:HGNC:10982],EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 39;Epileptic encephalopathy with global cerebral demyelination,SLC25A12,8604,NM_003705
HLA-F_SIG,HLA-F,HLA-F_SIG,HLA-F,SIG,32,-5.24436562134979,0.237637557806931,0.256240313765716,0.176514216799494,-0.0797260969662218,1.32354100875858e-06,-3.83491131857611,5.81438764557133,5.94282624155877,5.3923751158983,-0.550451125660471,0.000965662745199258,ENSG00000204642,HLA-F,protein_coding,6,1,29722775,29738528,p22.1,major histocompatibility complex, class I, F [Source:HGNC Symbol;Acc:HGNC:4963],NA,HLA-F,3134,NM_001098478;NM_001098479;NM_018950
RGL3_SIG,RGL3,RGL3_SIG,RGL3,SIG,8,-5.24430095947644,-0.169244776726496,-0.153385348052592,-0.221354328083608,-0.0679689800310161,1.32354100875858e-06,-2.30061135235318,0.386988316617071,0.429897737103299,0.246000220733749,-0.18389751636955,0.0538689781631825,ENSG00000205517,RGL3,protein_coding,19,-1,11384341,11419342,p13.2,ral guanine nucleotide dissociation stimulator like 3 [Source:HGNC Symbol;Acc:HGNC:30282],NA,RGL3,57139,NM_001035223;NM_001161616
OGFOD2_SIG,OGFOD2,OGFOD2_SIG,OGFOD2,SIG,8,5.24376811181477,0.379763123297099,0.3663174679583,0.423941705124578,0.0576242371662774,1.3260206688948e-06,3.9326697728335,1.60549685522485,1.56553168314365,1.73681099206306,0.171279308919409,0.000706102963414954,ENSG00000111325,OGFOD2,protein_coding,12,1,122974580,122980043,q24.31,2-oxoglutarate and iron dependent oxygenase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25823],NA,OGFOD2,79676,NM_001304833;NM_001304834;NM_001304835;NM_001304836;NM_001304837;NM_001304838;NM_024623
ACSM3_SIG,ACSM3,ACSM3_SIG,ACSM3,SIG,24,5.24163901663545,0.0156891560059436,0.00404845152292366,0.0539371850215806,0.049888733498657,1.34005245690827e-06,4.72811679060625,4.1076940964972,3.94864641798695,4.63027932588804,0.68163290790109,4.21084980054742e-05,ENSG00000005187,ACSM3,protein_coding,16,1,20610243,20797581,p12.3,acyl-CoA synthetase medium chain family member 3 [Source:HGNC Symbol;Acc:HGNC:10522],NA,ACSM3,6296,NM_005622;NM_202000
SLC7A6OS_SIG,SLC7A6OS,SLC7A6OS_SIG,SLC7A6OS,SIG,39,5.24055351514327,0.213685676878876,0.20315085405432,0.248300094730987,0.0451492406766663,1.34659132676027e-06,4.02709255591147,5.01502983938352,4.96729670839804,5.1718672697644,0.204570561366357,0.000521679627614886,ENSG00000103061,SLC7A6OS,protein_coding,16,-1,68284503,68310946,q22.1,solute carrier family 7 member 6 opposite strand [Source:HGNC Symbol;Acc:HGNC:25807],NA,SLC7A6OS,84138,NM_032178
TKT_SIG,TKT,TKT_SIG,TKT,SIG,28,-5.23781279718151,0.37827396235744,0.391538024601406,0.334692043555838,-0.0568459810455684,1.36492388212754e-06,-3.57087473847948,9.51924454301989,9.59102681239619,9.28338851506921,-0.30763829732698,0.00218360646914184,ENSG00000163931,TKT,protein_coding,3,-1,53224712,53256052,p21.1,transketolase [Source:HGNC Symbol;Acc:HGNC:11834],Short Stature Developmental Delay and Congenital Heart Defects;Transketolase deficiency,TKT,7086,NM_001064;NM_001135055;NM_001258028
KAT2B_SIG,KAT2B,KAT2B_SIG,KAT2B,SIG,38,-5.23768339495929,0.0824063037361518,0.0935351678316978,0.0458400359936436,-0.0476951318380541,1.36492388212754e-06,-3.95712323378778,5.56839333118756,5.63826454784309,5.33881647646223,-0.299448071380864,0.000651754930929126,ENSG00000114166,KAT2B,protein_coding,3,1,20040446,20154404,p24.3,lysine acetyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:8638],NA,KAT2B,8850,NM_003884
ADAMTS3_SIG,ADAMTS3,ADAMTS3_SIG,ADAMTS3,SIG,26,-5.23629752138383,-0.118762096748254,-0.110823030237043,-0.144847600999375,-0.0340245707623321,1.37381556112871e-06,-4.47933347001795,1.15474082316366,1.30636520253153,0.656546433812089,-0.649818768719443,0.000106938972384264,ENSG00000156140,ADAMTS3,protein_coding,4,-1,72280969,72569221,q13.3,ADAM metallopeptidase with thrombospondin type 1 motif 3 [Source:HGNC Symbol;Acc:HGNC:219],HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3;Hennekam syndrome,ADAMTS3,9508,NM_014243
ZSCAN20_TF,ZSCAN20,ZSCAN20_TF,ZSCAN20,TF,82,5.2354643043917,0.16703549374707,0.151055110740756,0.2195424664821,0.0684873557413436,1.37863262289377e-06,4.43628686865958,1.69428264571601,1.61726137963023,1.94735251999788,0.330091140367652,0.000125225940980622,ENSG00000121903,ZSCAN20,protein_coding,1,1,33472645,33496507,p35.1,zinc finger and SCAN domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13093],NA,ZSCAN20,7579,NM_145238
CEACAM8_SIG,CEACAM8,CEACAM8_SIG,CEACAM8,SIG,59,-5.23465911477244,0.24556154877293,0.300612071874151,0.0646812585832056,-0.235930813290945,1.38325715542674e-06,-4.29574677651001,4.73633095376272,5.04715533184156,3.71505085436079,-1.33210447748078,0.000207957939864467,ENSG00000124469,CEACAM8,protein_coding,19,-1,42580243,42595055,q13.2,carcinoembryonic antigen related cell adhesion molecule 8 [Source:HGNC Symbol;Acc:HGNC:1820],NA,CEACAM8,1088,NM_001816
CHD7_SIG,CHD7,CHD7_SIG,CHD7,SIG,41,-5.23443438124099,-0.11020285386063,-0.0975336108232916,-0.151830366697597,-0.0542967558743057,1.38354357708308e-06,-4.52544858330447,5.42410300156075,5.58679584061378,4.8895408161008,-0.697255024512984,9.02511248244525e-05,ENSG00000171316,CHD7,protein_coding,8,1,60678740,60868028,q12.2,chromodomain helicase DNA binding protein 7 [Source:HGNC Symbol;Acc:HGNC:20626],CHARGE SYNDROME;HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA;IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM;Kallmann Syndrome;KALLMANN SYNDROME TYPE 5;Normosmic congenital hypogonadotropic hypogonadism;OMENN SYNDROME,CHD7,55636,NM_001316690;NM_017780
TRMT1_SIG,TRMT1,TRMT1_SIG,TRMT1,SIG,45,5.23347267587636,0.351964970755571,0.336051809274967,0.404251072763269,0.0681992634883013,1.38936282932309e-06,3.81030979861054,5.77516201490219,5.71917731675752,5.95911173737755,0.23993442062003,0.00104160704127346,ENSG00000104907,TRMT1,protein_coding,19,-1,13104902,13117567,p13.13,tRNA methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:25980],Autosomal Recessive Mental Retardation,TRMT1,55621,NM_001136035;NM_001142554;NM_001351760;NM_001351761;NM_001351762;NM_017722
LRRK2_SIG,LRRK2,LRRK2_SIG,LRRK2,SIG,63,-5.22975867100495,0.258706222924372,0.30365479826441,0.111018046807103,-0.192636751457308,1.41613811071196e-06,-4.61438658432012,4.86242559879012,5.13456032195323,3.96826865125419,-1.16629167069904,6.51024568832109e-05,ENSG00000188906,LRRK2,protein_coding,12,1,40196744,40369285,q12,leucine rich repeat kinase 2 [Source:HGNC Symbol;Acc:HGNC:18618],Hereditary late-onset Parkinson disease;PARKINSON DISEASE 8 AUTOSOMAL DOMINANT;Young-onset Parkinson disease,LRRK2,120892,NM_198578
C3_SIG,C3,C3_SIG,C3,SIG,8,-5.22935117888843,0.0502637906816757,0.0767695266121463,-0.0368264845184419,-0.113596011130588,1.4178349694536e-06,-3.64078005667688,1.79956316233469,1.91075656568414,1.4342134084722,-0.476543157211941,0.00176096441002502,ENSG00000125730,C3,protein_coding,19,-1,6677704,6730562,p13.3,complement C3 [Source:HGNC Symbol;Acc:HGNC:1318],Atypical hemolytic uremic syndrome with C3 anomaly;Complement component 3 deficiency;COMPLEMENT COMPONENT 3 DEFICIENCY AUTOSOMAL RECESSIVE;HEMOLYTIC UREMIC SYNDROME ATYPICAL SUSCEPTIBILITY TO 5;MACULAR DEGENERATION AGE-RELATED 9,C3,718,NM_000064
GLDC_SIG,GLDC,GLDC_SIG,GLDC,SIG,22,-5.2288581428848,-0.168942041908248,-0.144667431672389,-0.248701475540359,-0.10403404386797,1.4201919523484e-06,-3.20928176935319,0.247249181080564,0.280784582461823,0.137061433685001,-0.143723148776822,0.00619162895032088,ENSG00000178445,GLDC,protein_coding,9,-1,6532464,6645783,p24.1,glycine decarboxylase [Source:HGNC Symbol;Acc:HGNC:4313],Atypical glycine encephalopathy;GLDC-Related Glycine Encephalopathy;GLYCINE ENCEPHALOPATHY;Infantile glycine encephalopathy;Neonatal glycine encephalopathy,GLDC,2731,NM_000170
GDF9_SIG,GDF9,GDF9_SIG,GDF9,SIG,35,5.22732604772635,0.0481476215356878,0.0385163233450475,0.0797933155906489,0.0412769922456015,1.43056888474395e-06,2.60685027094456,0.83336897353342,0.806087277845936,0.923008830792295,0.116921552946359,0.0277098562689248,ENSG00000164404,GDF9,protein_coding,5,-1,132861181,132866884,q31.1,growth differentiation factor 9 [Source:HGNC Symbol;Acc:HGNC:4224],PREMATURE OVARIAN FAILURE 14,GDF9,2661,NM_001288824;NM_001288825;NM_001288826;NM_001288827;NM_001288828;NM_005260
MECOM_TF,MECOM,MECOM_TF,MECOM,TF,142,-5.22501185514833,-0.0910315258076407,-0.0831637517284992,-0.116882783496249,-0.0337190317677492,1.44712401272569e-06,-0.253410043170837,1.0149439415163,1.02848999266332,0.970435487747534,-0.0580545049157817,0.855666949930993,ENSG00000085276,MECOM,protein_coding,3,-1,169083499,169663775,q26.2,MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498],Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2);MYELODYSPLASTIC SYNDROME;Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome;RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA;Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,MECOM,2122,NM_001105077;NM_001105078;NM_001163999;NM_001164000;NM_001205194;NM_001366468;NM_001366470;NM_004991;NM_005241
RASAL2_SIG,RASAL2,RASAL2_SIG,RASAL2,SIG,71,5.22453955626584,-0.0117783873182241,-0.0216892969017797,0.0207860298848869,0.0424753267866665,1.44936863282856e-06,1.74292075029002,2.81450120136134,2.74655127340016,3.03776525037664,0.291213976976476,0.151912005775398,ENSG00000075391,RASAL2,protein_coding,1,1,178094141,178484147,q25.2,RAS protein activator like 2 [Source:HGNC Symbol;Acc:HGNC:9874],NA,RASAL2,9462,NM_004841;NM_170692
ZFP36L1_SIG,ZFP36L1,ZFP36L1_SIG,ZFP36L1,SIG,20,-5.22429840231553,0.151430730589635,0.176813754157862,0.0680293674368891,-0.108784386720973,1.449805911112e-06,-4.62447435503236,6.61675155358693,6.80779386680089,5.98904109588392,-0.818752770916974,6.26016417255657e-05,ENSG00000185650,ZFP36L1,protein_coding,14,-1,68787660,68796253,q24.1,ZFP36 ring finger protein like 1 [Source:HGNC Symbol;Acc:HGNC:1107],NA,ZFP36L1,677,NM_001244698;NM_001244701;NM_004926
NCBP2_SIG,NCBP2,NCBP2_SIG,NCBP2,SIG,49,5.22409487925711,0.468600709072248,0.449646616133268,0.530878443014612,0.0812318268813442,1.44994983118248e-06,4.1744369759777,6.03935934884376,5.98014301486505,6.23392730334523,0.253784288480182,0.000314520870651686,ENSG00000114503,NCBP2,protein_coding,3,-1,196935402,196942594,q29,nuclear cap binding protein subunit 2 [Source:HGNC Symbol;Acc:HGNC:7659],NA,NCBP2,22916,NM_001042540;NM_001308036;NM_007362
EDIL3_SIG,EDIL3,EDIL3_SIG,EDIL3,SIG,14,-5.22152191594812,-0.097482410686911,-0.0895079155933809,-0.123684323137081,-0.0341764075437003,1.46877591418755e-06,-1.91119514915722,0.4285754412529,0.478215897848381,0.265471083867748,-0.212744813980633,0.114051565900139,ENSG00000164176,EDIL3,protein_coding,5,-1,83940554,84384880,q14.3,EGF like repeats and discoidin domains 3 [Source:HGNC Symbol;Acc:HGNC:3173],NA,EDIL3,10085,NM_001278642;NM_005711
SYNE2_SIG,SYNE2,SYNE2_SIG,SYNE2,SIG,31,-5.21953599307448,-0.0130677718724455,0.0103127724358588,-0.0898895603140166,-0.100202332749875,1.48313038087315e-06,-4.15559053644147,4.97319678137412,5.15783683178299,4.36652233003069,-0.791314501752304,0.000335268274178199,ENSG00000054654,SYNE2,protein_coding,14,1,63852983,64226433,q23.2,spectrin repeat containing nuclear envelope protein 2 [Source:HGNC Symbol;Acc:HGNC:17084],Autosomal dominant Emery-Dreifuss muscular dystrophy;Emery-dreifuss muscular dystrophy 5 autosomal dominant,SYNE2,23224,NM_015180;NM_182910;NM_182913;NM_182914
NEDD9_SIG,NEDD9,NEDD9_SIG,NEDD9,SIG,16,-5.21826853299094,0.508236307392332,0.531951912821665,0.43031360383881,-0.101638308982856,1.49100367942832e-06,-3.4638491179109,4.7304122785859,4.83585503339342,4.38395751278974,-0.451897520603685,0.00299749051393205,ENSG00000111859,NEDD9,protein_coding,6,-1,11183298,11382348,p24.2,neural precursor cell expressed, developmentally down-regulated 9 [Source:HGNC Symbol;Acc:HGNC:7733],NA,NEDD9,4739,NM_001142393;NM_001271033;NM_006403;NM_182966
PFKFB4_SIG,PFKFB4,PFKFB4_SIG,PFKFB4,SIG,15,-5.21818587722266,0.430337878617991,0.479584722180168,0.268526821199406,-0.211057900980762,1.49100367942832e-06,-4.77660816358138,4.16581828897547,4.31067705819963,3.68985376152464,-0.620823296674987,3.50370439407352e-05,ENSG00000114268,PFKFB4,protein_coding,3,-1,48517684,48562015,p21.31,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 [Source:HGNC Symbol;Acc:HGNC:8875],NA,PFKFB4,5210,NM_001317134;NM_001317135;NM_001317136;NM_001317137;NM_001317138;NM_004567
SLC2A11_SIG,SLC2A11,SLC2A11_SIG,SLC2A11,SIG,83,5.21793876783058,0.0210088348610286,0.00754645072591494,0.0652423827335447,0.0576959320076297,1.49150816905368e-06,4.20542686912983,2.96752338876434,2.88824604712978,3.22800608270644,0.339760035576656,0.000282846494546716,ENSG00000133460,SLC2A11,protein_coding,22,1,23856703,23886309,q11.23,solute carrier family 2 member 11 [Source:HGNC Symbol;Acc:HGNC:14239],NA,SLC2A11,66035,NM_001024938;NM_001024939;NM_001282864;NM_030807
CHD4_SIG,CHD4,CHD4_SIG,CHD4,SIG,19,5.21713361697157,0.525359612137408,0.508616842503336,0.580371569506499,0.0717547270031625,1.49651461159344e-06,3.83210184418292,8.66808648014946,8.61928287320771,8.82844118867236,0.209158315464649,0.000972760014708257,ENSG00000111642,CHD4,protein_coding,12,-1,6570082,6614524,p13.31,chromodomain helicase DNA binding protein 4 [Source:HGNC Symbol;Acc:HGNC:1919],SIFRIM-HITZ-WEISS SYNDROME;Syndromic INTELLECTUAL DISABILITY with or without congenital heart disease,CHD4,1108,NM_001273;NM_001297553;NM_001363606
TSHZ2_TF,TSHZ2,TSHZ2_TF,TSHZ2,TF,84,-5.21433011621211,-0.207603914398091,-0.191314801097694,-0.261125286670823,-0.0698104855731291,1.51781431672315e-06,-3.14514889838047,0.991493811324355,1.07188331933381,0.727356856436157,-0.344526462897649,0.00735972613110651,ENSG00000182463,TSHZ2,protein_coding,20,1,52972358,53495330,q13.2,teashirt zinc finger homeobox 2 [Source:HGNC Symbol;Acc:HGNC:13010],NA,TSHZ2,128553,NM_001193421;NM_173485
ANGPT1_SIG,ANGPT1,ANGPT1_SIG,ANGPT1,SIG,106,5.21265093949945,0.065332220779528,0.0471856132655889,0.124956788325328,0.0777711750597392,1.53010294757157e-06,2.12853310469355,4.64591664807448,4.51837719917434,5.06497483731778,0.54659763814344,0.0761986515262958,ENSG00000154188,ANGPT1,protein_coding,8,-1,107249482,107498055,q23.1,angiopoietin 1 [Source:HGNC Symbol;Acc:HGNC:484],NA,ANGPT1,284,NM_001146;NM_001199859;NM_001314051
FCN2_SIG,FCN2,FCN2_SIG,FCN2,SIG,1,-5.21227721056722,0.907213120420084,0.981329145792337,0.663689037054109,-0.317640108738229,1.53167007153433e-06,-2.06535441152163,0.453657837417854,0.476050833850911,0.38008084913781,-0.0959699847131012,0.0858251860990975,ENSG00000160339,FCN2,protein_coding,9,1,134880810,134887523,q34.3,ficolin 2 [Source:HGNC Symbol;Acc:HGNC:3624],NA,FCN2,2220,NM_004108;NM_015837
PTK7_SIG,PTK7,PTK7_SIG,PTK7,SIG,173,5.21112997455925,0.12444435683851,0.104827752970286,0.18889891240553,0.0840711594352444,1.53964742742339e-06,4.65616064253458,4.70372103019223,4.50713879252101,5.34963409682622,0.842495304305214,5.5207324722249e-05,ENSG00000112655,PTK7,protein_coding,6,1,43076307,43161719,p21.1,protein tyrosine kinase 7 (inactive) [Source:HGNC Symbol;Acc:HGNC:9618],NA,PTK7,5754,NM_001270398;NM_002821;NM_152880;NM_152881;NM_152882
LCN2_SIG,LCN2,LCN2_SIG,LCN2,SIG,17,-5.21066380446097,0.0290936795641394,0.0909125043882694,-0.174025316286573,-0.264937820674843,1.54199470118549e-06,-4.33711554332988,4.20075957969952,4.52224241349262,3.14445884009362,-1.37778357339899,0.000179079720919358,ENSG00000148346,LCN2,protein_coding,9,1,128149071,128153453,q34.11,lipocalin 2 [Source:HGNC Symbol;Acc:HGNC:6526],NA,LCN2,3934,NM_005564
PRR4_SIG,PRR4,PRR4_SIG,PRR4,SIG,78,5.21025088175794,0.0625301224584111,0.0482533550188884,0.109439501188271,0.061186146169383,1.54390356270185e-06,4.2130510779979,1.90644526654133,1.83968733666018,2.12579275043657,0.286105413776392,0.000275557782365286,ENSG00000111215,PRR4,protein_coding,12,-1,10845849,10849475,p13.2,proline rich 4 [Source:HGNC Symbol;Acc:HGNC:18020],NA,PRR4,5554;11272,NM_001098538;NM_007244
CHST10_SIG,CHST10,CHST10_SIG,CHST10,SIG,18,5.20968195407606,0.278330688376885,0.265605797617817,0.320141043728106,0.0545352461102883,1.54711632533614e-06,2.40173288323645,3.73941279557165,3.68273187111036,3.92565011880162,0.242918247691262,0.0437377302378628,ENSG00000115526,CHST10,protein_coding,2,-1,100391860,100417668,q11.2,carbohydrate sulfotransferase 10 [Source:HGNC Symbol;Acc:HGNC:19650],NA,CHST10,9486,NM_004854
CUBN_SIG,CUBN,CUBN_SIG,CUBN,SIG,123,5.20857144879335,0.0103128084987885,-0.000270029438702091,0.0450849902934003,0.0453550197321025,1.55486794718102e-06,3.98545251737777,2.70012848865818,2.5932690528466,3.05123806346769,0.457969010621092,0.000595157513774668,ENSG00000107611,CUBN,protein_coding,10,-1,16823966,17129817,p13,cubilin [Source:HGNC Symbol;Acc:HGNC:2548],Imerslund-Grasbeck syndrome;MEGALOBLASTIC ANEMIA 1,CUBN,8029,NM_001081
ALOX12_SIG,ALOX12,ALOX12_SIG,ALOX12,SIG,20,-5.20833204857652,-0.185037438725565,-0.174401115297677,-0.219985358560054,-0.0455842432623769,1.55534111744007e-06,-4.1680880078635,0.920228765132543,1.05382047348384,0.481284580549714,-0.572535892934125,0.00032148189542402,ENSG00000108839,ALOX12,protein_coding,17,1,6996049,7010754,p13.1,arachidonate 12-lipoxygenase, 12S type [Source:HGNC Symbol;Acc:HGNC:429],NA,ALOX12,239,NM_000697
SDR39U1_SIG,SDR39U1,SDR39U1_SIG,SDR39U1,SIG,44,5.2075038336166,0.34970880175192,0.33746304072589,0.38994487369459,0.0524818329686998,1.56075932758722e-06,4.23808921713613,5.29261001221383,5.2429417508668,5.45580572806834,0.212863977201538,0.000252484025346517,ENSG00000100445,SDR39U1,protein_coding,14,-1,24439766,24442905,q12,short chain dehydrogenase/reductase family 39U member 1 [Source:HGNC Symbol;Acc:HGNC:20275],NA,SDR39U1,56948,NM_001290292;NM_001290293;NM_001308075;NM_020195
LSM7_SIG,LSM7,LSM7_SIG,LSM7,SIG,16,5.20555031468138,0.445149722583226,0.432298563171689,0.487374960649707,0.0550763974780183,1.57571843421659e-06,5.18031526360246,5.05990550095977,4.98397927436532,5.30937738834154,0.325398113976226,6.81758948571247e-06,ENSG00000130332,LSM7,protein_coding,19,-1,2321520,2328611,p13.3,LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated [Source:HGNC Symbol;Acc:HGNC:20470],NA,LSM7,51690,NM_016199
THAP9_TF,THAP9,THAP9_TF,THAP9,TF,56,5.20383043505463,0.16736893061252,0.157678859661075,0.199207735167271,0.0415288755061969,1.58881680052751e-06,3.85527464039083,2.59980775139412,2.55260160160865,2.7549136721178,0.202312070509151,0.000904093199582181,ENSG00000168152,THAP9,protein_coding,4,1,82900684,82919969,q21.22,THAP domain containing 9 [Source:HGNC Symbol;Acc:HGNC:23192],NA,THAP9,79725,NM_001317776;NM_024672
MMP8_SIG,MMP8,MMP8_SIG,MMP8,SIG,36,-5.20305405174839,0.204595092116727,0.252188454877612,0.0482169001881051,-0.203971554689507,1.59329656924484e-06,-4.47896864100347,5.71084860070332,6.0679204008073,4.53761268607597,-1.53030771473133,0.000107054932139773,ENSG00000118113,MMP8,protein_coding,11,-1,102711796,102727050,q22.2,matrix metallopeptidase 8 [Source:HGNC Symbol;Acc:HGNC:7175],NA,MMP8,4317,NM_001304441;NM_001304442;NM_002424
DYRK1B_SIG,DYRK1B,DYRK1B_SIG,DYRK1B,SIG,19,5.2029428448076,0.22167819672361,0.209842944245556,0.260565454865787,0.050722510620231,1.59329656924484e-06,4.83951703120161,4.02032896339305,3.93098427205108,4.31389009208807,0.382905820036991,2.74963052712338e-05,ENSG00000105204,DYRK1B,protein_coding,19,-1,39825350,39834201,q13.2,dual specificity tyrosine phosphorylation regulated kinase 1B [Source:HGNC Symbol;Acc:HGNC:3092],ABDOMINAL OBESITY-METABOLIC SYNDROME 3,DYRK1B,9149,NM_004714;NM_006483;NM_006484
LONRF3_SIG,LONRF3,LONRF3_SIG,LONRF3,SIG,41,-5.1998936308747,0.0690348532132993,0.0832952572222353,0.0221792400410811,-0.0611160171811542,1.61807111075526e-06,-5.10661168145693,2.63779049960316,2.79325223425465,2.12698765717683,-0.666264577077825,9.20176217417753e-06,ENSG00000175556,LONRF3,protein_coding,X,1,118974614,119018355,q24,LON peptidase N-terminal domain and ring finger 3 [Source:HGNC Symbol;Acc:HGNC:21152],NA,LONRF3,79836,NM_001031855;NM_001289109;NM_024778
CYBB_SIG,CYBB,CYBB_SIG,CYBB,SIG,42,-5.19831456442937,0.510921044083416,0.553758531709761,0.370169299025425,-0.183589232684336,1.63027725704445e-06,-4.60700906244946,7.50001050987395,7.76950997940679,6.61451225283747,-1.15499772656932,6.67785601487614e-05,ENSG00000165168,CYBB,protein_coding,X,1,37780011,37813461,p21.1,cytochrome b-245 beta chain [Source:HGNC Symbol;Acc:HGNC:2578],Chronic granulomatous disease;GRANULOMATOUS DISEASE CHRONIC X-LINKED;IMMUNODEFICIENCY 34;X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,CYBB,1536,NM_000397
MSANTD4_TF,MSANTD4,MSANTD4_TF,MSANTD4,TF,77,5.19777646644612,0.205409086390598,0.192033822827218,0.249356380955988,0.0573225581287703,1.63340393845026e-06,4.26385264585037,3.74810458124186,3.667769633426,4.01206226692256,0.344292633496557,0.000229778848633885,ENSG00000170903,MSANTD4,protein_coding,11,-1,105995623,106022403,q22.3,Myb/SANT DNA binding domain containing 4 with coiled-coils [Source:HGNC Symbol;Acc:HGNC:29383],NA,MSANTD4,84437,NM_001318747;NM_001318748;NM_001318749;NM_001318750;NM_032424
PDCD1LG2_SIG,PDCD1LG2,PDCD1LG2_SIG,PDCD1LG2,SIG,13,-5.1954349732491,-0.103761093433854,-0.0944290984460715,-0.134423362679425,-0.0399942642333532,1.6524830600986e-06,-0.834858346353551,0.374726896799615,0.383265306105959,0.346672123364484,-0.0365931827414755,0.516504886961396,ENSG00000197646,PDCD1LG2,protein_coding,9,1,5510570,5571254,p24.1,programmed cell death 1 ligand 2 [Source:HGNC Symbol;Acc:HGNC:18731],NA,PDCD1LG2,80380,NM_025239
SCML4_SIG,SCML4,SCML4_SIG,SCML4,SIG,43,-5.19383943698053,-0.0176659755252572,0.00430058432056173,-0.0898418150186622,-0.0941423993392239,1.66508958224331e-06,-3.68498373859884,1.93947465124663,2.05434736281689,1.5620357418015,-0.492311621015393,0.00153940927497658,ENSG00000146285,SCML4,protein_coding,6,-1,107702154,107824317,q21,Scm polycomb group protein like 4 [Source:HGNC Symbol;Acc:HGNC:21397],NA,SCML4,256380,NM_001286408;NM_001286409;NM_198081
SLC22A17_SIG,SLC22A17,SLC22A17_SIG,SLC22A17,SIG,45,-5.19342113382403,-0.240829855648716,-0.228868728274313,-0.280130702736039,-0.0512619744617251,1.66721030273176e-06,-4.60333215676238,1.10587766426303,1.23318596359638,0.687578966453467,-0.545606997142912,6.77265770542213e-05,ENSG00000092096,SLC22A17,protein_coding,14,-1,23346306,23352912,q11.2,solute carrier family 22 member 17 [Source:HGNC Symbol;Acc:HGNC:23095],NA,SLC22A17,51310,NM_001289050;NM_016609;NM_020372
SLC46A3_SIG,SLC46A3,SLC46A3_SIG,SLC46A3,SIG,22,5.19265854835642,0.0111011335976443,-0.00297214337512102,0.0573419007938731,0.0603140441689942,1.67242599854213e-06,4.67889665248582,4.04739976869493,3.93650187522976,4.41177856150908,0.475276686279318,5.07450745965408e-05,ENSG00000139508,SLC46A3,protein_coding,13,-1,28700064,28718970,q12.3,solute carrier family 46 member 3 [Source:HGNC Symbol;Acc:HGNC:27501],NA,SLC46A3,283537,NM_001135919;NM_001347960;NM_181785
LUC7L_SIG,LUC7L,LUC7L_SIG,LUC7L,SIG,84,5.19130850811628,0.130767926723934,0.119591365018526,0.167490915184563,0.0478995501660373,1.68296141986732e-06,4.62390056155808,5.88561391667008,5.82064653810533,6.0990781605257,0.278431622420369,6.26836453508636e-05,ENSG00000007392,LUC7L,protein_coding,16,-1,188969,229463,p13.3,LUC7 like [Source:HGNC Symbol;Acc:HGNC:6723],NA,LUC7L,55692,NM_001320226;NM_001330420;NM_018032;NM_201412
BCAR3_SIG,BCAR3,BCAR3_SIG,BCAR3,SIG,33,-5.19090872576185,-0.106312099449333,-0.097675876538084,-0.134688260443437,-0.0370123839053533,1.68494033719029e-06,-2.58751033601902,0.957516381400825,1.01590108864627,0.76568091473723,-0.250220173909037,0.0289953402641167,ENSG00000137936,BCAR3,protein_coding,1,-1,93561741,93847150,p22.1,BCAR3, NSP family adaptor protein [Source:HGNC Symbol;Acc:HGNC:973],NA,BCAR3,8412,NM_001261408;NM_001261409;NM_001261410;NM_001308251;NM_003567
PADI4_SIG,PADI4,PADI4_SIG,PADI4,SIG,41,-5.1900894542428,0.275840372757134,0.302052270833145,0.189715564793097,-0.112336706040048,1.69072780211155e-06,-3.47858530033666,5.8650710822406,6.03893104404369,5.29381692203047,-0.745114122013224,0.00286924240442321,ENSG00000159339,PADI4,protein_coding,1,1,17308195,17364004,p36.13,peptidyl arginine deiminase 4 [Source:HGNC Symbol;Acc:HGNC:18368],Rheumatoid arthritis,PADI4,23569,NM_012387
PTCD1_SIG,PTCD1,PTCD1_SIG,PTCD1,SIG,16,5.18592647735268,0.221769649599788,0.214608876776759,0.245297903161168,0.0306890263844086,1.7272625904134e-06,2.92158135907486,2.47011979691817,2.43782030193691,2.57624670899945,0.138426407062541,0.0131392660127891,ENSG00000106246,PTCD1,protein_coding,7,-1,99416739,99466163,q22.1,pentatricopeptide repeat domain 1 [Source:HGNC Symbol;Acc:HGNC:22198],NA,PTCD1,26024,NM_015545
UBN1_TF,UBN1,UBN1_TF,UBN1,TF,134,-5.18541555226726,0.117134162228973,0.132301775587545,0.0672977183365221,-0.0650040572510234,1.73032654581992e-06,-3.49186516970079,7.04237425794414,7.08095906010519,6.91559562227213,-0.165363437833061,0.00276197741591233,ENSG00000118900,UBN1,protein_coding,16,1,4846665,4882360,p13.3,ubinuclein 1 [Source:HGNC Symbol;Acc:HGNC:12506],NA,UBN1,29855,NM_001079514;NM_001288656
PHF14_SIG,PHF14,PHF14_SIG,PHF14,SIG,33,5.18521144424105,0.277681651024204,0.256203642988525,0.348252248855724,0.092048605867199,1.73054580617132e-06,3.30618589232008,5.40049721557052,5.33531128344215,5.61467956399229,0.279368280550141,0.00472400833452144,ENSG00000106443,PHF14,protein_coding,7,1,10973336,11169630,p21.3,PHD finger protein 14 [Source:HGNC Symbol;Acc:HGNC:22203],NA,PHF14,9678,NM_001007157;NM_014660
ZNF513_TF,ZNF513,ZNF513_TF,ZNF513,TF,161,5.18416854734231,-0.0289029853898622,-0.0370095419221281,-0.00226715678384551,0.0347423851382826,1.73857316830788e-06,4.21996963151422,4.53588722666957,4.49184105085096,4.68061037578784,0.188769324936875,0.00026865111434287,ENSG00000163795,ZNF513,protein_coding,2,-1,27377235,27380790,p23.3,zinc finger protein 513 [Source:HGNC Symbol;Acc:HGNC:26498],Retinitis pigmentosa;Retinitis pigmentosa 58,ZNF513,130557,NM_001201459;NM_144631
LILRB3_SIG,LILRB3,LILRB3_SIG,LILRB3,SIG,43,-5.18070278221571,0.4054298466532,0.464201397191918,0.212323323454558,-0.25187807373736,1.76947965912761e-06,-4.46701205839812,3.04762405970884,3.24199283927635,2.40898378398702,-0.833009055289332,0.00011181623994839,ENSG00000204577,LILRB3,protein_coding,19,-1,54216278,54223506,q13.42,leukocyte immunoglobulin like receptor B3 [Source:HGNC Symbol;Acc:HGNC:6607],NA,LILRB3,11025;102725035;107987425;107987462,NM_001081450;NM_001320960;NM_006864
TSEN2_SIG,TSEN2,TSEN2_SIG,TSEN2,SIG,74,5.17870225780499,0.16760573055312,0.146359269623662,0.237415530749909,0.0910562611262473,1.78683093099893e-06,4.37279476266652,3.16213800106883,3.0666365947111,3.47592833624425,0.409291741533148,0.000157024896676091,ENSG00000154743,TSEN2,protein_coding,3,1,12484432,12539623,p25.2,tRNA splicing endonuclease subunit 2 [Source:HGNC Symbol;Acc:HGNC:28422],Pontocerebellar hypoplasia type 2;Pontocerebellar Hypoplasia Type 2 and Type 4;PONTOCEREBELLAR HYPOPLASIA TYPE 2B,TSEN2,80746,NM_001145392;NM_001145393;NM_001145394;NM_001321277;NM_001321278;NM_001321279;NM_025265
ZFP62_TF,ZFP62,ZFP62_TF,ZFP62,TF,156,5.17731077887324,0.111639452854591,0.0941553846194771,0.169087105627109,0.0749317210076318,1.79846868561151e-06,4.31890417003209,4.43937137160867,4.3413936968972,4.7612980170892,0.419904320191994,0.000191291405561548,ENSG00000196670,ZFP62,protein_coding,5,-1,180847611,180861285,q35.3,ZFP62 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:23241],NA,ZFP62,643836,NM_001172638;NM_152283
RALA_SIG,RALA,RALA_SIG,RALA,SIG,27,5.17576388648479,0.345278742616483,0.332797060077944,0.386289985243113,0.0534929251651691,1.81168814956325e-06,4.65597353558856,5.49898541240877,5.3966561475559,5.83521013978249,0.438553992226588,5.5207324722249e-05,ENSG00000006451,RALA,protein_coding,7,1,39623565,39708120,p14.1,RAS like proto-oncogene A [Source:HGNC Symbol;Acc:HGNC:9839],NA,RALA,5898,NM_005402
CATSPER2_SIG,CATSPER2,CATSPER2_SIG,CATSPER2,SIG,120,5.17496463700329,0.00166942615390571,-0.0119087221106718,0.0462833418803745,0.0581920639910464,1.81770947763344e-06,4.06253982508328,2.80512684945584,2.71094080395248,3.11459528468116,0.403654480728684,0.000461317501094857,ENSG00000166762,CATSPER2,protein_coding,15,-1,43628503,43668118,q15.3,cation channel sperm associated 2 [Source:HGNC Symbol;Acc:HGNC:18810],Deafness-infertility syndrome;SPERMATOGENIC FAILURE 7,CATSPER2,117155,NM_001282309;NM_001282310;NM_172095
MSRA_SIG,MSRA,MSRA_SIG,MSRA,SIG,31,-5.17413425322329,0.247283399111052,0.261883894388885,0.199310343198175,-0.0625735511907101,1.82320917127916e-06,-3.04748745024393,4.68349514399141,4.72980898787361,4.5313210855213,-0.198487902352318,0.00951252405309745,ENSG00000175806,MSRA,protein_coding,8,1,10054292,10428891,p23.1,methionine sulfoxide reductase A [Source:HGNC Symbol;Acc:HGNC:7377],NA,MSRA,4482,NM_001135670;NM_001135671;NM_001199729;NM_012331
CRYZL1_SIG,CRYZL1,CRYZL1_SIG,CRYZL1,SIG,28,5.17404144359119,0.210525557064355,0.196111648406393,0.2578855426548,0.0617738942484075,1.82320917127916e-06,3.97640744723851,4.34249969690285,4.29053246710784,4.51324916622929,0.222716699121443,0.000612408079688715,ENSG00000205758,CRYZL1,protein_coding,21,-1,33589341,33643926,q22.11,crystallin zeta like 1 [Source:HGNC Symbol;Acc:HGNC:2420],NA,CRYZL1,9946,NM_145858
CACHD1_SIG,CACHD1,CACHD1_SIG,CACHD1,SIG,151,5.17364465497161,-0.0836053785625518,-0.0931466051241074,-0.0522556341460121,0.0408909709780954,1.82533367889283e-06,2.11985595795537,1.67489170588645,1.60185005577282,1.91488569911695,0.313035643344125,0.0774086796121814,ENSG00000158966,CACHD1,protein_coding,1,1,64470129,64693058,p31.3,cache domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29314],NA,CACHD1,57685,NM_001293274;NM_020925
MORC4_TF,MORC4,MORC4_TF,MORC4,TF,239,-5.17256710567937,-0.104920245088357,-0.0974014618970909,-0.129624818431087,-0.0322233565339962,1.83413483446658e-06,-2.8624736580245,1.26199373510235,1.32894164969666,1.04202201572104,-0.286919633975611,0.015224524493583,ENSG00000133131,MORC4,protein_coding,X,-1,106813871,107000212,q22.3,MORC family CW-type zinc finger 4 [Source:HGNC Symbol;Acc:HGNC:23485],NA,MORC4,79710,NM_001085354;NM_024657
PCP2_SIG,PCP2,PCP2_SIG,PCP2,SIG,41,5.1723364254134,0.0451050546897391,0.0339652365680467,0.0817073142324425,0.0477420776643958,1.83464227649719e-06,2.96343865671512,1.43644658884402,1.38841165533152,1.59427565609936,0.205864000767841,0.0118336460800459,ENSG00000174788,PCP2,protein_coding,19,-1,7631611,7633719,p13.2,Purkinje cell protein 2 [Source:HGNC Symbol;Acc:HGNC:30209],NA,PCP2,126006,NM_001271830;NM_174895
TRIM25_SIG,TRIM25,TRIM25_SIG,TRIM25,SIG,7,-5.16926469698735,0.303272707973482,0.31315215274756,0.270811675144367,-0.0423404776031932,1.86326742111951e-06,-3.99372537402482,7.26219042443601,7.3211550831891,7.0684494028187,-0.252705680370395,0.000580525567500451,ENSG00000121060,TRIM25,protein_coding,17,-1,56836387,56914080,q22,tripartite motif containing 25 [Source:HGNC Symbol;Acc:HGNC:12932],NA,TRIM25,7706,NM_005082
IL18RAP_SIG,IL18RAP,IL18RAP_SIG,IL18RAP,SIG,49,-5.16786347531359,0.0251724303205405,0.0544644969986182,-0.0710729316217149,-0.125537428620333,1.8754924575974e-06,-4.56359016207947,3.26063062720664,3.47587581128036,2.5533964509644,-0.922479360315955,7.88185265220013e-05,ENSG00000115607,IL18RAP,protein_coding,2,1,102418689,102452565,q12.1,interleukin 18 receptor accessory protein [Source:HGNC Symbol;Acc:HGNC:5989],NA,IL18RAP,8807,NM_003853
SYTL3_SIG,SYTL3,SYTL3_SIG,SYTL3,SIG,25,-5.16765015467502,0.173806782579296,0.19098856702848,0.117352347960548,-0.0736362190679316,1.87584033682646e-06,-1.70622305226756,3.72984750983493,3.78850632201838,3.53711141266072,-0.251394909357664,0.161616435378396,ENSG00000164674,SYTL3,protein_coding,6,1,158650014,158764876,q25.3,synaptotagmin like 3 [Source:HGNC Symbol;Acc:HGNC:15587],NA,SYTL3,94120,NM_001009991;NM_001242384;NM_001242394;NM_001242395;NM_001318745
TRPM7_SIG,TRPM7,TRPM7_SIG,TRPM7,SIG,38,5.16615460081883,0.450673342559315,0.438987247103387,0.489070513343078,0.050083266239691,1.88909985892006e-06,3.31586827403669,6.86848054358028,6.83337726821539,6.98381987692205,0.150442608706666,0.00460057937295412,ENSG00000092439,TRPM7,protein_coding,15,-1,50552473,50686797,q21.2,transient receptor potential cation channel subfamily M member 7 [Source:HGNC Symbol;Acc:HGNC:17994],Amyotrophic lateral sclerosis-parkinsonism-dementia complex;AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1,TRPM7,54822,NM_001301212;NM_017672
CD40LG_SIG,CD40LG,CD40LG_SIG,CD40LG,SIG,14,-5.16547583679499,-0.0275228894061438,0.0106497505018591,-0.152947277675296,-0.163597028177155,1.89416117190094e-06,-3.84023248814906,1.28318897876129,1.382801674519,0.955890121271649,-0.426911553247352,0.000948656615408238,ENSG00000102245,CD40LG,protein_coding,X,1,136648193,136660390,q26.3,CD40 ligand [Source:HGNC Symbol;Acc:HGNC:11935],IMMUNODEFICIENCY WITH HYPER-IgM TYPE 1;X-linked hyper-IgM syndrome,CD40LG,959,NM_000074
SLAMF7_SIG,SLAMF7,SLAMF7_SIG,SLAMF7,SIG,27,-5.16076422836611,-0.107520014004383,-0.0860140312896491,-0.178182528638511,-0.0921684973488615,1.94061341922003e-06,-4.80257357951696,3.03059444894267,3.21145601095754,2.43633503089382,-0.775120980063714,3.15169173438215e-05,ENSG00000026751,SLAMF7,protein_coding,1,1,160739057,160754821,q23.3,SLAM family member 7 [Source:HGNC Symbol;Acc:HGNC:21394],NA,SLAMF7,57823,NM_001282588;NM_001282589;NM_001282590;NM_001282591;NM_001282592;NM_001282593;NM_001282594;NM_001282595;NM_001282596;NM_021181
NUDT17_SIG,NUDT17,NUDT17_SIG,NUDT17,SIG,41,5.16037428606916,0.116645438065136,0.10488374021312,0.15529101672176,0.0504072765086403,1.94280974363137e-06,3.59011477680319,2.94019611365185,2.8877473209209,3.11252786119638,0.224780540275475,0.00206014412924525,ENSG00000186364,NUDT17,protein_coding,1,1,145845630,145848954,q21.1,nudix hydrolase 17 [Source:HGNC Symbol;Acc:HGNC:26618],NA,NUDT17,200035,NM_001012758
CERS1_SIG,CERS1,CERS1_SIG,CERS1,SIG,38,5.15934906608229,-0.0673165511407828,-0.0781481407201637,-0.0317270425228168,0.0464210981973471,1.95107165534467e-06,3.58128047623892,0.364815927345119,0.31635173487852,0.524055416878228,0.207703681999707,0.00211377860865873,ENSG00000223802,CERS1,protein_coding,19,-1,18868545,18896727,p13.11,ceramide synthase 1 [Source:HGNC Symbol;Acc:HGNC:14253],CONGENITAL HEART DEFECTS MULTIPLE TYPES 6;EPILEPSY PROGRESSIVE MYOCLONIC 8;Progressive myoclonic epilepsy type 8;RIGHT ATRIAL ISOMERISM,CERS1,2657;10715,NM_001290265;NM_001492;NM_021267;NM_198207
FCGR2A_SIG,FCGR2A,FCGR2A_SIG,FCGR2A,SIG,24,-5.15922385769906,0.189734575292177,0.232530378649235,0.0491197928332738,-0.183410585815961,1.95107165534467e-06,-4.48556633095047,6.07061321323332,6.27160778918185,5.41020246368813,-0.861405325493726,0.000104711127031555,ENSG00000143226,FCGR2A,protein_coding,1,1,161505430,161524013,q23.3,Fc fragment of IgG receptor IIa [Source:HGNC Symbol;Acc:HGNC:3616],Cystic Fibrosis;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;Systemic lupus erythematosus;THROMBOCYTOPENIC PURPURA AUTOIMMUNE,FCGR2A,2212;9103,NM_001136219;NM_021642;NM_201563
TNFRSF13B_SIG,TNFRSF13B,TNFRSF13B_SIG,TNFRSF13B,SIG,20,-5.15903888185179,-0.321209054215219,-0.301350839819411,-0.386457472944303,-0.0851066331248923,1.95114708281494e-06,-3.33201288840423,0.549561208264558,0.600761674653223,0.381331104416088,-0.219430570237136,0.00439217521358299,ENSG00000240505,TNFRSF13B,protein_coding,17,-1,16929816,16972118,p11.2,TNF receptor superfamily member 13B [Source:HGNC Symbol;Acc:HGNC:18153],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 2;Immunoglobulin A deficiency 2,TNFRSF13B,23495,NM_012452
RBM28_SIG,RBM28,RBM28_SIG,RBM28,SIG,44,5.15498342244849,0.323119611155535,0.306483921716527,0.377779733597987,0.0712958118814594,1.99196033677127e-06,4.76538255608398,5.63407591443579,5.54862172334879,5.91485397086452,0.366232247515734,3.65354688460654e-05,ENSG00000106344,RBM28,protein_coding,7,-1,128297685,128343908,q32.1,RNA binding motif protein 28 [Source:HGNC Symbol;Acc:HGNC:21863],ALOPECIA NEUROLOGIC DEFECTS AND ENDOCRINOPATHY SYNDROME;ANE syndrome,RBM28,55131,NM_001166135;NM_018077
LYVE1_SIG,LYVE1,LYVE1_SIG,LYVE1,SIG,15,-5.1543023882994,-0.149090639759854,-0.135148858953587,-0.194899348123302,-0.0597504891697152,1.99731938758773e-06,-2.99572296741566,0.66923402547718,0.742830831415796,0.427415948821728,-0.315414882594068,0.0108893375404911,ENSG00000133800,LYVE1,protein_coding,11,-1,10556966,10611689,p15.4,lymphatic vessel endothelial hyaluronan receptor 1 [Source:HGNC Symbol;Acc:HGNC:14687],NA,LYVE1,10894,NM_006691
ACER2_SIG,ACER2,ACER2_SIG,ACER2,SIG,1,-5.15263384093819,0.119725613964387,0.132085011652304,0.0791161644183751,-0.0529688472339289,2.01327205235602e-06,0.280402868220564,1.14494727531007,1.14128267092748,1.15698811828143,0.0157054473539539,0.839452261654802,ENSG00000177076,ACER2,protein_coding,9,1,19409009,19452505,p22.1,alkaline ceramidase 2 [Source:HGNC Symbol;Acc:HGNC:23675],NA,ACER2,340485,NM_001010887
B4GALNT4_SIG,B4GALNT4,B4GALNT4_SIG,B4GALNT4,SIG,40,-5.15052038460031,-0.129235538040647,-0.117871198567333,-0.166575510595819,-0.0487043120284852,2.03416871660426e-06,-2.49457903135619,0.549943279724404,0.603641875050572,0.373505037938421,-0.230136837112151,0.0357302557744006,ENSG00000182272,B4GALNT4,protein_coding,11,1,369499,382117,p15.5,beta-1,4-N-acetyl-galactosaminyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:26315],NA,B4GALNT4,338707,NM_178537
DHX32_SIG,DHX32,DHX32_SIG,DHX32,SIG,11,5.15012912379134,0.134272026810981,0.119557439560684,0.182619956347674,0.0630625167869902,2.03649201017222e-06,2.23181066648922,4.15493241881551,4.10065282002342,4.33327967198949,0.232626851966072,0.0621553461452374,ENSG00000089876,DHX32,protein_coding,10,-1,125836337,125896436,q26.2,DEAH-box helicase 32 (putative) [Source:HGNC Symbol;Acc:HGNC:16717],NA,DHX32,55760,NM_018180
L3MBTL1_TF,L3MBTL1,L3MBTL1_TF,L3MBTL1,TF,193,5.14890041715825,0.0704656596105519,0.0599666971481087,0.104962250558579,0.0449955534104709,2.04794207587656e-06,3.71689486159431,3.9330053391743,3.86478969569607,4.1571424534599,0.292352757763836,0.00139762236043159,ENSG00000185513,L3MBTL1,protein_coding,20,1,43489442,43550950,q13.11,L3MBTL1, histone methyl-lysine binding protein [Source:HGNC Symbol;Acc:HGNC:15905],NA,L3MBTL1,26013,NM_015478;NM_032107
TARBP1_SIG,TARBP1,TARBP1_SIG,TARBP1,SIG,152,5.14742355842322,0.197328912164614,0.183894626234258,0.241470137364353,0.0575755111300953,2.06218074526928e-06,4.48737386775246,6.71726656486213,6.59790280483769,7.10946177637101,0.511558971533319,0.00010408948006836,ENSG00000059588,TARBP1,protein_coding,1,-1,234391313,234479179,q42.2,TAR (HIV-1) RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11568],NA,TARBP1,6894,NM_005646
DAGLB_SIG,DAGLB,DAGLB_SIG,DAGLB,SIG,45,-5.14539458259668,0.0484846781754771,0.0592549366510817,0.0130966860413478,-0.0461582506097337,2.08263275899226e-06,-1.36505341489585,5.5202482329881,5.54082033452182,5.45265418509161,-0.0881661494302133,0.269833266206048,ENSG00000164535,DAGLB,protein_coding,7,-1,6409126,6484190,p22.1,diacylglycerol lipase beta [Source:HGNC Symbol;Acc:HGNC:28923],NA,DAGLB,221955,NM_001142936;NM_139179
QTRT1_SIG,QTRT1,QTRT1_SIG,QTRT1,SIG,46,5.14487454343859,0.274522525107041,0.261119848439014,0.318559891301987,0.0574400428629736,2.08644553524685e-06,4.50599106594691,4.38715915387146,4.3063123169689,4.65279876083701,0.346486443868111,9.6649617507642e-05,ENSG00000213339,QTRT1,protein_coding,19,1,10701430,10713437,p13.2,queuine tRNA-ribosyltransferase catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:23797],NA,QTRT1,81890,NM_031209
ZNF749_SIG,ZNF749,ZNF749_SIG,ZNF749,SIG,111,5.14309884881466,0.181790320392963,0.166799390854227,0.231046231734522,0.0642468408802942,2.10429140239606e-06,4.0915656895016,2.40386283237706,2.33466409957785,2.63123009728876,0.296565997710902,0.000416736867698111,ENSG00000186230,ZNF749,protein_coding,19,1,57435325,57447101,q13.43,zinc finger protein 749 [Source:HGNC Symbol;Acc:HGNC:32783],NA,ZNF749,388567,NM_001023561;NM_001321952;NM_001321953;NM_001321954
GPR137_SIG,GPR137,GPR137_SIG,GPR137,SIG,15,5.13922751598616,0.180902163752754,0.17368523931872,0.204614915464581,0.0309296761458612,2.14608894302034e-06,2.45410671205039,3.77409088787625,3.74773599473999,3.86068553675251,0.11294954201252,0.0390199022698309,ENSG00000173264,GPR137,protein_coding,11,1,64270062,64289500,q13.1,G protein-coupled receptor 137 [Source:HGNC Symbol;Acc:HGNC:24300],NA,GPR137,56834,NM_001170726;NM_001170880;NM_001170881;NM_001177358;NM_020155
ACP5_SIG,ACP5,ACP5_SIG,ACP5,SIG,11,-5.13877117941071,0.00580911156158658,0.018763434852854,-0.036755093538292,-0.055518528391146,2.14928828568559e-06,-2.13292098578187,3.06912161428241,3.13778905242597,2.84350003181072,-0.294289020615243,0.0755525425600473,ENSG00000102575,ACP5,protein_coding,19,-1,11574660,11579008,p13.2,acid phosphatase 5, tartrate resistant [Source:HGNC Symbol;Acc:HGNC:124],Spondyloenchondrodysplasia;Spondyloenchondrodysplasia with immune dysregulation,ACP5,54,NM_001111034;NM_001111035;NM_001111036;NM_001322023;NM_001611
ZNF789_TF,ZNF789,ZNF789_TF,ZNF789,TF,115,5.13849876791833,0.166690003244941,0.154335978579356,0.207281798574722,0.0529458199953665,2.15038852007272e-06,3.80924230073254,3.74787018247917,3.68446227780605,3.95621044069087,0.27174816288482,0.00104371308641222,ENSG00000198556,ZNF789,protein_coding,7,1,99472890,99503650,q22.1,zinc finger protein 789 [Source:HGNC Symbol;Acc:HGNC:27801],NA,ZNF789,285989,NM_001013258;NM_001350999;NM_001351000;NM_001351001;NM_001351002;NM_001351004;NM_213603
TASP1_SIG,TASP1,TASP1_SIG,TASP1,SIG,55,5.13811600625773,0.184793317572063,0.171786097889757,0.227531325099641,0.0557452272098843,2.15090597255529e-06,3.13881553613461,3.01743870933852,2.96462659583172,3.19096422514657,0.226337629314853,0.00748433236745107,ENSG00000089123,TASP1,protein_coding,20,-1,13389392,13638932,p12.1,taspase 1 [Source:HGNC Symbol;Acc:HGNC:15859],NA,TASP1,55617,NM_001323602;NM_001323603;NM_001323604;NM_017714
RNF208_SIG,RNF208,RNF208_SIG,RNF208,SIG,37,5.13805619548193,-0.0794664008581277,-0.0871099971367169,-0.0543517273713347,0.0327582697653821,2.15090597255529e-06,3.46059495388423,1.44200858324661,1.3740224051398,1.6653917398833,0.291369334743505,0.00302611143652935,ENSG00000212864,RNF208,protein_coding,9,-1,137220247,137221581,q34.3,ring finger protein 208 [Source:HGNC Symbol;Acc:HGNC:25420],NA,RNF208,727800,NM_031297
ASAH2B_SIG,ASAH2B,ASAH2B_SIG,ASAH2B,SIG,20,-5.13792581522698,-0.228041422027535,-0.220357102750181,-0.253289899653125,-0.0329327969029436,2.15090597255529e-06,-3.54883543053536,0.200710963454817,0.224352154190474,0.123032765323371,-0.101319388867104,0.00233215148663493,ENSG00000204147,ASAH2B,protein_coding,10,1,50739318,50816495,q11.23,N-acylsphingosine amidohydrolase 2B [Source:HGNC Symbol;Acc:HGNC:23456],NA,ASAH2B,653308,NM_001079516;NM_001321957;NM_001321958;NM_001321959;NM_001321960
IL17RA_SIG,IL17RA,IL17RA_SIG,IL17RA,SIG,42,-5.13731373338095,0.405572697944572,0.43150862463113,0.320354653117312,-0.111153971513818,2.15460873439669e-06,-5.53178396352894,7.6805303603474,7.87728644490442,7.03404608251721,-0.843240362387213,1.38164482323387e-06,ENSG00000177663,IL17RA,protein_coding,22,1,17084954,17115694,q11.1,interleukin 17 receptor A [Source:HGNC Symbol;Acc:HGNC:5985],Chronic mucocutaneous candidiasis;IMMUNODEFICIENCY 51,IL17RA,23765,NM_001289905;NM_014339
FBRSL1_SIG,FBRSL1,FBRSL1_SIG,FBRSL1,SIG,25,5.13725144874117,0.23580228286179,0.226631180382059,0.26593590529519,0.0393047249131307,2.15460873439669e-06,3.81695535312195,6.77118929770628,6.72152106597602,6.93438491624856,0.212863850272548,0.00102100438652918,ENSG00000112787,FBRSL1,protein_coding,12,1,132489551,132585188,q24.33,fibrosin like 1 [Source:HGNC Symbol;Acc:HGNC:29308],NA,FBRSL1,57666,NM_001142641
ISYNA1_SIG,ISYNA1,ISYNA1_SIG,ISYNA1,SIG,38,5.13634962751206,0.166875972004276,0.148933436423502,0.225830017483963,0.0768965810604618,2.1623185739103e-06,4.74274311251948,4.9395683107328,4.79612410680987,5.4108849807653,0.614760873955428,3.98265882159666e-05,ENSG00000105655,ISYNA1,protein_coding,19,-1,18434388,18438301,p13.11,inositol-3-phosphate synthase 1 [Source:HGNC Symbol;Acc:HGNC:29821],NA,ISYNA1,51477,NM_001170938;NM_001253389;NM_016368
ZNF703_TF,ZNF703,ZNF703_TF,ZNF703,TF,148,-5.1362294562236,0.0283158832879837,0.0459111678392867,-0.0294971945234404,-0.0754083623627272,2.1623185739103e-06,-4.19812856449856,2.43206548558124,2.61671627213529,1.82535575833221,-0.791360513803075,0.0002900134569424,ENSG00000183779,ZNF703,protein_coding,8,1,37695782,37700019,p11.23,zinc finger protein 703 [Source:HGNC Symbol;Acc:HGNC:25883],NA,ZNF703,80139,NM_025069
TAF7_TF,TAF7,TAF7_TF,TAF7,TF,25,5.13574100804164,0.2527629926682,0.246532825235681,0.27323354280362,0.0267007175679392,2.16592610181138e-06,2.9477940343951,6.68514230980713,6.64013230109615,6.83303233842893,0.192900037332786,0.0123067637068709,ENSG00000178913,TAF7,protein_coding,5,-1,141260225,141320821,q31.3,TATA-box binding protein associated factor 7 [Source:HGNC Symbol;Acc:HGNC:11541],NA,TAF7,6879,NM_005642
EDA_SIG,EDA,EDA_SIG,EDA,SIG,22,-5.13523657090404,-0.212552919931244,-0.197694788018956,-0.261372496214476,-0.0636777081955195,2.16972548664404e-06,-4.44147176774963,0.748331397057227,0.831412555324848,0.475350448463614,-0.356062106861235,0.000122988974235961,ENSG00000158813,EDA,protein_coding,X,1,69616067,70039472,q13.1,ectodysplasin A [Source:HGNC Symbol;Acc:HGNC:3157],ECTODERMAL DYSPLASIA 1 HYPOHIDROTIC X-LINKED;ectodermal dysplasia type 1;Oligodontia;TOOTH AGENESIS SELECTIVE X-LINKED 1;tooth agenesis selective X-linked type 1;X-linked hypohidrotic ectodermal dysplasia,EDA,1896,NM_001005609;NM_001005610;NM_001005612;NM_001005613;NM_001399
COL7A1_SIG,COL7A1,COL7A1_SIG,COL7A1,SIG,23,-5.13371180696661,-0.0836199744763773,-0.0794509144033414,-0.0973183147163522,-0.0178674003130108,2.18365236373008e-06,-1.86576348551593,1.70535591569712,1.74397216591029,1.57847395071099,-0.165498215199296,0.123494600027307,ENSG00000114270,COL7A1,protein_coding,3,-1,48564073,48595267,p21.31,collagen type VII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2214],Acral dystrophic epidermolysis bullosa;Centripetalis recessive dystrophic epidermolysis bullosa;Dominant dystrophic epidermolysis bullosa nails only;Dystrophic epidermolysis bullosa pruriginosa;EPIDERMOLYSIS BULLOSA DYSTROPHICA AUTOSOMAL DOMINANT;EPIDERMOLYSIS BULLOSA DYSTROPHICA AUTOSOMAL RECESSIVE;EPIDERMOLYSIS BULLOSA DYSTROPHICA PRETIBIAL;EPIDERMOLYSIS BULLOSA PRURIGINOSA;Epidermolysis bullosa simplex superficialis;EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS;Generalized dominant dystrophic epidermolysis bullosa;NAIL DISORDER NONSYNDROMIC CONGENITAL 8;Pretibial dystrophic epidermolysis bullosa;Recessive dystrophic epidermolysis bullosa generalized intermediate;Recessive dystrophic epidermolysis bullosa inversa;Severe generalized recessive dystrophic epidermolysis bullosa;TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN,COL7A1,1294,NM_000094
LTA4H_SIG,LTA4H,LTA4H_SIG,LTA4H,SIG,20,-5.13368386291317,0.513213235279501,0.534826763346107,0.442197357346367,-0.0926294059997398,2.18365236373008e-06,-3.655828284282,7.77402156111239,7.86463257713265,7.47629965133155,-0.388332925801103,0.00168469972683414,ENSG00000111144,LTA4H,protein_coding,12,-1,96000753,96043520,q23.1,leukotriene A4 hydrolase [Source:HGNC Symbol;Acc:HGNC:6710],NA,LTA4H,4048,NM_000895;NM_001256643;NM_001256644
MMP25_SIG,MMP25,MMP25_SIG,MMP25,SIG,58,-5.13297773236549,0.142489811161118,0.182139892445453,0.0122109726554456,-0.169928919790007,2.18983268937608e-06,-5.09877307299185,4.47564468883317,4.76665819647635,3.51945744943414,-1.24720074704221,9.43345968948034e-06,ENSG00000008516,MMP25,protein_coding,16,1,3046561,3060726,p13.3,matrix metallopeptidase 25 [Source:HGNC Symbol;Acc:HGNC:14246],NA,MMP25,64386,NM_022468
CUL9_SIG,CUL9,CUL9_SIG,CUL9,SIG,93,5.13279239511957,0.200071261991565,0.188460610545134,0.23822054531555,0.0497599347704157,2.18996131985385e-06,3.696587989599,6.13243409015411,6.0912582554935,6.26772611832471,0.176467862831215,0.00148740645150421,ENSG00000112659,CUL9,protein_coding,6,1,43182184,43224587,p21.1,cullin 9 [Source:HGNC Symbol;Acc:HGNC:15982],NA,CUL9,23113,NM_015089
ZNF490_TF,ZNF490,ZNF490_TF,ZNF490,TF,13,5.13260010193161,0.175831932504532,0.162442430269702,0.219826011276117,0.0573835810064153,2.19017273161996e-06,4.26846984012278,2.06930256639377,2.01545162433288,2.24624137602242,0.230789751689548,0.000226663768900414,ENSG00000188033,ZNF490,protein_coding,19,-1,12576100,12640098,p13.13,zinc finger protein 490 [Source:HGNC Symbol;Acc:HGNC:23705],NA,ZNF490,57474,NM_020714
IL7_SIG,IL7,IL7_SIG,IL7,SIG,63,-5.13034368315325,-0.0877660420292581,-0.0796944531781632,-0.114286976825713,-0.0345925236475497,2.21454255273231e-06,-3.63994633807738,0.865684275565374,0.951267831692685,0.584481162575637,-0.366786669117048,0.00176567412473984,ENSG00000104432,IL7,protein_coding,8,-1,78675743,78805523,q21.13,interleukin 7 [Source:HGNC Symbol;Acc:HGNC:6023],NA,IL7,3574,NM_000880;NM_001199886;NM_001199887;NM_001199888
ALPK3_SIG,ALPK3,ALPK3_SIG,ALPK3,SIG,38,-5.13007749918598,-0.0787499389285418,-0.0743276368717556,-0.0932803599722682,-0.0189527231005126,2.21562866957311e-06,-3.10710440140756,1.64384063843352,1.75540628648183,1.27726779484619,-0.478138491635643,0.00816847164142202,ENSG00000136383,ALPK3,protein_coding,15,1,84816680,84873482,q25.3,alpha kinase 3 [Source:HGNC Symbol;Acc:HGNC:17574],CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 27,ALPK3,57538,NM_020778
NFYB_TF,NFYB,NFYB_TF,NFYB,TF,92,5.12957128616656,0.0890195631149039,0.0761575366877701,0.131280507089772,0.055122970402002,2.21954527336304e-06,3.96895014847065,4.67206861005934,4.61609397936356,4.85598525377406,0.239891274410499,0.000627083527622614,ENSG00000120837,NFYB,protein_coding,12,-1,104117086,104138241,q23.3,nuclear transcription factor Y subunit beta [Source:HGNC Symbol;Acc:HGNC:7805],NA,NFYB,4801,NM_006166
USP11_SIG,USP11,USP11_SIG,USP11,SIG,93,5.12828895030363,0.432052245960057,0.416708370025066,0.482467838317887,0.0657594682928209,2.23265428098163e-06,4.33991782087213,5.75334054047941,5.65675808787279,6.07068288475832,0.413924796885526,0.000177099829547113,ENSG00000102226,USP11,protein_coding,X,1,47232690,47248328,p11.3,ubiquitin specific peptidase 11 [Source:HGNC Symbol;Acc:HGNC:12609],NA,USP11,8237,NM_004651
SLC17A9_SIG,SLC17A9,SLC17A9_SIG,SLC17A9,SIG,74,5.12420946631431,0.18292371951074,0.165903755762792,0.238846457539711,0.0729427017769185,2.27806358578295e-06,4.87224674716726,6.34982323944268,6.20361846663754,6.83021035008814,0.626591883450595,2.39747746896989e-05,ENSG00000101194,SLC17A9,protein_coding,20,1,62952707,62969585,q13.33,solute carrier family 17 member 9 [Source:HGNC Symbol;Acc:HGNC:16192],Disseminated superficial actinic porokeratosis;POROKERATOSIS 8 DISSEMINATED SUPERFICIAL ACTINIC TYPE,SLC17A9,63910,NM_001302643;NM_022082
TIGD1_TF,TIGD1,TIGD1_TF,TIGD1,TF,133,5.12414926632369,0.0741573695579593,0.0619769050745511,0.114178895717729,0.0522019906431782,2.27806358578295e-06,3.20306395139861,3.8136817478796,3.74671337430174,4.03372068963543,0.287007315333696,0.00629481708884287,ENSG00000221944,TIGD1,protein_coding,2,-1,232547970,232550592,q37.1,tigger transposable element derived 1 [Source:HGNC Symbol;Acc:HGNC:14523],NA,TIGD1,200765,NM_145702
RGMA_SIG,RGMA,RGMA_SIG,RGMA,SIG,11,-5.12381722902096,0.0068506823723468,0.0195097288553133,-0.0347433275002573,-0.0542530563555706,2.27998348213511e-06,-3.61545275522391,0.726371113789401,0.811286589213734,0.447363123109452,-0.363923466104282,0.00190537408985855,ENSG00000182175,RGMA,protein_coding,15,-1,93035273,93089204,q26.1,repulsive guidance molecule BMP co-receptor a [Source:HGNC Symbol;Acc:HGNC:30308],NA,RGMA,56963,NM_001166283;NM_001166286;NM_001166287;NM_001166288;NM_001166289;NM_020211
ZNF493_TF,ZNF493,ZNF493_TF,ZNF493,TF,75,5.12354430897008,0.0705971473037538,0.0576884612954902,0.113011401330906,0.0553229400354155,2.28119100486889e-06,3.9220584818388,4.12060997969097,4.02377507912925,4.43878179582237,0.41500671669312,0.000728292708275484,ENSG00000196268,ZNF493,protein_coding,19,1,21397119,21427573,p12,zinc finger protein 493 [Source:HGNC Symbol;Acc:HGNC:23708],NA,ZNF493,284443,NM_001076678;NM_145326;NM_175910
ZNF428_TF,ZNF428,ZNF428_TF,ZNF428,TF,293,5.12235397506165,0.0843638878372122,0.0690771139015342,0.134591859340154,0.0655147454386198,2.29353697673793e-06,3.92446825998588,4.70619209190912,4.64610264747059,4.90362883792143,0.257526190450846,0.000724197996931517,ENSG00000131116,ZNF428,protein_coding,19,-1,43607224,43619629,q13.31,zinc finger protein 428 [Source:HGNC Symbol;Acc:HGNC:20804],NA,ZNF428,126299,NM_182498
BCL6_SIG,BCL6,BCL6_SIG,BCL6,SIG,33,-5.12019989247125,0.305673246912415,0.341538894347268,0.187828976769325,-0.153709917577943,2.31776456550882e-06,-5.42729350274518,6.5888520477934,6.81419272924062,5.84844695160968,-0.965745777630936,2.26450430614394e-06,ENSG00000113916,BCL6,protein_coding,3,-1,187721377,187745725,q27.3,BCL6, transcription repressor [Source:HGNC Symbol;Acc:HGNC:1001],Follicular lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Intravascular large B-cell lymphoma;Primary mediastinal large B-cell lymphoma,BCL6,604,NM_001130845;NM_001134738;NM_001706
L3MBTL1_SIG,L3MBTL1,L3MBTL1_SIG,L3MBTL1,SIG,99,5.11627947558082,0.10973154371328,0.09778743084168,0.148976486005678,0.0511890551639981,2.36426914092767e-06,3.71689486159431,3.9330053391743,3.86478969569607,4.1571424534599,0.292352757763836,0.00139762236043159,ENSG00000185513,L3MBTL1,protein_coding,20,1,43489442,43550950,q13.11,L3MBTL1, histone methyl-lysine binding protein [Source:HGNC Symbol;Acc:HGNC:15905],NA,L3MBTL1,26013,NM_015478;NM_032107
ARHGAP10_SIG,ARHGAP10,ARHGAP10_SIG,ARHGAP10,SIG,24,-5.11424626077809,0.0333837001587801,0.0390013192814162,0.014925808755833,-0.0240755105255833,2.38768845163258e-06,-1.44321750834737,3.18082011184551,3.22912611243889,3.02210039561012,-0.207025716828766,0.240817036289828,ENSG00000071205,ARHGAP10,protein_coding,4,1,147732063,148072780,q31.23,Rho GTPase activating protein 10 [Source:HGNC Symbol;Acc:HGNC:26099],NA,ARHGAP10,79658,NM_024605
PLXNB1_SIG,PLXNB1,PLXNB1_SIG,PLXNB1,SIG,70,5.11330762954333,-0.0452735611766187,-0.0560437073978398,-0.00988593787832103,0.0461577695195188,2.39739518917916e-06,2.47017858422078,3.71551760669018,3.61705300943803,4.03904414051866,0.421991131080628,0.0376745263732337,ENSG00000164050,PLXNB1,protein_coding,3,-1,48403854,48430086,p21.31,plexin B1 [Source:HGNC Symbol;Acc:HGNC:9103],NA,PLXNB1,5364,NM_001130082;NM_002673
HHEX_TF,HHEX,HHEX_TF,HHEX,TF,118,5.11248935026916,0.150408956876244,0.142225325821797,0.177298030340853,0.0350727045190556,2.40560775623708e-06,2.88790032884518,6.42604307490203,6.37083323363179,6.6074468390757,0.236613605443908,0.0142965423249465,ENSG00000152804,HHEX,protein_coding,10,1,92689955,92695647,q23.33,hematopoietically expressed homeobox [Source:HGNC Symbol;Acc:HGNC:4901],NA,HHEX,3087,NM_002729
CTSH_SIG,CTSH,CTSH_SIG,CTSH,SIG,31,-5.10951735817857,0.472801288370394,0.513410411468023,0.339371312478183,-0.17403909898984,2.44129476871169e-06,-4.33716147620968,5.15106704407064,5.37137308528562,4.42720433722141,-0.944168748064209,0.000179079720919358,ENSG00000103811,CTSH,protein_coding,15,-1,78921058,78949574,q25.1,cathepsin H [Source:HGNC Symbol;Acc:HGNC:2535],Narcolepsy type 1,CTSH,1512,NM_001319137;NM_004390
IDNK_SIG,IDNK,IDNK_SIG,IDNK,SIG,32,5.10936294432084,-0.0205294902680946,-0.0327765234251068,0.0197107615335169,0.0524872849586236,2.44129476871169e-06,3.13333566710056,2.9005539579545,2.8506537932942,3.06451164183836,0.213857848544159,0.00760033541157161,ENSG00000148057,IDNK,protein_coding,9,1,83623049,83644130,q21.32,IDNK, gluconokinase [Source:HGNC Symbol;Acc:HGNC:31367],NA,IDNK,414328,NM_001001551;NM_001256915;NM_001351535
MGA_TF,MGA,MGA_TF,MGA,TF,118,5.10723320091735,0.479830596967824,0.46642933847072,0.523863303458308,0.0574339649875882,2.46671311314023e-06,4.41606384697657,6.57354288270264,6.48832384251148,6.85354830047358,0.365224457962101,0.000134900520558723,ENSG00000174197,MGA,protein_coding,15,1,41621224,41773081,q15.1,MGA, MAX dimerization protein [Source:HGNC Symbol;Acc:HGNC:14010],NA,MGA,23269,NM_001080541;NM_001164273
PLAGL2_TF,PLAGL2,PLAGL2_TF,PLAGL2,TF,40,-5.10546600254773,0.126838843352284,0.137725499378415,0.0910684021235645,-0.046657097254851,2.4876131894245e-06,-3.44404868715611,6.00232608161937,6.05333421371409,5.83472793330814,-0.218606280405948,0.00316499554894908,ENSG00000126003,PLAGL2,protein_coding,20,-1,32192504,32207743,q11.21,PLAG1 like zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:9047],NA,PLAGL2,5326,NM_002657
CACNA1D_SIG,CACNA1D,CACNA1D_SIG,CACNA1D,SIG,16,-5.10402280200863,0.0711007434518926,0.0823129743808098,0.0342605561140218,-0.0480524182667881,2.50439117757732e-06,-1.08593840602075,0.725095069960628,0.741487458875705,0.671234363525375,-0.0702530953503307,0.389060721235117,ENSG00000157388,CACNA1D,protein_coding,3,1,53328963,53813733,p21.1,calcium voltage-gated channel subunit alpha1 D [Source:HGNC Symbol;Acc:HGNC:1391],Primary aldosteronism seizures and neurologic abnormalities;Primary hyperaldosteronism-seizures-neurological abnormalities syndrome;Sinoatrial node dysfunction and deafness,CACNA1D,776,NM_000720;NM_001128839;NM_001128840
ALG10B_SIG,ALG10B,ALG10B_SIG,ALG10B,SIG,44,5.1014015292424,0.31521068785422,0.305726980752446,0.34637143976005,0.0406444590076045,2.53702670462647e-06,3.67820622636961,2.71776843346996,2.65507329378538,2.92376674957645,0.268693455791063,0.00157300732415508,ENSG00000175548,ALG10B,protein_coding,12,1,38316762,38329721,q12,ALG10B, alpha-1,2-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:31088],NA,ALG10B,144245,NM_001013620;NM_001308340
SMG6_SIG,SMG6,SMG6_SIG,SMG6,SIG,45,5.09692843844628,0.355289170541542,0.344592599601877,0.390435046486155,0.0458424468842782,2.59533074177608e-06,4.27265486517407,5.62649044605111,5.58223120908824,5.77191365321481,0.189682444126568,0.000224110310792818,ENSG00000070366,SMG6,protein_coding,17,-1,2059839,2303785,p13.3,SMG6, nonsense mediated mRNA decay factor [Source:HGNC Symbol;Acc:HGNC:17809],NA,SMG6,23293,NM_001256827;NM_001256828;NM_001282326;NM_017575
POLG2_SIG,POLG2,POLG2_SIG,POLG2,SIG,150,5.09663700932366,0.231405340389528,0.218088759976058,0.27515981889093,0.057071058914872,2.59697090259728e-06,4.53786872221184,4.75056776553357,4.67422762432639,5.00139965807144,0.327172033745053,8.65203890294816e-05,ENSG00000256525,POLG2,protein_coding,17,-1,64477785,64497054,q23.3,DNA polymerase gamma 2, accessory subunit [Source:HGNC Symbol;Acc:HGNC:9180],Autosomal dominant progressive external ophthalmoplegia;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONSAUTOSOMAL DOMINANT 4,POLG2,11232,NM_007215
YBX2_TF,YBX2,YBX2_TF,YBX2,TF,207,-5.0961459606312,-0.104269890932935,-0.0945445804251684,-0.136224482601313,-0.0416799021761442,2.60135420214582e-06,-2.64226627559924,0.274890179311675,0.309571179131767,0.160938322759941,-0.148632856371826,0.0255010429350649,ENSG00000006047,YBX2,protein_coding,17,-1,7288263,7294639,p13.1,Y-box binding protein 2 [Source:HGNC Symbol;Acc:HGNC:17948],NA,YBX2,51087,NM_015982
ZDHHC18_TF,ZDHHC18,ZDHHC18_TF,ZDHHC18,TF,356,-5.09318893326862,0.083593563504998,0.0980187696576609,0.0361964575748199,-0.061822312082841,2.63988228244981e-06,-2.58814526460311,6.00235213584943,6.06399342682147,5.79981646551275,-0.264176961308718,0.0289457484516205,ENSG00000204160,ZDHHC18,protein_coding,1,1,26826688,26857604,p36.11,zinc finger DHHC-type containing 18 [Source:HGNC Symbol;Acc:HGNC:20712],NA,ZDHHC18,84243,NM_032283
DYSF_SIG,DYSF,DYSF_SIG,DYSF,SIG,13,-5.0927673661886,0.413764014497258,0.449996376162305,0.294714826169244,-0.155281549993061,2.64336876690062e-06,-3.11274202309247,6.46820820627599,6.62928629542427,5.93895162764591,-0.690334667778364,0.00805829017564308,ENSG00000135636,DYSF,protein_coding,2,1,71453722,71686768,p13.2,dysferlin [Source:HGNC Symbol;Acc:HGNC:3097],Autosomal recessive limb-girdle muscular dystrophy type 2B;Congenital myopathy Paradas type;Distal myopathy with anterior tibial onset;MIYOSHI MUSCULAR DYSTROPHY 1;MIYOSHI MYOPATHY;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 2;MYOPATHY DISTAL WITH ANTERIOR TIBIAL ONSET,DYSF,8291,NM_001130455;NM_001130976;NM_001130977;NM_001130978;NM_001130979;NM_001130980;NM_001130981;NM_001130982;NM_001130983;NM_001130984;NM_001130985;NM_001130986;NM_001130987;NM_003494
POU2AF1_SIG,POU2AF1,POU2AF1_SIG,POU2AF1,SIG,122,-5.09240241525998,-0.299452407531615,-0.275613331132245,-0.377780801415261,-0.102167470283016,2.6460710612535e-06,-3.96826659673699,1.82613407004087,1.95226034322674,1.41171917243015,-0.540541170796586,0.000628167752602663,ENSG00000110777,POU2AF1,protein_coding,11,-1,111352255,111455630,q23.1,POU class 2 associating factor 1 [Source:HGNC Symbol;Acc:HGNC:9211],Primary biliary cholangitis,POU2AF1,5450,NM_006235
DAPK1_SIG,DAPK1,DAPK1_SIG,DAPK1,SIG,74,5.09052089575381,0.146882696584435,0.131519907048293,0.197360433631761,0.0658405265834682,2.67005224457251e-06,4.40411612377606,6.32694365573616,6.17970594418861,6.81072470796384,0.631018763775225,0.000140944549977683,ENSG00000196730,DAPK1,protein_coding,9,1,87497228,87708634,q21.33,death associated protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:2674],NA,DAPK1,1612,NM_001288729;NM_001288730;NM_001288731;NM_004938
ID3_TF,ID3,ID3_TF,ID3,TF,107,-5.08986703757802,-0.105000649137799,-0.0966775321518295,-0.132348033520272,-0.0356705013684423,2.6768593731981e-06,-0.449626678274781,0.977597674576911,0.987330042623003,0.945619893854039,-0.0417101487689638,0.739210639354591,ENSG00000117318,ID3,protein_coding,1,-1,23557926,23559501,p36.12,inhibitor of DNA binding 3, HLH protein [Source:HGNC Symbol;Acc:HGNC:5362],NA,ID3,3399,NM_002167
CRYZ_SIG,CRYZ,CRYZ_SIG,CRYZ,SIG,7,5.08691416617063,0.237445319770672,0.215208671913295,0.310508591302054,0.095299919388759,2.71419844770706e-06,2.79024715685051,3.46498635673171,3.38849331405589,3.7163206398094,0.327827325753506,0.0181213992170875,ENSG00000116791,CRYZ,protein_coding,1,-1,74705482,74733408,p31.1,crystallin zeta [Source:HGNC Symbol;Acc:HGNC:2419],NA,CRYZ,1429,NM_001130042;NM_001130043;NM_001134759;NM_001889
PLA2G6_SIG,PLA2G6,PLA2G6_SIG,PLA2G6,SIG,124,5.08689774021071,0.0350929727345607,0.0224601622383086,0.0766007786508176,0.0541406164125092,2.71419844770706e-06,2.96038432853524,4.95315609528517,4.89044833358776,5.15919588371952,0.268747550131765,0.0119272366947545,ENSG00000184381,PLA2G6,protein_coding,22,-1,38111495,38205690,q13.1,phospholipase A2 group VI [Source:HGNC Symbol;Acc:HGNC:9039],Adult-onset dystonia-parkinsonism;Infantile neuroaxonal dystrophy;Infantile neuroaxonal dystrophy 1;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B;PARKINSON DISEASE 14 AUTOSOMAL RECESSIVE,PLA2G6,8398,NM_001004426;NM_001199562;NM_001349864;NM_001349865;NM_001349866;NM_001349867;NM_001349868;NM_001349869;NM_003560
RFNG_SIG,RFNG,RFNG_SIG,RFNG,SIG,29,5.08547679007075,0.153972538533382,0.148163193061915,0.173060387939631,0.0248971948777164,2.73214025171407e-06,1.48031085170991,4.98570571633612,4.9697267442547,5.03820805317508,0.0684813089203794,0.228535170282789,ENSG00000169733,RFNG,protein_coding,17,-1,82047902,82051831,q25.3,RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:9974],NA,RFNG,5986,NM_002917
FNDC3A_SIG,FNDC3A,FNDC3A_SIG,FNDC3A,SIG,51,5.08397668824713,0.170769048479474,0.162842804595747,0.196812421240291,0.033969616644544,2.75134445577252e-06,3.06411408747631,6.37544722248464,6.33457003324209,6.50975798713874,0.175187953896653,0.00911624466947768,ENSG00000102531,FNDC3A,protein_coding,13,1,48975912,49209779,q14.2,fibronectin type III domain containing 3A [Source:HGNC Symbol;Acc:HGNC:20296],NA,FNDC3A,22862,NM_001079673;NM_001278438;NM_014923
CHDH_SIG,CHDH,CHDH_SIG,CHDH,SIG,15,-5.08243551493494,-0.141272232671754,-0.128593167028152,-0.182932019786443,-0.0543388527582905,2.76962666751351e-06,-1.68090203778589,0.479049899554429,0.506302033093222,0.389507175069825,-0.116794858023396,0.168176939234685,ENSG00000016391,CHDH,protein_coding,3,-1,53812335,53846419,p21.1,choline dehydrogenase [Source:HGNC Symbol;Acc:HGNC:24288],NA,CHDH,55349,NM_018397
FCER1G_SIG,FCER1G,FCER1G_SIG,FCER1G,SIG,56,-5.08219610695783,0.488993715146308,0.527527922531037,0.362381319453628,-0.165146603077409,2.76962666751351e-06,-5.30525384540956,6.85031447990295,7.06165791628822,6.15590033177992,-0.9057575845083,3.8814726911531e-06,ENSG00000158869,FCER1G,protein_coding,1,1,161215234,161220699,q23.3,Fc fragment of IgE receptor Ig [Source:HGNC Symbol;Acc:HGNC:3611],NA,FCER1G,2207,NM_004106
ACOT11_SIG,ACOT11,ACOT11_SIG,ACOT11,SIG,57,5.08216301535016,-0.0178949792548022,-0.0295487788202846,0.0203960764603543,0.0499448552806388,2.76962666751351e-06,2.94589379131243,3.44060374920072,3.3575267840748,3.71357092032872,0.356044136253914,0.0123742859692206,ENSG00000162390,ACOT11,protein_coding,1,1,54542257,54639192,p32.3,acyl-CoA thioesterase 11 [Source:HGNC Symbol;Acc:HGNC:18156],NA,ACOT11,26027,NM_015547;NM_147161
FIZ1_TF,FIZ1,FIZ1_TF,FIZ1,TF,33,5.08203808597206,0.263505802375979,0.253529261728599,0.296285864503086,0.0427566027744868,2.76962666751351e-06,3.71791765150062,3.43926557485815,3.39159006017558,3.59591369452944,0.204323634353859,0.00139292954922012,ENSG00000179943,FIZ1,protein_coding,19,-1,55591376,55601970,q13.42,FLT3 interacting zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:25917],NA,FIZ1,84922,NM_032836
ZNF71_TF,ZNF71,ZNF71_TF,ZNF71,TF,74,5.08009785707385,0.230234791961187,0.21524102343147,0.279500031415975,0.0642590079845054,2.79556127393695e-06,4.39246800420451,3.49011562721291,3.4095086007968,3.75496728543725,0.345458684640446,0.000146584670016526,ENSG00000197951,ZNF71,protein_coding,19,1,56595264,56626481,q13.43,zinc finger protein 71 [Source:HGNC Symbol;Acc:HGNC:13141],NA,ZNF71,58491,NM_021216
SFRP1_SIG,SFRP1,SFRP1_SIG,SFRP1,SIG,35,-5.078959741123,-0.159255688664873,-0.152267465564616,-0.182216993137144,-0.0299495275725274,2.80984488384858e-06,-2.11957245583218,0.311680177552869,0.347396652280552,0.194326046304767,-0.153070605975786,0.0774322544558447,ENSG00000104332,SFRP1,protein_coding,8,-1,41261962,41309473,p11.21,secreted frizzled related protein 1 [Source:HGNC Symbol;Acc:HGNC:10776],NA,SFRP1,6422,NM_003012
NFXL1_SIG,NFXL1,NFXL1_SIG,NFXL1,SIG,9,5.07828075933284,0.131886300498821,0.121260349861152,0.166800138308303,0.0455397884471502,2.81738521161555e-06,2.48270038292775,3.71271301275583,3.67508955726721,3.83633293793269,0.161243380665476,0.0366535278999844,ENSG00000170448,NFXL1,protein_coding,4,-1,47847233,47914667,p12,nuclear transcription factor, X-box binding like 1 [Source:HGNC Symbol;Acc:HGNC:18726],NA,NFXL1,152518,NM_001278623;NM_001278624;NM_152995
KIAA1324_SIG,KIAA1324,KIAA1324_SIG,KIAA1324,SIG,28,-5.0778338907382,-0.00569859131952811,0.0188544863917518,-0.0863729895137334,-0.105227475905485,2.8214987270587e-06,-3.45694643587791,1.38168960324298,1.48643786933653,1.03751672893557,-0.448921140400961,0.00305574738667411,ENSG00000116299,KIAA1324,protein_coding,1,1,109113679,109206781,p13.3,KIAA1324 [Source:HGNC Symbol;Acc:HGNC:29618],NA,KIAA1324,57535,NM_001267048;NM_001284352;NM_001284353;NM_020775
ZNF527_TF,ZNF527,ZNF527_TF,ZNF527,TF,34,5.07725946195407,0.130935112658122,0.120670587747036,0.164661408794546,0.04399082104751,2.82751696355416e-06,4.05856094081179,2.52754495465823,2.46000564989859,2.74945981315421,0.289454163255625,0.000467345882885734,ENSG00000189164,ZNF527,protein_coding,19,1,37371061,37393066,q13.12,zinc finger protein 527 [Source:HGNC Symbol;Acc:HGNC:29385],NA,ZNF527,84503,NM_032453
CORO1A_SIG,CORO1A,CORO1A_SIG,CORO1A,SIG,33,-5.07572879372903,0.731664542059907,0.75142596499964,0.666734152400782,-0.0846918125988587,2.84700344161588e-06,-4.45179296617901,9.02009307045523,9.10727723686188,8.73363080940479,-0.373646427457087,0.000118147829713096,ENSG00000102879,CORO1A,protein_coding,16,1,30182827,30189076,p11.2,coronin 1A [Source:HGNC Symbol;Acc:HGNC:2252],Immunodeficiency 8;Severe combined immunodeficiency due to CORO1A deficiency,CORO1A,11151,NM_001193333;NM_007074
GTF3A_TF,GTF3A,GTF3A_TF,GTF3A,TF,162,5.07561530705977,0.136505692650892,0.127461436262568,0.16622253506967,0.0387610988071013,2.84700344161588e-06,3.70781504003936,7.32305914533228,7.26761571346136,7.50523042147962,0.237614708018265,0.00143671226852867,ENSG00000122034,GTF3A,protein_coding,13,1,27424619,27435823,q12.2,general transcription factor IIIA [Source:HGNC Symbol;Acc:HGNC:4662],NA,GTF3A,2971,NM_002097
ZNF114_TF,ZNF114,ZNF114_TF,ZNF114,TF,79,5.07416022239523,0.0980419964043137,0.0867516855042652,0.135138732218759,0.0483870467144934,2.86632288678108e-06,4.15354033238813,1.00525347182327,0.926610036307199,1.26365333137609,0.337043295068889,0.000337714513323111,ENSG00000178150,ZNF114,protein_coding,19,1,48270081,48287608,q13.33,zinc finger protein 114 [Source:HGNC Symbol;Acc:HGNC:12894],NA,ZNF114,163071,NM_001331097;NM_001331098;NM_153608
PDE6B_SIG,PDE6B,PDE6B_SIG,PDE6B,SIG,60,5.07382829566707,0.172215573889677,0.155835426294631,0.22603605884483,0.0702006325501994,2.86877984071728e-06,4.29866993945257,2.50400473705775,2.41800247577181,2.78658359556869,0.368581119796885,0.000205444675772038,ENSG00000133256,PDE6B,protein_coding,4,1,625584,670782,p16.3,phosphodiesterase 6B [Source:HGNC Symbol;Acc:HGNC:8786],Congenital stationary night blindness;NIGHT BLINDNESS CONGENITAL STATIONARY AUTOSOMAL DOMINANT 2;Retinitis pigmentosa;RETINITIS PIGMENTOSA 40,PDE6B,5158,NM_000283;NM_001145291;NM_001145292;NM_001350154;NM_001350155
IGFBP6_SIG,IGFBP6,IGFBP6_SIG,IGFBP6,SIG,12,5.07186666014372,0.107552860364877,0.0960395809071932,0.14538220715441,0.0493426262472166,2.89439073557747e-06,2.74818369985992,0.985926127063703,0.933060738871374,1.15962668826707,0.226565949395697,0.0200049661870252,ENSG00000167779,IGFBP6,protein_coding,12,1,53097436,53102345,q13.13,insulin like growth factor binding protein 6 [Source:HGNC Symbol;Acc:HGNC:5475],NA,IGFBP6,3489,NM_002178
PTPRM_SIG,PTPRM,PTPRM_SIG,PTPRM,SIG,45,-5.07180004173751,-0.110009149632521,-0.0999262768879576,-0.143138588650374,-0.0432123117624163,2.89439073557747e-06,-3.39963995305707,2.75801711419729,2.93325108103354,2.18224836602103,-0.751002715012507,0.00360617441287887,ENSG00000173482,PTPRM,protein_coding,18,1,7566782,8406861,p11.23,protein tyrosine phosphatase, receptor type M [Source:HGNC Symbol;Acc:HGNC:9675],NA,PTPRM,5797,NM_001105244;NM_002845
EXOSC10_SIG,EXOSC10,EXOSC10_SIG,EXOSC10,SIG,26,5.06964420286523,0.56789691986461,0.561320238874199,0.589506014547389,0.0281857756731909,2.92477427793214e-06,4.9653916226822,6.47924106023734,6.43410890308493,6.6275324337381,0.193423530653169,1.63440864281514e-05,ENSG00000171824,EXOSC10,protein_coding,1,-1,11066618,11099869,p36.22,exosome component 10 [Source:HGNC Symbol;Acc:HGNC:9138],NA,EXOSC10,5394,NM_001001998;NM_002685
DUSP14_SIG,DUSP14,DUSP14_SIG,DUSP14,SIG,41,5.06803693038276,0.241222506414218,0.227030748634018,0.287852567692021,0.0608218190580031,2.94696301593354e-06,3.8604162848541,3.28466555784261,3.1956049165188,3.57729337933513,0.381688462816329,0.000889542936506966,ENSG00000276023,DUSP14,protein_coding,17,1,37489891,37513501,q12,dual specificity phosphatase 14 [Source:HGNC Symbol;Acc:HGNC:17007],NA,DUSP14,11072,NM_007026
TIGD2_TF,TIGD2,TIGD2_TF,TIGD2,TF,49,5.06680793212345,0.164540650361268,0.150794682215644,0.209705974268319,0.0589112920526757,2.96342287389145e-06,5.37164455349843,2.85764123676367,2.76183955463166,3.17241819234029,0.41057863770863,2.90192758804414e-06,ENSG00000180346,TIGD2,protein_coding,4,1,89111500,89114899,q22.1,tigger transposable element derived 2 [Source:HGNC Symbol;Acc:HGNC:18333],NA,TIGD2,166815,NM_145715
SLPI_SIG,SLPI,SLPI_SIG,SLPI,SIG,25,-5.06631818708014,0.126829930090319,0.161858634610018,0.0117356152398778,-0.15012301937014,2.9684288413983e-06,-4.16531411433244,3.38345086381214,3.60601736292312,2.65216093816175,-0.953856424761369,0.000324227183768091,ENSG00000124107,SLPI,protein_coding,20,-1,45252239,45254564,q13.12,secretory leukocyte peptidase inhibitor [Source:HGNC Symbol;Acc:HGNC:11092],NA,SLPI,6590,NM_003064
MYCN_TF,MYCN,MYCN_TF,MYCN,TF,147,5.06358710031823,0.03968770467185,0.0251685569492571,0.0873934757603693,0.062224918811112,3.00682306303723e-06,1.9027604089403,3.48982772171009,3.37969175280859,3.85170304810071,0.472011295292114,0.115740080731377,ENSG00000134323,MYCN,protein_coding,2,1,15940550,15947007,p24.3,MYCN proto-oncogene, bHLH transcription factor [Source:HGNC Symbol;Acc:HGNC:7559],FEINGOLD SYNDROME 1;Feingold syndrome type 1;Hereditary retinoblastoma;Neuroblastoma;Non-hereditary retinoblastoma,MYCN,4613,NM_001293228;NM_001293231;NM_001293233;NM_005378
OLR1_SIG,OLR1,OLR1_SIG,OLR1,SIG,9,-5.06353373957766,0.205429480790145,0.258967128505839,0.0295200668671506,-0.229447061638689,3.00682306303723e-06,-4.84189297654715,2.69084011757432,2.94842966927033,1.84447444771599,-1.10395522155434,2.724509826591e-05,ENSG00000173391,OLR1,protein_coding,12,-1,10158301,10172138,p13.2,oxidized low density lipoprotein receptor 1 [Source:HGNC Symbol;Acc:HGNC:8133],MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,OLR1,4973,NM_001172632;NM_001172633;NM_002543
DZIP3_TF,DZIP3,DZIP3_TF,DZIP3,TF,108,5.06227726897889,0.08092698277177,0.0674099286678228,0.125340160541882,0.0579302318740595,3.02404635120383e-06,2.65736344497536,3.74455038667839,3.68533329925726,3.93912081677639,0.253787517519129,0.0246689990637663,ENSG00000198919,DZIP3,protein_coding,3,1,108589705,108694840,q13.13,DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938],NA,DZIP3,9666,NM_014648
TXK_SIG,TXK,TXK_SIG,TXK,SIG,76,5.06192747865064,-0.0229891596550948,-0.0309241095039896,0.00308281841984534,0.0340069279238349,3.02693430053135e-06,5.31286950414445,3.67354677745551,3.5020082063201,4.23717351118614,0.735165304866041,3.75669754185329e-06,ENSG00000074966,TXK,protein_coding,4,-1,48066393,48134250,p12,TXK tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:12434],NA,TXK,7294,NM_003328
CXCR5_SIG,CXCR5,CXCR5_SIG,CXCR5,SIG,14,-5.05891462249143,-0.224810489431715,-0.203052864848093,-0.296299827349329,-0.0932469625012357,3.07244225500561e-06,-3.01652480621217,1.4418310838128,1.52518796276468,1.16794419582803,-0.357243766936657,0.0103020453207882,ENSG00000160683,CXCR5,protein_coding,11,1,118883766,118897799,q23.3,C-X-C motif chemokine receptor 5 [Source:HGNC Symbol;Acc:HGNC:1060],NA,CXCR5,643,NM_001716
ZNF22_TF,ZNF22,ZNF22_TF,ZNF22,TF,211,5.05776886168191,0.301442865543919,0.288244851127889,0.344807770053735,0.0565629189258464,3.08823836887047e-06,4.39583301687331,5.76809982355053,5.67644148719955,6.06926292870374,0.392821441504187,0.000145163262061855,ENSG00000165512,ZNF22,protein_coding,10,1,45000923,45005326,q11.21,zinc finger protein 22 [Source:HGNC Symbol;Acc:HGNC:13012],NA,ZNF22,7570,NM_006963
CEACAM1_SIG,CEACAM1,CEACAM1_SIG,CEACAM1,SIG,37,-5.05657628483945,0.142101513515439,0.178325812268051,0.0230788176139973,-0.155246994654054,3.10487591371046e-06,-4.94203085320732,4.09450697245561,4.3809110322294,3.1534650617703,-1.2274459704591,1.80058453404729e-05,ENSG00000079385,CEACAM1,protein_coding,19,-1,42507304,42561234,q13.2,carcinoembryonic antigen related cell adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:1814],NA,CEACAM1,634,NM_001024912;NM_001184813;NM_001184815;NM_001184816;NM_001205344;NM_001712
MMAB_SIG,MMAB,MMAB_SIG,MMAB,SIG,22,5.05606637214832,0.297016844924261,0.284910445133489,0.336795015665371,0.0518845705318826,3.11045378180046e-06,3.94085827032175,3.59599200178741,3.52950023656025,3.81446494467665,0.284964708116396,0.000688762808190967,ENSG00000139428,MMAB,protein_coding,12,-1,109553715,109573580,q24.11,metabolism of cobalamin associated B [Source:HGNC Symbol;Acc:HGNC:19331],METHYLMALONIC ACIDURIA cblB TYPE;Methylmalonic aciduria type cblB;Vitamin B12-responsive methylmalonic acidemia type cblB,MMAB,326625,NM_052845
ZNF519_TF,ZNF519,ZNF519_TF,ZNF519,TF,106,5.05550710236303,0.217961424190481,0.205963573407464,0.257382933906106,0.051419360498641,3.11684933050572e-06,4.19375996308198,2.50497839601185,2.43080246990247,2.74869929608555,0.317896826183078,0.000294166627500475,ENSG00000175322,ZNF519,protein_coding,18,-1,14057457,14132490,p11.21,zinc finger protein 519 [Source:HGNC Symbol;Acc:HGNC:30574],NA,ZNF519,162655,NM_145287
PROCR_SIG,PROCR,PROCR_SIG,PROCR,SIG,21,5.05491918781786,0.0452935581520831,0.0361929558674896,0.0751955370871761,0.0390025812196866,3.12372828412894e-06,3.3415162242777,1.1694723872803,1.10411846280146,1.38420671056791,0.280088247766448,0.00427657549472815,ENSG00000101000,PROCR,protein_coding,20,1,35172072,35216240,q11.22,protein C receptor [Source:HGNC Symbol;Acc:HGNC:9452],NA,PROCR,10544,NM_006404
ZNF510_TF,ZNF510,ZNF510_TF,ZNF510,TF,80,5.05262824592333,0.235083141675341,0.224138545472896,0.271043957769087,0.0469054122961911,3.1586766460804e-06,3.85146227648178,4.14215836468489,4.07777493411593,4.35370392226863,0.275928988152694,0.000916403845719554,ENSG00000081386,ZNF510,protein_coding,9,-1,96755865,96778129,q22.33,zinc finger protein 510 [Source:HGNC Symbol;Acc:HGNC:29161],NA,ZNF510,22869,NM_001314059;NM_001314060;NM_014930
UBE3D_SIG,UBE3D,UBE3D_SIG,UBE3D,SIG,48,5.05171816288988,0.167728248305906,0.153646239028747,0.213997707359426,0.0603514683306786,3.17099285041672e-06,2.77482442791461,1.70723454937521,1.66666394288226,1.84053797070919,0.173874027826933,0.0187563740690852,ENSG00000118420,UBE3D,protein_coding,6,-1,82892390,83065841,q14.1,ubiquitin protein ligase E3D [Source:HGNC Symbol;Acc:HGNC:21381],NA,UBE3D,90025,NM_001304437;NM_001350602;NM_001350603;NM_001350604;NM_198920
TARDBP_SIG,TARDBP,TARDBP_SIG,TARDBP,SIG,22,5.0511746148304,0.527765902882044,0.518335660271169,0.558750985746346,0.0404153254751768,3.17725357508894e-06,2.6527972293024,7.32512222299443,7.29458676733893,7.42545300586251,0.130866238523582,0.0249081527373872,ENSG00000120948,TARDBP,protein_coding,1,1,11012344,11026420,p36.22,TAR DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11571],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;Frontotemporal dementia with motor neuron disease,TARDBP,23435,NM_007375
ZNF749_TF,ZNF749,ZNF749_TF,ZNF749,TF,183,5.05062011639962,0.257295947437514,0.243694960822802,0.301984903457284,0.0582899426344822,3.18371069734315e-06,4.0915656895016,2.40386283237706,2.33466409957785,2.63123009728876,0.296565997710902,0.000416736867698111,ENSG00000186230,ZNF749,protein_coding,19,1,57435325,57447101,q13.43,zinc finger protein 749 [Source:HGNC Symbol;Acc:HGNC:32783],NA,ZNF749,388567,NM_001023561;NM_001321952;NM_001321953;NM_001321954
PWP1_SIG,PWP1,PWP1_SIG,PWP1,SIG,53,5.05026942605408,0.441127653929385,0.427547259927723,0.485748948506273,0.0582016885785502,3.18678048991915e-06,4.94063363613919,5.39629226442948,5.33253495147465,5.60578057842392,0.273245626949267,1.81089273269513e-05,ENSG00000136045,PWP1,protein_coding,12,1,107685799,107713162,q23.3,PWP1 homolog, endonuclein [Source:HGNC Symbol;Acc:HGNC:17015],NA,PWP1,11137,NM_001317962;NM_001317963;NM_007062
NQO2_SIG,NQO2,NQO2_SIG,NQO2,SIG,5,-5.0500495023106,-0.0742731266527026,-0.0472809430481746,-0.162961729924723,-0.115680786876549,3.18767243257387e-06,-2.63037980679791,4.43823492628647,4.4962849609629,4.24749909806391,-0.248785862898989,0.0262127087944247,ENSG00000124588,NQO2,protein_coding,6,1,2987987,3028869,p25.2,N-ribosyldihydronicotinamide:quinone reductase 2 [Source:HGNC Symbol;Acc:HGNC:7856],Breast Cancer,NQO2,4835,NM_000904;NM_001290221;NM_001290222;NM_001318940
ADAMTS17_SIG,ADAMTS17,ADAMTS17_SIG,ADAMTS17,SIG,13,-5.04908489982857,-0.0264813842572327,-0.00807854541365795,-0.0869478547432641,-0.0788693093296063,3.20101991101744e-06,-0.654209685717562,0.71819165866327,0.727530517002609,0.68750683840544,-0.0400236785971692,0.618328375733419,ENSG00000140470,ADAMTS17,protein_coding,15,-1,99971437,100342005,q26.3,ADAM metallopeptidase with thrombospondin type 1 motif 17 [Source:HGNC Symbol;Acc:HGNC:17109],Ichthyosis-short stature-brachydactyly-microspherophakia syndrome;WEILL-MARCHESANI SYNDROME 4,ADAMTS17,170691,NM_139057
ALOX5_SIG,ALOX5,ALOX5_SIG,ALOX5,SIG,21,-5.04846826046798,0.520126358830273,0.552979871463239,0.412179103036241,-0.140800768426998,3.20857477176078e-06,-0.899980237364533,6.41322573364903,6.45467926353033,6.27702127832475,-0.177657985205577,0.481859479913141,ENSG00000012779,ALOX5,protein_coding,10,1,45374176,45446119,q11.21,arachidonate 5-lipoxygenase [Source:HGNC Symbol;Acc:HGNC:435],ASTHMA SUSCEPTIBILITY TO,ALOX5,240,NM_000698;NM_001256153;NM_001256154;NM_001320861;NM_001320862
SLC22A1_SIG,SLC22A1,SLC22A1_SIG,SLC22A1,SIG,15,-5.04728712619653,0.104124774723943,0.12976533171157,0.0198772303360265,-0.109888101375543,3.22566241120205e-06,-4.09211317130731,0.313757168643442,0.359313683135528,0.164071478169445,-0.195242204966083,0.000416108375500997,ENSG00000175003,SLC22A1,protein_coding,6,1,160121815,160158718,q25.3,solute carrier family 22 member 1 [Source:HGNC Symbol;Acc:HGNC:10963],NA,SLC22A1,6580,NM_003057;NM_153187
PARP1_SIG,PARP1,PARP1_SIG,PARP1,SIG,33,5.0456710784709,0.526467350471583,0.509999851462641,0.580574847215248,0.0705749957526069,3.2502249479021e-06,4.57477825679186,7.48658110150945,7.38496496565586,7.82046269074268,0.435497725086824,7.57090426839903e-05,ENSG00000143799,PARP1,protein_coding,1,-1,226360691,226408093,q42.12,poly(ADP-ribose) polymerase 1 [Source:HGNC Symbol;Acc:HGNC:270],Autosomal Recessive Mental Retardation,PARP1,142,NM_001618
HEY1_TF,HEY1,HEY1_TF,HEY1,TF,124,-5.04439167914893,-0.107115509236225,-0.0977501180160952,-0.13788750895951,-0.0401373909434144,3.26920842143455e-06,-2.44505553866404,0.462718592029384,0.515365986421124,0.289734296170812,-0.225631690250312,0.0397724746947468,ENSG00000164683,HEY1,protein_coding,8,-1,79764010,79767857,q21.13,hes related family bHLH transcription factor with YRPW motif 1 [Source:HGNC Symbol;Acc:HGNC:4880],NA,HEY1,23462,NM_001040708;NM_001282851;NM_012258
SEMA3D_SIG,SEMA3D,SEMA3D_SIG,SEMA3D,SIG,5,5.04352984462985,-0.0906225079733574,-0.0986982652694491,-0.0640878768576273,0.0346103884118218,3.2811288379261e-06,2.26585819098142,0.344355416628071,0.313200156662892,0.446722699370803,0.133522542707911,0.0580007199574871,ENSG00000153993,SEMA3D,protein_coding,7,-1,84995553,85186855,q21.11,semaphorin 3D [Source:HGNC Symbol;Acc:HGNC:10726],Hirschsprung disease,SEMA3D,223117,NM_152754
FADS1_SIG,FADS1,FADS1_SIG,FADS1,SIG,18,5.0426547365172,0.201873175629663,0.191021895579291,0.237527381509457,0.046505485930167,3.29332134550464e-06,4.57356359782882,5.91699857176107,5.79207954080461,6.32744681633231,0.535367275527699,7.59657495876999e-05,ENSG00000149485,FADS1,protein_coding,11,-1,61799625,61829318,q12.2,fatty acid desaturase 1 [Source:HGNC Symbol;Acc:HGNC:3574],NA,FADS1,3992,NM_013402
ZNF483_TF,ZNF483,ZNF483_TF,ZNF483,TF,96,-5.0414939199287,-0.0701843571525098,-0.0585143768098073,-0.108528578278533,-0.0500142014687254,3.31049919208784e-06,-3.22425756679892,0.589510191547308,0.645415566204478,0.405821103388033,-0.239594462816446,0.00594090072468306,ENSG00000173258,ZNF483,protein_coding,9,1,111525159,111577844,q31.3,zinc finger protein 483 [Source:HGNC Symbol;Acc:HGNC:23384],NA,ZNF483,158399,NM_001007169;NM_133464
ACYP2_SIG,ACYP2,ACYP2_SIG,ACYP2,SIG,30,5.04124330404446,0.21306714901331,0.204478847916043,0.241285852618618,0.0368070047025752,3.31197326592245e-06,4.93761768035265,2.87456542297457,2.81360341794331,3.07486915379158,0.261265735848273,1.83351401004425e-05,ENSG00000170634,ACYP2,protein_coding,2,1,53970838,54305300,p16.2,acylphosphatase 2 [Source:HGNC Symbol;Acc:HGNC:180],NA,ACYP2,98,NM_001320586;NM_001320587;NM_001320588;NM_001320589;NM_001320590;NM_138448
EFNA4_SIG,EFNA4,EFNA4_SIG,EFNA4,SIG,13,5.04070724118063,0.0392683377308582,0.0269979720528212,0.0795852535301228,0.0525872814773017,3.31839681022182e-06,4.25722371651003,1.56619174657101,1.49915182070638,1.78646578869765,0.287313967991262,0.000235634589453327,ENSG00000243364,EFNA4,protein_coding,1,1,155063737,155069553,q21.3,ephrin A4 [Source:HGNC Symbol;Acc:HGNC:3224],NA,EFNA4,1945,NM_005227;NM_182689;NM_182690
PYGB_SIG,PYGB,PYGB_SIG,PYGB,SIG,61,5.03990654124832,0.282887788251455,0.272865604757859,0.315817819730412,0.0429522149725528,3.3294351050135e-06,3.22018390036517,5.89914578440463,5.84580770537011,6.0743994726609,0.228591767290789,0.00600741525242032,ENSG00000100994,PYGB,protein_coding,20,1,25248085,25298012,p11.21,glycogen phosphorylase B [Source:HGNC Symbol;Acc:HGNC:9723],NA,PYGB,5834,NM_002862
ATAT1_SIG,ATAT1,ATAT1_SIG,ATAT1,SIG,165,5.03966127804479,0.144110878787103,0.130436059107395,0.189042429163286,0.0586063700558908,3.33083062513798e-06,3.57287510378955,4.01629043961394,3.94750019902051,4.2423155158495,0.294815316828993,0.00217048742353191,ENSG00000137343,ATAT1,protein_coding,6,1,30626842,30646823,p21.33,alpha tubulin acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:21186],NA,ATAT1,79969,NM_001031722;NM_001190724;NM_001254952;NM_001318762;NM_001318763;NM_024909
ZNF799_TF,ZNF799,ZNF799_TF,ZNF799,TF,16,5.03947172083407,0.0193225668664813,0.012618170194672,0.0413512987881403,0.0287331285934684,3.33125932433853e-06,4.35376453067808,2.11096487461724,2.04228978499421,2.33661159766431,0.294321812670094,0.000168277529596518,ENSG00000196466,ZNF799,protein_coding,19,-1,12390016,12401271,p13.2,zinc finger protein 799 [Source:HGNC Symbol;Acc:HGNC:28071],NA,ZNF799,90576,NM_001080821;NM_001322497;NM_001322498
EXD3_SIG,EXD3,EXD3_SIG,EXD3,SIG,118,5.03681455679352,0.123588155582106,0.111900865881223,0.161989250313582,0.0500883844323589,3.37491083130475e-06,4.79932999195485,3.55574834735034,3.45868577463566,3.87466822912718,0.415982454491518,3.19752758220636e-05,ENSG00000187609,EXD3,protein_coding,9,-1,137306896,137423211,q34.3,exonuclease 3'-5' domain containing 3 [Source:HGNC Symbol;Acc:HGNC:26023],NA,EXD3,54932,NM_001286823;NM_017820
ABCB9_SIG,ABCB9,ABCB9_SIG,ABCB9,SIG,15,5.03551021657857,0.0700012460026891,0.0611718688573073,0.0990120566232291,0.0378401877659218,3.39505271869225e-06,3.42044915664009,2.26213060835136,2.2098952345267,2.43376112234667,0.223865887819965,0.00339206336848775,ENSG00000150967,ABCB9,protein_coding,12,-1,122920951,122981649,q24.31,ATP binding cassette subfamily B member 9 [Source:HGNC Symbol;Acc:HGNC:50],NA,ABCB9,23457,NM_001243013;NM_001243014;NM_019624;NM_019625;NM_203444
IRS2_SIG,IRS2,IRS2_SIG,IRS2,SIG,42,-5.03321453041777,0.1928000408189,0.210063987937303,0.136075643144148,-0.0739883447931549,3.43302816758745e-06,-4.53812828566982,6.86073540473472,7.02723251682263,6.3136734650173,-0.71355905180533,8.65203890294816e-05,ENSG00000185950,IRS2,protein_coding,13,-1,109752695,109786583,q34,insulin receptor substrate 2 [Source:HGNC Symbol;Acc:HGNC:6126],DIABETES MELLITUS NONINSULIN-DEPENDENT,IRS2,8660,NM_003749
RETSAT_SIG,RETSAT,RETSAT_SIG,RETSAT,SIG,29,5.03294568595376,0.282799071418714,0.269263391088165,0.32727344964766,0.0580100585594951,3.43489703086504e-06,4.98858441174304,4.8242730191038,4.73361616488604,5.12214554010502,0.388529375218973,1.48041103524434e-05,ENSG00000042445,RETSAT,protein_coding,2,-1,85341955,85354531,p11.2,retinol saturase [Source:HGNC Symbol;Acc:HGNC:25991],NA,RETSAT,54884,NM_017750
PTPMT1_SIG,PTPMT1,PTPMT1_SIG,PTPMT1,SIG,25,5.03128478651082,0.342004013340677,0.330630091858152,0.379375469640401,0.048745377782249,3.46182122009543e-06,4.63561037370749,3.72430138902227,3.66896779726013,3.90611176195502,0.237143964694883,5.97600233960131e-05,ENSG00000110536,PTPMT1,protein_coding,11,1,47565430,47573461,p11.2,protein tyrosine phosphatase, mitochondrial 1 [Source:HGNC Symbol;Acc:HGNC:26965],NA,PTPMT1,114971,NM_001143984;NM_175732
SOX5_TF,SOX5,SOX5_TF,SOX5,TF,202,-5.02527189089642,-0.0773213834688682,-0.0719929317902643,-0.0948291532699953,-0.0228362214797312,3.56900896901886e-06,-2.35022106238868,0.273710426615155,0.307377024309862,0.163091605618261,-0.144285418691601,0.048723428623461,ENSG00000134532,SOX5,protein_coding,12,-1,23529500,24562544,p12.1,SRY-box 5 [Source:HGNC Symbol;Acc:HGNC:11201],12p12.1 microdeletion syndrome;12p12.5 intragenic deletions associated with intellectual disability;Developmental and speech delay due to SOX5 deficiency;Lamb-shaffer syndrome,SOX5,6660,NM_001261414;NM_001261415;NM_001330785;NM_006940;NM_152989;NM_178010
ZNF385C_SIG,ZNF385C,ZNF385C_SIG,ZNF385C,SIG,34,5.02427294319796,0.0666728131096718,0.0558730308129783,0.102157812084522,0.0462847812715437,3.58456243846565e-06,0.869197800095553,2.39039403048371,2.36120675820441,2.48629506797284,0.125088309768432,0.498314621841969,ENSG00000187595,ZNF385C,protein_coding,17,-1,42025576,42098479,q21.2,zinc finger protein 385C [Source:HGNC Symbol;Acc:HGNC:33722],NA,ZNF385C,201181,NM_001242704
PCBD2_SIG,PCBD2,PCBD2_SIG,PCBD2,SIG,56,5.02356703831582,0.13989333544215,0.125626174875212,0.18677114873352,0.0611449738583087,3.59469133835478e-06,4.26889518327371,3.53093111485139,3.46266522167468,3.75523333528916,0.292568113614483,0.000226346179658701,ENSG00000132570,PCBD2,protein_coding,5,1,134904906,135007959,q31.1,pterin-4 alpha-carbinolamine dehydratase 2 [Source:HGNC Symbol;Acc:HGNC:24474],NA,PCBD2,84105,NM_032151
ZDHHC3_TF,ZDHHC3,ZDHHC3_TF,ZDHHC3,TF,290,-5.02279499037609,0.179041701997034,0.192984422808472,0.133229905045166,-0.0597545177633064,3.60609188718239e-06,-3.96415277903193,6.52714510399913,6.5715848866969,6.38112867513501,-0.190456211561889,0.000636197624012573,ENSG00000163812,ZDHHC3,protein_coding,3,-1,44915257,44976185,p21.31,zinc finger DHHC-type containing 3 [Source:HGNC Symbol;Acc:HGNC:18470],NA,ZDHHC3,51304,NM_001135179;NM_001330761;NM_001349376;NM_001349377;NM_001349378;NM_001349379;NM_001349380;NM_001349381;NM_016598
NR3C2_TF,NR3C2,NR3C2_TF,NR3C2,TF,142,-5.02179830004747,-0.221148561724256,-0.209426121598807,-0.259665150707872,-0.0502390291090646,3.62176366567773e-06,-3.67716797243893,1.51297960565091,1.61019111149661,1.19357037215788,-0.416620739338733,0.0015761857542321,ENSG00000151623,NR3C2,protein_coding,4,-1,148078762,148444698,q31.23,nuclear receptor subfamily 3 group C member 2 [Source:HGNC Symbol;Acc:HGNC:7979],Hypertension due to gain-of-function mutations in the mineralocorticoid receptor;HYPERTENSION EARLY-ONSET AUTOSOMAL DOMINANT WITH SEVERE EXACERBATIONIN PREGNANCY;PSEUDOHYPOALDOSTERONISM TYPE I AUTOSOMAL DOMINANT;Renal pseudohypoaldosteronism type 1,NR3C2,4306,NM_000901;NM_001166104;NM_001354819
LEF1_TF,LEF1,LEF1_TF,LEF1,TF,105,-5.0215283589615,-0.165148454495787,-0.147840655031127,-0.2220169384511,-0.0741762834199731,3.62376379811026e-06,-5.39157474434514,3.29167345382574,3.50434390658782,2.59289910903602,-0.911444797551805,2.63636732138925e-06,ENSG00000138795,LEF1,protein_coding,4,-1,108047545,108168956,q25,lymphoid enhancer binding factor 1 [Source:HGNC Symbol;Acc:HGNC:6551],NA,LEF1,51176,NM_001130713;NM_001130714;NM_001166119;NM_016269
DHX34_SIG,DHX34,DHX34_SIG,DHX34,SIG,36,-5.02135826667967,0.178959203831647,0.197229264087135,0.118929005849329,-0.0783002582378064,3.62388278376354e-06,-3.25179469632793,5.14867280541813,5.20325974768789,4.96931570938889,-0.233944038299,0.00549731380718103,ENSG00000134815,DHX34,protein_coding,19,1,47349315,47382704,q13.32,DExH-box helicase 34 [Source:HGNC Symbol;Acc:HGNC:16719],NA,DHX34,9704,NM_014681
BLK_SIG,BLK,BLK_SIG,BLK,SIG,45,-5.01852141662973,-0.271742533696568,-0.254139146253376,-0.329582235295627,-0.0754430890422507,3.67466491326894e-06,-3.32628257701448,1.73639261731084,1.84350546495684,1.38445040361686,-0.45905506133998,0.00446059691409302,ENSG00000136573,BLK,protein_coding,8,1,11486894,11564599,p23.1,BLK proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:1057],MATURITY-ONSET DIABETES OF THE YOUNG TYPE 11;MODY;Systemic lupus erythematosus,BLK,640,NM_001330465;NM_001715
PKN3_SIG,PKN3,PKN3_SIG,PKN3,SIG,58,5.01801889059255,0.0125509067700541,0.000521979627721726,0.052074524523432,0.0515525448957101,3.68115203978817e-06,2.88010445845864,3.74830483873704,3.66322070313462,4.02786699857355,0.364646295438929,0.014574890625417,ENSG00000160447,PKN3,protein_coding,9,1,128702503,128720916,q34.11,protein kinase N3 [Source:HGNC Symbol;Acc:HGNC:17999],NA,PKN3,29941,NM_001317926;NM_013355
ANXA3_SIG,ANXA3,ANXA3_SIG,ANXA3,SIG,56,-5.01715303513559,0.188061093895744,0.228630184536679,0.0547626532183842,-0.173867531318295,3.69463049794765e-06,-4.17767362759595,4.66724596756158,4.91511349062945,3.85282410605286,-1.06228938457659,0.000311105426637897,ENSG00000138772,ANXA3,protein_coding,4,1,78551747,78610451,q21.21,annexin A3 [Source:HGNC Symbol;Acc:HGNC:541],NA,ANXA3,306,NM_005139
ARAP2_SIG,ARAP2,ARAP2_SIG,ARAP2,SIG,53,-5.01367279414135,0.110327541172163,0.120616849170367,0.0765198148923483,-0.0440970342780189,3.75892399554053e-06,-5.07672526691932,5.61195503943212,5.75893650832418,5.12901592735821,-0.629920580965972,1.02985867535256e-05,ENSG00000047365,ARAP2,protein_coding,4,-1,35948221,36244514,p14,ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 [Source:HGNC Symbol;Acc:HGNC:16924],NA,ARAP2,116984,NM_015230
CAMP_SIG,CAMP,CAMP_SIG,CAMP,SIG,9,-5.01321994625267,0.182642295820577,0.255000029184275,-0.05510454237443,-0.310104571558705,3.76320959859835e-06,-4.4147175665069,3.150892972917,3.4390003902036,2.20425431611816,-1.23474607408544,0.000135470893358889,ENSG00000164047,CAMP,protein_coding,3,1,48223347,48225491,p21.31,cathelicidin antimicrobial peptide [Source:HGNC Symbol;Acc:HGNC:1472],NA,CAMP,820,NM_004345
PM20D1_SIG,PM20D1,PM20D1_SIG,PM20D1,SIG,4,-5.01312711161522,-0.0583310443804827,-0.0425339761725197,-0.11023569706379,-0.06770172089127,3.76320959859835e-06,-2.42124536380283,0.18624825305405,0.202711661370471,0.132154197157239,-0.0705574642132314,0.0418568281231961,ENSG00000162877,PM20D1,protein_coding,1,-1,205828025,205850132,q32.1,peptidase M20 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26518],NA,PM20D1,148811,NM_152491
CNTNAP3_SIG,CNTNAP3,CNTNAP3_SIG,CNTNAP3,SIG,7,-5.01252854230801,0.0673147228704386,0.0980710752850534,-0.0337418636347241,-0.131812938919777,3.77173950766273e-06,-1.55974647869127,1.29098663823106,1.34967338049623,1.09815877078835,-0.251514609707881,0.202635192284288,ENSG00000106714,CNTNAP3,protein_coding,9,-1,39072767,39288315,p12,contactin associated protein like 3 [Source:HGNC Symbol;Acc:HGNC:13834],NA,CNTNAP3,79937,NM_033655
GPR15_SIG,GPR15,GPR15_SIG,GPR15,SIG,6,-5.0114334410951,-0.266916290242432,-0.244873342942888,-0.339343117083793,-0.0944697741409053,3.79005921589054e-06,-2.80224331263342,0.460388194648903,0.509942808540227,0.297565891863125,-0.212376916677102,0.0175944344363947,ENSG00000154165,GPR15,protein_coding,3,1,98531978,98534681,q11.2,G protein-coupled receptor 15 [Source:HGNC Symbol;Acc:HGNC:4469],NA,GPR15,2838,NM_005290
CHPF2_SIG,CHPF2,CHPF2_SIG,CHPF2,SIG,31,5.01075530285199,0.247671886624642,0.242632868558779,0.264228660269622,0.0215957917108426,3.80022283618435e-06,3.19723026540721,6.52024048160053,6.47751479797674,6.66062487065011,0.183110072673375,0.00640147010950985,ENSG00000033100,CHPF2,protein_coding,7,1,151232489,151238827,q36.1,chondroitin polymerizing factor 2 [Source:HGNC Symbol;Acc:HGNC:29270],NA,CHPF2,54480,NM_001284295;NM_019015
WDR6_SIG,WDR6,WDR6_SIG,WDR6,SIG,76,5.0100767114092,0.227888336596178,0.210098861506086,0.286339469035052,0.0762406075289668,3.81042371719731e-06,3.7759625951718,7.25222035982951,7.18584232109562,7.47031962995515,0.28447730885953,0.0011588698611173,ENSG00000178252,WDR6,protein_coding,3,1,49007062,49015953,p21.31,WD repeat domain 6 [Source:HGNC Symbol;Acc:HGNC:12758],NA,WDR6,11180,NM_001320546;NM_001320547;NM_018031
GALNT3_SIG,GALNT3,GALNT3_SIG,GALNT3,SIG,40,-5.00991320789452,0.112991755463349,0.124983399599213,0.07359063901694,-0.0513927605822731,3.81044140152309e-06,-2.90213404711307,4.03810492343909,4.1212594528192,3.76488289833301,-0.356376554486182,0.0137963736989187,ENSG00000115339,GALNT3,protein_coding,2,-1,165747591,165794682,q24.3,polypeptide N-acetylgalactosaminyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:4125],Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome;TUMORAL CALCINOSIS HYPERPHOSPHATEMIC FAMILIAL 1,GALNT3,2591,NM_004482
FN1_SIG,FN1,FN1_SIG,FN1,SIG,10,-5.00746916650069,-0.236286500928684,-0.219220520657309,-0.292360436106062,-0.0731399154487529,3.85587275200999e-06,-4.66383443316478,2.49073690445469,2.78757352441134,1.51541658173999,-1.27215694267135,5.37780380352844e-05,ENSG00000115414,FN1,protein_coding,2,-1,215360440,215436073,q35,fibronectin 1 [Source:HGNC Symbol;Acc:HGNC:3778],Fibronectin glomerulopathy;GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2;PLASMA FIBRONECTIN DEFICIENCY;Spondylometaphyseal dysplasia 'corner fracture' type;Spondylometaphyseal Dysplasia with Corner Fractures,FN1,2335,NM_001306129;NM_001306130;NM_001306131;NM_001306132;NM_001365518;NM_002026;NM_054034;NM_212474;NM_212476;NM_212478;NM_212482
KDM1A_TF,KDM1A,KDM1A_TF,KDM1A,TF,288,5.0062557958811,0.281604143406118,0.268714847995804,0.323954685468579,0.0552398374727751,3.87660491846672e-06,3.49610558542205,6.60036830452166,6.55195202654022,6.75945036074636,0.207498334206138,0.00273205012518969,ENSG00000004487,KDM1A,protein_coding,1,1,23019443,23083689,p36.12,lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079],Cleft palate psychomotor retardation and distinctive facial features;Developmental delay and distinctive facial features;Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,KDM1A,23028,NM_001009999;NM_001363654;NM_015013
SFMBT1_SIG,SFMBT1,SFMBT1_SIG,SFMBT1,SIG,40,-5.00609316479353,-0.0806067089425304,-0.0705480565106399,-0.113656566933028,-0.0431085104223876,3.87660491846672e-06,-3.4398361752129,3.14566098865442,3.24119535559189,2.8317623544313,-0.409433001160586,0.0031999639923674,ENSG00000163935,SFMBT1,protein_coding,3,-1,52903572,53046750,p21.1,Scm like with four mbt domains 1 [Source:HGNC Symbol;Acc:HGNC:20255],NA,SFMBT1,51460,NM_016329
CCAR1_SIG,CCAR1,CCAR1_SIG,CCAR1,SIG,34,5.00594965399264,0.463652637560816,0.456183329657072,0.488194649244543,0.0320113195874707,3.87660491846672e-06,4.51954896994948,6.62629494864408,6.57884118741853,6.78221444981374,0.203373262395211,9.22575170977549e-05,ENSG00000060339,CCAR1,protein_coding,10,1,68721012,68792377,q21.3,cell division cycle and apoptosis regulator 1 [Source:HGNC Symbol;Acc:HGNC:24236],NA,CCAR1,55749,NM_001282959;NM_001282960;NM_018237
EPHB6_SIG,EPHB6,EPHB6_SIG,EPHB6,SIG,18,5.00472188692336,0.151250073571282,0.142158701982466,0.181121723077395,0.0389630210949292,3.89670406706178e-06,2.10592790491737,5.35327147090342,5.30350804206022,5.51677987995966,0.213271837899439,0.0795198597445903,ENSG00000106123,EPHB6,protein_coding,7,1,142855061,142871094,q34,EPH receptor B6 [Source:HGNC Symbol;Acc:HGNC:3396],NA,EPHB6,2051,NM_001280794;NM_001280795;NM_004445
LZTR1_TF,LZTR1,LZTR1_TF,LZTR1,TF,227,5.00462956114873,0.221023343418173,0.210624229087277,0.255191861933976,0.0445676328466995,3.89670406706178e-06,3.98981467580584,5.86789076410506,5.80233414902417,6.08329107079943,0.280956921775264,0.000587291869055862,ENSG00000099949,LZTR1,protein_coding,22,1,20982013,20999038,q11.21,leucine zipper like transcription regulator 1 [Source:HGNC Symbol;Acc:HGNC:6742],Giant cell glioblastoma;Gliosarcoma;Neurofibromatosis type 3;Noonan Syndrome;NOONAN SYNDROME 10;Schwannomatosis 2,LZTR1,8216,NM_006767
AHCY_SIG,AHCY,AHCY_SIG,AHCY,SIG,22,5.0024250623372,0.327596716421895,0.314591604290103,0.370327799140641,0.0557361948505378,3.9382334714271e-06,4.2431458929087,6.67927267324097,6.60248138240423,6.93158691456172,0.32910553215749,0.000247709570650313,ENSG00000101444,AHCY,protein_coding,20,-1,34280268,34311802,q11.22,adenosylhomocysteinase [Source:HGNC Symbol;Acc:HGNC:343],HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY;Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency,AHCY,191,NM_000687;NM_001161766;NM_001322084;NM_001322085;NM_001322086
AQP9_SIG,AQP9,AQP9_SIG,AQP9,SIG,53,-5.00202881918002,0.319606215818825,0.354999691688372,0.20331336653317,-0.151686325155201,3.94302800475206e-06,-4.53954624650931,4.66291039927477,4.94327148415054,3.7417239775401,-1.20154750661044,8.62899030449197e-05,ENSG00000103569,AQP9,protein_coding,15,1,58138169,58185911,q21.3,aquaporin 9 [Source:HGNC Symbol;Acc:HGNC:643],NA,AQP9,366,NM_001320635;NM_001320636;NM_020980
RAPGEF1_SIG,RAPGEF1,RAPGEF1_SIG,RAPGEF1,SIG,39,-5.00113075887808,0.181146851692036,0.193233080259625,0.141434957827099,-0.0517981224325263,3.95812151762456e-06,-3.40242161498974,7.4201931020683,7.48073453548853,7.22127124940183,-0.2594632860867,0.00357698461411805,ENSG00000107263,RAPGEF1,protein_coding,9,-1,131576770,131740074,q34.13,Rap guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:4568],NA,RAPGEF1,2889,NM_001304275;NM_005312;NM_198679
FKTN_SIG,FKTN,FKTN_SIG,FKTN,SIG,99,5.00016589960125,0.160978405849709,0.143798170583844,0.217427750294694,0.0736295797108508,3.97464934130917e-06,4.04301934174485,3.92437944522766,3.84498216377295,4.18525622715031,0.340274063377361,0.00049346685155942,ENSG00000106692,FKTN,protein_coding,9,1,105558130,105641118,q31.2,fukutin [Source:HGNC Symbol;Acc:HGNC:3622],Autosomal recessive limb-girdle muscular dystrophy type 2M;CARDIOMYOPATHY DILATED 1X;CARDIOMYOPATHY DILATED TYPE 1X;Congenital muscular dystrophy Fukuyama type;Congenital muscular dystrophy without intellectual disability;Familial isolated dilated cardiomyopathy;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 1;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 4;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION)TYPE B 4;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 4;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITH BRAIN AND EYE ANOMALIES TYPE A4;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY CONGENITAL WITHOUT MENTAL RETARDATION TYPE B4;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY LIMB-GIRDLE TYPE C4;Walker-Warburg syndrome,FKTN,2218,NM_001079802;NM_001198963;NM_001351496;NM_001351497;NM_001351498;NM_001351499;NM_001351500;NM_001351501;NM_001351502;NM_006731
ETV5_TF,ETV5,ETV5_TF,ETV5,TF,93,4.99679622949238,-0.0510729159730538,-0.0555876020676864,-0.0362389473764039,0.0193486546912827,4.0413193654495e-06,1.00315821270402,2.23122132741977,2.1996747267709,2.33487444383747,0.13519971706657,0.428921709414488,ENSG00000244405,ETV5,protein_coding,3,-1,186046314,186110318,q27.2,ETS variant 5 [Source:HGNC Symbol;Acc:HGNC:3494],NA,ETV5,2119,NM_004454
KCNN3_SIG,KCNN3,KCNN3_SIG,KCNN3,SIG,52,-4.99635148557732,-0.194885835082168,-0.176818633625422,-0.254249497011477,-0.0774308633860552,4.04725930121551e-06,-2.78055573540553,0.369999756626341,0.398457355445338,0.276496217649634,-0.121961137795704,0.0185048731474867,ENSG00000143603,KCNN3,protein_coding,1,-1,154697455,154870281,q21.3,potassium calcium-activated channel subfamily N member 3 [Source:HGNC Symbol;Acc:HGNC:6292],NA,KCNN3,3782,NM_001204087;NM_001365837;NM_001365838;NM_002249;NM_170782
CDK18_SIG,CDK18,CDK18_SIG,CDK18,SIG,71,4.99612583493639,-0.00398985939635738,-0.0115335422440439,0.020796527103184,0.0323300693472279,4.04861028291038e-06,3.12273394439532,3.07949011617215,2.97759388880915,3.41429200607914,0.436698117269985,0.00784043965913228,ENSG00000117266,CDK18,protein_coding,1,1,205504595,205532793,q32.1,cyclin dependent kinase 18 [Source:HGNC Symbol;Acc:HGNC:8751],NA,CDK18,5129,NM_002596;NM_212502;NM_212503
NPL_SIG,NPL,NPL_SIG,NPL,SIG,16,-4.99585488904875,0.348868285562509,0.394668920158226,0.198380486176583,-0.196288433981643,4.05091515651518e-06,-4.8975614449034,3.82884995799979,4.03785567368811,3.14211689216674,-0.895738781521368,2.14545981681594e-05,ENSG00000135838,NPL,protein_coding,1,1,182789293,182830384,q25.3,N-acetylneuraminate pyruvate lyase [Source:HGNC Symbol;Acc:HGNC:16781],NA,NPL,80896,NM_001200050;NM_001200051;NM_001200052;NM_001200056;NM_030769
GCNT4_SIG,GCNT4,GCNT4_SIG,GCNT4,SIG,18,-4.99530737672027,-0.0570313794918042,-0.026388222356904,-0.157716038649334,-0.13132781629243,4.05903710185595e-06,-4.52460463230229,0.897299870097817,0.99177287361264,0.586888572834828,-0.404884300777812,9.04933135811442e-05,ENSG00000176928,GCNT4,protein_coding,5,-1,75025346,75052770,q13.3,glucosaminyl (N-acetyl) transferase 4 [Source:HGNC Symbol;Acc:HGNC:17973],NA,GCNT4,51301,NM_016591
RASD1_SIG,RASD1,RASD1_SIG,RASD1,SIG,53,-4.99495511543815,-0.0574613122171505,-0.0502049039836636,-0.0813037964128931,-0.0310988924292296,4.06306430270919e-06,-3.68461547254636,2.20479437918228,2.35260290219269,1.71913780357664,-0.633465098616051,0.00154118239040525,ENSG00000108551,RASD1,protein_coding,17,-1,17494437,17496395,p11.2,ras related dexamethasone induced 1 [Source:HGNC Symbol;Acc:HGNC:15828],NA,RASD1,51655,NM_001199989;NM_016084
AGO4_SIG,AGO4,AGO4_SIG,AGO4,SIG,31,-4.99262953938793,0.385265294000047,0.397327894021893,0.345631036785409,-0.0516968572364838,4.10850301305985e-06,-4.37458980647696,7.47214238193072,7.53620822277386,7.2616403334461,-0.274567889327765,0.000156542258353454,ENSG00000134698,AGO4,protein_coding,1,1,35808016,35857890,p34.3,argonaute RISC catalytic component 4 [Source:HGNC Symbol;Acc:HGNC:18424],NA,AGO4,192670,NM_017629
HMGN2_SIG,HMGN2,HMGN2_SIG,HMGN2,SIG,24,-4.99248687117873,0.133994552072895,0.151864251375576,0.0752798257926572,-0.0765844255829186,4.10850301305985e-06,-2.81059288123256,6.48848886529388,6.53800822044871,6.3257824126423,-0.212225807806402,0.0172596181099599,ENSG00000198830,HMGN2,protein_coding,1,1,26472440,26476642,p36.11,high mobility group nucleosomal binding domain 2 [Source:HGNC Symbol;Acc:HGNC:4986],NA,HMGN2,3151,NM_005517
SLC15A3_SIG,SLC15A3,SLC15A3_SIG,SLC15A3,SIG,95,-4.99167085075735,0.367287199297658,0.397489607219002,0.268050716127529,-0.129438891091473,4.12247277671934e-06,-4.25205985989674,4.53210291198868,4.73930483009809,3.85129660962919,-0.888008220468902,0.000240051429486462,ENSG00000110446,SLC15A3,protein_coding,11,-1,60937084,60952530,q12.2,solute carrier family 15 member 3 [Source:HGNC Symbol;Acc:HGNC:18068],NA,SLC15A3,51296,NM_016582
SRFBP1_SIG,SRFBP1,SRFBP1_SIG,SRFBP1,SIG,17,4.99082025536934,0.438979822455037,0.430107825804608,0.468130668592161,0.0380228427875523,4.13723080205834e-06,4.8849573803755,3.74931992832702,3.6816820805152,3.97155857113729,0.289876490622083,2.27602669615791e-05,ENSG00000151304,SRFBP1,protein_coding,5,1,121961961,122075570,q23.1,serum response factor binding protein 1 [Source:HGNC Symbol;Acc:HGNC:26333],NA,SRFBP1,153443,NM_152546
UNK_SIG,UNK,UNK_SIG,UNK,SIG,112,4.9904404224168,0.240555395303548,0.227858460680137,0.282273894780472,0.0544154341003351,4.14193478623097e-06,4.44060557516868,5.6494293955981,5.58785221704374,5.85175441084813,0.263902193804386,0.000123262201271399,ENSG00000132478,UNK,protein_coding,17,1,75784806,75825799,q25.1,unk zinc finger [Source:HGNC Symbol;Acc:HGNC:29369],NA,UNK,85451,NM_001080419
B4GALT5_SIG,B4GALT5,B4GALT5_SIG,B4GALT5,SIG,84,-4.9893371204817,0.259262720010468,0.272862032190412,0.214579265704937,-0.0582827664854757,4.16220497727873e-06,-2.7598655665362,6.94676116082563,7.02299707021877,6.69627174424819,-0.32672532597058,0.0194915568458134,ENSG00000158470,B4GALT5,protein_coding,20,-1,49632945,49713878,q13.13,beta-1,4-galactosyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:928],NA,B4GALT5,9334,NM_004776
SLC24A1_SIG,SLC24A1,SLC24A1_SIG,SLC24A1,SIG,111,4.98816778630438,0.229545633766847,0.213086926719529,0.283624242636608,0.0705373159170792,4.18400184486045e-06,4.71458632381389,4.09303850021535,3.97015569372091,4.49679629298282,0.526640599261915,4.41082463957369e-05,ENSG00000074621,SLC24A1,protein_coding,15,1,65611366,65660995,q22.31,solute carrier family 24 member 1 [Source:HGNC Symbol;Acc:HGNC:10975],Congenital stationary night blindness;Night blindness congenital stationary type 1D,SLC24A1,9187,NM_001254740;NM_001301031;NM_001301032;NM_001301033;NM_004727
APLN_SIG,APLN,APLN_SIG,APLN,SIG,59,-4.98678521132274,-0.0203048973884014,-0.0134442804120094,-0.0428469245965466,-0.0294026441845372,4.21055300237204e-06,-3.37821630242123,0.583875396470127,0.662871675357963,0.324316194410093,-0.338555480947869,0.00385144309964936,ENSG00000171388,APLN,protein_coding,X,-1,129645259,129654956,q26.1,apelin [Source:HGNC Symbol;Acc:HGNC:16665],NA,APLN,8862,NM_017413
RPUSD4_SIG,RPUSD4,RPUSD4_SIG,RPUSD4,SIG,24,4.98655226669375,0.410861528249385,0.398704929848432,0.450804637281088,0.0520997074326561,4.21069479108664e-06,3.92094907656678,4.60431478127938,4.54792546332897,4.78959396883075,0.241668505501784,0.000730063066735061,ENSG00000165526,RPUSD4,protein_coding,11,-1,126202096,126211692,q24.2,RNA pseudouridine synthase D4 [Source:HGNC Symbol;Acc:HGNC:25898],NA,RPUSD4,84881,NM_001144827;NM_001363516;NM_032795
ZNHIT6_TF,ZNHIT6,ZNHIT6_TF,ZNHIT6,TF,227,4.98645894996879,0.441521415047812,0.429550297968097,0.48085508545259,0.0513047874844932,4.21069479108664e-06,3.8873929806953,4.97243730116725,4.90881909140621,5.18146856181067,0.272649470404461,0.00081564907442208,ENSG00000117174,ZNHIT6,protein_coding,1,-1,85649417,85708433,p22.3,zinc finger HIT-type containing 6 [Source:HGNC Symbol;Acc:HGNC:26089],NA,ZNHIT6,54680,NM_001170670;NM_017953
NPAS1_SIG,NPAS1,NPAS1_SIG,NPAS1,SIG,14,4.98596829980432,0.0310170120462366,0.0196632744118501,0.0683221499877921,0.0486588755759419,4.21791014482882e-06,1.23076952878038,0.724862186875417,0.703633246270653,0.794614420291073,0.0909811740204197,0.32346355698483,ENSG00000130751,NPAS1,protein_coding,19,1,47019820,47045775,q13.32,neuronal PAS domain protein 1 [Source:HGNC Symbol;Acc:HGNC:7894],NA,NPAS1,4861,NM_001321086;NM_002517
SNRNP70_SIG,SNRNP70,SNRNP70_SIG,SNRNP70,SIG,60,4.98538630441297,0.134636310556453,0.12323266429707,0.172105433980139,0.0488727696830692,4.22713650571689e-06,3.34589115219819,8.14890236671821,8.10582887946748,8.29042953911347,0.184600659645986,0.0042252615388982,ENSG00000104852,SNRNP70,protein_coding,19,1,49085419,49108605,q13.33,small nuclear ribonucleoprotein U1 subunit 70 [Source:HGNC Symbol;Acc:HGNC:11150],NA,SNRNP70,6625,NM_001301069;NM_003089
CACNA1H_SIG,CACNA1H,CACNA1H_SIG,CACNA1H,SIG,34,-4.98125956452095,-0.0510123544942934,-0.040384963271348,-0.0859309256553999,-0.045545962384052,4.31333432801287e-06,-2.46840961956917,1.12393700642596,1.20349264220511,0.862539917437337,-0.340952724767776,0.037829324281953,ENSG00000196557,CACNA1H,protein_coding,16,1,1153106,1221771,p13.3,calcium voltage-gated channel subunit alpha1 H [Source:HGNC Symbol;Acc:HGNC:1395],Childhood absence epilepsy;EPILEPSY CHILDHOOD ABSENCE SUSCEPTIBILITY TO 6;HYPERALDOSTERONISM FAMILIAL TYPE IV,CACNA1H,8912,NM_001005407;NM_021098
SALL2_TF,SALL2,SALL2_TF,SALL2,TF,284,-4.98116312454367,-0.102437770257805,-0.0948950608399178,-0.127220958345146,-0.0323258975052286,4.31333432801287e-06,-3.23366942722051,1.0401839235322,1.12485084238763,0.76199261872151,-0.362858223666123,0.00578140414020789,ENSG00000165821,SALL2,protein_coding,14,-1,21521080,21537216,q11.2,spalt like transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:10526],COLOBOMA OCULAR AUTOSOMAL RECESSIVE;Coloboma of choroid and retina;Coloboma of eye lens;Coloboma of eyelid;Coloboma of iris;Coloboma of macula;Coloboma of optic disc;Precursor T-cell acute lymphoblastic leukemia,SALL2,6297,NM_001291446;NM_001291447;NM_001364564;NM_005407
AGK_SIG,AGK,AGK_SIG,AGK,SIG,6,4.98058315106843,0.421541997074526,0.40985706272597,0.459935352791209,0.0500782900652382,4.32272137728996e-06,4.05063420428199,4.38346248338107,4.32362016176373,4.5800872544095,0.25646709264577,0.000481226246656553,ENSG00000006530,AGK,protein_coding,7,1,141551189,141655244,q34,acylglycerol kinase [Source:HGNC Symbol;Acc:HGNC:21869],CATARACT 38;Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;Sengers syndrome;Total early-onset cataract,AGK,55750,NM_001364948;NM_018238
CLNS1A_SIG,CLNS1A,CLNS1A_SIG,CLNS1A,SIG,46,4.98041113018923,0.400164905770205,0.384674017586762,0.451063538372944,0.0663895207861815,4.32300770382389e-06,5.11402483420969,6.54373387006605,6.45566895797948,6.83309000977905,0.377421051799567,8.96887962046202e-06,ENSG00000074201,CLNS1A,protein_coding,11,-1,77514936,77637805,q14.1,chloride nucleotide-sensitive channel 1A [Source:HGNC Symbol;Acc:HGNC:2080],NA,CLNS1A,1207,NM_001293;NM_001311199;NM_001311200;NM_001311201;NM_001311202
DUSP18_SIG,DUSP18,DUSP18_SIG,DUSP18,SIG,62,4.97998405716442,0.0988119056141019,0.0875556089029564,0.135796880522151,0.0482412716191947,4.32899837708873e-06,4.61029775053832,3.64379762931447,3.55243706526805,3.94398233975268,0.391545274484629,6.60696766322162e-05,ENSG00000167065,DUSP18,protein_coding,22,-1,30652051,30667890,q12.2,dual specificity phosphatase 18 [Source:HGNC Symbol;Acc:HGNC:18484],NA,DUSP18,150290,NM_001304794;NM_001304795;NM_001304796;NM_152511
LAMC1_SIG,LAMC1,LAMC1_SIG,LAMC1,SIG,109,-4.97949200360924,-0.123816380647077,-0.116692646728479,-0.147222934951041,-0.0305302882225621,4.33645516933696e-06,-3.94354667591822,3.3930202269388,3.62854639510467,2.61914853153667,-1.009397863568,0.000682859101340292,ENSG00000135862,LAMC1,protein_coding,1,1,183023420,183145592,q25.3,laminin subunit gamma 1 [Source:HGNC Symbol;Acc:HGNC:6492],NA,LAMC1,3915,NM_002293
BDH2_SIG,BDH2,BDH2_SIG,BDH2,SIG,34,4.97827884175592,0.284900247487532,0.273142036978348,0.323534367731993,0.0503923307536452,4.36013859949274e-06,3.96866075767886,2.6554527560836,2.59592273699139,2.85105139024374,0.25512865325235,0.000627606700672633,ENSG00000164039,BDH2,protein_coding,4,-1,103077592,103099870,q24,3-hydroxybutyrate dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:32389],NA,BDH2,56898,NM_020139
OXSM_SIG,OXSM,OXSM_SIG,OXSM,SIG,26,4.97805702364224,0.0940345721497484,0.080117496505692,0.139762106408791,0.0596446099030991,4.36038842363317e-06,4.16663275455384,2.70615908879187,2.65251223664979,2.8824273172587,0.229915080608912,0.000323087326718048,ENSG00000151093,OXSM,protein_coding,3,1,25782917,25794534,p24.2,3-oxoacyl-ACP synthase, mitochondrial [Source:HGNC Symbol;Acc:HGNC:26063],NA,OXSM,54995,NM_001145391;NM_017897
USP2_SIG,USP2,USP2_SIG,USP2,SIG,29,-4.97795037521773,-0.0721138650584869,-0.0668838380747951,-0.0892982394334744,-0.0224144013586793,4.36038842363317e-06,-2.13421976347498,1.25137202319863,1.31891599139429,1.02944184198434,-0.289474149409947,0.0753993017524247,ENSG00000036672,USP2,protein_coding,11,-1,119355215,119381711,q23.3,ubiquitin specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:12618],NA,USP2,9099,NM_001243759;NM_004205;NM_171997
ZNF823_TF,ZNF823,ZNF823_TF,ZNF823,TF,23,4.97676720692344,-0.00912755577163615,-0.019065294659291,0.0235250148592299,0.0425903095185208,4.38352446694902e-06,5.06838554690056,1.93832653469463,1.8450935007915,2.24466364609064,0.399570145299136,1.06538352156492e-05,ENSG00000197933,ZNF823,protein_coding,19,-1,11721265,11739009,p13.2,zinc finger protein 823 [Source:HGNC Symbol;Acc:HGNC:30936],NA,ZNF823,55552,NM_001080493;NM_001297610;NM_017507
ZNF467_TF,ZNF467,ZNF467_TF,ZNF467,TF,292,-4.97227465083055,0.225224063643887,0.240830593899494,0.173945464232609,-0.066885129666885,4.4826976985132e-06,-3.17801549643995,4.95237914158539,5.05493217853252,4.6154191630448,-0.439513015487719,0.00674452544064429,ENSG00000181444,ZNF467,protein_coding,7,-1,149764182,149773588,q36.1,zinc finger protein 467 [Source:HGNC Symbol;Acc:HGNC:23154],NA,ZNF467,168544,NM_001329856;NM_207336
ABHD14A_SIG,ABHD14A,ABHD14A_SIG,ABHD14A,SIG,22,4.97126504569336,0.124470097863667,0.112106540207896,0.165093215875483,0.0529866756675874,4.50242643245784e-06,4.5159316238555,2.89882108223238,2.81364971287122,3.17866986727617,0.365020154404944,9.32259273415248e-05,ENSG00000248487,ABHD14A,protein_coding,3,1,51971426,51981199,p21.2,abhydrolase domain containing 14A [Source:HGNC Symbol;Acc:HGNC:24538],NA,ABHD14A,25864,NM_015407
TRPT1_SIG,TRPT1,TRPT1_SIG,TRPT1,SIG,24,4.97077651228058,0.000858092425006999,-0.00715153097580863,0.0271754264562584,0.0343269574320671,4.50755019926672e-06,2.39913063701524,3.34547217469828,3.31604062922942,3.44217582409595,0.126135194866528,0.0439775391724533,ENSG00000149743,TRPT1,protein_coding,11,-1,64223799,64226254,q13.1,tRNA phosphotransferase 1 [Source:HGNC Symbol;Acc:HGNC:20316],NA,TRPT1,83707,NM_001033678;NM_001160389;NM_001160390;NM_001160392;NM_001160393;NM_001330298;NM_031472
P4HA1_SIG,P4HA1,P4HA1_SIG,P4HA1,SIG,13,4.97072806156222,0.200371365231378,0.190964448511619,0.231279805882013,0.040315357370394,4.50755019926672e-06,2.20588107712024,5.49595718341857,5.4582118626973,5.6199775229313,0.161765660233997,0.06568923478615,ENSG00000122884,P4HA1,protein_coding,10,-1,73007217,73096974,q22.1,prolyl 4-hydroxylase subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:8546],EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE,P4HA1,5033,NM_000917;NM_001017962;NM_001142595;NM_001142596
PRPF40B_SIG,PRPF40B,PRPF40B_SIG,PRPF40B,SIG,59,4.96949101898256,-0.0285806402516726,-0.0397501467585198,0.00811916684225386,0.0478693136007737,4.53270390574263e-06,3.6950403244369,2.46927911644574,2.39205809279066,2.72300533702673,0.330947244236063,0.00149382852482881,ENSG00000110844,PRPF40B,protein_coding,12,1,49568218,49644666,q13.12,pre-mRNA processing factor 40 homolog B [Source:HGNC Symbol;Acc:HGNC:25031],NA,PRPF40B,25766,NM_001031698;NM_001363607;NM_012272
RING1_SIG,RING1,RING1_SIG,RING1,SIG,19,4.9692327432462,0.202647220949301,0.193168806614056,0.233790582336533,0.0406217757224777,4.53504896758953e-06,1.86898763443665,5.70877794155139,5.68868317902291,5.77480358985924,0.0861204108363234,0.122813465460171,ENSG00000204227,RING1,protein_coding,6,1,33208500,33212722,p21.32,ring finger protein 1 [Source:HGNC Symbol;Acc:HGNC:10018],NA,RING1,6015,NM_002931
ZNF587_TF,ZNF587,ZNF587_TF,ZNF587,TF,71,4.96854796903165,0.237382628417498,0.227597803990046,0.269532765821986,0.0419349618319405,4.54738736064938e-06,4.72261126008572,5.27778174958239,5.21222907448486,5.49316911061711,0.280940036132252,4.29157987094977e-05,ENSG00000198466,ZNF587,protein_coding,19,1,57849859,57865117,q13.43,zinc finger protein 587 [Source:HGNC Symbol;Acc:HGNC:30955],NA,ZNF587,84914,NM_001204817;NM_032828
ADAT2_SIG,ADAT2,ADAT2_SIG,ADAT2,SIG,36,4.96820740906671,0.190085976753462,0.17743289336999,0.23166039358487,0.0542275002148792,4.55167557347067e-06,3.33089247104084,4.50093566976394,4.43351631195361,4.72245641685503,0.288940104901418,0.0044049782086509,ENSG00000189007,ADAT2,protein_coding,6,-1,143422832,143450695,q24.2,adenosine deaminase, tRNA specific 2 [Source:HGNC Symbol;Acc:HGNC:21172],NA,ADAT2,134637,NM_001286259;NM_182503
HECTD2_SIG,HECTD2,HECTD2_SIG,HECTD2,SIG,52,-4.96745574667508,-0.0962908895317277,-0.0886757522926016,-0.121312054746,-0.032636302453398,4.56563615982169e-06,-4.82997411999272,1.67252587548352,1.78672832200712,1.29728926547743,-0.489439056529682,2.83749823762004e-05,ENSG00000165338,HECTD2,protein_coding,10,1,91409280,91514829,q23.32,HECT domain E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:26736],NA,HECTD2,143279,NM_001284274;NM_001348365;NM_173497;NM_182765
ZNF16_TF,ZNF16,ZNF16_TF,ZNF16,TF,77,4.96721217701714,0.249923941170545,0.243462107701183,0.271155679712733,0.0276935720115507,4.5676617526198e-06,3.02667301887252,2.88516481445646,2.84955985049067,3.00215255320119,0.152592702710516,0.0100385877374377,ENSG00000170631,ZNF16,protein_coding,8,-1,144930358,144950888,q24.3,zinc finger protein 16 [Source:HGNC Symbol;Acc:HGNC:12947],NA,ZNF16,7564,NM_001029976;NM_006958
PDE9A_SIG,PDE9A,PDE9A_SIG,PDE9A,SIG,32,4.96591613047301,-0.0660478188207224,-0.0758733869052928,-0.0337638093999912,0.0421095775053016,4.5945467186219e-06,5.64647514153523,1.54326271559769,1.33969128869764,2.21214026112645,0.872448972428805,8.30306597970319e-07,ENSG00000160191,PDE9A,protein_coding,21,1,42653621,42775509,q22.3,phosphodiesterase 9A [Source:HGNC Symbol;Acc:HGNC:8795],NA,PDE9A,5152,NM_001001567;NM_001001568;NM_001001569;NM_001001570;NM_001001571;NM_001001572;NM_001001573;NM_001001574;NM_001001575;NM_001001576;NM_001001577;NM_001001578;NM_001001579;NM_001001580;NM_001001581;NM_001001582;NM_001001583;NM_001001584;NM_001001585;NM_001315533;NM_002606
ZNF174_TF,ZNF174,ZNF174_TF,ZNF174,TF,14,4.96495891375691,0.158076044462274,0.144332097863553,0.203234726143787,0.0589026282802349,4.61352411671303e-06,3.54028252120988,3.06797290056586,3.01341984392901,3.24721865808695,0.233798814157941,0.00239892875608586,ENSG00000103343,ZNF174,protein_coding,16,1,3401215,3409364,p13.3,zinc finger protein 174 [Source:HGNC Symbol;Acc:HGNC:12963],NA,ZNF174,7727,NM_001032292;NM_001347868;NM_001347869;NM_001347870;NM_003450
LGALS3_SIG,LGALS3,LGALS3_SIG,LGALS3,SIG,63,-4.96349422576856,0.0274580530158723,0.0471829282406907,-0.0373522512942455,-0.0845351795349364,4.64470521502424e-06,-3.62166487670153,4.89148514723973,5.06143075940972,4.33309242153834,-0.728338337871379,0.00187036663264869,ENSG00000131981,LGALS3,protein_coding,14,1,55124110,55145423,q22.3,galectin 3 [Source:HGNC Symbol;Acc:HGNC:6563],NA,LGALS3,3958,NM_001357678;NM_002306
GATA3_SIG,GATA3,GATA3_SIG,GATA3,SIG,11,-4.9627829037119,0.114204547255182,0.142782272723652,0.020306306430209,-0.122475966293443,4.65798259712621e-06,-4.83878385320766,2.56669164038308,2.75084489985153,1.96161664498675,-0.789228254864783,2.75469514138877e-05,ENSG00000107485,GATA3,protein_coding,10,1,8045378,8075198,p14,GATA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:4172],Hypoparathyroidism-sensorineural deafness-renal disease syndrome;HYPOPARATHYROIDISM SENSORINEURAL DEAFNESS AND RENAL DISEASE;Precursor B-cell acute lymphoblastic leukemia,GATA3,2625,NM_001002295;NM_002051
ULK3_SIG,ULK3,ULK3_SIG,ULK3,SIG,67,4.96128607876087,0.203954979490756,0.192423606062679,0.241843777897294,0.0494201718346149,4.69023192218047e-06,2.83553829496765,5.72120629175069,5.67641866217475,5.86836564607162,0.19194698389687,0.0162760426849764,ENSG00000140474,ULK3,protein_coding,15,-1,74836118,74843346,q24.1,unc-51 like kinase 3 [Source:HGNC Symbol;Acc:HGNC:19703],NA,ULK3,25989,NM_001099436;NM_001284364;NM_001284365
NFAM1_SIG,NFAM1,NFAM1_SIG,NFAM1,SIG,52,-4.96093262149347,0.571724435133329,0.613743795886106,0.433660821231348,-0.180082974654758,4.69498005465391e-06,-3.9483536401289,5.92604839964662,6.12843862892583,5.26105193201494,-0.867386696910893,0.000670042878388604,ENSG00000235568,NFAM1,protein_coding,22,-1,42380410,42432395,q13.2,NFAT activating protein with ITAM motif 1 [Source:HGNC Symbol;Acc:HGNC:29872],NA,NFAM1,150372,NM_001318323;NM_145912
LTBP4_SIG,LTBP4,LTBP4_SIG,LTBP4,SIG,72,4.96039925914301,-0.0394649928292138,-0.0463747031844645,-0.0167616588048185,0.0296130443796462,4.70409042371268e-06,4.00124531990493,4.8195581949452,4.69472762819441,5.22971577141209,0.534988143217679,0.000566965773915339,ENSG00000090006,LTBP4,protein_coding,19,1,40592883,40629818,q13.2,latent transforming growth factor beta binding protein 4 [Source:HGNC Symbol;Acc:HGNC:6717],CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IC;Cutis laxa with severe pulmonary gastrointestinal and urinary anomalies;Duchenne Muscular Dystrophy,LTBP4,8425,NM_001042544;NM_001042545;NM_003573
GAMT_SIG,GAMT,GAMT_SIG,GAMT,SIG,30,4.96014004037926,0.306582412636919,0.289377285472932,0.36311354474716,0.0737362592742281,4.70657343808458e-06,3.68354565412834,3.33868074579351,3.23920515197187,3.66552912549319,0.426323973521328,0.00154675663654642,ENSG00000130005,GAMT,protein_coding,19,-1,1397026,1401570,p13.3,guanidinoacetate N-methyltransferase [Source:HGNC Symbol;Acc:HGNC:4136],CEREBRAL CREATINE DEFICIENCY SYNDROME 2;GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY,GAMT,2593,NM_000156;NM_138924
HPSE_SIG,HPSE,HPSE_SIG,HPSE,SIG,21,-4.95995125418202,0.0620090320367224,0.0866515108175434,-0.0189591125288323,-0.105610623346376,4.70735347225517e-06,-4.35331452461346,3.57508847390109,3.75799620494867,2.97410592903049,-0.783890275918185,0.000168444291317801,ENSG00000173083,HPSE,protein_coding,4,-1,83292461,83335153,q21.23,heparanase [Source:HGNC Symbol;Acc:HGNC:5164],NA,HPSE,10855,NM_001098540;NM_001166498;NM_001199830;NM_006665
ADRB2_SIG,ADRB2,ADRB2_SIG,ADRB2,SIG,32,4.95939524978003,-0.100984707221783,-0.111996607395165,-0.0648027495092424,0.0471938578859229,4.71704437894779e-06,2.95797878414542,3.94607829654253,3.83230490681296,4.31990514851111,0.487600241698153,0.011994206055841,ENSG00000169252,ADRB2,protein_coding,5,1,148825245,148828687,q32,adrenoceptor beta 2 [Source:HGNC Symbol;Acc:HGNC:286],ASTHMA SUSCEPTIBILITY TO;OBESITY LEANNESS INCLUDED,ADRB2,154,NM_000024
HSD17B7_SIG,HSD17B7,HSD17B7_SIG,HSD17B7,SIG,16,4.95607507139987,0.131441755635056,0.117068729825465,0.17866741186657,0.0615986820411051,4.79313253561674e-06,5.69684491465057,2.69284636804225,2.58874101526025,3.0349068128974,0.446165797637148,6.45216458955925e-07,ENSG00000132196,HSD17B7,protein_coding,1,1,162790702,162812817,q23.3,hydroxysteroid 17-beta dehydrogenase 7 [Source:HGNC Symbol;Acc:HGNC:5215],NA,HSD17B7,51478,NM_001304512;NM_001304513;NM_016371
HTRA1_SIG,HTRA1,HTRA1_SIG,HTRA1,SIG,30,-4.95597274629699,-0.200330892054953,-0.193649672877417,-0.222283469352573,-0.0286337964751569,4.79313253561674e-06,-2.37895356231659,0.293171089703321,0.322599590203854,0.196477445201571,-0.126122145002282,0.0458820333499175,ENSG00000166033,HTRA1,protein_coding,10,1,122458551,122514907,q26.13,HtrA serine peptidase 1 [Source:HGNC Symbol;Acc:HGNC:9476],CARASIL;Cerebral arteriopathy autosomal dominant with subcortical infarcts and leukoencephalopathy type 2;CEREBRAL ARTERIOPATHY AUTOSOMAL RECESSIVE WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY;HTRA1-related autosomal dominant cerebral small vessel disease;MACULAR DEGENERATION AGE-RELATED 7;Malignant peripheral nerve sheath tumor,HTRA1,5654,NM_002775
NPAS2_TF,NPAS2,NPAS2_TF,NPAS2,TF,60,-4.95567296603987,-0.151948267213642,-0.138840392375677,-0.195016998824099,-0.0561766064484223,4.79667342103136e-06,-2.48250112233412,0.325237481042077,0.347930114758347,0.250675970260047,-0.0972541444983,0.0366695203931265,ENSG00000170485,NPAS2,protein_coding,2,1,100820139,100996829,q11.2,neuronal PAS domain protein 2 [Source:HGNC Symbol;Acc:HGNC:7895],NA,NPAS2,4862,NM_002518
TRPM2_SIG,TRPM2,TRPM2_SIG,TRPM2,SIG,36,-4.9546517922645,0.0472651579061575,0.0573914666542497,0.0139930005909974,-0.0433984660632522,4.81806209875411e-06,-3.84499375001497,5.24269883219228,5.3679320562323,4.83121823891792,-0.536713817314376,0.000934847609084042,ENSG00000142185,TRPM2,protein_coding,21,1,44350163,44443081,q22.3,transient receptor potential cation channel subfamily M member 2 [Source:HGNC Symbol;Acc:HGNC:12339],NA,TRPM2,7226,NM_001320350;NM_001320351;NM_001320352;NM_003307
LUC7L3_SIG,LUC7L3,LUC7L3_SIG,LUC7L3,SIG,156,4.95394482807322,0.0781895680349073,0.0652674103830444,0.120648086033886,0.055380675650841,4.83173189730075e-06,4.1318529748542,7.54443517575217,7.46720931742529,7.79817728168337,0.33096796425808,0.000364753997283189,ENSG00000108848,LUC7L3,protein_coding,17,1,50719565,50756219,q21.33,LUC7 like 3 pre-mRNA splicing factor [Source:HGNC Symbol;Acc:HGNC:24309],NA,LUC7L3,51747,NM_001330330;NM_006107;NM_016424
PCSK5_SIG,PCSK5,PCSK5_SIG,PCSK5,SIG,33,-4.94769366015658,-0.0905668646712045,-0.0768402544934308,-0.135668583826747,-0.0588283293333158,4.98462647314164e-06,-2.77637271677438,1.60143567366267,1.68387758856505,1.33055509612626,-0.353322492438783,0.0186916402288141,ENSG00000099139,PCSK5,protein_coding,9,1,75890644,76362339,q21.13,proprotein convertase subtilisin/kexin type 5 [Source:HGNC Symbol;Acc:HGNC:8747],NA,PCSK5,5125,NM_001190482;NM_006200
FUK_SIG,FUK,FUK_SIG,FUK,SIG,29,4.94757067092196,0.150629201138501,0.145202155111964,0.168460923797119,0.0232587686851547,4.98462647314164e-06,4.50675004146882,4.01196524588237,3.95471941157781,4.20005870145451,0.245339289876705,9.64391509686986e-05,ENSG00000157353,FUK,protein_coding,16,1,70454595,70480274,q22.1,fucokinase [Source:HGNC Symbol;Acc:HGNC:29500],NA,FUK,197258,NM_145059
F11R_SIG,F11R,F11R_SIG,F11R,SIG,29,4.94711522059386,0.218832461710963,0.205781660467011,0.261713665798233,0.0559320053312222,4.99230213750129e-06,2.90931926249291,5.69378411952889,5.63032942779576,5.90227810665202,0.271948678856256,0.0135472388240235,ENSG00000158769,F11R,protein_coding,1,-1,160995211,161021343,q23.3,F11 receptor [Source:HGNC Symbol;Acc:HGNC:14685],NA,F11R,50848,NM_001348091;NM_016946
ACAD10_SIG,ACAD10,ACAD10_SIG,ACAD10,SIG,161,4.94563759574842,0.145715926098772,0.129665889052898,0.198451762106644,0.0687858730537467,5.02630217104264e-06,4.32405094978186,5.11230769951867,5.03780535348262,5.35710112220855,0.319295768725923,0.000187280384379075,ENSG00000111271,ACAD10,protein_coding,12,1,111686056,111757107,q24.12,acyl-CoA dehydrogenase family member 10 [Source:HGNC Symbol;Acc:HGNC:21597],NA,ACAD10,80724,NM_001136538;NM_025247
ZRANB2_TF,ZRANB2,ZRANB2_TF,ZRANB2,TF,196,4.94259825698104,0.117456677112762,0.1055097191666,0.156710967507294,0.0512012483406947,5.09857649944165e-06,3.91147491274813,6.82480962390942,6.77002318007387,7.00482222508334,0.23479904500947,0.000752220328776105,ENSG00000132485,ZRANB2,protein_coding,1,-1,71063291,71081289,p31.1,zinc finger RANBP2-type containing 2 [Source:HGNC Symbol;Acc:HGNC:13058],NA,ZRANB2,9406,NM_005455;NM_203350
ZSCAN31_TF,ZSCAN31,ZSCAN31_TF,ZSCAN31,TF,108,4.94254466763722,0.19220437415465,0.174225361143831,0.251278274047339,0.0770529129035081,5.09857649944165e-06,3.71413925047239,1.90701413380194,1.81022660875757,2.22503028751915,0.414803678761579,0.00141017094053875,ENSG00000235109,ZSCAN31,protein_coding,6,-1,28324693,28356271,p22.1,zinc finger and SCAN domain containing 31 [Source:HGNC Symbol;Acc:HGNC:14097],NA,ZSCAN31,64288,NM_001135215;NM_001135216;NM_001243241;NM_001243242;NM_001243243;NM_001243244;NM_030899;NM_145909
PSAP_SIG,PSAP,PSAP_SIG,PSAP,SIG,55,-4.94172686298307,0.665187513979715,0.695748449584032,0.564773011279816,-0.130975438304216,5.11593104010401e-06,-4.61060295473222,10.0983351743212,10.2296554809766,9.66685416673918,-0.562801314237463,6.60599276654883e-05,ENSG00000197746,PSAP,protein_coding,10,-1,71816298,71851325,q22.1,prosaposin [Source:HGNC Symbol;Acc:HGNC:9498],Atypical Gaucher disease due to saposin C deficiency;atypical Krabbe disease;COMBINED SAPOSIN DEFICIENCY;Encephalopathy due to prosaposin deficiency;GAUCHER DISEASE ATYPICAL DUE TO SAPOSIN C DEFICIENCY;Infantile Krabbe disease;KRABBE DISEASE ATYPICAL DUE TO SAPOSIN A DEFICIENCY;Metachromatic leukodystrophy adult form;METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY;Metachromatic leukodystrophy juvenile form;Metachromatic leukodystrophy late infantile form,PSAP,5660,NM_001042465;NM_001042466;NM_002778
AQP11_SIG,AQP11,AQP11_SIG,AQP11,SIG,7,4.94116047559733,-0.0110519138102738,-0.0226435369003977,0.0270348477715622,0.0496783846719598,5.12672869173261e-06,3.31855770468868,0.296488713913348,0.27651998120591,0.362100264237786,0.0855802830318762,0.00456153320071202,ENSG00000178301,AQP11,protein_coding,11,1,77589391,77610355,q14.1,aquaporin 11 [Source:HGNC Symbol;Acc:HGNC:19940],NA,AQP11,282679,NM_173039
SETMAR_SIG,SETMAR,SETMAR_SIG,SETMAR,SIG,85,4.94080069830549,0.232932019564693,0.216872679724096,0.285698421898083,0.0688257421739871,5.13210923712999e-06,4.5197042805962,3.56429915166464,3.47387257141112,3.86141505821192,0.387542486800802,9.22508576969971e-05,ENSG00000170364,SETMAR,protein_coding,3,1,4303304,4317567,p26.1,SET domain and mariner transposase fusion gene [Source:HGNC Symbol;Acc:HGNC:10762],NA,SETMAR,6419,NM_001243723;NM_001276325;NM_001320676;NM_001320677;NM_001320678;NM_006515
B2M_SIG,B2M,B2M_SIG,B2M,SIG,15,-4.94064440688609,0.741178196449298,0.759063412904099,0.682412485240666,-0.0766509276634321,5.13213893091604e-06,-5.34139050074894,11.5844745455024,11.6662972617034,11.3156284779846,-0.350668783718802,3.30675185006628e-06,ENSG00000166710,B2M,protein_coding,15,1,44711487,44718877,q21.1,beta-2-microglobulin [Source:HGNC Symbol;Acc:HGNC:914],AMYLOIDOSIS FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;Immunodeficiency by defective expression of HLA class 1;Variant ABeta2M amyloidosis,B2M,567,NM_004048
SMARCC2_SIG,SMARCC2,SMARCC2_SIG,SMARCC2,SIG,73,4.9399825600486,0.394813758399077,0.380887262515286,0.440572244874388,0.059684982359102,5.14230309139953e-06,3.32802144328311,7.29792216440503,7.25329799441878,7.44454443721698,0.191246442798203,0.00444073201834425,ENSG00000139613,SMARCC2,protein_coding,12,-1,56162359,56189567,q13.2,SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 [Source:HGNC Symbol;Acc:HGNC:11105],NA,SMARCC2,6601,NM_001130420;NM_001330288;NM_003075;NM_139067
TERF2_TF,TERF2,TERF2_TF,TERF2,TF,125,4.93980170476642,0.365590448208052,0.353455559574941,0.405462225145415,0.052006665570474,5.14230309139953e-06,5.41012910144913,5.39226435925124,5.31607451891815,5.64260240605997,0.326527887141821,2.4347392523649e-06,ENSG00000132604,TERF2,protein_coding,16,-1,69355567,69408571,q22.1,telomeric repeat binding factor 2 [Source:HGNC Symbol;Acc:HGNC:11729],NA,TERF2,7014,NM_005652
AACS_SIG,AACS,AACS_SIG,AACS,SIG,23,4.93979383516382,0.0925376374716609,0.0846981652915565,0.11829590320629,0.0335977379147334,5.14230309139953e-06,2.57809015178906,3.97992146353159,3.93081828456109,4.14126048014892,0.210442195587824,0.0296266908862548,ENSG00000081760,AACS,protein_coding,12,1,125065434,125143333,q24.31,acetoacetyl-CoA synthetase [Source:HGNC Symbol;Acc:HGNC:21298],NA,AACS,65985,NM_001319839;NM_001319840;NM_023928
TARSL2_SIG,TARSL2,TARSL2_SIG,TARSL2,SIG,95,4.9364765242281,0.0971697243504035,0.0859850716922922,0.133919297369912,0.04793422567762,5.22635720548115e-06,3.67454023553783,4.41558108245302,4.33476008819633,4.68113577786785,0.346375689671515,0.00158831198099466,ENSG00000185418,TARSL2,protein_coding,15,-1,101653596,101724473,q26.3,threonyl-tRNA synthetase like 2 [Source:HGNC Symbol;Acc:HGNC:24728],NA,TARSL2,123283,NM_152334
TWIST1_TF,TWIST1,TWIST1_TF,TWIST1,TF,115,4.93506352152878,-0.0702764353946982,-0.0761423652619458,-0.0510026658308846,0.0251396994310613,5.25782261839495e-06,1.87427321495884,0.524562433974492,0.477739707220114,0.678408536167447,0.200668828947333,0.12167366842059,ENSG00000122691,TWIST1,protein_coding,7,-1,19020991,19117636,p21.1,twist family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:12428],CRANIOSYNOSTOSIS 1;CRANIOSYNOSTOSIS TYPE 1;Isolated brachycephaly;Isolated plagiocephaly;Isolated scaphocephaly;ROBINOW-SORAUF SYNDROME;SAETHRE-CHOTZEN SYNDROME;SWEENEY-COX SYNDROME,TWIST1,7291,NM_000474
EHMT1_SIG,EHMT1,EHMT1_SIG,EHMT1,SIG,123,4.93499589946103,0.506602556476338,0.492796321806215,0.551965898963884,0.0591695771576694,5.25782261839495e-06,3.95613509110879,6.69301638203474,6.64524679062835,6.84997361094145,0.204726820313104,0.000653471892828044,ENSG00000181090,EHMT1,protein_coding,9,1,137618992,137870016,q34.3,euchromatic histone lysine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24650],9q subtelomeric deletion syndrome;KLEEFSTRA SYNDROME 1;Kleefstra syndrome due to 9q34 microdeletion;Kleefstra syndrome due to a point mutation,EHMT1,79813,NM_001145527;NM_001354259;NM_001354263;NM_001354611;NM_001354612;NM_024757
ZBTB41_TF,ZBTB41,ZBTB41_TF,ZBTB41,TF,90,4.93406295766725,0.333749341488782,0.326461158767189,0.357696227574017,0.0312350688068276,5.27883369845913e-06,4.29928989382098,4.09715601594136,4.03547031390117,4.29983760835913,0.264367294457953,0.000205085628677558,ENSG00000177888,ZBTB41,protein_coding,1,-1,197153680,197200542,q31.3,zinc finger and BTB domain containing 41 [Source:HGNC Symbol;Acc:HGNC:24819],NA,ZBTB41,360023,NM_194314
SMYD3_SIG,SMYD3,SMYD3_SIG,SMYD3,SIG,24,4.93338713131001,0.245572818889539,0.232678745860755,0.287939058841261,0.0552603129805066,5.29295252193541e-06,4.32721972822516,4.49795929320457,4.35828266312499,4.95689679203746,0.598614128912471,0.000185401208838031,ENSG00000185420,SMYD3,protein_coding,1,-1,245749342,246507312,q44,SET and MYND domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15513],NA,SMYD3,64754,NM_001167740;NM_022743
ZNF346_TF,ZNF346,ZNF346_TF,ZNF346,TF,48,4.93321845269538,0.326163675438356,0.314503001403298,0.364477318696405,0.0499743172931075,5.29334300973145e-06,3.60818884448924,3.98257504141677,3.93660204142636,4.13362918424239,0.197027142816037,0.00194896397759558,ENSG00000113761,ZNF346,protein_coding,5,1,177022696,177081189,q35.2,zinc finger protein 346 [Source:HGNC Symbol;Acc:HGNC:16403],NA,ZNF346,23567,NM_001308213;NM_001308214;NM_001308215;NM_001308218;NM_001308221;NM_001308223;NM_012279
KDM2B_TF,KDM2B,KDM2B_TF,KDM2B,TF,269,4.93264769517947,0.125890216092468,0.118678069603471,0.149587268842032,0.0309091992385609,5.30464918292434e-06,2.39222195918579,6.27969037032053,6.24723483635897,6.38632998190851,0.13909514554954,0.044548007762151,ENSG00000089094,KDM2B,protein_coding,12,-1,121429096,121581023,q24.31,lysine demethylase 2B [Source:HGNC Symbol;Acc:HGNC:13610],NA,KDM2B,84678,NM_001005366;NM_032590
REV3L_SIG,REV3L,REV3L_SIG,REV3L,SIG,20,4.92963383607667,0.571539533918718,0.559879647977065,0.609850587727009,0.0499709397499443,5.3828900266402e-06,3.04196111246597,6.06572001020727,6.02003757676774,6.21581943436572,0.195781857597979,0.00964851654105409,ENSG00000009413,REV3L,protein_coding,6,-1,111299028,111483715,q21,REV3 like, DNA directed polymerase zeta catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9968],Moebius syndrome,REV3L,5980,NM_001286431;NM_001286432;NM_002912
HLA-C_SIG,HLA-C,HLA-C_SIG,HLA-C,SIG,13,-4.92830007143695,0.588909289386898,0.608876935675519,0.523301308724285,-0.0855756269512347,5.41548826667792e-06,-3.937274676189,10.0274598248325,10.1111205296576,9.75257465183559,-0.358545877821992,0.000696609195548273,ENSG00000204525,HLA-C,protein_coding,6,-1,31268749,31272130,p21.33,major histocompatibility complex, class I, C [Source:HGNC Symbol;Acc:HGNC:4933],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;Precursor B-cell acute lymphoblastic leukemia;PSORIASIS 1 SUSCEPTIBILITY TO,HLA-C,3107,NM_002117
ZNF296_TF,ZNF296,ZNF296_TF,ZNF296,TF,55,-4.92757022602645,0.239145501959626,0.247784133142639,0.210761428072583,-0.0370227050700568,5.43147004763138e-06,-3.20360942050132,3.11407244315171,3.17602724268572,2.91050667325424,-0.265520569431484,0.00628545269833269,ENSG00000170684,ZNF296,protein_coding,19,-1,45071500,45076587,q13.32,zinc finger protein 296 [Source:HGNC Symbol;Acc:HGNC:15981],NA,ZNF296,162979,NM_145288
SLC25A4_SIG,SLC25A4,SLC25A4_SIG,SLC25A4,SIG,30,-4.92610710990788,-0.119065402907946,-0.111696675574295,-0.143276935575657,-0.0315802600013619,5.4679714055267e-06,-2.88818510926925,1.20390953795765,1.25873280802705,1.02377593630106,-0.234956871725991,0.0142905246430654,ENSG00000151729,SLC25A4,protein_coding,4,1,185143266,185150382,q35.1,solute carrier family 25 member 4 [Source:HGNC Symbol;Acc:HGNC:10990],Autosomal dominant progressive external ophthalmoplegia;Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;FONTAINE PROGEROID SYNDROME;MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE) AUTOSOMAL DOMINANT;MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE) AUTOSOMAL RECESSIVE;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS AUTOSOMAL DOMINANT 2;Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number,SLC25A4,291,NM_001151
MAPK14_SIG,MAPK14,MAPK14_SIG,MAPK14,SIG,31,-4.92524795506008,0.315895987618026,0.326846075510351,0.279917127400385,-0.0469289481099656,5.48773436317649e-06,-3.51700470650424,7.45647889400287,7.51684726181544,7.25812568547586,-0.258721576339577,0.00256950716284699,ENSG00000112062,MAPK14,protein_coding,6,1,36027677,36111236,p21.31,mitogen-activated protein kinase 14 [Source:HGNC Symbol;Acc:HGNC:6876],NA,MAPK14,1432,NM_001315;NM_139012;NM_139013;NM_139014
SYNGAP1_SIG,SYNGAP1,SYNGAP1_SIG,SYNGAP1,SIG,119,4.92377186920304,0.0706103326195755,0.0557413839358031,0.119465449723399,0.063724065787596,5.52496888726124e-06,2.97172287113899,6.02631962676915,5.95305087512201,6.2670598107526,0.314008935630594,0.0115880891046031,ENSG00000197283,SYNGAP1,protein_coding,6,1,33419661,33457541,p21.32,synaptic Ras GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:11497],Autosomal dominant non-syndromic intellectual disability;Epileptic encephalopathy;MENTAL RETARDATION AUTOSOMAL DOMINANT 5;MENTAL RETARDATION AUTOSOMAL DOMINANT TYPE 5;Undetermined early-onset epileptic encephalopathy,SYNGAP1,8831,NM_001130066;NM_006772
FUBP3_SIG,FUBP3,FUBP3_SIG,FUBP3,SIG,32,4.9214587317287,0.396515957972962,0.38742187721494,0.426396509035034,0.0389746318200942,5.58629570205294e-06,2.75792262903651,5.76262085670033,5.72980934696407,5.87043010297661,0.140620756012542,0.0195702338644671,ENSG00000107164,FUBP3,protein_coding,9,1,130578965,130638352,q34.11,far upstream element binding protein 3 [Source:HGNC Symbol;Acc:HGNC:4005],NA,FUBP3,8939,NM_003934
ABCA13_SIG,ABCA13,ABCA13_SIG,ABCA13,SIG,18,-4.92089403805557,0.205463198135347,0.236450871788416,0.103646556132408,-0.132804315656007,5.59804556349511e-06,-3.7641430587029,3.70394850841268,3.9236855217456,2.98195546460453,-0.941730057141069,0.00120130522723921,ENSG00000179869,ABCA13,protein_coding,7,1,48171458,48647497,p12.3,ATP binding cassette subfamily A member 13 [Source:HGNC Symbol;Acc:HGNC:14638],NA,ABCA13,154664,NM_152701
PDK2_SIG,PDK2,PDK2_SIG,PDK2,SIG,36,4.91984203556396,0.100944558281498,0.0911444985665081,0.133144754487893,0.0420002559213848,5.61957805917556e-06,2.74231245765492,4.3143882483944,4.26036024192093,4.49190884109295,0.231548599172018,0.0202565575337794,ENSG00000005882,PDK2,protein_coding,17,1,50094737,50112152,q21.33,pyruvate dehydrogenase kinase 2 [Source:HGNC Symbol;Acc:HGNC:8810],NA,PDK2,5164,NM_001199898;NM_001199899;NM_001199900;NM_002611
ZNF121_TF,ZNF121,ZNF121_TF,ZNF121,TF,170,4.91983592222067,0.134008530738343,0.11937864469543,0.182078156307916,0.0626995116124862,5.61957805917556e-06,4.01209396570361,5.56974239198606,5.48963066084886,5.83296665143686,0.343335990587996,0.000546259353264835,ENSG00000197961,ZNF121,protein_coding,19,-1,9560353,9584533,p13.2,zinc finger protein 121 [Source:HGNC Symbol;Acc:HGNC:12904],NA,ZNF121,7675,NM_001008727;NM_001308269
CARF_TF,CARF,CARF_TF,CARF,TF,270,4.91917869258855,0.0853391972670017,0.0730604005428998,0.125683815074765,0.0526234145318649,5.6340659703423e-06,3.91983438574876,4.236213555686,4.15393290676714,4.50656425927655,0.352631352509405,0.000733182209319748,ENSG00000138380,CARF,protein_coding,2,1,202912214,202988263,q33.2,calcium responsive transcription factor [Source:HGNC Symbol;Acc:HGNC:14435],NA,CARF,79800,NM_001104586;NM_001282910;NM_001282911;NM_001282912;NM_001322427;NM_001322428;NM_001322429;NM_001352676;NM_001352677;NM_001352678;NM_001352679;NM_024744
ZMYND15_TF,ZMYND15,ZMYND15_TF,ZMYND15,TF,254,-4.9189342535448,0.177596798799823,0.197206495358563,0.11316493867825,-0.0840415566803127,5.63669480409484e-06,-3.28242738424685,1.48220987382159,1.58274883189563,1.15186758300688,-0.430881248888748,0.00504578510048336,ENSG00000141497,ZMYND15,protein_coding,17,1,4739833,4746119,p13.2,zinc finger MYND-type containing 15 [Source:HGNC Symbol;Acc:HGNC:20997],Male infertility with azoospermia or oligozoospermia due to single gene mutation;Spermatogenic failure 14,ZMYND15,84225,NM_001136046;NM_001267822;NM_032265
KLF12_TF,KLF12,KLF12_TF,KLF12,TF,91,-4.91673104503377,-0.0934342607388051,-0.082703338792154,-0.128693004277802,-0.0459896654856478,5.69602309836803e-06,-4.82159682420461,3.93773813018699,4.13503899912912,3.28946384652002,-0.845575152609093,2.93264074058237e-05,ENSG00000118922,KLF12,protein_coding,13,-1,73686089,73995056,q22.1,Kruppel like factor 12 [Source:HGNC Symbol;Acc:HGNC:6346],NA,KLF12,11278,NM_007249
NEURL4_SIG,NEURL4,NEURL4_SIG,NEURL4,SIG,38,4.91643512888837,0.345008768082713,0.332678666696298,0.385521958352359,0.0528432916560608,5.6989600579768e-06,4.07404688668228,4.80777674278313,4.7429683547045,5.02071858932721,0.277750234622708,0.000442593066490828,ENSG00000215041,NEURL4,protein_coding,17,-1,7315628,7329393,p13.1,neuralized E3 ubiquitin protein ligase 4 [Source:HGNC Symbol;Acc:HGNC:34410],NA,NEURL4,84461,NM_001005408;NM_032442
SAV1_SIG,SAV1,SAV1_SIG,SAV1,SIG,10,4.91632429900644,0.199957767610167,0.190088224501945,0.232386266394324,0.0422980418923787,5.6989600579768e-06,2.9022328839886,4.57099736501819,4.52109968591504,4.73494688207142,0.213847196156379,0.0137963736989187,ENSG00000151748,SAV1,protein_coding,14,-1,50632058,50668331,q22.1,salvador family WW domain containing protein 1 [Source:HGNC Symbol;Acc:HGNC:17795],NA,SAV1,60485,NM_021818
MAT2A_SIG,MAT2A,MAT2A_SIG,MAT2A,SIG,44,4.91601348935179,0.0958039355602102,0.0832869940735285,0.13693102901645,0.0536440349429219,5.7035615268273e-06,2.95237443097599,8.16943960744281,8.10847127750645,8.36976412009084,0.261292842584385,0.0121727963750601,ENSG00000168906,MAT2A,protein_coding,2,1,85539168,85545281,p11.2,methionine adenosyltransferase 2A [Source:HGNC Symbol;Acc:HGNC:6904],Familial thoracic aortic aneurysm and aortic dissection,MAT2A,4144,NM_005911
PRKACB_SIG,PRKACB,PRKACB_SIG,PRKACB,SIG,48,4.91507067446703,0.358834169828158,0.343827072368121,0.408143204339709,0.0643161319715876,5.7266150516972e-06,4.54893909809123,6.51744493173505,6.40276488593757,6.8942507964982,0.491485910560625,8.32029279490607e-05,ENSG00000142875,PRKACB,protein_coding,1,1,84078062,84238498,p31.1,protein kinase cAMP-activated catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:9381],NA,PRKACB,5567,NM_001242857;NM_001242858;NM_001242859;NM_001242860;NM_001242861;NM_001242862;NM_001300915;NM_001300916;NM_001300917;NM_002731;NM_182948;NM_207578
XBP1_TF,XBP1,XBP1_TF,XBP1,TF,149,4.91468555735343,0.159065112021927,0.152226137674113,0.181536027736175,0.0293098900620624,5.73341774712894e-06,4.45594096578886,7.91979075410678,7.83805664239787,8.18834569257894,0.350289050181075,0.00011659435422144,ENSG00000100219,XBP1,protein_coding,22,-1,28794555,28800597,q12.1,X-box binding protein 1 [Source:HGNC Symbol;Acc:HGNC:12801],MAJOR AFFECTIVE DISORDER 7,XBP1,7494,NM_001079539;NM_005080
ARNT2_SIG,ARNT2,ARNT2_SIG,ARNT2,SIG,53,-4.90981090810168,-0.160605588718632,-0.153695643277198,-0.183309695169061,-0.0296140518918627,5.87321821671541e-06,-1.76579135312944,0.38274192422638,0.419193366811151,0.262972898590703,-0.156220468220448,0.146442115398098,ENSG00000172379,ARNT2,protein_coding,15,1,80404350,80597933,q25.1,aryl hydrocarbon receptor nuclear translocator 2 [Source:HGNC Symbol;Acc:HGNC:16876],Septo-optic dysplasia spectrum;WEBB-DATTANI SYNDROME,ARNT2,9915,NM_014862
KDR_SIG,KDR,KDR_SIG,KDR,SIG,21,-4.90945905876962,-0.248687798236023,-0.238367010368442,-0.282598958372361,-0.0442319480039189,5.87919329288608e-06,-3.07694996055014,0.319237294689371,0.368637369166729,0.156922764263768,-0.21171460490296,0.00880529367482997,ENSG00000128052,KDR,protein_coding,4,-1,55078259,55125595,q12,kinase insert domain receptor [Source:HGNC Symbol;Acc:HGNC:6307],HEMANGIOMA CAPILLARY INFANTILE,KDR,3791,NM_002253
ING1_SIG,ING1,ING1_SIG,ING1,SIG,5,-4.90716589193202,0.157564083889913,0.165383696922254,0.131871069640791,-0.0335126272814633,5.94370753560123e-06,-3.12716367778253,5.14144157104036,5.18205666148519,5.00799198815021,-0.174064673334976,0.00774105590963676,ENSG00000153487,ING1,protein_coding,13,1,110712736,110723339,q34,inhibitor of growth family member 1 [Source:HGNC Symbol;Acc:HGNC:6062],SQUAMOUS CELL CARCINOMA HEAD AND NECK;Squamous cell carcinoma of salivary glands;Squamous cell carcinoma of the hypopharynx;Squamous cell carcinoma of the larynx;Squamous cell carcinoma of the lip;Squamous cell carcinoma of the nasal cavity and paranasal sinuses;Squamous cell carcinoma of the oral cavity;Squamous cell carcinoma of the oropharynx,ING1,3621,NM_001267728;NM_005537;NM_198217;NM_198218;NM_198219
ZFP41_TF,ZFP41,ZFP41_TF,ZFP41,TF,167,4.90671581820563,0.225093376562619,0.209629302082231,0.275903906998182,0.0662746049159515,5.9527352700386e-06,3.83565745702625,2.67627293782716,2.60273674940698,2.91789184263632,0.315155093229347,0.000964211443151622,ENSG00000181638,ZFP41,protein_coding,8,1,143246821,143262705,q24.3,ZFP41 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:26786],NA,ZFP41,286128,NM_001271156;NM_173832
DROSHA_SIG,DROSHA,DROSHA_SIG,DROSHA,SIG,50,4.90293343077947,0.362711575460763,0.346073139545094,0.417380722040819,0.0713075824957249,6.06384850101611e-06,3.69314615927013,6.03217498001436,5.96587340642593,6.25002300751919,0.284149601093258,0.00150192774591001,ENSG00000113360,DROSHA,protein_coding,5,-1,31400497,31532196,p13.3,drosha ribonuclease III [Source:HGNC Symbol;Acc:HGNC:17904],NA,DROSHA,29102,NM_001100412;NM_013235
ARSD_SIG,ARSD,ARSD_SIG,ARSD,SIG,52,4.90101815050686,0.261504253973096,0.249000455936187,0.302588161808656,0.0535877058724691,6.11853002584583e-06,3.68083971935319,6.03920389106935,5.93522573469559,6.38084640486886,0.445620670173266,0.00155821876194794,ENSG00000006756,ARSD,protein_coding,X,-1,2903972,2929349,p22.33,arylsulfatase D [Source:HGNC Symbol;Acc:HGNC:717],NA,ARSD,414,NM_001669;NM_009589
SP140_TF,SP140,SP140_TF,SP140,TF,180,-4.89879810759648,0.0402589096046118,0.0483636835518496,0.0136289380636877,-0.0347347454881618,6.17804909973284e-06,-1.30128948981478,3.25359115171775,3.29663375686053,3.11216544910575,-0.184468307754779,0.294569672052442,ENSG00000079263,SP140,protein_coding,2,1,230203110,230313215,q37.1,SP140 nuclear body protein [Source:HGNC Symbol;Acc:HGNC:17133],NA,SP140,11262,NM_001005176;NM_001278451;NM_001278452;NM_001278453;NM_007237
CEACAM6_SIG,CEACAM6,CEACAM6_SIG,CEACAM6,SIG,40,-4.89867444247795,0.152500609220659,0.188171553520054,0.0352960779512199,-0.152875475568834,6.17804909973284e-06,-4.50687681153096,4.37483616245592,4.69581909308291,3.3201779618244,-1.37564113125851,9.64391509686986e-05,ENSG00000086548,CEACAM6,protein_coding,19,1,41750977,41772211,q13.2,carcinoembryonic antigen related cell adhesion molecule 6 [Source:HGNC Symbol;Acc:HGNC:1818],NA,CEACAM6,4680,NM_002483
SRSF6_SIG,SRSF6,SRSF6_SIG,SRSF6,SIG,46,4.8986600913564,0.282252259581317,0.270285452751958,0.321571767734922,0.0512863149829631,6.17804909973284e-06,3.37334656841911,8.35979816128914,8.31263433047272,8.51476503397167,0.202130703498952,0.00390756961323979,ENSG00000124193,SRSF6,protein_coding,20,1,43457896,43464243,q13.11,serine and arginine rich splicing factor 6 [Source:HGNC Symbol;Acc:HGNC:10788],NA,SRSF6,6431,NM_006275
RRP8_SIG,RRP8,RRP8_SIG,RRP8,SIG,49,4.89752142527016,0.387929913537686,0.38011265468233,0.413615192633857,0.0335025379515275,6.20576907722241e-06,4.8828448156285,4.80011140992661,4.74621688689227,4.97719341418232,0.230976527290053,2.29613219386799e-05,ENSG00000132275,RRP8,protein_coding,11,-1,6595072,6603616,p15.4,ribosomal RNA processing 8 [Source:HGNC Symbol;Acc:HGNC:29030],NA,RRP8,23378,NM_015324
DIS3L2_SIG,DIS3L2,DIS3L2_SIG,DIS3L2,SIG,30,4.8974766675704,0.375533792111925,0.365604622090543,0.408158207896466,0.042553585805923,6.20576907722241e-06,3.45665536519212,4.71806855053939,4.68003074470691,4.84304991256039,0.163019167853477,0.00305830055297225,ENSG00000144535,DIS3L2,protein_coding,2,1,231961245,232344350,q37.1,DIS3 like 3'-5' exoribonuclease 2 [Source:HGNC Symbol;Acc:HGNC:28648],Nephroblastoma;Perlman syndrome,DIS3L2,129563,NM_001257281;NM_001257282;NM_152383
CD14_SIG,CD14,CD14_SIG,CD14,SIG,42,-4.89392267248139,0.285280812464834,0.334940114734289,0.122114533579483,-0.212825581154806,6.31408282594512e-06,-4.6172608473264,4.76280862212969,5.07716169049946,3.72993425462901,-1.34722743587045,6.43471177235125e-05,ENSG00000170458,CD14,protein_coding,5,-1,140631728,140633701,q31.3,CD14 molecule [Source:HGNC Symbol;Acc:HGNC:1628],NA,CD14,929,NM_000591;NM_001040021;NM_001174104;NM_001174105
CREB5_TF,CREB5,CREB5_TF,CREB5,TF,238,-4.8900063573218,0.147665013148924,0.163839126535026,0.0945214977374458,-0.0693176287975804,6.43604849223366e-06,-2.57653438743098,4.35456174075697,4.46218943281905,4.00092789541015,-0.461261537408897,0.0297292931205394,ENSG00000146592,CREB5,protein_coding,7,1,28299321,28825894,p15.1,cAMP responsive element binding protein 5 [Source:HGNC Symbol;Acc:HGNC:16844],NA,CREB5,9586,NM_001011666;NM_004904;NM_182898;NM_182899
PTPRA_SIG,PTPRA,PTPRA_SIG,PTPRA,SIG,31,4.88695670243863,0.280903457682128,0.27342033314049,0.305490866890369,0.0320705337498796,6.53147584237501e-06,2.5844481156568,6.88116864070285,6.85445003037174,6.9689583603622,0.114508329990461,0.0292042257491753,ENSG00000132670,PTPRA,protein_coding,20,1,2864184,3039076,p13,protein tyrosine phosphatase, receptor type A [Source:HGNC Symbol;Acc:HGNC:9664],NA,PTPRA,5786,NM_002836;NM_080840;NM_080841
ZRANB2_SIG,ZRANB2,ZRANB2_SIG,ZRANB2,SIG,172,4.88469689345878,0.179326467724496,0.167492683264999,0.218208902377129,0.0507162191121302,6.59766939612769e-06,3.91147491274813,6.82480962390942,6.77002318007387,7.00482222508334,0.23479904500947,0.000752220328776105,ENSG00000132485,ZRANB2,protein_coding,1,-1,71063291,71081289,p31.1,zinc finger RANBP2-type containing 2 [Source:HGNC Symbol;Acc:HGNC:13058],NA,ZRANB2,9406,NM_005455;NM_203350
ZNF704_TF,ZNF704,ZNF704_TF,ZNF704,TF,154,-4.88466715916146,-0.0659670479188125,-0.061642469347368,-0.0801763775107014,-0.0185339081633333,6.59766939612769e-06,-4.93312853487691,2.49819646335182,2.72976137404171,1.7373403282279,-0.992421045813806,1.86293895357403e-05,ENSG00000164684,ZNF704,protein_coding,8,-1,80628451,80874781,q21.13,zinc finger protein 704 [Source:HGNC Symbol;Acc:HGNC:32291],NA,ZNF704,619279,NM_001033723;NM_001367783
RUNX2_TF,RUNX2,RUNX2_TF,RUNX2,TF,105,4.88414786075682,0.0836409849927872,0.0773632961566969,0.104267676882798,0.0269043807261014,6.60918005539148e-06,1.9125423045258,6.53787785314488,6.49097665719733,6.6919817826868,0.201005125489465,0.113811123903244,ENSG00000124813,RUNX2,protein_coding,6,1,45328157,45664349,p21.1,runt related transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:10472],CLEIDOCRANIAL DYSPLASIA;Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome;METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY,RUNX2,860,NM_001015051;NM_001024630;NM_001278478
JAZF1_TF,JAZF1,JAZF1_TF,JAZF1,TF,295,-4.88402096693516,0.126457296697024,0.145938660114198,0.0624471026120243,-0.0834915575021741,6.60918005539148e-06,-3.78118537975349,4.18344293711082,4.32202888871833,3.72808909611474,-0.593939792603589,0.00114172849830516,ENSG00000153814,JAZF1,protein_coding,7,-1,27830573,28180795,p15.1,JAZF zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:28917],Endometrial stromal sarcoma;Systemic lupus erythematosus,JAZF1,221895,NM_175061
TARDBP_TF,TARDBP,TARDBP_TF,TARDBP,TF,88,4.88272679685162,0.411458640391182,0.404081816228182,0.435696776926752,0.0316149606985697,6.64761903710534e-06,2.6527972293024,7.32512222299443,7.29458676733893,7.42545300586251,0.130866238523582,0.0249081527373872,ENSG00000120948,TARDBP,protein_coding,1,1,11012344,11026420,p36.22,TAR DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11571],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;Frontotemporal dementia with motor neuron disease,TARDBP,23435,NM_007375
GATA2_TF,GATA2,GATA2_TF,GATA2,TF,173,4.88234223662425,0.0688414391685066,0.0548393783812436,0.114848210326657,0.060008831945413,6.65549634001719e-06,3.89225257028024,6.2515498656803,6.04732495546514,6.92257457067295,0.875249615207801,0.000802022600286991,ENSG00000179348,GATA2,protein_coding,3,-1,128479427,128493185,q21.3,GATA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4171],Deafness-lymphedema-leukemia syndrome;Emberger syndrome;IMMUNODEFICIENCY 21;Inherited acute myeloid leukemia;LEUKEMIA ACUTE MYELOID;LYMPHEDEMA PRIMARY WITH MYELODYSPLASIA;Monocytopenia with susceptibility to infections;MYELODYSPLASTIC SYNDROME,GATA2,2624,NM_001145661;NM_001145662;NM_032638
EIF4A2_SIG,EIF4A2,EIF4A2_SIG,EIF4A2,SIG,28,4.88098920596289,0.127106841955196,0.118735617444804,0.154612293917915,0.0358766764731111,6.69619710514749e-06,3.33671715714118,8.71464234310354,8.67800689899534,8.83501594517331,0.157009046177965,0.00433461215352824,ENSG00000156976,EIF4A2,protein_coding,3,1,186783205,186789897,q27.3,eukaryotic translation initiation factor 4A2 [Source:HGNC Symbol;Acc:HGNC:3284],NA,EIF4A2,1974,NM_001967
ALDH5A1_SIG,ALDH5A1,ALDH5A1_SIG,ALDH5A1,SIG,93,4.88079905983141,0.221309024087113,0.205062373453089,0.274690876170336,0.069628502717247,6.69752909600545e-06,4.02367314569478,4.65628518265078,4.52745384648038,5.07958814435353,0.552134297873152,0.000526136419155072,ENSG00000112294,ALDH5A1,protein_coding,6,1,24494852,24537207,p22.3,aldehyde dehydrogenase 5 family member A1 [Source:HGNC Symbol;Acc:HGNC:408],Succinate-semialdehyde dehydrogenase deficiency;SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY,ALDH5A1,7915,NM_001080;NM_170740
MARCO_SIG,MARCO,MARCO_SIG,MARCO,SIG,9,-4.88008489511357,0.45740479600472,0.520655965904923,0.249579523475483,-0.27107644242944,6.71366857220003e-06,-5.50089890473611,2.11233625721948,2.36893514406548,1.26922562901119,-1.09970951505429,1.59562856231461e-06,ENSG00000019169,MARCO,protein_coding,2,1,118942166,118994660,q14.2,macrophage receptor with collagenous structure [Source:HGNC Symbol;Acc:HGNC:6895],NA,MARCO,8685,NM_006770
ITGAM_SIG,ITGAM,ITGAM_SIG,ITGAM,SIG,24,-4.88002288279655,0.621296892305902,0.659456023485729,0.495916889857896,-0.163539133627833,6.71366857220003e-06,-3.86584068912337,7.70191253252955,7.86733605248723,7.15837810981148,-0.708957942675744,0.000875119442662847,ENSG00000169896,ITGAM,protein_coding,16,1,31259967,31332892,p11.2,integrin subunit alpha M [Source:HGNC Symbol;Acc:HGNC:6149],Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 6,ITGAM,3684,NM_000632;NM_001145808
ZNF385C_TF,ZNF385C,ZNF385C_TF,ZNF385C,TF,80,4.87959686603944,0.0467152151941081,0.0369885386219252,0.078674295359852,0.0416857567379268,6.72305003664144e-06,0.869197800095553,2.39039403048371,2.36120675820441,2.48629506797284,0.125088309768432,0.498314621841969,ENSG00000187595,ZNF385C,protein_coding,17,-1,42025576,42098479,q21.2,zinc finger protein 385C [Source:HGNC Symbol;Acc:HGNC:33722],NA,ZNF385C,201181,NM_001242704
GOLGB1_SIG,GOLGB1,GOLGB1_SIG,GOLGB1,SIG,48,4.87942017014896,0.409903404676934,0.402076296362936,0.435621046280069,0.0335447499171328,6.72394282478609e-06,4.67989402118026,7.36163493211309,7.30440336486971,7.54968151019849,0.245278145328775,5.05767733611894e-05,ENSG00000173230,GOLGB1,protein_coding,3,-1,121663199,121749767,q13.33,golgin B1 [Source:HGNC Symbol;Acc:HGNC:4429],NA,GOLGB1,2804,NM_001256486;NM_001256487;NM_001256488;NM_001366282;NM_001366283;NM_001366284;NM_004487
CYBA_SIG,CYBA,CYBA_SIG,CYBA,SIG,34,-4.87897794006194,0.349216403955165,0.364050785969465,0.300474863051036,-0.0635759229184289,6.73389828014153e-06,-2.50897026857304,8.06553351742209,8.10621747525778,7.931857655962,-0.17435981929578,0.034603777909283,ENSG00000051523,CYBA,protein_coding,16,-1,88643289,88651054,q24.2,cytochrome b-245 alpha chain [Source:HGNC Symbol;Acc:HGNC:2577],Chronic granulomatous disease;Granulomatous disease chronic autosomal recessive cytochrome b-negative,CYBA,1535,NM_000101
ZBTB18_SIG,ZBTB18,ZBTB18_SIG,ZBTB18,SIG,16,-4.87686427669051,0.360101540337258,0.370713031065634,0.325235213658309,-0.0454778174073247,6.80124314426583e-06,-3.50762698519973,5.56072092384703,5.62566382358084,5.34733711043591,-0.278326713144939,0.00264407730282088,ENSG00000179456,ZBTB18,protein_coding,1,1,244048939,244057476,q44,zinc finger and BTB domain containing 18 [Source:HGNC Symbol;Acc:HGNC:13030],Distal monosomy 1q;Mental retardation autosomal dominant 22;ZBTB18 syndrome,ZBTB18,10472,NM_001278196;NM_006352;NM_205768
DNPEP_SIG,DNPEP,DNPEP_SIG,DNPEP,SIG,47,4.87616838652577,0.310709660238652,0.300824871335015,0.343188252350603,0.0423633810155879,6.81661067968101e-06,3.44193859597352,5.3333156808403,5.2904719153528,5.47408805315636,0.18361613780356,0.00318362738404378,ENSG00000123992,DNPEP,protein_coding,2,-1,219373527,219400022,q35,aspartyl aminopeptidase [Source:HGNC Symbol;Acc:HGNC:2981],NA,DNPEP,23549,NM_001319116;NM_001319117;NM_001319118;NM_001319119;NM_001319120;NM_001319121;NM_001319122;NM_012100
KLHL42_SIG,KLHL42,KLHL42_SIG,KLHL42,SIG,28,4.87611846125426,0.296279804319332,0.280070025463307,0.349540506274846,0.0694704808115391,6.81661067968101e-06,3.15746927354997,5.17347492765243,5.11911556406696,5.35208426514753,0.232968701080568,0.00710861769998065,ENSG00000087448,KLHL42,protein_coding,12,1,27780048,27803040,p11.22,kelch like family member 42 [Source:HGNC Symbol;Acc:HGNC:29252],NA,KLHL42,57542,NM_020782
DUSP16_SIG,DUSP16,DUSP16_SIG,DUSP16,SIG,21,-4.87596844746906,0.160639941651475,0.178272206071612,0.10270535855674,-0.075566847514872,6.81661067968101e-06,-5.10926365080544,2.93209740402998,3.08404904495533,2.43282772670384,-0.651221318251492,9.12962803856059e-06,ENSG00000111266,DUSP16,protein_coding,12,-1,12474210,12562383,p13.2,dual specificity phosphatase 16 [Source:HGNC Symbol;Acc:HGNC:17909],NA,DUSP16,80824,NM_030640
ZRANB3_SIG,ZRANB3,ZRANB3_SIG,ZRANB3,SIG,79,4.87488691789165,0.325662383613149,0.30940355209116,0.379084258613968,0.0696807065228078,6.84885796048387e-06,4.65364041338981,3.19202408176565,3.10628092716031,3.47375158975462,0.367470662594308,5.57881975595228e-05,ENSG00000121988,ZRANB3,protein_coding,2,-1,135136916,135531218,q21.3,zinc finger RANBP2-type containing 3 [Source:HGNC Symbol;Acc:HGNC:25249],NA,ZRANB3,84083,NM_001286568;NM_001286569;NM_032143
IL10_SIG,IL10,IL10_SIG,IL10,SIG,20,-4.87402020289906,0.114966564462185,0.132891057159225,0.0560718027433418,-0.0768192544158829,6.87377155686217e-06,-2.6764129294403,1.03837637707593,1.11571755599359,0.784255360632182,-0.331462195361407,0.0236654092557125,ENSG00000136634,IL10,protein_coding,1,-1,206767602,206772494,q32.1,interleukin 10 [Source:HGNC Symbol;Acc:HGNC:5962],Behcet disease;GRAFT-VERSUS-HOST DISEASE SUSCEPTIBILITY TO;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome;Rheumatoid arthritis;Systemic lupus erythematosus,IL10,3586,NM_000572
FPGS_SIG,FPGS,FPGS_SIG,FPGS,SIG,35,4.87352368131824,0.239248071735323,0.224871105355614,0.286486675554367,0.0616155701987527,6.88585382213581e-06,4.05750069370699,6.22518522855071,6.1565290228432,6.4507699044468,0.294240881603598,0.000469233844410395,ENSG00000136877,FPGS,protein_coding,9,1,127794597,127814327,q34.11,folylpolyglutamate synthase [Source:HGNC Symbol;Acc:HGNC:3824],NA,FPGS,2356,NM_001018078;NM_001288803;NM_004957
ACIN1_SIG,ACIN1,ACIN1_SIG,ACIN1,SIG,31,4.87233708815009,0.523114514849134,0.515049772796352,0.549612953022558,0.0345631802262061,6.92210420707395e-06,4.46573902607111,8.20963152370624,8.17143447641554,8.3351361076614,0.163701631245853,0.000112413870540757,ENSG00000100813,ACIN1,protein_coding,14,-1,23058564,23095614,q11.2,apoptotic chromatin condensation inducer 1 [Source:HGNC Symbol;Acc:HGNC:17066],NA,ACIN1,22985,NM_001164814;NM_001164815;NM_001164816;NM_001164817;NM_014977
ZNF792_TF,ZNF792,ZNF792_TF,ZNF792,TF,152,4.87173837227144,0.223587133907523,0.208643880003571,0.272686396734796,0.064042516731225,6.93786228515739e-06,4.26536504013951,4.03564723700872,3.92436287451609,4.40129585662738,0.476932982111298,0.00022891554725302,ENSG00000180884,ZNF792,protein_coding,19,-1,34956354,34964229,q13.11,zinc finger protein 792 [Source:HGNC Symbol;Acc:HGNC:24751],NA,ZNF792,126375,NM_175872
EPOR_SIG,EPOR,EPOR_SIG,EPOR,SIG,37,-4.87071538113691,-0.0416936942541403,-0.0249619325669298,-0.0966694826549749,-0.0717075500880451,6.96860734552788e-06,-3.77487170090384,2.98715741028904,3.10886501582913,2.58726099208586,-0.521604023743277,0.00116221667416675,ENSG00000187266,EPOR,protein_coding,19,-1,11377207,11384342,p13.2,erythropoietin receptor [Source:HGNC Symbol;Acc:HGNC:3416],ERYTHROCYTOSIS FAMILIAL 1;Primary familial polycythemia,EPOR,2057,NM_000121
FZD9_SIG,FZD9,FZD9_SIG,FZD9,SIG,12,-4.86851082223416,-0.0127138498811554,-0.00219070265691784,-0.0472899050465073,-0.0450992023895894,7.04145882099887e-06,-1.58734732294884,0.211710033801002,0.225327848187151,0.166965786532226,-0.058362061654925,0.194254450154196,ENSG00000188763,FZD9,protein_coding,7,1,73433783,73436120,q11.23,frizzled class receptor 9 [Source:HGNC Symbol;Acc:HGNC:4047],NA,FZD9,8326,NM_003508
ZNF830_TF,ZNF830,ZNF830_TF,ZNF830,TF,49,4.86814192151947,0.219073109432329,0.209667113147074,0.24997852579817,0.0403114126510961,7.04617977226577e-06,5.48047495037742,4.04498281663152,3.9543535711285,4.34276462328428,0.388411052155773,1.75174067777473e-06,ENSG00000198783,ZNF830,protein_coding,17,1,34961540,34963777,q12,zinc finger protein 830 [Source:HGNC Symbol;Acc:HGNC:28291],NA,ZNF830,91603,NM_052857
KCNIP1_SIG,KCNIP1,KCNIP1_SIG,KCNIP1,SIG,29,4.86807976598277,-0.0891073331616251,-0.0986986290376282,-0.0575930752833293,0.041105553754299,7.04617977226577e-06,1.32934701536502,0.303802037695528,0.279447288651907,0.383824784553139,0.104377495901233,0.283271186465211,ENSG00000182132,KCNIP1,protein_coding,5,1,170353487,170736632,q35.1,potassium voltage-gated channel interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:15521],NA,KCNIP1,30820,NM_001034837;NM_001034838;NM_001278339;NM_001278340;NM_014592
ZNF541_TF,ZNF541,ZNF541_TF,ZNF541,TF,83,-4.86753847342003,-0.0929489746414495,-0.0893255438013551,-0.104854533116046,-0.0155289893146907,7.06017201034233e-06,-0.320006885241342,0.325524053373539,0.329536445233491,0.312340480119411,-0.0171959651140798,0.815917119151848,ENSG00000118156,ZNF541,protein_coding,19,-1,47520685,47555856,q13.33,zinc finger protein 541 [Source:HGNC Symbol;Acc:HGNC:25294],NA,ZNF541,84215,NM_001277075
FTO_SIG,FTO,FTO_SIG,FTO,SIG,37,4.8645583004819,0.177446059818744,0.163327506048324,0.223835593635838,0.0605080875875142,7.16197928715722e-06,4.55358339105869,4.68908869358295,4.54245741196498,5.17087719032774,0.628419778362758,8.18411530709312e-05,ENSG00000140718,FTO,protein_coding,16,1,53701692,54158512,q12.2,FTO, alpha-ketoglutarate dependent dioxygenase [Source:HGNC Symbol;Acc:HGNC:24678],BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14;GROWTH RETARDATION DEVELOPMENTAL DELAY AND FACIAL DYSMORPHISM;GROWTH RETARDATION DEVELOPMENTAL DELAY COARSE FACIES AND EARLY DEATH;Lethal polymalformative syndrome Boissel type,FTO,79068,NM_001080432
CD47_SIG,CD47,CD47_SIG,CD47,SIG,47,4.86334472499241,0.228120905039697,0.215019126737165,0.271169605176588,0.0561504784394235,7.20062419044241e-06,3.2839955803909,7.58166321428103,7.52251520238044,7.7760066819544,0.253491479573963,0.00502794412721532,ENSG00000196776,CD47,protein_coding,3,-1,108043091,108091862,q13.12,CD47 molecule [Source:HGNC Symbol;Acc:HGNC:1682],NA,CD47,961,NM_001777;NM_198793
PTGES2_SIG,PTGES2,PTGES2_SIG,PTGES2,SIG,10,4.86233570547044,0.190900358293081,0.180308601028404,0.225701846448448,0.045393245420044,7.23199190419309e-06,4.18486421883246,4.58773453195851,4.53520821543196,4.76032100054576,0.225112785113802,0.000304212515357219,ENSG00000148334,PTGES2,protein_coding,9,-1,128120693,128128462,q34.11,prostaglandin E synthase 2 [Source:HGNC Symbol;Acc:HGNC:17822],NA,PTGES2,80142,NM_001256335;NM_025072;NM_198938
ZC3H8_SIG,ZC3H8,ZC3H8_SIG,ZC3H8,SIG,75,4.86120059928301,0.240469565539109,0.224242292756946,0.293787747537647,0.0695454547807017,7.26812185525835e-06,4.26738369853176,4.21359279132254,4.14190930924202,4.44912423244424,0.307214923202217,0.000227311269055312,ENSG00000144161,ZC3H8,protein_coding,2,-1,112211529,112255136,q14.1,zinc finger CCCH-type containing 8 [Source:HGNC Symbol;Acc:HGNC:30941],NA,ZC3H8,84524,NM_032494
NDUFC2_SIG,NDUFC2,NDUFC2_SIG,NDUFC2,SIG,6,4.86088476033965,0.299621787620905,0.286955431386264,0.341239815249011,0.0542843838627475,7.27425934581665e-06,4.63443312323399,3.12728110619162,3.05594062257075,3.36168555237448,0.305744929803725,5.9968808675729e-05,ENSG00000151366,NDUFC2,protein_coding,11,-1,78068297,78079862,q14.1,NADH:ubiquinone oxidoreductase subunit C2 [Source:HGNC Symbol;Acc:HGNC:7706],NA,NDUFC2,4718,NM_001204054;NM_001204055;NM_004549
MTMR2_SIG,MTMR2,MTMR2_SIG,MTMR2,SIG,63,4.85854196592915,0.34005395226392,0.329278406320548,0.37545931750643,0.0461809111858821,7.35532262691077e-06,2.80389355738454,5.10655266072054,5.05616968474974,5.27209672462461,0.215927039874861,0.0175365828649393,ENSG00000087053,MTMR2,protein_coding,11,-1,95832882,95925315,q21,myotubularin related protein 2 [Source:HGNC Symbol;Acc:HGNC:7450],CHARCOT-MARIE-TOOTH DISEASE TYPE 4B1,MTMR2,8898,NM_001243571;NM_016156;NM_201278;NM_201281
NFATC1_TF,NFATC1,NFATC1_TF,NFATC1,TF,130,4.85368215586318,0.0950954227767992,0.0903230985995391,0.110775916502082,0.0204528179025429,7.53232173717614e-06,3.27980461441145,5.09132554745563,5.01860290170551,5.33027138349172,0.311668481786212,0.0050885558624317,ENSG00000131196,NFATC1,protein_coding,18,1,79395856,79529325,q23,nuclear factor of activated T cells 1 [Source:HGNC Symbol;Acc:HGNC:7775],NA,NFATC1,4772,NM_001278669;NM_001278670;NM_001278672;NM_001278673;NM_001278675;NM_006162;NM_172387;NM_172388;NM_172389;NM_172390
PHYHD1_SIG,PHYHD1,PHYHD1_SIG,PHYHD1,SIG,37,4.85323160642993,-0.0414633901578091,-0.0520640367529205,-0.00663269420244294,0.0454313425504776,7.54380263776844e-06,2.6560929495611,1.14505536522463,1.08986147569166,1.32640671654728,0.23654524085562,0.0247437837126992,ENSG00000175287,PHYHD1,protein_coding,9,1,128920966,128942041,q34.11,phytanoyl-CoA dioxygenase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23396],NA,PHYHD1,254295,NM_001100876;NM_001100877;NM_174933
KDSR_SIG,KDSR,KDSR_SIG,KDSR,SIG,51,4.85216265907444,0.372072548161724,0.361389993548934,0.40717237046089,0.0457823769119565,7.57890671721179e-06,3.81231228008513,4.86577724854036,4.79931095750512,5.08416649051328,0.284855533008165,0.00103592531486345,ENSG00000119537,KDSR,protein_coding,18,-1,63327726,63367510,q21.33,3-ketodihydrosphingosine reductase [Source:HGNC Symbol;Acc:HGNC:4021],Erythrokeratodermia variabilis;ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4;Progressive symmetric erythrokeratodermia,KDSR,2531,NM_002035
TRMT44_SIG,TRMT44,TRMT44_SIG,TRMT44,SIG,55,4.85176464984343,0.35351889606937,0.340257588779408,0.397091762879243,0.0568341740998356,7.58845114112855e-06,3.6926739562062,3.76509440846164,3.71159955612539,3.94086320899505,0.229263652869664,0.00150377544585531,ENSG00000155275,TRMT44,protein_coding,4,1,8436140,8493531,p16.1,tRNA methyltransferase 44 homolog [Source:HGNC Symbol;Acc:HGNC:26653],NA,TRMT44,152992,NM_001350233;NM_152544
PHKB_SIG,PHKB,PHKB_SIG,PHKB,SIG,21,4.85012377284458,0.399426908693863,0.38467954687754,0.447882526090354,0.0632029792128138,7.64577581063778e-06,2.36858716192332,6.65350850805098,6.61692286055589,6.77371849267768,0.15679563212179,0.0468714264100275,ENSG00000102893,PHKB,protein_coding,16,1,47461123,47701523,q12.1,phosphorylase kinase regulatory subunit beta [Source:HGNC Symbol;Acc:HGNC:8927],Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency;GLYCOGEN STORAGE DISEASE IXb,PHKB,5257,NM_000293;NM_001031835;NM_001363837
ZNF678_TF,ZNF678,ZNF678_TF,ZNF678,TF,47,4.84993138991037,0.0890319894103631,0.0775888563948147,0.126630855032879,0.0490419986380644,7.64747524622055e-06,3.52885962280893,3.83979311516302,3.7720548963954,4.0623615482566,0.290306651861193,0.00247819127925287,ENSG00000181450,ZNF678,protein_coding,1,1,227563543,227677443,q42.13,zinc finger protein 678 [Source:HGNC Symbol;Acc:HGNC:28652],NA,ZNF678,339500,NM_001367909;NM_001367910;NM_001367911;NM_178549
ITPR3_SIG,ITPR3,ITPR3_SIG,ITPR3,SIG,38,-4.84907503800331,-0.0199929704018247,-0.00413804218473325,-0.0720877345436964,-0.0679496923589631,7.67113724930721e-06,-2.38146456523549,4.28916555649358,4.37544617893166,4.00567208276844,-0.369774096163222,0.0456315271399721,ENSG00000096433,ITPR3,protein_coding,6,1,33620365,33696574,p21.31,inositol 1,4,5-trisphosphate receptor type 3 [Source:HGNC Symbol;Acc:HGNC:6182],DIABETES MELLITUS INSULIN-DEPENDENT,ITPR3,3710,NM_002224
YY2_TF,YY2,YY2_TF,YY2,TF,18,4.84902225612084,0.315168634799498,0.306231297541222,0.344534171505262,0.03830287396404,7.67113724930721e-06,2.89640978202247,0.819937158704553,0.795892411844171,0.898941326960091,0.10304891511592,0.0140049305597186,ENSG00000230797,YY2,protein_coding,X,1,21855987,21858727,p22.12,YY2 transcription factor [Source:HGNC Symbol;Acc:HGNC:31684],NA,YY2,404281,NM_206923
MYO18A_SIG,MYO18A,MYO18A_SIG,MYO18A,SIG,60,4.8486445646054,0.174639403109584,0.160067502552744,0.222518504939199,0.0624510023864548,7.68002348644825e-06,3.13719061820334,7.41125752517679,7.34633529028843,7.62457343980996,0.278238149521534,0.00751577388584587,ENSG00000196535,MYO18A,protein_coding,17,-1,29071124,29180412,q11.2,myosin XVIIIA [Source:HGNC Symbol;Acc:HGNC:31104],NA,MYO18A,399687,NM_001346765;NM_001346766;NM_001346767;NM_001346768;NM_078471;NM_203318
NTN1_SIG,NTN1,NTN1_SIG,NTN1,SIG,35,4.84775457140866,0.0493653044936145,0.0315071335323649,0.10804215193772,0.0765350184053553,7.70880015829975e-06,2.96003583031289,2.2341334937483,2.10823629750124,2.64779570998864,0.539559412487399,0.0119387079514252,ENSG00000065320,NTN1,protein_coding,17,1,9021510,9244000,p13.1,netrin 1 [Source:HGNC Symbol;Acc:HGNC:8029],Familial congenital mirror movements,NTN1,9423,NM_004822
PCGF2_TF,PCGF2,PCGF2_TF,PCGF2,TF,100,-4.84741604554498,-0.0409681085593224,-0.0319119716016711,-0.0707239871344622,-0.038812015532791,7.71621203844388e-06,-2.93319873766627,0.588899853660843,0.647667946035441,0.395804693001453,-0.251863253033988,0.0127777915262311,ENSG00000277258,PCGF2,protein_coding,17,-1,38733898,38749817,q12,polycomb group ring finger 2 [Source:HGNC Symbol;Acc:HGNC:12929],Intellectual dusbility,PCGF2,7703,NM_007144
RAPH1_SIG,RAPH1,RAPH1_SIG,RAPH1,SIG,34,-4.84645622763507,0.100741059626688,0.134156535634961,-0.00905264725763905,-0.1432091828926,7.74784983849104e-06,-3.56331590742894,1.66102166048613,1.79061883824709,1.23520236212872,-0.555416476118367,0.00223487409020341,ENSG00000173166,RAPH1,protein_coding,2,-1,203394345,203535335,q33.2,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 [Source:HGNC Symbol;Acc:HGNC:14436],NA,RAPH1,65059,NM_001329728;NM_203365;NM_213589
ITPKA_SIG,ITPKA,ITPKA_SIG,ITPKA,SIG,32,4.84587699117564,0.021934556857061,0.0110563025512776,0.0576773924332064,0.0466210898819289,7.76471450857621e-06,1.8556550409337,1.30349686140875,1.26000790366554,1.44638915113643,0.186381247470894,0.125657812673236,ENSG00000137825,ITPKA,protein_coding,15,1,41493393,41503551,q15.1,inositol-trisphosphate 3-kinase A [Source:HGNC Symbol;Acc:HGNC:6178],NA,ITPKA,3706,NM_002220
CHD9_SIG,CHD9,CHD9_SIG,CHD9,SIG,107,4.84568081541001,0.30117835389455,0.290659288726057,0.335740996591027,0.04508170786497,7.76661716556918e-06,3.44601980529673,7.07637020032963,7.02639021327217,7.24059015780414,0.214199944531978,0.00315267341142144,ENSG00000177200,CHD9,protein_coding,16,1,53055033,53329150,q12.2,chromodomain helicase DNA binding protein 9 [Source:HGNC Symbol;Acc:HGNC:25701],NA,CHD9,80205,NM_001308319;NM_001352127;NM_001352156;NM_001352157;NM_001352158;NM_025134
DHRS12_SIG,DHRS12,DHRS12_SIG,DHRS12,SIG,31,4.84422070212475,0.0983860845181522,0.0903838480171581,0.124679147307133,0.0342952992899749,7.8181356866157e-06,3.48735325573666,3.06074725945995,3.00317319074488,3.24991919952376,0.246746008778886,0.00280123079259568,ENSG00000102796,DHRS12,protein_coding,13,-1,51767993,51804162,q14.3,dehydrogenase/reductase 12 [Source:HGNC Symbol;Acc:HGNC:25832],NA,DHRS12,79758,NM_001031719;NM_001270424;NM_024705
PTGER2_SIG,PTGER2,PTGER2_SIG,PTGER2,SIG,12,-4.84369957472058,0.310593683139781,0.317791554818273,0.286943533339023,-0.0308480214792494,7.83286426553128e-06,-5.14518896894246,5.89635576636518,6.0387229412317,5.42857790608948,-0.610145035142212,7.91598698861568e-06,ENSG00000125384,PTGER2,protein_coding,14,1,52314305,52328598,q22.1,prostaglandin E receptor 2 [Source:HGNC Symbol;Acc:HGNC:9594],ASTHMA NASAL POLYPS AND ASPIRIN INTOLERANCE,PTGER2,5732,NM_000956
MTMR3_SIG,MTMR3,MTMR3_SIG,MTMR3,SIG,60,-4.84339829935825,0.243441699984557,0.26091235862223,0.186038107317919,-0.0748742513043107,7.83702206269765e-06,-3.889771382537,7.14653606019663,7.21351365148569,6.92646683167541,-0.28704681981028,0.000808836915567518,ENSG00000100330,MTMR3,protein_coding,22,1,29883155,30030866,q12.2,myotubularin related protein 3 [Source:HGNC Symbol;Acc:HGNC:7451],NA,MTMR3,8897,NM_021090;NM_153050;NM_153051
C4B_SIG,C4B,C4B_SIG,C4B,SIG,11,-4.84329974334787,-0.21973294632,-0.210872403596312,-0.248846158126402,-0.0379737545300893,7.83702206269765e-06,-1.91179623443962,0.9267847738254,0.955928569524144,0.831026587958098,-0.124901981566046,0.113955335497553,ENSG00000224389,C4B,protein_coding,6,1,32014795,32035418,p21.33,complement C4B (Chido blood group) [Source:HGNC Symbol;Acc:HGNC:1324],COMPLEMENT COMPONENT 4B DEFICIENCY;Immunodeficiency due to a classical component pathway complement deficiency;Systemic lupus erythematosus,C4B,721,NM_001002029
GSPT2_SIG,GSPT2,GSPT2_SIG,GSPT2,SIG,32,4.84279945257331,0.0435659720045075,0.0360103271310234,0.068391662303098,0.0323813351720745,7.85097188959907e-06,1.64939860109968,3.16230657717557,3.11861508350137,3.30586434210511,0.187249258603744,0.176595915067394,ENSG00000189369,GSPT2,protein_coding,X,1,51743431,51746232,p11.22,G1 to S phase transition 2 [Source:HGNC Symbol;Acc:HGNC:4622],XL Intellectual disability,GSPT2,23708,NM_018094
IL10RA_SIG,IL10RA,IL10RA_SIG,IL10RA,SIG,53,-4.84157430512029,0.163149211527469,0.185513343872228,0.0896670623946904,-0.0958462814775381,7.8936985704714e-06,-4.26786689423247,6.69053559900112,6.86665239024886,6.11186614204427,-0.754786248204591,0.000227059113366616,ENSG00000110324,IL10RA,protein_coding,11,1,117986348,118003037,q23.3,interleukin 10 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:5964],Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome;INFLAMMATORY BOWEL DISEASE 28 AUTOSOMAL RECESSIVE,IL10RA,3587,NM_001558
SRRM5_TF,SRRM5,SRRM5_TF,SRRM5,TF,82,4.84111818410232,0.051886281255441,0.0466306783555758,0.0691546907835694,0.0225240124279936,7.90599362305004e-06,4.77141512082184,0.986488213535864,0.922823580641663,1.1956720073311,0.272848426689434,3.57374766893819e-05,ENSG00000226763,SRRM5,protein_coding,19,1,43596617,43614497,q13.31,serine/arginine repetitive matrix 5 [Source:HGNC Symbol;Acc:HGNC:37248],NA,SRRM5,100170229,NM_001145641
WDR75_SIG,WDR75,WDR75_SIG,WDR75,SIG,50,4.84020068179378,0.37793286599429,0.3690678046703,0.407060924630257,0.0379931199599575,7.93671670396256e-06,4.32992601289282,5.38859894497788,5.33117241158025,5.57728612614152,0.246113714561271,0.000183730006508233,ENSG00000115368,WDR75,protein_coding,2,1,189441446,189475552,q32.2,WD repeat domain 75 [Source:HGNC Symbol;Acc:HGNC:25725],NA,WDR75,84128,NM_001303096;NM_032168
CASP6_SIG,CASP6,CASP6_SIG,CASP6,SIG,46,4.83966397303502,0.213902372873665,0.197524433273966,0.267715602986962,0.0701911697129967,7.95230651464012e-06,3.98946046901083,4.0659450061745,3.96827242962856,4.38686918625401,0.41859675662545,0.000587549291427875,ENSG00000138794,CASP6,protein_coding,4,-1,109688622,109703583,q25,caspase 6 [Source:HGNC Symbol;Acc:HGNC:1507],NA,CASP6,839,NM_001226;NM_032992
NR1I2_TF,NR1I2,NR1I2_TF,NR1I2,TF,319,4.83895577241046,0.0925174609357282,0.0812730389801504,0.12946341878977,0.0481903798096191,7.97480650712487e-06,4.84990782345831,1.94008621720424,1.8033408320891,2.38939248258257,0.586051650493474,2.64517762234894e-05,ENSG00000144852,NR1I2,protein_coding,3,1,119780484,119818485,q13.33,nuclear receptor subfamily 1 group I member 2 [Source:HGNC Symbol;Acc:HGNC:7968],NA,NR1I2,8856,NM_003889;NM_022002;NM_033013
SLC11A1_SIG,SLC11A1,SLC11A1_SIG,SLC11A1,SIG,43,-4.83825136469768,0.403414937950348,0.448233956945425,0.256152446966527,-0.192081509978897,7.99721805624114e-06,-4.62622751850159,5.70109947809336,5.96895269981921,4.82101032099416,-1.14794237882505,6.21650885822935e-05,ENSG00000018280,SLC11A1,protein_coding,2,1,218382029,218396894,q35,solute carrier family 11 member 1 [Source:HGNC Symbol;Acc:HGNC:10907],BURULI ULCER SUSCEPTIBILITY TO;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED;Tuberculosis,SLC11A1,6556,NM_000578
S100A11_SIG,S100A11,S100A11_SIG,S100A11,SIG,54,-4.83721951279085,-0.0439843346439314,-0.0214621203028995,-0.117985896050179,-0.0965237757472797,8.03291106812644e-06,-4.58088023380862,6.24948806615694,6.43246491313351,5.64827842609105,-0.784186487042467,7.38927696773428e-05,ENSG00000163191,S100A11,protein_coding,1,-1,152032506,152047907,q21.3,S100 calcium binding protein A11 [Source:HGNC Symbol;Acc:HGNC:10488],NA,S100A11,6282,NM_005620
ZC3H8_TF,ZC3H8,ZC3H8_TF,ZC3H8,TF,84,4.83676694111087,0.293204102884846,0.2783780517142,0.341918271016969,0.063540219302769,8.04529019872819e-06,4.26738369853176,4.21359279132254,4.14190930924202,4.44912423244424,0.307214923202217,0.000227311269055312,ENSG00000144161,ZC3H8,protein_coding,2,-1,112211529,112255136,q14.1,zinc finger CCCH-type containing 8 [Source:HGNC Symbol;Acc:HGNC:30941],NA,ZC3H8,84524,NM_032494
GNAO1_SIG,GNAO1,GNAO1_SIG,GNAO1,SIG,15,-4.835791290279,-0.108166395782025,-0.0771533929456981,-0.210066262244241,-0.132912869298543,8.07891141563079e-06,-2.9512135581278,0.674012781256335,0.729929303766586,0.490287064436939,-0.239642239329647,0.0122021430434909,ENSG00000087258,GNAO1,protein_coding,16,1,56191489,56357444,q13,G protein subunit alpha o1 [Source:HGNC Symbol;Acc:HGNC:4389],Early infantile epileptic encephalopathy;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 17;NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS,GNAO1,2775,NM_020988;NM_138736
ZNF330_TF,ZNF330,ZNF330_TF,ZNF330,TF,36,4.8346071420343,0.250952102910588,0.245478848186022,0.268935654148448,0.0234568059624257,8.12117715998796e-06,2.06776065321113,5.02998758542456,5.01108061274875,5.09211049564507,0.0810298828963223,0.0854316708974567,ENSG00000109445,ZNF330,protein_coding,4,1,141220887,141234697,q31.21,zinc finger protein 330 [Source:HGNC Symbol;Acc:HGNC:15462],NA,ZNF330,27309,NM_001292002;NM_014487
ARSK_SIG,ARSK,ARSK_SIG,ARSK,SIG,39,4.83440611158214,0.216682547719497,0.195516397584362,0.286228469592084,0.0907120720077218,8.12341899831727e-06,4.79223396735338,2.1479735373774,2.05385899563076,2.45720703168778,0.403348036057016,3.28674244914951e-05,ENSG00000164291,ARSK,protein_coding,5,1,95555074,95605064,q15,arylsulfatase family member K [Source:HGNC Symbol;Acc:HGNC:25239],NA,ARSK,153642,NM_198150
TRIM25_TF,TRIM25,TRIM25_TF,TRIM25,TF,61,-4.83313422675796,0.0956873506358968,0.100258665111445,0.0806673173590956,-0.0195913477523495,8.16951462862595e-06,-3.99372537402482,7.26219042443601,7.3211550831891,7.0684494028187,-0.252705680370395,0.000580525567500451,ENSG00000121060,TRIM25,protein_coding,17,-1,56836387,56914080,q22,tripartite motif containing 25 [Source:HGNC Symbol;Acc:HGNC:12932],NA,TRIM25,7706,NM_005082
PLA2G12A_SIG,PLA2G12A,PLA2G12A_SIG,PLA2G12A,SIG,76,4.83229826472842,0.0622196689368875,0.0476243532124159,0.110175706317294,0.0625513531048781,8.1978889116638e-06,4.02897601136791,3.84269263678636,3.75879090595441,4.11836975237707,0.359578846422658,0.00051880428801659,ENSG00000123739,PLA2G12A,protein_coding,4,-1,109709989,109730070,q25,phospholipase A2 group XIIA [Source:HGNC Symbol;Acc:HGNC:18554],NA,PLA2G12A,81579,NM_030821
FGR_SIG,FGR,FGR_SIG,FGR,SIG,99,-4.83197327161151,0.576837798228438,0.613179136388963,0.457430544272425,-0.155748592116538,8.20527024097739e-06,-4.51589265123278,7.60172143708004,7.8092906714076,6.91970823857521,-0.889582432832386,9.32259273415248e-05,ENSG00000000938,FGR,protein_coding,1,-1,27612064,27635185,p35.3,FGR proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:3697],NA,FGR,2268,NM_001042729;NM_001042747;NM_005248
SLC51A_SIG,SLC51A,SLC51A_SIG,SLC51A,SIG,24,-4.8317392544401,0.147425818902754,0.185177552921446,0.0233844071270517,-0.161793145794394,8.20890904526284e-06,-3.49787274285453,0.984937849779736,1.07655004398779,0.683926354524717,-0.392623689463069,0.00272247256597596,ENSG00000163959,SLC51A,protein_coding,3,1,196211487,196243178,q29,solute carrier family 51 alpha subunit [Source:HGNC Symbol;Acc:HGNC:29955],NA,SLC51A,200931,NM_152672
CCR7_SIG,CCR7,CCR7_SIG,CCR7,SIG,15,-4.82928852495307,-0.0325125158033134,-0.00742919059189513,-0.114929155783688,-0.107499965191792,8.30450021806696e-06,-4.54309320894239,2.64769219251443,2.81972175501982,2.08245220142528,-0.737269553594532,8.49069627125738e-05,ENSG00000126353,CCR7,protein_coding,17,-1,40553769,40565472,q21.2,C-C motif chemokine receptor 7 [Source:HGNC Symbol;Acc:HGNC:1608],NA,CCR7,1236,NM_001301714;NM_001301716;NM_001301717;NM_001301718;NM_001838
ZNF107_TF,ZNF107,ZNF107_TF,ZNF107,TF,16,4.8282743257137,0.107657978995094,0.0983403029793342,0.138273200189735,0.0399328972104005,8.34079589673701e-06,3.06980466385949,5.04346170532797,4.97331411477262,5.27394664572413,0.300632530951514,0.00898393551962999,ENSG00000196247,ZNF107,protein_coding,7,1,64666083,64711582,q11.21,zinc finger protein 107 [Source:HGNC Symbol;Acc:HGNC:12887],NA,ZNF107,51427,NM_001013746;NM_001282359;NM_001282360;NM_016220
FPR2_SIG,FPR2,FPR2_SIG,FPR2,SIG,15,-4.826583793451,0.192518499493069,0.225322352261444,0.0847344118255534,-0.14058794043589,8.40573280914504e-06,-4.08298527626477,2.69657164821712,2.89575147677452,2.04212364009995,-0.853627836674569,0.000429142952124196,ENSG00000171049,FPR2,protein_coding,19,1,51752026,51770531,q13.41,formyl peptide receptor 2 [Source:HGNC Symbol;Acc:HGNC:3827],NA,FPR2,2358,NM_001005738;NM_001462
RBM47_SIG,RBM47,RBM47_SIG,RBM47,SIG,80,-4.82600774565241,0.375487409860803,0.415167846669542,0.245108831774944,-0.170059014894598,8.42391544547816e-06,-4.79244662948123,4.4848793060206,4.72541103864956,3.694560755954,-1.03085028269556,3.28674244914951e-05,ENSG00000163694,RBM47,protein_coding,4,-1,40423267,40630875,p14,RNA binding motif protein 47 [Source:HGNC Symbol;Acc:HGNC:30358],NA,RBM47,54502,NM_001098634;NM_019027
ECE1_SIG,ECE1,ECE1_SIG,ECE1,SIG,35,-4.82557981323162,0.150026872072107,0.168664637905561,0.0887884986193299,-0.0798761392862316,8.43586712166069e-06,-2.62862250869572,5.73184101037179,5.83993348674608,5.37668001657054,-0.463253470175541,0.0263187197792287,ENSG00000117298,ECE1,protein_coding,1,-1,21217247,21345572,p36.12,endothelin converting enzyme 1 [Source:HGNC Symbol;Acc:HGNC:3146],Hirschsprung disease;HIRSCHSPRUNG DISEASE CARDIAC DEFECTS AND AUTONOMIC DYSFUNCTION;HYPERTENSION ESSENTIAL,ECE1,1889,NM_001113347;NM_001113348;NM_001113349;NM_001397
ZC3HC1_SIG,ZC3HC1,ZC3HC1_SIG,ZC3HC1,SIG,33,4.82513263231298,0.296143489220323,0.283363145301749,0.33813604780992,0.0547729025081709,8.44865468716898e-06,5.16134150091627,3.40805140689964,3.33628951422571,3.6438404828283,0.30755096860259,7.43601936222239e-06,ENSG00000091732,ZC3HC1,protein_coding,7,-1,130018286,130051451,q32.2,zinc finger C3HC-type containing 1 [Source:HGNC Symbol;Acc:HGNC:29913],NA,ZC3HC1,51530,NM_001282190;NM_001282191;NM_001363701;NM_016478
DHCR24_SIG,DHCR24,DHCR24_SIG,DHCR24,SIG,22,4.82494469433536,0.136008392665038,0.127423079068652,0.164217280196021,0.0367942011273687,8.45046600962636e-06,2.96055255251497,4.34348433092871,4.21344203555354,4.77076615859,0.557324123036464,0.0119227514253281,ENSG00000116133,DHCR24,protein_coding,1,-1,54849627,54887195,p32.3,24-dehydrocholesterol reductase [Source:HGNC Symbol;Acc:HGNC:2859],DESMOSTEROLOSIS,DHCR24,1718,NM_014762
SMARCA2_SIG,SMARCA2,SMARCA2_SIG,SMARCA2,SIG,14,4.82364137090955,0.5794523730357,0.56664390488282,0.621537339823733,0.0548934349409133,8.49970895696198e-06,2.71614295794313,7.72387451500902,7.67746599813254,7.87635964188887,0.198893643756328,0.0215622794012427,ENSG00000080503,SMARCA2,protein_coding,9,1,1980290,2193624,p24.3,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [Source:HGNC Symbol;Acc:HGNC:11098],Coffin Siris;Intellectual disability-sparse hair-brachydactyly syndrome;NICOLAIDES-BARAITSER SYNDROME,SMARCA2,6595,NM_001289396;NM_001289397;NM_001289398;NM_001289399;NM_001289400;NM_003070;NM_139045
MAP3K9_SIG,MAP3K9,MAP3K9_SIG,MAP3K9,SIG,9,-4.82255450254119,-0.0577906663975604,-0.0354979265780839,-0.131038240090126,-0.095540313512042,8.5399541501253e-06,-1.57067323207967,1.59630711766458,1.63537057147267,1.467955769438,-0.16741480203467,0.199383971255438,ENSG00000006432,MAP3K9,protein_coding,14,-1,70722526,70809534,q24.2,mitogen-activated protein kinase kinase kinase 9 [Source:HGNC Symbol;Acc:HGNC:6861],NA,MAP3K9,4293,NM_001284230;NM_001284231;NM_001284232;NM_033141
HLA-E_SIG,HLA-E,HLA-E_SIG,HLA-E,SIG,54,-4.82192903632016,0.388532217949055,0.405591038160564,0.332481808682667,-0.0731092294778962,8.56055630640575e-06,-4.59212518231817,10.1482910143896,10.2390057349644,9.85022836107261,-0.388777373891783,7.05533920186512e-05,ENSG00000204592,HLA-E,protein_coding,6,1,30489509,30494194,p22.1,major histocompatibility complex, class I, E [Source:HGNC Symbol;Acc:HGNC:4962],NA,HLA-E,3133,NM_005516
ZSCAN29_TF,ZSCAN29,ZSCAN29_TF,ZSCAN29,TF,38,4.82178223857442,0.320908484296587,0.310143091487761,0.356280489239874,0.0461373977521128,8.56063863071674e-06,3.91748115363559,5.15517976258467,5.09495548034833,5.3530595470755,0.258104066727165,0.000737701375960759,ENSG00000140265,ZSCAN29,protein_coding,15,-1,43358172,43371025,q15.3,zinc finger and SCAN domain containing 29 [Source:HGNC Symbol;Acc:HGNC:26673],NA,ZSCAN29,146050,NM_152455
NPHP4_SIG,NPHP4,NPHP4_SIG,NPHP4,SIG,19,4.8209129954327,0.175329020531025,0.165330519107793,0.208181239493073,0.04285072038528,8.59179014975918e-06,4.43165548367919,4.15611539979465,4.09031487338499,4.37231712942642,0.282002256041427,0.000127304271040082,ENSG00000131697,NPHP4,protein_coding,1,-1,5862811,5992473,p36.31,nephrocystin 4 [Source:HGNC Symbol;Acc:HGNC:19104],Juvenile nephronophthisis;NEPHRONOPHTHISIS 4;NEPHRONOPHTHISIS TYPE 4;Senior-Loken syndrome;SENIOR-LOKEN SYNDROME 4,NPHP4,261734,NM_001291593;NM_001291594;NM_015102
ZNF345_TF,ZNF345,ZNF345_TF,ZNF345,TF,110,4.82007602521362,0.138129289364766,0.125675883657014,0.179047622404522,0.0533717387475085,8.61547441586858e-06,3.73920057619103,2.76417817333365,2.69993433209565,2.97526508025853,0.275330748162885,0.00130159188947204,ENSG00000251247,ZNF345,protein_coding,19,1,36850361,36913029,q13.12,zinc finger protein 345 [Source:HGNC Symbol;Acc:HGNC:16367],NA,ZNF345,25850,NM_001242472;NM_001242474;NM_001242475;NM_001242476;NM_003419
CHST15_SIG,CHST15,CHST15_SIG,CHST15,SIG,53,-4.82007455315117,0.421817673057053,0.467797732484156,0.270740334939429,-0.197057397544728,8.61547441586858e-06,-4.01723055715633,4.41613678634267,4.63870959834747,3.68482611832692,-0.953883480020552,0.000537482805292877,ENSG00000182022,CHST15,protein_coding,10,-1,124007668,124093598,q26.13,carbohydrate sulfotransferase 15 [Source:HGNC Symbol;Acc:HGNC:18137],NA,CHST15,51363,NM_001270764;NM_001270765;NM_014863;NM_015892
GRK6_SIG,GRK6,GRK6_SIG,GRK6,SIG,22,-4.81606367085078,0.441741020403944,0.459707815717665,0.382707264373146,-0.077000551344519,8.78400903853569e-06,-3.42104343156328,7.09542173934191,7.14638929195484,6.92795692361369,-0.21843236834115,0.00338707401666149,ENSG00000198055,GRK6,protein_coding,5,1,177403204,177442901,q35.3,G protein-coupled receptor kinase 6 [Source:HGNC Symbol;Acc:HGNC:4545],NA,GRK6,2870,NM_001004105;NM_001004106;NM_002082
NEIL1_SIG,NEIL1,NEIL1_SIG,NEIL1,SIG,24,-4.81549038495565,-0.000594619880379807,0.011688582499672,-0.0409537134148357,-0.0526422959145078,8.8028925078712e-06,-2.4753839928505,2.08876733101989,2.16542703462682,1.83688544773997,-0.328541586886847,0.0372663641042591,ENSG00000140398,NEIL1,protein_coding,15,1,75346955,75357114,q24.2,nei like DNA glycosylase 1 [Source:HGNC Symbol;Acc:HGNC:18448],NA,NEIL1,79661,NM_001256552;NM_001352520;NM_024608
GABPB1-AS1_TF,GABPB1-AS1,GABPB1-AS1_TF,GABPB1-AS1,TF,139,4.81438037708219,0.139026684731699,0.128566040623994,0.173397372514159,0.044831331890165,8.84555966011987e-06,3.04089408926819,4.48299195708746,4.41236996016904,4.71503566124799,0.302665701078949,0.00966921226483035,ENSG00000244879,GABPB1-AS1,antisense,15,1,50354959,50372202,q21.2,GABPB1 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:44157],NA,GABPB1-AS1,NA,NA
PRPF39_SIG,PRPF39,PRPF39_SIG,PRPF39,SIG,87,4.81331161109945,0.342750788174205,0.333012481040841,0.374748083040972,0.0417356020001312,8.88659277204571e-06,4.04183668183165,5.47723357286728,5.42865337169871,5.6368542338497,0.208200862150993,0.000495556974945244,ENSG00000185246,PRPF39,protein_coding,14,1,45084099,45116282,q21.2,pre-mRNA processing factor 39 [Source:HGNC Symbol;Acc:HGNC:20314],NA,PRPF39,55015,NM_017922
GNB2_SIG,GNB2,GNB2_SIG,GNB2,SIG,52,-4.81043430605536,0.244041687965459,0.255025301704099,0.20795267139564,-0.0470726303084593,9.00897722822421e-06,-3.66105935757909,7.25838564568768,7.31109970901819,7.08518229474458,-0.225917414273614,0.0016563884728625,ENSG00000172354,GNB2,protein_coding,7,1,100673567,100679174,q22.1,G protein subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:4398],NA,GNB2,2783,NM_005273
ACAD11_SIG,ACAD11,ACAD11_SIG,ACAD11,SIG,65,4.80947490645415,0.25195000930442,0.240886999435776,0.288299898872822,0.0474128994370459,9.04555662529499e-06,4.37050338274455,2.12015094166796,2.06248081952728,2.30963848584449,0.247157666317212,0.000158238369615991,ENSG00000240303,ACAD11,protein_coding,3,-1,132558138,132660082,q22.1,acyl-CoA dehydrogenase family member 11 [Source:HGNC Symbol;Acc:HGNC:30211],NA,ACAD11,84129,NM_032169
ADIPOR1_SIG,ADIPOR1,ADIPOR1_SIG,ADIPOR1,SIG,40,-4.80933590101167,0.172368620203397,0.190045204775409,0.114288413752502,-0.0757567910229066,9.04555662529499e-06,-4.7560222101455,7.14000768447715,7.21334305741945,6.89904860195244,-0.314294455467006,3.77326017260627e-05,ENSG00000159346,ADIPOR1,protein_coding,1,-1,202940826,202958572,q32.1,adiponectin receptor 1 [Source:HGNC Symbol;Acc:HGNC:24040],NA,ADIPOR1,51094,NM_001290553;NM_001290557;NM_001290629;NM_015999
MAVS_SIG,MAVS,MAVS_SIG,MAVS,SIG,44,4.80850731675432,0.193690138413043,0.177430407697281,0.247114967907686,0.0696845602104048,9.07657947824254e-06,3.37403427243184,6.04900968986877,5.99317028193993,6.23248203020639,0.239311748266462,0.00390051665892536,ENSG00000088888,MAVS,protein_coding,20,1,3846799,3876123,p13,mitochondrial antiviral signaling protein [Source:HGNC Symbol;Acc:HGNC:29233],NA,MAVS,57506,NM_001206491;NM_020746
CSNK1A1_SIG,CSNK1A1,CSNK1A1_SIG,CSNK1A1,SIG,27,4.80817523982666,0.154136753572319,0.149639213996948,0.168914383605681,0.0192751696087326,9.08512110903514e-06,3.3102774234435,6.8598280282907,6.82207636252844,6.98386921579529,0.161792853266859,0.00467799856855156,ENSG00000113712,CSNK1A1,protein_coding,5,-1,149492197,149551552,q32,casein kinase 1 alpha 1 [Source:HGNC Symbol;Acc:HGNC:2451],NA,CSNK1A1,1452,NM_001025105;NM_001271741;NM_001271742;NM_001892
CCR3_SIG,CCR3,CCR3_SIG,CCR3,SIG,16,-4.80775830308034,-0.0656533850415613,-0.0491883048077505,-0.119752934381225,-0.0705646295734746,9.09753439396091e-06,-2.46516299971519,1.01970611082251,1.08650573232865,0.800221640159458,-0.286284092169193,0.0380943788056295,ENSG00000183625,CCR3,protein_coding,3,1,46163604,46266706,p21.31,C-C motif chemokine receptor 3 [Source:HGNC Symbol;Acc:HGNC:1604],NA,CCR3,1232,NM_001164680;NM_001837;NM_178328;NM_178329
PRKAA1_SIG,PRKAA1,PRKAA1_SIG,PRKAA1,SIG,24,-4.80710735022671,0.158546243213769,0.166135077754591,0.133611501151067,-0.0325235766035247,9.12063397055654e-06,-1.8855064311801,6.68470116058167,6.70943923879761,6.60341890358646,-0.106020335211154,0.119249462336915,ENSG00000132356,PRKAA1,protein_coding,5,-1,40759379,40798374,p13.1,protein kinase AMP-activated catalytic subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:9376],NA,PRKAA1,5562,NM_001355028;NM_001355029;NM_001355034;NM_001355035;NM_001355036;NM_001355037;NM_006251;NM_206907
CYB5RL_SIG,CYB5RL,CYB5RL_SIG,CYB5RL,SIG,97,4.80682273561643,0.138245373303885,0.121752535995621,0.19243612445961,0.0706835884639896,9.12706099840936e-06,3.64571366385648,2.71581963246554,2.64440863450164,2.95045576863262,0.30604713413098,0.00173194064284489,ENSG00000215883,CYB5RL,protein_coding,1,-1,54169651,54200036,p32.3,cytochrome b5 reductase like [Source:HGNC Symbol;Acc:HGNC:32220],NA,CYB5RL,606495,NM_001031672;NM_001353353;NM_001353354;NM_001353356
PEX10_SIG,PEX10,PEX10_SIG,PEX10,SIG,19,4.80629354120841,0.178937245223,0.165315957248372,0.223692905711063,0.058376948462691,9.14021277537725e-06,3.24433690568654,3.82594675386503,3.784061979077,3.96356815673997,0.179506177662969,0.00561619474243305,ENSG00000157911,PEX10,protein_coding,1,-1,2403964,2413797,p36.32,peroxisomal biogenesis factor 10 [Source:HGNC Symbol;Acc:HGNC:8851],ADRENOLEUKODYSTROPHY NEONATAL;Autosomal recessive ataxia due to PEX10 deficiency;Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 6B;PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 7;Zellweger Syndrome,PEX10,5192,NM_002617;NM_153818
SLC23A1_SIG,SLC23A1,SLC23A1_SIG,SLC23A1,SIG,93,4.80624755088961,0.0471842001986649,0.0310671554505702,0.100140204370976,0.0690730489204058,9.14021277537725e-06,4.48974083792258,1.13991037852065,1.02769230181102,1.50862691628088,0.480934614469857,0.000103200490678368,ENSG00000170482,SLC23A1,protein_coding,5,-1,139367196,139384553,q31.2,solute carrier family 23 member 1 [Source:HGNC Symbol;Acc:HGNC:10974],NA,SLC23A1,9963,NM_005847;NM_152685
RTKN_SIG,RTKN,RTKN_SIG,RTKN,SIG,43,4.80528183770751,0.137621551221165,0.119704585499244,0.196491581450334,0.0767869959510896,9.17785941218001e-06,3.30511808907521,2.36957455257031,2.26892910563534,2.70026673535667,0.431337629721335,0.00473789850383224,ENSG00000114993,RTKN,protein_coding,2,-1,74425836,74442422,p13.1,rhotekin [Source:HGNC Symbol;Acc:HGNC:10466],NA,RTKN,6242,NM_001015055;NM_001015056;NM_033046
ZNF346_SIG,ZNF346,ZNF346_SIG,ZNF346,SIG,27,4.80436990747526,0.317282976343732,0.305435276971356,0.356211131424398,0.0507758544530419,9.21318091526421e-06,3.60818884448924,3.98257504141677,3.93660204142636,4.13362918424239,0.197027142816037,0.00194896397759558,ENSG00000113761,ZNF346,protein_coding,5,1,177022696,177081189,q35.2,zinc finger protein 346 [Source:HGNC Symbol;Acc:HGNC:16403],NA,ZNF346,23567,NM_001308213;NM_001308214;NM_001308215;NM_001308218;NM_001308221;NM_001308223;NM_012279
SEMA4A_SIG,SEMA4A,SEMA4A_SIG,SEMA4A,SIG,19,-4.80147050391292,0.432574548650443,0.461432393434437,0.337755915788749,-0.123676477645688,9.3406582663648e-06,-3.06393425880845,6.03767638884559,6.14853264138705,5.67343441620937,-0.475098225177676,0.00911920474107711,ENSG00000196189,SEMA4A,protein_coding,1,1,156147366,156177752,q22,semaphorin 4A [Source:HGNC Symbol;Acc:HGNC:10729],CONE-ROD DYSTROPHY 10;Cone rod dystrophy;Familial colorectal cancer Type X;Retinitis pigmentosa;RETINITIS PIGMENTOSA 35,SEMA4A,64218,NM_001193300;NM_001193301;NM_001193302;NM_022367
IAH1_SIG,IAH1,IAH1_SIG,IAH1,SIG,11,4.80133284894929,0.352773217779906,0.346167450371641,0.37447788212135,0.0283104317497095,9.3406582663648e-06,4.85755796189699,4.58403550508603,4.53582261397868,4.74244929015304,0.206626676174368,2.5603800487851e-05,ENSG00000134330,IAH1,protein_coding,2,1,9473658,9496543,p25.1,isoamyl acetate hydrolyzing esterase 1 (putative) [Source:HGNC Symbol;Acc:HGNC:27696],NA,IAH1,285148,NM_001039613;NM_001320858;NM_001320859;NM_001320860;NM_001320863
GHRL_SIG,GHRL,GHRL_SIG,GHRL,SIG,11,-4.80072621441592,0.125925574625723,0.132417626180409,0.104594548088899,-0.02782307809151,9.36230355813392e-06,-3.48501137413105,2.33259822209108,2.41503042031899,2.06174957077079,-0.353280849548204,0.00281948215816607,ENSG00000157017,GHRL,protein_coding,3,-1,10285675,10292947,p25.3,ghrelin and obestatin prepropeptide [Source:HGNC Symbol;Acc:HGNC:18129],OBESITY LEANNESS INCLUDED,GHRL,51738,NM_001134941;NM_001134944;NM_001134945;NM_001134946;NM_001302821;NM_001302822;NM_001302823;NM_001302824;NM_001302825;NM_016362
ZNF354B_TF,ZNF354B,ZNF354B_TF,ZNF354B,TF,50,4.80044618353171,0.180477607587885,0.167611294869115,0.222752635092414,0.0551413402232997,9.36870849992173e-06,4.30638152208817,3.72290610887735,3.64690167897615,3.97263494998131,0.325733271005156,0.000199669431614169,ENSG00000178338,ZNF354B,protein_coding,5,1,178859953,178888122,q35.3,zinc finger protein 354B [Source:HGNC Symbol;Acc:HGNC:17197],NA,ZNF354B,117608,NM_058230
ZCWPW1_TF,ZCWPW1,ZCWPW1_TF,ZCWPW1,TF,111,4.79932071441822,-0.0171850192121572,-0.0284015220610035,0.019669204434052,0.0480707264950556,9.41478064543595e-06,2.06942375483316,2.79308881045347,2.75828623652875,2.90744012477754,0.149153888248792,0.085152442162905,ENSG00000078487,ZCWPW1,protein_coding,7,-1,100400826,100428992,q22.1,zinc finger CW-type and PWWP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23486],NA,ZCWPW1,55063,NM_001258008;NM_017984
INPP5B_SIG,INPP5B,INPP5B_SIG,INPP5B,SIG,11,4.79895733389779,0.401848208327945,0.388941128523094,0.4442571848296,0.0553160563065066,9.42514856543032e-06,3.33204947124785,5.79898030517366,5.74406769638534,5.97940744833531,0.235339751949975,0.00439217521358299,ENSG00000204084,INPP5B,protein_coding,1,-1,37860697,37947057,p34.3,inositol polyphosphate-5-phosphatase B [Source:HGNC Symbol;Acc:HGNC:6077],NA,INPP5B,3633,NM_001297434;NM_001350227;NM_001350228;NM_001365820;NM_001365821;NM_001365822;NM_001365825;NM_005540
AKAP9_SIG,AKAP9,AKAP9_SIG,AKAP9,SIG,44,4.79856273754815,0.276287581967645,0.26836972633376,0.302303393336124,0.0339336670023647,9.43700191794525e-06,3.69848255160694,7.19513262297967,7.14332787785612,7.36534821409991,0.222020336243787,0.00147845505461039,ENSG00000127914,AKAP9,protein_coding,7,1,91940867,92110673,q21.2,A-kinase anchoring protein 9 [Source:HGNC Symbol;Acc:HGNC:379],Brugada syndrome;LONG QT SYNDROME 11;Romano-Ward syndrome,AKAP9,10142,NM_005751;NM_147185
NPAS2_SIG,NPAS2,NPAS2_SIG,NPAS2,SIG,12,-4.79840059748437,-0.21326979434277,-0.187840558903106,-0.296822996501665,-0.108982437598559,9.43791609190431e-06,-2.48250112233412,0.325237481042077,0.347930114758347,0.250675970260047,-0.0972541444983,0.0366695203931265,ENSG00000170485,NPAS2,protein_coding,2,1,100820139,100996829,q11.2,neuronal PAS domain protein 2 [Source:HGNC Symbol;Acc:HGNC:7895],NA,NPAS2,4862,NM_002518
SYNJ1_SIG,SYNJ1,SYNJ1_SIG,SYNJ1,SIG,59,-4.7979521234446,0.362804915198486,0.372883627298557,0.329689146869683,-0.0431944804288735,9.45233467830251e-06,-3.40811304519887,5.28992892213853,5.34984530937054,5.09306079266193,-0.25678451670861,0.00351909234551619,ENSG00000159082,SYNJ1,protein_coding,21,-1,32628759,32728048,q22.11,synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503],Atypical juvenile parkinsonism;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 53;Parkinson disease 20 early-onset;Undetermined early-onset epileptic encephalopathy,SYNJ1,8867,NM_001160302;NM_001160306;NM_003895;NM_203446
ZNF783_TF,ZNF783,ZNF783_TF,ZNF783,TF,155,4.7977433097554,0.176317070171683,0.165897543040508,0.210552659316974,0.0446551162764662,9.45546144298488e-06,2.96911554660054,4.67485750015241,4.62414241183574,4.84149279033574,0.217350378500009,0.0116589041614063,ENSG00000204946,ZNF783,protein_coding,7,1,149262171,149297302,q36.1,zinc finger family member 783 [Source:HGNC Symbol;Acc:HGNC:27222],NA,ZNF783,100289678,NM_001195220
ATP2C2_SIG,ATP2C2,ATP2C2_SIG,ATP2C2,SIG,12,-4.79690764654129,-0.0478817224508541,-0.00961913558605636,-0.173601650720904,-0.163982515134847,9.48822971278219e-06,-4.00151820148549,1.27313614737474,1.437772787252,0.732187187778041,-0.70558559947396,0.000566965773915339,ENSG00000064270,ATP2C2,protein_coding,16,1,84368527,84464187,q24.1,ATPase secretory pathway Ca2+ transporting 2 [Source:HGNC Symbol;Acc:HGNC:29103],NA,ATP2C2,9914,NM_001286527;NM_001291454;NM_014861
AXL_SIG,AXL,AXL_SIG,AXL,SIG,26,-4.79566174068391,-0.153265626600513,-0.147077174620392,-0.173599111678052,-0.0265219370576596,9.53505287131861e-06,-2.92927924997053,1.12546721651184,1.22423329279566,0.800950108722121,-0.423283184073541,0.0128970227410548,ENSG00000167601,AXL,protein_coding,19,1,41219223,41261766,q13.2,AXL receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:905],Hypogonadotropic hypogonadism 7 with or without anosmia,AXL,558,NM_001278599;NM_001699;NM_021913
PGM2L1_SIG,PGM2L1,PGM2L1_SIG,PGM2L1,SIG,59,4.79563638271963,0.225325432796125,0.213311338977455,0.26480031248604,0.0514889735085842,9.53505287131861e-06,3.57019375857719,4.02727964475876,3.95257364420587,4.27274221800395,0.320168573798075,0.00218635328630904,ENSG00000165434,PGM2L1,protein_coding,11,-1,74330316,74398433,q13.4,phosphoglucomutase 2 like 1 [Source:HGNC Symbol;Acc:HGNC:20898],NA,PGM2L1,283209,NM_173582
LPCAT4_SIG,LPCAT4,LPCAT4_SIG,LPCAT4,SIG,30,4.79309232047693,0.122089241062734,0.107137151484637,0.171217535390766,0.0640803839061294,9.64996857011177e-06,4.27118128929365,4.72023203335776,4.63397530646536,5.00364699314705,0.369671686681688,0.000224832010655221,ENSG00000176454,LPCAT4,protein_coding,15,-1,34358633,34367196,q14,lysophosphatidylcholine acyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:30059],NA,LPCAT4,254531,NM_153613
PTPRF_SIG,PTPRF,PTPRF_SIG,PTPRF,SIG,62,4.79293231903564,-0.126551897716459,-0.134442039926556,-0.100627144740427,0.033814895186128,9.65082632156681e-06,1.55651864347892,1.7639403372298,1.70812965861146,1.94731828126151,0.239188622650052,0.203569950189143,ENSG00000142949,PTPRF,protein_coding,1,1,43525187,43623666,p34.2,protein tyrosine phosphatase, receptor type F [Source:HGNC Symbol;Acc:HGNC:9670],ATHELIA;BREASTS AND/OR NIPPLES APLASIA OR HYPOPLASIA OF 2;Isolated congenital breast hypoplasia/aplasia,PTPRF,5792,NM_001329137;NM_001329138;NM_001329139;NM_001329140;NM_002840;NM_130440
MCOLN1_SIG,MCOLN1,MCOLN1_SIG,MCOLN1,SIG,7,-4.79127744739471,0.207914669609578,0.237361568648076,0.111160572768801,-0.126200995879274,9.72388939831901e-06,-1.60609520186911,4.48522563504702,4.51308543858933,4.39368628055087,-0.119399158038458,0.188829125521756,ENSG00000090674,MCOLN1,protein_coding,19,1,7522624,7534009,p13.2,mucolipin 1 [Source:HGNC Symbol;Acc:HGNC:13356],MUCOLIPIDOSIS IV;Mucolipidosis type IV,MCOLN1,57192,NM_020533
FASTKD2_SIG,FASTKD2,FASTKD2_SIG,FASTKD2,SIG,62,4.78998315426906,0.484475581302976,0.471903092981439,0.525785185788028,0.0538820928065896,9.7798951790813e-06,3.95138290701035,4.59392719283624,4.53623827820768,4.78347648375863,0.24723820555095,0.000663595799390067,ENSG00000118246,FASTKD2,protein_coding,2,1,206765357,206796189,q33.3,FAST kinase domains 2 [Source:HGNC Symbol;Acc:HGNC:29160],FASTKD2-related infantile mitochondrial encephalomyopathy;MITOCHONDRIAL COMPLEX IV DEFICIENCY,FASTKD2,22868,NM_001136193;NM_001136194;NM_014929
ERN1_SIG,ERN1,ERN1_SIG,ERN1,SIG,21,-4.78943553229201,0.181306795135237,0.195572798391404,0.134432784436401,-0.061140013955003,9.79784135188822e-06,-2.95966704552167,5.55954326178799,5.61424668604033,5.37980343924458,-0.234443246795755,0.0119469159771438,ENSG00000178607,ERN1,protein_coding,17,-1,64039142,64130819,q23.3,endoplasmic reticulum to nucleus signaling 1 [Source:HGNC Symbol;Acc:HGNC:3449],NA,ERN1,2081,NM_001433
CSF2RB_SIG,CSF2RB,CSF2RB_SIG,CSF2RB,SIG,29,-4.789331425217,0.092313103932047,0.102211172821466,0.0597908775810998,-0.042420295240366,9.79784135188822e-06,-2.34807479071736,6.64636232247361,6.72810918331803,6.37776549398479,-0.350343689333243,0.0489716931545088,ENSG00000100368,CSF2RB,protein_coding,22,1,36913628,36940439,q12.3,colony stimulating factor 2 receptor beta common subunit [Source:HGNC Symbol;Acc:HGNC:2436],Hereditary pulmonary alveolar proteinosis;SURFACTANT METABOLISM DYSFUNCTION PULMONARY 5,CSF2RB,1439,NM_000395
CPNE3_SIG,CPNE3,CPNE3_SIG,CPNE3,SIG,29,-4.78914489651075,0.293596786224608,0.311347940983284,0.235271563446103,-0.0760763775371815,9.80002638030495e-06,-2.41134076048387,6.55594211656954,6.63067919208111,6.31037743988866,-0.320301752192448,0.0427907976028607,ENSG00000085719,CPNE3,protein_coding,8,1,86514435,86561498,q21.3,copine 3 [Source:HGNC Symbol;Acc:HGNC:2316],NA,CPNE3,8895,NM_003909
NADK_SIG,NADK,NADK_SIG,NADK,SIG,29,-4.78768933345831,0.52920178105666,0.564409583870898,0.413519000381304,-0.150890583489594,9.8643856103771e-06,-3.87767178632083,6.6702252030309,6.75866572644391,6.37963491181673,-0.379030814627178,0.000840045216127325,ENSG00000008130,NADK,protein_coding,1,-1,1751232,1780457,p36.33,NAD kinase [Source:HGNC Symbol;Acc:HGNC:29831],NA,NADK,65220,NM_001198993;NM_001198994;NM_001198995;NM_001353641;NM_001353642;NM_023018
CACNA1A_SIG,CACNA1A,CACNA1A_SIG,CACNA1A,SIG,16,-4.78752414883211,0.0333910852127473,0.0382015808169231,0.0175851710847412,-0.0206164097321819,9.86554344214434e-06,-2.88052291976762,1.26449746494114,1.31881638851998,1.08602100175353,-0.232795386766451,0.0145604485220458,ENSG00000141837,CACNA1A,protein_coding,19,-1,13206442,13633025,p13.13,calcium voltage-gated channel subunit alpha1 A [Source:HGNC Symbol;Acc:HGNC:1388],ALTERNATING HEMIPLEGIA OF CHILDHOOD;Benign paroxysmal torticollis of infancy;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 42;EPISODIC ATAXIA TYPE 2;Familial or sporadic hemiplegic migraine;Familial paroxysmal ataxia;MIGRAINE FAMILIAL HEMIPLEGIC 1;SPINOCEREBELLAR ATAXIA 6;Spinocerebellar ataxia type 6;Undetermined early-onset epileptic encephalopathy,CACNA1A,773,NM_000068;NM_001127221;NM_001127222;NM_001174080;NM_023035
NSUN4_SIG,NSUN4,NSUN4_SIG,NSUN4,SIG,33,4.78498308351796,0.304013155857789,0.294509053173157,0.335240921821579,0.0407318686484227,9.98413932745916e-06,3.99066681447462,5.04428880150133,4.99701095823628,5.19963028651507,0.202619328278799,0.000586162605127134,ENSG00000117481,NSUN4,protein_coding,1,1,46340177,46365152,p33,NOP2/Sun RNA methyltransferase family member 4 [Source:HGNC Symbol;Acc:HGNC:31802],NA,NSUN4,387338,NM_001256127;NM_001256128;NM_199044
ACSF2_SIG,ACSF2,ACSF2_SIG,ACSF2,SIG,42,4.78472466946969,0.0438658102998605,0.0335813677885626,0.0776575499798395,0.044076182191277,9.98995258787274e-06,3.88303707415412,4.2966864871458,4.20999962453125,4.58151475002218,0.371515125490925,0.0008262241749843,ENSG00000167107,ACSF2,protein_coding,17,1,50426158,50474845,q21.33,acyl-CoA synthetase family member 2 [Source:HGNC Symbol;Acc:HGNC:26101],NA,ACSF2,80221,NM_001288968;NM_001288969;NM_001288970;NM_001288971;NM_001288972;NM_025149
MAP3K3_SIG,MAP3K3,MAP3K3_SIG,MAP3K3,SIG,51,-4.78419291461245,0.429218937301386,0.446947104834417,0.37096924397857,-0.0759778608558472,1.00093843573256e-05,-4.26785609269243,6.5839464111775,6.66095826653924,6.33090745784605,-0.330050808693193,0.000227059113366616,ENSG00000198909,MAP3K3,protein_coding,17,1,63622415,63696303,q23.3,mitogen-activated protein kinase kinase kinase 3 [Source:HGNC Symbol;Acc:HGNC:6855],NA,MAP3K3,4215,NM_001330431;NM_001363768;NM_002401;NM_203351
PLGRKT_SIG,PLGRKT,PLGRKT_SIG,PLGRKT,SIG,10,4.7833433348753,0.146523482623031,0.136965597852381,0.177927961155166,0.0409623633027858,1.00447336068694e-05,1.25932629177603,3.17898330461608,3.16206722825351,3.23456469837881,0.0724974701252995,0.311452789335777,ENSG00000107020,PLGRKT,protein_coding,9,-1,5357971,5437925,p24.1,plasminogen receptor with a C-terminal lysine [Source:HGNC Symbol;Acc:HGNC:23633],NA,PLGRKT,55848,NM_018465
TESK2_SIG,TESK2,TESK2_SIG,TESK2,SIG,19,-4.781832604887,0.0239529818173136,0.0312310862136689,3.92102292890461e-05,-0.03119187598438,1.01134233471859e-05,-3.40375108421988,4.1358333959,4.18491883170885,3.97455267824235,-0.210366153466502,0.00356317743144176,ENSG00000070759,TESK2,protein_coding,1,-1,45343883,45491163,p34.1,testis associated actin remodelling kinase 2 [Source:HGNC Symbol;Acc:HGNC:11732],NA,TESK2,10420,NM_001320800;NM_007170
DTX1_SIG,DTX1,DTX1_SIG,DTX1,SIG,13,-4.78078090482167,-0.166474427292072,-0.145630185017947,-0.234962651907056,-0.089332466889109,1.01593406234676e-05,-4.23269276823799,1.12588286637175,1.23593133890328,0.764295028053852,-0.471636310849428,0.000257484774106287,ENSG00000135144,DTX1,protein_coding,12,1,113056709,113098028,q24.13,deltex E3 ubiquitin ligase 1 [Source:HGNC Symbol;Acc:HGNC:3060],NA,DTX1,1840,NM_004416
NSMAF_SIG,NSMAF,NSMAF_SIG,NSMAF,SIG,36,4.77911785577346,0.304363753361915,0.292766453652515,0.342469166692801,0.0497027130402861,1.02365373438387e-05,2.70940124347759,6.47847720808142,6.43703941720157,6.61462994954376,0.177590532342189,0.021905830310405,ENSG00000035681,NSMAF,protein_coding,8,-1,58583508,58659853,q12.1,neutral sphingomyelinase activation associated factor [Source:HGNC Symbol;Acc:HGNC:8017],NA,NSMAF,8439,NM_001144772;NM_003580
ZFP36L2_SIG,ZFP36L2,ZFP36L2_SIG,ZFP36L2,SIG,11,4.77757598413365,0.135958185599123,0.132110428928635,0.1486008146593,0.0164903857306647,1.03080863117294e-05,1.86176185485501,9.34013221187087,9.30261009013049,9.46341918330354,0.160809093173048,0.124342274795273,ENSG00000152518,ZFP36L2,protein_coding,2,-1,43222402,43226606,p21,ZFP36 ring finger protein like 2 [Source:HGNC Symbol;Acc:HGNC:1108],NA,ZFP36L2,678,NM_006887
CXXC5_TF,CXXC5,CXXC5_TF,CXXC5,TF,98,4.77607179262619,0.098565662878157,0.0889969921095592,0.130005581117836,0.0410085890082763,1.03770360811014e-05,4.78682051659802,6.06892917159734,5.92151494824733,6.55329019117596,0.63177524292863,3.35611283613791e-05,ENSG00000171604,CXXC5,protein_coding,5,1,139647299,139683882,q31.2,CXXC finger protein 5 [Source:HGNC Symbol;Acc:HGNC:26943],NA,CXXC5,51523,NM_001317199;NM_001317200;NM_001317201;NM_001317202;NM_001317203;NM_001317204;NM_001317205;NM_001317206;NM_001317207;NM_001317208;NM_001317209;NM_001317210;NM_001317211;NM_016463
ABHD14B_SIG,ABHD14B,ABHD14B_SIG,ABHD14B,SIG,17,4.77595288616271,0.454401331768166,0.446751043763556,0.479537992354742,0.0327869485911868,1.03770360811014e-05,3.84347722287474,5.72079865610566,5.66050778636403,5.91889722811385,0.258389441749815,0.000938415515486707,ENSG00000114779,ABHD14B,protein_coding,3,-1,51968510,51983409,p21.2,abhydrolase domain containing 14B [Source:HGNC Symbol;Acc:HGNC:28235],NA,ABHD14B,84836,NM_001146314;NM_001254753;NM_032750
GNG5_SIG,GNG5,GNG5_SIG,GNG5,SIG,63,-4.7738770398031,0.0333076622656489,0.0444303051451549,-0.00323816433844249,-0.0476684694835973,1.04772922374677e-05,-4.96821127831697,6.24684454027605,6.30440768592739,6.05770849027879,-0.246699195648601,1.61758053322363e-05,ENSG00000174021,GNG5,protein_coding,1,-1,84498325,84506581,p22.3,G protein subunit gamma 5 [Source:HGNC Symbol;Acc:HGNC:4408],NA,GNG5,2787,NM_005274
OBSCN_SIG,OBSCN,OBSCN_SIG,OBSCN,SIG,79,4.77261279455283,-0.00117766785461346,-0.0122306004812592,0.0351391107757938,0.0473697112570531,1.05359245460932e-05,3.37032533781632,5.36619585778434,5.23566935759481,5.79506864412136,0.559399286526546,0.00394158666544681,ENSG00000154358,OBSCN,protein_coding,1,1,228208130,228378874,q42.13,obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF [Source:HGNC Symbol;Acc:HGNC:15719],NA,OBSCN,84033,NM_001098623;NM_001271223;NM_052843
EPHA4_SIG,EPHA4,EPHA4_SIG,EPHA4,SIG,8,-4.76933650038842,0.222257015431088,0.254747867650489,0.11550135813877,-0.139246509511718,1.06940570689722e-05,-4.73916716440468,1.50619358120075,1.64610644114828,1.046479898516,-0.59962654263228,4.03356708113763e-05,ENSG00000116106,EPHA4,protein_coding,2,-1,221418027,221574202,q36.1,EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388],Amyotrophic lateral sclerosis,EPHA4,2043,NM_001304536;NM_001304537;NM_004438
GNA15_SIG,GNA15,GNA15_SIG,GNA15,SIG,69,4.76933099288011,0.209255007566264,0.196183312302906,0.252204863431584,0.0560215511286774,1.06940570689722e-05,4.54768117144964,7.23966179295585,7.10739028883455,7.67426816364012,0.566877874805574,8.36245020274303e-05,ENSG00000060558,GNA15,protein_coding,19,1,3136193,3163769,p13.3,G protein subunit alpha 15 [Source:HGNC Symbol;Acc:HGNC:4383],NA,GNA15,2769,NM_002068
HAAO_SIG,HAAO,HAAO_SIG,HAAO,SIG,15,4.76617596615,0.168883446247245,0.159937049506516,0.198278749823929,0.0383417003174133,1.08552172983838e-05,4.20588675206669,3.19472339585888,3.09872869513058,3.5101345553947,0.411405860264111,0.000282540452441912,ENSG00000162882,HAAO,protein_coding,2,-1,42767089,42792593,p21,3-hydroxyanthranilate 3,4-dioxygenase [Source:HGNC Symbol;Acc:HGNC:4796],Congenital vertebral-cardiac-renal anomalies syndrome;VERTEBRAL CARDIAC RENAL AND LIMB DEFECTS SYNDROME 1,HAAO,23498,NM_012205
GJA1_SIG,GJA1,GJA1_SIG,GJA1,SIG,33,-4.76277779674495,-0.127520813979477,-0.118736212631067,-0.156384504124253,-0.0376482914931854,1.10319954447968e-05,-3.76766070332222,0.947166474365725,1.09761146083831,0.452847233098671,-0.644764227739635,0.0011890838828302,ENSG00000152661,GJA1,protein_coding,6,1,121435577,121449727,q22.31,gap junction protein alpha 1 [Source:HGNC Symbol;Acc:HGNC:4274],ATRIOVENTRICULAR SEPTAL DEFECT 3;Autosomal dominant oculodentodigital dysplasia;Autosomal dominant palmoplantar keratoderma and congenital alopecia;Autosomal recessive non-syndromic sensorineural deafness type DFNB;AUTOSOMAL RECESSIVE OCULODENTODIGITAL DYSPLASIA;Craniometaphyseal dysplasia;CRANIOMETAPHYSEAL DYSPLASIA AUTOSOMAL RECESSIVE;Erythrokeratodermia variabilis;ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3;HALLERMANN-STREIFF SYNDROME;HYPOPLASTIC LEFT HEART SYNDROME;HYPOPLASTIC LEFT HEART SYNDROME 1;OCULODENTODIGITAL DYSPLASIA;OCULODENTODIGITAL DYSPLASIA AUTOSOMAL RECESSIVE;PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1;Syndactyly type 3;SYNDACTYLY TYPE III,GJA1,2697,NM_000165
HACL1_SIG,HACL1,HACL1_SIG,HACL1,SIG,8,4.76234768855932,0.300523994300106,0.293078621976024,0.324987360507806,0.0319087385317817,1.1047837749568e-05,2.21990150517701,3.90328809717545,3.875367242285,3.99502804895837,0.119660806673377,0.0637723872352857,ENSG00000131373,HACL1,protein_coding,3,-1,15560704,15601852,p25.1,2-hydroxyacyl-CoA lyase 1 [Source:HGNC Symbol;Acc:HGNC:17856],NA,HACL1,26061,NM_001284413;NM_001284415;NM_001284416;NM_012260
NOS3_SIG,NOS3,NOS3_SIG,NOS3,SIG,30,-4.76189567575084,-0.0684942232765504,-0.0577079743375168,-0.103934755504804,-0.0462267811672868,1.10609767576283e-05,-3.68522742789892,0.837182619209781,0.902220195142148,0.623487726860577,-0.278732468281572,0.00153884412898272,ENSG00000164867,NOS3,protein_coding,7,1,150991017,151014588,q36.1,nitric oxide synthase 3 [Source:HGNC Symbol;Acc:HGNC:7876],Alzheimer disease;HYPERTENSION ESSENTIAL;PREECLAMPSIA/ECLAMPSIA 1;STROKE ISCHEMIC,NOS3,4846,NM_000603;NM_001160109;NM_001160110;NM_001160111
JADE3_SIG,JADE3,JADE3_SIG,JADE3,SIG,40,4.76182691051762,0.43851018262483,0.423572465370153,0.487591253604484,0.0640187882343312,1.10609767576283e-05,3.44709259839945,3.57765717466972,3.50528732986156,3.81544380761083,0.310156477749264,0.00314246839945103,ENSG00000102221,JADE3,protein_coding,X,1,46912276,47061242,p11.3,jade family PHD finger 3 [Source:HGNC Symbol;Acc:HGNC:22982],NA,JADE3,9767,NM_001077445;NM_014735
PAK6_SIG,PAK6,PAK6_SIG,PAK6,SIG,28,4.76106828425807,0.0405022186210018,0.0319677386161146,0.0685440814942026,0.0365763428780881,1.10949212691144e-05,1.59358938094704,1.01814998884463,0.988617184978302,1.11518634440541,0.126569159427105,0.1924660105597,ENSG00000137843,PAK6,protein_coding,15,1,40238759,40277487,q15.1,p21 (RAC1) activated kinase 6 [Source:HGNC Symbol;Acc:HGNC:16061],NA,PAK6,56924;106821730,NM_001128629;NM_001276717;NM_001276718;NM_020168
BCO2_SIG,BCO2,BCO2_SIG,BCO2,SIG,28,4.76086799344849,0.09687596498141,0.087868848810921,0.126470775255874,0.0386019264449529,1.10974991521596e-05,3.23283273449807,1.38629790902684,1.32661426453933,1.58240131234297,0.255787047803647,0.00579167231318799,ENSG00000197580,BCO2,protein_coding,11,1,112175467,112224699,q23.1,beta-carotene oxygenase 2 [Source:HGNC Symbol;Acc:HGNC:18503],NA,BCO2,83875,NM_001037290;NM_001256397;NM_001256398;NM_001256400;NM_031938
FANCF_SIG,FANCF,FANCF_SIG,FANCF,SIG,54,4.76074093893573,0.0328583125771187,0.0177855148987111,0.0823832192347437,0.0645977043360325,1.10974991521596e-05,5.59454111735112,3.40373591281708,3.28019440573686,3.80965800750922,0.529463601772354,1.05243383761052e-06,ENSG00000183161,FANCF,protein_coding,11,-1,22622890,22625841,p14.3,FA complementation group F [Source:HGNC Symbol;Acc:HGNC:3587],Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP F,FANCF,2188,NM_022725
RDX_SIG,RDX,RDX_SIG,RDX,SIG,17,4.75994582755663,0.220672533781306,0.214775947822812,0.240047030502074,0.0252710826792618,1.11335754686314e-05,2.89828071826926,5.26506740471686,5.21627287016946,5.42539230394403,0.209119433774564,0.0139443435177688,ENSG00000137710,RDX,protein_coding,11,-1,109864295,110296722,q22.3,radixin [Source:HGNC Symbol;Acc:HGNC:9944],Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness autosomal recessive 24,RDX,5962,NM_001260492;NM_001260493;NM_001260494;NM_001260495;NM_001260496;NM_002906
MS4A1_SIG,MS4A1,MS4A1_SIG,MS4A1,SIG,48,-4.75971213151607,-0.32205097199775,-0.305105432608069,-0.377729172849559,-0.0726237402414904,1.11387440670377e-05,-3.38347624480698,2.87656518469539,3.02569235032745,2.38657592619004,-0.639116424137411,0.00379572875964405,ENSG00000156738,MS4A1,protein_coding,11,1,60455752,60470760,q12.2,membrane spanning 4-domains A1 [Source:HGNC Symbol;Acc:HGNC:7315],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 5,MS4A1,931,NM_021950;NM_152866
PRDX6_SIG,PRDX6,PRDX6_SIG,PRDX6,SIG,30,4.75923105396913,0.261780095337811,0.250414015494979,0.299125786249974,0.0487117707549952,1.11575855401665e-05,3.91918207329246,7.10991840210002,7.06403611683941,7.26067448224201,0.196638365402593,0.000734748839353524,ENSG00000117592,PRDX6,protein_coding,1,1,173477330,173488815,q25.1,peroxiredoxin 6 [Source:HGNC Symbol;Acc:HGNC:16753],NA,PRDX6,9588,NM_004905
MBD2_TF,MBD2,MBD2_TF,MBD2,TF,214,-4.75842946286349,0.196013207702354,0.215462613677039,0.132108016642675,-0.0833545970343641,1.11942196507199e-05,-2.45096227326304,6.84940569529892,6.88643640734425,6.72773335572141,-0.158703051622842,0.0392816486334968,ENSG00000134046,MBD2,protein_coding,18,-1,54151606,54224669,q21.2,methyl-CpG binding domain protein 2 [Source:HGNC Symbol;Acc:HGNC:6917],NA,MBD2,8932,NM_003927;NM_015832
ACY1_SIG,ACY1,ACY1_SIG,ACY1,SIG,8,4.75724534174349,0.187181872335135,0.17172191833149,0.237978864061397,0.0662569457299069,1.12479433974254e-05,3.49476561027491,0.754699588715735,0.724227295770424,0.854822836964615,0.130595541194191,0.00274251063882475,ENSG00000243989,ACY1,protein_coding,3,1,51983340,51989197,p21.2,aminoacylase 1 [Source:HGNC Symbol;Acc:HGNC:177],Aminoacylase-1 deficiency;Aminoacylase 1 deficiency;Neurological conditions associated with aminoacylase 1 deficiency,ACY1,95,NM_000666;NM_001198895;NM_001198896;NM_001198897;NM_001198898
ZNF365_TF,ZNF365,ZNF365_TF,ZNF365,TF,84,-4.75718327006252,-0.112282191056202,-0.0968486796429185,-0.162992299985563,-0.066143620342645,1.12479433974254e-05,-3.13603760999001,0.45111383966424,0.496994092356441,0.300364437961293,-0.196629654395148,0.00754102052496208,ENSG00000138311,ZNF365,protein_coding,10,1,62374192,62670301,q21.2,zinc finger protein 365 [Source:HGNC Symbol;Acc:HGNC:18194],Narcolepsy type 1;Narcolepsy type 2;NEPHROLITHIASIS URIC ACID SUSCEPTIBILITY TO,ZNF365,22891,NM_014951;NM_199450;NM_199451
RAP2B_SIG,RAP2B,RAP2B_SIG,RAP2B,SIG,14,-4.75701787571626,0.286770275791588,0.299644112195636,0.244470527606857,-0.0551735845887788,1.12493797253675e-05,-3.16872302154564,6.70650725972253,6.75880864747747,6.53465984281347,-0.224148804664003,0.00689932582753801,ENSG00000181467,RAP2B,protein_coding,3,1,153162270,153170620,q25.2,RAP2B, member of RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9862],NA,RAP2B,5912,NM_002886
PUS7L_SIG,PUS7L,PUS7L_SIG,PUS7L,SIG,68,4.75680551855339,0.245691416126816,0.230325848357941,0.296178281653119,0.0658524332951779,1.12534379043688e-05,4.50491091512306,3.89987178828477,3.82527536304555,4.14497432835652,0.319698965310976,9.69561953421883e-05,ENSG00000129317,PUS7L,protein_coding,12,-1,43718993,43758817,q12,pseudouridine synthase 7 like [Source:HGNC Symbol;Acc:HGNC:25276],NA,PUS7L,83448,NM_001098614;NM_001098615;NM_001271826;NM_031292
CHTOP_SIG,CHTOP,CHTOP_SIG,CHTOP,SIG,48,4.75574914999358,0.188253198023853,0.180997309451887,0.212093974760312,0.0310966653084251,1.13046424091618e-05,4.28297484859478,6.46540418543468,6.42403412834509,6.60133437301477,0.177300244669686,0.000217306220616537,ENSG00000160679,CHTOP,protein_coding,1,1,153633982,153646306,q21.3,chromatin target of PRMT1 [Source:HGNC Symbol;Acc:HGNC:24511],NA,CHTOP,26097,NM_001206612;NM_001244664;NM_001317077;NM_015607
ADCY1_SIG,ADCY1,ADCY1_SIG,ADCY1,SIG,39,4.75464975942711,-0.0734015855905841,-0.0815606481360106,-0.0465932372270402,0.0349674109089703,1.13584914944878e-05,1.33303194742252,0.576146306543338,0.546992093935356,0.671938719398136,0.124946625462779,0.281847277307849,ENSG00000164742,ADCY1,protein_coding,7,1,45574140,45723116,p12.3,adenylate cyclase 1 [Source:HGNC Symbol;Acc:HGNC:232],Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness autosomal recessive 44,ADCY1,107,NM_001281768;NM_021116
RXFP1_SIG,RXFP1,RXFP1_SIG,RXFP1,SIG,41,4.75425264759473,-0.00843709643691516,-0.015966557950337,0.0163025628214708,0.0322691207718077,1.13729943772375e-05,3.03942918715075,1.81022888637115,1.66103850495763,2.30042585387271,0.639387348915085,0.00971186418649034,ENSG00000171509,RXFP1,protein_coding,4,1,158315311,158653372,q32.1,relaxin family peptide receptor 1 [Source:HGNC Symbol;Acc:HGNC:19718],NA,RXFP1,59350,NM_001253727;NM_001253728;NM_001253729;NM_001253730;NM_001253732;NM_001253733;NM_021634
COL15A1_SIG,COL15A1,COL15A1_SIG,COL15A1,SIG,11,-4.75406569678947,-0.253000216417161,-0.242270520778115,-0.288254930659744,-0.0459844098816289,1.13756819603124e-05,-3.291290850246,0.333245774223789,0.380348168661475,0.178480763928534,-0.201867404732941,0.00492327136483235,ENSG00000204291,COL15A1,protein_coding,9,1,98943179,99070792,q22.33,collagen type XV alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2192],NA,COL15A1,1306,NM_001855
KLF5_TF,KLF5,KLF5_TF,KLF5,TF,437,-4.75382016040743,-0.0287123267706729,-0.0166968655048153,-0.0681916995013477,-0.0514948339965323,1.13816745449795e-05,-2.67474704467825,3.03489509388791,3.14362103303503,2.67765272240452,-0.465968310630516,0.0237502430098137,ENSG00000102554,KLF5,protein_coding,13,1,73054976,73077541,q22.1,Kruppel like factor 5 [Source:HGNC Symbol;Acc:HGNC:6349],NA,KLF5,688,NM_001286818;NM_001730
ATP6AP2_SIG,ATP6AP2,ATP6AP2_SIG,ATP6AP2,SIG,42,-4.75259226174127,0.356189438346509,0.368266380652625,0.316508056483557,-0.0517583241690679,1.14431622049367e-05,-3.75525341079456,7.1309095997762,7.18172790738781,6.96393516048091,-0.217792746906899,0.00123619757996755,ENSG00000182220,ATP6AP2,protein_coding,X,1,40579372,40606848,p11.4,ATPase H+ transporting accessory protein 2 [Source:HGNC Symbol;Acc:HGNC:18305],MENTAL RETARDATION X-LINKED SYNDROMIC HEDERA TYPE;MENTAL RETARDATION X-LINKED WITH EPILEPSY;PARKINSONISM WITH SPASTICITY X-LINKED;X-linked intellectual disability Hedera type;X-linked parkinsonism-spasticity syndrome,ATP6AP2,10159,NM_005765
XPNPEP3_SIG,XPNPEP3,XPNPEP3_SIG,XPNPEP3,SIG,19,4.75208581947832,0.220043588316179,0.210576017348603,0.251151321495358,0.0405753041467554,1.1463984718007e-05,4.75714158867354,4.26314837197596,4.21242103248199,4.42982391602755,0.21740288354556,3.76024126350624e-05,ENSG00000196236,XPNPEP3,protein_coding,22,1,40857077,40932815,q13.2,X-prolyl aminopeptidase 3 [Source:HGNC Symbol;Acc:HGNC:28052],Late-onset nephronophthisis;NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1;NEPHRONOPHTHISIS-LIKE NEPHROPATHY TYPE 1,XPNPEP3,63929,NM_001204827;NM_022098
MYLK2_SIG,MYLK2,MYLK2_SIG,MYLK2,SIG,8,4.75170847049591,-0.141995129863692,-0.152937095481083,-0.106042957120836,0.0468941383602468,1.14775161111123e-05,4.45372074446589,0.362848722318843,0.308657449516475,0.540905761526625,0.23224831201015,0.000117448219162193,ENSG00000101306,MYLK2,protein_coding,20,1,31819308,31834689,q11.21,myosin light chain kinase 2 [Source:HGNC Symbol;Acc:HGNC:16243],CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 1,MYLK2,85366,NM_033118
SARS2_SIG,SARS2,SARS2_SIG,SARS2,SIG,10,4.75140269403782,0.404115983764516,0.392257615363929,0.443079194223586,0.0508215788596572,1.14869999402435e-05,5.68312564102203,2.19339189618134,2.1196423141234,2.43571195151457,0.316069637391162,6.911460437336e-07,ENSG00000104835,SARS2,protein_coding,19,-1,38915266,38930896,q13.2,seryl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:17697],Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome;HYPERURICEMIA PULMONARY HYPERTENSION RENAL FAILURE AND ALKALOSISSYNDROME,SARS2,54938,NM_001145901;NM_017827
IFT46_SIG,IFT46,IFT46_SIG,IFT46,SIG,62,4.74838090659491,0.0219298571261586,0.00198093665382251,0.0874763101066917,0.085495373452869,1.16519362073128e-05,4.02275860202499,3.34596281865318,3.26893432126812,3.59905645291837,0.330122131650253,0.000527547934908807,ENSG00000118096,IFT46,protein_coding,11,-1,118544528,118572970,q23.3,intraflagellar transport 46 [Source:HGNC Symbol;Acc:HGNC:26146],NA,IFT46,56912,NM_001168618;NM_020153
TNFRSF17_SIG,TNFRSF17,TNFRSF17_SIG,TNFRSF17,SIG,100,-4.74771457082921,-0.288257519202748,-0.263114833192414,-0.37086920180813,-0.107754368615716,1.1681885169935e-05,-3.83029551269441,0.384193390253607,0.434633977700878,0.218460031498288,-0.21617394620259,0.000977829876448367,ENSG00000048462,TNFRSF17,protein_coding,16,1,11965210,11968068,p13.13,TNF receptor superfamily member 17 [Source:HGNC Symbol;Acc:HGNC:11913],NA,TNFRSF17,608,NM_001192
MRI1_SIG,MRI1,MRI1_SIG,MRI1,SIG,25,4.7474754385441,0.321489710694406,0.302484974918964,0.383933842528002,0.0814488676090383,1.1681885169935e-05,3.90786148039393,5.16978721977267,5.0962571077872,5.41138615915351,0.315129051366309,0.000760824777096445,ENSG00000037757,MRI1,protein_coding,19,1,13764522,13774282,p13.13,methylthioribose-1-phosphate isomerase 1 [Source:HGNC Symbol;Acc:HGNC:28469],NA,MRI1,84245,NM_001031727;NM_001329572;NM_032285
TSHZ2_SIG,TSHZ2,TSHZ2_SIG,TSHZ2,SIG,18,-4.74744574894355,-0.265649218037034,-0.236115483518708,-0.362688631454389,-0.12657314793568,1.1681885169935e-05,-3.14514889838047,0.991493811324355,1.07188331933381,0.727356856436157,-0.344526462897649,0.00735972613110651,ENSG00000182463,TSHZ2,protein_coding,20,1,52972358,53495330,q13.2,teashirt zinc finger homeobox 2 [Source:HGNC Symbol;Acc:HGNC:13010],NA,TSHZ2,128553,NM_001193421;NM_173485
KLRB1_SIG,KLRB1,KLRB1_SIG,KLRB1,SIG,7,-4.74698471714969,-0.0477730193265925,-0.00833815366152024,-0.177344720797544,-0.169006567136024,1.17005250315875e-05,-4.27982012158423,2.27959994246728,2.42607846644039,1.79831336369849,-0.627765102741901,0.000219549247518688,ENSG00000111796,KLRB1,protein_coding,12,-1,9594551,9607886,p13.31,killer cell lectin like receptor B1 [Source:HGNC Symbol;Acc:HGNC:6373],NA,KLRB1,3820,NM_002258
CEBPE_TF,CEBPE,CEBPE_TF,CEBPE,TF,522,-4.74630497824242,0.10026982508961,0.112333388038988,0.0606324039702263,-0.0517009840687618,1.17318701672568e-05,-3.01497970468954,2.9985907545791,3.13572208386017,2.54801638694129,-0.587705696918884,0.0103418995082856,ENSG00000092067,CEBPE,protein_coding,14,-1,23117304,23119616,q11.2,CCAAT enhancer binding protein epsilon [Source:HGNC Symbol;Acc:HGNC:1836],Recurrent infection due to specific granule deficiency;SPECIFIC GRANULE DEFICIENCY 1,CEBPE,1053,NM_001805
CCND1_SIG,CCND1,CCND1_SIG,CCND1,SIG,39,-4.74503511825854,-0.154933015468251,-0.146844245911093,-0.181510401156054,-0.034666155244961,1.17976455770067e-05,-3.43328051252363,1.5084822327961,1.63248819336647,1.10103407663629,-0.531454116730177,0.00326420647039038,ENSG00000110092,CCND1,protein_coding,11,1,69641087,69654474,q13.3,cyclin D1 [Source:HGNC Symbol;Acc:HGNC:1582],B-cell chronic lymphocytic leukemia;MANTLE CELL LYMPHOMA;Multiple myeloma;MYELOMA MULTIPLE AMYLOIDOSIS SYSTEMIC INCLUDED;VON HIPPEL-LINDAU SYNDROME,CCND1,595,NM_053056
ARRB2_SIG,ARRB2,ARRB2_SIG,ARRB2,SIG,24,-4.74352256416366,0.712572624525016,0.741573887327816,0.617282761030104,-0.124291126297711,1.1878005794133e-05,-3.59092780490991,7.82147317486796,7.90579104744344,7.54442873640564,-0.3613623110378,0.00205484922776474,ENSG00000141480,ARRB2,protein_coding,17,1,4710596,4721499,p13.2,arrestin beta 2 [Source:HGNC Symbol;Acc:HGNC:712],NA,ARRB2,409,NM_001257328;NM_001257329;NM_001257330;NM_001257331;NM_001330064;NM_004313;NM_199004
RDH14_SIG,RDH14,RDH14_SIG,RDH14,SIG,57,4.74233666001752,0.208037941502779,0.197906271000806,0.241327716009261,0.0434214450084552,1.19396204810833e-05,4.01922236001919,3.06855960355139,3.01791703394707,3.23495661796561,0.21703958401854,0.000533687986168008,ENSG00000240857,RDH14,protein_coding,2,-1,18554723,18560679,p24.2,retinol dehydrogenase 14 [Source:HGNC Symbol;Acc:HGNC:19979],NA,RDH14,57665,NM_020905
DDX50_SIG,DDX50,DDX50_SIG,DDX50,SIG,28,4.74107946712003,0.481928549672705,0.470432539651711,0.5197011540274,0.0492686143756891,1.20057683460587e-05,3.58238118471895,5.38569411704327,5.34646566965151,5.51458758704477,0.168121917393262,0.00210748892111262,ENSG00000107625,DDX50,protein_coding,10,1,68901286,68946847,q22.1,DExD-box helicase 50 [Source:HGNC Symbol;Acc:HGNC:17906],NA,DDX50,79009,NM_024045
TGFBR3_SIG,TGFBR3,TGFBR3_SIG,TGFBR3,SIG,33,-4.74051071673455,-0.214041677679638,-0.186585068198282,-0.304256251689805,-0.117671183491523,1.20313198571712e-05,-4.12562542936342,2.70861246603521,2.85908323186874,2.21420852115361,-0.644874710715128,0.000373122893040183,ENSG00000069702,TGFBR3,protein_coding,1,-1,91680343,91906335,p22.1,transforming growth factor beta receptor 3 [Source:HGNC Symbol;Acc:HGNC:11774],Familial cerebral saccular aneurysm,TGFBR3,7049,NM_001195683;NM_001195684;NM_003243
MFN2_SIG,MFN2,MFN2_SIG,MFN2,SIG,36,-4.73757804843323,0.138681898657682,0.146719463297255,0.112272757699086,-0.0344467055981688,1.21983832166287e-05,-3.04605526593104,6.83872312195897,6.87039395434469,6.73466181554875,-0.135732138795939,0.00955105672929202,ENSG00000116688,MFN2,protein_coding,1,1,11980181,12013514,p36.22,mitofusin 2 [Source:HGNC Symbol;Acc:HGNC:16877],Autosomal dominant Charcot-Marie-Tooth disease type 2A2;CHARCOT-MARIE-TOOTH DISEASE AXONAL AUTOSOMAL DOMINANT TYPE 2A2A;CHARCOT-MARIE-TOOTH DISEASE AXONAL AUTOSOMAL RECESSIVE TYPE 2A2B;Hereditary motor and sensory neuropathy type 5;Hereditary motor and sensory neuropathy type 6;Multiple symmetric lipomatosis;NEUROPATHY HEREDITARY MOTOR AND SENSORY TYPE VIA;Severe early-onset axonal neuropathy due to MFN2 deficiency,MFN2,9927,NM_001127660;NM_014874
ERF_TF,ERF,ERF_TF,ERF,TF,80,4.73639805565445,0.0711103288243653,0.0649955375117564,0.0912017859943657,0.0262062484826092,1.22612417414423e-05,2.83223318358563,5.57599994672831,5.53131906961442,5.72280854295963,0.191489473345202,0.0164094568599051,ENSG00000105722,ERF,protein_coding,19,-1,42247569,42255128,q13.2,ETS2 repressor factor [Source:HGNC Symbol;Acc:HGNC:3444],CHITAYAT SYNDROME;Chitayat syndrome: hyperphalangism characteristic facies hallux valgus and bronchomalacia;Complex craniosynostosis;CRANIOSYNOSTOSIS 4;Crouzon disease;Familial lambdoid synostosis;Isolated cloverleaf skull syndrome;Isolated scaphocephaly,ERF,2077,NM_001301035;NM_001308402;NM_001312656;NM_006494
REXO4_TF,REXO4,REXO4_TF,REXO4,TF,314,4.73604824692925,0.186699898083443,0.173777174655037,0.229160275062493,0.0553831004074558,1.22740629879458e-05,3.44233991539682,4.97496505081544,4.91484680361223,5.17249643448312,0.257649630870895,0.00317967506295418,ENSG00000148300,REXO4,protein_coding,9,-1,133406059,133418096,q34.2,REX4 homolog, 3'-5' exonuclease [Source:HGNC Symbol;Acc:HGNC:12820],NA,REXO4,57109,NM_001279349;NM_001279350;NM_001279351;NM_020385
PARP12_SIG,PARP12,PARP12_SIG,PARP12,SIG,35,-4.7353399031451,0.198724198100671,0.21273978737976,0.152672976183667,-0.0600668111960934,1.23024480772112e-05,-4.23040038317188,5.25191886865357,5.33762130761806,4.97032514062739,-0.367296166990671,0.000259530192865045,ENSG00000059378,PARP12,protein_coding,7,-1,140023744,140063721,q34,poly(ADP-ribose) polymerase family member 12 [Source:HGNC Symbol;Acc:HGNC:21919],NA,PARP12,64761,NM_022750
ZNF688_TF,ZNF688,ZNF688_TF,ZNF688,TF,82,4.73530428591232,0.10114094104899,0.0930024676600937,0.127881639326793,0.0348791716666991,1.23024480772112e-05,3.92290146539113,3.41193172408374,3.36254374059595,3.57420652697221,0.211662786376258,0.000726324221257062,ENSG00000229809,ZNF688,protein_coding,16,-1,30569346,30572734,p11.2,zinc finger protein 688 [Source:HGNC Symbol;Acc:HGNC:30489],NA,ZNF688,146542,NM_001024683;NM_145271
TRAF3IP2_SIG,TRAF3IP2,TRAF3IP2_SIG,TRAF3IP2,SIG,22,4.7319754317468,0.131039948626424,0.120830507681336,0.164585254588854,0.0437547469075179,1.24974969873012e-05,4.66558631893387,4.82553309955085,4.72763083715681,5.14721196170268,0.419581124545869,5.34028795241078e-05,ENSG00000056972,TRAF3IP2,protein_coding,6,-1,111555378,111606906,q21,TRAF3 interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:1343],CANDIDIASIS FAMILIAL 8;Chronic mucocutaneous candidiasis;PSORIASIS 13 SUSCEPTIBILITY TO,TRAF3IP2,10758,NM_001164281;NM_001164283;NM_147200;NM_147686
SREBF2_TF,SREBF2,SREBF2_TF,SREBF2,TF,234,4.73139455708736,0.142964918049156,0.138446995440727,0.157809520905421,0.0193625254646932,1.25248211922911e-05,2.35744658323418,7.58603375587113,7.54658372107286,7.71565529877976,0.169071577706904,0.0479655264646478,ENSG00000198911,SREBF2,protein_coding,22,1,41833079,41907307,q13.2,sterol regulatory element binding transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:11290],NA,SREBF2,6721,NM_004599
GALM_SIG,GALM,GALM_SIG,GALM,SIG,45,-4.73116727490103,-0.0957978132185662,-0.085040351194964,-0.131143759867545,-0.0461034086725809,1.25303593665278e-05,-3.05027320762001,2.24655680140182,2.34246589859313,1.93142691063038,-0.411038987962746,0.00944518497536459,ENSG00000143891,GALM,protein_coding,2,1,38666081,38741237,p22.1,galactose mutarotase [Source:HGNC Symbol;Acc:HGNC:24063],NA,GALM,130589,NM_138801
UFSP2_SIG,UFSP2,UFSP2_SIG,UFSP2,SIG,15,4.73076835228884,0.151573501168314,0.143470576009448,0.178197398118874,0.0347268221094256,1.25465099407328e-05,3.45396470421404,3.5954124882496,3.54411448697838,3.76396306385504,0.219848576876667,0.00308067878062146,ENSG00000109775,UFSP2,protein_coding,4,-1,185399537,185425979,q35.1,UFM1 specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:25640],BEUKES HIP DYSPLASIA;Hip dysplasia beukes type;SPONDYLOEPIMETAPHYSEAL DYSPLASIA DI ROCCO TYPE,UFSP2,55325,NM_018359
CTNNBIP1_SIG,CTNNBIP1,CTNNBIP1_SIG,CTNNBIP1,SIG,35,4.73063000548864,0.232264250505118,0.223137589099478,0.262251852266508,0.0391142631670297,1.25465693512053e-05,0.926826258406834,5.18796486002892,5.17349945995332,5.23549403170588,0.0619945717525604,0.467403624870039,ENSG00000178585,CTNNBIP1,protein_coding,1,-1,9848276,9910336,p36.22,catenin beta interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:16913],NA,CTNNBIP1,56998,NM_001012329;NM_020248
GGT1_SIG,GGT1,GGT1_SIG,GGT1,SIG,46,-4.73028782737239,0.066194744076852,0.0761160337407336,0.0335962208955266,-0.0425198128452071,1.25592386447029e-05,-3.36762384611983,3.99343465538263,4.11128434803372,3.60621423667192,-0.505070111361801,0.00397492582899296,ENSG00000100031,GGT1,protein_coding,22,1,24594811,24629005,q11.23,gamma-glutamyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:4250],Gamma-glutamyl transpeptidase deficiency;GLUTATHIONURIA,GGT1,2678,NM_001288833;NM_013421
ZRANB3_TF,ZRANB3,ZRANB3_TF,ZRANB3,TF,462,4.72876115444878,0.276038736586227,0.263967748987514,0.315700552981995,0.0517328039944809,1.26393424962937e-05,4.65364041338981,3.19202408176565,3.10628092716031,3.47375158975462,0.367470662594308,5.57881975595228e-05,ENSG00000121988,ZRANB3,protein_coding,2,-1,135136916,135531218,q21.3,zinc finger RANBP2-type containing 3 [Source:HGNC Symbol;Acc:HGNC:25249],NA,ZRANB3,84083,NM_001286568;NM_001286569;NM_032143
C7orf50_SIG,C7orf50,C7orf50_SIG,C7orf50,SIG,42,4.72869871376023,0.0343094402753255,0.0277318800319209,0.0559214239322266,0.0281895439003057,1.26393424962937e-05,3.458441652813,4.48650160273896,4.41418548514155,4.72411170341618,0.309926218274628,0.00304341203835512,ENSG00000146540,C7orf50,protein_coding,7,-1,996986,1138260,p22.3,chromosome 7 open reading frame 50 [Source:HGNC Symbol;Acc:HGNC:22421],NA,C7orf50,84310,NM_001134395;NM_001134396;NM_001318252;NM_001350968;NM_001350969;NM_032350
GTF2I_SIG,GTF2I,GTF2I_SIG,GTF2I,SIG,41,4.72858552703286,0.465330767039989,0.446797369428066,0.526226216336304,0.079428846908238,1.26393424962937e-05,3.79061155793663,6.55589236575624,6.49270116724434,6.76352058943818,0.270819422193845,0.00110812776325972,ENSG00000263001,GTF2I,protein_coding,7,1,74650231,74760692,q11.23,general transcription factor IIi [Source:HGNC Symbol;Acc:HGNC:4659],Williams syndrome,GTF2I,2969,NM_001163636;NM_001280800;NM_001518;NM_032999;NM_033000;NM_033001
ADO_SIG,ADO,ADO_SIG,ADO,SIG,34,4.72759252526813,0.268580419871052,0.261474322380045,0.291929025912931,0.0304547035328858,1.26927285737333e-05,3.96655344946383,4.71844372495367,4.66275799453074,4.90141112491473,0.238653130383999,0.000631258906644547,ENSG00000181915,ADO,protein_coding,10,1,62804857,62808483,q21.3,2-aminoethanethiol dioxygenase [Source:HGNC Symbol;Acc:HGNC:23506],NA,ADO,84890,NM_032804
ZNF558_TF,ZNF558,ZNF558_TF,ZNF558,TF,75,4.72689563147757,0.232211187738342,0.225688605195915,0.253642530377745,0.0279539251818301,1.2727767999348e-05,1.27826773271618,4.09369653160476,4.07257246841094,4.16310416781302,0.0905316994020771,0.303801181928019,ENSG00000167785,ZNF558,protein_coding,19,-1,8806170,8832314,p13.2,zinc finger protein 558 [Source:HGNC Symbol;Acc:HGNC:26422],NA,ZNF558,148156,NM_001304350;NM_144693
ACKR2_SIG,ACKR2,ACKR2_SIG,ACKR2,SIG,21,-4.72591591896261,-0.00607269859220089,-0.0014659672777555,-0.0212091014825214,-0.0197431342047659,1.27806825309065e-05,-4.87851482832146,0.577066014294709,0.642429488587418,0.362300313047236,-0.280129175540182,2.33721965883465e-05,ENSG00000144648,ACKR2,protein_coding,3,1,42804752,42887974,p22.1,atypical chemokine receptor 2 [Source:HGNC Symbol;Acc:HGNC:1565],NA,ACKR2,1238,NM_001296
DIDO1_SIG,DIDO1,DIDO1_SIG,DIDO1,SIG,118,4.72481682177243,0.177391953161834,0.166028460250309,0.214729144156845,0.0487006839065359,1.28271968002792e-05,4.59527585540116,6.88623852773622,6.82163321536121,7.09851312553984,0.276879910178629,6.97500306345077e-05,ENSG00000101191,DIDO1,protein_coding,20,-1,62877738,62937952,q13.33,death inducer-obliterator 1 [Source:HGNC Symbol;Acc:HGNC:2680],NA,DIDO1,11083,NM_001193369;NM_001193370;NM_022105;NM_033081;NM_080796;NM_080797
ZNF573_TF,ZNF573,ZNF573_TF,ZNF573,TF,142,4.72480654138406,0.0380576547692713,0.0228401769975243,0.0880579388764398,0.0652177618789155,1.28271968002792e-05,4.66289328265424,1.95683268802165,1.86236191441541,2.26723665844215,0.404874744026738,5.39428035841172e-05,ENSG00000189144,ZNF573,protein_coding,19,-1,37735833,37817300,q13.13,zinc finger protein 573 [Source:HGNC Symbol;Acc:HGNC:26420],NA,ZNF573,126231,NM_001172689;NM_001172690;NM_001172691;NM_001172692;NM_152360
RTEL1_SIG,RTEL1,RTEL1_SIG,RTEL1,SIG,11,4.7247676387138,0.0935787035500134,0.087588270972032,0.113261553449095,0.025673282477063,1.28271968002792e-05,3.19221768404576,1.12562247523091,1.0987014713765,1.21407720218113,0.115375730804628,0.00649655297587753,ENSG00000258366,RTEL1,protein_coding,20,1,63657810,63696253,q13.33,regulator of telomere elongation helicase 1 [Source:HGNC Symbol;Acc:HGNC:15888],Dyskeratosis congenita;DYSKERATOSIS CONGENITA AUTOSOMAL DOMINANT 4;DYSKERATOSIS CONGENITA AUTOSOMAL RECESSIVE 5;HOYERAAL-HREIDARSSON SYNDROME;Idiopathic pulmonary fibrosis;PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE TELOMERE-RELATED 3,RTEL1,51750,NM_001283009;NM_001283010;NM_016434;NM_032957
IGF1_SIG,IGF1,IGF1_SIG,IGF1,SIG,84,-4.72365717831054,-0.150802977756066,-0.137105610906277,-0.195808611691087,-0.0587030007848098,1.28888100474403e-05,0.575317384107802,0.474998976803437,0.463967617759498,0.511244870804952,0.0472772530454543,0.665737506929479,ENSG00000017427,IGF1,protein_coding,12,-1,102395874,102481744,q23.2,insulin like growth factor 1 [Source:HGNC Symbol;Acc:HGNC:5464],Growth delay due to insulin-like growth factor type 1 deficiency;INSULIN-LIKE GROWTH FACTOR I DEFICIENCY,IGF1,3479,NM_000618;NM_001111283;NM_001111284;NM_001111285
BCL11B_TF,BCL11B,BCL11B_TF,BCL11B,TF,304,-4.72328492647565,-0.188335370357438,-0.169553999860945,-0.25004558770306,-0.0804915878421151,1.29013811253254e-05,-3.88081020834573,3.58322546882244,3.74287032612134,3.05867808055464,-0.6841922455667,0.000831597991384068,ENSG00000127152,BCL11B,protein_coding,14,-1,99169287,99272197,q32.2,BCL11B, BAF complex component [Source:HGNC Symbol;Acc:HGNC:13222],IMMUNODEFICIENCY 49;INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY DYSMORPHICFACIES AND T-CELL ABNORMALITIES,BCL11B,64919,NM_001282237;NM_001282238;NM_022898;NM_138576
SLC9A7_SIG,SLC9A7,SLC9A7_SIG,SLC9A7,SIG,117,4.72307092783409,0.202634292397886,0.186331765153684,0.256199739057407,0.0698679739037227,1.29013811253254e-05,3.98113419578478,4.38125502932841,4.25534900685063,4.79494624604113,0.539597239190502,0.000603129052148179,ENSG00000065923,SLC9A7,protein_coding,X,-1,46599251,46759118,p11.3,solute carrier family 9 member A7 [Source:HGNC Symbol;Acc:HGNC:17123],NA,SLC9A7,84679,NM_001257291;NM_032591
HMGB2_TF,HMGB2,HMGB2_TF,HMGB2,TF,239,-4.72304985629394,0.0106277058241224,0.0226960395271449,-0.0290253906286657,-0.0517214301558106,1.29013811253254e-05,-2.65750253318984,8.10114695333332,8.16315731036651,7.89739863736712,-0.265758672999391,0.0246642102782597,ENSG00000164104,HMGB2,protein_coding,4,-1,173331695,173335125,q34.1,high mobility group box 2 [Source:HGNC Symbol;Acc:HGNC:5000],NA,HMGB2,3148,NM_001130688;NM_001130689;NM_002129
AFMID_SIG,AFMID,AFMID_SIG,AFMID,SIG,34,4.72137889773426,0.256639777530291,0.23387866364873,0.331426294569705,0.0975476309209744,1.29936014686546e-05,4.79395956019096,3.6782692175174,3.56632691350892,4.04607964497385,0.479752731464938,3.27286135509154e-05,ENSG00000183077,AFMID,protein_coding,17,1,78187317,78207701,q25.3,arylformamidase [Source:HGNC Symbol;Acc:HGNC:20910],NA,AFMID,125061,NM_001010982;NM_001145526
AATK_SIG,AATK,AATK_SIG,AATK,SIG,18,-4.72132926067153,0.37676214884096,0.401772247169774,0.294586111474855,-0.107186135694919,1.29936014686546e-05,-3.61094467049862,3.39777649967283,3.52687652224054,2.97359071123609,-0.553285811004446,0.00192997162166434,ENSG00000181409,AATK,protein_coding,17,-1,81117295,81166221,q25.3,apoptosis associated tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:21],NA,AATK,9625,NM_001080395;NM_004920
RORC_SIG,RORC,RORC_SIG,RORC,SIG,6,-4.7189632508668,-0.0045638358966319,0.0182835285264556,-0.0796337475724907,-0.0979172760989462,1.31368308739614e-05,-3.81322250106567,0.696487743210177,0.759883844081701,0.488186268918025,-0.271697575163676,0.00103381908468156,ENSG00000143365,RORC,protein_coding,1,-1,151806071,151831845,q21.3,RAR related orphan receptor C [Source:HGNC Symbol;Acc:HGNC:10260],Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency;IMMUNODEFICIENCY 42,RORC,6097,NM_001001523;NM_005060
ANAPC4_SIG,ANAPC4,ANAPC4_SIG,ANAPC4,SIG,50,4.71809152968894,0.196606795287964,0.185484198819813,0.233152469397604,0.0476682705777908,1.31844138500496e-05,3.18787603391769,5.19128837171736,5.153938833922,5.31400828161643,0.160069447694428,0.00656842016659159,ENSG00000053900,ANAPC4,protein_coding,4,1,25377213,25418498,p15.2,anaphase promoting complex subunit 4 [Source:HGNC Symbol;Acc:HGNC:19990],NA,ANAPC4,29945,NM_001286756;NM_013367
WNK2_SIG,WNK2,WNK2_SIG,WNK2,SIG,24,-4.71606861344789,-0.15633879107533,-0.147213600879525,-0.186321558861548,-0.039107957982023,1.33072141683838e-05,-2.68328487485403,0.233101534991299,0.257292883681656,0.153615675008697,-0.103677208672959,0.0233046281968166,ENSG00000165238,WNK2,protein_coding,9,1,93184916,93320572,q22.31,WNK lysine deficient protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:14542],NA,WNK2,65268,NM_001282394;NM_006648
SH3BP5_SIG,SH3BP5,SH3BP5_SIG,SH3BP5,SIG,34,-4.71309029295262,0.110326426350615,0.123157388730206,0.0681675499605325,-0.0549898387696734,1.34942638266445e-05,-1.79224229007477,5.12207595112259,5.19024247109196,4.89810024265177,-0.29214222844019,0.140108393717216,ENSG00000131370,SH3BP5,protein_coding,3,-1,15254353,15341368,p25.1,SH3 domain binding protein 5 [Source:HGNC Symbol;Acc:HGNC:10827],NA,SH3BP5,9467,NM_001018009;NM_004844
GDF11_SIG,GDF11,GDF11_SIG,GDF11,SIG,18,4.7098901559556,0.283941728875501,0.268533040422066,0.334570276651074,0.066037236229008,1.36987324877547e-05,2.54888035231929,3.95879391757918,3.85903328640539,4.28657884857879,0.427545562173394,0.0316988231830082,ENSG00000135414,GDF11,protein_coding,12,1,55743280,55757278,q13.2,growth differentiation factor 11 [Source:HGNC Symbol;Acc:HGNC:4216],NA,GDF11,10220,NM_005811
VCAM1_SIG,VCAM1,VCAM1_SIG,VCAM1,SIG,78,-4.7094305624518,-0.23267645843189,-0.217068302809391,-0.283960398334389,-0.0668920955249978,1.37114076921522e-05,-2.97970301463891,0.906096077334769,1.00800415794083,0.571255241057723,-0.436748916883104,0.0113487998659262,ENSG00000162692,VCAM1,protein_coding,1,1,100719742,100739045,p21.2,vascular cell adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:12663],NA,VCAM1,7412,NM_001078;NM_001199834;NM_080682
SIAE_SIG,SIAE,SIAE_SIG,SIAE,SIG,62,-4.70942987740465,0.0712703024264194,0.0775454511534599,0.0506519566090005,-0.0268934945444593,1.37114076921522e-05,-3.8641918323423,4.15021429989994,4.28930485418015,3.69320247869354,-0.596102375486615,0.000880001885386756,ENSG00000110013,SIAE,protein_coding,11,-1,124633113,124695707,q24.2,sialic acid acetylesterase [Source:HGNC Symbol;Acc:HGNC:18187],AUTOIMMUNE DISEASE SUSCEPTIBILITY TO 6,SIAE,54414,NM_001199922;NM_170601
TCF7_SIG,TCF7,TCF7_SIG,TCF7,SIG,68,-4.70836623951472,-0.336591363509868,-0.308413000519691,-0.429177413334735,-0.120764412815044,1.37717523783074e-05,-4.6580724402399,4.26189046968111,4.45622398482548,3.6233660627782,-0.832857922047273,5.47648596967285e-05,ENSG00000081059,TCF7,protein_coding,5,1,134114681,134151865,q31.1,transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:11639],NA,TCF7,6932,NM_001134851;NM_001346425;NM_001346450;NM_001366502;NM_003202;NM_201632;NM_201634;NM_213648
ZNF251_TF,ZNF251,ZNF251_TF,ZNF251,TF,199,4.70826320067782,0.127340807761949,0.116413078267144,0.16324620467345,0.0468331264063058,1.37717523783074e-05,2.8123259134371,4.43416151235227,4.38022864588327,4.611369502179,0.231140856295737,0.0171800185483056,ENSG00000198169,ZNF251,protein_coding,8,-1,144720907,144756417,q24.3,zinc finger protein 251 [Source:HGNC Symbol;Acc:HGNC:13045],NA,ZNF251,90987,NM_138367
CMPK1_SIG,CMPK1,CMPK1_SIG,CMPK1,SIG,10,-4.70741383193619,0.287728168835171,0.294179242701455,0.266531783274522,-0.0276474594269331,1.38200450335904e-05,-1.52653432437375,7.34867272646247,7.36733851767855,7.28734226960962,-0.0799962480689363,0.213285726858192,ENSG00000162368,CMPK1,protein_coding,1,1,47333797,47378839,p33,cytidine/uridine monophosphate kinase 1 [Source:HGNC Symbol;Acc:HGNC:18170],NA,CMPK1,51727,NM_001136140;NM_001366135;NM_016308
FBLN2_SIG,FBLN2,FBLN2_SIG,FBLN2,SIG,39,-4.70691530922022,-0.105670963665757,-0.0986954030783722,-0.128590662738594,-0.0298952596602219,1.38373381967246e-05,-2.19893041094825,1.40115443653,1.48332796847123,1.13115568872309,-0.352172279748137,0.066565034638079,ENSG00000163520,FBLN2,protein_coding,3,1,13549125,13638422,p25.1,fibulin 2 [Source:HGNC Symbol;Acc:HGNC:3601],NA,FBLN2,2199,NM_001004019;NM_001165035;NM_001998
MS4A2_SIG,MS4A2,MS4A2_SIG,MS4A2,SIG,21,-4.70688781623775,-0.0624968704302146,-0.0503260656275242,-0.102486657639055,-0.0521605920115306,1.38373381967246e-05,-2.59485515501444,1.29266507498094,1.39050662817701,0.971185685908106,-0.419320942268909,0.0285329196806241,ENSG00000149534,MS4A2,protein_coding,11,1,60088261,60098467,q12.1,membrane spanning 4-domains A2 [Source:HGNC Symbol;Acc:HGNC:7316],IgE RESPONSIVENESS ATOPIC,MS4A2,2206,NM_000139;NM_001256916
RYR3_SIG,RYR3,RYR3_SIG,RYR3,SIG,51,-4.706368332235,-0.113687509294563,-0.104411329423465,-0.144166386013884,-0.0397550565904194,1.3863423306297e-05,-4.98843375106295,1.09676986643462,1.27207461771469,0.520768540800092,-0.751306076914596,1.48041103524434e-05,ENSG00000198838,RYR3,protein_coding,15,1,33310945,33866121,q13.3,ryanodine receptor 3 [Source:HGNC Symbol;Acc:HGNC:10485],Epileptic encephalopathy,RYR3,6263,NM_001036;NM_001243996
ACSL6_SIG,ACSL6,ACSL6_SIG,ACSL6,SIG,24,-4.70525340407163,-0.0475566370596214,-0.0223728052437186,-0.130303513026159,-0.107930707782441,1.39301625476292e-05,-3.78517599220974,1.4687535326649,1.58902050961212,1.07359060840973,-0.515429901202386,0.00112789695034564,ENSG00000164398,ACSL6,protein_coding,5,-1,131949973,132012243,q31.1,acyl-CoA synthetase long chain family member 6 [Source:HGNC Symbol;Acc:HGNC:16496],NA,ACSL6,23305,NM_001009185;NM_001205247;NM_001205248;NM_001205250;NM_001205251;NM_015256
PSTPIP1_SIG,PSTPIP1,PSTPIP1_SIG,PSTPIP1,SIG,41,-4.70446517067673,0.497622038256796,0.524421750341899,0.409565841405743,-0.114855908936156,1.39748191556045e-05,-2.21227763796443,5.72408930996502,5.79258780736166,5.49902281851893,-0.293564988842731,0.0647721046438282,ENSG00000140368,PSTPIP1,protein_coding,15,1,76993359,77037332,q24.3,proline-serine-threonine phosphatase interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:9580],Hyperzincemia and hypercalprotectinemia;Pyogenic arthritis-pyoderma gangrenosum-acne syndrome;PYOGENIC STERILE ARTHRITIS PYODERMA GANGRENOSUM AND ACNE,PSTPIP1,9051,NM_001321135;NM_001321136;NM_001321137;NM_003978
CD28_SIG,CD28,CD28_SIG,CD28,SIG,31,-4.70356587158372,-0.227578852677726,-0.191867659576455,-0.344915630010473,-0.153047970434017,1.40268405245581e-05,-4.60918670239145,2.49435150064181,2.66824996729585,1.92297082449282,-0.745279142803035,6.63680318029564e-05,ENSG00000178562,CD28,protein_coding,2,1,203706475,203738912,q33.2,CD28 molecule [Source:HGNC Symbol;Acc:HGNC:1653],Classic mycosis fungoides;Sezary syndrome,CD28,940,NM_001243077;NM_001243078;NM_006139
VNN2_SIG,VNN2,VNN2_SIG,VNN2,SIG,32,-4.70343671158678,0.162569823167803,0.200693556753562,0.0373061271003074,-0.163387429653255,1.40268405245581e-05,-4.1150370726966,5.08733872960444,5.30727781704677,4.3646817280082,-0.942596089038569,0.000385547112272486,ENSG00000112303,VNN2,protein_coding,6,-1,132743870,132763459,q23.2,vanin 2 [Source:HGNC Symbol;Acc:HGNC:12706],NA,VNN2,8875,NM_001242350;NM_004665;NM_078488
ZNF80_TF,ZNF80,ZNF80_TF,ZNF80,TF,32,-4.70291573739808,-0.0245817719664185,-0.010314045018309,-0.0714614462244927,-0.0611474012061838,1.40492781215325e-05,-2.16764012326114,0.259019070673646,0.278935067937004,0.193580793951184,-0.0853542739858197,0.0706238575871568,ENSG00000174255,ZNF80,protein_coding,3,-1,114234631,114237578,q13.31,zinc finger protein 80 [Source:HGNC Symbol;Acc:HGNC:13155],NA,ZNF80,7634,NM_007136
COL1A2_SIG,COL1A2,COL1A2_SIG,COL1A2,SIG,17,-4.70284055195984,-0.219111687905917,-0.20589966010746,-0.262522636386562,-0.0566229762791013,1.40492781215325e-05,-2.90943061421808,0.586873640703508,0.665495591272464,0.328544374548365,-0.336951216724099,0.0135446322151617,ENSG00000164692,COL1A2,protein_coding,7,1,94394561,94431232,q21.3,collagen type I alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2198],EHLERS-DANLOS SYNDROME ARTHROCHALASIA TYPE 2;Ehlers-Danlos syndrome cardiac valvular  type;Ehlers-Danlos syndrome type 7B;Ehlers-Danlos/osteogenesis imperfecta syndrome;High bone mass osteogenesis imperfecta;Osteogenesis imperfecta type 1;Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4;OSTEOGENESIS IMPERFECTA TYPE II;OSTEOGENESIS IMPERFECTA TYPE III;OSTEOGENESIS IMPERFECTA TYPE IV;OSTEOPOROSIS,COL1A2,1278,NM_000089
GPC4_SIG,GPC4,GPC4_SIG,GPC4,SIG,74,4.70219372356455,-0.113591476522212,-0.122849570034324,-0.0831720264109866,0.0396775436233371,1.4077392916708e-05,2.35240244121423,1.20877442757343,1.09258390754823,1.59054327908479,0.497959371536558,0.0484992616825701,ENSG00000076716,GPC4,protein_coding,X,-1,133300103,133415489,q26.2,glypican 4 [Source:HGNC Symbol;Acc:HGNC:4452],Simpson-Golabi-Behmel syndrome;SIMPSON-GOLABI-BEHMEL SYNDROME TYPE 1;WILMS TUMOR 1,GPC4,2239,NM_001448
CEBPB_TF,CEBPB,CEBPB_TF,CEBPB,TF,146,-4.7021628624412,0.290604350626223,0.310874967569824,0.224000894954392,-0.0868740726154315,1.4077392916708e-05,-3.98399891790065,6.43454098149127,6.57060670124132,5.98746790231253,-0.583138798928792,0.000597280370059501,ENSG00000172216,CEBPB,protein_coding,20,1,50190734,50192689,q13.13,CCAAT enhancer binding protein beta [Source:HGNC Symbol;Acc:HGNC:1834],NA,CEBPB,1051,NM_001285878;NM_001285879;NM_005194
PTAFR_SIG,PTAFR,PTAFR_SIG,PTAFR,SIG,32,-4.70186378862903,0.393985033931455,0.425965008512516,0.288907974593686,-0.13705703391883,1.40887332169716e-05,-3.44485116578514,5.68848736659829,5.84799090649501,5.16440430693765,-0.683586599557365,0.00316096559396413,ENSG00000169403,PTAFR,protein_coding,1,-1,28147166,28193936,p35.3,platelet activating factor receptor [Source:HGNC Symbol;Acc:HGNC:9582],NA,PTAFR,5724,NM_000952;NM_001164721;NM_001164722;NM_001164723
ZFP2_TF,ZFP2,ZFP2_TF,ZFP2,TF,44,4.70086799964813,0.0300185269887932,0.0170014817294716,0.0727888185551357,0.0557873368256642,1.41482864316707e-05,2.42534933988102,0.988685606126875,0.946016206100267,1.12888506335716,0.18286885725689,0.041479971874949,ENSG00000198939,ZFP2,protein_coding,5,1,178895898,178933212,q35.3,ZFP2 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:26138],NA,ZFP2,80108,NM_030613
PLSCR4_SIG,PLSCR4,PLSCR4_SIG,PLSCR4,SIG,122,-4.6973024621269,-0.12030316185425,-0.111056312259696,-0.150685667664926,-0.0396293554052299,1.43879522070111e-05,-2.63953884566585,1.03652399243866,1.12341528512094,0.751024030768335,-0.372391254352603,0.0256758235353725,ENSG00000114698,PLSCR4,protein_coding,3,-1,146192335,146251179,q24,phospholipid scramblase 4 [Source:HGNC Symbol;Acc:HGNC:16497],NA,PLSCR4,57088,NM_001128304;NM_001128305;NM_001128306;NM_001177304;NM_020353
UTP14A_SIG,UTP14A,UTP14A_SIG,UTP14A,SIG,49,4.69510691800659,0.45689722986187,0.440920351296806,0.509392688004223,0.0684723367074178,1.45337832911844e-05,4.85435103059914,4.71336550024915,4.63991084513749,4.95471650990175,0.314805664764252,2.59690404648384e-05,ENSG00000156697,UTP14A,protein_coding,X,1,129906121,129929761,q26.1,UTP14A, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:10665],NA,UTP14A,10813,NM_001166221;NM_006649
SIGLEC1_SIG,SIGLEC1,SIGLEC1_SIG,SIGLEC1,SIG,27,-4.69373611399515,0.0116917095390538,0.0328690974020699,-0.0578911362965703,-0.0907602336986403,1.46219368693995e-05,-3.41301656276406,2.3214812291123,2.50149745497178,1.72999934414544,-0.771498110826335,0.0034710963516675,ENSG00000088827,SIGLEC1,protein_coding,20,-1,3686970,3707128,p13,sialic acid binding Ig like lectin 1 [Source:HGNC Symbol;Acc:HGNC:11127],NA,SIGLEC1,6614,NM_023068
GNG12_SIG,GNG12,GNG12_SIG,GNG12,SIG,49,-4.69037467203619,-0.235770534231855,-0.228880269188867,-0.258409976515958,-0.0295297073270907,1.4845821399593e-05,-2.71228239619529,0.331124786550602,0.366190681085098,0.215908275937256,-0.150282405147842,0.0217689837111097,ENSG00000172380,GNG12,protein_coding,1,-1,67701475,67833467,p31.3,G protein subunit gamma 12 [Source:HGNC Symbol;Acc:HGNC:19663],NA,GNG12,55970,NM_018841
BMPR1B_SIG,BMPR1B,BMPR1B_SIG,BMPR1B,SIG,50,4.69035916637766,-0.0625409575365343,-0.0700516336671054,-0.0378630216789434,0.0321886119881619,1.4845821399593e-05,3.19978390510781,0.47256823143567,0.409243183083644,0.680636247449469,0.271393064365825,0.00635529685737927,ENSG00000138696,BMPR1B,protein_coding,4,1,94757968,95158448,q22.3,bone morphogenetic protein receptor type 1B [Source:HGNC Symbol;Acc:HGNC:1077],ACROMESOMELIC DYSPLASIA DEMIRHAN TYPE;Acromesomelic dysplasia Grebe type;Brachydactyly type A1;BRACHYDACTYLY TYPE A1 D;Brachydactyly type A2;BRACHYDACTYLY TYPE A2;Brachydactyly type C;Fibular aplasia-complex brachydactyly syndrome,BMPR1B,658,NM_001203;NM_001256792;NM_001256793;NM_001256794
SDR42E1_SIG,SDR42E1,SDR42E1_SIG,SDR42E1,SIG,26,-4.68945876645192,-0.134502294110083,-0.125017266946658,-0.165667383361337,-0.0406501164146781,1.49015013158861e-05,-3.81894446485038,0.537160887715854,0.598280977661814,0.336337735036272,-0.261943242625541,0.00101482243181777,ENSG00000184860,SDR42E1,protein_coding,16,-1,81988855,82011481,q23.3,short chain dehydrogenase/reductase family 42E, member 1 [Source:HGNC Symbol;Acc:HGNC:29834],NA,SDR42E1,93517,NM_145168
SLAMF1_SIG,SLAMF1,SLAMF1_SIG,SLAMF1,SIG,15,-4.68916735941368,0.0805512795334172,0.104876266539929,0.000626322226305706,-0.104249944313624,1.49129438651607e-05,-3.08710559616173,2.20433717699611,2.30314424013748,1.87968539810304,-0.423458842034434,0.00857444608193384,ENSG00000117090,SLAMF1,protein_coding,1,-1,160608106,160647295,q23.3,signaling lymphocytic activation molecule family member 1 [Source:HGNC Symbol;Acc:HGNC:10903],NA,SLAMF1,6504,NM_001330754;NM_003037
ZNF593_TF,ZNF593,ZNF593_TF,ZNF593,TF,242,4.68841431666669,0.0558448756439075,0.0489792100729715,0.0784034910912686,0.029424281018297,1.49581003376106e-05,2.74583276973785,3.38916266439536,3.3474429100859,3.52624185712642,0.178798947040519,0.0200872152744373,ENSG00000142684,ZNF593,protein_coding,1,1,26169908,26170873,p36.11,zinc finger protein 593 [Source:HGNC Symbol;Acc:HGNC:30943],NA,ZNF593,51042,NM_015871
ZFP28_TF,ZFP28,ZFP28_TF,ZFP28,TF,29,4.68665928608772,0.140707201501958,0.124839389320831,0.192844298668517,0.0680049093476857,1.50770007680663e-05,2.31339195919534,2.75248287648336,2.70518050720334,2.90790494697487,0.202724439771536,0.0525162178149132,ENSG00000196867,ZFP28,protein_coding,19,1,56538948,56556810,q13.43,ZFP28 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:17801],NA,ZFP28,140612,NM_001308440;NM_020828
SDC1_SIG,SDC1,SDC1_SIG,SDC1,SIG,96,-4.68514969396459,-0.185517536446099,-0.170131537645057,-0.236071532506667,-0.0659399948616096,1.51786079027241e-05,-2.17264151891403,0.928751581178999,0.978547595718631,0.765136104834494,-0.213411490884137,0.0699670575635304,ENSG00000115884,SDC1,protein_coding,2,-1,20200797,20225433,p24.1,syndecan 1 [Source:HGNC Symbol;Acc:HGNC:10658],NA,SDC1,6382,NM_001006946;NM_002997
SLC2A14_SIG,SLC2A14,SLC2A14_SIG,SLC2A14,SIG,9,-4.68416563116378,0.0181820373937993,0.0321804274602333,-0.027812672824484,-0.0599931002847172,1.52417234262402e-05,-4.36196390573244,2.28674477240213,2.43222649879281,1.80873338568989,-0.62349311310292,0.000163386360842726,ENSG00000173262,SLC2A14,protein_coding,12,-1,7812512,7891148,p13.31,solute carrier family 2 member 14 [Source:HGNC Symbol;Acc:HGNC:18301],NA,SLC2A14,144195,NM_001286233;NM_001286234;NM_001286235;NM_001286236;NM_001286237;NM_153449
POLI_SIG,POLI,POLI_SIG,POLI,SIG,63,4.68248024916105,0.162640093570661,0.150547450430852,0.202373063887179,0.0518256134563276,1.53575671313699e-05,4.11692831724092,4.61985156236133,4.54961877336225,4.85061644050116,0.300997667138903,0.000383401403894819,ENSG00000101751,POLI,protein_coding,18,1,54269404,54321266,q21.2,DNA polymerase iota [Source:HGNC Symbol;Acc:HGNC:9182],NA,POLI,11201,NM_001351610;NM_001351611;NM_001351612;NM_001351613;NM_001351614;NM_001351615;NM_001351616;NM_001351617;NM_001351618;NM_001351619;NM_001351620;NM_001351621;NM_001351632;NM_007195
TRNT1_SIG,TRNT1,TRNT1_SIG,TRNT1,SIG,35,4.68173700359277,0.223088913769085,0.208217191751361,0.27195314325589,0.0637359515045289,1.53963281263328e-05,2.80364181710871,4.14965881530043,4.09762848484188,4.32061561537849,0.222987130536609,0.0175449427340562,ENSG00000072756,TRNT1,protein_coding,3,1,3126933,3150879,p26.2,tRNA nucleotidyl transferase 1 [Source:HGNC Symbol;Acc:HGNC:17341],Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome;RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS;SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY PERIODIC FEVERS AND DEVELOPMENTAL DELAY,TRNT1,51095,NM_001302946;NM_182916
PIK3CB_SIG,PIK3CB,PIK3CB_SIG,PIK3CB,SIG,42,4.681569944925,0.158828067420229,0.151821227963956,0.181850539919415,0.030029311955459,1.53963281263328e-05,4.12872524349862,5.94863896404662,5.87894155369871,6.17764474090404,0.298703187205325,0.000369095281783955,ENSG00000051382,PIK3CB,protein_coding,3,-1,138652699,138834938,q22.3,phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:8976],NA,PIK3CB,5291,NM_001256045;NM_006219
DMAP1_SIG,DMAP1,DMAP1_SIG,DMAP1,SIG,54,4.68156194425595,0.350865036386565,0.341949023977727,0.38016050572989,0.038211481752163,1.53963281263328e-05,2.98666486624634,5.62970066826824,5.59673220413766,5.73802562184017,0.141293417702513,0.0111415294705804,ENSG00000178028,DMAP1,protein_coding,1,1,44213455,44220681,p34.1,DNA methyltransferase 1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18291],NA,DMAP1,55929,NM_001034023;NM_001034024;NM_019100
SLC9B1_SIG,SLC9B1,SLC9B1_SIG,SLC9B1,SIG,21,-4.68104624713435,-0.121298328191908,-0.113548074416476,-0.146763447739757,-0.0332153733232806,1.5425045286722e-05,-5.1540064639717,0.763209270822026,0.813641430102449,0.597503604614924,-0.216137825487525,7.66178786653218e-06,ENSG00000164037,SLC9B1,protein_coding,4,-1,102885048,103019739,q24,solute carrier family 9 member B1 [Source:HGNC Symbol;Acc:HGNC:24244],NA,SLC9B1,150159,NM_001100874;NM_139173
ZNF888_TF,ZNF888,ZNF888_TF,ZNF888,TF,50,4.67961326899126,0.161122078795396,0.149585926098241,0.199026580514619,0.0494406544163779,1.55231162035655e-05,3.07101777768037,1.62077546852173,1.5763972237681,1.76658970128366,0.190192477515563,0.00895721172507208,ENSG00000213793,ZNF888,protein_coding,19,-1,52904417,52923481,q13.41,zinc finger protein 888 [Source:HGNC Symbol;Acc:HGNC:38695],NA,ZNF888,388559,NM_001310127
IFITM2_SIG,IFITM2,IFITM2_SIG,IFITM2,SIG,18,-4.67879743135037,0.222966186994768,0.244843335234542,0.151084128492653,-0.0937592067418892,1.55714374206403e-05,-3.74616028196259,7.3482497537279,7.44980616354776,7.01456440717694,-0.435241756370818,0.00127152087839628,ENSG00000185201,IFITM2,protein_coding,11,1,307631,315272,p15.5,interferon induced transmembrane protein 2 [Source:HGNC Symbol;Acc:HGNC:5413],NA,IFITM2,10581,NM_006435
CPQ_SIG,CPQ,CPQ_SIG,CPQ,SIG,10,-4.67870878143479,0.302023207831641,0.312617693560647,0.26721275472205,-0.0454049388385968,1.55714374206403e-05,-4.00561262516329,4.73216904639589,4.81792381360947,4.4504033826941,-0.367520430915366,0.000559013535187878,ENSG00000104324,CPQ,protein_coding,8,1,96645242,97149654,q22.1,carboxypeptidase Q [Source:HGNC Symbol;Acc:HGNC:16910],NA,CPQ,10404,NM_016134
STK17A_SIG,STK17A,STK17A_SIG,STK17A,SIG,39,-4.67830438180015,-0.0576095440693987,-0.0479852673682767,-0.0892321675159427,-0.0412469001476662,1.55871205883036e-05,-4.92152641900921,5.10354282182566,5.2083139439177,4.75929484923756,-0.449019094680135,1.95502489360688e-05,ENSG00000164543,STK17A,protein_coding,7,1,43582758,43650713,p13,serine/threonine kinase 17a [Source:HGNC Symbol;Acc:HGNC:11395],NA,STK17A,9263,NM_004760
MAFB_TF,MAFB,MAFB_TF,MAFB,TF,257,-4.6782354697303,0.177652931695612,0.201798555950111,0.0983173091451138,-0.103481246804997,1.55871205883036e-05,-4.44799480763827,4.92388976061824,5.21795485706905,3.95767587227986,-1.26027898478919,0.000120037067146853,ENSG00000204103,MAFB,protein_coding,20,-1,40685848,40689236,q12,MAF bZIP transcription factor B [Source:HGNC Symbol;Acc:HGNC:6408],Duane retraction syndrome;DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS;Duane Syndrome Aberrant Extraocular Muscle Innervation and Inner-Ear Defects;Multicentric carpo-tarsal osteolysis with or without nephropathy;MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME,MAFB,9935,NM_005461
MORC2_TF,MORC2,MORC2_TF,MORC2,TF,90,4.67745714964221,0.368359827282992,0.357186874940896,0.405070956407021,0.0478840814661248,1.56362145029906e-05,3.10685898901705,5.25136021116933,5.20431649270526,5.40593242897984,0.201615936274572,0.00817061494590058,ENSG00000133422,MORC2,protein_coding,22,-1,30925130,30968774,q12.2,MORC family CW-type zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:23573],Autosomal dominant Charcot-Marie-Tooth disease type 2Z;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2Z;MORC2 - axonal neuropathy,MORC2,22880,NM_001303256;NM_001303257;NM_014941
ZNF74_TF,ZNF74,ZNF74_TF,ZNF74,TF,580,4.67670109409207,0.200620895424641,0.184528846717946,0.253494769746638,0.0689659230286923,1.56837583347731e-05,4.39077904772418,3.75395904452222,3.63249745223841,4.15304713345473,0.520549681216316,0.000147440769458592,ENSG00000185252,ZNF74,protein_coding,22,1,20394115,20408461,q11.21,zinc finger protein 74 [Source:HGNC Symbol;Acc:HGNC:13144],NA,ZNF74,7625,NM_001256523;NM_001256524;NM_001256525;NM_003426
DDX17_SIG,DDX17,DDX17_SIG,DDX17,SIG,216,4.67647900722824,0.0971058159929491,0.0842113077364131,0.13947348597871,0.0552621782422971,1.56905566818332e-05,2.81516070205522,9.80206334416658,9.7508072028322,9.97047637997954,0.219669177147338,0.0170636216406822,ENSG00000100201,DDX17,protein_coding,22,-1,38483438,38507660,q13.1,DEAD-box helicase 17 [Source:HGNC Symbol;Acc:HGNC:2740],NA,DDX17,10521,NM_001098504;NM_006386
SLC16A9_SIG,SLC16A9,SLC16A9_SIG,SLC16A9,SIG,54,4.67609001890195,-0.127105447280356,-0.136900253258882,-0.0949225133509116,0.0419777399079703,1.5710138132645e-05,2.09692681762757,1.55178490017089,1.46876085287651,1.82457819842385,0.355817345547343,0.0808231652052533,ENSG00000165449,SLC16A9,protein_coding,10,-1,59650761,59736002,q21.2,solute carrier family 16 member 9 [Source:HGNC Symbol;Acc:HGNC:23520],NA,SLC16A9,220963,NM_001323977;NM_001323978;NM_001323979;NM_001323980;NM_001323981;NM_194298
SMARCAD1_SIG,SMARCAD1,SMARCAD1_SIG,SMARCAD1,SIG,108,4.67593906115401,0.372062977857894,0.35708954357243,0.421261404795845,0.0641718612234151,1.57115116682651e-05,3.82114744801189,5.20327312855164,5.13751443556406,5.41933740551083,0.281822969946773,0.00100746894190312,ENSG00000163104,SMARCAD1,protein_coding,4,1,94207611,94291292,q22.3,SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 [Source:HGNC Symbol;Acc:HGNC:18398],Absence of fingerprints-congenital milia syndrome;Adermatoglyphia;Basan syndrome;Huriez syndrome;Isolated congenital adermatoglyphia,SMARCAD1,56916,NM_001128429;NM_001128430;NM_001254949;NM_020159
LBX2_TF,LBX2,LBX2_TF,LBX2,TF,82,4.67395841559261,0.056770703401139,0.0523794567135931,0.0711990853745044,0.0188196286609112,1.5853603920266e-05,0.0594639848081163,1.00468980584685,1.00357224585488,1.00836178867761,0.00478954282272927,0.967074329423253,ENSG00000179528,LBX2,protein_coding,2,-1,74497517,74503316,p13.1,ladybird homeobox 2 [Source:HGNC Symbol;Acc:HGNC:15525],NA,LBX2,85474,NM_001009812;NM_001282430
RNF187_SIG,RNF187,RNF187_SIG,RNF187,SIG,12,4.67274514890136,0.165154358237175,0.160750928033436,0.179622771763745,0.0188718437303091,1.59319234585134e-05,2.29439357682539,6.20602735153379,6.17861956184084,6.29608151766777,0.117461955826935,0.0545858760187668,ENSG00000168159,RNF187,protein_coding,1,1,228487382,228496188,q42.13,ring finger protein 187 [Source:HGNC Symbol;Acc:HGNC:27146],NA,RNF187,149603,NM_001010858
TIGD4_TF,TIGD4,TIGD4_TF,TIGD4,TF,8,4.67268098524009,-0.0181902049626667,-0.0274292894974541,0.0121667870802061,0.0395960765776602,1.59319234585134e-05,3.84201530596926,0.286052558723634,0.263808568412496,0.35913995546023,0.095331387047734,0.000942427650893001,ENSG00000169989,TIGD4,protein_coding,4,-1,152769354,152779764,q31.3,tigger transposable element derived 4 [Source:HGNC Symbol;Acc:HGNC:18335],NA,TIGD4,201798,NM_145720
HDAC6_SIG,HDAC6,HDAC6_SIG,HDAC6,SIG,30,4.67113495292938,0.284789322635082,0.270311997759478,0.332357675797784,0.0620456780383066,1.60419479110699e-05,2.23225302617459,6.45362833546773,6.42463402630196,6.54889535129812,0.124261324996157,0.0621240288446955,ENSG00000094631,HDAC6,protein_coding,X,1,48801377,48824982,p11.23,histone deacetylase 6 [Source:HGNC Symbol;Acc:HGNC:14064],CHONDRODYSPLASIA WITH PLATYSPONDYLY DISTINCTIVE BRACHYDACTYLYHYDROCEPHALY AND MICROPHTHALMIA;X-linked dominant chondrodysplasia Chassaing-Lacombe type,HDAC6,10013,NM_001321225;NM_001321226;NM_001321227;NM_001321228;NM_001321229;NM_001321230;NM_001321231;NM_006044
ATR_SIG,ATR,ATR_SIG,ATR,SIG,76,4.6698935823772,0.327155744117317,0.315020807110065,0.36702767999829,0.0520068728882257,1.6128430273077e-05,3.80011740700033,5.3301018679143,5.2672917407095,5.53647800015862,0.269186259449117,0.00107607659682148,ENSG00000175054,ATR,protein_coding,3,-1,142449235,142578733,q23,ATR serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:882],CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME FAMILIAL;Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome;Seckel syndrome;SECKEL SYNDROME 1;SECKEL SYNDROME TYPE 1,ATR,545,NM_001184;NM_001354579
OR52K3P_SIG,OR52K3P,OR52K3P_SIG,OR52K3P,SIG,7,-4.66976518173096,-0.0361406004168333,-0.0048945229115283,-0.13880628364855,-0.133911760737022,1.6128430273077e-05,-4.34367273343595,1.64891435956454,1.79511908549275,1.16852740294328,-0.626591682549469,0.000174382844305968,ENSG00000225101,OR52K3P,transcribed_unprocessed_pseudogene,11,1,4393783,4476361,p15.4,olfactory receptor family 52 subfamily K member 3 pseudogene [Source:HGNC Symbol;Acc:HGNC:15224],NA,OR52K3P,NA,NA
ZBTB7B_TF,ZBTB7B,ZBTB7B_TF,ZBTB7B,TF,623,-4.6688067102112,0.0806092536263898,0.0974339438004998,0.0253281287685998,-0.0721058150318999,1.61933926749295e-05,-3.85673009919312,6.17622111400722,6.27658523019523,5.84645330367518,-0.430131926520059,0.000899962036963068,ENSG00000160685,ZBTB7B,protein_coding,1,1,155002630,155018522,q21.3,zinc finger and BTB domain containing 7B [Source:HGNC Symbol;Acc:HGNC:18668],NA,ZBTB7B,51043,NM_001252406;NM_001256455
TRAFD1_TF,TRAFD1,TRAFD1_TF,TRAFD1,TF,167,-4.66780160465242,0.241529235316572,0.250923295100016,0.210663038885255,-0.0402602562147603,1.62622988166761e-05,-2.39676243754843,5.49899497768868,5.53605517508805,5.37722575766221,-0.158829417425839,0.044179962865476,ENSG00000135148,TRAFD1,protein_coding,12,1,112125538,112153604,q24.13,TRAF-type zinc finger domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24808],NA,TRAFD1,10906,NM_001143906;NM_006700
TULP4_TF,TULP4,TULP4_TF,TULP4,TF,119,-4.66734397794641,0.0279440906102379,0.0327745394437136,0.0120726158716746,-0.0207019235720391,1.6288047442891e-05,-4.72778126949074,4.12715451275609,4.24364359127081,3.74440468335058,-0.49923890792023,4.21332867631518e-05,ENSG00000130338,TULP4,protein_coding,6,1,158232236,158511828,q25.3,tubby like protein 4 [Source:HGNC Symbol;Acc:HGNC:15530],NA,TULP4,56995,NM_001007466;NM_020245
GPR55_SIG,GPR55,GPR55_SIG,GPR55,SIG,30,4.66641731015597,0.0781903188272121,0.0670618607586026,0.114755252481215,0.047693391722612,1.63511067496303e-05,5.10822602502198,1.67360809794999,1.55084373218739,2.07697672831281,0.52613299612542,9.14729005405598e-06,ENSG00000135898,GPR55,protein_coding,2,-1,230907318,230961066,q37.1,G protein-coupled receptor 55 [Source:HGNC Symbol;Acc:HGNC:4511],NA,GPR55,9290,NM_005683
ZNF30_TF,ZNF30,ZNF30_TF,ZNF30,TF,33,4.66574437020702,0.0587091119967393,0.0439143173434012,0.107320580143422,0.0634062628000204,1.63941596448904e-05,4.28869410503598,1.31137797002806,1.22964193362394,1.57993923249873,0.350297298874797,0.000213438300023084,ENSG00000168661,ZNF30,protein_coding,19,1,34926903,34945170,q13.11,zinc finger protein 30 [Source:HGNC Symbol;Acc:HGNC:13090],NA,ZNF30,90075,NM_001099437;NM_001099438;NM_194325
NR5A2_TF,NR5A2,NR5A2_TF,NR5A2,TF,133,-4.6653226946334,-0.00641017887121285,-0.000505853062929902,-0.0258101065269997,-0.0253042534640698,1.64103976707073e-05,-2.6632189891235,0.529961070239207,0.598473659629708,0.304848276527561,-0.293625383102147,0.0243761674392421,ENSG00000116833,NR5A2,protein_coding,1,1,200027614,200177420,q32.1,nuclear receptor subfamily 5 group A member 2 [Source:HGNC Symbol;Acc:HGNC:7984],NA,NR5A2,2494,NM_001276464;NM_003822;NM_205860
ATG10_SIG,ATG10,ATG10_SIG,ATG10,SIG,8,4.66521562077308,0.263266002447251,0.247916303999008,0.313700725920048,0.06578442192104,1.64103976707073e-05,4.15351464507264,2.91917701074924,2.85787919706382,3.12058411285847,0.262704915794645,0.000337714513323111,ENSG00000152348,ATG10,protein_coding,5,1,81972023,82276857,q14.1,autophagy related 10 [Source:HGNC Symbol;Acc:HGNC:20315],NA,ATG10,83734,NM_001131028;NM_031482
RSPO1_SIG,RSPO1,RSPO1_SIG,RSPO1,SIG,14,-4.66514426510415,-0.145492002081412,-0.139608750356288,-0.164822686321104,-0.0252139359648158,1.64103976707073e-05,-3.05623185951587,0.276933881393885,0.31026480677142,0.16741798372484,-0.14284682304658,0.00930447079959861,ENSG00000169218,RSPO1,protein_coding,1,-1,37611350,37634892,p34.3,R-spondin 1 [Source:HGNC Symbol;Acc:HGNC:21679],PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46XX SEX REVERSAL PALMOPLANTAR HYPERKERATOSIS AND TRUE HERMAPHRODITISM INCLUDED;Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,RSPO1,284654,NM_001038633;NM_001242908;NM_001242909;NM_001242910
PDK4_SIG,PDK4,PDK4_SIG,PDK4,SIG,12,-4.66443203467553,0.0831228583550466,0.115899337039407,-0.0245712858935646,-0.140470622932971,1.6456764111082e-05,-2.64346100466346,2.58149025295132,2.71804914116366,2.13279676311075,-0.585252378052915,0.0254284627446213,ENSG00000004799,PDK4,protein_coding,7,-1,95583499,95596516,q21.3,pyruvate dehydrogenase kinase 4 [Source:HGNC Symbol;Acc:HGNC:8812],NA,PDK4,5166,NM_002612
TYW3_SIG,TYW3,TYW3_SIG,TYW3,SIG,15,4.66361272272051,0.39922187502741,0.390302924067293,0.42852699961065,0.0382240755433564,1.65118542963304e-05,2.56476477111801,4.86683395942365,4.83007949598649,4.98759862500289,0.157519129016404,0.0305140898752943,ENSG00000162623,TYW3,protein_coding,1,1,74733152,74766678,p31.1,tRNA-yW synthesizing protein 3 homolog [Source:HGNC Symbol;Acc:HGNC:24757],NA,TYW3,127253,NM_001162916;NM_138467
ZNF74_SIG,ZNF74,ZNF74_SIG,ZNF74,SIG,189,4.66310338690061,0.161603949694479,0.141294024247769,0.228336561876524,0.0870425376287547,1.65421799313437e-05,4.39077904772418,3.75395904452222,3.63249745223841,4.15304713345473,0.520549681216316,0.000147440769458592,ENSG00000185252,ZNF74,protein_coding,22,1,20394115,20408461,q11.21,zinc finger protein 74 [Source:HGNC Symbol;Acc:HGNC:13144],NA,ZNF74,7625,NM_001256523;NM_001256524;NM_001256525;NM_003426
RNF125_SIG,RNF125,RNF125_SIG,RNF125,SIG,44,4.66217597420937,0.214516915915066,0.203053457049173,0.252182566474431,0.0491291094252588,1.66062752072405e-05,4.79010326010658,5.97963206694785,5.85574325696592,6.38669529974563,0.530952042779713,3.31028286917639e-05,ENSG00000101695,RNF125,protein_coding,18,1,32018825,32073219,q12.1,ring finger protein 125 [Source:HGNC Symbol;Acc:HGNC:21150],TENORIO SYNDROME,RNF125,54941,NM_017831
HMOX1_SIG,HMOX1,HMOX1_SIG,HMOX1,SIG,30,-4.66114448493934,0.264686465262271,0.302184572035101,0.141478400151545,-0.160706171883556,1.66790452083382e-05,-4.71895117660531,4.34807210320011,4.58945079966406,3.55497067196142,-1.03448012770264,4.34496289425152e-05,ENSG00000100292,HMOX1,protein_coding,22,1,35380361,35394207,q12.3,heme oxygenase 1 [Source:HGNC Symbol;Acc:HGNC:5013],HEME OXYGENASE 1 DEFICIENCY;PULMONARY DISEASE CHRONIC OBSTRUCTIVE,HMOX1,3162,NM_002133
CAMK4_SIG,CAMK4,CAMK4_SIG,CAMK4,SIG,82,-4.66041523825169,-0.283948811906285,-0.255295430078745,-0.378095637911061,-0.122800207832317,1.67275420778011e-05,-4.16869573476736,2.65379280175113,2.81024245609697,2.13974393747195,-0.670498518625026,0.000321147673626705,ENSG00000152495,CAMK4,protein_coding,5,1,111223653,111494886,q22.1,calcium/calmodulin dependent protein kinase IV [Source:HGNC Symbol;Acc:HGNC:1464],NA,CAMK4,814,NM_001323374;NM_001323375;NM_001323376;NM_001323377;NM_001744
NDUFA10_SIG,NDUFA10,NDUFA10_SIG,NDUFA10,SIG,23,4.66024626293266,0.415273346368455,0.407132256479504,0.442022641717864,0.03489038523836,1.673057660927e-05,5.00780545495489,6.36027950455343,6.31506081791134,6.50885518923457,0.193794371323226,1.37994623165751e-05,ENSG00000130414,NDUFA10,protein_coding,2,-1,239892450,240025345,q37.3,NADH:ubiquinone oxidoreductase subunit A10 [Source:HGNC Symbol;Acc:HGNC:7684],LEIGH SYNDROME DUP;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 22,NDUFA10,4705,NM_001322019;NM_001322020;NM_004544
REXO4_SIG,REXO4,REXO4_SIG,REXO4,SIG,83,4.66011070364086,0.139024953266479,0.122476553974962,0.193398265224321,0.0709217112493591,1.6730901631452e-05,3.44233991539682,4.97496505081544,4.91484680361223,5.17249643448312,0.257649630870895,0.00317967506295418,ENSG00000148300,REXO4,protein_coding,9,-1,133406059,133418096,q34.2,REX4 homolog, 3'-5' exonuclease [Source:HGNC Symbol;Acc:HGNC:12820],NA,REXO4,57109,NM_001279349;NM_001279350;NM_001279351;NM_020385
GPSM3_SIG,GPSM3,GPSM3_SIG,GPSM3,SIG,55,-4.65984161172887,0.192100041858448,0.206058132179653,0.146237745088774,-0.0598203870908786,1.67420907238632e-05,-4.12184811536492,7.37911347505179,7.44423644944771,7.16513798775091,-0.279098461696803,0.000377448189482707,ENSG00000213654,GPSM3,protein_coding,6,-1,32190766,32195523,p21.32,G protein signaling modulator 3 [Source:HGNC Symbol;Acc:HGNC:13945],NA,GPSM3,63940,NM_001276501;NM_022107
GTF2I_TF,GTF2I,GTF2I_TF,GTF2I,TF,135,4.65966423269481,0.466416469145735,0.451397534580266,0.515764397003708,0.0643668624234421,1.67458304752183e-05,3.79061155793663,6.55589236575624,6.49270116724434,6.76352058943818,0.270819422193845,0.00110812776325972,ENSG00000263001,GTF2I,protein_coding,7,1,74650231,74760692,q11.23,general transcription factor IIi [Source:HGNC Symbol;Acc:HGNC:4659],Williams syndrome,GTF2I,2969,NM_001163636;NM_001280800;NM_001518;NM_032999;NM_033000;NM_033001
RBPJ_TF,RBPJ,RBPJ_TF,RBPJ,TF,216,-4.65934859980109,0.154380276108444,0.16182446410324,0.129920801268399,-0.031903662834841,1.6760830147056e-05,-3.06039876877862,6.80294795020996,6.85314552350908,6.63801306651286,-0.215132456996215,0.00920150728601152,ENSG00000168214,RBPJ,protein_coding,4,1,26163455,26435131,p15.2,recombination signal binding protein for immunoglobulin kappa J region [Source:HGNC Symbol;Acc:HGNC:5724],Adams-Oliver syndrome;ADAMS-OLIVER SYNDROME 3;Adams Oliver syndrome,RBPJ,3516,NM_001363577;NM_005349;NM_015874;NM_203283;NM_203284
VDR_TF,VDR,VDR_TF,VDR,TF,325,-4.6575724867283,0.182355872097313,0.200711097826239,0.12204584470227,-0.0786652531239687,1.68901441707474e-05,-3.66472798841699,3.75100339188754,3.88712247273292,3.3037549833956,-0.583367489337318,0.00163795039755363,ENSG00000111424,VDR,protein_coding,12,-1,47841537,47943048,q13.11,vitamin D receptor [Source:HGNC Symbol;Acc:HGNC:12679],Hypocalcemic vitamin D resistant rickets;OSTEOPOROSIS;rickets vitamin D-dependent type 2A;VITAMIN D-DEPENDENT RICKETS TYPE 2A,VDR,7421,NM_000376;NM_001017535;NM_001017536;NM_001364085
ZDHHC24_TF,ZDHHC24,ZDHHC24_TF,ZDHHC24,TF,107,4.65750368082416,0.253907508119935,0.244409955748921,0.285113751624692,0.0407037958757705,1.68901441707474e-05,3.8843328452009,4.7198015959446,4.66088317877066,4.9133906809447,0.252507502174038,0.000823377829294194,ENSG00000174165,ZDHHC24,protein_coding,11,-1,66520637,66546235,q13.2,zinc finger DHHC-type containing 24 [Source:HGNC Symbol;Acc:HGNC:27387],NA,ZDHHC24,254359,NM_001348571;NM_207340
NLE1_SIG,NLE1,NLE1_SIG,NLE1,SIG,67,4.65638235775446,0.340557626483838,0.32609784063393,0.388068351419251,0.0619705107853211,1.69715417721177e-05,3.93221607184776,3.87798084040526,3.80210777773693,4.12727804631549,0.32517026857856,0.000706657055507359,ENSG00000073536,NLE1,protein_coding,17,-1,35128730,35142304,q12,notchless homolog 1 [Source:HGNC Symbol;Acc:HGNC:19889],NA,NLE1,54475,NM_001014445;NM_018096
ZNF443_TF,ZNF443,ZNF443_TF,ZNF443,TF,14,4.65544712726037,-0.030504361485764,-0.0447401199347508,0.0162702734180498,0.0610103933528007,1.70251612962207e-05,3.87383052413596,1.69520033908609,1.63581431897182,1.89032583374728,0.254511514775458,0.000850733293459714,ENSG00000180855,ZNF443,protein_coding,19,-1,12429706,12441021,p13.2,zinc finger protein 443 [Source:HGNC Symbol;Acc:HGNC:20878],NA,ZNF443,10224,NM_005815
MTR_SIG,MTR,MTR_SIG,MTR,SIG,30,4.65534735084592,0.518612361030782,0.506232270531915,0.559289801241347,0.0530575307094321,1.70251612962207e-05,3.50801204322376,6.21605389913219,6.15627471234085,6.41247122716085,0.256196514819993,0.00264193591381265,ENSG00000116984,MTR,protein_coding,1,1,236795292,236921278,q43,5-methyltetrahydrofolate-homocysteine methyltransferase [Source:HGNC Symbol;Acc:HGNC:7468],HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA cblG COMPLEMENTATION TYPE;Methylcobalamin deficiency type cblG;METHYLCOBALAMIN DEFICIENCY TYPE G;Neural tube defects folate-sensitive,MTR,4548,NM_000254;NM_001291939;NM_001291940
ZSCAN2_TF,ZSCAN2,ZSCAN2_TF,ZSCAN2,TF,155,4.65533953085837,0.162183952298554,0.147358889649645,0.210894872430685,0.0635359827810405,1.70251612962207e-05,2.39374109405376,3.69981649127058,3.64731939986997,3.872306934444,0.224987534574028,0.0444192743920077,ENSG00000176371,ZSCAN2,protein_coding,15,1,84600986,84627796,q25.2,zinc finger and SCAN domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20994],NA,ZSCAN2,54993,NM_001007072;NM_017894;NM_181877
ACPP_SIG,ACPP,ACPP_SIG,ACPP,SIG,12,-4.65406827285373,0.665342343726505,0.689732394871462,0.585203604250219,-0.104528790621243,1.71196486494552e-05,-2.78795843786894,4.15388079300781,4.26100503642912,3.80190113605208,-0.459103900377035,0.0182014315386668,ENSG00000014257,ACPP,protein_coding,3,1,132317369,132368298,q22.1,acid phosphatase, prostate [Source:HGNC Symbol;Acc:HGNC:125],NA,ACPP,55,NM_001099;NM_001134194;NM_001292037
ALDH3A1_SIG,ALDH3A1,ALDH3A1_SIG,ALDH3A1,SIG,48,4.65265256547511,-0.0240912143056937,-0.0307233340514413,-0.00229996371252285,0.0284233703389184,1.72267081553105e-05,0.944110418390326,0.318219234349483,0.309714337066829,0.346163896849629,0.036449559782799,0.458724797196964,ENSG00000108602,ALDH3A1,protein_coding,17,-1,19737984,19748943,p11.2,aldehyde dehydrogenase 3 family member A1 [Source:HGNC Symbol;Acc:HGNC:405],NA,ALDH3A1,218,NM_000691;NM_001135167;NM_001135168;NM_001330150
OPTN_SIG,OPTN,OPTN_SIG,OPTN,SIG,34,-4.6522546572584,-0.0184264991463222,-0.00564455222300654,-0.0604243247515024,-0.0547797725284958,1.72490474276287e-05,-2.53660042667244,4.56500446442796,4.66020781917879,4.25219344167526,-0.408014377503529,0.0326177261701074,ENSG00000123240,OPTN,protein_coding,10,1,13099449,13138308,p13,optineurin [Source:HGNC Symbol;Acc:HGNC:17142],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 12;GLAUCOMA NORMAL TENSION SUSCEPTIBILITY TO;GLAUCOMA PRIMARY OPEN ANGLE,OPTN,10133,NM_001008211;NM_001008212;NM_001008213;NM_021980
ALOX15_SIG,ALOX15,ALOX15_SIG,ALOX15,SIG,20,-4.6517800769361,-0.109705576493138,-0.101358036490214,-0.137133207931318,-0.0357751714411046,1.72778442502455e-05,-2.99606492137979,0.921757599378444,1.00955773780607,0.633271430259108,-0.376286307546959,0.0108828193802985,ENSG00000161905,ALOX15,protein_coding,17,-1,4630902,4642294,p13.2,arachidonate 15-lipoxygenase [Source:HGNC Symbol;Acc:HGNC:433],NA,ALOX15,246,NM_001140
GPAT2_SIG,GPAT2,GPAT2_SIG,GPAT2,SIG,2,-4.65075924326241,0.0980647621520574,0.113865184482162,0.0461490887817126,-0.0677160957004497,1.73526008736092e-05,-2.23624697068576,0.886503005607317,0.968815543607512,0.616047523606676,-0.352768020000836,0.0616307042049991,ENSG00000186281,GPAT2,protein_coding,2,-1,96021946,96039451,q11.2,glycerol-3-phosphate acyltransferase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:27168],NA,GPAT2,150763,NM_001321525;NM_001321526;NM_001321527;NM_001321528;NM_001321529;NM_001321530;NM_001321531;NM_207328
PIGB_SIG,PIGB,PIGB_SIG,PIGB,SIG,20,-4.65030416714643,0.130090888697396,0.134146758325337,0.116764459919874,-0.0173822984054632,1.73799288688523e-05,-3.87573193491547,3.87760831992553,3.92926886134233,3.70786654098464,-0.221402320357691,0.000846176250047197,ENSG00000069943,PIGB,protein_coding,15,1,55318960,55355648,q21.3,phosphatidylinositol glycan anchor biosynthesis class B [Source:HGNC Symbol;Acc:HGNC:8959],NA,PIGB,9488,NM_004855
FBXO2_SIG,FBXO2,FBXO2_SIG,FBXO2,SIG,3,-4.64858376715569,0.0641014334359534,0.0918944235099592,-0.0272183910929229,-0.119112814602882,1.75144106975852e-05,-3.45505520078556,0.395723501546826,0.432177507422546,0.27594605366946,-0.156231453753087,0.00307124528854657,ENSG00000116661,FBXO2,protein_coding,1,-1,11637018,11655785,p36.22,F-box protein 2 [Source:HGNC Symbol;Acc:HGNC:13581],NA,FBXO2,26232,NM_012168
PRSS23_SIG,PRSS23,PRSS23_SIG,PRSS23,SIG,10,-4.6448588239648,-0.325172166108718,-0.30284707346483,-0.398526041938638,-0.0956789684738082,1.78221288491973e-05,-2.94925824486069,1.52497024771285,1.6098345869435,1.24613027595498,-0.363704310988516,0.0122589231814987,ENSG00000150687,PRSS23,protein_coding,11,1,86791059,86952910,q14.2,serine protease 23 [Source:HGNC Symbol;Acc:HGNC:14370],NA,PRSS23,11098,NM_001293178;NM_001293179;NM_001293180;NM_007173
MTMR14_SIG,MTMR14,MTMR14_SIG,MTMR14,SIG,29,-4.64467172874699,0.625586512936648,0.641363446776435,0.573748016034491,-0.0676154307419441,1.78270182048214e-05,-4.88349118215334,6.26365128109721,6.32503706541695,6.06195513261807,-0.263081932798872,2.29081733687384e-05,ENSG00000163719,MTMR14,protein_coding,3,1,9649433,9702393,p25.3,myotubularin related protein 14 [Source:HGNC Symbol;Acc:HGNC:26190],Autosomal dominant centronuclear myopathy;CENTRONUCLEAR MYOPATHY AUTOSOMAL MODIFIER OF;MYOPATHY CENTRONUCLEAR 1,MTMR14,64419,NM_001077525;NM_001077526;NM_022485
ZNF280C_TF,ZNF280C,ZNF280C_TF,ZNF280C,TF,126,4.64358337929258,0.229469895730905,0.219034963924976,0.2637561002361,0.0447211363111243,1.79041057867558e-05,2.95987228866617,3.20333657570612,3.16416827705498,3.3320324141313,0.167864137076321,0.0119430174382581,ENSG00000056277,ZNF280C,protein_coding,X,-1,130202707,130268899,q26.1,zinc finger protein 280C [Source:HGNC Symbol;Acc:HGNC:25955],NA,ZNF280C,55609,NM_017666
WNT7A_SIG,WNT7A,WNT7A_SIG,WNT7A,SIG,12,-4.64352005697406,-0.165527855042081,-0.12567212516316,-0.296482396072819,-0.170810270909659,1.79041057867558e-05,-2.83210954976669,0.439175947624685,0.483703052501282,0.292872603030152,-0.190830449471129,0.016410701151855,ENSG00000154764,WNT7A,protein_coding,3,-1,13816258,13880121,p25.1,Wnt family member 7A [Source:HGNC Symbol;Acc:HGNC:12786],FIBULAR APLASIA OR HYPOPLASIA FEMORAL BOWING AND POLY- SYN- AND OLIGODACTYLY;FUHRMANN SYNDROME;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME;Phocomelia Schinzel type;Ulna and fibula absence of with severe limb deficiency,WNT7A,7476,NM_004625
PCBP1_SIG,PCBP1,PCBP1_SIG,PCBP1,SIG,35,-4.64103111432672,0.208725759035926,0.216576916028256,0.182929100346841,-0.0336478156814146,1.81097204774057e-05,-4.45836016590516,8.72392830378687,8.76515452480984,8.58847072042567,-0.17668380438417,0.000115639857292526,ENSG00000169564,PCBP1,protein_coding,2,1,70087454,70089203,p13.3,poly(rC) binding protein 1 [Source:HGNC Symbol;Acc:HGNC:8647],NA,PCBP1,5093,NM_006196
RFX3_TF,RFX3,RFX3_TF,RFX3,TF,118,4.63929296954996,0.154642284629464,0.145014829554655,0.186275351303838,0.0412605217491831,1.82511794220861e-05,3.36937749612335,4.10148517008078,4.04249849973949,4.29529851548791,0.252800015748422,0.00395244159474694,ENSG00000080298,RFX3,protein_coding,9,-1,3218297,3526004,p24.2,regulatory factor X3 [Source:HGNC Symbol;Acc:HGNC:9984],NA,RFX3,5991,NM_001282116;NM_001282117;NM_002919;NM_134428
SLC10A7_SIG,SLC10A7,SLC10A7_SIG,SLC10A7,SIG,3,4.63605297169688,0.115265100571377,0.0998069869008645,0.166056045488776,0.0662490585879108,1.85277744810636e-05,1.19145731280097,3.8387638167387,3.82428115413261,3.88634970815872,0.06206855402611,0.340780271931937,ENSG00000120519,SLC10A7,protein_coding,4,-1,146253975,146521964,q31.22,solute carrier family 10 member 7 [Source:HGNC Symbol;Acc:HGNC:23088],Chondrodysplasia with multiple dislocations and amelogenesis imperfecta,SLC10A7,84068,NM_001029998;NM_001300842;NM_001317816;NM_001317817;NM_001317818;NM_032128
ADCY6_SIG,ADCY6,ADCY6_SIG,ADCY6,SIG,78,4.63555861941101,0.0748096820839498,0.0618081793962587,0.117528905200649,0.0557207258043906,1.85604242918003e-05,2.4878645079199,4.09340294708126,3.98159267316777,4.46077956136843,0.479186888200668,0.0362505452950641,ENSG00000174233,ADCY6,protein_coding,12,-1,48766194,48789037,q13.12,adenylate cyclase 6 [Source:HGNC Symbol;Acc:HGNC:237],Hypomyelination neuropathy-arthrogryposis syndrome;LETHAL CONGENITAL CONTRACTURE SYNDROME 8,ADCY6,112,NM_015270
SDC3_SIG,SDC3,SDC3_SIG,SDC3,SIG,29,-4.63484206429484,-0.202599058360987,-0.185334419544561,-0.259325728757816,-0.0739913092132551,1.86131174242629e-05,-3.17778232856174,1.91299415738599,2.0352767506183,1.51120849390838,-0.524068256709922,0.00674860734973585,ENSG00000162512,SDC3,protein_coding,1,-1,30869466,30908758,p35.2,syndecan 3 [Source:HGNC Symbol;Acc:HGNC:10660],OBESITY LEANNESS INCLUDED,SDC3,9672,NM_014654
TATDN1_SIG,TATDN1,TATDN1_SIG,TATDN1,SIG,26,4.63351059934941,0.35976058461318,0.348158997637583,0.397880084675858,0.0497210870382749,1.87215141617156e-05,3.20636397194813,3.56255595034682,3.51753046304702,3.71049683718905,0.192966374142037,0.00624204412325819,ENSG00000147687,TATDN1,protein_coding,8,-1,124488485,124539458,q24.13,TatD DNase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24220],NA,TATDN1,83940,NM_001146160;NM_001317889;NM_001317890;NM_001317891;NM_032026
ENGASE_SIG,ENGASE,ENGASE_SIG,ENGASE,SIG,19,4.63117679430007,0.226779728991983,0.216621679546895,0.260156177168701,0.0435344976218059,1.8921921767245e-05,2.97162869797589,6.1695512802921,6.11411613295257,6.35169533583624,0.237579202883661,0.0115896578469083,ENSG00000167280,ENGASE,protein_coding,17,1,79074939,79088599,q25.3,endo-beta-N-acetylglucosaminidase [Source:HGNC Symbol;Acc:HGNC:24622],NA,ENGASE,64772,NM_001042573
EPS8_SIG,EPS8,EPS8_SIG,EPS8,SIG,11,-4.62897302856195,-0.0911248251190868,-0.0786233180967015,-0.132201205335495,-0.0535778872387939,1.9112377987067e-05,-3.66632011941543,3.09748745713032,3.2586098740712,2.56808523003889,-0.690524644032308,0.00163117740098632,ENSG00000151491,EPS8,protein_coding,12,-1,15620134,15882329,p12.3,epidermal growth factor receptor pathway substrate 8 [Source:HGNC Symbol;Acc:HGNC:3420],Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness autosomal recessive 102,EPS8,2059,NM_004447
ZMYM3_TF,ZMYM3,ZMYM3_TF,ZMYM3,TF,294,4.62675619202498,0.372368651901708,0.357824606151953,0.420156230793759,0.0623316246418052,1.93058863888018e-05,3.86099689664471,6.14062600759681,6.04903896375255,6.44155486594221,0.392515902189658,0.000888042679882282,ENSG00000147130,ZMYM3,protein_coding,X,-1,71239624,71255146,q13.1,zinc finger MYM-type containing 3 [Source:HGNC Symbol;Acc:HGNC:13054],NA,ZMYM3,9203,NM_001171162;NM_001171163;NM_005096;NM_201599
MEX3B_SIG,MEX3B,MEX3B_SIG,MEX3B,SIG,57,4.62547934667707,0.180863439677096,0.165455896473457,0.231488224489053,0.0660323280155965,1.94130301228862e-05,3.3546421469594,4.45914143714535,4.32078264515413,4.91374889654507,0.59296625139094,0.00412080872140909,ENSG00000183496,MEX3B,protein_coding,15,-1,82041778,82046119,q25.2,mex-3 RNA binding family member B [Source:HGNC Symbol;Acc:HGNC:25297],NA,MEX3B,84206,NM_032246
ZNF512_TF,ZNF512,ZNF512_TF,ZNF512,TF,143,4.62419439142259,0.161004997222922,0.145845664545597,0.210814233162703,0.0649685686171056,1.95215091904184e-05,3.13578166021024,4.94140119169547,4.87441455536075,5.16150013965238,0.287085584291632,0.00754469489994897,ENSG00000243943,ZNF512,protein_coding,2,1,27582969,27623217,p23.3,zinc finger protein 512 [Source:HGNC Symbol;Acc:HGNC:29380],NA,ZNF512,84450,NM_001271286;NM_001271287;NM_001271288;NM_001271289;NM_001271318;NM_032434
TFAP2E_TF,TFAP2E,TFAP2E_TF,TFAP2E,TF,60,4.62321626235439,0.197047487133108,0.186399476021376,0.23203380935737,0.0456343333359937,1.96015444048529e-05,5.02366369215017,2.45391956481488,2.36944165485287,2.73148984040433,0.362048185551461,1.29694893476282e-05,ENSG00000116819,TFAP2E,protein_coding,1,1,35573314,35595328,p34.3,transcription factor AP-2 epsilon [Source:HGNC Symbol;Acc:HGNC:30774],NA,TFAP2E,339488,NM_178548
ZNF235_TF,ZNF235,ZNF235_TF,ZNF235,TF,44,4.62236377333028,0.154232894077287,0.142467018655565,0.192892199034377,0.0504251803788119,1.966828021142e-05,3.88454647363446,2.51040061521422,2.44967918838543,2.70991387479451,0.260234686409082,0.000823232751912769,ENSG00000159917,ZNF235,protein_coding,19,-1,44228729,44305046,q13.31,zinc finger protein 235 [Source:HGNC Symbol;Acc:HGNC:12866],NA,ZNF235,9310,NM_004234
VDAC1_SIG,VDAC1,VDAC1_SIG,VDAC1,SIG,21,4.62225192724983,0.365554147023469,0.355090113322142,0.399935972042112,0.0448458587199693,1.966828021142e-05,4.68187311314475,6.09017643561391,6.01429057320644,6.33951569780988,0.325225124603437,5.02432358292968e-05,ENSG00000213585,VDAC1,protein_coding,5,-1,133971871,134004975,q31.1,voltage dependent anion channel 1 [Source:HGNC Symbol;Acc:HGNC:12669],NA,VDAC1,7416,NM_003374
MYO9A_SIG,MYO9A,MYO9A_SIG,MYO9A,SIG,82,4.62044205231632,0.400104726709973,0.387151694051857,0.44266469115807,0.0555129971062138,1.98282464661078e-05,2.26036675787942,5.62219086502473,5.58188812939145,5.75461413924838,0.172726009856931,0.0586538199402464,ENSG00000066933,MYO9A,protein_coding,15,-1,71822291,72118577,q23,myosin IXA [Source:HGNC Symbol;Acc:HGNC:7608],MYASTHENIC SYNDROME CONGENITAL 24 PRESYNAPTIC;Presynaptic congenital myasthenic syndromes,MYO9A,4649,NM_006901
KDM1A_SIG,KDM1A,KDM1A_SIG,KDM1A,SIG,63,4.61945867489205,0.408587839582906,0.395314116675348,0.452201500564884,0.056887383889536,1.99100036466884e-05,3.49610558542205,6.60036830452166,6.55195202654022,6.75945036074636,0.207498334206138,0.00273205012518969,ENSG00000004487,KDM1A,protein_coding,1,1,23019443,23083689,p36.12,lysine demethylase 1A [Source:HGNC Symbol;Acc:HGNC:29079],Cleft palate psychomotor retardation and distinctive facial features;Developmental delay and distinctive facial features;Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,KDM1A,23028,NM_001009999;NM_001363654;NM_015013
LMO4_TF,LMO4,LMO4_TF,LMO4,TF,130,-4.61681805063432,-0.0220495867512499,-0.0172293483424007,-0.0378875129517546,-0.020658164609354,2.0152338326192e-05,-1.95845947668103,4.99843550448182,5.05911930233908,4.79904588295083,-0.260073419388253,0.104755690086527,ENSG00000143013,LMO4,protein_coding,1,1,87328880,87348923,p22.3,LIM domain only 4 [Source:HGNC Symbol;Acc:HGNC:6644],NA,LMO4,8543,NM_006769
TRPV4_SIG,TRPV4,TRPV4_SIG,TRPV4,SIG,11,-4.61629870533045,-0.0960072032142635,-0.0640020698373302,-0.201166927167044,-0.137164857329714,2.01902073311601e-05,-1.48065921693008,0.515022771552483,0.545933479494065,0.413459016887286,-0.132474462606779,0.228448083678687,ENSG00000111199,TRPV4,protein_coding,12,-1,109783085,109833401,q24.11,transient receptor potential cation channel subfamily V member 4 [Source:HGNC Symbol;Acc:HGNC:18083],Autosomal dominant brachyolmia;Autosomal dominant Charcot-Marie-Tooth disease type 2C;Autosomal dominant congenital benign spinal muscular atrophy;AVASCULAR NECROSIS OF FEMORAL HEAD PRIMARY 2;BRACHYOLMIA TYPE 3;DIGITAL ARTHROPATHY-BRACHYDACTYLY FAMILIAL;Familial avascular necrosis of femoral head;Familial digital arthropathy-brachydactyly;HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE IIC;METATROPIC DYSPLASIA;NEURONOPATHY DISTAL HEREDITARY MOTOR TYPE VIII;Parastremmatic dwarfism;SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY;SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1;Spondyloepiphyseal dysplasia Maroteaux type;SPONDYLOMETAPHYSEAL DYSPLASIA KOZLOWSKI TYPE,TRPV4,59341,NM_001177428;NM_001177431;NM_001177433;NM_021625;NM_147204
ZNF431_TF,ZNF431,ZNF431_TF,ZNF431,TF,85,4.61516772566041,0.166674494475028,0.155340145667288,0.203915926271889,0.0485757806046007,2.02878152031703e-05,4.07570142650763,4.90138797123282,4.83390249314631,5.12312597065993,0.289223477513625,0.000440439867033091,ENSG00000196705,ZNF431,protein_coding,19,1,21142024,21196053,p12,zinc finger protein 431 [Source:HGNC Symbol;Acc:HGNC:20809],NA,ZNF431,170959,NM_001319124;NM_001319126;NM_001319127;NM_133473
DZIP3_SIG,DZIP3,DZIP3_SIG,DZIP3,SIG,59,4.6143172254424,0.0551493899313875,0.0420437184657283,0.0982108818899819,0.0561671634242535,2.03583698858244e-05,2.65736344497536,3.74455038667839,3.68533329925726,3.93912081677639,0.253787517519129,0.0246689990637663,ENSG00000198919,DZIP3,protein_coding,3,1,108589705,108694840,q13.13,DAZ interacting zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:30938],NA,DZIP3,9666,NM_014648
POLN_SIG,POLN,POLN_SIG,POLN,SIG,35,4.61414850313705,-0.145445547331532,-0.149940011127947,-0.130678023429027,0.0192619876989201,2.03622262319903e-05,3.20406575673855,0.977879098314609,0.933385718300405,1.12407163264699,0.19068591434659,0.00628059331454533,ENSG00000130997,POLN,protein_coding,4,-1,2071918,2242121,p16.3,DNA polymerase nu [Source:HGNC Symbol;Acc:HGNC:18870],NA,POLN,353497,NM_181808
PADI6_SIG,PADI6,PADI6_SIG,PADI6,SIG,5,-4.61362791623104,0.0100113336006466,0.0312859216663599,-0.0598908843295541,-0.0911768059959141,2.04006160389992e-05,-2.50831649158801,0.22367744684577,0.247453669429713,0.145555572641385,-0.101898096788328,0.0346375327915546,ENSG00000276747,PADI6,protein_coding,1,1,17372196,17401699,p36.13,peptidyl arginine deiminase 6 [Source:HGNC Symbol;Acc:HGNC:20449],PREIMPLANTATION EMBRYONIC LETHALITY 2,PADI6,353238,NM_207421
FUBP1_SIG,FUBP1,FUBP1_SIG,FUBP1,SIG,44,4.61290154403397,0.468028667155705,0.456363308622246,0.506357702337069,0.0499943937148235,2.04593347152287e-05,3.77628123657064,7.6484172636949,7.59943258127772,7.80936693449417,0.209934353216446,0.00115849557385537,ENSG00000162613,FUBP1,protein_coding,1,-1,77944055,77979110,p31.1,far upstream element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4004],NA,FUBP1,8880,NM_001303433;NM_003902
RTN1_SIG,RTN1,RTN1_SIG,RTN1,SIG,8,-4.61263023523111,-0.138711353541974,-0.123396823432486,-0.189030523901721,-0.0656337004692354,2.0473334841456e-05,-3.02632197429671,1.47430791167713,1.59729187312966,1.0702177526188,-0.527074120510858,0.0100448936706874,ENSG00000139970,RTN1,protein_coding,14,-1,59595976,59870776,q23.1,reticulon 1 [Source:HGNC Symbol;Acc:HGNC:10467],NA,RTN1,6252,NM_021136;NM_206852
EXT1_SIG,EXT1,EXT1_SIG,EXT1,SIG,13,-4.61040005434003,-0.0916217559319038,-0.0773180893388908,-0.138619517594661,-0.06130142825577,2.06813578382434e-05,-3.16443993852839,2.80534015598512,2.91073348435438,2.45904779134328,-0.451685693011096,0.00697964700476871,ENSG00000182197,EXT1,protein_coding,8,-1,117794490,118111853,q24.11,exostosin glycosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3512],CHONDROSARCOMA;EXOSTOSES MULTIPLE TYPE I;HEREDITARY MULTIPLE EXOSTOSES TYPE 1;Multiple osteochondromas;TRICHO-RHINO-PHALANGEAL SYNDROME TYPE 2;Trichorhinophalangeal syndrome type 2,EXT1,2131,NM_000127
G3BP1_SIG,G3BP1,G3BP1_SIG,G3BP1,SIG,17,4.60855096665164,0.572487801003295,0.56022756782225,0.61277142431244,0.0525438564901901,2.0853153931285e-05,4.27455200101533,7.33535399009897,7.26844537178504,7.55519659313048,0.28675122134544,0.00022303865282798,ENSG00000145907,G3BP1,protein_coding,5,1,151771045,151812785,q33.1,G3BP stress granule assembly factor 1 [Source:HGNC Symbol;Acc:HGNC:30292],NA,G3BP1,10146,NM_005754;NM_198395
PADI3_SIG,PADI3,PADI3_SIG,PADI3,SIG,19,4.60820626488354,-0.025072222678603,-0.0317267621944462,-0.00320730712654682,0.0285194550678994,2.08747895171333e-05,0.276405221192151,0.293795079809105,0.288458873687128,0.311328328495598,0.0228694548084698,0.841798547327489,ENSG00000142619,PADI3,protein_coding,1,1,17249098,17284233,p36.13,peptidyl arginine deiminase 3 [Source:HGNC Symbol;Acc:HGNC:18337],UNCOMBABLE HAIR SYNDROME;UNCOMBABLE HAIR SYNDROME 1,PADI3,51702,NM_016233
NGLY1_SIG,NGLY1,NGLY1_SIG,NGLY1,SIG,25,4.60794677647146,0.35949560674381,0.349508561274236,0.392310184715268,0.042801623441031,2.08878933528392e-05,2.93988758514107,5.90108044180439,5.86371064373438,6.02386692117729,0.160156277442909,0.0125701641312838,ENSG00000151092,NGLY1,protein_coding,3,-1,25718944,25790039,p24.2,N-glycanase 1 [Source:HGNC Symbol;Acc:HGNC:17646],Alacrimia-choreoathetosis-liver dysfunction syndrome;CONGENITAL DISORDER OF DEGLYCOSYLATION,NGLY1,55768,NM_001145293;NM_001145294;NM_001145295;NM_018297
CACNA1I_SIG,CACNA1I,CACNA1I_SIG,CACNA1I,SIG,26,-4.60740008587641,-0.285992288600858,-0.258564983833732,-0.376110575692843,-0.117545591859111,2.09298921733923e-05,-4.01536131587151,1.59308897655957,1.72252672888321,1.16779350463906,-0.554733224244148,0.000540896013104012,ENSG00000100346,CACNA1I,protein_coding,22,1,39570753,39689737,q13.1,calcium voltage-gated channel subunit alpha1 I [Source:HGNC Symbol;Acc:HGNC:1396],NA,CACNA1I,8911,NM_001003406;NM_021096
SPSB1_SIG,SPSB1,SPSB1_SIG,SPSB1,SIG,29,-4.60443072279131,-0.0162975652525435,-0.00951740069007628,-0.0385752488149358,-0.0290578481248596,2.12175856906248e-05,-4.20925891988361,1.46487194980527,1.57380689779381,1.10694283498579,-0.466864062808024,0.000279420240389487,ENSG00000171621,SPSB1,protein_coding,1,1,9292894,9369532,p36.22,splA/ryanodine receptor domain and SOCS box containing 1 [Source:HGNC Symbol;Acc:HGNC:30628],NA,SPSB1,80176,NM_025106
SLC26A2_SIG,SLC26A2,SLC26A2_SIG,SLC26A2,SIG,25,4.604277076328,0.372038432899677,0.362284538431703,0.404086943294446,0.0418024048627424,2.12201154296382e-05,4.42908052894351,4.64410836653518,4.53792913535672,4.99298298326442,0.4550538479077,0.000128566039967243,ENSG00000155850,SLC26A2,protein_coding,5,1,149960737,149993455,q32,solute carrier family 26 member 2 [Source:HGNC Symbol;Acc:HGNC:10994],Achondrogenesis type 1B;ACHONDROGENESIS TYPE IB;Atelosteogenesis type 2;Atelosteogenesis type II;ATELOSTEOGENESIS TYPE II;Diastrophic dwarfism;Diastrophic dysplasia;EPIPHYSEAL DYSPLASIA MULTIPLE 4;Multiple epiphyseal dysplasia type 4,SLC26A2,1836,NM_000112
FAM120C_SIG,FAM120C,FAM120C_SIG,FAM120C,SIG,32,4.60397208424497,0.17618499191511,0.163966829773733,0.216330381808204,0.0523635520344709,2.12271054052608e-05,2.8272973175702,3.4534372235115,3.40995512842859,3.5963069644982,0.186351836069611,0.0165974752257199,ENSG00000184083,FAM120C,protein_coding,X,-1,54068324,54183281,p11.22,family with sequence similarity 120C [Source:HGNC Symbol;Acc:HGNC:16949],NA,FAM120C,54954,NM_001300788;NM_017848;NM_198456
CELSR3_SIG,CELSR3,CELSR3_SIG,CELSR3,SIG,10,-4.60395108641151,-0.163723598800051,-0.159628451748118,-0.177179081970687,-0.0175506302225686,2.12271054052608e-05,-2.78086306652034,2.61598697687829,2.70183636356405,2.33391042062505,-0.367925942938997,0.0184956500286402,ENSG00000008300,CELSR3,protein_coding,3,-1,48636463,48662886,p21.31,cadherin EGF LAG seven-pass G-type receptor 3 [Source:HGNC Symbol;Acc:HGNC:3230],NA,CELSR3,1951,NM_001407
BRSK1_SIG,BRSK1,BRSK1_SIG,BRSK1,SIG,64,4.60358746527065,-0.0879124091547661,-0.0962172067537755,-0.0606252170437353,0.0355919897100404,2.12510849524239e-05,2.82279522352417,1.21430635278551,1.15503131553349,1.40906718947071,0.254035873937221,0.0167545128303877,ENSG00000160469,BRSK1,protein_coding,19,1,55282072,55312533,q13.42,BR serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:18994],NA,BRSK1,84446,NM_032430
EPHX2_SIG,EPHX2,EPHX2_SIG,EPHX2,SIG,48,-4.60288274892398,-0.210115678825505,-0.196050293971801,-0.256330514773387,-0.0602802208015863,2.13099833718145e-05,-3.587129702946,1.26231129691405,1.35696597818525,0.951303058451536,-0.405662919733717,0.00207932402657499,ENSG00000120915,EPHX2,protein_coding,8,1,27490779,27545564,p21.2,epoxide hydrolase 2 [Source:HGNC Symbol;Acc:HGNC:3402],HYPERCHOLESTEROLEMIA FAMILIAL,EPHX2,2053,NM_001256482;NM_001256483;NM_001256484;NM_001979
PILRA_SIG,PILRA,PILRA_SIG,PILRA,SIG,42,-4.60272616267296,0.524463685120951,0.560836458357358,0.404953144487044,-0.155883313870314,2.13128608925721e-05,-3.91914532588472,5.02977222863267,5.17757687963635,4.54412837533489,-0.633448504301456,0.000734748839353524,ENSG00000085514,PILRA,protein_coding,7,1,100367530,100400096,q22.1,paired immunoglobin like type 2 receptor alpha [Source:HGNC Symbol;Acc:HGNC:20396],NA,PILRA,29992,NM_013439;NM_178272;NM_178273
GMPR2_SIG,GMPR2,GMPR2_SIG,GMPR2,SIG,36,4.60146906567085,0.233197159059246,0.222224754283255,0.269249346180361,0.0470245918971055,2.14287015108982e-05,2.21383395791448,5.87738372433699,5.84267120097912,5.99143915822717,0.148767957248057,0.0645822062429054,ENSG00000100938,GMPR2,protein_coding,14,1,24232422,24239242,q12,guanosine monophosphate reductase 2 [Source:HGNC Symbol;Acc:HGNC:4377],NA,GMPR2,51292,NM_001002000;NM_001002001;NM_001002002;NM_001283021;NM_001283022;NM_001283023;NM_001351022;NM_001351023;NM_001351024;NM_001351025;NM_001351026;NM_016576
UTP3_SIG,UTP3,UTP3_SIG,UTP3,SIG,41,4.60128052345676,0.0996298817062464,0.0874984496749454,0.139490301237664,0.0519918515627184,2.14348956165585e-05,5.10212557740588,5.16597153900339,5.06842753674129,5.48647326072171,0.41804572398042,9.37210994189286e-06,ENSG00000132467,UTP3,protein_coding,4,1,70688532,70690551,q13.3,UTP3, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:24477],NA,UTP3,57050,NM_020368
SPI1_SIG,SPI1,SPI1_SIG,SPI1,SIG,63,-4.5998490904863,0.485675286714057,0.505701476126513,0.419874950073131,-0.0858265260533817,2.15694218847908e-05,-3.64681511774951,8.07535047082004,8.15213052248477,7.82307315820733,-0.32905736427744,0.00172600926388314,ENSG00000066336,SPI1,protein_coding,11,-1,47354860,47378576,p11.2,Spi-1 proto-oncogene [Source:HGNC Symbol;Acc:HGNC:11241],NA,SPI1,6688,NM_001080547;NM_003120
LIMD1_SIG,LIMD1,LIMD1_SIG,LIMD1,SIG,37,4.59497830259855,0.430052250863815,0.421246093718149,0.458986767199573,0.0377406734814238,2.2054221388539e-05,1.83914276986232,6.01072035039315,5.97429820139471,6.13039312567374,0.156094924279033,0.129036666915843,ENSG00000144791,LIMD1,protein_coding,3,1,45555394,45686341,p21.31,LIM domains containing 1 [Source:HGNC Symbol;Acc:HGNC:6612],NA,LIMD1,8994,NM_014240
HERC2_SIG,HERC2,HERC2_SIG,HERC2,SIG,54,4.5949599489074,0.417501427115887,0.405121517211865,0.458178273943386,0.0530567567315218,2.2054221388539e-05,2.11037456704817,6.81832339656713,6.77724071972264,6.95330933477045,0.176068615047806,0.0788151588444746,ENSG00000128731,HERC2,protein_coding,15,-1,28111040,28322172,q13.1,HECT and RLD domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:4868],Developmental delay with autism spectrum disorder and gait instability;Mental retardation autosomal recessive 38;PRADER-WILLI SYNDROME;SKIN/HAIR/EYE PIGMENTATION VARIATION IN 1,HERC2,8924,NM_004667
ZNF562_TF,ZNF562,ZNF562_TF,ZNF562,TF,17,4.5944779625024,0.320710900684052,0.314156626950156,0.342246371523996,0.0280897445738396,2.20916683892823e-05,2.5083794141958,5.37253797791208,5.33458151861381,5.49725205846355,0.162670539849733,0.0346373510999143,ENSG00000171466,ZNF562,protein_coding,19,-1,9641807,9675100,p13.2,zinc finger protein 562 [Source:HGNC Symbol;Acc:HGNC:25950],NA,ZNF562,54811,NM_001130031;NM_001130032;NM_001300885;NM_017656
PRDM15_SIG,PRDM15,PRDM15_SIG,PRDM15,SIG,52,4.59392384881466,0.269907044855177,0.257826487249554,0.309600305559364,0.0517738183098098,2.21363484097229e-05,3.7569237110427,4.32889334599935,4.27444444374682,4.50779688197193,0.233352438225108,0.0012314138104114,ENSG00000141956,PRDM15,protein_coding,21,-1,41798225,41879482,q22.3,PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999],NA,PRDM15,63977,NM_001040424;NM_001282934;NM_022115
RNASE1_SIG,RNASE1,RNASE1_SIG,RNASE1,SIG,19,-4.59375024195547,-0.164121848512629,-0.148241205908493,-0.21630110278336,-0.068059896874867,2.21363484097229e-05,-3.61225919390796,1.49313658448612,1.62781149298324,1.05063331370987,-0.577178179273373,0.00192180882384768,ENSG00000129538,RNASE1,protein_coding,14,-1,20801228,20802855,q11.2,ribonuclease A family member 1, pancreatic [Source:HGNC Symbol;Acc:HGNC:10044],NA,RNASE1,6035,NM_002933;NM_198232;NM_198234;NM_198235
PAPSS1_SIG,PAPSS1,PAPSS1_SIG,PAPSS1,SIG,19,4.59367237644942,0.440706102059189,0.429250085380714,0.478347299717037,0.0490972143363238,2.21363484097229e-05,2.24850886257968,5.72115756969111,5.67667192715589,5.86732468087825,0.190652753722355,0.0601558304605085,ENSG00000138801,PAPSS1,protein_coding,4,-1,107590276,107720234,q25,3'-phosphoadenosine 5'-phosphosulfate synthase 1 [Source:HGNC Symbol;Acc:HGNC:8603],NA,PAPSS1,9061,NM_005443
NUDT18_SIG,NUDT18,NUDT18_SIG,NUDT18,SIG,28,4.59326180378928,0.206439116097431,0.195038450183566,0.243898446957275,0.0488599967737094,2.21663649597036e-05,3.12918211825382,3.34141433101527,3.28501271324184,3.52673393227083,0.241721219028997,0.00769546431242922,ENSG00000275074,NUDT18,protein_coding,8,-1,22106874,22109419,p21.3,nudix hydrolase 18 [Source:HGNC Symbol;Acc:HGNC:26194],NA,NUDT18,79873,NM_024815
LARP6_SIG,LARP6,LARP6_SIG,LARP6,SIG,43,4.59224428657136,-0.131539359303112,-0.140406834075612,-0.102403370764899,0.0380034633107135,2.2261096773725e-05,2.82398811540041,0.408334630752889,0.356321038705804,0.579236433193309,0.222915394487504,0.0167142732723513,ENSG00000166173,LARP6,protein_coding,15,-1,70829130,70854159,q23,La ribonucleoprotein domain family member 6 [Source:HGNC Symbol;Acc:HGNC:24012],NA,LARP6,55323,NM_001286679;NM_018357;NM_197958
CPEB4_SIG,CPEB4,CPEB4_SIG,CPEB4,SIG,39,-4.59169127791039,0.334370743601843,0.355649416303699,0.264455104724318,-0.0911943115793808,2.23065086718292e-05,-3.6578611009955,6.26563235534995,6.35640964894638,5.96736410496165,-0.389045543984735,0.00167284183996684,ENSG00000113742,CPEB4,protein_coding,5,1,173888349,173961980,q35.2,cytoplasmic polyadenylation element binding protein 4 [Source:HGNC Symbol;Acc:HGNC:21747],NA,CPEB4,80315,NM_001308189;NM_001308191;NM_001308192;NM_001308193;NM_030627
SLC39A8_SIG,SLC39A8,SLC39A8_SIG,SLC39A8,SIG,30,4.59134013577783,-0.00729699661765459,-0.0179839773034423,0.0278173684927906,0.045801345796233,2.23304030351801e-05,2.80858540821617,6.04154925639936,5.97479599689026,6.2608813947864,0.286085397896139,0.0173428814622542,ENSG00000138821,SLC39A8,protein_coding,4,-1,102251041,102431258,q24,solute carrier family 39 member 8 [Source:HGNC Symbol;Acc:HGNC:20862],CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIn;Intellectual Disability with Cerebellar Atrophy;SLC39A8-CDG,SLC39A8,64116,NM_001135146;NM_001135147;NM_001135148;NM_022154
ZNF511_TF,ZNF511,ZNF511_TF,ZNF511,TF,181,4.58941401407122,0.0791894975418006,0.0744164472501244,0.0948723770715939,0.0204559298214695,2.25142308092847e-05,3.13386337929977,4.49138447204571,4.45567633159068,4.60871121925508,0.153034887664402,0.00758980107493166,ENSG00000198546,ZNF511,protein_coding,10,1,133308914,133313162,q26.3,zinc finger protein 511 [Source:HGNC Symbol;Acc:HGNC:28445],NA,ZNF511,118472,NM_145806
HPD_SIG,HPD,HPD_SIG,HPD,SIG,7,-4.5893736832575,0.0258733752717658,0.0394726335750392,-0.0188099020104183,-0.0582825355854576,2.25142308092847e-05,-0.969305633091604,0.588442545594145,0.608606016525865,0.522191141104206,-0.0864148754216597,0.445865053535631,ENSG00000158104,HPD,protein_coding,12,-1,121839527,121863596,q24.31,4-hydroxyphenylpyruvate dioxygenase [Source:HGNC Symbol;Acc:HGNC:5147],HAWKINSINURIA;Tyrosinemia type 3;TYROSINEMIA TYPE III,HPD,3242,NM_001171993;NM_002150
MYO5A_SIG,MYO5A,MYO5A_SIG,MYO5A,SIG,14,-4.58880405619866,0.491029359003325,0.500621856243493,0.459511153785629,-0.0411107024578644,2.25560526720076e-05,-2.91194638785836,6.75516000430305,6.80515396136671,6.5908941453796,-0.214259815987106,0.0134736819392913,ENSG00000197535,MYO5A,protein_coding,15,-1,52307283,52529050,q21.2,myosin VA [Source:HGNC Symbol;Acc:HGNC:7602],ELEJALDE SYNDROME;Griscelli syndrome type 1;GRISCELLI SYNDROME TYPE 1;Griscelli syndrome type 3;Neuroectodermal melanolysosomal disease,MYO5A,4644,NM_000259;NM_001142495
KRI1_SIG,KRI1,KRI1_SIG,KRI1,SIG,30,4.58873117425016,0.37402917566284,0.362536214802471,0.411791761346909,0.049255546544438,2.25560526720076e-05,3.08468129145205,5.97831843739974,5.92530785177155,6.15249607589239,0.227188224120842,0.00863198695557674,ENSG00000129347,KRI1,protein_coding,19,-1,10553078,10566037,p13.2,KRI1 homolog [Source:HGNC Symbol;Acc:HGNC:25769],NA,KRI1,65095,NM_023008
TFB1M_SIG,TFB1M,TFB1M_SIG,TFB1M,SIG,54,4.58764637053791,0.198961812503332,0.18064659452738,0.259140385852887,0.0784937913255065,2.26597087397485e-05,5.05855946286859,2.77170497823336,2.67969589337869,3.07402054275585,0.394324649377158,1.11399077379127e-05,ENSG00000029639,TFB1M,protein_coding,6,-1,155256134,155314493,q25.3,transcription factor B1, mitochondrial [Source:HGNC Symbol;Acc:HGNC:17037],Mitochondrial non-syndromic sensorineural deafness,TFB1M,51106,NM_001350501;NM_001350502;NM_016020
THAP4_TF,THAP4,THAP4_TF,THAP4,TF,205,4.58666233135005,0.236295520235215,0.230668480682411,0.254784364480141,0.0241158837977296,2.27528447222514e-05,3.95498764056023,5.34388013441032,5.30191845775114,5.48175421486191,0.179835757110775,0.000655630982861313,ENSG00000176946,THAP4,protein_coding,2,-1,241584405,241637158,q37.3,THAP domain containing 4 [Source:HGNC Symbol;Acc:HGNC:23187],NA,THAP4,51078,NM_001164356;NM_015963
AGFG1_SIG,AGFG1,AGFG1_SIG,AGFG1,SIG,45,-4.58564135907056,0.401597190102024,0.417360709422601,0.349802769477272,-0.0675579399453294,2.2850390029957e-05,-3.68333993418664,6.89920057287885,6.97029505464844,6.66560441849307,-0.304690636155369,0.00154755030024869,ENSG00000173744,AGFG1,protein_coding,2,1,227472152,227561214,q36.3,ArfGAP with FG repeats 1 [Source:HGNC Symbol;Acc:HGNC:5175],NA,AGFG1,3267,NM_001135187;NM_001135188;NM_001135189;NM_004504
FCGR3A_SIG,FCGR3A,FCGR3A_SIG,FCGR3A,SIG,29,-4.58512808799099,0.0585954123061591,0.0869579573480847,-0.0345958071173108,-0.121553764465396,2.28926461153538e-05,-4.03304510510963,4.99559744829309,5.20931723249616,4.29337530019726,-0.915941932298899,0.000511318706482007,ENSG00000203747,FCGR3A,protein_coding,1,-1,161541759,161550737,q23.3,Fc fragment of IgG receptor IIIa [Source:HGNC Symbol;Acc:HGNC:3619],Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity;IMMUNODEFICIENCY 20,FCGR3A,2214,NM_000569;NM_001127592;NM_001127593;NM_001127595;NM_001127596;NM_001329120;NM_001329122
PLXNC1_SIG,PLXNC1,PLXNC1_SIG,PLXNC1,SIG,29,-4.58475361960409,0.291493442827116,0.305981137226039,0.243891018373511,-0.062090118852528,2.29197529076784e-05,-2.40010566581513,6.07962199944387,6.17369419209109,5.77052765217444,-0.403166539916644,0.0438914387288237,ENSG00000136040,PLXNC1,protein_coding,12,1,94148577,94307675,q22,plexin C1 [Source:HGNC Symbol;Acc:HGNC:9106],NA,PLXNC1,10154,NM_005761
NUDT5_SIG,NUDT5,NUDT5_SIG,NUDT5,SIG,35,4.58461437659412,0.277771500826398,0.265557249787545,0.317904039954058,0.052346790166513,2.29210806150003e-05,2.99382742393284,5.6375087500329,5.57724616533486,5.83551438546933,0.258268220134465,0.010936264431587,ENSG00000165609,NUDT5,protein_coding,10,-1,12165330,12196144,p14,nudix hydrolase 5 [Source:HGNC Symbol;Acc:HGNC:8052],NA,NUDT5,11164,NM_001321647;NM_001321648;NM_014142
OXSR1_SIG,OXSR1,OXSR1_SIG,OXSR1,SIG,16,-4.5842417192167,0.347639306921684,0.354667758166704,0.324545824259477,-0.0301219339072271,2.29480349444335e-05,-2.25261725658038,6.48321435348103,6.50950595018079,6.39682767861042,-0.112678271570363,0.0596490848435767,ENSG00000172939,OXSR1,protein_coding,3,1,38165089,38255484,p22.2,oxidative stress responsive kinase 1 [Source:HGNC Symbol;Acc:HGNC:8508],NA,OXSR1,9943,NM_005109
RFX5_TF,RFX5,RFX5_TF,RFX5,TF,99,4.58290316980088,0.195251900081823,0.18624043425443,0.224861002086113,0.0386205678316826,2.30662933041932e-05,2.32222704632892,6.45651950482499,6.42359012053834,6.56471605319541,0.141125932657074,0.0515898147369279,ENSG00000143390,RFX5,protein_coding,1,-1,151340640,151347357,q21.3,regulatory factor X5 [Source:HGNC Symbol;Acc:HGNC:9986],BARE LYMPHOCYTE SYNDROME TYPE II;Immunodeficiency by defective expression of HLA class 2,RFX5,5993,NM_000449;NM_001025603
MED27_SIG,MED27,MED27_SIG,MED27,SIG,10,4.58289448099513,0.379013443774388,0.375455151867362,0.390704974326044,0.0152498224586824,2.30662933041932e-05,2.26278459558858,3.16147388965623,3.14285115828272,3.22266286416917,0.0798117058864519,0.0583564554147434,ENSG00000160563,MED27,protein_coding,9,-1,131852928,132079867,q34.13,mediator complex subunit 27 [Source:HGNC Symbol;Acc:HGNC:2377],NA,MED27,9442,NM_001253881;NM_001253882;NM_004269
ABCC3_SIG,ABCC3,ABCC3_SIG,ABCC3,SIG,19,-4.58278662009775,0.0204213023138493,0.0421814595544244,-0.0510763571908978,-0.0932578167453222,2.30662933041932e-05,-2.56545155920868,2.21196051476443,2.32166701814364,1.85149628937562,-0.470170728768023,0.0304655774594818,ENSG00000108846,ABCC3,protein_coding,17,1,50634777,50692253,q21.33,ATP binding cassette subfamily C member 3 [Source:HGNC Symbol;Acc:HGNC:54],NA,ABCC3,8714,NM_001144070;NM_003786
RNF2_SIG,RNF2,RNF2_SIG,RNF2,SIG,30,4.58191853249337,0.468178633273186,0.458027551668473,0.501532187117241,0.0435046354487673,2.31482293527131e-05,4.98893119606958,4.68538911404556,4.61210588758923,4.92617685811635,0.314070970527124,1.47975630824682e-05,ENSG00000121481,RNF2,protein_coding,1,1,185045526,185102603,q25.3,ring finger protein 2 [Source:HGNC Symbol;Acc:HGNC:10061],NA,RNF2,6045,NM_007212
IL1R2_SIG,IL1R2,IL1R2_SIG,IL1R2,SIG,15,-4.58138464632696,0.145648622599249,0.17651857163457,0.0442187900546222,-0.132299781579948,2.31933486995315e-05,-2.78214649899629,2.66297697570763,2.81647387283357,2.15863002800812,-0.657843844825448,0.0184447057760999,ENSG00000115590,IL1R2,protein_coding,2,1,101991960,102028544,q11.2,interleukin 1 receptor type 2 [Source:HGNC Symbol;Acc:HGNC:5994],NA,IL1R2,7850,NM_001261419;NM_004633
S100A16_SIG,S100A16,S100A16_SIG,S100A16,SIG,52,-4.5812342777774,-0.0863624186170353,-0.0783473910513589,-0.112697509189972,-0.0343501181386135,2.31959758040131e-05,-2.63872788523067,1.59282544576463,1.73857741842832,1.11392610701249,-0.624651311415838,0.0257233854896611,ENSG00000188643,S100A16,protein_coding,1,-1,153606886,153613145,q21.3,S100 calcium binding protein A16 [Source:HGNC Symbol;Acc:HGNC:20441],NA,S100A16,140576,NM_001317007;NM_001317008;NM_080388
BPHL_SIG,BPHL,BPHL_SIG,BPHL,SIG,7,4.58105312584331,0.261505767685359,0.244106884775652,0.318673525817252,0.0745666410415992,2.32020266461706e-05,3.76669378446944,2.46879641354733,2.40374098342858,2.68254996965179,0.27880898622321,0.0011917289792722,ENSG00000137274,BPHL,protein_coding,6,1,3118374,3153578,p25.2,biphenyl hydrolase like [Source:HGNC Symbol;Acc:HGNC:1094],NA,BPHL,670,NM_001302777;NM_004332
ZBTB7A_TF,ZBTB7A,ZBTB7A_TF,ZBTB7A,TF,117,-4.5808195332635,0.141765990749803,0.154354764698936,0.100402876345509,-0.0539518883534279,2.32139075744237e-05,-2.94529792091051,5.97598073023658,6.02678843956457,5.80904111387316,-0.21774732569141,0.012390452321746,ENSG00000178951,ZBTB7A,protein_coding,19,-1,4043303,4066899,p13.3,zinc finger and BTB domain containing 7A [Source:HGNC Symbol;Acc:HGNC:18078],NA,ZBTB7A,51341,NM_001317990;NM_015898
PTPRE_SIG,PTPRE,PTPRE_SIG,PTPRE,SIG,32,-4.57877580465804,0.508204787423547,0.528818461246699,0.44047414486176,-0.0883443163849389,2.34276742103113e-05,-3.21407867639601,7.08556818164348,7.17862220265953,6.77981925544791,-0.39880294721162,0.00611277734251871,ENSG00000132334,PTPRE,protein_coding,10,1,127907061,128085855,q26.2,protein tyrosine phosphatase, receptor type E [Source:HGNC Symbol;Acc:HGNC:9669],NA,PTPRE,5791,NM_001316676;NM_001316677;NM_001323354;NM_001323355;NM_001323356;NM_001323357;NM_006504;NM_130435
GTF2H4_TF,GTF2H4,GTF2H4_TF,GTF2H4,TF,6,4.57737828524477,-0.00175242753938098,-0.0156855999425136,0.0440279960709118,0.0597135960134253,2.35704282306016e-05,3.24179224964708,0.519882745892007,0.4976660302769,0.592880525770215,0.0952144954933148,0.00565830627470512,ENSG00000213780,GTF2H4,protein_coding,6,1,30908207,30914106,p21.33,general transcription factor IIH subunit 4 [Source:HGNC Symbol;Acc:HGNC:4658],NA,GTF2H4,2968,NM_001517
ST14_SIG,ST14,ST14_SIG,ST14,SIG,11,-4.57666972467615,0.0551791715577707,0.0836281716002367,-0.0382961142960459,-0.121924285896282,2.363233606908e-05,-3.79886085866692,3.6769731595471,3.86213053063528,3.06859894025739,-0.793531590377888,0.00107920911133937,ENSG00000149418,ST14,protein_coding,11,1,130159782,130210362,q24.3,suppression of tumorigenicity 14 [Source:HGNC Symbol;Acc:HGNC:11344],Ichthyosis-hypotrichosis syndrome;ichthyosis autosomal recessive with hypotrichosis;ICHTHYOSIS CONGENITAL AUTOSOMAL RECESSIVE 11,ST14,6768,NM_021978
CAT_SIG,CAT,CAT_SIG,CAT,SIG,53,4.57657658776922,0.155332351899733,0.143029540689199,0.195755874448631,0.0527263337594319,2.363233606908e-05,2.43605810734018,8.88568665120304,8.81097726144595,9.13116036040489,0.320183098958939,0.0405271431030616,ENSG00000121691,CAT,protein_coding,11,1,34438934,34472060,p13,catalase [Source:HGNC Symbol;Acc:HGNC:1516],ACATALASEMIA,CAT,847,NM_001752
DMTF1_TF,DMTF1,DMTF1_TF,DMTF1,TF,87,4.57481537840219,0.340267164178228,0.331846183513511,0.367936100648014,0.0360899171345034,2.3817631629879e-05,4.00023813835715,6.79186318414027,6.74103389575486,6.95887370312091,0.217839807366045,0.000568488338771093,ENSG00000135164,DMTF1,protein_coding,7,1,87152361,87196337,q21.12,cyclin D binding myb like transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:14603],NA,DMTF1,9988,NM_001142326;NM_001142327;NM_021145
ZC3HC1_TF,ZC3HC1,ZC3HC1_TF,ZC3HC1,TF,271,4.57427235050283,0.31246893010322,0.302382198982971,0.345611046641178,0.0432288476582064,2.38548799393815e-05,5.16134150091627,3.40805140689964,3.33628951422571,3.6438404828283,0.30755096860259,7.43601936222239e-06,ENSG00000091732,ZC3HC1,protein_coding,7,-1,130018286,130051451,q32.2,zinc finger C3HC-type containing 1 [Source:HGNC Symbol;Acc:HGNC:29913],NA,ZC3HC1,51530,NM_001282190;NM_001282191;NM_001363701;NM_016478
SERPINA1_SIG,SERPINA1,SERPINA1_SIG,SERPINA1,SIG,29,-4.57423576660767,0.536842235935263,0.580988347015891,0.391790728098913,-0.189197618916978,2.38548799393815e-05,-3.4023098668324,7.08186395985012,7.2965998132171,6.37630329878718,-0.920296514429916,0.00357698461411805,ENSG00000197249,SERPINA1,protein_coding,14,-1,94376747,94390693,q32.13,serpin family A member 1 [Source:HGNC Symbol;Acc:HGNC:8941],ALPHA-1-ANTITRYPSIN DEFICIENCY;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation;PULMONARY DISEASE CHRONIC OBSTRUCTIVE,SERPINA1,5265,NM_000295;NM_001002235;NM_001002236;NM_001127700;NM_001127701;NM_001127702;NM_001127703;NM_001127704;NM_001127705;NM_001127706;NM_001127707
RASSF5_SIG,RASSF5,RASSF5_SIG,RASSF5,SIG,67,-4.57310898779373,0.437804891608095,0.454902350864045,0.381627525481405,-0.0732748253826397,2.39691392369608e-05,-4.05359282772348,7.39719951118539,7.48123978728732,7.12106717542193,-0.360172611865386,0.000476553225791821,ENSG00000266094,RASSF5,protein_coding,1,1,206507530,206589448,q32.1,Ras association domain family member 5 [Source:HGNC Symbol;Acc:HGNC:17609],NA,RASSF5,83593,NM_182663;NM_182664;NM_182665
NEURL2_SIG,NEURL2,NEURL2_SIG,NEURL2,SIG,81,4.57262598922286,0.0957141219074682,0.0847307581205306,0.131802317207406,0.0470715590868751,2.40100213167128e-05,2.15354404096192,1.66882548919454,1.63335176815035,1.78538200119686,0.152030233046512,0.0726138716819098,ENSG00000124257,NEURL2,protein_coding,20,-1,45888625,45891287,q13.12,neuralized E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:16156],NA,NEURL2,140825,NM_001278535;NM_080749
ESR2_SIG,ESR2,ESR2_SIG,ESR2,SIG,14,-4.57163460423399,-0.208646779319702,-0.203294693038107,-0.226232205673516,-0.0229375126354089,2.41094132339059e-05,-1.42774973667658,0.267669429117248,0.283642415367436,0.215186760009487,-0.068455655357949,0.246316301739607,ENSG00000140009,ESR2,protein_coding,14,-1,64084232,64338112,q23.3,estrogen receptor 2 [Source:HGNC Symbol;Acc:HGNC:3468],Familial medullary thyroid carcinoma;OVARIAN DYSGENESIS 8,ESR2,2100,NM_001040275;NM_001214902;NM_001271876;NM_001271877;NM_001291712;NM_001291723;NM_001437
LRRC41_SIG,LRRC41,LRRC41_SIG,LRRC41,SIG,27,4.57021391380337,0.435808600719468,0.423664852053619,0.47570948919297,0.0520446371393512,2.42588498729913e-05,4.45627117792668,6.15457993764991,6.09243845363922,6.3587590993993,0.266320645760081,0.000116557486566226,ENSG00000132128,LRRC41,protein_coding,1,-1,46261196,46303608,p33,leucine rich repeat containing 41 [Source:HGNC Symbol;Acc:HGNC:16917],NA,LRRC41,10489,NM_006369
CDK6_SIG,CDK6,CDK6_SIG,CDK6,SIG,105,4.57001398976611,0.227073474171424,0.21182434171549,0.277177766526632,0.0653534248111417,2.42674197497494e-05,2.53070863737142,9.00072724127853,8.92000174299934,9.26596816419586,0.345966421196527,0.0330484321162639,ENSG00000105810,CDK6,protein_coding,7,-1,92604921,92836594,q21.2,cyclin dependent kinase 6 [Source:HGNC Symbol;Acc:HGNC:1777],Autosomal recessive primary microcephaly;Microcephaly 12 primary autosomal recessive,CDK6,1021,NM_001145306;NM_001259
BNC2_TF,BNC2,BNC2_TF,BNC2,TF,43,-4.56891171653516,-0.113352657228226,-0.0989730240612869,-0.160600023348169,-0.0616269992868822,2.43807370818105e-05,-3.6901167033533,0.545395545184761,0.606644680504057,0.344148386278504,-0.262496294225552,0.00151672321570276,ENSG00000173068,BNC2,protein_coding,9,-1,16409503,16870843,p22.2,basonuclin 2 [Source:HGNC Symbol;Acc:HGNC:30988],NA,BNC2,54796,NM_001317939;NM_001317940;NM_017637
MAF_TF,MAF,MAF_TF,MAF,TF,149,-4.56789175245303,0.00306749875317207,0.0133938041768882,-0.030861790496181,-0.0442555946730693,2.44849495767693e-05,-3.09164266011462,3.34140878307261,3.45242786913122,2.9766317860229,-0.475796083108325,0.00847140809889492,ENSG00000178573,MAF,protein_coding,16,-1,79585843,79600737,q23.2,MAF bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:6776],Ayme-Gripp syndrome;Ayme-Gripp syndrome: CATARACT DEAFNESS INTELLECTUAL DISABILITY SEIZURES AND A DOWN SYNDROME-LIKE FACIES;Cataract-microcornea syndrome;Cataract 21 multiple types;CATARACT CONGENITAL CERULEAN TYPE 4;CATARACT PULVERULENT JUVENILE-ONSET MAF-RELATED;Cerulean cataract;Pulverulent cataract,MAF,4094,NM_001031804;NM_005360
MS4A3_SIG,MS4A3,MS4A3_SIG,MS4A3,SIG,40,-4.56750482518068,0.282603597332215,0.311081936531947,0.189031911390237,-0.12205002514171,2.4515469954009e-05,-3.20978738461088,5.64133877715229,5.84274722215773,4.97956817213445,-0.863179050023276,0.00618326842457817,ENSG00000149516,MS4A3,protein_coding,11,1,60056587,60071115,q12.1,membrane spanning 4-domains A3 [Source:HGNC Symbol;Acc:HGNC:7317],NA,MS4A3,932,NM_001031666;NM_001031809;NM_006138
ZNF142_TF,ZNF142,ZNF142_TF,ZNF142,TF,55,4.56596295552434,0.397024829517843,0.391875474789015,0.413944137912564,0.0220686631235491,2.46815845377333e-05,3.63494294338299,5.53401542936009,5.49494157090658,5.66240096427877,0.167459393372184,0.00179267332074806,ENSG00000115568,ZNF142,protein_coding,2,-1,218637916,218659655,q35,zinc finger protein 142 [Source:HGNC Symbol;Acc:HGNC:12927],NA,ZNF142,7701,NM_001105537;NM_001366287;NM_001366288;NM_001366289;NM_001366291
TAS2R10_SIG,TAS2R10,TAS2R10_SIG,TAS2R10,SIG,55,4.56430936133217,-0.0799326244693978,-0.0923400918995066,-0.0391652314847546,0.053174860414752,2.48504583105799e-05,4.81965141960334,0.287897052803951,0.254549047197085,0.397469071226509,0.142920024029425,2.94833521953382e-05,ENSG00000121318,TAS2R10,protein_coding,12,-1,10825317,10826358,p13.2,taste 2 receptor member 10 [Source:HGNC Symbol;Acc:HGNC:14918],NA,TAS2R10,50839,NM_023921
LRP8_SIG,LRP8,LRP8_SIG,LRP8,SIG,23,4.56428129084374,0.137190299255245,0.130599546113253,0.158845631007506,0.0282460848942525,2.48504583105799e-05,4.8492012585341,4.4045537987497,4.31724965638256,4.69141026652747,0.37416061014491,2.64814355551986e-05,ENSG00000157193,LRP8,protein_coding,1,-1,53242364,53328070,p32.3,LDL receptor related protein 8 [Source:HGNC Symbol;Acc:HGNC:6700],MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,LRP8,7804,NM_001018054;NM_004631;NM_017522;NM_033300
MAF_SIG,MAF,MAF_SIG,MAF,SIG,12,-4.5638657023627,0.190464244976179,0.207121269947161,0.135734020071522,-0.0713872498756399,2.48848353995724e-05,-3.09164266011462,3.34140878307261,3.45242786913122,2.9766317860229,-0.475796083108325,0.00847140809889492,ENSG00000178573,MAF,protein_coding,16,-1,79585843,79600737,q23.2,MAF bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:6776],Ayme-Gripp syndrome;Ayme-Gripp syndrome: CATARACT DEAFNESS INTELLECTUAL DISABILITY SEIZURES AND A DOWN SYNDROME-LIKE FACIES;Cataract-microcornea syndrome;Cataract 21 multiple types;CATARACT CONGENITAL CERULEAN TYPE 4;CATARACT PULVERULENT JUVENILE-ONSET MAF-RELATED;Cerulean cataract;Pulverulent cataract,MAF,4094,NM_001031804;NM_005360
ZNF740_TF,ZNF740,ZNF740_TF,ZNF740,TF,113,4.56299120328726,0.359401026713774,0.347225929904449,0.399404916230129,0.0521789863256806,2.49674245096091e-05,3.55774621504976,5.52426108060615,5.46489799267525,5.71931122666484,0.254413233989595,0.00227609641351876,ENSG00000139651,ZNF740,protein_coding,12,1,53180704,53195142,q13.13,zinc finger protein 740 [Source:HGNC Symbol;Acc:HGNC:27465],NA,ZNF740,283337,NM_001004304
SLC35B4_SIG,SLC35B4,SLC35B4_SIG,SLC35B4,SIG,62,4.56291952170804,0.301161619260296,0.287428896114095,0.346283423883526,0.0588545277694308,2.49674245096091e-05,5.4121939022565,4.52993968100634,4.41354625090446,4.91237523705536,0.498828986150898,2.41797299912464e-06,ENSG00000205060,SLC35B4,protein_coding,7,-1,134289332,134316930,q33,solute carrier family 35 member B4 [Source:HGNC Symbol;Acc:HGNC:20584],NA,SLC35B4,84912,NM_032826
GNPTAB_SIG,GNPTAB,GNPTAB_SIG,GNPTAB,SIG,29,4.5623282315825,0.388396816583972,0.379894715028712,0.416332293122685,0.0364375780939729,2.50229145662609e-05,5.07762240341854,7.05030077107593,6.95104719292621,7.37641967071074,0.425372477784527,1.02985867535256e-05,ENSG00000111670,GNPTAB,protein_coding,12,-1,101745499,101830959,q23.2,N-acetylglucosamine-1-phosphate transferase subunits alpha and beta [Source:HGNC Symbol;Acc:HGNC:29670],MUCOLIPIDOSIS II ALPHA/BETA;MUCOLIPIDOSIS III ALPHA/BETA;MUCOLIPIDOSIS TYPE II;Mucolipidosis Type III Alpha/Beta;Mucolipidosis type III complementation group A,GNPTAB,79158,NM_024312
PUS10_SIG,PUS10,PUS10_SIG,PUS10,SIG,34,4.55921009309646,0.275521220902551,0.256613908321046,0.337645247956067,0.0810313396350205,2.53821477454382e-05,4.17297101002632,3.00124047980926,2.92357241497374,3.25643554998313,0.332863135009387,0.000316114978538202,ENSG00000162927,PUS10,protein_coding,2,-1,60940222,61018259,p15,pseudouridine synthase 10 [Source:HGNC Symbol;Acc:HGNC:26505],NA,PUS10,150962,NM_001322123;NM_001322124;NM_001322127;NM_144709
SSTR3_SIG,SSTR3,SSTR3_SIG,SSTR3,SIG,5,-4.55880813357747,0.286591648597375,0.314788963449855,0.193943328367797,-0.120845635082058,2.54156050087449e-05,-3.5021596176823,0.597707522687448,0.649759404211427,0.426679911965806,-0.223079492245621,0.00268998088911123,ENSG00000278195,SSTR3,protein_coding,22,-1,37204237,37212477,q13.1,somatostatin receptor 3 [Source:HGNC Symbol;Acc:HGNC:11332],NA,SSTR3,6753,NM_001051;NM_001278687
WRNIP1_SIG,WRNIP1,WRNIP1_SIG,WRNIP1,SIG,77,4.5580279332368,0.145375079986358,0.130537370242421,0.194127554859294,0.0635901846168726,2.54949748857016e-05,3.27968289425437,6.2625033511261,6.20495150610054,6.45160227049581,0.246650764395271,0.0050895884899934,ENSG00000124535,WRNIP1,protein_coding,6,1,2765414,2786952,p25.2,Werner helicase interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20876],NA,WRNIP1,56897,NM_020135;NM_130395
CPM_SIG,CPM,CPM_SIG,CPM,SIG,54,-4.55750822048273,0.0702768198829516,0.0919733189667436,-0.00101167710665071,-0.0929849960733943,2.55428992905035e-05,-3.90769127859866,2.88159789335747,3.05587416428895,2.3089758602969,-0.746898303992046,0.00076108847693131,ENSG00000135678,CPM,protein_coding,12,-1,68842197,68971570,q15,carboxypeptidase M [Source:HGNC Symbol;Acc:HGNC:2311],NA,CPM,1368,NM_001005502;NM_001874;NM_198320
CEBPB_SIG,CEBPB,CEBPB_SIG,CEBPB,SIG,29,-4.55659281949817,0.470106204273742,0.497679748042084,0.379507417606334,-0.11817233043575,2.56391506334886e-05,-3.98399891790065,6.43454098149127,6.57060670124132,5.98746790231253,-0.583138798928792,0.000597280370059501,ENSG00000172216,CEBPB,protein_coding,20,1,50190734,50192689,q13.13,CCAAT enhancer binding protein beta [Source:HGNC Symbol;Acc:HGNC:1834],NA,CEBPB,1051,NM_001285878;NM_001285879;NM_005194
PPP4C_SIG,PPP4C,PPP4C_SIG,PPP4C,SIG,34,-4.55607643409482,0.128790252524091,0.137493867738818,0.100192659675703,-0.0373012080631149,2.56869391498329e-05,-2.52373240949897,6.15044028079679,6.17336911353414,6.07510268751693,-0.0982664260172016,0.0335749233359048,ENSG00000149923,PPP4C,protein_coding,16,1,30075978,30085376,p11.2,protein phosphatase 4 catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9319],NA,PPP4C,5531,NM_001303503;NM_001303504;NM_001303506;NM_001303507;NM_002720
SORL1_SIG,SORL1,SORL1_SIG,SORL1,SIG,59,-4.55412166681136,0.118761470315993,0.125274241394642,0.0973623653432919,-0.0279118760513497,2.59057438058486e-05,-3.64690083709748,8.66179560470551,8.76066691836372,8.33693271697138,-0.423734201392335,0.00172592510174828,ENSG00000137642,SORL1,protein_coding,11,1,121452314,121633763,q24.1,sortilin related receptor 1 [Source:HGNC Symbol;Acc:HGNC:11185],Early-onset autosomal dominant Alzheimer disease,SORL1,6653,NM_003105
MTSS1_SIG,MTSS1,MTSS1_SIG,MTSS1,SIG,32,-4.55404351850133,0.0370468613445345,0.0486492726871413,-0.00107534735260204,-0.0497246200397434,2.59057438058486e-05,-4.65897315342506,5.10570780949395,5.30849225642327,4.43941605529764,-0.869076201125631,5.46078619951272e-05,ENSG00000170873,MTSS1,protein_coding,8,-1,124550790,124728429,q24.13,MTSS1, I-BAR domain containing [Source:HGNC Symbol;Acc:HGNC:20443],NA,MTSS1,9788,NM_001282971;NM_001282974;NM_001363294;NM_001363296;NM_001363297;NM_001363298;NM_014751
TBPL1_TF,TBPL1,TBPL1_TF,TBPL1,TF,224,-4.55333161592141,0.00474792691953798,0.00970610457664287,-0.0115432282395209,-0.0212493328161638,2.597816767244e-05,-3.41209172438325,3.90559568976779,3.95611592604284,3.7396006277212,-0.216515298321638,0.00347877969093765,ENSG00000028839,TBPL1,protein_coding,6,1,133952170,133990432,q23.2,TATA-box binding protein like 1 [Source:HGNC Symbol;Acc:HGNC:11589],NA,TBPL1,9519,NM_001253676;NM_004865
LSG1_SIG,LSG1,LSG1_SIG,LSG1,SIG,16,4.55152153360996,0.394057301709891,0.38643138838325,0.419113874068853,0.0326824856856033,2.6181677897233e-05,4.70703927846993,5.65701437770065,5.59446010269967,5.86254985270389,0.268089750004218,4.53744099365149e-05,ENSG00000041802,LSG1,protein_coding,3,-1,194640791,194672463,q29,large 60S subunit nuclear export GTPase 1 [Source:HGNC Symbol;Acc:HGNC:25652],NA,LSG1,55341,NM_018385
RNF144A_SIG,RNF144A,RNF144A_SIG,RNF144A,SIG,27,4.55144078606548,0.13655481867684,0.124747738873347,0.175349509459747,0.0506017705864003,2.6181677897233e-05,4.35365212951149,5.57687841812363,5.46685578792852,5.93838134590758,0.471525557979065,0.000168277529596518,ENSG00000151692,RNF144A,protein_coding,2,1,6917412,7068286,p25.1,ring finger protein 144A [Source:HGNC Symbol;Acc:HGNC:20457],NA,RNF144A,9781,NM_001349181;NM_001349182;NM_001349183;NM_001349184;NM_001349185;NM_001349186;NM_014746
LIMK2_SIG,LIMK2,LIMK2_SIG,LIMK2,SIG,29,-4.55094450070811,0.441486371133413,0.457339749026764,0.389396700912404,-0.0679430481143606,2.62222942280733e-05,-3.59096574039884,5.47254145336218,5.55616844352028,5.19776705712843,-0.358401386391856,0.00205484922776474,ENSG00000182541,LIMK2,protein_coding,22,1,31212239,31280080,q12.2,LIM domain kinase 2 [Source:HGNC Symbol;Acc:HGNC:6614],NA,LIMK2,3985,NM_001031801;NM_005569;NM_016733
SCAND2P_TF,SCAND2P,SCAND2P_TF,SCAND2P,TF,21,4.55086528212636,0.199746645532177,0.189599969333853,0.233085724469529,0.0434857551356756,2.62222942280733e-05,3.37174364272423,3.21967037587247,3.17048228404296,3.38128839188371,0.210806107840743,0.00392696738626586,ENSG00000176700,SCAND2P,transcribed_unprocessed_pseudogene,15,1,84631451,84647478,q25.2,SCAN domain containing 2 pseudogene [Source:HGNC Symbol;Acc:HGNC:10567],NA,SCAND2P,NA,NA
NME3_SIG,NME3,NME3_SIG,NME3,SIG,37,4.54916498565951,0.128369398744338,0.123101183412301,0.145679249121029,0.0225780657087279,2.64193907675734e-05,2.95831228794915,3.72010514285038,3.65536805019805,3.93281273299374,0.277444682795684,0.0119844414574807,ENSG00000103024,NME3,protein_coding,16,-1,1770286,1771730,p13.3,NME/NM23 nucleoside diphosphate kinase 3 [Source:HGNC Symbol;Acc:HGNC:7851],NA,NME3,4832,NM_002513
SSH3_SIG,SSH3,SSH3_SIG,SSH3,SIG,35,4.5486678379884,0.134376608499504,0.126591017370508,0.159957836494777,0.0333668191242696,2.64662006770405e-05,2.8056424504424,5.21024834592958,5.16650441247983,5.35397841297873,0.187474000498898,0.0174724487890457,ENSG00000172830,SSH3,protein_coding,11,1,67303478,67312607,q13.2,slingshot protein phosphatase 3 [Source:HGNC Symbol;Acc:HGNC:30581],NA,SSH3,54961,NM_017857
HSD17B8_SIG,HSD17B8,HSD17B8_SIG,HSD17B8,SIG,22,4.54845716690597,0.0455774066513944,0.0316362464697502,0.091384075819654,0.0597478293499038,2.64770371038485e-05,2.94967128068843,2.72029303239847,2.66709136933898,2.89509849673681,0.228007127397832,0.0122446116552489,ENSG00000204228,HSD17B8,protein_coding,6,1,33204655,33206831,p21.32,hydroxysteroid 17-beta dehydrogenase 8 [Source:HGNC Symbol;Acc:HGNC:3554],NA,HSD17B8,7923,NM_014234
LSR_SIG,LSR,LSR_SIG,LSR,SIG,22,-4.54779036335765,-0.120796992573106,-0.100194962921312,-0.188489375714712,-0.0882944127933992,2.65453436797199e-05,-3.85840287978643,1.78562598282205,1.89889590869493,1.41345336923974,-0.48544253945519,0.000895976631031641,ENSG00000105699,LSR,protein_coding,19,1,35248330,35267964,q13.12,lipolysis stimulated lipoprotein receptor [Source:HGNC Symbol;Acc:HGNC:29572],NA,LSR,51599,NM_001260489;NM_001260490;NM_015925;NM_205834;NM_205835
DCAF4_SIG,DCAF4,DCAF4_SIG,DCAF4,SIG,20,4.54700235430221,0.276628855057446,0.266303994312651,0.31055339750463,0.0442494031919788,2.66291496929938e-05,3.32836749555339,3.36493035244051,3.30001205881199,3.57823331721995,0.27822125840796,0.0044362052825442,ENSG00000119599,DCAF4,protein_coding,14,1,72926332,72959703,q24.2,DDB1 and CUL4 associated factor 4 [Source:HGNC Symbol;Acc:HGNC:20229],NA,DCAF4,26094,NM_001163508;NM_001163509;NM_001352447;NM_001352448;NM_001352449;NM_015604;NM_181340;NM_181341
ATP1A1_SIG,ATP1A1,ATP1A1_SIG,ATP1A1,SIG,19,-4.54675644616896,0.156015855834618,0.162328599525722,0.135273983706702,-0.0270546158190208,2.6644530382212e-05,-4.31379296962477,8.01270902396515,8.06282837929409,7.84803114217007,-0.21479723712402,0.000194730000974736,ENSG00000163399,ATP1A1,protein_coding,1,1,116372668,116410261,p13.1,ATPase Na+/K+ transporting subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:799],Autosomal dominant Charcot-Marie-Tooth disease type 2DD;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2DD,ATP1A1,476,NM_000701;NM_001160233;NM_001160234
MED12_SIG,MED12,MED12_SIG,MED12,SIG,43,4.54616197088156,0.473640562288885,0.458328586860932,0.523951338695019,0.0656227518340879,2.67040944417787e-05,2.85493671317619,6.85024405271389,6.80410031299112,7.00185919751728,0.19775888452616,0.0155002826916761,ENSG00000184634,MED12,protein_coding,X,1,71118556,71142454,q13.1,mediator complex subunit 12 [Source:HGNC Symbol;Acc:HGNC:11957],Blepharophimosis-intellectual disability syndrome MKB type;FG syndrome type 1;LUJAN-FRYNS SYNDROME;OHDO SYNDROME X-LINKED;OPITZ-KAVEGGIA SYNDROME;X-linked intellectual disability with marfanoid habitus;X-linked non-syndromic intellectual disability,MED12,9968,NM_005120
MAST3_SIG,MAST3,MAST3_SIG,MAST3,SIG,34,-4.54563129969149,0.406915043680121,0.430924908419721,0.32802548810715,-0.102899420312571,2.67485823636207e-05,-4.51862403287771,5.69707571210002,5.81092621774542,5.32299547926511,-0.487930738480317,9.24813911712598e-05,ENSG00000099308,MAST3,protein_coding,19,1,18097793,18151692,p13.11,microtubule associated serine/threonine kinase 3 [Source:HGNC Symbol;Acc:HGNC:19036],NA,MAST3,23031,NM_015016
PIK3C3_SIG,PIK3C3,PIK3C3_SIG,PIK3C3,SIG,45,4.54551569889033,0.300992844898875,0.287747255960989,0.344514065694788,0.0567668097337988,2.67485823636207e-05,4.07510196903606,5.79015741159842,5.72999386860734,5.98783762428341,0.257843755676074,0.000441146278932514,ENSG00000078142,PIK3C3,protein_coding,18,1,41955234,42087830,q12.3,phosphatidylinositol 3-kinase catalytic subunit type 3 [Source:HGNC Symbol;Acc:HGNC:8974],NA,PIK3C3,5289,NM_001308020;NM_002647
MTA3_TF,MTA3,MTA3_TF,MTA3,TF,181,4.54543900086826,-0.038405992252143,-0.0426671445656048,-0.0244050632221969,0.0182620813434078,2.67485823636207e-05,4.28986141434448,3.35963283049534,3.24062544986455,3.75065708113936,0.510031631274807,0.000212832177687381,ENSG00000057935,MTA3,protein_coding,2,1,42494569,42756947,p21,metastasis associated 1 family member 3 [Source:HGNC Symbol;Acc:HGNC:23784],NA,MTA3,57504,NM_001282755;NM_001282756;NM_001330442;NM_001330443;NM_001330444;NM_020744
RBM26_SIG,RBM26,RBM26_SIG,RBM26,SIG,79,4.54356352611061,0.341414824164053,0.332113060776472,0.371977761008965,0.0398647002324931,2.69719058840664e-05,2.88431952757001,6.87021159857583,6.83695646455981,6.97947846748562,0.142522002925813,0.014429854277327,ENSG00000139746,RBM26,protein_coding,13,-1,79311824,79406477,q31.1,RNA binding motif protein 26 [Source:HGNC Symbol;Acc:HGNC:20327],NA,RBM26,64062,NM_001286631;NM_001286632;NM_001366735;NM_022118
ETS1_SIG,ETS1,ETS1_SIG,ETS1,SIG,20,-4.54313751502794,0.196647108286119,0.215290044239956,0.135391747294941,-0.0798982969450145,2.70105962296281e-05,-3.51482366966563,6.88610099507613,7.0030822787537,6.50173392013555,-0.501348358618147,0.00258670064675042,ENSG00000134954,ETS1,protein_coding,11,-1,128458761,128587558,q24.3,ETS proto-oncogene 1, transcription factor [Source:HGNC Symbol;Acc:HGNC:3488],Systemic lupus erythematosus,ETS1,2113,NM_001143820;NM_001162422;NM_001330451;NM_005238
ZNF20_TF,ZNF20,ZNF20_TF,ZNF20,TF,8,4.54263244986482,-0.0379719904795589,-0.0435997584663218,-0.0194807528087666,0.0241190056575553,2.70594958852783e-05,3.02754428626531,0.468579924167508,0.450027724849674,0.529537150497534,0.0795094256478605,0.0100221660103553,ENSG00000132010,ZNF20,protein_coding,19,-1,12092843,12140355,p13.2,zinc finger protein 20 [Source:HGNC Symbol;Acc:HGNC:12992],NA,ZNF20,7568,NM_001203250;NM_021143
DPF2_SIG,DPF2,DPF2_SIG,DPF2,SIG,16,4.54201045065279,0.370606126885568,0.359636054043219,0.406650651938999,0.0470145978957795,2.7123531424218e-05,3.14770182270778,5.91928767616198,5.88409361240228,6.03492531422957,0.150831701827285,0.00731279320489203,ENSG00000133884,DPF2,protein_coding,11,1,65333852,65354262,q13.1,double PHD fingers 2 [Source:HGNC Symbol;Acc:HGNC:9964],COFFIN-SIRIS SYNDROME;COFFIN-SIRIS SYNDROME 7;Coffin Siris like disorder,DPF2,5977,NM_001330308;NM_006268
CD40_SIG,CD40,CD40_SIG,CD40,SIG,17,-4.54142851960377,0.00193745874677176,0.0126309258828071,-0.0331982189859157,-0.0458291448687228,2.7176348497044e-05,-1.37290473977312,2.16508129942768,2.20329258609507,2.03952992894914,-0.163762657145932,0.266903743857689,ENSG00000101017,CD40,protein_coding,20,1,46118272,46129863,q13.12,CD40 molecule [Source:HGNC Symbol;Acc:HGNC:11919],Hyper-IgM syndrome type 3;IMMUNODEFICIENCY WITH HYPER-IgM TYPE 3,CD40,958,NM_001250;NM_001302753;NM_001322421;NM_001322422;NM_001362758;NM_152854
TCF7_TF,TCF7,TCF7_TF,TCF7,TF,209,-4.54135287829459,-0.17166759601044,-0.153179828639091,-0.232413117373444,-0.0792332887343521,2.7176348497044e-05,-4.6580724402399,4.26189046968111,4.45622398482548,3.6233660627782,-0.832857922047273,5.47648596967285e-05,ENSG00000081059,TCF7,protein_coding,5,1,134114681,134151865,q31.1,transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:11639],NA,TCF7,6932,NM_001134851;NM_001346425;NM_001346450;NM_001366502;NM_003202;NM_201632;NM_201634;NM_213648
KDM8_SIG,KDM8,KDM8_SIG,KDM8,SIG,19,4.5412037559813,0.292571026703106,0.280843202389932,0.331105306589249,0.0502621041993173,2.71796303769821e-05,4.63121161782776,2.14359166471011,2.0802499373771,2.35171448309001,0.271464545712907,6.07758568274336e-05,ENSG00000155666,KDM8,protein_coding,16,1,27203495,27221768,p12.1,lysine demethylase 8 [Source:HGNC Symbol;Acc:HGNC:25840],NA,KDM8,79831,NM_001145348;NM_024773
KCNG1_SIG,KCNG1,KCNG1_SIG,KCNG1,SIG,18,-4.54087348307735,-0.182952503492515,-0.171035556788636,-0.222108185519545,-0.051072628730909,2.72062904269956e-05,-2.93999307480858,0.341034990467103,0.383013485349132,0.203105650140437,-0.179907835208695,0.0125679922980926,ENSG00000026559,KCNG1,protein_coding,20,-1,51003656,51023107,q13.13,potassium voltage-gated channel modifier subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:6248],NA,KCNG1,3755,NM_002237
AUH_SIG,AUH,AUH_SIG,AUH,SIG,43,4.54052370796864,0.230114557201075,0.220555599240554,0.2615225619285,0.0409669626879462,2.72355024212533e-05,3.62140751198056,3.78234328115665,3.73360431943353,3.9424855839612,0.208881264527675,0.00187170490652448,ENSG00000148090,AUH,protein_coding,9,-1,91213815,91361913,q22.31,AU RNA binding methylglutaconyl-CoA hydratase [Source:HGNC Symbol;Acc:HGNC:890],3-@METHYLGLUTACONIC ACIDURIA TYPE I;3-methylglutaconic aciduria type 1,AUH,549,NM_001306190;NM_001351431;NM_001351432;NM_001351433;NM_001698
ZBTB48_TF,ZBTB48,ZBTB48_TF,ZBTB48,TF,27,4.53971334890403,0.264523370092843,0.254349746079907,0.297950991849634,0.0436012457697269,2.73243747673649e-05,4.852066421169,5.06749315738105,5.0109383476634,5.25331610359618,0.242377755932778,2.61996541225746e-05,ENSG00000204859,ZBTB48,protein_coding,1,1,6579994,6589280,p36.31,zinc finger and BTB domain containing 48 [Source:HGNC Symbol;Acc:HGNC:4930],NA,ZBTB48,3104,NM_001278647;NM_001278648;NM_005341
RASSF1_SIG,RASSF1,RASSF1_SIG,RASSF1,SIG,42,4.53878272641399,0.193019822623209,0.183350525841113,0.224790369192952,0.0414398433518396,2.7429166190957e-05,1.45454827362488,6.90482154892083,6.88316464560619,6.97597994552606,0.092815299919872,0.237076744459459,ENSG00000068028,RASSF1,protein_coding,3,-1,50329782,50340980,p21.31,Ras association domain family member 1 [Source:HGNC Symbol;Acc:HGNC:9882],LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,RASSF1,11186,NM_001206957;NM_007182;NM_170712;NM_170713;NM_170714
ITGAX_SIG,ITGAX,ITGAX_SIG,ITGAX,SIG,20,-4.5385191282843,0.722128269462137,0.75069214159416,0.628275546742631,-0.12241659485153,2.74474093341462e-05,-3.19035416964557,7.52125259967738,7.63362609863517,7.15202538881609,-0.481600709819078,0.00652675834350917,ENSG00000140678,ITGAX,protein_coding,16,1,31355134,31382997,p11.2,integrin subunit alpha X [Source:HGNC Symbol;Acc:HGNC:6152],NA,ITGAX,3687,NM_000887;NM_001286375
ST3GAL3_SIG,ST3GAL3,ST3GAL3_SIG,ST3GAL3,SIG,54,4.53825323211891,0.130414160062118,0.117939296127106,0.171402998705731,0.0534637025786248,2.74609704254851e-05,1.8417687857519,4.16134069296045,4.11892370859779,4.30071078443776,0.181787075839972,0.128515243121978,ENSG00000126091,ST3GAL3,protein_coding,1,1,43705824,43931165,p34.1,ST3 beta-galactoside alpha-2,3-sialyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:10866],Autosomal recessive non-syndromic intellectual disability;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 15;MENTAL RETARDATION AUTOSOMAL RECESSIVE 12;West syndrome,ST3GAL3,6487,NM_001270459;NM_001270460;NM_001270461;NM_001270462;NM_001270463;NM_001270464;NM_001270465;NM_001270466;NM_001350619;NM_001350620;NM_001350621;NM_001363573;NM_006279;NM_174963;NM_174964;NM_174965;NM_174966;NM_174967;NM_174968;NM_174969;NM_174970;NM_174971
GZMM_SIG,GZMM,GZMM_SIG,GZMM,SIG,14,-4.5381684015135,0.00704647736741608,0.0426866064929299,-0.110056804044987,-0.152743410537917,2.74609704254851e-05,-3.65720136582984,1.70858035433148,1.80800982151004,1.38188353360192,-0.426126287908124,0.00167666889965776,ENSG00000197540,GZMM,protein_coding,19,1,544034,549924,p13.3,granzyme M [Source:HGNC Symbol;Acc:HGNC:4712],NA,GZMM,3004,NM_001258351;NM_005317
TGM3_SIG,TGM3,TGM3_SIG,TGM3,SIG,19,-4.53797616203359,0.0703198767561802,0.0935844085648659,-0.00612072775807286,-0.0997051363229389,2.74699640256939e-05,-2.24399367768977,1.01069221100777,1.08741098544865,0.758616237844904,-0.328794747603744,0.0606661145979222,ENSG00000125780,TGM3,protein_coding,20,1,2296001,2341079,p13,transglutaminase 3 [Source:HGNC Symbol;Acc:HGNC:11779],UNCOMBABLE HAIR SYNDROME;Uncombable hair syndrome 2,TGM3,7053,NM_003245
EHMT2_SIG,EHMT2,EHMT2_SIG,EHMT2,SIG,63,4.53611168321283,0.280466945787677,0.261543180299114,0.342645032392955,0.0811018520938406,2.76976368909956e-05,3.61857359161983,6.31983164782088,6.25709653824686,6.52596129356412,0.268864755317259,0.00188609679713291,ENSG00000204371,EHMT2,protein_coding,6,-1,31879759,31897687,p21.33,euchromatic histone lysine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:14129],NA,EHMT2,10919,NM_001289413;NM_001318833;NM_001363689;NM_006709;NM_025256
FBXO42_SIG,FBXO42,FBXO42_SIG,FBXO42,SIG,22,4.53577625394493,0.275737882842531,0.270932750524034,0.291526174746164,0.0205934242221302,2.77255229900544e-05,3.23526264806556,5.34361361730024,5.30917344067651,5.45677419763534,0.147600756958834,0.00576206742897096,ENSG00000037637,FBXO42,protein_coding,1,-1,16246840,16352480,p36.13,F-box protein 42 [Source:HGNC Symbol;Acc:HGNC:29249],NA,FBXO42,54455,NM_018994
ZMIZ1_SIG,ZMIZ1,ZMIZ1_SIG,ZMIZ1,SIG,64,4.53561132716725,0.261614839131901,0.252652201207495,0.291063506597807,0.0384113053903122,2.77310300385591e-05,2.47611585242718,8.23552786828311,8.18775530091177,8.39249487536036,0.204739574448586,0.0372083060195345,ENSG00000108175,ZMIZ1,protein_coding,10,1,79068966,79316528,q22.3,zinc finger MIZ-type containing 1 [Source:HGNC Symbol;Acc:HGNC:16493],NA,ZMIZ1,57178,NM_020338
NAT9_SIG,NAT9,NAT9_SIG,NAT9,SIG,26,4.53506723993913,0.351305639615119,0.343966098499734,0.375421274708524,0.0314551762087897,2.77864215999688e-05,1.6185678585737,4.61095187454686,4.58874820551538,4.68390678707887,0.0951585815634957,0.185387529250303,ENSG00000109065,NAT9,protein_coding,17,-1,74770547,74776367,q25.1,N-acetyltransferase 9 (putative) [Source:HGNC Symbol;Acc:HGNC:23133],NA,NAT9,26151,NM_001305077;NM_001305078;NM_001305079;NM_001305080;NM_001305081;NM_001305082;NM_001305083;NM_001305084;NM_001305085;NM_001305086;NM_001305087;NM_001305088;NM_015654
ZMAT1_SIG,ZMAT1,ZMAT1_SIG,ZMAT1,SIG,109,4.53410663956775,0.0897310429094594,0.078471699437933,0.126726028601617,0.0482543291636844,2.78969159140611e-05,2.27863439991777,5.14590594197948,5.08853193300622,5.33442054289163,0.245888609885411,0.0564181502400136,ENSG00000166432,ZMAT1,protein_coding,X,-1,101882288,101932079,q22.1,zinc finger matrin-type 1 [Source:HGNC Symbol;Acc:HGNC:29377],NA,ZMAT1,84460,NM_001011657;NM_001282400;NM_001282401
MRPL32_SIG,MRPL32,MRPL32_SIG,MRPL32,SIG,18,4.53364463288927,0.274035375514249,0.26711051725645,0.296788481218445,0.0296779639619951,2.79417703193198e-05,4.3085175246573,4.45395748364644,4.40537642785927,4.61358095266141,0.208204524802142,0.000198483185473349,ENSG00000106591,MRPL32,protein_coding,7,1,42932376,42948958,p14.1,mitochondrial ribosomal protein L32 [Source:HGNC Symbol;Acc:HGNC:14035],NA,MRPL32,64983,NM_031903
ABHD4_SIG,ABHD4,ABHD4_SIG,ABHD4,SIG,29,4.53114868000834,0.0739863989204089,0.064670934468895,0.104594353546812,0.0399234190779171,2.82575491802072e-05,1.69356133876694,4.76585384024074,4.72682204175603,4.89410117811907,0.167279136363038,0.164839224454104,ENSG00000100439,ABHD4,protein_coding,14,1,22598237,22613215,q11.2,abhydrolase domain containing 4 [Source:HGNC Symbol;Acc:HGNC:20154],NA,ABHD4,63874,NM_022060
B3GALNT2_SIG,B3GALNT2,B3GALNT2_SIG,B3GALNT2,SIG,12,4.53073458284376,0.0151161258587287,0.00881045520306527,0.0358347580130515,0.0270243028099862,2.82965471072271e-05,4.22849231341024,3.48751177268387,3.4079809614891,3.74882729518097,0.340846333691868,0.000261063698331002,ENSG00000162885,B3GALNT2,protein_coding,1,-1,235447190,235504452,q42.3,beta-1,3-N-acetylgalactosaminyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:28596],Autosomal recessive non-syndromic intellectual disability;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES) TYPE A 11;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 11;Walker-Warburg syndrome,B3GALNT2,148789,NM_001277155;NM_152490
SGK1_SIG,SGK1,SGK1_SIG,SGK1,SIG,41,-4.53043545338317,0.26696990700311,0.290576350962956,0.189405876849327,-0.101170474113629,2.83201876379166e-05,-3.6992586203334,5.44898752664089,5.6297502346065,4.85505291475387,-0.774697319852627,0.00147448449854622,ENSG00000118515,SGK1,protein_coding,6,-1,134169246,134318112,q23.2,serum/glucocorticoid regulated kinase 1 [Source:HGNC Symbol;Acc:HGNC:10810],NA,SGK1,6446,NM_001143676;NM_001143677;NM_001143678;NM_001291995;NM_005627
SERPING1_SIG,SERPING1,SERPING1_SIG,SERPING1,SIG,49,4.52882220942986,0.000575616160388534,-0.0106068181447377,0.0373179003058032,0.0479247184505407,2.85206820894271e-05,2.04355916827356,4.94064023441018,4.84461556689678,5.25614985623994,0.411534289343159,0.0896362996617397,ENSG00000149131,SERPING1,protein_coding,11,1,57597387,57614853,q12.1,serpin family G member 1 [Source:HGNC Symbol;Acc:HGNC:1228],ANGIOEDEMA HEREDITARY TYPE I;C1 inhibitor deficiency;COMPLEMENT COMPONENT 4 PARTIAL DEFICIENCY OF;Hereditary angioedema type 1;Hereditary angioedema type 2,SERPING1,710,NM_000062;NM_001032295
MXD1_TF,MXD1,MXD1_TF,MXD1,TF,273,-4.52840975503,0.0152141664885003,0.0276625612175264,-0.0256877019068712,-0.0533502631243978,2.85530179499385e-05,-3.17415952857815,7.4862224646833,7.5813389792369,7.17369677400718,-0.407642205229724,0.00680586218844033,ENSG00000059728,MXD1,protein_coding,2,1,69897688,69942945,p13.3,MAX dimerization protein 1 [Source:HGNC Symbol;Acc:HGNC:6761],NA,MXD1,4084,NM_001202513;NM_001202514;NM_002357
ZCWPW1_SIG,ZCWPW1,ZCWPW1_SIG,ZCWPW1,SIG,39,4.52833756902622,-0.00492531705663277,-0.0173719444529614,0.0359707443884471,0.0533426888414084,2.85530179499385e-05,2.06942375483316,2.79308881045347,2.75828623652875,2.90744012477754,0.149153888248792,0.085152442162905,ENSG00000078487,ZCWPW1,protein_coding,7,-1,100400826,100428992,q22.1,zinc finger CW-type and PWWP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23486],NA,ZCWPW1,55063,NM_001258008;NM_017984
RORA_SIG,RORA,RORA_SIG,RORA,SIG,72,-4.52670787155693,-0.0243464492583251,-0.000990027382023803,-0.101088978280458,-0.100098950898434,2.87573341402709e-05,-4.08542004385143,3.66204496509318,3.83900393984073,3.08060833377981,-0.758395606060923,0.000425746995762623,ENSG00000069667,RORA,protein_coding,15,-1,60488284,61229302,q22.2,RAR related orphan receptor A [Source:HGNC Symbol;Acc:HGNC:10258],INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY ORCEREBELLAR ATAXIA;Intellectual disability,RORA,6095,NM_002943;NM_134260;NM_134261;NM_134262
MYH9_SIG,MYH9,MYH9_SIG,MYH9,SIG,11,-4.52643262064682,0.70580597429871,0.719031929965356,0.662349262822585,-0.0566826671427716,2.87781243692501e-05,-3.2451632397575,10.7002054387893,10.7427952334114,10.5602675421736,-0.182527691237869,0.00560694983151969,ENSG00000100345,MYH9,protein_coding,22,-1,36281277,36388067,q12.3,myosin heavy chain 9 [Source:HGNC Symbol;Acc:HGNC:7579],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 17;DEAFNESS AUTOSOMAL DOMINANT TYPE 17;EPSTEIN SYNDROME;FECHTNER SYNDROME;Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss;MACROTHROMBOCYTOPENIA WITH PROGRESSIVE SENSORINEURAL DEAFNESS;MAY-HEGGLIN ANOMALY;MYH9-related disease;Nodular fasciitis;SEBASTIAN SYNDROME,MYH9,4627,NM_002473
PLA2G7_SIG,PLA2G7,PLA2G7_SIG,PLA2G7,SIG,23,-4.52616955741198,-0.101864903192927,-0.0799151986827962,-0.173985360869071,-0.094070162186275,2.87972772268731e-05,-2.9585138994028,1.11862780686712,1.21508383400311,0.801700860563142,-0.413382973439969,0.011983142637691,ENSG00000146070,PLA2G7,protein_coding,6,-1,46704201,46735693,p12.3,phospholipase A2 group VII [Source:HGNC Symbol;Acc:HGNC:9040],ASTHMA SUSCEPTIBILITY TO;IgE RESPONSIVENESS ATOPIC;PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY,PLA2G7,7941,NM_001168357;NM_005084
ZNF554_TF,ZNF554,ZNF554_TF,ZNF554,TF,68,4.5253783149815,0.0618947724331413,0.0525078820024937,0.0927374124195549,0.0402295304170612,2.88885166550018e-05,2.80424519099184,2.4484652350866,2.40543679020835,2.58984441111513,0.184407620906783,0.0175227974203052,ENSG00000172006,ZNF554,protein_coding,19,1,2819874,2835773,p13.3,zinc finger protein 554 [Source:HGNC Symbol;Acc:HGNC:26629],NA,ZNF554,115196,NM_001102651
SPN_SIG,SPN,SPN_SIG,SPN,SIG,43,4.52523432126742,0.336649170020961,0.319798208855502,0.392016613850328,0.072218404994826,2.8891483479628e-05,3.23120552408557,8.98179264593355,8.88610267039214,9.29620256556962,0.410099895177478,0.00581752490170561,ENSG00000197471,SPN,protein_coding,16,1,29662979,29670876,p11.2,sialophorin [Source:HGNC Symbol;Acc:HGNC:11249],NA,SPN,6693,NM_001030288;NM_003123
SLC18B1_SIG,SLC18B1,SLC18B1_SIG,SLC18B1,SIG,54,-4.52459554770168,0.00857041102937262,0.0173601964295055,-0.020310312428207,-0.0376705088577124,2.896213507829e-05,-2.45178992182485,2.13741058506829,2.20962900125621,1.90012150330799,-0.309507497948226,0.0392103548876301,ENSG00000146409,SLC18B1,protein_coding,6,-1,132769370,132813339,q23.2,solute carrier family 18 member B1 [Source:HGNC Symbol;Acc:HGNC:21573],NA,SLC18B1,116843,NM_052831
LCP1_SIG,LCP1,LCP1_SIG,LCP1,SIG,37,-4.52371126367848,0.521989540466492,0.537879758959505,0.469778822560879,-0.0681009363986265,2.90666725256437e-05,-3.31587417821995,10.6659758961127,10.7271870821262,10.4648534277826,-0.262333654343653,0.00460057937295412,ENSG00000136167,LCP1,protein_coding,13,-1,46125920,46211871,q14.13,lymphocyte cytosolic protein 1 [Source:HGNC Symbol;Acc:HGNC:6528],NA,LCP1,3936,NM_002298
ZFP14_TF,ZFP14,ZFP14_TF,ZFP14,TF,126,4.5202002345137,0.100093224782608,0.0876898719750901,0.140847098293023,0.0531572263179333,2.9535890597022e-05,3.71215698826285,2.98197818951824,2.90661078953083,3.22961393233399,0.323003142803163,0.00141782896851399,ENSG00000142065,ZFP14,protein_coding,19,-1,36334453,36379201,q13.12,ZFP14 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:29312],NA,ZFP14,57677,NM_001297619;NM_020917
B3GALNT1_SIG,B3GALNT1,B3GALNT1_SIG,B3GALNT1,SIG,13,4.51989450813659,0.173587942546054,0.157213237517926,0.227390544781332,0.0701773072634067,2.95615169747416e-05,2.22478563739726,3.31746881898856,3.24327349788812,3.56125344546145,0.317979947573334,0.0631125973553268,ENSG00000169255,B3GALNT1,protein_coding,3,-1,161083883,161105411,q26.1,beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) [Source:HGNC Symbol;Acc:HGNC:918],BLOOD GROUP GLOBOSIDE SYSTEM;BLOOD GROUP P1PK SYSTEM P(1) PHENOTYPE INCLUDED,B3GALNT1,8706,NM_001038628;NM_001349130;NM_001349131;NM_001349132;NM_001349133;NM_001349134;NM_001349135;NM_001349136;NM_001349137;NM_001349138;NM_001349139;NM_001349140;NM_001349141;NM_001349142;NM_001349143;NM_001349144;NM_001349145;NM_001349146;NM_001349147;NM_001349148;NM_001349149;NM_001349150;NM_001349151;NM_001349152;NM_001349153;NM_001349154;NM_001349155;NM_001349156;NM_001349157;NM_001349158;NM_001349159;NM_001349160;NM_001349161;NM_001349162;NM_001349163;NM_003781;NM_033167;NM_033168;NM_033169
MSR1_SIG,MSR1,MSR1_SIG,MSR1,SIG,14,-4.51933557401317,0.224545436213172,0.267158117616733,0.0845323401729035,-0.182625777443829,2.96004416129419e-05,-3.14910223252509,2.32685895529713,2.49013123252206,1.79039290155807,-0.699738330963995,0.00728918636159595,ENSG00000038945,MSR1,protein_coding,8,-1,16107878,16567490,p22,macrophage scavenger receptor 1 [Source:HGNC Symbol;Acc:HGNC:7376],BARRETT ESOPHAGUS;Familial prostate cancer,MSR1,4481,NM_001363744;NM_002445;NM_138715;NM_138716
TRIM6_SIG,TRIM6,TRIM6_SIG,TRIM6,SIG,14,4.51927233087082,-0.0126390491145646,-0.0231738553392375,0.0219753141950749,0.0451491695343124,2.96004416129419e-05,0.76594790691764,1.72109005100292,1.70036265113286,1.7891943648617,0.0888317137288382,0.55458968290534,ENSG00000121236,TRIM6,protein_coding,11,1,5596109,5612958,p15.4,tripartite motif containing 6 [Source:HGNC Symbol;Acc:HGNC:16277],NA,TRIM6,117854,NM_001003818;NM_001198644;NM_001198645;NM_058166
MEF2A_TF,MEF2A,MEF2A_TF,MEF2A,TF,228,-4.51924992012321,0.0732457341493865,0.0789588217873154,0.0544741604819061,-0.0244846613054094,2.96004416129419e-05,-3.08204596005162,6.49231255895141,6.54761829343795,6.31059371706706,-0.237024576370891,0.00868461171724704,ENSG00000068305,MEF2A,protein_coding,15,1,99565417,99716466,q26.3,myocyte enhancer factor 2A [Source:HGNC Symbol;Acc:HGNC:6993],CORONARY ARTERY DISEASE AUTOSOMAL DOMINANT 1,MEF2A,4205,NM_001130926;NM_001130927;NM_001130928;NM_001171894;NM_001319206;NM_001352614;NM_001352615;NM_001352616;NM_001352617;NM_001352618;NM_001365205;NM_001365206;NM_001365207;NM_001365208;NM_001365209;NM_005587
METTL3_SIG,METTL3,METTL3_SIG,METTL3,SIG,123,4.51908773825074,0.177869377083001,0.163771683873292,0.224190369057758,0.0604186851844662,2.96060782037647e-05,3.39973696648617,5.75574042931997,5.69372318006693,5.9595113911514,0.265788211084476,0.00360617441287887,ENSG00000165819,METTL3,protein_coding,14,-1,21498133,21511342,q11.2,methyltransferase like 3 [Source:HGNC Symbol;Acc:HGNC:17563],NA,METTL3,56339,NM_019852
ETS1_TF,ETS1,ETS1_TF,ETS1,TF,160,-4.51893671820591,0.00269083756870575,0.0130042624918986,-0.0311961300360707,-0.0442003925279694,2.96101640718827e-05,-3.51482366966563,6.88610099507613,7.0030822787537,6.50173392013555,-0.501348358618147,0.00258670064675042,ENSG00000134954,ETS1,protein_coding,11,-1,128458761,128587558,q24.3,ETS proto-oncogene 1, transcription factor [Source:HGNC Symbol;Acc:HGNC:3488],Systemic lupus erythematosus,ETS1,2113,NM_001143820;NM_001162422;NM_001330451;NM_005238
CMKLR1_SIG,CMKLR1,CMKLR1_SIG,CMKLR1,SIG,36,-4.5178430838581,0.0124253386604062,0.0304875694083344,-0.0469219909399295,-0.077409560348264,2.97463651547637e-05,-3.60748410618135,1.89896618270037,2.02691510405764,1.47856258395506,-0.548352520102583,0.0019533567788228,ENSG00000174600,CMKLR1,protein_coding,12,-1,108288044,108339317,q23.3,chemerin chemokine-like receptor 1 [Source:HGNC Symbol;Acc:HGNC:2121],NA,CMKLR1,1240,NM_001142343;NM_001142344;NM_001142345;NM_004072
NMU_SIG,NMU,NMU_SIG,NMU,SIG,14,-4.51745579157252,-0.297343945497584,-0.276166327269854,-0.36692754824584,-0.0907612209759857,2.97836896081822e-05,-2.64615812406635,0.355444613987356,0.407817562022634,0.183362070442873,-0.224455491579761,0.0252643043681294,ENSG00000109255,NMU,protein_coding,4,-1,55595229,55636698,q12,neuromedin U [Source:HGNC Symbol;Acc:HGNC:7859],NA,NMU,10874,NM_001292045;NM_001292046;NM_006681
NUAK1_SIG,NUAK1,NUAK1_SIG,NUAK1,SIG,14,-4.51578894472138,-0.251075069656982,-0.241559149271218,-0.282341665210206,-0.0407825159389876,2.99960284462036e-05,-1.75421745084867,0.604129872288618,0.6380895570819,0.492548050824977,-0.145541506256924,0.149116189215575,ENSG00000074590,NUAK1,protein_coding,12,-1,106063340,106140033,q23.3,NUAK family kinase 1 [Source:HGNC Symbol;Acc:HGNC:14311],NA,NUAK1,9891,NM_014840
SLC9A9_SIG,SLC9A9,SLC9A9_SIG,SLC9A9,SIG,45,-4.51570754491254,-0.0723336818913076,-0.0576923914799547,-0.120440778957181,-0.0627483874772262,2.99960284462036e-05,-4.26955569001681,2.56705379797779,2.70559267903843,2.11185461734997,-0.59373806168846,0.000226019072995228,ENSG00000181804,SLC9A9,protein_coding,3,-1,143265222,143848485,q24,solute carrier family 9 member A9 [Source:HGNC Symbol;Acc:HGNC:20653],AUTISM SUSCEPTIBILITY TO 16;SUSCEPTIBILITY TO AUTISM TYPE 16,SLC9A9,285195,NM_173653
INHBA_SIG,INHBA,INHBA_SIG,INHBA,SIG,23,-4.51493795488454,0.0947152179516984,0.116608814847787,0.022779113864549,-0.0938297009832383,3.00879019454757e-05,-3.16772858719569,2.64780575397423,2.80796065007209,2.12158252393842,-0.686378126133662,0.006916143694154,ENSG00000122641,INHBA,protein_coding,7,-1,41667168,41705834,p14.1,inhibin subunit beta A [Source:HGNC Symbol;Acc:HGNC:6066],Adenocarcinoma of ovary,INHBA,3624,NM_002192
DDX52_SIG,DDX52,DDX52_SIG,DDX52,SIG,71,4.51470932815512,0.347961281907792,0.340345752699272,0.3729837350215,0.0326379823222277,3.01031170602761e-05,4.83470190601712,5.44552953681209,5.38326760279852,5.65010446285667,0.266836860058148,2.79545756479225e-05,ENSG00000278053,DDX52,protein_coding,17,-1,37609739,37643446,q12,DExD-box helicase 52 [Source:HGNC Symbol;Acc:HGNC:20038],NA,DDX52,11056,NM_001291476;NM_007010
CASD1_SIG,CASD1,CASD1_SIG,CASD1,SIG,64,4.51365695645154,0.312397656714564,0.302492837701338,0.344942062043736,0.0424492243423976,3.02356249298132e-05,2.3799404956607,4.66298311682429,4.62007901862166,4.80395372520439,0.183874706582729,0.0457835548825345,ENSG00000127995,CASD1,protein_coding,7,1,94509219,94557019,q21.3,CAS1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:16014],NA,CASD1,64921,NM_001363428;NM_022900
POLR2H_SIG,POLR2H,POLR2H_SIG,POLR2H,SIG,20,4.51104074670134,0.248212731433618,0.230473016967599,0.306500364679106,0.0760273477115063,3.05934774888039e-05,6.20175149859732,4.41651787507764,4.31216509550626,4.75939129366929,0.447226198163034,5.20480383570387e-08,ENSG00000163882,POLR2H,protein_coding,3,1,184361718,184368596,q27.1,RNA polymerase II subunit H [Source:HGNC Symbol;Acc:HGNC:9195],NA,POLR2H,5437,NM_001278698;NM_001278699;NM_001278700;NM_001278714;NM_001278715;NM_001346879;NM_006232
ZNF425_TF,ZNF425,ZNF425_TF,ZNF425,TF,25,4.51091816014621,0.0572997345930565,0.0428411631266591,0.104806469411219,0.0619653062845605,3.05936529146472e-05,2.76284198713225,1.39331346373793,1.34346000918002,1.55711767157105,0.213657662391028,0.0193318288386195,ENSG00000204947,ZNF425,protein_coding,7,-1,149102784,149126324,q36.1,zinc finger protein 425 [Source:HGNC Symbol;Acc:HGNC:20690],NA,ZNF425,155054,NM_001001661
WDR33_SIG,WDR33,WDR33_SIG,WDR33,SIG,36,4.50986012088933,0.502303152103727,0.495693674560822,0.524020006887555,0.028326332326733,3.07290533073976e-05,4.84107539494189,6.15335654145377,6.10684866286822,6.30616814252059,0.199319479652368,2.73320922776252e-05,ENSG00000136709,WDR33,protein_coding,2,-1,127701027,127811187,q14.3,WD repeat domain 33 [Source:HGNC Symbol;Acc:HGNC:25651],NA,WDR33,55339,NM_001006622;NM_001006623;NM_018383
CCL2_SIG,CCL2,CCL2_SIG,CCL2,SIG,17,-4.50866100500122,-0.189681992485524,-0.178089985742878,-0.227770014639929,-0.0496800288970509,3.08855573769937e-05,-3.46737889241604,1.10302807579944,1.26757727426328,0.562366423703982,-0.7052108505593,0.00296743757555219,ENSG00000108691,CCL2,protein_coding,17,1,34255218,34257203,q12,C-C motif chemokine ligand 2 [Source:HGNC Symbol;Acc:HGNC:10618],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED;Neural tube defects susceptibility to,CCL2,6347,NM_002982
HSP90AB1_SIG,HSP90AB1,HSP90AB1_SIG,HSP90AB1,SIG,50,4.50846994491766,0.471308343957117,0.457740558826055,0.51588820938775,0.058147650561695,3.08957239646626e-05,4.13004866252246,9.94470323877762,9.8685896616018,10.194790706641,0.326201045039202,0.000367139655241454,ENSG00000096384,HSP90AB1,protein_coding,6,1,44246166,44253888,p21.1,heat shock protein 90 alpha family class B member 1 [Source:HGNC Symbol;Acc:HGNC:5258],NA,HSP90AB1,3326,NM_001271969;NM_001271970;NM_001271971;NM_001271972;NM_007355
ZNF208_TF,ZNF208,ZNF208_TF,ZNF208,TF,49,-4.50497626385891,-0.126821306505007,-0.116512768832537,-0.160692216000266,-0.0441794471677288,3.13904850481037e-05,-2.30329632087294,0.469560078141792,0.516467065786353,0.315437118738232,-0.201029947048122,0.0536061299322177,ENSG00000160321,ZNF208,protein_coding,19,-1,21932958,22010949,p12,zinc finger protein 208 [Source:HGNC Symbol;Acc:HGNC:12999],NA,ZNF208,7757,NM_001329971;NM_001329973;NM_001329974;NM_007153
TCF4_TF,TCF4,TCF4_TF,TCF4,TF,171,4.50470628875923,-0.00297979254959138,-0.0104463188644435,0.0215530796277799,0.0319993984922233,3.14124878216453e-05,3.33454796411417,5.43795717432517,5.2975825307272,5.8991881461471,0.601605615419897,0.00435830311931509,ENSG00000196628,TCF4,protein_coding,18,-1,55222331,55664787,q21.2,transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:11634],Autosomal dominant non-syndromic intellectual disability;CORNEAL DYSTROPHY FUCHS ENDOTHELIAL 3;Fuchs endothelial corneal dystrophy;PITT-HOPKINS SYNDROME;Primary sclerosing cholangitis,TCF4,6925,NM_001083962;NM_001243226;NM_001243227;NM_001243228;NM_001243230;NM_001243231;NM_001243232;NM_001243233;NM_001243234;NM_001243235;NM_001243236;NM_001306207;NM_001306208;NM_001330604;NM_001330605;NM_001348211;NM_001348212;NM_001348213;NM_001348214;NM_001348215;NM_001348216;NM_001348217;NM_001348218;NM_001348219;NM_001348220;NM_003199
ZDHHC18_SIG,ZDHHC18,ZDHHC18_SIG,ZDHHC18,SIG,55,-4.50275597888412,0.319875956008988,0.337778741671589,0.2610525174033,-0.0767262242682884,3.16841673435409e-05,-2.58814526460311,6.00235213584943,6.06399342682147,5.79981646551275,-0.264176961308718,0.0289457484516205,ENSG00000204160,ZDHHC18,protein_coding,1,1,26826688,26857604,p36.11,zinc finger DHHC-type containing 18 [Source:HGNC Symbol;Acc:HGNC:20712],NA,ZDHHC18,84243,NM_032283
ZNF592_TF,ZNF592,ZNF592_TF,ZNF592,TF,113,-4.50109435420691,0.287762974108758,0.296917410879545,0.257684110433315,-0.0392333004462295,3.19147099030478e-05,-2.99363016248199,6.71856942603657,6.74665401964774,6.62629147559988,-0.120362544047854,0.0109395337132937,ENSG00000166716,ZNF592,protein_coding,15,1,84748592,84806445,q25.3,zinc finger protein 592 [Source:HGNC Symbol;Acc:HGNC:28986],CAMOS syndrome,ZNF592,9640,NM_014630
MED7_SIG,MED7,MED7_SIG,MED7,SIG,21,4.50064906557938,0.18612824744351,0.174788433317299,0.223387636715348,0.0485992033980493,3.19634334242968e-05,4.87514218662937,3.28799867406912,3.21862214517407,3.51595012615285,0.297327980978781,2.36934116081301e-05,ENSG00000155868,MED7,protein_coding,5,-1,157137424,157159019,q33.3,mediator complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:2378],NA,MED7,9443,NM_001100816;NM_004270
HLA-B_SIG,HLA-B,HLA-B_SIG,HLA-B,SIG,19,-4.5003607283805,0.604889480903491,0.621716769846437,0.549599817233812,-0.0721169526126245,3.1988606747704e-05,-3.76310926601136,10.750705399188,10.8360958362797,10.4701368201725,-0.365959016107261,0.00120552468994538,ENSG00000234745,HLA-B,protein_coding,6,-1,31269491,31357188,p21.33,major histocompatibility complex, class I, B [Source:HGNC Symbol;Acc:HGNC:4932],Abacavir toxicity;Allopurinol toxicity;Behcet disease;Flucloxacilline toxicity;Phenytoin or carbamazepine toxicity;Pulmonary arterial hypertension associated with connective tissue disease;SEVERE CUTANEOUS ADVERSE REACTION SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS SUSCEPTIBILITY TO INCLUDED;SPONDYLOARTHROPATHY SUSCEPTIBILITY TO 1;Stevens-Johnson syndrome;Takayasu arteritis,HLA-B,3106,NM_005514
CLEC7A_SIG,CLEC7A,CLEC7A_SIG,CLEC7A,SIG,30,-4.50010806440245,0.525558851171782,0.56039767497919,0.411088430090297,-0.149309244888893,3.20084355597128e-05,-3.29744821127528,4.85334386714638,5.02989561365471,4.27324527147618,-0.756650342178531,0.00484486363327518,ENSG00000172243,CLEC7A,protein_coding,12,-1,10116777,10130258,p13.2,C-type lectin domain containing 7A [Source:HGNC Symbol;Acc:HGNC:14558],Aspergillosis susceptibility to;CANDIDIASIS FAMILIAL 4;Chronic mucocutaneous candidiasis,CLEC7A,64581,NM_022570;NM_197947;NM_197948;NM_197949;NM_197950;NM_197954
FBXL19_TF,FBXL19,FBXL19_TF,FBXL19,TF,140,4.49761344923801,0.319308983914932,0.308962526115552,0.353304488112896,0.0443419619973442,3.23677821114447e-05,3.33887707900832,5.28279417366469,5.22096595659635,5.48594402974639,0.264978073150034,0.00430910203368165,ENSG00000099364,FBXL19,protein_coding,16,1,30923055,30948783,p11.2,F-box and leucine rich repeat protein 19 [Source:HGNC Symbol;Acc:HGNC:25300],NA,FBXL19,54620,NM_001099784;NM_001282351
RNF212_SIG,RNF212,RNF212_SIG,RNF212,SIG,4,-4.49688901880246,-0.0634992832483855,-0.0413545926487082,-0.136260409504468,-0.0949058168557597,3.24597624563265e-05,0.176050893735223,0.747660369902378,0.742747010178848,0.763804266136837,0.021057255957989,0.901133877821489,ENSG00000178222,RNF212,protein_coding,4,-1,1056250,1113564,p16.3,ring finger protein 212 [Source:HGNC Symbol;Acc:HGNC:27729],RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,RNF212,285498,NM_001131034;NM_001193318;NM_194439
NDUFA5_SIG,NDUFA5,NDUFA5_SIG,NDUFA5,SIG,20,4.49661777663677,0.107428280844119,0.0974604788131533,0.140179630374437,0.0427191515612838,3.24827242685739e-05,3.33668617217864,5.21921867366531,5.17719608923032,5.357292879666,0.180096790435674,0.00433461215352824,ENSG00000128609,NDUFA5,protein_coding,7,-1,123536997,123557904,q31.32,NADH:ubiquinone oxidoreductase subunit A5 [Source:HGNC Symbol;Acc:HGNC:7688],NA,NDUFA5,4698,NM_001282419;NM_001282420;NM_001282421;NM_001282422;NM_001291304;NM_005000
ABHD1_SIG,ABHD1,ABHD1_SIG,ABHD1,SIG,45,4.49599942428242,-0.0826426037514752,-0.0887515576919062,-0.0625703265186304,0.0261812311732758,3.2558791435172e-05,1.59217398269468,0.492500141084,0.47771180659069,0.54109038299059,0.0633785763999001,0.192899397997934,ENSG00000143994,ABHD1,protein_coding,2,1,27123789,27130812,p23.3,abhydrolase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:17553],NA,ABHD1,84696,NM_032604
TREM1_SIG,TREM1,TREM1_SIG,TREM1,SIG,29,-4.49525711399354,0.479702442371265,0.50618319503374,0.392694255051704,-0.113488939982037,3.26379268792759e-05,-2.9584554893775,5.22482420084677,5.3721541713856,4.74074001193349,-0.631414159452111,0.011983142637691,ENSG00000124731,TREM1,protein_coding,6,-1,41267926,41286682,p21.1,triggering receptor expressed on myeloid cells 1 [Source:HGNC Symbol;Acc:HGNC:17760],NA,TREM1,54210,NM_001242589;NM_001242590;NM_018643
SLC28A3_SIG,SLC28A3,SLC28A3_SIG,SLC28A3,SIG,16,-4.49520204779186,0.13480336204374,0.156892091802715,0.062226107121392,-0.094665984681323,3.26379268792759e-05,-1.85677016434002,2.009492918641,2.0885926327652,1.74959385794719,-0.338998774818012,0.125440837265797,ENSG00000197506,SLC28A3,protein_coding,9,-1,84275457,84340683,q21.33,solute carrier family 28 member 3 [Source:HGNC Symbol;Acc:HGNC:16484],NA,SLC28A3,64078,NM_001199633;NM_022127
SLC45A3_SIG,SLC45A3,SLC45A3_SIG,SLC45A3,SIG,16,4.49512097582814,0.197362159972774,0.180522373660513,0.252692886427347,0.0721705127668349,3.26379268792759e-05,3.39882432746604,4.78626874330758,4.63914062275767,5.26968971082873,0.630549088071056,0.0036136348468647,ENSG00000158715,SLC45A3,protein_coding,1,-1,205657851,205680509,q32.1,solute carrier family 45 member 3 [Source:HGNC Symbol;Acc:HGNC:8642],NA,SLC45A3,85414,NM_033102
BEGAIN_SIG,BEGAIN,BEGAIN_SIG,BEGAIN,SIG,17,4.49134280018172,0.013788754923026,0.0082587547006757,0.0319587556536055,0.0237000009529296,3.32035823050135e-05,5.02289884460265,1.78492703543547,1.62438393355663,2.31242579875163,0.688041865194997,1.29725769234342e-05,ENSG00000183092,BEGAIN,protein_coding,14,-1,100537147,100587413,q32.2,brain enriched guanylate kinase associated [Source:HGNC Symbol;Acc:HGNC:24163],NA,BEGAIN,57596,NM_001159531;NM_020836
PPT1_SIG,PPT1,PPT1_SIG,PPT1,SIG,25,-4.49107289056976,0.417562923058013,0.429700504989317,0.377682296712299,-0.0520182082770182,3.32268784420999e-05,-4.39275088798404,7.77397404900527,7.86511938671728,7.47449651080865,-0.390622875908629,0.000146477893113438,ENSG00000131238,PPT1,protein_coding,1,-1,40071461,40097727,p34.2,palmitoyl-protein thioesterase 1 [Source:HGNC Symbol;Acc:HGNC:9325],CEROID LIPOFUSCINOSIS NEURONAL 1;CLN1 disease;NEURONAL CEROID LIPOFUSCINOSIS TYPE 1,PPT1,5538,NM_000310;NM_001142604;NM_001363695
GSR_SIG,GSR,GSR_SIG,GSR,SIG,21,-4.4893466297844,0.299466680325852,0.312099396238865,0.257959185183092,-0.0541402110557729,3.34783181073923e-05,-3.96161818439087,6.31344163509596,6.38861908644745,6.06643000922678,-0.322189077220672,0.000641050762978996,ENSG00000104687,GSR,protein_coding,8,-1,30678066,30727846,p12,glutathione-disulfide reductase [Source:HGNC Symbol;Acc:HGNC:4623],Hemolytic anemia due to glutathione reductase deficiency,GSR,2936,NM_000637;NM_001195102;NM_001195103;NM_001195104
CREB3L4_TF,CREB3L4,CREB3L4_TF,CREB3L4,TF,268,4.48866964117364,0.143093863044818,0.130182480888313,0.185516975844765,0.0553344949564527,3.35658834172554e-05,2.81331636596024,3.9419186416697,3.87202309665272,4.17157543243977,0.299552335787043,0.017135047844296,ENSG00000143578,CREB3L4,protein_coding,1,1,153967534,153974361,q21.3,cAMP responsive element binding protein 3 like 4 [Source:HGNC Symbol;Acc:HGNC:18854],NA,CREB3L4,148327,NM_001255978;NM_001255979;NM_001255980;NM_001255981;NM_130898
ZNF253_TF,ZNF253,ZNF253_TF,ZNF253,TF,60,4.48648080037358,0.19053664026447,0.176231245180956,0.237540081253159,0.0613088360722031,3.38932511859386e-05,3.73822419902629,3.34713501966859,3.25788170304694,3.64039591713972,0.382514214092775,0.00130544693956695,ENSG00000256771,ZNF253,protein_coding,19,1,19865886,19894674,p13.11,zinc finger protein 253 [Source:HGNC Symbol;Acc:HGNC:13497],NA,ZNF253,56242,NM_001331133;NM_001331134;NM_021047
PXN_SIG,PXN,PXN_SIG,PXN,SIG,59,-4.48586318927447,0.418661775674426,0.434937584926802,0.365184116702333,-0.0697534682244685,3.39606016033676e-05,-2.8759785828325,7.21294606105215,7.29815666567955,6.93296836013358,-0.365188305545964,0.0147312928578185,ENSG00000089159,PXN,protein_coding,12,-1,120210439,120265771,q24.23,paxillin [Source:HGNC Symbol;Acc:HGNC:9718],NA,PXN,5829,NM_001080855;NM_001243756;NM_002859;NM_025157
SCPEP1_SIG,SCPEP1,SCPEP1_SIG,SCPEP1,SIG,64,-4.48581687746407,0.166632081159797,0.189432430160969,0.0917166487273739,-0.0977157814335949,3.39606016033676e-05,-4.85504005381473,5.98408852462033,6.18599562142825,5.32067949225143,-0.865316129176821,2.59068465212606e-05,ENSG00000121064,SCPEP1,protein_coding,17,1,56978105,57006768,q22,serine carboxypeptidase 1 [Source:HGNC Symbol;Acc:HGNC:29507],NA,SCPEP1,59342,NM_021626
TGIF2_TF,TGIF2,TGIF2_TF,TGIF2,TF,70,4.48389659919439,0.374342061534249,0.36174286368698,0.415739425889563,0.0539965622025835,3.42322247683198e-05,3.6478687001406,5.3390419591358,5.2602126389399,5.5980525826366,0.337839943696705,0.00172090820321025,ENSG00000118707,TGIF2,protein_coding,20,1,36573488,36593950,q11.23,TGFB induced factor homeobox 2 [Source:HGNC Symbol;Acc:HGNC:15764],NA,TGIF2,60436,NM_001199513;NM_001199514;NM_001199515;NM_021809
PPP2R5A_SIG,PPP2R5A,PPP2R5A_SIG,PPP2R5A,SIG,24,-4.48387767234631,-0.0383702993856865,-0.0312325616481586,-0.0618228662375639,-0.0305903045894053,3.42322247683198e-05,-4.00876726919994,6.28228984824186,6.33760833673879,6.10052910032338,-0.237079236415403,0.000552473757134534,ENSG00000066027,PPP2R5A,protein_coding,1,1,212285410,212361853,q32.3,protein phosphatase 2 regulatory subunit B'alpha [Source:HGNC Symbol;Acc:HGNC:9309],NA,PPP2R5A,5525,NM_001199756;NM_006243
LITAF_TF,LITAF,LITAF_TF,LITAF,TF,262,-4.48308198463308,0.095547891136733,0.104532527711741,0.0660269423902767,-0.0385055853214646,3.43408099845516e-05,-2.56903565747884,7.52660262035359,7.58730132259082,7.32716402728843,-0.26013729530239,0.0302109494651599,ENSG00000189067,LITAF,protein_coding,16,-1,11547722,11636381,p13.13,lipopolysaccharide induced TNF factor [Source:HGNC Symbol;Acc:HGNC:16841],CHARCOT-MARIE-TOOTH DISEASE DEMYELINATING TYPE 1C;Charcot-Marie-Tooth disease type 1C,LITAF,9516,NM_001136472;NM_001136473;NM_004862
AK3_SIG,AK3,AK3_SIG,AK3,SIG,35,4.4820128875929,0.479888980237523,0.468596240846648,0.516993695378973,0.0483974545323251,3.44939057378859e-05,3.28385586617402,5.86383108928847,5.81114563025002,6.03694045470053,0.225794824450508,0.00502883693380405,ENSG00000147853,AK3,protein_coding,9,-1,4709556,4742043,p24.1,adenylate kinase 3 [Source:HGNC Symbol;Acc:HGNC:17376],NA,AK3,50808,NM_001199852;NM_001199853;NM_001199855;NM_001199856;NM_016282
ERCC2_SIG,ERCC2,ERCC2_SIG,ERCC2,SIG,49,4.48184341041286,0.191602303706257,0.176764468316583,0.240355191415188,0.0635907230986058,3.45018894743098e-05,4.22099919349095,4.55210134495483,4.47393452950937,4.80893516713276,0.335000637623389,0.000267684646193822,ENSG00000104884,ERCC2,protein_coding,19,-1,45349837,45370918,q13.32,ERCC excision repair 2, TFIIH core complex helicase subunit [Source:HGNC Symbol;Acc:HGNC:3434],CEREBRO-OCULO-FACIO-SKELETAL SYNDROME TYPE 2;CEREBROOCULOFACIOSKELETAL SYNDROME 2;COFS syndrome;Trichothiodystrophy;TRICHOTHIODYSTROPHY 1 PHOTOSENSITIVE;TRICHOTHIODYSTROPHY PHOTOSENSITIVE;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP D,ERCC2,2068,NM_000400;NM_001130867
SLC22A31_SIG,SLC22A31,SLC22A31_SIG,SLC22A31,SIG,22,-4.48034313425735,0.0190305916824151,0.032168630038888,-0.0241372486317102,-0.0563058786705981,3.47105196966125e-05,-2.75518530577597,0.768021373006344,0.84473603958124,0.515958897117404,-0.328777142463836,0.0196910093150786,ENSG00000259803,SLC22A31,protein_coding,16,-1,89195761,89201651,q24.3,solute carrier family 22 member 31 [Source:HGNC Symbol;Acc:HGNC:27091],NA,SLC22A31,146429,NM_001242757
IL23A_SIG,IL23A,IL23A_SIG,IL23A,SIG,19,-4.48031687113976,-0.117388563888894,-0.105271290660191,-0.157202461640344,-0.0519311709801529,3.47105196966125e-05,-2.60391953005334,0.999147073464356,1.04196544592425,0.858458135381831,-0.183507310542423,0.0279108638889691,ENSG00000110944,IL23A,protein_coding,12,1,56334174,56340410,q13.3,interleukin 23 subunit alpha [Source:HGNC Symbol;Acc:HGNC:15488],NA,IL23A,51561,NM_016584
ZNF574_TF,ZNF574,ZNF574_TF,ZNF574,TF,80,4.47993005949686,0.0387607487333834,0.0263486657471634,0.0795433071166778,0.0531946413695143,3.47539468287064e-05,2.1898434976133,4.87020323745095,4.8340953411098,4.98884346828616,0.154748127176356,0.06772679732025,ENSG00000105732,ZNF574,protein_coding,19,1,42068477,42081552,q13.2,zinc finger protein 574 [Source:HGNC Symbol;Acc:HGNC:26166],NA,ZNF574,64763,NM_001330519;NM_022752
NAT10_SIG,NAT10,NAT10_SIG,NAT10,SIG,30,4.47928458400606,0.633119482670159,0.615130005102983,0.692227766105168,0.0770977610021856,3.48396245777391e-05,3.86764561589177,6.15913914109224,6.09110631815759,6.38267555930609,0.291569241148499,0.00086987366903033,ENSG00000135372,NAT10,protein_coding,11,1,34105617,34147670,p13,N-acetyltransferase 10 [Source:HGNC Symbol;Acc:HGNC:29830],NA,NAT10,55226,NM_001144030;NM_024662
DDHD2_SIG,DDHD2,DDHD2_SIG,DDHD2,SIG,102,4.47837890906075,0.213035092683724,0.201181370703492,0.251983036333058,0.0508016656295654,3.49680997992203e-05,4.24710050629108,5.88878774097859,5.81641276278587,6.12659124075467,0.310178477968798,0.000244099834156424,ENSG00000085788,DDHD2,protein_coding,8,1,38225218,38275558,p11.23,DDHD domain containing 2 [Source:HGNC Symbol;Acc:HGNC:29106],Autosomal recessive spastic paraplegia type 54;Complex Hereditary Spastic Paraplegia;SPASTIC PARAPLEGIA 54 AUTOSOMAL RECESSIVE,DDHD2,23259,NM_001164232;NM_001164234;NM_001362914;NM_015214
MPST_SIG,MPST,MPST_SIG,MPST,SIG,29,4.47571131937801,0.0931771783914981,0.0838196967781048,0.123923189406933,0.0401034926288283,3.53877441272765e-05,3.77432402913179,5.36760790131184,5.29904603842228,5.59288259366325,0.293836555240969,0.00116354922599371,ENSG00000128309,MPST,protein_coding,22,1,37019635,37029822,q12.3,mercaptopyruvate sulfurtransferase [Source:HGNC Symbol;Acc:HGNC:7223],NA,MPST,4357,NM_001013436;NM_001130517;NM_021126
USP21_SIG,USP21,USP21_SIG,USP21,SIG,16,4.47403013562623,0.371163345450198,0.363715822094754,0.395633779332372,0.0319179572376176,3.56472883237917e-05,3.17014211275553,4.96115547544855,4.9278376953192,5.07062818158782,0.142790486268621,0.00687249806021967,ENSG00000143258,USP21,protein_coding,1,1,161159450,161165723,q23.3,ubiquitin specific peptidase 21 [Source:HGNC Symbol;Acc:HGNC:12620],NA,USP21,27005,NM_001014443;NM_001319847;NM_001319848;NM_012475
PEBP1_SIG,PEBP1,PEBP1_SIG,PEBP1,SIG,48,4.47326238870943,0.341593299585714,0.32911129146327,0.382605611988032,0.0534943205247617,3.57555314169311e-05,4.3129811491083,6.99416808691003,6.91840417062742,7.24310666898147,0.324702498354049,0.00019503216511452,ENSG00000089220,PEBP1,protein_coding,12,1,118136124,118145584,q24.23,phosphatidylethanolamine binding protein 1 [Source:HGNC Symbol;Acc:HGNC:8630],NA,PEBP1,5037,NM_002567
ZDHHC12_SIG,ZDHHC12,ZDHHC12_SIG,ZDHHC12,SIG,46,-4.47310561818743,0.253466895420797,0.261527056142155,0.226983510193478,-0.0345435459486765,3.57617316579301e-05,-3.85955012884501,4.67604187129643,4.73013463867923,4.49830849275295,-0.231826145926281,0.000892394495468972,ENSG00000160446,ZDHHC12,protein_coding,9,-1,128720870,128724127,q34.11,zinc finger DHHC-type containing 12 [Source:HGNC Symbol;Acc:HGNC:19159],NA,ZDHHC12,84885,NM_001318015;NM_001318016;NM_001318020;NM_001318023;NM_032799
CYB5R4_SIG,CYB5R4,CYB5R4_SIG,CYB5R4,SIG,15,-4.47273957382987,0.256531273330194,0.26124247053077,0.241051625385445,-0.0201908451453254,3.58029783693171e-05,-2.62109396397326,6.14965670179024,6.18167471547594,6.04445465682294,-0.137220058652999,0.0268062095841801,ENSG00000065615,CYB5R4,protein_coding,6,1,83859656,83967423,q14.2,cytochrome b5 reductase 4 [Source:HGNC Symbol;Acc:HGNC:20147],NA,CYB5R4,51167,NM_016230
HINT3_SIG,HINT3,HINT3_SIG,HINT3,SIG,6,4.47087503500446,0.168830577235217,0.162476097688796,0.189709581459172,0.027233483770376,3.60963775438782e-05,2.68046697421568,5.01285873955189,4.98435777336273,5.10650477131624,0.12214699795351,0.0234623427725149,ENSG00000111911,HINT3,protein_coding,6,1,125956770,125980244,q22.32,histidine triad nucleotide binding protein 3 [Source:HGNC Symbol;Acc:HGNC:18468],NA,HINT3,135114,NM_138571
PRDM15_TF,PRDM15,PRDM15_TF,PRDM15,TF,77,4.47064014699885,0.35035012152778,0.339524459470731,0.385920154000942,0.046395694530211,3.61158481198188e-05,3.7569237110427,4.32889334599935,4.27444444374682,4.50779688197193,0.233352438225108,0.0012314138104114,ENSG00000141956,PRDM15,protein_coding,21,-1,41798225,41879482,q22.3,PR/SET domain 15 [Source:HGNC Symbol;Acc:HGNC:13999],NA,PRDM15,63977,NM_001040424;NM_001282934;NM_022115
OR2T8_SIG,OR2T8,OR2T8_SIG,OR2T8,SIG,45,4.46982333935049,0.0226506232034498,0.00483319401658508,0.0811936048174338,0.0763604108008487,3.62337903319577e-05,2.59121563363098,0.729246399850095,0.692863749516022,0.848789393804905,0.155925644288882,0.0287453884243184,ENSG00000177462,OR2T8,protein_coding,1,1,247920252,247921956,q44,olfactory receptor family 2 subfamily T member 8 [Source:HGNC Symbol;Acc:HGNC:15020],NA,OR2T8,343172,NM_001005522
PRPSAP2_SIG,PRPSAP2,PRPSAP2_SIG,PRPSAP2,SIG,19,4.46879725847252,0.25964714741467,0.251496236225827,0.286428712749439,0.0349324765236121,3.63835896892599e-05,2.49069994538463,4.50731197330797,4.47569649575366,4.61119139955784,0.135494903804172,0.036007065522058,ENSG00000141127,PRPSAP2,protein_coding,17,1,18840085,18931287,p11.2,phosphoribosyl pyrophosphate synthetase associated protein 2 [Source:HGNC Symbol;Acc:HGNC:9467],NA,PRPSAP2,5636,NM_001243936;NM_001243940;NM_001243941;NM_001243942;NM_001353096;NM_001353097;NM_001353098;NM_001353099;NM_001353100;NM_001353101;NM_001353102;NM_001353103;NM_001353104;NM_001353105;NM_001353106;NM_001353107;NM_002767
ITGA3_SIG,ITGA3,ITGA3_SIG,ITGA3,SIG,75,4.46870191446627,-0.0213001511539519,-0.0278720741386427,0.000293310081460762,0.0281653842201035,3.63835896892599e-05,1.46528226104572,1.72612944572456,1.68557810948022,1.8593695505274,0.173791441047171,0.233633341812116,ENSG00000005884,ITGA3,protein_coding,17,1,50055968,50090481,q21.33,integrin subunit alpha 3 [Source:HGNC Symbol;Acc:HGNC:6139],Interstitial lung disease nephrotic syndrome and epidermolysis bullosa congenital;Junctional epidermolysis bullosa with respiratory and renal involvement,ITGA3,3675,NM_002204
IGHMBP2_SIG,IGHMBP2,IGHMBP2_SIG,IGHMBP2,SIG,6,4.46844625993996,0.325207273663816,0.322368824821719,0.334533605573562,0.0121647807518424,3.64067763318315e-05,4.10206376618215,4.68991855773958,4.6428519578878,4.84456595725253,0.201713999364729,0.000402900744736901,ENSG00000132740,IGHMBP2,protein_coding,11,1,68903842,68940602,q13.3,immunoglobulin mu DNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:5542],CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2S;Charcot-Marie-Tooth disease type 2S;SPINAL MUSCULAR ATROPHY DISTAL AUTOSOMAL RECESSIVE 1;Spinal Muscular Atrophy with Respiratory Distress 1;Spinal muscular atrophy with respiratory distress type 1,IGHMBP2,3508,NM_002180
ZNF81_TF,ZNF81,ZNF81_TF,ZNF81,TF,108,4.46797111455558,0.143039409130224,0.133775498766223,0.1734779717548,0.0397024729885772,3.6467376677657e-05,3.59603826234911,4.07084912881196,4.00529787258963,4.28623182782818,0.280933955238554,0.00202376343317788,ENSG00000197779,ZNF81,protein_coding,X,1,47836902,48002561,p11.23,zinc finger protein 81 [Source:HGNC Symbol;Acc:HGNC:13156],X-linked non-syndromic intellectual disability,ZNF81,347344,NM_007137
BMPR2_SIG,BMPR2,BMPR2_SIG,BMPR2,SIG,52,-4.46750420153617,-0.0208685223554059,-0.013979815050584,-0.0435028463569635,-0.0295230313063796,3.65266760924261e-05,-1.30077369346265,4.44903838122061,4.49525844033404,4.29717247270506,-0.198085967628979,0.294779851138247,ENSG00000204217,BMPR2,protein_coding,2,1,202376936,202567751,q33.1,bone morphogenetic protein receptor type 2 [Source:HGNC Symbol;Acc:HGNC:1078],Drug- or toxin-induced pulmonary arterial hypertension;Heritable pulmonary arterial hypertension;PULMONARY HYPERTENSION PRIMARY 1;PULMONARY VENOOCCLUSIVE DISEASE;PULMONARY VENOOCCLUSIVE DISEASE 1 AUTOSOMAL DOMINANT,BMPR2,659,NM_001204
TNIP1_SIG,TNIP1,TNIP1_SIG,TNIP1,SIG,14,-4.46695354606256,0.417693293308935,0.424596949195472,0.395009852538887,-0.029587096656585,3.66003943870348e-05,-0.28057400488452,7.52943875666191,7.53368531263782,7.51548578702679,-0.0181995256110296,0.839390023291404,ENSG00000145901,TNIP1,protein_coding,5,-1,151029945,151093577,q33.1,TNFAIP3 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:16903],Systemic lupus erythematosus,TNIP1,10318,NM_001252385;NM_001252386;NM_001252390;NM_001252391;NM_001252392;NM_001252393;NM_001258454;NM_001258455;NM_001258456;NM_001364486;NM_001364487;NM_006058
ZNF17_TF,ZNF17,ZNF17_TF,ZNF17,TF,51,4.46673248739507,0.0792761085224776,0.0628558811211317,0.133228284269757,0.0703724031486254,3.66178294504607e-05,4.6372802248969,2.53169995090655,2.45131609087211,2.79581834816257,0.344502257290463,5.94104732196327e-05,ENSG00000186272,ZNF17,protein_coding,19,1,57411163,57421939,q13.43,zinc finger protein 17 [Source:HGNC Symbol;Acc:HGNC:12958],NA,ZNF17,7565,NM_001330617;NM_006959
UST_SIG,UST,UST_SIG,UST,SIG,77,4.46487224918969,0.0470625183260889,0.0405795217277846,0.0683637928633747,0.0277842711355901,3.69018976564905e-05,2.58842646086573,1.79925192973941,1.71911908326516,2.06254556815481,0.343426484889641,0.0289297266339097,ENSG00000111962,UST,protein_coding,6,1,148747030,149076990,q25.1,uronyl 2-sulfotransferase [Source:HGNC Symbol;Acc:HGNC:17223],NA,UST,10090,NM_005715
CAPN3_SIG,CAPN3,CAPN3_SIG,CAPN3,SIG,34,-4.46484012564021,0.0355525536831334,0.0473952570560986,-0.00335918597089519,-0.0507544430269939,3.69018976564905e-05,-3.1583041607552,2.0015063778402,2.07635417834973,1.75557789045174,-0.320776287897984,0.0070949150179256,ENSG00000092529,CAPN3,protein_coding,15,1,42359500,42412318,q15.1,calpain 3 [Source:HGNC Symbol;Acc:HGNC:1480],Autosomal recessive limb-girdle muscular dystrophy type 2A;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL DOMINANT 4;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 1,CAPN3,825,NM_000070;NM_024344;NM_173087;NM_173088;NM_173089;NM_173090
MAN1B1_SIG,MAN1B1,MAN1B1_SIG,MAN1B1,SIG,28,4.46394099860494,0.32767689493867,0.321225522582395,0.348874261252146,0.0276487386697504,3.70365877139473e-05,3.43313216258026,6.00866791319797,5.97028106625711,6.13479612457508,0.164515058317972,0.00326521042500605,ENSG00000177239,MAN1B1,protein_coding,9,1,137086985,137109183,q34.3,mannosidase alpha class 1B member 1 [Source:HGNC Symbol;Acc:HGNC:6823],Autosomal Recessive Mental Retardation;Autosomal recessive non-syndromic intellectual disability;MAN1B1-CDG;MENTAL RETARDATION AUTOSOMAL RECESSIVE 15,MAN1B1,11253,NM_016219
ZYX_SIG,ZYX,ZYX_SIG,ZYX,SIG,19,-4.46291423869877,0.225477418691025,0.234231700200907,0.196713350872843,-0.0375183493280641,3.71939086862696e-05,-3.6273708174337,9.05791258642471,9.11745781363419,8.8622639827364,-0.255193830897794,0.00183517662256885,ENSG00000159840,ZYX,protein_coding,7,1,143381295,143391111,q34,zyxin [Source:HGNC Symbol;Acc:HGNC:13200],NA,ZYX,7791,NM_001010972;NM_001362783;NM_003461
ATP2A2_SIG,ATP2A2,ATP2A2_SIG,ATP2A2,SIG,34,4.46223387990767,0.230433975608885,0.224473147384724,0.2500195540597,0.0255464066749765,3.72915241827548e-05,3.82248383245555,7.59872983610984,7.54717153245271,7.76813569098327,0.220964158530564,0.00100335573299373,ENSG00000174437,ATP2A2,protein_coding,12,1,110280756,110351093,q24.11,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [Source:HGNC Symbol;Acc:HGNC:812],Acrokeratosis verruciformis;Acrokeratosis verruciformis of Hopf;DARIER-WHITE DISEASE;DARIER DISEASE,ATP2A2,488,NM_001681;NM_170665
GPR179_SIG,GPR179,GPR179_SIG,GPR179,SIG,10,4.46158370110142,-0.192154628863421,-0.197542682483855,-0.174451024110568,0.0230916583732875,3.73841243945398e-05,0.859064723954507,0.255418232619524,0.250948262487702,0.27010527733837,0.0191570148506677,0.503552957623757,ENSG00000277399,GPR179,protein_coding,17,-1,38325530,38343847,q12,G protein-coupled receptor 179 [Source:HGNC Symbol;Acc:HGNC:31371],Congenital stationary night blindness;NIGHT BLINDNESS CONGENITAL STATIONARY TYPE 1E,GPR179,440435,NM_001004334
FOXP3_TF,FOXP3,FOXP3_TF,FOXP3,TF,103,-4.45963350883921,-0.0524929970542354,-0.0378160135018768,-0.100717371583414,-0.0629013580815367,3.77049794097278e-05,-3.19001091488949,0.907804127789501,0.968509629322404,0.708343194181389,-0.260166435141015,0.00653225165141724,ENSG00000049768,FOXP3,protein_coding,X,-1,49250436,49270477,p11.23,forkhead box P3 [Source:HGNC Symbol;Acc:HGNC:6106],DIABETES MELLITUS INSULIN-DEPENDENT;Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome;IMMUNODYSREGULATION POLYENDOCRINOPATHY AND ENTEROPATHY X-LINKED;IPEX Syndrome,FOXP3,50943,NM_001114377;NM_014009
GTF2H4_SIG,GTF2H4,GTF2H4_SIG,GTF2H4,SIG,5,4.45927394798646,0.346635091057947,0.335847926477136,0.382078631823471,0.0462307053463358,3.77473575962414e-05,3.24179224964708,0.519882745892007,0.4976660302769,0.592880525770215,0.0952144954933148,0.00565830627470512,ENSG00000213780,GTF2H4,protein_coding,6,1,30908207,30914106,p21.33,general transcription factor IIH subunit 4 [Source:HGNC Symbol;Acc:HGNC:4658],NA,GTF2H4,2968,NM_001517
IGFBP4_SIG,IGFBP4,IGFBP4_SIG,IGFBP4,SIG,53,-4.45790638032253,-0.186929517523545,-0.180685534238332,-0.207445462603529,-0.0267599283651968,3.79678850406796e-05,-3.09499005032776,1.77070351228575,1.87824329570157,1.41735850963377,-0.460884786067807,0.00839829392405248,ENSG00000141753,IGFBP4,protein_coding,17,1,40443450,40457725,q21.2,insulin like growth factor binding protein 4 [Source:HGNC Symbol;Acc:HGNC:5473],NA,IGFBP4,3487,NM_001552
DNAJC21_SIG,DNAJC21,DNAJC21_SIG,DNAJC21,SIG,24,4.45372908907226,0.453075188171684,0.445230647502741,0.478850107512496,0.0336194600097547,3.86930921828505e-05,2.62447886370973,6.1357945662424,6.11259327397575,6.21202738368996,0.0994341097142124,0.0265839462860415,ENSG00000168724,DNAJC21,protein_coding,5,1,34929559,34958964,p13.2,DnaJ heat shock protein family (Hsp40) member C21 [Source:HGNC Symbol;Acc:HGNC:27030],BONE MARROW FAILURE SYNDROME 3;SHWACHMAN-DIAMOND SYNDROME;SHWACHMAN-DIAMOND SYNDROME 1,DNAJC21,134218,NM_001012339;NM_001348420;NM_194283
ZBED4_TF,ZBED4,ZBED4_TF,ZBED4,TF,109,4.45208555688344,0.308501634079697,0.298282166041335,0.342079886205741,0.0437977201644057,3.89507978130355e-05,1.99433584571775,6.67823848039759,6.64930989667589,6.77328954119747,0.12397964452158,0.0981213618373516,ENSG00000100426,ZBED4,protein_coding,22,1,49853844,49890080,q13.33,zinc finger BED-type containing 4 [Source:HGNC Symbol;Acc:HGNC:20721],NA,ZBED4,9889,NM_014838
ZBTB18_TF,ZBTB18,ZBTB18_TF,ZBTB18,TF,130,-4.4520668739629,-0.0159544404198591,-0.00877211264841113,-0.0395535173831881,-0.0307814047347769,3.89507978130355e-05,-3.50762698519973,5.56072092384703,5.62566382358084,5.34733711043591,-0.278326713144939,0.00264407730282088,ENSG00000179456,ZBTB18,protein_coding,1,1,244048939,244057476,q44,zinc finger and BTB domain containing 18 [Source:HGNC Symbol;Acc:HGNC:13030],Distal monosomy 1q;Mental retardation autosomal dominant 22;ZBTB18 syndrome,ZBTB18,10472,NM_001278196;NM_006352;NM_205768
PATZ1_TF,PATZ1,PATZ1_TF,PATZ1,TF,146,4.45186356479589,0.285532247718707,0.27416661338599,0.322876474811919,0.0487098614259291,3.89661633839288e-05,2.67506638347509,5.90273141057121,5.85779423114148,6.05038214298318,0.192587911841699,0.023733122387526,ENSG00000100105,PATZ1,protein_coding,22,-1,31325804,31346346,q12.2,POZ/BTB and AT hook containing zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13071],NA,PATZ1,23598,NM_014323;NM_032050;NM_032051;NM_032052
SPPL2B_SIG,SPPL2B,SPPL2B_SIG,SPPL2B,SIG,62,4.45137938548729,0.135000405489793,0.124610641205013,0.1691382024255,0.0445275612204866,3.90325751552347e-05,3.43208765640127,6.51776434026307,6.45926491817049,6.7099767271387,0.250711808968208,0.00327624214660415,ENSG00000005206,SPPL2B,protein_coding,19,1,2328615,2355095,p13.3,signal peptide peptidase like 2B [Source:HGNC Symbol;Acc:HGNC:30627],NA,SPPL2B,56928,NM_001077238;NM_152988
KCNK10_SIG,KCNK10,KCNK10_SIG,KCNK10,SIG,10,-4.45066946836598,-0.0909163744421209,-0.0767547831829396,-0.137447317150859,-0.0606925339679198,3.91402284669237e-05,-1.95980026292272,0.348996244062647,0.390516752503449,0.212571716328584,-0.177945036174865,0.104480665133584,ENSG00000100433,KCNK10,protein_coding,14,-1,88180103,88326907,q31.3,potassium two pore domain channel subfamily K member 10 [Source:HGNC Symbol;Acc:HGNC:6273],NA,KCNK10,54207,NM_021161;NM_138317;NM_138318
COL4A3_SIG,COL4A3,COL4A3_SIG,COL4A3,SIG,13,-4.44826320574698,-0.316983904176696,-0.299506211715376,-0.374410607978179,-0.0749043962628031,3.95593497332606e-05,-2.4816085616091,0.456197033128971,0.491078221254959,0.341587415000723,-0.149490806254236,0.0367433994139473,ENSG00000169031,COL4A3,protein_coding,2,1,227164565,227314792,q36.3,collagen type IV alpha 3 chain [Source:HGNC Symbol;Acc:HGNC:2204],Alport syndrome autosomal dominant;ALPORT SYNDROME AUTOSOMAL RECESSIVE;Autosomal dominant Alport syndrome;Autosomal recessive Alport syndrome;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;HEMATURIA BENIGN FAMILIAL,COL4A3,1285,NM_000091
NSUN7_SIG,NSUN7,NSUN7_SIG,NSUN7,SIG,44,-4.44803471773605,-0.107584291526289,-0.101210605832406,-0.128526401663333,-0.0273157958309279,3.9579612375387e-05,-1.45943287654523,1.10535047688847,1.14575192087136,0.972602875230409,-0.173149045640948,0.235504630891327,ENSG00000179299,NSUN7,protein_coding,4,1,40749925,40811184,p14,NOP2/Sun RNA methyltransferase family member 7 [Source:HGNC Symbol;Acc:HGNC:25857],NA,NSUN7,79730,NM_001330648;NM_024677
SIRT7_SIG,SIRT7,SIRT7_SIG,SIRT7,SIG,29,-4.44774003191729,-0.112189399387545,-0.103752499899552,-0.13991064056238,-0.0361581406628277,3.96120978069601e-05,-2.98008966878375,5.23045223371694,5.26922013909508,5.10307197318875,-0.166148165906328,0.0113383901796419,ENSG00000187531,SIRT7,protein_coding,17,-1,81911939,81921323,q25.3,sirtuin 7 [Source:HGNC Symbol;Acc:HGNC:14935],NA,SIRT7,51547,NM_016538
KCNJ15_SIG,KCNJ15,KCNJ15_SIG,KCNJ15,SIG,24,-4.44577841004084,-0.0451857220620203,-0.004070191720719,-0.180279607469153,-0.176209415748434,3.99533095123652e-05,-3.83531967510767,2.16546646486552,2.35796702009009,1.5329646405562,-0.825002379533894,0.000964893351944696,ENSG00000157551,KCNJ15,protein_coding,21,1,38155549,38307357,q22.13,potassium voltage-gated channel subfamily J member 15 [Source:HGNC Symbol;Acc:HGNC:6261],NA,KCNJ15,3772,NM_001276435;NM_001276436;NM_001276437;NM_001276438;NM_001276439;NM_002243;NM_170736;NM_170737
CD209_SIG,CD209,CD209_SIG,CD209,SIG,10,-4.44274484027906,0.0468852801865551,0.0824485827397377,-0.0699655710596165,-0.152414153799354,4.04986818088791e-05,-1.84105726700946,0.760665198884146,0.805557853414173,0.613160762571201,-0.192397090842972,0.128673243162145,ENSG00000090659,CD209,protein_coding,19,-1,7739993,7747564,p13.2,CD209 molecule [Source:HGNC Symbol;Acc:HGNC:1641],DENGUE VIRUS SUSCEPTIBILITY TO DENGUE FEVER SUSCEPTIBILITY TO INCLUDED;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,CD209,30835,NM_001144893;NM_001144894;NM_001144895;NM_001144896;NM_001144897;NM_001144899;NM_021155
COL4A4_SIG,COL4A4,COL4A4_SIG,COL4A4,SIG,11,-4.44128408864737,-0.336476442288075,-0.322827821290927,-0.381321911278702,-0.0584940899877747,4.07521941168932e-05,-2.8802120398925,0.468427835444178,0.507705201407221,0.339373632994179,-0.168331568413043,0.0145722573259863,ENSG00000081052,COL4A4,protein_coding,2,-1,227002711,227164453,q36.3,collagen type IV alpha 4 chain [Source:HGNC Symbol;Acc:HGNC:2206],ALPORT SYNDROME AUTOSOMAL RECESSIVE;Autosomal dominant Alport syndrome;Autosomal recessive Alport syndrome,COL4A4,1286,NM_000092
PTPRN2_SIG,PTPRN2,PTPRN2_SIG,PTPRN2,SIG,15,-4.43810725979873,-0.0690415000445067,-0.0623458024153243,-0.0910416493975345,-0.0286958469822103,4.13354521235472e-05,-2.43462289690827,2.41532225760855,2.50039586447446,2.13579469219197,-0.364601172282487,0.0406542141365069,ENSG00000155093,PTPRN2,protein_coding,7,-1,157539056,158587823,q36.3,protein tyrosine phosphatase, receptor type N2 [Source:HGNC Symbol;Acc:HGNC:9677],NA,PTPRN2,5799,NM_001308267;NM_001308268;NM_002847;NM_130842;NM_130843
ZMYND10_TF,ZMYND10,ZMYND10_TF,ZMYND10,TF,208,4.43792313038241,-0.0132211774723703,-0.017796495168462,0.0018120092433594,0.0196085044118212,4.13480876902602e-05,1.71641394816117,1.30276625397046,1.27620166935787,1.3900498891261,0.113848219768228,0.158923382602962,ENSG00000004838,ZMYND10,protein_coding,3,-1,50341110,50345732,p21.31,zinc finger MYND-type containing 10 [Source:HGNC Symbol;Acc:HGNC:19412],CILIARY DYSKINESIA PRIMARY 22;Primary ciliary dyskinesia;PRIMARY CILIARY DYSKINESIA-22,ZMYND10,51364,NM_001308379;NM_015896
FBXO6_SIG,FBXO6,FBXO6_SIG,FBXO6,SIG,12,-4.43676298303199,0.147214812591825,0.160632834998199,0.103127024685167,-0.057505810313032,4.15486379569853e-05,-2.40985605071879,3.45982311322453,3.50738076681208,3.30356225143687,-0.203818515375211,0.0429423206609689,ENSG00000116663,FBXO6,protein_coding,1,1,11664200,11674354,p36.22,F-box protein 6 [Source:HGNC Symbol;Acc:HGNC:13585],NA,FBXO6,26270,NM_018438
RBM4B_SIG,RBM4B,RBM4B_SIG,RBM4B,SIG,91,4.43576013356035,0.0867730012928267,0.0661317639550241,0.154594209688464,0.0884624457334398,4.17196422831168e-05,4.3947050375702,3.73358183448216,3.63493025672719,4.05772273281993,0.422792476092736,0.000145667313704586,ENSG00000173914,RBM4B,protein_coding,11,-1,66664998,66677887,q13.2,RNA binding motif protein 4B [Source:HGNC Symbol;Acc:HGNC:28842],NA,RBM4B,83759,NM_001286135;NM_031492
AXIN2_SIG,AXIN2,AXIN2_SIG,AXIN2,SIG,16,-4.43402331365376,-0.273640542378184,-0.241458266034263,-0.37938230750821,-0.137924041473947,4.20178678698754e-05,-3.20872677267563,0.809848114475256,0.877561831855932,0.587360185938748,-0.290201645917183,0.00620054582366607,ENSG00000168646,AXIN2,protein_coding,17,-1,65528563,65561648,q24.1,axin 2 [Source:HGNC Symbol;Acc:HGNC:904],AXIN2-related attenuated familial adenomatous polyposis;Colorectal Cancer;Oligodontia;Oligodontia-cancer predisposition syndrome;Oligodontia-colorectal cancer syndrome,AXIN2,8313,NM_001363813;NM_004655
RBM8A_SIG,RBM8A,RBM8A_SIG,RBM8A,SIG,40,4.43398925256073,0.325780188871478,0.311080412690131,0.374079453467331,0.0629990407771991,4.20178678698754e-05,3.13838505921817,6.43980334755121,6.40195252334492,6.56417034137188,0.162217818026965,0.00749135034347902,ENSG00000265241,RBM8A,protein_coding,1,-1,145917714,145927678,q21.1,RNA binding motif protein 8A [Source:HGNC Symbol;Acc:HGNC:9905],THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME,RBM8A,9939,NM_005105
HCLS1_TF,HCLS1,HCLS1_TF,HCLS1,TF,409,-4.43281031880067,0.267731677379112,0.282195034482427,0.220209218325361,-0.0619858161570664,4.22252129625908e-05,-3.90393422042112,8.24650587477355,8.31182695740181,8.03187946042357,-0.279947496978234,0.000769703793359128,ENSG00000180353,HCLS1,protein_coding,3,-1,121631399,121660927,q13.33,hematopoietic cell-specific Lyn substrate 1 [Source:HGNC Symbol;Acc:HGNC:4844],NA,HCLS1,3059,NM_001292041;NM_005335
MECOM_SIG,MECOM,MECOM_SIG,MECOM,SIG,42,-4.43055586543721,-0.145709782743965,-0.137276992160307,-0.173417523233126,-0.0361405310728197,4.2645741226303e-05,-0.253410043170837,1.0149439415163,1.02848999266332,0.970435487747534,-0.0580545049157817,0.855666949930993,ENSG00000085276,MECOM,protein_coding,3,-1,169083499,169663775,q26.2,MDS1 and EVI1 complex locus [Source:HGNC Symbol;Acc:HGNC:3498],Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2);MYELODYSPLASTIC SYNDROME;Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome;RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA;Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,MECOM,2122,NM_001105077;NM_001105078;NM_001163999;NM_001164000;NM_001205194;NM_001366468;NM_001366470;NM_004991;NM_005241
ZBTB40_TF,ZBTB40,ZBTB40_TF,ZBTB40,TF,77,4.42992616750383,0.299415306912067,0.290157167182787,0.329834908879703,0.039677741696916,4.2747042832739e-05,3.8638586148299,5.99015216076814,5.93727439856461,6.16389337943689,0.226618980872286,0.000880730431763779,ENSG00000184677,ZBTB40,protein_coding,1,1,22428838,22531157,p36.12,zinc finger and BTB domain containing 40 [Source:HGNC Symbol;Acc:HGNC:29045],Autosomal Recessive Mental Retardation,ZBTB40,9923,NM_001083621;NM_001330398;NM_014870
NR3C2_SIG,NR3C2,NR3C2_SIG,NR3C2,SIG,40,-4.42618809860276,-0.282413094590768,-0.263448705626018,-0.344724658332088,-0.0812759527060697,4.3470369342086e-05,-3.67716797243893,1.51297960565091,1.61019111149661,1.19357037215788,-0.416620739338733,0.0015761857542321,ENSG00000151623,NR3C2,protein_coding,4,-1,148078762,148444698,q31.23,nuclear receptor subfamily 3 group C member 2 [Source:HGNC Symbol;Acc:HGNC:7979],Hypertension due to gain-of-function mutations in the mineralocorticoid receptor;HYPERTENSION EARLY-ONSET AUTOSOMAL DOMINANT WITH SEVERE EXACERBATIONIN PREGNANCY;PSEUDOHYPOALDOSTERONISM TYPE I AUTOSOMAL DOMINANT;Renal pseudohypoaldosteronism type 1,NR3C2,4306,NM_000901;NM_001166104;NM_001354819
ADPRM_SIG,ADPRM,ADPRM_SIG,ADPRM,SIG,108,4.42575079107581,0.201064712336633,0.190987884788106,0.234174288567507,0.0431864037794008,4.35347199166565e-05,3.88289716024269,3.78282438032193,3.71035984536819,4.02092213802708,0.31056229265889,0.0008262241749843,ENSG00000170222,ADPRM,protein_coding,17,1,10697594,10711233,p13.1,ADP-ribose/CDP-alcohol diphosphatase, manganese dependent [Source:HGNC Symbol;Acc:HGNC:30925],NA,ADPRM,56985,NM_020233
NEK3_SIG,NEK3,NEK3_SIG,NEK3,SIG,25,4.42493926326773,0.13103288800721,0.124296456656111,0.153166876732249,0.0288704200761381,4.36748170102988e-05,3.09858892541845,4.17921275941665,4.1260411090241,4.35391961070646,0.227878501682357,0.0083249559155168,ENSG00000136098,NEK3,protein_coding,13,-1,52132639,52159861,q14.3,NIMA related kinase 3 [Source:HGNC Symbol;Acc:HGNC:7746],NA,NEK3,4752,NM_001146099;NM_002498;NM_152720
ADM2_SIG,ADM2,ADM2_SIG,ADM2,SIG,31,4.42440006897292,-0.0395971564130135,-0.0458878233442305,-0.0189278222104433,0.0269600011337871,4.37601195481824e-05,4.15123464284651,1.1253648060739,1.02943320540346,1.44056863684819,0.411135431444727,0.000340328438644396,ENSG00000128165,ADM2,protein_coding,22,1,50481543,50486440,q13.33,adrenomedullin 2 [Source:HGNC Symbol;Acc:HGNC:28898],NA,ADM2,79924,NM_001253845
SUGP2_SIG,SUGP2,SUGP2_SIG,SUGP2,SIG,57,4.4228226155068,0.28693771385437,0.280070146371473,0.309502578441032,0.0294324320695591,4.40568998521907e-05,4.45132525884404,7.73622599688631,7.68662978702804,7.89918497213489,0.212555185106844,0.000118333600832514,ENSG00000064607,SUGP2,protein_coding,19,-1,18990888,19034023,p13.11,SURP and G-patch domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18641],NA,SUGP2,10147,NM_001017392;NM_001321697;NM_001321698;NM_001321699;NM_001352071;NM_014884
RNF207_SIG,RNF207,RNF207_SIG,RNF207,SIG,19,4.42245320348855,-0.0803050996007297,-0.085743535057181,-0.0624359545295328,0.0233075805276482,4.41082417539507e-05,0.470060561392866,1.20749524567836,1.19761496583493,1.2399590223068,0.0423440564718743,0.727038675111833,ENSG00000158286,RNF207,protein_coding,1,1,6205475,6221299,p36.31,ring finger protein 207 [Source:HGNC Symbol;Acc:HGNC:32947],NA,RNF207,388591,NM_207396
MEFV_SIG,MEFV,MEFV_SIG,MEFV,SIG,69,-4.42209741435226,0.328477146765294,0.36733233219322,0.200810108930679,-0.166522223262542,4.41568659238492e-05,-3.7533809031119,3.9423248450059,4.15044862739409,3.25848956001614,-0.891959067377945,0.00124391735377615,ENSG00000103313,MEFV,protein_coding,16,-1,3242028,3256627,p13.3,MEFV, pyrin innate immunity regulator [Source:HGNC Symbol;Acc:HGNC:6998],Behcet disease;FAMILIAL MEDITERRANEAN FEVER;FAMILIAL MEDITERRANEAN FEVER AUTOSOMAL DOMINANT;Intermittent hydrarthrosis,MEFV,4210,NM_000243;NM_001198536
SLC15A4_SIG,SLC15A4,SLC15A4_SIG,SLC15A4,SIG,13,-4.42196497366085,0.254060577782631,0.264855567251545,0.218591326670485,-0.0462642405810597,4.4159869394455e-05,-3.49242253552823,5.19388697167495,5.25733815086372,4.98540452576897,-0.271933625094752,0.0027610931549929,ENSG00000139370,SLC15A4,protein_coding,12,-1,128793194,128823958,q24.33,solute carrier family 15 member 4 [Source:HGNC Symbol;Acc:HGNC:23090],NA,SLC15A4,121260,NM_145648
ALKBH8_SIG,ALKBH8,ALKBH8_SIG,ALKBH8,SIG,17,4.42129174710936,0.374335978770459,0.365200218270719,0.404353477555316,0.0391532592845967,4.42735760508936e-05,2.74964397402494,3.49640754239045,3.45057791442829,3.64699060569467,0.196412691266381,0.0199481185962404,ENSG00000137760,ALKBH8,protein_coding,11,-1,107502726,107565746,q22.3,alkB homolog 8, tRNA methyltransferase [Source:HGNC Symbol;Acc:HGNC:25189],NA,ALKBH8,91801,NM_001301010;NM_138775
EIF3I_SIG,EIF3I,EIF3I_SIG,EIF3I,SIG,42,4.42074539750904,0.175754335400501,0.167194366028724,0.203879949050624,0.0366855830219003,4.43588342526978e-05,5.00761572347616,6.82247751141758,6.77452789582217,6.98002624837393,0.205498352551764,1.37994623165751e-05,ENSG00000084623,EIF3I,protein_coding,1,1,32221928,32231604,p35.2,eukaryotic translation initiation factor 3 subunit I [Source:HGNC Symbol;Acc:HGNC:3272],NA,EIF3I,8668,NM_003757
YARS2_SIG,YARS2,YARS2_SIG,YARS2,SIG,33,4.42064085379407,0.366815037920821,0.352772090005024,0.412956152501295,0.0601840624962711,4.43588342526978e-05,4.77406956120442,3.67650257637936,3.60533731820193,3.91033128181948,0.304993963617553,3.54513451550935e-05,ENSG00000139131,YARS2,protein_coding,12,-1,32727490,32755902,p11.21,tyrosyl-tRNA synthetase 2 [Source:HGNC Symbol;Acc:HGNC:24249],Mitochondrial myopathy and sideroblastic anemia;MYOPATHY LACTIC ACIDOSIS AND SIDEROBLASTIC ANEMIA 2,YARS2,51067,NM_001040436
AK9_SIG,AK9,AK9_SIG,AK9,SIG,118,4.4188016030625,0.114245498907763,0.101557894346767,0.155933342465322,0.0543754481185552,4.47136375643136e-05,1.77598354532987,3.26450882618274,3.23051700580976,3.37619623597967,0.145679230169903,0.143987226640823,ENSG00000155085,AK9,protein_coding,6,-1,109492856,109691217,q21,adenylate kinase 9 [Source:HGNC Symbol;Acc:HGNC:33814],Postsynaptic congenital myasthenic syndromes,AK9,221264,NM_001145128;NM_001329602;NM_001329603;NM_145025
THRB_TF,THRB,THRB_TF,THRB,TF,201,-4.41797175976891,-0.111238400123524,-0.106026891270239,-0.128361929212889,-0.0223350379426507,4.4861219325595e-05,-2.07804690290014,0.727289367721375,0.783813889893904,0.541565937725924,-0.24224795216798,0.0837698204785311,ENSG00000151090,THRB,protein_coding,3,-1,24117153,24495756,p24.2,thyroid hormone receptor beta [Source:HGNC Symbol;Acc:HGNC:11799],Generalized resistance to thyroid hormone;Peripheral resistance to thyroid hormones;Pituitary resistance to thyroid hormone;THYROID HORMONE RESISTANCE GENERALIZED AUTOSOMAL DOMINANT;THYROID HORMONE RESISTANCE GENERALIZED AUTOSOMAL RECESSIVE;THYROID HORMONE RESISTANCE SELECTIVE PITUITARY,THRB,7068,NM_000461;NM_001128176;NM_001128177;NM_001252634;NM_001354708;NM_001354709;NM_001354710;NM_001354711;NM_001354712;NM_001354713;NM_001354714;NM_001354715
LAS1L_SIG,LAS1L,LAS1L_SIG,LAS1L,SIG,40,4.41693286897944,0.604787038631925,0.592403428002068,0.645476044987172,0.0530726169851048,4.50528062241349e-05,3.31285190843195,5.68797009035361,5.64626705627767,5.82499434517453,0.178727288896854,0.00464324894083994,ENSG00000001497,LAS1L,protein_coding,X,-1,65512582,65534775,q12,LAS1 like, ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:25726],Intellectual disability;Spinal muscular atrophy with respiratory distress type 2;Wilson-Turner syndrome;WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME,LAS1L,81887,NM_001170649;NM_001170650;NM_031206
ACSL1_SIG,ACSL1,ACSL1_SIG,ACSL1,SIG,41,-4.41515714217496,0.441064487311876,0.460287822520145,0.377902100198994,-0.0823857223211508,4.53995692708989e-05,-3.28653981757068,7.30224500806098,7.41506891963884,6.93153787001943,-0.483531049619409,0.00499520263427733,ENSG00000151726,ACSL1,protein_coding,4,-1,184755595,184826818,q35.1,acyl-CoA synthetase long chain family member 1 [Source:HGNC Symbol;Acc:HGNC:3569],NA,ACSL1,2180,NM_001286708;NM_001286710;NM_001286711;NM_001286712;NM_001995
TLR1_SIG,TLR1,TLR1_SIG,TLR1,SIG,19,-4.41469720434717,0.406208092580704,0.428087988926351,0.334317004587862,-0.0937709843384895,4.54606426400185e-05,-2.6848757388087,4.60903786755243,4.6838646428187,4.36317846310611,-0.320686179712587,0.0232297645241273,ENSG00000174125,TLR1,protein_coding,4,-1,38790677,38856817,p14,toll like receptor 1 [Source:HGNC Symbol;Acc:HGNC:11847],LEPROSY SUSCEPTIBILITY TO 5,TLR1,7096,NM_003263
NID1_SIG,NID1,NID1_SIG,NID1,SIG,21,-4.41463156324552,-0.0261226646926727,-0.0111401089971898,-0.0753510619778307,-0.0642109529806409,4.54606426400185e-05,-3.05471507455449,4.2619156827552,4.44167714239355,3.6712708868006,-0.770406255592954,0.0093419140700068,ENSG00000116962,NID1,protein_coding,1,-1,235975830,236065109,q42.3,nidogen 1 [Source:HGNC Symbol;Acc:HGNC:7821],NA,NID1,4811,NM_002508
PSAT1_SIG,PSAT1,PSAT1_SIG,PSAT1,SIG,28,-4.41206674444843,-0.0483650574516042,-0.0418943031937034,-0.0696261071561355,-0.0277318039624322,4.59777253447441e-05,-2.26868567405977,1.47217723768567,1.54061984424505,1.24729438756201,-0.293325456683046,0.0576306281304013,ENSG00000135069,PSAT1,protein_coding,9,1,78297125,78330093,q21.2,phosphoserine aminotransferase 1 [Source:HGNC Symbol;Acc:HGNC:19129],Neu-Laxova syndrome;Neu-laxova syndrome 2;PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY,PSAT1,29968,NM_021154;NM_058179
DHRS9_SIG,DHRS9,DHRS9_SIG,DHRS9,SIG,20,-4.41141867283205,0.0565451416050921,0.076998244671559,-0.0106579113275851,-0.0876561559991443,4.60575276883673e-05,-2.66736904517471,2.90426686590452,3.02236789025431,2.51622064304094,-0.506147247213366,0.024137087796971,ENSG00000073737,DHRS9,protein_coding,2,1,169064789,169096167,q31.1,dehydrogenase/reductase 9 [Source:HGNC Symbol;Acc:HGNC:16888],NA,DHRS9,10170,NM_001142270;NM_001142271;NM_001289763;NM_199204
SLC34A1_SIG,SLC34A1,SLC34A1_SIG,SLC34A1,SIG,4,-4.41133341236272,0.151641083462767,0.174288717382649,0.0772274291545816,-0.0970612882280676,4.60575276883673e-05,-2.80404077159505,0.224891010946744,0.256339074344348,0.12156165978319,-0.134777414561158,0.0175312440331885,ENSG00000131183,SLC34A1,protein_coding,5,1,177379235,177398848,q35.3,solute carrier family 34 member 1 [Source:HGNC Symbol;Acc:HGNC:11019],Autosomal recessive infantile hypercalcemia;Dominant hypophosphatemia with nephrolithiasis or osteoporosis;FANCONI RENOTUBULAR SYNDROME 2;HYPERCALCEMIA INFANTILE 2;NEPHROLITHIASIS/OSTEOPOROSIS HYPOPHOSPHATEMIC 1;Primary Fanconi syndrome,SLC34A1,6569,NM_001167579;NM_003052
ARHGAP44_SIG,ARHGAP44,ARHGAP44_SIG,ARHGAP44,SIG,45,-4.41132011238359,-0.159995726700361,-0.154522486857923,-0.177979229039801,-0.0234567421818775,4.60575276883673e-05,-2.77829977817802,0.421226046128422,0.485252964811718,0.210851884740451,-0.274401080071267,0.0186111264424581,ENSG00000006740,ARHGAP44,protein_coding,17,1,12789498,12991643,p12,Rho GTPase activating protein 44 [Source:HGNC Symbol;Acc:HGNC:29096],NA,ARHGAP44,9912,NM_001321164;NM_001321166;NM_001321167;NM_001321168;NM_014859
OR2T32P_SIG,OR2T32P,OR2T32P_SIG,OR2T32P,SIG,26,4.41122252151968,-0.117091604016582,-0.128143176776447,-0.0807792935198821,0.0473638832565653,4.60575276883673e-05,3.29859987860995,0.371961171018673,0.343414573255571,0.465757135097438,0.122342561841867,0.00482713202731726,ENSG00000197067,OR2T32P,transcribed_unprocessed_pseudogene,1,-1,248083522,248087522,q44,olfactory receptor family 2 subfamily T member 32 pseudogene [Source:HGNC Symbol;Acc:HGNC:31254],NA,OR2T32P,NA,NA
CD8A_SIG,CD8A,CD8A_SIG,CD8A,SIG,13,-4.41004841097109,-0.18754404789984,-0.153920252716871,-0.298022232072454,-0.144101979355582,4.62829265592142e-05,-3.98524155979442,3.6269665695759,3.78277397492544,3.11502795199883,-0.667746022926602,0.000595311951517716,ENSG00000153563,CD8A,protein_coding,2,-1,86784610,86808396,p11.2,CD8a molecule [Source:HGNC Symbol;Acc:HGNC:1706],CD8 DEFICIENCY FAMILIAL;Susceptibility to respiratory infections associated with CD8alpha chain mutation,CD8A,925,NM_001145873;NM_001768;NM_171827
PER3_SIG,PER3,PER3_SIG,PER3,SIG,4,-4.40973118235502,-0.188692901055789,-0.181747322274137,-0.21151408848122,-0.0297667662070836,4.63159786275029e-05,-1.20057577648673,2.2943013033802,2.33177490389493,2.1711737588318,-0.160601145063133,0.336727196430399,ENSG00000049246,PER3,protein_coding,1,1,7784320,7845177,p36.23,period circadian regulator 3 [Source:HGNC Symbol;Acc:HGNC:8847],ADVANCED SLEEP PHASE SYNDROME FAMILIAL 3;FAMILIAL ADVANCED SLEEP-PHASE SYNDROME,PER3,8863,NM_001289861;NM_001289862;NM_001289863;NM_001289864;NM_016831
TAS2R31_SIG,TAS2R31,TAS2R31_SIG,TAS2R31,SIG,49,4.4096598275661,-0.0330648808312849,-0.0446098665102027,0.00486864354230214,0.0494785100525049,4.63159786275029e-05,2.19634963484462,0.504078970634872,0.484319683577566,0.569002342394594,0.0846826588170283,0.0668724837831999,ENSG00000256436,TAS2R31,protein_coding,12,-1,11030387,11031407,p13.2,taste 2 receptor member 31 [Source:HGNC Symbol;Acc:HGNC:19113],NA,TAS2R31,259290,NM_176885
VIPR1_SIG,VIPR1,VIPR1_SIG,VIPR1,SIG,28,-4.40928872269805,0.0769262957740762,0.0985860833198402,0.00575842240942276,-0.0928276609104176,4.63703723301412e-05,-2.89364583366123,2.59055815617704,2.70254273845689,2.22260881440037,-0.479933924056518,0.01409444165828,ENSG00000114812,VIPR1,protein_coding,3,1,42489299,42537573,p22.1,vasoactive intestinal peptide receptor 1 [Source:HGNC Symbol;Acc:HGNC:12694],NA,VIPR1,7433,NM_001251882;NM_001251883;NM_001251884;NM_001251885;NM_004624
RHOXF1_TF,RHOXF1,RHOXF1_TF,RHOXF1,TF,47,4.40828273111194,-0.00591406460889956,-0.0114763639650642,0.0123620618470701,0.0238384258121344,4.65611067575355e-05,2.01837317463009,0.27406923462763,0.25991785609805,0.320566621224819,0.0606487651267691,0.0938608216523743,ENSG00000101883,RHOXF1,protein_coding,X,-1,120109053,120115937,q24,Rhox homeobox family member 1 [Source:HGNC Symbol;Acc:HGNC:29993],NA,RHOXF1,158800,NM_139282
WDR46_SIG,WDR46,WDR46_SIG,WDR46,SIG,45,4.40700901792584,0.441818523783137,0.426022496541875,0.493719756147282,0.067697259605407,4.68103956839173e-05,4.23112358292219,5.41348964191297,5.35537407611271,5.60444078668524,0.249066710572524,0.000259034927890029,ENSG00000227057,WDR46,protein_coding,6,-1,33279108,33289247,p21.32,WD repeat domain 46 [Source:HGNC Symbol;Acc:HGNC:13923],NA,WDR46,9277,NM_001164267;NM_005452
ALDH7A1_SIG,ALDH7A1,ALDH7A1_SIG,ALDH7A1,SIG,14,4.4066298526251,-0.00403440976665638,-0.0164820572230306,0.0368650033042876,0.0533470605273182,4.68671099174922e-05,2.0743554874828,1.85775384160458,1.79602192186887,2.06058729216477,0.264565370295902,0.084355683246152,ENSG00000164904,ALDH7A1,protein_coding,5,-1,126531200,126595362,q23.2,aldehyde dehydrogenase 7 family member A1 [Source:HGNC Symbol;Acc:HGNC:877],EPILEPSY PYRIDOXINE-DEPENDENT;Pyridoxine-dependent epilepsy,ALDH7A1,501,NM_001182;NM_001201377;NM_001202404
KCNK13_SIG,KCNK13,KCNK13_SIG,KCNK13,SIG,9,-4.40506957766338,0.0390318153207774,0.0789102651147042,-0.0919973768592677,-0.170907641973972,4.71802999353642e-05,-3.1429742409163,0.402069265912888,0.45117360819338,0.240726426991269,-0.210447181202111,0.00739771432135858,ENSG00000152315,KCNK13,protein_coding,14,1,90061994,90185853,q32.11,potassium two pore domain channel subfamily K member 13 [Source:HGNC Symbol;Acc:HGNC:6275],NA,KCNK13,56659,NM_022054
LY96_SIG,LY96,LY96_SIG,LY96,SIG,16,-4.40447961729914,0.252598707057407,0.286862559759558,0.140017476750338,-0.14684508300922,4.72834090663934e-05,-2.89682115331727,1.87275885623631,1.95399562419769,1.60583804722034,-0.348157576977353,0.0139956760068445,ENSG00000154589,LY96,protein_coding,8,1,73991352,74029087,q21.11,lymphocyte antigen 96 [Source:HGNC Symbol;Acc:HGNC:17156],NA,LY96,23643,NM_001195797;NM_015364
IFNGR2_SIG,IFNGR2,IFNGR2_SIG,IFNGR2,SIG,41,-4.40234946604576,0.410250844312423,0.431073194322287,0.341834551422871,-0.0892386428994165,4.77244908954285e-05,-4.19649973967667,6.45539550515781,6.55734602840178,6.12041521449904,-0.436930813902735,0.000291727902330298,ENSG00000159128,IFNGR2,protein_coding,21,1,33402896,33479348,q22.11,interferon gamma receptor 2 [Source:HGNC Symbol;Acc:HGNC:5440],Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency;Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency;IMMUNODEFICIENCY 28;Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,IFNGR2,3460,NM_001329128;NM_005534
ZNF625_TF,ZNF625,ZNF625_TF,ZNF625,TF,28,4.40222597519068,0.0831861221714186,0.0704094171662167,0.125166724331368,0.0547573071651509,4.77259976549779e-05,2.92903582460173,0.410945714664581,0.38907814372494,0.48279630489483,0.0937181611698897,0.0129028378924257,ENSG00000257591,ZNF625,protein_coding,19,-1,12142090,12156729,p13.2,zinc finger protein 625 [Source:HGNC Symbol;Acc:HGNC:30571],NA,ZNF625,90589,NM_145233
PIGG_SIG,PIGG,PIGG_SIG,PIGG,SIG,115,4.40130974191396,0.245932769054474,0.23642349906283,0.27717751331273,0.0407540142498995,4.78920533682093e-05,3.14623453915101,5.53250229357428,5.49169269627091,5.66659097042822,0.174898274157306,0.00734243828301588,ENSG00000174227,PIGG,protein_coding,4,1,499210,540200,p16.3,phosphatidylinositol glycan anchor biosynthesis class G [Source:HGNC Symbol;Acc:HGNC:25985],Early-onset epilepsy-intellectual disability-brain anomalies syndrome;Intellectual Disability with Seizures and Hypotonia;MENTAL RETARDATION AUTOSOMAL RECESSIVE 53,PIGG,54872,NM_001127178;NM_001289051;NM_001289052;NM_001289053;NM_001289055;NM_001289057;NM_001345986;NM_001345987;NM_001345988;NM_001345989;NM_001345990;NM_001345991;NM_001345994;NM_017733
ZNF761_TF,ZNF761,ZNF761_TF,ZNF761,TF,89,4.40116547505318,0.249494937459647,0.235089373949557,0.296827503278515,0.0617381293289584,4.78920533682093e-05,3.32764475890097,4.02135656417111,3.96007065032571,4.22272456680603,0.262653916480324,0.00444377640605891,ENSG00000160336,ZNF761,protein_coding,19,1,53445001,53458261,q13.42,zinc finger protein 761 [Source:HGNC Symbol;Acc:HGNC:23179],NA,ZNF761,388561;110116772,NM_001008401;NM_001289951;NM_001289952;NM_001289953;NM_001350496
DPP7_SIG,DPP7,DPP7_SIG,DPP7,SIG,41,4.40112292649952,0.0621688045701484,0.0575948754994975,0.0771974286594302,0.0196025531599327,4.78920533682093e-05,3.60374595447997,7.10249251415087,7.05432650827617,7.26075224773916,0.206425739462989,0.00197440373940586,ENSG00000176978,DPP7,protein_coding,9,-1,137110546,137115177,q34.3,dipeptidyl peptidase 7 [Source:HGNC Symbol;Acc:HGNC:14892],NA,DPP7,29952,NM_013379
TAS2R5_SIG,TAS2R5,TAS2R5_SIG,TAS2R5,SIG,107,4.40079871693815,0.0245693396957082,0.0113636314167311,0.0679595240409185,0.0565958926241874,4.79379425157373e-05,2.71759161729416,0.986223873816594,0.944885346737823,1.1220504627897,0.177165116051876,0.021490227121624,ENSG00000127366,TAS2R5,protein_coding,7,1,141790217,141791367,q34,taste 2 receptor member 5 [Source:HGNC Symbol;Acc:HGNC:14912],NA,TAS2R5,54429,NM_018980
PHYH_SIG,PHYH,PHYH_SIG,PHYH,SIG,32,4.40067946274051,0.0274953481313357,0.0207605692515331,0.04962390730783,0.0288633380562969,4.79385802609696e-05,4.74089083276338,3.59658738877032,3.51483090592752,3.86521583239665,0.350384926469132,4.00599322256452e-05,ENSG00000107537,PHYH,protein_coding,10,-1,13277796,13302412,p13,phytanoyl-CoA 2-hydroxylase [Source:HGNC Symbol;Acc:HGNC:8940],Refsum disease;REFSUM DISEASE CLASSIC,PHYH,5264,NM_001037537;NM_001323080;NM_001323082;NM_001323083;NM_001323084;NM_006214
ZNF169_TF,ZNF169,ZNF169_TF,ZNF169,TF,110,4.40014428575931,0.00138029507833019,-0.00894902644968065,0.0353194943846515,0.0442685208343323,4.80312104184017e-05,3.06987851831516,2.85488763039568,2.80153352741135,3.03019396877279,0.228660441361441,0.00898393551962999,ENSG00000175787,ZNF169,protein_coding,9,1,94259311,94301454,q22.32,zinc finger protein 169 [Source:HGNC Symbol;Acc:HGNC:12957],NA,ZNF169,169841,NM_001301275;NM_003448;NM_194320
PLA2G4C_SIG,PLA2G4C,PLA2G4C_SIG,PLA2G4C,SIG,15,-4.39966365452663,-0.153524411147275,-0.145681756320742,-0.179293134148741,-0.0336113778279985,4.81119260587974e-05,-2.09983588604501,1.09417609817373,1.14269658676276,0.93475163566693,-0.207944951095828,0.0803731086291052,ENSG00000105499,PLA2G4C,protein_coding,19,-1,48047843,48110817,q13.33,phospholipase A2 group IVC [Source:HGNC Symbol;Acc:HGNC:9037],NA,PLA2G4C,8605,NM_001159322;NM_001159323;NM_003706
IL2RB_SIG,IL2RB,IL2RB_SIG,IL2RB,SIG,33,-4.39823021693368,-0.273770910727011,-0.250399973166814,-0.35056113413909,-0.100161160972277,4.84047928594821e-05,-3.97152741689556,4.16184282311589,4.31884511533227,3.64597814869063,-0.67286696664164,0.000621281933254794,ENSG00000100385,IL2RB,protein_coding,22,-1,37125843,37175054,q12.3,interleukin 2 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:6009],Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,IL2RB,3560,NM_000878;NM_001346222;NM_001346223
SH3RF3_SIG,SH3RF3,SH3RF3_SIG,SH3RF3,SIG,26,4.39760749950273,0.00890587133038134,0.00156749229622733,0.0330176881568874,0.0314501958606599,4.8517863673506e-05,0.326003097625415,2.86716033698748,2.85563018804184,2.90504511209458,0.049414924052739,0.8125204548264,ENSG00000172985,SH3RF3,protein_coding,2,1,109129348,109504632,q13,SH3 domain containing ring finger 3 [Source:HGNC Symbol;Acc:HGNC:24699],NA,SH3RF3,344558,NM_001099289
TMPRSS3_SIG,TMPRSS3,TMPRSS3_SIG,TMPRSS3,SIG,6,-4.39741819403746,-0.0923029007444281,-0.0707440653320204,-0.163139074242339,-0.0923950089103187,4.85342177587877e-05,-0.747827896882118,0.323863720810976,0.333144376644503,0.29337013735796,-0.0397742392865436,0.564515604507751,ENSG00000160183,TMPRSS3,protein_coding,21,-1,42371837,42396846,q22.3,transmembrane serine protease 3 [Source:HGNC Symbol;Acc:HGNC:11877],Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness autosomal recessive 8,TMPRSS3,64699,NM_001256317;NM_024022;NM_032404;NM_032405
PTK2B_SIG,PTK2B,PTK2B_SIG,PTK2B,SIG,9,-4.39628542679296,0.618486887785564,0.627660680283398,0.588344426721255,-0.0393162535621424,4.87619906781884e-05,-4.22451775637497,8.03070532304539,8.09510896283595,7.81909336373352,-0.276015599102435,0.000264300992655258,ENSG00000120899,PTK2B,protein_coding,8,1,27311482,27459391,p21.2,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:HGNC:9612],NA,PTK2B,2185,NM_004103;NM_173174;NM_173175;NM_173176
GYG2_SIG,GYG2,GYG2_SIG,GYG2,SIG,44,4.39461581690598,-0.11452945616186,-0.122795716400136,-0.0873688868075261,0.0354268295926102,4.91120059211723e-05,1.80343704196451,1.16431173624241,1.11226223401761,1.33533152926677,0.223069295249162,0.137360774679054,ENSG00000056998,GYG2,protein_coding,X,1,2828822,2882820,p22.33,glycogenin 2 [Source:HGNC Symbol;Acc:HGNC:4700],NA,GYG2,8908,NM_001079855;NM_001184702;NM_001184703;NM_001184704;NM_003918
MBD6_TF,MBD6,MBD6_TF,MBD6,TF,193,-4.39376390350017,0.0231086084793155,0.0284167841460529,0.00566745986003574,-0.0227493242860172,4.92786328851501e-05,-2.15980063254403,7.12185562686449,7.14994420160797,7.02956459556449,-0.120379606043477,0.0718189981549816,ENSG00000166987,MBD6,protein_coding,12,1,57520710,57530148,q13.3,methyl-CpG binding domain protein 6 [Source:HGNC Symbol;Acc:HGNC:20445],NA,MBD6,114785,NM_052897
TAS2R4_SIG,TAS2R4,TAS2R4_SIG,TAS2R4,SIG,127,4.39364425480307,-0.0426727764317502,-0.0541891088795265,-0.00483339838905646,0.0493557104904701,4.92794652257673e-05,2.91024067105265,0.498141176078107,0.465384126997489,0.605771480200137,0.140387353202648,0.0135208018002423,ENSG00000127364,TAS2R4,protein_coding,7,1,141778442,141780819,q34,taste 2 receptor member 4 [Source:HGNC Symbol;Acc:HGNC:14911],NA,TAS2R4,50832,NM_016944
SPI1_TF,SPI1,SPI1_TF,SPI1,TF,348,-4.3897648924673,0.271587210150491,0.286869628467624,0.221373549965623,-0.0654960785020011,5.01400586234842e-05,-3.64681511774951,8.07535047082004,8.15213052248477,7.82307315820733,-0.32905736427744,0.00172600926388314,ENSG00000066336,SPI1,protein_coding,11,-1,47354860,47378576,p11.2,Spi-1 proto-oncogene [Source:HGNC Symbol;Acc:HGNC:11241],NA,SPI1,6688,NM_001080547;NM_003120
RAF1_SIG,RAF1,RAF1_SIG,RAF1,SIG,41,-4.38900867263265,0.339392253950643,0.350940482726085,0.301448073688475,-0.0494924090376102,5.02878870790316e-05,-3.00528594256375,7.13905886071836,7.17681901202151,7.01498979215085,-0.161829219870663,0.0105951573633212,ENSG00000132155,RAF1,protein_coding,3,-1,12583601,12664226,p25.2,Raf-1 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:9829],Cardiomyopathy dilated 1nn;Familial isolated dilated cardiomyopathy;LEOPARD SYNDROME 2;Noonan Syndrome;NOONAN SYNDROME 5;Noonan syndrome with multiple lentigines;Pilomyxoid astrocytoma,RAF1,5894,NM_001354689;NM_001354690;NM_001354691;NM_001354692;NM_001354693;NM_001354694;NM_001354695;NM_002880
ARHGAP9_SIG,ARHGAP9,ARHGAP9_SIG,ARHGAP9,SIG,43,-4.3884108967842,0.397759911947749,0.411278108251187,0.353342981236453,-0.0579351270147334,5.03885652590389e-05,-3.41832150118712,7.25389291413298,7.31586851527463,7.05025879609611,-0.265609719178521,0.00341544770600627,ENSG00000123329,ARHGAP9,protein_coding,12,-1,57472264,57488814,q13.3,Rho GTPase activating protein 9 [Source:HGNC Symbol;Acc:HGNC:14130],NA,ARHGAP9,64333,NM_001080156;NM_001080157;NM_001319850;NM_001319851;NM_001319852;NM_032496
SLC26A11_SIG,SLC26A11,SLC26A11_SIG,SLC26A11,SIG,25,-4.38832237345721,0.275005656465096,0.296539067021812,0.204253021778742,-0.0922860452430692,5.03885652590389e-05,-2.93882509282181,2.80470580845142,2.90808328163855,2.4650369679794,-0.443046313659146,0.012604881613324,ENSG00000181045,SLC26A11,protein_coding,17,1,80219699,80253500,q25.3,solute carrier family 26 member 11 [Source:HGNC Symbol;Acc:HGNC:14471],NA,SLC26A11,284129,NM_001166347;NM_001166348;NM_001166349;NM_173626
ZNF83_TF,ZNF83,ZNF83_TF,ZNF83,TF,64,4.38808247931496,0.146822128211127,0.138461677087521,0.174292181902977,0.0358305048154561,5.03885652590389e-05,3.44016741498583,5.72728911806316,5.66542574967686,5.93055447133243,0.265128721655573,0.00319681958635861,ENSG00000167766,ZNF83,protein_coding,19,-1,52594060,52690496,q13.41,zinc finger protein 83 [Source:HGNC Symbol;Acc:HGNC:13158],NA,ZNF83,55769,NM_001105549;NM_001105550;NM_001105551;NM_001105552;NM_001277945;NM_001277946;NM_001277947;NM_001277948;NM_001277949;NM_001277951;NM_001277952;NM_001348015;NM_001348016;NM_001348017;NM_001348018;NM_001348019;NM_018300
IRF2BP1_SIG,IRF2BP1,IRF2BP1_SIG,IRF2BP1,SIG,16,4.38799954538715,0.153781264313963,0.143202252647491,0.188540874075228,0.045338621427737,5.03885652590389e-05,2.10275449088089,4.53205005828838,4.50021391678385,4.63665452323183,0.136440606447979,0.0799627044597153,ENSG00000170604,IRF2BP1,protein_coding,19,-1,45883608,45886141,q13.32,interferon regulatory factor 2 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:21728],NA,IRF2BP1,26145,NM_015649
ZNF10_TF,ZNF10,ZNF10_TF,ZNF10,TF,99,4.38799464286993,-0.0158941731796054,-0.0259649598728351,0.0171955545267209,0.043160514399556,5.03885652590389e-05,3.68651822489068,3.06137042430085,2.97872812634779,3.33290940328951,0.354181276941722,0.00153205950463868,ENSG00000256223,ZNF10,protein_coding,12,1,133130575,133159465,q24.33,zinc finger protein 10 [Source:HGNC Symbol;Acc:HGNC:12879],NA,ZNF10,7556,NM_015394
SELL_SIG,SELL,SELL_SIG,SELL,SIG,30,-4.38699689414976,0.150686762941076,0.158252297930664,0.125828576546714,-0.0324237213839506,5.05932770354714e-05,-3.01239957223367,8.38831492470936,8.50169711073672,8.01577345633374,-0.485923654402981,0.0104027223691851,ENSG00000188404,SELL,protein_coding,1,-1,169690665,169711702,q24.2,selectin L [Source:HGNC Symbol;Acc:HGNC:10720],NA,SELL,6402,NM_000655
NOL6_SIG,NOL6,NOL6_SIG,NOL6,SIG,17,4.38640453108778,0.452393840477984,0.439832971456749,0.493665267262043,0.0538322958052931,5.07042484770512e-05,3.98606829352569,5.70838201935802,5.65128550941729,5.8959848377347,0.244699328317417,0.000594391842023846,ENSG00000165271,NOL6,protein_coding,9,-1,33461353,33473930,p13.3,nucleolar protein 6 [Source:HGNC Symbol;Acc:HGNC:19910],NA,NOL6,65083,NM_022917;NM_139235
GZMK_SIG,GZMK,GZMK_SIG,GZMK,SIG,9,-4.38577271522102,-0.243330113892619,-0.212400293086186,-0.344956667970897,-0.132556374884711,5.08246727654287e-05,-3.46437566135421,2.19828845832216,2.31685879635265,1.8087002047934,-0.508158591559258,0.0029923663723012,ENSG00000113088,GZMK,protein_coding,5,1,55024253,55034570,q11.2,granzyme K [Source:HGNC Symbol;Acc:HGNC:4711],NA,GZMK,3003,NM_002104
INPP5K_SIG,INPP5K,INPP5K_SIG,INPP5K,SIG,25,-4.38546921194819,0.0527383644000356,0.0596531524646187,0.0300183464735483,-0.0296348059910703,5.08591333642852e-05,-1.62975433289402,5.32747908640724,5.34638903685288,5.26534639208584,-0.0810426447670453,0.182232138849375,ENSG00000132376,INPP5K,protein_coding,17,-1,1494577,1516742,p13.3,inositol polyphosphate-5-phosphatase K [Source:HGNC Symbol;Acc:HGNC:33882],Marinesco-Sjogren syndrome;MUSCULAR DYSTROPHY CONGENITAL WITH CATARACTS AND INTELLECTUAL DISABILITY,INPP5K,51763,NM_001135642;NM_016532;NM_130766
EGR2_TF,EGR2,EGR2_TF,EGR2,TF,52,-4.385394255906,0.126936352276723,0.140256793180388,0.083169189307541,-0.0570876038728467,5.08591333642852e-05,-2.4992962600262,2.62922803531639,2.73352456256837,2.28653944577417,-0.4469851167942,0.0353550827869845,ENSG00000122877,EGR2,protein_coding,10,-1,62811996,62919900,q21.3,early growth response 2 [Source:HGNC Symbol;Acc:HGNC:3239],CHARCOT-MARIE-TOOTH DISEASE DEMYELINATING TYPE 1D;Charcot-Marie-Tooth disease type 1D;Charcot-Marie-Tooth disease type 4E;Dejerine-Sottas syndrome;HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS;Neuropathy congenital hypomyelinating 1;NEUROPATHY CONGENITAL HYPOMYELINATING 1 AUTOSOMAL RECESSIVE,EGR2,1959,NM_000399;NM_001136177;NM_001136178;NM_001136179;NM_001321037
RBM12B_SIG,RBM12B,RBM12B_SIG,RBM12B,SIG,129,4.38449773543101,0.111242418349108,0.0962330052345622,0.160559061439759,0.0643260562051968,5.10419628759443e-05,5.14941472426545,4.90850929031092,4.78982898596633,5.29845886172886,0.508629875762534,7.79023554848431e-06,ENSG00000183808,RBM12B,protein_coding,8,-1,93729356,93741017,q22.1,RNA binding motif protein 12B [Source:HGNC Symbol;Acc:HGNC:32310],NA,RBM12B,389677,NM_203390
RARRES2_SIG,RARRES2,RARRES2_SIG,RARRES2,SIG,46,-4.38381986444326,-0.124856986279949,-0.118209890734967,-0.146697443070605,-0.0284875523356379,5.11740108702896e-05,-1.89393575833206,0.349763523676369,0.383817357856923,0.237872354225977,-0.145945003630947,0.117490882085916,ENSG00000106538,RARRES2,protein_coding,7,-1,150338317,150341662,q36.1,retinoic acid receptor responder 2 [Source:HGNC Symbol;Acc:HGNC:9868],NA,RARRES2,5919,NM_002889
CRBN_SIG,CRBN,CRBN_SIG,CRBN,SIG,43,4.38294378500228,0.273344128802667,0.264525873922803,0.302318394836505,0.0377925209137015,5.13506384700161e-05,1.65396908180526,5.87183226984852,5.85081896489149,5.94087598613588,0.0900570212443892,0.175358487823423,ENSG00000113851,CRBN,protein_coding,3,-1,3144628,3179727,p26.2,cereblon [Source:HGNC Symbol;Acc:HGNC:30185],Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 2;MENTAL RETARDATION AUTOSOMAL RECESSIVE TYPE 2A,CRBN,51185,NM_001173482;NM_016302
ZBED5_TF,ZBED5,ZBED5_TF,ZBED5,TF,27,4.38283901512026,0.386850975704154,0.378562614877604,0.414084161277107,0.0355215463995028,5.13506384700161e-05,2.51920324066275,5.78804233230501,5.75455178927392,5.89808268797858,0.143530898704656,0.0338855164892335,ENSG00000236287,ZBED5,protein_coding,11,-1,10812074,10858796,p15.4,zinc finger BED-type containing 5 [Source:HGNC Symbol;Acc:HGNC:30803],NA,ZBED5,58486,NM_001143667;NM_021211
TAP1_SIG,TAP1,TAP1_SIG,TAP1,SIG,29,-4.3816641526535,0.265451984972625,0.277745553339774,0.225058831766276,-0.0526867215734985,5.16010738895138e-05,-3.14607622480458,6.29558167535499,6.35825514455499,6.08965456226929,-0.268600582285701,0.00734498608715823,ENSG00000168394,TAP1,protein_coding,6,-1,32845209,32853978,p21.32,transporter 1, ATP binding cassette subfamily B member [Source:HGNC Symbol;Acc:HGNC:43],BARE LYMPHOCYTE SYNDROME TYPE I;Immunodeficiency by defective expression of HLA class 1,TAP1,6890,NM_000593;NM_001292022
TPD52L2_SIG,TPD52L2,TPD52L2_SIG,TPD52L2,SIG,44,-4.38006478496341,0.352121241146115,0.369225640686693,0.295921071227073,-0.0733045694596199,5.19537943939346e-05,-4.31325993076359,7.07104575076363,7.13094197575706,6.87424386864234,-0.256698107114721,0.000194993072315318,ENSG00000101150,TPD52L2,protein_coding,20,1,63865228,63891545,q13.33,TPD52 like 2 [Source:HGNC Symbol;Acc:HGNC:12007],NA,TPD52L2,7165,NM_001243891;NM_001243892;NM_001243894;NM_001243895;NM_003288;NM_199359;NM_199360;NM_199361;NM_199362;NM_199363
PLCG1_SIG,PLCG1,PLCG1_SIG,PLCG1,SIG,56,-4.37994127750401,-0.0679080745149524,-0.0575393473651228,-0.101976749435821,-0.044437402070698,5.19557886389223e-05,-3.84355753041958,4.63862650883648,4.7752326654635,4.18977770849054,-0.585454956972958,0.000938415515486707,ENSG00000124181,PLCG1,protein_coding,20,1,41136960,41196801,q12,phospholipase C gamma 1 [Source:HGNC Symbol;Acc:HGNC:9065],NA,PLCG1,5335,NM_002660;NM_182811
CDH1_SIG,CDH1,CDH1_SIG,CDH1,SIG,35,-4.3782476482102,-0.224889970181006,-0.205873731738391,-0.287371896492455,-0.0814981647540637,5.23334498374823e-05,-2.7678461652207,1.31646040568251,1.42328713876414,0.965458282700034,-0.457828856064104,0.019074128969287,ENSG00000039068,CDH1,protein_coding,16,1,68737292,68835541,q22.1,cadherin 1 [Source:HGNC Symbol;Acc:HGNC:1748],Blepharo-cheilo-odontic syndrome;Blepharo-cheiro-dontic syndrome;BLEPHAROCHEILODONTIC SYNDROME 1;Breast Cancer;Cleft lip/palate;Endometrial Cancer;GASTRIC CANCER HEREDITARY DIFFUSE;Hereditary diffuse gastric cancer;OVARIAN CANCER OVARIAN CANCER EPITHELIAL INCLUDED;Prostate Cancer,CDH1,999,NM_001317184;NM_001317185;NM_001317186;NM_004360
SEMA4G_SIG,SEMA4G,SEMA4G_SIG,SEMA4G,SIG,67,4.377306455184,0.00994455005738328,0.000228414695739873,0.0418689948170687,0.0416405801213288,5.25321362163764e-05,2.86291427667411,0.600766299771872,0.562664557614455,0.725957738289099,0.163293180674643,0.0152185315966594,ENSG00000095539,SEMA4G,protein_coding,10,1,100969518,100985871,q24.31,semaphorin 4G [Source:HGNC Symbol;Acc:HGNC:10735],NA,SEMA4G,57715,NM_001203244;NM_017893
RIOK2_SIG,RIOK2,RIOK2_SIG,RIOK2,SIG,21,4.37708186237052,0.275622891908006,0.267697046058082,0.30166495684347,0.0339679107853876,5.25361452939086e-05,4.12005975508094,4.12860782256795,4.07589520797926,4.30180641335938,0.225911205380126,0.000379721919215174,ENSG00000058729,RIOK2,protein_coding,5,-1,97160867,97183247,q15,RIO kinase 2 [Source:HGNC Symbol;Acc:HGNC:18999],NA,RIOK2,55781,NM_001159749;NM_018343
PTCD2_SIG,PTCD2,PTCD2_SIG,PTCD2,SIG,39,4.37705981903425,0.275882357546795,0.257749870176856,0.335460530333736,0.0777106601568794,5.25361452939086e-05,5.05233292434793,2.37586779228047,2.2928156924602,2.64875326311849,0.355937570658283,1.14040266129342e-05,ENSG00000049883,PTCD2,protein_coding,5,1,72320367,72368395,q13.2,pentatricopeptide repeat domain 2 [Source:HGNC Symbol;Acc:HGNC:25734],NA,PTCD2,79810,NM_001284403;NM_001284404;NM_001284405;NM_024754
MOCS1_SIG,MOCS1,MOCS1_SIG,MOCS1,SIG,90,-4.37665592158974,-0.186110971573288,-0.180259985595854,-0.205335639784857,-0.0250756541890027,5.26058170981185e-05,-2.61572099378607,0.557053191594788,0.613712691142787,0.370886264508505,-0.242826426634282,0.0271388987327487,ENSG00000124615,MOCS1,protein_coding,6,-1,39899578,39934551,p21.2,molybdenum cofactor synthesis 1 [Source:HGNC Symbol;Acc:HGNC:7190],Molybdenum Cofactor Deficiency;MOLYBDENUM COFACTOR DEFICIENCY COMPLEMENTATION GROUP A;Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,MOCS1,4337,NM_001075098;NM_001358529;NM_001358530;NM_001358531;NM_001358533;NM_001358534;NM_005943
COL1A1_SIG,COL1A1,COL1A1_SIG,COL1A1,SIG,45,-4.37591676628546,-0.243785240296496,-0.234702250833324,-0.273629348532631,-0.0389270976993075,5.27481483657885e-05,-2.04539454712789,0.945672524762082,1.00358668417498,0.755383143833987,-0.248203540340993,0.0893086563571782,ENSG00000108821,COL1A1,protein_coding,17,-1,50183289,50201632,q21.33,collagen type I alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2197],CAFFEY DISEASE;COL1A1/2-Related Osteogenesis Imperfecta;DERMATOFIBROSARCOMA PROTUBERANS;EHLERS-DANLOS SYNDROME ARTHROCHALASIA TYPE 1;Ehlers-Danlos Syndrome Classic Type COL1A1-Related;Ehlers-Danlos syndrome type 1;Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome type 7A;EHLERS-DANLOS SYNDROME TYPE VIIA;Ehlers-Danlos syndrome vascular-like type;Ehlers-Danlos/osteogenesis imperfecta syndrome;High bone mass osteogenesis imperfecta;Osteogenesis imperfecta type 1;Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4;OSTEOGENESIS IMPERFECTA TYPE I;OSTEOGENESIS IMPERFECTA TYPE II;OSTEOGENESIS IMPERFECTA TYPE IIA;Osteogenesis imperfecta type III;OSTEOGENESIS IMPERFECTA TYPE III;OSTEOGENESIS IMPERFECTA TYPE IV;OSTEOPOROSIS,COL1A1,1277,NM_000088
NDUFB9_SIG,NDUFB9,NDUFB9_SIG,NDUFB9,SIG,62,-4.3758369990746,0.0476192383082853,0.0558827328201026,0.0204677563408853,-0.0354149764792174,5.27481483657885e-05,-3.61454063782217,6.50611993744348,6.56180453041623,6.3231562748187,-0.238648255597531,0.00190973061399909,ENSG00000147684,NDUFB9,protein_coding,8,1,124539101,124580648,q24.13,NADH:ubiquinone oxidoreductase subunit B9 [Source:HGNC Symbol;Acc:HGNC:7704],Isolated complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 24,NDUFB9,4715,NM_001278645;NM_001278646;NM_001311168;NM_005005
PTCD3_SIG,PTCD3,PTCD3_SIG,PTCD3,SIG,37,4.37105943127844,0.452126643855632,0.441420625882452,0.487303560053225,0.0458829341707737,5.38874221921527e-05,2.76533648674733,5.81145428253563,5.77594008072482,5.92814380277114,0.152203722046328,0.0192072702151824,ENSG00000132300,PTCD3,protein_coding,2,1,86106223,86142157,p11.2,pentatricopeptide repeat domain 3 [Source:HGNC Symbol;Acc:HGNC:24717],NA,PTCD3,55037,NM_017952
SLC35F5_SIG,SLC35F5,SLC35F5_SIG,SLC35F5,SIG,61,4.37083915626643,0.300443838089434,0.29194297856534,0.328375233668602,0.0364322551032622,5.39134585871061e-05,2.41193527022878,4.81221721145087,4.7772217407016,4.92720232962704,0.149980588925437,0.042739838313975,ENSG00000115084,SLC35F5,protein_coding,2,-1,113705011,113756693,q14.1,solute carrier family 35 member F5 [Source:HGNC Symbol;Acc:HGNC:23617],NA,SLC35F5,80255,NM_001330314;NM_001330315;NM_001330316;NM_001330317;NM_025181
EPM2A_SIG,EPM2A,EPM2A_SIG,EPM2A,SIG,17,4.37065673234644,0.467813916401895,0.454207548773983,0.512520552893609,0.0583130041196258,5.39301697270654e-05,3.22411793502545,3.11953720461262,3.06311200104742,3.30493430204116,0.241822300993741,0.00594215368688737,ENSG00000112425,EPM2A,protein_coding,6,-1,145382535,145736023,q24.3,EPM2A, laforin glucan phosphatase [Source:HGNC Symbol;Acc:HGNC:3413],Lafora disease;MYOCLONIC EPILEPSY OF LAFORA,EPM2A,7957,NM_001018041;NM_001360057;NM_001360064;NM_001360071;NM_005670
NLRP12_SIG,NLRP12,NLRP12_SIG,NLRP12,SIG,79,-4.37041375956793,0.327502433087031,0.358842665801483,0.224527382739546,-0.134315283061937,5.3961861222441e-05,-3.4868240943052,3.71761995786698,3.89405071995133,3.13791888244697,-0.756131837504361,0.00280466327084616,ENSG00000142405,NLRP12,protein_coding,19,-1,53793603,53824394,q13.42,NLR family pyrin domain containing 12 [Source:HGNC Symbol;Acc:HGNC:22938],FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2;NLRP12-associated hereditary periodic fever syndrome,NLRP12,91662,NM_001277126;NM_001277129;NM_144687
ZDHHC23_TF,ZDHHC23,ZDHHC23_TF,ZDHHC23,TF,80,4.36944457826017,0.0980740709203682,0.087240706013635,0.133669412756777,0.0464287067431421,5.41483135179618e-05,3.45141707707025,3.64112648311348,3.53508376953301,3.98955254202076,0.454468772487745,0.00310308914973296,ENSG00000184307,ZDHHC23,protein_coding,3,1,113947901,113965401,q13.31,zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654],NA,ZDHHC23,254887,NM_001320466;NM_001320467;NM_001320468;NM_173570
GATA3_TF,GATA3,GATA3_TF,GATA3,TF,94,-4.36943128075044,-0.0381992930326939,-0.0252980054919135,-0.0805892378095438,-0.0552912323176303,5.41483135179618e-05,-4.83878385320766,2.56669164038308,2.75084489985153,1.96161664498675,-0.789228254864783,2.75469514138877e-05,ENSG00000107485,GATA3,protein_coding,10,1,8045378,8075198,p14,GATA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:4172],Hypoparathyroidism-sensorineural deafness-renal disease syndrome;HYPOPARATHYROIDISM SENSORINEURAL DEAFNESS AND RENAL DISEASE;Precursor B-cell acute lymphoblastic leukemia,GATA3,2625,NM_001002295;NM_002051
SLC26A8_SIG,SLC26A8,SLC26A8_SIG,SLC26A8,SIG,30,-4.36838387980039,0.10717792220995,0.123821773672723,0.0524909816894084,-0.0713307919833146,5.43800721533028e-05,-4.41058931990296,2.49908421228505,2.6613020593681,1.96608271472647,-0.695219344641629,0.000137515118226639,ENSG00000112053,SLC26A8,protein_coding,6,-1,35943514,36024868,p21.31,solute carrier family 26 member 8 [Source:HGNC Symbol;Acc:HGNC:14468],Non-syndromic male infertility due to sperm motility disorder;Spermatogenic failure 3,SLC26A8,116369,NM_001193476;NM_052961;NM_138718
ACBD4_SIG,ACBD4,ACBD4_SIG,ACBD4,SIG,103,4.36648664481846,0.049983318493828,0.0384255110204897,0.0879589716205109,0.0495334606000211,5.48255984845095e-05,2.43174761532642,3.57117890055201,3.52596545714088,3.71973735747429,0.193771900333414,0.0409201751910573,ENSG00000181513,ACBD4,protein_coding,17,1,45132600,45144181,q21.31,acyl-CoA binding domain containing 4 [Source:HGNC Symbol;Acc:HGNC:23337],NA,ACBD4,79777,NM_001135705;NM_001135706;NM_001135707;NM_001321352;NM_001321353;NM_024722
OR52K2_SIG,OR52K2,OR52K2_SIG,OR52K2,SIG,16,-4.36582390325195,-0.0838100814552952,-0.0724344571043711,-0.121187132894046,-0.0487526757896746,5.49633065736767e-05,-2.45267371379081,0.213955061625843,0.233560392310731,0.149537546518353,-0.0840228457923776,0.0391377973968106,ENSG00000181963,OR52K2,protein_coding,11,1,4449295,4450361,p15.4,olfactory receptor family 52 subfamily K member 2 [Source:HGNC Symbol;Acc:HGNC:15223],NA,OR52K2,119774,NM_001005172
DCAF8_SIG,DCAF8,DCAF8_SIG,DCAF8,SIG,74,4.36542734476654,0.363288097392234,0.353751747965484,0.394621816937271,0.0408700689717868,5.50342919827625e-05,2.92478372857992,6.3853483501802,6.34664806615157,6.51250642627428,0.165858360122711,0.0130422865324398,ENSG00000132716,DCAF8,protein_coding,1,-1,160215715,160262531,q23.2,DDB1 and CUL4 associated factor 8 [Source:HGNC Symbol;Acc:HGNC:24891],Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons;GIANT AXONAL NEUROPATHY 2 AUTOSOMAL DOMINANT,DCAF8,50717,NM_015726
PHOSPHO1_SIG,PHOSPHO1,PHOSPHO1_SIG,PHOSPHO1,SIG,34,-4.36528895914308,-0.0231302603300888,-0.00270446976969779,-0.0902435721713735,-0.0875391024016757,5.50403293249645e-05,-2.59772037134619,1.72218272641708,1.83195805034293,1.36149237637499,-0.470465673967938,0.0283333627066519,ENSG00000173868,PHOSPHO1,protein_coding,17,-1,49223362,49230766,q21.32,phosphoethanolamine/phosphocholine phosphatase [Source:HGNC Symbol;Acc:HGNC:16815],NA,PHOSPHO1,162466,NM_001143804;NM_178500
HFE_SIG,HFE,HFE_SIG,HFE,SIG,31,-4.36492611008605,-0.101814513918811,-0.0765419361418362,-0.184852983757442,-0.108311047615606,5.5102935268132e-05,-3.05430219701817,0.955635126120935,1.03148459165888,0.706415453639103,-0.325069138019781,0.00935308324172425,ENSG00000010704,HFE,protein_coding,6,1,26087281,26098343,p22.2,homeostatic iron regulator [Source:HGNC Symbol;Acc:HGNC:4886],Alzheimer disease;Familial porphyria cutanea tarda;HEMOCHROMATOSIS TYPE 1;MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 7;PORPHYRIA CUTANEA TARDA;PORPHYRIA VARIEGATA;Sporadic porphyria cutanea tarda;Symptomatic form of hemochromatosis type 1;TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2,HFE,3077,NM_000410;NM_001300749;NM_139003;NM_139004;NM_139006;NM_139007;NM_139008;NM_139009;NM_139010;NM_139011
ZFP64_TF,ZFP64,ZFP64_TF,ZFP64,TF,115,4.36262768941282,0.203515979401719,0.190859578235467,0.245101297519404,0.0542417192839368,5.56561159640245e-05,3.6717182330828,3.64952997343795,3.57507818147792,3.89415728987802,0.319079108400102,0.00160408435247217,ENSG00000020256,ZFP64,protein_coding,20,-1,52051663,52204308,q13.2,ZFP64 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:15940],NA,ZFP64,55734,NM_001319146;NM_018197;NM_022088;NM_199426;NM_199427
GRN_SIG,GRN,GRN_SIG,GRN,SIG,48,-4.36163835170839,0.521816921740093,0.54305046734318,0.452049557615661,-0.0910009097275192,5.58792191450895e-05,-3.082503565991,9.20567472467956,9.30958087186061,8.86426881251324,-0.445312059347371,0.0086744794031304,ENSG00000030582,GRN,protein_coding,17,1,44345246,44353106,q21.31,granulin precursor [Source:HGNC Symbol;Acc:HGNC:4601],Behavioral variant of frontotemporal dementia;CEROID LIPOFUSCINOSIS NEURONAL 11;CLN11 disease;FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS GRN-RELATED;Progressive non-fluent aphasia;Semantic dementia,GRN,2896,NM_002087
RAD50_SIG,RAD50,RAD50_SIG,RAD50,SIG,56,4.36100833677837,0.339780171281467,0.323305071698721,0.393912641339063,0.0706075696403415,5.60111137548898e-05,4.64457787432304,5.82605146009348,5.7323159012437,6.13403972488565,0.401723823641952,5.76888171719305e-05,ENSG00000113522,RAD50,protein_coding,5,1,132556019,132646349,q31.1,RAD50 double strand break repair protein [Source:HGNC Symbol;Acc:HGNC:9816],Hereditary breast and ovarian cancer syndrome;NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER,RAD50,10111,NM_005732
CD3E_SIG,CD3E,CD3E_SIG,CD3E,SIG,82,-4.35885146580484,-0.258329871435653,-0.229903164324722,-0.351731909085854,-0.121828744761131,5.65363953889999e-05,-4.15319860683097,4.28891411349422,4.44560304828958,3.77407904202376,-0.671524006265819,0.000337880607064752,ENSG00000198851,CD3E,protein_coding,11,1,118304545,118316175,q23.3,CD3e molecule [Source:HGNC Symbol;Acc:HGNC:1674],IMMUNODEFICIENCY 18;T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,CD3E,916,NM_000733
CXCL16_SIG,CXCL16,CXCL16_SIG,CXCL16,SIG,58,-4.35851343704538,0.383805580639333,0.412504281202374,0.289509850217912,-0.122994430984461,5.65942358686092e-05,-3.75540278350565,4.23982866021015,4.44779488022547,3.55651108015983,-0.891283800065639,0.00123619757996755,ENSG00000161921,CXCL16,protein_coding,17,-1,4733533,4739928,p13.2,C-X-C motif chemokine ligand 16 [Source:HGNC Symbol;Acc:HGNC:16642],NA,CXCL16,58191,NM_001100812;NM_022059
NIFK_SIG,NIFK,NIFK_SIG,NIFK,SIG,22,4.35812286288055,0.637631318419089,0.622422121010729,0.687604395617985,0.0651822746072553,5.66556855403549e-05,3.3861203545978,4.96013071619579,4.91153307387899,5.11980868380813,0.208275609929145,0.00376810656375943,ENSG00000155438,NIFK,protein_coding,2,-1,121726945,121736911,q14.3,nucleolar protein interacting with the FHA domain of MKI67 [Source:HGNC Symbol;Acc:HGNC:17838],NA,NIFK,84365,NM_032390
RORA_TF,RORA,RORA_TF,RORA,TF,275,-4.35804762168677,-0.10519733202237,-0.0913440624795826,-0.150715217662957,-0.0593711551833745,5.66556855403549e-05,-4.08542004385143,3.66204496509318,3.83900393984073,3.08060833377981,-0.758395606060923,0.000425746995762623,ENSG00000069667,RORA,protein_coding,15,-1,60488284,61229302,q22.2,RAR related orphan receptor A [Source:HGNC Symbol;Acc:HGNC:10258],INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY ORCEREBELLAR ATAXIA;Intellectual disability,RORA,6095,NM_002943;NM_134260;NM_134261;NM_134262
CASP10_SIG,CASP10,CASP10_SIG,CASP10,SIG,32,4.35786136082325,0.0915269965841514,0.0873136710539085,0.105370780469235,0.0180571094153266,5.6674376932443e-05,4.10304591265192,5.40561952349811,5.34216972846728,5.61409742145657,0.271927692989291,0.000402059677743209,ENSG00000003400,CASP10,protein_coding,2,1,201182881,201229406,q33.1,caspase 10 [Source:HGNC Symbol;Acc:HGNC:1500],Autoimmune lymphoproliferative syndrome;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE IIA;GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;LYMPHOMA NON-HODGKIN FAMILIAL,CASP10,843,NM_001206524;NM_001206542;NM_001230;NM_001306083;NM_032974;NM_032976;NM_032977
ZSCAN18_TF,ZSCAN18,ZSCAN18_TF,ZSCAN18,TF,170,4.35699351031168,0.0532812831558569,0.0382873638798219,0.102547017919972,0.0642596540401499,5.68698513111659e-05,2.99769163430671,4.63850749185433,4.53649219958835,4.97370059501398,0.437208395425623,0.0108286776849781,ENSG00000121413,ZSCAN18,protein_coding,19,-1,58083838,58118427,q13.43,zinc finger and SCAN domain containing 18 [Source:HGNC Symbol;Acc:HGNC:21037],NA,ZSCAN18,65982,NM_001145542;NM_001145543;NM_001145544;NM_023926
ZMYM4_TF,ZMYM4,ZMYM4_TF,ZMYM4,TF,188,4.35605805595876,0.458263210154105,0.444326183106109,0.504056299026091,0.0597301159199824,5.70835924858936e-05,4.37309231084298,6.61997200982608,6.55227004159178,6.84242133402448,0.290151292432702,0.000157024896676091,ENSG00000146463,ZMYM4,protein_coding,1,1,35268967,35422058,p34.3,zinc finger MYM-type containing 4 [Source:HGNC Symbol;Acc:HGNC:13055],NA,ZMYM4,9202,NM_001350138;NM_001350139;NM_001350140;NM_005095
ERCC3_SIG,ERCC3,ERCC3_SIG,ERCC3,SIG,85,4.3555810473265,0.385019012782792,0.377466737686381,0.409833630956715,0.0323668932703338,5.71655070507137e-05,4.04725010248126,5.80010667042627,5.75994486527827,5.93206688734114,0.172122022062873,0.00048722876746427,ENSG00000163161,ERCC3,protein_coding,2,-1,127257290,127294176,q14.3,ERCC excision repair 3, TFIIH core complex helicase subunit [Source:HGNC Symbol;Acc:HGNC:3435],Trichothiodystrophy;TRICHOTHIODYSTROPHY 2 PHOTOSENSITIVE;TRICHOTHIODYSTROPHY PHOTOSENSITIVE;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP B,ERCC3,2071,NM_000122;NM_001303416;NM_001303418
CA13_SIG,CA13,CA13_SIG,CA13,SIG,66,4.35551620603997,-0.0434971281568593,-0.0526850271528477,-0.0133083171700401,0.0393767099828076,5.71655070507137e-05,3.77870530130663,1.64461501833855,1.56628639376861,1.90198049906835,0.335694105299733,0.00115094576875131,ENSG00000185015,CA13,protein_coding,8,1,85220587,85284073,q21.2,carbonic anhydrase 13 [Source:HGNC Symbol;Acc:HGNC:14914],NA,CA13,377677,NM_198584
SLC35A3_SIG,SLC35A3,SLC35A3_SIG,SLC35A3,SIG,42,4.35321617628981,0.379619427444389,0.371927571235945,0.404892669272134,0.0329650980361892,5.77388084191218e-05,2.12218558311689,4.96914695945202,4.94759854200374,5.03994890249635,0.0923503604926078,0.0770854883381204,ENSG00000117620,SLC35A3,protein_coding,1,1,99969351,100035634,p21.2,solute carrier family 35 member A3 [Source:HGNC Symbol;Acc:HGNC:11023],ARTHROGRYPOSIS MENTAL RETARDATION AND SEIZURES;Autism spectrum disorder-epilepsy-arthrogryposis syndrome,SLC35A3,23443,NM_001271684;NM_001271685;NM_012243
IL7R_SIG,IL7R,IL7R_SIG,IL7R,SIG,38,-4.35284092773418,-0.0535364931941082,-0.0278861583799091,-0.137816164726477,-0.109930006346568,5.78077313851477e-05,-4.02332357550287,4.61094541109002,4.78578204716475,4.03648217827306,-0.749299868891692,0.000526706517178441,ENSG00000168685,IL7R,protein_coding,5,1,35852695,35879603,p13.2,interleukin 7 receptor [Source:HGNC Symbol;Acc:HGNC:6024],OMENN SYNDROME;Severe combined immunodeficiency autosomal recessive T cell-negative B cell-positive NK cell-positive;T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,IL7R,3575,NM_002185
ERAL1_SIG,ERAL1,ERAL1_SIG,ERAL1,SIG,28,4.35239952852658,0.628525056956705,0.614680548753221,0.674014155339578,0.0593336065863565,5.78942154770797e-05,4.5575595435115,4.98194093307971,4.9213675768502,5.18096767497669,0.259600098126488,8.07272689804024e-05,ENSG00000132591,ERAL1,protein_coding,17,1,28855010,28861061,q11.2,Era like 12S mitochondrial rRNA chaperone 1 [Source:HGNC Symbol;Acc:HGNC:3424],Perrault syndrome;PERRAULT SYNDROME 6,ERAL1,26284,NM_001317985;NM_001317986;NM_005702
TDRD9_SIG,TDRD9,TDRD9_SIG,TDRD9,SIG,12,-4.35228066309153,0.02247458113376,0.0321149093288373,-0.00920078293577971,-0.041315692264617,5.7895577291771e-05,-3.75099051227439,2.36535299156856,2.5390687079955,1.79457278045145,-0.744495927544052,0.00125309938170197,ENSG00000156414,TDRD9,protein_coding,14,1,103928456,104052667,q32.33,tudor domain containing 9 [Source:HGNC Symbol;Acc:HGNC:20122],Male infertility with azoospermia or oligozoospermia due to single gene mutation;SPERMATOGENIC FAILURE 30,TDRD9,122402,NM_153046
PYGL_SIG,PYGL,PYGL_SIG,PYGL,SIG,36,-4.35084161962653,0.407886292697049,0.420159011768504,0.36756164431941,-0.0525973674490942,5.824667939524e-05,-2.99555326003145,7.67271093147055,7.74868577203075,7.42307931248702,-0.325606459543731,0.0108931092668853,ENSG00000100504,PYGL,protein_coding,14,-1,50857891,50944483,q22.1,glycogen phosphorylase L [Source:HGNC Symbol;Acc:HGNC:9725],Glycogen storage disease due to liver glycogen phosphorylase deficiency;Glycogen Storage Disease Type VI;GLYCOGEN STORAGE DISEASE VI,PYGL,5836,NM_001163940;NM_002863
PDCL_SIG,PDCL,PDCL_SIG,PDCL,SIG,72,4.34996124577664,0.221911990763614,0.214343037743606,0.246781407829355,0.0324383700857489,5.84507152347253e-05,4.39330207629351,4.5978870932938,4.53071847243855,4.81858399038961,0.287865517951063,0.000146359742991799,ENSG00000136940,PDCL,protein_coding,9,-1,122798389,122828631,q33.2,phosducin like [Source:HGNC Symbol;Acc:HGNC:8770],NA,PDCL,5082,NM_005388
UBAP2_SIG,UBAP2,UBAP2_SIG,UBAP2,SIG,39,4.34984213599784,0.320293177348068,0.30604998638939,0.367092233355151,0.0610422469657607,5.84521861479197e-05,4.55548450407004,5.96004574913394,5.89049758718188,6.18856113840499,0.29806355122311,8.14520384326273e-05,ENSG00000137073,UBAP2,protein_coding,9,-1,33921693,34048949,p13.3,ubiquitin associated protein 2 [Source:HGNC Symbol;Acc:HGNC:14185],NA,UBAP2,55833,NM_001282529;NM_001282530;NM_018449
LGR6_SIG,LGR6,LGR6_SIG,LGR6,SIG,8,-4.34935752317996,-0.16989968981701,-0.146445348990108,-0.246963952533973,-0.100518603543865,5.8551174597796e-05,-3.81214144703448,1.24615219782264,1.34532932645045,0.92028448947411,-0.425044836976344,0.00103630029783415,ENSG00000133067,LGR6,protein_coding,1,1,202193901,202319781,q32.1,leucine rich repeat containing G protein-coupled receptor 6 [Source:HGNC Symbol;Acc:HGNC:19719],NA,LGR6,59352,NM_001017403;NM_001017404;NM_021636
SHPRH_SIG,SHPRH,SHPRH_SIG,SHPRH,SIG,78,4.34860618798174,0.536211465674771,0.526520451313686,0.568053370004051,0.0415329186903651,5.8721696074024e-05,3.2935845085295,5.26642899249938,5.21652575761915,5.43039676424871,0.21387100662956,0.00489833683986964,ENSG00000146414,SHPRH,protein_coding,6,-1,145864245,145964423,q24.3,SNF2 histone linker PHD RING helicase [Source:HGNC Symbol;Acc:HGNC:19336],NA,SHPRH,257218,NM_001042683;NM_173082
ZNF66_TF,ZNF66,ZNF66_TF,ZNF66,TF,82,4.34773215411662,0.148987380409041,0.138609385215397,0.18308650747387,0.0444771222584726,5.89182828821522e-05,3.49714453626641,2.37811499049453,2.30792261090236,2.60874709486877,0.300824483966406,0.00272506571618243,ENSG00000160229,ZNF66,protein_coding,19,1,20776304,20807322,p12,zinc finger protein 66 [Source:HGNC Symbol;Acc:HGNC:13135],NA,ZNF66,7617,NM_001355197
ZNF518B_TF,ZNF518B,ZNF518B_TF,ZNF518B,TF,45,4.34764615676368,-0.0656029746809228,-0.0693741060877815,-0.0532121143441014,0.01616199174368,5.89182828821522e-05,1.9407408473639,4.43607253465093,4.39173233419908,4.58176176470702,0.190029430507939,0.10817468210449,ENSG00000178163,ZNF518B,protein_coding,4,-1,10439880,10457426,p16.1,zinc finger protein 518B [Source:HGNC Symbol;Acc:HGNC:29365],NA,ZNF518B,85460,NM_053042
PIM1_SIG,PIM1,PIM1_SIG,PIM1,SIG,17,4.34695761549954,0.0223599893785609,0.0166691133109032,0.0410585821722932,0.0243894688613899,5.90729404685427e-05,2.1988813863841,7.41625115778414,7.34810603754436,7.64015655285772,0.292050515313366,0.0665663996643523,ENSG00000137193,PIM1,protein_coding,6,1,37170152,37175428,p21.2,Pim-1 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:8986],NA,PIM1,5292,NM_001243186;NM_002648
NTHL1_SIG,NTHL1,NTHL1_SIG,NTHL1,SIG,37,4.34659372730163,0.37859147686786,0.366353165397077,0.418803071700431,0.0524499063033537,5.91404355103966e-05,3.83776112369647,2.76188856899567,2.67522223551354,3.0466493790084,0.37142714349486,0.000956313237084641,ENSG00000065057,NTHL1,protein_coding,16,-1,2039815,2047866,p13.3,nth like DNA glycosylase 1 [Source:HGNC Symbol;Acc:HGNC:8028],FAMILIAL ADENOMATOUS POLYPOSIS 3;NTHL1-related attenuated familial adenomatous polyposis,NTHL1,4913,NM_001318193;NM_001318194;NM_002528
LACTB_SIG,LACTB,LACTB_SIG,LACTB,SIG,17,-4.34634191336387,0.333097880032503,0.346491090856078,0.289091615897899,-0.0573994749581783,5.91777865218695e-05,-2.73060241774673,4.71136197934859,4.76149567441016,4.54663698128914,-0.214858693121018,0.0208359813302135,ENSG00000103642,LACTB,protein_coding,15,1,63121833,63142061,q22.2,lactamase beta [Source:HGNC Symbol;Acc:HGNC:16468],NA,LACTB,114294,NM_001288585;NM_032857;NM_171846
MFAP4_SIG,MFAP4,MFAP4_SIG,MFAP4,SIG,43,-4.34601421438402,-0.0727661624458553,-0.0670526996092195,-0.0915389689090871,-0.0244862692998676,5.92356517383816e-05,-1.97943547152161,2.25697381901679,2.34591814511562,1.96472817612062,-0.381189968994996,0.100902315779261,ENSG00000166482,MFAP4,protein_coding,17,-1,19383442,19387240,p11.2,microfibril associated protein 4 [Source:HGNC Symbol;Acc:HGNC:7035],NA,MFAP4,4239,NM_001198695;NM_002404
DUSP3_SIG,DUSP3,DUSP3_SIG,DUSP3,SIG,32,4.34444911905225,0.277194897053228,0.26711402083142,0.310317776067738,0.0432037552363174,5.96287677633045e-05,3.35791530910804,6.43381929963945,6.3613388523707,6.67196934066533,0.310630488294628,0.00408810257503747,ENSG00000108861,DUSP3,protein_coding,17,-1,43766125,43778977,q21.31,dual specificity phosphatase 3 [Source:HGNC Symbol;Acc:HGNC:3069],NA,DUSP3,1845,NM_004090
AMDHD2_SIG,AMDHD2,AMDHD2_SIG,AMDHD2,SIG,14,-4.34389804850389,0.0803624080757124,0.087503409907924,0.0568991163413031,-0.030604293566621,5.97478242332172e-05,-2.32736378776689,3.87326218342697,3.90826727012131,3.75824547000272,-0.15002180011859,0.0510686286585642,ENSG00000162066,AMDHD2,protein_coding,16,1,2520357,2531422,p13.3,amidohydrolase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24262],NA,AMDHD2,51005,NM_001145815;NM_001330449;NM_015944
MAST4_SIG,MAST4,MAST4_SIG,MAST4,SIG,207,4.3427298257907,0.15123739385601,0.136420719152545,0.199920753595967,0.0635000344434223,6.0035596833435e-05,3.91523237534838,4.56071831007438,4.42288211536365,5.01360866412395,0.590726548760299,0.000743269692104998,ENSG00000069020,MAST4,protein_coding,5,1,66596361,67169595,q12.3,microtubule associated serine/threonine kinase family member 4 [Source:HGNC Symbol;Acc:HGNC:19037],NA,MAST4,375449,NM_001164664;NM_001290226;NM_001290227;NM_001290228;NM_001297651;NM_015183;NM_198828
SP140_SIG,SP140,SP140_SIG,SP140,SIG,36,-4.34196841234875,0.0911052016535294,0.0998765370013089,0.0622850997965396,-0.0375914372047694,6.02130769852739e-05,-1.30128948981478,3.25359115171775,3.29663375686053,3.11216544910575,-0.184468307754779,0.294569672052442,ENSG00000079263,SP140,protein_coding,2,1,230203110,230313215,q37.1,SP140 nuclear body protein [Source:HGNC Symbol;Acc:HGNC:17133],NA,SP140,11262,NM_001005176;NM_001278451;NM_001278452;NM_001278453;NM_007237
ZNF561_TF,ZNF561,ZNF561_TF,ZNF561,TF,19,4.34064326233609,0.0724958851928466,0.0606870549637614,0.111296327374126,0.0506092724103649,6.05462207973754e-05,3.53956149671414,4.66269359336054,4.6048489856627,4.85275444722488,0.247905461562185,0.00240134473013208,ENSG00000171469,ZNF561,protein_coding,19,-1,9604680,9621236,p13.2,zinc finger protein 561 [Source:HGNC Symbol;Acc:HGNC:28684],NA,ZNF561,93134,NM_001330365;NM_152289
HDAC10_SIG,HDAC10,HDAC10_SIG,HDAC10,SIG,26,4.33995834921671,0.290455333359237,0.281991023563249,0.318266636974623,0.036275613411374,6.07040138564717e-05,3.90814768687232,1.91991733146389,1.87035982822009,2.0827491278364,0.212389299616311,0.000760468415939314,ENSG00000100429,HDAC10,protein_coding,22,-1,50245183,50251405,q13.33,histone deacetylase 10 [Source:HGNC Symbol;Acc:HGNC:18128],NA,HDAC10,83933,NM_001159286;NM_032019
GNG4_SIG,GNG4,GNG4_SIG,GNG4,SIG,18,4.33805398449004,-0.0306251959935884,-0.036557063642652,-0.0111347737180936,0.0254222899245585,6.12007971655852e-05,2.4961178501195,0.439831256149313,0.391682628622257,0.598033889452498,0.206351260830241,0.0356291474077157,ENSG00000168243,GNG4,protein_coding,1,-1,235547685,235650754,q42.3,G protein subunit gamma 4 [Source:HGNC Symbol;Acc:HGNC:4407],NA,GNG4,2786,NM_001098721;NM_001098722;NM_004485
HMGN3_TF,HMGN3,HMGN3_TF,HMGN3,TF,119,4.33749820135922,0.0742028364221476,0.0664077284518075,0.0998153340389794,0.0334076055871719,6.13241970011138e-05,1.15678304036628,5.97056765492976,5.94859251416522,6.04277168887039,0.0941791747051709,0.356372067120714,ENSG00000118418,HMGN3,protein_coding,6,-1,79201245,79234738,q14.1,high mobility group nucleosomal binding domain 3 [Source:HGNC Symbol;Acc:HGNC:12312],NA,HMGN3,9324,NM_001201362;NM_001201363;NM_001318884;NM_001318885;NM_001318886;NM_001318887;NM_001318888;NM_004242;NM_138730
MRPS21_SIG,MRPS21,MRPS21_SIG,MRPS21,SIG,12,4.3366952037007,0.215927116245829,0.204604664304988,0.253129458337167,0.0485247940321791,6.15169651163998e-05,3.76451923206313,5.22930742264525,5.18693472662611,5.36853199527955,0.18159726865344,0.00120063207518308,ENSG00000266472,MRPS21,protein_coding,1,1,150293720,150308979,q21.2,mitochondrial ribosomal protein S21 [Source:HGNC Symbol;Acc:HGNC:14046],NA,MRPS21,54460,NM_018997;NM_031901
ZNF771_TF,ZNF771,ZNF771_TF,ZNF771,TF,131,4.33475082433329,0.178078997391804,0.164293582315402,0.22337393264284,0.0590803503274385,6.20306433311506e-05,4.31350681356232,1.15967203358596,1.10387486040465,1.34300560261028,0.239130742205627,0.000194878787971437,ENSG00000179965,ZNF771,protein_coding,16,1,30407297,30431108,p11.2,zinc finger protein 771 [Source:HGNC Symbol;Acc:HGNC:29653],NA,ZNF771,51333,NM_001142305;NM_016643
ZDHHC20_TF,ZDHHC20,ZDHHC20_TF,ZDHHC20,TF,89,-4.33464053156888,0.186608818479487,0.193498287274563,0.163971992438525,-0.0295262948360378,6.20306433311506e-05,-2.56520932118236,5.33606249032825,5.37571836707533,5.20576460958785,-0.169953757487474,0.030482909905573,ENSG00000180776,ZDHHC20,protein_coding,13,-1,21372573,21459370,q12.11,zinc finger DHHC-type containing 20 [Source:HGNC Symbol;Acc:HGNC:20749],NA,ZDHHC20,253832,NM_001286638;NM_001330059;NM_153251
ZMIZ1_TF,ZMIZ1,ZMIZ1_TF,ZMIZ1,TF,97,4.33276968743179,0.139932002996793,0.131918523918756,0.166262005681772,0.0343434817630153,6.25282341466758e-05,2.47611585242718,8.23552786828311,8.18775530091177,8.39249487536036,0.204739574448586,0.0372083060195345,ENSG00000108175,ZMIZ1,protein_coding,10,1,79068966,79316528,q22.3,zinc finger MIZ-type containing 1 [Source:HGNC Symbol;Acc:HGNC:16493],NA,ZMIZ1,57178,NM_020338
TRMT12_SIG,TRMT12,TRMT12_SIG,TRMT12,SIG,29,4.33216676247507,0.158649678569849,0.144189331241629,0.206162248362571,0.0619729171209424,6.26426801313454e-05,3.14590844127565,3.54724084828777,3.49216327761527,3.72821000906887,0.236046731453603,0.00734777276516965,ENSG00000183665,TRMT12,protein_coding,8,1,124450820,124462150,q24.13,tRNA methyltransferase 12 homolog [Source:HGNC Symbol;Acc:HGNC:26091],NA,TRMT12,55039,NM_017956
CD160_SIG,CD160,CD160_SIG,CD160,SIG,11,-4.33208835939939,-0.260840547665204,-0.236337998461331,-0.341348923620784,-0.105010925159452,6.26426801313454e-05,-3.53537908716371,0.916513307367065,0.995071729137088,0.658392778694135,-0.336678950442953,0.00243111386134321,ENSG00000117281,CD160,protein_coding,1,1,145719471,145739288,q21.1,CD160 molecule [Source:HGNC Symbol;Acc:HGNC:17013],NA,CD160,11126,NM_007053
PRSS33_SIG,PRSS33,PRSS33_SIG,PRSS33,SIG,6,-4.33202902838622,-0.0751007233011432,-0.0664491482891223,-0.103527326912069,-0.0370781786229467,6.26426801313454e-05,-3.22168764671774,0.334331001229563,0.381993215245428,0.177726583748866,-0.204266631496562,0.00598334951776969,ENSG00000103355,PRSS33,protein_coding,16,-1,2783953,2787948,p13.3,serine protease 33 [Source:HGNC Symbol;Acc:HGNC:30405],NA,PRSS33,260429,NM_152891
ZNF165_TF,ZNF165,ZNF165_TF,ZNF165,TF,56,4.33179900441145,-0.19600067476642,-0.207586553200455,-0.157932788483161,0.0496537647172936,6.2653294541082e-05,3.27734321807769,1.45836685143835,1.39817924316722,1.65612613575779,0.257946892590569,0.00511991168223725,ENSG00000197279,ZNF165,protein_coding,6,1,28080568,28089563,p22.1,zinc finger protein 165 [Source:HGNC Symbol;Acc:HGNC:12953],NA,ZNF165,7718,NM_003447
ZFPL1_TF,ZFPL1,ZFPL1_TF,ZFPL1,TF,97,4.33176654492526,0.0771555261853202,0.0676523952062921,0.108380099402127,0.0407277041958349,6.2653294541082e-05,1.65865757653144,4.83276725084523,4.81999497749856,4.87473329184145,0.0547383143428971,0.174125966180138,ENSG00000162300,ZFPL1,protein_coding,11,1,65084210,65088398,q13.1,zinc finger protein like 1 [Source:HGNC Symbol;Acc:HGNC:12868],NA,ZFPL1,7542,NM_006782
ZMAT1_TF,ZMAT1,ZMAT1_TF,ZMAT1,TF,154,4.33149902836461,0.0837671720888562,0.0746772584956789,0.113634031037867,0.0389567725421884,6.26861781526074e-05,2.27863439991777,5.14590594197948,5.08853193300622,5.33442054289163,0.245888609885411,0.0564181502400136,ENSG00000166432,ZMAT1,protein_coding,X,-1,101882288,101932079,q22.1,zinc finger matrin-type 1 [Source:HGNC Symbol;Acc:HGNC:29377],NA,ZMAT1,84460,NM_001011657;NM_001282400;NM_001282401
HIF1AN_SIG,HIF1AN,HIF1AN_SIG,HIF1AN,SIG,41,4.3314260643736,0.296107958520794,0.2863965607853,0.328016836794563,0.0416202760092636,6.26861781526074e-05,2.2453843795076,6.44753639684891,6.42120588611217,6.53405093212674,0.112845046014571,0.0605125897656192,ENSG00000166135,HIF1AN,protein_coding,10,1,100529072,100559998,q24.31,hypoxia inducible factor 1 subunit alpha inhibitor [Source:HGNC Symbol;Acc:HGNC:17113],NA,HIF1AN,55662,NM_017902
ZNF35_TF,ZNF35,ZNF35_TF,ZNF35,TF,37,4.32793738723774,0.171813762466613,0.164138008659871,0.19703409640305,0.0328960877431789,6.36236392489507e-05,2.87361268466922,2.91977305579753,2.87061801324867,3.08128248131523,0.210664468066561,0.014813615919802,ENSG00000169981,ZNF35,protein_coding,3,1,44648732,44660791,p21.31,zinc finger protein 35 [Source:HGNC Symbol;Acc:HGNC:13099],NA,ZNF35,7584,NM_003420
TYROBP_SIG,TYROBP,TYROBP_SIG,TYROBP,SIG,33,-4.32793219050804,0.316590703357046,0.334579419346909,0.257484922247497,-0.0770944970994116,6.36236392489507e-05,-3.44184624264822,7.28690871231172,7.3874561844248,6.95653844679731,-0.430917737627481,0.00318394593590502,ENSG00000011600,TYROBP,protein_coding,19,-1,35904401,35908295,q13.12,TYRO protein tyrosine kinase binding protein [Source:HGNC Symbol;Acc:HGNC:12449],Nasu-Hakola disease;POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSINGLEUKOENCEPHALOPATHY 1,TYROBP,7305,NM_001173514;NM_001173515;NM_003332;NM_198125
CDC16_SIG,CDC16,CDC16_SIG,CDC16,SIG,36,4.32574586923906,0.260833323970835,0.246764642983457,0.30705899007222,0.0602943470887627,6.42042563704489e-05,3.20201377720242,5.78933848408609,5.73924983512495,5.95391547352984,0.21466563840489,0.00631269221070231,ENSG00000130177,CDC16,protein_coding,13,1,114234887,114272723,q34,cell division cycle 16 [Source:HGNC Symbol;Acc:HGNC:1720],NA,CDC16,8881,NM_001078645;NM_001318517;NM_001318518;NM_001330101;NM_001330104;NM_001330105;NM_003903
RASSF2_SIG,RASSF2,RASSF2_SIG,RASSF2,SIG,43,-4.32570562738419,0.339554298050729,0.3556614414356,0.28663082692901,-0.0690306145065893,6.42042563704489e-05,-2.32794005786336,8.06415281272659,8.11597924858363,7.89386595205347,-0.222113296530164,0.0510043069055233,ENSG00000101265,RASSF2,protein_coding,20,-1,4780023,4823608,p13,Ras association domain family member 2 [Source:HGNC Symbol;Acc:HGNC:9883],NA,RASSF2,9770,NM_014737;NM_170774
DHX30_SIG,DHX30,DHX30_SIG,DHX30,SIG,24,4.32501496133396,0.392752700749075,0.386060115011526,0.414742625315305,0.0286825103037787,6.43729349843729e-05,3.03789725334679,6.14779864059156,6.11423434198259,6.25808133602101,0.143846994038422,0.00974664372998166,ENSG00000132153,DHX30,protein_coding,3,1,47802909,47850195,p21.31,DExH-box helicase 30 [Source:HGNC Symbol;Acc:HGNC:16716],Neurodevelopmental disorder;NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE,DHX30,22907,NM_001330990;NM_014966;NM_138615
AOC2_SIG,AOC2,AOC2_SIG,AOC2,SIG,30,-4.32454071131128,-0.0949071049677985,-0.0847970036836698,-0.128126009187078,-0.0433290055034088,6.44787195216633e-05,-2.41282485794521,1.30352686807853,1.35109062366026,1.14724595688142,-0.203844666778835,0.0426695651826059,ENSG00000131480,AOC2,protein_coding,17,1,42844580,42850707,q21.31,amine oxidase, copper containing 2 [Source:HGNC Symbol;Acc:HGNC:549],NA,AOC2,314,NM_001158;NM_009590
FCER2_SIG,FCER2,FCER2_SIG,FCER2,SIG,12,-4.32411381583236,-0.0131634117929429,0.0101730035985515,-0.0898402052221391,-0.100013208820691,6.45708110588286e-05,-3.2769157185277,2.52374937849117,2.67127568806811,2.03902007559551,-0.632255612472607,0.00512413409592109,ENSG00000104921,FCER2,protein_coding,19,-1,7688758,7702146,p13.2,Fc fragment of IgE receptor II [Source:HGNC Symbol;Acc:HGNC:3612],NA,FCER2,2208,NM_001207019;NM_001220500;NM_002002
ZNF337_TF,ZNF337,ZNF337_TF,ZNF337,TF,130,4.32385401219128,0.20278894627646,0.193143083916536,0.234482494030497,0.0413394101139613,6.46140573422672e-05,2.9566767010955,5.02391371899621,4.97602671568102,5.18125672988896,0.205230014207942,0.0120408834253822,ENSG00000130684,ZNF337,protein_coding,20,-1,25673195,25696853,p11.21,zinc finger protein 337 [Source:HGNC Symbol;Acc:HGNC:15809],NA,ZNF337,26152,NM_001290261;NM_015655
UCN_SIG,UCN,UCN_SIG,UCN,SIG,23,4.32176446207339,0.130759492835579,0.120881281769898,0.16321647205139,0.042335190281492,6.51959907587476e-05,2.86885395945406,1.64842901742695,1.6028832926171,1.79807925608786,0.195195963470762,0.0149808524905714,ENSG00000163794,UCN,protein_coding,2,-1,27307400,27308445,p23.3,urocortin [Source:HGNC Symbol;Acc:HGNC:12516],NA,UCN,7349,NM_003353
IL27_SIG,IL27,IL27_SIG,IL27,SIG,3,-4.32084394095586,0.176903548096546,0.200203847554429,0.100345421306359,-0.09985842624807,6.54248149725542e-05,-1.23711931130812,0.23349456754759,0.24413898516037,0.198520052534171,-0.0456189326261996,0.320749527198908,ENSG00000197272,IL27,protein_coding,16,-1,28499362,28512051,p11.2,interleukin 27 [Source:HGNC Symbol;Acc:HGNC:19157],NA,IL27,246778,NM_145659
ALPL_SIG,ALPL,ALPL_SIG,ALPL,SIG,12,-4.32076729595311,-0.112569945271805,-0.0843557136500794,-0.205273849171761,-0.120918135521682,6.54248149725542e-05,-3.42978958497704,2.77551664744836,2.97297294522856,2.1267316690277,-0.846241276200863,0.00329700715233951,ENSG00000162551,ALPL,protein_coding,1,1,21509397,21578410,p36.12,alkaline phosphatase, biomineralization associated [Source:HGNC Symbol;Acc:HGNC:438],Adult hypophosphatasia;Childhood-onset hypophosphatasia;Hypophosphatasia;HYPOPHOSPHATASIA ADULT;HYPOPHOSPHATASIA CHILDHOOD;HYPOPHOSPHATASIA INFANTILE;Infantile hypophosphatasia;ODONTOHYPOPHOSPHATASIA;Perinatal lethal hypophosphatasia;Prenatal benign hypophosphatasia,ALPL,249,NM_000478;NM_001127501;NM_001177520
LRRN3_SIG,LRRN3,LRRN3_SIG,LRRN3,SIG,12,-4.32058998238749,-0.0857586233171452,-0.0712329894125056,-0.133485706146676,-0.0622527167341702,6.54441754166509e-05,-2.55012058671325,0.394781023704959,0.431286757959241,0.274833611155173,-0.156453146804068,0.0316054174739876,ENSG00000173114,LRRN3,protein_coding,7,1,111091006,111125454,q31.1,leucine rich repeat neuronal 3 [Source:HGNC Symbol;Acc:HGNC:17200],NA,LRRN3,54674,NM_001099658;NM_001099660;NM_018334
AMMECR1L_SIG,AMMECR1L,AMMECR1L_SIG,AMMECR1L,SIG,35,4.31928967500579,0.20105254963354,0.193151122072028,0.22701438304994,0.0338632609779118,6.57975317226943e-05,2.61706253575131,5.21720588211226,5.18629200609096,5.31878004618221,0.132488040091247,0.0270632764611022,ENSG00000144233,AMMECR1L,protein_coding,2,-1,127861630,127885922,q14.3,AMMECR1 like [Source:HGNC Symbol;Acc:HGNC:28658],NA,AMMECR1L,83607,NM_001199140;NM_031445
MAML3_TF,MAML3,MAML3_TF,MAML3,TF,77,4.31805460096383,0.200952299871933,0.194197025941454,0.223148199929222,0.0289511739877675,6.613316158407e-05,1.96026193175969,5.76492389937181,5.72795573378742,5.88639072914907,0.158434995361647,0.104396604381683,ENSG00000196782,MAML3,protein_coding,4,-1,139716753,140154184,q31.1,mastermind like transcriptional coactivator 3 [Source:HGNC Symbol;Acc:HGNC:16272],NA,MAML3,55534,NM_018717
ITPA_SIG,ITPA,ITPA_SIG,ITPA,SIG,42,4.31774786212635,0.229235670423223,0.217201763777765,0.268775649401155,0.0515738856233897,6.61915439256132e-05,4.7628624756583,4.48953176776498,4.41039506821728,4.74955235199313,0.339157283775846,3.68297017457113e-05,ENSG00000125877,ITPA,protein_coding,20,1,3208868,3223870,p13,inosine triphosphatase [Source:HGNC Symbol;Acc:HGNC:6176],EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 35;INOSINE TRIPHOSPHATASE DEFICIENCY;ITPA-related encephalopathy;Susceptibility to adverse reaction due to mercaptopurine,ITPA,3704,NM_001267623;NM_001324236;NM_001324237;NM_001324238;NM_001324240;NM_001351739;NM_033453;NM_181493
THBS1_SIG,THBS1,THBS1_SIG,THBS1,SIG,30,-4.31735221147829,0.0631840247806353,0.0781836308693665,0.0138996047748043,-0.064284026094562,6.62766721172021e-05,-1.60885784283066,5.18104070540674,5.30208131488784,4.78333584568315,-0.518745469204689,0.188105007729117,ENSG00000137801,THBS1,protein_coding,15,1,39581079,39599466,q14,thrombospondin 1 [Source:HGNC Symbol;Acc:HGNC:11785],NA,THBS1,7057,NM_003246
ABTB1_SIG,ABTB1,ABTB1_SIG,ABTB1,SIG,44,-4.31430677961198,0.236975451883621,0.247214115711764,0.203334127876866,-0.0438799878348976,6.71628210603964e-05,-3.6984244139144,6.30568931658821,6.38439637116447,6.0470804229805,-0.337315948183968,0.00147845505461039,ENSG00000114626,ABTB1,protein_coding,3,1,127672935,127680926,q21.3,ankyrin repeat and BTB domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18275],NA,ABTB1,80325,NM_032548;NM_172027
PPM1K_SIG,PPM1K,PPM1K_SIG,PPM1K,SIG,137,4.31359834798273,0.0761099610210518,0.0653803566560789,0.111364375363106,0.0459840187070267,6.73444041186793e-05,3.44505207310165,4.76640884564377,4.68353713024365,5.03870162481561,0.355164494571959,0.00315938240431546,ENSG00000163644,PPM1K,protein_coding,4,-1,88257620,88284769,q22.1,protein phosphatase, Mg2+/Mn2+ dependent 1K [Source:HGNC Symbol;Acc:HGNC:25415],Intermediate maple syrup urine disease;MAPLE SYRUP URINE DISEASE MILD VARIANT,PPM1K,152926,NM_152542
GCM1_TF,GCM1,GCM1_TF,GCM1,TF,82,-4.31255533994247,-0.015970784274205,-0.00522581983522719,-0.0512756674308465,-0.0460498475956192,6.76287626642705e-05,-2.23421293018403,0.201499860990237,0.220803016870584,0.138075205954811,-0.082727810915773,0.0618954654417373,ENSG00000137270,GCM1,protein_coding,6,-1,53126961,53148841,p12.1,glial cells missing transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:4197],NA,GCM1,8521,NM_003643
SNRNP200_SIG,SNRNP200,SNRNP200_SIG,SNRNP200,SIG,55,4.31192078020012,0.421181621491853,0.412796275982932,0.448733471021163,0.0359371950382304,6.77889021469434e-05,2.36879924950216,8.58285617449739,8.55856897573876,8.66265697041859,0.10408799467983,0.046849944073217,ENSG00000144028,SNRNP200,protein_coding,2,-1,96274338,96321271,q11.2,small nuclear ribonucleoprotein U5 subunit 200 [Source:HGNC Symbol;Acc:HGNC:30859],Retinitis pigmentosa;RETINITIS PIGMENTOSA 33,SNRNP200,23020,NM_014014
NOP10_SIG,NOP10,NOP10_SIG,NOP10,SIG,29,-4.31096055930989,-0.0778479083114211,-0.0709468983442887,-0.100522655346285,-0.0295757570019958,6.80495734780147e-05,-3.17423937073718,5.41836919667239,5.45608600313646,5.29444254686186,-0.161643456274602,0.00680586218844033,ENSG00000182117,NOP10,protein_coding,15,-1,34341713,34343177,q14,NOP10 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:14378],Dyskeratosis congenita;Dyskeratosis congenita autosomal recessive 1;NOP10-RELATED DYSKERATOSIS CONGENITA,NOP10,55505,NM_018648
ITK_SIG,ITK,ITK_SIG,ITK,SIG,59,-4.31059351577757,-0.101872619310716,-0.0725717913054623,-0.198146768470836,-0.125574977165374,6.80957949827996e-05,-3.96481165305965,3.61459110800608,3.76861876791487,3.10850022544862,-0.660118542466249,0.0006351785162462,ENSG00000113263,ITK,protein_coding,5,1,157142933,157255191,q33.3,IL2 inducible T cell kinase [Source:HGNC Symbol;Acc:HGNC:6171],Autosomal recessive lymphoproliferative disease;LYMPHOPROLIFERATIVE SYNDROME 1,ITK,3702,NM_005546
WWP2_SIG,WWP2,WWP2_SIG,WWP2,SIG,13,-4.31058708641713,0.655750049756359,0.667312420437648,0.617759403232124,-0.0495530172055242,6.80957949827996e-05,-2.71456075101718,6.38934400489393,6.41943524887283,6.29047277467754,-0.128962474195284,0.021656879619443,ENSG00000198373,WWP2,protein_coding,16,1,69762306,69941741,q22.1,WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:16804],NA,WWP2,11060,NM_001270453;NM_001270454;NM_001270455;NM_007014;NM_199424
RPP14_SIG,RPP14,RPP14_SIG,RPP14,SIG,53,4.30886823480345,0.305228483261354,0.29845538236671,0.327482957629468,0.0290275752627578,6.85924801987218e-05,4.15706402999785,4.49957991408245,4.45372025166459,4.65026166202686,0.19654141036227,0.000333909790729604,ENSG00000163684,RPP14,protein_coding,3,1,58306247,58324695,p14.3,ribonuclease P/MRP subunit p14 [Source:HGNC Symbol;Acc:HGNC:30327],NA,RPP14,11102,NM_001098783;NM_007042
TRIP6_SIG,TRIP6,TRIP6_SIG,TRIP6,SIG,36,-4.30842049639457,-0.0847424098442594,-0.0784115282041139,-0.105543878090452,-0.0271323498863378,6.86967964203207e-05,-1.92359060440468,3.74522640009851,3.80196867549697,3.55878749521785,-0.243181180279116,0.111582217130009,ENSG00000087077,TRIP6,protein_coding,7,1,100867387,100873454,q22.1,thyroid hormone receptor interactor 6 [Source:HGNC Symbol;Acc:HGNC:12311],NA,TRIP6,7205,NM_003302
RBM19_SIG,RBM19,RBM19_SIG,RBM19,SIG,18,4.30753717430023,0.476733872189586,0.468136845578178,0.504981245341356,0.0368443997631789,6.89368615776324e-05,3.07277967820724,5.66546138706602,5.63174938214124,5.77622940324743,0.144480021106182,0.00891597349458472,ENSG00000122965,RBM19,protein_coding,12,-1,113816738,113966325,q24.21,RNA binding motif protein 19 [Source:HGNC Symbol;Acc:HGNC:29098],NA,RBM19,9904,NM_001146698;NM_001146699;NM_016196
RBM18_SIG,RBM18,RBM18_SIG,RBM18,SIG,30,4.30681812183993,0.291140219899934,0.287061101769986,0.304543036612622,0.0174819348426366,6.91263995470732e-05,3.50894406697789,5.18454293299508,5.15080450325105,5.29539777358262,0.144593270331574,0.0026350671100106,ENSG00000119446,RBM18,protein_coding,9,-1,122237622,122264840,q33.2,RNA binding motif protein 18 [Source:HGNC Symbol;Acc:HGNC:28413],NA,RBM18,92400,NM_033117
SLC25A37_SIG,SLC25A37,SLC25A37_SIG,SLC25A37,SIG,38,-4.30646762420528,0.0730744019351636,0.0861795129088007,0.0300147515932134,-0.0561647613155873,6.92011070549072e-05,-4.91794040381988,7.05069833033255,7.18387884931546,6.61310519653159,-0.570773652783864,1.97753787365442e-05,ENSG00000147454,SLC25A37,protein_coding,8,1,23528956,23575463,p21.2,solute carrier family 25 member 37 [Source:HGNC Symbol;Acc:HGNC:29786],NA,SLC25A37,51312,NM_001317812;NM_001317813;NM_001317814;NM_016612
AARSD1_SIG,AARSD1,AARSD1_SIG,AARSD1,SIG,63,4.30590184510802,0.227367597185321,0.219383708284041,0.253600375003811,0.0342166667197698,6.93056677410498e-05,3.04385809479995,1.56102779206649,1.52080758986211,1.69317988502374,0.172372295161636,0.00960101359505149,ENSG00000266967,AARSD1,protein_coding,17,-1,42950526,42964498,q21.31,alanyl-tRNA synthetase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28417],NA,AARSD1,80755,NM_001261434
SCYL2_SIG,SCYL2,SCYL2_SIG,SCYL2,SIG,20,4.30589495378689,0.159712376359813,0.155897606309023,0.172246620812408,0.0163490145033841,6.93056677410498e-05,2.46662061578197,6.42163611835639,6.39765818216114,6.50042076585507,0.10276258369393,0.0379674265080731,ENSG00000136021,SCYL2,protein_coding,12,1,100267140,100341724,q23.1,SCY1 like pseudokinase 2 [Source:HGNC Symbol;Acc:HGNC:19286],NA,SCYL2,55681,NM_001317784;NM_001330253;NM_001330254;NM_001330256;NM_017988
ZNF320_TF,ZNF320,ZNF320_TF,ZNF320,TF,78,4.30579938650969,0.187755830103567,0.172140580818445,0.239063077754683,0.0669224969362373,6.93056677410498e-05,3.0018141087065,4.13819554003514,4.05981967870081,4.39571622727651,0.3358965485757,0.010703637443929,ENSG00000182986,ZNF320,protein_coding,19,-1,52863790,52897693,q13.41,zinc finger protein 320 [Source:HGNC Symbol;Acc:HGNC:13842],NA,ZNF320,162967,NM_001351774;NM_001351775;NM_001351776;NM_001351777
P2RY14_SIG,P2RY14,P2RY14_SIG,P2RY14,SIG,45,4.30510345710662,-0.0123742592199417,-0.0184406285791642,0.00755809724607504,0.0259987258252391,6.94889658267485e-05,4.79149322182797,1.88806336307862,1.70908381132147,2.47613903313781,0.767055221816344,3.29315536173367e-05,ENSG00000174944,P2RY14,protein_coding,3,-1,151212117,151278542,q25.1,purinergic receptor P2Y14 [Source:HGNC Symbol;Acc:HGNC:16442],NA,P2RY14,9934,NM_001081455;NM_014879
FBXL19_SIG,FBXL19,FBXL19_SIG,FBXL19,SIG,26,4.30458094361109,0.354866747809724,0.342863568077792,0.394305766928928,0.0514421988511368,6.95608219779142e-05,3.33887707900832,5.28279417366469,5.22096595659635,5.48594402974639,0.264978073150034,0.00430910203368165,ENSG00000099364,FBXL19,protein_coding,16,1,30923055,30948783,p11.2,F-box and leucine rich repeat protein 19 [Source:HGNC Symbol;Acc:HGNC:25300],NA,FBXL19,54620,NM_001099784;NM_001282351
ENO3_SIG,ENO3,ENO3_SIG,ENO3,SIG,22,4.30454588460254,0.070450877482817,0.0650741108355286,0.0881173964667644,0.0230432856312358,6.95608219779142e-05,2.51355765766187,3.18252109834958,3.14235810109059,3.31448523220053,0.172127131109943,0.0342489408106556,ENSG00000108515,ENO3,protein_coding,17,1,4948092,4957131,p13.2,enolase 3 [Source:HGNC Symbol;Acc:HGNC:3354],Glycogen storage disease due to muscle beta-enolase deficiency;GLYCOGEN STORAGE DISEASE XIII,ENO3,2027,NM_001193503;NM_001976;NM_053013
ZNF708_TF,ZNF708,ZNF708_TF,ZNF708,TF,55,4.30454115030565,0.191091705770749,0.181053027388336,0.224075934741534,0.043022907353199,6.95608219779142e-05,3.80476154605889,4.44002642556633,4.37483247408351,4.65423512329559,0.279402649212077,0.00105966115520211,ENSG00000182141,ZNF708,protein_coding,19,-1,21291160,21329425,p12,zinc finger protein 708 [Source:HGNC Symbol;Acc:HGNC:12945],NA,ZNF708,7562,NM_001297560;NM_001297561;NM_021269
SLC30A9_SIG,SLC30A9,SLC30A9_SIG,SLC30A9,SIG,17,4.30416604223722,0.475686947156232,0.465516067389814,0.509105552103036,0.0435894847132219,6.9643826940988e-05,2.38691066480554,6.06119578770729,6.0323848059766,6.15586044196526,0.123475635988658,0.0450760659342474,ENSG00000014824,SLC30A9,protein_coding,4,1,41990502,42090461,p13,solute carrier family 30 member 9 [Source:HGNC Symbol;Acc:HGNC:1329],Birk-Landau-Perez syndrome;Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,SLC30A9,10463,NM_006345
IRAK2_SIG,IRAK2,IRAK2_SIG,IRAK2,SIG,11,-4.30388981096142,0.15094248236765,0.166042713376073,0.101327437625688,-0.0647152757503853,6.96958107006836e-05,-2.8568718722321,2.90620069208348,3.00716874872551,2.57444850597396,-0.432720242751555,0.0154328667562317,ENSG00000134070,IRAK2,protein_coding,3,1,10164919,10243745,p25.3,interleukin 1 receptor associated kinase 2 [Source:HGNC Symbol;Acc:HGNC:6113],NA,IRAK2,3656,NM_001570
FFAR2_SIG,FFAR2,FFAR2_SIG,FFAR2,SIG,29,-4.30370474360318,-0.0295468833112131,-0.00106090927594399,-0.123143655141383,-0.122082745865439,6.97018620662044e-05,-3.75766122215122,2.35224955727153,2.51651607709523,1.81251670642224,-0.703999370672984,0.00122859094426791,ENSG00000126262,FFAR2,protein_coding,19,1,35443907,35451767,q13.12,free fatty acid receptor 2 [Source:HGNC Symbol;Acc:HGNC:4501],NA,FFAR2,2867,NM_005306
CCNB1IP1_SIG,CCNB1IP1,CCNB1IP1_SIG,CCNB1IP1,SIG,63,4.3036487058944,0.498254321821475,0.485046445424407,0.541651629983273,0.056605184558866,6.97018620662044e-05,3.05789879881009,5.59273195620066,5.52558076621253,5.81337158044739,0.287790814234855,0.0092651062871341,ENSG00000100814,CCNB1IP1,protein_coding,14,-1,20311368,20333312,q11.2,cyclin B1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:19437],NA,CCNB1IP1,57820,NM_021178;NM_182849;NM_182852
NAGLU_SIG,NAGLU,NAGLU_SIG,NAGLU,SIG,10,4.30317838525215,0.333557382525078,0.326494262556265,0.356764776708319,0.0302705141520539,6.97808695637184e-05,5.08394178882118,4.32444558096683,4.26670606389568,4.51416113705776,0.247455073162072,1.00385390922976e-05,ENSG00000108784,NAGLU,protein_coding,17,1,42536241,42544449,q21.2,N-acetyl-alpha-glucosaminidase [Source:HGNC Symbol;Acc:HGNC:7632],Autosomal dominant Charcot-Marie-Tooth disease type 2V;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2V;MUCOPOLYSACCHARIDOSIS TYPE 3B;MUCOPOLYSACCHARIDOSIS TYPE IIIB;Sanfilippo syndrome type B,NAGLU,4669,NM_000263
ITGA2_SIG,ITGA2,ITGA2_SIG,ITGA2,SIG,44,4.30317615576742,-0.0671678122566046,-0.0748824136010318,-0.0418198364106294,0.0330625771904024,6.97808695637184e-05,2.53018366977904,1.32597061053013,1.24289892062992,1.59892044877368,0.356021528143765,0.0330853051601051,ENSG00000164171,ITGA2,protein_coding,5,1,52989340,53094779,q11.2,integrin subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:6137],BLEEDING DISORDER PLATELET-TYPE 9;Fetal and neonatal alloimmune thrombocytopenia,ITGA2,3673,NM_002203
ZNF839_TF,ZNF839,ZNF839_TF,ZNF839,TF,121,4.30250704242159,0.0380882073915342,0.0298671895940011,0.0651001230119999,0.0352329334179987,6.9957007858118e-05,3.10147225550452,4.36043017388935,4.32553559230988,4.47508379907901,0.149548206769128,0.00827066700226995,ENSG00000022976,ZNF839,protein_coding,14,1,102317377,102342702,q32.31,zinc finger protein 839 [Source:HGNC Symbol;Acc:HGNC:20345],NA,ZNF839,55778,NM_001267827;NM_001267828;NM_018335
GJB2_SIG,GJB2,GJB2_SIG,GJB2,SIG,11,-4.30176542466419,-0.154946879555182,-0.144975448287233,-0.1877101537213,-0.0427347054340675,7.01565360966404e-05,-2.09603394608727,0.254938874195044,0.286949319137962,0.149761697954027,-0.137187621183934,0.0809371540108662,ENSG00000165474,GJB2,protein_coding,13,-1,20187463,20192938,q12.11,gap junction protein beta 2 [Source:HGNC Symbol;Acc:HGNC:4284],Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB;Bart-Pumphrey syndrome;DEAFNESS AUTOSOMAL DOMINANT 3A;DEAFNESS AUTOSOMAL RECESSIVE 1A;Deafness autosomal recessive type 1A;DEAFNESS X-LINKED 2;ICHTHYOSIS HYSTRIX-LIKE WITH DEAFNESS;Ichthyosis hystrix-like with deafness syndrome;KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME AUTOSOMAL DOMINANT;Keratoderma hereditarium mutilans;KERATODERMA PALMOPLANTAR WITH DEAFNESS;KID syndrome;Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome;KNUCKLE PADS LEUKONYCHIA AND SENSORINEURAL DEAFNESS;Palmoplantar keratoderma-deafness syndrome;palmoplantar keratoderma with deafness;Porokeratotic eccrine ostial and dermal duct nevus;VOHWINKEL SYNDROME,GJB2,2706,NM_004004
CAPN10_SIG,CAPN10,CAPN10_SIG,CAPN10,SIG,39,4.30067404678036,0.210332331788924,0.203302332483369,0.233430900935746,0.0301285684523764,7.0467761705002e-05,4.02172812890214,4.90246428719083,4.86079526942746,5.0393767741276,0.178581504700133,0.000529011847069358,ENSG00000142330,CAPN10,protein_coding,2,1,240586734,240617705,q37.3,calpain 10 [Source:HGNC Symbol;Acc:HGNC:1477],Autosomal Recessive Mental Retardation;DIABETES MELLITUS NONINSULIN-DEPENDENT 1,CAPN10,11132,NM_023083;NM_023085
GPAM_SIG,GPAM,GPAM_SIG,GPAM,SIG,67,4.30004001293625,0.270587908268981,0.261901088022684,0.299130317649672,0.0372292296269871,7.06343916443395e-05,2.85328654088685,3.47000377705743,3.41559421085083,3.64877806602197,0.233183855171143,0.0155620972181108,ENSG00000119927,GPAM,protein_coding,10,-1,112149865,112215377,q25.2,glycerol-3-phosphate acyltransferase, mitochondrial [Source:HGNC Symbol;Acc:HGNC:24865],NA,GPAM,57678,NM_001244949;NM_020918
ZNF34_TF,ZNF34,ZNF34_TF,ZNF34,TF,71,4.29906968239289,0.0876778280633129,0.0824129013985903,0.10497687281883,0.0225639714202397,7.09089108620096e-05,1.66868439075081,3.04158854574739,3.02247445758887,3.10439197826822,0.0819175206793475,0.171326900445231,ENSG00000196378,ZNF34,protein_coding,8,-1,144773114,144787345,q24.3,zinc finger protein 34 [Source:HGNC Symbol;Acc:HGNC:13098],NA,ZNF34,80778,NM_001286769;NM_001286770;NM_030580
LARP1B_SIG,LARP1B,LARP1B_SIG,LARP1B,SIG,45,4.29876408288938,0.0917071066516173,0.0809469871952805,0.127061784865295,0.0461147976700149,7.09713227466174e-05,4.26641067952889,4.59189479451623,4.53314338796841,4.78493513031619,0.251791742347772,0.000228074888490141,ENSG00000138709,LARP1B,protein_coding,4,1,128061286,128222931,q28.2,La ribonucleoprotein domain family member 1B [Source:HGNC Symbol;Acc:HGNC:24704],NA,LARP1B,55132,NM_001278604;NM_001350531;NM_018078;NM_032239;NM_178043
SLC12A5_SIG,SLC12A5,SLC12A5_SIG,SLC12A5,SIG,41,4.29862980877922,-0.0457989614753548,-0.051550857468488,-0.0268998746407743,0.0246509828277139,7.09786142806551e-05,3.44729963050986,0.864993074288984,0.796704197447622,1.08937081248203,0.292666615034409,0.00314082377986389,ENSG00000124140,SLC12A5,protein_coding,20,1,46021690,46060152,q13.12,solute carrier family 12 member 5 [Source:HGNC Symbol;Acc:HGNC:13818],EPILEPSY IDIOPATHIC GENERALIZED SUSCEPTIBILITY TO 14;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 34;Febrile seizures;Malignant migrating partial seizures of infancy,SLC12A5,57468,NM_001134771;NM_020708
IL6_SIG,IL6,IL6_SIG,IL6,SIG,41,-4.29852029512062,-0.0688904811087158,-0.0578842847510263,-0.105053697712553,-0.0471694129615263,7.09786142806551e-05,-2.82560614052472,0.801813905509899,0.893657662307512,0.500041561746315,-0.393616100561197,0.016662130238169,ENSG00000136244,IL6,protein_coding,7,1,22725884,22732002,p15.3,interleukin 6 [Source:HGNC Symbol;Acc:HGNC:6018],ARTERIOVENOUS MALFORMATIONS OF THE BRAIN;DIABETES MELLITUS INSULIN-DEPENDENT;INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1;KAPOSI SARCOMA SUSCEPTIBILITY TO;RHEUMATOID ARTHRITIS SYSTEMIC JUVENILE;Systemic-onset juvenile idiopathic arthritis,IL6,3569,NM_000600;NM_001318095
MIB1_SIG,MIB1,MIB1_SIG,MIB1,SIG,48,4.29736739980924,0.535871210384134,0.522078287815093,0.581190813110983,0.0591125252958894,7.13131333366684e-05,2.70418155139382,6.35202363153235,6.29756504019515,6.53095900306885,0.233393962873703,0.0221992454575122,ENSG00000101752,MIB1,protein_coding,18,1,21704957,21870957,q11.2,mindbomb E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:21086],Left ventricular noncompaction;LEFT VENTRICULAR NONCOMPACTION 7,MIB1,57534,NM_020774
ANAPC1_SIG,ANAPC1,ANAPC1_SIG,ANAPC1,SIG,101,4.29655477141599,0.571193710760849,0.555075773319964,0.624152648066614,0.0690768747466502,7.15393134250567e-05,3.40423327666399,5.48545169755311,5.41853485624486,5.70532131899452,0.28678646274966,0.00355856363589815,ENSG00000153107,ANAPC1,protein_coding,2,-1,111611639,111884690,q13,anaphase promoting complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:19988],NA,ANAPC1,64682,NM_022662
HDAC4_SIG,HDAC4,HDAC4_SIG,HDAC4,SIG,41,-4.29623423015185,0.293729851752912,0.309264787741184,0.242686490648592,-0.0665782970925916,7.16071402507405e-05,-3.45021705599889,5.56928787647932,5.64671061007709,5.31489889465807,-0.331811715419018,0.00311322328223302,ENSG00000068024,HDAC4,protein_coding,2,-1,239048168,239401654,q37.3,histone deacetylase 4 [Source:HGNC Symbol;Acc:HGNC:14063],2q37 microdeletion syndrome;BRACHYDACTYLY-MENTAL RETARDATION SYNDROME,HDAC4,9759,NM_006037
ZNF577_TF,ZNF577,ZNF577_TF,ZNF577,TF,15,4.29550304027221,0.190982408627063,0.180622185874949,0.225023140526865,0.044400954651916,7.18078576159296e-05,3.10837028044015,3.60728818509012,3.54555831862655,3.81011488918468,0.264556570558127,0.00814281065178551,ENSG00000161551,ZNF577,protein_coding,19,-1,51804816,51890950,q13.41,zinc finger protein 577 [Source:HGNC Symbol;Acc:HGNC:28673],NA,ZNF577,84765,NM_001135590;NM_032679
SLC30A9_TF,SLC30A9,SLC30A9_TF,SLC30A9,TF,246,4.29511650711647,0.283336059208787,0.274408393721005,0.312669817240071,0.0382614235190658,7.18905561166232e-05,2.38691066480554,6.06119578770729,6.0323848059766,6.15586044196526,0.123475635988658,0.0450760659342474,ENSG00000014824,SLC30A9,protein_coding,4,1,41990502,42090461,p13,solute carrier family 30 member 9 [Source:HGNC Symbol;Acc:HGNC:1329],Birk-Landau-Perez syndrome;Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,SLC30A9,10463,NM_006345
ZNF280B_TF,ZNF280B,ZNF280B_TF,ZNF280B,TF,20,4.29501455191963,0.110189226493364,0.100739508817167,0.141238298858011,0.0404987900408443,7.18905561166232e-05,3.15736235087129,2.0817334373182,2.01948057165998,2.28627856733806,0.266797995678085,0.00710936174437143,ENSG00000275004,ZNF280B,protein_coding,22,-1,22484421,22508742,q11.22,zinc finger protein 280B [Source:HGNC Symbol;Acc:HGNC:23022],NA,ZNF280B,140883,NM_080764
MPI_SIG,MPI,MPI_SIG,MPI,SIG,33,4.29491701219724,0.178951125973129,0.163819762531564,0.228668462995414,0.06484870046385,7.18905561166232e-05,3.17352715183485,4.6308264866316,4.56822351749532,4.83652195665079,0.26829843915547,0.00681321859558363,ENSG00000178802,MPI,protein_coding,15,1,74890005,74902219,q24.1,mannose phosphate isomerase [Source:HGNC Symbol;Acc:HGNC:7216],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ib;Congenital Disorders of Glycosylation;MPI-CDG,MPI,4351,NM_001289155;NM_001289156;NM_001289157;NM_001330372;NM_002435
LTA_SIG,LTA,LTA_SIG,LTA,SIG,14,-4.29462509172818,0.012595057134147,0.0371126141843031,-0.0679626303163658,-0.105075244500669,7.19494865735239e-05,-2.95356008596705,1.10142475717997,1.16456957754119,0.893948918850238,-0.270620658690956,0.0121399745608922,ENSG00000226979,LTA,protein_coding,6,1,31572054,31574324,p21.33,lymphotoxin alpha [Source:HGNC Symbol;Acc:HGNC:6709],LEPROSY SUSCEPTIBILITY TO 4;MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED;PSORIATIC ARTHRITIS SUSCEPTIBILITY TOPSORIATIC ARTHRITIS SUSCEPTIBILITY TO 1 INCLUDED,LTA,4049,NM_000595;NM_001159740
FLT1_SIG,FLT1,FLT1_SIG,FLT1,SIG,10,-4.2939551642665,-0.196563388288592,-0.185000065709226,-0.234557162477938,-0.0495570967687125,7.21296784256177e-05,-4.2183298901627,0.696205489164387,0.788836085688317,0.391847814871474,-0.396988270816844,0.000270351579353884,ENSG00000102755,FLT1,protein_coding,13,-1,28300346,28495145,q12.3,fms related tyrosine kinase 1 [Source:HGNC Symbol;Acc:HGNC:3763],Preeclampsia,FLT1,2321,NM_001159920;NM_001160030;NM_001160031;NM_002019
WDSUB1_SIG,WDSUB1,WDSUB1_SIG,WDSUB1,SIG,15,4.29380887126194,0.334406309248759,0.328054161566642,0.355277651632858,0.0272234900662154,7.21296784256177e-05,2.54715189073431,3.9142315628145,3.88231941776235,4.0190857537001,0.136766335937747,0.0318387502579165,ENSG00000196151,WDSUB1,protein_coding,2,-1,159235793,159286799,q24.2,WD repeat, sterile alpha motif and U-box domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26697],NA,WDSUB1,151525,NM_001128212;NM_001128213;NM_001307994;NM_001330274;NM_001330276;NM_001330277;NM_001330278;NM_001330279;NM_001330280;NM_152528
PROS1_SIG,PROS1,PROS1_SIG,PROS1,SIG,54,-4.29373997966255,-0.117354078611972,-0.109976153597624,-0.141595832230544,-0.03161967863292,7.21296784256177e-05,-2.8441223652783,1.41696865947391,1.51496832833404,1.09496974750493,-0.419998580829106,0.0159233070069732,ENSG00000184500,PROS1,protein_coding,3,-1,93873033,93980003,q11.1,protein S [Source:HGNC Symbol;Acc:HGNC:9456],Severe hereditary thrombophilia due to congenital protein S deficiency;THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY AUTOSOMAL DOMINANT;THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY AUTOSOMAL RECESSIVE,PROS1,5627,NM_000313;NM_001314077
OMG_SIG,OMG,OMG_SIG,OMG,SIG,21,-4.29318086670534,0.0513334443835881,0.0623161183703661,0.0152475155698891,-0.0470686028004771,7.22758169108894e-05,-2.220245090513,0.788914999059364,0.8196500472683,0.687928412087145,-0.131721635181155,0.063722844799677,ENSG00000126861,OMG,protein_coding,17,-1,31272013,31297539,q11.2,oligodendrocyte myelin glycoprotein [Source:HGNC Symbol;Acc:HGNC:8135],NA,OMG,4974,NM_002544
S100A6_SIG,S100A6,S100A6_SIG,S100A6,SIG,33,-4.29145740048188,0.170692578355911,0.186971577986258,0.117204436713341,-0.0697671412729165,7.27803013948231e-05,-3.67702894306325,7.30393578583339,7.40438632076619,6.97388402819707,-0.430502292569114,0.00157624046036347,ENSG00000197956,S100A6,protein_coding,1,-1,153534599,153536244,q21.3,S100 calcium binding protein A6 [Source:HGNC Symbol;Acc:HGNC:10496],NA,S100A6,6277,NM_014624
SIRPA_SIG,SIRPA,SIRPA_SIG,SIRPA,SIG,45,-4.29141707944337,0.341314339944743,0.363679465174584,0.267828928475264,-0.0958505366993207,7.27803013948231e-05,-2.6876245772853,6.60606447750861,6.69524388530217,6.31304642332978,-0.382197461972394,0.0230977087960452,ENSG00000198053,SIRPA,protein_coding,20,1,1894167,1940592,p13,signal regulatory protein alpha [Source:HGNC Symbol;Acc:HGNC:9662],NA,SIRPA,140885,NM_001040022;NM_001040023;NM_001330728;NM_080792
FARS2_SIG,FARS2,FARS2_SIG,FARS2,SIG,31,4.29086892286536,0.330957161734147,0.316018712052978,0.380040639257988,0.0640219272050102,7.29241225354956e-05,4.1609284539765,3.47891637864279,3.40870162925486,3.70962198377456,0.300920354519695,0.000329614427583352,ENSG00000145982,FARS2,protein_coding,6,1,5261044,5829192,p25.1,phenylalanyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:21062],Autosomal recessive spastic paraplegia type 77;Combined oxidative phosphorylation defect type 14;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14;Spastic paraplegia 77 autosomal recessive,FARS2,10667,NM_001318872;NM_006567
PIK3R5_SIG,PIK3R5,PIK3R5_SIG,PIK3R5,SIG,63,-4.29039242128934,0.385029267515808,0.403680964462141,0.323745120406429,-0.0799358440557118,7.30446514773991e-05,-2.14839511662859,6.59211753594625,6.65254802952167,6.39356019991273,-0.258987829608933,0.0733357511901756,ENSG00000141506,PIK3R5,protein_coding,17,-1,8878911,8965712,p13.1,phosphoinositide-3-kinase regulatory subunit 5 [Source:HGNC Symbol;Acc:HGNC:30035],Ataxia-oculomotor apraxia 3;Spinocerebellar ataxia with axonal neuropathy type 2,PIK3R5,23533,NM_001142633;NM_001251851;NM_001251852;NM_001251853;NM_001251855;NM_014308
LPAR3_SIG,LPAR3,LPAR3_SIG,LPAR3,SIG,50,4.29020998768736,-0.015584593280182,-0.0223628100197984,0.00668669029284315,0.0290495003126414,7.30685642841814e-05,0.885626442008659,0.673588110533307,0.648756136276553,0.755178883091215,0.106422746814662,0.489426052718284,ENSG00000171517,LPAR3,protein_coding,1,-1,84811602,84893206,p22.3,lysophosphatidic acid receptor 3 [Source:HGNC Symbol;Acc:HGNC:14298],NA,LPAR3,23566,NM_012152
SIRPG_SIG,SIRPG,SIRPG_SIG,SIRPG,SIG,29,-4.28966406561109,-0.264431424783838,-0.240881164379375,-0.341810851827073,-0.100929687447697,7.32122257396469e-05,-3.54041191442982,1.28973083820635,1.37595528679363,1.0064219357053,-0.369533351088323,0.00239850001531408,ENSG00000089012,SIRPG,protein_coding,20,-1,1629152,1657779,p13,signal regulatory protein gamma [Source:HGNC Symbol;Acc:HGNC:15757],NA,SIRPG,55423,NM_001039508;NM_018556;NM_080816
TRMT2B_SIG,TRMT2B,TRMT2B_SIG,TRMT2B,SIG,24,4.28937560364005,0.32654018119872,0.318983486923842,0.351369319530459,0.0323858326066171,7.32540406105527e-05,1.69477844404436,4.78452773875767,4.76583765823257,4.84593800334017,0.080100345107601,0.164522535128504,ENSG00000188917,TRMT2B,protein_coding,X,-1,101009346,101052116,q22.1,tRNA methyltransferase 2 homolog B [Source:HGNC Symbol;Acc:HGNC:25748],NA,TRMT2B,79979,NM_001167970;NM_001167971;NM_001167972;NM_024917
PCSK6_SIG,PCSK6,PCSK6_SIG,PCSK6,SIG,26,-4.2893179868386,-0.137422737524719,-0.12598175399539,-0.175014540549659,-0.0490327865542689,7.32540406105527e-05,-2.51925653519232,1.40970591313085,1.50176713152564,1.10721905269082,-0.394548078834826,0.0338855164892335,ENSG00000140479,PCSK6,protein_coding,15,-1,101297142,101525202,q26.3,proprotein convertase subtilisin/kexin type 6 [Source:HGNC Symbol;Acc:HGNC:8569],NA,PCSK6,5046,NM_001291309;NM_002570;NM_138319;NM_138322;NM_138323;NM_138324;NM_138325
GMIP_SIG,GMIP,GMIP_SIG,GMIP,SIG,37,-4.28917420381748,0.716773267861699,0.731971150261027,0.666837368549622,-0.065133781711405,7.32653300786973e-05,-2.74477380877215,7.09306135828415,7.13573604473947,6.95284453135955,-0.182891513379921,0.0201433375477305,ENSG00000089639,GMIP,protein_coding,19,-1,19629476,19643657,p13.11,GEM interacting protein [Source:HGNC Symbol;Acc:HGNC:24852],NA,GMIP,51291,NM_001288998;NM_001288999;NM_016573
STAT3_TF,STAT3,STAT3_TF,STAT3,TF,216,-4.28769448156452,0.13558571391341,0.140467219068259,0.119546482690336,-0.0209207363779237,7.371860341565e-05,-2.61817499560188,8.0561250628115,8.09066331975627,7.9426422185644,-0.14802110119187,0.0269860189665183,ENSG00000168610,STAT3,protein_coding,17,-1,42313324,42388568,q21.2,signal transducer and activator of transcription 3 [Source:HGNC Symbol;Acc:HGNC:11364],AUTOIMMUNE DISEASE MULTISYSTEM INFANTILE-ONSET 1;Autosomal dominant hyper IgE syndrome;Chronic lymphoproliferative disorder of natural killer cells;HYPER-IgE RECURRENT INFECTION SYNDROME 1 AUTOSOMAL DOMINANT;Permanent neonatal diabetes mellitus;STAT3-related early-onset multisystem autoimmune disease;T-cell large granular lymphocyte leukemia,STAT3,6774,NM_003150;NM_139276;NM_213662
SERPINB9_SIG,SERPINB9,SERPINB9_SIG,SERPINB9,SIG,87,-4.28543820823407,0.138584583980642,0.14942610336586,0.10296244885778,-0.0464636545080801,7.44341282176935e-05,-2.52127423682986,4.67349945648837,4.77220753339016,4.34917291809676,-0.423034615293403,0.0337420520552452,ENSG00000170542,SERPINB9,protein_coding,6,-1,2887270,2903309,p25.2,serpin family B member 9 [Source:HGNC Symbol;Acc:HGNC:8955],NA,SERPINB9,5272,NM_004155
SEMA4B_SIG,SEMA4B,SEMA4B_SIG,SEMA4B,SIG,29,-4.28431652528588,0.0573314050834987,0.0711446932223671,0.0119448869129312,-0.0591998063094361,7.47737773135227e-05,-4.74384532416454,4.25340558563628,4.37889412372795,3.84108610333509,-0.537808020392853,3.96431774996994e-05,ENSG00000185033,SEMA4B,protein_coding,15,1,90160604,90229679,q26.1,semaphorin 4B [Source:HGNC Symbol;Acc:HGNC:10730],NA,SEMA4B,10509,NM_001324029;NM_001324030;NM_001324031;NM_001324032;NM_001324033;NM_001324034;NM_020210;NM_198925
IGLL1_SIG,IGLL1,IGLL1_SIG,IGLL1,SIG,57,4.28332152462465,0.0128678002323431,0.000222927861609924,0.0544152380218948,0.054192310160285,7.50721302849694e-05,1.79478248670802,3.82309232769457,3.71279706736306,4.18549104021237,0.472693972849309,0.139435877979967,ENSG00000128322,IGLL1,protein_coding,22,-1,23573125,23580302,q11.23,immunoglobulin lambda like polypeptide 1 [Source:HGNC Symbol;Acc:HGNC:5870],AGAMMAGLOBULINEMIA 2 AUTOSOMAL RECESSIVE;Autosomal agammaglobulinemia,IGLL1,3543,NM_020070;NM_152855
TSPO_SIG,TSPO,TSPO_SIG,TSPO,SIG,57,-4.28193850505496,0.233752053917056,0.245202789852248,0.196128207272857,-0.0490745825793906,7.55032014937692e-05,-2.53497697642228,6.4600865931674,6.52584505921744,6.24402306186014,-0.281821997357294,0.0327316896188714,ENSG00000100300,TSPO,protein_coding,22,1,43151547,43163242,q13.2,translocator protein [Source:HGNC Symbol;Acc:HGNC:1158],NA,TSPO,706,NM_000714;NM_001256530;NM_001256531
MAK_SIG,MAK,MAK_SIG,MAK,SIG,5,-4.28086719200445,0.120890068356935,0.13692064827808,0.068218162901745,-0.0687024853763346,7.58303316026771e-05,-2.79800890020845,1.08307273544152,1.13605426299277,0.908990573487382,-0.227063689505392,0.0177835643700203,ENSG00000111837,MAK,protein_coding,6,-1,10762723,10838555,p24.2,male germ cell associated kinase [Source:HGNC Symbol;Acc:HGNC:6816],Retinitis pigmentosa;REtinitis pigmentosa 62,MAK,4117,NM_001242385;NM_001242957;NM_005906
ZDHHC19_SIG,ZDHHC19,ZDHHC19_SIG,ZDHHC19,SIG,13,-4.2805519644536,-0.0959896049322914,-0.0841918330840012,-0.134753712433816,-0.0505618793498153,7.5900512815902e-05,-2.47407398017948,0.706481094873492,0.764699728493311,0.515191298694086,-0.249508429799225,0.0373758008366891,ENSG00000163958,ZDHHC19,protein_coding,3,-1,196197452,196211437,q29,zinc finger DHHC-type containing 19 [Source:HGNC Symbol;Acc:HGNC:20713],NA,ZDHHC19,131540,NM_001039617
ZNF546_TF,ZNF546,ZNF546_TF,ZNF546,TF,83,4.27863748066792,0.161133801332618,0.148236335442925,0.203511189255895,0.0552748538129696,7.65185799718881e-05,2.77416105551452,2.04709623556095,1.99475994710285,2.21905832620897,0.224298379106119,0.0187882844403668,ENSG00000187187,ZNF546,protein_coding,19,1,39984134,40021038,q13.2,zinc finger protein 546 [Source:HGNC Symbol;Acc:HGNC:28671],NA,ZNF546,339327,NM_001297763;NM_178544
TNFRSF10C_SIG,TNFRSF10C,TNFRSF10C_SIG,TNFRSF10C,SIG,34,-4.27841255247491,0.136792745364068,0.162719969628881,0.0516032942082554,-0.111116675420625,7.65583257934919e-05,-4.76293113875256,3.3277280981376,3.53477496086943,2.64743126344731,-0.887343697422123,3.68297017457113e-05,ENSG00000173535,TNFRSF10C,protein_coding,8,1,23102590,23117437,p21.3,TNF receptor superfamily member 10c [Source:HGNC Symbol;Acc:HGNC:11906],NA,TNFRSF10C,8794,NM_003841
ADAM17_SIG,ADAM17,ADAM17_SIG,ADAM17,SIG,49,4.27800938238335,0.210133262906358,0.202734459712924,0.234443616256212,0.0317091565432882,7.66594523885276e-05,3.1042382970677,6.35545760639299,6.30927329490024,6.50720605844061,0.197932763540367,0.00821536046291064,ENSG00000151694,ADAM17,protein_coding,2,-1,9488486,9556732,p25.1,ADAM metallopeptidase domain 17 [Source:HGNC Symbol;Acc:HGNC:195],INFLAMMATORY SKIN AND BOWEL DISEASE NEONATAL 1;Neonatal inflammatory skin and bowel disease,ADAM17,6868,NM_003183
ZBTB12_SIG,ZBTB12,ZBTB12_SIG,ZBTB12,SIG,54,4.27739124258423,0.230235242936419,0.212048055869155,0.289993143300286,0.0779450874311306,7.68348587475898e-05,3.19457174754543,2.75746190297303,2.66114663088425,3.0739263684076,0.412779737523355,0.0064542050040345,ENSG00000204366,ZBTB12,protein_coding,6,-1,31899607,31901992,p21.33,zinc finger and BTB domain containing 12 [Source:HGNC Symbol;Acc:HGNC:19066],NA,ZBTB12,221527,NM_181842
GPI_SIG,GPI,GPI_SIG,GPI,SIG,72,-4.27714233162627,0.370754174625879,0.384242027519668,0.326436943689145,-0.0578050838305236,7.68830831458474e-05,-3.85792245867029,7.88704940749783,7.96738596265998,7.62308644053649,-0.344299522123484,0.000897122343013292,ENSG00000105220,GPI,protein_coding,19,1,34359480,34402413,q13.11,glucose-6-phosphate isomerase [Source:HGNC Symbol;Acc:HGNC:4458],Hemolytic anemia due to glucophosphate isomerase deficiency;HEMOLYTIC ANEMIA NONSPHEROCYTIC DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY,GPI,2821,NM_000175;NM_001184722;NM_001289789;NM_001289790;NM_001329909;NM_001329910;NM_001329911
ZNF470_TF,ZNF470,ZNF470_TF,ZNF470,TF,18,4.27676075457925,0.00221497467840153,-0.0141213408228876,0.0558914398969229,0.0700127807198106,7.6977192833076e-05,3.44123950498924,2.46213783781484,2.38233190809303,2.7243573211865,0.342025413093466,0.00318801730364148,ENSG00000197016,ZNF470,protein_coding,19,1,56567468,56588911,q13.43,zinc finger protein 470 [Source:HGNC Symbol;Acc:HGNC:22220],NA,ZNF470,388566,NM_001001668
IRF6_TF,IRF6,IRF6_TF,IRF6,TF,115,-4.27651487665367,-0.0937972838368107,-0.0873725260858289,-0.114907202161465,-0.0275346760756361,7.70244830657208e-05,-1.45650701715713,0.73100439309574,0.759163358146089,0.638482079358877,-0.120681278787212,0.236380788046172,ENSG00000117595,IRF6,protein_coding,1,-1,209785617,209806175,q32.2,interferon regulatory factor 6 [Source:HGNC Symbol;Acc:HGNC:6121],Autosomal dominant popliteal pterygium syndrome;Cleft lip and alveolus;Cleft lip/palate;Isolated cleft lip;Oligodontia;OROFACIAL CLEFT 6 SUSCEPTIBILITY TO;POPLITEAL PTERYGIUM SYNDROME;Van der Woude syndrome;VAN DER WOUDE SYNDROME 1,IRF6,3664,NM_001206696;NM_006147
LSM11_SIG,LSM11,LSM11_SIG,LSM11,SIG,13,4.27547188091141,0.246565917417181,0.235762570593429,0.282062628409511,0.0463000578160822,7.73481089027869e-05,2.72064309785712,2.98793569824928,2.9409345367446,3.1423680860504,0.201433549305796,0.0213172810631999,ENSG00000155858,LSM11,protein_coding,5,1,157743712,157760709,q33.3,LSM11, U7 small nuclear RNA associated [Source:HGNC Symbol;Acc:HGNC:30860],NA,LSM11,134353,NM_173491
LITAF_SIG,LITAF,LITAF_SIG,LITAF,SIG,27,-4.27439576519398,0.40056372661977,0.415115226311461,0.352751656204214,-0.0623635701072472,7.76845781447623e-05,-2.56903565747884,7.52660262035359,7.58730132259082,7.32716402728843,-0.26013729530239,0.0302109494651599,ENSG00000189067,LITAF,protein_coding,16,-1,11547722,11636381,p13.13,lipopolysaccharide induced TNF factor [Source:HGNC Symbol;Acc:HGNC:16841],CHARCOT-MARIE-TOOTH DISEASE DEMYELINATING TYPE 1C;Charcot-Marie-Tooth disease type 1C,LITAF,9516,NM_001136472;NM_001136473;NM_004862
RBM11_SIG,RBM11,RBM11_SIG,RBM11,SIG,37,-4.27425977814131,-0.0956965731909745,-0.0860237134869577,-0.127478826504173,-0.041455113017215,7.76939911117402e-05,-2.07539625692739,0.53539372405474,0.568606958826726,0.426264524089643,-0.142342434737083,0.0841744511892112,ENSG00000185272,RBM11,protein_coding,21,1,14216130,14228372,q11.2,RNA binding motif protein 11 [Source:HGNC Symbol;Acc:HGNC:9897],NA,RBM11,54033,NM_001320602;NM_144770
PIF1_SIG,PIF1,PIF1_SIG,PIF1,SIG,14,-4.27325954699545,-0.136537668051904,-0.113825238760163,-0.211164221439052,-0.0973389826788889,7.80053416287e-05,-3.97760225612013,1.47969829968758,1.57392668585448,1.1700907451392,-0.403835940715284,0.000610041372415642,ENSG00000140451,PIF1,protein_coding,15,-1,64815632,64825668,q22.31,PIF1 5'-to-3' DNA helicase [Source:HGNC Symbol;Acc:HGNC:26220],NA,PIF1,80119,NM_001286496;NM_001286497;NM_001286499;NM_025049
HSD11B1L_SIG,HSD11B1L,HSD11B1L_SIG,HSD11B1L,SIG,20,4.27220334315904,0.0493248341171092,0.0441897232793995,0.0661973411552984,0.0220076178758988,7.83375500497818e-05,3.79580666860876,1.47963454007174,1.4353896923377,1.62501046834071,0.189620776003006,0.00108951080737076,ENSG00000167733,HSD11B1L,protein_coding,19,1,5680604,5688523,p13.3,hydroxysteroid 11-beta dehydrogenase 1 like [Source:HGNC Symbol;Acc:HGNC:30419],NA,HSD11B1L,374875,NM_001267868;NM_001267869;NM_001267870;NM_001267871;NM_198533;NM_198704;NM_198705;NM_198706;NM_198707;NM_198708
WRAP53_SIG,WRAP53,WRAP53_SIG,WRAP53,SIG,9,4.2714272957891,0.361368322380962,0.351740693069082,0.393001961548567,0.0412612684794851,7.85723227740859e-05,3.51271436290795,3.67861594395116,3.63388298363208,3.82559567071385,0.191712687081768,0.00260530957913506,ENSG00000141499,WRAP53,protein_coding,17,1,7686071,7703502,p13.1,WD repeat containing antisense to TP53 [Source:HGNC Symbol;Acc:HGNC:25522],Dyskeratosis congenita;DYSKERATOSIS CONGENITA AUTOSOMAL RECESSIVE 3,WRAP53,55135,NM_001143990;NM_001143991;NM_001143992;NM_018081
SLC7A7_SIG,SLC7A7,SLC7A7_SIG,SLC7A7,SIG,54,-4.27010893129372,0.346496315910883,0.388066472710964,0.209908657853473,-0.178157814857492,7.89996460206493e-05,-3.44688558432892,4.35935309134312,4.55700720983706,3.70991813057732,-0.847089079259737,0.00314411372875308,ENSG00000155465,SLC7A7,protein_coding,14,-1,22773222,22829820,q11.2,solute carrier family 7 member 7 [Source:HGNC Symbol;Acc:HGNC:11065],LYSINURIC PROTEIN INTOLERANCE,SLC7A7,9056,NM_001126105;NM_001126106
LSP1_SIG,LSP1,LSP1_SIG,LSP1,SIG,55,-4.26984803638886,0.166736798058302,0.179407583146043,0.125104218484295,-0.0543033646617482,7.90535284031896e-05,-2.46648510397142,7.95995972467162,8.05223373817006,7.65677368031961,-0.395460057850443,0.037977166591541,ENSG00000130592,LSP1,protein_coding,11,1,1852970,1892267,p15.5,lymphocyte specific protein 1 [Source:HGNC Symbol;Acc:HGNC:6707],NA,LSP1,4046,NM_001013253;NM_001013254;NM_001013255;NM_001242932;NM_001289005;NM_002339
CTSS_SIG,CTSS,CTSS_SIG,CTSS,SIG,53,-4.26931823321503,0.471932096599016,0.499677778692976,0.380767712576003,-0.118910066116973,7.92028861783996e-05,-3.11955157037226,8.47899391800081,8.59422409796919,8.10038046953327,-0.493843628435926,0.0079089618756875,ENSG00000163131,CTSS,protein_coding,1,-1,150730188,150765792,q21.3,cathepsin S [Source:HGNC Symbol;Acc:HGNC:2545],NA,CTSS,1520,NM_001199739;NM_004079
SFRP5_SIG,SFRP5,SFRP5_SIG,SFRP5,SIG,50,4.26879163454795,-0.073481757997323,-0.0805082531577587,-0.0503947024701773,0.0301135506875814,7.93513838496651e-05,0.916815502692323,0.449914066684966,0.431812877471009,0.509389402673681,0.0775765252026724,0.472904572501288,ENSG00000120057,SFRP5,protein_coding,10,-1,97766751,97771999,q24.2,secreted frizzled related protein 5 [Source:HGNC Symbol;Acc:HGNC:10779],NA,SFRP5,6425,NM_003015
UBE4B_SIG,UBE4B,UBE4B_SIG,UBE4B,SIG,29,4.2683481519144,0.174155523415152,0.161540055664841,0.215606346023316,0.0540662903584754,7.94705473095e-05,1.77036396425439,6.58878346638321,6.56642410590991,6.66224993650979,0.0958258305998782,0.145309446217663,ENSG00000130939,UBE4B,protein_coding,1,1,10032832,10181239,p36.22,ubiquitination factor E4B [Source:HGNC Symbol;Acc:HGNC:12500],NA,UBE4B,10277,NM_001105562;NM_006048
ATP6V0D1_SIG,ATP6V0D1,ATP6V0D1_SIG,ATP6V0D1,SIG,62,-4.26808058376779,0.416364827089864,0.434159581436372,0.357896348522765,-0.0762632329136071,7.9527169935064e-05,-4.3272755150501,6.47601868959237,6.56240190245395,6.19218813304716,-0.370213769406797,0.000185401208838031,ENSG00000159720,ATP6V0D1,protein_coding,16,-1,67438014,67481181,q22.1,ATPase H+ transporting V0 subunit d1 [Source:HGNC Symbol;Acc:HGNC:13724],NA,ATP6V0D1,9114,NM_004691
PELP1_SIG,PELP1,PELP1_SIG,PELP1,SIG,16,4.26579047044841,0.58580725665542,0.572323484521089,0.630111079382505,0.0577875948614157,8.03083240881507e-05,3.41824158588603,5.35045667980271,5.30192887315584,5.50990518735673,0.207976314200897,0.00341564003116691,ENSG00000141456,PELP1,protein_coding,17,-1,4669774,4704337,p13.2,proline, glutamate and leucine rich protein 1 [Source:HGNC Symbol;Acc:HGNC:30134],NA,PELP1,27043,NM_001278241;NM_014389
MTRF1_SIG,MTRF1,MTRF1_SIG,MTRF1,SIG,24,4.26512010085699,0.183305360214043,0.170966445029363,0.223847510106564,0.0528810650772009,8.05106559030675e-05,3.30780481753212,3.88873837468638,3.84377392159017,4.03647872057392,0.192704798983741,0.00470678242229868,ENSG00000120662,MTRF1,protein_coding,13,-1,41216369,41263577,q14.11,mitochondrial translation release factor 1 [Source:HGNC Symbol;Acc:HGNC:7469],NA,MTRF1,9617,NM_001354073;NM_001354074;NM_001354076;NM_004294
CHST12_SIG,CHST12,CHST12_SIG,CHST12,SIG,25,4.2644942164905,0.167544546980645,0.154594572637604,0.210094462679206,0.0554998900416022,8.06837830950351e-05,3.14245315125538,4.89179260340281,4.79220299901501,5.21901558924843,0.42681259023342,0.0074077003332415,ENSG00000136213,CHST12,protein_coding,7,1,2403588,2448484,p22.3,carbohydrate sulfotransferase 12 [Source:HGNC Symbol;Acc:HGNC:17423],NA,CHST12,55501,NM_001243794;NM_001243795;NM_018641
TTBK2_SIG,TTBK2,TTBK2_SIG,TTBK2,SIG,67,4.26439535384701,0.269899006397734,0.262511652904595,0.294171739303762,0.0316600863991669,8.06837830950351e-05,1.70952657274155,5.86942515313447,5.84501789455723,5.94962043131682,0.104602536759586,0.160791855970227,ENSG00000128881,TTBK2,protein_coding,15,-1,42738730,42920809,q15.2,tau tubulin kinase 2 [Source:HGNC Symbol;Acc:HGNC:19141],SPINOCEREBELLAR ATAXIA 11;Spinocerebellar ataxia type 11,TTBK2,146057,NM_173500
ZC3H7B_TF,ZC3H7B,ZC3H7B_TF,ZC3H7B,TF,162,4.26431490235925,0.455071506393705,0.445527139127629,0.486431570267953,0.0409044311403239,8.06837830950351e-05,1.89280019219631,6.81959494527615,6.79218670150792,6.90965060337176,0.117463901863843,0.117722549324344,ENSG00000100403,ZC3H7B,protein_coding,22,1,41301525,41360147,q13.2,zinc finger CCCH-type containing 7B [Source:HGNC Symbol;Acc:HGNC:30869],NA,ZC3H7B,23264,NM_017590
MBD2_SIG,MBD2,MBD2_SIG,MBD2,SIG,34,-4.2632126556254,0.124772775886124,0.140225374975663,0.0739999503062107,-0.0662254246694519,8.10436198516302e-05,-2.45096227326304,6.84940569529892,6.88643640734425,6.72773335572141,-0.158703051622842,0.0392816486334968,ENSG00000134046,MBD2,protein_coding,18,-1,54151606,54224669,q21.2,methyl-CpG binding domain protein 2 [Source:HGNC Symbol;Acc:HGNC:6917],NA,MBD2,8932,NM_003927;NM_015832
MIB2_SIG,MIB2,MIB2_SIG,MIB2,SIG,47,4.26268829121393,0.176236658218316,0.168712298661796,0.200959553904024,0.0322472552422281,8.11682810854983e-05,2.20676192628716,5.37207275082196,5.34030336272744,5.47645788313252,0.136154520405088,0.065562091558533,ENSG00000197530,MIB2,protein_coding,1,1,1615415,1630610,p36.33,mindbomb E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:30577],Left ventricular noncompaction,MIB2,142678,NM_001170686;NM_001170687;NM_001170688;NM_001170689;NM_080875
EDAR_SIG,EDAR,EDAR_SIG,EDAR,SIG,20,-4.26265257075226,-0.245663896786895,-0.218091173327424,-0.33625998815373,-0.118168814826306,8.11682810854983e-05,-2.62781995382792,0.47502293926294,0.515372469785378,0.342445910403504,-0.172926559381873,0.0263663689240824,ENSG00000135960,EDAR,protein_coding,2,-1,108894471,108989372,q13,ectodysplasin A receptor [Source:HGNC Symbol;Acc:HGNC:2895],Autosomal dominant hypohidrotic ectodermal dysplasia;Autosomal recessive hypohidrotic ectodermal dysplasia;ECTODERMAL DYSPLASIA 10A HYPOHIDROTIC/HAIR/NAIL TYPE AUTOSOMAL DOMINANT;ECTODERMAL DYSPLASIA 10B HYPOHIDROTIC/HAIR/TOOTH TYPE AUTOSOMALRECESSIVE;HAIR MORPHOLOGY 1,EDAR,10913,NM_022336
TIGIT_SIG,TIGIT,TIGIT_SIG,TIGIT,SIG,32,-4.26210896175274,-0.225438243623325,-0.198589089291401,-0.313656893571074,-0.115067804279673,8.13265936392764e-05,-3.7520080838158,1.68585444759218,1.79807928170547,1.31711570693423,-0.480963574771238,0.00124841180017099,ENSG00000181847,TIGIT,protein_coding,3,1,114276913,114310288,q13.31,T cell immunoreceptor with Ig and ITIM domains [Source:HGNC Symbol;Acc:HGNC:26838],NA,TIGIT,201633,NM_173799
PNKD_SIG,PNKD,PNKD_SIG,PNKD,SIG,28,4.25980707550537,0.208241363521206,0.202392063529931,0.227460492063966,0.0250684285340349,8.2128846961176e-05,1.31178649004438,6.49431445807299,6.4681070890498,6.58042438486348,0.112317295813685,0.290253852542144,ENSG00000127838,PNKD,protein_coding,2,1,218270392,218346793,q35,PNKD, MBL domain containing [Source:HGNC Symbol;Acc:HGNC:9153],Paroxysmal non-kinesigenic dyskinesia;PAROXYSMAL NONKINESIGENIC DYSKINESIA 1,PNKD,25953,NM_001077399;NM_015488;NM_022572
ZNF260_TF,ZNF260,ZNF260_TF,ZNF260,TF,62,4.25938437493525,0.326287394878586,0.313857561757705,0.36712827513291,0.0532707133752048,8.22444540245546e-05,3.70245837017243,3.64585344154296,3.56921618763004,3.89766156154257,0.328445373912536,0.00145992978464727,ENSG00000254004,ZNF260,protein_coding,19,-1,36510687,36528271,q13.12,zinc finger protein 260 [Source:HGNC Symbol;Acc:HGNC:13499],NA,ZNF260,339324,NM_001012756;NM_001166036;NM_001166037;NM_001166038
PRRC2A_SIG,PRRC2A,PRRC2A_SIG,PRRC2A,SIG,27,4.259012129311,0.484134159752213,0.474008085353836,0.517405547061166,0.0433974617073297,8.23416433452007e-05,2.54919656956026,8.89861745251729,8.87396701733614,8.97961173954109,0.105644722204952,0.0316770733305895,ENSG00000204469,PRRC2A,protein_coding,6,1,31620720,31637771,p21.33,proline rich coiled-coil 2A [Source:HGNC Symbol;Acc:HGNC:13918],NA,PRRC2A,7916,NM_004638;NM_080686
GPR141_SIG,GPR141,GPR141_SIG,GPR141,SIG,27,-4.25873010613047,0.35585871022149,0.375397036146385,0.291661353611122,-0.0837356825352624,8.24056946893371e-05,-3.14317711581752,2.840845538996,2.93948270344176,2.5167519986742,-0.422730704767558,0.00739771432135858,ENSG00000187037,GPR141,protein_coding,7,1,37683796,37833788,p14.1,G protein-coupled receptor 141 [Source:HGNC Symbol;Acc:HGNC:19997],NA,GPR141,353345,NM_001329993;NM_001329994;NM_181791
EOMES_TF,EOMES,EOMES_TF,EOMES,TF,108,-4.25763306824952,-0.0662055523061339,-0.0541989476695031,-0.105655824683635,-0.0514568770141322,8.27709504442939e-05,-2.82667924650939,1.51737098912154,1.59886928502266,1.24959087401785,-0.349278411004809,0.0166192488214572,ENSG00000163508,EOMES,protein_coding,3,-1,27715949,27722711,p24.1,eomesodermin [Source:HGNC Symbol;Acc:HGNC:3372],Microcephaly-polymicrogyria-corpus callosum agenesis syndrome;POLYMICROGYRIA AND CORPUS CALLOSUM AGENESIS,EOMES,8320,NM_001278182;NM_001278183;NM_005442
RCOR2_TF,RCOR2,RCOR2_TF,RCOR2,TF,194,4.25688467911493,-0.0494028115116007,-0.0540169855574101,-0.0342419539325127,0.0197750316248974,8.30082568381093e-05,1.58658597815756,0.879969454507437,0.841593796351484,1.00606090273414,0.164467106382653,0.194508236132599,ENSG00000167771,RCOR2,protein_coding,11,-1,63911230,63917164,q13.1,REST corepressor 2 [Source:HGNC Symbol;Acc:HGNC:27455],NA,RCOR2,283248,NM_173587
NMUR1_SIG,NMUR1,NMUR1_SIG,NMUR1,SIG,32,-4.25588132113516,0.00348984577416817,0.0121522360141793,-0.0249722935858684,-0.0371245296000476,8.33411539107922e-05,-4.56434158097625,1.83803221035005,2.00176119914618,1.30006553287706,-0.70169566626912,7.85907116017165e-05,ENSG00000171596,NMUR1,protein_coding,2,-1,231523187,231530445,q37.1,neuromedin U receptor 1 [Source:HGNC Symbol;Acc:HGNC:4518],NA,NMUR1,10316,NM_006056
KCTD13_SIG,KCTD13,KCTD13_SIG,KCTD13,SIG,31,4.25544482505771,0.145428019533483,0.138721841021201,0.167462606073837,0.0287407650526359,8.34635983247381e-05,1.94201115801785,4.30714585959561,4.28639935699242,4.37531293957751,0.0889135825850847,0.107947593855001,ENSG00000174943,KCTD13,protein_coding,16,-1,29905012,29926236,p11.2,potassium channel tetramerization domain containing 13 [Source:HGNC Symbol;Acc:HGNC:22234],NA,KCTD13,253980,NM_178863
TET3_TF,TET3,TET3_TF,TET3,TF,81,-4.25519586976319,0.137123799071247,0.142123707964753,0.120695526992583,-0.0214281809721698,8.34854921427434e-05,-3.0263464547721,7.08245522419732,7.11932709045388,6.96130480649721,-0.15802228395667,0.0100448936706874,ENSG00000187605,TET3,protein_coding,2,1,73986404,74108176,p13.1,tet methylcytosine dioxygenase 3 [Source:HGNC Symbol;Acc:HGNC:28313],NA,TET3,200424,NM_001287491;NM_001366022
SDHB_SIG,SDHB,SDHB_SIG,SDHB,SIG,65,-4.25517018198753,0.175894245896983,0.185910219146509,0.142984619505682,-0.042925599640827,8.34854921427434e-05,-2.75781477527676,5.48445237049045,5.51263772864188,5.39184333656434,-0.120794392077539,0.0195709253468128,ENSG00000117118,SDHB,protein_coding,1,-1,17018722,17054170,p36.13,succinate dehydrogenase complex iron sulfur subunit B [Source:HGNC Symbol;Acc:HGNC:10681],Carney-Stratakis syndrome;COWDEN SYNDROME;Gastrointestinal stromal tumor;Hereditary pheochromocytoma-paraganglioma;Isolated succinate-CoQ reductase deficiency;PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA;PARAGANGLIOMAS 4;Pheochromocytoma;Sporadic pheochromocytoma,SDHB,6390,NM_003000
SND1_SIG,SND1,SND1_SIG,SND1,SIG,38,4.25348919803027,0.389572638614609,0.38148152175078,0.416157736881479,0.0346762151306989,8.40626826180241e-05,3.70821270804231,7.71790039958476,7.66416482585084,7.89446014185336,0.230295316002523,0.00143532225167038,ENSG00000197157,SND1,protein_coding,7,1,127652194,128092609,q32.1,staphylococcal nuclease and tudor domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30646],NA,SND1,27044,NM_014390
HUS1_SIG,HUS1,HUS1_SIG,HUS1,SIG,18,4.2533342185431,0.198257775602161,0.194475677636667,0.210684668917356,0.0162089912806887,8.40626826180241e-05,6.2258320622639,4.16449623042217,4.10230982000992,4.36882300749102,0.266513187481103,4.57702162883624e-08,ENSG00000136273,HUS1,protein_coding,7,-1,47963288,47979615,p12.3,HUS1 checkpoint clamp component [Source:HGNC Symbol;Acc:HGNC:5309],NA,HUS1,3364,NM_001363683;NM_004507
JAG1_SIG,JAG1,JAG1_SIG,JAG1,SIG,97,4.25330469092432,0.0320779163268895,0.0250954593635825,0.0550202749206126,0.0299248155570301,8.40626826180241e-05,3.1397391432095,4.93765068848957,4.80067602940853,5.38771028261298,0.587034253204453,0.0074665480638149,ENSG00000101384,JAG1,protein_coding,20,-1,10637684,10673999,p12.2,jagged 1 [Source:HGNC Symbol;Acc:HGNC:6188],Alagille Syndrome;Alagille syndrome 1;Alagille syndrome due to 20p12 microdeletion;Alagille syndrome due to a JAG1 point mutation;DEAFNESS CONGENITAL HEART DEFECTS AND POSTERIOR EMBRYOTOXON;Tetralogy of Fallot,JAG1,182,NM_000214
CCR4_SIG,CCR4,CCR4_SIG,CCR4,SIG,17,-4.25255135020289,-0.0671866772602047,-0.0502470565742322,-0.122845430942685,-0.0725983743684533,8.43054526299036e-05,-3.21414510316392,1.6075577341241,1.70443220666945,1.28925589576081,-0.415176310908642,0.00611261358917177,ENSG00000183813,CCR4,protein_coding,3,1,32951574,32956349,p22.3,C-C motif chemokine receptor 4 [Source:HGNC Symbol;Acc:HGNC:1605],NA,CCR4,1233,NM_005508
ZNF808_TF,ZNF808,ZNF808_TF,ZNF808,TF,25,4.25238904728888,0.21920337205961,0.208168767019637,0.255459931476666,0.0472911644570287,8.43259947321885e-05,3.30837291578857,4.73217824917499,4.67916121786695,4.90637706633002,0.22721584846307,0.00470063320575658,ENSG00000198482,ZNF808,protein_coding,19,1,52527652,52564464,q13.41,zinc finger protein 808 [Source:HGNC Symbol;Acc:HGNC:33230],NA,ZNF808,388558,NM_001039886;NM_001321424;NM_001321425
HRAS_SIG,HRAS,HRAS_SIG,HRAS,SIG,25,4.25186986063178,0.109385484698518,0.102380455470626,0.132402009304449,0.0300215538338223,8.44685596598429e-05,2.92223056238943,3.35932302069401,3.32421284918801,3.47468501278514,0.150472163597131,0.0131194511263982,ENSG00000174775,HRAS,protein_coding,11,-1,532242,537287,p15.5,HRas proto-oncogene, GTPase [Source:HGNC Symbol;Acc:HGNC:5173],Bladder Cancer;CONGENITAL MYOPATHY WITH EXCESS OF MUSCLE SPINDLES;COSTELLO SYNDROME;Differentiated thyroid carcinoma;Linear nevus sebaceus syndrome;Melanocytic nevus syndrome congenital;NEVUS EPIDERMAL;Phakomatosis pigmentokeratotica;SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME;THYROID CANCER NONMEDULLARY 2;Woolly hair nevus,HRAS,3265,NM_001130442;NM_001318054;NM_005343;NM_176795
KNDC1_SIG,KNDC1,KNDC1_SIG,KNDC1,SIG,6,-4.25179546668727,-0.0230311162322365,-0.0116136230748417,-0.0605457366065336,-0.048932113531692,8.44685596598429e-05,-2.57812861227742,0.571408693027013,0.628022828822891,0.385390818269129,-0.242632010553761,0.0296266908862548,ENSG00000171798,KNDC1,protein_coding,10,1,133160219,133226412,q26.3,kinase non-catalytic C-lobe domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29374],NA,KNDC1,85442,NM_152643
ZNF517_TF,ZNF517,ZNF517_TF,ZNF517,TF,24,4.25096430183759,0.183567588912553,0.1764786750047,0.206859734609783,0.0303810596050831,8.47367145559778e-05,0.755739244128842,2.57003934393134,2.56119578915939,2.59909673818203,0.0379009490226386,0.560251395838781,ENSG00000197363,ZNF517,protein_coding,8,1,144798876,144811169,q24.3,zinc finger protein 517 [Source:HGNC Symbol;Acc:HGNC:27984],NA,ZNF517,340385,NM_001317936;NM_213605
REV1_SIG,REV1,REV1_SIG,REV1,SIG,24,4.25077816453785,0.436741196807965,0.427772412602361,0.466210059197804,0.0384376465954431,8.47367145559778e-05,2.48920874850973,5.61180317697461,5.58552333587841,5.69815122629071,0.112627890412302,0.0361316135455672,ENSG00000135945,REV1,protein_coding,2,-1,99400475,99490035,q11.2,REV1, DNA directed polymerase [Source:HGNC Symbol;Acc:HGNC:14060],NA,REV1,51455,NM_001037872;NM_001321454;NM_001321455;NM_001321458;NM_001321459;NM_001321460;NM_016316
BCAT1_SIG,BCAT1,BCAT1_SIG,BCAT1,SIG,57,4.25076296247463,0.098086853506835,0.0838599493290678,0.144832395805213,0.0609724464761451,8.47367145559778e-05,4.26757411633888,5.65243544454236,5.45238474279868,6.30974489312872,0.857360150330034,0.000227231745716292,ENSG00000060982,BCAT1,protein_coding,12,-1,24810024,24949101,p12.1,branched chain amino acid transaminase 1 [Source:HGNC Symbol;Acc:HGNC:976],NA,BCAT1,586,NM_001178091;NM_001178092;NM_001178093;NM_001178094;NM_005504
ZNF563_TF,ZNF563,ZNF563_TF,ZNF563,TF,18,4.24970135074832,0.084025486806985,0.0710887759184011,0.126531822583761,0.0554430466653598,8.5098446891249e-05,3.22115722725866,0.96136001110008,0.915397719248054,1.11237897004245,0.196981250794398,0.00599197097623518,ENSG00000188868,ZNF563,protein_coding,19,-1,12317477,12333720,p13.2,zinc finger protein 563 [Source:HGNC Symbol;Acc:HGNC:30498],NA,ZNF563,147837,NM_145276
BMP3_SIG,BMP3,BMP3_SIG,BMP3,SIG,29,-4.24949922235321,-0.0663615415238972,-0.058622813373806,-0.0917887911599111,-0.0331659777861052,8.51344160798018e-05,-2.88272290834364,0.47608398210631,0.549438759650192,0.235061141604985,-0.314377618045206,0.0144868550397087,ENSG00000152785,BMP3,protein_coding,4,1,81030708,81057632,q21.21,bone morphogenetic protein 3 [Source:HGNC Symbol;Acc:HGNC:1070],NA,BMP3,651,NM_001201
SFMBT2_SIG,SFMBT2,SFMBT2_SIG,SFMBT2,SIG,41,-4.24869699739196,0.0318177858783821,0.0386538232758964,0.00935652014369238,-0.0292973031322042,8.53988547949689e-05,-3.33565608594804,5.2619128594604,5.35741596364949,4.94811694569627,-0.409299017953219,0.00434471587923371,ENSG00000198879,SFMBT2,protein_coding,10,-1,7158624,7411486,p14,Scm like with four mbt domains 2 [Source:HGNC Symbol;Acc:HGNC:20256],NA,SFMBT2,57713,NM_001018039;NM_001029880
ALG12_SIG,ALG12,ALG12_SIG,ALG12,SIG,16,4.24846826555622,0.233944255505433,0.223708452971033,0.267576178118461,0.043867725147428,8.54451180781876e-05,3.53124533922581,4.37502963577218,4.33446224021648,4.50832250688376,0.173860266667284,0.002459782314708,ENSG00000182858,ALG12,protein_coding,22,-1,49900229,49918438,q13.33,ALG12, alpha-1,6-mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:19358],ALG12-CDG;Congenital disorder of glycosylation type 1G;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ig,ALG12,79087,NM_024105
SRBD1_SIG,SRBD1,SRBD1_SIG,SRBD1,SIG,29,4.24834941849074,0.131911098111863,0.11867723562521,0.17539378913944,0.0567165535142301,8.54495072112228e-05,3.45242455373195,4.99416587531914,4.92561494620141,5.21940464242024,0.293789696218822,0.00309378602224157,ENSG00000068784,SRBD1,protein_coding,2,-1,45388680,45612165,p21,S1 RNA binding domain 1 [Source:HGNC Symbol;Acc:HGNC:25521],NA,SRBD1,55133,NM_018079
LRP1_SIG,LRP1,LRP1_SIG,LRP1,SIG,53,-4.24769130695494,0.155618862156312,0.190929698348839,0.0395975432380082,-0.151332155110831,8.56598056950141e-05,-5.02503104766291,6.28092661819743,6.62862817814464,5.13847863551376,-1.49014954263087,1.29012671320416e-05,ENSG00000123384,LRP1,protein_coding,12,1,57128493,57213351,q13.3,LDL receptor related protein 1 [Source:HGNC Symbol;Acc:HGNC:6692],Atrophoderma vermiculata;Keratosis follicularis spinulosa decalvans;KERATOSIS PILARIS ATROPHICANS,LRP1,4035,NM_002332
KCNJ2_SIG,KCNJ2,KCNJ2_SIG,KCNJ2,SIG,14,-4.24688984914858,0.0174389364322772,0.0450029928314227,-0.0731286774506294,-0.118131670282052,8.59255417946906e-05,-2.60260654607931,1.60598605824408,1.69805136707399,1.30348575780294,-0.394565609271058,0.0279956935754452,ENSG00000123700,KCNJ2,protein_coding,17,1,70168673,70180048,q24.3,potassium voltage-gated channel subfamily J member 2 [Source:HGNC Symbol;Acc:HGNC:6263],ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS;Andersen Tawil syndrome;ATRIAL FIBRILLATION FAMILIAL 9;Familial atrial fibrillation;Familial short QT syndrome;SHORT QT SYNDROME 3,KCNJ2,3759,NM_000891
FOXP3_SIG,FOXP3,FOXP3_SIG,FOXP3,SIG,9,-4.24657627268425,-0.184296109076184,-0.156405901114997,-0.275935363805799,-0.119529462690801,8.60046828499386e-05,-3.19001091488949,0.907804127789501,0.968509629322404,0.708343194181389,-0.260166435141015,0.00653225165141724,ENSG00000049768,FOXP3,protein_coding,X,-1,49250436,49270477,p11.23,forkhead box P3 [Source:HGNC Symbol;Acc:HGNC:6106],DIABETES MELLITUS INSULIN-DEPENDENT;Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome;IMMUNODYSREGULATION POLYENDOCRINOPATHY AND ENTEROPATHY X-LINKED;IPEX Syndrome,FOXP3,50943,NM_001114377;NM_014009
RNF149_SIG,RNF149,RNF149_SIG,RNF149,SIG,53,-4.24609745694003,0.235396734993923,0.251988745898377,0.180880127736432,-0.0711086181619447,8.6147384391115e-05,-2.38612276994668,6.5043405076445,6.55825030497649,6.32720831641081,-0.231041988565678,0.0451360535994897,ENSG00000163162,RNF149,protein_coding,2,-1,101271219,101308701,q11.2,ring finger protein 149 [Source:HGNC Symbol;Acc:HGNC:23137],NA,RNF149,284996,NM_173647
ARHGAP31_SIG,ARHGAP31,ARHGAP31_SIG,ARHGAP31,SIG,21,-4.24599007944854,0.133543539278398,0.158740160142241,0.050754642154344,-0.107985517987897,8.61474774236042e-05,-4.42704832877617,3.8701688597812,4.05137957629196,3.27476221981726,-0.776617356474691,0.000129233824734628,ENSG00000031081,ARHGAP31,protein_coding,3,1,119294373,119420714,q13.32,Rho GTPase activating protein 31 [Source:HGNC Symbol;Acc:HGNC:29216],Adams-Oliver syndrome;ADAMS-OLIVER SYNDROME 1,ARHGAP31,57514,NM_020754
TBX21_TF,TBX21,TBX21_TF,TBX21,TF,161,-4.24550883190825,-0.12353533373117,-0.105656626556269,-0.182279657305843,-0.0766230307495745,8.62913680508607e-05,-3.3035051675923,2.34826525511437,2.45911430433738,1.98404695052449,-0.475067353812888,0.00476315616882443,ENSG00000073861,TBX21,protein_coding,17,1,47733236,47746122,q21.32,T-box 21 [Source:HGNC Symbol;Acc:HGNC:11599],ASTHMA NASAL POLYPS AND ASPIRIN INTOLERANCE,TBX21,30009,NM_013351
LRSAM1_SIG,LRSAM1,LRSAM1_SIG,LRSAM1,SIG,20,4.24498651583967,0.20933347657954,0.200573072811158,0.238117660389938,0.0375445875787802,8.64513319338721e-05,4.38652827968708,4.7498930205073,4.69586008190509,4.92742981877171,0.231569736866625,0.000149615081220194,ENSG00000148356,LRSAM1,protein_coding,9,1,127451486,127503501,q33.3,leucine rich repeat and sterile alpha motif containing 1 [Source:HGNC Symbol;Acc:HGNC:25135],CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2P;Charcot-Marie-Tooth disease type 2P,LRSAM1,90678,NM_001005373;NM_001005374;NM_001190723;NM_138361
PAK4_SIG,PAK4,PAK4_SIG,PAK4,SIG,14,4.24484463700886,0.238910488379106,0.226481778253789,0.279747678790861,0.0532659005370715,8.64647770653866e-05,2.81515131491162,3.88347371175331,3.83944071262953,4.02815356601714,0.188712853387607,0.0170636216406822,ENSG00000130669,PAK4,protein_coding,19,1,39125770,39182816,q13.2,p21 (RAC1) activated kinase 4 [Source:HGNC Symbol;Acc:HGNC:16059],NA,PAK4,10298,NM_001014831;NM_001014832;NM_001014834;NM_001014835;NM_005884
ERI3_SIG,ERI3,ERI3_SIG,ERI3,SIG,71,4.24462512999618,0.358909713067873,0.347129695493159,0.397615485099075,0.0504857896059158,8.65081838621114e-05,3.59729305411976,4.36722898416631,4.31636057266923,4.53436805051388,0.218007477844652,0.00201458140586019,ENSG00000117419,ERI3,protein_coding,1,-1,44221070,44355260,p34.1,ERI1 exoribonuclease family member 3 [Source:HGNC Symbol;Acc:HGNC:17276],NA,ERI3,79033,NM_001301698;NM_001301699;NM_001301700;NM_001301701;NM_024066
C14orf93_SIG,C14orf93,C14orf93_SIG,C14orf93,SIG,7,4.2436397451631,0.0268966524797621,0.0151535221109263,0.065481223691651,0.0503277015807248,8.6847694868543e-05,2.79011638873376,3.84899389359444,3.81531338638959,3.95965841726754,0.144345030877954,0.0181213992170875,ENSG00000100802,C14orf93,protein_coding,14,-1,22985894,23010166,q11.2,chromosome 14 open reading frame 93 [Source:HGNC Symbol;Acc:HGNC:20162],NA,C14orf93,60686,NM_001130706;NM_001130708;NM_001282968;NM_001282969;NM_001282970;NM_021944
USP51_SIG,USP51,USP51_SIG,USP51,SIG,94,4.24248314214005,0.0829314447985257,0.0722728883729354,0.11795241591118,0.0456795275382442,8.72514630824183e-05,1.53171692847388,1.85539680396848,1.82680180976997,1.94935178490642,0.12254997513645,0.211640453552142,ENSG00000247746,USP51,protein_coding,X,-1,55484616,55489202,p11.21,ubiquitin specific peptidase 51 [Source:HGNC Symbol;Acc:HGNC:23086],NA,USP51,158880,NM_201286
LONP2_SIG,LONP2,LONP2_SIG,LONP2,SIG,46,4.24238548634004,0.0836325532637959,0.0703466517370402,0.127286229708851,0.0569395779718105,8.72514630824183e-05,2.41440195686601,6.39379679627581,6.36544047508918,6.48696756588901,0.121527090799832,0.0425204277425841,ENSG00000102910,LONP2,protein_coding,16,1,48244296,48363122,q12.1,lon peptidase 2, peroxisomal [Source:HGNC Symbol;Acc:HGNC:20598],NA,LONP2,83752,NM_001300948;NM_001348078;NM_031490
CYB561_SIG,CYB561,CYB561_SIG,CYB561,SIG,71,4.24104998418414,0.130523540560984,0.120306714656512,0.164093111389966,0.043786396733454,8.77305316266e-05,2.72286528199271,4.29807644808241,4.22703359785581,4.53150295596979,0.30446935811398,0.0212108938049125,ENSG00000008283,CYB561,protein_coding,17,-1,63432304,63446354,q23.3,cytochrome b561 [Source:HGNC Symbol;Acc:HGNC:2571],ORTHOSTATIC HYPOTENSION 2,CYB561,1534,NM_001017916;NM_001017917;NM_001330421;NM_001915
C2orf49_SIG,C2orf49,C2orf49_SIG,C2orf49,SIG,41,4.23990909047229,0.269549801343436,0.261881115082108,0.294746913344941,0.0328657982628322,8.81356597217079e-05,3.50990277871789,4.78887737418093,4.74781247311498,4.92380490625476,0.175992433139784,0.00262847060892989,ENSG00000135974,C2orf49,protein_coding,2,1,105337532,105349211,q12.2,chromosome 2 open reading frame 49 [Source:HGNC Symbol;Acc:HGNC:28772],NA,C2orf49,79074,NM_001286537;NM_024093
GPR75_SIG,GPR75,GPR75_SIG,GPR75,SIG,43,4.23962565746514,0.192225729323943,0.185040751587106,0.215833513316407,0.0307927617293007,8.8205047846087e-05,3.06761646919778,1.87890322053698,1.83303866405862,2.02960104896588,0.19656238490726,0.00903349281866903,ENSG00000119737,GPR75,protein_coding,2,-1,53852913,53859989,p16.2,G protein-coupled receptor 75 [Source:HGNC Symbol;Acc:HGNC:4526],NA,GPR75,10936,NM_006794
CXCR1_SIG,CXCR1,CXCR1_SIG,CXCR1,SIG,31,-4.23937873486912,0.0882574180533392,0.121491142064919,-0.0209391036989932,-0.142430245763912,8.82601490455089e-05,-3.3703823569871,2.384694276445,2.55167505906166,1.8360431335617,-0.715631925499962,0.00394158666544681,ENSG00000163464,CXCR1,protein_coding,2,-1,218162845,218166995,q35,C-X-C motif chemokine receptor 1 [Source:HGNC Symbol;Acc:HGNC:6026],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,CXCR1,3577,NM_000634
THAP6_TF,THAP6,THAP6_TF,THAP6,TF,57,4.23796302547984,0.265739812731789,0.258113586683726,0.290797412603995,0.0326838259202695,8.87761968923811e-05,3.3321443003034,3.25373526419707,3.20818349553359,3.40340536123421,0.19522186570062,0.00439217521358299,ENSG00000174796,THAP6,protein_coding,4,1,75513946,75550473,q21.1,THAP domain containing 6 [Source:HGNC Symbol;Acc:HGNC:23189],NA,THAP6,152815,NM_001317791;NM_144721
EPHB1_SIG,EPHB1,EPHB1_SIG,EPHB1,SIG,27,-4.23707953194542,0.00971855800946306,0.0178939231522666,-0.0171433560311772,-0.0350372791834438,8.90837904279922e-05,-1.29557470874385,0.899405554748682,0.927831628275596,0.806005598874538,-0.121826029401058,0.296835050193859,ENSG00000154928,EPHB1,protein_coding,3,1,134597801,135260467,q22.2,EPH receptor B1 [Source:HGNC Symbol;Acc:HGNC:3392],NA,EPHB1,2047,NM_004441
B3GNTL1_SIG,B3GNTL1,B3GNTL1_SIG,B3GNTL1,SIG,30,4.23583340298171,0.17770481351543,0.168506254642463,0.207928649812322,0.0394223951698595,8.95368097135839e-05,2.67332884338848,5.34581014412436,5.29523925752979,5.51197162864937,0.216732371119574,0.0238243900436769,ENSG00000175711,B3GNTL1,protein_coding,17,-1,82942155,83051810,q25.3,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1 [Source:HGNC Symbol;Acc:HGNC:21727],NA,B3GNTL1,146712,NM_001009905;NM_001320742;NM_001320743
MID2_SIG,MID2,MID2_SIG,MID2,SIG,13,-4.23561043576831,-0.175501939175443,-0.161090274315847,-0.222854552285544,-0.0617642779696967,8.95831917055508e-05,-2.38883630464559,0.930117007854144,0.985127962194331,0.749366729307813,-0.235761232886518,0.0448770050987122,ENSG00000080561,MID2,protein_coding,X,1,107825755,107927193,q22.3,midline 2 [Source:HGNC Symbol;Acc:HGNC:7096],Mental retardation X-linked 101;X-linked non-syndromic intellectual disability,MID2,11043,NM_012216;NM_052817
EOMES_SIG,EOMES,EOMES_SIG,EOMES,SIG,13,-4.2353882150698,-0.19914591228658,-0.176582066814272,-0.273284261695591,-0.0967021948813183,8.96293158483965e-05,-2.82667924650939,1.51737098912154,1.59886928502266,1.24959087401785,-0.349278411004809,0.0166192488214572,ENSG00000163508,EOMES,protein_coding,3,-1,27715949,27722711,p24.1,eomesodermin [Source:HGNC Symbol;Acc:HGNC:3372],Microcephaly-polymicrogyria-corpus callosum agenesis syndrome;POLYMICROGYRIA AND CORPUS CALLOSUM AGENESIS,EOMES,8320,NM_001278182;NM_001278183;NM_005442
EIF2B4_SIG,EIF2B4,EIF2B4_SIG,EIF2B4,SIG,43,4.23499388690007,0.320831572416506,0.305774003553085,0.370306441539175,0.0645324379860909,8.97150558989497e-05,4.28018720089185,4.88939832224788,4.83759518428698,5.05960863269081,0.222013448403822,0.000219549247518688,ENSG00000115211,EIF2B4,protein_coding,2,-1,27364352,27370486,p23.3,eukaryotic translation initiation factor 2B subunit delta [Source:HGNC Symbol;Acc:HGNC:3260],Congenital or early infantile CACH syndrome;Cree leukoencephalopathy;Juvenile or adult CACH syndrome;Late infantile CACH syndrome;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER;OVARIOLEUKODYSTROPHY,EIF2B4,8890,NM_001034116;NM_001318965;NM_001318966;NM_001318967;NM_001318968;NM_001318969;NM_015636;NM_172195
CXCR6_SIG,CXCR6,CXCR6_SIG,CXCR6,SIG,12,-4.23496037284411,-0.0823466240514405,-0.0716061864685713,-0.117636633252296,-0.0460304467837249,8.97150558989497e-05,-2.21248570893494,0.414723106571219,0.443291059557562,0.320856975330378,-0.122434084227184,0.0647443916115032,ENSG00000172215,CXCR6,protein_coding,3,1,45940933,45948351,p21.31,C-X-C motif chemokine receptor 6 [Source:HGNC Symbol;Acc:HGNC:16647],NA,CXCR6,10663,NM_006564
CD93_SIG,CD93,CD93_SIG,CD93,SIG,17,-4.23449436098233,0.0736141284340852,0.0959040375535964,0.000375855612834109,-0.0955281819407624,8.98587226589835e-05,-3.50506903674373,6.32593917796246,6.51066411515487,5.71898581290169,-0.791678302253172,0.00266688076122654,ENSG00000125810,CD93,protein_coding,20,-1,23079360,23086324,p11.21,CD93 molecule [Source:HGNC Symbol;Acc:HGNC:15855],NA,CD93,22918,NM_012072
ZNF837_TF,ZNF837,ZNF837_TF,ZNF837,TF,32,4.23246273250262,0.190116744042892,0.177214603928896,0.232509490131737,0.0552948862028406,9.06316356908637e-05,3.56957567145341,1.24620441619472,1.19483728172122,1.41498214375052,0.220144862029308,0.00219034227695015,ENSG00000152475,ZNF837,protein_coding,19,-1,58367618,58381030,q13.43,zinc finger protein 837 [Source:HGNC Symbol;Acc:HGNC:25164],NA,ZNF837,116412,NM_138466
CD163_SIG,CD163,CD163_SIG,CD163,SIG,15,-4.23146768532665,0.0178866030575978,0.0442723612594728,-0.0688094596057059,-0.113081820865179,9.09905235334595e-05,-3.48149666387116,4.56239549408704,4.79932147501757,3.78392441388671,-1.01539706113086,0.00284539114866443,ENSG00000177575,CD163,protein_coding,12,-1,7470813,7503893,p13.31,CD163 molecule [Source:HGNC Symbol;Acc:HGNC:1631],NA,CD163,9332,NM_004244;NM_203416
TRIM52_SIG,TRIM52,TRIM52_SIG,TRIM52,SIG,74,4.23084913887868,0.198752569514262,0.189857518020992,0.227979167277864,0.0381216492568723,9.11979816310513e-05,3.61394483134684,5.02150933156832,4.97235201858134,5.18302621709698,0.210674198515635,0.00191306346655395,ENSG00000183718,TRIM52,protein_coding,5,-1,181254417,181261139,q35.3,tripartite motif containing 52 [Source:HGNC Symbol;Acc:HGNC:19024],NA,TRIM52,84851,NM_001346048;NM_001346049;NM_001346050;NM_001346051;NM_032765
MYCL_TF,MYCL,MYCL_TF,MYCL,TF,381,-4.23042778028637,0.0932757961604178,0.11310945885069,0.0281080473209511,-0.0850014115297391,9.13258059722338e-05,-2.60906507943014,1.9703873153111,2.08238646277997,1.60239011648481,-0.479996346295166,0.0275787528024762,ENSG00000116990,MYCL,protein_coding,1,-1,39895426,39902256,p34.2,MYCL proto-oncogene, bHLH transcription factor [Source:HGNC Symbol;Acc:HGNC:7555],NA,MYCL,4610,NM_001033081;NM_001033082;NM_005376
ACSF3_SIG,ACSF3,ACSF3_SIG,ACSF3,SIG,32,4.22981114101779,0.0647803988320607,0.0501299678795714,0.112917529104526,0.0627875612249543,9.15332370674303e-05,1.89163490161129,5.52774882443805,5.49931031736107,5.62118963340527,0.121879316044196,0.117931352518109,ENSG00000176715,ACSF3,protein_coding,16,1,89088375,89164121,q24.3,acyl-CoA synthetase family member 3 [Source:HGNC Symbol;Acc:HGNC:27288],Combined malonic and methylmalonic acidemia;Combined malonic and methylmalonic aciduria,ACSF3,197322,NM_001127214;NM_001243279;NM_001284316;NM_174917
ZNF248_TF,ZNF248,ZNF248_TF,ZNF248,TF,221,4.2279237989112,0.045741429376079,0.0293452832665048,0.0996144808789657,0.0702691976124608,9.22606481300396e-05,3.40101277746189,3.37211799182062,3.28068724848124,3.67253329136431,0.391846042883073,0.00359147477542316,ENSG00000198105,ZNF248,protein_coding,10,-1,37776526,37858106,p11.21,zinc finger protein 248 [Source:HGNC Symbol;Acc:HGNC:13041],NA,ZNF248,57209,NM_001267597;NM_001267605;NM_001267606;NM_001267607;NM_001352469;NM_001352470;NM_001352471;NM_001352472;NM_001352473;NM_001352474;NM_001352476;NM_001352477;NM_001352478;NM_001352479;NM_001352480;NM_001352481;NM_001352482;NM_001352483;NM_001352484;NM_001352485;NM_001352486;NM_001352487;NM_001352488;NM_001352489;NM_001352490;NM_001352491;NM_001352492;NM_001352493;NM_001352494;NM_021045
PKDCC_SIG,PKDCC,PKDCC_SIG,PKDCC,SIG,16,-4.22774640762791,-0.241677202482982,-0.231988706192836,-0.273510833150603,-0.0415221269577662,9.22898220904481e-05,-1.88743446177463,0.308906229895371,0.339896962194726,0.207079538054636,-0.13281742414009,0.118885792381298,ENSG00000162878,PKDCC,protein_coding,2,1,42048021,42058517,p21,protein kinase domain containing, cytoplasmic [Source:HGNC Symbol;Acc:HGNC:25123],NA,PKDCC,91461,NM_138370
DOCK5_SIG,DOCK5,DOCK5_SIG,DOCK5,SIG,26,-4.227262562867,0.253998353803225,0.25933427082999,0.236466055000995,-0.0228682158289946,9.24448035631386e-05,-3.07263292237586,7.12932155259982,7.21051421675584,6.86254565608719,-0.347968560668646,0.00891707577638574,ENSG00000147459,DOCK5,protein_coding,8,1,25184689,25418082,p21.2,dedicator of cytokinesis 5 [Source:HGNC Symbol;Acc:HGNC:23476],NA,DOCK5,80005,NM_001322810;NM_024940
MAP2K1_SIG,MAP2K1,MAP2K1_SIG,MAP2K1,SIG,46,-4.22659863172065,0.273639183992786,0.287063883598584,0.22952945671659,-0.0575344268819939,9.26741522235746e-05,-2.87619639332976,5.54562456132386,5.60412199182313,5.35341871825486,-0.250703273568265,0.0147234888777066,ENSG00000169032,MAP2K1,protein_coding,15,1,66386817,66492312,q22.31,mitogen-activated protein kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:6840],CARDIOFACIOCUTANEOUS SYNDROME;CARDIOFACIOCUTANEOUS SYNDROME 3;NOONAN SYNDROME 1,MAP2K1,5604,NM_002755
NFXL1_TF,NFXL1,NFXL1_TF,NFXL1,TF,11,4.22215595086455,0.16935824060885,0.159765861889665,0.200876056400458,0.0411101945107936,9.44757787693001e-05,2.48270038292775,3.71271301275583,3.67508955726721,3.83633293793269,0.161243380665476,0.0366535278999844,ENSG00000170448,NFXL1,protein_coding,4,-1,47847233,47914667,p12,nuclear transcription factor, X-box binding like 1 [Source:HGNC Symbol;Acc:HGNC:18726],NA,NFXL1,152518,NM_001278623;NM_001278624;NM_152995
KLHL23_SIG,KLHL23,KLHL23_SIG,KLHL23,SIG,86,4.22199559322459,0.123478084149466,0.107982439350619,0.174392345631395,0.066409906280776,9.44985013425986e-05,4.52773500997519,3.03165932603483,2.88146413474633,3.52515781169705,0.643693676950712,8.95740450294913e-05,ENSG00000213160,KLHL23,protein_coding,2,1,169694488,169776989,q31.1,kelch like family member 23 [Source:HGNC Symbol;Acc:HGNC:27506],NA,KLHL23,151230;100526832,NM_001199290;NM_144711
POLR1A_SIG,POLR1A,POLR1A_SIG,POLR1A,SIG,44,4.22172497505765,0.722833414532046,0.707762143574521,0.772353304821058,0.0645911612465363,9.45675063696533e-05,3.91327203150588,5.84448645767186,5.76716517426108,6.09854210316441,0.331376928903332,0.000748523038485447,ENSG00000068654,POLR1A,protein_coding,2,-1,86020216,86106155,p11.2,RNA polymerase I subunit A [Source:HGNC Symbol;Acc:HGNC:17264],Acrofacial dysostosis cincinnati type;Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome,POLR1A,25885,NM_015425
PCGF1_SIG,PCGF1,PCGF1_SIG,PCGF1,SIG,15,4.22072736000488,0.113978954245619,0.110473053139622,0.125498343593893,0.0150252904542705,9.49057121303136e-05,0.746492937524981,3.5282374937894,3.51991569972165,3.55558053144061,0.0356648317189617,0.565086005245573,ENSG00000115289,PCGF1,protein_coding,2,-1,74505043,74507695,p13.1,polycomb group ring finger 1 [Source:HGNC Symbol;Acc:HGNC:17615],NA,PCGF1,84759,NM_032673
PRPF8_SIG,PRPF8,PRPF8_SIG,PRPF8,SIG,19,4.22070824735079,0.6547669766721,0.648155882649611,0.676489142745994,0.028333260096383,9.49057121303136e-05,3.65199932639419,9.08837768558793,9.04270519121629,9.23844445280904,0.195739261592751,0.00170209626474715,ENSG00000174231,PRPF8,protein_coding,17,-1,1650629,1684867,p13.3,pre-mRNA processing factor 8 [Source:HGNC Symbol;Acc:HGNC:17340],Retinitis pigmentosa;RETINITIS PIGMENTOSA 13,PRPF8,10594,NM_006445
ENPEP_SIG,ENPEP,ENPEP_SIG,ENPEP,SIG,3,-4.21963974426963,-0.248325997375611,-0.221839599830474,-0.335352732166777,-0.113513132336303,9.5311782063651e-05,-1.09813290437037,0.415239277201643,0.439345417493453,0.336033387671409,-0.103312029822045,0.38328798212191,ENSG00000138792,ENPEP,protein_coding,4,1,110365733,110565285,q25,glutamyl aminopeptidase [Source:HGNC Symbol;Acc:HGNC:3355],NA,ENPEP,2028,NM_001977
ZNF112_TF,ZNF112,ZNF112_TF,ZNF112,TF,23,4.21953104457832,-0.168724110898989,-0.17751232074501,-0.139848564262065,0.0376637564829453,9.531293408533e-05,2.97750534589415,0.758580736063695,0.698669172987462,0.955433014742745,0.256763841755283,0.0114167154906196,ENSG00000062370,ZNF112,protein_coding,19,-1,44326555,44367217,q13.31,zinc finger protein 112 [Source:HGNC Symbol;Acc:HGNC:12892],NA,ZNF112,7771,NM_001083335;NM_001348281;NM_001348282;NM_001348283;NM_001348284;NM_001348285;NM_013380
CEBPA_TF,CEBPA,CEBPA_TF,CEBPA,TF,172,4.21913084219039,0.0996222951879993,0.0941881504057547,0.11747734232966,0.0232891919239059,9.54374109753958e-05,2.25003093781127,2.52000876308581,2.46039547383931,2.71588099918145,0.255485525342135,0.059986646156489,ENSG00000245848,CEBPA,protein_coding,19,-1,33299934,33302534,q13.11,CCAAT enhancer binding protein alpha [Source:HGNC Symbol;Acc:HGNC:1833],Acute myeloid leukemia with CEBPA somatic mutations;Acute myeloid leukemia with t(8;21)(q22;q22) translocation;Inherited acute myeloid leukemia;LEUKEMIA ACUTE MYELOID,CEBPA,1050,NM_001285829;NM_001287424;NM_001287435;NM_004364
RFX7_TF,RFX7,RFX7_TF,RFX7,TF,118,4.21854727441545,0.480622865392399,0.473074549043204,0.505424476254038,0.0323499272108334,9.56189816277747e-05,2.8456466370738,6.26893678714243,6.21621527054118,6.44216462740367,0.225949356862499,0.0158572241491701,ENSG00000181827,RFX7,protein_coding,15,-1,56087280,56243266,q21.3,regulatory factor X7 [Source:HGNC Symbol;Acc:HGNC:25777],NA,RFX7,64864,NM_022841
ZFP36L2_TF,ZFP36L2,ZFP36L2_TF,ZFP36L2,TF,13,4.21849050050224,0.0978343074234488,0.0950101532569389,0.10711367111341,0.0121035178564712,9.56189816277747e-05,1.86176185485501,9.34013221187087,9.30261009013049,9.46341918330354,0.160809093173048,0.124342274795273,ENSG00000152518,ZFP36L2,protein_coding,2,-1,43222402,43226606,p21,ZFP36 ring finger protein like 2 [Source:HGNC Symbol;Acc:HGNC:1108],NA,ZFP36L2,678,NM_006887
NOL11_SIG,NOL11,NOL11_SIG,NOL11,SIG,63,4.21802461110208,0.367299204365397,0.359151935566244,0.394068801848331,0.0349168662820876,9.57717727709213e-05,3.55013852509817,5.42913363931403,5.37311953343391,5.61317998720586,0.240060453771958,0.00232247641363294,ENSG00000130935,NOL11,protein_coding,17,1,67717931,67744531,q24.2,nucleolar protein 11 [Source:HGNC Symbol;Acc:HGNC:24557],NA,NOL11,25926,NM_001303272;NM_015462
NDUFV1_SIG,NDUFV1,NDUFV1_SIG,NDUFV1,SIG,32,4.21774243413184,0.126721441715156,0.118825802999106,0.152664254639321,0.0338384516402152,9.5846711226428e-05,3.08371028445022,6.60378274442095,6.57160158645549,6.70952083487891,0.137919248423414,0.0086521831757331,ENSG00000167792,NDUFV1,protein_coding,11,1,67605653,67612554,q13.2,NADH:ubiquinone oxidoreductase core subunit V1 [Source:HGNC Symbol;Acc:HGNC:7716],Isolated complex I deficiency;Leigh syndrome with leukodystrophy;Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 4,NDUFV1,4723,NM_001166102;NM_007103
DARS_SIG,DARS,DARS_SIG,DARS,SIG,31,4.21744634446518,0.507726938195063,0.494026512743707,0.552742621820948,0.0587161090772411,9.59276386699499e-05,3.49140019072552,6.27376438440995,6.22452907295813,6.43553755060877,0.211008477650645,0.00276609178539093,ENSG00000115866,DARS,protein_coding,2,-1,135905881,135986100,q21.3,aspartyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:2678],HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,DARS,1615,NM_001293312;NM_001349
ATF2_TF,ATF2,ATF2_TF,ATF2,TF,49,4.21631275770708,0.383027531535062,0.376796212331687,0.403501866060435,0.0267056537287481,9.63657239247199e-05,3.16818598975707,5.81254245841574,5.77969006081549,5.92048605053082,0.14079598971533,0.00690935705639644,ENSG00000115966,ATF2,protein_coding,2,-1,175072250,175168382,q31.1,activating transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:784],NA,ATF2,1386,NM_001256090;NM_001256091;NM_001256092;NM_001256093;NM_001256094;NM_001880
APPL1_SIG,APPL1,APPL1_SIG,APPL1,SIG,33,4.21586509068426,0.428040634281682,0.420532620199038,0.452709823410368,0.0321772032113297,9.65119050049121e-05,2.66555360395974,6.71189217661921,6.67307689748573,6.8394280937721,0.166351196286369,0.0242409904727458,ENSG00000157500,APPL1,protein_coding,3,1,57227726,57278105,p14.3,adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 [Source:HGNC Symbol;Acc:HGNC:24035],MATURITY-ONSET DIABETES OF THE YOUNG TYPE 14;MODY,APPL1,26060,NM_012096
DDX43_SIG,DDX43,DDX43_SIG,DDX43,SIG,2,-4.21525362985481,0.288794289318991,0.304265849138091,0.237959164199088,-0.066306684939003,9.66993750551597e-05,0.567925546140443,0.648767000105483,0.634427989289074,0.695880892787969,0.0614529034988949,0.670083026834005,ENSG00000080007,DDX43,protein_coding,6,1,73394828,73417566,q13,DEAD-box helicase 43 [Source:HGNC Symbol;Acc:HGNC:18677],NA,DDX43,55510,NM_018665
SLC2A3_SIG,SLC2A3,SLC2A3_SIG,SLC2A3,SIG,29,-4.21516579630011,0.377027669833894,0.4004860006542,0.299950297138601,-0.100535703515599,9.66993750551597e-05,-3.78177006923023,8.05812459986697,8.21373443925654,7.54683512758695,-0.666899311669588,0.00113941454850192,ENSG00000059804,SLC2A3,protein_coding,12,-1,7919230,7936187,p13.31,solute carrier family 2 member 3 [Source:HGNC Symbol;Acc:HGNC:11007],HUNTINGTON DISEASE,SLC2A3,6515,NM_006931
MARC1_SIG,MARC1,MARC1_SIG,MARC1,SIG,66,-4.21511046408405,0.184727119000178,0.202512869101938,0.126288225808684,-0.0762246432932543,9.66993750551597e-05,-3.44449503773985,4.00668419473537,4.18561559136989,3.4187667486505,-0.766848842719388,0.00316097567187638,ENSG00000186205,MARC1,protein_coding,1,1,220786913,220819659,q41,mitochondrial amidoxime reducing component 1 [Source:HGNC Symbol;Acc:HGNC:26189],NA,MARC1,64757,NM_022746
GRIN3A_SIG,GRIN3A,GRIN3A_SIG,GRIN3A,SIG,15,-4.21459921274025,-0.0201086851155331,0.000425084856589587,-0.0875767864525075,-0.0880018713090971,9.68733842790488e-05,-3.97855554357047,0.350765512516058,0.400176168345885,0.188416214789481,-0.211759953556404,0.000608301307407241,ENSG00000198785,GRIN3A,protein_coding,9,-1,101569352,101738580,q31.1,glutamate ionotropic receptor NMDA type subunit 3A [Source:HGNC Symbol;Acc:HGNC:16767],NA,GRIN3A,116443,NM_133445
RGMB_SIG,RGMB,RGMB_SIG,RGMB,SIG,19,-4.21383091723313,-0.320712109987627,-0.29652003619508,-0.400200352448852,-0.103680316253772,9.7158274613608e-05,-1.79650969143771,1.11527600833885,1.16123192535843,0.96427799527451,-0.196953930083922,0.138978648180019,ENSG00000174136,RGMB,protein_coding,5,1,98768650,98798643,q15,repulsive guidance molecule BMP co-receptor b [Source:HGNC Symbol;Acc:HGNC:26896],NA,RGMB,285704,NM_001012761;NM_001366508;NM_001366509;NM_001366510;NM_001366511
SRR_SIG,SRR,SRR_SIG,SRR,SIG,4,4.21240616109515,0.389684431516666,0.374785635220154,0.438637619348066,0.0638519841279126,9.77276833858486e-05,3.9668459937533,2.86287707556934,2.78647996476685,3.11389615392037,0.327416189153517,0.000630723986138316,ENSG00000167720,SRR,protein_coding,17,1,2303383,2325260,p13.3,serine racemase [Source:HGNC Symbol;Acc:HGNC:14398],NA,SRR,63826,NM_001304803;NM_021947
MEN1_SIG,MEN1,MEN1_SIG,MEN1,SIG,120,4.21207326060852,0.333142420775147,0.316628668483784,0.387401892589628,0.0707732241058444,9.78261885823787e-05,3.76303074546605,5.32142683600228,5.245642703742,5.57043184200032,0.324789138258318,0.00120552468994538,ENSG00000133895,MEN1,protein_coding,11,-1,64803510,64811294,q13.1,menin 1 [Source:HGNC Symbol;Acc:HGNC:7010],Familial isolated hyperparathyroidism;Insulinoma;Multiple endocrine neoplasia type 1;MULTIPLE ENDOCRINE NEOPLASIA TYPE I;Null pituitary adenoma;Prolactinoma;Silent pituitary adenoma,MEN1,4221,NM_000244;NM_130799;NM_130800;NM_130801;NM_130802;NM_130803;NM_130804
CHSY3_SIG,CHSY3,CHSY3_SIG,CHSY3,SIG,27,-4.21125995798776,-0.151885311749286,-0.146893375667677,-0.168287387446004,-0.0213940117783275,9.81333155138749e-05,-2.97179649240989,0.283224837699234,0.319604364059997,0.163692108228153,-0.155912255831844,0.0115880891046031,ENSG00000198108,CHSY3,protein_coding,5,1,129904465,130186634,q23.3,chondroitin sulfate synthase 3 [Source:HGNC Symbol;Acc:HGNC:24293],NA,CHSY3,337876,NM_175856
MET_SIG,MET,MET_SIG,MET,SIG,26,-4.2100060870069,-0.133758720491317,-0.128609304875603,-0.150678228942949,-0.0220689240673457,9.86335268151846e-05,-0.58897374479847,0.61425174884907,0.630854431509998,0.559700077248878,-0.0711543542611194,0.657853869852389,ENSG00000105976,MET,protein_coding,7,1,116672196,116798386,q31.2,MET proto-oncogene, receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:7029],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 97;Hepatocellular Carcinoma;Hereditary papillary renal cell carcinoma;Osteofibrous dysplasia;OSTEOFIBROUS DYSPLASIA SUSCEPTIBILITY TO;Papillary renal cell carcinoma;Pediatric hepatocellular carcinoma;Renal cell carcinoma papillary 1,MET,4233,NM_000245;NM_001127500;NM_001324401;NM_001324402
NRBP1_SIG,NRBP1,NRBP1_SIG,NRBP1,SIG,25,-4.20954698751842,0.0534183502521397,0.0604041455516376,0.0304650228395037,-0.0299391227121337,9.8788095027449e-05,-2.93958812564348,7.05559061272654,7.08374310240368,6.96308957521593,-0.120653527187752,0.0125802088010859,ENSG00000115216,NRBP1,protein_coding,2,1,27427790,27442259,p23.3,nuclear receptor binding protein 1 [Source:HGNC Symbol;Acc:HGNC:7993],NA,NRBP1,29959,NM_001321357;NM_001321358;NM_001321359;NM_001321361;NM_001321362;NM_001321363;NM_013392
EDNRB_SIG,EDNRB,EDNRB_SIG,EDNRB,SIG,27,-4.20920282434025,-0.139350452740188,-0.132139419726466,-0.163043846928133,-0.0309044272016675,9.88925939214781e-05,-1.90096639902058,0.589541373921605,0.635596153754135,0.438218525900436,-0.197377627853699,0.116123032308701,ENSG00000136160,EDNRB,protein_coding,13,-1,77895481,77975529,q22.3,endothelin receptor type B [Source:HGNC Symbol;Acc:HGNC:3180],ABCD syndrome;Hirschsprung disease;HIRSCHSPRUNG DISEASE SUSCEPTIBILITY TO 2;Waardenburg-Shah syndrome;Waardenburg syndrome type 2;WAARDENBURG SYNDROME TYPE 4A,EDNRB,1910,NM_000115;NM_001122659;NM_001201397;NM_003991
EXOSC2_SIG,EXOSC2,EXOSC2_SIG,EXOSC2,SIG,40,4.20884867990481,0.355614659576869,0.344758348137702,0.391285397162704,0.0465270490250028,9.89666506147137e-05,3.35426722322712,4.81953715028019,4.77014678869486,4.98181976691769,0.211672978222826,0.00412358771326724,ENSG00000130713,EXOSC2,protein_coding,9,1,130693721,130704894,q34.12,exosome component 2 [Source:HGNC Symbol;Acc:HGNC:17097],Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome;SHORT STATURE HEARING LOSS RETINITIS PIGMENTOSA AND DISTINCTIVE FACIES,EXOSC2,23404,NM_001282708;NM_001282709;NM_014285
MEIS2_TF,MEIS2,MEIS2_TF,MEIS2,TF,85,-4.20872908434346,-0.0866005773248438,-0.0829142408208912,-0.0987128258378309,-0.0157985850169396,9.89666506147137e-05,-2.87156799665511,0.606101791907084,0.680040724608189,0.363159584460596,-0.316881140147593,0.0148883716831591,ENSG00000134138,MEIS2,protein_coding,15,-1,36889204,37101299,q14,Meis homeobox 2 [Source:HGNC Symbol;Acc:HGNC:7001],15q14 microdeletion syndrome;CLEFT PALATE CARDIAC DEFECTS AND MENTAL RETARDATION,MEIS2,4212,NM_001220482;NM_002399;NM_170674;NM_170675;NM_170676;NM_170677;NM_172315;NM_172316
NID2_SIG,NID2,NID2_SIG,NID2,SIG,48,-4.20871812142444,-0.0617708361784812,-0.0515754756214691,-0.0952698780086641,-0.0436944023871949,9.89666506147137e-05,-3.18504993085016,0.743300955352662,0.811576932543255,0.518965601726431,-0.292611330816824,0.00661564643777951,ENSG00000087303,NID2,protein_coding,14,-1,52004803,52069228,q22.1,nidogen 2 [Source:HGNC Symbol;Acc:HGNC:13389],NA,NID2,22795,NM_007361
ZNF569_TF,ZNF569,ZNF569_TF,ZNF569,TF,30,4.20693835161051,0.301919384280645,0.293067102293839,0.331005453665863,0.0379383513720237,9.9702606039409e-05,3.62612819967816,3.01983615842712,2.96276695588425,3.20734925249654,0.24458229661229,0.00184299113827987,ENSG00000196437,ZNF569,protein_coding,19,-1,37411155,37469275,q13.12,zinc finger protein 569 [Source:HGNC Symbol;Acc:HGNC:24737],NA,ZNF569,148266,NM_001330482;NM_152484
POLE4_SIG,POLE4,POLE4_SIG,POLE4,SIG,65,-4.20641262585706,0.0582373361091117,0.0673422784600192,0.0283210969561299,-0.0390211815038893,9.98882749313465e-05,-2.68821581940925,3.62864038331726,3.67757414395941,3.46785802692161,-0.209716117037798,0.023069818391635,ENSG00000115350,POLE4,protein_coding,2,1,74958492,74970128,p12,DNA polymerase epsilon 4, accessory subunit [Source:HGNC Symbol;Acc:HGNC:18755],NA,POLE4,56655,NM_019896
ICOS_SIG,ICOS,ICOS_SIG,ICOS,SIG,25,-4.20611819306814,0.0168796687779479,0.0362313932149062,-0.0467045686577723,-0.0829359618726786,9.9971974989429e-05,-3.96247539861268,1.75377603042011,1.8847113412468,1.32356000913241,-0.561151332114391,0.000638993668675128,ENSG00000163600,ICOS,protein_coding,2,1,203936748,203961577,q33.2,inducible T cell costimulator [Source:HGNC Symbol;Acc:HGNC:5351],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 1;IMMUNODEFICIENCY COMMON VARIABLE 2,ICOS,29851,NM_012092
TPP2_SIG,TPP2,TPP2_SIG,TPP2,SIG,44,4.20589982891511,0.383455598124718,0.374411719207056,0.413171200282752,0.0387594810756959,0.000100022106104138,2.45675767112736,6.94683337387214,6.91373510127919,7.05558484096327,0.141849739684081,0.0388177004751963,ENSG00000134900,TPP2,protein_coding,13,1,102596986,102679958,q33.1,tripeptidyl peptidase 2 [Source:HGNC Symbol;Acc:HGNC:12016],Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome,TPP2,7174,NM_001330588;NM_003291
TSC22D1_TF,TSC22D1,TSC22D1_TF,TSC22D1,TF,165,4.20565229864733,0.0610597416561514,0.0501139810047985,0.097024383796311,0.0469104027915125,0.00010008518688517,2.54212630777307,6.64179312285074,6.55758812197889,6.91846669714396,0.360878575165069,0.0322133995527329,ENSG00000102804,TSC22D1,protein_coding,13,-1,44432143,44577147,q14.11,TSC22 domain family member 1 [Source:HGNC Symbol;Acc:HGNC:16826],NA,TSC22D1,8848,NM_001243797;NM_001243798;NM_001243799;NM_006022;NM_183422
MSC_TF,MSC,MSC_TF,MSC,TF,47,-4.20553878540829,-0.0687465924037744,-0.058898241754601,-0.101105458822487,-0.042207217067886,0.000100088992472918,-1.13143337336976,0.918989998884547,0.94991191737796,0.817389409549049,-0.132522507828911,0.367582520938484,ENSG00000178860,MSC,protein_coding,8,-1,71841549,71844468,q13.3,musculin [Source:HGNC Symbol;Acc:HGNC:7321],NA,MSC,9242,NM_005098
IL15_SIG,IL15,IL15_SIG,IL15,SIG,48,-4.20418727533416,0.117880987752906,0.128706403618771,0.0823117641936349,-0.0463946394251362,0.000100642173729155,-1.34482353973153,1.6320686130558,1.67430801759837,1.4932819981302,-0.181026019468177,0.277197747279829,ENSG00000164136,IL15,protein_coding,4,1,141636583,141733987,q31.21,interleukin 15 [Source:HGNC Symbol;Acc:HGNC:5977],NA,IL15,3600,NM_000585;NM_172175
CD8B_SIG,CD8B,CD8B_SIG,CD8B,SIG,7,-4.2031879503657,-0.131883034074337,-0.0958540888399209,-0.250263854130276,-0.154409765290355,0.00010104086653384,-3.23689977301252,1.98424717126621,2.08235641433161,1.6618882297656,-0.420468184566009,0.00573825775703724,ENSG00000172116,CD8B,protein_coding,2,-1,86815339,86861924,p11.2,CD8b molecule [Source:HGNC Symbol;Acc:HGNC:1707],NA,CD8B,926,NM_001178100;NM_004931;NM_172101;NM_172102;NM_172213
RPAP1_SIG,RPAP1,RPAP1_SIG,RPAP1,SIG,23,4.20290482459304,0.548605384210482,0.532298598139381,0.602184824158383,0.0698862260190023,0.000101120517986418,3.378459853867,4.65883406915172,4.5997168600545,4.85307632761403,0.253359467559531,0.00384981301942964,ENSG00000103932,RPAP1,protein_coding,15,-1,41517176,41544269,q15.1,RNA polymerase II associated protein 1 [Source:HGNC Symbol;Acc:HGNC:24567],NA,RPAP1,26015,NM_015540
PPP2R5C_SIG,PPP2R5C,PPP2R5C_SIG,PPP2R5C,SIG,43,-4.2022143365973,0.368250958206279,0.380170524979584,0.329086667379707,-0.0510838575998766,0.000101382581359025,-2.65984928637403,6.91266700643395,6.94850856478431,6.79490188613993,-0.15360667864438,0.0245570390115724,ENSG00000078304,PPP2R5C,protein_coding,14,1,101761798,101927989,q32.31,protein phosphatase 2 regulatory subunit B'gamma [Source:HGNC Symbol;Acc:HGNC:9311],NA,PPP2R5C,5527,NM_001161725;NM_001161726;NM_001352912;NM_001352913;NM_001352914;NM_001352915;NM_001352916;NM_002719;NM_178586;NM_178587
NCAM1_SIG,NCAM1,NCAM1_SIG,NCAM1,SIG,10,-4.20158558726156,-0.0792429332827745,-0.0686310263631355,-0.114110627447303,-0.0454796010841673,0.00010161757752251,-3.49945712046372,2.74104721819189,2.92937321718622,2.1222617929248,-0.807111424261411,0.00271185932541895,ENSG00000149294,NCAM1,protein_coding,11,1,112961247,113278436,q23.2,neural cell adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:7656],NA,NCAM1,4684,NM_000615;NM_001076682;NM_001242607;NM_001242608;NM_181351
RARA_TF,RARA,RARA_TF,RARA,TF,196,-4.20066907463177,0.280846606531521,0.294027783567242,0.237537024842725,-0.0564907587245177,0.000101982656015181,-1.70039082872065,6.20190307316658,6.23830858821243,6.08228495230165,-0.156023635910783,0.163025137912014,ENSG00000131759,RARA,protein_coding,17,1,40309180,40357643,q21.2,retinoic acid receptor alpha [Source:HGNC Symbol;Acc:HGNC:9864],ACUTE PROMYELOCYTIC LEUKEMIA,RARA,5914,NM_000964;NM_001024809;NM_001145301;NM_001145302
TRMT11_SIG,TRMT11,TRMT11_SIG,TRMT11,SIG,59,4.20005891625581,0.324764800185994,0.316226905587974,0.35281788243663,0.036590976848656,0.000102204244794353,2.36584457370197,2.99699777163269,2.96122157163501,3.11454814305364,0.153326571418629,0.0471496237915145,ENSG00000066651,TRMT11,protein_coding,6,1,125986479,126203817,q22.32,tRNA methyltransferase 11 homolog [Source:HGNC Symbol;Acc:HGNC:21080],NA,TRMT11,60487,NM_001031712;NM_001350580;NM_001350581;NM_001350582;NM_001350583;NM_001350584;NM_001350585;NM_001350586;NM_001350587;NM_001350588;NM_001350589;NM_001350590;NM_001350591;NM_001350592;NM_001350593;NM_001350594;NM_001350595;NM_001350596;NM_001350597
KATNAL1_SIG,KATNAL1,KATNAL1_SIG,KATNAL1,SIG,17,4.19996833939941,0.225791484525437,0.214771774537122,0.261999103058472,0.0472273285213508,0.000102204244794353,1.94126887091734,4.50363453940509,4.46540478360325,4.62924659418256,0.163841810579309,0.108081350256526,ENSG00000102781,KATNAL1,protein_coding,13,-1,30202630,30307551,q12.3,katanin catalytic subunit A1 like 1 [Source:HGNC Symbol;Acc:HGNC:28361],NA,KATNAL1,84056,NM_001014380;NM_032116
GDPD1_SIG,GDPD1,GDPD1_SIG,GDPD1,SIG,44,4.19939665263218,0.11998632034877,0.109384772984954,0.154819975972737,0.0454352029877827,0.000102353295437861,2.82097002196965,1.83957802011348,1.77723729186698,2.04441184149482,0.26717454962784,0.016834570339933,ENSG00000153982,GDPD1,protein_coding,17,1,59220467,59275970,q22,glycerophosphodiester phosphodiesterase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20883],NA,GDPD1,284161,NM_001165993;NM_001165994;NM_182569
CATSPER3_SIG,CATSPER3,CATSPER3_SIG,CATSPER3,SIG,9,4.19938796951467,-0.0947607848775445,-0.100966033590912,-0.0743721105336219,0.0265939230572904,0.000102353295437861,3.53040234529547,0.397738493458147,0.376729560478145,0.466767844678155,0.09003828420001,0.00246634937792382,ENSG00000152705,CATSPER3,protein_coding,5,1,134967907,135011696,q31.1,cation channel sperm associated 3 [Source:HGNC Symbol;Acc:HGNC:20819],NA,CATSPER3,347732,NM_178019
IKZF3_TF,IKZF3,IKZF3_TF,IKZF3,TF,120,-4.19932466185075,-0.170953283712575,-0.156056737401916,-0.219899078733311,-0.0638423413313949,0.000102353295437861,-2.42673310816952,2.45988840506588,2.53630185818568,2.20881563052939,-0.327486227656297,0.0413515785007437,ENSG00000161405,IKZF3,protein_coding,17,-1,39757718,39864312,q21.1,IKAROS family zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:13178],B-cell chronic lymphocytic leukemia,IKZF3,22806,NM_001257408;NM_001257409;NM_001257410;NM_001257411;NM_001257412;NM_001257413;NM_001257414;NM_001284514;NM_001284515;NM_001284516;NM_012481;NM_183228;NM_183229;NM_183230;NM_183231;NM_183232
NAT8L_SIG,NAT8L,NAT8L_SIG,NAT8L,SIG,54,4.1976379128119,-0.122438451801641,-0.12845052382679,-0.102684500861869,0.0257660229649209,0.000103070830096679,2.1044898816877,1.13332013944051,1.07739881466382,1.31706163513534,0.239662820471516,0.0797078437740753,ENSG00000185818,NAT8L,protein_coding,4,1,2059512,2069089,p16.3,N-acetyltransferase 8 like [Source:HGNC Symbol;Acc:HGNC:26742],N-ACETYLASPARTATE DEFICIENCY,NAT8L,339983,NM_178557
JUNB_TF,JUNB,JUNB_TF,JUNB,TF,129,-4.19746329423197,0.20493284807126,0.218125484381678,0.161585614479887,-0.0565398699017906,0.000103102752571572,-3.78210718999207,9.27521130126816,9.38518011964214,8.91388518375367,-0.471294935888462,0.00113860177378506,ENSG00000171223,JUNB,protein_coding,19,1,12791486,12793315,p13.13,JunB proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6205],NA,JUNB,3726,NM_002229
ANAPC7_SIG,ANAPC7,ANAPC7_SIG,ANAPC7,SIG,33,4.19735807946419,0.209346316430328,0.192145593768621,0.265862976604508,0.0737173828358871,0.000103103113125989,3.41211568499616,5.37052481811337,5.31599282644863,5.54970136215465,0.233708535706025,0.00347877969093765,ENSG00000196510,ANAPC7,protein_coding,12,-1,110372900,110403730,q24.11,anaphase promoting complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:17380],NA,ANAPC7,51434,NM_001137664;NM_016238
SATB1_SIG,SATB1,SATB1_SIG,SATB1,SIG,38,4.19631102331939,0.287450073770838,0.278915599393317,0.31549191815412,0.0365763187608031,0.000103532972618612,1.32716848205183,7.67403622845546,7.64799050498943,7.75961503412958,0.111624529140152,0.284157592592039,ENSG00000182568,SATB1,protein_coding,3,-1,18345377,18445588,p24.3,SATB homeobox 1 [Source:HGNC Symbol;Acc:HGNC:10541],NA,SATB1,6304,NM_001131010;NM_001195470;NM_001322871;NM_001322872;NM_001322873;NM_001322874;NM_001322875;NM_001322876;NM_002971
IL17RC_SIG,IL17RC,IL17RC_SIG,IL17RC,SIG,41,4.19516519602853,0.0305875433603612,0.0231853737535964,0.0549089577825885,0.0317235840289922,0.000104009853074794,2.57231629049994,3.162764822938,3.08592551166718,3.415236845685,0.329311334017825,0.0300000830326712,ENSG00000163702,IL17RC,protein_coding,3,1,9917074,9933630,p25.3,interleukin 17 receptor C [Source:HGNC Symbol;Acc:HGNC:18358],CANDIDIASIS FAMILIAL 9;Chronic mucocutaneous candidiasis,IL17RC,84818,NM_001203263;NM_001203264;NM_001203265;NM_032732;NM_153460;NM_153461
SOCS3_SIG,SOCS3,SOCS3_SIG,SOCS3,SIG,22,-4.19449990116717,0.161575722036997,0.173623323760478,0.121990744945559,-0.0516325788149184,0.000104221677831851,-3.3092321044799,6.36039293358818,6.50637100518757,5.88075069833304,-0.625620306854533,0.00469034612820775,ENSG00000184557,SOCS3,protein_coding,17,-1,78356778,78360077,q25.3,suppressor of cytokine signaling 3 [Source:HGNC Symbol;Acc:HGNC:19391],NA,SOCS3,9021,NM_003955
FOLR2_SIG,FOLR2,FOLR2_SIG,FOLR2,SIG,16,-4.19449540476632,-0.0499439756550217,-0.0241478254687902,-0.134702754838354,-0.110554929369564,0.000104221677831851,-2.13142580945475,1.30095535493935,1.36534242870689,1.08939782684599,-0.275944601860894,0.0758039757298376,ENSG00000165457,FOLR2,protein_coding,11,1,72216601,72221950,q13.4,folate receptor beta [Source:HGNC Symbol;Acc:HGNC:3793],NA,FOLR2,2350,NM_000803;NM_001113534;NM_001113535;NM_001113536
PKD1_SIG,PKD1,PKD1_SIG,PKD1,SIG,57,4.19425496941508,0.38074152624764,0.373646671439221,0.404053192046731,0.0304065206075093,0.000104284306909847,2.58329405260552,6.51737762677259,6.4774797193793,6.64847075106481,0.170991031685508,0.029275237497808,ENSG00000008710,PKD1,protein_coding,16,-1,2088710,2135898,p13.3,polycystin 1, transient receptor potential channel interacting [Source:HGNC Symbol;Acc:HGNC:9008],Autosomal dominant polycystic kidney disease;Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis;POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,PKD1,5310,NM_000296;NM_001009944
CEBPG_TF,CEBPG,CEBPG_TF,CEBPG,TF,110,4.1935043245681,0.0108519614058386,0.00549759327338627,0.0284448852696106,0.0229472919962243,0.000104582071999682,1.36578455180264,5.6492184409521,5.63252105441597,5.70408128242793,0.0715602280119514,0.269547426422324,ENSG00000153879,CEBPG,protein_coding,19,1,33373685,33382686,q13.11,CCAAT enhancer binding protein gamma [Source:HGNC Symbol;Acc:HGNC:1837],NA,CEBPG,1054,NM_001252296;NM_001806
KAT8_SIG,KAT8,KAT8_SIG,KAT8,SIG,43,4.19243809367231,0.268712659555229,0.263501698161761,0.285834389848055,0.0223326916862949,0.000105026705124539,3.0834720908958,5.86020587643538,5.83254243203756,5.95110005088537,0.118557618847819,0.00865750797748351,ENSG00000103510,KAT8,protein_coding,16,1,31114489,31131393,p11.2,lysine acetyltransferase 8 [Source:HGNC Symbol;Acc:HGNC:17933],NA,KAT8,84148,NM_032188;NM_182958
NOP9_SIG,NOP9,NOP9_SIG,NOP9,SIG,6,4.19075744303797,0.572659768187655,0.557361712051767,0.622924809777001,0.0655630977252341,0.000105759187325085,3.2334651651133,5.91404095331681,5.86652122287711,6.07017721047582,0.203655987598706,0.00578245369664448,ENSG00000196943,NOP9,protein_coding,14,1,24299850,24309124,q12,NOP9 nucleolar protein [Source:HGNC Symbol;Acc:HGNC:19826],NA,NOP9,161424,NM_001286367;NM_174913
CXCL1_SIG,CXCL1,CXCL1_SIG,CXCL1,SIG,30,-4.19035186888001,0.0879930020911061,0.114622324219518,0.000496657954894655,-0.114125666264624,0.000105899789162092,-4.57984531189721,2.50470542488998,2.71828802700751,1.80293401793239,-0.91535400907512,7.42074838916816e-05,ENSG00000163739,CXCL1,protein_coding,4,1,73869393,73871242,q13.3,C-X-C motif chemokine ligand 1 [Source:HGNC Symbol;Acc:HGNC:4602],NA,CXCL1,2919,NM_001511
ZNF765_TF,ZNF765,ZNF765_TF,ZNF765,TF,46,4.18970899210906,0.157729765689678,0.148052048954256,0.189527977820352,0.0414759288660961,0.000106151535171513,3.04937364729507,3.52415325028636,3.47469987038073,3.68664292711916,0.21194305673843,0.00946345199174564,ENSG00000196417,ZNF765,protein_coding,19,1,53389793,53430413,q13.42,zinc finger protein 765 [Source:HGNC Symbol;Acc:HGNC:25092],NA,ZNF765,91661,NM_001040185;NM_001350495
SNRNP48_SIG,SNRNP48,SNRNP48_SIG,SNRNP48,SIG,26,4.18870382229843,0.281727560359594,0.275025593842349,0.303748307487685,0.0287227136453357,0.00010657384355238,3.11720259724418,4.87170326860474,4.83456949086095,4.99371425262007,0.15914476175912,0.00795855960893106,ENSG00000168566,SNRNP48,protein_coding,6,1,7590198,7611967,p24.3,small nuclear ribonucleoprotein U11/U12 subunit 48 [Source:HGNC Symbol;Acc:HGNC:21368],NA,SNRNP48,154007,NM_152551
SLC30A4_SIG,SLC30A4,SLC30A4_SIG,SLC30A4,SIG,18,-4.18807090854238,-0.0688181471244275,-0.0521491815150882,-0.123587605555114,-0.0714384240400255,0.000106822440161327,-3.89252415962905,1.01555780315799,1.09595897731582,0.751382516639435,-0.344576460676381,0.000801837781411506,ENSG00000104154,SLC30A4,protein_coding,15,-1,45479606,45522755,q21.1,solute carrier family 30 member 4 [Source:HGNC Symbol;Acc:HGNC:11015],NA,SLC30A4,7782,NM_013309
CBX7_SIG,CBX7,CBX7_SIG,CBX7,SIG,60,-4.18707683385787,0.0261688277307636,0.036970198109748,-0.00932138922875644,-0.0462915873385045,0.00010724205321312,-4.38835729427027,4.05021918811355,4.15799082760692,3.69611237263534,-0.461878454971575,0.000148657780061164,ENSG00000100307,CBX7,protein_coding,22,-1,39120167,39152680,q13.1,chromobox 7 [Source:HGNC Symbol;Acc:HGNC:1557],NA,CBX7,23492,NM_001346743;NM_001346744;NM_175709
TLR8_SIG,TLR8,TLR8_SIG,TLR8,SIG,46,-4.18660476428999,0.341769906986513,0.377983735544966,0.222781613151598,-0.155202122393368,0.000107416036545782,-3.97296337990451,3.85911977702902,4.08903235116889,3.10369274771232,-0.985339603456563,0.000619198175198938,ENSG00000101916,TLR8,protein_coding,X,1,12906620,12923169,p22.2,toll like receptor 8 [Source:HGNC Symbol;Acc:HGNC:15632],NA,TLR8,51311,NM_016610;NM_138636
THBD_SIG,THBD,THBD_SIG,THBD,SIG,20,-4.18568901844632,0.132406633462035,0.150576461569087,0.0727057696817197,-0.0778706918873676,0.000107800692239646,-3.83970541261226,3.8048082344227,3.98683717980215,3.20671312817596,-0.780124051626189,0.000950053354450306,ENSG00000178726,THBD,protein_coding,20,-1,23045633,23049741,p11.21,thrombomodulin [Source:HGNC Symbol;Acc:HGNC:11784],Atypical hemolytic uremic syndrome with thrombomodulin anomaly;HEMOLYTIC UREMIC SYNDROME ATYPICAL SUSCEPTIBILITY TO 6;Thrombomodulin-related bleeding disorder;Thrombophilia due to thrombomodulin defect,THBD,7056,NM_000361
PKNOX1_TF,PKNOX1,PKNOX1_TF,PKNOX1,TF,25,4.18451558840155,0.0623883076450584,0.0491631046931374,0.105842545915656,0.0566794412225187,0.00010830745609371,2.86948677996383,4.18722166178152,4.14447510050973,4.32767464881741,0.183199548307685,0.0149640872546755,ENSG00000160199,PKNOX1,protein_coding,21,1,42974510,43033931,q22.3,PBX/knotted 1 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9022],NA,PKNOX1,5316,NM_001286258;NM_001320694;NM_004571
PHAX_SIG,PHAX,PHAX_SIG,PHAX,SIG,19,4.18441586402295,0.211697494447248,0.202798371924575,0.240937468450313,0.038139096525738,0.00010830745609371,3.17545480672406,4.29349147907908,4.23766799953143,4.47691148330706,0.239243483775625,0.0067894610973109,ENSG00000164902,PHAX,protein_coding,5,1,126600925,126627252,q23.2,phosphorylated adaptor for RNA export [Source:HGNC Symbol;Acc:HGNC:10241],NA,PHAX,51808,NM_032177
NEFL_SIG,NEFL,NEFL_SIG,NEFL,SIG,17,-4.18356059934995,-0.279999441242778,-0.258728890243929,-0.34988839452471,-0.0911595042807811,0.000108666236326779,-3.28000538339295,0.442919290826336,0.495636893819089,0.269704309564434,-0.225932584254655,0.00508602703849195,ENSG00000277586,NEFL,protein_coding,8,-1,24950955,24957110,p21.2,neurofilament light [Source:HGNC Symbol;Acc:HGNC:7739],Autosomal dominant Charcot-Marie-Tooth disease type 2E;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2E;CHARCOT-MARIE-TOOTH DISEASE DEMYELINATING TYPE 1F;CHARCOT-MARIE-TOOTH DISEASE DOMINANT INTERMEDIATE G;Charcot-Marie-Tooth disease type 1F;Charcot-Marie-Tooth disease type 2B5,NEFL,4747,NM_006158
ATP11B_SIG,ATP11B,ATP11B_SIG,ATP11B,SIG,25,-4.18276277596036,0.297057738906012,0.303726487001095,0.275146138022167,-0.0285803489789279,0.00010899859895411,-2.70339303234348,7.25585379550084,7.29917559723684,7.11351073265398,-0.185664864582854,0.0222244405784669,ENSG00000058063,ATP11B,protein_coding,3,1,182793503,182921629,q26.33,ATPase phospholipid transporting 11B (putative) [Source:HGNC Symbol;Acc:HGNC:13553],NA,ATP11B,23200,NM_014616
ADAMTS4_SIG,ADAMTS4,ADAMTS4_SIG,ADAMTS4,SIG,30,-4.18124380166469,-0.144102859225215,-0.137085368051282,-0.167160330225281,-0.0300749621739985,0.000109679325138812,-1.24979754014523,0.51124505964352,0.535549086233983,0.431388972274856,-0.104160113959128,0.315602285709905,ENSG00000158859,ADAMTS4,protein_coding,1,-1,161184302,161199054,q23.3,ADAM metallopeptidase with thrombospondin type 1 motif 4 [Source:HGNC Symbol;Acc:HGNC:220],NA,ADAMTS4,9507,NM_001320336;NM_005099
DCLRE1C_SIG,DCLRE1C,DCLRE1C_SIG,DCLRE1C,SIG,25,4.17875839586037,0.296037735495911,0.291489284196645,0.310982646907785,0.0194933627111404,0.000110834035431196,3.05610019944706,5.41908336515934,5.38144439802004,5.54275425718847,0.161309859168428,0.00930562333234875,ENSG00000152457,DCLRE1C,protein_coding,10,-1,14897359,14954432,p13,DNA cross-link repair 1C [Source:HGNC Symbol;Acc:HGNC:17642],OMENN SYNDROME;Severe combined immunodeficiency due to DCLRE1C deficiency;SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION,DCLRE1C,64421,NM_001033855;NM_001033857;NM_001033858;NM_001289076;NM_001289077;NM_001289078;NM_001289079;NM_001350965;NM_001350966;NM_001350967;NM_022487
ZNF540_TF,ZNF540,ZNF540_TF,ZNF540,TF,97,4.17832909953144,-0.0408466436374203,-0.0483663416529242,-0.0161390644436214,0.0322272772093027,0.000110992743410689,3.444458075289,0.94055777490378,0.887885240478292,1.11362467373038,0.225739433252093,0.00316097567187638,ENSG00000171817,ZNF540,protein_coding,19,1,37551406,37614179,q13.12,zinc finger protein 540 [Source:HGNC Symbol;Acc:HGNC:25331],NA,ZNF540,163255,NM_001172225;NM_001172226;NM_152606
ZBTB12_TF,ZBTB12,ZBTB12_TF,ZBTB12,TF,305,4.17804207944868,0.219187228782727,0.206508162378403,0.260847018396935,0.0543388560185324,0.000111082191690439,3.19457174754543,2.75746190297303,2.66114663088425,3.0739263684076,0.412779737523355,0.0064542050040345,ENSG00000204366,ZBTB12,protein_coding,6,-1,31899607,31901992,p21.33,zinc finger and BTB domain containing 12 [Source:HGNC Symbol;Acc:HGNC:19066],NA,ZBTB12,221527,NM_181842
MSMO1_SIG,MSMO1,MSMO1_SIG,MSMO1,SIG,10,4.17590143532343,0.302733986948152,0.295904300624516,0.325174384868671,0.0292700842441556,0.000112080992167038,3.62224824141405,3.02729778669006,2.95843419171517,3.25356388446467,0.295129692749495,0.00186667483694524,ENSG00000052802,MSMO1,protein_coding,4,1,165327667,165343164,q32.3,methylsterol monooxygenase 1 [Source:HGNC Symbol;Acc:HGNC:10545],Microcephaly-congenital cataract-psoriasiform dermatitis syndrome;MICROCEPHALY CONGENITAL CATARACT AND PSORIASIFORM DERMATITIS,MSMO1,6307,NM_001017369;NM_006745
ACVRL1_SIG,ACVRL1,ACVRL1_SIG,ACVRL1,SIG,23,-4.1755809250452,-0.0811070021590536,-0.0621732184578001,-0.143318005748886,-0.0811447872910861,0.000112187794502305,-2.06164937985309,1.16460244735561,1.22896769684192,0.953116627614883,-0.275851069227035,0.0864508649828814,ENSG00000139567,ACVRL1,protein_coding,12,1,51906908,51923361,q13.13,activin A receptor like type 1 [Source:HGNC Symbol;Acc:HGNC:175],HEREDITARY HEMORRHAGIC TELANGIECTASIA;Heritable pulmonary arterial hypertension;TELANGIECTASIA HEREDITARY HEMORRHAGIC TYPE 2,ACVRL1,94,NM_000020;NM_001077401
TRIM68_SIG,TRIM68,TRIM68_SIG,TRIM68,SIG,47,4.1722162399505,0.257680365568049,0.24304993099431,0.305751793453191,0.0627018624588816,0.000113791174876011,4.64669782636474,3.57634078008023,3.47744791863143,3.90127446769771,0.423826549066285,5.72691974125742e-05,ENSG00000167333,TRIM68,protein_coding,11,-1,4598672,4608231,p15.4,tripartite motif containing 68 [Source:HGNC Symbol;Acc:HGNC:21161],NA,TRIM68,55128,NM_001304496;NM_018073
SOX4_TF,SOX4,SOX4_TF,SOX4,TF,111,4.17214221074439,0.122594275392956,0.111638482528515,0.158591880518978,0.0469533979904633,0.000113791174876011,1.62567623041234,7.67454456296531,7.61325507262133,7.87592431695266,0.26266924433133,0.183350734774154,ENSG00000124766,SOX4,protein_coding,6,1,21592768,21598619,p22.3,SRY-box 4 [Source:HGNC Symbol;Acc:HGNC:11200],NA,SOX4,6659,NM_003107
GNL3_SIG,GNL3,GNL3_SIG,GNL3,SIG,26,4.17158121862639,0.576783962029197,0.563359760041038,0.620892054276007,0.0575322942349692,0.000114019843123413,4.52630196543643,6.15245725215594,6.07794113299928,6.39729592938495,0.319354796385664,9.00056625761609e-05,ENSG00000163938,GNL3,protein_coding,3,1,52681156,52694497,p21.1,G protein nucleolar 3 [Source:HGNC Symbol;Acc:HGNC:29931],NA,GNL3,26354,NM_014366;NM_206825;NM_206826
KDM6B_SIG,KDM6B,KDM6B_SIG,KDM6B,SIG,20,-4.17120914155334,-0.0502419668329907,-0.0384706416659433,-0.0889191780961463,-0.0504485364302029,0.000114145212128494,-2.26325200696838,7.19787391175745,7.23899186965302,7.06277205010058,-0.17621981955244,0.0583100164426154,ENSG00000132510,KDM6B,protein_coding,17,1,7839904,7854796,p13.1,lysine demethylase 6B [Source:HGNC Symbol;Acc:HGNC:29012],Autosomal Recessive Mental Retardation,KDM6B,23135,NM_001080424;NM_001348716
VDR_SIG,VDR,VDR_SIG,VDR,SIG,21,-4.17112363420786,0.420600211339062,0.445851040907015,0.337633199901503,-0.108217841005512,0.000114145212128494,-3.66472798841699,3.75100339188754,3.88712247273292,3.3037549833956,-0.583367489337318,0.00163795039755363,ENSG00000111424,VDR,protein_coding,12,-1,47841537,47943048,q13.11,vitamin D receptor [Source:HGNC Symbol;Acc:HGNC:12679],Hypocalcemic vitamin D resistant rickets;OSTEOPOROSIS;rickets vitamin D-dependent type 2A;VITAMIN D-DEPENDENT RICKETS TYPE 2A,VDR,7421,NM_000376;NM_001017535;NM_001017536;NM_001364085
HMG20A_TF,HMG20A,HMG20A_TF,HMG20A,TF,151,4.17021378736415,0.440589266910337,0.431808856062406,0.469439188267823,0.0376303322054166,0.000114549827856347,3.64235268825287,5.3227132982675,5.26944134656496,5.49774971100444,0.228308364439481,0.00175222628384321,ENSG00000140382,HMG20A,protein_coding,15,1,77420412,77485607,q24.3,high mobility group 20A [Source:HGNC Symbol;Acc:HGNC:5001],NA,HMG20A,10363,NM_001304504;NM_001304505;NM_018200
SCLY_SIG,SCLY,SCLY_SIG,SCLY,SIG,88,4.16942308394094,0.0246533988469281,0.0155527405024997,0.0545555619786213,0.0390028214761218,0.000114895736614917,3.40337838785461,1.96909357906052,1.91888560004914,2.13406265295507,0.215177052905935,0.00356720453632191,ENSG00000132330,SCLY,protein_coding,2,1,238060889,238099413,q37.3,selenocysteine lyase [Source:HGNC Symbol;Acc:HGNC:18161],NA,SCLY,51540,NM_016510
RNF214_SIG,RNF214,RNF214_SIG,RNF214,SIG,28,4.16831189897913,0.425986929250146,0.413397550458202,0.467352030995104,0.053954480536902,0.000115404764543064,2.6745796852249,4.95982360790575,4.91955823508909,5.09212411858906,0.172565883499961,0.0237587969230319,ENSG00000167257,RNF214,protein_coding,11,1,117232625,117286454,q23.3,ring finger protein 214 [Source:HGNC Symbol;Acc:HGNC:25335],NA,RNF214,257160,NM_001077239;NM_001278249;NM_207343
ACYP1_SIG,ACYP1,ACYP1_SIG,ACYP1,SIG,49,4.16402507939082,0.22159339931107,0.203977422141086,0.2794744671553,0.0754970450142138,0.000117540898648747,3.2553350504971,2.86212042001031,2.79231214271962,3.09149047396544,0.299178331245818,0.005442946423181,ENSG00000119640,ACYP1,protein_coding,14,-1,75053237,75069483,q24.3,acylphosphatase 1 [Source:HGNC Symbol;Acc:HGNC:179],NA,ACYP1,97,NM_001107;NM_001302616;NM_001302617
GSS_SIG,GSS,GSS_SIG,GSS,SIG,14,4.16125593389995,0.478651764997078,0.468341102080307,0.5125296574379,0.0441885553575934,0.000118918138425741,5.30268461539928,5.22472536725831,5.15966827580781,5.43848438202426,0.278816106216456,3.92623710438434e-06,ENSG00000100983,GSS,protein_coding,20,-1,34928432,34956027,q11.22,glutathione synthetase [Source:HGNC Symbol;Acc:HGNC:4624],GLUTATHIONE SYNTHETASE DEFICIENCY;GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES HEMOLYTIC ANEMIA DUE TO;Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria,GSS,2937,NM_000178;NM_001322494;NM_001322495
DBT_SIG,DBT,DBT_SIG,DBT,SIG,154,4.1611589562011,0.303362476129816,0.288922733936595,0.350807343336115,0.0618846093995206,0.000118918138425741,4.21444010669924,3.93797479534487,3.85695617596718,4.204178830443,0.34722265447582,0.00027413003642676,ENSG00000137992,DBT,protein_coding,1,-1,100186919,100249834,p21.2,dihydrolipoamide branched chain transacylase E2 [Source:HGNC Symbol;Acc:HGNC:2698],Classic maple syrup urine disease;Intermediate maple syrup urine disease;Intermittent maple syrup urine disease;Maple Syrup Urine Disease;Maple Syrup Urine Diseaseq;Thiamine-responsive maple syrup urine disease,DBT,1629,NM_001918
ANGEL2_SIG,ANGEL2,ANGEL2_SIG,ANGEL2,SIG,101,4.16071568660837,0.315614415923607,0.308641781392829,0.338524500810449,0.0298827194176201,0.000119095218594683,4.67722474905746,5.40392853889976,5.34616082795943,5.59373673198943,0.247575904029994,5.10817138886366e-05,ENSG00000174606,ANGEL2,protein_coding,1,-1,212992182,213015867,q32.3,angel homolog 2 [Source:HGNC Symbol;Acc:HGNC:30534],NA,ANGEL2,90806,NM_001300753;NM_001300755;NM_001300757;NM_001300758;NM_144567
ZDHHC3_SIG,ZDHHC3,ZDHHC3_SIG,ZDHHC3,SIG,54,-4.16043995767061,0.168268911002382,0.180865801434706,0.126879128153315,-0.0539866732813917,0.000119185096997563,-3.96415277903193,6.52714510399913,6.5715848866969,6.38112867513501,-0.190456211561889,0.000636197624012573,ENSG00000163812,ZDHHC3,protein_coding,3,-1,44915257,44976185,p21.31,zinc finger DHHC-type containing 3 [Source:HGNC Symbol;Acc:HGNC:18470],NA,ZDHHC3,51304,NM_001135179;NM_001330761;NM_001349376;NM_001349377;NM_001349378;NM_001349379;NM_001349380;NM_001349381;NM_016598
GNPDA2_SIG,GNPDA2,GNPDA2_SIG,GNPDA2,SIG,61,4.1600943243735,0.165613707493634,0.158509470463839,0.188956200591534,0.0304467301276953,0.000119311571751681,2.46120561737392,3.57814976094962,3.53711166640741,3.71298921444547,0.175877548038061,0.0384235943730572,ENSG00000163281,GNPDA2,protein_coding,4,-1,44682200,44726595,p12,glucosamine-6-phosphate deaminase 2 [Source:HGNC Symbol;Acc:HGNC:21526],NA,GNPDA2,132789,NM_001270880;NM_001270881;NM_138335
UCK2_SIG,UCK2,UCK2_SIG,UCK2,SIG,37,4.15954682162731,0.351937834190157,0.337052676611433,0.40084620909168,0.0637935324802477,0.000119543796428571,3.10587337344561,5.21548516675703,5.14300351919086,5.45363915161729,0.310635632426434,0.00819152754487594,ENSG00000143179,UCK2,protein_coding,1,1,165827614,165911618,q24.1,uridine-cytidine kinase 2 [Source:HGNC Symbol;Acc:HGNC:12562],NA,UCK2,7371,NM_001363568;NM_012474
GEMIN4_SIG,GEMIN4,GEMIN4_SIG,GEMIN4,SIG,9,4.15917841383713,0.502252314845593,0.490930805379978,0.539451560232617,0.0485207548526391,0.000119682596968823,2.85868400328175,4.88109294205414,4.83176538435839,5.04316920305446,0.211403818696064,0.0153668342888449,ENSG00000179409,GEMIN4,protein_coding,17,-1,744421,753999,p13.3,gem nuclear organelle associated protein 4 [Source:HGNC Symbol;Acc:HGNC:15717],NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY CATARACTS AND RENAL ABNORMALITIES,GEMIN4,50628,NM_015721
TAF10_SIG,TAF10,TAF10_SIG,TAF10,SIG,3,-4.15897203037055,-0.0891124491827681,-0.08115699777779,-0.11525178951341,-0.0340947917356203,0.000119736616791633,-4.0962590936703,6.23016770037888,6.26566184245119,6.11354409071273,-0.152117751738457,0.000410676310117308,ENSG00000166337,TAF10,protein_coding,11,-1,6606294,6612539,p15.4,TATA-box binding protein associated factor 10 [Source:HGNC Symbol;Acc:HGNC:11543],NA,TAF10,6881,NM_006284
MUTYH_SIG,MUTYH,MUTYH_SIG,MUTYH,SIG,20,4.15877471130896,0.344688317748512,0.33341551025831,0.381727542359179,0.0483120321008692,0.000119785927810011,3.21809302013973,4.2366988770767,4.19389538544998,4.37733892099304,0.183443535543062,0.00603718448343025,ENSG00000132781,MUTYH,protein_coding,1,-1,45329163,45340470,p34.1,mutY DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:7527],FAMILIAL ADENOMATOUS POLYPOSIS 2;GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;MUTYH-related attenuated familial adenomatous polyposis;Pilomatrixoma,MUTYH,4595,NM_001048171;NM_001048172;NM_001048173;NM_001048174;NM_001128425;NM_001293190;NM_001293191;NM_001293192;NM_001293195;NM_001293196;NM_001350650;NM_001350651;NM_012222
CHI3L2_SIG,CHI3L2,CHI3L2_SIG,CHI3L2,SIG,14,-4.15856191877791,-0.107617344421864,-0.0969532723396238,-0.142656438406366,-0.0457031660667422,0.000119843395537884,-4.53937808772868,1.07827603467098,1.16402414645214,0.796532238818592,-0.367491907633549,8.63009001900944e-05,ENSG00000064886,CHI3L2,protein_coding,1,1,111200771,111243440,p13.2,chitinase 3 like 2 [Source:HGNC Symbol;Acc:HGNC:1933],NA,CHI3L2,1117,NM_001025197;NM_001025199;NM_004000
DHX40_SIG,DHX40,DHX40_SIG,DHX40,SIG,34,4.15780178952644,0.245290128189735,0.237996168326816,0.269255996310754,0.0312598279839372,0.000120188468747706,2.36060687419506,5.54788541421941,5.52181944262425,5.63353074946066,0.111711306836414,0.0476348967682477,ENSG00000108406,DHX40,protein_coding,17,1,59565558,59608345,q23.1,DEAH-box helicase 40 [Source:HGNC Symbol;Acc:HGNC:18018],NA,DHX40,79665,NM_001166301;NM_024612
GATM_SIG,GATM,GATM_SIG,GATM,SIG,37,-4.15734813580707,-0.119682213322936,-0.114614269291223,-0.136334029427135,-0.0217197601359125,0.000120372960434258,-2.80449721460303,2.1607285759767,2.28003328180142,1.7687273996955,-0.511305882105911,0.0175170993157327,ENSG00000171766,GATM,protein_coding,15,-1,45361124,45402327,q21.1,glycine amidinotransferase [Source:HGNC Symbol;Acc:HGNC:4175],ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY;CEREBRAL CREATINE DEFICIENCY SYNDROME 3;L-Arginine:glycine amidinotransferase deficiency,GATM,2628,NM_001321015;NM_001482
NUDT13_SIG,NUDT13,NUDT13_SIG,NUDT13,SIG,17,4.15672853158581,0.197609082715791,0.187513705915367,0.230779606488611,0.0432659005732441,0.000120635638071758,2.64263012194407,1.8662561062234,1.82656275527173,1.99667711649317,0.170114361221434,0.0254791541490209,ENSG00000166321,NUDT13,protein_coding,10,1,73110375,73131828,q22.2,nudix hydrolase 13 [Source:HGNC Symbol;Acc:HGNC:18827],NA,NUDT13,25961,NM_001283014;NM_001283015;NM_001283016;NM_001283017;NM_001283019;NM_015901
PCGF3_SIG,PCGF3,PCGF3_SIG,PCGF3,SIG,31,4.15664377110103,0.0124749045594304,0.00742064900655659,0.0290817442331587,0.0216610952266021,0.000120635638071758,2.28025662146959,6.56966937824396,6.53299427044089,6.69017330388262,0.157179033441729,0.0562398413054119,ENSG00000185619,PCGF3,protein_coding,4,1,705748,770640,p16.3,polycomb group ring finger 3 [Source:HGNC Symbol;Acc:HGNC:10066],NA,PCGF3,10336,NM_001317836;NM_006315
CD96_SIG,CD96,CD96_SIG,CD96,SIG,65,4.15501693494069,-0.00841207104192941,-0.0168442785159022,0.0192937535154097,0.036138032031312,0.000121442437382278,2.03116593523375,5.23557986474945,5.12020839229339,5.61465755996222,0.494449167668836,0.0916982362950095,ENSG00000153283,CD96,protein_coding,3,1,111292719,111665750,q13.13,CD96 molecule [Source:HGNC Symbol;Acc:HGNC:16892],C Syndrome,CD96,10225,NM_001318889;NM_005816;NM_198196
HSPB1_SIG,HSPB1,HSPB1_SIG,HSPB1,SIG,51,4.15476600186949,0.0421492341524202,0.0354837615561519,0.064050072683016,0.0285663111268641,0.000121521023703781,0.987346472679729,5.31966936047356,5.29003704690854,5.41703267647291,0.12699562956437,0.437083526907626,ENSG00000106211,HSPB1,protein_coding,7,1,76302673,76304295,q11.23,heat shock protein family B (small) member 1 [Source:HGNC Symbol;Acc:HGNC:5246],Autosomal dominant Charcot-Marie-Tooth disease type 2F;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2F;Distal hereditary motor neuropathy type 2;NEURONOPATHY DISTAL HEREDITARY MOTOR TYPE IIB,HSPB1,3315,NM_001540
UPB1_SIG,UPB1,UPB1_SIG,UPB1,SIG,21,-4.15385245478626,0.124917014031217,0.142981170355246,0.0655633575379796,-0.0774178128172664,0.000121952521728055,-3.25748027118294,1.78177334705025,1.88382173884232,1.44647148830486,-0.437350250537464,0.0054076727320582,ENSG00000100024,UPB1,protein_coding,22,1,24494107,24528390,q11.23,beta-ureidopropionase 1 [Source:HGNC Symbol;Acc:HGNC:16297],BETA-UREIDOPROPIONASE DEFICIENCY,UPB1,51733,NM_016327
GNAI3_SIG,GNAI3,GNAI3_SIG,GNAI3,SIG,23,-4.15357737134224,0.255778870950892,0.260733240724962,0.239500227407517,-0.0212330133174455,0.000122044339650905,-1.94774331717505,6.54220079335221,6.56233139710546,6.47605738102011,-0.0862740160853432,0.106883650831332,ENSG00000065135,GNAI3,protein_coding,1,1,109548615,109618324,p13.3,G protein subunit alpha i3 [Source:HGNC Symbol;Acc:HGNC:4387],Auriculocondylar syndrome;AURICULOCONDYLAR SYNDROME 1,GNAI3,2773,NM_006496
ZDHHC12_TF,ZDHHC12,ZDHHC12_TF,ZDHHC12,TF,202,-4.15319028995181,0.203458682135906,0.210183197147396,0.181363847098156,-0.0288193500492394,0.000122196060575801,-3.85955012884501,4.67604187129643,4.73013463867923,4.49830849275295,-0.231826145926281,0.000892394495468972,ENSG00000160446,ZDHHC12,protein_coding,9,-1,128720870,128724127,q34.11,zinc finger DHHC-type containing 12 [Source:HGNC Symbol;Acc:HGNC:19159],NA,ZDHHC12,84885,NM_001318015;NM_001318016;NM_001318020;NM_001318023;NM_032799
ZDHHC4_TF,ZDHHC4,ZDHHC4_TF,ZDHHC4,TF,399,4.15305177060048,0.195502876653459,0.190641800876649,0.211474982777263,0.0208331819006137,0.000122215104539724,3.5256332678635,4.70566477219955,4.65854745736976,4.86047880664031,0.201931349270552,0.00250271930082153,ENSG00000136247,ZDHHC4,protein_coding,7,1,6577434,6589374,p22.1,zinc finger DHHC-type containing 4 [Source:HGNC Symbol;Acc:HGNC:18471],NA,ZDHHC4,55146,NM_001134387;NM_001134388;NM_001134389;NM_018106
DACH1_TF,DACH1,DACH1_TF,DACH1,TF,215,-4.15168359265989,0.0251239303841153,0.0288265402072371,0.0129582123938578,-0.0158683278133794,0.000122892931407818,-2.32676700574039,3.88750715096359,3.99401046987356,3.53756767454511,-0.456442795328458,0.0511124843703243,ENSG00000276644,DACH1,protein_coding,13,-1,71437966,71867204,q21.33,dachshund family transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:2663],NA,DACH1,1602,NM_004392;NM_080759;NM_080760
TARS_SIG,TARS,TARS_SIG,TARS,SIG,32,4.15015311014892,0.350350928796695,0.340002658765446,0.384352387470798,0.0443497287053518,0.000123612085936504,3.06390758078015,6.64831059489654,6.59881093407083,6.81095233760961,0.212141403538786,0.00911920474107711,ENSG00000113407,TARS,protein_coding,5,1,33440696,33469539,p13.3,threonyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:11572],NA,TARS,6897,NM_001258437;NM_001258438;NM_152295
ATRX_SIG,ATRX,ATRX_SIG,ATRX,SIG,67,4.15014267806137,0.259086841488519,0.247262732917031,0.297937483937691,0.0506747510206595,0.000123612085936504,3.42830032571611,6.98054152721638,6.92933891647969,7.14877867677979,0.2194397603001,0.00331271513665395,ENSG00000085224,ATRX,protein_coding,X,-1,77504878,77786233,q21.1,ATRX, chromatin remodeler [Source:HGNC Symbol;Acc:HGNC:886],Alpha-thalassemia - myelodysplastic syndrome;Alpha-thalassemia - X-linked intellectual disability syndrome;ALPHA-THALASSEMIA MENTAL RETARDATION SYNDROME X-LINKED NON-DELETION TYPE;ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME;ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME X-LINKED;Carpenter-Waziri syndrome;Chudley-Lowry-Hoar syndrome;Holmes-Gang syndrome;Juberg-Marsidi syndrome;Mental retardation-hypotonic facies syndrome X-linked 1;MENTAL RETARDATION SYNDROMIC X-LINKED WITH HYPOTONIC FACIES SYNDROME TYPE 1;Neuroendocrine tumor of stomach;Smith-Fineman-Myers syndrome,ATRX,546,NM_000489;NM_138270
SOX8_TF,SOX8,SOX8_TF,SOX8,TF,82,-4.14998592113585,-0.095445217727488,-0.0897962948826685,-0.114005964217609,-0.0242096693349407,0.000123641251420402,-2.13264095513986,0.424100238707543,0.458154982021497,0.312206082104551,-0.145948899916946,0.0755976753971596,ENSG00000005513,SOX8,protein_coding,16,1,981770,986979,p13.3,SRY-box 8 [Source:HGNC Symbol;Acc:HGNC:11203],NA,SOX8,30812,NM_014587
P2RX1_SIG,P2RX1,P2RX1_SIG,P2RX1,SIG,32,4.14985782148936,0.130278401257563,0.126365528659669,0.143134982650644,0.0167694539909752,0.000123654964004351,0.843370299843123,7.10191700897564,7.08427683057073,7.15987759516319,0.0756007645924609,0.511964222035034,ENSG00000108405,P2RX1,protein_coding,17,-1,3896592,3916476,p13.2,purinergic receptor P2X 1 [Source:HGNC Symbol;Acc:HGNC:8533],NA,P2RX1,5023,NM_002558
FUBP1_TF,FUBP1,FUBP1_TF,FUBP1,TF,90,4.14825211468385,0.282419437443888,0.272840988964007,0.313891482449209,0.0410504934852019,0.000124469433549719,3.77628123657064,7.6484172636949,7.59943258127772,7.80936693449417,0.209934353216446,0.00115849557385537,ENSG00000162613,FUBP1,protein_coding,1,-1,77944055,77979110,p31.1,far upstream element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4004],NA,FUBP1,8880,NM_001303433;NM_003902
NT5M_SIG,NT5M,NT5M_SIG,NT5M,SIG,53,4.14680369034778,0.172371935448764,0.159396490943155,0.215005538824336,0.0556090478811813,0.000125202984773087,2.32976864717769,3.31305912693172,3.24838983493988,3.52554394347635,0.277154108536468,0.0508587922219795,ENSG00000205309,NT5M,protein_coding,17,1,17303335,17347663,p11.2,5',3'-nucleotidase, mitochondrial [Source:HGNC Symbol;Acc:HGNC:15769],NA,NT5M,56953,NM_020201
ZNF683_TF,ZNF683,ZNF683_TF,ZNF683,TF,61,-4.14480378903612,-0.0605252766088593,-0.0513740663535382,-0.0905935388763428,-0.0392194725228045,0.000126244098213149,-2.7510889519627,0.976303001708816,1.04318782735307,0.756538574591994,-0.286649252761072,0.0198777986511168,ENSG00000176083,ZNF683,protein_coding,1,-1,26361634,26374522,p36.11,zinc finger protein 683 [Source:HGNC Symbol;Acc:HGNC:28495],NA,ZNF683,257101,NM_001114759;NM_001307925;NM_173574
PGPEP1_SIG,PGPEP1,PGPEP1_SIG,PGPEP1,SIG,27,4.14415928549763,0.174527485587915,0.169688959274709,0.19042550061702,0.020736541342311,0.000126542940417185,0.28174571154026,6.1206017425811,6.11653032072955,6.13397927152191,0.0174489507923513,0.83858000788048,ENSG00000130517,PGPEP1,protein_coding,19,1,18340598,18369950,p13.11,pyroglutamyl-peptidase I [Source:HGNC Symbol;Acc:HGNC:13568],NA,PGPEP1,54858,NM_001300927;NM_001308366;NM_001329471;NM_001329476;NM_001329477;NM_001329478;NM_017712
ZDHHC24_SIG,ZDHHC24,ZDHHC24_SIG,ZDHHC24,SIG,42,4.14361775956974,0.330323201553145,0.320426929214951,0.362839524950068,0.0424125957351161,0.000126773163565108,3.8843328452009,4.7198015959446,4.66088317877066,4.9133906809447,0.252507502174038,0.000823377829294194,ENSG00000174165,ZDHHC24,protein_coding,11,-1,66520637,66546235,q13.2,zinc finger DHHC-type containing 24 [Source:HGNC Symbol;Acc:HGNC:27387],NA,ZDHHC24,254359,NM_001348571;NM_207340
HINT1_SIG,HINT1,HINT1_SIG,HINT1,SIG,25,4.14344025707544,0.40583352787455,0.393029129154858,0.447905123667825,0.0548759945129667,0.000126773163565108,4.46224268987558,6.99668437591794,6.91375326685431,7.26917230569843,0.355419038844121,0.000113776718834477,ENSG00000169567,HINT1,protein_coding,5,-1,131159027,131171735,q23.3,histidine triad nucleotide binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4912],Autosomal recessive axonal neuropathy with neuromyotonia;Neuromyotonia and axonal neuropathy autosomal recessive,HINT1,3094,NM_005340
ZNF883_TF,ZNF883,ZNF883_TF,ZNF883,TF,76,-4.14337665257789,-0.08927100517503,-0.0859396537625734,-0.100216874101673,-0.0142772203390998,0.000126773163565108,-3.91290555509466,0.531307629785415,0.612040397222831,0.26604282249105,-0.345997574731781,0.000748694296447922,ENSG00000228623,ZNF883,transcribed_unprocessed_pseudogene,9,-1,112957722,113012227,q32,zinc finger protein 883 [Source:HGNC Symbol;Acc:HGNC:27271],NA,ZNF883,NA,NA
ZNRF1_SIG,ZNRF1,ZNRF1_SIG,ZNRF1,SIG,46,4.14333243915875,0.381936284345462,0.367297118431452,0.430036400920065,0.0627392824886125,0.000126773163565108,1.29897208067114,5.47017080597768,5.43187842513954,5.59598862873157,0.164110203592031,0.295386217122109,ENSG00000186187,ZNRF1,protein_coding,16,1,74999030,75110994,q23.1,zinc and ring finger 1 [Source:HGNC Symbol;Acc:HGNC:18452],NA,ZNRF1,84937,NM_032268
COMT_SIG,COMT,COMT_SIG,COMT,SIG,39,4.14223797572382,0.325928519327914,0.314913906768435,0.362119389166201,0.0472054823977659,0.000127305309192311,2.82173330939659,6.56314294229407,6.50810474032421,6.74398274876647,0.23587800844226,0.0168023191927588,ENSG00000093010,COMT,protein_coding,22,1,19941607,19969975,q11.21,catechol-O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:2228],22q11.2 Deletion Syndrome;Cisplatin toxicity;PANIC DISORDER 1;Schizophrenia;Toxicity or absent response to clozapine,COMT,1312,NM_000754;NM_001135161;NM_001135162;NM_007310
DCAF17_SIG,DCAF17,DCAF17_SIG,DCAF17,SIG,104,4.1421672306651,0.435140278241623,0.420694868202172,0.482603768371246,0.061908900169074,0.000127305309192311,3.36531787322072,4.96189860266579,4.90445442187653,5.15064376811623,0.246189346239703,0.00400186746175165,ENSG00000115827,DCAF17,protein_coding,2,1,171434217,171485052,q31.1,DDB1 and CUL4 associated factor 17 [Source:HGNC Symbol;Acc:HGNC:25784],WOODHOUSE-SAKATI SYNDROME,DCAF17,80067,NM_001164821;NM_025000
ZNF718_TF,ZNF718,ZNF718_TF,ZNF718,TF,5,4.14183283223382,-0.0164903494867201,-0.0256047693150537,0.0134570299492331,0.0390617992642869,0.000127434186377562,1.44663675859016,3.19840988978578,3.15676391414185,3.33524666690152,0.178482752759661,0.239790420527046,ENSG00000250312,ZNF718,protein_coding,4,1,124501,202303,p16.3,zinc finger protein 718 [Source:HGNC Symbol;Acc:HGNC:26889],NA,ZNF718,255403,NM_001039127;NM_001289930;NM_001289931
DDX10_SIG,DDX10,DDX10_SIG,DDX10,SIG,39,4.14089684490354,0.507359837497664,0.491752937256542,0.558639652575638,0.0668867153190963,0.000127898263938476,3.44454945416224,4.51461024000029,4.44841339826517,4.73211414855857,0.2837007502934,0.00316097567187638,ENSG00000178105,DDX10,protein_coding,11,1,108665069,108940927,q22.3,DEAD-box helicase 10 [Source:HGNC Symbol;Acc:HGNC:2735],NA,DDX10,1662,NM_004398
AASS_SIG,AASS,AASS_SIG,AASS,SIG,112,-4.14028475422387,-0.161623512288978,-0.153228202379739,-0.189208101990762,-0.0359798996110233,0.00012818282986768,-2.24074011448025,1.2787189694357,1.3649804361401,0.995288435978378,-0.369692000161721,0.0610813871984863,ENSG00000008311,AASS,protein_coding,7,-1,122073549,122144255,q31.32,aminoadipate-semialdehyde synthase [Source:HGNC Symbol;Acc:HGNC:17366],HYPERLYSINEMIA;HYPERLYSINEMIA TYPE I;Saccharopinuria,AASS,10157,NM_005763
PRMT1_SIG,PRMT1,PRMT1_SIG,PRMT1,SIG,50,4.14003830274156,0.566471019871149,0.553802349010103,0.608096652700303,0.0542943036902002,0.000128249550726485,3.93117401930061,6.55257995212498,6.48541844627692,6.77325347134004,0.287835025063122,0.000709205938448665,ENSG00000126457,PRMT1,protein_coding,19,1,49675786,49689029,q13.33,protein arginine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:5187],NA,PRMT1,3276,NM_001207042;NM_001536;NM_198318
FOXO6_TF,FOXO6,FOXO6_TF,FOXO6,TF,86,4.13992347597619,-0.0917760096770921,-0.0953328395328343,-0.0800892830082247,0.0152435565246097,0.000128249550726485,1.10346501860438,0.37031796150444,0.357870638851149,0.411216307365253,0.0533456685141035,0.380793461812412,ENSG00000204060,FOXO6,protein_coding,1,1,41361922,41383590,p34.2,forkhead box O6 [Source:HGNC Symbol;Acc:HGNC:24814],NA,FOXO6,100132074,NM_001291281
NOL8_SIG,NOL8,NOL8_SIG,NOL8,SIG,63,4.13985863784042,0.383649905314272,0.370119170894981,0.428108032691944,0.0579888617969637,0.000128249550726485,3.93720995548683,5.7929254630276,5.73125764378401,5.9955482976851,0.264290653901084,0.000696609195548273,ENSG00000198000,NOL8,protein_coding,9,-1,92297358,92325636,q22.31,nucleolar protein 8 [Source:HGNC Symbol;Acc:HGNC:23387],NA,NOL8,55035,NM_001256394;NM_001330722;NM_017948
EBI3_SIG,EBI3,EBI3_SIG,EBI3,SIG,15,-4.13919854647559,0.0969478551901279,0.103203642926536,0.0763931240562143,-0.0268105188703221,0.00012856181606495,-2.36042866401365,0.66698934320863,0.714811046960693,0.509860888023281,-0.204950158937412,0.0476468950918083,ENSG00000105246,EBI3,protein_coding,19,1,4229523,4237528,p13.3,Epstein-Barr virus induced 3 [Source:HGNC Symbol;Acc:HGNC:3129],NA,EBI3,10148,NM_005755
FBXW9_SIG,FBXW9,FBXW9_SIG,FBXW9,SIG,13,4.1382965511386,0.479713651435198,0.467414436414259,0.520125357932568,0.0527109215183094,0.000129010738933105,4.34448574460294,2.83222920313322,2.7613514575091,3.06511322446964,0.303761766960538,0.000173927872947127,ENSG00000132004,FBXW9,protein_coding,19,-1,12688053,12696631,p13.13,F-box and WD repeat domain containing 9 [Source:HGNC Symbol;Acc:HGNC:28136],NA,FBXW9,84261,NM_032301
PRKG2_SIG,PRKG2,PRKG2_SIG,PRKG2,SIG,19,-4.13732131003435,-0.0847468356657538,-0.0784117883830993,-0.105561991023047,-0.0271502026399478,0.000129502473461089,-2.36153754942846,0.812486642750469,0.869874435112451,0.623926753561102,-0.245947681551349,0.0475426756884825,ENSG00000138669,PRKG2,protein_coding,4,-1,81087370,81215117,q21.21,protein kinase cGMP-dependent 2 [Source:HGNC Symbol;Acc:HGNC:9416],NA,PRKG2,5593,NM_001282480;NM_001282481;NM_001282482;NM_001282483;NM_001282485;NM_001363401;NM_006259
FEZ1_SIG,FEZ1,FEZ1_SIG,FEZ1,SIG,42,-4.13694762670464,-0.14491572017216,-0.133813231903806,-0.181395324482468,-0.0475820925786619,0.000129602101075971,-3.37222577203973,1.14870893774722,1.27234217556182,0.742485442070677,-0.529856733491139,0.00392169977531058,ENSG00000149557,FEZ1,protein_coding,11,-1,125442881,125592568,q24.2,fasciculation and elongation protein zeta 1 [Source:HGNC Symbol;Acc:HGNC:3659],NA,FEZ1,9638,NM_005103;NM_022549
KLF4_TF,KLF4,KLF4_TF,KLF4,TF,259,-4.13694066082647,0.125532857689223,0.144316476532692,0.063815252917824,-0.0805012236148682,0.000129602101075971,-3.9008544074446,5.92639414761624,6.12269957147011,5.28139061209637,-0.841308959373738,0.00077817737201804,ENSG00000136826,KLF4,protein_coding,9,-1,107484852,107490482,q31.2,Kruppel like factor 4 [Source:HGNC Symbol;Acc:HGNC:6348],NA,KLF4,9314,NM_001314052;NM_004235
PLA2G16_SIG,PLA2G16,PLA2G16_SIG,PLA2G16,SIG,28,-4.13621755100289,-0.0573362874116865,-0.0450559725756871,-0.0976858933013986,-0.0526299207257114,0.000129908753796373,-1.61972749427644,1.84630534253229,1.90645802310976,1.64866082063491,-0.257797202474843,0.185040924975271,ENSG00000176485,PLA2G16,protein_coding,11,-1,63573195,63616883,q13.1,phospholipase A2 group XVI [Source:HGNC Symbol;Acc:HGNC:17825],NA,PLA2G16,11145,NM_001128203;NM_007069
OR2A7_SIG,OR2A7,OR2A7_SIG,OR2A7,SIG,25,4.13617406992456,-0.0366595567018049,-0.0428081179511303,-0.0164571411683071,0.0263509767828232,0.000129908753796373,2.6799759950085,0.213197206364407,0.194656719799782,0.274115947933889,0.079459228134107,0.0234705450424358,ENSG00000243896,OR2A7,protein_coding,7,-1,144257663,144264792,q35,olfactory receptor family 2 subfamily A member 7 [Source:HGNC Symbol;Acc:HGNC:8234],NA,OR2A7,401427,NM_001005328
PCYT2_SIG,PCYT2,PCYT2_SIG,PCYT2,SIG,21,4.13609221450239,0.329785272062489,0.320544139515022,0.360148993289879,0.0396048537748572,0.000129908753796373,2.00290213431129,4.53060874686129,4.49595678773082,4.64446518400426,0.148508396273436,0.0965796584826014,ENSG00000185813,PCYT2,protein_coding,17,-1,81900965,81911464,q25.3,phosphate cytidylyltransferase 2, ethanolamine [Source:HGNC Symbol;Acc:HGNC:8756],NA,PCYT2,5833,NM_001184917;NM_001256433;NM_001256434;NM_001256435;NM_001282203;NM_001282204;NM_001330518;NM_002861
STAT1_SIG,STAT1,STAT1_SIG,STAT1,SIG,14,-4.13589320131258,0.191689299914937,0.202332368648996,0.1567192169316,-0.0456131517173957,0.000129963720806096,-1.97223738743683,7.13345012045312,7.17376748423632,7.00097878230834,-0.172788701927979,0.102161957712457,ENSG00000115415,STAT1,protein_coding,2,-1,190964358,191020960,q32.2,signal transducer and activator of transcription 1 [Source:HGNC Symbol;Acc:HGNC:11362],Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;IMMUNODEFICIENCY 31A;IMMUNODEFICIENCY 31B;IMMUNODEFICIENCY 31C;Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency;Susceptibility to viral and mycobacterial infections,STAT1,6772,NM_007315;NM_139266
LBR_SIG,LBR,LBR_SIG,LBR,SIG,30,-4.13393581261185,0.0987963065724105,0.104805054974477,0.0790532761084784,-0.0257517788659986,0.000131018037496943,-1.1719177329636,7.19010139630496,7.21171191544028,7.11909540486033,-0.0926165105799442,0.349594979467734,ENSG00000143815,LBR,protein_coding,1,-1,225401502,225428925,q42.12,lamin B receptor [Source:HGNC Symbol;Acc:HGNC:6518],Greenberg dysplasia;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;PELGER-HUET ANOMALY;PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES;Regressive spondylometaphyseal dysplasia;Reynolds syndrome,LBR,3930,NM_002296;NM_194442
NPRL2_SIG,NPRL2,NPRL2_SIG,NPRL2,SIG,29,4.13349583939088,0.259462158019835,0.250994210579858,0.287285413894042,0.0362912033141832,0.000131211031168432,3.67359057265934,4.45062907052864,4.40536624850001,4.59934977147987,0.193983522979867,0.00159283477811,ENSG00000114388,NPRL2,protein_coding,3,-1,50347330,50351091,p21.31,NPR2 like, GATOR1 complex subunit [Source:HGNC Symbol;Acc:HGNC:24969],EPILEPSY FAMILIAL FOCAL WITH VARIABLE FOCI 2;FAMILIAL FOCAL EPILEPSY WITH VARIABLE FOCI,NPRL2,10641,NM_006545
DDX54_SIG,DDX54,DDX54_SIG,DDX54,SIG,30,4.13011183861183,0.673773341067295,0.666315810777663,0.698276654876087,0.0319608440984232,0.000133098434782903,4.10230595733158,6.53620356393264,6.49153087384476,6.68298525993565,0.191454386090889,0.000402797993539463,ENSG00000123064,DDX54,protein_coding,12,-1,113157174,113185479,q24.13,DEAD-box helicase 54 [Source:HGNC Symbol;Acc:HGNC:20084],NA,DDX54,79039,NM_001111322;NM_024072
SBNO2_SIG,SBNO2,SBNO2_SIG,SBNO2,SIG,20,-4.12980943799844,0.424432907734164,0.436925078680037,0.383387203197722,-0.0535378754823148,0.000133214596364851,-3.31384218914756,6.63088152413715,6.68142361267407,6.46481466180158,-0.216608950872488,0.00463012173817625,ENSG00000064932,SBNO2,protein_coding,19,-1,1107637,1174268,p13.3,strawberry notch homolog 2 [Source:HGNC Symbol;Acc:HGNC:29158],NA,SBNO2,22904,NM_001100122;NM_014963
NEIL2_SIG,NEIL2,NEIL2_SIG,NEIL2,SIG,24,4.12903733722897,0.222608849356227,0.213446572758015,0.252713472464639,0.039266899706624,0.000133603510110671,3.40384355475375,2.87231758220806,2.81081291214757,3.07440435526393,0.263591443116351,0.00356280779015406,ENSG00000154328,NEIL2,protein_coding,8,1,11769639,11787345,p23.1,nei like DNA glycosylase 2 [Source:HGNC Symbol;Acc:HGNC:18956],NA,NEIL2,252969,NM_001135746;NM_001135747;NM_001135748;NM_001349439;NM_001349440;NM_001349441;NM_001349442;NM_145043
WDR83_SIG,WDR83,WDR83_SIG,WDR83,SIG,30,4.12876950341323,0.193375720907891,0.179069130447953,0.240383089561976,0.061313959114023,0.000133693340752938,5.167924007411,3.18261548078386,3.12597765473802,3.36871119493446,0.242733540196444,7.22688805810435e-06,ENSG00000123154,WDR83,protein_coding,19,1,12666802,12675832,p13.13,WD repeat domain 83 [Source:HGNC Symbol;Acc:HGNC:32672],NA,WDR83,84292,NM_001099737;NM_032332
HELZ2_SIG,HELZ2,HELZ2_SIG,HELZ2,SIG,26,-4.12867926828327,0.357097192793277,0.370542515176837,0.312919704961577,-0.0576228102152603,0.000133693340752938,-2.63167525152942,5.71742248964886,5.79504164566101,5.46238811989467,-0.332653525766332,0.0261607992778275,ENSG00000130589,HELZ2,protein_coding,20,-1,63558086,63574239,q13.33,helicase with zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:30021],NA,HELZ2,85441,NM_001037335;NM_033405
SEMA7A_SIG,SEMA7A,SEMA7A_SIG,SEMA7A,SIG,47,4.12838300361735,0.0232359940467769,0.0126925061922782,0.0578788827115585,0.0451863765192802,0.000133806500987657,4.80609933989012,3.77819881568439,3.61174828810635,4.32510769201222,0.713359403905876,3.10759776169892e-05,ENSG00000138623,SEMA7A,protein_coding,15,-1,74409289,74433958,q24.1,semaphorin 7A (John Milton Hagen blood group) [Source:HGNC Symbol;Acc:HGNC:10741],BLOOD GROUP JOHN MILTON HAGEN SYSTEM,SEMA7A,8482,NM_001146029;NM_001146030;NM_003612
PNISR_SIG,PNISR,PNISR_SIG,PNISR,SIG,64,4.12779741236428,0.199043072702407,0.191351753968866,0.224314548541184,0.032962794572318,0.000134088337122112,2.93812968530648,8.26291452567241,8.22536829217622,8.38628072144559,0.160912429269372,0.0126162816820806,ENSG00000132424,PNISR,protein_coding,6,-1,99398050,99425331,q16.2,PNN interacting serine and arginine rich protein [Source:HGNC Symbol;Acc:HGNC:21222],NA,PNISR,25957,NM_001322405;NM_001322406;NM_001322408;NM_001322410;NM_001322412;NM_001322413;NM_001322414;NM_001322415;NM_001322416;NM_001322419;NM_015491;NM_032870
SMARCA4_SIG,SMARCA4,SMARCA4_SIG,SMARCA4,SIG,19,4.12618770068376,0.710979627438265,0.697628184291826,0.754848654919421,0.0572204706275955,0.000134970216776933,3.77316084256252,7.43151750278092,7.38505532666313,7.58417893859651,0.199123611933382,0.00116768233356134,ENSG00000127616,SMARCA4,protein_coding,19,1,10960825,11079426,p13.2,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [Source:HGNC Symbol;Acc:HGNC:11100],COFFIN-SIRIS SYNDROME;COFFIN-SIRIS SYNDROME 4;Coffin Siris;Familial rhabdoid tumor;Rhabdoid tumor predisposition syndrome 2;Small cell carcinoma of the ovary;SMARCA4-deficient sarcoma of thorax,SMARCA4,6597,NM_001128844;NM_001128845;NM_001128846;NM_001128847;NM_001128848;NM_001128849;NM_003072
XIRP1_SIG,XIRP1,XIRP1_SIG,XIRP1,SIG,17,-4.12531504223807,-0.0218005609898365,-0.0152587880192978,-0.043294957893035,-0.028036169873737,0.000135423213211909,-3.063060287369,0.367522730770024,0.425479919520522,0.177091967732675,-0.248387951787848,0.00914339381129567,ENSG00000168334,XIRP1,protein_coding,3,-1,39183210,39192596,p22.2,xin actin binding repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:14301],NA,XIRP1,165904,NM_001198621;NM_001351377;NM_194293
ZNF865_TF,ZNF865,ZNF865_TF,ZNF865,TF,152,-4.1249375511198,0.0254081499755307,0.0297191552585609,0.0112434183312888,-0.0184757369272721,0.000135585656807913,-2.20226499289513,5.17406414981908,5.19551992572745,5.10356660040584,-0.0919533253216134,0.0661044598747804,ENSG00000261221,ZNF865,protein_coding,19,1,55605405,55617269,q13.42,zinc finger protein 865 [Source:HGNC Symbol;Acc:HGNC:38705],NA,ZNF865,100507290,NM_001195605
NGRN_SIG,NGRN,NGRN_SIG,NGRN,SIG,29,4.12361783719476,0.297780836469163,0.291044096759776,0.319915838371433,0.0288717416116572,0.000136305066817979,2.46742001751869,4.10052641989931,4.06979950151269,4.20148629459821,0.131686793085515,0.0379151092634573,ENSG00000182768,NGRN,protein_coding,15,1,90265659,90278141,q26.1,neugrin, neurite outgrowth associated [Source:HGNC Symbol;Acc:HGNC:18077],NA,NGRN,51335,NM_001033088
ROR2_SIG,ROR2,ROR2_SIG,ROR2,SIG,15,-4.12189453136358,-0.145739201709227,-0.141307406833208,-0.160300813444717,-0.0189934066115087,0.000137268438114237,-2.75665454035335,0.360803113607966,0.410711898044669,0.196817107601655,-0.213894790443014,0.0196260440810815,ENSG00000169071,ROR2,protein_coding,9,-1,91563091,91950228,q22.31,receptor tyrosine kinase like orphan receptor 2 [Source:HGNC Symbol;Acc:HGNC:10257],Autosomal recessive Robinow syndrome;Brachydactyly type B;BRACHYDACTYLY TYPE B1;ROBINOW SYNDROME AUTOSOMAL DOMINANT;Robinow syndrome autosomal recessive;ROR2-Related Disorders AR,ROR2,4920,NM_001318204;NM_004560
IL21R_SIG,IL21R,IL21R_SIG,IL21R,SIG,14,-4.12176501354652,0.0725258008054365,0.0937199502043338,0.00288788135191681,-0.0908320688524169,0.000137285121491673,-2.34422965607008,2.03848138483784,2.10517133136052,1.81935727483474,-0.285814056525783,0.0493673468595071,ENSG00000103522,IL21R,protein_coding,16,1,27402174,27452042,p12.1,interleukin 21 receptor [Source:HGNC Symbol;Acc:HGNC:6006],Combined immunodeficiency due to IL21R deficiency;IgE RESPONSIVENESS ATOPIC;IMMUNODEFICIENCY 56,IL21R,50615,NM_021798;NM_181078;NM_181079
ARHGAP33_SIG,ARHGAP33,ARHGAP33_SIG,ARHGAP33,SIG,36,4.12140206973024,0.0978096439278675,0.090561615877703,0.121624593235551,0.031062977357848,0.00013744104885027,1.76274560868225,5.03406323000275,4.99969025814338,5.14700299468355,0.147312736540165,0.147106903552416,ENSG00000004777,ARHGAP33,protein_coding,19,1,35774532,35788822,q13.12,Rho GTPase activating protein 33 [Source:HGNC Symbol;Acc:HGNC:23085],NA,ARHGAP33,115703,NM_001172630;NM_052948
IMPDH2_SIG,IMPDH2,IMPDH2_SIG,IMPDH2,SIG,61,4.12108773158806,0.481637731629401,0.468334143258866,0.525349521989729,0.0570153787308626,0.000137568132145999,3.36341210932662,7.6078119247836,7.52959032543762,7.86482575120612,0.335235425768493,0.00402775335145911,ENSG00000178035,IMPDH2,protein_coding,3,-1,49024325,49029408,p21.31,inosine monophosphate dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:6053],IMPDH2 ENZYME ACTIVITY VARIATION IN,IMPDH2,3615,NM_000884
CTSF_SIG,CTSF,CTSF_SIG,CTSF,SIG,44,4.12078241594442,0.0262162512317814,0.0187266485985204,0.0508249455982105,0.0320982969996901,0.000137689953839879,2.02757672775762,3.5007030174195,3.4301611372271,3.73248348090881,0.302322343681714,0.092326376677836,ENSG00000174080,CTSF,protein_coding,11,-1,66563464,66568841,q13.2,cathepsin F [Source:HGNC Symbol;Acc:HGNC:2531],CEROID LIPOFUSCINOSIS NEURONAL 13;CLN13 disease,CTSF,8722,NM_003793
PDCD11_SIG,PDCD11,PDCD11_SIG,PDCD11,SIG,107,4.1198072005872,0.514083781285742,0.496150190704966,0.573008436051147,0.0768582453461813,0.000138213175123712,3.66416387539486,5.9253637684092,5.85144638680418,6.1682351651114,0.316788778307222,0.00163980660130348,ENSG00000148843,PDCD11,protein_coding,10,1,103396626,103446294,q24.33,programmed cell death 11 [Source:HGNC Symbol;Acc:HGNC:13408],NA,PDCD11,22984,NM_014976
CYP19A1_SIG,CYP19A1,CYP19A1_SIG,CYP19A1,SIG,3,-4.11946588664598,0.120312172485587,0.135286612773528,0.0711104401109222,-0.0641761726626059,0.000138357182347258,-3.53698859773043,0.306121028266858,0.36001738400605,0.129033002266655,-0.230984381739395,0.00241950923722476,ENSG00000137869,CYP19A1,protein_coding,15,-1,51208057,51338610,q21.2,cytochrome P450 family 19 subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:2594],AROMATASE DEFICIENCY;AROMATASE EXCESS SYNDROME,CYP19A1,1588,NM_000103;NM_001347248;NM_001347249;NM_001347250;NM_001347251;NM_001347252;NM_001347253;NM_001347254;NM_001347255;NM_001347256;NM_031226
ACSS3_SIG,ACSS3,ACSS3_SIG,ACSS3,SIG,42,-4.11931874997826,-0.110995202316527,-0.101940023728881,-0.14074793196165,-0.038807908232769,0.000138384697422808,-3.01566584260174,0.268321779006841,0.313088944436908,0.121229664022337,-0.191859280414572,0.0103258062060976,ENSG00000111058,ACSS3,protein_coding,12,1,80936414,81261210,q21.31,acyl-CoA synthetase short chain family member 3 [Source:HGNC Symbol;Acc:HGNC:24723],NA,ACSS3,79611,NM_001330242;NM_001330243;NM_024560
EWSR1_TF,EWSR1,EWSR1_TF,EWSR1,TF,96,4.11901228916808,0.387790478717222,0.381810083866673,0.407440347511881,0.0256302636452075,0.000138507966188882,3.70202503532129,8.47208817453012,8.43988015874756,8.57791451210137,0.138034353353811,0.00146130628265719,ENSG00000182944,EWSR1,protein_coding,22,1,29268009,29300525,q12.2,EWS RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:3508],Desmoplastic small round cell tumor;Ewing sarcoma;Extraskeletal Ewing sarcoma;Extraskeletal myxoid chondrosarcoma;Melanoma of soft tissue,EWSR1,2130,NM_001163285;NM_001163286;NM_001163287;NM_005243;NM_013986
SDC2_SIG,SDC2,SDC2_SIG,SDC2,SIG,25,-4.11864006923131,-0.104408009285502,-0.0906981151020138,-0.14945480445982,-0.0587566893578065,0.000138645708886754,-3.13454810099825,1.30374349529333,1.43838237540193,0.861358603507902,-0.577023771894032,0.00757356908894092,ENSG00000169439,SDC2,protein_coding,8,1,96493813,96611790,q22.1,syndecan 2 [Source:HGNC Symbol;Acc:HGNC:10659],NA,SDC2,6383,NM_002998
CCR1_SIG,CCR1,CCR1_SIG,CCR1,SIG,32,-4.11858077567083,0.211547022167166,0.241630183628431,0.11270234879444,-0.128927834833991,0.000138645708886754,-3.91766989116267,3.90421803930891,4.09933300340916,3.26312601440807,-0.836206989001095,0.000737537929877392,ENSG00000163823,CCR1,protein_coding,3,-1,46201711,46208313,p21.31,C-C motif chemokine receptor 1 [Source:HGNC Symbol;Acc:HGNC:1602],Behcet disease,CCR1,1230,NM_001295
CXCL10_SIG,CXCL10,CXCL10_SIG,CXCL10,SIG,14,-4.11835068342856,0.0310069161303632,0.0372630177115037,0.0104511537923302,-0.0268118639191734,0.000138723290138617,-1.51930407215696,0.719599749758041,0.756171626778499,0.599435010976538,-0.156736615801961,0.215660205162794,ENSG00000169245,CXCL10,protein_coding,4,-1,76021118,76023497,q21.1,C-X-C motif chemokine ligand 10 [Source:HGNC Symbol;Acc:HGNC:10637],NA,CXCL10,3627,NM_001565
PPP2R5E_SIG,PPP2R5E,PPP2R5E_SIG,PPP2R5E,SIG,15,4.11819148054799,0.42289337769545,0.415016230850714,0.448775431613868,0.033759200763154,0.000138758253630056,3.49188633963311,5.95616656573384,5.92823489868435,6.04794204318217,0.119707144497826,0.00276197741591233,ENSG00000154001,PPP2R5E,protein_coding,14,-1,63371364,63543377,q23.2,protein phosphatase 2 regulatory subunit B'epsilon [Source:HGNC Symbol;Acc:HGNC:9313],NA,PPP2R5E,5529,NM_001282179;NM_001282180;NM_001282181;NM_001282182;NM_001354926;NM_006246
COL4A3BP_SIG,COL4A3BP,COL4A3BP_SIG,COL4A3BP,SIG,26,-4.1180183739038,0.469243146798145,0.476760917523966,0.444541900127589,-0.0322190173963776,0.000138801621247788,-2.47905882407033,6.04267282964816,6.07377244708453,5.9404883723572,-0.133284074727332,0.036952566034898,ENSG00000113163,COL4A3BP,protein_coding,5,-1,75356345,75512138,q13.3,collagen type IV alpha 3 binding protein [Source:HGNC Symbol;Acc:HGNC:2205],Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 34,COL4A3BP,10087,NM_001130105;NM_005713;NM_031361
PPARGC1A_SIG,PPARGC1A,PPARGC1A_SIG,PPARGC1A,SIG,49,4.11771933941723,-0.101171299148488,-0.110029296626168,-0.0720664502932568,0.037962846332911,0.000138920893651186,1.25983370471901,0.935111483382143,0.889618835828765,1.08458732534324,0.19496848951448,0.311329505562175,ENSG00000109819,PPARGC1A,protein_coding,4,-1,23755041,23904089,p15.2,PPARG coactivator 1 alpha [Source:HGNC Symbol;Acc:HGNC:9237],Amyotrophic lateral sclerosis,PPARGC1A,10891,NM_001330751;NM_001330752;NM_001330753;NM_001354825;NM_001354826;NM_001354827;NM_001354828;NM_013261
SLC31A1_SIG,SLC31A1,SLC31A1_SIG,SLC31A1,SIG,19,-4.11739400139614,0.191302403442871,0.203604744696451,0.150880425038249,-0.0527243196582014,0.000138999627340232,-1.48994629002592,4.602177226138,4.63446156474514,4.49610011357168,-0.138361451173461,0.225275172008652,ENSG00000136868,SLC31A1,protein_coding,9,1,113221544,113264492,q32,solute carrier family 31 member 1 [Source:HGNC Symbol;Acc:HGNC:11016],Autosomal Recessive Mental Retardation,SLC31A1,1317,NM_001859
THG1L_SIG,THG1L,THG1L_SIG,THG1L,SIG,18,4.11738676677736,0.477103891372194,0.469443941382049,0.502272298482671,0.0328283571006218,0.000138999627340232,3.77674125031561,4.01729166656083,3.9530653159326,4.22832110433927,0.275255788406668,0.00115697616241627,ENSG00000113272,THG1L,protein_coding,5,1,157731420,157741449,q33.3,tRNA-histidine guanylyltransferase 1 like [Source:HGNC Symbol;Acc:HGNC:26053],NA,THG1L,54974,NM_001317824;NM_001317825;NM_001317826;NM_017872
KDM2B_SIG,KDM2B,KDM2B_SIG,KDM2B,SIG,48,4.11434739732351,0.246490197310873,0.241555446154589,0.262704379681522,0.0211489335269327,0.000140782026693609,2.39222195918579,6.27969037032053,6.24723483635897,6.38632998190851,0.13909514554954,0.044548007762151,ENSG00000089094,KDM2B,protein_coding,12,-1,121429096,121581023,q24.31,lysine demethylase 2B [Source:HGNC Symbol;Acc:HGNC:13610],NA,KDM2B,84678,NM_001005366;NM_032590
CD1D_SIG,CD1D,CD1D_SIG,CD1D,SIG,57,-4.11393999369993,0.17293810860408,0.209563874103572,0.0525963076771779,-0.156967566426394,0.000140969160907114,-4.10375959944395,3.55618728662392,3.78416335969129,2.80712304654542,-0.977040313145874,0.000401206447582098,ENSG00000158473,CD1D,protein_coding,1,1,158179947,158184896,q23.1,CD1d molecule [Source:HGNC Symbol;Acc:HGNC:1637],NA,CD1D,912,NM_001319145;NM_001766
TAS2R14_SIG,TAS2R14,TAS2R14_SIG,TAS2R14,SIG,77,4.11331170572466,-0.0334702981158754,-0.0428326738345735,-0.0027082064687246,0.0401244673658488,0.000141291739428883,2.98924535333903,1.27003244890645,1.22564147042299,1.4158885210664,0.190247050643407,0.0110727561178165,ENSG00000212127,TAS2R14,protein_coding,12,-1,10937406,11171573,p13.2,taste 2 receptor member 14 [Source:HGNC Symbol;Acc:HGNC:14920],NA,TAS2R14,50840;106707243,NM_001316893;NM_023922
RFPL2_SIG,RFPL2,RFPL2_SIG,RFPL2,SIG,11,-4.11211322784666,-0.0278643279268467,-0.0216994976112886,-0.0481201989636802,-0.0264207013523916,0.000141965330573958,-2.74100115677521,0.289857454372898,0.316443787488142,0.202502359851382,-0.113941427636759,0.0203228038510265,ENSG00000128253,RFPL2,protein_coding,22,-1,32190435,32205001,q12.3,ret finger protein like 2 [Source:HGNC Symbol;Acc:HGNC:9979],NA,RFPL2,10739,NM_001098527;NM_001159545;NM_001159546;NM_001364985;NM_006605
G6PC3_SIG,G6PC3,G6PC3_SIG,G6PC3,SIG,44,4.11184310684914,0.43100663984034,0.41967693820754,0.468232802348112,0.0485558641405729,0.000142069475243377,4.27977324331171,4.78772472767354,4.71205160256462,5.03636499588858,0.324313393323965,0.000219549247518688,ENSG00000141349,G6PC3,protein_coding,17,1,44070735,44076344,q21.31,glucose-6-phosphatase catalytic subunit 3 [Source:HGNC Symbol;Acc:HGNC:24861],Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency;NEUTROPENIA SEVERE CONGENITAL 4 AUTOSOMAL RECESSIVE,G6PC3,92579,NM_001319945;NM_138387
HAS3_SIG,HAS3,HAS3_SIG,HAS3,SIG,17,-4.11159944615049,-0.0486737924938568,-0.0448723413835631,-0.061164274713393,-0.0162919333298299,0.000142157417310705,-0.103659993421339,1.12184142080535,1.12317304432991,1.11746608636754,-0.00570695796236962,0.942405472582769,ENSG00000103044,HAS3,protein_coding,16,1,69105653,69118719,q22.1,hyaluronan synthase 3 [Source:HGNC Symbol;Acc:HGNC:4820],NA,HAS3,3038,NM_001199280;NM_005329;NM_138612
PHC2_SIG,PHC2,PHC2_SIG,PHC2,SIG,19,-4.11016868954377,0.493842909801344,0.509107003155856,0.443689460207947,-0.0654175429479098,0.00014297869643963,-3.54397220301552,6.99548156777039,7.0545400712479,6.80143219920142,-0.253107872046479,0.00237059005513788,ENSG00000134686,PHC2,protein_coding,1,-1,33323623,33431052,p35.1,polyhomeotic homolog 2 [Source:HGNC Symbol;Acc:HGNC:3183],NA,PHC2,1912,NM_001330488;NM_004427;NM_198040
GPR68_SIG,GPR68,GPR68_SIG,GPR68,SIG,5,-4.10822835926164,0.0834702156512243,0.115502149322096,-0.0217775664102118,-0.137279715732308,0.000144122050872219,-1.85863372324486,1.03916311065383,1.07963045662321,0.90619897389727,-0.173431482725944,0.125035743827581,ENSG00000119714,GPR68,protein_coding,14,-1,91232532,91253925,q32.11,G protein-coupled receptor 68 [Source:HGNC Symbol;Acc:HGNC:4519],AMELOGENESIS IMPERFECTA HYPOMATURATION TYPE IIA6;Hypomaturation amelogenesis imperfecta,GPR68,8111,NM_001177676;NM_001348437;NM_003485
DDX60L_SIG,DDX60L,DDX60L_SIG,DDX60L,SIG,21,-4.10792633134004,0.431187351887102,0.443991439745806,0.389116777494216,-0.0548746622515903,0.000144210524502867,-4.66160361721687,6.23484740162238,6.34244383933349,5.88131624914301,-0.461127590190479,5.41167551870207e-05,ENSG00000181381,DDX60L,protein_coding,4,-1,168356735,168537786,q32.3,DExD/H-box 60 like [Source:HGNC Symbol;Acc:HGNC:26429],NA,DDX60L,91351,NM_001012967;NM_001291510;NM_001345927
DDN_TF,DDN,DDN_TF,DDN,TF,121,-4.10788509140506,-0.0452818988022536,-0.0369604882218147,-0.0726236764236957,-0.0356631882018809,0.000144210524502867,-2.8937755350765,1.03023870773694,1.08631156776775,0.845999310492822,-0.240312257274933,0.0140931896864685,ENSG00000181418,DDN,protein_coding,12,-1,48995149,48999375,q13.12,dendrin [Source:HGNC Symbol;Acc:HGNC:24458],NA,DDN,23109,NM_015086
GALNT2_SIG,GALNT2,GALNT2_SIG,GALNT2,SIG,7,4.10764039408466,0.541327639626775,0.531667468700338,0.57306820124221,0.0414007325418723,0.000144259914062892,3.28951721497738,6.86971000019629,6.81730646218063,7.04189305367631,0.224586591495686,0.00495012529152302,ENSG00000143641,GALNT2,protein_coding,1,1,230057990,230282122,q42.13,polypeptide N-acetylgalactosaminyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:4124],NA,GALNT2,2590,NM_001291866;NM_004481
ZNF532_TF,ZNF532,ZNF532_TF,ZNF532,TF,267,-4.10760464678973,-0.0486204084490169,-0.0420538316898246,-0.0701963035149345,-0.0281424718251098,0.000144259914062892,-2.84965718394641,3.0826628648391,3.22385377676955,2.61874986849621,-0.605103908273342,0.0156980160748396,ENSG00000074657,ZNF532,protein_coding,18,1,58862600,58986480,q21.32,zinc finger protein 532 [Source:HGNC Symbol;Acc:HGNC:30940],NA,ZNF532,55205,NM_001318726;NM_001318727;NM_001318728;NM_001353525;NM_001353526;NM_001353527;NM_001353528;NM_001353529;NM_001353530;NM_001353531;NM_001353532;NM_001353533;NM_001353534;NM_001353535;NM_001353536;NM_001353537;NM_018181
CAMK1_SIG,CAMK1,CAMK1_SIG,CAMK1,SIG,17,-4.10653408619519,0.0340765835797059,0.0618677904290858,-0.0572373817825425,-0.119105172211628,0.000144866747414266,-3.14583636161405,2.79335993007658,2.9395714352804,2.31295069869259,-0.626620736587813,0.00734815584260995,ENSG00000134072,CAMK1,protein_coding,3,-1,9757347,9769992,p25.3,calcium/calmodulin dependent protein kinase I [Source:HGNC Symbol;Acc:HGNC:1459],NA,CAMK1,8536,NM_003656
PLXNA1_SIG,PLXNA1,PLXNA1_SIG,PLXNA1,SIG,38,-4.10451242888089,-0.0966638570945274,-0.0892220903283717,-0.121115376469039,-0.0318932861406673,0.000146075758763994,-1.88059173990069,3.17784018131297,3.23852620163624,2.97844325739366,-0.260082944242576,0.120323661439092,ENSG00000114554,PLXNA1,protein_coding,3,1,126988594,127037392,q21.3,plexin A1 [Source:HGNC Symbol;Acc:HGNC:9099],NA,PLXNA1,5361,NM_032242
EPHB2_SIG,EPHB2,EPHB2_SIG,EPHB2,SIG,14,-4.1031812391808,0.0072871827127329,0.0363507122995762,-0.0882072716440378,-0.124557983943614,0.000146855236341572,-2.77803525167371,1.46523091204768,1.57228222947264,1.11349086907996,-0.458791360392674,0.018618448017842,ENSG00000133216,EPHB2,protein_coding,1,1,22710839,22921500,p36.12,EPH receptor B2 [Source:HGNC Symbol;Acc:HGNC:3393],Familial prostate cancer;PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY,EPHB2,2048,NM_001309192;NM_001309193;NM_004442;NM_017449
PLXNA4_SIG,PLXNA4,PLXNA4_SIG,PLXNA4,SIG,12,-4.10230443538348,-0.130171198875719,-0.123753079520527,-0.151259305328494,-0.0275062258079664,0.000147348927111051,-3.5667176500186,1.41029218813367,1.51250978985393,1.07443435390996,-0.438075435943975,0.00220961785799013,ENSG00000221866,PLXNA4,protein_coding,7,-1,132123332,132648688,q32.3,plexin A4 [Source:HGNC Symbol;Acc:HGNC:9102],NA,PLXNA4,91584,NM_001105543;NM_020911;NM_181775
ZNF782_TF,ZNF782,ZNF782_TF,ZNF782,TF,41,4.10218903123641,0.230379147283919,0.218843562811536,0.268281781978889,0.0494382191673525,0.000147358390755587,3.80078446738223,2.72813169679516,2.66570362606804,2.93325250061285,0.267548874544806,0.0010743573860691,ENSG00000196597,ZNF782,protein_coding,9,-1,96816472,96875623,q22.33,zinc finger protein 782 [Source:HGNC Symbol;Acc:HGNC:33110],NA,ZNF782,158431,NM_001001662;NM_001346991;NM_001346993;NM_001346995
ANXA5_SIG,ANXA5,ANXA5_SIG,ANXA5,SIG,52,-4.10198474841998,0.0212848167001927,0.0407644530395664,-0.0427197027006065,-0.0834841557401728,0.000147424513449574,-4.20805845293598,6.25504638526712,6.4687360971001,5.55292304638734,-0.915813050712757,0.000280640413066346,ENSG00000164111,ANXA5,protein_coding,4,-1,121667946,121696995,q27,annexin A5 [Source:HGNC Symbol;Acc:HGNC:543],PREGNANCY LOSS RECURRENT SUSCEPTIBILITY TO 3,ANXA5,308,NM_001154
NONO_SIG,NONO,NONO_SIG,NONO,SIG,48,4.10150642376398,0.504017340155232,0.492678778232808,0.541272615043195,0.0485938368103868,0.00014766550470058,2.9089023225725,8.44835784984572,8.42008655557079,8.5412492453205,0.121162689749704,0.0135607658498724,ENSG00000147140,NONO,protein_coding,X,1,71283192,71301168,q13.1,non-POU domain containing octamer binding [Source:HGNC Symbol;Acc:HGNC:7871],Macrocephaly-intellectual disability-left ventricular non compaction syndrome;MENTAL RETARDATION X-LINKED SYNDROMIC 34;MiT family translocation renal cell carcinoma;Syndromic intellectual disability,NONO,4841,NM_001145408;NM_001145409;NM_001145410;NM_007363
PARN_SIG,PARN,PARN_SIG,PARN,SIG,38,4.09908092206078,0.442963629475447,0.429072006910832,0.488607532187756,0.0595355252769239,0.000149156610417575,3.6154204816564,5.69824302384826,5.6542186708833,5.84289446930454,0.188675798421241,0.00190537408985855,ENSG00000140694,PARN,protein_coding,16,-1,14435700,14632728,p13.12,poly(A)-specific ribonuclease [Source:HGNC Symbol;Acc:HGNC:8609],Dyskeratosis congenita;DYSKERATOSIS CONGENITA AUTOSOMAL RECESSIVE 6;HOYERAAL-HREIDARSSON SYNDROME;Idiopathic pulmonary fibrosis;PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE TELOMERE-RELATED 4,PARN,5073,NM_001134477;NM_001242992;NM_002582
INHBB_SIG,INHBB,INHBB_SIG,INHBB,SIG,20,-4.09817880796768,-0.176695152984069,-0.170388310956023,-0.197417633933363,-0.02702932297734,0.00014967402705105,-1.72554721842552,0.296486796720207,0.315179742001437,0.235067119367595,-0.0801126226338418,0.156476451465485,ENSG00000163083,INHBB,protein_coding,2,1,120346136,120351803,q14.2,inhibin subunit beta B [Source:HGNC Symbol;Acc:HGNC:6067],NA,INHBB,3625,NM_002193
ASGR2_SIG,ASGR2,ASGR2_SIG,ASGR2,SIG,16,-4.09758358119348,0.164251392984373,0.205298143411122,0.0293834987250557,-0.175914644686066,0.000149994228668602,-3.53246625010774,2.36251521963109,2.52337137747459,1.83398784385958,-0.689383533615007,0.00245100527805866,ENSG00000161944,ASGR2,protein_coding,17,-1,7101322,7115700,p13.1,asialoglycoprotein receptor 2 [Source:HGNC Symbol;Acc:HGNC:743],NA,ASGR2,433,NM_001181;NM_001201352;NM_080912;NM_080913;NM_080914
TDRD3_SIG,TDRD3,TDRD3_SIG,TDRD3,SIG,18,4.09644779792014,0.17392442560863,0.162306571679249,0.212097374233738,0.0497908025544887,0.000150666347708477,2.80322470540041,4.22848649164543,4.19136377204294,4.35046114176792,0.159097369724985,0.0175569736095336,ENSG00000083544,TDRD3,protein_coding,13,1,60396457,60573878,q21.2,tudor domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20612],NA,TDRD3,81550,NM_001146070;NM_001146071;NM_030794
PPIP5K2_SIG,PPIP5K2,PPIP5K2_SIG,PPIP5K2,SIG,14,4.09453804014235,0.305514277493898,0.291742625468404,0.350763991291948,0.0590213658235442,0.000151847738808955,1.73235066755343,6.93387332824938,6.90885972880877,7.01606086926853,0.10720114045976,0.154646235113975,ENSG00000145725,PPIP5K2,protein_coding,5,1,103120149,103212799,q21.1,diphosphoinositol pentakisphosphate kinase 2 [Source:HGNC Symbol;Acc:HGNC:29035],NA,PPIP5K2,23262,NM_001276277;NM_001281471;NM_001345871;NM_001345872;NM_001345873;NM_001345874;NM_001345875;NM_001345876;NM_001345877;NM_001345878;NM_015216
CROT_SIG,CROT,CROT_SIG,CROT,SIG,28,4.09398955920392,0.0653428424575134,0.0569382144591882,0.0929580487377248,0.0360198342785365,0.000152104808045891,1.6589762380197,2.51170101947737,2.48160848085241,2.61057650353084,0.128968022678428,0.174053667056877,ENSG00000005469,CROT,protein_coding,7,1,87345681,87399795,q21.12,carnitine O-octanoyltransferase [Source:HGNC Symbol;Acc:HGNC:2366],NA,CROT,54677,NM_001143935;NM_001243745;NM_021151
C11orf95_TF,C11orf95,C11orf95_TF,C11orf95,TF,144,4.09389851180052,0.175597852314353,0.164462042146006,0.21218694286749,0.0477249007214841,0.000152104808045891,1.31488170300387,4.42280535796197,4.38514146034218,4.54655816442701,0.16141670408483,0.289064759122378,ENSG00000188070,C11orf95,protein_coding,11,-1,63759892,63768775,q13.1,chromosome 11 open reading frame 95 [Source:HGNC Symbol;Acc:HGNC:28449],Ependymoma,C11orf95,65998,NM_001144936
PIP4K2B_SIG,PIP4K2B,PIP4K2B_SIG,PIP4K2B,SIG,139,4.09384507162539,0.27137314564837,0.258963542704304,0.312147555321729,0.053184012617425,0.000152104808045891,2.89151142354061,6.68185060975862,6.62360155085561,6.87324037472566,0.249638823870059,0.0141721606995327,ENSG00000276293,PIP4K2B,protein_coding,17,-1,38765689,38800126,q12,phosphatidylinositol-5-phosphate 4-kinase type 2 beta [Source:HGNC Symbol;Acc:HGNC:8998],NA,PIP4K2B,8396,NM_003559
LCK_SIG,LCK,LCK_SIG,LCK,SIG,73,-4.09315314917087,-0.117785304415849,-0.0918089660272133,-0.203136130549937,-0.111327164522724,0.000152493612602581,-3.5447821975628,3.4917041298789,3.61994158294269,3.07035249838358,-0.549589084559103,0.0023645630289473,ENSG00000182866,LCK,protein_coding,1,1,32251239,32286165,p35.2,LCK proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6524],Immunodeficiency 22;Severe combined immunodeficiency due to LCK deficiency,LCK,3932,NM_001042771;NM_001330468;NM_005356
RPL39L_SIG,RPL39L,RPL39L_SIG,RPL39L,SIG,43,-4.09220747111382,-0.0919752376685397,-0.0866382642640755,-0.109511007426065,-0.0228727431619896,0.000153050811646291,-2.12005533369887,1.07834962842122,1.12395446877781,0.928505152963852,-0.195449315813961,0.0773858377294306,ENSG00000163923,RPL39L,protein_coding,3,-1,187120948,187180908,q27.3,ribosomal protein L39 like [Source:HGNC Symbol;Acc:HGNC:17094],NA,RPL39L,116832,NM_052969
ZNF821_TF,ZNF821,ZNF821_TF,ZNF821,TF,332,-4.0910052341444,-0.140931876049493,-0.130526273798104,-0.175121712018342,-0.0445954382202378,0.000153776071396605,-3.5876224538879,2.48632672948211,2.56725291067755,2.22042641983996,-0.346826490837594,0.0020765305907939,ENSG00000102984,ZNF821,protein_coding,16,-1,71859680,71895336,q22.2,zinc finger protein 821 [Source:HGNC Symbol;Acc:HGNC:28043],NA,ZNF821,55565,NM_001201552;NM_001201553;NM_001201554;NM_001201556;NM_001318238;NM_001318239;NM_017530
KCNH3_SIG,KCNH3,KCNH3_SIG,KCNH3,SIG,13,-4.09091096257337,0.19065593130513,0.212733847352142,0.118114207150661,-0.0946196402014807,0.000153776071396605,-3.47246942756625,1.80612603669822,1.92731688169235,1.40792754600321,-0.519389335689139,0.00291796284453999,ENSG00000135519,KCNH3,protein_coding,12,1,49539030,49558337,q13.12,potassium voltage-gated channel subfamily H member 3 [Source:HGNC Symbol;Acc:HGNC:6252],NA,KCNH3,23416,NM_001314030;NM_012284
KCNA6_SIG,KCNA6,KCNA6_SIG,KCNA6,SIG,15,-4.09062362426244,-0.133927336992961,-0.121174979853111,-0.175827939023898,-0.0546529591707866,0.000153866933390876,-2.86061195406419,0.318568373465593,0.350973366718256,0.212094824206845,-0.13887854251141,0.0152954808490326,ENSG00000151079,KCNA6,protein_coding,12,1,4809176,4813412,p13.32,potassium voltage-gated channel subfamily A member 6 [Source:HGNC Symbol;Acc:HGNC:6225],NA,KCNA6,NA,NA
ASNS_SIG,ASNS,ASNS_SIG,ASNS,SIG,11,4.0905737193912,0.0118232427547993,0.00739982274610373,0.0263573370690846,0.018957514322981,0.000153866933390876,3.38239889420084,4.01918086306053,3.94005385338684,4.27916960913122,0.339115755744378,0.00380652723733047,ENSG00000070669,ASNS,protein_coding,7,-1,97851677,97872542,q21.3,asparagine synthetase (glutamine-hydrolyzing) [Source:HGNC Symbol;Acc:HGNC:753],Asparagine synthetase deficiency;Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,ASNS,440,NM_001178075;NM_001178076;NM_001178077;NM_001352496;NM_001673;NM_133436;NM_183356
SIRT4_SIG,SIRT4,SIRT4_SIG,SIRT4,SIG,9,4.09015430352907,0.0700672075991628,0.0552240600333426,0.118837549601143,0.0636134895678005,0.00015406214408316,2.50542026411019,0.379503591733278,0.362198470531034,0.436363275683508,0.0741648051524735,0.0348440802638905,ENSG00000089163,SIRT4,protein_coding,12,1,120302316,120313249,q24.31,sirtuin 4 [Source:HGNC Symbol;Acc:HGNC:14932],NA,SIRT4,23409,NM_012240
PRKRIP1_SIG,PRKRIP1,PRKRIP1_SIG,PRKRIP1,SIG,46,4.09007956104732,0.173918507779321,0.168929165794074,0.190312060016562,0.0213828942224885,0.00015406214408316,3.89688030565989,5.16636489945015,5.12023719560072,5.31792735495544,0.197690159354718,0.000789369092699658,ENSG00000128563,PRKRIP1,protein_coding,7,1,102363872,102426676,q22.1,PRKR interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:21894],NA,PRKRIP1,79706,NM_024653
ENTPD5_SIG,ENTPD5,ENTPD5_SIG,ENTPD5,SIG,20,4.0891504276516,0.392114894297371,0.379653818217051,0.433058429989848,0.0534046117727962,0.000154613819826239,4.16604147645754,4.35369882301815,4.28584803608693,4.57663712293503,0.290789086848102,0.000323342643509492,ENSG00000187097,ENTPD5,protein_coding,14,-1,73958010,74019399,q24.3,ectonucleoside triphosphate diphosphohydrolase 5 [Source:HGNC Symbol;Acc:HGNC:3367],NA,ENTPD5,957,NM_001249;NM_001321984;NM_001321985;NM_001321986;NM_001321987;NM_001321988;NM_001330189
ZFR_TF,ZFR,ZFR_TF,ZFR,TF,246,4.0879852298258,0.0999187859775472,0.094939887237216,0.116278024695778,0.0213381374585626,0.000155325313212849,0.947401286693013,7.35045056024632,7.33740409219602,7.3933175266973,0.0559134345012805,0.457068210065472,ENSG00000056097,ZFR,protein_coding,5,-1,32354350,32444740,p13.3,zinc finger RNA binding protein [Source:HGNC Symbol;Acc:HGNC:17277],Autosomal recessive spastic paraplegia type 71,ZFR,51663,NM_016107
CD5L_SIG,CD5L,CD5L_SIG,CD5L,SIG,25,-4.08770502860546,-0.236811408627711,-0.217327794139525,-0.300828999088892,-0.083501204949366,0.000155446008831897,-2.47057037411278,0.693361851855469,0.770256322195055,0.440708592168256,-0.329547730026799,0.0376522969625617,ENSG00000073754,CD5L,protein_coding,1,-1,157830911,157898256,q23.1,CD5 molecule like [Source:HGNC Symbol;Acc:HGNC:1690],NA,CD5L,922,NM_001347698;NM_005894
PML_SIG,PML,PML_SIG,PML,SIG,22,4.08717907540206,0.128988363121722,0.122105340484182,0.151604008930781,0.0294986684465984,0.000155731635658973,1.48835975961728,6.75189169220663,6.73301703648155,6.81390841816047,0.0808913816789253,0.22581867223772,ENSG00000140464,PML,protein_coding,15,1,73994673,74047812,q24.1,promyelocytic leukemia [Source:HGNC Symbol;Acc:HGNC:9113],ACUTE PROMYELOCYTIC LEUKEMIA,PML,5371,NM_002675;NM_033238;NM_033239;NM_033240;NM_033244;NM_033246;NM_033247;NM_033249;NM_033250
NTRK2_SIG,NTRK2,NTRK2_SIG,NTRK2,SIG,21,-4.08538741831631,-0.274264798243807,-0.265783524108385,-0.302131841831621,-0.036348317723236,0.00015679933174795,-1.74694119327456,0.254119278945967,0.278573965830473,0.173768164896875,-0.104805800933598,0.150987691154932,ENSG00000148053,NTRK2,protein_coding,9,1,84668551,85027070,q21.33,neurotrophic receptor tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:8032],Epilepsy and intellectual disability;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 58;OBESITY HYPERPHAGIA AND DEVELOPMENTAL DELAY;Pilomyxoid astrocytoma;Undetermined early-onset epileptic encephalopathy;West syndrome,NTRK2,4915,NM_001007097;NM_001018064;NM_001018065;NM_001018066;NM_001291937;NM_006180
PARP8_SIG,PARP8,PARP8_SIG,PARP8,SIG,14,-4.0853722514524,0.034926363283524,0.0424321839688199,0.0102643810318376,-0.0321678029369822,0.00015679933174795,-2.15460132699487,6.9470791785857,7.00840113334689,6.74559275579894,-0.262808377547946,0.0724710043487804,ENSG00000151883,PARP8,protein_coding,5,1,50665899,50846519,q11.1,poly(ADP-ribose) polymerase family member 8 [Source:HGNC Symbol;Acc:HGNC:26124],NA,PARP8,79668,NM_001178055;NM_001178056;NM_001331028;NM_024615
RBM5_SIG,RBM5,RBM5_SIG,RBM5,SIG,51,4.08529341530174,0.276867266071444,0.27045590209696,0.297933176273318,0.027477274176358,0.00015679933174795,3.57029124645765,7.22142851494931,7.17855087774262,7.36231218005698,0.18376130231436,0.00218612644568869,ENSG00000003756,RBM5,protein_coding,3,1,50088908,50119021,p21.31,RNA binding motif protein 5 [Source:HGNC Symbol;Acc:HGNC:9902],NA,RBM5,10181,NM_005778
CAP1_SIG,CAP1,CAP1_SIG,CAP1,SIG,60,-4.08468882413211,0.607299093083682,0.622620865732499,0.556956125808997,-0.065664739923502,0.000157140577946934,-3.17370607181178,8.81291449001483,8.86502467069383,8.64169532492669,-0.223329345767146,0.00681154572755443,ENSG00000131236,CAP1,protein_coding,1,1,40040233,40072649,p34.2,cyclase associated actin cytoskeleton regulatory protein 1 [Source:HGNC Symbol;Acc:HGNC:20040],NA,CAP1,10487,NM_001105530;NM_001330502;NM_001350475;NM_001350476;NM_001350477;NM_001350478;NM_001350479;NM_001350480;NM_001350481;NM_001350482;NM_001350483;NM_001350484;NM_001350485;NM_006367
PHGDH_SIG,PHGDH,PHGDH_SIG,PHGDH,SIG,40,4.08255733243403,0.00753282955495884,0.00108881517325485,0.0287060196662719,0.027617204493017,0.000158521155980368,2.74113001871489,3.67818172193313,3.56871233168425,4.03786686132231,0.469154529638057,0.0203191523495617,ENSG00000092621,PHGDH,protein_coding,1,1,119648411,119744226,p12,phosphoglycerate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:8923],3-phosphoglycerate dehydrogenase deficiency infantile/juvenile form;Neu-Laxova syndrome;NEU-LAXOVA SYNDROME 1;PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY,PHGDH,26227,NM_006623
ZNF680_TF,ZNF680,ZNF680_TF,ZNF680,TF,54,4.08199201668327,0.142743833065321,0.129737873900577,0.18547769889234,0.0557398249917633,0.00015879591154512,3.99903205148681,3.82500430808495,3.73058538276431,4.13523791985274,0.404652537088428,0.000570495055935429,ENSG00000173041,ZNF680,protein_coding,7,-1,64519878,64563075,q11.21,zinc finger protein 680 [Source:HGNC Symbol;Acc:HGNC:26897],NA,ZNF680,340252,NM_001130022;NM_178558
ZNF382_TF,ZNF382,ZNF382_TF,ZNF382,TF,7,4.08195546693621,-0.186185796253606,-0.204198130611201,-0.127002411935793,0.0771957186754074,0.00015879591154512,3.79742812551017,2.17467956564324,2.08044956716807,2.48429241777594,0.403842850607866,0.00108405422424951,ENSG00000161298,ZNF382,protein_coding,19,1,36604817,36634114,q13.12,zinc finger protein 382 [Source:HGNC Symbol;Acc:HGNC:17409],NA,ZNF382,84911,NM_001256838;NM_032825
ABCB7_SIG,ABCB7,ABCB7_SIG,ABCB7,SIG,11,4.08117937240821,0.515459479804772,0.506685134183553,0.544289472560204,0.0376043383766502,0.000159200613756686,1.45395420059305,4.87694736661094,4.85629945718057,4.94479049759647,0.0884910404158966,0.237260002978075,ENSG00000131269,ABCB7,protein_coding,X,-1,75051048,75156732,q13.3,ATP binding cassette subfamily B member 7 [Source:HGNC Symbol;Acc:HGNC:48],Anemia sideroblastic and spinocerebellar ataxia;Anemia sideroblastic with ataxia;X-linked sideroblastic anemia and spinocerebellar ataxia,ABCB7,22,NM_001271696;NM_001271697;NM_001271698;NM_001271699;NM_004299
MACF1_SIG,MACF1,MACF1_SIG,MACF1,SIG,65,4.08113402153407,0.206458149627997,0.197697463033897,0.235243262722898,0.0375457996890016,0.000159200613756686,2.70930346666307,9.08573917628242,9.03233865029225,9.26119804739298,0.228859397100722,0.0219091698319734,ENSG00000127603,MACF1,protein_coding,1,1,39081316,39487177,p34.3,microtubule-actin crosslinking factor 1 [Source:HGNC Symbol;Acc:HGNC:13664],NA,MACF1,23499;643314,NM_012090;NM_015038
CD3G_SIG,CD3G,CD3G_SIG,CD3G,SIG,29,-4.08106499035334,-0.09777431527725,-0.0668388430419477,-0.1994194383361,-0.132580595294153,0.000159200613756686,-3.66852312007561,1.92443911243311,2.04468040907365,1.52936056632848,-0.515319842745174,0.0016195392042448,ENSG00000160654,CD3G,protein_coding,11,1,118344344,118355161,q23.3,CD3g molecule [Source:HGNC Symbol;Acc:HGNC:1675],Combined immunodeficiency due to CD3gamma deficiency;IMMUNODEFICIENCY 17,CD3G,917,NM_000073
ZNF43_TF,ZNF43,ZNF43_TF,ZNF43,TF,82,4.08032462663578,-0.0474757049970378,-0.0590283831800393,-0.00951690525289006,0.0495114779271493,0.000159640126340926,3.1747454976454,4.51646535201486,4.43404109613366,4.7872879070531,0.353246810919438,0.00680202296942682,ENSG00000198521,ZNF43,protein_coding,19,-1,21804949,21852125,p12,zinc finger protein 43 [Source:HGNC Symbol;Acc:HGNC:13109],NA,ZNF43,7594,NM_001256648;NM_001256649;NM_001256650;NM_001256651;NM_001256653;NM_001256654;NM_003423
AEBP2_TF,AEBP2,AEBP2_TF,AEBP2,TF,39,4.07984801936423,0.213236084487578,0.207472276594991,0.232174310420367,0.0247020338253765,0.000159899274812144,2.95031517751512,5.02393941398953,4.9927143849583,5.12653593794925,0.133821552990948,0.0122294258122938,ENSG00000139154,AEBP2,protein_coding,12,1,19404045,19720801,p12.3,AE binding protein 2 [Source:HGNC Symbol;Acc:HGNC:24051],NA,AEBP2,121536,NM_001114176;NM_001267043;NM_153207
LRP5_SIG,LRP5,LRP5_SIG,LRP5,SIG,24,4.07954788256867,0.13710823681396,0.123948405048456,0.180347684043473,0.0563992789950169,0.000160037312561657,2.04435308814308,4.37783969442612,4.30668342241051,4.61163887390599,0.304955451495473,0.089507280706493,ENSG00000162337,LRP5,protein_coding,11,1,68312591,68449275,q13.2,LDL receptor related protein 5 [Source:HGNC Symbol;Acc:HGNC:6697],Autosomal dominant osteopetrosis type 1;Bone mineral density quantitative trait locus 1;ENDOSTEAL HYPEROSTOSIS AUTOSOMAL DOMINANT;ENDOSTEAL HYPEROSTOSIS WORTH TYPE;EXUDATIVE VITREORETINOPATHY 1;Exudative vitreoretinopathy 4;Familial exudative vitreoretinopathy;HIGH BONE MASS TRAIT;HYPEROSTOSIS CORTICALIS GENERALISATA;Isolated polycystic liver disease;LRP5-related primary osteoporosis;OSTEOPETROSIS AUTOSOMAL DOMINANT 1;Osteopetrosis autosomal dominant type 1;OSTEOPOROSIS;OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME;Osteosclerosis-developmental delay-craniosynostosis syndrome;POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS;RETINOPATHY OF PREMATURITY;Van Buchem disease type 2;VITREORETINOPATHY EXUDATIVE TYPE 4,LRP5,4041,NM_001291902;NM_002335
CLIC4_SIG,CLIC4,CLIC4_SIG,CLIC4,SIG,55,4.07938178905533,0.0732544651713922,0.0667630574483019,0.094583376261546,0.0278203188132441,0.000160046462549194,3.57404333894125,6.35881135019037,6.2725410599723,6.6422708751926,0.369729815220296,0.00216315011436901,ENSG00000169504,CLIC4,protein_coding,1,1,24745382,24844321,p36.11,chloride intracellular channel 4 [Source:HGNC Symbol;Acc:HGNC:13518],NA,CLIC4,25932,NM_013943
CD247_SIG,CD247,CD247_SIG,CD247,SIG,63,-4.07933563278007,-0.157519953699857,-0.133693437305837,-0.235807078994496,-0.10211364168866,0.000160046462549194,-3.85489336684235,3.47551131323837,3.61999833566586,3.00076823954802,-0.619230096117845,0.000905193340322291,ENSG00000198821,CD247,protein_coding,1,-1,167430640,167518610,q24.2,CD247 molecule [Source:HGNC Symbol;Acc:HGNC:1677],IMMUNODEFICIENCY 25;Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis;T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,CD247,919,NM_000734;NM_198053
SP100_TF,SP100,SP100_TF,SP100,TF,178,-4.07650196616502,0.189832360780563,0.195900229014611,0.16989507944012,-0.0260051495744916,0.000161939230356823,-2.5068135285683,7.15889804612733,7.18904080730697,7.05985754510854,-0.129183262198434,0.0347417163960953,ENSG00000067066,SP100,protein_coding,2,1,230415942,230545606,q37.1,SP100 nuclear antigen [Source:HGNC Symbol;Acc:HGNC:11206],NA,SP100,6672,NM_001080391;NM_001206701;NM_001206702;NM_001206703;NM_001206704;NM_003113
MCAT_SIG,MCAT,MCAT_SIG,MCAT,SIG,8,4.07624935810035,0.402121142097399,0.388046137780429,0.448367584853161,0.060321447072732,0.000162045884033183,4.31306679327983,3.42463918884111,3.35883471242065,3.64085389707976,0.282019184659107,0.00019503216511452,ENSG00000100294,MCAT,protein_coding,22,-1,43132206,43143394,q13.2,malonyl-CoA-acyl carrier protein transacylase [Source:HGNC Symbol;Acc:HGNC:29622],NA,MCAT,27349,NM_014507;NM_173467
P2RY10_SIG,P2RY10,P2RY10_SIG,P2RY10,SIG,26,-4.07528926385853,-0.0357724605794936,-0.0236026771488865,-0.0757588918514883,-0.052156214702602,0.00016264642140119,-3.22354682420401,2.13499985140032,2.23282193218661,1.81358444310253,-0.419237489084086,0.00594831249772113,ENSG00000078589,P2RY10,protein_coding,X,1,78945332,78963727,q21.1,P2Y receptor family member 10 [Source:HGNC Symbol;Acc:HGNC:19906],NA,P2RY10,27334,NM_001324218;NM_001324221;NM_001324225;NM_014499;NM_198333
EDEM1_SIG,EDEM1,EDEM1_SIG,EDEM1,SIG,29,-4.07474218009035,0.141754179334655,0.146611727176072,0.125793664998572,-0.0208180621774998,0.000162959627619808,-1.21381478596979,7.28977616659797,7.30822932253994,7.22914436850293,-0.079084954037011,0.330959784895775,ENSG00000134109,EDEM1,protein_coding,3,1,5187646,5219958,p26.1,ER degradation enhancing alpha-mannosidase like protein 1 [Source:HGNC Symbol;Acc:HGNC:18967],NA,EDEM1,9695,NM_014674
ZNF571_TF,ZNF571,ZNF571_TF,ZNF571,TF,62,4.07202852130946,-0.0642023769756411,-0.0751402797810314,-0.0282635534722158,0.0468767263088157,0.000164799968354364,4.2455088818749,2.30829207902836,2.22899417180468,2.56884234562046,0.33984817381578,0.000245596697895472,ENSG00000180479,ZNF571,protein_coding,19,-1,37554782,37594790,q13.12,zinc finger protein 571 [Source:HGNC Symbol;Acc:HGNC:25000],NA,ZNF571,51276,NM_001290314;NM_001321272;NM_016536
PABPN1_SIG,PABPN1,PABPN1_SIG,PABPN1,SIG,54,4.07065599519302,0.340018539307273,0.331797175509853,0.36703159178451,0.035234416274657,0.000165703306664994,3.16709155818502,6.39472718925069,6.35983018419117,6.5093887773034,0.149558593112232,0.00692721581755077,ENSG00000100836,PABPN1,protein_coding,14,1,23321289,23326185,q11.2,poly(A) binding protein nuclear 1 [Source:HGNC Symbol;Acc:HGNC:8565],OCULOPHARYNGEAL MUSCULAR DYSTROPHY,PABPN1,8106,NM_001360551;NM_001360552;NM_004643
MAPK7_SIG,MAPK7,MAPK7_SIG,MAPK7,SIG,25,-4.06938865988182,0.187941223634099,0.203064253865087,0.138251267160852,-0.0648129867042352,0.00016649216876186,-4.51237725297489,4.46380252361259,4.57311507517337,4.10463271134148,-0.468482363831893,9.43819367618234e-05,ENSG00000166484,MAPK7,protein_coding,17,1,19377721,19383544,p11.2,mitogen-activated protein kinase 7 [Source:HGNC Symbol;Acc:HGNC:6880],NA,MAPK7,5598,NM_002749;NM_139032;NM_139033;NM_139034
MTMR6_SIG,MTMR6,MTMR6_SIG,MTMR6,SIG,33,-4.0693508302502,0.462636713956268,0.473159689900788,0.428061221567131,-0.0450984683336574,0.00016649216876186,-4.16862458035594,5.51337500838988,5.58489752157322,5.2783724650732,-0.306525056500025,0.000321147673626705,ENSG00000139505,MTMR6,protein_coding,13,-1,25246201,25288009,q12.13,myotubularin related protein 6 [Source:HGNC Symbol;Acc:HGNC:7453],NA,MTMR6,9107,NM_004685
NFE4_TF,NFE4,NFE4_TF,NFE4,TF,201,-4.06900173359458,-0.0278361084629932,-0.0226644295096127,-0.0448287678812433,-0.0221643383716306,0.000166670746651934,-1.63935488230442,0.713885099569241,0.750157823678616,0.594703291781297,-0.155454531897318,0.179535160749738,ENSG00000230257,NFE4,protein_coding,7,1,102973430,102988856,q22.1,nuclear factor, erythroid 4 [Source:HGNC Symbol;Acc:HGNC:29902],NA,NFE4,58160,NM_001085386
MICAL2_SIG,MICAL2,MICAL2_SIG,MICAL2,SIG,9,-4.06817212092681,0.231067861236489,0.252941239140178,0.15919819098151,-0.0937430481586685,0.000167193897333271,-0.852388267985994,5.59325118890589,5.62098221785186,5.50213495094055,-0.118847266911306,0.50682964583401,ENSG00000133816,MICAL2,protein_coding,11,1,12094008,12359144,p15.3,microtubule associated monooxygenase, calponin and LIM domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24693],NA,MICAL2,9645;84953,NM_001282663;NM_001282664;NM_001282665;NM_001282666;NM_001282667;NM_001282668;NM_001346292;NM_001346293;NM_001346294;NM_001346295;NM_001346296;NM_001346297;NM_001346298;NM_001346299;NM_014632;NM_032867
DGCR8_SIG,DGCR8,DGCR8_SIG,DGCR8,SIG,19,4.06774841617884,0.410331034175467,0.400984774160185,0.441040174225677,0.0400554000654923,0.000167426805770077,1.77241748273333,5.74772946990496,5.72345094831789,5.82750175511964,0.10405080680175,0.1448670595819,ENSG00000128191,DGCR8,protein_coding,22,1,20080232,20111877,q11.21,DGCR8, microprocessor complex subunit [Source:HGNC Symbol;Acc:HGNC:2847],VELOCARDIOFACIAL SYNDROME,DGCR8,54487,NM_001190326;NM_022720
DNASE1L3_SIG,DNASE1L3,DNASE1L3_SIG,DNASE1L3,SIG,25,-4.06730561149475,-0.163656458942817,-0.155328607919207,-0.191019398020394,-0.0356907901011872,0.00016753939795341,-2.07041207548974,0.40506848037622,0.440299381978464,0.289309803683133,-0.150989578295331,0.0849714299807049,ENSG00000163687,DNASE1L3,protein_coding,3,-1,58192257,58214697,p14.3,deoxyribonuclease 1 like 3 [Source:HGNC Symbol;Acc:HGNC:2959],Autosomal systemic lupus erythematosus;Hypocomplementemic urticarial vasculitis;SYSTEMIC LUPUS ERYTHEMATOSUS 16,DNASE1L3,1776,NM_001256560;NM_004944
ZNF649_TF,ZNF649,ZNF649_TF,ZNF649,TF,30,4.06723714493368,0.255257409568764,0.245870537942395,0.286099987769691,0.0402294498272961,0.00016753939795341,3.01173849261303,3.20232195516343,3.15461484808974,3.35907387840557,0.204459030315838,0.0104159777924643,ENSG00000198093,ZNF649,protein_coding,19,-1,51889235,51905040,q13.41,zinc finger protein 649 [Source:HGNC Symbol;Acc:HGNC:25741],NA,ZNF649,65251,NM_023074
ZNF860_TF,ZNF860,ZNF860_TF,ZNF860,TF,104,-4.0672216141064,-0.0506239202068199,-0.0432913182371999,-0.0747167552498571,-0.0314254370126572,0.00016753939795341,-1.57622661747383,0.242699318576889,0.256144123538912,0.198523530844529,-0.0576205926943829,0.197744524131094,ENSG00000197385,ZNF860,protein_coding,3,1,31981771,31991628,p23,zinc finger protein 860 [Source:HGNC Symbol;Acc:HGNC:34513],NA,ZNF860,344787,NM_001137674
CXCL12_SIG,CXCL12,CXCL12_SIG,CXCL12,SIG,57,-4.06719511066189,-0.300282904469045,-0.287678581849216,-0.34169710736277,-0.054018525513554,0.00016753939795341,-3.42834173335555,1.53053215805657,1.72251756121826,0.899722976239602,-0.822794584978656,0.00331271513665395,ENSG00000107562,CXCL12,protein_coding,10,-1,44370165,44386493,q11.21,C-X-C motif chemokine ligand 12 [Source:HGNC Symbol;Acc:HGNC:10672],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,CXCL12,6387,NM_000609;NM_001033886;NM_001178134;NM_001277990;NM_199168
LPAR4_SIG,LPAR4,LPAR4_SIG,LPAR4,SIG,35,4.06708692479357,0.0308920743231058,0.0190498376332501,0.0698022805897746,0.0507524429565246,0.00016754596242298,1.13854683328781,1.54715772161606,1.51347988317847,1.65781347648244,0.144333593303969,0.364220592142873,ENSG00000147145,LPAR4,protein_coding,X,1,78747709,78757094,q21.1,lysophosphatidic acid receptor 4 [Source:HGNC Symbol;Acc:HGNC:4478],Differentiated thyroid carcinoma,LPAR4,2846,NM_001278000;NM_005296
GDE1_SIG,GDE1,GDE1_SIG,GDE1,SIG,11,4.06624553388904,0.180371736042922,0.17651902413098,0.19303064661073,0.0165116224797494,0.000168080308555666,1.96922549457353,6.48758169805806,6.46797965251366,6.55198841913251,0.0840087666188536,0.102716540113759,ENSG00000006007,GDE1,protein_coding,16,-1,19501693,19522123,p12.3,glycerophosphodiester phosphodiesterase 1 [Source:HGNC Symbol;Acc:HGNC:29644],NA,GDE1,51573,NM_001324066;NM_001324067;NM_016641
LAMB3_SIG,LAMB3,LAMB3_SIG,LAMB3,SIG,39,-4.06318252392573,-0.117390537557354,-0.10840733001661,-0.146906790905512,-0.0384994608889025,0.000170229838013243,-2.75456977300399,1.79402942886958,1.90437792995034,1.43145578246138,-0.472922147488964,0.0197195977211854,ENSG00000196878,LAMB3,protein_coding,1,-1,209614870,209652425,q32.2,laminin subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:6490],Amelogenesis imperfecta type IA;EPIDERMOLYSIS BULLOSA JUNCTIONAL HERLITZ TYPE;EPIDERMOLYSIS BULLOSA JUNCTIONAL NON-HERLITZ TYPE;Hypoplastic amelogenesis imperfecta;Junctional epidermolysis bullosa generalized intermediate;Junctional epidermolysis bullosa generalized severe,LAMB3,3914,NM_000228;NM_001017402;NM_001127641
GPRC5C_SIG,GPRC5C,GPRC5C_SIG,GPRC5C,SIG,42,4.06258576448766,-0.0314002191600288,-0.03650611905282,-0.0146236909408578,0.0218824281119621,0.000170589181542852,1.94559457832264,1.63141757437428,1.58077144814544,1.79782627484047,0.217054826695024,0.107292311536632,ENSG00000170412,GPRC5C,protein_coding,17,1,74424851,74451653,q25.1,G protein-coupled receptor class C group 5 member C [Source:HGNC Symbol;Acc:HGNC:13309],NA,GPRC5C,55890,NM_018653;NM_022036
SKAP1_SIG,SKAP1,SKAP1_SIG,SKAP1,SIG,9,-4.06249247358708,-0.0304454103758084,-0.0137643559945833,-0.0852545890569766,-0.0714902330623933,0.000170589181542852,-3.17739286671389,2.61647720116431,2.73176008185918,2.23769059316688,-0.494069488692305,0.00675364313890752,ENSG00000141293,SKAP1,protein_coding,17,-1,48133442,48430275,q21.32,src kinase associated phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:15605],NA,SKAP1,8631,NM_001075099;NM_003726
JRKL_TF,JRKL,JRKL_TF,JRKL,TF,52,4.061962322059,0.0649905544893931,0.0489338951056049,0.117748149607554,0.0688142545019492,0.000170856273250923,2.93276195397515,3.60408686475543,3.52159544614399,3.87513009733588,0.353534651191891,0.0127915136447088,ENSG00000183340,JRKL,protein_coding,11,1,96389989,96507574,q21,JRK like [Source:HGNC Symbol;Acc:HGNC:6200],NA,JRKL,8690,NM_001261833;NM_003772
GBAP1_SIG,GBAP1,GBAP1_SIG,GBAP1,SIG,19,4.06188356192403,0.0171576052314787,0.00254937107918884,0.0651560888747169,0.062606717795528,0.000170856273250923,3.2032166073586,2.97336420705931,2.90686288310926,3.19186855718091,0.285005674071646,0.00629275672110491,ENSG00000160766,GBAP1,transcribed_unprocessed_pseudogene,1,-1,155213821,155227422,q22,glucosylceramidase beta pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:4178],NA,GBAP1,NA,NA
CERK_SIG,CERK,CERK_SIG,CERK,SIG,15,-4.06183063040539,0.205962204625197,0.211840289149882,0.186648498329801,-0.0251917908200812,0.000170856273250923,-4.25985085856434,6.47482442326031,6.54477989723432,6.24497072306,-0.299809174174317,0.000233114437077304,ENSG00000100422,CERK,protein_coding,22,-1,46684410,46738252,q13.31,ceramide kinase [Source:HGNC Symbol;Acc:HGNC:19256],NA,CERK,64781,NM_022766
TRMT61A_SIG,TRMT61A,TRMT61A_SIG,TRMT61A,SIG,33,4.06154634254207,0.43154153718455,0.421237619736175,0.465397265943497,0.0441596462073222,0.000170992082328068,2.50560887493861,3.81435584303282,3.77734143301892,3.93597461879277,0.158633185773848,0.0348298462417536,ENSG00000166166,TRMT61A,protein_coding,14,1,103529196,103537073,q32.33,tRNA methyltransferase 61A [Source:HGNC Symbol;Acc:HGNC:23790],NA,TRMT61A,115708,NM_152307
ZNF496_TF,ZNF496,ZNF496_TF,ZNF496,TF,384,4.06127870251306,0.322377893716283,0.311231724520917,0.359001021072489,0.0477692965515722,0.000171115812385331,3.35944586435357,6.17638557612996,6.09575544259268,6.44131315775248,0.345557715159804,0.00406737912674504,ENSG00000162714,ZNF496,protein_coding,1,-1,247297412,247331846,q44,zinc finger protein 496 [Source:HGNC Symbol;Acc:HGNC:23713],NA,ZNF496,84838,NM_001329733;NM_032752
HES1_TF,HES1,HES1_TF,HES1,TF,101,-4.06066962359858,-0.0505667337334325,-0.0448946834835369,-0.0692034702688038,-0.0243087867852668,0.000171490289546935,-0.512821995140249,0.775725143330009,0.78725315905038,0.737847377391648,-0.0494057816587318,0.702068765749059,ENSG00000114315,HES1,protein_coding,3,1,194136148,194138732,q29,hes family bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5192],NA,HES1,3280,NM_005524
CREBBP_SIG,CREBBP,CREBBP_SIG,CREBBP,SIG,49,-4.06029647105462,0.27088084784975,0.282303941688067,0.233347825238139,-0.0489561164499278,0.000171691978040705,-2.30768937634333,7.9278489548026,7.96123319422238,7.81815788242336,-0.143075311799018,0.0531155344694997,ENSG00000005339,CREBBP,protein_coding,16,-1,3725054,3880726,p13.3,CREB binding protein [Source:HGNC Symbol;Acc:HGNC:2348],Acute myeloid leukemia with t(8;16)(p11;p13) translocation;CREBBP intellectual disability without typical RTS features;RUBINSTEIN-TAYBI SYNDROME 1;Rubinstein-Taybi syndrome due to 16p13.3 microdeletion;Rubinstein-Taybi syndrome due to CREBBP mutations;RUBINSTEIN-TAYBI SYNDROME TYPE 1,CREBBP,1387,NM_001079846;NM_004380
SMARCA4_TF,SMARCA4,SMARCA4_TF,SMARCA4,TF,296,4.05986587082131,0.409713193385464,0.399745042664633,0.442465688611052,0.0427206459464187,0.000171936208474847,3.77316084256252,7.43151750278092,7.38505532666313,7.58417893859651,0.199123611933382,0.00116768233356134,ENSG00000127616,SMARCA4,protein_coding,19,1,10960825,11079426,p13.2,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [Source:HGNC Symbol;Acc:HGNC:11100],COFFIN-SIRIS SYNDROME;COFFIN-SIRIS SYNDROME 4;Coffin Siris;Familial rhabdoid tumor;Rhabdoid tumor predisposition syndrome 2;Small cell carcinoma of the ovary;SMARCA4-deficient sarcoma of thorax,SMARCA4,6597,NM_001128844;NM_001128845;NM_001128846;NM_001128847;NM_001128848;NM_001128849;NM_003072
ZNF813_TF,ZNF813,ZNF813_TF,ZNF813,TF,82,4.05970628791377,0.263002648029816,0.25328659370664,0.294926826520252,0.0416402328136126,0.000171981067371972,3.02875176524738,3.07372656941463,3.01326068300625,3.27240019618505,0.259139513178808,0.00998931092863828,ENSG00000198346,ZNF813,protein_coding,19,1,53467733,53496255,q13.42,zinc finger protein 813 [Source:HGNC Symbol;Acc:HGNC:33257],NA,ZNF813,126017,NM_001004301
TAS2R19_SIG,TAS2R19,TAS2R19_SIG,TAS2R19,SIG,22,4.05909374438915,-0.0880578810663863,-0.0976529070481651,-0.0565313671262558,0.0411215399219095,0.000172359960768649,2.20191920135035,0.242732955709682,0.23227495314564,0.27709496413439,0.0448200109887498,0.0661381062838668,ENSG00000212124,TAS2R19,protein_coding,12,-1,11021619,11022620,p13.2,taste 2 receptor member 19 [Source:HGNC Symbol;Acc:HGNC:19108],NA,TAS2R19,259294,NM_176888
PRLR_SIG,PRLR,PRLR_SIG,PRLR,SIG,13,-4.05864909387287,0.025158360973849,0.0506665268779435,-0.0586541841396043,-0.109320711017548,0.000172615532245854,-3.06112593209356,1.80784106433538,1.95423812299081,1.32682215732469,-0.627415965666122,0.00918253655544982,ENSG00000113494,PRLR,protein_coding,5,-1,35048756,35230487,p13.2,prolactin receptor [Source:HGNC Symbol;Acc:HGNC:9446],Familial  hyperprolactinemia;HYPERPROLACTINEMIA;MULTIPLE FIBROADENOMAS OF THE BREAST,PRLR,5618,NM_000949;NM_001204314;NM_001204315;NM_001204316;NM_001204317;NM_001204318
FYN_SIG,FYN,FYN_SIG,FYN,SIG,35,-4.05762763823431,0.0699173537497822,0.0803262413477698,0.03571672307068,-0.0446095182770898,0.000173298865332427,-0.917504514340918,6.05804500800111,6.08263557708108,5.97724742388123,-0.10538815319985,0.47253830640864,ENSG00000010810,FYN,protein_coding,6,-1,111660332,111873452,q21,FYN proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:4037],NA,FYN,2534,NM_002037;NM_153047;NM_153048
IMP4_SIG,IMP4,IMP4_SIG,IMP4,SIG,29,4.05720729080297,0.415908388519235,0.405238663074784,0.450966057836715,0.0457273947619308,0.000173537730312707,4.0909890161145,5.63263652197835,5.58589890423002,5.78620298029429,0.200304076064271,0.000417426349628332,ENSG00000136718,IMP4,protein_coding,2,1,130342225,130347810,q21.1,IMP4, U3 small nucleolar ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:30856],NA,IMP4,92856,NM_001320304;NM_001320305;NM_001320306;NM_001320307;NM_001320309;NM_001320310;NM_001320311;NM_033416
PARP16_SIG,PARP16,PARP16_SIG,PARP16,SIG,43,4.05678454975437,0.0561867774028333,0.0482045034062531,0.0824142491058824,0.0342097456996293,0.000173778706343014,2.68490719597261,4.00129763107936,3.9584273475104,4.14215713423454,0.183729786724141,0.0232297645241273,ENSG00000138617,PARP16,protein_coding,15,-1,65234460,65300618,q22.31,poly(ADP-ribose) polymerase family member 16 [Source:HGNC Symbol;Acc:HGNC:26040],NA,PARP16,54956,NM_001316943;NM_001316944;NM_017851
PCGF2_SIG,PCGF2,PCGF2_SIG,PCGF2,SIG,13,-4.05654019029331,-0.121714990010021,-0.112643014715543,-0.151522908834734,-0.0388798941191905,0.000173849380317398,-2.93319873766627,0.588899853660843,0.647667946035441,0.395804693001453,-0.251863253033988,0.0127777915262311,ENSG00000277258,PCGF2,protein_coding,17,-1,38733898,38749817,q12,polycomb group ring finger 2 [Source:HGNC Symbol;Acc:HGNC:12929],Intellectual dusbility,PCGF2,7703,NM_007144
MAFK_TF,MAFK,MAFK_TF,MAFK,TF,55,4.0564926035585,0.0718455571954594,0.0640818910602211,0.097354745925528,0.0332728548653067,0.000173849380317398,3.09814174880859,5.00745387776723,4.95046376527534,5.19470710452631,0.244243339250966,0.00832816037049167,ENSG00000198517,MAFK,protein_coding,7,1,1530702,1543043,p22.3,MAF bZIP transcription factor K [Source:HGNC Symbol;Acc:HGNC:6782],NA,MAFK,7975,NM_002360
CD27_SIG,CD27,CD27_SIG,CD27,SIG,24,-4.05603636180036,-0.302670414205098,-0.281578919211704,-0.371971040611966,-0.0903921214002616,0.000174115789707898,-4.43223598608336,2.10142212246797,2.23960160089667,1.64740383620225,-0.592197764694422,0.000127087443247765,ENSG00000139193,CD27,protein_coding,12,1,6444867,6451718,p13.31,CD27 molecule [Source:HGNC Symbol;Acc:HGNC:11922],Autosomal recessive lymphoproliferative disease;LYMPHOPROLIFERATIVE SYNDROME 2,CD27,939,NM_001242
ICAM2_SIG,ICAM2,ICAM2_SIG,ICAM2,SIG,13,4.05577907769398,0.212873407650383,0.206781707180275,0.23288899490931,0.0261072877290352,0.00017423421781497,1.51719279963728,4.91683519057038,4.88525391915883,5.02060222520835,0.135348306049519,0.216440646848419,ENSG00000108622,ICAM2,protein_coding,17,-1,64002594,64020634,q23.3,intercellular adhesion molecule 2 [Source:HGNC Symbol;Acc:HGNC:5345],NA,ICAM2,3384,NM_000873;NM_001099786;NM_001099787;NM_001099788;NM_001099789
IFNGR1_SIG,IFNGR1,IFNGR1_SIG,IFNGR1,SIG,49,-4.05539158914731,0.523464850740924,0.537351256814371,0.477838087928171,-0.0595131688861994,0.000174449901839176,-2.53794434303055,6.41490940021173,6.47531471977508,6.21643477878929,-0.258879940985786,0.0325093327945117,ENSG00000027697,IFNGR1,protein_coding,6,-1,137197484,137219449,q23.3,interferon gamma receptor 1 [Source:HGNC Symbol;Acc:HGNC:5439],Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency;Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency;HELICOBACTER PYLORI INFECTION SUSCEPTIBILITY TO;HEPATITIS B VIRUS SUSCEPTIBILITY TO;IMMUNODEFICIENCY 27A;Immunodeficiency 27b;Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,IFNGR1,3459,NM_000416;NM_001363526;NM_001363527
CENPA_TF,CENPA,CENPA_TF,CENPA,TF,312,-4.05478787599023,-0.0206546244637708,-0.00752063711866256,-0.0638091543119836,-0.0562885171933209,0.000174827499740368,-3.40915977046249,1.74227800028096,1.82876420756646,1.45810903348573,-0.370655174080723,0.00350726931219682,ENSG00000115163,CENPA,protein_coding,2,1,26764289,26801067,p23.3,centromere protein A [Source:HGNC Symbol;Acc:HGNC:1851],NA,CENPA,1058,NM_001042426;NM_001809
ZNF566_TF,ZNF566,ZNF566_TF,ZNF566,TF,75,4.05451231017981,0.254668425115271,0.243023639760621,0.29292986270912,0.049906222948499,0.000174892197405858,2.34995176525745,2.5357644285519,2.49315674690011,2.67576109683634,0.182604349936233,0.0487476067919967,ENSG00000186017,ZNF566,protein_coding,19,-1,36445119,36489902,q13.12,zinc finger protein 566 [Source:HGNC Symbol;Acc:HGNC:25919],NA,ZNF566,84924,NM_001145343;NM_001145344;NM_001145345;NM_001300970;NM_032838
GKAP1_SIG,GKAP1,GKAP1_SIG,GKAP1,SIG,57,4.0545048551244,0.124145473715757,0.114843601856504,0.154708766967587,0.0398651651110829,0.000174892197405858,3.04182741058744,2.89920866710148,2.83768097430332,3.10137108629544,0.263690111992117,0.00964953146063002,ENSG00000165113,GKAP1,protein_coding,9,-1,83739425,83829516,q21.32,G kinase anchoring protein 1 [Source:HGNC Symbol;Acc:HGNC:17496],NA,GKAP1,80318,NM_001135953;NM_025211
VN1R1_SIG,VN1R1,VN1R1_SIG,VN1R1,SIG,103,4.052938099737,0.0243968448792531,0.0141687430205469,0.0580034652721451,0.0438347222515983,0.000175994098328028,1.69250833112413,0.543997286441731,0.527312199885864,0.598819713696722,0.0715075138108576,0.165046662673598,ENSG00000178201,VN1R1,protein_coding,19,-1,57454790,57457142,q13.43,vomeronasal 1 receptor 1 [Source:HGNC Symbol;Acc:HGNC:13548],NA,VN1R1,57191,NM_020633
ZKSCAN3_TF,ZKSCAN3,ZKSCAN3_TF,ZKSCAN3,TF,280,4.05218631487147,0.176581652532718,0.161038690247619,0.227651385755189,0.0666126955075704,0.000176486607598363,3.73891353596591,3.05807674559597,2.95209719671161,3.40629526335887,0.454198066647261,0.00130227464008718,ENSG00000189298,ZKSCAN3,protein_coding,6,1,28349947,28369172,p22.1,zinc finger with KRAB and SCAN domains 3 [Source:HGNC Symbol;Acc:HGNC:13853],NA,ZKSCAN3,80317,NM_001242894;NM_001242895;NM_024493
CASP9_SIG,CASP9,CASP9_SIG,CASP9,SIG,10,4.05150579580469,0.0936889862912313,0.0878930829782339,0.112732668605366,0.024839585627132,0.000176926523797985,1.61391471208343,4.44223566723523,4.42264795588896,4.50659529023014,0.0839473343411834,0.186694493682149,ENSG00000132906,CASP9,protein_coding,1,-1,15490832,15526534,p36.21,caspase 9 [Source:HGNC Symbol;Acc:HGNC:1511],NA,CASP9,842,NM_001229;NM_001278054;NM_032996
PFKFB3_SIG,PFKFB3,PFKFB3_SIG,PFKFB3,SIG,46,-4.05129919881651,0.327204696237854,0.346675909965493,0.263227851132755,-0.0834480588327379,0.000177008561597063,-2.97801968043397,6.58755352432469,6.68600281161677,6.2640772946507,-0.42192551696608,0.0114034596321735,ENSG00000170525,PFKFB3,protein_coding,10,1,6144934,6254644,p15.1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 [Source:HGNC Symbol;Acc:HGNC:8874],NA,PFKFB3,5209,NM_001145443;NM_001282630;NM_001314063;NM_001323016;NM_001323017;NM_001363545;NM_004566
CASP5_SIG,CASP5,CASP5_SIG,CASP5,SIG,21,-4.05062163767628,0.153821985926232,0.180203180877505,0.0671409168006202,-0.113062264076884,0.000177447495805221,-3.02489642247298,0.841324291517239,0.916781424369949,0.593393712144046,-0.323387712225904,0.0100727167219444,ENSG00000137757,CASP5,protein_coding,11,-1,104994235,105023168,q22.3,caspase 5 [Source:HGNC Symbol;Acc:HGNC:1506],NA,CASP5,838,NM_001136109;NM_001136110;NM_001136112;NM_004347
ZDHHC23_SIG,ZDHHC23,ZDHHC23_SIG,ZDHHC23,SIG,36,4.04983865158767,0.0506615712597891,0.0389906078782862,0.0890090223704415,0.0500184144921555,0.000177967628344502,3.45141707707025,3.64112648311348,3.53508376953301,3.98955254202076,0.454468772487745,0.00310308914973296,ENSG00000184307,ZDHHC23,protein_coding,3,1,113947901,113965401,q13.31,zinc finger DHHC-type containing 23 [Source:HGNC Symbol;Acc:HGNC:28654],NA,ZDHHC23,254887,NM_001320466;NM_001320467;NM_001320468;NM_173570
LAIR2_SIG,LAIR2,LAIR2_SIG,LAIR2,SIG,2,4.04963401007438,0.303662383601024,0.294086557030376,0.335125813761725,0.0410392567313493,0.000178048696556297,1.28180546320549,1.33401611398936,1.30929863090759,1.41523070125804,0.105932070350453,0.30228200760545,ENSG00000167618,LAIR2,protein_coding,19,1,54497879,54510687,q13.42,leukocyte associated immunoglobulin like receptor 2 [Source:HGNC Symbol;Acc:HGNC:6478],NA,LAIR2,3904,NM_002288;NM_021270
MTHFD2L_SIG,MTHFD2L,MTHFD2L_SIG,MTHFD2L,SIG,97,4.0486841255851,0.08792202171868,0.075318011843647,0.12933519702236,0.0540171851787128,0.0001786978902314,2.16981588030936,4.21260350237212,4.1665177530976,4.36402810713124,0.197510354033637,0.0703452634664494,ENSG00000163738,MTHFD2L,protein_coding,4,1,74114174,74303099,q13.3,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like [Source:HGNC Symbol;Acc:HGNC:31865],NA,MTHFD2L,441024,NM_001004346;NM_001144978;NM_001351310;NM_001351311;NM_001351314;NM_001351329;NM_001351331
EFNB2_SIG,EFNB2,EFNB2_SIG,EFNB2,SIG,18,-4.04496039122946,-0.0781811641719093,-0.073050336668131,-0.0950395973986092,-0.0219892607304781,0.000181486136881804,-1.60148391462447,1.02209290489354,1.06488332158007,0.881495821494961,-0.183387500085106,0.190168721521263,ENSG00000125266,EFNB2,protein_coding,13,-1,106489731,106535662,q33.3,ephrin B2 [Source:HGNC Symbol;Acc:HGNC:3227],NA,EFNB2,1948,NM_004093
FKBP3_SIG,FKBP3,FKBP3_SIG,FKBP3,SIG,45,4.04478289730591,0.442368807796267,0.428945424972723,0.486474208502198,0.0575287835294747,0.000181547692512179,4.02203345089292,5.37230821517446,5.31150850796218,5.57207868172909,0.260570173766914,0.000528583870858317,ENSG00000100442,FKBP3,protein_coding,14,-1,45115599,45135319,q21.2,FKBP prolyl isomerase 3 [Source:HGNC Symbol;Acc:HGNC:3719],NA,FKBP3,2287,NM_002013
CSNK2A1_SIG,CSNK2A1,CSNK2A1_SIG,CSNK2A1,SIG,30,4.04422916233904,0.66045051176589,0.651158307462836,0.690982040190211,0.0398237327273752,0.000181901155115024,2.64945128823353,6.78941869837368,6.75625104570535,6.89839812856961,0.142147082864259,0.025077338224182,ENSG00000101266,CSNK2A1,protein_coding,20,-1,472498,543835,p13,casein kinase 2 alpha 1 [Source:HGNC Symbol;Acc:HGNC:2457],CSNK2A1 syndrome;OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME,CSNK2A1,1457,NM_001362770;NM_001362771;NM_001895;NM_177559;NM_177560
CLIC5_SIG,CLIC5,CLIC5_SIG,CLIC5,SIG,7,-4.04385303254194,-0.0774778375691658,-0.0532195380202502,-0.157183678944174,-0.103964140923924,0.000182117205016096,-2.08417068031107,0.359803705546594,0.382949300072791,0.283753894960516,-0.0991954051122752,0.08280674061842,ENSG00000112782,CLIC5,protein_coding,6,-1,45880827,46080348,p21.1,chloride intracellular channel 5 [Source:HGNC Symbol;Acc:HGNC:13517],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 103,CLIC5,53405,NM_001114086;NM_001256023;NM_016929
HACE1_SIG,HACE1,HACE1_SIG,HACE1,SIG,36,4.04304214475846,0.117535176918652,0.1091885501302,0.144959807794996,0.0357712576647965,0.000182672071095478,1.23682227155256,4.20968698941202,4.18759483137843,4.28227550866523,0.0946806772868055,0.320871535426627,ENSG00000085382,HACE1,protein_coding,6,-1,104728094,104859919,q16.3,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:21033],HACE1 related disorder;Neuroblastoma;Spastic paraplegia-severe developmental delay-epilepsy syndrome;Spastic paraplegia and psychomotor retardation with or without seizures,HACE1,57531,NM_001321080;NM_001321083;NM_001321084;NM_001350554;NM_001350555;NM_001350556;NM_001350557;NM_001350558;NM_001350559;NM_001350560;NM_020771
TMEM8A_SIG,TMEM8A,TMEM8A_SIG,TMEM8A,SIG,23,-4.04166846756719,0.419862585944267,0.429161434403845,0.389309226719939,-0.0398522076839058,0.000183668939446463,-2.69694904161954,5.98311195978857,6.01583940766899,5.87557891675288,-0.140260490916116,0.0225718514914527,ENSG00000129925,TMEM8A,protein_coding,16,-1,370788,387113,p13.3,transmembrane protein 8A [Source:HGNC Symbol;Acc:HGNC:17205],NA,TMEM8A,58986,NM_021259
WDR36_SIG,WDR36,WDR36_SIG,WDR36,SIG,19,4.04067110855051,0.398596880316463,0.391479069710793,0.421983972306521,0.0305049025957276,0.000184374843477196,3.66528834514508,5.1055248739032,5.04699763772631,5.29782864991299,0.250831012186683,0.00163586857442007,ENSG00000134987,WDR36,protein_coding,5,1,111091716,111130502,q22.1,WD repeat domain 36 [Source:HGNC Symbol;Acc:HGNC:30696],GLAUCOMA 1 OPEN ANGLE G,WDR36,134430,NM_139281
TBCK_SIG,TBCK,TBCK_SIG,TBCK,SIG,135,4.03809951305788,0.223203474392408,0.207017215075327,0.276386897862817,0.0693696827874898,0.000186329492644955,3.71267355068408,4.50857344490611,4.41553807363976,4.81426109335268,0.398723019712916,0.00141664928740417,ENSG00000145348,TBCK,protein_coding,4,-1,106041599,106321495,q24,TBC1 domain containing kinase [Source:HGNC Symbol;Acc:HGNC:28261],HYPOTONIA INFANTILE WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTICFACIES 3;Severe Infantile Syndromic Encephalopathy;TBCK-related intellectual disability syndrome,TBCK,93627,NM_001163435;NM_001163436;NM_001163437;NM_001290768;NM_033115
RNF141_TF,RNF141,RNF141_TF,RNF141,TF,174,-4.03761212862482,0.306252507594185,0.320672412321294,0.258872820633683,-0.0617995916876116,0.000186639022005972,-1.69280218539267,5.4364630889956,5.46340197530867,5.34794960539554,-0.115452369913127,0.164990865668704,ENSG00000110315,RNF141,protein_coding,11,-1,10511673,10541230,p15.4,ring finger protein 141 [Source:HGNC Symbol;Acc:HGNC:21159],NA,RNF141,50862,NM_016422
CNKSR2_SIG,CNKSR2,CNKSR2_SIG,CNKSR2,SIG,11,-4.03572661026805,-0.0701970159664432,-0.063828969962617,-0.0911205956933007,-0.0272916257306838,0.000188065946890172,-0.90832323115752,1.78575391101543,1.81322159416991,1.69550295207928,-0.117718642090627,0.477575180625597,ENSG00000149970,CNKSR2,protein_coding,X,1,21372801,21654695,p22.12,connector enhancer of kinase suppressor of Ras 2 [Source:HGNC Symbol;Acc:HGNC:19701],Intellectual disability with epilepsy;MENTAL RETARDATION X-LINKED SYNDROMIC HOUGE TYPE;Undetermined early-onset epileptic encephalopathy;X-linked non-syndromic intellectual disability,CNKSR2,22866,NM_001168647;NM_001168648;NM_001168649;NM_001330770;NM_001330771;NM_001330772;NM_001330773;NM_014927
RXRA_TF,RXRA,RXRA_TF,RXRA,TF,286,-4.03505371357605,0.215492486914359,0.233291786439621,0.157009074188497,-0.076282712251124,0.00018852711871557,-2.36277011612399,6.3345710302885,6.40954147809722,6.088239558917,-0.321301919180224,0.0474554308689675,ENSG00000186350,RXRA,protein_coding,9,1,134317098,134440585,q34.2,retinoid X receptor alpha [Source:HGNC Symbol;Acc:HGNC:10477],NA,RXRA,6256,NM_001291920;NM_001291921;NM_002957
ATF7_TF,ATF7,ATF7_TF,ATF7,TF,63,4.03433862505932,0.277851248517571,0.267680348860231,0.311269918820259,0.0435895699600281,0.000189023331122512,3.78255471876461,6.22807577485858,6.16740784461042,6.42741325995964,0.26000541534922,0.0011369204543501,ENSG00000170653,ATF7,protein_coding,12,-1,53507856,53626410,q13.13,activating transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:792],NA,ATF7,11016,NM_001130060;NM_001206682;NM_001206683;NM_001366555;NM_001366556;NM_001366561;NM_006856
HS3ST3B1_SIG,HS3ST3B1,HS3ST3B1_SIG,HS3ST3B1,SIG,12,-4.03375900341925,-0.0603206508474638,-0.0540946964557568,-0.0807773581345011,-0.0266826616787442,0.000189352328511673,-2.04663246732341,2.80550341060669,2.85839305798493,2.63172314064964,-0.226669917335288,0.0891104700490607,ENSG00000125430,HS3ST3B1,protein_coding,17,1,14301081,14349404,p12,heparan sulfate-glucosamine 3-sulfotransferase 3B1 [Source:HGNC Symbol;Acc:HGNC:5198],NA,HS3ST3B1,9953,NM_006041
RNF157_SIG,RNF157,RNF157_SIG,RNF157,SIG,27,-4.03373459830915,-0.196142289614066,-0.174982379624348,-0.26566770815171,-0.090685328527362,0.000189352328511673,-2.80892627317897,2.16455927326253,2.25381073932548,1.87130445619857,-0.382506283126916,0.017328480836692,ENSG00000141576,RNF157,protein_coding,17,-1,76142465,76240493,q25.1,ring finger protein 157 [Source:HGNC Symbol;Acc:HGNC:29402],NA,RNF157,114804,NM_001330501;NM_052916
QKI_SIG,QKI,QKI_SIG,QKI,SIG,29,-4.03281637888111,0.348533103774252,0.35590248089793,0.324319436082166,-0.0315830448157645,0.000190014881032854,-2.68990872723276,7.58162235189768,7.61563049455608,7.46988131173438,-0.145749182821695,0.0229757335012279,ENSG00000112531,QKI,protein_coding,6,1,163414000,163578592,q26,QKI, KH domain containing RNA binding [Source:HGNC Symbol;Acc:HGNC:21100],Angiocentric glioma;Intellectual disability,QKI,9444,NM_001301085;NM_006775;NM_206853;NM_206854;NM_206855
KCNQ5_SIG,KCNQ5,KCNQ5_SIG,KCNQ5,SIG,45,4.03167459208807,0.15491382124633,0.144105344367801,0.190427388132928,0.0463220437651265,0.000190861146590196,2.05525001984876,4.18789705799384,4.11271291821841,4.43493066011312,0.32221774189471,0.0875580072291603,ENSG00000185760,KCNQ5,protein_coding,6,1,72621792,73198851,q13,potassium voltage-gated channel subfamily Q member 5 [Source:HGNC Symbol;Acc:HGNC:6299],Autosomal dominant non-syndromic intellectual disability;Intellectual Disability with or without Epileptic Encephalopathy;MENTAL RETARDATION AUTOSOMAL DOMINANT 46,KCNQ5,56479,NM_001160130;NM_001160132;NM_001160133;NM_001160134;NM_019842
BLMH_SIG,BLMH,BLMH_SIG,BLMH,SIG,11,4.02973437196808,0.530408124943852,0.521592442616408,0.559373938305453,0.0377814956890448,0.000192363288693686,3.47509721575218,5.70920611032735,5.65457242806186,5.88871678062824,0.23414435256638,0.00289711119758519,ENSG00000108578,BLMH,protein_coding,17,-1,30248203,30292056,q11.2,bleomycin hydrolase [Source:HGNC Symbol;Acc:HGNC:1059],Resistance to bleomycine in the treatment of testicular cancer,BLMH,642,NM_000386
LILRB4_SIG,LILRB4,LILRB4_SIG,LILRB4,SIG,107,-4.02879686950536,0.00592353570755925,0.0300231903060934,-0.0732610436876245,-0.103284233993718,0.000193051632514925,-4.2144962453708,3.9412306517938,4.21085911934125,3.05530854413789,-1.15555057520336,0.00027413003642676,ENSG00000186818,LILRB4,protein_coding,19,1,54643889,54670359,q13.42,leukocyte immunoglobulin like receptor B4 [Source:HGNC Symbol;Acc:HGNC:6608],NA,LILRB4,11006,NM_001278426;NM_001278427;NM_001278428;NM_001278429
CES1_SIG,CES1,CES1_SIG,CES1,SIG,23,-4.02731141517498,-0.0602773060071537,-0.0426701819512764,-0.118129285047893,-0.0754591030966171,0.000194194225930953,-1.63418832374327,2.33754110016116,2.44207495500886,1.99407271994729,-0.448002235061568,0.180987940957341,ENSG00000198848,CES1,protein_coding,16,-1,55802851,55833337,q12.2,carboxylesterase 1 [Source:HGNC Symbol;Acc:HGNC:1863],DRUG METABOLISM ALTERED CES1-RELATEDCARBOXYLESTERASE 1 DEFICIENCY INCLUDED,CES1,1066,NM_001025194;NM_001025195;NM_001266
PAN3_SIG,PAN3,PAN3_SIG,PAN3,SIG,47,4.02693026099476,0.33782746887417,0.330932609462519,0.360482006941025,0.0295493974785056,0.000194428389765223,1.74517434071574,7.28241105268858,7.25353805333669,7.37727947913047,0.123741425793777,0.151376280730508,ENSG00000152520,PAN3,protein_coding,13,1,28138506,28295335,q12.2,poly(A) specific ribonuclease subunit PAN3 [Source:HGNC Symbol;Acc:HGNC:29991],NA,PAN3,255967,NM_175854
DDX19A_SIG,DDX19A,DDX19A_SIG,DDX19A,SIG,12,4.02662309920512,0.540838023242667,0.528368192045339,0.581810325748172,0.053442133702833,0.000194519109831315,2.70343638947285,5.20616345362222,5.1770727702539,5.3017471275467,0.124674357292797,0.0222244405784669,ENSG00000168872,DDX19A,protein_coding,16,1,70346861,70373383,q22.1,DEAD-box helicase 19A [Source:HGNC Symbol;Acc:HGNC:25628],NA,DDX19A,55308,NM_001320522;NM_001320525;NM_001320526;NM_001320527;NM_018332
LSM2_SIG,LSM2,LSM2_SIG,LSM2,SIG,39,4.0265400344246,0.271792744253853,0.25967840503979,0.311597001671488,0.0519185966316973,0.000194519109831315,2.5717436227518,5.0165479172336,4.97588541175793,5.15015329236796,0.174267880610037,0.0300263207802323,ENSG00000204392,LSM2,protein_coding,6,-1,31797396,31806966,p21.33,LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated [Source:HGNC Symbol;Acc:HGNC:13940],NA,LSM2,57819,NM_021177
SAMSN1_SIG,SAMSN1,SAMSN1_SIG,SAMSN1,SIG,25,-4.02652764429884,0.461487015677343,0.47795971164115,0.407362443224832,-0.070597268416318,0.000194519109831315,-2.7276301714397,5.85983620176295,5.9414113721385,5.59180349910041,-0.349607873038093,0.0209792188912368,ENSG00000155307,SAMSN1,protein_coding,21,-1,14485228,14658821,q11.2,SAM domain, SH3 domain and nuclear localization signals 1 [Source:HGNC Symbol;Acc:HGNC:10528],NA,SAMSN1,64092;388813,NM_001256370;NM_001256579;NM_001286523;NM_022136
PURB_TF,PURB,PURB_TF,PURB,TF,25,4.02465806401864,0.11855681954897,0.111295226619709,0.142416339173686,0.0311211125539771,0.000195989574600699,3.79425628399032,6.61876909420402,6.56675281359581,6.78967973048812,0.222926916892312,0.00109457329069812,ENSG00000146676,PURB,protein_coding,7,-1,44876293,44885481,p13,purine rich element binding protein B [Source:HGNC Symbol;Acc:HGNC:9702],NA,PURB,5814,NM_033224
C1QA_SIG,C1QA,C1QA_SIG,C1QA,SIG,19,-4.02399474430183,-0.155323617590169,-0.127546325851442,-0.246591861874558,-0.119045536023115,0.000196461262468707,-1.86201238978065,2.52630416282688,2.62282900876491,2.20915109760194,-0.413677911162968,0.124315381693399,ENSG00000173372,C1QA,protein_coding,1,1,22636628,22639678,p36.12,complement C1q A chain [Source:HGNC Symbol;Acc:HGNC:1241],Autosomal systemic lupus erythematosus;C1q DEFICIENCY;Immunodeficiency due to a classical component pathway complement deficiency,C1QA,712,NM_001347465;NM_001347466;NM_015991
CLPP_SIG,CLPP,CLPP_SIG,CLPP,SIG,16,4.02388916805584,0.493995225830861,0.486304256976745,0.519265552065814,0.0329612950890694,0.000196467981160298,4.18168450484596,4.84237412121019,4.79871104832769,4.9858385035384,0.187127455210701,0.00030763746341233,ENSG00000125656,CLPP,protein_coding,19,1,6361531,6368906,p13.3,caseinolytic mitochondrial matrix peptidase proteolytic subunit [Source:HGNC Symbol;Acc:HGNC:2084],Perrault syndrome;PERRAULT SYNDROME 3,CLPP,8192,NM_006012
DHX37_SIG,DHX37,DHX37_SIG,DHX37,SIG,14,4.0229018815414,0.591043615191872,0.581394109686212,0.622749133281896,0.0413550235956841,0.00019721198528744,4.2647108433746,5.43044213206703,5.37814074426586,5.60228954912802,0.224148804862167,0.000229324460395712,ENSG00000150990,DHX37,protein_coding,12,-1,124946825,124989131,q24.31,DEAH-box helicase 37 [Source:HGNC Symbol;Acc:HGNC:17210],NA,DHX37,57647,NM_032656
PRDM11_SIG,PRDM11,PRDM11_SIG,PRDM11,SIG,26,4.02245603745486,0.475102353356933,0.461256924021475,0.520594478316296,0.0593375542948204,0.000197503998168574,2.67811282716194,2.73504326187335,2.67511205726461,2.93196007701635,0.256848019751744,0.0235686096606091,ENSG00000019485,PRDM11,protein_coding,11,1,45095806,45235110,p11.2,PR/SET domain 11 [Source:HGNC Symbol;Acc:HGNC:13996],NA,PRDM11,56981,NM_001256695;NM_001256696;NM_001359633
CSGALNACT2_SIG,CSGALNACT2,CSGALNACT2_SIG,CSGALNACT2,SIG,23,-4.02170664217845,0.140998242761761,0.155974830118986,0.0917894557308771,-0.0641853743881089,0.000198051566764074,-3.6975474854977,7.19177752199255,7.26278660618014,6.95846195966191,-0.304324646518232,0.00148308629169349,ENSG00000169826,CSGALNACT2,protein_coding,10,1,43138445,43185302,q11.21,chondroitin sulfate N-acetylgalactosaminyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:24292],NA,CSGALNACT2,55454,NM_001319654;NM_001319656;NM_018590
CNOT10_SIG,CNOT10,CNOT10_SIG,CNOT10,SIG,32,4.02071445812564,0.409105285754635,0.39631313528131,0.451136637309846,0.0548235020285359,0.000198805394876748,3.41685763353143,5.24922026151079,5.21103486794143,5.37468655466727,0.163651686725842,0.00342979459500096,ENSG00000182973,CNOT10,protein_coding,3,1,32685145,32773875,p22.3,CCR4-NOT transcription complex subunit 10 [Source:HGNC Symbol;Acc:HGNC:23817],NA,CNOT10,25904,NM_001256741;NM_001256742;NM_015442
NSMCE1_SIG,NSMCE1,NSMCE1_SIG,NSMCE1,SIG,34,4.01840576631991,0.122070075665049,0.110048580169805,0.161569275149421,0.051520694979616,0.000200680007038409,2.82001842014018,4.75175039631177,4.70899614037874,4.89222866580603,0.183232525427289,0.0168767794687933,ENSG00000169189,NSMCE1,protein_coding,16,-1,27224994,27268772,p12.1,NSE1 homolog, SMC5-SMC6 complex component [Source:HGNC Symbol;Acc:HGNC:29897],NA,NSMCE1,197370,NM_145080
ACTN1_SIG,ACTN1,ACTN1_SIG,ACTN1,SIG,52,-4.01772608481298,0.235068932977113,0.247962488625498,0.19270439298956,-0.0552580956359378,0.000201176393161467,-3.24696474229185,7.75616171897736,7.83791374866446,7.48754790714831,-0.350365841516155,0.00557741311969874,ENSG00000072110,ACTN1,protein_coding,14,-1,68874143,68979440,q24.1,actinin alpha 1 [Source:HGNC Symbol;Acc:HGNC:163],Autosomal dominant macrothrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 15,ACTN1,87,NM_001102;NM_001130004;NM_001130005
AGRN_SIG,AGRN,AGRN_SIG,AGRN,SIG,56,4.01672338968302,-0.0990238841964523,-0.103906387309765,-0.0829813739669964,0.0209250133427687,0.000201950461406483,1.51208539621495,4.18954885988025,4.1330890015786,4.37505982287139,0.241970821292787,0.21817624841331,ENSG00000188157,AGRN,protein_coding,1,1,1020120,1056118,p36.33,agrin [Source:HGNC Symbol;Acc:HGNC:329],MYASTHENIC SYNDROME CONGENITAL 8;Postsynaptic congenital myasthenic syndromes;Presynaptic congenital myasthenic syndromes,AGRN,375790,NM_001305275;NM_001364727;NM_198576
RNF166_SIG,RNF166,RNF166_SIG,RNF166,SIG,36,-4.01635269830344,0.320225521925035,0.333054156191655,0.278074295048996,-0.0549798611426589,0.000202184713131245,-2.75423318135089,6.75511202230766,6.79960547722255,6.60891924187303,-0.190686235349524,0.0197282964137809,ENSG00000158717,RNF166,protein_coding,16,-1,88696495,88706421,q24.3,ring finger protein 166 [Source:HGNC Symbol;Acc:HGNC:28856],NA,RNF166,115992,NM_001171815;NM_001171816;NM_178841
MAPKAP1_SIG,MAPKAP1,MAPKAP1_SIG,MAPKAP1,SIG,29,4.01604671870647,0.375299241282352,0.3700116940026,0.392672610915823,0.0226609169132228,0.000202363701320954,0.77608457797458,6.2810479686515,6.27198306692586,6.31083264575002,0.0388495788241522,0.548553022693569,ENSG00000119487,MAPKAP1,protein_coding,9,-1,125437393,125707234,q33.3,mitogen-activated protein kinase associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18752],NA,MAPKAP1,79109,NM_001006617;NM_001006618;NM_001006619;NM_001006620;NM_001006621;NM_024117
NAGS_SIG,NAGS,NAGS_SIG,NAGS,SIG,10,-4.01584283838547,0.273952069820078,0.289169869938501,0.223950726573831,-0.0652191433646696,0.00020245518863386,-1.27488356223097,0.30992183353121,0.321394945825954,0.272224464562765,-0.049170481263189,0.305082023496444,ENSG00000161653,NAGS,protein_coding,17,1,44004546,44009063,q21.31,N-acetylglutamate synthase [Source:HGNC Symbol;Acc:HGNC:17996],Hyperammonemia due to N-acetylglutamate synthase deficiency;N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY,NAGS,162417,NM_153006
EFEMP2_SIG,EFEMP2,EFEMP2_SIG,EFEMP2,SIG,31,-4.0147508333207,-0.0619861818096812,-0.056763663366378,-0.0791458852662489,-0.0223822218998708,0.000203249670316252,-2.67692986023118,2.39849314188775,2.47303050594432,2.15358465998762,-0.319445845956699,0.0236388043784575,ENSG00000172638,EFEMP2,protein_coding,11,-1,65866441,65873592,q13.1,EGF containing fibulin extracellular matrix protein 2 [Source:HGNC Symbol;Acc:HGNC:3219],Autosomal recessive cutis laxa type 1;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IB;Lethal arteriopathy syndrome due to Fibulin-4 deficiency,EFEMP2,30008,NM_016938
SMARCA5_SIG,SMARCA5,SMARCA5_SIG,SMARCA5,SIG,16,4.01472465525961,0.459931299054247,0.451676237693059,0.487055072098151,0.0353788344050925,0.000203249670316252,2.81542529862747,7.25733415448142,7.22049021946568,7.37839279810457,0.157902578638886,0.0170543062394597,ENSG00000153147,SMARCA5,protein_coding,4,1,143513702,143557486,q31.21,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 [Source:HGNC Symbol;Acc:HGNC:11101],Extraskeletal Ewing sarcoma,SMARCA5,8467,NM_003601
QPCTL_SIG,QPCTL,QPCTL_SIG,QPCTL,SIG,22,4.0144938419372,0.26810960015478,0.259243225531586,0.297241973916702,0.0379987483851167,0.00020336482867652,2.94164173511545,3.48366728250669,3.43844034687962,3.63227007099562,0.193829724115998,0.012513871033478,ENSG00000011478,QPCTL,protein_coding,19,1,45692666,45703989,q13.32,glutaminyl-peptide cyclotransferase like [Source:HGNC Symbol;Acc:HGNC:25952],NA,QPCTL,54814,NM_001163377;NM_017659
PRPF6_SIG,PRPF6,PRPF6_SIG,PRPF6,SIG,17,4.01380763941779,0.409729108363325,0.400785883635451,0.439113989612052,0.0383281059766004,0.000203873251738815,3.08122056570855,6.93641102971404,6.90129852035897,7.05178070330928,0.150482182950308,0.00870067650818163,ENSG00000101161,PRPF6,protein_coding,20,1,63981132,64033100,q13.33,pre-mRNA processing factor 6 [Source:HGNC Symbol;Acc:HGNC:15860],Retinitis pigmentosa;Retinitis pigmentosa 60,PRPF6,24148,NM_012469
CTSD_SIG,CTSD,CTSD_SIG,CTSD,SIG,35,-4.01360106818501,0.48346113527645,0.495451803560225,0.444063225201189,-0.0513885783590357,0.00020396783236798,-2.91664491137987,8.66951882027833,8.74025688085915,8.4370937640842,-0.30316311677495,0.0133072283281547,ENSG00000117984,CTSD,protein_coding,11,-1,1752755,1764573,p15.5,cathepsin D [Source:HGNC Symbol;Acc:HGNC:2529],CEROID LIPOFUSCINOSIS NEURONAL 10;CLN10 disease;NEURONAL CEROID LIPOFUSCINOSIS TYPE 10,CTSD,1509,NM_001909
METAP1_SIG,METAP1,METAP1_SIG,METAP1,SIG,30,4.01328545209945,0.505054047189666,0.49324478111709,0.543855921428127,0.050611140311037,0.000204156816032406,3.53961673001731,5.58193178742565,5.53823037612832,5.72552213883119,0.187291762702872,0.00240134473013208,ENSG00000164024,METAP1,protein_coding,4,1,98995659,99062809,q23,methionyl aminopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:15789],NA,METAP1,23173,NM_015143
SMYD4_SIG,SMYD4,SMYD4_SIG,SMYD4,SIG,39,4.01291775801915,0.26760063675805,0.253638053304218,0.313477696677785,0.0598396433735677,0.000204391094916827,3.78322280952301,4.04853585660538,3.97681404846942,4.28419322619495,0.307379177725526,0.00113459957642851,ENSG00000186532,SMYD4,protein_coding,17,-1,1779485,1830634,p13.3,SET and MYND domain containing 4 [Source:HGNC Symbol;Acc:HGNC:21067],NA,SMYD4,114826,NM_052928
ZNF584_TF,ZNF584,ZNF584_TF,ZNF584,TF,245,4.01234111897072,0.274357481755404,0.262461766920099,0.313443401928549,0.0509816350084493,0.000204793807131605,5.02358839631435,2.51664493135005,2.4242875772418,2.82010480913432,0.39581723189252,1.29694893476282e-05,ENSG00000171574,ZNF584,protein_coding,19,1,58401504,58418327,q13.43,zinc finger protein 584 [Source:HGNC Symbol;Acc:HGNC:27318],NA,ZNF584,201514,NM_001318002;NM_001363680;NM_173548
PPAT_SIG,PPAT,PPAT_SIG,PPAT,SIG,34,4.01225919518379,0.542191590666482,0.526481139852501,0.593811643340992,0.0673305034884912,0.000204793807131605,4.44357293192412,3.89258254787779,3.79986482200517,4.19722650431638,0.397361682311212,0.000121940408378896,ENSG00000128059,PPAT,protein_coding,4,-1,56393362,56435615,q12,phosphoribosyl pyrophosphate amidotransferase [Source:HGNC Symbol;Acc:HGNC:9238],NA,PPAT,5471,NM_002703
GPER1_SIG,GPER1,GPER1_SIG,GPER1,SIG,8,-4.01179333118681,0.0202434310425753,0.0444540499187383,-0.0593057452648172,-0.103759795183556,0.000205114143814213,-1.8141349275634,0.95820838807201,1.01288568550744,0.778554410784159,-0.234331274723283,0.134935608694005,ENSG00000164850,GPER1,protein_coding,7,1,1082208,1093815,p22.3,G protein-coupled estrogen receptor 1 [Source:HGNC Symbol;Acc:HGNC:4485],NA,GPER1,2852,NM_001039966;NM_001098201;NM_001505
CD5_SIG,CD5,CD5_SIG,CD5,SIG,38,-4.01061799279518,0.0623721000444162,0.088062638264214,-0.0220396683920624,-0.110102306656276,0.000206053313081255,-4.14027850413349,3.42931364676642,3.58987160167302,2.90176608064474,-0.688105521028279,0.000354126030944017,ENSG00000110448,CD5,protein_coding,11,1,61102489,61127852,q12.2,CD5 molecule [Source:HGNC Symbol;Acc:HGNC:1685],NA,CD5,921,NM_001346456;NM_014207
ZNF32_TF,ZNF32,ZNF32_TF,ZNF32,TF,94,4.00957485018945,0.0583329976805235,0.0513578552263772,0.0812513228870041,0.029893467660627,0.000206880699375514,0.863855143172537,3.91437446353864,3.90022946472791,3.96085088820247,0.0606214234745516,0.501141290412509,ENSG00000169740,ZNF32,protein_coding,10,-1,43643860,43648881,q11.21,zinc finger protein 32 [Source:HGNC Symbol;Acc:HGNC:13095],NA,ZNF32,7580,NM_001005368;NM_001324164;NM_001324165;NM_001324166;NM_001324167;NM_001324168;NM_006973
AMPD3_SIG,AMPD3,AMPD3_SIG,AMPD3,SIG,28,-4.00815852289519,0.272342408988359,0.28511674944166,0.230369576070369,-0.0547471733712908,0.000208039650001663,-3.07750744236742,5.63463764666034,5.71953738257558,5.35568137151023,-0.363856011065352,0.00879355624606603,ENSG00000133805,AMPD3,protein_coding,11,1,10308313,10507579,p15.4,adenosine monophosphate deaminase 3 [Source:HGNC Symbol;Acc:HGNC:470],Adenosine monophosphate deaminase deficiency;ERYTHROCYTE AMP DEAMINASE DEFICIENCY,AMPD3,272,NM_000480;NM_001025389;NM_001025390;NM_001172430;NM_001172431
BGN_SIG,BGN,BGN_SIG,BGN,SIG,21,-4.00745607966547,-0.306638549032509,-0.297142490786432,-0.337839883269616,-0.0406973924831834,0.000208573585673159,-3.01322365737263,0.346291241476768,0.401452672972358,0.165046537991256,-0.236406134981102,0.010379986219458,ENSG00000182492,BGN,protein_coding,X,1,153494980,153509546,q28,biglycan [Source:HGNC Symbol;Acc:HGNC:1044],MEESTER-LOEYS SYNDROME;Severe syndromic form of thoracic aortic aneurysm and dissection;Spondyloepimetaphyseal dysplasia X-linked;X-Linked Spondyloepimetaphyseal Dysplasia,BGN,633,NM_001711
CPE_SIG,CPE,CPE_SIG,CPE,SIG,34,-4.00612244181562,-0.149432912811842,-0.144178558417416,-0.166697220107811,-0.0225186616903942,0.000209668116233923,-2.94395570903447,0.31736536670586,0.363928787518758,0.164371269749196,-0.199557517769563,0.012431122032621,ENSG00000109472,CPE,protein_coding,4,1,165361194,165498547,q32.3,carboxypeptidase E [Source:HGNC Symbol;Acc:HGNC:2303],NA,CPE,1363,NM_001873
PPOX_SIG,PPOX,PPOX_SIG,PPOX,SIG,39,4.00523155889822,0.19175931080411,0.183066616535992,0.220321020542211,0.0372544040062186,0.00021037366455878,1.1892004811376,4.25641536186648,4.23314230603112,4.33288397389694,0.0997416678658237,0.341877818751919,ENSG00000143224,PPOX,protein_coding,1,1,161166056,161178013,q23.3,protoporphyrinogen oxidase [Source:HGNC Symbol;Acc:HGNC:9280],PORPHYRIA VARIEGATA,PPOX,5498,NM_000309;NM_001122764;NM_001350128;NM_001350129;NM_001350130;NM_001350131
ARHGAP30_SIG,ARHGAP30,ARHGAP30_SIG,ARHGAP30,SIG,66,-4.00446920718172,0.553469175507352,0.567605709158329,0.507020564939856,-0.0605851442184734,0.00021096673702397,-3.37853438907256,8.24699311875583,8.30811402084783,8.04616729759639,-0.261946723251441,0.00384965984143027,ENSG00000186517,ARHGAP30,protein_coding,1,-1,161046946,161069970,q23.3,Rho GTPase activating protein 30 [Source:HGNC Symbol;Acc:HGNC:27414],NA,ARHGAP30,257106,NM_001025598;NM_001287600;NM_001287602;NM_181720
CP_SIG,CP,CP_SIG,CP,SIG,20,-4.0038794285935,-0.192348391130707,-0.186800602914744,-0.210576838126016,-0.0237762352112721,0.000211407047902829,-0.468317087404152,1.40667499202845,1.42435771324308,1.34857462232324,-0.0757830909198345,0.728240059581068,ENSG00000047457,CP,protein_coding,3,-1,149162410,149221829,q25.1,ceruloplasmin [Source:HGNC Symbol;Acc:HGNC:2295],Aceruloplasminemia;ACERULOPLASMINEMIAHYPOCERULOPLASMINEMIA INCLUDED,CP,1356,NM_000096
DCUN1D2_SIG,DCUN1D2,DCUN1D2_SIG,DCUN1D2,SIG,53,4.00353318616984,0.224870630147141,0.217079429405246,0.250470289727653,0.0333908603224069,0.000211630177026429,2.84917818543499,4.48638865552505,4.44668774161593,4.61683451551217,0.170146773896232,0.0157192020953296,ENSG00000150401,DCUN1D2,protein_coding,13,-1,113455819,113490951,q34,defective in cullin neddylation 1 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20328],NA,DCUN1D2,55208,NM_001014283
NCOA1_TF,NCOA1,NCOA1_TF,NCOA1,TF,203,-4.00219915992549,0.0836686436676958,0.089221762764553,0.0654226809208796,-0.0237990818436735,0.00021272401562458,-2.25004865153707,7.0154339986686,7.04287152661789,6.92528212112093,-0.117589405496964,0.059986646156489,ENSG00000084676,NCOA1,protein_coding,2,1,24491914,24770702,p23.3,nuclear receptor coactivator 1 [Source:HGNC Symbol;Acc:HGNC:7668],NA,NCOA1,8648,NM_001362950;NM_001362952;NM_001362954;NM_001362955;NM_003743;NM_147223;NM_147233
ZNF717_TF,ZNF717,ZNF717_TF,ZNF717,TF,6,4.0021198024447,-0.0650762525110312,-0.0733532212135279,-0.0378804982028276,0.0354727230107004,0.00021272401562458,2.89058919677544,1.66973996539346,1.61177594063384,1.86019318960365,0.248417248969805,0.0142023164393897,ENSG00000227124,ZNF717,protein_coding,3,-1,75678660,75785583,p12.3,zinc finger protein 717 [Source:HGNC Symbol;Acc:HGNC:29448],NA,ZNF717,100131827,NM_001128223;NM_001290208;NM_001290209;NM_001290210;NM_001324026;NM_001324027;NM_001324028
CHSY1_SIG,CHSY1,CHSY1_SIG,CHSY1,SIG,21,-4.00190148145929,0.24076625272298,0.246117386089748,0.223183957375026,-0.0229334287147223,0.00021272401562458,-3.6243324209923,7.00970757456176,7.07431552833831,6.79742429786736,-0.276891230470945,0.0018537628641138,ENSG00000131873,CHSY1,protein_coding,15,-1,101175727,101252048,q26.3,chondroitin sulfate synthase 1 [Source:HGNC Symbol;Acc:HGNC:17198],Temtamy preaxial brachydactyly syndrome,CHSY1,22856,NM_014918
PI4K2A_SIG,PI4K2A,PI4K2A_SIG,PI4K2A,SIG,39,-4.00187891756659,0.0481499938963823,0.0621781863600512,0.0020573615157558,-0.0601208248442954,0.00021272401562458,-2.45220032108534,3.59323379762638,3.67807670084329,3.31446425848511,-0.363612442358177,0.0391751237398638,ENSG00000155252,PI4K2A,protein_coding,10,1,97640686,97676434,q24.2,phosphatidylinositol 4-kinase type 2 alpha [Source:HGNC Symbol;Acc:HGNC:30031],NA,PI4K2A,55361,NM_018425
SLTM_SIG,SLTM,SLTM_SIG,SLTM,SIG,30,4.00183034455717,0.185132168889568,0.180351431661301,0.200840305496729,0.0204888738354275,0.00021272401562458,3.66687942195758,7.5661986254853,7.53484735575291,7.66920994032031,0.134362584567397,0.00162808778754031,ENSG00000137776,SLTM,protein_coding,15,-1,58879050,58933679,q22.1,SAFB like transcription modulator [Source:HGNC Symbol;Acc:HGNC:20709],NA,SLTM,79811,NM_001013843;NM_024755
SAFB2_SIG,SAFB2,SAFB2_SIG,SAFB2,SIG,21,4.00171184301215,0.132446057589201,0.127619771007633,0.148303856357211,0.020684085349578,0.000212743699407711,3.58524498422991,6.56866162344526,6.53648648806924,6.67437992539503,0.13789343732579,0.0020921197614341,ENSG00000130254,SAFB2,protein_coding,19,-1,5586999,5624046,p13.3,scaffold attachment factor B2 [Source:HGNC Symbol;Acc:HGNC:21605],NA,SAFB2,9667,NM_014649
TTF1_TF,TTF1,TTF1_TF,TTF1,TF,30,4.00078049099653,0.352290386128831,0.345969054715346,0.373060475058853,0.0270914203435066,0.000213495667477839,3.08064991405574,4.57585654181212,4.54386300176158,4.68097817340675,0.137115171645172,0.00871092783938636,ENSG00000125482,TTF1,protein_coding,9,-1,132375548,132406851,q34.13,transcription termination factor 1 [Source:HGNC Symbol;Acc:HGNC:12397],NA,TTF1,7270,NM_001205296;NM_007344
TRIM7_SIG,TRIM7,TRIM7_SIG,TRIM7,SIG,6,-3.99997846531225,0.172757855319804,0.206334098068629,0.062435914859376,-0.143898183209254,0.000214133102342349,-0.711222410810589,1.1011487977655,1.12200534735988,1.03262013481253,-0.0893852125473528,0.585309552651676,ENSG00000146054,TRIM7,protein_coding,5,-1,181193924,181205293,q35.3,tripartite motif containing 7 [Source:HGNC Symbol;Acc:HGNC:16278],NA,TRIM7,81786,NM_033342;NM_203293;NM_203294;NM_203295;NM_203296;NM_203297
AMBRA1_SIG,AMBRA1,AMBRA1_SIG,AMBRA1,SIG,57,3.99973262067679,0.43190825811647,0.425823614782591,0.451900657642074,0.0260770428594822,0.000214268240569796,4.83787807242352,5.2420601985278,5.18569463968252,5.42726132044801,0.241566680765491,2.75963064047488e-05,ENSG00000110497,AMBRA1,protein_coding,11,-1,46396414,46594125,p11.2,autophagy and beclin 1 regulator 1 [Source:HGNC Symbol;Acc:HGNC:25990],NA,AMBRA1,55626,NM_001267782;NM_001267783;NM_001300731;NM_001367468;NM_001367470;NM_001367471;NM_017749
TARBP2_SIG,TARBP2,TARBP2_SIG,TARBP2,SIG,27,3.99929424174384,0.343627039054101,0.331569289948047,0.383245357545422,0.0516760675973753,0.000214577967528774,1.46234920658132,4.27098990275015,4.24832971818289,4.34544479489974,0.0971150767168546,0.234584755100507,ENSG00000139546,TARBP2,protein_coding,12,1,53500921,53506431,q13.13,TARBP2, RISC loading complex RNA binding subunit [Source:HGNC Symbol;Acc:HGNC:11569],NA,TARBP2,6895,NM_004178;NM_134323;NM_134324
RRBP1_SIG,RRBP1,RRBP1_SIG,RRBP1,SIG,21,3.99911048834979,0.1766009230077,0.170782665471881,0.195718054911105,0.0249353894392242,0.000214657107512196,3.32263843530599,7.02621190869582,6.97433739022444,7.19665675510176,0.222319364877318,0.00450826813569296,ENSG00000125844,RRBP1,protein_coding,20,-1,17613678,17682295,p12.1,ribosome binding protein 1 [Source:HGNC Symbol;Acc:HGNC:10448],NA,RRBP1,6238,NM_001042576;NM_001365613;NM_004587
IL4R_SIG,IL4R,IL4R_SIG,IL4R,SIG,31,-3.99823908595345,0.0851187168788777,0.0994898406263902,0.0378993102799083,-0.0615905303464819,0.00021531756829679,-1.78439519088667,6.36083704389477,6.41011932744766,6.19890954079239,-0.211209786655272,0.141831392424748,ENSG00000077238,IL4R,protein_coding,16,1,27313668,27364778,p12.1,interleukin 4 receptor [Source:HGNC Symbol;Acc:HGNC:6015],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;IgE RESPONSIVENESS ATOPIC,IL4R,3566,NM_000418;NM_001257406;NM_001257407;NM_001257997
PWWP2B_SIG,PWWP2B,PWWP2B_SIG,PWWP2B,SIG,37,3.99819039767965,0.224267333671093,0.215592656130739,0.2527698455894,0.0371771894586604,0.00021531756829679,2.72126370243221,4.32175404353186,4.2665034916492,4.5032915711463,0.236788079497099,0.0212956042232395,ENSG00000171813,PWWP2B,protein_coding,10,1,132397168,132417859,q26.3,PWWP domain containing 2B [Source:HGNC Symbol;Acc:HGNC:25150],NA,PWWP2B,170394,NM_001098637;NM_138499
PIWIL2_SIG,PIWIL2,PIWIL2_SIG,PIWIL2,SIG,59,3.9978804071613,-0.0449342698633785,-0.0523276398353963,-0.0206417685267488,0.0316858713086474,0.000215511922860764,1.11372201965779,0.686141376353423,0.672885485391265,0.729696446657659,0.0568109612663945,0.375893365511465,ENSG00000197181,PIWIL2,protein_coding,8,1,22275316,22357568,p21.3,piwi like RNA-mediated gene silencing 2 [Source:HGNC Symbol;Acc:HGNC:17644],NA,PIWIL2,55124,NM_001135721;NM_001330480;NM_018068
PBRM1_SIG,PBRM1,PBRM1_SIG,PBRM1,SIG,58,3.99774976617161,0.494574847029827,0.481173220732823,0.538608762005698,0.0574355412728753,0.000215543141545957,3.70278888015104,7.08622006468274,7.02819716639237,7.27686673049396,0.24866956410159,0.00145890206337337,ENSG00000163939,PBRM1,protein_coding,3,-1,52545352,52685917,p21.1,polybromo 1 [Source:HGNC Symbol;Acc:HGNC:30064],Clear cell papillary renal cell carcinoma,PBRM1,55193,NM_001350074;NM_001350075;NM_001350076;NM_001350077;NM_001350078;NM_001350079;NM_018313;NM_181042
ALG9_SIG,ALG9,ALG9_SIG,ALG9,SIG,62,3.99688160938998,0.204145855619366,0.195840706048487,0.231434204209399,0.0355934981609127,0.000216246854085447,3.16865391714034,2.75872045788928,2.71455821894514,2.90382495727716,0.189266738332019,0.0068996048700322,ENSG00000086848,ALG9,protein_coding,11,-1,111782195,111871581,q23.1,ALG9, alpha-1,2-mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:15672],ALG9-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Il;GILLESSEN-KAESBACH-NISHIMURA SYNDROME,ALG9,79796,NM_001077690;NM_001077691;NM_001077692;NM_001352409;NM_001352410;NM_001352411;NM_001352412;NM_001352413;NM_001352414;NM_001352415;NM_001352416;NM_001352417;NM_001352418;NM_001352419;NM_001352420;NM_001352421;NM_001352422;NM_001352423;NM_024740
XYLT2_SIG,XYLT2,XYLT2_SIG,XYLT2,SIG,39,3.99464295741727,0.142222604648985,0.126365138321407,0.194325708296743,0.0679605699753366,0.000218211468490738,2.99432577494033,4.25815844829606,4.19640190521922,4.46107280411999,0.264670898900769,0.010923371582214,ENSG00000015532,XYLT2,protein_coding,17,1,50346092,50363138,q21.33,xylosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:15517],Pseudoxanthoma elasticum;Spondylo-ocular syndrome;SPONDYLOOCULAR SYNDROME,XYLT2,64132,NM_022167
GZMA_SIG,GZMA,GZMA_SIG,GZMA,SIG,19,-3.9943810722708,-0.260260959227434,-0.232258157226529,-0.352270165801834,-0.120012008575304,0.000218364014989338,-3.35977787767111,2.45977578880345,2.57962093853011,2.06599886827298,-0.513622070257134,0.00406342122573726,ENSG00000145649,GZMA,protein_coding,5,1,55102646,55110252,q11.2,granzyme A [Source:HGNC Symbol;Acc:HGNC:4708],NA,GZMA,3001,NM_006144
ERCC6L2_SIG,ERCC6L2,ERCC6L2_SIG,ERCC6L2,SIG,87,3.9937965696957,0.344296944813196,0.336398002054386,0.370250613877857,0.0338526118234703,0.000218814380328358,2.68179154235384,4.8154598892755,4.77898988825507,4.93528989262833,0.156300004373263,0.0233925359032262,ENSG00000182150,ERCC6L2,protein_coding,9,1,95875701,96014571,q22.32,ERCC excision repair 6 like 2 [Source:HGNC Symbol;Acc:HGNC:26922],Bone marrow failure syndrome 2;Pancytopenia-developmental delay syndrome,ERCC6L2,375748,NM_001010895;NM_020207
UPP1_SIG,UPP1,UPP1_SIG,UPP1,SIG,35,-3.99350972805497,0.409517286519315,0.431494558592087,0.337306249708781,-0.0941883088833055,0.000218990433289267,-1.2977917851405,5.27479623697567,5.32715086777458,5.10277387863639,-0.224376989138192,0.295885210672575,ENSG00000183696,UPP1,protein_coding,7,1,48088628,48108736,p12.3,uridine phosphorylase 1 [Source:HGNC Symbol;Acc:HGNC:12576],NA,UPP1,7378,NM_001287426;NM_001287428;NM_001287429;NM_001287430;NM_003364
MS4A4A_SIG,MS4A4A,MS4A4A_SIG,MS4A4A,SIG,16,-3.99301798356633,0.223908579728443,0.256085377650013,0.118184815128999,-0.137900562521014,0.000219356197267019,-3.85591113591376,2.17481926692371,2.33619862715348,1.64457279759734,-0.691625829556139,0.000902671139316645,ENSG00000110079,MS4A4A,protein_coding,11,1,60185702,60317944,q12.2,membrane spanning 4-domains A4A [Source:HGNC Symbol;Acc:HGNC:13371],NA,MS4A4A,51338,NM_001243266;NM_024021;NM_148975
C9orf3_SIG,C9orf3,C9orf3_SIG,C9orf3,SIG,5,3.99146672976895,0.133402212333972,0.125396778338617,0.159705781175855,0.0343090028372378,0.000220649724529218,3.343020347328,2.54695929355654,2.49784082952969,2.70834853250191,0.210507702972225,0.0042579333219822,ENSG00000148120,C9orf3,protein_coding,9,1,94726701,95087218,q22.32,chromosome 9 open reading frame 3 [Source:HGNC Symbol;Acc:HGNC:1361],NA,C9orf3,84909,NM_001193329;NM_001193331;NM_032823
CD3D_SIG,CD3D,CD3D_SIG,CD3D,SIG,14,-3.99143176824492,0.0886689825862407,0.108690226155141,0.0228848965741393,-0.0858053295810018,0.000220649724529218,-4.11513526327345,3.04952817106683,3.2083680400906,2.52762574427446,-0.680742295816133,0.000385547112272486,ENSG00000167286,CD3D,protein_coding,11,-1,118338954,118342744,q23.3,CD3d molecule [Source:HGNC Symbol;Acc:HGNC:1673],IMMUNODEFICIENCY 19;T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,CD3D,915,NM_000732;NM_001040651
ZMYND11_SIG,ZMYND11,ZMYND11_SIG,ZMYND11,SIG,10,3.99117215461412,0.450816671961833,0.440164760901605,0.485815808302581,0.0456510474009766,0.000220801901694149,2.22320329300819,6.13842737857822,6.09738215427122,6.27329025844406,0.175908104172835,0.06330786430347,ENSG00000015171,ZMYND11,protein_coding,10,1,134465,254637,p15.3,zinc finger MYND-type containing 11 [Source:HGNC Symbol;Acc:HGNC:16966],Autosomal dominant non-syndromic intellectual disability;Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 30,ZMYND11,10771,NM_001202464;NM_001202465;NM_001202466;NM_001202467;NM_001202468;NM_001330057;NM_006624;NM_212479
ZNF594_TF,ZNF594,ZNF594_TF,ZNF594,TF,147,3.99099633135034,-0.0529308441702526,-0.0662356932571445,-0.00921491145617928,0.0570207818009654,0.000220834015759993,2.72002518762658,2.38326680334486,2.29527763820387,2.67237406023669,0.377096422032824,0.0213510393461268,ENSG00000180626,ZNF594,protein_coding,17,-1,5179535,5191868,p13.2,zinc finger protein 594 [Source:HGNC Symbol;Acc:HGNC:29392],NA,ZNF594,84622,NM_032530
DHRS1_SIG,DHRS1,DHRS1_SIG,DHRS1,SIG,12,3.99094550389374,-0.00246541136016575,-0.00639846590253974,0.0104574821362059,0.0168559480387457,0.000220834015759993,1.50506411226176,3.84643045316138,3.82658974226198,3.91162136040229,0.0850316181403178,0.22022656964316,ENSG00000157379,DHRS1,protein_coding,14,-1,24290598,24299780,q12,dehydrogenase/reductase 1 [Source:HGNC Symbol;Acc:HGNC:16445],NA,DHRS1,115817,NM_001136050;NM_138452
PRMT5_SIG,PRMT5,PRMT5_SIG,PRMT5,SIG,76,3.98992145448958,0.513919521239619,0.495284558535161,0.575148684411409,0.0798641258762483,0.000221699821417295,3.74566189185922,5.66444127298038,5.59305753178963,5.89898785117856,0.305930319388939,0.00127365315745542,ENSG00000100462,PRMT5,protein_coding,14,-1,22920525,22929408,q11.2,protein arginine methyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:10894],NA,PRMT5,10419,NM_001039619;NM_001282953;NM_001282954;NM_001282955;NM_001282956;NM_006109
CAPN5_SIG,CAPN5,CAPN5_SIG,CAPN5,SIG,75,3.98817969076547,-0.0624597369189882,-0.067379464735573,-0.0462949169502097,0.0210845477853634,0.000223243111702784,3.26741356327213,1.99208846014805,1.90115209176531,2.29087938483418,0.389727293068872,0.00526916215265286,ENSG00000149260,CAPN5,protein_coding,11,1,77066961,77126155,q13.5,calpain 5 [Source:HGNC Symbol;Acc:HGNC:1482],Autosomal dominant neovascular inflammatory vitreoretinopathy;VITREORETINOPATHY NEOVASCULAR INFLAMMATORY,CAPN5,726,NM_004055
ELOVL3_SIG,ELOVL3,ELOVL3_SIG,ELOVL3,SIG,47,-3.98756871776516,0.0770047002840921,0.0914285359205536,0.0296120974785756,-0.0618164384419781,0.000223684869057758,-1.61429163320019,0.558121014462394,0.588483499929394,0.458358562213678,-0.130124937715716,0.186594211166262,ENSG00000119915,ELOVL3,protein_coding,10,1,102226299,102229589,q24.32,ELOVL fatty acid elongase 3 [Source:HGNC Symbol;Acc:HGNC:18047],NA,ELOVL3,83401,NM_152310
ZNF843_TF,ZNF843,ZNF843_TF,ZNF843,TF,20,3.9875185831916,-0.0547272708795919,-0.0672415953338097,-0.0136087762443048,0.0536328190895048,0.000223684869057758,3.38134459476428,0.529575765788536,0.494579285691233,0.64456420039396,0.149984914702727,0.00381756425776024,ENSG00000176723,ZNF843,protein_coding,16,-1,31432593,31443160,p11.2,zinc finger protein 843 [Source:HGNC Symbol;Acc:HGNC:28710],NA,ZNF843,283933,NM_001136509;NM_001353381
RTN2_SIG,RTN2,RTN2_SIG,RTN2,SIG,35,3.98725239047558,0.0251477476981949,0.0198128661810208,0.0426766441117668,0.0228637779307459,0.000223845384642262,1.62446774593709,2.57894820098184,2.54205448116968,2.7001704232218,0.158115942052116,0.183712722827019,ENSG00000125744,RTN2,protein_coding,19,-1,45485294,45497055,q13.32,reticulon 2 [Source:HGNC Symbol;Acc:HGNC:10468],Autosomal dominant spastic paraplegia type 12;SPASTIC PARAPLEGIA 12 AUTOSOMAL DOMINANT,RTN2,6253,NM_005619;NM_206900;NM_206901
IVD_SIG,IVD,IVD_SIG,IVD,SIG,30,3.98626753006478,0.422428436512228,0.407735807188473,0.470704218575994,0.0629684113875216,0.000224685275641621,3.78374506219418,5.52405612088123,5.44850916769648,5.77228182420258,0.323772656506106,0.00113314516787468,ENSG00000128928,IVD,protein_coding,15,1,40405485,40435947,q15.1,isovaleryl-CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:6186],ISOVALERIC ACIDEMIA,IVD,3712,NM_001159508;NM_001354597;NM_001354598;NM_001354599;NM_001354600;NM_001354601;NM_002225
ATIC_SIG,ATIC,ATIC_SIG,ATIC,SIG,37,3.98534846124818,0.691651132564154,0.676231637512629,0.742315187733449,0.0660835502208196,0.00022546566372141,3.50934673381723,5.9022124705459,5.83237911067036,6.13166493870842,0.299285828038061,0.00263175552925935,ENSG00000138363,ATIC,protein_coding,2,1,215311956,215349773,q35,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase [Source:HGNC Symbol;Acc:HGNC:794],AICA-ribosiduria;AICA-RIBOSURIA;AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY,ATIC,471,NM_004044
PPIL2_SIG,PPIL2,PPIL2_SIG,PPIL2,SIG,12,3.98501161566191,0.324436912346525,0.318443429465545,0.344129784669744,0.0256863552041991,0.000225694587612314,3.19856634262414,5.9196708514744,5.8862426946616,6.02950622385933,0.143263529197735,0.0063778967163665,ENSG00000100023,PPIL2,protein_coding,22,1,21666009,21700015,q11.21,peptidylprolyl isomerase like 2 [Source:HGNC Symbol;Acc:HGNC:9261],NA,PPIL2,23759,NM_001317996;NM_014337;NM_148175;NM_148176
POLD2_SIG,POLD2,POLD2_SIG,POLD2,SIG,36,3.98184621075009,0.3697801671093,0.355169663870863,0.417786106321306,0.0626164424504431,0.000228629966492958,3.96075428059921,5.79852426741163,5.71584682095954,6.07017873432565,0.354331913366115,0.00064288981387272,ENSG00000106628,POLD2,protein_coding,7,-1,44114681,44124358,p13,DNA polymerase delta 2, accessory subunit [Source:HGNC Symbol;Acc:HGNC:9176],NA,POLD2,5425,NM_001127218;NM_001256879;NM_006230
ZNF383_TF,ZNF383,ZNF383_TF,ZNF383,TF,52,3.98135525581044,0.30909007004647,0.30116270773345,0.335137117646392,0.0339744099129419,0.000229010380570359,3.98089494974199,3.06459672085949,3.01766838587962,3.21878982150764,0.201121435628014,0.000603504100749151,ENSG00000188283,ZNF383,protein_coding,19,1,37217926,37248738,q13.12,zinc finger protein 383 [Source:HGNC Symbol;Acc:HGNC:18609],NA,ZNF383,163087,NM_001345947;NM_001345948;NM_001345949;NM_152604
PARP9_SIG,PARP9,PARP9_SIG,PARP9,SIG,33,-3.98109668757254,0.397794083474359,0.409828406655628,0.358252735878761,-0.0515756707768674,0.000229167231641458,-3.20245496421621,6.06606209983549,6.13646739287142,5.83473042271745,-0.301736970153964,0.00630430765847781,ENSG00000138496,PARP9,protein_coding,3,-1,122527924,122564577,q21.1,poly(ADP-ribose) polymerase family member 9 [Source:HGNC Symbol;Acc:HGNC:24118],NA,PARP9,83666,NM_001146102;NM_001146103;NM_001146104;NM_001146105;NM_001146106;NM_031458
DHPS_SIG,DHPS,DHPS_SIG,DHPS,SIG,13,3.97942940361267,0.371270885944918,0.361606020330537,0.403026872963598,0.0414208526330607,0.000230687223748896,1.85945405243793,5.42468058284533,5.40293363367821,5.49613484439442,0.0932012107162077,0.124870308901571,ENSG00000095059,DHPS,protein_coding,19,-1,12675717,12681880,p13.13,deoxyhypusine synthase [Source:HGNC Symbol;Acc:HGNC:2869],NA,DHPS,1725,NM_001206974;NM_001930;NM_013406
TRMT10C_SIG,TRMT10C,TRMT10C_SIG,TRMT10C,SIG,34,3.97915587321869,0.160702329014187,0.153111800956994,0.18564263548782,0.0325308345308255,0.000230789143645367,2.62208857938005,4.16551378056543,4.11947917708175,4.31677033486896,0.197291157787214,0.0267428450971499,ENSG00000174173,TRMT10C,protein_coding,3,1,101561868,101566446,q12.3,tRNA methyltransferase 10C, mitochondrial RNase P subunit [Source:HGNC Symbol;Acc:HGNC:26022],Combined oxidative phosphorylation defect type 30;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30;Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies,TRMT10C,54931,NM_017819
KCNC3_SIG,KCNC3,KCNC3_SIG,KCNC3,SIG,29,-3.97913279022028,-0.110999480483315,-0.0921183104816389,-0.173037610488824,-0.0809193000071851,0.000230789143645367,-1.61951895740705,1.88747987049025,1.95594825896289,1.66251230836583,-0.293435950597061,0.185087457750274,ENSG00000131398,KCNC3,protein_coding,19,-1,50311937,50333515,q13.33,potassium voltage-gated channel subfamily C member 3 [Source:HGNC Symbol;Acc:HGNC:6235],SPINOCEREBELLAR ATAXIA 13;Spinocerebellar ataxia type 13,KCNC3,3748,NM_004977
TSSK6_SIG,TSSK6,TSSK6_SIG,TSSK6,SIG,37,3.97850619147831,0.185390569240949,0.173743313356628,0.223660124289431,0.0499168109328024,0.000231304945061844,4.00086484316505,1.72204355160263,1.66659984131368,1.90421574255202,0.237615901238339,0.000567431112677236,ENSG00000178093,TSSK6,protein_coding,19,-1,19512418,19515685,p13.11,testis specific serine kinase 6 [Source:HGNC Symbol;Acc:HGNC:30410],NA,TSSK6,83983,NM_032037
TIAL1_SIG,TIAL1,TIAL1_SIG,TIAL1,SIG,37,3.97834508081759,0.567179420232293,0.560364750546762,0.589570477770466,0.0292057272237042,0.000231368558486073,3.46235920453666,6.79003870411831,6.75820306669452,6.89464151279651,0.136438446101995,0.00300968385170618,ENSG00000151923,TIAL1,protein_coding,10,-1,119571802,119597029,q26.11,TIA1 cytotoxic granule associated RNA binding protein like 1 [Source:HGNC Symbol;Acc:HGNC:11804],NA,TIAL1,7073,NM_001033925;NM_001323964;NM_001323965;NM_001323967;NM_001323968;NM_001323969;NM_001323970;NM_003252
PFAS_SIG,PFAS,PFAS_SIG,PFAS,SIG,27,3.97809009568003,0.677846636258563,0.661436491070688,0.731765684733007,0.070329193662319,0.000231523590226619,4.27423911392425,5.33029123164538,5.23817867964207,5.63294675965626,0.394768080014186,0.000223069976194911,ENSG00000178921,PFAS,protein_coding,17,1,8247618,8270491,p13.1,phosphoribosylformylglycinamidine synthase [Source:HGNC Symbol;Acc:HGNC:8863],NA,PFAS,5198,NM_012393
CREB5_SIG,CREB5,CREB5_SIG,CREB5,SIG,7,-3.97751778617167,0.308619098728152,0.323580475951243,0.259460287852283,-0.0641201880989597,0.000231988046300899,-2.57653438743098,4.35456174075697,4.46218943281905,4.00092789541015,-0.461261537408897,0.0297292931205394,ENSG00000146592,CREB5,protein_coding,7,1,28299321,28825894,p15.1,cAMP responsive element binding protein 5 [Source:HGNC Symbol;Acc:HGNC:16844],NA,CREB5,9586,NM_001011666;NM_004904;NM_182898;NM_182899
EIF2AK4_SIG,EIF2AK4,EIF2AK4_SIG,EIF2AK4,SIG,31,3.9772952829668,0.371208598530223,0.36489554401119,0.391951491949904,0.0270559479387145,0.000232111823962447,3.17883055064707,6.6590061009834,6.61475491709908,6.80440284803188,0.189647930932805,0.00673229423832056,ENSG00000128829,EIF2AK4,protein_coding,15,1,39934115,40035591,q15.1,eukaryotic translation initiation factor 2 alpha kinase 4 [Source:HGNC Symbol;Acc:HGNC:19687],Heritable pulmonary arterial hypertension;Pulmonary capillary hemangiomatosis;PULMONARY VENOOCCLUSIVE DISEASE;PULMONARY VENOOCCLUSIVE DISEASE 2 AUTOSOMAL RECESSIVE,EIF2AK4,440275,NM_001013703
ZBTB6_TF,ZBTB6,ZBTB6_TF,ZBTB6,TF,51,3.97685165298065,0.190927247321427,0.184775076872774,0.211141521652715,0.0263664447799412,0.000232451666828618,4.55043203312136,3.43191055294413,3.32813309518257,3.7728936284464,0.444760533263823,8.27198142597367e-05,ENSG00000186130,ZBTB6,protein_coding,9,-1,122908056,122913323,q33.2,zinc finger and BTB domain containing 6 [Source:HGNC Symbol;Acc:HGNC:16764],NA,ZBTB6,10773,NM_006626
PNPLA4_SIG,PNPLA4,PNPLA4_SIG,PNPLA4,SIG,7,3.97595503801325,0.5106793171795,0.496270532642376,0.558022466372909,0.0617519337305333,0.000233235625111895,4.70910388478041,2.91204599111333,2.82341559223748,3.20326015884826,0.379844566610779,4.49527994693274e-05,ENSG00000006757,PNPLA4,protein_coding,X,-1,7898247,7927739,p22.31,patatin like phospholipase domain containing 4 [Source:HGNC Symbol;Acc:HGNC:24887],NA,PNPLA4,8228,NM_001142389;NM_001172672;NM_004650
ABCA2_SIG,ABCA2,ABCA2_SIG,ABCA2,SIG,75,3.97388777237956,0.139731731529422,0.129668563082393,0.172796427855376,0.0431278647729831,0.000235175894886383,2.17488399027221,6.92922534644792,6.87281419037406,7.11457628783347,0.241762097459409,0.0697128760617079,ENSG00000107331,ABCA2,protein_coding,9,-1,137007234,137028922,q34.3,ATP binding cassette subfamily A member 2 [Source:HGNC Symbol;Acc:HGNC:32],NA,ABCA2,20,NM_001606;NM_212533
MYBBP1A_SIG,MYBBP1A,MYBBP1A_SIG,MYBBP1A,SIG,15,3.9734487567174,0.788566187607055,0.775410690143936,0.831791393557306,0.0563807034133701,0.000235515433971745,3.09200661248671,5.71714602486062,5.66250959978472,5.89666570725285,0.234156107468133,0.00846260558975824,ENSG00000132382,MYBBP1A,protein_coding,17,-1,4538897,4555631,p13.2,MYB binding protein 1a [Source:HGNC Symbol;Acc:HGNC:7546],NA,MYBBP1A,10514,NM_001105538;NM_014520
CD81_SIG,CD81,CD81_SIG,CD81,SIG,24,3.9730158048077,0.152106861907631,0.14803893048947,0.165472922281591,0.0174339917921211,0.000235849451466827,0.829406843927395,6.13154907161758,6.1110210179044,6.19899839096088,0.087977373056482,0.51945729343117,ENSG00000110651,CD81,protein_coding,11,1,2376177,2397419,p15.5,CD81 molecule [Source:HGNC Symbol;Acc:HGNC:1701],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 6,CD81,975,NM_001297649;NM_004356
ZC3H7B_SIG,ZC3H7B,ZC3H7B_SIG,ZC3H7B,SIG,33,3.97270468845769,0.713227843407715,0.702551526077047,0.748307171779908,0.045755645702861,0.000236063125274009,1.89280019219631,6.81959494527615,6.79218670150792,6.90965060337176,0.117463901863843,0.117722549324344,ENSG00000100403,ZC3H7B,protein_coding,22,1,41301525,41360147,q13.2,zinc finger CCCH-type containing 7B [Source:HGNC Symbol;Acc:HGNC:30869],NA,ZC3H7B,23264,NM_017590
DIMT1_SIG,DIMT1,DIMT1_SIG,DIMT1,SIG,39,3.97165800533898,0.409153298766894,0.393427059963219,0.460825226264686,0.0673981663014673,0.000237007903313706,3.04217209348315,4.32927659170345,4.27999197825447,4.49121175017866,0.211219771924193,0.00964556558319153,ENSG00000086189,DIMT1,protein_coding,5,-1,62347284,62403939,q12.1,DIM1 dimethyladenosine transferase 1 homolog [Source:HGNC Symbol;Acc:HGNC:30217],NA,DIMT1,27292,NM_001348076;NM_001348077;NM_014473
CCL4_SIG,CCL4,CCL4_SIG,CCL4,SIG,21,-3.97137273017978,-0.0135543056637634,-0.00179321646955561,-0.0521978844447318,-0.0504046679751761,0.000237196872680585,-1.93283535181037,2.36760388377026,2.43885770310936,2.13348419165609,-0.305373511453272,0.109681983657249,ENSG00000275302,CCL4,protein_coding,17,1,36103827,36105621,q12,C-C motif chemokine ligand 4 [Source:HGNC Symbol;Acc:HGNC:10630],NA,CCL4,6351,NM_002984
ZNF501_TF,ZNF501,ZNF501_TF,ZNF501,TF,20,3.97039335758063,0.173669077704148,0.159687453414194,0.219608700371141,0.0599212469569471,0.000238078675369723,2.42171213953684,1.60138172743097,1.54731406906583,1.77903260491644,0.231718535850604,0.0418229311876809,ENSG00000186446,ZNF501,protein_coding,3,1,44729596,44737083,p21.31,zinc finger protein 501 [Source:HGNC Symbol;Acc:HGNC:23717],NA,ZNF501,115560,NM_001258280;NM_145044
ALCAM_SIG,ALCAM,ALCAM_SIG,ALCAM,SIG,34,3.96965313645724,0.244274420402777,0.237157972736263,0.26765703416418,0.030499061427916,0.000238723868789948,3.67425480189688,6.19865021875035,6.09556529821616,6.53735781479124,0.441792516575081,0.0015896244271525,ENSG00000170017,ALCAM,protein_coding,3,1,105366909,105576900,q13.11,activated leukocyte cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:400],NA,ALCAM,214,NM_001243280;NM_001243281;NM_001243283;NM_001627
CNR1_SIG,CNR1,CNR1_SIG,CNR1,SIG,4,-3.96910409907101,-0.185352775233512,-0.169671739650736,-0.236876177862635,-0.0672044382118994,0.000239178772986532,-3.73566044872458,0.375494674930275,0.428030261043012,0.202877749131282,-0.22515251191173,0.00131516925978631,ENSG00000118432,CNR1,protein_coding,6,-1,88139864,88166359,q15,cannabinoid receptor 1 [Source:HGNC Symbol;Acc:HGNC:2159],NA,CNR1,1268,NM_001160226;NM_001160258;NM_001160259;NM_001365869;NM_001365870;NM_001365872;NM_001365874;NM_016083;NM_033181
POLM_SIG,POLM,POLM_SIG,POLM,SIG,21,3.96886653705672,0.191371432651014,0.184337753093662,0.214482094053741,0.0301443409600791,0.000239321543539462,3.26394052091486,4.79287347541776,4.74227646507323,4.95912079512122,0.216844330047983,0.00531835050258751,ENSG00000122678,POLM,protein_coding,7,-1,44072062,44082530,p13,DNA polymerase mu [Source:HGNC Symbol;Acc:HGNC:9185],NA,POLM,27434,NM_001284330;NM_001284331;NM_013284
PPIL3_SIG,PPIL3,PPIL3_SIG,PPIL3,SIG,6,3.96559710965125,0.189014013685498,0.182986770608937,0.208817812365627,0.0258310417566902,0.00024252900526336,2.58423242553481,4.51162448037985,4.47859378256431,4.62015391605946,0.141560133495154,0.0292148361511176,ENSG00000240344,PPIL3,protein_coding,2,-1,200870907,200889303,q33.1,peptidylprolyl isomerase like 3 [Source:HGNC Symbol;Acc:HGNC:9262],NA,PPIL3,53938,NM_032472;NM_130906
FANCL_SIG,FANCL,FANCL_SIG,FANCL,SIG,63,3.96517662859592,0.282109156267622,0.268901928220969,0.325504334135194,0.0566024059142254,0.000242859835870162,3.51666053066087,3.07565978794171,2.9938352833807,3.3445117314993,0.350676448118604,0.00257151508926589,ENSG00000115392,FANCL,protein_coding,2,-1,58159243,58241372,p16.1,FA complementation group L [Source:HGNC Symbol;Acc:HGNC:20748],FANCL-Related Fanconi Anemia;Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP L,FANCL,55120,NM_001114636;NM_018062
ATP1B2_SIG,ATP1B2,ATP1B2_SIG,ATP1B2,SIG,46,-3.96449551782152,-0.242013675376765,-0.219222763166072,-0.3168981012119,-0.0976753380458279,0.000243456955028116,-3.54598753525513,0.930860337764497,1.04763754806927,0.547163789620255,-0.500473758449012,0.00235563599767665,ENSG00000129244,ATP1B2,protein_coding,17,1,7646627,7657770,p13.1,ATPase Na+/K+ transporting subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:805],NA,ATP1B2,482,NM_001303263;NM_001678
GTF3A_SIG,GTF3A,GTF3A_SIG,GTF3A,SIG,11,3.96433604461968,0.213304791583086,0.206203207554061,0.236638567678451,0.0304353601243904,0.000243522459177446,3.70781504003936,7.32305914533228,7.26761571346136,7.50523042147962,0.237614708018265,0.00143671226852867,ENSG00000122034,GTF3A,protein_coding,13,1,27424619,27435823,q12.2,general transcription factor IIIA [Source:HGNC Symbol;Acc:HGNC:4662],NA,GTF3A,2971,NM_002097
RBM10_SIG,RBM10,RBM10_SIG,RBM10,SIG,29,3.96359938887996,0.475348948755585,0.461923059715836,0.519462584171902,0.0575395244560653,0.000244177986832753,2.81004063265355,6.4081582317228,6.37833391780682,6.50615240601817,0.127818488211344,0.0172800896256712,ENSG00000182872,RBM10,protein_coding,X,1,47145221,47186813,p11.3,RNA binding motif protein 10 [Source:HGNC Symbol;Acc:HGNC:9896],TARP syndrome,RBM10,8241,NM_001204466;NM_001204467;NM_001204468;NM_005676;NM_152856
HNRNPDL_SIG,HNRNPDL,HNRNPDL_SIG,HNRNPDL,SIG,26,3.9622853830808,0.346962739587965,0.338016963817639,0.376356002833321,0.0383390390156816,0.000245428180081493,3.01517762577799,8.63270576886653,8.60083112289528,8.73743674848634,0.136605625591059,0.0103376934283905,ENSG00000152795,HNRNPDL,protein_coding,4,-1,82422564,82430408,q21.22,heterogeneous nuclear ribonucleoprotein D like [Source:HGNC Symbol;Acc:HGNC:5037],Autosomal dominant limb-girdle muscular dystrophy type 1G;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL DOMINANT 3,HNRNPDL,9987,NM_001207000;NM_031372
TGFBR2_SIG,TGFBR2,TGFBR2_SIG,TGFBR2,SIG,32,-3.96207216854195,0.374966875731725,0.3866237366406,0.336665761316848,-0.049957975323753,0.000245549528473486,-1.05223607488485,6.44140863209112,6.4638189534401,6.36777471908735,-0.096044234352748,0.404948333320083,ENSG00000163513,TGFBR2,protein_coding,3,1,30606502,30694142,p24.1,transforming growth factor beta receptor 2 [Source:HGNC Symbol;Acc:HGNC:11773],COLORECTAL CANCER HEREDITARY NONPOLYPOSIS TYPE 6;ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA SUSCEPTIBILITY TO INCLUDED;Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome;LOEYS-DIETZ SYNDROME 2;Lynch syndrome;Marfan syndrome type 2;Squamous cell carcinoma of the esophagus;TGFBR2-Related Loeys-Dietz Syndrome,TGFBR2,7048,NM_001024847;NM_003242
ZNF816_TF,ZNF816,ZNF816_TF,ZNF816,TF,37,3.96127962533017,0.147759740643717,0.133231249147569,0.19549621270249,0.0622649635549207,0.000246267883172109,3.19732630845644,2.8172583219684,2.750631820294,3.03617397032715,0.285542150033151,0.00640123930618476,ENSG00000180257,ZNF816,protein_coding,19,-1,52949379,52962911,q13.41,zinc finger protein 816 [Source:HGNC Symbol;Acc:HGNC:26995],NA,ZNF816,125893,NM_001031665;NM_001202456;NM_001202457
HCK_SIG,HCK,HCK_SIG,HCK,SIG,52,-3.9603875130957,0.674583346741466,0.696726649887469,0.601826779261743,-0.0948998706257253,0.000247032133710725,-2.5725206738971,6.56072577077699,6.65462034542368,6.25221502550933,-0.402405319914347,0.0299901751264252,ENSG00000101336,HCK,protein_coding,20,1,32052188,32101856,q11.21,HCK proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:4840],NA,HCK,3055,NM_001172129;NM_001172130;NM_001172131;NM_001172132;NM_001172133;NM_002110
PPFIA1_SIG,PPFIA1,PPFIA1_SIG,PPFIA1,SIG,14,-3.96034948942548,0.267781187130323,0.273958813334257,0.247483272460253,-0.0264755408740037,0.000247032133710725,-4.29574165876319,5.88628093330691,5.94111147546503,5.70612343764451,-0.234988037820525,0.000207957939864467,ENSG00000131626,PPFIA1,protein_coding,11,1,70270700,70385312,q13.3,PTPRF interacting protein alpha 1 [Source:HGNC Symbol;Acc:HGNC:9245],NA,PPFIA1,8500,NM_003626;NM_177423
EEF1A2_SIG,EEF1A2,EEF1A2_SIG,EEF1A2,SIG,33,3.95929136445812,-0.0828755920696302,-0.0888539833313822,-0.0632323064953024,0.0256216768360798,0.000248030271743987,0.0407567129804952,0.923576806031806,0.922265411235671,0.927885674647675,0.00562026341200391,0.977592393025729,ENSG00000101210,EEF1A2,protein_coding,20,-1,63488014,63499185,q13.33,eukaryotic translation elongation factor 1 alpha 2 [Source:HGNC Symbol;Acc:HGNC:3192],Autosomal dominant non-syndromic intellectual disability;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 33;INFANTILE EPILEPTIC ENCEPHALOPATHY;MENTAL RETARDATION AUTOSOMAL DOMINANT 38;Undetermined early-onset epileptic encephalopathy,EEF1A2,1917,NM_001958
TTC3_SIG,TTC3,TTC3_SIG,TTC3,SIG,95,3.95818614181083,0.183510135611988,0.1715890263563,0.222679494594961,0.0510904682386603,0.000249081315881804,2.44293780527877,7.80209353019161,7.75512592717285,7.9564156543961,0.201289727223254,0.0399489759397687,ENSG00000182670,TTC3,protein_coding,21,1,37073226,37203112,q22.13,tetratricopeptide repeat domain 3 [Source:HGNC Symbol;Acc:HGNC:12393],NA,TTC3,7267,NM_001001894;NM_001320703;NM_001320704;NM_001330681;NM_001330682;NM_001330683;NM_001353936;NM_001353937;NM_001353938;NM_003316
NR2C1_TF,NR2C1,NR2C1_TF,NR2C1,TF,160,3.95669176771037,0.276967108545621,0.270448753763485,0.298384559972637,0.0279358062091523,0.000250544219927202,3.1441281433085,5.14616398801271,5.10566524146554,5.27923129809629,0.173566056630748,0.0073782855132469,ENSG00000120798,NR2C1,protein_coding,12,-1,95020229,95073628,q22,nuclear receptor subfamily 2 group C member 1 [Source:HGNC Symbol;Acc:HGNC:7971],NA,NR2C1,7181,NM_001032287;NM_001127362;NM_003297
LILRB2_SIG,LILRB2,LILRB2_SIG,LILRB2,SIG,53,-3.9561301416132,0.458511646293408,0.492601032394036,0.346503663391344,-0.146097369002693,0.000251033767683223,-3.19087602031549,5.86641775878884,6.02751870707561,5.33708607156086,-0.690432635514748,0.00651629206774828,ENSG00000131042,LILRB2,protein_coding,19,-1,54273821,54281184,q13.42,leukocyte immunoglobulin like receptor B2 [Source:HGNC Symbol;Acc:HGNC:6606],NA,LILRB2,10288,NM_001080978;NM_001278403;NM_001278404;NM_001278405;NM_001278406;NM_005874
PLCXD1_SIG,PLCXD1,PLCXD1_SIG,PLCXD1,SIG,6,3.95543497737506,0.0963890373333589,0.0873323712251104,0.126146654546176,0.038814283321065,0.00025166478123428,2.08563326838176,5.82085406227348,5.77945462413134,5.95688078759766,0.177426163466325,0.0825671331224078,ENSG00000182378,PLCXD1,protein_coding,X,1,276322,303356,p22.33,phosphatidylinositol specific phospholipase C X domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23148],NA,PLCXD1,55344,NM_018390
RASSF7_SIG,RASSF7,RASSF7_SIG,RASSF7,SIG,19,3.95186544044773,0.234494763525366,0.225746611850739,0.263238690456282,0.0374920786055431,0.00025534772351439,3.58302617334878,3.54631584508751,3.47534905436133,3.77949244318785,0.304143388826522,0.00210425397725988,ENSG00000099849,RASSF7,protein_coding,11,1,560404,564025,p15.5,Ras association domain family member 7 [Source:HGNC Symbol;Acc:HGNC:1166],NA,RASSF7,8045,NM_001143993;NM_001143994;NM_003475
CERS6_TF,CERS6,CERS6_TF,CERS6,TF,97,3.94998656796985,0.324014621441215,0.31571124712455,0.351297137053113,0.0355858899285628,0.000257258232960829,2.09899510531376,7.23912924862924,7.20015917762184,7.36717376765355,0.167014590031709,0.0805079149338461,ENSG00000172292,CERS6,protein_coding,2,1,168455862,168775137,q24.3,ceramide synthase 6 [Source:HGNC Symbol;Acc:HGNC:23826],NA,CERS6,253782,NM_001256126;NM_203463
OR7E7P_SIG,OR7E7P,OR7E7P_SIG,OR7E7P,SIG,72,3.94938132934317,0.014492127070236,0.00727776587906873,0.0381964566983572,0.0309186908192883,0.000257781145645931,1.80815146715241,0.948043782561717,0.924316453894227,1.02600500532633,0.101688551432101,0.136290045446147,ENSG00000238228,OR7E7P,unprocessed_pseudogene,7,-1,97946987,97947998,q21.3,olfactory receptor family 7 subfamily E member 7 pseudogene [Source:HGNC Symbol;Acc:HGNC:8457],NA,OR7E7P,NA,NA
CLCN6_SIG,CLCN6,CLCN6_SIG,CLCN6,SIG,43,3.94931038158331,0.135642978242149,0.131042058986396,0.150760284368194,0.0197182253817976,0.000257781145645931,2.14339566022085,5.30205699631872,5.27706208829635,5.38418312267796,0.107121034381611,0.0740480198454191,ENSG00000011021,CLCN6,protein_coding,1,1,11806096,11848079,p36.22,chloride voltage-gated channel 6 [Source:HGNC Symbol;Acc:HGNC:2024],NA,CLCN6,1185,NM_001256959;NM_001286
TMLHE_SIG,TMLHE,TMLHE_SIG,TMLHE,SIG,66,3.94720800401075,0.32763110550027,0.315160649273628,0.368605461673522,0.053444812399894,0.000259951277390811,3.68676554419382,3.90790876006402,3.84878390339765,4.10217614625351,0.253392242855866,0.00153195986201272,ENSG00000185973,TMLHE,protein_coding,X,-1,155489011,155669944,q28,trimethyllysine hydroxylase, epsilon [Source:HGNC Symbol;Acc:HGNC:18308],AUTISM SUSCEPTIBILITY TO X-LINKED 6,TMLHE,55217,NM_001184797;NM_018196
ARIH2_SIG,ARIH2,ARIH2_SIG,ARIH2,SIG,30,3.94616080262873,0.331568415224679,0.323117387179028,0.359336078803247,0.0362186916242185,0.000260986670274641,2.45668748029972,6.8757379083292,6.8536873235238,6.94818982983264,0.094502506308835,0.0388205782183392,ENSG00000177479,ARIH2,protein_coding,3,1,48918821,48986382,p21.31,ariadne RBR E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:690],NA,ARIH2,10425,NM_001317333;NM_001317334;NM_001349209;NM_001349210;NM_001349211;NM_001349212;NM_001349213;NM_001349214;NM_001349215;NM_001349216;NM_001349217;NM_001349218;NM_001349219;NM_001349220;NM_001349221;NM_001349222;NM_001349223;NM_001349224;NM_001349225;NM_001349226;NM_001349227;NM_001349228;NM_001349229;NM_001349230;NM_006321
NSUN3_SIG,NSUN3,NSUN3_SIG,NSUN3,SIG,45,3.94550584690383,0.318786365606177,0.312280928990325,0.340161371629692,0.0278804426393673,0.000261514352720152,3.30201315361019,4.09658268448469,4.05954006202156,4.2182941582921,0.158754096270533,0.00478229738916378,ENSG00000178694,NSUN3,protein_coding,3,1,94062980,94131832,q11.2,NOP2/Sun RNA methyltransferase family member 3 [Source:HGNC Symbol;Acc:HGNC:26208],NA,NSUN3,63899,NM_022072
ALDH1L2_SIG,ALDH1L2,ALDH1L2_SIG,ALDH1L2,SIG,35,-3.94543715616368,-0.0606490787079389,-0.0543385883429527,-0.0813835470500364,-0.0270449587070838,0.000261514352720152,-0.829681197118333,1.3305272120894,1.35460261094814,1.251422330125,-0.103180280823139,0.519339672376615,ENSG00000136010,ALDH1L2,protein_coding,12,-1,105019784,105107643,q23.3,aldehyde dehydrogenase 1 family member L2 [Source:HGNC Symbol;Acc:HGNC:26777],NA,ALDH1L2,160428,NM_001034173
COL4A1_SIG,COL4A1,COL4A1_SIG,COL4A1,SIG,22,-3.94539195360285,-0.143911996753835,-0.136790909761802,-0.167309854013371,-0.030518944251569,0.000261514352720152,-0.377569419520739,0.518436733389308,0.526001052490394,0.493582542057167,-0.0324185104332271,0.78163064207186,ENSG00000187498,COL4A1,protein_coding,13,-1,110148963,110307157,q34,collagen type IV alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2202],Angiopathy hereditary with nephropathy aneurysms and muscle cramps;BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES;COL4A1-related familial vascular leukoencephalopathy;Familial porencephaly;Familial schizencephaly;HANAC syndrome;HEMORRHAGE INTRACEREBRAL SUSCEPTIBILITY TO;Pontine autosomal dominant microangiopathy with leukoencephalopathy;PORENCEPHALY 1;Retinal arterial tortuosity;Retinal arteries tortuosity of;Schizencephaly;Walker-Warburg syndrome,COL4A1,1282,NM_001303110;NM_001845
EPAS1_TF,EPAS1,EPAS1_TF,EPAS1,TF,181,-3.94459542211591,-0.102622566195024,-0.098098421869777,-0.117487611835119,-0.0193891899653422,0.000262281179271814,-1.05320123481509,2.54094426168423,2.57965415610513,2.41375460858698,-0.165899547518149,0.404465500356727,ENSG00000116016,EPAS1,protein_coding,2,1,46293667,46386697,p21,endothelial PAS domain protein 1 [Source:HGNC Symbol;Acc:HGNC:3374],Autosomal dominant secondary polycythemia;ERYTHROCYTOSIS FAMILIAL 4;Multiple paragangliomas associated with polycythemia;Sporadic pheochromocytoma;Sporadic secreting paraganglioma,EPAS1,2034,NM_001430
FST_SIG,FST,FST_SIG,FST,SIG,28,-3.9443385838959,-0.183594691058285,-0.176360304431452,-0.207364818546452,-0.0310045141149999,0.00026245847464109,-0.984987736944034,0.316176838299391,0.330858030536298,0.267938635235267,-0.0629193953010302,0.438180594047522,ENSG00000134363,FST,protein_coding,5,1,53480626,53487134,q11.2,follistatin [Source:HGNC Symbol;Acc:HGNC:3971],NA,FST,10468,NM_006350;NM_013409
PPM1M_SIG,PPM1M,PPM1M_SIG,PPM1M,SIG,32,-3.9420722888758,0.468790103812658,0.483112941096363,0.421729352737628,-0.0613835883587355,0.000264846630533494,-2.85739046996207,5.42902050849139,5.50085230491032,5.19300174882922,-0.307850556081096,0.0154125402592755,ENSG00000164088,PPM1M,protein_coding,3,1,52245759,52250599,p21.2,protein phosphatase, Mg2+/Mn2+ dependent 1M [Source:HGNC Symbol;Acc:HGNC:26506],NA,PPM1M,132160,NM_001122870;NM_144641
OSGEPL1_SIG,OSGEPL1,OSGEPL1_SIG,OSGEPL1,SIG,71,3.94193996386436,0.211602927052707,0.19527362588041,0.265256345190255,0.0699827193098448,0.000264888001160455,3.10167766842055,2.34210357004762,2.28291909616672,2.53656684137055,0.25364774520383,0.0082664853974654,ENSG00000128694,OSGEPL1,protein_coding,2,-1,189746660,189763227,q32.2,O-sialoglycoprotein endopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:23075],NA,OSGEPL1,64172,NM_001354347;NM_022353
SLC48A1_SIG,SLC48A1,SLC48A1_SIG,SLC48A1,SIG,25,3.94145446059568,0.112015635792733,0.103586571585583,0.13971113247337,0.0361245608877873,0.000265319877784266,1.9462140352916,4.52716115819074,4.48981891224188,4.64985710916554,0.160038196923657,0.107157344790348,ENSG00000211584,SLC48A1,protein_coding,12,1,47753916,47782751,q13.11,solute carrier family 48 member 1 [Source:HGNC Symbol;Acc:HGNC:26035],NA,SLC48A1,55652,NM_017842
TAF10_TF,TAF10,TAF10_TF,TAF10,TF,28,-3.93956061421736,-0.16790263262575,-0.160972551535677,-0.190672899064558,-0.0297003475288805,0.00026731724838984,-4.0962590936703,6.23016770037888,6.26566184245119,6.11354409071273,-0.152117751738457,0.000410676310117308,ENSG00000166337,TAF10,protein_coding,11,-1,6606294,6612539,p15.4,TATA-box binding protein associated factor 10 [Source:HGNC Symbol;Acc:HGNC:11543],NA,TAF10,6881,NM_006284
TRPC1_SIG,TRPC1,TRPC1_SIG,TRPC1,SIG,64,-3.93888485619799,-0.161304925307467,-0.153173767331329,-0.188021587229062,-0.0348478198977333,0.000267965255125984,-2.61121984005528,0.839604941899323,0.893685590739582,0.661911381424186,-0.231774209315396,0.0274457348058624,ENSG00000144935,TRPC1,protein_coding,3,1,142724034,142807888,q23,transient receptor potential cation channel subfamily C member 1 [Source:HGNC Symbol;Acc:HGNC:12333],NA,TRPC1,7220,NM_001251845;NM_003304
CAMTA1_TF,CAMTA1,CAMTA1_TF,CAMTA1,TF,225,3.93851970399594,0.0676797867873764,0.0645568185255932,0.0779409682189499,0.0133841496933566,0.000268267325926471,0.796104177985741,4.21463716416046,4.20719800281347,4.23908012287198,0.0318821200585129,0.537458601254899,ENSG00000171735,CAMTA1,protein_coding,1,1,6785454,7769706,p36.31,calmodulin binding transcription activator 1 [Source:HGNC Symbol;Acc:HGNC:18806],CEREBELLAR ATAXIA NONPROGRESSIVE WITH MENTAL RETARDATION;Epithelioid hemangioendothelioma;Non-progressive cerebellar ataxia with intellectual disability,CAMTA1,23261,NM_001195563;NM_001242701;NM_001349608;NM_001349609;NM_001349610;NM_001349612;NM_001349613;NM_001349614;NM_001349615;NM_001349616;NM_001349617;NM_001349618;NM_001349619;NM_001349620;NM_001349621;NM_001349622;NM_001349623;NM_001349624;NM_001349625;NM_001349626;NM_001349627;NM_015215
ATP8B1_SIG,ATP8B1,ATP8B1_SIG,ATP8B1,SIG,29,3.93510076057123,-0.0904004508213914,-0.0950407862511532,-0.0751536344093168,0.0198871518418364,0.000272007700766873,1.37286364508083,0.406007657978802,0.379465812891169,0.493216577552454,0.113750764661286,0.266905457441483,ENSG00000081923,ATP8B1,protein_coding,18,-1,57646426,57803315,q21.31,ATPase phospholipid transporting 8B1 [Source:HGNC Symbol;Acc:HGNC:3706],ATP8B1-Related Intrahepatic Cholestasis;Benign recurrent intrahepatic cholestasis type 1;Cholestasis benign recurrent intrahepatic 1;CHOLESTASIS INTRAHEPATIC OF PREGNANCY 1;CHOLESTASIS PROGRESSIVE FAMILIAL INTRAHEPATIC 1;Intrahepatic cholestasis of pregnancy;Progressive familial intrahepatic cholestasis type 1,ATP8B1,5205,NM_005603
CREBBP_TF,CREBBP,CREBBP_TF,CREBBP,TF,413,-3.93470308924932,-0.0358909075526809,-0.0278271211871227,-0.0623862056109432,-0.0345590844238206,0.000272350926384261,-2.30768937634333,7.9278489548026,7.96123319422238,7.81815788242336,-0.143075311799018,0.0531155344694997,ENSG00000005339,CREBBP,protein_coding,16,-1,3725054,3880726,p13.3,CREB binding protein [Source:HGNC Symbol;Acc:HGNC:2348],Acute myeloid leukemia with t(8;16)(p11;p13) translocation;CREBBP intellectual disability without typical RTS features;RUBINSTEIN-TAYBI SYNDROME 1;Rubinstein-Taybi syndrome due to 16p13.3 microdeletion;Rubinstein-Taybi syndrome due to CREBBP mutations;RUBINSTEIN-TAYBI SYNDROME TYPE 1,CREBBP,1387,NM_001079846;NM_004380
WNT10B_SIG,WNT10B,WNT10B_SIG,WNT10B,SIG,16,-3.93455161644626,-0.0519656327468357,-0.0403682370208535,-0.0900713615607772,-0.0497031245399238,0.000272415229286213,-2.40992702451334,1.1773952793454,1.23718835586564,0.980932313636035,-0.25625604222961,0.0429390274129409,ENSG00000169884,WNT10B,protein_coding,12,-1,48965340,48971735,q13.12,Wnt family member 10B [Source:HGNC Symbol;Acc:HGNC:12775],Isolated split hand-split foot malformation;Oligodontia;SPLIT-HAND/FOOT MALFORMATION 6;SPLIT-HAND/FOOT MALFORMATION TYPE 6;TOOTH AGENESIS SELECTIVE 8,WNT10B,7480,NM_003394
RFTN1_SIG,RFTN1,RFTN1_SIG,RFTN1,SIG,46,3.93445390724442,0.118523262834234,0.111835761083214,0.140496482873296,0.0286607217900817,0.000272418602887591,5.88319952025708,5.42564729468298,5.29630547195633,5.85062756935625,0.554322097399918,2.55003793781569e-07,ENSG00000131378,RFTN1,protein_coding,3,-1,16313574,16514026,p24.3,raftlin, lipid raft linker 1 [Source:HGNC Symbol;Acc:HGNC:30278],NA,RFTN1,23180,NM_015150
KIN_SIG,KIN,KIN_SIG,KIN,SIG,32,3.93395970084242,0.331276570001958,0.326123096686226,0.348209410896506,0.0220863142102806,0.00027281010996876,4.45337936747011,4.05485610703889,4.00607218268391,4.21514614420525,0.209073961521337,0.000117557674547876,ENSG00000151657,KIN,protein_coding,10,-1,7750962,7787993,p14,Kin17 DNA and RNA binding protein [Source:HGNC Symbol;Acc:HGNC:6327],NA,KIN,22944,NM_012311
SPAG1_SIG,SPAG1,SPAG1_SIG,SPAG1,SIG,5,-3.93391955594828,0.202850219502392,0.213207818507896,0.168818108484309,-0.0443897100235868,0.00027281010996876,1.68329351588458,3.22233298887053,3.18092619828902,3.35838387220976,0.177457673920735,0.167593374311934,ENSG00000104450,SPAG1,protein_coding,8,1,100157906,100259278,q22.2,sperm associated antigen 1 [Source:HGNC Symbol;Acc:HGNC:11212],Ciliary dyskinesia primary 28;Primary ciliary dyskinesia;Primary Ciliary Dyskinesia Associated with Defective Outer and Inner Dynein Arms.,SPAG1,6674,NM_003114;NM_172218
PATL1_SIG,PATL1,PATL1_SIG,PATL1,SIG,19,-3.93244732999804,0.504759715942727,0.520826625190719,0.451968442699324,-0.0688581824913949,0.000274378730977102,-3.02717930982297,6.79196489876118,6.83191480864356,6.66070090914767,-0.171213899495885,0.0100324897077495,ENSG00000166889,PATL1,protein_coding,11,-1,59636716,59669037,q12.1,PAT1 homolog 1, processing body mRNA decay factor [Source:HGNC Symbol;Acc:HGNC:26721],NA,PATL1,219988,NM_152716
TRAF5_SIG,TRAF5,TRAF5_SIG,TRAF5,SIG,113,3.93162668662538,0.145898872435335,0.13409852538179,0.184671441325554,0.0505729159437646,0.000275208827991105,2.82389015609423,5.11153414699315,5.02666333991584,5.39039537024715,0.363732030331308,0.0167142732723513,ENSG00000082512,TRAF5,protein_coding,1,1,211326615,211374946,q32.3,TNF receptor associated factor 5 [Source:HGNC Symbol;Acc:HGNC:12035],NA,TRAF5,7188,NM_001033910;NM_001319207;NM_004619;NM_145759
PKM_SIG,PKM,PKM_SIG,PKM,SIG,39,-3.93100019233287,0.242695132960042,0.251843099458023,0.212637528752391,-0.0392055707056314,0.000275818456459088,-2.49358934838954,9.59014467252535,9.6398790538766,9.42673170522839,-0.213147348648217,0.03580320884707,ENSG00000067225,PKM,protein_coding,15,-1,72199029,72231822,q23,pyruvate kinase M1/2 [Source:HGNC Symbol;Acc:HGNC:9021],NA,PKM,5315,NM_001206796;NM_001206797;NM_001206798;NM_001206799;NM_001316318;NM_002654;NM_182470;NM_182471
CCR5_SIG,CCR5,CCR5_SIG,CCR5,SIG,27,-3.93046477123901,0.0708095262830509,0.0990683913560225,-0.0220410303852846,-0.121109421741307,0.000276324682589693,-3.11221632576766,2.61685002532147,2.75091338502421,2.17635612915533,-0.574557255868882,0.00806804690790664,ENSG00000160791,CCR5,protein_coding,3,1,46370854,46376206,p21.31,C-C motif chemokine receptor 5 (gene/pseudogene) [Source:HGNC Symbol;Acc:HGNC:1606],DIABETES MELLITUS INSULIN-DEPENDENT 22;HEPATITIS C VIRUS SUSCEPTIBILITY TO;Susceptibility/resistance to HIV infection;WEST NILE VIRUS SUSCEPTIBILITY TO,CCR5,1234,NM_000579;NM_001100168
HNRNPA1L2_SIG,HNRNPA1L2,HNRNPA1L2_SIG,HNRNPA1L2,SIG,75,3.92795125758685,0.303972427611754,0.290600980758448,0.347907181558332,0.0573062007998841,0.000279118061043009,3.32745987752964,4.84492507080561,4.79336589215574,5.01433380065517,0.220967908499435,0.0044447510994053,ENSG00000139675,HNRNPA1L2,protein_coding,13,1,52642425,52643796,q14.3,heterogeneous nuclear ribonucleoprotein A1-like 2 [Source:HGNC Symbol;Acc:HGNC:27067],NA,HNRNPA1L2,144983,NM_001011724;NM_001011725
IMMP1L_SIG,IMMP1L,IMMP1L_SIG,IMMP1L,SIG,38,3.92711174109898,0.0848602241183605,0.0766434367518117,0.111858239751306,0.0352148029994947,0.000279983647278536,2.19006073498249,1.85987992331811,1.82989130077958,1.95841396880185,0.128522668022272,0.0676964361507447,ENSG00000148950,IMMP1L,protein_coding,11,-1,31432401,31509645,p13,inner mitochondrial membrane peptidase subunit 1 [Source:HGNC Symbol;Acc:HGNC:26317],NA,IMMP1L,196294,NM_001304274;NM_144981
MBD5_SIG,MBD5,MBD5_SIG,MBD5,SIG,48,3.92490475526865,0.182448623321986,0.174504590043804,0.2085504469503,0.0340458569064957,0.000282441529574076,2.42026673168065,4.31348508824656,4.27984515364027,4.42401630195296,0.144171148312686,0.0419547402245931,ENSG00000204406,MBD5,protein_coding,2,1,148021011,148516971,q23.1,methyl-CpG binding domain protein 5 [Source:HGNC Symbol;Acc:HGNC:20444],2q23.1 microdeletion syndrome;Autosomal dominant non-syndromic intellectual disability;EHMT1-LIKE INTELLECTUAL DISABILITY;Mental retardation autosomal dominant 1,MBD5,55777,NM_018328
SOD2_SIG,SOD2,SOD2_SIG,SOD2,SIG,33,-3.92481907390669,0.189417144343117,0.202926586598251,0.145028976933392,-0.0578976096648588,0.000282441529574076,-4.18514048841535,7.87318242895726,7.99269017755687,7.48051411212995,-0.512176065426921,0.000304023078214459,ENSG00000112096,SOD2,protein_coding,6,-1,159669069,159745186,q25.3,superoxide dismutase 2 [Source:HGNC Symbol;Acc:HGNC:11180],MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 6,SOD2,6648,NM_000636;NM_001024465;NM_001024466;NM_001322814;NM_001322815;NM_001322816
CTLA4_SIG,CTLA4,CTLA4_SIG,CTLA4,SIG,17,-3.92315775656467,-0.086558609787913,-0.0656716372719171,-0.155187233769043,-0.0895155964971253,0.000284285391745245,-3.66225391730924,1.16520783052068,1.26044043238227,0.852300710118333,-0.408139722263936,0.00165011100060415,ENSG00000163599,CTLA4,protein_coding,2,1,203867771,203873965,q33.2,cytotoxic T-lymphocyte associated protein 4 [Source:HGNC Symbol;Acc:HGNC:2505],Adult-onset myasthenia gravis;Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE V;CELIAC DISEASE SUSCEPTIBILITY TO 3;Classic mycosis fungoides;DIABETES MELLITUS INSULIN-DEPENDENT 12;Granulomatosis with polyangiitis;HASHIMOTO THYROIDITIS;Sezary syndrome;Systemic lupus erythematosus,CTLA4,1493,NM_001037631;NM_005214
TBX21_SIG,TBX21,TBX21_SIG,TBX21,SIG,35,-3.92289968435504,-0.145857912126939,-0.119792092866492,-0.231502746839835,-0.111710653973343,0.000284478500407615,-3.3035051675923,2.34826525511437,2.45911430433738,1.98404695052449,-0.475067353812888,0.00476315616882443,ENSG00000073861,TBX21,protein_coding,17,1,47733236,47746122,q21.32,T-box 21 [Source:HGNC Symbol;Acc:HGNC:11599],ASTHMA NASAL POLYPS AND ASPIRIN INTOLERANCE,TBX21,30009,NM_013351
HUWE1_SIG,HUWE1,HUWE1_SIG,HUWE1,SIG,21,3.92066177236771,0.810602131821243,0.803367389331729,0.834373428572504,0.0310060392407746,0.000286917010404395,3.88401075139395,8.56030056908306,8.50503781113217,8.74187820235029,0.236840391218122,0.000824180360060442,ENSG00000086758,HUWE1,protein_coding,X,-1,53532096,53686728,p11.22,HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:30892],MENTAL RETARDATION SYNDROMIC X-LINKED TURNER TYPE;MENTAL RETARDATION X-LINKED SYNDROMIC TURNER TYPE;X-linked intellectual disability Turner type,HUWE1,10075,NM_031407
NRL_TF,NRL,NRL_TF,NRL,TF,31,3.92065450275084,0.155465550378853,0.148615500130883,0.177972858336469,0.0293573582055856,0.000286917010404395,0.320978382300037,1.34388875755105,1.34089509074571,1.35372509134002,0.0128300005943114,0.815387231371456,ENSG00000129535,NRL,protein_coding,14,-1,24080107,24115014,q12,neural retina leucine zipper [Source:HGNC Symbol;Acc:HGNC:8002],Retinitis pigmentosa;RETINITIS PIGMENTOSA 27,NRL,4901,NM_001354768;NM_001354769;NM_001354770;NM_006177
UGGT2_SIG,UGGT2,UGGT2_SIG,UGGT2,SIG,104,3.92039953753774,-0.0648936223698118,-0.0726127631993376,-0.0395307310727985,0.0330820321265392,0.000287108160865155,0.723312191674526,2.04192839783061,2.01035448870578,2.14567124209791,0.135316753392136,0.578238584663661,ENSG00000102595,UGGT2,protein_coding,13,-1,95801580,96053482,q32.1,UDP-glucose glycoprotein glucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:15664],NA,UGGT2,55757,NM_020121
HARS2_SIG,HARS2,HARS2_SIG,HARS2,SIG,31,3.92004347480774,0.273120969672305,0.268909325840156,0.286959227977935,0.0180499021377782,0.000287420013309383,4.74845977815651,4.72109913995907,4.65926128722723,4.92428065607798,0.265019368850754,3.88782172389622e-05,ENSG00000112855,HARS2,protein_coding,5,1,140691430,140699305,q31.3,histidyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:4817],Perrault syndrome;PERRAULT SYNDROME 2,HARS2,23438,NM_001278731;NM_001278732;NM_001363535;NM_001363536;NM_012208
GRB2_SIG,GRB2,GRB2_SIG,GRB2,SIG,26,-3.91968834726844,0.593220610523296,0.611419106760609,0.53342555145784,-0.0779935553027681,0.000287731097483174,-2.68569396160476,7.46455947052475,7.50174746537106,7.34237034460117,-0.159377120769887,0.023188507926583,ENSG00000177885,GRB2,protein_coding,17,-1,75318076,75405709,q25.1,growth factor receptor bound protein 2 [Source:HGNC Symbol;Acc:HGNC:4566],NA,GRB2,2885,NM_002086;NM_203506
GNGT2_SIG,GNGT2,GNGT2_SIG,GNGT2,SIG,28,-3.91941585721175,0.00873990396497421,0.0287879866453861,-0.0571323676992362,-0.0859203543446222,0.00028779761945886,-3.08990545474422,1.30725810027277,1.37888504304193,1.07191243117411,-0.306972611867812,0.00850842787015551,ENSG00000167083,GNGT2,protein_coding,17,-1,49202791,49210574,q21.32,G protein subunit gamma transducin 2 [Source:HGNC Symbol;Acc:HGNC:4412],NA,GNGT2,2793,NM_001198754;NM_001198755;NM_001198756;NM_031498
DEK_SIG,DEK,DEK_SIG,DEK,SIG,11,-3.91939419559523,0.230999722928193,0.237479603892829,0.209708685472962,-0.0277709184198671,0.00028779761945886,-1.84961726725567,7.57647491348163,7.59776307331095,7.50652810261388,-0.0912349706970623,0.126938791734314,ENSG00000124795,DEK,protein_coding,6,-1,18223860,18264548,p22.3,DEK proto-oncogene [Source:HGNC Symbol;Acc:HGNC:2768],Acute myeloid leukemia with t(6;9)(p23;q34),DEK,7913,NM_001134709;NM_003472
CDKL5_SIG,CDKL5,CDKL5_SIG,CDKL5,SIG,58,-3.91934957010468,-0.0881001400374406,-0.08133620556944,-0.110324496146585,-0.0289882905771453,0.00028779761945886,-3.25240923995024,1.56728756540647,1.64333159296008,1.31742861773035,-0.325902975229725,0.00549005003428491,ENSG00000008086,CDKL5,protein_coding,X,1,18425583,18653629,p22.13,cyclin dependent kinase like 5 [Source:HGNC Symbol;Acc:HGNC:11411],Atypical Rett syndrome;CDKL5-related epileptic encephalopathy;Early infantile epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 2;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE TYPE 2;West syndrome,CDKL5,6792,NM_001037343;NM_001323289;NM_003159
NPTN_SIG,NPTN,NPTN_SIG,NPTN,SIG,77,-3.91864546539009,0.462328980004667,0.478081925789876,0.410569300996124,-0.0675126247937522,0.000288526605729085,-2.66524092280688,5.82360650135632,5.86948627666273,5.67285866820669,-0.196627608456035,0.0242568430712987,ENSG00000156642,NPTN,protein_coding,15,-1,73560014,73634134,q24.1,neuroplastin [Source:HGNC Symbol;Acc:HGNC:17867],NA,NPTN,27020,NM_001161363;NM_001161364;NM_012428;NM_017455
PAK1_SIG,PAK1,PAK1_SIG,PAK1,SIG,43,-3.91827565980383,0.237365970984019,0.252050362396335,0.189117256343554,-0.0629331060527809,0.000288856557703588,-2.54017467848528,6.40412652546932,6.47687740950226,6.16508790650394,-0.311789502998323,0.0323567612855215,ENSG00000149269,PAK1,protein_coding,11,-1,77321707,77474635,q14.1,p21 (RAC1) activated kinase 1 [Source:HGNC Symbol;Acc:HGNC:8590],INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY SEIZURES ANDSPEECH DELAY,PAK1,5058,NM_001128620;NM_002576
ATP6V0A2_SIG,ATP6V0A2,ATP6V0A2_SIG,ATP6V0A2,SIG,49,3.91794294079872,0.249338921393073,0.240040207280996,0.279891839189895,0.0398516319088988,0.000289142416055483,0.89260881958274,6.10763678756124,6.09017233206858,6.16501999846566,0.0748476663970754,0.485730698047051,ENSG00000185344,ATP6V0A2,protein_coding,12,1,123712353,123761755,q24.31,ATPase H+ transporting V0 subunit a2 [Source:HGNC Symbol;Acc:HGNC:18481],Autosomal recessive cutis laxa type 2 classic type;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIA;WRINKLY SKIN SYNDROME,ATP6V0A2,23545,NM_012463
EXOSC7_SIG,EXOSC7,EXOSC7_SIG,EXOSC7,SIG,23,3.91764229682275,0.460096702807241,0.453642595695158,0.481303054746945,0.027660459051787,0.000289390073881431,2.9714171030283,3.83792052471207,3.80522136241264,3.94536062941022,0.140139266997588,0.0115936744319284,ENSG00000075914,EXOSC7,protein_coding,3,1,44975241,45036066,p21.31,exosome component 7 [Source:HGNC Symbol;Acc:HGNC:28112],NA,EXOSC7,23016,NM_015004
SMARCC1_SIG,SMARCC1,SMARCC1_SIG,SMARCC1,SIG,81,3.91601578363841,0.514152382034066,0.501534413556083,0.555611421318867,0.0540770077627838,0.000291234594422252,2.48761723827277,7.74566488402912,7.70909094574921,7.86583639552027,0.156745449771066,0.0362712759525278,ENSG00000173473,SMARCC1,protein_coding,3,-1,47585269,47782106,p21.31,SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 [Source:HGNC Symbol;Acc:HGNC:11104],NA,SMARCC1,6599,NM_003074
PGLYRP2_SIG,PGLYRP2,PGLYRP2_SIG,PGLYRP2,SIG,65,-3.91470362648208,-0.0105759861074834,-0.00466816157231826,-0.0299874095801691,-0.0253192480078508,0.000292708601666411,-2.36639906703192,0.364142901818015,0.392435939229244,0.271180064609691,-0.121255874619553,0.0470898658611516,ENSG00000161031,PGLYRP2,protein_coding,19,-1,15468645,15498956,p13.12,peptidoglycan recognition protein 2 [Source:HGNC Symbol;Acc:HGNC:30013],NA,PGLYRP2,114770,NM_001363546;NM_052890
CYB5A_SIG,CYB5A,CYB5A_SIG,CYB5A,SIG,5,3.91434704368116,0.206503757375096,0.196365829767205,0.239814090943883,0.0434482611766786,0.000293027096087677,4.78323498119989,3.1986732743909,3.09990531494667,3.52319656970766,0.423291254760995,3.4076967202495e-05,ENSG00000166347,CYB5A,protein_coding,18,-1,74250846,74291973,q22.3,cytochrome b5 type A [Source:HGNC Symbol;Acc:HGNC:2570],46XY disorder of sex development due to isolated 17 20 lyase deficiency;Hereditary methemoglobinemia;METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA,CYB5A,1528,NM_001190807;NM_001914;NM_148923
OGFR_SIG,OGFR,OGFR_SIG,OGFR,SIG,32,-3.91405932706736,0.414952101093555,0.433333541299409,0.354555940417177,-0.0787776008822315,0.000293262248482482,-1.91183807838751,6.25321109234057,6.28304818974216,6.15517491516392,-0.127873274578244,0.113954562822733,ENSG00000060491,OGFR,protein_coding,20,1,62804835,62814000,q13.33,opioid growth factor receptor [Source:HGNC Symbol;Acc:HGNC:15768],NA,OGFR,11054,NM_007346
PMS2P1_SIG,PMS2P1,PMS2P1_SIG,PMS2P1,SIG,33,3.91388230401723,0.379821335021576,0.372056760116291,0.40533350971037,0.0332767495940782,0.000293363025957384,1.8605206300528,3.51940578220069,3.49088094063072,3.61313026164487,0.122249321014148,0.124657635932285,ENSG00000078319,PMS2P1,unprocessed_pseudogene,7,-1,100320992,100341908,q22.1,PMS1 homolog 2, mismatch repair system component pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:9123],NA,PMS2P1,NA,NA
MTA3_SIG,MTA3,MTA3_SIG,MTA3,SIG,58,3.91333168613387,-0.0341460439777106,-0.039536106645673,-0.0164358380686914,0.0231002685769815,0.000293918475233565,4.28986141434448,3.35963283049534,3.24062544986455,3.75065708113936,0.510031631274807,0.000212832177687381,ENSG00000057935,MTA3,protein_coding,2,1,42494569,42756947,p21,metastasis associated 1 family member 3 [Source:HGNC Symbol;Acc:HGNC:23784],NA,MTA3,57504,NM_001282755;NM_001282756;NM_001330442;NM_001330443;NM_001330444;NM_020744
ADAMDEC1_SIG,ADAMDEC1,ADAMDEC1_SIG,ADAMDEC1,SIG,30,3.91307503054515,0.0678130714732973,0.0599684340077758,0.0935883088600108,0.0336198748522349,0.000293945993446776,1.1435240325627,1.07513843921755,1.04304017614949,1.1806041607269,0.13756398457741,0.362144832200973,ENSG00000134028,ADAMDEC1,protein_coding,8,1,24384285,24406013,p21.2,ADAM like decysin 1 [Source:HGNC Symbol;Acc:HGNC:16299],NA,ADAMDEC1,27299,NM_001145271;NM_001145272;NM_014479
PPM1H_SIG,PPM1H,PPM1H_SIG,PPM1H,SIG,57,3.91303898274669,0.00949113907989978,0.000575435717503197,0.0387855929849171,0.038210157267414,0.000293945993446776,1.76244110525789,4.05960968035787,3.9979520992959,4.26219887527578,0.264246775979874,0.147181785875872,ENSG00000111110,PPM1H,protein_coding,12,-1,62643994,62935150,q14.2,protein phosphatase, Mg2+/Mn2+ dependent 1H [Source:HGNC Symbol;Acc:HGNC:18583],NA,PPM1H,57460,NM_020700
KY_SIG,KY,KY_SIG,KY,SIG,38,3.91302705152121,0.0351699423419706,0.028313969409379,0.0576967105490572,0.029382741139678,0.000293945993446776,4.07567041938512,0.499128891312106,0.44135629001674,0.688953152711165,0.247596862694425,0.000440439867033091,ENSG00000174611,KY,protein_coding,3,-1,134599923,134651636,q22.2,kyphoscoliosis peptidase [Source:HGNC Symbol;Acc:HGNC:26576],Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome;Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome;MYOPATHY MYOFIBRILLAR 7,KY,339855,NM_001350859;NM_001350860;NM_001366276;NM_178554
GPX3_SIG,GPX3,GPX3_SIG,GPX3,SIG,30,-3.91262813053979,-0.0235525542927951,-0.0118720962386465,-0.0619312021849977,-0.0500591059463511,0.000294317593092909,-0.998611763465523,1.60452331491905,1.63593886881514,1.50130078068904,-0.134638088126099,0.431196080378056,ENSG00000211445,GPX3,protein_coding,5,1,151020438,151028992,q33.1,glutathione peroxidase 3 [Source:HGNC Symbol;Acc:HGNC:4555],NA,GPX3,2878,NM_001329790;NM_002084
ZNF549_TF,ZNF549,ZNF549_TF,ZNF549,TF,84,3.91209209631344,0.223526438745645,0.21436472001193,0.253629228870709,0.0392645088587795,0.000294748603392769,2.90745708323121,3.49711161519888,3.4443128046622,3.670593421248,0.226280616585802,0.0136036518098595,ENSG00000121406,ZNF549,protein_coding,19,1,57527325,57557542,q13.43,zinc finger protein 549 [Source:HGNC Symbol;Acc:HGNC:26632],NA,ZNF549,256051,NM_001199295;NM_153263
NHLRC1_SIG,NHLRC1,NHLRC1_SIG,NHLRC1,SIG,6,3.91208703732303,-0.0671084299568993,-0.078737703374766,-0.028897960155337,0.0498397432194291,0.000294748603392769,4.11538228128161,1.03602296568503,0.962411779746795,1.27788829091068,0.31547651116388,0.000385474834836918,ENSG00000187566,NHLRC1,protein_coding,6,-1,18120440,18122687,p22.3,NHL repeat containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:21576],Lafora disease;MYOCLONIC EPILEPSY OF LAFORA,NHLRC1,378884,NM_198586
TXNRD3_SIG,TXNRD3,TXNRD3_SIG,TXNRD3,SIG,31,3.91078869587219,0.064211072562518,0.0543787570559232,0.0965172520841866,0.0421384950282633,0.000296222490841943,3.55219083199687,2.11236583918539,2.02418237446126,2.40211150899325,0.377929134531996,0.00231115086425608,ENSG00000197763,TXNRD3,protein_coding,3,-1,126571779,126655124,q21.3,thioredoxin reductase 3 [Source:HGNC Symbol;Acc:HGNC:20667],NA,TXNRD3,114112;645840,NM_001039783;NM_001173513;NM_052883
CGGBP1_TF,CGGBP1,CGGBP1_TF,CGGBP1,TF,61,3.91012815209752,0.351000620583104,0.339827334233395,0.38771284716072,0.0478855129273248,0.000296918329242992,3.40432864614296,7.45577850757589,7.42052399160155,7.57161477434872,0.151090782747167,0.00355815695051206,ENSG00000163320,CGGBP1,protein_coding,3,-1,88051944,88149885,p11.1,CGG triplet repeat binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1888],NA,CGGBP1,8545,NM_001008390;NM_001195308;NM_003663
PPARG_SIG,PPARG,PPARG_SIG,PPARG,SIG,23,-3.90965966131884,-0.0442593615649643,-0.0305427735465438,-0.089328150768346,-0.0587853772218021,0.000297300394474095,-2.11191639207998,1.14697945039275,1.22070927101661,0.904724325485797,-0.315984945530812,0.0785680484720719,ENSG00000132170,PPARG,protein_coding,3,1,12287368,12434356,p25.2,peroxisome proliferator activated receptor gamma [Source:HGNC Symbol;Acc:HGNC:9236],Berardinelli-Seip congenital lipodystrophy;CAROTID INTIMAL MEDIAL THICKNESS 1;DIABETES MELLITUS NONINSULIN-DEPENDENT;Differentiated thyroid carcinoma;Giant cell glioblastoma;Gliosarcoma;LIPODYSTROPHY FAMILIAL PARTIAL TYPE 3;OBESITY LEANNESS INCLUDED;PPARG-related familial partial lipodystrophy,PPARG,5468,NM_001330615;NM_001354666;NM_001354667;NM_001354668;NM_001354669;NM_001354670;NM_005037;NM_015869;NM_138711;NM_138712
TRIM73_SIG,TRIM73,TRIM73_SIG,TRIM73,SIG,62,3.90962990156308,0.0635513772789982,0.0543796068932288,0.093687194260812,0.0393075873675833,0.000297300394474095,0.495620282160293,1.05090045823228,1.04297685860716,1.07693514271482,0.0339582841076572,0.712184519692767,ENSG00000178809,TRIM73,protein_coding,7,1,75395063,75410996,q11.23,tripartite motif containing 73 [Source:HGNC Symbol;Acc:HGNC:18162],NA,TRIM73,375593,NM_198924
MECR_SIG,MECR,MECR_SIG,MECR,SIG,69,3.90762841467825,0.426433164195079,0.411115736030619,0.47676185673545,0.0656461207048311,0.000299656925988666,3.69747881758998,3.30644940512712,3.2406141048741,3.52276539167277,0.282151286798667,0.00148308629169349,ENSG00000116353,MECR,protein_coding,1,-1,29192873,29230942,p35.3,mitochondrial trans-2-enoyl-CoA reductase [Source:HGNC Symbol;Acc:HGNC:19691],Childhood-Onset Dystonia and Optic Atrophy;DYSTONIA CHILDHOOD-ONSET WITH OPTIC ATROPHY AND BASAL GANGLIAABNORMALITIES;MEPAN syndrome,MECR,51102,NM_001024732;NM_001349711;NM_001349712;NM_001349713;NM_001349714;NM_001349715;NM_001349716;NM_001349717;NM_016011
PRKRA_SIG,PRKRA,PRKRA_SIG,PRKRA,SIG,48,3.90697064860987,0.327953056045785,0.31742397127817,0.362548620282235,0.0451246490040647,0.000300356964914951,3.18359951452378,5.3629364617247,5.32283307119373,5.49470474489788,0.171871673704151,0.00664090578078013,ENSG00000180228,PRKRA,protein_coding,2,-1,178431414,178451512,q31.2,protein activator of interferon induced protein kinase EIF2AK2 [Source:HGNC Symbol;Acc:HGNC:9438],DYSTONIA 16,PRKRA,8575,NM_001139517;NM_001139518;NM_001316362;NM_003690
MYO9B_SIG,MYO9B,MYO9B_SIG,MYO9B,SIG,34,-3.90449540461049,0.345571690160184,0.354788757477735,0.315287040402515,-0.0395017170752198,0.000303290920055493,-1.56061682506477,8.52222436548421,8.54040546815262,8.46248645671656,-0.0779190114360571,0.202331734957813,ENSG00000099331,MYO9B,protein_coding,19,1,17075781,17214537,p13.11,myosin IXB [Source:HGNC Symbol;Acc:HGNC:7609],CELIAC DISEASE SUSCEPTIBILITY TO 4,MYO9B,4650,NM_001130065;NM_004145
KDM5B_TF,KDM5B,KDM5B_TF,KDM5B,TF,134,3.90443272496306,0.0477745357488746,0.0356407846803998,0.0876425749738632,0.0520017902934636,0.000303290920055493,1.44350679786864,7.03915627334029,7.00799768320447,7.14153449807229,0.133536814867817,0.240719440717489,ENSG00000117139,KDM5B,protein_coding,1,-1,202724495,202809470,q32.1,lysine demethylase 5B [Source:HGNC Symbol;Acc:HGNC:18039],Autism;Autosomal dominant non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 65,KDM5B,10765,NM_001314042;NM_001347591;NM_006618
GTF2F1_SIG,GTF2F1,GTF2F1_SIG,GTF2F1,SIG,15,3.90370046621702,0.50679660266375,0.500473255834358,0.527573313674611,0.0271000578402525,0.000304092607476036,3.99601567386156,6.77134370985587,6.73637404845497,6.88624402588742,0.149869977432456,0.000575548427593671,ENSG00000125651,GTF2F1,protein_coding,19,-1,6379572,6393981,p13.3,general transcription factor IIF subunit 1 [Source:HGNC Symbol;Acc:HGNC:4652],NA,GTF2F1,2962,NM_002096
ADPRHL1_SIG,ADPRHL1,ADPRHL1_SIG,ADPRHL1,SIG,5,3.90328998580015,0.0366001967603229,0.0323549872646996,0.0505487422459422,0.0181937549812425,0.000304491055531306,1.63198583921601,0.843324238929774,0.819910718878816,0.920254376240067,0.100343657361251,0.181568683905694,ENSG00000153531,ADPRHL1,protein_coding,13,-1,113399610,113453524,q34,ADP-ribosylhydrolase like 1 [Source:HGNC Symbol;Acc:HGNC:21303],NA,ADPRHL1,113622,NM_138430;NM_199162
BMS1_SIG,BMS1,BMS1_SIG,BMS1,SIG,33,3.90282188592427,0.691253985267653,0.681558571914144,0.723110343429184,0.0415517715150401,0.000304962639413361,3.96370766369924,5.86496599113905,5.80883346182585,6.04940144459672,0.240567982770871,0.000636663224148998,ENSG00000165733,BMS1,protein_coding,10,1,42782795,42834937,q11.21,BMS1, ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:23505],Aplasia cutis congenita;APLASIA CUTIS CONGENITA NONSYNDROMIC,BMS1,9790,NM_014753
SLC5A2_SIG,SLC5A2,SLC5A2_SIG,SLC5A2,SIG,8,-3.90176921277711,-0.0381532045875269,-0.0341319643400022,-0.051365851115108,-0.017233886775106,0.000306173650881353,-2.361408530962,0.344532173582976,0.359966583860631,0.293819111242108,-0.0661474726185236,0.0475483433082009,ENSG00000140675,SLC5A2,protein_coding,16,1,31483002,31490860,p11.2,solute carrier family 5 member 2 [Source:HGNC Symbol;Acc:HGNC:11037],Familial renal glucosuria;RENAL GLUCOSURIA,SLC5A2,6524,NM_003041
GSTZ1_SIG,GSTZ1,GSTZ1_SIG,GSTZ1,SIG,13,3.90083696009934,0.365449056939061,0.3579308763431,0.390151650325792,0.032220773982692,0.000307211653135675,4.31793482635716,3.25221906013955,3.18428463463489,3.47543217251197,0.291147537877078,0.000191825828193067,ENSG00000100577,GSTZ1,protein_coding,14,1,77320996,77331597,q24.3,glutathione S-transferase zeta 1 [Source:HGNC Symbol;Acc:HGNC:4643],MALEYLACETOACETATE ISOMERASE DEFICIENCY,GSTZ1,2954,NM_001312660;NM_145870;NM_145871
CERS6_SIG,CERS6,CERS6_SIG,CERS6,SIG,33,3.90076276706329,0.40788086429952,0.398821820978149,0.437646292355453,0.0388244713773045,0.000307211653135675,2.09899510531376,7.23912924862924,7.20015917762184,7.36717376765355,0.167014590031709,0.0805079149338461,ENSG00000172292,CERS6,protein_coding,2,1,168455862,168775137,q24.3,ceramide synthase 6 [Source:HGNC Symbol;Acc:HGNC:23826],NA,CERS6,253782,NM_001256126;NM_203463
NSMCE2_SIG,NSMCE2,NSMCE2_SIG,NSMCE2,SIG,18,-3.90031022745607,-0.0156174693101774,-0.0108305656750011,-0.031345866968614,-0.020515301293613,0.000307667512800435,-2.32798645731458,3.73775847484356,3.76345859110794,3.65331523568916,-0.110143355418783,0.0510037162512821,ENSG00000156831,NSMCE2,protein_coding,8,1,125091679,125367120,q24.13,NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase [Source:HGNC Symbol;Acc:HGNC:26513],Microcephalic primordial dwarfism-insulin resistance syndrome;SECKEL SYNDROME 10,NSMCE2,286053,NM_001349485;NM_001349486;NM_001349487;NM_173685
UPF3B_SIG,UPF3B,UPF3B_SIG,UPF3B,SIG,27,3.90010250677891,0.450288916326621,0.441623398834954,0.478761330942099,0.0371379321071459,0.000307812621358973,3.36016580818316,4.55793720998361,4.51023130673023,4.71468517781613,0.204453871085899,0.00405864539344529,ENSG00000125351,UPF3B,protein_coding,X,-1,119805311,119852998,q24,UPF3B, regulator of nonsense mediated mRNA decay [Source:HGNC Symbol;Acc:HGNC:20439],MENTAL RETARDATION SYNDROMIC X-LINKED TYPE 14;MENTAL RETARDATION X-LINKED SYNDROMIC 14;X-linked intellectual disability with marfanoid habitus;X-linked non-syndromic intellectual disability,UPF3B,65109,NM_023010;NM_080632
RND2_SIG,RND2,RND2_SIG,RND2,SIG,9,3.89919161588988,-0.111484488638952,-0.116133702222111,-0.0962085011514304,0.0199252010706804,0.00030885345469282,3.14642733566561,0.249569019451494,0.229753089809388,0.314678502561268,0.0849254127518797,0.00733902605816532,ENSG00000108830,RND2,protein_coding,17,1,43025231,43032041,q21.31,Rho family GTPase 2 [Source:HGNC Symbol;Acc:HGNC:18315],NA,RND2,8153,NM_005440
ALDH18A1_SIG,ALDH18A1,ALDH18A1_SIG,ALDH18A1,SIG,59,3.89878317547493,0.442961089220055,0.427661664581955,0.493230627316669,0.0655689627347142,0.000309255361245692,2.99549857446588,5.94324767725271,5.86342287336906,6.20552917572755,0.342106302358497,0.0108931092668853,ENSG00000059573,ALDH18A1,protein_coding,10,-1,95605941,95656711,q24.1,aldehyde dehydrogenase 18 family member A1 [Source:HGNC Symbol;Acc:HGNC:9722],ALDH18A1-related DeBarsy syndrome;Autosomal dominant cutis laxa;Autosomal dominant spastic paraplegia type 9A;Autosomal dominant spastic paraplegia type 9B;Autosomal recessive spastic paraplegia type 9B;Cutis laxa autosomal dominant 3;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIIA;MENTAL RETARDATION-JOINT HYPERMOBILITY-SKIN LAXITY WITH OR WITHOUT METABOLIC ABNORMALITIES;Spastic paraplegia 9 autosomal dominant;SPASTIC PARAPLEGIA 9A AUTOSOMAL DOMINANT;SPASTIC PARAPLEGIA 9B AUTOSOMAL RECESSIVE,ALDH18A1,5832,NM_001017423;NM_001323412;NM_001323413;NM_001323414;NM_001323415;NM_001323416;NM_001323417;NM_001323418;NM_001323419;NM_002860
CYP27A1_SIG,CYP27A1,CYP27A1_SIG,CYP27A1,SIG,11,-3.89696894897561,-0.060218404515333,-0.0439980220448929,-0.113513946918208,-0.0695159248733148,0.000311460048082367,-2.55525510372739,2.51250788997959,2.64859075816919,2.06537846592804,-0.583212292241146,0.0312071352474339,ENSG00000135929,CYP27A1,protein_coding,2,1,218781749,218815293,q35,cytochrome P450 family 27 subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:2605],CEREBROTENDINOUS XANTHOMATOSIS,CYP27A1,1593,NM_000784
RBMX_SIG,RBMX,RBMX_SIG,RBMX,SIG,62,3.89538203755382,0.305429528246086,0.295721366122955,0.337327775222088,0.0416064090991333,0.000313385463585833,2.75032481655084,7.93210393155825,7.89740310507963,8.04612093284514,0.148717827765516,0.0199154617156876,ENSG00000147274,RBMX,protein_coding,X,-1,136848004,136880764,q26.3,RNA binding motif protein X-linked [Source:HGNC Symbol;Acc:HGNC:9910],MENTAL RETARDATION X-LINKED SYNDROMIC 11,RBMX,27316,NM_001164803;NM_002139
RBM14_SIG,RBM14,RBM14_SIG,RBM14,SIG,17,3.89200691377271,0.277605947093102,0.265156600707876,0.318510942358845,0.053354341650969,0.00031765581814287,3.14297138698753,6.13215089234548,6.07651795713637,6.31494482231828,0.23842686518191,0.00739771432135858,ENSG00000239306,RBM14,protein_coding,11,1,66616582,66627347,q13.2,RNA binding motif protein 14 [Source:HGNC Symbol;Acc:HGNC:14219],NA,RBM14,10432,NM_001198836;NM_001198837;NM_006328
PARP3_SIG,PARP3,PARP3_SIG,PARP3,SIG,95,3.89047412258038,0.0368511879747384,0.0315167799663875,0.0543785285736057,0.0228617486072184,0.000319545955109215,2.42514816763324,3.77336105683874,3.71916225447531,3.95144283603287,0.232280581557555,0.0414931098748324,ENSG00000041880,PARP3,protein_coding,3,1,51942345,51948867,p21.2,poly(ADP-ribose) polymerase family member 3 [Source:HGNC Symbol;Acc:HGNC:273],NA,PARP3,10039,NM_001003931;NM_005485
GPRC5A_SIG,GPRC5A,GPRC5A_SIG,GPRC5A,SIG,17,-3.89004239783258,-0.194110175539885,-0.185869957682047,-0.221185177072781,-0.0353152193907335,0.000319991632425009,-1.24393007809301,0.551324909768714,0.580933961116062,0.454038026770285,-0.126895934345777,0.31799699683164,ENSG00000013588,GPRC5A,protein_coding,12,1,12890782,12917937,p13.1,G protein-coupled receptor class C group 5 member A [Source:HGNC Symbol;Acc:HGNC:9836],NA,GPRC5A,9052,NM_003979
MRPL21_SIG,MRPL21,MRPL21_SIG,MRPL21,SIG,6,3.88929444189226,0.324247705715745,0.317087621027313,0.34777369826345,0.0306860772361376,0.000320855717490654,5.2557487898951,4.19085846046393,4.13437585617748,4.37644416026226,0.242068304084776,4.82336446616064e-06,ENSG00000197345,MRPL21,protein_coding,11,-1,68891276,68903835,q13.3,mitochondrial ribosomal protein L21 [Source:HGNC Symbol;Acc:HGNC:14479],NA,MRPL21,219927,NM_181514;NM_181515
MUC1_SIG,MUC1,MUC1_SIG,MUC1,SIG,18,3.88817582671063,-0.0787215805533884,-0.083629264824591,-0.0625963322337227,0.0210329325908683,0.000322139083332889,0.177960365622851,3.24978512892336,3.24527320659103,3.26461001658673,0.0193368099957068,0.900099478528412,ENSG00000185499,MUC1,protein_coding,1,-1,155185824,155192916,q22,mucin 1, cell surface associated [Source:HGNC Symbol;Acc:HGNC:7508],MEDULLARY CYSTIC KIDNEY DISEASE 1;MUC1-related autosomal dominant tubulointerstitial kidney disease,MUC1,4582,NM_001018016;NM_001018017;NM_001044390;NM_001044391;NM_001044392;NM_001044393;NM_001204285;NM_001204286;NM_001204287;NM_001204288;NM_001204289;NM_001204290;NM_001204291;NM_001204292;NM_001204293;NM_001204294;NM_001204295;NM_001204296;NM_001204297;NM_002456
ZNF658_TF,ZNF658,ZNF658_TF,ZNF658,TF,20,3.88813852175876,0.0334708109504245,0.0244801039124746,0.0630117055036884,0.0385316015912137,0.000322139083332889,2.9697823481665,1.58919204727568,1.53691580105129,1.76095685629869,0.2240410552474,0.0116415889096092,ENSG00000274349,ZNF658,protein_coding,9,1,66856426,66932141,q21.11,zinc finger protein 658 [Source:HGNC Symbol;Acc:HGNC:25226],NA,ZNF658,26149,NM_001317916;NM_033160
KCNG2_SIG,KCNG2,KCNG2_SIG,KCNG2,SIG,17,-3.88779781545843,0.05842089155053,0.0639380152228633,0.0402931994842918,-0.0236448157385716,0.000322402093373597,-3.16368724895556,0.859214995455876,0.922699933358803,0.650621628060545,-0.272078305298258,0.00699222004492937,ENSG00000178342,KCNG2,protein_coding,18,1,79863668,79900184,q23,potassium voltage-gated channel modifier subfamily G member 2 [Source:HGNC Symbol;Acc:HGNC:6249],NA,KCNG2,26251,NM_012283
SMAD9_TF,SMAD9,SMAD9_TF,SMAD9,TF,83,3.88765672316243,-0.0847768201639668,-0.0887814636681968,-0.0716187057929252,0.0171627578752715,0.000322402093373597,2.92523905470438,0.314632736807122,0.27269437029131,0.452430226787646,0.179735856496336,0.013029184370638,ENSG00000120693,SMAD9,protein_coding,13,-1,36844831,36920765,q13.3,SMAD family member 9 [Source:HGNC Symbol;Acc:HGNC:6774],Heritable pulmonary arterial hypertension;PULMONARY HYPERTENSION PRIMARY 2,SMAD9,4093,NM_001127217;NM_005905
AOAH_SIG,AOAH,AOAH_SIG,AOAH,SIG,40,-3.8875023278394,0.218612606850086,0.249122160292569,0.118366931253357,-0.130755229039211,0.000322402093373597,-3.74520880660889,6.11726863931118,6.26343884066272,5.63699512058471,-0.626443720078002,0.00127516346851114,ENSG00000136250,AOAH,protein_coding,7,-1,36512949,36724549,p14.2,acyloxyacyl hydrolase [Source:HGNC Symbol;Acc:HGNC:548],NA,AOAH,313,NM_001177506;NM_001177507;NM_001637
LY6G5C_SIG,LY6G5C,LY6G5C_SIG,LY6G5C,SIG,8,3.88748991851637,0.0670500405954052,0.0602472273267153,0.0894021413353863,0.0291549140086711,0.000322402093373597,1.93127363876132,1.99137666110974,1.96448046562231,2.07974987485414,0.115269409231825,0.10999548284778,ENSG00000204428,LY6G5C,protein_coding,6,-1,31676684,31684040,p21.33,lymphocyte antigen 6 family member G5C [Source:HGNC Symbol;Acc:HGNC:13932],NA,LY6G5C,80741,NM_025262
TRPV1_SIG,TRPV1,TRPV1_SIG,TRPV1,SIG,43,3.88747355935881,-0.0689018855278446,-0.0753464649122329,-0.0477268389791402,0.0276196259330926,0.000322402093373597,4.32629300732351,0.33203025679597,0.307731267259032,0.411869793845909,0.104138526586878,0.000185800362467819,ENSG00000196689,TRPV1,protein_coding,17,-1,3565444,3609411,p13.2,transient receptor potential cation channel subfamily V member 1 [Source:HGNC Symbol;Acc:HGNC:12716],NA,TRPV1,7442,NM_018727;NM_080704;NM_080705;NM_080706
POLR1B_SIG,POLR1B,POLR1B_SIG,POLR1B,SIG,22,3.8863669389449,0.450101068853516,0.437149908750922,0.492654880619181,0.0555049718682586,0.000323750248806875,3.70929556266012,4.44357609233362,4.37345512549155,4.67397355481469,0.300518429323139,0.00143135302655244,ENSG00000125630,POLR1B,protein_coding,2,1,112541915,112577150,q14.1,RNA polymerase I subunit B [Source:HGNC Symbol;Acc:HGNC:20454],NA,POLR1B,84172,NM_001137604;NM_001282772;NM_001282774;NM_001282776;NM_001282777;NM_001282779;NM_019014
CCT4_SIG,CCT4,CCT4_SIG,CCT4,SIG,46,3.88462416818332,0.663969531411534,0.652366136904346,0.70209497050658,0.0497288336022342,0.000325956084537706,3.70543795228323,6.95289800275572,6.90142070662146,7.12203769005401,0.220616983432549,0.00144662698065582,ENSG00000115484,CCT4,protein_coding,2,-1,61868085,61888671,p15,chaperonin containing TCP1 subunit 4 [Source:HGNC Symbol;Acc:HGNC:1617],NA,CCT4,10575,NM_001256721;NM_006430
SC5D_SIG,SC5D,SC5D_SIG,SC5D,SIG,34,3.88282035107043,0.286711692061126,0.281014815897163,0.305429999457002,0.0244151835598383,0.000328258480768212,2.18668904767686,4.39946876655459,4.36139702651314,4.5245616266908,0.163164600177665,0.0681514260906591,ENSG00000109929,SC5D,protein_coding,11,1,121292681,121313410,q23.3,sterol-C5-desaturase [Source:HGNC Symbol;Acc:HGNC:10547],LATHOSTEROLOSIS,SC5D,6309,NM_001024956;NM_006918
KLF7_TF,KLF7,KLF7_TF,KLF7,TF,215,-3.88254548735795,-0.120223880833821,-0.113078949234949,-0.143700084658686,-0.0306211354237371,0.000328503815338625,-6.2837817461162,6.57226046152612,6.69689711032229,6.16274004405299,-0.534157066269299,3.44975484157585e-08,ENSG00000118263,KLF7,protein_coding,2,-1,207074137,207167267,q33.3,Kruppel like factor 7 [Source:HGNC Symbol;Acc:HGNC:6350],NA,KLF7,8609,NM_001270942;NM_001270943;NM_001270944;NM_003709
LPCAT1_SIG,LPCAT1,LPCAT1_SIG,LPCAT1,SIG,20,-3.88098516589526,0.239349037462333,0.253361285077541,0.193308795298075,-0.060052489779466,0.000330492039874802,-2.87464471511765,6.08849470479645,6.16027746007993,5.85263708029361,-0.307640379786317,0.0147770975616155,ENSG00000153395,LPCAT1,protein_coding,5,-1,1456480,1523962,p15.33,lysophosphatidylcholine acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:25718],NA,LPCAT1,79888,NM_024830
UBE2E1_SIG,UBE2E1,UBE2E1_SIG,UBE2E1,SIG,43,3.88022658363669,0.344991964370058,0.336517455667607,0.37283677867811,0.0363193230105036,0.000331397459155973,1.49136054641769,6.47568435628196,6.45588448219002,6.54074108544122,0.0848566032511995,0.224833111223792,ENSG00000170142,UBE2E1,protein_coding,3,1,23805903,23891316,p24.2,ubiquitin conjugating enzyme E2 E1 [Source:HGNC Symbol;Acc:HGNC:12477],NA,UBE2E1,7324,NM_001202476;NM_003341;NM_182666
SORD_SIG,SORD,SORD_SIG,SORD,SIG,16,3.87939826983313,0.0219180477323027,0.00857130090564775,0.0657716444484546,0.0572003435428068,0.000332400495633465,2.87749508175223,4.3653813178311,4.29701939224472,4.58999907332922,0.292979681084497,0.0146724214250166,ENSG00000140263,SORD,protein_coding,15,1,45023181,45077185,q21.1,sorbitol dehydrogenase [Source:HGNC Symbol;Acc:HGNC:11184],NA,SORD,6652,NM_003104
IGF2_SIG,IGF2,IGF2_SIG,IGF2,SIG,14,-3.87718880399298,-0.257422367915516,-0.249983687067096,-0.28186374784604,-0.0318800607789445,0.000335304060451621,-3.17846949283545,0.683008398517212,0.777924368245673,0.371141640837985,-0.406782727407688,0.00673934106813518,ENSG00000167244,IGF2,protein_coding,11,-1,2129112,2149603,p15.5,insulin like growth factor 2 [Source:HGNC Symbol;Acc:HGNC:5466],BECKWITH-WIEDEMANN SYNDROME;Beckwith-Wiedemann syndrome due to imprinting defect of 11p15;Chromosome 11p15.5-Related Russell-Silver Syndrome;Growth restriction severe with distinctive facies;Isolated hemihyperplasia;SILVER-RUSSELL SYNDROME;Silver-Russell syndrome due to 11p15 microduplication;Silver-Russell syndrome due to a point mutation;Silver-Russell syndrome due to an imprinting defect of 11p15;WILMS TUMOR 1,IGF2,3481,NM_000612;NM_001127598;NM_001291861;NM_001291862
ZCCHC24_TF,ZCCHC24,ZCCHC24_TF,ZCCHC24,TF,164,-3.87570111916962,0.0730371582507794,0.0845184390614629,0.0353129498728196,-0.0492054891886432,0.000337230336695436,-3.40727511639475,2.9192227521215,3.0128174995926,2.61169715328789,-0.401120346304718,0.00352742159500602,ENSG00000165424,ZCCHC24,protein_coding,10,-1,79382325,79445627,q22.3,zinc finger CCHC-type containing 24 [Source:HGNC Symbol;Acc:HGNC:26911],NA,ZCCHC24,219654,NM_153367
USP46_SIG,USP46,USP46_SIG,USP46,SIG,45,3.87545839615482,0.379025178418831,0.372114424057194,0.401731942749924,0.0296175186927294,0.000337437500576852,2.13536316996497,3.98653164952231,3.94464041834549,4.12417426624614,0.179533847900648,0.0752300716257888,ENSG00000109189,USP46,protein_coding,4,-1,52590960,52659301,q12,ubiquitin specific peptidase 46 [Source:HGNC Symbol;Acc:HGNC:20075],NA,USP46,64854,NM_001134223;NM_001286767;NM_001286768;NM_022832
OSR2_TF,OSR2,OSR2_TF,OSR2,TF,19,-3.8740042946921,-0.00551145174279002,0.000192833203423047,-0.0242541022803472,-0.0244469354837703,0.000339328511692497,-1.73296287174838,0.350895500721953,0.374089360957909,0.274687102803811,-0.0994022581540975,0.154469029633991,ENSG00000164920,OSR2,protein_coding,8,1,98944403,98952104,q22.2,odd-skipped related transciption factor 2 [Source:HGNC Symbol;Acc:HGNC:15830],NA,OSR2,116039,NM_001142462;NM_001286841;NM_053001
NOP14_SIG,NOP14,NOP14_SIG,NOP14,SIG,20,3.87265525007164,0.929476389190351,0.917113074402761,0.970098709206719,0.0529856348039588,0.000341082382493222,3.66899822856164,6.01202750423519,5.95840095846054,6.18822901178045,0.229828053319912,0.00161794375150122,ENSG00000087269,NOP14,protein_coding,4,-1,2937933,2963406,p16.3,NOP14 nucleolar protein [Source:HGNC Symbol;Acc:HGNC:16821],NA,NOP14,8602,NM_001291978;NM_001291979;NM_003703
IL31RA_SIG,IL31RA,IL31RA_SIG,IL31RA,SIG,21,-3.8725036406276,0.118727508226595,0.135623827859234,0.0632110294336391,-0.0724127984255951,0.000341164222008623,-2.63052721216978,0.886711684567961,0.968497417938334,0.617987132065305,-0.350510285873029,0.0262102788752698,ENSG00000164509,IL31RA,protein_coding,5,1,55851357,55922854,q11.2,interleukin 31 receptor A [Source:HGNC Symbol;Acc:HGNC:18969],AMYLOIDOSIS PRIMARY LOCALIZED CUTANEOUS 2;Familial primary localized cutaneous amyloidosis,IL31RA,133396,NM_001242636;NM_001242637;NM_001242638;NM_001242639;NM_001297570;NM_001297572;NM_139017
ACBD6_SIG,ACBD6,ACBD6_SIG,ACBD6,SIG,39,3.87237072769032,0.488194456561518,0.477372604452943,0.523751970632549,0.0463793661796053,0.000341219940121415,2.57573154716293,4.96649991660083,4.93532766497444,5.06892302908755,0.133595364113117,0.0297720256714342,ENSG00000230124,ACBD6,protein_coding,1,-1,180269653,180502954,q25.3,acyl-CoA binding domain containing 6 [Source:HGNC Symbol;Acc:HGNC:23339],Autosomal Recessive Mental Retardation,ACBD6,84320,NM_032360
PPM1F_SIG,PPM1F,PPM1F_SIG,PPM1F,SIG,64,3.86932116414838,0.176961609751978,0.170527326716096,0.198102825441304,0.0275754987252084,0.000345383865692497,1.14824135718623,7.4231595155403,7.40031539620994,7.49821876476862,0.0979033685586836,0.359845109919031,ENSG00000100034,PPM1F,protein_coding,22,-1,21919425,21952848,q11.22,protein phosphatase, Mg2+/Mn2+ dependent 1F [Source:HGNC Symbol;Acc:HGNC:19388],NA,PPM1F,9647,NM_014634
SMAD1_SIG,SMAD1,SMAD1_SIG,SMAD1,SIG,111,3.86836192315862,0.162119326423785,0.150769327834166,0.199412178932534,0.0486428510983688,0.00034661274236852,3.49954898845469,3.6479496532406,3.51949108776899,4.07002779693305,0.550536709164054,0.00271161568907796,ENSG00000170365,SMAD1,protein_coding,4,1,145481194,145559176,q31.21,SMAD family member 1 [Source:HGNC Symbol;Acc:HGNC:6767],NA,SMAD1,4086,NM_001003688;NM_001354811;NM_001354812;NM_001354813;NM_001354814;NM_001354816;NM_001354817;NM_005900
ZFP3_TF,ZFP3,ZFP3_TF,ZFP3,TF,25,3.86808936911486,0.0123982473238639,0.00504157638036489,0.0365701661382176,0.0315285897578528,0.000346867859301567,3.88130730139422,3.18019930797626,3.06251365950129,3.566880724394,0.504367064892703,0.000830190137363103,ENSG00000180787,ZFP3,protein_coding,17,1,5078467,5096374,p13.2,ZFP3 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:12861],NA,ZFP3,124961,NM_153018
RASAL1_SIG,RASAL1,RASAL1_SIG,RASAL1,SIG,1,-3.86741278177551,-0.226268079180026,-0.21441772006574,-0.265204973412679,-0.0507872533469394,0.000347698627154934,-1.5057628041107,0.454885831761534,0.488124433794381,0.345673282225038,-0.142451151569343,0.220023979110507,ENSG00000111344,RASAL1,protein_coding,12,-1,113098819,113136239,q24.13,RAS protein activator like 1 [Source:HGNC Symbol;Acc:HGNC:9873],NA,RASAL1,8437,NM_001193520;NM_001193521;NM_001301202;NM_004658
ABCD2_SIG,ABCD2,ABCD2_SIG,ABCD2,SIG,53,-3.862452811982,-0.0927686910683331,-0.0807591861887062,-0.132228492815679,-0.0514693066269722,0.000354701176784379,-2.78420451922186,1.08893186801864,1.1592357147075,0.857933514612389,-0.30130220009511,0.0183643282011307,ENSG00000173208,ABCD2,protein_coding,12,-1,39550033,39619803,q12,ATP binding cassette subfamily D member 2 [Source:HGNC Symbol;Acc:HGNC:66],NA,ABCD2,225,NM_005164
HMBOX1_TF,HMBOX1,HMBOX1_TF,HMBOX1,TF,82,3.86214692205206,0.208082980888438,0.202104931312158,0.227725143781929,0.0256202124697708,0.000355010310423026,2.95557826179062,5.36977959334456,5.32883266005896,5.50431951699727,0.17548685693831,0.0120777005300946,ENSG00000147421,HMBOX1,protein_coding,8,1,28890395,29064764,p21.1,homeobox containing 1 [Source:HGNC Symbol;Acc:HGNC:26137],NA,HMBOX1,79618,NM_001135726;NM_001324382;NM_001324383;NM_001324384;NM_001324385;NM_001324386;NM_001324387;NM_001324388;NM_001324389;NM_001324390;NM_001324391;NM_001324392;NM_001324393;NM_001324394;NM_001324395;NM_001330498;NM_024567
BPTF_SIG,BPTF,BPTF_SIG,BPTF,SIG,72,3.86200921596763,0.413884919506359,0.406307175330957,0.438783221796963,0.0324760464660059,0.000355075155194612,3.1142427253507,7.60357766859746,7.55957893660849,7.74814493084693,0.188565994238431,0.00802357496316675,ENSG00000171634,BPTF,protein_coding,17,1,67825503,67984378,q24.2,bromodomain PHD finger transcription factor [Source:HGNC Symbol;Acc:HGNC:3581],Developmental and Speech Delay Postnatal Microcephaly and Dysmorphic Features;NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES,BPTF,2186,NM_004459;NM_182641
ZFYVE27_TF,ZFYVE27,ZFYVE27_TF,ZFYVE27,TF,112,3.86131257989862,0.34531363755062,0.340447317603682,0.361302974519131,0.020855656915449,0.000355953607090692,2.16946079810138,5.38449424779439,5.36202261225807,5.45832962169941,0.0963070094413397,0.0703866780252769,ENSG00000155256,ZFYVE27,protein_coding,10,1,97737121,97760907,q24.2,zinc finger FYVE-type containing 27 [Source:HGNC Symbol;Acc:HGNC:26559],SPASTIC PARAPLEGIA 33 AUTOSOMAL DOMINANT,ZFYVE27,118813,NM_001002261;NM_001002262;NM_001174119;NM_001174120;NM_001174121;NM_001174122;NM_144588
APEX1_SIG,APEX1,APEX1_SIG,APEX1,SIG,31,3.86022475157208,0.370019311132101,0.356888496230417,0.413163417237636,0.0562749210072192,0.000357405882885617,3.21135500876957,7.74153493069772,7.6829525796564,7.93401979840494,0.251067218748546,0.00615842046693041,ENSG00000100823,APEX1,protein_coding,14,1,20455191,20457772,q11.2,apurinic/apyrimidinic endodeoxyribonuclease 1 [Source:HGNC Symbol;Acc:HGNC:587],NA,APEX1,328,NM_001244249;NM_001641;NM_080648;NM_080649
TRIM32_SIG,TRIM32,TRIM32_SIG,TRIM32,SIG,56,3.859952351079,-0.0822981608208754,-0.0877802587454682,-0.0642855533543565,0.0234947053911118,0.000357668328806625,3.29008050203504,2.10849122979198,2.01554958132105,2.41387093191076,0.398321350589711,0.00494236120790353,ENSG00000119401,TRIM32,protein_coding,9,1,116687302,116701300,q33.1,tripartite motif containing 32 [Source:HGNC Symbol;Acc:HGNC:16380],Autosomal recessive limb-girdle muscular dystrophy type 2H;Bardet-Biedl syndrome;BARDET-BIEDL SYNDROME 11;BARDET-BIEDL SYNDROME TYPE 11;LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2H;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 8,TRIM32,22954,NM_001099679;NM_012210
ATXN3_SIG,ATXN3,ATXN3_SIG,ATXN3,SIG,34,3.85924075582308,0.410810826931966,0.405774521086789,0.427358688994688,0.0215841679078991,0.000358574810363894,2.23392448556924,4.90946434488133,4.88405441353216,4.99295411931435,0.108899705782189,0.0619157981952776,ENSG00000066427,ATXN3,protein_coding,14,-1,92044496,92106625,q32.12,ataxin 3 [Source:HGNC Symbol;Acc:HGNC:7106],MACHADO-JOSEPH DISEASE;Machado-Joseph disease type 1;Machado-Joseph disease type 2;Machado-Joseph disease type 3,ATXN3,4287,NM_001127696;NM_001127697;NM_001164778;NM_001164779;NM_001164780;NM_001164781;NM_004993;NM_030660
P2RY2_SIG,P2RY2,P2RY2_SIG,P2RY2,SIG,73,-3.85881169281899,0.221736508652418,0.23517476566481,0.1775822356117,-0.05759253005311,0.000359068197425786,-2.00572993723821,3.79208936049334,3.87162672763029,3.53075229704337,-0.340874430586912,0.0960315091193143,ENSG00000175591,P2RY2,protein_coding,11,1,73218298,73236352,q13.4,purinergic receptor P2Y2 [Source:HGNC Symbol;Acc:HGNC:8541],NA,P2RY2,5029,NM_002564;NM_176071;NM_176072
GABBR1_SIG,GABBR1,GABBR1_SIG,GABBR1,SIG,40,-3.85866255488847,-0.0916747802461148,-0.0823160204773548,-0.122424990914898,-0.0401089704375432,0.000359150735414444,-3.8667036883009,4.80326123313485,4.99658141373275,4.16806635402746,-0.828515059705285,0.000872633881142707,ENSG00000204681,GABBR1,protein_coding,6,-1,29555629,29633976,p22.1,gamma-aminobutyric acid type B receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:4070],NA,GABBR1,2550,NM_001319053;NM_001470;NM_021903;NM_021904
GRSF1_SIG,GRSF1,GRSF1_SIG,GRSF1,SIG,22,3.85736712211245,0.269282792680749,0.258909493341385,0.30336649051009,0.0444569971687052,0.000360921651125987,2.91469386407028,6.17260654574415,6.13516345162543,6.29563385499139,0.160470403365959,0.0133796786476011,ENSG00000132463,GRSF1,protein_coding,4,-1,70815783,70839897,q13.3,G-rich RNA sequence binding factor 1 [Source:HGNC Symbol;Acc:HGNC:4610],NA,GRSF1,2926,NM_001098477;NM_002092
PRKACA_SIG,PRKACA,PRKACA_SIG,PRKACA,SIG,38,-3.85583103689427,0.633252689582273,0.653984215946669,0.565134817242116,-0.0888493987045532,0.000363057809861183,-2.56710754042407,6.47907117920944,6.5278329724263,6.31885385863976,-0.20897911378654,0.0303519009433529,ENSG00000072062,PRKACA,protein_coding,19,-1,14091688,14118084,p13.12,protein kinase cAMP-activated catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9380],Fibrolamellar hepatocellular carcinoma;PIGMENTED NODULAR ADRENOCORTICAL DISEASE PRIMARY 4;Primary pigmented nodular adrenocortical disease,PRKACA,5566,NM_001304349;NM_002730;NM_207518
KARS_SIG,KARS,KARS_SIG,KARS,SIG,30,3.85473763047709,0.552504211295666,0.544301331578627,0.579456530365939,0.0351551987873123,0.000364545684495805,3.4971829385688,7.22842790648235,7.19105015963525,7.3512405032657,0.16019034363045,0.00272506571618243,ENSG00000065427,KARS,protein_coding,16,-1,75627474,75648643,q23.1,lysyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:6215],Autosomal recessive intermediate Charcot-Marie-Tooth disease type B;Autosomal recessive non-syndromic sensorineural deafness type DFNB;CHARCOT-MARIE-TOOTH DISEASE RECESSIVE INTERMEDIATE B;DEAFNESS AUTOSOMAL RECESSIVE 89,KARS,3735,NM_001130089;NM_005548
ZMIZ2_SIG,ZMIZ2,ZMIZ2_SIG,ZMIZ2,SIG,41,3.85368149656689,0.0907379968982756,0.0861008735003308,0.105974259491523,0.0198733859911922,0.000365983547571704,3.18350346467254,6.63963515100555,6.60279358597685,6.76068600752842,0.157892421551568,0.00664178161675184,ENSG00000122515,ZMIZ2,protein_coding,7,1,44748581,44769881,p13,zinc finger MIZ-type containing 2 [Source:HGNC Symbol;Acc:HGNC:22229],NA,ZMIZ2,83637,NM_001300959;NM_031449;NM_174929
ZCCHC24_SIG,ZCCHC24,ZCCHC24_SIG,ZCCHC24,SIG,20,-3.85075114952771,0.0293167137022746,0.0453703209132823,-0.0234308528481791,-0.0688011737614614,0.000370250216706205,-3.40727511639475,2.9192227521215,3.0128174995926,2.61169715328789,-0.401120346304718,0.00352742159500602,ENSG00000165424,ZCCHC24,protein_coding,10,-1,79382325,79445627,q22.3,zinc finger CCHC-type containing 24 [Source:HGNC Symbol;Acc:HGNC:26911],NA,ZCCHC24,219654,NM_153367
U2AF2_SIG,U2AF2,U2AF2_SIG,U2AF2,SIG,14,3.85042677767602,0.560554579752531,0.5493329088003,0.597425784309863,0.0480928755095637,0.00037060030449264,2.16947951094568,7.80795809118051,7.78839001676412,7.87225319283437,0.083863176070251,0.0703866780252769,ENSG00000063244,U2AF2,protein_coding,19,1,55654146,55674715,q13.42,U2 small nuclear RNA auxiliary factor 2 [Source:HGNC Symbol;Acc:HGNC:23156],NA,U2AF2,11338,NM_001012478;NM_007279
SYK_SIG,SYK,SYK_SIG,SYK,SIG,46,-3.8501546639434,0.363110720529372,0.375074822920416,0.323800098387368,-0.051274724533048,0.00037087159953768,-2.64645333935906,8.14803764850684,8.19567006975829,7.99153112153779,-0.204138948220494,0.0252525579252832,ENSG00000165025,SYK,protein_coding,9,1,90801787,90898549,q22.2,spleen associated tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:11491],NA,SYK,6850,NM_001135052;NM_001174167;NM_001174168;NM_003177
DDB1_SIG,DDB1,DDB1_SIG,DDB1,SIG,28,3.84791965394273,0.789270180206562,0.777171600628169,0.829022655964138,0.0518510553359687,0.000374128697242074,2.59455234201758,7.63516994354372,7.60128302323937,7.74651268168659,0.145229658447215,0.0285505276534607,ENSG00000167986,DDB1,protein_coding,11,-1,61299451,61342596,q12.2,damage specific DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2717],NA,DDB1,1642,NM_001923
SMARCD3_SIG,SMARCD3,SMARCD3_SIG,SMARCD3,SIG,17,-3.84720554132206,0.150367228123814,0.165541915190369,0.100507542047988,-0.0650343731423818,0.00037507829098504,-2.12200043633486,3.8561656452779,3.94304576391923,3.57070239831352,-0.372343365605706,0.0770978336742007,ENSG00000082014,SMARCD3,protein_coding,7,-1,151238764,151277896,q36.1,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 [Source:HGNC Symbol;Acc:HGNC:11108],NA,SMARCD3,6604,NM_001003801;NM_001003802;NM_003078
SPG7_SIG,SPG7,SPG7_SIG,SPG7,SIG,51,3.84526585192301,0.30886175143843,0.301811368932388,0.33202729395828,0.030215925025892,0.000377914648394759,3.67369646038648,6.2530397851466,6.21006683696778,6.39423661487702,0.184169777909241,0.00159263898332043,ENSG00000197912,SPG7,protein_coding,16,1,89490719,89557768,q24.3,SPG7, paraplegin matrix AAA peptidase subunit [Source:HGNC Symbol;Acc:HGNC:11237],Primary lateral sclerosis;SPASTIC PARAPLEGIA 7 AUTOSOMAL RECESSIVE;Spastic paraplegia type 7,SPG7,6687,NM_001363850;NM_003119;NM_199367
DDX51_SIG,DDX51,DDX51_SIG,DDX51,SIG,103,3.84502081050408,0.200189509701923,0.192515956613454,0.225402612706893,0.0328866560934397,0.000378149259297386,3.0441102031768,5.02640886691431,4.98137649552241,5.17437237291627,0.192995877393858,0.00959917574994284,ENSG00000185163,DDX51,protein_coding,12,-1,132136594,132144319,q24.33,DEAD-box helicase 51 [Source:HGNC Symbol;Acc:HGNC:20082],NA,DDX51,317781,NM_175066
APTX_SIG,APTX,APTX_SIG,APTX,SIG,20,3.84491333467463,0.308844892909273,0.300082532280861,0.337635506402625,0.0375529741217644,0.000378171841890582,3.63930237969791,4.24792277201966,4.21098060311874,4.36930418412267,0.15832358100393,0.00176909185959555,ENSG00000137074,APTX,protein_coding,9,-1,32972606,33025168,p21.1,aprataxin [Source:HGNC Symbol;Acc:HGNC:15984],Ataxia-oculomotor apraxia type 1;ATAXIA EARLY-ONSET WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA;Ataxia with Oculomotor Apraxia 1,APTX,54840,NM_001195248;NM_001195249;NM_001195250;NM_001195251;NM_001195252;NM_001195254;NM_175069;NM_175073
KIF13B_SIG,KIF13B,KIF13B_SIG,KIF13B,SIG,21,-3.8445295243212,0.307916472977887,0.314364198582237,0.286731088849306,-0.0276331097329307,0.000378620873925131,-1.64968210070287,5.38356023445832,5.41074102649471,5.29425191776733,-0.116489108727384,0.176520031211641,ENSG00000197892,KIF13B,protein_coding,8,-1,29067278,29263124,p12,kinesin family member 13B [Source:HGNC Symbol;Acc:HGNC:14405],NA,KIF13B,23303,NM_015254
RPP38_SIG,RPP38,RPP38_SIG,RPP38,SIG,55,3.84405897672291,0.109017866425778,0.0966800924528192,0.149556266622641,0.0528761741698219,0.000379204520721156,3.0493670708025,3.34594840577272,3.3007270374245,3.49453290177402,0.19380586434952,0.00946345199174564,ENSG00000152464,RPP38,protein_coding,10,1,15097180,15139818,p13,ribonuclease P/MRP subunit p38 [Source:HGNC Symbol;Acc:HGNC:30329],NA,RPP38,10557,NM_001097590;NM_001265601;NM_006414;NM_183005
PKLR_SIG,PKLR,PKLR_SIG,PKLR,SIG,44,-3.84369289209506,-0.212058177060592,-0.189366883391366,-0.286615284830908,-0.0972484014395425,0.000379627334722283,-3.47502094939715,1.15155432672864,1.30336766587215,0.652739069542815,-0.650628596329336,0.00289711119758519,ENSG00000143627,PKLR,protein_coding,1,-1,155289293,155301438,q22,pyruvate kinase L/R [Source:HGNC Symbol;Acc:HGNC:9020],Adenosine triphosphate elevated of erythrocytes;Hemolytic anemia due to red cell pyruvate kinase deficiency;PYRUVATE KINASE DEFICIENCY OF RED CELLS,PKLR,5313,NM_000298;NM_181871
BRWD1_SIG,BRWD1,BRWD1_SIG,BRWD1,SIG,136,3.84338224489452,0.271414903144541,0.263495856168652,0.297434628922461,0.0339387727538088,0.000379964747925707,2.1004368499513,6.70485352971264,6.67458705977013,6.80430050238087,0.129713442610735,0.0803096222695529,ENSG00000185658,BRWD1,protein_coding,21,-1,39184176,39321559,q22.2,bromodomain and WD repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:12760],NA,BRWD1,54014,NM_001007246;NM_018963;NM_033656
FASTKD1_SIG,FASTKD1,FASTKD1_SIG,FASTKD1,SIG,124,3.84261707383844,0.295655455363942,0.277669821813639,0.354751108457797,0.0770812866441584,0.000381007699097906,3.92572665246254,4.63912142978253,4.54451132448159,4.94998320434277,0.405471879861184,0.000721738561711352,ENSG00000138399,FASTKD1,protein_coding,2,-1,169528508,169573875,q31.1,FAST kinase domains 1 [Source:HGNC Symbol;Acc:HGNC:26150],NA,FASTKD1,79675,NM_001281476;NM_001322046;NM_001322048;NM_001322049;NM_024622
TRMT13_SIG,TRMT13,TRMT13_SIG,TRMT13,SIG,275,3.84216173626429,0.170509422637254,0.154955748558676,0.221614351752579,0.0666586031939028,0.000381571264013363,3.09118588321758,3.92469397959562,3.84583015368037,4.18381797903145,0.337987825351075,0.00847971069538306,ENSG00000122435,TRMT13,protein_coding,1,1,100133150,100150498,p21.2,tRNA methyltransferase 13 homolog [Source:HGNC Symbol;Acc:HGNC:25502],NA,TRMT13,54482,NM_019083
CDK3_SIG,CDK3,CDK3_SIG,CDK3,SIG,21,3.84176448627337,0.0838976085351847,0.0769730449457201,0.106649746043425,0.0296767010977052,0.000382045199185607,1.17458125765596,0.746500235463284,0.737602874691897,0.775734420854985,0.0381315461630876,0.348382526099844,ENSG00000250506,CDK3,protein_coding,17,1,76000906,76005999,q25.1,cyclin dependent kinase 3 [Source:HGNC Symbol;Acc:HGNC:1772],NA,CDK3,1018,NM_001258
SIT1_SIG,SIT1,SIT1_SIG,SIT1,SIG,23,-3.84088211234118,-0.147885171205226,-0.128805171909262,-0.210576597463396,-0.081771425554134,0.000383276548219883,-2.78317603116011,1.27261570614992,1.33999618032549,1.05122271957305,-0.288773460752437,0.0184068129589005,ENSG00000137078,SIT1,protein_coding,9,-1,35649295,35650950,p13.3,signaling threshold regulating transmembrane adaptor 1 [Source:HGNC Symbol;Acc:HGNC:17710],NA,SIT1,27240,NM_014450
TCIRG1_SIG,TCIRG1,TCIRG1_SIG,TCIRG1,SIG,37,-3.84056712720007,0.390544367372725,0.405824375530642,0.340338626282425,-0.0654857492482169,0.000383623939444887,-2.35838813000305,7.62507576408546,7.67867063487914,7.44897833147766,-0.229692303401473,0.0478877541663504,ENSG00000110719,TCIRG1,protein_coding,11,1,68039025,68050895,q13.2,T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [Source:HGNC Symbol;Acc:HGNC:11647],Autosomal dominant severe congenital neutropenia;Autosomal recessive malignant osteopetrosis;Intermediate osteopetrosis;OSTEOPETROSIS AUTOSOMAL RECESSIVE 1,TCIRG1,10312,NM_001351059;NM_006019;NM_006053
ZNF730_TF,ZNF730,ZNF730_TF,ZNF730,TF,61,3.8391720400047,0.0218938985884273,0.0126447409529001,0.0522839879623025,0.0396392470094023,0.000385664589697011,4.17832983069705,1.09008659119677,1.01645439906676,1.33202093676681,0.315566537700056,0.00031075124913915,ENSG00000183850,ZNF730,protein_coding,19,1,23075210,23147221,p12,zinc finger protein 730 [Source:HGNC Symbol;Acc:HGNC:32470],NA,ZNF730,100129543,NM_001277403
ZFHX3_TF,ZFHX3,ZFHX3_TF,ZFHX3,TF,262,-3.83853162668719,0.020976971951369,0.0277554169858519,-0.00129506173336057,-0.0290504787192123,0.000386525929398472,-1.55500826147923,4.04224637113632,4.10583923955035,3.83329837491881,-0.272540864631534,0.204125750957079,ENSG00000140836,ZFHX3,protein_coding,16,-1,72782885,73891871,q22.3,zinc finger homeobox 3 [Source:HGNC Symbol;Acc:HGNC:777],Prostate Cancer,ZFHX3,463;388289,NM_001164766;NM_006885;NM_207385
HKR1_TF,HKR1,HKR1_TF,HKR1,TF,65,3.83622190922118,0.0973345450936821,0.0885851643249728,0.126082510476584,0.0374973461516113,0.000389938953994466,2.71320355721568,4.89669376933854,4.84955383588326,5.05158212212017,0.202028286236906,0.0217240538837818,ENSG00000181666,HKR1,protein_coding,19,1,37312837,37369365,q13.12,HKR1, GLI-Kruppel zinc finger family member [Source:HGNC Symbol;Acc:HGNC:4928],NA,HKR1,284459,NM_001329761;NM_001329762;NM_001329763;NM_001329764;NM_001329765;NM_001329766;NM_001329767;NM_001329768;NM_001329769;NM_001329770;NM_001329771;NM_001329772;NM_001329773;NM_001329774;NM_001329775;NM_001329776;NM_001329777;NM_001329778;NM_001329779;NM_001353803;NM_001353804;NM_181786
PAN2_SIG,PAN2,PAN2_SIG,PAN2,SIG,29,3.83618692207449,0.311580868587875,0.300848292764086,0.346845046294613,0.0459967535305267,0.000389938953994466,2.24017324289244,6.02011819415875,5.985981621552,6.13228121843808,0.146299596886074,0.0611384081177588,ENSG00000135473,PAN2,protein_coding,12,-1,56316223,56334053,q13.3,poly(A) specific ribonuclease subunit PAN2 [Source:HGNC Symbol;Acc:HGNC:20074],NA,PAN2,9924,NM_001127460;NM_001166279;NM_014871
TRERF1_TF,TRERF1,TRERF1_TF,TRERF1,TF,180,-3.83556364630957,0.105780885622046,0.110762371122326,0.0894131475496996,-0.0213492235726261,0.000390782044680626,-1.96770022938459,5.80963473978197,5.85142454910726,5.67232536628461,-0.179099182822645,0.102971046187212,ENSG00000124496,TRERF1,protein_coding,6,-1,42224931,42452051,p21.1,transcriptional regulating factor 1 [Source:HGNC Symbol;Acc:HGNC:18273],NA,TRERF1,55809,NM_001297573;NM_033502
METTL16_SIG,METTL16,METTL16_SIG,METTL16,SIG,28,3.83483987878675,0.509327922890911,0.503149981611581,0.529626872808709,0.0264768911971283,0.000391787017025221,2.76362203187018,5.39680859004012,5.35996608888633,5.51786252240258,0.157896433516251,0.019294231541581,ENSG00000127804,METTL16,protein_coding,17,-1,2405562,2511891,p13.3,methyltransferase like 16 [Source:HGNC Symbol;Acc:HGNC:28484],NA,METTL16,79066,NM_024086
MS4A6A_SIG,MS4A6A,MS4A6A_SIG,MS4A6A,SIG,61,-3.83439394614611,0.114193728163892,0.141743304425442,0.0236736918759429,-0.118069612549499,0.000392350752080786,-4.32875485568493,5.47163845603751,5.73648516265807,4.60142784856995,-1.13505731408812,0.000184510576242475,ENSG00000110077,MS4A6A,protein_coding,11,-1,60172014,60184666,q12.2,membrane spanning 4-domains A6A [Source:HGNC Symbol;Acc:HGNC:13375],NA,MS4A6A,64231,NM_001247999;NM_001330275;NM_022349;NM_152851;NM_152852
TCF3_TF,TCF3,TCF3_TF,TCF3,TF,160,3.83396476325513,0.115320729832243,0.105089670162019,0.148937068748694,0.043847398586675,0.000392888510961996,1.33097195147099,6.71915729934026,6.69477835681051,6.79925953908089,0.10448118227038,0.282622295986885,ENSG00000071564,TCF3,protein_coding,19,-1,1609284,1652615,p13.3,transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:11633],AGAMMAGLOBULINEMIA 8 AUTOSOMAL DOMINANT;Autosomal agammaglobulinemia;Precursor B-cell acute lymphoblastic leukemia,TCF3,6929,NM_001136139;NM_001351778;NM_001351779;NM_003200
SLC17A5_SIG,SLC17A5,SLC17A5_SIG,SLC17A5,SIG,47,-3.83377059622082,0.267558496282803,0.273024556821067,0.249598583085651,-0.0234259737354157,0.000393051106342736,-2.43471032041847,3.59130709459964,3.63494005295571,3.44794166000113,-0.186998392954581,0.0406492483441496,ENSG00000119899,SLC17A5,protein_coding,6,-1,73593379,73653992,q13,solute carrier family 17 member 5 [Source:HGNC Symbol;Acc:HGNC:10933],Free sialic acid storage disease infantile form;INFANTILE SIALIC ACID STORAGE DISEASE;INFANTILE SIALIC ACID STORAGE DISORDER;Intermediate severe Salla disease;SALLA DISEASE,SLC17A5,26503,NM_012434
AREL1_SIG,AREL1,AREL1_SIG,AREL1,SIG,55,-3.83348506208267,0.382662146096875,0.387990792493942,0.365153736506511,-0.0228370559874319,0.000393359957811775,-2.98832210612544,5.91730238629157,5.95568247662405,5.79119637519913,-0.16448610142492,0.0110947219481858,ENSG00000119682,AREL1,protein_coding,14,-1,74653437,74713108,q24.3,apoptosis resistant E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:20363],NA,AREL1,9870,NM_001039479
ILVBL_SIG,ILVBL,ILVBL_SIG,ILVBL,SIG,23,3.83215972111871,0.419678611326321,0.4116921018832,0.445919999496575,0.0342278976133755,0.000395238384546323,3.03413690243807,4.65105244004046,4.60943835868389,4.78778442164062,0.178346062956724,0.00983773764439967,ENSG00000105135,ILVBL,protein_coding,19,-1,15114984,15125786,p13.12,ilvB acetolactate synthase like [Source:HGNC Symbol;Acc:HGNC:6041],NA,ILVBL,10994,NM_006844
LIAS_SIG,LIAS,LIAS_SIG,LIAS,SIG,13,3.8321287799143,0.313847191973986,0.301791859622955,0.353457569698802,0.0516657100758466,0.000395238384546323,2.89405394831975,3.18668422280519,3.14513145917422,3.32321473187839,0.178083272704176,0.0140852666066559,ENSG00000121897,LIAS,protein_coding,4,1,39458587,39485109,p14,lipoic acid synthetase [Source:HGNC Symbol;Acc:HGNC:16429],HYPERGLYCINEMIA LACTIC ACIDOSIS AND SEIZURES;Lipoic acid synthetase deficiency;Neonatal-onset epilepsy defective mitochondrial energy metabolism and glycine elevation,LIAS,11019,NM_001278590;NM_001278591;NM_001278592;NM_006859;NM_194451
KDM5B_SIG,KDM5B,KDM5B_SIG,KDM5B,SIG,64,3.83188725177548,0.227321823926301,0.216813463829897,0.261849292814484,0.0450358289845864,0.000395478184699976,1.44350679786864,7.03915627334029,7.00799768320447,7.14153449807229,0.133536814867817,0.240719440717489,ENSG00000117139,KDM5B,protein_coding,1,-1,202724495,202809470,q32.1,lysine demethylase 5B [Source:HGNC Symbol;Acc:HGNC:18039],Autism;Autosomal dominant non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 65,KDM5B,10765,NM_001314042;NM_001347591;NM_006618
LYN_SIG,LYN,LYN_SIG,LYN,SIG,46,-3.83171790211689,0.45281055800704,0.463677560163131,0.417104693779884,-0.0465728663832468,0.000395602063727053,-4.23728065716367,8.25648690486841,8.34368925201775,7.969964907092,-0.373724344925757,0.000253270458934033,ENSG00000254087,LYN,protein_coding,8,1,55879835,56014169,q12.1,LYN proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6735],NA,LYN,4067,NM_001111097;NM_002350
TNFRSF10A_SIG,TNFRSF10A,TNFRSF10A_SIG,TNFRSF10A,SIG,11,-3.83147854514861,0.156959413861442,0.160995304434349,0.14369863055046,-0.0172966738838893,0.000395781452862238,-1.29395526834105,3.90597510726838,3.93267312058643,3.81825306350906,-0.114420057077374,0.297441698557861,ENSG00000104689,TNFRSF10A,protein_coding,8,-1,23190452,23225126,p21.3,TNF receptor superfamily member 10a [Source:HGNC Symbol;Acc:HGNC:11904],NA,TNFRSF10A,8797,NM_003844
MATR3_SIG,MATR3,MATR3_SIG,MATR3,SIG,40,3.83142184928427,0.425235668904448,0.414832490489234,0.459417540840151,0.0445850503509172,0.000395781452862238,3.9519231286336,8.74963691153507,8.70536096474987,8.89511502240072,0.189754057650845,0.0006630910810425,ENSG00000015479,MATR3,protein_coding,5,1,139293648,139331677,q31.2,matrin 3 [Source:HGNC Symbol;Acc:HGNC:6912],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 21;Vocal cord and pharyngeal distal myopathy,MATR3,9782,NM_001194955;NM_001194956;NM_018834
CYP2J2_SIG,CYP2J2,CYP2J2_SIG,CYP2J2,SIG,52,-3.83124063339413,-0.159250635634912,-0.154720541686713,-0.174135230036139,-0.0194146883494256,0.0003959246617572,-3.30183888027054,0.242782544598472,0.272856502192838,0.143968112502696,-0.128888389690142,0.00478422586101889,ENSG00000134716,CYP2J2,protein_coding,1,-1,59893308,59926773,p32.1,cytochrome P450 family 2 subfamily J member 2 [Source:HGNC Symbol;Acc:HGNC:2634],NA,CYP2J2,1573,NM_000775
AGO3_SIG,AGO3,AGO3_SIG,AGO3,SIG,78,3.82990183134119,0.220590292664154,0.212694512068489,0.246533571764197,0.0338390596957081,0.000397935751256394,3.17255504769932,6.23555805197474,6.19214013444574,6.37821692385577,0.186076789410029,0.00682642928473656,ENSG00000126070,AGO3,protein_coding,1,1,35930718,36072500,p34.3,argonaute RISC catalytic component 3 [Source:HGNC Symbol;Acc:HGNC:18421],NA,AGO3,192669,NM_024852;NM_177422
GCDH_SIG,GCDH,GCDH_SIG,GCDH,SIG,23,3.82916020069881,0.441634477905768,0.425477087018275,0.494723047964674,0.0692459609463989,0.000398987255388597,3.46140900628072,4.42382835626892,4.36255195607134,4.62516509977526,0.262613143703926,0.0030188420801498,ENSG00000105607,GCDH,protein_coding,19,1,12891160,12914207,p13.13,glutaryl-CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4189],GLUTARIC ACIDEMIA I;Glutaricacidemia Type 1;Glutaryl-CoA dehydrogenase deficiency,GCDH,2639,NM_000159;NM_013976
DDAH2_SIG,DDAH2,DDAH2_SIG,DDAH2,SIG,43,3.82805537322073,0.26004804517674,0.250290776705495,0.292107641582259,0.0418168648767645,0.000400632023181752,2.25950926861473,6.32468213249572,6.27304465625889,6.49434812584529,0.221303469586396,0.0587532985134687,ENSG00000213722,DDAH2,protein_coding,6,-1,31727038,31730617,p21.33,dimethylarginine dimethylaminohydrolase 2 [Source:HGNC Symbol;Acc:HGNC:2716],NA,DDAH2,23564,NM_001303007;NM_001303008;NM_013974
EIF2S3_SIG,EIF2S3,EIF2S3_SIG,EIF2S3,SIG,13,3.82792852539432,0.32151964125949,0.31498556772002,0.342988740032034,0.0280031723120133,0.00040068848486382,3.35291964005552,7.58667043446282,7.54626955861277,7.71941616939867,0.173146610785893,0.00413808302245725,ENSG00000130741,EIF2S3,protein_coding,X,1,24054946,24078810,p22.11,eukaryotic translation initiation factor 2 subunit gamma [Source:HGNC Symbol;Acc:HGNC:3267],MEHMO syndrome;Syndromic ID with severe microcephaly,EIF2S3,1968,NM_001415
OSTF1_SIG,OSTF1,OSTF1_SIG,OSTF1,SIG,73,-3.82755643757261,0.24090944802482,0.256444869590596,0.189864491451556,-0.0665803781390404,0.000401144372385506,-4.6625279393431,5.7905610953423,5.88313450098429,5.48639133394719,-0.396743167037097,5.39569325058321e-05,ENSG00000134996,OSTF1,protein_coding,9,1,75088543,75147265,q21.13,osteoclast stimulating factor 1 [Source:HGNC Symbol;Acc:HGNC:8510],NA,OSTF1,26578,NM_012383
NMT2_SIG,NMT2,NMT2_SIG,NMT2,SIG,60,-3.82661760011989,-0.0780211537120578,-0.0713180727310666,-0.1000455626496,-0.0287274899185339,0.000402526127666005,-3.17411173839118,2.55042255071267,2.64732446063936,2.23203056095354,-0.415293899685817,0.00680586218844033,ENSG00000152465,NMT2,protein_coding,10,-1,15102584,15168693,p13,N-myristoyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:7858],NA,NMT2,9397,NM_001308295;NM_004808
RBM15B_SIG,RBM15B,RBM15B_SIG,RBM15B,SIG,44,3.82624484022906,0.364537079930942,0.359475764523887,0.38116711626841,0.0216913517445226,0.000402985131637693,1.57084113338193,6.82145872443937,6.80233573106384,6.88429141695898,0.0819556858951396,0.199356415521923,ENSG00000259956,RBM15B,protein_coding,3,1,51391285,51397908,p21.2,RNA binding motif protein 15B [Source:HGNC Symbol;Acc:HGNC:24303],NA,RBM15B,29890,NM_013286
DEGS1_SIG,DEGS1,DEGS1_SIG,DEGS1,SIG,51,-3.82580160665619,0.259753262017186,0.265328676383137,0.241434043386203,-0.0238946329969347,0.00040356010930412,-1.62728317887108,5.48337971117881,5.51081301895065,5.39324169992849,-0.117571319022165,0.182958885394638,ENSG00000143753,DEGS1,protein_coding,1,1,224175756,224193441,q42.11,delta 4-desaturase, sphingolipid 1 [Source:HGNC Symbol;Acc:HGNC:13709],NA,DEGS1,8560,NM_001321541;NM_001321542;NM_003676
C4A_SIG,C4A,C4A_SIG,C4A,SIG,7,-3.82508730830121,-0.126077281029331,-0.115188062991939,-0.161856140295047,-0.0466680773031076,0.000404580813830644,-2.30298845719688,1.22618505878727,1.26175015995485,1.10932829780808,-0.152421862146761,0.0536339444302233,ENSG00000244731,C4A,protein_coding,6,1,31982057,32002681,p21.33,complement C4A (Rodgers blood group) [Source:HGNC Symbol;Acc:HGNC:1323],Autosomal systemic lupus erythematosus;Behcet disease;BLOOD GROUP CHIDO/RODGERS SYSTEM;COMPLEMENT COMPONENT 4A DEFICIENCY;Immunodeficiency due to a classical component pathway complement deficiency;Systemic lupus erythematosus,C4A,720;110384692,NM_001252204;NM_007293
ZFHX2_TF,ZFHX2,ZFHX2_TF,ZFHX2,TF,26,3.82404058874941,-0.0860849247702441,-0.0992238989032639,-0.0429140097617502,0.0563098891415136,0.000406151515775702,2.23654573549773,1.29678668383743,1.25164413471192,1.44511220239267,0.193468067680753,0.0615897004572049,ENSG00000136367,ZFHX2,protein_coding,14,-1,23520857,23556192,q11.2,zinc finger homeobox 2 [Source:HGNC Symbol;Acc:HGNC:20152],MARSILI SYNDROME,ZFHX2,85446,NM_033400
PIGL_SIG,PIGL,PIGL_SIG,PIGL,SIG,58,3.82270385917784,0.054440686986772,0.0471436319268268,0.0784167250408777,0.0312730931140507,0.000408167172492099,1.56418510448647,3.41007210008366,3.38621804082024,3.48844972337776,0.102231682557521,0.201332975470258,ENSG00000108474,PIGL,protein_coding,17,1,16217191,16351797,p11.2,phosphatidylinositol glycan anchor biosynthesis class L [Source:HGNC Symbol;Acc:HGNC:8966],CHIME syndrome;Coloboma congenital heart disease ichthyosiform dermatosis mental retardation and ear anomalies syndrome;Hyperphosphatasia-intellectual disability syndrome;ZUNICH NEUROECTODERMAL SYNDROME,PIGL,9487,NM_004278
CPAMD8_SIG,CPAMD8,CPAMD8_SIG,CPAMD8,SIG,7,-3.82263649196197,-0.0519543890084635,-0.0320289805510919,-0.117423588225542,-0.0853946076744496,0.000408167172492099,-2.51873679632438,1.21996626797659,1.30022298896368,0.956265613304738,-0.343957375658942,0.0339039706860644,ENSG00000160111,CPAMD8,protein_coding,19,-1,16892947,17026815,p13.11,C3 and PZP like, alpha-2-macroglobulin domain containing 8 [Source:HGNC Symbol;Acc:HGNC:23228],Anterior Segment Dysgenesis;ANTERIOR SEGMENT DYSGENESIS 8,CPAMD8,27151,NM_015692
LMTK2_SIG,LMTK2,LMTK2_SIG,LMTK2,SIG,49,-3.82192257412711,0.212316547220968,0.22463096434586,0.171854890953466,-0.052776073392394,0.000409198247104176,-2.99827104358057,5.31884483995968,5.39225746037534,5.07763194430826,-0.314625516067073,0.0108118792525137,ENSG00000164715,LMTK2,protein_coding,7,1,98106862,98209638,q21.3,lemur tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:17880],NA,LMTK2,22853,NM_014916
NCOA1_SIG,NCOA1,NCOA1_SIG,NCOA1,SIG,37,-3.82007600153116,0.312342366227842,0.318374355236715,0.292522973770116,-0.0258513814665987,0.00041212023939882,-2.25004865153707,7.0154339986686,7.04287152661789,6.92528212112093,-0.117589405496964,0.059986646156489,ENSG00000084676,NCOA1,protein_coding,2,1,24491914,24770702,p23.3,nuclear receptor coactivator 1 [Source:HGNC Symbol;Acc:HGNC:7668],NA,NCOA1,8648,NM_001362950;NM_001362952;NM_001362954;NM_001362955;NM_003743;NM_147223;NM_147233
HTRA3_SIG,HTRA3,HTRA3_SIG,HTRA3,SIG,22,3.81906564303419,0.0254630659900785,0.0209110333807602,0.0404197445635528,0.0195087111827925,0.000413657466205968,-2.09422313823329,3.63268396612801,3.73586637507099,3.29365605102965,-0.442210324041338,0.0811626297360635,ENSG00000170801,HTRA3,protein_coding,4,1,8269754,8307098,p16.1,HtrA serine peptidase 3 [Source:HGNC Symbol;Acc:HGNC:30406],NA,HTRA3,94031,NM_001297559;NM_053044
ZNF254_TF,ZNF254,ZNF254_TF,ZNF254,TF,61,3.8186356659434,0.362047678984205,0.352553525438079,0.393242754921478,0.0406892294833997,0.000414224624141497,3.39927133924517,4.56010684633734,4.48943191235175,4.79232448657571,0.302892574223962,0.00361019359405243,ENSG00000213096,ZNF254,protein_coding,19,1,24033405,24129961,p12,zinc finger protein 254 [Source:HGNC Symbol;Acc:HGNC:13047],NA,ZNF254,9534,NM_001278661;NM_001278662;NM_001278663;NM_001278664;NM_001278665;NM_001278677;NM_001278678;NM_203282
GNAI2_SIG,GNAI2,GNAI2_SIG,GNAI2,SIG,70,-3.8177846999076,0.332773965529569,0.343390557174907,0.297890878694885,-0.0454996784800216,0.000415500791406867,-2.79711218500802,9.21149323612192,9.24560515246438,9.09941122528241,-0.146193927181972,0.0178195045910544,ENSG00000114353,GNAI2,protein_coding,3,1,50226292,50259362,p21.31,G protein subunit alpha i2 [Source:HGNC Symbol;Acc:HGNC:4385],VENTRICULAR TACHYCARDIA FAMILIAL,GNAI2,2771,NM_001166425;NM_001282617;NM_001282618;NM_001282619;NM_001282620;NM_002070
ZSWIM7_TF,ZSWIM7,ZSWIM7_TF,ZSWIM7,TF,209,3.81614980985258,0.22192767771488,0.21122746173878,0.257085530207782,0.0458580684690022,0.000418106332953237,3.17431464680329,3.89671920210663,3.84326421080495,4.0723570306693,0.22909281986435,0.00680586218844033,ENSG00000214941,ZSWIM7,protein_coding,17,-1,15976560,15999717,p12,zinc finger SWIM-type containing 7 [Source:HGNC Symbol;Acc:HGNC:26993],NA,ZSWIM7,125150,NM_001042697;NM_001042698
ZNF550_TF,ZNF550,ZNF550_TF,ZNF550,TF,68,3.81568769392866,0.291773435534215,0.280200419570863,0.329799059413797,0.0495986398429334,0.000418671199936561,3.38607296493059,4.11463011734229,4.03565931019951,4.3741056265257,0.338446316326188,0.00376810656375943,ENSG00000251369,ZNF550,protein_coding,19,-1,57535257,57559863,q13.43,zinc finger protein 550 [Source:HGNC Symbol;Acc:HGNC:28643],NA,ZNF550,162972,NM_001277090;NM_001277091;NM_001277092;NM_001277093
CHST14_SIG,CHST14,CHST14_SIG,CHST14,SIG,68,3.81563271934814,0.30003748803959,0.286804609991404,0.343516944483631,0.0567123344922275,0.000418671199936561,3.35675201943663,4.11024217040586,4.03646488974606,4.35265323543091,0.316188345684851,0.00409786768849098,ENSG00000169105,CHST14,protein_coding,15,1,40470998,40474571,q15.1,carbohydrate sulfotransferase 14 [Source:HGNC Symbol;Acc:HGNC:24464],EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE;EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE 1,CHST14,113189,NM_130468
ABCE1_SIG,ABCE1,ABCE1_SIG,ABCE1,SIG,50,3.81541318400017,0.788073185093304,0.775772624294036,0.828489313433758,0.052716689139722,0.000418887782401882,2.8265331809341,6.19214955962639,6.14172021756458,6.35784596925804,0.216125751693455,0.0166242580281083,ENSG00000164163,ABCE1,protein_coding,4,1,145098288,145129524,q31.21,ATP binding cassette subfamily E member 1 [Source:HGNC Symbol;Acc:HGNC:69],NA,ABCE1,6059,NM_001040876;NM_002940
ZMYND11_TF,ZMYND11,ZMYND11_TF,ZMYND11,TF,34,3.81477032600987,0.227142710399257,0.217074711009674,0.260223279822172,0.0431485688124985,0.000419699862079204,2.22320329300819,6.13842737857822,6.09738215427122,6.27329025844406,0.175908104172835,0.06330786430347,ENSG00000015171,ZMYND11,protein_coding,10,1,134465,254637,p15.3,zinc finger MYND-type containing 11 [Source:HGNC Symbol;Acc:HGNC:16966],Autosomal dominant non-syndromic intellectual disability;Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 30,ZMYND11,10771,NM_001202464;NM_001202465;NM_001202466;NM_001202467;NM_001202468;NM_001330057;NM_006624;NM_212479
PON2_SIG,PON2,PON2_SIG,PON2,SIG,30,3.81475132827265,-0.051108762871564,-0.0576805072475299,-0.0295158884933904,0.0281646187541395,0.000419699862079204,-1.08297172885575,3.75776865026719,3.79570717616524,3.633113493745,-0.162593682420247,0.390604204360738,ENSG00000105854,PON2,protein_coding,7,-1,95404862,95435329,q21.3,paraoxonase 2 [Source:HGNC Symbol;Acc:HGNC:9205],Amyotrophic lateral sclerosis,PON2,5445,NM_000305;NM_001018161
MAN1A1_SIG,MAN1A1,MAN1A1_SIG,MAN1A1,SIG,72,-3.81031703517034,0.0417005112927667,0.0500499223160782,0.014266732216172,-0.0357831900999062,0.000427141286911299,-2.10206388042461,7.02317063894793,7.09518616671841,6.78654819055922,-0.308637976159184,0.0800594059577855,ENSG00000111885,MAN1A1,protein_coding,6,-1,119177205,119349761,q22.31,mannosidase alpha class 1A member 1 [Source:HGNC Symbol;Acc:HGNC:6821],NA,MAN1A1,4121,NM_005907
PNPLA2_SIG,PNPLA2,PNPLA2_SIG,PNPLA2,SIG,17,-3.80955652212291,0.093233344239601,0.0988047938774102,0.0749271525725135,-0.0238776413048966,0.000428298131976656,-1.51682393225385,7.41946616637061,7.43819993494452,7.35791235534205,-0.0802875796024684,0.216564870381827,ENSG00000177666,PNPLA2,protein_coding,11,1,818914,825573,p15.5,patatin like phospholipase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30802],NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY;Neutral lipid storage myopathy,PNPLA2,57104,NM_020376
FLYWCH1_TF,FLYWCH1,FLYWCH1_TF,FLYWCH1,TF,130,3.80875117032841,0.075938934113502,0.0714233657028654,0.0907758017484508,0.0193524360455852,0.000429535806386074,2.13583595952479,5.56816852426153,5.53538595757589,5.67588267194291,0.14049671436702,0.0751641171885369,ENSG00000059122,FLYWCH1,protein_coding,16,1,2911937,2951208,p13.3,FLYWCH-type zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:25404],NA,FLYWCH1,84256,NM_001308068;NM_020912;NM_032296
PCBP3_SIG,PCBP3,PCBP3_SIG,PCBP3,SIG,61,-3.80819918193783,0.0435413919664067,0.0510585325738736,0.0188422156847298,-0.032216316889144,0.000430335814194417,-3.31311476657087,2.18966597206205,2.31526788070829,1.77697398651012,-0.538293894198171,0.0046399750896083,ENSG00000183570,PCBP3,protein_coding,21,1,45643694,45942454,q22.3,poly(rC) binding protein 3 [Source:HGNC Symbol;Acc:HGNC:8651],NA,PCBP3,54039,NM_001130141;NM_001348238;NM_001348239;NM_001348240;NM_001348241;NM_001348242;NM_001348243;NM_001348244;NM_001348245;NM_020528
ZNF827_TF,ZNF827,ZNF827_TF,ZNF827,TF,179,3.80805793492451,-0.0854407438067226,-0.0938852899383215,-0.0576943779457548,0.0361909119925666,0.000430421923271828,0.542265474180942,3.60290559504116,3.58079079248526,3.67556851772483,0.0947777252395734,0.685069938750273,ENSG00000151612,ZNF827,protein_coding,4,-1,145757627,145938823,q31.22,zinc finger protein 827 [Source:HGNC Symbol;Acc:HGNC:27193],NA,ZNF827,152485,NM_001306215;NM_178835
MAN2C1_SIG,MAN2C1,MAN2C1_SIG,MAN2C1,SIG,36,3.80652601131917,0.246631522854492,0.241052144624731,0.26496376560942,0.0239116209846893,0.000432930495514023,4.34497253991067,7.12043929770602,7.06785954120821,7.29320135477028,0.225341813562079,0.000173637348465884,ENSG00000140400,MAN2C1,protein_coding,15,-1,75355207,75368612,q24.2,mannosidase alpha class 2C member 1 [Source:HGNC Symbol;Acc:HGNC:6827],NA,MAN2C1,4123,NM_001256494;NM_001256495;NM_001256496;NM_006715
ZNF141_TF,ZNF141,ZNF141_TF,ZNF141,TF,30,3.80643683102671,0.130424606177807,0.119023206007708,0.167886349593848,0.04886314358614,0.000432930495514023,3.50391685512337,4.26546572454266,4.19048374238322,4.51183509449508,0.321351352111862,0.0026760747476576,ENSG00000131127,ZNF141,protein_coding,4,1,337814,384868,p16.3,zinc finger protein 141 [Source:HGNC Symbol;Acc:HGNC:12926],POLYDACTYLY POSTAXIAL TYPE A6;Postaxial Polydactyly Type A,ZNF141,7700,NM_001348277;NM_001348278;NM_001348279;NM_001348280;NM_003441
RSPO2_SIG,RSPO2,RSPO2_SIG,RSPO2,SIG,18,-3.80372999840393,0.0582434467240829,0.0678403944049093,0.0267106186299391,-0.0411297757749702,0.00043752883010539,-0.824557944283769,0.386275798630758,0.400874913490367,0.338307278377756,-0.0625676351126101,0.521871768813645,ENSG00000147655,RSPO2,protein_coding,8,-1,107899316,108083642,q23.1,R-spondin 2 [Source:HGNC Symbol;Acc:HGNC:28583],HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY;Tetra-amelia with lung agenesis;Tetraamelia-multiple malformations syndrome;TETRAAMELIA SYNDROME 2,RSPO2,340419,NM_001282863;NM_001317942;NM_178565
KRBOX4_TF,KRBOX4,KRBOX4_TF,KRBOX4,TF,54,3.80285632511834,0.346738590473801,0.33348747723596,0.390277962540992,0.0567904853050324,0.000438912658803296,3.05317280939003,3.3744592363116,3.3232151550043,3.54283264632128,0.219617491316976,0.00937248009336216,ENSG00000147121,KRBOX4,protein_coding,X,1,46447292,46497422,p11.3,KRAB box domain containing 4 [Source:HGNC Symbol;Acc:HGNC:26007],NA,KRBOX4,55634,NM_001129898;NM_001129899;NM_001129900;NM_017776
ASNSD1_SIG,ASNSD1,ASNSD1_SIG,ASNSD1,SIG,28,3.80273321031408,0.245711455527571,0.240702083917475,0.262170819389315,0.0214687354718406,0.000438968330315523,2.70102060140151,5.2589477790409,5.22885498315374,5.35782410838441,0.128969125230663,0.0223447217144548,ENSG00000138381,ASNSD1,protein_coding,2,1,189661385,189670831,q32.2,asparagine synthetase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24910],NA,ASNSD1,54529,NM_001353497;NM_019048
STAT3_SIG,STAT3,STAT3_SIG,STAT3,SIG,31,-3.802391347059,0.33670577011228,0.342335717387341,0.318207371922795,-0.0241283454645457,0.000439401715518663,-2.61817499560188,8.0561250628115,8.09066331975627,7.9426422185644,-0.14802110119187,0.0269860189665183,ENSG00000168610,STAT3,protein_coding,17,-1,42313324,42388568,q21.2,signal transducer and activator of transcription 3 [Source:HGNC Symbol;Acc:HGNC:11364],AUTOIMMUNE DISEASE MULTISYSTEM INFANTILE-ONSET 1;Autosomal dominant hyper IgE syndrome;Chronic lymphoproliferative disorder of natural killer cells;HYPER-IgE RECURRENT INFECTION SYNDROME 1 AUTOSOMAL DOMINANT;Permanent neonatal diabetes mellitus;STAT3-related early-onset multisystem autoimmune disease;T-cell large granular lymphocyte leukemia,STAT3,6774,NM_003150;NM_139276;NM_213662
ABCA9_SIG,ABCA9,ABCA9_SIG,ABCA9,SIG,34,3.8023054953115,-0.0545580078580402,-0.0593237634144676,-0.0388990967440644,0.020424666670403,0.000439401715518663,3.7082597072161,1.0601016033997,0.94536510319204,1.43709296122487,0.491727858032827,0.00143532225167038,ENSG00000154258,ABCA9,protein_coding,17,-1,68974488,69060949,q24.2,ATP binding cassette subfamily A member 9 [Source:HGNC Symbol;Acc:HGNC:39],NA,ABCA9,10350,NM_080283
ENG_SIG,ENG,ENG_SIG,ENG,SIG,47,3.80186340552194,0.0997817092922062,0.0942259139378218,0.118036465456612,0.0238105515187902,0.000439868766690513,0.473230857876722,5.84770200641049,5.83116641930039,5.90203322120082,0.0708668019004355,0.725260694889909,ENSG00000106991,ENG,protein_coding,9,-1,127815012,127854756,q34.11,endoglin [Source:HGNC Symbol;Acc:HGNC:3349],Familial cerebral saccular aneurysm;Generalized juvenile polyposis/juvenile polyposis coli;HEREDITARY HEMORRHAGIC TELANGIECTASIA;Heritable pulmonary arterial hypertension;TELANGIECTASIA HEREDITARY HEMORRHAGIC TYPE 1,ENG,2022,NM_000118;NM_001114753;NM_001278138
CHST13_SIG,CHST13,CHST13_SIG,CHST13,SIG,11,3.80185915480626,0.0472717295302205,0.0405044625013065,0.0695070354823664,0.02900257298106,0.000439868766690513,2.16232891178344,3.09336970950892,3.02015694348285,3.33392594073742,0.313768997254566,0.0714218484079879,ENSG00000180767,CHST13,protein_coding,3,1,126524283,126543291,q21.3,carbohydrate sulfotransferase 13 [Source:HGNC Symbol;Acc:HGNC:21755],NA,CHST13,166012,NM_152889
JAKMIP1_SIG,JAKMIP1,JAKMIP1_SIG,JAKMIP1,SIG,15,-3.80171350180259,-0.168968849129122,-0.144072954353702,-0.250769646248357,-0.106696691894654,0.000439964837885615,-2.84215747908405,1.02622205515478,1.09245219955492,0.808608723554318,-0.283843476000604,0.016004240925282,ENSG00000152969,JAKMIP1,protein_coding,4,-1,6026203,6200591,p16.1,janus kinase and microtubule interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:26460],NA,JAKMIP1,152789,NM_001099433;NM_001306133;NM_001306134;NM_144720
ZFR_SIG,ZFR,ZFR_SIG,ZFR,SIG,39,3.80079063577868,0.168505149269791,0.163645218111834,0.184473494503077,0.0208282763912426,0.000441290056113099,0.947401286693013,7.35045056024632,7.33740409219602,7.3933175266973,0.0559134345012805,0.457068210065472,ENSG00000056097,ZFR,protein_coding,5,-1,32354350,32444740,p13.3,zinc finger RNA binding protein [Source:HGNC Symbol;Acc:HGNC:17277],Autosomal recessive spastic paraplegia type 71,ZFR,51663,NM_016107
CDK9_SIG,CDK9,CDK9_SIG,CDK9,SIG,45,3.80078537103485,0.175984068895265,0.169696046033531,0.196644715440962,0.0269486694074315,0.000441290056113099,2.91060495055585,6.73647062225432,6.7020013938582,6.84972665841303,0.147725264554833,0.0135110965693631,ENSG00000136807,CDK9,protein_coding,9,1,127785679,127790787,q34.11,cyclin dependent kinase 9 [Source:HGNC Symbol;Acc:HGNC:1780],NA,CDK9,1025,NM_001261
TFB2M_SIG,TFB2M,TFB2M_SIG,TFB2M,SIG,35,3.8006188846881,0.36685903313584,0.359341633750525,0.391559059687591,0.0322174259370664,0.000441423666878525,4.30672844423259,3.83936883996392,3.76139628650957,4.09556437274249,0.334168086232924,0.000199461761580398,ENSG00000162851,TFB2M,protein_coding,1,-1,246540561,246566261,q44,transcription factor B2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:18559],NA,TFB2M,64216,NM_022366
KATNAL2_SIG,KATNAL2,KATNAL2_SIG,KATNAL2,SIG,7,3.7995799833836,-0.117504376922665,-0.123445054396481,-0.0979850080801292,0.0254600463163513,0.00044311459997997,1.04367488380949,1.18814618143534,1.1703976832611,1.24646267543643,0.0760649921753321,0.40919797884014,ENSG00000167216,KATNAL2,protein_coding,18,1,46917492,47102243,q21.1,katanin catalytic subunit A1 like 2 [Source:HGNC Symbol;Acc:HGNC:25387],NA,KATNAL2,83473,NM_001353899;NM_001353900;NM_001353901;NM_001353902;NM_001353903;NM_001353904;NM_001353905;NM_001353906;NM_001353907;NM_001353908;NM_001353909;NM_001367621;NM_031303
ZAP70_SIG,ZAP70,ZAP70_SIG,ZAP70,SIG,26,-3.79948421863058,-0.0128558869181107,0.00332896430140762,-0.0660346837822422,-0.0693636480836498,0.000443122337926924,-3.6952273127068,4.71169274216092,4.85966159831769,4.22550935764581,-0.634152240671884,0.00149317380013532,ENSG00000115085,ZAP70,protein_coding,2,1,97713560,97739862,q11.2,zeta chain of T cell receptor associated protein kinase 70 [Source:HGNC Symbol;Acc:HGNC:12858],AUTOIMMUNE DISEASE MULTISYSTEM INFANTILE-ONSET 2;Combined immunodeficiency due to ZAP70 deficiency;IMMUNODEFICIENCY 48,ZAP70,7535,NM_001079;NM_207519
HNRNPA3_SIG,HNRNPA3,HNRNPA3_SIG,HNRNPA3,SIG,29,3.79938551609874,0.350545973915798,0.345152121633626,0.368268631414365,0.0231165097807389,0.000443135384960268,1.52031874258877,7.70356330287557,7.68618631900854,7.7606591070101,0.0744727880015549,0.215331221006893,ENSG00000170144,HNRNPA3,protein_coding,2,1,177212563,177223958,q31.2,heterogeneous nuclear ribonucleoprotein A3 [Source:HGNC Symbol;Acc:HGNC:24941],NA,HNRNPA3,220988,NM_001330247;NM_001330248;NM_001330249;NM_001330250;NM_001330251;NM_194247
FBXL8_SIG,FBXL8,FBXL8_SIG,FBXL8,SIG,30,3.79889916243807,0.170826692521086,0.165417342398204,0.188600271496268,0.0231829290980637,0.00044384209700533,2.7491458223217,1.9975811429659,1.95656456502127,2.13234989906969,0.175785334048421,0.0199667685956458,ENSG00000135722,FBXL8,protein_coding,16,1,67159932,67164570,q22.1,F-box and leucine rich repeat protein 8 [Source:HGNC Symbol;Acc:HGNC:17875],NA,FBXL8,55336,NM_018378
ZNF471_TF,ZNF471,ZNF471_TF,ZNF471,TF,44,3.79854476976072,-0.0438049652911943,-0.05673171763356,-0.00133135045199278,0.0554003671815671,0.000444208105638354,1.8418702323834,2.31314435709856,2.2574371223984,2.49618241397051,0.238745291572107,0.128506704451458,ENSG00000196263,ZNF471,protein_coding,19,1,56507850,56530221,q13.43,zinc finger protein 471 [Source:HGNC Symbol;Acc:HGNC:23226],NA,ZNF471,57573,NM_001321768;NM_020813
PPP6C_SIG,PPP6C,PPP6C_SIG,PPP6C,SIG,45,-3.79851215578568,0.27282251143102,0.278481479763627,0.254228758338166,-0.0242527214254611,0.000444208105638354,-1.80699335664233,6.46659741740818,6.48236567681111,6.41478742222715,-0.0675782545839594,0.136557531305546,ENSG00000119414,PPP6C,protein_coding,9,-1,125146573,125189939,q33.3,protein phosphatase 6 catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9323],NA,PPP6C,5537,NM_001123355;NM_001123369;NM_002721
ZFP37_TF,ZFP37,ZFP37_TF,ZFP37,TF,44,-3.79740311668897,-0.0995749326788511,-0.0941517508167578,-0.117393958797157,-0.0232422079803995,0.000446035288310075,-0.427230313219697,0.357131917385265,0.361712026994956,0.342082985810565,-0.0196290411843907,0.752232586720609,ENSG00000136866,ZFP37,protein_coding,9,-1,113038380,113056759,q32,ZFP37 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:12863],NA,ZFP37,7539,NM_001282515;NM_001282518;NM_003408
COL5A2_SIG,COL5A2,COL5A2_SIG,COL5A2,SIG,14,3.7967183810436,-0.0288715880416479,-0.0374577109215907,-0.000660041436121892,0.0367976694854687,0.000447070373544695,0.813210584581487,0.855566029166238,0.842726499678157,0.897753054627078,0.0550265549489211,0.528029271395926,ENSG00000204262,COL5A2,protein_coding,2,-1,189031898,189225312,q32.2,collagen type V alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2210],Ehlers-Danlos syndrome type 1;Ehlers-Danlos syndrome type 2,COL5A2,1290,NM_000393
ZNF665_TF,ZNF665,ZNF665_TF,ZNF665,TF,76,3.79664575450881,0.165182111352271,0.149657003040667,0.216193181518968,0.0665361784783011,0.000447070373544695,2.51567114028395,1.93582584863769,1.88404172232306,2.10597369224288,0.221931969919817,0.0341107894008973,ENSG00000197497,ZNF665,protein_coding,19,-1,53159213,53193386,q13.42,zinc finger protein 665 [Source:HGNC Symbol;Acc:HGNC:25885],NA,ZNF665,79788,NM_001353457;NM_001353458;NM_001353459;NM_024733
ALDH1A3_SIG,ALDH1A3,ALDH1A3_SIG,ALDH1A3,SIG,19,-3.79457669393858,-0.287860261923706,-0.280861339283027,-0.310856722028796,-0.0299953827457697,0.00045064903793926,-2.45790434383612,0.363057212650987,0.406545980147529,0.220165548019491,-0.186380432128038,0.038712757180658,ENSG00000184254,ALDH1A3,protein_coding,15,1,100877714,100916626,q26.3,aldehyde dehydrogenase 1 family member A3 [Source:HGNC Symbol;Acc:HGNC:409],Anophthalmia/Microphthalmia;Isolated microphthalmia-anophthalmia-coloboma;MICROPHTHALMIA ISOLATED 8,ALDH1A3,220,NM_000693;NM_001293815
FUS_SIG,FUS,FUS_SIG,FUS,SIG,20,3.79438897062061,0.352282306823347,0.347507796610848,0.367969983235845,0.0204621866249971,0.000450824295210919,1.51374804227728,8.72205670311887,8.70464616059893,8.77926277139864,0.0746166107997084,0.217565707495796,ENSG00000089280,FUS,protein_coding,16,1,31180110,31194871,p11.2,FUS RNA binding protein [Source:HGNC Symbol;Acc:HGNC:4010],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;;Frontotemporal dementia with motor neuron disease;Juvenile amyotrophic lateral sclerosis;Myxofibrosarcoma;Myxoid/round cell liposarcoma;TREMOR HEREDITARY ESSENTIAL 4,FUS,2521,NM_001170634;NM_001170937;NM_004960
CARD9_SIG,CARD9,CARD9_SIG,CARD9,SIG,58,3.79317505531353,0.100591782780449,0.0899788072796357,0.135462987997406,0.0454841807177704,0.000452868345321333,3.80321075894549,5.21242690444315,5.07493426227854,5.66418844298402,0.589254180705474,0.00106492695429921,ENSG00000187796,CARD9,protein_coding,9,-1,136361903,136373681,q34.3,caspase recruitment domain family member 9 [Source:HGNC Symbol;Acc:HGNC:16391],CANDIDIASIS FAMILIAL 2;Predisposition to invasive fungal disease due to CARD9 deficiency,CARD9,64170,NM_052813;NM_052814
ZNF117_TF,ZNF117,ZNF117_TF,ZNF117,TF,26,3.793055014241,0.1944629005266,0.185159069240946,0.225032631893747,0.0398735626528008,0.000452920959910824,1.99361315020768,5.33752581611567,5.28668678225896,5.50456835593057,0.21788157367161,0.0982384457453014,ENSG00000152926,ZNF117,protein_coding,7,-1,64971776,65006684,q11.21,zinc finger protein 117 [Source:HGNC Symbol;Acc:HGNC:12897],NA,ZNF117,51351;109504726,NM_001348050;NM_015852
CSTF3_SIG,CSTF3,CSTF3_SIG,CSTF3,SIG,64,3.79240216056497,0.337096831349067,0.319346588825873,0.395419056782418,0.0760724679565453,0.000453946922419797,3.730907978381,4.55727645209137,4.47939674547172,4.81316691669877,0.333770171227044,0.0013335545216821,ENSG00000176102,CSTF3,protein_coding,11,-1,33077188,33162371,p13,cleavage stimulation factor subunit 3 [Source:HGNC Symbol;Acc:HGNC:2485],NA,CSTF3,1479,NM_001033505;NM_001033506;NM_001326
CDC42_SIG,CDC42,CDC42_SIG,CDC42,SIG,20,-3.79215975132242,0.379089138454108,0.384662056423491,0.360778122268994,-0.0238839341544969,0.000454223571886218,-2.21336619527334,8.49717869794,8.51563756982274,8.43652811889673,-0.07910945092601,0.0646392680641908,ENSG00000070831,CDC42,protein_coding,1,1,22025511,22101360,p36.12,cell division cycle 42 [Source:HGNC Symbol;Acc:HGNC:1736],Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome;Takenouchi-Kosaki syndrome,CDC42,998,NM_001039802;NM_001791;NM_044472
FADS2_SIG,FADS2,FADS2_SIG,FADS2,SIG,30,3.79095966753062,0.236364039244009,0.228202818378138,0.263179479231868,0.0349766608537299,0.000456039008359347,3.8617334556616,6.35275562109665,6.21780096138695,6.7961780744285,0.578377113041548,0.000885979272170464,ENSG00000134824,FADS2,protein_coding,11,1,61792980,61867354,q12.2,fatty acid desaturase 2 [Source:HGNC Symbol;Acc:HGNC:3575],NA,FADS2,9415,NM_001281501;NM_001281502;NM_004265
HNRNPH1_SIG,HNRNPH1,HNRNPH1_SIG,HNRNPH1,SIG,70,3.79094495849865,0.371401781752553,0.363431117662745,0.397591106619065,0.0341599889563205,0.000456039008359347,4.00562635666377,9.77279859944409,9.72010742361472,9.94592674859774,0.225819324983018,0.000559013535187878,ENSG00000169045,HNRNPH1,protein_coding,5,-1,179614178,179634784,q35.3,heterogeneous nuclear ribonucleoprotein H1 [Source:HGNC Symbol;Acc:HGNC:5041],Precursor T-cell acute lymphoblastic leukemia,HNRNPH1,3187,NM_001257293;NM_001363572;NM_001364228;NM_001364229;NM_001364231;NM_001364238;NM_001364239;NM_001364242;NM_001364243;NM_001364245;NM_001364246;NM_001364247;NM_001364248;NM_005520
HOXA1_TF,HOXA1,HOXA1_TF,HOXA1,TF,73,3.79089598136542,-0.054731044044373,-0.059771096679721,-0.0381708710996582,0.0216002255800628,0.000456039008359347,2.45877995356606,1.67981635454265,1.61475390363843,1.89359297894221,0.278839075303776,0.0386372208530592,ENSG00000105991,HOXA1,protein_coding,7,-1,27092993,27095996,p15.2,homeobox A1 [Source:HGNC Symbol;Acc:HGNC:5099],Athabaskan brainstem dysgenesis syndrome;BOSLEY-SALIH-ALORAINY SYNDROME,HOXA1,3198,NM_005522;NM_153620
SLC10A3_SIG,SLC10A3,SLC10A3_SIG,SLC10A3,SIG,19,-3.79010441220497,0.175238672844113,0.180163736911907,0.159056319478503,-0.0211074174334048,0.000457327060379482,-3.95939795110024,5.05723058041214,5.10625959682641,4.89613524076526,-0.210124356061145,0.000646064771178971,ENSG00000126903,SLC10A3,protein_coding,X,-1,154487306,154490690,q28,solute carrier family 10 member 3 [Source:HGNC Symbol;Acc:HGNC:22979],NA,SLC10A3,8273,NM_001142391;NM_001142392;NM_019848
FDFT1_SIG,FDFT1,FDFT1_SIG,FDFT1,SIG,17,3.79000453589573,0.342380173967295,0.334690239618417,0.367647101113608,0.0329568614951914,0.000457343335658965,2.97276655969581,6.76503867491372,6.71944406051278,6.91484955080251,0.195405490289729,0.0115646136731195,ENSG00000079459,FDFT1,protein_coding,8,1,11795573,11839304,p23.1,farnesyl-diphosphate farnesyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:3629],SQUALENE SYNTHASE DEFICIENCY,FDFT1,2222,NM_001287742;NM_001287743;NM_001287744;NM_001287745;NM_001287747;NM_001287748;NM_001287749;NM_001287750;NM_001287751;NM_001287756;NM_004462
NAPEPLD_SIG,NAPEPLD,NAPEPLD_SIG,NAPEPLD,SIG,26,3.7871388527559,-0.0697607375929352,-0.0841073917248158,-0.0226217311596133,0.0614856605652026,0.00046247886292828,3.20832797222966,2.4776510086815,2.39935564421284,2.7349072062214,0.335551562008564,0.00620587936388697,ENSG00000161048,NAPEPLD,protein_coding,7,-1,103099776,103149560,q22.1,N-acyl phosphatidylethanolamine phospholipase D [Source:HGNC Symbol;Acc:HGNC:21683],NA,NAPEPLD,222236,NM_001122838;NM_198990
NAMPT_SIG,NAMPT,NAMPT_SIG,NAMPT,SIG,82,-3.78565964282553,0.391372319500392,0.413537176994132,0.318544930592387,-0.0949922464017453,0.000464990073346164,-4.1685342099895,7.39221200697837,7.56625437705325,6.82035850530375,-0.745895871749499,0.000321147673626705,ENSG00000105835,NAMPT,protein_coding,7,-1,106248298,106286326,q22.3,nicotinamide phosphoribosyltransferase [Source:HGNC Symbol;Acc:HGNC:30092],NA,NAMPT,10135,NM_005746
PATZ1_SIG,PATZ1,PATZ1_SIG,PATZ1,SIG,73,3.78561051815242,0.325787479026357,0.315455826740411,0.359734336537324,0.0442785097969133,0.000464990073346164,2.67506638347509,5.90273141057121,5.85779423114148,6.05038214298318,0.192587911841699,0.023733122387526,ENSG00000100105,PATZ1,protein_coding,22,-1,31325804,31346346,q12.2,POZ/BTB and AT hook containing zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13071],NA,PATZ1,23598,NM_014323;NM_032050;NM_032051;NM_032052
KIR2DL3_SIG,KIR2DL3,KIR2DL3_SIG,KIR2DL3,SIG,4,-3.78460322235663,-0.118416690965237,-0.0987358066622734,-0.183082453674975,-0.0843466470127015,0.000466613168794888,-2.4171808148079,0.298175732533734,0.326188887358596,0.206132509537761,-0.120056377820835,0.0422370954756594,ENSG00000243772,KIR2DL3,protein_coding,19,1,54738515,54753052,q13.42,killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 [Source:HGNC Symbol;Acc:HGNC:6331],NA,KIR2DL3,3804,NM_015868
GZMB_SIG,GZMB,GZMB_SIG,GZMB,SIG,9,-3.78456198275686,-0.116423359430884,-0.0868913961967169,-0.213456952914577,-0.12656555671786,0.000466613168794888,-3.05811818785063,2.70020953067645,2.81407984735737,2.32606420443913,-0.488015642918239,0.00926001111585863,ENSG00000100453,GZMB,protein_coding,14,-1,24630954,24634267,q12,granzyme B [Source:HGNC Symbol;Acc:HGNC:4709],NA,GZMB,3002,NM_001346011;NM_004131
FKBP1A_SIG,FKBP1A,FKBP1A_SIG,FKBP1A,SIG,30,-3.78420938660147,0.353428545541526,0.361555420233164,0.326725957269001,-0.034829462964163,0.000467091921464894,-1.72060976837966,7.70137461905555,7.72652217602047,7.61874693188511,-0.107775244135362,0.157695916328628,ENSG00000088832,FKBP1A,protein_coding,20,-1,1368978,1393172,p13,FKBP prolyl isomerase 1A [Source:HGNC Symbol;Acc:HGNC:3711],NA,FKBP1A,2280,NM_000801;NM_001199786;NM_054014
CD274_SIG,CD274,CD274_SIG,CD274,SIG,40,-3.78412502851336,0.128900563449067,0.138488074648561,0.0973987409364443,-0.0410893337121167,0.000467091921464894,-2.71060885779602,1.23897986702368,1.30677371854317,1.01622864060253,-0.29054507794064,0.0218618222646399,ENSG00000120217,CD274,protein_coding,9,1,5450503,5470566,p24.1,CD274 molecule [Source:HGNC Symbol;Acc:HGNC:17635],NA,CD274,29126,NM_001267706;NM_014143
ANK3_SIG,ANK3,ANK3_SIG,ANK3,SIG,25,-3.78387117317883,-0.198438631333037,-0.181859321559053,-0.252913506304701,-0.0710541847456485,0.000467351596572803,-1.59742270239537,1.56511127714283,1.61261152010705,1.40903905026039,-0.203572469846655,0.191381833274146,ENSG00000151150,ANK3,protein_coding,10,-1,60026298,60733490,q21.2,ankyrin 3 [Source:HGNC Symbol;Acc:HGNC:494],Intellectual disability-hypotonia-spasticity-sleep disorder syndrome;MENTAL RETARDATION AUTOSOMAL RECESSIVE 37,ANK3,288,NM_001149;NM_001204403;NM_001204404;NM_001320874;NM_020987
ING4_SIG,ING4,ING4_SIG,ING4,SIG,88,3.78373443856139,0.107339241610923,0.095309507901557,0.146865509513125,0.0515560016115685,0.000467351596572803,1.98180532009036,4.66608642008996,4.62146253939746,4.8127077423653,0.191245202967831,0.100414802291252,ENSG00000111653,ING4,protein_coding,12,-1,6650301,6663142,p13.31,inhibitor of growth family member 4 [Source:HGNC Symbol;Acc:HGNC:19423],NA,ING4,51147,NM_001127582;NM_001127583;NM_001127584;NM_001127585;NM_001127586;NM_016162
METTL15_SIG,METTL15,METTL15_SIG,METTL15,SIG,44,3.78371416843879,0.277890725314155,0.261027892555992,0.333297175805262,0.0722692832492698,0.000467351596572803,3.31279433967837,2.75000666514491,2.69230471190986,2.93959879720293,0.247294085293067,0.00464324894083994,ENSG00000169519,METTL15,protein_coding,11,1,28108248,28527041,p14.1,methyltransferase like 15 [Source:HGNC Symbol;Acc:HGNC:26606],NA,METTL15,196074,NM_001113528;NM_001297775;NM_152636
TNFRSF1B_SIG,TNFRSF1B,TNFRSF1B_SIG,TNFRSF1B,SIG,43,-3.78362248882473,0.46712542053383,0.489913496854832,0.392250312621967,-0.0976631842328654,0.000467353234274935,-3.03354733862596,7.24272330789199,7.36787893285868,6.83149768300143,-0.53638124985725,0.00985472155119213,ENSG00000028137,TNFRSF1B,protein_coding,1,1,12166991,12209228,p36.22,TNF receptor superfamily member 1B [Source:HGNC Symbol;Acc:HGNC:11917],Classic mycosis fungoides;Sezary syndrome,TNFRSF1B,7133,NM_001066
CASP3_SIG,CASP3,CASP3_SIG,CASP3,SIG,15,3.78310997375966,0.388837310041646,0.382689883267249,0.409035998014663,0.0263461147474134,0.000468146148220206,4.39829114090439,5.61019292385945,5.504473514966,5.95755669593794,0.453083180971935,0.000144193655872721,ENSG00000164305,CASP3,protein_coding,4,-1,184627696,184649509,q35.1,caspase 3 [Source:HGNC Symbol;Acc:HGNC:1504],NA,CASP3,836,NM_001354777;NM_001354779;NM_001354780;NM_001354781;NM_001354782;NM_001354783;NM_001354784;NM_004346;NM_032991
GUCY2D_SIG,GUCY2D,GUCY2D_SIG,GUCY2D,SIG,6,3.78111537152393,0.0190850596340846,0.013907550996677,0.0360968737284239,0.0221893227317469,0.000471741297153649,1.69150625952944,0.627667007342164,0.597621863400331,0.726386766008187,0.128764902607857,0.165289373919463,ENSG00000132518,GUCY2D,protein_coding,17,1,8002594,8020339,p13.1,guanylate cyclase 2D, retinal [Source:HGNC Symbol;Acc:HGNC:4689],Central areolar choroidal dystrophy;CHOROIDAL DYSTROPHY CENTRAL AREOLAR 1;CONE-ROD DYSTROPHY 6;Cone rod dystrophy;Leber congenital amaurosis;LEBER CONGENITAL AMAUROSIS 1,GUCY2D,3000,NM_000180
KDM1B_SIG,KDM1B,KDM1B_SIG,KDM1B,SIG,31,-3.78100354652305,0.424601643452408,0.43426093769298,0.392863962376244,-0.0413969753167357,0.000471781211533587,-2.78693199885088,6.53208486322531,6.58477418220193,6.35896281515927,-0.225811367042663,0.0182372598806671,ENSG00000165097,KDM1B,protein_coding,6,1,18155329,18223861,p22.3,lysine demethylase 1B [Source:HGNC Symbol;Acc:HGNC:21577],NA,KDM1B,221656,NM_001364614;NM_153042
LNX1_SIG,LNX1,LNX1_SIG,LNX1,SIG,9,3.78057005204295,-0.138783336462635,-0.143237263906096,-0.12414900343412,0.0190882604719759,0.000472431245269629,5.70237511897836,0.46798891670391,0.37689056785403,0.767312062924944,0.390421495070914,6.31892118036258e-07,ENSG00000072201,LNX1,protein_coding,4,-1,53459301,53701405,q12,ligand of numb-protein X 1 [Source:HGNC Symbol;Acc:HGNC:6657],NA,LNX1,84708,NM_001126328;NM_032622
GDF7_SIG,GDF7,GDF7_SIG,GDF7,SIG,7,-3.77943128948291,-0.0888497056438416,-0.0822147138111516,-0.110650393094109,-0.0284356792829569,0.000474275445898128,0.0993704715375924,0.291959871507265,0.290688916318977,0.296135867125925,0.00544695080694779,0.944543537920576,ENSG00000143869,GDF7,protein_coding,2,1,20667144,20679243,p24.1,growth differentiation factor 7 [Source:HGNC Symbol;Acc:HGNC:4222],NA,GDF7,151449,NM_182828
SP100_SIG,SP100,SP100_SIG,SP100,SIG,33,-3.77938220867937,0.370403347075579,0.377404567851856,0.347399335953528,-0.0300052318983281,0.000474275445898128,-2.5068135285683,7.15889804612733,7.18904080730697,7.05985754510854,-0.129183262198434,0.0347417163960953,ENSG00000067066,SP100,protein_coding,2,1,230415942,230545606,q37.1,SP100 nuclear antigen [Source:HGNC Symbol;Acc:HGNC:11206],NA,SP100,6672,NM_001080391;NM_001206701;NM_001206702;NM_001206703;NM_001206704;NM_003113
CREBZF_TF,CREBZF,CREBZF_TF,CREBZF,TF,68,3.77932792239384,0.389225878190451,0.381514823768066,0.414562199864,0.0330473760959341,0.000474275445898128,1.94917174064747,6.27797755045496,6.24740062859247,6.37844457943171,0.131043950839246,0.106596751455231,ENSG00000137504,CREBZF,protein_coding,11,-1,85659708,85682908,q14.1,CREB/ATF bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:24905],NA,CREBZF,58487,NM_001039618
ZNF143_TF,ZNF143,ZNF143_TF,ZNF143,TF,174,-3.77884004318238,0.11724734307762,0.125037759603614,0.0916502602064963,-0.0333874993971178,0.000475032561567347,-2.7038102778156,4.20863251554758,4.2489695254344,4.07609662591946,-0.172872899514937,0.0222146020748794,ENSG00000166478,ZNF143,protein_coding,11,1,9460319,9528524,p15.4,zinc finger protein 143 [Source:HGNC Symbol;Acc:HGNC:12928],NA,ZNF143,7702,NM_001282656;NM_001282657;NM_003442
MBD1_SIG,MBD1,MBD1_SIG,MBD1,SIG,6,3.77867089568013,0.195299391784522,0.190157433041459,0.212194399083156,0.0220369660416966,0.000475182370875256,-0.306548133450096,6.65567857061671,6.65788279261633,6.64843612690365,-0.00944666571268826,0.823900394534394,ENSG00000141644,MBD1,protein_coding,18,-1,50266882,50281774,q21.1,methyl-CpG binding domain protein 1 [Source:HGNC Symbol;Acc:HGNC:6916],NA,MBD1,4152,NM_001204136;NM_001204137;NM_001204138;NM_001204139;NM_001204140;NM_001204141;NM_001204142;NM_001204143;NM_001204151;NM_001323942;NM_001323947;NM_001323949;NM_001323950;NM_001323951;NM_001323952;NM_001323953;NM_001323954;NM_002384;NM_015844;NM_015845;NM_015846;NM_015847
EFNA5_SIG,EFNA5,EFNA5_SIG,EFNA5,SIG,10,-3.77809549091406,-0.195480934548982,-0.187950888239751,-0.220222515279311,-0.0322716270395596,0.000476037550314772,-2.17485505202944,0.320012103596425,0.351708486878964,0.215866844239513,-0.13584164263945,0.0697128760617079,ENSG00000184349,EFNA5,protein_coding,5,-1,107376889,107670937,q21.3,ephrin A5 [Source:HGNC Symbol;Acc:HGNC:3225],NA,EFNA5,1946,NM_001962
EWSR1_SIG,EWSR1,EWSR1_SIG,EWSR1,SIG,20,3.77804188197652,0.679889734395235,0.673684826628751,0.700277288485113,0.0265924618563622,0.000476037550314772,3.70202503532129,8.47208817453012,8.43988015874756,8.57791451210137,0.138034353353811,0.00146130628265719,ENSG00000182944,EWSR1,protein_coding,22,1,29268009,29300525,q12.2,EWS RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:3508],Desmoplastic small round cell tumor;Ewing sarcoma;Extraskeletal Ewing sarcoma;Extraskeletal myxoid chondrosarcoma;Melanoma of soft tissue,EWSR1,2130,NM_001163285;NM_001163286;NM_001163287;NM_005243;NM_013986
GTF2IRD2_TF,GTF2IRD2,GTF2IRD2_TF,GTF2IRD2,TF,39,3.77648461011117,0.108645066547181,0.104699085234065,0.121610433718847,0.0169113484847826,0.000478848261193751,2.17084506701922,2.35048160405539,2.32043801075568,2.44919626775443,0.128758256998757,0.0702268408899866,ENSG00000196275,GTF2IRD2,protein_coding,7,-1,74796144,74851551,q11.23,GTF2I repeat domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30775],NA,GTF2IRD2,84163,NM_001281447;NM_173537
ALG11_SIG,ALG11,ALG11_SIG,ALG11,SIG,62,3.77535298118105,0.175339651678851,0.169482205478426,0.194585546337393,0.0251033408589676,0.000480852737691581,4.34516498938068,3.18670945985228,3.12864602383298,3.37748932105857,0.248843297225591,0.000173579933159693,ENSG00000253710,ALG11,protein_coding,13,1,52012398,52033600,q14.3,ALG11, alpha-1,2-mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:32456],ALG11-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ip,ALG11,440138,NM_001004127
USP18_SIG,USP18,USP18_SIG,USP18,SIG,31,-3.7737765932891,0.0484648952429993,0.0575047665312537,0.0187624610101635,-0.0387423055210902,0.000483727167519939,-1.27620113986741,1.81069827419261,1.84692511828349,1.69166721503686,-0.155257903246631,0.304602117485277,ENSG00000184979,USP18,protein_coding,22,1,18149899,18177397,q11.21,ubiquitin specific peptidase 18 [Source:HGNC Symbol;Acc:HGNC:12616],PSEUDO-TORCH SYNDROME 2;Severe pseudo-TORCH syndrome;USP18 deficiency,USP18,11274,NM_017414
APOBEC3D_SIG,APOBEC3D,APOBEC3D_SIG,APOBEC3D,SIG,89,3.77348430991897,0.146799286184649,0.135764289251304,0.183057133251353,0.0472928440000484,0.000484118707470908,2.66532920852792,3.01075878517679,2.94103594858804,3.23984810539695,0.298812156808902,0.0242538238129733,ENSG00000243811,APOBEC3D,protein_coding,22,1,39021113,39033277,q13.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3D [Source:HGNC Symbol;Acc:HGNC:17354],NA,APOBEC3D,140564,NM_001363781;NM_152426
LPXN_SIG,LPXN,LPXN_SIG,LPXN,SIG,44,3.77172336166157,0.125111957481505,0.116887075163076,0.152136570813488,0.0352494956504128,0.000487371861907662,3.27300353035596,5.26721528484219,5.17038115458807,5.58538456996285,0.415003415374775,0.00518257922270899,ENSG00000110031,LPXN,protein_coding,11,-1,58526871,58578220,q12.1,leupaxin [Source:HGNC Symbol;Acc:HGNC:14061],NA,LPXN,9404,NM_001143995;NM_001307951;NM_004811
PPT2_SIG,PPT2,PPT2_SIG,PPT2,SIG,106,3.77104676148815,0.13084792530996,0.118430915825845,0.171646670757767,0.0532157549319224,0.00048851811010125,3.04764097727162,3.16549345791764,3.08436777372284,3.43204927741484,0.347681503691994,0.0095093824404633,ENSG00000221988,PPT2,protein_coding,6,1,32153441,32163678,p21.32,palmitoyl-protein thioesterase 2 [Source:HGNC Symbol;Acc:HGNC:9326],NA,PPT2,9374,NM_001204103;NM_005155;NM_138717
SMYD5_SIG,SMYD5,SMYD5_SIG,SMYD5,SIG,66,3.76816548957117,0.418070860196,0.408470637155133,0.449614450187423,0.0411438130322901,0.000494010908230744,2.85514120091319,4.35447705220577,4.30324080396226,4.52282472500586,0.219583921043592,0.0154951922398855,ENSG00000135632,SMYD5,protein_coding,2,1,73214222,73227221,p13.2,SMYD family member 5 [Source:HGNC Symbol;Acc:HGNC:16258],NA,SMYD5,10322,NM_006062
TIA1_SIG,TIA1,TIA1_SIG,TIA1,SIG,83,3.76699697608382,0.315602389972132,0.299993719808119,0.366888020511031,0.0668943007029115,0.000496148084853384,1.86843855096883,6.644057966967,6.60382596007261,6.77624884676283,0.172422886690216,0.122944333098414,ENSG00000116001,TIA1,protein_coding,2,-1,70209444,70248660,p13.3,TIA1 cytotoxic granule associated RNA binding protein [Source:HGNC Symbol;Acc:HGNC:11802],Distal myopathy Welander type;WELANDER DISTAL MYOPATHY,TIA1,7072,NM_001351508;NM_001351509;NM_001351510;NM_001351511;NM_001351512;NM_001351513;NM_001351514;NM_001351515;NM_001351516;NM_001351517;NM_001351518;NM_001351519;NM_001351520;NM_001351521;NM_001351522;NM_001351523;NM_001351524;NM_001351525;NM_022037;NM_022173
STAMBP_SIG,STAMBP,STAMBP_SIG,STAMBP,SIG,20,3.76659083335503,0.459198016944436,0.448548443660976,0.494189472018661,0.0456410283576853,0.000496775476664061,4.00211891307519,5.26175176324616,5.21613707562116,5.41162859401405,0.19549151839289,0.000565990941834335,ENSG00000124356,STAMBP,protein_coding,2,1,73828916,73873659,p13.1,STAM binding protein [Source:HGNC Symbol;Acc:HGNC:16950],Microcephaly-capillary malformation syndrome,STAMBP,10617,NM_001353967;NM_001353968;NM_001353969;NM_001353970;NM_001353971;NM_001353972;NM_001353973;NM_001353974;NM_001353975;NM_001353976;NM_006463;NM_201647;NM_213622
SLC9A8_SIG,SLC9A8,SLC9A8_SIG,SLC9A8,SIG,27,-3.76604506305726,0.123021301162851,0.132217855038719,0.0928040527135685,-0.0394138023251506,0.000497681750637758,-1.94339603366142,5.54649090971746,5.57863032968362,5.44088995840007,-0.137740371283556,0.107666454222455,ENSG00000197818,SLC9A8,protein_coding,20,1,49812713,49892242,q13.13,solute carrier family 9 member A8 [Source:HGNC Symbol;Acc:HGNC:20728],NA,SLC9A8,23315,NM_001260491;NM_015266
CAPRIN1_SIG,CAPRIN1,CAPRIN1_SIG,CAPRIN1,SIG,39,3.76476872824601,0.618756635406949,0.60817474812441,0.653525693621007,0.0453509454965972,0.000500049550716693,2.92596351612515,8.5173405104183,8.47698460483882,8.64993848589372,0.172953881054898,0.0130050165207182,ENSG00000135387,CAPRIN1,protein_coding,11,1,34051731,34102610,p13,cell cycle associated protein 1 [Source:HGNC Symbol;Acc:HGNC:6743],AUTISM OR INTELLECTUAL DISABILITY,CAPRIN1,4076,NM_005898;NM_203364
ZNF618_TF,ZNF618,ZNF618_TF,ZNF618,TF,99,3.76393064144042,0.189354646672739,0.180777040255078,0.217538210616483,0.0367611703614058,0.00050154773405141,0.393196599870697,5.09213245953861,5.08234598884331,5.12428800610887,0.0419420172655575,0.772518788114399,ENSG00000157657,ZNF618,protein_coding,9,1,113876282,114056591,q32,zinc finger protein 618 [Source:HGNC Symbol;Acc:HGNC:29416],NA,ZNF618,114991,NM_001318040;NM_001318041;NM_001318042;NM_133374
ZNF132_TF,ZNF132,ZNF132_TF,ZNF132,TF,14,3.76366879551722,-0.00858201645839514,-0.0237008091546849,0.0410940166865569,0.0647948258412417,0.000501891799756709,3.35743644057711,1.45823904227008,1.3923089315925,1.67486654878215,0.282557617189652,0.00409332427805897,ENSG00000131849,ZNF132,protein_coding,19,-1,58432814,58440153,q13.43,zinc finger protein 132 [Source:HGNC Symbol;Acc:HGNC:12916],NA,ZNF132,7691,NM_003433
ZNF76_TF,ZNF76,ZNF76_TF,ZNF76,TF,112,3.7634095258602,0.228242005813208,0.219384706485658,0.257344560746586,0.0379598542609287,0.000502202862095817,2.5081775357624,5.31181277252106,5.27854560624714,5.4211191759925,0.142573569745355,0.0346424949662652,ENSG00000065029,ZNF76,protein_coding,6,1,35258909,35295985,p21.31,zinc finger protein 76 [Source:HGNC Symbol;Acc:HGNC:13149],NA,ZNF76,7629,NM_001292032;NM_003427
CNOT4_SIG,CNOT4,CNOT4_SIG,CNOT4,SIG,40,3.76330831520291,0.361038602702278,0.356353774545394,0.376431609503465,0.0200778349580706,0.000502202862095817,3.08486526732493,5.02950676426214,4.9940060449671,5.14615198480299,0.152145939835889,0.00862824997946332,ENSG00000080802,CNOT4,protein_coding,7,-1,135361795,135510127,q33,CCR4-NOT transcription complex subunit 4 [Source:HGNC Symbol;Acc:HGNC:7880],NA,CNOT4,4850,NM_001008225;NM_001190847;NM_001190848;NM_001190849;NM_001190850;NM_013316
RBM38_SIG,RBM38,RBM38_SIG,RBM38,SIG,48,-3.76324276638126,0.0345105354475965,0.0459579164606942,-0.00310228788115343,-0.0490602043418475,0.000502202862095817,-1.91807488024962,6.36727128886635,6.42759866456033,6.16905276872897,-0.25854589583136,0.112666951485613,ENSG00000132819,RBM38,protein_coding,20,1,57391396,57409333,q13.31,RNA binding motif protein 38 [Source:HGNC Symbol;Acc:HGNC:15818],NA,RBM38,55544,NM_001291780;NM_017495;NM_183425
APOBEC3F_SIG,APOBEC3F,APOBEC3F_SIG,APOBEC3F,SIG,67,3.76302748348819,0.166681727425976,0.15399601996151,0.208363337666366,0.0543673177048562,0.000502453957760512,2.41357241924763,3.25162465888113,3.20243428785032,3.41325016369664,0.210815875846319,0.0426022462191882,ENSG00000128394,APOBEC3F,protein_coding,22,1,39040604,39055972,q13.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3F [Source:HGNC Symbol;Acc:HGNC:17356],NA,APOBEC3F,200316,NM_001006666;NM_145298
CAPN7_SIG,CAPN7,CAPN7_SIG,CAPN7,SIG,37,3.7627606647697,-0.0145572415968116,-0.0196210676323171,0.00208104394842086,0.0217021115807381,0.000502786940964338,1.96752698287617,5.39236295923503,5.37376446379824,5.45347230138448,0.079707837586242,0.102984509805887,ENSG00000131375,CAPN7,protein_coding,3,1,15206152,15252916,p25.1,calpain 7 [Source:HGNC Symbol;Acc:HGNC:1484],NA,CAPN7,23473,NM_014296
GLRX_SIG,GLRX,GLRX_SIG,GLRX,SIG,19,-3.7626812939489,0.0755825121023646,0.0920831277549987,0.0213662035294239,-0.0707169242255749,0.000502786940964338,-1.56857798226287,5.53965820913079,5.57565461315368,5.42138431019845,-0.154270302955227,0.20013026520939,ENSG00000173221,GLRX,protein_coding,5,-1,95751319,95822726,q15,glutaredoxin [Source:HGNC Symbol;Acc:HGNC:4330],NA,GLRX,2745,NM_001118890;NM_001243658;NM_001243659;NM_002064
CD6_SIG,CD6,CD6_SIG,CD6,SIG,36,-3.76220945535397,-0.0361448864694946,-0.0103787504241608,-0.120805047761305,-0.110426297337145,0.000503554905946463,-2.77743555827203,4.05004062352778,4.16014320262895,3.68827500648106,-0.471868196147889,0.0186417231297117,ENSG00000013725,CD6,protein_coding,11,1,60971680,61020377,q12.2,CD6 molecule [Source:HGNC Symbol;Acc:HGNC:1691],NA,CD6,923,NM_001254750;NM_001254751;NM_006725
TCOF1_SIG,TCOF1,TCOF1_SIG,TCOF1,SIG,13,3.76097725102099,0.617611854592364,0.604982272773224,0.659109051998109,0.0541267792248851,0.000505859695264392,3.68253645142288,5.89020810281654,5.82653508306189,6.09941945343897,0.272884370377084,0.00155198071846721,ENSG00000070814,TCOF1,protein_coding,5,1,150357629,150400308,q32,treacle ribosome biogenesis factor 1 [Source:HGNC Symbol;Acc:HGNC:11654],Treacher-Collins syndrome;TREACHER COLLINS SYNDROME 1;TREACHER COLLINS SYNDROME TYPE 1,TCOF1,6949,NM_000356;NM_001008657;NM_001135243;NM_001135244;NM_001135245;NM_001195141
ZNF585B_TF,ZNF585B,ZNF585B_TF,ZNF585B,TF,45,3.75993050788472,-0.0541073238330914,-0.0674227149137783,-0.0103567531394058,0.0570659617743725,0.000507797785533954,2.9287241530418,3.64132086351566,3.57285247611145,3.8662884221295,0.293435946018051,0.012909346322321,ENSG00000245680,ZNF585B,protein_coding,19,-1,37181579,37218153,q13.12,zinc finger protein 585B [Source:HGNC Symbol;Acc:HGNC:30948],NA,ZNF585B,92285,NM_152279
PI3_SIG,PI3,PI3_SIG,PI3,SIG,16,-3.75971295708949,-0.0777114994627282,-0.0564616029575852,-0.147532587979627,-0.0910709850220414,0.00050805633750948,-2.23291882948714,1.15960389969744,1.24445005330606,0.880823680697689,-0.363626372608372,0.0620371526626897,ENSG00000124102,PI3,protein_coding,20,1,45174902,45176544,q13.12,peptidase inhibitor 3 [Source:HGNC Symbol;Acc:HGNC:8947],NA,PI3,5266,NM_002638
CPSF7_SIG,CPSF7,CPSF7_SIG,CPSF7,SIG,11,3.75947750214359,0.419256630641437,0.413220503406294,0.439089620128337,0.0258691167220436,0.00050835144087124,2.58245197980445,7.28568335317788,7.26281750158825,7.36081400840094,0.0979965068126881,0.0293314066759816,ENSG00000149532,CPSF7,protein_coding,11,-1,61402641,61430031,q12.2,cleavage and polyadenylation specific factor 7 [Source:HGNC Symbol;Acc:HGNC:30098],NA,CPSF7,79869,NM_001136040;NM_001142565;NM_024811
MIPEP_SIG,MIPEP,MIPEP_SIG,MIPEP,SIG,27,3.75923820816364,0.418306034030783,0.403330963148791,0.467509838357328,0.0641788752085362,0.000508654559260155,3.72920511777689,3.01757644507396,2.93949428015771,3.2741321297988,0.334637849641098,0.00134065995773546,ENSG00000027001,MIPEP,protein_coding,13,-1,23730189,23889400,q12.12,mitochondrial intermediate peptidase [Source:HGNC Symbol;Acc:HGNC:7104],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31;Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,MIPEP,4285,NM_005932
OR2L13_SIG,OR2L13,OR2L13_SIG,OR2L13,SIG,76,3.75615210042101,-0.0479924862335684,-0.0597088153241094,-0.00949597636464781,0.0502128389594617,0.000514779393194852,3.02325115580986,0.699230271441539,0.647181239149988,0.870248520399494,0.223067281249506,0.0101240094028982,ENSG00000196071,OR2L13,protein_coding,1,1,248095184,248101103,q44,olfactory receptor family 2 subfamily L member 13 [Source:HGNC Symbol;Acc:HGNC:19578],NA,OR2L13,284521,NM_001304535;NM_175911
ASB2_SIG,ASB2,ASB2_SIG,ASB2,SIG,19,-3.75587356170742,-0.0766644338191742,-0.0693823420848632,-0.100591306660482,-0.0312089645756184,0.000515166820781041,-1.02503614854597,1.33098122326097,1.35419910348236,1.25469390253355,-0.0995052009488112,0.418282622762342,ENSG00000100628,ASB2,protein_coding,14,-1,93934153,93976791,q32.12,ankyrin repeat and SOCS box containing 2 [Source:HGNC Symbol;Acc:HGNC:16012],NA,ASB2,51676,NM_001202429;NM_016150
ESAM_SIG,ESAM,ESAM_SIG,ESAM,SIG,93,-3.75529253525973,-0.0762985006855448,-0.0667775005049408,-0.107581786993244,-0.0408042864883028,0.000516177652730117,-2.44755453274565,2.24263040950725,2.35294380638457,1.8801721054818,-0.472771700902763,0.0395738680781242,ENSG00000149564,ESAM,protein_coding,11,-1,124752583,124762290,q24.2,endothelial cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:17474],NA,ESAM,90952,NM_138961
ZDHHC7_SIG,ZDHHC7,ZDHHC7_SIG,ZDHHC7,SIG,24,-3.75499143686884,0.423004236307873,0.438775413063508,0.371184655539357,-0.0675907575241514,0.000516612679332259,-1.25755083036896,6.94364956516783,6.96435254820242,6.87562547805417,-0.0887270701482549,0.312147941849412,ENSG00000153786,ZDHHC7,protein_coding,16,-1,84974181,85011535,q24.1,zinc finger DHHC-type containing 7 [Source:HGNC Symbol;Acc:HGNC:18459],NA,ZDHHC7,55625,NM_001145548;NM_017740
HS6ST1_SIG,HS6ST1,HS6ST1_SIG,HS6ST1,SIG,25,3.75426608243124,0.188710024998528,0.179605161585994,0.218626004782568,0.039020843196574,0.000517924548755506,1.77576223053986,5.0891756107026,5.04796496573707,5.22458201558936,0.176617049852297,0.143996654772128,ENSG00000136720,HS6ST1,protein_coding,2,-1,128236716,128318868,q14.3,heparan sulfate 6-O-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:5201],HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA;Kallmann Syndrome;Normosmic congenital hypogonadotropic hypogonadism,HS6ST1,9394,NM_004807
MRPS17_SIG,MRPS17,MRPS17_SIG,MRPS17,SIG,20,3.75412993538759,0.261819792849203,0.254921696708616,0.284484965882558,0.0295632691739412,0.00051801983448067,2.887953091907,1.75774602325607,1.72322059472502,1.87118671700096,0.147966122275936,0.014296452151443,ENSG00000239789,MRPS17,protein_coding,7,1,55951877,55956500,p11.2,mitochondrial ribosomal protein S17 [Source:HGNC Symbol;Acc:HGNC:14047],NA,MRPS17,51373,NM_015969
CD46_SIG,CD46,CD46_SIG,CD46,SIG,34,-3.75390030406857,0.0456576434502887,0.0503172602785341,0.0303474738717684,-0.0199697864067657,0.00051813554412014,-3.47816002158119,7.24467258471702,7.28740057632608,7.10428061228725,-0.183119964038824,0.00287308256694296,ENSG00000117335,CD46,protein_coding,1,1,207752057,207795513,q32.2,CD46 molecule [Source:HGNC Symbol;Acc:HGNC:6953],Atypical hemolytic uremic syndrome with MCP/CD46 anomaly;HELLP syndrome;HEMOLYTIC UREMIC SYNDROME ATYPICAL SUSCEPTIBILITY TO 2,CD46,4179,NM_002389;NM_153826;NM_172350;NM_172351;NM_172352;NM_172353;NM_172355;NM_172356;NM_172359;NM_172361
LYPLAL1_SIG,LYPLAL1,LYPLAL1_SIG,LYPLAL1,SIG,24,3.75389394534608,-0.0737091795831069,-0.0867198559063269,-0.0309598145210984,0.0557600413852286,0.00051813554412014,1.4801789177694,3.38742939333536,3.36425643560512,3.46356911159185,0.099312675986734,0.228576644544884,ENSG00000143353,LYPLAL1,protein_coding,1,1,219173869,219212865,q41,lysophospholipase like 1 [Source:HGNC Symbol;Acc:HGNC:20440],NA,LYPLAL1,127018,NM_001300769;NM_001300770;NM_001300771;NM_001300772;NM_001350628;NM_001350629;NM_138794
MPHOSPH10_SIG,MPHOSPH10,MPHOSPH10_SIG,MPHOSPH10,SIG,24,3.75293065899321,0.243946027388893,0.23592218567407,0.270310078737595,0.0343878930635255,0.000519944624028341,2.35353985987303,5.23366088168167,5.20251611389488,5.33599369012398,0.133477576229102,0.0484117690576338,ENSG00000124383,MPHOSPH10,protein_coding,2,1,71130632,71150101,p13.3,M-phase phosphoprotein 10 [Source:HGNC Symbol;Acc:HGNC:7213],NA,MPHOSPH10,10199,NM_005791
CASP7_SIG,CASP7,CASP7_SIG,CASP7,SIG,27,3.75270859580547,0.221305484473669,0.217265776728919,0.234578809920707,0.0173130331917889,0.000520218784406564,1.88627564507204,4.45626642029372,4.42704706914624,4.5522728597783,0.125225790632052,0.119104983578781,ENSG00000165806,CASP7,protein_coding,10,1,113679162,113730907,q25.3,caspase 7 [Source:HGNC Symbol;Acc:HGNC:1508],NA,CASP7,840,NM_001227;NM_001267056;NM_001267057;NM_001267058;NM_001320911;NM_033338;NM_033339;NM_033340
ZCCHC4_SIG,ZCCHC4,ZCCHC4_SIG,ZCCHC4,SIG,22,3.75205049451327,0.315179073192274,0.305754231619325,0.346146409789104,0.0403921781697788,0.000521399472561781,3.23029068100452,2.85671694421726,2.81814048493887,2.98346816756055,0.165327682621682,0.00583376231586906,ENSG00000168228,ZCCHC4,protein_coding,4,1,25312774,25370383,p15.2,zinc finger CCHC-type containing 4 [Source:HGNC Symbol;Acc:HGNC:22917],NA,ZCCHC4,29063,NM_001318148;NM_024936
CTHRC1_SIG,CTHRC1,CTHRC1_SIG,CTHRC1,SIG,40,-3.74954463328803,-0.0861393969221181,-0.0763010371601693,-0.11846543613995,-0.0421643989797806,0.000526448053554727,-1.74026709200109,0.397328767326098,0.429845252527412,0.290488887378923,-0.139356365148489,0.152617513774841,ENSG00000164932,CTHRC1,protein_coding,8,1,103371538,103382989,q22.3,collagen triple helix repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:18831],BARRETT ESOPHAGUS,CTHRC1,115908,NM_001256099;NM_138455
TEAD4_TF,TEAD4,TEAD4_TF,TEAD4,TF,219,3.74937528979858,-0.0671911983149725,-0.0702634795041732,-0.0570965601218844,0.0131669193822889,0.000526614761555847,1.75123202386748,0.646936021433112,0.61037739384187,0.767057226375765,0.156679832533894,0.149894218109871,ENSG00000197905,TEAD4,protein_coding,12,1,2959330,3040676,p13.33,TEA domain transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:11717],NA,TEAD4,7004,NM_003213;NM_201441;NM_201443
ZNF263_TF,ZNF263,ZNF263_TF,ZNF263,TF,37,3.7486957642402,0.179384620904023,0.170400571494017,0.208903640394045,0.038503068900028,0.000527854153901761,2.39626240492537,5.53649918448998,5.51060445939673,5.62158185265353,0.110977393256804,0.0442195973352628,ENSG00000006194,ZNF263,protein_coding,16,1,3263800,3301401,p13.3,zinc finger protein 263 [Source:HGNC Symbol;Acc:HGNC:13056],NA,ZNF263,10127,NM_005741
PI4KA_SIG,PI4KA,PI4KA_SIG,PI4KA,SIG,29,3.74806878450835,0.24217119630456,0.237504346776937,0.257505130466751,0.0200007836898134,0.000528985492955685,1.4316741177474,7.69146326297453,7.67587025058493,7.74269744654035,0.0668271959554155,0.244865064534377,ENSG00000241973,PI4KA,protein_coding,22,-1,20707691,20859417,q11.21,phosphatidylinositol 4-kinase alpha [Source:HGNC Symbol;Acc:HGNC:8983],Bilateral perisylvian polymicrogyria;POLYMICROGYRIA PERISYLVIAN WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS,PI4KA,5297,NM_058004
KIR3DL1_SIG,KIR3DL1,KIR3DL1_SIG,KIR3DL1,SIG,7,-3.74725243612648,-0.134440568238425,-0.111883605973486,-0.208556301394654,-0.0966726954211681,0.000530519358560347,-2.74412096009169,0.341333687469034,0.376881885897211,0.22453246406217,-0.152349421835041,0.0201746263865153,ENSG00000167633,KIR3DL1,protein_coding,19,1,54816468,54830778,q13.42,killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 [Source:HGNC Symbol;Acc:HGNC:6338],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,KIR3DL1,3811,NM_013289
ST3GAL5_SIG,ST3GAL5,ST3GAL5_SIG,ST3GAL5,SIG,33,-3.74689681373393,0.210810404486005,0.221388096270928,0.176055131478399,-0.0453329647925287,0.000531081520329296,-2.57267750069891,3.77786905747532,3.85184755414432,3.53479685413435,-0.317050700009973,0.0299880844240725,ENSG00000115525,ST3GAL5,protein_coding,2,-1,85837120,85905199,p11.2,ST3 beta-galactoside alpha-2,3-sialyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:10872],AMISH INFANTILE EPILEPSY SYNDROME;Salt-and-pepper syndrome;SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME,ST3GAL5,8869,NM_001042437;NM_001354223;NM_001354224;NM_001354226;NM_001354227;NM_001354229;NM_001354233;NM_001354234;NM_001354238;NM_001354247;NM_001354248;NM_001363847;NM_003896
IFITM1_SIG,IFITM1,IFITM1_SIG,IFITM1,SIG,60,-3.74636873979102,0.0992108280948184,0.108333666714334,0.0692357869164087,-0.0390978797979256,0.000532009717839589,-2.17811852453308,4.29298544869824,4.37721716525413,4.01622409430032,-0.360993070953804,0.0692821642265843,ENSG00000185885,IFITM1,protein_coding,11,1,313506,315272,p15.5,interferon induced transmembrane protein 1 [Source:HGNC Symbol;Acc:HGNC:5412],NA,IFITM1,8519,NM_003641
TAS2R3_SIG,TAS2R3,TAS2R3_SIG,TAS2R3,SIG,46,3.74544375788857,0.117596473088218,0.109248296711238,0.145026195469725,0.0357778987584877,0.000533782800685123,2.70353435989574,0.274060528342423,0.253490766189374,0.341646889702441,0.0881561235130666,0.0222235931521269,ENSG00000127362,TAS2R3,protein_coding,7,1,141764097,141765197,q34,taste 2 receptor member 3 [Source:HGNC Symbol;Acc:HGNC:14910],NA,TAS2R3,50831,NM_016943
C1QB_SIG,C1QB,C1QB_SIG,C1QB,SIG,17,-3.74404359457443,-0.273065534471729,-0.252048928549201,-0.342120096788609,-0.0900711682394082,0.000536575871598437,-3.06419553031653,2.00114663265758,2.14491277313291,1.5287721710958,-0.616140602037108,0.00911542988805367,ENSG00000173369,C1QB,protein_coding,1,1,22652762,22661637,p36.12,complement C1q B chain [Source:HGNC Symbol;Acc:HGNC:1242],C1q DEFICIENCY;Immunodeficiency due to a classical component pathway complement deficiency,C1QB,713,NM_000491
NMRAL1_SIG,NMRAL1,NMRAL1_SIG,NMRAL1,SIG,18,3.74350167721074,0.267681487180802,0.255556880649585,0.307519480069089,0.0519625994195046,0.000537542738890912,3.55174917302853,4.80791416846558,4.75454074627325,4.98328398424038,0.228743237967132,0.00231442028707975,ENSG00000153406,NMRAL1,protein_coding,16,-1,4461680,4495763,p13.3,NmrA like redox sensor 1 [Source:HGNC Symbol;Acc:HGNC:24987],NA,NMRAL1,57407,NM_001305141;NM_001305142;NM_001351994;NM_001351995;NM_001351996;NM_020677
ZNF160_TF,ZNF160,ZNF160_TF,ZNF160,TF,32,3.74248685665302,0.352714239576234,0.345368954721822,0.376848746955018,0.0314797922331963,0.00053952602748583,2.36208315638407,5.23109221076834,5.19165127158707,5.36068386807823,0.169032596491169,0.0474890578098127,ENSG00000170949,ZNF160,protein_coding,19,-1,53066606,53103436,q13.42,zinc finger protein 160 [Source:HGNC Symbol;Acc:HGNC:12948],NA,ZNF160,90338,NM_001102603;NM_001322125;NM_001322126;NM_001322128;NM_001322129;NM_001322130;NM_001322131;NM_001322132;NM_001322133;NM_001322134;NM_001322135;NM_001322136;NM_001322137;NM_001322138;NM_001322139;NM_033288;NM_198893
SLC39A13_SIG,SLC39A13,SLC39A13_SIG,SLC39A13,SIG,65,3.74183406581131,0.103488920069203,0.0980896520772433,0.121229372042787,0.0231397199655432,0.000540736488024666,1.70635198577062,4.59319874601231,4.57121690872628,4.6654247828093,0.0942078740830253,0.161585352366288,ENSG00000165915,SLC39A13,protein_coding,11,1,47407132,47416496,p11.2,solute carrier family 39 member 13 [Source:HGNC Symbol;Acc:HGNC:20859],EHLERS-DANLOS SYNDROME-LIKE SPONDYLOCHEIRODYSPLASIA;Ehlers-Danlos syndrome spondylocheiro dysplastic type;EHLERS-DANLOS SYNDROME SPONDYLODYSPLASTIC TYPE 3;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION,SLC39A13,91252,NM_001128225;NM_001330245;NM_152264
CSTF2T_SIG,CSTF2T,CSTF2T_SIG,CSTF2T,SIG,40,3.74158208643547,0.245983607005274,0.239011637218621,0.26889150773285,0.0298798705142295,0.000541085738039035,1.81299877279185,5.35912195232635,5.32935859523397,5.45691583991561,0.127557244681635,0.135240300717202,ENSG00000177613,CSTF2T,protein_coding,10,-1,51695487,51699591,q21.1,cleavage stimulation factor subunit 2 tau variant [Source:HGNC Symbol;Acc:HGNC:17086],NA,CSTF2T,23283,NM_015235
ZNF280D_TF,ZNF280D,ZNF280D_TF,ZNF280D,TF,29,3.74098207041264,0.236202311160087,0.226339229568706,0.268609579246055,0.0422703496773488,0.000542185658406357,3.10875811986531,5.91026503418955,5.86192360323955,6.06910116445384,0.20717756121429,0.00813823634673006,ENSG00000137871,ZNF280D,protein_coding,15,-1,56630181,56734086,q21.3,zinc finger protein 280D [Source:HGNC Symbol;Acc:HGNC:25953],NA,ZNF280D,54816,NM_001002843;NM_001002844;NM_001288588;NM_001288589;NM_017661
PNOC_SIG,PNOC,PNOC_SIG,PNOC,SIG,14,-3.74040547019634,-0.114299604040036,-0.101032311886545,-0.157892135401508,-0.0568598235149627,0.000543237085082642,-2.40689940373202,0.897145639582294,0.944193183582254,0.742560852153852,-0.201632331428402,0.0432280258809226,ENSG00000168081,PNOC,protein_coding,8,1,28316986,28343355,p21.1,prepronociceptin [Source:HGNC Symbol;Acc:HGNC:9163],NA,PNOC,5368,NM_001284244;NM_006228
ZCCHC4_TF,ZCCHC4,ZCCHC4_TF,ZCCHC4,TF,156,3.73989569244807,0.343156155024849,0.335115764397834,0.369574581370757,0.0344588169729235,0.000544145775623567,3.23029068100452,2.85671694421726,2.81814048493887,2.98346816756055,0.165327682621682,0.00583376231586906,ENSG00000168228,ZCCHC4,protein_coding,4,1,25312774,25370383,p15.2,zinc finger CCHC-type containing 4 [Source:HGNC Symbol;Acc:HGNC:22917],NA,ZCCHC4,29063,NM_001318148;NM_024936
OASL_SIG,OASL,OASL_SIG,OASL,SIG,32,-3.73936282948799,0.301255714599731,0.315643560656147,0.253981363271505,-0.0616621973846422,0.000545105974859477,-2.04237036167486,2.87268910372517,2.96249479294694,2.57761326771077,-0.384881525236167,0.0898162288731565,ENSG00000135114,OASL,protein_coding,12,-1,121019111,121039242,q24.31,2'-5'-oligoadenylate synthetase like [Source:HGNC Symbol;Acc:HGNC:8090],NA,OASL,8638,NM_001261825;NM_003733;NM_198213
MYD88_SIG,MYD88,MYD88_SIG,MYD88,SIG,22,-3.73927201848605,0.55553675401895,0.580650757290551,0.473019314697975,-0.107631442592575,0.000545108510484954,-3.94182874932559,7.29641864548154,7.37698875666055,7.03168828017909,-0.345300476481459,0.000687002080504538,ENSG00000172936,MYD88,protein_coding,3,1,38138478,38143022,p22.2,MYD88, innate immune signal transduction adaptor [Source:HGNC Symbol;Acc:HGNC:7562],MACROGLOBULINEMIA WALDENSTROM SUSCEPTIBILITY TO 1;MYD88 DEFICIENCY;Pyogenic bacterial infections due to MyD88 deficiency;Waldenstrom macroglobulinemia,MYD88,4615,NM_001172566;NM_001172567;NM_001172568;NM_001172569;NM_001365876;NM_001365877;NM_002468
NFATC3_TF,NFATC3,NFATC3_TF,NFATC3,TF,24,3.73916032460895,0.366943727191532,0.358843479060814,0.393558828192463,0.034715349131649,0.000545156391847635,0.0325673713167739,6.74440353555337,6.74405844121919,6.74553741693711,0.00147897571792558,0.9823094812892,ENSG00000072736,NFATC3,protein_coding,16,1,68084751,68229259,q22.1,nuclear factor of activated T cells 3 [Source:HGNC Symbol;Acc:HGNC:7777],NA,NFATC3,4775,NM_004555;NM_173163;NM_173165
URB1_SIG,URB1,URB1_SIG,URB1,SIG,15,3.73891957661999,0.369840304891104,0.352606279197353,0.426466389313427,0.0738601101160743,0.000545410921121314,2.71031100044788,5.09750175970256,5.029709246318,5.32024858939466,0.290539343076658,0.0218676136702499,ENSG00000142207,URB1,protein_coding,21,-1,32311018,32393012,q22.11,URB1 ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:17344],NA,URB1,9875,NM_014825
BPTF_TF,BPTF,BPTF_TF,BPTF,TF,109,3.73886383028663,0.440871347853286,0.434404598183402,0.462119239625764,0.0277146414423615,0.000545410921121314,3.1142427253507,7.60357766859746,7.55957893660849,7.74814493084693,0.188565994238431,0.00802357496316675,ENSG00000171634,BPTF,protein_coding,17,1,67825503,67984378,q24.2,bromodomain PHD finger transcription factor [Source:HGNC Symbol;Acc:HGNC:3581],Developmental and Speech Delay Postnatal Microcephaly and Dysmorphic Features;NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES,BPTF,2186,NM_004459;NM_182641
SERGEF_SIG,SERGEF,SERGEF_SIG,SERGEF,SIG,35,3.73737195328835,-0.00119988607521239,-0.00603310743796841,0.0146806984024146,0.0207138058403831,0.000548369830078971,2.50397504575918,2.67440121539694,2.64151431117635,2.78245818640747,0.140943875231129,0.0349692830949317,ENSG00000129158,SERGEF,protein_coding,11,-1,17788048,18013047,p15.1,secretion regulating guanine nucleotide exchange factor [Source:HGNC Symbol;Acc:HGNC:17499],NA,SERGEF,26297,NM_012139
PDE3B_SIG,PDE3B,PDE3B_SIG,PDE3B,SIG,32,-3.73724604031188,0.0266325453854696,0.0312873923882245,0.0113380480907035,-0.0199493442975209,0.000548369830078971,-2.46388308350399,5.85795411123162,5.9308780341741,5.61834693584921,-0.312531098324885,0.0382027586262262,ENSG00000152270,PDE3B,protein_coding,11,1,14643804,14872044,p15.2,phosphodiesterase 3B [Source:HGNC Symbol;Acc:HGNC:8779],NA,PDE3B,5140,NM_000922
ACOT7_SIG,ACOT7,ACOT7_SIG,ACOT7,SIG,15,3.73723470848757,0.304888510654891,0.296291777439344,0.333134919791689,0.0368431423523449,0.000548369830078971,5.93229904612162,3.93081630839776,3.79564122941346,4.37496299648902,0.579321767075557,2.00644468537438e-07,ENSG00000097021,ACOT7,protein_coding,1,-1,6264269,6394391,p36.31,acyl-CoA thioesterase 7 [Source:HGNC Symbol;Acc:HGNC:24157],NA,ACOT7,11332,NM_007274;NM_181864;NM_181865;NM_181866
ACVR1B_SIG,ACVR1B,ACVR1B_SIG,ACVR1B,SIG,27,-3.73628777616357,0.271232215377576,0.276810786290192,0.252902625236124,-0.0239081610540674,0.000550242226428587,-2.17382115315364,4.71392605129016,4.76951518647822,4.53127603567227,-0.238239150805945,0.0698377203853214,ENSG00000135503,ACVR1B,protein_coding,12,1,51951699,51997078,q13.13,activin A receptor type 1B [Source:HGNC Symbol;Acc:HGNC:172],NA,ACVR1B,91,NM_004302;NM_020327;NM_020328
ZMYM1_TF,ZMYM1,ZMYM1_TF,ZMYM1,TF,114,3.736069689031,0.307960085365267,0.293425222304056,0.355717492566387,0.0622922702623311,0.000550455928631696,3.88434013773397,3.75713151893895,3.67288900964131,4.03392833520263,0.361039325561323,0.000823377829294194,ENSG00000197056,ZMYM1,protein_coding,1,1,35032172,35115859,p34.3,zinc finger MYM-type containing 1 [Source:HGNC Symbol;Acc:HGNC:26253],NA,ZMYM1,79830,NM_001289088;NM_001289089;NM_001289090;NM_001289091;NM_001319955;NM_024772
SKIL_TF,SKIL,SKIL_TF,SKIL,TF,115,-3.73601120652932,0.0952055356266981,0.106503443210424,0.0580838392801702,-0.0484196039302538,0.000550455928631696,-4.59309395328967,4.78762279416053,4.91586875310876,4.36624321475918,-0.549625538349578,7.03841047591097e-05,ENSG00000136603,SKIL,protein_coding,3,1,170357678,170396835,q26.2,SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897],NA,SKIL,6498,NM_001145097;NM_001145098;NM_001248008;NM_005414
PRPF31_SIG,PRPF31,PRPF31_SIG,PRPF31,SIG,19,3.73474441653143,0.672807862437452,0.664859851844061,0.698922754387166,0.0340629025431049,0.000553037497022573,3.90759902387282,5.73120247699052,5.6965918457344,5.84492312254634,0.14833127681194,0.000761106839943663,ENSG00000105618,PRPF31,protein_coding,19,1,54115410,54131719,q13.42,pre-mRNA processing factor 31 [Source:HGNC Symbol;Acc:HGNC:15446],Retinitis pigmentosa;RETINITIS PIGMENTOSA 11,PRPF31,26121,NM_015629
ZNF831_TF,ZNF831,ZNF831_TF,ZNF831,TF,252,-3.73312882886546,-0.109410159454513,-0.0984383284508795,-0.145460461323594,-0.0470221328727143,0.000556400719344902,-2.07092105236424,2.26719952597343,2.33179527561933,2.05495634856549,-0.276838927053834,0.0849000315596909,ENSG00000124203,ZNF831,protein_coding,20,1,59123381,59259113,q13.32,zinc finger protein 831 [Source:HGNC Symbol;Acc:HGNC:16167],NA,ZNF831,128611,NM_178457
ZFC3H1_TF,ZFC3H1,ZFC3H1_TF,ZFC3H1,TF,91,3.73283638751521,0.15661455093641,0.150495468961443,0.176720105997014,0.0262246370355708,0.000556849606707948,2.43010787248558,6.92210226134093,6.88625839649022,7.0398749601361,0.15361656364588,0.0410857216400406,ENSG00000133858,ZFC3H1,protein_coding,12,-1,71609472,71667725,q21.1,zinc finger C3H1-type containing [Source:HGNC Symbol;Acc:HGNC:28328],NA,ZFC3H1,196441,NM_144982
TBXA2R_SIG,TBXA2R,TBXA2R_SIG,TBXA2R,SIG,65,3.73159635933399,0.102722189702693,0.0904975093182644,0.1428889966801,0.0523914873618361,0.000559231976054521,3.3545676812231,1.66396101541771,1.55329616459909,2.0275740966789,0.474277932079809,0.00412098228554154,ENSG00000006638,TBXA2R,protein_coding,19,-1,3594506,3606840,p13.3,thromboxane A2 receptor [Source:HGNC Symbol;Acc:HGNC:11608],Bleeding diathesis due to thromboxane synthesis deficiency;BLEEDING DISORDER PLATELET-TYPE 13 SUSCEPTIBILITY TO,TBXA2R,6915,NM_001060;NM_201636
SLC35E3_SIG,SLC35E3,SLC35E3_SIG,SLC35E3,SIG,4,3.73158256914684,0.267259721342371,0.261076219448903,0.287576941849478,0.0265007224005749,0.000559231976054521,2.63077980252755,3.82617885369237,3.79265038051588,3.93634383698657,0.143693456470693,0.0262015627445783,ENSG00000175782,SLC35E3,protein_coding,12,1,68746176,68793964,q15,solute carrier family 35 member E3 [Source:HGNC Symbol;Acc:HGNC:20864],NA,SLC35E3,55508,NM_001354997;NM_001354998;NM_018656
PRSS27_SIG,PRSS27,PRSS27_SIG,PRSS27,SIG,29,3.73129310272684,0.02740598821883,0.0222388817143926,0.0443836238762669,0.0221447421618741,0.000559676508780153,0.388272291560376,1.0462351446666,1.04102341093343,1.06335941264702,0.0223360017135922,0.775473997659631,ENSG00000172382,PRSS27,protein_coding,16,-1,2712419,2720551,p13.3,serine protease 27 [Source:HGNC Symbol;Acc:HGNC:15475],NA,PRSS27,83886,NM_001318395;NM_031948
NDUFA6_SIG,NDUFA6,NDUFA6_SIG,NDUFA6,SIG,57,-3.73008235868918,0.0708230857861731,0.075891561249305,0.0541695235501683,-0.0217220376991367,0.00056217349321285,-2.12300009423458,4.96782656852673,4.9906595039999,4.89280406625773,-0.0978554377421652,0.0769835748065304,ENSG00000184983,NDUFA6,protein_coding,22,-1,42085525,42090955,q13.2,NADH:ubiquinone oxidoreductase subunit A6 [Source:HGNC Symbol;Acc:HGNC:7690],MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 33,NDUFA6,4700,NM_002490
ZC4H2_TF,ZC4H2,ZC4H2_TF,ZC4H2,TF,73,3.72993512971262,0.0619455920450929,0.0535814563131261,0.0894277523072698,0.0358462959941438,0.000562302760619573,2.75917462811198,2.83057567772188,2.77364498184798,3.0176336784504,0.243988696602417,0.0195241728195931,ENSG00000126970,ZC4H2,protein_coding,X,-1,64915802,65034713,q11.2,zinc finger C4H2-type containing [Source:HGNC Symbol;Acc:HGNC:24931],Arthrogryposis Multiplex Congenita and Intellectual Disability;Intellectual disability-developmental delay-contractures syndrome;Wieacker-Wolff syndrome,ZC4H2,55906,NM_001178032;NM_001178033;NM_001243804;NM_018684
DHODH_SIG,DHODH,DHODH_SIG,DHODH,SIG,59,3.72953162040039,0.204402751771182,0.185919320305148,0.265134026588148,0.0792147062829997,0.000563004438606852,3.67773980194386,2.99266818202278,2.9092873576296,3.26663374788607,0.357346390256473,0.00157379420144171,ENSG00000102967,DHODH,protein_coding,16,1,72008588,72027664,q22.2,dihydroorotate dehydrogenase (quinone) [Source:HGNC Symbol;Acc:HGNC:2867],Postaxial acrofacial dysostosis,DHODH,1723,NM_001361
MTMR8_SIG,MTMR8,MTMR8_SIG,MTMR8,SIG,17,3.72927735189542,-0.0262503432322375,-0.0328500508746344,-0.00456558955007644,0.0282844613245579,0.0005633732430237,1.32761752571759,1.19642460305917,1.17974769916929,1.25122014441164,0.0714724452423555,0.283986349070403,ENSG00000102043,MTMR8,protein_coding,X,-1,64268081,64395452,q11.2,myotubularin related protein 8 [Source:HGNC Symbol;Acc:HGNC:16825],NA,MTMR8,55613,NM_017677
ELAC2_SIG,ELAC2,ELAC2_SIG,ELAC2,SIG,21,3.72914865022603,0.600324324564353,0.587943658526048,0.641003655833068,0.0530599973070191,0.000563461509152288,4.49745385252864,6.02164690472124,5.9590270418205,6.2273978828237,0.268370841003203,9.98503868525492e-05,ENSG00000006744,ELAC2,protein_coding,17,-1,12991612,13018065,p12,elaC ribonuclease Z 2 [Source:HGNC Symbol;Acc:HGNC:14198],Combined oxidative phosphorylation defect type 17;Combined oxidative phosphorylation deficiency 17;Familial prostate cancer;Infantile hypertrophic cardiomyopathy lactic acidosis and isolated complex I deficiency;PROSTATE CANCER HEREDITARY 2,ELAC2,60528,NM_001165962;NM_018127;NM_173717
ECSIT_SIG,ECSIT,ECSIT_SIG,ECSIT,SIG,15,3.72816045450048,0.505168964982244,0.499227846100428,0.524689784165357,0.0254619380649295,0.000565474887271021,3.07121612913212,4.37104975342311,4.33023076836253,4.50516927576501,0.174938507402477,0.00895290918084343,ENSG00000130159,ECSIT,protein_coding,19,-1,11505929,11529172,p13.2,ECSIT signalling integrator [Source:HGNC Symbol;Acc:HGNC:29548],NA,ECSIT,51295,NM_001142464;NM_001142465;NM_001243204;NM_016581
VCAN_SIG,VCAN,VCAN_SIG,VCAN,SIG,55,-3.7267812844153,0.175042357286203,0.215333895239687,0.0426558754390396,-0.172678019800647,0.000568313415196431,-3.6256209372915,7.29569843081412,7.60239738194954,6.2879733056549,-1.31442407629463,0.00184609510249682,ENSG00000038427,VCAN,protein_coding,5,1,83471618,83582303,q14.2,versican [Source:HGNC Symbol;Acc:HGNC:2464],Wagner disease;WAGNER VITREORETINOPATHY,VCAN,1462,NM_001126336;NM_001164097;NM_001164098;NM_004385
LARP4_SIG,LARP4,LARP4_SIG,LARP4,SIG,25,3.72671971803862,0.387421391384188,0.374715415146706,0.429169599021628,0.0544541838749225,0.000568313415196431,3.73229750758203,5.12525110704177,5.0666182304523,5.31790198726431,0.251283756812013,0.00132836298799157,ENSG00000161813,LARP4,protein_coding,12,1,50392383,50480004,q13.12,La ribonucleoprotein domain family member 4 [Source:HGNC Symbol;Acc:HGNC:24320],NA,LARP4,113251,NM_001170803;NM_001170804;NM_001170808;NM_001330415;NM_001352304;NM_001352305;NM_001352306;NM_001352307;NM_001352308;NM_001352309;NM_001352310;NM_001352311;NM_001352312;NM_001352313;NM_001352314;NM_001352315;NM_001352316;NM_001352317;NM_001352318;NM_001352319;NM_001352320;NM_001352321;NM_001352322;NM_001352323;NM_001352324;NM_001352325;NM_001352326;NM_052879;NM_199188;NM_199190
ITGB2_SIG,ITGB2,ITGB2_SIG,ITGB2,SIG,56,-3.72527931929778,0.689813342730936,0.71001890369929,0.623423642406345,-0.0865952612929444,0.000571366484974911,-3.77440508316463,9.59555206253321,9.7093124369881,9.22176797503858,-0.48754446194952,0.00116354050611819,ENSG00000160255,ITGB2,protein_coding,21,-1,44885953,44931989,q22.3,integrin subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:6155],Leukocyte adhesion deficiency type I;LEUKOCYTE ADHESION DEFICIENCY TYPE I,ITGB2,3689,NM_000211;NM_001127491;NM_001303238
SPCS3_SIG,SPCS3,SPCS3_SIG,SPCS3,SIG,45,-3.72493351974682,0.219440121876867,0.222503811410281,0.209373713409937,-0.0131300980003441,0.000571845459202088,-0.826062563362243,7.35859966436251,7.36631627585871,7.33324508373211,-0.0330711921266048,0.521045355035161,ENSG00000129128,SPCS3,protein_coding,4,1,176319966,176332245,q34.2,signal peptidase complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:26212],NA,SPCS3,60559,NM_021928
KLRC1_SIG,KLRC1,KLRC1_SIG,KLRC1,SIG,5,-3.72488967040117,-0.136457627578274,-0.111427864416569,-0.218698277966736,-0.107270413550167,0.000571845459202088,-2.75647448336913,0.566682395189571,0.616999073273338,0.401356167200052,-0.215642906073286,0.0196310747053199,ENSG00000134545,KLRC1,protein_coding,12,-1,10442264,10454685,p13.2,killer cell lectin like receptor C1 [Source:HGNC Symbol;Acc:HGNC:6374],NA,KLRC1,3821,NM_001304448;NM_002259;NM_007328;NM_213657;NM_213658
CSNK1E_SIG,CSNK1E,CSNK1E_SIG,CSNK1E,SIG,64,3.72471449649185,0.157325757861823,0.145370428082817,0.196607555707127,0.0512371276243091,0.000572040613834591,1.71526530233804,6.35359265002345,6.3205655548693,6.46211024838709,0.141544693517796,0.159278702511869,ENSG00000213923,CSNK1E,protein_coding,22,-1,38290691,38318084,q13.1,casein kinase 1 epsilon [Source:HGNC Symbol;Acc:HGNC:2453],NA,CSNK1E,1454,NM_001894;NM_152221
EPAS1_SIG,EPAS1,EPAS1_SIG,EPAS1,SIG,40,-3.72430943958441,-0.119408823078865,-0.112677863191232,-0.141524834138228,-0.0288469709469957,0.000572757529081624,-1.05320123481509,2.54094426168423,2.57965415610513,2.41375460858698,-0.165899547518149,0.404465500356727,ENSG00000116016,EPAS1,protein_coding,2,1,46293667,46386697,p21,endothelial PAS domain protein 1 [Source:HGNC Symbol;Acc:HGNC:3374],Autosomal dominant secondary polycythemia;ERYTHROCYTOSIS FAMILIAL 4;Multiple paragangliomas associated with polycythemia;Sporadic pheochromocytoma;Sporadic secreting paraganglioma,EPAS1,2034,NM_001430
HEXB_SIG,HEXB,HEXB_SIG,HEXB,SIG,41,-3.72388681793168,0.412394696883482,0.427563630172427,0.36255391607695,-0.0650097140954765,0.000573515246601535,-2.87565523842213,6.35146459247661,6.41698695859548,6.13617681808603,-0.280810140509447,0.0147416684475362,ENSG00000049860,HEXB,protein_coding,5,1,74640023,74722647,q13.3,hexosaminidase subunit beta [Source:HGNC Symbol;Acc:HGNC:4879],GM2-GANGLIOSIDOSIS TYPE 2;SANDHOFF DISEASE;Sandhoff disease adult form;Sandhoff disease infantile form;Sandhoff disease juvenile form,HEXB,3074,NM_000521;NM_001292004
UPF2_SIG,UPF2,UPF2_SIG,UPF2,SIG,27,3.72198447882748,0.350469476793857,0.34336894040049,0.373799810657777,0.030430870257287,0.000577650586169769,2.28225765242268,6.78221166752805,6.75110145653015,6.88443093223544,0.133329475705286,0.0560246455931558,ENSG00000151461,UPF2,protein_coding,10,-1,11920022,12043170,p14,UPF2, regulator of nonsense mediated mRNA decay [Source:HGNC Symbol;Acc:HGNC:17854],NA,UPF2,26019,NM_015542;NM_080599
CDH5_SIG,CDH5,CDH5_SIG,CDH5,SIG,38,-3.72089159173446,-0.128645559038755,-0.122597260682736,-0.148518539351386,-0.0259212786686504,0.000579951901827135,-1.30037068183863,0.562933621289814,0.589712544940076,0.474945729296095,-0.114766815643981,0.294927327015609,ENSG00000179776,CDH5,protein_coding,16,1,66366622,66404784,q21,cadherin 5 [Source:HGNC Symbol;Acc:HGNC:1764],NA,CDH5,1003,NM_001795
KLRF1_SIG,KLRF1,KLRF1_SIG,KLRF1,SIG,11,-3.719887435449,-0.261359192979086,-0.236669227024618,-0.342483366829479,-0.10581413980486,0.000582057281224927,-2.93115237589775,1.60565568958908,1.69314168441853,1.31820170657801,-0.374939977840519,0.0128494115659446,ENSG00000150045,KLRF1,protein_coding,12,1,9827481,9845007,p13.31,killer cell lectin like receptor F1 [Source:HGNC Symbol;Acc:HGNC:13342],NA,KLRF1,51348,NM_001291822;NM_001291823;NM_016523
ZKSCAN4_TF,ZKSCAN4,ZKSCAN4_TF,ZKSCAN4,TF,74,3.7197822012769,0.238121125036496,0.222411370195492,0.289738890942652,0.0673275207471592,0.000582094665666052,3.17483990633268,2.79797440101439,2.71688855061329,3.06439933804659,0.347510787433301,0.00680116117365452,ENSG00000187626,ZKSCAN4,protein_coding,6,-1,28241697,28252269,p22.1,zinc finger with KRAB and SCAN domains 4 [Source:HGNC Symbol;Acc:HGNC:13854],NA,ZKSCAN4,387032,NM_001304506;NM_019110
ADAT1_SIG,ADAT1,ADAT1_SIG,ADAT1,SIG,8,3.7190694600199,0.316501892913278,0.309682995705877,0.338906840880454,0.0292238451745768,0.000583533837062898,3.95636531681491,4.55008675978437,4.50259301390831,4.7061376390914,0.203544625183088,0.000653471892828044,ENSG00000065457,ADAT1,protein_coding,16,-1,75596981,75623300,q23.1,adenosine deaminase, tRNA specific 1 [Source:HGNC Symbol;Acc:HGNC:228],NA,ADAT1,23536,NM_001324444;NM_001324445;NM_001324446;NM_001324448;NM_001324449;NM_001324450;NM_001324451;NM_001324452;NM_012091
MS4A7_SIG,MS4A7,MS4A7_SIG,MS4A7,SIG,45,-3.71874856349156,0.204724046345869,0.230376592349591,0.120437109476497,-0.109939482873094,0.000584069799208766,-3.69585644695135,4.70797678498691,4.86964730652127,4.17677364280257,-0.692873663718705,0.00149036777409164,ENSG00000166927,MS4A7,protein_coding,11,1,60378485,60395951,q12.2,membrane spanning 4-domains A7 [Source:HGNC Symbol;Acc:HGNC:13378],NA,MS4A7,58475,NM_021201;NM_206938;NM_206939;NM_206940
MAP4K5_SIG,MAP4K5,MAP4K5_SIG,MAP4K5,SIG,47,3.71809021027752,0.266258777858816,0.255841483611394,0.300487030386057,0.0446455467746623,0.000585387575082524,2.08811227937103,5.97278375600166,5.93904190474139,6.08364983871395,0.144607933972559,0.0822036085462922,ENSG00000012983,MAP4K5,protein_coding,14,-1,50418501,50561126,q22.1,mitogen-activated protein kinase kinase kinase kinase 5 [Source:HGNC Symbol;Acc:HGNC:6867],NA,MAP4K5,11183,NM_006575;NM_198794
CASP2_SIG,CASP2,CASP2_SIG,CASP2,SIG,28,3.71683919939017,0.280346344423808,0.27287779948722,0.304885849215454,0.0320080497282338,0.000588085581213309,2.58706438366151,7.12986670053948,7.08079537622512,7.29110105185806,0.210305675632932,0.0290214597272963,ENSG00000106144,CASP2,protein_coding,7,1,143288215,143307696,q34,caspase 2 [Source:HGNC Symbol;Acc:HGNC:1503],Autosomal Recessive Mental Retardation,CASP2,835,NM_001224;NM_032982;NM_032983
GAS6_SIG,GAS6,GAS6_SIG,GAS6,SIG,24,-3.7161679609536,-0.0283114516998607,-0.0170591749726074,-0.0652832180894075,-0.0482240431168,0.00058944190496714,-0.696523872885036,2.36118513851911,2.39111442559798,2.26284605240283,-0.128268373195157,0.594181033359461,ENSG00000183087,GAS6,protein_coding,13,-1,113820549,113864076,q34,growth arrest specific 6 [Source:HGNC Symbol;Acc:HGNC:4168],NA,GAS6,2621,NM_000820
HEBP1_SIG,HEBP1,HEBP1_SIG,HEBP1,SIG,16,3.71580087598964,0.223745425255494,0.218018291207147,0.24256315141435,0.0245448602072034,0.000590090862646178,0.903140898967443,4.91818127059828,4.90337570223947,4.96682813806291,0.0634524358234395,0.480184874697355,ENSG00000013583,HEBP1,protein_coding,12,-1,12974870,13000265,p13.1,heme binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17176],NA,HEBP1,50865,NM_015987
ARAP1_SIG,ARAP1,ARAP1_SIG,ARAP1,SIG,54,-3.71537534841845,0.58734313784063,0.6030147902105,0.535850565768199,-0.0671642244423011,0.000590832792282387,-3.70539855740197,7.94030225470841,8.007974069654,7.71795200560147,-0.290022064052528,0.00144662698065582,ENSG00000186635,ARAP1,protein_coding,11,-1,72685069,72793599,q13.4,ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 [Source:HGNC Symbol;Acc:HGNC:16925],NA,ARAP1,116985,NM_001040118;NM_001135190;NM_015242
S1PR1_SIG,S1PR1,S1PR1_SIG,S1PR1,SIG,19,-3.71530544876878,0.203018679886708,0.218574690940331,0.15190607213909,-0.0666686188012414,0.000590832792282387,-2.69797083815487,3.53964048334148,3.64882954135935,3.18087643556845,-0.4679531057909,0.022509345363588,ENSG00000170989,S1PR1,protein_coding,1,1,101236865,101243713,p21.2,sphingosine-1-phosphate receptor 1 [Source:HGNC Symbol;Acc:HGNC:3165],NA,S1PR1,1901,NM_001320730;NM_001400
MAP3K2_SIG,MAP3K2,MAP3K2_SIG,MAP3K2,SIG,40,-3.7124498404997,0.538554038878693,0.547548718866512,0.509000090347289,-0.038548628519223,0.000597331182014093,-1.86805344472617,7.1844194244862,7.21052320964343,7.09864984468385,-0.111873364959588,0.12299758402675,ENSG00000169967,MAP3K2,protein_coding,2,-1,127298730,127388465,q14.3,mitogen-activated protein kinase kinase kinase 2 [Source:HGNC Symbol;Acc:HGNC:6854],NA,MAP3K2,10746,NM_006609
YBX3_TF,YBX3,YBX3_TF,YBX3,TF,120,3.71197969395775,0.0361756224233805,0.0310330276777246,0.0530727194448212,0.0220396917670967,0.00059823194855813,0.748308813958822,7.46000103091877,7.44078238132326,7.52314802244685,0.0823656411235802,0.564339513017756,ENSG00000060138,YBX3,protein_coding,12,-1,10699089,10723323,p13.2,Y-box binding protein 3 [Source:HGNC Symbol;Acc:HGNC:2428],NA,YBX3,8531,NM_001145426;NM_003651
TET3_SIG,TET3,TET3_SIG,TET3,SIG,14,-3.71130454184884,0.395100252294814,0.400170445917979,0.378441044675842,-0.0217294012421371,0.000599619536005739,-3.0263464547721,7.08245522419732,7.11932709045388,6.96130480649721,-0.15802228395667,0.0100448936706874,ENSG00000187605,TET3,protein_coding,2,1,73986404,74108176,p13.1,tet methylcytosine dioxygenase 3 [Source:HGNC Symbol;Acc:HGNC:28313],NA,TET3,200424,NM_001287491;NM_001366022
TNC_SIG,TNC,TNC_SIG,TNC,SIG,47,-3.709663802862,-0.354169968270413,-0.346065237479297,-0.380799798012652,-0.0347345605333551,0.00060330686939784,-2.68003514179392,0.555832537889244,0.630920078226633,0.309116333923537,-0.321803744303095,0.0234704244915371,ENSG00000041982,TNC,protein_coding,9,-1,115019575,115118257,q33.1,tenascin C [Source:HGNC Symbol;Acc:HGNC:5318],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 56,TNC,3371,NM_002160
PRSS53_SIG,PRSS53,PRSS53_SIG,PRSS53,SIG,37,3.70941371628282,0.0660883908969232,0.0600845574084844,0.0858152723589366,0.0257307149504521,0.000603691238195872,2.03325034307318,1.86231439173648,1.83737358969246,1.9442627413097,0.106889151617242,0.0913463421131977,ENSG00000151006,PRSS53,protein_coding,16,-1,31083425,31089628,p11.2,serine protease 53 [Source:HGNC Symbol;Acc:HGNC:34407],NA,PRSS53,339105,NM_001039503
ZBTB8A_TF,ZBTB8A,ZBTB8A_TF,ZBTB8A,TF,250,3.70914920023663,0.0614608938911258,0.0495856628091736,0.100479510303254,0.0508938474940808,0.000604110313971807,4.46717928621022,2.39012643615782,2.24509370623426,2.86666254876378,0.621568842529516,0.00011181623994839,ENSG00000160062,ZBTB8A,protein_coding,1,1,32539427,32605941,p35.1,zinc finger and BTB domain containing 8A [Source:HGNC Symbol;Acc:HGNC:24172],NA,ZBTB8A,653121,NM_001040441;NM_001291496
NOTCH2_TF,NOTCH2,NOTCH2_TF,NOTCH2,TF,286,-3.70875385368755,0.264487326988522,0.274126597921684,0.232815436779561,-0.0413111611421228,0.000604842111004574,-2.21770572266597,7.90912960392046,7.95869243199056,7.74628031169012,-0.212412120300445,0.0640451777112478,ENSG00000134250,NOTCH2,protein_coding,1,-1,119911553,120100779,p12,notch 2 [Source:HGNC Symbol;Acc:HGNC:7882],Acroosteolysis dominant type;Alagille syndrome 2;Alagille syndrome due to a NOTCH2 point mutation;Hajdu-Cheney syndrome,NOTCH2,4853,NM_001200001;NM_024408
RC3H2_SIG,RC3H2,RC3H2_SIG,RC3H2,SIG,75,3.70860218575275,0.338085582187446,0.330971257357295,0.361461220915086,0.0304899635577912,0.000604992397520917,3.15634181131222,6.30090116128414,6.2581953415739,6.44122028318919,0.18302494161529,0.00713289114670475,ENSG00000056586,RC3H2,protein_coding,9,-1,122844556,122905359,q33.2,ring finger and CCCH-type domains 2 [Source:HGNC Symbol;Acc:HGNC:21461],NA,RC3H2,54542,NM_001100588;NM_001354478;NM_001354479;NM_001354482;NM_001354486;NM_018835
BCAM_SIG,BCAM,BCAM_SIG,BCAM,SIG,61,3.70846711978386,-0.114560480050903,-0.119681582705164,-0.0977339999011869,0.0219475828039776,0.000605103115209329,1.31458091185561,1.89811568897379,1.85344838939356,2.04487967330883,0.191431283915275,0.289180968084763,ENSG00000187244,BCAM,protein_coding,19,1,44809059,44821421,q13.32,basal cell adhesion molecule (Lutheran blood group) [Source:HGNC Symbol;Acc:HGNC:6722],BLOOD GROUP--LUTHERAN SYSTEM;LUTHERAN NULL,BCAM,4059,NM_001013257;NM_005581
ING5_SIG,ING5,ING5_SIG,ING5,SIG,18,3.70819122426814,0.13862908780236,0.131929992735212,0.160640400165846,0.0287104074306334,0.000605550530862286,2.6928489777705,4.95084698166104,4.90848024918714,5.09005195978956,0.181571710602425,0.0228062087322313,ENSG00000168395,ING5,protein_coding,2,1,241687085,241729478,q37.3,inhibitor of growth family member 5 [Source:HGNC Symbol;Acc:HGNC:19421],NA,ING5,84289,NM_001330161;NM_001330162;NM_032329
ZNF525_TF,ZNF525,ZNF525_TF,ZNF525,TF,40,3.7071246440123,0.181742387418792,0.172113249188335,0.213380984461724,0.0412677352733893,0.000607743275921441,2.65945063492343,3.28301428838428,3.23205299436198,3.45045854017183,0.218405545809848,0.024579357219296,ENSG00000203326,ZNF525,protein_coding,19,1,53365693,53392217,q13.42,zinc finger protein 525 [Source:HGNC Symbol;Acc:HGNC:29423],NA,ZNF525,170958,NM_001348156;NM_001348157
MSRB1_SIG,MSRB1,MSRB1_SIG,MSRB1,SIG,89,-3.70709829171102,0.315698563393691,0.330413825844864,0.26734841533984,-0.0630654105050234,0.000607743275921441,-2.09331061458167,5.38692438329958,5.46134177727059,5.14241008882341,-0.318931688447178,0.0812810022221065,ENSG00000198736,MSRB1,protein_coding,16,-1,1938210,1943326,p13.3,methionine sulfoxide reductase B1 [Source:HGNC Symbol;Acc:HGNC:14133],NA,MSRB1,51734,NM_016332
CXCR2_SIG,CXCR2,CXCR2_SIG,CXCR2,SIG,58,-3.70590022187422,0.0767197658977164,0.0944719020297719,0.0183913186066769,-0.0760805834230951,0.000610410106563396,-2.47705704592149,3.29393365787703,3.42738578512106,2.85544809693234,-0.57193768818872,0.0371285468216522,ENSG00000180871,CXCR2,protein_coding,2,1,218125289,218137251,q35,C-X-C motif chemokine receptor 2 [Source:HGNC Symbol;Acc:HGNC:6027],Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,CXCR2,3579,NM_001168298;NM_001557
RRP1_SIG,RRP1,RRP1_SIG,RRP1,SIG,11,3.70569942069976,0.638452335289468,0.621188124891056,0.695177598027109,0.0739894731360533,0.000610680358643293,2.47372634940197,4.26320145818425,4.21558992488169,4.41963935332126,0.204049428439573,0.0373984395896334,ENSG00000160214,RRP1,protein_coding,21,1,43789513,43805293,q22.3,ribosomal RNA processing 1 [Source:HGNC Symbol;Acc:HGNC:18785],NA,RRP1,8568,NM_003683
GNLY_SIG,GNLY,GNLY_SIG,GNLY,SIG,6,-3.70497903113462,-0.0872556054992644,-0.0537131638830141,-0.197466485095515,-0.143753321212501,0.000612201436362415,-2.71035555472731,4.33687683532544,4.45449490878652,3.95041745109618,-0.504077457690345,0.0218676136702499,ENSG00000115523,GNLY,protein_coding,2,1,85685175,85698854,p11.2,granulysin [Source:HGNC Symbol;Acc:HGNC:4414],NA,GNLY,10578,NM_001302758;NM_006433;NM_012483
OPLAH_SIG,OPLAH,OPLAH_SIG,OPLAH,SIG,27,-3.70489172301702,0.0463609141901358,0.0549745007590037,0.0180591297495695,-0.0369153710094342,0.000612201436362415,-0.998449783827865,2.60327675526695,2.63753803704913,2.49070397226835,-0.146834064780781,0.431251319933454,ENSG00000178814,OPLAH,protein_coding,8,-1,144051266,144063965,q24.3,5-oxoprolinase, ATP-hydrolysing [Source:HGNC Symbol;Acc:HGNC:8149],5-Oxoprolinase deficiency,OPLAH,26873,NM_017570
AHCYL2_SIG,AHCYL2,AHCYL2_SIG,AHCYL2,SIG,27,3.70412301039969,0.465435365619687,0.455768127106344,0.497199149306388,0.0414310222000444,0.000613846189057499,2.78982346817659,4.50084863099901,4.44322961032847,4.69016827034507,0.246938660016595,0.01812995265888,ENSG00000158467,AHCYL2,protein_coding,7,1,129225023,129430211,q32.1,adenosylhomocysteinase like 2 [Source:HGNC Symbol;Acc:HGNC:22204],NA,AHCYL2,23382,NM_001130720;NM_001130722;NM_001130723;NM_015328
RNF121_SIG,RNF121,RNF121_SIG,RNF121,SIG,16,3.70337979501909,0.30311454060924,0.293960952966997,0.333190614290898,0.0392296613239016,0.000615433204790722,1.93502304959564,3.70932558904204,3.68407105372282,3.79230477651949,0.108233722796669,0.109291436925271,ENSG00000137522,RNF121,protein_coding,11,1,71929018,71997597,q13.4,ring finger protein 121 [Source:HGNC Symbol;Acc:HGNC:21070],NA,RNF121,55298,NM_001300926;NM_018320
PDE5A_SIG,PDE5A,PDE5A_SIG,PDE5A,SIG,37,-3.70149043654617,-0.182514424231168,-0.170519669219428,-0.221925762126886,-0.0514060929074583,0.000619818450293259,-2.80112638375471,0.885917274897571,0.962712926600888,0.633588705015243,-0.329124221585645,0.0176474115917794,ENSG00000138735,PDE5A,protein_coding,4,-1,119494397,119628804,q26,phosphodiesterase 5A [Source:HGNC Symbol;Acc:HGNC:8784],NA,PDE5A,8654,NM_001083;NM_033430;NM_033437
C1QBP_SIG,C1QBP,C1QBP_SIG,C1QBP,SIG,39,3.70129093613737,0.716083450097626,0.705448761268851,0.751025999106458,0.0455772378376064,0.000620089622233548,3.60037259723914,6.67784714298531,6.61294784276274,6.89108770085947,0.278139858096732,0.00199415206843824,ENSG00000108561,C1QBP,protein_coding,17,-1,5432777,5448830,p13.2,complement C1q binding protein [Source:HGNC Symbol;Acc:HGNC:1243],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33;Severe Neonatal- Childhood- or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies,C1QBP,708,NM_001212
ZHX1_TF,ZHX1,ZHX1_TF,ZHX1,TF,91,3.70116681027074,0.309540669293286,0.303907671597999,0.328049090292087,0.0241414186940873,0.000620176688767334,2.63661774411071,5.73577692930631,5.69991973694472,5.85359341849438,0.153673681549653,0.0258503912385671,ENSG00000165156,ZHX1,protein_coding,8,-1,123248451,123275541,q24.13,zinc fingers and homeoboxes 1 [Source:HGNC Symbol;Acc:HGNC:12871],NA,ZHX1,11244,NM_001017926;NM_007222
TPST1_SIG,TPST1,TPST1_SIG,TPST1,SIG,14,-3.70077533409058,0.0800831879965184,0.0922915829951745,0.0399698901437915,-0.0523216928513829,0.000620917758351684,-2.68160540183674,1.93943793272323,2.03095398042005,1.63874234743367,-0.39221163298638,0.0234022808377214,ENSG00000169902,TPST1,protein_coding,7,1,66205317,66420543,q11.21,tyrosylprotein sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:12020],NA,TPST1,8460,NM_003596
SHB_SIG,SHB,SHB_SIG,SHB,SIG,6,-3.70016818824904,-0.0551197469555764,-0.0492893523674809,-0.0742767577450331,-0.0249874053775524,0.000622188267916689,-0.0294543419989063,1.97349563641048,1.97415749775106,1.97132094914856,-0.00283654860249437,0.98369569887501,ENSG00000107338,SHB,protein_coding,9,-1,37915898,38069227,p13.1,SH2 domain containing adaptor protein B [Source:HGNC Symbol;Acc:HGNC:10838],NA,SHB,6461,NM_003028
ZMIZ2_TF,ZMIZ2,ZMIZ2_TF,ZMIZ2,TF,108,3.69990560185959,0.0486744682757061,0.0447724384420091,0.0614954234435678,0.0167229850015586,0.000622615376785846,3.18350346467254,6.63963515100555,6.60279358597685,6.76068600752842,0.157892421551568,0.00664178161675184,ENSG00000122515,ZMIZ2,protein_coding,7,1,44748581,44769881,p13,zinc finger MIZ-type containing 2 [Source:HGNC Symbol;Acc:HGNC:22229],NA,ZMIZ2,83637,NM_001300959;NM_031449;NM_174929
NTSR1_SIG,NTSR1,NTSR1_SIG,NTSR1,SIG,13,-3.6996171805726,-0.0957225072828163,-0.0878790816862784,-0.121493762814298,-0.0336146811280194,0.00062310623794984,-1.85652646127819,1.80491190841804,1.87298403735448,1.58124634191257,-0.291737695441918,0.125476901501218,ENSG00000101188,NTSR1,protein_coding,20,1,62708836,62762771,q13.33,neurotensin receptor 1 [Source:HGNC Symbol;Acc:HGNC:8039],NA,NTSR1,4923,NM_002531
MTOR_SIG,MTOR,MTOR_SIG,MTOR,SIG,19,3.69815881308525,0.711873964543076,0.704633194892793,0.735665064822576,0.0310318699297827,0.000626478138561293,2.45458531452817,6.53951801038787,6.51184886125787,6.63043092895787,0.1185820677,0.0389890548781817,ENSG00000198793,MTOR,protein_coding,1,-1,11106535,11262507,p36.22,mechanistic target of rapamycin kinase [Source:HGNC Symbol;Acc:HGNC:3942],Epileptic encephalopathy;FOCAL CORTICAL DYSPLASIA TYPE II;Isolated focal cortical dysplasia type IIa;Isolated focal cortical dysplasia type IIb;Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome;SMITH-KINGSMORE SYNDROME,MTOR,2475,NM_004958
PHF20L1_SIG,PHF20L1,PHF20L1_SIG,PHF20L1,SIG,22,-3.69742588652475,0.374562306274619,0.38075932491139,0.354200673610942,-0.0265586513004476,0.000628070413291295,-1.87448063845774,6.61892713233317,6.63899157879937,6.55300109394422,-0.0859904848551505,0.121627224634762,ENSG00000129292,PHF20L1,protein_coding,8,1,132775358,132848807,q24.22,PHD finger protein 20 like 1 [Source:HGNC Symbol;Acc:HGNC:24280],NA,PHF20L1,51105,NM_001277196;NM_001362971;NM_016018;NM_198513
NOP56_SIG,NOP56,NOP56_SIG,NOP56,SIG,43,3.69593738645937,0.377724233495283,0.361158577273367,0.432154246795866,0.0709956695224992,0.000631542327789255,3.11684792494668,6.74443690007326,6.68615703575157,6.93592788284452,0.249770847092949,0.00796481638689064,ENSG00000101361,NOP56,protein_coding,20,1,2652593,2658393,p13,NOP56 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:15911],SPINOCEREBELLAR ATAXIA 36;Spinocerebellar ataxia type 36,NOP56,10528,NM_006392
P2RY4_SIG,P2RY4,P2RY4_SIG,P2RY4,SIG,52,3.69392293752625,0.0833464981452597,0.0767916778010585,0.104883764990492,0.0280920871894339,0.000636347790604738,3.23471796342872,0.3788540166432,0.357286576233377,0.449718463704048,0.0924318874706707,0.00577028497779427,ENSG00000186912,P2RY4,protein_coding,X,-1,70258170,70259764,q13.1,pyrimidinergic receptor P2Y4 [Source:HGNC Symbol;Acc:HGNC:8542],NA,P2RY4,5030,NM_002565
TXNL4B_SIG,TXNL4B,TXNL4B_SIG,TXNL4B,SIG,8,3.69287437314014,0.0511641060802759,0.0424549992074228,0.0797797429482219,0.0373247437407992,0.000638756140081435,2.84567285794498,3.70323727033338,3.67108078622187,3.8088942895569,0.137813503335035,0.0158572241491701,ENSG00000140830,TXNL4B,protein_coding,16,-1,72044289,72094431,q22.2,thioredoxin like 4B [Source:HGNC Symbol;Acc:HGNC:26041],NA,TXNL4B,54957,NM_001142317;NM_001142318;NM_001324354;NM_001324355;NM_017853
GSTM2_SIG,GSTM2,GSTM2_SIG,GSTM2,SIG,11,3.69134518903311,-0.0433601188068635,-0.0484929377403402,-0.0264951423111545,0.0219977954291857,0.000642385996150524,1.41038972660111,4.33687888693112,4.29628142586445,4.47027054472161,0.173989118857155,0.25266732594003,ENSG00000213366,GSTM2,protein_coding,1,1,109668022,109709551,p13.3,glutathione S-transferase mu 2 [Source:HGNC Symbol;Acc:HGNC:4634],NA,GSTM2,2946,NM_000848;NM_001142368
USO1_SIG,USO1,USO1_SIG,USO1,SIG,78,3.69106600448804,0.246602138067258,0.231305039808756,0.296864032345194,0.0655589925364382,0.000642868136582857,3.64561460528886,6.24128386374924,6.17668781054265,6.4535280385709,0.276840228028252,0.00173211534486893,ENSG00000138768,USO1,protein_coding,4,1,75724593,75814286,q21.1,USO1 vesicle transport factor [Source:HGNC Symbol;Acc:HGNC:30904],NA,USO1,8615,NM_001290049;NM_003715
OXER1_SIG,OXER1,OXER1_SIG,OXER1,SIG,16,3.69090511677145,0.137376525432659,0.131831281976774,0.155596611073424,0.0237653290966503,0.000643051504862218,3.32972226107831,2.57907889935796,2.5001431166895,2.83843932812577,0.338296211436264,0.00441762561621517,ENSG00000162881,OXER1,protein_coding,2,-1,42762481,42764261,p21,oxoeicosanoid receptor 1 [Source:HGNC Symbol;Acc:HGNC:24884],NA,OXER1,165140,NM_148962
ZSWIM5_TF,ZSWIM5,ZSWIM5_TF,ZSWIM5,TF,109,-3.6902159931912,-0.155918955471498,-0.149364743472311,-0.177454223468828,-0.0280894799965169,0.000644572198569236,-1.05371041895858,0.808386271413343,0.829841256225567,0.737891321316034,-0.0919499349095324,0.404198649577654,ENSG00000162415,ZSWIM5,protein_coding,1,-1,45016399,45306209,p34.1,zinc finger SWIM-type containing 5 [Source:HGNC Symbol;Acc:HGNC:29299],NA,ZSWIM5,57643,NM_020883
TRAF2_SIG,TRAF2,TRAF2_SIG,TRAF2,SIG,8,3.68952368794669,0.150429146008187,0.141421140231131,0.180026879275654,0.0386057390445227,0.000646104355560581,2.86097878786453,4.24716878728731,4.21133339837596,4.36491363656749,0.153580238191531,0.0152803379124326,ENSG00000127191,TRAF2,protein_coding,9,1,136881912,136926607,q34.3,TNF receptor associated factor 2 [Source:HGNC Symbol;Acc:HGNC:12032],NA,TRAF2,7186,NM_021138
ZNF250_TF,ZNF250,ZNF250_TF,ZNF250,TF,30,3.68922838547853,0.247252089749196,0.236031783891473,0.284118808995999,0.0480870251045264,0.000646464739419445,1.7091010254661,2.71625625196947,2.68999797748135,2.8025334395733,0.112535462091951,0.160880671326803,ENSG00000196150,ZNF250,protein_coding,8,-1,144876497,144902168,q24.3,zinc finger protein 250 [Source:HGNC Symbol;Acc:HGNC:13044],NA,ZNF250,58500,NM_001109689;NM_001363098;NM_001363099;NM_001363100;NM_001363101;NM_001363102;NM_001363103;NM_001363104;NM_001363106;NM_001363107;NM_021061
VWF_SIG,VWF,VWF_SIG,VWF,SIG,57,3.68920524895365,-0.0332077267461368,-0.0409200510918438,-0.00786723246738513,0.0330528186244588,0.000646464739419445,1.69006544462371,3.31525224656276,3.22268564954196,3.61939963677394,0.396713987231982,0.165711511326597,ENSG00000110799,VWF,protein_coding,12,-1,5948874,6124770,p13.31,von Willebrand factor [Source:HGNC Symbol;Acc:HGNC:12726],von Willebrand disease type 1;VON WILLEBRAND DISEASE TYPE 1;VON WILLEBRAND DISEASE TYPE 2;Von Willebrand disease type 2A;VON WILLEBRAND DISEASE TYPE 2B;von Willebrand disease type 2M;von Willebrand disease type 2N;von Willebrand disease type 3;VON WILLEBRAND DISEASE TYPE 3,VWF,7450,NM_000552
MLYCD_SIG,MLYCD,MLYCD_SIG,MLYCD,SIG,38,3.68903869609724,0.144974703749947,0.130619217116282,0.192142731260563,0.0615235141442817,0.000646663737164931,3.23648122173438,2.80700359513505,2.75031258975613,2.99327404138006,0.24296145162393,0.00574429053753046,ENSG00000103150,MLYCD,protein_coding,16,1,83899115,83927031,q23.3,malonyl-CoA decarboxylase [Source:HGNC Symbol;Acc:HGNC:7150],Malonic aciduria;MALONYL-CoA DECARBOXYLASE DEFICIENCY,MLYCD,23417,NM_012213
NOA1_SIG,NOA1,NOA1_SIG,NOA1,SIG,36,3.68819189366169,0.448080224942072,0.440769813199129,0.472100149240311,0.0313303360411817,0.000648594301689115,3.81566676159636,5.59645082626301,5.54338318884305,5.77081592064288,0.227432731799834,0.00102499108419539,ENSG00000084092,NOA1,protein_coding,4,-1,56963350,56977606,q12,nitric oxide associated 1 [Source:HGNC Symbol;Acc:HGNC:28473],NA,NOA1,84273,NM_032313
GALNT7_SIG,GALNT7,GALNT7_SIG,GALNT7,SIG,40,3.68758669067241,0.463278051473125,0.449216049370977,0.509481772665898,0.0602657232949206,0.000649913112423498,2.82688924223528,5.81582376576424,5.74674411678855,6.04279975525578,0.296055638467229,0.0166109247878461,ENSG00000109586,GALNT7,protein_coding,4,1,173168811,173323967,q34.1,polypeptide N-acetylgalactosaminyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:4129],NA,GALNT7,51809,NM_017423
LPL_SIG,LPL,LPL_SIG,LPL,SIG,15,-3.68541106018272,-0.0117889862322545,-0.00107266268430904,-0.0469997636040751,-0.0459271009197662,0.000655263465667616,-3.28929203537423,1.76739859986492,1.91152248076668,1.29384870547341,-0.617673775293268,0.00495194858460935,ENSG00000175445,LPL,protein_coding,8,1,19901717,19967259,p21.3,lipoprotein lipase [Source:HGNC Symbol;Acc:HGNC:6677],Familial lipoprotein lipase deficiency;HYPERLIPIDEMIA FAMILIAL COMBINED;Hyperlipoproteinemia type 5;Hyperlipoproteinemia type I,LPL,4023,NM_000237
MCTS1_SIG,MCTS1,MCTS1_SIG,MCTS1,SIG,31,3.68500369384797,0.280433910602604,0.270393108959155,0.31342511600251,0.0430320070433549,0.000656085143878744,3.18371767149212,4.16787659561942,4.12491504819966,4.30903596571291,0.184120917513247,0.00664085112097156,ENSG00000232119,MCTS1,protein_coding,X,1,120594010,120621159,q24,MCTS1, re-initiation and release factor [Source:HGNC Symbol;Acc:HGNC:23357],NA,MCTS1,28985,NM_001137554;NM_014060
ZNF284_TF,ZNF284,ZNF284_TF,ZNF284,TF,13,3.68439639092721,0.0630082475755871,0.0482686624061969,0.111438313132155,0.0631696507259578,0.000657423640650117,2.59104556905567,1.44014996638002,1.40183482802153,1.56604256384364,0.164207735822105,0.0287520295266132,ENSG00000186026,ZNF284,protein_coding,19,1,44072159,44089613,q13.31,zinc finger protein 284 [Source:HGNC Symbol;Acc:HGNC:13078],NA,ZNF284,342909,NM_001037813
FCGR2B_SIG,FCGR2B,FCGR2B_SIG,FCGR2B,SIG,14,-3.68209966825893,-0.0201394421751046,0.00451284839815975,-0.101139825487259,-0.105652673885419,0.000663146698549233,-1.22461729690926,2.50267147913685,2.5539606652402,2.33414986765443,-0.219810797585768,0.326060549053802,ENSG00000072694,FCGR2B,protein_coding,1,1,161663147,161678654,q23.3,Fc fragment of IgG receptor IIb [Source:HGNC Symbol;Acc:HGNC:3618],MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;Systemic lupus erythematosus,FCGR2B,2213,NM_001002273;NM_001002274;NM_001002275;NM_001190828;NM_004001
USP19_SIG,USP19,USP19_SIG,USP19,SIG,28,3.681442832528,0.471188175674038,0.467205475445557,0.484274190710473,0.0170687152649153,0.00066462778379144,2.16059912765618,6.38612878822145,6.36677577857765,6.44971724847966,0.082941469902015,0.0716968370384393,ENSG00000172046,USP19,protein_coding,3,-1,49108046,49120938,p21.31,ubiquitin specific peptidase 19 [Source:HGNC Symbol;Acc:HGNC:12617],NA,USP19,10869,NM_001199160;NM_001199161;NM_001199162;NM_001351098;NM_001351099;NM_001351100;NM_001351101;NM_001351102;NM_001351103;NM_001351104;NM_001351105;NM_001351106;NM_001351107;NM_001351108;NM_006677
L1CAM_SIG,L1CAM,L1CAM_SIG,L1CAM,SIG,9,-3.67954113144855,0.191830279875908,0.198062512026637,0.171352945666369,-0.0267095663602687,0.00066937185836483,-2.47025941236058,0.716637798515428,0.755799117605071,0.587964892935174,-0.167834224669897,0.037673439455024,ENSG00000198910,L1CAM,protein_coding,X,-1,153861514,153886174,q28,L1 cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:6470],CORPUS CALLOSUM PARTIAL AGENESIS OF X-LINKED;HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS;HYDROCEPHALUS DUE TO STENOSIS OF THE AQUEDUCT OF SYLVIUS;Hydrocephalus with stenosis of the aqueduct of Sylvius;MASA SYNDROME;MENTAL RETARDATION-APHASIA-SHUFFLING GAIT-ADDUCTED THUMBS SYNDROME;Partial agenesis of the corpus callosum;SPASTIC PARAPLEGIA X-LINKED TYPE 1;X-linked complicated corpus callosum dysgenesis;X-linked complicated spastic paraplegia type 1,L1CAM,3897,NM_000425;NM_001143963;NM_001278116;NM_024003
NDUFA11_SIG,NDUFA11,NDUFA11_SIG,NDUFA11,SIG,12,3.67882259286357,0.0394898043351855,0.0354739103643524,0.0526848845250656,0.0172109741607132,0.00067102824278029,2.32408438964931,2.53907487752577,2.51808737632557,2.6080338100407,0.089946433715129,0.0513985041199497,ENSG00000174886,NDUFA11,protein_coding,19,-1,5891276,5904006,p13.3,NADH:ubiquinone oxidoreductase subunit A11 [Source:HGNC Symbol;Acc:HGNC:20371],Isolated complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 14,NDUFA11,126328,NM_001193375;NM_175614
BRD8_TF,BRD8,BRD8_TF,BRD8,TF,49,3.67782090737396,0.24133320766381,0.229855625792929,0.279045262382418,0.0491896365894892,0.000673435453272434,3.05981218572967,5.47850444500506,5.41875622125652,5.67482003732166,0.256063816065136,0.00921786687771886,ENSG00000112983,BRD8,protein_coding,5,-1,138139766,138178986,q31.2,bromodomain containing 8 [Source:HGNC Symbol;Acc:HGNC:19874],NA,BRD8,10902,NM_001164326;NM_001300961;NM_001300962;NM_001300966;NM_006696;NM_139199
ASCC1_SIG,ASCC1,ASCC1_SIG,ASCC1,SIG,11,3.67737790303491,0.426174709398214,0.418831993184422,0.450300776957813,0.0314687837733904,0.000674372689663226,3.99262899791395,4.32995230935086,4.27024570080145,4.52613116601321,0.255885465211764,0.000582921240356022,ENSG00000138303,ASCC1,protein_coding,10,-1,72096032,72217134,q22.1,activating signal cointegrator 1 complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:24268],BARRETT ESOPHAGUS;Prenatal-onset spinal muscular atrophy with congenital bone fractures;Prenatal Spinal Muscular Atrophy and Congenital Bone Fractures;Spinal muscular atrophy with congenital bone fractures 2,ASCC1,51008,NM_001198798;NM_001198799;NM_001198800
SLC33A1_SIG,SLC33A1,SLC33A1_SIG,SLC33A1,SIG,18,3.67640908916117,0.46815460945971,0.458867988613002,0.498667792241753,0.039799803628751,0.000676703970769163,4.40546020553302,4.90992796892054,4.84843452416506,5.1119778588314,0.263543334666336,0.000140317985717368,ENSG00000169359,SLC33A1,protein_coding,3,-1,155821024,155854456,q25.31,solute carrier family 33 member 1 [Source:HGNC Symbol;Acc:HGNC:95],Autosomal-Recessive Disorder with Congenital Cataracts Hearing Loss and Low Serum Copper and Ceruloplasmin;Autosomal dominant spastic paraplegia type 42;Congenital cataract-hearing loss-severe developmental delay syndrome;CONGENITAL CATARACTS HEARING LOSS AND NEURODEGENERATION;SPASTIC PARAPLEGIA 42 AUTOSOMAL DOMINANT,SLC33A1,9197,NM_001190992;NM_001363883;NM_004733
ZXDC_SIG,ZXDC,ZXDC_SIG,ZXDC,SIG,22,3.67476127083283,0.130813488927863,0.125032351299562,0.149808655420855,0.0247763041212934,0.000680851156196895,3.93543972733451,6.22839293361272,6.18640074958144,6.36636725257267,0.179966502991237,0.000700327676115103,ENSG00000070476,ZXDC,protein_coding,3,-1,126437601,126475891,q21.3,ZXD family zinc finger C [Source:HGNC Symbol;Acc:HGNC:28160],NA,ZXDC,79364,NM_001040653;NM_025112
IRF8_TF,IRF8,IRF8_TF,IRF8,TF,404,-3.67402835002744,0.0701443939841855,0.0819585507262771,0.0313264504030271,-0.05063210032325,0.000682572574335887,-3.51708820583413,5.76663698916506,5.95233688868927,5.15648017644262,-0.795856712246654,0.00256950716284699,ENSG00000140968,IRF8,protein_coding,16,1,85899162,85922606,q24.1,interferon regulatory factor 8 [Source:HGNC Symbol;Acc:HGNC:5358],IMMUNODEFICIENCY 32A;IMMUNODEFICIENCY 32B;Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,IRF8,3394,NM_001363907;NM_002163
FAM20B_SIG,FAM20B,FAM20B_SIG,FAM20B,SIG,33,3.6733551621852,0.43595899508824,0.425433969506365,0.470541222000115,0.0451072524937499,0.000684138062890146,2.16370627804366,6.09538863333732,6.05645601889625,6.22331008078655,0.166854061890297,0.0712109348297735,ENSG00000116199,FAM20B,protein_coding,1,1,179025804,179076567,q25.2,FAM20B, glycosaminoglycan xylosylkinase [Source:HGNC Symbol;Acc:HGNC:23017],NA,FAM20B,9917,NM_001324310;NM_001324311;NM_014864
TAS2R20_SIG,TAS2R20,TAS2R20_SIG,TAS2R20,SIG,38,3.67303409817809,0.0181965808870432,0.0104539903541061,0.0436365212095509,0.0331825308554449,0.000684762349841557,2.65869473451962,0.390189103927242,0.370830330946079,0.45379650086535,0.0829661699192703,0.0246108763970741,ENSG00000255837,TAS2R20,protein_coding,12,-1,10996495,10997875,p13.2,taste 2 receptor member 20 [Source:HGNC Symbol;Acc:HGNC:19109],NA,TAS2R20,259295,NM_176889
PANX1_SIG,PANX1,PANX1_SIG,PANX1,SIG,22,3.67283835932797,0.192193782908554,0.187856237796913,0.206445716846805,0.0185894790498929,0.000685051048015825,0.291887906643156,4.13409064598047,4.12913213628364,4.15038289212719,0.0212507558435454,0.832764976991536,ENSG00000110218,PANX1,protein_coding,11,1,94128841,94181968,q21,pannexin 1 [Source:HGNC Symbol;Acc:HGNC:8599],NA,PANX1,24145,NM_015368
SOX13_TF,SOX13,SOX13_TF,SOX13,TF,148,-3.67241619144039,-0.0639085208481437,-0.0596709910859618,-0.0778318329238845,-0.0181608418379228,0.000685947639418225,-1.85047233139738,1.64337103946336,1.70009912685617,1.45697875231556,-0.243120374540604,0.126731842147841,ENSG00000143842,SOX13,protein_coding,1,1,204073115,204127743,q32.1,SRY-box 13 [Source:HGNC Symbol;Acc:HGNC:11192],NA,SOX13,9580,NM_005686
THAP2_TF,THAP2,THAP2_TF,THAP2,TF,42,-3.67161111522626,0.0131643799913287,0.0183947075675981,-0.00402098204498508,-0.0224156896125832,0.000687875452769306,-1.24025719668044,3.32260937750227,3.34531846302067,3.24799381079893,-0.0973246522217407,0.319418142755749,ENSG00000173451,THAP2,protein_coding,12,1,71664301,71680644,q21.1,THAP domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20854],NA,THAP2,83591,NM_031435
FIP1L1_SIG,FIP1L1,FIP1L1_SIG,FIP1L1,SIG,44,3.67100792838228,0.292146354978162,0.286536980330374,0.310577157392324,0.0240401770619501,0.000689263627822337,2.82454160922863,6.25403265017141,6.22362340387126,6.35394874515765,0.130325341286395,0.0166987592964237,ENSG00000145216,FIP1L1,protein_coding,4,1,53377641,53460862,q12,factor interacting with PAPOLA and CPSF1 [Source:HGNC Symbol;Acc:HGNC:19124],ACUTE PROMYELOCYTIC LEUKEMIA;Chronic eosinophilic leukemia;Primary hypereosinophilic syndrome,FIP1L1,81608,NM_001134937;NM_001134938;NM_030917
RNF114_SIG,RNF114,RNF114_SIG,RNF114,SIG,15,3.67045596773056,0.302718686185608,0.297848102534379,0.31872203246822,0.0208739299338409,0.000690516041248807,1.49154854801741,6.56407577039514,6.54915675368887,6.61309539671574,0.0639386430268737,0.224778148946087,ENSG00000124226,RNF114,protein_coding,20,1,49936336,49953885,q13.13,ring finger protein 114 [Source:HGNC Symbol;Acc:HGNC:13094],NA,RNF114,55905,NM_018683
XCL2_SIG,XCL2,XCL2_SIG,XCL2,SIG,6,-3.6699083523984,-0.138795227504164,-0.122893858565667,-0.191042582587799,-0.0681487240221323,0.000691758853670032,-2.01629837482172,0.72588208632896,0.761742735548915,0.608054238891966,-0.153688496656949,0.0941725775105583,ENSG00000143185,XCL2,protein_coding,1,-1,168540768,168543997,q24.2,X-C motif chemokine ligand 2 [Source:HGNC Symbol;Acc:HGNC:10646],NA,XCL2,6846,NM_003175
ZCCHC3_SIG,ZCCHC3,ZCCHC3_SIG,ZCCHC3,SIG,40,3.66961734761469,0.142945029082848,0.138035841183322,0.159075217895577,0.0210393767122554,0.000692308536738801,2.84777751756675,1.72011637531702,1.68638825563581,1.83093733998385,0.144549084348031,0.0157775371610348,ENSG00000247315,ZCCHC3,protein_coding,20,1,296968,300321,p13,zinc finger CCHC-type containing 3 [Source:HGNC Symbol;Acc:HGNC:16230],NA,ZCCHC3,85364,NM_033089
MAP2K3_SIG,MAP2K3,MAP2K3_SIG,MAP2K3,SIG,28,-3.66906090061759,0.27795187995415,0.289006930368561,0.241628142878231,-0.0473787874903295,0.000693578395149741,-0.898440738669326,6.7284270393151,6.74529232719786,6.67301252198604,-0.0722798052118233,0.482794260843941,ENSG00000034152,MAP2K3,protein_coding,17,1,21284672,21315240,p11.2,mitogen-activated protein kinase kinase 3 [Source:HGNC Symbol;Acc:HGNC:6843],NA,MAP2K3,5606,NM_001316332;NM_002756;NM_145109
HDHD3_SIG,HDHD3,HDHD3_SIG,HDHD3,SIG,3,3.66871991024179,-0.0317585426420599,-0.0417508733405647,0.00107340108159904,0.0428242744221636,0.000694265232280428,4.95520163440507,3.33602005203746,3.25775281560465,3.59318382888811,0.335431013283458,1.70464332823671e-05,ENSG00000119431,HDHD3,protein_coding,9,-1,113373419,113376999,q32,haloacid dehalogenase like hydrolase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28171],NA,HDHD3,81932,NM_001304509;NM_001304510;NM_001304511;NM_031219
DHX33_SIG,DHX33,DHX33_SIG,DHX33,SIG,7,3.6683320136703,0.649187701618814,0.633965886193531,0.69920223801617,0.0652363518226387,0.000695080239247704,2.65032366829021,4.84485888412335,4.79739821059404,5.00080109714822,0.203402886554172,0.0250331285745695,ENSG00000005100,DHX33,protein_coding,17,-1,5440917,5468982,p13.2,DEAH-box helicase 33 [Source:HGNC Symbol;Acc:HGNC:16718],NA,DHX33,56919,NM_001199699;NM_020162
PPA2_SIG,PPA2,PPA2_SIG,PPA2,SIG,32,3.66768916484658,0.136189907169144,0.130041905583599,0.156390483807364,0.0263485782237649,0.000696590240696861,3.99170666506198,5.04305543777614,4.99176312681944,5.21158731663387,0.219824189814428,0.000584323274451087,ENSG00000138777,PPA2,protein_coding,4,-1,105369077,105474067,q24,pyrophosphatase (inorganic) 2 [Source:HGNC Symbol;Acc:HGNC:28883],Sudden arrhythmic cardiac death after infectious or alcohol trigger;SUDDEN CARDIAC FAILURE ALCOHOL-INDUCED;SUDDEN CARDIAC FAILURE INFANTILE,PPA2,27068,NM_006903;NM_176866;NM_176867;NM_176869
CDC42BPB_SIG,CDC42BPB,CDC42BPB_SIG,CDC42BPB,SIG,65,3.66753785798725,-0.00936251370266691,-0.0147103584495422,0.00820897617992332,0.0229193346294655,0.00069676309402456,2.0264507369418,4.63227560911829,4.55932935284917,4.87195616543108,0.312626812581912,0.0925407927026484,ENSG00000198752,CDC42BPB,protein_coding,14,-1,102932380,103057549,q32.32,CDC42 binding protein kinase beta [Source:HGNC Symbol;Acc:HGNC:1738],NA,CDC42BPB,9578,NM_006035
S1PR5_SIG,S1PR5,S1PR5_SIG,S1PR5,SIG,28,-3.66738513341284,-0.246214911528292,-0.220029786251804,-0.332251751722467,-0.112221965470663,0.000696939920209934,-3.40235656934596,2.13514119257489,2.25505976654683,1.74112302095281,-0.513936745594018,0.00357698461411805,ENSG00000180739,S1PR5,protein_coding,19,-1,10512742,10517931,p13.2,sphingosine-1-phosphate receptor 5 [Source:HGNC Symbol;Acc:HGNC:14299],NA,S1PR5,53637,NM_001166215;NM_030760
CLOCK_TF,CLOCK,CLOCK_TF,CLOCK,TF,72,3.66721940358661,0.206002326286876,0.201049892303651,0.222274609374617,0.0212247170709668,0.000697152302390839,2.96473920653779,4.30544113883489,4.25587926599586,4.46828729244886,0.212408026453001,0.0117957922690347,ENSG00000134852,CLOCK,protein_coding,4,-1,55427903,55546909,q12,clock circadian regulator [Source:HGNC Symbol;Acc:HGNC:2082],NA,CLOCK,9575,NM_001267843;NM_004898
RNF122_SIG,RNF122,RNF122_SIG,RNF122,SIG,10,-3.66696528092338,0.093070718809491,0.0971622304613974,0.0796271805246557,-0.0175350499367416,0.000697605826661315,-3.33500062240226,3.78828680494866,3.85135386218966,3.58106647401397,-0.270287388175692,0.00435399647109115,ENSG00000133874,RNF122,protein_coding,8,-1,33547754,33567128,p12,ring finger protein 122 [Source:HGNC Symbol;Acc:HGNC:21147],NA,RNF122,79845,NM_024787
TSR1_SIG,TSR1,TSR1_SIG,TSR1,SIG,41,3.66545763209475,0.651981635307098,0.64054196007749,0.689569139632951,0.0490271795554604,0.000701488010058672,3.44753280401286,5.64142225881279,5.58822389750379,5.81621687454236,0.227992977038566,0.00313887630427358,ENSG00000167721,TSR1,protein_coding,17,-1,2322503,2337507,p13.3,TSR1, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:25542],NA,TSR1,55720,NM_018128
PBK_SIG,PBK,PBK_SIG,PBK,SIG,40,-3.6650450483605,-0.101966320122834,-0.0868186338720684,-0.151737289232492,-0.0649186553604236,0.000702378983232233,-1.91444905083439,0.950468962652488,0.997011335734206,0.797544022526843,-0.199467313207363,0.113415064095882,ENSG00000168078,PBK,protein_coding,8,-1,27809624,27838082,p21.1,PDZ binding kinase [Source:HGNC Symbol;Acc:HGNC:18282],NA,PBK,55872,NM_001278945;NM_018492
PAFAH1B3_SIG,PAFAH1B3,PAFAH1B3_SIG,PAFAH1B3,SIG,17,3.66439470006564,0.311829271844728,0.303197268283005,0.340191569261818,0.0369943009788132,0.000703924636218415,2.79014075968786,3.60153320055736,3.54743946148504,3.779269771795,0.231830310309964,0.0181213992170875,ENSG00000079462,PAFAH1B3,protein_coding,19,-1,42297033,42303546,q13.2,platelet activating factor acetylhydrolase 1b catalytic subunit 3 [Source:HGNC Symbol;Acc:HGNC:8576],NA,PAFAH1B3,5050,NM_001145939;NM_001145940;NM_002573
FBP1_SIG,FBP1,FBP1_SIG,FBP1,SIG,46,-3.66408668773839,0.151625144428098,0.17265344708151,0.0825321499954564,-0.0901212970860538,0.000704530719654738,-2.95509305656071,3.50336431909602,3.64935516198558,3.02368012103035,-0.625675040955226,0.0120926133891034,ENSG00000165140,FBP1,protein_coding,9,-1,94603133,94640249,q22.32,fructose-bisphosphatase 1 [Source:HGNC Symbol;Acc:HGNC:3606],FRUCTOSE-16-BISPHOSPHATASE DEFICIENCY,FBP1,2203,NM_000507;NM_001127628
ANG_SIG,ANG,ANG_SIG,ANG,SIG,4,-3.66387312992706,-0.106823409718765,-0.0859933837696821,-0.175264923551465,-0.0892715397817826,0.000704877226387208,-1.84499288525378,0.566167052591881,0.592466138788698,0.479755769373767,-0.112710369414931,0.127870358744458,ENSG00000214274,ANG,protein_coding,14,1,20684177,20698971,q11.2,angiogenin [Source:HGNC Symbol;Acc:HGNC:483],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 9,ANG,283,NM_001097577;NM_001145
MRC1_SIG,MRC1,MRC1_SIG,MRC1,SIG,34,3.66291101537397,-0.0461289714565153,-0.0537380451521114,-0.0211277293138423,0.0326103158382692,0.000707288783948622,6.4347515537555,0.839281622076984,0.646337025328345,1.47324243996537,0.826905414637024,1.58672830261631e-08,ENSG00000260314,MRC1,protein_coding,10,1,17809348,17911164,p12.33,mannose receptor C-type 1 [Source:HGNC Symbol;Acc:HGNC:7228],NA,MRC1,4360,NM_002438
QDPR_SIG,QDPR,QDPR_SIG,QDPR,SIG,35,3.66246239696579,0.231845763426317,0.22057098853527,0.268891452354045,0.0483204638187752,0.000708260630950515,2.95204286520284,4.31710169354756,4.26690258818472,4.4820416111683,0.21513902298358,0.0121770005847442,ENSG00000151552,QDPR,protein_coding,4,-1,17460261,17512206,p15.32,quinoid dihydropteridine reductase [Source:HGNC Symbol;Acc:HGNC:9752],BH4-Deficient Hyperphenylalaninemia C;Dihydropteridine reductase deficiency;HYPERPHENYLALANINEMIA BH4-DEFICIENT C,QDPR,5860,NM_000320;NM_001306140
NFKB2_TF,NFKB2,NFKB2_TF,NFKB2,TF,171,-3.66238412093626,0.0942730299648979,0.105913188029053,0.0560267963255304,-0.0498863917035228,0.000708260630950515,-2.36410044801231,5.68823935592935,5.75675062889036,5.46313088762891,-0.293619741261449,0.0473070388617419,ENSG00000077150,NFKB2,protein_coding,10,1,102394110,102402524,q24.32,nuclear factor kappa B subunit 2 [Source:HGNC Symbol;Acc:HGNC:7795],Common variable immunodeficiency;Deficiency in anterior pituitary function-variable immunodeficiency syndrome;IMMUNODEFICIENCY COMMON VARIABLE 10,NFKB2,4791,NM_001077494;NM_001261403;NM_001288724;NM_001322934;NM_001322935;NM_002502
ZNF721_TF,ZNF721,ZNF721_TF,ZNF721,TF,37,-3.6616574773148,0.0221222813810172,0.0282693126914274,0.00192489278966933,-0.0263444199017582,0.000710030029056445,-1.84248578788742,4.20798679423245,4.26611928197476,4.01698004879346,-0.249139233181293,0.128396283704221,ENSG00000182903,ZNF721,protein_coding,4,-1,425815,499156,p16.3,zinc finger protein 721 [Source:HGNC Symbol;Acc:HGNC:29425],NA,ZNF721,170960,NM_133474
ST6GALNAC2_SIG,ST6GALNAC2,ST6GALNAC2_SIG,ST6GALNAC2,SIG,9,-3.66130681391417,0.345634435980823,0.368146617300775,0.271665840215264,-0.0964807770855114,0.000710759635086895,-1.58819438632901,2.20698640097769,2.2566506785854,2.04380377455233,-0.212846904033069,0.19399678068911,ENSG00000070731,ST6GALNAC2,protein_coding,17,-1,76565379,76586956,q25.1,ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:10867],NA,ST6GALNAC2,10610,NM_006456
CPSF6_SIG,CPSF6,CPSF6_SIG,CPSF6,SIG,79,3.66035003518626,0.314410795963745,0.305564830138549,0.343476112246531,0.0379112821079827,0.000713175215911215,2.84168829934022,7.35929475984309,7.31850697586874,7.49331176433025,0.17480478846151,0.0160202938722597,ENSG00000111605,CPSF6,protein_coding,12,1,69239569,69274358,q15,cleavage and polyadenylation specific factor 6 [Source:HGNC Symbol;Acc:HGNC:13871],NA,CPSF6,11052,NM_001300947;NM_007007
MTHFSD_SIG,MTHFSD,MTHFSD_SIG,MTHFSD,SIG,65,3.65970288530234,0.223126740754566,0.20696819693565,0.276219099016718,0.0692509020810676,0.000714734393614894,3.75273524813298,3.89605660713071,3.82494471673916,4.1297099612744,0.304765244535247,0.00124634839316401,ENSG00000103248,MTHFSD,protein_coding,16,-1,86530176,86555235,q24.1,methenyltetrahydrofolate synthetase domain containing [Source:HGNC Symbol;Acc:HGNC:25778],NA,MTHFSD,64779,NM_001159377;NM_001159378;NM_001159379;NM_001159380;NM_022764
SAMD4A_SIG,SAMD4A,SAMD4A_SIG,SAMD4A,SIG,27,-3.65784019328471,0.0789373106248568,0.0901897153844474,0.0419651235576305,-0.0482245918268169,0.000719701494458263,-2.67416207637247,1.57781101008148,1.64615504224177,1.3532520472691,-0.292902994972669,0.0237784859705195,ENSG00000020577,SAMD4A,protein_coding,14,1,54567097,54793315,q22.2,sterile alpha motif domain containing 4A [Source:HGNC Symbol;Acc:HGNC:23023],NA,SAMD4A,23034,NM_001161576;NM_001161577;NM_015589
DGKK_SIG,DGKK,DGKK_SIG,DGKK,SIG,10,-3.65743401888091,-0.166953081003837,-0.152661730494384,-0.213910375534895,-0.0612486450405114,0.000720596456146715,-0.945135142920986,0.271366970605855,0.283569326380626,0.231273515917322,-0.0522958104633044,0.458215862435839,ENSG00000274588,DGKK,protein_coding,X,-1,50365409,50470825,p11.22,diacylglycerol kinase kappa [Source:HGNC Symbol;Acc:HGNC:32395],NA,DGKK,139189,NM_001013742
WIZ_TF,WIZ,WIZ_TF,WIZ,TF,50,3.65681462187707,0.427893399070966,0.419603242840836,0.455132483827106,0.0355292409862709,0.000722092669440094,1.80305603663979,5.59669962451725,5.57600004574584,5.66471252619472,0.0887124804488853,0.137432905441573,ENSG00000011451,WIZ,protein_coding,19,-1,15419980,15449951,p13.12,WIZ zinc finger [Source:HGNC Symbol;Acc:HGNC:30917],NA,WIZ,58525,NM_001330395;NM_021241
MARS_SIG,MARS,MARS_SIG,MARS,SIG,9,3.65640608473354,0.409308038645419,0.404760771787804,0.424249058320441,0.0194882865326378,0.00072299714874818,3.09141033067956,6.85563994567847,6.82518898639095,6.95569309762317,0.130504111232225,0.00847646037056253,ENSG00000166986,MARS,protein_coding,12,1,57475445,57517569,q13.3,methionyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:6898],Autosomal dominant Charcot-Marie-Tooth disease type 2U;Autosomal recessive spastic paraplegia type 70;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2U;INTERSTITIAL LUNG AND LIVER DISEASE;Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency,MARS,4141,NM_004990
TGDS_SIG,TGDS,TGDS_SIG,TGDS,SIG,50,3.6547754570905,0.177271038791107,0.165494052028482,0.21596685243973,0.0504728004112479,0.0007273515328425,4.02739553476694,3.08078330152786,3.01838865641899,3.28579427831416,0.267405621895166,0.000521442785638425,ENSG00000088451,TGDS,protein_coding,13,-1,94574054,94596242,q32.1,TDP-glucose 4,6-dehydratase [Source:HGNC Symbol;Acc:HGNC:20324],Catel Manzke syndrome,TGDS,23483,NM_001304430;NM_014305
MYBL1_TF,MYBL1,MYBL1_TF,MYBL1,TF,200,-3.65469081233022,-0.0864411912786533,-0.077995913096596,-0.11418996244827,-0.0361940493516744,0.0007273515328425,-2.14014775186791,2.5986502187579,2.66645467974253,2.37586413266554,-0.290590547076988,0.0745020339065896,ENSG00000185697,MYBL1,protein_coding,8,-1,66562175,66614247,q13.1,MYB proto-oncogene like 1 [Source:HGNC Symbol;Acc:HGNC:7547],NA,MYBL1,4603,NM_001080416;NM_001144755;NM_001294282
DAP3_SIG,DAP3,DAP3_SIG,DAP3,SIG,22,3.65402941587596,0.475338506951963,0.468161523690442,0.498920023382674,0.030758499692232,0.000728980241069057,0.610122112766214,6.33279648076158,6.32701900376822,6.35177961945405,0.024760615685831,0.644610339614406,ENSG00000132676,DAP3,protein_coding,1,1,155687960,155739010,q22,death associated protein 3 [Source:HGNC Symbol;Acc:HGNC:2673],NA,DAP3,7818,NM_001199849;NM_001199850;NM_001199851;NM_004632;NM_033657
KCNQ4_SIG,KCNQ4,KCNQ4_SIG,KCNQ4,SIG,35,-3.65332640320643,-0.0690251456096111,-0.0638275498738247,-0.0861029601700523,-0.0222754102962276,0.000730730855853374,-1.98620852157332,0.680690902145559,0.708248761846325,0.590143648843043,-0.118105113003282,0.0996723950766327,ENSG00000117013,KCNQ4,protein_coding,1,1,40783787,40840452,p34.2,potassium voltage-gated channel subfamily Q member 4 [Source:HGNC Symbol;Acc:HGNC:6298],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 2A,KCNQ4,9132,NM_004700;NM_172163
GLI4_TF,GLI4,GLI4_TF,GLI4,TF,39,3.65278875348729,0.188075408046407,0.180248072969132,0.213793794728885,0.0335457217597535,0.00073201370231461,2.4376129978905,3.50937079196525,3.47763460328987,3.61364684047007,0.136012237180199,0.0404063836914991,ENSG00000250571,GLI4,protein_coding,8,1,143267433,143276931,q24.3,GLI family zinc finger 4 [Source:HGNC Symbol;Acc:HGNC:4320],NA,GLI4,2738,NM_138465
GALT_SIG,GALT,GALT_SIG,GALT,SIG,97,3.6520459449656,0.105514024314394,0.0965314534791396,0.135028185630228,0.0384967321510884,0.000733884915125392,1.96935173853901,4.2252689394191,4.19362965086923,4.32922660179726,0.135596950928026,0.102705005754058,ENSG00000213930,GALT,protein_coding,9,1,34638133,34651035,p13.3,galactose-1-phosphate uridylyltransferase [Source:HGNC Symbol;Acc:HGNC:4135],Classic galactosemia;GALACTOSEMIA,GALT,2592,NM_000155;NM_001258332
CCL18_SIG,CCL18,CCL18_SIG,CCL18,SIG,5,-3.65175659470751,-0.369610666875074,-0.347821718518716,-0.44120292576025,-0.0933812072415341,0.000734462391913481,-1.59993740788944,0.363599072059441,0.395923149608219,0.257391388684881,-0.138531760923338,0.190648893297986,ENSG00000275385,CCL18,protein_coding,17,1,36064280,36072032,q12,C-C motif chemokine ligand 18 [Source:HGNC Symbol;Acc:HGNC:10616],NA,CCL18,6362,NM_002988
CLCN2_SIG,CLCN2,CLCN2_SIG,CLCN2,SIG,30,3.65149864423884,0.0507314833484201,0.0460286381886062,0.066183688873523,0.0201550506849168,0.000734715926840197,2.72865356493799,2.17882235233932,2.13046365199923,2.33771522488531,0.207251572886073,0.0209172424742827,ENSG00000114859,CLCN2,protein_coding,3,-1,184346185,184361650,q27.1,chloride voltage-gated channel 2 [Source:HGNC Symbol;Acc:HGNC:2020],EPILEPSY IDIOPATHIC GENERALIZED SUSCEPTIBILITY TO 11;Hyperaldosteronism familial type II;Juvenile myoclonic epilepsy;LEUKOENCEPHALOPATHY WITH ATAXIA;Leukoencephalopathy with mild cerebellar ataxia and white matter edema,CLCN2,1181,NM_001171087;NM_001171088;NM_001171089;NM_004366
MRPL9_SIG,MRPL9,MRPL9_SIG,MRPL9,SIG,22,3.65149324807342,0.473553116674764,0.46554388405754,0.499869166702784,0.0343252826452442,0.000734715926840197,5.02149880682321,5.55488840937973,5.49839143681954,5.74052131922036,0.242129882400819,1.30384068490434e-05,ENSG00000143436,MRPL9,protein_coding,1,-1,151759647,151763496,q21.3,mitochondrial ribosomal protein L9 [Source:HGNC Symbol;Acc:HGNC:14277],NA,MRPL9,65005,NM_001300733;NM_031420
FZD7_SIG,FZD7,FZD7_SIG,FZD7,SIG,27,3.6503066973174,-0.0460471467566539,-0.0519462832201749,-0.0266642698050847,0.0252820134150902,0.000737867473734814,1.79730325530037,1.72022298323139,1.67348618766488,1.87378674009279,0.200300552427916,0.138806810942426,ENSG00000155760,FZD7,protein_coding,2,1,202034587,202038445,q33.1,frizzled class receptor 7 [Source:HGNC Symbol;Acc:HGNC:4045],NA,FZD7,8324,NM_003507
FBXL17_SIG,FBXL17,FBXL17_SIG,FBXL17,SIG,18,3.6500503037061,0.223151492462911,0.218222447145808,0.239346927076248,0.0211244799304399,0.000738353334026727,1.57878678167505,4.73636166022957,4.71032912362931,4.82189713763043,0.111568014001119,0.196936010172279,ENSG00000145743,FBXL17,protein_coding,5,-1,107859035,108382098,q21.3,F-box and leucine rich repeat protein 17 [Source:HGNC Symbol;Acc:HGNC:13615],NA,FBXL17,64839,NM_001163315
FTSJ1_SIG,FTSJ1,FTSJ1_SIG,FTSJ1,SIG,11,3.64784290521191,0.321644252106277,0.311366091818463,0.355415350194809,0.0440492583763466,0.000744471131928671,2.44526220379356,4.97773376223915,4.95304958322782,5.05883892184781,0.105789338619983,0.0397544700449509,ENSG00000068438,FTSJ1,protein_coding,X,1,48476021,48486364,p11.23,FtsJ RNA methyltransferase homolog 1 [Source:HGNC Symbol;Acc:HGNC:13254],MENTAL RETARDATION X-LINKED 9;MENTAL RETARDATION X-LINKED TYPE 44;X-linked non-syndromic intellectual disability,FTSJ1,24140,NM_001282157;NM_012280;NM_177439
PIGV_SIG,PIGV,PIGV_SIG,PIGV,SIG,24,3.64702373020418,0.0110983815229452,-0.00448273165584918,0.0622934676818409,0.06677619933769,0.000746593971498619,1.86945914787256,3.54533343191691,3.50804401265651,3.66785580948681,0.159811796830295,0.122693490905352,ENSG00000060642,PIGV,protein_coding,1,1,26787472,26798398,p36.11,phosphatidylinositol glycan anchor biosynthesis class V [Source:HGNC Symbol;Acc:HGNC:26031],Hyperphosphatasia-intellectual disability syndrome;HYPERPHOSPHATASIA WITH MENTAL RETARDATION;HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1,PIGV,55650,NM_001202554;NM_017837
TICAM2_SIG,TICAM2,TICAM2_SIG,TICAM2,SIG,19,-3.64553867162364,0.353727085918633,0.382392601999503,0.259540390224345,-0.122852211775158,0.000750663996089637,-1.97974869940501,0.462965968699708,0.484334679099782,0.392754491670895,-0.0915801874288866,0.100837234936384,ENSG00000243414,TICAM2,protein_coding,5,-1,115578650,115602479,q22.3,toll like receptor adaptor molecule 2 [Source:HGNC Symbol;Acc:HGNC:21354],NA,TICAM2,353376,NM_021649
ANKRD17_SIG,ANKRD17,ANKRD17_SIG,ANKRD17,SIG,84,3.64512783139545,0.482549315426828,0.47094564869477,0.520675648975018,0.0497300002802477,0.000751609023409913,2.90837456071609,7.17150707809952,7.12566998713518,7.32211466269663,0.196444675561449,0.0135748963532132,ENSG00000132466,ANKRD17,protein_coding,4,-1,73073376,73258798,q13.3,ankyrin repeat domain 17 [Source:HGNC Symbol;Acc:HGNC:23575],NA,ANKRD17,26057,NM_001286771;NM_015574;NM_032217;NM_198889
PRMT3_TF,PRMT3,PRMT3_TF,PRMT3,TF,317,3.6447897506661,0.377866853862075,0.369920832425623,0.403975210010417,0.0340543775847939,0.000752342339689703,1.73580781099772,4.02971591721545,4.00435729568865,4.11303710223208,0.108679806543433,0.153770988959932,ENSG00000185238,PRMT3,protein_coding,11,1,20387558,20509338,p15.1,protein arginine methyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:30163],NA,PRMT3,10196,NM_001145166;NM_001145167;NM_005788
RP9_SIG,RP9,RP9_SIG,RP9,SIG,18,3.64348734415293,0.291768189237166,0.284410788510912,0.315942505909141,0.0315317173982291,0.000755904748190301,3.70067825952957,3.53201253160352,3.48432743901537,3.68869212153601,0.204364682520639,0.00146801265529433,ENSG00000164610,RP9,protein_coding,7,-1,33094797,33109404,p14.3,RP9, pre-mRNA splicing factor [Source:HGNC Symbol;Acc:HGNC:10288],Retinitis pigmentosa;RETINITIS PIGMENTOSA 9,RP9,6100,NM_203288
ZNF202_TF,ZNF202,ZNF202_TF,ZNF202,TF,135,3.64281920997234,0.290496368605341,0.279561021196003,0.326426795807452,0.046865774611449,0.000757613232344676,2.49664240880489,3.74214464021478,3.69335176176406,3.90246409798142,0.209112336217354,0.0355853353472706,ENSG00000166261,ZNF202,protein_coding,11,-1,123723914,123741675,q24.1,zinc finger protein 202 [Source:HGNC Symbol;Acc:HGNC:12994],NA,ZNF202,7753,NM_001301779;NM_001301780;NM_001301819;NM_003455
COG7_SIG,COG7,COG7_SIG,COG7,SIG,4,3.63996740009198,0.194814575803915,0.1845046966093,0.22868989315765,0.04418519654835,0.00076579395431548,4.38332116550768,4.2642912306005,4.21495442079772,4.42639789138107,0.211443470583352,0.000151405038724703,ENSG00000168434,COG7,protein_coding,16,-1,23388493,23453189,p12.2,component of oligomeric golgi complex 7 [Source:HGNC Symbol;Acc:HGNC:18622],COG7-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIe,COG7,91949,NM_153603
JMJD4_SIG,JMJD4,JMJD4_SIG,JMJD4,SIG,26,3.639617511549,0.296820744184432,0.284129571224076,0.338520312482746,0.0543907412586702,0.000766575346568861,3.38144360925854,3.47152469202511,3.41345371019874,3.66232934659745,0.248875636398707,0.00381707332314548,ENSG00000081692,JMJD4,protein_coding,1,-1,227730425,227735411,q42.13,jumonji domain containing 4 [Source:HGNC Symbol;Acc:HGNC:25724],NA,JMJD4,65094,NM_001161465;NM_023007
ZDHHC7_TF,ZDHHC7,ZDHHC7_TF,ZDHHC7,TF,224,-3.63789038369872,0.244495690615516,0.256556693411027,0.204866681430267,-0.0516900119807595,0.000771471474710891,-1.25755083036896,6.94364956516783,6.96435254820242,6.87562547805417,-0.0887270701482549,0.312147941849412,ENSG00000153786,ZDHHC7,protein_coding,16,-1,84974181,85011535,q24.1,zinc finger DHHC-type containing 7 [Source:HGNC Symbol;Acc:HGNC:18459],NA,ZDHHC7,55625,NM_001145548;NM_017740
SENP3_SIG,SENP3,SENP3_SIG,SENP3,SIG,13,3.6371857759552,0.338081116678569,0.330324246684784,0.363567975229578,0.0332437285447936,0.000773322220827624,1.11720087160628,4.18034232458914,4.16734730273948,4.22304025352372,0.0556929507842368,0.374200746780938,ENSG00000161956,SENP3,protein_coding,17,1,7561919,7571969,p13.1,SUMO specific peptidase 3 [Source:HGNC Symbol;Acc:HGNC:17862],NA,SENP3,26168,NM_015670
CUL4B_SIG,CUL4B,CUL4B_SIG,CUL4B,SIG,15,3.63691772881513,0.419217243749648,0.411109466321649,0.445857083870217,0.034747617548568,0.000773829344062882,2.88677253341352,6.33066739128015,6.2980355919963,6.43788616035565,0.139850568359347,0.0143386263191729,ENSG00000158290,CUL4B,protein_coding,X,-1,120524609,120575794,q24,cullin 4B [Source:HGNC Symbol;Acc:HGNC:2555],MENTAL RETARDATION SYNDROMIC X-LINKED CABEZAS TYPE;MENTAL RETARDATION X-LINKED SYNDROMIC CABEZAS TYPE;X-linked intellectual disability Cabezas type,CUL4B,8450,NM_001079872;NM_001330624;NM_003588
PCYOX1L_SIG,PCYOX1L,PCYOX1L_SIG,PCYOX1L,SIG,38,3.63684239350288,0.188296223883917,0.17783563980031,0.222666714444338,0.044831074644028,0.000773829344062882,3.81429062087679,5.04755706258497,4.95764190221707,5.34299258950805,0.385350687290975,0.00103003823937846,ENSG00000145882,PCYOX1L,protein_coding,5,1,149358037,149369653,q32,prenylcysteine oxidase 1 like [Source:HGNC Symbol;Acc:HGNC:28477],NA,PCYOX1L,78991,NM_001301054;NM_001301057;NM_024028
TPR_SIG,TPR,TPR_SIG,TPR,SIG,12,3.63671566023208,0.629068408278164,0.623641632661483,0.646899242447257,0.0232576097857735,0.00077394809617633,1.73905975524884,7.90742612358834,7.88920974333893,7.96727994440782,0.0780702010688888,0.152925778248058,ENSG00000047410,TPR,protein_coding,1,-1,186311652,186375693,q31.1,translocated promoter region, nuclear basket protein [Source:HGNC Symbol;Acc:HGNC:12017],Differentiated thyroid carcinoma,TPR,7175,NM_003292
SOCS5_SIG,SOCS5,SOCS5_SIG,SOCS5,SIG,40,3.63591512507228,0.377064865451006,0.369022751167373,0.403488955240084,0.0344662040727113,0.000776093325515153,5.14677505121127,5.06562053764905,4.98179366444543,5.34105169246095,0.359258028015527,7.86979031356134e-06,ENSG00000171150,SOCS5,protein_coding,2,1,46698952,46780245,p21,suppressor of cytokine signaling 5 [Source:HGNC Symbol;Acc:HGNC:16852],NA,SOCS5,9655,NM_014011;NM_144949
PSPH_SIG,PSPH,PSPH_SIG,PSPH,SIG,29,3.63560805683287,0.329835028290317,0.313370626407899,0.383932348761118,0.0705617223532188,0.000776538717667253,4.11857603164545,3.07330647485996,2.97587996974493,3.39342213452363,0.417542164778701,0.000381258373665741,ENSG00000146733,PSPH,protein_coding,7,-1,56011051,56051604,p11.2,phosphoserine phosphatase [Source:HGNC Symbol;Acc:HGNC:9577],3-Phosphoserine phosphatase deficiency;NEU-LAXOVA;PHOSPHOSERINE PHOSPHATASE DEFICIENCY,PSPH,5723,NM_004577
SLC25A13_SIG,SLC25A13,SLC25A13_SIG,SLC25A13,SIG,17,3.63559296582896,0.174720652600769,0.170907175435769,0.187250649000055,0.0163434735642857,0.000776538717667253,0.94134719395864,4.2975472391919,4.2848896344159,4.33913651202733,0.0542468776114234,0.460041640614278,ENSG00000004864,SLC25A13,protein_coding,7,-1,96120220,96322147,q21.3,solute carrier family 25 member 13 [Source:HGNC Symbol;Acc:HGNC:10983],Citrullinemia type II;CITRULLINEMIA TYPE II ADULT-ONSET;CITRULLINEMIA TYPE II NEONATAL-ONSET;Neonatal intrahepatic cholestasis due to citrin deficiency,SLC25A13,10165,NM_001160210;NM_014251
TFPI_SIG,TFPI,TFPI_SIG,TFPI,SIG,114,3.63346786611127,0.12394870337491,0.111208647809135,0.16580888594817,0.0546002381390351,0.000782700988213668,2.84991829790994,4.66391800521945,4.5192405755292,5.13928670277314,0.620046127243949,0.0156875986985666,ENSG00000003436,TFPI,protein_coding,2,-1,187464230,187565760,q32.1,tissue factor pathway inhibitor [Source:HGNC Symbol;Acc:HGNC:11760],NA,TFPI,7035,NM_001032281;NM_001318941;NM_001329239;NM_001329240;NM_001329241;NM_006287
RAVER1_SIG,RAVER1,RAVER1_SIG,RAVER1,SIG,9,3.63298872523725,0.780908416721687,0.771098056177596,0.813142458509413,0.0420444023318164,0.000783891568858695,2.680082812161,5.32573560978285,5.29331633428989,5.43225608640256,0.138939752112668,0.0234704244915371,ENSG00000161847,RAVER1,protein_coding,19,-1,10316212,10333638,p13.2,ribonucleoprotein, PTB binding 1 [Source:HGNC Symbol;Acc:HGNC:30296],NA,RAVER1,125950,NM_133452
PNN_SIG,PNN,PNN_SIG,PNN,SIG,47,3.63277685325366,0.245769260937414,0.2383755521221,0.270062875616303,0.0316873234942035,0.000784270861948859,2.9485570557302,7.86170410831812,7.81754865516417,8.00678631153826,0.18923765637409,0.0122826281113699,ENSG00000100941,PNN,protein_coding,14,1,39175183,39183220,q21.1,pinin, desmosome associated protein [Source:HGNC Symbol;Acc:HGNC:9162],NA,PNN,5411,NM_002687
TCEANC_TF,TCEANC,TCEANC_TF,TCEANC,TF,84,-3.63172707561417,0.0214071542776049,0.0246390795003316,0.0107879714029316,-0.0138511080973999,0.000787203005049839,-1.68455920483518,2.48309927094343,2.50594166097162,2.40804570370794,-0.097895957263677,0.167218150403562,ENSG00000176896,TCEANC,protein_coding,X,1,13653189,13681964,p22.2,transcription elongation factor A N-terminal and central domain containing [Source:HGNC Symbol;Acc:HGNC:28277],NA,TCEANC,170082,NM_001297563;NM_001297564;NM_152634
BMX_SIG,BMX,BMX_SIG,BMX,SIG,12,-3.63153985747348,0.104659839979556,0.125400586301824,0.0365116734921048,-0.0888889128097191,0.000787508631342239,-2.12363688225047,1.94414933616748,2.03229523408058,1.6545271001673,-0.377768133913276,0.0768849902151217,ENSG00000102010,BMX,protein_coding,X,1,15464246,15556529,p22.2,BMX non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:1079],NA,BMX,660,NM_001320866;NM_001721;NM_203281
CTSL_SIG,CTSL,CTSL_SIG,CTSL,SIG,40,-3.62831181706143,-0.0894492338661809,-0.0759962014652393,-0.133652054612132,-0.0576558531468926,0.000797149947859419,-3.59982419177733,3.55138058697518,3.7531697143352,2.88835916850655,-0.864810545828651,0.00199781340434122,ENSG00000135047,CTSL,protein_coding,9,1,87726109,87731469,q21.33,cathepsin L [Source:HGNC Symbol;Acc:HGNC:2537],NA,CTSL,1514,NM_001257971;NM_001257972;NM_001257973;NM_001912;NM_145918
HS2ST1_SIG,HS2ST1,HS2ST1_SIG,HS2ST1,SIG,14,3.6279048991493,0.472387069149513,0.4657655374849,0.494143530333245,0.028377992848345,0.000798137857896665,1.8956077758191,5.04799092133418,5.01670800536933,5.15077764521869,0.134069639849364,0.117209449395329,ENSG00000153936,HS2ST1,protein_coding,1,1,86914635,87109982,p22.3,heparan sulfate 2-O-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:5193],NA,HS2ST1,9653,NM_001134492;NM_012262
LPAR2_SIG,LPAR2,LPAR2_SIG,LPAR2,SIG,25,-3.6274841124078,-0.0889560534294923,-0.0814189525595949,-0.113720813430584,-0.0323018608709891,0.000799169870174868,-2.86732176533561,5.46312645408286,5.52110399960421,5.2726288045127,-0.248475195091511,0.0150296469865639,ENSG00000064547,LPAR2,protein_coding,19,-1,19623655,19628930,p13.11,lysophosphatidic acid receptor 2 [Source:HGNC Symbol;Acc:HGNC:3168],NA,LPAR2,9170,NM_004720
PLTP_SIG,PLTP,PLTP_SIG,PLTP,SIG,25,3.6256346000407,0.181143342879499,0.172027928479146,0.211093990194943,0.0390660617157964,0.000804640725246526,3.06895794706293,4.06036472681878,3.96255589999512,4.38173658638226,0.419180686387138,0.00899769531630749,ENSG00000100979,PLTP,protein_coding,20,-1,45898621,45912155,q13.12,phospholipid transfer protein [Source:HGNC Symbol;Acc:HGNC:9093],NA,PLTP,5360,NM_001242920;NM_001242921;NM_006227;NM_182676
MID1_SIG,MID1,MID1_SIG,MID1,SIG,16,3.62507510708334,-0.198873450222858,-0.203321169315735,-0.184259516060548,0.0190616532551866,0.000806113154890722,1.6950598001478,0.468675863552449,0.44977855238864,0.530767028804963,0.0809884764163227,0.164465221374758,ENSG00000101871,MID1,protein_coding,X,-1,10445310,10833654,p22.2,midline 1 [Source:HGNC Symbol;Acc:HGNC:7095],Opitz G/BBB Syndrome X-Linked;OPITZ GBBB SYNDROME TYPE I;X-linked Opitz G/BBB syndrome,MID1,4281,NM_000381;NM_001098624;NM_001193277;NM_001193278;NM_001193279;NM_001193280;NM_001193281;NM_001347733;NM_033289;NM_033290
BCAT2_SIG,BCAT2,BCAT2_SIG,BCAT2,SIG,23,3.62472735026707,0.343898395547125,0.327769189115114,0.396894359538017,0.0691251704229028,0.000806926804017961,4.53313333100743,3.56596963780768,3.47328727368509,3.87049740563905,0.397210131953961,8.79506074031678e-05,ENSG00000105552,BCAT2,protein_coding,19,-1,48795062,48811029,q13.33,branched chain amino acid transaminase 2 [Source:HGNC Symbol;Acc:HGNC:977],NA,BCAT2,587,NM_001164773;NM_001190;NM_001284325
SMAD6_TF,SMAD6,SMAD6_TF,SMAD6,TF,132,3.62430362730004,0.00282501078496079,-0.000417939898062117,0.0134804201720361,0.0138983600700982,0.000807978703796741,1.29664844799957,1.20064678365581,1.17056204923424,1.29949662532667,0.128934576092426,0.296404892463571,ENSG00000137834,SMAD6,protein_coding,15,1,66702236,66782849,q22.31,SMAD family member 6 [Source:HGNC Symbol;Acc:HGNC:6772],AORTIC VALVE DISEASE 2;Craniosynostosis 7;Familial bicuspid aortic valve;Non-syndromic craniosynostosis,SMAD6,4091,NM_005585
TESK1_SIG,TESK1,TESK1_SIG,TESK1,SIG,35,3.62413061732678,0.041661264822375,0.0369857913121164,0.0570235349275105,0.020037743615394,0.00080824764033467,3.1445390483469,4.82597665110057,4.78645975249282,4.95581788938319,0.169358136890363,0.00737222099282457,ENSG00000107140,TESK1,protein_coding,9,1,35605262,35610041,p13.3,testis associated actin remodelling kinase 1 [Source:HGNC Symbol;Acc:HGNC:11731],NA,TESK1,7016,NM_001318230;NM_006285
TRIM28_TF,TRIM28,TRIM28_TF,TRIM28,TF,341,3.62157389247813,0.258546238487461,0.251138584126964,0.282885674243382,0.0317470901164187,0.000816004618729972,2.40392079051589,8.07670142723036,8.04364391043949,8.18531898240038,0.141675071960885,0.0435177048530728,ENSG00000130726,TRIM28,protein_coding,19,1,58544064,58550722,q13.43,tripartite motif containing 28 [Source:HGNC Symbol;Acc:HGNC:16384],Nephroblastoma,TRIM28,10155,NM_005762
WDR77_SIG,WDR77,WDR77_SIG,WDR77,SIG,18,3.62083313494982,0.488768754499323,0.475080954502107,0.533742954490176,0.0586619999880685,0.000818069567057285,2.72289665949358,3.8720978362838,3.83249922496858,4.00220755917667,0.169708334208084,0.0212108938049125,ENSG00000116455,WDR77,protein_coding,1,-1,111439890,111449256,p13.2,WD repeat domain 77 [Source:HGNC Symbol;Acc:HGNC:29652],NA,WDR77,79084,NM_001317062;NM_001317063;NM_001317064;NM_024102
RAD1_SIG,RAD1,RAD1_SIG,RAD1,SIG,30,3.62073883833879,0.324502279420147,0.317981089481423,0.345929046361667,0.0279479568802435,0.000818092726595996,3.33048121190787,4.23551326842533,4.19931564050215,4.3544483316015,0.155132691099351,0.00440953955741335,ENSG00000113456,RAD1,protein_coding,5,-1,34905260,34918989,p13.2,RAD1 checkpoint DNA exonuclease [Source:HGNC Symbol;Acc:HGNC:9806],NA,RAD1,5810,NM_002853
ZNF835_TF,ZNF835,ZNF835_TF,ZNF835,TF,38,-3.62063497995498,-0.0336045173538493,-0.0270972485414183,-0.0549855434518369,-0.0278882949104185,0.000818146209984804,-1.76222214757062,0.525735546079311,0.559108425643336,0.416081798940371,-0.143026626702965,0.147212851411989,ENSG00000127903,ZNF835,protein_coding,19,-1,56661980,56671783,q13.43,zinc finger protein 835 [Source:HGNC Symbol;Acc:HGNC:34332],NA,ZNF835,90485,NM_001005850
CAD_SIG,CAD,CAD_SIG,CAD,SIG,47,3.62053995267698,0.60198238159522,0.585309996425545,0.656763075724153,0.0714530792986077,0.000818171852733647,3.01664198271113,6.18003576816857,6.09983343781276,6.44355771076622,0.343724272953458,0.0102998814597872,ENSG00000084774,CAD,protein_coding,2,1,27217369,27243943,p23.3,carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase [Source:HGNC Symbol;Acc:HGNC:1424],CAD-CDG;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 50;Uridine-responsive epileptic encephalopathy,CAD,790,NM_001306079;NM_004341
MCCC2_SIG,MCCC2,MCCC2_SIG,MCCC2,SIG,51,3.62022852524382,0.426112989379114,0.410856676959824,0.476240873042495,0.0653841960826707,0.0008188822050343,3.62275468162349,5.31774828680378,5.24619070089966,5.55286606906016,0.306675368160507,0.00186354418759294,ENSG00000131844,MCCC2,protein_coding,5,1,71587288,71658706,q13.2,methylcrotonoyl-CoA carboxylase 2 [Source:HGNC Symbol;Acc:HGNC:6937],3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY;3-Methylcrotonyl-CoA Carboxylase Deficiency,MCCC2,64087,NM_022132
ALDH3A2_SIG,ALDH3A2,ALDH3A2_SIG,ALDH3A2,SIG,47,-3.61883932480019,0.0431451031101693,0.0536183514025762,0.00873300157797527,-0.0448853498246009,0.000823013637666343,-3.32481510888612,4.55054102225352,4.64769263302125,4.23132858687381,-0.416364046147442,0.00448016307283348,ENSG00000072210,ALDH3A2,protein_coding,17,1,19648136,19677598,p11.2,aldehyde dehydrogenase 3 family member A2 [Source:HGNC Symbol;Acc:HGNC:403],SJOEGREN-LARSSON SYNDROME;Sjogren-Larsson syndrome,ALDH3A2,224,NM_000382;NM_001031806
SCN1B_SIG,SCN1B,SCN1B_SIG,SCN1B,SIG,21,-3.61850859493357,-0.048433774718213,-0.041327403537364,-0.0717832800267169,-0.0304558764893531,0.000823789395742259,-1.04178509870069,1.69757111466693,1.72317005531205,1.61346030969011,-0.109709745621941,0.410058912013071,ENSG00000105711,SCN1B,protein_coding,19,1,35030470,35040449,q13.11,sodium voltage-gated channel beta subunit 1 [Source:HGNC Symbol;Acc:HGNC:10586],Atrial fibrillation familial 13;Brugada syndrome;BRUGADA SYNDROME 5;DRAVET SYNDROME;Epilepsy generalized with febrile seizures plus type 1;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 52;Familial atrial fibrillation;Familial progressive cardiac conduction defect;Generalized epilepsy with febrile seizures-plus;GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS TYPE 1,SCN1B,6324,NM_001037;NM_001321605;NM_199037
TFAM_SIG,TFAM,TFAM_SIG,TFAM,SIG,14,3.61838060684952,0.388845975484861,0.380999679050013,0.41462666377079,0.0336269847207767,0.000823920336152963,1.54946248541979,5.54105424196857,5.52120160543122,5.60628433344844,0.0850827280172205,0.206014751350811,ENSG00000108064,TFAM,protein_coding,10,1,58385345,58399220,q21.1,transcription factor A, mitochondrial [Source:HGNC Symbol;Acc:HGNC:11741],MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE),TFAM,7019,NM_001270782;NM_003201
ZMAT3_SIG,ZMAT3,ZMAT3_SIG,ZMAT3,SIG,15,3.61726675612886,0.131745113199565,0.126965872156201,0.147448333770618,0.0204824616144167,0.000827195346373601,1.76029485718528,5.66305332226065,5.61602911733537,5.81756142415802,0.201532306822652,0.147693765737133,ENSG00000172667,ZMAT3,protein_coding,3,-1,178960121,179072215,q26.32,zinc finger matrin-type 3 [Source:HGNC Symbol;Acc:HGNC:29983],NA,ZMAT3,64393,NM_022470;NM_152240
SAP18_SIG,SAP18,SAP18_SIG,SAP18,SIG,18,3.61517231080423,0.35726527956529,0.3520002371085,0.374564704780458,0.0225644676719575,0.00083355617382633,1.24157626379721,6.81831946571167,6.80650732206483,6.85713079483699,0.0506234727721609,0.318948582914575,ENSG00000150459,SAP18,protein_coding,13,1,21140514,21149084,q12.11,Sin3A associated protein 18 [Source:HGNC Symbol;Acc:HGNC:10530],NA,SAP18,10284,NM_005870
SAFB2_TF,SAFB2,SAFB2_TF,SAFB2,TF,79,3.61510917384973,0.105110481288424,0.101608537298763,0.116616868683023,0.0150083313842598,0.00083355617382633,3.58524498422991,6.56866162344526,6.53648648806924,6.67437992539503,0.13789343732579,0.0020921197614341,ENSG00000130254,SAFB2,protein_coding,19,-1,5586999,5624046,p13.3,scaffold attachment factor B2 [Source:HGNC Symbol;Acc:HGNC:21605],NA,SAFB2,9667,NM_014649
SPIB_TF,SPIB,SPIB_TF,SPIB,TF,151,-3.61464070486033,-0.0598761556059541,-0.0534102243371213,-0.0811213583464045,-0.0277111340092832,0.000834785047509137,-1.76762996399341,1.18748585376089,1.23413743289598,1.03420209374562,-0.199935339150357,0.145980360435185,ENSG00000269404,SPIB,protein_coding,19,1,50418938,50431314,q13.33,Spi-B transcription factor [Source:HGNC Symbol;Acc:HGNC:11242],Primary biliary cholangitis,SPIB,6689,NM_001243998;NM_001243999;NM_001244000;NM_003121
ZBTB44_TF,ZBTB44,ZBTB44_TF,ZBTB44,TF,49,3.61387256159285,0.425363566059806,0.417749767912674,0.450380331400384,0.0326305634877105,0.000836983034859406,1.06536952168487,6.90305495050343,6.88605978322819,6.95889621440778,0.0728364311795921,0.398877098638109,ENSG00000196323,ZBTB44,protein_coding,11,-1,130226677,130314917,q24.3,zinc finger and BTB domain containing 44 [Source:HGNC Symbol;Acc:HGNC:25001],NA,ZBTB44,29068,NM_001301098;NM_001301099;NM_014155
ZNF286B_TF,ZNF286B,ZNF286B_TF,ZNF286B,TF,154,3.61363118555122,-0.0311746840259415,-0.0364812628432799,-0.0137387821975437,0.0227424806457363,0.000837482515822474,4.71995318840111,1.07784648745473,1.00234054466448,1.32593744233696,0.323596897672478,4.33056570416333e-05,ENSG00000249459,ZNF286B,protein_coding,17,-1,18658429,18682262,p11.2,zinc finger protein 286B [Source:HGNC Symbol;Acc:HGNC:33241],NA,ZNF286B,729288,NM_001145045
PRKCA_SIG,PRKCA,PRKCA_SIG,PRKCA,SIG,26,-3.61274806188403,0.10089306882851,0.111628596959728,0.0656191906830825,-0.0460094062766449,0.00084005973363252,-2.27921571469989,4.62439648903324,4.71975258814206,4.3110835919614,-0.408668996180667,0.0563673147837645,ENSG00000154229,PRKCA,protein_coding,17,1,66302613,66810743,q24.2,protein kinase C alpha [Source:HGNC Symbol;Acc:HGNC:9393],NA,PRKCA,5578,NM_002737
KAT6B_SIG,KAT6B,KAT6B_SIG,KAT6B,SIG,68,3.61072090135191,0.23016444558867,0.221433913217538,0.258850480522389,0.0374165673048501,0.000846370287971907,2.24439622629132,6.48649091393733,6.44719963289386,6.61559083736587,0.168391204472005,0.0606093518416023,ENSG00000156650,KAT6B,protein_coding,10,1,74824927,75032624,q22.2,lysine acetyltransferase 6B [Source:HGNC Symbol;Acc:HGNC:17582],Blepharophimosis-intellectual disability syndrome SBBYS type;blepharophimosis/intellectual disability phenotype which is Noonan-like;Genitopatellar syndrome;Noonan Syndrome;OHDO SYNDROME SBBYS VARIANT,KAT6B,23522,NM_001256468;NM_001256469;NM_012330
ZNF585A_TF,ZNF585A,ZNF585A_TF,ZNF585A,TF,21,3.60979553795382,0.0712544396201219,0.0582245543813209,0.114066919690468,0.0558423653091472,0.000849111239731065,2.69874243289285,2.67278086568402,2.62475815474221,2.83056977306424,0.205811618322022,0.0224696264575519,ENSG00000196967,ZNF585A,protein_coding,19,-1,37106734,37172741,q13.12,zinc finger protein 585A [Source:HGNC Symbol;Acc:HGNC:26305],NA,ZNF585A,199704,NM_001288800;NM_152655;NM_199126
ADM_SIG,ADM,ADM_SIG,ADM,SIG,23,-3.60964801300962,0.0993694848631089,0.117665625740349,0.0392535934093188,-0.0784120323310305,0.000849310224349895,-3.44165818836813,3.91437510682935,4.09969046446955,3.30548178886869,-0.79420867560086,0.0031848414464367,ENSG00000148926,ADM,protein_coding,11,1,10305073,10307397,p15.4,adrenomedullin [Source:HGNC Symbol;Acc:HGNC:259],NA,ADM,133,NM_001124
FNTB_SIG,FNTB,FNTB_SIG,FNTB,SIG,9,3.60922978391821,0.314196433981175,0.302116560347804,0.353887447347965,0.0517708870001615,0.000850396237060323,3.86445049443975,2.80076737582035,2.74524917844017,2.98318431006951,0.237935131629339,0.000879509411671082,ENSG00000257365,FNTB,protein_coding,14,1,64986895,65062652,q23.3,farnesyltransferase, CAAX box, beta [Source:HGNC Symbol;Acc:HGNC:3785],NA,FNTB,2342;100529261,NM_001202558;NM_002028
CMSS1_SIG,CMSS1,CMSS1_SIG,CMSS1,SIG,22,3.60715258359643,0.671962191729706,0.657323517616634,0.720060692386943,0.0627371747703093,0.000856944233239067,4.39070467769974,3.74771142200395,3.66143084740289,4.03120473855029,0.369773891147394,0.000147440769458592,ENSG00000184220,CMSS1,protein_coding,3,1,99817837,100181732,q12.1,cms1 ribosomal small subunit homolog [Source:HGNC Symbol;Acc:HGNC:28666],NA,CMSS1,84319,NM_001167924;NM_032359
ZNF57_TF,ZNF57,ZNF57_TF,ZNF57,TF,33,3.60608305205261,0.11318229814536,0.109171890180109,0.126359352888326,0.0171874627082168,0.000860194647206051,3.15906579964809,2.13648360117967,2.07173444966178,2.34923081330988,0.277496363648097,0.007085950459779,ENSG00000171970,ZNF57,protein_coding,19,1,2900898,2918473,p13.3,zinc finger protein 57 [Source:HGNC Symbol;Acc:HGNC:13125],NA,ZNF57,126295,NM_001319083;NM_173480
XPO1_SIG,XPO1,XPO1_SIG,XPO1,SIG,16,3.60523308334334,0.508073569552965,0.493198678195613,0.556948212584262,0.0637495343886484,0.000862726842096575,3.95557948679519,7.94257984241003,7.87283962343792,8.17172627617555,0.298886652737637,0.000654746625292489,ENSG00000082898,XPO1,protein_coding,2,-1,61477849,61538626,p15,exportin 1 [Source:HGNC Symbol;Acc:HGNC:12825],Primary mediastinal large B-cell lymphoma,XPO1,7514,NM_003400
ZNF572_TF,ZNF572,ZNF572_TF,ZNF572,TF,17,3.60409533338675,0.0350250287182032,0.019434999587126,0.0862494101488853,0.0668144105617591,0.000866225161453388,3.23480721231892,1.34303382108825,1.28216371764367,1.54303558954898,0.260871871905311,0.00576967897232418,ENSG00000180938,ZNF572,protein_coding,8,1,124973295,124979389,q24.13,zinc finger protein 572 [Source:HGNC Symbol;Acc:HGNC:26758],NA,ZNF572,137209,NM_152412
ZMYM2_TF,ZMYM2,ZMYM2_TF,ZMYM2,TF,119,3.60320518100418,0.054418759780032,0.0459177433819965,0.082350670802149,0.0364329274201526,0.000868908290763891,2.31369803505214,7.00791921751916,6.97823136068288,7.10546503283835,0.127233672155472,0.0524969071960303,ENSG00000121741,ZMYM2,protein_coding,13,1,19958670,20091829,q12.11,zinc finger MYM-type containing 2 [Source:HGNC Symbol;Acc:HGNC:12989],NA,ZMYM2,7750,NM_001190964;NM_001190965;NM_001353157;NM_001353159;NM_001353161;NM_001353162;NM_001353163;NM_001353164;NM_001353165;NM_003453;NM_197968
ANAPC2_SIG,ANAPC2,ANAPC2_SIG,ANAPC2,SIG,47,3.60303360674057,0.266033588793093,0.261372057016252,0.281350050345569,0.0199779933293169,0.000869192241825094,3.25286818901102,5.5871380133932,5.55556102784594,5.69089096590563,0.135329938059695,0.0054834948543237,ENSG00000176248,ANAPC2,protein_coding,9,-1,137174784,137188560,q34.3,anaphase promoting complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:19989],NA,ANAPC2,29882,NM_013366
HOXB7_TF,HOXB7,HOXB7_TF,HOXB7,TF,52,3.60243445140283,-0.0599280303930316,-0.0643214044254434,-0.04549265857225,0.0188287458531934,0.000870908231006242,4.50575705796356,0.982017661876308,0.833813744035469,1.46897339192478,0.635159647889311,9.66942567207867e-05,ENSG00000260027,HOXB7,protein_coding,17,-1,48607227,48633572,q21.32,homeobox B7 [Source:HGNC Symbol;Acc:HGNC:5118],NA,HOXB7,3217,NM_004502
PCMT1_SIG,PCMT1,PCMT1_SIG,PCMT1,SIG,76,-3.6018718524395,0.123727030238368,0.133082506110466,0.0929876095157587,-0.0400948965947073,0.00087250467974135,-3.15966079331627,5.57734880624004,5.64091221187385,5.36849761630036,-0.272414595573492,0.00707288381472267,ENSG00000120265,PCMT1,protein_coding,6,1,149749443,149811420,q25.1,protein-L-isoaspartate (D-aspartate) O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:8728],NA,PCMT1,5110,NM_001252049;NM_001252050;NM_001252051;NM_001252052;NM_001252053;NM_001360452;NM_001360456;NM_005389
ATF6B_SIG,ATF6B,ATF6B_SIG,ATF6B,SIG,36,3.60061592904277,0.27776393671159,0.267175486249357,0.312554559658929,0.0453790734095722,0.000876409365192842,1.41514471871185,7.47667797627145,7.46017075642283,7.53091598434549,0.0707452279226553,0.250874796264842,ENSG00000213676,ATF6B,protein_coding,6,-1,32115264,32128253,p21.32,activating transcription factor 6 beta [Source:HGNC Symbol;Acc:HGNC:2349],NA,ATF6B,1388,NM_001136153;NM_004381
HRH2_SIG,HRH2,HRH2_SIG,HRH2,SIG,11,-3.60053788204254,0.333766745500292,0.351898848771611,0.274189834751674,-0.0777090140199362,0.000876409365192842,0.630287241187325,4.33674725282494,4.3141042874135,4.41114556774825,0.0970412803347517,0.632275488627654,ENSG00000113749,HRH2,protein_coding,5,1,175658030,175710756,q35.2,histamine receptor H2 [Source:HGNC Symbol;Acc:HGNC:5183],NA,HRH2,3274,NM_001131055
AK8_SIG,AK8,AK8_SIG,AK8,SIG,12,3.59980086928589,-0.0528765734968565,-0.060266325827259,-0.0285959586969624,0.0316703671302967,0.00087860442620083,0.732545986803832,0.377425924900451,0.370577609971221,0.399927531096494,0.0293499211252733,0.573112151358757,ENSG00000165695,AK8,protein_coding,9,-1,132725578,132878777,q34.13,adenylate kinase 8 [Source:HGNC Symbol;Acc:HGNC:26526],NA,AK8,158067,NM_001317958;NM_001317959;NM_152572
KCNJ14_SIG,KCNJ14,KCNJ14_SIG,KCNJ14,SIG,35,3.59918037016419,0.0455935911205721,0.0379738559222167,0.0706298639151683,0.0326560079929518,0.000880410124425589,2.11471231649263,1.37420695069834,1.34100107666237,1.48331196538798,0.14231088872561,0.078136666974495,ENSG00000182324,KCNJ14,protein_coding,19,1,48455509,48466980,q13.33,potassium voltage-gated channel subfamily J member 14 [Source:HGNC Symbol;Acc:HGNC:6260],NA,KCNJ14,3770,NM_013348
FASTK_SIG,FASTK,FASTK_SIG,FASTK,SIG,28,3.59864066402627,0.326642200673316,0.320614859427506,0.34644632190955,0.0258314624820443,0.000881945328694809,2.96072139951001,5.18537664380165,5.14604507991,5.31460892515993,0.168563845249933,0.0119182437670694,ENSG00000164896,FASTK,protein_coding,7,-1,151076593,151080866,q36.1,Fas activated serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:24676],NA,FASTK,10922,NM_001258461;NM_006712;NM_033015
TRIM2_SIG,TRIM2,TRIM2_SIG,TRIM2,SIG,47,3.59802869906589,-0.0569465977865125,-0.0618431768836444,-0.0408578378959364,0.0209853389877079,0.000883544408738528,2.93116646481378,1.49781980766994,1.4217999618095,1.74759930121142,0.325799339401921,0.0128494115659446,ENSG00000109654,TRIM2,protein_coding,4,1,153152342,153339317,q31.3,tripartite motif containing 2 [Source:HGNC Symbol;Acc:HGNC:15974],CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2R;Charcot-Marie-Tooth disease type 2R,TRIM2,23321,NM_001130067;NM_001302694;NM_001351054;NM_001351055;NM_001351056;NM_001351057;NM_015271
SPPL2A_SIG,SPPL2A,SPPL2A_SIG,SPPL2A,SIG,55,-3.59799636682234,0.0764612302629966,0.0839046879360969,0.0520041550513815,-0.0319005328847153,0.000883544408738528,-2.17341138679531,4.67653184755992,4.70818338088096,4.57253395236219,-0.135649428518768,0.0698669611603079,ENSG00000138600,SPPL2A,protein_coding,15,-1,50702266,50765709,q21.2,signal peptide peptidase like 2A [Source:HGNC Symbol;Acc:HGNC:30227],NA,SPPL2A,84888,NM_032802
ATF6B_TF,ATF6B,ATF6B_TF,ATF6B,TF,253,3.59733070616057,0.224685064440952,0.216787557123701,0.250634017054778,0.0338464599310767,0.000885513399586805,1.41514471871185,7.47667797627145,7.46017075642283,7.53091598434549,0.0707452279226553,0.250874796264842,ENSG00000213676,ATF6B,protein_coding,6,-1,32115264,32128253,p21.32,activating transcription factor 6 beta [Source:HGNC Symbol;Acc:HGNC:2349],NA,ATF6B,1388,NM_001136153;NM_004381
SENP6_SIG,SENP6,SENP6_SIG,SENP6,SIG,18,3.59651657651573,0.416349050530122,0.411254930077074,0.433086874875852,0.021831944798778,0.000887992965104017,1.47925277958165,7.14967937155167,7.13256898050368,7.20589922785221,0.0733302473485347,0.228917745822041,ENSG00000112701,SENP6,protein_coding,6,1,75601509,75718281,q14.1,SUMO specific peptidase 6 [Source:HGNC Symbol;Acc:HGNC:20944],NA,SENP6,26054,NM_001100409;NM_001304792;NM_015571
ZNF600_TF,ZNF600,ZNF600_TF,ZNF600,TF,18,3.59544913182361,0.0392187626173987,0.0327726091970094,0.0603989809986777,0.0276263718016683,0.000891345999359801,1.10698710867951,3.80538512753814,3.78320970117514,3.87824724273086,0.0950375415557251,0.379108756721958,ENSG00000189190,ZNF600,protein_coding,19,-1,52749942,52786807,q13.41,zinc finger protein 600 [Source:HGNC Symbol;Acc:HGNC:30951],NA,ZNF600,162966,NM_001321866;NM_001321867;NM_198457
MRPL43_SIG,MRPL43,MRPL43_SIG,MRPL43,SIG,23,3.5951250250133,0.241932090248071,0.232504578199006,0.272908201266425,0.0404036230674185,0.000892160026769724,3.24987745934976,4.810700509826,4.77071026293259,4.94209703533292,0.17138677240033,0.00552638869646515,ENSG00000055950,MRPL43,protein_coding,10,-1,100969458,100987515,q24.31,mitochondrial ribosomal protein L43 [Source:HGNC Symbol;Acc:HGNC:14517],NA,MRPL43,84545,NM_001308396;NM_032112;NM_176792;NM_176793;NM_176794
PDXK_SIG,PDXK,PDXK_SIG,PDXK,SIG,23,-3.59431052590403,0.345926247774872,0.358259292337333,0.305403387069644,-0.0528559052676888,0.000894658250876187,-1.46427789010029,5.81537711432956,5.84906598764142,5.70468510201918,-0.144380885622232,0.233991021040918,ENSG00000160209,PDXK,protein_coding,21,1,43719094,43762307,q22.3,pyridoxal kinase [Source:HGNC Symbol;Acc:HGNC:8819],NA,PDXK,8566;105372824,NM_001331030;NM_003681
SLC41A3_SIG,SLC41A3,SLC41A3_SIG,SLC41A3,SIG,27,3.59381423227013,0.397282019220159,0.391068802895376,0.417696872858729,0.0266280699633529,0.000896067477301078,3.00253823852902,4.74015005524414,4.69634205309661,4.88409063372889,0.187748580632278,0.0106838028327348,ENSG00000114544,SLC41A3,protein_coding,3,-1,126006355,126101561,q21.3,solute carrier family 41 member 3 [Source:HGNC Symbol;Acc:HGNC:31046],NA,SLC41A3,54946,NM_001008485;NM_001008486;NM_001008487;NM_001164475;NM_017836
RSL1D1_SIG,RSL1D1,RSL1D1_SIG,RSL1D1,SIG,29,3.59091703998515,0.452592747934339,0.442523356449304,0.485677891385166,0.0431545349358623,0.000905787773078436,3.26764120099759,7.74303667001251,7.69080280814811,7.91466221613839,0.223859407990281,0.00526803218475395,ENSG00000171490,RSL1D1,protein_coding,16,-1,11833850,11851580,p13.13,ribosomal L1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24534],NA,RSL1D1,26156,NM_015659
PDXP_SIG,PDXP,PDXP_SIG,PDXP,SIG,6,3.58711865325856,0.240904517238784,0.234143544941225,0.263119140502192,0.0289755955609663,0.000918775457527393,1.61554188399816,1.18174219992044,1.16343025206718,1.24191002858113,0.0784797765139464,0.186248262317099,ENSG00000241360,PDXP,protein_coding,22,1,37658723,37666932,q13.1,pyridoxal phosphatase [Source:HGNC Symbol;Acc:HGNC:30259],NA,PDXP,57026,NM_020315
ACADS_SIG,ACADS,ACADS_SIG,ACADS,SIG,15,3.58494657614158,0.257249697529826,0.252593077301174,0.272550021138253,0.0199569438370784,0.000925898623637813,4.37368885578985,4.18726247341423,4.12609870106864,4.38822915397833,0.262130452909691,0.000156822364617931,ENSG00000122971,ACADS,protein_coding,12,1,120725774,120740008,q24.31,acyl-CoA dehydrogenase short chain [Source:HGNC Symbol;Acc:HGNC:90],ACYL-CoA DEHYDROGENASE SHORT-CHAIN DEFICIENCY OF;Short chain acyl-CoA dehydrogenase deficiency,ACADS,35,NM_000017;NM_001302554
EIF3B_SIG,EIF3B,EIF3B_SIG,EIF3B,SIG,18,3.58493055285332,0.413647257724545,0.407382392041241,0.43423181639826,0.0268494243570196,0.000925898623637813,3.14073919293526,7.56238877939353,7.524405451161,7.68719114358612,0.162785692425119,0.00744686074287964,ENSG00000106263,EIF3B,protein_coding,7,1,2354086,2380745,p22.3,eukaryotic translation initiation factor 3 subunit B [Source:HGNC Symbol;Acc:HGNC:3280],NA,EIF3B,8662,NM_001037283;NM_001362791;NM_003751
ZC3H11A_SIG,ZC3H11A,ZC3H11A_SIG,ZC3H11A,SIG,36,3.58471245067988,0.341719545381067,0.336868394176503,0.357659042196061,0.0207906480195578,0.000926365626746926,2.22432683302381,7.51195460811584,7.49167184686274,7.57859796651888,0.0869261196561394,0.063164305203161,ENSG00000058673,ZC3H11A,protein_coding,1,1,203795654,203854999,q32.1,zinc finger CCCH-type containing 11A [Source:HGNC Symbol;Acc:HGNC:29093],NA,ZC3H11A,9877,NM_001319238;NM_001319239;NM_001350261;NM_001350262;NM_001350263;NM_001350264;NM_001350265;NM_001350266;NM_014827
POLL_SIG,POLL,POLL_SIG,POLL,SIG,35,3.58329297774366,0.187404356375593,0.178956769260364,0.215160714039916,0.0362039447795523,0.000931108001801521,2.62438563277812,4.48554483424415,4.45046939671594,4.6007927004083,0.150323303692364,0.0265848975039792,ENSG00000166169,POLL,protein_coding,10,-1,101578882,101588270,q24.32,DNA polymerase lambda [Source:HGNC Symbol;Acc:HGNC:9184],NA,POLL,27343,NM_001174084;NM_001174085;NM_001308382;NM_013274
NUDT2_SIG,NUDT2,NUDT2_SIG,NUDT2,SIG,4,3.58307976018437,0.273976618771202,0.26730611598509,0.295893985068429,0.028587869083339,0.000931560095444323,2.75610985611991,3.46610360321416,3.43123861564361,3.58065999094599,0.149421375302377,0.0196443026351346,ENSG00000164978,NUDT2,protein_coding,9,1,34329506,34343711,p13.3,nudix hydrolase 2 [Source:HGNC Symbol;Acc:HGNC:8049],NA,NUDT2,318,NM_001161;NM_001244390;NM_147172;NM_147173
ELK4_TF,ELK4,ELK4_TF,ELK4,TF,122,3.58132357879914,0.272997331372922,0.266333162669462,0.294893885684292,0.0285607230148298,0.000937333532761705,3.21996896351424,6.41140511697784,6.36064464753462,6.57818951657698,0.217544869042365,0.00601000425386647,ENSG00000158711,ELK4,protein_coding,1,-1,205597556,205631962,q32.1,ELK4, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3326],NA,ELK4,2005,NM_001973;NM_021795
MX1_SIG,MX1,MX1_SIG,MX1,SIG,37,-3.58129324979859,0.240504649155327,0.254741143001806,0.193727597945467,-0.0610135450563388,0.000937333532761705,-2.30042207236537,5.01114573553424,5.1111866854941,4.6824397570947,-0.428746928399397,0.0538899862366656,ENSG00000157601,MX1,protein_coding,21,1,41420304,41459214,q22.3,MX dynamin like GTPase 1 [Source:HGNC Symbol;Acc:HGNC:7532],NA,MX1,4599,NM_001144925;NM_001178046;NM_001282920;NM_002462
DLX4_TF,DLX4,DLX4_TF,DLX4,TF,446,3.58018878332927,-0.00705933802582561,-0.0112807481582139,0.00681100955202177,0.0180917577102357,0.000940993086868104,5.67539729025941,1.06939881993538,0.956357185651929,1.44082133258101,0.484464146929081,7.16405038694391e-07,ENSG00000108813,DLX4,protein_coding,17,1,49968970,49974959,q21.33,distal-less homeobox 4 [Source:HGNC Symbol;Acc:HGNC:2917],Cleft lip/palate;Orofacial cleft 15,DLX4,1748,NM_001934;NM_138281
PMPCB_SIG,PMPCB,PMPCB_SIG,PMPCB,SIG,22,3.58008668528997,0.442704004943901,0.437429618750925,0.460034131006537,0.0226045122556122,0.00094104953953411,2.59329601836808,6.10301854229875,6.07364612289432,6.19952792034189,0.125881797447566,0.028609726168189,ENSG00000105819,PMPCB,protein_coding,7,1,103297435,103329511,q22.1,peptidase, mitochondrial processing beta subunit [Source:HGNC Symbol;Acc:HGNC:9119],MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6,PMPCB,9512,NM_004279
ARHGAP29_SIG,ARHGAP29,ARHGAP29_SIG,ARHGAP29,SIG,14,-3.57830312700753,-0.0318009768042683,-0.019859334304296,-0.07103780216132,-0.051178467857024,0.000947180154488484,-2.28555739032867,0.667569912296317,0.717764946517811,0.502643371282836,-0.215121575234975,0.0556200410938927,ENSG00000137962,ARHGAP29,protein_coding,1,-1,94148988,94275068,p22.1,Rho GTPase activating protein 29 [Source:HGNC Symbol;Acc:HGNC:30207],Cleft lip/palate,ARHGAP29,9411,NM_001328664;NM_001328665;NM_001328666;NM_001328667;NM_004815
LIPE_SIG,LIPE,LIPE_SIG,LIPE,SIG,54,-3.57722984066709,-0.0985292437451418,-0.0929523873438626,-0.116853200492202,-0.0239008131483394,0.00095076211964247,-2.6116362036777,1.87373272988645,1.93671069510031,1.66680512989805,-0.269905565202256,0.0274159875398738,ENSG00000079435,LIPE,protein_coding,19,-1,42401514,42427388,q13.2,lipase E, hormone sensitive type [Source:HGNC Symbol;Acc:HGNC:6621],LIPE-related familial partial lipodystrophy;LIPODYSTROPHY FAMILIAL PARTIAL TYPE 6,LIPE,3991,NM_005357
C12orf65_SIG,C12orf65,C12orf65_SIG,C12orf65,SIG,75,3.57456357265592,0.216839075189057,0.20877908368201,0.243321904426499,0.0345428207444897,0.000960185708312375,3.35077371121831,2.98141558819605,2.9195837084726,3.18457747871596,0.264993770243359,0.00416375307239885,ENSG00000130921,C12orf65,protein_coding,12,1,123232916,123257959,q24.31,chromosome 12 open reading frame 65 [Source:HGNC Symbol;Acc:HGNC:26784],Autosomal recessive spastic paraplegia type 55;Combined oxidative phosphorylation defect type 7;Combined oxidative phosphorylation deficiency 7;SPASTIC PARAPLEGIA 55 AUTOSOMAL RECESSIVE,C12orf65,91574,NM_001143905;NM_001194995;NM_152269
RPL36A_SIG,RPL36A,RPL36A_SIG,RPL36A,SIG,52,3.57441524621754,0.232456382920693,0.225090031186648,0.256660110046841,0.031570078860193,0.000960412871157332,2.42800903349232,3.03513987563675,2.99120697909796,3.17949082140706,0.188283842309106,0.0412474785859794,ENSG00000241343,RPL36A,protein_coding,X,1,101390824,101396154,q22.1,ribosomal protein L36a [Source:HGNC Symbol;Acc:HGNC:10359],NA,RPL36A,6173,NM_001199972;NM_021029
ZNF654_TF,ZNF654,ZNF654_TF,ZNF654,TF,27,3.57388954606847,0.270230255673205,0.266486420341448,0.282531428906121,0.0160450085646723,0.000962026476532306,2.37927367742056,4.97363966178887,4.94168824331732,5.07862289390968,0.136934650592364,0.0458558490971227,ENSG00000175105,ZNF654,protein_coding,3,1,88059255,88144664,p11.1,zinc finger protein 654 [Source:HGNC Symbol;Acc:HGNC:25612],NA,ZNF654,55279,NM_001350134;NM_001350135;NM_001350136;NM_001350137;NM_001366093;NM_001366095;NM_001366096
KCTD12_SIG,KCTD12,KCTD12_SIG,KCTD12,SIG,49,-3.57380120338392,0.101051372430503,0.139032925333777,-0.0237451585373973,-0.162778083871174,0.000962033670945843,-3.29152635691486,5.69963253015694,5.88622354803089,5.08654775714253,-0.799675790888357,0.00492127861777798,ENSG00000178695,KCTD12,protein_coding,13,-1,76880166,76886390,q22.3,potassium channel tetramerization domain containing 12 [Source:HGNC Symbol;Acc:HGNC:14678],NA,KCTD12,115207,NM_138444
JAK2_SIG,JAK2,JAK2_SIG,JAK2,SIG,25,-3.57339416972469,0.429064496578202,0.441295807086318,0.388875904908679,-0.0524199021776384,0.000963213116177378,-4.34272090790703,6.50433402130387,6.57258661119637,6.28007551165708,-0.292511099539292,0.00017504493761333,ENSG00000096968,JAK2,protein_coding,9,1,4984390,5128183,p24.1,Janus kinase 2 [Source:HGNC Symbol;Acc:HGNC:6192],BUDD-CHIARI SYNDROME;ERYTHROCYTOSIS FAMILIAL 1;Essential thrombocythemia;Familial thrombocytosis;LEUKEMIA ACUTE MYELOID;MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA INCLUDED;POLYCYTHEMIA VERA;Primary myelofibrosis;THROMBOCYTHEMIA 3,JAK2,3717,NM_001322194;NM_001322195;NM_001322196;NM_001322198;NM_001322199;NM_001322204;NM_004972
ZKSCAN8_TF,ZKSCAN8,ZKSCAN8_TF,ZKSCAN8,TF,160,3.57261666515586,0.319118110454549,0.311634684229062,0.343706510909721,0.0320718266806587,0.000965759776138656,2.96308832937185,6.13037182888101,6.0751412462847,6.31184374312603,0.236702496841338,0.0118430884269202,ENSG00000198315,ZKSCAN8,protein_coding,6,1,28141883,28159460,p22.1,zinc finger with KRAB and SCAN domains 8 [Source:HGNC Symbol;Acc:HGNC:12983],NA,ZKSCAN8,7745,NM_001278119;NM_001278121;NM_001278122;NM_006298
RNF150_SIG,RNF150,RNF150_SIG,RNF150,SIG,71,-3.57250325640574,-0.146481267835073,-0.140830030179208,-0.165049620132917,-0.0242195899537091,0.000965859686282781,-0.94440904491344,0.796326419747263,0.824433946070339,0.703973118971442,-0.120460827098897,0.458548697282777,ENSG00000170153,RNF150,protein_coding,4,-1,140859807,141212877,q31.21,ring finger protein 150 [Source:HGNC Symbol;Acc:HGNC:23138],NA,RNF150,57484,NM_020724
DIS3L_SIG,DIS3L,DIS3L_SIG,DIS3L,SIG,22,3.57193577849468,0.413840756323853,0.402222151464207,0.452016172291263,0.0497940208270566,0.000967636436725239,3.28274866352227,5.44776240526512,5.39947435455369,5.60642314331696,0.206948788763277,0.00504112066509794,ENSG00000166938,DIS3L,protein_coding,15,1,66293217,66333898,q22.31,DIS3 like exosome 3'-5' exoribonuclease [Source:HGNC Symbol;Acc:HGNC:28698],NA,DIS3L,115752,NM_001143688;NM_001323936;NM_001323937;NM_001323938;NM_001323939;NM_001323940;NM_001323941;NM_001323943;NM_001323944;NM_001323945;NM_001323946;NM_001323948;NM_133375
OLAH_SIG,OLAH,OLAH_SIG,OLAH,SIG,14,-3.57171280804146,0.0109192341474378,0.0209088060897354,-0.02190364509154,-0.0428124511812753,0.000968141696187797,-0.931828988726364,0.430007858270075,0.454240800646715,0.350385333318256,-0.103855467328458,0.464830671787036,ENSG00000152463,OLAH,protein_coding,10,1,15032227,15073852,p13,oleoyl-ACP hydrolase [Source:HGNC Symbol;Acc:HGNC:25625],NA,OLAH,55301,NM_001039702;NM_018324
PIGP_SIG,PIGP,PIGP_SIG,PIGP,SIG,17,3.57074377744585,0.296245104608065,0.286732222920927,0.327501715865805,0.0407694929448787,0.000971410738542882,1.98522915182613,3.12314602374051,3.08968311314543,3.23309558712436,0.14341247397893,0.0998382074156276,ENSG00000185808,PIGP,protein_coding,21,-1,37059170,37073170,q22.13,phosphatidylinositol glycan anchor biosynthesis class P [Source:HGNC Symbol;Acc:HGNC:3046],Early infantile epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 55,PIGP,51227,NM_001320480;NM_016430;NM_153681;NM_153682
ACAT2_SIG,ACAT2,ACAT2_SIG,ACAT2,SIG,10,3.57037572201273,0.386560959158462,0.378355924061085,0.413520360192698,0.0351644361316131,0.000972456447635905,2.3808960513048,4.55032122135886,4.51309821303724,4.67262539155848,0.159527178521242,0.045684591790887,ENSG00000120437,ACAT2,protein_coding,6,1,159760328,159779055,q25.3,acetyl-CoA acetyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:94],ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY,ACAT2,39,NM_001303253;NM_005891
PANK1_SIG,PANK1,PANK1_SIG,PANK1,SIG,8,3.5688665703433,0.226278046526574,0.212162886689249,0.272656428849214,0.0604935421599657,0.000977752590098165,3.81831949584518,1.8548124301698,1.76176996663124,2.1605233817965,0.398753415165261,0.00101638524624678,ENSG00000152782,PANK1,protein_coding,10,-1,89579497,89645572,q23.31,pantothenate kinase 1 [Source:HGNC Symbol;Acc:HGNC:8598],NA,PANK1,53354,NM_138316;NM_148977;NM_148978
BLVRB_SIG,BLVRB,BLVRB_SIG,BLVRB,SIG,37,-3.568728919887,0.0612558096638426,0.0700152396646498,0.0324748253754761,-0.0375404142891736,0.000977944453168035,-3.1911079355882,4.76454387825595,4.86352842320823,4.43930894484131,-0.424219478366924,0.00651368422860019,ENSG00000090013,BLVRB,protein_coding,19,-1,40447765,40465840,q13.2,biliverdin reductase B [Source:HGNC Symbol;Acc:HGNC:1063],NA,BLVRB,645,NM_000713
PPAN_SIG,PPAN,PPAN_SIG,PPAN,SIG,49,3.56820930004733,0.223595319763706,0.215458711010094,0.250329891382713,0.034871180372619,0.000979563190698472,3.00752928000996,2.21369728375929,2.16662523619313,2.36836258290523,0.201737346712093,0.0105409787244578,ENSG00000130810,PPAN,protein_coding,19,1,10106362,10112012,p13.2,peter pan homolog [Source:HGNC Symbol;Acc:HGNC:9227],NA,PPAN,56342,NM_001346139;NM_001346141;NM_020230
ZNF784_TF,ZNF784,ZNF784_TF,ZNF784,TF,25,3.56722251843519,-0.0323907929242748,-0.0349604408785425,-0.0239476639316809,0.0110127769468614,0.000982771034943373,0.651241304423589,3.12070337206033,3.11346513861748,3.14448613908685,0.0310210004693703,0.62016656853191,ENSG00000179922,ZNF784,protein_coding,19,-1,55620742,55624601,q13.42,zinc finger protein 784 [Source:HGNC Symbol;Acc:HGNC:33111],NA,ZNF784,147808,NM_203374
GLT8D1_SIG,GLT8D1,GLT8D1_SIG,GLT8D1,SIG,91,3.56717999342572,0.318539583897994,0.305435590261041,0.36159556299084,0.0561599727297987,0.000982771034943373,3.23549593221911,4.73833144447861,4.67111742625158,4.95917750436741,0.288060078115825,0.00576175733857583,ENSG00000016864,GLT8D1,protein_coding,3,-1,52694488,52706032,p21.1,glycosyltransferase 8 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24870],NA,GLT8D1,55830,NM_001010983;NM_001278280;NM_001278281;NM_018446;NM_152932
SLC46A2_SIG,SLC46A2,SLC46A2_SIG,SLC46A2,SIG,17,-3.56641309601291,0.0951391961638361,0.136746688947693,-0.0415711372688356,-0.178317826216528,0.000985326218624923,-1.23046297517503,0.982062909153893,1.02292961353022,0.847786594774547,-0.17514301875567,0.323549510116746,ENSG00000119457,SLC46A2,protein_coding,9,-1,112878920,112890876,q32,solute carrier family 46 member 2 [Source:HGNC Symbol;Acc:HGNC:16055],NA,SLC46A2,57864,NM_033051
STK25_SIG,STK25,STK25_SIG,STK25,SIG,33,3.56616889577935,0.320453481464457,0.31319620389283,0.344298822056948,0.0311026181641182,0.000985920352936313,3.73752668354644,5.99432215848189,5.9466629254515,6.15091678129602,0.204253855844521,0.0013074595654676,ENSG00000115694,STK25,protein_coding,2,-1,241492670,241509730,q37.3,serine/threonine kinase 25 [Source:HGNC Symbol;Acc:HGNC:11404],NA,STK25,10494,NM_001271977;NM_001271978;NM_001271979;NM_001271980;NM_001282305;NM_001282306;NM_001282307;NM_001282308;NM_006374
ZNF436_TF,ZNF436,ZNF436_TF,ZNF436,TF,24,3.56578264943176,0.125114850294944,0.117822684313697,0.149074824233327,0.0312521399196305,0.000987049435684303,3.25741995935882,3.59451220994803,3.54347520713099,3.76220521920399,0.218730012072999,0.0054076727320582,ENSG00000125945,ZNF436,protein_coding,1,-1,23359448,23369836,p36.12,zinc finger protein 436 [Source:HGNC Symbol;Acc:HGNC:20814],NA,ZNF436,80818,NM_001077195;NM_030634
LILRB1_SIG,LILRB1,LILRB1_SIG,LILRB1,SIG,50,-3.56542851687797,0.155515870302163,0.186543514555806,0.053567896325908,-0.132975618229898,0.000987603166142034,-3.10553531147844,4.08205347118807,4.23192060502703,3.58963288857435,-0.642287716452688,0.00819332121562378,ENSG00000104972,LILRB1,protein_coding,19,1,54617158,54637528,q13.42,leukocyte immunoglobulin like receptor B1 [Source:HGNC Symbol;Acc:HGNC:6605],NA,LILRB1,10859,NM_001081637;NM_001081638;NM_001081639;NM_001278398;NM_006669
ZNF302_TF,ZNF302,ZNF302_TF,ZNF302,TF,38,3.56539465986018,0.0689306955105826,0.0568890141758924,0.108496219895993,0.0516072057201008,0.000987603166142034,2.24286466133769,4.29302762167273,4.24519318937171,4.45019789923323,0.205004709861512,0.0608024060266402,ENSG00000089335,ZNF302,protein_coding,19,1,34677639,34686397,q13.11,zinc finger protein 302 [Source:HGNC Symbol;Acc:HGNC:13848],NA,ZNF302,55900,NM_001012320;NM_001289181;NM_001289182;NM_001289183;NM_001289184;NM_001289185;NM_001289186;NM_001289187;NM_001289188;NM_001289189;NM_001289190;NM_001289191;NM_001289192;NM_018443;NM_018675
GLOD4_SIG,GLOD4,GLOD4_SIG,GLOD4,SIG,8,3.56537733642347,0.536302926444513,0.528233890198044,0.562815474111486,0.0345815839134426,0.000987603166142034,2.68645734906569,5.5430193475875,5.51153219999868,5.64647711823648,0.134944918237806,0.0231557839757668,ENSG00000167699,GLOD4,protein_coding,17,-1,757097,783390,p13.3,glyoxalase domain containing 4 [Source:HGNC Symbol;Acc:HGNC:14111],NA,GLOD4,51031,NM_001366247;NM_016080
SSB_SIG,SSB,SSB_SIG,SSB,SIG,15,3.56351415803126,0.464457083283796,0.456519619826273,0.490537320358514,0.0340177005322417,0.000994316704313091,4.54892203531845,6.43005033160337,6.37323495841442,6.61672941493848,0.243494456524055,8.32029279490607e-05,ENSG00000138385,SSB,protein_coding,2,1,169791933,169812064,q31.1,Sjogren syndrome antigen B [Source:HGNC Symbol;Acc:HGNC:11316],NA,SSB,6741,NM_001294145;NM_003142
ABCG2_SIG,ABCG2,ABCG2_SIG,ABCG2,SIG,42,-3.56316397279976,-0.100792010586482,-0.0895861110304778,-0.137611394841926,-0.0480252838114483,0.000995318180109388,-2.74591520870105,0.740757387628005,0.800733841817919,0.543691895289717,-0.257041946528202,0.0200850955605957,ENSG00000118777,ABCG2,protein_coding,4,-1,88090150,88231628,q22.1,ATP binding cassette subfamily G member 2 (Junior blood group) [Source:HGNC Symbol;Acc:HGNC:74],BLOOD GROUP JUNIOR SYSTEM;URIC ACID CONCENTRATION SERUM QUANTITATIVE TRAIT LOCUS 1,ABCG2,9429,NM_001257386;NM_001348985;NM_001348986;NM_001348987;NM_001348988;NM_001348989;NM_004827
NVL_SIG,NVL,NVL_SIG,NVL,SIG,43,3.56229341478913,0.319462578389378,0.305217498270873,0.366267841635894,0.0610503433650212,0.000998298164126459,3.63152240676774,4.54097159604785,4.49368851286826,4.69633029792365,0.202641785055391,0.00181245423812755,ENSG00000143748,NVL,protein_coding,1,-1,224227334,224330189,q42.11,nuclear VCP-like [Source:HGNC Symbol;Acc:HGNC:8070],NA,NVL,4931,NM_001243146;NM_001243147;NM_002533;NM_206840
ZNF155_TF,ZNF155,ZNF155_TF,ZNF155,TF,10,3.56189504745931,0.078157297543554,0.0711680844722461,0.101121854777852,0.0299537703056055,0.000999486915904508,1.74311103971124,2.91786959593146,2.89246757536477,3.00133337779346,0.108865802428692,0.151862353264644,ENSG00000204920,ZNF155,protein_coding,19,1,43967862,43998326,q13.31,zinc finger protein 155 [Source:HGNC Symbol;Acc:HGNC:12940],NA,ZNF155,7711,NM_001260486;NM_001260487;NM_001260488;NM_003445;NM_198089
MBTD1_SIG,MBTD1,MBTD1_SIG,MBTD1,SIG,149,3.55932669198601,0.27130121018786,0.262232231448157,0.30109928318974,0.0388670517415836,0.00100898109750007,0.685834036288154,5.99628645330162,5.98522294391788,6.03263798413392,0.0474150402160456,0.600096202792502,ENSG00000011258,MBTD1,protein_coding,17,-1,51177425,51260163,q21.33,mbt domain containing 1 [Source:HGNC Symbol;Acc:HGNC:19866],NA,MBTD1,54799,NM_017643
SETDB2_TF,SETDB2,SETDB2_TF,SETDB2,TF,77,3.55804681348719,0.322417317469606,0.31075824843689,0.360725687148527,0.0499674387116371,0.00101357706862329,2.77885800146737,5.54144549784437,5.4795232223832,5.74490440293106,0.265381180547856,0.0185879841846289,ENSG00000136169,SETDB2,protein_coding,13,1,49444374,49495003,q14.2,SET domain bifurcated histone lysine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:20263],NA,SETDB2,83852,NM_001160308;NM_001320699;NM_031915
CHRNB1_SIG,CHRNB1,CHRNB1_SIG,CHRNB1,SIG,32,3.5578820069965,0.164247849440076,0.157172361729476,0.187495880489189,0.0303235187597126,0.0010138810690127,2.50142673974232,3.02593265387887,2.97913981165889,3.17968056403023,0.200540752371347,0.0351780895387409,ENSG00000170175,CHRNB1,protein_coding,17,1,7445061,7457710,p13.1,cholinergic receptor nicotinic beta 1 subunit [Source:HGNC Symbol;Acc:HGNC:1961],MYASTHENIC SYNDROME CONGENITAL 2A SLOW-CHANNEL;MYASTHENIC SYNDROME CONGENITAL 2C ASSOCIATED WITH ACETYLCHOLINERECEPTOR DEFICIENCY;Postsynaptic congenital myasthenic syndromes,CHRNB1,1140,NM_000747
PTGDR_SIG,PTGDR,PTGDR_SIG,PTGDR,SIG,30,-3.55750519191396,-0.120390172664318,-0.10785923207266,-0.161563263179767,-0.0537040311071066,0.00101500387290928,-3.05822912566738,1.20971409422771,1.28607252366797,0.958822111781153,-0.327250411886816,0.00925995502012075,ENSG00000168229,PTGDR,protein_coding,14,1,52267713,52276724,q22.1,prostaglandin D2 receptor [Source:HGNC Symbol;Acc:HGNC:9591],ASTHMA-RELATED TRAITS SUSCEPTIBILITY TO 1,PTGDR,5729,NM_000953;NM_001281469
GOT1_SIG,GOT1,GOT1_SIG,GOT1,SIG,18,3.55671981005582,0.222935682704279,0.209416859487462,0.267354673273819,0.0579378137863571,0.00101770883687906,2.96817398948836,3.64689841831484,3.59138550770271,3.82929798175468,0.237912474051972,0.0116826972335517,ENSG00000120053,GOT1,protein_coding,10,-1,99396870,99430624,q24.2,glutamic-oxaloacetic transaminase 1 [Source:HGNC Symbol;Acc:HGNC:4432],ASPARTATE AMINOTRANSFERASE SERUM LEVEL OF QUANTITATIVE TRAIT LOCUS 1,GOT1,2805,NM_002079
ZFC3H1_SIG,ZFC3H1,ZFC3H1_SIG,ZFC3H1,SIG,47,3.55646380648756,0.256334376825158,0.249905407806493,0.277458132172201,0.0275527243657081,0.00101836748449755,2.43010787248558,6.92210226134093,6.88625839649022,7.0398749601361,0.15361656364588,0.0410857216400406,ENSG00000133858,ZFC3H1,protein_coding,12,-1,71609472,71667725,q21.1,zinc finger C3H1-type containing [Source:HGNC Symbol;Acc:HGNC:28328],NA,ZFC3H1,196441,NM_144982
CHRNE_SIG,CHRNE,CHRNE_SIG,CHRNE,SIG,16,3.55605458673477,-0.124393821644536,-0.128531944656053,-0.110797131749552,0.0177348129065014,0.00101962075789059,2.36437490219985,2.22464963454167,2.16541987619524,2.41926169767995,0.253841821484708,0.0473045333197466,ENSG00000108556,CHRNE,protein_coding,17,-1,4897771,4934438,p13.2,cholinergic receptor nicotinic epsilon subunit [Source:HGNC Symbol;Acc:HGNC:1966],MYASTHENIC SYNDROME CONGENITAL 4A SLOW-CHANNEL;MYASTHENIC SYNDROME CONGENITAL 4B FAST-CHANNEL;MYASTHENIC SYNDROME CONGENITAL 4C ASSOCIATED WITH ACETYLCHOLINERECEPTOR DEFICIENCY;Postsynaptic congenital myasthenic syndromes,CHRNE,1145,NM_000080
SCYL3_SIG,SCYL3,SCYL3_SIG,SCYL3,SIG,42,3.55583674377878,0.387375159248583,0.378440178063139,0.416732954572186,0.0382927765090477,0.00102013259808506,2.95082905574346,4.23187728562159,4.18140520678725,4.39771411607729,0.216308909290038,0.012214076834196,ENSG00000000457,SCYL3,protein_coding,1,-1,169849631,169894267,q24.2,SCY1 like pseudokinase 3 [Source:HGNC Symbol;Acc:HGNC:19285],NA,SCYL3,57147,NM_020423;NM_181093
KIN_TF,KIN,KIN_TF,KIN,TF,48,3.55505247949651,0.347096663244996,0.343033838302221,0.36044594519983,0.0174121068976093,0.00102284605398479,4.45337936747011,4.05485610703889,4.00607218268391,4.21514614420525,0.209073961521337,0.000117557674547876,ENSG00000151657,KIN,protein_coding,10,-1,7750962,7787993,p14,Kin17 DNA and RNA binding protein [Source:HGNC Symbol;Acc:HGNC:6327],NA,KIN,22944,NM_012311
CTDSP1_SIG,CTDSP1,CTDSP1_SIG,CTDSP1,SIG,29,-3.55381061035492,0.347528854964521,0.354427345201756,0.324862387042176,-0.0295649581595795,0.00102735227084641,-2.91011537109873,7.08850777697363,7.11943470997742,6.98689071138977,-0.132543998587649,0.013523852093489,ENSG00000144579,CTDSP1,protein_coding,2,1,218398256,218405941,q35,CTD small phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:21614],NA,CTDSP1,58190,NM_001206878;NM_021198;NM_182642
EIF2B5_SIG,EIF2B5,EIF2B5_SIG,EIF2B5,SIG,14,3.55366822720195,0.329869862410772,0.321424215691171,0.35761984448946,0.0361956287982882,0.00102757299555123,3.90335666638436,5.61219538008547,5.57329064344096,5.74002522906031,0.166734585619347,0.000771268997863842,ENSG00000145191,EIF2B5,protein_coding,3,1,184135038,184146127,q27.1,eukaryotic translation initiation factor 2B subunit epsilon [Source:HGNC Symbol;Acc:HGNC:3261],Congenital or early infantile CACH syndrome;Cree leukoencephalopathy;Juvenile or adult CACH syndrome;Late infantile CACH syndrome;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER;OVARIOLEUKODYSTROPHY,EIF2B5,8893,NM_003907
KLRD1_SIG,KLRD1,KLRD1_SIG,KLRD1,SIG,21,-3.55338395641184,-0.342639116178574,-0.318130326116187,-0.423167997812132,-0.105037671695945,0.00102834843359096,-3.03917818666367,1.85593560129112,1.95332338965508,1.53594715380953,-0.41737623584555,0.00971399655544767,ENSG00000134539,KLRD1,protein_coding,12,1,10226058,10329608,p13.2,killer cell lectin like receptor D1 [Source:HGNC Symbol;Acc:HGNC:6378],NA,KLRD1,3824,NM_001114396;NM_001351060;NM_001351062;NM_001351063;NM_002262;NM_007334
CIZ1_TF,CIZ1,CIZ1_TF,CIZ1,TF,326,3.55294189612163,0.153602754981381,0.146661341747972,0.17641025560544,0.0297489138574676,0.00102974196778823,2.45035758584363,7.42183571920475,7.39522383219697,7.50927477651602,0.114050944319045,0.039328694133335,ENSG00000148337,CIZ1,protein_coding,9,-1,128161251,128204383,q34.11,CDKN1A interacting zinc finger protein 1 [Source:HGNC Symbol;Acc:HGNC:16744],Adult-onset cervical dystonia DYT23 type,CIZ1,25792,NM_001131015;NM_001131016;NM_001131017;NM_001131018;NM_001257975;NM_001257976;NM_012127
CLEC4A_SIG,CLEC4A,CLEC4A_SIG,CLEC4A,SIG,15,-3.55278969806403,0.398706906665025,0.435947036702463,0.276346479399158,-0.159600557303305,0.00102977342487554,-2.27200343504652,2.49439924117203,2.58080747241904,2.21048648136042,-0.370320991058621,0.0572258654482118,ENSG00000111729,CLEC4A,protein_coding,12,1,8123632,8138607,p13.31,C-type lectin domain family 4 member A [Source:HGNC Symbol;Acc:HGNC:13257],NA,CLEC4A,50856,NM_016184;NM_194447;NM_194448;NM_194450
PDK3_SIG,PDK3,PDK3_SIG,PDK3,SIG,31,-3.55276225501101,0.166691543949206,0.174318133194587,0.141632750714384,-0.0326853824802026,0.00102977342487554,-1.44467690773522,3.84434232018909,3.86538473390215,3.77520296084616,-0.0901817730559871,0.240374529083352,ENSG00000067992,PDK3,protein_coding,X,1,24465221,24550466,p22.11,pyruvate dehydrogenase kinase 3 [Source:HGNC Symbol;Acc:HGNC:8811],Charcot-Marie-Tooth disease X-linked dominant 6;X-linked Charcot-Marie-Tooth disease type 6,PDK3,5165,NM_001142386;NM_005391
CLCN4_SIG,CLCN4,CLCN4_SIG,CLCN4,SIG,28,-3.55237485239432,-0.153418929693196,-0.139532607371615,-0.19904541732125,-0.059512809949635,0.00103095475636014,-4.42762760472686,1.470891438086,1.62234439266782,0.973260301602899,-0.649084091064918,0.000129205348298737,ENSG00000073464,CLCN4,protein_coding,X,1,10156945,10237660,p22.2,chloride voltage-gated channel 4 [Source:HGNC Symbol;Acc:HGNC:2022],CLCN4-related X-linked intellectual disability syndrome;INFANTILE EPILEPTIC ENCEPHALOPATHY AND/OR INTELLECTUAL DISABILITY;RAYNAUD-CLAES SYNDROME;X-linked non-syndromic intellectual disability,CLCN4,1183,NM_001256944;NM_001830
ARHGAP26_SIG,ARHGAP26,ARHGAP26_SIG,ARHGAP26,SIG,35,-3.55067195175748,0.495383376246796,0.510552743202937,0.445541170533763,-0.0650115726691742,0.00103730963488788,-2.07159612809542,6.04310681960317,6.09522680059841,5.87185545347594,-0.223371347122473,0.0848015881375543,ENSG00000145819,ARHGAP26,protein_coding,5,1,142770377,143229011,q31.3,Rho GTPase activating protein 26 [Source:HGNC Symbol;Acc:HGNC:17073],Juvenile myelomonocytic leukemia,ARHGAP26,23092,NM_001135608;NM_001349547;NM_015071
FASN_SIG,FASN,FASN_SIG,FASN,SIG,14,3.54980438350313,0.266416364806441,0.257248841160627,0.296538228214117,0.0392893870534904,0.00104039495236494,3.18277272252749,7.06965975451108,7.00113550127262,7.29481087229457,0.293675371021951,0.00665457532765426,ENSG00000169710,FASN,protein_coding,17,-1,82078338,82098294,q25.3,fatty acid synthase [Source:HGNC Symbol;Acc:HGNC:3594],Autosomal Recessive Mental Retardation,FASN,2194,NM_004104
USP5_SIG,USP5,USP5_SIG,USP5,SIG,45,3.54941258445434,0.682364325735271,0.671808638410393,0.717047298374156,0.0452386599637629,0.00104160506567646,3.5922804085389,6.06032524528873,6.00049337527828,6.25691567532306,0.256422300044778,0.00204811250088987,ENSG00000111667,USP5,protein_coding,12,1,6852128,6866632,p13.31,ubiquitin specific peptidase 5 [Source:HGNC Symbol;Acc:HGNC:12628],NA,USP5,8078,NM_001098536;NM_003481
ZNF607_TF,ZNF607,ZNF607_TF,ZNF607,TF,65,3.5469914707793,-0.0238157908055847,-0.0377673218832743,0.0220249541639666,0.0597922760472407,0.00105088214606706,3.43762922100516,2.27259268799459,2.18537570975621,2.55916275934927,0.373787049593061,0.003219954683743,ENSG00000198182,ZNF607,protein_coding,19,-1,37696371,37719761,q13.12,zinc finger protein 607 [Source:HGNC Symbol;Acc:HGNC:28192],NA,ZNF607,84775,NM_001172677;NM_032689
ZNF570_TF,ZNF570,ZNF570_TF,ZNF570,TF,31,3.54658216947476,0.119908602073704,0.112703920235825,0.143581128112451,0.0308772078766258,0.0010521734762696,4.18425752782129,2.21218691802403,2.15453550116779,2.40161300198023,0.24707750081244,0.00030488368349996,ENSG00000171827,ZNF570,protein_coding,19,1,37467585,37488652,q13.12,zinc finger protein 570 [Source:HGNC Symbol;Acc:HGNC:26416],NA,ZNF570,148268,NM_001300993;NM_001321991;NM_001321992;NM_001321993;NM_001321994;NM_144694
DUOX2_SIG,DUOX2,DUOX2_SIG,DUOX2,SIG,6,-3.5457202644146,-0.17318776333497,-0.169163733692368,-0.186409575017804,-0.0172458413254357,0.0010552772387355,-3.48501722739783,0.318969050369031,0.366251994356714,0.163610805838073,-0.202641188518641,0.00281948215816607,ENSG00000140279,DUOX2,protein_coding,15,-1,45092650,45114344,q21.1,dual oxidase 2 [Source:HGNC Symbol;Acc:HGNC:13273],Familial thyroid dyshormonogenesis;Genetic transient congenital hypothyroidism;THYROID DYSHORMONOGENESIS 6,DUOX2,50506,NM_001363711;NM_014080
AFF2_SIG,AFF2,AFF2_SIG,AFF2,SIG,54,-3.54318367429563,0.138534551691125,0.150726691382929,0.0984746641323404,-0.0522520272505889,0.00106513377232995,-3.87494093952581,4.66183379177568,4.85918975116666,4.01337849663392,-0.845811254532741,0.000848633764585366,ENSG00000155966,AFF2,protein_coding,X,1,148500619,149000663,q28,AF4/FMR2 family member 2 [Source:HGNC Symbol;Acc:HGNC:3776],FRAGILE X-E MENTAL RETARDATION SYNDROME;FRAXE intellectual disability;MENTAL RETARDATION X-LINKED ASSOCIATED WITH FRAGILE SITE FRAXE,AFF2,2334,NM_001169122;NM_001169123;NM_001169124;NM_001169125;NM_001170628;NM_002025
ZNF575_TF,ZNF575,ZNF575_TF,ZNF575,TF,97,3.54252290891836,0.169042773961232,0.161470776729726,0.193922193436179,0.0324514167064537,0.00106715277463685,3.07712932541432,1.63886442536074,1.59648826186209,1.77810039114204,0.181612129279956,0.00880309496790165,ENSG00000176472,ZNF575,protein_coding,19,1,43525497,43536130,q13.31,zinc finger protein 575 [Source:HGNC Symbol;Acc:HGNC:27606],NA,ZNF575,284346,NM_174945
ZNF217_TF,ZNF217,ZNF217_TF,ZNF217,TF,90,-3.54251277256822,0.135527282323073,0.139759766832558,0.121620547506193,-0.0181392193263655,0.00106715277463685,-1.15126263536529,6.61073928358464,6.62959349113998,6.54878974447422,-0.080803746665759,0.35871305976581,ENSG00000171940,ZNF217,protein_coding,20,-1,53567065,53609907,q13.2,zinc finger protein 217 [Source:HGNC Symbol;Acc:HGNC:13009],NA,ZNF217,7764,NM_006526
TRIM24_SIG,TRIM24,TRIM24_SIG,TRIM24,SIG,21,3.54233966495572,0.438821760689114,0.430397532146543,0.466501368757561,0.0361038366110182,0.0010675064717773,0.781349806237052,6.22368704386409,6.20890498143775,6.27225667755066,0.0633516961129147,0.545272849542238,ENSG00000122779,TRIM24,protein_coding,7,1,138460259,138589996,q33,tripartite motif containing 24 [Source:HGNC Symbol;Acc:HGNC:11812],Differentiated thyroid carcinoma,TRIM24,8805,NM_003852;NM_015905
CMPK2_SIG,CMPK2,CMPK2_SIG,CMPK2,SIG,24,-3.54129513968164,0.138295947625634,0.14989361523292,0.100189325487406,-0.0497042897455139,0.00107108534643613,-1.50552732413821,4.25972903495529,4.30279929477132,4.11821246698833,-0.18458682778299,0.220076553482631,ENSG00000134326,CMPK2,protein_coding,2,-1,6840570,6866635,p25.2,cytidine/uridine monophosphate kinase 2 [Source:HGNC Symbol;Acc:HGNC:27015],NA,CMPK2,129607,NM_001256477;NM_001256478;NM_207315
CSNK1A1L_SIG,CSNK1A1L,CSNK1A1L_SIG,CSNK1A1L,SIG,17,3.54128541157667,0.0266754242855901,0.0233009024853392,0.0377631387721288,0.0144622362867897,0.00107108534643613,2.05599791557955,1.14901190965148,1.13061365994122,1.20946330155662,0.0788496416153935,0.0874331547331988,ENSG00000180138,CSNK1A1L,protein_coding,13,-1,37103259,37105664,q13.3,casein kinase 1 alpha 1 like [Source:HGNC Symbol;Acc:HGNC:20289],NA,CSNK1A1L,122011,NM_145203
DVL1_SIG,DVL1,DVL1_SIG,DVL1,SIG,21,3.54030266237476,0.348275656755747,0.343824921740176,0.362899500378338,0.0190745786381622,0.00107473310668001,0.881063637354859,4.85232786605965,4.84205049204613,4.88609638067551,0.0440458886293796,0.491822230816277,ENSG00000107404,DVL1,protein_coding,1,-1,1335276,1349418,p36.33,dishevelled segment polarity protein 1 [Source:HGNC Symbol;Acc:HGNC:3084],Autosomal dominant Robinow syndrome;ROBINOW SYNDROME AUTOSOMAL DOMINANT 1;ROBINOW SYNDROME AUTOSOMAL DOMINANT 2,DVL1,1855,NM_001330311;NM_004421
ZCRB1_TF,ZCRB1,ZCRB1_TF,ZCRB1,TF,252,3.5400028668163,0.230617856726548,0.225520038905001,0.247367829568775,0.021847790663774,0.00107541609567582,4.01227847813461,5.30598706391172,5.25806262796908,5.46345306772322,0.205390439754134,0.000546049474007581,ENSG00000139168,ZCRB1,protein_coding,12,-1,42312086,42326118,q12,zinc finger CCHC-type and RNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:29620],NA,ZCRB1,85437,NM_033114
KIF1C_SIG,KIF1C,KIF1C_SIG,KIF1C,SIG,49,-3.53996375071833,0.182952269544946,0.199830393438246,0.127495576752677,-0.0723348166855686,0.00107541609567582,-2.11480274000611,4.88327325648318,4.94280100161224,4.68768209391626,-0.255118907695977,0.078136666974495,ENSG00000129250,KIF1C,protein_coding,17,1,4997950,5028401,p13.2,kinesin family member 1C [Source:HGNC Symbol;Acc:HGNC:6317],Autosomal recessive spastic paraplegia type 58;SPASTIC ATAXIA 2 AUTOSOMAL RECESSIVE,KIF1C,10749,NM_006612
THY1_SIG,THY1,THY1_SIG,THY1,SIG,26,-3.53984811359075,-0.216429636856203,-0.209401135022997,-0.239523285736735,-0.0301221507137374,0.00107553853591244,-2.92840369026534,0.350384372463546,0.402486007391436,0.179193286271906,-0.223292721119529,0.0129205150002178,ENSG00000154096,THY1,protein_coding,11,-1,119417378,119424985,q23.3,Thy-1 cell surface antigen [Source:HGNC Symbol;Acc:HGNC:11801],NA,THY1,7070,NM_001311160;NM_001311162;NM_006288
CDK13_SIG,CDK13,CDK13_SIG,CDK13,SIG,33,3.53930073866046,0.303329576687104,0.297652027183619,0.321984382198554,0.024332355014936,0.00107742200412869,2.5732238581606,6.46273379372116,6.43492948546358,6.55409080656748,0.119161321103898,0.0299565825468763,ENSG00000065883,CDK13,protein_coding,7,1,39950121,40099580,p14.1,cyclin dependent kinase 13 [Source:HGNC Symbol;Acc:HGNC:1733],CONGENITAL HEART DEFECTS DYSMORPHIC FACIAL FEATURES AND INTELLECTUAL DEVELOPMENTAL DISORDER;Syndromic INTELLECTUAL DISABILITY with or without congenital heart disease,CDK13,8621,NM_003718;NM_031267
ACADSB_SIG,ACADSB,ACADSB_SIG,ACADSB,SIG,12,3.53908255865681,0.19598508730362,0.188531122970315,0.220476684398765,0.0319455614284498,0.00107796349072456,1.1328060353644,4.36823783197126,4.34666493200076,4.43912021758861,0.0924552855878497,0.366920336906477,ENSG00000196177,ACADSB,protein_coding,10,1,123008979,123058311,q26.13,acyl-CoA dehydrogenase short/branched chain [Source:HGNC Symbol;Acc:HGNC:91],2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,ACADSB,36,NM_001330174;NM_001609
PEMT_SIG,PEMT,PEMT_SIG,PEMT,SIG,12,3.53893561077806,0.425890396120429,0.419039519416592,0.448400419575895,0.0293609001593032,0.0010782143360996,4.27205462512704,3.42418546960904,3.35682493439006,3.64551294247139,0.288688008081329,0.000224200170779467,ENSG00000133027,PEMT,protein_coding,17,-1,17505563,17591708,p11.2,phosphatidylethanolamine N-methyltransferase [Source:HGNC Symbol;Acc:HGNC:8830],NA,PEMT,10400,NM_001267551;NM_001267552;NM_007169;NM_148172;NM_148173
TAB2_SIG,TAB2,TAB2_SIG,TAB2,SIG,44,-3.53844263964268,0.0269804125825146,0.0346434024727578,0.00180201722885846,-0.0328413852438994,0.00107987977620448,-2.5672819727206,7.49258198392727,7.53351650738135,7.3580828354353,-0.175433671946046,0.030340567736945,ENSG00000055208,TAB2,protein_coding,6,1,149218641,149411613,q25.1,TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [Source:HGNC Symbol;Acc:HGNC:17075],CONGENITAL HEART DEFECTS MULTIPLE TYPES 2;CONGENITAL HEART DISEASE NONSYNDROMIC 2;Polyvalvular heart disease syndrome,TAB2,23118,NM_001292034;NM_001292035;NM_015093
HECW2_SIG,HECW2,HECW2_SIG,HECW2,SIG,21,-3.53754821953925,0.092106128869815,0.10921872183004,0.0358790377147892,-0.0733396841152509,0.0010831173061332,-2.63064539295986,0.847747894134024,0.896643429665999,0.687091134528962,-0.209552295137036,0.026206501325103,ENSG00000138411,HECW2,protein_coding,2,-1,196189099,196593684,q32.3,HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:29853],NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA SEIZURES AND ABSENT LANGUAGE,HECW2,57520,NM_001304840;NM_001348768;NM_020760
HHLA3_SIG,HHLA3,HHLA3_SIG,HHLA3,SIG,8,3.53748124024266,0.362863387784155,0.350562558038219,0.403280399806517,0.0527178417682977,0.0010831173061332,1.53857361719731,1.72287714327226,1.69520509336693,1.81379959296119,0.118594499594264,0.209498531688262,ENSG00000197568,HHLA3,protein_coding,1,1,70354805,70385339,p31.1,HERV-H LTR-associating 3 [Source:HGNC Symbol;Acc:HGNC:4906],NA,HHLA3,11147,NM_001031693;NM_001036645;NM_001036646
SLC4A10_SIG,SLC4A10,SLC4A10_SIG,SLC4A10,SIG,11,-3.53712880842216,-0.133375650197519,-0.118522108783553,-0.182180143414838,-0.0636580346312847,0.00108421282866548,-2.09384326431015,0.475307939061489,0.507805623819425,0.368529831999699,-0.139275791819726,0.0812145171939416,ENSG00000144290,SLC4A10,protein_coding,2,1,161424332,161985282,q24.2,solute carrier family 4 member 10 [Source:HGNC Symbol;Acc:HGNC:13811],NA,SLC4A10,57282,NM_001178015;NM_001178016;NM_001354440;NM_001354441;NM_001354442;NM_001354443;NM_001354444;NM_001354445;NM_001354446;NM_001354447;NM_001354448;NM_001354449;NM_001354450;NM_001354451;NM_001354453;NM_001354455;NM_001354460;NM_001354461;NM_022058
RPL7L1_SIG,RPL7L1,RPL7L1_SIG,RPL7L1,SIG,81,3.53686668602053,0.497888621461878,0.487762953050639,0.531158674813094,0.0433957217624557,0.00108493841635121,3.06873401816351,6.21885870348745,6.16419181039124,6.3984784950893,0.234286684698056,0.00900279056839407,ENSG00000146223,RPL7L1,protein_coding,6,1,42879618,42889925,p21.1,ribosomal protein L7 like 1 [Source:HGNC Symbol;Acc:HGNC:21370],NA,RPL7L1,285855,NM_001366481;NM_198486
CDC42BPG_SIG,CDC42BPG,CDC42BPG_SIG,CDC42BPG,SIG,54,3.53655076988331,-0.0251070582205116,-0.0317394701201158,-0.00331484769324062,0.0284246224268752,0.00108588565935129,3.10254502203424,2.7661709778382,2.69763843138821,2.9913493447453,0.293710913357081,0.0082485060642864,ENSG00000171219,CDC42BPG,protein_coding,11,-1,64823052,64844653,q13.1,CDC42 binding protein kinase gamma [Source:HGNC Symbol;Acc:HGNC:29829],NA,CDC42BPG,55561,NM_017525
TGFBR1_SIG,TGFBR1,TGFBR1_SIG,TGFBR1,SIG,22,-3.5360305057449,0.365924864898553,0.371166773520236,0.348701450855877,-0.0224653226643589,0.00108767479227564,-0.769730794581299,5.85922675430042,5.87358222510675,5.81205877879391,-0.0615234463128403,0.552309726722851,ENSG00000106799,TGFBR1,protein_coding,9,1,99104038,99154192,q22.33,transforming growth factor beta receptor 1 [Source:HGNC Symbol;Acc:HGNC:11772],AORTIC ANEURYSM FAMILIAL THORACIC TYPE 5;Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome;LOEYS-DIETZ SYNDROME 1;LOEYS-DIETZ SYNDROME TYPE 1A;LOEYS-DIETZ SYNDROME TYPE 2A;Multiple self-healing squamous epithelioma;MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA SUSCEPTIBILITY TO,TGFBR1,7046,NM_001130916;NM_001306210;NM_004612
MARCH9_SIG,MARCH9,MARCH9_SIG,MARCH9,SIG,46,-3.53587701074081,-0.10041956730125,-0.0947270786893943,-0.11912345845449,-0.0243963797650955,0.00108795531004846,-2.01867572028212,3.04665207145942,3.09096377438891,2.90105647611968,-0.189907298269223,0.0938337987212371,ENSG00000139266,MARCH9,protein_coding,12,1,57755103,57760411,q14.1,membrane associated ring-CH-type finger 9 [Source:HGNC Symbol;Acc:HGNC:25139],NA,MARCH9,92979,NM_138396
SIRT5_SIG,SIRT5,SIRT5_SIG,SIRT5,SIG,37,3.53505677781007,0.0745084103884447,0.0604917690170749,0.120563089180088,0.0600713201630134,0.00109098557422824,2.9008732474154,3.93943958762045,3.87514958505963,4.15067816746317,0.275528582403541,0.0138429780242375,ENSG00000124523,SIRT5,protein_coding,6,1,13574529,13615158,p23,sirtuin 5 [Source:HGNC Symbol;Acc:HGNC:14933],NA,SIRT5,23408,NM_001193267;NM_001242827;NM_012241;NM_031244
POU2F2_TF,POU2F2,POU2F2_TF,POU2F2,TF,447,-3.53432886377304,0.13179357639501,0.143724354222309,0.0925924492481689,-0.05113190497414,0.00109364161093519,-3.50942419932045,5.80750755666308,5.93900925810021,5.37543053765537,-0.56357872044484,0.00263166417097803,ENSG00000028277,POU2F2,protein_coding,19,-1,42086110,42196585,q13.2,POU class 2 homeobox 2 [Source:HGNC Symbol;Acc:HGNC:9213],NA,POU2F2,5452,NM_001207025;NM_001207026;NM_001247994;NM_002698
SLC38A11_SIG,SLC38A11,SLC38A11_SIG,SLC38A11,SIG,8,-3.53305193830909,-0.129588453634004,-0.11920218021825,-0.16371478057148,-0.0445126003532298,0.00109858286977081,-2.54163688232066,0.310913410639619,0.341814151182254,0.209382405999531,-0.132431745182723,0.0322502791918444,ENSG00000169507,SLC38A11,protein_coding,2,-1,164896186,164955525,q24.3,solute carrier family 38 member 11 [Source:HGNC Symbol;Acc:HGNC:26836],NA,SLC38A11,151258,NM_001199148;NM_001351537;NM_001351538;NM_001351539;NM_001351540;NM_173512
PUS1_SIG,PUS1,PUS1_SIG,PUS1,SIG,34,3.53228900960581,0.414949477281436,0.400255833846659,0.463228591424276,0.0629727575776169,0.00110140195402142,3.41581572325039,4.54833263113586,4.48897587960428,4.74336195759675,0.254386077992466,0.00343968191496133,ENSG00000177192,PUS1,protein_coding,12,1,131929200,131945896,q24.33,pseudouridine synthase 1 [Source:HGNC Symbol;Acc:HGNC:15508],Mitochondrial myopathy and sideroblastic anemia;MYOPATHY LACTIC ACIDOSIS AND SIDEROBLASTIC ANEMIA 1,PUS1,80324,NM_001002019;NM_001002020;NM_025215
HDAC2_SIG,HDAC2,HDAC2_SIG,HDAC2,SIG,32,3.53202137918196,0.550406887068316,0.537495299199794,0.592830675779174,0.0553353765793806,0.00110216160249302,2.57056677021674,6.58248901495528,6.54661351289596,6.70036566457875,0.153752151682785,0.0300971006022974,ENSG00000196591,HDAC2,protein_coding,6,-1,113933028,114011308,q21,histone deacetylase 2 [Source:HGNC Symbol;Acc:HGNC:4853],NA,HDAC2,3066,NM_001527
MTIF2_SIG,MTIF2,MTIF2_SIG,MTIF2,SIG,14,3.53189816999908,0.417696199137261,0.408807674270798,0.446901352269926,0.0380936779991277,0.0011023196552517,4.39072944574007,5.27102323699015,5.21516873267777,5.45454517973081,0.23937644705304,0.000147440769458592,ENSG00000085760,MTIF2,protein_coding,2,-1,55236595,55269347,p16.1,mitochondrial translational initiation factor 2 [Source:HGNC Symbol;Acc:HGNC:7441],NA,MTIF2,4528,NM_001005369;NM_001321001;NM_001321002;NM_001321003;NM_001321004;NM_001321005;NM_002453
TK2_SIG,TK2,TK2_SIG,TK2,SIG,36,3.53165991642018,0.178881543054284,0.172355582876384,0.20032398363881,0.0279684007624258,0.00110295753273372,1.87286619436306,4.48500615531252,4.44915612844849,4.60279910072291,0.153642972274426,0.121944119109137,ENSG00000166548,TK2,protein_coding,16,-1,66508003,66552544,q21,thymidine kinase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:11831],Autosomal recessive progressive external ophthalmoplegia;MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE);Mitochondrial DNA Depletion Syndrome Myopathic Form;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNADELETIONS AUTOSOMAL RECESSIVE 3,TK2,7084,NM_001172643;NM_001172644;NM_001172645;NM_001271934;NM_001271935;NM_001272050;NM_004614
TRUB2_SIG,TRUB2,TRUB2_SIG,TRUB2,SIG,52,3.53133944809024,0.552549313074516,0.536144519232916,0.60645077855406,0.0703062593211438,0.00110372350205355,3.51749486207625,4.0278885122644,3.95865828991612,4.25535924283731,0.29670095292119,0.00256675144142692,ENSG00000167112,TRUB2,protein_coding,9,-1,128305159,128322447,q34.11,TruB pseudouridine synthase family member 2 [Source:HGNC Symbol;Acc:HGNC:17170],NA,TRUB2,26995,NM_001329861;NM_001329862;NM_001329863;NM_015679
NOC4L_SIG,NOC4L,NOC4L_SIG,NOC4L,SIG,4,3.53130584817156,0.442065023818818,0.43108397725257,0.478145605393631,0.0470616281410603,0.00110372350205355,3.76692730324531,4.22944362342754,4.1872394207426,4.36811457510663,0.180875154364029,0.0011913197804915,ENSG00000184967,NOC4L,protein_coding,12,1,132144457,132152473,q24.33,nucleolar complex associated 4 homolog [Source:HGNC Symbol;Acc:HGNC:28461],NA,NOC4L,79050,NM_024078
ZNF417_TF,ZNF417,ZNF417_TF,ZNF417,TF,45,3.53043180870784,0.292435599103344,0.285784662529628,0.314288676416983,0.0285040138873547,0.00110701994487263,4.04443852216699,3.79532065934969,3.73689141788798,3.98730245272387,0.250411034835897,0.000491549810257677,ENSG00000173480,ZNF417,protein_coding,19,-1,57900296,57916610,q13.43,zinc finger protein 417 [Source:HGNC Symbol;Acc:HGNC:20646],NA,ZNF417,147687,NM_001297734;NM_152475
ZNF207_SIG,ZNF207,ZNF207_SIG,ZNF207,SIG,19,3.5302443415288,0.507553521220162,0.499557965349217,0.533824633367552,0.034266668018335,0.00110744802256919,2.96187341752692,8.0102383627854,7.98048877116557,8.10798702096484,0.12749824979927,0.0118838471647432,ENSG00000010244,ZNF207,protein_coding,17,1,32350117,32381886,q11.2,zinc finger protein 207 [Source:HGNC Symbol;Acc:HGNC:12998],NA,ZNF207,7756,NM_001032293;NM_001098507;NM_003457
MXI1_TF,MXI1,MXI1_TF,MXI1,TF,38,-3.52999971686507,0.052621037005383,0.0597210718882101,0.0292923509618081,-0.0304287209264021,0.0011081157145973,-0.844301425678582,5.59201050877151,5.60650393876786,5.5443892387835,-0.0621146999843613,0.511497701233323,ENSG00000119950,MXI1,protein_coding,10,1,110207605,110287365,q25.2,MAX interactor 1, dimerization protein [Source:HGNC Symbol;Acc:HGNC:7534],Prostate Cancer,MXI1,4601,NM_001008541;NM_005962;NM_130439
HNRNPUL2_SIG,HNRNPUL2,HNRNPUL2_SIG,HNRNPUL2,SIG,12,3.52980331855029,0.539107402320301,0.529384275921424,0.571054817630896,0.0416705417094725,0.00110858178093828,1.99990727260796,6.10455532094309,6.08177709471371,6.1793980642682,0.0976209695544946,0.0970962455171404,ENSG00000214753,HNRNPUL2,protein_coding,11,-1,62712630,62727472,q12.3,heterogeneous nuclear ribonucleoprotein U like 2 [Source:HGNC Symbol;Acc:HGNC:25451],NA,HNRNPUL2,221092,NM_001079559
PGAM4_SIG,PGAM4,PGAM4_SIG,PGAM4,SIG,33,-3.52968212503216,0.23833059475975,0.248098801371861,0.206235058748526,-0.0418637426233345,0.00110873294236677,-2.02999999394546,1.0683589926924,1.09614608034344,0.977058561838973,-0.11908751850447,0.0918959055399961,ENSG00000226784,PGAM4,protein_coding,X,-1,77968874,77969638,q21.1,phosphoglycerate mutase family member 4 [Source:HGNC Symbol;Acc:HGNC:21731],NA,PGAM4,441531,NM_001029891
PLK1_SIG,PLK1,PLK1_SIG,PLK1,SIG,17,-3.52911276983902,-0.158662910908891,-0.131870904740731,-0.24669378831856,-0.114822883577829,0.00111076385839105,-3.37909259380066,3.9173361719973,4.03144536184216,3.54240597679274,-0.489039385049419,0.00384362984742358,ENSG00000166851,PLK1,protein_coding,16,1,23677656,23690367,p12.2,polo like kinase 1 [Source:HGNC Symbol;Acc:HGNC:9077],NA,PLK1,5347,NM_005030
VENTX_TF,VENTX,VENTX_TF,VENTX,TF,149,-3.52803604294111,0.0760135358893074,0.0832254503073411,0.0523172456586255,-0.0309082046487156,0.00111446711408307,2.37854548014661,2.62453956575547,2.51220211425358,2.99364833497597,0.481446220722388,0.0459207898421485,ENSG00000151650,VENTX,protein_coding,10,1,133237855,133241928,q26.3,VENT homeobox [Source:HGNC Symbol;Acc:HGNC:13639],NA,VENTX,27287,NM_014468
HINFP_TF,HINFP,HINFP_TF,HINFP,TF,73,3.52802875951085,0.323285133087203,0.309546144664773,0.368427523618045,0.0588813789532718,0.00111446711408307,2.99686596006498,4.24145926197935,4.19287544871658,4.40109179127129,0.208216342554702,0.0108561565822808,ENSG00000172273,HINFP,protein_coding,11,1,119121587,119136044,q23.3,histone H4 transcription factor [Source:HGNC Symbol;Acc:HGNC:17850],NA,HINFP,25988,NM_001243259;NM_001351957;NM_001351958;NM_001351959;NM_001351960;NM_001351961;NM_001351962;NM_001351963;NM_001351964;NM_001351965;NM_001351966;NM_001351969;NM_001351971;NM_001351972;NM_001351974;NM_015517;NM_198971
CNOT7_TF,CNOT7,CNOT7_TF,CNOT7,TF,97,3.52797665866549,0.40420595172009,0.39691211814908,0.428171404881978,0.0312592867328978,0.00111446711408307,2.14810833126318,6.43369455971757,6.41105569767354,6.50807939214797,0.0970236944744328,0.0733810198558208,ENSG00000198791,CNOT7,protein_coding,8,-1,17224966,17246878,p22,CCR4-NOT transcription complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:14101],NA,CNOT7,29883,NM_001322087;NM_001322088;NM_001322089;NM_001322090;NM_001322091;NM_001322092;NM_001322093;NM_001322094;NM_001322095;NM_001322096;NM_001322097;NM_001322098;NM_001322099;NM_001322100;NM_013354;NM_054026
NTPCR_SIG,NTPCR,NTPCR_SIG,NTPCR,SIG,12,3.52595462038568,-0.179073542731181,-0.192738959564902,-0.134172887420383,0.0585660721445196,0.00112265013171052,1.59817746761326,4.16236972395881,4.12836266155596,4.27410721471103,0.145744553155065,0.191183381260774,ENSG00000135778,NTPCR,protein_coding,1,1,232950605,232983882,q42.2,nucleoside-triphosphatase, cancer-related [Source:HGNC Symbol;Acc:HGNC:28204],NA,NTPCR,84284,NM_001329452;NM_001329453;NM_032324
TUT1_SIG,TUT1,TUT1_SIG,TUT1,SIG,21,3.52570152588082,0.149668873820237,0.139624961643494,0.182670299543824,0.04304533790033,0.0011231882754996,3.03859082764308,2.72017629089394,2.67402040052224,2.87183135925812,0.19781095873588,0.0097294642887601,ENSG00000149016,TUT1,protein_coding,11,-1,62575045,62592177,q12.3,terminal uridylyl transferase 1, U6 snRNA-specific [Source:HGNC Symbol;Acc:HGNC:26184],NA,TUT1,64852,NM_022830
CERS2_TF,CERS2,CERS2_TF,CERS2,TF,217,3.52565764754515,0.279057126803356,0.272154085954936,0.301738546733876,0.0295844607789392,0.0011231882754996,1.20799679417526,7.39727926529086,7.38258200675072,7.44557025763704,0.0629882508863213,0.333233064973669,ENSG00000143418,CERS2,protein_coding,1,-1,150960583,150975004,q21.3,ceramide synthase 2 [Source:HGNC Symbol;Acc:HGNC:14076],NA,CERS2,29956,NM_022075;NM_181746
IRF3_TF,IRF3,IRF3_TF,IRF3,TF,152,3.52506129263374,0.1701700536879,0.16218884790576,0.196394015543505,0.034205167637745,0.00112535874616354,2.50062180112383,5.97429884460213,5.93595680391303,6.10027983543775,0.164323031524729,0.035251643766283,ENSG00000126456,IRF3,protein_coding,19,-1,49659569,49665875,q13.33,interferon regulatory factor 3 [Source:HGNC Symbol;Acc:HGNC:6118],ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 7,IRF3,3661,NM_001197122;NM_001197123;NM_001197124;NM_001197125;NM_001197126;NM_001197127;NM_001197128;NM_001571
GTF2IRD1_TF,GTF2IRD1,GTF2IRD1_TF,GTF2IRD1,TF,103,3.52445074477376,0.0458899961147904,0.0433418683062654,0.0542624160570866,0.0109205477508212,0.00112759355317512,1.19201825458346,1.21845052665986,1.18915122094839,1.31471967399755,0.125568453049156,0.340635773130241,ENSG00000006704,GTF2IRD1,protein_coding,7,1,74453790,74602604,q11.23,GTF2I repeat domain containing 1 [Source:HGNC Symbol;Acc:HGNC:4661],Williams syndrome,GTF2IRD1,9569,NM_001199207;NM_005685;NM_016328
PGS1_SIG,PGS1,PGS1_SIG,PGS1,SIG,8,-3.52282783902142,0.22089185101843,0.22530038092644,0.206406681320683,-0.0188936996057566,0.00113415677031187,-0.956575157962333,6.02423661836226,6.03712747965359,5.9818809312622,-0.0552465483913868,0.452256878776803,ENSG00000087157,PGS1,protein_coding,17,1,78378649,78425114,q25.3,phosphatidylglycerophosphate synthase 1 [Source:HGNC Symbol;Acc:HGNC:30029],NA,PGS1,9489,NM_024419
ATF2_SIG,ATF2,ATF2_SIG,ATF2,SIG,27,3.5222030183624,0.414796994162092,0.409640266210209,0.431740528861134,0.0221002626509246,0.00113646900841256,3.16818598975707,5.81254245841574,5.77969006081549,5.92048605053082,0.14079598971533,0.00690935705639644,ENSG00000115966,ATF2,protein_coding,2,-1,175072250,175168382,q31.1,activating transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:784],NA,ATF2,1386,NM_001256090;NM_001256091;NM_001256092;NM_001256093;NM_001256094;NM_001880
ST6GALNAC6_SIG,ST6GALNAC6,ST6GALNAC6_SIG,ST6GALNAC6,SIG,58,3.52083417651404,0.0296126431580697,0.0215740658465077,0.0560251114674876,0.0344510456209798,0.00114198557577394,3.60687084603119,5.00305066141874,4.9320601981497,5.2363050407313,0.304244842581603,0.00195617915867783,ENSG00000160408,ST6GALNAC6,protein_coding,9,-1,127885321,127905408,q34.11,ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:23364],NA,ST6GALNAC6,30815,NM_001286999;NM_001287000;NM_001287001;NM_001287002;NM_001287003;NM_013443
NANS_SIG,NANS,NANS_SIG,NANS,SIG,7,3.5205942507096,0.141382872067256,0.137715828804122,0.153431728503269,0.015715899699147,0.00114238760080038,3.43503896937929,5.2134292935563,5.16729828255017,5.36500261543358,0.197704332883412,0.00324698967083966,ENSG00000095380,NANS,protein_coding,9,1,98056732,98083077,q22.33,N-acetylneuraminate synthase [Source:HGNC Symbol;Acc:HGNC:19237],infantile-onset severe developmental delay and skeletal dysplasia;Spondyloepimetaphyseal dysplasia Genevieve type,NANS,54187,NM_018946
IL18R1_SIG,IL18R1,IL18R1_SIG,IL18R1,SIG,30,-3.52057095337938,0.115370339862011,0.124213866541271,0.0863130379158732,-0.0379008286253973,0.00114238760080038,-2.43809724933003,3.06070269147784,3.1560883049328,2.74729281869723,-0.408795486235571,0.0403618772819083,ENSG00000115604,IL18R1,protein_coding,2,1,102311529,102398775,q12.1,interleukin 18 receptor 1 [Source:HGNC Symbol;Acc:HGNC:5988],NA,IL18R1,8809,NM_001282399;NM_003855
ZNF555_TF,ZNF555,ZNF555_TF,ZNF555,TF,14,3.51996403588562,0.0129706140276201,0.00975445740194792,0.0235379857976858,0.0137835283957379,0.00114463830183921,0.517102905564927,2.84769838762585,2.83538899527518,2.88814353392093,0.0527545386457552,0.699732162252646,ENSG00000186300,ZNF555,protein_coding,19,1,2841437,2860471,p13.3,zinc finger protein 555 [Source:HGNC Symbol;Acc:HGNC:28382],NA,ZNF555,148254,NM_001172775;NM_152791
RRAGC_SIG,RRAGC,RRAGC_SIG,RRAGC,SIG,28,-3.51841759546701,0.0753032200322343,0.0788887172564087,0.0635223005813754,-0.0153664166750333,0.00115096179910112,-2.62498645516946,5.21694499248541,5.24700283982037,5.11818349409911,-0.128819345721257,0.0265550346811236,ENSG00000116954,RRAGC,protein_coding,1,-1,38838198,38859772,p34.3,Ras related GTP binding C [Source:HGNC Symbol;Acc:HGNC:19902],NA,RRAGC,64121,NM_001271851;NM_022157
B4GALT1_SIG,B4GALT1,B4GALT1_SIG,B4GALT1,SIG,49,-3.51823726529672,0.458272854669761,0.47290421301553,0.410198391533662,-0.0627058214818681,0.00115137582588131,-2.03665769981119,7.1869277781051,7.22740147979257,7.05394275827481,-0.173458721517761,0.0907738766035993,ENSG00000086062,B4GALT1,protein_coding,9,-1,33104082,33167356,p21.1,beta-1,4-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:924],B4GALT1-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IId,B4GALT1,2683,NM_001497
WDR59_SIG,WDR59,WDR59_SIG,WDR59,SIG,61,3.51743995594069,0.123546639172668,0.114304572252034,0.153913430483322,0.0396088582312876,0.00115425012010756,2.1513457667913,5.15756265897525,5.12585945476178,5.26173032996236,0.135870875200575,0.0729180680731464,ENSG00000103091,WDR59,protein_coding,16,-1,74871362,75000173,q23.1,WD repeat domain 59 [Source:HGNC Symbol;Acc:HGNC:25706],NA,WDR59,79726,NM_001324171;NM_001324172;NM_030581
INPP5F_SIG,INPP5F,INPP5F_SIG,INPP5F,SIG,37,3.51740586623962,0.176640057379928,0.171945876174688,0.192063795625719,0.0201179194510312,0.00115425012010756,2.59522123611359,4.25788425306884,4.22107285844626,4.3788359782573,0.157763119811044,0.0285172168143885,ENSG00000198825,INPP5F,protein_coding,10,1,119726042,119829278,q26.11,inositol polyphosphate-5-phosphatase F [Source:HGNC Symbol;Acc:HGNC:17054],NA,INPP5F,22876,NM_001243194;NM_001243195;NM_014937
PTPDC1_SIG,PTPDC1,PTPDC1_SIG,PTPDC1,SIG,16,3.51651464103872,-0.105300503516795,-0.1113750508758,-0.0853412764800661,0.0260337743957337,0.00115771027832172,2.96918998186887,2.36359111358441,2.29576242439851,2.5864568066238,0.290694382225292,0.0116580730212475,ENSG00000158079,PTPDC1,protein_coding,9,1,94030794,94109856,q22.32,protein tyrosine phosphatase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30184],NA,PTPDC1,138639,NM_001253829;NM_001253830;NM_152422;NM_177995
ZNF91_TF,ZNF91,ZNF91_TF,ZNF91,TF,35,3.51644167466532,0.279075484311617,0.268320222727497,0.314414200945154,0.0460939782176571,0.00115771027832172,3.01200216177784,4.53483949042472,4.46289397842416,4.77123188699799,0.308337908573829,0.0104131835074155,ENSG00000167232,ZNF91,protein_coding,19,-1,23304991,23395471,p12,zinc finger protein 91 [Source:HGNC Symbol;Acc:HGNC:13166],NA,ZNF91,7644,NM_001300951;NM_003430
TLR10_SIG,TLR10,TLR10_SIG,TLR10,SIG,20,-3.51628366569177,0.0355978654706862,0.049958587271364,-0.0115873633029692,-0.0615459505743333,0.0011580295660892,-2.8067989177277,1.72214668433415,1.80346270417415,1.45496547628842,-0.348497227885731,0.0174252606674549,ENSG00000174123,TLR10,protein_coding,4,-1,38772238,38782990,p14,toll like receptor 10 [Source:HGNC Symbol;Acc:HGNC:15634],NA,TLR10,81793,NM_001017388;NM_001195106;NM_001195107;NM_001195108;NM_030956
THOC1_SIG,THOC1,THOC1_SIG,THOC1,SIG,52,3.51616449667002,0.368623784359071,0.361971275742781,0.390482026955451,0.0285107512126698,0.00115817958411087,2.78074022839864,5.4312588704298,5.39350127579327,5.55531953852128,0.161818262728008,0.0184971229023772,ENSG00000079134,THOC1,protein_coding,18,-1,214520,268050,p11.32,THO complex 1 [Source:HGNC Symbol;Acc:HGNC:19070],NA,THOC1,9984,NM_005131
ZNF182_TF,ZNF182,ZNF182_TF,ZNF182,TF,53,3.51590550554213,0.315992565963352,0.310141248731065,0.335218322583721,0.0250770738526554,0.00115893990105416,2.43511493339713,3.85224789297366,3.81927794308609,3.96057772831853,0.141299785232438,0.0406086901303696,ENSG00000147118,ZNF182,protein_coding,X,-1,47974851,48003978,p11.23,zinc finger protein 182 [Source:HGNC Symbol;Acc:HGNC:13001],NA,ZNF182,7569,NM_001007088;NM_001178099;NM_006962
ADD1_SIG,ADD1,ADD1_SIG,ADD1,SIG,11,3.51556938323698,0.387553003698935,0.383625722456117,0.400456927782481,0.0168312053263641,0.00116003768622257,1.74336636506279,8.27742150638919,8.26249317543727,8.32647173665981,0.0639785612225427,0.15179150736201,ENSG00000087274,ADD1,protein_coding,4,1,2843857,2930076,p16.3,adducin 1 [Source:HGNC Symbol;Acc:HGNC:243],HYPERTENSION ESSENTIAL,ADD1,118,NM_001119;NM_001286645;NM_001354754;NM_001354755;NM_001354756;NM_001354757;NM_001354758;NM_001354759;NM_001354761;NM_001354762;NM_014189;NM_014190;NM_176801
FBXW7_SIG,FBXW7,FBXW7_SIG,FBXW7,SIG,25,-3.51507078462598,0.305661320311053,0.316654601796726,0.2695405382867,-0.0471140635100257,0.00116184714623941,-2.51769085316691,5.67726234835698,5.71126160361622,5.56555050964802,-0.1457110939682,0.0339713538124931,ENSG00000109670,FBXW7,protein_coding,4,-1,152320544,152536092,q31.3,F-box and WD repeat domain containing 7 [Source:HGNC Symbol;Acc:HGNC:16712],NA,FBXW7,55294,NM_001013415;NM_001257069;NM_001349798;NM_018315;NM_033632
PIPOX_SIG,PIPOX,PIPOX_SIG,PIPOX,SIG,30,3.51255787295818,-0.059811229892097,-0.0651958229377071,-0.0421189955993778,0.0230768273383293,0.00117251596331195,0.194590029692623,1.304102429431,1.30065919577611,1.31541591143993,0.0147567156638209,0.890518652712762,ENSG00000179761,PIPOX,protein_coding,17,1,28950513,29057216,q11.2,pipecolic acid and sarcosine oxidase [Source:HGNC Symbol;Acc:HGNC:17804],NA,PIPOX,51268,NM_016518
TIMM13_SIG,TIMM13,TIMM13_SIG,TIMM13,SIG,28,3.51084470759485,0.200839253203058,0.187848306834668,0.243523791270625,0.0556754844359573,0.00117972182667055,3.76561646180378,5.04225394408249,4.97692401688989,5.25690941914392,0.279985402254039,0.00119574805197824,ENSG00000099800,TIMM13,protein_coding,19,-1,2425625,2427586,p13.3,translocase of inner mitochondrial membrane 13 [Source:HGNC Symbol;Acc:HGNC:11816],NA,TIMM13,26517,NM_012458
ACVR1C_SIG,ACVR1C,ACVR1C_SIG,ACVR1C,SIG,15,-3.50967318165274,-0.193432691716794,-0.175550600087645,-0.25218813564114,-0.076637535553495,0.0011845537643186,-1.82790713233572,0.626818559519199,0.655532390149061,0.532473116021084,-0.123059274127977,0.131763230704712,ENSG00000123612,ACVR1C,protein_coding,2,-1,157526767,157628864,q24.1,activin A receptor type 1C [Source:HGNC Symbol;Acc:HGNC:18123],NA,ACVR1C,130399,NM_001111031;NM_001111032;NM_001111033;NM_145259
CD2_SIG,CD2,CD2_SIG,CD2,SIG,14,-3.50945584341652,-0.0442956969729817,-0.0230027710918543,-0.114258167725258,-0.0912553966334033,0.00118514459862906,-1.28348477712816,3.07427878695538,3.12042792210598,2.92264591431769,-0.19778200778829,0.301731613723221,ENSG00000116824,CD2,protein_coding,1,1,116754430,116769229,p13.1,CD2 molecule [Source:HGNC Symbol;Acc:HGNC:1639],NA,CD2,914,NM_001328609;NM_001767
APOE_SIG,APOE,APOE_SIG,APOE,SIG,26,-3.50771146044178,-0.182491108045695,-0.168483218346579,-0.228517031342794,-0.060033812996215,0.00119256238218535,-2.7161050371038,1.97289795307939,2.08101545359747,1.6176547370914,-0.463360716506074,0.0215622794012427,ENSG00000130203,APOE,protein_coding,19,1,44905791,44909393,q13.32,apolipoprotein E [Source:HGNC Symbol;Acc:HGNC:613],Alzheimer disease 2;ALZHEIMER DISEASE 4;Hyperlipoproteinemia type 3;HYPERLIPOPROTEINEMIA TYPE III;LIPOPROTEIN GLOMERULOPATHY;MACULAR DEGENERATION AGE-RELATED 1;SEA-BLUE HISTIOCYTE DISEASE;Sea-blue histiocytosis,APOE,348,NM_000041;NM_001302688;NM_001302689;NM_001302690;NM_001302691
CDC20_SIG,CDC20,CDC20_SIG,CDC20,SIG,33,-3.50677453099203,-0.0503469464059245,-0.0203551708988496,-0.148891351643456,-0.128536180744607,0.00119638800669686,-2.79875984766276,3.28784764893894,3.39376243934483,2.93984190903388,-0.453920530310946,0.0177583984576495,ENSG00000117399,CDC20,protein_coding,1,1,43358981,43363203,p34.2,cell division cycle 20 [Source:HGNC Symbol;Acc:HGNC:1723],NA,CDC20,991,NM_001255
DLG2_SIG,DLG2,DLG2_SIG,DLG2,SIG,14,-3.50631902166657,-0.119858441755605,-0.11466381962728,-0.13692648589153,-0.0222626662642505,0.00119805608032874,-2.92916147479755,0.79786482215721,0.830305347044731,0.691274526098213,-0.139030820946518,0.0128997664803521,ENSG00000150672,DLG2,protein_coding,11,-1,83455012,85627922,q14.1,discs large MAGUK scaffold protein 2 [Source:HGNC Symbol;Acc:HGNC:2901],NA,DLG2,1740,NM_001142699;NM_001142700;NM_001142702;NM_001206769;NM_001300983;NM_001351274;NM_001351275;NM_001351276;NM_001364
JAK3_SIG,JAK3,JAK3_SIG,JAK3,SIG,27,-3.5058326477309,0.137499233019892,0.143608371070964,0.117426350852085,-0.0261820202188787,0.00119986548931086,-3.87462444822604,6.79016689480325,6.88439621037425,6.48055628649856,-0.403839923875683,0.000849181385787094,ENSG00000105639,JAK3,protein_coding,19,-1,17824780,17848071,p13.11,Janus kinase 3 [Source:HGNC Symbol;Acc:HGNC:6193],Severe Combined Immune Deficiency Autosomal Recessive T Cell-Negative B Cell -Positive NK Cell-Negative JAK3-Related;Severe combined immunodeficiency autosomal recessive T cell-negative B cell-positive NK cell-negative;T-B+ severe combined immunodeficiency due to JAK3 deficiency,JAK3,3718,NM_000215
GLUD2_SIG,GLUD2,GLUD2_SIG,GLUD2,SIG,44,3.50565003452476,0.444624766501846,0.438618878169937,0.464358399592405,0.0257395214224683,0.00120030703183427,2.19863234822168,4.91081461648068,4.88067019605085,5.00986056932156,0.129190373270714,0.0665947704616081,ENSG00000182890,GLUD2,protein_coding,X,1,121047588,121050080,q24,glutamate dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:4336],Parkinson disease late-onset,GLUD2,2747,NM_012084
RTCA_SIG,RTCA,RTCA_SIG,RTCA,SIG,10,3.50514913669977,0.337319795755048,0.333154020995979,0.351007341391991,0.017853320396012,0.00120218529871681,1.83987948364385,4.97385701739849,4.95775871790761,5.02675143001138,0.0689927121037696,0.128902045954755,ENSG00000137996,RTCA,protein_coding,1,1,100266207,100292769,p21.2,RNA 3'-terminal phosphate cyclase [Source:HGNC Symbol;Acc:HGNC:17981],NA,RTCA,8634,NM_001130841;NM_003729
ZNF438_TF,ZNF438,ZNF438_TF,ZNF438,TF,369,-3.50375549651012,-0.0387500531430134,-0.0300179985656741,-0.0674410896114139,-0.0374230910457399,0.00120810982490589,-2.85072159126528,4.1560396312083,4.22309311634563,3.93572103718565,-0.287372079159982,0.0156644678373868,ENSG00000183621,ZNF438,protein_coding,10,-1,30820207,31031937,p11.23,zinc finger protein 438 [Source:HGNC Symbol;Acc:HGNC:21029],NA,ZNF438,220929,NM_001143766;NM_001143767;NM_001143768;NM_001143769;NM_001143770;NM_001143771;NM_182755
ABL1_SIG,ABL1,ABL1_SIG,ABL1,SIG,28,3.5009182601478,0.336362437058502,0.329802665750116,0.357915971357482,0.0281133056073655,0.00122065674965919,2.88849970180089,6.46993339445827,6.43067394580571,6.59892872574525,0.168254779939541,0.0142785436113904,ENSG00000097007,ABL1,protein_coding,9,1,130713946,130887675,q34.12,ABL proto-oncogene 1, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:76],Chronic myeloid leukemia;Congenital heart defects and skeletal malformations;CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,ABL1,25,NM_005157;NM_007313
SCN11A_SIG,SCN11A,SCN11A_SIG,SCN11A,SIG,42,3.49962680453179,-0.0619523115046612,-0.0699952586597398,-0.0355254851379743,0.0344697735217653,0.00122619564910911,0.0304686076201831,0.531080106397947,0.530693375913827,0.532350792274342,0.00165741636051523,0.983271195441478,ENSG00000168356,SCN11A,protein_coding,3,-1,38845769,38950561,p22.2,sodium voltage-gated channel alpha subunit 11 [Source:HGNC Symbol;Acc:HGNC:10583],Channelopathy-associated congenital insensitivity to pain;congenital inability to experience pain;Episodic pain syndrome familial 3;Familial episodic pain syndrome with predominantly lower limb involvement;Hereditary sensory and autonomic neuropathy type 7;NEUROPATHY HEREDITARY SENSORY AND AUTONOMIC TYPE VII;PAROXYSMAL EXTREME PAIN DISORDER;Primary erythromelalgia;Sodium channelopathy-related small fiber neuropathy,SCN11A,11280,NM_001349253;NM_014139
CD68_SIG,CD68,CD68_SIG,CD68,SIG,38,-3.49868693965907,0.107946208505261,0.120587498815698,0.0664105403423973,-0.0541769584733007,0.0012301349146492,-1.65159758847682,0.721268827281129,0.745549712134026,0.641488777050181,-0.104060935083845,0.176055938665817,ENSG00000129226,CD68,protein_coding,17,1,7579491,7582111,p13.1,CD68 molecule [Source:HGNC Symbol;Acc:HGNC:1693],NA,CD68,968,NM_001040059;NM_001251
PNMA1_SIG,PNMA1,PNMA1_SIG,PNMA1,SIG,29,3.49817959766714,0.082391431940784,0.0750563586417165,0.106492387066292,0.0314360284245752,0.00123208619738581,0.353302933145078,5.20643607365755,5.1987282875514,5.23176165657774,0.0330333690263407,0.795554241165786,ENSG00000176903,PNMA1,protein_coding,14,-1,73711783,73714372,q24.3,PNMA family member 1 [Source:HGNC Symbol;Acc:HGNC:9158],NA,PNMA1,9240,NM_006029
SETDB2_SIG,SETDB2,SETDB2_SIG,SETDB2,SIG,29,3.49554325585523,0.397827983273256,0.383418295093055,0.445174101579631,0.0617558064865769,0.00124392731584959,2.77885800146737,5.54144549784437,5.4795232223832,5.74490440293106,0.265381180547856,0.0185879841846289,ENSG00000136169,SETDB2,protein_coding,13,1,49444374,49495003,q14.2,SET domain bifurcated histone lysine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:20263],NA,SETDB2,83852,NM_001160308;NM_001320699;NM_031915
POP5_SIG,POP5,POP5_SIG,POP5,SIG,52,3.49506949827182,0.250949107914512,0.238475020344677,0.291935395643971,0.0534603752992943,0.00124574209023323,2.34208223684313,3.7077223583416,3.66215969809147,3.85742824202058,0.195268543929111,0.0496038362888488,ENSG00000167272,POP5,protein_coding,12,-1,120578764,120581398,q24.31,POP5 homolog, ribonuclease P/MRP subunit [Source:HGNC Symbol;Acc:HGNC:17689],NA,POP5,51367,NM_015918;NM_198202
MESP1_TF,MESP1,MESP1_TF,MESP1,TF,125,3.4944073838225,0.0255296870802241,0.0215666430491663,0.0385511174679852,0.0169844744188189,0.00124843999181101,1.44518185898436,0.541728022430364,0.527943712490511,0.587019326518453,0.0590756140279424,0.240247134978531,ENSG00000166823,MESP1,protein_coding,15,-1,89748661,89751310,q26.1,mesoderm posterior bHLH transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:29658],NA,MESP1,55897,NM_018670
SLC6A12_SIG,SLC6A12,SLC6A12_SIG,SLC6A12,SIG,13,-3.49368870419585,0.0526148844242483,0.0909318068806775,-0.0732835750754477,-0.164215381956125,0.00125140844391507,-2.16952656648529,1.09230320174742,1.15478770308713,0.886996983059783,-0.267790720027351,0.0703866780252769,ENSG00000111181,SLC6A12,protein_coding,12,-1,190077,214570,p13.33,solute carrier family 6 member 12 [Source:HGNC Symbol;Acc:HGNC:11045],NA,SLC6A12,6539,NM_001122847;NM_001122848;NM_001206931;NM_003044
ACHE_SIG,ACHE,ACHE_SIG,ACHE,SIG,21,-3.49181960790375,-0.255907742167401,-0.225704982253339,-0.355145381885032,-0.129440399631693,0.00125979827031399,-3.15181962358879,1.00233317570631,1.10689416644264,0.658775634715486,-0.448118531727156,0.00723014840120746,ENSG00000087085,ACHE,protein_coding,7,-1,100889994,100896974,q22.1,acetylcholinesterase (Cartwright blood group) [Source:HGNC Symbol;Acc:HGNC:108],YT BLOOD GROUP ANTIGEN,ACHE,43,NM_000665;NM_001282449;NM_001302621;NM_001302622;NM_001367915;NM_001367917
SLC9A3R2_SIG,SLC9A3R2,SLC9A3R2_SIG,SLC9A3R2,SIG,96,3.4904523961769,0.0218272937086543,0.0163902220367119,0.0396919577736079,0.023301735736896,0.00126586061209908,2.68002444279067,2.93691026111092,2.82604238805417,3.30119041544024,0.475148027386073,0.0234704244915371,ENSG00000065054,SLC9A3R2,protein_coding,16,1,2025356,2039026,p13.3,SLC9A3 regulator 2 [Source:HGNC Symbol;Acc:HGNC:11076],NA,SLC9A3R2,9351,NM_001130012;NM_001252073;NM_001252075;NM_001252076;NM_004785
PIGO_SIG,PIGO,PIGO_SIG,PIGO,SIG,22,3.48935201020489,0.18765690468954,0.177663400516867,0.220492704114039,0.0428293035971715,0.00127068091561889,3.49230448092515,4.5871942986526,4.54205004501131,4.73552541775971,0.1934753727484,0.00276115389874868,ENSG00000165282,PIGO,protein_coding,9,-1,35088688,35096601,p13.3,phosphatidylinositol glycan anchor biosynthesis class O [Source:HGNC Symbol;Acc:HGNC:23215],Hyperphosphatasia-intellectual disability syndrome;HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2,PIGO,84720,NM_001201484;NM_032634;NM_152850
ZEB2_TF,ZEB2,ZEB2_TF,ZEB2,TF,241,-3.48881039699139,0.0910115264622733,0.0980080286778609,0.0680230191824853,-0.0299850094953758,0.00127279879415582,-3.32985478607409,8.08904573274829,8.14602424540774,7.90183061972437,-0.244193625683372,0.00441650640667604,ENSG00000169554,ZEB2,protein_coding,2,-1,144364364,144524583,q22.3,zinc finger E-box binding homeobox 2 [Source:HGNC Symbol;Acc:HGNC:14881],MOWAT-WILSON SYNDROME;Mowat-Wilson syndrome due to a ZEB2 point mutation;Mowat-Wilson syndrome due to monosomy 2q22,ZEB2,9839,NM_001171653;NM_014795
ZNF684_TF,ZNF684,ZNF684_TF,ZNF684,TF,16,3.48873757169231,0.195593720208203,0.191990568356831,0.207432647719855,0.0154420793630241,0.00127279879415582,2.49493403484617,2.35577453489135,2.32877007193678,2.44450348459923,0.11573341266245,0.0357025496567272,ENSG00000117010,ZNF684,protein_coding,1,1,40531573,40548167,p34.2,zinc finger protein 684 [Source:HGNC Symbol;Acc:HGNC:28418],NA,ZNF684,127396,NM_152373
MKRN3_SIG,MKRN3,MKRN3_SIG,MKRN3,SIG,13,3.4885417919699,-0.0427123438552314,-0.0470749603361648,-0.0283780325607361,0.0186969277754287,0.00127332818915447,0.995434303261887,1.16404396531128,1.12695820408744,1.28589718076101,0.158938976673567,0.432784160345254,ENSG00000179455,MKRN3,protein_coding,15,1,23565674,23630075,q11.2,makorin ring finger protein 3 [Source:HGNC Symbol;Acc:HGNC:7114],Idiopathic central precocious puberty;PRADER-WILLI SYNDROME;Precocious puberty central 2,MKRN3,7681,NM_005664
ABHD17A_SIG,ABHD17A,ABHD17A_SIG,ABHD17A,SIG,23,-3.48830377132547,0.143670176037051,0.151690042177255,0.117319187290667,-0.0343708548865887,0.00127405916776489,-3.92366857369946,5.683741108498,5.73546771456934,5.51378225997787,-0.221685454591472,0.000725284256400585,ENSG00000129968,ABHD17A,protein_coding,19,-1,1876810,1885547,p13.3,abhydrolase domain containing 17A [Source:HGNC Symbol;Acc:HGNC:28756],NA,ABHD17A,81926,NM_001130111;NM_031213
DKC1_SIG,DKC1,DKC1_SIG,DKC1,SIG,46,3.4880864983357,0.597341471296575,0.586568717683852,0.632737661738381,0.0461689440545289,0.00127469170648081,3.11965427982277,6.39031441285846,6.34140321620235,6.55102263044285,0.209619414240501,0.00790771692480512,ENSG00000130826,DKC1,protein_coding,X,1,154762742,154777689,q28,dyskerin pseudouridine synthase 1 [Source:HGNC Symbol;Acc:HGNC:2890],DKC1-Related Dyskeratosis Congenita;Dyskeratosis congenita;DYSKERATOSIS CONGENITA X-LINKED;HOYERAAL-HREIDARSSON SYNDROME,DKC1,1736,NM_001142463;NM_001288747;NM_001363
RRP12_SIG,RRP12,RRP12_SIG,RRP12,SIG,26,-3.48788373187933,-0.0448579174585264,-0.0400313583185525,-0.0607166117755836,-0.020685253457031,0.00127525544063625,-2.63963877672312,6.12977478441906,6.18972545515038,5.93279400915903,-0.256931445991346,0.0256758235353725,ENSG00000052749,RRP12,protein_coding,10,-1,97356358,97426076,q24.1,ribosomal RNA processing 12 homolog [Source:HGNC Symbol;Acc:HGNC:29100],NA,RRP12,23223,NM_001145114;NM_001284337;NM_015179
ZNRF2_SIG,ZNRF2,ZNRF2_SIG,ZNRF2,SIG,14,-3.48631667077281,0.108371319295194,0.114502313616473,0.0882266236681344,-0.0262756899483382,0.00128210983716236,-1.95966659797938,5.14808443110854,5.17194491425763,5.06968570076155,-0.102259213496075,0.104503757184524,ENSG00000180233,ZNRF2,protein_coding,7,1,30284597,30367689,p14.3,zinc and ring finger 2 [Source:HGNC Symbol;Acc:HGNC:22316],NA,ZNRF2,223082,NM_147128
IFNG_SIG,IFNG,IFNG_SIG,IFNG,SIG,15,-3.48628108408853,-0.123807235417938,-0.113471037419654,-0.157769028840871,-0.044297991421217,0.00128210983716236,-1.99777087978577,0.927442975074668,0.976434697103797,0.766470174121815,-0.209964522981982,0.0974620980717472,ENSG00000111537,IFNG,protein_coding,12,-1,68154768,68159740,q15,interferon gamma [Source:HGNC Symbol;Acc:HGNC:5438],APLASTIC ANEMIA APLASTIC ANEMIA SUSCEPTIBILITY TO INCLUDED;HEPATITIS C VIRUS SUSCEPTIBILITY TO;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;Idiopathic aplastic anemia;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED;Tuberous sclerosis 2,IFNG,3458,NM_000619
LCMT1_SIG,LCMT1,LCMT1_SIG,LCMT1,SIG,25,3.48589229080366,0.23769110954196,0.22795794558462,0.26967150540179,0.0417135598171705,0.00128356907885458,2.5399756654248,4.04683840953055,4.02099881144923,4.13173994608349,0.110741134634261,0.0323707195489715,ENSG00000205629,LCMT1,protein_coding,16,1,25111731,25178231,p12.1,leucine carboxyl methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:17557],NA,LCMT1,51451,NM_001032391;NM_016309
DTD2_SIG,DTD2,DTD2_SIG,DTD2,SIG,89,3.48526864745211,0.211548217608399,0.194605465615646,0.267217259870305,0.0726117942546589,0.0012861583931793,2.85456685525978,3.02839035641741,2.96918370948839,3.22292648204134,0.253742772552951,0.0155126283697885,ENSG00000129480,DTD2,protein_coding,14,-1,31446036,31457506,q12,D-tyrosyl-tRNA deacylase 2 (putative) [Source:HGNC Symbol;Acc:HGNC:20277],NA,DTD2,112487,NM_080664
ZNF236_TF,ZNF236,ZNF236_TF,ZNF236,TF,66,3.48485887332114,0.390772580367315,0.386078522263561,0.406195914136795,0.0201173918732339,0.00128772298566037,3.58445434151575,4.88743297808474,4.85140455243327,5.00581209093957,0.154407538506294,0.00209569048609327,ENSG00000130856,ZNF236,protein_coding,18,1,76822607,76970727,q23,zinc finger protein 236 [Source:HGNC Symbol;Acc:HGNC:13028],NA,ZNF236,7776,NM_001306089;NM_007345
NKRF_SIG,NKRF,NKRF_SIG,NKRF,SIG,46,3.48444012760147,0.228772319242281,0.223109796721155,0.24737775038312,0.0242679536619645,0.00128933262913928,2.74732226780469,4.39431674843678,4.35613430054416,4.5197733629411,0.163639062396944,0.0200370877940667,ENSG00000186416,NKRF,protein_coding,X,-1,119588337,119606443,q24,NFKB repressing factor [Source:HGNC Symbol;Acc:HGNC:19374],NA,NKRF,55922,NM_001173487;NM_001173488;NM_017544
TCFL5_TF,TCFL5,TCFL5_TF,TCFL5,TF,85,3.48328417611301,0.0129544715703335,0.00827408023325168,0.0283329002493167,0.020058820016065,0.00129450459900561,3.23273531215199,3.74590230467278,3.69405302114892,3.9162642362512,0.222211215102281,0.00579244911715788,ENSG00000101190,TCFL5,protein_coding,20,-1,62841115,62861763,q13.33,transcription factor like 5 [Source:HGNC Symbol;Acc:HGNC:11646],NA,TCFL5,10732,NM_001301726;NM_006602
RNASE3_SIG,RNASE3,RNASE3_SIG,RNASE3,SIG,42,-3.4828615591152,0.295341384418104,0.315214431987222,0.230044228119572,-0.0851702038676494,0.001296140914045,-3.25778012599372,5.36739686545521,5.56995680104087,4.70184279138804,-0.868114009652823,0.00540650792159811,ENSG00000169397,RNASE3,protein_coding,14,1,20891399,20892348,q11.2,ribonuclease A family member 3 [Source:HGNC Symbol;Acc:HGNC:10046],NA,RNASE3,6037,NM_002935
SAFB_TF,SAFB,SAFB_TF,SAFB,TF,75,3.48214815149558,0.440511997947736,0.43621401767366,0.454633933133988,0.0184199154603285,0.0012990977941341,4.30793700852663,6.96950383564187,6.9274927283257,7.10754033110927,0.180047602783574,0.000198794451845876,ENSG00000160633,SAFB,protein_coding,19,1,5623035,5668478,p13.3,scaffold attachment factor B [Source:HGNC Symbol;Acc:HGNC:10520],NA,SAFB,6294,NM_001201338;NM_001201339;NM_001201340;NM_001320571;NM_001320572;NM_002967
ATP8B2_SIG,ATP8B2,ATP8B2_SIG,ATP8B2,SIG,141,3.48204615908279,0.130003067729365,0.120595561453212,0.160913445493871,0.0403178840406592,0.0012990977941341,2.7346188546398,5.85503206508449,5.77184742531553,6.12835302432535,0.356505599009824,0.0206460444673236,ENSG00000143515,ATP8B2,protein_coding,1,1,154325553,154351304,q21.3,ATPase phospholipid transporting 8B2 [Source:HGNC Symbol;Acc:HGNC:13534],NA,ATP8B2,57198,NM_001005855;NM_001367934;NM_020452
USP31_SIG,USP31,USP31_SIG,USP31,SIG,43,3.48199824598289,0.0578219838408337,0.0521437238763291,0.0764791237242059,0.0243353998478768,0.0012990977941341,2.36571303952803,3.66416019139837,3.62072705909802,3.80686905467095,0.186141995572937,0.0471519331949765,ENSG00000103404,USP31,protein_coding,16,-1,23061406,23149270,p12.2,ubiquitin specific peptidase 31 [Source:HGNC Symbol;Acc:HGNC:20060],NA,USP31,57478,NM_020718
GTPBP2_SIG,GTPBP2,GTPBP2_SIG,GTPBP2,SIG,7,-3.48166731338392,0.264364771682203,0.268462917929805,0.25089943401151,-0.0175634839182948,0.00130029452681332,-3.53928429150376,6.1823539879383,6.22009446053775,6.0583495779687,-0.161744882569043,0.00240233694540163,ENSG00000172432,GTPBP2,protein_coding,6,-1,43605316,43629264,p21.1,GTP binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4670],JABERI-ELAHI SYNDROME,GTPBP2,54676,NM_001286216;NM_019096
GLO1_SIG,GLO1,GLO1_SIG,GLO1,SIG,10,3.48136855699825,0.369053563524754,0.362215676218082,0.39152090753239,0.0293052313143084,0.00130133600497128,1.58901277674419,6.19575574768212,6.17363128101549,6.26845042387246,0.0948191428569628,0.193779896570607,ENSG00000124767,GLO1,protein_coding,6,-1,38675925,38703145,p21.2,glyoxalase I [Source:HGNC Symbol;Acc:HGNC:4323],NA,GLO1,2739,NM_006708
EARS2_SIG,EARS2,EARS2_SIG,EARS2,SIG,54,3.48109941484309,0.556820025308725,0.541256772290517,0.607956428082834,0.0666996557923166,0.00130223434550011,3.20081636985538,3.73298453673937,3.66362530413394,3.9608791581572,0.29725385402326,0.00633513340007535,ENSG00000103356,EARS2,protein_coding,16,-1,23522014,23557731,p12.2,glutamyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:29419],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12;Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,EARS2,124454,NM_001083614;NM_001308211
PDCD7_SIG,PDCD7,PDCD7_SIG,PDCD7,SIG,39,3.48078250103155,0.476902968783636,0.46593306470096,0.512946939341001,0.0470138746400409,0.00130336577522236,1.95025631934646,4.8214802201125,4.79159566309827,4.91967233601639,0.128076672918116,0.106385966114189,ENSG00000090470,PDCD7,protein_coding,15,-1,65117379,65133808,q22.31,programmed cell death 7 [Source:HGNC Symbol;Acc:HGNC:8767],NA,PDCD7,10081,NM_005707
RPL17_SIG,RPL17,RPL17_SIG,RPL17,SIG,33,3.48055981895215,0.292974672587919,0.284928219499132,0.319413018451076,0.0344847989519439,0.00130403939264639,1.88071654123063,4.75521431619735,4.72636420579064,4.85000753610509,0.123643330314442,0.120310729693058,ENSG00000265681,RPL17,protein_coding,18,-1,49488453,49492523,q21.1,ribosomal protein L17 [Source:HGNC Symbol;Acc:HGNC:10307],NA,RPL17,6139,NM_000985;NM_001035006;NM_001199340;NM_001199341;NM_001199342;NM_001199343;NM_001199344;NM_001199345
HLA-G_SIG,HLA-G,HLA-G_SIG,HLA-G,SIG,7,-3.48026419077232,0.618177351557022,0.628475786112822,0.584339638016538,-0.0441361480962841,0.001304805784661,-2.37985024197014,3.74567623733362,3.8058348099906,3.54801235574641,-0.257822454244194,0.0457894678493505,ENSG00000204632,HLA-G,protein_coding,6,1,29826967,29831125,p22.1,major histocompatibility complex, class I, G [Source:HGNC Symbol;Acc:HGNC:4964],ASTHMA SUSCEPTIBILITY TO,HLA-G,3135,NM_001363567;NM_002127
LAMA5_SIG,LAMA5,LAMA5_SIG,LAMA5,SIG,25,3.48023394321448,-0.0929560254636257,-0.0969070240500292,-0.0799741729654429,0.0169328510845864,0.001304805784661,0.29347249723522,2.76994648664953,2.75922362115508,2.80517875898847,0.0459551378333889,0.831691769884667,ENSG00000130702,LAMA5,protein_coding,20,-1,62307955,62367312,q13.33,laminin subunit alpha 5 [Source:HGNC Symbol;Acc:HGNC:6485],LAMA5-related multisystemic syndrome,LAMA5,3911,NM_005560
IL1R1_SIG,IL1R1,IL1R1_SIG,IL1R1,SIG,21,-3.47934256807335,0.0740143758450153,0.0884905740090244,0.0264497247346996,-0.0620408492743248,0.00130874256111245,3.27723663717473,3.43292491169788,3.27353076974711,3.95664852096468,0.683117751217568,0.00511991168223725,ENSG00000115594,IL1R1,protein_coding,2,1,102064544,102179874,q11.2,interleukin 1 receptor type 1 [Source:HGNC Symbol;Acc:HGNC:5993],NA,IL1R1,3554,NM_000877;NM_001288706;NM_001320978;NM_001320980;NM_001320981;NM_001320982;NM_001320983;NM_001320984;NM_001320985;NM_001320986
ZBED3_TF,ZBED3,ZBED3_TF,ZBED3,TF,98,3.47908451174993,0.209220984289806,0.200297857731318,0.238539828696266,0.0382419709649477,0.00130959194157406,3.220785319241,4.92014595301158,4.81527833435254,5.26471098574843,0.449432651395893,0.00599851886313532,ENSG00000132846,ZBED3,protein_coding,5,-1,77072072,77087285,q13.3,zinc finger BED-type containing 3 [Source:HGNC Symbol;Acc:HGNC:20711],NA,ZBED3,84327,NM_001329564;NM_032367
FBXO22_SIG,FBXO22,FBXO22_SIG,FBXO22,SIG,43,3.47758323472769,0.38212206257558,0.368842074380438,0.425756309502472,0.0569142351220332,0.00131653420955153,3.62752953182966,3.87089795470501,3.80855187165097,4.075749370454,0.267197498803025,0.00183486096307279,ENSG00000167196,FBXO22,protein_coding,15,1,75903876,75942511,q24.2,F-box protein 22 [Source:HGNC Symbol;Acc:HGNC:13593],NA,FBXO22,26263,NM_012170;NM_147188
DNM2_SIG,DNM2,DNM2_SIG,DNM2,SIG,9,-3.47712766377097,0.210864752301878,0.216510838560065,0.19231332602498,-0.0241975125350844,0.00131835923890015,-1.37224747632766,7.79370101097116,7.803952036135,7.76001907114708,-0.0439329649879251,0.267151583066925,ENSG00000079805,DNM2,protein_coding,19,1,10718079,10833488,p13.2,dynamin 2 [Source:HGNC Symbol;Acc:HGNC:2974],Autosomal dominant centronuclear myopathy;Autosomal dominant Charcot-Marie-Tooth disease type 2M;Autosomal dominant intermediate Charcot-Marie-Tooth disease type B;CHARCOT-MARIE-TOOTH DISEASE DOMINANT INTERMEDIATE B;Fetal akinesia-cerebral and retinal hemorrhage syndrome;Lethal congenital contracture syndrome 5;MYOPATHY CENTRONUCLEAR 1,DNM2,1785,NM_001005360;NM_001005361;NM_001005362;NM_001190716;NM_004945
MTAP_SIG,MTAP,MTAP_SIG,MTAP,SIG,11,3.47535793937185,0.265595698469509,0.251120565396206,0.313156849996073,0.062036284599867,0.00132667170792217,2.7116665408856,4.2540615029069,4.19369169056133,4.45241945775664,0.258727767195311,0.0218063551611652,ENSG00000099810,MTAP,protein_coding,9,1,21802543,21937651,p21.3,methylthioadenosine phosphorylase [Source:HGNC Symbol;Acc:HGNC:7413],Diaphyseal medullary stenosis-bone malignancy syndrome;Diaphyseal medullary stenosis with malignant fibrous histiocytoma,MTAP,4507,NM_002451
TAF6_TF,TAF6,TAF6_TF,TAF6,TF,173,3.47436513151037,0.308777765870549,0.302440323166,0.329600791899783,0.0271604687337829,0.00133117283970682,2.72585961835344,5.29878303414804,5.2623735407128,5.41841422686384,0.156040686151037,0.0210654314025762,ENSG00000106290,TAF6,protein_coding,7,-1,100107070,100119841,q22.1,TATA-box binding protein associated factor 6 [Source:HGNC Symbol;Acc:HGNC:11540],ALAZAMI-YUAN SYNDROME,TAF6,6878,NM_001190415;NM_005641;NM_139315
MRPL4_SIG,MRPL4,MRPL4_SIG,MRPL4,SIG,44,3.47420681379116,0.542894317130095,0.532986129184057,0.575449791809934,0.0424636626258775,0.00133154075781198,4.11709417514682,5.26423012756118,5.20662074920803,5.45351808500725,0.246897335799218,0.000383293291511741,ENSG00000105364,MRPL4,protein_coding,19,1,10251901,10260045,p13.2,mitochondrial ribosomal protein L4 [Source:HGNC Symbol;Acc:HGNC:14276],NA,MRPL4,51073,NM_015956;NM_146387;NM_146388
GLIS3_TF,GLIS3,GLIS3_TF,GLIS3,TF,108,-3.47384901407791,-0.0556855877802767,-0.0527991769743662,-0.0651695089996968,-0.0123703320253305,0.00133289943399104,-2.07184485260129,0.947715007798164,1.01058073472557,0.74115619075099,-0.269424543974575,0.0847584212629946,ENSG00000107249,GLIS3,protein_coding,9,-1,3824127,4348392,p24.2,GLIS family zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:28510],DIABETES MELLITUS NEONATAL WITH CONGENITAL HYPOTHYROIDISM;Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,GLIS3,169792,NM_001042413;NM_152629
ATP6V0B_SIG,ATP6V0B,ATP6V0B_SIG,ATP6V0B,SIG,38,-3.47338442154444,0.0938981864186576,0.101208737964903,0.0698778027667081,-0.0313309351981951,0.00133479053748818,-1.36614423540457,6.93816236654286,6.95813697527864,6.87253150926816,-0.0856054660104872,0.269462956059766,ENSG00000117410,ATP6V0B,protein_coding,1,1,43974487,43978295,p34.1,ATPase H+ transporting V0 subunit b [Source:HGNC Symbol;Acc:HGNC:861],NA,ATP6V0B,533,NM_001039457;NM_001294333;NM_004047
MANBAL_SIG,MANBAL,MANBAL_SIG,MANBAL,SIG,46,3.47267724665918,0.222746322867258,0.214672372433021,0.249275017151178,0.0346026447181569,0.00133788078697808,3.21378937229208,3.37349731131976,3.32591310263287,3.52984542557667,0.203932322943804,0.00611768798849949,ENSG00000101363,MANBAL,protein_coding,20,1,37289638,37317260,q11.23,mannosidase beta like [Source:HGNC Symbol;Acc:HGNC:15799],NA,MANBAL,63905,NM_001003897;NM_022077
IRF1_TF,IRF1,IRF1_TF,IRF1,TF,96,-3.47259555925055,0.0889183535251096,0.0948839749608387,0.0693170259505713,-0.0255669490102674,0.00133788078697808,-1.34711033635532,7.11395847400578,7.14678198294888,7.00610980176415,-0.140672181184736,0.276443748669495,ENSG00000125347,IRF1,protein_coding,5,-1,132481609,132490777,q31.1,interferon regulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:6116],GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,IRF1,3659,NM_001354924;NM_001354925;NM_002198
PRDX2_SIG,PRDX2,PRDX2_SIG,PRDX2,SIG,31,-3.47202491492646,-0.0889660375542616,-0.0778945383113542,-0.125343820780957,-0.0474492824696028,0.00134030800169429,-1.78178929201145,5.22053778038054,5.29480155756696,4.97652822676798,-0.31827333079898,0.142509433642618,ENSG00000167815,PRDX2,protein_coding,19,-1,12796820,12801800,p13.13,peroxiredoxin 2 [Source:HGNC Symbol;Acc:HGNC:9353],NA,PRDX2,7001,NM_005809
DOLPP1_SIG,DOLPP1,DOLPP1_SIG,DOLPP1,SIG,32,3.47159672875164,0.205068367520393,0.193784651898264,0.24214343313596,0.048358781237696,0.001342027081598,3.63168195265718,3.61098961704704,3.54037503260315,3.84300896593413,0.302633933330985,0.00181190276272835,ENSG00000167130,DOLPP1,protein_coding,9,1,129081111,129090438,q34.11,dolichyldiphosphatase 1 [Source:HGNC Symbol;Acc:HGNC:29565],NA,DOLPP1,57171,NM_001135917;NM_020438
GPBAR1_SIG,GPBAR1,GPBAR1_SIG,GPBAR1,SIG,21,-3.47117748927842,0.0866174503274431,0.122914941484989,-0.0326457349044919,-0.15556067638948,0.00134370349374056,-3.14644011769089,2.18954662107822,2.31867510697794,1.76526731026485,-0.553407796713092,0.00733902605816532,ENSG00000179921,GPBAR1,protein_coding,2,1,218259496,218263861,q35,G protein-coupled bile acid receptor 1 [Source:HGNC Symbol;Acc:HGNC:19680],NA,GPBAR1,151306,NM_001077191;NM_001077194;NM_001321950;NM_170699
PARP2_SIG,PARP2,PARP2_SIG,PARP2,SIG,24,3.4704672966538,0.365959024982292,0.359437226168948,0.387387792511851,0.0279505663429027,0.00134639024141322,3.18677026268322,4.51536834438246,4.46860462142154,4.66902057696834,0.200415955546807,0.00658565262352921,ENSG00000129484,PARP2,protein_coding,14,1,20343582,20357905,q11.2,poly(ADP-ribose) polymerase 2 [Source:HGNC Symbol;Acc:HGNC:272],NA,PARP2,10038,NM_001042618;NM_005484
NPW_SIG,NPW,NPW_SIG,NPW,SIG,28,3.47044643101777,0.0228954483341118,0.0150585641761993,0.048645210567253,0.0335866463910537,0.00134639024141322,1.9470519211591,2.05328584135863,1.99103994091461,2.25780808567467,0.266768144760054,0.107003780358924,ENSG00000183971,NPW,protein_coding,16,1,2009926,2020755,p13.3,neuropeptide W [Source:HGNC Symbol;Acc:HGNC:30509],NA,NPW,283869,NM_001099456
USP22_SIG,USP22,USP22_SIG,USP22,SIG,40,3.47038904690864,0.422841815342124,0.417608194677082,0.44003799752726,0.0224298028501777,0.00134639024141322,2.38364585715599,7.9743970555944,7.93800114680631,8.09398361304095,0.155982466234636,0.0453935420463751,ENSG00000124422,USP22,protein_coding,17,-1,20999596,21043760,p11.2,ubiquitin specific peptidase 22 [Source:HGNC Symbol;Acc:HGNC:12621],NA,USP22,23326,NM_015276
ZNF518A_TF,ZNF518A,ZNF518A_TF,ZNF518A,TF,72,3.46729662386756,0.260630778256362,0.252321478857601,0.287932761995148,0.0356112831375468,0.00136155105038996,2.36419682550676,5.86074876904283,5.81853045267065,5.99946609426568,0.180935641595023,0.0473067653494892,ENSG00000177853,ZNF518A,protein_coding,10,1,96129715,96205288,q24.1,zinc finger protein 518A [Source:HGNC Symbol;Acc:HGNC:29009],NA,ZNF518A,9849,NM_001278524;NM_001278525;NM_001278526;NM_001330732;NM_001330733;NM_001330734;NM_001330735;NM_001330736;NM_001330737;NM_001330738;NM_014803
EBF3_TF,EBF3,EBF3_TF,EBF3,TF,272,-3.4662671884524,-0.0866431876409252,-0.0826907785481576,-0.0996296746600187,-0.0169388961118612,0.00136634809784904,0.55545473373315,0.487912570511073,0.471681971663402,0.541241681010566,0.0695597093471641,0.677699909282073,ENSG00000108001,EBF3,protein_coding,10,-1,129835283,129963841,q26.3,EBF transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:19087],HYPOTONIA ATAXIA AND DELAYED DEVELOPMENT SYNDROME;Intellectual Disability Ataxia and Facial Dysmorphism,EBF3,253738,NM_001005463
CBL_SIG,CBL,CBL_SIG,CBL,SIG,31,-3.46616315797647,0.595646672817585,0.602477211376231,0.573203474696319,-0.0292737366799126,0.0013664498873169,-1.59349654577637,7.25657296868499,7.28581688424675,7.16048581755349,-0.12533106669326,0.19247286117035,ENSG00000110395,CBL,protein_coding,11,1,119206276,119313926,q23.3,Cbl proto-oncogene [Source:HGNC Symbol;Acc:HGNC:1541],Juvenile myelomonocytic leukemia;Noonan syndrome-like disorder with juvenile myelomonocytic leukemia;Noonan syndrome-like disorder with or without juvenile meylomonocytic leukemia;Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,CBL,867,NM_005188
U2SURP_SIG,U2SURP,U2SURP_SIG,U2SURP,SIG,37,3.46584826748698,0.461474895899385,0.45624515881372,0.478658317752287,0.0224131589385677,0.00136762394380866,2.52207466199318,7.37857996076027,7.35327314833532,7.46173091587082,0.108457767535501,0.033686652045865,ENSG00000163714,U2SURP,protein_coding,3,1,142964497,143060546,q23,U2 snRNP associated SURP domain containing [Source:HGNC Symbol;Acc:HGNC:30855],NA,U2SURP,23350,NM_001080415;NM_001320219;NM_001320220;NM_001320222
ZNFX1_SIG,ZNFX1,ZNFX1_SIG,ZNFX1,SIG,45,-3.46533009525221,0.194522574109069,0.20435047272042,0.162230907243202,-0.042119565477218,0.00136983417033021,-2.81276288374974,6.37296348983553,6.42417746563184,6.20468899793338,-0.219488467698455,0.0171593158617029,ENSG00000124201,ZNFX1,protein_coding,20,-1,49237946,49278426,q13.13,zinc finger NFX1-type containing 1 [Source:HGNC Symbol;Acc:HGNC:29271],NA,ZNFX1,57169,NM_021035
DPH5_SIG,DPH5,DPH5_SIG,DPH5,SIG,42,3.46465442515196,0.356721217237619,0.347376394388055,0.387425635171899,0.0400492407838438,0.00137285146219526,2.07199095822059,4.33579596740395,4.29947783647535,4.4551269690265,0.15564913255115,0.0847364624623586,ENSG00000117543,DPH5,protein_coding,1,-1,100989623,101026088,p21.2,diphthamide biosynthesis 5 [Source:HGNC Symbol;Acc:HGNC:24270],NA,DPH5,51611,NM_001077394;NM_001077395;NM_015958
RRAGB_SIG,RRAGB,RRAGB_SIG,RRAGB,SIG,24,3.46382132770238,0.203417885124341,0.193777442805305,0.235093624172603,0.0413161813672975,0.00137668035988544,-0.586341420151435,4.13445452750603,4.14389970925868,4.10342035889017,-0.0404793503685088,0.659500985233805,ENSG00000083750,RRAGB,protein_coding,X,1,55717739,55758774,p11.21,Ras related GTP binding B [Source:HGNC Symbol;Acc:HGNC:19901],NA,RRAGB,10325,NM_001354011;NM_001354013;NM_006064;NM_016656
NDUFA4L2_SIG,NDUFA4L2,NDUFA4L2_SIG,NDUFA4L2,SIG,4,3.46363279627753,-0.0690340678392899,-0.074276902922661,-0.0518076097082135,0.0224692932144475,0.001377215779269,-0.742458210457524,0.31716011069149,0.324312349155844,0.293659898594328,-0.0306524505615163,0.567651294406451,ENSG00000185633,NDUFA4L2,protein_coding,12,-1,57234903,57240715,q13.3,NDUFA4, mitochondrial complex associated like 2 [Source:HGNC Symbol;Acc:HGNC:29836],NA,NDUFA4L2,56901,NM_020142
PIK3CG_SIG,PIK3CG,PIK3CG_SIG,PIK3CG,SIG,28,-3.46352031938429,0.184954546081066,0.188822426210202,0.172245797085332,-0.0165766291248695,0.00137736207011089,-1.07088294761891,6.19169266076755,6.21256413008418,6.12311497587005,-0.0894491542141278,0.396262471278884,ENSG00000105851,PIK3CG,protein_coding,7,1,106865278,106908980,q22.3,phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [Source:HGNC Symbol;Acc:HGNC:8978],NA,PIK3CG,5294,NM_001282426;NM_001282427;NM_002649
SGMS1_SIG,SGMS1,SGMS1_SIG,SGMS1,SIG,35,-3.46175417046737,0.0267375791250701,0.033152452649391,0.00566013754515841,-0.0274923151042325,0.00138599968107776,-1.69461037863238,4.34382590836668,4.3769605215251,4.23495503656044,-0.142005484964655,0.164567615031924,ENSG00000198964,SGMS1,protein_coding,10,-1,50305586,50625163,q11.23,sphingomyelin synthase 1 [Source:HGNC Symbol;Acc:HGNC:29799],NA,SGMS1,259230,NM_147156
GALNT1_SIG,GALNT1,GALNT1_SIG,GALNT1,SIG,38,3.46081077840996,0.251335432954648,0.24349729153104,0.277089326203647,0.0335920346726079,0.00139043215503249,0.507581995046316,6.9635769326707,6.95634482624283,6.98733956807658,0.0309947418337523,0.705080008030814,ENSG00000141429,GALNT1,protein_coding,18,1,35581117,35711834,q12.2,polypeptide N-acetylgalactosaminyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:4123],NA,GALNT1,2589,NM_020474
CUL4A_SIG,CUL4A,CUL4A_SIG,CUL4A,SIG,10,3.4606296262709,0.570897915024861,0.56481496555573,0.590884748994865,0.0260697834391352,0.00139093459549771,0.752114460314252,6.73121263303498,6.72336275456082,6.75700509087865,0.0336423363178325,0.562261638215713,ENSG00000139842,CUL4A,protein_coding,13,1,113208193,113267108,q34,cullin 4A [Source:HGNC Symbol;Acc:HGNC:2554],NA,CUL4A,8451,NM_001008895;NM_001278513;NM_001278514;NM_001354938;NM_001354939;NM_001354940;NM_001354941;NM_001354942;NM_001354943;NM_001354944;NM_003589
NPM3_SIG,NPM3,NPM3_SIG,NPM3,SIG,41,3.46048540974132,0.523973844269478,0.514537752948116,0.554978144325383,0.0404403913772662,0.00139096844818958,4.3139919862312,4.02233048330729,3.93635240681798,4.30482987748646,0.368477470668481,0.000194730000974736,ENSG00000107833,NPM3,protein_coding,10,-1,101781325,101783413,q24.32,nucleophosmin/nucleoplasmin 3 [Source:HGNC Symbol;Acc:HGNC:7931],NA,NPM3,10360,NM_006993
UBTF_SIG,UBTF,UBTF_SIG,UBTF,SIG,35,3.46045537691029,0.381007842424256,0.372525824290837,0.40887733057692,0.0363515062860834,0.00139096844818958,2.05046310180108,7.38254211409093,7.35456335637922,7.47447231800084,0.119908961621618,0.0884761181415547,ENSG00000108312,UBTF,protein_coding,17,-1,44205033,44221626,q21.31,upstream binding transcription factor [Source:HGNC Symbol;Acc:HGNC:12511],Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder;Childhood-Onset Neurodegeneration;NEURODEGENERATION CHILDHOOD-ONSET WITH BRAIN ATROPHY,UBTF,7343,NM_001076683;NM_001076684;NM_014233
THTPA_SIG,THTPA,THTPA_SIG,THTPA,SIG,12,3.46036253977986,-0.00146361693986688,-0.00809125473511547,0.0203129072445213,0.0284041619796368,0.00139101507397372,1.47453981017713,2.46316149662941,2.44251921226225,2.5309861452644,0.0884669330021506,0.230350050105412,ENSG00000259431,THTPA,protein_coding,14,1,23555988,23560271,q11.2,thiamine triphosphatase [Source:HGNC Symbol;Acc:HGNC:18987],NA,THTPA,79178,NM_001126339;NM_001256062;NM_001256321;NM_001256322;NM_001256323;NM_024328
ZNF397_TF,ZNF397,ZNF397_TF,ZNF397,TF,86,3.45980557320737,0.149176315193563,0.13870996587986,0.183565748652874,0.0448557827730144,0.00139346159353918,3.05049726837664,3.80926506405895,3.7442403252403,4.02291777732022,0.278677452079925,0.00944155631063967,ENSG00000186812,ZNF397,protein_coding,18,1,35241030,35267133,q12.2,zinc finger protein 397 [Source:HGNC Symbol;Acc:HGNC:18818],NA,ZNF397,84307,NM_001135178;NM_032347
TEFM_SIG,TEFM,TEFM_SIG,TEFM,SIG,28,3.4592182066664,0.157899397816622,0.146061866504751,0.196794143555628,0.0507322770508772,0.00139606971434052,3.78339811293928,2.44179158348042,2.38371991590841,2.63259849121703,0.248878575308625,0.00113416437018083,ENSG00000172171,TEFM,protein_coding,17,-1,30897336,30906238,q11.2,transcription elongation factor, mitochondrial [Source:HGNC Symbol;Acc:HGNC:26223],NA,TEFM,79736,NM_024683
MOB1B_SIG,MOB1B,MOB1B_SIG,MOB1B,SIG,37,3.45825380485284,0.217178010579343,0.211700023089826,0.235177112330613,0.0234770892407866,0.00140064141696397,2.24283844647476,6.03497347471481,5.98759614423435,6.19064184629344,0.20304570205909,0.0608024060266402,ENSG00000173542,MOB1B,protein_coding,4,1,70902326,71022449,q13.3,MOB kinase activator 1B [Source:HGNC Symbol;Acc:HGNC:29801],NA,MOB1B,92597,NM_001244766;NM_001244767;NM_173468
ENDOG_SIG,ENDOG,ENDOG_SIG,ENDOG,SIG,28,3.45796331411098,0.369329846820674,0.358344032470574,0.405426093971002,0.0470820615004278,0.00140171664986058,3.31888533294989,2.8748418974088,2.8121867335304,3.08070886443782,0.268522130907422,0.00455819727826557,ENSG00000167136,ENDOG,protein_coding,9,1,128818500,128822676,q34.11,endonuclease G [Source:HGNC Symbol;Acc:HGNC:3346],NA,ENDOG,2021,NM_004435
CBFA2T3_TF,CBFA2T3,CBFA2T3_TF,CBFA2T3,TF,56,3.4570395482106,0.294612243395656,0.283664328035252,0.330583965294127,0.0469196372588749,0.00140609346517184,1.89442533407454,6.11578084991417,6.06483408778672,6.28317735404722,0.218343266260502,0.117390931317706,ENSG00000129993,CBFA2T3,protein_coding,16,-1,88874858,88977204,q24.3,CBFA2/RUNX1 translocation partner 3 [Source:HGNC Symbol;Acc:HGNC:1537],Acute megakaryoblastic leukemia without Down syndrome,CBFA2T3,863,NM_005187;NM_175931
PLD2_SIG,PLD2,PLD2_SIG,PLD2,SIG,27,-3.45583841200131,0.227216284375262,0.248894349094309,0.155988357441251,-0.0929059916530586,0.00141193510507044,-1.93858879015525,3.06766258011826,3.13793353525984,2.8367722989388,-0.301161236321037,0.108578394837541,ENSG00000129219,PLD2,protein_coding,17,1,4807152,4823434,p13.2,phospholipase D2 [Source:HGNC Symbol;Acc:HGNC:9068],NA,PLD2,5338,NM_001243108;NM_002663
NR4A1_SIG,NR4A1,NR4A1_SIG,NR4A1,SIG,31,-3.4553017380244,0.172002868346831,0.184619785833546,0.130547282319051,-0.0540725035144951,0.00141430942198474,-3.08141419261433,5.18066474489285,5.32953517283113,4.69151905309563,-0.638016119735506,0.00869662707258504,ENSG00000123358,NR4A1,protein_coding,12,1,52022832,52059507,q13.13,nuclear receptor subfamily 4 group A member 1 [Source:HGNC Symbol;Acc:HGNC:7980],NA,NR4A1,3164,NM_001202233;NM_001202234;NM_002135;NM_173157
RBMX2_SIG,RBMX2,RBMX2_SIG,RBMX2,SIG,15,3.45439106012356,0.168650918251941,0.165044861950293,0.180499388957357,0.015454527007064,0.00141865382587466,2.29325620567936,3.91829930885683,3.89355626904726,3.99959786823115,0.106041599183895,0.0547197250885411,ENSG00000134597,RBMX2,protein_coding,X,1,130401987,130413656,q26.1,RNA binding motif protein X-linked 2 [Source:HGNC Symbol;Acc:HGNC:24282],NA,RBMX2,51634,NM_016024
ZNF491_TF,ZNF491,ZNF491_TF,ZNF491,TF,34,3.45341604091323,0.0136273023913851,0.00281464243496862,0.0491546136767533,0.0463399712417847,0.00142335009471288,0.740648752803528,1.39550038234438,1.38309193052978,1.4362710097352,0.0531790792054187,0.568651784819414,ENSG00000177599,ZNF491,protein_coding,19,1,11797667,11809622,p13.2,zinc finger protein 491 [Source:HGNC Symbol;Acc:HGNC:23706],NA,ZNF491,126069,NM_152356
PPARG_TF,PPARG,PPARG_TF,PPARG,TF,196,-3.45314922164372,-0.00633226693269098,-0.000410296948763316,-0.0257901683084533,-0.0253798713596899,0.00142431670225532,-2.11191639207998,1.14697945039275,1.22070927101661,0.904724325485797,-0.315984945530812,0.0785680484720719,ENSG00000132170,PPARG,protein_coding,3,1,12287368,12434356,p25.2,peroxisome proliferator activated receptor gamma [Source:HGNC Symbol;Acc:HGNC:9236],Berardinelli-Seip congenital lipodystrophy;CAROTID INTIMAL MEDIAL THICKNESS 1;DIABETES MELLITUS NONINSULIN-DEPENDENT;Differentiated thyroid carcinoma;Giant cell glioblastoma;Gliosarcoma;LIPODYSTROPHY FAMILIAL PARTIAL TYPE 3;OBESITY LEANNESS INCLUDED;PPARG-related familial partial lipodystrophy,PPARG,5468,NM_001330615;NM_001354666;NM_001354667;NM_001354668;NM_001354669;NM_001354670;NM_005037;NM_015869;NM_138711;NM_138712
CD9_SIG,CD9,CD9_SIG,CD9,SIG,64,3.45297763922214,0.108450637511816,0.103518745217743,0.124655426478056,0.0211366812603127,0.0014246903427724,0.414683991173424,5.01413384842642,4.99589428927284,5.07406382850248,0.0781695392296361,0.760306732542667,ENSG00000010278,CD9,protein_coding,12,1,6199715,6238271,p13.31,CD9 molecule [Source:HGNC Symbol;Acc:HGNC:1709],NA,CD9,928,NM_001330312;NM_001769
TARS2_SIG,TARS2,TARS2_SIG,TARS2,SIG,27,3.45291112785092,0.475437985337256,0.462442597638546,0.518137116347301,0.0556945187087549,0.0014246903427724,2.90885370021366,4.61049776255763,4.56712078195876,4.75302212738247,0.18590134542371,0.0135607658498724,ENSG00000143374,TARS2,protein_coding,1,1,150487364,150507609,q21.2,threonyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:30740],Combined oxidative phosphorylation defect type 21;Combined oxidative phosphorylation deficiency 21,TARS2,80222,NM_001271895;NM_001271896;NM_025150
DCXR_SIG,DCXR,DCXR_SIG,DCXR,SIG,10,3.45276770912884,0.17481338351675,0.167929161028241,0.197432971693276,0.029503810665035,0.00142500611113187,2.90177919780644,4.49313389107509,4.45122360847193,4.63083910534261,0.179615496870677,0.0138097590599948,ENSG00000169738,DCXR,protein_coding,17,-1,82035136,82037732,q25.3,dicarbonyl and L-xylulose reductase [Source:HGNC Symbol;Acc:HGNC:18985],Pentosuria,DCXR,51181,NM_001195218;NM_016286
ZC3H10_SIG,ZC3H10,ZC3H10_SIG,ZC3H10,SIG,40,3.45242929578354,0.178298920571229,0.168826652687175,0.209422086475976,0.0405954337888008,0.00142635262027827,2.17577557778538,2.68362757595062,2.65097649074992,2.79090971303864,0.139933222288728,0.0695864819799487,ENSG00000135482,ZC3H10,protein_coding,12,1,56118260,56127514,q13.2,zinc finger CCCH-type containing 10 [Source:HGNC Symbol;Acc:HGNC:25893],NA,ZC3H10,84872,NM_001303124;NM_001303125;NM_032786
PRRC2B_SIG,PRRC2B,PRRC2B_SIG,PRRC2B,SIG,45,3.45216952164297,0.510284763337502,0.505428594876027,0.526240745425205,0.020812150549178,0.00142728433015662,2.85795536756511,8.26506707227255,8.23249187132598,8.37209987538272,0.139608004056743,0.0153924253630132,ENSG00000130723,PRRC2B,protein_coding,9,1,131373636,131500197,q34.13,proline rich coiled-coil 2B [Source:HGNC Symbol;Acc:HGNC:28121],NA,PRRC2B,84726,NM_013318
GOT2_SIG,GOT2,GOT2_SIG,GOT2,SIG,20,3.45205301309151,0.633334208251114,0.6204568203166,0.675645625750233,0.0551888054336328,0.0014274585682043,4.07285457963612,5.45109914323568,5.381304315028,5.68042500734664,0.299120692318639,0.000444492843136275,ENSG00000125166,GOT2,protein_coding,16,-1,58707131,58734342,q21,glutamic-oxaloacetic transaminase 2 [Source:HGNC Symbol;Acc:HGNC:4433],NA,GOT2,2806,NM_001286220;NM_002080
ABCB8_SIG,ABCB8,ABCB8_SIG,ABCB8,SIG,24,3.45151827891479,0.169040760989389,0.163626021153954,0.186832049020107,0.023206027866153,0.00142984735022531,2.90451441212811,4.39740854844705,4.35188167494809,4.54699684708649,0.195115172138392,0.013707539145006,ENSG00000197150,ABCB8,protein_coding,7,1,151028422,151047782,q36.1,ATP binding cassette subfamily B member 8 [Source:HGNC Symbol;Acc:HGNC:49],NA,ABCB8,11194,NM_001282291;NM_001282292;NM_001282293;NM_007188
ANO8_SIG,ANO8,ANO8_SIG,ANO8,SIG,97,3.45055159642236,0.103830626691635,0.097567406572907,0.124409778510314,0.0268423719374067,0.00143453382211995,2.8712608638064,4.04414445760047,3.97235787854954,4.28001464591067,0.30765676736113,0.0148998155906217,ENSG00000074855,ANO8,protein_coding,19,-1,17323223,17334855,p13.11,anoctamin 8 [Source:HGNC Symbol;Acc:HGNC:29329],NA,ANO8,57719,NM_020959
ALG1L2_SIG,ALG1L2,ALG1L2_SIG,ALG1L2,SIG,4,3.45027767489602,-0.104055363738811,-0.1115335349488,-0.0794842297631315,0.0320493051856683,0.00143554600134343,1.67498289757307,0.721957200501934,0.699643514295476,0.795273598037436,0.09563008374196,0.169746216198009,ENSG00000251287,ALG1L2,protein_coding,3,1,130081831,130113227,q22.1,ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2 [Source:HGNC Symbol;Acc:HGNC:37258],NA,ALG1L2,644974,NM_001136152
KLHL2_SIG,KLHL2,KLHL2_SIG,KLHL2,SIG,24,-3.45005989781171,0.434164422611763,0.444596052793369,0.399889066300772,-0.0447069864925978,0.00143626019243075,-2.27675591763693,4.80377012910788,4.85093427616488,4.64880221734918,-0.202132058815701,0.0566534642903048,ENSG00000109466,KLHL2,protein_coding,4,1,165207561,165323156,q32.3,kelch like family member 2 [Source:HGNC Symbol;Acc:HGNC:6353],NA,KLHL2,11275,NM_001161521;NM_001161522;NM_001331023;NM_001331024;NM_007246
C1orf35_SIG,C1orf35,C1orf35_SIG,C1orf35,SIG,7,3.44987576379246,0.195332440413081,0.190885115770528,0.209945078524327,0.0190599627537991,0.00143679574971167,1.18326488913363,3.78792974775558,3.77543189892057,3.82899410821347,0.0535622092929065,0.344175056240228,ENSG00000143793,C1orf35,protein_coding,1,-1,228100726,228105411,q42.13,chromosome 1 open reading frame 35 [Source:HGNC Symbol;Acc:HGNC:19032],NA,C1orf35,79169,NM_024319
PDZD4_SIG,PDZD4,PDZD4_SIG,PDZD4,SIG,26,-3.4496498458592,-0.242530445397609,-0.223888702916128,-0.303781884979618,-0.0798931820634895,0.00143755406526724,-3.55384868096604,2.02475191079754,2.1453146445204,1.62861721427958,-0.516697430240821,0.00230150872511051,ENSG00000067840,PDZD4,protein_coding,X,-1,153802166,153830565,q28,PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:21167],NA,PDZD4,57595,NM_001303512;NM_001303513;NM_001303514;NM_001303515;NM_001303516;NM_032512
E2F6_TF,E2F6,E2F6_TF,E2F6,TF,139,3.44930001780739,0.213721611209351,0.209382442142981,0.227978880998853,0.0185964388558723,0.00143897307390858,2.93107393402278,3.17312939352125,3.13203592884737,3.30815077744969,0.176114848602313,0.0128502774724358,ENSG00000169016,E2F6,protein_coding,2,-1,11444375,11466177,p25.1,E2F transcription factor 6 [Source:HGNC Symbol;Acc:HGNC:3120],NA,E2F6,1876,NM_001278275;NM_001278276;NM_001278277;NM_001278278;NM_198256;NM_212540
RTKN2_SIG,RTKN2,RTKN2_SIG,RTKN2,SIG,20,-3.44906644656079,-0.00982873576584984,-0.00260685164623599,-0.0335577835874382,-0.0309509319412023,0.00143977344453312,-2.56069038226477,1.57646546264583,1.63733738409481,1.37645772074207,-0.260879663352733,0.030830365862218,ENSG00000182010,RTKN2,protein_coding,10,-1,62183035,62268844,q21.2,rhotekin 2 [Source:HGNC Symbol;Acc:HGNC:19364],NA,RTKN2,219790,NM_001282941;NM_145307
IL32_SIG,IL32,IL32_SIG,IL32,SIG,19,-3.44896563381321,-0.307139206786843,-0.28016004158202,-0.395785035316973,-0.115624993734953,0.00143986626057827,-4.4233509054009,3.40854062892234,3.57565006407081,2.85946677057737,-0.716183293493446,0.000131089108002304,ENSG00000008517,IL32,protein_coding,16,1,3065297,3082192,p13.3,interleukin 32 [Source:HGNC Symbol;Acc:HGNC:16830],NA,IL32,9235,NM_001012631;NM_001012632;NM_001012633;NM_001012634;NM_001012635;NM_001012636;NM_001012718;NM_001308078;NM_004221
MBTPS2_SIG,MBTPS2,MBTPS2_SIG,MBTPS2,SIG,44,3.44825176909006,0.542789068930219,0.532196261697091,0.577594006981924,0.0453977452848329,0.00144323173618429,3.1934109433075,3.50637567367565,3.4533180350059,3.6807079150191,0.227389880013198,0.0064775949978177,ENSG00000012174,MBTPS2,protein_coding,X,1,21839617,21885423,p22.12,membrane bound transcription factor peptidase, site 2 [Source:HGNC Symbol;Acc:HGNC:15455],BRESEK syndrome;Ichthyosis follicularis-alopecia-photophobia syndrome;IFAP syndrome with or without BRESHECK syndrome;Keratosis follicularis spinulosa decalvans;KERATOSIS FOLLICULARIS SPINULOSA DECALVANS X-LINKED;Mutilating palmoplantar keratoderma with periorificial keratotic plaques;OSTEOGENESIS IMPERFECTA TYPE XIX;PALMOPLANTAR KERATODERMA MUTILATING WITH PERIORIFICIAL KERATOTICPLAQUES X-LINKED,MBTPS2,51360,NM_015884
TNFSF8_SIG,TNFSF8,TNFSF8_SIG,TNFSF8,SIG,24,-3.44736216169803,0.315487604523436,0.323984526086497,0.287569147959094,-0.0364153781274031,0.00144754595375665,-2.84521765140666,3.68180076214184,3.78303628141713,3.34916977023732,-0.433866511179812,0.0158736235488765,ENSG00000106952,TNFSF8,protein_coding,9,-1,114893343,114930595,q33.1,TNF superfamily member 8 [Source:HGNC Symbol;Acc:HGNC:11938],NA,TNFSF8,944,NM_001244;NM_001252290
ZNF747_TF,ZNF747,ZNF747_TF,ZNF747,TF,83,3.44685472151432,0.246532573710558,0.235528089806101,0.282690163682345,0.047162073876244,0.00144944557665804,2.5188160140504,3.17211017965505,3.13515276789829,3.29354167542725,0.158388907528959,0.0339014191069611,ENSG00000169955,ZNF747,protein_coding,16,-1,30530367,30535347,p11.2,zinc finger protein 747 [Source:HGNC Symbol;Acc:HGNC:28350],NA,ZNF747,65988,NM_001305018;NM_001305019;NM_001305020;NM_023931
GTF3C4_SIG,GTF3C4,GTF3C4_SIG,GTF3C4,SIG,79,3.44684115149603,0.404716639081344,0.398564594806071,0.424930498842955,0.0263659040368836,0.00144944557665804,3.16349987144372,5.48533003912331,5.43612664870113,5.64699832193903,0.210871673237904,0.00699378326900218,ENSG00000125484,GTF3C4,protein_coding,9,1,132670035,132694953,q34.13,general transcription factor IIIC subunit 4 [Source:HGNC Symbol;Acc:HGNC:4667],NA,GTF3C4,9329,NM_012204
PRPF19_SIG,PRPF19,PRPF19_SIG,PRPF19,SIG,31,3.4462068002754,0.73554116354776,0.723650144409505,0.774611655002024,0.0509615105925185,0.00145240448460159,3.21197592726165,6.79847873348338,6.75213624769942,6.95074690105926,0.198610653359833,0.00615014736614811,ENSG00000110107,PRPF19,protein_coding,11,-1,60890547,60906585,q12.2,pre-mRNA processing factor 19 [Source:HGNC Symbol;Acc:HGNC:17896],NA,PRPF19,27339,NM_014502
FMR1_SIG,FMR1,FMR1_SIG,FMR1,SIG,53,-3.44262300409674,0.317564962147045,0.323593178029538,0.297757967104565,-0.0258352109249735,0.00147133275820182,-1.89040757567539,5.72400176503555,5.74797997138506,5.64521622988718,-0.102763741497874,0.118209255577433,ENSG00000102081,FMR1,protein_coding,X,1,147911951,147951125,q27.3,fragile X mental retardation 1 [Source:HGNC Symbol;Acc:HGNC:3775],Fragile X-associated tremor/ataxia syndrome;Fragile X syndrome;FRAGILE X TREMOR/ATAXIA SYNDROME;PREMATURE OVARIAN FAILURE 1;PREMATURE OVARIAN FAILURE SYNDROME TYPE 1;Symptomatic form of fragile X syndrome in female carrier;Xq27.3q28 duplication syndrome,FMR1,2332,NM_001185075;NM_001185076;NM_001185081;NM_001185082;NM_002024
MBD1_TF,MBD1,MBD1_TF,MBD1,TF,19,3.44166024042408,0.225638715488585,0.223349278741792,0.233161150513761,0.00981187177196857,0.00147612383740878,-0.306548133450096,6.65567857061671,6.65788279261633,6.64843612690365,-0.00944666571268826,0.823900394534394,ENSG00000141644,MBD1,protein_coding,18,-1,50266882,50281774,q21.1,methyl-CpG binding domain protein 1 [Source:HGNC Symbol;Acc:HGNC:6916],NA,MBD1,4152,NM_001204136;NM_001204137;NM_001204138;NM_001204139;NM_001204140;NM_001204141;NM_001204142;NM_001204143;NM_001204151;NM_001323942;NM_001323947;NM_001323949;NM_001323950;NM_001323951;NM_001323952;NM_001323953;NM_001323954;NM_002384;NM_015844;NM_015845;NM_015846;NM_015847
NOLC1_SIG,NOLC1,NOLC1_SIG,NOLC1,SIG,21,3.4412000198377,0.83182127078375,0.816843838288887,0.88103283469544,0.0641889964065532,0.00147818143223362,2.20930708632784,6.9367733643227,6.89399675450247,7.07732508230349,0.183328327801022,0.0651844478753687,ENSG00000166197,NOLC1,protein_coding,10,1,102152176,102163871,q24.32,nucleolar and coiled-body phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:15608],NA,NOLC1,9221,NM_001284388;NM_001284389;NM_004741
MEX3A_SIG,MEX3A,MEX3A_SIG,MEX3A,SIG,58,3.43924116455931,-0.0502110878675937,-0.05646962059248,-0.0296473374858246,0.0268222831066553,0.00148846089479745,4.9981403321812,1.76974337384873,1.58380818181944,2.38067329051638,0.796865108696936,1.43067017512096e-05,ENSG00000254726,MEX3A,protein_coding,1,-1,156072013,156082465,q22,mex-3 RNA binding family member A [Source:HGNC Symbol;Acc:HGNC:33482],NA,MEX3A,92312,NM_001093725
SMARCAL1_SIG,SMARCAL1,SMARCAL1_SIG,SMARCAL1,SIG,91,3.43912630121304,0.295906767577124,0.279675024626305,0.349239637272673,0.0695646126463679,0.00148863413995683,2.77343889684884,4.7090894184608,4.64975140250524,4.90405718517193,0.254305782666694,0.0188189826394327,ENSG00000138375,SMARCAL1,protein_coding,2,1,216412414,216483053,q35,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 [Source:HGNC Symbol;Acc:HGNC:11102],SCHIMKE IMMUNOOSSEOUS DYSPLASIA,SMARCAL1,50485,NM_001127207;NM_014140
ZNF84_TF,ZNF84,ZNF84_TF,ZNF84,TF,3,3.43836760610101,-0.258070576698982,-0.273579057150291,-0.207114140930393,0.0664649162198986,0.00149235222558079,0.992309215833652,0.751260862559724,0.741281858587994,0.784049018466838,0.0427671598788448,0.434242104668941,ENSG00000198040,ZNF84,protein_coding,12,1,133037292,133063304,q24.33,zinc finger protein 84 [Source:HGNC Symbol;Acc:HGNC:13159],NA,ZNF84,7637,NM_001127372;NM_001289971;NM_001289972;NM_003428
ABCA1_SIG,ABCA1,ABCA1_SIG,ABCA1,SIG,4,-3.43684640480386,-0.0467627675408221,-0.0385619527296891,-0.073708301920259,-0.0351463491905699,0.00150029685731647,-3.55095083889213,4.82438950311666,4.95351452360524,4.4001215786542,-0.553392944951036,0.00231800846388187,ENSG00000165029,ABCA1,protein_coding,9,-1,104781006,104928155,q31.1,ATP binding cassette subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:29],APOLIPOPROTEIN A-I DEFICIENCY;HYPERCHOLESTEROLEMIA FAMILIAL;HYPOALPHALIPOPROTEINEMIA PRIMARY;TANGIER DISEASE,ABCA1,19,NM_005502
ADK_SIG,ADK,ADK_SIG,ADK,SIG,17,3.43617875183198,0.336936204013681,0.329248420943062,0.362196062674284,0.032947641731222,0.00150353655082386,4.45595458552,4.5800173948333,4.51537953533305,4.79239893319126,0.277019397858208,0.00011659435422144,ENSG00000156110,ADK,protein_coding,10,1,74151185,74709303,q22.2,adenosine kinase [Source:HGNC Symbol;Acc:HGNC:257],Autosomal Recessive Mental Retardation;HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY;Hypermethioninemia encephalopathy due to adenosine kinase deficiency,ADK,132,NM_001123;NM_001202449;NM_001202450;NM_006721
RYK_SIG,RYK,RYK_SIG,RYK,SIG,9,3.43574637985608,0.183672955373427,0.179309079353873,0.198011405151962,0.0187023257980896,0.00150547488884622,1.52852097060208,5.29547934763112,5.26934280136899,5.38135657106385,0.11201376969486,0.212731813367257,ENSG00000163785,RYK,protein_coding,3,-1,134065303,134250744,q22.2,receptor-like tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:10481],NA,RYK,6259,NM_001005861;NM_002958
AMD1_SIG,AMD1,AMD1_SIG,AMD1,SIG,45,3.4352953221872,0.353122874562159,0.342820131951149,0.386974743141191,0.0441546111900418,0.00150751955524407,2.44467830555591,7.48447285893215,7.4389563898112,7.63402697175812,0.195070581946918,0.0397949534986064,ENSG00000123505,AMD1,protein_coding,6,1,110874770,110895713,q21,adenosylmethionine decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:457],NA,AMD1,262,NM_001287214;NM_001287215;NM_001287216;NM_001634
DXO_SIG,DXO,DXO_SIG,DXO,SIG,43,3.43490947862314,0.0704144928986155,0.0647339157830706,0.0890792462782628,0.024345330495192,0.00150920363098592,1.90527802843899,4.40022008116015,4.37734101746511,4.47539414758669,0.0980531301215813,0.115269645726179,ENSG00000204348,DXO,protein_coding,6,-1,31969810,31972290,p21.33,decapping exoribonuclease [Source:HGNC Symbol;Acc:HGNC:2992],NA,DXO,1797,NM_005510
GCAT_SIG,GCAT,GCAT_SIG,GCAT,SIG,22,3.43420975831802,-0.0551859555958955,-0.0636334232813681,-0.0274299903436282,0.0362034329377399,0.00151264023719324,3.78835683954981,2.60450543617431,2.50106516968284,2.94438059750343,0.443315427820584,0.00111534977743631,ENSG00000100116,GCAT,protein_coding,22,1,37807905,37817176,q13.1,glycine C-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:4188],NA,GCAT,23464,NM_001171690;NM_014291
ZBTB39_TF,ZBTB39,ZBTB39_TF,ZBTB39,TF,130,3.43399425521612,0.225936796027187,0.21749410368496,0.253677070865932,0.0361829671809721,0.00151337840780623,4.01370532580184,4.7671661615505,4.68945999780729,5.02248641384962,0.333026416042335,0.000543622099072947,ENSG00000166860,ZBTB39,protein_coding,12,-1,56998836,57006546,q13.3,zinc finger and BTB domain containing 39 [Source:HGNC Symbol;Acc:HGNC:29014],NA,ZBTB39,9880,NM_014830
ENOPH1_SIG,ENOPH1,ENOPH1_SIG,ENOPH1,SIG,12,3.43336569871781,0.485357055732743,0.476443938389968,0.514643012716149,0.0381990743261816,0.00151642578917486,2.7323847484448,4.86051467930188,4.82872719994169,4.9649592543425,0.13623205440081,0.0207535374584125,ENSG00000145293,ENOPH1,protein_coding,4,1,82430590,82461177,q21.22,enolase-phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:24599],NA,ENOPH1,58478,NM_001292017;NM_021204
MRPL42_SIG,MRPL42,MRPL42_SIG,MRPL42,SIG,22,3.43256502703107,0.660096070674761,0.652495174119626,0.685070445070204,0.032575270950577,0.00152044367859264,3.22848445284386,5.28847612218505,5.24633419990589,5.42694243824518,0.180608238339292,0.0058646708791567,ENSG00000198015,MRPL42,protein_coding,12,1,93467488,93516214,q22,mitochondrial ribosomal protein L42 [Source:HGNC Symbol;Acc:HGNC:14493],NA,MRPL42,28977,NM_014050;NM_172177
B4GALT4_SIG,B4GALT4,B4GALT4_SIG,B4GALT4,SIG,21,-3.43128672131031,0.208716927207898,0.212414546748172,0.196567605861281,-0.0158469408868917,0.00152715835861953,-0.665854417719574,4.0901048496101,4.09855707882248,4.06233323934086,-0.0362238394816146,0.61164556852333,ENSG00000121578,B4GALT4,protein_coding,3,-1,119211732,119240946,q13.32,beta-1,4-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:927],NA,B4GALT4,8702,NM_003778;NM_212543
HECTD4_SIG,HECTD4,HECTD4_SIG,HECTD4,SIG,45,3.43106916340703,0.505276871752837,0.499632290752029,0.523823352184065,0.0241910614320361,0.00152791485770558,1.37715537295011,6.92875089460798,6.9104355763503,6.98892979745465,0.0784942211043491,0.265252157973587,ENSG00000173064,HECTD4,protein_coding,12,-1,112160188,112382439,q24.13,HECT domain E3 ubiquitin protein ligase 4 [Source:HGNC Symbol;Acc:HGNC:26611],NA,HECTD4,283450,NM_001109662
CCL20_SIG,CCL20,CCL20_SIG,CCL20,SIG,6,-3.4291339448773,-0.0153296171567431,-0.00686520849826396,-0.0431412456060318,-0.0362760371077677,0.00153837947487286,-1.38453367139,0.272447192999141,0.296310349914091,0.19403967742145,-0.102270672492641,0.262475630714487,ENSG00000115009,CCL20,protein_coding,2,1,227805739,227817564,q36.3,C-C motif chemokine ligand 20 [Source:HGNC Symbol;Acc:HGNC:10619],NA,CCL20,6364,NM_001130046;NM_004591
NOTCH2_SIG,NOTCH2,NOTCH2_SIG,NOTCH2,SIG,32,-3.4284631708867,0.439878093034878,0.451261667943146,0.40247491833628,-0.0487867496068659,0.00154171325482591,-2.21770572266597,7.90912960392046,7.95869243199056,7.74628031169012,-0.212412120300445,0.0640451777112478,ENSG00000134250,NOTCH2,protein_coding,1,-1,119911553,120100779,p12,notch 2 [Source:HGNC Symbol;Acc:HGNC:7882],Acroosteolysis dominant type;Alagille syndrome 2;Alagille syndrome due to a NOTCH2 point mutation;Hajdu-Cheney syndrome,NOTCH2,4853,NM_001200001;NM_024408
BMP8B_SIG,BMP8B,BMP8B_SIG,BMP8B,SIG,37,-3.42725126412004,-0.0946178369531971,-0.0873299721887483,-0.1185636783221,-0.0312337061333522,0.00154813618594824,-2.82978346276839,1.62838811931987,1.72755687709441,1.30254791520353,-0.425008961890877,0.0165048323009146,ENSG00000116985,BMP8B,protein_coding,1,-1,39757182,39788865,p34.2,bone morphogenetic protein 8b [Source:HGNC Symbol;Acc:HGNC:1075],NA,BMP8B,656,NM_001720
CLC_SIG,CLC,CLC_SIG,CLC,SIG,29,-3.42675817141598,-0.0111143391563707,0.000303236144639744,-0.0486292294311191,-0.0489324655757589,0.0015504747866061,-0.46278113746019,3.75758352626207,3.7856515418817,3.66536004636901,-0.120291495512689,0.73176790591085,ENSG00000105205,CLC,protein_coding,19,-1,39731255,39738029,q13.2,Charcot-Leyden crystal galectin [Source:HGNC Symbol;Acc:HGNC:2014],NA,CLC,1178,NM_001828
GSTCD_SIG,GSTCD,GSTCD_SIG,GSTCD,SIG,28,3.42656540351702,0.324398968829496,0.312076224423447,0.364887986163655,0.052811761740208,0.0015511005327721,4.22901718680179,3.38396694040401,3.30881344355161,3.63089985863334,0.322086415081733,0.000260582067876918,ENSG00000138780,GSTCD,protein_coding,4,1,105708778,105847728,q24,glutathione S-transferase C-terminal domain containing [Source:HGNC Symbol;Acc:HGNC:25806],NA,GSTCD,79807,NM_001031720;NM_024751
TCP1_SIG,TCP1,TCP1_SIG,TCP1,SIG,35,3.42463347963977,0.423682391697976,0.414866585733566,0.452648611295325,0.0377820255617591,0.00156169293133927,1.30911826808861,7.59220944647798,7.57533840498397,7.6476428685297,0.0723044635457271,0.291341960102893,ENSG00000120438,TCP1,protein_coding,6,-1,159778498,159789703,q25.3,t-complex 1 [Source:HGNC Symbol;Acc:HGNC:11655],NA,TCP1,6950,NM_001008897;NM_030752
ADORA2A_SIG,ADORA2A,ADORA2A_SIG,ADORA2A,SIG,46,-3.42415505805634,0.0458862415419356,0.0596010834234866,0.00082318964541099,-0.0587778937780758,0.00156396611181785,-2.27466480951439,1.27488323442907,1.32886016723153,1.09753045522098,-0.231329712010556,0.0568965540869197,ENSG00000128271,ADORA2A,protein_coding,22,1,24417879,24442357,q11.23,adenosine A2a receptor [Source:HGNC Symbol;Acc:HGNC:263],Acute encephalopathy with biphasic seizures and late reduced diffusion,ADORA2A,135,NM_000675;NM_001278497;NM_001278498;NM_001278499;NM_001278500
ZNF362_TF,ZNF362,ZNF362_TF,ZNF362,TF,64,3.42343243081197,0.317526433141,0.313209121542837,0.331711885534966,0.0185027639921289,0.00156765034679839,1.68309477356568,4.82655984086364,4.80420998393078,4.89999508507162,0.0957851011408392,0.167632412223106,ENSG00000160094,ZNF362,protein_coding,1,1,33256492,33300719,p35.1,zinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079],NA,ZNF362,149076,NM_152493
SULT1B1_SIG,SULT1B1,SULT1B1_SIG,SULT1B1,SIG,37,-3.42306446982222,0.337545065245061,0.348403438204206,0.301867554093587,-0.0465358841106189,0.00156929380273665,-1.98792103668834,3.8404703378348,3.92327669747158,3.56839229902822,-0.354884398443363,0.099343864841197,ENSG00000173597,SULT1B1,protein_coding,4,-1,69721167,69787961,q13.3,sulfotransferase family 1B member 1 [Source:HGNC Symbol;Acc:HGNC:17845],NA,SULT1B1,27284,NM_014465
ZFP1_TF,ZFP1,ZFP1_TF,ZFP1,TF,57,3.42233581061992,0.0708834839153127,0.0631815304213408,0.0961899025383632,0.0330083721170223,0.00157302461598394,1.78737765110297,3.40307822603311,3.37466910691651,3.49642247455906,0.121753367642543,0.141157712042759,ENSG00000184517,ZFP1,protein_coding,16,1,75148494,75172236,q23.1,ZFP1 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:23328],NA,ZFP1,162239,NM_001318469;NM_001318471;NM_001318472;NM_001318473;NM_001318474;NM_001318475;NM_001318476;NM_153688
ZNF606_TF,ZNF606,ZNF606_TF,ZNF606,TF,47,3.42155862562923,0.11950892286955,0.10961432295714,0.152019751153182,0.0424054281960418,0.00157704506347339,2.41789103580421,3.4184475226745,3.36565622301222,3.59190465013629,0.226248427124076,0.0421697083632766,ENSG00000166704,ZNF606,protein_coding,19,-1,57977053,58003349,q13.43,zinc finger protein 606 [Source:HGNC Symbol;Acc:HGNC:25879],NA,ZNF606,80095,NM_001348022;NM_001348023;NM_001348024;NM_001348025;NM_025027
USP49_SIG,USP49,USP49_SIG,USP49,SIG,23,3.42040204921456,0.291567735240412,0.287111323958099,0.306210229453726,0.0190989054956278,0.00158328195692446,1.48652618045835,4.56886475077729,4.54679469592643,4.64138064528727,0.0945859493608462,0.226421784044848,ENSG00000164663,USP49,protein_coding,6,-1,41789896,41895361,p21.1,ubiquitin specific peptidase 49 [Source:HGNC Symbol;Acc:HGNC:20078],NA,USP49,25862,NM_001286554;NM_018561
HIST2H4B_SIG,HIST2H4B,HIST2H4B_SIG,HIST2H4B,SIG,20,3.42021259686855,-0.0896063074499066,-0.0967516716956356,-0.0661286820710826,0.0306229896245529,0.00158390099717085,2.6717470823108,0.466701870991787,0.43705793724053,0.564103367603061,0.127045430362531,0.0239104048251791,ENSG00000270276,HIST2H4B,protein_coding,1,-1,149854045,149861210,q21.2,histone cluster 2 H4 family member b [Source:HGNC Symbol;Acc:HGNC:29607],NA,HIST2H4B,554313,NM_001034077
PRDM1_TF,PRDM1,PRDM1_TF,PRDM1,TF,82,-3.4196886100508,0.0836839436576288,0.0934656478356886,0.0515440585011465,-0.0419215893345421,0.00158647007417748,-1.27619828784942,4.07725200977055,4.12471568338063,3.92129993933743,-0.2034157440432,0.304602117485277,ENSG00000057657,PRDM1,protein_coding,6,1,105993463,106109939,q21,PR/SET domain 1 [Source:HGNC Symbol;Acc:HGNC:9346],NA,PRDM1,639,NM_001198;NM_182907
ZNF90_TF,ZNF90,ZNF90_TF,ZNF90,TF,124,-3.41960409973474,-0.0168974606085513,-0.012497642542525,-0.0313540056826375,-0.0188563631401124,0.00158647839291421,0.0715661063961125,1.55492587870635,1.55273249499793,1.56213271089115,0.00940021589322462,0.960914124388453,ENSG00000213988,ZNF90,protein_coding,19,1,20077994,20127076,p12,zinc finger protein 90 [Source:HGNC Symbol;Acc:HGNC:13165],NA,ZNF90,7643,NM_007138
REPIN1_TF,REPIN1,REPIN1_TF,REPIN1,TF,63,3.41899888715096,0.231335232860951,0.227197346241988,0.244931146037543,0.0177337997955552,0.00158952589539822,3.00982210560489,6.89706804209445,6.85218172942104,7.04455164087851,0.192369911457468,0.0104711607974635,ENSG00000214022,REPIN1,protein_coding,7,1,150368189,150374044,q36.1,replication initiator 1 [Source:HGNC Symbol;Acc:HGNC:17922],NA,REPIN1,29803,NM_001099695;NM_001099696;NM_001362746;NM_001362747;NM_013400;NM_014374
DECR2_SIG,DECR2,DECR2_SIG,DECR2,SIG,22,3.41872407721962,0.14720067897404,0.140292320598729,0.169899570778633,0.0296072501799039,0.00159064644377141,2.65198510868666,3.31189742976339,3.26901501461856,3.45279679381067,0.183781779192104,0.0249476909364474,ENSG00000242612,DECR2,protein_coding,16,1,401858,412487,p13.3,2,4-dienoyl-CoA reductase 2 [Source:HGNC Symbol;Acc:HGNC:2754],NA,DECR2,26063,NM_020664
MTFMT_SIG,MTFMT,MTFMT_SIG,MTFMT,SIG,12,3.41847151653437,0.0363370922972112,0.0245900171355448,0.0749346249712578,0.0503446078357131,0.00159163768515551,2.63085685832447,3.06236968593153,3.02302094939189,3.19165839170462,0.16863744231273,0.0261991515105371,ENSG00000103707,MTFMT,protein_coding,15,-1,65001512,65029639,q22.31,mitochondrial methionyl-tRNA formyltransferase [Source:HGNC Symbol;Acc:HGNC:29666],Combined oxidative phosphorylation defect type 15;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 27,MTFMT,123263,NM_139242
USP8_SIG,USP8,USP8_SIG,USP8,SIG,34,-3.41794365171416,0.478355945307056,0.484841999261578,0.457044625170769,-0.0277973740908089,0.00159424139976142,-1.46582202967203,6.09142590336433,6.10705405902097,6.04007624906395,-0.0669778099570201,0.233435982496989,ENSG00000138592,USP8,protein_coding,15,1,50424380,50514421,q21.2,ubiquitin specific peptidase 8 [Source:HGNC Symbol;Acc:HGNC:12631],Autosomal recessive spastic paraplegia type 59;Cushing disease;PITUITARY ADENOMA 4 ACTH-SECRETING,USP8,9101,NM_001128610;NM_001283049;NM_005154
ZKSCAN5_SIG,ZKSCAN5,ZKSCAN5_SIG,ZKSCAN5,SIG,48,3.41674912432846,0.225653299850546,0.220404812085746,0.242898331077748,0.0224935189920017,0.00160076431689929,3.16420468274087,4.38610420570688,4.34380997935824,4.52507094942385,0.181260970065608,0.00698391789121854,ENSG00000196652,ZKSCAN5,protein_coding,7,1,99504651,99534700,q22.1,zinc finger with KRAB and SCAN domains 5 [Source:HGNC Symbol;Acc:HGNC:12867],NA,ZKSCAN5,23660,NM_001318082;NM_001318083;NM_001318084;NM_014569;NM_145102
ZNF106_TF,ZNF106,ZNF106_TF,ZNF106,TF,229,-3.41471416691475,0.283983251198009,0.294249237862631,0.250252152157107,-0.0439970857055235,0.00161186581611464,-1.66607496409545,7.48490189939799,7.50860620523467,7.40701632307748,-0.101589882157182,0.172070410785182,ENSG00000103994,ZNF106,protein_coding,15,-1,42412823,42491141,q15.1,zinc finger protein 106 [Source:HGNC Symbol;Acc:HGNC:12886],NA,ZNF106,64397,NM_001284306;NM_001284307;NM_001366845;NM_022473
EDC3_SIG,EDC3,EDC3_SIG,EDC3,SIG,89,3.41470098741237,0.322307508835115,0.306774031755309,0.373346076383047,0.066572044627738,0.00161186581611464,2.75449138041984,4.73960527908065,4.68133477079062,4.93106552060505,0.249730749814431,0.0197196871964236,ENSG00000179151,EDC3,protein_coding,15,-1,74630558,74696292,q24.1,enhancer of mRNA decapping 3 [Source:HGNC Symbol;Acc:HGNC:26114],Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 50,EDC3,80153,NM_001142443;NM_001142444;NM_001351378;NM_001351379;NM_025083
ZXDC_TF,ZXDC,ZXDC_TF,ZXDC,TF,103,3.41423427140201,0.120625470787793,0.11578079444566,0.136543693054803,0.0207628986091435,0.00161413786221138,3.93543972733451,6.22839293361272,6.18640074958144,6.36636725257267,0.179966502991237,0.000700327676115103,ENSG00000070476,ZXDC,protein_coding,3,-1,126437601,126475891,q21.3,ZXD family zinc finger C [Source:HGNC Symbol;Acc:HGNC:28160],NA,ZXDC,79364,NM_001040653;NM_025112
DBP_TF,DBP,DBP_TF,DBP,TF,84,-3.41324877075014,0.0655792791394393,0.071911563082152,0.0447732033276686,-0.0271383597544836,0.00161920520674966,-1.00828694395778,3.30956335663325,3.32993850397991,3.24261644392277,-0.0873220600571453,0.426464068389806,ENSG00000105516,DBP,protein_coding,19,-1,48630030,48637438,q13.33,D-box binding PAR bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:2697],NA,DBP,1628,NM_001352
ETS2_TF,ETS2,ETS2_TF,ETS2,TF,59,3.41321429108957,0.092925773261595,0.0883862815553102,0.107841246010817,0.0194549644555064,0.00161920520674966,2.64263309163886,7.77432519672447,7.7018644777702,8.01241041614561,0.310545938375407,0.0254791541490209,ENSG00000157557,ETS2,protein_coding,21,1,38805307,38824955,q22.2,ETS proto-oncogene 2, transcription factor [Source:HGNC Symbol;Acc:HGNC:3489],NA,ETS2,2114,NM_001256295;NM_005239
RNF115_SIG,RNF115,RNF115_SIG,RNF115,SIG,30,3.41076058920424,0.433195967269771,0.425623611922401,0.458076563411128,0.032452951488727,0.00163334883868206,1.82507457464667,5.95337354505377,5.93452152182101,6.01531590710427,0.0807943852832622,0.132436243929394,ENSG00000265491,RNF115,protein_coding,1,-1,145738868,145824095,q21.1,ring finger protein 115 [Source:HGNC Symbol;Acc:HGNC:18154],NA,RNF115,27246,NM_014455
ICAM1_SIG,ICAM1,ICAM1_SIG,ICAM1,SIG,49,-3.40978983159713,0.431832163507608,0.449528931116841,0.373685641362989,-0.0758432897538519,0.0016386746540262,-1.87632535534532,5.64717950281011,5.72340252569897,5.39673242760383,-0.326670098095149,0.121184089501175,ENSG00000090339,ICAM1,protein_coding,19,1,10271093,10286615,p13.2,intercellular adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:5344],MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED,ICAM1,3383,NM_000201
PIGF_SIG,PIGF,PIGF_SIG,PIGF,SIG,32,3.40925437452645,0.251710804925512,0.23947318780737,0.291920118313693,0.0524469305063236,0.00164139529113588,3.45622329304379,3.10773584738406,3.04565519516875,3.31171513323436,0.266059938065606,0.00306095884267737,ENSG00000151665,PIGF,protein_coding,2,-1,46580937,46617119,p21,phosphatidylinositol glycan anchor biosynthesis class F [Source:HGNC Symbol;Acc:HGNC:8962],NA,PIGF,5281,NM_002643;NM_173074
CTNNBL1_SIG,CTNNBL1,CTNNBL1_SIG,CTNNBL1,SIG,21,-3.4083726487386,0.0157841310068446,0.021703617337069,-0.00366560979246427,-0.0253692271295333,0.00164620812883175,-2.11785141344079,5.76119038166432,5.79058015219717,5.66462399277064,-0.12595615942653,0.077701377721607,ENSG00000132792,CTNNBL1,protein_coding,20,1,37693955,37872129,q11.23,catenin beta like 1 [Source:HGNC Symbol;Acc:HGNC:15879],NA,CTNNBL1,56259,NM_001281495;NM_030877
MOCS3_SIG,MOCS3,MOCS3_SIG,MOCS3,SIG,44,3.40801269145079,0.110039175584097,0.0998350190062519,0.143567118625589,0.043732099619337,0.00164788023110417,2.31361137238384,2.26314188741631,2.21440410669061,2.42328030980075,0.20887620311014,0.0524987383165927,ENSG00000124217,MOCS3,protein_coding,20,1,50958826,50963931,q13.13,molybdenum cofactor synthesis 3 [Source:HGNC Symbol;Acc:HGNC:15765],NA,MOCS3,27304,NM_014484
HEATR1_SIG,HEATR1,HEATR1_SIG,HEATR1,SIG,23,3.40636030570452,0.614135804773066,0.607009101430971,0.637552115754234,0.0305430143232629,0.00165738346316727,3.36534909813305,5.8140193421758,5.76352489800554,5.97992965873522,0.216404760729682,0.00400186746175165,ENSG00000119285,HEATR1,protein_coding,1,-1,236549005,236604516,q43,HEAT repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:25517],NA,HEATR1,55127,NM_018072
ZNF589_TF,ZNF589,ZNF589_TF,ZNF589,TF,42,3.40561725746508,0.0834426440016261,0.0768250950494236,0.105186019130291,0.0283609240808679,0.00166136555747887,3.98783876366341,4.58994228176358,4.5173453180292,4.82847516260511,0.311129844575912,0.000590661143170217,ENSG00000164048,ZNF589,protein_coding,3,1,48241100,48299253,p21.31,zinc finger protein 589 [Source:HGNC Symbol;Acc:HGNC:16747],NA,ZNF589,51385,NM_016089
NAP1L4_SIG,NAP1L4,NAP1L4_SIG,NAP1L4,SIG,30,3.40553926998398,0.403325236455505,0.39615888368983,0.426871824114152,0.0307129404243219,0.00166136555747887,2.94782316965904,6.67195111973566,6.63598016944149,6.79014138498794,0.154161215546452,0.0123067637068709,ENSG00000205531,NAP1L4,protein_coding,11,-1,2944431,2992377,p15.4,nucleosome assembly protein 1 like 4 [Source:HGNC Symbol;Acc:HGNC:7640],NA,NAP1L4,4676,NM_005969
ZNF154_TF,ZNF154,ZNF154_TF,ZNF154,TF,41,-3.40514767697277,-0.0699967651705243,-0.0620924948979527,-0.0959679389232596,-0.0338754440253068,0.00166324475287827,-0.674822374742729,2.44332685387954,2.47114702651571,2.35191771521781,-0.119229311297905,0.60636842090171,ENSG00000179909,ZNF154,protein_coding,19,-1,57697367,57709194,q13.43,zinc finger protein 154 [Source:HGNC Symbol;Acc:HGNC:12939],NA,ZNF154,7710,NM_001085384
ZNF692_TF,ZNF692,ZNF692_TF,ZNF692,TF,201,3.40501702749844,0.0962358979048587,0.0852597105593276,0.132300513468747,0.047040802909419,0.00166353568026365,2.63012182672082,4.73970973522682,4.67418089827648,4.9550187709208,0.280837872644325,0.0262211020211134,ENSG00000171163,ZNF692,protein_coding,1,-1,248850006,248859144,q44,zinc finger protein 692 [Source:HGNC Symbol;Acc:HGNC:26049],NA,ZNF692,55657,NM_001136036;NM_001193328;NM_001350072;NM_001350073;NM_017865
RPP40_SIG,RPP40,RPP40_SIG,RPP40,SIG,29,3.40425839468318,0.463064619153993,0.446826341094636,0.516418961349024,0.0695926202543879,0.00166765693110418,2.87718861493626,2.3443078098975,2.27433761157437,2.57420989010209,0.29987227852772,0.0146843259909787,ENSG00000124787,RPP40,protein_coding,6,-1,4994732,5004063,p25.1,ribonuclease P/MRP subunit p40 [Source:HGNC Symbol;Acc:HGNC:20992],NA,RPP40,10799,NM_001286132;NM_001286133;NM_006638
MAP3K10_SIG,MAP3K10,MAP3K10_SIG,MAP3K10,SIG,52,3.40389685113009,0.0387354864936076,0.0343376116497553,0.0531856466948368,0.0188480350450814,0.00166935926541982,3.05105346079534,3.38436573563799,3.33545222475893,3.54508155709776,0.209629332338832,0.00942749590516907,ENSG00000130758,MAP3K10,protein_coding,19,1,40191426,40215575,q13.2,mitogen-activated protein kinase kinase kinase 10 [Source:HGNC Symbol;Acc:HGNC:6849],NA,MAP3K10,4294,NM_002446
FANCM_SIG,FANCM,FANCM_SIG,FANCM,SIG,64,3.40357967969913,0.188352062343281,0.179973553043775,0.215881450041657,0.0359078969978814,0.00167079188294274,2.18337582943398,3.70475969578202,3.67120986730106,3.81499484650519,0.143784979204134,0.0685775356367742,ENSG00000187790,FANCM,protein_coding,14,1,45135930,45200890,q21.2,FA complementation group M [Source:HGNC Symbol;Acc:HGNC:23168],FANCM-Related Fanconi Anemia;Fanconi anemia;Male infertility with azoospermia or oligozoospermia due to single gene mutation;PREMATURE OVARIAN FAILURE 15;SPERMATOGENIC FAILURE 28,FANCM,57697,NM_001308133;NM_001308134;NM_020937
MKNK2_SIG,MKNK2,MKNK2_SIG,MKNK2,SIG,12,-3.40192631987332,0.153996571908839,0.164986705413627,0.117886133250252,-0.0471005721633746,0.00168042289298696,-2.36307157294188,7.4429044761035,7.47977059747426,7.32177293445675,-0.157997663017513,0.0474222783804109,ENSG00000099875,MKNK2,protein_coding,19,-1,2037465,2051244,p13.3,MAP kinase interacting serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:7111],NA,MKNK2,2872,NM_017572;NM_199054
MRPS26_SIG,MRPS26,MRPS26_SIG,MRPS26,SIG,29,3.40074369953755,0.442978333596757,0.42703039806925,0.495378693187138,0.0683482951178881,0.00168719768295143,3.73177433773837,4.06207087687229,3.99272227157586,4.28993057998912,0.297208308413258,0.00133030977655348,ENSG00000125901,MRPS26,protein_coding,20,1,3046052,3048250,p13,mitochondrial ribosomal protein S26 [Source:HGNC Symbol;Acc:HGNC:14045],NA,MRPS26,64949,NM_030811
SREBF2_SIG,SREBF2,SREBF2_SIG,SREBF2,SIG,37,3.39999818063232,0.271719050276092,0.266580073514436,0.288604259635822,0.0220241861213863,0.00169129205695137,2.35744658323418,7.58603375587113,7.54658372107286,7.71565529877976,0.169071577706904,0.0479655264646478,ENSG00000198911,SREBF2,protein_coding,22,1,41833079,41907307,q13.2,sterol regulatory element binding transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:11290],NA,SREBF2,6721,NM_004599
CBFB_TF,CBFB,CBFB_TF,CBFB,TF,182,3.39904441951396,0.128301918646198,0.125528447631864,0.137414751979008,0.0118863043471433,0.00169668703166655,1.68654474855323,6.28588861136715,6.26292618197152,6.36133659366706,0.0984104116955401,0.166688873099494,ENSG00000067955,CBFB,protein_coding,16,1,67028984,67101058,q22.1,core-binding factor subunit beta [Source:HGNC Symbol;Acc:HGNC:1539],Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22);LEUKEMIA ACUTE MYELOID,CBFB,865,NM_001755;NM_022845
ZC3H14_SIG,ZC3H14,ZC3H14_SIG,ZC3H14,SIG,18,3.39882071257453,0.489660360185555,0.480018560902638,0.521340557829426,0.041321996926788,0.00169756124822582,2.11888136823785,5.65126636425061,5.62700935357749,5.730967970748,0.103958617170506,0.0775264290271815,ENSG00000100722,ZC3H14,protein_coding,14,1,88562970,88627596,q31.3,zinc finger CCCH-type containing 14 [Source:HGNC Symbol;Acc:HGNC:20509],Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 56,ZC3H14,79882,NM_001160103;NM_001160104;NM_001326295;NM_001326296;NM_001326297;NM_001326298;NM_001326299;NM_001326300;NM_001326301;NM_001326302;NM_001326303;NM_001326304;NM_001326305;NM_001326306;NM_001326307;NM_001326308;NM_001326309;NM_001326310;NM_001326311;NM_001326312;NM_001326313;NM_001326314;NM_001326315;NM_001326316;NM_024824;NM_207660;NM_207661;NM_207662
RPIA_SIG,RPIA,RPIA_SIG,RPIA,SIG,38,-3.39747408054236,-0.0377623347609784,-0.0321743860697045,-0.0561227376037354,-0.023948351534031,0.00170542187445564,-2.75590573121887,5.37638962963832,5.41602822922429,5.24614851671301,-0.169879712511283,0.019653675683794,ENSG00000153574,RPIA,protein_coding,2,1,88691673,88750929,p11.2,ribose 5-phosphate isomerase A [Source:HGNC Symbol;Acc:HGNC:10297],Ribose-5-P isomerase deficiency;RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY,RPIA,22934,NM_144563
SLC4A5_SIG,SLC4A5,SLC4A5_SIG,SLC4A5,SIG,126,3.39565223800588,0.0337810556919797,0.0273426039758535,0.0549359684735372,0.0275933644976838,0.00171629321400743,0.438554848101636,1.65940808799068,1.65096507057176,1.68714943093857,0.0361843603668137,0.745500510664189,ENSG00000188687,SLC4A5,protein_coding,2,-1,74216242,74343414,p13.1,solute carrier family 4 member 5 [Source:HGNC Symbol;Acc:HGNC:18168],NA,SLC4A5,57835,NM_021196;NM_133478
ZNF446_TF,ZNF446,ZNF446_TF,ZNF446,TF,163,3.39536723857926,0.14433076867579,0.138541081350257,0.163354027031112,0.0248129456808549,0.00171756128721648,2.05096812409867,3.74820997042194,3.72535036758929,3.82332009401493,0.0979697264256389,0.0883766246335412,ENSG00000083838,ZNF446,protein_coding,19,1,58474017,58481230,q13.43,zinc finger protein 446 [Source:HGNC Symbol;Acc:HGNC:21036],NA,ZNF446,55663,NM_001304453;NM_017908
NANP_SIG,NANP,NANP_SIG,NANP,SIG,19,3.39527421696964,0.0603532656688824,0.0569974516244331,0.07137951181493,0.0143820601904968,0.00171762544794826,2.47134424137986,3.08365921896112,3.04044364072609,3.22565326173338,0.18520962100729,0.0375932642292791,ENSG00000170191,NANP,protein_coding,20,-1,25612935,25624014,p11.21,N-acetylneuraminic acid phosphatase [Source:HGNC Symbol;Acc:HGNC:16140],NA,NANP,140838,NM_152667
KCNN4_SIG,KCNN4,KCNN4_SIG,KCNN4,SIG,7,3.395015132118,0.39773617597782,0.389814589994935,0.423764244207297,0.0339496542123618,0.00171873195477712,2.9560270256656,5.11983380292664,5.05034951388184,5.34813932407386,0.297789810192019,0.0120642301520523,ENSG00000104783,KCNN4,protein_coding,19,-1,43766533,43781257,q13.31,potassium calcium-activated channel subfamily N member 4 [Source:HGNC Symbol;Acc:HGNC:6293],Dehydrated hereditary stomatocytosis;Dehydrated hereditary stomatocytosis 2,KCNN4,3783,NM_002250
IBA57_SIG,IBA57,IBA57_SIG,IBA57,SIG,42,3.39429577877383,0.233142075679961,0.224575190466905,0.261290412808571,0.0367152223416658,0.00172273257669734,3.17604176571794,3.98547825598629,3.92994455893329,4.16794611773183,0.238001558798537,0.00677843268903126,ENSG00000181873,IBA57,protein_coding,1,1,228165804,228182257,q42.13,IBA57, iron-sulfur cluster assembly [Source:HGNC Symbol;Acc:HGNC:27302],Autosomal recessive spastic paraplegia type 74;MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3;Multiple mitochondrial dysfunctions syndrome type 3;SPASTIC PARAPLEGIA 74 AUTOSOMAL RECESSIVE,IBA57,200205,NM_001010867;NM_001310327
TRUB1_SIG,TRUB1,TRUB1_SIG,TRUB1,SIG,51,3.39419491112553,0.352433609854675,0.344011856423407,0.380105085414554,0.036093228991146,0.00172284660328947,3.97237555805343,3.69780521120433,3.62798704193481,3.92720776737561,0.299220725440799,0.000620254772764729,ENSG00000165832,TRUB1,protein_coding,10,1,114938195,114977676,q25.3,TruB pseudouridine synthase family member 1 [Source:HGNC Symbol;Acc:HGNC:16060],NA,TRUB1,142940,NM_139169
DAGLA_SIG,DAGLA,DAGLA_SIG,DAGLA,SIG,43,-3.39330921517883,0.024701963675489,0.0330476852154772,-0.00271969281304387,-0.0357673780285212,0.00172790522407593,-2.15684825181452,1.97319276649002,2.04363252046787,1.7417478605628,-0.301884659905068,0.0721918488694671,ENSG00000134780,DAGLA,protein_coding,11,1,61680391,61747001,q12.2,diacylglycerol lipase alpha [Source:HGNC Symbol;Acc:HGNC:1165],NA,DAGLA,747,NM_006133
UBAP2L_SIG,UBAP2L,UBAP2L_SIG,UBAP2L,SIG,17,3.39193084368993,0.616593723158085,0.611648096377416,0.632843639723141,0.0211955433457242,0.00173609660417004,2.54070977823645,7.73268998033168,7.70657934271133,7.81848207536996,0.111902732658629,0.032319367107333,ENSG00000143569,UBAP2L,protein_coding,1,1,154220179,154271510,q21.3,ubiquitin associated protein 2 like [Source:HGNC Symbol;Acc:HGNC:29877],NA,UBAP2L,9898,NM_001127320;NM_001287815;NM_001287816;NM_001330730;NM_014847
DTHD1_SIG,DTHD1,DTHD1_SIG,DTHD1,SIG,25,-3.39156035057515,-0.274269376939501,-0.255079302886354,-0.33732247739984,-0.0822431745134856,0.00173792082071531,-2.6786100346062,0.835779526283767,0.895751320155708,0.638729346418821,-0.257021973736887,0.0235599180192664,ENSG00000197057,DTHD1,protein_coding,4,1,36281622,36345756,p14,death domain containing 1 [Source:HGNC Symbol;Acc:HGNC:37261],NA,DTHD1,401124,NM_001136536;NM_001170700
GNS_SIG,GNS,GNS_SIG,GNS,SIG,75,-3.3912500482394,0.440316848655296,0.455891138481312,0.389144182084099,-0.0667469563972127,0.00173936482425559,-2.86745655881877,7.21524009765651,7.29249853957517,6.96139093135233,-0.331107608222844,0.0150296469865639,ENSG00000135677,GNS,protein_coding,12,-1,64713445,64759431,q14.3,glucosamine (N-acetyl)-6-sulfatase [Source:HGNC Symbol;Acc:HGNC:4422],MUCOPOLYSACCHARIDOSIS TYPE 3D;MUCOPOLYSACCHARIDOSIS TYPE IIID;Sanfilippo syndrome type D,GNS,2799,NM_002076
NAF1_SIG,NAF1,NAF1_SIG,NAF1,SIG,49,3.39103303009366,0.39093574434904,0.383191389123736,0.416381482946469,0.0331900938227326,0.00174021761236462,2.49532041975703,3.9606648054637,3.93120242457552,4.05746977123915,0.126267346663625,0.0356915864954373,ENSG00000145414,NAF1,protein_coding,4,-1,163110073,163166890,q32.2,nuclear assembly factor 1 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:25126],NA,NAF1,92345,NM_001128931;NM_138386
XCL1_SIG,XCL1,XCL1_SIG,XCL1,SIG,12,-3.39093950783064,-0.17861918919613,-0.169289675222986,-0.209273306536462,-0.0399836313134763,0.00174028656729922,-2.92158643859713,0.652051585589326,0.704657625370993,0.479203169163846,-0.225454456207147,0.0131392660127891,ENSG00000143184,XCL1,protein_coding,1,1,168576605,168582069,q24.2,X-C motif chemokine ligand 1 [Source:HGNC Symbol;Acc:HGNC:10645],NA,XCL1,6375,NM_002995
CCR10_SIG,CCR10,CCR10_SIG,CCR10,SIG,27,-3.38911472636986,0.0567730679373433,0.0622204599215021,0.0388744942751074,-0.0233459656463949,0.00175138123455508,-1.9635400509439,0.58634932759695,0.608129402324717,0.514786224920001,-0.0933431774047166,0.103798457463549,ENSG00000184451,CCR10,protein_coding,17,-1,42678889,42683917,q21.2,C-C motif chemokine receptor 10 [Source:HGNC Symbol;Acc:HGNC:4474],NA,CCR10,2826,NM_016602
ARL6IP4_SIG,ARL6IP4,ARL6IP4_SIG,ARL6IP4,SIG,29,3.38881987061696,0.216123105042542,0.211525423756324,0.231229772125827,0.0197043483695026,0.00175273707667272,2.6531519408023,1.54139527491456,1.51391296868246,1.63169428110578,0.117781312423323,0.0248853914542537,ENSG00000182196,ARL6IP4,protein_coding,12,1,122980060,122982913,q24.31,ADP ribosylation factor like GTPase 6 interacting protein 4 [Source:HGNC Symbol;Acc:HGNC:18076],NA,ARL6IP4,51329,NM_001002251;NM_001002252;NM_001278378;NM_001278379;NM_001278380;NM_016638;NM_018694
ZNFX1_TF,ZNFX1,ZNFX1_TF,ZNFX1,TF,310,-3.38761121030481,-0.0562813281247325,-0.0484933790013288,-0.0818703038159162,-0.0333769248145874,0.00175994787249315,-2.81276288374974,6.37296348983553,6.42417746563184,6.20468899793338,-0.219488467698455,0.0171593158617029,ENSG00000124201,ZNFX1,protein_coding,20,-1,49237946,49278426,q13.13,zinc finger NFX1-type containing 1 [Source:HGNC Symbol;Acc:HGNC:29271],NA,ZNFX1,57169,NM_021035
GPCPD1_SIG,GPCPD1,GPCPD1_SIG,GPCPD1,SIG,30,-3.38562876209058,0.208308399072546,0.218533061729089,0.174713078915335,-0.0438199828137536,0.0017721760748026,-1.83754134359234,7.01669692062157,7.05119946586068,6.90333141483592,-0.147868051024755,0.129398615577536,ENSG00000125772,GPCPD1,protein_coding,20,-1,5544404,5611026,p12.3,glycerophosphocholine phosphodiesterase 1 [Source:HGNC Symbol;Acc:HGNC:26957],NA,GPCPD1,56261,NM_019593
RFXAP_TF,RFXAP,RFXAP_TF,RFXAP,TF,63,3.38516251341832,0.191848441880096,0.183111763997776,0.220554669207719,0.0374429052099439,0.00177465460554849,3.04177783215496,3.33714200378898,3.27925154773642,3.52735350224742,0.248101954510998,0.00964953146063002,ENSG00000133111,RFXAP,protein_coding,13,1,36819224,36829104,q13.3,regulatory factor X associated protein [Source:HGNC Symbol;Acc:HGNC:9988],BARE LYMPHOCYTE SYNDROME TYPE II;Immunodeficiency by defective expression of HLA class 2,RFXAP,5994,NM_000538
THYN1_TF,THYN1,THYN1_TF,THYN1,TF,104,3.38506202731606,0.141291097031492,0.133336619602659,0.167427237154801,0.0340906175521418,0.00177477000172505,2.66555703302322,4.82744730803006,4.78868062957768,4.95482353723072,0.166142907653042,0.0242409904727458,ENSG00000151500,THYN1,protein_coding,11,-1,134248279,134253370,q25,thymocyte nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:29560],NA,THYN1,29087,NM_001037304;NM_001037305;NM_014174;NM_199297;NM_199298
RNF144B_SIG,RNF144B,RNF144B_SIG,RNF144B,SIG,17,-3.38483975374987,0.215051192327193,0.22586083637686,0.179533790449716,-0.046327045927144,0.00177559204306694,-2.68602780086908,4.71190142388392,4.81384405599414,4.37694706123606,-0.436896994758078,0.0231757054162409,ENSG00000137393,RNF144B,protein_coding,6,1,18387350,18468874,p22.3,ring finger protein 144B [Source:HGNC Symbol;Acc:HGNC:21578],NA,RNF144B,255488,NM_182757
SLC8A1_SIG,SLC8A1,SLC8A1_SIG,SLC8A1,SIG,31,-3.38476970364899,0.178585371268302,0.204208164082367,0.0943961948792281,-0.109811969203139,0.00177559204306694,-2.47899232398658,3.3030764332501,3.42377755486357,2.90648703366298,-0.51729052120059,0.036954916854779,ENSG00000183023,SLC8A1,protein_coding,2,-1,40097270,40611053,p22.1,solute carrier family 8 member A1 [Source:HGNC Symbol;Acc:HGNC:11068],NA,SLC8A1,6546,NM_001112800;NM_001112801;NM_001112802;NM_001252624;NM_001351483;NM_001351484;NM_001351485;NM_001351486;NM_001351487;NM_001351488;NM_001351489;NM_001351490;NM_001351491;NM_001351492;NM_001351493;NM_001351494;NM_021097
HNRNPU_SIG,HNRNPU,HNRNPU_SIG,HNRNPU,SIG,13,3.38458971325828,0.499101672610901,0.493596025455734,0.517191656120735,0.0235956306650012,0.00177622226137022,1.34185262471421,9.41780936044951,9.40454671011411,9.46138664012296,0.0568399300088539,0.278420435948724,ENSG00000153187,HNRNPU,protein_coding,1,-1,244840638,244864560,q44,heterogeneous nuclear ribonucleoprotein U [Source:HGNC Symbol;Acc:HGNC:5048],1q44 microdeletion syndrome;Epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 54,HNRNPU,3192,NM_004501;NM_031844
PES1_SIG,PES1,PES1_SIG,PES1,SIG,21,3.38413042549241,0.743335645314568,0.730318576493998,0.786106014296439,0.055787437802441,0.00177866135025919,3.40205487731801,5.82620258306909,5.78068773130143,5.97575138173427,0.195063650432842,0.00357948468387011,ENSG00000100029,PES1,protein_coding,22,-1,30576625,30607083,q12.2,pescadillo ribosomal biogenesis factor 1 [Source:HGNC Symbol;Acc:HGNC:8848],NA,PES1,23481,NM_001243225;NM_001282327;NM_001282328;NM_014303
ALG8_SIG,ALG8,ALG8_SIG,ALG8,SIG,72,3.38276090009634,0.275684941607191,0.261405542123214,0.322602968483114,0.0611974263598996,0.00178701696122209,3.09352196703809,4.17489927260716,4.10792288884581,4.39496453353731,0.287041644691499,0.0084305061213945,ENSG00000159063,ALG8,protein_coding,11,-1,78100936,78139653,q14.1,ALG8, alpha-1,3-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:23161],ALG8-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ih;POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS,ALG8,79053,NM_001007027;NM_024079
KLRK1_SIG,KLRK1,KLRK1_SIG,KLRK1,SIG,5,-3.38119127612311,-0.0647043648518124,-0.0464405545324258,-0.124714027329797,-0.078273472797371,0.00179671685849258,-1.83836556004074,0.338711982146177,0.357661409080065,0.276449579363402,-0.0812118297166623,0.129216304101608,ENSG00000213809,KLRK1,protein_coding,12,-1,10372353,10391874,p13.2,killer cell lectin like receptor K1 [Source:HGNC Symbol;Acc:HGNC:18788],NA,KLRK1,22914;100528032,NM_001199805;NM_007360
ITGA6_SIG,ITGA6,ITGA6_SIG,ITGA6,SIG,50,3.38072951640917,0.179584282081889,0.168901719769286,0.214684129680442,0.045782409911156,0.00179919812242501,1.52631761804425,6.02751614163198,5.97038761564357,6.2152241555939,0.244836539950327,0.213360686978384,ENSG00000091409,ITGA6,protein_coding,2,1,172427354,172506459,q31.1,integrin subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:6142],EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;Epidermolysis Bullosa with Pyloric Atresia;Junctional epidermolysis bullosa-pyloric atresia syndrome,ITGA6,3655,NM_000210;NM_001079818;NM_001316306
MALT1_SIG,MALT1,MALT1_SIG,MALT1,SIG,39,-3.38053458692023,0.0371861533685036,0.0450724272768198,0.0112741105268933,-0.0337983167499264,0.00179993414707551,-1.57181050312935,5.22878573264059,5.25950280409879,5.12785821213507,-0.131644591963713,0.19909556633413,ENSG00000172175,MALT1,protein_coding,18,1,58671386,58754477,q21.32,MALT1 paracaspase [Source:HGNC Symbol;Acc:HGNC:6819],Combined immunodeficiency due to MALT1 deficiency;Immunodeficiency 12;MALT lymphoma,MALT1,10892,NM_006785;NM_173844
ARID3A_TF,ARID3A,ARID3A_TF,ARID3A,TF,197,-3.37898874159733,0.0888543783019838,0.0959713321673111,0.0654701013159084,-0.0305012308514026,0.00180954218289609,-3.61979537683764,5.74572210160491,5.81774748588018,5.50906726755761,-0.308680218322564,0.00187919941620869,ENSG00000116017,ARID3A,protein_coding,19,1,925781,975939,p13.3,AT-rich interaction domain 3A [Source:HGNC Symbol;Acc:HGNC:3031],NA,ARID3A,1820,NM_005224
RRP9_SIG,RRP9,RRP9_SIG,RRP9,SIG,59,3.378250810052,0.373273906016552,0.358286894144113,0.422516945025995,0.0642300508818822,0.00181386085117803,3.1219345802404,3.73071426263507,3.66955217280835,3.93167541492287,0.262123242114518,0.00785874743846464,ENSG00000114767,RRP9,protein_coding,3,-1,51933429,51941904,p21.2,ribosomal RNA processing 9, U3 small nucleolar RNA binding protein [Source:HGNC Symbol;Acc:HGNC:16829],NA,RRP9,9136,NM_004704
BYSL_SIG,BYSL,BYSL_SIG,BYSL,SIG,12,3.37805852041131,0.535711695251291,0.522130506289904,0.580335601838705,0.0582050955488016,0.00181458512039289,3.29140289568694,3.25323018194155,3.18580846433825,3.47475868263814,0.28895021829989,0.00492237469482651,ENSG00000112578,BYSL,protein_coding,6,1,41921499,41933046,p21.1,bystin like [Source:HGNC Symbol;Acc:HGNC:1157],NA,BYSL,705,NM_004053
PARP11_SIG,PARP11,PARP11_SIG,PARP11,SIG,53,3.37689081586042,0.31978806501909,0.312913168057041,0.342377012180108,0.0294638441230677,0.00182175928171212,1.31058924056089,4.22093402869482,4.19936760640355,4.29179513050901,0.0924275241054612,0.290717039321105,ENSG00000111224,PARP11,protein_coding,12,-1,3791047,3873448,p13.32,poly(ADP-ribose) polymerase family member 11 [Source:HGNC Symbol;Acc:HGNC:1186],NA,PARP11,57097,NM_001286521;NM_001286522;NM_020367
CCT6A_SIG,CCT6A,CCT6A_SIG,CCT6A,SIG,19,3.3755905417983,0.665035308427319,0.655818297720583,0.695319772178025,0.0395014744574422,0.00182984103051018,2.98740808746341,7.08799792462966,7.04869325011656,7.21714185517272,0.168448605056159,0.0111202467787593,ENSG00000146731,CCT6A,protein_coding,7,1,56051685,56063989,p11.2,chaperonin containing TCP1 subunit 6A [Source:HGNC Symbol;Acc:HGNC:1620],NA,CCT6A,908,NM_001009186;NM_001762
GCSH_SIG,GCSH,GCSH_SIG,GCSH,SIG,8,3.37326761395588,0.297422913494763,0.28579331784438,0.335634442060309,0.0498411242159301,0.0018447962838817,3.70087150070985,0.857463114308584,0.819808100888758,0.981186729830872,0.161378628942114,0.00146733370648604,ENSG00000140905,GCSH,protein_coding,16,-1,81081938,81096425,q23.2,glycine cleavage system protein H [Source:HGNC Symbol;Acc:HGNC:4208],Atypical glycine encephalopathy;GLYCINE ENCEPHALOPATHY;Infantile glycine encephalopathy;Neonatal glycine encephalopathy,GCSH,2653,NM_004483
SF3A2_SIG,SF3A2,SF3A2_SIG,SF3A2,SIG,19,3.37289766811755,0.422924433552233,0.416002173659799,0.44566900177023,0.0296668281104302,0.00184666347686223,1.33805218540086,6.10861372160765,6.09500929166617,6.15331399141538,0.0583046997492057,0.279916134781068,ENSG00000104897,SF3A2,protein_coding,19,1,2236824,2248655,p13.3,splicing factor 3a subunit 2 [Source:HGNC Symbol;Acc:HGNC:10766],NA,SF3A2,8175,NM_007165
STAP1_SIG,STAP1,STAP1_SIG,STAP1,SIG,33,3.37282404790798,0.0138283246851553,0.00577281490924178,0.0402964282345852,0.0345236133253435,0.00184666347686223,2.25970986961583,3.24987735703893,3.17353692604006,3.50071020174948,0.327173275709421,0.0587305522156415,ENSG00000035720,STAP1,protein_coding,4,1,67558727,67607337,q13.2,signal transducing adaptor family member 1 [Source:HGNC Symbol;Acc:HGNC:24133],NA,STAP1,26228,NM_001317769;NM_012108
CHERP_SIG,CHERP,CHERP_SIG,CHERP,SIG,14,3.37195073765983,0.203461962687349,0.197271808126864,0.223801041957513,0.0265292338306491,0.00185197409441243,2.52285349214085,5.84256233604954,5.81712439818755,5.92614413188178,0.109019733694222,0.0336334020596299,ENSG00000085872,CHERP,protein_coding,19,-1,16517894,16542437,p13.11,calcium homeostasis endoplasmic reticulum protein [Source:HGNC Symbol;Acc:HGNC:16930],NA,CHERP,10523,NM_006387
IRF8_SIG,IRF8,IRF8_SIG,IRF8,SIG,53,-3.37150656584573,-0.00780614307817652,0.00797282687086649,-0.0596513300536036,-0.0676241569244701,0.00185440765511918,-3.51708820583413,5.76663698916506,5.95233688868927,5.15648017644262,-0.795856712246654,0.00256950716284699,ENSG00000140968,IRF8,protein_coding,16,1,85899162,85922606,q24.1,interferon regulatory factor 8 [Source:HGNC Symbol;Acc:HGNC:5358],IMMUNODEFICIENCY 32A;IMMUNODEFICIENCY 32B;Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,IRF8,3394,NM_001363907;NM_002163
NMB_SIG,NMB,NMB_SIG,NMB,SIG,28,3.37033007385922,0.0712099058669485,0.0665700922263803,0.0864550078288154,0.019884915602435,0.00186178641621911,3.09373027808487,1.98781547455371,1.93663758162665,2.15597140845689,0.219333826830244,0.00842773531905203,ENSG00000197696,NMB,protein_coding,15,-1,84655129,84658563,q25.2,neuromedin B [Source:HGNC Symbol;Acc:HGNC:7842],NA,NMB,4828,NM_021077;NM_205858
GTPBP10_SIG,GTPBP10,GTPBP10_SIG,GTPBP10,SIG,73,3.37022000640866,0.21696126851168,0.202217812162324,0.265404053659566,0.0631862414972424,0.00186197296912866,3.23157153243543,4.0601640753299,3.99310598345307,4.28049780578235,0.287391822329273,0.00581248180176254,ENSG00000105793,GTPBP10,protein_coding,7,1,90335223,90391455,q21.13,GTP binding protein 10 [Source:HGNC Symbol;Acc:HGNC:25106],NA,GTPBP10,85865,NM_001042717;NM_033107
ZNF492_TF,ZNF492,ZNF492_TF,ZNF492,TF,62,3.36996083490681,0.046240875119967,0.0396788691497675,0.0678017518791939,0.0281228827294262,0.00186316757907758,1.85376203525264,1.33895752069327,1.29773307250587,1.4744092790233,0.176676206517433,0.12607244167238,ENSG00000229676,ZNF492,protein_coding,19,1,22634324,22667671,p12,zinc finger protein 492 [Source:HGNC Symbol;Acc:HGNC:23707],NA,ZNF492,57615,NM_020855
GPT_SIG,GPT,GPT_SIG,GPT,SIG,8,-3.36905596478429,-0.121843220604002,-0.111178585768745,-0.156884163634133,-0.0457055778653885,0.00186873606833697,-1.9704085538471,0.564475155528851,0.599997537546143,0.447758757472031,-0.152238780074112,0.102507175114128,ENSG00000167701,GPT,protein_coding,8,1,144502973,144507174,q24.3,glutamic--pyruvic transaminase [Source:HGNC Symbol;Acc:HGNC:4552],NA,GPT,2875,NM_005309
DCP2_SIG,DCP2,DCP2_SIG,DCP2,SIG,42,-3.36865157886092,-0.134352438532549,-0.130803748569853,-0.146012419838549,-0.015208671268696,0.00187092017867794,-1.29993748153521,6.13145945413395,6.14935137954744,6.0726716992039,-0.0766796803435445,0.295078089128357,ENSG00000172795,DCP2,protein_coding,5,1,112976702,113022195,q22.2,decapping mRNA 2 [Source:HGNC Symbol;Acc:HGNC:24452],NA,DCP2,167227,NM_001242377;NM_152624
EPHA2_SIG,EPHA2,EPHA2_SIG,EPHA2,SIG,28,-3.36831134333683,-0.126267179366248,-0.121977103318979,-0.140363143521561,-0.0183860402025816,0.00187267090414057,-0.482821507888139,0.517141671420371,0.52572247789439,0.48894759300574,-0.03677488488865,0.719411748210125,ENSG00000142627,EPHA2,protein_coding,1,-1,16124337,16156069,p36.13,EPH receptor A2 [Source:HGNC Symbol;Acc:HGNC:3386],Cataract 6 multiple types;Early-onset nuclear cataract;Early-onset posterior polar cataract;Early-onset posterior subcapsular cataract;Total early-onset cataract,EPHA2,1969,NM_001329090;NM_004431
ZSCAN32_TF,ZSCAN32,ZSCAN32_TF,ZSCAN32,TF,21,3.36801261686168,0.200182116145678,0.192060720765349,0.226866700966759,0.0348059802014094,0.00187414104348784,3.45623318702215,3.72846643158128,3.67236279833491,3.91280694081935,0.240444142484441,0.00306095884267737,ENSG00000140987,ZSCAN32,protein_coding,16,-1,3382081,3401065,p13.3,zinc finger and SCAN domain containing 32 [Source:HGNC Symbol;Acc:HGNC:20812],NA,ZSCAN32,54925,NM_001284527;NM_001284528;NM_001284529;NM_001324340;NM_001324341;NM_001324342;NM_001324343;NM_001324344;NM_001324345;NM_001324346;NM_017810
GZMH_SIG,GZMH,GZMH_SIG,GZMH,SIG,16,-3.36754783054149,-0.352910831770527,-0.327057557900167,-0.437857303058854,-0.110799745158687,0.00187674229505954,-2.94974269075818,2.45209305814074,2.56258836582116,2.0890370471908,-0.473551318630357,0.0122438458013353,ENSG00000100450,GZMH,protein_coding,14,-1,24606480,24609699,q12,granzyme H [Source:HGNC Symbol;Acc:HGNC:4710],NA,GZMH,2999,NM_001270780;NM_001270781;NM_033423
VPS11_SIG,VPS11,VPS11_SIG,VPS11,SIG,6,3.36710930598956,0.284576454363568,0.282052870945226,0.292868228452406,0.0108153575071798,0.00187916797740299,1.59132523324302,6.15562861635479,6.1440973642817,6.19351701602352,0.0494196517418245,0.193142006929018,ENSG00000160695,VPS11,protein_coding,11,1,119067692,119081978,q23.3,VPS11, CORVET/HOPS core subunit [Source:HGNC Symbol;Acc:HGNC:14583],Leukodystrophy hypomyelinating 12;VPS11-related autosomal recessive hypomyelinating leukodystrophy,VPS11,55823,NM_001290185;NM_021729
SULF2_SIG,SULF2,SULF2_SIG,SULF2,SIG,16,-3.3666461948443,0.34185898285863,0.363799241802479,0.269769560614554,-0.0940296811879242,0.00188176436962432,-1.18739988459037,5.26727650190952,5.33436653632516,5.04683781740101,-0.287528718924152,0.342622117238807,ENSG00000196562,SULF2,protein_coding,20,-1,47656348,47786616,q13.12,sulfatase 2 [Source:HGNC Symbol;Acc:HGNC:20392],NA,SULF2,55959,NM_001161841;NM_018837;NM_198596
IRF3_SIG,IRF3,IRF3_SIG,IRF3,SIG,66,3.36651068369157,0.196417080681843,0.187803855406856,0.224717678013942,0.0369138226070856,0.00188212734194717,2.50062180112383,5.97429884460213,5.93595680391303,6.10027983543775,0.164323031524729,0.035251643766283,ENSG00000126456,IRF3,protein_coding,19,-1,49659569,49665875,q13.33,interferon regulatory factor 3 [Source:HGNC Symbol;Acc:HGNC:6118],ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 7,IRF3,3661,NM_001197122;NM_001197123;NM_001197124;NM_001197125;NM_001197126;NM_001197127;NM_001197128;NM_001571
RNF165_SIG,RNF165,RNF165_SIG,RNF165,SIG,10,-3.36631632177836,-0.0735978640781676,-0.0658787407258108,-0.0989606979501971,-0.0330819572243864,0.00188289222376281,-1.45840191923791,0.922563112852728,0.957801034118509,0.806781371550874,-0.151019662567635,0.235798976909796,ENSG00000141622,RNF165,protein_coding,18,1,46326809,46463140,q21.1,ring finger protein 165 [Source:HGNC Symbol;Acc:HGNC:31696],NA,RNF165,494470,NM_001256758;NM_152470
UTP20_SIG,UTP20,UTP20_SIG,UTP20,SIG,39,3.36482896667035,0.572514138167294,0.562059659517029,0.606864568018165,0.0448049085011361,0.00189250650533909,3.12632484357237,4.57937843049842,4.51964616364049,4.77564159303161,0.255995429391124,0.00775721359551532,ENSG00000120800,UTP20,protein_coding,12,1,101280105,101386618,q23.2,UTP20, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:17897],NA,UTP20,27340,NM_014503
ZNF419_TF,ZNF419,ZNF419_TF,ZNF419,TF,25,3.36448054809345,0.226197135585047,0.218219929309221,0.252407956205618,0.0341880268963964,0.00189433263913132,2.49351795233277,2.91568859668568,2.87040571710582,3.06447520101952,0.194069483913698,0.03580320884707,ENSG00000105136,ZNF419,protein_coding,19,1,57487711,57496097,q13.43,zinc finger protein 419 [Source:HGNC Symbol;Acc:HGNC:20648],NA,ZNF419,79744,NM_001098491;NM_001098492;NM_001098493;NM_001098494;NM_001098495;NM_001098496;NM_001291743;NM_001291744;NM_001291745;NM_024691
FGL2_SIG,FGL2,FGL2_SIG,FGL2,SIG,51,-3.36367412893144,0.260381688308003,0.288751904552196,0.167165263505651,-0.121586641046545,0.00189930969826156,-2.7489479141952,6.09719717166828,6.25769998104716,5.56983079799481,-0.687869183052348,0.0199734050842395,ENSG00000127951,FGL2,protein_coding,7,-1,77193369,77199848,q11.23,fibrinogen like 2 [Source:HGNC Symbol;Acc:HGNC:3696],NA,FGL2,10875,NM_006682
PFDN1_TF,PFDN1,PFDN1_TF,PFDN1,TF,392,3.36286841105056,0.167432549401979,0.164650330398878,0.176574126126456,0.0119237957275782,0.00190429400186809,2.88347787306492,5.28170321639624,5.24988807126224,5.38623869326513,0.13635062200289,0.0144568273095162,ENSG00000113068,PFDN1,protein_coding,5,-1,140245039,140303121,q31.3,prefoldin subunit 1 [Source:HGNC Symbol;Acc:HGNC:8866],NA,PFDN1,5201,NM_002622
ZFP30_TF,ZFP30,ZFP30_TF,ZFP30,TF,35,3.3621488907522,0.172907072110726,0.163981609564126,0.202233591906697,0.0382519823425717,0.00190869445796041,2.02034487734177,2.44098767003725,2.39706791189272,2.58529544679784,0.188227534905117,0.0935661393524113,ENSG00000120784,ZFP30,protein_coding,19,-1,37613749,37692337,q13.12,ZFP30 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:29555],NA,ZFP30,22835,NM_001320666;NM_001320667;NM_001320668;NM_001320669;NM_001320670;NM_001320671;NM_014898
VEGFB_SIG,VEGFB,VEGFB_SIG,VEGFB,SIG,8,3.36153577172722,0.122084724565594,0.117201636330913,0.138129157336688,0.0209275210057743,0.00191236738646347,2.03039182131004,3.96848074936725,3.93850150650784,4.06698397590535,0.128482469397509,0.0918498700185503,ENSG00000173511,VEGFB,protein_coding,11,1,64234538,64238793,q13.1,vascular endothelial growth factor B [Source:HGNC Symbol;Acc:HGNC:12681],NA,VEGFB,7423,NM_001243733;NM_003377
P2RY6_SIG,P2RY6,P2RY6_SIG,P2RY6,SIG,14,-3.36134076882684,-0.0476035564642161,-0.0314512662848479,-0.100675367053568,-0.0692241007687205,0.00191314844921557,-0.553431656953949,0.920071023738373,0.931572046729953,0.882281948194612,-0.0492900985353409,0.678555570042756,ENSG00000171631,P2RY6,protein_coding,11,1,73264505,73298617,q13.4,pyrimidinergic receptor P2Y6 [Source:HGNC Symbol;Acc:HGNC:8543],NA,P2RY6,5031,NM_001277204;NM_001277205;NM_001277206;NM_001277207;NM_001277208;NM_176796;NM_176797;NM_176798
P2RY12_SIG,P2RY12,P2RY12_SIG,P2RY12,SIG,11,-3.36098243090882,-0.0439560484450137,-0.0198231157358226,-0.123249970203784,-0.103426854467961,0.00191506210863451,-2.15876830851446,0.595487588468283,0.64020716035434,0.44855185227124,-0.1916553080831,0.0719322303195127,ENSG00000169313,P2RY12,protein_coding,3,-1,151337380,151384812,q25.1,purinergic receptor P2Y12 [Source:HGNC Symbol;Acc:HGNC:18124],Bleeding disorder due to P2Y12 defect;BLEEDING DISORDER PLATELET-TYPE 8;Resistance to clopidogrel,P2RY12,64805,NM_022788;NM_176876
HLX_TF,HLX,HLX_TF,HLX,TF,65,-3.35953898102707,0.0826398652313361,0.0883219593203092,0.0639701275104244,-0.0243518318098849,0.00192452184096923,-0.0859759375718365,5.44368857242723,5.44648460368134,5.43450161259232,-0.0119829910890161,0.952450663731899,ENSG00000136630,HLX,protein_coding,1,1,220879431,220885059,q41,H2.0 like homeobox [Source:HGNC Symbol;Acc:HGNC:4978],Diaphragmatic hernia-short bowel-asplenia syndrome,HLX,3142,NM_021958
PPM1J_SIG,PPM1J,PPM1J_SIG,PPM1J,SIG,30,-3.35926236847549,-0.0854899906289001,-0.0772361616875223,-0.112609714293427,-0.0353735526059047,0.00192587638086188,-1.85081071071736,0.611374509034332,0.649424014797508,0.486354704383896,-0.163069310413612,0.126676774478363,ENSG00000155367,PPM1J,protein_coding,1,-1,112709994,112715477,p13.2,protein phosphatase, Mg2+/Mn2+ dependent 1J [Source:HGNC Symbol;Acc:HGNC:20785],NA,PPM1J,333926,NM_005167
HKDC1_SIG,HKDC1,HKDC1_SIG,HKDC1,SIG,18,-3.35786586346111,-0.175051580360135,-0.158271709786924,-0.230185440814969,-0.0719137310280451,0.00193497205095414,0.145116724374205,0.389521168376938,0.387916233779268,0.394794524912137,0.00687829113286856,0.918483181170357,ENSG00000156510,HKDC1,protein_coding,10,1,69220332,69267552,q22.1,hexokinase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23302],NA,HKDC1,80201,NM_025130
FDPS_SIG,FDPS,FDPS_SIG,FDPS,SIG,17,3.35779577218516,0.35471576545783,0.344399103723411,0.388613368299494,0.0442142645760839,0.00193497205095414,1.64780887021134,5.95859691153851,5.93927604422849,6.02207976127146,0.0828037170429701,0.177066290680117,ENSG00000160752,FDPS,protein_coding,1,1,155308748,155320666,q22,farnesyl diphosphate synthase [Source:HGNC Symbol;Acc:HGNC:3631],Disseminated superficial actinic porokeratosis;POROKERATOSIS 9 MULTIPLE TYPES,FDPS,2224,NM_001135821;NM_001135822;NM_001242824;NM_001242825;NM_002004
CD22_SIG,CD22,CD22_SIG,CD22,SIG,16,-3.3566743414423,-0.0845058402855699,-0.0741990183434948,-0.11837111238096,-0.044172094037465,0.00194225928809678,-1.40676370894242,2.8459164418686,2.89394471880559,2.68810924621851,-0.205835472587077,0.254023548227834,ENSG00000012124,CD22,protein_coding,19,1,35319261,35347361,q13.12,CD22 molecule [Source:HGNC Symbol;Acc:HGNC:1643],NA,CD22,933,NM_001185099;NM_001185100;NM_001185101;NM_001278417;NM_001771
ZNF234_TF,ZNF234,ZNF234_TF,ZNF234,TF,130,3.35208018414759,0.157768197123213,0.143978532903649,0.20307709384464,0.059098560940991,0.0019741925478155,3.31889107284843,2.64088404668487,2.55916663223528,2.90938412273352,0.350217490498239,0.00455819727826557,ENSG00000263002,ZNF234,protein_coding,19,1,44141554,44160313,q13.31,zinc finger protein 234 [Source:HGNC Symbol;Acc:HGNC:13027],NA,ZNF234,10780,NM_001144824;NM_006630
IPO7_SIG,IPO7,IPO7_SIG,IPO7,SIG,22,3.35040773113899,0.245742244449491,0.233517756997039,0.285908417507548,0.0523906605105097,0.00198556256796921,2.84288117660027,6.97900457192226,6.93047878077499,7.13844645712044,0.207967676345454,0.0159757312503319,ENSG00000205339,IPO7,protein_coding,11,1,9384652,9448127,p15.4,importin 7 [Source:HGNC Symbol;Acc:HGNC:9852],NA,IPO7,10527,NM_006391
BCKDHB_SIG,BCKDHB,BCKDHB_SIG,BCKDHB,SIG,45,3.34984086346331,0.407497569660765,0.39544065187232,0.447113156679941,0.0516725048076207,0.0019890395838917,1.63943176536605,3.88361825478673,3.84900011432337,3.99736357345205,0.14836345912868,0.179520710074851,ENSG00000083123,BCKDHB,protein_coding,6,1,80106647,80346270,q14.1,branched chain keto acid dehydrogenase E1 subunit beta [Source:HGNC Symbol;Acc:HGNC:987],Classic maple syrup urine disease;Intermediate maple syrup urine disease;Intermittent maple syrup urine disease;Maple Syrup Urine Disease;Thiamine-responsive maple syrup urine disease,BCKDHB,594,NM_000056;NM_001318975;NM_183050
ZNF100_TF,ZNF100,ZNF100_TF,ZNF100,TF,26,3.34970274873529,0.242929057881619,0.236037048235417,0.265574232433425,0.0295371841980086,0.00198944086256742,3.2168193515911,4.35418710475013,4.29246528226732,4.55698737862221,0.264522096354898,0.00605846242241751,ENSG00000197020,ZNF100,protein_coding,19,-1,21722771,21767579,p12,zinc finger protein 100 [Source:HGNC Symbol;Acc:HGNC:12880],NA,ZNF100,163227,NM_001351669;NM_001351670;NM_001351671;NM_173531
ANXA11_SIG,ANXA11,ANXA11_SIG,ANXA11,SIG,16,-3.34841360026422,0.499369970846573,0.508593330509702,0.469064646239149,-0.0395286842705539,0.00199812610377675,-2.30816887404272,7.75562785142837,7.78172805261697,7.66987004752298,-0.111858005093986,0.053054794263029,ENSG00000122359,ANXA11,protein_coding,10,-1,80150889,80205572,q22.3,annexin A11 [Source:HGNC Symbol;Acc:HGNC:535],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 23,ANXA11,311,NM_001157;NM_001278407;NM_001278408;NM_001278409;NM_145868;NM_145869
CORO1C_SIG,CORO1C,CORO1C_SIG,CORO1C,SIG,23,-3.34763520880075,0.319053908889048,0.324022046069918,0.302730029580474,-0.0212920164894441,0.00200315173610206,-1.62438664046406,7.16389997957358,7.19272967820715,7.06917382692044,-0.12355585128671,0.18372003000016,ENSG00000110880,CORO1C,protein_coding,12,-1,108645109,108731596,q24.11,coronin 1C [Source:HGNC Symbol;Acc:HGNC:2254],NA,CORO1C,23603,NM_001105237;NM_001276471;NM_014325
DSEL_SIG,DSEL,DSEL_SIG,DSEL,SIG,25,-3.34649163309854,-0.133641156622625,-0.128302780807744,-0.151181534300094,-0.0228787534923503,0.0020108360695482,-0.900237320475983,1.08106099597059,1.10589035238884,0.999478824882028,-0.106411527506815,0.481790877440308,ENSG00000171451,DSEL,protein_coding,18,-1,67506587,67516720,q22.1,dermatan sulfate epimerase like [Source:HGNC Symbol;Acc:HGNC:18144],NA,DSEL,92126,NM_032160
GNL3L_SIG,GNL3L,GNL3L_SIG,GNL3L,SIG,7,3.34579847650065,0.34772463385171,0.340446225341839,0.371639404669856,0.0311931793280169,0.00201527165137166,3.24603556108678,4.35864739185694,4.31761553877943,4.49346633768306,0.175850798903626,0.00559330708511338,ENSG00000130119,GNL3L,protein_coding,X,1,54530211,54567289,p11.22,G protein nucleolar 3 like [Source:HGNC Symbol;Acc:HGNC:25553],NA,GNL3L,54552,NM_001184819;NM_019067
APLP2_SIG,APLP2,APLP2_SIG,APLP2,SIG,25,-3.34542073643542,0.18978371528124,0.199562934860329,0.157651993807092,-0.0419109410532376,0.00201742053687223,-3.59228057009195,9.89926389585565,9.97025758979546,9.66599890148201,-0.304258688313446,0.00204811250088987,ENSG00000084234,APLP2,protein_coding,11,1,130068147,130144811,q24.3,amyloid beta precursor like protein 2 [Source:HGNC Symbol;Acc:HGNC:598],NA,APLP2,334,NM_001142276;NM_001142277;NM_001142278;NM_001243299;NM_001328682;NM_001328684;NM_001328685;NM_001328686;NM_001642
IKBKE_SIG,IKBKE,IKBKE_SIG,IKBKE,SIG,21,3.34458495048076,0.364616910519274,0.354997460345527,0.396223675375869,0.0412262150303413,0.00202288021217566,2.13079242427529,4.89538189512486,4.85145376057661,5.0397171943548,0.188263433778186,0.0758786205615801,ENSG00000263528,IKBKE,protein_coding,1,1,206470476,206496889,q32.1,inhibitor of nuclear factor kappa B kinase subunit epsilon [Source:HGNC Symbol;Acc:HGNC:14552],NA,IKBKE,9641,NM_001193321;NM_001193322;NM_014002
FOS_TF,FOS,FOS_TF,FOS,TF,25,-3.34450679173243,0.288977462903056,0.297425456023214,0.261219771222539,-0.0362056848006751,0.00202288021217566,-2.44133304226646,10.2907511442932,10.366271330808,10.0426133886015,-0.323657942206504,0.0400736663785784,ENSG00000170345,FOS,protein_coding,14,1,75278826,75282230,q24.3,Fos proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:3796],Berardinelli-Seip congenital lipodystrophy,FOS,2353,NM_005252
DAPP1_SIG,DAPP1,DAPP1_SIG,DAPP1,SIG,26,-3.3442468811441,0.375985329109234,0.389950330766124,0.330100323665167,-0.0598500071009574,0.00202417687417434,-2.00962931661741,5.06621670462775,5.12013959613898,4.88904148966228,-0.231098106476692,0.0953677667109307,ENSG00000070190,DAPP1,protein_coding,4,1,99816827,99870190,q23,dual adaptor of phosphotyrosine and 3-phosphoinositides 1 [Source:HGNC Symbol;Acc:HGNC:16500],NA,DAPP1,27071,NM_001306151;NM_014395
ZSCAN12_TF,ZSCAN12,ZSCAN12_TF,ZSCAN12,TF,37,3.34313516866056,0.241598087728552,0.234043118289618,0.266421558742192,0.0323784404525732,0.00203170223085224,2.05299343278677,3.65864202465568,3.61621271997243,3.79805259718637,0.181839877213943,0.0880123098714661,ENSG00000158691,ZSCAN12,protein_coding,6,-1,28378955,28399734,p22.1,zinc finger and SCAN domain containing 12 [Source:HGNC Symbol;Acc:HGNC:13172],NA,ZSCAN12,9753,NM_001163391
NEK1_SIG,NEK1,NEK1_SIG,NEK1,SIG,20,3.34275527022958,0.403418890151284,0.391628388913182,0.442159108505047,0.050530719591864,0.0020334068892973,2.63598890758063,4.05294976068133,4.00521138771465,4.20980441471473,0.204593027000083,0.0258863994924968,ENSG00000137601,NEK1,protein_coding,4,-1,169392857,169612629,q33,NIMA related kinase 1 [Source:HGNC Symbol;Acc:HGNC:7744],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS SUSCEPTIBILITY TO 24;Orofaciodigital syndrome type 2;SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY;Short rib-polydactyly syndorme type II;Short rib-polydactyly syndrome Majewski type,NEK1,4750,NM_001199397;NM_001199398;NM_001199399;NM_001199400;NM_012224
TOP3B_SIG,TOP3B,TOP3B_SIG,TOP3B,SIG,25,3.34273818192522,0.400830928658458,0.396525967529106,0.414975800940615,0.0184498334115092,0.0020334068892973,1.90936627315523,4.81133047643089,4.79212915921355,4.87442051871643,0.0822913595028752,0.114408584069501,ENSG00000100038,TOP3B,protein_coding,22,-1,21957025,21982816,q11.22,DNA topoisomerase III beta [Source:HGNC Symbol;Acc:HGNC:11993],NA,TOP3B,8940,NM_001282112;NM_001282113;NM_001349845;NM_001349847;NM_001349848;NM_001349850;NM_001349851;NM_001349852;NM_003935
ZNF599_TF,ZNF599,ZNF599_TF,ZNF599,TF,54,3.34208473987852,-0.0389507816771063,-0.0477953701805603,-0.00988999088004329,0.037905379300517,0.00203706578381602,1.43806570290211,1.75181123576979,1.72598441968065,1.8366707743484,0.110686354667754,0.242707325786323,ENSG00000153896,ZNF599,protein_coding,19,-1,34758073,34773229,q13.11,zinc finger protein 599 [Source:HGNC Symbol;Acc:HGNC:26408],NOT IN OMIM,ZNF599,148103,NM_001007248
MAGI3_SIG,MAGI3,MAGI3_SIG,MAGI3,SIG,81,-3.34207504891762,-0.121200235552637,-0.116487737479404,-0.136684157793262,-0.020196420313858,0.00203706578381602,-3.53799767802712,1.55358330261975,1.66203494396033,1.19724219535787,-0.464792748602456,0.00241217594707753,ENSG00000081026,MAGI3,protein_coding,1,1,113390515,113685923,p13.2,membrane associated guanylate kinase, WW and PDZ domain containing 3 [Source:HGNC Symbol;Acc:HGNC:29647],NA,MAGI3,260425,NM_001142782;NM_152900
KHDRBS1_SIG,KHDRBS1,KHDRBS1_SIG,KHDRBS1,SIG,32,3.34179180723358,0.528317792067241,0.520980957901396,0.552424532897877,0.0314435749964811,0.00203854273266453,1.55799239090116,8.15288614184616,8.13845638989226,8.20029818398042,0.0618417940881689,0.203130986946113,ENSG00000121774,KHDRBS1,protein_coding,1,1,32013868,32060850,p35.2,KH RNA binding domain containing, signal transduction associated 1 [Source:HGNC Symbol;Acc:HGNC:18116],NA,KHDRBS1,10657,NM_001271878;NM_006559
POLK_SIG,POLK,POLK_SIG,POLK,SIG,32,3.34155946752674,0.362959068341419,0.358681933626344,0.377012510976668,0.0183305773503242,0.00203964674947799,2.40168980399964,5.28432025991771,5.25340426633386,5.38590138169324,0.132497115359383,0.0437377472663287,ENSG00000122008,POLK,protein_coding,5,1,75511756,75601144,q13.3,DNA polymerase kappa [Source:HGNC Symbol;Acc:HGNC:9183],NA,POLK,51426,NM_001345921;NM_001345922;NM_016218
RARA_SIG,RARA,RARA_SIG,RARA,SIG,23,-3.34105614910902,0.683653493943304,0.69654683494107,0.641289659236358,-0.0552571757047112,0.00204274427922865,-1.70039082872065,6.20190307316658,6.23830858821243,6.08228495230165,-0.156023635910783,0.163025137912014,ENSG00000131759,RARA,protein_coding,17,1,40309180,40357643,q21.2,retinoic acid receptor alpha [Source:HGNC Symbol;Acc:HGNC:9864],ACUTE PROMYELOCYTIC LEUKEMIA,RARA,5914,NM_000964;NM_001024809;NM_001145301;NM_001145302
SMARCD1_SIG,SMARCD1,SMARCD1_SIG,SMARCD1,SIG,74,3.34023364408126,0.306304269859489,0.299255387410496,0.329464883620468,0.0302094962099726,0.00204819915164331,3.62878317133423,6.29439569422735,6.24653814894965,6.4516419144255,0.205103765475846,0.00182876001292571,ENSG00000066117,SMARCD1,protein_coding,12,1,50084972,50100712,q13.12,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 [Source:HGNC Symbol;Acc:HGNC:11106],NA,SMARCD1,6602,NM_003076;NM_139071
TCF7L2_TF,TCF7L2,TCF7L2_TF,TCF7L2,TF,136,-3.33991914794099,0.00470050769228557,0.0089827845458718,-0.00936983054092633,-0.0183526150867981,0.00204991456766031,-2.97149314160534,4.57962495290498,4.65372547459808,4.33615181019911,-0.317573664398968,0.0115927893014432,ENSG00000148737,TCF7L2,protein_coding,10,1,112950247,113167678,q25.2,transcription factor 7 like 2 [Source:HGNC Symbol;Acc:HGNC:11641],DIABETES MELLITUS NONINSULIN-DEPENDENT,TCF7L2,6934,NM_001146274;NM_001146283;NM_001146284;NM_001146285;NM_001146286;NM_001198525;NM_001198526;NM_001198527;NM_001198528;NM_001198529;NM_001198530;NM_001198531;NM_001349870;NM_001349871;NM_001363501;NM_001367943;NM_030756
TCERG1_SIG,TCERG1,TCERG1_SIG,TCERG1,SIG,30,3.33869101592809,0.544644881757839,0.538012950946408,0.566435511566825,0.0284225606204164,0.0020583905363935,3.52047959299924,6.87958784074221,6.83413825136212,7.02892220584822,0.194783954486103,0.00254065835411655,ENSG00000113649,TCERG1,protein_coding,5,1,146447311,146511961,q32,transcription elongation regulator 1 [Source:HGNC Symbol;Acc:HGNC:15630],NA,TCERG1,10915,NM_001040006;NM_006706
CBX5_SIG,CBX5,CBX5_SIG,CBX5,SIG,32,3.33679262389561,0.365478547724203,0.357165548491049,0.392792688061708,0.0356271395706582,0.00207150076885999,3.50988973137803,6.94166765175213,6.87434912678112,7.16285709094262,0.288507964161496,0.00262847060892989,ENSG00000094916,CBX5,protein_coding,12,-1,54230942,54280133,q13.13,chromobox 5 [Source:HGNC Symbol;Acc:HGNC:1555],NA,CBX5,23468,NM_001127321;NM_001127322;NM_012117
MAPK8_SIG,MAPK8,MAPK8_SIG,MAPK8,SIG,59,3.33670396743215,0.415382943840779,0.409230634026785,0.435597676086761,0.0263670420599755,0.00207150076885999,2.78169042926383,5.33180416495782,5.29234917991304,5.46144197296206,0.169092793049019,0.0184651196467924,ENSG00000107643,MAPK8,protein_coding,10,1,48306639,48439360,q11.22,mitogen-activated protein kinase 8 [Source:HGNC Symbol;Acc:HGNC:6881],NA,MAPK8,5599,NM_001278547;NM_001278548;NM_001323302;NM_001323320;NM_001323321;NM_001323322;NM_001323323;NM_001323324;NM_001323325;NM_001323326;NM_001323327;NM_001323328;NM_001323329;NM_001323330;NM_001323331;NM_139046;NM_139049
GRWD1_SIG,GRWD1,GRWD1_SIG,GRWD1,SIG,36,3.33668079524091,0.556144878604871,0.545127674415423,0.592344263798773,0.0472165893833495,0.00207150076885999,3.49760372698708,4.77602187389256,4.71515119492249,4.97602553336565,0.260874338443156,0.00272314324253442,ENSG00000105447,GRWD1,protein_coding,19,1,48445773,48457022,q13.33,glutamate rich WD repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:21270],NA,GRWD1,83743,NM_031485
SGSH_SIG,SGSH,SGSH_SIG,SGSH,SIG,32,-3.33617100303479,0.319460183234307,0.338279261007878,0.257626070549716,-0.0806531904581623,0.00207469146920078,-2.04431509148967,4.14779397163118,4.23262249092344,3.8690716939566,-0.363550796966837,0.089507280706493,ENSG00000181523,SGSH,protein_coding,17,-1,80206716,80220923,q25.3,N-sulfoglucosamine sulfohydrolase [Source:HGNC Symbol;Acc:HGNC:10818],MUCOPOLYSACCHARIDOSIS TYPE 3A;MUCOPOLYSACCHARIDOSIS TYPE IIIA;Sanfilippo syndrome type A,SGSH,6448,NM_000199;NM_001352921;NM_001352922
ETV6_TF,ETV6,ETV6_TF,ETV6,TF,43,3.33446457524197,0.188713819439695,0.180611875658223,0.215334491864531,0.0347226162063081,0.00208684781640242,1.92071219067621,7.77065135885623,7.73317190097397,7.8937981490408,0.160626248066825,0.112157923830631,ENSG00000139083,ETV6,protein_coding,12,1,11649854,11895402,p13.2,ETS variant 6 [Source:HGNC Symbol;Acc:HGNC:3495],Chronic myelomonocytic leukemia;Congenital mesoblastic nephroma;Differentiated thyroid carcinoma;Fibrosarcoma;Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome;LEUKEMIA ACUTE MYELOID;Precursor B-cell acute lymphoblastic leukemia;Primary hypereosinophilic syndrome;Thrombocytopenia 5,ETV6,2120,NM_001987
ECI2_SIG,ECI2,ECI2_SIG,ECI2,SIG,6,3.33404638816868,0.354218477751943,0.344271525662543,0.386901320331401,0.0426297946688578,0.00208937208126443,0.704931873922217,4.52447765121105,4.51075277672121,4.56957366739194,0.0588208906707309,0.58915347315266,ENSG00000198721,ECI2,protein_coding,6,-1,4115689,4135597,p25.2,enoyl-CoA delta isomerase 2 [Source:HGNC Symbol;Acc:HGNC:14601],NA,ECI2,10455,NM_001166010;NM_006117;NM_206836
ZNF691_TF,ZNF691,ZNF691_TF,ZNF691,TF,154,3.33381616800903,0.0943939655423215,0.0797381565509801,0.142548766513872,0.0628106099628918,0.00209048616608322,2.81769944203733,2.48863701642627,2.42949425596951,2.68296322935562,0.25346897338611,0.0169704150546925,ENSG00000164011,ZNF691,protein_coding,1,1,42846573,42852477,p34.2,zinc finger protein 691 [Source:HGNC Symbol;Acc:HGNC:28028],NA,ZNF691,51058,NM_001242739;NM_015911
ZCCHC10_TF,ZCCHC10,ZCCHC10_TF,ZCCHC10,TF,52,3.33327722018704,0.236905928368034,0.232452153885231,0.251539758811531,0.0190876049262999,0.0020939233975952,2.4449203697656,3.73497467732193,3.70170360236835,3.84429392359798,0.142590321229632,0.0397796098695779,ENSG00000155329,ZCCHC10,protein_coding,5,-1,132996985,133026604,q31.1,zinc finger CCHC-type containing 10 [Source:HGNC Symbol;Acc:HGNC:25954],NA,ZCCHC10,54819,NM_001300816;NM_001300817;NM_001300818;NM_001300819;NM_001300822;NM_001308127;NM_001308128;NM_001308129;NM_001308130;NM_017665
RNF32_SIG,RNF32,RNF32_SIG,RNF32,SIG,11,3.33142865480399,-0.11208579700115,-0.11631478586351,-0.0981905478819673,0.0181242379815428,0.00210725924892065,1.25334428377491,0.618224651918183,0.602626885817161,0.669474454821542,0.0668475690043808,0.314020616617378,ENSG00000105982,RNF32,protein_coding,7,1,156640281,156677130,q36.3,ring finger protein 32 [Source:HGNC Symbol;Acc:HGNC:17118],NA,RNF32,140545,NM_001184996;NM_001184997;NM_001308273;NM_001308274;NM_030936
FLNA_SIG,FLNA,FLNA_SIG,FLNA,SIG,28,-3.33086533058494,0.479751151279313,0.487397409779291,0.454627730493669,-0.0327696792856215,0.00211090671051699,-3.27741692688664,10.9885787956237,11.04264696944,10.8109262245131,-0.231720744926843,0.00511970806386681,ENSG00000196924,FLNA,protein_coding,X,-1,154348524,154374638,q28,filamin A [Source:HGNC Symbol;Acc:HGNC:3754],Cardiac valvular dysplasia X-linked;Childhood Interstitial Lung Disease;Congenital short bowel syndrome;Congenital valvular dysplasia;Ehlers-Danlos syndrome cardiac valvular  type;Ehlers-Danlos syndrome with periventricular heterotopia;Epileptic encephalopathy;FG SYNDROME 2;FG SYNDROME TYPE 2;FRONTOMETAPHYSEAL DYSPLASIA;FRONTOMETAPHYSEAL DYSPLASIA 1;Intestinal pseudoobstruction neuronal chronic idiopathic X-linked;MELNICK-NEEDLES SYNDROME;Neuronal intestinal pseudoobstruction;Otopalatodigital syndrome type 1;Otopalatodigital syndrome type 2;OTOPALATODIGITAL SYNDROME TYPE I;OTOPALATODIGITAL SYNDROME TYPE II;Periventricular nodular heterotopia;Periventricular nodular heterotopia 1;TERMINAL OSSEOUS DYSPLASIA;Terminal osseous dysplasia-pigmentary defects syndrome;X-LINKED CONGENITAL IDIOPATHIC INTESTINAL PSEUDOOBSTRUCTION;X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome,FLNA,2316,NM_001110556;NM_001456
SEC11C_SIG,SEC11C,SEC11C_SIG,SEC11C,SIG,66,-3.32987085777676,-0.0911164621598318,-0.0860608296763302,-0.107727826034194,-0.0216669963578636,0.0021178369098444,-2.14734482932901,4.40696578251251,4.4438185665406,4.28587806356307,-0.157940502977532,0.0734870978337099,ENSG00000166562,SEC11C,protein_coding,18,1,59139866,59158832,q21.32,SEC11 homolog C, signal peptidase complex subunit [Source:HGNC Symbol;Acc:HGNC:23400],NA,SEC11C,90701,NM_001307941;NM_033280
E4F1_TF,E4F1,E4F1_TF,E4F1,TF,151,3.32969745050759,0.149658543606111,0.14659256916272,0.159732459634397,0.013139890471677,0.00211853290813097,2.35713247081287,5.18624769233065,5.16504331227963,5.255919226784,0.0908759145043793,0.0479951640924449,ENSG00000167967,E4F1,protein_coding,16,1,2223580,2235742,p13.3,E4F transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:3121],NA,E4F1,1877,NM_001288776;NM_001288778;NM_004424
XPA_TF,XPA,XPA_TF,XPA,TF,178,-3.32884956342889,0.0586021054168479,0.0631534004896295,0.0436478501777084,-0.0195055503119211,0.00212436788264005,-2.17458840902828,3.84890441756021,3.88817021472651,3.71988822687096,-0.168281987855547,0.069738253514313,ENSG00000136936,XPA,protein_coding,9,-1,97674909,97697357,q22.33,XPA, DNA damage recognition and repair factor [Source:HGNC Symbol;Acc:HGNC:12814],Xeroderma pigmentosum;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP A;Xeroderma pigmentosum group A,XPA,7507,NM_000380;NM_001354975
RNF145_SIG,RNF145,RNF145_SIG,RNF145,SIG,29,-3.32850693446632,0.138786563725879,0.144128579067872,0.121234227602188,-0.022894351465684,0.00212635745918435,-1.80782008937245,5.45570518343239,5.49284646194617,5.33366955402995,-0.159176907916222,0.136366574897696,ENSG00000145860,RNF145,protein_coding,5,-1,159157409,159210053,q33.3,ring finger protein 145 [Source:HGNC Symbol;Acc:HGNC:20853],NA,RNF145,153830,NM_001199380;NM_001199381;NM_001199382;NM_001199383;NM_144726
BTLA_SIG,BTLA,BTLA_SIG,BTLA,SIG,44,-3.32814080914746,-0.0146894375684817,-0.00468542989461523,-0.0475597484969003,-0.042874318602285,0.0021285283705788,-1.46554005893307,1.45192073616742,1.49237834322575,1.31898859869003,-0.173389744535727,0.23354497671228,ENSG00000186265,BTLA,protein_coding,3,-1,112463966,112499472,q13.2,B and T lymphocyte associated [Source:HGNC Symbol;Acc:HGNC:21087],NA,BTLA,151888,NM_001085357;NM_181780
ZNF506_TF,ZNF506,ZNF506_TF,ZNF506,TF,25,3.32765556094026,0.215645769214191,0.206556475918359,0.245510590043352,0.0389541141249934,0.00213161262208298,1.61106684514125,4.38797448994012,4.35372802496959,4.500498589129,0.146770564159419,0.187549284766006,ENSG00000081665,ZNF506,protein_coding,19,-1,19785839,19821751,p13.11,zinc finger protein 506 [Source:HGNC Symbol;Acc:HGNC:23780],NA,ZNF506,440515,NM_001099269;NM_001145404
HDHD2_SIG,HDHD2,HDHD2_SIG,HDHD2,SIG,28,3.32619625785441,0.318364285626911,0.304018681137592,0.365499843234675,0.0614811620970835,0.00214217533329272,2.59343177913363,5.04957504989895,4.99582543583959,5.22618092466542,0.230355488825836,0.0286059733485652,ENSG00000167220,HDHD2,protein_coding,18,-1,47107408,47150500,q21.1,haloacid dehalogenase like hydrolase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25364],NA,HDHD2,84064,NM_001318765;NM_032124
ILF2_TF,ILF2,ILF2_TF,ILF2,TF,265,3.32546449125633,0.24781592014042,0.241817956260107,0.267523515747164,0.0257055594870575,0.00214671635796832,1.3091565836937,7.48576498585737,7.46989715165683,7.53790215537342,0.0680050037165935,0.291341960102893,ENSG00000143621,ILF2,protein_coding,1,-1,153661788,153671028,q21.3,interleukin enhancer binding factor 2 [Source:HGNC Symbol;Acc:HGNC:6037],NA,ILF2,3608,NM_001267809;NM_004515
APRT_SIG,APRT,APRT_SIG,APRT,SIG,31,3.32539827450181,0.344140445255015,0.338701822760926,0.362010204878451,0.0233083821175252,0.00214671635796832,3.26396534142078,5.92822143191783,5.88411799449571,6.07313272630482,0.189014731809117,0.00531835050258751,ENSG00000198931,APRT,protein_coding,16,-1,88809339,88811944,q24.3,adenine phosphoribosyltransferase [Source:HGNC Symbol;Acc:HGNC:626],Adenine phosphoribosyltransferase deficiency,APRT,353,NM_000485;NM_001030018
APOBEC3B_SIG,APOBEC3B,APOBEC3B_SIG,APOBEC3B,SIG,14,-3.32536050017363,0.16863509871894,0.185828285298112,0.112143199958801,-0.0736850853393112,0.00214671635796832,-3.41084569427056,3.16162115056469,3.26851952411208,2.81038363748041,-0.458135886631669,0.00349021448387858,ENSG00000179750,APOBEC3B,protein_coding,22,1,38982347,38992804,q13.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3B [Source:HGNC Symbol;Acc:HGNC:17352],NA,APOBEC3B,9582,NM_001270411;NM_004900
GAD1_SIG,GAD1,GAD1_SIG,GAD1,SIG,17,-3.32504555561551,-0.212340427741864,-0.201607464854728,-0.247605877228168,-0.0459984123734401,0.00214851239891954,-2.61569956257768,0.670618464330661,0.745062893380098,0.42601534031108,-0.319047553069018,0.0271388987327487,ENSG00000128683,GAD1,protein_coding,2,1,170813213,170861151,q31.1,glutamate decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:4092],CEREBRAL PALSY SPASTIC QUADRIPLEGIC 1;CEREBRAL PALSY SPASTIC QUADRIPLEGIC TYPE 1;Inherited congenital spastic tetraplegia,GAD1,2571,NM_000817;NM_013445
ZSCAN5A_TF,ZSCAN5A,ZSCAN5A_TF,ZSCAN5A,TF,212,3.3224458992932,0.233831404579476,0.223592499446291,0.267473521445659,0.043881021999368,0.0021673014996001,3.0548423039155,2.50497070641438,2.4521710761055,2.67845520600068,0.22628412989518,0.0093396481214618,ENSG00000131848,ZSCAN5A,protein_coding,19,-1,56219670,56368383,q13.43,zinc finger and SCAN domain containing 5A [Source:HGNC Symbol;Acc:HGNC:23710],NA,ZSCAN5A,79149,NM_001322061;NM_001322062;NM_001322064;NM_001322065;NM_001322066;NM_001322067;NM_001322068;NM_001322070;NM_001322072;NM_001322073;NM_001322074;NM_001322075;NM_001322076;NM_001322077;NM_001322078;NM_024303
GFM1_SIG,GFM1,GFM1_SIG,GFM1,SIG,18,3.32243236787519,0.531077115057122,0.523845308630585,0.554838764744313,0.0309934561137273,0.0021673014996001,1.93315427499169,5.26118674876463,5.23643154959223,5.34252526033107,0.106093710738842,0.109639612914942,ENSG00000168827,GFM1,protein_coding,3,1,158644278,158692575,q25.32,G elongation factor mitochondrial 1 [Source:HGNC Symbol;Acc:HGNC:13780],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1;Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,GFM1,85476,NM_001308164;NM_001308166;NM_024996
RECQL5_SIG,RECQL5,RECQL5_SIG,RECQL5,SIG,62,3.32237180084359,0.322554368368348,0.308652714228679,0.368231231970114,0.0595785177414348,0.0021673014996001,2.56893993432506,4.63871985813117,4.59151440620603,4.79382348588518,0.202309079679148,0.0302153762292812,ENSG00000108469,RECQL5,protein_coding,17,-1,75626845,75667189,q25.1,RecQ like helicase 5 [Source:HGNC Symbol;Acc:HGNC:9950],NA,RECQL5,9400,NM_001003715;NM_001003716;NM_004259
HADHA_SIG,HADHA,HADHA_SIG,HADHA,SIG,19,3.32091986120248,0.37216572292045,0.367332757403333,0.388045466762406,0.0207127093590731,0.00217744212944609,2.18490497314631,8.03412984800678,8.01009225093079,8.11311052411363,0.103018273182847,0.0683756836369541,ENSG00000084754,HADHA,protein_coding,2,-1,26190635,26244672,p23.3,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha [Source:HGNC Symbol;Acc:HGNC:4801],Acute fatty liver of pregnancy;LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;Mitochondrial trifunctional protein deficiency,HADHA,3030,NM_000182
ZDHHC20_SIG,ZDHHC20,ZDHHC20_SIG,ZDHHC20,SIG,21,-3.32090566504085,0.330199466485261,0.335582340737658,0.312512879655958,-0.0230694610816993,0.00217744212944609,-2.56520932118236,5.33606249032825,5.37571836707533,5.20576460958785,-0.169953757487474,0.030482909905573,ENSG00000180776,ZDHHC20,protein_coding,13,-1,21372573,21459370,q12.11,zinc finger DHHC-type containing 20 [Source:HGNC Symbol;Acc:HGNC:20749],NA,ZDHHC20,253832,NM_001286638;NM_001330059;NM_153251
MRM1_SIG,MRM1,MRM1_SIG,MRM1,SIG,79,3.32055727806114,0.265492761832811,0.248511276458843,0.321289070918707,0.0727777944598635,0.00217952324315855,2.71256424145399,2.7527092969203,2.67707033225518,3.00123732367712,0.324166991421943,0.0217566869633112,ENSG00000278619,MRM1,protein_coding,17,1,36601583,36608964,q12,mitochondrial rRNA methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26202],NA,MRM1,79922,NM_024864
ZNF543_TF,ZNF543,ZNF543_TF,ZNF543,TF,28,3.31972065121462,0.0748266271679775,0.065722119667858,0.104741437525513,0.039019317857655,0.00218542498003863,2.58465634367227,2.77736089486932,2.72643060568922,2.94470327360391,0.218272667914687,0.0291942517311323,ENSG00000178229,ZNF543,protein_coding,19,1,57320472,57330770,q13.43,zinc finger protein 543 [Source:HGNC Symbol;Acc:HGNC:25281],NA,ZNF543,125919,NM_213598
RNF170_SIG,RNF170,RNF170_SIG,RNF170,SIG,96,3.31929564728695,0.264304530371909,0.252138299147903,0.304279290107931,0.0521409909600281,0.00218811357928829,2.55594651139219,3.89787427827273,3.84136051005251,4.08356237385345,0.242201863800941,0.0311652642660013,ENSG00000120925,RNF170,protein_coding,8,-1,42849637,42897290,p11.21,ring finger protein 170 [Source:HGNC Symbol;Acc:HGNC:25358],ATAXIA SENSORY 1 AUTOSOMAL DOMINANT,RNF170,81790,NM_001160223;NM_001160224;NM_001160225;NM_030954
FOS_SIG,FOS,FOS_SIG,FOS,SIG,20,-3.31770474428917,0.439409266283874,0.450357919722137,0.403435119272441,-0.046922800449696,0.00219996974875472,-2.44133304226646,10.2907511442932,10.366271330808,10.0426133886015,-0.323657942206504,0.0400736663785784,ENSG00000170345,FOS,protein_coding,14,1,75278826,75282230,q24.3,Fos proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:3796],Berardinelli-Seip congenital lipodystrophy,FOS,2353,NM_005252
TLR7_SIG,TLR7,TLR7_SIG,TLR7,SIG,37,-3.31684188606738,0.0907375699311733,0.118990442902456,-0.00209329840304075,-0.121083741305497,0.00220612958764777,-1.96478747539402,2.20018519164416,2.28706115054604,1.91473561239516,-0.37232553815088,0.103533681645705,ENSG00000196664,TLR7,protein_coding,X,1,12867072,12890361,p22.2,toll like receptor 7 [Source:HGNC Symbol;Acc:HGNC:15631],NA,TLR7,51284,NM_016562
PLAUR_SIG,PLAUR,PLAUR_SIG,PLAUR,SIG,70,-3.316441999767,0.311865042598145,0.325756329912964,0.266222241420883,-0.0595340884920811,0.00220864314986425,-1.42419372187503,6.3574225241284,6.41402191120127,6.17145310946037,-0.242568801740905,0.247564499737893,ENSG00000011422,PLAUR,protein_coding,19,-1,43646095,43670547,q13.31,plasminogen activator, urokinase receptor [Source:HGNC Symbol;Acc:HGNC:9053],NA,PLAUR,5329,NM_001005376;NM_001005377;NM_001301037;NM_002659
PURB_SIG,PURB,PURB_SIG,PURB,SIG,20,3.31586366256227,0.0835833670801107,0.0764864117283518,0.106901934664461,0.0304155229361093,0.00221257179605762,3.79425628399032,6.61876909420402,6.56675281359581,6.78967973048812,0.222926916892312,0.00109457329069812,ENSG00000146676,PURB,protein_coding,7,-1,44876293,44885481,p13,purine rich element binding protein B [Source:HGNC Symbol;Acc:HGNC:9702],NA,PURB,5814,NM_033224
RBAK_TF,RBAK,RBAK_TF,RBAK,TF,40,3.31577724869006,0.31834059114978,0.314434229016537,0.331175781016148,0.0167415519996108,0.00221260925280722,2.82403989054631,4.77219902060991,4.73244051099706,4.90283412362355,0.170393612626491,0.0167142732723513,ENSG00000146587,RBAK,protein_coding,7,1,5045821,5069487,p22.1,RB associated KRAB zinc finger [Source:HGNC Symbol;Acc:HGNC:17680],NA,RBAK,57786,NM_001204456;NM_021163
RNASE6_SIG,RNASE6,RNASE6_SIG,RNASE6,SIG,40,-3.31554955298684,0.177130393296298,0.200586307797805,0.100060959934203,-0.100525347863602,0.00221376564931965,-2.80097766440105,4.07470737325534,4.21498067386388,3.61380938554156,-0.601171288322322,0.0176501897410462,ENSG00000169413,RNASE6,protein_coding,14,1,20781268,20782467,q11.2,ribonuclease A family member k6 [Source:HGNC Symbol;Acc:HGNC:10048],NA,RNASE6,6039,NM_005615
PGK1_SIG,PGK1,PGK1_SIG,PGK1,SIG,35,-3.31520927208583,0.290151043217509,0.295209203901332,0.273531372399234,-0.0216778315020981,0.00221581504583472,-3.3502126897564,8.43842057073936,8.48025321244733,8.3009704622703,-0.179282750177029,0.00417023301828688,ENSG00000102144,PGK1,protein_coding,X,1,77910739,78129295,q21.1,phosphoglycerate kinase 1 [Source:HGNC Symbol;Acc:HGNC:8896],Glycogen storage disease due to phosphoglycerate kinase 1 deficiency;PHOSPHOGLYCERATE KINASE 1 DEFICIENCY,PGK1,5230,NM_000291
P2RY11_SIG,P2RY11,P2RY11_SIG,P2RY11,SIG,50,3.31507245585182,0.199934084732555,0.192583168589653,0.224087094916375,0.0315039263267221,0.00221625258600458,2.36953164577662,3.13106795098151,3.08425674990525,3.28487618308923,0.200619433183977,0.0467733873346291,ENSG00000244165,P2RY11,protein_coding,19,1,10111693,10115372,p13.2,purinergic receptor P2Y11 [Source:HGNC Symbol;Acc:HGNC:8540],Narcolepsy type 1,P2RY11,5032,NM_002566
STYXL1_SIG,STYXL1,STYXL1_SIG,STYXL1,SIG,42,3.31490236148754,0.174222597478396,0.164461236623905,0.20629564028601,0.0418344036621057,0.00221695426348842,3.14340168237088,4.21989412664617,4.1563693421074,4.42861841870214,0.272249076594738,0.00739375567980315,ENSG00000127952,STYXL1,protein_coding,7,-1,75996338,76048004,q11.23,serine/threonine/tyrosine interacting like 1 [Source:HGNC Symbol;Acc:HGNC:18165],NA,STYXL1,51657,NM_001317785;NM_001317786;NM_001317787;NM_001317788;NM_001317789;NM_016086
ATG3_SIG,ATG3,ATG3_SIG,ATG3,SIG,59,-3.31477072410283,-0.0677704976137562,-0.0562011712962645,-0.105783998371229,-0.0495828270749648,0.0022173512415151,-3.17634225378593,6.46548644115414,6.51141053415247,6.31459299273105,-0.196817541421414,0.00677276114380436,ENSG00000144848,ATG3,protein_coding,3,-1,112532509,112562046,q13.2,autophagy related 3 [Source:HGNC Symbol;Acc:HGNC:20962],NA,ATG3,64422,NM_001278712;NM_022488
PTGER4_SIG,PTGER4,PTGER4_SIG,PTGER4,SIG,11,-3.31353351776397,0.276075144636703,0.281678409625805,0.257664416815366,-0.0240139928104396,0.0022265348881823,-2.07128510057224,6.97172866325707,7.03140498993988,6.77564930415639,-0.25575568578349,0.0848494287769033,ENSG00000171522,PTGER4,protein_coding,5,1,40679915,40693735,p13.1,prostaglandin E receptor 4 [Source:HGNC Symbol;Acc:HGNC:9596],NA,PTGER4,5734,NM_000958
DDX1_SIG,DDX1,DDX1_SIG,DDX1,SIG,40,3.31290436657398,0.602842282181543,0.592434799950965,0.637038295224868,0.0446034952739028,0.00223089863334648,3.49769973926505,6.04926066756201,5.99657798321241,6.22236091613928,0.225782932926873,0.00272285478373276,ENSG00000079785,DDX1,protein_coding,2,1,15591178,15631111,p24.3,DEAD-box helicase 1 [Source:HGNC Symbol;Acc:HGNC:2734],NA,DDX1,1653,NM_004939
PTGDR2_SIG,PTGDR2,PTGDR2_SIG,PTGDR2,SIG,51,3.31172437211606,0.00807731018969895,-0.000844243025635398,0.0373909850400832,0.0382352280657185,0.00223967588062284,2.18956614288172,1.83874280751298,1.76450968375668,2.08265164271226,0.318141958955587,0.0677604844740192,ENSG00000183134,PTGDR2,protein_coding,11,-1,60850933,60855950,q12.2,prostaglandin D2 receptor 2 [Source:HGNC Symbol;Acc:HGNC:4502],NA,PTGDR2,11251,NM_004778
MOV10_SIG,MOV10,MOV10_SIG,MOV10,SIG,49,3.31073628682888,0.158750418377713,0.150614310458138,0.185483344399176,0.0348690339410387,0.00224648912855539,1.16736118440869,5.75656402637425,5.7344665099103,5.82917015189865,0.0947036419883522,0.35158759107816,ENSG00000155363,MOV10,protein_coding,1,1,112673141,112700746,p13.2,Mov10 RISC complex RNA helicase [Source:HGNC Symbol;Acc:HGNC:7200],NA,MOV10,4343,NM_001130079;NM_001286072;NM_001321324;NM_020963
SUOX_SIG,SUOX,SUOX_SIG,SUOX,SIG,15,3.31071133828805,0.0800725729840057,0.0701543488575396,0.112661023685251,0.0425066748277117,0.00224648912855539,4.75070050047364,4.33147689755421,4.24248256838127,4.62388683626533,0.381404267884065,3.85474200182193e-05,ENSG00000139531,SUOX,protein_coding,12,1,55997180,56006641,q13.2,sulfite oxidase [Source:HGNC Symbol;Acc:HGNC:11460],Isolated sulfite oxidase deficiency;SULFITE OXIDASE DEFICIENCY ISOLATED,SUOX,6821,NM_000456;NM_001032386;NM_001032387
ESD_SIG,ESD,ESD_SIG,ESD,SIG,23,3.31044473862571,0.474954009397089,0.46857223923058,0.49592268280133,0.0273504435707499,0.00224738336313739,2.39595632908821,5.85099990509965,5.8171881336028,5.96209572573217,0.14490759212937,0.0442358540766467,ENSG00000139684,ESD,protein_coding,13,-1,46771256,46797161,q14.2,esterase D [Source:HGNC Symbol;Acc:HGNC:3465],NA,ESD,2098,NM_001984
CXCL5_SIG,CXCL5,CXCL5_SIG,CXCL5,SIG,20,-3.31043691651588,-0.0941764334663415,-0.0841170727392336,-0.127228618712553,-0.0431115459733197,0.00224738336313739,-2.13977459998971,0.71253699333035,0.785105634902641,0.474097171021398,-0.311008463881243,0.0745639839656104,ENSG00000163735,CXCL5,protein_coding,4,-1,73995642,73998677,q13.3,C-X-C motif chemokine ligand 5 [Source:HGNC Symbol;Acc:HGNC:10642],NA,CXCL5,6374,NM_002994
NKRF_TF,NKRF,NKRF_TF,NKRF,TF,107,3.30971253637196,0.249341735283327,0.245029652131113,0.263510008497745,0.0184803563666328,0.00225255118289755,2.74732226780469,4.39431674843678,4.35613430054416,4.5197733629411,0.163639062396944,0.0200370877940667,ENSG00000186416,NKRF,protein_coding,X,-1,119588337,119606443,q24,NFKB repressing factor [Source:HGNC Symbol;Acc:HGNC:19374],NA,NKRF,55922,NM_001173487;NM_001173488;NM_017544
RBM12_SIG,RBM12,RBM12_SIG,RBM12,SIG,50,3.30907947664191,0.317536128792068,0.310982301177481,0.339070133811424,0.0280878326339435,0.00225699367532529,2.34249789894594,6.3832519448589,6.35037771066982,6.49126728576589,0.140889575096074,0.0495745664082867,ENSG00000244462,RBM12,protein_coding,20,-1,35648925,35664956,q11.22,RNA binding motif protein 12 [Source:HGNC Symbol;Acc:HGNC:9898],SCHIZOPHRENIA 19,RBM12,10137,NM_001198838;NM_001198840;NM_006047;NM_152838
FZD2_SIG,FZD2,FZD2_SIG,FZD2,SIG,25,-3.30899413494709,0.0397708697646401,0.0520611523938162,-0.000611487445509866,-0.0526726398393261,0.00225702487847162,-0.418684090830544,1.72605488216021,1.74026789669253,1.67935497726832,-0.0609129194242125,0.757808090873996,ENSG00000180340,FZD2,protein_coding,17,1,44557459,44559570,q21.31,frizzled class receptor 2 [Source:HGNC Symbol;Acc:HGNC:4040],Autosomal dominant omodysplasia;Autosomal dominant Robinow syndrome,FZD2,2535,NM_001466
KDM4A_SIG,KDM4A,KDM4A_SIG,KDM4A,SIG,49,3.30712266763233,0.344003353814637,0.334145409436887,0.376393742484387,0.0422483330474999,0.00227149747991414,3.12843726880716,5.82099817821374,5.76253295943717,6.01309818276532,0.250565223328143,0.00771203032301903,ENSG00000066135,KDM4A,protein_coding,1,1,43650149,43705518,p34.2,lysine demethylase 4A [Source:HGNC Symbol;Acc:HGNC:22978],NA,KDM4A,9682,NM_014663
CLOCK_SIG,CLOCK,CLOCK_SIG,CLOCK,SIG,20,3.30688471597088,0.306309575745867,0.29988846074228,0.327407525043365,0.0275190643010848,0.00227276674775977,2.96473920653779,4.30544113883489,4.25587926599586,4.46828729244886,0.212408026453001,0.0117957922690347,ENSG00000134852,CLOCK,protein_coding,4,-1,55427903,55546909,q12,clock circadian regulator [Source:HGNC Symbol;Acc:HGNC:2082],NA,CLOCK,9575,NM_001267843;NM_004898
KCNK1_SIG,KCNK1,KCNK1_SIG,KCNK1,SIG,18,-3.30669073902303,-0.151477311167036,-0.147562309815244,-0.164340887037211,-0.016778577221967,0.00227357698538165,-0.794200813185922,0.257686277742047,0.26880148631848,0.221164878133767,-0.0476366081847133,0.538305663789662,ENSG00000135750,KCNK1,protein_coding,1,1,233614004,233672512,q42.2,potassium two pore domain channel subfamily K member 1 [Source:HGNC Symbol;Acc:HGNC:6272],NA,KCNK1,3775,NM_002245
ZBTB5_TF,ZBTB5,ZBTB5_TF,ZBTB5,TF,264,3.30658723344428,0.164347300251891,0.153939384340456,0.198544738246606,0.0446053539061505,0.00227357698538165,3.17047378324096,5.13085636631993,5.06814307618945,5.3369143196058,0.268771243416352,0.00686601332585669,ENSG00000168795,ZBTB5,protein_coding,9,-1,37438102,37465450,p13.2,zinc finger and BTB domain containing 5 [Source:HGNC Symbol;Acc:HGNC:23836],NA,ZBTB5,9925,NM_014872
ZNF790_TF,ZNF790,ZNF790_TF,ZNF790,TF,51,3.30654058397054,0.19527840929868,0.180552945163185,0.243662077172449,0.0631091320092634,0.00227357698538165,2.57005838476871,1.87356378231815,1.82549993213159,2.03148786150254,0.205987929370944,0.0301297209821117,ENSG00000197863,ZNF790,protein_coding,19,-1,36817428,36850787,q13.12,zinc finger protein 790 [Source:HGNC Symbol;Acc:HGNC:33114],NA,ZNF790,388536,NM_001242800;NM_001242801;NM_001242802;NM_206894
SLC38A6_SIG,SLC38A6,SLC38A6_SIG,SLC38A6,SIG,11,3.30613268616018,0.0468566369221777,0.0416394402800996,0.0639988544604345,0.0223594141803349,0.00227622812656373,3.29183955177243,2.44855745776404,2.40051900759898,2.60639807973494,0.205879072135966,0.00491899294959474,ENSG00000139974,SLC38A6,protein_coding,14,1,60981114,61083733,q23.1,solute carrier family 38 member 6 [Source:HGNC Symbol;Acc:HGNC:19863],NA,SLC38A6,145389,NM_001172702;NM_153811
PM20D2_SIG,PM20D2,PM20D2_SIG,PM20D2,SIG,39,3.30538376394429,0.246487806237696,0.234237282746267,0.286739526280963,0.0525022435346968,0.00228165714159293,2.39371194094647,5.71904073511462,5.65516178797025,5.92892870430326,0.273766916333008,0.0444192743920077,ENSG00000146281,PM20D2,protein_coding,6,1,89146055,89165565,q15,peptidase M20 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:21408],NA,PM20D2,135293,NM_001010853
OCRL_SIG,OCRL,OCRL_SIG,OCRL,SIG,28,3.30483377673503,0.169573640203982,0.162119276791038,0.194066548560798,0.0319472717697596,0.00228547542099793,3.02553613113548,5.12886923047648,5.08474503832602,5.27384871897087,0.189103680644849,0.0100620944577049,ENSG00000122126,OCRL,protein_coding,X,1,129539849,129592561,q26.1,OCRL, inositol polyphosphate-5-phosphatase [Source:HGNC Symbol;Acc:HGNC:8108],DENT DISEASE 2;Dent disease type 2;LOWE OCULOCEREBRORENAL SYNDROME;Oculocerebrorenal syndrome of Lowe,OCRL,4952,NM_000276;NM_001318784;NM_001587
ZNF624_TF,ZNF624,ZNF624_TF,ZNF624,TF,43,3.30459356410707,0.240181286983028,0.235199520635648,0.256549947838708,0.02135042720306,0.0022867711274291,1.61020546543482,2.90791270877699,2.88367213221986,2.98756031746473,0.103888185244872,0.187739151940576,ENSG00000197566,ZNF624,protein_coding,17,-1,16620734,16653856,p11.2,zinc finger protein 624 [Source:HGNC Symbol;Acc:HGNC:29254],NA,ZNF624,57547,NM_020787
ASGR1_SIG,ASGR1,ASGR1_SIG,ASGR1,SIG,16,-3.3043169433602,0.0325803406627689,0.0517508775775406,-0.0304085663429096,-0.0821594439204504,0.00228836483052936,-1.76312262162717,2.05141221785977,2.10215467692107,1.88468699522977,-0.217467681691301,0.147011178358013,ENSG00000141505,ASGR1,protein_coding,17,-1,7173431,7179564,p13.1,asialoglycoprotein receptor 1 [Source:HGNC Symbol;Acc:HGNC:742],NA,ASGR1,432,NM_001197216;NM_001671
MAFA_TF,MAFA,MAFA_TF,MAFA,TF,47,3.30209414622682,-0.0726839144021919,-0.0770529324083965,-0.0583285695246625,0.0187243628837341,0.00230578318235752,-0.345033439093426,0.254209211581275,0.25772225708502,0.242666347783254,-0.0150559093017657,0.800719961942309,ENSG00000182759,MAFA,protein_coding,8,-1,143419182,143430406,q24.3,MAF bZIP transcription factor A [Source:HGNC Symbol;Acc:HGNC:23145],INSULINOMATOSIS AND DIABETES MELLITUS,MAFA,389692,NM_201589
SLC37A2_SIG,SLC37A2,SLC37A2_SIG,SLC37A2,SIG,51,-3.30198253486347,0.229083741023045,0.258505431238038,0.132412473173782,-0.126092958064257,0.00230578318235752,-2.80561432854874,2.42369329970652,2.54608118552736,2.02156167486663,-0.524519510660728,0.0174724487890457,ENSG00000134955,SLC37A2,protein_coding,11,1,125063067,125090312,q24.2,solute carrier family 37 member 2 [Source:HGNC Symbol;Acc:HGNC:20644],NA,SLC37A2,219855,NM_001145290;NM_198277
ZNF675_TF,ZNF675,ZNF675_TF,ZNF675,TF,32,3.30194668573957,0.288927420532836,0.279452770666893,0.320058412949504,0.0406056422826101,0.00230578318235752,3.06760711844769,3.99494377575556,3.93758452120538,4.18340989784901,0.245825376643635,0.00903349281866903,ENSG00000197372,ZNF675,protein_coding,19,-1,23525631,23687220,p12,zinc finger protein 675 [Source:HGNC Symbol;Acc:HGNC:30768],NA,ZNF675,171392,NM_138330
MGST2_SIG,MGST2,MGST2_SIG,MGST2,SIG,52,3.30012157385452,0.278648108685155,0.26798462055491,0.313685283970244,0.0457006634153338,0.00232011168187271,3.33602022209135,4.56903298884133,4.48616175022245,4.84132420144623,0.355162451223779,0.00434194115977014,ENSG00000085871,MGST2,protein_coding,4,1,139665768,139740745,q31.1,microsomal glutathione S-transferase 2 [Source:HGNC Symbol;Acc:HGNC:7063],NA,MGST2,4258,NM_001204366;NM_001204367;NM_001204368;NM_002413
CCT3_SIG,CCT3,CCT3_SIG,CCT3,SIG,33,3.30004598726737,0.73611570969988,0.724709180644121,0.773594305168806,0.0488851245246856,0.00232011168187271,2.98897166708625,7.1334446593615,7.07908287041732,7.31206196589238,0.232979095475059,0.0110768994098612,ENSG00000163468,CCT3,protein_coding,1,-1,156308968,156367873,q22,chaperonin containing TCP1 subunit 3 [Source:HGNC Symbol;Acc:HGNC:1616],NA,CCT3,7203,NM_001008800;NM_005998
MAOA_SIG,MAOA,MAOA_SIG,MAOA,SIG,23,3.29901692226389,-0.150067675448408,-0.154439874523488,-0.135701878487434,0.0187379960360542,0.00232795932672088,0.43629329408726,1.06701649351273,1.05368597050865,1.1108167833833,0.0571308128746497,0.746759922500957,ENSG00000189221,MAOA,protein_coding,X,1,43654907,43746824,p11.3,monoamine oxidase A [Source:HGNC Symbol;Acc:HGNC:6833],BRUNNER SYNDROME;Monoamine oxidase A deficiency,MAOA,4128,NM_000240;NM_001270458
FMNL2_TF,FMNL2,FMNL2_TF,FMNL2,TF,141,-3.29890999924166,-0.0101214309232184,-0.00129629902604797,-0.039118292871064,-0.037821993845016,0.00232817194875741,-2.10831514040603,2.06572547381094,2.12972141600344,1.85545309232133,-0.274268323682112,0.0791221132229566,ENSG00000157827,FMNL2,protein_coding,2,1,152335174,152649826,q23.3,formin like 2 [Source:HGNC Symbol;Acc:HGNC:18267],NA,FMNL2,114793,NM_052905
WDR3_SIG,WDR3,WDR3_SIG,WDR3,SIG,112,3.29791811539749,0.427064308705113,0.411833940251493,0.477106947909868,0.065273007658375,0.00233573538456501,2.42736149113166,4.51254242878835,4.45471031660183,4.70256222597266,0.247851909370835,0.0413045616365459,ENSG00000065183,WDR3,protein_coding,1,1,117929720,117966543,p12,WD repeat domain 3 [Source:HGNC Symbol;Acc:HGNC:12755],NA,WDR3,10885,NM_006784
SSBP1_SIG,SSBP1,SSBP1_SIG,SSBP1,SIG,14,3.29760939963466,0.47170161222865,0.465524893415262,0.49199654547264,0.0264716520573781,0.00233746819018076,3.15020638962265,5.84605042973525,5.80567255673474,5.97872058387978,0.173048027145043,0.00726735783688247,ENSG00000106028,SSBP1,protein_coding,7,1,141738334,141787922,q34,single stranded DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11317],Autosomal dominant non-syndromic sensorineural deafness type DFNA,SSBP1,6742,NM_001256510;NM_001256511;NM_001256512;NM_001256513;NM_003143
STAT5A_SIG,STAT5A,STAT5A_SIG,STAT5A,SIG,47,3.29754736441874,0.240792161226841,0.229547896848424,0.277737601327354,0.0481897044789301,0.00233746819018076,1.00105729412749,7.71569464849954,7.7005010718727,7.76561640027347,0.0651153284007727,0.429897276894029,ENSG00000126561,STAT5A,protein_coding,17,1,42287547,42311943,q21.2,signal transducer and activator of transcription 5A [Source:HGNC Symbol;Acc:HGNC:11366],NA,STAT5A,6776,NM_001288718;NM_001288719;NM_001288720;NM_003152
SMG1_SIG,SMG1,SMG1_SIG,SMG1,SIG,63,3.29734800991793,0.331356810904094,0.324939560370403,0.352442062657648,0.0275025022872454,0.00233845165195541,2.67798262470199,8.15661753850896,8.11886049164175,8.28067640678693,0.161815915145176,0.0235744872422464,ENSG00000157106,SMG1,protein_coding,16,-1,18804853,18926454,p12.3,SMG1, nonsense mediated mRNA decay associated PI3K related kinase [Source:HGNC Symbol;Acc:HGNC:30045],NA,SMG1,23049,NM_015092
DCAF13_SIG,DCAF13,DCAF13_SIG,DCAF13,SIG,21,3.29536006637746,0.709155199760642,0.699579931403542,0.740616795791112,0.0410368643875706,0.00235437818850277,2.75695804348411,5.05150205586096,5.01180615098407,5.18193145759932,0.170125306615256,0.0196107231516682,ENSG00000164934,DCAF13,protein_coding,8,1,103414714,103443453,q22.3,DDB1 and CUL4 associated factor 13 [Source:HGNC Symbol;Acc:HGNC:24535],NA,DCAF13,25879,NM_015420
POLDIP3_SIG,POLDIP3,POLDIP3_SIG,POLDIP3,SIG,5,3.29400398604257,0.285847749487286,0.282148471989522,0.298002518408512,0.01585404641899,0.00236508250068077,1.60409680300127,6.85925741023264,6.8460840116839,6.90254143403565,0.0564574223517492,0.18933757181495,ENSG00000100227,POLDIP3,protein_coding,22,-1,42583721,42614962,q13.2,DNA polymerase delta interacting protein 3 [Source:HGNC Symbol;Acc:HGNC:23782],NA,POLDIP3,84271,NM_001278657;NM_032311;NM_178136
RP2_SIG,RP2,RP2_SIG,RP2,SIG,30,-3.2903247652767,0.393489989256917,0.399302240251343,0.374392593132372,-0.0249096471189706,0.00239553582394766,-1.88586709924524,5.40603161570693,5.43512202672005,5.31044883666385,-0.124673190056203,0.119194642967695,ENSG00000102218,RP2,protein_coding,X,1,46837043,46882358,p11.3,RP2, ARL3 GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:10274],Retinitis pigmentosa;RETINITIS PIGMENTOSA 2,RP2,6102,NM_006915
NFKB2_SIG,NFKB2,NFKB2_SIG,NFKB2,SIG,54,-3.28957047953223,0.258721151766016,0.271969645413128,0.215190386925503,-0.0567792584876255,0.00240127212460478,-2.36410044801231,5.68823935592935,5.75675062889036,5.46313088762891,-0.293619741261449,0.0473070388617419,ENSG00000077150,NFKB2,protein_coding,10,1,102394110,102402524,q24.32,nuclear factor kappa B subunit 2 [Source:HGNC Symbol;Acc:HGNC:7795],Common variable immunodeficiency;Deficiency in anterior pituitary function-variable immunodeficiency syndrome;IMMUNODEFICIENCY COMMON VARIABLE 10,NFKB2,4791,NM_001077494;NM_001261403;NM_001288724;NM_001322934;NM_001322935;NM_002502
WSB2_SIG,WSB2,WSB2_SIG,WSB2,SIG,19,-3.28913868524835,0.0548847876310792,0.0605119735595031,0.0363954624376865,-0.0241165111218164,0.00240426471928936,-0.829145380487165,5.31365748908927,5.32881019233129,5.26387003557977,-0.0649401567515221,0.519573213043396,ENSG00000176871,WSB2,protein_coding,12,-1,118032694,118062430,q24.23,WD repeat and SOCS box containing 2 [Source:HGNC Symbol;Acc:HGNC:19222],NA,WSB2,55884,NM_001278557;NM_001278558;NM_018639
HBEGF_SIG,HBEGF,HBEGF_SIG,HBEGF,SIG,36,-3.28804159826001,0.296885039184261,0.309125701098006,0.256665721467673,-0.0524599796303323,0.00241295677678927,-1.96917591900203,4.53376129382338,4.6273890997914,4.22612707421417,-0.40126202557723,0.102719044176594,ENSG00000113070,HBEGF,protein_coding,5,-1,140332843,140346603,q31.3,heparin binding EGF like growth factor [Source:HGNC Symbol;Acc:HGNC:3059],NA,HBEGF,1839,NM_001945
ZNF714_TF,ZNF714,ZNF714_TF,ZNF714,TF,34,3.28778930391286,0.178854798551968,0.17394661598163,0.194981684140219,0.0210350681585887,0.00241442307015282,3.52181844858582,4.17940358319454,4.10050820344165,4.43863125952546,0.338123056083814,0.00253113069318708,ENSG00000160352,ZNF714,protein_coding,19,1,21082159,21125270,p12,zinc finger protein 714 [Source:HGNC Symbol;Acc:HGNC:27124],NA,ZNF714,148206,NM_182515
METTL1_SIG,METTL1,METTL1_SIG,METTL1,SIG,16,3.28732606584969,0.499121972523191,0.485706081075304,0.543202758709106,0.0574966776338021,0.00241770088283354,2.28027062309718,2.86454188459468,2.82120123273538,3.00694688356095,0.185745650825576,0.0562398413054119,ENSG00000037897,METTL1,protein_coding,12,-1,57768471,57772119,q14.1,methyltransferase like 1 [Source:HGNC Symbol;Acc:HGNC:7030],NA,METTL1,4234,NM_005371;NM_023033
NOTUM_SIG,NOTUM,NOTUM_SIG,NOTUM,SIG,20,3.28659429059349,-0.111658933835106,-0.116225945582439,-0.0966530380938683,0.0195729074885712,0.00242329243308072,-0.752759558642909,0.490435053344278,0.500970512683797,0.455818544085858,-0.045151968597939,0.561927837658184,ENSG00000185269,NOTUM,protein_coding,17,-1,81952507,81961840,q25.3,notum, palmitoleoyl-protein carboxylesterase [Source:HGNC Symbol;Acc:HGNC:27106],NA,NOTUM,147111,NM_178493
AGPAT5_SIG,AGPAT5,AGPAT5_SIG,AGPAT5,SIG,28,3.28576083453684,0.417258349921663,0.406761958819894,0.451746492113187,0.0449845332932925,0.0024297727966279,1.07596938515769,5.01456677090507,4.98538907011805,5.11043635920529,0.125047289087238,0.393947958998033,ENSG00000155189,AGPAT5,protein_coding,8,1,6708642,6761503,p23.1,1-acylglycerol-3-phosphate O-acyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:20886],NA,AGPAT5,55326,NM_018361
EP400_SIG,EP400,EP400_SIG,EP400,SIG,17,3.28492825662784,0.861829118836825,0.856266510967803,0.880106258977895,0.0238397480100917,0.00243626151256718,2.13672498738414,7.08982098578072,7.06543487486805,7.16994677877948,0.104511903911433,0.0750353855514365,ENSG00000183495,EP400,protein_coding,12,1,131949920,132081102,q24.33,E1A binding protein p400 [Source:HGNC Symbol;Acc:HGNC:11958],NA,EP400,57634,NM_015409
NHLRC3_SIG,NHLRC3,NHLRC3_SIG,NHLRC3,SIG,21,3.2839560591958,0.300092841569987,0.294426096055313,0.318712148261058,0.024286052205745,0.00244397664194204,1.40924349875459,4.94134963429567,4.91248307595469,5.03619689741603,0.12371382146134,0.253101202788224,ENSG00000188811,NHLRC3,protein_coding,13,1,39038306,39050109,q13.3,NHL repeat containing 3 [Source:HGNC Symbol;Acc:HGNC:33751],NA,NHLRC3,387921,NM_001012754;NM_001017370
RPGR_SIG,RPGR,RPGR_SIG,RPGR,SIG,23,3.28369049818999,-0.0207796768711828,-0.0243850675343859,-0.0089333932635154,0.0154516742708704,0.00244557575198777,1.55665720951463,4.45205034482087,4.42583514262495,4.53818600917891,0.112350866553962,0.203534112424453,ENSG00000156313,RPGR,protein_coding,X,-1,38269163,38327564,p11.4,retinitis pigmentosa GTPase regulator [Source:HGNC Symbol;Acc:HGNC:10295],Achromatopsia;Cone-rod dystrophy X-linked 1;Cone rod dystrophy;MACULAR DEGENERATION X-LINKED ATROPHIC;Primary ciliary dyskinesia;Primary ciliary dyskinesia-retinitis pigmentosa syndrome;Retinitis pigmentosa;RETINITIS PIGMENTOSA 3;RETINITIS PIGMENTOSA X-LINKED AND SINORESPIRATORY INFECTIONS WITH OR WITHOUT DEAFNESS,RPGR,6103,NM_000328;NM_001034853;NM_001367245;NM_001367251
FBXL4_SIG,FBXL4,FBXL4_SIG,FBXL4,SIG,45,3.28338864437811,0.280289461015224,0.270925264446273,0.311057535456062,0.0401322710097886,0.00244749105884143,1.70866013883756,4.77639558711445,4.75231445366339,4.85551931131081,0.103204857647424,0.160966126998734,ENSG00000112234,FBXL4,protein_coding,6,-1,98868535,98948006,q16.2,F-box and leucine rich repeat protein 4 [Source:HGNC Symbol;Acc:HGNC:13601],Fatal encephalopathy lactic acidosis and severe mtDNA depletion in muscle;Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type);Mitochondrial DNA depletion syndrome encephalomyopathic form with variable craniofacial anomalies,FBXL4,26235,NM_001278716;NM_012160
MRPL10_SIG,MRPL10,MRPL10_SIG,MRPL10,SIG,15,3.28290468270705,0.349173230864013,0.345387822850631,0.361611000050841,0.0162231772002105,0.00245099067506597,3.18802519790734,5.24661680949691,5.21166442524758,5.36146035774467,0.149795932497088,0.00656635042341111,ENSG00000159111,MRPL10,protein_coding,17,-1,47823272,47831541,q21.32,mitochondrial ribosomal protein L10 [Source:HGNC Symbol;Acc:HGNC:14055],NA,MRPL10,124995,NM_145255;NM_148887
PDCD1_SIG,PDCD1,PDCD1_SIG,PDCD1,SIG,8,-3.28266013039944,0.0783820116442132,0.0937866730825552,0.0277666954896612,-0.066019977592894,0.00245241158777646,-1.12852275939281,0.890260914331831,0.912068749533424,0.818606598669454,-0.0934621508639696,0.368912543278273,ENSG00000188389,PDCD1,protein_coding,2,-1,241849884,241858894,q37.3,programmed cell death 1 [Source:HGNC Symbol;Acc:HGNC:8760],MULTIPLE SCLEROSIS SUSCEPTIBILITY TO;Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 2,PDCD1,5133,NM_005018
MAP3K12_SIG,MAP3K12,MAP3K12_SIG,MAP3K12,SIG,60,3.28225586954655,0.141129209351029,0.135606152429439,0.159276396379109,0.0236702439496707,0.00245462085174561,1.71570280460934,3.99991048205783,3.95282309686806,4.15462617625279,0.20180307938473,0.159143638536008,ENSG00000139625,MAP3K12,protein_coding,12,-1,53479669,53500063,q13.13,mitogen-activated protein kinase kinase kinase 12 [Source:HGNC Symbol;Acc:HGNC:6851],NA,MAP3K12,7786,NM_001193511;NM_006301
LAMA2_SIG,LAMA2,LAMA2_SIG,LAMA2,SIG,11,-3.28224398512731,-0.121215837832087,-0.116397266936768,-0.137048285059561,-0.0206510181227926,0.00245462085174561,-1.01301604540011,0.400911149177063,0.41180029922546,0.365132513303759,-0.0466677859217013,0.424241870021222,ENSG00000196569,LAMA2,protein_coding,6,1,128883141,129516569,q22.33,laminin subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:6482],Congenital Muscular Dystrophy;Congenital muscular dystrophy type 1A;MUSCULAR DYSTROPHY CONGENITAL MEROSIN-DEFICIENT 1A;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 23,LAMA2,3908,NM_000426;NM_001079823
LCMT2_SIG,LCMT2,LCMT2_SIG,LCMT2,SIG,39,3.28112809959462,-0.0137270604733128,-0.0253690182713527,0.0245250865773897,0.0498941048487424,0.00246364434731973,2.55613065294312,2.51346152122496,2.45381583389677,2.70944020816042,0.25562437426365,0.031152790575829,ENSG00000168806,LCMT2,protein_coding,15,-1,43323649,43330605,q15.3,leucine carboxyl methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:17558],NA,LCMT2,9836,NM_014793
EPRS_SIG,EPRS,EPRS_SIG,EPRS,SIG,34,3.27601704736151,0.698007509314882,0.68425194184141,0.743204373870576,0.0589524320291659,0.00250794443574897,3.02699902666081,7.14214919880626,7.09387463153743,7.30076563411813,0.206891002580707,0.0100349556808833,ENSG00000136628,EPRS,protein_coding,1,-1,219968600,220046530,q41,glutamyl-prolyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:3418],LEUKODYSTROPHY HYPOMYELINATING 15,EPRS,2058,NM_004446
TRRAP_SIG,TRRAP,TRRAP_SIG,TRRAP,SIG,22,3.27564543989269,0.606522919036343,0.602222947949893,0.620651395463251,0.0184284475133585,0.00251052451510976,2.93033345152026,7.01754064796706,6.97918058967024,7.14358083951377,0.164400249843533,0.0128704605798396,ENSG00000196367,TRRAP,protein_coding,7,1,98877933,99050831,q22.1,transformation/transcription domain associated protein [Source:HGNC Symbol;Acc:HGNC:12347],NA,TRRAP,8295,NM_001244580;NM_003496
GPATCH4_SIG,GPATCH4,GPATCH4_SIG,GPATCH4,SIG,21,3.27492210664265,0.478699049851178,0.464397678036229,0.525689271528868,0.0612915934926392,0.00251623809693341,2.79263420264702,4.47785751388889,4.41694701551308,4.67799200855228,0.261044993039199,0.0180162378080062,ENSG00000160818,GPATCH4,protein_coding,1,-1,156594487,156601496,q23.1,G-patch domain containing 4 [Source:HGNC Symbol;Acc:HGNC:25982],NA,GPATCH4,54865,NM_015590;NM_182679
GLYCTK_SIG,GLYCTK,GLYCTK_SIG,GLYCTK,SIG,8,-3.27480350670033,0.098995400523629,0.102605560723987,0.0871334455795965,-0.0154721151443904,0.00251657150152081,-0.675986734847405,3.37907288372141,3.38845774202721,3.34823692071662,-0.0402208213105881,0.605696404544037,ENSG00000168237,GLYCTK,protein_coding,3,1,52287089,52295257,p21.2,glycerate kinase [Source:HGNC Symbol;Acc:HGNC:24247],D-GLYCERIC ACIDURIA,GLYCTK,132158,NM_001144951;NM_145262
ZNF322_TF,ZNF322,ZNF322_TF,ZNF322,TF,73,3.27419900684026,0.172868371940191,0.160844736488068,0.212374602711454,0.0515298662233866,0.00252123728436448,3.15900672103451,1.95633916074636,1.89172323830635,2.16864862019213,0.276925381885779,0.00708599790473012,ENSG00000181315,ZNF322,protein_coding,6,-1,26634383,26659752,p22.2,zinc finger protein 322 [Source:HGNC Symbol;Acc:HGNC:23640],NA,ZNF322,79692,NM_001242797;NM_001242798;NM_001242799;NM_024639
CAMK2A_SIG,CAMK2A,CAMK2A_SIG,CAMK2A,SIG,1,3.27277640429998,-0.514267524156586,-0.525740215642786,-0.476571537844789,0.0491686777979967,0.00253323301980106,0.735769199535511,0.252922508018953,0.243859973255022,0.282699407957587,0.0388394347025654,0.571446087084641,ENSG00000070808,CAMK2A,protein_coding,5,-1,150219491,150290291,q32,calcium/calmodulin dependent protein kinase II alpha [Source:HGNC Symbol;Acc:HGNC:1460],Autosomal dominant non-syndromic intellectual disability;Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 53;MENTAL RETARDATION AUTOSOMAL RECESSIVE 63,CAMK2A,815,NM_015981;NM_171825
FAM200B_TF,FAM200B,FAM200B_TF,FAM200B,TF,256,-3.27262616780915,0.120139556009691,0.129002725686092,0.0910177127872305,-0.0379850128988618,0.00253385226614204,-2.66912177487254,4.03695534449445,4.08059597229755,3.89356471028424,-0.187031262013309,0.02403807513639,ENSG00000237765,FAM200B,protein_coding,4,1,15681662,15705565,p15.32,family with sequence similarity 200 member B [Source:HGNC Symbol;Acc:HGNC:27740],NA,FAM200B,285550,NM_001145191
CHST2_SIG,CHST2,CHST2_SIG,CHST2,SIG,23,-3.2723778891443,-0.0595438067782269,-0.0535299486974527,-0.0793036261864851,-0.0257736774890325,0.00253535096534043,-1.73065151124273,4.39544360425202,4.45735223627499,4.19202952760509,-0.265322708669903,0.155120602772144,ENSG00000175040,CHST2,protein_coding,3,1,143119771,143124014,q24,carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970],NA,CHST2,9435,NM_004267
MVK_SIG,MVK,MVK_SIG,MVK,SIG,18,3.27197865461525,0.137999210391047,0.129786125454724,0.164985060896106,0.0351989354413818,0.00253820550119919,4.11042987785707,2.91296767998014,2.84629393623829,3.13203855227481,0.285744616036519,0.000392124397183813,ENSG00000110921,MVK,protein_coding,12,1,109573255,109598125,q24.11,mevalonate kinase [Source:HGNC Symbol;Acc:HGNC:7530],Disseminated superficial actinic porokeratosis;HYPER-IgD SYNDROME;Hyperimmunoglobulinemia D with periodic fever;MEVALONIC ACIDURIA;POROKERATOSIS 3 MULTIPLE TYPES;Porokeratosis of Mibelli,MVK,4598,NM_000431;NM_001114185;NM_001301182
PTRH2_SIG,PTRH2,PTRH2_SIG,PTRH2,SIG,36,3.27188979209152,0.143409866545734,0.132787191623736,0.178312941289444,0.0455257496657083,0.00253827525605011,3.38279849325722,3.6726182673893,3.60896606663457,3.88176121272628,0.272795146091712,0.00380270009486391,ENSG00000141378,PTRH2,protein_coding,17,-1,59674636,59707626,q23.1,peptidyl-tRNA hydrolase 2 [Source:HGNC Symbol;Acc:HGNC:24265],Infantile multisystem neurologic-endocrine-pancreatic disease;NEUROLOGIC ENDOCRINE AND PANCREATIC DISEASE MULTISYSTEM INFANTILE-ONSET,PTRH2,51651,NM_001015509;NM_016077
STK35_SIG,STK35,STK35_SIG,STK35,SIG,12,3.27069728181928,0.372029142778919,0.368310916593649,0.384246171673377,0.0159352550797283,0.00254827130660769,1.35677084684073,5.121257815073,5.10667049725254,5.16918757362593,0.0625170763733909,0.273005020582335,ENSG00000125834,STK35,protein_coding,20,1,2101611,2177038,p13,serine/threonine kinase 35 [Source:HGNC Symbol;Acc:HGNC:16254],NA,STK35,140901,NM_080836
CS_SIG,CS,CS_SIG,CS,SIG,9,3.26934699849934,0.408738943283531,0.40413144041284,0.423877881287231,0.0197464408743912,0.00255973059532172,-1.45175196435966,7.76930479962827,7.78155626629929,7.72904998056633,-0.0525062857329582,0.237983110089831,ENSG00000062485,CS,protein_coding,12,-1,56271699,56300391,q13.3,citrate synthase [Source:HGNC Symbol;Acc:HGNC:2422],NA,CS,1431,NM_004077
AK5_SIG,AK5,AK5_SIG,AK5,SIG,22,-3.26884988055587,-0.047629170505358,-0.043089102740281,-0.0625465360191825,-0.0194574332789015,0.0025634971538751,-3.00889308476635,2.1955530356367,2.34214775782974,1.71388466271669,-0.628263095113051,0.0104995487690668,ENSG00000154027,AK5,protein_coding,1,1,77282019,77559966,p31.1,adenylate kinase 5 [Source:HGNC Symbol;Acc:HGNC:365],NA,AK5,26289,NM_012093;NM_174858
CNOT7_SIG,CNOT7,CNOT7_SIG,CNOT7,SIG,23,3.26864537924637,0.501537010581725,0.495041689379893,0.522878780244887,0.0278370908649939,0.00256461561550047,2.14810833126318,6.43369455971757,6.41105569767354,6.50807939214797,0.0970236944744328,0.0733810198558208,ENSG00000198791,CNOT7,protein_coding,8,-1,17224966,17246878,p22,CCR4-NOT transcription complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:14101],NA,CNOT7,29883,NM_001322087;NM_001322088;NM_001322089;NM_001322090;NM_001322091;NM_001322092;NM_001322093;NM_001322094;NM_001322095;NM_001322096;NM_001322097;NM_001322098;NM_001322099;NM_001322100;NM_013354;NM_054026
GANAB_SIG,GANAB,GANAB_SIG,GANAB,SIG,47,3.26733013388567,0.651489660074497,0.642087288708569,0.682383165991118,0.0402958772825488,0.00257582350338833,2.12135514320125,8.77206102628139,8.74006138253361,8.87720271288125,0.137141330347644,0.0771946759888208,ENSG00000089597,GANAB,protein_coding,11,-1,62624826,62646726,q12.3,glucosidase II alpha subunit [Source:HGNC Symbol;Acc:HGNC:4138],Autosomal dominant polycystic kidney disease;POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,GANAB,23193,NM_001278192;NM_001278193;NM_001278194;NM_001329222;NM_001329223;NM_001329224;NM_001329225;NM_198334;NM_198335
PTGR1_SIG,PTGR1,PTGR1_SIG,PTGR1,SIG,61,3.2662786917739,-0.0169093072693313,-0.0225692750865202,0.00168772984428951,0.0242570049308097,0.00258466732052684,2.33453395008152,2.09376690216815,2.02294657168744,2.32646227374761,0.303515702060167,0.0504139669964362,ENSG00000106853,PTGR1,protein_coding,9,-1,111549722,111599893,q31.3,prostaglandin reductase 1 [Source:HGNC Symbol;Acc:HGNC:18429],NA,PTGR1,22949,NM_001146108;NM_001146109;NM_012212
MARCH1_SIG,MARCH1,MARCH1_SIG,MARCH1,SIG,31,-3.26442848719417,0.320346946790617,0.354557058084965,0.2079422953949,-0.146614762690065,0.00260086276978562,-2.08282692380897,4.22266380170872,4.33167380993482,3.86448806039439,-0.467185749540431,0.083025624810099,ENSG00000145416,MARCH1,protein_coding,4,-1,163524298,164384050,q32.3,membrane associated ring-CH-type finger 1 [Source:HGNC Symbol;Acc:HGNC:26077],NA,MARCH1,55016,NM_001166373;NM_017923
DAD1_SIG,DAD1,DAD1_SIG,DAD1,SIG,14,3.264199876514,0.330140017664953,0.319546017016372,0.364948876938859,0.0454028599224862,0.0026022176194854,1.67815663913929,6.13915968236729,6.11118956456979,6.23106149798767,0.119871933417881,0.168835683125518,ENSG00000129562,DAD1,protein_coding,14,-1,22564907,22589224,q11.2,defender against cell death 1 [Source:HGNC Symbol;Acc:HGNC:2664],NA,DAD1,1603,NM_001344
SFN_SIG,SFN,SFN_SIG,SFN,SIG,25,-3.26300074852316,-0.134555269225444,-0.127429439805924,-0.157968708746726,-0.0305392689408023,0.00261250574886787,-1.9278275226245,0.537930049354131,0.566726489140862,0.443313175769155,-0.123413313371707,0.110715336005424,ENSG00000175793,SFN,protein_coding,1,1,26863149,26864456,p36.11,stratifin [Source:HGNC Symbol;Acc:HGNC:10773],NA,SFN,2810,NM_006142
GNPNAT1_SIG,GNPNAT1,GNPNAT1_SIG,GNPNAT1,SIG,13,3.26282833149652,0.579994096986298,0.571244647370702,0.608742288580397,0.0374976412096947,0.00261334808424198,3.26137431659056,4.01123322744197,3.95167655159937,4.20691944806767,0.255242896468301,0.00535537174333935,ENSG00000100522,GNPNAT1,protein_coding,14,-1,52775193,52791668,q22.1,glucosamine-phosphate N-acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:19980],NA,GNPNAT1,64841,NM_198066
ZNF485_TF,ZNF485,ZNF485_TF,ZNF485,TF,128,3.26250635577626,0.0400085750410579,0.0273669454494028,0.0815453579850675,0.0541784125356648,0.00261557062725584,2.37258877030259,1.48290816173297,1.43397608924256,1.64368497134432,0.20970888210176,0.0465111143776592,ENSG00000198298,ZNF485,protein_coding,10,1,43606419,43617904,q11.21,zinc finger protein 485 [Source:HGNC Symbol;Acc:HGNC:23440],NA,ZNF485,220992,NM_001318140;NM_001318141;NM_001318142;NM_145312
SURF6_SIG,SURF6,SURF6_SIG,SURF6,SIG,6,3.26226981896142,0.267171644441982,0.255142747169375,0.306695164051977,0.0515524168826028,0.00261700609441353,3.23430998517948,4.92583494827966,4.88262175554725,5.06782115297189,0.185199397424638,0.00577613761612304,ENSG00000148296,SURF6,protein_coding,9,-1,133328776,133336188,q34.2,surfeit 6 [Source:HGNC Symbol;Acc:HGNC:11478],NA,SURF6,6838,NM_001278942;NM_006753
ZNF529_TF,ZNF529,ZNF529_TF,ZNF529,TF,159,3.26203996052725,0.150446585005656,0.141982131227821,0.178258361704258,0.0362762304764363,0.00261838073844465,2.61008556103531,4.23422834543586,4.17425119672556,4.4312961197697,0.257044923044141,0.0275112541233613,ENSG00000186020,ZNF529,protein_coding,19,-1,36534774,36605276,q13.12,zinc finger protein 529 [Source:HGNC Symbol;Acc:HGNC:29328],NA,ZNF529,57711,NM_001145649;NM_001145650;NM_001321351;NM_001352272;NM_001352273;NM_020951
XPO5_SIG,XPO5,XPO5_SIG,XPO5,SIG,60,3.26188231576238,0.646370548903389,0.634419563219545,0.685638073293162,0.0512185100736174,0.00261908893458415,3.23743981572064,5.38942854375513,5.33469460404296,5.56926863138086,0.234574027337902,0.00573098345386923,ENSG00000124571,XPO5,protein_coding,6,-1,43522334,43576038,p21.1,exportin 5 [Source:HGNC Symbol;Acc:HGNC:17675],NA,XPO5,57510,NM_020750
RNFT1_SIG,RNFT1,RNFT1_SIG,RNFT1,SIG,20,3.26050609209015,0.269427850062411,0.263407386156431,0.289209374324916,0.025801988168485,0.00263108079493581,1.94277979957295,4.23619388955891,4.20885714677797,4.32601461583913,0.117157469061162,0.107800519719496,ENSG00000189050,RNFT1,protein_coding,17,-1,59952240,59964761,q23.1,ring finger protein, transmembrane 1 [Source:HGNC Symbol;Acc:HGNC:30206],NA,RNFT1,51136,NM_016125
CLK2_SIG,CLK2,CLK2_SIG,CLK2,SIG,33,3.26027628385289,0.398378021529259,0.388915526802235,0.429469075632339,0.0405535488301035,0.00263246201037291,2.90543054380895,5.92095378122445,5.87879401782876,6.05947871809601,0.180684700267246,0.0136741705453182,ENSG00000176444,CLK2,protein_coding,1,-1,155262868,155278491,q22,CDC like kinase 2 [Source:HGNC Symbol;Acc:HGNC:2069],NA,CLK2,1196,NM_001294338;NM_001294339;NM_003993
ARRB1_SIG,ARRB1,ARRB1_SIG,ARRB1,SIG,50,3.25977487265424,0.360167467877558,0.354128747474025,0.380008977774882,0.0258802303008565,0.0026359344481327,1.6519723926364,6.67934712270045,6.64810737672542,6.78199200233268,0.133884625607263,0.175974512461241,ENSG00000137486,ARRB1,protein_coding,11,-1,75260122,75351705,q13.4,arrestin beta 1 [Source:HGNC Symbol;Acc:HGNC:711],NA,ARRB1,408,NM_004041;NM_020251
EXOSC5_SIG,EXOSC5,EXOSC5_SIG,EXOSC5,SIG,60,3.25964290758427,0.395377638448453,0.381359497446032,0.441437244599265,0.060077747153233,0.0026359344481327,2.5659506780221,3.58416429080344,3.52091082738241,3.79199709918683,0.271086271804423,0.0304335953383729,ENSG00000077348,EXOSC5,protein_coding,19,-1,41386374,41397359,q13.2,exosome component 5 [Source:HGNC Symbol;Acc:HGNC:24662],NA,EXOSC5,56915,NM_020158
PTPN9_SIG,PTPN9,PTPN9_SIG,PTPN9,SIG,39,3.25963191183047,0.335258201898246,0.328995842136314,0.355834526830309,0.0268386846939947,0.0026359344481327,3.16899831372981,5.69547661479146,5.64500012026834,5.86132795393885,0.216327833670516,0.00689551551322968,ENSG00000169410,PTPN9,protein_coding,15,-1,75463251,75579289,q24.2,protein tyrosine phosphatase, non-receptor type 9 [Source:HGNC Symbol;Acc:HGNC:9661],NA,PTPN9,5780,NM_002833
IFIT1_SIG,IFIT1,IFIT1_SIG,IFIT1,SIG,27,-3.25957870772012,0.15532909503267,0.169137637447693,0.109958169954738,-0.0591794674929545,0.0026359344481327,-1.68807913279145,2.78052108239783,2.85344351833471,2.54091879289094,-0.312524725443772,0.166285162142512,ENSG00000185745,IFIT1,protein_coding,10,1,89392546,89406487,q23.31,interferon induced protein with tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:5407],NA,IFIT1,3434,NM_001270927;NM_001270928;NM_001270929;NM_001270930;NM_001548
ECSIT_TF,ECSIT,ECSIT_TF,ECSIT,TF,501,3.25875749978243,0.260880517051934,0.257383671571284,0.272370152202641,0.014986480631357,0.00264282227660966,3.07121612913212,4.37104975342311,4.33023076836253,4.50516927576501,0.174938507402477,0.00895290918084343,ENSG00000130159,ECSIT,protein_coding,19,-1,11505929,11529172,p13.2,ECSIT signalling integrator [Source:HGNC Symbol;Acc:HGNC:29548],NA,ECSIT,51295,NM_001142464;NM_001142465;NM_001243204;NM_016581
ZNF197_TF,ZNF197,ZNF197_TF,ZNF197,TF,18,3.25857955473578,0.31101079994303,0.301139442679683,0.3434452595226,0.0423058168429168,0.00264372666806067,2.4004628949132,4.24683603143184,4.20000184264137,4.40071979460053,0.200717951959158,0.0438587440330958,ENSG00000186448,ZNF197,protein_coding,3,1,44584888,44648471,p21.31,zinc finger protein 197 [Source:HGNC Symbol;Acc:HGNC:12988],NA,ZNF197,10168;110354863,NM_001024855;NM_001323293;NM_001323294;NM_001323295;NM_001323296;NM_001351732;NM_001351733;NM_001351734;NM_001351735;NM_006991
SLC25A38_SIG,SLC25A38,SLC25A38_SIG,SLC25A38,SIG,42,3.25778418173432,0.0523742453098387,0.0460509500737929,0.0731507867997034,0.0270998367259104,0.0026503919642341,2.78596048709896,4.88948863264536,4.84735106679742,5.02794063471717,0.180589567919745,0.0182865184847382,ENSG00000144659,SLC25A38,protein_coding,3,1,39383324,39397351,p22.1,solute carrier family 25 member 38 [Source:HGNC Symbol;Acc:HGNC:26054],ANEMIA SIDEROBLASTIC 2 PYRIDOXINE-REFRACTORY;ANEMIA SIDEROBLASTIC PYRIDOXINE-REFRACTORY AUTOSOMAL RECESSIVE;Autosomal recessive sideroblastic anemia,SLC25A38,54977,NM_001354798;NM_017875
CLCN7_SIG,CLCN7,CLCN7_SIG,CLCN7,SIG,18,3.25765341532156,0.200853054700124,0.197597938783947,0.211548435567563,0.0139504967836163,0.00265085824177564,2.18212620074901,7.42745838189064,7.39526160596878,7.53324778849105,0.137986182522268,0.0687311742676676,ENSG00000103249,CLCN7,protein_coding,16,-1,1444934,1475084,p13.3,chloride voltage-gated channel 7 [Source:HGNC Symbol;Acc:HGNC:2025],Albers-Schonberg osteopetrosis;Autosomal recessive malignant osteopetrosis;CLCN7-Related Osteopetrosis;Intermediate osteopetrosis;OSTEOPETROSIS AUTOSOMAL DOMINANT 2;OSTEOPETROSIS AUTOSOMAL RECESSIVE 4,CLCN7,1186,NM_001114331;NM_001287
DNMT3A_SIG,DNMT3A,DNMT3A_SIG,DNMT3A,SIG,74,3.25673065073924,0.221752929506093,0.210961487337377,0.257210525203306,0.0462490378659297,0.00265873300693807,1.56322010158615,6.10339555029843,6.07068224639344,6.21088212027195,0.140199873878511,0.201645094047387,ENSG00000119772,DNMT3A,protein_coding,2,-1,25227855,25342590,p23.3,DNA methyltransferase 3 alpha [Source:HGNC Symbol;Acc:HGNC:2978],LEUKEMIA ACUTE MYELOID;Microcephalic primordial dwarfism;Tall stature-intellectual disability-facial dysmorphism syndrome;Tatton-Brown-rahman syndrome;Tatton-Brown Rahman syndrome (OVERGROWTH SYNDROME WITH INTELLECTUAL DISABILITY),DNMT3A,1788,NM_001320892;NM_001320893;NM_022552;NM_153759;NM_175629;NM_175630
ZG16B_SIG,ZG16B,ZG16B_SIG,ZG16B,SIG,36,3.25623410543983,-0.0106050712308305,-0.0156652345271231,0.00602117959984518,0.0216864141269683,0.00266262922108515,2.04391926165357,1.90635800401859,1.85140192377771,2.08692798195288,0.235526058175169,0.0895670549905102,ENSG00000162078,ZG16B,protein_coding,16,1,2830169,2839585,p13.3,zymogen granule protein 16B [Source:HGNC Symbol;Acc:HGNC:30456],NA,ZG16B,124220,NM_145252
DNAJC14_SIG,DNAJC14,DNAJC14_SIG,DNAJC14,SIG,34,3.25593649125698,0.465551257034872,0.461009927997809,0.480472766728077,0.0194628387302674,0.00266440974363166,1.23236195347235,5.14712817733067,5.13338400379163,5.19228760467322,0.0589036008815933,0.322770500525073,ENSG00000135392,DNAJC14,protein_coding,12,-1,55820960,55830824,q13.2,DnaJ heat shock protein family (Hsp40) member C14 [Source:HGNC Symbol;Acc:HGNC:24581],NA,DNAJC14,85406,NM_032364
EIF2D_SIG,EIF2D,EIF2D_SIG,EIF2D,SIG,40,3.25588271077739,0.629596928859867,0.620791108311959,0.658530339231566,0.0377392309196075,0.00266440974363166,1.96816032837696,5.79353917666554,5.766804524032,5.88138160674716,0.114577082715158,0.102888358732648,ENSG00000143486,EIF2D,protein_coding,1,-1,206571292,206612465,q32.1,eukaryotic translation initiation factor 2D [Source:HGNC Symbol;Acc:HGNC:6583],NA,EIF2D,1939,NM_001201478;NM_006893
RUNX3_SIG,RUNX3,RUNX3_SIG,RUNX3,SIG,46,-3.25566280956611,0.198209110015145,0.205839312997935,0.173138443071691,-0.0327008699262436,0.00266571560895678,-1.34392690116776,6.59210397581823,6.63832796777665,6.44022514509769,-0.198102822678962,0.277586536121277,ENSG00000020633,RUNX3,protein_coding,1,-1,24899511,24965121,p36.11,runt related transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:10473],NA,RUNX3,864,NM_001031680;NM_001320672;NM_004350
PRR3_SIG,PRR3,PRR3_SIG,PRR3,SIG,49,3.2544634306752,0.213610672918259,0.201781622002497,0.252477554498622,0.0506959324961254,0.00267524585247373,2.51739510747581,3.94686259242434,3.90085299182025,4.09803699440921,0.197184002588958,0.0339870463707014,ENSG00000204576,PRR3,protein_coding,6,1,30556886,30563723,p21.33,proline rich 3 [Source:HGNC Symbol;Acc:HGNC:21149],NA,PRR3,80742,NM_001077497;NM_025263
RENBP_SIG,RENBP,RENBP_SIG,RENBP,SIG,28,-3.25444617626929,0.22895268094242,0.233199349677168,0.214999340813964,-0.0182000088632032,0.00267524585247373,-2.40406653349422,4.29336581038053,4.34223060671076,4.13281005100975,-0.209420555701008,0.0435054698638503,ENSG00000102032,RENBP,protein_coding,X,-1,153935269,153944687,q28,renin binding protein [Source:HGNC Symbol;Acc:HGNC:9959],NA,RENBP,5973,NM_002910
ITGAL_SIG,ITGAL,ITGAL_SIG,ITGAL,SIG,40,-3.25440706439564,0.380902023894821,0.39192220191463,0.344692867544022,-0.0472293343706078,0.00267524585247373,-2.24629260171572,7.67865649733053,7.7477201522317,7.45173305979812,-0.295987092433581,0.0604010368904127,ENSG00000005844,ITGAL,protein_coding,16,1,30472658,30523185,p11.2,integrin subunit alpha L [Source:HGNC Symbol;Acc:HGNC:6148],NA,ITGAL,3683,NM_001114380;NM_002209
ADH5_SIG,ADH5,ADH5_SIG,ADH5,SIG,21,3.25305736025693,0.428564958449691,0.422405722950544,0.448802446518318,0.026396723567774,0.00268722204887146,3.66019259348105,5.32481622971898,5.2748982746772,5.48883236771339,0.213934093036198,0.00166056318394779,ENSG00000197894,ADH5,protein_coding,4,-1,99070978,99088801,q23,alcohol dehydrogenase 5 (class III), chi polypeptide [Source:HGNC Symbol;Acc:HGNC:253],NA,ADH5,128,NM_000671
MADCAM1_SIG,MADCAM1,MADCAM1_SIG,MADCAM1,SIG,13,3.25244566681443,0.0185703468874579,0.0139390538502364,0.0337874525811856,0.0198483987309493,0.00269193236457647,0.327008616271806,0.438102393669921,0.435701338415212,0.445991575221109,0.0102902368058969,0.811961879360715,ENSG00000099866,MADCAM1,protein_coding,19,1,489176,505343,p13.3,mucosal vascular addressin cell adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:6765],NA,MADCAM1,8174,NM_130760;NM_130762
DDX55_SIG,DDX55,DDX55_SIG,DDX55,SIG,16,3.25236835975419,0.392306619494958,0.383687509448562,0.420626552504548,0.0369390430559866,0.00269193236457647,2.78414619080306,4.85922223086153,4.82152097940759,4.98309777135304,0.16157679194545,0.0183643282011307,ENSG00000111364,DDX55,protein_coding,12,1,123602077,123620943,q24.31,DEAD-box helicase 55 [Source:HGNC Symbol;Acc:HGNC:20085],NA,DDX55,57696,NM_020936
ST8SIA4_SIG,ST8SIA4,ST8SIA4_SIG,ST8SIA4,SIG,18,-3.25231757715191,0.292022961798415,0.304610753965917,0.250663073248051,-0.053947680717866,0.00269193236457647,-2.51914708171867,5.01770360198826,5.07310236351295,4.8356790998357,-0.237423263677254,0.0338866469519705,ENSG00000113532,ST8SIA4,protein_coding,5,-1,100806933,100903282,q21.1,ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:10871],NA,ST8SIA4,7903,NM_005668;NM_175052
SLC45A4_SIG,SLC45A4,SLC45A4_SIG,SLC45A4,SIG,31,-3.251748398402,0.0438990108215693,0.053450625148236,0.0125151351768075,-0.0409354899714286,0.00269656305495668,-1.27857472322417,4.15254115531117,4.18668476356102,4.04035501391881,-0.146329749642211,0.303677957888621,ENSG00000022567,SLC45A4,protein_coding,8,-1,141207166,141308305,q24.3,solute carrier family 45 member 4 [Source:HGNC Symbol;Acc:HGNC:29196],NA,SLC45A4,57210,NM_001080431;NM_001286646;NM_001286648
SLC38A9_SIG,SLC38A9,SLC38A9_SIG,SLC38A9,SIG,20,3.25085787347483,0.326865889969375,0.316443418577133,0.361111153115312,0.0446677345381792,0.00270425596674586,2.24502144724388,3.65147958408029,3.61129168218217,3.78352554745983,0.172233865277666,0.0605535712477187,ENSG00000177058,SLC38A9,protein_coding,5,-1,55625845,55773194,q11.2,solute carrier family 38 member 9 [Source:HGNC Symbol;Acc:HGNC:26907],NA,SLC38A9,153129,NM_001258286;NM_001258287;NM_001282429;NM_001349382;NM_001349383;NM_001349384;NM_001349385;NM_173514
ZC3H14_TF,ZC3H14,ZC3H14_TF,ZC3H14,TF,185,3.25015832111276,0.310705196407094,0.30311939773397,0.33562996347593,0.03251056574196,0.00271014842763972,2.11888136823785,5.65126636425061,5.62700935357749,5.730967970748,0.103958617170506,0.0775264290271815,ENSG00000100722,ZC3H14,protein_coding,14,1,88562970,88627596,q31.3,zinc finger CCCH-type containing 14 [Source:HGNC Symbol;Acc:HGNC:20509],Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 56,ZC3H14,79882,NM_001160103;NM_001160104;NM_001326295;NM_001326296;NM_001326297;NM_001326298;NM_001326299;NM_001326300;NM_001326301;NM_001326302;NM_001326303;NM_001326304;NM_001326305;NM_001326306;NM_001326307;NM_001326308;NM_001326309;NM_001326310;NM_001326311;NM_001326312;NM_001326313;NM_001326314;NM_001326315;NM_001326316;NM_024824;NM_207660;NM_207661;NM_207662
KALRN_SIG,KALRN,KALRN_SIG,KALRN,SIG,21,-3.24957166090383,-0.138273082273714,-0.131491001567208,-0.160557061737948,-0.0290660601707401,0.00271497485375968,-1.04087859060249,1.03710603705887,1.06653535662473,0.940409701342467,-0.126125655282259,0.410539478812743,ENSG00000160145,KALRN,protein_coding,3,1,124080023,124726325,q21.1,kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814],Coronary Heart Disease Susceptibility To 5,KALRN,8997,NM_001024660;NM_001322988;NM_001322989;NM_001322990;NM_001322991;NM_001322992;NM_001322993;NM_001322995;NM_001322996;NM_001322997;NM_001322998;NM_001322999;NM_001323000;NM_001323001;NM_003947;NM_007064
YBX3_SIG,YBX3,YBX3_SIG,YBX3,SIG,13,3.24933976602128,-0.129552220673628,-0.137075500705322,-0.104832871998061,0.0322426287072613,0.00271641913991356,0.748308813958822,7.46000103091877,7.44078238132326,7.52314802244685,0.0823656411235802,0.564339513017756,ENSG00000060138,YBX3,protein_coding,12,-1,10699089,10723323,p13.2,Y-box binding protein 3 [Source:HGNC Symbol;Acc:HGNC:2428],NA,YBX3,8531,NM_001145426;NM_003651
MSL3_TF,MSL3,MSL3_TF,MSL3,TF,252,-3.24921268517773,0.11004291577019,0.116823666946825,0.087763304761249,-0.0290603621855757,0.00271686296775773,-1.4238800446521,5.86109774962022,5.88004327252712,5.7988481743547,-0.0811950981724197,0.247657925560039,ENSG00000005302,MSL3,protein_coding,X,1,11758159,11775772,p22.2,MSL complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7370],MSL3 syndrome,MSL3,10943,NM_001193270;NM_001282174;NM_006800;NM_078628;NM_078629
MRPL1_SIG,MRPL1,MRPL1_SIG,MRPL1,SIG,26,3.24889354347788,0.664280901191519,0.65442280067929,0.696671802874557,0.0422490021952667,0.00271914233628549,2.12919648984075,3.91593520960786,3.88007849197246,4.03375013898129,0.153671647008822,0.0760958767430524,ENSG00000169288,MRPL1,protein_coding,4,1,77862830,77952785,q21.1,mitochondrial ribosomal protein L1 [Source:HGNC Symbol;Acc:HGNC:14275],NA,MRPL1,65008,NM_020236
EIF4ENIF1_SIG,EIF4ENIF1,EIF4ENIF1_SIG,EIF4ENIF1,SIG,22,3.24772806842873,0.396959220055837,0.390031428503224,0.419721963728708,0.0296905352254838,0.00272953071103079,2.57186886814708,5.18070083498975,5.15399713232985,5.26844157230084,0.114444439970986,0.0300193615884391,ENSG00000184708,EIF4ENIF1,protein_coding,22,-1,31436977,31496108,q12.2,eukaryotic translation initiation factor 4E nuclear import factor 1 [Source:HGNC Symbol;Acc:HGNC:16687],NA,EIF4ENIF1,56478,NM_001164501;NM_001164502;NM_019843
ZNF461_TF,ZNF461,ZNF461_TF,ZNF461,TF,53,3.24753913895193,0.111373016359124,0.102738810155184,0.13974255102921,0.037003740874026,0.00273057022171284,2.07669216881002,2.74902615836682,2.71233009376583,2.86959894205578,0.157268848289947,0.0839767840599441,ENSG00000197808,ZNF461,protein_coding,19,-1,36636618,36666853,q13.12,zinc finger protein 461 [Source:HGNC Symbol;Acc:HGNC:21629],NA,ZNF461,92283,NM_001297623;NM_001322821;NM_001322823;NM_001322825;NM_001322826;NM_001322827;NM_001322828;NM_153257
FURIN_SIG,FURIN,FURIN_SIG,FURIN,SIG,12,-3.24722055702211,0.126163449796004,0.133344182405892,0.102569614077802,-0.0307745683280894,0.00273285500527273,-2.36416241977752,7.87734147917265,7.91769724218265,7.74474397213979,-0.172953270042862,0.0473067653494892,ENSG00000140564,FURIN,protein_coding,15,1,90868588,90883458,q26.1,furin, paired basic amino acid cleaving enzyme [Source:HGNC Symbol;Acc:HGNC:8568],NA,FURIN,5045,NM_001289823;NM_001289824;NM_002569
MTHFS_SIG,MTHFS,MTHFS_SIG,MTHFS,SIG,7,-3.24703859615368,0.297357994758599,0.307636081745462,0.26358713751605,-0.0440489442294111,0.00273382903591407,-1.84188441592257,1.70971648467661,1.73125686353258,1.63894095414985,-0.0923159093827282,0.128506704451458,ENSG00000136371,MTHFS,protein_coding,15,-1,79833585,79897379,q25.1,methenyltetrahydrofolate synthetase [Source:HGNC Symbol;Acc:HGNC:7437],NA,MTHFS,10588,NM_001199758;NM_006441
GALNT14_SIG,GALNT14,GALNT14_SIG,GALNT14,SIG,43,-3.24679377207642,-0.0143146268753516,-0.00873887588872585,-0.0326349515456934,-0.0238960756569676,0.00273540763679418,-2.51999341139539,2.72014824586509,2.8179049893211,2.39894751736677,-0.418957471954329,0.0338334421481092,ENSG00000158089,GALNT14,protein_coding,2,-1,30910467,31155202,p23.1,polypeptide N-acetylgalactosaminyltransferase 14 [Source:HGNC Symbol;Acc:HGNC:22946],NA,GALNT14,79623,NM_001253826;NM_001253827;NM_001329095;NM_001329096;NM_001329097;NM_024572
DUS2_SIG,DUS2,DUS2_SIG,DUS2,SIG,13,-3.24657562138917,0.472685856766625,0.480504562047269,0.44699582513022,-0.0335087369170489,0.00273673074820477,-0.0621128294511371,3.66610635172934,3.66692282251371,3.66342366200925,-0.00349916050446557,0.965879444307668,ENSG00000167264,DUS2,protein_coding,16,1,67987746,68079320,q22.1,dihydrouridine synthase 2 [Source:HGNC Symbol;Acc:HGNC:26014],NA,DUS2,54920,NM_001271762;NM_001271763;NM_017803
ZNF568_TF,ZNF568,ZNF568_TF,ZNF568,TF,23,3.24598516349164,-0.098435587928139,-0.108731109516905,-0.0646074455650492,0.0441236639518562,0.00274163788764205,3.27234997855322,2.59482499017464,2.52920074898998,2.81044749692424,0.281246747934268,0.00519236068585609,ENSG00000198453,ZNF568,protein_coding,19,1,36916329,36998700,q13.12,zinc finger protein 568 [Source:HGNC Symbol;Acc:HGNC:25392],NA,ZNF568,374900,NM_001204835;NM_001204836;NM_001204837;NM_001204838;NM_001204839;NM_198539
DDX56_SIG,DDX56,DDX56_SIG,DDX56,SIG,15,3.24587048720297,0.365446719725829,0.358224295937099,0.389177540745942,0.0309532448088423,0.00274196724451075,3.36102865263062,5.22213292183339,5.17772878542512,5.36803222717487,0.190303441749753,0.00404911070255257,ENSG00000136271,DDX56,protein_coding,7,-1,44565417,44575051,p13,DEAD-box helicase 56 [Source:HGNC Symbol;Acc:HGNC:18193],NA,DDX56,54606,NM_001257189;NM_019082
ESF1_SIG,ESF1,ESF1_SIG,ESF1,SIG,14,3.24567768559398,0.59925919590266,0.59092148929293,0.626654517620343,0.0357330283274125,0.00274304943234422,3.41069472527986,3.97474660328033,3.92660556635681,4.13292429602903,0.20631872967222,0.0034908768673407,ENSG00000089048,ESF1,protein_coding,20,-1,13714322,13784886,p12.1,ESF1 nucleolar pre-rRNA processing protein homolog [Source:HGNC Symbol;Acc:HGNC:15898],NA,ESF1,51575,NM_001276380;NM_016649
TNFSF4_SIG,TNFSF4,TNFSF4_SIG,TNFSF4,SIG,14,3.2453130192931,0.0772375007652048,0.0685062018407158,0.10592605437424,0.0374198525335245,0.0027457890385579,2.2824538790899,2.95111940701492,2.86115607817223,3.24671320178376,0.385557123611537,0.0560080166808891,ENSG00000117586,TNFSF4,protein_coding,1,-1,173183731,173207331,q25.1,TNF superfamily member 4 [Source:HGNC Symbol;Acc:HGNC:11934],MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED;Narcolepsy type 1;Systemic lupus erythematosus,TNFSF4,7292,NM_001297562;NM_003326
GNA12_SIG,GNA12,GNA12_SIG,GNA12,SIG,53,3.2443527480664,0.214396191255815,0.209470538618406,0.230580478493017,0.0211099398746105,0.00275428554548751,3.16046577326007,6.38956466961244,6.31290546893924,6.64144490039578,0.328539431456538,0.00705613623213108,ENSG00000146535,GNA12,protein_coding,7,-1,2728105,2844308,p22.2,G protein subunit alpha 12 [Source:HGNC Symbol;Acc:HGNC:4380],NA,GNA12,2768,NM_001282440;NM_001282441;NM_001293092;NM_007353
OR2W3_SIG,OR2W3,OR2W3_SIG,OR2W3,SIG,79,3.24170782097668,0.0508138882949657,0.0397122861515355,0.0872905810519504,0.0475782949004147,0.00277863754142028,1.92160408722414,2.61614893879937,2.55459347218232,2.81840261482684,0.263809142644527,0.112023855538935,ENSG00000238243,OR2W3,protein_coding,1,1,247895587,247896531,q44,olfactory receptor family 2 subfamily W member 3 [Source:HGNC Symbol;Acc:HGNC:15021],NA,OR2W3,343171,NM_001001957
SBK1_SIG,SBK1,SBK1_SIG,SBK1,SIG,25,-3.24168389521216,-0.0318740796286095,-0.0207064892041391,-0.068567591023298,-0.0478611018191589,0.00277863754142028,-2.18796654507933,1.90779427841348,1.96993229004014,1.70362652592586,-0.266305764114283,0.0679803165486419,ENSG00000188322,SBK1,protein_coding,16,1,28292525,28323849,p12.1,SH3 domain binding kinase 1 [Source:HGNC Symbol;Acc:HGNC:17699],NA,SBK1,388228,NM_001024401
SLCO3A1_SIG,SLCO3A1,SLCO3A1_SIG,SLCO3A1,SIG,27,-3.24102399360017,0.580436733015545,0.590690784449665,0.546744849732008,-0.0439459347176574,0.002784292045901,-1.7864971220073,5.6637623708281,5.69882154376465,5.54856794546515,-0.150253598299502,0.141311517117448,ENSG00000176463,SLCO3A1,protein_coding,15,1,91853708,92172435,q26.1,solute carrier organic anion transporter family member 3A1 [Source:HGNC Symbol;Acc:HGNC:10952],NA,SLCO3A1,28232,NM_001145044;NM_013272
PLEC_SIG,PLEC,PLEC_SIG,PLEC,SIG,33,-3.24071589353781,0.356732771646792,0.367467304171686,0.321462164779284,-0.0460051393924024,0.00278651658002187,-1.55676696973213,8.84269766824488,8.88589209673431,8.70077311749387,-0.185118979240445,0.203504897972173,ENSG00000178209,PLEC,protein_coding,8,-1,143915147,143976734,q24.3,plectin [Source:HGNC Symbol;Acc:HGNC:9069],Autosomal recessive limb-girdle muscular dystrophy type 2Q;EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;EPIDERMOLYSIS BULLOSA SIMPLEX OGNA TYPE;EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;Epidermolysis bullosa simplex with nail dystrophy;EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 17;Muscular dystrophy limb-girdle type 2Q,PLEC,5339,NM_000445;NM_201378;NM_201379;NM_201380;NM_201381;NM_201382;NM_201383;NM_201384
PPRC1_SIG,PPRC1,PPRC1_SIG,PPRC1,SIG,12,3.24023525824427,0.495518685124159,0.487252842444617,0.522677882499798,0.0354250400551816,0.00278971362694435,1.2412324268879,5.88912164797799,5.86818137603115,5.95792539866044,0.0897440226292937,0.319090140979885,ENSG00000148840,PPRC1,protein_coding,10,1,102132994,102150333,q24.32,peroxisome proliferator-activated receptor gamma, coactivator-related 1 [Source:HGNC Symbol;Acc:HGNC:30025],NA,PPRC1,23082,NM_001288727;NM_001288728;NM_015062
ZNF710_TF,ZNF710,ZNF710_TF,ZNF710,TF,200,-3.2402281673263,0.204558491402875,0.215378583142322,0.169006761401835,-0.0463718217404869,0.00278971362694435,-2.61315283094513,5.14253202230249,5.18506428654221,5.00278315408625,-0.182281132455965,0.0273200975546151,ENSG00000140548,ZNF710,protein_coding,15,1,90001324,90082206,q26.1,zinc finger protein 710 [Source:HGNC Symbol;Acc:HGNC:25352],NA,ZNF710,374655,NM_198526
AKR1A1_SIG,AKR1A1,AKR1A1_SIG,AKR1A1,SIG,22,3.24004325423349,0.180098109277001,0.171675365227141,0.207772839726538,0.0360974744993963,0.00279073660834924,1.60524270942395,5.72019567613702,5.69134976955964,5.8149750834627,0.12362531390306,0.189042248376105,ENSG00000117448,AKR1A1,protein_coding,1,1,45550543,45570049,p34.1,aldo-keto reductase family 1 member A1 [Source:HGNC Symbol;Acc:HGNC:380],NA,AKR1A1,10327,NM_001202413;NM_001202414;NM_006066;NM_153326
SRXN1_SIG,SRXN1,SRXN1_SIG,SRXN1,SIG,12,-3.23993916634911,0.19502047700083,0.200788950712472,0.17606692051972,-0.0247220301927525,0.00279096888866521,-0.50971898380604,0.80691089708788,0.812522386093353,0.788473147498471,-0.0240492385948815,0.703779496931006,ENSG00000271303,SRXN1,protein_coding,20,-1,646615,653370,p13,sulfiredoxin 1 [Source:HGNC Symbol;Acc:HGNC:16132],NA,SRXN1,140809,NM_080725
ZNF224_TF,ZNF224,ZNF224_TF,ZNF224,TF,71,3.23939223336412,0.287368558278646,0.281531300438782,0.306548119752483,0.0250168193137012,0.00279553923449622,2.17336967280002,4.55177247622136,4.52181090975427,4.65021762318464,0.128406713430372,0.0698671431876259,ENSG00000267680,ZNF224,protein_coding,19,1,44094339,44109886,q13.31,zinc finger protein 224 [Source:HGNC Symbol;Acc:HGNC:13017],NA,ZNF224,7767,NM_001321645;NM_013398
ZNF385A_TF,ZNF385A,ZNF385A_TF,ZNF385A,TF,299,-3.23864574740734,0.202544384736171,0.214569555424312,0.163033109617991,-0.0515364458063212,0.00280207615936313,-0.964100047863348,5.70640028933378,5.74104914957343,5.59255403426064,-0.148495115312782,0.448800856323795,ENSG00000161642,ZNF385A,protein_coding,12,-1,54369133,54391298,q13.13,zinc finger protein 385A [Source:HGNC Symbol;Acc:HGNC:17521],NA,ZNF385A,25946,NM_001130967;NM_001130968;NM_001290001;NM_001290002;NM_001290004;NM_015481
TYMP_SIG,TYMP,TYMP_SIG,TYMP,SIG,58,-3.23728137993916,0.311144275444123,0.333140687263064,0.238870350896177,-0.0942703363668861,0.00281471589509733,-2.03419467824397,5.7973789636272,5.88773624905699,5.50049074007217,-0.387245508984812,0.0911888520964652,ENSG00000025708,TYMP,protein_coding,22,-1,50525752,50530032,q13.33,thymidine phosphorylase [Source:HGNC Symbol;Acc:HGNC:3148],MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE);Mitochondrial neurogastrointestinal encephalomyopathy,TYMP,1890,NM_001113755;NM_001113756;NM_001257988;NM_001257989;NM_001953
ZNF226_TF,ZNF226,ZNF226_TF,ZNF226,TF,21,3.23662552539523,0.0292299412136407,0.0150438309716377,0.0758414462945076,0.0607976153228698,0.00282039816724556,1.89242167272587,3.54295986988909,3.50848428675627,3.65623678589695,0.147752499140679,0.117782447756173,ENSG00000167380,ZNF226,protein_coding,19,1,44165073,44178381,q13.31,zinc finger protein 226 [Source:HGNC Symbol;Acc:HGNC:13019],NA,ZNF226,7769,NM_001032372;NM_001032373;NM_001032374;NM_001146220;NM_001319088;NM_001319089;NM_001319090;NM_015919;NM_016444
UCK1_SIG,UCK1,UCK1_SIG,UCK1,SIG,10,3.23653808324852,0.158030615334331,0.155793924931114,0.165379740944902,0.00958581601378815,0.00282046859221598,3.91311259191148,4.59013342518352,4.5597541265421,4.68995112071961,0.130196994177517,0.000748694296447922,ENSG00000130717,UCK1,protein_coding,9,-1,131523801,131531264,q34.13,uridine-cytidine kinase 1 [Source:HGNC Symbol;Acc:HGNC:14859],NA,UCK1,83549,NM_001135954;NM_001261450;NM_001261451;NM_001318519;NM_031432
CBR4_SIG,CBR4,CBR4_SIG,CBR4,SIG,24,3.23586197044891,0.158568091703733,0.147870327647798,0.193717887887519,0.0458475602397206,0.00282636220939166,1.11491991240387,4.18567736864968,4.16545251790881,4.25213044965541,0.0866779317466042,0.375375294636218,ENSG00000145439,CBR4,protein_coding,4,-1,168863770,169010275,q32.3,carbonyl reductase 4 [Source:HGNC Symbol;Acc:HGNC:25891],NA,CBR4,84869,NM_032783
ZNF480_TF,ZNF480,ZNF480_TF,ZNF480,TF,34,3.23431003800417,0.262774155603524,0.252855750999744,0.295363199301656,0.0425074483019119,0.00284096766950556,2.02674427990439,4.23534742659173,4.19720638649786,4.36066798690018,0.16346160040233,0.0924844803586209,ENSG00000198464,ZNF480,protein_coding,19,1,52297169,52325922,q13.41,zinc finger protein 480 [Source:HGNC Symbol;Acc:HGNC:23305],NA,ZNF480,147657,NM_001297624;NM_001297625;NM_144684
GSTO1_SIG,GSTO1,GSTO1_SIG,GSTO1,SIG,46,-3.23307849069364,0.0559694044309951,0.0596386478824725,0.0439133188047119,-0.0157253290777605,0.00285244165286623,-4.06411810040968,5.28881113292401,5.36082146878907,5.0522057436531,-0.308615725135969,0.000458589124259995,ENSG00000148834,GSTO1,protein_coding,10,1,104235356,104267459,q25.1,glutathione S-transferase omega 1 [Source:HGNC Symbol;Acc:HGNC:13312],NA,GSTO1,9446,NM_001191002;NM_001191003;NM_004832
LILRA1_SIG,LILRA1,LILRA1_SIG,LILRA1,SIG,81,-3.23288372025154,0.424581981062037,0.447768550440502,0.348397538818507,-0.0993710116219952,0.00285323201129869,-2.12040056174725,4.32022834526546,4.42143220996541,3.98770136125135,-0.433730848714061,0.0773273142740839,ENSG00000104974,LILRA1,protein_coding,19,1,54593582,54602090,q13.42,leukocyte immunoglobulin like receptor A1 [Source:HGNC Symbol;Acc:HGNC:6602],NA,LILRA1,11024,NM_001278318;NM_001278319;NM_006863
ZNF507_TF,ZNF507,ZNF507_TF,ZNF507,TF,49,3.23283876151439,-0.042995271526235,-0.048428249554964,-0.0251440580032681,0.0232841915516961,0.00285323201129869,2.02917604068376,5.08611561905061,5.04292193360472,5.22803772837286,0.185115794768141,0.0920427891879276,ENSG00000168813,ZNF507,protein_coding,19,1,32345594,32387667,q13.11,zinc finger protein 507 [Source:HGNC Symbol;Acc:HGNC:23783],NA,ZNF507,22847,NM_001136156;NM_014910
ZBTB9_SIG,ZBTB9,ZBTB9_SIG,ZBTB9,SIG,60,3.23238103853688,0.12986049942855,0.121606677735094,0.156980199278478,0.0353735215433845,0.00285700402711357,2.8577224873697,2.89997392407188,2.84356748807934,3.08530935661878,0.241741868539441,0.0154012910133312,ENSG00000213588,ZBTB9,protein_coding,6,1,33453970,33457544,p21.32,zinc finger and BTB domain containing 9 [Source:HGNC Symbol;Acc:HGNC:28323],NA,ZBTB9,221504,NM_152735
SKIL_SIG,SKIL,SKIL_SIG,SKIL,SIG,35,-3.23127570713972,0.311727117426603,0.322806278686923,0.275324158999836,-0.0474821196870868,0.00286727082428062,-4.59309395328967,4.78762279416053,4.91586875310876,4.36624321475918,-0.549625538349578,7.03841047591097e-05,ENSG00000136603,SKIL,protein_coding,3,1,170357678,170396835,q26.2,SKI like proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10897],NA,SKIL,6498,NM_001145097;NM_001145098;NM_001248008;NM_005414
CASKIN1_SIG,CASKIN1,CASKIN1_SIG,CASKIN1,SIG,40,3.23090139378757,-0.123901011066296,-0.127818839233857,-0.111028147087169,0.0167906921466877,0.00287022225881771,2.51409569398241,0.445720462605218,0.414245088075723,0.549139550344991,0.134894462269268,0.0342162334751452,ENSG00000167971,CASKIN1,protein_coding,16,-1,2177180,2196525,p13.3,CASK interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20879],NA,CASKIN1,57524,NM_020764
ST3GAL1_SIG,ST3GAL1,ST3GAL1_SIG,ST3GAL1,SIG,40,-3.23031374202577,0.121457714839504,0.128575522821654,0.0980706314695824,-0.0305048913520715,0.00287532154782935,-3.8555487114829,7.10828399963636,7.17820041116494,6.878558647471,-0.299641763693939,0.000903676125278439,ENSG00000008513,ST3GAL1,protein_coding,8,-1,133454848,133571940,q24.22,ST3 beta-galactoside alpha-2,3-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10862],NA,ST3GAL1,6482,NM_003033;NM_173344
PSPN_SIG,PSPN,PSPN_SIG,PSPN,SIG,14,3.22992312389207,0.0396864868735577,0.0273593450124419,0.0801899529886527,0.0528306079762109,0.00287844489887704,2.83194335706032,1.65734740801359,1.61018185287027,1.81231994634162,0.202138093471352,0.0164166817932269,ENSG00000125650,PSPN,protein_coding,19,-1,6375148,6379058,p13.3,persephin [Source:HGNC Symbol;Acc:HGNC:9579],NA,PSPN,5623,NM_004158
PSMB3_SIG,PSMB3,PSMB3_SIG,PSMB3,SIG,41,-3.2276882191848,0.156793959551088,0.162090252371689,0.139391854569113,-0.0226983978025757,0.00290021272801284,-2.06603107307634,5.68803935069851,5.71223877684577,5.60852695050037,-0.103711826345401,0.0857089401967153,ENSG00000277791,PSMB3,protein_coding,17,1,38752741,38764225,q12,proteasome subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:9540],NA,PSMB3,5691,NM_002795
ERCC5_SIG,ERCC5,ERCC5_SIG,ERCC5,SIG,27,3.22696776784524,0.278784430898356,0.274521838660405,0.292790091108768,0.0182682524483637,0.00290670959741749,2.37059979253741,5.04799034027286,5.02142028393858,5.13529195394263,0.113871670004048,0.0466867699628359,ENSG00000134899,ERCC5,protein_coding,13,1,102807146,102876001,q33.1,ERCC excision repair 5, endonuclease [Source:HGNC Symbol;Acc:HGNC:3437],CEREBROOCULOFACIOSKELETAL SYNDROME 3;COFS syndrome;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP G,ERCC5,2073;100533467,NM_000123;NM_001204425
OTUD4_SIG,OTUD4,OTUD4_SIG,OTUD4,SIG,37,3.22620194429223,0.328486379147121,0.320685685989417,0.354117228093864,0.0334315421044471,0.00291298009504454,3.65907356256571,6.82555510005016,6.77916166034036,6.97799068766807,0.198829027327705,0.0016668684006796,ENSG00000164164,OTUD4,protein_coding,4,-1,145110838,145180161,q31.21,OTU deubiquitinase 4 [Source:HGNC Symbol;Acc:HGNC:24949],NA,OTUD4,54726,NM_001102653;NM_001366057;NM_017493
ZNF273_TF,ZNF273,ZNF273_TF,ZNF273,TF,97,3.22619064671193,-0.11709568422175,-0.126634656701448,-0.0857533460741703,0.0408813106272778,0.00291298009504454,2.94810021950759,4.14776510223958,4.07406808297468,4.38991245125283,0.315844368278157,0.0122987223621484,ENSG00000198039,ZNF273,protein_coding,7,1,64870172,64930966,q11.21,zinc finger protein 273 [Source:HGNC Symbol;Acc:HGNC:13067],NA,ZNF273,10793,NM_021148
PPME1_SIG,PPME1,PPME1_SIG,PPME1,SIG,21,3.22558620218126,0.379059983230856,0.367915401906252,0.415677893297414,0.0477624913911623,0.00291832036500312,3.54912429264779,4.60742712216728,4.5469147606054,4.80625345301343,0.259338692408032,0.0023308248636726,ENSG00000214517,PPME1,protein_coding,11,1,74171267,74254703,q13.4,protein phosphatase methylesterase 1 [Source:HGNC Symbol;Acc:HGNC:30178],NA,PPME1,51400,NM_001271593;NM_016147
ORAI3_SIG,ORAI3,ORAI3_SIG,ORAI3,SIG,27,3.22365284824695,0.250425465707138,0.237924173809301,0.291501139085745,0.0535769652764435,0.00293726997370439,3.56086963666273,3.60439800650841,3.5285485842687,3.85361753672462,0.325068952455921,0.00225293042775731,ENSG00000175938,ORAI3,protein_coding,16,1,30949068,30956461,p11.2,ORAI calcium release-activated calcium modulator 3 [Source:HGNC Symbol;Acc:HGNC:28185],NA,ORAI3,93129,NM_152288
PPWD1_SIG,PPWD1,PPWD1_SIG,PPWD1,SIG,59,3.22310780697288,0.380678252308747,0.375505005240126,0.397676064105644,0.022171058865518,0.00294204080344464,2.91371522405703,5.41679246753309,5.38094676983799,5.53457118853128,0.153624418693291,0.0134128618021153,ENSG00000113593,PPWD1,protein_coding,5,1,65563236,65587549,q12.3,peptidylprolyl isomerase domain and WD repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:28954],NA,PPWD1,23398,NM_001278926;NM_001278927;NM_001278929;NM_015342
ALDH6A1_SIG,ALDH6A1,ALDH6A1_SIG,ALDH6A1,SIG,29,3.22278594622304,0.55058858527677,0.538141276274617,0.591486886283844,0.0533456100092273,0.00294452387926387,3.00616522972938,4.2286857907955,4.15986782424277,4.45480196661161,0.294934142368841,0.0105738105298929,ENSG00000119711,ALDH6A1,protein_coding,14,-1,74056850,74084493,q24.3,aldehyde dehydrogenase 6 family member A1 [Source:HGNC Symbol;Acc:HGNC:7179],Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency;METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY,ALDH6A1,4329,NM_001278593;NM_001278594;NM_005589
B3GAT1_SIG,B3GAT1,B3GAT1_SIG,B3GAT1,SIG,7,-3.22227783847982,-0.340714420115932,-0.318096775730247,-0.415029537383183,-0.0969327616529356,0.00294892546828254,-2.12642550898381,1.1067606440171,1.16224916564128,0.924441215823382,-0.237807949817895,0.0764993685075393,ENSG00000109956,B3GAT1,protein_coding,11,-1,134378504,134412242,q25,beta-1,3-glucuronyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:921],NA,B3GAT1,27087,NM_018644;NM_054025
TRIM56_SIG,TRIM56,TRIM56_SIG,TRIM56,SIG,91,3.22160994630538,0.140105713312641,0.131055848521431,0.169840983340903,0.038785134819472,0.00295498047967918,2.55966972023904,4.98149640456566,4.93022996168956,5.14994328830141,0.219713326611857,0.030893104275965,ENSG00000169871,TRIM56,protein_coding,7,1,101085481,101097967,q22.1,tripartite motif containing 56 [Source:HGNC Symbol;Acc:HGNC:19028],NA,TRIM56,81844,NM_030961
LCLAT1_SIG,LCLAT1,LCLAT1_SIG,LCLAT1,SIG,10,3.22121143565143,0.104962348714264,0.0944971260630428,0.139348080282563,0.0448509542195203,0.00295826497210079,1.63017658777458,3.51868555988881,3.49085449622504,3.61013048335548,0.11927598713044,0.182116735686629,ENSG00000172954,LCLAT1,protein_coding,2,1,30447226,30644225,p23.1,lysocardiolipin acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26756],NA,LCLAT1,253558,NM_001002257;NM_001304445;NM_001304446;NM_182551
HMGB3_SIG,HMGB3,HMGB3_SIG,HMGB3,SIG,63,3.22085651219294,-0.104619604900829,-0.110990032882486,-0.0836881986753821,0.0273018342071043,0.00296110254960392,1.09805372709704,4.84329859853695,4.81400915334834,4.9395353470138,0.125526193665466,0.383289027974995,ENSG00000029993,HMGB3,protein_coding,X,1,150980509,150990771,q28,high mobility group box 3 [Source:HGNC Symbol;Acc:HGNC:5004],Colobomatous microphthalmia microcephaly intellectual disability and short stature;Microphthalmia syndromic 13,HMGB3,3149,NM_001301228;NM_001301229;NM_001301231;NM_005342
SAT1_SIG,SAT1,SAT1_SIG,SAT1,SIG,46,-3.22075883923683,0.381525708740214,0.397640308760646,0.328577737244509,-0.0690625715161371,0.00296128372701168,-3.10694376968219,8.74305015087266,8.83200832394343,8.45075901078301,-0.381249313160423,0.00816981794757368,ENSG00000130066,SAT1,protein_coding,X,1,23783173,23786226,p22.11,spermidine/spermine N1-acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10540],Keratosis follicularis spinulosa decalvans,SAT1,6303,NM_002970
CLEC4C_SIG,CLEC4C,CLEC4C_SIG,CLEC4C,SIG,5,-3.22012903639474,-0.0864788602150212,-0.0803646613972988,-0.106568370616109,-0.0262037092188103,0.00296696797374094,-1.64372485370558,0.57780565981911,0.615159784923633,0.455070677332821,-0.160089107590812,0.178272753643905,ENSG00000198178,CLEC4C,protein_coding,12,-1,7729415,7751605,p13.31,C-type lectin domain family 4 member C [Source:HGNC Symbol;Acc:HGNC:13258],NA,CLEC4C,170482,NM_130441;NM_203503
ETNK1_SIG,ETNK1,ETNK1_SIG,ETNK1,SIG,47,3.21889930357571,0.180308080977508,0.16878180152312,0.218180142041927,0.0493983405188073,0.00297888844014775,2.55957107454611,5.22070736965093,5.16943387456668,5.38917742492777,0.219743550361097,0.0308964122495607,ENSG00000139163,ETNK1,protein_coding,12,1,22625075,22690665,p12.1,ethanolamine kinase 1 [Source:HGNC Symbol;Acc:HGNC:24649],NA,ETNK1,55500,NM_001039481;NM_018638
ZNF441_TF,ZNF441,ZNF441_TF,ZNF441,TF,12,3.21802392806316,0.289485015661507,0.283812450092679,0.308123445387653,0.0243109952949736,0.00298716020533172,2.23443917571166,2.53532521415183,2.49264860208536,2.6755483680845,0.182899765999134,0.061873054532093,ENSG00000197044,ZNF441,protein_coding,19,1,11767000,11784078,p13.2,zinc finger protein 441 [Source:HGNC Symbol;Acc:HGNC:20875],NA,ZNF441,126068,NM_152355
ZKSCAN5_TF,ZKSCAN5,ZKSCAN5_TF,ZKSCAN5,TF,61,3.21739239171272,0.256753859447379,0.251893931444843,0.272722194312854,0.0208282628680111,0.00299290808418371,3.16420468274087,4.38610420570688,4.34380997935824,4.52507094942385,0.181260970065608,0.00698391789121854,ENSG00000196652,ZKSCAN5,protein_coding,7,1,99504651,99534700,q22.1,zinc finger with KRAB and SCAN domains 5 [Source:HGNC Symbol;Acc:HGNC:12867],NA,ZKSCAN5,23660,NM_001318082;NM_001318083;NM_001318084;NM_014569;NM_145102
OR2T33_SIG,OR2T33,OR2T33_SIG,OR2T33,SIG,4,3.21672512213952,-0.145671893226485,-0.154348354465978,-0.117163520582437,0.0371848338835402,0.0029989968408098,2.22871411175735,0.322878571308581,0.305249518268563,0.380802602725782,0.0755530844572191,0.0625539904934586,ENSG00000177212,OR2T33,protein_coding,1,-1,248269917,248277976,q44,olfactory receptor family 2 subfamily T member 33 [Source:HGNC Symbol;Acc:HGNC:31255],NA,OR2T33,391195,NM_001004695
ACER3_SIG,ACER3,ACER3_SIG,ACER3,SIG,14,-3.21664912299086,0.318201425364925,0.332079348766121,0.272602534189568,-0.0594768145765528,0.0029989968408098,-1.77963828433983,5.48456854246766,5.51097394824296,5.39780792349166,-0.113166024751301,0.143036180933792,ENSG00000078124,ACER3,protein_coding,11,1,76860867,77026797,q13.5,alkaline ceramidase 3 [Source:HGNC Symbol;Acc:HGNC:16066],Alkaline ceramidase 3 deficiency;LEUKODYSTROPHY PROGRESSIVE EARLY CHILDHOOD-ONSET,ACER3,55331,NM_001300953;NM_001300954;NM_001300955;NM_018367
PRKAR1B_SIG,PRKAR1B,PRKAR1B_SIG,PRKAR1B,SIG,13,3.21591973298055,0.29180796968819,0.281903112370485,0.324352500874935,0.0424493885044505,0.00300579047906673,3.97907470285911,3.15180201943499,3.0539052781887,3.4734627406728,0.419557462484102,0.000607207936253314,ENSG00000188191,PRKAR1B,protein_coding,7,-1,549197,727650,p22.3,protein kinase cAMP-dependent type I regulatory subunit beta [Source:HGNC Symbol;Acc:HGNC:9390],PRKAR1B-related neurodegenerative dementia with intermediate filaments,PRKAR1B,5575,NM_001164758;NM_001164759;NM_001164760;NM_001164761;NM_001164762;NM_002735
FAR1_SIG,FAR1,FAR1_SIG,FAR1,SIG,29,-3.21376027321887,0.182957958204892,0.190188625551056,0.159200051210354,-0.0309885743407015,0.00302764180725698,-1.57955101871185,6.47602310693549,6.50812476014052,6.3705462464047,-0.137578513735812,0.196741907403293,ENSG00000197601,FAR1,protein_coding,11,1,13668668,13732346,p15.3,fatty acyl-CoA reductase 1 [Source:HGNC Symbol;Acc:HGNC:26222],Peroxisomal fatty acyl-coa reductase 1 disorder;Severe intellectual disability-epilepsy-cataract syndrome due to fatty acyl-CoA reductase 1 deficiency;Severe intellectual disability epilepsy and cataracts,FAR1,84188,NM_032228
ZNF18_TF,ZNF18,ZNF18_TF,ZNF18,TF,59,3.21343903765088,0.24143479728403,0.235660639911677,0.260407028650336,0.0247463887386589,0.00303009898698054,3.48782709378348,3.82125919166338,3.7770473708456,3.96652660292181,0.189479232076213,0.00279737628474711,ENSG00000154957,ZNF18,protein_coding,17,-1,11977439,11997475,p12,zinc finger protein 18 [Source:HGNC Symbol;Acc:HGNC:12969],NA,ZNF18,7566,NM_001303281;NM_001303282;NM_144680
PNPT1_SIG,PNPT1,PNPT1_SIG,PNPT1,SIG,7,3.21336714665528,0.609590469945847,0.601352327718156,0.636658651551116,0.03530632383296,0.00303009898698054,0.995081726339332,4.66783875275758,4.6518208701994,4.7204689383059,0.0686480681065058,0.432903016249534,ENSG00000138035,PNPT1,protein_coding,2,-1,55634061,55693863,p16.1,polyribonucleotide nucleotidyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:23166],Autosomal recessive non-syndromic sensorineural deafness type DFNB;Combined oxidative phosphorylation defect type 13;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13;DEAFNESS AUTOSOMAL RECESSIVE 70;Hearing loss;Respiratory chain disorder,PNPT1,87178,NM_033109
FCGR1A_SIG,FCGR1A,FCGR1A_SIG,FCGR1A,SIG,23,-3.2116134490907,0.146059663131641,0.163270717695113,0.0895090552802325,-0.073761662414881,0.0030472538386767,-2.74083499444748,3.65780809529019,3.76287121769973,3.31260069308742,-0.450270524612315,0.0203271772097941,ENSG00000150337,FCGR1A,protein_coding,1,1,149782671,149792518,q21.2,Fc fragment of IgG receptor Ia [Source:HGNC Symbol;Acc:HGNC:3613],NA,FCGR1A,2209,NM_000566
ZMYM5_TF,ZMYM5,ZMYM5_TF,ZMYM5,TF,78,3.21158534270661,0.152689974976791,0.145896519603314,0.175011328346784,0.0291148087434699,0.0030472538386767,1.8419801678158,4.66665830584112,4.6427406856408,4.74524477221359,0.102504086572786,0.128497228455685,ENSG00000132950,ZMYM5,protein_coding,13,-1,19823482,19863649,q12.11,zinc finger MYM-type containing 5 [Source:HGNC Symbol;Acc:HGNC:13029],NA,ZMYM5,9205,NM_001039649;NM_001039650;NM_001142684
OXCT2_SIG,OXCT2,OXCT2_SIG,OXCT2,SIG,10,-3.21084806327511,-0.111087614634792,-0.104450340173152,-0.132895802151607,-0.0284454619784555,0.00305423150975911,-0.950782357506892,0.234276775092906,0.242024852456841,0.208818806611405,-0.0332060458454363,0.455241074188923,ENSG00000198754,OXCT2,protein_coding,1,-1,39769523,39771348,p34.2,3-oxoacid CoA-transferase 2 [Source:HGNC Symbol;Acc:HGNC:18606],NA,OXCT2,64064,NM_022120
SPOP_SIG,SPOP,SPOP_SIG,SPOP,SIG,70,3.21059964821045,0.343495029050017,0.330562837422681,0.385986515825551,0.0554236784028707,0.00305602144216013,3.73494400669748,5.46912019983649,5.40304212992147,5.68623385812868,0.283191728207209,0.00131689362443421,ENSG00000121067,SPOP,protein_coding,17,-1,49598884,49678163,q21.33,speckle type BTB/POZ protein [Source:HGNC Symbol;Acc:HGNC:11254],NA,SPOP,8405,NM_001007226;NM_001007227;NM_001007228;NM_001007229;NM_001007230;NM_003563
RSKR_SIG,RSKR,RSKR_SIG,RSKR,SIG,76,3.21044831517175,0.042852558339706,0.0373964963233763,0.0607796192505035,0.0233831229271271,0.00305677979205574,2.79245902180363,2.39380872593222,2.34798225780386,2.54438140692541,0.196399149121554,0.0180232762472137,ENSG00000167524,RSKR,protein_coding,17,-1,28607964,28614200,q11.2,ribosomal protein S6 kinase related [Source:HGNC Symbol;Acc:HGNC:26314],NA,RSKR,124923,NM_001174103
PEX12_SIG,PEX12,PEX12_SIG,PEX12,SIG,47,3.21027445487981,0.167365651699656,0.16179694481029,0.185662831479,0.0238658866687093,0.00305777815211275,2.07618781623905,1.83442748256071,1.79656631495461,1.95882846183789,0.162262146883277,0.084052817177883,ENSG00000108733,PEX12,protein_coding,17,-1,35574795,35578863,q12,peroxisomal biogenesis factor 12 [Source:HGNC Symbol;Acc:HGNC:8854],Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER);Peroxisome biogenesis disorder 3B;Peroxisome biogenesis disorder complementation group 3;Zellweger Syndrome,PEX12,5193,NM_000286
CBX8_SIG,CBX8,CBX8_SIG,CBX8,SIG,12,3.2094973055668,-0.00745135240866267,-0.0172681293623556,0.0248037718677571,0.0420719012301129,0.00306520317584218,2.83292349359617,2.15956211275783,2.10234130508432,2.34757333797078,0.245232032886463,0.0163817024527205,ENSG00000141570,CBX8,protein_coding,17,-1,79792132,79801683,q25.3,chromobox 8 [Source:HGNC Symbol;Acc:HGNC:15962],NA,CBX8,57332,NM_020649
DDHD1_SIG,DDHD1,DDHD1_SIG,DDHD1,SIG,68,3.20885084206122,0.348393081136998,0.341440033775632,0.371238808181486,0.0297987744058541,0.00307124852964129,4.26932246225156,4.59225317827247,4.51812197855902,4.8358271201881,0.317705141629086,0.000226141247342684,ENSG00000100523,DDHD1,protein_coding,14,-1,53036745,53153282,q22.1,DDHD domain containing 1 [Source:HGNC Symbol;Acc:HGNC:19714],Autosomal recessive spastic paraplegia type 28;Hereditary Spastic Paraplegia;SPASTIC PARAPLEGIA 28 AUTOSOMAL RECESSIVE,DDHD1,80821,NM_001160147;NM_001160148;NM_030637
NOL7_SIG,NOL7,NOL7_SIG,NOL7,SIG,3,3.20860230308487,0.528444687316185,0.52361877828079,0.544301245575339,0.0206824672945482,0.00307235407861199,2.30430311907817,5.51651639650672,5.49900748640786,5.57404567254584,0.0750381861379736,0.0535049236148018,ENSG00000225921,NOL7,protein_coding,6,1,13615335,13632739,p23,nucleolar protein 7 [Source:HGNC Symbol;Acc:HGNC:21040],NA,NOL7,51406,NM_001317724;NM_016167
DUS3L_SIG,DUS3L,DUS3L_SIG,DUS3L,SIG,42,3.20858743140231,0.267333150956422,0.259514497670662,0.29302301175249,0.0335085140818286,0.00307235407861199,3.08287161008287,5.18291975226173,5.13633831928704,5.33597303203568,0.19963471274864,0.00866857105185271,ENSG00000141994,DUS3L,protein_coding,19,-1,5784832,5791225,p13.3,dihydrouridine synthase 3 like [Source:HGNC Symbol;Acc:HGNC:26920],NA,DUS3L,56931,NM_001161619;NM_020175
HIBADH_SIG,HIBADH,HIBADH_SIG,HIBADH,SIG,21,3.20838580374906,0.425151508449951,0.412695733209138,0.466077627098336,0.0533818938891978,0.00307365456051835,2.62350061740477,4.28778610060277,4.23528064646134,4.46030402135318,0.225023374891838,0.026642540333347,ENSG00000106049,HIBADH,protein_coding,7,-1,27525442,27662883,p15.2,3-hydroxyisobutyrate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4907],NA,HIBADH,11112,NM_152740
CTBP1_TF,CTBP1,CTBP1_TF,CTBP1,TF,201,3.20742671625335,0.271621544582295,0.26430950984886,0.295646801563578,0.0313372917147182,0.0030823369385453,1.91767606076504,7.04411598630878,7.02459387166867,7.10826007726912,0.0836662056004426,0.112727869468743,ENSG00000159692,CTBP1,protein_coding,4,-1,1211448,1249953,p16.3,C-terminal binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2494],HYPOTONIA ATAXIA DEVELOPMENTAL DELAY AND TOOTH ENAMEL DEFECTSYNDROME;Wolf-Hirschhorn syndrome,CTBP1,1487,NM_001012614;NM_001328
BAIAP2L1_SIG,BAIAP2L1,BAIAP2L1_SIG,BAIAP2L1,SIG,17,-3.20741470270036,-0.158369042862002,-0.155024093830448,-0.169359589679966,-0.0143354958495179,0.0030823369385453,-1.92393030261511,0.429064362539037,0.454612829618619,0.345119399277557,-0.109493430341062,0.11152489635816,ENSG00000006453,BAIAP2L1,protein_coding,7,-1,98291650,98401090,q22.1,BAI1 associated protein 2 like 1 [Source:HGNC Symbol;Acc:HGNC:21649],NA,BAIAP2L1,55971,NM_018842
ILF2_SIG,ILF2,ILF2_SIG,ILF2,SIG,49,3.20575907223131,0.504755479248868,0.497191915153592,0.529607189847631,0.0324152746940391,0.00309926466976261,1.3091565836937,7.48576498585737,7.46989715165683,7.53790215537342,0.0680050037165935,0.291341960102893,ENSG00000143621,ILF2,protein_coding,1,-1,153661788,153671028,q21.3,interleukin enhancer binding factor 2 [Source:HGNC Symbol;Acc:HGNC:6037],NA,ILF2,3608,NM_001267809;NM_004515
SMS_SIG,SMS,SMS_SIG,SMS,SIG,13,3.20496859029711,0.089641027372452,0.0850331666759327,0.104781141089587,0.0197479744136542,0.0031069260653339,4.23373242831495,5.20941093018894,5.16150300576258,5.36682268187555,0.205319676112973,0.000256421907470402,ENSG00000102172,SMS,protein_coding,X,1,21940709,21994837,p22.11,spermine synthase [Source:HGNC Symbol;Acc:HGNC:11123],MENTAL RETARDATION X-LINKED SYNDROMIC SNYDER-ROBINSON TYPE;SNYDER-ROBINSON SYNDROME;X-linked intellectual disability Snyder type,SMS,6611,NM_001258423;NM_004595
TFEB_TF,TFEB,TFEB_TF,TFEB,TF,434,-3.20411996432926,0.195343492044056,0.206432396456881,0.158908520401917,-0.0475238760549637,0.00311523391378004,-0.951744085444526,4.21328899458234,4.24361426221501,4.11364882950354,-0.12996543271147,0.454723469606864,ENSG00000112561,TFEB,protein_coding,6,-1,41683978,41736259,p21.1,transcription factor EB [Source:HGNC Symbol;Acc:HGNC:11753],MiT family translocation renal cell carcinoma,TFEB,7942,NM_001167827;NM_001271943;NM_001271944;NM_001271945;NM_007162
POU5F1B_TF,POU5F1B,POU5F1B_TF,POU5F1B,TF,74,-3.20367088573527,-0.109784752452377,-0.1029548816712,-0.132225756447672,-0.0292708747764719,0.00311894932692961,-0.582088567981161,0.258310083098613,0.263340389305136,0.241781934134323,-0.0215584551708127,0.661958883579623,ENSG00000212993,POU5F1B,protein_coding,8,1,127322183,127420066,q24.21,POU class 5 homeobox 1B [Source:HGNC Symbol;Acc:HGNC:9223],NA,POU5F1B,5462,NM_001159542
ZNF85_TF,ZNF85,ZNF85_TF,ZNF85,TF,31,3.20361700381638,0.123090132638642,0.113084541256513,0.155965647179925,0.0428811059234114,0.00311894932692961,2.54801068457145,3.31690464936801,3.26065361217384,3.50172948586314,0.241075873689298,0.0317645555729721,ENSG00000105750,ZNF85,protein_coding,19,1,20923222,20950697,p12,zinc finger protein 85 [Source:HGNC Symbol;Acc:HGNC:13160],NA,ZNF85,7639,NM_001256171;NM_001256172;NM_001256173;NM_003429
SRPK2_SIG,SRPK2,SRPK2_SIG,SRPK2,SIG,16,3.20236247282125,0.288188118024041,0.284646691881825,0.299824232491325,0.0151775406095004,0.00313169708061591,0.962044696261722,5.0723492798097,5.05788755007928,5.11986639178107,0.06197884170179,0.449815479566568,ENSG00000135250,SRPK2,protein_coding,7,-1,105110704,105399308,q22.3,SRSF protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:11306],NA,SRPK2,6733,NM_001278273;NM_001350738;NM_001350739;NM_001350740;NM_001350741;NM_001350742;NM_001350743;NM_001350744;NM_001350745;NM_001350746;NM_182691;NM_182692
ASCC3_SIG,ASCC3,ASCC3_SIG,ASCC3,SIG,7,3.20153263712243,0.506518940837458,0.497847876579178,0.535009580543237,0.0371617039640601,0.00313986084386288,2.65734461608616,5.87903407445871,5.84492322038521,5.99111259498593,0.146189374600725,0.0246689990637663,ENSG00000112249,ASCC3,protein_coding,6,-1,100508194,100881372,q16.3,activating signal cointegrator 1 complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:18697],Autosomal Recessive Mental Retardation,ASCC3,10973,NM_001284271;NM_006828;NM_022091
ZCCHC3_TF,ZCCHC3,ZCCHC3_TF,ZCCHC3,TF,37,3.20085541340121,0.206399092127929,0.202775051784287,0.218306653257037,0.0155316014727498,0.00314637730061908,2.84777751756675,1.72011637531702,1.68638825563581,1.83093733998385,0.144549084348031,0.0157775371610348,ENSG00000247315,ZCCHC3,protein_coding,20,1,296968,300321,p13,zinc finger CCHC-type containing 3 [Source:HGNC Symbol;Acc:HGNC:16230],NA,ZCCHC3,85364,NM_033089
PFKM_SIG,PFKM,PFKM_SIG,PFKM,SIG,42,-3.20059780358683,-0.0488135580279449,-0.0409791480412986,-0.0745551908412114,-0.0335760427999129,0.00314831875019174,-1.96479397231504,2.7538692166587,2.80590757822126,2.58288602866742,-0.223021549553841,0.103533681645705,ENSG00000152556,PFKM,protein_coding,12,1,48105139,48146404,q13.11,phosphofructokinase, muscle [Source:HGNC Symbol;Acc:HGNC:8877],Glycogen storage disease due to muscle phosphofructokinase deficiency;GLYCOGEN STORAGE DISEASE VII,PFKM,5213,NM_000289;NM_001166686;NM_001166687;NM_001166688;NM_001354735;NM_001354736;NM_001354737;NM_001354738;NM_001354739;NM_001354740;NM_001354741;NM_001354742;NM_001354743;NM_001354744;NM_001354745;NM_001354746;NM_001354747;NM_001354748
ZBTB9_TF,ZBTB9,ZBTB9_TF,ZBTB9,TF,86,3.20016300130457,0.160598861604059,0.15337837179912,0.184323328106,0.0309449563068804,0.00315109610634709,2.8577224873697,2.89997392407188,2.84356748807934,3.08530935661878,0.241741868539441,0.0154012910133312,ENSG00000213588,ZBTB9,protein_coding,6,1,33453970,33457544,p21.32,zinc finger and BTB domain containing 9 [Source:HGNC Symbol;Acc:HGNC:28323],NA,ZBTB9,221504,NM_152735
IDE_SIG,IDE,IDE_SIG,IDE,SIG,24,3.20015802556611,0.508432666956065,0.496941604991999,0.546189013409426,0.049247408417428,0.00315109610634709,3.53968820848315,5.30952274291977,5.25124391395335,5.50101032380944,0.249766409856091,0.00240134473013208,ENSG00000119912,IDE,protein_coding,10,-1,92451684,92574076,q23.33,insulin degrading enzyme [Source:HGNC Symbol;Acc:HGNC:5381],NA,IDE,3416,NM_001165946;NM_001322793;NM_001322794;NM_001322795;NM_001322796;NM_001322797;NM_004969
INPPL1_SIG,INPPL1,INPPL1_SIG,INPPL1,SIG,37,3.20010422099115,0.237977662210812,0.232834163213111,0.254877730346115,0.022043567133004,0.00315109610634709,2.74021136248603,7.57377489280858,7.52745549348703,7.7259672048651,0.198511711378068,0.0203480570566149,ENSG00000165458,INPPL1,protein_coding,11,1,72223701,72239147,q13.4,inositol polyphosphate phosphatase like 1 [Source:HGNC Symbol;Acc:HGNC:6080],Opsismodysplasia;SCHNECKENBECKEN DYSPLASIA,INPPL1,3636,NM_001567
COL4A2_SIG,COL4A2,COL4A2_SIG,COL4A2,SIG,20,-3.19985878040316,-0.233343917299032,-0.226933034147783,-0.254408247653137,-0.0274752135053548,0.00315290774402193,-0.601212043364455,0.527724938972404,0.540325754658851,0.486322258859789,-0.0540034957990624,0.650296177266114,ENSG00000134871,COL4A2,protein_coding,13,1,110305812,110513209,q34,collagen type IV alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2203],Familial porencephaly;HEMORRHAGE INTRACEREBRAL SUSCEPTIBILITY TO;Porencephaly 2,COL4A2,1284,NM_001846
DGKZ_SIG,DGKZ,DGKZ_SIG,DGKZ,SIG,24,-3.19952686806133,0.255857506523294,0.259718163088927,0.243172492093357,-0.0165456709955692,0.00315566700401411,-2.59015271469562,6.81193374342595,6.84189194896399,6.71349963951527,-0.128392309448719,0.0288039734175227,ENSG00000149091,DGKZ,protein_coding,11,1,46332905,46380554,p11.2,diacylglycerol kinase zeta [Source:HGNC Symbol;Acc:HGNC:2857],NA,DGKZ,8525,NM_001105540;NM_001199266;NM_001199267;NM_001199268;NM_003646;NM_201532;NM_201533
STAT1_TF,STAT1,STAT1_TF,STAT1,TF,71,-3.19942971548248,0.151775945276527,0.157163536665121,0.134073859285433,-0.0230896773796881,0.00315585751406022,-1.97223738743683,7.13345012045312,7.17376748423632,7.00097878230834,-0.172788701927979,0.102161957712457,ENSG00000115415,STAT1,protein_coding,2,-1,190964358,191020960,q32.2,signal transducer and activator of transcription 1 [Source:HGNC Symbol;Acc:HGNC:11362],Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;IMMUNODEFICIENCY 31A;IMMUNODEFICIENCY 31B;IMMUNODEFICIENCY 31C;Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency;Susceptibility to viral and mycobacterial infections,STAT1,6772,NM_007315;NM_139266
IQGAP1_SIG,IQGAP1,IQGAP1_SIG,IQGAP1,SIG,52,-3.19809202284192,0.407369422920095,0.420356164975878,0.36469869902252,-0.0556574659533585,0.00316965695040244,-2.66738130784843,8.73444750608981,8.80544439837294,8.50117200287379,-0.304272395499156,0.024137087796971,ENSG00000140575,IQGAP1,protein_coding,15,1,90388242,90502239,q26.1,IQ motif containing GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:6110],NA,IQGAP1,8826,NM_003870
HIF1A_TF,HIF1A,HIF1A_TF,HIF1A,TF,298,-3.19758382032519,-0.0618863100427153,-0.0522901746031455,-0.0934164693441587,-0.0411262947410132,0.00317436966410143,-2.30344717990001,8.10754831524309,8.17900850035275,7.8727505641685,-0.306257936184244,0.0535948949607537,ENSG00000100644,HIF1A,protein_coding,14,1,61695513,61748259,q23.2,hypoxia inducible factor 1 subunit alpha [Source:HGNC Symbol;Acc:HGNC:4910],NA,HIF1A,3091,NM_001243084;NM_001530;NM_181054
SNRK_SIG,SNRK,SNRK_SIG,SNRK,SIG,44,-3.19733797532465,0.266740458751706,0.275258826618997,0.23875153575918,-0.0365072908598175,0.00317619851321515,-3.32164107902514,6.89558045094069,6.94532881177813,6.73212155104627,-0.21320726073186,0.00451841020351888,ENSG00000163788,SNRK,protein_coding,3,1,43286512,43424764,p22.1,SNF related kinase [Source:HGNC Symbol;Acc:HGNC:30598],NA,SNRK,54861,NM_001100594;NM_001330750;NM_017719
GSTK1_SIG,GSTK1,GSTK1_SIG,GSTK1,SIG,55,3.19691292192801,0.22411027897159,0.219425328625385,0.239503687251979,0.020078358626594,0.00318000353035683,1.8959308754819,7.61727622807664,7.5886118711018,7.71145911527971,0.122847244177908,0.117154185051844,ENSG00000197448,GSTK1,protein_coding,7,1,143244093,143270854,q34,glutathione S-transferase kappa 1 [Source:HGNC Symbol;Acc:HGNC:16906],NA,GSTK1,373156,NM_001143679;NM_001143680;NM_001143681;NM_015917
ADAMTS1_SIG,ADAMTS1,ADAMTS1_SIG,ADAMTS1,SIG,60,3.19541989272176,-0.198425469102694,-0.203384327497692,-0.182132077233417,0.0212522502642751,0.00319516880309725,1.53602044794783,1.43940046691849,1.3729869520015,1.65761630164574,0.284629349644248,0.210306031582528,ENSG00000154734,ADAMTS1,protein_coding,21,-1,26835755,26845409,q21.3,ADAM metallopeptidase with thrombospondin type 1 motif 1 [Source:HGNC Symbol;Acc:HGNC:217],NA,ADAMTS1,9510,NM_006988
POR_SIG,POR,POR_SIG,POR,SIG,13,-3.19538086260854,0.252239287507919,0.260573736086866,0.224854670748523,-0.0357190653383428,0.00319516880309725,-0.696066840020139,5.24850111306789,5.26060300649229,5.20873774895915,-0.051865257533147,0.594403557403616,ENSG00000127948,POR,protein_coding,7,1,75899200,75986855,q11.23,cytochrome p450 oxidoreductase [Source:HGNC Symbol;Acc:HGNC:9208],Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis;Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis;Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency;DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY,POR,5447,NM_000941;NM_001367562
POLR2A_SIG,POLR2A,POLR2A_SIG,POLR2A,SIG,15,3.19527381213093,0.467713953897145,0.462812845723446,0.483817595039299,0.0210047493158534,0.0031954717991449,3.30100007072391,8.60834309950208,8.56867286810857,8.73868814550932,0.170015277400744,0.00479541451751198,ENSG00000181222,POLR2A,protein_coding,17,1,7484366,7514616,p13.1,RNA polymerase II subunit A [Source:HGNC Symbol;Acc:HGNC:9187],NA,POLR2A,5430,NM_000937
SCMH1_TF,SCMH1,SCMH1_TF,SCMH1,TF,134,3.1951583772837,0.184398324128942,0.175926474785363,0.21223440054356,0.0363079257581968,0.00319586787957701,1.22956371794603,5.63042567590756,5.60612300418733,5.71027731155973,0.104154307372403,0.323922085375712,ENSG00000010803,SCMH1,protein_coding,1,-1,41027200,41242154,p34.2,Scm polycomb group protein homolog 1 [Source:HGNC Symbol;Acc:HGNC:19003],NA,SCMH1,22955,NM_001031694;NM_001172218;NM_001172219;NM_001172220;NM_001172221;NM_001172222;NM_001350667;NM_001350668;NM_012236
NUPL2_SIG,NUPL2,NUPL2_SIG,NUPL2,SIG,36,3.19491914082986,0.230367051184553,0.216755318447906,0.27509131589068,0.0583359974427741,0.00319763557603479,2.49395132138701,4.56319177668278,4.51753135689182,4.71321887028165,0.195687513389833,0.0357717941644415,ENSG00000136243,NUPL2,protein_coding,7,1,23181841,23201011,p15.3,nucleoporin like 2 [Source:HGNC Symbol;Acc:HGNC:17010],NA,NUPL2,11097,NM_007342
IFI27_SIG,IFI27,IFI27_SIG,IFI27,SIG,16,-3.19170286331038,0.0192146037502278,0.029744294228194,-0.0153829506773752,-0.045127244905569,0.00323256132586233,-3.09284930945281,1.13564914148915,1.24518205415292,0.775755285593907,-0.469426768559018,0.0084433343040575,ENSG00000165949,IFI27,protein_coding,14,1,94104836,94116698,q32.12,interferon alpha inducible protein 27 [Source:HGNC Symbol;Acc:HGNC:5397],NA,IFI27,3429,NM_001288954;NM_001288957;NM_001288958;NM_001288960;NM_001288995;NM_001366993;NM_005532
SRPK1_SIG,SRPK1,SRPK1_SIG,SRPK1,SIG,55,-3.19126783779481,0.11570889670509,0.124187814050081,0.0878495968572647,-0.0363382171928161,0.00323654005785781,-1.73101898648539,6.49434930953623,6.52673903968973,6.38792591046044,-0.138813129229287,0.155036658972189,ENSG00000096063,SRPK1,protein_coding,6,-1,35832966,35921342,p21.31,SRSF protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:11305],NA,SRPK1,6732,NM_003137
MGST1_SIG,MGST1,MGST1_SIG,MGST1,SIG,39,3.19007449192145,0.21021584713823,0.202709576795101,0.234879306837083,0.0321697300419817,0.00324903860711537,2.21574582358324,5.91628439777507,5.81607991137657,6.24552771022729,0.429447798850719,0.0643001775999394,ENSG00000008394,MGST1,protein_coding,12,1,16347142,16609259,p12.3,microsomal glutathione S-transferase 1 [Source:HGNC Symbol;Acc:HGNC:7061],NA,MGST1,4257,NM_001260511;NM_001260512;NM_001267598;NM_020300;NM_145764;NM_145791;NM_145792
CELSR2_SIG,CELSR2,CELSR2_SIG,CELSR2,SIG,54,-3.18993112863383,-0.0976088255778426,-0.0917099729175687,-0.116990770033028,-0.0252807971154595,0.00324975477329688,-0.930096237144098,2.15696471142425,2.18263647785311,2.07261462172943,-0.110021856123682,0.465622719261899,ENSG00000143126,CELSR2,protein_coding,1,1,109249539,109275751,p13.3,cadherin EGF LAG seven-pass G-type receptor 2 [Source:HGNC Symbol;Acc:HGNC:3231],NA,CELSR2,1952,NM_001408
ZNF45_TF,ZNF45,ZNF45_TF,ZNF45,TF,24,3.18950124412754,0.165214984907373,0.155495419513621,0.197150699772558,0.0416552802589367,0.00325369519135061,3.10886209644969,4.14730155317924,4.09867565457199,4.30707236288878,0.208396708316793,0.00813823634673006,ENSG00000124459,ZNF45,protein_coding,19,-1,43912624,43935282,q13.31,zinc finger protein 45 [Source:HGNC Symbol;Acc:HGNC:13111],NA,ZNF45,7596,NM_003425
THAP3_TF,THAP3,THAP3_TF,THAP3,TF,15,3.18820572878918,0.153716331508443,0.149652935292347,0.167067490504184,0.0174145552118371,0.00326740867580396,3.98846988396049,3.20920820066802,3.1619037021342,3.36463726727917,0.202733565144977,0.000589471430416016,ENSG00000041988,THAP3,protein_coding,1,1,6624866,6635586,p36.31,THAP domain containing 3 [Source:HGNC Symbol;Acc:HGNC:20855],NA,THAP3,90326,NM_001195752;NM_001195753;NM_138350
BAZ1A_SIG,BAZ1A,BAZ1A_SIG,BAZ1A,SIG,60,-3.18699040669165,0.120123197552874,0.129120421662842,0.0905608897629796,-0.0385595318998629,0.0032798126507724,-3.59113143934929,7.38221893832325,7.44478054159545,7.17665938471461,-0.268121156880837,0.00205436615966042,ENSG00000198604,BAZ1A,protein_coding,14,-1,34752731,34875647,q13.2,bromodomain adjacent to zinc finger domain 1A [Source:HGNC Symbol;Acc:HGNC:960],NA,BAZ1A,11177,NM_013448;NM_182648
ECH1_SIG,ECH1,ECH1_SIG,ECH1,SIG,36,3.18695068857792,0.339146080918055,0.328904994892119,0.372795363574704,0.0438903686825858,0.0032798126507724,3.68665259783525,5.63241058277184,5.57836276025297,5.80999628533385,0.231633525080877,0.00153205950463868,ENSG00000104823,ECH1,protein_coding,19,-1,38815422,38831841,q13.2,enoyl-CoA hydratase 1 [Source:HGNC Symbol;Acc:HGNC:3149],NA,ECH1,1891,NM_001398
GPR132_SIG,GPR132,GPR132_SIG,GPR132,SIG,24,-3.18686953833571,0.302153355306281,0.308796809947715,0.280324861484426,-0.0284719484632896,0.00327982994302938,-1.65869602669339,4.13863044857691,4.18303662096299,3.99272445359405,-0.190312167368938,0.174125737906616,ENSG00000183484,GPR132,protein_coding,14,-1,105049395,105065445,q32.33,G protein-coupled receptor 132 [Source:HGNC Symbol;Acc:HGNC:17482],NA,GPR132,29933,NM_001278694;NM_001278695;NM_013345
YWHAG_SIG,YWHAG,YWHAG_SIG,YWHAG,SIG,16,3.18540652223663,0.476807790137178,0.468816460213659,0.50306501702874,0.0342485568150808,0.0032955512758241,2.97118086892274,7.12571804546841,7.05823648072733,7.34744318676054,0.289206706033213,0.0115984965003048,ENSG00000170027,YWHAG,protein_coding,7,-1,76326799,76358991,q11.23,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [Source:HGNC Symbol;Acc:HGNC:12852],Early-Onset Epilepsy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 56;Undetermined early-onset epileptic encephalopathy,YWHAG,7532,NM_012479
MARCH3_SIG,MARCH3,MARCH3_SIG,MARCH3,SIG,15,-3.18502379737399,-0.186180514530431,-0.181984929068089,-0.199966009620984,-0.0179810805528956,0.00329900506358663,-2.0056213417534,2.25024637744897,2.29890465481871,2.09036918037695,-0.208535474441763,0.0960473157952821,ENSG00000173926,MARCH3,protein_coding,5,-1,126867714,127030558,q23.2,membrane associated ring-CH-type finger 3 [Source:HGNC Symbol;Acc:HGNC:28728],NA,MARCH3,115123,NM_178450
DUSP10_SIG,DUSP10,DUSP10_SIG,DUSP10,SIG,35,3.18275758158033,0.11722229576622,0.109135171119554,0.143794276748123,0.034659105628569,0.00332386102976123,2.57460613488807,6.31603957314097,6.23954765461908,6.56737016257004,0.32782250795096,0.0298565784614697,ENSG00000143507,DUSP10,protein_coding,1,-1,221701424,221742089,q41,dual specificity phosphatase 10 [Source:HGNC Symbol;Acc:HGNC:3065],NA,DUSP10,11221,NM_007207
DRAP1_TF,DRAP1,DRAP1_TF,DRAP1,TF,117,3.18269170761994,0.0322369276644631,0.0300640048561364,0.0393765311775366,0.00931252632140028,0.00332386102976123,1.18525311170137,6.02671805957021,6.01372110649586,6.06942233395737,0.0557012274615136,0.34340166864307,ENSG00000175550,DRAP1,protein_coding,11,1,65919274,65921563,q13.1,DR1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:3019],NA,DRAP1,10589,NM_006442
MITF_TF,MITF,MITF_TF,MITF,TF,225,3.18216424096915,0.0602319650505975,0.0573206443819022,0.0697977329620251,0.0124770885801228,0.00332900539940095,1.96345282124378,3.48097232832258,3.42075986417184,3.67881328196072,0.258053417788884,0.103800624797092,ENSG00000187098,MITF,protein_coding,3,1,69739435,69968337,p13,melanocyte inducing transcription factor [Source:HGNC Symbol;Acc:HGNC:7105],ALBINISM OCULAR WITH SENSORINEURAL DEAFNESS;Clear cell papillary renal cell carcinoma;Coloboma osteopetrosis microphthalmia macrocephaly albinism and deafness;COLOBOMA OSTEOPETROSIS MICROPHTHALMIA MACROCEPHALY ALBINISM ANDDEAFNESS;Familial melanoma;MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 8;MITF-related melanoma and renal cell carcinoma predisposition syndrome;Ocular albinism with congenital sensorineural deafness;Papillary renal cell carcinoma;TIETZ ALBINISM-DEAFNESS SYNDROME;Tietz syndrome;Waardenburg syndrome type 2;WAARDENBURG SYNDROME TYPE 2 WITH OCULAR ALBINISM;Waardenburg syndrome type 2A,MITF,4286,NM_000248;NM_001184967;NM_001184968;NM_001354604;NM_001354605;NM_001354606;NM_001354607;NM_001354608;NM_006722;NM_198158;NM_198159;NM_198177;NM_198178
TNKS_SIG,TNKS,TNKS_SIG,TNKS,SIG,45,3.18193185582623,0.442441138642348,0.436507927099218,0.461935976569774,0.0254280494705562,0.00333027222259133,2.56342287234186,5.91727499799816,5.88075188983176,6.03727949625922,0.156527606427462,0.0306204068076311,ENSG00000173273,TNKS,protein_coding,8,1,9555912,9782346,p23.1,tankyrase [Source:HGNC Symbol;Acc:HGNC:11941],NA,TNKS,8658,NM_003747
CDC42SE1_SIG,CDC42SE1,CDC42SE1_SIG,CDC42SE1,SIG,31,-3.18189487302825,0.42907849656719,0.437101792215123,0.402716239438267,-0.0343855527768556,0.00333027222259133,-2.77170914599127,7.98279845609272,8.02621392606864,7.84014762617184,-0.186066299896806,0.0189024181585171,ENSG00000197622,CDC42SE1,protein_coding,1,-1,151050971,151070325,q21.3,CDC42 small effector 1 [Source:HGNC Symbol;Acc:HGNC:17719],NA,CDC42SE1,56882,NM_001038707;NM_020239
SQLE_SIG,SQLE,SQLE_SIG,SQLE,SIG,21,3.18146997301944,0.237406184721472,0.232246456302614,0.254359578097718,0.0221131217951044,0.00333424515394717,0.979876473783968,4.97102972717815,4.9466089012181,5.05126958390404,0.104660682685949,0.440792503536346,ENSG00000104549,SQLE,protein_coding,8,1,124998497,125022283,q24.13,squalene epoxidase [Source:HGNC Symbol;Acc:HGNC:11279],NA,SQLE,6713,NM_003129
RUNX3_TF,RUNX3,RUNX3_TF,RUNX3,TF,208,-3.18124657154598,0.0272103347279477,0.0327406092303386,0.00903943279152053,-0.0237011764388181,0.00333590136951928,-1.34392690116776,6.59210397581823,6.63832796777665,6.44022514509769,-0.198102822678962,0.277586536121277,ENSG00000020633,RUNX3,protein_coding,1,-1,24899511,24965121,p36.11,runt related transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:10473],NA,RUNX3,864,NM_001031680;NM_001320672;NM_004350
TRIM28_SIG,TRIM28,TRIM28_SIG,TRIM28,SIG,44,3.18099395119825,0.383819393717647,0.374617031346457,0.414055727222986,0.0394386958765284,0.00333789514237088,2.40392079051589,8.07670142723036,8.04364391043949,8.18531898240038,0.141675071960885,0.0435177048530728,ENSG00000130726,TRIM28,protein_coding,19,1,58544064,58550722,q13.43,tripartite motif containing 28 [Source:HGNC Symbol;Acc:HGNC:16384],Nephroblastoma,TRIM28,10155,NM_005762
USB1_SIG,USB1,USB1_SIG,USB1,SIG,17,-3.18060007591045,0.307129888691721,0.316060358499024,0.277786916467724,-0.0382734420313002,0.00334151889908416,-2.35769589426571,5.92898606637129,5.96210746549575,5.82015861210518,-0.141948853390578,0.0479388000977414,ENSG00000103005,USB1,protein_coding,16,1,57999546,58021618,q21,U6 snRNA biogenesis phosphodiesterase 1 [Source:HGNC Symbol;Acc:HGNC:25792],Dyskeratosis congenita;POIKILODERMA WITH NEUTROPENIA,USB1,79650,NM_001195302;NM_001204911;NM_001330568;NM_001330569;NM_024598
ACOT13_SIG,ACOT13,ACOT13_SIG,ACOT13,SIG,41,3.17850417301725,-0.0454230011554827,-0.0581714378327423,-0.00353528064448679,0.0546361571882556,0.00336484846908116,1.494971520091,3.72090298684921,3.6873669044618,3.83109297183638,0.143726067374574,0.223632665145946,ENSG00000112304,ACOT13,protein_coding,6,1,24667035,24705065,p22.3,acyl-CoA thioesterase 13 [Source:HGNC Symbol;Acc:HGNC:20999],NA,ACOT13,55856,NM_001160094;NM_018473
TRIM5_SIG,TRIM5,TRIM5_SIG,TRIM5,SIG,25,3.17835350208924,0.333361243145892,0.320369775191274,0.376047494996779,0.0556777198055047,0.00336567436046886,3.23449722677018,4.49308311355301,4.42409956677895,4.71974333866776,0.295643771888804,0.00577354914026042,ENSG00000132256,TRIM5,protein_coding,11,-1,5663557,5938619,p15.4,tripartite motif containing 5 [Source:HGNC Symbol;Acc:HGNC:16276],NA,TRIM5,85363,NM_033034;NM_033092;NM_033093
THOC2_SIG,THOC2,THOC2_SIG,THOC2,SIG,32,3.17733952819966,0.700559675225453,0.691878805925563,0.729082531496521,0.0372037255709585,0.00337653887356003,2.10160537180612,6.73408520854692,6.70474623611184,6.83048468940506,0.125738453293222,0.0801340893361614,ENSG00000125676,THOC2,protein_coding,X,-1,123600561,123733056,q25,THO complex 2 [Source:HGNC Symbol;Acc:HGNC:19073],MENTAL RETARDATION X-LINKED 12;X-linked intellectual disability-short stature-overweight syndrome,THOC2,57187,NM_001081550
ZNF622_SIG,ZNF622,ZNF622_SIG,ZNF622,SIG,15,-3.17604822983298,0.192935536406739,0.196701414903016,0.180561935633257,-0.0161394792697589,0.0033906754878503,-0.323029814120211,4.72665652465039,4.73025290319551,4.71483985228786,-0.0154130509076501,0.814276472269004,ENSG00000173545,ZNF622,protein_coding,5,-1,16451519,16465800,p15.1,zinc finger protein 622 [Source:HGNC Symbol;Acc:HGNC:30958],NA,ZNF622,90441,NM_033414
PPIC_SIG,PPIC,PPIC_SIG,PPIC,SIG,31,3.17562642452484,-0.159573057939833,-0.163190704697804,-0.147686504306499,0.0155042003913044,0.00339467842959411,1.7861653174869,0.307274247871332,0.283743129445013,0.384590779843526,0.100847650398513,0.141390301323197,ENSG00000168938,PPIC,protein_coding,5,-1,123023250,123036741,q23.2,peptidylprolyl isomerase C [Source:HGNC Symbol;Acc:HGNC:9256],NA,PPIC,5480,NM_000943
AKT2_SIG,AKT2,AKT2_SIG,AKT2,SIG,21,3.17452648708781,0.10041856134993,0.0973963389227691,0.110348720753459,0.0129523818306901,0.0034066374797699,2.44244136288623,7.10138450961377,7.08171584136025,7.16601013387534,0.0842942925150866,0.0399847564175648,ENSG00000105221,AKT2,protein_coding,19,-1,40230317,40285536,q13.2,AKT serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:392],AKT2-related familial partial lipodystrophy;DIABETES MELLITUS NONINSULIN-DEPENDENT;Hypoinsulinemic hypoglycemia and body hemihypertrophy;HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY,AKT2,208,NM_001243027;NM_001243028;NM_001330511;NM_001626
RET_SIG,RET,RET_SIG,RET,SIG,27,-3.17392502791196,0.0340614244492951,0.0430498608011757,0.00452799072168735,-0.0385218700794885,0.00341276944821226,-2.77693580399813,2.01835422881013,2.11710816090917,1.69387702334186,-0.423231137567314,0.0186620685200443,ENSG00000165731,RET,protein_coding,10,1,43077069,43130351,q11.21,ret proto-oncogene [Source:HGNC Symbol;Acc:HGNC:9967],CENTRAL HYPOVENTILATION SYNDROME CONGENITAL;Differentiated thyroid carcinoma;Familial medullary thyroid carcinoma;Haddad syndrome;Hereditary pheochromocytoma-paraganglioma;Hirschsprung disease;HIRSCHSPRUNG DISEASE SUSCEPTIBILITY TO 1;Multiple endocrine neoplasia IIB;Multiple endocrine neoplasia type 2A;Multiple endocrine neoplasia type 2B;MULTIPLE ENDOCRINE NEOPLASIA TYPE IIA;MULTIPLE ENDOCRINE NEOPLASIA TYPE IIB;Pheochromocytoma;RENAL AGENESIS;Renal agenesis bilateral;Renal agenesis unilateral;Sporadic pheochromocytoma;THYROID CARCINOMA FAMILIAL MEDULLARY,RET,5979,NM_001355216;NM_020630;NM_020975
ZKSCAN2_TF,ZKSCAN2,ZKSCAN2_TF,ZKSCAN2,TF,85,3.17360182207918,0.270706844203124,0.264356263930168,0.291573036528551,0.0272167725983827,0.00341563602494834,2.63162881414841,3.63727652854985,3.5883300339605,3.79810072505773,0.20977069109723,0.0261608477008924,ENSG00000155592,ZKSCAN2,protein_coding,16,-1,25236001,25257845,p12.1,zinc finger with KRAB and SCAN domains 2 [Source:HGNC Symbol;Acc:HGNC:25677],NA,ZKSCAN2,342357,NM_001012981
ZNF623_TF,ZNF623,ZNF623_TF,ZNF623,TF,37,3.17318517822495,0.256973672484258,0.244166948313284,0.29905290904603,0.0548859607327463,0.00341960536594357,3.25957217221259,4.24582979642762,4.18001546262354,4.46207689321248,0.282061430588941,0.00538266441352309,ENSG00000183309,ZNF623,protein_coding,8,1,143636013,143656418,q24.3,zinc finger protein 623 [Source:HGNC Symbol;Acc:HGNC:29084],NA,ZNF623,9831,NM_001082480;NM_001261843;NM_014789
ABCD1_SIG,ABCD1,ABCD1_SIG,ABCD1,SIG,65,-3.17280984378226,0.311230640371092,0.321648977396966,0.276998961571791,-0.0446500158251755,0.00342309196302406,-3.68929540745248,4.68063362014259,4.75719536608417,4.42907359776312,-0.328121768321054,0.00152072635142644,ENSG00000101986,ABCD1,protein_coding,X,1,153724856,153744755,q28,ATP binding cassette subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:61],Adrenoleukodystrophy;Adrenoleukodystrophy X-Linked;Adrenomyeloneuropathy;CADDS;X-linked cerebral adrenoleukodystrophy,ABCD1,215,NM_000033
EIF3J_SIG,EIF3J,EIF3J_SIG,EIF3J,SIG,13,3.17271646821025,0.78534808991536,0.776420559231749,0.814681405018653,0.0382608457869038,0.0034232561451526,3.1575041728827,5.85296780194495,5.81571984098342,5.97535395938999,0.159634118406566,0.00710861769998065,ENSG00000104131,EIF3J,protein_coding,15,1,44537125,44563029,q21.1,eukaryotic translation initiation factor 3 subunit J [Source:HGNC Symbol;Acc:HGNC:3270],NA,EIF3J,8669,NM_001284335;NM_001284336;NM_003758
KLF2_TF,KLF2,KLF2_TF,KLF2,TF,43,-3.17057426943118,0.18465612236535,0.18909373554732,0.170075393338877,-0.0190183422084436,0.00344715095610337,-4.486467119672,7.58252037832815,7.72659269793016,7.10913989963585,-0.617452798294311,0.000104467209504085,ENSG00000127528,KLF2,protein_coding,19,1,16324817,16327874,p13.11,Kruppel like factor 2 [Source:HGNC Symbol;Acc:HGNC:6347],NA,KLF2,10365,NM_016270
LRPPRC_SIG,LRPPRC,LRPPRC_SIG,LRPPRC,SIG,35,3.17053732217611,0.656854101551971,0.645940887662166,0.69271180433276,0.0467709166705945,0.00344715095610337,2.22734653324347,7.1648891187986,7.12903716537934,7.28268839431904,0.153651228939697,0.0627282467333164,ENSG00000138095,LRPPRC,protein_coding,2,-1,43886224,43995989,p21,leucine rich pentatricopeptide repeat containing [Source:HGNC Symbol;Acc:HGNC:15714],Congenital lactic acidosis Saguenay-Lac-Saint-Jean type;LEIGH SYNDROME FRENCH CANADIAN TYPE,LRPPRC,10128,NM_133259
ZNF343_TF,ZNF343,ZNF343_TF,ZNF343,TF,33,3.1695575866964,0.183897752139194,0.173031584482484,0.219600874439815,0.0465692899573309,0.00345784829227941,3.01353803847249,3.02936192131491,2.97919332489894,3.19420159525312,0.215008270354177,0.0103728854815638,ENSG00000088876,ZNF343,protein_coding,20,-1,2481817,2524702,p13,zinc finger protein 343 [Source:HGNC Symbol;Acc:HGNC:16017],NA,ZNF343,79175,NM_001282495;NM_001282496;NM_001282497;NM_001282498;NM_001282499;NM_001321800;NM_001321801;NM_001321802;NM_001321803;NM_001321805;NM_024325
ATRIP_SIG,ATRIP,ATRIP_SIG,ATRIP,SIG,41,3.1689967357534,0.352204148327667,0.338717047957154,0.396518906687922,0.0578018587307674,0.0034635808881399,3.42260442168586,3.32498967511007,3.26942462309556,3.50756056030061,0.238135937205045,0.00337008859707427,ENSG00000164053,ATRIP,protein_coding,3,1,48446710,48467645,p21.31,ATR interacting protein [Source:HGNC Symbol;Acc:HGNC:33499],Seckel syndrome,ATRIP,84126,NM_001271022;NM_001271023;NM_032166;NM_130384
SPCS1_SIG,SPCS1,SPCS1_SIG,SPCS1,SIG,32,3.16831104882791,0.261989202599573,0.256239042357045,0.280882586253597,0.0246435438965524,0.00347081240824554,2.30226996265445,6.03762996630143,6.01112157866482,6.12472895425029,0.113607375585473,0.053692518590212,ENSG00000114902,SPCS1,protein_coding,3,1,52704955,52711148,p21.1,signal peptidase complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:23401],NA,SPCS1,28972,NM_014041
H1F0_SIG,H1F0,H1F0_SIG,H1F0,SIG,75,-3.16747309387573,-0.0676046069293221,-0.0612624943032422,-0.0884429769864419,-0.0271804826831997,0.0034798796534631,-2.1679180647974,7.6297088011878,7.7493882440839,7.23647634595774,-0.51291189812616,0.0705948147079598,ENSG00000189060,H1F0,protein_coding,22,1,37805093,37807436,q13.1,H1 histone family member 0 [Source:HGNC Symbol;Acc:HGNC:4714],NA,H1F0,3005,NM_005318
AKNA_TF,AKNA,AKNA_TF,AKNA,TF,323,-3.16691476497531,0.116990634717367,0.122273424991465,0.0996328952453311,-0.0226405297461341,0.00348561551768663,-1.68018969596035,7.94701590796451,7.97854588642629,7.84341740730439,-0.135128479121905,0.168355036782421,ENSG00000106948,AKNA,protein_coding,9,-1,114334156,114394405,q32,AT-hook transcription factor [Source:HGNC Symbol;Acc:HGNC:24108],NA,AKNA,80709,NM_001317950;NM_001317952;NM_030767
MRPL45_SIG,MRPL45,MRPL45_SIG,MRPL45,SIG,50,3.16601623391421,0.68148274463326,0.673323003567891,0.708293322419471,0.0349703188515799,0.00349544599153917,3.5122849709514,5.39395309609521,5.33799271523885,5.57782291890899,0.239830203670141,0.00260885184816867,ENSG00000278845,MRPL45,protein_coding,17,1,38297023,38323217,q12,mitochondrial ribosomal protein L45 [Source:HGNC Symbol;Acc:HGNC:16651],NA,MRPL45,84311,NM_001278279;NM_032351
NFE2_TF,NFE2,NFE2_TF,NFE2,TF,59,3.16481968763466,0.0524643817760403,0.0439387416720109,0.080477199260708,0.0365384575886971,0.00350889388562514,1.39729191928531,6.80237201846308,6.75427471355234,6.96040602031266,0.206131306760324,0.257558146648278,ENSG00000123405,NFE2,protein_coding,12,-1,54292111,54301015,q13.13,nuclear factor, erythroid 2 [Source:HGNC Symbol;Acc:HGNC:7780],NA,NFE2,4778,NM_001136023;NM_001261461;NM_006163
TNF_SIG,TNF,TNF_SIG,TNF,SIG,25,-3.16421384135956,0.154739460514289,0.163654848355131,0.125446043322954,-0.0382088050321772,0.00351477401987445,-1.07946973234404,3.16524272006781,3.21161596384969,3.01287349049878,-0.198742473350908,0.392316712029341,ENSG00000232810,TNF,protein_coding,6,1,31575565,31578336,p21.33,tumor necrosis factor [Source:HGNC Symbol;Acc:HGNC:11892],ASTHMA SUSCEPTIBILITY TO;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;MIGRAINE WITH OR WITHOUT AURA SUSCEPTIBILITY TO 1,TNF,7124,NM_000594
ZNF444_TF,ZNF444,ZNF444_TF,ZNF444,TF,54,3.16417363955888,0.0198005190143977,0.0149049431413137,0.035885982597388,0.0209810394560745,0.00351477401987445,3.57068281878436,3.95578822211615,3.88929972417495,4.17425042963724,0.284950705462292,0.00218403327918273,ENSG00000167685,ZNF444,protein_coding,19,1,56132599,56160893,q13.43,zinc finger protein 444 [Source:HGNC Symbol;Acc:HGNC:16052],NA,ZNF444,55311,NM_001253792;NM_018337
PFN1_SIG,PFN1,PFN1_SIG,PFN1,SIG,55,-3.16391834289347,0.241491406335226,0.247892609893183,0.22045888035908,-0.0274337295341035,0.00351689918295153,-2.82184475703988,9.34808530369516,9.3856626423207,9.2246169053541,-0.161045736966603,0.0167990692000436,ENSG00000108518,PFN1,protein_coding,17,-1,4945652,4949061,p13.2,profilin 1 [Source:HGNC Symbol;Acc:HGNC:8881],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 18,PFN1,5216,NM_005022
MKI67_SIG,MKI67,MKI67_SIG,MKI67,SIG,48,-3.16336271000045,0.261521482663564,0.293889641305636,0.155168961411041,-0.138720679894595,0.00352265848134868,-3.13613762885434,6.53725571503467,6.67564085392881,6.08256168723962,-0.593079166689193,0.0075399029858564,ENSG00000148773,MKI67,protein_coding,10,-1,128096659,128126423,q26.2,marker of proliferation Ki-67 [Source:HGNC Symbol;Acc:HGNC:7107],NA,MKI67,4288,NM_001145966;NM_002417
CD1A_SIG,CD1A,CD1A_SIG,CD1A,SIG,16,-3.16256450655481,0.0312313290465324,0.0570046792474661,-0.0534525358993926,-0.110457215146859,0.00353136742159235,-2.97050158017655,0.391229872677723,0.433008568680196,0.253957014383883,-0.179051554296312,0.0116183384406505,ENSG00000158477,CD1A,protein_coding,1,1,158254424,158258269,q23.1,CD1a molecule [Source:HGNC Symbol;Acc:HGNC:1634],NA,CD1A,909,NM_001320652;NM_001763
SH2D1B_SIG,SH2D1B,SH2D1B_SIG,SH2D1B,SIG,8,-3.16213974498137,-0.211959022920963,-0.193740573061314,-0.271819643888384,-0.0780790708270704,0.0035355591091163,-2.89380434091815,1.19986257382498,1.27694645638836,0.94658695968813,-0.330359496700233,0.0140931896864685,ENSG00000198574,SH2D1B,protein_coding,1,-1,162395268,162412138,q23.3,SH2 domain containing 1B [Source:HGNC Symbol;Acc:HGNC:30416],NA,SH2D1B,117157,NM_053282
SYNCRIP_SIG,SYNCRIP,SYNCRIP_SIG,SYNCRIP,SIG,23,3.16055468776226,0.470502100336869,0.463577302260168,0.493255008303174,0.0296777060430062,0.00355388451834025,2.05904960581111,7.69822758856837,7.67320798943906,7.7804348428504,0.107226853411348,0.0869141680135084,ENSG00000135316,SYNCRIP,protein_coding,6,-1,85607785,85643792,q14.3,synaptotagmin binding cytoplasmic RNA interacting protein [Source:HGNC Symbol;Acc:HGNC:16918],NA,SYNCRIP,10492,NM_001159673;NM_001159674;NM_001159675;NM_001159676;NM_001159677;NM_001253771;NM_006372
RC3H2_TF,RC3H2,RC3H2_TF,RC3H2,TF,84,3.15929817721726,0.387260120579548,0.381565213085507,0.405971959488538,0.024406746403031,0.00356827175369623,3.15634181131222,6.30090116128414,6.2581953415739,6.44122028318919,0.18302494161529,0.00713289114670475,ENSG00000056586,RC3H2,protein_coding,9,-1,122844556,122905359,q33.2,ring finger and CCCH-type domains 2 [Source:HGNC Symbol;Acc:HGNC:21461],NA,RC3H2,54542,NM_001100588;NM_001354478;NM_001354479;NM_001354482;NM_001354486;NM_018835
C7_SIG,C7,C7_SIG,C7,SIG,24,-3.15907650206156,-0.309654922643775,-0.301436122734427,-0.336659550917346,-0.0352234281829193,0.00356965840266991,-1.84086392986927,0.393099933486452,0.433142621341933,0.261531101961302,-0.171611519380631,0.128707389700993,ENSG00000112936,C7,protein_coding,5,1,40909252,40982939,p13.1,complement C7 [Source:HGNC Symbol;Acc:HGNC:1346],Complement component 7 deficiency;Immunodeficiency due to a late component of complement deficiency,C7,730,NM_000587
ZC3H11A_TF,ZC3H11A,ZC3H11A_TF,ZC3H11A,TF,47,3.15902626511383,0.36580637321532,0.361918723650034,0.378580078929828,0.0166613552797939,0.00356965840266991,2.22432683302381,7.51195460811584,7.49167184686274,7.57859796651888,0.0869261196561394,0.063164305203161,ENSG00000058673,ZC3H11A,protein_coding,1,1,203795654,203854999,q32.1,zinc finger CCCH-type containing 11A [Source:HGNC Symbol;Acc:HGNC:29093],NA,ZC3H11A,9877,NM_001319238;NM_001319239;NM_001350261;NM_001350262;NM_001350263;NM_001350264;NM_001350265;NM_001350266;NM_014827
TP53_TF,TP53,TP53_TF,TP53,TF,487,3.15882223273694,0.330904792298775,0.320751758003004,0.36426476212774,0.0435130041247367,0.00357118628950989,2.65857358360376,5.78067325259004,5.70391432063822,6.0328811718603,0.328966851222082,0.024612964097939,ENSG00000141510,TP53,protein_coding,17,-1,7661779,7687550,p13.1,tumor protein p53 [Source:HGNC Symbol;Acc:HGNC:11998],Adrenocortical carcinoma;ADRENOCORTICAL CARCINOMA HEREDITARY;Adult hepatocellular carcinoma;B-cell chronic lymphocytic leukemia;BASAL CELL CARCINOMA SUSCEPTIBILITY TO 7;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;Choroid plexus carcinoma;Colorectal Cancer;Essential thrombocythemia;Familial pancreatic carcinoma;Giant cell glioblastoma;GLIOMA SUSCEPTIBILITY 1;Gliosarcoma;Hepatocellular Carcinoma;Hereditary breast and ovarian cancer syndrome;Li-Fraumeni syndrome;NASOPHARYNGEAL CARCINOMA;OSTEOGENIC SARCOMA;OSTEOSARCOMA;Pancreatic Cancer;PAPILLOMA OF CHOROID PLEXUS;Precursor B-cell acute lymphoblastic leukemia;Small cell lung cancer,TP53,7157,NM_000546;NM_001126112;NM_001126113;NM_001126114;NM_001126115;NM_001126116;NM_001126117;NM_001126118;NM_001276695;NM_001276696;NM_001276697;NM_001276698;NM_001276699;NM_001276760;NM_001276761
ZNF146_TF,ZNF146,ZNF146_TF,ZNF146,TF,249,3.15834196407289,0.314222655342032,0.303762618968788,0.348591346282689,0.0448287273139014,0.00357610244348775,2.68037223666522,6.14293408665566,6.0804303637307,6.34830346198052,0.267873098249812,0.0234624274395052,ENSG00000167635,ZNF146,protein_coding,19,1,36214602,36238774,q13.12,zinc finger protein 146 [Source:HGNC Symbol;Acc:HGNC:12931],NA,ZNF146,7705,NM_001099638;NM_001099639;NM_007145
METAP2_SIG,METAP2,METAP2_SIG,METAP2,SIG,32,3.15797132007368,0.244141529494382,0.237971220977392,0.26441540033592,0.0264441793585282,0.00357967850185301,1.99924132771191,6.42604985500115,6.40070084378391,6.50933946328635,0.108638619502432,0.0972043906799184,ENSG00000111142,METAP2,protein_coding,12,1,95473520,95515839,q22,methionyl aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:16672],NA,METAP2,10988,NM_001317182;NM_001317183;NM_001330246;NM_006838
P4HB_SIG,P4HB,P4HB_SIG,P4HB,SIG,109,-3.15639721320828,0.193658150087509,0.202220049128906,0.165526196094344,-0.0366938530345617,0.00359807714598773,-2.22983936519202,9.36247336928506,9.41128538309902,9.20209103818203,-0.209194344916989,0.0624125129870866,ENSG00000185624,P4HB,protein_coding,17,-1,81843161,81860624,q25.3,prolyl 4-hydroxylase subunit beta [Source:HGNC Symbol;Acc:HGNC:8548],COLE-CARPENTER SYNDROME;COLE-CARPENTER SYNDROME 1,P4HB,5034,NM_000918
ZNF862_TF,ZNF862,ZNF862_TF,ZNF862,TF,184,3.15593301321201,0.0422441800989041,0.037502543233219,0.0578238440861551,0.0203213008529362,0.00360282871355058,1.18821074091383,4.58638024735163,4.55943818990154,4.67490415040192,0.115465960500385,0.342242931278974,ENSG00000106479,ZNF862,protein_coding,7,1,149838375,149867479,q36.1,zinc finger protein 862 [Source:HGNC Symbol;Acc:HGNC:34519],NA,ZNF862,643641,NM_001099220
SLC22A15_SIG,SLC22A15,SLC22A15_SIG,SLC22A15,SIG,71,-3.15547612738681,0.0542844236618552,0.0625039653720086,0.0272773580427795,-0.0352266073292291,0.00360749564533874,-3.93513030418515,4.43818147140822,4.6254412500376,3.82289934162596,-0.802541908411639,0.000700971723502703,ENSG00000163393,SLC22A15,protein_coding,1,1,115976513,116070054,p13.1,solute carrier family 22 member 15 [Source:HGNC Symbol;Acc:HGNC:20301],NA,SLC22A15,55356,NM_018420
THOP1_SIG,THOP1,THOP1_SIG,THOP1,SIG,35,3.15385456785119,0.675123392091822,0.664558786534531,0.709835667494351,0.0452768809598205,0.0036248051891622,4.15110054458001,5.17790546835001,5.11426399195625,5.38701317650094,0.272749184544688,0.000340374538060445,ENSG00000172009,THOP1,protein_coding,19,1,2785503,2815807,p13.3,thimet oligopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:11793],NA,THOP1,7064,NM_003249
FGF7_SIG,FGF7,FGF7_SIG,FGF7,SIG,5,-3.15384420843033,-0.248416200244906,-0.23920247205022,-0.278689878598875,-0.0394874065486546,0.0036248051891622,-2.40771899743331,0.329541498388736,0.371345946797931,0.192184025044237,-0.179161921753694,0.0431639770826151,ENSG00000140285,FGF7,protein_coding,15,1,49423178,49488775,q21.2,fibroblast growth factor 7 [Source:HGNC Symbol;Acc:HGNC:3685],NA,FGF7,2252,NM_002009
NMRK1_SIG,NMRK1,NMRK1_SIG,NMRK1,SIG,12,-3.15384167057981,-0.0499319253946519,-0.045316405290599,-0.0650972057365398,-0.0197808004459407,0.0036248051891622,-3.28622979386167,3.56899757311194,3.62417808734321,3.38769016920918,-0.236487918134024,0.00499854813078405,ENSG00000106733,NMRK1,protein_coding,9,-1,75060573,75088217,q21.13,nicotinamide riboside kinase 1 [Source:HGNC Symbol;Acc:HGNC:26057],NA,NMRK1,54981,NM_001127603;NM_001330678;NM_001330679;NM_017881
BID_SIG,BID,BID_SIG,BID,SIG,10,-3.15351344897768,0.345226660302382,0.355357067834271,0.311941035554749,-0.0434160322795214,0.00362789883914268,-0.804278690140513,5.77714462484576,5.78906738934117,5.73796982721798,-0.0510975621231982,0.532715000973951,ENSG00000015475,BID,protein_coding,22,-1,17734138,17774770,q11.21,BH3 interacting domain death agonist [Source:HGNC Symbol;Acc:HGNC:1050],NA,BID,637,NM_001196;NM_001244567;NM_001244569;NM_001244570;NM_001244572;NM_197966;NM_197967
PSMC5_SIG,PSMC5,PSMC5_SIG,PSMC5,SIG,16,3.1516773593449,0.620814055746984,0.613194654303234,0.645849231919303,0.032654577616069,0.00364979633359549,2.49346391026612,6.70868891382991,6.68373972463774,6.79066482117561,0.10692509653787,0.03580320884707,ENSG00000087191,PSMC5,protein_coding,17,1,63827152,63832026,q23.3,proteasome 26S subunit, ATPase 5 [Source:HGNC Symbol;Acc:HGNC:9552],NA,PSMC5,5705,NM_001199163;NM_002805
BIRC3_SIG,BIRC3,BIRC3_SIG,BIRC3,SIG,28,-3.1507408258181,0.192783743426651,0.201609786379745,0.163783888009342,-0.0378258983704037,0.00366052548669243,-1.00324344283717,5.21198049880132,5.24064557219816,5.11779525764029,-0.122850314557866,0.42889795460221,ENSG00000023445,BIRC3,protein_coding,11,1,102317450,102339403,q22.2,baculoviral IAP repeat containing 3 [Source:HGNC Symbol;Acc:HGNC:591],MALT lymphoma,BIRC3,330,NM_001165;NM_182962
ZBTB33_TF,ZBTB33,ZBTB33_TF,ZBTB33,TF,94,3.14934300836492,0.112143569856278,0.10863969582988,0.123656298800158,0.0150166029702779,0.0036770839703822,1.60755643167336,5.98880092405866,5.9631113460171,6.07320953762377,0.110098191606672,0.188473109210807,ENSG00000177485,ZBTB33,protein_coding,X,1,120250752,120258398,q24,zinc finger and BTB domain containing 33 [Source:HGNC Symbol;Acc:HGNC:16682],NA,ZBTB33,10009,NM_001184742;NM_006777
N6AMT1_SIG,N6AMT1,N6AMT1_SIG,N6AMT1,SIG,75,3.14891690216605,0.0261729263754642,0.0109138977617242,0.0763097346777524,0.0653958369160282,0.00368145114463846,3.22631963311821,2.02126010589845,1.9374174117562,2.29674324379442,0.359325832038216,0.00590555857685847,ENSG00000156239,N6AMT1,protein_coding,21,-1,28872191,28885371,q21.3,N-6 adenine-specific DNA methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:16021],NA,N6AMT1,29104,NM_013240;NM_182749
IRF9_TF,IRF9,IRF9_TF,IRF9,TF,179,-3.14838887620903,0.0748088389508629,0.079938289434806,0.0579549302179067,-0.0219833592168994,0.00368710865326926,-1.71639283006851,3.6038973116076,3.64068274916373,3.48303087392317,-0.157651875240557,0.158923382602962,ENSG00000213928,IRF9,protein_coding,14,1,24161053,24166565,q12,interferon regulatory factor 9 [Source:HGNC Symbol;Acc:HGNC:6131],NA,IRF9,10379,NM_006084
KNOP1_SIG,KNOP1,KNOP1_SIG,KNOP1,SIG,24,3.14814541699356,0.348307353804518,0.333934636920576,0.395531994994612,0.061597358074036,0.00368918099593731,2.722499620951,3.56894973638709,3.49964744409929,3.79665726818986,0.297009824090575,0.0212282882498001,ENSG00000103550,KNOP1,protein_coding,16,-1,19701937,19718235,p12.3,lysine rich nucleolar protein 1 [Source:HGNC Symbol;Acc:HGNC:34404],NA,KNOP1,400506,NM_001012991;NM_001348527;NM_001348528;NM_001348529;NM_001348530;NM_001348531;NM_001348532;NM_001348533;NM_001348534;NM_001348535;NM_001348536;NM_001348537
FBXW7_TF,FBXW7,FBXW7_TF,FBXW7,TF,89,-3.14712972534167,0.107443463478348,0.113988151905543,0.0859394872175644,-0.0280486646879787,0.00370101772602104,-2.51769085316691,5.67726234835698,5.71126160361622,5.56555050964802,-0.1457110939682,0.0339713538124931,ENSG00000109670,FBXW7,protein_coding,4,-1,152320544,152536092,q31.3,F-box and WD repeat domain containing 7 [Source:HGNC Symbol;Acc:HGNC:16712],NA,FBXW7,55294,NM_001013415;NM_001257069;NM_001349798;NM_018315;NM_033632
H2AFZ_SIG,H2AFZ,H2AFZ_SIG,H2AFZ,SIG,36,-3.14689486431826,0.162294884322169,0.171634556896819,0.131607388719749,-0.0400271681770697,0.00370298848038219,-2.66271694048027,6.26513841936203,6.3100998118945,6.11740812961247,-0.192691682282035,0.0243956640126828,ENSG00000164032,H2AFZ,protein_coding,4,-1,99948086,99950355,q23,H2A histone family member Z [Source:HGNC Symbol;Acc:HGNC:4741],NA,H2AFZ,3015,NM_002106
FGFR4_SIG,FGFR4,FGFR4_SIG,FGFR4,SIG,26,3.14248517235338,-0.138554548853459,-0.142647679648287,-0.125105690527597,0.01754198912069,0.00375820427237708,2.26269551070331,0.698681856112408,0.67229457765748,0.785382913892885,0.113088336235405,0.058361823093074,ENSG00000160867,FGFR4,protein_coding,5,1,177086905,177098144,q35.2,fibroblast growth factor receptor 4 [Source:HGNC Symbol;Acc:HGNC:3691],NA,FGFR4,2264,NM_001291980;NM_001354984;NM_002011;NM_022963;NM_213647
HELB_SIG,HELB,HELB_SIG,HELB,SIG,8,3.14199285328869,0.13672676286991,0.133577443592155,0.147074526211108,0.0134970826189536,0.00376351018085562,2.15777049935146,3.920639552768,3.88475439892736,4.03854791538726,0.153793516459898,0.0720761330889653,ENSG00000127311,HELB,protein_coding,12,1,66302545,66347645,q14.3,DNA helicase B [Source:HGNC Symbol;Acc:HGNC:17196],NA,HELB,92797,NM_033647
RPL22_SIG,RPL22,RPL22_SIG,RPL22,SIG,19,3.14102317594153,0.500800637217285,0.490311375337461,0.535265354822421,0.04495397948496,0.00377497132516486,3.40591428347097,7.75104793284837,7.68955970326286,7.95308068720076,0.263520983937893,0.00354185800741006,ENSG00000116251,RPL22,protein_coding,1,-1,6185020,6209389,p36.31,ribosomal protein L22 [Source:HGNC Symbol;Acc:HGNC:10315],NA,RPL22,6146,NM_000983
IPO5_SIG,IPO5,IPO5_SIG,IPO5,SIG,44,3.14011224128278,0.641352371479538,0.633118156863678,0.668407648074509,0.0352894912108313,0.00378570512506507,2.53279396808913,7.29028670796103,7.25175028322491,7.41690638923686,0.165156106011949,0.0328901171865968,ENSG00000065150,IPO5,protein_coding,13,1,97953658,98024297,q32.2,importin 5 [Source:HGNC Symbol;Acc:HGNC:6402],NA,IPO5,3843,NM_002271
MRPS14_SIG,MRPS14,MRPS14_SIG,MRPS14,SIG,77,3.13804234893824,0.265643688046811,0.250567163266504,0.315180840896393,0.0646136776298884,0.00381151014605981,2.78236331944851,3.84434850350052,3.78471368100133,4.04029149171214,0.255577810710812,0.018437901775984,ENSG00000120333,MRPS14,protein_coding,1,-1,175010789,175023425,q25.1,mitochondrial ribosomal protein S14 [Source:HGNC Symbol;Acc:HGNC:14049],NA,MRPS14,63931,NM_022100
LARP1_SIG,LARP1,LARP1_SIG,LARP1,SIG,22,3.13724808090712,0.555361805570733,0.542720601726629,0.596897189629935,0.0541765879033061,0.00382081795967763,2.0238646742545,7.98677826822202,7.95387545374449,8.09488751579107,0.141012062046581,0.0929571381317132,ENSG00000155506,LARP1,protein_coding,5,1,154712843,154817605,q33.2,La ribonucleoprotein domain family member 1 [Source:HGNC Symbol;Acc:HGNC:29531],NA,LARP1,23367,NM_001367713;NM_001367714;NM_001367719;NM_015315
EDA2R_SIG,EDA2R,EDA2R_SIG,EDA2R,SIG,9,3.13709577020253,0.201786839731557,0.19445611060559,0.225873521145449,0.0314174105398586,0.00382176997257243,3.61457652283083,1.67213679199296,1.54894282406028,2.07691697234321,0.527974148282928,0.00190973061399909,ENSG00000131080,EDA2R,protein_coding,X,-1,66595637,66639298,q12,ectodysplasin A2 receptor [Source:HGNC Symbol;Acc:HGNC:17756],X-linked hypohidrotic ectodermal dysplasia,EDA2R,60401,NM_001199687;NM_001242310;NM_001324199;NM_001324201;NM_001324204;NM_001324205;NM_001324206;NM_021783
SLC6A8_SIG,SLC6A8,SLC6A8_SIG,SLC6A8,SIG,28,-3.13644176018511,-0.0835162932268166,-0.0678028329119893,-0.135146234261249,-0.0673434013492602,0.00382926874063789,-3.53791480486032,2.09185312514478,2.23477626277728,1.62224853006656,-0.612527732710727,0.00241230115671869,ENSG00000130821,SLC6A8,protein_coding,X,1,153687926,153696588,q28,solute carrier family 6 member 8 [Source:HGNC Symbol;Acc:HGNC:11055],CEREBRAL CREATINE DEFICIENCY SYNDROME 1;X-LINKED CREATINE DEFICIENCY SYNDROME;X-linked creatine transporter deficiency,SLC6A8,6535,NM_001142805;NM_001142806;NM_005629
APCDD1_SIG,APCDD1,APCDD1_SIG,APCDD1,SIG,4,-3.13596440036273,-0.035080417824055,-0.0159238166114508,-0.0980235360940404,-0.0820997194825896,0.0038344707004734,-2.64832931007757,1.07132417017773,1.15242922333509,0.804836138374993,-0.347593084960098,0.0251401824318542,ENSG00000154856,APCDD1,protein_coding,18,1,10454635,10489949,p11.22,APC down-regulated 1 [Source:HGNC Symbol;Acc:HGNC:15718],HYPOTRICHOSIS 1;Hypotrichosis simplex,APCDD1,147495,NM_153000
TMEM222_SIG,TMEM222,TMEM222_SIG,TMEM222,SIG,20,3.1352872681473,0.279671824356422,0.276717028280877,0.289380440033213,0.0126634117523361,0.00384229515926489,1.92181137335453,4.92822761271298,4.91071950209019,4.98575426190214,0.0750347598119471,0.111990468258497,ENSG00000186501,TMEM222,protein_coding,1,1,27322145,27336400,p36.11,transmembrane protein 222 [Source:HGNC Symbol;Acc:HGNC:25363],NA,TMEM222,84065,NM_032125
ZNF282_TF,ZNF282,ZNF282_TF,ZNF282,TF,43,3.13465096019121,0.261921763722947,0.255834348986457,0.281923269285701,0.0260889202992448,0.0038495985091643,2.13464620042831,5.07822621309861,5.04855877649339,5.17570493337291,0.127146156879523,0.0753419274513653,ENSG00000170265,ZNF282,protein_coding,7,1,149195546,149226238,q36.1,zinc finger protein 282 [Source:HGNC Symbol;Acc:HGNC:13076],NA,ZNF282,8427,NM_001303481;NM_003575
ZNF547_TF,ZNF547,ZNF547_TF,ZNF547,TF,11,3.13400752675308,-0.0436835805507762,-0.05423978040063,-0.00899892390125645,0.0452408564993734,0.00385700822372397,1.70299289887992,0.996664866096949,0.974172388635379,1.07056872061354,0.0963963319781569,0.162371303409078,ENSG00000152433,ZNF547,protein_coding,19,1,57363477,57379565,q13.43,zinc finger protein 547 [Source:HGNC Symbol;Acc:HGNC:26432],NA,ZNF547,284306,NM_173631
PDGFB_SIG,PDGFB,PDGFB_SIG,PDGFB,SIG,24,-3.13383586742083,-0.178944593984497,-0.168359776855828,-0.213723278835836,-0.0453635019800077,0.0038582235523423,-3.76443917131516,0.678349576655875,0.760808072393401,0.407414519232576,-0.353393553160826,0.00120063851117915,ENSG00000100311,PDGFB,protein_coding,22,-1,39223359,39244751,q13.1,platelet derived growth factor subunit B [Source:HGNC Symbol;Acc:HGNC:8800],BASAL GANGLIA CALCIFICATION IDIOPATHIC 1;BASAL GANGLIA CALCIFICATION IDIOPATHIC 5;Bilateral striopallidodentate calcinosis;DERMATOFIBROSARCOMA PROTUBERANS;Familial multiple meningioma;MENINGIOMA FAMILIAL SUSCEPTIBILITY TO,PDGFB,5155,NM_002608;NM_033016
ESR1_SIG,ESR1,ESR1_SIG,ESR1,SIG,71,-3.13355069647517,-0.0172535696445125,-0.0116405878251182,-0.0356962241939509,-0.0240556363688325,0.00386093254636558,0.396637232193743,0.784085293651162,0.776646265583191,0.808527814445922,0.0318815488627307,0.770368644867513,ENSG00000091831,ESR1,protein_coding,6,1,151656691,152129619,q25.1,estrogen receptor 1 [Source:HGNC Symbol;Acc:HGNC:3467],Breast Cancer;ESTROGEN RESISTANCE;Estrogen resistance syndrome;MIGRAINE WITH OR WITHOUT AURA SUSCEPTIBILITY TO 1;MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,ESR1,2099,NM_000125;NM_001122740;NM_001122741;NM_001122742;NM_001291230;NM_001291241;NM_001328100
DNAJC6_SIG,DNAJC6,DNAJC6_SIG,DNAJC6,SIG,110,3.13340138153722,-0.0418017094205751,-0.0496980901502131,-0.0158564584517643,0.0338416316984487,0.00386185535717521,2.5793487494694,2.67840292494465,2.57210175235761,3.02767820630208,0.455576453944477,0.0295575504620028,ENSG00000116675,DNAJC6,protein_coding,1,1,65248219,65415871,p31.3,DnaJ heat shock protein family (Hsp40) member C6 [Source:HGNC Symbol;Acc:HGNC:15469],Atypical juvenile parkinsonism;PARKINSON DISEASE 19A JUVENILE-ONSET;Young-onset Parkinson disease,DNAJC6,9829,NM_001256864;NM_001256865;NM_014787
HIVEP3_TF,HIVEP3,HIVEP3_TF,HIVEP3,TF,250,3.13327691295153,0.0771254660115593,0.0735120553157825,0.0889981011548258,0.0154860458390432,0.0038624515907149,2.11349464496176,5.15075015502593,5.08970850488816,5.35131557690718,0.261607072019018,0.078325862273571,ENSG00000127124,HIVEP3,protein_coding,1,-1,41506365,42035925,p34.2,human immunodeficiency virus type I enhancer binding protein 3 [Source:HGNC Symbol;Acc:HGNC:13561],NA,HIVEP3,59269,NM_001127714;NM_024503
NOC2L_SIG,NOC2L,NOC2L_SIG,NOC2L,SIG,23,3.13199019799626,0.534469960199772,0.524316595152579,0.567831016783405,0.0435144216308266,0.00387837339288626,2.12535980235572,6.24578691059722,6.21818315755185,6.3364849563177,0.11830179876585,0.0766332114265476,ENSG00000188976,NOC2L,protein_coding,1,-1,944203,959309,p36.33,NOC2 like nucleolar associated transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:24517],NA,NOC2L,26155,NM_015658
EGR2_SIG,EGR2,EGR2_SIG,EGR2,SIG,20,-3.13161973581631,0.353794724777344,0.365103632817281,0.316636884074693,-0.0484667487425886,0.00388222329990476,-2.4992962600262,2.62922803531639,2.73352456256837,2.28653944577417,-0.4469851167942,0.0353550827869845,ENSG00000122877,EGR2,protein_coding,10,-1,62811996,62919900,q21.3,early growth response 2 [Source:HGNC Symbol;Acc:HGNC:3239],CHARCOT-MARIE-TOOTH DISEASE DEMYELINATING TYPE 1D;Charcot-Marie-Tooth disease type 1D;Charcot-Marie-Tooth disease type 4E;Dejerine-Sottas syndrome;HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS;Neuropathy congenital hypomyelinating 1;NEUROPATHY CONGENITAL HYPOMYELINATING 1 AUTOSOMAL RECESSIVE,EGR2,1959,NM_000399;NM_001136177;NM_001136178;NM_001136179;NM_001321037
ZFPM2_TF,ZFPM2,ZFPM2_TF,ZFPM2,TF,185,-3.12952979748833,-0.0894288723459854,-0.0848836641909566,-0.104363127712509,-0.0194794635215521,0.00390889278095699,-1.97384350794182,0.352870712893918,0.393094090491257,0.220708186502659,-0.172385903988599,0.101900135351788,ENSG00000169946,ZFPM2,protein_coding,8,1,104590733,105804539,q22.3,zinc finger protein, FOG family member 2 [Source:HGNC Symbol;Acc:HGNC:16700],46XY GONADAL DYSGENESIS;46XY partial gonadal dysgenesis;46XY sex reversal 9;Congenital diaphragmatic hernia;DIAPHRAGMATIC HERNIA 3;Tetralogy of Fallot,ZFPM2,23414,NM_012082
OLA1_SIG,OLA1,OLA1_SIG,OLA1,SIG,56,3.1291284546635,0.563513831253973,0.55620309465192,0.587534822946435,0.0313317282945154,0.00391318147176001,3.50295804814969,6.414166937717,6.36419131715422,6.57837254813757,0.214181230983355,0.00268398579701549,ENSG00000138430,OLA1,protein_coding,2,-1,174072447,174248599,q31.1,Obg like ATPase 1 [Source:HGNC Symbol;Acc:HGNC:28833],NA,OLA1,29789,NM_001011708;NM_001328688;NM_013341
MATK_SIG,MATK,MATK_SIG,MATK,SIG,19,3.1285704993753,0.346676399325055,0.339132331448168,0.371464050920541,0.0323317194723731,0.00391956289982655,2.09732818614108,4.83326337613741,4.77666139403216,5.01924131734039,0.242579923308226,0.080758942055491,ENSG00000007264,MATK,protein_coding,19,-1,3777970,3802129,p13.3,megakaryocyte-associated tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6906],NA,MATK,4145,NM_002378;NM_139354;NM_139355
BACH2_TF,BACH2,BACH2_TF,BACH2,TF,112,-3.1281401711921,-0.0402575257715398,-0.0339605781159956,-0.0609474966397564,-0.026986918523761,0.00392424945354597,-1.63258643798372,2.97114719610504,3.02736836872095,2.78642048608131,-0.240947882639641,0.181423993505892,ENSG00000112182,BACH2,protein_coding,6,-1,89926528,90296908,q15,BTB domain and CNC homolog 2 [Source:HGNC Symbol;Acc:HGNC:14078],NA,BACH2,60468,NM_001170794;NM_021813
ATP13A2_SIG,ATP13A2,ATP13A2_SIG,ATP13A2,SIG,29,3.12773963278661,0.218285227406586,0.213919908243338,0.232628418942975,0.0187085106996372,0.00392854305179459,1.70438975069785,5.64290926527816,5.60818760189932,5.75699473066579,0.148807128766475,0.162046292908225,ENSG00000159363,ATP13A2,protein_coding,1,-1,16985958,17011928,p36.13,ATPase cation transporting 13A2 [Source:HGNC Symbol;Acc:HGNC:30213],ATP13A2-related juvenile neuronal ceroid lipofuscinosis;Autosomal recessive spastic paraplegia type 78;KUFOR-RAKEB SYNDROME;Parkinson disease 9;SPASTIC PARAPLEGIA 78 AUTOSOMAL RECESSIVE,ATP13A2,23400,NM_001141973;NM_001141974;NM_022089
CLIC1_SIG,CLIC1,CLIC1_SIG,CLIC1,SIG,56,3.12725358089994,0.230095111128037,0.226147487063283,0.243065875912228,0.016918388848945,0.00393398522625045,-0.99516400023275,8.84083484507657,8.85218898756297,8.80352837690697,-0.0486606106560022,0.432874505587043,ENSG00000213719,CLIC1,protein_coding,6,-1,31730581,31739763,p21.33,chloride intracellular channel 1 [Source:HGNC Symbol;Acc:HGNC:2062],NA,CLIC1,1192,NM_001287593;NM_001287594;NM_001288
SOX6_TF,SOX6,SOX6_TF,SOX6,TF,293,-3.1270996616953,-0.115590248691166,-0.106573616899338,-0.1452163245786,-0.0386427076792616,0.00393498652732635,-2.07521139708802,0.931334997811261,0.993448717655954,0.727247061178697,-0.266201656477257,0.0842022577163557,ENSG00000110693,SOX6,protein_coding,11,-1,15966449,16739591,p15.2,SRY-box 6 [Source:HGNC Symbol;Acc:HGNC:16421],NA,SOX6,55553,NM_001145811;NM_001145819;NM_017508;NM_033326
SLC35F3_SIG,SLC35F3,SLC35F3_SIG,SLC35F3,SIG,13,3.12589831723077,-0.114133188026219,-0.118410756346908,-0.100078320686814,0.0183324356600948,0.00395003379086612,2.80651255602768,0.327610565435193,0.289280302949415,0.453552856459892,0.164272553510476,0.0174344344338164,ENSG00000183780,SLC35F3,protein_coding,1,1,233904676,234324511,q42.2,solute carrier family 35 member F3 [Source:HGNC Symbol;Acc:HGNC:23616],NA,SLC35F3,148641,NM_001300845;NM_173508
HCAR3_SIG,HCAR3,HCAR3_SIG,HCAR3,SIG,31,-3.12495812560771,0.317200003845791,0.330850334721272,0.272348916683493,-0.058501418037779,0.00396161504797234,-0.43374125513898,3.47413868032868,3.49184662069311,3.41595544770268,-0.0758911729904378,0.748181123171207,ENSG00000255398,HCAR3,protein_coding,12,-1,122714756,122716892,q24.31,hydroxycarboxylic acid receptor 3 [Source:HGNC Symbol;Acc:HGNC:16824],NA,HCAR3,8843,NM_006018
TRPM4_SIG,TRPM4,TRPM4_SIG,TRPM4,SIG,78,-3.12376047687383,-0.0811315406185626,-0.073177828483709,-0.10726516620451,-0.0340873377208012,0.00397670521978921,-2.41300126986371,1.87391077730517,1.98878905238992,1.49645358774101,-0.492335464648911,0.0426539528584886,ENSG00000130529,TRPM4,protein_coding,19,1,49157741,49211836,q13.33,transient receptor potential cation channel subfamily M member 4 [Source:HGNC Symbol;Acc:HGNC:17993],Brugada syndrome;Familial progressive cardiac conduction defect;PROGRESSIVE FAMILIAL HEART BLOCK TYPE IB,TRPM4,54795,NM_001195227;NM_001321281;NM_001321282;NM_001321283;NM_001321285;NM_017636
ZNF671_TF,ZNF671,ZNF671_TF,ZNF671,TF,18,3.12326802737879,0.0148055953952865,0.00445692768025192,0.048808360744686,0.0443514330644343,0.00398229493350868,2.72915624161406,3.88600975739261,3.83848721135309,4.04215526580819,0.2036680544551,0.0208982762238071,ENSG00000083814,ZNF671,protein_coding,19,-1,57719751,57727624,q13.43,zinc finger protein 671 [Source:HGNC Symbol;Acc:HGNC:26279],NA,ZNF671,79891,NM_001321375;NM_001321376;NM_024833
XPNPEP1_SIG,XPNPEP1,XPNPEP1_SIG,XPNPEP1,SIG,32,3.12186027402788,0.331713948681925,0.326314317864899,0.34945559279501,0.0231412749301113,0.00400031074526897,1.09156287260515,6.42861257076516,6.41597779513224,6.47012683355902,0.0541490384267772,0.386198879627429,ENSG00000108039,XPNPEP1,protein_coding,10,-1,109864766,109923553,q25.1,X-prolyl aminopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:12822],NA,XPNPEP1,7511,NM_001167604;NM_001324128;NM_001324131;NM_001324132;NM_001324133;NM_001324134;NM_001324135;NM_001324136;NM_020383
ALDH8A1_SIG,ALDH8A1,ALDH8A1_SIG,ALDH8A1,SIG,27,3.1214339393654,-0.126068932700931,-0.129301001503488,-0.115449278063959,0.0138517234395289,0.0040049654105514,1.92368631223108,0.780379867983499,0.755340210159805,0.862653029404206,0.107312819244401,0.111567615544018,ENSG00000118514,ALDH8A1,protein_coding,6,-1,134917393,134950115,q23.3,aldehyde dehydrogenase 8 family member A1 [Source:HGNC Symbol;Acc:HGNC:15471],NA,ALDH8A1,64577,NM_001193480;NM_022568;NM_170771
TUFM_SIG,TUFM,TUFM_SIG,TUFM,SIG,24,3.12135970779108,0.582509556557912,0.574691411854963,0.608197746296173,0.0335063344412098,0.0040049654105514,4.04429224094577,7.38319167765488,7.33429251136836,7.54386036688203,0.209567855513664,0.000491598959859975,ENSG00000178952,TUFM,protein_coding,16,-1,28842411,28846348,p11.2,Tu translation elongation factor, mitochondrial [Source:HGNC Symbol;Acc:HGNC:12420],Combined oxidative phosphorylation defect type 4;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4,TUFM,7284,NM_003321
ZNF787_TF,ZNF787,ZNF787_TF,ZNF787,TF,45,-3.12055203045574,0.0711123782148066,0.0739884646037254,0.0616623800797877,-0.0123260845239377,0.00401488665876273,-2.10616057863538,5.60423582516676,5.62616501037506,5.53218278805377,-0.0939822223212881,0.0794899412245978,ENSG00000142409,ZNF787,protein_coding,19,-1,56087366,56121295,q13.43,zinc finger protein 787 [Source:HGNC Symbol;Acc:HGNC:26998],NA,ZNF787,126208,NM_001002836;NM_001351682
ABCB10_SIG,ABCB10,ABCB10_SIG,ABCB10,SIG,30,-3.12014633459137,0.16654912624469,0.174724358439211,0.139687649034122,-0.0350367094050885,0.0040193415960088,-2.48302002304347,5.27698943151513,5.32659776292899,5.11399062829817,-0.212607134630825,0.036629672060225,ENSG00000135776,ABCB10,protein_coding,1,-1,229516582,229558707,q42.13,ATP binding cassette subfamily B member 10 [Source:HGNC Symbol;Acc:HGNC:41],NA,ABCB10,23456,NM_012089
NAA10_SIG,NAA10,NAA10_SIG,NAA10,SIG,2,3.11986985862946,0.0818786525763361,0.0743404868347866,0.106646911441427,0.0323064246066407,0.00402203645856983,3.06219121440013,3.99740291339511,3.96779174659628,4.0946967471627,0.126905000566411,0.009161612465477,ENSG00000102030,NAA10,protein_coding,X,-1,153929225,153935080,q28,N(alpha)-acetyltransferase 10, NatA catalytic subunit [Source:HGNC Symbol;Acc:HGNC:18704],Microphthalmia Lenz type;MICROPHTHALMIA SYNDROMIC 1;Nonpecific severe ID;OGDEN SYNDROME;X-linked anophthalmia syndrome;X-linked anophthalmia syndrome/Lenz,NAA10,8260,NM_001256119;NM_001256120;NM_003491
ZDHHC4_SIG,ZDHHC4,ZDHHC4_SIG,ZDHHC4,SIG,38,3.11953096766734,0.235921218487111,0.230944619331978,0.252272901425406,0.0213282820934282,0.0040255859180148,3.5256332678635,4.70566477219955,4.65854745736976,4.86047880664031,0.201931349270552,0.00250271930082153,ENSG00000136247,ZDHHC4,protein_coding,7,1,6577434,6589374,p22.1,zinc finger DHHC-type containing 4 [Source:HGNC Symbol;Acc:HGNC:18471],NA,ZDHHC4,55146,NM_001134387;NM_001134388;NM_001134389;NM_018106
SLC25A43_SIG,SLC25A43,SLC25A43_SIG,SLC25A43,SIG,20,3.11916404755005,0.341469416450204,0.333964027566275,0.366129979925973,0.0321659523596979,0.00402885873755576,2.229967112814,3.74192309703701,3.69347641964495,3.90110503703952,0.207628617394576,0.0623985796953739,ENSG00000077713,SLC25A43,protein_coding,X,1,119399336,119454478,q24,solute carrier family 25 member 43 [Source:HGNC Symbol;Acc:HGNC:30557],NA,SLC25A43,203427,NM_145305
ZNF681_TF,ZNF681,ZNF681_TF,ZNF681,TF,46,3.11913352520031,-0.0612152970094488,-0.0712352795554804,-0.0282924972153451,0.0429427823401352,0.00402885873755576,3.38764965436909,2.33831390689342,2.24608332649478,2.64135724248895,0.395273915994177,0.00375087867133451,ENSG00000196172,ZNF681,protein_coding,19,-1,23739195,23758891,p12,zinc finger protein 681 [Source:HGNC Symbol;Acc:HGNC:26457],NA,ZNF681,148213,NM_138286
EPX_SIG,EPX,EPX_SIG,EPX,SIG,24,-3.11875516055788,-0.0631403735962264,-0.0519863057440732,-0.0997894536818726,-0.0478031479377995,0.00403295437606688,-0.470071936440774,3.91233175535104,3.94627927121593,3.80078991750928,-0.145489353706647,0.727038675111833,ENSG00000121053,EPX,protein_coding,17,1,58192726,58205174,q22,eosinophil peroxidase [Source:HGNC Symbol;Acc:HGNC:3423],EOSINOPHIL PEROXIDASE DEFICIENCY,EPX,8288,NM_000502
TLR3_SIG,TLR3,TLR3_SIG,TLR3,SIG,28,3.11858804570377,-0.00189817410464316,-0.00753017044192481,0.0166069567178537,0.0241371271597785,0.00403416095210871,2.30521871058334,1.07683287601505,1.0270411893892,1.24043413207142,0.213392942682218,0.0533872667519139,ENSG00000164342,TLR3,protein_coding,4,1,186069152,186088069,q35.1,toll like receptor 3 [Source:HGNC Symbol;Acc:HGNC:11849],ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 2;Herpes simplex virus encephalitis;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,TLR3,7098,NM_003265
MYB_TF,MYB,MYB_TF,MYB,TF,176,3.11844515812614,0.0566564783659169,0.0481731008164275,0.0845304331713821,0.0363573323549547,0.00403503632918862,1.34171508058856,7.99172824462598,7.94931708534783,8.13107919653988,0.181762111192048,0.278470676286874,ENSG00000118513,MYB,protein_coding,6,1,135181308,135219173,q23.3,MYB proto-oncogene, transcription factor [Source:HGNC Symbol;Acc:HGNC:7545],Acute basophilic leukemia;Angiocentric glioma;Precursor T-cell acute lymphoblastic leukemia,MYB,4602,NM_001130172;NM_001130173;NM_001161656;NM_001161657;NM_001161658;NM_001161659;NM_001161660;NM_005375
MED1_SIG,MED1,MED1_SIG,MED1,SIG,36,3.11766383082704,0.556090493174487,0.55226943180494,0.568645409102998,0.0163759772980584,0.00404466420756994,1.88909350939323,6.78613028089697,6.76255255652884,6.86359994667797,0.101047390149133,0.118490181028883,ENSG00000125686,MED1,protein_coding,17,-1,39404285,39451272,q12,mediator complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:9234],NA,MED1,5469,NM_004774
ZNF559_TF,ZNF559,ZNF559_TF,ZNF559,TF,56,3.11593489057089,0.191644141895338,0.183716975846802,0.217690544626245,0.0339735687794429,0.0040673638785467,1.92006022271525,3.13689155749127,3.09263012201943,3.28232198832731,0.189691866307875,0.11228183395497,ENSG00000188321,ZNF559,protein_coding,19,1,9323772,9351162,p13.2,zinc finger protein 559 [Source:HGNC Symbol;Acc:HGNC:28197],NA,ZNF559,84527,NM_001202406;NM_001202407;NM_001202408;NM_001202409;NM_001202410;NM_001202411;NM_001202412;NM_032497
SLC19A2_SIG,SLC19A2,SLC19A2_SIG,SLC19A2,SIG,5,-3.11531654717282,-0.0341891296850683,-0.0291054122944469,-0.0508927725399673,-0.0217873602455203,0.0040748097289321,-2.75293510620099,3.04795892799755,3.10533336185478,2.85944293103806,-0.245890430816717,0.0197892531138495,ENSG00000117479,SLC19A2,protein_coding,1,-1,169463909,169485944,q24.2,solute carrier family 19 member 2 [Source:HGNC Symbol;Acc:HGNC:10938],THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME,SLC19A2,10560,NM_001319667;NM_006996
CASS4_SIG,CASS4,CASS4_SIG,CASS4,SIG,25,3.11518444006699,0.0914039237867183,0.0872324377302574,0.10511023511509,0.0178777973848323,0.00407554435550286,2.15947760339202,3.6835332401898,3.62060667092047,3.89029196778904,0.269685296868573,0.0718607367887219,ENSG00000087589,CASS4,protein_coding,20,1,56412112,56460387,q13.31,Cas scaffold protein family member 4 [Source:HGNC Symbol;Acc:HGNC:15878],NA,CASS4,57091,NM_001164114;NM_001164115;NM_001164116;NM_020356
CSTB_SIG,CSTB,CSTB_SIG,CSTB,SIG,13,-3.11457426519817,0.408113994866583,0.417748551967197,0.376457592964566,-0.041290959002631,0.00408289094355189,-2.24914298615858,5.66951377677273,5.72028170270837,5.50270487726989,-0.217576825438485,0.0600928002189621,ENSG00000160213,CSTB,protein_coding,21,-1,43772511,43776445,q22.3,cystatin B [Source:HGNC Symbol;Acc:HGNC:2482],MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG;Unverricht-Lundborg disease,CSTB,1476,NM_000100
SVOPL_SIG,SVOPL,SVOPL_SIG,SVOPL,SIG,94,3.11423433043033,0.0496106961939656,0.0380575039112509,0.0875711851228856,0.0495136812116346,0.00408650494846746,1.93171663790153,1.37309121718869,1.31612475221376,1.56026674496346,0.244141992749704,0.109912562597458,ENSG00000157703,SVOPL,protein_coding,7,-1,138594285,138701352,q34,SVOP like [Source:HGNC Symbol;Acc:HGNC:27034],NA,SVOPL,136306,NM_001139456;NM_001331192;NM_174959
BRD8_SIG,BRD8,BRD8_SIG,BRD8,SIG,29,3.11380371861619,0.153751024990641,0.143825731431688,0.186362703827201,0.0425369723955132,0.00409137915236775,3.05981218572967,5.47850444500506,5.41875622125652,5.67482003732166,0.256063816065136,0.00921786687771886,ENSG00000112983,BRD8,protein_coding,5,-1,138139766,138178986,q31.2,bromodomain containing 8 [Source:HGNC Symbol;Acc:HGNC:19874],NA,BRD8,10902,NM_001164326;NM_001300961;NM_001300962;NM_001300966;NM_006696;NM_139199
ENO2_SIG,ENO2,ENO2_SIG,ENO2,SIG,53,3.11370880026464,-0.0600114577839069,-0.0648566110885082,-0.0440916683545026,0.0207649427340056,0.00409160147150533,2.44941996030914,3.23257223921229,3.1609343123841,3.46795399879063,0.307019686406531,0.0394074598198498,ENSG00000111674,ENO2,protein_coding,12,1,6913745,6923698,p13.31,enolase 2 [Source:HGNC Symbol;Acc:HGNC:3353],NA,ENO2,2026,NM_001975
PTPN12_SIG,PTPN12,PTPN12_SIG,PTPN12,SIG,10,-3.11282229778951,0.280840460138183,0.288491108219122,0.25570261644367,-0.0327884917754529,0.00410281430522491,-2.30698043620434,7.03028171359428,7.06583546740757,6.91346223677918,-0.152373230628392,0.0531855884793661,ENSG00000127947,PTPN12,protein_coding,7,1,77537295,77640069,q11.23,protein tyrosine phosphatase, non-receptor type 12 [Source:HGNC Symbol;Acc:HGNC:9645],NA,PTPN12,5782,NM_001131008;NM_001131009;NM_002835
FOXP1_TF,FOXP1,FOXP1_TF,FOXP1,TF,93,3.11113016694769,0.0867372960197116,0.0816593117898318,0.10342210134646,0.0217627895566277,0.00412529619093252,2.0433152815363,7.03048227492252,7.00789623614746,7.10469354518343,0.0967973090359645,0.0896547045460494,ENSG00000114861,FOXP1,protein_coding,3,-1,70952817,71583993,p13,forkhead box P1 [Source:HGNC Symbol;Acc:HGNC:3823],Intellectual disability-severe speech delay-mild dysmorphism syndrome;MALT lymphoma;Mental retardation with language impairment and autistic features;MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES;Precursor B-cell acute lymphoblastic leukemia,FOXP1,27086,NM_001012505;NM_001244808;NM_001244810;NM_001244812;NM_001244813;NM_001244814;NM_001244815;NM_001244816;NM_001349337;NM_001349338;NM_001349340;NM_001349341;NM_001349342;NM_001349343;NM_001349344;NM_032682
TRIM3_SIG,TRIM3,TRIM3_SIG,TRIM3,SIG,68,3.1106944418392,0.0692608752693047,0.0650305394191786,0.0831605502054332,0.0181300107862547,0.0041295157583964,3.30050107826301,3.17400664487496,3.11703773792606,3.36119019627846,0.244152458352399,0.00480081109044065,ENSG00000110171,TRIM3,protein_coding,11,-1,6448613,6474459,p15.4,tripartite motif containing 3 [Source:HGNC Symbol;Acc:HGNC:10064],NA,TRIM3,10612,NM_001248006;NM_001248007;NM_006458;NM_033278
PHLPP2_SIG,PHLPP2,PHLPP2_SIG,PHLPP2,SIG,28,-3.11063035745636,0.113597602760362,0.118737166979948,0.0967104631817219,-0.0220267037982265,0.0041295157583964,-0.581133787178202,3.44971554552509,3.46133887157839,3.41152461706424,-0.049814254514147,0.662478760501618,ENSG00000040199,PHLPP2,protein_coding,16,-1,71637835,71724701,q22.2,PH domain and leucine rich repeat protein phosphatase 2 [Source:HGNC Symbol;Acc:HGNC:29149],NA,PHLPP2,23035,NM_001289003;NM_015020
HSPE1_SIG,HSPE1,HSPE1_SIG,HSPE1,SIG,14,3.11059167653735,0.128066486742605,0.124844949343246,0.138651538197642,0.013806588854396,0.0041295157583964,2.99281194042336,2.73065209872019,2.67674257934767,2.90778337665846,0.231040797310784,0.0109593819705768,ENSG00000115541,HSPE1,protein_coding,2,1,197500140,197503449,q33.1,heat shock protein family E (Hsp10) member 1 [Source:HGNC Symbol;Acc:HGNC:5269],NA,HSPE1,3336,NM_002157
PIP5K1A_SIG,PIP5K1A,PIP5K1A_SIG,PIP5K1A,SIG,33,3.10912482116148,0.462156304620031,0.456188880772076,0.48176355440617,0.0255746736340935,0.00414896586407873,2.00173303439405,6.02068542317273,5.98848621946461,6.12648280678513,0.137996587320525,0.0967667189531386,ENSG00000143398,PIP5K1A,protein_coding,1,1,151197949,151249536,q21.3,phosphatidylinositol-4-phosphate 5-kinase type 1 alpha [Source:HGNC Symbol;Acc:HGNC:8994],NA,PIP5K1A,8394,NM_001135636;NM_001135637;NM_001135638;NM_001330689;NM_003557
TRIM74_SIG,TRIM74,TRIM74_SIG,TRIM74,SIG,79,3.10904368800194,-0.0197798652002077,-0.0263836422662809,0.00191825944546104,0.0283019017117419,0.00414899807820435,0.686577833803261,1.08538948481465,1.07344890862714,1.1246228065736,0.0511738979464636,0.599845959538814,ENSG00000155428,TRIM74,protein_coding,7,-1,72959485,72969466,q11.23,tripartite motif containing 74 [Source:HGNC Symbol;Acc:HGNC:17453],NA,TRIM74,378108,NM_001317815;NM_198853
GTF2H3_TF,GTF2H3,GTF2H3_TF,GTF2H3,TF,586,3.10815555684552,0.36266926557624,0.355813509125498,0.385195322485818,0.0293818133603199,0.00416037715951479,2.29276686988642,4.63963857669591,4.60105313108541,4.76641932655898,0.165366195473574,0.0547722967508109,ENSG00000111358,GTF2H3,protein_coding,12,1,123633739,123662604,q24.31,general transcription factor IIH subunit 3 [Source:HGNC Symbol;Acc:HGNC:4657],NA,GTF2H3,2967,NM_001271866;NM_001271867;NM_001271868;NM_001516
IP6K2_SIG,IP6K2,IP6K2_SIG,IP6K2,SIG,71,3.10796179942172,0.303292484757626,0.293356362676328,0.335939743024746,0.0425833803484177,0.0041619955164916,3.93954893176266,6.0919198101171,6.02468739388371,6.31282632059822,0.288138926714508,0.000690992357503608,ENSG00000068745,IP6K2,protein_coding,3,-1,48688003,48740353,p21.31,inositol hexakisphosphate kinase 2 [Source:HGNC Symbol;Acc:HGNC:17313],NA,IP6K2,51447,NM_001005909;NM_001005910;NM_001005911;NM_001146178;NM_001146179;NM_001190316;NM_001190317;NM_016291
INSL3_SIG,INSL3,INSL3_SIG,INSL3,SIG,22,-3.10779397790252,-0.0101517314461608,-0.00439176175966943,-0.0290773461303466,-0.0246855843706771,0.00416324929992317,-4.08269944822511,1.23879430454255,1.31460821696801,0.989691449430307,-0.324916767537705,0.000429308391285349,ENSG00000248099,INSL3,protein_coding,19,-1,17816512,17821574,p13.11,insulin like 3 [Source:HGNC Symbol;Acc:HGNC:6086],Cryptorchidism unilateral or bilateral,INSL3,3640,NM_001265587;NM_005543
ZFAND3_TF,ZFAND3,ZFAND3_TF,ZFAND3,TF,118,-3.10681413940858,0.0269629612070888,0.0316355977007328,0.0116100127279726,-0.0200255849727604,0.00417595925373784,-2.33253615683742,6.74688975057393,6.77438671147902,6.65654259331432,-0.117844118164703,0.0505924497118223,ENSG00000156639,ZFAND3,protein_coding,6,1,37819727,38154624,p21.2,zinc finger AN1-type containing 3 [Source:HGNC Symbol;Acc:HGNC:18019],NA,ZFAND3,60685,NM_021943
DUSP6_SIG,DUSP6,DUSP6_SIG,DUSP6,SIG,14,-3.1057598636166,0.233079206336736,0.238931228094345,0.213851134847448,-0.025080093246897,0.00418975905894458,-1.72315934911832,7.60498479794265,7.66101328271493,7.42089120511944,-0.240122077595489,0.157103551184595,ENSG00000139318,DUSP6,protein_coding,12,-1,89347235,89352501,q21.33,dual specificity phosphatase 6 [Source:HGNC Symbol;Acc:HGNC:3072],Hypogonadotropic hypogonadism 19 with or without anosmia;Hypogonadotropic hypogonadism 7 with or without anosmia;Kallmann Syndrome;Normosmic congenital hypogonadotropic hypogonadism,DUSP6,1848,NM_001946;NM_022652
MRPL39_SIG,MRPL39,MRPL39_SIG,MRPL39,SIG,10,3.10493688591614,0.409310956559629,0.403075432223735,0.429799107948995,0.0267236757252596,0.00420031469594149,4.80669828521201,3.63413237266154,3.57030101750156,3.8438639681872,0.273562950685638,3.10379489767009e-05,ENSG00000154719,MRPL39,protein_coding,21,-1,25585656,25607517,q21.3,mitochondrial ribosomal protein L39 [Source:HGNC Symbol;Acc:HGNC:14027],NA,MRPL39,54148,NM_017446;NM_080794
EIF3M_SIG,EIF3M,EIF3M_SIG,EIF3M,SIG,23,3.10364225529029,0.898907423933816,0.889798208207727,0.928837704176681,0.0390394959689541,0.00421761250122401,3.17297294281401,7.4611558951866,7.42337744387561,7.58528509235128,0.161907648475665,0.00682172386795731,ENSG00000149100,EIF3M,protein_coding,11,1,32583798,32606264,p13,eukaryotic translation initiation factor 3 subunit M [Source:HGNC Symbol;Acc:HGNC:24460],NA,EIF3M,10480,NM_001307929;NM_006360
SLC2A6_SIG,SLC2A6,SLC2A6_SIG,SLC2A6,SIG,16,-3.10305053789747,0.227641057068194,0.240732785072466,0.184625379339871,-0.0561074057325957,0.00422492933339572,-1.3649021894873,3.26052937166849,3.31123355307622,3.09392991847165,-0.217303634604565,0.269870704718978,ENSG00000160326,SLC2A6,protein_coding,9,-1,133471094,133479127,q34.2,solute carrier family 2 member 6 [Source:HGNC Symbol;Acc:HGNC:11011],NA,SLC2A6,11182,NM_001145099;NM_017585
SLC25A25_SIG,SLC25A25,SLC25A25_SIG,SLC25A25,SIG,13,-3.10236722876678,0.215315043172592,0.223019405097499,0.190000711133611,-0.0330186939638883,0.00423335010601247,-0.124041670826882,4.08734026335131,4.08936604409276,4.08068412662938,-0.00868191746338536,0.930706916457142,ENSG00000148339,SLC25A25,protein_coding,9,1,128068201,128109245,q34.11,solute carrier family 25 member 25 [Source:HGNC Symbol;Acc:HGNC:20663],NA,SLC25A25,114789,NM_001006641;NM_001006642;NM_001265614;NM_001330988;NM_052901
ATP11A_SIG,ATP11A,ATP11A_SIG,ATP11A,SIG,17,-3.10230365995382,0.197192298004882,0.207665239570251,0.162781204290101,-0.0448840352801493,0.00423335010601247,-1.54671636621188,6.81585007950553,6.84589078174266,6.71714491501209,-0.128745866730572,0.206866737930836,ENSG00000068650,ATP11A,protein_coding,13,1,112690329,112887168,q34,ATPase phospholipid transporting 11A [Source:HGNC Symbol;Acc:HGNC:13552],Idiopathic pulmonary fibrosis,ATP11A,23250,NM_015205;NM_032189
TBL3_SIG,TBL3,TBL3_SIG,TBL3,SIG,25,3.10119452284388,0.582892310920601,0.5709250235388,0.62221339803223,0.0512883744934294,0.00424810957329385,3.17513740205523,4.77930562402742,4.74022922307558,4.90769951286917,0.167470289793593,0.00679554191129495,ENSG00000183751,TBL3,protein_coding,16,1,1972037,1982933,p13.3,transducin beta like 3 [Source:HGNC Symbol;Acc:HGNC:11587],NA,TBL3,10607,NM_006453
NUP43_SIG,NUP43,NUP43_SIG,NUP43,SIG,26,3.10077004890071,0.290517158893919,0.278667998634256,0.329450114032809,0.0507821153985529,0.00425307215305279,2.93102794672426,4.31222126552493,4.25340477091661,4.50547546209514,0.252070691178524,0.0128502774724358,ENSG00000120253,NUP43,protein_coding,6,-1,149724315,149749665,q25.1,nucleoporin 43 [Source:HGNC Symbol;Acc:HGNC:21182],NA,NUP43,348995,NM_198887
MAPKAPK2_SIG,MAPKAPK2,MAPKAPK2_SIG,MAPKAPK2,SIG,21,-3.10036216740307,0.215929346846908,0.226816397547261,0.180157608831464,-0.0466587887157963,0.00425780156644383,-4.51549716812949,7.71581300762052,7.79115001100444,7.4682771393591,-0.322872871645333,9.33102549856471e-05,ENSG00000162889,MAPKAPK2,protein_coding,1,1,206684944,206734283,q32.1,mitogen-activated protein kinase-activated protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:6887],NA,MAPKAPK2,9261,NM_004759;NM_032960
SRGAP2_SIG,SRGAP2,SRGAP2_SIG,SRGAP2,SIG,38,-3.09940893191804,0.21366834362809,0.227232736332471,0.169099624742267,-0.0581331115902039,0.00426921780328845,-2.11759216320919,5.64426097958215,5.69398778272316,5.48087291211882,-0.213114870604341,0.0777435713022408,ENSG00000266028,SRGAP2,protein_coding,1,1,206203345,206464443,q32.1,SLIT-ROBO Rho GTPase activating protein 2 [Source:HGNC Symbol;Acc:HGNC:19751],NA,SRGAP2,23380,NM_001170637;NM_001300952;NM_015326
PDE4B_SIG,PDE4B,PDE4B_SIG,PDE4B,SIG,22,-3.09931691298208,0.218949080023964,0.231794984857563,0.176741106999285,-0.0550538778582777,0.00426921780328845,-4.87538835932598,5.61643234542237,5.81842490142792,4.95274251854702,-0.865682382880904,2.36864837079498e-05,ENSG00000184588,PDE4B,protein_coding,1,1,65792514,66374579,p31.3,phosphodiesterase 4B [Source:HGNC Symbol;Acc:HGNC:8781],NA,PDE4B,5142,NM_001037339;NM_001037340;NM_001037341;NM_001297440;NM_001297441;NM_001297442;NM_002600
OGFOD1_SIG,OGFOD1,OGFOD1_SIG,OGFOD1,SIG,46,3.09929736574914,0.465704371714302,0.454772268272293,0.501624140166619,0.046851871894326,0.00426921780328845,3.18285117722593,4.85208767577478,4.79340038318148,5.04491735143847,0.251516968256992,0.00665410177477672,ENSG00000087263,OGFOD1,protein_coding,16,1,56451490,56479100,q13,2-oxoglutarate and iron dependent oxygenase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25585],NA,OGFOD1,55239,NM_001324357;NM_001324358;NM_001324359;NM_001324360;NM_001324361;NM_001324362;NM_001324363;NM_018233
C11orf54_SIG,C11orf54,C11orf54_SIG,C11orf54,SIG,106,3.0992541623496,0.143339683391612,0.131084983231246,0.183605126775672,0.0525201435444261,0.00426921780328845,2.16551935859545,4.46395563214616,4.41644817274174,4.62005157018923,0.203603397447487,0.0709226136760938,ENSG00000182919,C11orf54,protein_coding,11,1,93741591,93764749,q21,chromosome 11 open reading frame 54 [Source:HGNC Symbol;Acc:HGNC:30204],NA,C11orf54,28970,NM_001286067;NM_001286068;NM_001286069;NM_001286070;NM_001286071;NM_001351985;NM_001351986;NM_001351987;NM_001351988;NM_001351989;NM_001351990;NM_001351991;NM_001351992;NM_001351993;NM_014039
SOX7_TF,SOX7,SOX7_TF,SOX7,TF,60,-3.09859958442233,-0.106800512977582,-0.10361061619536,-0.117281602404882,-0.0136709862095213,0.00427752420842592,-0.731226540442336,0.31626269431367,0.32204107455457,0.297276587807854,-0.0247644867467156,0.573815799114438,ENSG00000171056,SOX7,protein_coding,8,-1,10723768,10730511,p23.1,SRY-box 7 [Source:HGNC Symbol;Acc:HGNC:18196],NA,SOX7,83595,NM_031439
TADA3_TF,TADA3,TADA3_TF,TADA3,TF,130,-3.09808710762272,0.236761801186237,0.2423018910412,0.218558648805642,-0.0237432422355582,0.00428379080090168,-4.42693854458602,6.28275922519512,6.3449724216754,6.0783444367599,-0.266627984915506,0.000129233824734628,ENSG00000171148,TADA3,protein_coding,3,-1,9779860,9793011,p25.3,transcriptional adaptor 3 [Source:HGNC Symbol;Acc:HGNC:19422],NA,TADA3,10474,NM_001278270;NM_006354;NM_133480
DUSP19_SIG,DUSP19,DUSP19_SIG,DUSP19,SIG,32,3.09729989724826,-0.196483726196202,-0.207052537295542,-0.161757632584086,0.0452949047114556,0.00429404412324545,0.90131301065131,1.45469690446434,1.43425595283825,1.52186003123576,0.0876040783975144,0.481262652285766,ENSG00000162999,DUSP19,protein_coding,2,1,183078559,183100005,q32.1,dual specificity phosphatase 19 [Source:HGNC Symbol;Acc:HGNC:18894],NA,DUSP19,142679,NM_001142314;NM_001321519;NM_080876
ZNF736_TF,ZNF736,ZNF736_TF,ZNF736,TF,141,3.0970064441751,0.286096105725924,0.280075700963381,0.305877435659993,0.0258017346966124,0.00429715679608867,3.09396293592164,5.14003000595143,5.07641970048787,5.34903529533173,0.272615594843868,0.00842270175750968,ENSG00000234444,ZNF736,protein_coding,7,1,64307459,64356634,q11.21,zinc finger protein 736 [Source:HGNC Symbol;Acc:HGNC:32467],NA,ZNF736,728927,NM_001170905;NM_001294255
TRMT10B_SIG,TRMT10B,TRMT10B_SIG,TRMT10B,SIG,77,3.09673669769625,0.121164888123772,0.108864146699558,0.161581609946193,0.0527174632466349,0.00429992782205134,3.22834310131909,3.47947501943412,3.42286918490811,3.66546561859101,0.242596433682905,0.00586635930278571,ENSG00000165275,TRMT10B,protein_coding,9,1,37753803,37778972,p13.2,tRNA methyltransferase 10B [Source:HGNC Symbol;Acc:HGNC:26454],NA,TRMT10B,158234,NM_001286950;NM_001286951;NM_001286952;NM_001286953;NM_001286954;NM_144964
PIAS2_SIG,PIAS2,PIAS2_SIG,PIAS2,SIG,28,3.09570731033368,0.232042489076331,0.226080524194862,0.251631802258303,0.0255512780634418,0.00431373797752088,1.40787946849331,4.67321072343665,4.65381664329565,4.73693412961421,0.0831174863185593,0.253620665728354,ENSG00000078043,PIAS2,protein_coding,18,-1,46803218,46920160,q21.1,protein inhibitor of activated STAT 2 [Source:HGNC Symbol;Acc:HGNC:17311],NA,PIAS2,9063,NM_001324046;NM_001324047;NM_001324048;NM_001324049;NM_001324051;NM_001324052;NM_001324053;NM_001324054;NM_001324055;NM_001324057;NM_001324058;NM_001324059;NM_001324060;NM_001354033;NM_001354034;NM_001354035;NM_001354036;NM_001354037;NM_001354038;NM_001354039;NM_004671;NM_173206
CAPN15_TF,CAPN15,CAPN15_TF,CAPN15,TF,98,3.09350961132267,0.287918935039806,0.284704552205568,0.298480478638019,0.0137759264324506,0.00434466423062561,0.591200236763998,6.39773325008127,6.39042540643159,6.42174473635879,0.031319329927208,0.656699990349759,ENSG00000103326,CAPN15,protein_coding,16,1,527712,554636,p13.3,calpain 15 [Source:HGNC Symbol;Acc:HGNC:11182],NA,CAPN15,6650,NM_005632
ZMYND19_TF,ZMYND19,ZMYND19_TF,ZMYND19,TF,489,3.09274911943774,0.247200059420454,0.239043694017418,0.273999545744716,0.0349558517272989,0.00435465810511288,3.26622564930015,3.97897947658386,3.92715702585136,4.14925324327636,0.222096217424999,0.00528794504316927,ENSG00000165724,ZMYND19,protein_coding,9,-1,137582081,137590512,q34.3,zinc finger MYND-type containing 19 [Source:HGNC Symbol;Acc:HGNC:21146],NA,ZMYND19,116225,NM_138462
NUDT1_SIG,NUDT1,NUDT1_SIG,NUDT1,SIG,8,3.0926079830633,0.64163796429316,0.634801771586336,0.664099740329865,0.0292979687435287,0.00435536114924345,5.05283152534142,4.4436680796102,4.35590561336922,4.7320304686877,0.376124855318476,1.13873143643736e-05,ENSG00000106268,NUDT1,protein_coding,7,1,2242222,2251146,p22.3,nudix hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:8048],NA,NUDT1,4521,NM_001367553;NM_002452;NM_198948;NM_198949;NM_198950;NM_198952;NM_198953;NM_198954
ZNF627_TF,ZNF627,ZNF627_TF,ZNF627,TF,35,3.09254392346423,0.256532222470951,0.251446367526655,0.273242888716494,0.0217965211898389,0.00435536114924345,2.35397245861297,3.30936440835683,3.26133607519747,3.46717178873757,0.205835713540094,0.0483736408028849,ENSG00000198551,ZNF627,protein_coding,19,1,11559374,11619161,p13.2,zinc finger protein 627 [Source:HGNC Symbol;Acc:HGNC:30570],NA,ZNF627,199692,NM_001290083;NM_001290084;NM_001290085;NM_145295
ASB1_SIG,ASB1,ASB1_SIG,ASB1,SIG,14,3.09198085091044,0.0984275659611727,0.0932427926032085,0.115463249851627,0.0222204572484182,0.00436247540814192,2.1724361479765,4.79104499678369,4.75503429618331,4.90936587018497,0.154331574001659,0.0699961817485347,ENSG00000065802,ASB1,protein_coding,2,1,238426742,238452250,q37.3,ankyrin repeat and SOCS box containing 1 [Source:HGNC Symbol;Acc:HGNC:16011],NA,ASB1,51665,NM_001040445;NM_001330196
CD79A_SIG,CD79A,CD79A_SIG,CD79A,SIG,18,-3.09090180497682,0.0449374250452114,0.0538123859647519,0.0157768391667213,-0.0380355467980307,0.00437644944612887,-1.55086519894985,3.63586328223422,3.68659199782781,3.46918321671241,-0.2174087811154,0.205504097981764,ENSG00000105369,CD79A,protein_coding,19,1,41877120,41881372,q13.2,CD79a molecule [Source:HGNC Symbol;Acc:HGNC:1698],AGAMMAGLOBULINEMIA 3 AUTOSOMAL RECESSIVE;Autosomal agammaglobulinemia,CD79A,973,NM_001783;NM_021601
TSTA3_SIG,TSTA3,TSTA3_SIG,TSTA3,SIG,20,3.09082363609902,0.104326853940212,0.0985449378224442,0.123324578327163,0.0247796405047193,0.00437644944612887,3.30201366195698,5.12211264970399,5.06969013549634,5.29435805352911,0.224667918032764,0.00478229738916378,ENSG00000104522,TSTA3,protein_coding,8,-1,143612618,143618048,q24.3,tissue specific transplantation antigen P35B [Source:HGNC Symbol;Acc:HGNC:12390],NA,TSTA3,7264,NM_001317783;NM_003313
ZNF324B_TF,ZNF324B,ZNF324B_TF,ZNF324B,TF,169,3.09079554987242,0.231405509385015,0.219714665088203,0.269818283503113,0.0501036184149103,0.00437644944612887,3.46567259319501,2.46968891117784,2.40812840306762,2.6719591521114,0.26383074904378,0.00298091006362348,ENSG00000249471,ZNF324B,protein_coding,19,1,58451611,58457833,q13.43,zinc finger protein 324B [Source:HGNC Symbol;Acc:HGNC:33107],NA,ZNF324B,388569,NM_207395
LCAT_SIG,LCAT,LCAT_SIG,LCAT,SIG,39,3.09058412398913,0.0197059263055807,0.015465458817527,0.0336388909091857,0.0181734320916588,0.00437840788538246,1.68328172778034,2.81393701396371,2.77597264601328,2.93867708008656,0.162704434073273,0.167593374311934,ENSG00000213398,LCAT,protein_coding,16,-1,67939750,67944131,q22.1,lecithin-cholesterol acyltransferase [Source:HGNC Symbol;Acc:HGNC:6522],Familial LCAT deficiency;FISH-EYE DISEASE;LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY,LCAT,3931,NM_000229
ATG12_SIG,ATG12,ATG12_SIG,ATG12,SIG,19,3.08836485036313,0.227733575749667,0.223832836344781,0.240550290937151,0.0167174545923703,0.00441004106897415,0.975055878877364,5.15203396631882,5.14176877450573,5.18576245370467,0.0439936791989394,0.443121632081345,ENSG00000145782,ATG12,protein_coding,5,-1,115828200,115841837,q22.3,autophagy related 12 [Source:HGNC Symbol;Acc:HGNC:588],NA,ATG12,9140,NM_001277783;NM_004707
UTP23_SIG,UTP23,UTP23_SIG,UTP23,SIG,35,3.08828852034796,0.21648380983616,0.212521214682288,0.229503765341739,0.016982550659451,0.00441004106897415,0.319597149659519,4.46810835554078,4.46417332400678,4.48103774486677,0.0168644208599922,0.816138714821098,ENSG00000147679,UTP23,protein_coding,8,1,116766505,116849463,q24.11,UTP23, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:28224],NA,UTP23,84294,NM_032334
NDUFS8_SIG,NDUFS8,NDUFS8_SIG,NDUFS8,SIG,6,3.08736313589965,0.296216646867251,0.291997917982918,0.310078184630059,0.0180802666471404,0.00442262496645613,4.47210736313625,5.17250798049248,5.12452757159373,5.33015789544553,0.205630323851802,0.000109817409633106,ENSG00000110717,NDUFS8,protein_coding,11,1,68030617,68036644,q13.2,NADH:ubiquinone oxidoreductase core subunit S8 [Source:HGNC Symbol;Acc:HGNC:7715],Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 2;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I DEFICIENCY,NDUFS8,4728,NM_002496
NUDT4_SIG,NUDT4,NUDT4_SIG,NUDT4,SIG,11,-3.08690781810255,0.0817078414215042,0.0897237080954431,0.0553699937785619,-0.0343537143168813,0.00442823409193333,-2.10538678008436,5.33837120267645,5.373754175739,5.22211286261378,-0.151641313125227,0.0796024750867826,ENSG00000173598,NUDT4,protein_coding,12,1,93377883,93408146,q22,nudix hydrolase 4 [Source:HGNC Symbol;Acc:HGNC:8051],NA,NUDT4,11163,NM_001301022;NM_001301023;NM_001301024;NM_019094;NM_199040
RNF13_SIG,RNF13,RNF13_SIG,RNF13,SIG,58,-3.08682592138692,0.506649172420248,0.516958709148293,0.472774980313814,-0.0441837288344794,0.00442828395855803,-1.92419499387782,5.48409699947696,5.51861815538812,5.37067034434032,-0.147947811047802,0.111476869119629,ENSG00000082996,RNF13,protein_coding,3,1,149812708,149962139,q25.1,ring finger protein 13 [Source:HGNC Symbol;Acc:HGNC:10057],NA,RNF13,11342,NM_007282;NM_183381
ST18_TF,ST18,ST18_TF,ST18,TF,189,-3.08661525279406,-0.00756343624870376,-0.0040016517778921,-0.0192664423670849,-0.0152647905891927,0.00443025270015817,-1.56253888826247,1.33787819807507,1.40721821446489,1.11004671565139,-0.297171498813499,0.201783059882315,ENSG00000147488,ST18,protein_coding,8,-1,52110839,52460959,q11.23,ST18, C2H2C-type zinc finger [Source:HGNC Symbol;Acc:HGNC:18695],NA,ST18,9705,NM_001352826;NM_001352827;NM_001352828;NM_001352829;NM_001352830;NM_001352831;NM_001352832;NM_001352833;NM_001352834;NM_001352835;NM_001352836;NM_001352837;NM_001352838;NM_001352839;NM_001352840;NM_001352841;NM_001352842;NM_001352843;NM_001352844;NM_001352845;NM_001352846;NM_001352847;NM_001352848;NM_001352849;NM_001352850;NM_001352851;NM_001352852;NM_001352853;NM_001352854;NM_001352855;NM_001352856;NM_001352857;NM_001352858;NM_001352859;NM_001352860;NM_001352861;NM_001352862;NM_001352863;NM_001352864;NM_001352865;NM_001352866;NM_001352867;NM_001352868;NM_001352869;NM_001352870;NM_001352871;NM_001352872;NM_001352873;NM_001352874;NM_001352875;NM_001352876;NM_001352877;NM_001352878;NM_001352879;NM_001352880;NM_001352882;NM_001352883;NM_001352884;NM_014682
STK40_SIG,STK40,STK40_SIG,STK40,SIG,32,-3.08647219367014,0.302156639862732,0.307895001544327,0.283302022908919,-0.0245929786354087,0.00443121463433052,-0.750856018077381,6.64489304507533,6.65574198878063,6.60924651575792,-0.0464954730227065,0.56295370089293,ENSG00000196182,STK40,protein_coding,1,-1,36339624,36385896,p34.3,serine/threonine kinase 40 [Source:HGNC Symbol;Acc:HGNC:21373],NA,STK40,83931,NM_001282546;NM_001282547;NM_032017
PAICS_SIG,PAICS,PAICS_SIG,PAICS,SIG,66,3.08606406966464,0.560670149695426,0.547051759386794,0.60541628928093,0.0583645298941352,0.00443613005033898,3.08315917384061,6.5280253355608,6.45108984330803,6.78081338153417,0.329723538226136,0.00866180223617553,ENSG00000128050,PAICS,protein_coding,4,1,56435741,56464579,q12,phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase [Source:HGNC Symbol;Acc:HGNC:8587],NA,PAICS,10606,NM_001079524;NM_001079525;NM_006452
MAP2K6_SIG,MAP2K6,MAP2K6_SIG,MAP2K6,SIG,15,-3.08585785936078,0.0915445783325279,0.0991955593522408,0.0664056406963284,-0.0327899186559126,0.00443803600345118,-2.32307741999651,3.2128379297733,3.27092052029399,3.02199513234819,-0.248925387945791,0.0514846722889601,ENSG00000108984,MAP2K6,protein_coding,17,1,69414697,69553865,q24.3,mitogen-activated protein kinase kinase 6 [Source:HGNC Symbol;Acc:HGNC:6846],NA,MAP2K6,5608,NM_001330450;NM_002758
JAK1_SIG,JAK1,JAK1_SIG,JAK1,SIG,57,-3.08521349765149,0.306355676812914,0.311502008828355,0.289446300190752,-0.0220557086376029,0.0044464892531526,-2.86395301946223,8.10855450189657,8.14533948879289,7.9876895449515,-0.157649943841387,0.0151783539692319,ENSG00000162434,JAK1,protein_coding,1,-1,64833229,64966549,p31.3,Janus kinase 1 [Source:HGNC Symbol;Acc:HGNC:6190],NA,JAK1,3716,NM_001320923;NM_001321852;NM_001321853;NM_001321854;NM_001321855;NM_001321856;NM_001321857;NM_002227
DCP1B_SIG,DCP1B,DCP1B_SIG,DCP1B,SIG,39,3.08462034207522,0.27395999741008,0.261462832013669,0.315022112284004,0.0535592802703353,0.00445419035047187,2.88254844902969,3.71813585521915,3.6547726893136,3.92632911462311,0.271556425309512,0.0144902167416246,ENSG00000151065,DCP1B,protein_coding,12,-1,1946053,2004535,p13.33,decapping mRNA 1B [Source:HGNC Symbol;Acc:HGNC:24451],NA,DCP1B,196513,NM_001319292;NM_152640
NEU3_SIG,NEU3,NEU3_SIG,NEU3,SIG,22,3.08405116082266,0.125556506161534,0.120783548996761,0.14123907970293,0.0204555307061691,0.00446154408361099,0.443666523500582,4.23127399471466,4.2245525392889,4.25335877682789,0.0288062375389943,0.742573854950057,ENSG00000162139,NEU3,protein_coding,11,1,74988279,75018893,q13.4,neuraminidase 3 [Source:HGNC Symbol;Acc:HGNC:7760],NA,NEU3,10825,NM_001367860;NM_001367862;NM_001367863;NM_001367864;NM_001367866;NM_001367867;NM_006656
ANK1_SIG,ANK1,ANK1_SIG,ANK1,SIG,73,-3.0832026913769,-0.188736197158559,-0.166926529772942,-0.260396532854157,-0.0934700030812148,0.00447310538304197,-2.34222754990033,3.73037144950861,3.87055271505881,3.26977586270081,-0.600776852357995,0.049599251820612,ENSG00000029534,ANK1,protein_coding,8,-1,41653220,41896762,p11.21,ankyrin 1 [Source:HGNC Symbol;Acc:HGNC:492],8p11.2 deletion syndrome;Hereditary spherocytosis;SPHEROCYTOSIS TYPE 1,ANK1,286,NM_000037;NM_001142445;NM_001142446;NM_020475;NM_020476;NM_020477;NM_020478;NM_020480
GATAD2B_TF,GATAD2B,GATAD2B_TF,GATAD2B,TF,71,3.08286328252846,0.391785704225435,0.387896032078326,0.404566055565936,0.0166700234876101,0.0044770297206383,2.12724482243927,6.61832697074844,6.58984394170555,6.71191406617507,0.122070124469517,0.0763895859167882,ENSG00000143614,GATAD2B,protein_coding,1,-1,153789030,153923360,q21.3,GATA zinc finger domain containing 2B [Source:HGNC Symbol;Acc:HGNC:30778],MENTAL RETARDATION AUTOSOMAL DOMINANT 18;Nonspecific severe ID;Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,GATAD2B,57459,NM_020699
TIMM50_SIG,TIMM50,TIMM50_SIG,TIMM50,SIG,61,3.0827778790907,0.459368991172169,0.451783908990736,0.484291404054019,0.0325074950632837,0.00447713462641713,3.28342149968813,5.33954117226392,5.29847105435459,5.47448584539455,0.176014791039962,0.00503450807490269,ENSG00000105197,TIMM50,protein_coding,19,1,39480412,39493785,q13.2,translocase of inner mitochondrial membrane 50 [Source:HGNC Symbol;Acc:HGNC:23656],3-@METHYLGLUTACONIC ACIDURIA TYPE IX;3-methylglutaconic aciduria type 9,TIMM50,92609,NM_001001563;NM_001329559
AARS2_SIG,AARS2,AARS2_SIG,AARS2,SIG,43,3.082377865237,0.352327680397318,0.339795901437207,0.393503525551968,0.0537076241147607,0.00448197504847007,2.63801016952629,4.1526380056079,4.1064914942921,4.3042622570741,0.197770762782,0.0257639424646615,ENSG00000124608,AARS2,protein_coding,6,-1,44298731,44313347,p21.1,alanyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:21022],Combined oxidative phosphorylation defect type 8;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8;Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia;LEUKOENCEPHALOPATHY PROGRESSIVE WITH OVARIAN FAILURE;OVARIOLEUKODYSTROPHY,AARS2,57505,NM_020745
AK7_SIG,AK7,AK7_SIG,AK7,SIG,20,-3.08191132413468,-0.0503737736881886,-0.0386805422560962,-0.0887943912507781,-0.0501138489946819,0.00448782321450907,-3.17827228210903,0.38704197554234,0.424334919710347,0.264508016133173,-0.159826903577174,0.00674258313214189,ENSG00000140057,AK7,protein_coding,14,1,96392128,96489427,q32.2,adenylate kinase 7 [Source:HGNC Symbol;Acc:HGNC:20091],Non-syndromic male infertility due to sperm motility disorder;SPERMATOGENIC FAILURE 27,AK7,122481,NM_001350888;NM_001350890;NM_001350891;NM_001350892;NM_152327
INPP5A_SIG,INPP5A,INPP5A_SIG,INPP5A,SIG,9,-3.08107066408944,0.173426442056342,0.175595998013051,0.166297901055727,-0.00929809695732386,0.00449932854927799,0.277194835056777,4.59145158780877,4.58776469293719,4.60356567095823,0.0158009780210361,0.841486714635604,ENSG00000068383,INPP5A,protein_coding,10,1,132537787,132783480,q26.3,inositol polyphosphate-5-phosphatase A [Source:HGNC Symbol;Acc:HGNC:6076],NA,INPP5A,3632,NM_001321042;NM_005539
ECHDC3_SIG,ECHDC3,ECHDC3_SIG,ECHDC3,SIG,2,-3.08001107438481,-0.0492631936885974,-0.0369276947341992,-0.0897941188244772,-0.0528664240902779,0.00451390919484755,-0.207729471492997,1.99085390156519,1.99621183623945,1.97324925906401,-0.0229625771754415,0.88287588867052,ENSG00000134463,ECHDC3,protein_coding,10,1,11742366,11764070,p14,enoyl-CoA hydratase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:23489],NA,ECHDC3,79746,NM_024693
POU2F2_SIG,POU2F2,POU2F2_SIG,POU2F2,SIG,52,-3.07995041109595,0.243069125638456,0.261769480691716,0.18162510189203,-0.080144378799686,0.00451390919484755,-3.50942419932045,5.80750755666308,5.93900925810021,5.37543053765537,-0.56357872044484,0.00263166417097803,ENSG00000028277,POU2F2,protein_coding,19,-1,42086110,42196585,q13.2,POU class 2 homeobox 2 [Source:HGNC Symbol;Acc:HGNC:9213],NA,POU2F2,5452,NM_001207025;NM_001207026;NM_001247994;NM_002698
ANPEP_SIG,ANPEP,ANPEP_SIG,ANPEP,SIG,43,-3.07884197065606,0.144152864355162,0.14961135379111,0.126217827637045,-0.0233935261540651,0.00452954486181401,-1.21016707779497,7.55792536645616,7.6095852107413,7.38818587809067,-0.221399332650635,0.332565155059676,ENSG00000166825,ANPEP,protein_coding,15,-1,89784895,89815401,q26.1,alanyl aminopeptidase, membrane [Source:HGNC Symbol;Acc:HGNC:500],NA,ANPEP,290,NM_001150
SH3KBP1_SIG,SH3KBP1,SH3KBP1_SIG,SH3KBP1,SIG,34,-3.07760069315147,0.258054464148303,0.266503549758952,0.23029318285617,-0.0362103669027818,0.00454725614511719,-2.6841358985587,7.57419872718562,7.61511891763773,7.43974667284296,-0.175372244794766,0.0232584102131785,ENSG00000147010,SH3KBP1,protein_coding,X,-1,19533977,19887600,p22.12,SH3 domain containing kinase binding protein 1 [Source:HGNC Symbol;Acc:HGNC:13867],NA,SH3KBP1,30011,NM_001024666;NM_001184960;NM_001353890;NM_001353891;NM_001353892;NM_001353893;NM_001353894;NM_001353895;NM_001353897;NM_031892
PACSIN2_SIG,PACSIN2,PACSIN2_SIG,PACSIN2,SIG,18,3.0768336040138,0.38508530562157,0.379211291430789,0.404385637962706,0.0251743465319178,0.00455777503888073,3.91547633903021,6.37467640084839,6.3179720295651,6.56099076363636,0.24301873407126,0.000742786130621277,ENSG00000100266,PACSIN2,protein_coding,22,-1,42835412,43015149,q13.2,protein kinase C and casein kinase substrate in neurons 2 [Source:HGNC Symbol;Acc:HGNC:8571],NA,PACSIN2,11252,NM_001184970;NM_001184971;NM_001349968;NM_001349969;NM_001349970;NM_001349971;NM_001349972;NM_001349973;NM_001349974;NM_007229
BRD7_SIG,BRD7,BRD7_SIG,BRD7,SIG,21,3.07495003696206,0.501822922321042,0.496962093454763,0.517794217167388,0.0208321237126249,0.00458545173014382,1.94263380838711,5.77452461327416,5.75687432077194,5.83251843149574,0.0756441107238004,0.107827298072624,ENSG00000166164,BRD7,protein_coding,16,-1,50313487,50368934,q12.1,bromodomain containing 7 [Source:HGNC Symbol;Acc:HGNC:14310],NA,BRD7,29117,NM_001173984;NM_013263
NDUFS4_SIG,NDUFS4,NDUFS4_SIG,NDUFS4,SIG,32,3.07374820843171,0.455588783332159,0.450576304608397,0.472058356281661,0.0214820516732639,0.00460275322868213,3.37160246369548,4.36537865725511,4.32116671210436,4.51064647703616,0.1894797649318,0.00392696738626586,ENSG00000164258,NDUFS4,protein_coding,5,1,53560633,53683338,q11.2,NADH:ubiquinone oxidoreductase subunit S4 [Source:HGNC Symbol;Acc:HGNC:7711],Isolated complex I deficiency;Leigh syndrome;LEIGH SYNDROME DUP;Leigh syndrome with leukodystrophy;Mitochondrial complex I deficiency nuclear type 1;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I DEFICIENCY,NDUFS4,4724,NM_001318051;NM_002495
PMS2P2_SIG,PMS2P2,PMS2P2_SIG,PMS2P2,SIG,7,3.07363696791258,0.119913146379714,0.112465154341342,0.144385120220077,0.0319199658787351,0.00460325985671508,2.12204396437204,0.815648999308058,0.791217442694073,0.895924113896869,0.104706671202797,0.0770971976935947,ENSG00000278416,PMS2P2,unprocessed_pseudogene,7,-1,75344015,75359550,q11.23,PMS1 homolog 2, mismatch repair system component pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:9127],NA,PMS2P2,NA,NA
PRR12_TF,PRR12,PRR12_TF,PRR12,TF,32,3.07301178429879,0.486009393059756,0.48167119037512,0.500263487594987,0.0185922972198669,0.00461170301690242,2.75447214255015,5.89475739746881,5.8584971805363,6.01389811024704,0.155400929710742,0.0197196871964236,ENSG00000126464,PRR12,protein_coding,19,1,49591182,49626439,q13.33,proline rich 12 [Source:HGNC Symbol;Acc:HGNC:29217],NA,PRR12,57479,NM_020719
EMG1_SIG,EMG1,EMG1_SIG,EMG1,SIG,13,3.07271116727473,0.260147697354055,0.245307337556294,0.308908879546699,0.0636015419904055,0.00461440672050558,2.495218836216,4.1624274675562,4.12290172847592,4.29229775310567,0.169396024629747,0.0356973733434524,ENSG00000126749,EMG1,protein_coding,12,1,6970913,6997428,p13.31,EMG1, N1-specific pseudouridine methyltransferase [Source:HGNC Symbol;Acc:HGNC:16912],BOWEN-CONRADI SYNDROME,EMG1,10436,NM_001320049;NM_006331
PPP2R2B_SIG,PPP2R2B,PPP2R2B_SIG,PPP2R2B,SIG,7,-3.07263657478869,-0.251077818388367,-0.227337236067579,-0.329082588870956,-0.101745352803376,0.00461440672050558,0.561237307969794,0.956596776668696,0.944243431241978,0.997186340213628,0.0529429089716498,0.674173423925289,ENSG00000156475,PPP2R2B,protein_coding,5,-1,146581146,147084784,q32,protein phosphatase 2 regulatory subunit Bbeta [Source:HGNC Symbol;Acc:HGNC:9305],SPINOCEREBELLAR ATAXIA 12;Spinocerebellar ataxia type 12,PPP2R2B,5521,NM_001271899;NM_001271900;NM_001271948;NM_181674;NM_181675;NM_181676;NM_181677;NM_181678
TRIP10_SIG,TRIP10,TRIP10_SIG,TRIP10,SIG,70,3.07260179582982,0.0310196272421925,0.0266983017327232,0.0452182682018773,0.0185199664691543,0.00461440672050558,2.8603013754709,2.85197366620083,2.77179751345239,3.11540959665997,0.343612083207584,0.0153046152583424,ENSG00000125733,TRIP10,protein_coding,19,1,6737925,6751530,p13.3,thyroid hormone receptor interactor 10 [Source:HGNC Symbol;Acc:HGNC:12304],NA,TRIP10,9322,NM_001288962;NM_001288963;NM_004240
RAB2A_SIG,RAB2A,RAB2A_SIG,RAB2A,SIG,32,-3.07232006364199,0.203929440519935,0.208406051647537,0.189220575386384,-0.0191854762611532,0.00461755259774959,-3.03453671832303,6.2856804336021,6.32181347156623,6.1669575945771,-0.154855876989127,0.00983474664524199,ENSG00000104388,RAB2A,protein_coding,8,1,60516936,60623644,q12.1,RAB2A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9763],NA,RAB2A,5862,NM_001242644;NM_002865
UQCRC2_SIG,UQCRC2,UQCRC2_SIG,UQCRC2,SIG,45,3.07204707132221,0.338767436359402,0.332620459568681,0.358964645814629,0.0263441862459483,0.00462056530508379,1.89832797606236,7.35644789970793,7.33704564956255,7.42019815018561,0.0831525006230621,0.116700856991674,ENSG00000140740,UQCRC2,protein_coding,16,1,21952660,21983660,p12.2,ubiquinol-cytochrome c reductase core protein 2 [Source:HGNC Symbol;Acc:HGNC:12586],Isolated complex III deficiency;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 5,UQCRC2,7385,NM_003366
YWHAE_SIG,YWHAE,YWHAE_SIG,YWHAE,SIG,38,3.07175322627575,0.397511130871888,0.387394647378185,0.430751005208342,0.0433563578301573,0.00462390296251856,4.05532661161301,7.99431612809915,7.92846204256909,8.21069383769791,0.282231795128816,0.000473227805302286,ENSG00000108953,YWHAE,protein_coding,17,-1,1344275,1400222,p13.3,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [Source:HGNC Symbol;Acc:HGNC:12851],17p13.3 microduplication syndrome;Clear cell sarcoma of kidney;Distal 17p13.3 microdeletion syndrome;Endometrial stromal sarcoma;Miller-Dieker syndrome,YWHAE,7531,NM_006761
NOD1_SIG,NOD1,NOD1_SIG,NOD1,SIG,12,3.07112043748563,0.187229566992664,0.179224614924566,0.213531552359268,0.034306937434702,0.00463249913379184,3.64986668059971,4.93823763119696,4.88489131304572,5.11351839083672,0.228627077791002,0.00171294769244749,ENSG00000106100,NOD1,protein_coding,7,-1,30424527,30478784,p14.3,nucleotide binding oligomerization domain containing 1 [Source:HGNC Symbol;Acc:HGNC:16390],NA,NOD1,10392,NM_001354849;NM_006092
DDX18_SIG,DDX18,DDX18_SIG,DDX18,SIG,12,3.06991327653835,0.550832426312337,0.543114927644666,0.576189921934685,0.033074994290019,0.00465004443322833,2.08009585483877,6.20688874331572,6.1819446984949,6.28884774772699,0.106903049232086,0.0834407704502216,ENSG00000088205,DDX18,protein_coding,2,1,117814691,117832377,q14.1,DEAD-box helicase 18 [Source:HGNC Symbol;Acc:HGNC:2741],NA,DDX18,8886,NM_006773
TBP_SIG,TBP,TBP_SIG,TBP,SIG,15,3.06919350726633,0.428120281456264,0.423598037665047,0.442979082484549,0.0193810448195019,0.00466004145413265,0.412547353493855,4.37446044922698,4.37088858984456,4.38619655862639,0.0153079687818326,0.761250810362235,ENSG00000112592,TBP,protein_coding,6,1,170554302,170572870,q27,TATA-box binding protein [Source:HGNC Symbol;Acc:HGNC:11588],Parkinson disease late-onset;SPINOCEREBELLAR ATAXIA 17;Spinocerebellar ataxia type 17,TBP,6908,NM_001172085;NM_003194
OR8R1P_SIG,OR8R1P,OR8R1P_SIG,OR8R1P,SIG,13,-3.06900404608073,-0.0265873582598372,-0.0181978787943979,-0.0541527907891378,-0.0359549119947399,0.00466174887598116,-1.87161651063237,0.312848763782233,0.331593593311697,0.251258609613996,-0.0803349836977012,0.122233424168317,ENSG00000256347,OR8R1P,unprocessed_pseudogene,11,1,73248779,73249867,q13.4,olfactory receptor family 8 subfamily R member 1 pseudogene [Source:HGNC Symbol;Acc:HGNC:15318],NA,OR8R1P,NA,NA
ZNF781_TF,ZNF781,ZNF781_TF,ZNF781,TF,13,3.06892753623292,-0.0604496332478667,-0.0702810775353617,-0.0281463163032402,0.0421347612321215,0.00466174887598116,2.74360109295453,0.664814978684406,0.621974640826142,0.805576088790128,0.183601447963986,0.0201996760208165,ENSG00000196381,ZNF781,protein_coding,19,-1,37667751,37692315,q13.12,zinc finger protein 781 [Source:HGNC Symbol;Acc:HGNC:26745],NA,ZNF781,163115,NM_152605
PIN1_TF,PIN1,PIN1_TF,PIN1,TF,186,3.0682868098143,0.245508101474053,0.242295896230439,0.256062490131643,0.0137665939012044,0.00467053329773755,1.07429512208973,5.2862992589451,5.27737955884899,5.31560684497519,0.038227286126202,0.394705390285656,ENSG00000127445,PIN1,protein_coding,19,1,9835257,9849682,p13.2,peptidylprolyl cis/trans isomerase, NIMA-interacting 1 [Source:HGNC Symbol;Acc:HGNC:8988],NA,PIN1,5300,NM_006221
DUSP1_SIG,DUSP1,DUSP1_SIG,DUSP1,SIG,36,-3.06626028299515,0.46432426855625,0.473678070867774,0.433590346675529,-0.0400877241922444,0.00470107680244098,-1.05109209403594,9.37708428601834,9.40939821065256,9.27090996222017,-0.138488248432392,0.405460522204625,ENSG00000120129,DUSP1,protein_coding,5,-1,172768096,172771195,q35.1,dual specificity phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:3064],NA,DUSP1,1843,NM_004417
ADCK1_SIG,ADCK1,ADCK1_SIG,ADCK1,SIG,14,3.06480617476009,0.261547901530599,0.250679924535104,0.297256968801509,0.0465770442664045,0.00472275582273851,4.10383206123799,2.99166613659608,2.91398766462761,3.24689540163537,0.332907737007758,0.000401206447582098,ENSG00000063761,ADCK1,protein_coding,14,1,77800109,77935014,q24.3,aarF domain containing kinase 1 [Source:HGNC Symbol;Acc:HGNC:19038],NA,ADCK1,57143,NM_001142545;NM_020421
TERF1_TF,TERF1,TERF1_TF,TERF1,TF,46,3.06438098559297,0.287326190163783,0.283828510564642,0.298818565989535,0.0149900554248938,0.00472823652254806,1.28294116970311,4.3835907795282,4.36937142562983,4.43031151376572,0.0609400881358891,0.301979801879559,ENSG00000147601,TERF1,protein_coding,8,1,73008864,73048123,q21.11,telomeric repeat binding factor 1 [Source:HGNC Symbol;Acc:HGNC:11728],NA,TERF1,7013,NM_003218;NM_017489
HK1_SIG,HK1,HK1_SIG,HK1,SIG,23,-3.06422541436659,0.0688249387606773,0.0756982704441104,0.0462411346579685,-0.0294571357861418,0.00472945871521533,-0.303187578058675,7.03573085106259,7.04214990146608,7.01463968545112,-0.0275102160149581,0.82590392151684,ENSG00000156515,HK1,protein_coding,10,1,69269984,69401884,q22.1,hexokinase 1 [Source:HGNC Symbol;Acc:HGNC:4922],Charcot-Marie-Tooth disease type 4G;HEMOLYTIC ANEMIA NONSPHEROCYTIC DUE TO HEXOKINASE DEFICIENCY;NEUROPATHY HEREDITARY MOTOR AND SENSORY RUSSE TYPE;Nonspherocytic hemolytic anemia due to hexokinase deficiency;RETINITIS PIGMENTOSA 79,HK1,3098,NM_000188;NM_001322364;NM_001322365;NM_001322366;NM_001322367;NM_001358263;NM_033496;NM_033497;NM_033498;NM_033500
AKAP5_SIG,AKAP5,AKAP5_SIG,AKAP5,SIG,19,-3.06393408330811,0.00070481577180757,0.00697485207672271,-0.0198967320871993,-0.0268715841639219,0.00473282869883971,-2.10121430534569,1.01299246474262,1.04922606818253,0.893939196297196,-0.155286871885338,0.0801876024484916,ENSG00000179841,AKAP5,protein_coding,14,1,64465499,64474503,q23.3,A-kinase anchoring protein 5 [Source:HGNC Symbol;Acc:HGNC:375],NA,AKAP5,9495,NM_004857
TMED1_SIG,TMED1,TMED1_SIG,TMED1,SIG,15,3.06238145349941,0.399127724134342,0.394214011862781,0.4152727787409,0.0210587668781192,0.00475577681670729,1.20569925600897,3.70315815181382,3.68865022116569,3.75082706680055,0.0621768456348585,0.334209739982844,ENSG00000099203,TMED1,protein_coding,19,-1,10832067,10836318,p13.2,transmembrane p24 trafficking protein 1 [Source:HGNC Symbol;Acc:HGNC:17291],NA,TMED1,11018,NM_006858
CHD6_SIG,CHD6,CHD6_SIG,CHD6,SIG,127,3.06233021464515,0.409973586386254,0.403733420743223,0.430476987784786,0.0267435670415633,0.00475577681670729,2.50923889060469,6.48096223848089,6.44184530021933,6.60948932134032,0.16764402112099,0.0345911334585042,ENSG00000124177,CHD6,protein_coding,20,-1,41402083,41618384,q12,chromodomain helicase DNA binding protein 6 [Source:HGNC Symbol;Acc:HGNC:19057],NA,CHD6,84181,NM_032221
TRAF4_SIG,TRAF4,TRAF4_SIG,TRAF4,SIG,32,3.06168135088624,0.198983402360428,0.190512217835146,0.226817294372068,0.036305076536922,0.00476485178935238,6.09146946834039,4.78948224910087,4.59622272698456,5.42447782176872,0.828255094784161,9.1905719976298e-08,ENSG00000076604,TRAF4,protein_coding,17,1,28744005,28750956,q11.2,TNF receptor associated factor 4 [Source:HGNC Symbol;Acc:HGNC:12034],NA,TRAF4,9618,NM_004295
MOGS_SIG,MOGS,MOGS_SIG,MOGS,SIG,10,3.06077034201913,0.282366439190515,0.272603254025982,0.314445476159695,0.0418422221337131,0.00477812395875827,2.44098187698572,6.10640173831472,6.07641831600883,6.20491869731977,0.128500381310947,0.0400985903948595,ENSG00000115275,MOGS,protein_coding,2,-1,74461057,74465410,p13.1,mannosyl-oligosaccharide glucosidase [Source:HGNC Symbol;Acc:HGNC:24862],CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIb;Congenital Disorders of Glycosylation;MOGS-CDG,MOGS,7841,NM_001146158;NM_006302
PDGFC_SIG,PDGFC,PDGFC_SIG,PDGFC,SIG,15,3.0601286428072,0.160526642457749,0.153381540025596,0.184003407591966,0.0306218675663696,0.0047870555140455,2.64956067705362,4.15922898506647,4.06198124142362,4.47875728560729,0.416776044183677,0.0250732012953425,ENSG00000145431,PDGFC,protein_coding,4,-1,156760454,156971799,q32.1,platelet derived growth factor C [Source:HGNC Symbol;Acc:HGNC:8801],NA,PDGFC,56034,NM_016205
GTF3C1_SIG,GTF3C1,GTF3C1_SIG,GTF3C1,SIG,26,3.06005467082801,0.796244072004482,0.787418855014871,0.825241213541777,0.0378223585269069,0.0047870555140455,4.0663865380972,6.35061875782708,6.2946951696456,6.53436769042339,0.239672520777798,0.00045494689842496,ENSG00000077235,GTF3C1,protein_coding,16,-1,27459555,27549913,p12.1,general transcription factor IIIC subunit 1 [Source:HGNC Symbol;Acc:HGNC:4664],NA,GTF3C1,2975,NM_001286242;NM_001520
TAF9_SIG,TAF9,TAF9_SIG,TAF9,SIG,52,3.0594584557804,0.181608457597388,0.175247292053331,0.202509430099289,0.0272621380459586,0.00479534197306955,2.0026912126172,6.16930452853846,6.14602865616272,6.24578239491587,0.0997537387531473,0.0966099819519968,ENSG00000273841,TAF9,protein_coding,5,-1,69364743,69370013,q13.2,TATA-box binding protein associated factor 9 [Source:HGNC Symbol;Acc:HGNC:11542],NA,TAF9,6880,NM_001015892;NM_003187
HLA-DMB_SIG,HLA-DMB,HLA-DMB_SIG,HLA-DMB,SIG,29,-3.05886067223402,0.232128381901995,0.247413369465749,0.181906279906803,-0.0655070895589465,0.00480366666234899,-1.29598250120965,4.83967798064931,4.89483711515255,4.65844082442441,-0.236396290728137,0.296694618041613,ENSG00000242574,HLA-DMB,protein_coding,6,-1,32934629,32941028,p21.32,major histocompatibility complex, class II, DM beta [Source:HGNC Symbol;Acc:HGNC:4935],NA,HLA-DMB,3109,NM_002118
RASA2_SIG,RASA2,RASA2_SIG,RASA2,SIG,28,-3.05874715096338,0.226636516915042,0.235048520591103,0.198997076265128,-0.0360514443259751,0.00480423346035085,-1.15089810333492,5.79308687243526,5.81128269876428,5.73330058592563,-0.0779821128386455,0.358822170517331,ENSG00000155903,RASA2,protein_coding,3,1,141487047,141615342,q23,RAS p21 protein activator 2 [Source:HGNC Symbol;Acc:HGNC:9872],Noonan Syndrome,RASA2,5922,NM_001303245;NM_001303246;NM_006506
DHTKD1_SIG,DHTKD1,DHTKD1_SIG,DHTKD1,SIG,30,3.05840048238161,0.476821734016207,0.467858940263888,0.506270913488114,0.0384119732242259,0.0048085408499079,2.7425834287832,5.17056698636112,5.10713902368945,5.37897314942519,0.271834125735737,0.0202427947100806,ENSG00000181192,DHTKD1,protein_coding,10,1,12068954,12123221,p14,dehydrogenase E1 and transketolase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23537],2-aminoadipic 2-oxoadipic aciduria;2-Aminoadipic and 2-Oxoadipic Aciduria;Autosomal dominant Charcot-Marie-Tooth disease type 2Q;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2Q,DHTKD1,55526,NM_018706
ANGPTL4_SIG,ANGPTL4,ANGPTL4_SIG,ANGPTL4,SIG,30,-3.05717784139817,-0.201755540657948,-0.195339954498261,-0.222835323754063,-0.0274953692558022,0.00482693975027875,-0.804085565011802,0.514917436807865,0.536925665787466,0.442604684446318,-0.0943209813411487,0.532826526425039,ENSG00000167772,ANGPTL4,protein_coding,19,1,8363289,8374370,p13.2,angiopoietin like 4 [Source:HGNC Symbol;Acc:HGNC:16039],PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS,ANGPTL4,51129,NM_001039667;NM_139314
ZNF653_TF,ZNF653,ZNF653_TF,ZNF653,TF,22,3.05603740369847,0.102994336195631,0.0947749306021127,0.130000954574334,0.0352260239722217,0.00484407438297477,1.73220826974275,2.0034013143866,1.97953389833229,2.0818228242793,0.102288925947005,0.154680743538396,ENSG00000161914,ZNF653,protein_coding,19,-1,11483427,11505839,p13.2,zinc finger protein 653 [Source:HGNC Symbol;Acc:HGNC:25196],NA,ZNF653,115950,NM_138783
MAK16_SIG,MAK16,MAK16_SIG,MAK16,SIG,28,3.0559036782376,0.290686983981738,0.283987534052537,0.312699462320539,0.0287119282680022,0.00484497228014577,1.47711006135477,4.27967438601717,4.25631420205443,4.35642927618047,0.100115074126042,0.229485371178598,ENSG00000198042,MAK16,protein_coding,8,1,33485182,33501262,p12,MAK16 homolog [Source:HGNC Symbol;Acc:HGNC:13703],NA,MAK16,84549,NM_032509
PTRH1_SIG,PTRH1,PTRH1_SIG,PTRH1,SIG,17,3.05566576363445,0.225634039942344,0.216014655538532,0.257240588697728,0.0412259331591963,0.00484755464962568,3.98359121582011,1.94255829546708,1.87993290473636,2.14832743643943,0.268394531703068,0.000597614526615397,ENSG00000187024,PTRH1,protein_coding,9,-1,127690348,127724873,q34.11,peptidyl-tRNA hydrolase 1 homolog [Source:HGNC Symbol;Acc:HGNC:27039],NA,PTRH1,138428,NM_001002913;NM_001345977;NM_001345978;NM_001345979;NM_001345980
SLC10A4_SIG,SLC10A4,SLC10A4_SIG,SLC10A4,SIG,16,-3.05554269486235,-0.0526477416332839,-0.0427262511884603,-0.0852469245234186,-0.0425206733349584,0.00484828132686504,-1.6492417649914,0.373510232293313,0.400289856209009,0.285520039427453,-0.114769816781556,0.176639373054804,ENSG00000145248,SLC10A4,protein_coding,4,1,48483343,48489526,p11,solute carrier family 10 member 4 [Source:HGNC Symbol;Acc:HGNC:22980],NA,SLC10A4,201780,NM_152679
AGPAT3_SIG,AGPAT3,AGPAT3_SIG,AGPAT3,SIG,30,-3.05529431488867,0.154963087067684,0.163464498665183,0.127029877533043,-0.0364346211321401,0.00485103501535927,-2.41132640208266,6.33533074208378,6.39333146286913,6.14475694521762,-0.248574517651513,0.0427907976028607,ENSG00000160216,AGPAT3,protein_coding,21,1,43865223,43987592,q22.3,1-acylglycerol-3-phosphate O-acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:326],NA,AGPAT3,56894,NM_001037553;NM_020132
SUCNR1_SIG,SUCNR1,SUCNR1_SIG,SUCNR1,SIG,55,3.05348446046104,0.149027773831784,0.142901559312146,0.169156764396305,0.0262552050841589,0.00487912163030865,1.77976393861515,4.26252632707952,4.17902392902568,4.53689134925642,0.357867420230741,0.143020739926018,ENSG00000198829,SUCNR1,protein_coding,3,1,151873643,151884619,q25.1,succinate receptor 1 [Source:HGNC Symbol;Acc:HGNC:4542],NA,SUCNR1,56670,NM_033050
ZNF557_TF,ZNF557,ZNF557_TF,ZNF557,TF,20,3.05323252684032,0.182100910704889,0.17723628425539,0.198084683324674,0.0208483990692847,0.00488194898974099,2.87005031104246,3.78425712451504,3.74217244873436,3.92253534493727,0.180362896202915,0.0149504754895236,ENSG00000130544,ZNF557,protein_coding,19,1,7069703,7087968,p13.2,zinc finger protein 557 [Source:HGNC Symbol;Acc:HGNC:28632],NA,ZNF557,79230,NM_001044387;NM_001044388;NM_024341
PNKP_SIG,PNKP,PNKP_SIG,PNKP,SIG,20,3.05265037453859,0.109641481524406,0.106336082015409,0.120502079911109,0.0141659978956996,0.00489015602650229,0.694692137463941,5.27555978038796,5.26954020834859,5.29533837423163,0.0257981658830406,0.595059617472266,ENSG00000039650,PNKP,protein_coding,19,-1,49859882,49878351,q13.33,polynucleotide kinase 3'-phosphatase [Source:HGNC Symbol;Acc:HGNC:9154],ATAXIA-OCULOMOTOR APRAXIA 4;Ataxia-oculomotor apraxia type 4;Early infantile epileptic encephalopathy;Epileptic encephalopathy early infantile 10;MICROCEPHALY SEIZURES AND DEVELOPMENTAL DELAY,PNKP,11284,NM_007254
MRPS35_SIG,MRPS35,MRPS35_SIG,MRPS35,SIG,17,3.05212995100972,0.648046807211833,0.640806796063947,0.671835415269172,0.0310286192052251,0.00489736838233096,2.74399246303406,5.34565870410037,5.31166125381691,5.45736461217461,0.1457033583577,0.0201795868975386,ENSG00000061794,MRPS35,protein_coding,12,1,27710822,27756295,p11.22,mitochondrial ribosomal protein S35 [Source:HGNC Symbol;Acc:HGNC:16635],NA,MRPS35,60488,NM_001190864;NM_021821
UBAC1_SIG,UBAC1,UBAC1_SIG,UBAC1,SIG,25,-3.04927183031229,0.290946740112477,0.299300191358849,0.263499686017254,-0.0358005053415946,0.00494291963299092,-2.38637658702613,5.43437975812794,5.47242881392796,5.30936143192787,-0.163067382000087,0.0451153837703861,ENSG00000130560,UBAC1,protein_coding,9,-1,135932969,135961380,q34.3,UBA domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30221],NA,UBAC1,10422,NM_016172
PDCD6_SIG,PDCD6,PDCD6_SIG,PDCD6,SIG,31,3.04850879903213,0.332920805153016,0.320712749799378,0.373032987029255,0.0523202372298771,0.00495420117708389,2.36995310940769,5.64244046931479,5.61448232303536,5.73430294994721,0.119820626911845,0.0467416043862094,ENSG00000249915,PDCD6,protein_coding,5,1,271621,314974,p15.33,programmed cell death 6 [Source:HGNC Symbol;Acc:HGNC:8765],NA,PDCD6,10016,NM_001267556;NM_001267557;NM_001267558;NM_001267559;NM_013232
SMARCE1_SIG,SMARCE1,SMARCE1_SIG,SMARCE1,SIG,38,3.04740142754989,0.416365892473462,0.411388526035526,0.432720096483823,0.021331570448297,0.00497119855665497,2.60599163313423,5.69201979048034,5.66194115761468,5.79084958418179,0.128908426567111,0.0277646697765392,ENSG00000073584,SMARCE1,protein_coding,17,-1,40624962,40648654,q21.2,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 [Source:HGNC Symbol;Acc:HGNC:11109],COFFIN-SIRIS SYNDROME;COFFIN-SIRIS SYNDROME 5;Coffin Siris;Familial multiple meningioma;MENINGIOMA FAMILIAL SUSCEPTIBILITY TO,SMARCE1,6605,NM_003079
ACTN4_SIG,ACTN4,ACTN4_SIG,ACTN4,SIG,25,3.04679624713688,0.34545156189125,0.338789630857568,0.367340763859064,0.0285511330014958,0.004978800441806,3.04392914428743,8.69196680881724,8.65284803785791,8.82049991339791,0.167651875540006,0.00960101359505149,ENSG00000130402,ACTN4,protein_coding,19,1,38647649,38731589,q13.2,actinin alpha 4 [Source:HGNC Symbol;Acc:HGNC:166],Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1,ACTN4,81,NM_001322033;NM_004924
PHYKPL_SIG,PHYKPL,PHYKPL_SIG,PHYKPL,SIG,81,3.04678590991079,0.186076594812624,0.179150018022231,0.208835347123915,0.0296853291016832,0.004978800441806,3.01723003360361,6.10490985732362,6.05022212154129,6.28459813203699,0.234376010495705,0.0102889982020618,ENSG00000175309,PHYKPL,protein_coding,5,-1,178208471,178232802,q35.3,5-phosphohydroxy-L-lysine phospho-lyase [Source:HGNC Symbol;Acc:HGNC:28249],Phosphohydroxylysinuria,PHYKPL,85007,NM_001278346;NM_153373
NOTCH3_SIG,NOTCH3,NOTCH3_SIG,NOTCH3,SIG,26,3.04659642322306,-0.0291496921354071,-0.0327236455938426,-0.0174067022005476,0.0153169433932949,0.00498064572310864,1.78044020934413,1.83393367715228,1.76191721107243,2.07055920855749,0.308641997485063,0.1428578081478,ENSG00000074181,NOTCH3,protein_coding,19,-1,15159038,15200995,p13.12,notch 3 [Source:HGNC Symbol;Acc:HGNC:7883],CADASIL;CEREBRAL ARTERIOPATHY AUTOSOMAL DOMINANT WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY TYPE 1;Infantile myofibromatosis;Lateral meningocele syndrome;MYOFIBROMATOSIS INFANTILE 2,NOTCH3,4854,NM_000435
ZDHHC11_SIG,ZDHHC11,ZDHHC11_SIG,ZDHHC11,SIG,21,3.04566257553466,-0.0773570665720053,-0.080933883242778,-0.0656046689394665,0.0153292143033114,0.00499484221407718,0.648829709304666,1.38555369151397,1.37209642393975,1.42977042782925,0.057674003889497,0.621468969676112,ENSG00000188818,ZDHHC11,protein_coding,5,-1,795606,850986,p15.33,zinc finger DHHC-type containing 11 [Source:HGNC Symbol;Acc:HGNC:19158],NA,ZDHHC11,79844,NM_024786
ZNF582_TF,ZNF582,ZNF582_TF,ZNF582,TF,16,3.04513285339439,0.0284699486496039,0.0201100313425096,0.0559382483729137,0.0358282170304042,0.00500234940037506,1.61000412460342,1.73566683296928,1.71154529159694,1.81492332604984,0.103378034452901,0.187739151940576,ENSG00000018869,ZNF582,protein_coding,19,-1,56375846,56393545,q13.43,zinc finger protein 582 [Source:HGNC Symbol;Acc:HGNC:26421],NA,ZNF582,147948,NM_001320371;NM_144690
MASTL_SIG,MASTL,MASTL_SIG,MASTL,SIG,29,-3.04478645234133,0.114157616996396,0.122032928081348,0.0882815948601243,-0.0337513332212243,0.00500681440407522,-1.38134334509082,4.43336673627202,4.45618126031288,4.3584047287092,-0.0977765316036708,0.263690129312774,ENSG00000120539,MASTL,protein_coding,10,1,27154824,27186924,p12.1,microtubule associated serine/threonine kinase like [Source:HGNC Symbol;Acc:HGNC:19042],Autosomal thrombocytopenia with normal platelets,MASTL,84930,NM_001172303;NM_001172304;NM_001320756;NM_001320757;NM_032844
NUDT9_SIG,NUDT9,NUDT9_SIG,NUDT9,SIG,51,3.04160137619115,0.37361870933326,0.360915872194878,0.415356602787945,0.0544407305930664,0.00505877946449466,3.18212121553541,4.00330117475432,3.94590773038234,4.19187963483368,0.245971904451345,0.00666689987692882,ENSG00000170502,NUDT9,protein_coding,4,1,87422573,87459455,q22.1,nudix hydrolase 9 [Source:HGNC Symbol;Acc:HGNC:8056],NA,NUDT9,53343,NM_001248011;NM_024047;NM_198038
NDUFB4_SIG,NDUFB4,NDUFB4_SIG,NDUFB4,SIG,14,3.04087758839504,0.270419034785174,0.267325516935985,0.280583450575368,0.0132579336393835,0.00506954762256727,1.39695591035925,5.46111192455738,5.45005320392171,5.4974477209317,0.0473945170099837,0.257700535942939,ENSG00000065518,NDUFB4,protein_coding,3,1,120596328,120602507,q13.33,NADH:ubiquinone oxidoreductase subunit B4 [Source:HGNC Symbol;Acc:HGNC:7699],NA,NDUFB4,4710,NM_001168331;NM_004547
YWHAZ_SIG,YWHAZ,YWHAZ_SIG,YWHAZ,SIG,20,-3.0408049844198,0.371368739032641,0.374674867117258,0.360505746754615,-0.0141691203626427,0.00506954762256727,-1.97881074890424,9.35697322736815,9.37714895397376,9.29068155423541,-0.08646739973835,0.100980815167555,ENSG00000164924,YWHAZ,protein_coding,8,-1,100916523,100953388,q22.3,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [Source:HGNC Symbol;Acc:HGNC:12855],NA,YWHAZ,7534,NM_001135699;NM_001135700;NM_001135701;NM_001135702;NM_003406;NM_145690
RDH10_SIG,RDH10,RDH10_SIG,RDH10,SIG,30,-3.04070150853476,-0.0361670585302655,-0.0313055197237625,-0.0521406860373467,-0.0208351663135843,0.00506997521220271,0.51863590146588,2.45819197156865,2.44742880348281,2.49355666670783,0.0461278632250198,0.698849071875122,ENSG00000121039,RDH10,protein_coding,8,1,73294602,73325281,q21.11,retinol dehydrogenase 10 [Source:HGNC Symbol;Acc:HGNC:19975],NA,RDH10,157506,NM_172037
NAALADL1_SIG,NAALADL1,NAALADL1_SIG,NAALADL1,SIG,33,3.04001558303825,0.0168656630492098,0.0127016829603075,0.030547311912746,0.0178456289524387,0.00508021915498488,3.116802154183,2.95386821066527,2.85110794793571,3.29150907391953,0.440401125983823,0.00796481638689064,ENSG00000168060,NAALADL1,protein_coding,11,-1,65044818,65058553,q13.1,N-acetylated alpha-linked acidic dipeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:23536],NA,NAALADL1,10004,NM_005468
NABP1_SIG,NABP1,NABP1_SIG,NABP1,SIG,37,3.03769424606843,0.0267001504644528,0.0235645301650678,0.037002902876718,0.0134383727116501,0.00511818711674343,2.79490273904575,6.22838379318286,6.15823859444659,6.45886087474487,0.300622280298277,0.0179146332011847,ENSG00000173559,NABP1,protein_coding,2,1,191678068,191696659,q32.3,nucleic acid binding protein 1 [Source:HGNC Symbol;Acc:HGNC:26232],ACUTE PROMYELOCYTIC LEUKEMIA,NABP1,64859,NM_001031716;NM_001254736
MBNL2_TF,MBNL2,MBNL2_TF,MBNL2,TF,80,3.03716793045387,0.0224852597574429,0.0186503055501281,0.035085823581477,0.0164355180313488,0.00512580437937556,2.4722945835027,4.65873767310604,4.60820439496826,4.82477558698735,0.216571192019094,0.0375026395582042,ENSG00000139793,MBNL2,protein_coding,13,1,97221434,97394120,q32.1,muscleblind like splicing regulator 2 [Source:HGNC Symbol;Acc:HGNC:16746],NA,MBNL2,10150,NM_001306070;NM_144778;NM_207304
CES4A_SIG,CES4A,CES4A_SIG,CES4A,SIG,45,-3.03590835830513,-0.0600950577863738,-0.0536974728332257,-0.0811156940610029,-0.0274182212277772,0.00514593216658746,-1.66377406464428,1.87508874349118,1.92777171706478,1.70198754460652,-0.225784172458256,0.172719117060173,ENSG00000172824,CES4A,protein_coding,16,1,66988589,67009758,q22.1,carboxylesterase 4A [Source:HGNC Symbol;Acc:HGNC:26741],NA,CES4A,283848,NM_001190201;NM_001190202;NM_001318506;NM_173815
MRPS9_SIG,MRPS9,MRPS9_SIG,MRPS9,SIG,20,3.03555811603777,0.321086336457786,0.308853217218032,0.361280871102692,0.0524276538846597,0.00515057873659056,2.80805665960808,3.98039269425883,3.93638145450333,4.12500105345547,0.188619598952136,0.0173642921088063,ENSG00000135972,MRPS9,protein_coding,2,1,105038069,105099960,q12.1,mitochondrial ribosomal protein S9 [Source:HGNC Symbol;Acc:HGNC:14501],NA,MRPS9,64965,NM_182640
EFNA3_SIG,EFNA3,EFNA3_SIG,EFNA3,SIG,9,3.03506012047582,0.161453992957408,0.153221199364683,0.188504600476362,0.0352834011116782,0.00515775550942116,2.38545280110469,0.587354672213679,0.564972524888736,0.660896013424206,0.0959234885354703,0.0452026089426419,ENSG00000143590,EFNA3,protein_coding,1,1,155078837,155087538,q21.3,ephrin A3 [Source:HGNC Symbol;Acc:HGNC:3223],NA,EFNA3,1944,NM_004952
UTP6_SIG,UTP6,UTP6_SIG,UTP6,SIG,26,3.0347668647489,0.231143807430373,0.217678324410658,0.275387537352292,0.0577092129416346,0.00516143676015509,2.7400832241234,5.53257646729277,5.47827566396408,5.71099339251561,0.232717728551529,0.0203530384737873,ENSG00000108651,UTP6,protein_coding,17,-1,31860904,31901708,q11.2,UTP6, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:18279],NA,UTP6,55813,NM_018428
SLC13A3_SIG,SLC13A3,SLC13A3_SIG,SLC13A3,SIG,17,3.03433415994036,-0.171957475173621,-0.175883717941707,-0.159056963221337,0.0168267547203696,0.00516750888971512,0.749201493172667,0.263910117463491,0.2571691642912,0.286058963601017,0.0288897993098168,0.563824342375337,ENSG00000158296,SLC13A3,protein_coding,20,-1,46557823,46684467,q13.12,solute carrier family 13 member 3 [Source:HGNC Symbol;Acc:HGNC:14430],NA,SLC13A3,64849,NM_001011554;NM_001193339;NM_001193340;NM_001193342;NM_022829
RNF175_SIG,RNF175,RNF175_SIG,RNF175,SIG,23,-3.03359251731762,-0.106046360710954,-0.0998267934428153,-0.126482081734838,-0.026655288292023,0.00517888791383817,-1.8668243427738,0.95331190949529,1.00392895027387,0.786998775508536,-0.216930174765331,0.123263910594772,ENSG00000145428,RNF175,protein_coding,4,-1,153710125,153760235,q31.3,ring finger protein 175 [Source:HGNC Symbol;Acc:HGNC:27735],NA,RNF175,285533,NM_173662
RNPC3_SIG,RNPC3,RNPC3_SIG,RNPC3,SIG,57,3.03336381553793,0.215905976310019,0.209777604484859,0.236042055164114,0.0262644506792546,0.00518147458005654,2.39068346565326,5.11621924346358,5.07822463252009,5.24105867942073,0.162834046900635,0.0447007680655925,ENSG00000185946,RNPC3,protein_coding,1,1,103525691,103555239,p21.1,RNA binding region (RNP1, RRM) containing 3 [Source:HGNC Symbol;Acc:HGNC:18666],Isolated growth hormone deficiency type IA;ISOLATED GROWTH HORMONE DEFICIENCY TYPE V,RNPC3,55599,NM_017619
AKR1C3_SIG,AKR1C3,AKR1C3_SIG,AKR1C3,SIG,36,3.03199735946767,0.065133447745446,0.0546530119781012,0.0995691652667215,0.0449161532886204,0.0052036424801441,2.87549998583262,3.93244952750713,3.82981408120012,4.26968027965875,0.439866198458636,0.0147465591406331,ENSG00000196139,AKR1C3,protein_coding,10,1,5035354,5107686,p15.1,aldo-keto reductase family 1 member C3 [Source:HGNC Symbol;Acc:HGNC:386],NA,AKR1C3,8644,NM_001253908;NM_001253909;NM_003739
METTL5_SIG,METTL5,METTL5_SIG,METTL5,SIG,42,3.03058921591073,0.258726077927593,0.24794974876234,0.294134016613425,0.0461842678510843,0.00522661798018588,2.90386012194893,4.18615344817228,4.14443518334375,4.32322774689458,0.178792563550831,0.0137317352560364,ENSG00000138382,METTL5,protein_coding,2,-1,169810081,169824931,q31.1,methyltransferase like 5 [Source:HGNC Symbol;Acc:HGNC:25006],NA,METTL5,29081,NM_001293186;NM_001293187;NM_014168
DLG1_SIG,DLG1,DLG1_SIG,DLG1,SIG,45,3.03044057000376,0.154716003862312,0.149323311671898,0.172434849630817,0.0231115379589193,0.00522784013708177,-0.625716077819497,5.98665188679315,5.99359061863412,5.9638531964585,-0.0297374221756189,0.635152926529261,ENSG00000075711,DLG1,protein_coding,3,-1,197042560,197299300,q29,discs large MAGUK scaffold protein 1 [Source:HGNC Symbol;Acc:HGNC:2900],Cleft lip/palate,DLG1,1739,NM_001098424;NM_001204386;NM_001204387;NM_001204388;NM_001290983;NM_001363865;NM_001366205;NM_001366207;NM_001366210;NM_001366213;NM_001366214;NM_004087
PTER_SIG,PTER,PTER_SIG,PTER,SIG,36,3.03003621905913,0.279269008739954,0.269199196159852,0.312355535788859,0.0431563396290066,0.00523349202539593,3.39122684971977,3.83419708307515,3.76825937998159,4.05084953609687,0.282590156115287,0.00370571241722456,ENSG00000165983,PTER,protein_coding,10,1,16436943,16513745,p13,phosphotriesterase related [Source:HGNC Symbol;Acc:HGNC:9590],NA,PTER,9317,NM_001001484;NM_001261836;NM_001261837;NM_001261838;NM_030664
NME1_SIG,NME1,NME1_SIG,NME1,SIG,25,3.0295319433633,0.602657533972038,0.590546456476957,0.642451074313022,0.0519046178360653,0.00524088303476426,4.15607135405316,4.02855867054435,3.93255733880227,4.34399161769687,0.411434278894599,0.000334866900149332,ENSG00000239672,NME1,protein_coding,17,1,51153536,51162428,q21.33,NME/NM23 nucleoside diphosphate kinase 1 [Source:HGNC Symbol;Acc:HGNC:7849],NEUROBLASTOMA SUSCEPTIBILITY TO NEUROBLASTOMA SUSCEPTIBILITY TO 1 INCLUDED,NME1,4830,NM_000269;NM_198175
DUOX1_SIG,DUOX1,DUOX1_SIG,DUOX1,SIG,36,-3.02842020669556,-0.142192097617026,-0.138476966217386,-0.154398957930128,-0.0159219917127413,0.00525884629769446,-2.45357844440752,0.302921045415528,0.345615580959082,0.162639000058136,-0.182976580900946,0.0390576900948436,ENSG00000137857,DUOX1,protein_coding,15,1,45129933,45165576,q21.1,dual oxidase 1 [Source:HGNC Symbol;Acc:HGNC:3062],NA,DUOX1,53905,NM_017434;NM_175940
HHIPL2_SIG,HHIPL2,HHIPL2_SIG,HHIPL2,SIG,6,3.02794322554018,0.205847810333588,0.200080093834382,0.22479887883098,0.0247187849965974,0.00526579419781195,1.27602084110505,0.289884102431903,0.282559433124232,0.313950873014248,0.031391439890016,0.30465648998226,ENSG00000143512,HHIPL2,protein_coding,1,-1,222522258,222548104,q41,HHIP like 2 [Source:HGNC Symbol;Acc:HGNC:25842],NA,HHIPL2,79802,NM_024746
XPOT_SIG,XPOT,XPOT_SIG,XPOT,SIG,20,3.02768474096412,0.0423539037202954,0.0333292164743096,0.0720064475285344,0.038677231054225,0.00526893996348799,2.22151800734561,6.7635538481284,6.73413080311704,6.86022956745143,0.126098764334386,0.0635509672120245,ENSG00000184575,XPOT,protein_coding,12,1,64404392,64451125,q14.2,exportin for tRNA [Source:HGNC Symbol;Acc:HGNC:12826],NA,XPOT,11260,NM_007235
CTSZ_SIG,CTSZ,CTSZ_SIG,CTSZ,SIG,109,-3.02692449498225,0.256808760337877,0.271664838908864,0.207995930747492,-0.0636689081613717,0.00528084662560733,-1.74442805923206,7.70777705684946,7.7545511255417,7.55409083114639,-0.200460294395316,0.151526974118096,ENSG00000101160,CTSZ,protein_coding,20,-1,58995185,59007254,q13.32,cathepsin Z [Source:HGNC Symbol;Acc:HGNC:2547],NA,CTSZ,1522,NM_001336
KYNU_SIG,KYNU,KYNU_SIG,KYNU,SIG,10,-3.02646152495692,0.21410813498176,0.229793770049484,0.16256961975924,-0.0672241502902442,0.00528757608296474,-3.67463033423558,3.42677103351836,3.57908733223177,2.92630319488856,-0.65278413734321,0.00158821520353213,ENSG00000115919,KYNU,protein_coding,2,1,142877657,143055833,q22.2,kynureninase [Source:HGNC Symbol;Acc:HGNC:6469],Congenital vertebral-cardiac-renal anomalies syndrome;Hydroxykynureninuria;VERTEBRAL CARDIAC RENAL AND LIMB DEFECTS SYNDROME 2,KYNU,8942,NM_001032998;NM_001199241;NM_003937
TRMT2A_SIG,TRMT2A,TRMT2A_SIG,TRMT2A,SIG,12,3.02601467993878,0.420137948739356,0.410446786876327,0.451980337717878,0.0415335508415508,0.00529403107450814,2.1494511927916,5.61739210260859,5.59230335076512,5.69982657295141,0.107523222186284,0.0732048210190764,ENSG00000099899,TRMT2A,protein_coding,22,-1,20111875,20117392,q11.21,tRNA methyltransferase 2 homolog A [Source:HGNC Symbol;Acc:HGNC:24974],NA,TRMT2A,27037,NM_001257994;NM_001331039;NM_022727;NM_182984
SLC12A4_SIG,SLC12A4,SLC12A4_SIG,SLC12A4,SIG,30,3.02513894433038,0.0942686587434102,0.0879568866522709,0.115007338471439,0.0270504518191685,0.00530801581208258,2.69885170166821,4.94975572419759,4.89168619680719,5.14055559990893,0.248869403101741,0.0224654262982869,ENSG00000124067,SLC12A4,protein_coding,16,-1,67943474,67969601,q22.1,solute carrier family 12 member 4 [Source:HGNC Symbol;Acc:HGNC:10913],NA,SLC12A4,6560,NM_001145961;NM_001145962;NM_001145963;NM_001145964;NM_005072
PGD_SIG,PGD,PGD_SIG,PGD,SIG,60,-3.02504713992607,0.292566767314213,0.300686562704837,0.265887439602162,-0.0347991231026745,0.00530825881729228,-0.57782442697847,8.6977434941313,8.70909976044032,8.6604300476874,-0.0486697127529165,0.664221468680565,ENSG00000142657,PGD,protein_coding,1,1,10398592,10420511,p36.22,phosphogluconate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:8891],NA,PGD,5226,NM_001304451;NM_001304452;NM_002631
NR4A1_TF,NR4A1,NR4A1_TF,NR4A1,TF,59,-3.02448192929156,0.0888925552982534,0.0970626245056196,0.0620480421883362,-0.0350145823172832,0.0053168170936108,-3.08141419261433,5.18066474489285,5.32953517283113,4.69151905309563,-0.638016119735506,0.00869662707258504,ENSG00000123358,NR4A1,protein_coding,12,1,52022832,52059507,q13.13,nuclear receptor subfamily 4 group A member 1 [Source:HGNC Symbol;Acc:HGNC:7980],NA,NR4A1,3164,NM_001202233;NM_001202234;NM_002135;NM_173157
BCL3_TF,BCL3,BCL3_TF,BCL3,TF,161,-3.02331953552066,0.0708357953838907,0.0817947083930731,0.0348279383537203,-0.0469667700393526,0.00533590917280757,-2.04769459399765,5.60216298248507,5.66495972585795,5.39583082568845,-0.269128900169503,0.0889418844992072,ENSG00000069399,BCL3,protein_coding,19,1,44747705,44760044,q13.32,BCL3, transcription coactivator [Source:HGNC Symbol;Acc:HGNC:998],NA,BCL3,602,NM_005178
PIK3R3_SIG,PIK3R3,PIK3R3_SIG,PIK3R3,SIG,34,-3.02131753330967,-0.0651341299691731,-0.0611835187762797,-0.0781147096029657,-0.0169311908266858,0.00536993624667715,-1.53872105303334,1.58902986695259,1.63111452176721,1.45075171541886,-0.180362806348346,0.209484170275826,ENSG00000117461,PIK3R3,protein_coding,1,-1,46040140,46133036,p34.1,phosphoinositide-3-kinase regulatory subunit 3 [Source:HGNC Symbol;Acc:HGNC:8981],NA,PIK3R3,8503,NM_001114172;NM_001303428;NM_001303429;NM_001328648;NM_001328649;NM_001328650;NM_001328651;NM_001328652;NM_001328653;NM_001328654;NM_003629
HSD3B7_SIG,HSD3B7,HSD3B7_SIG,HSD3B7,SIG,17,3.02102352875688,-0.120517675082314,-0.123752991617479,-0.109887349323915,0.0138656422935645,0.00537376924282873,2.03345606399779,2.52187174918268,2.46062491535453,2.7231113460466,0.262486430692062,0.0913185828209256,ENSG00000099377,HSD3B7,protein_coding,16,1,30985207,30989147,p11.2,hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 [Source:HGNC Symbol;Acc:HGNC:18324],BILE ACID SYNTHESIS DEFECT CONGENITAL 1;Congenital bile acid synthesis defect type 1,HSD3B7,80270,NM_001142777;NM_001142778;NM_025193
ACOT4_SIG,ACOT4,ACOT4_SIG,ACOT4,SIG,27,3.01983347852576,-0.0521977289221609,-0.0560965550553708,-0.0393873001987571,0.0167092548566138,0.00539353919565097,1.9936956800105,1.04628141153065,1.00949620584595,1.1671470873518,0.157650881505847,0.0982336028212345,ENSG00000177465,ACOT4,protein_coding,14,1,73591706,73596496,q24.3,acyl-CoA thioesterase 4 [Source:HGNC Symbol;Acc:HGNC:19748],NA,ACOT4,122970,NM_152331
NAPSB_SIG,NAPSB,NAPSB_SIG,NAPSB,SIG,35,-3.01952108696129,-0.0101157577317496,0.00917420249477466,-0.0734970556189006,-0.0826712581136752,0.00539771519708505,-1.82763950439354,3.34316987814799,3.44796314521894,2.99884914348627,-0.449114001732674,0.131830337008268,ENSG00000131401,NAPSB,transcribed_unprocessed_pseudogene,19,-1,50333796,50344767,q13.33,napsin B aspartic peptidase, pseudogene [Source:HGNC Symbol;Acc:HGNC:13396],NA,NAPSB,NA,NA
CHPF_SIG,CHPF,CHPF_SIG,CHPF,SIG,96,-3.0191693544927,-0.115211938288588,-0.111316118309544,-0.128012489648304,-0.0166963713387595,0.00540259584530498,-0.939336830592492,1.89997411300792,1.92417370550884,1.8204611662192,-0.103712539289638,0.461142125682644,ENSG00000123989,CHPF,protein_coding,2,-1,219538948,219543809,q35,chondroitin polymerizing factor [Source:HGNC Symbol;Acc:HGNC:24291],NA,CHPF,79586,NM_001195731;NM_024536
CPSF4_SIG,CPSF4,CPSF4_SIG,CPSF4,SIG,25,3.0175655632838,0.338578966069399,0.334815906847689,0.350943303512161,0.0161273966644716,0.00542982851101772,2.39148454857953,4.87910930607086,4.85211545187079,4.96780339844253,0.115687946571746,0.0446272007131717,ENSG00000160917,CPSF4,protein_coding,7,1,99438922,99457373,q22.1,cleavage and polyadenylation specific factor 4 [Source:HGNC Symbol;Acc:HGNC:2327],NA,CPSF4,10898,NM_001081559;NM_001318160;NM_001318161;NM_001318162;NM_006693
ACAT1_SIG,ACAT1,ACAT1_SIG,ACAT1,SIG,38,-3.01747367243218,0.174213471176458,0.180574981009675,0.153311367438742,-0.0272636135709329,0.00542982851101772,-1.67367128805185,4.70934890160492,4.74629838919407,4.58794344238342,-0.158354946810642,0.170117534972731,ENSG00000075239,ACAT1,protein_coding,11,1,108121516,108147776,q22.3,acetyl-CoA acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:93],ALPHA-METHYLACETOACETIC ACIDURIA;Beta-ketothiolase deficiency,ACAT1,38,NM_000019
COX10_SIG,COX10,COX10_SIG,COX10,SIG,14,3.01741198342584,0.459000083147478,0.447504262386865,0.496772065646634,0.049267803259769,0.00542982851101772,2.13790031629137,4.12697707180021,4.09599563940455,4.22877320681452,0.132777567409971,0.0748608795994549,ENSG00000006695,COX10,protein_coding,17,1,14069496,14208677,p12,cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 [Source:HGNC Symbol;Acc:HGNC:2260],Isolated cytochrome C oxidase deficiency;Leigh syndrome;MITOCHONDRIAL COMPLEX IV DEFICIENCY,COX10,1352,NM_001303
GUSB_SIG,GUSB,GUSB_SIG,GUSB,SIG,40,-3.01716288778491,0.179573730022845,0.184092329385654,0.164726903545043,-0.0193654258406105,0.00543222609478192,-0.590303425621856,7.01647321988895,7.02586060522366,6.98562895378921,-0.0402316514344543,0.657175619021582,ENSG00000169919,GUSB,protein_coding,7,-1,65960684,65982215,q11.21,glucuronidase beta [Source:HGNC Symbol;Acc:HGNC:4696],Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS TYPE VII,GUSB,2990,NM_000181;NM_001284290;NM_001293104;NM_001293105
L2HGDH_SIG,L2HGDH,L2HGDH_SIG,L2HGDH,SIG,12,3.01709025355531,0.429714368018355,0.418447869449975,0.46673286331446,0.0482849938644846,0.00543222609478192,3.80955756947319,2.34465273966421,2.27980158116897,2.55773511757716,0.277933536408191,0.00104371308641222,ENSG00000087299,L2HGDH,protein_coding,14,-1,50237563,50312229,q21.3,L-2-hydroxyglutarate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:20499],L-2-HYDROXYGLUTARIC ACIDURIA,L2HGDH,79944,NM_024884
TFAP4_TF,TFAP4,TFAP4_TF,TFAP4,TF,273,3.01704449968826,0.283821102748736,0.273511134184078,0.317696713746899,0.0441855795628207,0.00543222609478192,2.66762307033052,3.46420193930323,3.39984896859206,3.67564741449707,0.275798445905009,0.0241288558820279,ENSG00000090447,TFAP4,protein_coding,16,-1,4257186,4273075,p13.3,transcription factor AP-4 [Source:HGNC Symbol;Acc:HGNC:11745],NA,TFAP4,7023,NM_003223
DCAF16_SIG,DCAF16,DCAF16_SIG,DCAF16,SIG,116,3.01676185738627,0.247354574023048,0.238760851281221,0.275591091603339,0.0368302403221178,0.00543473083340232,3.50556995319987,5.72249528036868,5.65999901497747,5.92784015236838,0.267841137390908,0.00266254848494358,ENSG00000163257,DCAF16,protein_coding,4,-1,17800655,17810758,p15.31,DDB1 and CUL4 associated factor 16 [Source:HGNC Symbol;Acc:HGNC:25987],NA,DCAF16,54876,NM_001345880;NM_001345881;NM_001345882;NM_001345884;NM_001345885;NM_017741
TGM2_SIG,TGM2,TGM2_SIG,TGM2,SIG,28,-3.01674906166371,-0.113079726793191,-0.106304691621589,-0.135340556642741,-0.0290358650211519,0.00543473083340232,0.592961936013416,2.72046073157954,2.6952443201941,2.80331465470314,0.108070334509039,0.655676755611052,ENSG00000198959,TGM2,protein_coding,20,-1,38127385,38166578,q11.23,transglutaminase 2 [Source:HGNC Symbol;Acc:HGNC:11778],NA,TGM2,7052,NM_001323316;NM_001323317;NM_001323318;NM_004613;NM_198951
TBXAS1_SIG,TBXAS1,TBXAS1_SIG,TBXAS1,SIG,46,3.01666893335124,0.307259336306222,0.300075788150057,0.330862423105046,0.0307866349549892,0.00543477217796347,3.86088905176984,6.32353135304229,6.22653773118387,6.64222468200564,0.415686950821768,0.000888128947798408,ENSG00000059377,TBXAS1,protein_coding,7,1,139777051,140020325,q34,thromboxane A synthase 1 [Source:HGNC Symbol;Acc:HGNC:11609],BLEEDING DISORDER PLATELET-TYPE 14;GHOSAL HEMATODIAPHYSEAL DYSPLASIA;Ghosal hematodiaphyseal syndrome,TBXAS1,6916,NM_001061;NM_001130966;NM_001166253;NM_001166254;NM_001314028;NM_030984
ASIC4_SIG,ASIC4,ASIC4_SIG,ASIC4,SIG,20,-3.01501492727345,-0.125880417036485,-0.120169144555809,-0.14464602661585,-0.0244768820600404,0.0054623399726111,-2.48469095032507,0.323877909651667,0.368393789755733,0.177611446452593,-0.190782343303139,0.0365211589582184,ENSG00000072182,ASIC4,protein_coding,2,1,219514170,219538772,q35,acid sensing ion channel subunit family member 4 [Source:HGNC Symbol;Acc:HGNC:21263],NA,ASIC4,55515,NM_018674;NM_182847
SCARF1_SIG,SCARF1,SCARF1_SIG,SCARF1,SIG,70,3.01497906114634,0.0623876039023829,0.0550871186197482,0.0863749126881827,0.0312877940684347,0.0054623399726111,2.01045164372442,4.74243154344308,4.67844905653288,4.95265971471942,0.274210658186536,0.0952347944803694,ENSG00000074660,SCARF1,protein_coding,17,-1,1633858,1645744,p13.3,scavenger receptor class F member 1 [Source:HGNC Symbol;Acc:HGNC:16820],NA,SCARF1,8578,NM_003693;NM_145350
GNAZ_SIG,GNAZ,GNAZ_SIG,GNAZ,SIG,23,-3.01393998041519,-0.18207636625926,-0.172273927577559,-0.214284379070565,-0.0420104514930057,0.00547967683711526,-1.93477546427021,1.03601858829585,1.09043189820266,0.857231998602065,-0.23319989960059,0.109324492947804,ENSG00000128266,GNAZ,protein_coding,22,1,23070519,23125032,q11.22,G protein subunit alpha z [Source:HGNC Symbol;Acc:HGNC:4395],NA,GNAZ,2781,NM_002073
ZNF420_TF,ZNF420,ZNF420_TF,ZNF420,TF,66,3.0136816693522,0.125153867939928,0.115070930136482,0.158283520722678,0.0432125905861961,0.00548293785373298,2.48903604076063,2.27203399464544,2.22345860121585,2.43163885877125,0.208180257555401,0.0361447037851695,ENSG00000197050,ZNF420,protein_coding,19,1,37007857,37130368,q13.12,zinc finger protein 420 [Source:HGNC Symbol;Acc:HGNC:20649],NA,ZNF420,147923,NM_001329515;NM_001329516;NM_001329517;NM_001329520;NM_001329521;NM_001329522;NM_001329524;NM_144689
ITGB3BP_SIG,ITGB3BP,ITGB3BP_SIG,ITGB3BP,SIG,43,3.01274478818813,0.196683977812158,0.187887958344011,0.225585184636071,0.0376972262920608,0.00549848206645122,2.74967720549682,3.73362291714636,3.69271415292118,3.86803742817196,0.175323275250782,0.0199481185962404,ENSG00000142856,ITGB3BP,protein_coding,1,-1,63440770,63593721,p31.3,integrin subunit beta 3 binding protein [Source:HGNC Symbol;Acc:HGNC:6157],NA,ITGB3BP,23421,NM_001206739;NM_001347145;NM_001347147;NM_001347148;NM_014288
ZNF526_TF,ZNF526,ZNF526_TF,ZNF526,TF,42,3.01120009510063,0.291820106064783,0.283942449037552,0.317703836297116,0.0337613872595637,0.00552511646419962,3.98873907249459,3.46873268072337,3.41384166816892,3.64908886483086,0.235247196661939,0.000589109786205473,ENSG00000167625,ZNF526,protein_coding,19,1,42220271,42228201,q13.2,zinc finger protein 526 [Source:HGNC Symbol;Acc:HGNC:29415],Autosomal Recessive Mental Retardation,ZNF526,116115,NM_001314033;NM_133444
GAL3ST2_SIG,GAL3ST2,GAL3ST2_SIG,GAL3ST2,SIG,22,3.01013030841644,0.0132984345017606,0.00365164506817765,0.0449950283549617,0.0413433832867841,0.00554319418479167,2.80850307780035,0.77480284101672,0.701814297583935,1.0146223408673,0.312808043283364,0.0173428814622542,ENSG00000154252,GAL3ST2,protein_coding,2,1,241776825,241804208,q37.3,galactose-3-O-sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:24869],NA,GAL3ST2,64090,NM_022134
USF1_TF,USF1,USF1_TF,USF1,TF,186,-3.0090549366301,0.0676216759850241,0.0728230315530777,0.050531507689991,-0.0222915238630868,0.00556142773907274,-2.09100415637939,6.29626044403908,6.32027026356419,6.21737103702799,-0.102899226536195,0.081710538584117,ENSG00000158773,USF1,protein_coding,1,-1,161039251,161045977,q23.3,upstream transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:12593],HYPERLIPIDEMIA COMBINED 1,USF1,7391,NM_001276373;NM_007122;NM_207005
TLR4_SIG,TLR4,TLR4_SIG,TLR4,SIG,48,-3.008820860911,0.39922650343093,0.412816366320369,0.3545740967942,-0.0582422695261687,0.00556428884918442,-2.35149370332111,5.70815153265026,5.8151509396737,5.35658205243036,-0.458568887243348,0.048595758787708,ENSG00000136869,TLR4,protein_coding,9,1,117704175,117724735,q33.1,toll like receptor 4 [Source:HGNC Symbol;Acc:HGNC:11850],Behcet disease,TLR4,7099,NM_003266;NM_138554;NM_138557
BIRC5_SIG,BIRC5,BIRC5_SIG,BIRC5,SIG,51,-3.00789732296189,0.256883186203329,0.290198482688507,0.147418640609174,-0.142779842079333,0.00557979691145437,-3.22856427926549,3.70610106123756,3.82430591752912,3.31771367627961,-0.506592241249509,0.00586424442284361,ENSG00000089685,BIRC5,protein_coding,17,1,78214186,78225636,q25.3,baculoviral IAP repeat containing 5 [Source:HGNC Symbol;Acc:HGNC:593],NA,BIRC5,332,NM_001012270;NM_001012271;NM_001168
NT5E_SIG,NT5E,NT5E_SIG,NT5E,SIG,51,-3.00753065316773,-0.085948862468741,-0.0808957929211657,-0.102551805267917,-0.0216560123467512,0.00558510279932812,-3.80946468556165,2.00501478865269,2.18694314971404,1.40725017373683,-0.779692975977204,0.00104371308641222,ENSG00000135318,NT5E,protein_coding,6,1,85449584,85495791,q14.3,5'-nucleotidase ecto [Source:HGNC Symbol;Acc:HGNC:8021],CALCIFICATION OF JOINTS AND ARTERIES;Hereditary arterial and articular multiple calcification syndrome,NT5E,4907,NM_001204813;NM_002526
ABCB1_SIG,ABCB1,ABCB1_SIG,ABCB1,SIG,89,-3.00744907789832,-0.00994391162315837,-0.00182949543276961,-0.03660556482015,-0.0347760693873803,0.00558517244319365,-2.58825245630044,3.13091864050892,3.24964656708943,2.74081259603009,-0.508833971059341,0.0289405432446472,ENSG00000085563,ABCB1,protein_coding,7,-1,87503633,87713323,q21.12,ATP binding cassette subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:40],COLCHICINE RESISTANCE;INFLAMMATORY BOWEL DISEASE 13,ABCB1,5243,NM_000927;NM_001348944;NM_001348945;NM_001348946
EOGT_SIG,EOGT,EOGT_SIG,EOGT,SIG,20,3.00729986697587,0.197891325196043,0.194054322704549,0.210498619096665,0.0164442963921159,0.00558648536092286,2.53830271966009,4.61854118282145,4.58060392419024,4.74319217546685,0.162588251276616,0.0324926509017305,ENSG00000163378,EOGT,protein_coding,3,-1,68975217,69013684,p14.1,EGF domain specific O-linked N-acetylglucosamine transferase [Source:HGNC Symbol;Acc:HGNC:28526],Adams-Oliver syndrome;ADAMS-OLIVER SYNDROME 4;Adams Oliver syndrome,EOGT,285203,NM_001278689;NM_173654
MEPCE_SIG,MEPCE,MEPCE_SIG,MEPCE,SIG,11,3.00660177421026,0.196762413680648,0.190444159568102,0.217522391479013,0.0270782319109115,0.00559789695395113,0.995619127623362,5.67779087903592,5.6647340435768,5.72069190983017,0.0559578662533705,0.432780168395837,ENSG00000146834,MEPCE,protein_coding,7,1,100428790,100434118,q22.1,methylphosphate capping enzyme [Source:HGNC Symbol;Acc:HGNC:20247],NA,MEPCE,56257,NM_001194990;NM_001194991;NM_001194992;NM_019606
HIRA_TF,HIRA,HIRA_TF,HIRA,TF,85,-3.00538722533448,0.0559479194769508,0.0595501923522179,0.0441118800296446,-0.0154383123225734,0.00561886402595196,-1.43379751097684,4.05729495245888,4.07087534903829,4.01267364941226,-0.0582016996260243,0.244235828560398,ENSG00000100084,HIRA,protein_coding,22,-1,19330698,19447450,q11.21,histone cell cycle regulator [Source:HGNC Symbol;Acc:HGNC:4916],22q11.2 Deletion Syndrome,HIRA,7290,NM_003325
SLC9A1_SIG,SLC9A1,SLC9A1_SIG,SLC9A1,SIG,25,-3.00436204314199,0.146534917484344,0.154311218036164,0.120984215671219,-0.0333270023649446,0.00563509584019087,-1.42232428334782,5.24713570270563,5.2691267254489,5.17487948512059,-0.0942472403283068,0.248241430611012,ENSG00000090020,SLC9A1,protein_coding,1,-1,27098809,27166981,p36.11,solute carrier family 9 member A1 [Source:HGNC Symbol;Acc:HGNC:11071],Lichtenstein-Knorr syndrome;Progressive autosomal recessive ataxia-deafness syndrome,SLC9A1,6548,NM_003047
SLC43A2_SIG,SLC43A2,SLC43A2_SIG,SLC43A2,SIG,43,-3.00435429462866,0.254770158241209,0.266443215722404,0.216415826517282,-0.0500273892051221,0.00563509584019087,-1.06774554752126,5.61018640660479,5.64832107826579,5.48488677114721,-0.16343430711858,0.397771418857572,ENSG00000167703,SLC43A2,protein_coding,17,-1,1569267,1628886,p13.3,solute carrier family 43 member 2 [Source:HGNC Symbol;Acc:HGNC:23087],NA,SLC43A2,124935,NM_001284498;NM_001284499;NM_001321364;NM_001321365;NM_152346
SLC4A11_SIG,SLC4A11,SLC4A11_SIG,SLC4A11,SIG,35,3.00328511445219,-0.0604463589700694,-0.0637725093765064,-0.0495175790632049,0.0142549303133015,0.00565348771646261,2.41131738256634,0.991511376699108,0.933175775041672,1.18318549643069,0.250009721389013,0.0427907976028607,ENSG00000088836,SLC4A11,protein_coding,20,-1,3227417,3239559,p13,solute carrier family 4 member 11 [Source:HGNC Symbol;Acc:HGNC:16438],Congenital hereditary endothelial dystrophy type II;Corneal dystrophy-perceptive deafness syndrome;CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS;Corneal dystrophy fuchs endothelial 4;Corneal endothelial dystrophy;Fuchs endothelial corneal dystrophy,SLC4A11,83959,NM_001174089;NM_001174090;NM_001363745;NM_032034
RAD54L2_SIG,RAD54L2,RAD54L2_SIG,RAD54L2,SIG,60,2.99974524903895,0.384096349624058,0.378836411075146,0.401379004856196,0.0225425937810502,0.00571814185359241,3.77551494803971,5.86316973877237,5.81507388820647,6.02119896206031,0.206125073853839,0.00116021440637373,ENSG00000164080,RAD54L2,protein_coding,3,1,51541144,51668667,p21.2,RAD54 like 2 [Source:HGNC Symbol;Acc:HGNC:29123],NA,RAD54L2,23132,NM_001322253;NM_001322256;NM_001322257;NM_015106
KTN1_SIG,KTN1,KTN1_SIG,KTN1,SIG,21,2.99814874588972,0.359105595711868,0.355031354604755,0.372492387920954,0.0174610333161993,0.00574629717238686,2.55719451956837,7.64731791339747,7.61592222745418,7.75047516721114,0.134552939756951,0.0310667447726299,ENSG00000126777,KTN1,protein_coding,14,1,55559072,55701526,q22.3,kinectin 1 [Source:HGNC Symbol;Acc:HGNC:6467],NA,KTN1,3895,NM_001079521;NM_001079522;NM_001271014;NM_004986
GAL_SIG,GAL,GAL_SIG,GAL,SIG,31,-2.99809310240404,-0.122324034414419,-0.118276057523346,-0.135624529913658,-0.0173484723903117,0.00574629717238686,-3.39973584879133,0.310682193388837,0.351682442980544,0.175967087587511,-0.175715355393033,0.00360617441287887,ENSG00000069482,GAL,protein_coding,11,1,68683779,68691175,q13.2,galanin and GMAP prepropeptide [Source:HGNC Symbol;Acc:HGNC:4114],EPILEPSY FAMILIAL TEMPORAL LOBE 8,GAL,51083,NM_015973
ZNF836_TF,ZNF836,ZNF836_TF,ZNF836,TF,43,2.99780975111928,0.21144260726664,0.203795656282534,0.236568303357277,0.0327726470747431,0.00575017416114384,2.07587155880604,2.12683013948877,2.09215543749986,2.2407613031666,0.148605865666733,0.0840932077984744,ENSG00000196267,ZNF836,protein_coding,19,-1,52153864,52171643,q13.41,zinc finger protein 836 [Source:HGNC Symbol;Acc:HGNC:34333],NA,ZNF836,162962,NM_001102657
RWDD3_SIG,RWDD3,RWDD3_SIG,RWDD3,SIG,17,2.99753556231849,0.154930449469698,0.151962893831744,0.164680989422973,0.0127180955912294,0.00575388074510739,0.834565097417604,2.13002258321383,2.12034129623045,2.16183252615921,0.0414912299287567,0.516649550071644,ENSG00000122481,RWDD3,protein_coding,1,1,95234210,95247225,p21.3,RWD domain containing 3 [Source:HGNC Symbol;Acc:HGNC:21393],NA,RWDD3,25950,NM_001128142;NM_001199682;NM_001278247;NM_001278248;NM_015485
SCMH1_SIG,SCMH1,SCMH1_SIG,SCMH1,SIG,56,2.99718005759744,0.274247445141207,0.264205839835156,0.307241291146802,0.0430354513116454,0.00575912577976634,1.22956371794603,5.63042567590756,5.60612300418733,5.71027731155973,0.104154307372403,0.323922085375712,ENSG00000010803,SCMH1,protein_coding,1,-1,41027200,41242154,p34.2,Scm polycomb group protein homolog 1 [Source:HGNC Symbol;Acc:HGNC:19003],NA,SCMH1,22955,NM_001031694;NM_001172218;NM_001172219;NM_001172220;NM_001172221;NM_001172222;NM_001350667;NM_001350668;NM_012236
UCP3_SIG,UCP3,UCP3_SIG,UCP3,SIG,106,2.99694459564788,-0.00923684655726228,-0.0129352268643208,0.00291497445164436,0.0158502013159653,0.00576139143741221,2.17373632018162,2.05224734480283,2.0202168432496,2.15749042133487,0.137273578085267,0.0698437702513239,ENSG00000175564,UCP3,protein_coding,11,-1,74000277,74009085,q13.4,uncoupling protein 3 [Source:HGNC Symbol;Acc:HGNC:12519],OBESITY LEANNESS INCLUDED,UCP3,7352,NM_003356;NM_022803
GK_SIG,GK,GK_SIG,GK,SIG,24,-2.99690466024569,0.387281481045737,0.393226650617872,0.36774735245158,-0.0254792981662918,0.00576139143741221,-0.549322507265591,3.46700482699489,3.4795284024075,3.42585593635346,-0.0536724660540413,0.681082928103518,ENSG00000198814,GK,protein_coding,X,1,30653359,30731456,p21.2,glycerol kinase [Source:HGNC Symbol;Acc:HGNC:4289],Glycerol Kinase Deficiency;Glycerol kinase deficiency adult form;Glycerol kinase deficiency infantile form;Glycerol kinase deficiency juvenile form,GK,2710,NM_000167;NM_001128127;NM_001205019;NM_203391
CLEC10A_SIG,CLEC10A,CLEC10A_SIG,CLEC10A,SIG,39,-2.99647756493101,-0.105334422661597,-0.0903207148117681,-0.154665177025319,-0.0643444622135509,0.00576799744896133,-1.05482817134275,1.84400046686893,1.89596112338246,1.67327259546733,-0.222688527915133,0.40367927797289,ENSG00000132514,CLEC10A,protein_coding,17,-1,7074537,7080307,p13.1,C-type lectin domain containing 10A [Source:HGNC Symbol;Acc:HGNC:16916],NA,CLEC10A,10462,NM_001330070;NM_006344;NM_182906
THNSL1_SIG,THNSL1,THNSL1_SIG,THNSL1,SIG,59,2.99553244765036,-0.000734272603820236,-0.0160096485749015,0.0494562484440183,0.0654658970189199,0.00578442804666168,2.60846229822366,2.08624525267524,2.00882990825833,2.34060995575935,0.331780047501019,0.0276126806157894,ENSG00000185875,THNSL1,protein_coding,10,1,25016612,25026664,p12.1,threonine synthase like 1 [Source:HGNC Symbol;Acc:HGNC:26160],NA,THNSL1,79896,NM_024838
LAMB1_SIG,LAMB1,LAMB1_SIG,LAMB1,SIG,34,-2.99365288293736,-0.253079813398405,-0.24965633615612,-0.264328381480199,-0.0146720453240791,0.00581869511076021,-2.62822170455147,0.446230825911686,0.49545662547285,0.28448891306786,-0.21096771240499,0.0263462103587014,ENSG00000091136,LAMB1,protein_coding,7,-1,107923799,108003187,q31.1,laminin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6486],Cobblestone brain malformation without muscular or ocular abnormalities;Cobblestone lissencephaly without muscular or ocular involvement;LISSENCEPHALY 5,LAMB1,3912,NM_002291
IPMK_SIG,IPMK,IPMK_SIG,IPMK,SIG,29,-2.99328079440434,0.371449942610349,0.377825262929866,0.350502461560509,-0.0273228013693576,0.00582431052962583,-2.76187695317229,4.61034366263402,4.66067851826216,4.44495770842729,-0.215720809834876,0.019383332190538,ENSG00000151151,IPMK,protein_coding,10,-1,58191517,58267894,q21.1,inositol polyphosphate multikinase [Source:HGNC Symbol;Acc:HGNC:20739],Hereditary neuroendocrine tumor of small intestine,IPMK,253430,NM_152230
KCNK6_SIG,KCNK6,KCNK6_SIG,KCNK6,SIG,14,-2.99288225567437,0.105961366500139,0.119028875054164,0.0630252669654868,-0.0560036080886772,0.00583043626280225,-1.62126479326613,3.34258717626221,3.39234596196144,3.17909402325046,-0.213251938710982,0.184625372369824,ENSG00000099337,KCNK6,protein_coding,19,1,38319845,38332076,q13.2,potassium two pore domain channel subfamily K member 6 [Source:HGNC Symbol;Acc:HGNC:6281],NA,KCNK6,9424,NM_004823
ISG15_SIG,ISG15,ISG15_SIG,ISG15,SIG,20,-2.99199306710366,0.0439743709471237,0.0537192962437971,0.0119553306866251,-0.041763965557172,0.005845956689302,-1.35054441069843,3.55470810308605,3.59790022802763,3.41279112113515,-0.185109106892484,0.275254053188156,ENSG00000187608,ISG15,protein_coding,1,1,1001138,1014540,p36.33,ISG15 ubiquitin-like modifier [Source:HGNC Symbol;Acc:HGNC:4053],IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION;Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,ISG15,9636,NM_005101
DHRS4_SIG,DHRS4,DHRS4_SIG,DHRS4,SIG,34,2.9906246271818,0.297871535006268,0.290570070522271,0.321862061167972,0.0312919906457018,0.00587008043550363,2.40742679232653,3.99480797142263,3.95535831020143,4.12442828686372,0.169069976662295,0.0431859942999334,ENSG00000157326,DHRS4,protein_coding,14,1,23953734,23969279,q11.2,dehydrogenase/reductase 4 [Source:HGNC Symbol;Acc:HGNC:16985],NA,DHRS4,10901,NM_001282987;NM_001282988;NM_001282989;NM_001282990;NM_001282991;NM_021004
NOTCH4_TF,NOTCH4,NOTCH4_TF,NOTCH4,TF,165,-2.99058020846173,0.0345113565385556,0.0445323573989542,0.00158521085438875,-0.0429471465445654,0.00587008043550363,-2.02459552351865,1.58717664303118,1.63120039953184,1.44252715738616,-0.188673242145689,0.0928473446933624,ENSG00000204301,NOTCH4,protein_coding,6,-1,32194843,32224067,p21.32,notch 4 [Source:HGNC Symbol;Acc:HGNC:7884],NA,NOTCH4,4855,NM_004557
AASDH_SIG,AASDH,AASDH_SIG,AASDH,SIG,83,2.98962756528712,0.24247065841254,0.229715904940366,0.284379134106829,0.0546632291664629,0.00588691903476122,4.02681306392582,3.93062675528734,3.86208324053402,4.15584116090537,0.293757920371354,0.000521679627614886,ENSG00000157426,AASDH,protein_coding,4,-1,56338287,56387508,q12,aminoadipate-semialdehyde dehydrogenase [Source:HGNC Symbol;Acc:HGNC:23993],NA,AASDH,132949,NM_001286668;NM_001286669;NM_001286670;NM_001286671;NM_001286672;NM_001323890;NM_001323892;NM_001323893;NM_001323899;NM_181806
LYPD3_SIG,LYPD3,LYPD3_SIG,LYPD3,SIG,18,-2.98933620117021,0.0902607163497115,0.100759971146995,0.055763164872924,-0.0449968062740706,0.00589103762961258,-1.62845247924422,0.878079023044245,0.905467581778535,0.788088044345863,-0.117379537432672,0.182648280510503,ENSG00000124466,LYPD3,protein_coding,19,-1,43460787,43465608,q13.31,LY6/PLAUR domain containing 3 [Source:HGNC Symbol;Acc:HGNC:24880],NA,LYPD3,27076,NM_014400
IMP3_SIG,IMP3,IMP3_SIG,IMP3,SIG,34,2.98818123841358,0.153185108368867,0.145705833180688,0.177759869701456,0.0320540365207672,0.00591184313991697,3.3345392767138,4.78556993986263,4.72382861172369,4.98843430374771,0.264605692024019,0.00435830311931509,ENSG00000177971,IMP3,protein_coding,15,-1,75639085,75648706,q24.2,IMP3, U3 small nucleolar ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:14497],NA,IMP3,55272,NM_018285
HMMR_SIG,HMMR,HMMR_SIG,HMMR,SIG,16,-2.98798498729431,0.00882423678442387,0.0444642804398052,-0.108278763797543,-0.152743044237349,0.00591413685979865,-1.79402547189065,3.0253846999692,3.08803379000643,2.81953768984691,-0.268496100159521,0.13964403226604,ENSG00000072571,HMMR,protein_coding,5,1,163460203,163491941,q34,hyaluronan mediated motility receptor [Source:HGNC Symbol;Acc:HGNC:5012],Breast Cancer,HMMR,3161,NM_001142556;NM_001142557;NM_012484;NM_012485
C1GALT1_SIG,C1GALT1,C1GALT1_SIG,C1GALT1,SIG,12,-2.98768124328545,0.247882668597003,0.252199469928601,0.233698892793182,-0.0185005771354196,0.00591851272425335,-1.41901094870874,5.53731240219143,5.55479602349092,5.47986621792168,-0.0749298055692398,0.249452980280254,ENSG00000106392,C1GALT1,protein_coding,7,1,7156934,7248651,p22.1,core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24337],NA,C1GALT1,56913,NM_020156
RAG1_SIG,RAG1,RAG1_SIG,RAG1,SIG,21,2.98724952240269,0.0363404411187553,0.0294405766065606,0.0590114245159665,0.0295708479094058,0.00592537185086932,0.725664036979185,1.19227484362302,1.17589888035317,1.24608158008113,0.0701826997279614,0.576678610039517,ENSG00000166349,RAG1,protein_coding,11,1,36510709,36593156,p12,recombination activating 1 [Source:HGNC Symbol;Acc:HGNC:9831],ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION SEVERE CYTOMEGALOVIRUS INFECTION AND AUTOIMMUNITY;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with granulomatosis;OMENN SYNDROME;SEVERE COMBINED IMMUNODEFICIENCY AUTOSOMAL RECESSIVE T CELL-NEGATIVE B CELL-NEGATIVE NK CELL-POSITIVE;Severe combined immunodeficiency due to complete RAG1/2 deficiency,RAG1,5896,NM_000448
FBXW5_SIG,FBXW5,FBXW5_SIG,FBXW5,SIG,25,-2.98680843310689,0.399604954325296,0.404793597877916,0.382556554080973,-0.0222370437969423,0.00593242006457626,-0.991381661772468,6.69897729275561,6.70923871405843,6.66526119418919,-0.0439775198692384,0.434751208057039,ENSG00000159069,FBXW5,protein_coding,9,-1,136940435,136944738,q34.3,F-box and WD repeat domain containing 5 [Source:HGNC Symbol;Acc:HGNC:13613],NA,FBXW5,54461,NM_018998
DOK2_SIG,DOK2,DOK2_SIG,DOK2,SIG,52,-2.98647784084472,0.3231701643196,0.337629027195109,0.275662472014356,-0.0619665551807526,0.00593732996014676,-1.84884906670276,5.4218973398283,5.48107508007228,5.22745619331236,-0.253618886759916,0.12709484323943,ENSG00000147443,DOK2,protein_coding,8,-1,21908873,21913690,p21.3,docking protein 2 [Source:HGNC Symbol;Acc:HGNC:2991],NA,DOK2,9046,NM_001317800;NM_003974;NM_201349
HMGN5_SIG,HMGN5,HMGN5_SIG,HMGN5,SIG,69,2.98624448562326,-0.0517865296672504,-0.0576234581593497,-0.0326080503360671,0.0250154078232826,0.00594035441643369,1.14320530368825,2.55230428068884,2.52020332841105,2.65777883817301,0.137575509761958,0.362288861678411,ENSG00000198157,HMGN5,protein_coding,X,-1,81113701,81201942,q21.1,high mobility group nucleosome binding domain 5 [Source:HGNC Symbol;Acc:HGNC:8013],NA,HMGN5,79366,NM_030763
CD1C_SIG,CD1C,CD1C_SIG,CD1C,SIG,32,-2.98596919137044,-0.179764209063889,-0.168807677104397,-0.215764242645077,-0.0469565655406808,0.00594419565066194,-3.20384798349328,1.64352920067787,1.7840592049404,1.181787758101,-0.602271446839397,0.00628279533846649,ENSG00000158481,CD1C,protein_coding,1,1,158289923,158294774,q23.1,CD1c molecule [Source:HGNC Symbol;Acc:HGNC:1636],NA,CD1C,911,NM_001765
GDPD5_SIG,GDPD5,GDPD5_SIG,GDPD5,SIG,36,-2.98546693377242,0.00337154757678948,0.00925041802752871,-0.015944741047068,-0.0251951590745966,0.00595245502328226,-1.01862848197617,3.72486630789658,3.75261978080221,3.63367632549234,-0.11894345530987,0.42122494394006,ENSG00000158555,GDPD5,protein_coding,11,-1,75434640,75525941,q13.5,glycerophosphodiester phosphodiesterase domain containing 5 [Source:HGNC Symbol;Acc:HGNC:28804],NA,GDPD5,81544,NM_001351167;NM_001351168;NM_030792
RPS19BP1_SIG,RPS19BP1,RPS19BP1_SIG,RPS19BP1,SIG,16,-2.98530347715909,0.133061303439596,0.135639016883022,0.124591673554055,-0.0110473433289664,0.00595412619465814,0.635348897998549,5.03051365475485,5.02472956107649,5.04951853398373,0.0247889729072338,0.629573917365146,ENSG00000187051,RPS19BP1,protein_coding,22,-1,39529093,39532761,q13.1,ribosomal protein S19 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:28749],NA,RPS19BP1,91582,NM_194326
CCDC47_SIG,CCDC47,CCDC47_SIG,CCDC47,SIG,22,2.98440938929176,0.461866973420469,0.456300147385233,0.48015797325053,0.0238578258652969,0.00597003988760323,2.97732950823119,6.12575813194735,6.08071323595025,6.27376279022354,0.193049554273287,0.0114213012468059,ENSG00000108588,CCDC47,protein_coding,17,-1,63745255,63776351,q23.3,coiled-coil domain containing 47 [Source:HGNC Symbol;Acc:HGNC:24856],NA,CCDC47,57003,NM_020198
FZD4_SIG,FZD4,FZD4_SIG,FZD4,SIG,22,-2.98424116093134,-0.123994956757303,-0.120274650616464,-0.136218819791486,-0.0159441691750219,0.00597180894255492,-0.204873109875339,0.528902032515735,0.532167288917724,0.518173332909199,-0.0139939560085243,0.884251579652122,ENSG00000174804,FZD4,protein_coding,11,-1,86945679,86955395,q14.2,frizzled class receptor 4 [Source:HGNC Symbol;Acc:HGNC:4042],EXUDATIVE VITREORETINOPATHY 1;Familial exudative vitreoretinopathy;Persistent hyperplastic primary vitreous;RETINOPATHY OF PREMATURITY,FZD4,8322,NM_012193
LATS1_SIG,LATS1,LATS1_SIG,LATS1,SIG,56,2.98299374219957,0.242263636605501,0.238124164561717,0.255864759035076,0.0177405944733596,0.00599468221955605,1.78655000673936,6.08754909102177,6.06744737611231,6.15359758286711,0.0861502067547991,0.141311517117448,ENSG00000131023,LATS1,protein_coding,6,-1,149658153,149718105,q25.1,large tumor suppressor kinase 1 [Source:HGNC Symbol;Acc:HGNC:6514],NA,LATS1,9113,NM_001270519;NM_001350339;NM_001350340;NM_001350392;NM_004690
ZNF134_TF,ZNF134,ZNF134_TF,ZNF134,TF,119,2.98241889902164,0.290428099514531,0.281439311712379,0.319962688007314,0.0385233762949347,0.00600442895480541,1.77906349085185,4.93015334539958,4.8898021073249,5.06273598478782,0.172933877462921,0.143167728656686,ENSG00000213762,ZNF134,protein_coding,19,1,57614233,57624724,q13.43,zinc finger protein 134 [Source:HGNC Symbol;Acc:HGNC:12918],NA,ZNF134,7693,NM_003435
ZNF7_TF,ZNF7,ZNF7_TF,ZNF7,TF,20,2.98178758867891,0.340202180433874,0.332636107936199,0.365062132926234,0.0324260249900345,0.00601529939613432,1.22762427522111,4.26587176432712,4.2504847570808,4.31642907385075,0.0659443167699488,0.32476731934325,ENSG00000147789,ZNF7,protein_coding,8,1,144827464,144847509,q24.3,zinc finger protein 7 [Source:HGNC Symbol;Acc:HGNC:13139],NA,ZNF7,7553,NM_001282795;NM_001282796;NM_001282797;NM_001330623;NM_001349805;NM_001349806;NM_001349807;NM_001349808;NM_001349809;NM_003416
IRF7_TF,IRF7,IRF7_TF,IRF7,TF,102,-2.98147603517074,0.125708661553847,0.130740906408111,0.109174142746979,-0.0215667636611313,0.00601989815794864,-1.30735496583532,5.5461041383448,5.57704353191377,5.44444613090387,-0.132597401009909,0.292021695483018,ENSG00000185507,IRF7,protein_coding,11,-1,612553,615999,p15.5,interferon regulatory factor 7 [Source:HGNC Symbol;Acc:HGNC:6122],IMMUNODEFICIENCY 39,IRF7,3665,NM_001572;NM_004029;NM_004031
TRMT6_SIG,TRMT6,TRMT6_SIG,TRMT6,SIG,6,-2.98134356031996,0.166147371301383,0.170253743025853,0.152655007063838,-0.0175987359620151,0.00602097809828816,-1.45945017526599,4.76383313210343,4.78809300473206,4.68412212203794,-0.103970882694124,0.235504630891327,ENSG00000089195,TRMT6,protein_coding,20,-1,5937228,5950558,p12.3,tRNA methyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:20900],NA,TRMT6,51605,NM_001281467;NM_015939
TBP_TF,TBP,TBP_TF,TBP,TF,66,2.9811461311415,0.392049481263583,0.388351104279583,0.404201291353867,0.0158501870742835,0.00602333602815724,0.412547353493855,4.37446044922698,4.37088858984456,4.38619655862639,0.0153079687818326,0.761250810362235,ENSG00000112592,TBP,protein_coding,6,1,170554302,170572870,q27,TATA-box binding protein [Source:HGNC Symbol;Acc:HGNC:11588],Parkinson disease late-onset;SPINOCEREBELLAR ATAXIA 17;Spinocerebellar ataxia type 17,TBP,6908,NM_001172085;NM_003194
VKORC1L1_SIG,VKORC1L1,VKORC1L1_SIG,VKORC1L1,SIG,81,2.98036339069233,0.350559741759064,0.335221910192097,0.400955474050527,0.0657335638584293,0.00603722185523715,2.71053844852113,4.65886256562776,4.58595028472327,4.89843148859967,0.312481203876397,0.0218619639159003,ENSG00000196715,VKORC1L1,protein_coding,7,1,65873074,65959563,q11.21,vitamin K epoxide reductase complex subunit 1 like 1 [Source:HGNC Symbol;Acc:HGNC:21492],NA,VKORC1L1,154807,NM_001284342;NM_173517
FLAD1_SIG,FLAD1,FLAD1_SIG,FLAD1,SIG,41,2.97998578680524,0.343402266735573,0.333437462849728,0.376143765217634,0.0427063023679067,0.00604313933976364,2.30283023131965,4.79104347643619,4.75915098040173,4.8958331062637,0.136682125861972,0.0536388967133625,ENSG00000160688,FLAD1,protein_coding,1,1,154983338,154993111,q21.3,flavin adenine dinucleotide synthetase 1 [Source:HGNC Symbol;Acc:HGNC:24671],LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY;Multiple acyl-CoA dehydrogenase deficiency mild type;Multiple acyl-CoA dehydrogenase deficiency severe neonatal type;Riboflavin-Responsive and Non-responsive Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.,FLAD1,80308,NM_001184891;NM_001184892;NM_025207;NM_201398
TTF2_SIG,TTF2,TTF2_SIG,TTF2,SIG,28,2.97811775231895,0.535844509409,0.524660386110619,0.572592343103683,0.0479319569930641,0.00607855628287495,3.15151082501878,5.17412814499824,5.12035735564663,5.35080359572497,0.230446240078337,0.00723638601710552,ENSG00000116830,TTF2,protein_coding,1,1,117060326,117107453,p13.1,transcription termination factor 2 [Source:HGNC Symbol;Acc:HGNC:12398],NA,TTF2,8458,NM_003594
SLC2A4_SIG,SLC2A4,SLC2A4_SIG,SLC2A4,SIG,28,-2.97683106891482,-0.095458384812512,-0.0823933073480794,-0.138386496481362,-0.0559931891332828,0.00610258013367564,-3.11260372748844,0.590001644737759,0.650006509167447,0.392842804468784,-0.257163704698663,0.0080605322920123,ENSG00000181856,SLC2A4,protein_coding,17,1,7281667,7288257,p13.1,solute carrier family 2 member 4 [Source:HGNC Symbol;Acc:HGNC:11009],NA,SLC2A4,6517,NM_001042
GYPE_SIG,GYPE,GYPE_SIG,GYPE,SIG,10,-2.9762876076093,-0.177904539413658,-0.1483259950694,-0.275091185116218,-0.126765190046818,0.0061118602062205,-2.52426437409423,1.05166178281524,1.13197720537713,0.787768251540473,-0.344208953836658,0.0335326463602663,ENSG00000197465,GYPE,protein_coding,4,-1,143870864,143905563,q31.21,glycophorin E (MNS blood group) [Source:HGNC Symbol;Acc:HGNC:4705],NA,GYPE,2996,NM_002102;NM_198682
ACP1_SIG,ACP1,ACP1_SIG,ACP1,SIG,65,2.97536897534831,0.46806535476268,0.460614491944644,0.4925467611648,0.0319322692201561,0.00612864509960112,2.08977389826098,6.34275984768388,6.31804211710383,6.42397524816116,0.105933131057326,0.0819174304850673,ENSG00000143727,ACP1,protein_coding,2,1,264140,278283,p25.3,acid phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:122],NA,ACP1,52,NM_001040649;NM_004300;NM_007099
SMAD1_TF,SMAD1,SMAD1_TF,SMAD1,TF,206,2.9749984960934,0.0932764443700898,0.0860699724778424,0.116954852016045,0.0308848795382028,0.00613450093357194,3.49954898845469,3.6479496532406,3.51949108776899,4.07002779693305,0.550536709164054,0.00271161568907796,ENSG00000170365,SMAD1,protein_coding,4,1,145481194,145559176,q31.21,SMAD family member 1 [Source:HGNC Symbol;Acc:HGNC:6767],NA,SMAD1,4086,NM_001003688;NM_001354811;NM_001354812;NM_001354813;NM_001354814;NM_001354816;NM_001354817;NM_005900
PTAR1_SIG,PTAR1,PTAR1_SIG,PTAR1,SIG,49,2.97491823685225,0.291580177564702,0.285847221197345,0.310417034200301,0.0245698130029562,0.00613455581928601,2.36224053414009,6.79746682531798,6.76449319224234,6.90580876256652,0.141315570324187,0.0474743335191279,ENSG00000188647,PTAR1,protein_coding,9,-1,69709522,69760011,q21.12,protein prenyltransferase alpha subunit repeat containing 1 [Source:HGNC Symbol;Acc:HGNC:30449],NA,PTAR1,375743,NM_001099666;NM_001366935;NM_001366936;NM_001366937;NM_001366938;NM_001366939
SKI_TF,SKI,SKI_TF,SKI,TF,83,2.97405547100811,0.035053081940761,0.0325253524558637,0.0433584788197091,0.0108331263638455,0.00614959230765615,2.74783873151047,6.52929227260883,6.47670448145098,6.70208072927034,0.22537624781936,0.0200143225865854,ENSG00000157933,SKI,protein_coding,1,1,2228319,2310213,p36.33,SKI proto-oncogene [Source:HGNC Symbol;Acc:HGNC:10896],1p36 deletion syndrome;Shprintzen-Goldberg craniosynostosis syndrome;SHPRINTZEN-GOLDBERG SYNDROME,SKI,6497,NM_003036
FOXRED1_SIG,FOXRED1,FOXRED1_SIG,FOXRED1,SIG,5,2.97401214564501,0.19422514183829,0.185506433515122,0.222872326328699,0.0373658928135766,0.00614959230765615,2.85801995135976,4.48468840326744,4.44477738920374,4.61582459233388,0.171047203130145,0.0153917259279329,ENSG00000110074,FOXRED1,protein_coding,11,1,126269055,126278131,q24.2,FAD dependent oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26927],Isolated complex I deficiency;Leigh syndrome with leukodystrophy;Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 19,FOXRED1,55572,NM_017547
ZNF598_TF,ZNF598,ZNF598_TF,ZNF598,TF,229,2.97305324298853,0.165232997170251,0.159109597216074,0.185352739876833,0.026243142660759,0.00616727994277363,2.47699317887156,6.02204669797375,5.99264777018833,6.11864317498298,0.125995404794649,0.0371306343345651,ENSG00000167962,ZNF598,protein_coding,16,-1,1997654,2009821,p13.3,zinc finger protein 598 [Source:HGNC Symbol;Acc:HGNC:28079],NA,ZNF598,90850,NM_178167
TLE2_SIG,TLE2,TLE2_SIG,TLE2,SIG,27,-2.97297477062621,-0.0547440679826316,-0.0441841977654217,-0.089440784410607,-0.0452565866451854,0.00616729989728722,-2.00188090452857,0.966457545421686,1.00790388596382,0.830276712211811,-0.17762717375201,0.0967598880560053,ENSG00000065717,TLE2,protein_coding,19,-1,2997639,3047635,p13.3,TLE family member 2, transcriptional corepressor [Source:HGNC Symbol;Acc:HGNC:11838],NA,TLE2,7089,NM_001144761;NM_001144762;NM_001300846;NM_003260
FOXO3_TF,FOXO3,FOXO3_TF,FOXO3,TF,106,-2.9717464151565,0.129391776196706,0.1344329142823,0.11282803677261,-0.0216048775096901,0.00619046391543618,-0.902503779742414,6.41526958471212,6.43199278294902,6.36032193336229,-0.0716708495867352,0.480571863178114,ENSG00000118689,FOXO3,protein_coding,6,1,108559835,108684774,q21,forkhead box O3 [Source:HGNC Symbol;Acc:HGNC:3821],NA,FOXO3,2309,NM_001455;NM_201559
KLRG1_SIG,KLRG1,KLRG1_SIG,KLRG1,SIG,24,-2.97047670128383,0.0182514174591018,0.0261039472040044,-0.00754975170272116,-0.0336536989067254,0.00621454335944358,-1.34257479785629,2.12618270511707,2.16266727444189,2.00630483447836,-0.15636243996353,0.278095378752864,ENSG00000139187,KLRG1,protein_coding,12,1,8950044,9010760,p13.31,killer cell lectin like receptor G1 [Source:HGNC Symbol;Acc:HGNC:6380],NA,KLRG1,10219,NM_001329099;NM_001329101;NM_001329102;NM_001329103;NM_005810
GAR1_SIG,GAR1,GAR1_SIG,GAR1,SIG,18,2.97010525121417,0.368773021684449,0.359090339173373,0.400587549935127,0.0414972107617544,0.0062204936300487,2.09086631072118,4.41074580644996,4.37733589786929,4.52052122035786,0.143185322488564,0.0817301780424042,ENSG00000109534,GAR1,protein_coding,4,1,109815510,109824740,q25,GAR1 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:14264],NA,GAR1,54433,NM_018983;NM_032993
ALAS1_SIG,ALAS1,ALAS1_SIG,ALAS1,SIG,38,-2.96974804859789,0.270851092268969,0.278506137988282,0.245698799191227,-0.032807338797055,0.00622616044949022,-0.409916073898074,5.79176859725816,5.80084176641867,5.76195675573081,-0.0388850106878583,0.762763086489867,ENSG00000023330,ALAS1,protein_coding,3,1,52198086,52214327,p21.2,5'-aminolevulinate synthase 1 [Source:HGNC Symbol;Acc:HGNC:396],NA,ALAS1,211,NM_000688;NM_001304443;NM_001304444;NM_199166
ANKIB1_SIG,ANKIB1,ANKIB1_SIG,ANKIB1,SIG,47,2.9689061907271,0.411984536359759,0.403037506784823,0.441381919248837,0.0383444124640142,0.00624166919559357,2.29328828576111,5.47061328532732,5.4365642375484,5.58248872802949,0.145924490481084,0.0547197250885411,ENSG00000001629,ANKIB1,protein_coding,7,1,92245974,92401383,q21.2,ankyrin repeat and IBR domain containing 1 [Source:HGNC Symbol;Acc:HGNC:22215],NA,ANKIB1,54467,NM_019004
FGF11_SIG,FGF11,FGF11_SIG,FGF11,SIG,7,2.9680137357371,-0.0243525757458086,-0.0299374253524599,-0.00600235560966853,0.0239350697427913,0.00625782450126146,0.154953272101953,0.711657266881193,0.709433479147294,0.718963998006861,0.0095305188595674,0.913040748775889,ENSG00000161958,FGF11,protein_coding,17,1,7438273,7444937,p13.1,fibroblast growth factor 11 [Source:HGNC Symbol;Acc:HGNC:3667],NA,FGF11,2256,NM_001303460;NM_004112
HIF1A_SIG,HIF1A,HIF1A_SIG,HIF1A,SIG,60,-2.96795683533581,0.0427993900834699,0.0556906046313949,0.000442542283144942,-0.05524806234825,0.00625782450126146,-2.30344717990001,8.10754831524309,8.17900850035275,7.8727505641685,-0.306257936184244,0.0535948949607537,ENSG00000100644,HIF1A,protein_coding,14,1,61695513,61748259,q23.2,hypoxia inducible factor 1 subunit alpha [Source:HGNC Symbol;Acc:HGNC:4910],NA,HIF1A,3091,NM_001243084;NM_001530;NM_181054
ACSS1_SIG,ACSS1,ACSS1_SIG,ACSS1,SIG,37,2.96680829281991,0.24375982919224,0.235998994618719,0.269259714219524,0.0332607196008046,0.00627966514758873,2.06075660623262,6.55853969530242,6.51472504478056,6.70250211844569,0.187777073665123,0.0866050089092029,ENSG00000154930,ACSS1,protein_coding,20,-1,25006230,25058980,p11.21,acyl-CoA synthetase short chain family member 1 [Source:HGNC Symbol;Acc:HGNC:16091],NA,ACSS1,84532,NM_001252675;NM_001252676;NM_001252677;NM_032501
CD86_SIG,CD86,CD86_SIG,CD86,SIG,31,-2.96638647193574,0.482228397779039,0.51217789322518,0.383822912741717,-0.128354980483463,0.00628670189667004,-1.00107542060396,4.29461138065698,4.34611863136399,4.12537327119108,-0.220745360172914,0.429897276894029,ENSG00000114013,CD86,protein_coding,3,1,122055362,122121139,q13.33,CD86 molecule [Source:HGNC Symbol;Acc:HGNC:1705],NA,CD86,942,NM_001206924;NM_001206925;NM_006889;NM_175862;NM_176892
AURKB_SIG,AURKB,AURKB_SIG,AURKB,SIG,31,-2.96529979453552,0.240503921491286,0.278937717940427,0.114221447444107,-0.16471627049632,0.0063073649425036,-2.72255431227134,3.21756655769604,3.30487732610658,2.93068831863285,-0.37418900747373,0.0212278203789225,ENSG00000178999,AURKB,protein_coding,17,-1,8204733,8210600,p13.1,aurora kinase B [Source:HGNC Symbol;Acc:HGNC:11390],NA,AURKB,9212,NM_001256834;NM_001284526;NM_001313950;NM_001313951;NM_001313952;NM_001313953;NM_001313954;NM_001313955;NM_004217
ARHGAP23_SIG,ARHGAP23,ARHGAP23_SIG,ARHGAP23,SIG,22,2.96498100292751,0.132335912011113,0.12424260215744,0.15892821581604,0.0346856136585993,0.00631231545963908,2.03600314619601,4.51792779483075,4.46085256092563,4.70546070623327,0.244608145307637,0.0908649240935857,ENSG00000275832,ARHGAP23,protein_coding,17,1,38419280,38512385,q12,Rho GTPase activating protein 23 [Source:HGNC Symbol;Acc:HGNC:29293],NA,ARHGAP23,57636,NM_001199417
ZNF772_TF,ZNF772,ZNF772_TF,ZNF772,TF,21,2.96474435926052,0.120543584713688,0.111186809523106,0.151287274625603,0.0401004651024971,0.00631558313994028,2.38402906634086,2.80579317902089,2.74899345587489,2.99242084078633,0.243427384911435,0.045351558861944,ENSG00000197128,ZNF772,protein_coding,19,-1,57466663,57477570,q13.43,zinc finger protein 772 [Source:HGNC Symbol;Acc:HGNC:33106],NA,ZNF772,400720,NM_001024596;NM_001144068;NM_001330613
DRD4_SIG,DRD4,DRD4_SIG,DRD4,SIG,16,2.96456176002535,0.0162508325971638,0.0117541267186189,0.0310257233409543,0.0192715966223353,0.00631774275663625,0.0679662174052736,0.813206405689965,0.812267712771872,0.816290682420839,0.00402296964896673,0.962974617556978,ENSG00000069696,DRD4,protein_coding,11,1,637293,640706,p15.5,dopamine receptor D4 [Source:HGNC Symbol;Acc:HGNC:3025],ATTENTION DEFICIT-HYPERACTIVITY DISORDER;NOVELTY SEEKING PERSONALITY TRAITRISK-TAKING BEHAVIOR INCLUDED,DRD4,1815,NM_000797
CCR2_SIG,CCR2,CCR2_SIG,CCR2,SIG,50,-2.96438490505258,0.0824373532017786,0.101331041666766,0.0203580911025345,-0.0809729505642313,0.0063197853314262,-2.79015096088281,2.89663378380514,3.05608667202462,2.37271715108399,-0.683369520940631,0.0181213992170875,ENSG00000121807,CCR2,protein_coding,3,1,46353734,46360928,p21.31,C-C motif chemokine receptor 2 [Source:HGNC Symbol;Acc:HGNC:1603],NA,CCR2,729230,NM_001123041;NM_001123396
NHP2_SIG,NHP2,NHP2_SIG,NHP2,SIG,43,2.9639055943547,0.510773578684351,0.502803392089057,0.536961334640317,0.0341579425512607,0.00632804552535641,2.87997097882038,4.92953969255683,4.88369082892969,5.0801859587603,0.196495129830607,0.0145761215055208,ENSG00000145912,NHP2,protein_coding,5,-1,178149460,178153967,q35.3,NHP2 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:14377],Dyskeratosis congenita;Dyskeratosis congenita autosomal recessive 1;Dyskeratosis congenita autosomal recessive 2,NHP2,55651,NM_001034833;NM_017838
METTL6_SIG,METTL6,METTL6_SIG,METTL6,SIG,51,2.96280807517219,0.297429097956539,0.282580316987712,0.346217949711256,0.0636376327235443,0.00634905459213246,2.67503543811023,3.16090961232232,3.11001499883309,3.3281347709298,0.218119772096705,0.023733122387526,ENSG00000206562,METTL6,protein_coding,3,-1,15381275,15440566,p25.1,methyltransferase like 6 [Source:HGNC Symbol;Acc:HGNC:28343],NA,METTL6,131965,NM_001301790;NM_001301791;NM_001301792;NM_001330662;NM_152396
CCL3_SIG,CCL3,CCL3_SIG,CCL3,SIG,23,-2.96212841489781,0.1822378666974,0.193181100372193,0.146281527480222,-0.0468995728919713,0.00636001656486086,-0.710484009633125,4.24843651317459,4.27900557103963,4.14799532304662,-0.131010247993012,0.585713771342515,ENSG00000277632,CCL3,protein_coding,17,-1,36088256,36090169,q12,C-C motif chemokine ligand 3 [Source:HGNC Symbol;Acc:HGNC:10627],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,CCL3,6348,NM_002983
ZNF780B_TF,ZNF780B,ZNF780B_TF,ZNF780B,TF,152,2.96212225584453,0.11151480958207,0.102766630314937,0.140258827174079,0.0374921968591427,0.00636001656486086,2.49346369179572,3.3376859614012,3.26488476591537,3.57688988942607,0.312005123510696,0.03580320884707,ENSG00000128000,ZNF780B,protein_coding,19,-1,40028260,40056231,q13.2,zinc finger protein 780B [Source:HGNC Symbol;Acc:HGNC:33109],NA,ZNF780B,163131,NM_001005851
GLUD1_SIG,GLUD1,GLUD1_SIG,GLUD1,SIG,46,2.96163601736943,0.37495294614696,0.369626004921392,0.39245575303097,0.0228297481095771,0.00636846781525889,2.7794250041254,6.8528907747474,6.81491015862692,6.97768422771469,0.162774069087772,0.0185611044722332,ENSG00000148672,GLUD1,protein_coding,10,-1,87050202,87094843,q23.2,glutamate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:4335],HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 6;Hyperinsulinism-hyperammonemia syndrome,GLUD1,2746,NM_001318900;NM_001318901;NM_001318902;NM_001318904;NM_001318905;NM_001318906;NM_005271
LSM6_SIG,LSM6,LSM6_SIG,LSM6,SIG,38,-2.96111856197117,0.0290035477919695,0.0359167523237147,0.0062887329019495,-0.0296280194217653,0.00637757570541341,-2.82564093534801,4.06979625552364,4.11146254544284,3.93289273150339,-0.178569813939452,0.016662130238169,ENSG00000164167,LSM6,protein_coding,4,1,146175703,146200000,q31.22,LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated [Source:HGNC Symbol;Acc:HGNC:17017],NA,LSM6,11157,NM_007080
MPHOSPH8_SIG,MPHOSPH8,MPHOSPH8_SIG,MPHOSPH8,SIG,34,2.96101552701128,0.211017381492408,0.201349095740022,0.24278460610739,0.0414355103673678,0.00637810793278651,2.94523451048345,5.79810974790017,5.74797792497674,5.96282859464856,0.214850669671813,0.012390452321746,ENSG00000196199,MPHOSPH8,protein_coding,13,1,19633659,19673441,q12.11,M-phase phosphoprotein 8 [Source:HGNC Symbol;Acc:HGNC:29810],NA,MPHOSPH8,54737,NM_017520
GSTA4_SIG,GSTA4,GSTA4_SIG,GSTA4,SIG,41,-2.95960967707739,-0.110190186177622,-0.10546982132066,-0.125699956421924,-0.020230135101264,0.00640567410847444,-2.98089646490271,1.06315914000953,1.12816224263255,0.849577517105342,-0.278584725527205,0.0113144105010671,ENSG00000170899,GSTA4,protein_coding,6,-1,52977948,52995304,p12.2,glutathione S-transferase alpha 4 [Source:HGNC Symbol;Acc:HGNC:4629],NA,GSTA4,2941,NM_001512
CD36_SIG,CD36,CD36_SIG,CD36,SIG,19,-2.95949475761289,0.196614299703644,0.210414786680292,0.15126984249466,-0.0591449441856322,0.00640645566210099,-0.677091731792974,6.2767992011821,6.31568452565391,6.14903313506046,-0.166651390593446,0.605005989621326,ENSG00000135218,CD36,protein_coding,7,1,80369575,80679277,q21.11,CD36 molecule [Source:HGNC Symbol;Acc:HGNC:1663],CORONARY HEART DISEASE SUSCEPTIBILITY TO 7;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;PLATELET GLYCOPROTEIN IV DEFICIENCY,CD36,948,NM_000072;NM_001001547;NM_001001548;NM_001127443;NM_001127444;NM_001289908;NM_001289909;NM_001289911
SLC25A17_SIG,SLC25A17,SLC25A17_SIG,SLC25A17,SIG,51,2.9580568646573,0.255665556048826,0.243821819066805,0.294580691846896,0.0507588727800915,0.00643480127917657,2.57939967192403,3.07661821942996,3.02854307753708,3.23457939993516,0.206036322398083,0.0295570577868179,ENSG00000100372,SLC25A17,protein_coding,22,-1,40769630,40819399,q13.2,solute carrier family 25 member 17 [Source:HGNC Symbol;Acc:HGNC:10987],NA,SLC25A17,10478,NM_001282726;NM_001282727;NM_006358
EGR1_SIG,EGR1,EGR1_SIG,EGR1,SIG,11,-2.95747005385549,0.318822152055484,0.32529855635226,0.297542537937504,-0.0277560184147559,0.00644544481465807,-2.26339868514858,7.48369364556529,7.59081236611401,7.13173213519093,-0.45908023092308,0.0583100164426154,ENSG00000120738,EGR1,protein_coding,5,1,138465479,138469303,q31.2,early growth response 1 [Source:HGNC Symbol;Acc:HGNC:3238],NA,EGR1,1958,NM_001964
SPON2_SIG,SPON2,SPON2_SIG,SPON2,SIG,26,2.95722119339114,-0.0376860055601093,-0.041351369547823,-0.0256426667433358,0.0157087028044873,0.00644903199959294,2.46844189493855,4.07908153045792,4.00316562274866,4.32851951293121,0.325353890182542,0.037829324281953,ENSG00000159674,SPON2,protein_coding,4,-1,1166932,1208962,p16.3,spondin 2 [Source:HGNC Symbol;Acc:HGNC:11253],NA,SPON2,10417,NM_001128325;NM_001199021;NM_012445
ECHS1_SIG,ECHS1,ECHS1_SIG,ECHS1,SIG,52,2.9569579784366,0.501704484540493,0.493562852120406,0.528455562492207,0.0348927103718012,0.00645292161472473,2.59755498442959,5.17012677135907,5.12492267492791,5.31865451677575,0.193731841847848,0.0283432639141786,ENSG00000127884,ECHS1,protein_coding,10,-1,133362485,133373354,q26.3,enoyl-CoA hydratase, short chain 1 [Source:HGNC Symbol;Acc:HGNC:3151],Leigh syndrome with leukodystrophy;MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY,ECHS1,1892,NM_004092
HSD17B4_SIG,HSD17B4,HSD17B4_SIG,HSD17B4,SIG,45,2.95683823204945,0.35555964432736,0.344646167061152,0.391418212487756,0.0467720454266045,0.00645381016341542,2.70205839749876,6.46460770217847,6.39617695291686,6.68945159260947,0.293274639692615,0.0222940293056794,ENSG00000133835,HSD17B4,protein_coding,5,1,119452443,119637199,q23.1,hydroxysteroid 17-beta dehydrogenase 4 [Source:HGNC Symbol;Acc:HGNC:5213],Bifunctional enzyme deficiency;D-BIFUNCTIONAL PROTEIN DEFICIENCY;Perrault syndrome;PERRAULT SYNDROME 1,HSD17B4,3295,NM_000414;NM_001199291;NM_001199292;NM_001292027;NM_001292028
RIN2_SIG,RIN2,RIN2_SIG,RIN2,SIG,33,-2.95564100481246,0.145008391253085,0.161088450286376,0.0921739115722746,-0.068914538714101,0.0064769301648718,-1.67091396180542,3.02038057684643,3.08471603810776,2.80899263270203,-0.275723405405732,0.170799586121476,ENSG00000132669,RIN2,protein_coding,20,1,19757606,20002459,p11.23,Ras and Rab interactor 2 [Source:HGNC Symbol;Acc:HGNC:18750],MACROCEPHALY ALOPECIA CUTIS LAXA AND SCOLIOSIS TALL FOREHEAD SPARSE HAIR SKIN HYPEREXTENSIBILITY AND SCOLIOSIS;MACS syndrome;RIN2 syndrome,RIN2,54453,NM_001242581;NM_018993
CLCNKA_SIG,CLCNKA,CLCNKA_SIG,CLCNKA,SIG,27,-2.95551606443401,-0.0426506545757349,-0.0372507610938442,-0.0603931617305188,-0.0231424006366748,0.0064769301648718,-2.34013261921911,0.265130356313294,0.287568868732182,0.191403815508376,-0.0961650532238055,0.0497937354020114,ENSG00000186510,CLCNKA,protein_coding,1,1,16018875,16034050,p36.13,chloride voltage-gated channel Ka [Source:HGNC Symbol;Acc:HGNC:2026],BARTTER SYNDROME TYPE 4B;BARTTER SYNDROME TYPE 4B NEONATAL WITH SENSORINEURAL DEAFNESS;Infantile Bartter syndrome with sensorineural deafness,CLCNKA,1187,NM_001042704;NM_001257139;NM_004070
OAS2_SIG,OAS2,OAS2_SIG,OAS2,SIG,49,-2.95550354607999,0.35171925340707,0.361389421407109,0.319945844264088,-0.041443577143021,0.0064769301648718,-2.10956885701158,5.21369145339385,5.30011715136439,4.9297213029192,-0.370395848445188,0.0789266640028428,ENSG00000111335,OAS2,protein_coding,12,1,112978395,113011723,q24.13,2'-5'-oligoadenylate synthetase 2 [Source:HGNC Symbol;Acc:HGNC:8087],NA,OAS2,4939,NM_001032731;NM_002535;NM_016817
SLC29A3_SIG,SLC29A3,SLC29A3_SIG,SLC29A3,SIG,60,2.95529168841964,0.18652467948416,0.176498354579513,0.219468318456573,0.0429699638770602,0.00647829815005017,3.67477240763599,3.39322997211799,3.30528318889949,3.68219797412161,0.376914785222125,0.00158779530935346,ENSG00000198246,SLC29A3,protein_coding,10,1,71319259,71381423,q22.1,solute carrier family 29 member 3 [Source:HGNC Symbol;Acc:HGNC:23096],Dysosteosclerosis;H syndrome;HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME,SLC29A3,55315,NM_001174098;NM_001363518;NM_018344
PTGES3_SIG,PTGES3,PTGES3_SIG,PTGES3,SIG,27,2.95528392550846,0.575404205403937,0.566028582405567,0.606209823827154,0.0401812414215873,0.00647829815005017,3.03024411509586,7.49862458607268,7.45754389857772,7.63360398784184,0.176060089264115,0.00994539537922801,ENSG00000110958,PTGES3,protein_coding,12,-1,56663341,56688408,q13.3,prostaglandin E synthase 3 [Source:HGNC Symbol;Acc:HGNC:16049],NA,PTGES3,10728,NM_001282601;NM_001282602;NM_001282603;NM_001282604;NM_001282605;NM_006601
GFRA2_SIG,GFRA2,GFRA2_SIG,GFRA2,SIG,16,-2.95460925549162,-0.118517876182931,-0.109818422759897,-0.147101794572902,-0.0372833718130044,0.006490855509364,-1.00292256326318,0.809336079581978,0.830205526947129,0.740765038239338,-0.0894404887077912,0.429031684039305,ENSG00000168546,GFRA2,protein_coding,8,-1,21690398,21812357,p21.3,GDNF family receptor alpha 2 [Source:HGNC Symbol;Acc:HGNC:4244],NA,GFRA2,2675,NM_001165038;NM_001165039;NM_001495
ADRA2C_SIG,ADRA2C,ADRA2C_SIG,ADRA2C,SIG,26,-2.95452377624154,0.00336027799786553,0.00717430526287224,-0.0091715258728708,-0.0163458311357432,0.00649102953851037,-0.841771968355137,0.576689727561622,0.599358310054877,0.502207242226643,-0.0971510678282339,0.512852239415,ENSG00000184160,ADRA2C,protein_coding,4,1,3766348,3768526,p16.3,adrenoceptor alpha 2C [Source:HGNC Symbol;Acc:HGNC:283],NA,ADRA2C,152,NM_000683
VLDLR_SIG,VLDLR,VLDLR_SIG,VLDLR,SIG,68,2.95417360436997,-0.022728480478704,-0.0266305805791145,-0.00990729443449794,0.0167232861446164,0.00649677434369158,-1.35199805356272,2.72105434718413,2.77949182039004,2.52904550665044,-0.250446313739601,0.274660572451402,ENSG00000147852,VLDLR,protein_coding,9,1,2621787,2660056,p24.2,very low density lipoprotein receptor [Source:HGNC Symbol;Acc:HGNC:12698],CEREBELLAR ATAXIA MENTAL RETARDATION AND DYSEQUILIBRIUM SYNDROME 1;CEREBELLAR ATAXIA MENTAL RETARDATION AND DYSEQUILIBRIUM SYNDROME TYPE 1;Dysequilibrium syndrome,VLDLR,7436,NM_001018056;NM_001322225;NM_001322226;NM_003383
ZNF674_TF,ZNF674,ZNF674_TF,ZNF674,TF,28,2.95392421112588,0.179516083793588,0.169993185847485,0.210805605616499,0.0408124197690144,0.00650040085382514,2.04686893040471,2.12252370453391,2.09150348750477,2.2244472747725,0.132943787267724,0.0890766863716255,ENSG00000251192,ZNF674,protein_coding,X,-1,46497727,46545457,p11.3,zinc finger protein 674 [Source:HGNC Symbol;Acc:HGNC:17625],NA,ZNF674,641339,NM_001039891;NM_001146291;NM_001190417
CNTLN_SIG,CNTLN,CNTLN_SIG,CNTLN,SIG,21,-2.95338965285424,0.07421436432359,0.0785918961688599,0.0598310454034174,-0.0187608507654426,0.00651004139082992,-0.0968529928333964,4.20900185319855,4.210884970869,4.2028144665671,-0.00807050430189993,0.945744425465645,ENSG00000044459,CNTLN,protein_coding,9,1,17134982,17503923,p22.2,centlein [Source:HGNC Symbol;Acc:HGNC:23432],NA,CNTLN,54875,NM_001114395;NM_001286984;NM_001286985;NM_001365029;NM_017738
ZDHHC11_TF,ZDHHC11,ZDHHC11_TF,ZDHHC11,TF,84,2.95159234526082,-0.022134988695729,-0.0245418921120384,-0.0142265917564265,0.0103153003556119,0.006546413122205,0.648829709304666,1.38555369151397,1.37209642393975,1.42977042782925,0.057674003889497,0.621468969676112,ENSG00000188818,ZDHHC11,protein_coding,5,-1,795606,850986,p15.33,zinc finger DHHC-type containing 11 [Source:HGNC Symbol;Acc:HGNC:19158],NA,ZDHHC11,79844,NM_024786
SRCAP_TF,SRCAP,SRCAP_TF,SRCAP,TF,75,2.95118250697806,0.427384268241145,0.423985595109951,0.438551337100782,0.0145657419908307,0.00655237346466258,3.17687728063897,7.99305761437579,7.9606541318052,8.09952619996487,0.138872068159665,0.0067629690544537,ENSG00000080603,SRCAP,protein_coding,16,1,30698209,30741409,p11.2,Snf2 related CREBBP activator protein [Source:HGNC Symbol;Acc:HGNC:16974],FLOATING-HARBOR SYNDROME,SRCAP,10847,NM_006662
ULK4_SIG,ULK4,ULK4_SIG,ULK4,SIG,10,2.95115694199737,0.238533631077653,0.230586952091551,0.264644147746275,0.034057195654724,0.00655237346466258,2.62573030913673,3.02451337316938,2.98241740988232,3.16282868111257,0.180411271230248,0.0265107373377575,ENSG00000168038,ULK4,protein_coding,3,-1,41246599,41962130,p22.1,unc-51 like kinase 4 [Source:HGNC Symbol;Acc:HGNC:15784],NA,ULK4,54986,NM_001322500;NM_001322501;NM_017886
PRTN3_SIG,PRTN3,PRTN3_SIG,PRTN3,SIG,40,-2.95050455529457,0.139178454547701,0.153064389810536,0.0935532386840982,-0.0595111511264378,0.00656458718469943,-1.99070152443532,6.73507722246348,6.8851643788351,6.24193370867101,-0.643230670164092,0.0988036912738894,ENSG00000196415,PRTN3,protein_coding,19,1,840999,848175,p13.3,proteinase 3 [Source:HGNC Symbol;Acc:HGNC:9495],Granulomatosis with polyangiitis,PRTN3,5657,NM_002777
CANT1_SIG,CANT1,CANT1_SIG,CANT1,SIG,25,-2.94997535976235,0.103010300952078,0.106651393667409,0.0910467106017051,-0.0156046830657043,0.00657419970425,-1.65059335354166,5.45753050703174,5.47892678455363,5.38722845231698,-0.0916983322366499,0.176317108446234,ENSG00000171302,CANT1,protein_coding,17,-1,78991716,79009867,q25.3,calcium activated nucleotidase 1 [Source:HGNC Symbol;Acc:HGNC:19721],DESBUQUOIS DYSPLASIA 1;Desbuquois syndrome;EPIPHYSEAL DYSPLASIA MULTIPLE 7,CANT1,124583,NM_001159772;NM_001159773;NM_138793
SLC16A3_SIG,SLC16A3,SLC16A3_SIG,SLC16A3,SIG,27,-2.94966004068923,0.289926904074659,0.299342003163772,0.258991578496143,-0.0403504246676287,0.00657926952835233,-2.37270117187144,6.26197794515107,6.33125636351199,6.0343488562509,-0.296907507261089,0.0465023258702409,ENSG00000141526,SLC16A3,protein_coding,17,1,82228397,82261129,q25.3,solute carrier family 16 member 3 [Source:HGNC Symbol;Acc:HGNC:10924],NA,SLC16A3,9123,NM_001042422;NM_001042423;NM_001206950;NM_001206951;NM_001206952;NM_004207
SLC31A2_SIG,SLC31A2,SLC31A2_SIG,SLC31A2,SIG,22,-2.94951784755195,0.418510201330632,0.430811353506066,0.378092129897063,-0.0527192236090035,0.00658065515722126,-2.07278781002791,4.2715276299227,4.32583075227235,4.09310308505955,-0.232727667212801,0.0846130598505629,ENSG00000136867,SLC31A2,protein_coding,9,1,113150976,113164140,q32,solute carrier family 31 member 2 [Source:HGNC Symbol;Acc:HGNC:11017],NA,SLC31A2,1318,NM_001860
POLR3A_SIG,POLR3A,POLR3A_SIG,POLR3A,SIG,92,2.94938074210979,0.412028103524639,0.40062101561136,0.449508535239699,0.0488875196283392,0.00658193299698299,3.13824438489636,4.79334250208874,4.73714644115362,4.97798670230415,0.240840261150526,0.00749314176768191,ENSG00000148606,POLR3A,protein_coding,10,-1,77969251,78029515,q22.3,RNA polymerase III subunit A [Source:HGNC Symbol;Acc:HGNC:30074],Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome;Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome;Hypomyelination-hypogonadotropic-hypogonadism-hypodontia syndrome;LEUKODYSTROPHY HYPOMYELINATING 7 WITH OR WITHOUT OLIGODONTIAAND/OR HYPOGONADOTROPIC HYPOGONADISM;Odontoleukodystrophy;Tremor-ataxia-central hypomyelination syndrome,POLR3A,11128,NM_007055
ZNF521_TF,ZNF521,ZNF521_TF,ZNF521,TF,380,2.9492574806567,-0.0340708471082638,-0.0384107203140203,-0.0198112637179208,0.0185994565960995,0.00658291646685266,0.128601416749554,3.98934273409894,3.98018091592727,4.0194458509487,0.0392649350214325,0.9278937071366,ENSG00000198795,ZNF521,protein_coding,18,-1,25061924,25352190,q11.2,zinc finger protein 521 [Source:HGNC Symbol;Acc:HGNC:24605],NA,ZNF521,25925,NM_001308225;NM_015461
ZNF511_SIG,ZNF511,ZNF511_SIG,ZNF511,SIG,22,2.94736690626051,0.123097242110152,0.119732438322839,0.134153025982751,0.0144205876599123,0.00662165056860227,3.13386337929977,4.49138447204571,4.45567633159068,4.60871121925508,0.153034887664402,0.00758980107493166,ENSG00000198546,ZNF511,protein_coding,10,1,133308914,133313162,q26.3,zinc finger protein 511 [Source:HGNC Symbol;Acc:HGNC:28445],NA,ZNF511,118472,NM_145806
CHST7_SIG,CHST7,CHST7_SIG,CHST7,SIG,13,-2.94603445600933,0.273614008052477,0.282648745832454,0.243928441061122,-0.0387203047713318,0.00664858428262091,-1.37128115371907,2.49204819392619,2.52723534575874,2.37643326647639,-0.150802079282347,0.267569266381526,ENSG00000147119,CHST7,protein_coding,X,1,46573784,46598408,p11.3,carbohydrate sulfotransferase 7 [Source:HGNC Symbol;Acc:HGNC:13817],NA,CHST7,56548,NM_019886
ERAP2_SIG,ERAP2,ERAP2_SIG,ERAP2,SIG,5,2.94579140792224,0.0949687256112725,0.0914410581839508,0.106559632872472,0.0151185746885211,0.00665215194328436,1.03914703047882,6.24362648241389,6.20627441939441,6.36635468947793,0.160080270083526,0.411399763333897,ENSG00000164308,ERAP2,protein_coding,5,1,96875939,96919716,q15,endoplasmic reticulum aminopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:29499],NA,ERAP2,64167,NM_001130140;NM_001329229;NM_001329233;NM_022350
BOP1_SIG,BOP1,BOP1_SIG,BOP1,SIG,19,2.94469874750733,0.64677926765829,0.636692857880624,0.679920328356335,0.043227470475711,0.00667402374797671,3.79426435964618,2.59712804187462,2.53902290964113,2.78804490492751,0.249021995286375,0.00109457329069812,ENSG00000261236,BOP1,protein_coding,8,-1,144262045,144291438,q24.3,BOP1 ribosomal biogenesis factor [Source:HGNC Symbol;Acc:HGNC:15519],NA,BOP1,23246,NM_015201
RAD18_SIG,RAD18,RAD18_SIG,RAD18,SIG,23,2.94407318785595,0.371833134485018,0.363883112550502,0.397954635127001,0.034071522576499,0.00668586267904753,1.66972071405691,4.38986539995692,4.36511177402517,4.47119874230407,0.106086968278896,0.171065202680415,ENSG00000070950,RAD18,protein_coding,3,-1,8775402,8963773,p25.3,RAD18, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:18278],NA,RAD18,56852,NM_020165
KIFAP3_SIG,KIFAP3,KIFAP3_SIG,KIFAP3,SIG,13,2.93991140620476,0.395603884224457,0.387340759319763,0.422754151768454,0.035413392448691,0.00677463529043907,0.537054001617805,3.86865853953321,3.85780277409031,3.90432748313132,0.0465247090410087,0.688101450219718,ENSG00000075945,KIFAP3,protein_coding,1,-1,169921326,170085208,q24.2,kinesin associated protein 3 [Source:HGNC Symbol;Acc:HGNC:17060],NA,KIFAP3,22920,NM_001204514;NM_001204516;NM_001204517;NM_014970
FAS_SIG,FAS,FAS_SIG,FAS,SIG,19,-2.93824052647794,0.217229531397849,0.222356001868506,0.200385414137119,-0.0219705877313873,0.00680881102622574,-1.78752573131238,4.56842866870218,4.60755757038102,4.43986227747171,-0.16769529290931,0.141147447196495,ENSG00000026103,FAS,protein_coding,10,1,88990531,89017059,q23.31,Fas cell surface death receptor [Source:HGNC Symbol;Acc:HGNC:11920],Autoimmune lymphoproliferative syndrome;Behcet disease;Vogt-Koyanagi-Harada disease,FAS,355,NM_000043;NM_001320619;NM_152871;NM_152872
ZNF181_TF,ZNF181,ZNF181_TF,ZNF181,TF,80,2.9381974854169,0.232290941911896,0.219872891199921,0.273093108536957,0.0532202173370356,0.00680881102622574,1.55803189986192,2.59601598815695,2.55820812218659,2.72024183348814,0.162033711301548,0.203130184986143,ENSG00000197841,ZNF181,protein_coding,19,1,34734155,34745378,q13.11,zinc finger protein 181 [Source:HGNC Symbol;Acc:HGNC:12971],NA,ZNF181,339318,NM_001029997;NM_001145665
PACSIN1_SIG,PACSIN1,PACSIN1_SIG,PACSIN1,SIG,74,-2.93706285061672,-0.0387495203766702,-0.0317705503382315,-0.0616804219315405,-0.0299098715933092,0.0068320721441314,-1.74553041194939,1.42721201513618,1.49187746973459,1.21473980716996,-0.27713766256463,0.15131001129923,ENSG00000124507,PACSIN1,protein_coding,6,1,34466061,34535229,p21.31,protein kinase C and casein kinase substrate in neurons 1 [Source:HGNC Symbol;Acc:HGNC:8570],NA,PACSIN1,29993,NM_001199583;NM_020804
IDI1_SIG,IDI1,IDI1_SIG,IDI1,SIG,12,-2.93690646513258,0.321141049930765,0.330381110766806,0.290780850040917,-0.0396002607258892,0.00683381748628098,-2.37063957634466,6.18660088909074,6.22410693895057,6.06336672526558,-0.160740213684981,0.0466867699628359,ENSG00000067064,IDI1,protein_coding,10,-1,1039152,1049170,p15.3,isopentenyl-diphosphate delta isomerase 1 [Source:HGNC Symbol;Acc:HGNC:5387],NA,IDI1,3422,NM_001317955;NM_001317956;NM_001317957;NM_004508
HCFC1_TF,HCFC1,HCFC1_TF,HCFC1,TF,128,2.93668202155211,0.508241876799505,0.503528382559879,0.523729072158277,0.0202006895983975,0.00683706372157439,1.81996999111817,7.86021907767111,7.83984065067642,7.92717676636794,0.0873361156915236,0.133624384061354,ENSG00000172534,HCFC1,protein_coding,X,-1,153947557,153971818,q28,host cell factor C1 [Source:HGNC Symbol;Acc:HGNC:4839],Cobalamin Disorder;MENTAL RETARDATION X-LINKED 3;METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA cblX TYPE;Methylmalonic acidemia with homocystinuria type cblX;X-linked non-syndromic intellectual disability,HCFC1,3054,NM_005334
SPATS2L_SIG,SPATS2L,SPATS2L_SIG,SPATS2L,SIG,50,2.93642293605468,-0.0442228244638121,-0.0475179774681801,-0.0333958931637459,0.0141220843044342,0.00683989650095828,0.662906413850249,3.0909712404611,3.06600976593825,3.17298751389332,0.106977747955066,0.613083423510842,ENSG00000196141,SPATS2L,protein_coding,2,1,200305881,200482264,q33.1,spermatogenesis associated serine rich 2 like [Source:HGNC Symbol;Acc:HGNC:24574],NA,SPATS2L,26010,NM_001100422;NM_001100423;NM_001100424;NM_001282735;NM_001282743;NM_001282744;NM_015535
GNB5_SIG,GNB5,GNB5_SIG,GNB5,SIG,40,2.93634300343655,0.126682721498383,0.121405438928674,0.144022364227429,0.0226169252987557,0.00683989650095828,2.34037912106014,3.96529976620449,3.90474214682252,4.16427480131668,0.259532654494159,0.0497777695120009,ENSG00000069966,GNB5,protein_coding,15,-1,52115105,52191369,q21.2,G protein subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:4401],INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA;LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA;Sinus Bradycardia and Cognitive Disability,GNB5,10681,NM_006578;NM_016194
NFKB1_TF,NFKB1,NFKB1_TF,NFKB1,TF,50,-2.93628585225314,0.112660236326758,0.115766051343085,0.102455415558824,-0.0133106357842616,0.00683989650095828,-0.484883685277603,6.52435145102427,6.53329258611396,6.49497343572959,-0.0383191503843704,0.718278921380761,ENSG00000109320,NFKB1,protein_coding,4,1,102501331,102617302,q24,nuclear factor kappa B subunit 1 [Source:HGNC Symbol;Acc:HGNC:7794],Common variable immunodeficiency;Immunodeficiency common variable 12,NFKB1,4790,NM_001165412;NM_001319226;NM_003998
IL16_SIG,IL16,IL16_SIG,IL16,SIG,87,-2.93624507262147,0.253399635529075,0.261410410443812,0.227078517952083,-0.0343318924917291,0.00683989650095828,-3.15870926606126,6.56627336292375,6.65272305696966,6.28222436820147,-0.370498688768192,0.00708988237460731,ENSG00000172349,IL16,protein_coding,15,1,81159575,81314058,q25.1,interleukin 16 [Source:HGNC Symbol;Acc:HGNC:5980],NA,IL16,3603,NM_001172128;NM_001352684;NM_001352685;NM_001352686;NM_004513;NM_172217
SERPINE1_SIG,SERPINE1,SERPINE1_SIG,SERPINE1,SIG,38,2.93587733368203,-0.00803681628605173,-0.0128526895633805,0.00778676733945717,0.0206394569028376,0.00684630859272034,0.934929979582777,2.73712948487804,2.69653412702696,2.870514232103,0.173980105076037,0.463368685045238,ENSG00000106366,SERPINE1,protein_coding,7,1,101127089,101139266,q22.1,serpin family E member 1 [Source:HGNC Symbol;Acc:HGNC:8583],Congenital plasminogen activator inhibitor type 1 deficiency;PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY,SERPINE1,5054,NM_000602
CDKN2AIP_SIG,CDKN2AIP,CDKN2AIP_SIG,CDKN2AIP,SIG,36,2.93502715122875,0.174257825100739,0.170221093809808,0.187521370770941,0.017300276961133,0.00686280157473231,2.42808171413754,5.07456529684244,5.0374630999889,5.19647251507549,0.159009415086597,0.0412471516800543,ENSG00000168564,CDKN2AIP,protein_coding,4,1,183444635,183449064,q35.1,CDKN2A interacting protein [Source:HGNC Symbol;Acc:HGNC:24325],NA,CDKN2AIP,55602,NM_001317343;NM_017632
TRIM8_SIG,TRIM8,TRIM8_SIG,TRIM8,SIG,18,-2.93497669045435,0.370765881088231,0.375325699002662,0.355783622226527,-0.0195420767761354,0.00686280157473231,-0.336155133572566,6.77077406181034,6.77653063862596,6.75185959513042,-0.0246710434955454,0.806154398783427,ENSG00000171206,TRIM8,protein_coding,10,1,102642310,102660680,q24.32,tripartite motif containing 8 [Source:HGNC Symbol;Acc:HGNC:15579],NA,TRIM8,81603,NM_001345950;NM_030912
SEMA3C_SIG,SEMA3C,SEMA3C_SIG,SEMA3C,SIG,50,-2.9348441818632,-0.0951676956165355,-0.0899821796649174,-0.112205819457566,-0.0222236397926491,0.00686402833041341,-1.65791891263862,1.51473685985319,1.57563422839998,1.31464550605657,-0.260988722343418,0.174297245576617,ENSG00000075223,SEMA3C,protein_coding,7,-1,80742538,80922359,q21.11,semaphorin 3C [Source:HGNC Symbol;Acc:HGNC:10725],Hirschsprung disease,SEMA3C,10512,NM_001350120;NM_001350121;NM_006379
UCHL3_SIG,UCHL3,UCHL3_SIG,UCHL3,SIG,6,2.93443435872374,0.507506412580312,0.504076146308329,0.51877728747397,0.014701141165641,0.00687139319434289,2.86823118637462,2.23484752568354,2.20578830860731,2.3303278103626,0.124539501755295,0.0150055956098564,ENSG00000118939,UCHL3,protein_coding,13,1,75549480,75606020,q22.2,ubiquitin C-terminal hydrolase L3 [Source:HGNC Symbol;Acc:HGNC:12515],NA,UCHL3,7347,NM_001270952;NM_006002
MTIF3_SIG,MTIF3,MTIF3_SIG,MTIF3,SIG,48,2.93415299704171,0.0513195127604306,0.0395690327407284,0.0899282328251661,0.0503592000844377,0.00687591884355278,2.91670919876555,5.00960022562449,4.95114490725365,5.20166770027153,0.250522793017878,0.0133066776016661,ENSG00000122033,MTIF3,protein_coding,13,-1,27435643,27450591,q12.2,mitochondrial translational initiation factor 3 [Source:HGNC Symbol;Acc:HGNC:29788],NA,MTIF3,219402,NM_001166261;NM_001166262;NM_001166263;NM_152912
PIGN_SIG,PIGN,PIGN_SIG,PIGN,SIG,39,2.93385519521649,0.384705828255061,0.373841518381637,0.420402846410598,0.0465613280289611,0.00688081182580309,2.28674155540419,4.508636281337,4.45846434041777,4.67348694435735,0.21502260393958,0.0554835497233186,ENSG00000197563,PIGN,protein_coding,18,-1,61905255,62187118,q21.33,phosphatidylinositol glycan anchor biosynthesis class N [Source:HGNC Symbol;Acc:HGNC:8967],Fryns syndrome;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1,PIGN,23556,NM_012327;NM_176787
NACC2_TF,NACC2,NACC2_TF,NACC2,TF,376,-2.93353160968004,0.21707332878683,0.227132195846899,0.184022765589463,-0.0431094302574355,0.0068862800961485,-2.57282569557184,4.49047211469971,4.58123805572791,4.19224116560705,-0.388996890120858,0.0299793566164098,ENSG00000148411,NACC2,protein_coding,9,-1,136006537,136095289,q34.3,NACC family member 2 [Source:HGNC Symbol;Acc:HGNC:23846],NA,NACC2,138151,NM_144653
SLC35F2_SIG,SLC35F2,SLC35F2_SIG,SLC35F2,SIG,29,2.93238842116362,0.157035434786623,0.151039462461324,0.176736486712603,0.0256970242512786,0.00690996868575866,1.27666080471856,3.99684220597415,3.95285917104512,4.14135789216953,0.188498721124415,0.304400256541299,ENSG00000110660,SLC35F2,protein_coding,11,-1,107790991,107928293,q22.3,solute carrier family 35 member F2 [Source:HGNC Symbol;Acc:HGNC:23615],NA,SLC35F2,54733,NM_017515
EEFSEC_SIG,EEFSEC,EEFSEC_SIG,EEFSEC,SIG,24,2.9321226853684,0.666105270045266,0.656380184695141,0.698059121909961,0.0416789372148193,0.00691416984641473,2.94446192884373,4.30306182324845,4.25943636306891,4.44640262098121,0.1869662579123,0.0124149755087685,ENSG00000132394,EEFSEC,protein_coding,3,1,128153481,128408646,q21.3,eukaryotic elongation factor, selenocysteine-tRNA specific [Source:HGNC Symbol;Acc:HGNC:24614],NA,EEFSEC,60678,NM_021937
KLF3_TF,KLF3,KLF3_TF,KLF3,TF,135,-2.93182274480469,0.101818489028491,0.109126072440282,0.0778078578183207,-0.031318214621961,0.00691825348657756,-2.63001284799603,7.04170106816412,7.09447788167161,6.8682915380681,-0.226186343603515,0.0262254276057166,ENSG00000109787,KLF3,protein_coding,4,1,38664197,38701517,p14,Kruppel like factor 3 [Source:HGNC Symbol;Acc:HGNC:16516],NA,KLF3,51274,NM_016531
FN3K_SIG,FN3K,FN3K_SIG,FN3K,SIG,46,-2.93178537730271,-0.0518124834643968,-0.043273089747973,-0.0798704913897892,-0.0365974016418162,0.00691825348657756,-2.30262242955004,1.80388475193958,1.87167890403138,1.58113253792365,-0.29054636610773,0.0536543451957169,ENSG00000167363,FN3K,protein_coding,17,1,82735615,82751196,q25.3,fructosamine 3 kinase [Source:HGNC Symbol;Acc:HGNC:24822],NA,FN3K,64122,NM_022158
ARHGAP4_SIG,ARHGAP4,ARHGAP4_SIG,ARHGAP4,SIG,70,2.93158269923377,0.142833738573065,0.139423904896092,0.154037477797406,0.0146135729013142,0.00692105469144448,-0.816443940395497,8.37249062613602,8.38955818569133,8.31641150188287,-0.0731466838084546,0.526148062215917,ENSG00000089820,ARHGAP4,protein_coding,X,-1,153907367,153934999,q28,Rho GTPase activating protein 4 [Source:HGNC Symbol;Acc:HGNC:674],NA,ARHGAP4,393,NM_001164741;NM_001666
ZNF285_TF,ZNF285,ZNF285_TF,ZNF285,TF,28,2.93125557478785,-0.195364646338669,-0.206371273145504,-0.159200015401925,0.0471712577435784,0.00692663168645679,2.0809248081305,1.52070209090714,1.46339059943369,1.70901127717706,0.245620677743373,0.0833132886627164,ENSG00000267508,ZNF285,protein_coding,19,-1,44382298,44401608,q13.31,zinc finger protein 285 [Source:HGNC Symbol;Acc:HGNC:13079],NA,ZNF285,26974,NM_001291488;NM_001291489;NM_001291490;NM_001291491;NM_152354
NPM1_SIG,NPM1,NPM1_SIG,NPM1,SIG,47,2.93086271710638,0.693645593984642,0.684152379207629,0.724837585394827,0.0406852061871975,0.00693296085874636,3.20639147398928,8.15670520297279,8.09849260516738,8.34797516719058,0.2494825620232,0.00624204412325819,ENSG00000181163,NPM1,protein_coding,5,1,171387116,171411137,q35.1,nucleophosmin 1 [Source:HGNC Symbol;Acc:HGNC:7910],Acute myeloblastic leukemia with maturation;Acute myeloblastic leukemia without maturation;Acute myeloid leukemia with NPM1 somatic mutations;ACUTE PROMYELOCYTIC LEUKEMIA;LEUKEMIA ACUTE MYELOID;Lymphomatoid papulosis;Primary cutaneous anaplastic large cell lymphoma,NPM1,4869,NM_001037738;NM_001355006;NM_001355007;NM_001355009;NM_001355010;NM_002520;NM_199185
RCVRN_SIG,RCVRN,RCVRN_SIG,RCVRN,SIG,5,-2.93081802721527,0.220634961203527,0.229288618641945,0.192201515334439,-0.0370871033075059,0.00693296085874636,-1.69952411038088,0.645825136142691,0.667778386891618,0.573693026539072,-0.0940853603525458,0.163237301984465,ENSG00000109047,RCVRN,protein_coding,17,-1,9896320,9905621,p13.1,recoverin [Source:HGNC Symbol;Acc:HGNC:9937],NA,RCVRN,5957,NM_002903
RRP1B_SIG,RRP1B,RRP1B_SIG,RRP1B,SIG,23,2.93038793282012,0.335820898374425,0.325007122700208,0.37135187558971,0.046344752889503,0.00694084700768658,2.27913424946661,5.67342736225823,5.63114322469322,5.8123609571147,0.181217732421474,0.0563673147837645,ENSG00000160208,RRP1B,protein_coding,21,1,43659560,43696079,q22.3,ribosomal RNA processing 1B [Source:HGNC Symbol;Acc:HGNC:23818],NA,RRP1B,23076,NM_015056
CAB39_SIG,CAB39,CAB39_SIG,CAB39,SIG,41,-2.93014494756443,0.365427557317515,0.372644431139546,0.34171497190227,-0.0309294592372757,0.00694455845068148,-2.33119176783892,7.0462011319917,7.07781431390104,6.94232924857527,-0.135485065325773,0.050711573619536,ENSG00000135932,CAB39,protein_coding,2,1,230712842,230821075,q37.1,calcium binding protein 39 [Source:HGNC Symbol;Acc:HGNC:20292],NA,CAB39,51719,NM_001130849;NM_001130850;NM_016289
RFFL_SIG,RFFL,RFFL_SIG,RFFL,SIG,23,-2.92902708022582,0.252451216996048,0.256937822038144,0.237709514714875,-0.0192283073232693,0.00696785912675814,-1.67547817143799,5.28543801709305,5.30697992507814,5.21465746228488,-0.0923224627932555,0.169584107457505,ENSG00000092871,RFFL,protein_coding,17,-1,35005990,35089319,q12,ring finger and FYVE like domain containing E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:24821],NA,RFFL,117584,NM_001017368
MANEAL_SIG,MANEAL,MANEAL_SIG,MANEAL,SIG,8,2.92880823167225,0.15453495557796,0.148374542928107,0.174776311427477,0.0264017684993694,0.00697104242273559,-0.361375335564899,2.4681604055614,2.48059193968654,2.42731393629308,-0.0532780033934642,0.791159741274108,ENSG00000185090,MANEAL,protein_coding,1,1,37793802,37801137,p34.3,mannosidase endo-alpha like [Source:HGNC Symbol;Acc:HGNC:26452],NA,MANEAL,149175,NM_001031740;NM_001113482;NM_152496
RTN3_SIG,RTN3,RTN3_SIG,RTN3,SIG,54,-2.92848456012368,0.37462104227433,0.383628611684635,0.345024742783328,-0.0386038689013063,0.00697657932856021,-1.05670343961986,7.61962642149326,7.63936828025658,7.55476031412803,-0.0846079661285523,0.402810080402854,ENSG00000133318,RTN3,protein_coding,11,1,63681446,63759891,q13.1,reticulon 3 [Source:HGNC Symbol;Acc:HGNC:10469],NA,RTN3,10313,NM_001265589;NM_001265590;NM_001265591;NM_006054;NM_201428;NM_201429;NM_201430
SOAT1_SIG,SOAT1,SOAT1_SIG,SOAT1,SIG,41,-2.92715704964508,0.40930293483438,0.416426472645066,0.38589702488498,-0.0305294477600862,0.00700469712174215,-0.844343150352469,5.4120691035002,5.4291472354489,5.35595524138306,-0.0731919940658408,0.511496530895765,ENSG00000057252,SOAT1,protein_coding,1,1,179293714,179358680,q25.2,sterol O-acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:11177],NA,SOAT1,6646,NM_001252511;NM_001252512;NM_003101
ZBTB38_TF,ZBTB38,ZBTB38_TF,ZBTB38,TF,231,-2.92681918544765,0.0273593971187137,0.0312199153976544,0.0146748370593372,-0.0165450783383173,0.00701057803992762,0.0679789447561732,4.7920591192295,4.79001875589973,4.79876317017017,0.00874441427044035,0.962974617556978,ENSG00000177311,ZBTB38,protein_coding,3,1,141324213,141449792,q23,zinc finger and BTB domain containing 38 [Source:HGNC Symbol;Acc:HGNC:26636],NA,ZBTB38,253461,NM_001080412;NM_001350099;NM_001350100
PRDM8_TF,PRDM8,PRDM8_TF,PRDM8,TF,76,2.92508572227608,0.0730193944329506,0.069041523658634,0.0860895412628478,0.0170480176042137,0.00704800833686734,1.02260814493362,4.83852221838241,4.80631930527493,4.9443317900213,0.138012484746369,0.419426188092586,ENSG00000152784,PRDM8,protein_coding,4,1,80183879,80204329,q21.21,PR/SET domain 8 [Source:HGNC Symbol;Acc:HGNC:13993],Early-onset Lafora body disease;Epilepsy progressive myoclonic 10,PRDM8,56978,NM_001099403;NM_020226
NGFR_SIG,NGFR,NGFR_SIG,NGFR,SIG,16,-2.92390352583439,-0.143766678573086,-0.140340012829608,-0.155025723158802,-0.0146857103291944,0.0070730831768118,0.308416511258347,0.873902012955257,0.865955395873372,0.900012326224307,0.0340569303509359,0.822876314359935,ENSG00000064300,NGFR,protein_coding,17,1,49495293,49515008,q21.33,nerve growth factor receptor [Source:HGNC Symbol;Acc:HGNC:7809],NA,NGFR,4804,NM_002507
SF3B1_SIG,SF3B1,SF3B1_SIG,SF3B1,SIG,36,2.92359627283526,0.409046786733366,0.402415719011652,0.430834580676142,0.0284188616644907,0.00707737341701253,2.26277220982125,9.37826052844452,9.35927725308752,9.44063414747469,0.0813568943871683,0.0583564554147434,ENSG00000115524,SF3B1,protein_coding,2,-1,197388515,197435091,q33.1,splicing factor 3b subunit 1 [Source:HGNC Symbol;Acc:HGNC:10768],Acquired idiopathic sideroblastic anemia;MYELODYSPLASTIC SYNDROME;Uveal melanoma,SF3B1,23451,NM_001005526;NM_001308824;NM_012433
ZNF614_TF,ZNF614,ZNF614_TF,ZNF614,TF,42,2.92356102974357,0.264515887222743,0.258571155915033,0.284048575805218,0.0254774198901849,0.00707737341701253,2.38569717823906,3.2108052034163,3.16912449744639,3.34775609446032,0.178631597013935,0.0451778281299756,ENSG00000142556,ZNF614,protein_coding,19,-1,52012765,52030240,q13.41,zinc finger protein 614 [Source:HGNC Symbol;Acc:HGNC:24722],NA,ZNF614,80110,NM_025040
SACM1L_SIG,SACM1L,SACM1L_SIG,SACM1L,SIG,11,2.92277382262421,0.440241321022925,0.434531089915289,0.459003508948014,0.0244724190327253,0.00709353898621984,1.68910838076274,5.89115674426053,5.86765092712395,5.96839014342357,0.100739216299616,0.165992177090661,ENSG00000211456,SACM1L,protein_coding,3,1,45689056,45745409,p21.31,SAC1 like phosphatidylinositide phosphatase [Source:HGNC Symbol;Acc:HGNC:17059],NA,SACM1L,22908,NM_001319071;NM_001319072;NM_001319073;NM_014016
SLC5A9_SIG,SLC5A9,SLC5A9_SIG,SLC5A9,SIG,11,-2.92228266284123,0.00612715001187553,0.0174988679619604,-0.0312370661098318,-0.048735934071792,0.0071029828356523,-2.06649067686431,0.245750538200456,0.268587410010945,0.170715102251707,-0.097872307759238,0.0856545897468861,ENSG00000117834,SLC5A9,protein_coding,1,1,48222685,48248644,p33,solute carrier family 5 member 9 [Source:HGNC Symbol;Acc:HGNC:22146],NA,SLC5A9,200010,NM_001011547;NM_001135181
CC2D1A_TF,CC2D1A,CC2D1A_TF,CC2D1A,TF,101,2.92125167829325,0.131424700111526,0.126782644771427,0.146677167657565,0.0198945228861379,0.00712477446937801,3.04663070885506,5.12018638292314,5.07804476767385,5.25865169017077,0.180606922496915,0.00953795432770094,ENSG00000132024,CC2D1A,protein_coding,19,1,13906201,13930879,p13.12,coiled-coil and C2 domain containing 1A [Source:HGNC Symbol;Acc:HGNC:30237],Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 3;MENTAL RETARDATION AUTOSOMAL RECESSIVE TYPE 3,CC2D1A,54862,NM_017721
GPC1_SIG,GPC1,GPC1_SIG,GPC1,SIG,80,2.92084810719845,-0.0414785284088948,-0.046105471684051,-0.0262757147905244,0.0198297568935264,0.00713225050024735,0.488802286801361,1.56837732494058,1.55354266366949,1.61711978340275,0.0635771197332646,0.716105895359105,ENSG00000063660,GPC1,protein_coding,2,1,240435663,240468076,q37.3,glypican 1 [Source:HGNC Symbol;Acc:HGNC:4449],Isolated Biliary atresia,GPC1,2817,NM_002081
FNDC3B_SIG,FNDC3B,FNDC3B_SIG,FNDC3B,SIG,72,2.92073014242213,0.18180879329963,0.17645787064452,0.199390396309275,0.0229325256647546,0.00713319229286484,0.328566758772273,7.03478607707963,7.02776766513675,7.05784657346338,0.0300789083266314,0.811063250307159,ENSG00000075420,FNDC3B,protein_coding,3,1,172039578,172401669,q26.31,fibronectin type III domain containing 3B [Source:HGNC Symbol;Acc:HGNC:24670],NA,FNDC3B,64778,NM_001135095;NM_022763
ALPK1_SIG,ALPK1,ALPK1_SIG,ALPK1,SIG,93,-2.92033179904421,0.163859525628281,0.168843890021441,0.147482328336468,-0.0213615616849737,0.00714055683703588,-2.076867665125,5.32106573311979,5.3605470242184,5.19134149093864,-0.169205533279766,0.0839623895505137,ENSG00000073331,ALPK1,protein_coding,4,1,112285509,112442621,q25,alpha kinase 1 [Source:HGNC Symbol;Acc:HGNC:20917],NA,ALPK1,80216,NM_001102406;NM_001253884;NM_025144
PSMB8_SIG,PSMB8,PSMB8_SIG,PSMB8,SIG,16,-2.92024136206407,0.215786874561836,0.221338182465023,0.197546862879936,-0.0237913195850873,0.00714086935149203,-1.88430510097388,6.2927968988527,6.31765978232747,6.21110456743558,-0.106555214891887,0.119523709164905,ENSG00000204264,PSMB8,protein_coding,6,-1,32840717,32844703,p21.32,proteasome subunit beta 8 [Source:HGNC Symbol;Acc:HGNC:9545],CANDLE syndrome;JMP syndrome;Nakajo-Nishimura syndrome;Nakajo syndrome;PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1,PSMB8,5696,NM_004159;NM_148919
OTUB1_SIG,OTUB1,OTUB1_SIG,OTUB1,SIG,33,2.9189821106148,0.149481545539788,0.147114879029771,0.15725773550127,0.010142856471498,0.00716801250968618,0.914789342517098,6.20369859333447,6.19712664406517,6.22529214093357,0.0281654968684001,0.474057846656085,ENSG00000167770,OTUB1,protein_coding,11,1,63985853,64001811,q13.1,OTU deubiquitinase, ubiquitin aldehyde binding 1 [Source:HGNC Symbol;Acc:HGNC:23077],NA,OTUB1,55611,NM_017670
CTU2_SIG,CTU2,CTU2_SIG,CTU2,SIG,12,2.91840222736261,0.354440842316489,0.348780278382214,0.373039838100535,0.024259559718321,0.00717958899311237,2.66314789786357,3.2244972407529,3.18817092252407,3.34385514350478,0.155684220980712,0.0243771904270983,ENSG00000174177,CTU2,protein_coding,16,1,88706483,88715396,q24.3,cytosolic thiouridylase subunit 2 [Source:HGNC Symbol;Acc:HGNC:28005],MICROCEPHALY FACIAL DYSMORPHISM RENAL AGENESIS AND AMBIGUOUSGENITALIA SYNDROME,CTU2,348180,NM_001012759;NM_001012762;NM_001318507;NM_001318513
BACH1_TF,BACH1,BACH1_TF,BACH1,TF,111,-2.91813163800749,0.180747157963489,0.188402783172857,0.155592960846996,-0.0328098223258606,0.00718405299579047,-2.36817844229306,6.99061734608587,7.03811646352699,6.83454881735079,-0.203567646176203,0.0469178484953552,ENSG00000156273,BACH1,protein_coding,21,1,29194071,29630751,q21.3,BTB domain and CNC homolog 1 [Source:HGNC Symbol;Acc:HGNC:935],NA,BACH1,571,NM_001186;NM_206866
EIF2B2_SIG,EIF2B2,EIF2B2_SIG,EIF2B2,SIG,28,2.91785036645319,0.456994205715193,0.44827493477329,0.485643238810016,0.0373683040367267,0.00718876597840493,2.97985007401649,4.10363828664787,4.05565204886007,4.26130735366493,0.205655304804861,0.0113453072798546,ENSG00000119718,EIF2B2,protein_coding,14,1,75002921,75012366,q24.3,eukaryotic translation initiation factor 2B subunit beta [Source:HGNC Symbol;Acc:HGNC:3258],Congenital or early infantile CACH syndrome;Cree leukoencephalopathy;Juvenile or adult CACH syndrome;Late infantile CACH syndrome;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER;OVARIOLEUKODYSTROPHY,EIF2B2,8892,NM_014239
NFATC2_SIG,NFATC2,NFATC2_SIG,NFATC2,SIG,78,2.91753633084185,0.103147541126113,0.0955280629047996,0.128182969567573,0.0326549066627729,0.00719423775186566,2.13626813296315,5.27544221082264,5.21106547248331,5.48696577965189,0.275900307168583,0.0751058214214023,ENSG00000101096,NFATC2,protein_coding,20,-1,51386957,51562831,q13.2,nuclear factor of activated T cells 2 [Source:HGNC Symbol;Acc:HGNC:7776],NA,NFATC2,4773,NM_001136021;NM_001258292;NM_001258294;NM_001258295;NM_001258296;NM_001258297;NM_012340;NM_173091
AP5Z1_TF,AP5Z1,AP5Z1_TF,AP5Z1,TF,70,2.91726403007821,0.17277494997423,0.171366910988168,0.177401363785578,0.00603445279740968,0.00719875010992353,1.25394204444996,5.74773486708649,5.73517192812664,5.78901309509743,0.0538411669707913,0.313736774270095,ENSG00000242802,AP5Z1,protein_coding,7,1,4775615,4794397,p22.1,adaptor related protein complex 5 subunit zeta 1 [Source:HGNC Symbol;Acc:HGNC:22197],Autosomal recessive spastic paraplegia type 48;SPASTIC PARAPLEGIA 48 AUTOSOMAL RECESSIVE,AP5Z1,9907,NM_001364858;NM_014855
NSUN2_SIG,NSUN2,NSUN2_SIG,NSUN2,SIG,5,2.91690869038495,0.47362015412596,0.470182504059015,0.484915290060208,0.014732786001193,0.00720414468058545,1.58880375371356,6.41534779413413,6.39776739575456,6.47311196023845,0.0753445644838972,0.193817485097004,ENSG00000037474,NSUN2,protein_coding,5,-1,6599239,6633291,p15.31,NOP2/Sun RNA methyltransferase family member 2 [Source:HGNC Symbol;Acc:HGNC:25994],Autosomal- Recessive Intellectual Disability MRT5;Autosomal recessive non-syndromic intellectual disability;Dubowitz syndrome;MENTAL RETARDATION AUTOSOMAL RECESSIVE 5,NSUN2,54888,NM_001193455;NM_017755
PBX2_TF,PBX2,PBX2_TF,PBX2,TF,279,-2.91687692785123,0.019824673983135,0.0229523503905447,0.00954802293021768,-0.0134043274603271,0.00720414468058545,-3.39764893875728,7.20152089446695,7.23736709954207,7.08374050636298,-0.153626593179094,0.00362657851345722,ENSG00000204304,PBX2,protein_coding,6,-1,32184733,32190202,p21.32,PBX homeobox 2 [Source:HGNC Symbol;Acc:HGNC:8633],NA,PBX2,5089,NM_002586
NFATC2_TF,NFATC2,NFATC2_TF,NFATC2,TF,253,2.91652899905127,0.0500874850593435,0.0438856583391265,0.0704649157114852,0.0265792573723587,0.00721041122786724,2.13626813296315,5.27544221082264,5.21106547248331,5.48696577965189,0.275900307168583,0.0751058214214023,ENSG00000101096,NFATC2,protein_coding,20,-1,51386957,51562831,q13.2,nuclear factor of activated T cells 2 [Source:HGNC Symbol;Acc:HGNC:7776],NA,NFATC2,4773,NM_001136021;NM_001258292;NM_001258294;NM_001258295;NM_001258296;NM_001258297;NM_012340;NM_173091
CUL5_SIG,CUL5,CUL5_SIG,CUL5,SIG,39,2.9161038790656,0.45412109115191,0.450015094059736,0.467612224454767,0.0175971303950311,0.00721846861555567,2.56276003519945,5.69873563556697,5.67280860426667,5.7839244526965,0.111115848429831,0.0306709867740161,ENSG00000166266,CUL5,protein_coding,11,1,108008898,108107761,q22.3,cullin 5 [Source:HGNC Symbol;Acc:HGNC:2556],NA,CUL5,8065,NM_003478
GEMIN5_SIG,GEMIN5,GEMIN5_SIG,GEMIN5,SIG,76,2.9146371160816,0.417214363524313,0.403636195207351,0.461828345137188,0.0581921499298365,0.0072506952396378,2.98124011913771,4.04026684904566,3.96563409806893,4.28548874511209,0.319854647043161,0.0113065753279931,ENSG00000082516,GEMIN5,protein_coding,5,-1,154887411,154938211,q33.2,gem nuclear organelle associated protein 5 [Source:HGNC Symbol;Acc:HGNC:20043],NA,GEMIN5,25929,NM_001252156;NM_015465
FBXO32_SIG,FBXO32,FBXO32_SIG,FBXO32,SIG,40,-2.91444538480309,0.0806601361636861,0.0870576290415936,0.0596398024219901,-0.0274178266196034,0.00725336787205808,-2.19506571743341,3.03173859288382,3.09271263315424,2.83139531770959,-0.261317315444657,0.0670417465835861,ENSG00000156804,FBXO32,protein_coding,8,-1,123497889,123541206,q24.13,F-box protein 32 [Source:HGNC Symbol;Acc:HGNC:16731],NA,FBXO32,114907,NM_001242463;NM_058229;NM_148177
EDN1_SIG,EDN1,EDN1_SIG,EDN1,SIG,11,-2.91413737622614,-0.0386707488080455,-0.0280711225215446,-0.0734980923208343,-0.0454269697992898,0.00725874498987535,-2.35080744720765,0.766898703212228,0.813882937680713,0.612521932815778,-0.201361004864935,0.0486691091619517,ENSG00000078401,EDN1,protein_coding,6,1,12290361,12297194,p24.1,endothelin 1 [Source:HGNC Symbol;Acc:HGNC:3176],Auriculocondylar syndrome;Auriculocondylar syndrome 3;Question mark ears isolated,EDN1,1906,NM_001168319;NM_001955
NOP2_SIG,NOP2,NOP2_SIG,NOP2,SIG,18,2.91391625339012,0.221128931887736,0.216476975842929,0.236413930320671,0.0199369544777414,0.00726210449918731,3.47625721715891,5.61936246303524,5.56693643823832,5.79161940165369,0.224682963415379,0.00289066486131821,ENSG00000111641,NOP2,protein_coding,12,-1,6556863,6568691,p13.31,NOP2 nucleolar protein [Source:HGNC Symbol;Acc:HGNC:7867],NA,NOP2,4839,NM_001033714;NM_001258308;NM_001258309;NM_001258310;NM_006170
BAZ1A_TF,BAZ1A,BAZ1A_TF,BAZ1A,TF,217,-2.91291492028867,0.0585741785338029,0.0645586496151315,0.0389109164094376,-0.0256477332056939,0.00728364283538013,-3.59113143934929,7.38221893832325,7.44478054159545,7.17665938471461,-0.268121156880837,0.00205436615966042,ENSG00000198604,BAZ1A,protein_coding,14,-1,34752731,34875647,q13.2,bromodomain adjacent to zinc finger domain 1A [Source:HGNC Symbol;Acc:HGNC:960],NA,BAZ1A,11177,NM_013448;NM_182648
NFATC3_SIG,NFATC3,NFATC3_SIG,NFATC3,SIG,13,2.91233484315922,0.441551153353001,0.435407852113407,0.461736285997383,0.0263284338839762,0.00729447426886093,0.0325673713167739,6.74440353555337,6.74405844121919,6.74553741693711,0.00147897571792558,0.9823094812892,ENSG00000072736,NFATC3,protein_coding,16,1,68084751,68229259,q22.1,nuclear factor of activated T cells 3 [Source:HGNC Symbol;Acc:HGNC:7777],NA,NFATC3,4775,NM_004555;NM_173163;NM_173165
PRMT3_SIG,PRMT3,PRMT3_SIG,PRMT3,SIG,21,2.91229752257478,0.606163497027832,0.597270300443043,0.635384000092139,0.038113699649096,0.00729447426886093,1.73580781099772,4.02971591721545,4.00435729568865,4.11303710223208,0.108679806543433,0.153770988959932,ENSG00000185238,PRMT3,protein_coding,11,1,20387558,20509338,p15.1,protein arginine methyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:30163],NA,PRMT3,10196,NM_001145166;NM_001145167;NM_005788
ZNF610_TF,ZNF610,ZNF610_TF,ZNF610,TF,43,2.91181123279062,-0.0401855733788384,-0.0520628430154179,-0.00116025885864836,0.0509025841567696,0.0073040470979744,1.25921778927564,1.72374271908182,1.68996715424785,1.83471957496486,0.144752420717002,0.311491044642248,ENSG00000167554,ZNF610,protein_coding,19,1,52336243,52367778,q13.41,zinc finger protein 610 [Source:HGNC Symbol;Acc:HGNC:26687],NA,ZNF610,162963,NM_001161425;NM_001161426;NM_001161427;NM_173530
ANO5_SIG,ANO5,ANO5_SIG,ANO5,SIG,38,2.91113955507069,-0.104917511833441,-0.1097591858584,-0.0890091543228586,0.0207500315355417,0.0073179723411232,2.34118681463244,0.710791745487821,0.651437055585862,0.905814298022831,0.254377242436969,0.049698322379479,ENSG00000171714,ANO5,protein_coding,11,1,21799934,22283357,p15.1,anoctamin 5 [Source:HGNC Symbol;Acc:HGNC:27337],Autosomal recessive limb-girdle muscular dystrophy type 2L;Distal anoctaminopathy;GNATHODIAPHYSEAL DYSPLASIA;LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2L;MIYOSHI MUSCULAR DYSTROPHY 3;MIYOSHI MUSCULAR DYSTROPHY TYPE 3;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 12,ANO5,203859,NM_001142649;NM_213599
PWP2_SIG,PWP2,PWP2_SIG,PWP2,SIG,5,2.91010282297379,0.540028381024596,0.528334516799755,0.578451077763361,0.0501165609636059,0.00734049105357005,-0.267878093914553,4.72156915157858,4.72596706824776,4.70711885395125,-0.0188482142965124,0.846666164107974,ENSG00000241945,PWP2,protein_coding,21,1,44107373,44131181,q22.3,PWP2, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:9711],NA,PWP2,5822,NM_005049
EBNA1BP2_SIG,EBNA1BP2,EBNA1BP2_SIG,EBNA1BP2,SIG,45,2.90948106695513,0.548118832406953,0.537737809918651,0.582227906297087,0.0444900963784358,0.00735330440233164,2.85712651030039,5.03089564768517,4.9805152903559,5.19643110748135,0.215915817125447,0.0154229269221951,ENSG00000117395,EBNA1BP2,protein_coding,1,-1,43164175,43270936,p34.2,EBNA1 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:15531],NA,EBNA1BP2,10969,NM_001159936;NM_006824
SLC9B2_SIG,SLC9B2,SLC9B2_SIG,SLC9B2,SIG,26,2.90856429184418,0.142446579174381,0.133509504873627,0.171811251876855,0.038301747003228,0.00737309177747968,2.27722817050205,4.07312283601645,4.0211892782333,4.24376166873251,0.222572390499215,0.0565957069906639,ENSG00000164038,SLC9B2,protein_coding,4,-1,103019868,103085829,q24,solute carrier family 9 member B2 [Source:HGNC Symbol;Acc:HGNC:25143],NA,SLC9B2,133308,NM_001300754;NM_001300756;NM_178833
SORT1_SIG,SORT1,SORT1_SIG,SORT1,SIG,9,-2.9069615713817,0.31003082448165,0.324383268400635,0.262872794462128,-0.0615104739385071,0.0074091577378451,0.880543499177134,5.66242100245567,5.6177366074936,5.80924115733103,0.191504549837423,0.492104268685109,ENSG00000134243,SORT1,protein_coding,1,-1,109309568,109397918,p13.3,sortilin 1 [Source:HGNC Symbol;Acc:HGNC:11186],LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS6,SORT1,6272,NM_001205228;NM_002959
RUVBL1_SIG,RUVBL1,RUVBL1_SIG,RUVBL1,SIG,90,2.90458294872517,0.548809458625073,0.534991318571793,0.594211918800135,0.0592206002283425,0.00746325313208531,2.3865977215093,4.90371019024986,4.84150648042771,5.10809380823694,0.266587327809229,0.0451039697044352,ENSG00000175792,RUVBL1,protein_coding,3,-1,128064778,128153914,q21.3,RuvB like AAA ATPase 1 [Source:HGNC Symbol;Acc:HGNC:10474],NA,RUVBL1,8607,NM_001319084;NM_001319086;NM_003707
MKRN2_SIG,MKRN2,MKRN2_SIG,MKRN2,SIG,12,2.90450096288581,0.418991776465243,0.413825729013522,0.435965932378039,0.022140203364517,0.00746325313208531,0.132555941259482,5.28585896689864,5.28458799000495,5.29003503383507,0.00544704383012018,0.92563273864275,ENSG00000075975,MKRN2,protein_coding,3,1,12557087,12583713,p25.2,makorin ring finger protein 2 [Source:HGNC Symbol;Acc:HGNC:7113],NA,MKRN2,23609,NM_001271707;NM_014160
PDE6D_SIG,PDE6D,PDE6D_SIG,PDE6D,SIG,34,2.90445516708944,0.319254536102995,0.310780839447824,0.347096682255702,0.0363158428078777,0.00746325313208531,2.71630894010075,4.28828690112019,4.243784880181,4.43450782706324,0.190722946882236,0.0215551648983247,ENSG00000156973,PDE6D,protein_coding,2,-1,231732433,231786272,q37.1,phosphodiesterase 6D [Source:HGNC Symbol;Acc:HGNC:8788],Joubert syndrome 22;Orofaciodigital syndrome type 6,PDE6D,5147,NM_001291018;NM_002601
PA2G4_TF,PA2G4,PA2G4_TF,PA2G4,TF,551,2.90362101486743,0.329235110623004,0.322816379812233,0.350325226144109,0.0275088463318763,0.00748133233902229,2.08886831486087,6.6117155698758,6.58152056158312,6.7109277399803,0.129407178397179,0.0820834984475945,ENSG00000170515,PA2G4,protein_coding,12,1,56104537,56113910,q13.2,proliferation-associated 2G4 [Source:HGNC Symbol;Acc:HGNC:8550],NA,PA2G4,5036,NM_006191
DCAF11_SIG,DCAF11,DCAF11_SIG,DCAF11,SIG,16,2.90351159679989,0.285801512397459,0.282040910887593,0.298157774501303,0.0161168636137099,0.00748211546210612,1.21619554012504,6.52927069517794,6.51770826054401,6.56726155183227,0.0495532912882525,0.329899533532996,ENSG00000100897,DCAF11,protein_coding,14,1,24114195,24125242,q12,DDB1 and CUL4 associated factor 11 [Source:HGNC Symbol;Acc:HGNC:20258],NA,DCAF11,80344,NM_001163484;NM_025230;NM_181357
PHKA2_SIG,PHKA2,PHKA2_SIG,PHKA2,SIG,35,2.9029054035297,0.193620813124666,0.187370158472164,0.214158678411458,0.0267885199392943,0.00749477872948964,0.23945522769312,6.27063084198132,6.26748336472428,6.28097255296874,0.0134891882444598,0.864271344792365,ENSG00000044446,PHKA2,protein_coding,X,-1,18892300,18984598,p22.13,phosphorylase kinase regulatory subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:8926],Glycogen storage disease due to liver phosphorylase kinase deficiency;GLYCOGEN STORAGE DISEASE IXa1,PHKA2,5256,NM_000292
KEAP1_SIG,KEAP1,KEAP1_SIG,KEAP1,SIG,60,2.90160598630314,0.407137606265301,0.394236806984656,0.44952594675885,0.0552891397741943,0.00752409265316389,2.46706007289934,5.35624057357626,5.31296240708145,5.4984402634878,0.185477856406355,0.0379379085777684,ENSG00000079999,KEAP1,protein_coding,19,-1,10486125,10503558,p13.2,kelch like ECH associated protein 1 [Source:HGNC Symbol;Acc:HGNC:23177],Familial multinodular goiter,KEAP1,9817,NM_012289;NM_203500
CFD_SIG,CFD,CFD_SIG,CFD,SIG,114,2.90148916085306,0.0985035197208659,0.0918554636884503,0.120347132398803,0.0284916687103527,0.00752505797324163,2.54967023410917,7.22141548532861,7.09022269751078,7.65247750244434,0.562254804933565,0.0316381372246181,ENSG00000197766,CFD,protein_coding,19,1,859643,863630,p13.3,complement factor D [Source:HGNC Symbol;Acc:HGNC:2771],COMPLEMENT FACTOR D DEFICIENCY;Recurrent Neisseria infections due to factor D deficiency,CFD,1675,NM_001317335;NM_001928
SLC2A4RG_TF,SLC2A4RG,SLC2A4RG_TF,SLC2A4RG,TF,135,2.9003857095989,0.0590283142604222,0.0560004578296947,0.0689769853899555,0.0129765275602609,0.00754975642649615,2.18581654469143,5.16768773121982,5.13239345870688,5.28365462661949,0.151261167912616,0.0682388634377562,ENSG00000125520,SLC2A4RG,protein_coding,20,1,63739776,63744050,q13.33,SLC2A4 regulator [Source:HGNC Symbol;Acc:HGNC:15930],NA,SLC2A4RG,56731,NM_020062
ZKSCAN1_TF,ZKSCAN1,ZKSCAN1_TF,ZKSCAN1,TF,110,2.9002418290523,0.266495176316195,0.255484295263666,0.302673785488789,0.0471894902251226,0.00755137675699359,2.00632991268425,6.67720214473644,6.62361272012381,6.85328168274937,0.229668962625562,0.0959125338360999,ENSG00000106261,ZKSCAN1,protein_coding,7,1,100015572,100041689,q22.1,zinc finger with KRAB and SCAN domains 1 [Source:HGNC Symbol;Acc:HGNC:13101],NA,ZKSCAN1,7586,NM_001287054;NM_001287055;NM_001346579;NM_001346580;NM_001346581;NM_003439
MTRR_SIG,MTRR,MTRR_SIG,MTRR,SIG,11,2.89990213525594,0.182554524739845,0.179009288889428,0.194203156819785,0.0151938679303563,0.00755771761871273,0.122925817529631,5.55602702099561,5.55464640328652,5.56056333632548,0.00591693303896436,0.931282435307954,ENSG00000124275,MTRR,protein_coding,5,1,7851186,7906025,p15.31,5-methyltetrahydrofolate-homocysteine methyltransferase reductase [Source:HGNC Symbol;Acc:HGNC:7473],Homocystinuria-megaloblastic anemia cbl E type;HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA cblE COMPLEMENTATION TYPE;Methylcobalamin deficiency type cblE;Neural tube defects folate-sensitive,MTRR,4552,NM_001364442;NM_002454;NM_024010
ALDH1B1_SIG,ALDH1B1,ALDH1B1_SIG,ALDH1B1,SIG,43,2.89963437466353,0.293492587201936,0.279851312587311,0.338313918078562,0.0584626054912515,0.00756232797583842,3.16258533468787,3.16992686753794,3.07600082816495,3.47854099690632,0.402540168741378,0.00701047021586253,ENSG00000137124,ALDH1B1,protein_coding,9,1,38392702,38398661,p13.1,aldehyde dehydrogenase 1 family member B1 [Source:HGNC Symbol;Acc:HGNC:407],NA,ALDH1B1,219,NM_000692
BATF2_TF,BATF2,BATF2_TF,BATF2,TF,195,-2.89860845910843,-0.0046099758891768,0.00165882248942588,-0.0252074562760142,-0.0268662787654401,0.00758402135084976,-0.66236429637924,1.0119600013584,1.02784906677878,0.959753072120017,-0.0680959946587628,0.613372526928151,ENSG00000168062,BATF2,protein_coding,11,-1,64987945,64997018,q13.1,basic leucine zipper ATF-like transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:25163],NA,BATF2,116071,NM_001300807;NM_001300808;NM_138456
NUDT7_SIG,NUDT7,NUDT7_SIG,NUDT7,SIG,16,2.8985831018151,0.286530066537182,0.278918018692297,0.311541080884664,0.032623062192367,0.00758402135084976,1.83416887105464,1.94342988477369,1.89373708422661,2.10670622942837,0.212969145201756,0.130252087832582,ENSG00000140876,NUDT7,protein_coding,16,1,77722492,77742260,q23.1,nudix hydrolase 7 [Source:HGNC Symbol;Acc:HGNC:8054],NA,NUDT7,283927,NM_001105663;NM_001243657;NM_001243660;NM_001243661
ZFYVE28_TF,ZFYVE28,ZFYVE28_TF,ZFYVE28,TF,61,-2.89821805270664,-0.0558150731837878,-0.0516701778911875,-0.0694340148594743,-0.0177638369682866,0.00759100118167347,-0.831603779994355,2.63428924114071,2.65649656013887,2.56132233586105,-0.0951742242778204,0.518320966907042,ENSG00000159733,ZFYVE28,protein_coding,4,-1,2269582,2418663,p16.3,zinc finger FYVE-type containing 28 [Source:HGNC Symbol;Acc:HGNC:29334],NA,ZFYVE28,57732,NM_001172656;NM_001172657;NM_001172658;NM_001172659;NM_001172660;NM_020972
BCCIP_SIG,BCCIP,BCCIP_SIG,BCCIP,SIG,19,2.8974804288959,0.59942889718092,0.591955672251014,0.623983779093469,0.0320281068424551,0.00760701739693951,2.23891741484212,5.53495561328084,5.5078348271048,5.62406676785923,0.116231940754425,0.0612980993272349,ENSG00000107949,BCCIP,protein_coding,10,1,125823546,125853695,q26.2,BRCA2 and CDKN1A interacting protein [Source:HGNC Symbol;Acc:HGNC:978],NA,BCCIP,56647,NM_016567;NM_078468;NM_078469
TRIM29_TF,TRIM29,TRIM29_TF,TRIM29,TF,134,-2.8968554546879,-0.124666867770638,-0.120060401754243,-0.139802398967362,-0.0197419972131184,0.00762032741903379,-1.5265597096709,0.35218234622558,0.381219503349864,0.256774544245791,-0.124444959104073,0.213285726858192,ENSG00000137699,TRIM29,protein_coding,11,-1,120111286,120185529,q23.3,tripartite motif containing 29 [Source:HGNC Symbol;Acc:HGNC:17274],NA,TRIM29,23650,NM_001330382;NM_012101
SLC25A36_SIG,SLC25A36,SLC25A36_SIG,SLC25A36,SIG,96,2.8959891205115,0.271176849436727,0.260873195733967,0.305031711602938,0.0441585158689714,0.00763953207007616,2.862128350399,7.1631454134592,7.10976653202219,7.33853316675221,0.228766634730017,0.0152369701542234,ENSG00000114120,SLC25A36,protein_coding,3,1,140941830,140980961,q23,solute carrier family 25 member 36 [Source:HGNC Symbol;Acc:HGNC:25554],NA,SLC25A36,55186,NM_001104647;NM_018155
DDX49_SIG,DDX49,DDX49_SIG,DDX49,SIG,9,2.89501557085527,0.308252281471023,0.302288579067166,0.327847303655127,0.025558724587961,0.00766139664488717,0.960927273772123,5.2772418372019,5.26849050270997,5.30599622196109,0.0375057192511177,0.450356044646096,ENSG00000105671,DDX49,protein_coding,19,1,18919705,18929189,p13.11,DEAD-box helicase 49 [Source:HGNC Symbol;Acc:HGNC:18684],NA,DDX49,54555,NM_019070
SNRPA_SIG,SNRPA,SNRPA_SIG,SNRPA,SIG,18,2.8947092063332,0.669316024974962,0.663764542860251,0.687556609066155,0.023792066205904,0.00766700736927235,3.21806081894671,6.11626744456914,6.08018611769327,6.23482037573275,0.154634258039482,0.00603718448343025,ENSG00000077312,SNRPA,protein_coding,19,1,40750637,40765389,q13.2,small nuclear ribonucleoprotein polypeptide A [Source:HGNC Symbol;Acc:HGNC:11151],NA,SNRPA,6626,NM_004596
PLCD1_SIG,PLCD1,PLCD1_SIG,PLCD1,SIG,27,-2.89440730839937,0.00942131961002518,0.0141368241601432,-0.00607248105464832,-0.0202093052147916,0.00767251283677276,-1.31692647138658,3.46371898145283,3.49345974864009,3.36599931783753,-0.127460430802556,0.288264029476484,ENSG00000187091,PLCD1,protein_coding,3,-1,38007496,38029762,p22.2,phospholipase C delta 1 [Source:HGNC Symbol;Acc:HGNC:9060],Leukonychia totalis;NAIL DISORDER NONSYNDROMIC CONGENITAL 3,PLCD1,5333,NM_001130964;NM_006225
CA1_SIG,CA1,CA1_SIG,CA1,SIG,21,-2.89378833260967,-0.264256170318246,-0.225554859783152,-0.391417619219268,-0.165862759436116,0.00768577925479494,-1.48626070988211,3.7127436606667,3.82304730844328,3.35031738940076,-0.472729919042522,0.226504898363886,ENSG00000133742,CA1,protein_coding,8,-1,85327608,85379014,q21.2,carbonic anhydrase 1 [Source:HGNC Symbol;Acc:HGNC:1368],NA,CA1,759,NM_001128829;NM_001128830;NM_001128831;NM_001164830;NM_001291967;NM_001291968;NM_001738
ZMAT3_TF,ZMAT3,ZMAT3_TF,ZMAT3,TF,110,2.89251202448985,0.150448975607841,0.147916484316837,0.158770018421139,0.0108535341043018,0.00771519534583036,1.76029485718528,5.66305332226065,5.61602911733537,5.81756142415802,0.201532306822652,0.147693765737133,ENSG00000172667,ZMAT3,protein_coding,3,-1,178960121,179072215,q26.32,zinc finger matrin-type 3 [Source:HGNC Symbol;Acc:HGNC:29983],NA,ZMAT3,64393,NM_022470;NM_152240
MAP3K8_SIG,MAP3K8,MAP3K8_SIG,MAP3K8,SIG,22,-2.89195908276965,0.314075807963878,0.328154589357884,0.267816954812145,-0.0603376345457391,0.0077269039094953,-3.1175317317205,6.06432037922837,6.15324936518115,5.77212513966922,-0.38112422551193,0.00795119609545999,ENSG00000107968,MAP3K8,protein_coding,10,1,30434021,30461833,p11.23,mitogen-activated protein kinase kinase kinase 8 [Source:HGNC Symbol;Acc:HGNC:6860],LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,MAP3K8,1326,NM_001244134;NM_001320961;NM_005204
TNFSF15_SIG,TNFSF15,TNFSF15_SIG,TNFSF15,SIG,7,-2.89110264873703,0.0960744560646341,0.109421276841079,0.0522206163706003,-0.057200660470479,0.00774610591919555,-1.86640873732506,0.701045620071084,0.737396153019732,0.581608154668384,-0.155787998351348,0.123368765260243,ENSG00000181634,TNFSF15,protein_coding,9,-1,114784652,114806039,q32,TNF superfamily member 15 [Source:HGNC Symbol;Acc:HGNC:11931],Primary biliary cholangitis,TNFSF15,9966,NM_001204344;NM_005118
SLC6A6_SIG,SLC6A6,SLC6A6_SIG,SLC6A6,SIG,35,-2.88979297189259,0.475574223308035,0.484083094728141,0.447616502927685,-0.0364665918004557,0.00777655498048661,-0.738560753721326,7.30835986550056,7.32405819732971,7.25677963234763,-0.0672785649820843,0.569932655055414,ENSG00000131389,SLC6A6,protein_coding,3,1,14402576,14489349,p25.1,solute carrier family 6 member 6 [Source:HGNC Symbol;Acc:HGNC:11052],NA,SLC6A6,6533,NM_001134367;NM_001134368;NM_003043
ZNF233_TF,ZNF233,ZNF233_TF,ZNF233,TF,2,2.88962893116168,-0.192218906821315,-0.204741701862227,-0.151072580258316,0.0536691216039111,0.00777871966470396,1.99024134380223,0.592710527243113,0.565613507412788,0.681743592399892,0.116130084987103,0.098864837999832,ENSG00000159915,ZNF233,protein_coding,19,1,44259880,44275317,q13.31,zinc finger protein 233 [Source:HGNC Symbol;Acc:HGNC:30946],NA,ZNF233,353355,NM_001207005;NM_001330529;NM_181756
MRPL23_SIG,MRPL23,MRPL23_SIG,MRPL23,SIG,16,2.88943676064753,0.436024792638217,0.430907508616387,0.452838725852799,0.0219312172364123,0.00778158139070955,3.10502347907485,5.17630679094154,5.14013980806252,5.29514116325831,0.155001355195782,0.00820286418985864,ENSG00000214026,MRPL23,protein_coding,11,1,1947278,1984522,p15.5,mitochondrial ribosomal protein L23 [Source:HGNC Symbol;Acc:HGNC:10322],NA,MRPL23,6150;107987373,NM_021134
CYP4F2_SIG,CYP4F2,CYP4F2_SIG,CYP4F2,SIG,12,-2.88836466292676,0.0288269368900877,0.0347507028400728,0.00936313448299398,-0.0253875683570788,0.00780625669877538,-2.23732179140998,1.19848577500393,1.26251449599109,0.988105691760377,-0.274408804230718,0.0614859357300798,ENSG00000186115,CYP4F2,protein_coding,19,-1,15878023,15898077,p13.12,cytochrome P450 family 4 subfamily F member 2 [Source:HGNC Symbol;Acc:HGNC:2645],Vitamin K antagonists toxicity or dose selection,CYP4F2,8529,NM_001082
CTSV_SIG,CTSV,CTSV_SIG,CTSV,SIG,15,-2.88665317929933,-0.193588909824024,-0.184994419068033,-0.221827950879423,-0.0368335318113903,0.00784693217542975,-1.9163387765595,0.318864606404455,0.350809311717374,0.213903431804861,-0.136905879912514,0.112984103417751,ENSG00000136943,CTSV,protein_coding,9,-1,97029677,97039643,q22.33,cathepsin V [Source:HGNC Symbol;Acc:HGNC:2538],NA,CTSV,1515,NM_001201575;NM_001333
SMAD4_TF,SMAD4,SMAD4_TF,SMAD4,TF,104,2.88599275150505,0.419159527211498,0.414980148230345,0.432891772435285,0.0179116242049404,0.00786150479847922,2.65872023503248,5.88265919282959,5.84482168264342,6.00698244058413,0.162160757940716,0.0246108763970741,ENSG00000141646,SMAD4,protein_coding,18,1,51028394,51085045,q21.2,SMAD family member 4 [Source:HGNC Symbol;Acc:HGNC:6770],Familial pancreatic carcinoma;Generalized juvenile polyposis/juvenile polyposis coli;HEREDITARY HEMORRHAGIC TELANGIECTASIA;Juvenile polyposis syndrome;Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome;Myhre syndrome;Pancreatic Cancer,SMAD4,4089,NM_005359
RARS_SIG,RARS,RARS_SIG,RARS,SIG,21,2.88353084953135,0.396996985212867,0.390919594353493,0.416965555179382,0.0260459608258896,0.00792129247441479,3.17300396293717,5.11399851828196,5.06944799834773,5.26037879806587,0.190930799718145,0.00682172386795731,ENSG00000113643,RARS,protein_coding,5,1,168486451,168519301,q34,arginyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:9870],LEUKODYSTROPHY HYPOMYELINATING 9;RARS-related autosomal recessive hypomyelinating leukodystrophy,RARS,5917,NM_002887
HIRA_SIG,HIRA,HIRA_SIG,HIRA,SIG,8,-2.88321374161663,0.289237622548324,0.291714264532985,0.281100084598724,-0.010614179934261,0.00792734419711186,-1.43379751097684,4.05729495245888,4.07087534903829,4.01267364941226,-0.0582016996260243,0.244235828560398,ENSG00000100084,HIRA,protein_coding,22,-1,19330698,19447450,q11.21,histone cell cycle regulator [Source:HGNC Symbol;Acc:HGNC:4916],22q11.2 Deletion Syndrome,HIRA,7290,NM_003325
ATXN7L3_SIG,ATXN7L3,ATXN7L3_SIG,ATXN7L3,SIG,19,-2.88293381360048,0.34430486665428,0.347183419747525,0.334846763633617,-0.0123366561139081,0.0079324639698043,-3.22667944430121,6.85837677320505,6.8863735321435,6.7663874224073,-0.119986109736196,0.00589935467797301,ENSG00000087152,ATXN7L3,protein_coding,17,-1,44191805,44200113,q21.31,ataxin 7 like 3 [Source:HGNC Symbol;Acc:HGNC:25416],NA,ATXN7L3,56970,NM_001098833;NM_020218
PGAM5_SIG,PGAM5,PGAM5_SIG,PGAM5,SIG,17,2.88225239881683,0.499322185240497,0.489217633717716,0.532522854529633,0.0433052208119161,0.00794770862599639,1.47695646476005,4.44281486065797,4.41540987568608,4.5328598112799,0.117449935593815,0.229532237955354,ENSG00000247077,PGAM5,protein_coding,12,1,132710819,132722734,q24.33,PGAM family member 5, mitochondrial serine/threonine protein phosphatase [Source:HGNC Symbol;Acc:HGNC:28763],NA,PGAM5,192111,NM_001170543;NM_001170544;NM_138575
ZNF385D_SIG,ZNF385D,ZNF385D_SIG,ZNF385D,SIG,58,-2.88134835274986,-0.01468054763128,-0.00926467434042634,-0.0324755598726563,-0.0232108855322301,0.00796860699958967,-3.21982501792169,0.950331320242326,1.06117921594063,0.586116805805026,-0.475062410135608,0.00601000425386647,ENSG00000151789,ZNF385D,protein_coding,3,-1,21412218,22373321,p24.3,zinc finger protein 385D [Source:HGNC Symbol;Acc:HGNC:26191],NA,ZNF385D,79750,NM_024697
TMUB2_SIG,TMUB2,TMUB2_SIG,TMUB2,SIG,17,-2.8794914679559,0.283404771692911,0.286386680104962,0.273607072624741,-0.0127796074802209,0.00801373717723206,-1.64671144498887,6.0074673163847,6.02111514767335,5.9626244421506,-0.0584907055227513,0.177357284889669,ENSG00000168591,TMUB2,protein_coding,17,1,44186970,44191929,q21.31,transmembrane and ubiquitin like domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28459],NA,TMUB2,79089,NM_001076674;NM_001330235;NM_001353173;NM_001353174;NM_001353175;NM_001353176;NM_001353177;NM_001353178;NM_001353180;NM_001353181;NM_001353182;NM_001353183;NM_001353184;NM_001353185;NM_001353186;NM_001353187;NM_001353188;NM_001353189;NM_001353190;NM_001353191;NM_024107;NM_177441
FBXL6_SIG,FBXL6,FBXL6_SIG,FBXL6,SIG,21,2.87929863905686,0.212330899876661,0.207149593947546,0.229355190786612,0.0222055968390658,0.00801669238279904,1.96081887609069,4.15896682006847,4.13111753886081,4.25047160117936,0.11935406231855,0.104270275996925,ENSG00000182325,FBXL6,protein_coding,8,-1,144355431,144359376,q24.3,F-box and leucine rich repeat protein 6 [Source:HGNC Symbol;Acc:HGNC:13603],NA,FBXL6,26233,NM_012162;NM_024555
CSTF1_SIG,CSTF1,CSTF1_SIG,CSTF1,SIG,78,2.87897262370742,0.248050872877699,0.239055808559153,0.277606084210065,0.0385502756509123,0.00802243212067742,2.75633563806639,4.19528861068716,4.147132724764,4.3535150930061,0.206382368242101,0.0196365217220757,ENSG00000101138,CSTF1,protein_coding,20,1,56392371,56406369,q13.2,cleavage stimulation factor subunit 1 [Source:HGNC Symbol;Acc:HGNC:2483],NA,CSTF1,1477,NM_001033521;NM_001033522;NM_001324
HTR7_SIG,HTR7,HTR7_SIG,HTR7,SIG,39,-2.8789198424401,0.0416283421165733,0.0507836421690595,0.0115466419441185,-0.039237000224941,0.00802243212067742,-1.00731989492964,1.73774914355609,1.77561022544532,1.61334844592003,-0.162261779525291,0.426943419063499,ENSG00000148680,HTR7,protein_coding,10,-1,90740823,90858039,q23.31,5-hydroxytryptamine receptor 7 [Source:HGNC Symbol;Acc:HGNC:5302],NA,HTR7,3363,NM_000872;NM_019859;NM_019860
PUS7_SIG,PUS7,PUS7_SIG,PUS7,SIG,21,2.87812571718876,0.557037918172939,0.541856730971659,0.606918961834287,0.0650622308626282,0.00803992289306601,2.95023105246414,3.61112248401268,3.53384390912124,3.86503780151314,0.331193892391904,0.012230693204901,ENSG00000091127,PUS7,protein_coding,7,-1,105439661,105522271,q22.3,pseudouridine synthase 7 [Source:HGNC Symbol;Acc:HGNC:26033],NA,PUS7,54517,NM_001318163;NM_001318164;NM_019042
NAA15_SIG,NAA15,NAA15_SIG,NAA15,SIG,20,2.87807986854413,0.536293186636782,0.53089043718111,0.55404507770542,0.0231546405243096,0.00803992289306601,2.64362945132036,5.92327486466177,5.88797601335949,6.03925680465496,0.151280791295473,0.02542271210634,ENSG00000164134,NAA15,protein_coding,4,1,139301505,139420033,q31.1,N(alpha)-acetyltransferase 15, NatA auxiliary subunit [Source:HGNC Symbol;Acc:HGNC:30782],CONGENITAL HEART DISEASE and NEURODEVELOPMENTAL DISORDER;MENTAL RETARDATION AUTOSOMAL DOMINANT 50,NAA15,80155,NM_057175
ZNF439_TF,ZNF439,ZNF439_TF,ZNF439,TF,126,2.87791106013752,0.007799359519864,0.000375655993832161,0.0321915282482543,0.031815872254422,0.00804227572315373,0.975109779298359,3.9159293602212,3.88829641491733,4.00672332336249,0.118426908445158,0.443121632081345,ENSG00000171291,ZNF439,protein_coding,19,1,11848726,11883750,p13.2,zinc finger protein 439 [Source:HGNC Symbol;Acc:HGNC:20873],NA,ZNF439,90594,NM_001348718;NM_001348719;NM_001348720;NM_001348721;NM_001348722;NM_001348723;NM_001348724;NM_001348725;NM_152262
ANXA1_SIG,ANXA1,ANXA1_SIG,ANXA1,SIG,61,2.87752927763269,0.157029501464584,0.152411890449825,0.172201651941648,0.0197897614918228,0.00805006182127973,1.95340624217882,9.23371724362176,9.18056971560266,9.40834483568451,0.22777512008185,0.105738512337516,ENSG00000135046,ANXA1,protein_coding,9,1,73151865,73170393,q21.13,annexin A1 [Source:HGNC Symbol;Acc:HGNC:533],NA,ANXA1,301,NM_000700
ZCRB1_SIG,ZCRB1,ZCRB1_SIG,ZCRB1,SIG,44,2.87705131915681,0.496145849089813,0.490540491298085,0.514563453262634,0.0240229619645488,0.00806031119270221,4.01227847813461,5.30598706391172,5.25806262796908,5.46345306772322,0.205390439754134,0.000546049474007581,ENSG00000139168,ZCRB1,protein_coding,12,-1,42312086,42326118,q12,zinc finger CCHC-type and RNA binding motif containing 1 [Source:HGNC Symbol;Acc:HGNC:29620],NA,ZCRB1,85437,NM_033114
NFE2L3_TF,NFE2L3,NFE2L3_TF,NFE2L3,TF,58,2.87642755080812,-0.0209682798960808,-0.0243399963859818,-0.00988978285783474,0.0144502135281471,0.00807430190570059,-1.71149409638791,3.18888089563771,3.24808644638913,2.99434837174021,-0.253738074648911,0.16028636933624,ENSG00000050344,NFE2L3,protein_coding,7,1,26152198,26187137,p15.2,nuclear factor, erythroid 2 like 3 [Source:HGNC Symbol;Acc:HGNC:7783],NA,NFE2L3,9603,NM_004289
ENY2_SIG,ENY2,ENY2_SIG,ENY2,SIG,7,-2.87629231454291,0.263431839655401,0.26699170457111,0.251735140646642,-0.0152565639244673,0.00807580555433731,-1.04936053954782,6.32105290352781,6.33188080283151,6.28547552010138,-0.0464052827301327,0.406413467559573,ENSG00000120533,ENY2,protein_coding,8,1,109334324,109345954,q23.1,ENY2, transcription and export complex 2 subunit [Source:HGNC Symbol;Acc:HGNC:24449],NA,ENY2,56943,NM_001193557;NM_020189
MICAL3_SIG,MICAL3,MICAL3_SIG,MICAL3,SIG,23,2.87510347900947,0.214776357857029,0.208971356681321,0.233849933148638,0.024878576467317,0.00810395303724017,0.581357319435362,4.18481858426749,4.1706309875153,4.23143497359613,0.0608039860808339,0.662411973602865,ENSG00000243156,MICAL3,protein_coding,22,-1,17787649,18024561,q11.21,microtubule associated monooxygenase, calponin and LIM domain containing 3 [Source:HGNC Symbol;Acc:HGNC:24694],NA,MICAL3,57553,NM_001122731;NM_001136004;NM_015241
SRCAP_SIG,SRCAP,SRCAP_SIG,SRCAP,SIG,40,2.87504105405233,0.479287024465829,0.475699180819973,0.491075653587928,0.0153764727679545,0.00810395303724017,3.17687728063897,7.99305761437579,7.9606541318052,8.09952619996487,0.138872068159665,0.0067629690544537,ENSG00000080603,SRCAP,protein_coding,16,1,30698209,30741409,p11.2,Snf2 related CREBBP activator protein [Source:HGNC Symbol;Acc:HGNC:16974],FLOATING-HARBOR SYNDROME,SRCAP,10847,NM_006662
TEK_SIG,TEK,TEK_SIG,TEK,SIG,44,-2.87446099972451,-0.105933104583891,-0.101591899985269,-0.120197062550793,-0.0186051625655232,0.00811688831203203,-1.62942671550727,0.724224740969457,0.762178386166711,0.599519906749911,-0.1626584794168,0.182336905314584,ENSG00000120156,TEK,protein_coding,9,1,27109141,27230174,p21.2,TEK receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:11724],Blue rubber bleb nevus;Congenital glaucoma;GLAUCOMA 3 PRIMARY CONGENITAL E;GLAUCOMA 3 PRIMARY INFANTILE B;Mucocutaneous venous malformations;VENOUS MALFORMATIONS MULTIPLE CUTANEOUS AND MUCOSAL,TEK,7010,NM_000459;NM_001290077;NM_001290078
NOD2_SIG,NOD2,NOD2_SIG,NOD2,SIG,36,-2.87392820587913,0.354972629365694,0.373573587126315,0.293855196723657,-0.0797183904026579,0.00812862576824617,0.146921392484481,4.26991702855404,4.26388279339826,4.28974380120875,0.02586100781049,0.917671545304477,ENSG00000167207,NOD2,protein_coding,16,1,50693588,50734041,q12.1,nucleotide binding oligomerization domain containing 2 [Source:HGNC Symbol;Acc:HGNC:5331],BLAU SYNDROME;INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1;PSORIATIC ARTHRITIS SUSCEPTIBILITY TOPSORIATIC ARTHRITIS SUSCEPTIBILITY TO 1 INCLUDED;YAO SYNDROME,NOD2,64127,NM_001293557;NM_022162
SRM_SIG,SRM,SRM_SIG,SRM,SIG,38,2.87275914784737,0.522341687317991,0.513242258147647,0.552239811734834,0.0389975535871871,0.00815678998534296,2.72385391442025,5.67604715807266,5.6205929864789,5.85825372188072,0.237660735401819,0.0211687738878593,ENSG00000116649,SRM,protein_coding,1,-1,11054584,11060020,p36.22,spermidine synthase [Source:HGNC Symbol;Acc:HGNC:11296],NA,SRM,6723,NM_003132
CCDC86_SIG,CCDC86,CCDC86_SIG,CCDC86,SIG,7,2.87225473591778,0.274076609695579,0.2613900290909,0.315761088825238,0.0543710597343378,0.00816784559299417,2.18367585236432,4.2389126805148,4.19555017373085,4.3813894885192,0.18583931478835,0.0685466505062515,ENSG00000110104,CCDC86,protein_coding,11,1,60842113,60851081,q12.2,coiled-coil domain containing 86 [Source:HGNC Symbol;Acc:HGNC:28359],NA,CCDC86,79080,NM_024098
LETM1_SIG,LETM1,LETM1_SIG,LETM1,SIG,26,2.86891287095046,0.538654997453849,0.530299050809235,0.566110250714723,0.0358111999054879,0.00825264628656952,3.2904844606611,5.69826736872189,5.65341746306228,5.84563134446062,0.192213881398348,0.00493633702632586,ENSG00000168924,LETM1,protein_coding,4,-1,1811479,1856156,p16.3,leucine zipper and EF-hand containing transmembrane protein 1 [Source:HGNC Symbol;Acc:HGNC:6556],Wolf-Hirschhorn syndrome,LETM1,3954,NM_012318
ZC3H10_TF,ZC3H10,ZC3H10_TF,ZC3H10,TF,42,2.86856218103777,0.257165460169782,0.251593530980168,0.275473227507084,0.0238796965269169,0.00825980322820315,2.17577557778538,2.68362757595062,2.65097649074992,2.79090971303864,0.139933222288728,0.0695864819799487,ENSG00000135482,ZC3H10,protein_coding,12,1,56118260,56127514,q13.2,zinc finger CCCH-type containing 10 [Source:HGNC Symbol;Acc:HGNC:25893],NA,ZC3H10,84872,NM_001303124;NM_001303125;NM_032786
TNR_SIG,TNR,TNR_SIG,TNR,SIG,19,2.86646532914821,-0.109563703080559,-0.113214770734899,-0.0975673379305817,0.0156474328043177,0.00831270925209942,1.20122550523586,0.499950084749039,0.472181970938861,0.59118817298248,0.119006202043618,0.336422757645174,ENSG00000116147,TNR,protein_coding,1,-1,175315194,175743616,q25.1,tenascin R [Source:HGNC Symbol;Acc:HGNC:11953],NA,TNR,7143,NM_001328635;NM_003285
ABCA3_SIG,ABCA3,ABCA3_SIG,ABCA3,SIG,48,2.86544048847516,-0.00883362640709921,-0.0131299543017628,0.00528287953250973,0.0184128338342724,0.00833764793222616,0.693196179626783,2.98752275163752,2.96538539711786,3.06025977363071,0.0948743765128555,0.59593296199163,ENSG00000167972,ABCA3,protein_coding,16,-1,2275881,2340746,p13.3,ATP binding cassette subfamily A member 3 [Source:HGNC Symbol;Acc:HGNC:33],Idiopathic pulmonary fibrosis;Infant acute respiratory distress syndrome;Interstitial lung disease due to ABCA3 deficiency;SURFACTANT METABOLISM DYSFUNCTION PULMONARY 3,ABCA3,21,NM_001089
SLC39A3_SIG,SLC39A3,SLC39A3_SIG,SLC39A3,SIG,41,2.86346215647504,0.262332519737953,0.254646867565599,0.287585376875688,0.0329385093100896,0.00838680357088914,1.6575442142641,4.96733347453774,4.92937013809043,5.09207015143606,0.162700013345625,0.17440538575572,ENSG00000141873,SLC39A3,protein_coding,19,-1,2732204,2740028,p13.3,solute carrier family 39 member 3 [Source:HGNC Symbol;Acc:HGNC:17128],NA,SLC39A3,29985,NM_144564;NM_213568
LIPT2_SIG,LIPT2,LIPT2_SIG,LIPT2,SIG,23,2.86342568749739,0.101887028725758,0.0976895944772558,0.115678598399408,0.0179890039221519,0.00838680357088914,2.22074502945702,1.44172635121766,1.41686968947892,1.5233982397878,0.106528550308877,0.063661211364093,ENSG00000175536,LIPT2,protein_coding,11,-1,74490519,74493724,q13.4,lipoyl(octanoyl) transferase 2 [Source:HGNC Symbol;Acc:HGNC:37216],ENCEPHALOPATHY NEONATAL SEVERE WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES;Lipoyl transferase 2 deficiency;Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy,LIPT2,387787,NM_001144869;NM_001329941;NM_001329942
MDH2_SIG,MDH2,MDH2_SIG,MDH2,SIG,39,2.86316532714163,0.405378665990004,0.398526782523631,0.427891997379516,0.0293652148558846,0.00839167159082449,2.50582629323864,6.95822489482414,6.9263047352159,7.06310541925122,0.136800684035318,0.0348171257181658,ENSG00000146701,MDH2,protein_coding,7,1,76048051,76067508,q11.23,malate dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:6971],Early-Onset Severe Encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 51;Hereditary pheochromocytoma-paraganglioma,MDH2,4191,NM_001282403;NM_001282404;NM_005918
RPS26_SIG,RPS26,RPS26_SIG,RPS26,SIG,13,2.86303511632222,0.308730856477281,0.304718069349325,0.321915728469135,0.0171976591198095,0.00839309416669277,3.2747025667678,4.03827971913013,3.98670954056331,4.20772459156394,0.221015051000626,0.00515481068104372,ENSG00000197728,RPS26,protein_coding,12,1,56041351,56044697,q13.2,ribosomal protein S26 [Source:HGNC Symbol;Acc:HGNC:10414],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 10,RPS26,6231,NM_001029
POLR2K_SIG,POLR2K,POLR2K_SIG,POLR2K,SIG,25,-2.86256974851347,0.101596257471575,0.105689793368898,0.0881460680946575,-0.0175437252742406,0.00840340089547975,-2.45091599244879,4.79662614993312,4.8220237643662,4.71317684536727,-0.108846918998936,0.039281957029774,ENSG00000147669,POLR2K,protein_coding,8,1,100150623,100154003,q22.2,RNA polymerase II subunit K [Source:HGNC Symbol;Acc:HGNC:9198],NA,POLR2K,5440,NM_005034
TNPO1_SIG,TNPO1,TNPO1_SIG,TNPO1,SIG,17,2.86235366208128,0.250781553000858,0.248068755577627,0.259695030248617,0.0116262746709902,0.00840710369670994,1.20668618109622,6.76631665607929,6.75048202928329,6.81834471555185,0.0678626862685558,0.333759048452623,ENSG00000083312,TNPO1,protein_coding,5,1,72816312,72916733,q13.2,transportin 1 [Source:HGNC Symbol;Acc:HGNC:6401],NA,TNPO1,3842,NM_002270;NM_153188
YY1_TF,YY1,YY1_TF,YY1,TF,78,2.8620470034419,0.239493841967973,0.23546594955775,0.25272834560156,0.0172623960438095,0.00841321220738796,1.53323615630148,7.50139414381976,7.48699316734059,7.54871163796562,0.0617184706250323,0.211196168966457,ENSG00000100811,YY1,protein_coding,14,1,100238298,100282792,q32.2,YY1 transcription factor [Source:HGNC Symbol;Acc:HGNC:12856],GABRIELE-DE VRIES SYNDROME;Intellectual disability,YY1,7528,NM_003403
PHKA1_SIG,PHKA1,PHKA1_SIG,PHKA1,SIG,128,2.86088409001931,-0.116435366126262,-0.121486296244496,-0.0998394528806337,0.0216468433638627,0.00844209677676873,0.841189790125888,1.40753375707518,1.37956976777537,1.49941543620312,0.119845668427743,0.513167254586663,ENSG00000067177,PHKA1,protein_coding,X,-1,72578814,72714319,q13.1,phosphorylase kinase regulatory subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:8925],Glycogen storage disease due to muscle phosphorylase kinase deficiency;GLYCOGEN STORAGE DISEASE TYPE IXd,PHKA1,5255,NM_001122670;NM_001172436;NM_002637
RBBP4_SIG,RBBP4,RBBP4_SIG,RBBP4,SIG,38,2.85954656365912,0.579872848025026,0.570339187825806,0.611197731536752,0.0408585437109467,0.00847573541634763,2.01681951070124,7.06301637761383,7.03463283709196,7.15627658218568,0.121643745093723,0.0940973434875406,ENSG00000162521,RBBP4,protein_coding,1,1,32651142,32686211,p35.1,RB binding protein 4, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:9887],NA,RBBP4,5928,NM_001135255;NM_001135256;NM_005610
TNFRSF8_SIG,TNFRSF8,TNFRSF8_SIG,TNFRSF8,SIG,19,-2.85761697159075,0.22002927765261,0.237281984423211,0.163341812549204,-0.0739401718740072,0.00852538647005948,-1.08885588322275,1.62104151539351,1.65312330737448,1.51562991317035,-0.137493394204128,0.387634594606761,ENSG00000120949,TNFRSF8,protein_coding,1,1,12063303,12144207,p36.22,TNF receptor superfamily member 8 [Source:HGNC Symbol;Acc:HGNC:11923],NA,TNFRSF8,943,NM_001243;NM_001281430
PF4_SIG,PF4,PF4_SIG,PF4,SIG,54,-2.85638554311269,-0.220513506850724,-0.205918513371536,-0.268468485425196,-0.0625499720536601,0.00855646336254613,-1.06582502281005,1.95284428585981,2.00900932993265,1.76830199819188,-0.240707331740775,0.398711958398857,ENSG00000163737,PF4,protein_coding,4,-1,73981077,73982124,q13.3,platelet factor 4 [Source:HGNC Symbol;Acc:HGNC:8861],NA,PF4,5196,NM_002619
MBOAT2_SIG,MBOAT2,MBOAT2_SIG,MBOAT2,SIG,67,-2.85530070107112,-0.028439253376947,-0.0212118478960753,-0.0521864428140972,-0.0309745949180219,0.00858367899723243,0.0567265979414957,4.62984416412622,4.62747299045446,4.63763516333345,0.0101621728789841,0.968460616150889,ENSG00000143797,MBOAT2,protein_coding,2,-1,8852690,9003709,p25.1,membrane bound O-acyltransferase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25193],NA,MBOAT2,129642,NM_001321265;NM_001321266;NM_001321267;NM_138799
SLC25A26_SIG,SLC25A26,SLC25A26_SIG,SLC25A26,SIG,54,2.85483423281696,0.352465073916152,0.344043666938339,0.380135411128967,0.0360917441906282,0.00859422493266535,3.1023067572121,3.85602459168945,3.80882164715204,4.01111998088381,0.202298333731768,0.00825048898248902,ENSG00000144741,SLC25A26,protein_coding,3,1,66133610,66388116,p14.1,solute carrier family 25 member 26 [Source:HGNC Symbol;Acc:HGNC:20661],Combined oxidative phosphorylation deficiency 28;INTRA-MITOCHONDRIAL METHYLATION DEFICIENCY;Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,SLC25A26,115286,NM_001164796;NM_001350991;NM_001350992;NM_001350993;NM_173471
LSM14B_SIG,LSM14B,LSM14B_SIG,LSM14B,SIG,31,2.85425405612875,0.041121892754025,0.0339900242325438,0.0645551750388918,0.0305651508063479,0.00860786329451203,3.13193110793132,6.10916300943208,6.0618293774861,6.26468780011172,0.202858422625622,0.00763404729399901,ENSG00000149657,LSM14B,protein_coding,20,1,62122461,62135374,q13.33,LSM family member 14B [Source:HGNC Symbol;Acc:HGNC:15887],NA,LSM14B,149986,NM_144703
RAP1A_SIG,RAP1A,RAP1A_SIG,RAP1A,SIG,16,-2.85392406612437,0.378398159479951,0.38469916356625,0.357694860339256,-0.0270043032269935,0.00861362872586574,-2.96410156267451,6.48040752414894,6.51953068457854,6.35185999702308,-0.167670687555464,0.0118122068455389,ENSG00000116473,RAP1A,protein_coding,1,1,111542218,111716691,p13.2,RAP1A, member of RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9855],Kabuki syndrome,RAP1A,5906,NM_001010935;NM_001291896;NM_002884
TAF13_TF,TAF13,TAF13_TF,TAF13,TF,84,-2.85386690448816,0.302488433637829,0.30899810494815,0.281099513618204,-0.0278985913299462,0.00861362872586574,-2.23764015504711,3.47140606112405,3.50965212906598,3.34574040931484,-0.163911719751149,0.0614549993314721,ENSG00000197780,TAF13,protein_coding,1,-1,109062486,109076002,p13.3,TATA-box binding protein associated factor 13 [Source:HGNC Symbol;Acc:HGNC:11546],Autosomal-Recessive Intellectual Disability and Microcephaly;Autosomal recessive primary microcephaly;MENTAL RETARDATION AUTOSOMAL RECESSIVE 60,TAF13,6884,NM_005645
NOC3L_SIG,NOC3L,NOC3L_SIG,NOC3L,SIG,38,2.85381188848495,0.36002313840761,0.346434675149446,0.404670946255865,0.0582362711064188,0.00861362872586574,2.05611153138072,3.51317765241479,3.46705405787623,3.66472660589861,0.197672548022381,0.0874175017193548,ENSG00000173145,NOC3L,protein_coding,10,-1,94333226,94362959,q23.33,NOC3 like DNA replication regulator [Source:HGNC Symbol;Acc:HGNC:24034],NA,NOC3L,64318,NM_022451
FUT11_SIG,FUT11,FUT11_SIG,FUT11,SIG,30,2.85211464643245,0.168478473803706,0.165399905959246,0.178593768149791,0.013193862190545,0.00865667597905847,1.89678569831019,4.49829538014236,4.47277296261637,4.58215475201346,0.109381789397091,0.116988017575783,ENSG00000196968,FUT11,protein_coding,10,1,73772276,73780251,q22.2,fucosyltransferase 11 [Source:HGNC Symbol;Acc:HGNC:19233],NA,FUT11,170384,NM_001284194;NM_173540
NUFIP1_SIG,NUFIP1,NUFIP1_SIG,NUFIP1,SIG,26,2.85207093612882,0.266733356135084,0.260642734617948,0.286745398262817,0.0261026636448685,0.00865667597905847,3.06956820065257,3.21569627296197,3.1701417110947,3.36537554766872,0.195233836574029,0.0089875755595536,ENSG00000083635,NUFIP1,protein_coding,13,-1,44939249,44989471,q14.12,nuclear FMR1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8057],NA,NUFIP1,26747,NM_012345
PRKCZ_SIG,PRKCZ,PRKCZ_SIG,PRKCZ,SIG,89,2.851998296848,-0.0581766500208458,-0.0621395018672168,-0.0451558510970552,0.0169836507701616,0.00865667597905847,2.09991488002969,2.71484340875968,2.65237794656399,2.92008707025983,0.267709123695839,0.0803731086291052,ENSG00000067606,PRKCZ,protein_coding,1,1,2050411,2185395,p36.33,protein kinase C zeta [Source:HGNC Symbol;Acc:HGNC:9412],NA,PRKCZ,5590,NM_001033581;NM_001033582;NM_001242874;NM_001350803;NM_001350804;NM_001350805;NM_001350806;NM_002744
EXOSC6_SIG,EXOSC6,EXOSC6_SIG,EXOSC6,SIG,28,2.85161478415489,0.400654794247939,0.395239339519025,0.418448431214372,0.0232090916953477,0.00866504194681767,2.44285320924104,4.63390251477896,4.59600465440372,4.7584240560119,0.162419401608185,0.0399526530752266,ENSG00000223496,EXOSC6,protein_coding,16,-1,70246778,70251940,q22.1,exosome component 6 [Source:HGNC Symbol;Acc:HGNC:19055],NA,EXOSC6,118460,NM_058219
HERC5_SIG,HERC5,HERC5_SIG,HERC5,SIG,12,-2.85116374626351,0.206984192665491,0.216012655993012,0.177319241732208,-0.0386934142608045,0.00867525755277062,-2.73510310319129,4.16020342072552,4.23795049057185,3.90474876265902,-0.333201727912832,0.0206186798256342,ENSG00000138646,HERC5,protein_coding,4,1,88457119,88506163,q22.1,HECT and RLD domain containing E3 ubiquitin protein ligase 5 [Source:HGNC Symbol;Acc:HGNC:24368],NA,HERC5,51191,NM_016323
HERC4_SIG,HERC4,HERC4_SIG,HERC4,SIG,72,2.85107618841017,0.200636666922377,0.191126702434902,0.231883693095509,0.0407569906606063,0.0086755613741473,2.64627856599422,5.62026638953907,5.57162044695078,5.78010305804347,0.208482611092696,0.025262175654909,ENSG00000148634,HERC4,protein_coding,10,-1,67921899,68075348,q21.3,HECT and RLD domain containing E3 ubiquitin protein ligase 4 [Source:HGNC Symbol;Acc:HGNC:24521],NA,HERC4,26091,NM_001278185;NM_001278186;NM_001278187;NM_015601;NM_022079
ELANE_SIG,ELANE,ELANE_SIG,ELANE,SIG,59,-2.84847787495752,0.146027968015976,0.159302920068007,0.102410268416446,-0.0568926516515612,0.0087446179778438,-2.31552948091954,7.18212540595187,7.35742847504102,6.60612960751612,-0.751298867524893,0.0523004220511467,ENSG00000197561,ELANE,protein_coding,19,1,851014,856247,p13.3,elastase, neutrophil expressed [Source:HGNC Symbol;Acc:HGNC:3309],Autosomal dominant severe congenital neutropenia;CYCLIC NEUTROPENIA;NEUTROPENIA SEVERE CONGENITAL 1 AUTOSOMAL DOMINANT,ELANE,1991,NM_001972
ZNF3_TF,ZNF3,ZNF3_TF,ZNF3,TF,83,2.84689243228046,0.133399400051422,0.128972506544019,0.147944907290031,0.0189724007460121,0.00878617529464167,3.28437482130873,4.7930032253469,4.74519707453805,4.95008057800452,0.204883503466463,0.00502398718506278,ENSG00000166526,ZNF3,protein_coding,7,-1,100064033,100082548,q22.1,zinc finger protein 3 [Source:HGNC Symbol;Acc:HGNC:13089],NA,ZNF3,7551,NM_001278284;NM_001278287;NM_001278290;NM_001278291;NM_001278292;NM_001318135;NM_001318136;NM_001318137;NM_001362776;NM_017715;NM_032924
BTK_SIG,BTK,BTK_SIG,BTK,SIG,47,2.8465595074798,0.343391952592634,0.334877768775759,0.371367127990935,0.0364893592151756,0.00879325577230836,1.88036406082118,7.04049565931143,7.00023055208797,7.17279529733138,0.172564745243413,0.12035848471073,ENSG00000010671,BTK,protein_coding,X,-1,101349447,101390796,q22.1,Bruton tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:1133],Agammaglobulinemia X-Linked;ISOLATED GROWTH HORMONE DEFICIENCY TYPE III WITHAGAMMAGLOBULINEMIA;Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia;X-linked agammaglobulinemia,BTK,695,NM_000061;NM_001287344;NM_001287345
RNF141_SIG,RNF141,RNF141_SIG,RNF141,SIG,12,-2.84639507396721,0.625106645318869,0.637827137223464,0.583310743346629,-0.0545163938768354,0.00879568591701563,-1.69280218539267,5.4364630889956,5.46340197530867,5.34794960539554,-0.115452369913127,0.164990865668704,ENSG00000110315,RNF141,protein_coding,11,-1,10511673,10541230,p15.4,ring finger protein 141 [Source:HGNC Symbol;Acc:HGNC:21159],NA,RNF141,50862,NM_016422
PLA2G1B_SIG,PLA2G1B,PLA2G1B_SIG,PLA2G1B,SIG,19,2.8462781709695,0.113677638786641,0.104952997830609,0.142344316213603,0.0373913183829944,0.00879667623527852,-0.531798296711448,0.303997343018638,0.308555846525434,0.289019402924881,-0.0195364436005526,0.691134923190159,ENSG00000170890,PLA2G1B,protein_coding,12,-1,120322115,120327779,q24.31,phospholipase A2 group IB [Source:HGNC Symbol;Acc:HGNC:9030],NA,PLA2G1B,5319,NM_000928
GPD1_SIG,GPD1,GPD1_SIG,GPD1,SIG,17,-2.84620636588432,-0.150208740810149,-0.147151414764408,-0.160254240674726,-0.013102825910318,0.00879667623527852,-2.03384193240973,0.335307071107723,0.347103598451034,0.296547052693985,-0.0505565457570488,0.0912513187412958,ENSG00000167588,GPD1,protein_coding,12,1,50103982,50111313,q13.12,glycerol-3-phosphate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:4455],HYPERTRIGLYCERIDEMIA TRANSIENT INFANTILE;Transient infantile hypertriglyceridemia and hepatosteatosis,GPD1,2819,NM_001257199;NM_005276
MAPK3_SIG,MAPK3,MAPK3_SIG,MAPK3,SIG,21,-2.8453071410322,0.384332460010872,0.390725273042698,0.3633275029063,-0.0273977701363989,0.00881943382680727,-2.57714687532152,5.91147831808231,5.94637255077094,5.79682583924825,-0.149546711522686,0.0296882820820763,ENSG00000102882,MAPK3,protein_coding,16,-1,30114105,30123506,p11.2,mitogen-activated protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:6877],NA,MAPK3,5595,NM_001040056;NM_001109891;NM_002746
FYTTD1_SIG,FYTTD1,FYTTD1_SIG,FYTTD1,SIG,32,2.84482695615765,0.438489228753601,0.434643867014444,0.451123988753686,0.0164801217392415,0.0088306207823025,2.13557407556922,6.8453566794425,6.82067162473442,6.9264647163405,0.10579309160608,0.0752041066868805,ENSG00000122068,FYTTD1,protein_coding,3,1,197737179,197787596,q29,forty-two-three domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25407],NA,FYTTD1,84248,NM_001011537;NM_032288
ZNHIT2_TF,ZNHIT2,ZNHIT2_TF,ZNHIT2,TF,271,2.84415984961435,0.203835463077588,0.198624444159307,0.220957382380511,0.0223329382212044,0.00884511391182976,2.18087711256977,2.19904347538554,2.16842754519443,2.29963867458487,0.131211129390438,0.0688921444825513,ENSG00000174276,ZNHIT2,protein_coding,11,-1,65116403,65117708,q13.1,zinc finger HIT-type containing 2 [Source:HGNC Symbol;Acc:HGNC:1177],NA,ZNHIT2,741,NM_014205
REPIN1_SIG,REPIN1,REPIN1_SIG,REPIN1,SIG,13,2.84415172900466,0.338459027248793,0.333506256357695,0.35473241731954,0.021226160961845,0.00884511391182976,3.00982210560489,6.89706804209445,6.85218172942104,7.04455164087851,0.192369911457468,0.0104711607974635,ENSG00000214022,REPIN1,protein_coding,7,1,150368189,150374044,q36.1,replication initiator 1 [Source:HGNC Symbol;Acc:HGNC:17922],NA,REPIN1,29803,NM_001099695;NM_001099696;NM_001362746;NM_001362747;NM_013400;NM_014374
ADNP_TF,ADNP,ADNP_TF,ADNP,TF,103,2.84320107715037,0.42310710005114,0.419422039371512,0.435215156569918,0.0157931171984063,0.00886941482593724,1.66189896512299,6.87569466774876,6.85279254251231,6.95094450781139,0.0981519652990885,0.173298082137003,ENSG00000101126,ADNP,protein_coding,20,-1,50888916,50931437,q13.13,activity dependent neuroprotector homeobox [Source:HGNC Symbol;Acc:HGNC:15766],ADNP syndrome;HELSMOORTEL-VAN DER AA SYNDROME;MENTAL RETARDATION AUTOSOMAL DOMINANT 28,ADNP,23394,NM_001282531;NM_001282532;NM_001347511;NM_015339;NM_181442
FZD1_SIG,FZD1,FZD1_SIG,FZD1,SIG,23,-2.84257687555089,-0.0113201388282813,-0.00661722914313954,-0.0267725563651757,-0.0201553272220362,0.00888467225832929,-1.71051007113263,3.26163858150404,3.31111859507384,3.09906139406043,-0.21205720101341,0.160551263817482,ENSG00000157240,FZD1,protein_coding,7,1,91264364,91271326,q21.13,frizzled class receptor 1 [Source:HGNC Symbol;Acc:HGNC:4038],NA,FZD1,8321,NM_003505
SLC38A7_SIG,SLC38A7,SLC38A7_SIG,SLC38A7,SIG,22,2.84177358624661,0.190645571063008,0.182687056198878,0.21679497704515,0.0341079208462718,0.00890495386925772,2.61198170116694,3.67886816247788,3.63765728198736,3.81427534123243,0.176618059245068,0.0273992476740573,ENSG00000103042,SLC38A7,protein_coding,16,-1,58665109,58684770,q21,solute carrier family 38 member 7 [Source:HGNC Symbol;Acc:HGNC:25582],NA,SLC38A7,55238,NM_001308384;NM_018231
HCAR2_SIG,HCAR2,HCAR2_SIG,HCAR2,SIG,28,-2.84119444047859,0.222041319331435,0.234406608917819,0.18141251069046,-0.0529940982273586,0.00891900585969007,0.189973199193508,3.13967435617921,3.1323135723347,3.16385978881117,0.0315462164764706,0.893132210933708,ENSG00000182782,HCAR2,protein_coding,12,-1,122701293,122703343,q24.31,hydroxycarboxylic acid receptor 2 [Source:HGNC Symbol;Acc:HGNC:24827],NA,HCAR2,338442,NM_177551
ACADM_SIG,ACADM,ACADM_SIG,ACADM,SIG,67,2.84078269108932,0.461888472296793,0.448941511889389,0.504428485063978,0.0554869731745885,0.00892839035559797,1.34532330963742,5.64123459968114,5.60939664118353,5.74584503474471,0.136448393561186,0.277018457153384,ENSG00000117054,ACADM,protein_coding,1,1,75724347,75787575,p31.1,acyl-CoA dehydrogenase medium chain [Source:HGNC Symbol;Acc:HGNC:89],ACYL-CoA DEHYDROGENASE MEDIUM-CHAIN DEFICIENCY OF;Medium-chain acyl-coenzyme A dehydrogenase deficiency;Medium chain acyl-CoA dehydrogenase deficiency,ACADM,34,NM_000016;NM_001127328;NM_001286042;NM_001286043;NM_001286044
GGPS1_SIG,GGPS1,GGPS1_SIG,GGPS1,SIG,65,2.83977021561905,0.271191399978983,0.258877251623146,0.31165217314816,0.0527749215250141,0.0089546313118531,2.81023100086748,4.59635818623929,4.54426167926737,4.76753242343273,0.223270744165357,0.0172763976217773,ENSG00000152904,GGPS1,protein_coding,1,1,235327350,235344532,q42.3,geranylgeranyl diphosphate synthase 1 [Source:HGNC Symbol;Acc:HGNC:4249],NA,GGPS1,9453,NM_001037277
MSL3_SIG,MSL3,MSL3_SIG,MSL3,SIG,61,-2.83947665156773,0.233009168717469,0.240460035363647,0.208527749737168,-0.0319322856264789,0.00896001720819039,-1.4238800446521,5.86109774962022,5.88004327252712,5.7988481743547,-0.0811950981724197,0.247657925560039,ENSG00000005302,MSL3,protein_coding,X,1,11758159,11775772,p22.2,MSL complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:7370],MSL3 syndrome,MSL3,10943,NM_001193270;NM_001282174;NM_006800;NM_078628;NM_078629
PHTF1_TF,PHTF1,PHTF1_TF,PHTF1,TF,68,2.83942566139177,0.104733347250696,0.0985916381286775,0.124913248651615,0.0263216105229376,0.00896001720819039,2.68730930195071,5.42398068926765,5.37489420097559,5.58526486508442,0.210370664108828,0.0231130266951868,ENSG00000116793,PHTF1,protein_coding,1,-1,113696831,113759489,p13.2,putative homeodomain transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:8939],NA,PHTF1,10745,NM_001323041;NM_001323042;NM_001323043;NM_001323044;NM_001323045;NM_001323046;NM_001323047;NM_001323048;NM_001323049;NM_001323050;NM_001323051;NM_001323052;NM_001323053;NM_006608
DCN_SIG,DCN,DCN_SIG,DCN,SIG,13,-2.83787337960041,-0.263196251448254,-0.254531788818193,-0.291665200089881,-0.0371334112716871,0.00900155235868521,-2.84545794617638,0.487530967367095,0.561599270143297,0.244163686816719,-0.317435583326578,0.0158641366056619,ENSG00000011465,DCN,protein_coding,12,-1,91140484,91182824,q21.33,decorin [Source:HGNC Symbol;Acc:HGNC:2705],Congenital Stromal Corneal Dystrophy;CORNEAL DYSTROPHY CONGENITAL STROMAL,DCN,1634,NM_001920;NM_133503;NM_133504;NM_133505;NM_133506;NM_133507
KCNIP2_SIG,KCNIP2,KCNIP2_SIG,KCNIP2,SIG,29,2.83539171966563,-0.0303884989596391,-0.0361028914961808,-0.0116126377681449,0.024490253728036,0.00906961337587149,1.06107562516296,1.38196381780413,1.36714434250987,1.43065637948526,0.0635120369753954,0.400731090190697,ENSG00000120049,KCNIP2,protein_coding,10,-1,101825974,101843920,q24.32,potassium voltage-gated channel interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:15522],NA,KCNIP2,30819,NM_014591;NM_173191;NM_173192;NM_173193;NM_173194;NM_173195;NM_173197
TLR2_SIG,TLR2,TLR2_SIG,TLR2,SIG,34,-2.83359948522501,0.335811934755379,0.345070944211802,0.305389475112846,-0.0396814690989563,0.00911844856433336,-1.22657237509547,6.2418893160696,6.28269991840048,6.10779733698242,-0.174902581418063,0.325183502684864,ENSG00000137462,TLR2,protein_coding,4,1,153684070,153705702,q31.3,toll like receptor 2 [Source:HGNC Symbol;Acc:HGNC:11848],LEPROSY SUSCEPTIBILITY TO 3;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,TLR2,7097,NM_001318787;NM_001318789;NM_001318790;NM_001318791;NM_001318793;NM_001318795;NM_001318796;NM_003264
TBK1_SIG,TBK1,TBK1_SIG,TBK1,SIG,18,-2.83339437362912,0.412482009963336,0.416985426758152,0.397685069066086,-0.0193003576920653,0.00912212094464591,-2.13300226603352,5.45052683324549,5.47826728353042,5.35937963945215,-0.118887644078267,0.0755525425600473,ENSG00000183735,TBK1,protein_coding,12,1,64452092,64502114,q14.2,TANK binding kinase 1 [Source:HGNC Symbol;Acc:HGNC:11584],Amyotrophic lateral sclerosis;ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 8;FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4;Frontotemporal dementia with motor neuron disease;Herpes simplex virus encephalitis,TBK1,29110,NM_013254
KLHL20_SIG,KLHL20,KLHL20_SIG,KLHL20,SIG,65,2.83223874785552,0.356767329132725,0.352459233278147,0.370922501226337,0.0184632679481896,0.00915296886110781,2.49860779710257,4.23772785079533,4.21167974967711,4.32331446875522,0.11163471907811,0.0354150218911875,ENSG00000076321,KLHL20,protein_coding,1,1,173714941,173786692,q25.1,kelch like family member 20 [Source:HGNC Symbol;Acc:HGNC:25056],NA,KLHL20,27252,NM_014458
AQP10_SIG,AQP10,AQP10_SIG,AQP10,SIG,36,-2.8311949346589,-0.0985170050025513,-0.0892383259532224,-0.129004093307489,-0.0397657673542667,0.00918070019943801,-2.05796865554669,0.338234182953863,0.368686819100372,0.238175521329619,-0.130511297770753,0.087091946850552,ENSG00000143595,AQP10,protein_coding,1,1,154321090,154325325,q21.3,aquaporin 10 [Source:HGNC Symbol;Acc:HGNC:16029],NA,AQP10,89872,NM_080429
PRKCE_SIG,PRKCE,PRKCE_SIG,PRKCE,SIG,35,-2.83098240499516,0.104284683314725,0.109029425796972,0.08869481515877,-0.0203346106382021,0.00918323839202228,2.34206622325303,4.34068682842535,4.28353771758413,4.52846247833225,0.244924760748128,0.0496038362888488,ENSG00000171132,PRKCE,protein_coding,2,1,45651345,46187990,p21,protein kinase C epsilon [Source:HGNC Symbol;Acc:HGNC:9401],NA,PRKCE,5581,NM_005400
TOLLIP_SIG,TOLLIP,TOLLIP_SIG,TOLLIP,SIG,38,-2.83095370592744,0.430653769344927,0.439573062149598,0.401347521558149,-0.0382255405914493,0.00918323839202228,-2.7249091205231,5.47875658827534,5.52205574257829,5.33648793842279,-0.185567804155506,0.0211103378159587,ENSG00000078902,TOLLIP,protein_coding,11,-1,1274371,1309654,p15.5,toll interacting protein [Source:HGNC Symbol;Acc:HGNC:16476],NA,TOLLIP,54472,NM_001318512;NM_001318514;NM_001318515;NM_001318516;NM_019009
MFAP2_SIG,MFAP2,MFAP2_SIG,MFAP2,SIG,55,2.83026661250153,-0.0885970660660586,-0.094371257528129,-0.0696247226906846,0.0247465348374445,0.0092007871902857,1.60122791732099,0.536352917447117,0.501981187349722,0.649288602052845,0.147307414703124,0.190238348452837,ENSG00000117122,MFAP2,protein_coding,1,-1,16974502,16980835,p36.13,microfibril associated protein 2 [Source:HGNC Symbol;Acc:HGNC:7033],NA,MFAP2,4237,NM_001135247;NM_001135248;NM_002403;NM_017459
KCNH2_SIG,KCNH2,KCNH2_SIG,KCNH2,SIG,39,-2.82935429716182,-0.161976748349068,-0.147387674139632,-0.209912277894355,-0.062524603754723,0.00922485651843994,-2.26344386437661,2.94853365615751,3.07926317423443,2.5189938110476,-0.560269363186832,0.0583100164426154,ENSG00000055118,KCNH2,protein_coding,7,-1,150944961,150978315,q36.1,potassium voltage-gated channel subfamily H member 2 [Source:HGNC Symbol;Acc:HGNC:6251],Familial short QT syndrome;LONG QT SYNDROME 2;Romano-Ward syndrome;SHORT QT SYNDROME 1,KCNH2,3757,NM_000238;NM_001204798;NM_172056;NM_172057
SLC52A2_SIG,SLC52A2,SLC52A2_SIG,SLC52A2,SIG,41,2.82925567609691,0.27974780579893,0.272073864706613,0.304962183673684,0.0328883189670706,0.00922549758712086,2.03161730561455,4.7148277940135,4.67584162024551,4.84292522210835,0.167083601862839,0.0916355819327943,ENSG00000185803,SLC52A2,protein_coding,8,1,144354135,144361286,q24.3,solute carrier family 52 member 2 [Source:HGNC Symbol;Acc:HGNC:30224],Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome;BROWN-VIALETTO-VAN LAERE SYNDROME 2;Riboflavin transporter deficiency,SLC52A2,79581,NM_001253815;NM_001253816;NM_001363118;NM_001363121;NM_024531
BCL2_SIG,BCL2,BCL2_SIG,BCL2,SIG,45,2.82881957419555,0.279230683389871,0.272768259598616,0.300464361561136,0.0276961019625199,0.00923587326306764,1.24156582106348,5.92795629835741,5.89284671731394,6.04331635035737,0.150469633043431,0.318948582914575,ENSG00000171791,BCL2,protein_coding,18,-1,63123346,63320128,q21.33,BCL2, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:990],Follicular lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Intravascular large B-cell lymphoma,BCL2,596,NM_000633;NM_000657
TOX_TF,TOX,TOX_TF,TOX,TF,145,2.82828333452517,0.12565668983648,0.118306367375234,0.149807749352001,0.0315013819767665,0.00924915249675142,1.03548416179019,4.26167008052815,4.22239412276811,4.39071965602544,0.168325533257327,0.413102148075515,ENSG00000198846,TOX,protein_coding,8,-1,58805412,59119147,q12.1,thymocyte selection associated high mobility group box [Source:HGNC Symbol;Acc:HGNC:18988],NA,TOX,9760,NM_014729
HDX_TF,HDX,HDX_TF,HDX,TF,55,-2.82755687464118,-0.0603444182431804,-0.0582211404404995,-0.067320902451989,-0.00909976201148935,0.00926795365109063,-0.0458742414414994,0.764174841070876,0.765147621126547,0.760978563745098,-0.00416905738144989,0.974807498620029,ENSG00000165259,HDX,protein_coding,X,-1,84317874,84502479,q21.1,highly divergent homeobox [Source:HGNC Symbol;Acc:HGNC:26411],NA,HDX,139324,NM_001177478;NM_001177479;NM_144657
MBNL2_SIG,MBNL2,MBNL2_SIG,MBNL2,SIG,32,2.82687289476848,0.101879432108711,0.0977155552930484,0.115560741645888,0.0178451863528398,0.00928555720915675,2.4722945835027,4.65873767310604,4.60820439496826,4.82477558698735,0.216571192019094,0.0375026395582042,ENSG00000139793,MBNL2,protein_coding,13,1,97221434,97394120,q32.1,muscleblind like splicing regulator 2 [Source:HGNC Symbol;Acc:HGNC:16746],NA,MBNL2,10150,NM_001306070;NM_144778;NM_207304
ENTPD6_SIG,ENTPD6,ENTPD6_SIG,ENTPD6,SIG,11,2.82570645571166,0.354750469319318,0.349864335615879,0.370804908630617,0.0209405730147387,0.0093172132823627,3.29161435382726,5.41262598352179,5.37292331207605,5.54307761827206,0.170154306196007,0.00492080337173429,ENSG00000197586,ENTPD6,protein_coding,20,1,25195693,25226729,p11.21,ectonucleoside triphosphate diphosphohydrolase 6 (putative) [Source:HGNC Symbol;Acc:HGNC:3368],NA,ENTPD6,955,NM_001114089;NM_001247;NM_001317941;NM_001322378;NM_001322379;NM_001322380;NM_001322381;NM_001322382;NM_001322383;NM_001322384;NM_001322385;NM_001322386;NM_001322387;NM_001322388;NM_001322389;NM_001322390;NM_001322391;NM_001322392;NM_001322393;NM_001322394;NM_001322395;NM_001322396;NM_001322397;NM_001322398
PITPNM3_SIG,PITPNM3,PITPNM3_SIG,PITPNM3,SIG,45,2.82453465830027,-0.0589236862421813,-0.0633826858504803,-0.0442726875291988,0.0191099983212814,0.00934855404120126,0.798683822614054,1.04428419351483,1.03229579097576,1.08367465900036,0.051378868024598,0.535919254426946,ENSG00000091622,PITPNM3,protein_coding,17,-1,6451263,6556555,p13.1,PITPNM family member 3 [Source:HGNC Symbol;Acc:HGNC:21043],CONE-ROD DYSTROPHY 5;Cone rod dystrophy,PITPNM3,83394,NM_001165966;NM_031220
ELAC1_SIG,ELAC1,ELAC1_SIG,ELAC1,SIG,18,2.82447777586447,0.212729657256622,0.202242090750277,0.247188804348898,0.0449467135986208,0.00934855404120126,2.94725414393958,2.49949460186053,2.45791457667766,2.63611468460425,0.178200107926588,0.0123261971471363,ENSG00000141642,ELAC1,protein_coding,18,1,50967991,50988121,q21.2,elaC ribonuclease Z 1 [Source:HGNC Symbol;Acc:HGNC:14197],NA,ELAC1,55520,NM_018696
MAPKAPK5_SIG,MAPKAPK5,MAPKAPK5_SIG,MAPKAPK5,SIG,30,2.82394482497662,0.401797870382586,0.39634221715374,0.419723588134507,0.0233813709807665,0.00936188228345294,2.98322613469554,5.31788407596473,5.29076658190744,5.40698441358155,0.116217831674113,0.0112499704120888,ENSG00000089022,MAPKAPK5,protein_coding,12,1,111842228,111902222,q24.12,mitogen-activated protein kinase-activated protein kinase 5 [Source:HGNC Symbol;Acc:HGNC:6889],NA,MAPKAPK5,8550,NM_003668;NM_139078
ATP2A3_SIG,ATP2A3,ATP2A3_SIG,ATP2A3,SIG,46,2.82370552276442,0.207489382024171,0.201518357109992,0.227108463885045,0.0255901067750531,0.00936664316144636,1.97889515361579,8.54540703933582,8.50980417563033,8.66238787722529,0.15258370159496,0.100980815167555,ENSG00000074370,ATP2A3,protein_coding,17,-1,3923870,3964464,p13.2,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [Source:HGNC Symbol;Acc:HGNC:813],NA,ATP2A3,489,NM_005173;NM_174953;NM_174954;NM_174955;NM_174956;NM_174957;NM_174958
CYTL1_SIG,CYTL1,CYTL1_SIG,CYTL1,SIG,80,2.82350884038977,0.0386955684861307,0.0300812029851518,0.0669999122750616,0.0369187092899098,0.00937016060696789,1.67210902041693,3.47869596676351,3.39150764569504,3.76517187884564,0.373664233150603,0.170528908016534,ENSG00000170891,CYTL1,protein_coding,4,-1,5014586,5019458,p16.2,cytokine like 1 [Source:HGNC Symbol;Acc:HGNC:24435],NA,CYTL1,54360,NM_018659
HLA-DQB2_SIG,HLA-DQB2,HLA-DQB2_SIG,HLA-DQB2,SIG,11,-2.82337399796367,0.444054464599477,0.462174580653508,0.384516940421945,-0.0776576402315631,0.00937187151934665,-1.07011408765142,1.76700981732513,1.79878820444883,1.66259511677584,-0.136193087672991,0.396696280884983,ENSG00000232629,HLA-DQB2,protein_coding,6,-1,32756098,32763532,p21.32,major histocompatibility complex, class II, DQ beta 2 [Source:HGNC Symbol;Acc:HGNC:4945],NA,HLA-DQB2,3120,NM_001198858;NM_001300790
HEXIM1_SIG,HEXIM1,HEXIM1_SIG,HEXIM1,SIG,22,-2.82328645381208,0.0468139927913492,0.0494308352814354,0.038215796038209,-0.0112150392432264,0.00937220024641927,-0.533033762826579,6.08183937736168,6.09145604447509,6.0502417568462,-0.0412142876288907,0.690421983890509,ENSG00000186834,HEXIM1,protein_coding,17,1,45148502,45152101,q21.31,HEXIM P-TEFb complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:24953],NA,HEXIM1,10614,NM_006460
ZNF225_TF,ZNF225,ZNF225_TF,ZNF225,TF,27,2.82319645272083,0.233801112019602,0.222400535898489,0.271260147846116,0.0488596119476268,0.00937260127976925,2.39041623331533,2.14244806595834,2.10107919906361,2.27837434289816,0.177295143834545,0.0447155838840614,ENSG00000256294,ZNF225,protein_coding,19,1,44112181,44134822,q13.31,zinc finger protein 225 [Source:HGNC Symbol;Acc:HGNC:13018],NA,ZNF225,7768,NM_001321685;NM_013362
SLC25A53_SIG,SLC25A53,SLC25A53_SIG,SLC25A53,SIG,54,2.82289067649079,0.00264821133670363,-0.00170983483010156,0.0169675058847778,0.0186773407148793,0.00937931316669304,1.02302524117124,2.3542787560609,2.34002117165072,2.40112510483722,0.0611039331864944,0.4192017865331,ENSG00000269743,SLC25A53,protein_coding,X,-1,104099214,104157009,q22.2,solute carrier family 25 member 53 [Source:HGNC Symbol;Acc:HGNC:31894],NA,SLC25A53,401612,NM_001012755
TRH_SIG,TRH,TRH_SIG,TRH,SIG,94,-2.82244624141515,0.0527540394156722,0.0595005172127579,0.0305870409395335,-0.0289134762732245,0.00939008924588421,-3.7273026889581,2.74084821092685,2.99536973584653,1.90456320047646,-1.09080653537008,0.00134916736682881,ENSG00000170893,TRH,protein_coding,3,1,129974688,129977935,q22.1,thyrotropin releasing hormone [Source:HGNC Symbol;Acc:HGNC:12298],Isolated thyrotropin-releasing hormone deficiency;THYROTROPIN-RELEASING HORMONE DEFICIENCY,TRH,7200,NM_007117
FBXO8_SIG,FBXO8,FBXO8_SIG,FBXO8,SIG,24,-2.82231987926043,0.226859717028043,0.230183289248927,0.215939408302279,-0.0142438809466485,0.00939155684535214,-2.26203464424935,3.05292872357446,3.07952844037018,2.96552965410283,-0.113998786267345,0.0584309166875776,ENSG00000164117,FBXO8,protein_coding,4,-1,174236658,174284264,q34.1,F-box protein 8 [Source:HGNC Symbol;Acc:HGNC:13587],NA,FBXO8,26269,NM_012180
PHF6_SIG,PHF6,PHF6_SIG,PHF6,SIG,37,2.82102752924972,0.377605525968673,0.365880266331075,0.416131379063636,0.0502511127325605,0.00942723400165415,2.69390797479178,5.03836506095677,4.98222070778542,5.22283936423405,0.240618656448623,0.0227459527379299,ENSG00000156531,PHF6,protein_coding,X,1,134373253,134428791,q26.2,PHD finger protein 6 [Source:HGNC Symbol;Acc:HGNC:18145],BOERJESON-FORSSMAN-LEHMANN SYNDROME;BORJESON-FORSSMAN-LEHMANN SYNDROME,PHF6,84295,NM_001015877;NM_032335;NM_032458
TAL1_SIG,TAL1,TAL1_SIG,TAL1,SIG,88,-2.82091175951321,-0.0595086692203925,-0.0501896873498712,-0.0901281810806768,-0.0399384937308055,0.0094283955963605,-2.8246460666751,3.55487683779347,3.71071516956916,3.04283660481619,-0.667878564752974,0.016696643823023,ENSG00000162367,TAL1,protein_coding,1,-1,47216290,47232220,p33,TAL bHLH transcription factor 1, erythroid differentiation factor [Source:HGNC Symbol;Acc:HGNC:11556],LEUKEMIA ACUTE LYMPHOBLASTIC;Precursor T-cell acute lymphoblastic leukemia,TAL1,6886,NM_001287347;NM_001290403;NM_001290404;NM_001290405;NM_003189
RSF1_SIG,RSF1,RSF1_SIG,RSF1,SIG,67,2.81971883399465,0.46432441740964,0.459737944222613,0.479394257881299,0.0196563136586862,0.00946126622265555,2.23187399874905,6.1375167915961,6.11310919744313,6.21771317238441,0.104603974941276,0.0621553461452374,ENSG00000048649,RSF1,protein_coding,11,-1,77659996,77821017,q14.1,remodeling and spacing factor 1 [Source:HGNC Symbol;Acc:HGNC:18118],NA,RSF1,51773,NM_016578
FFAR1_SIG,FFAR1,FFAR1_SIG,FFAR1,SIG,11,-2.81913086961968,-0.0642817560847259,-0.0515527380940569,-0.106105672339781,-0.0545529342457244,0.0094748392320066,-2.74979512416421,0.249515658333594,0.278857368862995,0.153107180879847,-0.125750187983149,0.0199447602481213,ENSG00000126266,FFAR1,protein_coding,19,1,35351552,35353862,q13.12,free fatty acid receptor 1 [Source:HGNC Symbol;Acc:HGNC:4498],NA,FFAR1,2864,NM_005303
CERS2_SIG,CERS2,CERS2_SIG,CERS2,SIG,11,2.81910626992944,0.419409040289403,0.413202749049756,0.439801140076816,0.0265983910270601,0.0094748392320066,1.20799679417526,7.39727926529086,7.38258200675072,7.44557025763704,0.0629882508863213,0.333233064973669,ENSG00000143418,CERS2,protein_coding,1,-1,150960583,150975004,q21.3,ceramide synthase 2 [Source:HGNC Symbol;Acc:HGNC:14076],NA,CERS2,29956,NM_022075;NM_181746
DPP3_SIG,DPP3,DPP3_SIG,DPP3,SIG,43,2.81882148287581,0.586914924013047,0.578967440716834,0.613028083414888,0.0340606426980546,0.00948099772101613,2.96167873704506,5.22961402734104,5.18035151716149,5.39147656078814,0.211125043626652,0.0118893396507726,ENSG00000254986,DPP3,protein_coding,11,1,66480013,66509657,q13.2,dipeptidyl peptidase 3 [Source:HGNC Symbol;Acc:HGNC:3008],NA,DPP3,10072,NM_001256670;NM_005700;NM_130443
TRIB1_SIG,TRIB1,TRIB1_SIG,TRIB1,SIG,62,-2.81745124458664,0.42703885080154,0.43596594645982,0.397706965067191,-0.0382589813926282,0.00951928671317726,-0.522329595909091,7.70936369506842,7.72779133500619,7.64881573527289,-0.0789755997333002,0.696871168914599,ENSG00000173334,TRIB1,protein_coding,8,1,125430358,125438403,q24.13,tribbles pseudokinase 1 [Source:HGNC Symbol;Acc:HGNC:16891],NA,TRIB1,10221,NM_001282985;NM_025195
PTGDS_SIG,PTGDS,PTGDS_SIG,PTGDS,SIG,18,2.81694269665153,-0.0608351270042405,-0.064819420402302,-0.0477438772677529,0.0170755431345492,0.00953210976389,4.05190235541044,2.38576462910473,2.19795528632068,3.00285246968087,0.804897183360188,0.000479367753295258,ENSG00000107317,PTGDS,protein_coding,9,1,136975092,136981742,q34.3,prostaglandin D2 synthase [Source:HGNC Symbol;Acc:HGNC:9592],NA,PTGDS,5730,NM_000954
ZNF189_TF,ZNF189,ZNF189_TF,ZNF189,TF,27,2.81648719807429,0.28301965374815,0.273318446349267,0.314895049487338,0.041576603138071,0.00954337216794342,1.84951886238357,3.95035930911663,3.90776951081878,4.09029721780959,0.182527706990809,0.126938791734314,ENSG00000136870,ZNF189,protein_coding,9,1,101398873,101410660,q31.1,zinc finger protein 189 [Source:HGNC Symbol;Acc:HGNC:12980],NA,ZNF189,7743,NM_001278231;NM_001278232;NM_001278240;NM_003452;NM_197977
PTTG1_TF,PTTG1,PTTG1_TF,PTTG1,TF,224,-2.81395624454374,0.00176834931180822,0.010069790973592,-0.0255078161483386,-0.0355776071219307,0.00961655213774537,-0.249827266853508,3.80235624459166,3.80798972518825,3.78384623691715,-0.0241434882710994,0.857961760311809,ENSG00000164611,PTTG1,protein_coding,5,1,160421855,160428739,q33.3,pituitary tumor-transforming 1 [Source:HGNC Symbol;Acc:HGNC:9690],NA,PTTG1,9232,NM_001282382;NM_001282383;NM_004219
ZNF385A_SIG,ZNF385A,ZNF385A_SIG,ZNF385A,SIG,36,-2.81208508406178,0.361307396251094,0.374275851787902,0.318696756630152,-0.0555790951577505,0.00967038113760108,-0.964100047863348,5.70640028933378,5.74104914957343,5.59255403426064,-0.148495115312782,0.448800856323795,ENSG00000161642,ZNF385A,protein_coding,12,-1,54369133,54391298,q13.13,zinc finger protein 385A [Source:HGNC Symbol;Acc:HGNC:17521],NA,ZNF385A,25946,NM_001130967;NM_001130968;NM_001290001;NM_001290002;NM_001290004;NM_015481
MRPS31_SIG,MRPS31,MRPS31_SIG,MRPS31,SIG,43,2.81175409630675,0.434362893421124,0.422297381975209,0.474006716743415,0.0517093347682055,0.00967804204616854,2.33646949777926,3.74596221577541,3.70325284588958,3.88629300254313,0.183040156653549,0.0502160828099192,ENSG00000102738,MRPS31,protein_coding,13,-1,40729135,40771173,q14.11,mitochondrial ribosomal protein S31 [Source:HGNC Symbol;Acc:HGNC:16632],NA,MRPS31,10240,NM_005830
SIGLEC8_SIG,SIGLEC8,SIGLEC8_SIG,SIGLEC8,SIG,14,-2.81138481098436,-0.107198365139187,-0.102967631234747,-0.121099347968063,-0.0181317167333161,0.00968686168102864,-2.36243937108403,0.453430150579003,0.492542058400246,0.324919596309205,-0.167622462091041,0.0474651706377588,ENSG00000105366,SIGLEC8,protein_coding,19,-1,51450847,51458456,q13.41,sialic acid binding Ig like lectin 8 [Source:HGNC Symbol;Acc:HGNC:10877],NA,SIGLEC8,27181,NM_014442
DEPDC1_SIG,DEPDC1,DEPDC1_SIG,DEPDC1,SIG,29,-2.80681234281169,0.129811426231564,0.16017063072281,0.030059754331753,-0.130110876391057,0.009823100410493,-2.65483477163226,2.19373489283795,2.27856205927241,1.9150170602676,-0.363544999004803,0.024805659828383,ENSG00000024526,DEPDC1,protein_coding,1,-1,68474152,68497221,p31.3,DEP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:22949],NA,DEPDC1,55635,NM_001114120;NM_017779
DPP4_SIG,DPP4,DPP4_SIG,DPP4,SIG,14,-2.80650944299921,-0.0247720852898175,-0.0132999525509768,-0.0624662357174367,-0.04916628316646,0.00983001109536514,2.74952247266825,2.25700736287118,2.15689814005399,2.5859376664134,0.429039526359416,0.0199496739135867,ENSG00000197635,DPP4,protein_coding,2,-1,161992245,162074215,q24.2,dipeptidyl peptidase 4 [Source:HGNC Symbol;Acc:HGNC:3009],NA,DPP4,1803,NM_001935
MBNL1_SIG,MBNL1,MBNL1_SIG,MBNL1,SIG,26,-2.80588476530674,-0.0422932194063787,-0.0384691494913483,-0.0548580205557641,-0.0163888710644156,0.00984675461968849,-1.8306497162387,9.07212003694383,9.09379518419463,9.00090169597693,-0.092893488217701,0.131119140957185,ENSG00000152601,MBNL1,protein_coding,3,1,152243828,152465780,q25.1,muscleblind like splicing regulator 1 [Source:HGNC Symbol;Acc:HGNC:6923],NA,MBNL1,4154,NM_001314057;NM_001363870;NM_021038;NM_207292;NM_207293;NM_207294;NM_207295;NM_207296;NM_207297
PAIP2_SIG,PAIP2,PAIP2_SIG,PAIP2,SIG,18,2.80548987060838,0.180572513912438,0.177884105053096,0.189405857307416,0.0115217522543193,0.00985649370783392,2.50989429257592,7.01951017167687,6.99411517139508,7.10295088688844,0.108835715493354,0.0345349735996176,ENSG00000120727,PAIP2,protein_coding,5,1,139341587,139369720,q31.2,poly(A) binding protein interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:17970],NA,PAIP2,51247,NM_001033112;NM_016480
ZFP82_TF,ZFP82,ZFP82_TF,ZFP82,TF,19,2.80516230106501,-0.0228382826808138,-0.031797979172848,0.00660072007872723,0.0383986992515752,0.00986418088731186,1.95725986104033,2.26807093294795,2.22968688404554,2.39418995077018,0.164503066724645,0.10494909082969,ENSG00000181007,ZFP82,protein_coding,19,-1,36383120,36418656,q13.12,ZFP82 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:28682],NA,ZFP82,284406,NM_001321917;NM_001321918;NM_001321919;NM_133466
KLF9_TF,KLF9,KLF9_TF,KLF9,TF,68,-2.80499085893419,0.035193541102393,0.0418321745396512,0.0133808883799734,-0.0284512861596777,0.00986670470672033,-0.148704090692423,5.43948788660896,5.4459970412798,5.41810066411906,-0.027896377160734,0.91679366089052,ENSG00000119138,KLF9,protein_coding,9,-1,70384597,70414624,q21.12,Kruppel like factor 9 [Source:HGNC Symbol;Acc:HGNC:1123],NA,KLF9,687,NM_001206
CTNNA1_SIG,CTNNA1,CTNNA1_SIG,CTNNA1,SIG,45,2.80485513261367,0.188319986351974,0.184252722513075,0.201683853251215,0.0174311307381403,0.00986670470672033,2.39661908706127,6.86738019288092,6.81235662200383,7.0481719257628,0.235815303758969,0.0441920800586444,ENSG00000044115,CTNNA1,protein_coding,5,1,138610967,138935034,q31.2,catenin alpha 1 [Source:HGNC Symbol;Acc:HGNC:2509],Butterfly-shaped pigment dystrophy;Hereditary diffuse gastric cancer;MACULAR DYSTROPHY PATTERNED 2,CTNNA1,1495,NM_001290307;NM_001290309;NM_001290310;NM_001290312;NM_001323982;NM_001323983;NM_001323984;NM_001323985;NM_001323986;NM_001323987;NM_001323988;NM_001323989;NM_001323990;NM_001323991;NM_001323992;NM_001323993;NM_001323994;NM_001323995;NM_001323996;NM_001323997;NM_001323998;NM_001323999;NM_001324000;NM_001324001;NM_001324002;NM_001324003;NM_001324004;NM_001324005;NM_001324006;NM_001324007;NM_001324008;NM_001324009;NM_001324010;NM_001324011;NM_001324012;NM_001324013;NM_001903
PA2G4_SIG,PA2G4,PA2G4_SIG,PA2G4,SIG,40,2.80485100254677,0.703725619784384,0.693231011180687,0.738207905196533,0.0449768940158454,0.00986670470672033,2.08886831486087,6.6117155698758,6.58152056158312,6.7109277399803,0.129407178397179,0.0820834984475945,ENSG00000170515,PA2G4,protein_coding,12,1,56104537,56113910,q13.2,proliferation-associated 2G4 [Source:HGNC Symbol;Acc:HGNC:8550],NA,PA2G4,5036,NM_006191
FAHD1_SIG,FAHD1,FAHD1_SIG,FAHD1,SIG,25,2.80459414041802,0.214975314126825,0.20315961547007,0.253798323999019,0.0506387085289485,0.00987223454568686,2.2240927231452,3.23072454074651,3.18641855154128,3.37630136242085,0.189882810879575,0.0631889889287427,ENSG00000180185,FAHD1,protein_coding,16,1,1826941,1840207,p13.3,fumarylacetoacetate hydrolase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:14169],NA,FAHD1,81889,NM_001018104;NM_001142398;NM_031208
ZBTB2_TF,ZBTB2,ZBTB2_TF,ZBTB2,TF,49,-2.80427971132702,0.122303958554917,0.127560052494731,0.10503393560981,-0.0225261168849212,0.0098795314024203,-1.76549077557492,4.8041428737637,4.82630553110376,4.73132271393208,-0.0949828171716778,0.146518412062911,ENSG00000181472,ZBTB2,protein_coding,6,-1,151364115,151391559,q25.1,zinc finger and BTB domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20868],NA,ZBTB2,57621,NM_020861
FOSL2_TF,FOSL2,FOSL2_TF,FOSL2,TF,75,-2.80406088440352,0.271528469111408,0.280263942302988,0.242826200053357,-0.0374377422496309,0.00988390212599242,-2.19662139440421,8.69388861453064,8.76144487514158,8.47191804395181,-0.289526831189772,0.0668532186868101,ENSG00000075426,FOSL2,protein_coding,2,1,28392448,28417317,p23.2,FOS like 2, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:3798],NA,FOSL2,2355,NM_005253
PANK3_SIG,PANK3,PANK3_SIG,PANK3,SIG,31,2.80336098051502,0.376982125202118,0.37305475227184,0.389886350544461,0.0168315982726209,0.00990303833391437,3.14913261091732,6.37394319714996,6.3328062144122,6.5091075690026,0.176301354590399,0.00728918636159595,ENSG00000120137,PANK3,protein_coding,5,-1,168548495,168579368,q34,pantothenate kinase 3 [Source:HGNC Symbol;Acc:HGNC:19365],NA,PANK3,79646,NM_024594
POLR3B_SIG,POLR3B,POLR3B_SIG,POLR3B,SIG,19,2.80325834932681,0.267138786735115,0.256860682988489,0.300909699045455,0.0440490160569656,0.00990384970637945,3.83028446498756,3.04729265306318,2.97796702978391,3.2750768438379,0.297109814053982,0.000977829876448367,ENSG00000013503,POLR3B,protein_coding,12,1,106357748,106510198,q23.3,RNA polymerase III subunit B [Source:HGNC Symbol;Acc:HGNC:30348],Autosomal Recessive Mental Retardation;Endosteal sclerosis-cerebellar hypoplasia syndrome;Hypogonadotropic hypogonadism 7 with or without anosmia;Hypomyelination-hypogonadotropic-hypogonadism-hypodontia syndrome;LEUKODYSTROPHY HYPOMYELINATING 7 WITH OR WITHOUT OLIGODONTIAAND/OR HYPOGONADOTROPIC HYPOGONADISM;LEUKODYSTROPHY HYPOMYELINATING 8 WITH OR WITHOUT OLIGODONTIAAND/OR HYPOGONADOTROPIC HYPOGONADISM,POLR3B,55703,NM_001160708;NM_018082
TFAM_TF,TFAM,TFAM_TF,TFAM,TF,166,2.80298350186912,0.323355133853522,0.319125179637278,0.337253554849756,0.0181283752124781,0.0099099520123142,1.54946248541979,5.54105424196857,5.52120160543122,5.60628433344844,0.0850827280172205,0.206014751350811,ENSG00000108064,TFAM,protein_coding,10,1,58385345,58399220,q21.1,transcription factor A, mitochondrial [Source:HGNC Symbol;Acc:HGNC:11741],MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE),TFAM,7019,NM_001270782;NM_003201
DBP_SIG,DBP,DBP_SIG,DBP,SIG,15,-2.802505619967,0.0574476147501489,0.0628423735873582,0.0397219785707468,-0.0231203950166115,0.00992230168679467,-1.00828694395778,3.30956335663325,3.32993850397991,3.24261644392277,-0.0873220600571453,0.426464068389806,ENSG00000105516,DBP,protein_coding,19,-1,48630030,48637438,q13.33,D-box binding PAR bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:2697],NA,DBP,1628,NM_001352
SLC2A4RG_SIG,SLC2A4RG,SLC2A4RG_SIG,SLC2A4RG,SIG,20,2.80197458401211,0.145569595370204,0.142121169130879,0.156900138727988,0.0147789695971092,0.00993630220483909,2.18581654469143,5.16768773121982,5.13239345870688,5.28365462661949,0.151261167912616,0.0682388634377562,ENSG00000125520,SLC2A4RG,protein_coding,20,1,63739776,63744050,q13.33,SLC2A4 regulator [Source:HGNC Symbol;Acc:HGNC:15930],NA,SLC2A4RG,56731,NM_020062
CD19_SIG,CD19,CD19_SIG,CD19,SIG,16,-2.80022277781003,0.0768494692097003,0.0848513095582098,0.0505577080645978,-0.034293601493612,0.00998803101148353,-0.675706136014024,1.74070291635581,1.76119294260941,1.67337854437968,-0.0878143982297329,0.605880452051304,ENSG00000177455,CD19,protein_coding,16,1,28931761,28939347,p11.2,CD19 molecule [Source:HGNC Symbol;Acc:HGNC:1633],Common variable immunodeficiency;IMMUNODEFICIENCY COMMON VARIABLE 2;IMMUNODEFICIENCY COMMON VARIABLE 3,CD19,930,NM_001178098;NM_001770
LIPT1_SIG,LIPT1,LIPT1_SIG,LIPT1,SIG,13,2.79982687757057,0.0749713711024005,0.0721263516202992,0.0843192922578763,0.0121929406375769,0.00999792816846312,0.0997150002814191,2.65256046232581,2.65125514677138,2.65684935629039,0.0055942095190113,0.944432641316518,ENSG00000144182,LIPT1,protein_coding,2,1,99154955,99163157,q11.2,lipoyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:29569],Leigh syndrome with leukodystrophy;Leigh syndrome with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase.;LIPOYLTRANSFERASE 1 DEFICIENCY,LIPT1,51601,NM_001204830;NM_015929;NM_145197;NM_145198;NM_145199
NIP7_SIG,NIP7,NIP7_SIG,NIP7,SIG,25,2.79959674564661,0.263138610325102,0.257839572014395,0.280549736203139,0.0227101641887444,0.0100026970022556,2.40149226766404,4.34421612149226,4.31218486743489,4.44946167053791,0.137276803103022,0.0437562337188985,ENSG00000132603,NIP7,protein_coding,16,1,69337996,69343106,q22.1,NIP7, nucleolar pre-rRNA processing protein [Source:HGNC Symbol;Acc:HGNC:24328],NA,NIP7,51388,NM_001199434;NM_016101
POGK_TF,POGK,POGK_TF,POGK,TF,63,2.79936851778519,0.322531770058013,0.317708705036588,0.338378983699837,0.0206702786632485,0.0100074091607688,2.52367968481216,6.19861127138105,6.16550244643372,6.30739741049369,0.141894964059971,0.0335757077001238,ENSG00000143157,POGK,protein_coding,1,1,166839447,166856344,q24.1,pogo transposable element derived with KRAB domain [Source:HGNC Symbol;Acc:HGNC:18800],NA,POGK,57645,NM_001314014;NM_017542
CDKN3_SIG,CDKN3,CDKN3_SIG,CDKN3,SIG,34,-2.79895764439509,0.171581849884053,0.195857963687654,0.0918174759579386,-0.104040487729715,0.0100177885859616,-2.3957275855961,2.53314999996637,2.59949675295863,2.31515352584894,-0.284343227109687,0.0442531254046635,ENSG00000100526,CDKN3,protein_coding,14,1,54396849,54420218,q22.2,cyclin dependent kinase inhibitor 3 [Source:HGNC Symbol;Acc:HGNC:1791],NA,CDKN3,1033,NM_001130851;NM_001330173;NM_005192
MIER1_TF,MIER1,MIER1_TF,MIER1,TF,84,-2.79833854364852,0.100558273228322,0.107632077144727,0.0773157746458481,-0.0303163024988787,0.0100346456374155,-2.50888257301557,6.75498959707027,6.79039168410398,6.63866845395952,-0.151723230144462,0.0346080386763395,ENSG00000198160,MIER1,protein_coding,1,1,66924895,66988619,p31.3,MIER1 transcriptional regulator [Source:HGNC Symbol;Acc:HGNC:29657],NA,MIER1,57708,NM_001077700;NM_001077701;NM_001077702;NM_001077703;NM_001077704;NM_001146110;NM_001146111;NM_001146112;NM_001146113;NM_001278215;NM_001350530;NM_020948
OAS3_SIG,OAS3,OAS3_SIG,OAS3,SIG,23,-2.7978108008529,0.257020105317104,0.267581417805714,0.222318649997386,-0.0452627678083279,0.01004868562396,-1.35301952635588,5.98240622916908,6.02946727204165,5.82777708830206,-0.201690183739584,0.27437657641911,ENSG00000111331,OAS3,protein_coding,12,1,112938444,112973251,q24.13,2'-5'-oligoadenylate synthetase 3 [Source:HGNC Symbol;Acc:HGNC:8088],NA,OAS3,4940,NM_006187
ZNF347_TF,ZNF347,ZNF347_TF,ZNF347,TF,19,2.79737101176142,-0.0242528155811752,-0.0351651783504306,0.011602090660664,0.0467672690110945,0.0100600040001142,2.40706171050998,2.6949480149887,2.63676097590114,2.88613400056212,0.249373024660981,0.0432163008257879,ENSG00000197937,ZNF347,protein_coding,19,-1,53124072,53159075,q13.42,zinc finger protein 347 [Source:HGNC Symbol;Acc:HGNC:16447],NA,ZNF347,84671,NM_001172674;NM_001172675;NM_032584
ZNF143_SIG,ZNF143,ZNF143_SIG,ZNF143,SIG,49,-2.79722333156252,0.329393208020507,0.336501659092033,0.306036868785496,-0.030464790306537,0.0100622322424488,-2.7038102778156,4.20863251554758,4.2489695254344,4.07609662591946,-0.172872899514937,0.0222146020748794,ENSG00000166478,ZNF143,protein_coding,11,1,9460319,9528524,p15.4,zinc finger protein 143 [Source:HGNC Symbol;Acc:HGNC:12928],NA,ZNF143,7702,NM_001282656;NM_001282657;NM_003442
ZCCHC7_TF,ZCCHC7,ZCCHC7_TF,ZCCHC7,TF,43,2.79650911410857,0.1946935227974,0.188345293153099,0.215551991628674,0.0272066984755748,0.0100799481471217,1.1094750391639,4.55925764711903,4.54140616830198,4.61791250608931,0.0765063377873228,0.377990827317175,ENSG00000147905,ZCCHC7,protein_coding,9,1,37120539,37358149,p13.2,zinc finger CCHC-type containing 7 [Source:HGNC Symbol;Acc:HGNC:26209],NA,ZCCHC7,84186,NM_001289119;NM_001289120;NM_001289121;NM_032226
RBM43_SIG,RBM43,RBM43_SIG,RBM43,SIG,14,2.79650273429965,0.313240360210286,0.30951641035174,0.325476195459794,0.0159597851080544,0.0100799481471217,2.55945762780198,3.62665268227956,3.58947875036595,3.74879560142428,0.159316851058335,0.0308999922311935,ENSG00000184898,RBM43,protein_coding,2,-1,151247940,151261863,q23.3,RNA binding motif protein 43 [Source:HGNC Symbol;Acc:HGNC:24790],NA,RBM43,375287,NM_198557
HFM1_SIG,HFM1,HFM1_SIG,HFM1,SIG,31,-2.79555564700101,-0.137811262831368,-0.132611225659545,-0.15489709925307,-0.0222858735935253,0.0101071501613376,-2.25617899096978,0.340266610435011,0.375348463508584,0.224997664621839,-0.150350798886745,0.0591755584070833,ENSG00000162669,HFM1,protein_coding,1,-1,91260766,91404856,p22.2,HFM1, ATP dependent DNA helicase homolog [Source:HGNC Symbol;Acc:HGNC:20193],Premature ovarian failure 9,HFM1,164045,NM_001017975
MARCH2_SIG,MARCH2,MARCH2_SIG,MARCH2,SIG,27,-2.79334469148564,0.162572268204108,0.167162593217864,0.147489771730341,-0.0196728214875226,0.0101741033066241,-3.30004496230183,4.83290995419785,4.88959146130194,4.64667071657013,-0.242920744731806,0.00480652668408654,ENSG00000099785,MARCH2,protein_coding,19,1,8413270,8439017,p13.2,membrane associated ring-CH-type finger 2 [Source:HGNC Symbol;Acc:HGNC:28038],NA,MARCH2,51257,NM_001005415;NM_001005416;NM_016496
ZDHHC16_TF,ZDHHC16,ZDHHC16_TF,ZDHHC16,TF,515,2.79300592970536,0.248289762791759,0.239695078357477,0.276529440218686,0.03683436186121,0.0101823673041912,2.16578742185653,4.39492982188381,4.34362759803675,4.56349427166704,0.21986667363029,0.0708819600812381,ENSG00000171307,ZDHHC16,protein_coding,10,1,97446170,97457370,q24.1,zinc finger DHHC-type containing 16 [Source:HGNC Symbol;Acc:HGNC:20714],NA,ZDHHC16,84287,NM_001287803;NM_001287804;NM_032327;NM_198043;NM_198044;NM_198045;NM_198046
SRD5A1_SIG,SRD5A1,SRD5A1_SIG,SRD5A1,SIG,14,-2.79204038578708,0.14434460742523,0.152677022454042,0.116966672330562,-0.0357103501234807,0.0102103986052693,-2.74448486033854,2.9902345625083,3.04830816034213,2.79942131248285,-0.248886847859282,0.0201581427058835,ENSG00000145545,SRD5A1,protein_coding,5,1,6633427,6674386,p15.31,steroid 5 alpha-reductase 1 [Source:HGNC Symbol;Acc:HGNC:11284],NA,SRD5A1,6715,NM_001047;NM_001324322;NM_001324323
MLXIP_TF,MLXIP,MLXIP_TF,MLXIP,TF,95,2.79151817402259,0.127256232828465,0.121617629677847,0.145783071751924,0.0241654420740772,0.0102244834985644,1.38362200805228,7.80949889987341,7.79122482156961,7.86954230001445,0.0783174784448412,0.262825571782472,ENSG00000175727,MLXIP,protein_coding,12,1,122078756,122147344,q24.31,MLX interacting protein [Source:HGNC Symbol;Acc:HGNC:17055],NA,MLXIP,22877,NM_014938
NEK2_SIG,NEK2,NEK2_SIG,NEK2,SIG,51,-2.78999151476411,0.230870742366502,0.26649504203258,0.113819472035101,-0.15267556999748,0.0102704037875193,-2.62502260066762,2.33081449580131,2.41115425260201,2.06684100917042,-0.344313243431597,0.0265550346811236,ENSG00000117650,NEK2,protein_coding,1,-1,211658657,211675630,q32.3,NIMA related kinase 2 [Source:HGNC Symbol;Acc:HGNC:7745],Retinitis pigmentosa;Retinitis pigmentosa 67,NEK2,4751,NM_001204182;NM_001204183;NM_002497
KPNB1_SIG,KPNB1,KPNB1_SIG,KPNB1,SIG,11,2.78907323219812,0.43645615346371,0.426519967334804,0.469103622172969,0.042583654838165,0.0102971487145693,0.98091914290804,8.08317977842274,8.07053492164575,8.12472716497568,0.0541922433299326,0.440337016858162,ENSG00000108424,KPNB1,protein_coding,17,1,47649476,47685505,q21.32,karyopherin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6400],NA,KPNB1,3837,NM_001276453;NM_002265
SLC39A9_SIG,SLC39A9,SLC39A9_SIG,SLC39A9,SIG,34,2.78877500330403,0.379807465436635,0.374973756589825,0.395689651647581,0.0207158950577564,0.0103042121519171,1.98140498022288,6.05989003148515,6.03735362813154,6.13393821393272,0.0965845858011739,0.10047239416031,ENSG00000029364,SLC39A9,protein_coding,14,1,69398015,69462390,q24.1,solute carrier family 39 member 9 [Source:HGNC Symbol;Acc:HGNC:20182],NA,SLC39A9,55334,NM_001252148;NM_001252150;NM_001252151;NM_001252152;NM_001330185;NM_018375
CALCOCO1_SIG,CALCOCO1,CALCOCO1_SIG,CALCOCO1,SIG,62,2.78852804390096,0.214359854074252,0.209395668026979,0.23067075108672,0.0212750830597402,0.0103079559966194,1.01158661740511,6.55343523667448,6.5377256788068,6.60505235538255,0.0673266765757542,0.424945338700177,ENSG00000012822,CALCOCO1,protein_coding,12,-1,53708517,53727745,q13.13,calcium binding and coiled-coil domain 1 [Source:HGNC Symbol;Acc:HGNC:29306],NA,CALCOCO1,57658,NM_001143682;NM_020898
SCN3A_SIG,SCN3A,SCN3A_SIG,SCN3A,SIG,46,-2.78850509835577,-0.0984850888347771,-0.0930597529448051,-0.116311192473256,-0.0232514395284512,0.0103079559966194,-1.64011169415111,0.82602915242731,0.891980513879798,0.609331821940563,-0.282648691939235,0.17933934883755,ENSG00000153253,SCN3A,protein_coding,2,-1,165087522,165204067,q24.3,sodium voltage-gated channel alpha subunit 3 [Source:HGNC Symbol;Acc:HGNC:10590],EPILEPSY FAMILIAL FOCAL WITH VARIABLE FOCI 4;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 62;Focal epilepsy;Undetermined early-onset epileptic encephalopathy,SCN3A,6328,NM_001081676;NM_001081677;NM_006922
HLTF_TF,HLTF,HLTF_TF,HLTF,TF,342,2.78790483141667,0.282316626824455,0.274763807361304,0.307133033631949,0.0323692262706445,0.0103246485959174,1.566441390823,4.73219370457513,4.69063091952053,4.86875714118311,0.17812622166258,0.200744591313686,ENSG00000071794,HLTF,protein_coding,3,-1,149030127,149086554,q24,helicase like transcription factor [Source:HGNC Symbol;Acc:HGNC:11099],NA,HLTF,6596,NM_001318934;NM_001318935;NM_003071;NM_139048
IL10RB_SIG,IL10RB,IL10RB_SIG,IL10RB,SIG,64,-2.7866259436123,0.302466287149039,0.315367598895061,0.260076262840683,-0.0552913360543782,0.0103630440736447,-1.63616707039065,5.06282011758534,5.09728745605094,4.94957029119838,-0.147717164852559,0.180421562018895,ENSG00000243646,IL10RB,protein_coding,21,1,33266367,33310187,q22.11,interleukin 10 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:5965],HEPATITIS B VIRUS SUSCEPTIBILITY TO;Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome;INFLAMMATORY BOWEL DISEASE 25 AUTOSOMAL RECESSIVE,IL10RB,3588,NM_000628
ABHD17C_SIG,ABHD17C,ABHD17C_SIG,ABHD17C,SIG,17,-2.78522063799713,0.205592029651833,0.211364062399722,0.186626779194483,-0.0247372832052395,0.0104056236790651,-1.8901362918192,2.86975966815429,2.93673623417902,2.64969380835875,-0.28704242582027,0.118271849403577,ENSG00000136379,ABHD17C,protein_coding,15,1,80679684,80755621,q25.1,abhydrolase domain containing 17C [Source:HGNC Symbol;Acc:HGNC:26925],NA,ABHD17C,58489,NM_021214
PLAU_SIG,PLAU,PLAU_SIG,PLAU,SIG,7,2.78507120571302,0.298682253918267,0.29260602746939,0.318646997964577,0.0260409704951863,0.0104079767007545,3.97091536040292,4.51931176081508,4.38301012240987,4.96716000128936,0.584149878879492,0.00062216933343113,ENSG00000122861,PLAU,protein_coding,10,1,73909177,73917496,q22.2,plasminogen activator, urokinase [Source:HGNC Symbol;Acc:HGNC:9052],Alzheimer disease;QUEBEC PLATELET DISORDER,PLAU,5328,NM_001145031;NM_001319191;NM_002658
ITPKC_SIG,ITPKC,ITPKC_SIG,ITPKC,SIG,10,2.78478308452093,0.338075684945668,0.333831007700589,0.352022481608069,0.01819147390748,0.0104147840824132,2.18235145785143,3.6600947993221,3.63010847420193,3.75862129614553,0.128512821943602,0.0687132488830054,ENSG00000086544,ITPKC,protein_coding,19,1,40717112,40740860,q13.2,inositol-trisphosphate 3-kinase C [Source:HGNC Symbol;Acc:HGNC:14897],Kawasaki disease,ITPKC,80271,NM_025194
RNF25_SIG,RNF25,RNF25_SIG,RNF25,SIG,18,2.7840561720022,0.290077189303566,0.284824871489996,0.307334804976724,0.0225099334867285,0.0104357051535947,3.8119621867023,3.42208767962099,3.37523340826584,3.57603742835937,0.200804020093528,0.00103671085408342,ENSG00000163481,RNF25,protein_coding,2,-1,218663892,218672002,q35,ring finger protein 25 [Source:HGNC Symbol;Acc:HGNC:14662],NA,RNF25,64320,NM_022453
TLR5_SIG,TLR5,TLR5_SIG,TLR5,SIG,72,-2.78355387793938,0.106572875976904,0.124452212524233,0.0478264844642514,-0.0766257280599818,0.0104494259700619,-1.86793577255534,2.29461940705952,2.37854707721033,2.01885706227827,-0.359690014932065,0.12301930510229,ENSG00000187554,TLR5,protein_coding,1,-1,223109404,223143248,q41,toll like receptor 5 [Source:HGNC Symbol;Acc:HGNC:11851],LEGIONNAIRE DISEASE SUSCEPTIBILITY TO;MELIOIDOSIS SUSCEPTIBILITY TOMELIOIDOSIS RESISTANCE TO INCLUDED;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 1,TLR5,7100,NM_003268
SRP68_SIG,SRP68,SRP68_SIG,SRP68,SIG,21,2.78345304028025,0.525265667692641,0.520232405831801,0.541803528092543,0.0215711222607411,0.01045022327083,3.39428562097902,6.01377131293002,5.98010370930314,6.12439343913264,0.1442897298295,0.0036679872752203,ENSG00000167881,SRP68,protein_coding,17,-1,76038775,76072517,q25.1,signal recognition particle 68 [Source:HGNC Symbol;Acc:HGNC:11302],NA,SRP68,6730,NM_001260502;NM_001260503;NM_014230
SLC4A2_SIG,SLC4A2,SLC4A2_SIG,SLC4A2,SIG,14,2.78306316255432,0.229265919724158,0.22220432261619,0.252468310221769,0.0302639876055791,0.0104603363882577,2.9014177030433,6.20932478399652,6.16385623503807,6.35872144485998,0.194865209821904,0.0138234493527194,ENSG00000164889,SLC4A2,protein_coding,7,1,151057210,151076526,q36.1,solute carrier family 4 member 2 [Source:HGNC Symbol;Acc:HGNC:11028],NA,SLC4A2,6522,NM_001199692;NM_001199693;NM_001199694;NM_003040
TNFSF10_SIG,TNFSF10,TNFSF10_SIG,TNFSF10,SIG,26,-2.78288854044026,0.258096107255852,0.271137552089002,0.215245645661216,-0.0558919064277854,0.010463514455223,-1.59575868716499,4.53565850636556,4.59813988129802,4.33036256015892,-0.267777321139094,0.191831288332691,ENSG00000121858,TNFSF10,protein_coding,3,-1,172505508,172523475,q26.31,TNF superfamily member 10 [Source:HGNC Symbol;Acc:HGNC:11925],NA,TNFSF10,8743,NM_001190942;NM_001190943;NM_003810
GSPT1_SIG,GSPT1,GSPT1_SIG,GSPT1,SIG,7,2.78276891622246,0.49120822010012,0.481862674724615,0.521915012048205,0.0400523373235892,0.0104647728075132,2.1942432022493,7.08938654792989,7.05534877251828,7.20122495285374,0.145876180335457,0.0671383675136972,ENSG00000103342,GSPT1,protein_coding,16,-1,11868128,11916082,p13.13,G1 to S phase transition 1 [Source:HGNC Symbol;Acc:HGNC:4621],NA,GSPT1,2935,NM_001130006;NM_001130007;NM_002094
LTB_SIG,LTB,LTB_SIG,LTB,SIG,39,-2.78269744104344,0.14728118245592,0.156103515394479,0.118293517086367,-0.0378099983081127,0.0104647728075132,-1.4363339330911,4.49597729546701,4.54761564393516,4.3263084362145,-0.221307207720656,0.243294810151109,ENSG00000227507,LTB,protein_coding,6,-1,31580525,31582522,p21.33,lymphotoxin beta [Source:HGNC Symbol;Acc:HGNC:6711],NA,LTB,4050,NM_002341;NM_009588
PMPCA_SIG,PMPCA,PMPCA_SIG,PMPCA,SIG,34,2.78228088456062,0.448950603481486,0.443533448225781,0.466749827893087,0.0232163796673061,0.0104757606538541,3.70235239941455,5.67515013176517,5.63511728024405,5.80668664390602,0.171569363661979,0.00146010273585435,ENSG00000165688,PMPCA,protein_coding,9,1,136410641,136423761,q34.3,peptidase, mitochondrial processing alpha subunit [Source:HGNC Symbol;Acc:HGNC:18667],Autosomal recessive cerebelloparenchymal disorder type 3;Spinocerebellar ataxia autosomal recessive 2,PMPCA,23203,NM_001282944;NM_001282946;NM_015160
SENP8_SIG,SENP8,SENP8_SIG,SENP8,SIG,16,2.78176040276719,0.11000738663311,0.095832017410133,0.156583599794322,0.060751582384189,0.0104901173658506,2.59347042495695,0.750194334179802,0.715610638637523,0.86382647667586,0.148215838038337,0.0286059733485652,ENSG00000166192,SENP8,protein_coding,15,1,72114258,72143692,q23,SUMO peptidase family member, NEDD8 specific [Source:HGNC Symbol;Acc:HGNC:22992],NA,SENP8,123228,NM_001166340;NM_001172109;NM_001172110;NM_001172111;NM_145204
RNF182_SIG,RNF182,RNF182_SIG,RNF182,SIG,11,-2.77851514471879,-0.111690121665634,-0.0840482052777605,-0.202513561225789,-0.118465355948028,0.0105921746462603,-2.80458578050841,0.460641471850494,0.525183514379009,0.248574760685375,-0.276608753693634,0.0175149532887952,ENSG00000180537,RNF182,protein_coding,6,1,13924446,13980310,p23,ring finger protein 182 [Source:HGNC Symbol;Acc:HGNC:28522],NA,RNF182,221687,NM_001165032;NM_001165033;NM_001165034;NM_152737
STK10_SIG,STK10,STK10_SIG,STK10,SIG,70,-2.77846438745464,0.301956711425219,0.307393637422003,0.284092526007211,-0.0233011114147923,0.0105921746462603,-0.400469841765683,7.83154680055182,7.83769382726021,7.81134942708138,-0.0263444001788296,0.767971742617551,ENSG00000072786,STK10,protein_coding,5,-1,172042079,172188224,q35.1,serine/threonine kinase 10 [Source:HGNC Symbol;Acc:HGNC:11388],NA,STK10,6793,NM_005990
LTC4S_SIG,LTC4S,LTC4S_SIG,LTC4S,SIG,6,2.778323278916,0.233345131416206,0.228030586660392,0.250807207042453,0.0227766203820613,0.0105942961348198,0.579428385250542,0.201705358784918,0.198966315880288,0.210705071185843,0.0117387553055544,0.663307229463996,ENSG00000213316,LTC4S,protein_coding,5,1,179793980,179796647,q35.3,leukotriene C4 synthase [Source:HGNC Symbol;Acc:HGNC:6719],LEUKOTRIENE C4 SYNTHASE DEFICIENCY,LTC4S,4056,NM_145867
TYSND1_SIG,TYSND1,TYSND1_SIG,TYSND1,SIG,26,2.7777140904286,0.146208281122618,0.138495342953393,0.171550792250073,0.0330554492966803,0.0106116938755985,2.93460098615163,3.77068388473697,3.70929648510448,3.97238534067231,0.263088855567829,0.0127329373215236,ENSG00000156521,TYSND1,protein_coding,10,-1,70137981,70146700,q22.1,trypsin domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28531],NA,TYSND1,219743,NM_001040273;NM_173555
B4GALT2_SIG,B4GALT2,B4GALT2_SIG,B4GALT2,SIG,22,2.77749808451598,0.0983836475912125,0.0912865053303483,0.121702829305481,0.0304163239751327,0.0106162658504687,3.53267377277899,3.5392468545378,3.44964351902646,3.83365781407506,0.384014295048606,0.00245035985866951,ENSG00000117411,B4GALT2,protein_coding,1,1,43978943,43991170,p34.1,beta-1,4-galactosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:925],NA,B4GALT2,8704,NM_001005417;NM_003780;NM_030587
TNXB_SIG,TNXB,TNXB_SIG,TNXB,SIG,31,-2.7772520547254,-0.0831825204135422,-0.0749398614588733,-0.110265542693168,-0.0353256812342951,0.0106218211224497,-1.82640481831038,2.40459777091804,2.46935020698586,2.19183976669522,-0.27751044029064,0.132124639026416,ENSG00000168477,TNXB,protein_coding,6,-1,32041153,32115334,p21.32,tenascin XB [Source:HGNC Symbol;Acc:HGNC:11976],EHLERS-DANLOS SYNDROME CLASSIC-LIKE;Ehlers-Danlos syndrome due to tenascin-X deficiency;EHLERS-DANLOS SYNDROME HYPERMOBILITY TYPE;Familial vesicoureteral reflux;Vesicoureteral reflux 8,TNXB,7148,NM_001365276;NM_019105;NM_032470
RNF8_SIG,RNF8,RNF8_SIG,RNF8,SIG,18,2.77667886527722,0.447127995313028,0.438796539538892,0.474502778570905,0.0357062390320125,0.0106380812272502,2.67620411632706,3.85809761127984,3.8161676627101,3.99586744229473,0.17969977958463,0.0236735663814431,ENSG00000112130,RNF8,protein_coding,6,1,37353979,37394734,p21.2,ring finger protein 8 [Source:HGNC Symbol;Acc:HGNC:10071],NA,RNF8,9025,NM_003958;NM_183078
CAMKK2_SIG,CAMKK2,CAMKK2_SIG,CAMKK2,SIG,36,-2.77647919967983,0.397220066759159,0.405073686897751,0.371415314875214,-0.0336583720225365,0.0106415852471832,-2.74799441471183,6.78719241593771,6.83680724373681,6.62417226745495,-0.212634976281858,0.0200135932982827,ENSG00000110931,CAMKK2,protein_coding,12,-1,121237675,121298308,q24.31,calcium/calmodulin dependent protein kinase kinase 2 [Source:HGNC Symbol;Acc:HGNC:1470],NA,CAMKK2,10645,NM_001270485;NM_001270486;NM_006549;NM_153499;NM_153500;NM_172214;NM_172215;NM_172216;NM_172226
SPINT1_SIG,SPINT1,SPINT1_SIG,SPINT1,SIG,30,-2.77641983498155,0.0678970999176174,0.0744190192638228,0.0464679363515138,-0.027951082912309,0.0106415852471832,-1.10289927528554,3.4386155300833,3.48094659922011,3.2995277314909,-0.18141886772921,0.381116563600725,ENSG00000166145,SPINT1,protein_coding,15,1,40844018,40858207,q15.1,serine peptidase inhibitor, Kunitz type 1 [Source:HGNC Symbol;Acc:HGNC:11246],NA,SPINT1,6692,NM_001032367;NM_003710;NM_181642
PARP14_SIG,PARP14,PARP14_SIG,PARP14,SIG,48,-2.77575290372392,0.305171128801511,0.311528243546624,0.284283466067571,-0.0272447774790528,0.0106609458521044,-0.593767151693835,6.99804144166845,7.01015365309713,6.95824417554565,-0.0519094775514742,0.655174209321233,ENSG00000173193,PARP14,protein_coding,3,1,122680839,122730840,q21.1,poly(ADP-ribose) polymerase family member 14 [Source:HGNC Symbol;Acc:HGNC:29232],NA,PARP14,54625,NM_017554
ATP9B_SIG,ATP9B,ATP9B_SIG,ATP9B,SIG,6,2.77557908194788,0.358151932962319,0.352949456787808,0.375245783249999,0.0222963264621912,0.0106641548300594,1.97537596790715,4.87624891193062,4.85545491371281,4.944572048932,0.0891171352191903,0.101645195817906,ENSG00000166377,ATP9B,protein_coding,18,1,79069285,79378287,q23,ATPase phospholipid transporting 9B (putative) [Source:HGNC Symbol;Acc:HGNC:13541],NA,ATP9B,374868,NM_001306085;NM_198531
G6PD_SIG,G6PD,G6PD_SIG,G6PD,SIG,46,-2.77403215571334,0.561143876662847,0.568065061369856,0.53840284119696,-0.0296622201728956,0.0107124944247783,-1.7759032625381,6.8675781440606,6.90224840729912,6.75366156484832,-0.148586842450803,0.143988412468314,ENSG00000160211,G6PD,protein_coding,X,-1,154531390,154547572,q28,glucose-6-phosphate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4057],Anemia nonspherocytic hemolytic due to g6pd deficiency;Class I glucose-6-phosphate dehydrogenase deficiency;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED,G6PD,2539,NM_000402;NM_001042351;NM_001360016
STK4_SIG,STK4,STK4_SIG,STK4,SIG,45,-2.77337622476971,0.486133347655531,0.490959125517161,0.470277220395888,-0.0206819051212736,0.0107316072265506,0.362024303636758,7.58842097941964,7.58374564336885,7.60378279787222,0.0200371545033747,0.790816005949032,ENSG00000101109,STK4,protein_coding,20,1,44966479,45080021,q13.12,serine/threonine kinase 4 [Source:HGNC Symbol;Acc:HGNC:11408],Combined immunodeficiency due to STK4 deficiency;T-cell immunodeficiency recurrent infections and autoimmunity with or without cardiac malformations,STK4,6789,NM_001352385;NM_006282
SLC35D1_SIG,SLC35D1,SLC35D1_SIG,SLC35D1,SIG,25,2.7698275002985,0.313132878287022,0.309132881085552,0.326275726234709,0.0171428451491573,0.0108466948551964,0.607371878539251,4.85224163169651,4.8431037684341,4.88226603955872,0.0391622711246242,0.646341849142444,ENSG00000116704,SLC35D1,protein_coding,1,-1,66999350,67054148,p31.3,solute carrier family 35 member D1 [Source:HGNC Symbol;Acc:HGNC:20800],SCHNECKENBECKEN DYSPLASIA,SLC35D1,23169,NM_015139
FTSJ3_SIG,FTSJ3,FTSJ3_SIG,FTSJ3,SIG,13,2.76952484289897,0.445178285113269,0.432769087723787,0.485951362250139,0.0531822745263528,0.0108529730142265,2.37903637961343,5.50600810274388,5.46789773078685,5.63122789631698,0.163330165530126,0.0458800689906929,ENSG00000108592,FTSJ3,protein_coding,17,-1,63819433,63830012,q23.3,FtsJ RNA methyltransferase homolog 3 [Source:HGNC Symbol;Acc:HGNC:17136],NA,FTSJ3,117246,NM_017647
DDR2_SIG,DDR2,DDR2_SIG,DDR2,SIG,28,-2.7694869709557,-0.182906610818669,-0.178532193225835,-0.197279697195122,-0.0187475039692863,0.0108529730142265,-0.529784303129103,0.996177594506301,1.00589394694887,0.964252436480718,-0.0416415104681519,0.692439544292499,ENSG00000162733,DDR2,protein_coding,1,1,162631373,162787405,q23.3,discoidin domain receptor tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:2731],Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome;SPONDYLOEPIMETAPHYSEAL DYSPLASIA SHORT LIMB-HAND TYPE;Spondylometaepiphyseal dysplasia short limb-hand type,DDR2,4921,NM_001014796;NM_001354982;NM_001354983;NM_006182
PGP_SIG,PGP,PGP_SIG,PGP,SIG,49,-2.76827391120697,0.0308505502183593,0.037347414777032,0.00950370952557766,-0.0278437052514542,0.0108909138123362,-2.15587529175122,4.43567864074352,4.46732064189801,4.33171206552165,-0.135608576376356,0.0723316770642476,ENSG00000184207,PGP,protein_coding,16,-1,2211997,2214807,p13.3,phosphoglycolate phosphatase [Source:HGNC Symbol;Acc:HGNC:8909],NA,PGP,283871,NM_001042371
FFAR3_SIG,FFAR3,FFAR3_SIG,FFAR3,SIG,9,-2.76798192249889,0.108061384533052,0.117862871683872,0.0758564981803543,-0.0420063735035181,0.0108981338711962,-2.9722802493325,0.490542531054218,0.538396263408732,0.333308839032244,-0.205087424376488,0.0115769894248951,ENSG00000185897,FFAR3,protein_coding,19,1,35358460,35360485,q13.12,free fatty acid receptor 3 [Source:HGNC Symbol;Acc:HGNC:4499],NA,FFAR3,2865,NM_005304
SLC14A2_SIG,SLC14A2,SLC14A2_SIG,SLC14A2,SIG,23,-2.76770995929225,0.164319969398777,0.170670247129429,0.143454771140921,-0.0272154759885087,0.0109046884499026,-2.06525963369645,0.384829597592382,0.402903566301285,0.325443700405986,-0.0774598658952986,0.0858283760190888,ENSG00000132874,SLC14A2,protein_coding,18,1,45212995,45683686,q12.3,solute carrier family 14 member 2 [Source:HGNC Symbol;Acc:HGNC:10919],NA,SLC14A2,8170,NM_001242692;NM_007163
DNASE2_SIG,DNASE2,DNASE2_SIG,DNASE2,SIG,22,2.76707702364173,0.192236705444551,0.189149262338991,0.202381161362818,0.0132318990238273,0.0109233360282743,1.97931653063839,4.47758761052781,4.4247087358861,4.65133248435059,0.226623748464491,0.100911914215522,ENSG00000105612,DNASE2,protein_coding,19,-1,12875209,12881466,p13.13,deoxyribonuclease 2, lysosomal [Source:HGNC Symbol;Acc:HGNC:2960],NA,DNASE2,1777,NM_001375
NNMT_SIG,NNMT,NNMT_SIG,NNMT,SIG,38,-2.76661215453582,-0.167111900726523,-0.161630266425183,-0.185122984859498,-0.0234927184343158,0.0109363733327496,0.0617569606380454,0.66788929879262,0.66624345023101,0.673297086923624,0.00705363669261428,0.965984046578793,ENSG00000166741,NNMT,protein_coding,11,1,114257787,114313285,q23.2,nicotinamide N-methyltransferase [Source:HGNC Symbol;Acc:HGNC:7861],NA,NNMT,4837,NM_006169
IFIT3_SIG,IFIT3,IFIT3_SIG,IFIT3,SIG,27,-2.76645214126012,0.103297740874791,0.1119124909311,0.0749921335469155,-0.0369203573841848,0.0109391924647666,-1.48582292406371,4.52085645102163,4.57898218904359,4.32987188323519,-0.249110305808399,0.226597764484548,ENSG00000119917,IFIT3,protein_coding,10,1,89327997,89340971,q23.31,interferon induced protein with tetratricopeptide repeats 3 [Source:HGNC Symbol;Acc:HGNC:5411],NA,IFIT3,3437,NM_001031683;NM_001289759;NM_001549
E2F3_TF,E2F3,E2F3_TF,E2F3,TF,23,2.76615399787093,0.276900862446789,0.275025367890039,0.283063201704683,0.00803783381464373,0.0109466487458221,-0.834098701629424,5.97795272336737,5.98773668161046,5.94580543199723,-0.0419312496132306,0.516869804037188,ENSG00000112242,E2F3,protein_coding,6,1,20401879,20493714,p22.3,E2F transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:3115],NA,E2F3,1871,NM_001243076;NM_001949
ZNF205_SIG,ZNF205,ZNF205_SIG,ZNF205,SIG,25,2.76548961655925,-0.0917232688811681,-0.0968001387332102,-0.075042125081601,0.0217580136516091,0.0109664177757338,1.81564050196045,0.734915504346629,0.686736476549542,0.893218024251345,0.206481547701803,0.134601492078934,ENSG00000122386,ZNF205,protein_coding,16,1,3112560,3120517,p13.3,zinc finger protein 205 [Source:HGNC Symbol;Acc:HGNC:12996],NA,ZNF205,7755,NM_001042428;NM_001278158;NM_003456
MTSS1L_SIG,MTSS1L,MTSS1L_SIG,MTSS1L,SIG,26,2.76539035494997,0.132814582887373,0.124386986899396,0.160505255419299,0.036118268519903,0.0109672016815347,1.76243416639555,4.74579127259749,4.69075180463829,4.92663523874917,0.235883434110879,0.147181785875872,ENSG00000132613,MTSS1L,protein_coding,16,-1,70661204,70686053,q22.1,MTSS1L, I-BAR domain containing [Source:HGNC Symbol;Acc:HGNC:25094],NA,MTSS1L,92154,NM_138383
DPEP3_SIG,DPEP3,DPEP3_SIG,DPEP3,SIG,10,-2.76372652672798,0.000810987592339221,0.00574716262056531,-0.0154078732146894,-0.0211550358352547,0.0110207106929151,1.16009618091139,1.20435251925308,1.1656643155646,1.33147090280094,0.165806587236338,0.354836250393103,ENSG00000141096,DPEP3,protein_coding,16,-1,67975663,67980508,q22.1,dipeptidase 3 [Source:HGNC Symbol;Acc:HGNC:23029],NA,DPEP3,64180,NM_001129758;NM_022357
ZFAND5_TF,ZFAND5,ZFAND5_TF,ZFAND5,TF,69,-2.76270627733392,0.388570271972545,0.39619106443609,0.363530525306612,-0.0326605391294781,0.0110526424665477,-2.48605749740104,8.14392356783956,8.18328364330973,8.01459760558041,-0.168686037729318,0.0364036645415446,ENSG00000107372,ZFAND5,protein_coding,9,-1,72351413,72365235,q21.13,zinc finger AN1-type containing 5 [Source:HGNC Symbol;Acc:HGNC:13008],NA,ZFAND5,7763,NM_001102420;NM_001102421;NM_001278243;NM_001278244;NM_001278245;NM_006007
CPEB3_SIG,CPEB3,CPEB3_SIG,CPEB3,SIG,6,-2.76239836371618,0.225542241713095,0.234647278030117,0.195625693814311,-0.0390215842158058,0.0110604987075724,-1.76001807411439,3.3199468699339,3.34934415688806,3.22335578422737,-0.125988372660692,0.147770000456351,ENSG00000107864,CPEB3,protein_coding,10,-1,92046692,92291078,q23.32,cytoplasmic polyadenylation element binding protein 3 [Source:HGNC Symbol;Acc:HGNC:21746],NA,CPEB3,22849,NM_001178137;NM_014912
ACOT2_SIG,ACOT2,ACOT2_SIG,ACOT2,SIG,13,2.76112226036772,0.132781592998534,0.129856711458793,0.142391918057684,0.0125352065988912,0.0111012270745343,0.521986544220396,2.97385720560904,2.96487592224239,3.00336713667088,0.0384912144284844,0.696959639540211,ENSG00000119673,ACOT2,protein_coding,14,1,73567620,73575658,q24.3,acyl-CoA thioesterase 2 [Source:HGNC Symbol;Acc:HGNC:18431],NA,ACOT2,10965,NM_006821
HSF5_TF,HSF5,HSF5_TF,HSF5,TF,88,2.76072524246571,-0.00964511629155914,-0.0146951060264386,0.00694770712304479,0.0216428131494834,0.0111121451511713,1.78742529859581,1.35100430280697,1.31274524579161,1.47671263300032,0.163967387208712,0.141157712042759,ENSG00000176160,HSF5,protein_coding,17,-1,58420167,58488384,q22,heat shock transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:26862],NA,HSF5,124535,NM_001080439
FXR2_SIG,FXR2,FXR2_SIG,FXR2,SIG,19,2.76049864151079,0.315433801857551,0.307906037121909,0.340167885988944,0.0322618488670343,0.0111172714627171,2.13554195895197,4.96353410950242,4.93263316823247,5.06506577367511,0.132432605442644,0.0752041066868805,ENSG00000129245,FXR2,protein_coding,17,-1,7591230,7614871,p13.1,FMR1 autosomal homolog 2 [Source:HGNC Symbol;Acc:HGNC:4024],NA,FXR2,9513,NM_004860
AIMP1_SIG,AIMP1,AIMP1_SIG,AIMP1,SIG,26,2.75979970919639,0.37130054858327,0.367527012911319,0.38369930864825,0.0161722957369311,0.0111384927747533,2.39599019191243,5.41706585608513,5.39192143280878,5.49968324685028,0.107761814041496,0.0442358540766467,ENSG00000164022,AIMP1,protein_coding,4,1,106315544,106349226,q24,aminoacyl tRNA synthetase complex interacting multifunctional protein 1 [Source:HGNC Symbol;Acc:HGNC:10648],Autosomal recessive non-syndromic intellectual disability;LEUKODYSTROPHY HYPOMYELINATING 3;Pelizaeus-Merzbacher-like disease due to AIMP1 mutation,AIMP1,9255,NM_001142415;NM_001142416;NM_004757
TFE3_TF,TFE3,TFE3_TF,TFE3,TF,252,-2.75738073061384,-0.0979373084761166,-0.0918749083467489,-0.117856623186896,-0.0259817148401473,0.0112186303303441,-0.565174710789901,6.60424446739302,6.61150047439676,6.58040330152357,-0.0310971728731903,0.671761719447724,ENSG00000068323,TFE3,protein_coding,X,-1,49028726,49043410,p11.23,transcription factor binding to IGHM enhancer 3 [Source:HGNC Symbol;Acc:HGNC:11752],Alveolar soft-tissue sarcoma;Epithelioid hemangioendothelioma;MiT family translocation renal cell carcinoma;RENAL CELL CARCINOMA Xp11-ASSOCIATED,TFE3,7030,NM_001282142;NM_006521
RAC2_SIG,RAC2,RAC2_SIG,RAC2,SIG,49,-2.75634481608683,0.343334373253059,0.350287881188275,0.320487132894495,-0.0298007482937801,0.0112516116292244,-3.10299964859022,7.73753864345093,7.79530173177931,7.5477456389434,-0.247556092835912,0.00824049928764876,ENSG00000128340,RAC2,protein_coding,22,-1,37225270,37244448,q13.1,Rac family small GTPase 2 [Source:HGNC Symbol;Acc:HGNC:9802],NEUTROPHIL IMMUNODEFICIENCY SYNDROME,RAC2,5880,NM_002872
PIK3IP1_SIG,PIK3IP1,PIK3IP1_SIG,PIK3IP1,SIG,39,-2.75545000393761,0.222299955731102,0.230713084053573,0.194656819814411,-0.0360562642391627,0.0112798131788677,-2.85019975752572,5.73168747431596,5.81962047367708,5.44276476212941,-0.376855711547674,0.0156787929281205,ENSG00000100100,PIK3IP1,protein_coding,22,-1,31281593,31292534,q12.2,phosphoinositide-3-kinase interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:24942],NA,PIK3IP1,113791,NM_001135911;NM_052880
CD244_SIG,CD244,CD244_SIG,CD244,SIG,64,2.75453693657677,0.193223459879991,0.18689907538534,0.214003580362414,0.0271045049770741,0.011308708547706,1.14294957367381,5.5799447355309,5.54525455203792,5.69392676700782,0.1486722149699,0.362395462864863,ENSG00000122223,CD244,protein_coding,1,-1,160830160,160862887,q23.3,CD244 molecule [Source:HGNC Symbol;Acc:HGNC:18171],Rheumatoid arthritis,CD244,51744,NM_001166663;NM_001166664;NM_016382
ZP3_SIG,ZP3,ZP3_SIG,ZP3,SIG,5,2.75416867855568,-0.00986925207520732,-0.0132242647536296,0.00115436101103742,0.0143786257646671,0.0113188129720393,3.20677852617497,2.28422834900982,2.22395776878958,2.48226025544772,0.258302486658135,0.00623559237333285,ENSG00000188372,ZP3,protein_coding,7,1,76397518,76442071,q11.23,zona pellucida glycoprotein 3 [Source:HGNC Symbol;Acc:HGNC:13189],Female infertility due to zona pellucida defect;OOCYTE MATURATION DEFECT 3,ZP3,7784,NM_001110354;NM_007155
ZSWIM3_TF,ZSWIM3,ZSWIM3_TF,ZSWIM3,TF,93,2.75328348244277,0.108438589275356,0.098605153234171,0.140748450553536,0.0421432973193646,0.0113468311233279,2.52292215090472,1.88087589407415,1.82361248707747,2.06902708849181,0.245414601414333,0.0336310911091045,ENSG00000132801,ZSWIM3,protein_coding,20,1,45857614,45879122,q13.12,zinc finger SWIM-type containing 3 [Source:HGNC Symbol;Acc:HGNC:16157],NA,ZSWIM3,140831,NM_080752
CSNK1G3_SIG,CSNK1G3,CSNK1G3_SIG,CSNK1G3,SIG,24,2.75304681432709,0.241682417830425,0.239896800167472,0.247549447294412,0.00765264712694009,0.0113524020604965,2.29789236956889,4.86410414475463,4.83472255280091,4.96064366117399,0.125921108373077,0.0541616989879629,ENSG00000151292,CSNK1G3,protein_coding,5,1,123512099,123617045,q23.2,casein kinase 1 gamma 3 [Source:HGNC Symbol;Acc:HGNC:2456],NA,CSNK1G3,1456,NM_001031812;NM_001044723;NM_001270572;NM_001270573;NM_001270574;NM_001364143;NM_001364144;NM_001364146;NM_004384
SIGIRR_SIG,SIGIRR,SIGIRR_SIG,SIGIRR,SIG,72,2.75243469542119,0.194670445076554,0.190242091535829,0.209220749567507,0.0189786580316775,0.0113710073920811,1.60592269153203,5.81043246113503,5.78492627645754,5.89423849650391,0.109312220046368,0.188858070870942,ENSG00000185187,SIGIRR,protein_coding,11,-1,405716,417455,p15.5,single Ig and TIR domain containing [Source:HGNC Symbol;Acc:HGNC:30575],NA,SIGIRR,59307,NM_001135053;NM_001135054;NM_021805
RPP30_SIG,RPP30,RPP30_SIG,RPP30,SIG,18,2.75179123580417,0.375582804883868,0.372035679979622,0.387237643854962,0.01520196387534,0.0113907299037564,1.87648916246917,4.51886563623597,4.49927271677267,4.58324237161536,0.0839696548426873,0.121163648462236,ENSG00000148688,RPP30,protein_coding,10,1,90871716,90908553,q23.31,ribonuclease P/MRP subunit p30 [Source:HGNC Symbol;Acc:HGNC:17688],NA,RPP30,10556,NM_001104546;NM_006413
CPSF1_SIG,CPSF1,CPSF1_SIG,CPSF1,SIG,7,2.750667002366,0.300459082308881,0.293618597371772,0.322934961387952,0.0293163640161803,0.0114272413715432,1.45896195879069,7.46002561009302,7.43738799052375,7.53440636010634,0.0970183695825852,0.23561496325725,ENSG00000071894,CPSF1,protein_coding,8,-1,144393229,144409335,q24.3,cleavage and polyadenylation specific factor 1 [Source:HGNC Symbol;Acc:HGNC:2324],NA,CPSF1,29894,NM_013291
PPP4R2_SIG,PPP4R2,PPP4R2_SIG,PPP4R2,SIG,43,-2.74868734011617,0.346488340657862,0.35174102720782,0.329229513422286,-0.0225115137855346,0.0114938154879331,-1.82715683553764,6.24232654703608,6.26784542336744,6.15847881051878,-0.109366612848652,0.131937953834312,ENSG00000163605,PPP4R2,protein_coding,3,1,72996785,73069199,p13,protein phosphatase 4 regulatory subunit 2 [Source:HGNC Symbol;Acc:HGNC:18296],NA,PPP4R2,151987,NM_001318025;NM_001318026;NM_001318027;NM_001318028;NM_174907
PPBP_SIG,PPBP,PPBP_SIG,PPBP,SIG,41,-2.7481012877945,-0.194364683060095,-0.18272302180197,-0.232615855765361,-0.0498928339633912,0.0115117115073887,-0.734962109282365,2.719678371151,2.76228906022458,2.5796718213378,-0.182617238886783,0.571930128157572,ENSG00000163736,PPBP,protein_coding,4,-1,73986439,73988190,q13.3,pro-platelet basic protein [Source:HGNC Symbol;Acc:HGNC:9240],NA,PPBP,5473,NM_002704
HECTD3_SIG,HECTD3,HECTD3_SIG,HECTD3,SIG,22,2.7475225699505,0.269109766014407,0.263744532595697,0.286738390104452,0.0229938575087552,0.0115293744905307,2.93068866811351,5.70682714632192,5.66986418860689,5.82827686452842,0.158412675921533,0.0128600352059203,ENSG00000126107,HECTD3,protein_coding,1,-1,45002540,45011324,p34.1,HECT domain E3 ubiquitin protein ligase 3 [Source:HGNC Symbol;Acc:HGNC:26117],NA,HECTD3,79654,NM_024602
ZBTB22_TF,ZBTB22,ZBTB22_TF,ZBTB22,TF,65,2.7461259497078,0.0334608770795287,0.0291277220475535,0.0476983864703046,0.018570664422751,0.011575889499134,0.502996032027646,4.66570333402135,4.6596218623766,4.68568531228267,0.026063449906074,0.707684696061429,ENSG00000236104,ZBTB22,protein_coding,6,-1,33314406,33317942,p21.32,zinc finger and BTB domain containing 22 [Source:HGNC Symbol;Acc:HGNC:13085],NA,ZBTB22,9278,NM_001145338;NM_005453
RPS6KA5_SIG,RPS6KA5,RPS6KA5_SIG,RPS6KA5,SIG,15,2.74556725622017,0.171716359975749,0.169409882984667,0.179294784375019,0.00988490139035287,0.0115929324809887,0.689716055110134,3.77071841621,3.75923241447548,3.80845813619484,0.0492257217193598,0.598154197644004,ENSG00000100784,RPS6KA5,protein_coding,14,-1,90847861,91060641,q32.11,ribosomal protein S6 kinase A5 [Source:HGNC Symbol;Acc:HGNC:10434],NA,RPS6KA5,9252,NM_001322227;NM_001322228;NM_001322229;NM_001322230;NM_001322231;NM_001322232;NM_001322233;NM_001322234;NM_001322235;NM_001322236;NM_001322237;NM_001322238;NM_004755;NM_182398
ZNF597_TF,ZNF597,ZNF597_TF,ZNF597,TF,9,2.74525110986501,0.140955227628967,0.13798567814445,0.150712318792377,0.0127266406479266,0.0116014199325049,2.14848912800304,2.48252552461902,2.44445696290282,2.60760794168652,0.163150978783699,0.0733259126942314,ENSG00000167981,ZNF597,protein_coding,16,-1,3432414,3443504,p13.3,zinc finger protein 597 [Source:HGNC Symbol;Acc:HGNC:26573],NA,ZNF597,146434,NM_152457
ACO1_SIG,ACO1,ACO1_SIG,ACO1,SIG,5,2.74343874210583,0.220971878885689,0.211683335413155,0.251491378866873,0.0398080434537181,0.0116610702093807,2.90112535422718,4.11363392877288,4.05882364971071,4.29372484569142,0.234901195980705,0.0138340988408779,ENSG00000122729,ACO1,protein_coding,9,1,32384603,32454769,p21.1,aconitase 1 [Source:HGNC Symbol;Acc:HGNC:117],NA,ACO1,48,NM_001278352;NM_001362840;NM_002197
HNRNPA2B1_SIG,HNRNPA2B1,HNRNPA2B1_SIG,HNRNPA2B1,SIG,16,2.74341574761772,0.408162315642341,0.401938892522319,0.428610705893843,0.0266718133715244,0.0116610702093807,1.45028995546059,10.1104285095944,10.0947035253164,10.1620963150794,0.0673927897629961,0.238491491630638,ENSG00000122566,HNRNPA2B1,protein_coding,7,-1,26173057,26201529,p15.2,heterogeneous nuclear ribonucleoprotein A2/B1 [Source:HGNC Symbol;Acc:HGNC:5033],INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUTFRONTOTEMPORAL DEMENTIA 2;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,HNRNPA2B1,3181,NM_002137;NM_031243
STT3B_SIG,STT3B,STT3B_SIG,STT3B,SIG,14,2.74317627027191,0.473589347481742,0.46661480188237,0.496505711593965,0.0298909097115949,0.0116650892505833,0.6648370837791,8.14243277270255,8.13283788259474,8.17395884019965,0.0411209576049157,0.612173228603781,ENSG00000163527,STT3B,protein_coding,3,1,31532638,31637622,p23,STT3B, catalytic subunit of the oligosaccharyltransferase complex [Source:HGNC Symbol;Acc:HGNC:30611],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ix;STT3B-CDG,STT3B,201595,NM_178862
NIM1K_SIG,NIM1K,NIM1K_SIG,NIM1K,SIG,3,2.74315062610909,-0.154589269733646,-0.158141317819055,-0.142918254595872,0.0152230632231835,0.0116650892505833,-0.61730895220413,0.509440946938225,0.514140575957343,0.493999308732552,-0.0201412672247914,0.640092698625513,ENSG00000177453,NIM1K,protein_coding,5,1,43192071,43280850,p12,NIM1 serine/threonine protein kinase [Source:HGNC Symbol;Acc:HGNC:28646],NA,NIM1K,167359,NM_153361
PYROXD1_SIG,PYROXD1,PYROXD1_SIG,PYROXD1,SIG,13,-2.74300148558972,0.16550021044826,0.169145399016052,0.153523162296942,-0.0156222367191095,0.0116668210113699,-2.06668518276526,3.75856408785276,3.78443324810053,3.67356541846724,-0.110867829633285,0.0856223567273415,ENSG00000121350,PYROXD1,protein_coding,12,1,21437615,21471250,p12.1,pyridine nucleotide-disulphide oxidoreductase domain 1 [Source:HGNC Symbol;Acc:HGNC:26162],Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization;MYOPATHY MYOFIBRILLAR 8,PYROXD1,79912,NM_001350912;NM_001350913;NM_024854
UBE3A_SIG,UBE3A,UBE3A_SIG,UBE3A,SIG,33,2.74293180795364,0.459975852977676,0.456188317273826,0.472420613147468,0.0162322958736418,0.0116668210113699,0.107897853559507,6.60608075662043,6.60489945720189,6.60996216899564,0.00506271179375779,0.940215550965399,ENSG00000114062,UBE3A,protein_coding,15,-1,25333728,25439056,q11.2,ubiquitin protein ligase E3A [Source:HGNC Symbol;Acc:HGNC:12496],15q11q13 microduplication syndrome;Angelman syndrome;Angelman syndrome due to a point mutation;Angelman syndrome due to imprinting defect in 15q11-q13;Angelman syndrome due to maternal 15q11q13 deletion;Angelman syndrome due to paternal uniparental disomy of chromosome 15,UBE3A,7337,NM_000462;NM_001354505;NM_001354506;NM_001354507;NM_001354508;NM_001354509;NM_001354511;NM_001354512;NM_001354513;NM_001354523;NM_001354526;NM_001354538;NM_001354539;NM_001354540;NM_001354541;NM_001354542;NM_001354543;NM_001354544;NM_001354545;NM_001354546;NM_001354547;NM_001354548;NM_001354549;NM_001354550;NM_001354551;NM_130838;NM_130839
SLC7A8_SIG,SLC7A8,SLC7A8_SIG,SLC7A8,SIG,18,-2.74287403031762,-0.140703437226052,-0.136522557421574,-0.15444061372648,-0.0179180563049063,0.0116668210113699,-1.79745262433928,1.96068063963865,2.01589069994982,1.77927615575912,-0.236614544190697,0.138772976459438,ENSG00000092068,SLC7A8,protein_coding,14,-1,23125295,23183674,q11.2,solute carrier family 7 member 8 [Source:HGNC Symbol;Acc:HGNC:11066],NA,SLC7A8,23428,NM_001267036;NM_001267037;NM_012244;NM_182728
RIOK3_SIG,RIOK3,RIOK3_SIG,RIOK3,SIG,44,-2.74242817612783,0.248837637937788,0.262304039561396,0.204590889745933,-0.0577131498154626,0.0116792082396609,-2.72891917919349,7.08990523466651,7.14688872599848,6.90267376314718,-0.244214962851292,0.0209064246545569,ENSG00000101782,RIOK3,protein_coding,18,1,23453287,23486603,q11.2,RIO kinase 3 [Source:HGNC Symbol;Acc:HGNC:11451],NA,RIOK3,8780,NM_001348193;NM_003831
ADAM8_SIG,ADAM8,ADAM8_SIG,ADAM8,SIG,23,-2.74237369690564,0.177393072601981,0.183873276323953,0.15610097465836,-0.0277723016655938,0.0116792082396609,-1.54809786777604,6.92386224856511,6.97836634205131,6.74477736996758,-0.233588972083727,0.20644504461629,ENSG00000151651,ADAM8,protein_coding,10,-1,133262420,133276868,q26.3,ADAM metallopeptidase domain 8 [Source:HGNC Symbol;Acc:HGNC:215],NA,ADAM8,101,NM_001109;NM_001164489;NM_001164490
PLA2G2C_SIG,PLA2G2C,PLA2G2C_SIG,PLA2G2C,SIG,8,-2.73992141836784,-0.156846825771708,-0.149646521618332,-0.180504967989943,-0.0308584463716114,0.0117639870145875,-1.80653619239188,0.302076503235626,0.325526848677917,0.225025368210957,-0.10050148046696,0.136637415064713,ENSG00000187980,PLA2G2C,protein_coding,1,-1,20161253,20177424,p36.12,phospholipase A2 group IIC [Source:HGNC Symbol;Acc:HGNC:9032],NA,PLA2G2C,391013,NM_001316722
ZNF576_TF,ZNF576,ZNF576_TF,ZNF576,TF,94,2.73921201109422,0.199194434430312,0.189893645508485,0.229754169459173,0.039860523950688,0.0117866793522916,2.27757359171185,2.35952548169317,2.32601348192524,2.46963633807353,0.143622856148288,0.0565567997033776,ENSG00000124444,ZNF576,protein_coding,19,1,43596392,43601157,q13.31,zinc finger protein 576 [Source:HGNC Symbol;Acc:HGNC:28357],NA,ZNF576,79177,NM_001145347;NM_024327
BMPR1A_SIG,BMPR1A,BMPR1A_SIG,BMPR1A,SIG,53,-2.73911269895368,-0.124893867136982,-0.119692403379581,-0.141984390911299,-0.0222919875317176,0.0117875175752714,-0.287811765320719,1.19774405020885,1.20659082360725,1.16867608047124,-0.0379147431360143,0.835147752069859,ENSG00000107779,BMPR1A,protein_coding,10,1,86756601,86932838,q23.2,bone morphogenetic protein receptor type 1A [Source:HGNC Symbol;Acc:HGNC:1076],Familial colorectal cancer Type X;Generalized juvenile polyposis/juvenile polyposis coli;Hereditary mixed polyposis syndrome;Juvenile polyposis of infancy;Juvenile polyposis syndrome;POLYPOSIS SYNDROME HEREDITARY MIXED 2,BMPR1A,657,NM_004329
STXBP1_SIG,STXBP1,STXBP1_SIG,STXBP1,SIG,143,2.73896404172746,-0.0989443337840343,-0.102911712402267,-0.0859086611812693,0.0170030512209978,0.01179012582368,2.44490411325578,1.77512869191975,1.69464284270452,2.03958219648408,0.344939353779562,0.0397796098695779,ENSG00000136854,STXBP1,protein_coding,9,1,127579370,127696027,q34.11,syntaxin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11444],9q33.3q34.11 microdeletion syndrome;Angelman/pitt hopkins syndrome-Like disorder;Atypical Rett syndrome;Autosomal dominant non-syndromic intellectual disability;DRAVET SYNDROME;Early infantile epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 4;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE TYPE 4;Undetermined early-onset epileptic encephalopathy;West syndrome,STXBP1,6812,NM_001032221;NM_003165
NOM1_SIG,NOM1,NOM1_SIG,NOM1,SIG,20,2.738864552911,0.457404111012909,0.451995933067389,0.47517383854819,0.0231779054808015,0.0117909716179852,1.90174488553094,4.86994932643622,4.84037447605961,4.96712383481652,0.126749358756906,0.115937123083712,ENSG00000146909,NOM1,protein_coding,7,1,156949712,156973176,q36.3,nucleolar protein with MIF4G domain 1 [Source:HGNC Symbol;Acc:HGNC:13244],NA,NOM1,64434,NM_001353366;NM_138400
EXTL3_SIG,EXTL3,EXTL3_SIG,EXTL3,SIG,27,-2.73871973487382,0.104190789780346,0.110288452820883,0.0841556112185796,-0.0261328416023037,0.0117934437809725,-1.26689931788644,5.14960113576999,5.17510100295794,5.06581585786671,-0.109285145091237,0.308509681393067,ENSG00000012232,EXTL3,protein_coding,8,1,28600469,28755599,p21.1,exostosin like glycosyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:3518],IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES;Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,EXTL3,2137,NM_001440
MBD3_SIG,MBD3,MBD3_SIG,MBD3,SIG,33,2.73842487974362,0.273377727403053,0.265844596271989,0.298129443976549,0.0322848477045598,0.0118013004564338,1.63363908350346,5.15556897705994,5.13061705978992,5.23755384809,0.106936788300076,0.181150030500664,ENSG00000071655,MBD3,protein_coding,19,-1,1573596,1592865,p13.3,methyl-CpG binding domain protein 3 [Source:HGNC Symbol;Acc:HGNC:6918],NA,MBD3,53615,NM_001281453;NM_001281454
GALR2_SIG,GALR2,GALR2_SIG,GALR2,SIG,20,-2.73819196638602,0.0959708972207931,0.101751391085729,0.07697784595029,-0.0247735451354386,0.0118069379199181,-0.438754706794518,0.289983800832152,0.294426756573591,0.27538551768171,-0.0190412388918808,0.745410782042424,ENSG00000182687,GALR2,protein_coding,17,1,76074781,76077537,q25.1,galanin receptor 2 [Source:HGNC Symbol;Acc:HGNC:4133],NA,GALR2,8811,NM_003857
ZGPAT_TF,ZGPAT,ZGPAT_TF,ZGPAT,TF,173,-2.73782040856143,-0.0265658787183308,-0.0239439897650232,-0.03518065670777,-0.0112366669427467,0.0118163411905872,-0.85608845399761,3.49894966379643,3.50662197498492,3.47374064131996,-0.0328813336649555,0.504960848044863,ENSG00000197114,ZGPAT,protein_coding,20,1,63707465,63736142,q13.33,zinc finger CCCH-type and G-patch domain containing [Source:HGNC Symbol;Acc:HGNC:15948],NA,ZGPAT,84619,NM_001083113;NM_001195653;NM_001195654;NM_032527;NM_181485
HRH1_SIG,HRH1,HRH1_SIG,HRH1,SIG,19,-2.73777271830661,-0.112960389913209,-0.106668033000076,-0.133635276913502,-0.0269672439134258,0.0118163411905872,-2.18479976161245,0.463888997534464,0.496069849938335,0.358151911064602,-0.137917938873732,0.0683868576367922,ENSG00000196639,HRH1,protein_coding,3,1,11137093,11263557,p25.3,histamine receptor H1 [Source:HGNC Symbol;Acc:HGNC:5182],NA,HRH1,3269,NM_000861;NM_001098211;NM_001098212;NM_001098213
SETD5_SIG,SETD5,SETD5_SIG,SETD5,SIG,46,2.73770263305046,0.518329784615352,0.513692062945776,0.533568012958245,0.0198759500124692,0.0118163411905872,1.43688516896226,7.25228521520823,7.23547510191034,7.30751844461559,0.0720433427052525,0.243113469897386,ENSG00000168137,SETD5,protein_coding,3,1,9397615,9479240,p25.3,SET domain containing 5 [Source:HGNC Symbol;Acc:HGNC:25566],Cornelia de Lange syndrome;Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency;Mental retardation autosomal dominant 23,SETD5,55209,NM_001080517;NM_001292043;NM_001349451
WDR12_SIG,WDR12,WDR12_SIG,WDR12,SIG,42,2.73740809709767,0.459265039895672,0.4458825237086,0.503236164510335,0.0573536408017351,0.0118242015268045,2.68459500436319,4.87503225906783,4.81462351601791,5.07351812908901,0.258894613071102,0.0232427661194253,ENSG00000138442,WDR12,protein_coding,2,-1,202874782,203014798,q33.2,WD repeat domain 12 [Source:HGNC Symbol;Acc:HGNC:14098],NA,WDR12,55759,NM_018256
SRSF5_SIG,SRSF5,SRSF5_SIG,SRSF5,SIG,41,2.7366029857374,0.165534204876145,0.161010999213915,0.180396166337758,0.019385167123843,0.011850444195771,1.12321375831201,9.1319973322413,9.11944240984893,9.17324922010195,0.0538068102530217,0.371306150350113,ENSG00000100650,SRSF5,protein_coding,14,1,69726900,69772005,q24.1,serine and arginine rich splicing factor 5 [Source:HGNC Symbol;Acc:HGNC:10787],NA,SRSF5,6430,NM_001039465;NM_001320214;NM_006925
MRTO4_SIG,MRTO4,MRTO4_SIG,MRTO4,SIG,60,2.73570171358529,0.495950918583437,0.484219597247985,0.534496688685638,0.0502770914376537,0.0118802095344147,2.16513474000778,4.34756623443047,4.30199299100981,4.49730689138409,0.195313900374283,0.07098413570138,ENSG00000053372,MRTO4,protein_coding,1,1,19251805,19260128,p36.13,MRT4 homolog, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:18477],NA,MRTO4,51154,NM_016183
GID4_SIG,GID4,GID4_SIG,GID4,SIG,49,2.73464006542476,0.251036037032623,0.238067603080215,0.293646605733394,0.0555790026531794,0.0119158450535604,2.97608149220875,4.11681842454164,4.05823645087263,4.30930205231127,0.251065601438636,0.0114639411151421,ENSG00000141034,GID4,protein_coding,17,1,18039292,18068404,p11.2,GID complex subunit 4 homolog [Source:HGNC Symbol;Acc:HGNC:28453],NA,GID4,79018,NM_024052
PNPLA8_SIG,PNPLA8,PNPLA8_SIG,PNPLA8,SIG,29,-2.7334050365807,0.318678759054931,0.325652240144545,0.295765892617628,-0.0298863475269166,0.011957869663976,-2.8918467485855,5.53947048754144,5.59460697222587,5.35830775214972,-0.236299220076147,0.0141593360108531,ENSG00000135241,PNPLA8,protein_coding,7,-1,108470417,108569666,q31.1,patatin like phospholipase domain containing 8 [Source:HGNC Symbol;Acc:HGNC:28900],Mitochondrial myopathy with lactic acidosis,PNPLA8,50640,NM_001256007;NM_001256008;NM_001256009;NM_001256010;NM_001256011;NM_015723
NT5C3A_SIG,NT5C3A,NT5C3A_SIG,NT5C3A,SIG,21,2.73325664290503,0.0462390909424968,0.0396392083326904,0.0679244195175749,0.0282852111848846,0.0119605049608399,1.24672255262591,4.99975208374976,4.98140103972315,5.06004837126576,0.0786473315426121,0.316744719815386,ENSG00000122643,NT5C3A,protein_coding,7,-1,33014113,33062797,p14.3,5'-nucleotidase, cytosolic IIIA [Source:HGNC Symbol;Acc:HGNC:17820],Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency;HEMOLYTIC ANEMIA DUE TO UMPH1 DEFICIENCY;Uridine 5-prime monophosphate hydrolase deficiency hemolytic anemia due to,NT5C3A,51251,NM_001002009;NM_001002010;NM_001166118;NM_001356996;NM_016489
SP110_SIG,SP110,SP110_SIG,SP110,SIG,63,-2.73272533159392,0.337745636193444,0.345077406762322,0.313655532895702,-0.0314218738666197,0.0119770571345996,-2.73208959414222,5.87195441463774,5.92449317232471,5.699327067952,-0.225166104372706,0.0207661366061722,ENSG00000135899,SP110,protein_coding,2,-1,230167293,230225729,q37.1,SP110 nuclear body protein [Source:HGNC Symbol;Acc:HGNC:5401],Hepatic veno-occlusive disease-immunodeficiency syndrome;HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,SP110,3431,NM_001185015;NM_004509;NM_004510;NM_080424
PIM2_SIG,PIM2,PIM2_SIG,PIM2,SIG,20,-2.73218985235111,0.0794964177018658,0.0849510340919398,0.0615741067059085,-0.0233769273860313,0.0119937814697575,-1.1720890223021,5.69868645887902,5.72768010016315,5.60342163751688,-0.12425846264627,0.349520910868709,ENSG00000102096,PIM2,protein_coding,X,-1,48913182,48919024,p11.23,Pim-2 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:8987],NA,PIM2,11040,NM_006875
HSPA8_SIG,HSPA8,HSPA8_SIG,HSPA8,SIG,32,2.73176717723569,0.231253948240369,0.222012836025631,0.261617602660223,0.0396047666345921,0.0120064154845642,3.79970417948085,9.77303583461845,9.68498693631903,10.0623393576023,0.377352421283231,0.00107659334866998,ENSG00000109971,HSPA8,protein_coding,11,-1,123057489,123063230,q24.1,heat shock protein family A (Hsp70) member 8 [Source:HGNC Symbol;Acc:HGNC:5241],NA,HSPA8,3312,NM_006597;NM_153201
BAIAP2_SIG,BAIAP2,BAIAP2_SIG,BAIAP2,SIG,40,2.73130559175999,0.159964819544649,0.155981713995833,0.173052166347902,0.0170704523520691,0.0120204807221229,3.57503192589023,3.61481876372613,3.51934813068914,3.92850798656196,0.409159855872828,0.00215615490185388,ENSG00000175866,BAIAP2,protein_coding,17,1,81035122,81117432,q25.3,BAI1 associated protein 2 [Source:HGNC Symbol;Acc:HGNC:947],NA,BAIAP2,10458,NM_001144888;NM_006340;NM_017450;NM_017451
PBX4_TF,PBX4,PBX4_TF,PBX4,TF,95,-2.73119707167255,-0.00601335548340684,0.00036985918921863,-0.0269867751220334,-0.0273566343112521,0.0120216749117789,-1.85115496424894,1.72482988566647,1.77469134874603,1.56099936411936,-0.213691984626667,0.126636500416291,ENSG00000105717,PBX4,protein_coding,19,-1,19561707,19618693,p13.11,PBX homeobox 4 [Source:HGNC Symbol;Acc:HGNC:13403],NA,PBX4,80714,NM_025245
UBE2K_TF,UBE2K,UBE2K_TF,UBE2K,TF,346,2.72853244474531,0.361919741039635,0.35634298008617,0.380243384172449,0.0239004040862786,0.0121164471483243,1.79432002392178,6.36749756199815,6.3475144184999,6.43315646206385,0.0856420435639568,0.139565611055011,ENSG00000078140,UBE2K,protein_coding,4,1,39698109,39782792,p14,ubiquitin conjugating enzyme E2 K [Source:HGNC Symbol;Acc:HGNC:4914],NA,UBE2K,3093,NM_001111112;NM_001111113;NM_001312646;NM_001312647;NM_001312648;NM_005339
PRPF4_SIG,PRPF4,PRPF4_SIG,PRPF4,SIG,18,2.72827779175679,0.503351263395266,0.495391548712993,0.529504611637019,0.0341130629240264,0.0121230187380476,3.81840409789915,5.33760682353377,5.28650754803602,5.50550444302638,0.218996894990363,0.00101637347589484,ENSG00000136875,PRPF4,protein_coding,9,1,113275343,113292905,q32,pre-mRNA processing factor 4 [Source:HGNC Symbol;Acc:HGNC:17349],Retinitis pigmentosa;RETINITIS PIGMENTOSA 70,PRPF4,9128,NM_001244926;NM_001322266;NM_001322267;NM_004697
CSF2RA_SIG,CSF2RA,CSF2RA_SIG,CSF2RA,SIG,23,-2.72810835472833,0.528430071429877,0.543480988598778,0.478977057874915,-0.0645039307238638,0.0121264606643285,0.245206520857792,4.83388938471151,4.82608416019325,4.85953512241436,0.0334509622211109,0.86080098173699,ENSG00000198223,CSF2RA,protein_coding,X,1,1268800,1310381,p22.33,colony stimulating factor 2 receptor alpha subunit [Source:HGNC Symbol;Acc:HGNC:2435],Hereditary pulmonary alveolar proteinosis;SURFACTANT METABOLISM DYSFUNCTION PULMONARY 4,CSF2RA,1438,NM_001161529;NM_001161530;NM_001161531;NM_001161532;NM_006140;NM_172245;NM_172246;NM_172247;NM_172249
ARHGAP6_SIG,ARHGAP6,ARHGAP6_SIG,ARHGAP6,SIG,28,-2.72767590788138,-0.0577866465071193,-0.0515684757746933,-0.0782177789136621,-0.0266493031389687,0.012139578593139,-2.74843472097543,1.35708845609513,1.45670768027944,1.029768148061,-0.426939532218437,0.019995500655334,ENSG00000047648,ARHGAP6,protein_coding,X,-1,11137543,11665920,p22.2,Rho GTPase activating protein 6 [Source:HGNC Symbol;Acc:HGNC:676],NA,ARHGAP6,395,NM_001287242;NM_006125;NM_013423;NM_013427
PLXND1_SIG,PLXND1,PLXND1_SIG,PLXND1,SIG,69,2.72602929759113,0.16621778580699,0.159021873712975,0.189861496973036,0.0308396232600605,0.0121975043444477,1.46451065478294,7.99906300633822,7.96087804822356,8.12452786871496,0.1636498204914,0.233918610311592,ENSG00000004399,PLXND1,protein_coding,3,-1,129555175,129606818,q22.1,plexin D1 [Source:HGNC Symbol;Acc:HGNC:9107],Moebius syndrome;TRUNCUS ARTERIOSIS;TRUNCUS ARTERIOSUS,PLXND1,23129,NM_015103
USP35_SIG,USP35,USP35_SIG,USP35,SIG,18,2.72562916695601,0.302427628774638,0.296945620970559,0.320439940130898,0.0234943191603397,0.0122094949897691,2.07482641776737,3.61002466627606,3.57494642488433,3.7252817451346,0.15033532025027,0.08426701163512,ENSG00000118369,USP35,protein_coding,11,1,78188812,78215232,q14.1,ubiquitin specific peptidase 35 [Source:HGNC Symbol;Acc:HGNC:20061],NA,USP35,57558,NM_020798
ERG_SIG,ERG,ERG_SIG,ERG,SIG,118,2.72392919732503,0.0846258539213557,0.0750623961065052,0.116048643884436,0.0409862477779312,0.0122696997625241,1.02602663104283,5.66525410463462,5.61921471408172,5.81652638787987,0.197311673798144,0.417806415450008,ENSG00000157554,ERG,protein_coding,21,-1,38380027,38661780,q22.2,ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446],Ewing sarcoma;Extraskeletal Ewing sarcoma,ERG,2078,NM_001136154;NM_001136155;NM_001243428;NM_001243429;NM_001243432;NM_001291391;NM_001331025;NM_004449;NM_182918
CNBP_TF,CNBP,CNBP_TF,CNBP,TF,60,-2.72365700083431,0.148724481484802,0.150991400758338,0.141276032443183,-0.00971536831515478,0.0122769971753517,-1.15086041022369,8.29113201108724,8.30193143197459,8.25564819960021,-0.0462832323743818,0.358822170517331,ENSG00000169714,CNBP,protein_coding,3,-1,129169484,129183922,q21.3,CCHC-type zinc finger nucleic acid binding protein [Source:HGNC Symbol;Acc:HGNC:13164],MYOTONIC DYSTROPHY 2;Proximal myotonic myopathy,CNBP,7555,NM_001127192;NM_001127193;NM_001127194;NM_001127195;NM_001127196;NM_003418
ELF1_TF,ELF1,ELF1_TF,ELF1,TF,37,2.72268666285807,0.338816449539137,0.333898366371018,0.354975865662956,0.0210774992919382,0.0123102858877778,1.70638702454454,8.3847373775724,8.35782824104851,8.47315311186519,0.115324870816675,0.161585352366288,ENSG00000120690,ELF1,protein_coding,13,-1,40931924,41061440,q14.11,E74 like ETS transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:3316],NA,ELF1,1997,NM_001145353;NM_172373
KCNQ1_SIG,KCNQ1,KCNQ1_SIG,KCNQ1,SIG,34,-2.7224600114004,0.422505215740675,0.434706959679086,0.382413771371609,-0.0522931883074771,0.0123159071913394,0.238696484306658,4.01146661474064,4.00224100535522,4.04177933129277,0.0395383259375512,0.864690737223915,ENSG00000053918,KCNQ1,protein_coding,11,1,2444684,2849110,p15.5,potassium voltage-gated channel subfamily Q member 1 [Source:HGNC Symbol;Acc:HGNC:6294],ATRIAL FIBRILLATION FAMILIAL 3;BECKWITH-WIEDEMANN SYNDROME;Familial atrial fibrillation;Familial short QT syndrome;Jervell and Lange-Nielsen syndrome;JERVELL AND LANGE-NIELSEN SYNDROME 1;Jervell and Lange-Nielsen syndrome type 1;LONG QT SYNDROME 1;Romano-Ward syndrome;SHORT QT SYNDROME 2,KCNQ1,3784,NM_000218;NM_181798
ZNF638_TF,ZNF638,ZNF638_TF,ZNF638,TF,118,2.72195402193894,0.341763173938137,0.33219464215805,0.373202635501281,0.0410079933432303,0.0123319509375573,2.53443539528817,6.87878677455246,6.83309577240949,7.0289143530222,0.195818580612706,0.0327739737998153,ENSG00000075292,ZNF638,protein_coding,2,1,71276561,71435069,p13.3,zinc finger protein 638 [Source:HGNC Symbol;Acc:HGNC:17894],NA,ZNF638,27332,NM_001014972;NM_001252612;NM_001252613;NM_014497
SCAF1_SIG,SCAF1,SCAF1_SIG,SCAF1,SIG,22,2.72081127485904,0.488893912331289,0.485311354531696,0.500665173672806,0.01535381914111,0.0123718224712634,2.26091935393427,5.95586077586131,5.93358066079649,6.02906686821715,0.0954862074206605,0.0585757376945018,ENSG00000126461,SCAF1,protein_coding,19,1,49642209,49658642,q13.33,SR-related CTD associated factor 1 [Source:HGNC Symbol;Acc:HGNC:30403],NA,SCAF1,58506,NM_021228
PHF20_SIG,PHF20,PHF20_SIG,PHF20,SIG,24,2.72035848296281,0.32898250044429,0.324703184253854,0.343043110784293,0.0183399265304387,0.0123859378669738,3.56595901622141,6.03867494258774,5.99105852666754,6.19512888061124,0.204070353943701,0.00221542750128419,ENSG00000025293,PHF20,protein_coding,20,1,35771974,35950370,q11.22,PHD finger protein 20 [Source:HGNC Symbol;Acc:HGNC:16098],NA,PHF20,51230,NM_016436
DNASE1L1_SIG,DNASE1L1,DNASE1L1_SIG,DNASE1L1,SIG,31,-2.72018012498955,0.47564375961138,0.48229661068213,0.453784391807487,-0.0285122188746429,0.0123897805955571,-2.20936830634322,5.53938492812456,5.56987098959556,5.43921644043409,-0.130654549161471,0.0651810850560859,ENSG00000013563,DNASE1L1,protein_coding,X,-1,154401236,154412112,q28,deoxyribonuclease 1 like 1 [Source:HGNC Symbol;Acc:HGNC:2957],NA,DNASE1L1,1774,NM_001009932;NM_001009933;NM_001009934;NM_001303620;NM_006730
DHX57_SIG,DHX57,DHX57_SIG,DHX57,SIG,13,2.71913128645388,0.269658180315438,0.266399591298914,0.280364972798303,0.0139653814993889,0.0124239350587633,2.57638213873568,4.50517743521143,4.46977788303087,4.62149024951901,0.151712366488141,0.0297346307426817,ENSG00000163214,DHX57,protein_coding,2,-1,38797729,38875934,p22.1,DExH-box helicase 57 [Source:HGNC Symbol;Acc:HGNC:20086],NA,DHX57,90957,NM_001329963;NM_198963
TET1_SIG,TET1,TET1_SIG,TET1,SIG,43,2.71911817475062,0.0452872103762194,0.0395299616652698,0.0642038847121969,0.024673923046927,0.0124239350587633,0.623921525027376,2.66102154103013,2.64238211204354,2.72226537912891,0.0798832670853728,0.636252530261139,ENSG00000138336,TET1,protein_coding,10,1,68560337,68694487,q21.3,tet methylcytosine dioxygenase 1 [Source:HGNC Symbol;Acc:HGNC:29484],NA,TET1,80312,NM_030625
SP110_TF,SP110,SP110_TF,SP110,TF,181,-2.71895237328675,0.190388437931414,0.195931310594077,0.172176142039809,-0.0237551685542671,0.0124273172456613,-2.73208959414222,5.87195441463774,5.92449317232471,5.699327067952,-0.225166104372706,0.0207661366061722,ENSG00000135899,SP110,protein_coding,2,-1,230167293,230225729,q37.1,SP110 nuclear body protein [Source:HGNC Symbol;Acc:HGNC:5401],Hepatic veno-occlusive disease-immunodeficiency syndrome;HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,SP110,3431,NM_001185015;NM_004509;NM_004510;NM_080424
CHN2_SIG,CHN2,CHN2_SIG,CHN2,SIG,15,2.71821343623265,0.0119860393566585,0.00837235019321931,0.0238595894651014,0.0154872392718821,0.0124522550980903,3.28993666978186,3.09730410340735,2.99421920881246,3.4360116142191,0.441792405406634,0.00494381997311145,ENSG00000106069,CHN2,protein_coding,7,1,29146569,29514328,p14.3,chimerin 2 [Source:HGNC Symbol;Acc:HGNC:1944],NA,CHN2,1124,NM_001039936;NM_001293070;NM_001293071;NM_001293072;NM_001293073;NM_001293075;NM_001293076;NM_001293077;NM_001293078;NM_001293079;NM_001293080;NM_001293081;NM_004067
PLCH2_SIG,PLCH2,PLCH2_SIG,PLCH2,SIG,23,-2.71783757896833,0.0189514963730309,0.0302509826305567,-0.0181753870445541,-0.0484263696751109,0.0124635544995076,-2.69988615812917,1.7122754092549,1.79009072136409,1.45659652661042,-0.33349419475367,0.0224051986764873,ENSG00000149527,PLCH2,protein_coding,1,1,2425980,2505532,p36.32,phospholipase C eta 2 [Source:HGNC Symbol;Acc:HGNC:29037],NA,PLCH2,9651,NM_001303012;NM_001303013;NM_014638
ZNF626_TF,ZNF626,ZNF626_TF,ZNF626,TF,34,-2.71723513288684,-0.0974496396009488,-0.0924229788780906,-0.113965810547483,-0.0215428316693926,0.0124834075087488,-1.79145892532222,1.30124657364713,1.35284610971593,1.13170524084966,-0.221140868866266,0.140301882793208,ENSG00000188171,ZNF626,protein_coding,19,-1,20619939,20661596,p12,zinc finger protein 626 [Source:HGNC Symbol;Acc:HGNC:30461],NA,ZNF626,199777,NM_001076675;NM_145297
PMVK_SIG,PMVK,PMVK_SIG,PMVK,SIG,51,2.71637236567232,0.289886608409258,0.28062448226142,0.320319308609296,0.0396948263478762,0.012513125273954,1.33056624795262,4.28825693485784,4.26149406948464,4.37619206394122,0.11469799445658,0.282792822295583,ENSG00000163344,PMVK,protein_coding,1,-1,154924740,154936719,q21.3,phosphomevalonate kinase [Source:HGNC Symbol;Acc:HGNC:9141],POROKERATOSIS 1 MULTIPLE TYPES;Porokeratosis of Mibelli,PMVK,10654,NM_001323011;NM_001323012;NM_001348696;NM_006556
SLC25A22_SIG,SLC25A22,SLC25A22_SIG,SLC25A22,SIG,23,2.71602727877107,0.397588553952882,0.389073386115117,0.425566962562679,0.0364935764475615,0.0125233099158673,2.25698307681656,3.9867047864487,3.94907007522681,4.11036169474916,0.161291619522347,0.0590709494856237,ENSG00000177542,SLC25A22,protein_coding,11,-1,790475,798281,p15.5,solute carrier family 25 member 22 [Source:HGNC Symbol;Acc:HGNC:19954],Early infantile epileptic encephalopathy;Early myoclonic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 3;Malignant migrating partial seizures of infancy,SLC25A22,79751,NM_001191060;NM_001191061;NM_024698
RAMP1_SIG,RAMP1,RAMP1_SIG,RAMP1,SIG,28,-2.71572473974441,0.0203982257042273,0.029283625036016,-0.00879665781450673,-0.0380802828505226,0.0125318916349363,-3.64944478222154,1.70840271652927,1.87012587800262,1.17702661454541,-0.693099263457214,0.00171372158431201,ENSG00000132329,RAMP1,protein_coding,2,1,237858893,237912106,q37.3,receptor activity modifying protein 1 [Source:HGNC Symbol;Acc:HGNC:9843],NA,RAMP1,10267,NM_001308353;NM_005855
ZNF473_TF,ZNF473,ZNF473_TF,ZNF473,TF,102,2.71508206688829,0.232586665207665,0.225753221871004,0.255039407599551,0.0292861857285468,0.0125533662099995,0.48915799706279,3.43153705843912,3.42263084250305,3.46080033937192,0.0381694968688633,0.715875838526093,ENSG00000142528,ZNF473,protein_coding,19,1,50025714,50053414,q13.33,zinc finger protein 473 [Source:HGNC Symbol;Acc:HGNC:23239],NA,ZNF473,25888,NM_001006656;NM_001308424;NM_015428
BCL6B_SIG,BCL6B,BCL6B_SIG,BCL6B,SIG,56,-2.71486472059966,-0.0644583497737197,-0.0596410416112196,-0.0802866480219343,-0.0206456064107145,0.0125587356253477,-0.637354995390439,0.837327340158539,0.857496009530183,0.771058855080279,-0.0864371544499042,0.628501731772996,ENSG00000161940,BCL6B,protein_coding,17,1,7023020,7030290,p13.1,BCL6B, transcription repressor [Source:HGNC Symbol;Acc:HGNC:1002],NA,BCL6B,255877,NM_181844
HSPD1_SIG,HSPD1,HSPD1_SIG,HSPD1,SIG,25,2.71476568966519,0.722599307486958,0.710405747712958,0.7626638610301,0.052258113317142,0.0125596199894936,2.52218942684365,7.2628551949336,7.21008013590974,7.43625896029769,0.226178824387944,0.0336841809300385,ENSG00000144381,HSPD1,protein_coding,2,-1,197486584,197516737,q33.1,heat shock protein family D (Hsp60) member 1 [Source:HGNC Symbol;Acc:HGNC:5261],Autosomal dominant spastic paraplegia type 13;LEUKODYSTROPHY HYPOMYELINATING 4;LEUKODYSTROPHY HYPOMYELINATING TYPE 4;Pelizaeus-Merzbacher-like disease due to HSPD1 mutation;SPASTIC PARAPLEGIA 13 AUTOSOMAL DOMINANT,HSPD1,3329,NM_002156;NM_199440
GNL2_SIG,GNL2,GNL2_SIG,GNL2,SIG,8,2.71434929219074,0.26296087429802,0.257285172084861,0.281609610141257,0.0243244380563956,0.0125725457586851,1.68870644147039,5.87890817389297,5.86418298560278,5.92729093541788,0.0631079498150991,0.166092683244355,ENSG00000134697,GNL2,protein_coding,1,-1,37566816,37595937,p34.3,G protein nucleolar 2 [Source:HGNC Symbol;Acc:HGNC:29925],NA,GNL2,29889,NM_001323623;NM_001323624;NM_013285
POLR2C_SIG,POLR2C,POLR2C_SIG,POLR2C,SIG,15,2.71383285078456,0.347215998095803,0.343181190213064,0.36047322399623,0.0172920337831661,0.0125892846969737,1.47245617151163,5.56328948916482,5.55135422087643,5.60250537068381,0.0511511498073736,0.23105569113562,ENSG00000102978,POLR2C,protein_coding,16,1,57462660,57472009,q21,RNA polymerase II subunit C [Source:HGNC Symbol;Acc:HGNC:9189],NA,POLR2C,5432,NM_032940
SGPP2_SIG,SGPP2,SGPP2_SIG,SGPP2,SIG,35,2.71267364318383,-0.129106167974932,-0.133507717086783,-0.114643935178852,0.0188637819079311,0.0126279997653503,2.9776640251006,0.954169754955486,0.869390559065552,1.23272997002241,0.363339410956861,0.0114127704200916,ENSG00000163082,SGPP2,protein_coding,2,1,222424543,222562621,q36.1,sphingosine-1-phosphate phosphatase 2 [Source:HGNC Symbol;Acc:HGNC:19953],NA,SGPP2,130367,NM_001320833;NM_001320834;NM_152386
RPF2_SIG,RPF2,RPF2_SIG,RPF2,SIG,16,2.71266406146204,0.453803382219409,0.445811077943331,0.480063810555096,0.0342527326117656,0.0126279997653503,1.98434715588776,3.93518990102934,3.90233010529872,4.04315780128708,0.140827695988361,0.0999627436449705,ENSG00000197498,RPF2,protein_coding,6,1,110982015,111028263,q21,ribosome production factor 2 homolog [Source:HGNC Symbol;Acc:HGNC:20870],NA,RPF2,84154,NM_001289111;NM_032194
EFTUD2_SIG,EFTUD2,EFTUD2_SIG,EFTUD2,SIG,20,2.71242886913504,0.645283404373886,0.639321167231762,0.664873612126579,0.0255524448948169,0.0126340792214299,1.64753134038191,7.017841662631,6.99934590800278,7.07861342783804,0.0792675198352591,0.177126350755588,ENSG00000108883,EFTUD2,protein_coding,17,-1,44849948,44899445,q21.31,elongation factor Tu GTP binding domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30858],Mandibulofacial dysostosis-microcephaly syndrome;MANDIBULOFACIAL DYSOSTOSIS GUION-ALMEIDA TYPE;MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY,EFTUD2,9343,NM_001142605;NM_001258353;NM_001258354;NM_004247
ATRN_SIG,ATRN,ATRN_SIG,ATRN,SIG,29,2.71187917791453,0.343039753959307,0.336523010360904,0.364451911496916,0.0279289011360123,0.0126501138823628,0.66148396662733,5.96911720948409,5.95842744517709,6.00424072077853,0.045813275601443,0.613892465302852,ENSG00000088812,ATRN,protein_coding,20,1,3471018,3651118,p13,attractin [Source:HGNC Symbol;Acc:HGNC:885],NA,ATRN,8455,NM_001207047;NM_001323332;NM_139321;NM_139322
HADHB_SIG,HADHB,HADHB_SIG,HADHB,SIG,27,2.71185713952521,0.315685640136713,0.30986845601632,0.334799245103718,0.0249307890873976,0.0126501138823628,2.65373894462609,6.52284944130743,6.49275029404853,6.6217466394438,0.128996345395268,0.0248591306380744,ENSG00000138029,HADHB,protein_coding,2,1,26243170,26290465,p23.3,hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta [Source:HGNC Symbol;Acc:HGNC:4803],Mitochondrial trifunctional protein deficiency,HADHB,3032,NM_000183;NM_001281512;NM_001281513
CDK8_SIG,CDK8,CDK8_SIG,CDK8,SIG,6,2.71175935540769,0.46070218374456,0.453517203738802,0.484309975192052,0.0307927714532506,0.0126509589134104,-0.205693095229615,4.07521495075622,4.0782911546643,4.06510742362966,-0.0131837310346345,0.883695540050057,ENSG00000132964,CDK8,protein_coding,13,1,26254104,26405238,q12.13,cyclin dependent kinase 8 [Source:HGNC Symbol;Acc:HGNC:1779],NA,CDK8,1024,NM_001260;NM_001318368;NM_001346501
SEMA4C_SIG,SEMA4C,SEMA4C_SIG,SEMA4C,SIG,44,2.71120458469669,-0.00650420915521716,-0.00979473710891406,0.00430752554978696,0.014102262658701,0.0126692558315966,0.78677191601754,4.02162242281223,3.99761510730338,4.1005036023413,0.102888495037924,0.542165606815665,ENSG00000168758,SEMA4C,protein_coding,2,-1,96859718,96870757,q11.2,semaphorin 4C [Source:HGNC Symbol;Acc:HGNC:10731],NA,SEMA4C,54910,NM_017789
ITPK1_SIG,ITPK1,ITPK1_SIG,ITPK1,SIG,22,-2.71047966593338,0.59207476108449,0.604711265524198,0.550554817925449,-0.054156447598749,0.0126940876790006,-0.579434547618261,6.4730727362375,6.48174071620978,6.44459223061429,-0.0371484855954874,0.663307229463996,ENSG00000100605,ITPK1,protein_coding,14,-1,92936914,93116320,q32.12,inositol-tetrakisphosphate 1-kinase [Source:HGNC Symbol;Acc:HGNC:6177],NA,ITPK1,3705,NM_001142593;NM_001142594;NM_014216
ATP13A1_SIG,ATP13A1,ATP13A1_SIG,ATP13A1,SIG,22,2.71030211405324,0.339536514857556,0.332712275062267,0.361959017042077,0.0292467419798096,0.0126979898369568,2.25330404675306,6.49589861746704,6.47018661828401,6.58038090049697,0.110194282212962,0.0595683344990258,ENSG00000105726,ATP13A1,protein_coding,19,-1,19645198,19663676,p13.11,ATPase 13A1 [Source:HGNC Symbol;Acc:HGNC:24215],NA,ATP13A1,57130,NM_020410
ZFAT_TF,ZFAT,ZFAT_TF,ZFAT,TF,32,2.70990567166972,0.365652020926177,0.358215669704678,0.390085746368243,0.0318700766635642,0.0127102788718136,-0.516267997493143,3.92656682342849,3.93463660644359,3.90005182209316,-0.034584784350435,0.700193523462317,ENSG00000066827,ZFAT,protein_coding,8,-1,134477788,134713049,q24.22,zinc finger and AT-hook domain containing [Source:HGNC Symbol;Acc:HGNC:19899],AUTOIMMUNE THYROID DISEASE SUSCEPTIBILITY TO 3,ZFAT,57623,NM_001029939;NM_001167583;NM_001174157;NM_001174158;NM_001289394;NM_020863
ZNF184_TF,ZNF184,ZNF184_TF,ZNF184,TF,18,2.70862149885624,0.0747694351238838,0.0695094321945542,0.0920523018916811,0.0225428696971269,0.0127566661827838,-0.439221104169483,3.84975040602527,3.85861328049449,3.82062953276928,-0.0379837477252056,0.745139997986527,ENSG00000096654,ZNF184,protein_coding,6,-1,27450743,27473118,p22.1,zinc finger protein 184 [Source:HGNC Symbol;Acc:HGNC:12975],NA,ZNF184,7738,NM_001318891;NM_001318892;NM_001318893;NM_001347832;NM_007149
TAL1_TF,TAL1,TAL1_TF,TAL1,TF,365,-2.70841092572713,-0.0515245303654726,-0.0466425119794788,-0.0675654479194521,-0.0209229359399732,0.0127606657506584,-2.8246460666751,3.55487683779347,3.71071516956916,3.04283660481619,-0.667878564752974,0.016696643823023,ENSG00000162367,TAL1,protein_coding,1,-1,47216290,47232220,p33,TAL bHLH transcription factor 1, erythroid differentiation factor [Source:HGNC Symbol;Acc:HGNC:11556],LEUKEMIA ACUTE LYMPHOBLASTIC;Precursor T-cell acute lymphoblastic leukemia,TAL1,6886,NM_001287347;NM_001290403;NM_001290404;NM_001290405;NM_003189
PRC1_SIG,PRC1,PRC1_SIG,PRC1,SIG,27,-2.7083662665169,0.223837767085543,0.242140787548072,0.163699271280088,-0.0784415162679845,0.0127606657506584,-2.42540801360778,5.06049555759674,5.12420831928734,4.8511536263276,-0.273054692959742,0.0414781937737311,ENSG00000198901,PRC1,protein_coding,15,-1,90966040,90995629,q26.1,protein regulator of cytokinesis 1 [Source:HGNC Symbol;Acc:HGNC:9341],NA,PRC1,9055,NM_001267580;NM_003981;NM_199413
LEPR_SIG,LEPR,LEPR_SIG,LEPR,SIG,20,2.70826854984097,0.029578038139446,0.024160536965924,0.0473783991381614,0.0232178621722372,0.0127615168736553,2.58398832954053,3.85220675450523,3.77349391798582,4.11083464592615,0.33734072794033,0.0292278582982158,ENSG00000116678,LEPR,protein_coding,1,1,65420652,65641559,p31.3,leptin receptor [Source:HGNC Symbol;Acc:HGNC:6554],LEPTIN RECEPTOR DEFICIENCY;Obesity due to leptin receptor gene deficiency,LEPR,3953,NM_001003679;NM_001003680;NM_001198687;NM_001198688;NM_001198689;NM_002303
ARHGAP15_SIG,ARHGAP15,ARHGAP15_SIG,ARHGAP15,SIG,23,2.70721234249452,0.154230194819902,0.150810071717088,0.165467742157721,0.0146576704406326,0.0127992768051244,1.85573659772729,6.20561941647757,6.18240072306906,6.28190940910555,0.0995086860364908,0.125656167380252,ENSG00000075884,ARHGAP15,protein_coding,2,1,143091362,143768352,q22.2,Rho GTPase activating protein 15 [Source:HGNC Symbol;Acc:HGNC:21030],NA,ARHGAP15,55843,NM_018460
ZBED6_TF,ZBED6,ZBED6_TF,ZBED6,TF,36,2.70606665436938,0.421770258871993,0.419035243059397,0.430756739399096,0.0117214963396997,0.0128405955441917,2.21186832948924,4.31417081444712,4.27921070953881,4.42903973057444,0.149829021035631,0.0648332482854359,ENSG00000257315,ZBED6,protein_coding,1,1,203795714,203854999,q32.1,zinc finger BED-type containing 6 [Source:HGNC Symbol;Acc:HGNC:33273],NA,ZBED6,100381270,NM_001174108
PGF_SIG,PGF,PGF_SIG,PGF,SIG,15,-2.70550476668994,-0.139710858642273,-0.134708934725246,-0.156145751512504,-0.0214368167872579,0.0128594116190466,-1.535598296858,0.430158994662511,0.451162872501081,0.361146253192922,-0.0900166193081596,0.210449805537247,ENSG00000119630,PGF,protein_coding,14,-1,74941834,74955626,q24.3,placental growth factor [Source:HGNC Symbol;Acc:HGNC:8893],NA,PGF,5228,NM_001207012;NM_001293643;NM_002632
PRG2_SIG,PRG2,PRG2_SIG,PRG2,SIG,18,-2.70506792550176,-0.0122018033053963,-0.00441249301806446,-0.0377952513923437,-0.0333827583742792,0.0128734052618809,-2.42822431509288,1.10256705076403,1.16202999816198,0.907188795027927,-0.254841203134047,0.041235842840054,ENSG00000186652,PRG2,protein_coding,11,-1,57386780,57390650,q12.1,proteoglycan 2, pro eosinophil major basic protein [Source:HGNC Symbol;Acc:HGNC:9362],NA,PRG2,5553,NM_001243245;NM_001302926;NM_001302927;NM_002728
IRF7_SIG,IRF7,IRF7_SIG,IRF7,SIG,14,-2.70333119106677,0.209269516915539,0.22041500905948,0.172648614156877,-0.0477663949026023,0.0129361155527076,-1.30735496583532,5.5461041383448,5.57704353191377,5.44444613090387,-0.132597401009909,0.292021695483018,ENSG00000185507,IRF7,protein_coding,11,-1,612553,615999,p15.5,interferon regulatory factor 7 [Source:HGNC Symbol;Acc:HGNC:6122],IMMUNODEFICIENCY 39,IRF7,3665,NM_001572;NM_004029;NM_004031
SPRY2_SIG,SPRY2,SPRY2_SIG,SPRY2,SIG,42,2.70330210807077,0.0868444269072765,0.0821562481056721,0.102248442969691,0.0200921948640187,0.0129361155527076,-0.313408084270049,4.38780848360211,4.40269777641936,4.33888652148829,-0.0638112549310668,0.819847041949263,ENSG00000136158,SPRY2,protein_coding,13,-1,80335976,80341126,q31.1,sprouty RTK signaling antagonist 2 [Source:HGNC Symbol;Acc:HGNC:11270],IgA NEPHROPATHY SUSCEPTIBILITY TO 3,SPRY2,10253,NM_001318536;NM_001318537;NM_001318538;NM_005842
ARHGEF7_SIG,ARHGEF7,ARHGEF7_SIG,ARHGEF7,SIG,15,2.70270246418506,0.439563058430825,0.435121264921226,0.454157522819504,0.0190362578982779,0.0129565273137206,1.95659351612657,6.27271643934636,6.23978263759293,6.38092750225045,0.141144864657521,0.105054948639196,ENSG00000102606,ARHGEF7,protein_coding,13,1,111114559,111305737,q34,Rho guanine nucleotide exchange factor 7 [Source:HGNC Symbol;Acc:HGNC:15607],NA,ARHGEF7,8874,NM_001113511;NM_001113512;NM_001113513;NM_001320851;NM_001320852;NM_001320853;NM_001320854;NM_001330597;NM_001330598;NM_001354046;NM_001354047;NM_001354048;NM_001354049;NM_001354050;NM_001354051;NM_001354052;NM_001354053;NM_001354054;NM_001354055;NM_001354056;NM_001354057;NM_001354058;NM_001354059;NM_001354060;NM_001354061;NM_003899;NM_145735
PSEN2_SIG,PSEN2,PSEN2_SIG,PSEN2,SIG,23,2.70257588254977,0.0873694301929415,0.0824823222332175,0.103427070632034,0.0209447483988167,0.0129585154177163,0.607609456123416,2.95716791820715,2.94182502867596,3.00758026952393,0.0657552408479677,0.646220613860509,ENSG00000143801,PSEN2,protein_coding,1,1,226870184,226896105,q42.13,presenilin 2 [Source:HGNC Symbol;Acc:HGNC:9509],ALZHEIMER DISEASE 4;Cardiomyopathy dilated 1V;Early-onset autosomal dominant Alzheimer disease;Familial isolated dilated cardiomyopathy,PSEN2,5664,NM_000447;NM_012486
DHRS7B_SIG,DHRS7B,DHRS7B_SIG,DHRS7B,SIG,19,2.70210981384895,-0.0182442006264658,-0.027686802425111,0.0127814909976542,0.0404682934227653,0.0129718464936947,2.26151078797709,3.19849397410868,3.1571413752123,3.33436679905393,0.177225423841639,0.0584981365203079,ENSG00000109016,DHRS7B,protein_coding,17,1,21123364,21193265,p11.2,dehydrogenase/reductase 7B [Source:HGNC Symbol;Acc:HGNC:24547],NA,DHRS7B,25979,NM_001330159;NM_015510
MBD3_TF,MBD3,MBD3_TF,MBD3,TF,367,2.70208292726372,0.240418577375138,0.235413937150597,0.256862395255775,0.0214484581051785,0.0129718464936947,1.63363908350346,5.15556897705994,5.13061705978992,5.23755384809,0.106936788300076,0.181150030500664,ENSG00000071655,MBD3,protein_coding,19,-1,1573596,1592865,p13.3,methyl-CpG binding domain protein 3 [Source:HGNC Symbol;Acc:HGNC:6918],NA,MBD3,53615,NM_001281453;NM_001281454
THAP1_TF,THAP1,THAP1_TF,THAP1,TF,56,2.70186402232913,0.185501808834037,0.182877716468816,0.194123826605478,0.0112461101366617,0.0129760304770987,1.00259062641394,4.06770900849487,4.05580830634351,4.10681131556364,0.0510030092201329,0.429198200904303,ENSG00000131931,THAP1,protein_coding,8,-1,42836674,42843325,p11.21,THAP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20856],DYSTONIA 6 TORSION;Primary dystonia DYT6 type,THAP1,55145,NM_018105;NM_199003
RCAN3_SIG,RCAN3,RCAN3_SIG,RCAN3,SIG,22,-2.70182463543317,-0.0399284841218204,-0.0354487010293254,-0.0546477714257323,-0.019199070396407,0.0129760304770987,-0.994702744401718,5.00629163828819,5.03026461605142,4.92752328278044,-0.10274133327098,0.433101273722194,ENSG00000117602,RCAN3,protein_coding,1,1,24502351,24541040,p36.11,RCAN family member 3 [Source:HGNC Symbol;Acc:HGNC:3042],NA,RCAN3,11123,NM_001251977;NM_001251978;NM_001251979;NM_001251980;NM_001251981;NM_001251982;NM_001251983;NM_001251984;NM_001251985;NM_013441
MGAT5B_SIG,MGAT5B,MGAT5B_SIG,MGAT5B,SIG,50,-2.69927854737916,-0.0779833479067679,-0.0725925211968494,-0.0956960642393573,-0.0231035430425078,0.0130727643208759,-1.36493893826928,0.45836079686797,0.484955600695196,0.370977870007084,-0.113977730688112,0.269870704718978,ENSG00000167889,MGAT5B,protein_coding,17,1,76868456,76950393,q25.2,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B [Source:HGNC Symbol;Acc:HGNC:24140],NA,MGAT5B,146664,NM_001199172;NM_144677;NM_198955
B3GALT6_SIG,B3GALT6,B3GALT6_SIG,B3GALT6,SIG,33,2.6989537581347,0.392360533829681,0.382567087039282,0.424539001855275,0.0419719148159927,0.013082558681321,2.05817708909303,4.18252951271641,4.13453924866564,4.34021180888322,0.205672560217573,0.0870814927056649,ENSG00000176022,B3GALT6,protein_coding,1,1,1232226,1235041,p36.33,beta-1,3-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:17978],Ehlers-Danlos syndrome;Ehlers-Danlos syndrome progeroid type;EHLERS-DANLOS SYNDROME SPONDYLODYSPLASTIC TYPE 2;Spondyloepimetaphyseal dysplasia with joint laxity;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 1;SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 1 WITH OR WITHOUT FRACTURES,B3GALT6,126792,NM_080605
ELF4_TF,ELF4,ELF4_TF,ELF4,TF,111,-2.69749614875103,0.199794146203616,0.203029148484561,0.189164852994796,-0.0138642954897646,0.0131357270915656,-2.30684439870693,7.47577743045568,7.51290607274368,7.3537833200808,-0.159122752662878,0.0531933053862462,ENSG00000102034,ELF4,protein_coding,X,-1,130064874,130110716,q26.1,E74 like ETS transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:3319],Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia,ELF4,2000,NM_001127197;NM_001421
HLA-A_SIG,HLA-A,HLA-A_SIG,HLA-A,SIG,7,-2.69745256750197,0.665902075674864,0.674064509164817,0.639082651350733,-0.0349818578140838,0.0131357270915656,-1.99722907912314,10.0678257574717,10.1034548333709,9.95075879380307,-0.152696039567784,0.0975600719680679,ENSG00000206503,HLA-A,protein_coding,6,1,29941260,29945884,p22.1,major histocompatibility complex, class I, A [Source:HGNC Symbol;Acc:HGNC:4931],Birdshot chorioretinopathy;Phenytoin or carbamazepine toxicity;SEVERE CUTANEOUS ADVERSE REACTION SUSCEPTIBILITY TO TOXIC EPIDERMAL NECROLYSIS SUSCEPTIBILITY TO INCLUDED,HLA-A,3105,NM_002116
MARK4_SIG,MARK4,MARK4_SIG,MARK4,SIG,42,2.69705835339566,0.271884127985696,0.268657799946259,0.282484920115276,0.0138271201690164,0.0131468707870196,0.714749810267387,5.3799798598793,5.37104736325672,5.4093294916392,0.0382821283824813,0.583203953214418,ENSG00000007047,MARK4,protein_coding,19,1,45079288,45305284,q13.32,microtubule affinity regulating kinase 4 [Source:HGNC Symbol;Acc:HGNC:13538],NA,MARK4,57787,NM_001199867;NM_031417
NOL9_SIG,NOL9,NOL9_SIG,NOL9,SIG,58,2.69701913083511,0.299731017758486,0.295384749597656,0.31401161314407,0.0186268635464134,0.0131468707870196,2.62868453812787,5.10051808518318,5.0690436107869,5.20393421534238,0.134890604555476,0.026317457846784,ENSG00000162408,NOL9,protein_coding,1,-1,6521347,6554513,p36.31,nucleolar protein 9 [Source:HGNC Symbol;Acc:HGNC:26265],NA,NOL9,79707,NM_024654
ZNF268_TF,ZNF268,ZNF268_TF,ZNF268,TF,17,2.69615954359328,0.0903251090709606,0.083502039446066,0.1127437664099,0.0292417269638344,0.0131778582211907,2.7821756943161,3.63344082035954,3.58115229583548,3.80524597236714,0.22409367653166,0.0184447057760999,ENSG00000090612,ZNF268,protein_coding,12,1,133181409,133214831,q24.33,zinc finger protein 268 [Source:HGNC Symbol;Acc:HGNC:13061],NA,ZNF268,10795,NM_001165881;NM_001165882;NM_001165883;NM_001165884;NM_001165885;NM_001165886;NM_001165887;NM_003415;NM_152943
SLC30A1_SIG,SLC30A1,SLC30A1_SIG,SLC30A1,SIG,16,-2.69534224915951,0.220412305200756,0.22778477892882,0.196188462951404,-0.0315963159774164,0.0132072337617384,-1.47711571429908,5.3710350495724,5.40564279819016,5.25732387554263,-0.148318922647537,0.229485371178598,ENSG00000170385,SLC30A1,protein_coding,1,-1,211571568,211579161,q32.3,solute carrier family 30 member 1 [Source:HGNC Symbol;Acc:HGNC:11012],NA,SLC30A1,7779,NM_021194
SLC1A3_SIG,SLC1A3,SLC1A3_SIG,SLC1A3,SIG,22,-2.69487228078959,0.070447762782448,0.0788862058161801,0.0427214499573284,-0.0361647558588518,0.0132228780684584,-1.68932977752084,2.66633351899389,2.72681849663299,2.46759716389399,-0.259221332738997,0.165928206605482,ENSG00000079215,SLC1A3,protein_coding,5,1,36606355,36688334,p13.2,solute carrier family 1 member 3 [Source:HGNC Symbol;Acc:HGNC:10941],ALTERNATING HEMIPLEGIA OF CHILDHOOD;Episodic ataxia type 6;EPISODIC ATAXIA TYPE 6,SLC1A3,6507,NM_001166695;NM_001289939;NM_001289940;NM_004172
IFIT2_SIG,IFIT2,IFIT2_SIG,IFIT2,SIG,17,-2.6942310036689,0.141692944391966,0.149051258047047,0.117515628096698,-0.031535629950349,0.0132453455281629,-0.953294082872457,4.69071050228892,4.73090748938815,4.55863468753429,-0.172272801853858,0.453994344075672,ENSG00000119922,IFIT2,protein_coding,10,1,89283694,89309271,q23.31,interferon induced protein with tetratricopeptide repeats 2 [Source:HGNC Symbol;Acc:HGNC:5409],NA,IFIT2,3433,NM_001547
HSD17B6_SIG,HSD17B6,HSD17B6_SIG,HSD17B6,SIG,1,2.69315080847851,-0.22579503778863,-0.236466572865787,-0.190731422535114,0.0457351503306732,0.0132853269661415,1.40129588946422,0.444158585332492,0.431841791848434,0.484628049637255,0.0527862577888218,0.256134313872059,ENSG00000025423,HSD17B6,protein_coding,12,1,56752161,56787790,q13.3,hydroxysteroid 17-beta dehydrogenase 6 [Source:HGNC Symbol;Acc:HGNC:23316],NA,HSD17B6,8630,NM_003725
PRMT6_SIG,PRMT6,PRMT6_SIG,PRMT6,SIG,29,2.69261472508373,0.251664219152646,0.242540271578788,0.28164290403818,0.0391026324593921,0.0133036908327935,1.40978994586631,3.68856766620411,3.65649907876048,3.79393588209032,0.137436803329834,0.252914418962724,ENSG00000198890,PRMT6,protein_coding,1,1,107056679,107067636,p13.3,protein arginine methyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:18241],NA,PRMT6,55170,NM_018137
EGR3_TF,EGR3,EGR3_TF,EGR3,TF,38,-2.69217345695773,0.081696481424505,0.0905483332567287,0.0526118254043413,-0.0379365078523875,0.0133182902263567,-2.00033357284861,3.10036831676427,3.20226737236428,2.76555713407855,-0.436710238285728,0.0970252514567394,ENSG00000179388,EGR3,protein_coding,8,-1,22687659,22693480,p21.3,early growth response 3 [Source:HGNC Symbol;Acc:HGNC:3240],NA,EGR3,1960,NM_001199880;NM_004430
FOXN2_TF,FOXN2,FOXN2_TF,FOXN2,TF,72,-2.69179737372176,0.153782194284324,0.155615181556156,0.147759521819733,-0.00785565973642223,0.0133302984426098,-0.144555192406964,6.42659659369076,6.42844576613152,6.42052074138541,-0.00792502474610767,0.918859964917142,ENSG00000170802,FOXN2,protein_coding,2,1,48314637,48379295,p16.3,forkhead box N2 [Source:HGNC Symbol;Acc:HGNC:5281],NA,FOXN2,3344,NM_002158
CDC23_SIG,CDC23,CDC23_SIG,CDC23,SIG,27,2.69156359395145,0.483478432621596,0.476070389819919,0.507819144684247,0.0317487548643282,0.0133366255594369,2.36427215069683,5.00171328381511,4.96260765525842,5.13020320621569,0.167595550957277,0.0473067653494892,ENSG00000094880,CDC23,protein_coding,5,-1,138187650,138213343,q31.2,cell division cycle 23 [Source:HGNC Symbol;Acc:HGNC:1724],NA,CDC23,8697,NM_004661
HNRNPA1_SIG,HNRNPA1,HNRNPA1_SIG,HNRNPA1,SIG,68,2.68890525586983,0.331987849654946,0.323703436758516,0.359208063457502,0.0355046266989856,0.0134402540273678,3.09821108334162,8.69327685659059,8.63763458035625,8.87610147850341,0.238466898147159,0.0083277715736634,ENSG00000135486,HNRNPA1,protein_coding,12,1,54280193,54287088,q13.13,heterogeneous nuclear ribonucleoprotein A1 [Source:HGNC Symbol;Acc:HGNC:5031],Amyotrophic lateral sclerosis;Amyotrophic lateral sclerosis 20;INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUTFRONTOTEMPORAL DEMENTIA 3;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,HNRNPA1,3178,NM_002136;NM_031157
HIST2H4A_SIG,HIST2H4A,HIST2H4A_SIG,HIST2H4A,SIG,21,2.68876487182431,-0.0348689847269139,-0.0401166298993426,-0.0176267220175053,0.0224899078818373,0.0134428650819593,3.25243546895092,0.384385793374881,0.352139307224835,0.490338533582177,0.138199226357342,0.00549005003428491,ENSG00000270882,HIST2H4A,protein_coding,1,1,149832659,149839767,q21.2,histone cluster 2 H4 family member a [Source:HGNC Symbol;Acc:HGNC:4794],NA,HIST2H4A,8370,NM_003548
RRM2_SIG,RRM2,RRM2_SIG,RRM2,SIG,37,-2.68858396095353,0.274215342082459,0.301541990399201,0.184427783327449,-0.117114207071752,0.0134471093348876,-2.80790101279955,5.1904975760136,5.30776192122248,4.80520044175587,-0.50256147946661,0.017370036739909,ENSG00000171848,RRM2,protein_coding,2,1,10120698,10211725,p25.1,ribonucleotide reductase regulatory subunit M2 [Source:HGNC Symbol;Acc:HGNC:10452],NA,RRM2,6241;348738,NM_001034;NM_001165931;NM_182626
CD1E_SIG,CD1E,CD1E_SIG,CD1E,SIG,11,-2.68795329430224,-0.124935219417173,-0.116079005604025,-0.154034207660372,-0.0379552020563466,0.0134694861004861,-2.67158348080865,0.565419934612761,0.634876376653195,0.337205910765622,-0.297670465887573,0.0239154270498477,ENSG00000158488,CD1E,protein_coding,1,1,158353696,158357553,q23.1,CD1e molecule [Source:HGNC Symbol;Acc:HGNC:1638],NA,CD1E,913,NM_001042583;NM_001042584;NM_001042585;NM_001042586;NM_001042587;NM_001185107;NM_001185108;NM_001185110;NM_001185112;NM_001185113;NM_001185114;NM_001185115;NM_030893
ZNF207_TF,ZNF207,ZNF207_TF,ZNF207,TF,61,2.68648377039345,0.258928722786459,0.253216857028372,0.277696281705887,0.0244794246775149,0.01352582090454,2.96187341752692,8.0102383627854,7.98048877116557,8.10798702096484,0.12749824979927,0.0118838471647432,ENSG00000010244,ZNF207,protein_coding,17,1,32350117,32381886,q11.2,zinc finger protein 207 [Source:HGNC Symbol;Acc:HGNC:12998],NA,ZNF207,7756,NM_001032293;NM_001098507;NM_003457
ITLN1_SIG,ITLN1,ITLN1_SIG,ITLN1,SIG,11,-2.68596771911475,-0.148924877968754,-0.132714194082687,-0.202188553594401,-0.0694743595117131,0.0135423738339349,-2.09497922322787,0.331195226260217,0.36986085132256,0.204151029626805,-0.165709821695755,0.0810915023879852,ENSG00000179914,ITLN1,protein_coding,1,-1,160876540,160885180,q23.3,intelectin 1 [Source:HGNC Symbol;Acc:HGNC:18259],NA,ITLN1,55600,NM_017625
MCEE_SIG,MCEE,MCEE_SIG,MCEE,SIG,21,2.68592410465745,0.231765312611152,0.220975102139685,0.267218861303112,0.0462437591634269,0.0135423738339349,2.10490383733193,2.7230457257277,2.6924321792989,2.82363309256518,0.131200913266281,0.0796579825306023,ENSG00000124370,MCEE,protein_coding,2,-1,71109684,71130239,p13.3,methylmalonyl-CoA epimerase [Source:HGNC Symbol;Acc:HGNC:16732],Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency;METHYLMALONYL-CoA EPIMERASE DEFICIENCY,MCEE,84693,NM_032601
PTGS2_SIG,PTGS2,PTGS2_SIG,PTGS2,SIG,32,-2.68535870727572,0.365812434767237,0.37664618126591,0.330215839128742,-0.0464303421371681,0.0135622419689979,-2.12129010327691,5.38381858657968,5.49045105994854,5.03345474551058,-0.456996314437958,0.0771946759888208,ENSG00000073756,PTGS2,protein_coding,1,-1,186671791,186680423,q31.1,prostaglandin-endoperoxide synthase 2 [Source:HGNC Symbol;Acc:HGNC:9605],NA,PTGS2,5743,NM_000963
ZNF777_TF,ZNF777,ZNF777_TF,ZNF777,TF,138,2.68387389932949,0.254895718711176,0.252041425669225,0.264274110134729,0.0122326844655038,0.0136195423906864,0.916233280999448,4.4633515045623,4.4510124720969,4.50389403980576,0.0528815677088595,0.473197266178672,ENSG00000196453,ZNF777,protein_coding,7,-1,149431363,149461062,q36.1,zinc finger protein 777 [Source:HGNC Symbol;Acc:HGNC:22213],NA,ZNF777,27153,NM_015694
C11orf68_SIG,C11orf68,C11orf68_SIG,C11orf68,SIG,33,2.68304816982042,0.224767986102959,0.214683117902942,0.2579039816173,0.0432208637143579,0.0136495359815368,1.80390361968564,4.24379736517142,4.21330474661131,4.34398739758319,0.130682650971877,0.137246261935323,ENSG00000175573,C11orf68,protein_coding,11,-1,65916810,65919062,q13.1,chromosome 11 open reading frame 68 [Source:HGNC Symbol;Acc:HGNC:28801],NA,C11orf68,83638,NM_001135635;NM_031450
ZC3H12B_TF,ZC3H12B,ZC3H12B_TF,ZC3H12B,TF,87,-2.68298727407179,-0.111413954480585,-0.106296959104735,-0.128226939286947,-0.0219299801822114,0.0136495359815368,-1.18656503786408,0.879483185540936,0.907207558772518,0.788388816351455,-0.118818742421063,0.342932654563514,ENSG00000102053,ZC3H12B,protein_coding,X,1,65366638,65507887,q11.2,zinc finger CCCH-type containing 12B [Source:HGNC Symbol;Acc:HGNC:17407],NA,ZC3H12B,340554,NM_001010888
TSTD1_SIG,TSTD1,TSTD1_SIG,TSTD1,SIG,18,2.68143777153287,0.113010492372719,0.105478081226339,0.137759843282256,0.0322817620559168,0.0137098136052528,0.837973387800809,3.52223237617518,3.50748509116935,3.57068774119434,0.0632026500249876,0.514687847173655,ENSG00000215845,TSTD1,protein_coding,1,-1,161037631,161038977,q23.3,thiosulfate sulfurtransferase like domain containing 1 [Source:HGNC Symbol;Acc:HGNC:35410],NA,TSTD1,100131187,NM_001113205;NM_001113206;NM_001113207
BCR_SIG,BCR,BCR_SIG,BCR,SIG,98,2.68084007744499,0.173308121740628,0.163988357586159,0.203930203962454,0.0399418463762957,0.0137312240234757,2.31691288599991,7.39252808913695,7.34092178766246,7.56209165112456,0.221169863462096,0.052166641195195,ENSG00000186716,BCR,protein_coding,22,1,23179704,23318037,q11.23,BCR, RhoGEF and GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:1014],Chronic myeloid leukemia;Distal 22q11.2 microdeletion syndrome;LEUKEMIA ACUTE LYMPHOBLASTIC;LEUKEMIA CHRONIC MYELOID;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,BCR,613,NM_004327;NM_021574
EXT2_SIG,EXT2,EXT2_SIG,EXT2,SIG,29,2.68072761288054,0.425383002966167,0.418537078455461,0.447876754929915,0.0293396764744542,0.0137327400370631,1.75178447351781,5.54203134610207,5.51330839407362,5.63640675990981,0.123098365836188,0.149761773425365,ENSG00000151348,EXT2,protein_coding,11,1,44095549,44245429,p11.2,exostosin glycosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:3513],Exostoses multiple type 2;EXOSTOSES MULTIPLE TYPE II;Multiple osteochondromas;Potocki-Shaffer syndrome;Seizures-scoliosis-macrocephaly syndrome;SEIZURES SCOLIOSIS AND MACROCEPHALY SYNDROME,EXT2,2132,NM_000401;NM_001178083;NM_207122
SLCO5A1_SIG,SLCO5A1,SLCO5A1_SIG,SLCO5A1,SIG,63,-2.67961835858119,-0.0147480449717445,-0.00838932211531989,-0.0356409914999969,-0.0272516693846769,0.013775217165732,-2.98886630624563,1.93476362564469,2.07378325096775,1.47798485672605,-0.595798394241695,0.0110768994098612,ENSG00000137571,SLCO5A1,protein_coding,8,-1,69667046,69834978,q13.3,solute carrier organic anion transporter family member 5A1 [Source:HGNC Symbol;Acc:HGNC:19046],NA,SLCO5A1,81796,NM_001146008;NM_001146009;NM_030958
GART_SIG,GART,GART_SIG,GART,SIG,77,2.67871511989806,0.511731697916712,0.498000342888557,0.556849007294938,0.0588486644063809,0.0138093128319257,1.93899449950454,5.89612297425505,5.85196926138338,6.0411994594048,0.189230198021422,0.108495914873937,ENSG00000159131,GART,protein_coding,21,-1,33503931,33543491,q22.11,phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase [Source:HGNC Symbol;Acc:HGNC:4163],NA,GART,2618,NM_000819;NM_001136005;NM_001136006;NM_175085
EIF3A_SIG,EIF3A,EIF3A_SIG,EIF3A,SIG,13,2.67721952052059,0.413566693811777,0.409157841852415,0.428052921678253,0.0188950798258377,0.0138679838408749,3.09961287382278,8.57777730034602,8.54128253407686,8.69768867523038,0.156406141153523,0.00831049274003176,ENSG00000107581,EIF3A,protein_coding,10,-1,119033670,119080823,q26.11,eukaryotic translation initiation factor 3 subunit A [Source:HGNC Symbol;Acc:HGNC:3271],NA,EIF3A,8661,NM_003750
SERBP1_SIG,SERBP1,SERBP1_SIG,SERBP1,SIG,77,2.67659180736044,0.683291460955155,0.672840263584523,0.717631109458658,0.0447908458741348,0.013890857010202,1.7501375873283,7.86756099997964,7.84133583477543,7.95372939993632,0.112393565160881,0.150162599672761,ENSG00000142864,SERBP1,protein_coding,1,-1,67407810,67430415,p31.3,SERPINE1 mRNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17860],NA,SERBP1,26135,NM_001018067;NM_001018068;NM_001018069;NM_015640
RXRB_TF,RXRB,RXRB_TF,RXRB,TF,56,2.67633880896184,0.332190437390911,0.324768945802481,0.356575338324322,0.0318063925218408,0.0138974643658528,2.30942712876424,5.68726247535488,5.65787608112599,5.78381777067838,0.125941689552392,0.0529184262547208,ENSG00000204231,RXRB,protein_coding,6,-1,33193588,33200688,p21.32,retinoid X receptor beta [Source:HGNC Symbol;Acc:HGNC:10478],NA,RXRB,6257,NM_001270401;NM_001291989;NM_021976
ARF1_SIG,ARF1,ARF1_SIG,ARF1,SIG,29,-2.67628139687383,0.123536974930859,0.12947996002148,0.104010023918817,-0.0254699361026631,0.0138974643658528,-2.19262834379089,8.73324804591335,8.75670768154233,8.65616638598955,-0.10054129555278,0.0673537397825542,ENSG00000143761,ARF1,protein_coding,1,1,228082660,228099212,q42.13,ADP ribosylation factor 1 [Source:HGNC Symbol;Acc:HGNC:652],PERIVENTRICULAR NODULAR HETEROTOPIA 8,ARF1,375,NM_001024226;NM_001024227;NM_001024228;NM_001658
BRD3_SIG,BRD3,BRD3_SIG,BRD3,SIG,23,2.67486668277712,0.539744771739918,0.531190919448559,0.567850286411525,0.036659366962966,0.0139530994687355,2.17939353180791,6.08883560935788,6.05897508567866,6.18694875858961,0.127973672910953,0.0690944723390409,ENSG00000169925,BRD3,protein_coding,9,-1,134030305,134068535,q34.2,bromodomain containing 3 [Source:HGNC Symbol;Acc:HGNC:1104],NA,BRD3,8019,NM_007371
CCNH_SIG,CCNH,CCNH_SIG,CCNH,SIG,19,2.67425276973916,0.108099618349383,0.105320521017104,0.117230938155443,0.0119104171383388,0.0139755217563438,2.52243681786383,5.26281149313474,5.23158862171846,5.36540092778823,0.133812306069772,0.0336647549700593,ENSG00000134480,CCNH,protein_coding,5,-1,87318416,87412930,q14.3,cyclin H [Source:HGNC Symbol;Acc:HGNC:1594],NA,CCNH,902,NM_001199189;NM_001239
HLA-DPA1_SIG,HLA-DPA1,HLA-DPA1_SIG,HLA-DPA1,SIG,38,-2.67294793852436,0.281191131081279,0.294312288435944,0.238078756915954,-0.0562335315199901,0.0140268385948252,-2.30341733276408,7.6298813494641,7.73993603946458,7.26827308231965,-0.47166295714493,0.0535948949607537,ENSG00000231389,HLA-DPA1,protein_coding,6,-1,33064569,33080775,p21.32,major histocompatibility complex, class II, DP alpha 1 [Source:HGNC Symbol;Acc:HGNC:4938],Granulomatosis with polyangiitis,HLA-DPA1,3113,NM_001242524;NM_001242525;NM_033554
MAPK1_SIG,MAPK1,MAPK1_SIG,MAPK1,SIG,29,-2.67264667336228,0.426759521801126,0.433193230328764,0.405620193781743,-0.0275730365470202,0.014036279835051,-2.05286268983802,7.37728808957444,7.40564555702647,7.28411355366066,-0.121532003365803,0.0880316970157518,ENSG00000100030,MAPK1,protein_coding,22,-1,21754500,21867680,q11.22,mitogen-activated protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:6871],Distal 22q11.2 microdeletion syndrome,MAPK1,5594,NM_002745;NM_138957
CPSF3_SIG,CPSF3,CPSF3_SIG,CPSF3,SIG,27,2.67231090915438,0.512332479049218,0.503935657671203,0.539922035005554,0.0359863773343505,0.0140471712187983,2.20570457199656,5.82970584101488,5.79884282076101,5.93111290756331,0.132270086802302,0.0656981883212375,ENSG00000119203,CPSF3,protein_coding,2,1,9423651,9473101,p25.1,cleavage and polyadenylation specific factor 3 [Source:HGNC Symbol;Acc:HGNC:2326],NA,CPSF3,51692,NM_001321833;NM_001321834;NM_001321835;NM_001321836;NM_016207
RAB23_SIG,RAB23,RAB23_SIG,RAB23,SIG,37,2.67192386932411,-0.0890193849050486,-0.0944031948890231,-0.0713297235291325,0.0230734713598905,0.0140602185720887,2.06889832524909,1.05299513721844,1.00602412347812,1.20732846807948,0.201304344601357,0.0852531849947539,ENSG00000112210,RAB23,protein_coding,6,-1,57186992,57222307,p11.2,RAB23, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:14263],acrocephalopolysyndactyly type 2;CARPENTER SYNDROME;CARPENTER SYNDROME 1,RAB23,51715,NM_001278666;NM_001278667;NM_001278668;NM_016277;NM_183227
LAP3_SIG,LAP3,LAP3_SIG,LAP3,SIG,19,-2.67179019100292,0.180760771183396,0.186867361181169,0.160696261190712,-0.0261710999904572,0.0140626561752913,-1.79573680977976,6.02512407565104,6.05526862411621,5.92607770212264,-0.129190921993574,0.139179416694493,ENSG00000002549,LAP3,protein_coding,4,1,17577192,17607972,p15.32,leucine aminopeptidase 3 [Source:HGNC Symbol;Acc:HGNC:18449],NA,LAP3,51056,NM_015907
HSPBAP1_SIG,HSPBAP1,HSPBAP1_SIG,HSPBAP1,SIG,75,-2.67034367234836,0.101499382759624,0.105787563118165,0.0874096472958446,-0.0183779158223204,0.0141202127978146,-1.42824323089273,4.39746021071432,4.42056916818671,4.32153077901932,-0.0990383891673954,0.24616764199795,ENSG00000169087,HSPBAP1,protein_coding,3,-1,122739999,122793831,q21.1,HSPB1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16389],Hereditary clear cell renal cell carcinoma,HSPBAP1,79663,NM_001320728;NM_024610
SLC25A28_SIG,SLC25A28,SLC25A28_SIG,SLC25A28,SIG,15,2.66907232035084,0.043890928872855,0.0394799609745818,0.0583841091100387,0.0189041481354569,0.0141705862898481,2.41836772026974,5.71839892362901,5.68818983998189,5.8176573413267,0.129467501344814,0.042124464659228,ENSG00000155287,SLC25A28,protein_coding,10,-1,99610522,99620609,q24.2,solute carrier family 25 member 28 [Source:HGNC Symbol;Acc:HGNC:23472],NA,SLC25A28,81894,NM_031212
RASA1_SIG,RASA1,RASA1_SIG,RASA1,SIG,9,2.66827610033821,0.295370776570128,0.29025144782232,0.31219142817007,0.0219399803477504,0.0142010219459973,0.845964534444943,5.45300421961393,5.44021237825254,5.49503455551564,0.0548221772630965,0.510592950881159,ENSG00000145715,RASA1,protein_coding,5,1,87267888,87391931,q14.3,RAS p21 protein activator 1 [Source:HGNC Symbol;Acc:HGNC:9871],BASAL CELL CARCINOMA SUSCEPTIBILITY TO 1;CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION;CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1;PARKES WEBER SYNDROME,RASA1,5921,NM_002890;NM_022650
ACOX3_SIG,ACOX3,ACOX3_SIG,ACOX3,SIG,22,2.6675758138563,0.463751686778105,0.454535603378594,0.494033103662211,0.0394975002836166,0.0142268015377802,3.19252963191706,3.51256503451767,3.46464696173427,3.67001013080597,0.205363169071696,0.00649084764075371,ENSG00000087008,ACOX3,protein_coding,4,-1,8366282,8440723,p16.1,acyl-CoA oxidase 3, pristanoyl [Source:HGNC Symbol;Acc:HGNC:121],NA,ACOX3,8310,NM_001101667;NM_003501
SLC25A46_SIG,SLC25A46,SLC25A46_SIG,SLC25A46,SIG,15,2.66751568041595,0.417403492727493,0.412510193749357,0.433481475084223,0.0209712813348657,0.0142268015377802,2.71743256860038,5.94719358110228,5.91086100902627,6.06657203220915,0.155711023182883,0.0214944065400551,ENSG00000164209,SLC25A46,protein_coding,5,1,110738136,110765161,q22.1,solute carrier family 25 member 46 [Source:HGNC Symbol;Acc:HGNC:25198],Hereditary motor and sensory neuropathy type 6;NEUROPATHY HEREDITARY MOTOR AND SENSORY TYPE VIB,SLC25A46,91137,NM_001303249;NM_001303250;NM_138773
HES6_TF,HES6,HES6_TF,HES6,TF,336,-2.66645394906087,0.0252473266653516,0.0285505661677188,0.014393825443288,-0.0141567407244309,0.0142686104653906,-2.59154404567101,2.284643371762,2.37150997971016,1.99922451707519,-0.372285462634964,0.0287255276445698,ENSG00000144485,HES6,protein_coding,2,-1,238238267,238240662,q37.3,hes family bHLH transcription factor 6 [Source:HGNC Symbol;Acc:HGNC:18254],NA,HES6,55502,NM_001142853;NM_001282434;NM_018645
TAPBP_SIG,TAPBP,TAPBP_SIG,TAPBP,SIG,19,-2.66558007804653,0.285140848318068,0.28797077226468,0.2758425267792,-0.0121282454854807,0.0143025349647432,-1.13072264798343,8.3819460310499,8.39347394621717,8.3440685955003,-0.0494053507168709,0.367917032326615,ENSG00000231925,TAPBP,protein_coding,6,-1,33299694,33314387,p21.32,TAP binding protein [Source:HGNC Symbol;Acc:HGNC:11566],BARE LYMPHOCYTE SYNDROME TYPE I;Immunodeficiency by defective expression of HLA class 1,TAPBP,6892,NM_003190;NM_172208;NM_172209
ALDOA_SIG,ALDOA,ALDOA_SIG,ALDOA,SIG,41,-2.6646812435015,0.226587755589425,0.23110757071886,0.211736934449853,-0.0193706362690074,0.0143375949690914,-1.24361951851421,9.73364524565441,9.74750520536656,9.68810537802879,-0.0593998273377673,0.318112291143967,ENSG00000149925,ALDOA,protein_coding,16,1,30064164,30070457,p11.2,aldolase, fructose-bisphosphate A [Source:HGNC Symbol;Acc:HGNC:414],Glycogen storage disease due to aldolase A deficiency;GLYCOGEN STORAGE DISEASE XII,ALDOA,226,NM_000034;NM_001127617;NM_001243177;NM_001355562;NM_001355563;NM_001355564;NM_001355565;NM_184041;NM_184043
FZD6_SIG,FZD6,FZD6_SIG,FZD6,SIG,60,-2.66459639045862,-0.0802793498359242,-0.0748724020898598,-0.0980450352872786,-0.023172633197419,0.0143379928538195,-1.65468162048744,2.61085385436631,2.67846690096249,2.38869670126456,-0.28977019969793,0.175194561409219,ENSG00000164930,FZD6,protein_coding,8,1,103298433,103332866,q22.3,frizzled class receptor 6 [Source:HGNC Symbol;Acc:HGNC:4044],Autosomal recessive nail dysplasia;NAIL DISORDER NON-SYNDROMIC CONGENITAL TYPE 10;NAIL DISORDER NONSYNDROMIC CONGENITAL 10,FZD6,8323,NM_001164615;NM_001164616;NM_001317796;NM_003506
ZNF326_TF,ZNF326,ZNF326_TF,ZNF326,TF,371,2.66315598511048,0.128297744445275,0.120746041885751,0.153110481426566,0.0323644395408145,0.0143936227473004,2.70420650601352,6.4476639711995,6.39897080400886,6.60765580625446,0.208685002245595,0.0221992454575122,ENSG00000162664,ZNF326,protein_coding,1,1,89995110,90035533,p22.2,zinc finger protein 326 [Source:HGNC Symbol;Acc:HGNC:14104],NA,ZNF326,284695,NM_001320185;NM_181781;NM_182975;NM_182976
THAP10_TF,THAP10,THAP10_TF,THAP10,TF,137,2.66306258016138,-0.0765769633950968,-0.0803184114249056,-0.0642836341542964,0.0160347772706091,0.0143936227473004,1.81699462057387,0.393270479458521,0.367994775708942,0.476319220349998,0.108324444641056,0.134290207145225,ENSG00000129028,THAP10,protein_coding,15,-1,70881342,70892433,q23,THAP domain containing 10 [Source:HGNC Symbol;Acc:HGNC:23193],NA,THAP10,56906,NM_020147
JRK_TF,JRK,JRK_TF,JRK,TF,7,2.66301330743716,-0.150582091179547,-0.16404262103035,-0.10635463595548,0.0576879850748706,0.0143936227473004,2.30288394131086,4.59535681073287,4.54448782042076,4.76249777890123,0.218009958480471,0.0536388967133625,ENSG00000234616,JRK,protein_coding,8,-1,142657460,142681968,q24.3,Jrk helix-turn-helix protein [Source:HGNC Symbol;Acc:HGNC:6199],Childhood absence epilepsy;Juvenile myoclonic epilepsy,JRK,8629,NM_001077527;NM_001279352;NM_003724
ABHD10_SIG,ABHD10,ABHD10_SIG,ABHD10,SIG,12,2.66299167433387,0.416661507829251,0.40663348883536,0.449610713094894,0.042977224259534,0.0143936227473004,2.50043760292927,4.62989263941723,4.5851577581223,4.77687867795773,0.191720919835434,0.0352589128939892,ENSG00000144827,ABHD10,protein_coding,3,1,111979010,111993368,q13.2,abhydrolase domain containing 10 [Source:HGNC Symbol;Acc:HGNC:25656],NA,ABHD10,55347,NM_001272069;NM_018394
ZNF548_TF,ZNF548,ZNF548_TF,ZNF548,TF,53,2.66221422286692,0.20227187070516,0.196302845548654,0.221884381933678,0.0255815363850244,0.0144236770269368,0.22977044842854,4.73042023277659,4.72608669765085,4.74465899104686,0.0185722933960104,0.870363302629774,ENSG00000188785,ZNF548,protein_coding,19,1,57389850,57402992,q13.43,zinc finger protein 548 [Source:HGNC Symbol;Acc:HGNC:26561],NA,ZNF548,147694,NM_001172773;NM_152909
NTAN1_SIG,NTAN1,NTAN1_SIG,NTAN1,SIG,11,-2.66142935012668,0.150364292811688,0.155231150032713,0.134373190514034,-0.0208579595186791,0.0144541053910214,-1.91015718662351,4.76674182367878,4.79730872400612,4.66630772260322,-0.131001001402895,0.114243693280894,ENSG00000157045,NTAN1,protein_coding,16,-1,15037854,15056079,p13.11,N-terminal asparagine amidase [Source:HGNC Symbol;Acc:HGNC:29909],NA,NTAN1,123803,NM_001270766;NM_001270767;NM_173474
GLUL_SIG,GLUL,GLUL_SIG,GLUL,SIG,14,-2.66084036344932,0.299009090333672,0.305123304878362,0.278919528258261,-0.0262037766201009,0.0144761668613055,-1.84528613580972,9.62864066574058,9.66735412834212,9.50143928862125,-0.165914839720862,0.12783670367648,ENSG00000135821,GLUL,protein_coding,1,-1,182381704,182392206,q25.3,glutamate-ammonia ligase [Source:HGNC Symbol;Acc:HGNC:4341],Congenital brain dysgenesis due to glutamine synthetase deficiency;CONGENITAL SYSTEMIC GLUTAMINE DEFICIENCY;GLUTAMINE DEFICIENCY CONGENITAL,GLUL,2752,NM_001033044;NM_001033056;NM_002065
NR4A2_TF,NR4A2,NR4A2_TF,NR4A2,TF,38,-2.66071924643993,0.20929466834603,0.217411222836671,0.182625989305354,-0.0347852335313174,0.0144781292099961,-1.5234981682641,5.9316739661651,6.00044926391357,5.70569798784868,-0.294751276064892,0.214211829722621,ENSG00000153234,NR4A2,protein_coding,2,-1,156324437,156342348,q24.1,nuclear receptor subfamily 4 group A member 2 [Source:HGNC Symbol;Acc:HGNC:7981],Parkinson disease late-onset,NR4A2,4929,NM_006186
TACR2_SIG,TACR2,TACR2_SIG,TACR2,SIG,27,-2.66019153140704,-0.0602704857461577,-0.0563122868117067,-0.0732759965307825,-0.0169637097190757,0.0144975854982021,-0.313670933382077,0.285381205525684,0.288007459469645,0.276752085424095,-0.0112553740455507,0.819707992919696,ENSG00000075073,TACR2,protein_coding,10,-1,69403903,69416867,q22.1,tachykinin receptor 2 [Source:HGNC Symbol;Acc:HGNC:11527],NA,TACR2,6865,NM_001057
CD82_SIG,CD82,CD82_SIG,CD82,SIG,32,2.65984627288503,0.107339326970717,0.101806141549969,0.125519793353176,0.0237136518032074,0.0145092034829339,0.527698789487207,7.31925059826285,7.30728522610388,7.35856539249944,0.051280166395551,0.693696551328793,ENSG00000085117,CD82,protein_coding,11,1,44564427,44620358,p11.2,CD82 molecule [Source:HGNC Symbol;Acc:HGNC:6210],Prostate Cancer,CD82,3732,NM_001024844;NM_002231
MECP2_SIG,MECP2,MECP2_SIG,MECP2,SIG,50,2.65957770254682,0.317658621651378,0.313902912941256,0.329998807413205,0.016095894471949,0.0145160039841784,2.63694969014233,6.40959639334195,6.37585411506734,6.5204638791014,0.144609764034058,0.0258306471049102,ENSG00000169057,MECP2,protein_coding,X,-1,154021573,154137103,q28,methyl-CpG binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6990],Atypical Rett syndrome;AUTISM SUSCEPTIBILITY TO X-LINKED 3;Chromosome Xq28 duplication syndrome;ENCEPHALOPATHY NEONATAL SEVERE DUE TO MECP2 MUTATIONS;LUBS X-LINKED MENTAL RETARDATION SYNDROME;MENTAL RETARDATION SYNDROMIC X-LINKED LUBS TYPE;MENTAL RETARDATION SYNDROMIC X-LINKED TYPE 13;MENTAL RETARDATION X-LINKED SYNDROMIC 13;Rett Syndrome;Rett syndrome (RTT);Severe neonatal-onset encephalopathy with microcephaly;Systemic lupus erythematosus;Trisomy Xq28;X-linked intellectual disability-psychosis-macroorchidism syndrome;X-linked non-syndromic intellectual disability,MECP2,4204,NM_001110792;NM_001316337;NM_004992
HLTF_SIG,HLTF,HLTF_SIG,HLTF,SIG,62,2.65950831139562,0.3018083275803,0.292366028085104,0.332833025921659,0.0404669978365552,0.0145160039841784,1.566441390823,4.73219370457513,4.69063091952053,4.86875714118311,0.17812622166258,0.200744591313686,ENSG00000071794,HLTF,protein_coding,3,-1,149030127,149086554,q24,helicase like transcription factor [Source:HGNC Symbol;Acc:HGNC:11099],NA,HLTF,6596,NM_001318934;NM_001318935;NM_003071;NM_139048
SNX27_SIG,SNX27,SNX27_SIG,SNX27,SIG,113,-2.65946213119518,0.324376990692387,0.334195258869622,0.292116966681472,-0.0420782921881501,0.0145160039841784,-1.39180184368676,5.66484901566379,5.69465055909552,5.56692965867382,-0.127720900421702,0.259717479163028,ENSG00000143376,SNX27,protein_coding,1,1,151612006,151699091,q21.3,sorting nexin family member 27 [Source:HGNC Symbol;Acc:HGNC:20073],NA,SNX27,81609,NM_001330723;NM_030918
SCLT1_SIG,SCLT1,SCLT1_SIG,SCLT1,SIG,24,-2.65804657203021,0.166678938973188,0.17154510648202,0.150690102872738,-0.0208550036092827,0.0145738548340087,-0.496913409483718,4.43594649900811,4.44281624012132,4.41337449249327,-0.0294417476280486,0.711430469594962,ENSG00000151466,SCLT1,protein_coding,4,-1,128864921,129093600,q28.2,sodium channel and clathrin linker 1 [Source:HGNC Symbol;Acc:HGNC:26406],NA,SCLT1,132320,NM_001300897;NM_001300898;NM_144643
CD151_SIG,CD151,CD151_SIG,CD151,SIG,55,2.65774141241398,0.215708021425047,0.212293345723641,0.226927670158236,0.014634324434595,0.0145837925272534,1.60134665871746,5.31988161890213,5.27907324240987,5.45396628451957,0.174893042109694,0.190207098673494,ENSG00000177697,CD151,protein_coding,11,1,832887,839831,p15.5,CD151 molecule (Raph blood group) [Source:HGNC Symbol;Acc:HGNC:1630],nephropathy with pretibial epidermolysis bullosa and deafness;Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome;RAPH BLOOD GROUP SYSTEM,CD151,977,NM_001039490;NM_004357;NM_139029;NM_139030
CXCL11_SIG,CXCL11,CXCL11_SIG,CXCL11,SIG,9,-2.6571431078398,-0.0530259217695374,-0.0475886893830078,-0.0708911138967062,-0.0233024245136983,0.0146064331527441,-1.61316979545056,0.220625866261201,0.238547385345709,0.161740874983531,-0.0768065103621785,0.186877454082616,ENSG00000169248,CXCL11,protein_coding,4,-1,76033682,76041415,q21.1,C-X-C motif chemokine ligand 11 [Source:HGNC Symbol;Acc:HGNC:10638],NA,CXCL11,6373,NM_001302123;NM_005409
USP15_SIG,USP15,USP15_SIG,USP15,SIG,15,-2.65658255801861,0.192295561107508,0.199037688138357,0.170142858006146,-0.0288948301322103,0.0146274668326617,0.0334769059570863,7.42057709970696,7.42007635741343,7.42222239581424,0.00214603840080486,0.981936804885327,ENSG00000135655,USP15,protein_coding,12,1,62260338,62417431,q14.1,ubiquitin specific peptidase 15 [Source:HGNC Symbol;Acc:HGNC:12613],NA,USP15,9958,NM_001252078;NM_001252079;NM_001351159;NM_001351160;NM_001351163;NM_001351164;NM_001351165;NM_001351166;NM_006313
PELI1_SIG,PELI1,PELI1_SIG,PELI1,SIG,45,-2.65649625848833,0.256228012007229,0.269174152063208,0.213690694680442,-0.0554834573827655,0.0146279395142022,-1.10552686703949,6.23849593250911,6.28446659343574,6.08744947517876,-0.197017118256983,0.379790084213712,ENSG00000197329,PELI1,protein_coding,2,-1,64092652,64144420,p14,pellino E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:8827],NA,PELI1,57162,NM_020651
TCEANC2_TF,TCEANC2,TCEANC2_TF,TCEANC2,TF,188,2.65512645397452,0.173609902426412,0.164659528863052,0.203018272706026,0.0383587438429736,0.0146841916436604,2.48561595731231,4.23042312719221,4.178270305814,4.40178239743488,0.223512091620878,0.0364443594899827,ENSG00000116205,TCEANC2,protein_coding,1,1,54053584,54112519,p32.3,transcription elongation factor A N-terminal and central domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26494],NA,TCEANC2,127428,NM_153035
GTPBP1_SIG,GTPBP1,GTPBP1_SIG,GTPBP1,SIG,47,-2.65503526286445,0.074722257953597,0.081900663500296,0.0511360683001571,-0.0307645952001388,0.0146848788778758,-2.61308610197213,6.34463301108195,6.38799037105693,6.20217311402127,-0.18581725703566,0.0273217890285264,ENSG00000100226,GTPBP1,protein_coding,22,1,38705742,38738299,q13.1,GTP binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4669],NA,GTPBP1,9567,NM_004286
ZNF429_TF,ZNF429,ZNF429_TF,ZNF429,TF,26,2.65324301171407,-0.0952904681931297,-0.101851935209199,-0.0737313622831863,0.0281205729260132,0.0147597880012412,1.94051066545144,3.05883228917011,3.01041553097334,3.21791592324523,0.207500392271884,0.108212877887674,ENSG00000197013,ZNF429,protein_coding,19,1,21496682,21556270,p12,zinc finger protein 429 [Source:HGNC Symbol;Acc:HGNC:20817],NA,ZNF429,353088,NM_001001415;NM_001346912;NM_001346913;NM_001346914;NM_001346915;NM_001346916
METTL14_SIG,METTL14,METTL14_SIG,METTL14,SIG,72,2.65307672842804,0.379039295757019,0.374671533777754,0.39339051368889,0.0187189799111356,0.0147637621588629,2.45654927973799,4.64732406941142,4.61795309995361,4.74382868334421,0.125875583390599,0.0388308060370652,ENSG00000145388,METTL14,protein_coding,4,1,118685392,118715433,q26,methyltransferase like 14 [Source:HGNC Symbol;Acc:HGNC:29330],NA,METTL14,57721,NM_020961
ELF3_TF,ELF3,ELF3_TF,ELF3,TF,185,-2.65266731028023,-0.0734169410723784,-0.0694299062777735,-0.0865171982546517,-0.0170872919768782,0.0147783783184822,-1.51628781254732,1.2372770743899,1.26555287677731,1.14437086654558,-0.121182010231727,0.2167050523274,ENSG00000163435,ELF3,protein_coding,1,1,202007945,202017183,q32.1,E74 like ETS transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:3318],NA,ELF3,1999,NM_001114309;NM_004433
NFIC_TF,NFIC,NFIC_TF,NFIC,TF,82,2.65230299907257,0.0742899714087182,0.0723536199115328,0.0806522691851845,0.00829864927365171,0.0147910311260883,3.18417925016709,6.34247718209322,6.297730508751,6.48950196593197,0.191771457180973,0.00663191738038642,ENSG00000141905,NFIC,protein_coding,19,1,3314403,3469217,p13.3,nuclear factor I C [Source:HGNC Symbol;Acc:HGNC:7786],NA,NFIC,4782,NM_001245002;NM_001245004;NM_001245005;NM_005597;NM_205843
DDX41_SIG,DDX41,DDX41_SIG,DDX41,SIG,11,2.65221396977874,0.370467445125233,0.365169447351523,0.387875152095993,0.0227057047444702,0.0147916288462942,3.16655203158399,6.40829314574331,6.37833175401797,6.50673771855514,0.128405964537164,0.00693871216441687,ENSG00000183258,DDX41,protein_coding,5,-1,177511577,177516961,q35.3,DEAD-box helicase 41 [Source:HGNC Symbol;Acc:HGNC:18674],DDX41-related hematologic malignancy predisposition syndrome;MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS FAMILIAL (MULTIPLE TYPES) SUSCEPTIBILITY TO,DDX41,51428,NM_001321732;NM_001321830;NM_016222
PPP2R5D_SIG,PPP2R5D,PPP2R5D_SIG,PPP2R5D,SIG,19,2.65192759837277,0.481754182384008,0.473533045749086,0.508766488470181,0.0352334427210949,0.0148008754050653,3.49778625740769,5.73301171974416,5.69020783436481,5.87365305741917,0.183445223054362,0.00272266342295484,ENSG00000112640,PPP2R5D,protein_coding,6,1,42984553,43012342,p21.1,protein phosphatase 2 regulatory subunit B'delta [Source:HGNC Symbol;Acc:HGNC:9312],Intellectual disability;Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome;MENTAL RETARDATION AUTOSOMAL DOMINANT 35,PPP2R5D,5528,NM_001270476;NM_006245;NM_180976;NM_180977
TSFM_SIG,TSFM,TSFM_SIG,TSFM,SIG,24,2.6515126616392,0.407883515417119,0.402354142890139,0.426051453720053,0.023697310829914,0.0148157669845124,2.74068673161791,3.27411350375062,3.2379262547286,3.39301446482296,0.155088210094361,0.0203324532229187,ENSG00000123297,TSFM,protein_coding,12,1,57782589,57808071,q14.1,Ts translation elongation factor, mitochondrial [Source:HGNC Symbol;Acc:HGNC:12367],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3;Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,TSFM,10102,NM_001172695;NM_001172696;NM_001172697;NM_005726
PRDM1_SIG,PRDM1,PRDM1_SIG,PRDM1,SIG,28,-2.65106586670972,0.0588915856621297,0.0680371867157441,0.0288417536288252,-0.0391954330869188,0.0148320709511165,-1.27619828784942,4.07725200977055,4.12471568338063,3.92129993933743,-0.2034157440432,0.304602117485277,ENSG00000057657,PRDM1,protein_coding,6,1,105993463,106109939,q21,PR/SET domain 1 [Source:HGNC Symbol;Acc:HGNC:9346],NA,PRDM1,639,NM_001198;NM_182907
ZKSCAN7_TF,ZKSCAN7,ZKSCAN7_TF,ZKSCAN7,TF,22,2.65037251732084,0.0540098420490085,0.043486532266254,0.0885864313352018,0.0450998990689478,0.0148592323842339,1.92083039515909,2.11572010033923,2.06297411862274,2.28902832597911,0.226054207356366,0.112145863420601,ENSG00000196345,ZKSCAN7,protein_coding,3,1,44555193,44594173,p21.31,zinc finger with KRAB and SCAN domains 7 [Source:HGNC Symbol;Acc:HGNC:12955],NA,ZKSCAN7,55888,NM_001288590;NM_001288591;NM_001288592;NM_018651;NM_025169
ERCC4_SIG,ERCC4,ERCC4_SIG,ERCC4,SIG,82,2.64973518371489,0.237650059811752,0.228216654796468,0.2686455334334,0.0404288786369314,0.0148839700028286,2.78533964854963,3.38037192008234,3.32817119614428,3.55188858445026,0.22371738830598,0.0183078374374206,ENSG00000175595,ERCC4,protein_coding,16,1,13920157,13952345,p13.12,ERCC excision repair 4, endonuclease catalytic subunit [Source:HGNC Symbol;Acc:HGNC:3436],Cockayne syndrome type 1;Fanconi anemia;Fanconi anemia complementation group Q;Primordial Dwarfism;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP F;Xeroderma pigmentosum group F;XFE PROGEROID SYNDROME,ERCC4,2072,NM_005236
ARHGAP17_SIG,ARHGAP17,ARHGAP17_SIG,ARHGAP17,SIG,36,2.64958767880924,0.163171923704392,0.158110988310786,0.179800711426243,0.0216897231154578,0.0148871489432614,2.09845826656729,5.83203830765653,5.80201672539506,5.93068064937278,0.128663923977724,0.0805826211627752,ENSG00000140750,ARHGAP17,protein_coding,16,-1,24919389,25015666,p12.1,Rho GTPase activating protein 17 [Source:HGNC Symbol;Acc:HGNC:18239],NA,ARHGAP17,55114,NM_001006634;NM_018054
NDST1_SIG,NDST1,NDST1_SIG,NDST1,SIG,10,-2.64836107949189,0.217299776200377,0.224175284104257,0.194708821659057,-0.0294664624452001,0.0149379481252211,-3.47105029442749,6.21362486634043,6.2811529285803,5.99174694755229,-0.289405981028017,0.00293124903771739,ENSG00000070614,NDST1,protein_coding,5,1,150485818,150558211,q33.1,N-deacetylase and N-sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:7680],Autosomal Recessive Mental Retardation;Autosomal recessive non-syndromic intellectual disability;Mental retardation autosomal recessive 46,NDST1,3340,NM_001301063;NM_001543
RAP2A_SIG,RAP2A,RAP2A_SIG,RAP2A,SIG,31,-2.64795716189365,0.1155790298293,0.118458482287064,0.106117971753789,-0.0123405105332746,0.0149524744092678,-1.05917935081003,4.87458422052306,4.89515441934211,4.80699642440329,-0.0881579949388226,0.401684387328069,ENSG00000125249,RAP2A,protein_coding,13,1,97434169,97469128,q32.1,RAP2A, member of RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9861],NA,RAP2A,5911,NM_021033
NCR3_SIG,NCR3,NCR3_SIG,NCR3,SIG,16,-2.64752813024821,-0.157173307490394,-0.146086124521907,-0.193602622958279,-0.0475164984363714,0.0149681250780435,-0.0832782805177026,1.26010644215422,1.26181361924108,1.25449714601167,-0.00731647322941214,0.954059176410303,ENSG00000204475,NCR3,protein_coding,6,-1,31588895,31593006,p21.33,natural cytotoxicity triggering receptor 3 [Source:HGNC Symbol;Acc:HGNC:19077],MALARIA MILD SUSCEPTIBILITY TO,NCR3,259197,NM_001145466;NM_001145467;NM_147130
ADPRHL2_SIG,ADPRHL2,ADPRHL2_SIG,ADPRHL2,SIG,16,2.6463332376868,0.219728488767713,0.215411746835617,0.233912069401742,0.0185003225661254,0.0150177601746322,2.78294694998988,4.24871040081729,4.21678909689038,4.35359468514857,0.136805588258185,0.0184137265051147,ENSG00000116863,ADPRHL2,protein_coding,1,1,36088892,36093932,p34.3,ADP-ribosylhydrolase like 2 [Source:HGNC Symbol;Acc:HGNC:21304],NEURODEGENERATION CHILDHOOD-ONSET STRESS-INDUCED WITH VARIABLEATAXIA AND SEIZURES,ADPRHL2,54936,NM_017825
WDR53_SIG,WDR53,WDR53_SIG,WDR53,SIG,19,2.64553334906429,0.156326038000721,0.152962073843274,0.167379063089477,0.0144169892462027,0.0150499602577534,2.25748999162945,3.52452015165545,3.50267939181338,3.5962826482794,0.0936032564660176,0.0589994157580388,ENSG00000185798,WDR53,protein_coding,3,-1,196554177,196568674,q29,WD repeat domain 53 [Source:HGNC Symbol;Acc:HGNC:28786],NA,WDR53,348793,NM_001345906;NM_001345907;NM_001345908;NM_001345909;NM_001345910;NM_001345911;NM_001345912;NM_001345913;NM_001345914;NM_001345915;NM_001345917;NM_001345918;NM_182627
EPS8L1_SIG,EPS8L1,EPS8L1_SIG,EPS8L1,SIG,50,2.64422812054278,-0.0789721963100165,-0.0838201566361517,-0.063043183809858,0.0207769728262938,0.0151047585858621,3.77832388039767,1.73201645392652,1.63512875402773,2.05036175359394,0.415232999566209,0.0011522842840955,ENSG00000131037,EPS8L1,protein_coding,19,1,55072020,55087923,q13.42,EPS8 like 1 [Source:HGNC Symbol;Acc:HGNC:21295],NA,EPS8L1,54869,NM_017729;NM_133180
PLCB1_SIG,PLCB1,PLCB1_SIG,PLCB1,SIG,48,2.64335476334132,0.0976122327012984,0.0915293433705629,0.117598869073715,0.0260695257031521,0.0151379270569395,1.05675773889129,4.31694758384732,4.28586030037923,4.41909151524248,0.133231214863253,0.402800170540008,ENSG00000182621,PLCB1,protein_coding,20,1,8077251,8968360,p12.3,phospholipase C beta 1 [Source:HGNC Symbol;Acc:HGNC:15917],Epileptic Encephalopathy Early Infantile 12;Malignant migrating partial seizures of infancy;West syndrome,PLCB1,23236,NM_015192;NM_182734
COLQ_SIG,COLQ,COLQ_SIG,COLQ,SIG,41,2.64333489851132,-0.0283264315130097,-0.0321460407757777,-0.0157762867924863,0.0163697539832912,0.0151379270569395,1.20234113075657,2.30825231172097,2.28369987611779,2.38892460013143,0.105224724013636,0.335854057430201,ENSG00000206561,COLQ,protein_coding,3,-1,15450133,15521751,p25.1,collagen like tail subunit of asymmetric acetylcholinesterase [Source:HGNC Symbol;Acc:HGNC:2226],MYASTHENIC SYNDROME CONGENITAL 5;Synaptic congenital myasthenic syndromes,COLQ,8292,NM_005677;NM_080538;NM_080539
TP53_SIG,TP53,TP53_SIG,TP53,SIG,45,2.64298980890673,0.470432920620016,0.457310012442417,0.51355104748927,0.0562410350468528,0.0151499924240969,2.65857358360376,5.78067325259004,5.70391432063822,6.0328811718603,0.328966851222082,0.024612964097939,ENSG00000141510,TP53,protein_coding,17,-1,7661779,7687550,p13.1,tumor protein p53 [Source:HGNC Symbol;Acc:HGNC:11998],Adrenocortical carcinoma;ADRENOCORTICAL CARCINOMA HEREDITARY;Adult hepatocellular carcinoma;B-cell chronic lymphocytic leukemia;BASAL CELL CARCINOMA SUSCEPTIBILITY TO 7;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;Choroid plexus carcinoma;Colorectal Cancer;Essential thrombocythemia;Familial pancreatic carcinoma;Giant cell glioblastoma;GLIOMA SUSCEPTIBILITY 1;Gliosarcoma;Hepatocellular Carcinoma;Hereditary breast and ovarian cancer syndrome;Li-Fraumeni syndrome;NASOPHARYNGEAL CARCINOMA;OSTEOGENIC SARCOMA;OSTEOSARCOMA;Pancreatic Cancer;PAPILLOMA OF CHOROID PLEXUS;Precursor B-cell acute lymphoblastic leukemia;Small cell lung cancer,TP53,7157,NM_000546;NM_001126112;NM_001126113;NM_001126114;NM_001126115;NM_001126116;NM_001126117;NM_001126118;NM_001276695;NM_001276696;NM_001276697;NM_001276698;NM_001276699;NM_001276760;NM_001276761
EIF2B3_SIG,EIF2B3,EIF2B3_SIG,EIF2B3,SIG,36,2.6421775857788,0.176014030371895,0.165648003441629,0.210073833142769,0.0444258297011395,0.0151829955178154,2.93905928214419,3.36247125367765,3.30494464787587,3.5514872441692,0.246542596293328,0.0125995827559209,ENSG00000070785,EIF2B3,protein_coding,1,-1,44850522,44986722,p34.1,eukaryotic translation initiation factor 2B subunit gamma [Source:HGNC Symbol;Acc:HGNC:3259],Congenital or early infantile CACH syndrome;Cree leukoencephalopathy;Juvenile or adult CACH syndrome;Late infantile CACH syndrome;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER;OVARIOLEUKODYSTROPHY,EIF2B3,8891,NM_001166588;NM_001261418;NM_020365
SLC39A14_SIG,SLC39A14,SLC39A14_SIG,SLC39A14,SIG,11,2.64113066165004,0.360747598011168,0.351756796991979,0.39028880135993,0.0385320043679511,0.0152266073955717,2.93494494784147,3.29543476985016,3.21066074018991,3.57397801016241,0.363317269972498,0.0127230796657694,ENSG00000104635,SLC39A14,protein_coding,8,1,22367249,22434129,p21.3,solute carrier family 39 member 14 [Source:HGNC Symbol;Acc:HGNC:20858],Dystonia-parkinsonism-hypermanganesemia syndrome;HYPERMANGANESEMIA WITH DYSTONIA 2;HYPEROSTOSIS CRANIALIS INTERNA,SLC39A14,23516,NM_001128431;NM_001135153;NM_001135154;NM_001351655;NM_001351656;NM_001351657;NM_001351658;NM_001351659;NM_001351660;NM_015359
PYGM_SIG,PYGM,PYGM_SIG,PYGM,SIG,33,-2.63963683553495,-0.0690195955448467,-0.0652126235663383,-0.0815282177599459,-0.0163155941936075,0.0152904789214721,-2.23661695974824,2.08195729676889,2.12747642311325,1.93239445306601,-0.195081970047237,0.0615849254955884,ENSG00000068976,PYGM,protein_coding,11,-1,64746389,64759974,q13.1,glycogen phosphorylase, muscle associated [Source:HGNC Symbol;Acc:HGNC:9726],Glycogen storage disease due to muscle glycogen phosphorylase deficiency;GLYCOGEN STORAGE DISEASE V,PYGM,5837,NM_001164716;NM_005609
ZSCAN22_TF,ZSCAN22,ZSCAN22_TF,ZSCAN22,TF,24,2.63855614757853,0.0858668224351328,0.0759403013539128,0.118482534559141,0.0425422332052288,0.0153358907707639,2.94306555611698,2.07815003679878,2.0290219078899,2.2395710317851,0.210549123895207,0.0124606430079173,ENSG00000182318,ZSCAN22,protein_coding,19,1,58326994,58342332,q13.43,zinc finger and SCAN domain containing 22 [Source:HGNC Symbol;Acc:HGNC:4929],NA,ZSCAN22,342945,NM_001321116;NM_001321117;NM_181846
ZNF587B_TF,ZNF587B,ZNF587B_TF,ZNF587B,TF,116,2.63695106380145,0.203445431580173,0.19848309950241,0.219750236978536,0.0212671374761263,0.0154052197490271,3.56272117598291,3.91432869013715,3.84994610695924,4.12587146343601,0.275925356476773,0.00223934661372794,ENSG00000269343,ZNF587B,protein_coding,19,1,57819721,57846238,q13.43,zinc finger protein 587B [Source:HGNC Symbol;Acc:HGNC:37142],NA,ZNF587B,100293516,NM_001204818
ZSCAN25_TF,ZSCAN25,ZSCAN25_TF,ZSCAN25,TF,77,2.63649899839506,0.306067334366257,0.302568540788528,0.317563370407368,0.0149948296188402,0.0154204556170166,2.95282639817201,4.8137810072871,4.77398027384064,4.94455484575406,0.170574571913416,0.0121590995369222,ENSG00000197037,ZSCAN25,protein_coding,7,1,99616946,99632408,q22.1,zinc finger and SCAN domain containing 25 [Source:HGNC Symbol;Acc:HGNC:21961],NA,ZSCAN25,221785,NM_001350979;NM_001350980;NM_001350981;NM_001350982;NM_001350983;NM_001350984;NM_001350985;NM_001350986;NM_145115
TNFRSF19_SIG,TNFRSF19,TNFRSF19_SIG,TNFRSF19,SIG,39,2.63646493125605,-0.0779342698058322,-0.0829079642800922,-0.0615921308189781,0.0213158334611141,0.0154204556170166,2.35829109823517,1.03096105699933,0.957508196697232,1.27230616942052,0.314797972723287,0.0478934316045529,ENSG00000127863,TNFRSF19,protein_coding,13,1,23570370,23676104,q12.12,TNF receptor superfamily member 19 [Source:HGNC Symbol;Acc:HGNC:11915],NA,TNFRSF19,55504,NM_001204458;NM_001204459;NM_001354985;NM_018647;NM_148957
CTSE_SIG,CTSE,CTSE_SIG,CTSE,SIG,20,-2.63554346578622,-0.139130661110923,-0.123310612070733,-0.191110822242976,-0.0678002101722428,0.015458953597871,-2.67234070743111,0.865913050821628,0.956845644543185,0.567134528593654,-0.389711115949531,0.0238780828542834,ENSG00000196188,CTSE,protein_coding,1,-1,206009264,206023895,q32.1,cathepsin E [Source:HGNC Symbol;Acc:HGNC:2530],NA,CTSE,1510,NM_001317331;NM_001910;NM_148964
RNF216_SIG,RNF216,RNF216_SIG,RNF216,SIG,20,2.63512891309597,0.400650175247824,0.397847385590191,0.409859341265761,0.01201195567557,0.0154744101949303,3.07211775616693,6.16051467858033,6.12487209293937,6.27762603140061,0.152753938461241,0.00892919386064075,ENSG00000011275,RNF216,protein_coding,7,-1,5620047,5781739,p22.1,ring finger protein 216 [Source:HGNC Symbol;Acc:HGNC:21698],Cerebellar ataxia-hypogonadism syndrome;GORDON HOLMES SYNDROME,RNF216,54476,NM_207111;NM_207116
KMT2A_SIG,KMT2A,KMT2A_SIG,KMT2A,SIG,72,2.63479179985011,0.166554582181668,0.161167718477824,0.184254277208584,0.0230865587307599,0.0154832758489738,1.91108291546737,7.69362175283039,7.66078771830213,7.80150500913754,0.14071729083541,0.114070766734611,ENSG00000118058,KMT2A,protein_coding,11,1,118436464,118526832,q23.3,lysine methyltransferase 2A [Source:HGNC Symbol;Acc:HGNC:7132],Acute biphenotypic leukemia;Acute myeloid leukemia with 11q23 abnormalities;Acute myeloid leukemia with t(9;11)(p22;q23);Acute undifferentiated leukemia;Bilineal acute leukemia;Cornelia de Lange syndrome;Precursor B-cell acute lymphoblastic leukemia;Wiedemann-Steiner syndrome,KMT2A,4297,NM_001197104;NM_005933
RBFOX2_SIG,RBFOX2,RBFOX2_SIG,RBFOX2,SIG,116,2.63478377257113,-0.135662902056296,-0.139058850210356,-0.124504786692956,0.0145540635174002,0.0154832758489738,1.90477233243527,2.0890282007639,2.01456344998668,2.33369809617475,0.319134646188075,0.115372385593543,ENSG00000100320,RBFOX2,protein_coding,22,-1,35738736,36028824,q12.3,RNA binding fox-1 homolog 2 [Source:HGNC Symbol;Acc:HGNC:9906],NA,RBFOX2,23543,NM_001031695;NM_001082576;NM_001082577;NM_001082578;NM_001082579;NM_001349982;NM_001349983;NM_001349989;NM_001349990;NM_001349991;NM_001349992;NM_001349994;NM_001349995;NM_001349996;NM_001349997;NM_001349998;NM_001349999;NM_014309
ARHGAP12_SIG,ARHGAP12,ARHGAP12_SIG,ARHGAP12,SIG,28,-2.63415180257001,0.0153782719970421,0.0189240951136787,0.00372771032809346,-0.0151963847855852,0.0155086829878076,-1.65586772614295,4.47653146586226,4.51030669076426,4.36555572689857,-0.144750963865684,0.174861740338503,ENSG00000165322,ARHGAP12,protein_coding,10,-1,31805404,31928876,p11.22,Rho GTPase activating protein 12 [Source:HGNC Symbol;Acc:HGNC:16348],NA,ARHGAP12,94134,NM_001270695;NM_001270696;NM_001270697;NM_001270698;NM_001270699;NM_018287
POMGNT2_SIG,POMGNT2,POMGNT2_SIG,POMGNT2,SIG,47,-2.63342839535915,-0.0860242723038566,-0.0822593745544313,-0.098394650623397,-0.0161352760689656,0.0155383101246205,-1.66620381107017,2.67998902671731,2.71346670444752,2.5699909427466,-0.143475761700922,0.172037823158694,ENSG00000144647,POMGNT2,protein_coding,3,-1,43079232,43106079,p22.1,protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) [Source:HGNC Symbol;Acc:HGNC:25902],MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 8;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 8;Walker-Warburg syndrome;WALKER WARBERG SYNDROME,POMGNT2,84892,NM_032806
DHX29_SIG,DHX29,DHX29_SIG,DHX29,SIG,14,2.63277290561839,0.394978617296242,0.392426514880985,0.403364096660658,0.0109375817796727,0.0155634340547138,3.31857847615698,5.57350496116747,5.54457148734172,5.66857208945207,0.124000602110353,0.00456153320071202,ENSG00000067248,DHX29,protein_coding,5,-1,55256055,55307694,q11.2,DExH-box helicase 29 [Source:HGNC Symbol;Acc:HGNC:15815],NA,DHX29,54505,NM_001345964;NM_001345965;NM_019030
FOXK2_TF,FOXK2,FOXK2_TF,FOXK2,TF,42,2.63272900474999,0.478238389643388,0.474391408589602,0.490878470248685,0.0164870616590831,0.0155634340547138,2.75712427528147,6.18031708750041,6.14951198098965,6.28153386603576,0.132021885046109,0.0196036414227878,ENSG00000141568,FOXK2,protein_coding,17,1,82519713,82644662,q25.3,forkhead box K2 [Source:HGNC Symbol;Acc:HGNC:6036],NA,FOXK2,3607,NM_004514
SETDB1_SIG,SETDB1,SETDB1_SIG,SETDB1,SIG,45,2.63238234451439,0.317289966364688,0.307431331306141,0.3496826244142,0.0422512931080595,0.0155758706188683,1.92125412569204,6.19618221505254,6.16961137498594,6.28348640384279,0.113875028856853,0.112073975843071,ENSG00000143379,SETDB1,protein_coding,1,1,150926263,150964744,q21.3,SET domain bifurcated histone lysine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10761],NA,SETDB1,9869,NM_001145415;NM_001243491;NM_001366417;NM_001366418;NM_012432
MCRS1_SIG,MCRS1,MCRS1_SIG,MCRS1,SIG,22,2.63098132194131,0.22293250966704,0.219126259661068,0.23543875968666,0.016312500025592,0.0156367602269519,2.48694340010987,5.52503578268994,5.49999379693639,5.60731659302306,0.107322796086669,0.0363265892763302,ENSG00000187778,MCRS1,protein_coding,12,-1,49556544,49568145,q13.12,microspherule protein 1 [Source:HGNC Symbol;Acc:HGNC:6960],NA,MCRS1,10445,NM_001012300;NM_001278341;NM_006337
SEC61A2_SIG,SEC61A2,SEC61A2_SIG,SEC61A2,SIG,23,2.63059761945093,0.445360991252711,0.438222237458081,0.468816896577924,0.0305946591198427,0.0156493460555895,1.1856494071363,3.91794178760136,3.89099054979077,4.00649585469334,0.115505304902571,0.343284173659834,ENSG00000065665,SEC61A2,protein_coding,10,1,12129637,12169961,p14,Sec61 translocon alpha 2 subunit [Source:HGNC Symbol;Acc:HGNC:17702],NA,SEC61A2,55176,NM_001142627;NM_001142628;NM_018144
CD33_SIG,CD33,CD33_SIG,CD33,SIG,40,2.6305572138779,0.235209039200413,0.22807313202856,0.258655591336503,0.0305824593079428,0.0156493460555895,2.32531378360485,6.20056613728314,6.12031637101077,6.4642439407495,0.343927569738731,0.0512533934298144,ENSG00000105383,CD33,protein_coding,19,1,51225064,51243860,q13.41,CD33 molecule [Source:HGNC Symbol;Acc:HGNC:1659],NA,CD33,945,NM_001082618;NM_001177608;NM_001772
IKBKG_SIG,IKBKG,IKBKG_SIG,IKBKG,SIG,28,-2.62963017638326,-0.156602335611123,-0.152630140577738,-0.169653833577961,-0.0170236930002236,0.0156886035762192,-2.64880414983517,3.27674992799895,3.30586545641385,3.18108462035,-0.124780836063841,0.0251117243273931,ENSG00000269335,IKBKG,protein_coding,X,1,154541199,154565046,q28,inhibitor of nuclear factor kappa B kinase subunit gamma [Source:HGNC Symbol;Acc:HGNC:5961],Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome;ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1;ECTODERMAL DYSPLASIA ANHIDROTIC WITH IMMUNODEFICIENCY-OSTEOPETROSIS-LYMPHEDEMA;Ectodermal dysplasia anhidrotic with immunodeficiency osteopetrosis and lymphedema;Ectodermal dysplasia anhidrotic with immunodeficiency X-linked;Hypohidrotic ectodermal dysplasia with immunodeficiency;IMMUNODEFICIENCY 33;IMMUNODEFICIENCY NEMO-RELATED WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA;IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA;Incontinentia pigmenti;INVASIVE PNEUMOCOCCAL DISEASE RECURRENT ISOLATED 2;susceptibility to X-linked familial atypical micobacteriosis type 1;X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency,IKBKG,8517,NM_001099856;NM_001099857;NM_001145255;NM_001321396;NM_001321397;NM_003639
SLC26A6_SIG,SLC26A6,SLC26A6_SIG,SLC26A6,SIG,18,-2.62770789155883,0.0219800422032391,0.0287468734889141,-0.000253832021121477,-0.0290007055100357,0.0157740339769282,-0.537465753526102,4.80506410678711,4.81690323638355,4.76616410954168,-0.0507391268418669,0.687840586539737,ENSG00000225697,SLC26A6,protein_coding,3,-1,48625723,48635493,p21.31,solute carrier family 26 member 6 [Source:HGNC Symbol;Acc:HGNC:14472],NA,SLC26A6,65010,NM_001040454;NM_001281732;NM_001281733;NM_022911;NM_134263;NM_134426
CDK1_SIG,CDK1,CDK1_SIG,CDK1,SIG,32,-2.62552186297738,0.260646737825385,0.293203576559145,0.153674267700174,-0.139529308858971,0.0158721690172601,-2.26666875938556,3.08578298344205,3.16468738627786,2.82652565983866,-0.338161726439205,0.057887049361263,ENSG00000170312,CDK1,protein_coding,10,1,60778331,60794852,q21.2,cyclin dependent kinase 1 [Source:HGNC Symbol;Acc:HGNC:1722],NA,CDK1,983,NM_001170406;NM_001320918;NM_001786;NM_033379
SCD_SIG,SCD,SCD_SIG,SCD,SIG,50,-2.62455868382384,-0.0529340754899757,-0.0493710543355657,-0.0646411449973228,-0.0152700906617572,0.0159136086459222,-1.38439562981691,4.4439205770396,4.49811482709286,4.26585375543606,-0.232261071656797,0.262518597999473,ENSG00000099194,SCD,protein_coding,10,1,100347233,100364826,q24.31,stearoyl-CoA desaturase [Source:HGNC Symbol;Acc:HGNC:10571],NA,SCD,6319,NM_005063
PCCB_SIG,PCCB,PCCB_SIG,PCCB,SIG,25,2.62420377828428,0.450130368289684,0.443736001149437,0.471140431750494,0.0274044306010565,0.0159266755323173,2.51430069644984,5.08402099458052,5.03629398979016,5.24083829603456,0.204544306244401,0.0342006424644993,ENSG00000114054,PCCB,protein_coding,3,1,136250340,136337896,q22.3,propionyl-CoA carboxylase subunit beta [Source:HGNC Symbol;Acc:HGNC:8654],PROPIONIC ACIDEMIA,PCCB,5096,NM_000532;NM_001178014
CCNF_SIG,CCNF,CCNF_SIG,CCNF,SIG,29,-2.62375462075488,0.0656672470166341,0.082148426766234,0.0115147992679486,-0.0706336274982855,0.0159426523904599,-2.47091240915833,3.2790335865653,3.34831516204078,3.05139412428875,-0.296921037752028,0.0376294855951655,ENSG00000162063,CCNF,protein_coding,16,1,2429394,2458854,p13.3,cyclin F [Source:HGNC Symbol;Acc:HGNC:1591],Amyotrophic lateral sclerosis,CCNF,899,NM_001323538;NM_001761
PRKCSH_SIG,PRKCSH,PRKCSH_SIG,PRKCSH,SIG,22,2.62371153490313,0.494810419591679,0.48917303041796,0.513333269733902,0.0241602393159424,0.0159426523904599,1.73021706190365,8.47583498540073,8.46012616750025,8.52744967278802,0.0673235052877654,0.155201553689506,ENSG00000130175,PRKCSH,protein_coding,19,1,11435288,11450968,p13.2,protein kinase C substrate 80K-H [Source:HGNC Symbol;Acc:HGNC:9411],Isolated polycystic liver disease;POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS,PRKCSH,5589,NM_001001329;NM_001289102;NM_001289103;NM_001289104;NM_002743
CHUK_SIG,CHUK,CHUK_SIG,CHUK,SIG,22,-2.62324101986073,0.165749925996409,0.168034116191224,0.158244729642016,-0.00978938654920772,0.0159611567186111,-1.51450761639795,5.20122926008861,5.21691791850741,5.14968081099828,-0.0672371075091344,0.217291317590101,ENSG00000213341,CHUK,protein_coding,10,-1,100188300,100229596,q24.31,conserved helix-loop-helix ubiquitous kinase [Source:HGNC Symbol;Acc:HGNC:1974],Cocoon syndrome;Fetal encasement syndrome,CHUK,1147,NM_001278;NM_001320928
KLHL13_SIG,KLHL13,KLHL13_SIG,KLHL13,SIG,30,-2.62267321608642,-0.0441041722889511,-0.0389540044477561,-0.0610261523385918,-0.0220721478908357,0.015984243379347,-2.04893039089239,2.19750584588587,2.27591491931705,1.93987603318344,-0.336038886133609,0.0887448409468189,ENSG00000003096,KLHL13,protein_coding,X,-1,117897813,118117340,q24,kelch like family member 13 [Source:HGNC Symbol;Acc:HGNC:22931],NA,KLHL13,90293,NM_001168299;NM_001168300;NM_001168301;NM_001168302;NM_001168303;NM_033495
PGAM1_SIG,PGAM1,PGAM1_SIG,PGAM1,SIG,86,-2.62244537875826,0.121843877977419,0.128938942871391,0.0985315218972259,-0.0304074209741647,0.0159913982586804,-2.3300448501073,5.38045979535805,5.43005042207278,5.21751916472394,-0.212531257348846,0.0508327460593762,ENSG00000171314,PGAM1,protein_coding,10,1,97426191,97433444,q24.1,phosphoglycerate mutase 1 [Source:HGNC Symbol;Acc:HGNC:8888],NA,PGAM1,5223,NM_001317079;NM_002629
ADAMTS10_SIG,ADAMTS10,ADAMTS10_SIG,ADAMTS10,SIG,85,-2.61982296527474,0.0215484630329981,0.0272320697672357,0.00287375519193187,-0.0243583145753039,0.0161113261065625,-2.46603330021682,3.4255881103964,3.52552706577725,3.09721725700218,-0.428309808775074,0.0380171323375549,ENSG00000142303,ADAMTS10,protein_coding,19,-1,8580240,8610735,p13.2,ADAM metallopeptidase with thrombospondin type 1 motif 10 [Source:HGNC Symbol;Acc:HGNC:13201],Weill-Marchesani syndrome;WEILL-MARCHESANI SYNDROME 1,ADAMTS10,81794,NM_001282352;NM_030957
HPGD_SIG,HPGD,HPGD_SIG,HPGD,SIG,58,-2.61963824685294,0.0286196632363422,0.0341991090986958,0.0102871982600373,-0.0239119108386584,0.0161164921950723,-2.12259060670488,2.68511014299556,2.79238893174799,2.33262269423757,-0.45976623751042,0.0770335160679583,ENSG00000164120,HPGD,protein_coding,4,-1,174490175,174523154,q34.1,15-hydroxyprostaglandin dehydrogenase [Source:HGNC Symbol;Acc:HGNC:5154],CRANIOOSTEOARTHROPATHY;DIGITAL CLUBBING ISOLATED CONGENITAL;HYPERTROPHIC OSTEOARTHROPATHY PRIMARY AUTOSOMAL RECESSIVE 1;Isolated congenital digital clubbing;Pachydermoperiostosis,HPGD,3248,NM_000860;NM_001145816;NM_001256301;NM_001256305;NM_001256306;NM_001256307
DNAJC17_SIG,DNAJC17,DNAJC17_SIG,DNAJC17,SIG,8,2.61930088883268,0.281078721782536,0.273063388984958,0.307414815260292,0.0343514262753347,0.0161288764189278,2.2484080630567,3.33088953222897,3.3019457707773,3.42599046271301,0.124044691935702,0.0601558471298158,ENSG00000104129,DNAJC17,protein_coding,15,-1,40765161,40807478,q15.1,DnaJ heat shock protein family (Hsp40) member C17 [Source:HGNC Symbol;Acc:HGNC:25556],NA,DNAJC17,55192,NM_018163
RASIP1_SIG,RASIP1,RASIP1_SIG,RASIP1,SIG,28,-2.61768742245524,-0.148957813112801,-0.145767097733065,-0.159441592217647,-0.0136744944845823,0.0162017516669454,-0.18322302104834,0.485959488725994,0.488610685768075,0.477248412730584,-0.0113622730374914,0.897045832616329,ENSG00000105538,RASIP1,protein_coding,19,-1,48720585,48740610,q13.33,Ras interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:24716],NA,RASIP1,54922,NM_017805
KLF1_TF,KLF1,KLF1_TF,KLF1,TF,343,-2.61693862698808,-0.0342404639103319,-0.0278853415688268,-0.0551215801752774,-0.0272362386064507,0.0162337497542436,-1.66841193055575,2.22503655618312,2.2997046612953,1.97969849652884,-0.320006164766453,0.171397149968982,ENSG00000105610,KLF1,protein_coding,19,-1,12884422,12887199,p13.13,Kruppel like factor 1 [Source:HGNC Symbol;Acc:HGNC:6345],ANEMIA CONGENITAL DYSERYTHROPOIETIC TYPE IV;ANEMIA DYSERYTHROPOIETIC CONGENITAL TYPE IV;BLOOD GROUP--LUTHERAN INHIBITOR;Congenital dyserythropoietic anemia type IV;FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6;Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome;Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,KLF1,10661,NM_006563
ZNF140_TF,ZNF140,ZNF140_TF,ZNF140,TF,14,2.61573415901168,0.288475540957457,0.279259307293177,0.318757451568663,0.0394981442754857,0.0162875249215677,2.27641977241608,2.68468902239381,2.64531571044221,2.81405847594904,0.168742765506828,0.0566927572183718,ENSG00000196387,ZNF140,protein_coding,12,1,133079838,133107544,q24.33,zinc finger protein 140 [Source:HGNC Symbol;Acc:HGNC:12925],NA,ZNF140,7699,NM_001300776;NM_001300777;NM_001300778;NM_003440
HADH_SIG,HADH,HADH_SIG,HADH,SIG,13,2.61520935374558,0.45693170280688,0.448507374019193,0.484611640252133,0.03610426623294,0.0163068902187599,1.85060379610776,4.87380674434218,4.83625861786424,4.99717915991256,0.160920542048321,0.126705446804163,ENSG00000138796,HADH,protein_coding,4,1,107989714,108035175,q25,hydroxyacyl-CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4799],3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency;HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 4;Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,HADH,3033,NM_001184705;NM_001331027;NM_005327
CHCHD3_TF,CHCHD3,CHCHD3_TF,CHCHD3,TF,584,2.61517758639879,0.39048686477349,0.385085334842294,0.408234748833136,0.0231494139908419,0.0163068902187599,1.89350087430291,7.42387241481672,7.39887635184797,7.50600233599975,0.107125984151777,0.117565860357996,ENSG00000106554,CHCHD3,protein_coding,7,-1,132784870,133082090,q33,coiled-coil-helix-coiled-coil-helix domain containing 3 [Source:HGNC Symbol;Acc:HGNC:21906],NA,CHCHD3,54927,NM_001317177;NM_001317178;NM_017812
ZNF232_TF,ZNF232,ZNF232_TF,ZNF232,TF,8,2.61312217139002,0.00324946309957864,-0.0030199576200143,0.0238489883210983,0.0268689459411125,0.0163994727226885,1.23280578245756,2.10350319107445,2.07793908479245,2.18749954028673,0.109560455494277,0.322570049620148,ENSG00000167840,ZNF232,protein_coding,17,-1,5105541,5123116,p13.2,zinc finger protein 232 [Source:HGNC Symbol;Acc:HGNC:13026],NA,ZNF232,7775,NM_001320952;NM_001320953;NM_001320954;NM_001320955;NM_014519
PUM1_SIG,PUM1,PUM1_SIG,PUM1,SIG,26,2.61309259720825,0.585119372627776,0.581423954897832,0.597261459454733,0.015837504556901,0.0163994727226885,3.35182099163718,6.95832006838687,6.92469849202639,7.06879096214272,0.144092470116332,0.00415077652306939,ENSG00000134644,PUM1,protein_coding,1,-1,30931506,31065991,p35.2,pumilio RNA binding family member 1 [Source:HGNC Symbol;Acc:HGNC:14957],SPINOCEREBELLAR ATAXIA 47,PUM1,9698,NM_001020658;NM_014676
TAF2_TF,TAF2,TAF2_TF,TAF2,TF,136,2.61235402297395,0.314848858412729,0.312571226869418,0.322332504912182,0.00976127804276491,0.0164313230168693,1.93190958114736,5.30552429501602,5.28555167275832,5.3711486252913,0.0855969525329804,0.109873426697927,ENSG00000064313,TAF2,protein_coding,8,-1,119730774,119832841,q24.12,TATA-box binding protein associated factor 2 [Source:HGNC Symbol;Acc:HGNC:11536],Autosomal Recessive Mental Retardation;Mental retardation autosomal recessive 40;Microcephaly-thin corpus callosum-intellectual disability syndrome,TAF2,6873,NM_003184
RNASE2_SIG,RNASE2,RNASE2_SIG,RNASE2,SIG,46,-2.61150935243688,0.269761705814434,0.281185608931581,0.232226024143811,-0.0489595847877699,0.0164683369748439,-2.71983093702433,7.68095930344769,7.83645883418967,7.17003227386687,-0.6664265603228,0.021357154188344,ENSG00000169385,RNASE2,protein_coding,14,1,20955487,20956436,q11.2,ribonuclease A family member 2 [Source:HGNC Symbol;Acc:HGNC:10045],NA,RNASE2,6036,NM_002934
SLC25A44_SIG,SLC25A44,SLC25A44_SIG,SLC25A44,SIG,15,-2.61061088663865,0.260048382232415,0.263584561092941,0.248429508833544,-0.0151550522593967,0.0165080206136862,-0.540886975310053,5.50298069348618,5.50939996165509,5.48188881235979,-0.0275111492952958,0.685792184149539,ENSG00000160785,SLC25A44,protein_coding,1,1,156193932,156212796,q22,solute carrier family 25 member 44 [Source:HGNC Symbol;Acc:HGNC:29036],NA,SLC25A44,9673,NM_001286184;NM_014655
JMJD8_SIG,JMJD8,JMJD8_SIG,JMJD8,SIG,12,2.61037612125548,0.388822504276854,0.383637996190914,0.405857316559228,0.0222193203683141,0.0165157141631604,2.80514508742315,5.23928107615992,5.20569972108407,5.34961981426627,0.143920093182198,0.0174952414475391,ENSG00000161999,JMJD8,protein_coding,16,-1,681670,684528,p13.3,jumonji domain containing 8 [Source:HGNC Symbol;Acc:HGNC:14148],NA,JMJD8,339123,NM_001005920;NM_001323918;NM_001323919;NM_001323920;NM_001323922
PRKCD_SIG,PRKCD,PRKCD_SIG,PRKCD,SIG,44,-2.60978264662149,0.27443679213862,0.285291137209058,0.238772515478609,-0.0465186217304489,0.0165407463141503,-1.32848101401547,6.87509500057517,6.90902747339335,6.76360258988686,-0.145424883506492,0.283630717177348,ENSG00000163932,PRKCD,protein_coding,3,1,53156009,53192717,p21.1,protein kinase C delta [Source:HGNC Symbol;Acc:HGNC:9399],Autoimmune lymphoproliferative syndrome;AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE III;Autosomal systemic lupus erythematosus;Common variable immunodeficiency,PRKCD,5580,NM_001316327;NM_001354676;NM_001354678;NM_001354679;NM_001354680;NM_006254;NM_212539
PIGU_SIG,PIGU,PIGU_SIG,PIGU,SIG,43,2.6094386421291,0.269943903009737,0.25932136128849,0.304846540093833,0.0455251788053425,0.0165537381826116,2.2024868555522,3.53347131567622,3.48200698440516,3.70256840413826,0.220561419733099,0.0660810241305619,ENSG00000101464,PIGU,protein_coding,20,-1,34560542,34698790,q11.22,phosphatidylinositol glycan anchor biosynthesis class U [Source:HGNC Symbol;Acc:HGNC:15791],NA,PIGU,128869,NM_080476
CYSLTR1_SIG,CYSLTR1,CYSLTR1_SIG,CYSLTR1,SIG,24,2.60894722792769,0.164076948620551,0.156266797116606,0.189738874990657,0.0334720778740515,0.0165738773817064,2.4179979765685,4.32805264484647,4.26068395260847,4.54940691934276,0.28872296673429,0.0421623042793875,ENSG00000173198,CYSLTR1,protein_coding,X,-1,78271468,78327691,q21.1,cysteinyl leukotriene receptor 1 [Source:HGNC Symbol;Acc:HGNC:17451],NA,CYSLTR1,10800,NM_001282186;NM_001282187;NM_001282188;NM_006639
BDH1_SIG,BDH1,BDH1_SIG,BDH1,SIG,21,2.60762140145068,0.107983123905593,0.101162646501686,0.130393263947003,0.0292306174453176,0.0166345382655706,2.34657294682337,4.29666456411197,4.24073986304715,4.48041715332496,0.239677290277813,0.0491125479502114,ENSG00000161267,BDH1,protein_coding,3,-1,197509783,197573323,q29,3-hydroxybutyrate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:1027],NA,BDH1,622,NM_004051;NM_203314;NM_203315
SRP72_SIG,SRP72,SRP72_SIG,SRP72,SIG,22,2.60746020840432,0.590445696867166,0.585551655408368,0.606526118803217,0.0209744633948491,0.0166387081823297,2.8298959228375,7.51718163251912,7.48533274345576,7.62182798229876,0.136495238843001,0.0165015924981373,ENSG00000174780,SRP72,protein_coding,4,1,56467336,56503681,q12,signal recognition particle 72 [Source:HGNC Symbol;Acc:HGNC:11303],Autosomal dominant aplasia and myelodysplasia;BONE MARROW FAILURE SYNDROME 1,SRP72,6731,NM_001267722;NM_006947
GPR82_SIG,GPR82,GPR82_SIG,GPR82,SIG,12,-2.60539362929695,0.0948132085342713,0.109037307508854,0.0480768833320719,-0.0609604241767817,0.0167357298010948,-0.133578778265695,0.375082389209964,0.37703851528001,0.368655117836957,-0.00838339744305258,0.924963355864691,ENSG00000171657,GPR82,protein_coding,X,1,41724181,41730130,p11.4,G protein-coupled receptor 82 [Source:HGNC Symbol;Acc:HGNC:4533],NA,GPR82,27197,NM_080817
DND1_SIG,DND1,DND1_SIG,DND1,SIG,16,2.60462362627623,0.0415942909599725,0.0388144931126768,0.0507279124582298,0.0119134193455529,0.0167696920284515,2.13091121079222,0.90930251977937,0.891851824239181,0.966640519411422,0.0747886951722416,0.0758706889030344,ENSG00000256453,DND1,protein_coding,5,-1,140670794,140673576,q31.3,DND microRNA-mediated repression inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:23799],NA,DND1,373863,NM_194249
EIF5B_SIG,EIF5B,EIF5B_SIG,EIF5B,SIG,21,2.6044284534058,0.585753069179751,0.578292366650682,0.610266806060979,0.0319744394102977,0.0167755541816437,2.32550811030036,6.72258145864234,6.68508809015269,6.84577395510834,0.160685864955651,0.0512325967329464,ENSG00000158417,EIF5B,protein_coding,2,1,99337371,99401326,q11.2,eukaryotic translation initiation factor 5B [Source:HGNC Symbol;Acc:HGNC:30793],NA,EIF5B,9669,NM_015904
SLC16A7_SIG,SLC16A7,SLC16A7_SIG,SLC16A7,SIG,23,2.60424790406122,0.180065374990212,0.174846493711043,0.197213127764626,0.0223666340535825,0.0167807025542036,1.82925764980782,3.78546797962969,3.73941777329325,3.93677580044942,0.197358027156173,0.131446945937852,ENSG00000118596,SLC16A7,protein_coding,12,1,59596029,59789855,q14.1,solute carrier family 16 member 7 [Source:HGNC Symbol;Acc:HGNC:10928],NA,SLC16A7,9194,NM_001270622;NM_001270623;NM_004731
TFG_SIG,TFG,TFG_SIG,TFG,SIG,18,2.60374740302912,0.33411588588088,0.328752252015872,0.351739254294479,0.0229870022786073,0.0168015297580667,3.49491257290482,6.12336589836961,6.08417055329241,6.25215060362329,0.167980050330889,0.00274238923065341,ENSG00000114354,TFG,protein_coding,3,1,100709331,100748964,q12.2,TRK-fused gene [Source:HGNC Symbol;Acc:HGNC:11758],Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation;Autosomal recessive spastic paraplegia type 57;Differentiated thyroid carcinoma;Extraskeletal myxoid chondrosarcoma;Hereditary motor and sensory neuropathy Okinawa type;Neuropathy hereditary motor and sensory Okinawa type;Spastic paraplegia 57 autosomal recessive,TFG,10342,NM_001007565;NM_001195478;NM_001195479;NM_006070
WDR48_SIG,WDR48,WDR48_SIG,WDR48,SIG,60,2.60290607125346,0.382177645800276,0.376724798925353,0.400094142675021,0.0233693437496681,0.0168391122212683,1.17311663179146,6.24189520964276,6.22405374908983,6.30051715145953,0.0764634023697007,0.34903414014043,ENSG00000114742,WDR48,protein_coding,3,1,39052013,39096671,p22.2,WD repeat domain 48 [Source:HGNC Symbol;Acc:HGNC:30914],Autosomal recessive spastic paraplegia type 60,WDR48,57599,NM_001303402;NM_001303403;NM_001346225;NM_001346226;NM_001346227;NM_001346228;NM_020839
ITGB3_SIG,ITGB3,ITGB3_SIG,ITGB3,SIG,59,-2.60250225584382,-0.233743546076909,-0.2205544799069,-0.277079049206938,-0.0565245693000377,0.0168552499323819,-1.11666799566627,1.94353664146175,1.99932801937768,1.7602221140237,-0.239105905353979,0.374454083957809,ENSG00000259207,ITGB3,protein_coding,17,1,47253846,47311816,q21.32,integrin subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:6156],Autosomal dominant macrothrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 16;Fetal and neonatal alloimmune thrombocytopenia;GLANZMANN THROMBASTHENIA;MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,ITGB3,3690,NM_000212
ZDHHC16_SIG,ZDHHC16,ZDHHC16_SIG,ZDHHC16,SIG,95,2.60217288602247,0.181352832759149,0.170421379989828,0.21727046328692,0.0468490832970924,0.0168677392886225,2.16578742185653,4.39492982188381,4.34362759803675,4.56349427166704,0.21986667363029,0.0708819600812381,ENSG00000171307,ZDHHC16,protein_coding,10,1,97446170,97457370,q24.1,zinc finger DHHC-type containing 16 [Source:HGNC Symbol;Acc:HGNC:20714],NA,ZDHHC16,84287,NM_001287803;NM_001287804;NM_032327;NM_198043;NM_198044;NM_198045;NM_198046
FLT3LG_SIG,FLT3LG,FLT3LG_SIG,FLT3LG,SIG,37,-2.60043656876094,0.0313158259695298,0.0390817232517602,0.00579930632791572,-0.0332824169238444,0.0169496117022155,-1.62523965188293,0.512986610016828,0.530143224169685,0.456614877800298,-0.0735283463693871,0.183484675882393,ENSG00000090554,FLT3LG,protein_coding,19,1,49474207,49486231,q13.33,fms related tyrosine kinase 3 ligand [Source:HGNC Symbol;Acc:HGNC:3766],NA,FLT3LG,2323,NM_001204502;NM_001204503;NM_001278637;NM_001278638;NM_001459
PCM1_SIG,PCM1,PCM1_SIG,PCM1,SIG,13,2.59921667739852,0.674098127433757,0.669915560754573,0.687840846522505,0.0179252857679323,0.0170062318651854,0.654215658039614,7.86195799083256,7.8533283528424,7.89031251565737,0.0369841628149743,0.618328375733419,ENSG00000078674,PCM1,protein_coding,8,1,17922840,18029944,p22,pericentriolar material 1 [Source:HGNC Symbol;Acc:HGNC:8727],Differentiated thyroid carcinoma,PCM1,5108,NM_001315507;NM_001315508;NM_001352632;NM_001352633;NM_001352634;NM_001352635;NM_001352636;NM_001352637;NM_001352638;NM_001352639;NM_001352640;NM_001352641;NM_001352642;NM_001352643;NM_001352644;NM_001352645;NM_001352646;NM_001352647;NM_001352648;NM_001352649;NM_001352650;NM_001352651;NM_001352652;NM_001352653;NM_001352654;NM_001352655;NM_001352656;NM_001352657;NM_001352658;NM_001352659;NM_001352660;NM_006197
CDCA3_SIG,CDCA3,CDCA3_SIG,CDCA3,SIG,20,-2.59803255747743,0.129344484862289,0.158258703694519,0.034340622984961,-0.123918080709558,0.0170612413055971,-2.56037840014452,2.80774043403124,2.88189909617166,2.56407625842702,-0.317822837744642,0.0308461011779061,ENSG00000111665,CDCA3,protein_coding,12,-1,6844793,6852066,p13.31,cell division cycle associated 3 [Source:HGNC Symbol;Acc:HGNC:14624],NA,CDCA3,83461,NM_001297602;NM_001297603;NM_001297604;NM_001331019;NM_031299
VAV1_TF,VAV1,VAV1_TF,VAV1,TF,216,-2.59776949180266,0.26603240792449,0.271833691722308,0.24697104687452,-0.0248626448477874,0.0170705673419157,-1.51147304809134,6.65297405429186,6.67568782885825,6.57834308071659,-0.097344748141662,0.218388790962453,ENSG00000141968,VAV1,protein_coding,19,1,6772708,6857366,p13.3,vav guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:12657],NA,VAV1,7409,NM_001258206;NM_001258207;NM_005428
THOC7_SIG,THOC7,THOC7_SIG,THOC7,SIG,38,2.59740335787346,0.206380205747156,0.200707651816853,0.225018597232436,0.0243109454155831,0.0170850247799119,2.30816316811486,5.64318218471174,5.6159300159341,5.73272502498112,0.11679500904702,0.053054794263029,ENSG00000163634,THOC7,protein_coding,3,-1,63833870,63863868,p14.1,THO complex 7 [Source:HGNC Symbol;Acc:HGNC:29874],NA,THOC7,80145,NM_001285387;NM_001285404;NM_025075
IL20RB_SIG,IL20RB,IL20RB_SIG,IL20RB,SIG,19,2.59676985542476,-0.120996662070227,-0.123922573021668,-0.11138295465835,0.0125396183633187,0.0171128080953571,1.81764336681685,0.952590476282872,0.933092623057731,1.01665485116548,0.083562228107747,0.134129975935669,ENSG00000174564,IL20RB,protein_coding,3,1,136946230,137011085,q22.3,interleukin 20 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:6004],NA,IL20RB,53833,NM_144717
TGFBRAP1_SIG,TGFBRAP1,TGFBRAP1_SIG,TGFBRAP1,SIG,73,2.59633227188494,0.276772654065563,0.268839120779569,0.302839977719544,0.0340008569399754,0.0171308595703367,2.14726965918444,6.80065668156412,6.75959825082027,6.93556295400821,0.175964703187943,0.0734879163309319,ENSG00000135966,TGFBRAP1,protein_coding,2,-1,105264391,105329735,q12.2,transforming growth factor beta receptor associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16836],NA,TGFBRAP1,9392,NM_001142621;NM_001328646;NM_004257
PHF20_TF,PHF20,PHF20_TF,PHF20,TF,53,2.59607124396634,0.357563789207335,0.353752387073684,0.370086967646471,0.0163345805727862,0.0171401182947009,3.56595901622141,6.03867494258774,5.99105852666754,6.19512888061124,0.204070353943701,0.00221542750128419,ENSG00000025293,PHF20,protein_coding,20,1,35771974,35950370,q11.22,PHD finger protein 20 [Source:HGNC Symbol;Acc:HGNC:16098],NA,PHF20,51230,NM_016436
NEK9_SIG,NEK9,NEK9_SIG,NEK9,SIG,65,2.59560719223531,0.469644949595697,0.459750478548085,0.502155354466425,0.0424048759183408,0.0171595170699191,1.89515144746289,6.7532078413663,6.71458147724552,6.88012303776315,0.165541560517631,0.117269257898196,ENSG00000119638,NEK9,protein_coding,14,-1,75079353,75127344,q24.3,NIMA related kinase 9 [Source:HGNC Symbol;Acc:HGNC:18591],ARTHROGRYPOSIS PERTHES DISEASE AND UPWARD GAZE PALSY;LETHAL CONGENITAL CONTRACTURE SYNDROME 10;NEK9-related lethal skeletal dysplasia;NEPHRONOPHTHISIS 9;NEVUS COMEDONICUS;Nevus comedonicus syndrome;RENAL-HEPATIC-PANCREATIC DYSPLASIA 2,NEK9,91754,NM_001329237;NM_001329238;NM_033116
PTPRH_SIG,PTPRH,PTPRH_SIG,PTPRH,SIG,57,2.59549542503066,-0.0340445982262233,-0.0393196135326351,-0.0167124050765842,0.022607208456051,0.0171613346807712,1.07557646965261,0.875994349628368,0.847943299655948,0.968162085252032,0.120218785596085,0.39414532203574,ENSG00000080031,PTPRH,protein_coding,19,-1,55181247,55209506,q13.42,protein tyrosine phosphatase, receptor type H [Source:HGNC Symbol;Acc:HGNC:9672],NA,PTPRH,5794,NM_001161440;NM_002842
GPR108_SIG,GPR108,GPR108_SIG,GPR108,SIG,25,2.59499528652019,0.0337753320274763,0.0296140627080463,0.0474480740770318,0.0178340113689856,0.0171825588959869,1.74794288449077,5.71427398589353,5.693620377309,5.78213584267127,0.0885154653622758,0.150749148159898,ENSG00000125734,GPR108,protein_coding,19,-1,6729914,6737603,p13.3,G protein-coupled receptor 108 [Source:HGNC Symbol;Acc:HGNC:17829],NA,GPR108,56927,NM_001080452;NM_020171
PPP1R12B_SIG,PPP1R12B,PPP1R12B_SIG,PPP1R12B,SIG,30,2.59422755919648,0.107263800853278,0.103768719038745,0.11874764110103,0.0149789220622845,0.0172172027070968,-0.208320666811958,5.47770746027094,5.4809371184925,5.46709572611438,-0.0138413923781143,0.882767271978299,ENSG00000077157,PPP1R12B,protein_coding,1,1,202348699,202592706,q32.1,protein phosphatase 1 regulatory subunit 12B [Source:HGNC Symbol;Acc:HGNC:7619],NA,PPP1R12B,4660,NM_001167857;NM_001167858;NM_001197131;NM_001331029;NM_002481;NM_032103;NM_032104
PDE7B_SIG,PDE7B,PDE7B_SIG,PDE7B,SIG,20,2.59303726614952,0.14618805465464,0.14097343872389,0.163321792712816,0.0223483539889253,0.017273119552783,3.58490063392761,1.52780717775482,1.43860343794522,1.82090517998634,0.382301742041121,0.00209431230186244,ENSG00000171408,PDE7B,protein_coding,6,1,135851701,136195574,q23.3,phosphodiesterase 7B [Source:HGNC Symbol;Acc:HGNC:8792],NA,PDE7B,27115,NM_018945
ESR1_TF,ESR1,ESR1_TF,ESR1,TF,208,-2.59261180148171,-0.00774040781043236,-0.00405664094430722,-0.0198442132277007,-0.0157875722833936,0.0172907108968914,0.396637232193743,0.784085293651162,0.776646265583191,0.808527814445922,0.0318815488627307,0.770368644867513,ENSG00000091831,ESR1,protein_coding,6,1,151656691,152129619,q25.1,estrogen receptor 1 [Source:HGNC Symbol;Acc:HGNC:3467],Breast Cancer;ESTROGEN RESISTANCE;Estrogen resistance syndrome;MIGRAINE WITH OR WITHOUT AURA SUSCEPTIBILITY TO 1;MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,ESR1,2099,NM_000125;NM_001122740;NM_001122741;NM_001122742;NM_001291230;NM_001291241;NM_001328100
TOP2A_SIG,TOP2A,TOP2A_SIG,TOP2A,SIG,30,-2.59218360574276,0.254626039137832,0.285635577073036,0.152737557350731,-0.132898019722305,0.0173047389043744,-2.02904991789932,5.07464044589852,5.16319007557296,4.78369166268251,-0.37949841289045,0.0920619001428744,ENSG00000131747,TOP2A,protein_coding,17,-1,40388525,40417896,q21.2,DNA topoisomerase II alpha [Source:HGNC Symbol;Acc:HGNC:11989],Neuroblastoma,TOP2A,7153,NM_001067
LILRA4_SIG,LILRA4,LILRA4_SIG,LILRA4,SIG,25,-2.5921821326951,-0.200159495331337,-0.193491335364355,-0.222069163794277,-0.0285778284299224,0.0173047389043744,-1.48717116774111,0.750762086224693,0.791082374212347,0.618281139979543,-0.172801234232804,0.226222243434514,ENSG00000239961,LILRA4,protein_coding,19,-1,54333185,54339162,q13.42,leukocyte immunoglobulin like receptor A4 [Source:HGNC Symbol;Acc:HGNC:15503],NA,LILRA4,23547,NM_012276
ZHX2_TF,ZHX2,ZHX2_TF,ZHX2,TF,82,-2.59203985584729,-0.0056667017512462,-0.00331434965797508,-0.013395858629137,-0.010081508971162,0.0173081065569665,-1.26106511992708,4.49918339471569,4.5309339995259,4.39485997891069,-0.136074020615205,0.310835800067898,ENSG00000178764,ZHX2,protein_coding,8,1,122781655,122974510,q24.13,zinc fingers and homeoboxes 2 [Source:HGNC Symbol;Acc:HGNC:18513],NA,ZHX2,22882,NM_014943
SLC1A4_SIG,SLC1A4,SLC1A4_SIG,SLC1A4,SIG,49,-2.59137689868819,0.19589264808501,0.201899144830571,0.176157015921022,-0.0257421289095492,0.0173376928015021,-2.2852863467878,5.40866948443798,5.47283804509076,5.19782992800742,-0.275008117083343,0.0556475118579044,ENSG00000115902,SLC1A4,protein_coding,2,1,64988477,65023865,p14,solute carrier family 1 member 4 [Source:HGNC Symbol;Acc:HGNC:10942],Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome;SPASTIC TETRAPLEGIA THIN CORPUS CALLOSUM AND PROGRESSIVE MICROCEPHALY,SLC1A4,6509,NM_001193493;NM_001348406;NM_001348407;NM_003038
FCER1A_SIG,FCER1A,FCER1A_SIG,FCER1A,SIG,13,-2.58971794688232,-0.0700629459925347,-0.0657100230926074,-0.0843654069494384,-0.018655383856831,0.0174176480551398,-1.31360235967278,3.6787006708694,3.7466593168827,3.45540797682568,-0.291251340057025,0.289549647665879,ENSG00000179639,FCER1A,protein_coding,1,1,159289714,159308224,q23.2,Fc fragment of IgE receptor Ia [Source:HGNC Symbol;Acc:HGNC:3609],NA,FCER1A,2205,NM_002001
GNAS_SIG,GNAS,GNAS_SIG,GNAS,SIG,12,2.58917238095035,0.386447221674935,0.381850606522747,0.401550385746411,0.0196997792236646,0.0174414515767348,0.811227333591448,9.88035900444432,9.87273061278948,9.90542371988164,0.0326931070921665,0.529141035252605,ENSG00000087460,GNAS,protein_coding,20,1,58839718,58911192,q13.32,GNAS complex locus [Source:HGNC Symbol;Acc:HGNC:4392],ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA;ALBRIGHT HEREDITARY OSTEODYSTROPHY;Cushing syndrome due to macronodular adrenal hyperplasia;GNAS hyperfunction;Mazabraud syndrome;McCune-Albright syndrome;Monostotic fibrous dysplasia;OSSEOUS HETEROPLASIA PROGRESSIVE;PITUITARY ADENOMA 3 MULTIPLE TYPES;Polyostotic fibrous dysplasia;Progressive osseous heteroplasia;Pseudohypoparathyroidism type 1A;Pseudohypoparathyroidism type 1B;Pseudohypoparathyroidism type 1C;PSEUDOHYPOPARATHYROIDISM TYPE IA;PSEUDOHYPOPARATHYROIDISM TYPE IB;PSEUDOHYPOPARATHYROIDISM TYPE IC;PSEUDOPSEUDOHYPOPARATHYROIDISM,GNAS,2778,NM_000516;NM_001077488;NM_001077489;NM_001077490;NM_001309840;NM_001309842;NM_001309861;NM_001309883;NM_016592;NM_080425;NM_080426
CDKN1A_SIG,CDKN1A,CDKN1A_SIG,CDKN1A,SIG,42,-2.58826659742962,0.206621363315243,0.214449601446178,0.180900009456458,-0.0335495919897199,0.017483559978571,-0.113035171387784,6.1210794176413,6.12569967578174,6.10589856946556,-0.019801106316188,0.93742302319635,ENSG00000124762,CDKN1A,protein_coding,6,1,36676460,36687339,p21.2,cyclin dependent kinase inhibitor 1A [Source:HGNC Symbol;Acc:HGNC:1784],Multiple endocrine neoplasia type 1,CDKN1A,1026,NM_000389;NM_001220777;NM_001220778;NM_001291549;NM_078467
RRS1_SIG,RRS1,RRS1_SIG,RRS1,SIG,13,2.58621989577063,0.359202050988954,0.349244714581851,0.391919013469436,0.0426742988875853,0.0175838801371923,2.13777180661107,3.78287971192966,3.74255944699924,3.91536058241531,0.172801135416076,0.0748773477670728,ENSG00000179041,RRS1,protein_coding,8,1,66429014,66430733,q13.1,ribosome biogenesis regulator homolog [Source:HGNC Symbol;Acc:HGNC:17083],NA,RRS1,23212,NM_015169
HGSNAT_SIG,HGSNAT,HGSNAT_SIG,HGSNAT,SIG,11,2.58611795213985,0.220304303465612,0.21596703072008,0.234555342486646,0.0185883117665663,0.0175844445986255,1.94255336130871,6.68766818464759,6.65751045690197,6.78675786152608,0.129247404624118,0.107837665648039,ENSG00000165102,HGSNAT,protein_coding,8,1,43140464,43202855,p11.21,heparan-alpha-glucosaminide N-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:26527],MUCOPOLYSACCHARIDOSIS TYPE 3C;MUCOPOLYSACCHARIDOSIS TYPE IIIC;Retinitis pigmentosa;RETINITIS PIGMENTOSA 73;Sanfilippo syndrome type C,HGSNAT,138050,NM_152419
GNPAT_SIG,GNPAT,GNPAT_SIG,GNPAT,SIG,51,2.58605809314914,0.334261447002465,0.323209010500842,0.370576595507797,0.0473675850069548,0.0175844445986255,3.07531588924074,5.4284046692621,5.38268367237887,5.57863080187843,0.195947129499563,0.00885027225962916,ENSG00000116906,GNPAT,protein_coding,1,1,231241207,231277973,q42.2,glyceronephosphate O-acyltransferase [Source:HGNC Symbol;Acc:HGNC:4416],Rhizomelic chondrodysplasia punctata type 2;RHIZOMELIC CHONDRODYSPLASIA PUNCTATA TYPE 2,GNPAT,8443,NM_001316350;NM_014236
GAS7_TF,GAS7,GAS7_TF,GAS7,TF,333,-2.58590282557379,0.233919897903031,0.240347783997632,0.212799700735056,-0.0275480832625753,0.0175885222703104,-1.53101625928419,7.58864763361494,7.63576714134182,7.4338263939409,-0.201940747400921,0.211900830170592,ENSG00000007237,GAS7,protein_coding,17,-1,9910609,10198551,p13.1,growth arrest specific 7 [Source:HGNC Symbol;Acc:HGNC:4169],NA,GAS7,8522,NM_001130831;NM_003644;NM_201432;NM_201433
CH25H_SIG,CH25H,CH25H_SIG,CH25H,SIG,10,-2.58449268084686,-0.0355616882463522,-0.0293376230028013,-0.0560121883323053,-0.0266745653295042,0.0176544512577257,0.0448671017106326,0.613744125174134,0.612614194740616,0.617456753741411,0.00484255900079498,0.975317258691345,ENSG00000138135,CH25H,protein_coding,10,-1,89205629,89207314,q23.31,cholesterol 25-hydroxylase [Source:HGNC Symbol;Acc:HGNC:1907],NA,CH25H,9023,NM_003956
SRRM2_SIG,SRRM2,SRRM2_SIG,SRRM2,SIG,49,2.58439991030679,0.113000222595681,0.109579995427342,0.124238111863083,0.0146581164357416,0.0176544512577257,4.0164768469941,10.6944867896031,10.6533814491751,10.8295471938663,0.176165744691222,0.000538988461700037,ENSG00000167978,SRRM2,protein_coding,16,1,2752626,2772538,p13.3,serine/arginine repetitive matrix 2 [Source:HGNC Symbol;Acc:HGNC:16639],NA,SRRM2,23524,NM_016333
ZNF440_TF,ZNF440,ZNF440_TF,ZNF440,TF,22,2.58437229489982,0.193383390812764,0.189823447529259,0.205080347315707,0.0152568997864475,0.0176544512577257,0.794210024564918,3.54352914434244,3.53071623918964,3.58562868984449,0.0549124506548459,0.538305663789662,ENSG00000171295,ZNF440,protein_coding,19,1,11814284,11835201,p13.2,zinc finger protein 440 [Source:HGNC Symbol;Acc:HGNC:20874],NA,ZNF440,126070,NM_152357
RBBP7_SIG,RBBP7,RBBP7_SIG,RBBP7,SIG,50,2.5843115672685,0.631888672479072,0.626228381984621,0.65048676981798,0.0242583878333588,0.0176544512577257,2.68122834972429,6.84573450047663,6.81480519748637,6.94735935315891,0.132554155672537,0.0234221159875503,ENSG00000102054,RBBP7,protein_coding,X,-1,16839283,16870414,p22.2,RB binding protein 7, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:9890],NA,RBBP7,5931,NM_001198719;NM_002893
TIRAP_SIG,TIRAP,TIRAP_SIG,TIRAP,SIG,26,-2.58408130320542,0.300750091987637,0.309732199063014,0.271237454454254,-0.038494744608761,0.0176623853448941,0.182697538774827,3.36083397049002,3.35759802212234,3.37146637226952,0.0138683501471756,0.897283331796659,ENSG00000150455,TIRAP,protein_coding,11,1,126283065,126298845,q24.2,TIR domain containing adaptor protein [Source:HGNC Symbol;Acc:HGNC:17192],BACTEREMIA SUSCEPTIBILITY TO 1;INVASIVE PNEUMOCOCCAL DISEASE RECURRENT ISOLATED 1;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS PROTECTION AGAINST INCLUDED,TIRAP,114609,NM_001039661;NM_001318776;NM_001318777;NM_148910
L3MBTL2_SIG,L3MBTL2,L3MBTL2_SIG,L3MBTL2,SIG,43,2.58396322767272,0.510098262227944,0.501105788474327,0.539644961704115,0.0385391732297889,0.017664576254912,2.03472188992177,4.98522870307796,4.95583297487074,5.08181466718741,0.125981692316676,0.0910894923543306,ENSG00000100395,L3MBTL2,protein_coding,22,1,41205282,41231271,q13.2,L3MBTL2, polycomb repressive complex 1 subunit [Source:HGNC Symbol;Acc:HGNC:18594],NA,L3MBTL2,83746,NM_031488
ADAM15_SIG,ADAM15,ADAM15_SIG,ADAM15,SIG,37,-2.58387431030844,0.30680657894717,0.311144812348,0.2925523834873,-0.0185924288607,0.0176652746027394,-1.43684188198323,6.78663934514602,6.81635873882438,6.68898990877425,-0.127368830050128,0.243113469897386,ENSG00000143537,ADAM15,protein_coding,1,1,155050566,155062775,q21.3,ADAM metallopeptidase domain 15 [Source:HGNC Symbol;Acc:HGNC:193],NA,ADAM15,8751,NM_001261464;NM_001261465;NM_001261466;NM_003815;NM_207191;NM_207194;NM_207195;NM_207196;NM_207197
GPC2_SIG,GPC2,GPC2_SIG,GPC2,SIG,51,2.58340700253713,0.0463333015862669,0.0408575301650219,0.0643251219703576,0.0234675918053357,0.0176853634182258,1.19564631304221,2.03350179141401,2.00376734301256,2.13120069330448,0.127433350291918,0.339015623608648,ENSG00000213420,GPC2,protein_coding,7,-1,100169606,100177381,q22.1,glypican 2 [Source:HGNC Symbol;Acc:HGNC:4450],NA,GPC2,221914,NM_152742
CDK7_SIG,CDK7,CDK7_SIG,CDK7,SIG,19,2.58252700349079,0.31186712885196,0.307777118471599,0.325305734387431,0.0175286159158318,0.0177266623433482,3.10877771688437,3.9687260930942,3.94020322644033,4.06244408352838,0.122240857088052,0.00813823634673006,ENSG00000134058,CDK7,protein_coding,5,1,69234795,69277430,q13.2,cyclin dependent kinase 7 [Source:HGNC Symbol;Acc:HGNC:1778],NA,CDK7,1022,NM_001324069;NM_001324070;NM_001324071;NM_001324072;NM_001324074;NM_001324075;NM_001324077;NM_001324078;NM_001799
RNF19B_SIG,RNF19B,RNF19B_SIG,RNF19B,SIG,38,-2.58181655780747,0.46259775705018,0.474300573682554,0.424145645258093,-0.0501549284244612,0.0177570526762733,-1.05508441912942,5.9879367052531,6.01188863500738,5.90923750748901,-0.102651127518378,0.403590396806327,ENSG00000116514,RNF19B,protein_coding,1,-1,32936445,32964685,p35.1,ring finger protein 19B [Source:HGNC Symbol;Acc:HGNC:26886],NA,RNF19B,127544,NM_001127361;NM_001300826;NM_153341
DLX2_SIG,DLX2,DLX2_SIG,DLX2,SIG,31,2.58178534706238,-0.0585401384449142,-0.0622324577882957,-0.0464082320309464,0.0158242257573494,0.0177570526762733,0.00129299225314881,0.345862133885884,0.345843932813687,0.34592193740882,7.80045951336995e-05,0.999143346039538,ENSG00000115844,DLX2,protein_coding,2,-1,172099438,172102900,q31.1,distal-less homeobox 2 [Source:HGNC Symbol;Acc:HGNC:2915],NA,DLX2,1746,NM_004405
DLK1_SIG,DLK1,DLK1_SIG,DLK1,SIG,26,-2.58165345138621,-0.0940592915684013,-0.0895641847229184,-0.108828928346417,-0.0192647436234985,0.0177599671079636,-1.51967357760374,1.11793202188322,1.20159582284701,0.843036675859328,-0.358559146987682,0.215520266521442,ENSG00000185559,DLK1,protein_coding,14,1,100725705,100738224,q32.2,delta like non-canonical Notch ligand 1 [Source:HGNC Symbol;Acc:HGNC:2907],Idiopathic central precocious puberty;Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation;Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion;Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14;Temple syndrome due to maternal uniparental disomy of chromosome 14;Temple syndrome due to paternal 14q32.2 hypomethylation;Temple syndrome due to paternal 14q32.2 microdeletion,DLK1,8788,NM_001317172;NM_003836
ZNF689_TF,ZNF689,ZNF689_TF,ZNF689,TF,47,2.5814617203111,0.209916026405933,0.206729616144305,0.220385660122709,0.0136560439784041,0.0177659620542563,1.78418656213632,4.37887420447131,4.35546224712575,4.45579920717817,0.100336960052422,0.141884169964516,ENSG00000156853,ZNF689,protein_coding,16,-1,30602558,30624012,p11.2,zinc finger protein 689 [Source:HGNC Symbol;Acc:HGNC:25173],NA,ZNF689,115509,NM_138447
DDR1_SIG,DDR1,DDR1_SIG,DDR1,SIG,48,-2.58128706904866,-0.0622393910505919,-0.0568880269395631,-0.0798224445582578,-0.0229344176186946,0.0177710799533655,0.449837641006714,1.80789874487631,1.79239599078952,1.85883636544719,0.0664403746576739,0.739184984248049,ENSG00000204580,DDR1,protein_coding,6,1,30876421,30900156,p21.33,discoidin domain receptor tyrosine kinase 1 [Source:HGNC Symbol;Acc:HGNC:2730],NA,DDR1,780,NM_001202521;NM_001202522;NM_001202523;NM_001297652;NM_001297653;NM_001297654;NM_001954;NM_013993;NM_013994
PYCR1_SIG,PYCR1,PYCR1_SIG,PYCR1,SIG,36,2.58108170027075,0.0242813829943648,0.0187452047924247,0.0424716828007394,0.0237264780083148,0.0177777814970031,1.39288490945178,3.26080742288682,3.21546575668008,3.4097871832804,0.194321426600316,0.259302368841307,ENSG00000183010,PYCR1,protein_coding,17,-1,81932384,81942412,q25.3,pyrroline-5-carboxylate reductase 1 [Source:HGNC Symbol;Acc:HGNC:9721],Autosomal recessive cutis laxa type 2B;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIB;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIIB;Geroderma osteodysplastica;PYCR1-related DeBarsy syndrome,PYCR1,5831,NM_001282279;NM_001282280;NM_001282281;NM_001330523;NM_006907;NM_153824
RIOK1_SIG,RIOK1,RIOK1_SIG,RIOK1,SIG,24,2.58025127111551,0.554892511115045,0.549804055679963,0.571611721830314,0.0218076661503504,0.0178167109986582,2.75822402242119,4.99170040436423,4.95772403356259,5.10333705128389,0.145613017721296,0.0195550787547823,ENSG00000124784,RIOK1,protein_coding,6,1,7389793,7418037,p24.3,RIO kinase 1 [Source:HGNC Symbol;Acc:HGNC:18656],NA,RIOK1,83732,NM_001348194;NM_031480
PUS3_SIG,PUS3,PUS3_SIG,PUS3,SIG,19,2.58006896700237,0.000561388679056849,-0.00882004699743997,0.0313861059018321,0.0402061528992721,0.0178222375701095,1.86010443271708,2.79628562429855,2.76800459378383,2.88920901027548,0.121204416491654,0.124752747187864,ENSG00000110060,PUS3,protein_coding,11,-1,125893485,125903221,q24.2,pseudouridine synthase 3 [Source:HGNC Symbol;Acc:HGNC:25461],Mental retardation autosomal recessive 55;Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,PUS3,83480,NM_001271985;NM_031307
RBM41_SIG,RBM41,RBM41_SIG,RBM41,SIG,33,2.5798501691646,0.378729555789665,0.371774107085499,0.401583172960497,0.0298090658749979,0.0178296501680437,1.50698772684424,3.99275315166311,3.97205201467246,4.0607711732038,0.0887191585313322,0.219708913364849,ENSG00000089682,RBM41,protein_coding,X,-1,107064420,107118823,q22.3,RNA binding motif protein 41 [Source:HGNC Symbol;Acc:HGNC:25617],NA,RBM41,55285,NM_001171080;NM_001324242;NM_001324243;NM_001324244;NM_018301
KIT_SIG,KIT,KIT_SIG,KIT,SIG,26,2.57923009425602,0.179267484548369,0.16893993943853,0.213200847052125,0.0442609076135949,0.0178578009515861,0.988663906012572,6.06785442047364,6.01689722401535,6.2352852088366,0.218387984821253,0.436314971963025,ENSG00000157404,KIT,protein_coding,4,1,54657918,54740715,q12,KIT proto-oncogene receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6342],Acute myeloblastic leukemia with maturation;Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22);Acute myeloid leukemia with t(8;21)(q22;q22) translocation;Aleukemic mast cell leukemia;Bullous diffuse cutaneous mastocytosis;Classic mast cell leukemia;Cutaneous mastocytoma;Gastrointestinal stromal tumor;human piebaldism;Isolated bone marrow mastocytosis;LEUKEMIA ACUTE MYELOID;Lymphoadenopathic mastocytosis with eosinophilia;MASTOCYTOSIS CUTANEOUS;Nodular urticaria pigmentosa;Piebald trait;PIEBALDISM;Plaque-form urticaria pigmentosa;Pseudoxanthomatous diffuse cutaneous mastocytosis;Smouldering systemic mastocytosis;Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease;Telangiectasia macularis eruptiva perstans;TESTICULAR GERM CELL TUMOR;Testicular seminomatous germ cell tumor;Typical urticaria pigmentosa,KIT,3815,NM_000222;NM_001093772
CAPN15_SIG,CAPN15,CAPN15_SIG,CAPN15,SIG,16,2.57891174392421,0.379979895699753,0.37646830197971,0.391517989351321,0.0150496873716105,0.0178703762825149,0.591200236763998,6.39773325008127,6.39042540643159,6.42174473635879,0.031319329927208,0.656699990349759,ENSG00000103326,CAPN15,protein_coding,16,1,527712,554636,p13.3,calpain 15 [Source:HGNC Symbol;Acc:HGNC:11182],NA,CAPN15,6650,NM_005632
ELP3_SIG,ELP3,ELP3_SIG,ELP3,SIG,95,2.57846371999407,0.404395009519798,0.39225513302483,0.444283175146122,0.0520280421212919,0.0178896729188872,1.59732582746952,4.92817709421527,4.89448574775476,5.03887723258553,0.144391484830768,0.191381833274146,ENSG00000134014,ELP3,protein_coding,8,1,28089673,28191156,p21.1,elongator acetyltransferase complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:20696],NA,ELP3,55140,NM_001284220;NM_001284222;NM_001284224;NM_001284225;NM_001284226;NM_018091
AURKA_SIG,AURKA,AURKA_SIG,AURKA,SIG,32,-2.57766037968289,0.0529553378109325,0.0613791582344583,0.0252770707050621,-0.0361020875293961,0.0179274116100357,-2.42030818449888,2.78053723902858,2.85756802720251,2.52743607788565,-0.330131949316864,0.0419547402245931,ENSG00000087586,AURKA,protein_coding,20,-1,56369389,56392337,q13.2,aurora kinase A [Source:HGNC Symbol;Acc:HGNC:11393],NA,AURKA,6790,NM_001323303;NM_001323304;NM_001323305;NM_003600;NM_198433;NM_198434;NM_198435;NM_198436;NM_198437
GFM2_SIG,GFM2,GFM2_SIG,GFM2,SIG,10,2.57747498350279,0.489432176703449,0.479572212159482,0.521829203062197,0.0422569909027151,0.0179331303149137,1.17174647943999,4.64964234973687,4.63278100496725,4.70504391112275,0.0722629061554921,0.349653678807015,ENSG00000164347,GFM2,protein_coding,5,-1,74721206,74767147,q13.3,G elongation factor mitochondrial 2 [Source:HGNC Symbol;Acc:HGNC:29682],NA,GFM2,84340,NM_001281302;NM_032380;NM_170681;NM_170691
KLF11_TF,KLF11,KLF11_TF,KLF11,TF,51,-2.57689104077368,0.0566380495218629,0.0603490980130083,0.0444446044795282,-0.0159044935334802,0.0179595471921404,-1.59624718273197,5.45509062868253,5.51760617251396,5.2496824132364,-0.267923759277559,0.191682945593521,ENSG00000172059,KLF11,protein_coding,2,1,10042849,10054836,p25.1,Kruppel like factor 11 [Source:HGNC Symbol;Acc:HGNC:11811],MATURITY-ONSET DIABETES OF THE YOUNG TYPE 7;MODY,KLF11,8462,NM_001177716;NM_001177718;NM_003597
FARSA_SIG,FARSA,FARSA_SIG,FARSA,SIG,62,2.57640025408852,0.22288516843184,0.212919736550821,0.255628730326618,0.0427089937757974,0.017981152603638,2.04066761483874,5.84852114848469,5.79119146742331,6.0368901005435,0.245698633120183,0.0901166016351578,ENSG00000179115,FARSA,protein_coding,19,-1,12922479,12934037,p13.13,phenylalanyl-tRNA synthetase subunit alpha [Source:HGNC Symbol;Acc:HGNC:3592],NA,FARSA,2193,NM_004461
POLR2I_SIG,POLR2I,POLR2I_SIG,POLR2I,SIG,19,2.57632408785349,0.416923377099693,0.410907457290146,0.436689970759631,0.0257825134694856,0.017981205437081,3.18360060432121,3.49233496318925,3.45465177715756,3.61615114586479,0.161499368707227,0.00664090578078013,ENSG00000105258,POLR2I,protein_coding,19,-1,36113709,36115213,q13.12,RNA polymerase II subunit I [Source:HGNC Symbol;Acc:HGNC:9196],NA,POLR2I,5438,NM_006233
UHRF2_SIG,UHRF2,UHRF2_SIG,UHRF2,SIG,28,2.57591860377219,0.415273021029463,0.411198472940603,0.428660821892862,0.0174623489522588,0.0179983933748192,1.03881207332873,6.53018464368859,6.51680005581888,6.57416257526052,0.057362519441642,0.411490229091773,ENSG00000147854,UHRF2,protein_coding,9,1,6413151,6507054,p24.1,ubiquitin like with PHD and ring finger domains 2 [Source:HGNC Symbol;Acc:HGNC:12557],NA,UHRF2,115426,NM_152896
ABCB6_SIG,ABCB6,ABCB6_SIG,ABCB6,SIG,36,-2.57567059794856,-0.0416654773954496,-0.0299120555402375,-0.0802838634911465,-0.0503718079509091,0.0180073937233349,-2.72298118482685,0.900104156534888,0.948129143534628,0.742307770678597,-0.205821372856031,0.0212108938049125,ENSG00000115657,ABCB6,protein_coding,2,-1,219209772,219218994,q35,ATP binding cassette subfamily B member 6 (Langereis blood group) [Source:HGNC Symbol;Acc:HGNC:47],BLOOD GROUP LANGEREIS SYSTEM;Coloboma of choroid and retina;Coloboma of eye lens;Coloboma of eyelid;Coloboma of iris;Coloboma of macula;Coloboma of optic disc;Colobomatous microphthalmia;Dyschromatosis universalis hereditaria;Dyschromatosis universalis hereditaria 3;Familial pseudohyperkalemia;Microphthalmia isolated with coloboma 7;PSEUDOHYPERKALEMIA FAMILIAL 2 DUE TO RED CELL LEAK,ABCB6,10058,NM_001349828;NM_005689
KDM5C_TF,KDM5C,KDM5C_TF,KDM5C,TF,71,2.57538612558969,0.255977787557603,0.249209867445943,0.278215239353057,0.0290053719071146,0.0180182982524004,2.96505457654088,7.40482007301776,7.3709272102087,7.51618233653326,0.145255126324563,0.0117877261928156,ENSG00000126012,KDM5C,protein_coding,X,-1,53191321,53225422,p11.22,lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114],MENTAL RETARDATION SYNDROMIC X-LINKED JARID1C-RELATED;MENTAL RETARDATION X-LINKED SYNDROMIC CLAES-JENSEN TYPE;Syndromic X-linked intellectual disability due to JARID1C mutation,KDM5C,8242,NM_001146702;NM_001282622;NM_001353978;NM_001353979;NM_001353981;NM_001353982;NM_001353984;NM_004187
ZNF670_TF,ZNF670,ZNF670_TF,ZNF670,TF,30,2.57491461133388,0.200474343970058,0.196157324867691,0.214658835306405,0.0185015104387136,0.018038961286221,1.7852605845787,1.18569602857717,1.16270769056794,1.26122913917891,0.0985214486109704,0.141610882296391,ENSG00000277462,ZNF670,protein_coding,1,-1,247034637,247078811,q44,zinc finger protein 670 [Source:HGNC Symbol;Acc:HGNC:28167],NA,ZNF670,93474,NM_001204220;NM_033213
CBFA2T2_TF,CBFA2T2,CBFA2T2_TF,CBFA2T2,TF,79,2.5744600038444,0.279718925788356,0.273639276598784,0.299694915982666,0.0260556393838823,0.0180587626040376,2.0965318620558,5.24737772350965,5.21760556165371,5.3452005410363,0.127594979382592,0.0808858000261261,ENSG00000078699,CBFA2T2,protein_coding,20,1,33490075,33650036,q11.21,CBFA2/RUNX1 translocation partner 2 [Source:HGNC Symbol;Acc:HGNC:1536],NA,CBFA2T2,9139,NM_001032999;NM_001039709;NM_005093
GNAQ_SIG,GNAQ,GNAQ_SIG,GNAQ,SIG,13,2.5738807262693,0.256709072248634,0.254151936675946,0.265111089130324,0.0109591524543783,0.0180850984246701,0.101019935818503,7.76017704899669,7.75899451299724,7.76406252442346,0.00506801142622408,0.943836237636676,ENSG00000156052,GNAQ,protein_coding,9,-1,77716087,78031458,q21.2,G protein subunit alpha q [Source:HGNC Symbol;Acc:HGNC:4390],Capillary malformations congenital;Congenital Hemangioma;Familial multiple nevi flammei;Phakomatosis cesioflammea;Sturge-Weber syndrome;Uveal melanoma,GNAQ,2776,NM_002072
STARD8_SIG,STARD8,STARD8_SIG,STARD8,SIG,41,-2.57367156672801,0.0793231308847482,0.083944757815906,0.0641377852538013,-0.0198069725621048,0.0180921068288881,-2.3625017111395,3.86255907458603,3.94594355956904,3.58858148107041,-0.357362078498629,0.0474641012161238,ENSG00000130052,STARD8,protein_coding,X,1,68647666,68725842,q13.1,StAR related lipid transfer domain containing 8 [Source:HGNC Symbol;Acc:HGNC:19161],NA,STARD8,9754,NM_001142503;NM_001142504;NM_014725
HDAC5_SIG,HDAC5,HDAC5_SIG,HDAC5,SIG,55,2.57328189014255,0.0776130460231045,0.0743762928469318,0.0882480921733862,0.0138717993264544,0.0181077723834984,0.326084288297307,6.58988990532419,6.58555965655969,6.6041178655504,0.0185582089907045,0.812492240594199,ENSG00000108840,HDAC5,protein_coding,17,-1,44076746,44123702,q21.31,histone deacetylase 5 [Source:HGNC Symbol;Acc:HGNC:14068],NA,HDAC5,10014,NM_001015053;NM_005474
TIGD5_TF,TIGD5,TIGD5_TF,TIGD5,TF,84,2.57322189891584,0.251448336742868,0.244994648762172,0.272653311536583,0.0276586627744109,0.0181077723834984,1.5320219844898,2.87404899408563,2.84434650416211,2.9716428895486,0.127296385386486,0.211576022431054,ENSG00000179886,TIGD5,protein_coding,8,1,143597835,143603224,q24.3,tigger transposable element derived 5 [Source:HGNC Symbol;Acc:HGNC:18336],NA,TIGD5,84948,NM_032862
BCKDK_SIG,BCKDK,BCKDK_SIG,BCKDK,SIG,41,2.5730635470181,0.332680396730493,0.326580108595128,0.352724200603837,0.0261440920087096,0.0181121307322646,2.25234035087237,5.44580133824855,5.41006521131384,5.56322004103402,0.153154829720183,0.0596727668530937,ENSG00000103507,BCKDK,protein_coding,16,1,31106107,31112791,p11.2,branched chain ketoacid dehydrogenase kinase [Source:HGNC Symbol;Acc:HGNC:16902],Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency;Branched-chain keto acid dehydrogenase kinase deficiency,BCKDK,10295,NM_001122957;NM_001271926;NM_005881
IRF1_SIG,IRF1,IRF1_SIG,IRF1,SIG,30,-2.57272711804591,0.187826897424379,0.19345997281229,0.169318221149817,-0.0241417516624735,0.0181258138858152,-1.34711033635532,7.11395847400578,7.14678198294888,7.00610980176415,-0.140672181184736,0.276443748669495,ENSG00000125347,IRF1,protein_coding,5,-1,132481609,132490777,q31.1,interferon regulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:6116],GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,IRF1,3659,NM_001354924;NM_001354925;NM_002198
TNIK_SIG,TNIK,TNIK_SIG,TNIK,SIG,61,-2.57247662565934,-0.0126222348435948,-0.00761637966843583,-0.0290700447048315,-0.0214536650363956,0.0181350036442699,-1.38208470786747,4.02019453883403,4.0714823152999,3.85167755901759,-0.219804756282315,0.263369632354628,ENSG00000154310,TNIK,protein_coding,3,-1,171058414,171460408,q26.31,TRAF2 and NCK interacting kinase [Source:HGNC Symbol;Acc:HGNC:30765],Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE 54,TNIK,23043,NM_001161560;NM_001161561;NM_001161562;NM_001161563;NM_001161564;NM_001161565;NM_001161566;NM_015028
CASK_SIG,CASK,CASK_SIG,CASK,SIG,26,-2.57154624146062,-0.0594828591624466,-0.0556358036688203,-0.0721231843557899,-0.0164873806869697,0.0181798637597165,-2.4465369947836,3.39903733467719,3.46176957815588,3.19291710610434,-0.268852472051542,0.0396475373041679,ENSG00000147044,CASK,protein_coding,X,-1,41514934,41923645,p11.4,calcium/calmodulin dependent serine protein kinase [Source:HGNC Symbol;Acc:HGNC:1497],Anemia nonspherocytic hemolytic due to g6pd deficiency;Early infantile epileptic encephalopathy;FG SYNDROME 4;FG SYNDROME TYPE 4;Mental retardation and microcephaly with pontine and cerebellar hypoplasia;MENTAL RETARDATION X-LINKED CASK-RELATED;MRX with/without nystagmus;X-linked intellectual disability Najm type,CASK,8573,NM_001126054;NM_001126055;NM_003688
CSPG4_SIG,CSPG4,CSPG4_SIG,CSPG4,SIG,71,2.57127862904923,-0.0183960011413396,-0.0238254300683393,-0.000556448952626421,0.0232689811157127,0.0181899769874154,0.246503887123896,1.30943663893668,1.29777974415832,1.34773786463701,0.0499581204786845,0.860071476666609,ENSG00000173546,CSPG4,protein_coding,15,-1,75674322,75712848,q24.2,chondroitin sulfate proteoglycan 4 [Source:HGNC Symbol;Acc:HGNC:2466],NA,CSPG4,1464,NM_001897
SOX15_TF,SOX15,SOX15_TF,SOX15,TF,158,-2.56967551100818,-0.0188606363176583,-0.0164981770239117,-0.0266230025685401,-0.0101248255446285,0.0182704017181028,-2.10258572065985,0.672548963916772,0.716347799016122,0.528638505733191,-0.187709293282931,0.0799880777786248,ENSG00000129194,SOX15,protein_coding,17,-1,7588178,7590170,p13.1,SRY-box 15 [Source:HGNC Symbol;Acc:HGNC:11196],NA,SOX15,6665,NM_006942
ESPL1_SIG,ESPL1,ESPL1_SIG,ESPL1,SIG,30,-2.56897398815138,0.157381106666324,0.187885865197021,0.0571511857797472,-0.130734679417274,0.0183034641684606,-2.03984258610368,3.71459662376164,3.77834456148769,3.50513911409033,-0.273205447397359,0.0902527462539416,ENSG00000135476,ESPL1,protein_coding,12,1,53268299,53293643,q13.13,extra spindle pole bodies like 1, separase [Source:HGNC Symbol;Acc:HGNC:16856],NA,ESPL1,9700,NM_012291
RBM20_SIG,RBM20,RBM20_SIG,RBM20,SIG,15,-2.56739800543266,-0.134424448954286,-0.130118509836201,-0.148572534627993,-0.0184540247917917,0.0183828915324961,-0.497909861901968,0.333304388157499,0.339774933108544,0.312044026175494,-0.0277309069330505,0.7109094611328,ENSG00000203867,RBM20,protein_coding,10,1,110644336,110839468,q25.2,RNA binding motif protein 20 [Source:HGNC Symbol;Acc:HGNC:27424],CARDIOMYOPATHY DILATED 1DD;Familial isolated dilated cardiomyopathy,RBM20,282996,NM_001134363
STRADB_SIG,STRADB,STRADB_SIG,STRADB,SIG,31,2.5659884979156,0.263709860046746,0.25689009315949,0.286117665533446,0.0292275723739565,0.0184537639311051,3.03719253482415,4.13502627723636,4.07872204008102,4.32002591360388,0.241303873522857,0.00976421296124253,ENSG00000082146,STRADB,protein_coding,2,1,201387858,201480846,q33.1,STE20 related adaptor beta [Source:HGNC Symbol;Acc:HGNC:13205],NA,STRADB,55437,NM_001206864;NM_018571
ZNF630_TF,ZNF630,ZNF630_TF,ZNF630,TF,26,2.56427915771237,0.199737196634121,0.191069682888958,0.228216170368226,0.0371464874792682,0.0185408887811753,1.71449546969808,1.60835870983451,1.58509955506089,1.68478164694783,0.0996820918869382,0.159461936869823,ENSG00000221994,ZNF630,protein_coding,X,-1,47983356,48071658,p11.23,zinc finger protein 630 [Source:HGNC Symbol;Acc:HGNC:28855],NA,ZNF630,57232,NM_001037735;NM_001190255;NM_001282201;NM_001282202
IMPA1_SIG,IMPA1,IMPA1_SIG,IMPA1,SIG,17,2.56369923435869,0.194666797071456,0.192001960354367,0.20342268914189,0.0114207287875228,0.0185678743836262,0.539225124522196,4.71383971758969,4.70640125597409,4.7382803771838,0.0318791212097045,0.686671061596275,ENSG00000133731,IMPA1,protein_coding,8,-1,81656914,81686331,q21.13,inositol monophosphatase 1 [Source:HGNC Symbol;Acc:HGNC:6050],MENTAL RETARDATION AUTOSOMAL RECESSIVE 59,IMPA1,3612,NM_001144878;NM_001144879;NM_005536
HELQ_SIG,HELQ,HELQ_SIG,HELQ,SIG,35,2.56207565701803,0.163704099580153,0.153229754506885,0.198119804820892,0.0448900503140064,0.0186508668014342,2.51014193183561,3.94909343053466,3.91607768368158,4.05757374162333,0.141496057941753,0.0345194082768965,ENSG00000163312,HELQ,protein_coding,4,-1,83407343,83455855,q21.23,helicase, POLQ like [Source:HGNC Symbol;Acc:HGNC:18536],NA,HELQ,113510,NM_001297755;NM_001297756;NM_001297757;NM_133636
PKMYT1_SIG,PKMYT1,PKMYT1_SIG,PKMYT1,SIG,45,-2.56014150679871,0.314851759050441,0.338594131794588,0.236841105748242,-0.101753026046347,0.0187509371326195,-2.11972183862836,3.62678641596356,3.69652623794711,3.39764128658905,-0.298884951358054,0.0774191674377353,ENSG00000127564,PKMYT1,protein_coding,16,-1,2968024,2980479,p13.3,protein kinase, membrane associated tyrosine/threonine 1 [Source:HGNC Symbol;Acc:HGNC:29650],NA,PKMYT1,9088,NM_001258450;NM_001258451;NM_004203;NM_182687
WDR5_SIG,WDR5,WDR5_SIG,WDR5,SIG,28,2.55996490672925,0.406335742368061,0.397976448461851,0.433801993774177,0.035825545312326,0.0187541440447668,2.3904854060423,5.4805005230456,5.45017603686556,5.5801381204943,0.129962083628738,0.0447123636684597,ENSG00000196363,WDR5,protein_coding,9,1,134135365,134159968,q34.2,WD repeat domain 5 [Source:HGNC Symbol;Acc:HGNC:12757],NA,WDR5,11091,NM_017588;NM_052821
CTU1_SIG,CTU1,CTU1_SIG,CTU1,SIG,22,2.55993176405844,0.137141710546554,0.126536063751957,0.171988835728799,0.0454527719768412,0.0187541440447668,1.37167386596423,2.12812193678469,2.10523139485616,2.20333371740698,0.0981023225508212,0.267395432529707,ENSG00000142544,CTU1,protein_coding,19,-1,51097606,51108409,q13.41,cytosolic thiouridylase subunit 1 [Source:HGNC Symbol;Acc:HGNC:29590],NA,CTU1,90353,NM_145232
DNASE1_SIG,DNASE1,DNASE1_SIG,DNASE1,SIG,124,2.55926854674666,0.0667639321799833,0.0601738733209086,0.0884169827169428,0.028243109396034,0.0187859021872962,1.1567587641509,4.80660761227718,4.76976805079244,4.92765188572704,0.157883834934602,0.356372067120714,ENSG00000213918,DNASE1,protein_coding,16,1,3611728,3680143,p13.3,deoxyribonuclease 1 [Source:HGNC Symbol;Acc:HGNC:2956],Autosomal systemic lupus erythematosus;Systemic lupus erythematosus,DNASE1,1773,NM_001351825;NM_005223
NLRP3_SIG,NLRP3,NLRP3_SIG,NLRP3,SIG,46,-2.55835942936573,0.203466771125911,0.21072816077951,0.179607919406944,-0.0311202413725653,0.0188310206237654,-0.45336394909489,6.01946353837142,6.03356461467581,5.97313143051414,-0.0604331841616671,0.737332359104732,ENSG00000162711,NLRP3,protein_coding,1,1,247416156,247449108,q44,NLR family pyrin domain containing 3 [Source:HGNC Symbol;Acc:HGNC:16400],CINCA SYNDROME;DEAFNESS AUTOSOMAL DOMINANT 34 WITH OR WITHOUT INFLAMMATION;FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1;Familial cold urticaria;KERATOENDOTHELIITIS FUGAX HEREDITARIA;MUCKLE-WELLS SYNDROME,NLRP3,114548,NM_001079821;NM_001127461;NM_001127462;NM_001243133;NM_004895;NM_183395
TFCP2_TF,TFCP2,TFCP2_TF,TFCP2,TF,254,2.55826363280627,0.29062784941562,0.281687286256544,0.320003985509728,0.038316699253184,0.0188321393281588,1.60675697093847,5.72849917180257,5.69666989641911,5.83308107663392,0.136411180214806,0.188663864658972,ENSG00000135457,TFCP2,protein_coding,12,-1,51093663,51173134,q13.13,transcription factor CP2 [Source:HGNC Symbol;Acc:HGNC:11748],NA,TFCP2,7024,NM_001173452;NM_001173453;NM_005653
FASTKD3_SIG,FASTKD3,FASTKD3_SIG,FASTKD3,SIG,29,2.55815098718216,0.0755829935163151,0.0682534009344094,0.0996659405711483,0.0314125396367391,0.0188341713998152,1.89407464777423,2.77193301562486,2.74647486320596,2.85558123071556,0.109106367509603,0.117474444717466,ENSG00000124279,FASTKD3,protein_coding,5,-1,7859159,7869037,p15.31,FAST kinase domains 3 [Source:HGNC Symbol;Acc:HGNC:28758],NA,FASTKD3,79072,NM_024091
COL18A1_SIG,COL18A1,COL18A1_SIG,COL18A1,SIG,56,-2.55732598400259,-0.0983681406718559,-0.0936480946612653,-0.113876863278082,-0.0202287686168168,0.0188748258660757,-2.28761322595048,4.09460192709166,4.17425537396271,3.83288345880107,-0.341371915161633,0.0553928607630045,ENSG00000182871,COL18A1,protein_coding,21,1,45405137,45513720,q22.3,collagen type XVIII alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2195],Knobloch syndrome;KNOBLOCH SYNDROME 1;Knobloch Syndrome Type I,COL18A1,80781,NM_030582;NM_130444;NM_130445
WDR26_SIG,WDR26,WDR26_SIG,WDR26,SIG,33,-2.55708045503894,0.266097396002107,0.274657833085227,0.237970245586142,-0.0366875874990846,0.0188840752604209,-2.1411892726796,7.93284020725193,7.96367098418984,7.83153908302739,-0.132131901162451,0.0743459186461527,ENSG00000162923,WDR26,protein_coding,1,-1,224385143,224437033,q42.12,WD repeat domain 26 [Source:HGNC Symbol;Acc:HGNC:21208],Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome;Intellectual Disability Seizures Abnormal Gait and Distinctive Facial Features;SKRABAN-DEARDORFF SYNDROME,WDR26,80232,NM_001115113;NM_025160
SRSF7_SIG,SRSF7,SRSF7_SIG,SRSF7,SIG,15,2.55539024183106,0.179747958890796,0.176055181822552,0.191881369257882,0.0158261874353302,0.0189719357586779,0.441506420960396,7.42911971782833,7.42292006075552,7.44949001963899,0.0265699588834662,0.744008087748539,ENSG00000115875,SRSF7,protein_coding,2,-1,38743599,38751494,p22.1,serine and arginine rich splicing factor 7 [Source:HGNC Symbol;Acc:HGNC:10789],NA,SRSF7,6432,NM_001031684;NM_001195446;NM_001363802
GCFC2_TF,GCFC2,GCFC2_TF,GCFC2,TF,98,2.55469620342827,0.0960520015748014,0.0914569530308103,0.111150018219344,0.0196930651885336,0.0190056992879425,1.35535264711922,4.03001064612836,4.00584382257129,4.10941592353016,0.103572100958868,0.273496755727117,ENSG00000005436,GCFC2,protein_coding,2,-1,75652000,75710989,p12,GC-rich sequence DNA-binding factor 2 [Source:HGNC Symbol;Acc:HGNC:1317],NA,GCFC2,6936,NM_001201334;NM_001201335;NM_003203
ZNF101_TF,ZNF101,ZNF101_TF,ZNF101,TF,82,-2.55400843683425,0.0992448168789801,0.102833995224086,0.0874518023164895,-0.0153821929075964,0.0190391724658569,-0.730209010862411,4.13746325831057,4.14943476903586,4.09812829449894,-0.0513064745369184,0.574335039914116,ENSG00000181896,ZNF101,protein_coding,19,1,19668796,19683509,p13.11,zinc finger protein 101 [Source:HGNC Symbol;Acc:HGNC:12881],NA,ZNF101,94039,NM_001300949;NM_033204
HMGCS1_SIG,HMGCS1,HMGCS1_SIG,HMGCS1,SIG,18,2.55344118112596,0.123634083959239,0.120290899245719,0.13461883373223,0.014327934486511,0.0190660984834712,-0.339913122010314,5.43561348143511,5.44220310777411,5.41396185203555,-0.0282412557385639,0.803787438826121,ENSG00000112972,HMGCS1,protein_coding,5,-1,43287470,43313512,p12,3-hydroxy-3-methylglutaryl-CoA synthase 1 [Source:HGNC Symbol;Acc:HGNC:5007],NA,HMGCS1,3157,NM_001098272;NM_001324219;NM_001324220;NM_001324222;NM_001324223;NM_001324224;NM_001330663;NM_001364188;NM_002130
CAST_SIG,CAST,CAST_SIG,CAST,SIG,16,-2.55179531077516,0.211439124731561,0.219996067867847,0.183323454426621,-0.036672613441226,0.0191522643033776,-1.47614701605622,7.50334988092791,7.54528247311496,7.36557136374189,-0.179711109373072,0.229806333811619,ENSG00000153113,CAST,protein_coding,5,1,96525267,96779595,q15,calpastatin [Source:HGNC Symbol;Acc:HGNC:1515],Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome;PEELING SKIN WITH LEUKONYCHIA ACRAL PUNCTATE KERATOSES CHEILITIS AND KNUCKLE PADS,CAST,831,NM_001042440;NM_001042441;NM_001042442;NM_001042443;NM_001042444;NM_001042445;NM_001042446;NM_001190442;NM_001284212;NM_001284213;NM_001330626;NM_001330627;NM_001330628;NM_001330629;NM_001330630;NM_001330631;NM_001330632;NM_001330633;NM_001330634;NM_001750;NM_173060
GALK2_SIG,GALK2,GALK2_SIG,GALK2,SIG,17,2.55067728366968,0.276798435455952,0.266635415610464,0.310191214948269,0.0435557993378046,0.0192096628019156,1.50433204298232,3.89678399029382,3.86795468615406,3.99150884675304,0.123554160598981,0.220427529419298,ENSG00000156958,GALK2,protein_coding,15,1,49155656,49367869,q21.1,galactokinase 2 [Source:HGNC Symbol;Acc:HGNC:4119],NA,GALK2,2585,NM_001001556;NM_001289030;NM_001289031;NM_001352047;NM_001352048;NM_002044
TFEB_SIG,TFEB,TFEB_SIG,TFEB,SIG,52,-2.55057244594397,0.338117020841336,0.349496685724148,0.300726693369237,-0.0487699923549116,0.0192112983360599,-0.951744085444526,4.21328899458234,4.24361426221501,4.11364882950354,-0.12996543271147,0.454723469606864,ENSG00000112561,TFEB,protein_coding,6,-1,41683978,41736259,p21.1,transcription factor EB [Source:HGNC Symbol;Acc:HGNC:11753],MiT family translocation renal cell carcinoma,TFEB,7942,NM_001167827;NM_001271943;NM_001271944;NM_001271945;NM_007162
GADD45B_SIG,GADD45B,GADD45B_SIG,GADD45B,SIG,31,-2.54999437177451,0.424179136457517,0.434678523178523,0.389681151517071,-0.0449973716614518,0.0192390341174064,-1.26077379722011,6.49032332785763,6.52933656977042,6.36213696157275,-0.167199608197672,0.310935765522351,ENSG00000099860,GADD45B,protein_coding,19,1,2476122,2478259,p13.3,growth arrest and DNA damage inducible beta [Source:HGNC Symbol;Acc:HGNC:4096],NA,GADD45B,4616,NM_015675
PDE8B_SIG,PDE8B,PDE8B_SIG,PDE8B,SIG,16,-2.54986714791206,-0.154668146477388,-0.15150864550292,-0.165049363964926,-0.0135407184620061,0.019241908142468,0.794452702891191,0.948933169803457,0.930882341726261,1.00824303348567,0.0773606917594121,0.53822390616672,ENSG00000113231,PDE8B,protein_coding,5,1,77210449,77429807,q13.3,phosphodiesterase 8B [Source:HGNC Symbol;Acc:HGNC:8794],Autosomal dominant striatal neurodegeneration;PIGMENTED NODULAR ADRENOCORTICAL DISEASE PRIMARY 3;Primary pigmented nodular adrenocortical disease;STRIATAL DEGENERATION AUTOSOMAL DOMINANT 1,PDE8B,8622,NM_001029851;NM_001029852;NM_001029853;NM_001029854;NM_001349748;NM_001349749;NM_001349751;NM_003719
ZBTB4_TF,ZBTB4,ZBTB4_TF,ZBTB4,TF,59,2.54979178215428,0.00801567112541917,0.00440346609616662,0.0198843447929633,0.0154808786967966,0.0192419210258896,1.52364214899144,6.32950588979202,6.30279592276343,6.41726721002882,0.114471287265387,0.214182907161171,ENSG00000174282,ZBTB4,protein_coding,17,-1,7459366,7484263,p13.1,zinc finger and BTB domain containing 4 [Source:HGNC Symbol;Acc:HGNC:23847],NA,ZBTB4,57659,NM_001128833;NM_020899
ATXN2_SIG,ATXN2,ATXN2_SIG,ATXN2,SIG,76,2.54965317342398,0.259636855443107,0.25202060005724,0.284661694568099,0.0326410945108589,0.0192454252124324,2.34308677809304,5.56608950689832,5.51802285978724,5.72402277597759,0.205999916190345,0.0495076087379498,ENSG00000204842,ATXN2,protein_coding,12,-1,111443485,111599676,q24.12,ataxin 2 [Source:HGNC Symbol;Acc:HGNC:10555],Amyotrophic lateral sclerosis;Parkinson disease late-onset;SPINOCEREBELLAR ATAXIA 2;Spinocerebellar ataxia type 2,ATXN2,6311,NM_001310121;NM_001310123;NM_002973
SLC27A4_SIG,SLC27A4,SLC27A4_SIG,SLC27A4,SIG,101,2.54892157196732,0.293473579764203,0.284494588078141,0.322975981018408,0.0384813929402668,0.0192813595706571,2.96452898966266,3.90080358172313,3.82508816319044,4.14958281404482,0.324494650854381,0.011799830767616,ENSG00000167114,SLC27A4,protein_coding,9,1,128340527,128361470,q34.11,solute carrier family 27 member 4 [Source:HGNC Symbol;Acc:HGNC:10998],ICHTHYOSIS PREMATURITY SYNDROME,SLC27A4,10999,NM_005094
EIF4E_SIG,EIF4E,EIF4E_SIG,EIF4E,SIG,13,2.54885246025154,0.294782414532828,0.290182804077707,0.309895420313941,0.0197126162362342,0.0192813595706571,2.67820965555267,4.20526009952081,4.17601641990484,4.30134647540187,0.125330055497027,0.0235683674206491,ENSG00000151247,EIF4E,protein_coding,4,-1,98871684,98930637,q23,eukaryotic translation initiation factor 4E [Source:HGNC Symbol;Acc:HGNC:3287],AUTISM SUSCEPTIBILITY TO 19,EIF4E,1977,NM_001130678;NM_001130679;NM_001331017;NM_001968
ATXN2L_SIG,ATXN2L,ATXN2L_SIG,ATXN2L,SIG,22,2.54810391498327,0.272457116055449,0.268363229041862,0.285908459100091,0.0175452300582289,0.0193148384950907,1.55862880130228,8.24461705317895,8.23123386861414,8.28859037389189,0.0573565052777471,0.202949798129289,ENSG00000168488,ATXN2L,protein_coding,16,1,28823035,28837237,p11.2,ataxin 2 like [Source:HGNC Symbol;Acc:HGNC:31326],NA,ATXN2L,11273,NM_001308230;NM_007245;NM_017492;NM_145714;NM_148414;NM_148415;NM_148416
CTRC_SIG,CTRC,CTRC_SIG,CTRC,SIG,27,-2.54809716412934,-0.108061787847805,-0.100610226046613,-0.132545490908866,-0.0319352648622534,0.0193148384950907,-1.24292049731539,0.295028267614672,0.304741195462723,0.263114361828217,-0.0416268336345061,0.318441154058554,ENSG00000162438,CTRC,protein_coding,1,1,15438439,15449242,p36.21,chymotrypsin C [Source:HGNC Symbol;Acc:HGNC:2523],Hereditary chronic pancreatitis;PANCREATITIS HEREDITARY;Tropical pancreatitis,CTRC,11330,NM_007272
MYCBP2_SIG,MYCBP2,MYCBP2_SIG,MYCBP2,SIG,20,2.54784967332939,0.619079364825632,0.614274584886491,0.634866498911379,0.0205919140248878,0.0193243865622726,0.461054719929783,7.98039137362929,7.97327905989224,8.0037604044796,0.0304813445873613,0.732847362251445,ENSG00000005810,MYCBP2,protein_coding,13,-1,77044657,77327094,q22.3,MYC binding protein 2, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:23386],NA,MYCBP2,23077,NM_015057
MRPL3_SIG,MRPL3,MRPL3_SIG,MRPL3,SIG,31,2.54723673470577,0.646451820389156,0.636730328253242,0.678393865978587,0.0416635377253447,0.0193541995763239,1.83838505109574,5.7363304268357,5.70508746998858,5.83898585647621,0.133898386487633,0.129216304101608,ENSG00000114686,MRPL3,protein_coding,3,-1,131462212,131502983,q22.1,mitochondrial ribosomal protein L3 [Source:HGNC Symbol;Acc:HGNC:10379],Combined oxidative phosphorylation defect type 9;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9,MRPL3,11222,NM_007208
NOP58_SIG,NOP58,NOP58_SIG,NOP58,SIG,36,2.54642966368689,0.428463510488576,0.422843716464405,0.446928547996569,0.0240848315321644,0.0193948377043949,1.57740557546391,6.39236076753348,6.37033696889959,6.46472467733057,0.0943877084309825,0.197337268592546,ENSG00000055044,NOP58,protein_coding,2,1,202265736,202303661,q33.1,NOP58 ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:29926],NA,NOP58,51602,NM_015934
ZNF326_SIG,ZNF326,ZNF326_SIG,ZNF326,SIG,152,2.5460773851645,0.321657663366154,0.313931631052803,0.347043198110022,0.0331115670572191,0.0194102467340409,2.70420650601352,6.4476639711995,6.39897080400886,6.60765580625446,0.208685002245595,0.0221992454575122,ENSG00000162664,ZNF326,protein_coding,1,1,89995110,90035533,p22.2,zinc finger protein 326 [Source:HGNC Symbol;Acc:HGNC:14104],NA,ZNF326,284695,NM_001320185;NM_181781;NM_182975;NM_182976
NPC1_SIG,NPC1,NPC1_SIG,NPC1,SIG,40,-2.54573564663177,0.237694463029579,0.241471135874571,0.225285395110319,-0.0161857407642517,0.0194250802265783,-1.49581375479889,4.6439321889548,4.67091514033029,4.55527392014963,-0.115641220180666,0.223349600580953,ENSG00000141458,NPC1,protein_coding,18,-1,23506184,23586506,q11.2,NPC intracellular cholesterol transporter 1 [Source:HGNC Symbol;Acc:HGNC:7897],Niemann-Pick disease type C adult neurologic onset;Niemann-Pick disease type C juvenile neurologic onset;Niemann-Pick disease type C late infantile neurologic onset;Niemann-Pick disease type C severe early infantile neurologic onset;Niemann-Pick disease type C severe perinatal form;NIEMANN-PICK DISEASE TYPE C1,NPC1,4864,NM_000271
LDHB_SIG,LDHB,LDHB_SIG,LDHB,SIG,27,2.54531164035324,0.623074714360699,0.615831486980615,0.646873890038114,0.0310424030574989,0.0194445049245074,1.90392396028032,8.12908305285724,8.09057589317495,8.25560657752761,0.165030684352656,0.115514445179183,ENSG00000111716,LDHB,protein_coding,12,-1,21635342,21757857,p12.1,lactate dehydrogenase B [Source:HGNC Symbol;Acc:HGNC:6541],Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency;LACTATE DEHYDROGENASE B DEFICIENCY,LDHB,3945,NM_001174097;NM_001315537;NM_002300
TRAT1_SIG,TRAT1,TRAT1_SIG,TRAT1,SIG,31,-2.54464501337754,0.0784775746104309,0.0831955003858523,0.0629758184911892,-0.0202196818946632,0.0194774742511828,-3.23006928247105,2.40457293407897,2.52475448482795,2.00969069590376,-0.515063788924188,0.0058370760623062,ENSG00000163519,TRAT1,protein_coding,3,1,108822698,108855005,q13.13,T cell receptor associated transmembrane adaptor 1 [Source:HGNC Symbol;Acc:HGNC:30698],NA,TRAT1,50852,NM_001317747;NM_016388
FARSB_SIG,FARSB,FARSB_SIG,FARSB,SIG,19,2.54356590896144,0.578975745725939,0.56888003244166,0.612147375088572,0.0432673426469121,0.0195335437479666,3.80175857388495,4.92624239402061,4.86108031675628,5.14034636217485,0.279266045418567,0.00107049045622544,ENSG00000116120,FARSB,protein_coding,2,-1,222566899,222656337,q36.1,phenylalanyl-tRNA synthetase subunit beta [Source:HGNC Symbol;Acc:HGNC:17800],NEURODEVELOPMENTAL DISORDER WITH BRAIN LIVER AND LUNGABNORMALITIES,FARSB,10056,NM_005687
CPEB2_SIG,CPEB2,CPEB2_SIG,CPEB2,SIG,22,-2.5423383059859,0.03974747039169,0.0452325241958464,0.0217251507494619,-0.0235073734463844,0.0195980805209021,-0.802611929985653,5.11585036570977,5.13870141304122,5.0407683530493,-0.0979330599919193,0.533696456242614,ENSG00000137449,CPEB2,protein_coding,4,1,15002674,15070153,p15.32,cytoplasmic polyadenylation element binding protein 2 [Source:HGNC Symbol;Acc:HGNC:21745],NA,CPEB2,132864,NM_001177381;NM_001177382;NM_001177383;NM_001177384;NM_182485;NM_182646
PRF1_SIG,PRF1,PRF1_SIG,PRF1,SIG,19,-2.54070174808445,-0.12276466425312,-0.115660588234586,-0.146106628314017,-0.0304460400794318,0.019685816042278,-2.30354735784175,3.92874315960288,4.020083800114,3.62862391220919,-0.391459887904816,0.0535883024913559,ENSG00000180644,PRF1,protein_coding,10,-1,70597348,70602759,q22.1,perforin 1 [Source:HGNC Symbol;Acc:HGNC:9360],APLASTIC ANEMIA APLASTIC ANEMIA SUSCEPTIBILITY TO INCLUDED;Familial hemophagocytic lymphohistiocytosis;Fatal post-viral neurodegenerative disorder;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FAMILIAL 2;Idiopathic aplastic anemia;LYMPHOMA NON-HODGKIN FAMILIAL,PRF1,5551,NM_001083116;NM_005041
FXR1_SIG,FXR1,FXR1_SIG,FXR1,SIG,47,2.53982925370761,0.299895667398453,0.294195066563955,0.318626212997515,0.0244311464335602,0.0197307531014436,1.64234731864267,7.60576049623584,7.58663306528728,7.66860776935252,0.0819747040652325,0.178654417924683,ENSG00000114416,FXR1,protein_coding,3,1,180868141,180982753,q26.33,FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023],NA,FXR1,8087,NM_001013438;NM_001013439;NM_005087
ZNF773_TF,ZNF773,ZNF773_TF,ZNF773,TF,38,2.53967690015588,0.156761007645886,0.150428638314116,0.177567364021704,0.0271387257075886,0.0197351115241111,2.14161369392819,2.91161440476776,2.87566708815911,3.02972701648192,0.154059928322811,0.0742820988456693,ENSG00000152439,ZNF773,protein_coding,19,1,57499915,57518404,q13.43,zinc finger protein 773 [Source:HGNC Symbol;Acc:HGNC:30487],NA,ZNF773,374928,NM_001304334;NM_001304335;NM_001304336;NM_001304337;NM_198542
ZNF106_SIG,ZNF106,ZNF106_SIG,ZNF106,SIG,19,-2.53860272463467,0.590369638130751,0.598469393015576,0.563756157794896,-0.0347132352206806,0.0197915515938586,-1.66607496409545,7.48490189939799,7.50860620523467,7.40701632307748,-0.101589882157182,0.172070410785182,ENSG00000103994,ZNF106,protein_coding,15,-1,42412823,42491141,q15.1,zinc finger protein 106 [Source:HGNC Symbol;Acc:HGNC:12886],NA,ZNF106,64397,NM_001284306;NM_001284307;NM_001366845;NM_022473
SP3_TF,SP3,SP3_TF,SP3,TF,73,-2.53815173538963,0.433272580189062,0.439782479229888,0.411882911912061,-0.0278995673178267,0.0198128229856086,-0.932766011923268,7.35078028455984,7.36121814803117,7.31648444743976,-0.0447337005914116,0.464362645485079,ENSG00000172845,SP3,protein_coding,2,-1,173880850,173965702,q31.1,Sp3 transcription factor [Source:HGNC Symbol;Acc:HGNC:11208],NA,SP3,6670,NM_001017371;NM_001172712;NM_003111
TET2_TF,TET2,TET2_TF,TET2,TF,206,-2.53649388723354,0.0723048218917982,0.0755980088791968,0.0614843503617742,-0.0141136585174227,0.0199026101411956,0.400031229831057,7.25433614638072,7.24847399249542,7.2735975091467,0.0251235166512771,0.768256874769127,ENSG00000168769,TET2,protein_coding,4,1,105145875,105279816,q24,tet methylcytosine dioxygenase 2 [Source:HGNC Symbol;Acc:HGNC:25941],Acquired idiopathic sideroblastic anemia;Acute myeloid leukaemia with myelodysplasia-related features;Essential thrombocythemia;MYELODYSPLASTIC SYNDROME;POLYCYTHEMIA VERA;Primary myelofibrosis;Refractory anemia;Refractory anemia with excess blasts,TET2,54790,NM_001127208;NM_017628
ACOX2_SIG,ACOX2,ACOX2_SIG,ACOX2,SIG,6,-2.5357835186002,-0.0559741240200239,-0.0502613947341985,-0.0747445202448788,-0.0244831255106803,0.0199387477083025,-1.22622704026841,0.687701950412923,0.713233545377503,0.603812424100729,-0.109421121276774,0.325312338326403,ENSG00000168306,ACOX2,protein_coding,3,-1,58505136,58537283,p14.3,acyl-CoA oxidase 2 [Source:HGNC Symbol;Acc:HGNC:120],BILE ACID SYNTHESIS DEFECT CONGENITAL 6,ACOX2,8309,NM_003500
RPUSD2_SIG,RPUSD2,RPUSD2_SIG,RPUSD2,SIG,44,2.5355975856437,0.267756572860052,0.263647291390615,0.2812584976882,0.0176112062975849,0.0199444559992685,2.17654406214243,3.11081263541567,3.07637111346458,3.22397763611209,0.147606522647506,0.0694833611691157,ENSG00000166133,RPUSD2,protein_coding,15,1,40569299,40574949,q15.1,RNA pseudouridine synthase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24180],NA,RPUSD2,27079,NM_001286407;NM_152260
TPCN1_SIG,TPCN1,TPCN1_SIG,TPCN1,SIG,19,2.53553304773601,0.00932608928717295,0.0063813383860329,0.0190016993909188,0.0126203610048861,0.0199444559992685,0.907717597686886,5.30964859975491,5.2829021043041,5.39752994195044,0.114627837646339,0.47785794901273,ENSG00000186815,TPCN1,protein_coding,12,1,113221050,113298585,q24.13,two pore segment channel 1 [Source:HGNC Symbol;Acc:HGNC:18182],NA,TPCN1,53373,NM_001143819;NM_001301214;NM_001351346;NM_001351347;NM_017901
LY86_SIG,LY86,LY86_SIG,LY86,SIG,54,-2.53518217895827,0.18644192967338,0.197319986262124,0.150699743738934,-0.0466202425231906,0.0199601652344225,-0.933461068593097,4.03287757577706,4.08413417642104,3.86446303080398,-0.219671145617053,0.464049166775522,ENSG00000112799,LY86,protein_coding,6,1,6588108,6654983,p25.1,lymphocyte antigen 86 [Source:HGNC Symbol;Acc:HGNC:16837],NA,LY86,9450,NM_004271
LNPEP_SIG,LNPEP,LNPEP_SIG,LNPEP,SIG,47,2.53509969290114,0.347252374677324,0.343358263009824,0.360047313013395,0.0166890500035712,0.0199605872105658,2.10431348893091,6.69837230581737,6.66142359979294,6.81977519704053,0.158351597247593,0.0797346472250979,ENSG00000113441,LNPEP,protein_coding,5,1,96935394,97037513,q15,leucyl and cystinyl aminopeptidase [Source:HGNC Symbol;Acc:HGNC:6656],NA,LNPEP,4012,NM_005575;NM_175920
FAM98B_SIG,FAM98B,FAM98B_SIG,FAM98B,SIG,32,2.53410464020081,0.489393278726535,0.479646731128198,0.521417649406785,0.0417709182785881,0.0200130701810976,1.76406442408074,4.55791138231298,4.51818380663758,4.68844484524643,0.170261038608851,0.146796585889299,ENSG00000171262,FAM98B,protein_coding,15,1,38454127,38487710,q14,family with sequence similarity 98 member B [Source:HGNC Symbol;Acc:HGNC:26773],NA,FAM98B,283742,NM_173611
ZSCAN23_TF,ZSCAN23,ZSCAN23_TF,ZSCAN23,TF,32,2.53314956470987,-0.0882326953344736,-0.0924007208407334,-0.0745377543853345,0.0178629664553989,0.0200633855197977,2.13031496452001,0.601116242705773,0.559897309266053,0.736549881150564,0.176652571884511,0.0759452693006485,ENSG00000187987,ZSCAN23,protein_coding,6,-1,28431930,28443502,p22.1,zinc finger and SCAN domain containing 23 [Source:HGNC Symbol;Acc:HGNC:21193],NA,ZSCAN23,222696,NM_001012455
GTF2H2_TF,GTF2H2,GTF2H2_TF,GTF2H2,TF,60,2.53194925563802,0.137218364087123,0.13240135269638,0.153045687228136,0.0206443345317563,0.0201239630378751,1.25367418701729,2.78138043305721,2.75944915132122,2.85344035876117,0.0939912074399415,0.313861811024215,ENSG00000145736,GTF2H2,protein_coding,5,-1,71032670,71067689,q13.2,general transcription factor IIH subunit 2 [Source:HGNC Symbol;Acc:HGNC:4656],NA,GTF2H2,2966;728340,NM_001515
ZNF77_TF,ZNF77,ZNF77_TF,ZNF77,TF,11,2.53194247807861,0.123871019988683,0.118411876112275,0.141808207011165,0.0233963308988893,0.0201239630378751,2.31374355482568,2.28008485830954,2.243230242716,2.40117859525975,0.15794835254375,0.0524964001296372,ENSG00000175691,ZNF77,protein_coding,19,-1,2933218,2944971,p13.3,zinc finger protein 77 [Source:HGNC Symbol;Acc:HGNC:13150],NA,ZNF77,58492,NM_021217
HLA-DRA_SIG,HLA-DRA,HLA-DRA_SIG,HLA-DRA,SIG,44,-2.53128441225144,0.361235393952407,0.373298000553304,0.321601115120889,-0.0516968854324146,0.0201574451138374,-2.40093597428077,9.21488935237197,9.32370981664812,8.85733639832177,-0.466373418326356,0.0438125259524939,ENSG00000204287,HLA-DRA,protein_coding,6,1,32439878,32445046,p21.32,major histocompatibility complex, class II, DR alpha [Source:HGNC Symbol;Acc:HGNC:4947],Graham Little-Piccardi-Lassueur syndrome,HLA-DRA,3122,NM_019111
HVCN1_SIG,HVCN1,HVCN1_SIG,HVCN1,SIG,48,-2.53085697236485,0.196028834710171,0.208343067285341,0.155567784820327,-0.0527752824650141,0.0201718988111758,-2.03652314979338,4.35872221446236,4.43724348064326,4.10072376843942,-0.336519712203844,0.0907859492414512,ENSG00000122986,HVCN1,protein_coding,12,-1,110627841,110704950,q24.11,hydrogen voltage gated channel 1 [Source:HGNC Symbol;Acc:HGNC:28240],NA,HVCN1,84329,NM_001040107;NM_001256413;NM_032369
THAP11_TF,THAP11,THAP11_TF,THAP11,TF,248,2.53081639813813,0.208077082700379,0.204258901706848,0.220622534536267,0.0163636328294192,0.0201718988111758,1.73629504484693,4.85116796653809,4.82557521105846,4.93525844882831,0.109683237769843,0.153658909895774,ENSG00000168286,THAP11,protein_coding,16,1,67842082,67844195,q22.1,THAP domain containing 11 [Source:HGNC Symbol;Acc:HGNC:23194],NA,THAP11,57215,NM_020457
TRIM72_SIG,TRIM72,TRIM72_SIG,TRIM72,SIG,16,-2.53080780251207,0.0165249290193167,0.0211935002360776,0.0011853378785309,-0.0200081623575468,0.0201718988111758,-0.820944921390841,0.452012532384234,0.466131644890672,0.405621162720222,-0.0605104821704494,0.523835308580561,ENSG00000177238,TRIM72,protein_coding,16,1,31214091,31231537,p11.2,tripartite motif containing 72 [Source:HGNC Symbol;Acc:HGNC:32671],NA,TRIM72,493829,NM_001008274
TBRG4_SIG,TBRG4,TBRG4_SIG,TBRG4,SIG,15,2.5297890399445,0.421603235069287,0.41473387422674,0.444173992123368,0.029440117896628,0.0202262326612411,2.32001521148476,5.1601823573191,5.12420533627556,5.2783925693193,0.154187233043732,0.05180291262948,ENSG00000136270,TBRG4,protein_coding,7,-1,45100100,45112047,p13,transforming growth factor beta regulator 4 [Source:HGNC Symbol;Acc:HGNC:17443],NA,TBRG4,9238,NM_001261834;NM_004749;NM_030900;NM_199122
HMGB3_TF,HMGB3,HMGB3_TF,HMGB3,TF,394,2.52876524508294,0.021526727777029,0.0177832558746603,0.0338267068848118,0.0160434510101514,0.0202809853505392,1.09805372709704,4.84329859853695,4.81400915334834,4.9395353470138,0.125526193665466,0.383289027974995,ENSG00000029993,HMGB3,protein_coding,X,1,150980509,150990771,q28,high mobility group box 3 [Source:HGNC Symbol;Acc:HGNC:5004],Colobomatous microphthalmia microcephaly intellectual disability and short stature;Microphthalmia syndromic 13,HMGB3,3149,NM_001301228;NM_001301229;NM_001301231;NM_005342
GCNT1_SIG,GCNT1,GCNT1_SIG,GCNT1,SIG,12,2.52778437565369,0.32509346324745,0.31823903567581,0.347615153839982,0.0293761181641721,0.0203333817533052,4.11628240746443,5.45483780826686,5.3203741681715,5.89664691143733,0.576272743265832,0.000384308867957669,ENSG00000187210,GCNT1,protein_coding,9,1,76419850,76651203,q21.13,glucosaminyl (N-acetyl) transferase 1 [Source:HGNC Symbol;Acc:HGNC:4203],NA,GCNT1,2650,NM_001097633;NM_001097634;NM_001097635;NM_001097636;NM_001490
CTCF_TF,CTCF,CTCF_TF,CTCF,TF,111,2.52644556946448,0.398894102514489,0.394328804560029,0.413894367221998,0.0195655626619688,0.0204066814315271,1.84588144001533,6.48135607094347,6.45955246606463,6.55299648697396,0.0934440209093336,0.127732569834862,ENSG00000102974,CTCF,protein_coding,16,1,67562467,67639177,q22.1,CCCTC-binding factor [Source:HGNC Symbol;Acc:HGNC:13723],Intellectual disability;Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome;MENTAL RETARDATION AUTOSOMAL DOMINANT 21,CTCF,10664,NM_001191022;NM_001363916;NM_006565
AASDHPPT_SIG,AASDHPPT,AASDHPPT_SIG,AASDHPPT,SIG,33,2.52546071686074,0.254623072798128,0.247935767929767,0.276595645937028,0.028659878007261,0.0204595939076605,1.97639885204328,4.56159334856868,4.53221718533521,4.65811502776438,0.125897842429172,0.101457145225386,ENSG00000149313,AASDHPPT,protein_coding,11,1,106075501,106098699,q22.3,aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase [Source:HGNC Symbol;Acc:HGNC:14235],NA,AASDHPPT,60496,NM_015423
ZNF277_TF,ZNF277,ZNF277_TF,ZNF277,TF,249,2.52500705389909,0.313593360532612,0.310622000793013,0.323356399677009,0.0127343988839964,0.0204816471509871,2.01487813958042,4.56722993709715,4.53715381392092,4.66605148467616,0.128897670755235,0.0944478857155923,ENSG00000198839,ZNF277,protein_coding,7,1,112206588,112343096,q31.1,zinc finger protein 277 [Source:HGNC Symbol;Acc:HGNC:13070],NA,ZNF277,11179,NM_021994
SSH2_SIG,SSH2,SSH2_SIG,SSH2,SIG,35,-2.5248936254562,0.452855464019913,0.459310717518537,0.431645345381576,-0.0276653721369606,0.020483881962748,0.716479589091458,7.09630311539137,7.08143934380256,7.14514122204031,0.0637018782377572,0.582276344025346,ENSG00000141298,SSH2,protein_coding,17,-1,29625938,29930276,q11.2,slingshot protein phosphatase 2 [Source:HGNC Symbol;Acc:HGNC:30580],NA,SSH2,85464,NM_001282129;NM_001282130;NM_001282131;NM_033389
THRA_TF,THRA,THRA_TF,THRA,TF,49,2.52452664052747,0.000312894471109575,-0.0011935900051188,0.00526277203585994,0.00645636204097888,0.0205009022097623,1.95431543543845,5.6366783725472,5.60992436466045,5.72458439846083,0.114660033800384,0.105537904267494,ENSG00000126351,THRA,protein_coding,17,1,40058290,40093867,q21.1,thyroid hormone receptor alpha [Source:HGNC Symbol;Acc:HGNC:11796],HYPOTHYROIDISM CONGENITAL NONGOITROUS 6;Peripheral resistance to thyroid hormones,THRA,7067,NM_001190918;NM_001190919;NM_003250;NM_199334
TBL1X_SIG,TBL1X,TBL1X_SIG,TBL1X,SIG,13,-2.52429086268893,0.414150764413206,0.424047487830934,0.381632958897816,-0.0424145289331173,0.020510277888781,1.2504394042967,5.21068678725226,5.17510194365552,5.32760841621299,0.152506472557477,0.315305024353076,ENSG00000101849,TBL1X,protein_coding,X,1,9463295,9741037,p22.31,transducin beta like 1 X-linked [Source:HGNC Symbol;Acc:HGNC:11585],NA,TBL1X,6907,NM_001139466;NM_001139467;NM_001139468;NM_005647
SAP130_SIG,SAP130,SAP130_SIG,SAP130,SIG,17,-2.52192626490712,0.219126796651759,0.222323656666321,0.208622828032483,-0.0137008286338382,0.0206442549317411,-1.55114761142011,5.43150315538135,5.44525687950587,5.38631234754366,-0.0589445319622027,0.205419662235318,ENSG00000136715,SAP130,protein_coding,2,-1,127941217,128028120,q14.3,Sin3A associated protein 130 [Source:HGNC Symbol;Acc:HGNC:29813],NA,SAP130,79595,NM_001145928;NM_001330299;NM_001330300;NM_001330301;NM_001330302;NM_001330303;NM_024545
ZNF366_TF,ZNF366,ZNF366_TF,ZNF366,TF,272,-2.52099898572341,0.102319642436766,0.109719357996645,0.0780062913114495,-0.0317130666851954,0.0206943188708324,0.142245908296971,0.744081674824485,0.740920491282987,0.754468420746549,0.013547929463562,0.920293091110107,ENSG00000178175,ZNF366,protein_coding,5,-1,72439903,72507410,q13.2,zinc finger protein 366 [Source:HGNC Symbol;Acc:HGNC:18316],NA,ZNF366,167465,NM_152625
NANOS3_SIG,NANOS3,NANOS3_SIG,NANOS3,SIG,43,2.52035269128395,0.0485645109403436,0.041458572094977,0.071912595717977,0.0304540236230001,0.0207279346691617,-0.125888381528792,0.576266645309337,0.577548262817342,0.572055616354465,-0.00549264646287778,0.929575487540133,ENSG00000187556,NANOS3,protein_coding,19,1,13862063,13880757,p13.12,nanos C2HC-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:22048],NA,NANOS3,342977,NM_001098622
ITGAV_SIG,ITGAV,ITGAV_SIG,ITGAV,SIG,54,2.5195276650355,0.0397421471747881,0.0360800068449564,0.0517748939728068,0.0156948871278503,0.020772141657303,3.79017624919584,4.25227983319451,4.13067475225526,4.65183938485202,0.521164632596763,0.00110935520477643,ENSG00000138448,ITGAV,protein_coding,2,1,186590056,186680901,q32.1,integrin subunit alpha V [Source:HGNC Symbol;Acc:HGNC:6150],NA,ITGAV,3685,NM_001144999;NM_001145000;NM_002210
DFFB_SIG,DFFB,DFFB_SIG,DFFB,SIG,28,2.51911115868207,0.366190707782876,0.358431020696098,0.391686822496574,0.0332558018004756,0.0207922940028473,1.40663083211517,3.51212549917324,3.48269340569672,3.60883094916754,0.126137543470825,0.254068609202675,ENSG00000169598,DFFB,protein_coding,1,1,3857267,3885429,p36.32,DNA fragmentation factor subunit beta [Source:HGNC Symbol;Acc:HGNC:2773],NA,DFFB,1677,NM_001282669;NM_001320132;NM_001320136;NM_004402
IL11RA_SIG,IL11RA,IL11RA_SIG,IL11RA,SIG,127,2.51800789190575,0.117930102184367,0.113550239596622,0.132321079258387,0.0187708396617654,0.0208530882032177,1.63923828286126,4.31247023571574,4.27864711440716,4.42360334858679,0.144956234179628,0.17956428830494,ENSG00000137070,IL11RA,protein_coding,9,1,34650702,34661892,p13.3,interleukin 11 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:5967],Autosomal Recessive Craniosynostosis;Craniosynostosis-dental anomalies;Craniosynostosis and dental anomalies;Crouzon-like craniosynostosis,IL11RA,3590,NM_001142784
MSANTD3_TF,MSANTD3,MSANTD3_TF,MSANTD3,TF,202,2.51679250436971,-0.0538058203637103,-0.061565040395617,-0.0283112402588737,0.0332538001367433,0.0209163915830033,1.70125976844363,3.6156936124765,3.57925396499873,3.73542388276061,0.156169917761877,0.162809951053195,ENSG00000066697,MSANTD3,protein_coding,9,1,100427156,100451711,q31.1,Myb/SANT DNA binding domain containing 3 [Source:HGNC Symbol;Acc:HGNC:23370],NA,MSANTD3,91283,NM_001198805;NM_001198806;NM_001198807;NM_080655
SLC16A14_SIG,SLC16A14,SLC16A14_SIG,SLC16A14,SIG,28,-2.51678985414268,-0.0285427983749832,-0.0241530947042136,-0.0429661104360831,-0.0188130157318694,0.0209163915830033,-1.11217356903158,1.33467209579703,1.3664519837197,1.23025246405111,-0.136199519668588,0.376718508926195,ENSG00000163053,SLC16A14,protein_coding,2,-1,230034982,230068993,q36.3,solute carrier family 16 member 14 [Source:HGNC Symbol;Acc:HGNC:26417],NA,SLC16A14,151473,NM_152527
SLC7A1_SIG,SLC7A1,SLC7A1_SIG,SLC7A1,SIG,21,2.51658539970114,0.404330199195725,0.398076171481574,0.424879147399363,0.0268029759177885,0.0209240709976538,0.754578523827057,6.10947838563528,6.09217844539672,6.1663210464191,0.0741426010223822,0.560935183595192,ENSG00000139514,SLC7A1,protein_coding,13,-1,29509414,29595688,q12.3,solute carrier family 7 member 1 [Source:HGNC Symbol;Acc:HGNC:11057],NA,SLC7A1,6541,NM_003045
TOMM5_SIG,TOMM5,TOMM5_SIG,TOMM5,SIG,18,2.51565354693144,0.464188996371646,0.459561900781588,0.479392310453266,0.0198304096716781,0.0209749985838536,2.05446293201503,3.05899468625154,3.03171600744104,3.14862463091461,0.116908623473569,0.0877166347422231,ENSG00000175768,TOMM5,protein_coding,9,-1,37582646,37592604,p13.2,translocase of outer mitochondrial membrane 5 [Source:HGNC Symbol;Acc:HGNC:31369],NA,TOMM5,401505,NM_001001790;NM_001134484;NM_001134485
HNRNPAB_SIG,HNRNPAB,HNRNPAB_SIG,HNRNPAB,SIG,18,2.51552575102457,0.51109045155595,0.501856903647667,0.541429251826022,0.0395723481783547,0.0209778894956501,2.28855616544271,7.18116559234777,7.14133991872891,7.31202137709548,0.17068145836657,0.0552783406481587,ENSG00000197451,HNRNPAB,protein_coding,5,1,178204533,178211163,q35.3,heterogeneous nuclear ribonucleoprotein A/B [Source:HGNC Symbol;Acc:HGNC:5034],NA,HNRNPAB,3182,NM_004499;NM_031266
NFATC4_SIG,NFATC4,NFATC4_SIG,NFATC4,SIG,54,-2.51545477753975,-0.1318702086306,-0.128379755770036,-0.143338839458166,-0.0149590836881304,0.0209778894956501,-2.1494340963402,0.504867911531705,0.557574106227857,0.331690414672919,-0.225883691554938,0.0732048210190764,ENSG00000100968,NFATC4,protein_coding,14,1,24365673,24379604,q12,nuclear factor of activated T cells 4 [Source:HGNC Symbol;Acc:HGNC:7778],NA,NFATC4,4776,NM_001136022;NM_001198965;NM_001198966;NM_001198967;NM_001288802;NM_001320043;NM_001363681;NM_004554
S100B_SIG,S100B,S100B_SIG,S100B,SIG,27,-2.51497850969571,0.0138868767479822,0.0183819220725822,-0.000882557889989004,-0.0192644799625713,0.0210017762893375,1.89371186472966,2.04707749527978,1.96656547866876,2.31161697843029,0.345051499761536,0.117530094222168,ENSG00000160307,S100B,protein_coding,21,-1,46598604,46605208,q22.3,S100 calcium binding protein B [Source:HGNC Symbol;Acc:HGNC:10500],NA,S100B,6285,NM_006272
ATP6V1C2_SIG,ATP6V1C2,ATP6V1C2_SIG,ATP6V1C2,SIG,20,-2.51447966545187,-0.141284201455949,-0.139526967439288,-0.147057970367836,-0.00753100292854795,0.0210270331120537,-2.53786340805893,0.349252184644208,0.382850837196028,0.23885661197394,-0.143994225222089,0.0325127009093392,ENSG00000143882,ATP6V1C2,protein_coding,2,1,10721100,10785110,p25.1,ATPase H+ transporting V1 subunit C2 [Source:HGNC Symbol;Acc:HGNC:18264],NA,ATP6V1C2,245973,NM_001039362;NM_144583
PRKCQ_SIG,PRKCQ,PRKCQ_SIG,PRKCQ,SIG,179,2.51361996668996,0.137769964865229,0.1301688041985,0.16274520705591,0.0325764028574102,0.0210738669459634,1.4269443930816,4.23750571185894,4.19436470140001,4.37925474622401,0.184890044823997,0.246602228974015,ENSG00000065675,PRKCQ,protein_coding,10,-1,6427143,6580301,p15.1,protein kinase C theta [Source:HGNC Symbol;Acc:HGNC:9410],NA,PRKCQ,5588,NM_001242413;NM_001282644;NM_001282645;NM_001323265;NM_001323266;NM_001323267;NM_006257
NDUFV3_SIG,NDUFV3,NDUFV3_SIG,NDUFV3,SIG,9,2.51335646740477,0.155540691736779,0.145959312520286,0.187022366305254,0.041063053784968,0.0210851275348738,3.13729960901906,5.20778684322597,5.1607336374462,5.36239023364524,0.201656596199039,0.0075144301482598,ENSG00000160194,NDUFV3,protein_coding,21,1,42879644,42913304,q22.3,NADH:ubiquinone oxidoreductase subunit V3 [Source:HGNC Symbol;Acc:HGNC:7719],NA,NDUFV3,4731,NM_001001503;NM_021075
GUK1_SIG,GUK1,GUK1_SIG,GUK1,SIG,20,-2.5128519349504,0.187903347328558,0.197360814202076,0.15682881331557,-0.0405320008865067,0.0211108122606589,-1.34680760025893,6.77913271206914,6.79648434601487,6.72212020053319,-0.0743641454816801,0.27651998540979,ENSG00000143774,GUK1,protein_coding,1,1,228139962,228148984,q42.13,guanylate kinase 1 [Source:HGNC Symbol;Acc:HGNC:4693],NA,GUK1,2987,NM_000858;NM_001159390;NM_001159391;NM_001242839;NM_001242840
NLN_SIG,NLN,NLN_SIG,NLN,SIG,28,2.51249543575281,0.398308577914222,0.388236451561428,0.431402707359116,0.0431662557976874,0.0211276586581542,2.22448890502562,4.70196053823793,4.64139192786735,4.9009716865984,0.259579758731047,0.0631513373810406,ENSG00000123213,NLN,protein_coding,5,1,65722205,65871725,q12.3,neurolysin [Source:HGNC Symbol;Acc:HGNC:16058],NA,NLN,57486,NM_020726
ART4_SIG,ART4,ART4_SIG,ART4,SIG,16,-2.51241995990007,-0.21075602250691,-0.186779254156855,-0.289536832799945,-0.102757578643089,0.0211276841770542,-2.02431663747651,0.418517536061684,0.460976990323031,0.279007900631544,-0.181969089691487,0.0928781779553475,ENSG00000111339,ART4,protein_coding,12,-1,14825569,14843526,p12.3,ADP-ribosyltransferase 4 (Dombrock blood group) [Source:HGNC Symbol;Acc:HGNC:726],Blood group dombrock system,ART4,420,NM_001354646;NM_021071
CKM_SIG,CKM,CKM_SIG,CKM,SIG,62,2.51223354186057,-0.0480699690086159,-0.0520491474932791,-0.0349955254161512,0.017053622077128,0.0211343542209308,2.34423674208679,1.06458650138686,1.01353279749371,1.23233438560721,0.218801588113498,0.0493673468595071,ENSG00000104879,CKM,protein_coding,19,-1,45306413,45322875,q13.32,creatine kinase, M-type [Source:HGNC Symbol;Acc:HGNC:1994],NA,CKM,1158,NM_001824
PIN1_SIG,PIN1,PIN1_SIG,PIN1,SIG,15,2.51183877288158,0.372789174044776,0.369169007776162,0.384684006070221,0.0155149982940587,0.0211535117734376,1.07429512208973,5.2862992589451,5.27737955884899,5.31560684497519,0.038227286126202,0.394705390285656,ENSG00000127445,PIN1,protein_coding,19,1,9835257,9849682,p13.2,peptidylprolyl cis/trans isomerase, NIMA-interacting 1 [Source:HGNC Symbol;Acc:HGNC:8988],NA,PIN1,5300,NM_006221
ABHD17B_SIG,ABHD17B,ABHD17B_SIG,ABHD17B,SIG,54,2.51032124088177,0.287922390111224,0.284372889934262,0.299585033549816,0.0152121436155545,0.0212401296063699,1.61523482137777,4.60391887373094,4.56787016982648,4.72236461513128,0.154494445304796,0.186348103199636,ENSG00000107362,ABHD17B,protein_coding,9,-1,71862452,71910931,q21.13,abhydrolase domain containing 17B [Source:HGNC Symbol;Acc:HGNC:24278],NA,ABHD17B,51104,NM_001025780;NM_016014
ZNF304_TF,ZNF304,ZNF304_TF,ZNF304,TF,41,2.50834257868606,0.246595569009931,0.240537334844367,0.266501195553927,0.0259638607095603,0.0213549137415945,2.86995514949073,3.83907939747464,3.7868471028295,4.01069979416584,0.22385269133634,0.0149506450117289,ENSG00000131845,ZNF304,protein_coding,19,1,57351307,57359898,q13.43,zinc finger protein 304 [Source:HGNC Symbol;Acc:HGNC:13505],NA,ZNF304,57343,NM_001290318;NM_001290319;NM_001329456;NM_020657
RABGGTB_SIG,RABGGTB,RABGGTB_SIG,RABGGTB,SIG,41,2.50785272291826,0.301760777922483,0.294747349197741,0.324804900875208,0.0300575516774676,0.0213799965700556,2.87977493774604,6.29473593392884,6.25360874667548,6.42986812061846,0.176259373942982,0.014578429541777,ENSG00000137955,RABGGTB,protein_coding,1,1,75786197,75795086,p31.1,Rab geranylgeranyltransferase subunit beta [Source:HGNC Symbol;Acc:HGNC:9796],NA,RABGGTB,5876,NM_004582
SLC30A7_SIG,SLC30A7,SLC30A7_SIG,SLC30A7,SIG,30,2.50655869433019,0.40834825595016,0.405300366965548,0.418362748328173,0.0130623813626251,0.0214538588050043,2.68921557714094,5.17978189792558,5.14849577344706,5.28257916406928,0.134083390622225,0.023004070052596,ENSG00000162695,SLC30A7,protein_coding,1,1,100896076,100981757,p21.2,solute carrier family 30 member 7 [Source:HGNC Symbol;Acc:HGNC:19306],NA,SLC30A7,148867,NM_001144884;NM_133496
GJA4_SIG,GJA4,GJA4_SIG,GJA4,SIG,19,-2.50614376574424,-0.124785248984621,-0.116522225384668,-0.15193518367018,-0.0354129582855116,0.0214744913884583,-1.92536232421571,0.353299958652705,0.388705236898849,0.23696833012966,-0.151736906769189,0.111227060547691,ENSG00000187513,GJA4,protein_coding,1,1,34792999,34795747,p34.3,gap junction protein alpha 4 [Source:HGNC Symbol;Acc:HGNC:4278],NA,GJA4,2701,NM_002060
ZSCAN16_TF,ZSCAN16,ZSCAN16_TF,ZSCAN16,TF,28,2.50604147190036,0.282003502455765,0.27779979631822,0.295815679764841,0.0180158834466214,0.0214761445695093,1.87023519187985,2.55506558256753,2.52894111400828,2.64090312211936,0.111962008111081,0.122489329591174,ENSG00000196812,ZSCAN16,protein_coding,6,1,28124609,28130082,p22.1,zinc finger and SCAN domain containing 16 [Source:HGNC Symbol;Acc:HGNC:20813],NA,ZSCAN16,80345,NM_001320555;NM_001320556;NM_001320557;NM_001320558;NM_025231
MRPL2_SIG,MRPL2,MRPL2_SIG,MRPL2,SIG,9,2.50585415731608,0.145048599578991,0.136571676198005,0.172901347830801,0.0363296716327953,0.0214814996227949,2.34265077520927,3.73503710444659,3.70683000847077,3.82771756265285,0.120887554182081,0.0495598768829296,ENSG00000112651,MRPL2,protein_coding,6,-1,43054029,43059438,p21.1,mitochondrial ribosomal protein L2 [Source:HGNC Symbol;Acc:HGNC:14056],NA,MRPL2,51069,NM_001300848;NM_015950
CHST3_SIG,CHST3,CHST3_SIG,CHST3,SIG,30,-2.50580320366625,-0.196447789697579,-0.193084886805891,-0.207497327770267,-0.0144124409643764,0.0214814996227949,-0.598625933381839,0.395762160384642,0.404919024978644,0.365675319575775,-0.0392437054028687,0.652037540873163,ENSG00000122863,CHST3,protein_coding,10,1,71964395,72013558,q22.1,carbohydrate sulfotransferase 3 [Source:HGNC Symbol;Acc:HGNC:1971],CHST3-related skeletal dysplasia;MULTIPLE JOINT DISLOCATIONS SHORT STATURE AND CRANIOFACIAL DYSMORPHISMWITH OR WITHOUT CONGENITAL HEART DEFECTS;SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS,CHST3,9469,NM_004273
PCYOX1_SIG,PCYOX1,PCYOX1_SIG,PCYOX1,SIG,27,2.50563563589848,0.283819738023661,0.276577089812672,0.307617010716911,0.0310399209042387,0.0214871214800673,1.91572479425575,4.72759125420266,4.68002962620577,4.88386517476387,0.203835548558094,0.113133584650974,ENSG00000116005,PCYOX1,protein_coding,2,1,70257386,70281185,p13.3,prenylcysteine oxidase 1 [Source:HGNC Symbol;Acc:HGNC:20588],NA,PCYOX1,51449,NM_016297
ZBTB45_TF,ZBTB45,ZBTB45_TF,ZBTB45,TF,66,2.50466438763559,0.195305212843002,0.188666607481533,0.217117773316399,0.028451165834866,0.0215404886322119,2.99969407185228,3.35777050557164,3.31399527091277,3.50160341945078,0.187608148538009,0.0107671313978027,ENSG00000119574,ZBTB45,protein_coding,19,-1,58513530,58538911,q13.43,zinc finger and BTB domain containing 45 [Source:HGNC Symbol;Acc:HGNC:23715],NA,ZBTB45,84878,NM_001316978;NM_001316979;NM_001316980;NM_001316981;NM_001316982;NM_032792
NFKB1_SIG,NFKB1,NFKB1_SIG,NFKB1,SIG,18,-2.5046082404618,0.167164675415731,0.171450590632705,0.153082382559961,-0.0183682080727444,0.0215404886322119,-0.484883685277603,6.52435145102427,6.53329258611396,6.49497343572959,-0.0383191503843704,0.718278921380761,ENSG00000109320,NFKB1,protein_coding,4,1,102501331,102617302,q24,nuclear factor kappa B subunit 1 [Source:HGNC Symbol;Acc:HGNC:7794],Common variable immunodeficiency;Immunodeficiency common variable 12,NFKB1,4790,NM_001165412;NM_001319226;NM_003998
CD4_SIG,CD4,CD4_SIG,CD4,SIG,48,-2.50422316533056,0.132327540610187,0.145437430085068,0.0892521894784336,-0.0561852406066344,0.0215593761011835,-2.22509939138655,6.39284227350354,6.48856511279025,6.07832437299009,-0.410240739800161,0.0630722251412198,ENSG00000010610,CD4,protein_coding,12,1,6786858,6820799,p13.31,CD4 molecule [Source:HGNC Symbol;Acc:HGNC:1678],OKT4 EPITOPE DEFICIENCY,CD4,920,NM_000616;NM_001195014;NM_001195015;NM_001195016;NM_001195017
ZNF12_TF,ZNF12,ZNF12_TF,ZNF12,TF,29,2.50392634631715,0.199497553860498,0.195304797011099,0.213273754937095,0.0179689579259951,0.0215728964433664,2.17485448894371,4.76227170717063,4.72869484613737,4.87259567913704,0.143900832999673,0.0697128760617079,ENSG00000164631,ZNF12,protein_coding,7,-1,6688433,6706947,p22.1,zinc finger protein 12 [Source:HGNC Symbol;Acc:HGNC:12902],NA,ZNF12,7559,NM_006956;NM_016265
DGAT1_SIG,DGAT1,DGAT1_SIG,DGAT1,SIG,27,-2.50330241974909,0.160390324705989,0.165392958903666,0.143953098056478,-0.0214398608471884,0.0216063876588251,-1.38587122917844,5.4559452541446,5.47603514391889,5.38993561631477,-0.0860995276041168,0.261884213626195,ENSG00000185000,DGAT1,protein_coding,8,-1,144314584,144326910,q24.3,diacylglycerol O-acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:2843],Congenital chronic diarrhea with protein-losing enteropathy;CONGENITAL DIARRHEAL DISORDERS;DIARRHEA 7 PROTEIN-LOSING ENTEROPATHY TYPE,DGAT1,8694,NM_012079
PHPT1_SIG,PHPT1,PHPT1_SIG,PHPT1,SIG,26,2.50310600252464,-0.0201442960555743,-0.0265414121820543,0.000874799788574269,0.0274162119706285,0.0216094703623383,3.45426727568427,4.86392038151111,4.8027312707911,5.06497031673399,0.262239045942893,0.00307797590530117,ENSG00000054148,PHPT1,protein_coding,9,1,136848724,136851027,q34.3,phosphohistidine phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:30033],NA,PHPT1,29085,NM_001135861;NM_001287342;NM_001287343;NM_014172
NDUFB5_SIG,NDUFB5,NDUFB5_SIG,NDUFB5,SIG,44,2.50310194144007,0.296252134370231,0.290004414974292,0.316780355242603,0.0267759402683107,0.0216094703623383,3.05423232508138,5.294313857227,5.24079151641368,5.47017297704219,0.229381460628503,0.00935356387400007,ENSG00000136521,NDUFB5,protein_coding,3,1,179604690,179627647,q26.33,NADH:ubiquinone oxidoreductase subunit B5 [Source:HGNC Symbol;Acc:HGNC:7700],NA,NDUFB5,4711,NM_001199957;NM_001199958;NM_002492
FASLG_SIG,FASLG,FASLG_SIG,FASLG,SIG,5,-2.50253539511879,-0.0336161083547115,-0.0275914912825473,-0.0534112787346799,-0.0258197874521325,0.0216395030638635,-1.85268209504683,0.551176303843125,0.580592106276371,0.45452438156246,-0.126067724713911,0.126301783582584,ENSG00000117560,FASLG,protein_coding,1,1,172659103,172666876,q24.3,Fas ligand [Source:HGNC Symbol;Acc:HGNC:11936],Autoimmune lymphoproliferative syndrome;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,FASLG,356,NM_000639;NM_001302746
IFI35_SIG,IFI35,IFI35_SIG,IFI35,SIG,22,-2.50222489736551,0.289905577324686,0.297437568110946,0.265157607598403,-0.0322799605125428,0.0216539053111817,-2.26557750812424,4.41529606037939,4.45706539763209,4.27805395226337,-0.179011445368722,0.0580312010109024,ENSG00000068079,IFI35,protein_coding,17,1,43006725,43014456,q21.31,interferon induced protein 35 [Source:HGNC Symbol;Acc:HGNC:5399],NA,IFI35,3430,NM_001330230;NM_005533
UBC_SIG,UBC,UBC_SIG,UBC,SIG,27,-2.50191626752737,0.509946786056103,0.51983381912944,0.477460820243707,-0.0423729988857331,0.021668201892684,-1.38084809776204,10.0052296087333,10.0296819553574,9.92488618411134,-0.104795771246019,0.26377212848413,ENSG00000150991,UBC,protein_coding,12,-1,124911604,124917368,q24.31,ubiquitin C [Source:HGNC Symbol;Acc:HGNC:12468],NA,UBC,7316,NM_021009
PPP5C_SIG,PPP5C,PPP5C_SIG,PPP5C,SIG,15,2.49991038408956,0.409990365227888,0.399434740936007,0.444673130758353,0.0452383898223461,0.0217866608302358,2.16120909079558,5.35355677619137,5.31633598811721,5.47585365129215,0.159517663174942,0.0716088201486301,ENSG00000011485,PPP5C,protein_coding,19,1,46346994,46392981,q13.32,protein phosphatase 5 catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9322],NA,PPP5C,5536,NM_001204284;NM_006247
SLC36A1_SIG,SLC36A1,SLC36A1_SIG,SLC36A1,SIG,32,-2.49963589112773,0.187077634154459,0.194853292674654,0.161529041873821,-0.0333242508008324,0.0217979388803392,-1.97316288951337,5.21535189229191,5.2641611097851,5.0549787491,-0.209182360685102,0.102005842593795,ENSG00000123643,SLC36A1,protein_coding,5,1,151437046,151492379,q33.1,solute carrier family 36 member 1 [Source:HGNC Symbol;Acc:HGNC:18761],NA,SLC36A1,206358,NM_001308150;NM_001308151;NM_001349740;NM_078483
SLC8A3_SIG,SLC8A3,SLC8A3_SIG,SLC8A3,SIG,50,2.49957706213626,-0.00254932830801041,-0.00908608933591579,0.0189286007836787,0.0280146901195946,0.0217979388803392,-1.24868530564861,1.63116889361016,1.68088003403707,1.46783228935032,-0.213047744686752,0.316008565781763,ENSG00000100678,SLC8A3,protein_coding,14,-1,70044217,70189070,q24.2,solute carrier family 8 member A3 [Source:HGNC Symbol;Acc:HGNC:11070],NA,SLC8A3,6547,NM_001130417;NM_033262;NM_058240;NM_182932;NM_182936;NM_183002
YARS_SIG,YARS,YARS_SIG,YARS,SIG,10,2.49933195616333,0.600790976474115,0.595576031964061,0.617925794150006,0.0223497621859447,0.0218084082573403,2.42411693193209,6.67514064465186,6.64576596474514,6.77165745005967,0.125891485314535,0.0415963106174,ENSG00000134684,YARS,protein_coding,1,-1,32775237,32818153,p35.1,tyrosyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:12840],Autosomal dominant intermediate Charcot-Marie-Tooth disease type C;CHARCOT-MARIE-TOOTH DISEASE DOMINANT INTERMEDIATE C,YARS,8565,NM_003680
ZNF239_SIG,ZNF239,ZNF239_SIG,ZNF239,SIG,19,2.49898557965556,-0.0762452850360108,-0.0815592313988914,-0.0587851755579745,0.0227740558409171,0.0218251185608084,0.107438646954251,1.06239477475548,1.06021140439693,1.06956870593358,0.00935730153664623,0.940467868848141,ENSG00000196793,ZNF239,protein_coding,10,-1,43556344,43574618,q11.21,zinc finger protein 239 [Source:HGNC Symbol;Acc:HGNC:13031],NA,ZNF239,8187,NM_001099282;NM_001099283;NM_001099284;NM_001324347;NM_001324348;NM_001324349;NM_001324350;NM_001324351;NM_001324352;NM_001324353;NM_005674
TNFRSF11A_SIG,TNFRSF11A,TNFRSF11A_SIG,TNFRSF11A,SIG,21,-2.49867155328257,-0.0403629485603028,-0.0369253572298592,-0.051657891503189,-0.0147325342733299,0.0218398467013123,-1.6976980645011,1.92369285771961,1.98206513458785,1.73189823372396,-0.250166900863893,0.163762249697888,ENSG00000141655,TNFRSF11A,protein_coding,18,1,62325287,62391288,q21.33,TNF receptor superfamily member 11a [Source:HGNC Symbol;Acc:HGNC:11908],Adult-onset myasthenia gravis;FAMILIAL EXPANSILE OSTEOLYSIS;Juvenile Paget disease;Osteopetrosis-hypogammaglobulinemia syndrome;OSTEOPETROSIS AUTOSOMAL RECESSIVE 7;PAGET DISEASE OF BONE 2 EARLY-ONSET,TNFRSF11A,8792,NM_001270949;NM_001270950;NM_001270951;NM_001278268;NM_003839
SLC22A18AS_SIG,SLC22A18AS,SLC22A18AS_SIG,SLC22A18AS,SIG,5,-2.49851196605496,0.263708841855933,0.274903023570588,0.226927959079212,-0.0479750644913755,0.0218450633444255,1.39341933396614,0.378615394758426,0.365292619392185,0.422390228104646,0.0570976087124605,0.259140071893188,ENSG00000254827,SLC22A18AS,protein_coding,11,-1,2887780,2903740,p15.4,solute carrier family 22 member 18 antisense [Source:HGNC Symbol;Acc:HGNC:10965],NA,SLC22A18AS,5003,NM_001302862;NM_007105
KLF16_TF,KLF16,KLF16_TF,KLF16,TF,131,2.49804379508482,0.109708078081424,0.107627068361469,0.11654568144699,0.00891861308552093,0.0218678750980772,-0.873145957143202,5.50489692450697,5.51671133692291,5.46607814085459,-0.0506331960683246,0.496113793000193,ENSG00000129911,KLF16,protein_coding,19,-1,1852399,1863579,p13.3,Kruppel like factor 16 [Source:HGNC Symbol;Acc:HGNC:16857],NA,KLF16,83855,NM_031918
RUVBL2_SIG,RUVBL2,RUVBL2_SIG,RUVBL2,SIG,45,2.49799216044183,0.442204330913741,0.431854160106586,0.476212034994395,0.0443578748878089,0.0218678750980772,2.22927038276159,5.80253812177467,5.75987519956817,5.94271629473888,0.182841095170711,0.062484241125855,ENSG00000183207,RUVBL2,protein_coding,19,1,48993562,49015970,q13.33,RuvB like AAA ATPase 2 [Source:HGNC Symbol;Acc:HGNC:10475],NA,RUVBL2,10856,NM_001321190;NM_001321191;NM_006666
B4GALT6_SIG,B4GALT6,B4GALT6_SIG,B4GALT6,SIG,171,2.49625790103122,0.102970633911283,0.0939412728681761,0.132638534481491,0.0386972616133148,0.0219704461691756,1.39345112922254,4.45811513081486,4.40703733783554,4.62594216488977,0.218904827054225,0.259140071893188,ENSG00000118276,B4GALT6,protein_coding,18,-1,31622247,31685836,q12.1,beta-1,4-galactosyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:929],NA,B4GALT6,9331,NM_001330570;NM_004775
PARS2_SIG,PARS2,PARS2_SIG,PARS2,SIG,150,2.49549748774672,0.157712277975938,0.145447682998276,0.198010232902543,0.0525625499042666,0.0220129415196522,1.51542519907083,1.38132727241173,1.34507654461856,1.50043680658929,0.155360261970729,0.216997957042952,ENSG00000162396,PARS2,protein_coding,1,-1,54756898,54764523,p32.3,prolyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:30563],NA,PARS2,25973,NM_152268
TOPORS_TF,TOPORS,TOPORS_TF,TOPORS,TF,84,2.49493180416928,0.0712330091615886,0.065044040586464,0.0915681916227125,0.0265241510362485,0.0220434086609189,2.45379233090113,5.79791653780804,5.74991844608642,5.9556245534648,0.205706107378382,0.0390398612237379,ENSG00000197579,TOPORS,protein_coding,9,-1,32540544,32552586,p21.1,TOP1 binding arginine/serine rich protein [Source:HGNC Symbol;Acc:HGNC:21653],Retinitis pigmentosa;RETINITIS PIGMENTOSA 31,TOPORS,10210,NM_001195622;NM_005802
PEX11B_SIG,PEX11B,PEX11B_SIG,PEX11B,SIG,44,2.49474787332516,0.302352227422188,0.298957998960059,0.31350469236918,0.0145466934091206,0.0220501804292324,3.52314396523634,4.00260721272888,3.95194976694827,4.16905310600803,0.217103339059766,0.00252226522788824,ENSG00000131779,PEX11B,protein_coding,1,-1,145911350,145918717,q21.1,peroxisomal biogenesis factor 11 beta [Source:HGNC Symbol;Acc:HGNC:8853],Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;PEROXISOME BIOGENESIS DISORDER 14B;Zellweger Syndrome,PEX11B,8799,NM_001184795;NM_003846
ZNF613_TF,ZNF613,ZNF613_TF,ZNF613,TF,69,2.49366284054882,0.355341116285054,0.347204277708729,0.382076443035833,0.034872165327104,0.022113022794073,2.92007851570961,2.21201665082621,2.14898256983834,2.41912863121491,0.270146061376569,0.0131919000067924,ENSG00000176024,ZNF613,protein_coding,19,1,51927147,51948759,q13.41,zinc finger protein 613 [Source:HGNC Symbol;Acc:HGNC:25827],NA,ZNF613,79898,NM_001031721;NM_024840
FBXO4_SIG,FBXO4,FBXO4_SIG,FBXO4,SIG,13,2.49306803848855,0.461421689968647,0.453511905010105,0.487410983403855,0.0338990783937506,0.0221454265688636,3.43191691996676,3.36917433826146,3.32069830277604,3.5284527405707,0.207754437794659,0.00327673569278235,ENSG00000151876,FBXO4,protein_coding,5,1,41925254,41941743,p13.1,F-box protein 4 [Source:HGNC Symbol;Acc:HGNC:13583],NA,FBXO4,26272,NM_001297437;NM_012176;NM_033484
PRCP_SIG,PRCP,PRCP_SIG,PRCP,SIG,26,-2.492517096123,0.395067811839872,0.400755371543728,0.376380115670062,-0.0243752558736658,0.0221751327624902,-1.60466745558119,6.355526870509,6.38822760940856,6.24808158555331,-0.140146023855256,0.189159801907016,ENSG00000137509,PRCP,protein_coding,11,-1,82822936,82970584,q14.1,prolylcarboxypeptidase [Source:HGNC Symbol;Acc:HGNC:9344],NA,PRCP,5547,NM_001319214;NM_005040;NM_199418
GTF2H3_SIG,GTF2H3,GTF2H3_SIG,GTF2H3,SIG,30,2.49242937702144,0.55053108847704,0.542677363030524,0.576336186372735,0.0336588233422109,0.0221759314037666,2.29276686988642,4.63963857669591,4.60105313108541,4.76641932655898,0.165366195473574,0.0547722967508109,ENSG00000111358,GTF2H3,protein_coding,12,1,123633739,123662604,q24.31,general transcription factor IIH subunit 3 [Source:HGNC Symbol;Acc:HGNC:4657],NA,GTF2H3,2967,NM_001271866;NM_001271867;NM_001271868;NM_001516
CREB1_SIG,CREB1,CREB1_SIG,CREB1,SIG,47,2.49233981820954,0.189104220327152,0.182929715375268,0.20939187945477,0.0264621640795019,0.0221768457856105,0.740099931991197,6.31436579395111,6.30513636526536,6.34469105963285,0.0395546943674825,0.568929655196397,ENSG00000118260,CREB1,protein_coding,2,1,207529737,207605988,q33.3,cAMP responsive element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2345],HISTIOCYTOMA ANGIOMATOID FIBROUS;Melanoma of soft tissue,CREB1,1385,NM_001320793;NM_004379;NM_134442
IGF1R_SIG,IGF1R,IGF1R_SIG,IGF1R,SIG,62,-2.4920027708762,-0.0465366152609883,-0.0418442690965481,-0.0619543240870062,-0.0201100549904581,0.0221932203681682,-1.90645091661977,5.17985740615699,5.26027971439956,4.91561267907427,-0.344667035325287,0.115062793280023,ENSG00000140443,IGF1R,protein_coding,15,1,98648539,98964530,q26.3,insulin like growth factor 1 receptor [Source:HGNC Symbol;Acc:HGNC:5465],Growth delay due to insulin-like growth factor I resistance;INSULIN-LIKE GROWTH FACTOR I RESISTANCE TO,IGF1R,3480,NM_000875;NM_001291858
AKAP12_SIG,AKAP12,AKAP12_SIG,AKAP12,SIG,26,-2.48798741715112,-0.173192403198089,-0.168451963314455,-0.188768134244315,-0.0203161709298603,0.0224406427408165,-2.38194243374405,1.3759257794221,1.46187923380433,1.09350728645191,-0.368371947352414,0.0455829202948385,ENSG00000131016,AKAP12,protein_coding,6,1,151239967,151358559,q25.1,A-kinase anchoring protein 12 [Source:HGNC Symbol;Acc:HGNC:370],NA,AKAP12,9590,NM_005100;NM_144497
TNS1_SIG,TNS1,TNS1_SIG,TNS1,SIG,23,2.48736678767023,-0.00869794271107083,-0.0131901628639925,0.00606220921995736,0.0192523720839499,0.022475095314524,1.63694049430384,4.3528349173349,4.29588401606363,4.53995930722622,0.244075291162589,0.180204874749985,ENSG00000079308,TNS1,protein_coding,2,-1,217799588,218033982,q35,tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973],NA,TNS1,7145,NM_001308022;NM_001308023;NM_022648
VPS72_TF,VPS72,VPS72_TF,VPS72,TF,307,2.48720985985742,0.218017981094688,0.208687373482257,0.248675691821246,0.0399883183389887,0.0224802737238348,1.73382768384411,4.82981815061437,4.79094889604224,4.95753141563708,0.166582519594834,0.154248502568113,ENSG00000163159,VPS72,protein_coding,1,-1,151169987,151195321,q21.3,vacuolar protein sorting 72 homolog [Source:HGNC Symbol;Acc:HGNC:11644],NA,VPS72,6944,NM_001271087;NM_001271088;NM_005997
SERHL2_SIG,SERHL2,SERHL2_SIG,SERHL2,SIG,22,-2.48691762048452,-0.00849392034267563,-0.00500962995084278,-0.0199423030586978,-0.0149326731078552,0.022491514091435,-2.01312372874563,0.348928335907665,0.374343255824318,0.265422170467235,-0.108921085357083,0.0947726141302914,ENSG00000183569,SERHL2,protein_coding,22,1,42553617,42574382,q13.2,serine hydrolase like 2 [Source:HGNC Symbol;Acc:HGNC:29446],NA,SERHL2,253190,NM_001284334;NM_014509
ZNF227_TF,ZNF227,ZNF227_TF,ZNF227,TF,29,2.4868821080991,0.300140947420104,0.293824663284254,0.320894452437894,0.0270697891536401,0.022491514091435,2.00367091921898,3.66704551227864,3.63269225731912,3.77992049285994,0.147228235540822,0.0964304690596917,ENSG00000131115,ZNF227,protein_coding,19,1,44207547,44237268,q13.31,zinc finger protein 227 [Source:HGNC Symbol;Acc:HGNC:13020],NA,ZNF227,7770,NM_001289166;NM_001289167;NM_001289168;NM_001289169;NM_001289170;NM_001289171;NM_001289172;NM_001289173;NM_182490
HTRA2_SIG,HTRA2,HTRA2_SIG,HTRA2,SIG,31,2.48638967818865,-0.0164808361718857,-0.022080369787749,0.00191763142309367,0.0239980012108428,0.0225179205232972,0.956249961924719,4.73985644156915,4.72602019887211,4.78531838185944,0.0592981829873319,0.452396783751362,ENSG00000115317,HTRA2,protein_coding,2,1,74529377,74533348,p13.1,HtrA serine peptidase 2 [Source:HGNC Symbol;Acc:HGNC:14348],3-methylglutaconic aciduria type 8;3-METHYLGLUTACONIC ACIDURIA TYPE VIII;Early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria;PARKINSON DISEASE 13 AUTOSOMAL DOMINANT SUSCEPTIBILITY TO;Young-onset Parkinson disease,HTRA2,27429,NM_001321727;NM_001321728;NM_013247;NM_145074
ABHD13_SIG,ABHD13,ABHD13_SIG,ABHD13,SIG,24,-2.48449741611977,0.42822337868386,0.435103629176176,0.405616841351962,-0.0294867878242143,0.0226331841542714,-1.76644945384117,5.38230583382842,5.40435263465862,5.30986634538634,-0.0944862892722833,0.146281805710458,ENSG00000139826,ABHD13,protein_coding,13,1,108218392,108234243,q33.3,abhydrolase domain containing 13 [Source:HGNC Symbol;Acc:HGNC:20293],NA,ABHD13,84945,NM_032859
TPH1_SIG,TPH1,TPH1_SIG,TPH1,SIG,56,2.48417424231941,0.118846339217472,0.114683587342077,0.132523952522342,0.0178403651802643,0.0226489667616351,1.22751542244239,1.23066431475313,1.2119308973498,1.29221697193548,0.0802860745856823,0.324806750941693,ENSG00000129167,TPH1,protein_coding,11,-1,18017564,18042426,p15.1,tryptophan hydroxylase 1 [Source:HGNC Symbol;Acc:HGNC:12008],NA,TPH1,7166,NM_004179
SLC35B2_SIG,SLC35B2,SLC35B2_SIG,SLC35B2,SIG,3,2.48363699672025,0.654060931835553,0.647902362229015,0.674296231971322,0.026393869742307,0.0226650608462878,1.18646576752848,5.28738070649261,5.27215867695477,5.33739594640268,0.0652372694479152,0.34296785280143,ENSG00000157593,SLC35B2,protein_coding,6,-1,44254096,44257890,p21.1,solute carrier family 35 member B2 [Source:HGNC Symbol;Acc:HGNC:16872],NA,SLC35B2,347734,NM_001286509;NM_001286510;NM_001286511;NM_001286512;NM_001286513;NM_001286517;NM_001286519;NM_001286520;NM_178148
TGIF1_TF,TGIF1,TGIF1_TF,TGIF1,TF,132,2.483627956749,-0.0643241965609161,-0.0677142017062983,-0.0531856082260889,0.0145285934802094,0.0226650608462878,0.0818479874477215,4.96906895846192,4.96721814228834,4.97515021160369,0.00793206931535363,0.954794148873906,ENSG00000177426,TGIF1,protein_coding,18,1,3411608,3459978,p11.31,TGFB induced factor homeobox 1 [Source:HGNC Symbol;Acc:HGNC:11776],Alobar holoprosencephaly;Holoprosencephaly;HOLOPROSENCEPHALY 4;Lobar holoprosencephaly;Microform holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Semilobar holoprosencephaly;Septopreoptic holoprosencephaly,TGIF1,7050,NM_001278682;NM_001278684;NM_001278686;NM_003244;NM_170695;NM_173207;NM_173208;NM_173209;NM_173210;NM_173211;NM_174886
DOLK_SIG,DOLK,DOLK_SIG,DOLK,SIG,33,2.4835636467957,0.144129868613026,0.140818008696184,0.15501169405408,0.0141936853578962,0.0226650608462878,2.17297301176301,2.49189949021547,2.45496225227716,2.6132647005842,0.158302448307033,0.0699228430722479,ENSG00000175283,DOLK,protein_coding,9,-1,128945530,128947619,q34.11,dolichol kinase [Source:HGNC Symbol;Acc:HGNC:23406],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Im;Congenital Disorders of Glycosylation;DK1-CDG;Familial isolated dilated cardiomyopathy,DOLK,22845,NM_014908
RREB1_TF,RREB1,RREB1_TF,RREB1,TF,93,2.48355730577528,0.0992141509034952,0.0952713116470413,0.112169194174701,0.0168978825276596,0.0226650608462878,1.65057850997311,7.43090207495754,7.40872853283137,7.50375799908638,0.0950294662550126,0.176317108446234,ENSG00000124782,RREB1,protein_coding,6,1,7107597,7251980,p24.3,ras responsive element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:10449],22q11.2 Deletion Syndrome,RREB1,6239,NM_001003698;NM_001003699;NM_001003700;NM_001168344
AFG3L2_SIG,AFG3L2,AFG3L2_SIG,AFG3L2,SIG,47,2.48354661260407,0.270190075568573,0.265898781987408,0.284290040192401,0.0183912582049926,0.0226650608462878,3.62996308922934,6.01022697360152,5.96579861661007,6.15620586085914,0.190407244249074,0.00182093277576321,ENSG00000141385,AFG3L2,protein_coding,18,-1,12328944,12377314,p11.21,AFG3 like matrix AAA peptidase subunit 2 [Source:HGNC Symbol;Acc:HGNC:315],Ataxia spastic 5 autosomal recessive;Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome;SPASTIC ATAXIA 5 AUTOSOMAL RECESSIVE;SPINOCEREBELLAR ATAXIA 28;Spinocerebellar ataxia type 28,AFG3L2,10939,NM_006796
CREB3_TF,CREB3,CREB3_TF,CREB3,TF,47,2.48244208585692,0.180602684817711,0.177965148687054,0.189268874961299,0.0113037262742455,0.0227306669149619,1.91914650128328,4.25775590080672,4.23917509491104,4.31880712017827,0.0796320252672355,0.112467868484927,ENSG00000107175,CREB3,protein_coding,9,1,35732598,35736999,p13.3,cAMP responsive element binding protein 3 [Source:HGNC Symbol;Acc:HGNC:2347],NA,CREB3,10488,NM_006368
PAIP1_SIG,PAIP1,PAIP1_SIG,PAIP1,SIG,67,2.48214826427787,0.463569792516909,0.458129181082855,0.481446087228802,0.0233169061459465,0.0227446370980281,2.2174076059163,4.76376864257703,4.735097437434,4.85797403090412,0.12287659347012,0.0640805796819341,ENSG00000172239,PAIP1,protein_coding,5,-1,43526267,43557758,p12,poly(A) binding protein interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:16945],NA,PAIP1,10605,NM_006451;NM_182789;NM_183323
CHD8_SIG,CHD8,CHD8_SIG,CHD8,SIG,56,2.48199676249175,0.639701874941273,0.636523712492307,0.650144408702158,0.0136206962098513,0.0227495273364104,2.73680079592483,7.29698591282121,7.27077543374888,7.38310605834458,0.112330624595691,0.0205363677931397,ENSG00000100888,CHD8,protein_coding,14,-1,21385194,21456126,q11.2,chromodomain helicase DNA binding protein 8 [Source:HGNC Symbol;Acc:HGNC:20153],Autism;AUTISM SUSCEPTIBILITY TO 18,CHD8,57680,NM_001170629;NM_020920
AGR2_SIG,AGR2,AGR2_SIG,AGR2,SIG,25,-2.48158926307833,0.083253433365526,0.0890894146806717,0.0640780661871898,-0.0250113484934819,0.022770770754147,-1.35628542739067,0.69006977406042,0.73986310294869,0.52646312199896,-0.21339998094973,0.273139229575441,ENSG00000106541,AGR2,protein_coding,7,-1,16791811,16833433,p21.1,anterior gradient 2, protein disulphide isomerase family member [Source:HGNC Symbol;Acc:HGNC:328],NA,AGR2,10551,NM_006408
ST3GAL6_SIG,ST3GAL6,ST3GAL6_SIG,ST3GAL6,SIG,42,-2.47938625128913,0.185620861642283,0.189132083636505,0.174083989375554,-0.0150480942609508,0.0229065191373256,-1.06117715734033,4.1084355834992,4.13908044321747,4.00774533013918,-0.131335113078293,0.400715760564041,ENSG00000064225,ST3GAL6,protein_coding,3,1,98732236,98821201,q12.1,ST3 beta-galactoside alpha-2,3-sialyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:18080],NA,ST3GAL6,10402,NM_001271142;NM_001271145;NM_001271146;NM_001271147;NM_001271148;NM_001323352;NM_001323353;NM_001323358;NM_001323359;NM_001323360;NM_001323362;NM_001323363;NM_001323364;NM_001323365;NM_001323366;NM_001323367;NM_001323368;NM_006100
MARC2_SIG,MARC2,MARC2_SIG,MARC2,SIG,39,2.47932041884267,-0.00380899862012384,-0.00855608535448621,0.0117885720784954,0.0203446574329816,0.0229065191373256,1.19380555679156,1.72357273336106,1.6763571449146,1.878709666828,0.202352521913404,0.339835486457563,ENSG00000117791,MARC2,protein_coding,1,1,220748225,220784815,q41,mitochondrial amidoxime reducing component 2 [Source:HGNC Symbol;Acc:HGNC:26064],NA,MARC2,54996,NM_001317338;NM_001331042;NM_017898
MAGOHB_SIG,MAGOHB,MAGOHB_SIG,MAGOHB,SIG,11,2.47910688584324,0.391742379170552,0.380989385123503,0.427073645325141,0.0460842602016378,0.0229154243946537,1.63200753151806,3.20169969212195,3.17481050929617,3.29004986426382,0.115239354967654,0.181568683905694,ENSG00000111196,MAGOHB,protein_coding,12,-1,10604193,10613609,p13.2,mago homolog B, exon junction complex subunit [Source:HGNC Symbol;Acc:HGNC:25504],NA,MAGOHB,55110,NM_001300739;NM_001319985;NM_018048
PIGW_SIG,PIGW,PIGW_SIG,PIGW,SIG,21,2.47712060512646,0.380355334755891,0.374498129506076,0.399600437719569,0.0251023082134927,0.0230385164631632,2.39303404918903,2.92195877246343,2.88232176571487,3.05219465178014,0.169872886065268,0.0444806152056803,ENSG00000277161,PIGW,protein_coding,17,1,36534987,36539310,q12,phosphatidylinositol glycan anchor biosynthesis class W [Source:HGNC Symbol;Acc:HGNC:23213],GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11;Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency;Hyperphosphatasia-intellectual disability syndrome;Hyperphosphatasia with mental retardation syndrome 5,PIGW,284098,NM_001346754;NM_001346755;NM_178517
ATP6V1E1_SIG,ATP6V1E1,ATP6V1E1_SIG,ATP6V1E1,SIG,46,-2.47671072579672,0.150294696656596,0.15591903985571,0.131814711859505,-0.0241043279962053,0.0230601468726344,-2.55985568371072,5.79046797207209,5.82115178025637,5.68964974518091,-0.131502035075456,0.0308805659988463,ENSG00000131100,ATP6V1E1,protein_coding,22,-1,17592136,17628749,q11.21,ATPase H+ transporting V1 subunit E1 [Source:HGNC Symbol;Acc:HGNC:857],Autosomal recessive cutis laxa type 2 classic type;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IIC,ATP6V1E1,529,NM_001039366;NM_001039367;NM_001696
ZNF638_SIG,ZNF638,ZNF638_SIG,ZNF638,SIG,92,2.47480076107306,0.266916227457014,0.257092165378606,0.299195288571783,0.0421031231931768,0.0231789648496903,2.53443539528817,6.87878677455246,6.83309577240949,7.0289143530222,0.195818580612706,0.0327739737998153,ENSG00000075292,ZNF638,protein_coding,2,1,71276561,71435069,p13.3,zinc finger protein 638 [Source:HGNC Symbol;Acc:HGNC:17894],NA,ZNF638,27332,NM_001014972;NM_001252612;NM_001252613;NM_014497
AGAP2_SIG,AGAP2,AGAP2_SIG,AGAP2,SIG,64,2.47467985040597,0.0671005570933348,0.0626274287467748,0.0817979788034606,0.0191705500566857,0.0231819476557041,0.880014479494374,5.63183553068573,5.6108041275611,5.70093871238096,0.0901345848198584,0.49242065573146,ENSG00000135439,AGAP2,protein_coding,12,-1,57723761,57742157,q14.1,ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 [Source:HGNC Symbol;Acc:HGNC:16921],NA,AGAP2,116986,NM_001122772;NM_014770
MTA2_TF,MTA2,MTA2_TF,MTA2,TF,99,2.47345941792201,0.293699932108974,0.292062092982669,0.299081403523976,0.00701931054130706,0.0232563965938927,-0.206291410179766,7.40424318395289,7.40613759856251,7.39801867880698,-0.00811891975553012,0.883361995210387,ENSG00000149480,MTA2,protein_coding,11,-1,62593214,62601865,q12.3,metastasis associated 1 family member 2 [Source:HGNC Symbol;Acc:HGNC:7411],NA,MTA2,9219,NM_001330292;NM_004739
PLCD3_SIG,PLCD3,PLCD3_SIG,PLCD3,SIG,46,2.47333485177273,0.171832700438289,0.168129369641681,0.184000787341429,0.015871417699748,0.0232596259184342,1.62298928158922,3.13866133670467,3.09540653626351,3.28078425243991,0.185377716176406,0.184156774108015,ENSG00000161714,PLCD3,protein_coding,17,-1,45108959,45133354,q21.31,phospholipase C delta 3 [Source:HGNC Symbol;Acc:HGNC:9061],NA,PLCD3,113026,NM_133373
PHF13_SIG,PHF13,PHF13_SIG,PHF13,SIG,6,-2.47145039766071,-0.12726480564948,-0.120926223908974,-0.148091574225427,-0.0271653503164526,0.0233776706916796,-2.67631117240389,3.88100752254377,3.94353836793711,3.67554903053708,-0.267989337400034,0.0236693002213549,ENSG00000116273,PHF13,protein_coding,1,1,6613731,6624030,p36.31,PHD finger protein 13 [Source:HGNC Symbol;Acc:HGNC:22983],NA,PHF13,148479,NM_153812
ZNF426_TF,ZNF426,ZNF426_TF,ZNF426,TF,81,2.47137483826821,0.328070076788554,0.323850290029851,0.341935090424292,0.0180848003944415,0.023377709329673,2.38723492300018,3.21987168705389,3.18274295798424,3.34186608256846,0.159123124584225,0.0450415575714318,ENSG00000130818,ZNF426,protein_coding,19,-1,9523223,9538645,p13.2,zinc finger protein 426 [Source:HGNC Symbol;Acc:HGNC:20725],NA,ZNF426,79088,NM_001300883;NM_001318055;NM_001318056;NM_024106
ZNF416_TF,ZNF416,ZNF416_TF,ZNF416,TF,37,2.47109143350012,0.204163088661475,0.199116542417406,0.220744597749133,0.0216280553317272,0.0233913409983899,1.9853698664729,2.25824441784437,2.22542327103352,2.3660853287943,0.140662057760786,0.0998143160948768,ENSG00000083817,ZNF416,protein_coding,19,-1,57571566,57578911,q13.43,zinc finger protein 416 [Source:HGNC Symbol;Acc:HGNC:20645],NA,ZNF416,55659,NM_001353405;NM_017879
E2F7_TF,E2F7,E2F7_TF,E2F7,TF,44,-2.46997315536129,0.0910382380221971,0.103536325792377,0.0499730924916045,-0.0535632333007729,0.0234596724046091,-1.6927828562475,2.34195440172282,2.39300763170272,2.17420807464599,-0.218799557056733,0.164990865668704,ENSG00000165891,E2F7,protein_coding,12,-1,77021248,77065569,q21.2,E2F transcription factor 7 [Source:HGNC Symbol;Acc:HGNC:23820],NA,E2F7,144455,NM_203394
STAT5A_TF,STAT5A,STAT5A_TF,STAT5A,TF,104,2.46985296414672,0.151232967786492,0.14482401800546,0.172290945638455,0.0274669276329951,0.0234596724046091,1.00105729412749,7.71569464849954,7.7005010718727,7.76561640027347,0.0651153284007727,0.429897276894029,ENSG00000126561,STAT5A,protein_coding,17,1,42287547,42311943,q21.2,signal transducer and activator of transcription 5A [Source:HGNC Symbol;Acc:HGNC:11366],NA,STAT5A,6776,NM_001288718;NM_001288719;NM_001288720;NM_003152
TFCP2L1_TF,TFCP2L1,TFCP2L1_TF,TFCP2L1,TF,106,2.4698232788923,-0.0629963956991831,-0.0647344341347241,-0.0572856979824056,0.00744873615231861,0.0234596724046091,-0.00390012748193619,1.14862552493954,1.14874509142789,1.14823266362068,-0.000512427807208461,0.997543371632111,ENSG00000115112,TFCP2L1,protein_coding,2,-1,121216587,121285202,q14.2,transcription factor CP2 like 1 [Source:HGNC Symbol;Acc:HGNC:17925],NA,TFCP2L1,29842,NM_014553
EIF3G_SIG,EIF3G,EIF3G_SIG,EIF3G,SIG,28,2.4694188356733,0.20302805321616,0.199014739777814,0.216214654513583,0.0171999147357694,0.0234812889189039,2.62569193709157,7.48190904386605,7.45656226925708,7.56519130329553,0.108629034038453,0.0265107373377575,ENSG00000130811,EIF3G,protein_coding,19,-1,10115014,10119918,p13.2,eukaryotic translation initiation factor 3 subunit G [Source:HGNC Symbol;Acc:HGNC:3274],NA,EIF3G,8666,NM_003755
PML_TF,PML,PML_TF,PML,TF,64,2.46933850780261,0.107423682061361,0.103136504274674,0.121510123360476,0.0183736190858018,0.0234816435748383,1.48835975961728,6.75189169220663,6.73301703648155,6.81390841816047,0.0808913816789253,0.22581867223772,ENSG00000140464,PML,protein_coding,15,1,73994673,74047812,q24.1,promyelocytic leukemia [Source:HGNC Symbol;Acc:HGNC:9113],ACUTE PROMYELOCYTIC LEUKEMIA,PML,5371,NM_002675;NM_033238;NM_033239;NM_033240;NM_033244;NM_033246;NM_033247;NM_033249;NM_033250
ALDH3B1_SIG,ALDH3B1,ALDH3B1_SIG,ALDH3B1,SIG,48,-2.4687109450938,0.424311437552316,0.431315870475242,0.40129687223413,-0.0300189982411121,0.0235179365182918,-0.857312857141631,6.15158685664048,6.17697138793655,6.06818053952481,-0.108790848411739,0.504487283953121,ENSG00000006534,ALDH3B1,protein_coding,11,1,68008578,68029282,q13.2,aldehyde dehydrogenase 3 family member B1 [Source:HGNC Symbol;Acc:HGNC:410],NA,ALDH3B1,221,NM_000694;NM_001030010;NM_001161473;NM_001290058;NM_001290059
OR2AK2_SIG,OR2AK2,OR2AK2_SIG,OR2AK2,SIG,18,2.4684203506435,0.00404898875879138,-0.00188240775285483,0.0235378630113432,0.0254202707641981,0.0235321137277044,2.46129677411243,0.267279167343889,0.247474314930483,0.332352253845081,0.0848779389145981,0.0384185003890941,ENSG00000187080,OR2AK2,protein_coding,1,1,247965233,247966386,q44,olfactory receptor family 2 subfamily AK member 2 [Source:HGNC Symbol;Acc:HGNC:19569],NA,OR2AK2,391191,NM_001004491
CCL22_SIG,CCL22,CCL22_SIG,CCL22,SIG,33,-2.46830234765214,-0.0431066101163116,-0.0376981362650809,-0.0608773099132125,-0.0231791736481317,0.0235349477039845,-0.740937167946902,0.375092507370339,0.390803648931775,0.323470185097051,-0.0673334638347247,0.568574079798798,ENSG00000102962,CCL22,protein_coding,16,1,57358783,57366189,q21,C-C motif chemokine ligand 22 [Source:HGNC Symbol;Acc:HGNC:10621],NA,CCL22,6367,NM_002990
SLC39A1_SIG,SLC39A1,SLC39A1_SIG,SLC39A1,SIG,47,2.46793024432133,0.36150778772942,0.355281871676555,0.381964369045977,0.0266824973694225,0.0235544974877066,1.8658857065619,5.78113826226852,5.74972826732134,5.88434253138071,0.134614264059375,0.123471325984499,ENSG00000143570,SLC39A1,protein_coding,1,-1,153959099,153968184,q21.3,solute carrier family 39 member 1 [Source:HGNC Symbol;Acc:HGNC:12876],NA,SLC39A1,27173,NM_001271957;NM_001271958;NM_001271959;NM_001271960;NM_001271961;NM_014437
IL15RA_SIG,IL15RA,IL15RA_SIG,IL15RA,SIG,33,2.46605819504552,0.0447408385351234,0.0411017401491801,0.0566978760889371,0.0155961359397571,0.0236730120142171,2.26665448787655,3.07821972805753,3.03128173092085,3.23244457579235,0.201162844871499,0.057887049361263,ENSG00000134470,IL15RA,protein_coding,10,-1,5943639,5978187,p15.1,interleukin 15 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:5978],NA,IL15RA,3601,NM_001243539;NM_001256765;NM_001351095;NM_001351096;NM_001351097;NM_002189;NM_172200
CDC25C_SIG,CDC25C,CDC25C_SIG,CDC25C,SIG,28,-2.46567091390467,0.104767596239115,0.134893433852655,0.00578270122319905,-0.129110732629456,0.0236936644143251,-1.13158411571424,1.43805205842135,1.46253842796905,1.35759684419321,-0.104941583775835,0.367515072989615,ENSG00000158402,CDC25C,protein_coding,5,-1,138285265,138338355,q31.2,cell division cycle 25C [Source:HGNC Symbol;Acc:HGNC:1727],NA,CDC25C,995,NM_001287582;NM_001287583;NM_001318098;NM_001790;NM_022809
CNGA4_SIG,CNGA4,CNGA4_SIG,CNGA4,SIG,17,-2.46505769289093,0.16074362996672,0.165545842252811,0.144964932455278,-0.0205809097975335,0.0237292917822206,-0.378699902357823,0.56375314393374,0.567609176668428,0.551083322091195,-0.0165258545772327,0.781152564705688,ENSG00000132259,CNGA4,protein_coding,11,1,6234765,6244429,p15.4,cyclic nucleotide gated channel alpha 4 [Source:HGNC Symbol;Acc:HGNC:2152],NA,CNGA4,1262,NM_001037329
PLA2G4B_SIG,PLA2G4B,PLA2G4B_SIG,PLA2G4B,SIG,10,2.46435208499932,0.0301772246778893,0.0274222471885121,0.0392292935715572,0.011807046383045,0.0237710928077143,1.5645285028245,0.986485319957536,0.969045787264991,1.04378664166162,0.0747408543966244,0.20124672442029,ENSG00000243708,PLA2G4B,protein_coding,15,1,41837775,41848147,q15.1,phospholipase A2 group IVB [Source:HGNC Symbol;Acc:HGNC:9036],NA,PLA2G4B,100137049,NM_001114633
PRKX_SIG,PRKX,PRKX_SIG,PRKX,SIG,25,2.46387300844285,0.221212646204486,0.217100516125625,0.234723930749312,0.0176234146236866,0.0237979134665519,1.38812238885856,6.18008891686752,6.15486312068892,6.26297367574007,0.108110555051145,0.261016523227661,ENSG00000183943,PRKX,protein_coding,X,-1,3604370,3713608,p22.33,protein kinase X-linked [Source:HGNC Symbol;Acc:HGNC:9441],NA,PRKX,5613,NM_005044
DAZAP1_SIG,DAZAP1,DAZAP1_SIG,DAZAP1,SIG,13,2.46374486116683,0.73337847179196,0.728864245325461,0.748210930181883,0.0193466848564221,0.0238014486939446,2.09809482533233,7.47787372215042,7.45917365161011,7.53931681106858,0.0801431594584691,0.0806309164211813,ENSG00000071626,DAZAP1,protein_coding,19,1,1407569,1435687,p13.3,DAZ associated protein 1 [Source:HGNC Symbol;Acc:HGNC:2683],NA,DAZAP1,26528,NM_001352033;NM_001352034;NM_001352035;NM_018959;NM_170711
TFE3_SIG,TFE3,TFE3_SIG,TFE3,SIG,26,-2.4629577884595,0.496777474660017,0.503639560647989,0.474230620699539,-0.0294089399484505,0.0238487779474067,-0.565174710789901,6.60424446739302,6.61150047439676,6.58040330152357,-0.0310971728731903,0.671761719447724,ENSG00000068323,TFE3,protein_coding,X,-1,49028726,49043410,p11.23,transcription factor binding to IGHM enhancer 3 [Source:HGNC Symbol;Acc:HGNC:11752],Alveolar soft-tissue sarcoma;Epithelioid hemangioendothelioma;MiT family translocation renal cell carcinoma;RENAL CELL CARCINOMA Xp11-ASSOCIATED,TFE3,7030,NM_001282142;NM_006521
NADK2_SIG,NADK2,NADK2_SIG,NADK2,SIG,27,2.4618648711966,0.465657891699676,0.459561918795959,0.485687516954746,0.0261255981587873,0.0239165750040156,1.04334501235131,4.81581725314189,4.79769576362071,4.87535929014003,0.0776635265193137,0.4093591640884,ENSG00000152620,NADK2,protein_coding,5,-1,36192589,36242279,p13.2,NAD kinase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:26404],24-@DIENOYL-CoA REDUCTASE DEFICIENCY;Dienoyl-CoA reductase deficiency with hyperlysinemia;Progressive encephalopathy with leukodystrophy due to DECR deficiency,NADK2,133686,NM_001085411;NM_001287340;NM_001287341;NM_153013
DDX46_SIG,DDX46,DDX46_SIG,DDX46,SIG,18,2.46133074235642,0.455913152081911,0.449648367519251,0.476497444216362,0.0268490766971107,0.0239472127552373,1.87082548046839,6.85953751918394,6.83585129294922,6.93736369109802,0.101512398148799,0.122358139027893,ENSG00000145833,DDX46,protein_coding,5,1,134758771,134855133,q31.1,DEAD-box helicase 46 [Source:HGNC Symbol;Acc:HGNC:18681],NA,DDX46,9879,NM_001300860;NM_014829
CCND3_SIG,CCND3,CCND3_SIG,CCND3,SIG,19,-2.4609992906988,0.407026102729974,0.412004791560962,0.390667553713871,-0.0213372378470919,0.0239643434722601,-1.22990732859076,7.61887958694338,7.64283000071633,7.5401853702608,-0.102644630455534,0.323815528013424,ENSG00000112576,CCND3,protein_coding,6,-1,41934933,42050357,p21.1,cyclin D3 [Source:HGNC Symbol;Acc:HGNC:1585],NA,CCND3,896,NM_001136017;NM_001136125;NM_001136126;NM_001287427;NM_001287434;NM_001760
DNAJC2_SIG,DNAJC2,DNAJC2_SIG,DNAJC2,SIG,20,2.46071252751525,0.343266154355717,0.338085173543975,0.360289377022867,0.0222042034788912,0.0239784984990889,2.73292835898988,5.51859180696316,5.47834866952903,5.65081925853245,0.172470589003424,0.0207268990065663,ENSG00000105821,DNAJC2,protein_coding,7,-1,103312289,103344830,q22.1,DnaJ heat shock protein family (Hsp40) member C2 [Source:HGNC Symbol;Acc:HGNC:13192],NA,DNAJC2,27000,NM_001129887;NM_014377
SLC14A1_SIG,SLC14A1,SLC14A1_SIG,SLC14A1,SIG,64,-2.45908382341463,-0.0318066199014711,-0.0280977617821229,-0.0439928680079011,-0.0158951062257784,0.0240825328547901,-2.06172523273329,1.96797582169219,2.04336766450143,1.72025976674754,-0.323107897753884,0.086443284072893,ENSG00000141469,SLC14A1,protein_coding,18,1,45687025,45752520,q12.3,solute carrier family 14 member 1 (Kidd blood group) [Source:HGNC Symbol;Acc:HGNC:10918],BLOOD GROUP--KIDD SYSTEM,SLC14A1,6563,NM_001128588;NM_001146036;NM_001146037;NM_001308278;NM_001308279;NM_015865
CCAR2_SIG,CCAR2,CCAR2_SIG,CCAR2,SIG,28,2.45887051599455,0.468719563920493,0.466505844045664,0.475993214937789,0.00948737089212475,0.0240918181934303,2.6782892318895,7.10870287912279,7.08390048495193,7.19019645996989,0.106295975017957,0.0235676533997652,ENSG00000158941,CCAR2,protein_coding,8,1,22604632,22621514,p21.3,cell cycle and apoptosis regulator 2 [Source:HGNC Symbol;Acc:HGNC:23360],NA,CCAR2,57805,NM_001363068;NM_021174
RNPEPL1_SIG,RNPEPL1,RNPEPL1_SIG,RNPEPL1,SIG,35,-2.45864427252846,0.285715440565615,0.290718288136871,0.269277512831487,-0.0214407753053841,0.0241019755024974,-1.86423430236234,6.81471664161459,6.83980827491799,6.73227270361769,-0.107535571300304,0.123802394540544,ENSG00000142327,RNPEPL1,protein_coding,2,1,240565804,240581372,q37.3,arginyl aminopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:10079],NA,RNPEPL1,57140,NM_018226
SLC29A4_SIG,SLC29A4,SLC29A4_SIG,SLC29A4,SIG,57,2.45813419679806,-0.0830839780374376,-0.086585127821043,-0.0715802001770196,0.0150049276440235,0.0241312029767933,1.52475114349644,0.845705331296291,0.812225123664429,0.955711727800979,0.143486604136551,0.213812323604924,ENSG00000164638,SLC29A4,protein_coding,7,1,5274369,5306870,p22.1,solute carrier family 29 member 4 [Source:HGNC Symbol;Acc:HGNC:23097],NA,SLC29A4,222962,NM_001040661;NM_001300847;NM_153247
CDK5_SIG,CDK5,CDK5_SIG,CDK5,SIG,27,2.45453247911057,0.516087766475868,0.509342482788007,0.53825084145027,0.0289083586622636,0.0243692185359408,1.54059558819115,3.30202756013183,3.27351936540919,3.39569734279195,0.122177977382765,0.208850232640282,ENSG00000164885,CDK5,protein_coding,7,-1,151053815,151057897,q36.1,cyclin dependent kinase 5 [Source:HGNC Symbol;Acc:HGNC:1774],LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA,CDK5,1020,NM_001164410;NM_004935
ZNF157_TF,ZNF157,ZNF157_TF,ZNF157,TF,46,2.45435810455818,-0.101448654401018,-0.10484199971013,-0.0902990912425054,0.0145429084676247,0.0243759575693744,1.23357941063003,0.218861706159619,0.212622901894727,0.239360634458548,0.0267377325638211,0.322327452196814,ENSG00000147117,ZNF157,protein_coding,X,1,47370583,47414305,p11.3,zinc finger protein 157 [Source:HGNC Symbol;Acc:HGNC:12942],NA,ZNF157,7712,NM_003446
SEC11A_SIG,SEC11A,SEC11A_SIG,SEC11A,SIG,45,-2.45384938785102,0.267059051406095,0.271448822178682,0.252635518867595,-0.0188133033110874,0.0244053797349315,-2.177595323648,6.54233279040973,6.57058124882428,6.44951642704762,-0.121064821776658,0.069352522155098,ENSG00000140612,SEC11A,protein_coding,15,-1,84669538,84716460,q25.3,SEC11 homolog A, signal peptidase complex subunit [Source:HGNC Symbol;Acc:HGNC:17718],NA,SEC11A,23478,NM_001271918;NM_001271919;NM_001271920;NM_001271921;NM_001271922;NM_014300
GPRC5B_SIG,GPRC5B,GPRC5B_SIG,GPRC5B,SIG,13,2.45344427603394,-0.124863173075296,-0.127960212462209,-0.114687186518296,0.0132730259439129,0.024427795142538,0.352977240266158,0.37432623905983,0.370137932360651,0.388087818214276,0.0179498858536249,0.795750665185514,ENSG00000167191,GPRC5B,protein_coding,16,-1,19856691,19886167,p12.3,G protein-coupled receptor class C group 5 member B [Source:HGNC Symbol;Acc:HGNC:13308],NA,GPRC5B,51704,NM_001304771;NM_016235
PRKCB_SIG,PRKCB,PRKCB_SIG,PRKCB,SIG,30,-2.4532981379473,0.329883042491418,0.335141825715584,0.312604183326299,-0.0225376423892858,0.02443263121102,-2.99440810727468,8.03560418212568,8.09319170309812,7.84638804178766,-0.246803661310461,0.010923371582214,ENSG00000166501,PRKCB,protein_coding,16,1,23835946,24220611,p12.2,protein kinase C beta [Source:HGNC Symbol;Acc:HGNC:9395],NA,PRKCB,5579,NM_002738;NM_212535
MORC3_TF,MORC3,MORC3_TF,MORC3,TF,67,-2.453172327631,0.292577393090734,0.294564156655724,0.286049455662911,-0.00851470099281272,0.024436087810961,-2.12042867479316,6.24977289296197,6.27192748976566,6.17697921774983,-0.0949482720158327,0.0773273142740839,ENSG00000159256,MORC3,protein_coding,21,1,36320189,36386148,q22.12,MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572],NA,MORC3,23515,NM_001320445;NM_001320446;NM_015358
GDI2_SIG,GDI2,GDI2_SIG,GDI2,SIG,24,2.451525032254,0.158162925204584,0.152876352491769,0.175533092689547,0.0226567401977781,0.0245431119797059,3.28939075145612,8.34586746351296,8.30074119895247,8.4941394756403,0.193398276687826,0.00495128084932774,ENSG00000057608,GDI2,protein_coding,10,-1,5765223,5842132,p15.1,GDP dissociation inhibitor 2 [Source:HGNC Symbol;Acc:HGNC:4227],NA,GDI2,2665,NM_001115156;NM_001494
PPM1L_SIG,PPM1L,PPM1L_SIG,PPM1L,SIG,26,2.448326753281,0.111028543571115,0.107443313956517,0.122808583733367,0.0153652697768497,0.0247519862400863,-1.14662022251619,4.67962431897074,4.70748006467368,4.58809829737538,-0.119381767298297,0.360556574721636,ENSG00000163590,PPM1L,protein_coding,3,1,160755602,161078902,q25.33,protein phosphatase, Mg2+/Mn2+ dependent 1L [Source:HGNC Symbol;Acc:HGNC:16381],NA,PPM1L,151742,NM_001317911;NM_001317912;NM_139245
SLC9A3R1_SIG,SLC9A3R1,SLC9A3R1_SIG,SLC9A3R1,SIG,25,-2.44832361784251,0.261096142662018,0.264281716384711,0.250629257573169,-0.013652458811542,0.0247519862400863,-1.24182276130661,7.15104506141728,7.17219657022029,7.08154724677882,-0.0906493234414673,0.31886981528322,ENSG00000109062,SLC9A3R1,protein_coding,17,1,74748628,74769353,q25.1,SLC9A3 regulator 1 [Source:HGNC Symbol;Acc:HGNC:11075],Dominant hypophosphatemia with nephrolithiasis or osteoporosis;NEPHROLITHIASIS/OSTEOPOROSIS HYPOPHOSPHATEMIC 2,SLC9A3R1,9368,NM_004252
HDGFL2_SIG,HDGFL2,HDGFL2_SIG,HDGFL2,SIG,25,2.44781802914355,0.264589035131639,0.257742138921977,0.287085979820529,0.029343840898552,0.0247815855277436,2.59058821175866,5.5217286458267,5.48714805993914,5.63535057088582,0.148202510946677,0.0287826897517724,ENSG00000167674,HDGFL2,protein_coding,19,1,4472297,4502208,p13.3,HDGF like 2 [Source:HGNC Symbol;Acc:HGNC:14680],NA,HDGFL2,84717,NM_001001520;NM_001348169;NM_032631
DAPK3_SIG,DAPK3,DAPK3_SIG,DAPK3,SIG,12,2.44623131385769,0.187844136665313,0.186061465420855,0.193701485039962,0.00764001961910632,0.0248857456176201,2.78753824758731,4.59299826794852,4.56888285907893,4.6722346113772,0.103351752298275,0.0182176020666942,ENSG00000167657,DAPK3,protein_coding,19,-1,3958453,3971123,p13.3,death associated protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:2676],NA,DAPK3,1613,NM_001348
POLG_SIG,POLG,POLG_SIG,POLG,SIG,22,2.44448454063171,0.435887290363755,0.42879399194373,0.459193842315266,0.0303998503715355,0.0250013788154521,3.32705309988865,6.52640408753601,6.48831906147396,6.65154060173989,0.163221540265936,0.00445025627382231,ENSG00000140521,POLG,protein_coding,15,-1,89305198,89334861,q26.1,DNA polymerase gamma, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9179],Alpers-Huttenlocher syndrome;Autosomal dominant progressive external ophthalmoplegia;Autosomal recessive progressive external ophthalmoplegia;MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE);Mitochondrial DNA depletion syndrome 4A;MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE);MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE);Mitochondrial neurogastrointestinal encephalomyopathy;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONSAUTOSOMAL DOMINANT 1;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNADELETIONS AUTOSOMAL RECESSIVE 1;Progressive myoclonic epilepsy type 5;Recessive mitochondrial ataxia syndrome;Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome;SENSORY ATAXIC NEUROPATHY DYSARTHRIA AND OPHTHALMOPARESIS;SPINOCEREBELLAR ATAXIA WITH EPILEPSY,POLG,5428,NM_001126131;NM_002693
ACLY_SIG,ACLY,ACLY_SIG,ACLY,SIG,51,2.44361396895229,0.66434972811906,0.655293520724997,0.694105838128125,0.0388123174031281,0.0250565696132215,2.65349337530903,7.31888344683617,7.27615396889009,7.45928030294474,0.183126334054656,0.0248704246838223,ENSG00000131473,ACLY,protein_coding,17,-1,41866917,41930542,q21.2,ATP citrate lyase [Source:HGNC Symbol;Acc:HGNC:115],NA,ACLY,47,NM_001096;NM_001303274;NM_001303275;NM_198830
CAPN1_SIG,CAPN1,CAPN1_SIG,CAPN1,SIG,38,2.44248426797471,0.458433475207294,0.453736282667581,0.473867107837779,0.0201308251701979,0.025129901000375,2.27129242175315,7.68327797918557,7.65289515299438,7.78310726524236,0.130212112247985,0.0573130383669154,ENSG00000014216,CAPN1,protein_coding,11,1,65180566,65212006,q13.1,calpain 1 [Source:HGNC Symbol;Acc:HGNC:1476],Autosomal recessive spastic paraplegia type 76;SPASTIC PARAPLEGIA 76 AUTOSOMAL RECESSIVE,CAPN1,823,NM_001198868;NM_001198869;NM_005186
MRPS12_SIG,MRPS12,MRPS12_SIG,MRPS12,SIG,45,2.44162386865151,0.424174650870236,0.417305175431154,0.446745784455791,0.0294406090246361,0.0251846282908711,2.49490311447379,3.86299680132131,3.82753183472568,3.97952454870693,0.151992713981252,0.0357025496567272,ENSG00000128626,MRPS12,protein_coding,19,1,38930548,38933162,q13.2,mitochondrial ribosomal protein S12 [Source:HGNC Symbol;Acc:HGNC:10380],NA,MRPS12,6183,NM_021107;NM_033362;NM_033363
IL4I1_SIG,IL4I1,IL4I1_SIG,IL4I1,SIG,49,-2.44135802557536,0.0176186161386314,0.0237754169762704,-0.00261087232789672,-0.0263862893041672,0.025197938810787,-2.40102227387751,1.55635085020102,1.63497583862733,1.29801160251455,-0.33696423611278,0.0438073339311993,ENSG00000104951,IL4I1,protein_coding,19,-1,49889654,49929539,q13.33,interleukin 4 induced 1 [Source:HGNC Symbol;Acc:HGNC:19094],NA,IL4I1,259307,NM_001258017;NM_001258018;NM_152899;NM_172374
TADA2A_TF,TADA2A,TADA2A_TF,TADA2A,TF,298,2.44098094095066,0.334259725135016,0.32591228085821,0.361687042044523,0.0357747611863127,0.0252190230902426,1.43769164585206,4.22503538479231,4.1983693931693,4.3126522144108,0.114282821241503,0.24284429309766,ENSG00000276234,TADA2A,protein_coding,17,1,37406886,37479725,q12,transcriptional adaptor 2A [Source:HGNC Symbol;Acc:HGNC:11531],NA,TADA2A,6871,NM_001166105;NM_001291918;NM_001488;NM_133439
PDXDC1_SIG,PDXDC1,PDXDC1_SIG,PDXDC1,SIG,14,2.43940730515584,0.339425651647235,0.336668839404361,0.348483749016676,0.0118149096123146,0.0253238631177754,2.23748858406831,6.45096967428195,6.4296164059923,6.52113041294793,0.0915140069556221,0.0614691989638782,ENSG00000179889,PDXDC1,protein_coding,16,1,14974591,15139339,p13.11,pyridoxal dependent decarboxylase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28995],NA,PDXDC1,23042;102724985,NM_001285444;NM_001285445;NM_001285447;NM_001285448;NM_001285449;NM_001285450;NM_001324019;NM_001324020;NM_001324021;NM_015027
ALDH4A1_SIG,ALDH4A1,ALDH4A1_SIG,ALDH4A1,SIG,47,-2.43746277973217,0.0818501688767318,0.0873785710549443,0.0636854188626047,-0.0236931521923396,0.0254551837096416,-2.83732282122346,2.88081633307362,2.95005715392782,2.6533107788384,-0.296746375089418,0.0161903862060423,ENSG00000159423,ALDH4A1,protein_coding,1,-1,18871430,18902724,p36.13,aldehyde dehydrogenase 4 family member A1 [Source:HGNC Symbol;Acc:HGNC:406],HYPERPROLINEMIA TYPE 2;HYPERPROLINEMIA TYPE II,ALDH4A1,8659,NM_001161504;NM_001319218;NM_003748;NM_170726
ABCF2_SIG,ABCF2,ABCF2_SIG,ABCF2,SIG,54,2.43668018909675,0.442694566505451,0.433357351875106,0.473373986005154,0.0400166341300485,0.0255050367918176,2.59620075276986,5.16279528311351,5.11218443139434,5.32908808161933,0.216903650224991,0.0284514651412711,ENSG00000033050,ABCF2,protein_coding,7,-1,151211484,151227205,q36.1,ATP binding cassette subfamily F member 2 [Source:HGNC Symbol;Acc:HGNC:71],NA,ABCF2,10061,NM_007189
CKLF_SIG,CKLF,CKLF_SIG,CKLF,SIG,24,-2.43447680481295,0.169681694701404,0.172765857158884,0.159548018055397,-0.0132178391034865,0.0256555203180275,0.465276586585585,2.6770248113794,2.6702458384763,2.69929857948956,0.0290527410132609,0.730098422883833,ENSG00000217555,CKLF,protein_coding,16,1,66552563,66566251,q21,chemokine like factor [Source:HGNC Symbol;Acc:HGNC:13253],NA,CKLF,51192,NM_001040138;NM_016326;NM_016951;NM_181640;NM_181641
PSMB9_SIG,PSMB9,PSMB9_SIG,PSMB9,SIG,33,-2.43398437869959,0.303245257898363,0.31157716189835,0.275869001898407,-0.0357081599999431,0.0256851160070841,-1.94665323636438,4.99434766661249,5.03546889491921,4.859235059319,-0.176233835600213,0.107077132327389,ENSG00000240065,PSMB9,protein_coding,6,1,32844136,32859851,p21.32,proteasome subunit beta 9 [Source:HGNC Symbol;Acc:HGNC:9546],PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3,PSMB9,5698,NM_002800
AK2_SIG,AK2,AK2_SIG,AK2,SIG,83,2.43311960837751,0.130470989939641,0.122967383249534,0.155125697635706,0.0321583143861723,0.0257412010835741,2.61899890431329,7.3407949720218,7.27944610759657,7.54236981227611,0.262923704679539,0.0269317280825579,ENSG00000004455,AK2,protein_coding,1,-1,33007940,33080996,p35.1,adenylate kinase 2 [Source:HGNC Symbol;Acc:HGNC:362],RETICULAR DYSGENESIS,AK2,204,NM_001199199;NM_001319139;NM_001319140;NM_001319141;NM_001319142;NM_001319143;NM_001625;NM_013411
GALE_SIG,GALE,GALE_SIG,GALE,SIG,36,-2.43259710988636,0.150266191958558,0.154269197683997,0.137113458860689,-0.0171557388233077,0.0257730223832645,-1.69437871939014,3.29140338325504,3.3223818945404,3.18961684617457,-0.132765048365827,0.164621588952398,ENSG00000117308,GALE,protein_coding,1,-1,23795599,23800781,p36.11,UDP-galactose-4-epimerase [Source:HGNC Symbol;Acc:HGNC:4116],Epimerase-deficiency galactosemia;Erythrocyte galactose epimerase deficiency;GALACTOSE EPIMERASE DEFICIENCY;Generalized galactose epimerase deficiency,GALE,2582,NM_000403;NM_001008216;NM_001127621
SHANK1_SIG,SHANK1,SHANK1_SIG,SHANK1,SIG,73,-2.43173155879523,-0.0413427567849667,-0.0378054681167419,-0.0529652766948481,-0.015159808578106,0.0258293291686772,-2.25461656744723,2.66626439406212,2.77205542728235,2.31866528490993,-0.453390142372418,0.0593845742940732,ENSG00000161681,SHANK1,protein_coding,19,-1,50661827,50719450,q13.33,SH3 and multiple ankyrin repeat domains 1 [Source:HGNC Symbol;Acc:HGNC:15474],Autism,SHANK1,50944,NM_016148
FKBP4_SIG,FKBP4,FKBP4_SIG,FKBP4,SIG,8,2.43135679142942,0.58784313795879,0.576304439455341,0.625756004470125,0.0494515650147845,0.0258507012138169,1.66103270405137,5.74494461188876,5.69570223172177,5.90674100386601,0.211038772144232,0.173541960359765,ENSG00000004478,FKBP4,protein_coding,12,1,2794970,2805423,p13.33,FKBP prolyl isomerase 4 [Source:HGNC Symbol;Acc:HGNC:3720],NA,FKBP4,2288,NM_002014
MED21_SIG,MED21,MED21_SIG,MED21,SIG,39,2.43094758350006,0.295557596375895,0.289528535987367,0.315367366223914,0.0258388302365475,0.0258745481299977,1.98442251890399,4.54354142434849,4.51475208613312,4.63813496419899,0.123382878065868,0.0999542369347277,ENSG00000152944,MED21,protein_coding,12,1,27022546,27066343,p11.23,mediator complex subunit 21 [Source:HGNC Symbol;Acc:HGNC:11473],NA,MED21,9412,NM_001271811;NM_004264
TRIM26_SIG,TRIM26,TRIM26_SIG,TRIM26,SIG,20,-2.42960018347708,0.243049467995316,0.24634437620397,0.232223341024024,-0.014121035179946,0.0259655418488022,-0.359100808242071,6.02760463456331,6.03194328851229,6.01334905730238,-0.018594231209919,0.792537059925692,ENSG00000234127,TRIM26,protein_coding,6,-1,30184455,30213427,p22.1,tripartite motif containing 26 [Source:HGNC Symbol;Acc:HGNC:12962],NA,TRIM26,7726,NM_001242783;NM_003449
JMJD6_SIG,JMJD6,JMJD6_SIG,JMJD6,SIG,63,-2.42923313658549,0.473519861941066,0.484518497641755,0.437381487495947,-0.0471370101458084,0.0259864576927633,-2.94533810997034,5.93740460532573,5.99308290644281,5.75446161594105,-0.238621290501763,0.012390452321746,ENSG00000070495,JMJD6,protein_coding,17,-1,76712832,76726799,q25.1,jumonji domain containing 6, arginine demethylase and lysine hydroxylase [Source:HGNC Symbol;Acc:HGNC:19355],NA,JMJD6,23210,NM_001081461;NM_015167
AKAP8L_SIG,AKAP8L,AKAP8L_SIG,AKAP8L,SIG,30,2.42709309723326,0.254614882912893,0.249839870896233,0.27030420811049,0.0204643372142575,0.0261348386621768,1.00881591228416,6.87192029480549,6.86127525885706,6.90689684149321,0.0456215826361496,0.426271052554762,ENSG00000011243,AKAP8L,protein_coding,19,-1,15380050,15419141,p13.12,A-kinase anchoring protein 8 like [Source:HGNC Symbol;Acc:HGNC:29857],NA,AKAP8L,26993,NM_001291478;NM_014371
OAT_SIG,OAT,OAT_SIG,OAT,SIG,15,-2.42421772254822,0.0133420833414659,0.0170067221719157,0.00130112718427342,-0.0157055949876422,0.0263369732800712,-2.89068301376024,5.68044753108803,5.7576187701944,5.42688488830995,-0.330733881884442,0.0142003744712757,ENSG00000065154,OAT,protein_coding,10,-1,124397303,124418976,q26.13,ornithine aminotransferase [Source:HGNC Symbol;Acc:HGNC:8091],GYRATE ATROPHY OF CHOROID AND RETINA,OAT,4942,NM_000274;NM_001171814;NM_001322965;NM_001322966;NM_001322967;NM_001322968;NM_001322969;NM_001322970;NM_001322971;NM_001322974
ZC3H12A_TF,ZC3H12A,ZC3H12A_TF,ZC3H12A,TF,141,-2.42414621523973,0.283873613834935,0.293909115454196,0.250899822800221,-0.0430092926539742,0.0263369732800712,-0.15698029776638,5.39332243536806,5.39862247636267,5.37590801495719,-0.0227144614054814,0.911847771133856,ENSG00000163874,ZC3H12A,protein_coding,1,1,37474580,37484377,p34.3,zinc finger CCCH-type containing 12A [Source:HGNC Symbol;Acc:HGNC:26259],NA,ZC3H12A,80149,NM_001323550;NM_001323551;NM_025079
LRRC47_SIG,LRRC47,LRRC47_SIG,LRRC47,SIG,16,2.42406394500463,0.367836682639721,0.35902543314448,0.39678793098123,0.0377624978367501,0.0263374843091289,2.00469864797166,5.36177848066444,5.33915829816673,5.43610193744265,0.0969436392759171,0.096240240996051,ENSG00000130764,LRRC47,protein_coding,1,-1,3778559,3796498,p36.32,leucine rich repeat containing 47 [Source:HGNC Symbol;Acc:HGNC:29207],NA,LRRC47,57470,NM_020710
CHFR_SIG,CHFR,CHFR_SIG,CHFR,SIG,21,-2.42382378740563,0.215441333251522,0.217946532661691,0.207209963760963,-0.010736568900728,0.0263494492458832,-0.893906476999448,6.10706705037474,6.11881704885052,6.06845991252574,-0.0503571363247736,0.48507325620369,ENSG00000072609,CHFR,protein_coding,12,-1,132822187,132956304,q24.33,checkpoint with forkhead and ring finger domains [Source:HGNC Symbol;Acc:HGNC:20455],NA,CHFR,55743,NM_001161344;NM_001161345;NM_001161346;NM_001161347;NM_018223
CELA1_SIG,CELA1,CELA1_SIG,CELA1,SIG,12,-2.42368099863139,0.00703525887832119,0.0110071278140792,-0.00601516762488355,-0.0170222954389627,0.0263543532020791,-1.15685540357483,0.32160826806552,0.330583040347939,0.292119730566144,-0.0384633097817944,0.356360134562363,ENSG00000139610,CELA1,protein_coding,12,-1,51328443,51346679,q13.13,chymotrypsin like elastase family member 1 [Source:HGNC Symbol;Acc:HGNC:3308],NA,CELA1,1990,NM_001971
DPAGT1_SIG,DPAGT1,DPAGT1_SIG,DPAGT1,SIG,55,2.42350327412949,0.339833285879549,0.327986754347118,0.378757603771823,0.0507708494247051,0.026361794199316,2.35268239597659,4.68514694454692,4.62942158803978,4.86824454449895,0.23882295645917,0.0484682851940196,ENSG00000172269,DPAGT1,protein_coding,11,-1,119096503,119108331,q23.3,dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 [Source:HGNC Symbol;Acc:HGNC:2995],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ij;Congenital myasthenic syndromes with glycosylation defect;DPAGT1-CDG;MYASTHENIC SYNDROME CONGENITAL 13;MYASTHENIC SYNDROME CONGENITAL WITH TUBULAR AGGREGATES 2,DPAGT1,1798,NM_001382
DCAF6_SIG,DCAF6,DCAF6_SIG,DCAF6,SIG,6,2.42332111222373,0.147499183321532,0.140393338299241,0.170846959823344,0.0304536215241028,0.0263695598066322,0.117684335484156,5.71879489180916,5.71719169105331,5.72406255143552,0.00687086038221199,0.934781613928543,ENSG00000143164,DCAF6,protein_coding,1,1,167935783,168075843,q24.2,DDB1 and CUL4 associated factor 6 [Source:HGNC Symbol;Acc:HGNC:30002],NA,DCAF6,55827,NM_001017977;NM_001198956;NM_001198957;NM_001349773;NM_001349774;NM_001349775;NM_001349776;NM_001349777;NM_001349778;NM_001349779;NM_001349780;NM_018442
SIK2_SIG,SIK2,SIK2_SIG,SIK2,SIG,20,2.42297609611216,0.428185503678838,0.422068929683559,0.448282818234754,0.0262138885511953,0.0263891556794458,2.53737800705356,5.14978624966184,5.11176541173123,5.27471186000529,0.162946448274066,0.0325536658288312,ENSG00000170145,SIK2,protein_coding,11,1,111602449,111730855,q23.1,salt inducible kinase 2 [Source:HGNC Symbol;Acc:HGNC:21680],NA,SIK2,23235,NM_015191
PPP2R1A_SIG,PPP2R1A,PPP2R1A_SIG,PPP2R1A,SIG,16,2.4225996848865,0.45130602448871,0.447830680281065,0.462725012599543,0.0148943323184774,0.0264110465022397,0.647574617229994,6.74805075272035,6.74139488833872,6.76992002140287,0.0285251330641588,0.622276212078346,ENSG00000105568,PPP2R1A,protein_coding,19,1,52190048,52229518,q13.41,protein phosphatase 2 scaffold subunit Aalpha [Source:HGNC Symbol;Acc:HGNC:9302],Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 36;Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,PPP2R1A,5518,NM_001363656;NM_014225
EIF6_SIG,EIF6,EIF6_SIG,EIF6,SIG,29,2.42160857530567,0.378689947239044,0.374702409355548,0.391791857427672,0.0170894480721246,0.0264777021466348,1.76741463229259,5.0884207356564,5.0667448181914,5.15964160732712,0.0928967891357199,0.146036452851662,ENSG00000242372,EIF6,protein_coding,20,-1,35278911,35284985,q11.22,eukaryotic translation initiation factor 6 [Source:HGNC Symbol;Acc:HGNC:6159],NA,EIF6,3692,NM_001267810;NM_002212;NM_181466;NM_181468
ELK1_TF,ELK1,ELK1_TF,ELK1,TF,77,2.42124940288309,0.177467473582746,0.174300792045422,0.187872284348238,0.0135714923028153,0.0264930813694853,2.15387933643708,5.49798779221128,5.47388577739105,5.57718012662061,0.10329434922956,0.0725768263650101,ENSG00000126767,ELK1,protein_coding,X,-1,47635521,47650604,p11.23,ELK1, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3321],NA,ELK1,2002,NM_001114123;NM_001257168;NM_005229
HIST1H4F_SIG,HIST1H4F,HIST1H4F_SIG,HIST1H4F,SIG,17,-2.42124720658831,-0.1379960419744,-0.134316162519379,-0.15008707446947,-0.0157709119500914,0.0264930813694853,-2.73513895161393,0.176536831379588,0.196023794592275,0.112508237966475,-0.0835155566257998,0.0206186798256342,ENSG00000274618,HIST1H4F,protein_coding,6,1,26240426,26240737,p22.2,histone cluster 1 H4 family member f [Source:HGNC Symbol;Acc:HGNC:4783],NA,HIST1H4F,8361,NM_003540
ABHD2_SIG,ABHD2,ABHD2_SIG,ABHD2,SIG,30,2.42105396203024,0.302454187026729,0.2997713093361,0.311269356581651,0.0114980472455505,0.0264979729584287,2.15814973706527,7.93223268737801,7.89298797668941,8.06117959392628,0.168191617236873,0.0720221434760229,ENSG00000140526,ABHD2,protein_coding,15,1,89087459,89202355,q26.1,abhydrolase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18717],NA,ABHD2,11057,NM_007011;NM_152924
SNRPE_SIG,SNRPE,SNRPE_SIG,SNRPE,SIG,51,2.42102982902598,0.452898091889097,0.446960415752861,0.472407599193874,0.0254471834410128,0.0264979729584287,2.02513419454383,3.40539879009004,3.37652059711872,3.50028428128153,0.123763684162815,0.0927627825312356,ENSG00000182004,SNRPE,protein_coding,1,1,203861599,203871152,q32.1,small nuclear ribonucleoprotein polypeptide E [Source:HGNC Symbol;Acc:HGNC:11161],Autosomal-Dominant Hypotrichosis Simplex;HYPOTRICHOSIS 11;Hypotrichosis simplex,SNRPE,6635,NM_001304464;NM_001328637;NM_001328638;NM_003094
PTPN7_SIG,PTPN7,PTPN7_SIG,PTPN7,SIG,13,2.42081886646889,-0.0490316059349718,-0.0537590522858927,-0.0334985679248029,0.0202604843610896,0.0265078768777906,0.553483328002759,7.08873098804278,7.07872266510206,7.12161547770514,0.0428928126030827,0.678554862246746,ENSG00000143851,PTPN7,protein_coding,1,-1,202147013,202161588,q32.1,protein tyrosine phosphatase, non-receptor type 7 [Source:HGNC Symbol;Acc:HGNC:9659],NA,PTPN7,5778,NM_001199797;NM_002832;NM_080588
DIS3_SIG,DIS3,DIS3_SIG,DIS3,SIG,40,2.41984747120647,0.535190246564934,0.531018770438948,0.548896525264602,0.0178777548256546,0.0265733005280012,2.86203477963008,6.13412193410638,6.10112530192919,6.24253943983145,0.141414137902265,0.0152372646528946,ENSG00000083520,DIS3,protein_coding,13,-1,72752169,72782096,q21.33,DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease [Source:HGNC Symbol;Acc:HGNC:20604],NA,DIS3,22894,NM_001128226;NM_001322348;NM_001322349;NM_014953
SH3BP2_SIG,SH3BP2,SH3BP2_SIG,SH3BP2,SIG,51,-2.41842863518981,0.516975954383493,0.523889204585141,0.494260989435223,-0.0296282151499173,0.0266716476929934,-0.457119371095159,7.49170881662149,7.50029107504117,7.46350996752826,-0.0367811075129129,0.735181164278993,ENSG00000087266,SH3BP2,protein_coding,4,1,2793071,2841098,p16.3,SH3 domain binding protein 2 [Source:HGNC Symbol;Acc:HGNC:10825],CHERUBISM,SH3BP2,6452,NM_001122681;NM_001145855;NM_001145856;NM_003023
DPYSL2_SIG,DPYSL2,DPYSL2_SIG,DPYSL2,SIG,35,-2.41735581507765,0.227730715233774,0.236647010370647,0.198434316926907,-0.0382126934437394,0.0267448737078935,-0.961531745792596,5.41672272817786,5.46204973580098,5.26779113170191,-0.194258604099069,0.450081322688534,ENSG00000092964,DPYSL2,protein_coding,8,1,26514031,26658178,p21.2,dihydropyrimidinase like 2 [Source:HGNC Symbol;Acc:HGNC:3014],NA,DPYSL2,1808,NM_001197293;NM_001244604;NM_001386
ZNF395_TF,ZNF395,ZNF395_TF,ZNF395,TF,226,2.41653242732227,0.0557003587906033,0.04966670915538,0.0755252075920513,0.0258584984366712,0.0267999062813951,2.09580088075615,5.87084609718894,5.81388282804111,6.05801112438897,0.244128296347856,0.0809676352201944,ENSG00000186918,ZNF395,protein_coding,8,-1,28345590,28402701,p21.1,zinc finger protein 395 [Source:HGNC Symbol;Acc:HGNC:18737],NA,ZNF395,55893,NM_018660
GNRHR2_SIG,GNRHR2,GNRHR2_SIG,GNRHR2,SIG,5,2.41603284411809,0.0965638060281664,0.0906721107750664,0.115922233288352,0.0252501225132858,0.0268311664918137,1.76375616176405,0.462816226311357,0.451635338863218,0.499553427926673,0.0479180890634546,0.146858189144438,ENSG00000211451,GNRHR2,transcribed_unitary_pseudogene,1,1,145919013,145925341,q21.1,gonadotropin releasing hormone receptor 2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:16341],NA,GNRHR2,NA,NA
POP1_SIG,POP1,POP1_SIG,POP1,SIG,32,2.41567893263544,0.310155990221362,0.297844702750954,0.350607363338416,0.0527626605874613,0.0268517149416154,2.03984435560607,2.45925740802405,2.41618019094813,2.6007968355592,0.184616644611064,0.0902527462539416,ENSG00000104356,POP1,protein_coding,8,1,98117293,98159835,q22.2,POP1 homolog, ribonuclease P/MRP subunit [Source:HGNC Symbol;Acc:HGNC:30129],Anauxetic dysplasia;ANAUXETIC DYSPLASIA 2,POP1,10940,NM_001145860;NM_001145861;NM_015029
PREP_SIG,PREP,PREP_SIG,PREP,SIG,34,2.41496868080866,0.366327319331228,0.357364546317635,0.395776430661606,0.0384118843439706,0.0268985810474598,2.3125323770528,5.31710877194109,5.28322327661284,5.42844682801963,0.14522355140679,0.0526069024917687,ENSG00000085377,PREP,protein_coding,6,-1,105273220,105454062,q21,prolyl endopeptidase [Source:HGNC Symbol;Acc:HGNC:9358],NA,PREP,5550,NM_002726
MYLK_SIG,MYLK,MYLK_SIG,MYLK,SIG,60,-2.41322865757635,-0.0819201405900798,-0.0762855169356718,-0.100433904025992,-0.02414838709032,0.027021774249407,-0.982703389576655,2.15819266936456,2.19987314320387,2.02124254103541,-0.178630602168453,0.439281449946849,ENSG00000065534,MYLK,protein_coding,3,-1,123610049,123884331,q21.1,myosin light chain kinase [Source:HGNC Symbol;Acc:HGNC:7590],AORTIC ANEURYSM FAMILIAL THORACIC 7;Familial thoracic aortic aneurysm and aortic dissection;Megacystis-microcolon-intestinal hypoperistalsis syndrome,MYLK,4638,NM_001321309;NM_053025;NM_053026;NM_053027;NM_053028;NM_053031;NM_053032
FBXL15_SIG,FBXL15,FBXL15_SIG,FBXL15,SIG,13,2.41264945636505,0.234069661118628,0.231594787461732,0.242201388848431,0.0106066013866991,0.0270591670097119,3.2335656430649,3.66925618181054,3.63896081655007,3.7687980962378,0.129837279687736,0.00578161698869774,ENSG00000107872,FBXL15,protein_coding,10,1,102419189,102423136,q24.32,F-box and leucine rich repeat protein 15 [Source:HGNC Symbol;Acc:HGNC:28155],NA,FBXL15,79176,NM_024326
SETDB1_TF,SETDB1,SETDB1_TF,SETDB1,TF,53,2.4122824055951,0.348250072468461,0.340712191143934,0.37301739682048,0.0323052056765459,0.0270808412702931,1.92125412569204,6.19618221505254,6.16961137498594,6.28348640384279,0.113875028856853,0.112073975843071,ENSG00000143379,SETDB1,protein_coding,1,1,150926263,150964744,q21.3,SET domain bifurcated histone lysine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10761],NA,SETDB1,9869,NM_001145415;NM_001243491;NM_001366417;NM_001366418;NM_012432
TAF1B_TF,TAF1B,TAF1B_TF,TAF1B,TF,374,2.41158959076552,0.125615675717885,0.123034159070862,0.134097801843818,0.0110636427729553,0.0271267553361204,2.32191992421638,3.5096603340865,3.47703448673614,3.6168595468091,0.139825060072959,0.0516262318139629,ENSG00000115750,TAF1B,protein_coding,2,1,9843443,9934416,p25.1,TATA-box binding protein associated factor, RNA polymerase I subunit B [Source:HGNC Symbol;Acc:HGNC:11533],NA,TAF1B,9014,NM_001318976;NM_001318977;NM_005680
SLCO2A1_SIG,SLCO2A1,SLCO2A1_SIG,SLCO2A1,SIG,27,2.41107863255688,-0.0763989256764417,-0.0790060580211024,-0.0678326336868423,0.0111734243342603,0.0271591911018583,0.821598179870093,0.417637150561798,0.402914102619168,0.466012879516153,0.0630987768969855,0.52343196269601,ENSG00000174640,SLCO2A1,protein_coding,3,-1,133928145,134052184,q22.2,solute carrier organic anion transporter family member 2A1 [Source:HGNC Symbol;Acc:HGNC:10955],Chronic enteropathy associated with SLCO2A1 gene;HYPERTROPHIC OSTEOARTHROPATHY PRIMARY AUTOSOMAL RECESSIVE 2;Pachydermoperiostosis,SLCO2A1,6578;80111,NM_005630;NM_025041
AKAP13_SIG,AKAP13,AKAP13_SIG,AKAP13,SIG,50,-2.41059612286856,0.463700170560724,0.468962457107407,0.446409800478768,-0.0225526566286383,0.0271895397609091,-0.987681210172349,8.2344097413876,8.25015159950254,8.18268649329567,-0.067465106206864,0.436887754839244,ENSG00000170776,AKAP13,protein_coding,15,1,85380571,85749358,q25.3,A-kinase anchoring protein 13 [Source:HGNC Symbol;Acc:HGNC:371],NA,AKAP13,11214,NM_001270546;NM_006738;NM_007200
TAF15_SIG,TAF15,TAF15_SIG,TAF15,SIG,18,2.41034113550716,0.461699528983795,0.45718334051992,0.476538433936528,0.019355093416608,0.0272029467982007,2.00006100752093,7.64375731827527,7.61919889046533,7.72444929536507,0.105250404899739,0.0970698955661861,ENSG00000270647,TAF15,protein_coding,17,1,35713791,35864615,q12,TATA-box binding protein associated factor 15 [Source:HGNC Symbol;Acc:HGNC:11547],Amyotrophic lateral sclerosis;CHONDROSARCOMA EXTRASKELETAL MYXOID;Extraskeletal myxoid chondrosarcoma,TAF15,8148,NM_003487;NM_139215
ZDHHC17_TF,ZDHHC17,ZDHHC17_TF,ZDHHC17,TF,112,-2.41021447021555,0.0732594483743984,0.0755053308952535,0.0658801200915888,-0.00962521080366466,0.0272067886181554,-0.824467674339417,5.96465638811665,5.97417057843025,5.93339547708622,-0.0407751013440292,0.521907971948857,ENSG00000186908,ZDHHC17,protein_coding,12,1,76763588,76853696,q21.2,zinc finger DHHC-type containing 17 [Source:HGNC Symbol;Acc:HGNC:18412],NA,ZDHHC17,23390,NM_001359626;NM_015336
ZNF701_TF,ZNF701,ZNF701_TF,ZNF701,TF,14,2.4097052569495,0.103686701827836,0.0933221265241364,0.137741734968561,0.0444196084444249,0.0272387807277321,1.38016249047084,3.66136044209039,3.63345220446263,3.75305893715304,0.119606732690411,0.264064724622077,ENSG00000167562,ZNF701,protein_coding,19,1,52555457,52587174,q13.41,zinc finger protein 701 [Source:HGNC Symbol;Acc:HGNC:25597],NA,ZNF701,55762,NM_001172655;NM_018260
KCNJ12_SIG,KCNJ12,KCNJ12_SIG,KCNJ12,SIG,17,-2.40963543406625,-0.125452493258326,-0.12232505704355,-0.135728355106874,-0.0134032980633245,0.0272387807277321,-0.282154148276343,0.76447871346068,0.771822444637633,0.740349311022117,-0.031473133615517,0.838373736379617,ENSG00000184185,KCNJ12,protein_coding,17,1,21376357,21419870,p11.2,potassium voltage-gated channel subfamily J member 12 [Source:HGNC Symbol;Acc:HGNC:6258],NA,KCNJ12,3768,NM_021012
ESRRB_TF,ESRRB,ESRRB_TF,ESRRB,TF,45,-2.4086959388195,-0.0572202064618832,-0.0559775668608857,-0.0613031651508748,-0.00532559828998917,0.0273033725704622,-1.23897183314197,0.240888729435034,0.248820797043606,0.214826221578296,-0.0339945754653109,0.319958581687359,ENSG00000119715,ESRRB,protein_coding,14,1,76310712,76501837,q24.3,estrogen related receptor beta [Source:HGNC Symbol;Acc:HGNC:3473],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 35,ESRRB,2103,NM_004452
GCLM_SIG,GCLM,GCLM_SIG,GCLM,SIG,62,-2.40820660276982,-0.013542253183398,-0.00888143418317146,-0.0288563727555708,-0.0199749385723994,0.0273343719298939,-0.23039636672029,3.7325056378172,3.73812929301726,3.71402791358843,-0.0241013794288326,0.86989278861979,ENSG00000023909,GCLM,protein_coding,1,-1,93885199,93909456,p22.1,glutamate-cysteine ligase modifier subunit [Source:HGNC Symbol;Acc:HGNC:4312],MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,GCLM,2730,NM_001308253;NM_002061
UPRT_SIG,UPRT,UPRT_SIG,UPRT,SIG,14,2.40756663626015,0.268677563222598,0.266536031027732,0.275714026148584,0.00917799512085141,0.0273766934980001,1.97337593900171,3.9084084301794,3.8904608385415,3.96737908841823,0.0769182498767323,0.101982984289613,ENSG00000094841,UPRT,protein_coding,X,1,75156388,75304885,q13.3,uracil phosphoribosyltransferase homolog [Source:HGNC Symbol;Acc:HGNC:28334],NA,UPRT,139596,NM_001307944;NM_145052
METTL7A_SIG,METTL7A,METTL7A_SIG,METTL7A,SIG,20,2.40620375923349,0.247306733869497,0.239343368667933,0.273472076674636,0.034128708006703,0.0274733929874521,1.68876179083802,6.32350875600587,6.27142640272787,6.49463648820503,0.223210085477157,0.166091809558715,ENSG00000185432,METTL7A,protein_coding,12,1,50923472,50932510,q13.12,methyltransferase like 7A [Source:HGNC Symbol;Acc:HGNC:24550],NA,METTL7A,25840,NM_014033
AHRR_TF,AHRR,AHRR_TF,AHRR,TF,40,2.40558004403076,-0.0628495999634156,-0.0648657942150532,-0.0562249617080349,0.00864083250701819,0.0275146763080037,0.951342195253646,1.0073549362584,0.982898796500932,1.08771082403294,0.104812027532012,0.454942105865318,ENSG00000063438,AHRR,protein_coding,5,1,321759,435110,p15.33,aryl-hydrocarbon receptor repressor [Source:HGNC Symbol;Acc:HGNC:346],NA,AHRR,NA,NA
EXOSC4_SIG,EXOSC4,EXOSC4_SIG,EXOSC4,SIG,10,2.40491318229876,0.0412041874624522,0.0374495323622823,0.0535409113630103,0.0160913790007279,0.0275592666561488,0.33837258511241,3.48865223792617,3.48316422899097,3.50668426728469,0.0235200382937156,0.804672489407296,ENSG00000178896,EXOSC4,protein_coding,8,1,144078648,144080648,q24.3,exosome component 4 [Source:HGNC Symbol;Acc:HGNC:18189],NA,EXOSC4,54512,NM_019037
HLA-DOB_SIG,HLA-DOB,HLA-DOB_SIG,HLA-DOB,SIG,16,-2.40398427440649,0.0862277219789474,0.0903367420150501,0.0727266561460386,-0.0176100858690115,0.0276218403363056,0.172285604611596,1.55461841755442,1.55129485017031,1.56553871038792,0.0142438602176133,0.903404761635784,ENSG00000241106,HLA-DOB,protein_coding,6,-1,32812763,32820466,p21.32,major histocompatibility complex, class II, DO beta [Source:HGNC Symbol;Acc:HGNC:4937],NA,HLA-DOB,3112,NM_002120
POLB_SIG,POLB,POLB_SIG,POLB,SIG,27,2.40393392460092,0.233322616320663,0.229002648762187,0.247516795441371,0.0185141466791844,0.0276218403363056,0.867558850036695,4.19394330174328,4.18260910872081,4.23118422167423,0.0485751129534214,0.499193211223406,ENSG00000070501,POLB,protein_coding,8,1,42338454,42371808,p11.21,DNA polymerase beta [Source:HGNC Symbol;Acc:HGNC:9174],NA,POLB,5423,NM_002690
ZNF551_TF,ZNF551,ZNF551_TF,ZNF551,TF,51,2.40214173449702,0.366013935266973,0.360303212109005,0.384777739928871,0.0244745278198666,0.0277518415028317,2.15017825954579,3.98606274808421,3.9360666614943,4.15033560402251,0.214268942528209,0.0731125144239145,ENSG00000204519,ZNF551,protein_coding,19,1,57681969,57717301,q13.43,zinc finger protein 551 [Source:HGNC Symbol;Acc:HGNC:25108],NA,ZNF551,90233,NM_001270938;NM_138347
DLAT_SIG,DLAT,DLAT_SIG,DLAT,SIG,31,2.40197600635789,0.669803200194205,0.661729211201616,0.696332021169855,0.0346028099682385,0.0277587128529397,2.51758955661764,5.12211333044976,5.08088863976805,5.25756588554682,0.176677245778771,0.0339737498506115,ENSG00000150768,DLAT,protein_coding,11,1,112024814,112064390,q23.1,dihydrolipoamide S-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:2896],PYRUVATE DEHYDROGENASE E2 DEFICIENCY,DLAT,1737,NM_001931
ZNF879_TF,ZNF879,ZNF879_TF,ZNF879,TF,8,2.40148226119625,-0.0288463675897876,-0.0345062197498774,-0.01024971049235,0.0242565092575273,0.0277904918000331,-0.142105707567851,1.92896797428917,1.9314326990178,1.92086959303795,-0.0105631059798558,0.920366181908178,ENSG00000234284,ZNF879,protein_coding,5,1,179023752,179035064,q35.3,zinc finger protein 879 [Source:HGNC Symbol;Acc:HGNC:37273],NA,ZNF879,345462,NM_001136116;NM_001353372;NM_001353373;NM_001353374
MRPL11_SIG,MRPL11,MRPL11_SIG,MRPL11,SIG,26,2.40126132712777,0.486376082821267,0.480890485401991,0.504400188627459,0.0235097032254684,0.0277974954442327,3.83071600166181,4.86254125333504,4.81205841495941,5.02841343656928,0.216355021609878,0.000977522386239724,ENSG00000174547,MRPL11,protein_coding,11,-1,66435075,66466738,q13.2,mitochondrial ribosomal protein L11 [Source:HGNC Symbol;Acc:HGNC:14042],NA,MRPL11,65003,NM_016050;NM_170738;NM_170739
ZNF286A_TF,ZNF286A,ZNF286A_TF,ZNF286A,TF,68,2.40123977199323,-0.10684892883985,-0.109468865531321,-0.0982405654250158,0.011228300106305,0.0277974954442327,4.27925329178907,1.67952377885037,1.59423106509011,1.9597712669198,0.365540201829697,0.000219837033112772,ENSG00000187607,ZNF286A,protein_coding,17,1,15699577,15720787,p12,zinc finger protein 286A [Source:HGNC Symbol;Acc:HGNC:13501],NA,ZNF286A,57335,NM_001130842;NM_001288642;NM_001288643;NM_001288644;NM_001288645;NM_001288646;NM_001288647;NM_001288648;NM_001288649;NM_020652
BTRC_SIG,BTRC,BTRC_SIG,BTRC,SIG,42,2.40115369325664,0.322010513449177,0.314406605951129,0.346994780942762,0.0325881749916329,0.027798327458652,0.876480961528909,4.22396035143815,4.20832282284724,4.27534080252257,0.0670179796753283,0.494406016506642,ENSG00000166167,BTRC,protein_coding,10,1,101354033,101557321,q24.32,beta-transducin repeat containing E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:1144],Isolated split hand-split foot malformation,BTRC,8945,NM_001256856;NM_003939;NM_033637
ZNF598_SIG,ZNF598,ZNF598_SIG,ZNF598,SIG,35,2.400778458767,0.243673786873615,0.23763081150292,0.263529277377328,0.0258984658744081,0.0278211353753588,2.47699317887156,6.02204669797375,5.99264777018833,6.11864317498298,0.125995404794649,0.0371306343345651,ENSG00000167962,ZNF598,protein_coding,16,-1,1997654,2009821,p13.3,zinc finger protein 598 [Source:HGNC Symbol;Acc:HGNC:28079],NA,ZNF598,90850,NM_178167
USP33_SIG,USP33,USP33_SIG,USP33,SIG,22,2.40051855946227,0.301177900159676,0.296415969777831,0.316824242842881,0.0204082730650501,0.027830423318235,0.447016449123016,6.02594667179135,6.02085344505584,6.04268155963661,0.0218281145807682,0.740718698176971,ENSG00000077254,USP33,protein_coding,1,-1,77695987,77759852,p31.1,ubiquitin specific peptidase 33 [Source:HGNC Symbol;Acc:HGNC:20059],NA,USP33,23032,NM_015017;NM_201624;NM_201626
ANO9_SIG,ANO9,ANO9_SIG,ANO9,SIG,39,-2.40050609670817,-0.142047131935018,-0.133811282321374,-0.169107780665565,-0.0352964983441915,0.027830423318235,-1.67209728957065,2.79039377131864,2.85065079986238,2.59240639181781,-0.258244408044561,0.170528908016534,ENSG00000185101,ANO9,protein_coding,11,-1,417933,442011,p15.5,anoctamin 9 [Source:HGNC Symbol;Acc:HGNC:20679],NA,ANO9,338440,NM_001012302;NM_001347882
APC2_SIG,APC2,APC2_SIG,APC2,SIG,12,2.39826688425299,-0.172817275274164,-0.175695312099849,-0.163360868561199,0.0123344435386499,0.0279954111494995,-0.511108920506365,0.571158995093266,0.579306818239802,0.544387576183219,-0.0349192420565821,0.70304726274686,ENSG00000115266,APC2,protein_coding,19,1,1446302,1473244,p13.3,APC2, WNT signaling pathway regulator [Source:HGNC Symbol;Acc:HGNC:24036],SOTOS SYNDROME;SOTOS SYNDROME 3,APC2,10297,NM_001351273;NM_005883
ADAMTS6_SIG,ADAMTS6,ADAMTS6_SIG,ADAMTS6,SIG,10,2.3973720761143,0.00608828338130612,0.00267483995147406,0.0173038832221829,0.0146290432707089,0.0280581242574791,1.10847625681747,1.48646575484524,1.45920700730515,1.57603021104839,0.116823203743242,0.378361602765679,ENSG00000049192,ADAMTS6,protein_coding,5,-1,65148738,65481920,q12.3,ADAM metallopeptidase with thrombospondin type 1 motif 6 [Source:HGNC Symbol;Acc:HGNC:222],NA,ADAMTS6,11174,NM_197941
HAL_SIG,HAL,HAL_SIG,HAL,SIG,65,-2.39645969728591,0.123294726471574,0.130893255751991,0.0983281302644863,-0.0325651254875049,0.0281223068987566,-1.23675100744138,4.31457283313177,4.36833053820645,4.13794037360069,-0.230390164605754,0.320889961436622,ENSG00000084110,HAL,protein_coding,12,-1,95972662,95996365,q23.1,histidine ammonia-lyase [Source:HGNC Symbol;Acc:HGNC:4806],HISTIDINEMIA,HAL,3034,NM_001258333;NM_001258334;NM_002108
PIN4_SIG,PIN4,PIN4_SIG,PIN4,SIG,25,2.39637866348248,0.295485966711252,0.287204630703422,0.322696070736981,0.0354914400335597,0.0281227593058249,1.7056204698316,3.14684814779151,3.11961799124243,3.23631866216706,0.116700670924624,0.161718152874461,ENSG00000102309,PIN4,protein_coding,X,1,72181353,72302926,q13.1,peptidylprolyl cis/trans isomerase, NIMA-interacting 4 [Source:HGNC Symbol;Acc:HGNC:8992],NA,PIN4,5303,NM_001170747;NM_006223
CEBPZ_TF,CEBPZ,CEBPZ_TF,CEBPZ,TF,161,2.39582604649124,0.339224174389543,0.336477762577093,0.348248098916165,0.0117703363390716,0.0281594198050621,1.75861582189317,5.89292502291954,5.87242366102883,5.96028664056046,0.0878629795316287,0.148035381880117,ENSG00000115816,CEBPZ,protein_coding,2,-1,37201612,37231596,p22.2,CCAAT enhancer binding protein zeta [Source:HGNC Symbol;Acc:HGNC:24218],NA,CEBPZ,10153,NM_005760
PIP5K1B_SIG,PIP5K1B,PIP5K1B_SIG,PIP5K1B,SIG,40,-2.39499750791974,0.0521351122953582,0.057194322322944,0.0355119936332907,-0.0216823286896534,0.0282173488111901,-2.69244518289732,3.82983833811242,3.91165891848464,3.56099928831797,-0.350659630166666,0.0228306251865611,ENSG00000107242,PIP5K1B,protein_coding,9,1,68705240,69009176,q21.11,phosphatidylinositol-4-phosphate 5-kinase type 1 beta [Source:HGNC Symbol;Acc:HGNC:8995],NA,PIP5K1B,8395,NM_001278253;NM_003558
ADPRH_SIG,ADPRH,ADPRH_SIG,ADPRH,SIG,54,2.39427891552494,0.222933566313982,0.21621322576676,0.245014685254856,0.0288014594880964,0.0282669054012966,3.45723993622888,3.85842042780373,3.75758857168368,4.18972509791243,0.432136526228744,0.00305316876168295,ENSG00000144843,ADPRH,protein_coding,3,1,119579268,119589945,q13.33,ADP-ribosylarginine hydrolase [Source:HGNC Symbol;Acc:HGNC:269],NA,ADPRH,141,NM_001125;NM_001291949;NM_001291950
NDUFC1_SIG,NDUFC1,NDUFC1_SIG,NDUFC1,SIG,9,2.39360171351918,0.223865660387498,0.218991277490325,0.239881489906779,0.0208902124164535,0.0283133421307429,3.10559744221281,4.31198097630034,4.27489991985165,4.43381873320319,0.158918813351537,0.00819314770590056,ENSG00000109390,NDUFC1,protein_coding,4,-1,139266880,139302551,q31.1,NADH:ubiquinone oxidoreductase subunit C1 [Source:HGNC Symbol;Acc:HGNC:7705],NA,NDUFC1,4717,NM_001184986;NM_001184987;NM_001184988;NM_001184989;NM_001184990;NM_001184991;NM_002494
GPR162_SIG,GPR162,GPR162_SIG,GPR162,SIG,50,2.3919785165326,0.121782827067521,0.118193911064106,0.133574979650171,0.0153810685860654,0.0284330464086914,1.43687246881782,3.56041779145787,3.50526405600239,3.74163720795443,0.236373151952043,0.243113469897386,ENSG00000250510,GPR162,protein_coding,12,1,6821624,6829972,p13.31,G protein-coupled receptor 162 [Source:HGNC Symbol;Acc:HGNC:16693],NA,GPR162,27239,NM_014449;NM_019858
CEPT1_SIG,CEPT1,CEPT1_SIG,CEPT1,SIG,33,2.39116729683524,0.446110144825784,0.440251363738685,0.465360425540537,0.0251090618018526,0.028488127537047,1.50948633332443,5.03148280588365,5.00597213472955,5.11530358253283,0.109331447803281,0.218963020946782,ENSG00000134255,CEPT1,protein_coding,1,1,111139627,111185104,p13.3,choline/ethanolamine phosphotransferase 1 [Source:HGNC Symbol;Acc:HGNC:24289],NA,CEPT1,10390,NM_001007794;NM_001330743;NM_006090
MPPE1_SIG,MPPE1,MPPE1_SIG,MPPE1,SIG,39,-2.39111776905741,0.333787244260884,0.337593832470443,0.321279883000905,-0.0163139494695377,0.028488127537047,0.983013293583438,5.0233303187538,5.00975417541193,5.06793764687708,0.0581834714651518,0.439101668983953,ENSG00000154889,MPPE1,protein_coding,18,-1,11882622,11909223,p11.21,metallophosphoesterase 1 [Source:HGNC Symbol;Acc:HGNC:15988],NA,MPPE1,65258,NM_001242904;NM_001319154;NM_001330563;NM_023075
STAT5B_TF,STAT5B,STAT5B_TF,STAT5B,TF,199,-2.39047234276645,0.125429948918329,0.128369826069351,0.115770352564969,-0.0125994735043822,0.0285324080437415,-2.76276048829272,7.57101631209239,7.61038902929133,7.44164881272445,-0.168740216566874,0.019333799928357,ENSG00000173757,STAT5B,protein_coding,17,-1,42199168,42276707,q21.2,signal transducer and activator of transcription 5B [Source:HGNC Symbol;Acc:HGNC:11367],ACUTE PROMYELOCYTIC LEUKEMIA;GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;Laron syndrome with immunodeficiency,STAT5B,6777,NM_012448
GALNT18_SIG,GALNT18,GALNT18_SIG,GALNT18,SIG,54,-2.39007032000176,-0.119001969187754,-0.115384834141856,-0.130886841481417,-0.0155020073395617,0.0285578154742701,-2.41381062256031,0.308566230474546,0.345758270577603,0.186363812993074,-0.159394457584529,0.0425794346702968,ENSG00000110328,GALNT18,protein_coding,11,-1,11270877,11622005,p15.4,polypeptide N-acetylgalactosaminyltransferase 18 [Source:HGNC Symbol;Acc:HGNC:30488],NA,GALNT18,374378,NM_198516
NFIL3_TF,NFIL3,NFIL3_TF,NFIL3,TF,74,-2.38994033728691,0.385298020524918,0.39531495791169,0.352385226254097,-0.0429297316575932,0.0285620798644994,-2.04781962046964,6.6768433160259,6.74856517756766,6.4411857709601,-0.307379406607566,0.08892982160818,ENSG00000165030,NFIL3,protein_coding,9,-1,91409045,91423832,q22.31,nuclear factor, interleukin 3 regulated [Source:HGNC Symbol;Acc:HGNC:7787],NA,NFIL3,4783,NM_001289999;NM_001290000;NM_005384
MARCH6_SIG,MARCH6,MARCH6_SIG,MARCH6,SIG,62,2.38821988832982,0.358957701345597,0.353564936907899,0.376676784498037,0.0231118475901382,0.0286902802330234,1.57333386646015,7.54958674800673,7.52708865082917,7.62350906730443,0.0964204164752606,0.198639011192946,ENSG00000145495,MARCH6,protein_coding,5,1,10353695,10440388,p15.2,membrane associated ring-CH-type finger 6 [Source:HGNC Symbol;Acc:HGNC:30550],NA,MARCH6,10299,NM_001270660;NM_001270661;NM_005885
NUDT21_SIG,NUDT21,NUDT21_SIG,NUDT21,SIG,20,2.38733455990908,0.586032252378248,0.58076604773707,0.603335496199261,0.0225694484621911,0.0287535910234255,1.63149635750878,6.99014218477021,6.97186932739134,7.05018157330081,0.0783122459094727,0.18170888546092,ENSG00000167005,NUDT21,protein_coding,16,-1,56429133,56452199,q13,nudix hydrolase 21 [Source:HGNC Symbol;Acc:HGNC:13870],NA,NUDT21,11051,NM_007006
PQBP1_SIG,PQBP1,PQBP1_SIG,PQBP1,SIG,16,2.38653684647984,0.443111656559662,0.438970021818959,0.4567198849934,0.0177498631744404,0.0288101565754437,2.26485211107909,5.50650291765109,5.48615814019255,5.57335004358628,0.0871919033937303,0.0581223057436495,ENSG00000102103,PQBP1,protein_coding,X,1,48890197,48903143,p11.23,polyglutamine binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9330],Hamel cerebro-palato-cardiac syndrome;RENPENNING SYNDROME 1;X-linked intellectual disability Golabi-Ito-Hall type;X-linked intellectual disability Porteous type;X-linked intellectual disability Sutherland-Haan type,PQBP1,10084,NM_001032381;NM_001032382;NM_001032383;NM_001032384;NM_001167989;NM_001167990;NM_001167992;NM_005710;NM_144495
NOL10_SIG,NOL10,NOL10_SIG,NOL10,SIG,14,2.38634805323807,0.53681395773073,0.531676132860292,0.553695382305026,0.022019249444734,0.0288190603168288,1.98202060874674,4.7491426326266,4.73061292278333,4.81002596496877,0.0794130421854379,0.100373147990314,ENSG00000115761,NOL10,protein_coding,2,-1,10570754,10689987,p25.1,nucleolar protein 10 [Source:HGNC Symbol;Acc:HGNC:25862],NA,NOL10,79954,NM_001261392;NM_001261394;NM_024894
DHRSX_SIG,DHRSX,DHRSX_SIG,DHRSX,SIG,7,2.38374777298736,0.249668346063457,0.243770394714561,0.269047329066974,0.0252769343524132,0.0290143433759321,-0.31682436833998,3.9522902058938,3.95625985457452,3.93924707451429,-0.0170127800602309,0.817727489668949,ENSG00000169084,DHRSX,protein_coding,X,-1,2219516,2502805,p22.33,dehydrogenase/reductase X-linked [Source:HGNC Symbol;Acc:HGNC:18399],NA,DHRSX,207063,NM_145177
SLC10A5_SIG,SLC10A5,SLC10A5_SIG,SLC10A5,SIG,35,2.38371328812566,0.0103298005977185,0.00514036183143405,0.0273808136869389,0.0222404518555047,0.0290143433759321,-0.529366698862511,0.655620008225299,0.664030451858175,0.627985693431565,-0.0360447584266101,0.692740635970719,ENSG00000253598,SLC10A5,protein_coding,8,-1,81693607,81696174,q21.13,solute carrier family 10 member 5 [Source:HGNC Symbol;Acc:HGNC:22981],NA,SLC10A5,347051,NM_001010893
NUDT10_SIG,NUDT10,NUDT10_SIG,NUDT10,SIG,45,-2.38218775131495,-0.141482638720902,-0.13748061486279,-0.154632145683269,-0.0171515308204784,0.0291288758852173,-1.57875880850916,0.731940636040327,0.782483836683219,0.565870119642253,-0.216613717040966,0.196936010172279,ENSG00000122824,NUDT10,protein_coding,X,1,51332231,51337525,p11.22,nudix hydrolase 10 [Source:HGNC Symbol;Acc:HGNC:17621],NA,NUDT10,170685,NM_001304963;NM_153183
STUB1_SIG,STUB1,STUB1_SIG,STUB1,SIG,29,2.38103686229023,0.298019310774,0.293839883541154,0.311751714539065,0.0179118309979105,0.0292102372517602,1.33722414070283,5.75594854370353,5.7423295324532,5.80069672352604,0.0583671910728371,0.280183594342018,ENSG00000103266,STUB1,protein_coding,16,1,680224,682870,p13.3,STIP1 homology and U-box containing protein 1 [Source:HGNC Symbol;Acc:HGNC:11427],Autosomal recessive cerebellar ataxia due to STUB1 deficiency;SPINOCEREBELLAR ATAXIA 48;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 16,STUB1,10273,NM_001293197;NM_005861
INSR_SIG,INSR,INSR_SIG,INSR,SIG,60,-2.38101002201401,0.0526402007966761,0.0567936289851564,0.0389932224630982,-0.0178004065220584,0.0292102372517602,-2.76528875915725,5.33181008969634,5.40575206661542,5.08885787981933,-0.31689418679609,0.0192072702151824,ENSG00000171105,INSR,protein_coding,19,-1,7112255,7294414,p13.2,insulin receptor [Source:HGNC Symbol;Acc:HGNC:6091],DIABETES MELLITUS INSULIN-RESISTANT WITH ACANTHOSIS NIGRICANS;DONOHUE SYNDROME;HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 5;Hyperinsulinism due to INSR deficiency;Insulin resistance syndrome type A;Leprechaunism;PINEAL HYPERPLASIA INSULIN-RESISTANT DIABETES MELLITUS AND SOMATIC ABNORMALITIES;RABSON-MENDENHALL SYNDROME,INSR,3643,NM_000208;NM_001079817
ULBP2_SIG,ULBP2,ULBP2_SIG,ULBP2,SIG,19,-2.37939080466585,-0.165433586956065,-0.160382266985665,-0.182030781144524,-0.021648514158859,0.0293328919649713,-1.09383652038805,0.389166357509711,0.403385397903699,0.342446653358035,-0.0609387445456643,0.385222984141481,ENSG00000131015,ULBP2,protein_coding,6,1,149942014,149949235,q25.1,UL16 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:14894],NA,ULBP2,80328,NM_025217
FPR3_SIG,FPR3,FPR3_SIG,FPR3,SIG,17,-2.37913185041015,-0.0391139426350446,-0.0325480837670806,-0.0606874789154978,-0.0281393951484172,0.0293475156135233,-1.16751110710973,0.662675342652718,0.687275168677738,0.581847342856225,-0.105427825821513,0.351544592011906,ENSG00000187474,FPR3,protein_coding,19,1,51795157,51826190,q13.41,formyl peptide receptor 3 [Source:HGNC Symbol;Acc:HGNC:3828],NA,FPR3,2359,NM_002030
GMPPB_SIG,GMPPB,GMPPB_SIG,GMPPB,SIG,12,-2.37829973762656,0.019564694260027,0.0223055144753918,0.0105591421238281,-0.0117463723515637,0.0294078298986073,0.995840459547737,0.410254923815484,0.405184967545548,0.426913351559559,0.0217283840140106,0.432660098690932,ENSG00000173540,GMPPB,protein_coding,3,-1,49716844,49723951,p21.31,GDP-mannose pyrophosphorylase B [Source:HGNC Symbol;Acc:HGNC:22932],Autosomal recessive limb-girdle muscular dystrophy type 2T;Congenital muscular dystrophy with cerebellar involvement;Congenital muscular dystrophy with intellectual disability;Congenital myasthenic syndromes with glycosylation defect;Muscle-eye-brain disease;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES) TYPE A 14;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 14;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION) TYPE B 14;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 14,GMPPB,29925,NM_013334;NM_021971
BARD1_SIG,BARD1,BARD1_SIG,BARD1,SIG,17,-2.37798353650032,0.212836416330952,0.218853476995157,0.193066074148565,-0.0257874028465921,0.0294238626748099,-2.44718330956333,3.89671290040334,3.94196711246194,3.74802048935366,-0.193946623108277,0.0395959262191192,ENSG00000138376,BARD1,protein_coding,2,-1,214725646,214809683,q35,BRCA1 associated RING domain 1 [Source:HGNC Symbol;Acc:HGNC:952],Breast Cancer;Hereditary breast and ovarian cancer syndrome,BARD1,580,NM_000465;NM_001282543;NM_001282545;NM_001282548;NM_001282549
NAE1_SIG,NAE1,NAE1_SIG,NAE1,SIG,22,2.37794829776902,0.474562122175046,0.469823622713199,0.490131477549685,0.020307854836486,0.0294238626748099,1.43390115657495,5.31708493921882,5.29749298451471,5.38145850467519,0.0839655201604783,0.244222627963905,ENSG00000159593,NAE1,protein_coding,16,-1,66802875,66873256,q22.1,NEDD8 activating enzyme E1 subunit 1 [Source:HGNC Symbol;Acc:HGNC:621],NA,NAE1,8883,NM_001018159;NM_001018160;NM_001286500;NM_003905
P4HA2_SIG,P4HA2,P4HA2_SIG,P4HA2,SIG,14,-2.37780545744294,-0.144085410475485,-0.140162884014382,-0.156973711704822,-0.0168108276904392,0.0294292588900578,-1.36469843714053,1.03295307951795,1.05586718649917,0.957663870865383,-0.0982033156337838,0.269919202816336,ENSG00000072682,P4HA2,protein_coding,5,-1,132191838,132295315,q31.1,prolyl 4-hydroxylase subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:8547],MYOPIA 25 AUTOSOMAL DOMINANT,P4HA2,8974,NM_001017973;NM_001017974;NM_001142598;NM_001142599;NM_001365678;NM_001365679;NM_004199
CNOT8_TF,CNOT8,CNOT8_TF,CNOT8,TF,195,2.37749251650897,0.196989939818281,0.195083992914212,0.203252336788792,0.00816834387458091,0.0294482362121432,0.875322804096555,6.77002982565155,6.75868085258894,6.80731930857156,0.0486384559826245,0.494970321022024,ENSG00000155508,CNOT8,protein_coding,5,1,154857553,154876793,q33.2,CCR4-NOT transcription complex subunit 8 [Source:HGNC Symbol;Acc:HGNC:9207],NA,CNOT8,9337,NM_001301073;NM_001301074;NM_001301075;NM_001301077;NM_001301080;NM_001301082;NM_001301083;NM_001301086;NM_004779
PLB1_SIG,PLB1,PLB1_SIG,PLB1,SIG,16,-2.37657485507151,0.186028895953807,0.195141000321543,0.156089124459818,-0.0390518758617257,0.0295155708919558,-1.73206123191646,4.6834792606752,4.73590862899715,4.5112113361888,-0.224697292808349,0.154716792917578,ENSG00000163803,PLB1,protein_coding,2,1,28457145,28644142,p23.2,phospholipase B1 [Source:HGNC Symbol;Acc:HGNC:30041],NA,PLB1,151056,NM_001170585;NM_153021
ETV2_TF,ETV2,ETV2_TF,ETV2,TF,81,-2.3754753412878,-0.0788881359448082,-0.0763775199285629,-0.0871373028553285,-0.0107597829267655,0.0295976194193098,-0.475442472803619,0.416050477955452,0.419842343941483,0.403591489715636,-0.0162508542258467,0.724145562259903,ENSG00000105672,ETV2,protein_coding,19,1,35641745,35644871,q13.12,ETS variant 2 [Source:HGNC Symbol;Acc:HGNC:3491],NA,ETV2,2116,NM_001300974;NM_001304549;NM_014209
ACOT9_SIG,ACOT9,ACOT9_SIG,ACOT9,SIG,17,-2.37049507567851,0.524097701129564,0.530631689108987,0.502628883482887,-0.0280028056260998,0.0299932880629508,-0.66056458018643,4.91891646475619,4.92953579742341,4.88402437170675,-0.0455114257166603,0.614442066435186,ENSG00000123130,ACOT9,protein_coding,X,-1,23701055,23766475,p22.11,acyl-CoA thioesterase 9 [Source:HGNC Symbol;Acc:HGNC:17152],NA,ACOT9,23597,NM_001033583;NM_001037171;NM_001330259
GSTM4_SIG,GSTM4,GSTM4_SIG,GSTM4,SIG,6,2.36982284399955,-0.0704435856229677,-0.074470564299846,-0.0572120842560822,0.0172584800437637,0.0300417513743807,2.49491853918798,3.62808607119713,3.57827907163632,3.79173764118268,0.213458569546369,0.0357025496567272,ENSG00000168765,GSTM4,protein_coding,1,1,109656099,109674836,p13.3,glutathione S-transferase mu 4 [Source:HGNC Symbol;Acc:HGNC:4636],NA,GSTM4,2948,NM_000850;NM_147148
NOP16_SIG,NOP16,NOP16_SIG,NOP16,SIG,16,2.36888001365546,0.29491396171325,0.287562957396299,0.319067261611801,0.0315043042155015,0.0301123053233974,1.44612350625994,3.77132385601305,3.74750063555363,3.84960015180827,0.102099516254639,0.239972459100088,ENSG00000048162,NOP16,protein_coding,5,-1,176383938,176388975,q35.2,NOP16 nucleolar protein [Source:HGNC Symbol;Acc:HGNC:26934],NA,NOP16,51491,NM_001256539;NM_001256540;NM_001291305;NM_001291307;NM_001291308;NM_001317975;NM_016391
UMPS_SIG,UMPS,UMPS_SIG,UMPS,SIG,74,2.36778513034532,0.389575689842245,0.379641053973989,0.422218064837944,0.0425770108639554,0.0301954085179027,2.44808467604735,3.66923527820585,3.61349044925638,3.85239685903982,0.23890640978344,0.03953473918948,ENSG00000114491,UMPS,protein_coding,3,1,124730433,124749273,q21.2,uridine monophosphate synthetase [Source:HGNC Symbol;Acc:HGNC:12563],Hereditary orotic aciduria;OROTIC ACIDURIA;OROTIC ACIDURIA TYPE 1,UMPS,7372,NM_000373
USP45_SIG,USP45,USP45_SIG,USP45,SIG,10,2.36725215266403,0.075802068815828,0.07208234667849,0.0880240129813673,0.0159416663028774,0.0302327740938722,2.69775599927474,2.95275480679478,2.88418251322899,3.17806377136809,0.293881258139102,0.0225203941626182,ENSG00000123552,USP45,protein_coding,6,-1,99432379,99521728,q16.2,ubiquitin specific peptidase 45 [Source:HGNC Symbol;Acc:HGNC:20080],NA,USP45,85015,NM_001080481;NM_001346021;NM_001346022;NM_001346023;NM_001346024;NM_001346025;NM_001346026;NM_001346027;NM_001346028;NM_001346029;NM_001346030;NM_001346033;NM_032929
GSTM1_SIG,GSTM1,GSTM1_SIG,GSTM1,SIG,4,2.36668671480583,-0.0920878992426654,-0.0970964529082106,-0.0756312229130169,0.0214652299951937,0.0302728341206839,1.44779195873414,2.14270012833067,2.06484403983345,2.39851299053584,0.333668950702389,0.239375700651641,ENSG00000134184,GSTM1,protein_coding,1,1,109687814,109709039,p13.3,glutathione S-transferase mu 1 [Source:HGNC Symbol;Acc:HGNC:4632],NA,GSTM1,2944,NM_000561;NM_146421
DNTT_SIG,DNTT,DNTT_SIG,DNTT,SIG,48,2.36638148220922,-0.0356285431182662,-0.0414045103252349,-0.0166503651525117,0.0247541451727234,0.0302916405345063,2.26717258317652,2.38097945322529,2.21894482830527,2.91337893510533,0.694434106800058,0.0578212980102657,ENSG00000107447,DNTT,protein_coding,10,1,96304409,96338564,q24.1,DNA nucleotidylexotransferase [Source:HGNC Symbol;Acc:HGNC:2983],NA,DNTT,1791,NM_001017520;NM_004088
TTK_SIG,TTK,TTK_SIG,TTK,SIG,55,-2.3662453318453,0.227470230875679,0.251176088551953,0.149579555653636,-0.101596532898317,0.0302966169048996,-2.14313989609495,3.19421728279603,3.26125939963258,2.97393604176163,-0.287323357870949,0.074068704832867,ENSG00000112742,TTK,protein_coding,6,1,80003887,80042527,q14.1,TTK protein kinase [Source:HGNC Symbol;Acc:HGNC:12401],NA,TTK,7272,NM_001166691;NM_003318
PUM2_SIG,PUM2,PUM2_SIG,PUM2,SIG,77,2.36583003261593,0.488126727929003,0.482760786311954,0.50575767895645,0.0229968926444958,0.0303244505881655,1.03379181033368,7.37641566494041,7.36322481582535,7.41975702631847,0.0565322104931233,0.413740871111882,ENSG00000055917,PUM2,protein_coding,2,-1,20248691,20352234,p24.1,pumilio RNA binding family member 2 [Source:HGNC Symbol;Acc:HGNC:14958],NA,PUM2,23369,NM_001282752;NM_001282790;NM_001282791;NM_001352917;NM_001352918;NM_001352919;NM_001352920;NM_001352923;NM_001352925;NM_001352926;NM_001352927;NM_001352928;NM_001352929;NM_001352930;NM_015317
COQ5_SIG,COQ5,COQ5_SIG,COQ5,SIG,119,2.36482741876375,0.29182485802106,0.28089994360297,0.327721005394784,0.0468210617918139,0.0303943596899447,2.15214887745818,3.76896533441404,3.72713229002215,3.9064167659874,0.179284475965254,0.0728038238147822,ENSG00000110871,COQ5,protein_coding,12,-1,120503279,120534434,q24.31,coenzyme Q5, methyltransferase [Source:HGNC Symbol;Acc:HGNC:28722],Autosomal Recessive Mental Retardation,COQ5,84274,NM_032314
EDF1_TF,EDF1,EDF1_TF,EDF1,TF,258,2.36482666403488,0.111932848767362,0.109896508564376,0.118623680862888,0.00872717229851282,0.0303943596899447,0.878022237992966,6.78956960537718,6.78240782963177,6.81310115425494,0.0306933246231732,0.493571824731688,ENSG00000107223,EDF1,protein_coding,9,-1,136862119,136866308,q34.3,endothelial differentiation related factor 1 [Source:HGNC Symbol;Acc:HGNC:3164],NA,EDF1,8721,NM_001281297;NM_001281298;NM_001281299;NM_003792;NM_153200
RBM6_SIG,RBM6,RBM6_SIG,RBM6,SIG,28,2.36412686714165,0.381162051555741,0.372305839110109,0.410261035305676,0.0379551961955674,0.0304456440217599,1.41828474045613,7.12925273449395,7.10302928607147,7.21541549359637,0.112386207524894,0.249702641508669,ENSG00000004534,RBM6,protein_coding,3,1,49940007,50100045,p21.31,RNA binding motif protein 6 [Source:HGNC Symbol;Acc:HGNC:9903],NA,RBM6,10180,NM_001167582;NM_001349190;NM_001349191;NM_001349192;NM_001349193;NM_001349194;NM_005777
JAKMIP2_SIG,JAKMIP2,JAKMIP2_SIG,JAKMIP2,SIG,41,-2.36381620998033,-0.0291998598018612,-0.0256118343267942,-0.0409890863627957,-0.0153772520360016,0.0304649898599056,0.109077179595453,1.8847029559242,1.88075315280835,1.8976808804477,0.0169277276393577,0.939554282286196,ENSG00000176049,JAKMIP2,protein_coding,5,-1,147585438,147782775,q32,janus kinase and microtubule interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:29067],NA,JAKMIP2,9832,NM_001270934;NM_001270941;NM_001282282;NM_014790
GEM_SIG,GEM,GEM_SIG,GEM,SIG,41,-2.36132831751085,-0.104388792828741,-0.0995766163099488,-0.120200229961915,-0.020623613651966,0.0306639321801469,-0.0540991047348418,0.572467833057076,0.573603876998573,0.568735117249303,-0.00486875974926959,0.970066819032501,ENSG00000164949,GEM,protein_coding,8,-1,94249253,94262350,q22.1,GTP binding protein overexpressed in skeletal muscle [Source:HGNC Symbol;Acc:HGNC:4234],NA,GEM,2669,NM_005261;NM_181702
CD276_SIG,CD276,CD276_SIG,CD276,SIG,53,2.36106189100598,0.00311378403798735,-0.00105618892304934,0.0168151237671079,0.0178713126901573,0.0306797356915185,3.41195728964709,2.1787446226666,2.02846315745037,2.67252657980564,0.644063422355268,0.00347967353600398,ENSG00000103855,CD276,protein_coding,15,1,73683966,73714514,q24.1,CD276 molecule [Source:HGNC Symbol;Acc:HGNC:19137],NA,CD276,80381,NM_001024736;NM_001329628;NM_001329629;NM_025240
GMEB2_TF,GMEB2,GMEB2_TF,GMEB2,TF,140,-2.35917695290533,0.27237449475903,0.278545142508416,0.252099509296762,-0.0264456332116539,0.0308297606557788,-2.12737110217928,4.97909799321376,5.01108029513644,4.87401328689639,-0.137067008240047,0.0763809034494706,ENSG00000101216,GMEB2,protein_coding,20,-1,63587602,63627101,q13.33,glucocorticoid modulatory element binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4371],NA,GMEB2,26205,NM_012384
MAP3K15_SIG,MAP3K15,MAP3K15_SIG,MAP3K15,SIG,68,-2.35847786885932,-0.00539787574369659,-0.000817260969835009,-0.0204484671435275,-0.0196312061736924,0.0308816162313649,-1.05248833124255,1.21739319033918,1.24480422110843,1.12732837495449,-0.11747584615394,0.404819636151047,ENSG00000180815,MAP3K15,protein_coding,X,-1,19360056,19515261,p22.12,mitogen-activated protein kinase kinase kinase 15 [Source:HGNC Symbol;Acc:HGNC:31689],NA,MAP3K15,389840,NM_001001671
RNF41_SIG,RNF41,RNF41_SIG,RNF41,SIG,23,2.35803773939594,0.313164729497025,0.306506577971057,0.335041513082351,0.0285349351112942,0.0309119762469207,3.28284890173835,5.78451342342352,5.74584355589666,5.9115715595832,0.165728003686533,0.00504041090105129,ENSG00000181852,RNF41,protein_coding,12,-1,56202175,56221933,q13.3,ring finger protein 41 [Source:HGNC Symbol;Acc:HGNC:18401],NA,RNF41,10193,NM_001242826;NM_005785;NM_194358;NM_194359
PDIK1L_SIG,PDIK1L,PDIK1L_SIG,PDIK1L,SIG,50,2.35763675169386,0.245420802896493,0.240796256681744,0.260615740459242,0.0198194837774979,0.0309390999598541,1.89165025951281,4.10287566148898,4.06780773655554,4.21809884341315,0.150291106857607,0.117931352518109,ENSG00000175087,PDIK1L,protein_coding,1,1,26111165,26125555,p36.11,PDLIM1 interacting kinase 1 like [Source:HGNC Symbol;Acc:HGNC:18981],NA,PDIK1L,149420,NM_001243532;NM_001243533;NM_152835
CSF1_SIG,CSF1,CSF1_SIG,CSF1,SIG,36,-2.35748180283918,-0.0648481966652554,-0.0597990353831598,-0.0814382980207126,-0.0216392626375528,0.0309457314828024,-2.82473278322473,4.1264927521553,4.26310588589959,3.67762102699547,-0.585484858904121,0.0166947048401501,ENSG00000184371,CSF1,protein_coding,1,1,109910242,109930992,p13.3,colony stimulating factor 1 [Source:HGNC Symbol;Acc:HGNC:2432],NA,CSF1,1435,NM_000757;NM_172210;NM_172211;NM_172212
NNT_SIG,NNT,NNT_SIG,NNT,SIG,31,2.3535880657822,0.626992252645575,0.61981538241569,0.650573397686626,0.0307580152709363,0.0312654124154687,1.56718630786549,6.79488668570336,6.76962899736086,6.87787623311442,0.10824723575356,0.200566680497427,ENSG00000112992,NNT,protein_coding,5,1,43602692,43707405,p12,nicotinamide nucleotide transhydrogenase [Source:HGNC Symbol;Acc:HGNC:7863],Familial glucocorticoid deficiency;GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOIDDEFICIENCY,NNT,23530,NM_001331026;NM_012343;NM_182977
KMT2A_TF,KMT2A,KMT2A_TF,KMT2A,TF,120,2.35299953950538,0.152397539416483,0.147486644711835,0.168533336303185,0.0210466915913507,0.0313085865480742,1.91108291546737,7.69362175283039,7.66078771830213,7.80150500913754,0.14071729083541,0.114070766734611,ENSG00000118058,KMT2A,protein_coding,11,1,118436464,118526832,q23.3,lysine methyltransferase 2A [Source:HGNC Symbol;Acc:HGNC:7132],Acute biphenotypic leukemia;Acute myeloid leukemia with 11q23 abnormalities;Acute myeloid leukemia with t(9;11)(p22;q23);Acute undifferentiated leukemia;Bilineal acute leukemia;Cornelia de Lange syndrome;Precursor B-cell acute lymphoblastic leukemia;Wiedemann-Steiner syndrome,KMT2A,4297,NM_001197104;NM_005933
HAMP_SIG,HAMP,HAMP_SIG,HAMP,SIG,11,-2.35284536548775,-0.00534379993870439,-2.46281610517243e-07,-0.0229011905262986,-0.022900944244688,0.0313152155341507,-1.54304694754892,0.461378337603672,0.479006657818354,0.403456714041147,-0.0755499437772071,0.208073168026997,ENSG00000105697,HAMP,protein_coding,19,1,35280716,35285143,q13.12,hepcidin antimicrobial peptide [Source:HGNC Symbol;Acc:HGNC:15598],Hemochromatosis type 2;HEMOCHROMATOSIS TYPE 2B,HAMP,57817,NM_021175
BMP6_SIG,BMP6,BMP6_SIG,BMP6,SIG,30,-2.35227241158199,0.0166998177039534,0.0224692416066253,-0.00225686083339738,-0.0247261024400226,0.0313571357226339,-2.02590362358419,1.57216013699259,1.63792260548962,1.35608345478806,-0.281839150701562,0.092644627531605,ENSG00000153162,BMP6,protein_coding,6,1,7726099,7881728,p24.3,bone morphogenetic protein 6 [Source:HGNC Symbol;Acc:HGNC:1073],Hemochromatosis type 5,BMP6,654,NM_001718
CDS2_SIG,CDS2,CDS2_SIG,CDS2,SIG,35,2.35206335730378,0.300508578718832,0.295246941830271,0.317796814209817,0.0225498723795463,0.0313684022824514,0.20281332879437,6.86620177148562,6.86319154507969,6.87609251539083,0.0129009703111445,0.885296019260999,ENSG00000101290,CDS2,protein_coding,20,1,5126879,5197887,p12.3,CDP-diacylglycerol synthase 2 [Source:HGNC Symbol;Acc:HGNC:1801],NA,CDS2,8760,NM_003818
ZNF287_TF,ZNF287,ZNF287_TF,ZNF287,TF,94,-2.35065756490481,-0.0916939867223598,-0.0882000632642276,-0.103174020941937,-0.0149739576777094,0.0314807682421663,-0.631446186128635,1.00558924337536,1.01684933144461,0.968591811147787,-0.0482575202968284,0.631832236919221,ENSG00000141040,ZNF287,protein_coding,17,-1,16546954,16569204,p11.2,zinc finger protein 287 [Source:HGNC Symbol;Acc:HGNC:13502],NA,ZNF287,57336,NM_001346167;NM_001346168;NM_001346169;NM_001346170;NM_001346171;NM_020653
RBL2_TF,RBL2,RBL2_TF,RBL2,TF,198,-2.35033754878305,0.191813258374711,0.195919351309406,0.178321810160713,-0.0175975411486933,0.0315014629061564,-1.69497654694545,7.2116043677367,7.24004561782065,7.11815454603229,-0.121891071788362,0.16448021028341,ENSG00000103479,RBL2,protein_coding,16,1,53433977,53491648,q12.2,RB transcriptional corepressor like 2 [Source:HGNC Symbol;Acc:HGNC:9894],NA,RBL2,5934,NM_001323608;NM_001323609;NM_001323610;NM_001323611;NM_005611
TEX2_SIG,TEX2,TEX2_SIG,TEX2,SIG,58,-2.34973877318195,0.220750271873028,0.226665673384021,0.201313952622624,-0.0253517207613974,0.0315457847595089,-3.03134563910462,6.20889007227815,6.26954302122487,6.0096018114532,-0.259941209771669,0.0099127144217326,ENSG00000136478,TEX2,protein_coding,17,-1,64147227,64263301,q23.3,testis expressed 2 [Source:HGNC Symbol;Acc:HGNC:30884],NA,TEX2,55852,NM_001288732;NM_001288733;NM_018469
SEPHS1_SIG,SEPHS1,SEPHS1_SIG,SEPHS1,SIG,28,2.34906430387975,0.408162712881163,0.400946763654797,0.431872260339223,0.0309254966844254,0.0315965828475754,1.8483765269119,5.00119606313053,4.97741531676874,5.07933280117641,0.101917484407676,0.127182117689069,ENSG00000086475,SEPHS1,protein_coding,10,-1,13317428,13348298,p13,selenophosphate synthetase 1 [Source:HGNC Symbol;Acc:HGNC:19685],NA,SEPHS1,22929,NM_001195602;NM_001195604;NM_012247
ATE1_SIG,ATE1,ATE1_SIG,ATE1,SIG,13,2.34796234811644,0.361088225496842,0.356913733252881,0.374804414298425,0.0178906810455441,0.0316837960368948,0.751055574730369,5.06074429292411,5.05163340457237,5.09068006893699,0.0390466643646211,0.562865655976357,ENSG00000107669,ATE1,protein_coding,10,-1,121740421,121928801,q26.13,arginyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:782],NA,ATE1,11101,NM_001001976;NM_001288734;NM_001288735;NM_001288736;NM_007041
GLRX3_SIG,GLRX3,GLRX3_SIG,GLRX3,SIG,6,2.34755305796742,0.267741981407542,0.264494105891641,0.278413572388359,0.0139194664967175,0.0317122035253592,0.732786550841096,4.42007698257086,4.41280215450223,4.44397998908209,0.0311778345798581,0.573042758712384,ENSG00000108010,GLRX3,protein_coding,10,1,130136391,130184521,q26.3,glutaredoxin 3 [Source:HGNC Symbol;Acc:HGNC:15987],NA,GLRX3,10539,NM_001199868;NM_001321980;NM_006541
RHOBTB3_SIG,RHOBTB3,RHOBTB3_SIG,RHOBTB3,SIG,29,2.34721852486033,-0.0288849362307849,-0.0332689756694888,-0.0144802352179007,0.018788740451588,0.0317342648306964,1.2172088853269,4.23283569339652,4.18421324206571,4.39259517634062,0.208381934274908,0.329416283225253,ENSG00000164292,RHOBTB3,protein_coding,5,1,95713522,95824383,q15,Rho related BTB domain containing 3 [Source:HGNC Symbol;Acc:HGNC:18757],NA,RHOBTB3,22836,NM_014899
HAVCR2_SIG,HAVCR2,HAVCR2_SIG,HAVCR2,SIG,31,-2.34658158118127,0.195010070730577,0.200441117646331,0.1771652022931,-0.023275915353231,0.0317821221933509,-2.17043638573099,4.15121100611695,4.22776840418428,3.89966526961005,-0.328103134574229,0.0702639844397106,ENSG00000135077,HAVCR2,protein_coding,5,-1,157085832,157142869,q33.3,hepatitis A virus cellular receptor 2 [Source:HGNC Symbol;Acc:HGNC:18437],NA,HAVCR2,84868,NM_032782
ATP8A1_SIG,ATP8A1,ATP8A1_SIG,ATP8A1,SIG,75,-2.34591341503161,0.0419842524830174,0.0464325163132275,0.02736852846947,-0.0190639878437574,0.0318327077771267,-2.17903654957709,6.33882129710146,6.39743949852645,6.14621863527649,-0.25122086324996,0.0691426967050842,ENSG00000124406,ATP8A1,protein_coding,4,-1,42408373,42657105,p13,ATPase phospholipid transporting 8A1 [Source:HGNC Symbol;Acc:HGNC:13531],NA,ATP8A1,10396,NM_001105529;NM_006095
CDC25B_SIG,CDC25B,CDC25B_SIG,CDC25B,SIG,23,-2.34503168249928,-0.0365719660661585,-0.0303536288078491,-0.0570036456291752,-0.0266500168213263,0.0319016311740853,0.243599634297343,5.44272771223421,5.43803776360418,5.45813754344713,0.0200997798429478,0.861766906408817,ENSG00000101224,CDC25B,protein_coding,20,1,3786772,3806121,p13,cell division cycle 25B [Source:HGNC Symbol;Acc:HGNC:1726],NA,CDC25B,994,NM_001287516;NM_001287517;NM_001287518;NM_001287519;NM_001287520;NM_001287522;NM_001287524;NM_004358;NM_021872;NM_021873
SSRP1_SIG,SSRP1,SSRP1_SIG,SSRP1,SIG,38,2.34449094112078,0.756062685743306,0.749343024174509,0.778141573755065,0.0287985495805555,0.0319414635422383,2.49214560486646,7.34788382963144,7.31458128082498,7.45730648999551,0.142725209170529,0.0358918755680999,ENSG00000149136,SSRP1,protein_coding,11,-1,57325986,57335892,q12.1,structure specific recognition protein 1 [Source:HGNC Symbol;Acc:HGNC:11327],NA,SSRP1,6749,NM_003146
RPS4X_SIG,RPS4X,RPS4X_SIG,RPS4X,SIG,9,2.3434885604944,0.718954328067516,0.710191728835131,0.747745725545352,0.0375539967102205,0.0320209435404112,3.01984790542645,10.6268577433146,10.5712868358647,10.8094478677931,0.238161031928398,0.0102185332483969,ENSG00000198034,RPS4X,protein_coding,X,-1,72255679,72277248,q13.1,ribosomal protein S4 X-linked [Source:HGNC Symbol;Acc:HGNC:10424],NA,RPS4X,6191,NM_001007
CTPS1_SIG,CTPS1,CTPS1_SIG,CTPS1,SIG,21,2.34135831249738,0.763027252812693,0.754875923229472,0.789810192871849,0.0349342696423772,0.0321977443001216,1.34726278434572,4.8671798234919,4.83937245459971,4.95854689270908,0.119174438109369,0.276405097679819,ENSG00000171793,CTPS1,protein_coding,1,1,40979335,41012565,p34.2,CTP synthase 1 [Source:HGNC Symbol;Acc:HGNC:2519],IMMUNODEFICIENCY 24;Severe combined immunodeficiency due to CTPS1 deficiency,CTPS1,1503,NM_001301237;NM_001905
EME2_SIG,EME2,EME2_SIG,EME2,SIG,40,2.33973460558754,0.0708104048285685,0.0687292323852981,0.0776485428564567,0.00891931047115856,0.0323315168551764,1.03797995784272,4.72265469266256,4.70711324700468,4.77371944268131,0.0666061956766306,0.41187437257541,ENSG00000197774,EME2,protein_coding,16,1,1773207,1781708,p13.3,essential meiotic structure-specific endonuclease subunit 2 [Source:HGNC Symbol;Acc:HGNC:27289],NA,EME2,197342,NM_001257370
ZNF398_TF,ZNF398,ZNF398_TF,ZNF398,TF,29,2.33927194783113,0.220126119778941,0.21814111457562,0.226648279732708,0.00850716515708797,0.0323650418618353,3.64643353735362,4.74457915645142,4.69710787695896,4.90055621764094,0.203448340681977,0.00172758956636437,ENSG00000197024,ZNF398,protein_coding,7,1,149126416,149182802,q36.1,zinc finger protein 398 [Source:HGNC Symbol;Acc:HGNC:18373],NA,ZNF398,57541,NM_020781;NM_170686
PTPN11_SIG,PTPN11,PTPN11_SIG,PTPN11,SIG,27,2.33863884755461,0.470866870255155,0.467540257529099,0.481797169212197,0.0142569116830977,0.0324133793785448,-0.0607337002797779,7.23329684856049,7.23402481970459,7.23090494337273,-0.00311987633186654,0.966425046763121,ENSG00000179295,PTPN11,protein_coding,12,1,112418351,112509913,q24.13,protein tyrosine phosphatase, non-receptor type 11 [Source:HGNC Symbol;Acc:HGNC:9644],Juvenile myelomonocytic leukemia;LEOPARD syndrome 1;LEOPARD syndrome type 1;Metachondromatosis;Noonan Syndrome;NOONAN SYNDROME 1;Noonan syndrome with multiple lentigines,PTPN11,5781,NM_001330437;NM_002834;NM_080601
OXCT1_SIG,OXCT1,OXCT1_SIG,OXCT1,SIG,15,2.33848756149539,0.13225605487856,0.127226420387342,0.148781996778278,0.021555576390936,0.032419952085822,1.4560707268717,4.68360440355376,4.65158628464678,4.78880679424814,0.137220509601368,0.236560123490773,ENSG00000083720,OXCT1,protein_coding,5,-1,41730065,41870425,p13.1,3-oxoacid CoA-transferase 1 [Source:HGNC Symbol;Acc:HGNC:8527],succinyl-CoA-3-ketoacid-CoA transferase deficiency;SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY,OXCT1,5019,NM_000436;NM_001364299;NM_001364301
PELI3_SIG,PELI3,PELI3_SIG,PELI3,SIG,17,-2.33823774691153,0.197332084623488,0.208736006765016,0.159862054729895,-0.0488739520351215,0.032435077562046,-0.952819434175094,2.23391810826897,2.25986619243196,2.14866011744772,-0.111206074984237,0.454260737824523,ENSG00000174516,PELI3,protein_coding,11,1,66466327,66477337,q13.2,pellino E3 ubiquitin protein ligase family member 3 [Source:HGNC Symbol;Acc:HGNC:30010],NA,PELI3,246330,NM_001098510;NM_001243135;NM_001243136;NM_145065
GPR173_SIG,GPR173,GPR173_SIG,GPR173,SIG,59,-2.33788597664544,-0.0727793405004947,-0.0678157953348781,-0.0890881317589493,-0.0212723364240713,0.0324590632535054,-0.322349879274209,1.03595798634441,1.04653382887649,1.00120878945329,-0.0453250394232035,0.814643576768703,ENSG00000184194,GPR173,protein_coding,X,1,53049091,53080615,p11.22,G protein-coupled receptor 173 [Source:HGNC Symbol;Acc:HGNC:18186],NA,GPR173,54328,NM_018969
CBX1_SIG,CBX1,CBX1_SIG,CBX1,SIG,9,2.33722883485748,0.224583556678739,0.213977231398472,0.259432911171043,0.0454556797725707,0.0325096114272438,1.22867665503904,5.1547725158808,5.1244587551799,5.25437487246947,0.129916117289566,0.324288155249468,ENSG00000108468,CBX1,protein_coding,17,-1,48070052,48101478,q21.32,chromobox 1 [Source:HGNC Symbol;Acc:HGNC:1551],NA,CBX1,10951,NM_001127228;NM_006807
LDHD_SIG,LDHD,LDHD_SIG,LDHD,SIG,24,-2.33661571275134,-0.0121485323965305,-0.00890365047422496,-0.0228102872841058,-0.0139066368098807,0.0325563938731829,-2.75826983136764,1.14743802626704,1.22240414983285,0.90112076312224,-0.321283386710608,0.0195550787547823,ENSG00000166816,LDHD,protein_coding,16,-1,75111860,75116771,q23.1,lactate dehydrogenase D [Source:HGNC Symbol;Acc:HGNC:19708],NA,LDHD,197257,NM_153486;NM_194436
FDXR_SIG,FDXR,FDXR_SIG,FDXR,SIG,22,2.33557961608863,0.173708378568367,0.168195591450436,0.191821821955857,0.0236262305054208,0.0326401266011513,1.49449358754749,3.1061030395524,3.07031675644187,3.2236865412013,0.153369784759425,0.223742055958863,ENSG00000161513,FDXR,protein_coding,17,-1,74862497,74873031,q25.1,ferredoxin reductase [Source:HGNC Symbol;Acc:HGNC:3642],AUDITORY NEUROPATHY AND OPTIC ATROPHY,FDXR,2232,NM_001258012;NM_001258013;NM_001258014;NM_001258015;NM_001258016;NM_004110;NM_024417
HPGDS_SIG,HPGDS,HPGDS_SIG,HPGDS,SIG,74,-2.33514161846395,0.00588509999296749,0.0121258922258549,-0.0146203602008053,-0.0267462524266601,0.0326668251619133,-3.48371150580424,2.45486957578381,2.64965098129263,1.81487352911195,-0.834777452180679,0.00282895177998752,ENSG00000163106,HPGDS,protein_coding,4,-1,94298535,94342876,q22.3,hematopoietic prostaglandin D synthase [Source:HGNC Symbol;Acc:HGNC:17890],NA,HPGDS,27306,NM_014485
SUV39H2_SIG,SUV39H2,SUV39H2_SIG,SUV39H2,SIG,47,2.3351227554464,0.291039709944649,0.281883226612169,0.321125298037083,0.0392420714249143,0.0326668251619133,2.15922076762721,2.81004270223631,2.76395067271073,2.96148794210608,0.197537269395346,0.0718797690195816,ENSG00000152455,SUV39H2,protein_coding,10,1,14878820,14904315,p13,suppressor of variegation 3-9 homolog 2 [Source:HGNC Symbol;Acc:HGNC:17287],NA,SUV39H2,79723,NM_001193424;NM_001193425;NM_001193426;NM_001193427;NM_024670
KHK_SIG,KHK,KHK_SIG,KHK,SIG,22,2.33469994948143,0.0508267465370636,0.0448328886725241,0.0705208509491218,0.0256879622765977,0.032697165269655,2.36184546257093,1.82826939869514,1.7816791791761,1.98135154854341,0.199672369367308,0.0475086427755023,ENSG00000138030,KHK,protein_coding,2,1,27086747,27100762,p23.3,ketohexokinase [Source:HGNC Symbol;Acc:HGNC:6315],Essential fructosuria;FRUCTOSURIA ESSENTIAL,KHK,3795,NM_000221;NM_006488
UBA1_SIG,UBA1,UBA1_SIG,UBA1,SIG,22,2.33435763643062,0.521572984616098,0.51307225061171,0.54950396777337,0.0364317171616598,0.0327204903296939,2.08638631717143,8.24037670050375,8.21562844049028,8.32169241197655,0.106063971486265,0.0824874838303805,ENSG00000130985,UBA1,protein_coding,X,1,47190861,47215128,p11.3,ubiquitin like modifier activating enzyme 1 [Source:HGNC Symbol;Acc:HGNC:12469],Infantile-onset X-linked spinal muscular atrophy;SPINAL MUSCULAR ATROPHY X-LINKED 2,UBA1,7317,NM_003334;NM_153280
CTSB_SIG,CTSB,CTSB_SIG,CTSB,SIG,39,-2.33398364586663,0.460577295431342,0.47228890454566,0.422096294055726,-0.0501926104899345,0.032746601656647,-1.85945648584019,8.24598850832456,8.30001771641181,8.06846396746647,-0.231553748945334,0.124870308901571,ENSG00000164733,CTSB,protein_coding,8,-1,11842524,11869448,p23.1,cathepsin B [Source:HGNC Symbol;Acc:HGNC:2527],Keratolytic winter erythema,CTSB,1508,NM_001317237;NM_001908;NM_147780;NM_147781;NM_147782;NM_147783
GIGYF2_SIG,GIGYF2,GIGYF2_SIG,GIGYF2,SIG,32,2.33389232867775,0.591211713979877,0.587789976556906,0.602454565512494,0.0146645889555877,0.0327479879178642,2.87517189210165,6.20768156458797,6.17266925780869,6.32272200114845,0.150052743339765,0.0147548064775,ENSG00000204120,GIGYF2,protein_coding,2,1,232697299,232860575,q37.1,GRB10 interacting GYF protein 2 [Source:HGNC Symbol;Acc:HGNC:11960],Hereditary late-onset Parkinson disease;PARKINSON DISEASE 11 AUTOSOMAL DOMINANT SUSCEPTIBILITY TO,GIGYF2,26058,NM_001103146;NM_001103147;NM_001103148;NM_015575
CDC27_SIG,CDC27,CDC27_SIG,CDC27,SIG,26,-2.33287948065634,0.282968997313976,0.28622162871328,0.272281779859123,-0.0139398488541569,0.032830100264771,-2.25925073294909,5.82780692561947,5.85765822010184,5.72972410089168,-0.127934119210162,0.0587865380097532,ENSG00000004897,CDC27,protein_coding,17,-1,47117703,47189422,q21.32,cell division cycle 27 [Source:HGNC Symbol;Acc:HGNC:1728],NA,CDC27,996,NM_001114091;NM_001256;NM_001293089;NM_001293091;NM_001353035;NM_001353047;NM_001353049;NM_001353050;NM_001353051
RFK_SIG,RFK,RFK_SIG,RFK,SIG,23,-2.33258294278925,0.163925787107155,0.166437809265891,0.155672000014165,-0.0107658092517263,0.03284949066015,-1.20558227876364,4.55380706026084,4.57059176234919,4.49865732482768,-0.0719344375215155,0.334254441812952,ENSG00000135002,RFK,protein_coding,9,-1,76385526,76394517,q21.13,riboflavin kinase [Source:HGNC Symbol;Acc:HGNC:30324],NA,RFK,55312,NM_018339
STK3_SIG,STK3,STK3_SIG,STK3,SIG,30,2.3317006512426,0.370928572020389,0.3628481834,0.397478420344524,0.0346302369445238,0.0329203432114052,0.352971563353897,4.00027056192571,3.99392163607332,4.02113131829786,0.0272096822245473,0.795750665185514,ENSG00000104375,STK3,protein_coding,8,-1,98371228,98942827,q22.2,serine/threonine kinase 3 [Source:HGNC Symbol;Acc:HGNC:11406],NA,STK3,6788,NM_001256312;NM_001256313;NM_006281
STK32C_SIG,STK32C,STK32C_SIG,STK32C,SIG,16,2.3314742570451,0.109130493428104,0.104633894431011,0.123905032989981,0.0192711385589695,0.0329336111095206,1.64526226689972,3.46801775286567,3.43228779978357,3.58541617013546,0.153128370351898,0.177783752784109,ENSG00000165752,STK32C,protein_coding,10,-1,132207492,132331847,q26.3,serine/threonine kinase 32C [Source:HGNC Symbol;Acc:HGNC:21332],NA,STK32C,282974,NM_001318878;NM_001318879;NM_001318880;NM_001318881;NM_001318883;NM_173575
MYT1_TF,MYT1,MYT1_TF,MYT1,TF,187,-2.33121002603589,-0.0518843500305418,-0.0479155193249412,-0.0649247937775149,-0.0170092744525737,0.0329502123008357,-2.79672523110724,0.578901455160553,0.637355965432265,0.386836635696355,-0.25051932973591,0.0178381590913238,ENSG00000196132,MYT1,protein_coding,20,1,64102394,64242253,q13.33,myelin transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:7622],OAVS/Goldenhar syndrome,MYT1,4661,NM_004535
RCAN1_TF,RCAN1,RCAN1_TF,RCAN1,TF,174,-2.33105513297405,0.168816689546318,0.173407705046791,0.153731924330481,-0.0196757807163102,0.0329572005449465,-2.39278639593383,3.75419836371286,3.81672392317977,3.54875723975017,-0.267966683429594,0.044500273866937,ENSG00000159200,RCAN1,protein_coding,21,-1,34513142,34615113,q22.12,regulator of calcineurin 1 [Source:HGNC Symbol;Acc:HGNC:3040],NA,RCAN1,1827,NM_001285389;NM_001285391;NM_001285392;NM_001285393;NM_001331016;NM_004414;NM_203417;NM_203418
HINT2_SIG,HINT2,HINT2_SIG,HINT2,SIG,20,2.33025853830206,0.324643579557448,0.320453846174203,0.338409846388109,0.0179560002139061,0.0330206978618528,3.99619311207423,3.23722823151798,3.17769339154947,3.43284270570022,0.255149314150751,0.000575342526082718,ENSG00000137133,HINT2,protein_coding,9,-1,35812960,35815354,p13.3,histidine triad nucleotide binding protein 2 [Source:HGNC Symbol;Acc:HGNC:18344],NA,HINT2,84681,NM_032593
GTF2F2_TF,GTF2F2,GTF2F2_TF,GTF2F2,TF,222,2.32989886463866,0.24862273951317,0.244665592858781,0.261624792806164,0.0169591999473828,0.0330457525830183,0.929252074768988,4.2324431286711,4.22054552632277,4.27153525067278,0.0509897243500096,0.466077373532587,ENSG00000188342,GTF2F2,protein_coding,13,1,45120510,45284893,q14.12,general transcription factor IIF subunit 2 [Source:HGNC Symbol;Acc:HGNC:4653],NA,GTF2F2,2963,NM_004128
SMAD2_SIG,SMAD2,SMAD2_SIG,SMAD2,SIG,10,2.32891237510738,0.324735029189825,0.320741932239462,0.337855204883873,0.0171132726444109,0.0331261720093095,0.923473085643243,6.35630704170707,6.34649840671213,6.3885354138333,0.0420370071211725,0.469136595552174,ENSG00000175387,SMAD2,protein_coding,18,-1,47808957,47931146,q21.1,SMAD family member 2 [Source:HGNC Symbol;Acc:HGNC:6768],Congenital heart disease,SMAD2,4087,NM_001003652;NM_001135937;NM_005901
SLC2A8_SIG,SLC2A8,SLC2A8_SIG,SLC2A8,SIG,21,-2.32770267577051,-0.0564927458939318,-0.0533009457888452,-0.066980089096359,-0.0136791433075137,0.0332265297639153,-0.943849475523383,1.80905873333228,1.83161858641985,1.73493350175882,-0.0966850846610322,0.45882192768185,ENSG00000136856,SLC2A8,protein_coding,9,1,127397138,127408424,q33.3,solute carrier family 2 member 8 [Source:HGNC Symbol;Acc:HGNC:13812],NA,SLC2A8,29988,NM_001271711;NM_001271712;NM_014580
ZBTB37_TF,ZBTB37,ZBTB37_TF,ZBTB37,TF,153,2.32712534364235,0.134222350345931,0.131160556196853,0.144282531121474,0.0131219749246215,0.0332667699495051,2.54400228448802,5.80012835675383,5.75232392815605,5.95720005071799,0.204876122561941,0.0320655378677814,ENSG00000185278,ZBTB37,protein_coding,1,1,173868082,173903549,q25.1,zinc finger and BTB domain containing 37 [Source:HGNC Symbol;Acc:HGNC:28365],NA,ZBTB37,84614,NM_001122770;NM_001346115;NM_032522
CNTNAP1_SIG,CNTNAP1,CNTNAP1_SIG,CNTNAP1,SIG,29,2.32709777399963,-0.0320275619473026,-0.0346946676426922,-0.0232642146624512,0.0114304529802409,0.0332667699495051,0.481967839656015,1.58262859419317,1.57019957384112,1.62346680392133,0.0532672300802172,0.71985386795378,ENSG00000108797,CNTNAP1,protein_coding,17,1,42682531,42699993,q21.2,contactin associated protein 1 [Source:HGNC Symbol;Acc:HGNC:8011],Hypomyelination neuropathy-arthrogryposis syndrome;LETHAL CONGENITAL CONTRACTURE SYNDROME 7;NEUROPATHY CONGENITAL HYPOMYELINATING 3,CNTNAP1,8506,NM_003632
RHOT2_SIG,RHOT2,RHOT2_SIG,RHOT2,SIG,30,2.32661541674196,0.159939601892795,0.157766555842674,0.167079610343192,0.00931305450051767,0.0333028726772241,2.39690652746484,6.52675725862478,6.50774988346125,6.58921006273353,0.0814601792722875,0.0441677596480776,ENSG00000140983,RHOT2,protein_coding,16,1,668105,674174,p13.3,ras homolog family member T2 [Source:HGNC Symbol;Acc:HGNC:21169],NA,RHOT2,89941,NM_001352275;NM_001352276;NM_001352277;NM_001352278;NM_001352279;NM_001352280;NM_001352281;NM_001352282;NM_001352283;NM_001352284;NM_001352285;NM_001352286;NM_001352287;NM_001352288;NM_001352289;NM_001352290;NM_001352291;NM_001352292;NM_001352293;NM_001352294;NM_138769
HNRNPAB_TF,HNRNPAB,HNRNPAB_TF,HNRNPAB,TF,544,2.32642735162889,0.281524799525882,0.276113582032391,0.299304514147352,0.0231909321149606,0.0333128702746102,2.28855616544271,7.18116559234777,7.14133991872891,7.31202137709548,0.17068145836657,0.0552783406481587,ENSG00000197451,HNRNPAB,protein_coding,5,1,178204533,178211163,q35.3,heterogeneous nuclear ribonucleoprotein A/B [Source:HGNC Symbol;Acc:HGNC:5034],NA,HNRNPAB,3182,NM_004499;NM_031266
ATG7_SIG,ATG7,ATG7_SIG,ATG7,SIG,65,-2.32546226142831,0.280792792882463,0.28890786703797,0.254128977800081,-0.0347788892378891,0.033391334761794,-1.59318027811058,4.75586523518699,4.78685202358208,4.65405150188886,-0.132800521693219,0.192581151004465,ENSG00000197548,ATG7,protein_coding,3,1,11272309,11557665,p25.3,autophagy related 7 [Source:HGNC Symbol;Acc:HGNC:16935],NA,ATG7,10533,NM_001136031;NM_001144912;NM_001349232;NM_001349233;NM_001349234;NM_001349235;NM_001349236;NM_001349237;NM_001349238;NM_006395
PTGS1_SIG,PTGS1,PTGS1_SIG,PTGS1,SIG,19,-2.32539362225575,0.0748486848421328,0.0795263752514786,0.0594791306399967,-0.0200472446114819,0.033391334761794,-2.112527002617,5.75393425403645,5.81980402962351,5.53750499139325,-0.282299038230261,0.0784794364209577,ENSG00000095303,PTGS1,protein_coding,9,1,122370530,122395703,q33.2,prostaglandin-endoperoxide synthase 1 [Source:HGNC Symbol;Acc:HGNC:9604],NA,PTGS1,5742,NM_000962;NM_001271164;NM_001271165;NM_001271166;NM_001271367;NM_001271368;NM_080591
MAP3K4_SIG,MAP3K4,MAP3K4_SIG,MAP3K4,SIG,27,2.3251124894893,0.334679549488861,0.32868747212345,0.354367803689498,0.0256803315660489,0.0334096387707892,1.15620761566354,5.17855070817562,5.16453999901026,5.22458589543323,0.0600458964229773,0.356584187346495,ENSG00000085511,MAP3K4,protein_coding,6,1,160991727,161117385,q26,mitogen-activated protein kinase kinase kinase 4 [Source:HGNC Symbol;Acc:HGNC:6856],NA,MAP3K4,4216,NM_001291958;NM_001301072;NM_001363582;NM_005922;NM_006724
SLC39A4_SIG,SLC39A4,SLC39A4_SIG,SLC39A4,SIG,8,2.32459983613359,0.185039679247465,0.1775754443073,0.209565022622291,0.0319895783149904,0.0334485735103929,0.498000068470471,3.25696608383469,3.24607971975802,3.2927355658009,0.0466558460428841,0.710872161118143,ENSG00000147804,SLC39A4,protein_coding,8,-1,144409742,144416895,q24.3,solute carrier family 39 member 4 [Source:HGNC Symbol;Acc:HGNC:17129],Acrodermatitis enteropathica;ACRODERMATITIS ENTEROPATHICA ZINC-DEFICIENCY TYPE,SLC39A4,55630,NM_001280557;NM_017767;NM_130849
SLC35G2_SIG,SLC35G2,SLC35G2_SIG,SLC35G2,SIG,50,2.32281055317795,0.0217356054807277,0.0159396058385428,0.0407796043050496,0.0248399984665069,0.0335968467772369,2.0073021934713,1.15433907387252,1.10246013733553,1.3247984367798,0.222338299444279,0.0957537224963231,ENSG00000168917,SLC35G2,protein_coding,3,1,136818647,136855888,q22.3,solute carrier family 35 member G2 [Source:HGNC Symbol;Acc:HGNC:28480],NA,SLC35G2,80723,NM_001097599;NM_001097600;NM_025246
NIT1_SIG,NIT1,NIT1_SIG,NIT1,SIG,33,2.32278790410016,0.268516700907504,0.261027340799356,0.293124598405702,0.032097257606346,0.0335968467772369,1.92096063531744,4.61488502684023,4.58332385302562,4.7185860265168,0.135262173491175,0.112129650359504,ENSG00000158793,NIT1,protein_coding,1,1,161118086,161125445,q23.3,nitrilase 1 [Source:HGNC Symbol;Acc:HGNC:7828],NA,NIT1,4817,NM_001185092;NM_001185093;NM_001185094;NM_005600
ZXDB_TF,ZXDB,ZXDB_TF,ZXDB,TF,196,2.32188769572395,0.238251310005047,0.23230091924293,0.257802593937719,0.0255016746947894,0.0336706784009745,1.80449988503424,4.27528404913546,4.23319494017179,4.41357683573035,0.18038189555856,0.137112525494792,ENSG00000198455,ZXDB,protein_coding,X,1,57591652,57597545,p11.21,zinc finger X-linked duplicated B [Source:HGNC Symbol;Acc:HGNC:13199],NA,ZXDB,158586,NM_007157
LRP12_SIG,LRP12,LRP12_SIG,LRP12,SIG,36,2.32149503715085,0.203625368633024,0.199438777682747,0.21738131032679,0.0179425326440434,0.033692389173522,-0.789661072135472,3.34603468555762,3.37045396025708,3.26579992583085,-0.104654034426226,0.540756365703044,ENSG00000147650,LRP12,protein_coding,8,-1,104489231,104589024,q22.3,LDL receptor related protein 12 [Source:HGNC Symbol;Acc:HGNC:31708],NA,LRP12,29967,NM_001135703;NM_013437
RAB1A_SIG,RAB1A,RAB1A_SIG,RAB1A,SIG,16,-2.32149456830145,0.34060396727121,0.347385124898285,0.31832302078225,-0.0290621041160349,0.033692389173522,-2.64839725365935,6.74243296719692,6.77798049892929,6.62563393436198,-0.152346564567318,0.0251385508566009,ENSG00000138069,RAB1A,protein_coding,2,-1,65070696,65130331,p14,RAB1A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9758],NA,RAB1A,5861,NM_004161;NM_015543
THOC3_SIG,THOC3,THOC3_SIG,THOC3,SIG,6,2.32138125267281,0.551566646484167,0.54137004185126,0.585069775992289,0.0436997341410289,0.0336933709302992,3.07267071104151,3.40190462774724,3.34145697485141,3.60051834440496,0.259061369553556,0.00891707577638574,ENSG00000051596,THOC3,protein_coding,5,-1,175917873,176034680,q35.2,THO complex 3 [Source:HGNC Symbol;Acc:HGNC:19072],NA,THOC3,84321,NM_032361
DHX38_SIG,DHX38,DHX38_SIG,DHX38,SIG,18,2.32126513947577,0.600412270049425,0.598143893500311,0.607865507282226,0.00972161378191411,0.0336933709302992,2.59857840226222,6.68203831674339,6.66194900346696,6.74804606036597,0.0860970568990094,0.0282776026913189,ENSG00000140829,DHX38,protein_coding,16,1,72093613,72112912,q22.2,DEAH-box helicase 38 [Source:HGNC Symbol;Acc:HGNC:17211],RETINITIS PIGMENTOSA 84,DHX38,9785,NM_014003
MMEL1_SIG,MMEL1,MMEL1_SIG,MMEL1,SIG,16,2.32125736787153,-0.0831318461322035,-0.0861459354304289,-0.0732284098666058,0.0129175255638229,0.0336933709302992,-0.282805140827326,1.33061874858699,1.33769872920154,1.30735595513919,-0.0303427740623482,0.837981435699765,ENSG00000142606,MMEL1,protein_coding,1,-1,2590639,2633016,p36.32,membrane metalloendopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:14668],Primary biliary cholangitis,MMEL1,79258,NM_033467
SLC6A19_SIG,SLC6A19,SLC6A19_SIG,SLC6A19,SIG,8,-2.32096305254015,-0.0463941622111817,-0.0234690567487776,-0.121719508730509,-0.0982504519817317,0.0337130010026745,-1.67816088760495,0.358769014054782,0.395156406677808,0.239210438293408,-0.1559459683844,0.168835683125518,ENSG00000174358,SLC6A19,protein_coding,5,1,1201595,1225111,p15.33,solute carrier family 6 member 19 [Source:HGNC Symbol;Acc:HGNC:27960],Hartnup disease;HARTNUP DISORDER;HYPERGLYCINURIA;IMINOGLYCINURIA,SLC6A19,340024,NM_001003841
FNTA_SIG,FNTA,FNTA_SIG,FNTA,SIG,20,2.3207926909298,0.278719249828655,0.274722830288188,0.291850342604474,0.0171275123162857,0.0337215202491002,1.81257392350672,5.35945043882252,5.33868986792617,5.42766374319624,0.088973875270077,0.135309878821423,ENSG00000168522,FNTA,protein_coding,8,1,43034194,43085788,p11.21,farnesyltransferase, CAAX box, alpha [Source:HGNC Symbol;Acc:HGNC:3782],NA,FNTA,2339,NM_002027
IGBP1_SIG,IGBP1,IGBP1_SIG,IGBP1,SIG,21,2.32043796811155,0.590843112508293,0.586233014569281,0.605990577165045,0.0197575625957634,0.0337465871731366,2.16718969655865,5.9974197134614,5.97208573710976,6.08065992147394,0.10857418436418,0.0706824158276331,ENSG00000089289,IGBP1,protein_coding,X,1,70133447,70166324,q13.1,immunoglobulin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:5461],AGENESIS OF THE CORPUS CALLOSUM WITH MENTAL RETARDATION-OCULAR COLOBOMA-MICROGNATHIA;Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome;CORPUS CALLOSUM AGENESIS OF WITH MENTAL RETARDATION OCULAR COLOBOMA AND MICROGNATHIA,IGBP1,3476,NM_001551
ZNF266_TF,ZNF266,ZNF266_TF,ZNF266,TF,9,2.31954167659877,0.148611294255624,0.145656294817677,0.158320578123163,0.0126642833054861,0.0338203432704973,0.948255410561218,5.75253626027382,5.73780997481488,5.80092262678178,0.0631126519669065,0.456660637968906,ENSG00000174652,ZNF266,protein_coding,19,-1,9412461,9435571,p13.2,zinc finger protein 266 [Source:HGNC Symbol;Acc:HGNC:13059],NA,ZNF266,10781,NM_001271314;NM_006631
ZFYVE19_TF,ZFYVE19,ZFYVE19_TF,ZFYVE19,TF,132,2.31908343010837,0.175797930781159,0.170719115656968,0.192485466189217,0.0217663505322487,0.0338521880329358,1.78826581455714,4.53166098396848,4.50309504920321,4.6255204839115,0.122425434708291,0.140978193700751,ENSG00000166140,ZFYVE19,protein_coding,15,1,40807086,40815084,q15.1,zinc finger FYVE-type containing 19 [Source:HGNC Symbol;Acc:HGNC:20758],NA,ZFYVE19,84936,NM_001077268;NM_001258420;NM_001258421;NM_032850
ATF6_TF,ATF6,ATF6_TF,ATF6,TF,136,2.318964937698,0.390120168259612,0.385813484679769,0.404270700021954,0.0184572153421853,0.0338521880329358,1.14251968211074,6.60491926997493,6.58938599820156,6.65595716294456,0.0665711647430031,0.362537474671189,ENSG00000118217,ATF6,protein_coding,1,1,161766320,161964070,q23.3,activating transcription factor 6 [Source:HGNC Symbol;Acc:HGNC:791],Achromatopsia;ACHROMATOPSIA 7;Cone rod dystrophy,ATF6,22926,NM_007348
ZC3H18_SIG,ZC3H18,ZC3H18_SIG,ZC3H18,SIG,22,2.31896160985874,0.354042503893884,0.351209591184709,0.3633506456526,0.0121410544678907,0.0338521880329358,1.48930187055456,6.26851778245977,6.25191545850571,6.32306827545167,0.0711528169459657,0.225522848547572,ENSG00000158545,ZC3H18,protein_coding,16,1,88570381,88631966,q24.2,zinc finger CCCH-type containing 18 [Source:HGNC Symbol;Acc:HGNC:25091],NA,ZC3H18,124245,NM_001294340;NM_144604
ENO1_TF,ENO1,ENO1_TF,ENO1,TF,360,2.31844070188906,0.217568346296317,0.215000684612184,0.226004948972756,0.0110042643605724,0.0338923074749761,1.11474931324382,9.94051905553869,9.92263807426135,9.99927085116426,0.0766327769029153,0.375455615952857,ENSG00000074800,ENO1,protein_coding,1,-1,8861000,8879250,p36.23,enolase 1 [Source:HGNC Symbol;Acc:HGNC:3350],NA,ENO1,2023,NM_001201483;NM_001353346;NM_001428
CHRNA5_SIG,CHRNA5,CHRNA5_SIG,CHRNA5,SIG,31,2.3164253943664,-0.0728281999479491,-0.0768842946298104,-0.0595010317075477,0.0173832629222626,0.0340674646897437,0.475554754127614,0.760693064522687,0.753299528349079,0.784986111950256,0.0316865836011768,0.724090430792774,ENSG00000169684,CHRNA5,protein_coding,15,1,78565520,78595269,q25.1,cholinergic receptor nicotinic alpha 5 subunit [Source:HGNC Symbol;Acc:HGNC:1959],SMOKING AS A QUANTITATIVE TRAIT LOCUS 3,CHRNA5,1138,NM_000745;NM_001307945
IQGAP3_SIG,IQGAP3,IQGAP3_SIG,IQGAP3,SIG,16,-2.31484826167528,0.221226888876012,0.24503614082551,0.142996489613376,-0.102039651212134,0.0342035944028988,-1.75286433755397,4.02869871285715,4.09576436830208,3.80834013068098,-0.287424237621098,0.149465961928439,ENSG00000183856,IQGAP3,protein_coding,1,-1,156525405,156572604,q22,IQ motif containing GTPase activating protein 3 [Source:HGNC Symbol;Acc:HGNC:20669],NA,IQGAP3,128239,NM_178229
ZFAND2A_TF,ZFAND2A,ZFAND2A_TF,ZFAND2A,TF,101,-2.31460902727525,-0.0792867186977953,-0.0719137738430091,-0.10351210893495,-0.0315983350919409,0.0342184735008074,-2.18745185698256,4.69052881983391,4.73221061363378,4.5535743544915,-0.178636259142282,0.0680482232957147,ENSG00000178381,ZFAND2A,protein_coding,7,-1,1152071,1160759,p22.3,zinc finger AN1-type containing 2A [Source:HGNC Symbol;Acc:HGNC:28073],NA,ZFAND2A,90637,NM_182491
CERCAM_SIG,CERCAM,CERCAM_SIG,CERCAM,SIG,34,2.3140592815462,0.218574130263354,0.212552506619787,0.238359465092214,0.0258069584724272,0.0342615846735978,2.50773179216135,3.69789669795053,3.60414061072356,4.00595241312483,0.401811802401261,0.0346770687535598,ENSG00000167123,CERCAM,protein_coding,9,1,128411751,128437351,q34.11,cerebral endothelial cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:23723],NA,CERCAM,51148,NM_001286760;NM_016174
TSSK3_SIG,TSSK3,TSSK3_SIG,TSSK3,SIG,42,2.31268617287426,0.000418522337050769,-0.00291195285428585,0.0113615122514425,0.0142734651057282,0.0343797658617417,0.258238209692103,0.324083135417726,0.322621763797571,0.328884785026808,0.00626302122923728,0.852717420002304,ENSG00000162526,TSSK3,protein_coding,1,1,32351521,32364312,p35.1,testis specific serine kinase 3 [Source:HGNC Symbol;Acc:HGNC:15473],NA,TSSK3,81629,NM_052841
FLYWCH2_SIG,FLYWCH2,FLYWCH2_SIG,FLYWCH2,SIG,17,2.31224005888268,0.18826201661787,0.179877871219283,0.215809922927511,0.0359320517082281,0.0344135893887946,0.867873490424081,3.14030804590134,3.12778453644059,3.18145671984382,0.0536721834032349,0.499055052349411,ENSG00000162076,FLYWCH2,protein_coding,16,1,2883213,2899382,p13.3,FLYWCH family member 2 [Source:HGNC Symbol;Acc:HGNC:25178],NA,FLYWCH2,114984,NM_001142499;NM_001142500;NM_138439
TEAD3_TF,TEAD3,TEAD3_TF,TEAD3,TF,168,2.31206235461778,-0.0828404496766807,-0.0851419595296911,-0.075278345873932,0.009863613655759,0.0344229278303126,3.31802184168178,0.682692708306147,0.608960989894454,0.924954068801712,0.315993078907258,0.00456928477373033,ENSG00000007866,TEAD3,protein_coding,6,-1,35473597,35497079,p21.31,TEA domain transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:11716],NA,TEAD3,7005,NM_003214
POLH_SIG,POLH,POLH_SIG,POLH,SIG,76,2.31126116914718,0.306509979875472,0.294809672650012,0.344953846473412,0.0501441738234006,0.0344892464162307,2.41958528244319,4.05283268687549,3.9945080266658,4.24447085613591,0.249962829470111,0.041998609933883,ENSG00000170734,POLH,protein_coding,6,1,43576150,43615660,p21.1,DNA polymerase eta [Source:HGNC Symbol;Acc:HGNC:9181],Xeroderma pigmentosum variant;XERODERMA PIGMENTOSUM VARIANT TYPE,POLH,5429,NM_001291969;NM_001291970;NM_006502
JADE2_SIG,JADE2,JADE2_SIG,JADE2,SIG,64,2.31080513564807,0.334810347173734,0.329973830217039,0.350701760031443,0.020727929814404,0.0345191848488425,2.37189095988464,6.09043074623147,6.03769342574049,6.26371051355897,0.226017087818487,0.0465614663871772,ENSG00000043143,JADE2,protein_coding,5,1,134524312,134583230,q31.1,jade family PHD finger 2 [Source:HGNC Symbol;Acc:HGNC:22984],NA,JADE2,23338,NM_001289984;NM_001289985;NM_001308143;NM_015288
UNKL_SIG,UNKL,UNKL_SIG,UNKL,SIG,83,2.31078311035648,0.221534777001314,0.217845765005283,0.233655816416844,0.015810051411561,0.0345191848488425,0.814464085217069,4.52703111632094,4.51378241567786,4.57056256129105,0.0567801456131934,0.527293684973941,ENSG00000059145,UNKL,protein_coding,16,-1,1363205,1414751,p13.3,unk like zinc finger [Source:HGNC Symbol;Acc:HGNC:14184],NA,UNKL,64718,NM_001037125;NM_001193388;NM_001193389;NM_001276414
CPPED1_SIG,CPPED1,CPPED1_SIG,CPPED1,SIG,49,-2.3093842868322,0.529810327314249,0.539728326266291,0.497222616471825,-0.0425057097944656,0.0346404826832981,-0.787242395654309,6.05104892487911,6.07269965147194,5.97991082321692,-0.0927888282550225,0.541968613647851,ENSG00000103381,CPPED1,protein_coding,16,-1,12659799,12803887,p13.12,calcineurin like phosphoesterase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25632],NA,CPPED1,55313,NM_001099455;NM_018340
ATP6V1C1_SIG,ATP6V1C1,ATP6V1C1_SIG,ATP6V1C1,SIG,13,-2.30925026779777,0.525249364040762,0.531210693717929,0.505662137958643,-0.0255485557592855,0.0346458630740786,-3.56865460298799,5.27326931044762,5.34021857047464,5.05329317035883,-0.28692540011581,0.00219569979945976,ENSG00000155097,ATP6V1C1,protein_coding,8,1,103021063,103073051,q22.3,ATPase H+ transporting V1 subunit C1 [Source:HGNC Symbol;Acc:HGNC:856],NA,ATP6V1C1,528,NM_001695
ZNF709_TF,ZNF709,ZNF709_TF,ZNF709,TF,111,2.30897400668184,0.0227643873881817,0.0179414251688003,0.0386112632518633,0.0206698380830629,0.0346595625757234,1.98604698809458,0.517611543269639,0.498279029989228,0.581132658333848,0.0828536283446205,0.0996826502036471,ENSG00000242852,ZNF709,protein_coding,19,-1,12461184,12513854,p13.2,zinc finger protein 709 [Source:HGNC Symbol;Acc:HGNC:20629],NA,ZNF709,163051,NM_152601
CCNE1_SIG,CCNE1,CCNE1_SIG,CCNE1,SIG,26,-2.30895028123645,0.110437120898029,0.118727260948177,0.0831980893046847,-0.0355291716434928,0.0346595625757234,-1.2876659085502,3.38338603516483,3.41635876243948,3.27504707411954,-0.141311688319941,0.299899184856804,ENSG00000105173,CCNE1,protein_coding,19,1,29811991,29824312,q12,cyclin E1 [Source:HGNC Symbol;Acc:HGNC:1589],NA,CCNE1,898,NM_001238;NM_001322259;NM_001322261;NM_001322262
BICC1_SIG,BICC1,BICC1_SIG,BICC1,SIG,75,-2.30866732954853,-0.146992245585506,-0.142503891864338,-0.161739693526488,-0.0192358016621502,0.0346786287205683,-1.04294580850765,0.750508494365609,0.778910578317018,0.657187361382411,-0.121723216934607,0.409564668904691,ENSG00000122870,BICC1,protein_coding,10,1,58513140,58831437,q21.1,BicC family RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19351],Autosomal dominant polycystic kidney disease;RENAL DYSPLASIA CYSTIC SUSCEPTIBILITY TO,BICC1,80114,NM_001080512
ZNF433_TF,ZNF433,ZNF433_TF,ZNF433,TF,39,2.30744770010041,-0.0712457256990223,-0.0760605045295614,-0.0554257381129655,0.0206347664165958,0.0347788375118709,2.07773304016938,1.07843450222964,1.04420408875619,1.19090586078529,0.146701772029103,0.0838168812828103,ENSG00000197647,ZNF433,protein_coding,19,-1,12014732,12035741,p13.2,zinc finger protein 433 [Source:HGNC Symbol;Acc:HGNC:20811],NA,ZNF433,163059,NM_001080411;NM_001308346;NM_001308348;NM_001308351;NM_001308355;NM_001308357
MYPOP_TF,MYPOP,MYPOP_TF,MYPOP,TF,52,2.30738493008664,0.0829813126579266,0.0768320840871452,0.103185920819066,0.0263538367319203,0.0347788375118709,3.24373806045216,2.92001547505947,2.86965066885553,3.08549983830097,0.215849169445431,0.00562683938927759,ENSG00000176182,MYPOP,protein_coding,19,-1,45890023,45902613,q13.32,Myb related transcription factor, partner of profilin [Source:HGNC Symbol;Acc:HGNC:20178],NA,MYPOP,339344,NM_001012643
UNC13B_SIG,UNC13B,UNC13B_SIG,UNC13B,SIG,93,2.30735182048548,-0.117496204240091,-0.120668965160308,-0.10707141835938,0.013597546800928,0.0347788375118709,1.46942583830298,2.58386682469974,2.51689421101188,2.80391969824558,0.287025487233702,0.232149667400976,ENSG00000198722,UNC13B,protein_coding,9,1,35161992,35405338,p13.3,unc-13 homolog B [Source:HGNC Symbol;Acc:HGNC:12566],NA,UNC13B,10497,NM_001330653;NM_006377
SAFB_SIG,SAFB,SAFB_SIG,SAFB,SIG,15,2.30629436566178,0.562719462480709,0.559455981708259,0.573442327875903,0.013986346167644,0.0348693859076609,4.30793700852663,6.96950383564187,6.9274927283257,7.10754033110927,0.180047602783574,0.000198794451845876,ENSG00000160633,SAFB,protein_coding,19,1,5623035,5668478,p13.3,scaffold attachment factor B [Source:HGNC Symbol;Acc:HGNC:10520],NA,SAFB,6294,NM_001201338;NM_001201339;NM_001201340;NM_001320571;NM_001320572;NM_002967
DHX35_SIG,DHX35,DHX35_SIG,DHX35,SIG,17,2.30571291659435,0.45830439793506,0.45518810351798,0.46854365101975,0.0133555475017695,0.0349161250036859,1.37833145878178,4.02287632774952,4.00867998346219,4.06952145897932,0.0608414755171271,0.264808026328647,ENSG00000101452,DHX35,protein_coding,20,1,38962299,39039723,q11.23,DEAH-box helicase 35 [Source:HGNC Symbol;Acc:HGNC:15861],NA,DHX35,60625,NM_001190809;NM_021931
EGR1_TF,EGR1,EGR1_TF,EGR1,TF,21,-2.30375057017294,0.177770296825883,0.180920195970699,0.167420628207199,-0.0134995677635,0.0350908734515054,-2.26339868514858,7.48369364556529,7.59081236611401,7.13173213519093,-0.45908023092308,0.0583100164426154,ENSG00000120738,EGR1,protein_coding,5,1,138465479,138469303,q31.2,early growth response 1 [Source:HGNC Symbol;Acc:HGNC:3238],NA,EGR1,1958,NM_001964
SLC25A34_SIG,SLC25A34,SLC25A34_SIG,SLC25A34,SIG,19,-2.30351580675193,-0.179021747044547,-0.17578502865275,-0.189656678903309,-0.0138716502505585,0.0351056659653161,-2.44780715650646,1.89485940637605,1.93773411807279,1.75398535365819,-0.183748764414598,0.0395556653810459,ENSG00000162461,SLC25A34,protein_coding,1,1,15736258,15741392,p36.21,solute carrier family 25 member 34 [Source:HGNC Symbol;Acc:HGNC:27653],NA,SLC25A34,284723,NM_207348
PSTK_SIG,PSTK,PSTK_SIG,PSTK,SIG,23,2.30145734012593,0.177424680301637,0.171805286226247,0.195888403692203,0.0240831174659556,0.0352865932548842,2.01657964750571,2.58146931604852,2.5449461819167,2.70147389962451,0.156527717707811,0.0941359578212798,ENSG00000179988,PSTK,protein_coding,10,1,122954381,122997513,q26.13,phosphoseryl-tRNA kinase [Source:HGNC Symbol;Acc:HGNC:28578],NA,PSTK,118672,NM_153336
SLC30A5_SIG,SLC30A5,SLC30A5_SIG,SLC30A5,SIG,50,2.30142050007992,0.441243791683778,0.433432670741097,0.46690890335259,0.0334762326114937,0.0352865932548842,1.34845506468027,5.14998873509068,5.12733597302998,5.22441923900442,0.097083265974443,0.275996935970156,ENSG00000145740,SLC30A5,protein_coding,5,1,69093949,69131069,q13.1,solute carrier family 30 member 5 [Source:HGNC Symbol;Acc:HGNC:19089],NA,SLC30A5,64924,NM_001251969;NM_022902;NM_024055
MORC3_SIG,MORC3,MORC3_SIG,MORC3,SIG,23,-2.30121593627549,0.33798268229149,0.34031104125958,0.330332359967765,-0.00997868129181507,0.0352986380147983,-2.12042867479316,6.24977289296197,6.27192748976566,6.17697921774983,-0.0949482720158327,0.0773273142740839,ENSG00000159256,MORC3,protein_coding,21,1,36320189,36386148,q22.12,MORC family CW-type zinc finger 3 [Source:HGNC Symbol;Acc:HGNC:23572],NA,MORC3,23515,NM_001320445;NM_001320446;NM_015358
SEPSECS_SIG,SEPSECS,SEPSECS_SIG,SEPSECS,SIG,62,2.29880573963955,0.481500411901403,0.477269511593408,0.495401941484814,0.0181324298914062,0.035517002242862,3.51704134292893,4.28844940830333,4.23611635027459,4.46040088468349,0.224284534408899,0.00256950716284699,ENSG00000109618,SEPSECS,protein_coding,4,-1,25120014,25160449,p15.2,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase [Source:HGNC Symbol;Acc:HGNC:30605],Pontocerebellar hypoplasia type 2;PONTOCEREBELLAR HYPOPLASIA TYPE 2D;Progressive cerebello-cerebral atrophy,SEPSECS,51091,NM_016955
RASA3_SIG,RASA3,RASA3_SIG,RASA3,SIG,37,-2.29779306958307,0.0246639075081867,0.029908356293776,0.00743214721267874,-0.0224762090810974,0.0356049845706768,-0.960149840309585,6.47622813308956,6.4956204024034,6.41251067677267,-0.0831097256307335,0.450747253685975,ENSG00000185989,RASA3,protein_coding,13,-1,113977783,114132623,q34,RAS p21 protein activator 3 [Source:HGNC Symbol;Acc:HGNC:20331],NA,RASA3,22821,NM_001320821;NM_001320822;NM_007368
ADAM12_SIG,ADAM12,ADAM12_SIG,ADAM12,SIG,13,-2.29673845254124,-0.0778952559097792,-0.0743135370156651,-0.0896637608475827,-0.0153502238319178,0.0356971039086444,-0.847993275683721,0.574687810073385,0.58592058962683,0.537780105826353,-0.0481404838004764,0.50956062838292,ENSG00000148848,ADAM12,protein_coding,10,-1,126012381,126388455,q26.2,ADAM metallopeptidase domain 12 [Source:HGNC Symbol;Acc:HGNC:190],NA,ADAM12,8038,NM_001288973;NM_001288974;NM_001288975;NM_003474;NM_021641
RNF43_SIG,RNF43,RNF43_SIG,RNF43,SIG,69,2.29646443587178,-0.0641415104299603,-0.0683877507734635,-0.0501895778727353,0.0181981729007282,0.0357158074383681,2.26324319923242,1.34554514439777,1.29930466565638,1.49747814597663,0.198173480320248,0.0583100164426154,ENSG00000108375,RNF43,protein_coding,17,-1,58352500,58417595,q22,ring finger protein 43 [Source:HGNC Symbol;Acc:HGNC:18505],Hyperplastic polyposis syndrome;SESSILE SERRATED POLYPOSIS CANCER SYNDROME,RNF43,54894,NM_001305544;NM_001305545;NM_017763
SOS1_SIG,SOS1,SOS1_SIG,SOS1,SIG,66,2.29616407029286,0.301243497345214,0.294098292359183,0.324720599442175,0.0306223070829918,0.0357365887299458,2.63522071600618,6.50503113488984,6.4499794991751,6.68591508080969,0.235935581634591,0.0259380531126399,ENSG00000115904,SOS1,protein_coding,2,-1,38981396,39124345,p22.1,SOS Ras/Rac guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:11187],FIBROMATOSIS GINGIVAL 1;Hereditary gingival fibromatosis;Noonan Syndrome;NOONAN SYNDROME 4,SOS1,6654,NM_005633
SGPL1_SIG,SGPL1,SGPL1_SIG,SGPL1,SIG,40,2.29609301007999,0.201325861721286,0.19799983376228,0.212254239300879,0.0142544055385987,0.0357365887299458,3.47435128624091,5.05307498200579,4.9892274271436,5.26285980512441,0.273632377980812,0.00290188645892576,ENSG00000166224,SGPL1,protein_coding,10,1,70815961,70881173,q22.1,sphingosine-1-phosphate lyase 1 [Source:HGNC Symbol;Acc:HGNC:10817],Familial steroid-resistant nephrotic syndrome with adrenal insufficiency;NEPHROTIC SYNDROME TYPE 14,SGPL1,8879,NM_003901
ZNF696_TF,ZNF696,ZNF696_TF,ZNF696,TF,195,2.29489337081217,0.252705143646499,0.244335392823387,0.280205753493866,0.0358703606704794,0.0358427002497148,1.27488662314045,2.37846448841341,2.34954411413211,2.47348857533769,0.123944461205581,0.305082023496444,ENSG00000185730,ZNF696,protein_coding,8,1,143289676,143298061,q24.3,zinc finger protein 696 [Source:HGNC Symbol;Acc:HGNC:25872],NA,ZNF696,79943,NM_030895
NPBWR1_SIG,NPBWR1,NPBWR1_SIG,NPBWR1,SIG,6,-2.29389241465296,-0.187547305799211,-0.184258254668133,-0.198354188087036,-0.0140959334189033,0.0359302601423338,-2.16992196493092,0.32266121138985,0.361243674319022,0.195890261765428,-0.165353412553594,0.070340861617789,ENSG00000183729,NPBWR1,protein_coding,8,1,52938431,52941117,q11.23,neuropeptides B and W receptor 1 [Source:HGNC Symbol;Acc:HGNC:4522],NA,NPBWR1,2831,NM_005285
ZNHIT3_TF,ZNHIT3,ZNHIT3_TF,ZNHIT3,TF,324,2.29381229398259,0.183231160563981,0.181158190227585,0.190042348812141,0.00888415858455689,0.0359307000676287,1.13234506973071,3.99932291349306,3.98712136625315,4.03941371156704,0.0522923453138892,0.367150672671002,ENSG00000273611,ZNHIT3,protein_coding,17,1,36486629,36499310,q12,zinc finger HIT-type containing 3 [Source:HGNC Symbol;Acc:HGNC:12309],PEHO syndrome,ZNHIT3,9326,NM_001281432;NM_001281433;NM_001281434;NM_004773
TRIM59_SIG,TRIM59,TRIM59_SIG,TRIM59,SIG,9,2.29331620028637,0.219299850236645,0.214538006936537,0.234945906794144,0.0204078998576068,0.035970555439777,2.39247613571707,2.91626239511401,2.87369239409886,3.05613525559236,0.182442861493505,0.0445275372814793,ENSG00000213186,TRIM59,protein_coding,3,-1,160432445,160485773,q25.33,tripartite motif containing 59 [Source:HGNC Symbol;Acc:HGNC:30834],NA,TRIM59,286827,NM_173084
GPATCH8_SIG,GPATCH8,GPATCH8_SIG,GPATCH8,SIG,36,2.29208016859891,0.579720470893384,0.57648369696896,0.590355585216492,0.0138718882475315,0.036080717881914,2.63621544096352,6.77646435483358,6.7468961083058,6.87361716485341,0.126721056547611,0.0258741371622205,ENSG00000186566,GPATCH8,protein_coding,17,-1,44395281,44503430,q21.31,G-patch domain containing 8 [Source:HGNC Symbol;Acc:HGNC:29066],NA,GPATCH8,23131,NM_001002909;NM_001304939;NM_001304940;NM_001304941;NM_001304942;NM_001304943
NCL_SIG,NCL,NCL_SIG,NCL,SIG,35,2.29199405937516,0.746887383242112,0.741001920471206,0.766225332346517,0.0252234118753106,0.0360817283985058,2.96822811043016,9.43731175542474,9.39519312315328,9.57570154717386,0.180508424020587,0.0116826972335517,ENSG00000115053,NCL,protein_coding,2,-1,231453531,231483641,q37.1,nucleolin [Source:HGNC Symbol;Acc:HGNC:7667],NA,NCL,4691,NM_005381
RIN1_SIG,RIN1,RIN1_SIG,RIN1,SIG,22,-2.29183376977923,0.29441616147067,0.306201093226532,0.255694242844268,-0.0505068503822646,0.0360897913444492,-1.8016562643437,3.2309320016091,3.28845989000147,3.04191179689132,-0.246548093110151,0.137810185675004,ENSG00000174791,RIN1,protein_coding,11,-1,66330241,66336840,q13.2,Ras and Rab interactor 1 [Source:HGNC Symbol;Acc:HGNC:18749],NA,RIN1,9610,NM_004292
ZNF786_TF,ZNF786,ZNF786_TF,ZNF786,TF,12,2.29124013297708,0.129058601672831,0.119760226680879,0.159610405217815,0.0398501785369357,0.0361390794175893,2.98426214823527,2.67505060041692,2.59961315653138,2.92291648746939,0.32330333093801,0.0112138827178352,ENSG00000197362,ZNF786,protein_coding,7,-1,149069643,149090782,q36.1,zinc finger protein 786 [Source:HGNC Symbol;Acc:HGNC:21806],NA,ZNF786,136051,NM_152411
TGFA_SIG,TGFA,TGFA_SIG,TGFA,SIG,38,-2.2902115449747,-0.0289890860053746,-0.0245854795841858,-0.0434580785321379,-0.018872598947952,0.0362298893511166,-1.11889938471832,2.3460167684983,2.38319243937258,2.22386813562566,-0.159324303746923,0.373311283656346,ENSG00000163235,TGFA,protein_coding,2,-1,70447284,70554193,p13.3,transforming growth factor alpha [Source:HGNC Symbol;Acc:HGNC:11765],Oligodontia,TGFA,7039,NM_001099691;NM_001308158;NM_001308159;NM_003236
SLC5A6_SIG,SLC5A6,SLC5A6_SIG,SLC5A6,SIG,16,2.289523162675,0.173062212955031,0.16840975846943,0.188348849122006,0.0199390906525756,0.0362883883490527,2.61239914433714,4.98888462917164,4.937545745694,5.15756953202674,0.220023786332739,0.0273694583517026,ENSG00000138074,SLC5A6,protein_coding,2,-1,27199587,27212958,p23.3,solute carrier family 5 member 6 [Source:HGNC Symbol;Acc:HGNC:11041],NA,SLC5A6,8884,NM_021095
BCL10_SIG,BCL10,BCL10_SIG,BCL10,SIG,43,-2.28927209679909,0.423415731159738,0.430250202105613,0.400959612337577,-0.0292905897680351,0.0363051627104264,-1.17473264693959,4.23012059426754,4.24804647536488,4.17122127066199,-0.076825204702887,0.348361015345585,ENSG00000142867,BCL10,protein_coding,1,-1,85265776,85276904,p22.3,BCL10, immune signaling adaptor [Source:HGNC Symbol;Acc:HGNC:989],IMMUNODEFICIENCY 37;LYMPHOMA MUCOSA-ASSOCIATED LYMPHOID TYPE;LYMPHOMA NON-HODGKIN FAMILIAL;MALT lymphoma;MESOTHELIOMA MALIGNANT;TESTICULAR GERM CELL TUMOR,BCL10,8915,NM_001320715;NM_003921
NADSYN1_SIG,NADSYN1,NADSYN1_SIG,NADSYN1,SIG,27,2.28661389660429,0.196749339158712,0.193510810764206,0.207390218169231,0.0138794074050249,0.0365496108725488,0.823793575549846,7.06793901398473,7.05988324416002,7.0944079719802,0.0345247278201751,0.522279335179979,ENSG00000172890,NADSYN1,protein_coding,11,1,71453109,71524107,q13.4,NAD synthetase 1 [Source:HGNC Symbol;Acc:HGNC:29832],NA,NADSYN1,55191,NM_018161
MAP4K3_SIG,MAP4K3,MAP4K3_SIG,MAP4K3,SIG,48,2.28657009912607,0.375759009161585,0.370160286743504,0.394154811392422,0.0239945246489187,0.0365496108725488,2.69630214240956,4.20762506635403,4.15060062451649,4.39499108953453,0.244390465018046,0.0226035710608416,ENSG00000011566,MAP4K3,protein_coding,2,-1,39249266,39437301,p22.1,mitogen-activated protein kinase kinase kinase kinase 3 [Source:HGNC Symbol;Acc:HGNC:6865],NA,MAP4K3,8491,NM_001270425;NM_003618
KDM4D_SIG,KDM4D,KDM4D_SIG,KDM4D,SIG,16,2.28540192806501,0.123620082478028,0.116990533906943,0.145402884925879,0.0284123510189357,0.036654746084153,-0.519400016804239,0.606164062785141,0.611921552870178,0.587246595362875,-0.0246749575073036,0.698444877077687,ENSG00000186280,KDM4D,protein_coding,11,1,94973709,94999519,q21,lysine demethylase 4D [Source:HGNC Symbol;Acc:HGNC:25498],NA,KDM4D,55693,NM_018039
RAD51AP1_SIG,RAD51AP1,RAD51AP1_SIG,RAD51AP1,SIG,24,-2.28458340949887,0.287503519901838,0.306576381722418,0.224835545348504,-0.0817408363739139,0.0367263850409194,-2.52441913108553,3.15135750557756,3.22165976066042,2.92036438173385,-0.301295378926568,0.0335221315371282,ENSG00000111247,RAD51AP1,protein_coding,12,1,4538798,4560048,p13.32,RAD51 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16956],NA,RAD51AP1,10635,NM_001130862;NM_006479
CD37_SIG,CD37,CD37_SIG,CD37,SIG,32,-2.28411231039904,0.214793877102193,0.218733003251949,0.201851034038709,-0.0168819692132393,0.0367645745346766,-0.566815240914868,8.13542864089233,8.14459236961174,8.10531924652853,-0.0392731230832161,0.670762365029504,ENSG00000104894,CD37,protein_coding,19,1,49335171,49343335,q13.33,CD37 molecule [Source:HGNC Symbol;Acc:HGNC:1666],NA,CD37,951,NM_001040031;NM_001774
HSP90AA1_SIG,HSP90AA1,HSP90AA1_SIG,HSP90AA1,SIG,17,2.28374361461814,0.522565289651867,0.517880325745886,0.537958742485803,0.0200784167399167,0.0367896243256559,2.71736713115638,9.76681050185149,9.72559483784648,9.90223339786795,0.176638560021479,0.0214955820074377,ENSG00000080824,HSP90AA1,protein_coding,14,-1,102080738,102139699,q32.31,heat shock protein 90 alpha family class A member 1 [Source:HGNC Symbol;Acc:HGNC:5253],NA,HSP90AA1,3320,NM_001017963;NM_005348
ZNF404_TF,ZNF404,ZNF404_TF,ZNF404,TF,10,2.28370199398896,-0.17587216736285,-0.184541515867228,-0.147387165134178,0.0371543507330499,0.0367896243256559,1.29536096100631,1.33723684175464,1.3024186022065,1.45163962884137,0.149221026634873,0.296921673401845,ENSG00000176222,ZNF404,protein_coding,19,-1,43872363,43901385,q13.31,zinc finger protein 404 [Source:HGNC Symbol;Acc:HGNC:19417],NA,ZNF404,342908,NM_001033719
ZNF180_TF,ZNF180,ZNF180_TF,ZNF180,TF,26,2.28170617038013,0.106695574035717,0.10327494533088,0.117934782637321,0.0146598373064407,0.0369756010327192,1.52674593272164,3.01284975194884,2.99040810986225,3.0865865759476,0.0961784660853513,0.213260015755609,ENSG00000167384,ZNF180,protein_coding,19,-1,44474428,44500524,q13.31,zinc finger protein 180 [Source:HGNC Symbol;Acc:HGNC:12970],NA,ZNF180,7733,NM_001278508;NM_001278509;NM_001288759;NM_001288760;NM_001288761;NM_001288762;NM_001291633;NM_013256
PDGFRA_SIG,PDGFRA,PDGFRA_SIG,PDGFRA,SIG,11,-2.28124119823951,-0.230597588436939,-0.225369486355615,-0.247775638132716,-0.0224061517771005,0.0370134150964525,-1.05787907614779,0.250548726382112,0.265901746775364,0.200103087947139,-0.065798658828226,0.402310858301244,ENSG00000134853,PDGFRA,protein_coding,4,1,54229280,54298245,q12,platelet derived growth factor receptor alpha [Source:HGNC Symbol;Acc:HGNC:8803],Chronic eosinophilic leukemia;Gastrointestinal stromal tumor;HYPEREOSINOPHILIC SYNDROME IDIOPATHIC;Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement;Precursor B-cell acute lymphoblastic leukemia;Primary hypereosinophilic syndrome,PDGFRA,5156,NM_001347827;NM_001347828;NM_001347829;NM_001347830;NM_006206
PSMA5_SIG,PSMA5,PSMA5_SIG,PSMA5,SIG,46,2.28115435328374,0.364228983522902,0.358661680226668,0.382521551496239,0.0238598712695708,0.0370145139552884,1.74570434247708,5.44489467679729,5.42156479980277,5.52154998692212,0.0999851871193443,0.15129061623525,ENSG00000143106,PSMA5,protein_coding,1,-1,109399042,109426448,p13.3,proteasome subunit alpha 5 [Source:HGNC Symbol;Acc:HGNC:9534],NA,PSMA5,5686,NM_001199772;NM_001199773;NM_001199774;NM_002790
ZNF267_TF,ZNF267,ZNF267_TF,ZNF267,TF,83,-2.28080882318244,0.240399026962306,0.244325404043278,0.227498073696254,-0.0168273303470243,0.0370407508184282,-0.449666789372016,5.2819259683289,5.28988310915136,5.25578107705508,-0.0341020320962818,0.739210639354591,ENSG00000185947,ZNF267,protein_coding,16,1,31873807,31917357,p11.2,zinc finger protein 267 [Source:HGNC Symbol;Acc:HGNC:13060],NA,ZNF267,10308,NM_001265588;NM_003414
NCOA5_SIG,NCOA5,NCOA5_SIG,NCOA5,SIG,48,2.28051198078552,0.200928840313755,0.193173960387479,0.22640916007152,0.0332351996840418,0.037062268775328,1.56316977411251,5.07431473878994,5.04348813984836,5.17560213531226,0.132113995463897,0.201647599287928,ENSG00000124160,NCOA5,protein_coding,20,-1,46060991,46089962,q13.12,nuclear receptor coactivator 5 [Source:HGNC Symbol;Acc:HGNC:15909],NA,NCOA5,57727,NM_001348148;NM_001348149;NM_001348150;NM_001348151;NM_020967
TBL2_SIG,TBL2,TBL2_SIG,TBL2,SIG,19,2.27892026027237,0.29698666941927,0.289948411640358,0.320112373549981,0.0301639619096226,0.0372075557726858,1.01648558704843,4.27512468460597,4.25571995471919,4.33888308280536,0.083163128086171,0.4222882419745,ENSG00000106638,TBL2,protein_coding,7,-1,73567533,73578791,q11.23,transducin beta like 2 [Source:HGNC Symbol;Acc:HGNC:11586],Williams syndrome,TBL2,26608,NM_012453
UTF1_TF,UTF1,UTF1_TF,UTF1,TF,63,2.27886943392191,0.0133813200616138,0.0111979356389809,0.0205552974502645,0.00935736181128347,0.0372075557726858,3.35547306322809,0.405268661844268,0.359039159196465,0.557165599115622,0.198126439919157,0.00411311927177266,ENSG00000171794,UTF1,protein_coding,10,1,133230217,133231558,q26.3,undifferentiated embryonic cell transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:12634],NA,UTF1,8433,NM_003577
AGPAT1_SIG,AGPAT1,AGPAT1_SIG,AGPAT1,SIG,31,2.27741105375377,0.315808569126034,0.311026061794142,0.331522521787965,0.0204964599938231,0.0373426944331844,0.563812341767684,5.92813264537831,5.91832384989187,5.96036154483375,0.0420376949418823,0.672539086233918,ENSG00000204310,AGPAT1,protein_coding,6,-1,32168212,32178096,p21.32,1-acylglycerol-3-phosphate O-acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:324],NA,AGPAT1,10554,NM_006411;NM_032741
SLC25A23_SIG,SLC25A23,SLC25A23_SIG,SLC25A23,SIG,92,2.27716957553835,-0.0980564532764643,-0.101164043894826,-0.087845798387561,0.0133182455072652,0.0373589385277992,1.97726485350806,2.51224712006874,2.44828130152802,2.72242052384537,0.274139222317345,0.101278699316856,ENSG00000125648,SLC25A23,protein_coding,19,-1,6436079,6465203,p13.3,solute carrier family 25 member 23 [Source:HGNC Symbol;Acc:HGNC:19375],NA,SLC25A23,79085,NM_024103
KCNK7_SIG,KCNK7,KCNK7_SIG,KCNK7,SIG,49,-2.27709344839983,0.144887321900304,0.155723896542376,0.109281433790639,-0.0464424627517375,0.0373589966119407,-2.19092816997318,1.33650003382119,1.38291713548179,1.1839866997935,-0.198930435688294,0.0675823939158126,ENSG00000173338,KCNK7,protein_coding,11,-1,65592855,65595996,q13.1,potassium two pore domain channel subfamily K member 7 [Source:HGNC Symbol;Acc:HGNC:6282],NA,KCNK7,10089,NM_005714;NM_033347;NM_033348;NM_033455
CHKB_SIG,CHKB,CHKB_SIG,CHKB,SIG,57,2.27659416599073,0.169330850703384,0.1654491854173,0.182084893786233,0.0166357083689332,0.0374005060604962,2.23788062333857,1.50998757206537,1.48573956559817,1.58965959331476,0.103920027716587,0.0614299009127316,ENSG00000100288,CHKB,protein_coding,22,-1,50578949,50601455,q13.33,choline kinase beta [Source:HGNC Symbol;Acc:HGNC:1938],Megaconial congenital muscular dystrophy;Muscular dystrophy congenital megaconial type;Proximal myopathy with focal depletion of mitochondria,CHKB,1120,NM_005198
SYNJ2_SIG,SYNJ2,SYNJ2_SIG,SYNJ2,SIG,48,2.27629081518189,0.0825913923334413,0.0774478917436494,0.0994914656999004,0.022043573956251,0.0374228392522751,4.22035699155819,4.74990940113455,4.62115014213246,5.17297553785568,0.551825395723217,0.000268319074790509,ENSG00000078269,SYNJ2,protein_coding,6,1,157981863,158099176,q25.3,synaptojanin 2 [Source:HGNC Symbol;Acc:HGNC:11504],NA,SYNJ2,8871,NM_001178088;NM_003898
TES_SIG,TES,TES_SIG,TES,SIG,10,-2.2754388303111,0.106720704081561,0.108933967001481,0.0994485544875383,-0.0094854125139431,0.0374990379978864,-2.30114003391685,6.11898497943372,6.17660475700414,5.92966285313091,-0.246941903873228,0.0538174947370065,ENSG00000135269,TES,protein_coding,7,1,116210506,116258783,q31.2,testin LIM domain protein [Source:HGNC Symbol;Acc:HGNC:14620],NA,TES,26136,NM_015641;NM_152829
NSDHL_SIG,NSDHL,NSDHL_SIG,NSDHL,SIG,33,2.2751656844567,0.54264495880879,0.53479754532482,0.568429317398977,0.0336317720741573,0.0375143643376756,2.60226187413128,3.65184477788145,3.61455090849077,3.77438177730797,0.159830868817205,0.0280127126182216,ENSG00000147383,NSDHL,protein_coding,X,1,152830967,152869729,q28,NAD(P) dependent steroid dehydrogenase-like [Source:HGNC Symbol;Acc:HGNC:13398],CHILD SYNDROME;CK SYNDROME;CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS;CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMBDEFECTS,NSDHL,50814,NM_001129765;NM_015922
MTF2_SIG,MTF2,MTF2_SIG,MTF2,SIG,57,2.27508647369253,0.27920859779995,0.274838060492577,0.293568934667032,0.0187308741744551,0.0375143643376756,-0.291414891011056,5.53947495677937,5.54402809218975,5.52451465471671,-0.0195134374730398,0.832879997065976,ENSG00000143033,MTF2,protein_coding,1,1,93079235,93139079,p22.1,metal response element binding transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:29535],NA,MTF2,22823,NM_001164391;NM_001164392;NM_001164393;NM_007358
ZNF316_TF,ZNF316,ZNF316_TF,ZNF316,TF,173,2.27505628854326,0.0234738530155568,0.0200905681626977,0.0345903603892368,0.0144997922265392,0.0375143643376756,1.89516997549577,5.19740605682004,5.17615755579578,5.26722256018547,0.0910650043896882,0.117269257898196,ENSG00000205903,ZNF316,protein_coding,7,1,6637318,6658279,p22.1,zinc finger protein 316 [Source:HGNC Symbol;Acc:HGNC:13843],NA,ZNF316,100131017,NM_001278559
FUT1_SIG,FUT1,FUT1_SIG,FUT1,SIG,49,-2.27399421205483,-0.0997680234946833,-0.0955300332651733,-0.113692848534502,-0.0181628152693285,0.0376114017692669,-1.67803901319339,0.75155567042719,0.789197535684605,0.627875256009968,-0.161322279674637,0.168852485475478,ENSG00000174951,FUT1,protein_coding,19,-1,48748011,48755390,q13.33,fucosyltransferase 1 (H blood group) [Source:HGNC Symbol;Acc:HGNC:4012],BOMBAY PHENOTYPEPARA-BOMBAY PHENOTYPE INCLUDED,FUT1,2523,NM_000148;NM_001329877
HAGHL_SIG,HAGHL,HAGHL_SIG,HAGHL,SIG,8,-2.27390115939917,-0.00199829399635098,0.00349984145528211,-0.020063596194574,-0.023563437649856,0.0376131304184327,-1.17155518457526,2.81121142521097,2.84397237521681,2.70356830376322,-0.140404071453594,0.349742822572793,ENSG00000103253,HAGHL,protein_coding,16,1,726936,735525,p13.3,hydroxyacylglutathione hydrolase like [Source:HGNC Symbol;Acc:HGNC:14177],NA,HAGHL,84264,NM_001290137;NM_001290139;NM_001323635;NM_001323636;NM_032304
PTP4A2_SIG,PTP4A2,PTP4A2_SIG,PTP4A2,SIG,16,-2.27372213951755,0.464340556126264,0.472744967863027,0.436726060419758,-0.0360189074432687,0.0376170640458067,-1.20736788778838,8.73235982004885,8.74700577936771,8.68423738228686,-0.0627683970808518,0.333502510458443,ENSG00000184007,PTP4A2,protein_coding,1,-1,31906421,31944856,p35.2,protein tyrosine phosphatase type IVA, member 2 [Source:HGNC Symbol;Acc:HGNC:9635],NA,PTP4A2,8073,NM_001195100;NM_001195101;NM_080391
ALDOC_SIG,ALDOC,ALDOC_SIG,ALDOC,SIG,24,-2.27371025508451,-0.0148597157428409,-0.0116968475245914,-0.025251997031375,-0.0135551495067835,0.0376170640458067,-2.45349767286725,2.97639130803285,3.04256533509903,2.75896236195825,-0.283602973140778,0.0390576900948436,ENSG00000109107,ALDOC,protein_coding,17,-1,28573115,28576948,q11.2,aldolase, fructose-bisphosphate C [Source:HGNC Symbol;Acc:HGNC:418],NA,ALDOC,230,NM_005165
KCNJ11_SIG,KCNJ11,KCNJ11_SIG,KCNJ11,SIG,30,-2.2732597937642,-0.121219910341797,-0.118243574915193,-0.130999298172066,-0.0127557232568726,0.0376533204999694,-1.12398283648821,0.336258924857637,0.350511021215635,0.289430608252786,-0.0610804129628491,0.370968022900316,ENSG00000187486,KCNJ11,protein_coding,11,-1,17385859,17389331,p15.1,potassium voltage-gated channel subfamily J member 11 [Source:HGNC Symbol;Acc:HGNC:6257],Autosomal dominant hyperinsulinism due to Kir6.2 deficiency;Autosomal recessive hyperinsulinism due to Kir6.2 deficiency;DEND syndrome;Diabetes Mellitus KCNJ11-Related Transient Neonatal;DIABETES MELLITUS NONINSULIN-DEPENDENT;DIABETES MELLITUS PERMANENT NEONATAL;DIABETES MELLITUS TRANSIENT NEONATAL 3;Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency;familial hyperinsulinism;HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 2;Intermediate DEND syndrome;MATURITY-ONSET DIABETES OF THE YOUNG TYPE 13;MODY;Permanent neonatal diabetes mellitus;Transient neonatal diabetes mellitus,KCNJ11,3767,NM_000525;NM_001166290
ZNF726_TF,ZNF726,ZNF726_TF,ZNF726,TF,76,2.27314610616268,0.073056422110056,0.0675471459845461,0.0911583293795885,0.0236111833950423,0.0376533204999694,2.70818363626715,2.56044784049701,2.49447385519476,2.77721950649009,0.282745651295333,0.0219644855407974,ENSG00000213967,ZNF726,protein_coding,19,1,23914876,23945159,p12,zinc finger protein 726 [Source:HGNC Symbol;Acc:HGNC:32462],NA,ZNF726,730087,NM_001244038;NM_001348687;NM_001348688;NM_001348689
FOXJ3_TF,FOXJ3,FOXJ3_TF,FOXJ3,TF,161,2.27311584941514,0.191397196419094,0.186402482819397,0.207808398246672,0.0214059154272751,0.0376533204999694,2.52918329504317,6.67268369174841,6.64479302544519,6.76432445245901,0.119531427013828,0.0331586925810401,ENSG00000198815,FOXJ3,protein_coding,1,-1,42176539,42335877,p34.2,forkhead box J3 [Source:HGNC Symbol;Acc:HGNC:29178],NA,FOXJ3,22887,NM_001198850;NM_001198851;NM_001198852;NM_014947
SLC4A1_SIG,SLC4A1,SLC4A1_SIG,SLC4A1,SIG,41,-2.27260492759051,-0.33025759623552,-0.306567015055347,-0.408098077256088,-0.101531062200741,0.0376962568098994,-1.31432403142865,3.46700126819702,3.56478236605771,3.14572051808332,-0.419061847974393,0.289243939055439,ENSG00000004939,SLC4A1,protein_coding,17,-1,44248390,44268141,q21.31,solute carrier family 4 member 1 (Diego blood group) [Source:HGNC Symbol;Acc:HGNC:11027],Autosomal dominant distal renal tubular acidosis;BLOOD GROUP--DIEGO SYSTEM;BLOOD GROUP--FROESE;BLOOD GROUP--SWANN SYSTEM;BLOOD GROUP--WALDNER TYPE;BLOOD GROUP--WRIGHT ANTIGEN;CRYOHYDROCYTOSIS;Dehydrated hereditary stomatocytosis;Distal renal tubular acidosis with anemia;Hereditary cryohydrocytosis with normal stomatin;Hereditary spherocytosis;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED;OVALOCYTOSIS SOUTHEAST ASIAN;Renal tubular acidosis distal AD;Renal tubular acidosis distal AR;RENAL TUBULAR ACIDOSIS DISTAL AUTOSOMAL DOMINANT;RENAL TUBULAR ACIDOSIS DISTAL WITH HEMOLYTIC ANEMIA;Southeast Asian ovalocytosis;SPHEROCYTOSIS TYPE 4,SLC4A1,6521,NM_000342
ASXL1_SIG,ASXL1,ASXL1_SIG,ASXL1,SIG,62,2.27150789532723,0.230526088579043,0.225944576420076,0.245579628529933,0.0196350521098566,0.0377971437993102,1.29424133908648,6.88137546635937,6.86749354540579,6.92698749234968,0.0594939469438848,0.297312491281599,ENSG00000171456,ASXL1,protein_coding,20,1,32358330,32439319,q11.21,ASXL transcriptional regulator 1 [Source:HGNC Symbol;Acc:HGNC:18318],Bohring-Opitz syndrome;MYELODYSPLASTIC SYNDROME,ASXL1,171023,NM_001164603;NM_001363734;NM_015338
KCNK12_SIG,KCNK12,KCNK12_SIG,KCNK12,SIG,30,-2.26801575231452,-0.0679968816587708,-0.0651150728154536,-0.077465682143956,-0.0123506093285025,0.0381362515812942,-1.44115551217795,0.306481076166633,0.329833714966011,0.229750977254391,-0.10008273771162,0.241552000907825,ENSG00000184261,KCNK12,protein_coding,2,-1,47516581,47570939,p16.3,potassium two pore domain channel subfamily K member 12 [Source:HGNC Symbol;Acc:HGNC:6274],NA,KCNK12,56660,NM_022055
RTN4_SIG,RTN4,RTN4_SIG,RTN4,SIG,26,2.26725757887788,0.363439244025208,0.360649707500969,0.372604864033422,0.0119551565324524,0.0382043190600547,2.24805299720468,8.04427436837583,8.0208601907062,8.12120666643315,0.100346475726946,0.060204836239318,ENSG00000115310,RTN4,protein_coding,2,-1,54972187,55112621,p16.1,reticulon 4 [Source:HGNC Symbol;Acc:HGNC:14085],NA,RTN4,57142,NM_001321859;NM_001321860;NM_001321861;NM_001321862;NM_001321863;NM_001321904;NM_007008;NM_020532;NM_153828;NM_207520;NM_207521
THOC6_SIG,THOC6,THOC6_SIG,THOC6,SIG,14,2.26496197522289,0.31593717728728,0.309123377611803,0.338325376220992,0.0292019986091887,0.0384264069009503,1.25734120142625,4.63318809889551,4.6155182159775,4.69124628562609,0.0757280696485817,0.312241027449663,ENSG00000131652,THOC6,protein_coding,16,1,3024027,3027755,p13.3,THO complex 6 [Source:HGNC Symbol;Acc:HGNC:28369],Beaulieu-Boycott-Innes syndrome;THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,THOC6,79228,NM_001142350;NM_001347703;NM_001347704;NM_024339
API5_SIG,API5,API5_SIG,API5,SIG,56,2.26335073532595,0.529181503106701,0.522838966978266,0.550021264671559,0.0271822976932928,0.0385779522924859,2.50836252295783,6.28529558004717,6.24883121356157,6.4051070699284,0.15627585636683,0.0346373510999143,ENSG00000166181,API5,protein_coding,11,1,43311963,43344529,p12,apoptosis inhibitor 5 [Source:HGNC Symbol;Acc:HGNC:594],NA,API5,8539,NM_001142930;NM_001142931;NM_001243747;NM_006595
EIF2AK2_SIG,EIF2AK2,EIF2AK2_SIG,EIF2AK2,SIG,29,-2.26330224739716,0.244454725268705,0.25021018953784,0.225543914098687,-0.0246662754391529,0.0385779522924859,0.344754364966067,7.1995520109126,7.19380264566564,7.21844278243832,0.0246401367726783,0.800854557390893,ENSG00000055332,EIF2AK2,protein_coding,2,-1,37099210,37157065,p22.2,eukaryotic translation initiation factor 2 alpha kinase 2 [Source:HGNC Symbol;Acc:HGNC:9437],NA,EIF2AK2,5610,NM_001135651;NM_001135652;NM_002759
LAMP1_SIG,LAMP1,LAMP1_SIG,LAMP1,SIG,28,-2.26251130258288,0.292325278561522,0.295312810767619,0.282509101312918,-0.0128037094547013,0.0386499926051676,-2.21641041655226,8.11032526893076,8.13359890004429,8.03385476670059,-0.099744133343698,0.0642246248417918,ENSG00000185896,LAMP1,protein_coding,13,1,113297239,113323672,q34,lysosomal associated membrane protein 1 [Source:HGNC Symbol;Acc:HGNC:6499],NA,LAMP1,3916,NM_005561
SLC6A16_SIG,SLC6A16,SLC6A16_SIG,SLC6A16,SIG,53,-2.26129391775749,0.150088290053665,0.153762458692369,0.138016021669351,-0.0157464370230181,0.0387652155801954,-0.949158047958306,1.72680949660275,1.74238506358453,1.67563263366263,-0.0667524299219021,0.456127775035088,ENSG00000063127,SLC6A16,protein_coding,19,-1,49289638,49325225,q13.33,solute carrier family 6 member 16 [Source:HGNC Symbol;Acc:HGNC:13622],NA,SLC6A16,28968,NM_014037
HCFC1_SIG,HCFC1,HCFC1_SIG,HCFC1,SIG,10,2.25981379763958,0.758786415675767,0.755464456469065,0.769701424497788,0.0142369680287235,0.0389073553541814,1.81996999111817,7.86021907767111,7.83984065067642,7.92717676636794,0.0873361156915236,0.133624384061354,ENSG00000172534,HCFC1,protein_coding,X,-1,153947557,153971818,q28,host cell factor C1 [Source:HGNC Symbol;Acc:HGNC:4839],Cobalamin Disorder;MENTAL RETARDATION X-LINKED 3;METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA cblX TYPE;Methylmalonic acidemia with homocystinuria type cblX;X-linked non-syndromic intellectual disability,HCFC1,3054,NM_005334
GPR183_SIG,GPR183,GPR183_SIG,GPR183,SIG,27,-2.25830011900263,0.131412844592453,0.136424349301288,0.114946471977708,-0.0214778773235796,0.0390520847268193,0.101576855113086,4.6248661251311,4.62024743715331,4.64004181420096,0.0197943770476519,0.943637934429378,ENSG00000169508,GPR183,protein_coding,13,-1,99294539,99307399,q32.3,G protein-coupled receptor 183 [Source:HGNC Symbol;Acc:HGNC:3128],NA,GPR183,1880,NM_004951
ELP4_SIG,ELP4,ELP4_SIG,ELP4,SIG,43,2.25823694186203,0.394840086966139,0.385045442306853,0.427022490846652,0.0419770485397993,0.0390520847268193,2.36960339256771,3.38643030808131,3.34452224616277,3.52412822581366,0.179605979650886,0.0467696913403515,ENSG00000109911,ELP4,protein_coding,11,1,31509755,31790324,p13,elongator acetyltransferase complex subunit 4 [Source:HGNC Symbol;Acc:HGNC:1171],ANIRIDIA 2,ELP4,26610,NM_001288725;NM_001288726;NM_019040
TLK1_SIG,TLK1,TLK1_SIG,TLK1,SIG,39,2.25787609976286,0.387000629230844,0.382047112596668,0.403276469600278,0.0212293570036096,0.0390789187468659,-0.258524761826126,6.60280932792091,6.60565533911427,6.59345814828557,-0.0121971908286938,0.852560563224042,ENSG00000198586,TLK1,protein_coding,2,-1,170990823,171231314,q31.1,tousled like kinase 1 [Source:HGNC Symbol;Acc:HGNC:11841],NA,TLK1,9874,NM_001136554;NM_001136555;NM_012290
RBMS1_SIG,RBMS1,RBMS1_SIG,RBMS1,SIG,17,-2.25782184610988,0.285740156397298,0.292157798570733,0.264653617827441,-0.027504180743292,0.0390789187468659,-1.50670915562145,6.39463759514629,6.41476148931394,6.32851622859541,-0.0862452607185312,0.219779834660555,ENSG00000153250,RBMS1,protein_coding,2,-1,160272151,160493807,q24.2,RNA binding motif single stranded interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:9907],NA,RBMS1,5937,NM_002897;NM_016836
DYNC1H1_SIG,DYNC1H1,DYNC1H1_SIG,DYNC1H1,SIG,20,2.25769687799035,0.619563300250776,0.616602245731245,0.629292479386379,0.0126902336551343,0.0390839395413781,3.25148934828429,8.50351722884315,8.46239891266436,8.63862026771634,0.176221355051981,0.00550091279458554,ENSG00000197102,DYNC1H1,protein_coding,14,1,101964573,102056443,q32.31,dynein cytoplasmic 1 heavy chain 1 [Source:HGNC Symbol;Acc:HGNC:2961],Autosomal dominant Charcot-Marie-Tooth disease type 2O;Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures;Autosomal dominant non-syndromic intellectual disability;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2O;MENTAL RETARDATION AUTOSOMAL DOMINANT 13;Severe ID with neuronal migration disorder;SPINAL MUSCULAR ATROPHY LOWER EXTREMITY-PREDOMINANT 1 AUTOSOMALDOMINANT;Spinal muscular atrophy lower extremity-predominant AD,DYNC1H1,1778,NM_001376
ZNF384_TF,ZNF384,ZNF384_TF,ZNF384,TF,27,2.25688696281628,0.29569869243343,0.29318173887259,0.303968682704761,0.0107869438321713,0.0391587139721862,0.496725891467197,6.48194778262674,6.47758807944537,6.49627252165124,0.0186844422058758,0.711439241083029,ENSG00000126746,ZNF384,protein_coding,12,-1,6666477,6689572,p13.31,zinc finger protein 384 [Source:HGNC Symbol;Acc:HGNC:11955],NA,ZNF384,171017,NM_001039920;NM_001135734;NM_133476
INHBC_SIG,INHBC,INHBC_SIG,INHBC,SIG,20,2.25676971735828,0.0195948894205944,0.0156017702278519,0.0327151381967485,0.0171133679688967,0.0391629568258144,-0.682802821116905,0.319181226900587,0.324697567039216,0.301056109302236,-0.0236414577369798,0.601834561182932,ENSG00000175189,INHBC,protein_coding,12,1,57434784,57452062,q13.3,inhibin subunit beta C [Source:HGNC Symbol;Acc:HGNC:6068],NA,INHBC,3626,NM_005538
STK33_SIG,STK33,STK33_SIG,STK33,SIG,57,2.25615335341789,-0.107480855352763,-0.111055705883266,-0.0957349178953948,0.0153207879878717,0.0392181040845472,3.45327009318018,0.999356233135458,0.909187211639055,1.29562587519507,0.386438663556013,0.00308636189003201,ENSG00000130413,STK33,protein_coding,11,-1,8391868,8594289,p15.4,serine/threonine kinase 33 [Source:HGNC Symbol;Acc:HGNC:14568],NA,STK33,65975,NM_001289058;NM_001289059;NM_001289061;NM_001352387;NM_001352388;NM_001352389;NM_001352390;NM_001352391;NM_001352392;NM_001352393;NM_001352394;NM_001352395;NM_001352396;NM_001352397;NM_001352398;NM_001352399;NM_030906
HNRNPK_SIG,HNRNPK,HNRNPK_SIG,HNRNPK,SIG,16,2.25557075736968,0.714727511523536,0.711150775639802,0.726479643712948,0.0153288680731459,0.0392698673314328,1.65831736646157,9.28345077097917,9.27164665455574,9.32223572494186,0.050589070386117,0.174207897037832,ENSG00000165119,HNRNPK,protein_coding,9,-1,83968083,83980616,q21.32,heterogeneous nuclear ribonucleoprotein K [Source:HGNC Symbol;Acc:HGNC:5044],Au-Kline syndrome;Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion;Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation,HNRNPK,3190,NM_001318186;NM_001318187;NM_001318188;NM_002140;NM_031262;NM_031263
ACKR3_SIG,ACKR3,ACKR3_SIG,ACKR3,SIG,24,-2.25499835340121,-0.0443846031319212,-0.0402006658411452,-0.0581318256587567,-0.0179311598176117,0.0393206460674549,-1.32348273065595,2.14402599082222,2.18790570683838,1.99984978105481,-0.188055925783573,0.285654647620132,ENSG00000144476,ACKR3,protein_coding,2,1,236567787,236582354,q37.3,atypical chemokine receptor 3 [Source:HGNC Symbol;Acc:HGNC:23692],NA,ACKR3,57007,NM_020311
BPGM_SIG,BPGM,BPGM_SIG,BPGM,SIG,23,-2.2539629209761,0.082468250656289,0.0899699165236152,0.0578199199493601,-0.0321499965742552,0.0394189104270097,-1.245125781649,3.99581915235731,4.02294207546733,3.90670097642439,-0.116241099042941,0.317411387855691,ENSG00000172331,BPGM,protein_coding,7,1,134646811,134679816,q33,bisphosphoglycerate mutase [Source:HGNC Symbol;Acc:HGNC:1093],BISPHOSPHOGLYCERATE MUTASE DEFICIENCY;Hemolytic anemia due to diphosphoglycerate mutase deficiency,BPGM,669,NM_001293085;NM_001724;NM_199186
PPP1R8_SIG,PPP1R8,PPP1R8_SIG,PPP1R8,SIG,44,2.25366282817864,0.377965358771153,0.374580057603243,0.389088491180002,0.0145084335767595,0.0394419217048374,2.46772574072636,5.5361915540768,5.5055170179475,5.6369793156445,0.131462297696998,0.0378919906610919,ENSG00000117751,PPP1R8,protein_coding,1,1,27830782,27851676,p35.3,protein phosphatase 1 regulatory subunit 8 [Source:HGNC Symbol;Acc:HGNC:9296],NA,PPP1R8,5511,NM_002713;NM_014110;NM_138558
CD2BP2_SIG,CD2BP2,CD2BP2_SIG,CD2BP2,SIG,17,2.25341529355403,0.282198466199623,0.27929939065754,0.291724000123612,0.0124246094660715,0.0394595533169095,1.32464049777374,5.79839651228609,5.78589958239141,5.83945785336861,0.053558270977204,0.285223999967563,ENSG00000169217,CD2BP2,protein_coding,16,-1,30350773,30355308,p11.2,CD2 cytoplasmic tail binding protein 2 [Source:HGNC Symbol;Acc:HGNC:1656],NA,CD2BP2,10421,NM_001243646;NM_006110
TNFSF14_SIG,TNFSF14,TNFSF14_SIG,TNFSF14,SIG,47,-2.2527118987956,0.213281599254965,0.218867349418071,0.194928420147616,-0.0239389292704552,0.0395239925287789,-0.233168350877859,1.72421896332816,1.73160635471333,1.69994610591975,-0.0316602487935814,0.868168625479414,ENSG00000125735,TNFSF14,protein_coding,19,-1,6661253,6670588,p13.3,TNF superfamily member 14 [Source:HGNC Symbol;Acc:HGNC:11930],NA,TNFSF14,8740,NM_003807;NM_172014
ZDHHC5_SIG,ZDHHC5,ZDHHC5_SIG,ZDHHC5,SIG,46,-2.25195177445401,0.351348789942712,0.355237040805094,0.338573108537745,-0.0166639322673488,0.0395874012967442,-1.73866968832552,6.53969801941499,6.55960267161994,6.47429701931302,-0.0853056523069259,0.153016251806452,ENSG00000156599,ZDHHC5,protein_coding,11,1,57667747,57701182,q12.1,zinc finger DHHC-type containing 5 [Source:HGNC Symbol;Acc:HGNC:18472],NA,ZDHHC5,25921,NM_015457
UBE3B_SIG,UBE3B,UBE3B_SIG,UBE3B,SIG,94,2.25194378049923,0.311654403447332,0.303646709175827,0.337965398910847,0.0343186897350204,0.0395874012967442,2.07781266652638,5.56368664293718,5.52890209476165,5.67797872979964,0.149076635037983,0.0838096056639089,ENSG00000151148,UBE3B,protein_coding,12,1,109477402,109536705,q24.11,ubiquitin protein ligase E3B [Source:HGNC Symbol;Acc:HGNC:13478],Blepharophimosis- mental retardation;KAUFMAN OCULOCEREBROFACIAL SYNDROME;Oculocerebrofacial syndrome Kaufman type,UBE3B,89910,NM_001270449;NM_001270450;NM_001270451;NM_130466;NM_183415
TREX1_SIG,TREX1,TREX1_SIG,TREX1,SIG,14,-2.25160047880655,0.220485335125561,0.233321964853587,0.178307837447761,-0.0550141274058261,0.0396149435471783,0.0604387078821194,4.12107369489612,4.12002053569073,4.12453407514242,0.00451353945169405,0.966539412719707,ENSG00000213689,TREX1,protein_coding,3,1,48465811,48467645,p21.31,three prime repair exonuclease 1 [Source:HGNC Symbol;Acc:HGNC:12269],Aicardi-Goutieres syndrome;AICARDI-GOUTIERES SYNDROME 1;Aicardi-Goutieres syndrome 1 dominant and recessive;CHILBLAIN LUPUS 1;Familial Chilblain lupus;Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;Systemic lupus erythematosus;VASCULOPATHY RETINAL WITH CEREBRAL LEUKODYSTROPHY,TREX1,11277,NM_007248;NM_033629
RSPRY1_SIG,RSPRY1,RSPRY1_SIG,RSPRY1,SIG,55,2.25143344215055,0.412604627287704,0.406465508031111,0.432776019130794,0.0263105110996829,0.0396243553968209,2.62703916180168,5.03477161054674,4.99941894657297,5.15093036360343,0.151511417030457,0.0264130959429886,ENSG00000159579,RSPRY1,protein_coding,16,1,57186137,57240469,q13,ring finger and SPRY domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29420],PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA;Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome;Spondyloepimetaphyseal dysplasia Faden-Alkuraya type,RSPRY1,89970,NM_001305163;NM_001305164;NM_001305182;NM_133368
PRKAB2_SIG,PRKAB2,PRKAB2_SIG,PRKAB2,SIG,42,2.25132272908055,0.225646074847845,0.220050617211693,0.244031149938057,0.023980532726364,0.0396279718497111,1.33369340108063,5.22578370892242,5.20362928244023,5.29857682450675,0.094947542066519,0.281588409270926,ENSG00000131791,PRKAB2,protein_coding,1,-1,147155106,147172550,q21.1,protein kinase AMP-activated non-catalytic subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:9379],NA,PRKAB2,5565,NM_005399
ZC3H3_TF,ZC3H3,ZC3H3_TF,ZC3H3,TF,76,-2.25074320658351,0.0909806556395703,0.0932565237929146,0.0835028031357247,-0.00975372065718988,0.0396798757350411,-2.81481850290398,5.47115461221063,5.51261003330356,5.33494394290528,-0.177666090398278,0.0170708371745535,ENSG00000014164,ZC3H3,protein_coding,8,-1,143437659,143541447,q24.3,zinc finger CCCH-type containing 3 [Source:HGNC Symbol;Acc:HGNC:28972],NA,ZC3H3,23144,NM_015117
RPS10_SIG,RPS10,RPS10_SIG,RPS10,SIG,16,2.2506141854185,0.331651484581298,0.328012174289611,0.343609218396841,0.0155970441072304,0.0396853844001088,1.78899273413092,2.26870613821973,2.24680636479349,2.34066253662025,0.093856171826765,0.140813155693875,ENSG00000124614,RPS10,protein_coding,6,-1,34417454,34426125,p21.31,ribosomal protein S10 [Source:HGNC Symbol;Acc:HGNC:10383],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 9,RPS10,6204,NM_001014;NM_001203245;NM_001204091
NME4_SIG,NME4,NME4_SIG,NME4,SIG,35,2.24990777241036,0.00997020257454869,0.00373688864707417,0.0304510911933936,0.0267142025463195,0.0397475812136472,1.31677040904674,5.91205843701964,5.88436615656079,6.00304735852726,0.118681201966469,0.288305571449134,ENSG00000103202,NME4,protein_coding,16,1,396725,410367,p13.3,NME/NM23 nucleoside diphosphate kinase 4 [Source:HGNC Symbol;Acc:HGNC:7852],NA,NME4,4833,NM_001286433;NM_001286435;NM_001286436;NM_001286438;NM_001286439;NM_001286440;NM_005009
SCML2_TF,SCML2,SCML2_TF,SCML2,TF,175,2.24985996979404,0.189232047616976,0.184788062838667,0.203833711888561,0.0190456490498937,0.0397475812136472,0.637150690795186,4.04826788702448,4.03030949499799,4.10727403225439,0.0769645372564031,0.628601433369239,ENSG00000102098,SCML2,protein_coding,X,-1,18239313,18354688,p22.13,Scm polycomb group protein like 2 [Source:HGNC Symbol;Acc:HGNC:10581],NA,SCML2,10389,NM_006089
ZNF462_TF,ZNF462,ZNF462_TF,ZNF462,TF,199,-2.2496345406511,-0.106825348789782,-0.103264466832936,-0.118525389505137,-0.0152609226722012,0.0397613993647496,-2.99434582500167,1.0537311277189,1.15201601270854,0.730795077038656,-0.421220935669882,0.010923371582214,ENSG00000148143,ZNF462,protein_coding,9,1,106863166,107013634,q31.2,zinc finger protein 462 [Source:HGNC Symbol;Acc:HGNC:21684],Craniofacial anomalies corpus callosum dysgenesis ptosis and developmental delay;Metopic ridging-ptosis-facial dysmorphism syndrome,ZNF462,58499,NM_001347997;NM_021224
ESRRA_TF,ESRRA,ESRRA_TF,ESRRA,TF,249,-2.24957500112866,0.151387571905386,0.157314080022986,0.131914759518987,-0.0253993205039987,0.0397613993647496,-1.26942195749435,4.84980025576457,4.86834768093693,4.78885871591251,-0.0794889650244243,0.307459116631178,ENSG00000173153,ESRRA,protein_coding,11,1,64305524,64316743,q13.1,estrogen related receptor alpha [Source:HGNC Symbol;Acc:HGNC:3471],NA,ESRRA,2101,NM_001282450;NM_001282451;NM_004451
ENO1_SIG,ENO1,ENO1_SIG,ENO1,SIG,29,2.24898202138908,0.352139105030262,0.348685235107352,0.363487534776969,0.0148022996696177,0.0398148415708635,1.11474931324382,9.94051905553869,9.92263807426135,9.99927085116426,0.0766327769029153,0.375455615952857,ENSG00000074800,ENO1,protein_coding,1,-1,8861000,8879250,p36.23,enolase 1 [Source:HGNC Symbol;Acc:HGNC:3350],NA,ENO1,2023,NM_001201483;NM_001353346;NM_001428
E2F8_TF,E2F8,E2F8_TF,E2F8,TF,171,-2.24880493436178,0.158491451136477,0.170253663295621,0.119844182613572,-0.0504094806820489,0.0398253378356817,-0.808504656269069,2.89695139768404,2.92350198110722,2.80971376643644,-0.113788214670783,0.530545209565621,ENSG00000129173,E2F8,protein_coding,11,-1,19224063,19241620,p15.1,E2F transcription factor 8 [Source:HGNC Symbol;Acc:HGNC:24727],NA,E2F8,79733,NM_001256371;NM_001256372;NM_024680
CCNB1_SIG,CCNB1,CCNB1_SIG,CCNB1,SIG,26,-2.24799877695983,0.043660341911494,0.0589874818146107,-0.00670026062731801,-0.0656877424419287,0.0399009170297402,-1.90590240248397,3.6436340929898,3.70411256435516,3.44491911564649,-0.259193448708677,0.115135683450833,ENSG00000134057,CCNB1,protein_coding,5,1,69167135,69178245,q13.2,cyclin B1 [Source:HGNC Symbol;Acc:HGNC:1579],NA,CCNB1,891,NM_001354844;NM_001354845;NM_031966
IKBKB_SIG,IKBKB,IKBKB_SIG,IKBKB,SIG,97,2.24791113268689,0.295682769661743,0.288876561222318,0.318046025962713,0.0291694647403946,0.0399021721190973,1.67832941466805,6.4477291644181,6.41882842818059,6.54268872634132,0.123860298160722,0.168834055996263,ENSG00000104365,IKBKB,protein_coding,8,1,42271302,42332653,p11.21,inhibitor of nuclear factor kappa B kinase subunit beta [Source:HGNC Symbol;Acc:HGNC:5960],IMMUNODEFICIENCY 15A;IMMUNODEFICIENCY 15B;Severe combined immunodeficiency due to IKK2 deficiency,IKBKB,3551,NM_001190720;NM_001242778;NM_001556
NAGA_SIG,NAGA,NAGA_SIG,NAGA,SIG,82,-2.24656884602639,0.319655136460787,0.329978591996582,0.285735211128886,-0.0442433808676963,0.0400335014825416,-2.09433399724803,5.9615327864648,6.02437570339034,5.75504891656658,-0.269326786823758,0.0811534740930816,ENSG00000198951,NAGA,protein_coding,22,-1,42058354,42070842,q13.2,alpha-N-acetylgalactosaminidase [Source:HGNC Symbol;Acc:HGNC:7631],Alpha-N-acetylgalactosaminidase deficiency type 1;Alpha-N-acetylgalactosaminidase deficiency type 2;Alpha-N-acetylgalactosaminidase deficiency type 3;KANZAKI DISEASE;Schindler disease;SCHINDLER DISEASE TYPE I,NAGA,4668,NM_000262
RAVER2_SIG,RAVER2,RAVER2_SIG,RAVER2,SIG,59,2.24634017667072,0.127813000039257,0.120772487908505,0.150946111326014,0.0301736234175082,0.0400494027991171,2.71359229843082,4.86612739424352,4.78056203498281,5.14727071752872,0.366708682545909,0.0217047778944512,ENSG00000162437,RAVER2,protein_coding,1,1,64745095,64833232,p31.3,ribonucleoprotein, PTB binding 2 [Source:HGNC Symbol;Acc:HGNC:25577],NA,RAVER2,55225,NM_001366165;NM_018211
ATP10D_SIG,ATP10D,ATP10D_SIG,ATP10D,SIG,32,2.24554331803672,0.388565598098232,0.38187911372745,0.410535475316516,0.0286563615890654,0.0401243744283065,2.02461388788664,4.6691467148848,4.61224829830365,4.85609865507999,0.24385035677634,0.0928473446933624,ENSG00000145246,ATP10D,protein_coding,4,1,47485288,47593486,p12,ATPase phospholipid transporting 10D (putative) [Source:HGNC Symbol;Acc:HGNC:13549],NA,ATP10D,57205,NM_020453
RCAN1_SIG,RCAN1,RCAN1_SIG,RCAN1,SIG,24,-2.24174458452008,0.283189337699452,0.288602395921156,0.265403574970995,-0.0231988209501609,0.0405132681708924,-2.39278639593383,3.75419836371286,3.81672392317977,3.54875723975017,-0.267966683429594,0.044500273866937,ENSG00000159200,RCAN1,protein_coding,21,-1,34513142,34615113,q22.12,regulator of calcineurin 1 [Source:HGNC Symbol;Acc:HGNC:3040],NA,RCAN1,1827,NM_001285389;NM_001285391;NM_001285392;NM_001285393;NM_001331016;NM_004414;NM_203417;NM_203418
MAZ_TF,MAZ,MAZ_TF,MAZ,TF,237,2.24001027009932,0.1971589502305,0.193836347338708,0.208076074017815,0.0142397266791072,0.04068756549496,-0.819156706555295,8.22036184454463,8.23047345716794,8.18713797449663,-0.0433354826713118,0.52467637154074,ENSG00000103495,MAZ,protein_coding,16,1,29806106,29811164,p11.2,MYC associated zinc finger protein [Source:HGNC Symbol;Acc:HGNC:6914],NA,MAZ,4150,NM_001042539;NM_001276275;NM_001276276;NM_002383
KCMF1_TF,KCMF1,KCMF1_TF,KCMF1,TF,49,-2.23935765935977,0.0732470409567482,0.0792053252441485,0.0536698211552901,-0.0255355040888586,0.0407483440747403,-2.23746832977716,6.08762601705673,6.10712372395801,6.02356212295251,-0.0835616010055081,0.0614691989638782,ENSG00000176407,KCMF1,protein_coding,2,1,84971093,85059472,p11.2,potassium channel modulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:20589],NA,KCMF1,56888,NM_020122
SLC16A4_SIG,SLC16A4,SLC16A4_SIG,SLC16A4,SIG,3,2.23859526529876,-0.415007139396343,-0.419137583040641,-0.401435681707936,0.0177019013327053,0.0408207876339172,1.02788805468452,0.316114741652299,0.310632437256604,0.334128027523869,0.0234955902672648,0.416942216425246,ENSG00000168679,SLC16A4,protein_coding,1,-1,110362851,110391082,p13.3,solute carrier family 16 member 4 [Source:HGNC Symbol;Acc:HGNC:10925],NA,SLC16A4,9122,NM_001201546;NM_001201547;NM_001201548;NM_001201549;NM_001319220;NM_004696
DUSP8_SIG,DUSP8,DUSP8_SIG,DUSP8,SIG,55,-2.23741362683786,0.165097332366253,0.175082338018793,0.132289456650767,-0.0427928813680261,0.0409376869510305,-2.61880432363331,2.13408538434653,2.25520326664856,1.7361266282113,-0.519076638437257,0.0269434909265566,ENSG00000184545,DUSP8,protein_coding,11,-1,1554051,1572271,p15.5,dual specificity phosphatase 8 [Source:HGNC Symbol;Acc:HGNC:3074],NA,DUSP8,1850,NM_004420
FUT4_SIG,FUT4,FUT4_SIG,FUT4,SIG,36,-2.23534171678679,0.259080858581178,0.26433928575491,0.241803169296055,-0.0225361164588553,0.0411494112026231,-2.13864193854017,6.98272275290424,7.03947585475294,6.79624827540136,-0.243227579351583,0.07472995230105,ENSG00000196371,FUT4,protein_coding,11,1,94543840,94549898,q21,fucosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:4015],NA,FUT4,2526,NM_002033
CLUH_SIG,CLUH,CLUH_SIG,CLUH,SIG,15,2.23488506086052,0.582520165071065,0.577322069194577,0.599599622950954,0.0222775537563777,0.0411899217482929,3.27153074729171,6.1117231958315,6.05729674633588,6.29055295845997,0.233256212124087,0.0052047442824787,ENSG00000132361,CLUH,protein_coding,17,-1,2689386,2712663,p13.3,clustered mitochondria homolog [Source:HGNC Symbol;Acc:HGNC:29094],NA,CLUH,23277,NM_001366661;NM_001366662;NM_015229
FBL_SIG,FBL,FBL_SIG,FBL,SIG,21,2.23409308099373,1.03104018701801,1.02347525315544,1.05589639828075,0.0324211451253053,0.0412661825851989,2.37280843933938,7.25875753962035,7.22245720171183,7.37803007846263,0.1555728767508,0.0464995479878289,ENSG00000105202,FBL,protein_coding,19,-1,39834458,39846379,q13.2,fibrillarin [Source:HGNC Symbol;Acc:HGNC:3599],NA,FBL,2091,NM_001436
OR2L2_SIG,OR2L2,OR2L2_SIG,OR2L2,SIG,19,2.23355881676393,-0.162766963209174,-0.168039545970576,-0.145442762707427,0.0225967832631492,0.0413150670583834,1.55177298011423,0.350555218540691,0.334239982519484,0.404162422610372,0.0699224400908885,0.205180405413808,ENSG00000203663,OR2L2,protein_coding,1,1,248030070,248042305,q44,olfactory receptor family 2 subfamily L member 2 [Source:HGNC Symbol;Acc:HGNC:8266],NA,OR2L2,26246,NM_001004686
DLD_SIG,DLD,DLD_SIG,DLD,SIG,37,2.23299309856951,0.284503309822976,0.28188952932323,0.293091445750713,0.0112019164274827,0.041367358755209,1.82393486843904,6.11431329447393,6.08957792415987,6.19558665407728,0.106008729917408,0.132703644902764,ENSG00000091140,DLD,protein_coding,7,1,107891162,107931730,q31.1,dihydrolipoamide dehydrogenase [Source:HGNC Symbol;Acc:HGNC:2898],Dihydrolipoamide Dehydrogenase (E3) Deficiency;DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY;Leigh syndrome;Pyruvate dehydrogenase E3 deficiency,DLD,1738,NM_000108;NM_001289750;NM_001289751;NM_001289752
MYC_TF,MYC,MYC_TF,MYC,TF,56,2.23268318867331,0.177594903040035,0.172921903936858,0.192949042950476,0.0200271390136177,0.0413923712961934,0.0577515194770918,6.40024900510769,6.39842613110373,6.40623844826357,0.00781231715983384,0.968173393116472,ENSG00000136997,MYC,protein_coding,8,1,127735434,127742950,q24.21,MYC proto-oncogene, bHLH transcription factor [Source:HGNC Symbol;Acc:HGNC:7553],BURKITT LYMPHOMA;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Precursor T-cell acute lymphoblastic leukemia,MYC,4609,NM_001354870;NM_002467
GYPB_SIG,GYPB,GYPB_SIG,GYPB,SIG,28,-2.23242202124778,-0.316098906190434,-0.287345089526588,-0.410575732371644,-0.123230642845057,0.0414121876584147,-2.33509543186255,1.05849811941409,1.14645657618438,0.769491761454568,-0.376964814729815,0.0503554069572357,ENSG00000250361,GYPB,protein_coding,4,-1,143996104,144019345,q31.21,glycophorin B (MNS blood group) [Source:HGNC Symbol;Acc:HGNC:4703],BLOOD GROUP Ss;MALARIA SUSCEPTIBILITY TO MALARIA RESISTANCE TO INCLUDED,GYPB,2994,NM_001304382;NM_002100
TFDP1_TF,TFDP1,TFDP1_TF,TFDP1,TF,319,-2.23135192300685,0.11129459936546,0.117839888307187,0.0897886499854997,-0.0280512383216874,0.0415185732644092,-0.19275387155865,6.27921851847081,6.28326061411175,6.26593734707917,-0.0173232670325786,0.891580445304897,ENSG00000198176,TFDP1,protein_coding,13,1,113584721,113641473,q34,transcription factor Dp-1 [Source:HGNC Symbol;Acc:HGNC:11749],NA,TFDP1,7027,NM_007111
YY1_SIG,YY1,YY1_SIG,YY1,SIG,31,2.23121057558824,0.268882452583805,0.264908855231783,0.281938558169023,0.01702970293724,0.0415256039066568,1.53323615630148,7.50139414381976,7.48699316734059,7.54871163796562,0.0617184706250323,0.211196168966457,ENSG00000100811,YY1,protein_coding,14,1,100238298,100282792,q32.2,YY1 transcription factor [Source:HGNC Symbol;Acc:HGNC:12856],GABRIELE-DE VRIES SYNDROME;Intellectual disability,YY1,7528,NM_003403
TREM2_SIG,TREM2,TREM2_SIG,TREM2,SIG,24,-2.23090361941425,-0.076815393494028,-0.072832670482334,-0.0899014833895942,-0.0170688129072602,0.041550381301348,-2.16076708484337,0.382660090191528,0.421798415658969,0.25406273508422,-0.167735680574749,0.0716811906965737,ENSG00000095970,TREM2,protein_coding,6,-1,41158506,41163186,p21.1,triggering receptor expressed on myeloid cells 2 [Source:HGNC Symbol;Acc:HGNC:17761],Amyotrophic lateral sclerosis;Behavioral variant of frontotemporal dementia;Early-onset autosomal dominant Alzheimer disease;Nasu-Hakola disease;POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2;Progressive non-fluent aphasia;Semantic dementia,TREM2,54209,NM_001271821;NM_018965
CGN_SIG,CGN,CGN_SIG,CGN,SIG,56,-2.23052121820425,-0.140994101232025,-0.13758450667324,-0.15219705478232,-0.01461254810908,0.04158326149821,-1.1580839694426,0.338205509492963,0.352531325132152,0.291134972392773,-0.0613963527393791,0.355749541473936,ENSG00000143375,CGN,protein_coding,1,1,151510510,151538692,q21.3,cingulin [Source:HGNC Symbol;Acc:HGNC:17429],NA,CGN,57530,NM_020770
PTPN13_SIG,PTPN13,PTPN13_SIG,PTPN13,SIG,11,-2.23033898238998,0.0344033706105984,0.0363576033379995,0.0279823202205662,-0.0083752831174332,0.0415946890112259,-3.46100595720592,1.52919354517064,1.62891711284861,1.2015303942287,-0.427386718619913,0.0030226218751429,ENSG00000163629,PTPN13,protein_coding,4,1,86594315,86815171,q21.3,protein tyrosine phosphatase, non-receptor type 13 [Source:HGNC Symbol;Acc:HGNC:9646],NA,PTPN13,5783,NM_006264;NM_080683;NM_080684;NM_080685
PKN1_SIG,PKN1,PKN1_SIG,PKN1,SIG,56,-2.22755191540842,0.249050230641103,0.250952758402564,0.242799067996299,-0.00815369040626516,0.0418863899511658,-1.94867299086109,7.95505908642931,7.97449431162751,7.89120048934949,-0.0832938222780272,0.106710880307336,ENSG00000123143,PKN1,protein_coding,19,1,14433053,14471867,p13.12,protein kinase N1 [Source:HGNC Symbol;Acc:HGNC:9405],NA,PKN1,5585,NM_002741;NM_213560
MED20_SIG,MED20,MED20_SIG,MED20,SIG,38,2.22732858990388,0.461214479346878,0.451510279568661,0.493099707189593,0.0415894276209326,0.0419023186677715,2.80496964639266,3.88091331464705,3.82263609263419,4.07239561554645,0.249759522912262,0.017502100931807,ENSG00000124641,MED20,protein_coding,6,-1,41905354,41921139,p21.1,mediator complex subunit 20 [Source:HGNC Symbol;Acc:HGNC:16840],NA,MED20,9477,NM_001305455;NM_001305456;NM_001305457;NM_004275
C1S_SIG,C1S,C1S_SIG,C1S,SIG,10,-2.2255806544902,-0.110499186998249,-0.106234675374588,-0.124511153761706,-0.0182764783871181,0.0420831512021108,2.84662210654703,1.3911343566154,1.3266619610947,1.60297222761199,0.276310266517287,0.0158235950105093,ENSG00000182326,C1S,protein_coding,12,1,6988259,7071032,p13.31,complement C1s [Source:HGNC Symbol;Acc:HGNC:1247],COMPLEMENT COMPONENT C1s DEFICIENCY;EHLERS-DANLOS SYNDROME PERIODONTAL TYPE 2;Ehlers-Danlos syndrome periodontitis type;Immunodeficiency due to a classical component pathway complement deficiency,C1S,716,NM_001346850;NM_001734;NM_201442
MME_SIG,MME,MME_SIG,MME,SIG,44,-2.22540270404121,-0.0645298695992626,-0.0569896631061981,-0.0893048337907605,-0.0323151706845624,0.0420942240775508,-1.79709591759924,2.49562591505359,2.59618179902978,2.16522801056039,-0.430953788469386,0.138846644074985,ENSG00000196549,MME,protein_coding,3,1,155024124,155183729,q25.2,membrane metalloendopeptidase [Source:HGNC Symbol;Acc:HGNC:7154],Charcot-Marie-Tooth disease axonal type 2t;Charcot-Marie-Tooth disease type 2T;MME-related autosomal dominant Charcot Marie Tooth disease type 2;Spinocerebellar ataxia 43;Spinocerebellar ataxia type 43,MME,4311,NM_000902;NM_001354642;NM_001354643;NM_001354644;NM_007287;NM_007288;NM_007289
SH3BP1_SIG,SH3BP1,SH3BP1_SIG,SH3BP1,SIG,20,-2.22524894907335,0.668090266167327,0.673257196803032,0.651113208364299,-0.0221439884387333,0.0421026779198937,0.11112890182762,6.48067735134963,6.47877302402271,6.48693442685237,0.00816140282966163,0.938345122364763,ENSG00000100092,SH3BP1,protein_coding,22,1,37634654,37656119,q13.1,SH3 domain binding protein 1 [Source:HGNC Symbol;Acc:HGNC:10824],NA,SH3BP1,23616,NM_001350055;NM_018957
FBXO30_SIG,FBXO30,FBXO30_SIG,FBXO30,SIG,49,2.2248861105399,0.308679334986123,0.305357245866198,0.319594770665878,0.0142375247996804,0.0421262203372587,1.56448679714061,4.35893130824249,4.33196415779584,4.44753765971005,0.11557350191421,0.20124672442029,ENSG00000118496,FBXO30,protein_coding,6,-1,145793502,145814795,q24.3,F-box protein 30 [Source:HGNC Symbol;Acc:HGNC:15600],NA,FBXO30,84085,NM_001348092;NM_032145
CHFR_TF,CHFR,CHFR_TF,CHFR,TF,223,-2.22488030991495,0.0429613889053862,0.0450263617247186,0.0361764782132941,-0.00884988351142453,0.0421262203372587,-0.893906476999448,6.10706705037474,6.11881704885052,6.06845991252574,-0.0503571363247736,0.48507325620369,ENSG00000072609,CHFR,protein_coding,12,-1,132822187,132956304,q24.33,checkpoint with forkhead and ring finger domains [Source:HGNC Symbol;Acc:HGNC:20455],NA,CHFR,55743,NM_001161344;NM_001161345;NM_001161346;NM_001161347;NM_018223
CACNA1C_SIG,CACNA1C,CACNA1C_SIG,CACNA1C,SIG,33,2.22447785418931,-0.0140415994487282,-0.0203245889387015,0.00660250887546952,0.0269270978141709,0.0421616593184532,-0.574706479434569,0.828552936601048,0.843247071919078,0.78027220627038,-0.0629748656486978,0.666086812703256,ENSG00000151067,CACNA1C,protein_coding,12,1,1970786,2697950,p13.33,calcium voltage-gated channel subunit alpha1 C [Source:HGNC Symbol;Acc:HGNC:1390],Brugada syndrome;BRUGADA SYNDROME 3;TIMOTHY SYNDROME,CACNA1C,775,NM_000719;NM_001129827;NM_001129829;NM_001129830;NM_001129831;NM_001129832;NM_001129833;NM_001129834;NM_001129835;NM_001129836;NM_001129837;NM_001129838;NM_001129839;NM_001129840;NM_001129841;NM_001129842;NM_001129843;NM_001129844;NM_001129846;NM_001167623;NM_001167624;NM_001167625;NM_199460
MYBL2_TF,MYBL2,MYBL2_TF,MYBL2,TF,206,-2.22438452407666,0.150450809034187,0.15739575280153,0.127631708084343,-0.0297640447171873,0.0421635710130089,-1.77322963200045,5.12634036368405,5.19515703825034,4.90022843296623,-0.294928605284106,0.144647617384202,ENSG00000101057,MYBL2,protein_coding,20,1,43667019,43716495,q13.12,MYB proto-oncogene like 2 [Source:HGNC Symbol;Acc:HGNC:7548],NA,MYBL2,4605,NM_001278610;NM_002466
IGF2BP3_SIG,IGF2BP3,IGF2BP3_SIG,IGF2BP3,SIG,29,2.22303910435023,0.0746259662723722,0.0693044998269883,0.0921107845929193,0.0228062847659312,0.042301530498375,1.38657653033172,2.72073575525415,2.67267926271295,2.87863565931811,0.205956396605154,0.261634604594594,ENSG00000136231,IGF2BP3,protein_coding,7,-1,23310209,23470491,p15.3,insulin like growth factor 2 mRNA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:28868],NA,IGF2BP3,10643,NM_006547
ZNF468_TF,ZNF468,ZNF468_TF,ZNF468,TF,37,2.22188712383329,0.234548679131719,0.231028835368631,0.246113880067578,0.0150850446989469,0.0424187721221557,1.12093465917036,3.97289867702498,3.9560080495667,4.02839645295931,0.0723884033926066,0.372358472384212,ENSG00000204604,ZNF468,protein_coding,19,-1,52838010,52890375,q13.41,zinc finger protein 468 [Source:HGNC Symbol;Acc:HGNC:33105],NA,ZNF468,90333;162967,NM_001008801;NM_001277120;NM_001351773;NM_207333
GRPR_SIG,GRPR,GRPR_SIG,GRPR,SIG,7,-2.22180024721425,0.331297663593629,0.337467535252607,0.311025228142703,-0.0264423071099043,0.0424199872407974,-1.31446423235779,0.278261587650803,0.284449764637518,0.257929006123025,-0.0265207585144933,0.289202291867266,ENSG00000126010,GRPR,protein_coding,X,1,16123556,16153021,p22.2,gastrin releasing peptide receptor [Source:HGNC Symbol;Acc:HGNC:4609],NA,GRPR,2925,NM_005314
SPP1_SIG,SPP1,SPP1_SIG,SPP1,SIG,25,-2.22114084663044,0.00740719083789381,0.0111736276910971,-0.00496824453691703,-0.0161418722280141,0.0424836852763031,-2.40250484764202,1.62050929248359,1.72583509970165,1.27443878305279,-0.451396316648861,0.0436608977778736,ENSG00000118785,SPP1,protein_coding,4,1,87975650,87983426,q22.1,secreted phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:11255],Pediatric systemic lupus erythematosus;Systemic lupus erythematosus,SPP1,6696,NM_000582;NM_001040058;NM_001040060;NM_001251829;NM_001251830
NRF1_TF,NRF1,NRF1_TF,NRF1,TF,88,-2.21957621813806,0.18081069739278,0.182714973949273,0.174553788707157,-0.00816118524211622,0.0426465426404755,-0.112907365747034,4.48330376983832,4.48433363065275,4.47991994144806,-0.00441368920468385,0.937480206795696,ENSG00000106459,NRF1,protein_coding,7,1,129611720,129757082,q32.2,nuclear respiratory factor 1 [Source:HGNC Symbol;Acc:HGNC:7996],NA,NRF1,4899,NM_001040110;NM_001293163;NM_001293164;NM_005011
POLR2F_SIG,POLR2F,POLR2F_SIG,POLR2F,SIG,16,2.21913805343649,0.247871637823078,0.242822039770317,0.264463174282149,0.0216411345118317,0.0426862640838138,1.04214842605414,4.30559279664079,4.29336991843399,4.34575368217743,0.0523837637434435,0.409900948834986,ENSG00000100142,POLR2F,protein_coding,22,1,37952607,38041915,q13.1,RNA polymerase II subunit F [Source:HGNC Symbol;Acc:HGNC:9193],NA,POLR2F,5435,NM_001301129;NM_001301130;NM_001301131;NM_021974
CHKA_SIG,CHKA,CHKA_SIG,CHKA,SIG,6,2.21859902435385,0.142303761937205,0.138751140207861,0.153976661905046,0.0152255216971849,0.0427370860866417,0.631336824730042,5.26473863344611,5.25418593639668,5.29941178089425,0.0452258444975727,0.631884698367052,ENSG00000110721,CHKA,protein_coding,11,-1,68052859,68121444,q13.2,choline kinase alpha [Source:HGNC Symbol;Acc:HGNC:1937],NA,CHKA,1119,NM_001277;NM_212469
ENPP3_SIG,ENPP3,ENPP3_SIG,ENPP3,SIG,19,-2.21664279686237,-0.140357796029045,-0.134660404443657,-0.159077796952464,-0.0244173925088069,0.0429439069057511,-0.870480978111677,0.993241440458582,1.01734025558122,0.914059619341336,-0.103280636239886,0.497603795751154,ENSG00000154269,ENPP3,protein_coding,6,1,131628442,131747418,q23.2,ectonucleotide pyrophosphatase/phosphodiesterase 3 [Source:HGNC Symbol;Acc:HGNC:3358],NA,ENPP3,5169,NM_005021
GNA13_SIG,GNA13,GNA13_SIG,GNA13,SIG,80,-2.21633084775371,0.432738265393049,0.44049506739992,0.407251630227617,-0.0332434371723033,0.0429699412012079,-1.59517511345209,7.59722839664379,7.62924916284098,7.49201730771018,-0.137231855130794,0.192011029361523,ENSG00000120063,GNA13,protein_coding,17,-1,65009289,65056740,q24.1,G protein subunit alpha 13 [Source:HGNC Symbol;Acc:HGNC:4381],NA,GNA13,10672,NM_001282425;NM_006572
PPIE_SIG,PPIE,PPIE_SIG,PPIE,SIG,4,2.21587266638922,0.386546930797167,0.382419761097124,0.400107631240165,0.0176878701430415,0.043012124411366,1.68117750022743,4.77017319007805,4.75055007651122,4.83464913465475,0.0840990581435239,0.168146692084975,ENSG00000084072,PPIE,protein_coding,1,1,39692182,39763914,p34.2,peptidylprolyl isomerase E [Source:HGNC Symbol;Acc:HGNC:9258],NA,PPIE,10450,NM_001195007;NM_001319293;NM_006112;NM_203456
HLA-DPB1_SIG,HLA-DPB1,HLA-DPB1_SIG,HLA-DPB1,SIG,46,-2.21467306496968,0.386720617141033,0.397247585935468,0.352132005387887,-0.0451155805475813,0.043136298527108,-1.64166037902593,7.33819317760731,7.41315142115721,7.09190180594337,-0.321249615213841,0.178879598183002,ENSG00000223865,HLA-DPB1,protein_coding,6,1,33075990,33089696,p21.32,major histocompatibility complex, class II, DP beta 1 [Source:HGNC Symbol;Acc:HGNC:4940],Chronic beryllium disease;Granulomatosis with polyangiitis,HLA-DPB1,3115,NM_002121
NR1D1_TF,NR1D1,NR1D1_TF,NR1D1,TF,29,-2.21433929118525,0.0376187987760463,0.0400080922117454,0.0297682632016065,-0.010239829010139,0.0431648462675886,1.03495777694484,2.95701205273696,2.93619847652423,3.02539951743593,0.0892010409116977,0.413290776322976,ENSG00000126368,NR1D1,protein_coding,17,-1,40092793,40100589,q21.1,nuclear receptor subfamily 1 group D member 1 [Source:HGNC Symbol;Acc:HGNC:7962],NA,NR1D1,9572,NM_021724
TRIM41_SIG,TRIM41,TRIM41_SIG,TRIM41,SIG,9,2.21415929320933,0.324364951484254,0.32207092447197,0.331902468810331,0.00983154433836117,0.0431763823525173,1.10002072223211,5.71468684659997,5.70447914182084,5.74822644801713,0.043747306196294,0.382529045565417,ENSG00000146063,TRIM41,protein_coding,5,1,181222499,181235808,q35.3,tripartite motif containing 41 [Source:HGNC Symbol;Acc:HGNC:19013],NA,TRIM41,90933,NM_033549;NM_201627
NUSAP1_SIG,NUSAP1,NUSAP1_SIG,NUSAP1,SIG,34,-2.21357798047463,0.287639069157679,0.311410149682296,0.209534090291078,-0.101876059391218,0.0432323814295688,-0.685645613351116,5.31692153641979,5.33802487226502,5.24758200435692,-0.0904428679080934,0.600159587016899,ENSG00000137804,NUSAP1,protein_coding,15,1,41332694,41381050,q15.1,nucleolar and spindle associated protein 1 [Source:HGNC Symbol;Acc:HGNC:18538],NA,NUSAP1,51203,NM_001243142;NM_001243143;NM_001243144;NM_001301136;NM_016359;NM_018454
AKAP8L_TF,AKAP8L,AKAP8L_TF,AKAP8L,TF,107,2.21289259329013,0.0127307267909643,0.00884289155807444,0.0255050425561739,0.0166621509980994,0.0432999905567207,1.00881591228416,6.87192029480549,6.86127525885706,6.90689684149321,0.0456215826361496,0.426271052554762,ENSG00000011243,AKAP8L,protein_coding,19,-1,15380050,15419141,p13.12,A-kinase anchoring protein 8 like [Source:HGNC Symbol;Acc:HGNC:29857],NA,AKAP8L,26993,NM_001291478;NM_014371
ZFAND1_TF,ZFAND1,ZFAND1_TF,ZFAND1,TF,352,2.21263038039703,0.387099593073992,0.383123002892867,0.400165532240544,0.0170425293476767,0.0433206844954167,0.960251242446045,5.5471307914153,5.53312575180181,5.59314735014532,0.0600215983435097,0.450731803092695,ENSG00000104231,ZFAND1,protein_coding,8,-1,81701334,81732903,q21.13,zinc finger AN1-type containing 1 [Source:HGNC Symbol;Acc:HGNC:25858],NA,ZFAND1,79752,NM_001170796;NM_001170797;NM_024699
TNFSF13B_SIG,TNFSF13B,TNFSF13B_SIG,TNFSF13B,SIG,42,-2.21133017406838,0.284070446708985,0.292495467710071,0.256388234848275,-0.0361072328617962,0.0434568058383925,-1.16241733111615,5.83621882605654,5.8729007416233,5.71569253205148,-0.157208209571827,0.353787972676637,ENSG00000102524,TNFSF13B,protein_coding,13,1,108251240,108308484,q33.3,TNF superfamily member 13b [Source:HGNC Symbol;Acc:HGNC:11929],NA,TNFSF13B,10673,NM_001145645;NM_006573
TAF1_SIG,TAF1,TAF1_SIG,TAF1,SIG,42,2.2111858314611,0.526007243340255,0.523015213324432,0.53583819910653,0.0128229857820974,0.0434644371562399,2.15492365523248,6.22421667098967,6.20163927061898,6.29839955792192,0.0967602873029332,0.0724332897226394,ENSG00000147133,TAF1,protein_coding,X,1,71366239,71532374,q13.1,TATA-box binding protein associated factor 1 [Source:HGNC Symbol;Acc:HGNC:11535],Dysmorphic Features Intellectual Disability and Neurological Manifestations;DYSTONIA 3 TORSION X-LINKED;Mental retardation X-linked syndromic 33;X-linked dystonia-parkinsonism;X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome,TAF1,6872,NM_001286074;NM_004606;NM_138923
ZNF682_TF,ZNF682,ZNF682_TF,ZNF682,TF,37,2.21105582797484,-0.00612839314346854,-0.0106717352056542,0.00879973077514158,0.0194714659807959,0.0434704740120323,2.07813215227649,1.93692872290637,1.88862558193981,2.09563904322509,0.207013461285287,0.08376052789123,ENSG00000197124,ZNF682,protein_coding,19,-1,19997058,20039505,p12,zinc finger protein 682 [Source:HGNC Symbol;Acc:HGNC:28857],NA,ZNF682,91120,NM_001077349;NM_033196
ACOT1_SIG,ACOT1,ACOT1_SIG,ACOT1,SIG,10,-2.21050251113404,0.0899959378984056,0.0919549340900048,0.083559236126008,-0.00839569796399674,0.0435236733598026,-0.41636888566823,0.891482330296591,0.896655761504229,0.874483913471494,-0.0221718480327342,0.759222716807666,ENSG00000184227,ACOT1,protein_coding,14,1,73537143,73543796,q24.3,acyl-CoA thioesterase 1 [Source:HGNC Symbol;Acc:HGNC:33128],NA,ACOT1,641371,NM_001037161
PRDM2_TF,PRDM2,PRDM2_TF,PRDM2,TF,24,2.21025021773637,0.386591670970746,0.382611505921703,0.399669356131887,0.017057850210184,0.043543351869086,3.47220795844022,7.17362738282103,7.10915796154377,7.38545548130346,0.276297519759696,0.00292008297507881,ENSG00000116731,PRDM2,protein_coding,1,1,13700198,13825079,p36.21,PR/SET domain 2 [Source:HGNC Symbol;Acc:HGNC:9347],NA,PRDM2,7799,NM_001007257;NM_001135610;NM_012231;NM_015866
FUCA1_SIG,FUCA1,FUCA1_SIG,FUCA1,SIG,8,-2.20990768644903,0.255399162029127,0.265206048591462,0.223176534752884,-0.0420295138385777,0.0435731047139545,-0.0911530037896816,3.94104704643095,3.943434526349,3.93320246955737,-0.0102320567916312,0.949149460605271,ENSG00000179163,FUCA1,protein_coding,1,-1,23845077,23868294,p36.11,alpha-L-fucosidase 1 [Source:HGNC Symbol;Acc:HGNC:4006],FUCOSIDOSIS,FUCA1,2517,NM_000147
IFIT1B_SIG,IFIT1B,IFIT1B_SIG,IFIT1B,SIG,13,-2.20959252288081,0.0701122473046413,0.0956372032407612,-0.0137554650568956,-0.109392668297657,0.0435998200625954,-1.8578331728284,0.770410973918263,0.830777065942654,0.572065242980981,-0.258711822961673,0.125211899152994,ENSG00000204010,IFIT1B,protein_coding,10,1,89378056,89385205,q23.31,interferon induced protein with tetratricopeptide repeats 1B [Source:HGNC Symbol;Acc:HGNC:23442],NA,IFIT1B,439996,NM_001010987
CXXC1_SIG,CXXC1,CXXC1_SIG,CXXC1,SIG,9,2.20938339040877,0.0469161909150523,0.0425285633863878,0.0613326813663788,0.018804117979991,0.0436147097954427,1.0978550365794,6.38563875856486,6.37444980272678,6.42240247060426,0.0479526678774765,0.383340297326502,ENSG00000154832,CXXC1,protein_coding,18,-1,50282343,50288304,q21.1,CXXC finger protein 1 [Source:HGNC Symbol;Acc:HGNC:24343],NA,CXXC1,30827,NM_001101654;NM_014593
PTPN4_SIG,PTPN4,PTPN4_SIG,PTPN4,SIG,131,2.20912913349144,0.096285438076829,0.0920568346908387,0.110179420630797,0.0181225859399584,0.0436346442836129,2.30178102474188,4.39443134512943,4.34907972448678,4.5434438129553,0.194364088468517,0.053750100273372,ENSG00000088179,PTPN4,protein_coding,2,1,119759922,119984899,q14.2,protein tyrosine phosphatase, non-receptor type 4 [Source:HGNC Symbol;Acc:HGNC:9656],NA,PTPN4,5775,NM_002830
GH1_SIG,GH1,GH1_SIG,GH1,SIG,39,2.20802071564172,0.00258017025759096,-0.00248114909063942,0.0192102195446336,0.021691368635273,0.0437501142314187,1.04073836318078,0.248969862396277,0.241396719210339,0.273853047150074,0.0324563279397349,0.41057962805665,ENSG00000259384,GH1,protein_coding,17,-1,63917200,63918839,q23.3,growth hormone 1 [Source:HGNC Symbol;Acc:HGNC:4261],Isolated growth hormone deficiency type IA;ISOLATED GROWTH HORMONE DEFICIENCY TYPE IA;ISOLATED GROWTH HORMONE DEFICIENCY TYPE IB;Isolated growth hormone deficiency type II;ISOLATED GROWTH HORMONE DEFICIENCY TYPE II;KOWARSKI SYNDROME;Short stature due to growth hormone qualitative anomaly,GH1,2688,NM_000515;NM_022559;NM_022560
SLC22A5_SIG,SLC22A5,SLC22A5_SIG,SLC22A5,SIG,37,2.20645133057242,-0.0648046038647678,-0.067901529369257,-0.0546289914928747,0.0132725378763823,0.0439175878087531,0.630410427381207,2.93434455986273,2.91796289391711,2.98817003368408,0.0702071397669711,0.632221593307223,ENSG00000197375,SLC22A5,protein_coding,5,1,132369752,132395614,q31.1,solute carrier family 22 member 5 [Source:HGNC Symbol;Acc:HGNC:10969],CARNITINE DEFICIENCY SYSTEMIC PRIMARY;Systemic primary carnitine deficiency,SLC22A5,6584,NM_001308122;NM_003060
RNASET2_SIG,RNASET2,RNASET2_SIG,RNASET2,SIG,6,-2.2063078100685,0.205137509691098,0.210301455494359,0.18817025919467,-0.0221311962996886,0.0439251964713343,-1.9351790647983,6.52989609881512,6.56726332639921,6.40711806532454,-0.160145261074672,0.10928932006902,ENSG00000026297,RNASET2,protein_coding,6,-1,166929504,166957191,q27,ribonuclease T2 [Source:HGNC Symbol;Acc:HGNC:21686],Cystic leukoencephalopathy without megalencephaly;LEUKOENCEPHALOPATHY CYSTIC WITHOUT MEGALENCEPHALY,RNASET2,8635,NM_003730
MERTK_SIG,MERTK,MERTK_SIG,MERTK,SIG,14,-2.2062063668619,0.195123402284029,0.197526832861102,0.187226416102218,-0.0103004167588839,0.0439280806586146,-1.42454129859385,3.96874641595569,4.01390165777048,3.82037919284993,-0.193522464920552,0.247455372709739,ENSG00000153208,MERTK,protein_coding,2,1,111898479,112029561,q13,MER proto-oncogene, tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:7027],Retinitis pigmentosa;RETINITIS PIGMENTOSA 38,MERTK,10461,NM_006343
UBE2I_SIG,UBE2I,UBE2I_SIG,UBE2I,SIG,5,2.20529028167714,0.456082488009656,0.454463056377639,0.461403477657712,0.00694042128007282,0.0440225574940152,1.15443805731618,7.14468149998982,7.13709997759774,7.16959221642095,0.0324922388232041,0.35740202933195,ENSG00000103275,UBE2I,protein_coding,16,1,1308880,1327018,p13.3,ubiquitin conjugating enzyme E2 I [Source:HGNC Symbol;Acc:HGNC:12485],NA,UBE2I,7329,NM_003345;NM_194259;NM_194260;NM_194261
S100A4_SIG,S100A4,S100A4_SIG,S100A4,SIG,32,-2.2027360541121,0.384312996901232,0.391902792567869,0.359375096853711,-0.0325276957141576,0.0443022205820332,-1.2579296774404,7.50272582320987,7.53879177139451,7.38422342203176,-0.154568349362751,0.311983702159903,ENSG00000196154,S100A4,protein_coding,1,-1,153543613,153550136,q21.3,S100 calcium binding protein A4 [Source:HGNC Symbol;Acc:HGNC:10494],NA,S100A4,6275,NM_002961;NM_019554
NFYC_TF,NFYC,NFYC_TF,NFYC,TF,103,-2.20115650792266,0.170602127318612,0.176323904425005,0.151802002540465,-0.0245219018845395,0.0444726385272145,-2.10785375414393,5.62898120564678,5.65312966152951,5.54963627917494,-0.103493382354578,0.0791975893848607,ENSG00000066136,NFYC,protein_coding,1,1,40691648,40771603,p34.2,nuclear transcription factor Y subunit gamma [Source:HGNC Symbol;Acc:HGNC:7806],NA,NFYC,4802,NM_001142587;NM_001142588;NM_001142589;NM_001142590;NM_001308114;NM_001308115;NM_014223
UTP18_SIG,UTP18,UTP18_SIG,UTP18,SIG,21,2.19988023214359,0.202513793893148,0.198364075357417,0.216148583367692,0.0177845080102751,0.0446090855202217,1.10278119358003,4.87764162903518,4.86480879395842,4.91980665857311,0.054997864614693,0.381141835849307,ENSG00000011260,UTP18,protein_coding,17,1,51260546,51297936,q21.33,UTP18, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:24274],NA,UTP18,51096,NM_016001
PARL_SIG,PARL,PARL_SIG,PARL,SIG,31,2.19941808217867,0.170108584786638,0.165387354705808,0.185621197909367,0.0202338432035589,0.0446530682741614,2.74149297885755,5.50271192636766,5.47020234356578,5.60952912700241,0.139326783436632,0.0203042036938463,ENSG00000175193,PARL,protein_coding,3,-1,183829271,183884933,q27.1,presenilin associated rhomboid like [Source:HGNC Symbol;Acc:HGNC:18253],NA,PARL,55486,NM_001037639;NM_001324436;NM_001324437;NM_001324438;NM_018622
NSUN5_SIG,NSUN5,NSUN5_SIG,NSUN5,SIG,47,-2.19860946118007,0.121817044534201,0.12686165718284,0.105241888688671,-0.0216197684941696,0.0447366011526656,-0.942716379841335,4.52960726718143,4.54441353193593,4.48095811155952,-0.0634554203764129,0.459485001089151,ENSG00000130305,NSUN5,protein_coding,7,-1,73302517,73308867,q11.23,NOP2/Sun RNA methyltransferase family member 5 [Source:HGNC Symbol;Acc:HGNC:16385],NA,NSUN5,55695,NM_001168347;NM_001168348;NM_018044;NM_148956
COX6B1_SIG,COX6B1,COX6B1_SIG,COX6B1,SIG,29,-2.19766793113465,0.0976374854341292,0.100329408419116,0.0887925956263149,-0.0115368127928013,0.0448354554744442,-2.29983990825281,6.42150524807193,6.44399403047236,6.34761353447052,-0.0963804960018439,0.0539550944098316,ENSG00000126267,COX6B1,protein_coding,19,1,35648223,35658861,q13.12,cytochrome c oxidase subunit 6B1 [Source:HGNC Symbol;Acc:HGNC:2280],Isolated cytochrome C oxidase deficiency;MITOCHONDRIAL COMPLEX IV DEFICIENCY,COX6B1,1340,NM_001863
PODXL2_SIG,PODXL2,PODXL2_SIG,PODXL2,SIG,54,-2.19713073287328,-0.105422810691224,-0.103102383676246,-0.113047070883295,-0.00994468720704942,0.0448882113753754,0.165153676552042,2.44950663005381,2.44352226704795,2.46916953707308,0.0256472700251253,0.907460758160687,ENSG00000114631,PODXL2,protein_coding,3,1,127629185,127672802,q21.3,podocalyxin like 2 [Source:HGNC Symbol;Acc:HGNC:17936],NA,PODXL2,50512,NM_015720
NR4A2_SIG,NR4A2,NR4A2_SIG,NR4A2,SIG,33,-2.1967770812556,0.291627678095397,0.299492409206088,0.265786418731698,-0.0337059904743901,0.0449200021258223,-1.5234981682641,5.9316739661651,6.00044926391357,5.70569798784868,-0.294751276064892,0.214211829722621,ENSG00000153234,NR4A2,protein_coding,2,-1,156324437,156342348,q24.1,nuclear receptor subfamily 4 group A member 2 [Source:HGNC Symbol;Acc:HGNC:7981],Parkinson disease late-onset,NR4A2,4929,NM_006186
USF2_TF,USF2,USF2_TF,USF2,TF,129,-2.19626697117137,-0.0416988388874909,-0.0385653422831489,-0.0519946134446146,-0.0134292711614658,0.0449587517563431,-1.85753784400291,7.40803843702022,7.42404654652869,7.35544036292097,-0.0686061836077182,0.125257195770004,ENSG00000105698,USF2,protein_coding,19,1,35268962,35279821,q13.12,upstream transcription factor 2, c-fos interacting [Source:HGNC Symbol;Acc:HGNC:12594],NA,USF2,7392,NM_001321150;NM_003367;NM_207291
MGAT2_SIG,MGAT2,MGAT2_SIG,MGAT2,SIG,77,2.19623728542811,0.286301029363522,0.27944631016874,0.308823678146375,0.0293773679776347,0.0449587517563431,1.81163628843239,5.44394821435336,5.40503076182161,5.57181984410056,0.166789082278947,0.135521359621601,ENSG00000168282,MGAT2,protein_coding,14,1,49620795,49623481,q21.3,mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7045],CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2A;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIa;MGAT2-CDG,MGAT2,4247,NM_002408
SF3A3_SIG,SF3A3,SF3A3_SIG,SF3A3,SIG,4,2.19621112537839,0.707467946560767,0.700268907361943,0.73112193249976,0.0308530251378173,0.0449587517563431,2.14460828709634,6.76681091520593,6.74395147407469,6.8419205074943,0.0979690334196058,0.0738770809674359,ENSG00000183431,SF3A3,protein_coding,1,-1,37956975,37990075,p34.3,splicing factor 3a subunit 3 [Source:HGNC Symbol;Acc:HGNC:10767],NA,SF3A3,10946,NM_001320830;NM_006802
TAF4B_TF,TAF4B,TAF4B_TF,TAF4B,TF,132,2.19593431047816,0.106249586739793,0.102026149402122,0.120126595134998,0.0181004457328763,0.0449817793151691,0.64302295157126,3.87660598693599,3.86319370151964,3.92067492473257,0.0574812232129322,0.625198277400663,ENSG00000141384,TAF4B,protein_coding,18,1,26225936,26391685,q11.2,TATA-box binding protein associated factor 4b [Source:HGNC Symbol;Acc:HGNC:11538],Male infertility with azoospermia or oligozoospermia due to single gene mutation;Spermatogenic failure 13,TAF4B,6875,NM_001293725;NM_005640
SLC25A51_SIG,SLC25A51,SLC25A51_SIG,SLC25A51,SIG,32,-2.19547979728407,-0.0377141995864173,-0.0354852978421347,-0.04503773388906,-0.00955243604692526,0.0450251951174153,0.533947779101935,3.47809960415701,3.47207748905578,3.49788655377534,0.0258090647195614,0.689827210215844,ENSG00000122696,SLC25A51,protein_coding,9,-1,37879400,37904353,p13.1,solute carrier family 25 member 51 [Source:HGNC Symbol;Acc:HGNC:23323],NA,SLC25A51,92014,NM_033412
MRPS7_SIG,MRPS7,MRPS7_SIG,MRPS7,SIG,23,2.1945402414816,0.163571653851773,0.157350568564688,0.184012362652192,0.026661794087504,0.045124354542104,3.10076391149414,4.61420008639999,4.57659367274879,4.7377640169682,0.161170344219418,0.00828580108857329,ENSG00000125445,MRPS7,protein_coding,17,1,75261674,75266376,q25.1,mitochondrial ribosomal protein S7 [Source:HGNC Symbol;Acc:HGNC:14499],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34;Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,MRPS7,51081,NM_015971
ELAVL1_SIG,ELAVL1,ELAVL1_SIG,ELAVL1,SIG,83,2.19372172331627,0.617697716380402,0.607630304677212,0.650776354833738,0.0431460501565256,0.0451990432119031,1.97051023264406,5.98607835509025,5.95628873864801,6.08395852340045,0.127669784752444,0.102501574440803,ENSG00000066044,ELAVL1,protein_coding,19,-1,7958573,8005659,p13.2,ELAV like RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:3312],NA,ELAVL1,1994,NM_001419
SERPINE2_SIG,SERPINE2,SERPINE2_SIG,SERPINE2,SIG,44,-2.19366982976672,-0.13190844384797,-0.12836633537647,-0.143546800254329,-0.0151804648778589,0.0451990432119031,-0.227305649172311,2.13757204203733,2.14667108972096,2.10767517107684,-0.0389959186441174,0.871555047426515,ENSG00000135919,SERPINE2,protein_coding,2,-1,223975045,224039318,q36.1,serpin family E member 2 [Source:HGNC Symbol;Acc:HGNC:8951],NA,SERPINE2,5270,NM_001136528;NM_001136530;NM_006216
STK31_SIG,STK31,STK31_SIG,STK31,SIG,43,-2.19366320198717,-0.0964460003837122,-0.093944571594933,-0.104664980689701,-0.0107204090947681,0.0451990432119031,-0.718577234191526,0.323620334369287,0.329616616697342,0.303918263862821,-0.0256983528345212,0.581137243600943,ENSG00000196335,STK31,protein_coding,7,1,23710203,23832513,p15.3,serine/threonine kinase 31 [Source:HGNC Symbol;Acc:HGNC:11407],NA,STK31,56164,NM_001260504;NM_001260505;NM_031414;NM_032944
IREB2_SIG,IREB2,IREB2_SIG,IREB2,SIG,34,2.19334512440692,0.485967903371248,0.482925374987925,0.495964782345024,0.0130394073570989,0.0452269255826622,1.02391119235615,6.67351021199667,6.6605906865164,6.71596008143186,0.0553693949154576,0.418809170052307,ENSG00000136381,IREB2,protein_coding,15,1,78437431,78501453,q25.1,iron responsive element binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6115],NA,IREB2,3658,NM_001320941;NM_001320942;NM_001320943;NM_001354994;NM_004136
ULK2_SIG,ULK2,ULK2_SIG,ULK2,SIG,25,-2.19323419854898,0.152673888713556,0.158528111253816,0.133438586081272,-0.0250895251725438,0.045230967474656,-2.11989573242584,3.99150093132714,4.0551313110067,3.78242968380859,-0.272701627198105,0.0774086796121814,ENSG00000083290,ULK2,protein_coding,17,-1,19770829,19867936,p11.2,unc-51 like autophagy activating kinase 2 [Source:HGNC Symbol;Acc:HGNC:13480],NA,ULK2,9706,NM_001142610;NM_014683
STYK1_SIG,STYK1,STYK1_SIG,STYK1,SIG,46,2.19027941666449,0.0738244484710496,0.0686870125192986,0.0907045951696599,0.0220175826503613,0.0455634696816255,-0.519095575581095,1.46197729413239,1.47672705105498,1.41351380710101,-0.0632132439539639,0.698584343256436,ENSG00000060140,STYK1,protein_coding,12,-1,10618923,10674318,p13.2,serine/threonine/tyrosine kinase 1 [Source:HGNC Symbol;Acc:HGNC:18889],NA,STYK1,55359,NM_018423
PLCD4_SIG,PLCD4,PLCD4_SIG,PLCD4,SIG,33,2.18985722211593,-0.00265427549470698,-0.00619523829828351,0.00898031657418734,0.0151755548724709,0.0456036081942423,1.28212862770771,0.577587275110035,0.562031812907151,0.628698079490942,0.0666662665837914,0.302227508995347,ENSG00000115556,PLCD4,protein_coding,2,1,218607855,218637184,q35,phospholipase C delta 4 [Source:HGNC Symbol;Acc:HGNC:9062],NA,PLCD4,84812,NM_032726
PI4KB_SIG,PI4KB,PI4KB_SIG,PI4KB,SIG,20,2.18825237216384,0.271198435808035,0.270066165851263,0.274918751380285,0.00485258552902222,0.0457811748865491,0.438037940806511,6.73833006018625,6.73552944604795,6.74753207806923,0.0120026320212849,0.745812575284112,ENSG00000143393,PI4KB,protein_coding,1,-1,151291797,151327715,q21.3,phosphatidylinositol 4-kinase beta [Source:HGNC Symbol;Acc:HGNC:8984],NA,PI4KB,5298,NM_001198773;NM_001198774;NM_001198775;NM_001330721;NM_002651
CPD_SIG,CPD,CPD_SIG,CPD,SIG,52,2.18792084828021,0.119764082640504,0.114467324020438,0.137167718106435,0.0227003940859975,0.0458109192150264,2.94479830424516,7.638357079858,7.57099911235963,7.85967611592408,0.288677003564442,0.0124055823509364,ENSG00000108582,CPD,protein_coding,17,1,30378927,30469989,q11.2,carboxypeptidase D [Source:HGNC Symbol;Acc:HGNC:2301],NA,CPD,1362,NM_001199775;NM_001304
NR2F6_SIG,NR2F6,NR2F6_SIG,NR2F6,SIG,17,2.18778056026866,0.0200095539173426,0.0155091127390213,0.03479671778897,0.0192876050499486,0.0458184148625519,0.394159577070213,2.99612282611772,2.98815086135267,3.02231642463143,0.0341655632787639,0.771877941751638,ENSG00000160113,NR2F6,protein_coding,19,-1,17231883,17245940,p13.11,nuclear receptor subfamily 2 group F member 6 [Source:HGNC Symbol;Acc:HGNC:7977],NA,NR2F6,2063,NM_005234
PARG_SIG,PARG,PARG_SIG,PARG,SIG,95,2.18706980987438,0.418346104768128,0.40929594437262,0.448082346067656,0.0387864016950363,0.0458923655214669,1.97306840899786,3.12576558134974,3.08958447440101,3.24464636132414,0.155061886923122,0.102019087761208,ENSG00000227345,PARG,protein_coding,10,-1,49818279,49970203,q11.23,poly(ADP-ribose) glycohydrolase [Source:HGNC Symbol;Acc:HGNC:8605],NA,PARG,8505,NM_001303486;NM_001303487;NM_001303489;NM_001324381;NM_003631
CD63_SIG,CD63,CD63_SIG,CD63,SIG,38,-2.18678916427142,0.257725338601675,0.261928425197954,0.243915196928187,-0.0180132282697667,0.0459162377646944,-3.00641339608797,8.04323647886098,8.09290043418706,7.88005491136099,-0.212845522826068,0.0105688829431351,ENSG00000135404,CD63,protein_coding,12,-1,55725323,55729707,q13.2,CD63 molecule [Source:HGNC Symbol;Acc:HGNC:1692],NA,CD63,967,NM_001257389;NM_001257390;NM_001257391;NM_001257392;NM_001257400;NM_001257401;NM_001267698;NM_001780
TLR6_SIG,TLR6,TLR6_SIG,TLR6,SIG,22,-2.18637325032712,0.380162967107093,0.384406760388634,0.366219074896312,-0.0181876854923221,0.0459559036816808,-0.204161694461746,4.05291469279448,4.05865422283384,4.03405623695087,-0.0245979858829683,0.884651989877404,ENSG00000174130,TLR6,protein_coding,4,-1,38823715,38856817,p14,toll like receptor 6 [Source:HGNC Symbol;Acc:HGNC:16711],NA,TLR6,10333,NM_006068
MAPK8IP2_SIG,MAPK8IP2,MAPK8IP2_SIG,MAPK8IP2,SIG,43,2.18347384906618,-0.0344987553489145,-0.0365725669210048,-0.0276848030406175,0.00888776388038724,0.0462864048641954,0.447627578115716,0.571172546539245,0.567289462053213,0.583931252707634,0.0166417906544209,0.740331336336844,ENSG00000008735,MAPK8IP2,protein_coding,22,1,50600793,50613981,q13.33,mitogen-activated protein kinase 8 interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:6883],NA,MAPK8IP2,23542,NM_012324
LYL1_TF,LYL1,LYL1_TF,LYL1,TF,73,2.18336441620113,0.182259141091454,0.176328146641277,0.201746694284893,0.0254185476436164,0.0462903379154628,0.394610971327516,6.01528162085415,6.00687952094796,6.04288852054593,0.036008999597975,0.771657493344204,ENSG00000104903,LYL1,protein_coding,19,-1,13099033,13103161,p13.13,LYL1, basic helix-loop-helix family member [Source:HGNC Symbol;Acc:HGNC:6734],NA,LYL1,4066,NM_005583
SERPINH1_SIG,SERPINH1,SERPINH1_SIG,SERPINH1,SIG,28,2.18320911257919,-0.0915765169206836,-0.095529521863401,-0.0785880721088976,0.0169414497545035,0.046299659154233,1.46729270576338,3.58530131937491,3.53407563173549,3.7536142930473,0.219538661311805,0.232881178379189,ENSG00000149257,SERPINH1,protein_coding,11,1,75562056,75572783,q13.5,serpin family H member 1 [Source:HGNC Symbol;Acc:HGNC:1546],Osteogenesis imperfecta type 3;OSTEOGENESIS IMPERFECTA TYPE X;PRETERM PREMATURE RUPTURE OF THE MEMBRANES,SERPINH1,871,NM_001207014;NM_001235
GATA1_TF,GATA1,GATA1_TF,GATA1,TF,394,-2.18247955172442,-0.0451421201631053,-0.0408703344423065,-0.0591779875314444,-0.0183076530891379,0.0463764739343254,-1.63402002893952,2.47057551456299,2.54742816391273,2.21805966669957,-0.329368497213154,0.181036462526909,ENSG00000102145,GATA1,protein_coding,X,1,48786554,48794311,p11.23,GATA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4170],Acute basophilic leukemia;Acute megakaryoblastic leukemia in Down syndrome;ANEMIA X-LINKED WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;Beta-thalassemia-X-linked thrombocytopenia syndrome;Blackfan-Diamond anemia;Congenital erythropoietic porphyria;DOWN SYNDROME;THROMBOCYTOPENIA WITH BETA-THALASSEMIA X-LINKED;Thrombocytopenia with congenital dyserythropoietic anemia;THROMBOCYTOPENIA X-LINKED WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;Transient myeloproliferative syndrome;X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,GATA1,2623,NM_002049
CXCL6_SIG,CXCL6,CXCL6_SIG,CXCL6,SIG,34,-2.18215282265868,0.0931268488547615,0.0996775018323275,0.0716032747856163,-0.0280742270467111,0.0464059767824015,-1.22811993588517,0.41304670193262,0.428195019310569,0.363273659119357,-0.0649213601912123,0.324534120906561,ENSG00000124875,CXCL6,protein_coding,4,1,73836640,73849064,q13.3,C-X-C motif chemokine ligand 6 [Source:HGNC Symbol;Acc:HGNC:10643],NA,CXCL6,6372,NM_002993
ZNF460_TF,ZNF460,ZNF460_TF,ZNF460,TF,89,2.18148988220672,0.175799096861996,0.170853746532635,0.192048105087039,0.0211943585544047,0.0464750901902835,2.34714703746617,3.96486270261606,3.91898466253922,4.11560483429711,0.196620171757882,0.0490603583002443,ENSG00000197714,ZNF460,protein_coding,19,1,57280051,57294069,q13.43,zinc finger protein 460 [Source:HGNC Symbol;Acc:HGNC:21628],NA,ZNF460,10794,NM_001330622;NM_006635
NHLH1_TF,NHLH1,NHLH1_TF,NHLH1,TF,158,-2.18085300246535,-0.198265835149355,-0.195862995568158,-0.206160879487572,-0.0102978839194143,0.0465412159546939,-2.33434731558131,0.476293849438161,0.495155957719747,0.414318350798665,-0.0808376069210816,0.050431884458979,ENSG00000171786,NHLH1,protein_coding,1,1,160367071,160372846,q23.2,nescient helix-loop-helix 1 [Source:HGNC Symbol;Acc:HGNC:7817],NA,NHLH1,4807,NM_005598
NPEPPS_SIG,NPEPPS,NPEPPS_SIG,NPEPPS,SIG,28,2.18063207987856,0.451003029547374,0.447246025034853,0.46334747294566,0.0161014479108077,0.0465527901327718,1.19680290547702,6.50868564497884,6.49620103680164,6.54970650041824,0.053505463616598,0.338420800285797,ENSG00000141279,NPEPPS,protein_coding,17,1,47522942,47623276,q21.32,aminopeptidase puromycin sensitive [Source:HGNC Symbol;Acc:HGNC:7900],NA,NPEPPS,9520,NM_001330257;NM_006310
DDX60_SIG,DDX60,DDX60_SIG,DDX60,SIG,31,-2.1806030562901,0.305500909476886,0.311255334928996,0.286593511562809,-0.0246618233661864,0.0465527901327718,-2.48362837576735,4.27249987695128,4.33680670239996,4.06120602190562,-0.27560068049434,0.0365896875396824,ENSG00000137628,DDX60,protein_coding,4,-1,168216294,168318804,q32.3,DExD/H-box helicase 60 [Source:HGNC Symbol;Acc:HGNC:25942],NA,DDX60,55601,NM_017631
EIF3D_SIG,EIF3D,EIF3D_SIG,EIF3D,SIG,27,2.18040736620798,0.669908584963565,0.66477645542587,0.686771296301704,0.0219948408758336,0.0465669236964807,1.01678659892078,8.13666497639534,8.12489389476037,8.17534138748171,0.0504474927213446,0.422117954032478,ENSG00000100353,EIF3D,protein_coding,22,-1,36510855,36529184,q12.3,eukaryotic translation initiation factor 3 subunit D [Source:HGNC Symbol;Acc:HGNC:3278],NA,EIF3D,8664,NM_003753
WDR43_SIG,WDR43,WDR43_SIG,WDR43,SIG,44,2.17948120748452,0.461784596075269,0.457472859848074,0.475951729393195,0.0184788695451214,0.0466673440652813,2.66241096170163,6.08265028996173,6.04548512267242,6.20476441105519,0.159279288382772,0.024401116596218,ENSG00000163811,WDR43,protein_coding,2,1,28894667,28948219,p23.2,WD repeat domain 43 [Source:HGNC Symbol;Acc:HGNC:28945],NA,WDR43,23160,NM_015131
USP25_SIG,USP25,USP25_SIG,USP25,SIG,24,-2.17906755885248,0.401795449200565,0.404430042099822,0.393138929674437,-0.0112911124253848,0.0467063602040302,-1.46419112586805,6.21158367929136,6.22899018500613,6.15439087479996,-0.0745993102061693,0.234003807262003,ENSG00000155313,USP25,protein_coding,21,1,15730025,15880069,q21.1,ubiquitin specific peptidase 25 [Source:HGNC Symbol;Acc:HGNC:12624],NA,USP25,29761,NM_001283041;NM_001283042;NM_001352560;NM_001352561;NM_013396
ADSL_SIG,ADSL,ADSL_SIG,ADSL,SIG,27,2.17899947849501,0.390117299600627,0.383759975143244,0.411005651389174,0.0272456762459306,0.0467063602040302,1.61008686879176,5.76079698179055,5.73984969702717,5.82962377458454,0.0897740775573723,0.187739151940576,ENSG00000239900,ADSL,protein_coding,22,1,40346500,40390463,q13.1,adenylosuccinate lyase [Source:HGNC Symbol;Acc:HGNC:291],Adenylosuccinase deficiency;Adenylosuccinate lyase deficiency,ADSL,158,NM_000026;NM_001123378;NM_001317923;NM_001363840
AATF_TF,AATF,AATF_TF,AATF,TF,130,2.17845952382064,0.210887293715328,0.207625904237032,0.221603287715443,0.0139773834784108,0.0467612827195071,0.845168937717595,6.2256013235177,6.21744189912231,6.25241086081684,0.0349689616945294,0.51101947085249,ENSG00000275700,AATF,protein_coding,17,1,36948954,37056871,q12,apoptosis antagonizing transcription factor [Source:HGNC Symbol;Acc:HGNC:19235],NA,AATF,26574,NM_012138
MLLT6_SIG,MLLT6,MLLT6_SIG,MLLT6,SIG,75,2.17734853844399,0.0602115172172552,0.0559702706065943,0.074147041795141,0.0181767711885467,0.0468839828454398,1.57329289440892,7.81213634446434,7.78292664416763,7.90811107401067,0.125184429843038,0.198640358319399,ENSG00000275023,MLLT6,protein_coding,17,1,38705542,38729803,q12,MLLT6, PHD finger containing [Source:HGNC Symbol;Acc:HGNC:7138],NA,MLLT6,4302,NM_005937
PGM3_SIG,PGM3,PGM3_SIG,PGM3,SIG,15,2.17674814650927,0.0528948830568641,0.0506030384974928,0.0604252294662267,0.00982219096873375,0.0469462599864823,2.26877393002107,3.71155309462827,3.67555427637405,3.82983492603498,0.154280649660931,0.0576235824222748,ENSG00000013375,PGM3,protein_coding,6,-1,83161150,83193936,q14.1,phosphoglucomutase 3 [Source:HGNC Symbol;Acc:HGNC:8907],IMMUNODEFICIENCY 23;PGM3-CDG,PGM3,5238,NM_001199917;NM_001199918;NM_001199919;NM_001367287;NM_015599
UBE2O_SIG,UBE2O,UBE2O_SIG,UBE2O,SIG,21,2.17544212783187,0.397048827998994,0.391911353643061,0.413929100882774,0.0220177472397134,0.0470925962710668,2.66716088873,5.35110647827645,5.31291620416614,5.47658880749606,0.163672603329919,0.0241487045587815,ENSG00000175931,UBE2O,protein_coding,17,-1,76389456,76453152,q25.1,ubiquitin conjugating enzyme E2 O [Source:HGNC Symbol;Acc:HGNC:29554],NA,UBE2O,63893,NM_022066
MNT_TF,MNT,MNT_TF,MNT,TF,88,-2.17518834164029,0.100210914511817,0.102399380864862,0.0930202393518084,-0.00937914151305391,0.0471080638482324,-0.239448017291204,5.81279198592071,5.81574500493881,5.80308920914696,-0.0126557957918481,0.864271344792365,ENSG00000070444,MNT,protein_coding,17,-1,2384073,2401104,p13.3,MAX network transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:7188],NA,MNT,4335,NM_020310
NELFE_SIG,NELFE,NELFE_SIG,NELFE,SIG,10,2.17516046741793,0.329081450992183,0.326729544280538,0.336809144473301,0.0100796001927624,0.0471080638482324,-0.805230602551259,5.8481267943502,5.85397170372424,5.82892209212122,-0.0250496116030215,0.532226488261328,ENSG00000204356,NELFE,protein_coding,6,-1,31952087,31959038,p21.33,negative elongation factor complex member E [Source:HGNC Symbol;Acc:HGNC:13974],NA,NELFE,7936,NM_002904
TOPORS_SIG,TOPORS,TOPORS_SIG,TOPORS,SIG,58,2.17461046124368,0.298285349443595,0.292257966977995,0.31808960611628,0.0258316391382848,0.0471645804099941,2.45379233090113,5.79791653780804,5.74991844608642,5.9556245534648,0.205706107378382,0.0390398612237379,ENSG00000197579,TOPORS,protein_coding,9,-1,32540544,32552586,p21.1,TOP1 binding arginine/serine rich protein [Source:HGNC Symbol;Acc:HGNC:21653],Retinitis pigmentosa;RETINITIS PIGMENTOSA 31,TOPORS,10210,NM_001195622;NM_005802
PDPK1_SIG,PDPK1,PDPK1_SIG,PDPK1,SIG,40,-2.17448998369177,0.221193624846267,0.224395264440564,0.210673951893574,-0.0137213125469895,0.0471698975757203,-1.02690914729565,6.11201694531877,6.12472761524281,6.07025331556835,-0.0544742996744584,0.417473861506371,ENSG00000140992,PDPK1,protein_coding,16,1,2537979,2603188,p13.3,3-phosphoinositide dependent protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:8816],NA,PDPK1,5170,NM_001261816;NM_002613;NM_031268
FOXM1_TF,FOXM1,FOXM1_TF,FOXM1,TF,274,-2.17419319307675,0.165307715882689,0.177413848011261,0.125530424603095,-0.0518834234081661,0.0471962517892571,-1.64033218693837,4.65045444775912,4.71190591123685,4.44854249633229,-0.263363414904564,0.179299789796793,ENSG00000111206,FOXM1,protein_coding,12,-1,2857681,2877155,p13.33,forkhead box M1 [Source:HGNC Symbol;Acc:HGNC:3818],NA,FOXM1,2305,NM_001243088;NM_001243089;NM_021953;NM_202002;NM_202003
SUCLA2_SIG,SUCLA2,SUCLA2_SIG,SUCLA2,SIG,42,2.17348245599545,0.634431607281572,0.626607700596232,0.660138729247692,0.0335310286514602,0.0472720594226743,2.32843356411019,4.37666499688644,4.34062354156326,4.49508692151975,0.154463379956493,0.0509582932811063,ENSG00000136143,SUCLA2,protein_coding,13,-1,47745736,48037968,q14.2,succinate-CoA ligase ADP-forming beta subunit [Source:HGNC Symbol;Acc:HGNC:11448],Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria);Mitochondrial DNA depletion syndrome encephalomyopathic form with methylmalonic aciduria,SUCLA2,8803,NM_003850
AKAP1_SIG,AKAP1,AKAP1_SIG,AKAP1,SIG,41,2.17334773023199,0.354345085580602,0.344216356144254,0.387625196585745,0.0434088404414907,0.0472777800875616,1.56269633306746,4.82277470105982,4.78868743010232,4.9347757342059,0.146088304103586,0.201735303218285,ENSG00000121057,AKAP1,protein_coding,17,1,57085092,57121346,q22,A-kinase anchoring protein 1 [Source:HGNC Symbol;Acc:HGNC:367],NA,AKAP1,8165,NM_001242902;NM_001242903;NM_003488
KAT6A_SIG,KAT6A,KAT6A_SIG,KAT6A,SIG,42,-2.17328282689846,0.402210594695283,0.406569910839204,0.387887127365254,-0.0186827834739503,0.0472777800875616,-2.29742849237,7.36857934534849,7.40571655675245,7.24655707930693,-0.15915947744552,0.0542220885911453,ENSG00000083168,KAT6A,protein_coding,8,-1,41929479,42051994,p11.21,lysine acetyltransferase 6A [Source:HGNC Symbol;Acc:HGNC:13013],Acute myeloid leukemia with t(8;16)(p11;p13) translocation;Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome;MENTAL RETARDATION AUTOSOMAL DOMINANT 32,KAT6A,7994,NM_001305878;NM_006766
SEC23IP_SIG,SEC23IP,SEC23IP_SIG,SEC23IP,SIG,86,2.173073166685,0.452458336565474,0.443636107216816,0.481445661568205,0.0378095543513881,0.0472937707942776,2.2403915763731,5.47841106859014,5.43788764916877,5.61155944668893,0.173671797520155,0.0611234503887998,ENSG00000107651,SEC23IP,protein_coding,10,1,119892730,119944657,q26.11,SEC23 interacting protein [Source:HGNC Symbol;Acc:HGNC:17018],NA,SEC23IP,11196,NM_007190
ACSL4_SIG,ACSL4,ACSL4_SIG,ACSL4,SIG,23,-2.17190266989224,0.411993594986927,0.415891786323895,0.399185252022606,-0.0167065343012882,0.0474247646001115,-0.683446515367136,6.45613255896563,6.46840349598667,6.41581376589652,-0.0525897300901406,0.601464861835915,ENSG00000068366,ACSL4,protein_coding,X,-1,109624244,109733403,q23,acyl-CoA synthetase long chain family member 4 [Source:HGNC Symbol;Acc:HGNC:3571],Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome;ALPORT SYNDROME WITH MENTAL RETARDATION MIDFACE HYPOPLASIA AND ELLIPTOCYTOSIS;MENTAL RETARDATION X-LINKED 63;MENTAL RETARDATION X-LINKED TYPE 63;X-linked non-syndromic intellectual disability,ACSL4,2182,NM_001318509;NM_001318510;NM_004458;NM_022977
KSR1_SIG,KSR1,KSR1_SIG,KSR1,SIG,42,2.17148353927192,0.11620401124662,0.112259343288692,0.129165063108383,0.0169057198196911,0.047465905201907,2.64955306271458,5.76848277571053,5.70976929756646,5.96139848961247,0.251629192046008,0.0250732012953425,ENSG00000141068,KSR1,protein_coding,17,1,27456470,27626438,q11.2,kinase suppressor of ras 1 [Source:HGNC Symbol;Acc:HGNC:6465],NA,KSR1,8844,NM_014238
GYS1_SIG,GYS1,GYS1_SIG,GYS1,SIG,67,-2.1708563323692,0.288627745445423,0.293878842155301,0.271374141970109,-0.0225047001851923,0.0475255874580403,-0.547193838624209,5.98118139421997,5.99134720822866,5.94777943390568,-0.0435677743229778,0.682371812633968,ENSG00000104812,GYS1,protein_coding,19,-1,48968130,48993310,q13.33,glycogen synthase 1 [Source:HGNC Symbol;Acc:HGNC:4706],GLYCOGEN STORAGE DISEASE 0 MUSCLE;Glycogen storage disease due to muscle and heart glycogen synthase deficiency,GYS1,2997,NM_001161587;NM_002103
LAMC3_SIG,LAMC3,LAMC3_SIG,LAMC3,SIG,39,2.17083428260962,-0.093330227774779,-0.0960422907771549,-0.084419163624115,0.0116231271530398,0.0475255874580403,0.697416136376339,0.785136878284735,0.768939715997404,0.838356125800249,0.0694164098028445,0.593720921267323,ENSG00000050555,LAMC3,protein_coding,9,1,131009174,131094473,q34.12,laminin subunit gamma 3 [Source:HGNC Symbol;Acc:HGNC:6494],CORTICAL MALFORMATIONS OCCIPITAL;occipital cortical malformations;Occipital pachygyria and polymicrogyria,LAMC3,10319,NM_006059
ZNF230_TF,ZNF230,ZNF230_TF,ZNF230,TF,50,-2.17074763893767,0.168044693670013,0.170689419532543,0.159354880121697,-0.0113345394108457,0.0475268825807855,-1.07671944677171,2.98108580376348,2.99953953155204,2.92045212674393,-0.0790874048081056,0.393623918805392,ENSG00000159882,ZNF230,protein_coding,19,1,44002957,44013924,q13.31,zinc finger protein 230 [Source:HGNC Symbol;Acc:HGNC:13024],NA,ZNF230,7773,NM_006300
GAPDH_SIG,GAPDH,GAPDH_SIG,GAPDH,SIG,68,-2.17047005280055,0.0898025871761997,0.0933930205226746,0.0780054490377822,-0.0153875714848925,0.0475511005324302,-1.78970991743772,11.1847328728697,11.2096829244454,11.1027541319781,-0.10692879246734,0.140663054197439,ENSG00000111640,GAPDH,protein_coding,12,1,6534512,6538374,p13.31,glyceraldehyde-3-phosphate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4141],NA,GAPDH,2597,NM_001256799;NM_001289745;NM_001289746;NM_001357943;NM_002046
ILF3_TF,ILF3,ILF3_TF,ILF3,TF,294,2.16900327536414,0.229777192888509,0.225292240738438,0.244513464238742,0.0192212235003042,0.0477183564957156,0.485977586350865,8.89335712029731,8.88786985233903,8.91138671501739,0.0235168626783599,0.717657315394533,ENSG00000129351,ILF3,protein_coding,19,1,10654261,10692417,p13.2,interleukin enhancer binding factor 3 [Source:HGNC Symbol;Acc:HGNC:6038],NA,ILF3,3609,NM_001137673;NM_004516;NM_012218;NM_017620;NM_153464
DPY30_SIG,DPY30,DPY30_SIG,DPY30,SIG,55,2.16864545366249,0.270690960195161,0.260851039359996,0.303022128653558,0.0421710892935611,0.047752322228238,2.6868913113071,3.63777122315768,3.59197004338505,3.78826081383916,0.196290770454105,0.0231343316429251,ENSG00000162961,DPY30,protein_coding,2,-1,31867809,32039805,p22.3,dpy-30, histone methyltransferase complex regulatory subunit [Source:HGNC Symbol;Acc:HGNC:24590],NA,DPY30,84661,NM_001321209;NM_001321210;NM_032574
TRIM4_SIG,TRIM4,TRIM4_SIG,TRIM4,SIG,33,2.16807785976562,0.172527193547906,0.164816987870287,0.197860726488654,0.0330437386183672,0.0478066279464219,2.08844000239549,4.76324750308228,4.72644769864454,4.88416114623484,0.157713447590296,0.0821490289107949,ENSG00000146833,TRIM4,protein_coding,7,-1,99876958,99919600,q22.1,tripartite motif containing 4 [Source:HGNC Symbol;Acc:HGNC:16275],NA,TRIM4,89122,NM_033017;NM_033091
MRPL15_SIG,MRPL15,MRPL15_SIG,MRPL15,SIG,17,2.16798190029107,0.41429678221444,0.408105967951014,0.434638029079982,0.0265320611289677,0.0478066279464219,1.97560085800921,4.19912664469753,4.16294847978008,4.31799775799774,0.155049278217662,0.101619593048961,ENSG00000137547,MRPL15,protein_coding,8,1,54135210,54147901,q11.23,mitochondrial ribosomal protein L15 [Source:HGNC Symbol;Acc:HGNC:14054],NA,MRPL15,29088,NM_014175
MECP2_TF,MECP2,MECP2_TF,MECP2,TF,90,2.16796743855893,0.211678821498686,0.209120905216832,0.220083403567639,0.0109624983508069,0.0478066279464219,2.63694969014233,6.40959639334195,6.37585411506734,6.5204638791014,0.144609764034058,0.0258306471049102,ENSG00000169057,MECP2,protein_coding,X,-1,154021573,154137103,q28,methyl-CpG binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6990],Atypical Rett syndrome;AUTISM SUSCEPTIBILITY TO X-LINKED 3;Chromosome Xq28 duplication syndrome;ENCEPHALOPATHY NEONATAL SEVERE DUE TO MECP2 MUTATIONS;LUBS X-LINKED MENTAL RETARDATION SYNDROME;MENTAL RETARDATION SYNDROMIC X-LINKED LUBS TYPE;MENTAL RETARDATION SYNDROMIC X-LINKED TYPE 13;MENTAL RETARDATION X-LINKED SYNDROMIC 13;Rett Syndrome;Rett syndrome (RTT);Severe neonatal-onset encephalopathy with microcephaly;Systemic lupus erythematosus;Trisomy Xq28;X-linked intellectual disability-psychosis-macroorchidism syndrome;X-linked non-syndromic intellectual disability,MECP2,4204,NM_001110792;NM_001316337;NM_004992
FUT7_SIG,FUT7,FUT7_SIG,FUT7,SIG,23,2.16648075241561,0.22436939510441,0.218617411009034,0.243268771417788,0.0246513604087543,0.0479758299881244,2.97066231476164,4.19443366343692,4.09986452579616,4.50516082997085,0.405296304174696,0.0116142473620799,ENSG00000180549,FUT7,protein_coding,9,-1,137030174,137033010,q34.3,fucosyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:4018],NA,FUT7,2529,NM_004479
C3AR1_SIG,C3AR1,C3AR1_SIG,C3AR1,SIG,31,-2.16641491974526,0.30123231718561,0.305559161275333,0.287015543747949,-0.0185436175273835,0.0479758299881244,0.058456848848076,4.74850683702959,4.74586092938589,4.75720053357317,0.0113396041872828,0.96779335710113,ENSG00000171860,C3AR1,protein_coding,12,-1,8058302,8066471,p13.31,complement C3a receptor 1 [Source:HGNC Symbol;Acc:HGNC:1319],NA,C3AR1,719,NM_001326475;NM_001326477;NM_004054
SNRPD2_SIG,SNRPD2,SNRPD2_SIG,SNRPD2,SIG,23,2.16482238584128,0.636355711513608,0.631381150876768,0.652700696463223,0.0213195455864545,0.0481595957768581,2.71725898356038,6.42513513772627,6.39194736211412,6.53418068616617,0.142233324052048,0.0214995323496415,ENSG00000125743,SNRPD2,protein_coding,19,-1,45687454,45692569,q13.32,small nuclear ribonucleoprotein D2 polypeptide [Source:HGNC Symbol;Acc:HGNC:11159],NA,SNRPD2,6633,NM_004597;NM_177542
ZHX3_TF,ZHX3,ZHX3_TF,ZHX3,TF,152,2.16455070553166,0.0947595588861582,0.0926994320087558,0.101528547197623,0.00882911518886742,0.0481833640454741,1.50974068819493,4.2425606650961,4.2128741096646,4.34010220437104,0.127228094706439,0.218886617567111,ENSG00000174306,ZHX3,protein_coding,20,-1,41178448,41317672,q12,zinc fingers and homeoboxes 3 [Source:HGNC Symbol;Acc:HGNC:15935],NA,ZHX3,23051,NM_015035
REL_TF,REL,REL_TF,REL,TF,119,-2.16403583467048,0.251215002639356,0.256096032117875,0.235177334352795,-0.0209186977650802,0.0482366877333085,-1.33160064538592,6.3306404360617,6.35701017531897,6.24399700707351,-0.113013168245462,0.28242047756756,ENSG00000162924,REL,protein_coding,2,1,60881521,60931610,p16.1,REL proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9954],NA,REL,5966,NM_001291746;NM_002908
DDX39A_SIG,DDX39A,DDX39A_SIG,DDX39A,SIG,29,-2.16271689617079,0.140463767588487,0.144616186022868,0.126820107018379,-0.0177960790044896,0.0483879476000053,-2.70869275915341,6.69120433465925,6.72625428841469,6.57604020089138,-0.150214087523315,0.0219370496512898,ENSG00000123136,DDX39A,protein_coding,19,-1,14408819,14419383,p13.12,DExD-box helicase 39A [Source:HGNC Symbol;Acc:HGNC:17821],NA,DDX39A,10212,NM_005804
SRC_SIG,SRC,SRC_SIG,SRC,SIG,78,2.16201242554143,0.0987516045970685,0.0952900430501635,0.110125306822613,0.01483526377245,0.0484645882360618,1.68101631680804,4.34427384217567,4.28724102023137,4.53166739999265,0.244426379761274,0.168172771412269,ENSG00000197122,SRC,protein_coding,20,1,37344685,37406050,q11.23,SRC proto-oncogene, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:11283],Colorectal Cancer;Hereditary thrombocytopenia with early-onset myelofibrosis;THROMBOCYTOPENIA 6,SRC,6714,NM_005417;NM_198291
PTGIR_SIG,PTGIR,PTGIR_SIG,PTGIR,SIG,58,-2.16170458785594,0.0134794454123099,0.0174698188384786,0.000368218440612714,-0.0171016003978658,0.0484928943926475,-1.22264033495415,2.84258164030176,2.88832030633288,2.69229745191377,-0.196022854419112,0.326994320315072,ENSG00000160013,PTGIR,protein_coding,19,-1,46620468,46625089,q13.32,prostaglandin I2 receptor [Source:HGNC Symbol;Acc:HGNC:9602],NA,PTGIR,5739,NM_000960
THAP8_TF,THAP8,THAP8_TF,THAP8,TF,156,2.16125648131202,0.150337205096868,0.14292694783688,0.174685193236828,0.0317582453999479,0.0485383474919352,1.80469646583867,1.99222458000227,1.95279943078315,2.12176435600797,0.168964925224828,0.137070504448939,ENSG00000161277,THAP8,protein_coding,19,-1,36034985,36054762,q13.12,THAP domain containing 8 [Source:HGNC Symbol;Acc:HGNC:23191],NA,THAP8,199745,NM_001331102;NM_001331103;NM_001331104;NM_152658
CIT_SIG,CIT,CIT_SIG,CIT,SIG,53,-2.15977961327049,0.266825024062386,0.291208953648738,0.186706398278657,-0.104502555370082,0.0487097481437373,-2.09019211198369,4.25206923571207,4.32073428991123,4.02645548620055,-0.294278803710682,0.0818414437721222,ENSG00000122966,CIT,protein_coding,12,-1,119685791,119877320,q24.23,citron rho-interacting serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:1985],Autosomal recessive primary microcephaly;MICROCEPHALY 17 PRIMARY AUTOSOMAL RECESSIVE;Primary microcephaly,CIT,11113,NM_001206999;NM_007174
GAK_SIG,GAK,GAK_SIG,GAK,SIG,19,-2.15682796682319,0.249929731088976,0.252529481512697,0.241387693982463,-0.0111417875302339,0.0490631929552351,-0.579729868441909,7.14099906227077,7.14598145833365,7.1246283323499,-0.0213531259837519,0.663253310677942,ENSG00000178950,GAK,protein_coding,4,-1,849276,932373,p16.3,cyclin G associated kinase [Source:HGNC Symbol;Acc:HGNC:4113],NA,GAK,2580,NM_001318134;NM_005255
TFEC_TF,TFEC,TFEC_TF,TFEC,TF,89,2.15621832027926,0.235083265664243,0.231871255800421,0.245637012359656,0.0137657565592343,0.0491290247148481,1.13528881708153,5.88248655957035,5.84597607048075,6.00244959515049,0.156473524669736,0.365727880989725,ENSG00000105967,TFEC,protein_coding,7,-1,115935148,116159896,q31.2,transcription factor EC [Source:HGNC Symbol;Acc:HGNC:11754],NA,TFEC,22797,NM_001018058;NM_001244583;NM_012252
PPP2R2D_SIG,PPP2R2D,PPP2R2D_SIG,PPP2R2D,SIG,19,2.15555886400846,0.228195218758178,0.224649991482209,0.239843822664933,0.0151938311827249,0.049201085295549,1.83195838504857,5.12211574463661,5.10211451072172,5.18783408464268,0.0857195739209553,0.130760320527679,ENSG00000175470,PPP2R2D,protein_coding,10,1,131901008,131959834,q26.3,protein phosphatase 2 regulatory subunit Bdelta [Source:HGNC Symbol;Acc:HGNC:23732],NA,PPP2R2D,55844,NM_001291310;NM_018461
SRSF2_SIG,SRSF2,SRSF2_SIG,SRSF2,SIG,21,2.15516377419772,0.377608579265849,0.373755213431645,0.390269638435376,0.0165144250037309,0.0492405334281349,1.56102521922353,8.28456344576208,8.26825584182181,8.33814557299439,0.0698897311725837,0.202256091203202,ENSG00000161547,SRSF2,protein_coding,17,-1,76734115,76737374,q25.1,serine and arginine rich splicing factor 2 [Source:HGNC Symbol;Acc:HGNC:10783],NA,SRSF2,6427,NM_001195427;NM_003016
SLC15A2_SIG,SLC15A2,SLC15A2_SIG,SLC15A2,SIG,35,2.15368604651391,0.1858562637319,0.180329246342643,0.204016463725175,0.0236872173825325,0.0494112506439173,0.431804037036904,4.61675309618254,4.6036366731259,4.65984991479723,0.0562132416713296,0.749287478291423,ENSG00000163406,SLC15A2,protein_coding,3,1,121894401,121944188,q13.33,solute carrier family 15 member 2 [Source:HGNC Symbol;Acc:HGNC:10921],NA,SLC15A2,6565,NM_001145998;NM_021082
PMM2_SIG,PMM2,PMM2_SIG,PMM2,SIG,19,2.15363327891178,0.286303156857746,0.278987108343905,0.310341601974652,0.0313544936307472,0.0494112506439173,2.0874866143796,3.81875063963238,3.7836677074508,3.93402313108613,0.150355423635324,0.0823136671365042,ENSG00000140650,PMM2,protein_coding,16,1,8788823,8849325,p13.2,phosphomannomutase 2 [Source:HGNC Symbol;Acc:HGNC:9115],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ia;Congenital Disorders of Glycosylation;PMM2-CDG,PMM2,5373,NM_000303
SP2_TF,SP2,SP2_TF,SP2,TF,61,-2.15330008360404,0.243268935023803,0.244640936103561,0.238760931476026,-0.00588000462753485,0.0494431582737156,-1.98614389675211,5.46026523912524,5.48215645042237,5.38833697343467,-0.0938194769877025,0.0996757499327077,ENSG00000167182,SP2,protein_coding,17,1,47896150,47928957,q21.32,Sp2 transcription factor [Source:HGNC Symbol;Acc:HGNC:11207],NA,SP2,6668,NM_003110
TP53RK_SIG,TP53RK,TP53RK_SIG,TP53RK,SIG,21,2.15269846705764,0.287445479451991,0.280746603874017,0.309456070636765,0.0287094667627488,0.0495084179091559,0.853637551751646,4.01653633314647,4.00007849629419,4.07061208280399,0.0705335865098028,0.506268591290565,ENSG00000172315,TP53RK,protein_coding,20,-1,46684365,46689444,q13.12,TP53 regulating kinase [Source:HGNC Symbol;Acc:HGNC:16197],GALLOWAY-MOWAT SYNDROME;GALLOWAY-MOWAT SYNDROME 4,TP53RK,112858,NM_033550
CDK4_SIG,CDK4,CDK4_SIG,CDK4,SIG,60,2.15237332611407,0.516166776920063,0.508493180405681,0.541380022610176,0.0328868422044951,0.0495393770299275,1.2822087927155,5.57538220644017,5.54636590130958,5.67072149472636,0.124355593416778,0.302208139601009,ENSG00000135446,CDK4,protein_coding,12,-1,57747727,57756013,q14.1,cyclin dependent kinase 4 [Source:HGNC Symbol;Acc:HGNC:1773],Dedifferentiated liposarcoma;Familial melanoma;MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 3;Well-differentiated liposarcoma,CDK4,1019,NM_000075
CD83_SIG,CD83,CD83_SIG,CD83,SIG,60,-2.15166563866815,0.332966713117229,0.343271901136347,0.299106809625843,-0.0441650915105039,0.0496179417834162,-1.86772410452453,5.51096567625217,5.59476302359811,5.23563153497263,-0.359131488625484,0.12305683697932,ENSG00000112149,CD83,protein_coding,6,1,14117256,14136918,p23,CD83 molecule [Source:HGNC Symbol;Acc:HGNC:1703],NA,CD83,9308,NM_001040280;NM_001251901;NM_004233
ZNF24_TF,ZNF24,ZNF24_TF,ZNF24,TF,66,2.15014194643431,0.343261577329389,0.340674719039328,0.35176125456816,0.0110865355288324,0.0497983888896849,1.76769599304969,6.46222884245516,6.43843970353382,6.54039315605387,0.101953452520057,0.145980156072322,ENSG00000172466,ZNF24,protein_coding,18,-1,35332227,35345482,q12.2,zinc finger protein 24 [Source:HGNC Symbol;Acc:HGNC:13032],NA,ZNF24,7572,NM_001308123;NM_006965
POFUT1_SIG,POFUT1,POFUT1_SIG,POFUT1,SIG,29,2.14894453867467,0.524483325751519,0.517649319196291,0.546937918718697,0.0292885995224058,0.0499385464257134,2.38078044222772,5.95057521520108,5.91332106616699,6.07298170488452,0.159660638717536,0.045684591790887,ENSG00000101346,POFUT1,protein_coding,20,1,32207880,32238658,q11.21,protein O-fucosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:14988],DOWLING-DEGOS DISEASE;Dowling-Degos disease 2,POFUT1,23509,NM_015352;NM_172236
CBL_TF,CBL,CBL_TF,CBL,TF,199,-2.14873610585195,0.293818300614109,0.297540191235134,0.281589231430744,-0.0159509598043895,0.0499551173972186,-1.59349654577637,7.25657296868499,7.28581688424675,7.16048581755349,-0.12533106669326,0.19247286117035,ENSG00000110395,CBL,protein_coding,11,1,119206276,119313926,q23.3,Cbl proto-oncogene [Source:HGNC Symbol;Acc:HGNC:1541],Juvenile myelomonocytic leukemia;Noonan syndrome-like disorder with juvenile myelomonocytic leukemia;Noonan syndrome-like disorder with or without juvenile meylomonocytic leukemia;Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,CBL,867,NM_005188
ABCA7_SIG,ABCA7,ABCA7_SIG,ABCA7,SIG,36,-2.14852975049915,0.143567784439347,0.146853202332048,0.132772839934761,-0.0140803623972863,0.0499714336422237,-2.38739709858936,6.87590893048527,6.93081645224576,6.69549850184364,-0.23531795040212,0.0450269220902136,ENSG00000064687,ABCA7,protein_coding,19,1,1040101,1065572,p13.3,ATP binding cassette subfamily A member 7 [Source:HGNC Symbol;Acc:HGNC:37],ALZHEIMER DISEASE 9 SUSCEPTIBILITY TO;Early-onset autosomal dominant Alzheimer disease,ABCA7,10347,NM_019112
NOL12_SIG,NOL12,NOL12_SIG,NOL12,SIG,9,2.14827093678743,0.0675162576223072,0.063771415297747,0.0798207395458621,0.016049324248115,0.0499943248754345,2.21267750873389,4.43162428383378,4.40849673444837,4.50761480324297,0.0991180687945983,0.0647262014484265,ENSG00000273899,NOL12,protein_coding,22,1,37681673,37693476,q13.1,nucleolar protein 12 [Source:HGNC Symbol;Acc:HGNC:28585],NA,NOL12,79159,NM_024313
AHNAK_SIG,AHNAK,AHNAK_SIG,AHNAK,SIG,65,2.14742573889082,0.28259475377624,0.276769325082868,0.301735448054461,0.0249661229715938,0.0500907399286551,3.00031406459078,10.5099768220335,10.4078985756595,10.8453767744051,0.437478198745621,0.0107508639563898,ENSG00000124942,AHNAK,protein_coding,11,-1,62433542,62556235,q12.3,AHNAK nucleoprotein [Source:HGNC Symbol;Acc:HGNC:347],NA,AHNAK,79026,NM_001346445;NM_001346446;NM_001620;NM_024060
PABPC4L_SIG,PABPC4L,PABPC4L_SIG,PABPC4L,SIG,22,-2.14732083194387,-0.145141101319343,-0.140300160873745,-0.161047048497735,-0.02074688762399,0.0500943654597377,-1.24946895688973,0.417820518809287,0.444116839599467,0.331418321927266,-0.112698517672201,0.315727378450304,ENSG00000254535,PABPC4L,protein_coding,4,-1,134196333,134201789,q28.3,poly(A) binding protein cytoplasmic 4 like [Source:HGNC Symbol;Acc:HGNC:31955],NA,PABPC4L,132430,NM_001114734;NM_001363585
IMMT_SIG,IMMT,IMMT_SIG,IMMT,SIG,27,2.14624379608939,0.720237785532647,0.71369256405349,0.741743513249875,0.0280509491963853,0.0502200802344343,2.74628512441801,6.36159119367195,6.32640170176586,6.47721380993485,0.150812108168991,0.0200765817483336,ENSG00000132305,IMMT,protein_coding,2,-1,86143932,86195770,p11.2,inner membrane mitochondrial protein [Source:HGNC Symbol;Acc:HGNC:6047],NA,IMMT,10989,NM_001100169;NM_001100170;NM_006839
HSDL1_SIG,HSDL1,HSDL1_SIG,HSDL1,SIG,26,-2.14607920663257,0.0945166416877214,0.0975582534020655,0.0845227746263049,-0.0130354787757605,0.0502312171661414,-2.8506374672033,3.97394517262092,4.02689586748108,3.79996431808038,-0.226931549400703,0.0156644678373868,ENSG00000103160,HSDL1,protein_coding,16,-1,84122141,84145192,q24.1,hydroxysteroid dehydrogenase like 1 [Source:HGNC Symbol;Acc:HGNC:16475],NA,HSDL1,83693,NM_001146051;NM_031463
PYGO2_SIG,PYGO2,PYGO2_SIG,PYGO2,SIG,48,2.14595663162128,0.122789949447138,0.114822294721648,0.148969386402319,0.0341470916806709,0.0502370736712904,1.83000464177103,4.77847592028002,4.74081731433609,4.9022113398101,0.161394025474006,0.131262478826921,ENSG00000163348,PYGO2,protein_coding,1,-1,154957026,154963853,q21.3,pygopus family PHD finger 2 [Source:HGNC Symbol;Acc:HGNC:30257],NA,PYGO2,90780,NM_138300
TATDN2_SIG,TATDN2,TATDN2_SIG,TATDN2,SIG,34,-2.14522738844499,0.116698347922404,0.119497530170842,0.107501034820393,-0.0119964953504487,0.0503170467165262,-1.69403203138083,5.04921382466529,5.06771540827055,4.98842290710516,-0.0792925011653897,0.164715460333942,ENSG00000157014,TATDN2,protein_coding,3,1,10248023,10281218,p25.3,TatD DNase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28988],NA,TATDN2,9797,NM_014760
ACSS2_SIG,ACSS2,ACSS2_SIG,ACSS2,SIG,36,2.1451690908031,0.311371301105117,0.306653562149176,0.326872443388925,0.0202188812397488,0.0503170467165262,2.95346892821097,5.34959771950817,5.29212571813049,5.53843429546342,0.246308577332927,0.0121399745608922,ENSG00000131069,ACSS2,protein_coding,20,1,34872146,34927962,q11.22,acyl-CoA synthetase short chain family member 2 [Source:HGNC Symbol;Acc:HGNC:15814],NA,ACSS2,55902,NM_001076552;NM_001242393;NM_018677
ZGPAT_SIG,ZGPAT,ZGPAT_SIG,ZGPAT,SIG,30,-2.14342664512385,0.077431312471401,0.0803379049490054,0.0678810800449867,-0.0124568249040189,0.050527246667203,-0.85608845399761,3.49894966379643,3.50662197498492,3.47374064131996,-0.0328813336649555,0.504960848044863,ENSG00000197114,ZGPAT,protein_coding,20,1,63707465,63736142,q13.33,zinc finger CCCH-type and G-patch domain containing [Source:HGNC Symbol;Acc:HGNC:15948],NA,ZGPAT,84619,NM_001083113;NM_001195653;NM_001195654;NM_032527;NM_181485
CSK_SIG,CSK,CSK_SIG,CSK,SIG,69,-2.14265328315657,0.384453051263525,0.392111573594529,0.359289335033084,-0.0328222385614456,0.0506154275655557,-2.0468095338174,7.37108773297808,7.40249714099133,7.26788539236312,-0.134611748628211,0.0890809201644949,ENSG00000103653,CSK,protein_coding,15,1,74782057,74803198,q24.1,C-terminal Src kinase [Source:HGNC Symbol;Acc:HGNC:2444],NA,CSK,1445,NM_001127190;NM_001354988;NM_004383
LTN1_SIG,LTN1,LTN1_SIG,LTN1,SIG,18,2.14248536978567,0.335312520863718,0.330651523952699,0.350627224999924,0.0199757010472252,0.0506270571106191,0.788956657837144,5.80421660804977,5.79337490669636,5.8398393410681,0.0464644343717432,0.541155047004094,ENSG00000198862,LTN1,protein_coding,21,-1,28928144,28992956,q21.3,listerin E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:13082],NA,LTN1,26046,NM_001320766;NM_015565
MTA2_SIG,MTA2,MTA2_SIG,MTA2,SIG,12,2.14172900162307,0.419627723413247,0.418116127298343,0.424594396362217,0.00647826906387471,0.0507132288814115,-0.206291410179766,7.40424318395289,7.40613759856251,7.39801867880698,-0.00811891975553012,0.883361995210387,ENSG00000149480,MTA2,protein_coding,11,-1,62593214,62601865,q12.3,metastasis associated 1 family member 2 [Source:HGNC Symbol;Acc:HGNC:7411],NA,MTA2,9219,NM_001330292;NM_004739
DCTN5_SIG,DCTN5,DCTN5_SIG,DCTN5,SIG,13,2.14021689016586,0.411018897574554,0.4083472954903,0.419797018708532,0.0114497232182319,0.0508955274841178,2.65468982433889,5.94162392412684,5.91406415082745,6.0321774649677,0.118113314140254,0.0248129233584906,ENSG00000166847,DCTN5,protein_coding,16,1,23641466,23677472,p12.2,dynactin subunit 5 [Source:HGNC Symbol;Acc:HGNC:24594],NA,DCTN5,84516,NM_001199011;NM_001199743;NM_032486
BRCC3_SIG,BRCC3,BRCC3_SIG,BRCC3,SIG,68,2.13968312462491,0.390736073382709,0.381750898776034,0.420258789947498,0.038507891171464,0.0509537472624574,2.11520075991188,4.53820049872755,4.5052538303556,4.64645383766394,0.141200007308345,0.0780810762038653,ENSG00000185515,BRCC3,protein_coding,X,1,155071420,155123074,q28,BRCA1/BRCA2-containing complex subunit 3 [Source:HGNC Symbol;Acc:HGNC:24185],Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,BRCC3,79184,NM_001018055;NM_001242640;NM_024332
PYCR2_SIG,PYCR2,PYCR2_SIG,PYCR2,SIG,18,2.13901145190039,0.282138751160913,0.272453328163292,0.313962283867384,0.041508955704092,0.0510295914322335,1.44469006276953,5.22365314873433,5.20058761544826,5.29943990095998,0.09885228551172,0.240374529083352,ENSG00000143811,PYCR2,protein_coding,1,-1,225919877,225924340,q42.12,pyrroline-5-carboxylate reductase 2 [Source:HGNC Symbol;Acc:HGNC:30262],Autosomal recessive primary microcephaly;LEUKODYSTROPHY HYPOMYELINATING 10;Postnatal microcephaly hypomyelination and reduced cerebral white-Matter volume;PYCR2-related microcephaly-progressive leukoencephalopathy,PYCR2,29920,NM_001271681;NM_013328
ALDH1A1_SIG,ALDH1A1,ALDH1A1_SIG,ALDH1A1,SIG,59,-2.13886772926459,-0.0341455814725832,-0.029593880573253,-0.0491011701418108,-0.0195072895685578,0.0510382147322353,0.285780215077288,2.90876378907508,2.893438516576,2.95911825585778,0.0656797392817855,0.8363133653701,ENSG00000165092,ALDH1A1,protein_coding,9,-1,72900671,73080442,q21.13,aldehyde dehydrogenase 1 family member A1 [Source:HGNC Symbol;Acc:HGNC:402],NA,ALDH1A1,216,NM_000689
PTCH1_SIG,PTCH1,PTCH1_SIG,PTCH1,SIG,21,-2.13849536988941,-0.140867235165875,-0.133671518962915,-0.164510302689885,-0.0308387837269699,0.051075986258899,-0.944057585476445,1.94929178370689,1.985164115539,1.83142555054422,-0.153738564994785,0.458733980480236,ENSG00000185920,PTCH1,protein_coding,9,-1,95442980,95517057,q22.32,patched 1 [Source:HGNC Symbol;Acc:HGNC:9585],Alobar holoprosencephaly;BASAL CELL CARCINOMA SUSCEPTIBILITY TO 1;Basal cell nevus syndrome;Gorlin syndrome;HOLOPROSENCEPHALY-7;HOLOPROSENCEPHALY 7;Lobar holoprosencephaly;Microform holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Monosomy 9q22.3;Semilobar holoprosencephaly;Septopreoptic holoprosencephaly,PTCH1,5727,NM_000264;NM_001083602;NM_001083603;NM_001083604;NM_001083605;NM_001083606;NM_001083607;NM_001354918;NM_001354919
NMNAT1_SIG,NMNAT1,NMNAT1_SIG,NMNAT1,SIG,97,2.13815358936349,0.168938266379936,0.15990555508691,0.198617174914166,0.0387116198272562,0.051109879964515,2.5660082906721,2.8486068785945,2.78223555795067,3.06668407499565,0.284448517044983,0.0304324824367754,ENSG00000173614,NMNAT1,protein_coding,1,1,9943428,9985501,p36.22,nicotinamide nucleotide adenylyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:17877],Cone rod dystrophy;Leber congenital amaurosis;LEBER CONGENITAL AMAUROSIS 9,NMNAT1,64802,NM_001297778;NM_001297779;NM_022787
VKORC1_SIG,VKORC1,VKORC1_SIG,VKORC1,SIG,11,2.13724198265611,0.354264043425152,0.348225605643113,0.374104624708995,0.0258790190658818,0.0512165729964756,2.53924829543522,2.9254697081586,2.88959506828429,3.04334352488846,0.153748456604164,0.0324215212009928,ENSG00000167397,VKORC1,protein_coding,16,-1,31090842,31095980,p11.2,vitamin K epoxide reductase complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:23663],COUMARIN RESISTANCE;Hereditary combined deficiency of vitamin K-dependent clotting factors;Resistance to vitamin K antagonists;VITAMIN K-DEPENDENT CLOTTING FACTORS COMBINED DEFICIENCY OF 2;Vitamin K antagonists toxicity or dose selection,VKORC1,79001,NM_001311311;NM_024006;NM_206824
PAPOLA_SIG,PAPOLA,PAPOLA_SIG,PAPOLA,SIG,10,2.13680841636145,0.485026914693553,0.479229406985894,0.504075868590148,0.024846461604255,0.0512622819259524,-0.640406064999945,8.15776701122586,8.1634271200214,8.13916951089763,-0.0242576091237706,0.626680037420836,ENSG00000090060,PAPOLA,protein_coding,14,1,96501433,96567111,q32.2,poly(A) polymerase alpha [Source:HGNC Symbol;Acc:HGNC:14981],NA,PAPOLA,10914,NM_001252006;NM_001252007;NM_001293627;NM_001293628;NM_001293632;NM_032632
CNOT1_SIG,CNOT1,CNOT1_SIG,CNOT1,SIG,31,2.13594847604142,0.560950820881643,0.553658074235281,0.584912702719693,0.0312546284844121,0.0513483484168614,1.33051404316962,8.00075227590911,7.98219494790238,8.06172635364554,0.0795314057431575,0.282800233521942,ENSG00000125107,CNOT1,protein_coding,16,-1,58519951,58629885,q21,CCR4-NOT transcription complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:7877],NA,CNOT1,23019,NM_001265612;NM_016284;NM_206999
RBMXL1_SIG,RBMXL1,RBMXL1_SIG,RBMXL1,SIG,53,2.13591298869619,0.355493605523144,0.349955273624194,0.373690981762554,0.0237357081383597,0.0513483484168614,1.51646892681778,6.0390419878823,6.02036211294151,6.10041871983063,0.0800566068891157,0.216651507739521,ENSG00000213516,RBMXL1,protein_coding,1,-1,88979456,88992960,p22.2,RBMX like 1 [Source:HGNC Symbol;Acc:HGNC:25073],NA,RBMXL1,494115,NM_001162536;NM_019610
PRKAR2B_SIG,PRKAR2B,PRKAR2B_SIG,PRKAR2B,SIG,53,2.13590783416469,-0.0276808429858788,-0.0309450523990076,-0.0169555834855987,0.0139894689134089,0.0513483484168614,1.19353583437907,5.0471677920732,4.99855690555288,5.20688927635425,0.208332370801378,0.339938808054711,ENSG00000005249,PRKAR2B,protein_coding,7,1,107044705,107161811,q22.3,protein kinase cAMP-dependent type II regulatory subunit beta [Source:HGNC Symbol;Acc:HGNC:9392],NA,PRKAR2B,5577,NM_002736
SAMHD1_SIG,SAMHD1,SAMHD1_SIG,SAMHD1,SIG,109,-2.1356703491455,0.247429980327671,0.25969469360733,0.207131636694507,-0.0525630569128226,0.0513690305849047,-1.1692111689484,7.28105074950065,7.33996029776491,7.08749080520382,-0.252469492561086,0.350908624466975,ENSG00000101347,SAMHD1,protein_coding,20,-1,36889773,36951901,q11.23,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 [Source:HGNC Symbol;Acc:HGNC:15925],Aicardi-Goutieres syndrome;AICARDI-GOUTIERES SYNDROME 5;CHILBLAIN LUPUS 2;Familial Chilblain lupus,SAMHD1,25939,NM_001363729;NM_001363733;NM_015474
MPO_SIG,MPO,MPO_SIG,MPO,SIG,103,-2.13529675109459,0.0829356529050151,0.0872346279041042,0.0688104493365794,-0.0184241785675248,0.0514071658330028,-0.820907638162105,10.2909023609702,10.3554372320613,10.0788592130997,-0.276578018961537,0.523835308580561,ENSG00000005381,MPO,protein_coding,17,-1,58269856,58280935,q22,myeloperoxidase [Source:HGNC Symbol;Acc:HGNC:7218],Alzheimer disease;MYELOPEROXIDASE DEFICIENCY,MPO,4353,NM_000250
ZNF564_TF,ZNF564,ZNF564_TF,ZNF564,TF,11,2.13474877652606,0.147032091670517,0.143871609339372,0.157416533615705,0.0135449242763332,0.05146769552581,1.49481628549704,0.50541297150257,0.49605467634463,0.536161655592947,0.0401069792483175,0.223675081834857,ENSG00000249709,ZNF564,protein_coding,19,-1,12525373,12551542,p13.2,zinc finger protein 564 [Source:HGNC Symbol;Acc:HGNC:31106],NA,ZNF564,163050,NM_144976
TET1_TF,TET1,TET1_TF,TET1,TF,78,2.13376873878959,0.0263264362745684,0.0223961702162854,0.0392401676089268,0.0168439973926414,0.0515838040214825,0.623921525027376,2.66102154103013,2.64238211204354,2.72226537912891,0.0798832670853728,0.636252530261139,ENSG00000138336,TET1,protein_coding,10,1,68560337,68694487,q21.3,tet methylcytosine dioxygenase 1 [Source:HGNC Symbol;Acc:HGNC:29484],NA,TET1,80312,NM_030625
LIMK1_SIG,LIMK1,LIMK1_SIG,LIMK1,SIG,34,2.13367059775962,0.19033367591813,0.186720894712341,0.202204242737154,0.0154833480248135,0.0515866482394502,3.00902734521274,5.1524225860133,5.09642196955219,5.33642461152838,0.240002641976194,0.0104967505198824,ENSG00000106683,LIMK1,protein_coding,7,1,74082933,74122525,q11.23,LIM domain kinase 1 [Source:HGNC Symbol;Acc:HGNC:6613],Williams syndrome,LIMK1,3984,NM_001204426;NM_002314
ARHGAP35_TF,ARHGAP35,ARHGAP35_TF,ARHGAP35,TF,54,2.13263147320281,0.40678883205379,0.40369727015399,0.416946821153135,0.0132495509991455,0.0517105911537096,0.0315768220350814,6.25910343692531,6.25864207546662,6.260619338861,0.0019772633943775,0.98281257394159,ENSG00000160007,ARHGAP35,protein_coding,19,1,46918676,47005077,q13.32,Rho GTPase activating protein 35 [Source:HGNC Symbol;Acc:HGNC:4591],NA,ARHGAP35,2909,NM_004491
RBP4_SIG,RBP4,RBP4_SIG,RBP4,SIG,16,2.13168520930493,0.00824464971601811,0.00417663893246927,0.0216109708619643,0.0174343319294951,0.0518227982142285,0.0615711694129266,0.268842256471043,0.267997655335912,0.271617374486473,0.00361971915056046,0.966048415875529,ENSG00000138207,RBP4,protein_coding,10,-1,93591687,93601744,q23.33,retinol binding protein 4 [Source:HGNC Symbol;Acc:HGNC:9922],Colobomatous microphthalmia;MICROPHTHALMIA ISOLATED WITH COLOBOMA 10;Progressive retinal dystrophy due to retinol transport defect;Retinal dystrophy iris coloboma and comedogenic acne syndrome,RBP4,5950,NM_001323517;NM_001323518;NM_006744
LTN1_TF,LTN1,LTN1_TF,LTN1,TF,48,2.12975974115303,0.346211397164278,0.342603187150204,0.358066944353379,0.0154637572031758,0.0520619455303466,0.788956657837144,5.80421660804977,5.79337490669636,5.8398393410681,0.0464644343717432,0.541155047004094,ENSG00000198862,LTN1,protein_coding,21,-1,28928144,28992956,q21.3,listerin E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:13082],NA,LTN1,26046,NM_001320766;NM_015565
MGST3_SIG,MGST3,MGST3_SIG,MGST3,SIG,16,2.12959086080554,0.175680977780254,0.172197001318862,0.187128329010542,0.0149313276916802,0.0520739713551119,2.1439930050909,5.10109522851471,5.06620892523751,5.21572165356837,0.149512728330866,0.0739609579506517,ENSG00000143198,MGST3,protein_coding,1,1,165631213,165661796,q24.1,microsomal glutathione S-transferase 3 [Source:HGNC Symbol;Acc:HGNC:7064],NA,MGST3,4259,NM_004528
TBX19_TF,TBX19,TBX19_TF,TBX19,TF,58,2.12945823498668,0.18151114134297,0.177154093919096,0.19582715430713,0.0186730603880344,0.052074592885702,0.975079492181426,2.26545940219579,2.24924083321722,2.31874898598252,0.0695081527652977,0.443121632081345,ENSG00000143178,TBX19,protein_coding,1,1,168280877,168314426,q24.2,T-box 19 [Source:HGNC Symbol;Acc:HGNC:11596],ACTH deficiency isolated;Congenital isolated ACTH deficiency,TBX19,9095,NM_005149
MMP17_SIG,MMP17,MMP17_SIG,MMP17,SIG,6,-2.1293713489368,0.138699143580507,0.146771251892888,0.112176501982684,-0.034594749910204,0.052074592885702,-2.98774283250169,2.68372968309478,2.79896122688791,2.30511175348876,-0.493849473399145,0.0111119215462871,ENSG00000198598,MMP17,protein_coding,12,1,131828393,131851783,q24.33,matrix metallopeptidase 17 [Source:HGNC Symbol;Acc:HGNC:7163],NA,MMP17,4326,NM_016155
RAD9A_SIG,RAD9A,RAD9A_SIG,RAD9A,SIG,9,2.1293579244806,0.0832147339507205,0.080501131603629,0.0921308559483068,0.0116297243446779,0.052074592885702,0.623718100775582,4.24032134537554,4.23228031295301,4.26674188047811,0.0344615675251018,0.636326973989351,ENSG00000172613,RAD9A,protein_coding,11,1,67317871,67398410,q13.2,RAD9 checkpoint clamp component A [Source:HGNC Symbol;Acc:HGNC:9827],NA,RAD9A,5883,NM_001243224;NM_004584
CNIH1_SIG,CNIH1,CNIH1_SIG,CNIH1,SIG,23,2.12905685517375,0.299005960365873,0.296364590058309,0.307684748519297,0.0113201584609886,0.0521037597589577,3.56500267864689,5.54066645212023,5.49330905610927,5.69626932472767,0.202960268618398,0.00222173767758156,ENSG00000100528,CNIH1,protein_coding,14,-1,54423561,54441391,q22.2,cornichon family AMPA receptor auxiliary protein 1 [Source:HGNC Symbol;Acc:HGNC:19431],NA,CNIH1,10175,NM_005776
BRD9_SIG,BRD9,BRD9_SIG,BRD9,SIG,33,2.12891742173233,0.25909691263703,0.256583841643874,0.267354145900256,0.0107703042563814,0.0521119811844175,1.30223256375423,5.54168305019008,5.52877674431163,5.5840894837907,0.0553127394790662,0.294176099261143,ENSG00000028310,BRD9,protein_coding,5,-1,850291,892801,p15.33,bromodomain containing 9 [Source:HGNC Symbol;Acc:HGNC:25818],NA,BRD9,65980,NM_001009877;NM_001317951;NM_023924
HSD17B11_SIG,HSD17B11,HSD17B11_SIG,HSD17B11,SIG,33,-2.12871971481142,0.0210813298530737,0.0226089548682441,0.0160619905175139,-0.00654696435073024,0.0521277612092476,-2.15132132746834,6.68797766280182,6.71961008006352,6.58404257751337,-0.135567502550145,0.0729180680731464,ENSG00000198189,HSD17B11,protein_coding,4,-1,87336515,87391188,q22.1,hydroxysteroid 17-beta dehydrogenase 11 [Source:HGNC Symbol;Acc:HGNC:22960],NA,HSD17B11,51170,NM_016245
CLIC3_SIG,CLIC3,CLIC3_SIG,CLIC3,SIG,11,-2.12815229908161,0.017133256026857,0.0249858100796309,-0.00866799300368571,-0.0336538030833167,0.0521915192910062,-0.121671208650396,1.10646326146519,1.10901773098046,1.09807000448645,-0.0109477264940095,0.932097414239964,ENSG00000169583,CLIC3,protein_coding,9,-1,136994635,136996803,q34.3,chloride intracellular channel 3 [Source:HGNC Symbol;Acc:HGNC:2064],NA,CLIC3,9022,NM_004669
LYG1_SIG,LYG1,LYG1_SIG,LYG1,SIG,31,2.12778641020864,-0.0615303469539368,-0.0652885282950768,-0.0491820368330483,0.0161064914620283,0.0522291608421682,1.88975602444728,1.03122286994923,1.00825021598078,1.10670444727414,0.0984542312933624,0.118353391523875,ENSG00000144214,LYG1,protein_coding,2,-1,99284238,99304742,q11.2,lysozyme g1 [Source:HGNC Symbol;Acc:HGNC:27014],NA,LYG1,129530,NM_174898
BATF_TF,BATF,BATF_TF,BATF,TF,145,-2.12698896679484,-0.165633469976085,-0.162019670852688,-0.177507381381533,-0.0154877105288454,0.0523089151636867,-2.65946720736913,3.25655104548501,3.31033319669499,3.07983826293794,-0.23049493375704,0.024579357219296,ENSG00000156127,BATF,protein_coding,14,1,75522425,75547015,q24.3,basic leucine zipper ATF-like transcription factor [Source:HGNC Symbol;Acc:HGNC:958],NA,BATF,10538,NM_006399
ZNF354C_TF,ZNF354C,ZNF354C_TF,ZNF354C,TF,97,-2.12696871708705,-0.111467030517488,-0.108028585061895,-0.12276477987158,-0.0147361948096857,0.0523089151636867,-0.914124903029605,2.24991518945322,2.27634463725493,2.1630755752476,-0.113269062007332,0.474343168775276,ENSG00000177932,ZNF354C,protein_coding,5,1,179060415,179083537,q35.3,zinc finger protein 354C [Source:HGNC Symbol;Acc:HGNC:16736],NA,ZNF354C,30832,NM_014594
KCMF1_SIG,KCMF1,KCMF1_SIG,KCMF1,SIG,24,-2.12694479038319,-0.00894519201495163,-0.00233064769103498,-0.0306786947935349,-0.0283480471024998,0.0523089151636867,-2.23746832977716,6.08762601705673,6.10712372395801,6.02356212295251,-0.0835616010055081,0.0614691989638782,ENSG00000176407,KCMF1,protein_coding,2,1,84971093,85059472,p11.2,potassium channel modulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:20589],NA,KCMF1,56888,NM_020122
MARK2_SIG,MARK2,MARK2_SIG,MARK2,SIG,40,-2.12631066650124,0.508955388839466,0.514660366977368,0.490210460672076,-0.0244499063052912,0.0523815416552562,-1.09228575687024,6.45230316016213,6.46699454842123,6.40403145588223,-0.0629630925389923,0.385871300702469,ENSG00000072518,MARK2,protein_coding,11,1,63838928,63911019,q13.1,microtubule affinity regulating kinase 2 [Source:HGNC Symbol;Acc:HGNC:3332],NA,MARK2,2011,NM_001039469;NM_001163296;NM_001163297;NM_004954;NM_017490
IWS1_SIG,IWS1,IWS1_SIG,IWS1,SIG,53,2.12530796108441,0.448955804940319,0.442246956702241,0.470999163436863,0.0287522067346219,0.0525023147380536,2.19487445193101,5.86472476329842,5.83030109108606,5.97783111485332,0.147530023767267,0.0670674219447682,ENSG00000163166,IWS1,protein_coding,2,-1,127436207,127526886,q14.3,IWS1, SUPT6H interacting protein [Source:HGNC Symbol;Acc:HGNC:25467],NA,IWS1,55677,NM_017969
GANC_SIG,GANC,GANC_SIG,GANC,SIG,34,-2.12506163819356,0.309496944455106,0.314883132768729,0.291799468567487,-0.0230836642012424,0.052524538253201,-0.759212016775114,4.76492827055607,4.77730652873391,4.72425685082887,-0.0530496779050446,0.558178441774563,ENSG00000214013,GANC,protein_coding,15,1,42273233,42356935,q15.1,glucosidase alpha, neutral C [Source:HGNC Symbol;Acc:HGNC:4139],NA,GANC,2595,NM_001301409;NM_001301410;NM_198141
NCBP1_SIG,NCBP1,NCBP1_SIG,NCBP1,SIG,16,2.12379854255172,0.622678280198307,0.615610821956064,0.645899928708531,0.0302891067524671,0.0526796407074625,2.10463649959264,5.46947394779961,5.43983945911596,5.56684441061731,0.127004951501356,0.0796937769093057,ENSG00000136937,NCBP1,protein_coding,9,1,97633668,97673748,q22.33,nuclear cap binding protein subunit 1 [Source:HGNC Symbol;Acc:HGNC:7658],NA,NCBP1,4686,NM_001351504;NM_001351505;NM_001351506;NM_001351507;NM_002486
POLD4_SIG,POLD4,POLD4_SIG,POLD4,SIG,49,-2.12345165314298,0.257891700195764,0.263538402883404,0.239338248507804,-0.0242001543756003,0.0527103543579444,-2.27435196816352,3.45541760092936,3.48922558671282,3.34433421906942,-0.144891367643403,0.0569235389585513,ENSG00000175482,POLD4,protein_coding,11,-1,67350772,67356972,q13.2,DNA polymerase delta 4, accessory subunit [Source:HGNC Symbol;Acc:HGNC:14106],NA,POLD4,57804,NM_001256870;NM_021173
PRKDC_SIG,PRKDC,PRKDC_SIG,PRKDC,SIG,20,2.12341181924435,0.696320250068194,0.688542749296041,0.721874895462411,0.0333321461663703,0.0527103543579444,1.6423582435974,7.86380210503915,7.83098183682242,7.97164012917985,0.140658292357431,0.178654417924683,ENSG00000253729,PRKDC,protein_coding,8,-1,47773108,47960183,q11.21,protein kinase, DNA-activated, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9413],Immunodeficiency 26 with or without neurologic abnormalities;Severe combined immunodeficiency due to DNA-PKcs deficiency,PRKDC,5591,NM_001081640;NM_006904
NT5DC1_SIG,NT5DC1,NT5DC1_SIG,NT5DC1,SIG,17,2.12144301493401,0.065249147485741,0.0623165998337863,0.0748846611993064,0.0125680613655201,0.0529585743571166,1.38086912557178,4.42454839334147,4.39726931677185,4.51417964492735,0.116910328155495,0.26377212848413,ENSG00000178425,NT5DC1,protein_coding,6,1,116100851,116249497,q22.1,5'-nucleotidase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21556],NA,NT5DC1,221294,NM_152729
PRAG1_SIG,PRAG1,PRAG1_SIG,PRAG1,SIG,45,2.1193984792924,0.0903949780041142,0.0876793601845207,0.0993177222684929,0.0116383620839721,0.0532177727793923,3.65166540961566,2.90731842359057,2.78963097921639,3.29400574082,0.504374761603603,0.0017034270657255,ENSG00000275342,PRAG1,protein_coding,8,-1,8317736,8386498,p23.1,PEAK1 related, kinase-activating pseudokinase 1 [Source:HGNC Symbol;Acc:HGNC:25438],NA,PRAG1,157285,NM_001080826
PIP4K2C_SIG,PIP4K2C,PIP4K2C_SIG,PIP4K2C,SIG,104,2.11908919614886,0.0489513484245905,0.04610090713557,0.0583170840885149,0.012216176952945,0.0532485520812592,0.584343678066461,4.50361211921559,4.49214997655958,4.54127344508535,0.0491234685257691,0.660712920573705,ENSG00000166908,PIP4K2C,protein_coding,12,1,57591174,57603418,q13.3,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma [Source:HGNC Symbol;Acc:HGNC:23786],NA,PIP4K2C,79837,NM_001146258;NM_001146259;NM_001146260;NM_024779
HR_SIG,HR,HR_SIG,HR,SIG,52,-2.11848245648166,-0.0998009459019955,-0.0965475747656783,-0.110490593921324,-0.0139430191556452,0.0533186441164065,0.153084245508829,0.435706031325605,0.433498009529436,0.442960960084446,0.00946295055501031,0.914325108175546,ENSG00000168453,HR,protein_coding,8,-1,22114419,22133384,p21.3,HR, lysine demethylase and nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:5172],Alopecia universalis;ALOPECIA UNIVERSALIS CONGENITA;ATRICHIA WITH PAPULAR LESIONS;HYPOTRICHOSIS 4;Marie Unna hereditary hypotrichosis,HR,55806,NM_005144;NM_018411
EIF4G1_SIG,EIF4G1,EIF4G1_SIG,EIF4G1,SIG,30,2.11831117681973,0.447714256386325,0.442645094420943,0.46437007427258,0.0217249798516369,0.053331228550936,2.31060908013611,8.67635451345822,8.64905678104082,8.76604706282966,0.116990281788842,0.0528114038869557,ENSG00000114867,EIF4G1,protein_coding,3,1,184314495,184335358,q27.1,eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296],Hereditary late-onset Parkinson disease;PARKINSON DISEASE 18 AUTOSOMAL DOMINANT SUSCEPTIBILITY TO,EIF4G1,1981,NM_001194946;NM_001194947;NM_001291157;NM_004953;NM_182917;NM_198241;NM_198242;NM_198244
ABHD8_SIG,ABHD8,ABHD8_SIG,ABHD8,SIG,22,-2.11778643403058,0.349371994834909,0.352649916461435,0.338601680919183,-0.014048235542251,0.0533905616858289,-2.26802467476281,3.61686491649968,3.65309165438932,3.49783420629087,-0.155257448098448,0.0577177409232809,ENSG00000127220,ABHD8,protein_coding,19,-1,17292131,17310236,p13.11,abhydrolase domain containing 8 [Source:HGNC Symbol;Acc:HGNC:23759],NA,ABHD8,79575,NM_024527
CPT1B_SIG,CPT1B,CPT1B_SIG,CPT1B,SIG,17,2.11702212031174,-0.0543628198803493,-0.0570873878705511,-0.0454106679125436,0.0116767199580073,0.0534816818352677,1.87713554289457,1.66431235765374,1.63235195726522,1.76932510178743,0.136973144522204,0.121014935372604,ENSG00000205560,CPT1B,protein_coding,22,-1,50568861,50578465,q13.33,carnitine palmitoyltransferase 1B [Source:HGNC Symbol;Acc:HGNC:2329],NA,CPT1B,1375,NM_001145134;NM_001145135;NM_001145137;NM_004377;NM_152245;NM_152246
DPYD_SIG,DPYD,DPYD_SIG,DPYD,SIG,21,-2.11581124189695,0.564163551489386,0.572291312889556,0.537458049745971,-0.0348332631435856,0.0536322085930328,0.118396201625475,5.48619493044884,5.48255662438155,5.49814936466995,0.0155927402883967,0.934352608749475,ENSG00000188641,DPYD,protein_coding,1,-1,97077743,97995000,p21.3,dihydropyrimidine dehydrogenase [Source:HGNC Symbol;Acc:HGNC:3012],1p21.3 microdeletion syndrome;5-@FLUOROURACIL TOXICITY;DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY,DPYD,1806,NM_000110;NM_001160301
RARG_TF,RARG,RARG_TF,RARG,TF,215,-2.11447450441767,0.0969994264246846,0.100398011818257,0.0858326458458035,-0.0145653659724536,0.0537998469562317,-0.207382729256143,3.17569281699317,3.18083516568947,3.15879652841962,-0.0220386372698513,0.88303943968435,ENSG00000172819,RARG,protein_coding,12,-1,53210567,53232980,q13.13,retinoic acid receptor gamma [Source:HGNC Symbol;Acc:HGNC:9866],NA,RARG,5916,NM_000966;NM_001042728;NM_001243730;NM_001243731;NM_001243732
CBX2_TF,CBX2,CBX2_TF,CBX2,TF,175,2.11386261300788,0.0807970024439875,0.0747709447016627,0.100596906454483,0.0258259617528207,0.0538712282793449,2.0621746892215,4.19458504940851,4.10332617676897,4.49443563093843,0.391109454169463,0.0863573256024916,ENSG00000173894,CBX2,protein_coding,17,1,79778148,79787983,q25.3,chromobox 2 [Source:HGNC Symbol;Acc:HGNC:1552],46XY complete gonadal dysgenesis;46XY SEX REVERSAL 5,CBX2,84733,NM_005189;NM_032647
ZBTB25_TF,ZBTB25,ZBTB25_TF,ZBTB25,TF,259,2.11375376659776,0.0990421783753256,0.0952748601595911,0.111420509655596,0.0161456494960048,0.0538755932420919,2.89369072058318,4.37691765318398,4.3309035804192,4.52810674941111,0.19720316899191,0.01409444165828,ENSG00000089775,ZBTB25,protein_coding,14,-1,64449106,64505213,q23.3,zinc finger and BTB domain containing 25 [Source:HGNC Symbol;Acc:HGNC:13112],NA,ZBTB25,7597,NM_001304507;NM_001304508;NM_001354682;NM_001354683;NM_001354684;NM_001354685;NM_001354686;NM_001354687;NM_006977
NFATC4_TF,NFATC4,NFATC4_TF,NFATC4,TF,163,-2.11277378132671,-0.0962413993697743,-0.0942817352208119,-0.102680295859222,-0.00839856063841035,0.053996200420775,-2.1494340963402,0.504867911531705,0.557574106227857,0.331690414672919,-0.225883691554938,0.0732048210190764,ENSG00000100968,NFATC4,protein_coding,14,1,24365673,24379604,q12,nuclear factor of activated T cells 4 [Source:HGNC Symbol;Acc:HGNC:7778],NA,NFATC4,4776,NM_001136022;NM_001198965;NM_001198966;NM_001198967;NM_001288802;NM_001320043;NM_001363681;NM_004554
TRPV6_SIG,TRPV6,TRPV6_SIG,TRPV6,SIG,12,2.11118920052772,-0.087983664767886,-0.0908440143505913,-0.0785853732818542,0.0122586410687373,0.0541979854530571,0.458030138226371,0.614881296011698,0.605087640437934,0.647060450039782,0.0419728096018478,0.73469383989598,ENSG00000165125,TRPV6,protein_coding,7,-1,142871208,142885745,q34,transient receptor potential cation channel subfamily V member 6 [Source:HGNC Symbol;Acc:HGNC:14006],HYPERPARATHYROIDISM TRANSIENT NEONATAL,TRPV6,55503,NM_018646
MBNL3_SIG,MBNL3,MBNL3_SIG,MBNL3,SIG,23,2.11092242497977,0.286789676099064,0.282356456556015,0.301355968883367,0.0189995123273519,0.054223532409992,0.824177678206162,6.01859961248604,6.00224711157389,6.07232925834024,0.0700821467663511,0.522059588287595,ENSG00000076770,MBNL3,protein_coding,X,-1,132369317,132489968,q26.2,muscleblind like splicing regulator 3 [Source:HGNC Symbol;Acc:HGNC:20564],NA,MBNL3,55796,NM_001170701;NM_001170702;NM_001170703;NM_001170704;NM_018388;NM_133486
DTX3_SIG,DTX3,DTX3_SIG,DTX3,SIG,79,-2.11063516650172,-0.144526087317593,-0.139574595829416,-0.16079527363589,-0.0212206778064743,0.0542518363164377,-1.53538498554499,2.37146653748591,2.43073442246736,2.17672920111829,-0.254005221349067,0.210475963243248,ENSG00000178498,DTX3,protein_coding,12,1,57604622,57609804,q13.3,deltex E3 ubiquitin ligase 3 [Source:HGNC Symbol;Acc:HGNC:24457],NA,DTX3,196403,NM_001286245;NM_001286246;NM_178502
PSMA1_SIG,PSMA1,PSMA1_SIG,PSMA1,SIG,30,2.10761467959635,0.170499785530737,0.166511952726034,0.183602664746188,0.0170907120201542,0.0546478549663712,1.01960612382461,4.41892591387894,4.40474656153472,4.46551521443853,0.060768652903805,0.420766723448308,ENSG00000129084,PSMA1,protein_coding,11,-1,14504874,14643635,p15.2,proteasome subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:9530],NA,PSMA1,5682,NM_002786;NM_148976
CHID1_SIG,CHID1,CHID1_SIG,CHID1,SIG,46,2.10724281573244,0.44506376425839,0.439808517517564,0.462331003549676,0.0225224860321125,0.0546877584931322,1.36549350257859,4.927218126238,4.90190744949103,5.01038177840663,0.108474328915602,0.269653645673666,ENSG00000177830,CHID1,protein_coding,11,-1,867860,915058,p15.5,chitinase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28474],NA,CHID1,66005,NM_001142674;NM_001142675;NM_001142676;NM_001142677;NM_023947
PLK3_SIG,PLK3,PLK3_SIG,PLK3,SIG,39,-2.10634901156484,0.275636394567341,0.285082818852115,0.244598143345941,-0.0404846755061743,0.0547982283562427,-1.68665622613204,5.39484685220592,5.4434946424094,5.23500411296592,-0.208490529443484,0.166680741028562,ENSG00000173846,PLK3,protein_coding,1,1,44800377,44805990,p34.1,polo like kinase 3 [Source:HGNC Symbol;Acc:HGNC:2154],NA,PLK3,1263,NM_004073
HOMEZ_TF,HOMEZ,HOMEZ_TF,HOMEZ,TF,203,2.10621353615631,0.150594135373607,0.141635718924741,0.180028932277021,0.0383932133522795,0.0548062452013886,1.93320741666976,3.58253322924896,3.52884485326754,3.75893789318791,0.230093039920375,0.109639612914942,ENSG00000215271,HOMEZ,protein_coding,14,-1,23272422,23299447,q11.2,homeobox and leucine zipper encoding [Source:HGNC Symbol;Acc:HGNC:20164],NA,HOMEZ,57594,NM_020834
SH3GL1_SIG,SH3GL1,SH3GL1_SIG,SH3GL1,SIG,15,-2.10600291488251,0.232768408166513,0.238239599453404,0.214791636795298,-0.0234479626581067,0.054824428846708,-0.626612402948135,5.88321239665284,5.89074115744515,5.85847503976384,-0.0322661176813065,0.634655980859226,ENSG00000141985,SH3GL1,protein_coding,19,-1,4360370,4400547,p13.3,SH3 domain containing GRB2 like 1, endophilin A2 [Source:HGNC Symbol;Acc:HGNC:10830],LEUKEMIA ACUTE MYELOID,SH3GL1,6455,NM_001199943;NM_001199944;NM_003025
KCNH8_SIG,KCNH8,KCNH8_SIG,KCNH8,SIG,41,2.10584980897552,0.0226976257581179,0.0188441023470918,0.035359202680061,0.0165151003329692,0.054834836357851,1.13971041325935,1.06065182102737,1.03390842194816,1.14852298943048,0.114614567482325,0.363732042462308,ENSG00000183960,KCNH8,protein_coding,3,1,19148510,19535642,p24.3,potassium voltage-gated channel subfamily H member 8 [Source:HGNC Symbol;Acc:HGNC:18864],NA,KCNH8,131096,NM_144633
FN3KRP_SIG,FN3KRP,FN3KRP_SIG,FN3KRP,SIG,18,2.10421840654955,0.50908220687888,0.503013146355819,0.529023405740367,0.0260102593845486,0.0550455892525749,3.33227243272047,4.84027361009945,4.79617557841169,4.98516714278781,0.188991564376123,0.00439199954319199,ENSG00000141560,FN3KRP,protein_coding,17,1,82716706,82730328,q25.3,fructosamine 3 kinase related protein [Source:HGNC Symbol;Acc:HGNC:25700],NA,FN3KRP,79672,NM_024619
ILF3_SIG,ILF3,ILF3_SIG,ILF3,SIG,44,2.10109501092981,0.418533749810045,0.413300087956838,0.435730067327724,0.0224299793708854,0.0554605133991973,0.485977586350865,8.89335712029731,8.88786985233903,8.91138671501739,0.0235168626783599,0.717657315394533,ENSG00000129351,ILF3,protein_coding,19,1,10654261,10692417,p13.2,interleukin enhancer binding factor 3 [Source:HGNC Symbol;Acc:HGNC:6038],NA,ILF3,3609,NM_001137673;NM_004516;NM_012218;NM_017620;NM_153464
ATP6V1F_SIG,ATP6V1F,ATP6V1F_SIG,ATP6V1F,SIG,48,-2.10035300126668,0.129569177243756,0.131651777699139,0.122726347176068,-0.00892543052307073,0.0555515165012378,-1.03765287825035,5.98956780077136,6.0033777057785,5.94419239860506,-0.0591853071734353,0.412034316259679,ENSG00000128524,ATP6V1F,protein_coding,7,1,128862856,128865847,q32.1,ATPase H+ transporting V1 subunit F [Source:HGNC Symbol;Acc:HGNC:16832],NA,ATP6V1F,9296,NM_001198909;NM_004231
NR2F6_TF,NR2F6,NR2F6_TF,NR2F6,TF,214,2.10010976554735,0.116625995522607,0.113280178418031,0.1276193945805,0.0143392161624686,0.0555743586696752,0.394159577070213,2.99612282611772,2.98815086135267,3.02231642463143,0.0341655632787639,0.771877941751638,ENSG00000160113,NR2F6,protein_coding,19,-1,17231883,17245940,p13.11,nuclear receptor subfamily 2 group F member 6 [Source:HGNC Symbol;Acc:HGNC:7977],NA,NR2F6,2063,NM_005234
SECISBP2_SIG,SECISBP2,SECISBP2_SIG,SECISBP2,SIG,84,2.09851304151638,0.231377101300509,0.226505107737854,0.247385080149235,0.0208799724113811,0.0557827355617346,0.829654196022083,6.41953999416316,6.40839417593978,6.45616196832571,0.0477677923859323,0.519339672376615,ENSG00000187742,SECISBP2,protein_coding,9,1,89318506,89359662,q22.2,SECIS binding protein 2 [Source:HGNC Symbol;Acc:HGNC:30972],Short stature-delayed bone age due to thyroid hormone metabolism deficiency;THYROID HORMONE METABOLISM ABNORMAL,SECISBP2,79048,NM_001282688;NM_001282689;NM_001282690;NM_001354696;NM_001354697;NM_001354698;NM_001354702;NM_024077
IL12RB1_SIG,IL12RB1,IL12RB1_SIG,IL12RB1,SIG,70,-2.09805028420191,0.16006380288259,0.164439247138862,0.145687343183411,-0.0187519039554514,0.0558358043250625,-2.00904843401839,3.80541652939613,3.86136113757419,3.62159853109677,-0.239762606477424,0.0954639281641893,ENSG00000096996,IL12RB1,protein_coding,19,-1,18058995,18098944,p13.11,interleukin 12 receptor subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:5971],IMMUNODEFICIENCY 30;Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency;Primary biliary cholangitis,IL12RB1,3594,NM_001290023;NM_001290024;NM_005535;NM_153701
SLC25A1_SIG,SLC25A1,SLC25A1_SIG,SLC25A1,SIG,20,2.09775575459142,0.388148282391173,0.384267023251518,0.400900990992897,0.0166339677413793,0.0558657905618708,0.404147343571843,5.14621197065042,5.13944172263961,5.16845707125733,0.029015348617717,0.765814543013296,ENSG00000100075,SLC25A1,protein_coding,22,-1,19175581,19178739,q11.21,solute carrier family 25 member 1 [Source:HGNC Symbol;Acc:HGNC:10979],COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA;DL-2-hydroxyglutaric aciduria;MYASTHENIC SYNDROME CONGENITAL 23 PRESYNAPTIC;Presynaptic congenital myasthenic syndromes,SLC25A1,6576,NM_001256534;NM_001287387;NM_005984
NCOA3_TF,NCOA3,NCOA3_TF,NCOA3,TF,280,2.09646051067987,0.140060481915891,0.137275388773632,0.149211502240456,0.0119361134668242,0.0560335265374828,2.29226410872313,6.92216711826374,6.89197911317283,7.02135627784818,0.129377164675347,0.0548388808519588,ENSG00000124151,NCOA3,protein_coding,20,1,47501887,47656877,q13.12,nuclear receptor coactivator 3 [Source:HGNC Symbol;Acc:HGNC:7670],Neurodevelopment disorder,NCOA3,8202,NM_001174087;NM_001174088;NM_006534;NM_181659
TRMU_SIG,TRMU,TRMU_SIG,TRMU,SIG,36,2.096006962194,0.297280745512559,0.295156287094904,0.304261108884855,0.00910482178995054,0.0560753786743629,1.97477693797151,4.66629190333303,4.6434025624772,4.74149973757363,0.09809717509643,0.101741078095925,ENSG00000100416,TRMU,protein_coding,22,1,46330875,46357340,q13.31,tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase [Source:HGNC Symbol;Acc:HGNC:25481],Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;Deafness aminoglycoside-induced;LIVER FAILURE INFANTILE TRANSIENT;Mitochondrial myopathy with reversible cytochrome C oxidase deficiency;Mitochondrial non-syndromic sensorineural deafness;Mitochondrial nonsyndromic sensorineural deafness with susceptibility to aminoglycoside exposure,TRMU,55687,NM_001282782;NM_001282783;NM_001282784;NM_001282785;NM_018006
ABCC2_SIG,ABCC2,ABCC2_SIG,ABCC2,SIG,46,2.09600422923676,0.000331024329816318,-0.00181735960558356,0.00739000011755878,0.00920735972314236,0.0560753786743629,1.68082490648731,2.04718093084418,2.02010717425075,2.13613755965116,0.116030385400405,0.168179018698044,ENSG00000023839,ABCC2,protein_coding,10,1,99782640,99852594,q24.2,ATP binding cassette subfamily C member 2 [Source:HGNC Symbol;Acc:HGNC:53],DUBIN-JOHNSON SYNDROME,ABCC2,1244,NM_000392
BBX_TF,BBX,BBX_TF,BBX,TF,78,2.09538374415563,0.183835171174427,0.179979624782361,0.196503395034073,0.0165237702517122,0.0561504429606707,2.12690631340949,6.17345988836349,6.13829727783066,6.28899418011418,0.150696902283516,0.0764385927644333,ENSG00000114439,BBX,protein_coding,3,1,107522936,107811339,q13.12,BBX, HMG-box containing [Source:HGNC Symbol;Acc:HGNC:14422],NA,BBX,56987,NM_001142568;NM_001276286;NM_020235
TLE3_SIG,TLE3,TLE3_SIG,TLE3,SIG,16,-2.09415489335702,0.481194488323907,0.487228298666546,0.461369111483807,-0.0258591871827397,0.0563097014887492,-0.204474627919359,7.46430034769636,7.46903204762007,7.44875333366131,-0.0202787139587536,0.884498476027666,ENSG00000140332,TLE3,protein_coding,15,-1,70047790,70098176,q23,TLE family member 3, transcriptional corepressor [Source:HGNC Symbol;Acc:HGNC:11839],NA,TLE3,7090,NM_001105192;NM_001282979;NM_001282980;NM_001282981;NM_001282982;NM_005078;NM_020908
HGF_SIG,HGF,HGF_SIG,HGF,SIG,67,-2.09306500331841,0.0940325224362549,0.0969077464325139,0.084585357877118,-0.0123223885553959,0.0564500700102962,-0.144365929722447,5.09788732926878,5.1060139755983,5.07118549132893,-0.034828484269374,0.918973336726048,ENSG00000019991,HGF,protein_coding,7,-1,81699008,81770438,q21.11,hepatocyte growth factor [Source:HGNC Symbol;Acc:HGNC:4893],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 39,HGF,3082,NM_000601;NM_001010931;NM_001010932;NM_001010933;NM_001010934
ARHGAP27_SIG,ARHGAP27,ARHGAP27_SIG,ARHGAP27,SIG,65,-2.09208366106531,0.465447209540077,0.472256039799081,0.443075338689064,-0.0291807011100169,0.056575652128137,-0.337780996812298,6.93890371937047,6.94629560498754,6.91461609520008,-0.0316795097874625,0.805083311969183,ENSG00000159314,ARHGAP27,protein_coding,17,-1,45393902,45434421,q21.31,Rho GTPase activating protein 27 [Source:HGNC Symbol;Acc:HGNC:31813],NA,ARHGAP27,201176,NM_001282290;NM_174919;NM_199282
SLC35G1_SIG,SLC35G1,SLC35G1_SIG,SLC35G1,SIG,123,-2.09185330284698,-0.131853042137877,-0.128695615149117,-0.142227445100946,-0.013531829951829,0.0565953914466181,-1.85720039404694,1.50898039088492,1.55838226801126,1.3466599374698,-0.211722330541462,0.125330487758899,ENSG00000176273,SLC35G1,protein_coding,10,1,93893973,93956062,q23.33,solute carrier family 35 member G1 [Source:HGNC Symbol;Acc:HGNC:26607],NA,SLC35G1,159371,NM_001134658;NM_001345993;NM_153226
SLC36A4_SIG,SLC36A4,SLC36A4_SIG,SLC36A4,SIG,61,-2.09178888098138,0.193880545333616,0.198562375182832,0.178497390114763,-0.0200649850680688,0.0565953914466181,0.0653854776658129,5.12969200709757,5.1282017802333,5.13458846679448,0.00638668656118315,0.964249661630137,ENSG00000180773,SLC36A4,protein_coding,11,-1,93144174,93197991,q21,solute carrier family 36 member 4 [Source:HGNC Symbol;Acc:HGNC:19660],NA,SLC36A4,120103,NM_001286139;NM_152313
ZNF699_TF,ZNF699,ZNF699_TF,ZNF699,TF,109,-2.09071445061277,0.105922223178602,0.110874576886609,0.0896502038522937,-0.0212243730343156,0.0567341974966152,-0.632850847486017,2.48238643551809,2.49263280945732,2.44871977828917,-0.0439130311681537,0.631064287956855,ENSG00000196110,ZNF699,protein_coding,19,-1,9294275,9309838,p13.2,zinc finger protein 699 [Source:HGNC Symbol;Acc:HGNC:24750],NA,ZNF699,374879,NM_198535
PARP6_SIG,PARP6,PARP6_SIG,PARP6,SIG,75,2.08839514870835,0.0787520264602271,0.0731908888952057,0.0970243356024406,0.023833446707235,0.0570471748089011,1.73738022003815,6.37792261063169,6.35520242559271,6.45257464718833,0.097372221595621,0.153339614433746,ENSG00000137817,PARP6,protein_coding,15,-1,72241181,72272999,q23,poly(ADP-ribose) polymerase family member 6 [Source:HGNC Symbol;Acc:HGNC:26921],NA,PARP6,56965,NM_001323515;NM_001323516;NM_001323519;NM_001323521;NM_001323522;NM_001323523;NM_001323524;NM_001323525;NM_001323526;NM_001323528;NM_001323530;NM_001323531;NM_001323532;NM_020214
MTPAP_SIG,MTPAP,MTPAP_SIG,MTPAP,SIG,59,2.08795874724397,0.352740698109727,0.34769058068269,0.369333941084277,0.0216433604015875,0.057097545333816,1.94127004206546,4.84083965031089,4.81540265011843,4.92441836522899,0.10901571511056,0.108081350256526,ENSG00000107951,MTPAP,protein_coding,10,-1,30309801,30374448,p11.23,mitochondrial poly(A) polymerase [Source:HGNC Symbol;Acc:HGNC:25532],Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome;SPASTIC ATAXIA 4 AUTOSOMAL RECESSIVE,MTPAP,55149,NM_018109
TBCA_SIG,TBCA,TBCA_SIG,TBCA,SIG,15,2.08754247903455,0.315008909488179,0.310679169092334,0.329235199360241,0.0185560302679062,0.0571451326920064,1.99359618921875,5.53815941237652,5.50983124825039,5.63123766593381,0.121406417683421,0.0982384457453014,ENSG00000171530,TBCA,protein_coding,5,-1,77691166,77868780,q14.1,tubulin folding cofactor A [Source:HGNC Symbol;Acc:HGNC:11579],NA,TBCA,6902,NM_001297738;NM_001297740;NM_004607
PRAME_SIG,PRAME,PRAME_SIG,PRAME,SIG,20,2.08603452517045,-0.110898612678706,-0.11308806144835,-0.103704709578446,0.00938335186990389,0.0573459345867206,0.622843908922471,1.96949009279937,1.93135194971272,2.09480113436976,0.163449184657039,0.63687970406827,ENSG00000185686,PRAME,protein_coding,22,-1,22547701,22559361,q11.22,preferentially expressed antigen in melanoma [Source:HGNC Symbol;Acc:HGNC:9336],NA,PRAME,23532,NM_001291715;NM_001291716;NM_001291717;NM_001291719;NM_001318126;NM_001318127;NM_006115;NM_206953;NM_206954;NM_206955;NM_206956
FBXO45_SIG,FBXO45,FBXO45_SIG,FBXO45,SIG,31,2.08581186406303,0.226808500152886,0.224234258467329,0.235266722834002,0.011032464366673,0.0573664817470592,1.87702229260712,4.83689026733807,4.80951505633832,4.9268373891944,0.117322332856086,0.121035377090894,ENSG00000174013,FBXO45,protein_coding,3,1,196568611,196589059,q29,F-box protein 45 [Source:HGNC Symbol;Acc:HGNC:29148],NA,FBXO45,200933,NM_001105573
SMAD2_TF,SMAD2,SMAD2_TF,SMAD2,TF,20,2.08456686650306,0.397397353501071,0.394309318538062,0.407543754093815,0.0132344355557531,0.057530882960549,0.923473085643243,6.35630704170707,6.34649840671213,6.3885354138333,0.0420370071211725,0.469136595552174,ENSG00000175387,SMAD2,protein_coding,18,-1,47808957,47931146,q21.1,SMAD family member 2 [Source:HGNC Symbol;Acc:HGNC:6768],Congenital heart disease,SMAD2,4087,NM_001003652;NM_001135937;NM_005901
APEH_SIG,APEH,APEH_SIG,APEH,SIG,55,2.08373658831226,0.235048643325764,0.226934352857362,0.261709883436225,0.0347755305788631,0.0576371471410008,1.44270282268699,6.28718948127119,6.26063301342286,6.37444644705856,0.113813433635692,0.241004399530153,ENSG00000164062,APEH,protein_coding,3,1,49674014,49683971,p21.31,acylaminoacyl-peptide hydrolase [Source:HGNC Symbol;Acc:HGNC:586],NA,APEH,327,NM_001640
MKRN1_SIG,MKRN1,MKRN1_SIG,MKRN1,SIG,19,-2.08324176794655,0.251828939796486,0.257234383357172,0.234068196668519,-0.0231661866886531,0.0576961939813896,-1.30818761609101,7.17084568562729,7.18945731226155,7.1096931981147,-0.0797641141468474,0.291687575757979,ENSG00000133606,MKRN1,protein_coding,7,-1,140453033,140479536,q34,makorin ring finger protein 1 [Source:HGNC Symbol;Acc:HGNC:7112],NA,MKRN1,23608,NM_001145125;NM_001291663;NM_013446
ZBTB47_TF,ZBTB47,ZBTB47_TF,ZBTB47,TF,342,-2.08249094231594,0.245117488269467,0.249668243480838,0.230165006860679,-0.0195032366201591,0.0577914765422982,-0.860168261213565,3.66640950227642,3.68594306510767,3.60222779583087,-0.0837152692768016,0.503023646046153,ENSG00000114853,ZBTB47,protein_coding,3,1,42653697,42667580,p22.1,zinc finger and BTB domain containing 47 [Source:HGNC Symbol;Acc:HGNC:26955],NA,ZBTB47,92999,NM_145166
RADIL_SIG,RADIL,RADIL_SIG,RADIL,SIG,51,-2.08224623114288,-0.0296526939947159,-0.0244088406556475,-0.0468824978230834,-0.022473657167436,0.0578152713307458,-2.90303700769466,0.856991561815565,0.922386852863126,0.642121319802151,-0.280265533060975,0.0137656326778466,ENSG00000157927,RADIL,protein_coding,7,-1,4797055,4883719,p22.1,Rap associating with DIL domain [Source:HGNC Symbol;Acc:HGNC:22226],NA,RADIL,55698,NM_018059
PPIA_SIG,PPIA,PPIA_SIG,PPIA,SIG,27,2.08198854889648,0.401712631003423,0.39797376818066,0.4139974659925,0.0160236978118396,0.0578409099851659,2.92172239791373,7.35103176314082,7.31304923366203,7.47583150285685,0.162782269194814,0.013137658935075,ENSG00000196262,PPIA,protein_coding,7,1,44796680,44824564,p13,peptidylprolyl isomerase A [Source:HGNC Symbol;Acc:HGNC:9253],NA,PPIA,5478,NM_001300981;NM_021130
SLC1A7_SIG,SLC1A7,SLC1A7_SIG,SLC1A7,SIG,8,-2.08085561239457,-0.113141333685965,-0.106826608236981,-0.133889717304055,-0.0270631090670737,0.0579905463256533,-1.73881185513346,0.330282578860547,0.350964088367291,0.262329047624101,-0.0886350407431901,0.152982105831486,ENSG00000162383,SLC1A7,protein_coding,1,-1,53087179,53142632,p32.3,solute carrier family 1 member 7 [Source:HGNC Symbol;Acc:HGNC:10945],NA,SLC1A7,6512,NM_001287595;NM_001287596;NM_001287597;NM_006671
RPS6KA3_SIG,RPS6KA3,RPS6KA3_SIG,RPS6KA3,SIG,29,2.08050685033475,0.292821782550461,0.288942286793463,0.3055686971806,0.0166264103871372,0.0580291680231634,1.76076441996258,7.47791545860264,7.44717944997377,7.57890520124035,0.131725751266577,0.147568200215223,ENSG00000177189,RPS6KA3,protein_coding,X,-1,20149911,20267519,p22.12,ribosomal protein S6 kinase A3 [Source:HGNC Symbol;Acc:HGNC:10432],COFFIN-LOWRY SYNDROME;Coffin-Lowry Syndrome 2 RPS6KA3 XLD;Coffin-Lowry Syndrome 2 RPS6KA3 XLR;MENTAL RETARDATION X-LINKED 19;Symptomatic form of Coffin-Lowry syndrome in female carriers;X-linked non-syndromic intellectual disability,RPS6KA3,6197,NM_004586
ZNF41_TF,ZNF41,ZNF41_TF,ZNF41,TF,128,2.07993054303732,0.242668452116055,0.236740440616204,0.262146204186994,0.0254057635707905,0.0581001168232936,2.72694943651891,3.60282662220785,3.54491056586163,3.79312223591687,0.248211670055236,0.0210097760563747,ENSG00000147124,ZNF41,protein_coding,X,-1,47445879,47482946,p11.3,zinc finger protein 41 [Source:HGNC Symbol;Acc:HGNC:13107],X-linked non-syndromic intellectual disability,ZNF41,7592,NM_001324140;NM_001324142;NM_001324143;NM_001324144;NM_001324147;NM_001324148;NM_001324150;NM_001324151;NM_001324152;NM_001324153;NM_001324154;NM_001324155;NM_001324156;NM_001324157;NM_007130;NM_153380
NUDT15_SIG,NUDT15,NUDT15_SIG,NUDT15,SIG,38,2.07964335428457,0.247874866773906,0.244720895932443,0.258237913824428,0.0135170178919848,0.0581300507905617,2.34616011595529,3.65388294578169,3.60957292621571,3.79947301006992,0.189900083854211,0.0491521849135044,ENSG00000136159,NUDT15,protein_coding,13,1,48037726,48047221,q14.2,nudix hydrolase 15 [Source:HGNC Symbol;Acc:HGNC:23063],Azathioprine or 6-mercatopurine toxicity or dose selection;THIOPURINES POOR METABOLISM OF 2,NUDT15,55270,NM_018283
MVD_SIG,MVD,MVD_SIG,MVD,SIG,32,2.07930759730059,0.107605325785384,0.105399267407059,0.114853803314166,0.00945453590710695,0.0581637613005368,0.955658814315685,4.46240017157869,4.4489865997871,4.50647333603677,0.0574867362496701,0.452663147522349,ENSG00000167508,MVD,protein_coding,16,-1,88651935,88663161,q24.2,mevalonate diphosphate decarboxylase [Source:HGNC Symbol;Acc:HGNC:7529],Disseminated superficial actinic porokeratosis;Porokeratosis 7 multiple types,MVD,4597,NM_002461
DHRS7_SIG,DHRS7,DHRS7_SIG,DHRS7,SIG,33,-2.07925326016605,0.0932713350691089,0.0958591800114961,0.0847684159726938,-0.0110907640388022,0.0581637613005368,-0.895893366999654,6.07752481692949,6.0897928061181,6.0372157095955,-0.052577096522599,0.484045733454308,ENSG00000100612,DHRS7,protein_coding,14,-1,60144119,60169856,q23.1,dehydrogenase/reductase 7 [Source:HGNC Symbol;Acc:HGNC:21524],NA,DHRS7,51635,NM_001322280;NM_001322281;NM_001322282;NM_016029
ALAS2_SIG,ALAS2,ALAS2_SIG,ALAS2,SIG,33,-2.07873753582884,-0.0723079919378543,-0.0524774266633184,-0.137465563554186,-0.0849881368908679,0.0582262265835853,-1.87543941406136,2.93158668223135,3.05662710205623,2.52073958852103,-0.53588751353519,0.121406116002607,ENSG00000158578,ALAS2,protein_coding,X,-1,55009055,55031064,p11.21,5'-aminolevulinate synthase 2 [Source:HGNC Symbol;Acc:HGNC:397],ANEMIA SIDEROBLASTIC 1;PROTOPORPHYRIA ERYTHROPOIETIC X-LINKED;X-linked erythropoietic protoporphyria;X-linked sideroblastic anemia,ALAS2,212,NM_000032;NM_001037967;NM_001037968
CD80_SIG,CD80,CD80_SIG,CD80,SIG,50,2.07836489876489,-0.0427263891012849,-0.0453541930207823,-0.0340921762229364,0.0112620167978459,0.0582602535926819,5.9068067992106,0.67473318736601,0.567903282263804,1.02574573270183,0.457842450438025,2.27588586194465e-07,ENSG00000121594,CD80,protein_coding,3,-1,119524293,119559614,q13.33,CD80 molecule [Source:HGNC Symbol;Acc:HGNC:1700],NA,CD80,941,NM_005191
CX3CR1_SIG,CX3CR1,CX3CR1_SIG,CX3CR1,SIG,79,-2.07834556656346,0.212200423981958,0.221068493407608,0.183062481583393,-0.0380060118242151,0.0582602535926819,-2.36083136572785,3.65067529993553,3.80786539745795,3.13419355093332,-0.67367184652463,0.0476115156007508,ENSG00000168329,CX3CR1,protein_coding,3,-1,39263494,39281735,p22.2,C-X3-C motif chemokine receptor 1 [Source:HGNC Symbol;Acc:HGNC:2558],Coronary Heart Disease Susceptibility To 1;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO;MACULAR DEGENERATION AGE-RELATED 12,CX3CR1,1524,NM_001171171;NM_001171172;NM_001171174;NM_001337
BCKDHA_SIG,BCKDHA,BCKDHA_SIG,BCKDHA,SIG,8,2.0775198736992,0.344683516981463,0.342352899317903,0.352341260733157,0.00998836141525396,0.0583669714884033,2.01807757576283,1.30323953762385,1.28648605535129,1.35828669366227,0.0718006383109712,0.0939059480159381,ENSG00000248098,BCKDHA,protein_coding,19,1,41397808,41425002,q13.2,branched chain keto acid dehydrogenase E1, alpha polypeptide [Source:HGNC Symbol;Acc:HGNC:986],Classic maple syrup urine disease;Intermediate maple syrup urine disease;Intermittent maple syrup urine disease;Maple Syrup Urine Disease;Thiamine-responsive maple syrup urine disease,BCKDHA,593,NM_000709;NM_001164783
KLF13_TF,KLF13,KLF13_TF,KLF13,TF,133,-2.07666335707674,0.0528266801222483,0.0567619515179526,0.03989650267922,-0.0168654488387326,0.0584782517423232,-0.897485370715552,8.42659869409674,8.44158382490696,8.37736183572032,-0.0642219891866417,0.483239259879562,ENSG00000169926,KLF13,protein_coding,15,1,31326835,31435665,q13.3,Kruppel like factor 13 [Source:HGNC Symbol;Acc:HGNC:13672],CHROMOSOME 15q13.3 DELETION SYNDROME,KLF13,51621,NM_015995
PLD4_SIG,PLD4,PLD4_SIG,PLD4,SIG,40,-2.0756625782369,0.175828240569873,0.180561614628817,0.160275725804772,-0.0202858888240448,0.0586103390459784,-0.603724633087307,4.58405975674392,4.61312591225956,4.48855667433539,-0.124569237924171,0.6487494160594,ENSG00000166428,PLD4,protein_coding,14,1,104924713,104937790,q32.33,phospholipase D family member 4 [Source:HGNC Symbol;Acc:HGNC:23792],NA,PLD4,122618,NM_001308174;NM_138790
CAMTA2_TF,CAMTA2,CAMTA2_TF,CAMTA2,TF,212,-2.07320891405526,0.0401734440927098,0.0441548138103692,0.0270918007346861,-0.0170630130756831,0.058951191541716,-0.582451810851546,6.02760536924424,6.03654595051375,5.99822917364441,-0.0383167768693458,0.661718343685471,ENSG00000108509,CAMTA2,protein_coding,17,-1,4967992,4987675,p13.2,calmodulin binding transcription activator 2 [Source:HGNC Symbol;Acc:HGNC:18807],NA,CAMTA2,23125,NM_001171166;NM_001171167;NM_001171168;NM_015099
PHF10_SIG,PHF10,PHF10_SIG,PHF10,SIG,20,2.07262765508069,0.255682737480793,0.251916852270191,0.268056360315628,0.0161395080454374,0.0590237817493643,1.13891259417953,6.39932534967235,6.38211344684978,6.45587874466082,0.0737652978110389,0.364070875700868,ENSG00000130024,PHF10,protein_coding,6,-1,169703902,169725566,q27,PHD finger protein 10 [Source:HGNC Symbol;Acc:HGNC:18250],NA,PHF10,55274,NM_018288;NM_133325
ZNF93_TF,ZNF93,ZNF93_TF,ZNF93,TF,28,2.07032235461129,0.290693663769221,0.285097193861023,0.309082064896154,0.023984871035131,0.0593452009823075,1.00349038252635,3.27794323932067,3.25540017334695,3.35201331323431,0.096613139887367,0.428761672749113,ENSG00000184635,ZNF93,protein_coding,19,1,19900913,19963464,p12,zinc finger protein 93 [Source:HGNC Symbol;Acc:HGNC:13169],NA,ZNF93,81931,NM_031218
ATP6V1B2_SIG,ATP6V1B2,ATP6V1B2_SIG,ATP6V1B2,SIG,23,-2.07012259952657,0.508919469015597,0.515292477624705,0.487979583585671,-0.027312894039034,0.0593536234493318,0.935278388828748,6.98932771725152,6.97181300517647,7.04687605692668,0.0750630517502095,0.463222045551052,ENSG00000147416,ATP6V1B2,protein_coding,8,1,20197381,20226819,p21.3,ATPase H+ transporting V1 subunit B2 [Source:HGNC Symbol;Acc:HGNC:854],Autosomal dominant deafness-onychodystrophy syndrome;DEAFNESS CONGENITAL WITH ONYCHODYSTROPHY AUTOSOMAL DOMINANT;Zimmermann-Laband syndrome;ZIMMERMANN-LABAND SYNDROME 2,ATP6V1B2,526,NM_001693
BATF_SIG,BATF,BATF_SIG,BATF,SIG,15,-2.0701110268228,0.0928653359344871,0.0980002647508083,0.0759934269665743,-0.022006837784234,0.0593536234493318,-2.65946720736913,3.25655104548501,3.31033319669499,3.07983826293794,-0.23049493375704,0.024579357219296,ENSG00000156127,BATF,protein_coding,14,1,75522425,75547015,q24.3,basic leucine zipper ATF-like transcription factor [Source:HGNC Symbol;Acc:HGNC:958],NA,BATF,10538,NM_006399
ROPN1L_SIG,ROPN1L,ROPN1L_SIG,ROPN1L,SIG,39,-2.06943163198392,0.11737834305156,0.123108077134421,0.0985520739221628,-0.024556003212258,0.0594408239657549,-0.472527101856726,1.63742370281188,1.64839546700026,1.60137362047861,-0.0470218465216502,0.725575547365643,ENSG00000145491,ROPN1L,protein_coding,5,1,10441524,10472029,p15.2,rhophilin associated tail protein 1 like [Source:HGNC Symbol;Acc:HGNC:24060],NA,ROPN1L,83853,NM_001201466;NM_031916
TRIM58_SIG,TRIM58,TRIM58_SIG,TRIM58,SIG,55,2.06933039534367,0.137947289247947,0.131082787736558,0.160502079928223,0.0294192921916649,0.059444401540302,2.52625227937807,4.21315885518438,4.12201542404248,4.51263012893633,0.390614704893855,0.0333815325762063,ENSG00000162722,TRIM58,protein_coding,1,1,247857187,247880138,q44,tripartite motif containing 58 [Source:HGNC Symbol;Acc:HGNC:24150],NA,TRIM58,25893,NM_015431
BAIAP2L2_SIG,BAIAP2L2,BAIAP2L2_SIG,BAIAP2L2,SIG,92,2.06905595429941,-0.0450395747159869,-0.0489434151472975,-0.0322126704416809,0.0167307447056167,0.0594730543281421,0.593152029120879,0.884551840528338,0.87729728338357,0.908388242575433,0.0310909591918628,0.655560002049057,ENSG00000128298,BAIAP2L2,protein_coding,22,-1,38084900,38110684,q13.1,BAI1 associated protein 2 like 2 [Source:HGNC Symbol;Acc:HGNC:26203],NA,BAIAP2L2,80115,NM_025045
PSMC2_SIG,PSMC2,PSMC2_SIG,PSMC2,SIG,31,2.068864371531,0.319578673675556,0.317359538249967,0.326870118645348,0.0095105803953815,0.0594887306557353,1.18197402096823,6.0690526252543,6.05747248151757,6.10710166896073,0.049629187443169,0.344765608203271,ENSG00000161057,PSMC2,protein_coding,7,1,103344254,103369395,q22.1,proteasome 26S subunit, ATPase 2 [Source:HGNC Symbol;Acc:HGNC:9548],NA,PSMC2,5701,NM_001204453;NM_002803
IFT52_SIG,IFT52,IFT52_SIG,IFT52,SIG,36,2.06879470264556,0.369364899238068,0.365479278605873,0.382131938458139,0.016652659852266,0.0594887306557353,1.77451516330609,4.20961764841265,4.18640231444938,4.28589660286337,0.0994942884139816,0.144315814876229,ENSG00000101052,IFT52,protein_coding,20,1,43590931,43647296,q13.12,intraflagellar transport 52 [Source:HGNC Symbol;Acc:HGNC:15901],Cranioectodermal dysplasia;SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY,IFT52,51098,NM_001303458;NM_001303459;NM_001323578;NM_001323579;NM_001323580;NM_001323581;NM_016004
MAP3K7_SIG,MAP3K7,MAP3K7_SIG,MAP3K7,SIG,30,2.06539220642076,0.481219371616468,0.476718405431487,0.496008260509979,0.0192898550784916,0.0599720264698352,0.428081935575252,5.9258171137188,5.9213572106306,5.94047108100861,0.0191138703780051,0.751630567942341,ENSG00000135341,MAP3K7,protein_coding,6,-1,90513573,90587072,q15,mitogen-activated protein kinase kinase kinase 7 [Source:HGNC Symbol;Acc:HGNC:6859],CARDIOSPONDYLOCARPOFACIAL SYNDROME;FRONTOMETAPHYSEAL DYSPLASIA;FRONTOMETAPHYSEAL DYSPLASIA 2,MAP3K7,6885,NM_003188;NM_145331;NM_145332;NM_145333
NDUFB2_SIG,NDUFB2,NDUFB2_SIG,NDUFB2,SIG,26,2.06459180930992,0.227473606109798,0.224347438322484,0.237745300268114,0.01339786194563,0.0600695592540348,2.45086122932088,4.1942356720118,4.155395412932,4.32185366613114,0.166458253199133,0.039283191588846,ENSG00000090266,NDUFB2,protein_coding,7,1,140690777,140722790,q34,NADH:ubiquinone oxidoreductase subunit B2 [Source:HGNC Symbol;Acc:HGNC:7697],NA,NDUFB2,4708,NM_004546
FDXACB1_SIG,FDXACB1,FDXACB1_SIG,FDXACB1,SIG,20,2.06457060960096,0.188627215182362,0.182764061408675,0.207891863295905,0.0251278018872302,0.0600695592540348,-0.0371260870288052,1.18141571993588,1.18189244074035,1.17984935157833,-0.00204308916202002,0.979764061755253,ENSG00000255561,FDXACB1,protein_coding,11,-1,111874056,111881243,q23.1,ferredoxin-fold anticodon binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25110],NA,FDXACB1,91893,NM_138378
ZNF581_TF,ZNF581,ZNF581_TF,ZNF581,TF,431,2.06424019140557,0.30532581098969,0.302496350389598,0.314622610104279,0.0121262597146814,0.0600998077593719,2.20508511452947,4.31344797848752,4.28372223665729,4.41111827307256,0.127396036415269,0.0657746874920278,ENSG00000171425,ZNF581,protein_coding,19,1,55635459,55645623,q13.42,zinc finger protein 581 [Source:HGNC Symbol;Acc:HGNC:25017],NA,ZNF581,51545,NM_016535
PTPN1_SIG,PTPN1,PTPN1_SIG,PTPN1,SIG,16,-2.06421036623487,0.284288686980522,0.291655797206806,0.260082467665591,-0.0315733295412145,0.0600998077593719,-0.858426855768717,6.727679194974,6.73922322500976,6.68974881057076,-0.049474414438997,0.503836303273301,ENSG00000196396,PTPN1,protein_coding,20,1,50510321,50585241,q13.13,protein tyrosine phosphatase, non-receptor type 1 [Source:HGNC Symbol;Acc:HGNC:9642],DIABETES MELLITUS NONINSULIN-DEPENDENT,PTPN1,5770,NM_001278618;NM_002827
ZNF367_TF,ZNF367,ZNF367_TF,ZNF367,TF,121,-2.06398993518433,0.263604397561602,0.271558599647563,0.237469162136304,-0.0340894375112588,0.0601208269682727,-3.03842270950184,4.08126189744437,4.15850937183392,3.82744876730731,-0.331060604526609,0.00973314994065481,ENSG00000165244,ZNF367,protein_coding,9,-1,96385941,96418370,q22.32,zinc finger protein 367 [Source:HGNC Symbol;Acc:HGNC:18320],NA,ZNF367,195828,NM_153695
SDF2L1_SIG,SDF2L1,SDF2L1_SIG,SDF2L1,SIG,50,-2.06329818743032,0.255346667473069,0.258569054980712,0.244758822805098,-0.0138102321756137,0.060210761753381,-0.512832734629996,3.59998314689016,3.61000524005262,3.56705341221352,-0.0429518278390956,0.702068765749059,ENSG00000128228,SDF2L1,protein_coding,22,1,21642302,21644299,q11.21,stromal cell derived factor 2 like 1 [Source:HGNC Symbol;Acc:HGNC:10676],NA,SDF2L1,23753,NM_022044
HNRNPA0_SIG,HNRNPA0,HNRNPA0_SIG,HNRNPA0,SIG,29,2.0628781619843,0.499868289210849,0.495772619870809,0.51332548847098,0.0175528686001712,0.0602610228678813,2.1468600396912,7.86482929334005,7.83650565826815,7.95789266571915,0.121387007451005,0.0735437090766259,ENSG00000177733,HNRNPA0,protein_coding,5,-1,137745651,137754376,q31.2,heterogeneous nuclear ribonucleoprotein A0 [Source:HGNC Symbol;Acc:HGNC:5030],NA,HNRNPA0,10949,NM_006805
SLC25A20_SIG,SLC25A20,SLC25A20_SIG,SLC25A20,SIG,47,2.06254745099791,0.219977712700445,0.211543348110331,0.247690624925104,0.0361472768147726,0.0602982374201511,1.59704501284065,4.71392535702839,4.67472480513026,4.84272717040794,0.168002365277682,0.191432283427882,ENSG00000178537,SLC25A20,protein_coding,3,-1,48856926,48898904,p21.31,solute carrier family 25 member 20 [Source:HGNC Symbol;Acc:HGNC:1421],CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY,SLC25A20,788,NM_000387
UBOX5_SIG,UBOX5,UBOX5_SIG,UBOX5,SIG,18,2.06225182216802,0.299818593861443,0.29802590247291,0.305708865566625,0.0076829630937148,0.0603303310905226,0.207226745484735,3.68388811618219,3.68162366290764,3.69132846265572,0.00970479974808387,0.883050569540314,ENSG00000185019,UBOX5,protein_coding,20,-1,3107573,3160196,p13,U-box domain containing 5 [Source:HGNC Symbol;Acc:HGNC:17777],NA,UBOX5,22888,NM_001267584;NM_014948;NM_199415
SETD7_SIG,SETD7,SETD7_SIG,SETD7,SIG,32,-2.06094624493699,0.153311022947997,0.159035401295994,0.13450235123315,-0.0245330500628438,0.060510623916674,-0.667286853441594,5.12506561561169,5.145420016693,5.05818686920165,-0.087233147491352,0.61079705371949,ENSG00000145391,SETD7,protein_coding,4,-1,139495941,139606699,q31.1,SET domain containing 7, histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:30412],NA,SETD7,80854,NM_001306199;NM_001306200;NM_030648
ADRA2B_SIG,ADRA2B,ADRA2B_SIG,ADRA2B,SIG,16,-2.06032694012357,0.143874234222043,0.15508148934194,0.107050395970954,-0.0480310933709854,0.0605903861332121,-0.739450980662148,0.430497147871621,0.442823153463346,0.389997415213094,-0.0528257382502519,0.569324905239126,ENSG00000274286,ADRA2B,protein_coding,2,-1,96112876,96116571,q11.2,adrenoceptor alpha 2B [Source:HGNC Symbol;Acc:HGNC:282],Autosomal Recessive Mental Retardation;Benign adult familial myoclonic epilepsy;Epilepsy familial adult myoclonic 2,ADRA2B,151,NM_000682
TAB1_SIG,TAB1,TAB1_SIG,TAB1,SIG,25,2.05919451440531,0.281442239940386,0.273814004952029,0.306506440616416,0.0326924356643868,0.0607458053813842,1.24288598891582,5.08879972636824,5.0700490806227,5.15040899096073,0.0803599103380232,0.318441154058554,ENSG00000100324,TAB1,protein_coding,22,1,39399778,39437060,q13.1,TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [Source:HGNC Symbol;Acc:HGNC:18157],NA,TAB1,10454,NM_006116;NM_153497
ALDH16A1_SIG,ALDH16A1,ALDH16A1_SIG,ALDH16A1,SIG,12,2.05911492551237,0.402731104963817,0.397989195364434,0.418311665076076,0.0203224697116424,0.0607462513492829,1.29841613355267,4.9833285993112,4.96347609335336,5.04855826174412,0.0850821683907591,0.29561775991733,ENSG00000161618,ALDH16A1,protein_coding,19,1,49453225,49471050,q13.33,aldehyde dehydrogenase 16 family member A1 [Source:HGNC Symbol;Acc:HGNC:28114],NA,ALDH16A1,126133,NM_001145396;NM_153329
HMBS_SIG,HMBS,HMBS_SIG,HMBS,SIG,47,-2.05886012209499,0.180496897208276,0.188441081760787,0.154394576535739,-0.0340465052250478,0.0607614196904242,-0.678623671704663,4.16973187134399,4.19109073444298,4.09955274973301,-0.0915379847099719,0.604227593909125,ENSG00000256269,HMBS,protein_coding,11,1,119084866,119093549,q23.3,hydroxymethylbilane synthase [Source:HGNC Symbol;Acc:HGNC:4982],Acute intermittent porphyria;PORPHYRIA ACUTE INTERMITTENT,HMBS,3145,NM_000190;NM_001024382;NM_001258208;NM_001258209
GTF2H1_SIG,GTF2H1,GTF2H1_SIG,GTF2H1,SIG,53,2.05883701559265,0.235410839402242,0.225762282761124,0.267113239794485,0.0413509570333615,0.0607614196904242,0.84074501813991,5.16885218944184,5.15110042552882,5.22717941372747,0.0760789881986463,0.513322218767776,ENSG00000110768,GTF2H1,protein_coding,11,1,18322295,18367045,p15.1,general transcription factor IIH subunit 1 [Source:HGNC Symbol;Acc:HGNC:4655],NA,GTF2H1,2965,NM_001142307;NM_005316
NOTCH4_SIG,NOTCH4,NOTCH4_SIG,NOTCH4,SIG,15,-2.05878237262228,-0.141780110834675,-0.131924219586085,-0.174163753508612,-0.0422395339225266,0.0607614196904242,-2.02459552351865,1.58717664303118,1.63120039953184,1.44252715738616,-0.188673242145689,0.0928473446933624,ENSG00000204301,NOTCH4,protein_coding,6,-1,32194843,32224067,p21.32,notch 4 [Source:HGNC Symbol;Acc:HGNC:7884],NA,NOTCH4,4855,NM_004557
EIF3E_SIG,EIF3E,EIF3E_SIG,EIF3E,SIG,29,2.05645724695857,1.14560868655774,1.13854402720314,1.16882113872285,0.030277111519713,0.061093554897665,2.3201488514277,8.79512965708905,8.7572989164647,8.91943066199763,0.162131745532937,0.0517991626489815,ENSG00000104408,EIF3E,protein_coding,8,-1,108201216,108435333,q23.1,eukaryotic translation initiation factor 3 subunit E [Source:HGNC Symbol;Acc:HGNC:3277],NA,EIF3E,3646,NM_001568
ASPRV1_SIG,ASPRV1,ASPRV1_SIG,ASPRV1,SIG,57,-2.05558177182929,0.044430546282974,0.0470759004036422,0.0357386684579214,-0.0113372319457209,0.0612119260655937,-1.62492551154585,1.09495348787121,1.11929093351611,1.01498759503799,-0.104303338478114,0.183588459056696,ENSG00000244617,ASPRV1,protein_coding,2,-1,69960089,69962265,p13.3,aspartic peptidase retroviral like 1 [Source:HGNC Symbol;Acc:HGNC:26321],NA,ASPRV1,151516,NM_152792
ZC3H13_SIG,ZC3H13,ZC3H13_SIG,ZC3H13,SIG,83,2.05437959489726,0.399419762607826,0.392507541695276,0.422131345606206,0.0296238039109309,0.0613790274249833,2.06418190790514,6.47195380611958,6.430125616316,6.60938928690278,0.179263670586785,0.0859870423166882,ENSG00000123200,ZC3H13,protein_coding,13,-1,45954465,46052759,q14.13,zinc finger CCCH-type containing 13 [Source:HGNC Symbol;Acc:HGNC:20368],NA,ZC3H13,23091,NM_001076788;NM_001330564;NM_001330565;NM_001330566;NM_001330567;NM_015070
HLA-DQB1_SIG,HLA-DQB1,HLA-DQB1_SIG,HLA-DQB1,SIG,5,-2.0540597884318,0.835220460993864,0.855659554177227,0.768063440534245,-0.087596113642981,0.0614081036470201,-0.0778884181942159,4.90127647876595,4.90640133440721,4.88443766737321,-0.0219636670340044,0.957179039342811,ENSG00000179344,HLA-DQB1,protein_coding,6,-1,32659467,32668383,p21.32,major histocompatibility complex, class II, DQ beta 1 [Source:HGNC Symbol;Acc:HGNC:4944],Bullous pemphigoid;CELIAC DISEASE SUSCEPTIBILITY TO 1;CREUTZFELDT-JAKOB DISEASE;Idiopathic achalasia;Limbic encephalitis with LGI1 antibodies;MULTIPLE SCLEROSIS SUSCEPTIBILITY TO;Narcolepsy type 1;Narcolepsy type 2;Pediatric multiple sclerosis,HLA-DQB1,3119,NM_001243961;NM_002123
ZNF615_TF,ZNF615,ZNF615_TF,ZNF615,TF,26,2.05402162518943,0.198703692790374,0.195229136354801,0.210120092507255,0.0148909561524536,0.0614081036470201,1.59161889700699,3.26512603416545,3.23860854303674,3.35225493358835,0.113646390551619,0.193042287422237,ENSG00000197619,ZNF615,protein_coding,19,-1,51991332,52008230,q13.41,zinc finger protein 615 [Source:HGNC Symbol;Acc:HGNC:24740],NA,ZNF615,284370,NM_001199324;NM_001321317;NM_001321318;NM_001321319;NM_001321320;NM_001321321;NM_001321322;NM_001321323;NM_198480
UTP15_SIG,UTP15,UTP15_SIG,UTP15,SIG,45,2.05390788731288,0.458822379639703,0.453922269386049,0.474922741901709,0.0210004725156607,0.0614081036470201,2.32120563831881,4.03210109208234,3.99820649386865,4.1434690576416,0.145262563772956,0.0516982522544014,ENSG00000164338,UTP15,protein_coding,5,1,73565443,73583380,q13.2,UTP15, small subunit processome component [Source:HGNC Symbol;Acc:HGNC:25758],NA,UTP15,84135,NM_001284430;NM_001284431;NM_032175
COA6_SIG,COA6,COA6_SIG,COA6,SIG,18,2.05387766042504,0.283972379054431,0.276639787949028,0.308065178400754,0.0314253904517254,0.0614081036470201,1.95744288542743,3.04489933751232,3.01518279220758,3.1425394149422,0.127356622734622,0.104930305563562,ENSG00000168275,COA6,protein_coding,1,1,234373456,234385068,q42.2,cytochrome c oxidase assembly factor 6 [Source:HGNC Symbol;Acc:HGNC:18025],CARDIOENCEPHALOMYOPATHY FATAL INFANTILE DUE TO CYTOCHROME c OXIDASEDEFICIENCY 4;Fatal infantile cytochrome C oxidase deficiency,COA6,388753,NM_001012985;NM_001206641;NM_001301733
ATP9A_SIG,ATP9A,ATP9A_SIG,ATP9A,SIG,31,-2.05353186664164,-0.108318086020723,-0.105189796729008,-0.118596750836357,-0.0134069541073488,0.0614381835773074,-0.028752352247316,2.94754971509429,2.94887648064807,2.94319034256044,-0.005686138087634,0.983962826063344,ENSG00000054793,ATP9A,protein_coding,20,-1,51596514,51768634,q13.2,ATPase phospholipid transporting 9A (putative) [Source:HGNC Symbol;Acc:HGNC:13540],NA,ATP9A,10079,NM_006045
RPS27L_SIG,RPS27L,RPS27L_SIG,RPS27L,SIG,13,2.05352226592765,0.182471755235196,0.177941702038135,0.197356215739825,0.0194145137016899,0.0614381835773074,1.00602610744562,4.81453926440612,4.79835078252061,4.86772999060135,0.0693792080807398,0.427560386765818,ENSG00000185088,RPS27L,protein_coding,15,-1,63125872,63158021,q22.2,ribosomal protein S27 like [Source:HGNC Symbol;Acc:HGNC:18476],NA,RPS27L,51065,NM_015920
ZC3H13_TF,ZC3H13,ZC3H13_TF,ZC3H13,TF,165,2.0533911923769,0.345391646927,0.339784573888805,0.363814886909638,0.0240303130208323,0.0614462946809409,2.06418190790514,6.47195380611958,6.430125616316,6.60938928690278,0.179263670586785,0.0859870423166882,ENSG00000123200,ZC3H13,protein_coding,13,-1,45954465,46052759,q14.13,zinc finger CCCH-type containing 13 [Source:HGNC Symbol;Acc:HGNC:20368],NA,ZC3H13,23091,NM_001076788;NM_001330564;NM_001330565;NM_001330566;NM_001330567;NM_015070
MIF4GD_SIG,MIF4GD,MIF4GD_SIG,MIF4GD,SIG,25,-2.05315575274248,0.192941155234297,0.19564221685961,0.184066238465411,-0.0115759783941989,0.0614699340081736,-0.108795481985643,5.0822762661068,5.08372621295529,5.07751215503318,-0.00621405792211773,0.939699500965036,ENSG00000125457,MIF4GD,protein_coding,17,-1,75266228,75271227,q25.1,MIF4G domain containing [Source:HGNC Symbol;Acc:HGNC:24030],NA,MIF4GD,57409,NM_001242498;NM_001242500;NM_001242501;NM_001365751;NM_001365755;NM_020679
SOCS1_SIG,SOCS1,SOCS1_SIG,SOCS1,SIG,17,2.05307660583567,0.194187052341923,0.189516315354917,0.209533759584942,0.0200174442300246,0.0614703249851544,4.08969987169517,1.95843651392068,1.84521646908189,2.33044523267668,0.485228763594787,0.000419032491577222,ENSG00000185338,SOCS1,protein_coding,16,-1,11254405,11256200,p13.13,suppressor of cytokine signaling 1 [Source:HGNC Symbol;Acc:HGNC:19383],NA,SOCS1,8651,NM_003745
TF_SIG,TF,TF_SIG,TF,SIG,12,-2.05259284072164,-0.19782178489939,-0.193180327763599,-0.21307228691699,-0.0198919591533911,0.0615309393344674,-1.37411853463791,1.05126074217879,1.08607856794003,0.936859314677551,-0.149219253262483,0.266402657124457,ENSG00000091513,TF,protein_coding,3,1,133746040,133796641,q22.1,transferrin [Source:HGNC Symbol;Acc:HGNC:11740],Atransferrinemia;Congenital atransferrinemia,TF,7018,NM_001063;NM_001354703;NM_001354704
PIAS1_SIG,PIAS1,PIAS1_SIG,PIAS1,SIG,30,-2.05199748892841,0.248792453556487,0.251585282487176,0.239616015641366,-0.0119692668458099,0.0616082330552378,-0.87723089597066,6.18884564410429,6.19844332287122,6.15731041387011,-0.0411329090011048,0.494017493573327,ENSG00000033800,PIAS1,protein_coding,15,1,68054179,68198603,q23,protein inhibitor of activated STAT 1 [Source:HGNC Symbol;Acc:HGNC:2752],NA,PIAS1,8554,NM_001320687;NM_016166
ATF6_SIG,ATF6,ATF6_SIG,ATF6,SIG,14,2.05186689884589,0.563455888462834,0.559668525986235,0.575900079457377,0.0162315534711424,0.0616162941611851,1.14251968211074,6.60491926997493,6.58938599820156,6.65595716294456,0.0665711647430031,0.362537474671189,ENSG00000118217,ATF6,protein_coding,1,1,161766320,161964070,q23.3,activating transcription factor 6 [Source:HGNC Symbol;Acc:HGNC:791],Achromatopsia;ACHROMATOPSIA 7;Cone rod dystrophy,ATF6,22926,NM_007348
B3GALT4_SIG,B3GALT4,B3GALT4_SIG,B3GALT4,SIG,49,-2.05122090990586,0.420358779477505,0.42654498076005,0.400032689549145,-0.0265122912109045,0.0616932411403158,-1.47808046658531,2.64425247029616,2.67321752116168,2.5490815888809,-0.12413593228078,0.22926848189792,ENSG00000235863,B3GALT4,protein_coding,6,1,33277132,33284832,p21.32,beta-1,3-galactosyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:919],NA,B3GALT4,8705,NM_003782
MGAT1_SIG,MGAT1,MGAT1_SIG,MGAT1,SIG,53,-2.05119795782391,0.426121154377581,0.431991561488111,0.406832673871557,-0.0251588876165538,0.0616932411403158,-0.860837976581487,7.56549635813984,7.57996840354437,7.51794535181064,-0.06202305173373,0.502660969204431,ENSG00000131446,MGAT1,protein_coding,5,-1,180784782,180815652,q35.3,mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7044],NA,MGAT1,4245,NM_001114617;NM_001114618;NM_001114619;NM_001114620;NM_001364384;NM_001364391;NM_001364392;NM_002406
PPEF2_SIG,PPEF2,PPEF2_SIG,PPEF2,SIG,29,2.05066139668273,0.0896251369342507,0.0872413022026834,0.0974577367665431,0.0102164345638597,0.0617619206785306,2.53801753380459,0.26108525648845,0.2463378454267,0.30954103569134,0.0632031902646392,0.0325066846763438,ENSG00000156194,PPEF2,protein_coding,4,-1,75859864,75902571,q21.1,protein phosphatase with EF-hand domain 2 [Source:HGNC Symbol;Acc:HGNC:9244],NA,PPEF2,5470,NM_006239
MGLL_SIG,MGLL,MGLL_SIG,MGLL,SIG,36,-2.05037703048733,0.0422833958044001,0.0444412695228739,0.0351932393008433,-0.00924803022203052,0.061788025801761,-1.63880535829367,5.64572036126312,5.70919655616247,5.43715572087957,-0.272040835282898,0.179682422622171,ENSG00000074416,MGLL,protein_coding,3,-1,127689062,128052190,q21.3,monoglyceride lipase [Source:HGNC Symbol;Acc:HGNC:17038],NA,MGLL,11343,NM_001003794;NM_001256585;NM_007283
VRK3_SIG,VRK3,VRK3_SIG,VRK3,SIG,16,2.05033365912262,0.19156895473335,0.183949890408438,0.21660302322949,0.0326531328210523,0.061788025801761,1.44559491339267,5.29197997148275,5.27474801231667,5.34859926588558,0.0738512535689066,0.240144535316211,ENSG00000105053,VRK3,protein_coding,19,-1,49976468,50025946,q13.33,VRK serine/threonine kinase 3 [Source:HGNC Symbol;Acc:HGNC:18996],NA,VRK3,51231,NM_001025778;NM_001308420;NM_016440
ACVR2B_SIG,ACVR2B,ACVR2B_SIG,ACVR2B,SIG,85,-2.04979318112806,-0.112694856261352,-0.109707462206163,-0.122510579585546,-0.0128031173793828,0.0618573774116702,-1.9113437101724,2.47166819958247,2.53370013883956,2.26784897059489,-0.26585116824467,0.114043212005195,ENSG00000114739,ACVR2B,protein_coding,3,1,38453890,38493142,p22.2,activin A receptor type 2B [Source:HGNC Symbol;Acc:HGNC:174],Heterotaxy Syndrome;HETEROTAXY VISCERAL 4 AUTOSOMAL;Situs ambiguus,ACVR2B,93,NM_001106
ZFPM1_TF,ZFPM1,ZFPM1_TF,ZFPM1,TF,147,2.0489595850957,0.0281177107573537,0.0251942538789039,0.0377233547865459,0.0125291009076419,0.0619642999649031,1.28670968635131,3.93565575754381,3.89817275257915,4.05881420242768,0.160641449848531,0.300264729591368,ENSG00000179588,ZFPM1,protein_coding,16,1,88453280,88537031,q24.2,zinc finger protein, FOG family member 1 [Source:HGNC Symbol;Acc:HGNC:19762],NA,ZFPM1,161882,NM_153813
ERG_TF,ERG,ERG_TF,ERG,TF,280,2.04892569161109,0.0390560167143965,0.0336548174205898,0.0568028143940474,0.0231479969734577,0.0619642999649031,1.02602663104283,5.66525410463462,5.61921471408172,5.81652638787987,0.197311673798144,0.417806415450008,ENSG00000157554,ERG,protein_coding,21,-1,38380027,38661780,q22.2,ETS transcription factor ERG [Source:HGNC Symbol;Acc:HGNC:3446],Ewing sarcoma;Extraskeletal Ewing sarcoma,ERG,2078,NM_001136154;NM_001136155;NM_001243428;NM_001243429;NM_001243432;NM_001291391;NM_001331025;NM_004449;NM_182918
IFIH1_SIG,IFIH1,IFIH1_SIG,IFIH1,SIG,23,-2.04879175352768,0.217206486496979,0.222490541937544,0.199844590049406,-0.0226459518881376,0.0619729060328282,-0.170740414480961,4.98923768273419,4.99238900318432,4.97888334411235,-0.0135056590719716,0.904303232689793,ENSG00000115267,IFIH1,protein_coding,2,-1,162267074,162318703,q24.2,interferon induced with helicase C domain 1 [Source:HGNC Symbol;Acc:HGNC:18873],Aicardi-Goutieres syndrome;Aicardi-Goutieres syndrome 7;Singleton-Merten dysplasia;Singleton-Merten syndrome;SINGLETON-MERTEN SYNDROME 1,IFIH1,64135,NM_022168
COX7B_SIG,COX7B,COX7B_SIG,COX7B,SIG,35,-2.0483206548675,-0.0788135541508992,-0.0763158761582581,-0.0870202104124342,-0.010704334254176,0.0620320287551602,-1.45711767169741,5.77985992310423,5.79498999944543,5.730146815126,-0.0648431843194298,0.236207389303129,ENSG00000131174,COX7B,protein_coding,X,1,77899438,77907376,q21.1,cytochrome c oxidase subunit 7B [Source:HGNC Symbol;Acc:HGNC:2291],LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1;LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME;Microphthalmia with Linear Skin Lesions,COX7B,1349,NM_001866
CD74_SIG,CD74,CD74_SIG,CD74,SIG,46,-2.04748042098466,0.280878545592387,0.287061781513618,0.260562198994055,-0.026499582519563,0.062146585824791,-0.530728655942789,10.7064427460922,10.7264564618491,10.6406833943197,-0.0857730675294483,0.691784816970166,ENSG00000019582,CD74,protein_coding,5,-1,150400041,150412929,q33.1,CD74 molecule [Source:HGNC Symbol;Acc:HGNC:1697],NA,CD74,972,NM_001025158;NM_001025159;NM_004355
CREM_SIG,CREM,CREM_SIG,CREM,SIG,26,-2.04713809517531,0.0883838220121498,0.094867813133146,0.0670792797574481,-0.0277885333756979,0.0621865023757379,-1.07389532058375,3.52086672203302,3.54085546525985,3.45518942285918,-0.0856660424006669,0.394856969841155,ENSG00000095794,CREM,protein_coding,10,1,35126791,35212958,p11.21,cAMP responsive element modulator [Source:HGNC Symbol;Acc:HGNC:2352],NA,CREM,1390,NM_001267562;NM_001267563;NM_001267564;NM_001267565;NM_001267567;NM_001267570;NM_001352445;NM_001352446;NM_001352465;NM_001352466;NM_001352467;NM_001881;NM_181571;NM_182717;NM_182718;NM_182719;NM_182720;NM_182721;NM_182723;NM_182724;NM_182769;NM_182770;NM_182771;NM_182772;NM_183011;NM_183012;NM_183013;NM_183060
EP300_TF,EP300,EP300_TF,EP300,TF,164,-2.04691747887442,0.0543880727177894,0.0584115793348869,0.0411679795473263,-0.0172435997875605,0.0622081544252496,-1.65615665673546,7.99947599508416,8.02145015178296,7.92727519450236,-0.0941749572806029,0.174798148702667,ENSG00000100393,EP300,protein_coding,22,1,41092592,41180077,q13.2,E1A binding protein p300 [Source:HGNC Symbol;Acc:HGNC:3373],Colorectal Cancer;RUBINSTEIN-TAYBI SYNDROME 1;RUBINSTEIN-TAYBI SYNDROME 2;Rubinstein-Taybi syndrome due to EP300 haploinsufficiency;RUBINSTEIN-TAYBI SYNDROME TYPE 2,EP300,2033,NM_001429
MAPK9_SIG,MAPK9,MAPK9_SIG,MAPK9,SIG,7,2.04574489261473,0.26392742489619,0.261179065422105,0.272957748882469,0.011778683460364,0.062372998343811,2.73172884028599,5.40488170921347,5.37889731132196,5.49025901657129,0.111361705249327,0.0207798792259082,ENSG00000050748,MAPK9,protein_coding,5,-1,180233143,180292099,q35.3,mitogen-activated protein kinase 9 [Source:HGNC Symbol;Acc:HGNC:6886],NA,MAPK9,5601,NM_001135044;NM_001308244;NM_001364609;NM_002752;NM_139068;NM_139069;NM_139070
BRIX1_SIG,BRIX1,BRIX1_SIG,BRIX1,SIG,30,2.04542302606714,0.496930100232343,0.492365501486746,0.511928067539306,0.0195625660525595,0.0624099519778909,1.82162645155534,4.73711633712073,4.71098562020849,4.82297440697525,0.111988786766765,0.133225590928936,ENSG00000113460,BRIX1,protein_coding,5,1,34915376,34925996,p13.2,BRX1, biogenesis of ribosomes [Source:HGNC Symbol;Acc:HGNC:24170],NA,BRIX1,55299,NM_018321
ZEB1_TF,ZEB1,ZEB1_TF,ZEB1,TF,482,2.04436634971415,-0.0561571624137017,-0.0599295959512025,-0.0437620236476279,0.0161675723035746,0.0625526567431901,2.42963585639828,4.73693297623191,4.64880172415081,5.02650709021264,0.377705366061829,0.0411196572765801,ENSG00000148516,ZEB1,protein_coding,10,1,31318495,31529814,p11.22,zinc finger E-box binding homeobox 1 [Source:HGNC Symbol;Acc:HGNC:11642],CORNEAL DYSTROPHY FUCHS ENDOTHELIAL 6;CORNEAL DYSTROPHY FUCHS ENDOTHELIAL TYPE 6;CORNEAL DYSTROPHY POSTERIOR POLYMORPHOUS 3;Fuchs endothelial corneal dystrophy;Posterior polymorphous corneal dystrophy;POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY TYPE 3,ZEB1,6935,NM_001128128;NM_001174093;NM_001174094;NM_001174095;NM_001174096;NM_001323638;NM_001323641;NM_001323642;NM_001323643;NM_001323644;NM_001323645;NM_001323646;NM_001323647;NM_001323648;NM_001323649;NM_001323650;NM_001323651;NM_001323652;NM_001323653;NM_001323654;NM_001323655;NM_001323656;NM_001323657;NM_001323658;NM_001323659;NM_001323660;NM_001323661;NM_001323662;NM_001323663;NM_001323664;NM_001323665;NM_001323666;NM_001323671;NM_001323672;NM_001323673;NM_001323674;NM_001323675;NM_001323676;NM_001323677;NM_001323678;NM_030751
ARFRP1_SIG,ARFRP1,ARFRP1_SIG,ARFRP1,SIG,22,2.04432356053638,0.367013415021466,0.360589670399609,0.388120004493282,0.0275303340936734,0.0625526567431901,0.911623662180567,4.63354364365511,4.61990373979082,4.6783604706378,0.0584567308469782,0.47583681923532,ENSG00000101246,ARFRP1,protein_coding,20,-1,63698642,63708025,q13.33,ADP ribosylation factor related protein 1 [Source:HGNC Symbol;Acc:HGNC:662],NA,ARFRP1,10139,NM_001134758;NM_001267544;NM_001267545;NM_001267546;NM_001267547;NM_001267548;NM_001267549;NM_003224
GEMIN6_SIG,GEMIN6,GEMIN6_SIG,GEMIN6,SIG,138,2.04360342419453,0.185177886089909,0.174976048883766,0.218698208338665,0.0437221594548982,0.0626498537175491,2.01733726373266,2.42901682479793,2.37712032899614,2.59953388243237,0.222413553436225,0.0940278142502565,ENSG00000152147,GEMIN6,protein_coding,2,1,38751534,38785002,p22.1,gem nuclear organelle associated protein 6 [Source:HGNC Symbol;Acc:HGNC:20044],NA,GEMIN6,79833,NM_024775
PISD_SIG,PISD,PISD_SIG,PISD,SIG,24,-2.04321813472356,0.183343032188189,0.188679511126698,0.165808887104519,-0.0228706240221794,0.062696530190452,-1.211101278069,5.99903224231186,6.01537769991148,5.94532573877028,-0.070051961141197,0.332166858793058,ENSG00000241878,PISD,protein_coding,22,-1,31618491,31662432,q12.2,phosphatidylserine decarboxylase [Source:HGNC Symbol;Acc:HGNC:8999],NA,PISD,23761,NM_001326411;NM_001326412;NM_001326413;NM_001326414;NM_001326415;NM_001326416;NM_001326417;NM_001326418;NM_001326419;NM_001326420;NM_001326421;NM_014338;NM_178022
FGF13_SIG,FGF13,FGF13_SIG,FGF13,SIG,36,-2.04300097192119,-0.0976506790328051,-0.0938881181661231,-0.110013379023332,-0.0161252608572085,0.0627178042960284,-0.871449238450157,0.750701630106949,0.779743166793605,0.655279438136507,-0.124463728657099,0.497144405858443,ENSG00000129682,FGF13,protein_coding,X,-1,138614727,139222777,q27.1,fibroblast growth factor 13 [Source:HGNC Symbol;Acc:HGNC:3670],NA,FGF13,2258,NM_001139498;NM_001139500;NM_001139501;NM_001139502;NM_004114;NM_033642
IDH3A_SIG,IDH3A,IDH3A_SIG,IDH3A,SIG,50,2.04240050832195,0.153284543611122,0.148724376091905,0.168267951174262,0.0195435750823569,0.0627970913576731,1.49174342410843,5.45448889050262,5.43087046941345,5.53209227408131,0.101221804667855,0.224722602534198,ENSG00000166411,IDH3A,protein_coding,15,1,78131498,78171945,q25.1,isocitrate dehydrogenase 3 (NAD(+)) alpha [Source:HGNC Symbol;Acc:HGNC:5384],NA,IDH3A,3419,NM_005530
NEK6_SIG,NEK6,NEK6_SIG,NEK6,SIG,18,2.04127828777575,0.314574257720917,0.310681793866646,0.327363781813521,0.0166819879468749,0.0629555753157359,1.62923193974572,5.8391018251939,5.80308287793835,5.95744979474784,0.154366916809494,0.18238502098452,ENSG00000119408,NEK6,protein_coding,9,1,124257606,124353307,q33.3,NIMA related kinase 6 [Source:HGNC Symbol;Acc:HGNC:7749],NA,NEK6,10783,NM_001145001;NM_001166167;NM_001166168;NM_001166169;NM_001166170;NM_001166171;NM_014397
MTF2_TF,MTF2,MTF2_TF,MTF2,TF,69,2.04105729791603,0.351535911420147,0.348103091632478,0.362815176436775,0.0147120848042971,0.0629775009418678,-0.291414891011056,5.53947495677937,5.54402809218975,5.52451465471671,-0.0195134374730398,0.832879997065976,ENSG00000143033,MTF2,protein_coding,1,1,93079235,93139079,p22.1,metal response element binding transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:29535],NA,MTF2,22823,NM_001164391;NM_001164392;NM_001164393;NM_007358
ICAM3_SIG,ICAM3,ICAM3_SIG,ICAM3,SIG,54,-2.03952313710597,0.160511119373227,0.164291954879874,0.148088374137099,-0.0162035807427751,0.0631990310326772,-0.915311777449287,7.72241845889885,7.74474955262803,7.64904486521723,-0.0957046874108018,0.473751595108423,ENSG00000076662,ICAM3,protein_coding,19,-1,10333776,10339661,p13.2,intercellular adhesion molecule 3 [Source:HGNC Symbol;Acc:HGNC:5346],NA,ICAM3,3385,NM_001320605;NM_001320606;NM_001320608;NM_002162
PRDX1_SIG,PRDX1,PRDX1_SIG,PRDX1,SIG,19,2.03924650562244,0.137032283357331,0.132304970696929,0.152564882098652,0.0202599114017223,0.0632123368069571,0.908966592711833,6.37753399938775,6.3544494130066,6.4533833546401,0.0989339416334962,0.477183987478686,ENSG00000117450,PRDX1,protein_coding,1,-1,45511036,45523047,p34.1,peroxiredoxin 1 [Source:HGNC Symbol;Acc:HGNC:9352],METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA cblC TYPE,PRDX1,5052,NM_001202431;NM_002574;NM_181696;NM_181697
RRM2B_SIG,RRM2B,RRM2B_SIG,RRM2B,SIG,14,2.03913198942294,0.332476250700228,0.329794644723825,0.341287241765549,0.0114925970417238,0.0632123368069571,2.43031233441347,5.01111300880754,4.97863113238446,5.11783917419767,0.139208041813219,0.0410674438293721,ENSG00000048392,RRM2B,protein_coding,8,-1,102204502,102239118,q22.3,ribonucleotide reductase regulatory TP53 inducible subunit M2B [Source:HGNC Symbol;Acc:HGNC:17296],Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy;Autosomal dominant progressive external ophthalmoplegia;KEARNS-SAYRE SYNDROME;Mitochondrial depletion syndrome;MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY);Mitochondrial DNA depletion syndrome encephalomyopathic form with renal tubulopathy;Mitochondrial neurogastrointestinal encephalomyopathy;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONSAUTOSOMAL DOMINANT 5,RRM2B,50484,NM_001172477;NM_001172478;NM_015713
BATF3_TF,BATF3,BATF3_TF,BATF3,TF,155,-2.03913107499959,-0.00854001610181155,-0.00476912593093554,-0.0209300838061184,-0.016160957875183,0.0632123368069571,1.74215694525848,1.0666629577599,1.03285818432925,1.17773578474632,0.144877600417075,0.152130913570999,ENSG00000123685,BATF3,protein_coding,1,-1,212686417,212699840,q32.3,basic leucine zipper ATF-like transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:28915],NA,BATF3,55509,NM_018664
ABCC6_SIG,ABCC6,ABCC6_SIG,ABCC6,SIG,33,2.0391023615513,0.0360954410553342,0.0325415948686676,0.0477723642400959,0.0152307693714284,0.0632123368069571,1.4454321940835,1.7772057979243,1.73617161725067,1.91203239156624,0.175860774315576,0.240184433032217,ENSG00000091262,ABCC6,protein_coding,16,-1,16148928,16223522,p13.11,ATP binding cassette subfamily C member 6 [Source:HGNC Symbol;Acc:HGNC:57],Arterial calcification generalized of infancy 2;Generalized arterial calcification of infancy;Pseudoxanthoma elasticum;PSEUDOXANTHOMA ELASTICUM FORME FRUSTEPSEUDOXANTHOMA ELASTICUM HETEROZYGOUS INCLUDED,ABCC6,368,NM_001079528;NM_001171;NM_001351800
KLK1_SIG,KLK1,KLK1_SIG,KLK1,SIG,36,-2.03905329376492,-0.0634133829242488,-0.0567483223755208,-0.0853128675843548,-0.0285645452088341,0.0632123368069571,-1.26082665260474,0.648899473514666,0.677046221343374,0.55641730207748,-0.120628919265895,0.310927620138944,ENSG00000167748,KLK1,protein_coding,19,-1,50819146,50823787,q13.33,kallikrein 1 [Source:HGNC Symbol;Acc:HGNC:6357],KALLIKREIN DECREASED URINARY ACTIVITY OF,KLK1,3816,NM_002257
SF3A1_SIG,SF3A1,SF3A1_SIG,SF3A1,SIG,11,2.03800385898928,0.449872146603312,0.448148311119795,0.455536177477724,0.00738786635792963,0.0633605736156023,2.38445381831213,7.79553442313251,7.7760512638849,7.85955051780322,0.083499253918327,0.0453139525800317,ENSG00000099995,SF3A1,protein_coding,22,-1,30331988,30356919,q12.2,splicing factor 3a subunit 1 [Source:HGNC Symbol;Acc:HGNC:10765],NA,SF3A1,10291,NM_005877
SLC16A1_SIG,SLC16A1,SLC16A1_SIG,SLC16A1,SIG,23,2.03783236576652,-0.0175840374985807,-0.0199333007939902,-0.00986502952794941,0.0100682712660409,0.0633750667091315,1.81271859876938,3.71379110845074,3.66043215193509,3.88911339414504,0.228681242209955,0.135278122073151,ENSG00000155380,SLC16A1,protein_coding,1,-1,112911847,112957013,p13.2,solute carrier family 16 member 1 [Source:HGNC Symbol;Acc:HGNC:10922],ERYTHROCYTE LACTATE TRANSPORTER DEFECT;Exercise-induced hyperinsulinism;HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 7;Ketoacidosis due to monocarboxylate transporter-1 deficiency;Metabolic myopathy due to lactate transporter defect;MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY,SLC16A1,6566,NM_001166496;NM_003051
FOXD4_TF,FOXD4,FOXD4_TF,FOXD4,TF,6,2.03763001373124,0.133095962486059,0.128908866975393,0.146853562021105,0.0179446950457123,0.0633942713995777,0.203991061882467,0.266601873598395,0.265184046340982,0.271260448872752,0.00607640253176914,0.884651989877404,ENSG00000170122,FOXD4,protein_coding,9,-1,116231,118204,p24.3,forkhead box D4 [Source:HGNC Symbol;Acc:HGNC:3805],NA,FOXD4,2298,NM_207305
PURA_SIG,PURA,PURA_SIG,PURA,SIG,8,2.03715955911636,-0.0785055079741153,-0.082540333032618,-0.0652482256390348,0.0172921073935833,0.0634544050209112,-0.0705310020764286,3.34501427812658,3.34672454395202,3.33939483327157,-0.0073297106804423,0.961539099638523,ENSG00000185129,PURA,protein_coding,5,1,140107777,140125619,q31.3,purine rich element binding protein A [Source:HGNC Symbol;Acc:HGNC:9701],Intellectual disability;Mental retardation autosomal dominant 31;PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation;Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,PURA,5813,NM_005859
F12_SIG,F12,F12_SIG,F12,SIG,36,2.03437272084763,0.118244539435975,0.115475363410874,0.127343260661306,0.0118678972504326,0.0638693653911435,0.227738025025016,2.44215667141981,2.43640992518603,2.46103883761654,0.0246289124305093,0.871360710611123,ENSG00000131187,F12,protein_coding,5,-1,177402140,177409576,q35.3,coagulation factor XII [Source:HGNC Symbol;Acc:HGNC:3530],ANGIOEDEMA HEREDITARY TYPE III;Congenital factor XII deficiency;FACTOR XII DEFICIENCY;Hereditary angioedema type 3,F12,2161,NM_000505
MRPL27_SIG,MRPL27,MRPL27_SIG,MRPL27,SIG,50,2.03418030532088,0.317201720130878,0.3092031544596,0.343482721622221,0.0342795671626209,0.0638871608373315,2.72728431418885,3.47683515825839,3.43034892845676,3.62957562760658,0.199226699149821,0.0209951759615262,ENSG00000108826,MRPL27,protein_coding,17,-1,50367857,50373207,q21.33,mitochondrial ribosomal protein L27 [Source:HGNC Symbol;Acc:HGNC:14483],NA,MRPL27,51264,NM_016504
UCHL5_SIG,UCHL5,UCHL5_SIG,UCHL5,SIG,25,2.03372857477217,0.623072020394991,0.616416291723333,0.644940843173297,0.0285245514499638,0.0639447990165418,1.55755488933297,5.18708578933946,5.16538920317515,5.25837457245077,0.0929853692756176,0.203262243478197,ENSG00000116750,UCHL5,protein_coding,1,-1,193012250,193060080,q31.2,ubiquitin C-terminal hydrolase L5 [Source:HGNC Symbol;Acc:HGNC:19678],NA,UCHL5,51377,NM_001199261;NM_001199262;NM_001199263;NM_001350840;NM_001350841;NM_001350842;NM_001350843;NM_001350844;NM_001350845;NM_001350846;NM_001350847;NM_001350848;NM_001350849;NM_001350850;NM_001350851;NM_001350852;NM_015984
ZNF544_TF,ZNF544,ZNF544_TF,ZNF544,TF,30,2.03166760562676,-0.0473506256113807,-0.0540865653758889,-0.025218252099425,0.0288683132764638,0.0642503539580675,1.65937331024617,3.69687119482149,3.65022036474282,3.85015249365141,0.199932128908592,0.173985759353455,ENSG00000198131,ZNF544,protein_coding,19,1,58228594,58277495,q13.43,zinc finger protein 544 [Source:HGNC Symbol;Acc:HGNC:16759],NA,ZNF544,27300,NM_001320767;NM_001320769;NM_001320770;NM_001320771;NM_001320773;NM_001320774;NM_001320776;NM_001320777;NM_001320780;NM_001320781;NM_001320782;NM_001320783;NM_001320785;NM_001320786;NM_001320787;NM_001320788;NM_001320789;NM_001320791;NM_001320792;NM_014480
PTPN22_SIG,PTPN22,PTPN22_SIG,PTPN22,SIG,50,-2.03126682344611,0.130392219977197,0.1345656058517,0.116679666389545,-0.0178859394621546,0.0643003934796763,-0.496742311419345,5.80301677773248,5.81375172535681,5.76774480696682,-0.0460069183899892,0.711439241083029,ENSG00000134242,PTPN22,protein_coding,1,-1,113813811,113871753,p13.2,protein tyrosine phosphatase, non-receptor type 22 [Source:HGNC Symbol;Acc:HGNC:9652],DIABETES MELLITUS INSULIN-DEPENDENT;Giant cell arteritis;Granulomatosis with polyangiitis;Oligoarticular juvenile idiopathic arthritis;Rheumatoid arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis;Systemic lupus erythematosus;Vogt-Koyanagi-Harada disease,PTPN22,26191,NM_001193431;NM_001308297;NM_012411;NM_015967
NBPF10_SIG,NBPF10,NBPF10_SIG,NBPF10,SIG,55,-2.03087626559888,0.0682936440585439,0.0716985158901706,0.0571062080403419,-0.0145923078498288,0.0643488855484595,-1.70920040893603,6.7418659576115,6.77297526794087,6.63964965224355,-0.133325615697319,0.160874528743723,ENSG00000271425,NBPF10,protein_coding,1,-1,146064699,146229000,q21.1,NBPF member 10 [Source:HGNC Symbol;Acc:HGNC:31992],NA,NBPF10,100132406,NM_001039703;NM_001302371
TCF25_TF,TCF25,TCF25_TF,TCF25,TF,168,2.02986776034752,0.0769225176715622,0.0742980661873933,0.0855457154052599,0.0112476492178666,0.064492983432319,1.31070475683611,6.87363972631687,6.86134793068633,6.91402705481724,0.0526791241309167,0.290676771277007,ENSG00000141002,TCF25,protein_coding,16,1,89873570,89913627,q24.3,transcription factor 25 [Source:HGNC Symbol;Acc:HGNC:29181],NA,TCF25,22980,NM_014972
ATP2A1_SIG,ATP2A1,ATP2A1_SIG,ATP2A1,SIG,11,2.02956123095181,-0.0432415559060553,-0.0475623630913984,-0.0290446180113567,0.0185177450800416,0.064528582444914,-0.515439367110233,1.54826244162447,1.55546941971456,1.52458237075702,-0.0308870489575397,0.700614369990861,ENSG00000196296,ATP2A1,protein_coding,16,1,28878405,28904509,p11.2,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:811],BRODY MYOPATHY,ATP2A1,487,NM_001286075;NM_004320;NM_173201
TNFAIP3_SIG,TNFAIP3,TNFAIP3_SIG,TNFAIP3,SIG,59,-2.02943377266389,0.55225593633686,0.561890056664219,0.520600969546967,-0.0412890871172524,0.0645364649448148,-1.06958806615406,7.77822696693256,7.82228040596398,7.63347995297216,-0.188800452991823,0.396874454639879,ENSG00000118503,TNFAIP3,protein_coding,6,1,137867214,137883312,q23.3,TNF alpha induced protein 3 [Source:HGNC Symbol;Acc:HGNC:11896],Autoinflammatory syndrome familial Behcet-like;Hereditary pediatric Behcet-like disease;Systemic lupus erythematosus,TNFAIP3,7128,NM_001270507;NM_001270508;NM_006290
ZFP57_TF,ZFP57,ZFP57_TF,ZFP57,TF,26,2.02926021226343,-0.0735140441374431,-0.0751120457232301,-0.0682634674984286,0.00684857822480133,0.0645514891158859,-0.269314542017632,1.00890708013743,1.02085957354325,0.969634601804016,-0.0512249717392367,0.845757802099566,ENSG00000204644,ZFP57,protein_coding,6,-1,29672392,29681110,p22.1,ZFP57 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:18791],Diabetes Mellitus 6q24-Related Transient Neonatal;DIABETES MELLITUS TRANSIENT NEONATAL 1;Transient neonatal diabetes mellitus,ZFP57,346171,NM_001109809
RASSF4_SIG,RASSF4,RASSF4_SIG,RASSF4,SIG,73,-2.02793108619601,0.186940544449545,0.198092887641716,0.15029713110384,-0.0477957565378765,0.0647457188689126,-1.05676353342414,5.07297205870939,5.12203680607092,4.91175931737866,-0.210277488692252,0.402800170540008,ENSG00000107551,RASSF4,protein_coding,10,1,44959407,44995891,q11.21,Ras association domain family member 4 [Source:HGNC Symbol;Acc:HGNC:20793],NA,RASSF4,83937,NM_032023
ZNF616_TF,ZNF616,ZNF616_TF,ZNF616,TF,186,2.02782356337049,0.205842235601721,0.198031928163025,0.231504674328867,0.0334727461658419,0.0647505271785907,1.60554225459309,2.86241271774524,2.81374101172439,3.02233403752804,0.208593025803648,0.188970677063063,ENSG00000204611,ZNF616,protein_coding,19,-1,52113091,52139938,q13.41,zinc finger protein 616 [Source:HGNC Symbol;Acc:HGNC:28062],NA,ZNF616,90317,NM_178523
AAR2_SIG,AAR2,AAR2_SIG,AAR2,SIG,28,2.0276179962827,0.24650186753967,0.244224094363287,0.253985979404928,0.00976188504164076,0.0647705621594256,1.3551988029311,4.88078004703552,4.86461353896896,4.93389857353993,0.0692850345709779,0.273547110063471,ENSG00000131043,AAR2,protein_coding,20,1,36236459,36270918,q11.23,AAR2 splicing factor homolog [Source:HGNC Symbol;Acc:HGNC:15886],NA,AAR2,25980,NM_001271874;NM_015511
SLC20A1_SIG,SLC20A1,SLC20A1_SIG,SLC20A1,SIG,18,2.02723936986106,0.184603488795287,0.182690964251187,0.190887498011616,0.00819653376042843,0.0648174902574356,3.12778392267753,6.48130764100343,6.43492609749967,6.63370414108719,0.19877804358752,0.00772622357877427,ENSG00000144136,SLC20A1,protein_coding,2,1,112645939,112663825,q14.1,solute carrier family 20 member 1 [Source:HGNC Symbol;Acc:HGNC:10946],NA,SLC20A1,6574,NM_005415
CCRL2_SIG,CCRL2,CCRL2_SIG,CCRL2,SIG,20,-2.02688878959606,0.138674638622603,0.141319519028421,0.1299843172892,-0.0113352017392209,0.0648600857434029,0.851707526931124,2.52850817218423,2.50741186881242,2.59782459754874,0.0904127287363204,0.507161166561987,ENSG00000121797,CCRL2,protein_coding,3,1,46407166,46412997,p21.31,C-C motif chemokine receptor like 2 [Source:HGNC Symbol;Acc:HGNC:1612],NA,CCRL2,9034,NM_001130910;NM_003965
MIF_SIG,MIF,MIF_SIG,MIF,SIG,50,2.02393345346039,0.252596231237485,0.249222592404288,0.263681044546561,0.0144584521422735,0.0653089580146021,2.6684995922901,6.13629989753376,6.08108806569385,6.3177102021506,0.236622136456753,0.0240777494655312,ENSG00000240972,MIF,protein_coding,22,1,23894383,23895227,q11.23,macrophage migration inhibitory factor [Source:HGNC Symbol;Acc:HGNC:7097],RHEUMATOID ARTHRITIS SYSTEMIC JUVENILE;Systemic-onset juvenile idiopathic arthritis,MIF,4282,NM_002415
XRN1_SIG,XRN1,XRN1_SIG,XRN1,SIG,52,-2.02337068237616,0.403473857332914,0.406647468142636,0.393046278958112,-0.0136011891845246,0.0653850201911382,-1.89813693150082,6.51453812166476,6.53986852419024,6.43130965622388,-0.108558867966362,0.116731083143465,ENSG00000114127,XRN1,protein_coding,3,-1,142306607,142448062,q23,5'-3' exoribonuclease 1 [Source:HGNC Symbol;Acc:HGNC:30654],NA,XRN1,54464,NM_001282857;NM_001282859;NM_019001
UBLCP1_SIG,UBLCP1,UBLCP1_SIG,UBLCP1,SIG,20,-2.02175739959526,0.320297011877566,0.322141544740689,0.314236403898734,-0.00790514084195459,0.0656175914409983,0.381246738210899,5.11245789659985,5.10777917927627,5.12783082494873,0.0200516456724565,0.779718404813492,ENSG00000164332,UBLCP1,protein_coding,5,1,159263290,159286036,q33.3,ubiquitin like domain containing CTD phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:28110],NA,UBLCP1,134510,NM_145049
RRAD_SIG,RRAD,RRAD_SIG,RRAD,SIG,17,-2.02173382240231,0.061400015104508,0.0668248562023623,0.0435755372115582,-0.023249318990804,0.0656175914409983,-2.00178012037828,0.998872864325913,1.0547787410578,0.815182126492578,-0.239596614565218,0.0967649477803951,ENSG00000166592,RRAD,protein_coding,16,-1,66921679,66925536,q22.1,RRAD, Ras related glycolysis inhibitor and calcium channel regulator [Source:HGNC Symbol;Acc:HGNC:10446],NA,RRAD,6236,NM_001128850;NM_004165
CYB5B_SIG,CYB5B,CYB5B_SIG,CYB5B,SIG,60,2.02161153481678,0.472141545993882,0.464062929859173,0.498685570436499,0.0346226405773269,0.0656247613855113,2.18319573423722,5.28692672992467,5.23834279741982,5.44655965101202,0.208216853592198,0.0685908708274501,ENSG00000103018,CYB5B,protein_coding,16,1,69424525,69466266,q22.1,cytochrome b5 type B [Source:HGNC Symbol;Acc:HGNC:24374],NA,CYB5B,80777,NM_030579
ALG2_SIG,ALG2,ALG2_SIG,ALG2,SIG,32,2.0212878241321,0.186132764182648,0.183110027833316,0.196064612187597,0.0129545843542812,0.0656635650905504,2.78860824920311,4.4958705707366,4.4548778908011,4.63056080481037,0.175682914009261,0.0181786138418095,ENSG00000119523,ALG2,protein_coding,9,-1,99216425,99221942,q22.33,ALG2, alpha-1,3/1,6-mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:23159],ALG2-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ii;Congenital myasthenic syndromes with glycosylation defect;MYASTHENIC SYNDROME CONGENITAL 14,ALG2,85365,NM_033087
SEPHS2_SIG,SEPHS2,SEPHS2_SIG,SEPHS2,SIG,13,2.02073764682305,0.276036561591534,0.273325209359602,0.284945290353594,0.011620080993992,0.0657379844822815,2.1434963957631,6.03979005975512,6.00861537925105,6.14222115283991,0.13360577358886,0.074037909927667,ENSG00000179918,SEPHS2,protein_coding,16,-1,30443631,30446181,p11.2,selenophosphate synthetase 2 [Source:HGNC Symbol;Acc:HGNC:19686],NA,SEPHS2,22928,NM_012248
TCF20_TF,TCF20,TCF20_TF,TCF20,TF,67,-2.01907050279519,0.236086036749808,0.239016383428648,0.226457754805047,-0.0125586286236005,0.0659841443361634,-1.12840412453041,6.26239454685128,6.27611347566388,6.21731806646703,-0.0587954091968409,0.368941603413479,ENSG00000100207,TCF20,protein_coding,22,-1,42160013,42343616,q13.2,transcription factor 20 [Source:HGNC Symbol;Acc:HGNC:11631],TCF20 syndrome,TCF20,6942,NM_005650;NM_181492
E4F1_SIG,E4F1,E4F1_SIG,E4F1,SIG,27,2.01902111899767,0.113192610623084,0.111326051195197,0.119325591600426,0.00799954040522905,0.0659841443361634,2.35713247081287,5.18624769233065,5.16504331227963,5.255919226784,0.0908759145043793,0.0479951640924449,ENSG00000167967,E4F1,protein_coding,16,1,2223580,2235742,p13.3,E4F transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:3121],NA,E4F1,1877,NM_001288776;NM_001288778;NM_004424
IMPDH1_SIG,IMPDH1,IMPDH1_SIG,IMPDH1,SIG,38,-2.01865453753466,0.306349435284188,0.311738586235816,0.288642225014551,-0.0230963612212649,0.066029884798495,-1.70889467177005,6.38374818740911,6.41534001498521,6.27994646823049,-0.135393546754717,0.160925252107627,ENSG00000106348,IMPDH1,protein_coding,7,-1,128392277,128410252,q32.1,inosine monophosphate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:6052],Leber congenital amaurosis;LEBER CONGENITAL AMAUROSIS 11;Retinitis pigmentosa;RETINITIS PIGMENTOSA 10,IMPDH1,3614,NM_000883;NM_001102605;NM_001142573;NM_001142574;NM_001142575;NM_001142576;NM_001304521;NM_183243
GABRR2_SIG,GABRR2,GABRR2_SIG,GABRR2,SIG,18,-2.01853316026489,-0.0565399635367522,-0.0542589732890114,-0.0640346457793292,-0.00977567249031761,0.0660369473852197,-2.52114851585763,1.31273136700298,1.36206782150127,1.15062587365148,-0.211441947849793,0.0337498459691429,ENSG00000111886,GABRR2,protein_coding,6,-1,89257208,89315299,q15,gamma-aminobutyric acid type A receptor rho2 subunit [Source:HGNC Symbol;Acc:HGNC:4091],NA,GABRR2,2570,NM_002043
ACSM1_SIG,ACSM1,ACSM1_SIG,ACSM1,SIG,23,2.01783655037193,-0.0890375052566218,-0.0925227199374003,-0.0775860855912066,0.0149366343461936,0.0661348447640199,4.42720785067858,0.689163605529894,0.625053099577532,0.899812410801939,0.274759311224407,0.000129233824734628,ENSG00000166743,ACSM1,protein_coding,16,-1,20623237,20698890,p12.3,acyl-CoA synthetase medium chain family member 1 [Source:HGNC Symbol;Acc:HGNC:18049],NA,ACSM1,116285,NM_001318890;NM_052956
RDH16_SIG,RDH16,RDH16_SIG,RDH16,SIG,77,2.01620652002889,-0.0168289226852797,-0.0199413256268367,-0.00660245587730677,0.0133388697495299,0.0663806587084047,1.53493073102235,0.513948296049373,0.499960398504814,0.559908530838638,0.0599481323338235,0.210580271815718,ENSG00000139547,RDH16,protein_coding,12,-1,56951431,56959374,q13.3,retinol dehydrogenase 16 [Source:HGNC Symbol;Acc:HGNC:29674],NA,RDH16,8608,NM_001320108;NM_003708
DVL3_SIG,DVL3,DVL3_SIG,DVL3,SIG,27,2.01611311041323,0.0881210777769309,0.0859976383778316,0.0950980929454,0.00910045456756849,0.0663833152818026,1.48462948765178,6.69564944929175,6.68130919656146,6.74276742254843,0.0614582259869697,0.227053622362191,ENSG00000161202,DVL3,protein_coding,3,1,184155311,184173614,q27.1,dishevelled segment polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:3087],Autosomal dominant Robinow syndrome;ROBINOW SYNDROME AUTOSOMAL DOMINANT 1;ROBINOW SYNDROME AUTOSOMAL DOMINANT 3,DVL3,1857,NM_004423
ERBB2_SIG,ERBB2,ERBB2_SIG,ERBB2,SIG,27,2.01596488581589,0.0543233411383253,0.0497702982646165,0.0692833391519398,0.0195130408873233,0.0663946618143074,0.48546603480578,2.28153827915925,2.2720890589763,2.31258571690324,0.0404966579269392,0.717960366233195,ENSG00000141736,ERBB2,protein_coding,17,1,39687914,39730426,q12,erb-b2 receptor tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:3430],GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;GLIOMA SUSCEPTIBILITY 1;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,ERBB2,2064,NM_001005862;NM_001289936;NM_001289937;NM_001289938;NM_004448
VCP_SIG,VCP,VCP_SIG,VCP,SIG,11,2.01540499747463,0.326478647341939,0.324154192948713,0.334116140348254,0.00996194739954124,0.0664712979356379,1.98350030157362,7.87454394291075,7.8566230429863,7.93342689980539,0.0768038568190931,0.100088411495485,ENSG00000165280,VCP,protein_coding,9,-1,35056064,35072627,p13.3,valosin containing protein [Source:HGNC Symbol;Acc:HGNC:12666],Adult-onset distal myopathy due to VCP mutation;Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 14 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;Autosomal dominant Charcot-Marie-Tooth disease type 2Y;Behavioral variant of frontotemporal dementia;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2Y;Frontotemporal dementia with motor neuron disease;INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1;Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;Progressive non-fluent aphasia;Spastic paraplegia-Paget disease of bone syndrome,VCP,7415,NM_001354927;NM_001354928;NM_007126
ZSWIM6_TF,ZSWIM6,ZSWIM6_TF,ZSWIM6,TF,195,-2.0150438222001,0.183994933077127,0.188591477725826,0.168892000659975,-0.0196994770658516,0.0665164552949614,-0.264134890395071,5.18299874844891,5.18885341933129,5.16376197269251,-0.0250914466387789,0.848882728270454,ENSG00000130449,ZSWIM6,protein_coding,5,1,61332258,61546172,q12.1,zinc finger SWIM-type containing 6 [Source:HGNC Symbol;Acc:HGNC:29316],Acromelic frontonasal dysostosis;Acromelic frontonasal dysplasia;NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES ABNORMALGAIT AND AUTISTIC FEATURES,ZSWIM6,57688,NM_020928
PTPRD_SIG,PTPRD,PTPRD_SIG,PTPRD,SIG,28,-2.01307315507722,-0.0693717119076813,-0.0658767265966911,-0.0808552350723636,-0.0149785084756725,0.0668176901110832,0.168174105642897,1.06813547979254,1.06169149146463,1.08930858429853,0.0276170928339073,0.905667997786347,ENSG00000153707,PTPRD,protein_coding,9,-1,8314246,10612723,p23,protein tyrosine phosphatase, receptor type D [Source:HGNC Symbol;Acc:HGNC:9668],NA,PTPRD,5789,NM_001040712;NM_001171025;NM_002839;NM_130391;NM_130392;NM_130393
RABGEF1_SIG,RABGEF1,RABGEF1_SIG,RABGEF1,SIG,75,-2.01252226635073,0.19973263470241,0.209193797448572,0.168645957107877,-0.0405478403406951,0.0668932898042063,-1.64577881994598,2.11844466110118,2.15395393182738,2.00177134300081,-0.152182588826568,0.177629760369643,ENSG00000154710,RABGEF1,protein_coding,7,1,66682164,66811464,q11.21,RAB guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:17676],NA,RABGEF1,27342,NM_001287060;NM_001287061;NM_001287062;NM_001367725;NM_001367727;NM_001367728;NM_001367729;NM_001367730;NM_001367731;NM_001367732;NM_001367733;NM_001367734;NM_001367735;NM_001367736;NM_001367737;NM_001367738;NM_001367739;NM_001367745;NM_001367747;NM_001367748;NM_001367750;NM_001367752;NM_001367753;NM_001367754;NM_014504
ZC3H12A_SIG,ZC3H12A,ZC3H12A_SIG,ZC3H12A,SIG,62,-2.01121466087061,0.54011419089561,0.55114052417001,0.503884810136864,-0.0472557140331463,0.0670898551417449,-0.15698029776638,5.39332243536806,5.39862247636267,5.37590801495719,-0.0227144614054814,0.911847771133856,ENSG00000163874,ZC3H12A,protein_coding,1,1,37474580,37484377,p34.3,zinc finger CCCH-type containing 12A [Source:HGNC Symbol;Acc:HGNC:26259],NA,ZC3H12A,80149,NM_001323550;NM_001323551;NM_025079
CD53_SIG,CD53,CD53_SIG,CD53,SIG,26,-2.01016749884464,0.448729141834365,0.455350882772182,0.426971993038681,-0.028378889733501,0.0672325910059067,-1.35622301583499,7.62824367080633,7.65788740318202,7.53084283585764,-0.127044567324383,0.273139229575441,ENSG00000143119,CD53,protein_coding,1,1,110871188,110899922,p13.3,CD53 molecule [Source:HGNC Symbol;Acc:HGNC:1686],NA,CD53,963,NM_000560;NM_001040033;NM_001320638
TNFRSF21_SIG,TNFRSF21,TNFRSF21_SIG,TNFRSF21,SIG,24,2.01013695206244,0.0797123961268351,0.0753158710222969,0.0941581214703178,0.0188422504480209,0.0672325910059067,3.73363574867599,3.76438690632336,3.61041955396279,4.2702796355081,0.659860081545311,0.00132213196380975,ENSG00000146072,TNFRSF21,protein_coding,6,-1,47231532,47309905,p12.3,TNF receptor superfamily member 21 [Source:HGNC Symbol;Acc:HGNC:13469],NA,TNFRSF21,27242,NM_014452
ITGA7_SIG,ITGA7,ITGA7_SIG,ITGA7,SIG,60,-2.01009260658724,-0.0677870031572303,-0.0613947312294168,-0.0887901823486176,-0.0273954511192007,0.0672325910059067,-2.45385593628544,2.93925910115298,3.03962741734102,2.60947749082085,-0.430149926520168,0.0390376778607518,ENSG00000135424,ITGA7,protein_coding,12,-1,55684568,55716043,q13.2,integrin subunit alpha 7 [Source:HGNC Symbol;Acc:HGNC:6143],Congenital fiber-type disproportion myopathy;Congenital Muscular Dystrophy;Congenital muscular dystrophy with integrin alpha-7 deficiency;MUSCULAR DYSTROPHY CONGENITAL DUE TO INTEGRIN ALPHA-7 DEFICIENCY,ITGA7,3679,NM_001144996;NM_001144997;NM_002206
TET2_SIG,TET2,TET2_SIG,TET2,SIG,22,-2.00911736997201,0.358005714564676,0.361083421740663,0.347893248129289,-0.0131901736113738,0.0673766282628144,0.400031229831057,7.25433614638072,7.24847399249542,7.2735975091467,0.0251235166512771,0.768256874769127,ENSG00000168769,TET2,protein_coding,4,1,105145875,105279816,q24,tet methylcytosine dioxygenase 2 [Source:HGNC Symbol;Acc:HGNC:25941],Acquired idiopathic sideroblastic anemia;Acute myeloid leukaemia with myelodysplasia-related features;Essential thrombocythemia;MYELODYSPLASTIC SYNDROME;POLYCYTHEMIA VERA;Primary myelofibrosis;Refractory anemia;Refractory anemia with excess blasts,TET2,54790,NM_001127208;NM_017628
TNKS2_SIG,TNKS2,TNKS2_SIG,TNKS2,SIG,46,-2.00835811801491,0.403578097218976,0.406081200612829,0.395353614639174,-0.0107275859736552,0.0674862120198201,-0.933691902119962,6.84980755041702,6.85987024479148,6.81674441175809,-0.0431258330333968,0.463975230054824,ENSG00000107854,TNKS2,protein_coding,10,1,91798426,91865475,q23.32,tankyrase 2 [Source:HGNC Symbol;Acc:HGNC:15677],NA,TNKS2,80351,NM_025235
SF3B3_SIG,SF3B3,SF3B3_SIG,SF3B3,SIG,33,2.00819106676588,0.605461188827906,0.597092131716946,0.632959519335348,0.0358673876184018,0.0675007281709336,1.56447514633644,7.08779014659477,7.0598603086683,7.17955961406743,0.11969930539913,0.20124672442029,ENSG00000189091,SF3B3,protein_coding,16,1,70523791,70577670,q22.1,splicing factor 3b subunit 3 [Source:HGNC Symbol;Acc:HGNC:10770],NA,SF3B3,23450,NM_012426
CSNK2A2_SIG,CSNK2A2,CSNK2A2_SIG,CSNK2A2,SIG,45,2.00664243423462,0.30794816521684,0.30449871486174,0.319282073526455,0.0147833586647158,0.0677375876624801,1.51839333289463,6.60653043976485,6.58972835126309,6.66173730198491,0.0720089507218225,0.216012770799868,ENSG00000070770,CSNK2A2,protein_coding,16,-1,58157907,58198106,q21,casein kinase 2 alpha 2 [Source:HGNC Symbol;Acc:HGNC:2459],NA,CSNK2A2,1459,NM_001896
RPL28_SIG,RPL28,RPL28_SIG,RPL28,SIG,32,2.0057691278236,0.616957396389541,0.611263317942116,0.635666511288222,0.0244031933461067,0.0678660594570109,2.81012732142459,10.046624483071,10.0067912588815,10.1775050768365,0.170713817954978,0.0172793237829835,ENSG00000108107,RPL28,protein_coding,19,1,55385345,55403250,q13.42,ribosomal protein L28 [Source:HGNC Symbol;Acc:HGNC:10330],NA,RPL28,6158,NM_000991;NM_001136134;NM_001136135;NM_001136136;NM_001136137
PTPRU_SIG,PTPRU,PTPRU_SIG,PTPRU,SIG,63,-2.00485414568621,-0.0530715238809503,-0.049336192411189,-0.0653447558530232,-0.0160085634418341,0.0680014688518706,-1.11415956736119,0.870945679350826,0.896311302128447,0.787601490224355,-0.108709811904092,0.37572069586589,ENSG00000060656,PTPRU,protein_coding,1,1,29236516,29326813,p35.3,protein tyrosine phosphatase, receptor type U [Source:HGNC Symbol;Acc:HGNC:9683],NA,PTPRU,10076,NM_001195001;NM_005704;NM_133177;NM_133178
ATP11C_SIG,ATP11C,ATP11C_SIG,ATP11C,SIG,15,2.00373308827947,0.171834457719107,0.168265991392243,0.183559418507375,0.0152934271151318,0.0681704792378134,1.26516304100144,4.96285212457222,4.94426027214975,5.02393963967462,0.0796793675248752,0.309240668996746,ENSG00000101974,ATP11C,protein_coding,X,-1,139726346,139945276,q27.1,ATPase phospholipid transporting 11C [Source:HGNC Symbol;Acc:HGNC:13554],HEMOLYTIC ANEMIA CONGENITAL X-LINKED,ATP11C,286410,NM_001010986;NM_001353810;NM_001353811;NM_001353812;NM_173694
RPL37_SIG,RPL37,RPL37_SIG,RPL37,SIG,26,2.00349414355322,1.47061331051901,1.4612849614971,1.50126360016245,0.0399786386653564,0.0681967572306437,2.40318461197035,9.54351833576118,9.50904645236942,9.65678309547697,0.147736643107557,0.0435900533800714,ENSG00000145592,RPL37,protein_coding,5,-1,40825262,40835222,p13.1,ribosomal protein L37 [Source:HGNC Symbol;Acc:HGNC:10347],NA,RPL37,6167,NM_000997
ACAP1_SIG,ACAP1,ACAP1_SIG,ACAP1,SIG,74,2.00311843426991,0.159469838645264,0.156488736322849,0.169264889133196,0.0127761528103471,0.0682452173883911,1.63231394544574,7.2146431634937,7.18519805929463,7.31139136300491,0.126193303710275,0.181502707858305,ENSG00000072818,ACAP1,protein_coding,17,1,7336529,7351477,p13.1,ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 [Source:HGNC Symbol;Acc:HGNC:16467],NA,ACAP1,9744,NM_014716
PPARA_TF,PPARA,PPARA_TF,PPARA,TF,24,2.0028957169865,0.293983521311743,0.289091082299871,0.310058678065034,0.0209675957651626,0.0682688878480223,1.75934551904059,4.58943321894098,4.55543113811482,4.70115434165553,0.145723203540707,0.147924000857334,ENSG00000186951,PPARA,protein_coding,22,1,46150521,46243756,q13.31,peroxisome proliferator activated receptor alpha [Source:HGNC Symbol;Acc:HGNC:9232],NA,PPARA,5465,NM_001001928;NM_001362872;NM_001362873;NM_005036
RPL10A_SIG,RPL10A,RPL10A_SIG,RPL10A,SIG,47,2.00198374473709,1.18434328047029,1.17525108742706,1.2142176290409,0.0389665416138447,0.0684044640472361,2.72584944452619,9.04437476896804,8.99702562980646,9.1999505119275,0.202924882121044,0.0210654314025762,ENSG00000198755,RPL10A,protein_coding,6,1,35468401,35470785,p21.31,ribosomal protein L10a [Source:HGNC Symbol;Acc:HGNC:10299],NA,RPL10A,4736,NM_007104
MANEA_SIG,MANEA,MANEA_SIG,MANEA,SIG,27,2.00189798747122,0.324583046875415,0.315671881877821,0.353862589010363,0.0381907071325415,0.068405925805997,1.33801741047163,3.51928551339241,3.49057309885906,3.613626304002,0.123053205142948,0.279916134781068,ENSG00000172469,MANEA,protein_coding,6,1,95577535,95609452,q16.1,mannosidase endo-alpha [Source:HGNC Symbol;Acc:HGNC:21072],NA,MANEA,79694,NM_024641
RPS6KB2_SIG,RPS6KB2,RPS6KB2_SIG,RPS6KB2,SIG,19,-2.00095344241454,0.209491019247148,0.210726912705749,0.2054302264546,-0.00529668625114934,0.0685470240152706,-0.434023655565131,5.43781056925223,5.44152383217828,5.42560984820947,-0.0159139839688115,0.748038289752532,ENSG00000175634,RPS6KB2,protein_coding,11,1,67428460,67435401,q13.2,ribosomal protein S6 kinase B2 [Source:HGNC Symbol;Acc:HGNC:10437],NA,RPS6KB2,6199,NM_003952
ALG1_SIG,ALG1,ALG1_SIG,ALG1,SIG,59,1.99961639491005,0.392987099894318,0.385172658683695,0.418663121014935,0.0334904623312403,0.0687523693142311,2.06708111651009,3.67570014393161,3.63386351827167,3.81316334252855,0.179299824256879,0.0855564801020371,ENSG00000033011,ALG1,protein_coding,16,1,5033923,5087379,p13.3,ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:18294],ALG1-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ik,ALG1,56052,NM_001330504;NM_019109
HERC3_SIG,HERC3,HERC3_SIG,HERC3,SIG,29,-1.99897904953879,0.290624333717394,0.293461609230852,0.281301857030321,-0.0121597522005305,0.0688438682089802,-0.0812020628539625,5.71391324734727,5.71491830040449,5.7106109301593,-0.00430737024518999,0.955122163511511,ENSG00000138641,HERC3,protein_coding,4,1,88592434,88708541,q22.1,HECT and RLD domain containing E3 ubiquitin protein ligase 3 [Source:HGNC Symbol;Acc:HGNC:4876],NA,HERC3,8916,NM_001271602;NM_001318505;NM_014606
ROCK2_SIG,ROCK2,ROCK2_SIG,ROCK2,SIG,31,1.99862899462684,0.363955369643538,0.356430759061998,0.388679090125742,0.0322483310637443,0.0688881179618569,0.755999229454782,5.90616128905096,5.89223024298729,5.95193472611728,0.0597044831299912,0.560087773139363,ENSG00000134318,ROCK2,protein_coding,2,-1,11179759,11348330,p25.1,Rho associated coiled-coil containing protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:10252],NA,ROCK2,9475,NM_001321643;NM_004850
PRPF38A_SIG,PRPF38A,PRPF38A_SIG,PRPF38A,SIG,21,1.99855459967247,0.34025948015696,0.337124053145627,0.350561597479911,0.0134375443342843,0.0688881179618569,0.134539886305486,6.4767126490775,6.47538173640018,6.48108564787439,0.00570391147420312,0.924511988658527,ENSG00000134748,PRPF38A,protein_coding,1,1,52404602,52420836,p32.3,pre-mRNA processing factor 38A [Source:HGNC Symbol;Acc:HGNC:25930],NA,PRPF38A,84950,NM_032864
EIF5A2_SIG,EIF5A2,EIF5A2_SIG,EIF5A2,SIG,16,-1.99826781475079,-0.00480457201992714,-0.0018855731225627,-0.0143955683969817,-0.012509995274419,0.0689224396303388,-3.12489855275886,2.06907131400073,2.149800261562,1.80381905772797,-0.345981203834037,0.00778745156593827,ENSG00000163577,EIF5A2,protein_coding,3,-1,170888418,170908644,q26.2,eukaryotic translation initiation factor 5A2 [Source:HGNC Symbol;Acc:HGNC:3301],NA,EIF5A2,56648,NM_020390
TRIM21_SIG,TRIM21,TRIM21_SIG,TRIM21,SIG,26,-1.99748072086544,0.0393676054289233,0.0440465687001383,0.02399386896636,-0.0200526997337782,0.0690386300806648,-1.82835799172676,4.88116939243311,4.91103745929911,4.78303145844483,-0.128006000854279,0.131665032505209,ENSG00000132109,TRIM21,protein_coding,11,-1,4384897,4393702,p15.4,tripartite motif containing 21 [Source:HGNC Symbol;Acc:HGNC:11312],NA,TRIM21,6737,NM_003141
CABP4_SIG,CABP4,CABP4_SIG,CABP4,SIG,15,-1.99730354097576,0.0181239207864469,0.0222240268444991,0.00465214373856118,-0.0175718831059378,0.0690550662361667,-1.62827501706087,0.816408987251527,0.853782066963083,0.693611725342128,-0.160170341620956,0.18270056348262,ENSG00000175544,CABP4,protein_coding,11,1,67452406,67460313,q13.2,calcium binding protein 4 [Source:HGNC Symbol;Acc:HGNC:1386],CONE-ROD SYNAPTIC DISORDER CONGENITAL NONPROGRESSIVE;Congenital stationary night blindness,CABP4,57010,NM_001300895;NM_001300896;NM_145200
SLC29A2_SIG,SLC29A2,SLC29A2_SIG,SLC29A2,SIG,92,1.99654338637158,-0.0749084135266238,-0.0781650960493807,-0.0642078852375655,0.0139572108118151,0.069153184147212,3.21940046545332,1.98929815045032,1.90137741841893,2.27818055569634,0.376803137277406,0.00601767590015113,ENSG00000174669,SLC29A2,protein_coding,11,-1,66362521,66372214,q13.2,solute carrier family 29 member 2 [Source:HGNC Symbol;Acc:HGNC:11004],NA,SLC29A2,3177,NM_001300868;NM_001300869;NM_001532
NUP107_SIG,NUP107,NUP107_SIG,NUP107,SIG,57,1.99647696810487,0.397170869268371,0.39124959944209,0.416626470126152,0.0253768706840624,0.069153184147212,1.320292427253,5.39234274395956,5.37300971030144,5.45586556883626,0.0828558585348249,0.286902722761826,ENSG00000111581,NUP107,protein_coding,12,1,68686951,68745809,q15,nucleoporin 107 [Source:HGNC Symbol;Acc:HGNC:29914],46XX gonadal dysgenesis;EARLY-CHILDHOOD-ONSET STEROID-RESISTANT NEPHROTIC SYNDROME;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;GALLOWAY-MOWAT SYNDROME;Nephrotic syndrome type 11;OVARIAN DYSGENESIS 6,NUP107,57122,NM_001330192;NM_020401
ADAM10_SIG,ADAM10,ADAM10_SIG,ADAM10,SIG,40,-1.99647426847581,0.515711891335801,0.52163212299779,0.496259701589264,-0.0253724214085257,0.069153184147212,-2.23385634774123,7.07792446121485,7.11955412676454,6.94114127440872,-0.178412852355824,0.0619201052342635,ENSG00000137845,ADAM10,protein_coding,15,-1,58588809,58749791,q21.3,ADAM metallopeptidase domain 10 [Source:HGNC Symbol;Acc:HGNC:188],ALZHEIMER DISEASE 18;Reticulate acropigmentation of Kitamura,ADAM10,102,NM_001110;NM_001320570
NR3C1_TF,NR3C1,NR3C1_TF,NR3C1,TF,159,-1.99623515216178,0.0943438414734022,0.0959839759860934,0.0889548280745596,-0.00702914791153367,0.0691795933312585,-0.356092035518774,6.95877998189371,6.96345376039555,6.94342328110194,-0.0200304792936121,0.794021820823534,ENSG00000113580,NR3C1,protein_coding,5,-1,143277931,143435512,q31.3,nuclear receptor subfamily 3 group C member 1 [Source:HGNC Symbol;Acc:HGNC:7978],Glucocorticoid resistance;GLUCOCORTICOID RESISTANCE GENERALIZED,NR3C1,2908,NM_000176;NM_001018074;NM_001018075;NM_001018076;NM_001018077;NM_001020825;NM_001024094;NM_001204258;NM_001204259;NM_001204260;NM_001204261;NM_001204262;NM_001204263;NM_001204264;NM_001204265;NM_001364182;NM_001364183;NM_001364184;NM_001364185
VPS41_SIG,VPS41,VPS41_SIG,VPS41,SIG,28,1.99615966752655,0.539933808683256,0.53209149100166,0.565701423922784,0.0336099329211241,0.0691795933312585,1.6808203226928,5.45125242116067,5.4182620190574,5.55964945664284,0.141387437585446,0.168179018698044,ENSG00000006715,VPS41,protein_coding,7,-1,38722974,38932394,p14.1,VPS41, HOPS complex subunit [Source:HGNC Symbol;Acc:HGNC:12713],NA,VPS41,27072,NM_014396;NM_080631
RGS1_SIG,RGS1,RGS1_SIG,RGS1,SIG,26,-1.99562465517631,0.0708955987383348,0.0754578258982103,0.0559054237844581,-0.019552402113752,0.069254757541251,-1.96224861754099,4.27653567993032,4.36726495104009,3.97842521771251,-0.388839733327581,0.104026183099345,ENSG00000090104,RGS1,protein_coding,1,1,192575763,192580024,q31.2,regulator of G protein signaling 1 [Source:HGNC Symbol;Acc:HGNC:9991],NA,RGS1,5996,NM_002922
SFTPD_SIG,SFTPD,SFTPD_SIG,SFTPD,SIG,25,-1.99472018569072,-0.0539447864528321,-0.0497817017034146,-0.0676234934866326,-0.0178417917832181,0.0693906877518416,-1.42448537102472,0.266100122136343,0.278424425162341,0.22560598362235,-0.0528184415399906,0.247463940100672,ENSG00000133661,SFTPD,protein_coding,10,-1,79937740,79982614,q22.3,surfactant protein D [Source:HGNC Symbol;Acc:HGNC:10803],NA,SFTPD,6441,NM_003019
MAZ_SIG,MAZ,MAZ_SIG,MAZ,SIG,29,1.99419316672931,0.32727274744767,0.32331767914843,0.34026797185946,0.0169502927110302,0.0694647236367426,-0.819156706555295,8.22036184454463,8.23047345716794,8.18713797449663,-0.0433354826713118,0.52467637154074,ENSG00000103495,MAZ,protein_coding,16,1,29806106,29811164,p11.2,MYC associated zinc finger protein [Source:HGNC Symbol;Acc:HGNC:6914],NA,MAZ,4150,NM_001042539;NM_001276275;NM_001276276;NM_002383
ARHGAP35_SIG,ARHGAP35,ARHGAP35_SIG,ARHGAP35,SIG,29,1.99385443948425,0.532701815808491,0.529437601683081,0.543427090791978,0.0139894891088966,0.0695030080714463,0.0315768220350814,6.25910343692531,6.25864207546662,6.260619338861,0.0019772633943775,0.98281257394159,ENSG00000160007,ARHGAP35,protein_coding,19,1,46918676,47005077,q13.32,Rho GTPase activating protein 35 [Source:HGNC Symbol;Acc:HGNC:4591],NA,ARHGAP35,2909,NM_004491
FOXJ2_TF,FOXJ2,FOXJ2_TF,FOXJ2,TF,84,-1.99380699319166,0.141530652310557,0.142966937123798,0.136811430781339,-0.00615550634245936,0.0695030080714463,-0.274106879946772,5.93277643038932,5.93591661074178,5.92245869494549,-0.0134579157962964,0.843109097362492,ENSG00000065970,FOXJ2,protein_coding,12,1,8032716,8055517,p13.31,forkhead box J2 [Source:HGNC Symbol;Acc:HGNC:24818],NA,FOXJ2,55810,NM_018416
LMBR1L_SIG,LMBR1L,LMBR1L_SIG,LMBR1L,SIG,75,1.99350470705526,0.129004557471988,0.124975756527196,0.142242046290593,0.0172662897633976,0.0695401341455902,2.33603002178882,5.53523644004793,5.49400879496068,5.67069870247748,0.176689907516808,0.0502524276276461,ENSG00000139636,LMBR1L,protein_coding,12,-1,49096551,49110900,q13.12,limb development membrane protein 1 like [Source:HGNC Symbol;Acc:HGNC:18268],NA,LMBR1L,55716,NM_001300750;NM_001300751;NM_001352161;NM_001352162;NM_001352163;NM_001352164;NM_001352165;NM_001352166;NM_001352167;NM_001352168;NM_018113
TNFAIP1_SIG,TNFAIP1,TNFAIP1_SIG,TNFAIP1,SIG,18,1.99329565810576,0.268130872068382,0.263002606558453,0.284980887315295,0.0219782807568417,0.0695619216950777,0.510510265763847,3.97941264575776,3.97140270938336,4.00573100813079,0.0343282987474271,0.70335332570102,ENSG00000109079,TNFAIP1,protein_coding,17,1,28335602,28347009,q11.2,TNF alpha induced protein 1 [Source:HGNC Symbol;Acc:HGNC:11894],NA,TNFAIP1,7126,NM_021137
MXD4_TF,MXD4,MXD4_TF,MXD4,TF,95,1.99320883138043,0.0828480467972394,0.0796846299882412,0.0932421305982334,0.0135575006099921,0.0695635867602775,1.62260430308945,6.69363177600089,6.66724092659909,6.78034456689252,0.113103640293433,0.184262745396682,ENSG00000123933,MXD4,protein_coding,4,-1,2247432,2262109,p16.3,MAX dimerization protein 4 [Source:HGNC Symbol;Acc:HGNC:13906],NA,MXD4,10608,NM_006454
KCTD5_SIG,KCTD5,KCTD5_SIG,KCTD5,SIG,33,-1.99170195112514,0.291729405171102,0.295335541712817,0.279880670819752,-0.015454870893065,0.069799424566403,0.226525678461275,4.76149824741883,4.7577024061685,4.77397029724133,0.0162678910728252,0.871929214080146,ENSG00000167977,KCTD5,protein_coding,16,1,2682523,2709030,p13.3,potassium channel tetramerization domain containing 5 [Source:HGNC Symbol;Acc:HGNC:21423],NA,KCTD5,54442,NM_018992
ATP6V0E1_SIG,ATP6V0E1,ATP6V0E1_SIG,ATP6V0E1,SIG,70,-1.99107949417343,0.137982161267062,0.144650553772528,0.116071728749104,-0.0285788250234243,0.0698895897449322,-1.49986336784817,6.14110686324996,6.17195311138145,6.03975490510365,-0.132198206277801,0.221991450499523,ENSG00000113732,ATP6V0E1,protein_coding,5,1,172983771,173035445,q35.1,ATPase H+ transporting V0 subunit e1 [Source:HGNC Symbol;Acc:HGNC:863],NA,ATP6V0E1,8992,NM_003945
NCF4_SIG,NCF4,NCF4_SIG,NCF4,SIG,32,-1.99079369214968,0.239294019678746,0.244370280206057,0.22261487794615,-0.0217554022599078,0.0699241567012337,0.330249866780086,6.82051131696169,6.81277230037835,6.84593951430696,0.0331672139286125,0.810065588962819,ENSG00000100365,NCF4,protein_coding,22,1,36860988,36878017,q12.3,neutrophil cytosolic factor 4 [Source:HGNC Symbol;Acc:HGNC:7662],Chronic granulomatous disease;GRANULOMATOUS DISEASE CHRONIC AUTOSOMAL RECESSIVE CYTOCHROME b-POSITIVETYPE III,NCF4,4689,NM_000631;NM_013416
SIPA1_SIG,SIPA1,SIPA1_SIG,SIPA1,SIG,61,-1.99065187252361,0.363689911397059,0.367534141275762,0.351058870367036,-0.0164752709087263,0.0699349210831522,-0.93384421599694,7.43258901516556,7.44885122866496,7.37915602795324,-0.0696952007117265,0.463975230054824,ENSG00000213445,SIPA1,protein_coding,11,1,65638101,65650918,q13.1,signal-induced proliferation-associated 1 [Source:HGNC Symbol;Acc:HGNC:10885],NA,SIPA1,6494,NM_006747;NM_153253
RBM23_SIG,RBM23,RBM23_SIG,RBM23,SIG,32,-1.99039607756029,0.329845565474113,0.332025173533271,0.322683996136882,-0.00934117739638881,0.0699645428032048,-0.523712949462004,6.13885899128542,6.14515436608229,6.11817418838143,-0.0269801777008585,0.696062170677421,ENSG00000100461,RBM23,protein_coding,14,-1,22893204,22919182,q11.2,RNA binding motif protein 23 [Source:HGNC Symbol;Acc:HGNC:20155],NA,RBM23,55147,NM_001077351;NM_001077352;NM_001308044;NM_001352762;NM_001352763;NM_001352764;NM_001352765;NM_001352766;NM_018107
NDUFAF2_SIG,NDUFAF2,NDUFAF2_SIG,NDUFAF2,SIG,22,1.99009790737986,0.405672454927267,0.401373773113294,0.419796695173178,0.0184229220598835,0.0700011887229268,3.18545561822271,2.78836094969333,2.73852143357266,2.95211935980411,0.213597926231451,0.00660770056547213,ENSG00000164182,NDUFAF2,protein_coding,5,1,60945205,61153026,q12.1,NADH:ubiquinone oxidoreductase complex assembly factor 2 [Source:HGNC Symbol;Acc:HGNC:28086],Isolated complex I deficiency;Leigh syndrome;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 10,NDUFAF2,91942,NM_174889
CDH2_SIG,CDH2,CDH2_SIG,CDH2,SIG,49,1.98918619025239,-0.100996612835046,-0.103906293747072,-0.0914362326955301,0.0124700610515421,0.0701395052195115,1.92543430365114,1.05929657220148,0.97984744301174,1.32034371096776,0.340496267956018,0.111227060547691,ENSG00000170558,CDH2,protein_coding,18,-1,27950966,28177130,q12.1,cadherin 2 [Source:HGNC Symbol;Acc:HGNC:1759],NA,CDH2,1000,NM_001308176;NM_001792
BFAR_SIG,BFAR,BFAR_SIG,BFAR,SIG,17,1.98862697605945,0.303235087250584,0.299076036843484,0.316900538588196,0.0178245017447113,0.07021953113284,0.0831995623977734,5.29388798000921,5.29292347829544,5.29705705706872,0.00413357877327951,0.954080444744517,ENSG00000103429,BFAR,protein_coding,16,1,14632931,14669236,p13.12,bifunctional apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:17613],NA,BFAR,51283,NM_001330500;NM_016561
ARHGAP1_SIG,ARHGAP1,ARHGAP1_SIG,ARHGAP1,SIG,30,-1.98686198886026,0.260528043936133,0.264329831268993,0.248036456985304,-0.0162933742836891,0.0705001424536077,-0.476108590954374,6.77610121529832,6.78226041298473,6.75586385147153,-0.0263965615131951,0.723712380024897,ENSG00000175220,ARHGAP1,protein_coding,11,-1,46677080,46700619,p11.2,Rho GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:673],NA,ARHGAP1,392,NM_004308
XK_SIG,XK,XK_SIG,XK,SIG,33,-1.98662549998501,-0.0661224209245284,-0.0572337331747756,-0.0953281092451447,-0.0380943760703692,0.0705267393653914,-0.762146128739164,2.74946666440866,2.78635381069944,2.62826604088183,-0.158087769817612,0.556692030625087,ENSG00000047597,XK,protein_coding,X,1,37685791,37732130,p21.1,X-linked Kx blood group [Source:HGNC Symbol;Acc:HGNC:12811],McLeod neuroacanthocytosis syndrome;MCLEOD SYNDROME,XK,7504,NM_021083
ZNF26_TF,ZNF26,ZNF26_TF,ZNF26,TF,36,1.98582399191118,0.306996537470269,0.302829684248155,0.320687626628642,0.0178579423804866,0.0706398787551137,1.01225254361055,0.896749927163794,0.886784703933704,0.929492803491235,0.0427080995575311,0.42456484845864,ENSG00000198393,ZNF26,protein_coding,12,1,132986365,133032952,q24.33,zinc finger protein 26 [Source:HGNC Symbol;Acc:HGNC:13053],NA,ZNF26,7574,NM_001256279;NM_001256280;NM_001330513;NM_001330514;NM_019591
MRPL37_SIG,MRPL37,MRPL37_SIG,MRPL37,SIG,36,1.98579307092574,0.519072072560617,0.514336826188017,0.534630739213449,0.0202939130254319,0.0706398787551137,2.59110406754948,5.7590432006172,5.72681470940626,5.86493681459598,0.138122105189717,0.0287509253942512,ENSG00000116221,MRPL37,protein_coding,1,1,54184041,54225464,p32.3,mitochondrial ribosomal protein L37 [Source:HGNC Symbol;Acc:HGNC:14034],NA,MRPL37,51253,NM_001330602;NM_016491
DSE_SIG,DSE,DSE_SIG,DSE,SIG,53,1.98455518011706,0.0739453247116559,0.0716471267176075,0.0814965466921009,0.00984941997449326,0.0708337228270699,3.1773937675529,5.00752227164978,4.90705627135746,5.33762484403884,0.430568572681388,0.00675364313890752,ENSG00000111817,DSE,protein_coding,6,1,116254173,116444860,q22.1,dermatan sulfate epimerase [Source:HGNC Symbol;Acc:HGNC:21144],EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE;Ehlers-Danlos syndrome musculocontractural type 2;EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE 2,DSE,29940,NM_001080976;NM_001322937;NM_001322938;NM_001322939;NM_001322940;NM_001322941;NM_001322943;NM_001322944;NM_013352
MYSM1_SIG,MYSM1,MYSM1_SIG,MYSM1,SIG,53,1.98357760118825,0.534395867841093,0.53082451004238,0.546130329179721,0.0153058191373414,0.070982891799572,1.90624039231916,6.40858318901131,6.3854400719301,6.48462485942098,0.0991847874908736,0.115108043115646,ENSG00000162601,MYSM1,protein_coding,1,-1,58654740,58700080,p32.1,Myb like, SWIRM and MPN domains 1 [Source:HGNC Symbol;Acc:HGNC:29401],BONE MARROW FAILURE SYNDROME 4;Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,MYSM1,114803,NM_001085487
PTDSS1_SIG,PTDSS1,PTDSS1_SIG,PTDSS1,SIG,34,-1.98350988202957,0.2109414123393,0.213664574379669,0.201993879920944,-0.0116706944587254,0.070982891799572,-2.92740872085013,7.37458911909725,7.41732480103086,7.23417187845826,-0.183152922572599,0.0129511735971349,ENSG00000156471,PTDSS1,protein_coding,8,1,96261715,96336995,q22.1,phosphatidylserine synthase 1 [Source:HGNC Symbol;Acc:HGNC:9587],Lenz-Majewski hyperostotic dwarfism,PTDSS1,9791,NM_001290225;NM_014754
TAOK2_SIG,TAOK2,TAOK2_SIG,TAOK2,SIG,17,1.98226577195413,0.413849451437151,0.410142167623331,0.426030526825417,0.0158883592020861,0.0711785497696937,1.94339361780289,5.84361091577889,5.82240094779664,5.91330081057769,0.0908998627810434,0.107666454222455,ENSG00000149930,TAOK2,protein_coding,16,1,29973868,29992261,p11.2,TAO kinase 2 [Source:HGNC Symbol;Acc:HGNC:16835],NA,TAOK2,9344,NM_001252043;NM_004783;NM_016151
ANAPC13_SIG,ANAPC13,ANAPC13_SIG,ANAPC13,SIG,14,1.98186957824856,0.166914503859256,0.159582611118904,0.191005008577557,0.0314223974586524,0.071232161665557,1.99619073783568,4.70807731000736,4.68049570702308,4.79870257695571,0.118206869932627,0.0977640050980133,ENSG00000129055,ANAPC13,protein_coding,3,-1,134477706,134486716,q22.2,anaphase promoting complex subunit 13 [Source:HGNC Symbol;Acc:HGNC:24540],NA,ANAPC13,25847,NM_001242374;NM_001242375;NM_015391
ZFYVE16_TF,ZFYVE16,ZFYVE16_TF,ZFYVE16,TF,241,-1.98054933655868,0.0369547010537643,0.0398699680272986,0.0273759667121518,-0.012494001315147,0.0714411956125218,-1.45737170327824,5.13075548797508,5.15936264753185,5.03676053514569,-0.122602112386166,0.236139434332637,ENSG00000039319,ZFYVE16,protein_coding,5,1,80408013,80483379,q14.1,zinc finger FYVE-type containing 16 [Source:HGNC Symbol;Acc:HGNC:20756],NA,ZFYVE16,9765,NM_001105251;NM_001284236;NM_001284237;NM_001349434;NM_014733
ADSS_SIG,ADSS,ADSS_SIG,ADSS,SIG,36,-1.97966114585442,0.295203993285547,0.29995280456026,0.279600756240059,-0.0203520483202008,0.0715778680470556,-1.96290812291238,5.98459470430365,6.01778244781529,5.87554926133685,-0.142233186478435,0.103904480554139,ENSG00000035687,ADSS,protein_coding,1,-1,244408494,244451909,q44,adenylosuccinate synthase [Source:HGNC Symbol;Acc:HGNC:292],NA,ADSS,159,NM_001126;NM_001365073
NET1_SIG,NET1,NET1_SIG,NET1,SIG,40,1.97936454297376,0.0867009058023376,0.0826934948320726,0.0998681132760655,0.017174618443993,0.0716149247514438,3.02683262891406,5.89208234661041,5.79761016657556,6.20249093815348,0.404880771577928,0.0100385877374377,ENSG00000173848,NET1,protein_coding,10,1,5412557,5459056,p15.1,neuroepithelial cell transforming 1 [Source:HGNC Symbol;Acc:HGNC:14592],NA,NET1,10276,NM_001047160;NM_005863
PANK2_SIG,PANK2,PANK2_SIG,PANK2,SIG,25,-1.97858736027136,0.137666177399846,0.141798920329991,0.124087164915085,-0.0177117554149054,0.0717331185141919,-1.87415750264935,5.02885035696462,5.04927899225419,4.96172769815604,-0.0875512940981514,0.121694875765144,ENSG00000125779,PANK2,protein_coding,20,1,3888839,3929882,p13,pantothenate kinase 2 [Source:HGNC Symbol;Acc:HGNC:15894],Atypical pantothenate kinase associated neurodegeneration;Classic pantothenate kinase associated neurodegeneration;Hypoprebetalipoproteinemia acanthocytosis retinitis pigmentosa and pallidal degeneration;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1,PANK2,80025,NM_001324191;NM_001324193;NM_024960;NM_153638;NM_153640
SLC25A19_SIG,SLC25A19,SLC25A19_SIG,SLC25A19,SIG,45,1.97674143811103,0.206776433715138,0.198273761165985,0.234713786376643,0.0364400252106587,0.0720323947260917,1.66032483839064,3.58027316716533,3.5354073254582,3.72768950420305,0.192282178744847,0.173742607086133,ENSG00000125454,SLC25A19,protein_coding,17,-1,75272981,75289510,q25.1,solute carrier family 25 member 19 [Source:HGNC Symbol;Acc:HGNC:14409],Amish lethal microcephaly;MICROCEPHALY AMISH TYPE;Progressive polyneuropathy with bilateral striatal necrosis;THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE),SLC25A19,60386,NM_001126121;NM_001126122;NM_021734
LYPLA2_SIG,LYPLA2,LYPLA2_SIG,LYPLA2,SIG,29,-1.97665126836385,0.151680111525057,0.154374051766954,0.142828593587397,-0.0115454581795568,0.072034648249851,-0.67980553904791,4.81251430771217,4.81880773678216,4.79183589791076,-0.026971838871395,0.603619933721177,ENSG00000011009,LYPLA2,protein_coding,1,1,23791145,23795539,p36.11,lysophospholipase 2 [Source:HGNC Symbol;Acc:HGNC:6738],NA,LYPLA2,11313,NM_007260
UQCRFS1_SIG,UQCRFS1,UQCRFS1_SIG,UQCRFS1,SIG,65,-1.97622945966934,0.0934148681671893,0.0966930491282096,0.0826437021524083,-0.0140493469758015,0.0720931232227134,-1.53036767014939,6.13967381860063,6.15639580549163,6.08473014738737,-0.0716656581042558,0.212092800255891,ENSG00000169021,UQCRFS1,protein_coding,19,-1,29205320,29213151,q12,ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [Source:HGNC Symbol;Acc:HGNC:12587],NA,UQCRFS1,7386,NM_006003
AGL_SIG,AGL,AGL_SIG,AGL,SIG,27,1.9757514497761,0.165694192993879,0.162176489689365,0.177252360994426,0.015075871305061,0.0721498887149027,1.63282798768011,4.78097797805777,4.75194103871708,4.87638506446291,0.124444025745826,0.181353484090526,ENSG00000162688,AGL,protein_coding,1,1,99850361,99924023,p21.2,amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase [Source:HGNC Symbol;Acc:HGNC:321],Glycogen storage disease due to glycogen debranching enzyme deficiency;GLYCOGEN STORAGE DISEASE III;Glycogen Storage Disease Type III,AGL,178,NM_000028;NM_000642;NM_000643;NM_000644;NM_000646
LRRFIP1_SIG,LRRFIP1,LRRFIP1_SIG,LRRFIP1,SIG,31,-1.97574109544489,0.285183898504402,0.288582621365755,0.274016666245667,-0.0145659551200882,0.0721498887149027,-1.60003449606077,8.61523643526947,8.63541342916609,8.54894059818056,-0.0864728309855388,0.190625949427024,ENSG00000124831,LRRFIP1,protein_coding,2,1,237627587,237813682,q37.3,LRR binding FLII interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:6702],NA,LRRFIP1,9208,NM_001137550;NM_001137552;NM_001137553;NM_004735
TRIM39_SIG,TRIM39,TRIM39_SIG,TRIM39,SIG,34,-1.97399354744085,0.123903353795228,0.129476988508396,0.105589982594818,-0.0238870059135787,0.0724338306932061,-0.765611241577679,4.09134416966539,4.10051376157986,4.06121551051784,-0.0392982510620206,0.554750962257733,ENSG00000204599,TRIM39,protein_coding,6,1,30326479,30343729,p22.1,tripartite motif containing 39 [Source:HGNC Symbol;Acc:HGNC:10065],NA,TRIM39,56658,NM_021253;NM_172016
MDH1_SIG,MDH1,MDH1_SIG,MDH1,SIG,30,1.97388036037682,0.282713076235436,0.277837092465913,0.298734165763865,0.0208970732979519,0.072440011150468,1.38108056202578,5.54574005660705,5.52448546006465,5.61557658810351,0.0910911280388581,0.263746994263688,ENSG00000014641,MDH1,protein_coding,2,1,63588609,63607197,p15,malate dehydrogenase 1 [Source:HGNC Symbol;Acc:HGNC:6970],NA,MDH1,4190,NM_001199111;NM_001199112;NM_001316374;NM_005917
PTPN18_SIG,PTPN18,PTPN18_SIG,PTPN18,SIG,55,-1.97322983379461,0.273866945557199,0.281418431636244,0.24905491986891,-0.0323635117673346,0.0725152151286348,-1.20826995689567,7.14410812245014,7.17076475331334,7.0565220496139,-0.114242703699442,0.333220150286963,ENSG00000072135,PTPN18,protein_coding,2,1,130356045,130375405,q21.1,protein tyrosine phosphatase, non-receptor type 18 [Source:HGNC Symbol;Acc:HGNC:9649],NA,PTPN18,26469,NM_001142370;NM_014369
KEL_SIG,KEL,KEL_SIG,KEL,SIG,47,-1.97321688259208,-0.145375810310304,-0.132953014104348,-0.186193569272732,-0.0532405551683838,0.0725152151286348,-1.68148580179691,2.2189550927453,2.30126602412812,1.9485048896303,-0.352761134497826,0.1680965579233,ENSG00000197993,KEL,protein_coding,7,-1,142941114,142962363,q34,Kell metallo-endopeptidase (Kell blood group) [Source:HGNC Symbol;Acc:HGNC:6308],BLOOD GROUP--KELL SYSTEM,KEL,3792,NM_000420
KIAA2026_SIG,KIAA2026,KIAA2026_SIG,KIAA2026,SIG,29,1.97319343869857,0.377494216022415,0.374660666187619,0.386804451193888,0.0121437850062693,0.0725152151286348,0.826020268856508,6.1607083347791,6.15186608359852,6.18976144580101,0.0378953622024882,0.521046853347212,ENSG00000183354,KIAA2026,protein_coding,9,-1,5881596,6008482,p24.1,KIAA2026 [Source:HGNC Symbol;Acc:HGNC:23378],NA,KIAA2026,158358,NM_001017969
UGP2_SIG,UGP2,UGP2_SIG,UGP2,SIG,29,1.97313133830906,0.182328525080811,0.177308796545601,0.198821918839358,0.0215131222937568,0.0725152151286348,3.60228069660447,6.51813129114143,6.44890444793867,6.74559091880764,0.296686470868968,0.00198338266275085,ENSG00000169764,UGP2,protein_coding,2,1,63840940,63891562,p15,UDP-glucose pyrophosphorylase 2 [Source:HGNC Symbol;Acc:HGNC:12527],NA,UGP2,7360,NM_001001521;NM_006759
GEMIN7_SIG,GEMIN7,GEMIN7_SIG,GEMIN7,SIG,34,1.97283026833572,0.219925274267049,0.214797564590289,0.236773463204975,0.0219758986146858,0.0725534250285263,1.66126665691313,3.70506556723488,3.67738785549336,3.79600662009988,0.118618764606523,0.1734985628841,ENSG00000142252,GEMIN7,protein_coding,19,1,45079195,45091524,q13.32,gem nuclear organelle associated protein 7 [Source:HGNC Symbol;Acc:HGNC:20045],NA,GEMIN7,79760,NM_001007269;NM_001007270;NM_001319054;NM_001319055;NM_024707
PDSS2_SIG,PDSS2,PDSS2_SIG,PDSS2,SIG,45,1.97171885823941,0.30008481622824,0.291949778867752,0.326814224698416,0.0348644458306643,0.0727299339946909,0.905615309778167,3.6670998670598,3.65173069825921,3.71759856454747,0.0658678662882655,0.479014867837891,ENSG00000164494,PDSS2,protein_coding,6,-1,107152562,107459564,q21,decaprenyl diphosphate synthase subunit 2 [Source:HGNC Symbol;Acc:HGNC:23041],COENZYME Q10 DEFICIENCY PRIMARY 3;Leigh syndrome with nephrotic syndrome,PDSS2,57107,NM_020381
ZNF28_TF,ZNF28,ZNF28_TF,ZNF28,TF,83,1.97115181912404,0.301939932763827,0.296484309100522,0.319865553371826,0.0233812442713032,0.0728136883021943,1.28843308007794,3.48194449919962,3.44901658775702,3.59013620822528,0.141119620468264,0.299561272213023,ENSG00000198538,ZNF28,protein_coding,19,-1,52797408,52857600,q13.41,zinc finger protein 28 [Source:HGNC Symbol;Acc:HGNC:13073],NA,ZNF28,7576,NM_006969
VDAC2_SIG,VDAC2,VDAC2_SIG,VDAC2,SIG,30,1.97075275922793,0.14846882021131,0.14452774346883,0.161418072365173,0.0168903288963426,0.0728687835257311,0.886223857303624,5.01716484462459,5.00742862304402,5.04915528696072,0.0417266639166981,0.489118351484133,ENSG00000165637,VDAC2,protein_coding,10,1,75210154,75231448,q22.2,voltage dependent anion channel 2 [Source:HGNC Symbol;Acc:HGNC:12672],NA,VDAC2,7417,NM_001184783;NM_001184823;NM_001324087;NM_001324088;NM_001324089;NM_001324090;NM_003375
LIN54_TF,LIN54,LIN54_TF,LIN54,TF,172,-1.96800085755558,0.179944057613766,0.182827836359876,0.17046878459083,-0.0123590517690466,0.0733275387713811,-0.61036957618421,4.59677579508945,4.60442922982497,4.5716287952442,-0.0328004345807704,0.644482483241819,ENSG00000189308,LIN54,protein_coding,4,-1,82909973,83012926,q21.22,lin-54 DREAM MuvB core complex component [Source:HGNC Symbol;Acc:HGNC:25397],NA,LIN54,132660,NM_001115007;NM_001115008;NM_001288996;NM_001288997;NM_194282
PSMA3_SIG,PSMA3,PSMA3_SIG,PSMA3,SIG,15,1.96732163663727,0.295650066319519,0.29277910561934,0.305083222905821,0.0123041172864804,0.0734311610328115,3.24158544583354,5.20788285208544,5.17435257564036,5.31805376040498,0.14370118476462,0.00565887217632642,ENSG00000100567,PSMA3,protein_coding,14,1,58244843,58272012,q23.1,proteasome subunit alpha 3 [Source:HGNC Symbol;Acc:HGNC:9532],NA,PSMA3,5684,NM_002788;NM_152132
JMJD7-PLA2G4B_SIG,JMJD7-PLA2G4B,JMJD7-PLA2G4B_SIG,JMJD7-PLA2G4B,SIG,69,1.96690959743881,0.0774281557981396,0.0748115572336528,0.0860255510814534,0.0112139938478008,0.0734888670695443,1.40358005659307,3.01952428200962,2.99636286181713,3.09562609121351,0.0992632293963776,0.255246130004173,ENSG00000168970,JMJD7-PLA2G4B,protein_coding,15,1,41828095,41848155,q15.1,JMJD7-PLA2G4B readthrough [Source:HGNC Symbol;Acc:HGNC:34449],NA,JMJD7-PLA2G4B,8681,NM_001198588;NM_005090
ARSE_SIG,ARSE,ARSE_SIG,ARSE,SIG,6,1.96655459418992,-0.192871583211076,-0.19486083710795,-0.186335463264202,0.00852537384374825,0.0735367795311017,2.76126922520071,0.311574991363109,0.279180077041509,0.418015424134083,0.138835347092574,0.0194165730140079,ENSG00000157399,ARSE,protein_coding,X,-1,2934632,2968310,p22.33,arylsulfatase E [Source:HGNC Symbol;Acc:HGNC:719],Brachytelephalangic chondrodysplasia punctata;Chondrodysplasia Punctata 1 X-Linked;Chondrodysplasia punctata 1 X-linked recessive,ARSE,415,NM_000047;NM_001282628;NM_001282631
PSMB5_SIG,PSMB5,PSMB5_SIG,PSMB5,SIG,35,1.96598401915816,0.485932860196238,0.478962931753386,0.508834053651326,0.0298711218979403,0.0736086890446898,2.10376271401397,4.2477793120744,4.20643251441525,4.38363307581163,0.17720056139638,0.0798121032624527,ENSG00000100804,PSMB5,protein_coding,14,-1,23016543,23035230,q11.2,proteasome subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:9542],NA,PSMB5,5693,NM_001130725;NM_001144932;NM_002797
ZNF611_TF,ZNF611,ZNF611_TF,ZNF611,TF,43,1.9659836720079,0.280877364584696,0.277073037972804,0.293377294880914,0.0163042569081104,0.0736086890446898,1.76467859359999,3.92598345373551,3.89819698287004,4.01728185800776,0.119084875137719,0.146674195972494,ENSG00000213020,ZNF611,protein_coding,19,-1,52702813,52735073,q13.41,zinc finger protein 611 [Source:HGNC Symbol;Acc:HGNC:28766],NA,ZNF611,81856,NM_001161499;NM_001161500;NM_001161501;NM_030972
CCDC137_SIG,CCDC137,CCDC137_SIG,CCDC137,SIG,16,1.9658277559833,0.318241851014155,0.313436469533591,0.334030961593151,0.0205944920595601,0.0736223169660173,1.50296048020071,4.63400338504274,4.61485895815809,4.69690650194944,0.0820475437913483,0.220838403455831,ENSG00000185298,CCDC137,protein_coding,17,1,81666737,81673904,q25.3,coiled-coil domain containing 137 [Source:HGNC Symbol;Acc:HGNC:33451],NA,CCDC137,339230,NM_199287
DYRK4_SIG,DYRK4,DYRK4_SIG,DYRK4,SIG,9,1.9652498944798,0.211285312329496,0.205522367124473,0.230220703717426,0.0246983365929526,0.073708771458528,1.49435087556216,3.25932986860333,3.23582402324147,3.33656336050661,0.10073933726514,0.223771348047406,ENSG00000010219,DYRK4,protein_coding,12,1,4562204,4615302,p13.32,dual specificity tyrosine phosphorylation regulated kinase 4 [Source:HGNC Symbol;Acc:HGNC:3095],NA,DYRK4,8798,NM_001282285;NM_001282286;NM_003845
SMPD3_SIG,SMPD3,SMPD3_SIG,SMPD3,SIG,22,-1.96426864029548,-0.157679330935137,-0.152043848703966,-0.176195915408985,-0.0241520667050197,0.0738650523965878,-0.489337116414779,1.69977031951447,1.71436699319412,1.65180982028136,-0.0625571729127624,0.715779797417618,ENSG00000103056,SMPD3,protein_coding,16,-1,68358327,68448508,q22.1,sphingomyelin phosphodiesterase 3 [Source:HGNC Symbol;Acc:HGNC:14240],NA,SMPD3,55512,NM_018667
THUMPD2_SIG,THUMPD2,THUMPD2_SIG,THUMPD2,SIG,36,1.96389294670564,0.423301182776974,0.418209894208669,0.440029702358544,0.0218198081498748,0.0739167438692231,2.96624728297118,4.2460826398051,4.19945345064588,4.39929283275683,0.199839382110952,0.0117441083188643,ENSG00000138050,THUMPD2,protein_coding,2,-1,39736060,39779267,p22.1,THUMP domain containing 2 [Source:HGNC Symbol;Acc:HGNC:14890],NA,THUMPD2,80745,NM_001321468;NM_001321469;NM_001321470;NM_001321474;NM_001321475;NM_001321477;NM_001321478;NM_001321479;NM_001321480;NM_001321481;NM_025264
NEDD4_SIG,NEDD4,NEDD4_SIG,NEDD4,SIG,96,1.96316660997915,0.110451023803866,0.105678438104858,0.126132376814893,0.0204539387100355,0.0740292015133858,1.02372521369351,4.87671896565379,4.84635181542056,4.97649674499153,0.130144929570966,0.418879239511395,ENSG00000069869,NEDD4,protein_coding,15,-1,55826922,55993746,q21.3,neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:7727],NA,NEDD4,4734,NM_001284338;NM_001284339;NM_001284340;NM_001329212;NM_006154;NM_198400
SLC25A39_SIG,SLC25A39,SLC25A39_SIG,SLC25A39,SIG,25,-1.96305681246006,0.139571893966397,0.144800257599472,0.122392984886293,-0.0224072727131795,0.0740348987280392,-0.211552745475742,6.31980999675604,6.32377075124167,6.30679608916037,-0.0169746620813073,0.880812310901403,ENSG00000013306,SLC25A39,protein_coding,17,-1,44319625,44324870,q21.31,solute carrier family 25 member 39 [Source:HGNC Symbol;Acc:HGNC:24279],NA,SLC25A39,51629,NM_001143780;NM_001321240;NM_001321241;NM_016016
SLC44A1_SIG,SLC44A1,SLC44A1_SIG,SLC44A1,SIG,19,-1.9622892959994,0.0978662412069668,0.102225479349557,0.0835430301670281,-0.0186824491825288,0.0741546460147213,1.39100931693511,6.6643479005099,6.61933927544728,6.81223338285852,0.192894107411243,0.259989708880265,ENSG00000070214,SLC44A1,protein_coding,9,1,105244622,105439171,q31.1,solute carrier family 44 member 1 [Source:HGNC Symbol;Acc:HGNC:18798],NA,SLC44A1,23446,NM_001286730;NM_001330731;NM_080546
NTRK1_SIG,NTRK1,NTRK1_SIG,NTRK1,SIG,80,1.96218795691151,0.00213677285243816,-0.00339436039367193,0.0203104963753713,0.0237048567690434,0.0741588837049344,1.04931070917471,2.12455254489946,2.08002898301807,2.27084424822401,0.190815265205935,0.406420558247757,ENSG00000198400,NTRK1,protein_coding,1,1,156815640,156881850,q23.1,neurotrophic receptor tyrosine kinase 1 [Source:HGNC Symbol;Acc:HGNC:8031],Congenital insensitivity to pain with anhidrosis;Differentiated thyroid carcinoma;Familial medullary thyroid carcinoma;Hereditary sensory and autonomic neuropathy type 4;Hereditary sensory and autonomic neuropathy type 5;INSENSITIVITY TO PAIN CONGENITAL WITH ANHIDROSIS;THYROID CARCINOMA FAMILIAL MEDULLARY,NTRK1,4914,NM_001007792;NM_001012331;NM_002529
STK11_SIG,STK11,STK11_SIG,STK11,SIG,20,1.96135394654911,0.189627253225211,0.186605615114593,0.199555492731526,0.0129498776169332,0.0742903463000782,0.807788992496838,6.20479691818317,6.19443764302556,6.23883453655819,0.0443968935326247,0.530890360983834,ENSG00000118046,STK11,protein_coding,19,1,1177558,1228435,p13.3,serine/threonine kinase 11 [Source:HGNC Symbol;Acc:HGNC:11389],Pancreatic Cancer;Peutz-Jeghers Syndrome;TESTICULAR GERM CELL TUMOR,STK11,6794,NM_000455
LRP11_SIG,LRP11,LRP11_SIG,LRP11,SIG,13,-1.96089354657977,0.162328543771497,0.167366132521774,0.145776466449157,-0.0215896660726173,0.0743457829511602,-1.49640369061232,2.37430800861687,2.42582226169049,2.20504689137498,-0.22077537031551,0.22311093737688,ENSG00000120256,LRP11,protein_coding,6,-1,149818798,149864026,q25.1,LDL receptor related protein 11 [Source:HGNC Symbol;Acc:HGNC:16936],NA,LRP11,84918,NM_032832
IMPAD1_SIG,IMPAD1,IMPAD1_SIG,IMPAD1,SIG,27,1.96088118084269,0.35979945849116,0.35783213510994,0.366263521029455,0.00843138591951447,0.0743457829511602,1.61629449955931,6.46737395750702,6.44685619719664,6.53478945566968,0.0879332584730356,0.186048565477832,ENSG00000104331,IMPAD1,protein_coding,8,-1,56957931,56993867,q12.1,inositol monophosphatase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26019],CHONDRODYSPLASIA WITH JOINT DISLOCATIONS GPAPP TYPE;Chondrodysplasia with joint dislocations GRAPP type,IMPAD1,54928,NM_017813
TP63_TF,TP63,TP63_TF,TP63,TF,216,1.96076969377678,-0.0850588904924555,-0.0869882621247735,-0.0787195265576963,0.0082687355670772,0.0743517962565515,0.307831635813358,0.912951116239358,0.904066303814037,0.942144071351128,0.0380777675370913,0.82308561090702,ENSG00000073282,TP63,protein_coding,3,1,189631389,189897276,q28,tumor protein p63 [Source:HGNC Symbol;Acc:HGNC:15979],Acro-Dermato-Ungual-Lacrimal-Tooth syndrome;Adult syndrome;ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE;Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome;Bladder exstrophy;Cleft lip and alveolus;Cleft lip/palate;ECTODERMAL DYSPLASIA RAPP-HODGKIN TYPE;ECTRODACTYLY-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME TYPE 3;ECTRODACTYLY ECTODERMAL DYSPLASIA AND CLEFT LIP/PALATE SYNDROME 3;EEC syndrome;Isolated cleft lip;Isolated split hand-split foot malformation;LIMB-MAMMARY SYNDROME;NON-SYNDROMIC OROFACIAL CLEFT TYPE 8;RAPP-HODGKIN SYNDROME;SPLIT-HAND/FOOT MALFORMATION 4;SPLIT-HAND/FOOT MALFORMATION TYPE 4,TP63,8626,NM_001114978;NM_001114979;NM_001114980;NM_001114981;NM_001114982;NM_001329144;NM_001329145;NM_001329146;NM_001329148;NM_001329149;NM_001329150;NM_001329964;NM_003722
TSC22D2_TF,TSC22D2,TSC22D2_TF,TSC22D2,TF,41,-1.96019639175816,0.346389243411357,0.352695040747526,0.325670195021088,-0.0270248457264384,0.0744381481510216,-0.193579055099617,5.77833175655692,5.78147587927298,5.76800106763272,-0.0134748116402568,0.891187815493095,ENSG00000196428,TSC22D2,protein_coding,3,1,150408335,150466431,q25.1,TSC22 domain family member 2 [Source:HGNC Symbol;Acc:HGNC:29095],NA,TSC22D2,9819,NM_001303264;NM_014779
SH3RF1_SIG,SH3RF1,SH3RF1_SIG,SH3RF1,SIG,55,1.95973490735713,0.267295164363212,0.262063016529391,0.28448650724577,0.0224234907163796,0.0745051044626072,0.362300150212083,4.1502634645297,4.1414213861811,4.17931600767511,0.0378946214940151,0.790665105678631,ENSG00000154447,SH3RF1,protein_coding,4,-1,169094259,169270956,q33,SH3 domain containing ring finger 1 [Source:HGNC Symbol;Acc:HGNC:17650],NA,SH3RF1,57630,NM_020870
CAMK2G_SIG,CAMK2G,CAMK2G_SIG,CAMK2G,SIG,45,-1.95830467391268,0.16615629701288,0.168671390094326,0.157892419745269,-0.0107789703490571,0.0747303365046649,-0.786279402689821,6.33788711193677,6.3488888194364,6.30173864443798,-0.0471501749984187,0.54246836480078,ENSG00000148660,CAMK2G,protein_coding,10,-1,73812501,73874591,q22.2,calcium/calmodulin dependent protein kinase II gamma [Source:HGNC Symbol;Acc:HGNC:1463],NA,CAMK2G,818,NM_001204492;NM_001222;NM_001320898;NM_001367525;NM_172169;NM_172170;NM_172171;NM_172173
CLCN1_SIG,CLCN1,CLCN1_SIG,CLCN1,SIG,28,1.95828946876681,-0.00285793588075234,-0.00561006776161415,0.00618478315636506,0.0117948509179791,0.0747303365046649,1.02619607277715,0.952242840221651,0.929067324300183,1.02839096396361,0.0993236396634312,0.417758915822753,ENSG00000188037,CLCN1,protein_coding,7,1,143316126,143352083,q34,chloride voltage-gated channel 1 [Source:HGNC Symbol;Acc:HGNC:2019],MYOTONIA CONGENITA AUTOSOMAL DOMINANT;MYOTONIA CONGENITA AUTOSOMAL RECESSIVE;Thomsen and Becker disease,CLCN1,1180,NM_000083
EIF1AX_SIG,EIF1AX,EIF1AX_SIG,EIF1AX,SIG,22,1.95819000549162,0.19795319236755,0.190111443667741,0.223718938095494,0.0336074944277531,0.0747342745734105,2.26741954093963,5.61359391154768,5.58137129181543,5.71946823352509,0.138096941709661,0.0577949957863095,ENSG00000173674,EIF1AX,protein_coding,X,-1,20124525,20141838,p22.12,eukaryotic translation initiation factor 1A X-linked [Source:HGNC Symbol;Acc:HGNC:3250],Differentiated thyroid carcinoma,EIF1AX,1964,NM_001412
CCL3L1_SIG,CCL3L1,CCL3L1;CCL3L3_SIG,CCL3L1;CCL3L3,SIG,11,-1.95811262558388,0.337233175210158,0.346884368970975,0.305522109996044,-0.0413622589749309,0.0747343589467605,-0.48436879439433,1.31910125202882,1.33420616562967,1.26947082162601,-0.0647353440036591,0.71855289584784,ENSG00000276085;ENSG00000277796,CCL3L1;CCL3L3,protein_coding,17;CHR_HSCHR17_10_CTG4,-1,36194869;36194906,36196758;36196795,q12,C-C motif chemokine ligand 3 like 1 [Source:HGNC Symbol;Acc:HGNC:10628];C-C motif chemokine ligand 3 like 3 [Source:HGNC Symbol;Acc:HGNC:30554],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,CCL3L1,6349;414062,NM_001001437
SLC30A6_SIG,SLC30A6,SLC30A6_SIG,SLC30A6,SIG,58,1.95795823426841,0.380676418844722,0.373320666757634,0.404845318559438,0.0315246518018035,0.0747478915469825,1.60652305400666,4.38384193152579,4.35519725259877,4.47796016228598,0.122762909687213,0.188710203458131,ENSG00000152683,SLC30A6,protein_coding,2,1,32165841,32224379,p22.3,solute carrier family 30 member 6 [Source:HGNC Symbol;Acc:HGNC:19305],NA,SLC30A6,55676,NM_001193513;NM_001193514;NM_001193515;NM_001330476;NM_001330477;NM_001330478;NM_001330479;NM_017964
DCAF7_SIG,DCAF7,DCAF7_SIG,DCAF7,SIG,104,1.95778572822741,0.327179368757782,0.31805410759972,0.357162369705697,0.039108262105977,0.0747645909533633,2.32370926939464,6.76214053587291,6.69635600574764,6.97828970628449,0.281933700536845,0.0514211150651166,ENSG00000136485,DCAF7,protein_coding,17,1,63550477,63594279,q23.3,DDB1 and CUL4 associated factor 7 [Source:HGNC Symbol;Acc:HGNC:30915],NA,DCAF7,10238,NM_005828
SCNN1D_SIG,SCNN1D,SCNN1D_SIG,SCNN1D,SIG,38,1.95565719339254,0.0109111084896748,0.0075244076043923,0.0220388399698886,0.0145144323654963,0.0751236061928418,2.88989048259314,2.8509560334303,2.7896507486944,3.05238768327684,0.262736934582446,0.0142294099523363,ENSG00000162572,SCNN1D,protein_coding,1,1,1280436,1292029,p36.33,sodium channel epithelial 1 delta subunit [Source:HGNC Symbol;Acc:HGNC:10601],NA,SCNN1D,6339,NM_001130413
OR2L1P_SIG,OR2L1P,OR2L1P_SIG,OR2L1P,SIG,42,1.95419767278184,-0.0717419200745387,-0.0770408351841984,-0.0543311989999427,0.0227096361842556,0.0753663509641683,2.02552882561712,0.586569540758502,0.557235450689769,0.682952979555767,0.125717528865999,0.0927014860699443,ENSG00000224227,OR2L1P,transcribed_unprocessed_pseudogene,1,1,247980872,247991204,q44,olfactory receptor family 2 subfamily L member 1 pseudogene [Source:HGNC Symbol;Acc:HGNC:8265],NA,OR2L1P,NA,NA
SCAF4_SIG,SCAF4,SCAF4_SIG,SCAF4,SIG,14,1.95225773438235,0.726268407020142,0.722325687626466,0.739223056456504,0.0168973688300381,0.0756944672443023,1.14691038242651,6.57083756026002,6.55765141701747,6.61416345948553,0.0565120424680642,0.360430883056446,ENSG00000156304,SCAF4,protein_coding,21,-1,31671033,31732075,q22.11,SR-related CTD associated factor 4 [Source:HGNC Symbol;Acc:HGNC:19304],NA,SCAF4,57466,NM_001145444;NM_001145445;NM_020706
GALK1_SIG,GALK1,GALK1_SIG,GALK1,SIG,76,1.95145970253538,0.325557848853507,0.320534796958046,0.342062162224308,0.0215273652662624,0.075821776959452,2.34410609322305,3.95006886995518,3.89936617846132,4.11666342772072,0.217297249259396,0.0493781070911382,ENSG00000108479,GALK1,protein_coding,17,-1,75751594,75765711,q25.1,galactokinase 1 [Source:HGNC Symbol;Acc:HGNC:4118],GALACTOKINASE DEFICIENCY;Galactosemia II,GALK1,2584,NM_000154
FBXO33_SIG,FBXO33,FBXO33_SIG,FBXO33,SIG,73,-1.94950314655962,0.442256190105219,0.449335584095259,0.418995324137945,-0.030340259957315,0.0761544705724931,-0.88940379577326,5.26922583362501,5.28768602383064,5.20857092294936,-0.0791151008812846,0.48744593972906,ENSG00000165355,FBXO33,protein_coding,14,-1,39397669,39432500,q21.1,F-box protein 33 [Source:HGNC Symbol;Acc:HGNC:19833],NA,FBXO33,254170,NM_203301
LONP1_SIG,LONP1,LONP1_SIG,LONP1,SIG,12,1.94726689779579,0.429592609882638,0.425755036420484,0.442201779829717,0.0164467434092328,0.0765381601978457,1.27514048197489,5.94376847157222,5.92880710087812,5.99292726099567,0.0641201601175502,0.304985191687928,ENSG00000196365,LONP1,protein_coding,19,-1,5691834,5720572,p13.3,lon peptidase 1, mitochondrial [Source:HGNC Symbol;Acc:HGNC:9479],CODAS syndrome,LONP1,9361,NM_001276479;NM_001276480;NM_004793
HLA-DQA1_SIG,HLA-DQA1,HLA-DQA1_SIG,HLA-DQA1,SIG,10,-1.94529343565998,0.687569096707922,0.706553900806396,0.625190454670078,-0.0813634461363183,0.0768764670605754,-0.648822609966389,4.30522858900934,4.34210025683564,4.18407882329436,-0.158021433541284,0.621468969676112,ENSG00000196735,HLA-DQA1,protein_coding,6,1,32628179,32647062,p21.32,major histocompatibility complex, class II, DQ alpha 1 [Source:HGNC Symbol;Acc:HGNC:4942],Adult-onset myasthenia gravis;CELIAC DISEASE SUSCEPTIBILITY TO 1;Idiopathic achalasia,HLA-DQA1,3117,NM_002122
CFP_SIG,CFP,CFP_SIG,CFP,SIG,33,-1.94446761936162,0.682367572239992,0.692664325471477,0.648535383050826,-0.0441289424206503,0.0770103697156447,-1.73911466503243,6.83573335037729,6.8926278289378,6.64879434939277,-0.243833479545031,0.152920257981071,ENSG00000126759,CFP,protein_coding,X,-1,47623172,47630305,p11.23,complement factor properdin [Source:HGNC Symbol;Acc:HGNC:8864],Properdin deficiency;PROPERDIN DEFICIENCY X-LINKED,CFP,5199,NM_001145252;NM_002621
NFKBIA_SIG,NFKBIA,NFKBIA_SIG,NFKBIA,SIG,45,-1.94435011767313,0.401581268371127,0.409341235675927,0.376084232941071,-0.033257002734856,0.0770152701761699,-1.04630098670632,8.85790936150529,8.89487099656536,8.73646398916508,-0.158407007400273,0.407917907343112,ENSG00000100906,NFKBIA,protein_coding,14,-1,35401511,35404749,q13.2,NFKB inhibitor alpha [Source:HGNC Symbol;Acc:HGNC:7797],ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2;Giant cell glioblastoma;Gliosarcoma;Hypohidrotic ectodermal dysplasia with immunodeficiency;NASOPHARYNGEAL CARCINOMA,NFKBIA,4792,NM_020529
SCML2_SIG,SCML2,SCML2_SIG,SCML2,SIG,30,1.94428596032441,0.264518427803779,0.259021833571236,0.282578665996422,0.023556832425186,0.0770152701761699,0.637150690795186,4.04826788702448,4.03030949499799,4.10727403225439,0.0769645372564031,0.628601433369239,ENSG00000102098,SCML2,protein_coding,X,-1,18239313,18354688,p22.13,Scm polycomb group protein like 2 [Source:HGNC Symbol;Acc:HGNC:10581],NA,SCML2,10389,NM_006089
PPP3CC_SIG,PPP3CC,PPP3CC_SIG,PPP3CC,SIG,37,-1.94334055440722,0.241864257596577,0.246070406827898,0.228044052979378,-0.0180263538485201,0.077170802650359,-1.54686820969289,4.72512638695999,4.74934029164869,4.64556641441143,-0.103773877237262,0.206829389962984,ENSG00000120910,PPP3CC,protein_coding,8,1,22440819,22541142,p21.3,protein phosphatase 3 catalytic subunit gamma [Source:HGNC Symbol;Acc:HGNC:9316],NA,PPP3CC,5533,NM_001243974;NM_001243975;NM_005605
RBM25_SIG,RBM25,RBM25_SIG,RBM25,SIG,24,1.94296427733655,0.510121175393259,0.505720912997307,0.524579180408529,0.0188582674112227,0.0772175664806305,2.86245602339334,7.86810169981491,7.83543716430149,7.97542803078756,0.139990866486071,0.015224524493583,ENSG00000119707,RBM25,protein_coding,14,1,73058532,73123899,q24.2,RNA binding motif protein 25 [Source:HGNC Symbol;Acc:HGNC:23244],NA,RBM25,58517,NM_021239
GADD45A_SIG,GADD45A,GADD45A_SIG,GADD45A,SIG,43,-1.94292549778983,0.0971847567834046,0.101957857076958,0.0815017129617304,-0.0204561441152273,0.0772175664806305,0.491682470552099,5.67748032607633,5.66284748413919,5.72555966386979,0.0627121797305997,0.714487885920562,ENSG00000116717,GADD45A,protein_coding,1,1,67685201,67688334,p31.3,growth arrest and DNA damage inducible alpha [Source:HGNC Symbol;Acc:HGNC:4095],NA,GADD45A,1647,NM_001199741;NM_001199742;NM_001924
HIPK1_SIG,HIPK1,HIPK1_SIG,HIPK1,SIG,24,-1.94263196433615,0.263750347756647,0.266830919080501,0.253628470549698,-0.0132024485308038,0.0772563887925648,-2.77750911414839,8.15530690831316,8.19412628147269,8.0277575393604,-0.16636874211229,0.0186402814365003,ENSG00000163349,HIPK1,protein_coding,1,1,113929324,113977869,p13.2,homeodomain interacting protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:19006],NA,HIPK1,204851,NM_152696;NM_181358;NM_198268;NM_198269
HNRNPR_SIG,HNRNPR,HNRNPR_SIG,HNRNPR,SIG,19,1.94017290874738,0.828830332080123,0.824874860447098,0.841826881731488,0.0169520212843895,0.0776847531698179,2.0076046307752,7.77154705750677,7.74969858403123,7.84333489892638,0.0936363148951508,0.0957297092483604,ENSG00000125944,HNRNPR,protein_coding,1,-1,23303771,23344336,p36.12,heterogeneous nuclear ribonucleoprotein R [Source:HGNC Symbol;Acc:HGNC:5047],NA,HNRNPR,10236,NM_001102397;NM_001102398;NM_001102399;NM_001297620;NM_001297621;NM_001297622;NM_005826
STRADA_SIG,STRADA,STRADA_SIG,STRADA,SIG,100,1.93962116906721,0.159485044785547,0.156254908034705,0.170098351252598,0.0138434432178922,0.0777703326244192,3.0117224456572,3.73126594004967,3.68508017159211,3.88301917926738,0.197939007675276,0.0104159777924643,ENSG00000266173,STRADA,protein_coding,17,-1,63682336,63741986,q23.3,STE20 related adaptor alpha [Source:HGNC Symbol;Acc:HGNC:30172],Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome;POLYHYDRAMNIOS MEGALENCEPHALY AND SYMPTOMATIC EPILEPSY,STRADA,92335,NM_001003786;NM_001003787;NM_001003788;NM_001165969;NM_001165970;NM_001363787;NM_153335
RGS12_SIG,RGS12,RGS12_SIG,RGS12,SIG,46,1.93910242457606,-0.00519430629562832,-0.00802509113601966,0.00410684389422891,0.0121319350302485,0.0778500299958806,1.82270008104204,4.07918579735765,4.03584574739648,4.22158881865863,0.185743071262148,0.132999504580288,ENSG00000159788,RGS12,protein_coding,4,1,3293028,3439913,p16.3,regulator of G protein signaling 12 [Source:HGNC Symbol;Acc:HGNC:9994],NA,RGS12,6002,NM_002926;NM_198227;NM_198229
NUFIP2_SIG,NUFIP2,NUFIP2_SIG,NUFIP2,SIG,25,1.93746978723863,0.451981276052893,0.447698891788452,0.466051967207486,0.0183530754190347,0.0781313063409516,3.63971775455637,8.07350389411823,8.02498576091167,8.23292061751119,0.207934856599524,0.0017667412921888,ENSG00000108256,NUFIP2,protein_coding,17,-1,29255839,29294148,q11.2,nuclear FMR1 interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:17634],NA,NUFIP2,57532,NM_020772
IDH1_SIG,IDH1,IDH1_SIG,IDH1,SIG,39,1.93717844669028,0.329024424830702,0.321076518153342,0.355138975342029,0.0340624571886873,0.0781700928568759,4.60109606750028,5.51409149443726,5.36267300275294,6.01160939568571,0.64893639293277,6.81660970669636e-05,ENSG00000138413,IDH1,protein_coding,2,-1,208236227,208266074,q34,isocitrate dehydrogenase (NADP(+)) 1, cytosolic [Source:HGNC Symbol;Acc:HGNC:5382],Enchondromatosis;Giant cell glioblastoma;GLIOMA SUSCEPTIBILITY 1;Gliosarcoma;Maffucci syndrome;Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria,IDH1,3417,NM_001282386;NM_001282387;NM_005896
GLB1L_SIG,GLB1L,GLB1L_SIG,GLB1L,SIG,4,1.93571430234244,-0.0868485108375679,-0.0896086309972793,-0.0777795445985158,0.0118290863987634,0.0784217005297121,-0.875076547283299,2.41901940785287,2.44029840651831,2.34910269795214,-0.0911957085661717,0.495059781371895,ENSG00000163521,GLB1L,protein_coding,2,-1,219236598,219245478,q35,galactosidase beta 1 like [Source:HGNC Symbol;Acc:HGNC:28129],NA,GLB1L,79411,NM_001286423;NM_001286427;NM_024506
CTSG_SIG,CTSG,CTSG_SIG,CTSG,SIG,52,-1.93533801883348,0.153156840116574,0.161233009962026,0.126620853481518,-0.034612156480508,0.0784760384586057,0.0162450057842325,7.13388367621187,7.13268557188931,7.13782030470029,0.00513473281098606,0.991292847616984,ENSG00000100448,CTSG,protein_coding,14,-1,24573518,24576250,q12,cathepsin G [Source:HGNC Symbol;Acc:HGNC:2532],NA,CTSG,1511,NM_001911
GTF2F2_SIG,GTF2F2,GTF2F2_SIG,GTF2F2,SIG,20,1.93391339664035,0.205758550618941,0.202288559957762,0.217159948505673,0.0148713885479116,0.0787086240928287,0.929252074768988,4.2324431286711,4.22054552632277,4.27153525067278,0.0509897243500096,0.466077373532587,ENSG00000188342,GTF2F2,protein_coding,13,1,45120510,45284893,q14.12,general transcription factor IIF subunit 2 [Source:HGNC Symbol;Acc:HGNC:4653],NA,GTF2F2,2963,NM_004128
PTBP2_SIG,PTBP2,PTBP2_SIG,PTBP2,SIG,27,1.93390541110477,0.428073395090447,0.423578704005911,0.442841665796777,0.0192629617908659,0.0787086240928287,1.9173511225906,5.38907209466301,5.35641093570975,5.4963873312237,0.139976395513951,0.1127919721579,ENSG00000117569,PTBP2,protein_coding,1,1,96721665,96823738,p21.3,polypyrimidine tract binding protein 2 [Source:HGNC Symbol;Acc:HGNC:17662],NA,PTBP2,58155,NM_001300985;NM_001300986;NM_001300987;NM_001300988;NM_001300989;NM_001300990;NM_021190
ADCK5_SIG,ADCK5,ADCK5_SIG,ADCK5,SIG,50,1.93321071561645,0.17741838337257,0.172687795804103,0.192961742526103,0.0202739467219995,0.0788211839611282,1.33805075029187,3.04498836208398,3.02296715758783,3.11734374828561,0.094376590697785,0.279916134781068,ENSG00000173137,ADCK5,protein_coding,8,1,144373101,144393242,q24.3,aarF domain containing kinase 5 [Source:HGNC Symbol;Acc:HGNC:21738],NA,ADCK5,203054,NM_174922
MAFG_TF,MAFG,MAFG_TF,MAFG,TF,62,1.93220839618046,0.100829100174371,0.0989458012832087,0.107017082245334,0.00807128096212492,0.0789900686899026,-0.0611474088890968,6.46829386613071,6.46916500698804,6.46543154617092,-0.003733460817119,0.966268067120611,ENSG00000197063,MAFG,protein_coding,17,-1,81918270,81927735,q25.3,MAF bZIP transcription factor G [Source:HGNC Symbol;Acc:HGNC:6781],NA,MAFG,4097,NM_002359;NM_032711
NFE2L2_TF,NFE2L2,NFE2L2_TF,NFE2L2,TF,156,-1.93073149618963,0.237801180479534,0.239969895255391,0.23067540335886,-0.00929449189653047,0.0792461594351472,-1.21521434413242,5.67521947013378,5.69566859258482,5.60802949636609,-0.0876390962187258,0.330322566920663,ENSG00000116044,NFE2L2,protein_coding,2,-1,177227595,177392697,q31.2,nuclear factor, erythroid 2 like 2 [Source:HGNC Symbol;Acc:HGNC:7782],IMMUNODEFICIENCY DEVELOPMENTAL DELAY AND HYPOHOMOCYSTEINEMIA,NFE2L2,4780,NM_001145412;NM_001145413;NM_001313900;NM_001313901;NM_001313902;NM_001313903;NM_001313904;NM_006164
BHLHE41_TF,BHLHE41,BHLHE41_TF,BHLHE41,TF,149,-1.93036294326917,-0.0902256309526945,-0.0878117523991046,-0.0981569462002041,-0.0103451938010994,0.0792995356043145,0.689556154706731,1.50385360775885,1.48013982607651,1.5817703190008,0.101630492924289,0.598212980704063,ENSG00000123095,BHLHE41,protein_coding,12,-1,26120030,26125037,p12.1,basic helix-loop-helix family member e41 [Source:HGNC Symbol;Acc:HGNC:16617],SHORT SLEEPER,BHLHE41,79365,NM_030762
ALG3_SIG,ALG3,ALG3_SIG,ALG3,SIG,39,1.92739330771075,0.355504742147525,0.346565017694404,0.384878122493496,0.0383131047990928,0.0798312121702313,0.473036213376214,4.71105704561195,4.70280461703204,4.73817216808881,0.0353675510567753,0.725291419604839,ENSG00000214160,ALG3,protein_coding,3,-1,184242301,184249548,q27.1,ALG3, alpha-1,3- mannosyltransferase [Source:HGNC Symbol;Acc:HGNC:23056],ALG3-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Id,ALG3,10195,NM_001006941;NM_005787
SFPQ_SIG,SFPQ,SFPQ_SIG,SFPQ,SIG,48,1.9247548308785,0.484311124666109,0.478508913949803,0.503375531305398,0.024866617355595,0.0803044675009433,3.72966727193731,9.28680097131603,9.22946553239796,9.47518884204685,0.245723309648897,0.00133861256141908,ENSG00000116560,SFPQ,protein_coding,1,-1,35176378,35193145,p34.3,splicing factor proline and glutamine rich [Source:HGNC Symbol;Acc:HGNC:10774],MiT family translocation renal cell carcinoma,SFPQ,6421,NM_005066
EHHADH_SIG,EHHADH,EHHADH_SIG,EHHADH,SIG,16,1.92430436921507,0.244671018948008,0.234463117086614,0.278211267921158,0.043748150834544,0.0803735903414817,2.00106066616052,2.36955823891077,2.30848485192534,2.57022793900575,0.261743087080414,0.0968794926833935,ENSG00000113790,EHHADH,protein_coding,3,-1,185190624,185281990,q27.2,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase [Source:HGNC Symbol;Acc:HGNC:3247],Bifunctional enzyme deficiency;FANCONI RENOTUBULAR SYNDROME 3;Primary Fanconi syndrome,EHHADH,1962,NM_001166415;NM_001966
CATSPER1_SIG,CATSPER1,CATSPER1_SIG,CATSPER1,SIG,24,-1.92374617784574,0.24362001332299,0.249853171943657,0.223139634997941,-0.0267135369457153,0.0804627464387959,-1.59312767456659,2.12200746915585,2.16416314481644,1.9834959634139,-0.180667181402546,0.192586982519536,ENSG00000175294,CATSPER1,protein_coding,11,-1,66016752,66026517,q13.1,cation channel sperm associated 1 [Source:HGNC Symbol;Acc:HGNC:17116],Non-syndromic male infertility due to sperm motility disorder;SPERMATOGENIC FAILURE 7,CATSPER1,117144,NM_053054
ECHDC2_SIG,ECHDC2,ECHDC2_SIG,ECHDC2,SIG,50,1.92296494113011,-0.054662368352296,-0.0567903159659567,-0.0476705404788396,0.00911977548711699,0.0805934105824084,-0.448908594296934,4.20627463725932,4.22155507900617,4.15606747151966,-0.065487607486501,0.73953400383899,ENSG00000121310,ECHDC2,protein_coding,1,-1,52895910,52927212,p32.3,enoyl-CoA hydratase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23408],NA,ECHDC2,55268,NM_001198961;NM_001198962;NM_001319958;NM_018281
FKBP5_SIG,FKBP5,FKBP5_SIG,FKBP5,SIG,13,1.9227089458202,0.220467523166471,0.217480145325694,0.230283193214738,0.0128030478890442,0.0806265863098526,2.09987296786677,7.67596718097187,7.61519584071945,7.87564444180125,0.260448601081804,0.0803731086291052,ENSG00000096060,FKBP5,protein_coding,6,-1,35573585,35728583,p21.31,FKBP prolyl isomerase 5 [Source:HGNC Symbol;Acc:HGNC:3721],MAJOR DEPRESSIVE DISORDER,FKBP5,2289,NM_001145775;NM_001145776;NM_001145777;NM_004117
PREPL_SIG,PREPL,PREPL_SIG,PREPL,SIG,45,1.92075608508108,0.319799462758047,0.309758412280364,0.352791485756147,0.0430330734757832,0.0809757316579115,1.46240078342039,4.64777268078377,4.60454031335429,4.78982188805206,0.185281574697766,0.234578461117466,ENSG00000138078,PREPL,protein_coding,2,-1,44316281,44361862,p21,prolyl endopeptidase like [Source:HGNC Symbol;Acc:HGNC:30228],2p21 microdeletion syndrome;2p21 microdeletion syndrome without cystinuria;Atypical hypotonia - cystinuria syndrome;HYPOTONIA-CYSTINURIA SYNDROME;MYASTHENIC SYNDROME CONGENITAL 22,PREPL,9581,NM_001042385;NM_001042386;NM_001171603;NM_001171606;NM_001171613;NM_001171617;NM_006036
RACGAP1_SIG,RACGAP1,RACGAP1_SIG,RACGAP1,SIG,45,-1.92017958894315,0.265193356494835,0.279969580332268,0.216642906743272,-0.0633266735889956,0.0810688416139236,-1.78465501903011,4.44498302191729,4.49206028029941,4.29030060151886,-0.201759678780552,0.141774620292604,ENSG00000161800,RACGAP1,protein_coding,12,-1,49976923,50033136,q13.12,Rac GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:9804],NA,RACGAP1,29127,NM_001126103;NM_001126104;NM_001319999;NM_001320000;NM_001320001;NM_001320002;NM_001320003;NM_001320004;NM_001320005;NM_001320006;NM_001320007;NM_013277
NUS1_SIG,NUS1,NUS1_SIG,NUS1,SIG,43,-1.91864165578408,0.183443737502515,0.185657379768183,0.17617034148675,-0.00948703828143273,0.0813400956296007,-2.10351685631274,5.0658181534017,5.08789364133465,4.99328440733626,-0.0946092339983942,0.0798362167178359,ENSG00000153989,NUS1,protein_coding,6,1,117675469,117710727,q22.1,NUS1, dehydrodolichyl diphosphate synthase subunit [Source:HGNC Symbol;Acc:HGNC:21042],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iaa;Epilepsy and intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 55 WITH SEIZURES;Undetermined early-onset epileptic encephalopathy,NUS1,116150,NM_138459
HNRNPC_SIG,HNRNPC,HNRNPC_SIG,HNRNPC,SIG,32,1.91857350426914,0.393662419580143,0.390651303650851,0.40355608620496,0.0129047825541097,0.0813400956296007,1.78110954897407,8.97095880945618,8.95620755618289,9.01942721306842,0.0632196568855291,0.142697061338591,ENSG00000092199,HNRNPC,protein_coding,14,-1,21209136,21269494,q11.2,heterogeneous nuclear ribonucleoprotein C (C1/C2) [Source:HGNC Symbol;Acc:HGNC:5035],NA,HNRNPC,3183,NM_001077442;NM_001077443;NM_004500;NM_031314
LGR4_SIG,LGR4,LGR4_SIG,LGR4,SIG,84,-1.91831014331007,-0.100227037756586,-0.09707045773401,-0.110598657830763,-0.013528200096753,0.0813748902967018,-1.72312477830158,1.83481211596138,1.89688607152574,1.63085483339276,-0.266031238132979,0.157103551184595,ENSG00000205213,LGR4,protein_coding,11,-1,27365961,27472790,p14.1,leucine rich repeat containing G protein-coupled receptor 4 [Source:HGNC Symbol;Acc:HGNC:13299],BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17,LGR4,55366,NM_001346432;NM_018490
MRPL40_SIG,MRPL40,MRPL40_SIG,MRPL40,SIG,22,1.91764694733058,0.509816157728655,0.505490129246846,0.524030251311742,0.0185401220648956,0.0814846192626036,1.71938706518303,3.72136646711119,3.701783125311,3.78571173302609,0.0839286077150897,0.158038660145939,ENSG00000185608,MRPL40,protein_coding,22,1,19431902,19436075,q11.21,mitochondrial ribosomal protein L40 [Source:HGNC Symbol;Acc:HGNC:14491],NA,MRPL40,64976,NM_001318151;NM_001318152;NM_003776
POLE_SIG,POLE,POLE_SIG,POLE,SIG,26,-1.91731347762497,0.117993169474429,0.12173813836235,0.105688271699833,-0.0160498666625165,0.081532610734852,-1.7394786783151,6.83035006363616,6.86663350479869,6.71113304267356,-0.155500462125129,0.152838369963908,ENSG00000177084,POLE,protein_coding,12,-1,132623753,132687365,q24.33,DNA polymerase epsilon, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9177],Colorectal cancer susceptibility to 12;Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;FACIAL DYSMORPHISM IMMUNODEFICIENCY LIVEDO AND SHORT STATURE;Polymerase proofreading-related adenomatous polyposis,POLE,5426,NM_006231
TNFSF12_SIG,TNFSF12,TNFSF12_SIG,TNFSF12,SIG,37,-1.916643640874,0.0726218926428714,0.0783572124643482,0.0537772703723046,-0.0245799420920437,0.0816437568230988,0.907986616340298,2.48630114485655,2.45623980239381,2.5850741272341,0.128834324840292,0.477770930910023,ENSG00000239697,TNFSF12,protein_coding,17,1,7549058,7557890,p13.1,TNF superfamily member 12 [Source:HGNC Symbol;Acc:HGNC:11927],Common variable immunodeficiency,TNFSF12,8742,NM_003809
ZNF644_TF,ZNF644,ZNF644_TF,ZNF644,TF,70,1.91575164961091,0.424187009024703,0.42116451355061,0.434118065582437,0.0129535520318267,0.0817967887115138,1.32846659853456,5.80024292470686,5.78075507557674,5.86427442899155,0.0835193534148012,0.283630717177348,ENSG00000122482,ZNF644,protein_coding,1,-1,90915298,91022272,p22.2,zinc finger protein 644 [Source:HGNC Symbol;Acc:HGNC:29222],MYOPIA 21 AUTOSOMAL DOMINANT,ZNF644,84146,NM_016620;NM_032186;NM_201269
SNRPD1_SIG,SNRPD1,SNRPD1_SIG,SNRPD1,SIG,30,1.91513001321035,0.413871368107656,0.408203364083474,0.432494809901397,0.024291445817923,0.0818991517101828,1.79171098687146,4.87422517625825,4.84815534787551,4.95988318380154,0.111727835926031,0.140236223307419,ENSG00000167088,SNRPD1,protein_coding,18,1,21612314,21633524,q11.2,small nuclear ribonucleoprotein D1 polypeptide [Source:HGNC Symbol;Acc:HGNC:11158],NA,SNRPD1,6632,NM_001291916;NM_006938
SLC35E2B_SIG,SLC35E2B,SLC35E2B_SIG,SLC35E2B,SIG,18,1.91490120580456,0.371332551816337,0.367072699745799,0.385329208619532,0.0182565088737333,0.0819276299369424,0.471746365200082,6.13565562368603,6.12703819747581,6.16397002409104,0.0369318266152315,0.725993298960746,ENSG00000189339,SLC35E2B,protein_coding,1,-1,1659529,1692728,p36.33,solute carrier family 35 member E2B [Source:HGNC Symbol;Acc:HGNC:33941],NA,SLC35E2B,728661,NM_001110781;NM_001290264
ANO6_SIG,ANO6,ANO6_SIG,ANO6,SIG,34,1.91384028232087,0.38155172235513,0.377252952548926,0.395676251718371,0.0184232991694447,0.0821129488907819,0.487904424852717,6.69935980312678,6.69115589504824,6.72631550109912,0.035159606050886,0.716546856148328,ENSG00000177119,ANO6,protein_coding,12,1,45215987,45440404,q12,anoctamin 6 [Source:HGNC Symbol;Acc:HGNC:25240],SCOTT SYNDROME,ANO6,196527,NM_001025356;NM_001142678;NM_001142679;NM_001204803
ABCD3_SIG,ABCD3,ABCD3_SIG,ABCD3,SIG,8,-1.91067199542713,0.207680429739713,0.210622782891779,0.198012697954356,-0.012610084937423,0.0826976472410028,-1.87735739690331,4.80592370582346,4.83842455521243,4.69913520068825,-0.139289354524177,0.120964737213791,ENSG00000117528,ABCD3,protein_coding,1,1,94418389,94518666,p21.3,ATP binding cassette subfamily D member 3 [Source:HGNC Symbol;Acc:HGNC:67],BILE ACID SYNTHESIS DEFECT CONGENITAL 5,ABCD3,5825,NM_001122674;NM_002858
DBR1_SIG,DBR1,DBR1_SIG,DBR1,SIG,43,1.91001863775318,0.208405767787286,0.205969813062734,0.216409619025098,0.0104398059623643,0.0828069428612276,2.00183375059927,3.81507294501025,3.78694191268883,3.90750347978065,0.120561567091817,0.0967616734635475,ENSG00000138231,DBR1,protein_coding,3,-1,138161012,138174949,q22.3,debranching RNA lariats 1 [Source:HGNC Symbol;Acc:HGNC:15594],NA,DBR1,51163,NM_016216
DEPDC1B_SIG,DEPDC1B,DEPDC1B_SIG,DEPDC1B,SIG,17,-1.90988260272799,0.256704401993069,0.27609383608923,0.192996261391397,-0.0830975746978329,0.0828180378338402,-0.552077544014322,2.47508724588441,2.48953171444815,2.42762684917497,-0.0619048652731773,0.679383966068109,ENSG00000035499,DEPDC1B,protein_coding,5,-1,60596912,60700190,q12.1,DEP domain containing 1B [Source:HGNC Symbol;Acc:HGNC:24902],NA,DEPDC1B,55789,NM_001145208;NM_018369
RNF20_SIG,RNF20,RNF20_SIG,RNF20,SIG,49,1.90782969439999,0.426023948149626,0.417789958808906,0.453078484554847,0.0352885257459409,0.0831939520952667,1.98611562530663,5.56387130131153,5.53096838963305,5.67198086825511,0.141012478622058,0.0996757499327077,ENSG00000155827,RNF20,protein_coding,9,1,101533853,101563344,q31.1,ring finger protein 20 [Source:HGNC Symbol;Acc:HGNC:10062],NA,RNF20,56254,NM_019592
ZNF652_TF,ZNF652,ZNF652_TF,ZNF652,TF,132,-1.90708271598079,0.170633233335105,0.172413772445909,0.164782890542463,-0.00763088190344572,0.0833216464595606,-0.524853993328143,5.58164068151231,5.58888143036157,5.55784964957904,-0.0310317807825289,0.695389425805787,ENSG00000198740,ZNF652,protein_coding,17,-1,49289206,49362473,q21.33,zinc finger protein 652 [Source:HGNC Symbol;Acc:HGNC:29147],NA,ZNF652,22834,NM_001145365;NM_014897
ZDHHC2_SIG,ZDHHC2,ZDHHC2_SIG,ZDHHC2,SIG,31,-1.90648932890567,0.16452884647719,0.168126527562681,0.152707894339148,-0.015418633223534,0.083420144901842,-3.01687508601841,6.00023586407587,6.07364533072503,5.75903333080004,-0.314611999924993,0.0102955981118318,ENSG00000104219,ZDHHC2,protein_coding,8,1,17156482,17224799,p22,zinc finger DHHC-type containing 2 [Source:HGNC Symbol;Acc:HGNC:18469],NA,ZDHHC2,51201,NM_016353
BAZ1B_TF,BAZ1B,BAZ1B_TF,BAZ1B,TF,164,1.90625265205187,0.350676867640869,0.346253986610575,0.365209191026121,0.0189552044155461,0.0834505320960706,1.13012950925112,7.02300629967391,7.00759623909486,7.07363935586224,0.0660431167673821,0.368166849708902,ENSG00000009954,BAZ1B,protein_coding,7,-1,73440406,73522293,q11.23,bromodomain adjacent to zinc finger domain 1B [Source:HGNC Symbol;Acc:HGNC:961],Williams syndrome,BAZ1B,9031,NM_032408
CBS_SIG,CBS,CBS_SIG,CBS,SIG,26,1.90577885907155,-0.13326078995944,-0.13544490561312,-0.126084409954491,0.00936049565862866,0.0835262736796898,1.39375648680256,0.664655380457179,0.636643354709964,0.756694893626598,0.120051538916635,0.259014559324365,ENSG00000160200,CBS,protein_coding,21,-1,43053191,43076943,q22.3,cystathionine-beta-synthase [Source:HGNC Symbol;Acc:HGNC:1550],Classic homocystinuria;Cystathionine beta-synthase deficiency;HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY,CBS,875,NM_000071;NM_001178008;NM_001178009;NM_001320298;NM_001321072
TDRD7_SIG,TDRD7,TDRD7_SIG,TDRD7,SIG,28,-1.90520109360468,0.438913622442751,0.44593321746041,0.415849238813301,-0.0300839786471092,0.0836219741573851,-1.4990499324531,4.74845072725649,4.78156632347601,4.63964233967806,-0.141923983797949,0.222260893078623,ENSG00000196116,TDRD7,protein_coding,9,1,97412096,97496125,q22.33,tudor domain containing 7 [Source:HGNC Symbol;Acc:HGNC:30831],CATARACT 36;CATARACT CONGENITAL AUTOSOMAL RECESSIVE TYPE 4,TDRD7,23424,NM_001302884;NM_014290
NDUFB11_SIG,NDUFB11,NDUFB11_SIG,NDUFB11,SIG,24,1.90510251976275,0.501097147480948,0.497450410078568,0.513079284660198,0.0156288745816301,0.0836259761969954,0.637398331024057,5.61991223381162,5.61319127727047,5.64199537673257,0.0288040994621018,0.628500892438269,ENSG00000147123,NDUFB11,protein_coding,X,-1,47142216,47145504,p11.3,NADH:ubiquinone oxidoreductase subunit B11 [Source:HGNC Symbol;Acc:HGNC:20372],Isolated complex I deficiency;LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1;LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 30,NDUFB11,54539,NM_001135998;NM_019056
LGALS1_SIG,LGALS1,LGALS1_SIG,LGALS1,SIG,68,1.9049306492083,0.204982479197037,0.20070352092639,0.219041913514876,0.0183383925884858,0.0836440145950471,2.40590457631714,7.12572672188039,7.03663423336282,7.41845918415239,0.381824950789571,0.0433177423943837,ENSG00000100097,LGALS1,protein_coding,22,1,37675636,37679802,q13.1,galectin 1 [Source:HGNC Symbol;Acc:HGNC:6561],NA,LGALS1,3956,NM_002305
HNRNPD_SIG,HNRNPD,HNRNPD_SIG,HNRNPD,SIG,17,1.90465082037451,0.592466759769518,0.58981355885246,0.601184419925565,0.011370861073105,0.0836827349591204,2.30628762297014,8.5449313090141,8.52440505690375,8.61237470880522,0.0879696519014637,0.0532541023477948,ENSG00000138668,HNRNPD,protein_coding,4,-1,82352498,82374503,q21.22,heterogeneous nuclear ribonucleoprotein D [Source:HGNC Symbol;Acc:HGNC:5036],NA,HNRNPD,3184,NM_001003810;NM_002138;NM_031369;NM_031370
NCSTN_SIG,NCSTN,NCSTN_SIG,NCSTN,SIG,21,1.9045601105039,0.465445940237893,0.46181869863978,0.477364019774548,0.0155453211347683,0.0836852374762,1.86333082424522,7.41430415541541,7.39090084534562,7.4912007456447,0.100299900299082,0.124011498340711,ENSG00000162736,NCSTN,protein_coding,1,1,160343316,160358952,q23.2,nicastrin [Source:HGNC Symbol;Acc:HGNC:17091],ACNE INVERSA FAMILIAL 1,NCSTN,23385,NM_001290184;NM_001290186;NM_001349729;NM_015331
TRMT5_SIG,TRMT5,TRMT5_SIG,TRMT5,SIG,26,1.90446350819189,0.1631297562254,0.155823014227061,0.187137622791369,0.0313146085643074,0.0836888708152316,2.39489170971531,2.84153186771234,2.79015964047229,3.01032632864394,0.220166688171653,0.0443230675391066,ENSG00000126814,TRMT5,protein_coding,14,-1,60971451,60981358,q23.1,tRNA methyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:23141],Combined oxidative phosphorylation defect type 26;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26,TRMT5,57570,NM_001350253;NM_001350254;NM_020810
MPP2_SIG,MPP2,MPP2_SIG,MPP2,SIG,63,-1.9039896529717,-0.105366949481649,-0.102810745916916,-0.113765904051486,-0.0109551581345694,0.0837576758828471,-1.16503333430112,0.877833673967545,0.90224267467156,0.797632671654351,-0.104610003017209,0.352635970261917,ENSG00000108852,MPP2,protein_coding,17,-1,43875357,43909711,q21.31,membrane palmitoylated protein 2 [Source:HGNC Symbol;Acc:HGNC:7220],NA,MPP2,4355,NM_001278370;NM_001278371;NM_001278372;NM_001278373;NM_001278374;NM_001278375;NM_001278376;NM_001278381;NM_005374
PIP5K1C_SIG,PIP5K1C,PIP5K1C_SIG,PIP5K1C,SIG,38,1.90390094209843,0.345900536065039,0.341978273239092,0.35878797106458,0.0168096978254877,0.0837576758828471,1.16758977806625,5.61397439240863,5.59450896549014,5.67793222371222,0.0834232582220828,0.351520928261655,ENSG00000186111,PIP5K1C,protein_coding,19,-1,3630183,3700479,p13.3,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [Source:HGNC Symbol;Acc:HGNC:8996],LETHAL CONGENITAL CONTRACTURE SYNDROME 3;lethal congenital contracture syndrome type 3,PIP5K1C,23396,NM_001195733;NM_001300849;NM_012398
PPM1B_SIG,PPM1B,PPM1B_SIG,PPM1B,SIG,33,-1.9038543144611,0.454832997571719,0.457877314723842,0.444830241214743,-0.013047073509099,0.0837576758828471,-0.142956354782216,6.01867114186571,6.02030973456522,6.01328719442445,-0.00702254014077737,0.919836221435449,ENSG00000138032,PPM1B,protein_coding,2,1,44167969,44244384,p21,protein phosphatase, Mg2+/Mn2+ dependent 1B [Source:HGNC Symbol;Acc:HGNC:9276],2p21 microdeletion syndrome,PPM1B,5495,NM_001033557;NM_002706;NM_177968;NM_177969
CYFIP2_SIG,CYFIP2,CYFIP2_SIG,CYFIP2,SIG,50,-1.90379396829848,0.0991777920217396,0.102727205344881,0.0875154339599887,-0.0152117713848924,0.0837576758828471,0.166644971379566,7.11654259700224,7.11160504511523,7.13276598177382,0.0211609366585889,0.906469165725657,ENSG00000055163,CYFIP2,protein_coding,5,1,157266079,157395595,q33.3,cytoplasmic FMR1 interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:13760],EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 65;Undetermined early-onset epileptic encephalopathy,CYFIP2,26999,NM_001037333;NM_001291721;NM_001291722;NM_014376
PLA2G15_SIG,PLA2G15,PLA2G15_SIG,PLA2G15,SIG,34,1.90306193643764,0.207138456651376,0.203547799647625,0.218936329663701,0.0153885300160757,0.0838831818941152,0.161327366898793,4.3920054469031,4.3889621555094,4.402004832911,0.0130426774015993,0.909677384281384,ENSG00000103066,PLA2G15,protein_coding,16,1,68245304,68261058,q22.1,phospholipase A2 group XV [Source:HGNC Symbol;Acc:HGNC:17163],NA,PLA2G15,23659,NM_012320
FBLN1_SIG,FBLN1,FBLN1_SIG,FBLN1,SIG,60,-1.90254643331784,-0.15739577308307,-0.154603599156838,-0.16657005884069,-0.0119664596838521,0.0839672463622236,-0.465746018722535,0.582546781603478,0.595491059737205,0.540015582021232,-0.0554754777159722,0.729762945212257,ENSG00000077942,FBLN1,protein_coding,22,1,45502238,45601135,q13.31,fibulin 1 [Source:HGNC Symbol;Acc:HGNC:3600],FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome;SYNPOLYDACTYLY 2;SYNPOLYDACTYLY 3/3-PRIME/4 ASSOCIATED WITH METACARPAL AND METATARSAL SYNOSTOSES;Synpolydactyly type 2,FBLN1,2192,NM_001996;NM_006485;NM_006486;NM_006487
C1QTNF1_SIG,C1QTNF1,C1QTNF1_SIG,C1QTNF1,SIG,18,-1.90205062966175,-0.248621367992418,-0.245179254445402,-0.2599311696469,-0.0147519152014982,0.0840475918474038,-0.448871499739446,0.29013737353269,0.296873285049747,0.26800509283379,-0.0288681922159571,0.73953400383899,ENSG00000173918,C1QTNF1,protein_coding,17,1,79022814,79049788,q25.3,C1q and TNF related 1 [Source:HGNC Symbol;Acc:HGNC:14324],NA,C1QTNF1,114897,NM_030968;NM_153372;NM_198593;NM_198594
ORAI2_SIG,ORAI2,ORAI2_SIG,ORAI2,SIG,20,-1.90174505456523,0.0710191266284932,0.0732885806151161,0.0635623492438749,-0.00972623137124121,0.0840914161408899,-2.183476168872,6.82176355293238,6.8597748219405,6.69686938333424,-0.162905438606263,0.0685671812166745,ENSG00000160991,ORAI2,protein_coding,7,1,102433106,102456825,q22.1,ORAI calcium release-activated calcium modulator 2 [Source:HGNC Symbol;Acc:HGNC:21667],NA,ORAI2,80228,NM_001126340;NM_001271818;NM_001271819;NM_032831
SRSF8_SIG,SRSF8,SRSF8_SIG,SRSF8,SIG,57,1.90012451498399,0.0917392622578861,0.0880600651848803,0.10382805264062,0.0157679874557395,0.0843885103323464,-3.91216950497251,3.61218701877872,3.7169968187198,3.26781196182947,-0.449184856890328,0.000750328918577984,ENSG00000263465,SRSF8,protein_coding,11,1,95067197,95071224,q21,serine and arginine rich splicing factor 8 [Source:HGNC Symbol;Acc:HGNC:16988],NA,SRSF8,10929,NM_032102
HIST1H4E_SIG,HIST1H4E,HIST1H4E_SIG,HIST1H4E,SIG,59,1.8984707253093,-0.173612771446173,-0.178194988776039,-0.158556914505184,0.0196380742708551,0.0846928917255556,3.03275915983479,2.09852581692743,1.99612657709796,2.43498046208143,0.438853884983472,0.00987520608153526,ENSG00000276966,HIST1H4E,protein_coding,6,1,26204552,26206038,p22.2,histone cluster 1 H4 family member e [Source:HGNC Symbol;Acc:HGNC:4790],NA,HIST1H4E,8367,NM_003545
ST3GAL2_SIG,ST3GAL2,ST3GAL2_SIG,ST3GAL2,SIG,26,1.89766618724188,0.20558493147221,0.203604245616995,0.212092899282201,0.00848865366520596,0.0848335654141711,1.45023333322114,5.62147105109528,5.59558463236117,5.70652642693594,0.110941794574774,0.23850015678546,ENSG00000157350,ST3GAL2,protein_coding,16,-1,70375977,70439237,q22.1,ST3 beta-galactoside alpha-2,3-sialyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:10863],NA,ST3GAL2,6483,NM_006927
UBR5_SIG,UBR5,UBR5_SIG,UBR5,SIG,43,1.89756577782174,0.6656463593941,0.662450893258849,0.67614574812421,0.0136948548653608,0.0848379683035391,1.56154949764059,7.58687738262078,7.56810468245541,7.64855911173554,0.0804544292801282,0.202105494796319,ENSG00000104517,UBR5,protein_coding,8,-1,102252273,102412759,q22.3,ubiquitin protein ligase E3 component n-recognin 5 [Source:HGNC Symbol;Acc:HGNC:16806],NA,UBR5,51366,NM_001282873;NM_015902
POU4F1_TF,POU4F1,POU4F1_TF,POU4F1,TF,116,-1.89738568691556,-0.0306053718159949,-0.0288227215168186,-0.0364626513704314,-0.00763992985361283,0.084857806511018,-2.84751262172125,1.16628151875716,1.32950057250605,0.629990342153642,-0.69951023035241,0.0157868185799273,ENSG00000152192,POU4F1,protein_coding,13,-1,78598362,78603552,q31.1,POU class 4 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9218],NA,POU4F1,5457,NM_006237
RPL21_SIG,RPL21,RPL21_SIG,RPL21,SIG,20,1.89705043311202,0.395260507043581,0.39096544384459,0.40937285755455,0.0184074137099602,0.0849077140972196,2.17403625082789,4.70354527623125,4.66757604202522,4.82172990290821,0.154153860882992,0.0698141212844182,ENSG00000122026,RPL21,protein_coding,13,1,27251309,27256691,q12.2,ribosomal protein L21 [Source:HGNC Symbol;Acc:HGNC:10313],Hypotrichosis 12;Hypotrichosis simplex,RPL21,6144,NM_000982
IL6R_SIG,IL6R,IL6R_SIG,IL6R,SIG,34,-1.89657810983284,0.440621237855639,0.446461794399547,0.421430837782796,-0.0250309566167512,0.0849842235552841,-0.983622680644284,7.18232758931594,7.2099954978228,7.09141874707911,-0.118576750743689,0.438826895667246,ENSG00000160712,IL6R,protein_coding,1,1,154405193,154469450,q21.3,interleukin 6 receptor [Source:HGNC Symbol;Acc:HGNC:6019],INTERLEUKIN 6 SERUM LEVEL OF QUANTITATIVE TRAIT LOCUS;SOLUBLE INTERLEUKIN-6 RECEPTOR SERUM LEVEL OF QUANTITATIVE TRAIT LOCUS,IL6R,3570,NM_000565;NM_001206866;NM_181359
RPS6KB1_SIG,RPS6KB1,RPS6KB1_SIG,RPS6KB1,SIG,47,1.89569782888396,0.42054331012696,0.417956608369961,0.429042473042814,0.0110858646728529,0.0851399901229938,1.81951700108219,5.40754899602616,5.38723083527381,5.47430866706962,0.0870778317958089,0.133747119143267,ENSG00000108443,RPS6KB1,protein_coding,17,1,59893046,59950574,q23.1,ribosomal protein S6 kinase B1 [Source:HGNC Symbol;Acc:HGNC:10436],NA,RPS6KB1,6198,NM_001272042;NM_001272043;NM_001272044;NM_001272060;NM_003161
STRBP_SIG,STRBP,STRBP_SIG,STRBP,SIG,40,1.89535573854868,0.0674869861026295,0.0617430594616172,0.0863598879230987,0.0246168284614816,0.0851913577027613,0.615016938198814,5.459382941271,5.44580188506653,5.50400641165711,0.0582045265905836,0.641493777167696,ENSG00000165209,STRBP,protein_coding,9,-1,123109500,123268576,q33.3,spermatid perinuclear RNA binding protein [Source:HGNC Symbol;Acc:HGNC:16462],NA,STRBP,55342,NM_001171137;NM_018387
ZNF222_TF,ZNF222,ZNF222_TF,ZNF222,TF,32,1.89511689139356,0.0950955065701301,0.0903310353748743,0.110750197640257,0.0204191622653822,0.0852221781641267,1.74760662866429,2.30645663246649,2.27217200572352,2.41910612033626,0.14693411461274,0.150820512791805,ENSG00000159885,ZNF222,protein_coding,19,1,44025342,44033110,q13.31,zinc finger protein 222 [Source:HGNC Symbol;Acc:HGNC:13015],NA,ZNF222,7673,NM_001129996;NM_013360
NFX1_SIG,NFX1,NFX1_SIG,NFX1,SIG,43,1.89504182652642,0.484960977370576,0.482218533241522,0.49397186522318,0.0117533319816573,0.0852221781641267,0.645445219099995,6.10498154918825,6.09734264300647,6.13008081235696,0.0327381693504841,0.623671853323008,ENSG00000086102,NFX1,protein_coding,9,1,33290512,33371157,p13.3,nuclear transcription factor, X-box binding 1 [Source:HGNC Symbol;Acc:HGNC:7803],NA,NFX1,4799,NM_001318758;NM_002504;NM_147134
FAXDC2_SIG,FAXDC2,FAXDC2_SIG,FAXDC2,SIG,39,-1.89453258360125,-0.0609270775293808,-0.0529527402784648,-0.0871284713538193,-0.0341757310753545,0.0853050727089047,0.852442093965209,2.75631209165572,2.72440987706625,2.86113365387826,0.136723776812013,0.506819777754294,ENSG00000170271,FAXDC2,protein_coding,5,-1,154818492,154859252,q33.2,fatty acid hydroxylase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:1334],NA,FAXDC2,10826,NM_032385
BLZF1_TF,BLZF1,BLZF1_TF,BLZF1,TF,41,1.89446019059498,0.203077794575939,0.199392133099515,0.215187825141335,0.0157956920418201,0.0853050727089047,-0.0997316178682014,4.50279536832216,4.50426845963484,4.49795521115191,-0.0063132484829333,0.944432641316518,ENSG00000117475,BLZF1,protein_coding,1,1,169367970,169396540,q24.2,basic leucine zipper nuclear factor 1 [Source:HGNC Symbol;Acc:HGNC:1065],NA,BLZF1,8548,NM_001320972;NM_001320973;NM_003666
CRTC2_TF,CRTC2,CRTC2_TF,CRTC2,TF,478,-1.89410918576283,-0.128858214365397,-0.124872000246164,-0.141955775042878,-0.017083774796714,0.0853582562152137,-1.29735648775651,6.55093080497694,6.56818557437839,6.49423656265791,-0.0739490117204724,0.296073579175007,ENSG00000160741,CRTC2,protein_coding,1,-1,153947669,153958615,q21.3,CREB regulated transcription coactivator 2 [Source:HGNC Symbol;Acc:HGNC:27301],NA,CRTC2,200186,NM_181715
ZDHHC5_TF,ZDHHC5,ZDHHC5_TF,ZDHHC5,TF,437,-1.89364062584726,0.139321363711423,0.141768704890325,0.131280099837889,-0.0104886050524353,0.0854228934453674,-1.73866968832552,6.53969801941499,6.55960267161994,6.47429701931302,-0.0853056523069259,0.153016251806452,ENSG00000156599,ZDHHC5,protein_coding,11,1,57667747,57701182,q12.1,zinc finger DHHC-type containing 5 [Source:HGNC Symbol;Acc:HGNC:18472],NA,ZDHHC5,25921,NM_015457
SLC22A16_SIG,SLC22A16,SLC22A16_SIG,SLC22A16,SIG,25,1.89362186223924,0.311679614697115,0.306652382779721,0.328197662425694,0.021545279645973,0.0854228934453674,1.64159701490459,3.89669752048664,3.84910448146048,4.05307464871545,0.203970167254972,0.178882477893375,ENSG00000004809,SLC22A16,protein_coding,6,-1,110424687,110476641,q21,solute carrier family 22 member 16 [Source:HGNC Symbol;Acc:HGNC:20302],NA,SLC22A16,85413,NM_033125
PORCN_SIG,PORCN,PORCN_SIG,PORCN,SIG,36,1.8924147282222,0.104228500536436,0.101686647379855,0.112580303765201,0.010893656385346,0.0856430477619079,1.50769418613735,2.97378657138933,2.95343398303405,3.04065936169956,0.0872253786655164,0.219551459084493,ENSG00000102312,PORCN,protein_coding,X,1,48508962,48520814,p11.23,porcupine O-acyltransferase [Source:HGNC Symbol;Acc:HGNC:17652],FOCAL DERMAL HYPOPLASIA,PORCN,64840,NM_001282167;NM_022825;NM_203473;NM_203474;NM_203475
DDX20_SIG,DDX20,DDX20_SIG,DDX20,SIG,55,1.89162892326344,0.393875223341508,0.389604884605633,0.407906336330811,0.0183014517251778,0.0857813124725553,3.03514141314914,4.77698530371999,4.73761578629049,4.90634228955978,0.168726503269293,0.009818559449757,ENSG00000064703,DDX20,protein_coding,1,1,111755245,111768000,p13.2,DEAD-box helicase 20 [Source:HGNC Symbol;Acc:HGNC:2743],NA,DDX20,11218,NM_007204
RASGRP2_SIG,RASGRP2,RASGRP2_SIG,RASGRP2,SIG,32,-1.88902298888687,0.148174463417419,0.150116183484393,0.141794526054504,-0.00832165742988843,0.0862764421357503,-2.77525725054812,7.77352826189458,7.81600922422528,7.63394795709374,-0.182061267131537,0.0187447112340209,ENSG00000068831,RASGRP2,protein_coding,11,-1,64726911,64745456,q13.1,RAS guanyl releasing protein 2 [Source:HGNC Symbol;Acc:HGNC:9879],Bleeding disorder due to CalDAG-GEFI deficiency;BLEEDING DISORDER PLATELET-TYPE 18,RASGRP2,10235,NM_001098670;NM_001098671;NM_001318398;NM_153819
CTSO_SIG,CTSO,CTSO_SIG,CTSO,SIG,34,1.88856378229995,0.192160285874077,0.189961847512582,0.199383726204701,0.00942187869211877,0.0863513556050559,0.22651538664163,4.68713633627455,4.68238852366677,4.70273629198586,0.020347768319092,0.871929214080146,ENSG00000256043,CTSO,protein_coding,4,-1,155924118,155953866,q32.1,cathepsin O [Source:HGNC Symbol;Acc:HGNC:2542],NA,CTSO,1519,NM_001334
SKP2_SIG,SKP2,SKP2_SIG,SKP2,SIG,19,1.88832624744339,0.350389704265382,0.341305537783824,0.380237679847643,0.0389321420638184,0.0863827546565637,2.09460708610422,4.27310275215376,4.23484361057767,4.39881136018947,0.163967749611804,0.081149762749129,ENSG00000145604,SKP2,protein_coding,5,1,36151989,36184319,p13.2,S-phase kinase associated protein 2 [Source:HGNC Symbol;Acc:HGNC:10901],NA,SKP2,6502,NM_001243120;NM_005983;NM_032637
RPLP0P6_SIG,RPLP0P6,RPLP0P6_SIG,RPLP0P6,SIG,31,1.88730574628069,1.17197204556493,1.16354479148797,1.19966159467495,0.0361168031869716,0.0865681668573951,2.18627288444022,9.40214232548172,9.36309565096212,9.53043854176039,0.167342890798267,0.0682044750449765,ENSG00000213553,RPLP0P6,processed_pseudogene,2,1,38481851,38482804,p22.1,ribosomal protein lateral stalk subunit P0 pseudogene 6 [Source:HGNC Symbol;Acc:HGNC:36404],NA,RPLP0P6,NA,NA
DUSP23_SIG,DUSP23,DUSP23_SIG,DUSP23,SIG,14,1.88581618642909,0.1782651480298,0.174203212635718,0.191611507181784,0.0174082945460653,0.0868464312170814,2.0347936174219,3.74521174376558,3.71198685394867,3.85437923887831,0.142392384929646,0.0910861806139217,ENSG00000158716,DUSP23,protein_coding,1,1,159780932,159782543,q23.2,dual specificity phosphatase 23 [Source:HGNC Symbol;Acc:HGNC:21480],NA,DUSP23,54935,NM_001319658;NM_001319659;NM_017823
ATAD2B_SIG,ATAD2B,ATAD2B_SIG,ATAD2B,SIG,36,1.88538403725917,0.478474351653942,0.475970523638329,0.486701215133813,0.0107306914954845,0.0869163944824557,1.58266814488568,5.41269709762332,5.39183554250419,5.48124220730044,0.0894066647962496,0.19572104414559,ENSG00000119778,ATAD2B,protein_coding,2,-1,23748664,23927123,p23.3,ATPase family, AAA domain containing 2B [Source:HGNC Symbol;Acc:HGNC:29230],NA,ATAD2B,54454,NM_001242338;NM_001354107;NM_017552
ZFYVE16_SIG,ZFYVE16,ZFYVE16_SIG,ZFYVE16,SIG,37,-1.88386092180107,0.279976336128219,0.28328166916884,0.269115956137605,-0.0141657130312351,0.0872022086271604,-1.45737170327824,5.13075548797508,5.15936264753185,5.03676053514569,-0.122602112386166,0.236139434332637,ENSG00000039319,ZFYVE16,protein_coding,5,1,80408013,80483379,q14.1,zinc finger FYVE-type containing 16 [Source:HGNC Symbol;Acc:HGNC:20756],NA,ZFYVE16,9765,NM_001105251;NM_001284236;NM_001284237;NM_001349434;NM_014733
THAP7_TF,THAP7,THAP7_TF,THAP7,TF,71,1.88330237097501,0.0666393271150341,0.0640249547576334,0.0752294077179222,0.0112044529602889,0.0872974475584307,1.18935209667833,3.965019728367,3.9496421756795,4.01554597291165,0.0659037972321531,0.341812648391052,ENSG00000184436,THAP7,protein_coding,22,-1,20999104,21002196,q11.21,THAP domain containing 7 [Source:HGNC Symbol;Acc:HGNC:23190],NA,THAP7,80764,NM_001008695;NM_030573
DLX1_TF,DLX1,DLX1_TF,DLX1,TF,63,1.88298336386816,-0.018448739582667,-0.0200975883012102,-0.0130310937931679,0.00706649450804226,0.087345263574609,-0.520204630553806,0.277975877912978,0.286615217435456,0.249589476624837,-0.0370257408106188,0.698078783389768,ENSG00000144355,DLX1,protein_coding,2,1,172084740,172089677,q31.1,distal-less homeobox 1 [Source:HGNC Symbol;Acc:HGNC:2914],NA,DLX1,1745,NM_001038493;NM_178120
OSMR_SIG,OSMR,OSMR_SIG,OSMR,SIG,20,-1.88102921619881,-0.258736630857573,-0.255122446691261,-0.270611807404025,-0.0154893607127636,0.0877179416219433,-1.38171896671945,0.417396394965634,0.444741820216581,0.327547140569665,-0.117194679646915,0.263528613488494,ENSG00000145623,OSMR,protein_coding,5,1,38845858,38945596,p13.1,oncostatin M receptor [Source:HGNC Symbol;Acc:HGNC:8507],AMYLOIDOSIS PRIMARY LOCALIZED CUTANEOUS 1;Familial primary localized cutaneous amyloidosis,OSMR,9180,NM_001168355;NM_001323504;NM_001323505;NM_001323506;NM_003999
HR_TF,HR,HR_TF,HR,TF,152,-1.87892890409162,-0.085442348394371,-0.0833662914472333,-0.0922636783635375,-0.00889738691630405,0.0881061674885082,0.153084245508829,0.435706031325605,0.433498009529436,0.442960960084446,0.00946295055501031,0.914325108175546,ENSG00000168453,HR,protein_coding,8,-1,22114419,22133384,p21.3,HR, lysine demethylase and nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:5172],Alopecia universalis;ALOPECIA UNIVERSALIS CONGENITA;ATRICHIA WITH PAPULAR LESIONS;HYPOTRICHOSIS 4;Marie Unna hereditary hypotrichosis,HR,55806,NM_005144;NM_018411
COX5B_SIG,COX5B,COX5B_SIG,COX5B,SIG,38,-1.878925823801,0.0836369412927818,0.0862508337656922,0.0750484374532194,-0.0112023963124728,0.0881061674885082,-0.706041100911304,6.25445823168249,6.2613538257335,6.23180127980062,-0.0295525459328802,0.588560613720032,ENSG00000135940,COX5B,protein_coding,2,1,97646040,97648383,q11.2,cytochrome c oxidase subunit 5B [Source:HGNC Symbol;Acc:HGNC:2269],NA,COX5B,1329,NM_001862
CRABP2_SIG,CRABP2,CRABP2_SIG,CRABP2,SIG,48,-1.87869527854647,-0.0905471102732548,-0.0852869559196161,-0.107830474578068,-0.0225435186584518,0.0881366587583918,-2.15226959083011,0.80096929419016,0.83088888125358,0.70266207955321,-0.12822680170037,0.0727891732627575,ENSG00000143320,CRABP2,protein_coding,1,-1,156699606,156705816,q23.1,cellular retinoic acid binding protein 2 [Source:HGNC Symbol;Acc:HGNC:2339],NA,CRABP2,1382,NM_001199723;NM_001878
COASY_SIG,COASY,COASY_SIG,COASY,SIG,21,1.87849604877467,0.495200103109243,0.4888024471678,0.516220972631126,0.0274185254633256,0.0881609029206254,3.26880979564847,5.78738191049036,5.75051144057926,5.90852774019829,0.158016299619033,0.00524881037912096,ENSG00000068120,COASY,protein_coding,17,1,42561467,42566277,q21.2,Coenzyme A synthase [Source:HGNC Symbol;Acc:HGNC:29932],COASY protein-associated neurodegeneration;Neurodegeneration with brain iron accumulation;NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6,COASY,80347,NM_001042529;NM_001042532;NM_025233
EIF2AK3_SIG,EIF2AK3,EIF2AK3_SIG,EIF2AK3,SIG,36,-1.87799954639742,0.403362858076652,0.407565963975069,0.389552652981853,-0.0180133109932158,0.0882445699162403,-0.502352413969519,4.88205968018358,4.89090201385694,4.85300629811394,-0.0378957157429972,0.708062796843508,ENSG00000172071,EIF2AK3,protein_coding,2,-1,88556740,88627464,p11.2,eukaryotic translation initiation factor 2 alpha kinase 3 [Source:HGNC Symbol;Acc:HGNC:3255],EPIPHYSEAL DYSPLASIA MULTIPLE WITH EARLY-ONSET DIABETES MELLITUS;WOLCOTT-RALLISON SYNDROME,EIF2AK3,9451,NM_001313915;NM_004836
SLC4A3_SIG,SLC4A3,SLC4A3_SIG,SLC4A3,SIG,23,-1.87766233845995,-0.151712217356221,-0.14698816538315,-0.167234102410594,-0.0202459370274431,0.0882964332237351,0.653884281474544,1.16107936177904,1.14066113864615,1.22816780921569,0.0875066705695449,0.618515776756293,ENSG00000114923,SLC4A3,protein_coding,2,1,219627394,219641980,q35,solute carrier family 4 member 3 [Source:HGNC Symbol;Acc:HGNC:11029],NA,SLC4A3,6508,NM_001326559;NM_005070;NM_201574
SNUPN_SIG,SNUPN,SNUPN_SIG,SNUPN,SIG,13,1.87671160181217,0.363808529794488,0.356949752948672,0.386344510859312,0.0293947579106403,0.0884711652700509,2.55480796500498,3.50873903731481,3.47078745741983,3.63343708554116,0.162649628121328,0.0312432262399075,ENSG00000169371,SNUPN,protein_coding,15,-1,75598083,75626469,q24.2,snurportin 1 [Source:HGNC Symbol;Acc:HGNC:14245],NA,SNUPN,10073,NM_001042581;NM_001042588;NM_005701
ZNF844_TF,ZNF844,ZNF844_TF,ZNF844,TF,15,1.87646780053698,-0.00206685880082456,-0.00668451582786696,0.0131054428594576,0.0197899586873247,0.0884988690850206,1.4287780473454,4.17919225718961,4.14196669888282,4.30150480591189,0.159538107029061,0.245979506266104,ENSG00000223547,ZNF844,protein_coding,19,1,12064731,12081565,p13.2,zinc finger protein 844 [Source:HGNC Symbol;Acc:HGNC:25932],NA,ZNF844,284391,NM_001136501
CA2_SIG,CA2,CA2_SIG,CA2,SIG,29,-1.87641761039339,-0.00965915385905764,-0.00486141954755847,-0.0254231380254121,-0.0205617184778537,0.0884988690850206,-2.14306090319239,4.51327388326868,4.62011177833956,4.16223508517867,-0.45787669316089,0.0740736592759169,ENSG00000104267,CA2,protein_coding,8,1,85463968,85481493,q21.2,carbonic anhydrase 2 [Source:HGNC Symbol;Acc:HGNC:1373],OSTEOPETROSIS AUTOSOMAL RECESSIVE 3;OSTEOPETROSIS AUTOSOMAL RECESSIVE TYPE 3;Osteopetrosis with renal tubular acidosis,CA2,760,NM_000067;NM_001293675
DGKA_SIG,DGKA,DGKA_SIG,DGKA,SIG,33,-1.87511475838901,0.191690717244167,0.194911332437019,0.181108695896225,-0.0138026365407938,0.0887446119526764,-0.184264700986881,6.12396987059553,6.12733927427915,6.11289897277792,-0.0144403015012271,0.89627042758285,ENSG00000065357,DGKA,protein_coding,12,1,55927319,55954027,q13.2,diacylglycerol kinase alpha [Source:HGNC Symbol;Acc:HGNC:2849],NA,DGKA,1606,NM_001345;NM_001351033;NM_001351034;NM_001351035;NM_001351036;NM_001351037;NM_001351038;NM_001351039;NM_001351040;NM_201444;NM_201445;NM_201554
PAX8_TF,PAX8,PAX8_TF,PAX8,TF,65,1.87473050609999,0.0131674050555895,0.0111878350310116,0.0196717065649167,0.00848387153390505,0.0888061600242874,-0.917694671265582,1.52941753876291,1.56055605660303,1.42710526585965,-0.133450790743379,0.472461656377399,ENSG00000125618,PAX8,protein_coding,2,-1,113215997,113278921,q14.1,paired box 8 [Source:HGNC Symbol;Acc:HGNC:8622],Athyreosis;CONGENITAL HYPOTHYROIDISM NON-GOITROUS TYPE 2;Differentiated thyroid carcinoma;HYPOTHYROIDISM CONGENITAL NONGOITROUS 2;Thyroid ectopia;Thyroid hypoplasia,PAX8,7849,NM_003466;NM_013952;NM_013953;NM_013992
LRP4_SIG,LRP4,LRP4_SIG,LRP4,SIG,43,-1.87401448045549,-0.0341148998653788,-0.0304101515500088,-0.046287644330166,-0.0158774927801574,0.088934467348479,-1.68593072010808,1.24241819528506,1.29924331271089,1.0557070951716,-0.243536217539294,0.166825369841761,ENSG00000134569,LRP4,protein_coding,11,-1,46856717,46918642,p11.2,LDL receptor related protein 4 [Source:HGNC Symbol;Acc:HGNC:6696],CENANI-LENZ SYNDACTYLY SYNDROME;Cenani-Lenz syndrome;MYASTHENIC SYNDROME CONGENITAL 17;Postsynaptic congenital myasthenic syndromes;SCLEROSTEOSIS;SCLEROSTEOSIS 2,LRP4,4038,NM_002334
B4GALT3_SIG,B4GALT3,B4GALT3_SIG,B4GALT3,SIG,27,1.87386958001358,0.120431292020616,0.118711365459452,0.126082479293014,0.00737111383356222,0.0889479514518078,0.472852904445987,5.36631262514092,5.36153007030888,5.38202673387479,0.0204966635659131,0.725382971178464,ENSG00000158850,B4GALT3,protein_coding,1,-1,161171310,161177968,q23.3,beta-1,4-galactosyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:926],NA,B4GALT3,8703,NM_001199873;NM_001199874;NM_003779
GNB3_SIG,GNB3,GNB3_SIG,GNB3,SIG,69,1.87315171778063,-0.0902890100617987,-0.0943289148184342,-0.0770150372899964,0.0173138775284378,0.0890767909094807,0.571722271947916,1.1306601124799,1.11645924601705,1.17732010228642,0.0608608562693712,0.667777676314212,ENSG00000111664,GNB3,protein_coding,12,1,6839954,6847393,p13.31,G protein subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:4400],Congenital stationary night blindness;GNB3 Autosomal-Recessive Congenital Stationary Night Blindness.;HYPERTENSION ESSENTIAL;NIGHT BLINDNESS CONGENITAL STATIONARY TYPE 1H,GNB3,2784,NM_001297571;NM_002075
CNOT8_SIG,CNOT8,CNOT8_SIG,CNOT8,SIG,49,1.87300771053934,0.275484646961657,0.273605574511383,0.281658742155417,0.00805316764403425,0.0890901124036841,0.875322804096555,6.77002982565155,6.75868085258894,6.80731930857156,0.0486384559826245,0.494970321022024,ENSG00000155508,CNOT8,protein_coding,5,1,154857553,154876793,q33.2,CCR4-NOT transcription complex subunit 8 [Source:HGNC Symbol;Acc:HGNC:9207],NA,CNOT8,9337,NM_001301073;NM_001301074;NM_001301075;NM_001301077;NM_001301080;NM_001301082;NM_001301083;NM_001301086;NM_004779
SLC44A4_SIG,SLC44A4,SLC44A4_SIG,SLC44A4,SIG,11,-1.87278847163379,-0.03108481537807,-0.0262068383401655,-0.047112454216899,-0.0209056158767336,0.089118595168037,-1.42666773141018,0.501616767499751,0.531696650320565,0.402782866802791,-0.128913783517773,0.246678270575521,ENSG00000204385,SLC44A4,protein_coding,6,-1,31863192,31879046,p21.33,solute carrier family 44 member 4 [Source:HGNC Symbol;Acc:HGNC:13941],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 72,SLC44A4,80736,NM_001178044;NM_001178045;NM_025257
CAMLG_SIG,CAMLG,CAMLG_SIG,CAMLG,SIG,25,1.8724913816605,0.614925177257546,0.610013474178539,0.631063630231425,0.021050156052886,0.089162777879169,3.21352564817015,4.98526548890273,4.93117095770404,5.1630046628413,0.231833705137262,0.00612205700645781,ENSG00000164615,CAMLG,protein_coding,5,1,134738548,134752157,q31.1,calcium modulating ligand [Source:HGNC Symbol;Acc:HGNC:1471],NA,CAMLG,819,NM_001745
GMPR_SIG,GMPR,GMPR_SIG,GMPR,SIG,40,-1.87193452110166,0.0170975511234351,0.0230679737412542,-0.00251955176368483,-0.0255875255049391,0.0892593747705753,-2.69934665679492,2.83568924952726,2.92988264146593,2.52619667601447,-0.403685965451457,0.022435209969478,ENSG00000137198,GMPR,protein_coding,6,1,16238580,16295549,p22.3,guanosine monophosphate reductase [Source:HGNC Symbol;Acc:HGNC:4376],NA,GMPR,2766,NM_006877
HIST4H4_SIG,HIST4H4,HIST4H4_SIG,HIST4H4,SIG,23,-1.87119900755388,-0.0731023169877084,-0.0709913592659373,-0.0800383209306704,-0.00904696166473317,0.0893921355752103,-1.32481761398957,1.23292237169736,1.25303318663566,1.1668439797572,-0.0861892068784567,0.285164838860013,ENSG00000197837,HIST4H4,protein_coding,12,-1,14767999,14771131,p12.3,histone cluster 4 H4 [Source:HGNC Symbol;Acc:HGNC:20510],NA,HIST4H4,121504,NM_175054
CHPT1_SIG,CHPT1,CHPT1_SIG,CHPT1,SIG,21,-1.87049963064746,0.040736605155043,0.0435678981592564,0.0314337852840561,-0.0121341128752005,0.0895177461987518,0.00514598873860976,5.22688449346012,5.22678520995311,5.22721071069743,0.000425500744328722,0.99674382962527,ENSG00000111666,CHPT1,protein_coding,12,1,101696947,101744140,q23.2,choline phosphotransferase 1 [Source:HGNC Symbol;Acc:HGNC:17852],NA,CHPT1,56994,NM_020244
NOTCH3_TF,NOTCH3,NOTCH3_TF,NOTCH3,TF,117,1.86957826277302,-0.00993707893852233,-0.0115850955298012,-0.00452216728146324,0.00706292824833797,0.0896884494659136,1.78044020934413,1.83393367715228,1.76191721107243,2.07055920855749,0.308641997485063,0.1428578081478,ENSG00000074181,NOTCH3,protein_coding,19,-1,15159038,15200995,p13.12,notch 3 [Source:HGNC Symbol;Acc:HGNC:7883],CADASIL;CEREBRAL ARTERIOPATHY AUTOSOMAL DOMINANT WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY TYPE 1;Infantile myofibromatosis;Lateral meningocele syndrome;MYOFIBROMATOSIS INFANTILE 2,NOTCH3,4854,NM_000435
RBM27_SIG,RBM27,RBM27_SIG,RBM27,SIG,31,1.86929111501777,0.563856686627985,0.561066409338405,0.573024740579465,0.0119583312410603,0.0897308390687785,4.6485730797964,6.24642816348223,6.19387232565315,6.41911163063494,0.225239304981797,5.68737668895336e-05,ENSG00000091009,RBM27,protein_coding,5,1,146203605,146289223,q32,RNA binding motif protein 27 [Source:HGNC Symbol;Acc:HGNC:29243],NA,RBM27,54439,NM_018989
R3HDM2_SIG,R3HDM2,R3HDM2_SIG,R3HDM2,SIG,48,1.86824263180987,0.0827166445377281,0.0799454671295538,0.091821941736015,0.0118764746064613,0.0899276640410199,-0.143781646572089,5.77038985157962,5.77191788703512,5.76536916365442,-0.00654872338069348,0.919343011738244,ENSG00000179912,R3HDM2,protein_coding,12,-1,57253762,57431005,q13.3,R3H domain containing 2 [Source:HGNC Symbol;Acc:HGNC:29167],NA,R3HDM2,22864,NM_001330121;NM_001330122;NM_001330123;NM_001351204;NM_001351205;NM_001351206;NM_001351207;NM_001351208;NM_001351209;NM_001351211;NM_001351212;NM_001351213;NM_001351214;NM_001351215;NM_001351216;NM_001351217;NM_001351218;NM_014925
TPRA1_SIG,TPRA1,TPRA1_SIG,TPRA1,SIG,9,1.86662839121313,0.159655234592158,0.154322698772223,0.177176423714801,0.0228537249425778,0.0902399345004689,2.50992508938581,4.43767325518563,4.39916163043748,4.56421145078671,0.165049820349224,0.0345349735996176,ENSG00000163870,TPRA1,protein_coding,3,-1,127571266,127598267,q21.3,transmembrane protein adipocyte associated 1 [Source:HGNC Symbol;Acc:HGNC:30413],NA,TPRA1,131601,NM_001136053;NM_001142646;NM_001353001;NM_001353002;NM_001353003;NM_001353004;NM_001353005;NM_001353006;NM_001353007
ST6GALNAC1_SIG,ST6GALNAC1,ST6GALNAC1_SIG,ST6GALNAC1,SIG,26,-1.86605794799796,-0.0459308316494947,-0.0393268583036272,-0.0676296012144881,-0.0283027429108608,0.0903402262248098,0.0659992924404056,1.00594610377647,1.00407036437871,1.01210924751198,0.00803888313326733,0.963881326942049,ENSG00000070526,ST6GALNAC1,protein_coding,17,-1,76624761,76643786,q25.1,ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:23614],NA,ST6GALNAC1,55808,NM_001289107;NM_018414
CYB5R3_SIG,CYB5R3,CYB5R3_SIG,CYB5R3,SIG,48,1.86485634093465,0.19424037801092,0.191997696378014,0.201609189090465,0.00961149271245092,0.0905693827676188,-0.649595620211269,7.05202190379987,7.0592300723722,7.0283379213479,-0.0308921510243005,0.621096896991673,ENSG00000100243,CYB5R3,protein_coding,22,-1,42617840,42649392,q13.2,cytochrome b5 reductase 3 [Source:HGNC Symbol;Acc:HGNC:2873],Hereditary methemoglobinemia;METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE,CYB5R3,1727,NM_000398;NM_001129819;NM_001171660;NM_001171661;NM_007326
ALDH2_SIG,ALDH2,ALDH2_SIG,ALDH2,SIG,23,-1.86264248686086,-0.0280889130834939,-0.0246168620639696,-0.0394970807190735,-0.0148802186551039,0.0910062812054975,1.60390351007449,4.82819981266474,4.75533814758072,5.06760242651224,0.31226427893152,0.189397343565942,ENSG00000111275,ALDH2,protein_coding,12,1,111766887,111817532,q24.12,aldehyde dehydrogenase 2 family member [Source:HGNC Symbol;Acc:HGNC:404],ALCOHOL SENSITIVITY ACUTE HANGOVER SUSCEPTIBILITY TO INCLUDED,ALDH2,217,NM_000690;NM_001204889
RPLP0_SIG,RPLP0,RPLP0_SIG,RPLP0,SIG,33,1.86113168587462,1.1027323171863,1.09435608951722,1.13025420809899,0.0358981185817661,0.0913003253146684,2.6676560562275,8.79458875129336,8.74594750372141,8.95440999331549,0.208462489594073,0.0241288558820279,ENSG00000089157,RPLP0,protein_coding,12,-1,120196699,120201235,q24.23,ribosomal protein lateral stalk subunit P0 [Source:HGNC Symbol;Acc:HGNC:10371],NA,RPLP0,6175,NM_001002;NM_053275
CELF1_SIG,CELF1,CELF1_SIG,CELF1,SIG,34,1.86040251506868,0.394491035896969,0.391443288456149,0.404505063202521,0.0130617747463716,0.0914342075824685,2.60867294278983,7.42776392935817,7.40010587489859,7.51864039401106,0.118534519112466,0.0276030300079293,ENSG00000149187,CELF1,protein_coding,11,-1,47465933,47565569,p11.2,CUGBP Elav-like family member 1 [Source:HGNC Symbol;Acc:HGNC:2549],NA,CELF1,10658,NM_001025596;NM_001172639;NM_001172640;NM_001330272;NM_006560;NM_198700
ULK1_SIG,ULK1,ULK1_SIG,ULK1,SIG,23,-1.85908389541344,0.114714005844934,0.119349614406451,0.0994827205713779,-0.0198668938350734,0.0916897307010943,0.778687184361047,6.80035190779208,6.78658405317852,6.84558914437947,0.0590050912009491,0.546839277122148,ENSG00000177169,ULK1,protein_coding,12,1,131894622,131923150,q24.33,unc-51 like autophagy activating kinase 1 [Source:HGNC Symbol;Acc:HGNC:12558],NA,ULK1,8408,NM_003565
GALNS_SIG,GALNS,GALNS_SIG,GALNS,SIG,43,-1.85887386652466,0.140314669257157,0.144378397556124,0.126962419131977,-0.0174159784241473,0.091716941829865,1.09194945740828,5.3620479744414,5.34314334460722,5.42416318675368,0.0810198421464606,0.386031419583406,ENSG00000141012,GALNS,protein_coding,16,-1,88813734,88856970,q24.3,galactosamine (N-acetyl)-6-sulfatase [Source:HGNC Symbol;Acc:HGNC:4122],Mucopolysaccharidosis type 4A;MUCOPOLYSACCHARIDOSIS TYPE IVA,GALNS,2588,NM_000512;NM_001323543;NM_001323544
TRIM17_SIG,TRIM17,TRIM17_SIG,TRIM17,SIG,26,-1.85829329154979,-0.0881546736189145,-0.0850232866006832,-0.0984435166788175,-0.0134202300781342,0.0918206302504147,-2.53522122121608,0.38813791296267,0.422152352704411,0.276376182382665,-0.145776170321746,0.0327172150149123,ENSG00000162931,TRIM17,protein_coding,1,-1,228407935,228416861,q42.13,tripartite motif containing 17 [Source:HGNC Symbol;Acc:HGNC:13430],NA,TRIM17,51127,NM_001024940;NM_001134855;NM_016102
EREG_SIG,EREG,EREG_SIG,EREG,SIG,30,-1.85775671838676,-0.0672667511578596,-0.0642434862162729,-0.0772003359659303,-0.0129568497496573,0.0919153198986247,-0.285689956438232,4.54523907788865,4.56609732215379,4.47670484673174,-0.0893924754220458,0.836348448283346,ENSG00000124882,EREG,protein_coding,4,1,74365145,74388749,q13.3,epiregulin [Source:HGNC Symbol;Acc:HGNC:3443],NA,EREG,2069,NM_001432
SLC12A8_SIG,SLC12A8,SLC12A8_SIG,SLC12A8,SIG,20,-1.85717048881344,-0.0577797541130492,-0.053022723758477,-0.0734099967066434,-0.0203872729481665,0.0920203552949001,-1.10805488155666,0.42624778554897,0.438007855160939,0.387607556823929,-0.0504002983370103,0.378573932445734,ENSG00000221955,SLC12A8,protein_coding,3,-1,125082636,125212864,q21.2,solute carrier family 12 member 8 [Source:HGNC Symbol;Acc:HGNC:15595],NA,SLC12A8,84561,NM_001195483;NM_024628
GEMIN2_SIG,GEMIN2,GEMIN2_SIG,GEMIN2,SIG,44,1.85604352097366,0.281335776069343,0.275155321827166,0.301642982865068,0.0264876610379012,0.0922374690504812,3.02801291038556,2.23780592855929,2.19401229089812,2.38169930944598,0.187687018547859,0.0100111915435836,ENSG00000092208,GEMIN2,protein_coding,14,1,39114223,39136973,q21.1,gem nuclear organelle associated protein 2 [Source:HGNC Symbol;Acc:HGNC:10884],NA,GEMIN2,8487,NM_001009182;NM_001009183;NM_003616
CD2AP_SIG,CD2AP,CD2AP_SIG,CD2AP,SIG,36,1.85588891749824,0.259619876344516,0.256722466360426,0.269139937720812,0.0124174713603859,0.0922533194238813,1.42340715948195,5.53421589839278,5.50695407879063,5.62379044851411,0.116836369723483,0.247853981844694,ENSG00000198087,CD2AP,protein_coding,6,1,47477789,47627263,p12.3,CD2 associated protein [Source:HGNC Symbol;Acc:HGNC:14258],Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3 SUSCEPTIBILITY TO;Sporadic idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,CD2AP,23607,NM_012120
MELK_SIG,MELK,MELK_SIG,MELK,SIG,46,-1.85494240802187,0.242117024764514,0.264378708664277,0.168971491951007,-0.0954072167132697,0.0924334113700323,-0.56030932720491,2.76519222078402,2.78236480429754,2.70876801781101,-0.0735967864865309,0.674820524414945,ENSG00000165304,MELK,protein_coding,9,1,36572862,36677683,p13.2,maternal embryonic leucine zipper kinase [Source:HGNC Symbol;Acc:HGNC:16870],NA,MELK,9833,NM_001256685;NM_001256687;NM_001256688;NM_001256689;NM_001256690;NM_001256691;NM_001256692;NM_001256693;NM_014791
TYK2_SIG,TYK2,TYK2_SIG,TYK2,SIG,39,-1.85152046969135,0.284656960351844,0.2882625781473,0.27280993045249,-0.0154526476948098,0.0931295500871187,-0.283146749356891,7.67605825593491,7.67884494614512,7.66690198810138,-0.0119429580437353,0.837778230541888,ENSG00000105397,TYK2,protein_coding,19,-1,10350529,10380676,p13.2,tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:12440],IMMUNODEFICIENCY 35;Lymphomatoid papulosis;Primary cutaneous anaplastic large cell lymphoma;Susceptibility to infection due to TYK2 deficiency,TYK2,7297,NM_003331
MLX_TF,MLX,MLX_TF,MLX,TF,243,-1.85080798427429,0.292583915363534,0.29755566034391,0.276248181856585,-0.0213074784873246,0.0932620819025766,-1.69665160116227,5.73382268689266,5.75779679568875,5.65505061513409,-0.102746180554655,0.164031952291465,ENSG00000108788,MLX,protein_coding,17,1,42567068,42573239,q21.2,MLX, MAX dimerization protein [Source:HGNC Symbol;Acc:HGNC:11645],Takayasu arteritis,MLX,6945,NM_170607;NM_198204;NM_198205
CDC5L_TF,CDC5L,CDC5L_TF,CDC5L,TF,104,1.84942254429,0.338845545249662,0.337032764527521,0.344801824765266,0.00776906023774528,0.0935357074478654,1.43854850764208,6.30871766584458,6.29319158364606,6.35973193592541,0.0665403522793496,0.242572077373255,ENSG00000096401,CDC5L,protein_coding,6,1,44387706,44450425,p21.1,cell division cycle 5 like [Source:HGNC Symbol;Acc:HGNC:1743],NA,CDC5L,988,NM_001253
CBX2_SIG,CBX2,CBX2_SIG,CBX2,SIG,61,1.84927056230745,0.0570770063087556,0.0508911123982792,0.0774020863003209,0.0265109739020418,0.0935511619156513,2.0621746892215,4.19458504940851,4.10332617676897,4.49443563093843,0.391109454169463,0.0863573256024916,ENSG00000173894,CBX2,protein_coding,17,1,79778148,79787983,q25.3,chromobox 2 [Source:HGNC Symbol;Acc:HGNC:1552],46XY complete gonadal dysgenesis;46XY SEX REVERSAL 5,CBX2,84733,NM_005189;NM_032647
TREX2_SIG,TREX2,TREX2_SIG,TREX2,SIG,22,-1.84723863950994,-0.0940484895848398,-0.0920826196504307,-0.100507776512184,-0.00842515686175325,0.0939613692210185,-1.49666258603576,0.619915268611057,0.632870685342036,0.577347470780694,-0.0555232145613422,0.223047740242482,ENSG00000183479,TREX2,protein_coding,X,-1,153444720,153470587,q28,three prime repair exonuclease 2 [Source:HGNC Symbol;Acc:HGNC:12270],NA,TREX2,11219,NM_080701
EIF4A3_SIG,EIF4A3,EIF4A3_SIG,EIF4A3,SIG,17,-1.84656872756838,0.120521666115942,0.12376322935375,0.109870815477429,-0.0138924138763215,0.0940858798410864,-1.19111191101816,5.98986159688919,6.00818344814418,5.92966122847997,-0.0785222196642047,0.340934539900442,ENSG00000141543,EIF4A3,protein_coding,17,-1,80134369,80147183,q25.3,eukaryotic translation initiation factor 4A3 [Source:HGNC Symbol;Acc:HGNC:18683],RICHIERI-COSTA-PEREIRA SYNDROME;Richieri Costa Pereira syndrome;ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES,EIF4A3,9775,NM_014740
LDHC_SIG,LDHC,LDHC_SIG,LDHC,SIG,1,1.84570111851108,-0.045272591996052,-0.0482977446575255,-0.0353328046797817,0.0129649399777439,0.0942522018277173,1.06963639647153,0.229160738738837,0.218973072414299,0.262634499519462,0.0436614271051636,0.396874454639879,ENSG00000166796,LDHC,protein_coding,11,1,18412318,18452063,p15.1,lactate dehydrogenase C [Source:HGNC Symbol;Acc:HGNC:6544],NA,LDHC,3948,NM_002301;NM_017448
DCHS1_SIG,DCHS1,DCHS1_SIG,DCHS1,SIG,90,-1.84548983976529,-0.0193192055627226,-0.0168067750916656,-0.0275743342533385,-0.0107675591616728,0.094280245373499,-2.03809284390764,3.78475918040902,3.8811876834661,3.46792267036431,-0.413265013101795,0.0905386327744073,ENSG00000166341,DCHS1,protein_coding,11,-1,6621330,6655809,p15.4,dachsous cadherin-related 1 [Source:HGNC Symbol;Acc:HGNC:13681],Cerebro-facio-articular syndrome;Familial mitral valve prolapse;MITRAL VALVE PROLAPSE 2;periventricular neuronal heterotopia;VAN MALDERGEM SYNDROME 1,DCHS1,8642,NM_003737
CREB3L1_TF,CREB3L1,CREB3L1_TF,CREB3L1,TF,154,-1.84437774531568,-0.0106873948586128,-0.00935166976193992,-0.0150762058905381,-0.00572453612859824,0.0944984898953513,1.32398732013687,0.457431181330128,0.434795048839677,0.531807045227324,0.0970119963876476,0.28545443049426,ENSG00000157613,CREB3L1,protein_coding,11,1,46277661,46321422,p11.2,cAMP responsive element binding protein 3 like 1 [Source:HGNC Symbol;Acc:HGNC:18856],Myxofibrosarcoma;Osteogenesis imperfecta type 3;OSTEOGENESIS IMPERFECTA TYPE XVI,CREB3L1,90993,NM_052854
CSDE1_SIG,CSDE1,CSDE1_SIG,CSDE1,SIG,31,1.84386132843733,0.492718839001778,0.488943317676676,0.505124123355688,0.0161808056790124,0.0945911001323906,0.684534061163662,9.59500674724233,9.58910268210098,9.61440581842106,0.0253031363200797,0.600853360394305,ENSG00000009307,CSDE1,protein_coding,1,-1,114716913,114758676,p13.2,cold shock domain containing E1 [Source:HGNC Symbol;Acc:HGNC:29905],NA,CSDE1,7812,NM_001007553;NM_001130523;NM_001242891;NM_001242892;NM_001242893;NM_007158
USP32_SIG,USP32,USP32_SIG,USP32,SIG,20,-1.84300351987158,0.0640347558011273,0.0680160648896253,0.050953311653205,-0.0170627532364203,0.0947560563833457,-0.159236456416376,6.35807608701057,6.36042864542882,6.35034625220776,-0.0100823932210518,0.910605392594438,ENSG00000170832,USP32,protein_coding,17,-1,60177327,60422470,q23.2,ubiquitin specific peptidase 32 [Source:HGNC Symbol;Acc:HGNC:19143],NA,USP32,84669,NM_032582
ZZEF1_TF,ZZEF1,ZZEF1_TF,ZZEF1,TF,198,-1.84046741897561,0.0673469968264153,0.0694902506501402,0.0603048771198906,-0.0091853735302497,0.0952777078833509,-0.994464618553995,7.20992273047751,7.22151317600893,7.17183983801712,-0.049673337991809,0.433230364984162,ENSG00000074755,ZZEF1,protein_coding,17,-1,4004445,4143030,p13.2,zinc finger ZZ-type and EF-hand domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29027],NA,ZZEF1,23140,NM_015113
MSL2_SIG,MSL2,MSL2_SIG,MSL2,SIG,51,1.84033357872211,0.366224160591616,0.361131924493771,0.382955793484537,0.0218238689907665,0.0952895033097545,1.41273568577757,7.03474513727568,7.01173350851406,7.1103547746353,0.0986212661212359,0.25181117832248,ENSG00000174579,MSL2,protein_coding,3,-1,136148917,136197241,q22.3,MSL complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:25544],NA,MSL2,55167,NM_001145417;NM_018133
P2RY1_SIG,P2RY1,P2RY1_SIG,P2RY1,SIG,36,1.83914259428617,0.160839674570114,0.156531801099507,0.174994115973537,0.0184623148740308,0.0955264348808062,2.45027307667824,3.34973229630467,3.28019133006882,3.57822404250818,0.298032712439362,0.0393331803557638,ENSG00000169860,P2RY1,protein_coding,3,1,152835131,152841439,q25.2,purinergic receptor P2Y1 [Source:HGNC Symbol;Acc:HGNC:8539],NA,P2RY1,5028,NM_002563
NUDT12_SIG,NUDT12,NUDT12_SIG,NUDT12,SIG,1,1.83892373378625,0.293522585942663,0.288505595486465,0.310006983155885,0.0215013876694203,0.0955563786543781,3.03018013186168,1.78525035427145,1.71890316416118,2.00324826463375,0.284345100472572,0.00994573010097812,ENSG00000112874,NUDT12,protein_coding,5,-1,103548855,103562790,q21.2,nudix hydrolase 12 [Source:HGNC Symbol;Acc:HGNC:18826],NA,NUDT12,83594,NM_001300741;NM_031438
ERAP1_SIG,ERAP1,ERAP1_SIG,ERAP1,SIG,4,1.83862035963368,0.333454814439724,0.330934011155601,0.34173745380184,0.0108034426462386,0.0956043561705163,0.639720736591955,7.1053822742555,7.09360968002664,7.14406365529318,0.0504539752665379,0.627083121318247,ENSG00000164307,ERAP1,protein_coding,5,-1,96760810,96808100,q15,endoplasmic reticulum aminopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:18173],Behcet disease,ERAP1,51752,NM_001040458;NM_001198541;NM_001349244;NM_016442
NAP1L1_SIG,NAP1L1,NAP1L1_SIG,NAP1L1,SIG,13,1.83815199189872,1.34710281528515,1.33900312301687,1.37371608988091,0.034712966864043,0.0956875650934946,2.01451279055478,9.24915972461087,9.21562744779934,9.35933720556302,0.143709757763684,0.0945124615712132,ENSG00000187109,NAP1L1,protein_coding,12,-1,76036585,76084958,q21.2,nucleosome assembly protein 1 like 1 [Source:HGNC Symbol;Acc:HGNC:7637],NA,NAP1L1,4673,NM_001307924;NM_001330231;NM_001330232;NM_004537;NM_139207
SCN8A_SIG,SCN8A,SCN8A_SIG,SCN8A,SIG,67,1.8366394615137,-0.02037153065996,-0.0236510432881439,-0.00959598916735561,0.0140550541207883,0.095994071707739,-0.199333787576418,1.38651234635931,1.39257112020596,1.36660494657744,-0.025966173628519,0.887510001813271,ENSG00000196876,SCN8A,protein_coding,12,1,51590266,51812864,q13.13,sodium voltage-gated channel alpha subunit 8 [Source:HGNC Symbol;Acc:HGNC:10596],Benign familial infantile epilepsy;Cognitive impairment with or without cerebellar ataxia;Epileptic encephalopathy early infantile 13;Infantile convulsions and choreoathetosis;SEIZURES BENIGN FAMILIAL INFANTILE 5;Undetermined early-onset epileptic encephalopathy,SCN8A,6334,NM_001177984;NM_001330260;NM_014191
EXOSC1_SIG,EXOSC1,EXOSC1_SIG,EXOSC1,SIG,12,1.83619204012999,0.337146864499728,0.332184281100706,0.353452495667943,0.0212682145672369,0.0960661696676157,1.28542921030531,3.93851371124179,3.92591845218407,3.97989813386003,0.0539796816759623,0.300881813388939,ENSG00000171311,EXOSC1,protein_coding,10,-1,97436142,97446017,q24.1,exosome component 1 [Source:HGNC Symbol;Acc:HGNC:17286],NA,EXOSC1,51013,NM_001318362;NM_001318363;NM_001318364;NM_001318365;NM_001318366;NM_016046
SNAPC5_TF,SNAPC5,SNAPC5_TF,SNAPC5,TF,95,1.83614580000938,0.177235936700017,0.171870685701373,0.194864618552706,0.0229939328513331,0.0960661696676157,-0.403821475338133,3.28604396442391,3.29100502621569,3.26974333282236,-0.0212616933933352,0.766007135283067,ENSG00000174446,SNAPC5,protein_coding,15,-1,66490135,66497780,q22.31,small nuclear RNA activating complex polypeptide 5 [Source:HGNC Symbol;Acc:HGNC:15484],NA,SNAPC5,10302,NM_001329613;NM_001329614;NM_001329615;NM_006049
PAPLN_SIG,PAPLN,PAPLN_SIG,PAPLN,SIG,48,1.83598380979644,0.0156636810598932,0.0121697410158542,0.0271437697760212,0.0149740287601669,0.0960840657017949,2.28504764674754,1.75102193266681,1.67850238786475,1.98930043701642,0.310798049151675,0.0556763466856528,ENSG00000100767,PAPLN,protein_coding,14,1,73237497,73274640,q24.2,papilin, proteoglycan like sulfated glycoprotein [Source:HGNC Symbol;Acc:HGNC:19262],NA,PAPLN,89932,NM_001365906;NM_173462
TRMT10A_SIG,TRMT10A,TRMT10A_SIG,TRMT10A,SIG,10,1.83579323771004,0.173924928872408,0.164488882572044,0.204929081002177,0.0404401984301329,0.0961080874997802,1.32581100680845,2.23154509469066,2.20995638124109,2.3024794388821,0.092523057641002,0.284696195241633,ENSG00000145331,TRMT10A,protein_coding,4,-1,99546709,99564039,q23,tRNA methyltransferase 10A [Source:HGNC Symbol;Acc:HGNC:28403],MICROCEPHALY SHORT STATURE AND IMPAIRED GLUCOSE METABOLISM 1;Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,TRMT10A,93587,NM_001134665;NM_001134666;NM_152292
RANGAP1_SIG,RANGAP1,RANGAP1_SIG,RANGAP1,SIG,14,1.83555647863627,0.504091545141887,0.499056517056976,0.520635208849452,0.0215786917924769,0.0961420099820121,0.322179343937535,6.09719445993581,6.09248155513319,6.11267971857298,0.0201981634397919,0.814706630383043,ENSG00000100401,RANGAP1,protein_coding,22,-1,41245611,41286251,q13.2,Ran GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:9854],NA,RANGAP1,5905,NM_001278651;NM_001317930;NM_002883
TXNL4A_SIG,TXNL4A,TXNL4A_SIG,TXNL4A,SIG,14,1.83499519528669,0.494033392594173,0.490397031581618,0.50598143592114,0.0155844043395218,0.096245508355362,1.65931055776985,5.0445230170259,5.03055792738551,5.0904083115586,0.0598503841730924,0.173985759353455,ENSG00000141759,TXNL4A,protein_coding,18,-1,79970813,80033949,q23,thioredoxin like 4A [Source:HGNC Symbol;Acc:HGNC:30551],BURN-MCKEOWN SYNDROME;Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome,TXNL4A,10907,NM_001305557;NM_001305563;NM_001305564;NM_006701
ZNF275_TF,ZNF275,ZNF275_TF,ZNF275,TF,58,1.83432225936626,0.314364884170094,0.311165462837917,0.324877268547247,0.0137118057093296,0.0963730586569848,0.942496566346854,4.4397890215494,4.424099157079,4.49134143338074,0.0672422763017401,0.459515394311935,ENSG00000063587,ZNF275,protein_coding,X,1,153334147,153360110,q28,zinc finger protein 275 [Source:HGNC Symbol;Acc:HGNC:13069],NA,ZNF275,10838,NM_001080485;NM_001367757
BAZ2B_TF,BAZ2B,BAZ2B_TF,BAZ2B,TF,73,1.83375764783006,0.0896796252638523,0.0881598205606604,0.0946732692886254,0.00651344872796507,0.0964774681605413,1.54365115057058,6.92710510053872,6.90541384346379,6.9983763737849,0.0929625303211149,0.207871206375248,ENSG00000123636,BAZ2B,protein_coding,2,-1,159318979,159616569,q24.2,bromodomain adjacent to zinc finger domain 2B [Source:HGNC Symbol;Acc:HGNC:963],NA,BAZ2B,29994,NM_001289975;NM_001329857;NM_001329858;NM_013450
SLFN11_SIG,SLFN11,SLFN11_SIG,SLFN11,SIG,9,1.8335063827856,0.0109712420634415,0.003470186646822,0.0356175670037628,0.0321473803569406,0.0965146093683479,3.48670691072106,5.4717434757351,5.37655155997198,5.78451691324248,0.407965353270495,0.00280518755186088,ENSG00000172716,SLFN11,protein_coding,17,-1,35350305,35373701,q12,schlafen family member 11 [Source:HGNC Symbol;Acc:HGNC:26633],NA,SLFN11,91607,NM_001104587;NM_001104588;NM_001104589;NM_001104590;NM_152270
PRDM10_TF,PRDM10,PRDM10_TF,PRDM10,TF,61,1.83219844612465,0.282727547470798,0.281095250586065,0.288090808663491,0.00699555807742619,0.0967791259564624,1.3067557393144,4.16621633973676,4.151788576428,4.21362184775125,0.0618332713232485,0.292260734158332,ENSG00000170325,PRDM10,protein_coding,11,-1,129899706,130002835,q24.3,PR/SET domain 10 [Source:HGNC Symbol;Acc:HGNC:13995],NA,PRDM10,56980,NM_001367891;NM_001367893;NM_001367895;NM_001367896;NM_001367897;NM_001367898;NM_001367899;NM_020228;NM_199437;NM_199438;NM_199439
ZNF92_TF,ZNF92,ZNF92_TF,ZNF92,TF,46,1.83087097062493,0.291917449807216,0.287357092425486,0.306901481204327,0.0195443887788402,0.0970406652729447,2.23914763090697,4.64584497300825,4.595895800784,4.80996368174506,0.214067880961052,0.0612746827454485,ENSG00000146757,ZNF92,protein_coding,7,1,65373799,65401135,q11.21,zinc finger protein 92 [Source:HGNC Symbol;Acc:HGNC:13168],NA,ZNF92,168374,NM_001287532;NM_001287533;NM_001287534;NM_007139;NM_152626
ECI1_SIG,ECI1,ECI1_SIG,ECI1,SIG,27,1.83082854758147,0.385354009401598,0.381360662904321,0.398475005035506,0.0171143421311848,0.0970406652729447,2.52159125691993,3.91040140191874,3.87715702724385,4.01963291870768,0.14247589146383,0.0337201837896089,ENSG00000167969,ECI1,protein_coding,16,-1,2239402,2252300,p13.3,enoyl-CoA delta isomerase 1 [Source:HGNC Symbol;Acc:HGNC:2703],NA,ECI1,1632,NM_001178029;NM_001919
SAT2_SIG,SAT2,SAT2_SIG,SAT2,SIG,12,-1.83002583715738,0.0178341207399902,0.0215466894865695,0.00563568057265814,-0.0159110089139113,0.0971970926344678,0.199067427746568,4.54372787365893,4.54051745347586,4.55427639711756,0.0137589436416919,0.88768864050797,ENSG00000141504,SAT2,protein_coding,17,-1,7626234,7627876,p13.1,spermidine/spermine N1-acetyltransferase family member 2 [Source:HGNC Symbol;Acc:HGNC:23160],NA,SAT2,112483,NM_001320845;NM_001320846;NM_001320847;NM_133491
NRBP2_SIG,NRBP2,NRBP2_SIG,NRBP2,SIG,90,1.82992692230092,0.0211478808664239,0.0184575035608286,0.0299876920133797,0.0115301884525511,0.097201514672137,1.94547680048522,3.65796931548216,3.59617293936026,3.86101455131128,0.264841611951022,0.107302843606572,ENSG00000185189,NRBP2,protein_coding,8,-1,143833583,143840973,q24.3,nuclear receptor binding protein 2 [Source:HGNC Symbol;Acc:HGNC:19339],NA,NRBP2,340371,NM_178564
RCHY1_TF,RCHY1,RCHY1_TF,RCHY1,TF,58,1.82964329589195,0.183181338145881,0.181742657697682,0.187908431047105,0.00616577334942273,0.0972458667670678,1.27864424502707,4.97908271897649,4.96388136144295,5.02903003658666,0.0651486751437103,0.303661044845295,ENSG00000163743,RCHY1,protein_coding,4,-1,75479037,75514764,q21.1,ring finger and CHY zinc finger domain containing 1 [Source:HGNC Symbol;Acc:HGNC:17479],NA,RCHY1,25898,NM_001009922;NM_001278536;NM_001278537;NM_001278538;NM_001278539;NM_015436
DHRS4L2_SIG,DHRS4L2,DHRS4L2_SIG,DHRS4L2,SIG,16,1.82942437217738,0.334592743174817,0.329788303105228,0.350378760546325,0.0205904574410973,0.0972762425516236,1.85195036999092,3.80032308946297,3.77080506112401,3.89731089686238,0.126505835738368,0.126444076904098,ENSG00000187630,DHRS4L2,protein_coding,14,1,23969874,24006408,q11.2,dehydrogenase/reductase 4 like 2 [Source:HGNC Symbol;Acc:HGNC:19731],NA,DHRS4L2,317749,NM_001193635;NM_001193636;NM_001193637;NM_198083
MSH6_SIG,MSH6,MSH6_SIG,MSH6,SIG,25,1.82869013889305,0.49612745126772,0.490196737717134,0.515614081505358,0.0254173437882243,0.0974181391284983,0.797431022603729,6.26660240417376,6.25079151992931,6.31855245240552,0.0677609324762071,0.536599772650078,ENSG00000116062,MSH6,protein_coding,2,1,47695530,47810101,p16.3,mutS homolog 6 [Source:HGNC Symbol;Acc:HGNC:7329],Colorectal cancer hereditary nonpolyposis type 5;Constitutional mismatch repair deficiency syndrome;Endometrial Cancer;Lynch syndrome;MISMATCH REPAIR CANCER SYNDROME;Muir-Torre syndrome,MSH6,2956,NM_000179;NM_001281492;NM_001281493;NM_001281494
BPNT1_TF,BPNT1,BPNT1_TF,BPNT1,TF,297,1.82845979838038,0.311307838211007,0.305229163203904,0.33128062752006,0.0260514643161564,0.0974510291881372,0.99919031080602,3.55395692794405,3.5280308052993,3.63914275949108,0.111111954191783,0.430892753905795,ENSG00000162813,BPNT1,protein_coding,1,-1,220057482,220090462,q41,3'(2'), 5'-bisphosphate nucleotidase 1 [Source:HGNC Symbol;Acc:HGNC:1096],NA,BPNT1,10380,NM_001286149;NM_001286150;NM_001286151;NM_006085
AMHR2_SIG,AMHR2,AMHR2_SIG,AMHR2,SIG,50,-1.82658634534491,-0.0132502447212918,-0.00893947593111153,-0.0274141993175985,-0.018474723386487,0.0978403747424319,-1.84582097342583,0.36305959576039,0.391342774749159,0.270129150511578,-0.121213624237581,0.127738844554219,ENSG00000135409,AMHR2,protein_coding,12,1,53423855,53431672,q13.13,anti-Mullerian hormone receptor type 2 [Source:HGNC Symbol;Acc:HGNC:465],Persistent Mullerian duct syndrome;PERSISTENT MULLERIAN DUCT SYNDROME TYPES I AND II,AMHR2,269,NM_001164690;NM_001164691;NM_020547
AHCYL1_SIG,AHCYL1,AHCYL1_SIG,AHCYL1,SIG,29,1.82630160188578,0.421292110195933,0.413896563728219,0.445591762875565,0.0316951991473466,0.0978851948489708,1.47123878986896,6.58839274751921,6.5627419207308,6.67267403553828,0.109932114807482,0.231478556643972,ENSG00000168710,AHCYL1,protein_coding,1,1,109984765,110023742,p13.3,adenosylhomocysteinase like 1 [Source:HGNC Symbol;Acc:HGNC:344],NA,AHCYL1,10768,NM_001242673;NM_001242674;NM_001242675;NM_001242676;NM_006621
USP13_SIG,USP13,USP13_SIG,USP13,SIG,17,-1.82608297021041,0.151321059141965,0.154508223222141,0.140848948592818,-0.013659274629323,0.097915659053777,0.354032417285281,3.81145208074436,3.80384848672518,3.83643531823595,0.0325868315107635,0.795106390870703,ENSG00000058056,USP13,protein_coding,3,1,179653040,179789401,q26.33,ubiquitin specific peptidase 13 [Source:HGNC Symbol;Acc:HGNC:12611],NA,USP13,8975,NM_003940
PARP4_SIG,PARP4,PARP4_SIG,PARP4,SIG,25,1.82530238267295,0.568845848377148,0.562180863126495,0.590745085629292,0.0285642225027971,0.0980683815920511,1.66722564744356,7.31244163382092,7.27930613729351,7.42131540812525,0.142009270831736,0.171726369946334,ENSG00000102699,PARP4,protein_coding,13,-1,24420931,24512778,q12.12,poly(ADP-ribose) polymerase family member 4 [Source:HGNC Symbol;Acc:HGNC:271],NA,PARP4,143,NM_006437
MDM4_SIG,MDM4,MDM4_SIG,MDM4,SIG,78,1.82500796719503,0.318372415782681,0.314167629754711,0.332188141303153,0.0180205115484425,0.0981153896156543,2.03469925408218,7.51088299512537,7.4771238667524,7.62180584549372,0.144681978741324,0.0910894923543306,ENSG00000198625,MDM4,protein_coding,1,1,204516379,204558120,q32.1,MDM4, p53 regulator [Source:HGNC Symbol;Acc:HGNC:6974],NA,MDM4,4194,NM_001204171;NM_001204172;NM_001278516;NM_001278517;NM_001278518;NM_001278519;NM_002393
RALBP1_SIG,RALBP1,RALBP1_SIG,RALBP1,SIG,7,1.82470900726211,0.573351238093412,0.568395990731025,0.589632765141254,0.0212367744102292,0.0981634055543191,2.85318193768184,6.5485848022297,6.50287632849958,6.69876978734295,0.195893458843374,0.0155620972181108,ENSG00000017797,RALBP1,protein_coding,18,1,9475009,9538114,p11.22,ralA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9841],NA,RALBP1,10928,NM_006788
GZF1_TF,GZF1,GZF1_TF,GZF1,TF,46,-1.82438673170833,0.431517048466956,0.437661303055831,0.411328783389224,-0.0263325196666072,0.0982165207839166,-1.45587173742996,5.26386156887342,5.29093329043153,5.17491162661104,-0.116021663820492,0.236599063952696,ENSG00000125812,GZF1,protein_coding,20,1,23362182,23373062,p11.21,GDNF inducible zinc finger protein 1 [Source:HGNC Symbol;Acc:HGNC:15808],JOINT LAXITY SHORT STATURE AND MYOPIA;LARSEN SYNDROME;Severe myopia-generalized joint laxity-short stature syndrome,GZF1,64412,NM_001317012;NM_001317019;NM_022482
RAPSN_SIG,RAPSN,RAPSN_SIG,RAPSN,SIG,26,-1.82374864981708,-0.108441076789418,-0.105398118631235,-0.118439367880591,-0.0130412492493554,0.0983385230434464,-0.0311436984170757,0.533071243105744,0.533426812132215,0.531902944875909,-0.00152386725630669,0.982898302574369,ENSG00000165917,RAPSN,protein_coding,11,-1,47437764,47449143,p11.2,receptor associated protein of the synapse [Source:HGNC Symbol;Acc:HGNC:9863],Congenital myasthenic syndrome with acetylcholine receptor deficiency;FETAL AKINESIA DEFORMATION SEQUENCE;Lethal multiple pterygium syndrome;MYASTHENIC SYNDROME CONGENITAL 11 ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY;Postsynaptic congenital myasthenic syndromes,RAPSN,5913,NM_005055;NM_032645
ZNF418_TF,ZNF418,ZNF418_TF,ZNF418,TF,29,-1.82297493628548,-0.090445776026298,-0.0856123025070457,-0.106327189018127,-0.0207148865110812,0.0984902618634491,-0.229643167361006,2.14076839377859,2.14864089710039,2.11490159714982,-0.0337392999505696,0.870393732930708,ENSG00000196724,ZNF418,protein_coding,19,-1,57921884,57935393,q13.43,zinc finger protein 418 [Source:HGNC Symbol;Acc:HGNC:20647],NA,ZNF418,147686,NM_001317027;NM_001317028;NM_001317029;NM_001317030;NM_133460
POLR2D_SIG,POLR2D,POLR2D_SIG,POLR2D,SIG,34,1.82255769525794,0.463006337499236,0.459355782833306,0.475001017115865,0.0156452342825589,0.0985642647356517,2.00643123540979,4.9328791075759,4.90915111402244,5.01084251496583,0.101691400943395,0.0958984044798728,ENSG00000144231,POLR2D,protein_coding,2,-1,127843553,127858155,q14.3,RNA polymerase II subunit D [Source:HGNC Symbol;Acc:HGNC:9191],NA,POLR2D,5433,NM_004805
ARHGEF1_SIG,ARHGEF1,ARHGEF1_SIG,ARHGEF1,SIG,114,-1.8223297146087,0.21095641971453,0.213912079131621,0.201244967344088,-0.0126671117875338,0.0985969370130509,-1.44434672086191,8.54381544839161,8.5632756662154,8.47987473268485,-0.0834009335305534,0.240490630061182,ENSG00000076928,ARHGEF1,protein_coding,19,1,41883161,41930150,q13.2,Rho guanine nucleotide exchange factor 1 [Source:HGNC Symbol;Acc:HGNC:681],NA,ARHGEF1,9138,NM_004706;NM_198977;NM_199002
AMDHD1_SIG,AMDHD1,AMDHD1_SIG,AMDHD1,SIG,11,1.82093568445877,0.003983699947817,0.00105816968134147,0.0135961565376652,0.0125379868563239,0.0988848169811236,1.97508008583301,0.763599456826445,0.731669773171316,0.868511274550439,0.136841501379124,0.101691516381145,ENSG00000139344,AMDHD1,protein_coding,12,1,95943331,95968720,q23.1,amidohydrolase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:28577],NA,AMDHD1,144193,NM_152435
PLRG1_SIG,PLRG1,PLRG1_SIG,PLRG1,SIG,51,1.81938368105518,0.382304788168706,0.3755872822709,0.404376593261494,0.0287893109905942,0.099196232184131,1.97632954492581,4.95705267538816,4.92567410851338,5.06015368083385,0.134479572320466,0.101464317544432,ENSG00000171566,PLRG1,protein_coding,4,-1,154535005,154550400,q31.3,pleiotropic regulator 1 [Source:HGNC Symbol;Acc:HGNC:9089],NA,PLRG1,5356,NM_001201564;NM_002669
RPS6KA4_SIG,RPS6KA4,RPS6KA4_SIG,RPS6KA4,SIG,77,1.81935903324822,0.21940886179881,0.215394418779759,0.232599174575692,0.0172047557959333,0.099196232184131,1.96221215605805,6.05439125005765,6.01223170874151,6.19291545723926,0.180683748497744,0.104026183099345,ENSG00000162302,RPS6KA4,protein_coding,11,1,64359148,64372215,q13.1,ribosomal protein S6 kinase A4 [Source:HGNC Symbol;Acc:HGNC:10433],NA,RPS6KA4,8986,NM_001006944;NM_001300802;NM_001318361;NM_003942
ZNF530_TF,ZNF530,ZNF530_TF,ZNF530,TF,23,1.81926154614168,0.144568728306254,0.141437492363194,0.154857074976311,0.013419582613117,0.0991978323266951,2.48348863862447,2.39157338521169,2.35568976349435,2.50947671371154,0.153786950217192,0.0365995373234408,ENSG00000183647,ZNF530,protein_coding,19,1,57599885,57612722,q13.43,zinc finger protein 530 [Source:HGNC Symbol;Acc:HGNC:29297],NA,ZNF530,348327,NM_001321981;NM_020880
ORC1_SIG,ORC1,ORC1_SIG,ORC1,SIG,37,-1.81919471044723,0.319199911901703,0.332085079654813,0.276862932141484,-0.0552221475133285,0.0991978323266951,-1.11182012912225,4.13014173828988,4.16172722306995,4.0263608597268,-0.135366363343144,0.376847210049267,ENSG00000085840,ORC1,protein_coding,1,-1,52372829,52404423,p32.3,origin recognition complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:8487],Ear-patella-short stature syndrome;Meier-Gorlin syndrome 1,ORC1,4998,NM_001190818;NM_001190819;NM_004153
ZBTB34_TF,ZBTB34,ZBTB34_TF,ZBTB34,TF,52,-1.81825126639285,0.19458627810593,0.196403410260829,0.188615701025547,-0.00778770923528208,0.0993879450824099,-0.291819936859305,5.9220957763884,5.92622311891843,5.90853450807546,-0.0176886108429679,0.832781737194124,ENSG00000177125,ZBTB34,protein_coding,9,1,126860665,126885878,q33.3,zinc finger and BTB domain containing 34 [Source:HGNC Symbol;Acc:HGNC:31446],NA,ZBTB34,403341,NM_001099270
ZCCHC9_TF,ZCCHC9,ZCCHC9_TF,ZCCHC9,TF,68,1.81616602813577,0.257014653428564,0.252340361691069,0.27237304056605,0.0200326788749816,0.0998301580074424,1.00529996754545,4.00339844412593,3.99031612848479,4.04638319551825,0.0560670670334659,0.427909488212711,ENSG00000131732,ZCCHC9,protein_coding,5,1,81301587,81313297,q14.1,zinc finger CCHC-type containing 9 [Source:HGNC Symbol;Acc:HGNC:25424],NA,ZCCHC9,84240,NM_001131035;NM_001131036;NM_032280
PCF11_SIG,PCF11,PCF11_SIG,PCF11,SIG,48,1.81554672127539,0.029726338823019,0.0273813016097051,0.0374314610953363,0.0100501594856311,0.0999495905701981,1.32003663716264,6.90698569572555,6.89030684874832,6.96178762150788,0.0714807727595596,0.286995288967557,ENSG00000165494,PCF11,protein_coding,11,1,83156988,83187451,q14.1,PCF11, cleavage and polyadenylation factor subunit [Source:HGNC Symbol;Acc:HGNC:30097],NA,PCF11,51585,NM_001346413;NM_001346414;NM_001346415;NM_015885
ANGPTL6_SIG,ANGPTL6,ANGPTL6_SIG,ANGPTL6,SIG,41,1.81418009768218,0.09381649277071,0.0893321710288167,0.108550692779788,0.0192185217509712,0.100234545165888,0.749306845267621,2.63462377974502,2.61162208795344,2.71020076706023,0.0985786791067861,0.563776129138213,ENSG00000130812,ANGPTL6,protein_coding,19,-1,10092338,10102796,p13.2,angiopoietin like 6 [Source:HGNC Symbol;Acc:HGNC:23140],Familial cerebral saccular aneurysm,ANGPTL6,83854,NM_001321411;NM_031917
GPKOW_SIG,GPKOW,GPKOW_SIG,GPKOW,SIG,21,1.81371902090494,0.424159265544959,0.418582795005281,0.442481954461042,0.0238991594557612,0.100319285337369,2.07990808087864,4.13498608329797,4.11045021258629,4.21560394420777,0.105153731621484,0.0834628190606056,ENSG00000068394,GPKOW,protein_coding,X,-1,49113407,49123735,p11.23,G-patch domain and KOW motifs [Source:HGNC Symbol;Acc:HGNC:30677],Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,GPKOW,27238,NM_015698
BEST4_SIG,BEST4,BEST4_SIG,BEST4,SIG,28,1.81330901505886,-0.0331239135676851,-0.0360752131535029,-0.0234267863571408,0.0126484267963622,0.100392755439092,0.226972286435342,0.56255231054678,0.560237822457933,0.57015705712442,0.00991923466648714,0.871749366493166,ENSG00000142959,BEST4,protein_coding,1,-1,44783585,44788170,p34.1,bestrophin 4 [Source:HGNC Symbol;Acc:HGNC:17106],NA,BEST4,266675,NM_153274
PRSS12_SIG,PRSS12,PRSS12_SIG,PRSS12,SIG,42,-1.8129536279446,0.122060530313372,0.127403286195989,0.104505760984773,-0.0228975252112157,0.10044674610468,-1.24066972074494,0.567416593403525,0.597512136131591,0.468531238725591,-0.128980897406,0.319323694770675,ENSG00000164099,PRSS12,protein_coding,4,-1,118280038,118353003,q26,serine protease 12 [Source:HGNC Symbol;Acc:HGNC:9477],Autosomal recessive non-syndromic intellectual disability;Mental retardation autosomal recessive 1;MENTAL RETARDATION AUTOSOMAL RECESSIVE TYPE 1,PRSS12,8492,NM_003619
SMN2_SIG,SMN2,SMN2_SIG,SMN2,SIG,2,-1.81290839620663,0.123538243057491,0.125708412174489,0.116407687387357,-0.0093007247871313,0.10044674610468,-0.885182448180104,3.02598208086767,3.04329884075732,2.96908415551594,-0.074214685241385,0.489598196376547,ENSG00000205571,SMN2,protein_coding,5,1,70049612,70078522,q13.2,survival of motor neuron 2, centromeric [Source:HGNC Symbol;Acc:HGNC:11118],Proximal spinal muscular atrophy type 1;Proximal spinal muscular atrophy type 2;Proximal spinal muscular atrophy type 3;Proximal spinal muscular atrophy type 4;SPINAL MUSCULAR ATROPHY TYPE I;SPINAL MUSCULAR ATROPHY TYPE II;SPINAL MUSCULAR ATROPHY TYPE III;SPINAL MUSCULAR ATROPHY TYPE IV,SMN2,6606;6607,NM_017411;NM_022875;NM_022876;NM_022877
WRN_SIG,WRN,WRN_SIG,WRN,SIG,50,1.81185884949111,0.233394012974048,0.229709853589455,0.245499108094853,0.0157892545053979,0.100662331839469,1.14542398288561,4.57355145084194,4.55230464317459,4.64336239032035,0.0910577471457623,0.361198029444068,ENSG00000165392,WRN,protein_coding,8,1,31033788,31175916,p12,Werner syndrome RecQ like helicase [Source:HGNC Symbol;Acc:HGNC:12791],Werner Syndrome,WRN,7486,NM_000553
ZCWPW2_TF,ZCWPW2,ZCWPW2_TF,ZCWPW2,TF,21,1.81100498000605,0.0741772731624897,0.0705657857017913,0.0860435891047843,0.0154778034029932,0.100834733533386,-0.430718467467574,0.68315818824954,0.686647416275214,0.671693581879468,-0.0149538343957458,0.750101657269885,ENSG00000206559,ZCWPW2,protein_coding,3,1,28348721,28538122,p24.1,zinc finger CW-type and PWWP domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23574],NA,ZCWPW2,152098,NM_001040432;NM_001324169;NM_001324170
ATP6V1E2_SIG,ATP6V1E2,ATP6V1E2_SIG,ATP6V1E2,SIG,15,1.81030199451397,0.251513179722798,0.248538926797493,0.261285725048798,0.0127467982513048,0.100971431643691,0.0387030979256626,2.78842986470907,2.78788545350739,2.79021864437173,0.00233319086433841,0.978903096263415,ENSG00000250565,ATP6V1E2,protein_coding,2,-1,46490750,46542577,p21,ATPase H+ transporting V1 subunit E2 [Source:HGNC Symbol;Acc:HGNC:18125],NA,ATP6V1E2,90423,NM_001318063
HDLBP_SIG,HDLBP,HDLBP_SIG,HDLBP,SIG,19,1.81023377656463,0.579797033428778,0.575863369111695,0.592721930470623,0.0168585613589284,0.100971431643691,4.49744050648483,8.3470464248885,8.29679874128228,8.5121459567375,0.215347215455221,9.98503868525492e-05,ENSG00000115677,HDLBP,protein_coding,2,-1,241227264,241317061,q37.3,high density lipoprotein binding protein [Source:HGNC Symbol;Acc:HGNC:4857],NA,HDLBP,3069,NM_001243900;NM_001320965;NM_001320966;NM_001320967;NM_005336;NM_203346
SMNDC1_SIG,SMNDC1,SMNDC1_SIG,SMNDC1,SIG,10,1.80947435342056,0.319284067822727,0.317203894364618,0.326118923470798,0.00891502910617948,0.101123182494666,-0.135168825582029,5.7271327250035,5.72828219459493,5.72335589634592,-0.00492629824901676,0.924122833540345,ENSG00000119953,SMNDC1,protein_coding,10,-1,110290730,110304951,q25.2,survival motor neuron domain containing 1 [Source:HGNC Symbol;Acc:HGNC:16900],NA,SMNDC1,10285,NM_005871
STIP1_SIG,STIP1,STIP1_SIG,STIP1,SIG,32,1.80885602032062,0.558779179329526,0.553090000737095,0.577472194704654,0.0243821939675584,0.101243611490744,1.64738428656177,6.67902909238847,6.65124339809745,6.77032494505897,0.119081546961517,0.177152512508662,ENSG00000168439,STIP1,protein_coding,11,1,64185272,64204543,q13.1,stress induced phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:11387],NA,STIP1,10963,NM_001282652;NM_001282653;NM_006819
ESCO2_SIG,ESCO2,ESCO2_SIG,ESCO2,SIG,31,-1.80844659906197,0.216255557600601,0.235142852692944,0.15419730229719,-0.0809455503957538,0.101317478895523,-1.47190704211312,2.34073961710406,2.38694019422979,2.18893772083381,-0.198002473395975,0.231232382181375,ENSG00000171320,ESCO2,protein_coding,8,1,27771949,27812640,p21.1,establishment of sister chromatid cohesion N-acetyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:27230],ROBERTS SYNDROME;SC PHOCOMELIA SYNDROME,ESCO2,157570,NM_001017420
AR_TF,AR,AR_TF,AR,TF,173,-1.80770183229588,-0.0491109783427473,-0.0475102998234408,-0.0543703506204689,-0.006860050797028,0.101466360929093,0.122398262913226,1.71691482172451,1.71082268278173,1.73693184967936,0.0261091668976362,0.931629468774358,ENSG00000169083,AR,protein_coding,X,1,67544032,67730619,q12,androgen receptor [Source:HGNC Symbol;Acc:HGNC:644],ANDROGEN INSENSITIVITY PARTIAL;ANDROGEN INSENSITIVITY SYNDROME;Complete androgen insensitivity syndrome;Familial hypospadias;HYPOSPADIAS 1 X-LINKED;Kennedy disease;Partial androgen insensitivity syndrome;Prostate Cancer;Spinal and Bulbar Muscular Atrophy;SPINAL AND BULBAR MUSCULAR ATROPHY X-LINKED 1,AR,367,NM_000044;NM_001011645;NM_001348061;NM_001348063;NM_001348064
SLC25A45_SIG,SLC25A45,SLC25A45_SIG,SLC25A45,SIG,72,-1.80572269031735,0.0527675072719207,0.0557386129783491,0.043005302807942,-0.0127333101704071,0.101892098350621,-0.666989880157588,4.0507999090034,4.06255183743719,4.01218642986382,-0.0503654075733663,0.610929505107597,ENSG00000162241,SLC25A45,protein_coding,11,-1,65375192,65383701,q13.1,solute carrier family 25 member 45 [Source:HGNC Symbol;Acc:HGNC:27442],NA,SLC25A45,283130,NM_001077241;NM_001278250;NM_001278251;NM_001300820;NM_001352381;NM_001352382;NM_001352383;NM_001352384;NM_182556
JAG2_SIG,JAG2,JAG2_SIG,JAG2,SIG,57,1.80508387789345,-0.0825164455934886,-0.0848554827709388,-0.0748310377247237,0.010024445046215,0.102017848546697,-1.78217019015416,1.13994555131108,1.1741198964518,1.02765841727727,-0.146461479174539,0.142426716789754,ENSG00000184916,JAG2,protein_coding,14,-1,105140982,105168824,q32.33,jagged 2 [Source:HGNC Symbol;Acc:HGNC:6189],NA,JAG2,3714,NM_002226;NM_145159
TAS2R30_SIG,TAS2R30,TAS2R30_SIG,TAS2R30,SIG,72,1.80492989469585,-0.0395405098907961,-0.0429985004949932,-0.0281785407627198,0.0148199597322735,0.102034760152711,1.11083126920575,0.253622596390847,0.246813662120121,0.275994808994662,0.0291811468745408,0.377348959391069,ENSG00000256188,TAS2R30,protein_coding,12,-1,11132958,11134644,p13.2,taste 2 receptor member 30 [Source:HGNC Symbol;Acc:HGNC:19112],NA,TAS2R30,259293,NM_001097643
SLC35B3_SIG,SLC35B3,SLC35B3_SIG,SLC35B3,SIG,67,1.80443129893846,0.208521560826433,0.201227341947133,0.232488280001276,0.0312609380541425,0.102129121992124,1.32626019494467,3.58135908412934,3.5567903628695,3.66208488255454,0.105294519685041,0.284575310922708,ENSG00000124786,SLC35B3,protein_coding,6,-1,8411463,8435611,p24.3,solute carrier family 35 member B3 [Source:HGNC Symbol;Acc:HGNC:21601],NA,SLC35B3,51000,NM_001142541;NM_015948
TNFRSF25_SIG,TNFRSF25,TNFRSF25_SIG,TNFRSF25,SIG,24,-1.80255101997447,0.0248330737751101,0.0292825328130617,0.0102134226504123,-0.0190691101626494,0.102534774300141,-1.16271980572908,3.69284837229484,3.73173908291157,3.56506460883988,-0.16667447407169,0.353677790309086,ENSG00000215788,TNFRSF25,protein_coding,1,-1,6460786,6466195,p36.31,TNF receptor superfamily member 25 [Source:HGNC Symbol;Acc:HGNC:11910],NA,TNFRSF25,8718,NM_001039664;NM_003790;NM_148965;NM_148966;NM_148967;NM_148970
RTCB_SIG,RTCB,RTCB_SIG,RTCB,SIG,12,1.80188230056695,0.549907199246875,0.54649057156916,0.561133261616512,0.014642690047352,0.102667900020357,1.28485257489713,5.65036125927488,5.63613417280109,5.69710740054594,0.0609732277448513,0.301127055765329,ENSG00000100220,RTCB,protein_coding,22,-1,32387582,32412248,q12.3,RNA 2',3'-cyclic phosphate and 5'-OH ligase [Source:HGNC Symbol;Acc:HGNC:26935],NA,RTCB,51493,NM_014306
ZNF319_TF,ZNF319,ZNF319_TF,ZNF319,TF,67,1.80086080360206,0.0890180534195195,0.0876802171976698,0.093413801005597,0.00573358380792708,0.102880912913687,0.410704213647131,4.96856645796429,4.9634695128851,4.98531356322452,0.021844050339423,0.762340480640318,ENSG00000166188,ZNF319,protein_coding,16,-1,57994668,58000453,q21,zinc finger protein 319 [Source:HGNC Symbol;Acc:HGNC:13644],NA,ZNF319,57567,NM_020807
TPT1_SIG,TPT1,TPT1_SIG,TPT1,SIG,13,1.80000006817672,0.576175202231882,0.571845932923083,0.590399944246505,0.0185540113234221,0.103057867147676,2.10364773734604,11.9736954592889,11.9453524279166,12.0668225623691,0.121470134452434,0.079826218381442,ENSG00000133112,TPT1,protein_coding,13,-1,45333471,45341370,q14.13,tumor protein, translationally-controlled 1 [Source:HGNC Symbol;Acc:HGNC:12022],NA,TPT1,7178,NM_001286272;NM_001286273;NM_003295
HIVEP2_TF,HIVEP2,HIVEP2_TF,HIVEP2,TF,115,1.79935060511963,0.0973203680597442,0.094844676496512,0.105454783196078,0.0106101066995664,0.103187162584592,0.305579828592165,5.27443693433466,5.26451826470983,5.30702684881624,0.0425085841064163,0.82435861912065,ENSG00000010818,HIVEP2,protein_coding,6,-1,142751469,142956698,q24.2,human immunodeficiency virus type I enhancer binding protein 2 [Source:HGNC Symbol;Acc:HGNC:4921],Autosomal dominant non-syndromic intellectual disability;HIVEP2 associated syndromic developmental delay with intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 43,HIVEP2,3097,NM_006734
SLC25A42_SIG,SLC25A42,SLC25A42_SIG,SLC25A42,SIG,31,1.79902897715819,0.135102895424199,0.132260839178645,0.14444108023102,0.0121802410523759,0.103242220863723,1.03113669104267,3.65573691127918,3.63596622689062,3.72069773141304,0.0847315045224203,0.41512385474514,ENSG00000181035,SLC25A42,protein_coding,19,1,19063999,19112888,p13.11,solute carrier family 25 member 42 [Source:HGNC Symbol;Acc:HGNC:28380],NA,SLC25A42,284439,NM_001321544;NM_178526
GON4L_TF,GON4L,GON4L_TF,GON4L,TF,89,1.79877762719069,0.364379132266249,0.361933538861495,0.372414653453296,0.0104811145918009,0.103281360031746,2.47414699678183,6.25039520521815,6.22409045549133,6.33682509717771,0.11273464168638,0.0373727413929981,ENSG00000116580,GON4L,protein_coding,1,-1,155749662,155859400,q22,gon-4 like [Source:HGNC Symbol;Acc:HGNC:25973],Autosomal Recessive Mental Retardation,GON4L,54856,NM_001282856;NM_001282858;NM_001282860;NM_001282861;NM_032292
SMN1_SIG,SMN1,SMN1_SIG,SMN1,SIG,10,1.79833170738937,0.0919748541481131,0.0878314953175263,0.105588747448613,0.0177572521310864,0.103364665998161,1.3528964931223,3.68568783966705,3.66679003942099,3.74778061190409,0.0809905724831008,0.274408789327149,ENSG00000172062,SMN1,protein_coding,5,1,70925030,70953942,q13.2,survival of motor neuron 1, telomeric [Source:HGNC Symbol;Acc:HGNC:11117],Proximal spinal muscular atrophy type 1;Proximal spinal muscular atrophy type 2;Proximal spinal muscular atrophy type 3;Proximal spinal muscular atrophy type 4;SPINAL MUSCULAR ATROPHY TYPE I;SPINAL MUSCULAR ATROPHY TYPE II;SPINAL MUSCULAR ATROPHY TYPE III;SPINAL MUSCULAR ATROPHY TYPE IV,SMN1,6606,NM_000344;NM_001297715;NM_022874
GLYR1_SIG,GLYR1,GLYR1_SIG,GLYR1,SIG,18,1.79812074283324,0.508193404503432,0.503390522309902,0.523974303139317,0.020583780829415,0.10339467329191,1.86545745937695,6.19624214435343,6.17471546319252,6.26697266816782,0.092257204975299,0.123549587670236,ENSG00000140632,GLYR1,protein_coding,16,-1,4803203,4847288,p13.3,glyoxylate reductase 1 homolog [Source:HGNC Symbol;Acc:HGNC:24434],NA,GLYR1,84656,NM_001308096;NM_001324096;NM_001324097;NM_001324098;NM_032569
RBPMS_SIG,RBPMS,RBPMS_SIG,RBPMS,SIG,98,1.79778498666076,0.0142281742177566,0.00804086669228195,0.034557898944316,0.026517032252034,0.103439811542812,2.45508988240263,2.74945249596098,2.60552028945669,3.22237260304652,0.616852313589829,0.0389516579936771,ENSG00000157110,RBPMS,protein_coding,8,1,30384511,30572256,p12,RNA binding protein, mRNA processing factor [Source:HGNC Symbol;Acc:HGNC:19097],NA,RBPMS,11030,NM_001008710;NM_001008711;NM_001008712;NM_006867
RNF219_SIG,RNF219,RNF219_SIG,RNF219,SIG,53,1.79776442191692,0.251258110902954,0.244828500157896,0.272383974779574,0.0275554746216782,0.103439811542812,0.795746846021069,3.80702536875262,3.78804307382653,3.86939576636691,0.0813526925403801,0.537596896512811,ENSG00000152193,RNF219,protein_coding,13,-1,78614289,78659155,q31.1,ring finger protein 219 [Source:HGNC Symbol;Acc:HGNC:20308],NA,RNF219,79596,NM_024546
ZNF697_TF,ZNF697,ZNF697_TF,ZNF697,TF,152,1.79722063593178,0.0591363359731765,0.0575458961822136,0.0643620667149119,0.00681617053269829,0.103545457018464,1.36777499412066,2.4886144188665,2.45287380229993,2.60604787329953,0.153174070999601,0.268846170199058,ENSG00000143067,ZNF697,protein_coding,1,-1,119619377,119648266,p12,zinc finger protein 697 [Source:HGNC Symbol;Acc:HGNC:32034],NA,ZNF697,90874,NM_001080470
DDX59_SIG,DDX59,DDX59_SIG,DDX59,SIG,11,1.79592821289909,0.39178678984415,0.390027705720034,0.397566637680531,0.0075389319604972,0.1038215813561,0.148155864588045,4.93395316167832,4.93258324873371,4.9384543042106,0.00587105547688358,0.916876893851693,ENSG00000118197,DDX59,protein_coding,1,-1,200623896,200669907,q32.1,DEAD-box helicase 59 [Source:HGNC Symbol;Acc:HGNC:25360],Orofaciodigital syndrome;Orofaciodigital syndrome type 5;OROFACIODIGITAL SYNDROME V,DDX59,83479,NM_001031725;NM_001320181;NM_001320182;NM_001349799;NM_001349800;NM_001349801;NM_001349802;NM_001349803
STAT4_SIG,STAT4,STAT4_SIG,STAT4,SIG,17,-1.79578329207023,0.107852577218807,0.116056725759853,0.0808960891553702,-0.0351606366044832,0.103836646560383,2.31254183665421,3.23948252849101,3.15588738316133,3.51415229171708,0.358264908555753,0.0526069024917687,ENSG00000138378,STAT4,protein_coding,2,-1,191029576,191151596,q32.3,signal transducer and activator of transcription 4 [Source:HGNC Symbol;Acc:HGNC:11365],Behcet disease;Oligoarticular juvenile idiopathic arthritis;Pediatric systemic lupus erythematosus;Rheumatoid factor-negative juvenile idiopathic arthritis;Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 11,STAT4,6775,NM_001243835;NM_003151
CBX3_SIG,CBX3,CBX3_SIG,CBX3,SIG,14,1.79556097930765,0.475292035849388,0.472462606815942,0.484588731244994,0.0121261244290523,0.103859447090545,1.72675856728405,6.98481108429918,6.96607368070056,7.04637683898034,0.0803031582797768,0.156157048309429,ENSG00000122565,CBX3,protein_coding,7,1,26201162,26213607,p15.2,chromobox 3 [Source:HGNC Symbol;Acc:HGNC:1553],NA,CBX3,11335,NM_007276;NM_016587
COLGALT1_SIG,COLGALT1,COLGALT1_SIG,COLGALT1,SIG,58,-1.79552566999244,0.231995078755058,0.237356457944401,0.214379118561504,-0.0229773393828964,0.103859447090545,-2.80269599149523,7.20783026910281,7.26207254913472,7.02960563471225,-0.232466914422471,0.0175763532530737,ENSG00000130309,COLGALT1,protein_coding,19,1,17555649,17583162,p13.11,collagen beta(1-O)galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26182],NA,COLGALT1,79709,NM_024656
TST_SIG,TST,TST_SIG,TST,SIG,34,1.79520499905095,0.2751604523731,0.269870120712538,0.292542970686372,0.0226728499738338,0.103914568569185,1.92553933760029,3.19934997283157,3.14785646332352,3.36854293264373,0.220686469320211,0.111211630736351,ENSG00000128311,TST,protein_coding,22,-1,37010859,37020183,q12.3,thiosulfate sulfurtransferase [Source:HGNC Symbol;Acc:HGNC:12388],NA,TST,7263,NM_001270483;NM_003312
DHX15_SIG,DHX15,DHX15_SIG,DHX15,SIG,45,1.79476347021164,0.617865968562257,0.614045012356277,0.630420538953337,0.0163755265970608,0.10399727042555,1.15841693596806,7.56165025026619,7.54857914888852,7.60459815479283,0.0560190059043045,0.355576199444258,ENSG00000109606,DHX15,protein_coding,4,-1,24517441,24584554,p15.2,DEAH-box helicase 15 [Source:HGNC Symbol;Acc:HGNC:2738],NA,DHX15,1665,NM_001358
PRPS2_SIG,PRPS2,PRPS2_SIG,PRPS2,SIG,16,1.79429211042462,0.409969578241825,0.40518314653107,0.425696425291449,0.0205132787603783,0.104086830523333,1.83055835872999,5.24420351981009,5.21296220678888,5.34685354830838,0.133891341519497,0.131134573165937,ENSG00000101911,PRPS2,protein_coding,X,1,12791355,12824222,p22.2,phosphoribosyl pyrophosphate synthetase 2 [Source:HGNC Symbol;Acc:HGNC:9465],NA,PRPS2,5634,NM_001039091;NM_002765
OLIG2_TF,OLIG2,OLIG2_TF,OLIG2,TF,24,1.79366433259401,0.0312862348825802,0.0300675718483688,0.0352904134235606,0.00522284157519173,0.104212173166526,-0.527171458218987,0.361816791118498,0.373515587040538,0.323377890231792,-0.0501376968087461,0.694015649230786,ENSG00000205927,OLIG2,protein_coding,21,1,33025935,33029196,q22.11,oligodendrocyte transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:9398],NA,OLIG2,10215,NM_005806
CHST11_SIG,CHST11,CHST11_SIG,CHST11,SIG,20,1.79290153739656,0.317687873704142,0.315413851768915,0.325159660062746,0.00974580829383134,0.104368506507748,0.729786343064708,7.28595341930079,7.27443424557961,7.3238021329561,0.0493678873764899,0.574529742966109,ENSG00000171310,CHST11,protein_coding,12,1,104455295,104762014,q23.3,carbohydrate sulfotransferase 11 [Source:HGNC Symbol;Acc:HGNC:17422],OSTEOCHONDRODYSPLASIA BRACHYDACTYLY AND OVERLAPPING MALFORMEDDIGITS,CHST11,50515,NM_001173982;NM_018413
PPP4R1_SIG,PPP4R1,PPP4R1_SIG,PPP4R1,SIG,10,-1.79281026463182,0.435031325496194,0.437273960014606,0.42766266922141,-0.00961129079319602,0.104371367108746,0.652012411689462,6.62084368381252,6.61395898694487,6.64346483066337,0.0295058437184963,0.619774017238107,ENSG00000154845,PPP4R1,protein_coding,18,-1,9546791,9615240,p11.22,protein phosphatase 4 regulatory subunit 1 [Source:HGNC Symbol;Acc:HGNC:9320],NA,PPP4R1,9989,NM_001042388;NM_005134
DCAF15_SIG,DCAF15,DCAF15_SIG,DCAF15,SIG,19,1.79247056092717,0.303707714502539,0.302205839989333,0.308642445045932,0.00643660505659917,0.104431053875593,0.864113171905739,5.5855135162255,5.57833044773921,5.60911502696618,0.0307845792269746,0.50101477328581,ENSG00000132017,DCAF15,protein_coding,19,1,13952492,13961449,p13.12,DDB1 and CUL4 associated factor 15 [Source:HGNC Symbol;Acc:HGNC:25095],NA,DCAF15,90379,NM_138353
RBM22_SIG,RBM22,RBM22_SIG,RBM22,SIG,24,1.79178553909085,0.480554287662477,0.47641028062103,0.494170310798659,0.0177600301776291,0.104567575171959,3.28213196871712,6.62870240778564,6.59534056934508,6.73831987694745,0.142979307602372,0.00504999036067331,ENSG00000086589,RBM22,protein_coding,5,-1,150690792,150701077,q33.1,RNA binding motif protein 22 [Source:HGNC Symbol;Acc:HGNC:25503],NA,RBM22,55696,NM_018047
MKRN4P_SIG,MKRN4P,MKRN4P_SIG,MKRN4P,SIG,1,-1.7917166214113,0.668993472391592,0.673523147647479,0.654110253693676,-0.0194128939538033,0.104567575171959,-1.48923797518179,0.395920986297949,0.405902146325785,0.363125746206488,-0.0427764001192965,0.225534327227642,ENSG00000238222,MKRN4P,processed_pseudogene,X,1,40834485,40836005,p11.4,makorin ring finger protein 4, pseudogene [Source:HGNC Symbol;Acc:HGNC:7115],NA,MKRN4P,NA,NA
C4BPA_SIG,C4BPA,C4BPA_SIG,C4BPA,SIG,10,1.79134108079857,-0.114544488362059,-0.118228825154355,-0.10243881033023,0.0157900148241248,0.104635560487332,0.420916778365896,0.308808662538769,0.302531971247415,0.32943207678179,0.026900105534375,0.75631242663053,ENSG00000123838,C4BPA,protein_coding,1,1,207104233,207144972,q32.2,complement component 4 binding protein alpha [Source:HGNC Symbol;Acc:HGNC:1325],NA,C4BPA,722,NM_000715
MSN_SIG,MSN,MSN_SIG,MSN,SIG,20,-1.79029343158493,0.475515010451144,0.478127860683019,0.466929931117843,-0.0111979295651753,0.104857747843606,-0.985491420825008,10.559335110965,10.5708143720713,10.5216175387586,-0.0491968333126723,0.43802795130637,ENSG00000147065,MSN,protein_coding,X,1,65588377,65741931,q12,moesin [Source:HGNC Symbol;Acc:HGNC:7373],Combined immunodeficiency due to Moesin deficiency;IMMUNODEFICIENCY 50,MSN,4478,NM_002444
ELOVL7_SIG,ELOVL7,ELOVL7_SIG,ELOVL7,SIG,77,-1.78980995189341,-0.0434347731895781,-0.0393114471987843,-0.0569828443021863,-0.0176713971034021,0.104950667773909,-0.992984049603924,1.6191843727579,1.65189548851169,1.51170499242403,-0.140190496087665,0.434002769957833,ENSG00000164181,ELOVL7,protein_coding,5,-1,60751791,60844274,q12.1,ELOVL fatty acid elongase 7 [Source:HGNC Symbol;Acc:HGNC:26292],NA,ELOVL7,79993,NM_001104558;NM_001297617;NM_001297618;NM_024930
COQ7_SIG,COQ7,COQ7_SIG,COQ7,SIG,10,1.78952881305628,0.226891206441985,0.221520696072195,0.24453716908558,0.0230164730133852,0.104997155080001,0.184903455725409,3.81303572818454,3.8103778532355,3.82176874587423,0.0113908926387303,0.895945807333929,ENSG00000167186,COQ7,protein_coding,16,1,19067614,19080095,p12.3,coenzyme Q7, hydroxylase [Source:HGNC Symbol;Acc:HGNC:2244],Coenzyme Q10 deficiency primary 8,COQ7,10229,NM_001190983;NM_016138
GP9_SIG,GP9,GP9_SIG,GP9,SIG,39,-1.78793662427099,-0.0839736237238687,-0.0774668400677317,-0.10535305573689,-0.0278862156691586,0.105345328665372,-1.73825982647377,1.17502488705257,1.23112710710452,0.990689021167595,-0.240438085936923,0.153125759475793,ENSG00000169704,GP9,protein_coding,3,1,129060767,129062406,q21.3,glycoprotein IX platelet [Source:HGNC Symbol;Acc:HGNC:4444],BERNARD-SOULIER SYNDROME,GP9,2815,NM_000174
RFXANK_TF,RFXANK,RFXANK_TF,RFXANK,TF,218,1.7867195697306,0.242727407514737,0.239506240222837,0.253311242902409,0.0138050026795718,0.105607805127182,0.735857368886454,5.28119280514415,5.27379190448207,5.30551005017668,0.0317181456946098,0.571430878837927,ENSG00000064490,RFXANK,protein_coding,19,1,19192229,19201869,p13.11,regulatory factor X associated ankyrin containing protein [Source:HGNC Symbol;Acc:HGNC:9987],BARE LYMPHOCYTE SYNDROME TYPE II;Immunodeficiency by defective expression of HLA class 2,RFXANK,8625,NM_001278727;NM_001278728;NM_003721;NM_134440
CREM_TF,CREM,CREM_TF,CREM,TF,88,-1.78621091457743,-0.000374305522679154,0.00344064046568187,-0.0129091280558654,-0.0163497685215473,0.105707058369767,-1.07389532058375,3.52086672203302,3.54085546525985,3.45518942285918,-0.0856660424006669,0.394856969841155,ENSG00000095794,CREM,protein_coding,10,1,35126791,35212958,p11.21,cAMP responsive element modulator [Source:HGNC Symbol;Acc:HGNC:2352],NA,CREM,1390,NM_001267562;NM_001267563;NM_001267564;NM_001267565;NM_001267567;NM_001267570;NM_001352445;NM_001352446;NM_001352465;NM_001352466;NM_001352467;NM_001881;NM_181571;NM_182717;NM_182718;NM_182719;NM_182720;NM_182721;NM_182723;NM_182724;NM_182769;NM_182770;NM_182771;NM_182772;NM_183011;NM_183012;NM_183013;NM_183060
CASP1_SIG,CASP1,CASP1_SIG,CASP1,SIG,71,-1.78517529185268,0.352931407957292,0.361203638364526,0.325751222333524,-0.0354524160310014,0.105928260467541,-0.366666098675365,5.64085523883073,5.65222937739876,5.60348306925009,-0.0487463081486679,0.788250930076081,ENSG00000137752,CASP1,protein_coding,11,-1,105025443,105035250,q22.3,caspase 1 [Source:HGNC Symbol;Acc:HGNC:1499],NA,CASP1,834,NM_001223;NM_001257118;NM_001257119;NM_033292;NM_033293;NM_033294;NM_033295
FBXL12_SIG,FBXL12,FBXL12_SIG,FBXL12,SIG,28,1.78441895782927,0.18448576418048,0.181386234774551,0.194669932228532,0.0132836974539805,0.106085113167034,1.76632299457499,4.68988174545566,4.67290504921884,4.74566231880522,0.0727572695863757,0.146309795712878,ENSG00000127452,FBXL12,protein_coding,19,-1,9810267,9827816,p13.2,F-box and leucine rich repeat protein 12 [Source:HGNC Symbol;Acc:HGNC:13611],NA,FBXL12,54850,NM_001316936;NM_001316937;NM_001316938;NM_001316939;NM_001316940;NM_001316941;NM_001316942;NM_017703
SH2B2_SIG,SH2B2,SH2B2_SIG,SH2B2,SIG,29,-1.78349123655007,0.0564984493524094,0.0619163435385224,0.0386967970266096,-0.0232195465119129,0.106270027242107,-1.89706258236951,2.44757791538536,2.49059214152674,2.30624545806368,-0.184346683463055,0.116945178173165,ENSG00000160999,SH2B2,protein_coding,7,1,102285091,102321711,q22.1,SH2B adaptor protein 2 [Source:HGNC Symbol;Acc:HGNC:17381],NA,SH2B2,10603,NM_001359228;NM_001359229;NM_001359230;NM_001359231;NM_020979
SP140L_TF,SP140L,SP140L_TF,SP140L,TF,80,-1.78346356647951,0.0522111154302157,0.0551051452243529,0.0427021603923363,-0.0124029848320166,0.106270027242107,-0.973262343861696,4.83384348641184,4.84924747785823,4.78323037165942,-0.0660171061988085,0.443900730168377,ENSG00000185404,SP140L,protein_coding,2,1,230327184,230403732,q37.1,SP140 nuclear body protein like [Source:HGNC Symbol;Acc:HGNC:25105],NA,SP140L,93349,NM_001308162;NM_001308163;NM_001352892;NM_001352893;NM_001352894;NM_138402
ZNF583_TF,ZNF583,ZNF583_TF,ZNF583,TF,52,1.78328924956514,0.0508909955186036,0.0436988626754112,0.0745222891462359,0.0308234264708247,0.10629083635928,0.513500270247397,1.98575782195418,1.97640620758462,2.01648455488276,0.0400783472981444,0.701792756612899,ENSG00000198440,ZNF583,protein_coding,19,1,56397966,56436035,q13.43,zinc finger protein 583 [Source:HGNC Symbol;Acc:HGNC:26427],NA,ZNF583,147949,NM_001159860;NM_001159861;NM_152478
DUSP2_SIG,DUSP2,DUSP2_SIG,DUSP2,SIG,38,-1.78321616222634,0.220099324347756,0.227087178147604,0.197139233291113,-0.0299479448564902,0.10629083635928,-1.39640380354679,4.56093415789611,4.61567693554303,4.38106503134193,-0.234611904201095,0.257892398312998,ENSG00000158050,DUSP2,protein_coding,2,-1,96143169,96145440,q11.2,dual specificity phosphatase 2 [Source:HGNC Symbol;Acc:HGNC:3068],NA,DUSP2,1844,NM_004418
GCFC2_SIG,GCFC2,GCFC2_SIG,GCFC2,SIG,19,1.78151479721489,0.0774234692872818,0.0731011363588697,0.0916254203377787,0.0185242839789088,0.106667792318456,1.35535264711922,4.03001064612836,4.00584382257129,4.10941592353016,0.103572100958868,0.273496755727117,ENSG00000005436,GCFC2,protein_coding,2,-1,75652000,75710989,p12,GC-rich sequence DNA-binding factor 2 [Source:HGNC Symbol;Acc:HGNC:1317],NA,GCFC2,6936,NM_001201334;NM_001201335;NM_003203
SNIP1_SIG,SNIP1,SNIP1_SIG,SNIP1,SIG,85,-1.7810525934966,0.367734571237852,0.374006618125318,0.347126417179033,-0.0268802009462859,0.106757005636748,-0.805622111719873,4.11534054722142,4.13271800783909,4.05824317662049,-0.0744748312186002,0.532074152961435,ENSG00000163877,SNIP1,protein_coding,1,-1,37534449,37554293,p34.3,Smad nuclear interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:30587],Psychomotor retardation epilepsy and craniofacial dysmorphism;SYMPTOMATIC EPILEPSY AND SKULL DYSPLASIA,SNIP1,79753,NM_024700
ACO2_SIG,ACO2,ACO2_SIG,ACO2,SIG,37,1.78016032543994,0.516954042762278,0.512476448191166,0.531666139210218,0.0191896910190515,0.106946505389055,0.816262002736622,6.60413239932327,6.59383480795055,6.63796734240504,0.0441325344544889,0.526192394923423,ENSG00000100412,ACO2,protein_coding,22,1,41469117,41528989,q13.2,aconitase 2 [Source:HGNC Symbol;Acc:HGNC:118],Autosomal recessive isolated optic atrophy;Infantile cerebellar-retinal degeneration;OPTIC ATROPHY 9,ACO2,50,NM_001098
EIF2A_SIG,EIF2A,EIF2A_SIG,EIF2A,SIG,19,1.77970324570243,0.986970092906876,0.982510581884178,1.00162277198145,0.019112190097275,0.107034704338446,2.01335099978954,7.12176809806822,7.0976145652161,7.20112970601087,0.103515140794764,0.0947301726460319,ENSG00000144895,EIF2A,protein_coding,3,1,150546678,150586016,q25.1,eukaryotic translation initiation factor 2A [Source:HGNC Symbol;Acc:HGNC:3254],NA,EIF2A,83939,NM_001319043;NM_001319044;NM_001319045;NM_001319046;NM_032025
ZNF329_TF,ZNF329,ZNF329_TF,ZNF329,TF,41,1.77884863382118,0.152614245183141,0.148067647623364,0.167553065736692,0.019485418113328,0.107215793740965,2.8195496730371,3.79846815621605,3.72794275591194,4.03019447150098,0.30225171558904,0.0168910513010908,ENSG00000181894,ZNF329,protein_coding,19,-1,58126248,58155110,q13.43,zinc finger protein 329 [Source:HGNC Symbol;Acc:HGNC:14209],NA,ZNF329,79673,NM_024620
LZTS1_TF,LZTS1,LZTS1_TF,LZTS1,TF,130,1.77849464026133,-0.0771968598931584,-0.0789409432900589,-0.0714663001604853,0.00747464312957377,0.107273923953766,5.33690458295827,0.377200851195509,0.30154699434215,0.625777809427972,0.324230815085822,3.37369437878953e-06,ENSG00000061337,LZTS1,protein_coding,8,-1,20246165,20303963,p21.3,leucine zipper tumor suppressor 1 [Source:HGNC Symbol;Acc:HGNC:13861],NA,LZTS1,11178,NM_001362884;NM_021020
NDUFS7_SIG,NDUFS7,NDUFS7_SIG,NDUFS7,SIG,22,1.77844203429859,0.324943057814268,0.322533955638303,0.33285867924958,0.0103247236112772,0.107273923953766,1.84284010371919,5.01158724248904,4.99345075816933,5.07117854811092,0.077727789941589,0.128327758810954,ENSG00000115286,NDUFS7,protein_coding,19,1,1383527,1395589,p13.3,NADH:ubiquinone oxidoreductase core subunit S7 [Source:HGNC Symbol;Acc:HGNC:7714],Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 3;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I DEFICIENCY,NDUFS7,374291,NM_001363602;NM_024407
DDIT3_TF,DDIT3,DDIT3_TF,DDIT3,TF,84,-1.77834435412302,0.32490795628148,0.3306349908318,0.306090557044714,-0.024544433787086,0.107278314477294,-0.828886233127316,5.12871732816204,5.15080993140415,5.05612734608082,-0.094682585323323,0.519731349274932,ENSG00000175197,DDIT3,protein_coding,12,-1,57516588,57521737,q13.3,DNA damage inducible transcript 3 [Source:HGNC Symbol;Acc:HGNC:2726],MYXOID LIPOSARCOMA;Myxoid/round cell liposarcoma,DDIT3,1649,NM_001195053;NM_001195054;NM_001195055;NM_001195056;NM_001195057;NM_004083
OSM_SIG,OSM,OSM_SIG,OSM,SIG,30,-1.77805914957269,0.136506260495669,0.140085877496246,0.124744661779487,-0.0153412157167587,0.107326538836178,0.970870044155177,4.63524035761472,4.59871100585434,4.75526537054165,0.15655436468731,0.445028266592873,ENSG00000099985,OSM,protein_coding,22,-1,30262829,30266851,q12.2,oncostatin M [Source:HGNC Symbol;Acc:HGNC:8506],NA,OSM,5008,NM_001319108;NM_020530
MLKL_SIG,MLKL,MLKL_SIG,MLKL,SIG,26,-1.77685257517172,0.0123501364589525,0.0190670629180437,-0.00971976476377579,-0.0287868276818194,0.107590423293689,-0.105029962750986,5.35932108798208,5.36149676253402,5.35217244302571,-0.00932431950830545,0.941627582161818,ENSG00000168404,MLKL,protein_coding,16,-1,74671855,74700960,q23.1,mixed lineage kinase domain like pseudokinase [Source:HGNC Symbol;Acc:HGNC:26617],NA,MLKL,197259,NM_001142497;NM_152649
CASP4_SIG,CASP4,CASP4_SIG,CASP4,SIG,47,1.77610306616631,0.088397057921549,0.0860435442135955,0.0961300315333964,0.010086487319801,0.107747593270393,-0.516042130903551,6.69866883768391,6.70629044467317,6.67362641471921,-0.0326640299539659,0.700269532830984,ENSG00000196954,CASP4,protein_coding,11,-1,104942866,104969366,q22.3,caspase 4 [Source:HGNC Symbol;Acc:HGNC:1505],NA,CASP4,837,NM_001225;NM_033306
HIST1H4I_SIG,HIST1H4I,HIST1H4I_SIG,HIST1H4I,SIG,32,1.77447073877593,-0.125859479815038,-0.129386980676149,-0.114269119842816,0.0151178608333321,0.10811237502653,-0.208196293000087,0.749433636770217,0.752197135720531,0.740353568790615,-0.0118435669299156,0.882777341686876,ENSG00000276180,HIST1H4I,protein_coding,6,1,27138588,27139881,p22.1,histone cluster 1 H4 family member i [Source:HGNC Symbol;Acc:HGNC:4793],NA,HIST1H4I,8294,NM_003495
EIF2AK1_SIG,EIF2AK1,EIF2AK1_SIG,EIF2AK1,SIG,20,1.77399812486266,0.233442673952663,0.22919273169525,0.247406769941306,0.0182140382460566,0.108204974253896,1.60489020609181,7.46905875524702,7.44908734779537,7.53467909401675,0.0855917462213788,0.189105292984692,ENSG00000086232,EIF2AK1,protein_coding,7,-1,6022247,6059175,p22.1,eukaryotic translation initiation factor 2 alpha kinase 1 [Source:HGNC Symbol;Acc:HGNC:24921],NA,EIF2AK1,27102,NM_001134335;NM_014413
TBL1XR1_SIG,TBL1XR1,TBL1XR1_SIG,TBL1XR1,SIG,21,1.77326745984931,0.382893060317342,0.380654437520003,0.390248535222883,0.00959409770287963,0.108358410389025,-0.884905510343697,6.90417865810369,6.91466513425732,6.86972309359888,-0.04494204065844,0.489708895664693,ENSG00000177565,TBL1XR1,protein_coding,3,-1,177019340,177228000,q26.32,transducin beta like 1 X-linked receptor 1 [Source:HGNC Symbol;Acc:HGNC:29529],ACUTE PROMYELOCYTIC LEUKEMIA;Intellectual disability with autism spectrum disorder;MENTAL RETARDATION AUTOSOMAL DOMINANT 41;PIERPONT SYNDROME,TBL1XR1,79718,NM_001321193;NM_001321194;NM_001321195;NM_024665
PPP1CA_SIG,PPP1CA,PPP1CA_SIG,PPP1CA,SIG,38,-1.77147690379825,0.50081445971277,0.503976076521383,0.490426290198757,-0.0135497863226256,0.108762212171712,-0.248099871012313,7.46141035257233,7.46431484512602,7.45186701989592,-0.0124478252301038,0.859133149369342,ENSG00000172531,PPP1CA,protein_coding,11,-1,67398183,67421183,q13.2,protein phosphatase 1 catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9281],NA,PPP1CA,5499,NM_001008709;NM_002708;NM_206873
TSEN15_SIG,TSEN15,TSEN15_SIG,TSEN15,SIG,10,1.77137940627584,0.430193311838615,0.427336197604152,0.439580972894708,0.0122447752905565,0.108766581640958,1.35111552332113,4.88435314375601,4.86801039112273,4.93805075955106,0.0700403684283338,0.275044215702105,ENSG00000198860,TSEN15,protein_coding,1,1,184051651,184123978,q25.3,tRNA splicing endonuclease subunit 15 [Source:HGNC Symbol;Acc:HGNC:16791],Pontocerebellar Hypoplasia and Progressive Microcephaly;Pontocerebellar hypoplasia type 2;PONTOCEREBELLAR HYPOPLASIA TYPE 2F,TSEN15,116461,NM_001127394;NM_001300764;NM_001300766;NM_001363643;NM_052965
OSTM1_SIG,OSTM1,OSTM1_SIG,OSTM1,SIG,87,-1.77129660185624,0.129857879040551,0.135727535353619,0.110571865440469,-0.0251556699131495,0.108767481949709,-2.74038349714047,4.66690701991633,4.72967698032832,4.46066286427694,-0.269014116051377,0.0203433062911782,ENSG00000081087,OSTM1,protein_coding,6,-1,108041409,108165854,q21,osteoclastogenesis associated transmembrane protein 1 [Source:HGNC Symbol;Acc:HGNC:21652],Infantile osteopetrosis with neuroaxonal dysplasia;OSTEOPETROSIS AUTOSOMAL RECESSIVE 5,OSTM1,28962,NM_014028
ZNF567_TF,ZNF567,ZNF567_TF,ZNF567,TF,37,1.77100873630548,0.22204434278669,0.218990640685679,0.232077935404297,0.0130872947186182,0.108816842962782,1.54417354152043,2.87262133643365,2.84744661298677,2.95533828490198,0.107891671915202,0.207702967096954,ENSG00000189042,ZNF567,protein_coding,19,1,36687612,36727701,q13.12,zinc finger protein 567 [Source:HGNC Symbol;Acc:HGNC:28696],NA,ZNF567,163081,NM_001300979;NM_001322911;NM_001322912;NM_001322913;NM_001322914;NM_001322915;NM_001322916;NM_001322917;NM_001322918;NM_001322919;NM_001322920;NM_001363651;NM_152603
UAP1L1_SIG,UAP1L1,UAP1L1_SIG,UAP1L1,SIG,25,1.77049333644097,0.0932091649473337,0.0905019185169972,0.102104403218439,0.0116024847014422,0.108920029316669,2.29480419590784,4.45507508653419,4.3988509712179,4.63981146543057,0.240960494212676,0.0545387893697941,ENSG00000197355,UAP1L1,protein_coding,9,1,137077517,137084539,q34.3,UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 [Source:HGNC Symbol;Acc:HGNC:28082],NA,UAP1L1,91373,NM_207309
USP37_SIG,USP37,USP37_SIG,USP37,SIG,31,1.76966279900845,0.293308988100641,0.289696051383792,0.305180065884574,0.015484014500782,0.109097906682433,1.34509123008607,4.86203823151343,4.84331624209961,4.92355333958739,0.0802370974877747,0.277115892999379,ENSG00000135913,USP37,protein_coding,2,-1,218450251,218568351,q35,ubiquitin specific peptidase 37 [Source:HGNC Symbol;Acc:HGNC:20063],NA,USP37,57695,NM_020935
BPNT1_SIG,BPNT1,BPNT1_SIG,BPNT1,SIG,57,1.76883757504429,0.326805940620124,0.317902108913057,0.356061387657631,0.0381592787445743,0.109274752053864,0.99919031080602,3.55395692794405,3.5280308052993,3.63914275949108,0.111111954191783,0.430892753905795,ENSG00000162813,BPNT1,protein_coding,1,-1,220057482,220090462,q41,3'(2'), 5'-bisphosphate nucleotidase 1 [Source:HGNC Symbol;Acc:HGNC:1096],NA,BPNT1,10380,NM_001286149;NM_001286150;NM_001286151;NM_006085
PCGF6_TF,PCGF6,PCGF6_TF,PCGF6,TF,258,1.76872001540073,0.297811493073408,0.294676765680473,0.308111311650195,0.0134345459697219,0.109283894568587,2.03817264808159,2.82782668656251,2.79816258055643,2.92529446343963,0.127131882883198,0.0905386327744073,ENSG00000156374,PCGF6,protein_coding,10,-1,103302796,103351144,q24.33,polycomb group ring finger 6 [Source:HGNC Symbol;Acc:HGNC:21156],NA,PCGF6,84108,NM_001011663;NM_032154
DEFB1_SIG,DEFB1,DEFB1_SIG,DEFB1,SIG,19,-1.76824758783105,0.067219606054869,0.0729617054948489,0.0483527078949351,-0.0246089975999139,0.109377226246254,-1.00248510722137,1.2238378698719,1.26840027206682,1.0774185483743,-0.190981723692518,0.429241845579659,ENSG00000164825,DEFB1,protein_coding,8,-1,6870592,6877936,p23.1,defensin beta 1 [Source:HGNC Symbol;Acc:HGNC:2766],NA,DEFB1,1672,NM_005218
ZBTB16_TF,ZBTB16,ZBTB16_TF,ZBTB16,TF,110,1.76808737865064,0.0186047571967119,0.0157452897747851,0.0280001501544715,0.0122548603796863,0.109396498973885,-0.425141566886636,4.07086943214206,4.0868308216404,4.01842486664754,-0.068405954992863,0.753597228594973,ENSG00000109906,ZBTB16,protein_coding,11,1,114059593,114250676,q23.2,zinc finger and BTB domain containing 16 [Source:HGNC Symbol;Acc:HGNC:12930],ACUTE PROMYELOCYTIC LEUKEMIA;Precursor T-cell acute lymphoblastic leukemia;SKELETAL DEFECTS GENITAL HYPOPLASIA AND MENTAL RETARDATION,ZBTB16,7704,NM_001018011;NM_001354750;NM_001354751;NM_001354752;NM_006006
REL_SIG,REL,REL_SIG,REL,SIG,48,-1.76779990519898,0.425614045423179,0.429846097972763,0.411708729903115,-0.0181373680696485,0.109445986824076,-1.33160064538592,6.3306404360617,6.35701017531897,6.24399700707351,-0.113013168245462,0.28242047756756,ENSG00000162924,REL,protein_coding,2,1,60881521,60931610,p16.1,REL proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9954],NA,REL,5966,NM_001291746;NM_002908
PPIB_SIG,PPIB,PPIB_SIG,PPIB,SIG,31,-1.76746799197647,0.268269618625303,0.271053133013155,0.259123785636647,-0.0119293473765079,0.109506047001836,0.0589864570897219,7.79792053978779,7.79714412130823,7.80047162907778,0.00332750776954605,0.967408145147912,ENSG00000166794,PPIB,protein_coding,15,-1,64155812,64163205,q22.31,peptidylprolyl isomerase B [Source:HGNC Symbol;Acc:HGNC:9255],Osteogenesis imperfecta type 2;Osteogenesis imperfecta type 3;Osteogenesis imperfecta type 4;OSTEOGENESIS IMPERFECTA TYPE IX,PPIB,5479,NM_000942
EXO1_SIG,EXO1,EXO1_SIG,EXO1,SIG,48,-1.76617156962099,0.248805859957447,0.268212243563679,0.1850420281084,-0.0831702154552784,0.109795506770843,-0.781768130212343,3.28769136568658,3.3131142488142,3.2041590354101,-0.108955213404105,0.545044807331249,ENSG00000174371,EXO1,protein_coding,1,1,241847967,241895148,q43,exonuclease 1 [Source:HGNC Symbol;Acc:HGNC:3511],NA,EXO1,9156,NM_001319224;NM_003686;NM_006027;NM_130398
RPS3_SIG,RPS3,RPS3_SIG,RPS3,SIG,39,1.76547987166826,1.400228171543,1.39247580890439,1.4257002202127,0.0332244113083164,0.109941411069123,2.15828209939168,10.6125787024733,10.5763295801746,10.7316829614546,0.155353381280007,0.0720058426818393,ENSG00000149273,RPS3,protein_coding,11,1,75399515,75422280,q13.4,ribosomal protein S3 [Source:HGNC Symbol;Acc:HGNC:10420],NA,RPS3,6188,NM_001005;NM_001256802;NM_001260506;NM_001260507
RGL2_SIG,RGL2,RGL2_SIG,RGL2,SIG,43,1.7634852264743,0.299302312470956,0.295909453694084,0.310450277023536,0.0145408233294521,0.110398599351303,1.23395862524527,6.54510458557184,6.52386621970849,6.6148877876943,0.0910215679858181,0.322159684507374,ENSG00000237441,RGL2,protein_coding,6,-1,33291654,33298942,p21.32,ral guanine nucleotide dissociation stimulator like 2 [Source:HGNC Symbol;Acc:HGNC:9769],NA,RGL2,5863,NM_001243738;NM_004761
ARSB_SIG,ARSB,ARSB_SIG,ARSB,SIG,33,-1.76304927203524,0.323804487951836,0.328388591037082,0.308742434957454,-0.0196461560796284,0.11048394282627,-0.392719793112757,5.14285490016287,5.15089555450673,5.11643560731877,-0.034459947187961,0.772835381758851,ENSG00000113273,ARSB,protein_coding,5,-1,78777209,78986087,q14.1,arylsulfatase B [Source:HGNC Symbol;Acc:HGNC:714],MUCOPOLYSACCHARIDOSIS TYPE 6;Mucopolysaccharidosis type 6 rapidly progressing;Mucopolysaccharidosis type 6 slowly progressing;MUCOPOLYSACCHARIDOSIS TYPE VI,ARSB,411,NM_000046;NM_198709
RPUSD3_SIG,RPUSD3,RPUSD3_SIG,RPUSD3,SIG,33,1.76270698828552,0.250741956733771,0.245413555826601,0.268249559714472,0.0228360038878712,0.110529520847825,1.52996136524971,4.23765761065856,4.20223627720834,4.35404199199497,0.151805714786624,0.212230841180191,ENSG00000156990,RPUSD3,protein_coding,3,-1,9837849,9844602,p25.3,RNA pseudouridine synthase D3 [Source:HGNC Symbol;Acc:HGNC:28437],NA,RPUSD3,285367,NM_001142547;NM_001351736;NM_001351737;NM_001351738;NM_173659
PPIH_SIG,PPIH,PPIH_SIG,PPIH,SIG,23,1.76270062913552,0.411773393362849,0.407434996145712,0.426028127076297,0.0185931309305848,0.110529520847825,2.28622410640833,4.37087625779262,4.344844394151,4.45640952404364,0.11156512989264,0.0555408605212143,ENSG00000171960,PPIH,protein_coding,1,1,42658423,42676758,p34.2,peptidylprolyl isomerase H [Source:HGNC Symbol;Acc:HGNC:14651],NA,PPIH,10465,NM_001330510;NM_006347
TRIM62_SIG,TRIM62,TRIM62_SIG,TRIM62,SIG,59,-1.76181786411542,0.0855343454474335,0.0885868986141532,0.0755045278996401,-0.0130823707145132,0.110721958480076,0.114456889577826,3.39525330660199,3.39344483669917,3.401195421997,0.00775058529783157,0.936769080130415,ENSG00000116525,TRIM62,protein_coding,1,-1,33145399,33182059,p35.1,tripartite motif containing 62 [Source:HGNC Symbol;Acc:HGNC:25574],NA,TRIM62,55223,NM_001330483;NM_018207
MAP3K6_SIG,MAP3K6,MAP3K6_SIG,MAP3K6,SIG,33,1.76082767509454,0.211730212711563,0.207172990217053,0.226703943764953,0.0195309535479002,0.110940436639,2.49848856251469,3.70979809111669,3.6375825229854,3.94707781497667,0.309495291991278,0.035422532114765,ENSG00000142733,MAP3K6,protein_coding,1,-1,27355184,27366961,p36.11,mitogen-activated protein kinase kinase kinase 6 [Source:HGNC Symbol;Acc:HGNC:6858],Hereditary diffuse gastric cancer,MAP3K6,9064,NM_001297609;NM_004672
PHIP_SIG,PHIP,PHIP_SIG,PHIP,SIG,42,1.76061868556998,0.449653980545503,0.44558246009145,0.463031833465963,0.0174493733745126,0.11097161400925,1.25059150297076,7.52871531044325,7.51304078695536,7.58021731618918,0.0671765292338168,0.315251787510603,ENSG00000146247,PHIP,protein_coding,6,-1,78934419,79078254,q14.1,pleckstrin homology domain interacting protein [Source:HGNC Symbol;Acc:HGNC:15673],Developmental delay ID obesity and dysmorphic features;DEVELOPMENTAL DELAY INTELLECTUAL DISABILITY OBESITY AND DYSMORPHIC FEATURES,PHIP,55023,NM_017934
ENTPD8_SIG,ENTPD8,ENTPD8_SIG,ENTPD8,SIG,45,1.75991673513121,-0.0569821680772192,-0.0610901404475111,-0.0434845445748318,0.0176055958726791,0.11112119922947,0.630398434268521,0.220336194173698,0.214273934543364,0.240255047244797,0.0259811127014327,0.632221593307223,ENSG00000188833,ENTPD8,protein_coding,9,-1,137434364,137441816,q34.3,ectonucleoside triphosphate diphosphohydrolase 8 [Source:HGNC Symbol;Acc:HGNC:24860],NA,ENTPD8,377841,NM_001033113;NM_198585
NDUFAF1_SIG,NDUFAF1,NDUFAF1_SIG,NDUFAF1,SIG,55,1.75798152966282,0.226215443461818,0.216818193928823,0.2570921204988,0.0402739265699769,0.111567912564827,1.64023146385377,3.04580195270003,3.00835495917765,3.16884207427358,0.160487115095928,0.179309079324312,ENSG00000137806,NDUFAF1,protein_coding,15,-1,41387353,41402519,q15.1,NADH:ubiquinone oxidoreductase complex assembly factor 1 [Source:HGNC Symbol;Acc:HGNC:18828],Fatal infantile hypertrophic cardiomyopathy due to mitochondrial complex I deficiency;Isolated complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 11,NDUFAF1,51103,NM_016013
GGT7_SIG,GGT7,GGT7_SIG,GGT7,SIG,107,1.75701529022343,-0.0267495706868736,-0.0287206182447766,-0.0202732715680492,0.00844734667672756,0.111781921192372,1.1052178725454,3.28555725731311,3.25765978783166,3.37722037132358,0.119560583491927,0.379932099353717,ENSG00000131067,GGT7,protein_coding,20,-1,34844720,34872856,q11.22,gamma-glutamyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:4259],NA,GGT7,2686,NM_001351702;NM_178026
CEBPZ_SIG,CEBPZ,CEBPZ_SIG,CEBPZ,SIG,28,1.75488736149684,0.439625797947095,0.437101717074786,0.447919206527539,0.0108174894527531,0.112277436821968,1.75861582189317,5.89292502291954,5.87242366102883,5.96028664056046,0.0878629795316287,0.148035381880117,ENSG00000115816,CEBPZ,protein_coding,2,-1,37201612,37231596,p22.2,CCAAT enhancer binding protein zeta [Source:HGNC Symbol;Acc:HGNC:24218],NA,CEBPZ,10153,NM_005760
RNF185_SIG,RNF185,RNF185_SIG,RNF185,SIG,52,-1.75042446744836,0.306229706888656,0.310517702818375,0.292140577405295,-0.0183771254130797,0.113343638603927,-1.08974479740352,4.6070031181029,4.62272406874947,4.55534856597845,-0.0673755027710197,0.387179832698988,ENSG00000138942,RNF185,protein_coding,22,1,31160182,31207019,q12.2,ring finger protein 185 [Source:HGNC Symbol;Acc:HGNC:26783],NA,RNF185,91445,NM_001135825;NM_152267
TRAF7_SIG,TRAF7,TRAF7_SIG,TRAF7,SIG,14,1.74948197650183,0.307622695082933,0.304606480087199,0.317533115783202,0.0129266356960032,0.113554535070951,1.60320173229829,6.64750995556966,6.63123033772671,6.7010001284822,0.0697697907554949,0.189623588734392,ENSG00000131653,TRAF7,protein_coding,16,1,2155698,2178129,p13.3,TNF receptor associated factor 7 [Source:HGNC Symbol;Acc:HGNC:20456],CARDIAC FACIAL AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY;Developmental Delay Congenital Anomalies and Dysmorphic Features;Developmental delay congenital malformations and dysmorphism,TRAF7,84231,NM_032271
BAX_SIG,BAX,BAX_SIG,BAX,SIG,19,1.74925118496383,0.237401464731015,0.234645225327282,0.246457679914709,0.0118124545874275,0.113591568117937,1.69505778529989,5.76721781103487,5.746263945508,5.83606622633744,0.0898022808294377,0.164465221374758,ENSG00000087088,BAX,protein_coding,19,1,48954815,48961798,q13.33,BCL2 associated X, apoptosis regulator [Source:HGNC Symbol;Acc:HGNC:959],NA,BAX,581,NM_001291428;NM_001291429;NM_001291430;NM_001291431;NM_004324;NM_138761;NM_138763;NM_138764
FPGT_SIG,FPGT,FPGT_SIG,FPGT,SIG,19,1.74852542163966,0.227351838348661,0.220481702907755,0.249925140511637,0.0294434376038813,0.113749748952732,2.20860488799065,2.94789430978634,2.90473875157133,3.08969114392135,0.184952392350019,0.0652742627526987,ENSG00000254685,FPGT,protein_coding,1,1,74198212,74234086,p31.1,fucose-1-phosphate guanylyltransferase [Source:HGNC Symbol;Acc:HGNC:3825],NA,FPGT,8790,NM_001199328;NM_001199329;NM_003838
GLYR1_TF,GLYR1,GLYR1_TF,GLYR1,TF,156,1.74810742640175,0.375576742573894,0.371789552346022,0.388020367608327,0.0162308152623048,0.113832684041265,1.86545745937695,6.19624214435343,6.17471546319252,6.26697266816782,0.092257204975299,0.123549587670236,ENSG00000140632,GLYR1,protein_coding,16,-1,4803203,4847288,p13.3,glyoxylate reductase 1 homolog [Source:HGNC Symbol;Acc:HGNC:24434],NA,GLYR1,84656,NM_001308096;NM_001324096;NM_001324097;NM_001324098;NM_032569
ZDHHC6_SIG,ZDHHC6,ZDHHC6_SIG,ZDHHC6,SIG,18,1.74582111237385,0.42767937861757,0.421708204071862,0.447298952124895,0.0255907480530334,0.114374370061548,1.30021281938666,5.25997216450908,5.24310320068589,5.31539875992814,0.0722955592422485,0.294974291335979,ENSG00000023041,ZDHHC6,protein_coding,10,-1,112424428,112446917,q25.2,zinc finger DHHC-type containing 6 [Source:HGNC Symbol;Acc:HGNC:19160],NA,ZDHHC6,64429,NM_001303134;NM_001351082;NM_001351083;NM_001351084;NM_001351085;NM_001351086;NM_022494
ACSBG1_SIG,ACSBG1,ACSBG1_SIG,ACSBG1,SIG,14,-1.74558266717538,-0.0969812775947779,-0.0907467913374304,-0.117466018154634,-0.0267192268172033,0.114413482411089,-0.283759263904568,0.935642044343695,0.942810044580166,0.912090043566721,-0.0307200010134445,0.837483130686509,ENSG00000103740,ACSBG1,protein_coding,15,-1,78167468,78245688,q25.1,acyl-CoA synthetase bubblegum family member 1 [Source:HGNC Symbol;Acc:HGNC:29567],NA,ACSBG1,23205,NM_001199377;NM_015162
ELK3_TF,ELK3,ELK3_TF,ELK3,TF,217,1.74357373889478,0.144475807516572,0.14233152137275,0.15152131913199,0.00918979775924034,0.114888886786985,0.622870470679157,5.97030654381802,5.95696488613065,6.01414341907651,0.0571785329458577,0.63687970406827,ENSG00000111145,ELK3,protein_coding,12,1,96194375,96269824,q23.1,ELK3, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3325],NA,ELK3,2004,NM_001303511;NM_005230
MAP3K14_SIG,MAP3K14,MAP3K14_SIG,MAP3K14,SIG,98,-1.74238652011323,0.164359264806638,0.167487284154236,0.154081486950243,-0.0134057972039935,0.115162536572407,0.492799118099912,4.68476589969908,4.67445275813986,4.7186519362508,0.0441991781109365,0.713761835189817,ENSG00000006062,MAP3K14,protein_coding,17,-1,45263119,45317145,q21.31,mitogen-activated protein kinase kinase kinase 14 [Source:HGNC Symbol;Acc:HGNC:6853],NIK deficiency,MAP3K14,9020,NM_003954
ZNF516_TF,ZNF516,ZNF516_TF,ZNF516,TF,160,-1.74203756214831,0.0886586274241214,0.0903790954071612,0.0830056611941333,-0.00737343421302787,0.115229182206712,0.891091124470165,6.39234831269384,6.37197039542007,6.45930432659338,0.0873339311733118,0.486514717049004,ENSG00000101493,ZNF516,protein_coding,18,-1,76357682,76495242,q23,zinc finger protein 516 [Source:HGNC Symbol;Acc:HGNC:28990],NA,ZNF516,9658,NM_014643
COPS5_SIG,COPS5,COPS5_SIG,COPS5,SIG,16,1.74082151334392,0.392275473115251,0.388310141392234,0.405304420205163,0.0169942788129288,0.115510611801077,2.0815850095388,5.25714509244647,5.23712826126904,5.32291468060089,0.0857864193318526,0.0832104501571507,ENSG00000121022,COPS5,protein_coding,8,-1,67043079,67083783,q13.1,COP9 signalosome subunit 5 [Source:HGNC Symbol;Acc:HGNC:2240],NA,COPS5,10987,NM_006837
RPE_SIG,RPE,RPE_SIG,RPE,SIG,52,1.74069535076151,0.334186238830201,0.326582645691035,0.359169473430317,0.0325868277392815,0.115522175465064,1.45829667806321,4.62100630772393,4.58460850097092,4.74059910134097,0.155990600370051,0.235812567520988,ENSG00000197713,RPE,protein_coding,2,1,210002565,210022260,q34,ribulose-5-phosphate-3-epimerase [Source:HGNC Symbol;Acc:HGNC:10293],NA,RPE,6120,NM_001278282;NM_001278283;NM_001278285;NM_001278286;NM_001278288;NM_001278289;NM_001318926;NM_001318927;NM_001318928;NM_001318929;NM_001318930;NM_001318931;NM_006916;NM_199229
PPM1A_SIG,PPM1A,PPM1A_SIG,PPM1A,SIG,32,-1.74051734411313,0.487030733439612,0.492631837729743,0.468627105057751,-0.0240047326719928,0.115546593915868,-2.68046930529796,6.66442323905173,6.70251664079498,6.53925920475249,-0.163257436042485,0.0234623427725149,ENSG00000100614,PPM1A,protein_coding,14,1,60245752,60299087,q23.1,protein phosphatase, Mg2+/Mn2+ dependent 1A [Source:HGNC Symbol;Acc:HGNC:9275],NA,PPM1A,5494,NM_021003;NM_177951;NM_177952
HSD17B3_SIG,HSD17B3,HSD17B3_SIG,HSD17B3,SIG,40,-1.7401768119063,-0.0648618914516109,-0.0629979000357755,-0.0709864346750698,-0.00798853463929443,0.115611320047975,-1.93263688757148,0.313808343059094,0.334359993690168,0.246281490985565,-0.0880785027046037,0.109718389512426,ENSG00000130948,HSD17B3,protein_coding,9,-1,96235306,96302176,q22.32,hydroxysteroid 17-beta dehydrogenase 3 [Source:HGNC Symbol;Acc:HGNC:5212],17-Beta-Hydroxysteroid Dehydrogenase III Deficiency;46XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency,HSD17B3,3293,NM_000197
NFX1_TF,NFX1,NFX1_TF,NFX1,TF,78,1.73952645357085,0.487177940146078,0.485042586796745,0.494194101151028,0.00915151435428314,0.11575296742473,0.645445219099995,6.10498154918825,6.09734264300647,6.13008081235696,0.0327381693504841,0.623671853323008,ENSG00000086102,NFX1,protein_coding,9,1,33290512,33371157,p13.3,nuclear transcription factor, X-box binding 1 [Source:HGNC Symbol;Acc:HGNC:7803],NA,NFX1,4799,NM_001318758;NM_002504;NM_147134
PIM3_SIG,PIM3,PIM3_SIG,PIM3,SIG,23,-1.73708877763568,0.433008464506194,0.44321688103078,0.39946652449684,-0.0437503565339396,0.116339565855307,-1.82519563060298,6.78185249915422,6.84161329604524,6.58549559508373,-0.25611770096151,0.132411962905494,ENSG00000198355,PIM3,protein_coding,22,1,49960768,49964072,q13.33,Pim-3 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:19310],NA,PIM3,415116,NM_001001852
PSMA7_SIG,PSMA7,PSMA7_SIG,PSMA7,SIG,20,-1.7369010065107,0.209797617444961,0.212457967420694,0.201056467524694,-0.0114014998960008,0.116366539970492,0.410799673815188,6.42702430788965,6.42337835938934,6.43900385296209,0.0156254935727497,0.762299499080713,ENSG00000101182,PSMA7,protein_coding,20,-1,62136733,62143440,q13.33,proteasome subunit alpha 7 [Source:HGNC Symbol;Acc:HGNC:9536],NA,PSMA7,5688,NM_002792
PARP15_SIG,PARP15,PARP15_SIG,PARP15,SIG,54,1.7349995506439,0.114171992517811,0.111551175305312,0.122783249073165,0.0112320737678527,0.116821443521827,0.808137178681528,4.75441202432874,4.73378284290363,4.82219362043984,0.088410777536211,0.530665943832084,ENSG00000173200,PARP15,protein_coding,3,1,122577628,122639047,q21.1,poly(ADP-ribose) polymerase family member 15 [Source:HGNC Symbol;Acc:HGNC:26876],NA,PARP15,165631,NM_001113523;NM_001308320;NM_001308321;NM_152615
CCDC9_SIG,CCDC9,CCDC9_SIG,CCDC9,SIG,21,-1.73488454194832,0.287881734406377,0.293257056156571,0.270219962941453,-0.0230370932151183,0.116830298154433,-1.63531946520519,4.68701678354854,4.71026658380732,4.61062458269825,-0.0996420011090722,0.180639455615923,ENSG00000105321,CCDC9,protein_coding,19,1,47255980,47273701,q13.32,coiled-coil domain containing 9 [Source:HGNC Symbol;Acc:HGNC:24560],NA,CCDC9,26093,NM_015603
PUF60_SIG,PUF60,PUF60_SIG,PUF60,SIG,21,1.73422994464511,0.468567114447346,0.465693987354363,0.478007389181434,0.0123134018270705,0.11697416742223,0.680463708842239,6.47102726515101,6.4636255870262,6.49534706470394,0.0317214776777447,0.603213465946498,ENSG00000179950,PUF60,protein_coding,8,-1,143816344,143829859,q24.3,poly(U) binding splicing factor 60 [Source:HGNC Symbol;Acc:HGNC:17042],8Q24.3 DELETION-LIKE;8q24.3 deletion syndrome;Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome;PUF60 syndrome;Verheij syndrome,PUF60,22827,NM_001136033;NM_001271096;NM_001271097;NM_001271098;NM_001271099;NM_001271100;NM_014281;NM_078480
STK17B_SIG,STK17B,STK17B_SIG,STK17B,SIG,16,-1.73386890622502,0.55229194932821,0.559348528966777,0.52910604480149,-0.0302424841652869,0.117041558374442,-0.957868193906338,8.23494566520363,8.26039368487574,8.15133074342387,-0.109062941451866,0.451834824368466,ENSG00000081320,STK17B,protein_coding,2,-1,196133583,196176503,q32.3,serine/threonine kinase 17b [Source:HGNC Symbol;Acc:HGNC:11396],NA,STK17B,9262,NM_004226
IFNAR1_SIG,IFNAR1,IFNAR1_SIG,IFNAR1,SIG,49,-1.73380159373779,0.4905743897866,0.495640038775812,0.473930114536329,-0.021709924239483,0.117041558374442,-2.01145345778768,5.85237704877602,5.89193083815565,5.72241459795724,-0.169516240198411,0.0950523719366439,ENSG00000142166,IFNAR1,protein_coding,21,1,33324429,33359864,q22.11,interferon alpha and beta receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:5432],NA,IFNAR1,3454,NM_000629
NDUFA3_SIG,NDUFA3,NDUFA3_SIG,NDUFA3,SIG,18,1.73306994415796,0.288259080532173,0.285114485244294,0.298591322192346,0.0134768369480515,0.117196902537536,1.43834800229931,4.42153185688059,4.40551292530167,4.47416548921131,0.0686525639096408,0.242612403408674,ENSG00000170906,NDUFA3,protein_coding,19,1,54102728,54109257,q13.42,NADH:ubiquinone oxidoreductase subunit A3 [Source:HGNC Symbol;Acc:HGNC:7686],NA,NDUFA3,4696,NM_004542
FCF1_SIG,FCF1,FCF1_SIG,FCF1,SIG,32,1.73302241729188,0.561663084584216,0.553583029343949,0.588211837516523,0.0346288081725735,0.117196902537536,0.703578120547392,5.10068987462472,5.09111273805443,5.13215760906997,0.0410448710155417,0.589933022313037,ENSG00000119616,FCF1,protein_coding,14,1,74713144,74738620,q24.3,FCF1, rRNA-processing protein [Source:HGNC Symbol;Acc:HGNC:20220],NA,FCF1,51077,NM_001318508;NM_015962
STAM_SIG,STAM,STAM_SIG,STAM,SIG,56,1.7328974153873,0.178953576171427,0.174606782701352,0.193235897573103,0.0186291148717505,0.11720828811003,0.137743470025045,5.70483008972755,5.70208236730259,5.71385832055243,0.0117759532498383,0.922555483013741,ENSG00000136738,STAM,protein_coding,10,1,17644151,17716824,p12.33,signal transducing adaptor molecule [Source:HGNC Symbol;Acc:HGNC:11357],NA,STAM,8027,NM_001324282;NM_001324283;NM_001324284;NM_001324285;NM_001324286;NM_001324287;NM_001324288;NM_001324289;NM_003473
SKP1_SIG,SKP1,SKP1_SIG,SKP1,SIG,31,1.7309955673957,0.278432200663604,0.273917519382914,0.293266153443015,0.0193486340601017,0.117665830260228,2.42737815971125,6.33226035736838,6.30278468920056,6.42910898134838,0.12632429214782,0.0413045616365459,ENSG00000113558,SKP1,protein_coding,5,-1,134148935,134177038,q31.1,S-phase kinase associated protein 1 [Source:HGNC Symbol;Acc:HGNC:10899],NA,SKP1,6500,NM_006930;NM_170679
AADAT_SIG,AADAT,AADAT_SIG,AADAT,SIG,52,-1.73091561114223,-0.0556595380675289,-0.0519943667930797,-0.0677022436835765,-0.0157078768904968,0.117665914178485,-3.6212654959029,1.07313642050425,1.18417245372831,0.708303739910902,-0.475868713817406,0.00187183678361424,ENSG00000109576,AADAT,protein_coding,4,-1,170060222,170091699,q33,aminoadipate aminotransferase [Source:HGNC Symbol;Acc:HGNC:17929],NA,AADAT,51166,NM_001286682;NM_001286683;NM_016228;NM_182662
SLC25A11_SIG,SLC25A11,SLC25A11_SIG,SLC25A11,SIG,36,1.72935572305128,0.233352174231801,0.227866235507612,0.251377401468422,0.0235111659608102,0.118038626641739,1.91638753303297,5.33427643717194,5.3019331626456,5.4405471963299,0.1386140336843,0.112981541569857,ENSG00000108528,SLC25A11,protein_coding,17,-1,4937130,4940053,p13.2,solute carrier family 25 member 11 [Source:HGNC Symbol;Acc:HGNC:10981],NA,SLC25A11,8402,NM_001165417;NM_001165418;NM_003562
GFOD2_SIG,GFOD2,GFOD2_SIG,GFOD2,SIG,60,-1.72845970455603,0.11644823183685,0.1195523825797,0.106248879396058,-0.0133035031836424,0.118239769299095,1.01996855570332,4.25587127462703,4.23857358520156,4.31270653988216,0.0741329546805983,0.420639677716523,ENSG00000141098,GFOD2,protein_coding,16,-1,67674531,67719339,q22.1,glucose-fructose oxidoreductase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28159],NA,GFOD2,81577,NM_001243650;NM_030819
ALYREF_SIG,ALYREF,ALYREF_SIG,ALYREF,SIG,53,-1.72839909263156,0.21933807637491,0.222073685930947,0.210349644976502,-0.0117240409544453,0.118239769299095,-1.87116876137708,6.06308237652778,6.0859320712295,5.98800480822216,-0.0979272630073406,0.122295302351499,ENSG00000183684,ALYREF,protein_coding,17,-1,81887844,81891586,q25.3,Aly/REF export factor [Source:HGNC Symbol;Acc:HGNC:19071],NA,ALYREF,10189,NM_005782
RPUSD1_SIG,RPUSD1,RPUSD1_SIG,RPUSD1,SIG,10,1.7278983273721,0.292147303554094,0.288518259805015,0.304071304443925,0.0155530446389105,0.118343602831642,1.48376657359897,4.75637235384646,4.73868098366484,4.81450114158606,0.0758201579212124,0.227359136600644,ENSG00000007376,RPUSD1,protein_coding,16,-1,784974,788397,p13.3,RNA pseudouridine synthase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:14173],NA,RPUSD1,113000,NM_001324086;NM_001324410;NM_001324411;NM_001324412;NM_001324413;NM_001324414;NM_001324415;NM_058192
PSMB2_SIG,PSMB2,PSMB2_SIG,PSMB2,SIG,37,1.7277957700445,0.238715462418828,0.236413262584209,0.246279833304006,0.00986657071979777,0.118343602831642,0.846240643784522,6.62892412337217,6.6209916255262,6.65498804486607,0.0339964193398775,0.510452563219489,ENSG00000126067,PSMB2,protein_coding,1,-1,35599541,35641526,p34.3,proteasome subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:9539],NA,PSMB2,5690,NM_001199779;NM_001199780;NM_002794
DERA_SIG,DERA,DERA_SIG,DERA,SIG,17,1.72774895425124,0.246768863064235,0.242987277153819,0.259194073912743,0.0162067967589237,0.118343602831642,0.0527452925511175,4.63361844372383,4.63275764080229,4.63644679618032,0.00368915537803811,0.970815576111343,ENSG00000023697,DERA,protein_coding,12,1,15911302,16037381,p12.3,deoxyribose-phosphate aldolase [Source:HGNC Symbol;Acc:HGNC:24269],NA,DERA,51071,NM_001300779;NM_015954
NANOS1_SIG,NANOS1,NANOS1_SIG,NANOS1,SIG,24,1.72760817913191,0.0662241611768537,0.0631751054450827,0.0762424871526728,0.0130673817075901,0.118359047355053,2.92246678959349,0.467026107653488,0.428821856108394,0.592554362730225,0.163732506621831,0.0131149659495135,ENSG00000188613,NANOS1,protein_coding,10,1,119029714,119033730,q26.11,nanos C2HC-type zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:23044],Male infertility with azoospermia or oligozoospermia due to single gene mutation;Male infertility with teratozoospermia due to single gene mutation;SPERMATOGENIC FAILURE 12,NANOS1,340719,NM_199461
ZNF430_TF,ZNF430,ZNF430_TF,ZNF430,TF,81,1.72698180011007,0.427800875174477,0.425045452051042,0.436854408294335,0.0118089562432935,0.118497225598459,2.30074201372774,4.54602938774357,4.51171198759419,4.65878655966297,0.14707457206878,0.0538563177070028,ENSG00000118620,ZNF430,protein_coding,19,1,21020634,21060050,p12,zinc finger protein 430 [Source:HGNC Symbol;Acc:HGNC:20808],NA,ZNF430,80264,NM_001172671;NM_025189
SLC19A1_SIG,SLC19A1,SLC19A1_SIG,SLC19A1,SIG,19,-1.72634412003824,0.235636635097116,0.239502747997143,0.222933692711315,-0.0165690552858272,0.118638388214774,0.396118817969395,4.87662359375976,4.86874203591627,4.90252014095978,0.0337781050435098,0.770681792163854,ENSG00000173638,SLC19A1,protein_coding,21,-1,45493572,45573365,q22.3,solute carrier family 19 member 1 [Source:HGNC Symbol;Acc:HGNC:10937],Methotrexate toxicity or dose selection,SLC19A1,6573,NM_001205206;NM_001205207;NM_001352510;NM_001352511;NM_001352512;NM_194255
ZNF845_TF,ZNF845,ZNF845_TF,ZNF845,TF,37,1.72521616999668,0.187315579450502,0.184524299066056,0.196486929285107,0.0119626302190504,0.118903925653159,0.646625544600217,3.61536002477148,3.60398456820683,3.65273652491244,0.0487519567056079,0.622851057332791,ENSG00000213799,ZNF845,protein_coding,19,1,53333746,53356906,q13.42,zinc finger protein 845 [Source:HGNC Symbol;Acc:HGNC:25112],NA,ZNF845,91664,NM_001321522;NM_001321523;NM_001321524;NM_138374
SCNM1_SIG,SCNM1,SCNM1_SIG,SCNM1,SIG,16,-1.72466425267961,0.100119501032256,0.102201404892648,0.093278959776682,-0.00892244511596633,0.119023701331541,-0.82808462183984,5.12156574782668,5.12950857361139,5.09546789167692,-0.0340406819344717,0.520165221956701,ENSG00000163156,SCNM1,protein_coding,1,1,151156664,151170297,q21.3,sodium channel modifier 1 [Source:HGNC Symbol;Acc:HGNC:23136],NA,SCNM1,79005;100534012,NM_001204848;NM_001204856;NM_024041
CNP_SIG,CNP,CNP_SIG,CNP,SIG,9,1.72455317241834,0.683016568775853,0.676631243697144,0.703996922605897,0.0273656789087531,0.119031672169927,-0.442578831058421,5.78184069158686,5.78889002197674,5.75867860602012,-0.0302114159566224,0.743278782758449,ENSG00000173786,CNP,protein_coding,17,1,41966763,41977740,q21.2,2',3'-cyclic nucleotide 3' phosphodiesterase [Source:HGNC Symbol;Acc:HGNC:2158],NA,CNP,1267,NM_001330216;NM_033133
PAPOLG_SIG,PAPOLG,PAPOLG_SIG,PAPOLG,SIG,64,1.72307459345934,0.367295612933218,0.363462807602712,0.379889116162021,0.0164263085593091,0.119387042146176,0.58517944026663,4.73989885185989,4.73045224807261,4.77093769287524,0.0404854448026306,0.6601852743733,ENSG00000115421,PAPOLG,protein_coding,2,1,60756253,60802086,p16.1,poly(A) polymerase gamma [Source:HGNC Symbol;Acc:HGNC:14982],NA,PAPOLG,64895,NM_022894
PSIP1_SIG,PSIP1,PSIP1_SIG,PSIP1,SIG,57,1.72214865372735,0.106344319949474,0.103271096391654,0.116442054496595,0.0131709581049404,0.119602425126281,1.0713990897432,6.60542396737837,6.58805293292949,6.66250022342469,0.0744472904951951,0.396108235004469,ENSG00000164985,PSIP1,protein_coding,9,-1,15464066,15510995,p22.3,PC4 and SFRS1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:9527],NA,PSIP1,11168,NM_001128217;NM_001317898;NM_001317900;NM_021144;NM_033222
RELB_SIG,RELB,RELB_SIG,RELB,SIG,38,-1.7216830075011,0.268039448283964,0.274635577835994,0.246366451184439,-0.0282691266515545,0.119700753575351,-1.34681640739878,4.72571069113357,4.7685043178203,4.58510306059146,-0.183401257228838,0.27651998540979,ENSG00000104856,RELB,protein_coding,19,1,45001449,45038198,q13.32,RELB proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9956],IMMUNODEFICIENCY 53,RELB,5971,NM_006509
EEF2_SIG,EEF2,EEF2_SIG,EEF2,SIG,30,1.72106705391907,1.31364963157654,1.30744727552297,1.33402880146683,0.0265815259438551,0.119837480456022,1.89049741433454,11.8876615635633,11.8584789596785,11.9835472620421,0.125068302363671,0.118195503576384,ENSG00000167658,EEF2,protein_coding,19,-1,3976056,3985463,p13.3,eukaryotic translation elongation factor 2 [Source:HGNC Symbol;Acc:HGNC:3214],SPINOCEREBELLAR ATAXIA 26;Spinocerebellar ataxia type 26,EEF2,1938,NM_001961
STAU2_SIG,STAU2,STAU2_SIG,STAU2,SIG,14,1.7207123307451,0.179612076714453,0.174027327380246,0.197961967383988,0.0239346400037414,0.119907646314802,1.39530343514834,4.94715550986143,4.92124626154279,5.0322858971941,0.111039635651309,0.258364247789495,ENSG00000040341,STAU2,protein_coding,8,-1,73420369,73747708,q21.11,staufen double-stranded RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:11371],NA,STAU2,27067,NM_001164380;NM_001164381;NM_001164382;NM_001164383;NM_001164384;NM_001164385;NM_014393
CIR1_SIG,CIR1,CIR1_SIG,CIR1,SIG,24,-1.71972888613275,0.208476971550735,0.212867202272617,0.194051927750268,-0.0188152745223484,0.120138451307237,-1.63531541183858,5.4298770642273,5.45421392445549,5.34991309490608,-0.104300829549406,0.180639455615923,ENSG00000138433,CIR1,protein_coding,2,-1,174348022,174395712,q31.1,corepressor interacting with RBPJ, 1 [Source:HGNC Symbol;Acc:HGNC:24217],NA,CIR1,9541,NM_004882
VRK1_SIG,VRK1,VRK1_SIG,VRK1,SIG,18,-1.7181467195861,0.358760642461682,0.367584438582253,0.329768169494093,-0.0378162690881595,0.120522941866467,-1.31351565616605,4.85164121468446,4.87359533792952,4.77950623830787,-0.0940890996216498,0.289574950753311,ENSG00000100749,VRK1,protein_coding,14,1,96797382,96931722,q32.2,VRK serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:12718],Microcephaly-complex motor and sensory axonal neuropathy syndrome;Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1A,VRK1,7443,NM_003384
OTUB2_SIG,OTUB2,OTUB2_SIG,OTUB2,SIG,12,1.7170875803637,0.102723655338201,0.0996986492860048,0.112662960938272,0.0129643116522673,0.120774100791355,-0.391506319584807,0.864989052864465,0.870889682557763,0.845601269586485,-0.025288412971278,0.773531511871112,ENSG00000089723,OTUB2,protein_coding,14,1,94026340,94048930,q32.12,OTU deubiquitinase, ubiquitin aldehyde binding 2 [Source:HGNC Symbol;Acc:HGNC:20351],NA,OTUB2,78990,NM_023112
ZNF776_TF,ZNF776,ZNF776_TF,ZNF776,TF,73,1.71599906036073,0.128144780442055,0.123620115980677,0.14301153510087,0.0193914191201934,0.121033222501752,2.08620235314726,5.07510949034284,5.03625488974343,5.20277460659806,0.166519716854628,0.0824899322736378,ENSG00000152443,ZNF776,protein_coding,19,1,57746815,57758148,q13.43,zinc finger protein 776 [Source:HGNC Symbol;Acc:HGNC:26765],NA,ZNF776,284309,NM_001348007;NM_173632
SRPK3_SIG,SRPK3,SRPK3_SIG,SRPK3,SIG,15,-1.71528718506443,-0.0192274879072202,-0.0170091000083107,-0.0265164767179225,-0.00950737670961165,0.121195809886395,-0.946571530309342,0.586454016285179,0.603682807632188,0.529845130430719,-0.0738376772014692,0.457561233563406,ENSG00000184343,SRPK3,protein_coding,X,1,153776412,153785732,q28,SRSF protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:11402],NA,SRPK3,26576,NM_001170760;NM_001170761;NM_014370
AQR_SIG,AQR,AQR_SIG,AQR,SIG,18,1.71504420208725,0.48755499157076,0.48553807348983,0.494182008122388,0.00864393463255837,0.121237807680231,0.807478556692321,5.88520359167049,5.87720368253613,5.91148900739769,0.0342853248615694,0.530969522351646,ENSG00000021776,AQR,protein_coding,15,-1,34851782,34969742,q14,aquarius intron-binding spliceosomal factor [Source:HGNC Symbol;Acc:HGNC:29513],NA,AQR,9716,NM_014691
HIC2_TF,HIC2,HIC2_TF,HIC2,TF,33,1.71485751501617,0.155383500135954,0.152545435595557,0.164708569340115,0.0121631337445579,0.121251261100745,0.160853925960301,4.44490029877648,4.44229093658633,4.45347391740126,0.0111829808149287,0.909798536054198,ENSG00000169635,HIC2,protein_coding,22,1,21417371,21451463,q11.21,HIC ZBTB transcriptional repressor 2 [Source:HGNC Symbol;Acc:HGNC:18595],NA,HIC2,23119,NM_015094
SLC16A5_SIG,SLC16A5,SLC16A5_SIG,SLC16A5,SIG,35,1.71483232147023,0.193925828542168,0.19093839571448,0.203741679261713,0.0128032835472332,0.121251261100745,0.680188823115773,4.93072890034871,4.91900722916222,4.9692429628186,0.0502357336563753,0.603392886283554,ENSG00000170190,SLC16A5,protein_coding,17,1,75087727,75106162,q25.1,solute carrier family 16 member 5 [Source:HGNC Symbol;Acc:HGNC:10926],NA,SLC16A5,9121,NM_001271765;NM_004695
MSS51_TF,MSS51,MSS51_TF,MSS51,TF,96,1.71397355524451,0.0527716820241907,0.0501910730000157,0.0612508259607655,0.0110597529607499,0.12145192831727,-0.495153436743927,1.95995886451781,1.96908120609761,1.92998545646989,-0.0390957496277226,0.712358811248174,ENSG00000166343,MSS51,protein_coding,10,-1,73423579,73433561,q22.2,MSS51 mitochondrial translational activator [Source:HGNC Symbol;Acc:HGNC:21000],NA,MSS51,118490,NM_001024593
RAB42_SIG,RAB42,RAB42_SIG,RAB42,SIG,20,-1.71369035467411,0.150429033807873,0.154306906805486,0.137687451101432,-0.0166194557040538,0.121504365306861,-1.12175773953609,0.79430166985509,0.810607712790325,0.74072467163932,-0.0698830411510043,0.372046342722765,ENSG00000188060,RAB42,protein_coding,1,1,28592200,28595443,p35.3,RAB42, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:28702],NA,RAB42,115273,NM_001193532;NM_152304
PRDM8_SIG,PRDM8,PRDM8_SIG,PRDM8,SIG,18,1.71349828566902,0.0824601900514208,0.0794912756285558,0.0922151945836915,0.0127239189551356,0.121533315281083,1.02260814493362,4.83852221838241,4.80631930527493,4.9443317900213,0.138012484746369,0.419426188092586,ENSG00000152784,PRDM8,protein_coding,4,1,80183879,80204329,q21.21,PR/SET domain 8 [Source:HGNC Symbol;Acc:HGNC:13993],Early-onset Lafora body disease;Epilepsy progressive myoclonic 10,PRDM8,56978,NM_001099403;NM_020226
NDUFS1_SIG,NDUFS1,NDUFS1_SIG,NDUFS1,SIG,34,1.7117532793792,0.553906177488644,0.54889311419152,0.570377671179193,0.0214845569876724,0.121963371874223,1.29993854561324,6.23920195715787,6.2220154912506,6.29567177371035,0.0736562824597469,0.295078089128357,ENSG00000023228,NDUFS1,protein_coding,2,-1,206114817,206159509,q33.3,NADH:ubiquinone oxidoreductase core subunit S1 [Source:HGNC Symbol;Acc:HGNC:7707],Isolated complex I deficiency;Leigh syndrome;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 5;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I DEFICIENCY,NDUFS1,4719,NM_001199981;NM_001199982;NM_001199983;NM_001199984;NM_005006
CITED2_TF,CITED2,CITED2_TF,CITED2,TF,222,-1.71119529897574,0.0649316476290935,0.0679146757575325,0.0551302694927938,-0.0127844062647387,0.122087078662115,-2.12456293880574,7.80744019099651,7.86413509029789,7.62115695043485,-0.242978139863031,0.0767466980285736,ENSG00000164442,CITED2,protein_coding,6,-1,139371807,139374648,q24.1,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 [Source:HGNC Symbol;Acc:HGNC:1987],ATRIAL SEPTAL DEFECT 8;Atrial septal defect ostium secundum type;Atrial septal defect sinus venosus type;Situs inversus totalis;Tetralogy of Fallot;VENTRICULAR SEPTAL DEFECT 2,CITED2,10370,NM_001168388;NM_001168389;NM_006079
SRSF1_SIG,SRSF1,SRSF1_SIG,SRSF1,SIG,63,1.71022395527172,0.372149990868979,0.363670370107322,0.400011601942996,0.0363412318356743,0.122317994872486,1.20220661451345,7.10802770366581,7.08428127423079,7.18605168609516,0.101770411864366,0.335908839992348,ENSG00000136450,SRSF1,protein_coding,17,-1,58000919,58007346,q22,serine and arginine rich splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:10780],NA,SRSF1,6426,NM_001078166;NM_006924
ENPP4_SIG,ENPP4,ENPP4_SIG,ENPP4,SIG,33,-1.70993088464944,-0.0644508223219817,-0.0615206698758272,-0.0740784660736321,-0.0125577961978048,0.122373270009178,-0.0732106546544771,4.39571577649768,4.3981854840294,4.38760102317915,-0.0105844608502582,0.960133909829242,ENSG00000001561,ENPP4,protein_coding,6,1,46129989,46146688,p21.1,ectonucleotide pyrophosphatase/phosphodiesterase 4 [Source:HGNC Symbol;Acc:HGNC:3359],NA,ENPP4,22875,NM_014936
NDUFS3_SIG,NDUFS3,NDUFS3_SIG,NDUFS3,SIG,39,1.70939817305862,0.388776543164178,0.38606014094952,0.397701864726628,0.0116417237771087,0.12249073780314,3.47312405350176,5.22095649075382,5.18102348898265,5.35216492514483,0.171141436162182,0.00291229785404111,ENSG00000213619,NDUFS3,protein_coding,11,1,47565336,47584562,p11.2,NADH:ubiquinone oxidoreductase core subunit S3 [Source:HGNC Symbol;Acc:HGNC:7710],Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 8,NDUFS3,4722,NM_004551
ZBTB49_TF,ZBTB49,ZBTB49_TF,ZBTB49,TF,35,-1.70895463714916,0.237379546629307,0.238865970768576,0.232495581600282,-0.00637038916829398,0.122585135527078,-0.367897569103512,3.25848866494482,3.26308515083643,3.24338592558667,-0.0196992252497624,0.787628863357831,ENSG00000168826,ZBTB49,protein_coding,4,1,4290251,4321786,p16.3,zinc finger and BTB domain containing 49 [Source:HGNC Symbol;Acc:HGNC:19883],NA,ZBTB49,166793,NM_001330625;NM_145291
RALB_SIG,RALB,RALB_SIG,RALB,SIG,40,-1.70885100069756,0.366025193287391,0.371289657956435,0.348727666517674,-0.0225619914387606,0.122591307540383,-0.983878885595956,6.53092395388768,6.54886264611461,6.47198253657061,-0.076880109543997,0.438682832729076,ENSG00000144118,RALB,protein_coding,2,1,120240064,120294710,q14.2,RAS like proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:9840],NA,RALB,5899,NM_002881
ZNF449_TF,ZNF449,ZNF449_TF,ZNF449,TF,81,1.70451335404473,0.0395709035829154,0.0381867989353232,0.0441186759964325,0.00593187706110919,0.123700841492843,2.88367393592493,2.80462298638673,2.76773651333819,2.92582139783193,0.158084884493738,0.0144524827722336,ENSG00000173275,ZNF449,protein_coding,X,1,135344796,135363152,q26.3,zinc finger protein 449 [Source:HGNC Symbol;Acc:HGNC:21039],NA,ZNF449,203523,NM_152695
SUPT16H_SIG,SUPT16H,SUPT16H_SIG,SUPT16H,SIG,44,1.70424852098335,0.616065605910671,0.610907962858326,0.633012147368376,0.0221041845100499,0.123749192349433,1.84119118783769,7.24226325851175,7.21273215242966,7.3392940356386,0.126561883208941,0.128657546690054,ENSG00000092201,SUPT16H,protein_coding,14,-1,21351476,21384019,q11.2,SPT16 homolog, facilitates chromatin remodeling subunit [Source:HGNC Symbol;Acc:HGNC:11465],NA,SUPT16H,11198,NM_007192
MRPL12_SIG,MRPL12,MRPL12_SIG,MRPL12,SIG,35,1.70367136887936,0.220451743363425,0.215108287132492,0.238008813836489,0.0229005267039963,0.123879308867526,1.98486577309131,1.7334768185607,1.70347356218476,1.83205894665307,0.128585384468308,0.099886791364727,ENSG00000262814,MRPL12,protein_coding,17,1,81703367,81707517,q25.3,mitochondrial ribosomal protein L12 [Source:HGNC Symbol;Acc:HGNC:10378],NA,MRPL12,6182,NM_002949
LPO_SIG,LPO,LPO_SIG,LPO,SIG,13,-1.70329322469524,0.300363607553358,0.303512785705138,0.290016307911796,-0.0134964777933415,0.123957391389053,0.0235524659439901,0.2814608514417,0.281215537791645,0.282266882006164,0.00105134421451845,0.987039960807303,ENSG00000167419,LPO,protein_coding,17,1,58218548,58268518,q22,lactoperoxidase [Source:HGNC Symbol;Acc:HGNC:6678],NA,LPO,4025,NM_001160102;NM_006151
ZNF75A_TF,ZNF75A,ZNF75A_TF,ZNF75A,TF,17,1.70269226899613,0.105385244118527,0.101386269978895,0.11852473057732,0.0171384605984253,0.124093915153417,1.00655044213072,4.52112852851929,4.50423512883805,4.57663541318623,0.0724002843481806,0.427289194847431,ENSG00000162086,ZNF75A,protein_coding,16,1,3305406,3318852,p13.3,zinc finger protein 75a [Source:HGNC Symbol;Acc:HGNC:13146],NA,ZNF75A,7627,NM_001302109;NM_001324041;NM_001324085;NM_001352495;NM_001352497;NM_001352498;NM_153028
NEK4_SIG,NEK4,NEK4_SIG,NEK4,SIG,25,1.70107842613904,0.297498849101096,0.291272938201096,0.317955413486812,0.0266824752857161,0.124479100686334,2.22398069567521,4.64873367656172,4.60975478965329,4.77680716211798,0.167052372464695,0.0632005167522652,ENSG00000114904,NEK4,protein_coding,3,-1,52708444,52770946,p21.1,NIMA related kinase 4 [Source:HGNC Symbol;Acc:HGNC:11399],NA,NEK4,6787,NM_001193533;NM_001348412;NM_001348413;NM_001348414;NM_003157
BUB1B_SIG,BUB1B,BUB1B_SIG,BUB1B,SIG,31,-1.70106482901227,0.325963870925565,0.343943578662598,0.266887688361031,-0.0770558903015666,0.124479100686334,-0.592625996497135,3.80880024113049,3.82675492856863,3.74980626811944,-0.0769486604491866,0.655875176268578,ENSG00000156970,BUB1B,protein_coding,15,1,40161023,40221136,q15.1,BUB1 mitotic checkpoint serine/threonine kinase B [Source:HGNC Symbol;Acc:HGNC:1149],Colorectal Cancer;Mosaic variegated aneuploidy syndrome;MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1;PREMATURE CHROMATID SEPARATION TRAIT,BUB1B,701,NM_001211
HSF1_TF,HSF1,HSF1_TF,HSF1,TF,198,1.70096640497867,0.170480380824223,0.169074531130196,0.175099601247454,0.00602507011725697,0.124483938451702,1.14503990442627,6.34586358015678,6.33582913146806,6.37883391156258,0.0430047800945256,0.361380626062339,ENSG00000185122,HSF1,protein_coding,8,1,144291591,144314720,q24.3,heat shock transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:5224],NA,HSF1,3297,NM_005526
SLC41A2_SIG,SLC41A2,SLC41A2_SIG,SLC41A2,SIG,31,-1.70073428611372,-0.0694945873895294,-0.0673637552700534,-0.0764958929249507,-0.00913213765489726,0.1245239191742,0.231016657092427,0.960655464970176,0.956039180795141,0.975823255831006,0.0197840750358648,0.869502839889304,ENSG00000136052,SLC41A2,protein_coding,12,-1,104802553,104958744,q23.3,solute carrier family 41 member 2 [Source:HGNC Symbol;Acc:HGNC:31045],NA,SLC41A2,84102,NM_001352169;NM_001352170;NM_001352171;NM_001352172;NM_032148
ASH2L_TF,ASH2L,ASH2L_TF,ASH2L,TF,316,1.69722554612848,0.327163392027876,0.322225567221194,0.343387673535547,0.0211621063143529,0.125427830964167,0.606810488428155,6.02442911462983,6.01418434233347,6.05809050931789,0.0439061669844261,0.646717455153339,ENSG00000129691,ASH2L,protein_coding,8,1,38105242,38144076,p11.23,ASH2 like, histone lysine methyltransferase complex subunit [Source:HGNC Symbol;Acc:HGNC:744],NA,ASH2L,9070,NM_001105214;NM_001261832;NM_001282272;NM_004674
EPHB4_SIG,EPHB4,EPHB4_SIG,EPHB4,SIG,18,1.69649438760945,-0.0703189227378987,-0.0725927770734403,-0.0628476870639762,0.009745090009464,0.125600057481188,1.90865961596603,3.48150458665673,3.4252167813203,3.66645023276214,0.241233451441838,0.11457368675577,ENSG00000196411,EPHB4,protein_coding,7,-1,100802565,100827523,q22.1,EPH receptor B4 [Source:HGNC Symbol;Acc:HGNC:3395],CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2;LYMPHATIC MALFORMATION 7;Vein of Galen aneurysmal malformation,EPHB4,2050,NM_004444
HNRNPM_SIG,HNRNPM,HNRNPM_SIG,HNRNPM,SIG,20,1.69563662233821,0.468097059035534,0.464766656733371,0.479039809456928,0.0142731527235577,0.125806015633386,0.877355119030313,8.20272108567477,8.19461977740374,8.22933966999387,0.034719892590127,0.493957974723249,ENSG00000099783,HNRNPM,protein_coding,19,1,8444767,8489114,p13.2,heterogeneous nuclear ribonucleoprotein M [Source:HGNC Symbol;Acc:HGNC:5046],NA,HNRNPM,4670,NM_001297418;NM_005968;NM_031203
ZMYND8_TF,ZMYND8,ZMYND8_TF,ZMYND8,TF,58,1.69549176530589,0.0442774243262655,0.041613285783324,0.0530310223959305,0.0114177366126066,0.125823170857931,1.07422923136324,5.90145296510598,5.87893053093854,5.97545524879901,0.0965247178604782,0.394722479171578,ENSG00000101040,ZMYND8,protein_coding,20,-1,47209214,47356889,q13.12,zinc finger MYND-type containing 8 [Source:HGNC Symbol;Acc:HGNC:9397],NA,ZMYND8,23613,NM_001281771;NM_001281772;NM_001281773;NM_001281774;NM_001281775;NM_001281776;NM_001281777;NM_001281778;NM_001281779;NM_001281780;NM_001281781;NM_001281782;NM_001281783;NM_001281784;NM_001363714;NM_001363741;NM_012408;NM_183047;NM_183048
CIRBP_SIG,CIRBP,CIRBP_SIG,CIRBP,SIG,54,1.6946620674217,0.203971056061997,0.200071844009967,0.216782752804381,0.0167109087944147,0.126021959830657,1.43235887175444,8.01393097196854,7.99202980629578,8.0858919448933,0.0938621385975162,0.244690879052303,ENSG00000099622,CIRBP,protein_coding,19,1,1259384,1274880,p13.3,cold inducible RNA binding protein [Source:HGNC Symbol;Acc:HGNC:1982],NA,CIRBP,1153,NM_001280;NM_001300815;NM_001300829
RTN4RL1_SIG,RTN4RL1,RTN4RL1_SIG,RTN4RL1,SIG,10,1.69426777075558,-0.0109164049358654,-0.0141991344659093,-0.000130293622864009,0.0140688408430454,0.126105348900239,1.21981188918473,0.495830135292287,0.472866797045502,0.571281103817435,0.0984143067719333,0.328277181495013,ENSG00000185924,RTN4RL1,protein_coding,17,-1,1934677,2025334,p13.3,reticulon 4 receptor like 1 [Source:HGNC Symbol;Acc:HGNC:21329],NA,RTN4RL1,146760,NM_178568
MAPKAPK3_SIG,MAPKAPK3,MAPKAPK3_SIG,MAPKAPK3,SIG,30,1.69342186551401,0.203395802953495,0.201518643595376,0.20956361227303,0.00804496867765376,0.126308788314262,1.33829840018193,7.79984859844752,7.78268229198311,7.85625217683059,0.0735698848474726,0.279850274190994,ENSG00000114738,MAPKAPK3,protein_coding,3,1,50611520,50649291,p21.2,mitogen-activated protein kinase-activated protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:6888],MACULAR DYSTROPHY PATTERNED 3;Martinique crinkled retinal pigment epitheliopathy,MAPKAPK3,7867,NM_001243925;NM_001243926;NM_004635
GRM2_SIG,GRM2,GRM2_SIG,GRM2,SIG,62,-1.6918063222298,-0.0457526483949278,-0.0412115385925134,-0.0606734377457181,-0.0194618991532047,0.126717471887841,-2.29318455031948,1.32360815262691,1.37694132104821,1.14837059924264,-0.228570721805569,0.0547240533462352,ENSG00000164082,GRM2,protein_coding,3,1,51707068,51718613,p21.2,glutamate metabotropic receptor 2 [Source:HGNC Symbol;Acc:HGNC:4594],NA,GRM2,2912,NM_000839;NM_001349116;NM_001349117
NUCKS1_SIG,NUCKS1,NUCKS1_SIG,NUCKS1,SIG,22,1.68925541134915,0.613879094734362,0.609044070996422,0.62976560130188,0.0207215303054576,0.127377326246364,1.85781453582314,7.64272719511236,7.61019750882624,7.74961045005244,0.139412941226198,0.125211899152994,ENSG00000069275,NUCKS1,protein_coding,1,-1,205712822,205750182,q32.1,nuclear casein kinase and cyclin dependent kinase substrate 1 [Source:HGNC Symbol;Acc:HGNC:29923],NA,NUCKS1,64710,NM_022731
KCTD11_SIG,KCTD11,KCTD11_SIG,KCTD11,SIG,10,1.68906085633728,0.0517057854456117,0.0477144987479871,0.0648200131663781,0.0171055144183911,0.127407917673913,2.95218335671934,2.51925446669269,2.45383378674184,2.73420812938834,0.280374342646497,0.0121741583046416,ENSG00000213859,KCTD11,protein_coding,17,1,7351889,7354944,p13.1,potassium channel tetramerization domain containing 11 [Source:HGNC Symbol;Acc:HGNC:21302],NA,KCTD11,147040,NM_001002914;NM_001363642
MRPL22_SIG,MRPL22,MRPL22_SIG,MRPL22,SIG,40,1.68887380766053,0.253464936182932,0.251815180151259,0.258885563144146,0.00707038299288718,0.127436506369038,3.74331831988958,4.24211339876711,4.19799949064073,4.38705909689665,0.189059606255927,0.00128367052437036,ENSG00000082515,MRPL22,protein_coding,5,1,154941073,154969411,q33.2,mitochondrial ribosomal protein L22 [Source:HGNC Symbol;Acc:HGNC:14480],NA,MRPL22,29093,NM_001014990;NM_014180
PIKFYVE_SIG,PIKFYVE,PIKFYVE_SIG,PIKFYVE,SIG,23,1.68867310330429,0.44067101980365,0.438722127581203,0.447074522820264,0.00835239523906174,0.127468757576491,1.14958198153337,7.39269463877348,7.37931267517402,7.43666394774313,0.05735127256911,0.359277756717887,ENSG00000115020,PIKFYVE,protein_coding,2,1,208266255,208358746,q34,phosphoinositide kinase, FYVE-type zinc finger containing [Source:HGNC Symbol;Acc:HGNC:23785],CORNEAL DYSTROPHY FLECK;FLECK CORNEAL DYSTROPHY,PIKFYVE,200576,NM_001178000;NM_015040;NM_152671
STK19_SIG,STK19,STK19_SIG,STK19,SIG,27,1.68796512195881,0.318049419205129,0.314400043135788,0.330040226290107,0.0156401831543189,0.127636923377411,1.73336854274114,4.16208289138945,4.14420299230536,4.22083113123717,0.0766281389318094,0.154360170678653,ENSG00000204344,STK19,protein_coding,6,1,31971091,31982821,p21.33,serine/threonine kinase 19 [Source:HGNC Symbol;Acc:HGNC:11398],NA,STK19,8859,NM_004197;NM_032454
OLIG1_TF,OLIG1,OLIG1_TF,OLIG1,TF,144,-1.68765735150175,0.10473402166084,0.106998854146436,0.0972924292081669,-0.00970642493826943,0.1276979168212,-0.246594761375241,2.96421230177868,2.97425162841208,2.93122594284037,-0.0430256855717061,0.860071476666609,ENSG00000184221,OLIG1,protein_coding,21,1,33070141,33072413,q22.11,oligodendrocyte transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:16983],NA,OLIG1,116448,NM_138983
PRKCH_SIG,PRKCH,PRKCH_SIG,PRKCH,SIG,100,-1.68665557812893,0.110816759181027,0.115556733790658,0.0952425568922388,-0.0203141768984189,0.127945185788419,-1.20632225325507,5.13978843780789,5.1803725861076,5.00644052196599,-0.173932064141609,0.333943291389118,ENSG00000027075,PRKCH,protein_coding,14,1,61187559,61550976,q23.1,protein kinase C eta [Source:HGNC Symbol;Acc:HGNC:9403],STROKE ISCHEMIC,PRKCH,5583,NM_006255
PRDM10_SIG,PRDM10,PRDM10_SIG,PRDM10,SIG,19,1.68627304404068,0.349656785358545,0.347987685853359,0.355140969447013,0.00715328359365438,0.128026373940412,1.3067557393144,4.16621633973676,4.151788576428,4.21362184775125,0.0618332713232485,0.292260734158332,ENSG00000170325,PRDM10,protein_coding,11,-1,129899706,130002835,q24.3,PR/SET domain 10 [Source:HGNC Symbol;Acc:HGNC:13995],NA,PRDM10,56980,NM_001367891;NM_001367893;NM_001367895;NM_001367896;NM_001367897;NM_001367898;NM_001367899;NM_020228;NM_199437;NM_199438;NM_199439
DHX9_SIG,DHX9,DHX9_SIG,DHX9,SIG,40,1.68612011723987,0.541070235462384,0.538189703464311,0.550534840598908,0.0123451371345966,0.128039878647624,1.26116458914918,8.10857746061374,8.09566636169392,8.15099964277884,0.0553332810849217,0.310820663894368,ENSG00000135829,DHX9,protein_coding,1,1,182839347,182887982,q25.3,DExH-box helicase 9 [Source:HGNC Symbol;Acc:HGNC:2750],NA,DHX9,1660,NM_001357
PDE1B_SIG,PDE1B,PDE1B_SIG,PDE1B,SIG,33,-1.68606226682312,0.00195336306699063,0.00501449662136006,-0.00810464718308037,-0.0131191438044403,0.128039878647624,-1.36645568284057,4.1414930391648,4.17594777561835,4.02828461938884,-0.147663156229506,0.269365247822928,ENSG00000123360,PDE1B,protein_coding,12,1,54549601,54579239,q13.2,phosphodiesterase 1B [Source:HGNC Symbol;Acc:HGNC:8775],NA,PDE1B,5153,NM_000924;NM_001165975;NM_001288768;NM_001288769;NM_001315534;NM_001315535
HHIP_SIG,HHIP,HHIP_SIG,HHIP,SIG,52,1.68370810398729,-0.0746486320145815,-0.0783365673972058,-0.0625311300431018,0.0158054373541041,0.128642697032068,1.58534628605982,0.641526933672776,0.593176090723796,0.80039398907657,0.207217898352774,0.194876098211889,ENSG00000164161,HHIP,protein_coding,4,1,144646156,144745271,q31.21,hedgehog interacting protein [Source:HGNC Symbol;Acc:HGNC:14866],NA,HHIP,64399,NM_022475
PPCS_SIG,PPCS,PPCS_SIG,PPCS,SIG,34,1.68366212980956,0.222571246308392,0.217412974472918,0.239519853767804,0.0221068792948857,0.128642697032068,2.27702989266503,5.36341127816817,5.33641820917788,5.4521027905648,0.115684581386916,0.056618963029068,ENSG00000127125,PPCS,protein_coding,1,1,42456117,42473385,p34.2,phosphopantothenoylcysteine synthetase [Source:HGNC Symbol;Acc:HGNC:25686],CARDIOMYOPATHY DILATED 2C;Familial isolated dilated cardiomyopathy,PPCS,79717,NM_001077447;NM_001287506;NM_001287508;NM_001287509;NM_001287510;NM_001287511;NM_024664
EIF2B1_SIG,EIF2B1,EIF2B1_SIG,EIF2B1,SIG,24,1.6822138720941,0.47905887815886,0.474575202593899,0.493790955015163,0.0192157524212644,0.129011999798697,1.15708643932159,5.67297333003571,5.66155667255448,5.71048520461689,0.0489285320624103,0.356246604177027,ENSG00000111361,EIF2B1,protein_coding,12,-1,123620406,123633766,q24.31,eukaryotic translation initiation factor 2B subunit alpha [Source:HGNC Symbol;Acc:HGNC:3257],Congenital or early infantile CACH syndrome;Cree leukoencephalopathy;Juvenile or adult CACH syndrome;Late infantile CACH syndrome;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER;OVARIOLEUKODYSTROPHY,EIF2B1,1967,NM_001414
PTBP1_SIG,PTBP1,PTBP1_SIG,PTBP1,SIG,28,1.67992390540464,0.4142848131905,0.411578044787886,0.423178480799086,0.0116004360112,0.129610302984113,1.33286414426276,8.29716423114371,8.28182838899628,8.34755342677097,0.0657250377746871,0.281913255088013,ENSG00000011304,PTBP1,protein_coding,19,1,797075,812327,p13.3,polypyrimidine tract binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9583],NA,PTBP1,5725,NM_002819;NM_031990;NM_031991
EP300_SIG,EP300,EP300_SIG,EP300,SIG,47,-1.67948779308923,0.308617601807946,0.312557989322242,0.295670614260972,-0.01688737506127,0.129689105596146,-1.65615665673546,7.99947599508416,8.02145015178296,7.92727519450236,-0.0941749572806029,0.174798148702667,ENSG00000100393,EP300,protein_coding,22,1,41092592,41180077,q13.2,E1A binding protein p300 [Source:HGNC Symbol;Acc:HGNC:3373],Colorectal Cancer;RUBINSTEIN-TAYBI SYNDROME 1;RUBINSTEIN-TAYBI SYNDROME 2;Rubinstein-Taybi syndrome due to EP300 haploinsufficiency;RUBINSTEIN-TAYBI SYNDROME TYPE 2,EP300,2033,NM_001429
CDK11B_SIG,CDK11B,CDK11B_SIG,CDK11B,SIG,32,-1.67947269683803,0.0492542038288336,0.0539488245633975,0.0338290214152664,-0.0201198031481313,0.129689105596146,-2.18630608964534,5.38272932768896,5.40658367061386,5.30435077236427,-0.102232898249594,0.0682044750449765,ENSG00000248333,CDK11B,protein_coding,1,-1,1635227,1659012,p36.33,cyclin dependent kinase 11B [Source:HGNC Symbol;Acc:HGNC:1729],NA,CDK11B,984,NM_001291345;NM_001787;NM_033486;NM_033487;NM_033489;NM_033490
PLXNB3_SIG,PLXNB3,PLXNB3_SIG,PLXNB3,SIG,20,-1.67914067027677,0.00120704219004263,0.00397637725035408,-0.00789220157955215,-0.0118685788299063,0.12975741209881,-1.31953641660001,1.10660357094733,1.13923024443201,0.999401643783362,-0.139828600648651,0.287160510004605,ENSG00000198753,PLXNB3,protein_coding,X,1,153764196,153779346,q28,plexin B3 [Source:HGNC Symbol;Acc:HGNC:9105],NA,PLXNB3,5365,NM_001163257;NM_005393
MRPS28_SIG,MRPS28,MRPS28_SIG,MRPS28,SIG,27,1.67892957481321,0.446600860211369,0.439957745726843,0.468428236374809,0.0284704906479657,0.129792904520506,2.2884875535746,2.58425262944653,2.54854795105195,2.70156800131441,0.153020050262452,0.0552783406481587,ENSG00000147586,MRPS28,protein_coding,8,-1,79918717,80030289,q21.13,mitochondrial ribosomal protein S28 [Source:HGNC Symbol;Acc:HGNC:14513],NA,MRPS28,28957,NM_014018
PSPC1_SIG,PSPC1,PSPC1_SIG,PSPC1,SIG,16,1.67864637773505,0.384222743798233,0.382748061523594,0.389068128414903,0.0063200668913087,0.129847988859005,0.96353874976706,6.14000370492884,6.13152610430095,6.16785867842045,0.0363325741194993,0.448969511545108,ENSG00000121390,PSPC1,protein_coding,13,-1,19674752,19783019,q12.11,paraspeckle component 1 [Source:HGNC Symbol;Acc:HGNC:20320],NA,PSPC1,55269,NM_001042414;NM_001354908;NM_001354909
KDM5C_SIG,KDM5C,KDM5C_SIG,KDM5C,SIG,24,1.67795208089046,0.218192292493624,0.209527519876173,0.246662259665248,0.0371347397890749,0.13001482977043,2.96505457654088,7.40482007301776,7.3709272102087,7.51618233653326,0.145255126324563,0.0117877261928156,ENSG00000126012,KDM5C,protein_coding,X,-1,53191321,53225422,p11.22,lysine demethylase 5C [Source:HGNC Symbol;Acc:HGNC:11114],MENTAL RETARDATION SYNDROMIC X-LINKED JARID1C-RELATED;MENTAL RETARDATION X-LINKED SYNDROMIC CLAES-JENSEN TYPE;Syndromic X-linked intellectual disability due to JARID1C mutation,KDM5C,8242,NM_001146702;NM_001282622;NM_001353978;NM_001353979;NM_001353981;NM_001353982;NM_001353984;NM_004187
HAT1_SIG,HAT1,HAT1_SIG,HAT1,SIG,15,1.67628645928102,0.327050791236525,0.322998604570844,0.340365118852336,0.017366514281492,0.130446414221996,1.34802828480227,5.53741484488864,5.52036218858513,5.59344500131445,0.0730828127293198,0.276119044242488,ENSG00000128708,HAT1,protein_coding,2,1,171922448,171983686,q31.1,histone acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:4821],NA,HAT1,8520,NM_003642
SULT1A4_SIG,SULT1A4,SULT1A4_SIG,SULT1A4,SIG,7,1.67531194569579,0.117782117608,0.1152686883547,0.1260405280117,0.0107718396569997,0.130690331068277,1.4947794996481,0.378317408748603,0.370936584623048,0.402568688018285,0.0316321033952362,0.223675081834857,ENSG00000213648,SULT1A4,protein_coding,16,1,29459889,29464976,p11.2,sulfotransferase family 1A member 4 [Source:HGNC Symbol;Acc:HGNC:30004],NA,SULT1A4,445329,NM_001017390
MNAT1_SIG,MNAT1,MNAT1_SIG,MNAT1,SIG,8,1.67465277395284,0.337904528667469,0.332694692085478,0.355022563151154,0.0223278710656755,0.130848404711557,-0.244338486057307,3.05551440739836,3.05920061500551,3.04340258240343,-0.0157980326020854,0.86127698846577,ENSG00000020426,MNAT1,protein_coding,14,1,60734742,60969965,q23.1,MNAT1, CDK activating kinase assembly factor [Source:HGNC Symbol;Acc:HGNC:7181],NA,MNAT1,4331,NM_001177963;NM_002431
CIR1_TF,CIR1,CIR1_TF,CIR1,TF,174,-1.67456106837668,-0.060888089132389,-0.0573997445276722,-0.0723497928336011,-0.0149500483059288,0.130851482362342,-1.63531541183858,5.4298770642273,5.45421392445549,5.34991309490608,-0.104300829549406,0.180639455615923,ENSG00000138433,CIR1,protein_coding,2,-1,174348022,174395712,q31.1,corepressor interacting with RBPJ, 1 [Source:HGNC Symbol;Acc:HGNC:24217],NA,CIR1,9541,NM_004882
PPP1R9B_SIG,PPP1R9B,PPP1R9B_SIG,PPP1R9B,SIG,27,-1.6739388803017,0.333170885176451,0.338527902289936,0.315569257517859,-0.0229586447720775,0.130999586835439,-1.1393241999119,7.6431757041313,7.66100279523017,7.58460097623502,-0.0764018189951577,0.363871093866991,ENSG00000108819,PPP1R9B,protein_coding,17,-1,50133737,50150677,q21.33,protein phosphatase 1 regulatory subunit 9B [Source:HGNC Symbol;Acc:HGNC:9298],NA,PPP1R9B,84687,NM_032595
SUCLG1_SIG,SUCLG1,SUCLG1_SIG,SUCLG1,SIG,18,1.673259442647,0.279190908900384,0.275542712326312,0.291177840500907,0.0156351281745958,0.131163491119097,2.75898563631063,5.58077322382671,5.55109893134666,5.6782744705469,0.127175539200242,0.0195306155632473,ENSG00000163541,SUCLG1,protein_coding,2,-1,84423528,84460045,p11.2,succinate-CoA ligase alpha subunit [Source:HGNC Symbol;Acc:HGNC:11449],Fatal Infantile Lactic Acidosis;Fatal infantile lactic acidosis with methylmalonic aciduria;MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA),SUCLG1,8802,NM_003849
RHBDD1_SIG,RHBDD1,RHBDD1_SIG,RHBDD1,SIG,8,1.67293150902908,0.160584014643886,0.154216653419197,0.181505344382147,0.0272886909629499,0.131231256307841,1.5647089442086,4.68806496580292,4.6635126407255,4.76873689105733,0.105224250331831,0.20124672442029,ENSG00000144468,RHBDD1,protein_coding,2,1,226835581,226999215,q36.3,rhomboid domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23081],NA,RHBDD1,84236,NM_001167608;NM_001349069;NM_001349071;NM_001349072;NM_032276
ME1_SIG,ME1,ME1_SIG,ME1,SIG,37,1.67263905495876,-0.000879171489166406,-0.00381013490013183,0.00875113686114854,0.0125612717612803,0.13128932773591,2.50632194275577,1.74727832327385,1.65592156768469,2.04745052020965,0.391528952524963,0.0347857166790139,ENSG00000065833,ME1,protein_coding,6,-1,83210402,83431051,q14.2,malic enzyme 1 [Source:HGNC Symbol;Acc:HGNC:6983],NA,ME1,4199,NM_002395
KMO_SIG,KMO,KMO_SIG,KMO,SIG,42,-1.6719053735709,0.18703434501502,0.195294248334263,0.159894662680364,-0.0353995856538991,0.131450144843361,-0.0620502767496118,1.48780799980241,1.48934558208724,1.48275594372366,-0.00658963836358786,0.965879444307668,ENSG00000117009,KMO,protein_coding,1,1,241532134,241595642,q43,kynurenine 3-monooxygenase [Source:HGNC Symbol;Acc:HGNC:6381],NA,KMO,8564,NM_003679
SYT17_SIG,SYT17,SYT17_SIG,SYT17,SIG,34,-1.67189142081191,0.0355753912199334,0.0434893871893508,0.00957226160613328,-0.0339171255832174,0.131450144843361,-2.24446696860749,0.817740977731086,0.877924558869423,0.619994925419407,-0.257929633450016,0.0606047257445726,ENSG00000103528,SYT17,protein_coding,16,1,19167971,19268332,p12.3,synaptotagmin 17 [Source:HGNC Symbol;Acc:HGNC:24119],NA,SYT17,51760,NM_001308157;NM_001330509;NM_016524
LRRC59_SIG,LRRC59,LRRC59_SIG,LRRC59,SIG,44,-1.67088883605194,0.222122592380354,0.224443859863787,0.214495570649075,-0.00994828921471281,0.131703193424558,-1.49882500503275,6.9570923491763,6.97688787316874,6.89204991320111,-0.0848379599676344,0.222293140184929,ENSG00000108829,LRRC59,protein_coding,17,-1,50375059,50397523,q21.33,leucine rich repeat containing 59 [Source:HGNC Symbol;Acc:HGNC:28817],NA,LRRC59,55379,NM_018509
HIST1H4K_SIG,HIST1H4K,HIST1H4K_SIG,HIST1H4K,SIG,32,1.6706023557741,-0.159323352322906,-0.163339011855714,-0.146129042429392,0.0172099694263216,0.131759779463789,1.18448390025096,0.446626922933685,0.435132478169163,0.484394384302828,0.0492619061336647,0.343721289751206,ENSG00000273542,HIST1H4K,protein_coding,6,-1,27831216,27831527,p22.1,histone cluster 1 H4 family member k [Source:HGNC Symbol;Acc:HGNC:4784],NA,HIST1H4K,8362,NM_003541
GABRD_SIG,GABRD,GABRD_SIG,GABRD,SIG,36,-1.66996232325739,-0.0441627137462344,-0.0412108763789421,-0.0538616079530522,-0.0126507315741101,0.131911620457602,-1.79121214956489,0.330156804074603,0.362257693616591,0.224682452722354,-0.137575240894237,0.140354165959318,ENSG00000187730,GABRD,protein_coding,1,1,2019329,2030758,p36.33,gamma-aminobutyric acid type A receptor delta subunit [Source:HGNC Symbol;Acc:HGNC:4084],1p36 deletion syndrome;EPILEPSY IDIOPATHIC GENERALIZED SUSCEPTIBILITY TO 10;Generalized epilepsy with febrile seizures-plus;Juvenile myoclonic epilepsy,GABRD,2563,NM_000815
NR2C2_TF,NR2C2,NR2C2_TF,NR2C2,TF,124,1.66988894034853,0.444348345028569,0.441661445853658,0.453176728031848,0.0115152821781895,0.131911620457602,1.89260562449961,4.98728638648048,4.96194065107838,5.0705652313731,0.108624580294722,0.117764352940831,ENSG00000177463,NR2C2,protein_coding,3,1,14947584,15053600,p25.1,nuclear receptor subfamily 2 group C member 2 [Source:HGNC Symbol;Acc:HGNC:7972],NA,NR2C2,7182,NM_001291694;NM_003298
PSMA4_SIG,PSMA4,PSMA4_SIG,PSMA4,SIG,43,1.66920805838124,0.500200940674765,0.494350131794034,0.519425026997167,0.0250748952031333,0.132076782851468,1.41327779618069,6.55033593640945,6.53350835220844,6.60562657021274,0.0721182180042979,0.25160948162814,ENSG00000041357,PSMA4,protein_coding,15,1,78540405,78552417,q25.1,proteasome subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:9533],NA,PSMA4,5685,NM_001102667;NM_001102668;NM_001330673;NM_001330675;NM_001330676;NM_002789
NCOA3_SIG,NCOA3,NCOA3_SIG,NCOA3,SIG,73,1.66897451916524,0.216760235849913,0.214241713182011,0.225035381758734,0.010793668576723,0.132118915419844,2.29226410872313,6.92216711826374,6.89197911317283,7.02135627784818,0.129377164675347,0.0548388808519588,ENSG00000124151,NCOA3,protein_coding,20,1,47501887,47656877,q13.12,nuclear receptor coactivator 3 [Source:HGNC Symbol;Acc:HGNC:7670],Neurodevelopment disorder,NCOA3,8202,NM_001174087;NM_001174088;NM_006534;NM_181659
SLC12A7_SIG,SLC12A7,SLC12A7_SIG,SLC12A7,SIG,21,1.66796293712229,0.203444493457049,0.200400014091522,0.213447782800923,0.0130477687094002,0.132375419828887,3.144345508487,6.0004050428474,5.91108159735084,6.29389636376465,0.38281476641381,0.00737566766390962,ENSG00000113504,SLC12A7,protein_coding,5,-1,1050384,1112063,p15.33,solute carrier family 12 member 7 [Source:HGNC Symbol;Acc:HGNC:10915],NA,SLC12A7,10723,NM_006598
KDM2A_TF,KDM2A,KDM2A_TF,KDM2A,TF,126,-1.66769114198227,-0.0164238834626367,-0.0136980998110946,-0.0253800297462752,-0.0116819299351805,0.132428171371324,-1.29140674063571,8.16524781039072,8.17862460568333,8.12129548300073,-0.057329122682603,0.298444371879052,ENSG00000173120,KDM2A,protein_coding,11,1,67119263,67258082,q13.2,lysine demethylase 2A [Source:HGNC Symbol;Acc:HGNC:13606],NA,KDM2A,22992,NM_001256405;NM_012308
ATP2B4_SIG,ATP2B4,ATP2B4_SIG,ATP2B4,SIG,8,1.66652108266691,0.419264200705367,0.414634337515099,0.434476608330534,0.0198422708154358,0.132728910464281,-1.4267150313308,7.66621956647488,7.70230673368653,7.5476474456366,-0.154659288049934,0.246673714537781,ENSG00000058668,ATP2B4,protein_coding,1,1,203626561,203744081,q32.1,ATPase plasma membrane Ca2+ transporting 4 [Source:HGNC Symbol;Acc:HGNC:817],NA,ATP2B4,493,NM_001001396;NM_001684
ZNF407_TF,ZNF407,ZNF407_TF,ZNF407,TF,53,-1.66575418129448,0.396233100932669,0.398330643232794,0.389341176232256,-0.00898946700053811,0.132918640292245,-0.237934314613854,4.58668239826528,4.58925913048741,4.57821599239254,-0.0110431380948795,0.865078473805634,ENSG00000215421,ZNF407,protein_coding,18,1,74597870,75065671,q22.3,zinc finger protein 407 [Source:HGNC Symbol;Acc:HGNC:19904],NA,ZNF407,55628,NM_001146189;NM_001146190;NM_017757
SOD1_SIG,SOD1,SOD1_SIG,SOD1,SIG,15,1.66532657105233,0.109307343780096,0.106874356694801,0.117301444203208,0.0104270875084078,0.132994430771377,-0.0620742935419654,6.39023096648764,6.39112012799508,6.38730943582032,-0.00381069217476069,0.965879444307668,ENSG00000142168,SOD1,protein_coding,21,1,31659622,31668931,q22.11,superoxide dismutase 1 [Source:HGNC Symbol;Acc:HGNC:11179],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 1,SOD1,6647,NM_000454
ZFAND6_SIG,ZFAND6,ZFAND6_SIG,ZFAND6,SIG,19,-1.6653053678067,0.361355963900292,0.364323629321277,0.351605063231339,-0.0127185660899378,0.132994430771377,-1.04050605346019,5.94823391861862,5.96133149186774,5.90519903508579,-0.0561324567819473,0.410653910651662,ENSG00000086666,ZFAND6,protein_coding,15,1,80059568,80138393,q25.1,zinc finger AN1-type containing 6 [Source:HGNC Symbol;Acc:HGNC:30164],NA,ZFAND6,54469,NM_001242911;NM_001242912;NM_001242913;NM_001242914;NM_001242915;NM_001242916;NM_001242917;NM_001242918;NM_001242919;NM_019006
COL2A1_SIG,COL2A1,COL2A1_SIG,COL2A1,SIG,35,1.66523868067512,-0.10325070801492,-0.106250430213429,-0.0933944779341045,0.0128559522793245,0.132994430771377,-0.297504457334266,0.637470425668725,0.646557679990443,0.607612304325939,-0.0389453756645032,0.829382813008721,ENSG00000139219,COL2A1,protein_coding,12,-1,47972967,48004554,q13.11,collagen type II alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2200],Achondrogenesis type 2;ACHONDROGENESIS TYPE II;Autosomal dominant rhegmatogenous retinal detachment;AVASCULAR NECROSIS OF FEMORAL HEAD PRIMARY 1;CZECH DYSPLASIA;Czech dysplasia metatarsal type;Dysspondyloenchondromatosis;Epiphyseal dysplasia multiple with myopia and conductive deafness;Familial avascular necrosis of femoral head;Hypochondrogenesis;KNIEST DYSPLASIA;Legg-Calve-Perthes disease;Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis;Multiple epiphyseal dysplasia Beighton type;OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA;Platyspondylic dysplasia Torrance type;Platyspondylic lethal skeletal dysplasia Torrance type;PRIMARY AVASCULAR NECROSIS OF FEMORAL HEAD;RHEGMATOGENOUS RETINAL DETACHMENT AUTOSOMAL DOMINANT;Spondyloepimetaphyseal dysplasia congenita Strudwick type;Spondyloepimetaphyseal dysplasia Strudwick type;SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA;Spondyloepiphyseal dysplasia stanescu type;Spondylometaphyseal dysplasia 'corner fracture' type;Spondylometaphyseal dysplasia Schmidt type;SPONDYLOPERIPHERAL DYSPLASIA;Spondyloperipheral dysplasia-short ulna syndrome;Stickler syndrome type 1;STICKLER SYNDROME TYPE 1 NON-SYNDROMIC OCULAR;STICKLER SYNDROME TYPE I;STICKLER SYNDROME TYPE I NONSYNDROMIC OCULAR;Weissenbacher-Zweymuller syndrome,COL2A1,1280,NM_001844;NM_033150
LCORL_TF,LCORL,LCORL_TF,LCORL,TF,42,1.66372405552504,0.272874514595004,0.271080155170397,0.27877026699014,0.00769011181974317,0.133391671874249,0.544684261908865,3.92340529603995,3.91702400064968,3.94437240946514,0.0273484088154653,0.683862053668208,ENSG00000178177,LCORL,protein_coding,4,-1,17841199,18021876,p15.31,ligand dependent nuclear receptor corepressor like [Source:HGNC Symbol;Acc:HGNC:30776],NA,LCORL,254251,NM_001166139;NM_153686
AGMAT_SIG,AGMAT,AGMAT_SIG,AGMAT,SIG,15,1.66340319097172,0.0498898288367059,0.0469756909835523,0.0594648532113533,0.0124891622278012,0.133458334212382,1.76150038801753,1.40328739156056,1.36899653290597,1.51595735571135,0.146960822805379,0.147418611475522,ENSG00000116771,AGMAT,protein_coding,1,-1,15571699,15585051,p36.21,agmatinase [Source:HGNC Symbol;Acc:HGNC:18407],NA,AGMAT,79814,NM_024758
POFUT2_SIG,POFUT2,POFUT2_SIG,POFUT2,SIG,10,1.66319429695362,0.127393183410742,0.125153201790456,0.134753123020252,0.00959992122979604,0.133476567174842,0.935482772046115,4.84789264618847,4.83648074553208,4.88538889120231,0.0489081456702253,0.463125718252273,ENSG00000186866,POFUT2,protein_coding,21,-1,45263928,45287898,q22.3,protein O-fucosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:14683],NA,POFUT2,23275,NM_015227;NM_133635
BAZ2B_SIG,BAZ2B,BAZ2B_SIG,BAZ2B,SIG,34,1.6631764353757,0.196205808854828,0.194804509692416,0.200810077531326,0.00600556783891083,0.133476567174842,1.54365115057058,6.92710510053872,6.90541384346379,6.9983763737849,0.0929625303211149,0.207871206375248,ENSG00000123636,BAZ2B,protein_coding,2,-1,159318979,159616569,q24.2,bromodomain adjacent to zinc finger domain 2B [Source:HGNC Symbol;Acc:HGNC:963],NA,BAZ2B,29994,NM_001289975;NM_001329857;NM_001329858;NM_013450
SMPD1_SIG,SMPD1,SMPD1_SIG,SMPD1,SIG,17,-1.66254027731957,0.372036486209941,0.376022075012041,0.358940980145896,-0.0170810948661457,0.133630790865184,-1.56682671293653,4.6064522659841,4.62879437101985,4.53304249229519,-0.0957518787246646,0.200660953361171,ENSG00000166311,SMPD1,protein_coding,11,1,6390440,6394998,p15.4,sphingomyelin phosphodiesterase 1 [Source:HGNC Symbol;Acc:HGNC:11120],Niemann-Pick disease type A;NIEMANN-PICK DISEASE TYPE A;Niemann-Pick disease type B;NIEMANN-PICK DISEASE TYPE BNIEMANN-PICK DISEASE TYPE E INCLUDED,SMPD1,6609,NM_000543;NM_001007593;NM_001318087;NM_001318088
PTPRO_SIG,PTPRO,PTPRO_SIG,PTPRO,SIG,33,-1.66142974830595,0.197756096204104,0.20604050884725,0.170535883233768,-0.0355046256134827,0.133917042677267,-0.757160986443987,2.01115623496473,2.03619597837737,1.92888279232319,-0.107313186054182,0.559433250601735,ENSG00000151490,PTPRO,protein_coding,12,1,15322508,15598331,p12.3,protein tyrosine phosphatase, receptor type O [Source:HGNC Symbol;Acc:HGNC:9678],Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;NEPHROTIC SYNDROME TYPE 6,PTPRO,5800,NM_002848;NM_030667;NM_030668;NM_030669;NM_030670;NM_030671
DPP8_SIG,DPP8,DPP8_SIG,DPP8,SIG,33,1.66092442719938,0.385587390483322,0.382525195225247,0.395648889188426,0.0131236939631791,0.134014038805328,0.302617025352476,6.0809900306363,6.07756101773693,6.09225678730569,0.0146957695687612,0.826257683189273,ENSG00000074603,DPP8,protein_coding,15,-1,65442463,65517704,q22.31,dipeptidyl peptidase 8 [Source:HGNC Symbol;Acc:HGNC:16490],NA,DPP8,54878,NM_001320875;NM_001320876;NM_017743;NM_130434;NM_197960;NM_197961
UBL5_SIG,UBL5,UBL5_SIG,UBL5,SIG,25,-1.66092004738524,0.0906822061055222,0.0925275582257599,0.0846189062818843,-0.00790865194387566,0.134014038805328,-1.61608371101416,5.34478498946855,5.35937630801377,5.29684208567711,-0.0625342223366516,0.186099910409787,ENSG00000198258,UBL5,protein_coding,19,1,9827892,9830115,p13.2,ubiquitin like 5 [Source:HGNC Symbol;Acc:HGNC:13736],NA,UBL5,59286,NM_001048241;NM_024292
CAPRIN2_SIG,CAPRIN2,CAPRIN2_SIG,CAPRIN2,SIG,77,1.66065079883994,-0.028729655253972,-0.0310967380623846,-0.0209520974549021,0.0101446406074826,0.134066565473632,0.789977639715187,4.21217918504048,4.19204234908259,4.27834307461639,0.0863007255337954,0.540613054098058,ENSG00000110888,CAPRIN2,protein_coding,12,-1,30709552,30754951,p11.21,caprin family member 2 [Source:HGNC Symbol;Acc:HGNC:21259],NA,CAPRIN2,65981,NM_001002259;NM_001206856;NM_001319842;NM_001319843;NM_001319844;NM_001319845;NM_001319846;NM_023925;NM_032156
RIT1_SIG,RIT1,RIT1_SIG,RIT1,SIG,31,-1.66041673926944,0.420808765132444,0.427945092023476,0.397360833919053,-0.0305842581044234,0.134109310163312,-0.911015683979338,6.41041983629908,6.42919905382822,6.34871669298903,-0.0804823608391861,0.476148177303369,ENSG00000143622,RIT1,protein_coding,1,-1,155897808,155911404,q22,Ras like without CAAX 1 [Source:HGNC Symbol;Acc:HGNC:10023],Noonan Syndrome;Noonan syndrome 8,RIT1,6016,NM_001256820;NM_001256821;NM_006912
HPDL_SIG,HPDL,HPDL_SIG,HPDL,SIG,3,1.66026918705374,0.149990203877262,0.143477258514689,0.171389881497146,0.0279126229824573,0.134127976110418,0.525418577440145,1.67894216721908,1.66592390230501,1.72171646622245,0.0557925639174396,0.6950049222035,ENSG00000186603,HPDL,protein_coding,1,1,45326905,45328533,p34.1,4-hydroxyphenylpyruvate dioxygenase like [Source:HGNC Symbol;Acc:HGNC:28242],NA,HPDL,84842,NM_032756
NDUFA8_SIG,NDUFA8,NDUFA8_SIG,NDUFA8,SIG,62,1.65938391853902,0.328449090136423,0.321426108681685,0.35152460063056,0.0300984919488746,0.134352205435732,1.62721138947055,3.7622400272514,3.7252164826924,3.88388881651669,0.158672333824296,0.182971642013666,ENSG00000119421,NDUFA8,protein_coding,9,-1,122144058,122159779,q33.2,NADH:ubiquinone oxidoreductase subunit A8 [Source:HGNC Symbol;Acc:HGNC:7692],NA,NDUFA8,4702,NM_014222
YOD1_SIG,YOD1,YOD1_SIG,YOD1,SIG,57,-1.65914172122061,0.22867346054132,0.235606843046507,0.205892346595707,-0.0297144964507999,0.134397287498988,-2.82847830340392,5.86989518664763,5.95328162075239,5.59591118887485,-0.357370431877544,0.0165440450606242,ENSG00000180667,YOD1,protein_coding,1,-1,207043849,207052980,q32.1,YOD1 deubiquitinase [Source:HGNC Symbol;Acc:HGNC:25035],NA,YOD1,55432,NM_001276320;NM_018566
VPS18_SIG,VPS18,VPS18_SIG,VPS18,SIG,18,-1.65897739758283,0.368325908779671,0.370323830878547,0.361761307597647,-0.00856252328090027,0.134420660593952,-1.46848039562645,5.43323375205021,5.45007567786669,5.37789599579607,-0.0721796820706188,0.232453051271697,ENSG00000104142,VPS18,protein_coding,15,1,40894450,40903975,q15.1,VPS18, CORVET/HOPS core subunit [Source:HGNC Symbol;Acc:HGNC:15972],NA,VPS18,57617,NM_020857
GLCE_SIG,GLCE,GLCE_SIG,GLCE,SIG,20,1.65850201486034,0.215870571095561,0.209377362147902,0.237205400495011,0.0278280383471093,0.134530826975425,2.03810808094445,3.74737072254178,3.69285718227796,3.92648664055146,0.233629458273493,0.0905386327744073,ENSG00000138604,GLCE,protein_coding,15,1,69160584,69272217,q23,glucuronic acid epimerase [Source:HGNC Symbol;Acc:HGNC:17855],NA,GLCE,26035,NM_001324091;NM_001324092;NM_001324093;NM_001324094;NM_015554
ACAD9_SIG,ACAD9,ACAD9_SIG,ACAD9,SIG,26,1.65820658395064,0.414056219753193,0.40637399028618,0.439297830859092,0.0329238405729119,0.134590816116285,1.2822214759957,4.95753864689067,4.93701130672345,5.02498562172583,0.0879743150023807,0.302208139601009,ENSG00000177646,ACAD9,protein_coding,3,1,128879596,128916067,q21.3,acyl-CoA dehydrogenase family member 9 [Source:HGNC Symbol;Acc:HGNC:21497],Acyl-CoA dehydrogenase 9 deficiency;acyl-CoA dehydrogenase family member type 9 deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 20,ACAD9,28976,NM_014049
MYSM1_TF,MYSM1,MYSM1_TF,MYSM1,TF,131,1.6579548746327,0.406940028330448,0.404256013387316,0.415758934572168,0.0115029211848515,0.134638616272042,1.90624039231916,6.40858318901131,6.3854400719301,6.48462485942098,0.0991847874908736,0.115108043115646,ENSG00000162601,MYSM1,protein_coding,1,-1,58654740,58700080,p32.1,Myb like, SWIRM and MPN domains 1 [Source:HGNC Symbol;Acc:HGNC:29401],BONE MARROW FAILURE SYNDROME 4;Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,MYSM1,114803,NM_001085487
PIK3C2A_SIG,PIK3C2A,PIK3C2A_SIG,PIK3C2A,SIG,45,1.65768665608783,0.482255762293054,0.480042017364977,0.489529495628164,0.00948747826318705,0.134691041083155,2.2991950947444,5.54165838502749,5.5109227014153,5.64264705975325,0.131724358337947,0.0540232620879641,ENSG00000011405,PIK3C2A,protein_coding,11,-1,17077730,17207983,p15.1,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha [Source:HGNC Symbol;Acc:HGNC:8971],NA,PIK3C2A,5286,NM_001321378;NM_001321380;NM_002645
LTBR_SIG,LTBR,LTBR_SIG,LTBR,SIG,52,1.65752160711088,0.2320207245321,0.227257588748023,0.247671027822639,0.020413439074616,0.134714658877783,1.5847949823864,6.21271039749,6.18076429528199,6.31767616188776,0.136911866605775,0.195048074221607,ENSG00000111321,LTBR,protein_coding,12,1,6375045,6391571,p13.31,lymphotoxin beta receptor [Source:HGNC Symbol;Acc:HGNC:6718],NA,LTBR,4055,NM_001270987;NM_002342
ADCY4_SIG,ADCY4,ADCY4_SIG,ADCY4,SIG,47,1.65701371580608,0.0106752702212613,0.00827364553442029,0.0185663227637389,0.0102926772293185,0.134834091627079,-1.56082784783006,3.47670515716719,3.52024695594633,3.33363924689288,-0.186607709053447,0.20229022271081,ENSG00000129467,ADCY4,protein_coding,14,-1,24318349,24335093,q12,adenylate cyclase 4 [Source:HGNC Symbol;Acc:HGNC:235],NA,ADCY4,196883,NM_001198568;NM_001198592;NM_139247
RPS24_SIG,RPS24,RPS24_SIG,RPS24,SIG,36,1.65685533963812,0.895259376404656,0.888009285531576,0.919081103559062,0.0310718180274857,0.13485586360255,2.31747271394389,9.74052033674927,9.70534306584624,9.8561027982878,0.150759732441561,0.0521123222449434,ENSG00000138326,RPS24,protein_coding,10,1,78033732,78056813,q22.3,ribosomal protein S24 [Source:HGNC Symbol;Acc:HGNC:10411],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 3,RPS24,6229,NM_001026;NM_001142282;NM_001142283;NM_001142284;NM_001142285;NM_033022
ZDHHC2_TF,ZDHHC2,ZDHHC2_TF,ZDHHC2,TF,134,-1.65656283385304,0.0890867096453412,0.091287443850277,0.0818557258291237,-0.00943171802115337,0.134895404961897,-3.01687508601841,6.00023586407587,6.07364533072503,5.75903333080004,-0.314611999924993,0.0102955981118318,ENSG00000104219,ZDHHC2,protein_coding,8,1,17156482,17224799,p22,zinc finger DHHC-type containing 2 [Source:HGNC Symbol;Acc:HGNC:18469],NA,ZDHHC2,51201,NM_016353
YTHDF2_SIG,YTHDF2,YTHDF2_SIG,YTHDF2,SIG,52,1.65655294865704,0.424538719982456,0.420522729102223,0.437734118588936,0.0172113894867136,0.134895404961897,2.96479650707494,6.53036002707393,6.49178837947957,6.65709544059823,0.165307061118662,0.0117956067162159,ENSG00000198492,YTHDF2,protein_coding,1,1,28736621,28769775,p35.3,YTH N6-methyladenosine RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:31675],NA,YTHDF2,51441,NM_001172828;NM_001173128;NM_016258
SCAND1_TF,SCAND1,SCAND1_TF,SCAND1,TF,107,1.65605652713853,0.0984933919441685,0.0967863472273444,0.10410225315659,0.00731590592924593,0.135011746459421,0.788179513663088,5.37001597753372,5.36213272647333,5.39591808816073,0.0337853616874008,0.541577512289965,ENSG00000171222,SCAND1,protein_coding,20,-1,35953617,35959472,q11.23,SCAN domain containing 1 [Source:HGNC Symbol;Acc:HGNC:10566],NA,SCAND1,51282,NM_016558;NM_033630
CNTF_SIG,CNTF,CNTF_SIG,CNTF,SIG,24,-1.65582513014448,0.176833035984524,0.181592572954601,0.161194557368558,-0.0203980155860426,0.135053978522882,-0.58303684601526,1.35023819688635,1.35872484560756,1.32235349394523,-0.0363713516623233,0.661410007270879,ENSG00000242689,CNTF,protein_coding,11,1,58622665,58625733,q12.1,ciliary neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:2169],NA,CNTF,1270,NM_000614
GPATCH1_SIG,GPATCH1,GPATCH1_SIG,GPATCH1,SIG,37,1.65462236158925,0.391034282306214,0.385330941984022,0.409773829079132,0.0244428870951098,0.135368342365345,2.53113191096431,3.41289430502206,3.37288325382838,3.5443591875156,0.171475933687217,0.0330129548311621,ENSG00000076650,GPATCH1,protein_coding,19,1,33080880,33130542,q13.11,G-patch domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24658],NA,GPATCH1,55094,NM_018025
GAB1_SIG,GAB1,GAB1_SIG,GAB1,SIG,33,1.65447543908002,0.0930509993555447,0.0900921431771398,0.102772955370303,0.0126808121931636,0.135386967472378,1.25673174133003,4.50108676586469,4.47331310308348,4.59234308643154,0.119029983348057,0.312509860925054,ENSG00000109458,GAB1,protein_coding,4,1,143336762,143474568,q31.21,GRB2 associated binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4066],DEAFNESS AUTOSOMAL RECESSIVE 26,GAB1,2549,NM_002039;NM_207123
REST_TF,REST,REST_TF,REST,TF,37,1.65388424921012,0.410177842974129,0.406556455484286,0.422076687583614,0.0155202320993278,0.135530218790548,1.35077281610926,6.74102429057478,6.72088457984573,6.80719762582737,0.0863130459816448,0.27519638738689,ENSG00000084093,REST,protein_coding,4,1,56907876,56966678,q12,RE1 silencing transcription factor [Source:HGNC Symbol;Acc:HGNC:9966],FIBROMATOSIS GINGIVAL 5;Hereditary gingival fibromatosis;Nephroblastoma;Wilms tumor 6,REST,5978,NM_001193508;NM_001363453;NM_005612
CSRNP2_TF,CSRNP2,CSRNP2_TF,CSRNP2,TF,33,1.65360592510949,0.235296065523145,0.23194736930353,0.24629892453045,0.0143515552269201,0.135585741134698,0.688413665468836,4.33975725889394,4.3275242798313,4.37995133295691,0.0524270531256113,0.598877638944172,ENSG00000110925,CSRNP2,protein_coding,12,-1,51061205,51083664,q13.12,cysteine and serine rich nuclear protein 2 [Source:HGNC Symbol;Acc:HGNC:16006],NA,CSRNP2,81566,NM_030809
RNASEH1_SIG,RNASEH1,RNASEH1_SIG,RNASEH1,SIG,30,1.6532972449125,0.479484523568233,0.47650496357838,0.489274506392035,0.0127695428136552,0.135649804528914,2.13697390101706,3.78099404992323,3.75708470250803,3.85955333428746,0.102468631779426,0.0750039102974562,ENSG00000171865,RNASEH1,protein_coding,2,-1,3541430,3558333,p25.3,ribonuclease H1 [Source:HGNC Symbol;Acc:HGNC:18466],Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONSAUTOSOMAL RECESSIVE 2,RNASEH1,246243,NM_001286834;NM_001286837;NM_002936
EPHX1_SIG,EPHX1,EPHX1_SIG,EPHX1,SIG,40,1.65298980480809,0.115587109516606,0.112304292134548,0.126373509486226,0.0140692173516788,0.135713542475886,1.85900126044428,3.50764063283028,3.45674638697797,3.67486458348786,0.21811819650989,0.124954134837989,ENSG00000143819,EPHX1,protein_coding,1,1,225810092,225845563,q42.12,epoxide hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:3401],Familial hypercholanemia;HYPERCHOLANEMIA FAMILIAL,EPHX1,2052,NM_000120;NM_001136018;NM_001291163
RPL24_SIG,RPL24,RPL24_SIG,RPL24,SIG,45,1.6529002917617,0.808964907158331,0.802216557690805,0.831138055408771,0.0289214977179655,0.135716079624482,1.84515959583173,7.58043889665677,7.55452121664202,7.66559698813378,0.11107577149176,0.12786188116277,ENSG00000114391,RPL24,protein_coding,3,-1,101681091,101686718,q12.3,ribosomal protein L24 [Source:HGNC Symbol;Acc:HGNC:10325],NA,RPL24,6152,NM_000986
USP1_SIG,USP1,USP1_SIG,USP1,SIG,18,-1.65279967339168,0.426652482257652,0.434945230697786,0.399404880240072,-0.0355403504577141,0.13572173893584,-1.63256308160552,6.23014628447039,6.25311461631619,6.15467890840563,-0.0984357079105527,0.181423993505892,ENSG00000162607,USP1,protein_coding,1,1,62436297,62451804,p31.3,ubiquitin specific peptidase 1 [Source:HGNC Symbol;Acc:HGNC:12607],NA,USP1,7398,NM_001017415;NM_001017416;NM_003368
RLF_SIG,RLF,RLF_SIG,RLF,SIG,93,-1.65262015761791,0.294819621677846,0.302162859786497,0.270691839320851,-0.0314710204656458,0.135749563586131,-1.19183177369664,5.9977847299801,6.02243794267745,5.91678131683168,-0.105656625845764,0.340674739174393,ENSG00000117000,RLF,protein_coding,1,1,40161387,40240921,p34.2,rearranged L-myc fusion [Source:HGNC Symbol;Acc:HGNC:10025],NA,RLF,6018,NM_012421
USP34_SIG,USP34,USP34_SIG,USP34,SIG,41,1.65241946003098,0.476723971672328,0.474224690961699,0.484935894007252,0.0107112030455529,0.135783345234308,-0.465733081468631,7.87228210495058,7.87707522051576,7.856533296665,-0.0205419238507601,0.729762945212257,ENSG00000115464,USP34,protein_coding,2,-1,61187463,61470769,p15,ubiquitin specific peptidase 34 [Source:HGNC Symbol;Acc:HGNC:20066],NA,USP34,9736,NM_014709
TRMT1L_SIG,TRMT1L,TRMT1L_SIG,TRMT1L,SIG,91,1.6520468192943,0.203581285074819,0.196464008064882,0.226966623821753,0.0305026157568707,0.135865459667087,1.05406951434464,4.02977133781626,4.00232617213703,4.11994831076228,0.117622138625246,0.404037548175103,ENSG00000121486,TRMT1L,protein_coding,1,-1,185118101,185157072,q25.3,tRNA methyltransferase 1 like [Source:HGNC Symbol;Acc:HGNC:16782],NA,TRMT1L,81627,NM_001202423;NM_030934
ERCC6L_SIG,ERCC6L,ERCC6L_SIG,ERCC6L,SIG,16,-1.65137398275352,0.130844426577492,0.140035340193242,0.100645710411458,-0.0393896297817842,0.136024298203325,-0.130533622610033,1.97719792449315,1.98059411186258,1.96603902313643,-0.0145550887261545,0.926868040973438,ENSG00000186871,ERCC6L,protein_coding,X,-1,72204657,72239027,q13.1,ERCC excision repair 6 like, spindle assembly checkpoint helicase [Source:HGNC Symbol;Acc:HGNC:20794],NA,ERCC6L,54821,NM_001009954;NM_017669
TSN_SIG,TSN,TSN_SIG,TSN,SIG,18,1.65132109325135,0.472303782335858,0.468834034905005,0.483704381037229,0.0148703461322241,0.136024298203325,2.04135191984543,6.51138393579565,6.48806632552184,6.587998940981,0.0999326154591519,0.090002542635143,ENSG00000211460,TSN,protein_coding,2,1,121737103,121767853,q14.3,translin [Source:HGNC Symbol;Acc:HGNC:12379],NA,TSN,7247,NM_001261401;NM_004622
ABHD12_SIG,ABHD12,ABHD12_SIG,ABHD12,SIG,30,1.65018307462043,0.223850674263489,0.222065965732585,0.229714716579319,0.0076487508467342,0.136322083974379,2.37215963367304,4.86135194201205,4.83391363280789,4.95150638654001,0.117592753732119,0.0465490717654757,ENSG00000100997,ABHD12,protein_coding,20,-1,25294743,25390983,p11.21,abhydrolase domain containing 12 [Source:HGNC Symbol;Acc:HGNC:15868],Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome;Polyneuropathy hearing loss ataxia retinitis pigmentosa and cataract,ABHD12,26090,NM_001042472;NM_015600
UNG_SIG,UNG,UNG_SIG,UNG,SIG,76,1.64971350988161,0.416928536434168,0.409190138472466,0.442354701165473,0.0331645626930072,0.136431770810717,1.40741471249664,4.79768525054463,4.75561466279337,4.93591718172738,0.18030251893401,0.253769234706705,ENSG00000076248,UNG,protein_coding,12,1,109097574,109110992,q24.11,uracil DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:12572],Hyper-IgM syndrome type 5;IMMUNODEFICIENCY WITH HYPER-IgM TYPE 5,UNG,7374,NM_003362;NM_080911
SNRPG_SIG,SNRPG,SNRPG_SIG,SNRPG,SIG,10,1.6487851431042,0.238519500902443,0.236661715517382,0.24462365288193,0.00796193736454798,0.136671029545947,1.40946110516849,3.07148948688278,3.05613345667453,3.12194501470991,0.0658115580353856,0.253034002447159,ENSG00000143977,SNRPG,protein_coding,2,-1,70281362,70293740,p13.3,small nuclear ribonucleoprotein polypeptide G [Source:HGNC Symbol;Acc:HGNC:11163],NA,SNRPG,6637,NM_001317165;NM_001317166;NM_001317167;NM_001317168;NM_001317169;NM_001317171;NM_003096
MUS81_SIG,MUS81,MUS81_SIG,MUS81,SIG,44,1.64837643197198,0.140703639195573,0.134207538897287,0.162047968747085,0.0278404298497981,0.13676373409736,0.247542327101834,5.18958470909692,5.18559649340521,5.20268884636967,0.0170923529644602,0.859513672396116,ENSG00000172732,MUS81,protein_coding,11,1,65857126,65867653,q13.1,MUS81 structure-specific endonuclease subunit [Source:HGNC Symbol;Acc:HGNC:29814],NA,MUS81,80198,NM_001350283;NM_025128
ZNF408_TF,ZNF408,ZNF408_TF,ZNF408,TF,50,1.64743322539084,0.225549278965143,0.223084905891179,0.233646504779596,0.0105615988884168,0.13700763424951,1.61446720936083,3.8976398660419,3.87589854006478,3.96907565139531,0.0931771113305345,0.186541821243509,ENSG00000175213,ZNF408,protein_coding,11,1,46700818,46705912,p11.2,zinc finger protein 408 [Source:HGNC Symbol;Acc:HGNC:20041],Exudative vitreoretinopathy 6;Familial exudative vitreoretinopathy;Retinitis pigmentosa;RETINITIS PIGMENTOSA 72,ZNF408,79797,NM_001184751;NM_024741
POLR2G_SIG,POLR2G,POLR2G_SIG,POLR2G,SIG,11,1.64621881757449,0.383084894594271,0.379730414159277,0.394106758880679,0.014376344721402,0.137328717654038,1.47064955728936,5.4114645365675,5.39814203028798,5.45523848577162,0.0570964554836388,0.231673252975844,ENSG00000168002,POLR2G,protein_coding,11,1,62761565,62766710,q12.3,RNA polymerase II subunit G [Source:HGNC Symbol;Acc:HGNC:9194],NA,POLR2G,5436,NM_002696
HSPA1A_SIG,HSPA1A,HSPA1A_SIG,HSPA1A,SIG,19,-1.64548030395737,0.0783820971597509,0.0825936305289758,0.0645442018037264,-0.0180494287252492,0.137515304544396,0.794983636698204,5.61481848008522,5.58412463151856,5.71566969680421,0.13154506528565,0.537989679024885,ENSG00000204389,HSPA1A,protein_coding,6,1,31815464,31817946,p21.33,heat shock protein family A (Hsp70) member 1A [Source:HGNC Symbol;Acc:HGNC:5232],NA,HSPA1A,3303,NM_005345
S1PR4_SIG,S1PR4,S1PR4_SIG,S1PR4,SIG,24,-1.64491745056798,0.200899929527966,0.203236660588443,0.193222098900684,-0.010014561687759,0.137652199048367,-0.67127514073982,5.23934807178464,5.25654332578199,5.18284938007907,-0.0736939457029235,0.608685909332783,ENSG00000125910,S1PR4,protein_coding,19,1,3172346,3180332,p13.3,sphingosine-1-phosphate receptor 4 [Source:HGNC Symbol;Acc:HGNC:3170],NA,S1PR4,8698,NM_003775
COX7C_SIG,COX7C,COX7C_SIG,COX7C,SIG,22,1.64475446667226,0.359694452461478,0.356304243791054,0.370833709521442,0.0145294657303873,0.137675606334815,1.20503500963645,5.74681360791142,5.72987138185909,5.80248092208336,0.0726095402242643,0.334499657481077,ENSG00000127184,COX7C,protein_coding,5,1,86617928,86620962,q14.3,cytochrome c oxidase subunit 7C [Source:HGNC Symbol;Acc:HGNC:2292],NA,COX7C,1350,NM_001867
BCDIN3D_SIG,BCDIN3D,BCDIN3D_SIG,BCDIN3D,SIG,56,1.6436098522985,0.208722338954403,0.204086185284757,0.223955415297526,0.0198692300127692,0.137978028786437,1.38263521423268,1.48889931905897,1.46532775343853,1.56634874895468,0.101020995516143,0.263175825409929,ENSG00000186666,BCDIN3D,protein_coding,12,-1,49836043,49843106,q13.12,BCDIN3 domain containing RNA methyltransferase [Source:HGNC Symbol;Acc:HGNC:27050],NA,BCDIN3D,144233,NM_181708
MRPL18_SIG,MRPL18,MRPL18_SIG,MRPL18,SIG,63,1.6428481547343,0.390834343036132,0.38455781140658,0.41145723267609,0.0268994212695107,0.138171885667409,0.733353883418448,5.06893490014374,5.05418117349386,5.11741143056474,0.0632302570708728,0.572727327038125,ENSG00000112110,MRPL18,protein_coding,6,1,159789812,159798436,q25.3,mitochondrial ribosomal protein L18 [Source:HGNC Symbol;Acc:HGNC:14477],NA,MRPL18,29074,NM_001318817;NM_014161
ZNF524_TF,ZNF524,ZNF524_TF,ZNF524,TF,187,-1.64276246767071,0.106835664752127,0.110355177963797,0.0952715499137841,-0.0150836280500125,0.138173339928636,-1.71924811295069,3.57854868173905,3.60131041295601,3.50376013631188,-0.0975502766441325,0.158053557065362,ENSG00000171443,ZNF524,protein_coding,19,1,55600022,55603138,q13.42,zinc finger protein 524 [Source:HGNC Symbol;Acc:HGNC:28322],NA,ZNF524,147807,NM_153219
ZNF850_TF,ZNF850,ZNF850_TF,ZNF850,TF,228,-1.64216319055922,0.0751859750833664,0.0783235049175198,0.0648769484854339,-0.013446556432086,0.138321106534634,-1.77138305922638,3.16210357325979,3.20564649951023,3.01903395843689,-0.18661254107334,0.14509655578133,ENSG00000267041,ZNF850,protein_coding,19,-1,36714383,36772825,q13.12,zinc finger protein 850 [Source:HGNC Symbol;Acc:HGNC:27994],NA,ZNF850,342892,NM_001193552;NM_001267779
TGS1_SIG,TGS1,TGS1_SIG,TGS1,SIG,48,1.64153278891197,0.317178159937766,0.314649214997257,0.32548755045658,0.0108383354593233,0.138477869984302,0.556059840116253,4.75952972411413,4.75191795001583,4.78453983900855,0.0326218889927165,0.677423790371395,ENSG00000137574,TGS1,protein_coding,8,1,55773142,55825448,q12.1,trimethylguanosine synthase 1 [Source:HGNC Symbol;Acc:HGNC:17843],NA,TGS1,96764,NM_001317902;NM_024831
SLC24A3_SIG,SLC24A3,SLC24A3_SIG,SLC24A3,SIG,53,1.64031368089489,-0.0394854029191604,-0.0422348886422134,-0.0304513784005575,0.0117835102416561,0.138783687569726,-1.00779831444607,2.61902907931528,2.66653186954857,2.46294848283451,-0.203583386714061,0.42665619554345,ENSG00000185052,SLC24A3,protein_coding,20,1,19212646,19722937,p11.23,solute carrier family 24 member 3 [Source:HGNC Symbol;Acc:HGNC:10977],NA,SLC24A3,57419,NM_020689
ADPGK_SIG,ADPGK,ADPGK_SIG,ADPGK,SIG,63,1.64030037367171,0.100501302562852,0.0989536148018352,0.105586562349048,0.00663294754721305,0.138783687569726,0.980268960579024,7.22301080075691,7.21386200186267,7.25307113998082,0.0392091381181475,0.440613369454383,ENSG00000159322,ADPGK,protein_coding,15,-1,72751369,72785846,q24.1,ADP dependent glucokinase [Source:HGNC Symbol;Acc:HGNC:25250],NA,ADPGK,83440,NM_001365223;NM_001365224;NM_001365225;NM_001365226;NM_031284
CYLD_SIG,CYLD,CYLD_SIG,CYLD,SIG,62,-1.63862774256554,0.262869075803065,0.268024777519639,0.245928913020035,-0.0220958644996044,0.13923915191053,0.374152460232267,7.28402901516244,7.2775053207932,7.30546401094709,0.0279586901538824,0.783873955478289,ENSG00000083799,CYLD,protein_coding,16,1,50742050,50801935,q12.1,CYLD lysine 63 deubiquitinase [Source:HGNC Symbol;Acc:HGNC:2584],BROOKE-SPIEGLER SYNDROME;CYLINDROMATOSIS FAMILIAL;Familial cylindromatosis;Familial multiple trichoepithelioma;TRICHOEPITHELIOMA MULTIPLE FAMILIAL 1,CYLD,1540,NM_001042355;NM_001042412;NM_015247
CDON_SIG,CDON,CDON_SIG,CDON,SIG,50,1.6384499321803,-0.105633722872568,-0.10773908034587,-0.098716119746004,0.00902296059986659,0.139266988315793,1.92069542124233,0.501370949905043,0.476795146459858,0.582120018367794,0.105324871907936,0.112157923830631,ENSG00000064309,CDON,protein_coding,11,-1,125955796,126063335,q24.2,cell adhesion associated, oncogene regulated [Source:HGNC Symbol;Acc:HGNC:17104],Alobar holoprosencephaly;Holoprosencephaly 11;Lobar holoprosencephaly;Microform holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Pituitary stalk interruption syndrome;Semilobar holoprosencephaly;Septopreoptic holoprosencephaly,CDON,50937,NM_001243597;NM_016952
ADSSL1_SIG,ADSSL1,ADSSL1_SIG,ADSSL1,SIG,24,-1.63680928218505,-0.0640068489741713,-0.0612594752994172,-0.0730339339055062,-0.011774458606089,0.139714487983078,-1.77481912593808,1.71385502370294,1.75327072269415,1.58434629844609,-0.168924424248059,0.144232423304002,ENSG00000185100,ADSSL1,protein_coding,14,1,104724186,104747325,q32.33,adenylosuccinate synthase like 1 [Source:HGNC Symbol;Acc:HGNC:20093],Adenylosuccinate synthetase-like 1-related distal myopathy;MYOPATHY DISTAL 5,ADSSL1,122622,NM_001320424;NM_152328;NM_199165
CHEK2_SIG,CHEK2,CHEK2_SIG,CHEK2,SIG,15,1.63633113182071,0.252776965665973,0.244896066822957,0.278671347578741,0.0337752807557833,0.13982868458439,0.0901556466866159,3.63053107706488,3.62852828075609,3.63711169350806,0.00858341275196514,0.949747760749156,ENSG00000183765,CHEK2,protein_coding,22,-1,28687743,28742422,q12.1,checkpoint kinase 2 [Source:HGNC Symbol;Acc:HGNC:16627],Breast Cancer;Familial prostate cancer;Hereditary breast and ovarian cancer syndrome;Li-Fraumeni syndrome;LI-FRAUMENI SYNDROME 2;OSTEOGENIC SARCOMA;OSTEOSARCOMA;Prostate Cancer,CHEK2,11200,NM_001005735;NM_001257387;NM_001349956;NM_007194;NM_145862
METTL4_SIG,METTL4,METTL4_SIG,METTL4,SIG,15,1.63525345751097,0.346055257591487,0.341505313020996,0.361005075465961,0.0194997624449653,0.140115444607658,1.6914319445913,3.39245208375082,3.36661285809929,3.47735239660586,0.110739538506564,0.165302022606649,ENSG00000101574,METTL4,protein_coding,18,-1,2537525,2571509,p11.32,methyltransferase like 4 [Source:HGNC Symbol;Acc:HGNC:24726],NA,METTL4,64863,NM_001308401;NM_022840
PTGER3_SIG,PTGER3,PTGER3_SIG,PTGER3,SIG,52,1.6349694551583,-0.146618562397212,-0.149312580417297,-0.137766788902646,0.011545791514651,0.140173973984784,2.02446084495567,1.01980463312182,0.945538067520687,1.2638233486684,0.318285281147713,0.0928597003309206,ENSG00000050628,PTGER3,protein_coding,1,-1,70852353,71047808,p31.1,prostaglandin E receptor 3 [Source:HGNC Symbol;Acc:HGNC:9595],NA,PTGER3,5733,NM_001126044;NM_198714;NM_198715;NM_198716;NM_198717;NM_198718;NM_198719
HDAC9_SIG,HDAC9,HDAC9_SIG,HDAC9,SIG,31,-1.63455755307782,0.16187811078886,0.167632933173388,0.142969408668269,-0.0246635245051199,0.140269364854868,-1.66230879425494,4.02998980085844,4.09788262654238,3.8069133736112,-0.290969252931181,0.173191432745632,ENSG00000048052,HDAC9,protein_coding,7,1,18086949,19002416,p21.1,histone deacetylase 9 [Source:HGNC Symbol;Acc:HGNC:14065],NA,HDAC9,9734,NM_001204144;NM_001204145;NM_001204146;NM_001204147;NM_001204148;NM_001321868;NM_001321869;NM_001321870;NM_001321871;NM_001321872;NM_001321873;NM_001321874;NM_001321875;NM_001321876;NM_001321877;NM_001321878;NM_001321879;NM_001321884;NM_001321885;NM_001321886;NM_001321887;NM_001321888;NM_001321889;NM_001321890;NM_001321891;NM_001321893;NM_001321894;NM_001321895;NM_001321896;NM_001321897;NM_001321898;NM_001321899;NM_001321900;NM_001321901;NM_001321902;NM_014707;NM_058176;NM_178423;NM_178425
CTH_SIG,CTH,CTH_SIG,CTH,SIG,26,-1.6340304533955,-0.178308103174399,-0.17613646641726,-0.185443481090715,-0.00930701467345562,0.140398011370896,-1.5059444175369,1.40979037170461,1.44074986547668,1.30806632073922,-0.132683544737466,0.219981949726725,ENSG00000116761,CTH,protein_coding,1,1,70411218,70439851,p31.1,cystathionine gamma-lyase [Source:HGNC Symbol;Acc:HGNC:2501],CYSTATHIONINURIA,CTH,1491,NM_001190463;NM_001902;NM_153742
UTS2_SIG,UTS2,UTS2_SIG,UTS2,SIG,4,-1.63263538884665,-0.0732668631732478,-0.0710446613373507,-0.0805683834911956,-0.00952372215384481,0.140777324789286,0.0108185246240244,0.518212134781303,0.517964726425377,0.519025047950773,0.00106032152539557,0.993984029469574,ENSG00000049247,UTS2,protein_coding,1,-1,7843083,7853512,p36.23,urotensin 2 [Source:HGNC Symbol;Acc:HGNC:12636],NA,UTS2,10911,NM_006786;NM_021995
SPEG_SIG,SPEG,SPEG_SIG,SPEG,SIG,38,-1.63255325500037,-0.128732974424571,-0.125261717883836,-0.140138531629842,-0.0148768137460061,0.140777728084913,-0.885574308634013,0.855300653964164,0.875325659765264,0.789504206331976,-0.0858214534332877,0.489434740525382,ENSG00000072195,SPEG,protein_coding,2,1,219434843,219493629,q35,striated muscle enriched protein kinase [Source:HGNC Symbol;Acc:HGNC:16901],Autosomal recessive centronuclear myopathy;Centronuclear myopathy with dilated cardiomyopathy;Myopathy centronuclear 5,SPEG,10290,NM_001173476;NM_005876
CDIPT_SIG,CDIPT,CDIPT_SIG,CDIPT,SIG,12,1.63246050126247,0.235600248952482,0.232231416728055,0.246669269118456,0.0144378523904012,0.140781202362716,1.28465763601974,5.584211465515,5.56780146029371,5.63813005409923,0.070328593805521,0.301190303980034,ENSG00000103502,CDIPT,protein_coding,16,-1,29858357,29863414,p11.2,CDP-diacylglycerol--inositol 3-phosphatidyltransferase [Source:HGNC Symbol;Acc:HGNC:1769],NA,CDIPT,10423,NM_001286585;NM_001286586;NM_006319
TRIM27_TF,TRIM27,TRIM27_TF,TRIM27,TF,309,1.63205606431503,0.221833823343501,0.215977849997056,0.241074878624678,0.0250970286276222,0.140874742772679,1.52514231812231,5.67649749527572,5.64502821518841,5.77989655841971,0.134868343231293,0.2137270447116,ENSG00000204713,TRIM27,protein_coding,6,-1,28903002,28923988,p22.1,tripartite motif containing 27 [Source:HGNC Symbol;Acc:HGNC:9975],Differentiated thyroid carcinoma,TRIM27,5987,NM_006510
ADAR_SIG,ADAR,ADAR_SIG,ADAR,SIG,41,-1.63164496360076,0.333816549186879,0.336427358769771,0.325238174843094,-0.0111891839266764,0.140970256347812,-1.29464902505477,8.67540736748682,8.69006845853583,8.62723521118293,-0.0628332473528915,0.29719627787169,ENSG00000160710,ADAR,protein_coding,1,-1,154582057,154628013,q21.3,adenosine deaminase, RNA specific [Source:HGNC Symbol;Acc:HGNC:225],Aicardi-Goutieres syndrome;AICARDI-GOUTIERES SYNDROME 6;AICARDI-GOUTIERES SYNDROME ASSOCIATED WITH A TYPE I INTERFERON SIGNATURE;DYSCHROMATOSIS SYMMETRICA HEREDITARIA;DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1;Familial infantile bilateral striatal necrosis,ADAR,103,NM_001025107;NM_001111;NM_001193495;NM_001365045;NM_001365046;NM_001365047;NM_001365048;NM_001365049;NM_015840;NM_015841
AFF3_TF,AFF3,AFF3_TF,AFF3,TF,203,-1.63112756476985,0.0181956080629625,0.0200437940668728,0.0121229969072574,-0.00792079715961549,0.141096575208582,-1.50814289816872,4.22690989145554,4.28692617863696,4.02971351928803,-0.257212659348933,0.219378720022544,ENSG00000144218,AFF3,protein_coding,2,-1,99545419,100142739,q11.2,AF4/FMR2 family member 3 [Source:HGNC Symbol;Acc:HGNC:6473],Skeletal dysplasia with severe neurological disease,AFF3,3899,NM_001025108;NM_002285
TEP1_SIG,TEP1,TEP1_SIG,TEP1,SIG,90,1.63025832313231,0.325854916260643,0.322416481420744,0.337152630734599,0.0147361493138552,0.141324890853513,1.35193307864967,6.37983964203333,6.35387894563429,6.46513907305874,0.111260127424451,0.274674212234801,ENSG00000129566,TEP1,protein_coding,14,-1,20365667,20413501,q11.2,telomerase associated protein 1 [Source:HGNC Symbol;Acc:HGNC:11726],NA,TEP1,7011,NM_001319035;NM_007110
ZCCHC9_SIG,ZCCHC9,ZCCHC9_SIG,ZCCHC9,SIG,17,1.62805784731441,0.252374348876301,0.247551901204181,0.268219534084695,0.0206676328805143,0.141939391255385,1.00529996754545,4.00339844412593,3.99031612848479,4.04638319551825,0.0560670670334659,0.427909488212711,ENSG00000131732,ZCCHC9,protein_coding,5,1,81301587,81313297,q14.1,zinc finger CCHC-type containing 9 [Source:HGNC Symbol;Acc:HGNC:25424],NA,ZCCHC9,84240,NM_001131035;NM_001131036;NM_032280
FKBP2_SIG,FKBP2,FKBP2_SIG,FKBP2,SIG,34,1.6279794721921,0.103977970019257,0.100867159655466,0.114199204071713,0.0133320444162474,0.141939391255385,1.45055390588734,4.95076440630646,4.93046747416743,5.01745432619184,0.0869868520244114,0.238422951622773,ENSG00000173486,FKBP2,protein_coding,11,1,64241003,64244134,q13.1,FKBP prolyl isomerase 2 [Source:HGNC Symbol;Acc:HGNC:3718],NA,FKBP2,2286,NM_001135208;NM_004470;NM_057092
TDG_SIG,TDG,TDG_SIG,TDG,SIG,20,1.62766208606807,0.374387125859559,0.370473797968585,0.387245203215617,0.0167714052470328,0.142008185125193,0.695077931873029,4.86009588006033,4.85005948111714,4.89307261944511,0.0430131383279697,0.594969593615527,ENSG00000139372,TDG,protein_coding,12,1,103965822,103988874,q23.3,thymine DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:11700],NA,TDG,6996,NM_003211
RBKS_SIG,RBKS,RBKS_SIG,RBKS,SIG,35,-1.62755659908621,0.0335272791081566,0.036112382290329,0.0250333686524475,-0.0110790136378815,0.142015368506742,-0.433959819044973,3.19216651189943,3.2038495193854,3.15377948730267,-0.0500700320827242,0.748041096492369,ENSG00000171174,RBKS,protein_coding,2,-1,27781379,27890681,p23.2,ribokinase [Source:HGNC Symbol;Acc:HGNC:30325],NA,RBKS,64080,NM_001287580;NM_022128
ZNF394_TF,ZNF394,ZNF394_TF,ZNF394,TF,157,-1.62739098441795,0.145707099436269,0.15124880794795,0.127498628612175,-0.0237501793357753,0.142040042152853,-1.96611714358047,5.99137120155395,6.03225230245707,5.85704758430082,-0.175204718156253,0.10325902604902,ENSG00000160908,ZNF394,protein_coding,7,-1,99473877,99504857,q22.1,zinc finger protein 394 [Source:HGNC Symbol;Acc:HGNC:18832],NA,ZNF394,84124,NM_001345967;NM_032164
PGAP1_SIG,PGAP1,PGAP1_SIG,PGAP1,SIG,17,-1.62631837958041,-0.0571961151546386,-0.0542021972898549,-0.0670332738532138,-0.012831076563359,0.14232874232454,-1.99550747262914,2.67394873700211,2.73028553333315,2.48884212048583,-0.241443412847322,0.0978950323339267,ENSG00000197121,PGAP1,protein_coding,2,-1,196833004,196927796,q33.1,post-GPI attachment to proteins 1 [Source:HGNC Symbol;Acc:HGNC:25712],Autosomal recessive non-syndromic intellectual disability;Autosomal recessive spastic paraplegia type 67;Intellectual disability encephalopathy impaired GPI-anchor maturation;Mental retardation autosomal recessive 42,PGAP1,80055,NM_001321099;NM_001321100;NM_024989
INTS12_SIG,INTS12,INTS12_SIG,INTS12,SIG,16,1.62583527008337,0.26658799429588,0.264606288325463,0.273099313912966,0.00849302558750329,0.142445976420728,2.10228421260159,4.55152456372047,4.53401343782221,4.60906112024331,0.0750476824210962,0.0800266276861514,ENSG00000138785,INTS12,protein_coding,4,-1,105682627,105895986,q24,integrator complex subunit 12 [Source:HGNC Symbol;Acc:HGNC:25067],NA,INTS12,57117,NM_001142471;NM_020395
ASB9_SIG,ASB9,ASB9_SIG,ASB9,SIG,25,-1.6253586265379,-0.044213618299187,-0.041060604947881,-0.0545735193106207,-0.0135129143627396,0.142546052965497,-0.603195891059712,1.6002963987949,1.61846011612838,1.5406156132706,-0.0778445028577796,0.649065911523673,ENSG00000102048,ASB9,protein_coding,X,-1,15235288,15270467,p22.2,ankyrin repeat and SOCS box containing 9 [Source:HGNC Symbol;Acc:HGNC:17184],NA,ASB9,140462,NM_001031739;NM_001168530;NM_001168531;NM_024087
USP14_SIG,USP14,USP14_SIG,USP14,SIG,53,1.62533043853466,0.360161195937167,0.357624769414294,0.368495168798033,0.0108703993837388,0.142546052965497,1.59403662013123,5.97865401345765,5.95574517758436,6.0539259027556,0.0981807251712378,0.192336111420278,ENSG00000101557,USP14,protein_coding,18,1,158383,214629,p11.32,ubiquitin specific peptidase 14 [Source:HGNC Symbol;Acc:HGNC:12612],NA,USP14,9097,NM_001037334;NM_005151
OGDHL_SIG,OGDHL,OGDHL_SIG,OGDHL,SIG,38,1.62418281950963,-0.153854409388714,-0.15574846828181,-0.147631073025683,0.00811739525612713,0.142857438221004,1.00938743084565,0.336087796543913,0.319436057152656,0.390800654543758,0.0713645973911015,0.42598305101813,ENSG00000197444,OGDHL,protein_coding,10,-1,49734641,49762379,q11.23,oxoglutarate dehydrogenase like [Source:HGNC Symbol;Acc:HGNC:25590],NA,OGDHL,55753,NM_001143996;NM_001143997;NM_001347819;NM_001347820;NM_001347821;NM_001347822;NM_001347823;NM_001347824;NM_001347825;NM_001347826;NM_018245
TNRC6A_SIG,TNRC6A,TNRC6A_SIG,TNRC6A,SIG,56,1.62295885886402,0.421391793521738,0.419293630588184,0.42828575744627,0.00899212685808612,0.143191686400746,2.01986261273587,6.18847163008004,6.16429261078576,6.2679169791898,0.103624368404042,0.0936475396005728,ENSG00000090905,TNRC6A,protein_coding,16,1,24610209,24827632,p12.1,trinucleotide repeat containing 6A [Source:HGNC Symbol;Acc:HGNC:11969],EPILEPSY FAMILIAL ADULT MYOCLONIC 6,TNRC6A,27327,NM_001330520;NM_001351850;NM_014494
PDHB_SIG,PDHB,PDHB_SIG,PDHB,SIG,62,1.62275362604547,0.478144480054412,0.471477367963119,0.50005070549723,0.0285733375341106,0.143197326432787,1.33722421894045,5.13643607399008,5.11219387468921,5.21608901455008,0.103895139860871,0.280183594342018,ENSG00000168291,PDHB,protein_coding,3,-1,58427630,58433857,p14.3,pyruvate dehydrogenase E1 beta subunit [Source:HGNC Symbol;Acc:HGNC:8808],PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY,PDHB,5162,NM_000925;NM_001173468;NM_001315536
GGH_SIG,GGH,GGH_SIG,GGH,SIG,37,-1.62273398302128,0.261606212793414,0.266874015564762,0.244297717973272,-0.0225762975914905,0.143197326432787,-1.33519289751752,4.07502891526199,4.11063223267615,3.95804658661546,-0.152585646060691,0.280943807057395,ENSG00000137563,GGH,protein_coding,8,-1,63015079,63038806,q12.3,gamma-glutamyl hydrolase [Source:HGNC Symbol;Acc:HGNC:4248],Methotrexate toxicity or dose selection,GGH,8836,NM_003878
IKZF1_TF,IKZF1,IKZF1_TF,IKZF1,TF,124,-1.62269710026423,0.269000072585996,0.271978528181161,0.259213718487594,-0.0127648096935673,0.143197326432787,-1.67120851660085,8.10549411461683,8.13088334034082,8.02207237295229,-0.10881096738853,0.170723927945063,ENSG00000185811,IKZF1,protein_coding,7,1,50304068,50405101,p12.2,IKAROS family zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13176],IMMUNODEFICIENCY COMMON VARIABLE 13;Pancytopenia due to IKZF1 mutations;Precursor B-cell acute lymphoblastic leukemia;Stevens-Johnson syndrome,IKZF1,10320,NM_001220765;NM_001220767;NM_001220768;NM_001220770;NM_001220771;NM_001291837;NM_001291838;NM_001291839;NM_001291840;NM_001291841;NM_001291842;NM_001291843;NM_001291844;NM_001291845;NM_001291846;NM_001291847;NM_006060
PTPRC_SIG,PTPRC,PTPRC_SIG,PTPRC,SIG,48,-1.62227677632163,0.408921722282918,0.412246359468245,0.397997914388273,-0.0142484450799722,0.143296707377268,0.54395802596309,9.18417216137189,9.17384648531092,9.21809938271508,0.0442528974041513,0.684200436759374,ENSG00000081237,PTPRC,protein_coding,1,1,198638457,198757476,q31.3,protein tyrosine phosphatase, receptor type C [Source:HGNC Symbol;Acc:HGNC:9666],HEPATITIS C VIRUS SUSCEPTIBILITY TO;Severe combined immunodeficiency autosomal recessive T cell-negative B cell-positive NK cell-positive;T-B+ severe combined immunodeficiency due to CD45 deficiency,PTPRC,5788,NM_001267798;NM_002838;NM_080921
B3GNT8_SIG,B3GNT8,B3GNT8_SIG,B3GNT8,SIG,34,-1.62198894333901,0.300822027149029,0.305718158534221,0.28473473831197,-0.0209834202222511,0.143357330942822,-0.616832044676441,3.59627855194452,3.616200897736,3.5308194157725,-0.0853814819635065,0.640400766386038,ENSG00000177191,B3GNT8,protein_coding,19,-1,41425359,41428730,q13.2,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 [Source:HGNC Symbol;Acc:HGNC:24139],NA,B3GNT8,374907,NM_198540
FARP2_SIG,FARP2,FARP2_SIG,FARP2,SIG,43,1.6216601715807,0.018077231425286,0.0165554533305237,0.0230773594509334,0.00652190612040961,0.143429968116639,1.74496213583985,4.45602581981117,4.42594841095462,4.5548515917684,0.128903180813784,0.15142054650599,ENSG00000006607,FARP2,protein_coding,2,1,241356285,241494841,q37.3,FERM, ARH/RhoGEF and pleckstrin domain protein 2 [Source:HGNC Symbol;Acc:HGNC:16460],NA,FARP2,9855,NM_001282983;NM_001282984;NM_014808
STK38_SIG,STK38,STK38_SIG,STK38,SIG,110,-1.62142673025475,0.178433774903447,0.182917220179589,0.163702454710409,-0.0192147654691793,0.143474693634112,-2.07031827173104,6.57123326670197,6.61542226428166,6.42604084608302,-0.189381418198637,0.0849753792250175,ENSG00000112079,STK38,protein_coding,6,-1,36493892,36547479,p21.31,serine/threonine kinase 38 [Source:HGNC Symbol;Acc:HGNC:17847],NA,STK38,11329,NM_001305102;NM_007271
PRKAR2A_SIG,PRKAR2A,PRKAR2A_SIG,PRKAR2A,SIG,24,1.62129064128286,0.0188570650965806,0.0169802632979218,0.0250236995778882,0.00804343627996625,0.143490897042303,1.83397289638407,6.129817813995,6.10769713501321,6.20250004493518,0.0948029099219731,0.130286643818663,ENSG00000114302,PRKAR2A,protein_coding,3,-1,48744597,48847874,p21.31,protein kinase cAMP-dependent type II regulatory subunit alpha [Source:HGNC Symbol;Acc:HGNC:9391],NA,PRKAR2A,5576,NM_001321982;NM_001321983;NM_001321989;NM_004157
ZC3H7A_TF,ZC3H7A,ZC3H7A_TF,ZC3H7A,TF,59,-1.62090353646622,0.181169916975959,0.183319076877973,0.174108391583626,-0.00921068529434736,0.143580688003033,-0.971355635367766,6.43090038112025,6.43992910862156,6.40123456218736,-0.0386945464342007,0.444835871056339,ENSG00000122299,ZC3H7A,protein_coding,16,-1,11750586,11797258,p13.13,zinc finger CCCH-type containing 7A [Source:HGNC Symbol;Acc:HGNC:30959],NA,ZC3H7A,29066,NM_014153
MGAT3_SIG,MGAT3,MGAT3_SIG,MGAT3,SIG,40,-1.61994386165302,-0.0177089274263516,-0.0130238619166127,-0.0331027141012079,-0.0200788521845953,0.143838556449044,-1.0794717002203,2.26282846275415,2.30423945500997,2.1267637739136,-0.177475681096364,0.392316712029341,ENSG00000128268,MGAT3,protein_coding,22,1,39457012,39492194,q13.1,mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7046],NA,MGAT3,4248,NM_001098270;NM_002409
SCYL1_TF,SCYL1,SCYL1_TF,SCYL1,TF,98,1.6189641128645,0.120701072892272,0.119293919237305,0.125324577758594,0.00603065852128918,0.144102680073971,-0.89206456729477,6.00064149357656,6.00824347459441,5.9756635559465,-0.0325799186479064,0.486028067965962,ENSG00000142186,SCYL1,protein_coding,11,1,65525077,65538704,q13.1,SCY1 like pseudokinase 1 [Source:HGNC Symbol;Acc:HGNC:14372],Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome;Episodes of Liver Failure Peripheral Neuropathy Cerebellar Atrophy and Ataxia;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 21,SCYL1,57410,NM_001048218;NM_020680
CD7_SIG,CD7,CD7_SIG,CD7,SIG,33,-1.61886486566485,0.00972173731289374,0.0141670475921938,-0.00488428217623497,-0.0190513297684286,0.14410809567342,-2.37610867007482,4.01346662230781,4.10847243745216,3.70130465826209,-0.407167779190072,0.0461655935282847,ENSG00000173762,CD7,protein_coding,17,-1,82314868,82317608,q25.3,CD7 molecule [Source:HGNC Symbol;Acc:HGNC:1695],NA,CD7,924,NM_006137
OPN3_SIG,OPN3,OPN3_SIG,OPN3,SIG,23,1.61724319159087,0.332932430852403,0.32768097401497,0.350187217603965,0.0225062435889946,0.144561702159516,3.1562815048162,4.26379448716086,4.17753296882863,4.54722519025249,0.369692221423866,0.00713297169045769,ENSG00000054277,OPN3,protein_coding,1,-1,241590102,241677376,q43,opsin 3 [Source:HGNC Symbol;Acc:HGNC:14007],NA,OPN3,23596,NM_014322
TFIP11_SIG,TFIP11,TFIP11_SIG,TFIP11,SIG,26,-1.61362364006557,0.192428481857884,0.194880876817503,0.184370612704849,-0.0105102641126542,0.145605156425988,0.0663161908818431,5.48729105557756,5.48649864913246,5.48989467675429,0.00339602762182519,0.963782863259002,ENSG00000100109,TFIP11,protein_coding,22,-1,26491225,26512505,q12.1,tuftelin interacting protein 11 [Source:HGNC Symbol;Acc:HGNC:17165],NA,TFIP11,24144,NM_001008697;NM_001346857;NM_001346858;NM_001346859;NM_001346861;NM_001346862;NM_012143
BMI1_SIG,BMI1,BMI1_SIG,BMI1,SIG,16,1.61355123320035,0.197065799802815,0.194164724775949,0.20659790346252,0.0124331786865709,0.145605156425988,0.68266642017476,5.55948393059415,5.54326215945687,5.6127840357595,0.0695218763026375,0.601872210140232,ENSG00000168283,BMI1,protein_coding,10,1,22321099,22331484,p12.2,BMI1 proto-oncogene, polycomb ring finger [Source:HGNC Symbol;Acc:HGNC:1066],NA,BMI1,648,NM_005180
SIN3A_SIG,SIN3A,SIN3A_SIG,SIN3A,SIG,36,1.61261475005703,0.508874680099405,0.506161091887343,0.517790755653323,0.0116296637659804,0.145858915854852,-0.167490651563595,7.06002885700651,7.06203348085127,7.05344223580227,-0.00859124504900151,0.906033824232018,ENSG00000169375,SIN3A,protein_coding,15,-1,75369379,75455842,q24.2,SIN3 transcription regulator family member A [Source:HGNC Symbol;Acc:HGNC:19353],15q24 microdeletion syndrome;SIN3A-related intellectual disability syndrome due to a point mutation;Syndromic intellectual disability;Witteveen-kolk syndrome,SIN3A,25942,NM_001145357;NM_001145358;NM_015477
MYLIP_SIG,MYLIP,MYLIP_SIG,MYLIP,SIG,22,-1.61162344384883,0.484675588162459,0.489660764236725,0.46829572391844,-0.0213650403182854,0.146129306448278,-2.02133836722333,6.26444124890626,6.3154950902382,6.09669291310131,-0.218802177136894,0.0933970452728756,ENSG00000007944,MYLIP,protein_coding,6,1,16129086,16148248,p22.3,myosin regulatory light chain interacting protein [Source:HGNC Symbol;Acc:HGNC:21155],NA,MYLIP,29116,NM_013262
PHRF1_SIG,PHRF1,PHRF1_SIG,PHRF1,SIG,16,1.61099987552263,0.625710240989904,0.623062209761208,0.634410915027049,0.0113487052658412,0.146290646662562,0.900892641568677,5.95275374713795,5.94060037876042,5.99268624323557,0.0520858644751573,0.481444927544208,ENSG00000070047,PHRF1,protein_coding,11,1,576470,612222,p15.5,PHD and ring finger domains 1 [Source:HGNC Symbol;Acc:HGNC:24351],NA,PHRF1,57661,NM_001286581;NM_001286582;NM_001286583;NM_020901
RPS23_SIG,RPS23,RPS23_SIG,RPS23,SIG,14,1.609985963951,1.78333077366453,1.77496264387319,1.81082605726463,0.0358634133914379,0.146568378623854,2.92958372652136,8.54469526844867,8.49045865693337,8.7229012777132,0.232442620779826,0.0128886787683177,ENSG00000186468,RPS23,protein_coding,5,-1,82273320,82278396,q14.2,ribosomal protein S23 [Source:HGNC Symbol;Acc:HGNC:10410],BRACHYCEPHALY TRICHOMEGALY AND DEVELOPMENTAL DELAY;Microcephaly hearing loss and dysmorphic features,RPS23,6228,NM_001025
UPF1_SIG,UPF1,UPF1_SIG,UPF1,SIG,17,-1.60944648396392,0.271841300637832,0.273421825628054,0.266648147098532,-0.006773678529522,0.146705011030754,0.310176789951303,6.78383824779194,6.78091711956048,6.79343624055245,0.0125191209919721,0.821969567429086,ENSG00000005007,UPF1,protein_coding,19,1,18831938,18868236,p13.11,UPF1, RNA helicase and ATPase [Source:HGNC Symbol;Acc:HGNC:9962],NA,UPF1,5976,NM_001297549;NM_002911
PRPF40A_SIG,PRPF40A,PRPF40A_SIG,PRPF40A,SIG,36,1.60904629219295,0.630982844150855,0.628410103976107,0.639436133296456,0.0110260293203492,0.146800186099873,1.9114642121762,7.55494222306451,7.53848852541836,7.60900437247328,0.0705158470549163,0.114021852798417,ENSG00000196504,PRPF40A,protein_coding,2,-1,152651593,152717997,q23.3,pre-mRNA processing factor 40 homolog A [Source:HGNC Symbol;Acc:HGNC:16463],NA,PRPF40A,55660,NM_001354431;NM_001354432;NM_001365596;NM_001365597;NM_001365600;NM_017892
SLC43A1_SIG,SLC43A1,SLC43A1_SIG,SLC43A1,SIG,18,1.60794436237015,0.233942758693956,0.228087671151846,0.253180903475176,0.0250932323233303,0.147104941806773,1.7928530772052,4.70073758110724,4.65678721315894,4.84514593293737,0.188358719778431,0.139968030343403,ENSG00000149150,SLC43A1,protein_coding,11,-1,57484534,57515780,q12.1,solute carrier family 43 member 1 [Source:HGNC Symbol;Acc:HGNC:9225],NA,SLC43A1,8501,NM_001198810;NM_003627
ANKZF1_TF,ANKZF1,ANKZF1_TF,ANKZF1,TF,79,1.60698928013258,0.0933263175926707,0.0906732814839407,0.102043436235641,0.0113701547517002,0.147366242418614,1.94142138232332,5.50987338480141,5.47728192758581,5.61695960136697,0.139677673781165,0.108062677894498,ENSG00000163516,ANKZF1,protein_coding,2,1,219229757,219236669,q35,ankyrin repeat and zinc finger domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25527],NA,ANKZF1,55139,NM_001042410;NM_001282792;NM_018089
RNPS1_SIG,RNPS1,RNPS1_SIG,RNPS1,SIG,48,1.60599379209776,0.384912312337889,0.380141208474725,0.400588796459712,0.0204475879849863,0.147640000772432,1.46873765143505,7.22749810564189,7.21046946966111,7.28344933815018,0.0729798684890674,0.232363455763998,ENSG00000205937,RNPS1,protein_coding,16,-1,2253116,2268397,p13.3,RNA binding protein with serine rich domain 1 [Source:HGNC Symbol;Acc:HGNC:10080],NA,RNPS1,10921,NM_001286625;NM_001286626;NM_001286627;NM_006711;NM_080594
PPP1CB_SIG,PPP1CB,PPP1CB_SIG,PPP1CB,SIG,35,-1.60530000508298,0.482099939872961,0.48504804947148,0.472413294049252,-0.0126347554222279,0.147823647685942,-1.35969354661609,7.22709381936118,7.24566197971613,7.16608414962347,-0.0795778300926618,0.27190368964158,ENSG00000213639,PPP1CB,protein_coding,2,1,28751640,28802940,p23.2,protein phosphatase 1 catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:9282],NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR;NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2;Rasopathy with developmental delay short stature and sparse slow-growing hair,PPP1CB,5500,NM_002709;NM_206876
RFX1_TF,RFX1,RFX1_TF,RFX1,TF,69,1.60487332381907,0.181587301471133,0.177722943785861,0.194284476722742,0.0165615329368809,0.14792730547141,1.81857095512992,4.30177286960568,4.27675610547413,4.38397080889503,0.107214703420897,0.133970551792072,ENSG00000132005,RFX1,protein_coding,19,-1,13961530,14007039,p13.12,regulatory factor X1 [Source:HGNC Symbol;Acc:HGNC:9982],NA,RFX1,5989,NM_002918
AOC1_SIG,AOC1,AOC1_SIG,AOC1,SIG,11,1.60439971713237,-0.0664330029977251,-0.0690772210718325,-0.0577448578970865,0.0113323631747461,0.148045104303973,1.87988862126717,1.62167401153728,1.55360248006804,1.84533761493619,0.291735134868144,0.120462788715421,ENSG00000002726,AOC1,protein_coding,7,1,150824627,150861504,q36.1,amine oxidase, copper containing 1 [Source:HGNC Symbol;Acc:HGNC:80],NA,AOC1,26,NM_001091;NM_001272072
FZD5_SIG,FZD5,FZD5_SIG,FZD5,SIG,18,-1.60409509772667,0.0350128500200584,0.0373720478542134,0.0272611999935492,-0.0101108478606643,0.148106378410807,-3.04867993933004,2.8703714102716,2.94834736618872,2.61416469797248,-0.334182668216237,0.00948340842933037,ENSG00000163251,FZD5,protein_coding,2,-1,207762598,207769906,q33.3,frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043],Autosomal Dominant Coloboma;Coloboma of choroid and retina;Coloboma of eye lens;Coloboma of eyelid;Coloboma of iris;Coloboma of macula;Coloboma of optic disc,FZD5,7855,NM_003468
TPST2_SIG,TPST2,TPST2_SIG,TPST2,SIG,24,1.60403342444272,0.266141732666726,0.26408667931043,0.272894050837413,0.00880737152698295,0.148106378410807,-1.25894752624358,5.70234068236273,5.72422300956089,5.63044160728308,-0.093781402277811,0.311600859047707,ENSG00000128294,TPST2,protein_coding,22,-1,26521996,26596717,q12.1,tyrosylprotein sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:12021],NA,TPST2,8459,NM_001008566;NM_001362922;NM_001362923;NM_003595
ABO_SIG,ABO,ABO_SIG,ABO,SIG,40,1.60188885840425,-0.0581593651725942,-0.0619271148725808,-0.0457796161583523,0.0161474987142287,0.148727040996947,1.13031335804793,1.92261865941944,1.87505159823683,2.07891043187658,0.203858833639748,0.368093753070953,ENSG00000175164,ABO,protein_coding,9,-1,133250401,133276024,q34.2,ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase [Source:HGNC Symbol;Acc:HGNC:79],BLOOD GROUP ABO SYSTEM,ABO,28,NM_020469
KDM2A_SIG,KDM2A,KDM2A_SIG,KDM2A,SIG,39,-1.60166799197449,0.182198986607946,0.185545546369894,0.171203147390119,-0.0143423989797744,0.148747650072518,-1.29140674063571,8.16524781039072,8.17862460568333,8.12129548300073,-0.057329122682603,0.298444371879052,ENSG00000173120,KDM2A,protein_coding,11,1,67119263,67258082,q13.2,lysine demethylase 2A [Source:HGNC Symbol;Acc:HGNC:13606],NA,KDM2A,22992,NM_001256405;NM_012308
RELB_TF,RELB,RELB_TF,RELB,TF,91,-1.60165814482704,0.159685861580537,0.164767311974556,0.14298966742876,-0.0217776445457961,0.148747650072518,-1.34681640739878,4.72571069113357,4.7685043178203,4.58510306059146,-0.183401257228838,0.27651998540979,ENSG00000104856,RELB,protein_coding,19,1,45001449,45038198,q13.32,RELB proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9956],IMMUNODEFICIENCY 53,RELB,5971,NM_006509
ZNF770_TF,ZNF770,ZNF770_TF,ZNF770,TF,71,1.60145466063584,0.273675727990033,0.270659230233543,0.28358707776136,0.0129278475278171,0.148784514026786,1.43288172844155,5.44696902948137,5.42074334294309,5.53313914239285,0.11239579944976,0.244536219101622,ENSG00000198146,ZNF770,protein_coding,15,-1,34978341,34988287,q14,zinc finger protein 770 [Source:HGNC Symbol;Acc:HGNC:26061],NA,ZNF770,54989,NM_014106
AREG_SIG,AREG,AREG_SIG,AREG,SIG,20,-1.60070955731871,0.310416000998298,0.316754922106452,0.289588117357219,-0.0271668047492329,0.148964489348522,-1.69824471438972,1.94892018596699,2.02540382533706,1.69761679946533,-0.327787025871732,0.16362326611226,ENSG00000109321,AREG,protein_coding,4,1,74445136,74455005,q13.3,amphiregulin [Source:HGNC Symbol;Acc:HGNC:651],NA,AREG,374,NM_001657
ABCC4_SIG,ABCC4,ABCC4_SIG,ABCC4,SIG,38,1.60069540627726,0.0356992818115202,0.0320568827281709,0.0476671645139534,0.0156102817857823,0.148964489348522,1.8179945802742,4.68655398322559,4.62489854922476,4.88913612351405,0.264237574289293,0.134073148386233,ENSG00000125257,ABCC4,protein_coding,13,-1,95019835,95301475,q32.1,ATP binding cassette subfamily C member 4 [Source:HGNC Symbol;Acc:HGNC:55],NA,ABCC4,10257,NM_001105515;NM_001301829;NM_001301830;NM_005845
NAGK_SIG,NAGK,NAGK_SIG,NAGK,SIG,45,-1.60050027236498,0.229616894132508,0.234286650317718,0.21427340952396,-0.0200132407937579,0.148998875112237,-1.40255666681093,6.03201124286274,6.06121375630932,5.93606012725257,-0.125153629056749,0.255624731639363,ENSG00000124357,NAGK,protein_coding,2,1,71064344,71079808,p13.3,N-acetylglucosamine kinase [Source:HGNC Symbol;Acc:HGNC:17174],NA,NAGK,55577,NM_001330425;NM_001330426;NM_001365466;NM_017567
CYP27B1_SIG,CYP27B1,CYP27B1_SIG,CYP27B1,SIG,21,1.59955720491145,0.15713930791876,0.154054647015619,0.167274622314795,0.0132199752991759,0.149259055784487,0.567496499910062,1.33352892224947,1.32289562719288,1.3684668917211,0.0455712645282172,0.670322012891563,ENSG00000111012,CYP27B1,protein_coding,12,-1,57762334,57768986,q14.1,cytochrome P450 family 27 subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:2606],Hypocalcemic vitamin D dependent rickets;VITAMIN D HYDROXYLATION-DEFICIENT RICKETS TYPE 1A,CYP27B1,1594,NM_000785
FGF9_SIG,FGF9,FGF9_SIG,FGF9,SIG,14,-1.5985620892939,0.0888849113181423,0.0970646140810415,0.0620087450971877,-0.0350558689838537,0.149535324271014,-1.71135458325745,0.478253072607457,0.512458233415671,0.365864687094754,-0.146593546320917,0.160310017876084,ENSG00000102678,FGF9,protein_coding,13,1,21671383,21704498,q12.11,fibroblast growth factor 9 [Source:HGNC Symbol;Acc:HGNC:3687],Multiple synostoses syndrome;MULTIPLE SYNOSTOSES SYNDROME 3;multiple synostoses syndrome type 3,FGF9,2254,NM_002010
NXF1_SIG,NXF1,NXF1_SIG,NXF1,SIG,22,-1.59699173869681,0.309978805548532,0.313831364783899,0.297320396632326,-0.0165109681515724,0.14998631445923,-0.937625770261219,8.13538864237168,8.14707516508922,8.09699006772834,-0.0500850973608795,0.462120352993422,ENSG00000162231,NXF1,protein_coding,11,-1,62792123,62806302,q12.3,nuclear RNA export factor 1 [Source:HGNC Symbol;Acc:HGNC:8071],NA,NXF1,10482,NM_001081491;NM_006362
MED30_SIG,MED30,MED30_SIG,MED30,SIG,26,-1.59687281274978,0.405567321435727,0.409422171450617,0.392901385672516,-0.0165207857781017,0.14999775061916,-1.78003664221834,3.96861175641759,3.9943024804965,3.88419937730119,-0.110103103195311,0.14295591296293,ENSG00000164758,MED30,protein_coding,8,1,117520713,117540262,q24.11,mediator complex subunit 30 [Source:HGNC Symbol;Acc:HGNC:23032],NA,MED30,90390,NM_001282986;NM_080651
PAF1_SIG,PAF1,PAF1_SIG,PAF1,SIG,26,1.59678911600618,0.108029996326196,0.105612101914514,0.115974506536006,0.0103624046214916,0.149998507974608,0.416735507926399,5.89904856057469,5.89491429542262,5.91263257464579,0.0177182792231712,0.758959253065226,ENSG00000006712,PAF1,protein_coding,19,-1,39385629,39391154,q13.2,PAF1 homolog, Paf1/RNA polymerase II complex component [Source:HGNC Symbol;Acc:HGNC:25459],NA,PAF1,54623,NM_001256826;NM_019088
PRSS36_SIG,PRSS36,PRSS36_SIG,PRSS36,SIG,17,1.594923793012,0.174463382322741,0.171133319158934,0.185405018432391,0.0142716992734568,0.150540215059439,0.54888075439839,1.59855408366366,1.58727096436882,1.63562718991813,0.0483562255493175,0.681297741775576,ENSG00000178226,PRSS36,protein_coding,16,-1,31138925,31150094,p11.2,serine protease 36 [Source:HGNC Symbol;Acc:HGNC:26906],NA,PRSS36,146547,NM_001258290;NM_001258291;NM_173502
RFX8_TF,RFX8,RFX8_TF,RFX8,TF,271,1.59444644606241,0.0188823060152148,0.0168148054319454,0.0256755222173856,0.0088607167854404,0.150660688173712,-1.5305668418773,3.31626367688851,3.38026411606516,3.1059765195938,-0.274287596471362,0.212041101797186,ENSG00000196460,RFX8,protein_coding,2,-1,101397359,101475112,q11.2,RFX family member 8, lacking RFX DNA binding domain [Source:HGNC Symbol;Acc:HGNC:37253],NA,RFX8,731220,NM_001145664
FIGNL1_SIG,FIGNL1,FIGNL1_SIG,FIGNL1,SIG,27,1.59417857714462,0.23378038829048,0.228522522069552,0.251056234444955,0.022533712375403,0.150717473577026,3.02078914564976,3.96766738461855,3.90196042573257,4.18356167810108,0.281601252368512,0.0101904296534681,ENSG00000132436,FIGNL1,protein_coding,7,-1,50444128,50542535,p12.1,fidgetin like 1 [Source:HGNC Symbol;Acc:HGNC:13286],NA,FIGNL1,63979,NM_001042762;NM_001287492;NM_001287493;NM_001287494;NM_001287495;NM_001287496;NM_001346558;NM_001346559;NM_001346560;NM_001346561;NM_001346562;NM_001346563;NM_001346564;NM_001346565;NM_022116
ARHGAP5_SIG,ARHGAP5,ARHGAP5_SIG,ARHGAP5,SIG,68,-1.59242430748533,0.0382660329842247,0.0418268218867868,0.0265662980186633,-0.0152605238681235,0.151227269712897,-1.55249706645698,4.71282498306175,4.78147693912126,4.4872542702948,-0.294222668826468,0.20496226048836,ENSG00000100852,ARHGAP5,protein_coding,14,1,32076114,32159728,q12,Rho GTPase activating protein 5 [Source:HGNC Symbol;Acc:HGNC:675],NA,ARHGAP5,394,NM_001030055;NM_001173
CD3EAP_SIG,CD3EAP,CD3EAP_SIG,CD3EAP,SIG,25,1.59193092361018,0.165651412462682,0.157352158723665,0.192920389033738,0.0355682303100735,0.151353046115986,1.60152237723747,2.02179173808657,1.97640757973324,2.17091111553323,0.194503535799989,0.190168399731774,ENSG00000117877,CD3EAP,protein_coding,19,1,45406209,45410766,q13.32,CD3e molecule associated protein [Source:HGNC Symbol;Acc:HGNC:24219],NA,CD3EAP,10849,NM_001297590;NM_012099
RDH11_SIG,RDH11,RDH11_SIG,RDH11,SIG,20,1.59163077105976,0.200631758902499,0.198637474733316,0.207184406886959,0.00854693215364333,0.15141987651891,1.34717679189182,5.31643301442843,5.29776153346815,5.37778216615509,0.0800206326869457,0.276429309248424,ENSG00000072042,RDH11,protein_coding,14,-1,67676800,67695793,q24.1,retinol dehydrogenase 11 [Source:HGNC Symbol;Acc:HGNC:17964],Retinal dystrophy juvenile cataracts and short stature syndrome;Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,RDH11,51109,NM_001252650;NM_016026
PC_SIG,PC,PC_SIG,PC,SIG,44,-1.59041556633307,-0.0842623713545108,-0.0823863172042764,-0.0904265492767096,-0.00804023207243323,0.151766482354977,0.392313823443281,1.88329995517646,1.87254743930502,1.91862965018262,0.0460822108775999,0.773093757789612,ENSG00000173599,PC,protein_coding,11,-1,66848417,66958439,q13.2,pyruvate carboxylase [Source:HGNC Symbol;Acc:HGNC:8636],PYRUVATE CARBOXYLASE DEFICIENCY;Pyruvate carboxylase deficiency benign type;Pyruvate carboxylase deficiency infantile type;Pyruvate carboxylase deficiency severe neonatal type,PC,5091,NM_000920;NM_001040716;NM_022172
STYX_SIG,STYX,STYX_SIG,STYX,SIG,20,1.58949918360546,0.551589531033269,0.547401814604357,0.565349170728266,0.0179473561239098,0.152022129349806,0.522356993669496,5.42592703242034,5.41947624129626,5.44712248897092,0.0276462476746609,0.696871168914599,ENSG00000198252,STYX,protein_coding,14,1,52730166,52774989,q22.1,serine/threonine/tyrosine interacting protein [Source:HGNC Symbol;Acc:HGNC:11447],NA,STYX,6815,NM_001130701;NM_145251
YKT6_SIG,YKT6,YKT6_SIG,YKT6,SIG,30,-1.58934689210769,0.336808909822391,0.339605683782634,0.327619509667309,-0.0119861741153242,0.152043867230184,0.505942769419198,6.22184184620897,6.21592434609456,6.24128506087061,0.0253607147760508,0.705942645356544,ENSG00000106636,YKT6,protein_coding,7,1,44200968,44214294,p13,YKT6 v-SNARE homolog [Source:HGNC Symbol;Acc:HGNC:16959],NA,YKT6,10652,NM_006555
ACTL6A_SIG,ACTL6A,ACTL6A_SIG,ACTL6A,SIG,71,1.58909945315909,0.4901207872578,0.483377984545586,0.512275710455072,0.0288977259094855,0.152094763755826,1.50560790399831,4.55307474686515,4.51796609280706,4.66843175305599,0.150465660248927,0.220058134926831,ENSG00000136518,ACTL6A,protein_coding,3,1,179562886,179588407,q26.33,actin like 6A [Source:HGNC Symbol;Acc:HGNC:24124],Non-specific syndromic intellectual disability,ACTL6A,86,NM_004301;NM_177989;NM_178042
AMY2B_SIG,AMY2B,AMY2B_SIG,AMY2B,SIG,42,1.58897099488905,-0.0824081121675488,-0.0845689754456131,-0.0753081328253376,0.00926084262027553,0.152109208438782,0.746936126174059,3.63939542393426,3.62396426975763,3.69009778765751,0.0661335178998813,0.564907439123829,ENSG00000240038,AMY2B,protein_coding,1,1,103553815,103579534,p21.1,amylase, alpha 2B (pancreatic) [Source:HGNC Symbol;Acc:HGNC:478],NA,AMY2B,280,NM_020978
NR4A3_TF,NR4A3,NR4A3_TF,NR4A3,TF,103,-1.58799743548039,0.190670573108591,0.19694567092198,0.170052394578884,-0.026893276343096,0.152382821318955,-0.309182094877628,3.13052169714596,3.14990337318845,3.06683904729206,-0.0830643258963898,0.822439404279992,ENSG00000119508,NR4A3,protein_coding,9,1,99821855,99866891,q31.1,nuclear receptor subfamily 4 group A member 3 [Source:HGNC Symbol;Acc:HGNC:7982],CHONDROSARCOMA EXTRASKELETAL MYXOID;Extraskeletal myxoid chondrosarcoma,NR4A3,8013,NM_006981;NM_173199;NM_173200
ARSA_SIG,ARSA,ARSA_SIG,ARSA,SIG,23,1.58657426305908,-0.0356705675729232,-0.0384041766785657,-0.0266887090829549,0.0117154675956107,0.152795020636764,1.25495434407548,5.24809403801631,5.22116904307595,5.33656187853465,0.115392835458692,0.31328956521994,ENSG00000100299,ARSA,protein_coding,22,-1,50622754,50628173,q13.33,arylsulfatase A [Source:HGNC Symbol;Acc:HGNC:713],Arylsulfatase A Deficiency;METACHROMATIC LEUKODYSTROPHY;Metachromatic leukodystrophy adult form;Metachromatic leukodystrophy juvenile form;Metachromatic leukodystrophy late infantile form,ARSA,410,NM_000487;NM_001085425;NM_001085426;NM_001085427;NM_001085428
HECTD1_SIG,HECTD1,HECTD1_SIG,HECTD1,SIG,56,1.58594296841671,0.516341516876144,0.513971652856732,0.524128212939927,0.0101565600831956,0.152964200132041,1.09085938109318,7.36692993948044,7.3546877551744,7.40715425934314,0.0524665041687459,0.386538389073986,ENSG00000092148,HECTD1,protein_coding,14,-1,31100112,31207804,q12,HECT domain E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:20157],NA,HECTD1,25831,NM_015382
HLA-DMA_SIG,HLA-DMA,HLA-DMA_SIG,HLA-DMA,SIG,45,-1.58564314351228,0.286918678433707,0.291439187125002,0.272065578448026,-0.0193736086769763,0.153031442167599,-0.12781985346559,6.57092975172474,6.57527942374526,6.55663797222874,-0.018641451516526,0.928332150268986,ENSG00000204257,HLA-DMA,protein_coding,6,-1,32948613,32969094,p21.32,major histocompatibility complex, class II, DM alpha [Source:HGNC Symbol;Acc:HGNC:4934],NA,HLA-DMA,3108,NM_006120
BCL6B_TF,BCL6B,BCL6B_TF,BCL6B,TF,207,-1.5853021551764,-0.0395485345237948,-0.0376275720478288,-0.0458602683733974,-0.00823269632556876,0.153111383434587,-0.637354995390439,0.837327340158539,0.857496009530183,0.771058855080279,-0.0864371544499042,0.628501731772996,ENSG00000161940,BCL6B,protein_coding,17,1,7023020,7030290,p13.1,BCL6B, transcription repressor [Source:HGNC Symbol;Acc:HGNC:1002],NA,BCL6B,255877,NM_181844
SRSF11_SIG,SRSF11,SRSF11_SIG,SRSF11,SIG,71,1.5849785350678,0.51063598017668,0.50646684927874,0.524334553127052,0.017867703848311,0.15318600417306,2.09433421097482,8.01155036381759,7.98442472901898,8.10067744958447,0.116252720565487,0.0811534740930816,ENSG00000116754,SRSF11,protein_coding,1,1,70205682,70253052,p31.1,serine and arginine rich splicing factor 11 [Source:HGNC Symbol;Acc:HGNC:10782],NA,SRSF11,9295,NM_001190987;NM_001350605;NM_001350606;NM_001350607;NM_001350608;NM_001350609;NM_001350610;NM_001350611;NM_001350612;NM_001350613;NM_001350614;NM_001350615;NM_001350616;NM_004768
ZNF700_TF,ZNF700,ZNF700_TF,ZNF700,TF,147,1.58260404353365,0.0373601861195883,0.0358353163358032,0.0423704725520252,0.00653515621622197,0.153893761533206,-1.37497841986788,4.32027996631548,4.34276343484593,4.24640571257256,-0.0963577222733711,0.266093110562768,ENSG00000196757,ZNF700,protein_coding,19,1,11925068,11950773,p13.2,zinc finger protein 700 [Source:HGNC Symbol;Acc:HGNC:25292],NA,ZNF700,90592,NM_001271848;NM_144566
ALG6_SIG,ALG6,ALG6_SIG,ALG6,SIG,26,1.5824430379367,0.254035644656642,0.248848252315872,0.271079933776315,0.0222316814604425,0.153918364407067,2.32078329031373,3.49442686119645,3.45478291089002,3.62468555506042,0.169902644170397,0.0517479149037245,ENSG00000088035,ALG6,protein_coding,1,1,63367575,63438562,p31.3,ALG6, alpha-1,3-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:23157],ALG6-CDG;CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ic,ALG6,29929,NM_013339
RAN_SIG,RAN,RAN_SIG,RAN,SIG,37,1.58217666352746,0.486157969098152,0.481498869657432,0.501466438689089,0.0199675690316562,0.153975561067105,1.11037630183001,7.02150799897067,7.00562132470171,7.07370707156865,0.0680857468669373,0.377579429741081,ENSG00000132341,RAN,protein_coding,12,1,130872037,130877678,q24.33,RAN, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9846],NA,RAN,5901,NM_001300796;NM_001300797;NM_006325
CSRP1_SIG,CSRP1,CSRP1_SIG,CSRP1,SIG,51,1.58142174338159,0.117654929296831,0.115404503396199,0.125049185827479,0.00964468243128026,0.154183984324333,0.302991068860255,6.22946195664862,6.22485672132016,6.24459344415644,0.019736722836278,0.826027070115611,ENSG00000159176,CSRP1,protein_coding,1,-1,201483530,201509456,q32.1,cysteine and glycine rich protein 1 [Source:HGNC Symbol;Acc:HGNC:2469],NA,CSRP1,1465,NM_001193570;NM_001193571;NM_001193572;NM_004078
AKAP17A_SIG,AKAP17A,AKAP17A_SIG,AKAP17A,SIG,22,1.58109808174622,-0.0306282063553138,-0.0338537766112268,-0.0200299040858853,0.0138238725253415,0.154258995268768,2.53968561095423,7.34985069993246,7.32302946556928,7.43797761284003,0.114948147270748,0.0323914508086996,ENSG00000197976,AKAP17A,protein_coding,X,1,1591604,1602520,p22.33,A-kinase anchoring protein 17A [Source:HGNC Symbol;Acc:HGNC:18783],NA,AKAP17A,8227,NM_005088
CBX4_SIG,CBX4,CBX4_SIG,CBX4,SIG,30,-1.58084586743278,0.393619431083321,0.400049802047169,0.372491069344963,-0.0275587327022058,0.15431189649442,0.388545605801861,6.31723539625581,6.30861346938507,6.34556458454541,0.0369511151603489,0.775286989689818,ENSG00000141582,CBX4,protein_coding,17,-1,79833156,79839440,q25.3,chromobox 4 [Source:HGNC Symbol;Acc:HGNC:1554],NA,CBX4,8535,NM_003655
SLC25A15_SIG,SLC25A15,SLC25A15_SIG,SLC25A15,SIG,22,1.57959689889711,0.322995694198517,0.318750251404144,0.336945006237173,0.0181947548330287,0.154673933956955,1.46633474799527,2.90058119006555,2.87041784013937,2.99968933982299,0.129271499683618,0.233240922761342,ENSG00000102743,SLC25A15,protein_coding,13,1,40789412,40812460,q14.11,solute carrier family 25 member 15 [Source:HGNC Symbol;Acc:HGNC:10985],Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,SLC25A15,10166,NM_014252
CAPN2_SIG,CAPN2,CAPN2_SIG,CAPN2,SIG,61,-1.57854685630979,0.400124711331933,0.40595943361829,0.380953480962472,-0.0250059526558181,0.15497477436579,-1.02162366876525,6.90333502061853,6.93465361587536,6.80043106477468,-0.13422255110067,0.419963086829616,ENSG00000162909,CAPN2,protein_coding,1,1,223701593,223776018,q41,calpain 2 [Source:HGNC Symbol;Acc:HGNC:1479],NA,CAPN2,824,NM_001146068;NM_001748
DPM2_SIG,DPM2,DPM2_SIG,DPM2,SIG,19,1.57841360665608,0.279266692941389,0.275277225390776,0.292374943464834,0.0170977180740576,0.154990864126685,0.958467814122107,4.49904257891972,4.48571950969076,4.54281837781487,0.0570988681241085,0.451615830450142,ENSG00000136908,DPM2,protein_coding,9,-1,127935099,127938484,q34.11,dolichyl-phosphate mannosyltransferase subunit 2, regulatory [Source:HGNC Symbol;Acc:HGNC:3006],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iu;Congenital muscular dystrophy with intellectual disability and severe epilepsy,DPM2,8818,NM_003863
SMAD3_TF,SMAD3,SMAD3_TF,SMAD3,TF,145,-1.57793263693852,0.0480208549554894,0.0496660120782818,0.0426153386948856,-0.00705067338339626,0.155115081575173,-1.64450895989865,6.151227744384,6.19133366869618,6.0194511359297,-0.171882532766481,0.178038853215165,ENSG00000166949,SMAD3,protein_coding,15,1,67063763,67195169,q22.33,SMAD family member 3 [Source:HGNC Symbol;Acc:HGNC:6769],Aneurysm - osteoarthritis syndrome;Familial thoracic aortic aneurysm and aortic dissection;LOEYS-DIETZ SYNDROME 3;SMAD3-Related Loeys-Dietz Syndrome,SMAD3,4088,NM_001145102;NM_001145103;NM_001145104;NM_005902
ADCK2_SIG,ADCK2,ADCK2_SIG,ADCK2,SIG,20,-1.57782925849386,0.139598246380874,0.141958202263395,0.131844105624021,-0.010114096639374,0.155121892033737,-1.5917144683419,4.06921001810159,4.09528485873495,3.98353554173485,-0.111749317000097,0.193019716286458,ENSG00000133597,ADCK2,protein_coding,7,1,140672945,140696261,q34,aarF domain containing kinase 2 [Source:HGNC Symbol;Acc:HGNC:19039],NA,ADCK2,90956,NM_052853
RECQL_SIG,RECQL,RECQL_SIG,RECQL,SIG,17,1.57739854468634,0.302316216419232,0.297711632648873,0.317445563093267,0.0197339304443935,0.155230545253002,0.3665665377668,5.29876664732742,5.29264640345061,5.3188760200655,0.0262296166148854,0.788256717952105,ENSG00000004700,RECQL,protein_coding,12,-1,21468910,21501669,p12.1,RecQ like helicase [Source:HGNC Symbol;Acc:HGNC:9948],NA,RECQL,5965,NM_002907;NM_032941
MARK3_SIG,MARK3,MARK3_SIG,MARK3,SIG,14,1.57698081932308,0.176715600377628,0.175100748474187,0.182021542346076,0.00692079387188878,0.155335210013345,1.18128996667637,6.74124049362734,6.73167978632136,6.77265424620414,0.0409744598827821,0.345072419607786,ENSG00000075413,MARK3,protein_coding,14,1,103385392,103503831,q32.32,microtubule affinity regulating kinase 3 [Source:HGNC Symbol;Acc:HGNC:6897],NA,MARK3,4140,NM_001128918;NM_001128919;NM_001128920;NM_001128921;NM_002376
CNOT6_SIG,CNOT6,CNOT6_SIG,CNOT6,SIG,26,1.57597582802846,0.341591718964478,0.336431693637894,0.358546087894682,0.0221143942567876,0.155622947983601,1.79273637749187,5.84579771977145,5.81874073446969,5.9346992429058,0.115958508436111,0.139992069452171,ENSG00000113300,CNOT6,protein_coding,5,1,180494379,180578405,q35.3,CCR4-NOT transcription complex subunit 6 [Source:HGNC Symbol;Acc:HGNC:14099],NA,CNOT6,57472,NM_001303241
TMF1_SIG,TMF1,TMF1_SIG,TMF1,SIG,32,1.57472100037213,0.365489586439854,0.363044285523519,0.373524146593526,0.0104798610700062,0.155989111934468,1.64053867433139,6.43256408440309,6.41287495798071,6.49725692836232,0.0843819703816102,0.179251464882552,ENSG00000144747,TMF1,protein_coding,3,-1,69019827,69052339,p14.1,TATA element modulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:11870],NA,TMF1,7110,NM_001363879;NM_007114
EXOSC3_SIG,EXOSC3,EXOSC3_SIG,EXOSC3,SIG,30,1.57426373860607,0.283972222871787,0.27770614584055,0.304560761688706,0.0268546158481554,0.156106507207541,2.31791421895296,3.38394573989335,3.34176765297599,3.52253088262182,0.180763229645824,0.052062820074447,ENSG00000107371,EXOSC3,protein_coding,9,-1,37766978,37801437,p13.2,exosome component 3 [Source:HGNC Symbol;Acc:HGNC:17944],Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1B,EXOSC3,51010,NM_001002269;NM_016042
DDX23_SIG,DDX23,DDX23_SIG,DDX23,SIG,77,1.57258802655978,0.398633492973617,0.391790812402297,0.421116586279381,0.0293257738770836,0.156605352422907,1.08358464084343,6.32633574985456,6.30606119779507,6.39295213519287,0.0868909373977936,0.39035490924041,ENSG00000174243,DDX23,protein_coding,12,-1,48829756,48852842,q13.12,DEAD-box helicase 23 [Source:HGNC Symbol;Acc:HGNC:17347],NA,DDX23,9416,NM_004818
TRA2A_SIG,TRA2A,TRA2A_SIG,TRA2A,SIG,20,1.57192250887947,0.206142926070918,0.203536618443627,0.214706508274875,0.0111698898312483,0.156788384253912,1.51614092192979,7.07174325953843,7.05265738096327,7.13445400342824,0.0817966224649716,0.216742635431184,ENSG00000164548,TRA2A,protein_coding,7,-1,23504780,23532041,p15.3,transformer 2 alpha homolog [Source:HGNC Symbol;Acc:HGNC:16645],NA,TRA2A,29896,NM_001282757;NM_001282758;NM_001282759;NM_001362760;NM_013293
ZNF521_SIG,ZNF521,ZNF521_SIG,ZNF521,SIG,157,1.57088065677939,-0.0389270142217547,-0.0419914083743093,-0.0288582905776468,0.0131331177966624,0.157082279076425,0.128601416749554,3.98934273409894,3.98018091592727,4.0194458509487,0.0392649350214325,0.9278937071366,ENSG00000198795,ZNF521,protein_coding,18,-1,25061924,25352190,q11.2,zinc finger protein 521 [Source:HGNC Symbol;Acc:HGNC:24605],NA,ZNF521,25925,NM_001308225;NM_015461
NUDT16L1_SIG,NUDT16L1,NUDT16L1_SIG,NUDT16L1,SIG,32,1.5708227650155,0.120973799221214,0.119125969105316,0.127045241030592,0.00791927192527589,0.157082279076425,2.59553048215282,4.24732620816016,4.21399006302622,4.35685925645741,0.14286919343119,0.0284994851917601,ENSG00000168101,NUDT16L1,protein_coding,16,1,4693694,4695859,p13.3,nudix hydrolase 16 like 1 [Source:HGNC Symbol;Acc:HGNC:28154],NA,NUDT16L1,84309,NM_001193452;NM_032349
ZNF2_TF,ZNF2,ZNF2_TF,ZNF2,TF,337,1.56657410265715,0.16389952314624,0.157832972183564,0.183832476309319,0.0259995041257557,0.158395085476796,1.96698679939432,1.64039548089061,1.5916650180015,1.80050985895485,0.208844840953356,0.103077153294496,ENSG00000275111,ZNF2,protein_coding,2,1,95165432,95184317,q11.1,zinc finger protein 2 [Source:HGNC Symbol;Acc:HGNC:12991],NA,ZNF2,7549,NM_001017396;NM_001282398;NM_001291604;NM_001291605;NM_021088
ATP1A3_SIG,ATP1A3,ATP1A3_SIG,ATP1A3,SIG,39,1.56532307424174,-0.0525160819572096,-0.0549317069535201,-0.0445790283979036,0.0103526785556164,0.158764994866768,1.62255056876757,2.01497840327026,1.96926403687309,2.16518275000384,0.195918713130748,0.18426877596591,ENSG00000105409,ATP1A3,protein_coding,19,-1,41966582,41997497,q13.2,ATPase Na+/K+ transporting subunit alpha 3 [Source:HGNC Symbol;Acc:HGNC:801],ALTERNATING HEMIPLEGIA OF CHILDHOOD;ALTERNATING HEMIPLEGIA OF CHILDHOOD 2;Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;CEREBELLAR ATAXIA AREFLEXIA PES CAVUS OPTIC ATROPHY AND SENSORINEURAL HEARING LOSS;DYSTONIA 12;Rapid-Onset Dystonia-Parkinsonism,ATP1A3,478,NM_001256213;NM_001256214;NM_152296
SFSWAP_SIG,SFSWAP,SFSWAP_SIG,SFSWAP,SIG,21,1.56482736018789,0.612419900272002,0.610321678722864,0.619314056790597,0.00899237806773237,0.158896107002436,2.16655365657566,6.3061584559886,6.28873525352302,6.36340612123265,0.0746708677096245,0.0707813811584796,ENSG00000061936,SFSWAP,protein_coding,12,1,131711081,131799737,q24.33,splicing factor SWAP [Source:HGNC Symbol;Acc:HGNC:10790],NA,SFSWAP,6433,NM_001261411;NM_004592
KANSL1_SIG,KANSL1,KANSL1_SIG,KANSL1,SIG,29,1.5647445743974,0.183051691668948,0.18084906653273,0.190288888545091,0.0094398220123611,0.158896429783578,0.883733312347894,6.86363736331416,6.8538639805447,6.89574990669952,0.0418859261548272,0.490364643371832,ENSG00000120071,KANSL1,protein_coding,17,-1,46029916,46225389,q21.31,KAT8 regulatory NSL complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:24565],17q21.31 microdeletion syndrome;Chromosome 17q21.31 microdeletion syndrome;Koolen-de Vries syndrome;Koolen-De Vries syndrome due to a point mutation,KANSL1,284058,NM_001193465;NM_001193466;NM_015443
ARHGAP18_SIG,ARHGAP18,ARHGAP18_SIG,ARHGAP18,SIG,9,1.56272739106958,0.330634458319182,0.328577244696379,0.337393874508395,0.00881662981201634,0.159510529540343,1.57908093120578,4.44396279567588,4.41032451941958,4.55448856051801,0.14416404109843,0.196838470285627,ENSG00000146376,ARHGAP18,protein_coding,6,-1,129576132,129710177,q22.33,Rho GTPase activating protein 18 [Source:HGNC Symbol;Acc:HGNC:21035],NA,ARHGAP18,93663,NM_033515
PCYT1B_SIG,PCYT1B,PCYT1B_SIG,PCYT1B,SIG,65,-1.56125044300292,-0.0989590433887325,-0.0949177917647604,-0.112237441581784,-0.0173196498170232,0.159954335441285,-2.20370389088912,1.18971927363963,1.25668137080908,0.969700954368552,-0.286980416440533,0.0659311570593474,ENSG00000102230,PCYT1B,protein_coding,X,-1,24558087,24672677,p22.11,phosphate cytidylyltransferase 1, choline, beta [Source:HGNC Symbol;Acc:HGNC:8755],NA,PCYT1B,9468,NM_001163264;NM_001163265;NM_004845
NFS1_SIG,NFS1,NFS1_SIG,NFS1,SIG,24,1.56058934677815,0.211639458031324,0.205439551155304,0.232010580623961,0.0265710294686573,0.160138876281059,2.53856483601247,3.47344221797639,3.43297734853861,3.60639821755767,0.173420869019059,0.0324766171204932,ENSG00000244005,NFS1,protein_coding,20,-1,35668052,35699355,q11.22,NFS1, cysteine desulfurase [Source:HGNC Symbol;Acc:HGNC:15910],Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,NFS1,9054,NM_001198989;NM_021100
RPP25L_SIG,RPP25L,RPP25L_SIG,RPP25L,SIG,49,1.56039710339841,0.133097512837965,0.126912366787732,0.153420135574444,0.0265077687867119,0.160174060125347,0.701151723751155,2.93190598783378,2.91810084372543,2.97726574704693,0.0591649033214985,0.591403420238852,ENSG00000164967,RPP25L,protein_coding,9,-1,34610486,34612104,p13.3,ribonuclease P/MRP subunit p25 like [Source:HGNC Symbol;Acc:HGNC:19909],NA,RPP25L,138716,NM_148178;NM_148179
MRPS11_SIG,MRPS11,MRPS11_SIG,MRPS11,SIG,41,1.55886694272447,0.430736925045616,0.425733661262304,0.447176220333642,0.0214425590713383,0.160636252100843,1.58874146012416,4.04275295866751,4.02422657729263,4.10362535461358,0.0793987773209536,0.193827134937776,ENSG00000181991,MRPS11,protein_coding,15,1,88467453,88480776,q25.3,mitochondrial ribosomal protein S11 [Source:HGNC Symbol;Acc:HGNC:14050],NA,MRPS11,64963,NM_001321970;NM_001321972;NM_001321974;NM_022839;NM_176805
IFI16_TF,IFI16,IFI16_TF,IFI16,TF,119,-1.55834542184189,0.0992208550396402,0.102223061224829,0.0893564632883052,-0.0128665979365242,0.16077674942224,-1.50757682019158,7.0690377622114,7.10639851031521,6.94628101844174,-0.160117491873471,0.219585550259462,ENSG00000163565,IFI16,protein_coding,1,1,158999968,159055155,q23.1,interferon gamma inducible protein 16 [Source:HGNC Symbol;Acc:HGNC:5395],NA,IFI16,3428,NM_001206567;NM_005531
STAT4_TF,STAT4,STAT4_TF,STAT4,TF,112,-1.55651773195556,0.0192860082285467,0.0226720826620065,0.00816033509003578,-0.0145117475719707,0.161335608087564,2.31254183665421,3.23948252849101,3.15588738316133,3.51415229171708,0.358264908555753,0.0526069024917687,ENSG00000138378,STAT4,protein_coding,2,-1,191029576,191151596,q32.3,signal transducer and activator of transcription 4 [Source:HGNC Symbol;Acc:HGNC:11365],Behcet disease;Oligoarticular juvenile idiopathic arthritis;Pediatric systemic lupus erythematosus;Rheumatoid factor-negative juvenile idiopathic arthritis;Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 11,STAT4,6775,NM_001243835;NM_003151
PRDX5_SIG,PRDX5,PRDX5_SIG,PRDX5,SIG,25,-1.55578675794534,0.207396081736952,0.209695615475508,0.199840470881698,-0.00985514459380974,0.161523500758854,-0.75966327924651,6.77542738096701,6.78661450879542,6.73866967524507,-0.0479448335503579,0.55793338882332,ENSG00000126432,PRDX5,protein_coding,11,1,64318121,64321811,q13.1,peroxiredoxin 5 [Source:HGNC Symbol;Acc:HGNC:9355],NA,PRDX5,25824,NM_001358511;NM_001358516;NM_012094;NM_181651;NM_181652
GPR153_SIG,GPR153,GPR153_SIG,GPR153,SIG,86,1.55573429661788,-0.0707492678869691,-0.0732551522467104,-0.0625156478478192,0.0107395043988912,0.161523500758854,1.522112171331,1.91867304433848,1.87025181643154,2.07777136460414,0.2075195481726,0.214715072492669,ENSG00000158292,GPR153,protein_coding,1,-1,6247353,6261098,p36.31,G protein-coupled receptor 153 [Source:HGNC Symbol;Acc:HGNC:23618],NA,GPR153,387509,NM_207370
RPL12_SIG,RPL12,RPL12_SIG,RPL12,SIG,87,1.55568595991646,0.275790571160295,0.270568119930224,0.292950053773386,0.0223819338431612,0.161523500758854,2.89408075886598,8.07769387327525,8.02763061577207,8.24218743364282,0.214556817870747,0.0140852666066559,ENSG00000197958,RPL12,protein_coding,9,-1,127447674,127451406,q33.3,ribosomal protein L12 [Source:HGNC Symbol;Acc:HGNC:10302],NA,RPL12,6136,NM_000976
GPX1_SIG,GPX1,GPX1_SIG,GPX1,SIG,56,1.55429752951348,0.173489848842205,0.170620261479783,0.182918493033021,0.0122982315532372,0.161943049182856,1.43819334494677,8.24311376202086,8.21119784148961,8.34798035805209,0.136782516562485,0.242666044256435,ENSG00000233276,GPX1,polymorphic_pseudogene,3,-1,49357176,49358358,p21.31,glutathione peroxidase 1 [Source:HGNC Symbol;Acc:HGNC:4553],GLUTATHIONE PEROXIDASE DEFICIENCY,GPX1,2876,NM_000581;NM_001329455;NM_001329502;NM_001329503;NM_201397
CCDC124_SIG,CCDC124,CCDC124_SIG,CCDC124,SIG,39,1.55414673400665,0.449274484953884,0.446126626125003,0.459617449677349,0.0134908235523463,0.161965171307134,2.85890394417215,5.0594238180841,5.02774666470848,5.16350589346113,0.135759228752653,0.0153586136535826,ENSG00000007080,CCDC124,protein_coding,19,1,17933015,17943991,p13.11,coiled-coil domain containing 124 [Source:HGNC Symbol;Acc:HGNC:25171],NA,CCDC124,115098,NM_001136203;NM_138442
PCYT1A_SIG,PCYT1A,PCYT1A_SIG,PCYT1A,SIG,32,-1.55166883776956,0.354693646415569,0.357618931729575,0.345081994669551,-0.0125369370600238,0.162694637091503,0.539662834607546,6.0910463716804,6.08439080032966,6.11291467754709,0.0285238772174284,0.68654651951341,ENSG00000161217,PCYT1A,protein_coding,3,-1,196214222,196287957,q29,phosphate cytidylyltransferase 1, choline, alpha [Source:HGNC Symbol;Acc:HGNC:8754],Leber congenital amaurosis;Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome;Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy,PCYT1A,5130,NM_001312673;NM_005017
CD109_SIG,CD109,CD109_SIG,CD109,SIG,77,1.55165294276571,-0.0239104117857121,-0.0274092554037298,-0.012414211326511,0.0149950440772189,0.162694637091503,2.57462137825954,4.25240701008965,4.11412774580266,4.70675316417548,0.592625418372826,0.0298565784614697,ENSG00000156535,CD109,protein_coding,6,1,73695785,73828316,q13,CD109 molecule [Source:HGNC Symbol;Acc:HGNC:21685],Fetal and neonatal alloimmune thrombocytopenia,CD109,135228,NM_001159587;NM_001159588;NM_133493
RAP1GAP_SIG,RAP1GAP,RAP1GAP_SIG,RAP1GAP,SIG,11,-1.55163549231615,-0.0430081860642966,-0.0325480432843277,-0.0773772266270513,-0.0448291833427236,0.162694637091503,1.10895491323531,1.30028378896182,1.26381208247009,1.42011939600609,0.156307313536002,0.378212103603216,ENSG00000076864,RAP1GAP,protein_coding,1,-1,21596215,21669363,p36.12,RAP1 GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:9858],NA,RAP1GAP,5909,NM_001145657;NM_001145658;NM_001330383;NM_001350524;NM_001350525;NM_001350526;NM_001350527;NM_001350528;NM_002885
PHF5A_SIG,PHF5A,PHF5A_SIG,PHF5A,SIG,29,-1.55110200733136,0.286459482662214,0.28883916054833,0.278640541036401,-0.0101986195119295,0.162840314685066,-1.14463509895251,4.91517453320081,4.92649897958782,4.87796563792922,-0.0485333416585947,0.361575583917233,ENSG00000100410,PHF5A,protein_coding,22,-1,41459717,41468692,q13.2,PHD finger protein 5A [Source:HGNC Symbol;Acc:HGNC:18000],NA,PHF5A,84844,NM_032758
ANO2_SIG,ANO2,ANO2_SIG,ANO2,SIG,41,1.55076099214409,-0.0281160723221473,-0.0314396854003128,-0.0171956293510323,0.0142440560492807,0.162923928157073,-0.101091025718686,0.287554746756396,0.289086449832948,0.282522008076295,-0.00656444175665359,0.943836237636676,ENSG00000047617,ANO2,protein_coding,12,-1,5531869,5946232,p13.31,anoctamin 2 [Source:HGNC Symbol;Acc:HGNC:1183],NA,ANO2,57101,NM_001278596;NM_001278597;NM_001364791
BRF2_TF,BRF2,BRF2_TF,BRF2,TF,161,1.55028481802862,0.233340315356741,0.231528409759531,0.239293719461859,0.00776530970232782,0.163051237070091,1.87205364227126,3.57299991719933,3.55020336409107,3.64790287741218,0.0976995133211142,0.122125632009012,ENSG00000104221,BRF2,protein_coding,8,-1,37843268,37849904,p11.23,BRF2, RNA polymerase III transcription initiation factor subunit [Source:HGNC Symbol;Acc:HGNC:17298],NA,BRF2,55290,NM_018310
ARHGAP20_SIG,ARHGAP20,ARHGAP20_SIG,ARHGAP20,SIG,10,-1.55009312581861,0.0199863865111969,0.022533467872634,0.0116174048950466,-0.0109160629775874,0.163063856072765,-0.185226358635393,0.317617432459565,0.320516357500498,0.308092393039357,-0.0124239644611406,0.895808019720283,ENSG00000137727,ARHGAP20,protein_coding,11,-1,110577042,110713189,q23.1,Rho GTPase activating protein 20 [Source:HGNC Symbol;Acc:HGNC:18357],NA,ARHGAP20,57569,NM_001258415;NM_001258416;NM_001258417;NM_001258418;NM_020809
PHC3_SIG,PHC3,PHC3_SIG,PHC3,SIG,76,1.55008171792692,0.300796200018581,0.297459612910166,0.31175927194623,0.014299659036064,0.163063856072765,2.05799498768219,6.99195167750189,6.96272063158568,7.08799654265517,0.125275911069493,0.087091946850552,ENSG00000173889,PHC3,protein_coding,3,-1,170086732,170181749,q26.2,polyhomeotic homolog 3 [Source:HGNC Symbol;Acc:HGNC:15682],NA,PHC3,80012,NM_001308116;NM_024947
ZRSR2_SIG,ZRSR2,ZRSR2_SIG,ZRSR2,SIG,15,1.54969386436161,-0.0828172788352008,-0.0848994581229117,-0.075975832604151,0.00892362551876054,0.163162692169159,0.0151927768559862,4.48894123766743,4.488761811878,4.489530779547,0.000768967669002563,0.991628859641664,ENSG00000169249,ZRSR2,protein_coding,X,1,15790472,15823260,p22.2,zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019],NA,ZRSR2,8233,NM_005089
CNBP_SIG,CNBP,CNBP_SIG,CNBP,SIG,15,-1.54814729673826,0.304896240139547,0.306426226449974,0.299869142262427,-0.00655708418754749,0.163636605662429,-1.15086041022369,8.29113201108724,8.30193143197459,8.25564819960021,-0.0462832323743818,0.358822170517331,ENSG00000169714,CNBP,protein_coding,3,-1,129169484,129183922,q21.3,CCHC-type zinc finger nucleic acid binding protein [Source:HGNC Symbol;Acc:HGNC:13164],MYOTONIC DYSTROPHY 2;Proximal myotonic myopathy,CNBP,7555,NM_001127192;NM_001127193;NM_001127194;NM_001127195;NM_001127196;NM_003418
NDUFA13_SIG,NDUFA13,NDUFA13_SIG,NDUFA13,SIG,20,1.54744103580598,0.427702405736557,0.424135585514348,0.439421957895244,0.0152863723808952,0.163838912730268,1.6762092102424,1.6032165862555,1.58396036362334,1.66648703204686,0.0825266684235178,0.169378883141909,ENSG00000186010,NDUFA13,protein_coding,19,1,19515736,19529054,p13.11,NADH:ubiquinone oxidoreductase subunit A13 [Source:HGNC Symbol;Acc:HGNC:17194],Differentiated thyroid carcinoma;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 28;THYROID CARCINOMA HURTHLE CELL,NDUFA13,51079,NM_015965
TBX6_TF,TBX6,TBX6_TF,TBX6,TF,39,1.54623503247763,0.0507665570616582,0.0473276992890853,0.0620656611715406,0.0147379618824551,0.164203662430184,-0.0200365515027652,1.49834930140475,1.49870142205465,1.49719233355508,-0.00150908849957212,0.988994481876866,ENSG00000149922,TBX6,protein_coding,16,-1,30085793,30091887,p11.2,T-box 6 [Source:HGNC Symbol;Acc:HGNC:11605],Autosomal dominant spondylocostal dysostosis;Spondylocostal dysostosis 5,TBX6,6911,NM_004608
ZNF239_TF,ZNF239,ZNF239_TF,ZNF239,TF,19,1.54540158731075,-0.0615832160301634,-0.0641260188726884,-0.0532282924047239,0.0108977264679646,0.164447842600803,0.107438646954251,1.06239477475548,1.06021140439693,1.06956870593358,0.00935730153664623,0.940467868848141,ENSG00000196793,ZNF239,protein_coding,10,-1,43556344,43574618,q11.21,zinc finger protein 239 [Source:HGNC Symbol;Acc:HGNC:13031],NA,ZNF239,8187,NM_001099282;NM_001099283;NM_001099284;NM_001324347;NM_001324348;NM_001324349;NM_001324350;NM_001324351;NM_001324352;NM_001324353;NM_005674
ADCY3_SIG,ADCY3,ADCY3_SIG,ADCY3,SIG,53,-1.54470344339719,0.0574869882762196,0.0613368181622429,0.0448375472221431,-0.0164992709400997,0.164631634524358,-2.45233488373199,5.45460331712522,5.52176198269276,5.23393913026044,-0.287822852432312,0.0391652071422707,ENSG00000138031,ADCY3,protein_coding,2,-1,24819169,24919839,p23.3,adenylate cyclase 3 [Source:HGNC Symbol;Acc:HGNC:234],BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19,ADCY3,109,NM_001320613;NM_004036
HNRNPH2_SIG,HNRNPH2,HNRNPH2_SIG,HNRNPH2,SIG,16,-1.54467238338434,0.277682876963077,0.279388026504864,0.272080242754348,-0.00730778375051676,0.164631634524358,-0.101903572572494,6.78392504936182,6.78497952387483,6.78046034739048,-0.004519176484357,0.943540362122856,ENSG00000126945,HNRNPH2,protein_coding,X,1,101408222,101414133,q22.1,heterogeneous nuclear ribonucleoprotein H2 [Source:HGNC Symbol;Acc:HGNC:5042],MENTAL RETARDATION X-LINKED SYNDROMIC BAIN TYPE;Neurodevelopmental Disorder in Females,HNRNPH2,3188,NM_001032393;NM_019597
ZNF766_TF,ZNF766,ZNF766_TF,ZNF766,TF,49,1.54426054091689,0.345064158334651,0.342120979300959,0.354734603731065,0.012613624430106,0.164738966430528,1.14263653799228,4.70717933666961,4.68857668247863,4.76830234329709,0.0797256608184522,0.362513433629426,ENSG00000196214,ZNF766,protein_coding,19,1,52269587,52296046,q13.41,zinc finger protein 766 [Source:HGNC Symbol;Acc:HGNC:28063],NA,ZNF766,90321,NM_001010851
DCPS_SIG,DCPS,DCPS_SIG,DCPS,SIG,37,1.54401345637464,0.455582405385526,0.450493720463257,0.472302370130125,0.0218086496668681,0.164774255303905,1.52125858513967,4.31135481887626,4.28353142340301,4.40277454685978,0.119243123456763,0.21501088970839,ENSG00000110063,DCPS,protein_coding,11,1,126304060,126350005,q24.2,decapping enzyme, scavenger [Source:HGNC Symbol;Acc:HGNC:29812],AL-RAQAD SYNDROME;Autosomal recessive non-syndromic intellectual disability,DCPS,28960,NM_001350236;NM_014026
GFPT2_SIG,GFPT2,GFPT2_SIG,GFPT2,SIG,4,-1.54387731193508,-0.294574134798005,-0.291221688088759,-0.305589316842671,-0.0143676287539122,0.164774255303905,-0.756113709479313,0.283376560666606,0.291201987642287,0.257664443460795,-0.0335375441814917,0.560032827250811,ENSG00000131459,GFPT2,protein_coding,5,-1,180300698,180353336,q35.3,glutamine-fructose-6-phosphate transaminase 2 [Source:HGNC Symbol;Acc:HGNC:4242],NA,GFPT2,9945,NM_005110
ZNF488_TF,ZNF488,ZNF488_TF,ZNF488,TF,80,1.54387442400361,0.099247676652178,0.0958587569470052,0.110382698540603,0.014523941593598,0.164774255303905,-1.05078072404037,0.454812488174632,0.469481748522962,0.406613489887265,-0.0628682586356969,0.405633723771316,ENSG00000265763,ZNF488,protein_coding,10,-1,47365496,47384293,q11.22,zinc finger protein 488 [Source:HGNC Symbol;Acc:HGNC:23535],NA,ZNF488,118738,NM_001346932;NM_001346933;NM_001346934;NM_001346935;NM_001346936;NM_153034
CRAT_SIG,CRAT,CRAT_SIG,CRAT,SIG,19,1.54382378775615,0.216855455468081,0.214854545567735,0.223429873712078,0.00857532814434355,0.164774255303905,1.77629424755337,4.98793120932141,4.95876724469201,5.08375566453228,0.124988419840269,0.143913850772686,ENSG00000095321,CRAT,protein_coding,9,-1,129094794,129111189,q34.11,carnitine O-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:2342],NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8,CRAT,1384,NM_000755;NM_001257363;NM_001346546;NM_001346547;NM_001346548;NM_001346549;NM_004003
PIGK_SIG,PIGK,PIGK_SIG,PIGK,SIG,17,1.54267599598672,0.536549845158088,0.532473201729147,0.549944530710324,0.017471328981177,0.165097734164964,-0.178360520130617,5.37960751829315,5.38305506355699,5.36827986956908,-0.0147751939879069,0.899832546039361,ENSG00000142892,PIGK,protein_coding,1,-1,77088989,77219430,p31.1,phosphatidylinositol glycan anchor biosynthesis class K [Source:HGNC Symbol;Acc:HGNC:8965],NA,PIGK,10026,NM_005482
DPP9_SIG,DPP9,DPP9_SIG,DPP9,SIG,23,-1.54266686100933,0.224959930835891,0.225987101491789,0.22158494153794,-0.00440215995384796,0.165097734164964,-0.631533342401661,6.18373681389709,6.18866407589403,6.16754723876429,-0.0211168371297319,0.631802622881501,ENSG00000142002,DPP9,protein_coding,19,-1,4675224,4724673,p13.3,dipeptidyl peptidase 9 [Source:HGNC Symbol;Acc:HGNC:18648],Idiopathic pulmonary fibrosis,DPP9,91039,NM_139159
ZNF669_TF,ZNF669,ZNF669_TF,ZNF669,TF,22,1.54248121743797,0.339364351510226,0.335638652402499,0.351605934292759,0.0159672818902603,0.165131504146915,0.453098880472266,3.24787003908604,3.24032326731937,3.2726665748908,0.0323433075714285,0.737438225503875,ENSG00000188295,ZNF669,protein_coding,1,-1,247099962,247104372,q44,zinc finger protein 669 [Source:HGNC Symbol;Acc:HGNC:25736],NA,ZNF669,79862,NM_001142572;NM_024804
HMGA1_TF,HMGA1,HMGA1_TF,HMGA1,TF,390,1.54199820467951,0.163210130551418,0.16125308197241,0.169640433025302,0.00838735105289162,0.165254755898842,1.0633041100701,8.29374896616967,8.26970924514318,8.372736620971,0.103027375827825,0.399740001310174,ENSG00000137309,HMGA1,protein_coding,6,1,34236873,34246231,p21.31,high mobility group AT-hook 1 [Source:HGNC Symbol;Acc:HGNC:5010],DIABETES MELLITUS NONINSULIN-DEPENDENT,HMGA1,3159,NM_001319077;NM_001319078;NM_001319079;NM_001319080;NM_001319081;NM_001319082;NM_002131;NM_145899;NM_145901;NM_145902;NM_145903;NM_145905
MTHFD1L_SIG,MTHFD1L,MTHFD1L_SIG,MTHFD1L,SIG,14,1.54193921908822,0.164334841923953,0.160459785117087,0.177067171432228,0.0166073863151411,0.165254755898842,2.09430896980907,4.49749184616934,4.45090157360301,4.65057417031588,0.199672596712872,0.0811534740930816,ENSG00000120254,MTHFD1L,protein_coding,6,1,150865549,151101887,q25.1,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like [Source:HGNC Symbol;Acc:HGNC:21055],NA,MTHFD1L,25902,NM_001242767;NM_001242768;NM_001242769;NM_001350486;NM_001350487;NM_001350488;NM_001350489;NM_001350491;NM_001350492;NM_001350493;NM_015440
RNF34_SIG,RNF34,RNF34_SIG,RNF34,SIG,43,1.54137052661912,0.338720932516008,0.333845029861613,0.354741755523305,0.0208967256616925,0.165413586276741,1.68121440988732,4.82378605886105,4.80010987964536,4.90157921914119,0.101469339495835,0.168146692084975,ENSG00000170633,RNF34,protein_coding,12,1,121400041,121430623,q24.31,ring finger protein 34 [Source:HGNC Symbol;Acc:HGNC:17297],NA,RNF34,80196,NM_001256858;NM_025126;NM_194271
PCGF6_SIG,PCGF6,PCGF6_SIG,PCGF6,SIG,13,1.53878554241006,0.421296121825607,0.417343990701521,0.434281695519031,0.0169377048175094,0.166197263553279,2.03817264808159,2.82782668656251,2.79816258055643,2.92529446343963,0.127131882883198,0.0905386327744073,ENSG00000156374,PCGF6,protein_coding,10,-1,103302796,103351144,q24.33,polycomb group ring finger 6 [Source:HGNC Symbol;Acc:HGNC:21156],NA,PCGF6,84108,NM_001011663;NM_032154
KRR1_SIG,KRR1,KRR1_SIG,KRR1,SIG,81,1.53874374822103,0.274171049891666,0.268949592570548,0.291327266803914,0.0223776742333662,0.166197263553279,1.02351256320092,5.74854454992274,5.73093206934205,5.80641412897358,0.0754820596315336,0.418991683299127,ENSG00000111615,KRR1,protein_coding,12,-1,75490863,75511636,q21.2,KRR1, small subunit processome component homolog [Source:HGNC Symbol;Acc:HGNC:5176],NA,KRR1,11103,NM_007043
CISD2_SIG,CISD2,CISD2_SIG,CISD2,SIG,14,1.53872837576524,0.231925038222049,0.22851081672685,0.243143194563415,0.0146323778365648,0.166197263553279,3.49605579875876,4.21580951766445,4.16485345265409,4.38323658841281,0.218383135758719,0.00273205012518969,ENSG00000145354,CISD2,protein_coding,4,1,102868974,102892807,q24,CDGSH iron sulfur domain 2 [Source:HGNC Symbol;Acc:HGNC:24212],Wolfram syndrome;WOLFRAM SYNDROME 2;Wolfram syndrome type 2,CISD2,493856,NM_001008388
RPL11_SIG,RPL11,RPL11_SIG,RPL11,SIG,37,1.5379977161323,0.926939922065145,0.92092613748025,0.946699499986945,0.0257733625066958,0.166409876942887,1.95690813295492,10.3143035565799,10.2862731578755,10.406403438037,0.120130280161417,0.104996970368362,ENSG00000142676,RPL11,protein_coding,1,1,23691742,23696835,p36.11,ribosomal protein L11 [Source:HGNC Symbol;Acc:HGNC:10301],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 7;Diamond-Blackfan anemia with cleft palate and abnormal thumbs,RPL11,6135,NM_000975;NM_001199802
TRIM27_SIG,TRIM27,TRIM27_SIG,TRIM27,SIG,77,1.53732827476386,0.15085771014722,0.143580753679334,0.174767709970272,0.0311869562909371,0.166602592648518,1.52514231812231,5.67649749527572,5.64502821518841,5.77989655841971,0.134868343231293,0.2137270447116,ENSG00000204713,TRIM27,protein_coding,6,-1,28903002,28923988,p22.1,tripartite motif containing 27 [Source:HGNC Symbol;Acc:HGNC:9975],Differentiated thyroid carcinoma,TRIM27,5987,NM_006510
MRPS23_SIG,MRPS23,MRPS23_SIG,MRPS23,SIG,30,1.53693743189576,0.446437515544639,0.443068952684017,0.457505650658109,0.0144366979740927,0.166703952049619,1.1609016140781,3.9942535044712,3.9778827917754,4.04804298904314,0.0701601972677396,0.354520272540142,ENSG00000181610,MRPS23,protein_coding,17,-1,57834781,57850056,q22,mitochondrial ribosomal protein S23 [Source:HGNC Symbol;Acc:HGNC:14509],NA,MRPS23,51649,NM_016070
AGPAT2_SIG,AGPAT2,AGPAT2_SIG,AGPAT2,SIG,28,-1.53634396372764,0.233701690080272,0.235064699914836,0.229223229195277,-0.00584147071955825,0.166871943798828,0.113668379246573,5.63297616457057,5.63132695108006,5.63839500889654,0.0070680578164825,0.937117263257612,ENSG00000169692,AGPAT2,protein_coding,9,-1,136673143,136687457,q34.3,1-acylglycerol-3-phosphate O-acyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:325],Berardinelli-Seip congenital lipodystrophy;LIPODYSTROPHY CONGENITAL GENERALIZED TYPE 1,AGPAT2,10555,NM_001012727;NM_006412
CERKL_SIG,CERKL,CERKL_SIG,CERKL,SIG,12,-1.5359151343237,-0.0789678272582969,-0.0778850411345507,-0.082525553093463,-0.00464051195891231,0.166985912164995,-1.010095757314,0.35382468855845,0.362395369625793,0.325663879337178,-0.0367314902886153,0.425714890758221,ENSG00000188452,CERKL,protein_coding,2,-1,181536672,181680665,q31.3,ceramide kinase like [Source:HGNC Symbol;Acc:HGNC:21699],Retinitis pigmentosa;RETINITIS PIGMENTOSA 26,CERKL,375298,NM_001030311;NM_001030312;NM_001030313;NM_001160277;NM_201548
SMURF2_SIG,SMURF2,SMURF2_SIG,SMURF2,SIG,49,1.5341078932677,0.258736060144444,0.256753027302888,0.265251739480986,0.00849871217809802,0.16755392026974,0.274150722918373,5.22848520906136,5.22472497792013,5.24084025423969,0.0161152763195558,0.843109097362492,ENSG00000108854,SMURF2,protein_coding,17,-1,64542282,64662307,q24.1,SMAD specific E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:16809],NA,SMURF2,64750,NM_022739
ARHGAP8_SIG,ARHGAP8,ARHGAP8_SIG,ARHGAP8,SIG,32,-1.53324385758016,0.112695905988865,0.118234466327223,0.0944977791628321,-0.0237366871643913,0.167811833156744,-2.08450501101778,0.372026748459493,0.40268213336362,0.271301912345931,-0.131380221017689,0.0827551492800771,ENSG00000241484,ARHGAP8,protein_coding,22,1,44752558,44862788,q13.31,Rho GTPase activating protein 8 [Source:HGNC Symbol;Acc:HGNC:677],NA,ARHGAP8,23779,NM_001017526;NM_001198726;NM_181335
GNG7_SIG,GNG7,GNG7_SIG,GNG7,SIG,98,-1.53279463256997,0.00494009710080267,0.00856514572068756,-0.00697077693596196,-0.0155359226566495,0.167933001859308,-1.70984894563266,4.33015096200175,4.38090260273608,4.16339557101752,-0.217507031718552,0.160729559342767,ENSG00000176533,GNG7,protein_coding,19,-1,2511219,2702694,p13.3,G protein subunit gamma 7 [Source:HGNC Symbol;Acc:HGNC:4410],NA,GNG7,2788,NM_052847
RNF5_SIG,RNF5,RNF5_SIG,RNF5,SIG,14,1.53105117818775,0.37043377362167,0.365858202462665,0.385467793144117,0.0196095906814528,0.168482313888388,0.355774951526527,5.00130513847871,4.99506947404933,5.02179375017523,0.0267242761258933,0.794206542319652,ENSG00000204308,RNF5,protein_coding,6,1,32178405,32180793,p21.32,ring finger protein 5 [Source:HGNC Symbol;Acc:HGNC:10068],NA,RNF5,6048,NM_006913
ZNF826P_TF,ZNF826P,ZNF826P_TF,ZNF826P,TF,93,1.53076840779526,0.0988864934094102,0.0975915569458171,0.10314128464693,0.00554972770111341,0.168548700635481,-0.457385673553229,0.655599203969193,0.662747531705788,0.632111841406095,-0.0306356902996936,0.73503696821963,ENSG00000231205,ZNF826P,transcribed_unprocessed_pseudogene,19,-1,20340269,20424969,p12,zinc finger protein 826, pseudogene [Source:HGNC Symbol;Acc:HGNC:33875],NA,ZNF826P,NA,NA
SLC12A6_SIG,SLC12A6,SLC12A6_SIG,SLC12A6,SIG,33,-1.53067165783991,0.167842164854971,0.169607615403702,0.162041398766284,-0.00756621663741812,0.168553492537385,-1.83677359485764,7.0307393344529,7.06189406904905,6.92837377792268,-0.133520291126375,0.129598117473481,ENSG00000140199,SLC12A6,protein_coding,15,-1,34229996,34338060,q14,solute carrier family 12 member 6 [Source:HGNC Symbol;Acc:HGNC:10914],AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY;Corpus callosum agenesis-neuronopathy syndrome,SLC12A6,9990,NM_001042494;NM_001042495;NM_001042496;NM_001042497;NM_005135;NM_133647
SUPV3L1_SIG,SUPV3L1,SUPV3L1_SIG,SUPV3L1,SIG,51,1.5296653540031,0.36943796550161,0.365011993508209,0.383980444908499,0.0189684514002899,0.168859713909718,1.8400879102247,4.79528224643927,4.76710528627443,4.88786368698086,0.120758400706425,0.128864199398459,ENSG00000156502,SUPV3L1,protein_coding,10,1,69180234,69209099,q22.1,Suv3 like RNA helicase [Source:HGNC Symbol;Acc:HGNC:11471],NA,SUPV3L1,6832,NM_001301683;NM_001323584;NM_001323585;NM_001323586;NM_001323587;NM_001323588;NM_003171
PASK_SIG,PASK,PASK_SIG,PASK,SIG,28,1.52599908668645,0.241562903963343,0.23947306150594,0.248429529180524,0.0089564676745831,0.17005148865568,1.2652747882851,4.79861997136185,4.77628155709052,4.87201761825337,0.0957360611628503,0.309200840231749,ENSG00000115687,PASK,protein_coding,2,-1,241106099,241150264,q37.3,PAS domain containing serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:17270],NA,PASK,23178,NM_001252119;NM_001252120;NM_001252122;NM_001252124;NM_015148
ZNF687_TF,ZNF687,ZNF687_TF,ZNF687,TF,93,-1.52534511166451,0.304849224044162,0.308813190160455,0.291824763947771,-0.0169884262126844,0.170242147060778,-0.441920717882711,6.16722064892998,6.1725146109962,6.14982620214095,-0.0226884088552523,0.743779831880517,ENSG00000143373,ZNF687,protein_coding,1,1,151281618,151292176,q21.3,zinc finger protein 687 [Source:HGNC Symbol;Acc:HGNC:29277],PAGET DISEASE OF BONE 6,ZNF687,57592,NM_001304763;NM_001304764;NM_020832
PAXBP1_TF,PAXBP1,PAXBP1_TF,PAXBP1,TF,93,1.52419377869306,0.124916565440668,0.123255363138931,0.130374801574945,0.00711943843601371,0.170599140915149,0.544939370038934,6.46735705610469,6.46045329537641,6.49004084135475,0.0295875459783473,0.68379704484153,ENSG00000159086,PAXBP1,protein_coding,21,-1,32733899,32771792,q22.11,PAX3 and PAX7 binding protein 1 [Source:HGNC Symbol;Acc:HGNC:13579],NA,PAXBP1,94104,NM_013329;NM_016631
AGO2_SIG,AGO2,AGO2_SIG,AGO2,SIG,25,-1.52244939304437,0.126469356259346,0.130221418078549,0.114141153139106,-0.0160802649394436,0.171155328744509,-0.97566496963456,5.39463244617542,5.41315585392285,5.33376982071959,-0.0793860332032512,0.442871963117346,ENSG00000123908,AGO2,protein_coding,8,-1,140520156,140635633,q24.3,argonaute RISC catalytic component 2 [Source:HGNC Symbol;Acc:HGNC:3263],NA,AGO2,27161,NM_001164623;NM_012154
OGG1_SIG,OGG1,OGG1_SIG,OGG1,SIG,25,-1.52176739274546,0.206887912973622,0.210414511924534,0.195300516420624,-0.0151139955039107,0.171356298022167,-1.17691991432827,4.0944695412419,4.12096513005076,4.00741260658424,-0.113552523466514,0.347202910395788,ENSG00000114026,OGG1,protein_coding,3,1,9749944,9788219,p25.3,8-oxoguanine DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:8125],Hereditary clear cell renal cell carcinoma;RENAL CELL CARCINOMA NONPAPILLARY,OGG1,4968,NM_001354648;NM_001354649;NM_001354650;NM_001354651;NM_001354652;NM_002542;NM_016819;NM_016820;NM_016821;NM_016826;NM_016827;NM_016828;NM_016829
ZNF667_TF,ZNF667,ZNF667_TF,ZNF667,TF,64,1.52070097157845,-0.031751155310741,-0.0361846582117302,-0.0171839314932049,0.0190007267185252,0.171686517582416,-2.12695371937352,2.400786323058,2.49221096925006,2.10039105699836,-0.391819912251698,0.0764372382060389,ENSG00000198046,ZNF667,protein_coding,19,-1,56439325,56478065,q13.43,zinc finger protein 667 [Source:HGNC Symbol;Acc:HGNC:28854],NA,ZNF667,63934,NM_001321355;NM_001321356;NM_022103
PDHX_SIG,PDHX,PDHX_SIG,PDHX,SIG,17,1.52016711982101,0.426754186138333,0.421505429710239,0.444000100116355,0.0224946704061156,0.171838148196765,1.01590505796084,3.96226711513493,3.94678726657823,4.0131294746784,0.0663422081001767,0.422564462301145,ENSG00000110435,PDHX,protein_coding,11,1,34915829,35020591,p13,pyruvate dehydrogenase complex component X [Source:HGNC Symbol;Acc:HGNC:21350],Lacticacidemia due to PDX1 deficiency;PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY,PDHX,8050,NM_001135024;NM_001166158;NM_003477
SLAMF6_SIG,SLAMF6,SLAMF6_SIG,SLAMF6,SIG,41,-1.51940252294859,0.153223361953598,0.157247424742063,0.140001441362925,-0.0172459833791385,0.172030894001602,-1.86632466474209,3.17833472195767,3.24620357800243,2.95533705209632,-0.290866525906106,0.123374151254235,ENSG00000162739,SLAMF6,protein_coding,1,-1,160485030,160523262,q23.3,SLAM family member 6 [Source:HGNC Symbol;Acc:HGNC:21392],NA,SLAMF6,114836,NM_001184714;NM_001184715;NM_001184716;NM_052931
MAN2B2_SIG,MAN2B2,MAN2B2_SIG,MAN2B2,SIG,40,1.51939974100938,0.301183785247098,0.297532358075288,0.313181331668762,0.0156489735934743,0.172030894001602,0.165220829110691,6.77717851291771,6.77479877943744,6.78499763721004,0.0101988577726038,0.907460758160687,ENSG00000013288,MAN2B2,protein_coding,4,1,6575175,6623362,p16.1,mannosidase alpha class 2B member 2 [Source:HGNC Symbol;Acc:HGNC:29623],NA,MAN2B2,23324,NM_001292038;NM_015274
DUSP4_SIG,DUSP4,DUSP4_SIG,DUSP4,SIG,38,-1.51934622071844,0.00496149067796703,0.0100570574932172,-0.0117810860007121,-0.0218381434939294,0.172030894001602,-1.3884513004437,2.14145555561431,2.20336785746207,1.93802942097166,-0.265338436490406,0.260909714560487,ENSG00000120875,DUSP4,protein_coding,8,-1,29333064,29350684,p12,dual specificity phosphatase 4 [Source:HGNC Symbol;Acc:HGNC:3070],NA,DUSP4,1846,NM_001394;NM_057158
ZC3H15_SIG,ZC3H15,ZC3H15_SIG,ZC3H15,SIG,32,1.51898363161071,0.343131604417771,0.339392266670409,0.355417999873388,0.0160257332029789,0.172125107246071,1.92589993469101,6.67393276176229,6.65240568388986,6.7446645890574,0.0922589051675456,0.111144857388944,ENSG00000065548,ZC3H15,protein_coding,2,1,186486253,186509361,q32.1,zinc finger CCCH-type containing 15 [Source:HGNC Symbol;Acc:HGNC:29528],NA,ZC3H15,55854,NM_018471
PUSL1_SIG,PUSL1,PUSL1_SIG,PUSL1,SIG,33,1.51860922197843,0.156837635117548,0.153178661673144,0.168859976434879,0.015681314761735,0.172223336191768,1.56458480672942,2.72998325264203,2.70928120769331,2.79800425747352,0.0887230497802099,0.20124672442029,ENSG00000169972,PUSL1,protein_coding,1,1,1308597,1311677,p36.33,pseudouridine synthase like 1 [Source:HGNC Symbol;Acc:HGNC:26914],NA,PUSL1,126789,NM_001346116;NM_153339
PPIL4_SIG,PPIL4,PPIL4_SIG,PPIL4,SIG,18,1.51823254503055,0.591149862663001,0.588670094080233,0.599297673720668,0.010627579640435,0.172322368619675,2.7360300942163,5.1271061532884,5.09215476846823,5.24194641769754,0.149791649229314,0.0205785622351378,ENSG00000131013,PPIL4,protein_coding,6,-1,149504733,149546038,q25.1,peptidylprolyl isomerase like 4 [Source:HGNC Symbol;Acc:HGNC:15702],NA,PPIL4,85313,NM_139126
SLC38A10_SIG,SLC38A10,SLC38A10_SIG,SLC38A10,SIG,57,1.51801367841735,0.309181352380692,0.304665970900383,0.324017605815992,0.0193516349156087,0.17236828326286,1.44361107437725,7.26617282176752,7.22947094241099,7.38676471108184,0.157293768670854,0.240698357957851,ENSG00000157637,SLC38A10,protein_coding,17,-1,81244811,81295547,q25.3,solute carrier family 38 member 10 [Source:HGNC Symbol;Acc:HGNC:28237],NA,SLC38A10,124565,NM_001037984;NM_138570
SLC35D2_SIG,SLC35D2,SLC35D2_SIG,SLC35D2,SIG,25,1.51773746639955,0.128991840311537,0.12693075308909,0.135763984042432,0.00883323095334193,0.172433526202854,1.48717875291617,4.59249210251176,4.56685143681082,4.67674000410057,0.109888567289748,0.226222243434514,ENSG00000130958,SLC35D2,protein_coding,9,-1,96313444,96383711,q22.32,solute carrier family 35 member D2 [Source:HGNC Symbol;Acc:HGNC:20799],NA,SLC35D2,11046,NM_001286990;NM_007001
GSK3A_SIG,GSK3A,GSK3A_SIG,GSK3A,SIG,18,-1.51671097828454,0.0149412728499972,0.0174279142170981,0.00677087978666566,-0.0106570344304324,0.172737208209596,-1.18447131048104,5.71905441872219,5.72974030247727,5.68394365781264,-0.0457966446646205,0.343721289751206,ENSG00000105723,GSK3A,protein_coding,19,-1,42230190,42242625,q13.2,glycogen synthase kinase 3 alpha [Source:HGNC Symbol;Acc:HGNC:4616],NA,GSK3A,2931,NM_019884
RAPGEF6_SIG,RAPGEF6,RAPGEF6_SIG,RAPGEF6,SIG,26,-1.5166715741997,0.132145469660818,0.134346769208748,0.124912628289047,-0.00943414091970092,0.172737208209596,-1.63597010407392,3.75439624258301,3.77688492088904,3.68050487100605,-0.0963800498829907,0.180452599068996,ENSG00000158987,RAPGEF6,protein_coding,5,-1,131423921,131635236,q31.1,Rap guanine nucleotide exchange factor 6 [Source:HGNC Symbol;Acc:HGNC:20655],NA,RAPGEF6,51735,NM_001164386;NM_001164387;NM_001164388;NM_001164389;NM_001164390;NM_016340
GLB1L2_SIG,GLB1L2,GLB1L2_SIG,GLB1L2,SIG,57,1.516116719142,-0.106553777885622,-0.108340310594464,-0.100683741842285,0.00765656875217837,0.172896589224257,1.36819058492674,1.02954089579123,0.995526964231028,1.14130095663191,0.145773992400879,0.26873439811926,ENSG00000149328,GLB1L2,protein_coding,11,1,134331874,134378341,q25,galactosidase beta 1 like 2 [Source:HGNC Symbol;Acc:HGNC:25129],NA,GLB1L2,89944,NM_138342
FAM133B_SIG,FAM133B,FAM133B_SIG,FAM133B,SIG,31,1.51473185854052,0.520196650502321,0.516137607541745,0.533533505944212,0.0173958984024669,0.173336621972084,2.60042404546597,3.51146907068348,3.47641857343585,3.62663499021139,0.150216416775541,0.0281408382510747,ENSG00000234545,FAM133B,protein_coding,7,-1,92560793,92590394,q21.2,family with sequence similarity 133 member B [Source:HGNC Symbol;Acc:HGNC:28629],NA,FAM133B,257415,NM_001040057;NM_001288584;NM_152789
CARM1_SIG,CARM1,CARM1_SIG,CARM1,SIG,26,1.51386395212104,0.327299666765293,0.325619125190349,0.33282144622582,0.00720232103547105,0.173602382365353,0.860033771003031,5.49450677562301,5.4854604967154,5.5242302634623,0.0387697667469019,0.503066910310589,ENSG00000142453,CARM1,protein_coding,19,1,10871513,10923070,p13.2,coactivator associated arginine methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:23393],NA,CARM1,10498,NM_199141
RPL6_SIG,RPL6,RPL6_SIG,RPL6,SIG,20,1.51373506748474,1.44779173211007,1.44127214107778,1.46921324550191,0.0279411044241326,0.173618056562416,2.09446705343023,8.43381256102828,8.40794982479053,8.51879012295235,0.110840298161825,0.0811534740930816,ENSG00000089009,RPL6,protein_coding,12,-1,112405190,112418838,q24.13,ribosomal protein L6 [Source:HGNC Symbol;Acc:HGNC:10362],NA,RPL6,6128,NM_000970;NM_001024662;NM_001320137;NM_001320138;NM_001320139;NM_001320140;NM_001320141;NM_001320142
ADAMTS5_SIG,ADAMTS5,ADAMTS5_SIG,ADAMTS5,SIG,38,1.51337063037927,-0.0664091143657946,-0.0697266265041412,-0.0555087173397986,0.0142179091643425,0.173713513642351,0.0465756902250968,0.525286873899781,0.524215293911563,0.528807779575354,0.00459248566379171,0.974436205206878,ENSG00000154736,ADAMTS5,protein_coding,21,-1,26917922,26967088,q21.3,ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:HGNC Symbol;Acc:HGNC:221],NA,ADAMTS5,11096,NM_007038
MED31_SIG,MED31,MED31_SIG,MED31,SIG,10,1.51224861312561,0.120740725610467,0.116547432292929,0.134518689368092,0.0179712570751633,0.174060764170298,1.21745849755439,1.9177947959186,1.90247247561698,1.96813956262392,0.0656670870069406,0.329318881519889,ENSG00000108590,MED31,protein_coding,17,-1,6643311,6651634,p13.1,mediator complex subunit 31 [Source:HGNC Symbol;Acc:HGNC:24260],NA,MED31,51003,NM_016060
CREBL2_TF,CREBL2,CREBL2_TF,CREBL2,TF,250,-1.51218109906141,0.177026248164746,0.181483551012566,0.16238082452191,-0.0191027264906564,0.174060764170298,0.804002899239113,4.6328268346797,4.61421275730913,4.69398737461154,0.0797746173024042,0.532857390935521,ENSG00000111269,CREBL2,protein_coding,12,1,12611827,12645108,p13.1,cAMP responsive element binding protein like 2 [Source:HGNC Symbol;Acc:HGNC:2350],NA,CREBL2,1389,NM_001310
GBA2_SIG,GBA2,GBA2_SIG,GBA2,SIG,32,1.51199364358038,0.205788201342711,0.202604633727904,0.21624849493422,0.0136438612063161,0.174096337484452,2.00234515236862,5.84900389911038,5.81887489720302,5.94799919109168,0.129124293888656,0.0966713412058322,ENSG00000070610,GBA2,protein_coding,9,-1,35736866,35749228,p13.3,glucosylceramidase beta 2 [Source:HGNC Symbol;Acc:HGNC:18986],Autosomal-Recessive Cerebellar Ataxia with Spasticity.;Autosomal recessive cerebellar ataxia with late-onset spasticity;Autosomal recessive spastic paraplegia type 46;SPASTIC PARAPLEGIA 46 AUTOSOMAL RECESSIVE,GBA2,57704,NM_001330660;NM_020944
MPL_SIG,MPL,MPL_SIG,MPL,SIG,93,1.51187775525606,0.0469519693113113,0.0417589320230126,0.0640148061157213,0.0222558740927087,0.17410763344617,-1.06124116417106,2.58365234948837,2.63084243907143,2.42859919800117,-0.202243241070251,0.400715760564041,ENSG00000117400,MPL,protein_coding,1,1,43337849,43352772,p34.2,MPL proto-oncogene, thrombopoietin receptor [Source:HGNC Symbol;Acc:HGNC:7217],AMEGAKARYOCYTIC THROMBOCYTOPENIA CONGENITAL;Congenital amegakaryocytic thrombocytopenia;Essential thrombocythemia;Familial thrombocytosis;Hereditary isolated aplastic anemia;MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA INCLUDED;POLYCYTHEMIA VERA;Primary myelofibrosis;THROMBOCYTHEMIA 2,MPL,4352,NM_005373
EIF5A_SIG,EIF5A,EIF5A_SIG,EIF5A,SIG,27,1.51154742243364,0.166121421112834,0.163474284198221,0.174819156689419,0.0113448724911985,0.174191706137484,1.34044055099088,7.62230885742265,7.60536366615976,7.67798591442927,0.0726222482695044,0.278960459797093,ENSG00000132507,EIF5A,protein_coding,17,1,7306999,7312463,p13.1,eukaryotic translation initiation factor 5A [Source:HGNC Symbol;Acc:HGNC:3300],NA,EIF5A,1984,NM_001143760;NM_001143761;NM_001143762;NM_001970
SNRPB_SIG,SNRPB,SNRPB_SIG,SNRPB,SIG,49,-1.51021322619195,0.340567983110145,0.343204528292981,0.331905048937969,-0.011299479355012,0.174616906058582,-1.45906831156936,5.87388700226828,5.89359901699927,5.80911895386643,-0.0844800631328394,0.235600885825298,ENSG00000125835,SNRPB,protein_coding,20,-1,2461634,2470853,p13,small nuclear ribonucleoprotein polypeptides B and B1 [Source:HGNC Symbol;Acc:HGNC:11153],Cerebro-costo-mandibular syndrome,SNRPB,6628,NM_003091;NM_198216
SLC25A30_SIG,SLC25A30,SLC25A30_SIG,SLC25A30,SIG,33,-1.50989516284734,0.0655441066256957,0.067725225171025,0.0583775742624709,-0.00934765090855403,0.174696978408242,0.497325808293425,4.56287720324651,4.55448905590754,4.59043825878886,0.0359492028813203,0.711239502680586,ENSG00000174032,SLC25A30,protein_coding,13,-1,45393316,45418455,q14.13,solute carrier family 25 member 30 [Source:HGNC Symbol;Acc:HGNC:27371],NA,SLC25A30,253512,NM_001010875;NM_001286806;NM_001286807
AKAP10_SIG,AKAP10,AKAP10_SIG,AKAP10,SIG,29,-1.5092547275364,0.400729962263794,0.404187938410897,0.389368040637596,-0.0148198977733013,0.174886794096817,-0.838034517820666,5.36186252479069,5.37343835724474,5.3238276467274,-0.049610710517335,0.514687847173655,ENSG00000108599,AKAP10,protein_coding,17,-1,19904302,19978343,p11.2,A-kinase anchoring protein 10 [Source:HGNC Symbol;Acc:HGNC:368],CARDIAC CONDUCTION DEFECT SUDDEN CARDIAC DEATH INCLUDED,AKAP10,11216,NM_001330152;NM_007202
CREB1_TF,CREB1,CREB1_TF,CREB1,TF,37,1.50851862578017,0.186923252085773,0.183634797663363,0.197728173759406,0.0140933760960433,0.175109355388157,0.740099931991197,6.31436579395111,6.30513636526536,6.34469105963285,0.0395546943674825,0.568929655196397,ENSG00000118260,CREB1,protein_coding,2,1,207529737,207605988,q33.3,cAMP responsive element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2345],HISTIOCYTOMA ANGIOMATOID FIBROUS;Melanoma of soft tissue,CREB1,1385,NM_001320793;NM_004379;NM_134442
PIK3R4_SIG,PIK3R4,PIK3R4_SIG,PIK3R4,SIG,36,1.50833334338024,0.47701329748894,0.474525792845816,0.485186527030635,0.010660734184819,0.175144331814992,1.50528198410163,4.84153862761974,4.81974718569533,4.91313907965706,0.0933918939617264,0.220165452325868,ENSG00000196455,PIK3R4,protein_coding,3,-1,130678934,130746829,q22.1,phosphoinositide-3-kinase regulatory subunit 4 [Source:HGNC Symbol;Acc:HGNC:8982],NA,PIK3R4,30849,NM_014602
DCAF10_SIG,DCAF10,DCAF10_SIG,DCAF10,SIG,25,1.50803445460536,0.184266670488645,0.18158218036448,0.193087138039472,0.0115049576749911,0.175218038477357,0.79035386296588,5.24322665585331,5.23335754336865,5.27565373973149,0.0422961963628356,0.540425909021818,ENSG00000122741,DCAF10,protein_coding,9,1,37800554,37867666,p13.2,DDB1 and CUL4 associated factor 10 [Source:HGNC Symbol;Acc:HGNC:23686],NA,DCAF10,79269,NM_001286810;NM_024345
CILP_SIG,CILP,CILP_SIG,CILP,SIG,47,1.50654373073396,-0.0933905992140835,-0.0952763319785012,-0.0871946201309968,0.00808171184750445,0.175698533833681,2.06266071199643,0.553646677331587,0.52532599710318,0.646700340939209,0.121374343836029,0.0862637762522619,ENSG00000138615,CILP,protein_coding,15,-1,65194760,65211473,q22.31,cartilage intermediate layer protein [Source:HGNC Symbol;Acc:HGNC:1980],INTERVERTEBRAL DISC DISEASE,CILP,8483,NM_003613
MYNN_TF,MYNN,MYNN_TF,MYNN,TF,51,1.50641073590988,0.232295684658806,0.230090932270416,0.239539871077802,0.00944893880738615,0.175715723952814,1.93297366976908,4.71914412851161,4.69887064354853,4.785757007676,0.086886364127464,0.109672481059125,ENSG00000085274,MYNN,protein_coding,3,1,169772831,169789716,q26.2,myoneurin [Source:HGNC Symbol;Acc:HGNC:14955],NA,MYNN,55892,NM_001185118;NM_001185119;NM_018657
KLHL17_SIG,KLHL17,KLHL17_SIG,KLHL17,SIG,40,1.50593584966423,-0.00555760146282678,-0.00746802134487623,0.0007194924353357,0.00818751378021201,0.175849747376803,0.0852628235017003,2.9518457455844,2.95012901384126,2.95748643559757,0.00735742175631091,0.952915866895204,ENSG00000187961,KLHL17,protein_coding,1,1,960584,965719,p36.33,kelch like family member 17 [Source:HGNC Symbol;Acc:HGNC:24023],NA,KLHL17,339451,NM_198317
IL13RA1_SIG,IL13RA1,IL13RA1_SIG,IL13RA1,SIG,17,-1.50476214512879,0.379836264721743,0.389306422136313,0.348720033216729,-0.0405863889195833,0.176222960777963,0.438493978616237,5.63306598689678,5.61593775235702,5.68934447181312,0.0734067194561012,0.745513446740359,ENSG00000131724,IL13RA1,protein_coding,X,1,118727133,118794535,q24,interleukin 13 receptor subunit alpha 1 [Source:HGNC Symbol;Acc:HGNC:5974],NA,IL13RA1,3597,NM_001560
BTF3_SIG,BTF3,BTF3_SIG,BTF3,SIG,26,1.50455017014005,1.42706042409511,1.42059424326067,1.44830644683686,0.0277122035761967,0.1762672221196,1.23704934788164,8.89409241106479,8.87708561492134,8.94997188410756,0.072886269186224,0.320767232280617,ENSG00000145741,BTF3,protein_coding,5,1,73498408,73505635,q13.2,basic transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:1125],NA,BTF3,689,NM_001037637;NM_001207
ITCH_SIG,ITCH,ITCH_SIG,ITCH,SIG,43,-1.50349831686621,0.557134059716403,0.559420561075951,0.549621269535033,-0.00979929154091721,0.176599300270863,-0.718355305609125,6.53073288236807,6.53817362056071,6.50628474259226,-0.031888877968452,0.58120283644561,ENSG00000078747,ITCH,protein_coding,20,1,34363235,34511393,q11.22,itchy E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:13890],AUTOIMMUNE DISEASE MULTISYSTEM WITH FACIAL DYSMORPHISM;AUTOIMMUNE DISEASE SYNDROMIC MULTISYSTEM;Syndromic multisystem autoimmune disease due to Itch deficiency,ITCH,83737,NM_001257137;NM_001257138;NM_001324197;NM_001324198;NM_031483
RPS2_SIG,RPS2,RPS2_SIG,RPS2,SIG,22,1.50272930810636,2.05798335122093,2.04933100669507,2.08641248323448,0.0370814765394152,0.176834739016524,2.10227010216169,9.47761559125009,9.44363902679598,9.58925287445644,0.145613847660455,0.0800266276861514,ENSG00000140988,RPS2,protein_coding,16,-1,1962058,1964841,p13.3,ribosomal protein S2 [Source:HGNC Symbol;Acc:HGNC:10404],NA,RPS2,6187,NM_002952
MEX3C_SIG,MEX3C,MEX3C_SIG,MEX3C,SIG,64,1.50139528638045,0.417297386350503,0.411874502974621,0.4351154317284,0.0232409287537788,0.177264615305817,0.551827180595285,6.4243009171458,6.41317528337802,6.46085657095421,0.0476812875761895,0.679421301692462,ENSG00000176624,MEX3C,protein_coding,18,-1,51174550,51218304,q21.2,mex-3 RNA binding family member C [Source:HGNC Symbol;Acc:HGNC:28040],NA,MEX3C,51320,NM_016626
TK1_SIG,TK1,TK1_SIG,TK1,SIG,20,-1.50127175785496,0.323678713100667,0.339219167579024,0.272617219814637,-0.0666019477643866,0.177278632125973,-1.54485970572827,4.17941931902618,4.23226183468039,4.00579391044808,-0.226467924232305,0.20746764660506,ENSG00000167900,TK1,protein_coding,17,-1,78174091,78187233,q25.3,thymidine kinase 1 [Source:HGNC Symbol;Acc:HGNC:11830],NA,TK1,7083,NM_001346663;NM_001363848;NM_003258
IP6K1_SIG,IP6K1,IP6K1_SIG,IP6K1,SIG,42,1.50080362441818,0.418151612091702,0.416081452757818,0.424953564188751,0.00887211143093248,0.177411187904248,1.02017496240096,5.61031703324891,5.59424765215451,5.66311642827338,0.0688687761188636,0.420639677716523,ENSG00000176095,IP6K1,protein_coding,3,-1,49724294,49786542,p21.31,inositol hexakisphosphate kinase 1 [Source:HGNC Symbol;Acc:HGNC:18360],NA,IP6K1,9807,NM_001006115;NM_001242829;NM_153273
KLF6_TF,KLF6,KLF6_TF,KLF6,TF,66,-1.50040276607366,0.28121722821252,0.284184638225137,0.271467166742494,-0.012717471482643,0.177520655944427,-0.668013962768633,9.94414255177053,9.95984777454376,9.89253967694422,-0.0673080975995415,0.61049397128647,ENSG00000067082,KLF6,protein_coding,10,-1,3775996,3785281,p15.2,Kruppel like factor 6 [Source:HGNC Symbol;Acc:HGNC:2235],GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;Prostate Cancer,KLF6,1316,NM_001160124;NM_001160125;NM_001300
IL27RA_SIG,IL27RA,IL27RA_SIG,IL27RA,SIG,64,1.4998443079424,0.13424058499688,0.131399066461543,0.143577003041559,0.0121779365800161,0.177683045962451,1.2083809116154,5.19924901306629,5.17025667137433,5.29450956433986,0.124252892965529,0.333187569620034,ENSG00000104998,IL27RA,protein_coding,19,1,14031762,14053218,p13.12,interleukin 27 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:17290],NA,IL27RA,9466,NM_004843
CSNK1G2_SIG,CSNK1G2,CSNK1G2_SIG,CSNK1G2,SIG,32,-1.49976561647066,0.280588639911982,0.28210416986525,0.2756090414941,-0.00649512837115015,0.177683045962451,-1.906998837415,7.10492511414706,7.12162559331699,7.05005211116014,-0.0715734821568557,0.114938922052059,ENSG00000133275,CSNK1G2,protein_coding,19,1,1941172,1981338,p13.3,casein kinase 1 gamma 2 [Source:HGNC Symbol;Acc:HGNC:2455],NA,CSNK1G2,1455,NM_001319
JAM3_SIG,JAM3,JAM3_SIG,JAM3,SIG,91,1.49902918561171,-0.0396998108397179,-0.0429095305539307,-0.02915358892159,0.0137559416323409,0.177908295405713,3.1269423888067,2.16907098116076,2.04120121498999,2.589214498579,0.548013283589006,0.00774453093194009,ENSG00000166086,JAM3,protein_coding,11,1,134068925,134152001,q25,junctional adhesion molecule 3 [Source:HGNC Symbol;Acc:HGNC:15532],Hemorrhagic destruction of the brain subependymal calcification and cataracts;Porencephaly-microcephaly-bilateral congenital cataract syndrome,JAM3,83700,NM_001205329;NM_032801
ECE2_SIG,ECE2,ECE2_SIG,ECE2,SIG,36,1.4988557454606,0.194512600218163,0.187981851568852,0.215970774351611,0.0279889227827595,0.17793178418689,1.35874412698997,1.81485778128354,1.78996122839149,1.896660740786,0.10669951239451,0.272217745513504,ENSG00000145194,ECE2,protein_coding,3,1,184276011,184293031,q27.1,endothelin converting enzyme 2 [Source:HGNC Symbol;Acc:HGNC:13275],NA,ECE2,9718,NM_001037324;NM_001100120;NM_001100121
SLC35A5_SIG,SLC35A5,SLC35A5_SIG,SLC35A5,SIG,69,1.49879551868828,0.413477200065261,0.406596516576298,0.436085160100426,0.0294886435241283,0.17793178418689,1.6024389584801,4.59438915350618,4.55813939557788,4.71349550098488,0.155356105407002,0.189830083231663,ENSG00000138459,SLC35A5,protein_coding,3,1,112561709,112585579,q13.2,solute carrier family 35 member A5 [Source:HGNC Symbol;Acc:HGNC:20792],NA,SLC35A5,55032,NM_001348905;NM_001348906;NM_001348907;NM_001348908;NM_001348909;NM_001348910;NM_001348911;NM_017945
POLR2J_SIG,POLR2J,POLR2J_SIG,POLR2J,SIG,25,-1.49864689075476,0.130155194494089,0.131925307044455,0.124339110400031,-0.00758619664442322,0.177954495710677,-1.21312842789997,4.62841935657434,4.64063529848791,4.58828126171544,-0.0523540367724742,0.331303155974897,ENSG00000005075,POLR2J,protein_coding,7,-1,102473118,102478907,q22.1,RNA polymerase II subunit J [Source:HGNC Symbol;Acc:HGNC:9197],NA,POLR2J,5439,NM_006234
EEF1B2_SIG,EEF1B2,EEF1B2_SIG,EEF1B2,SIG,43,1.49711080041608,0.795303587247746,0.788817458737898,0.816615152351529,0.0277976936136313,0.17845612406359,2.5864481996873,7.82545634476775,7.77829405463711,7.980418155197,0.20212410055989,0.0290619540515456,ENSG00000114942,EEF1B2,protein_coding,2,1,206159585,206162928,q33.3,eukaryotic translation elongation factor 1 beta 2 [Source:HGNC Symbol;Acc:HGNC:3208],Autosomal Recessive Mental Retardation,EEF1B2,1933,NM_001037663;NM_001959;NM_021121
IRF2_TF,IRF2,IRF2_TF,IRF2,TF,345,-1.495943588579,0.122202613048309,0.126184161548605,0.109120382261622,-0.0170637792869836,0.178831115690324,-0.788398886032741,5.15347684239507,5.17636996506844,5.07825658218255,-0.0981133828858844,0.541475801319512,ENSG00000168310,IRF2,protein_coding,4,-1,184387729,184474550,q35.1,interferon regulatory factor 2 [Source:HGNC Symbol;Acc:HGNC:6117],NA,IRF2,3660,NM_002199
SENP7_SIG,SENP7,SENP7_SIG,SENP7,SIG,66,1.49485314522067,0.227233095603851,0.22492074184719,0.234830829375737,0.00991008752854675,0.179142531619436,0.184768194953715,5.66347537577107,5.66081893018355,5.6722036969872,0.0113847668036503,0.895945807333929,ENSG00000138468,SENP7,protein_coding,3,-1,101324205,101513241,q12.3,SUMO specific peptidase 7 [Source:HGNC Symbol;Acc:HGNC:30402],NA,SENP7,57337,NM_001077203;NM_001282801;NM_001282802;NM_001282803;NM_020654
POLR2B_SIG,POLR2B,POLR2B_SIG,POLR2B,SIG,35,1.49474933926954,0.559895132810972,0.557731148873448,0.56700536574855,0.00927421687510229,0.179142531619436,1.92915416459637,6.81208721282196,6.78906354801813,6.88773639717741,0.0986728491592821,0.110446127922586,ENSG00000047315,POLR2B,protein_coding,4,1,56977722,57031158,q12,RNA polymerase II subunit B [Source:HGNC Symbol;Acc:HGNC:9188],NA,POLR2B,5431,NM_000938;NM_001303268;NM_001303269
SLC35F6_SIG,SLC35F6,SLC35F6_SIG,SLC35F6,SIG,39,-1.49472044909074,0.220368316581898,0.224241520098216,0.207642076456854,-0.0165994436413618,0.179142531619436,0.658200037907968,3.85264500715495,3.83871235801515,3.89842371147142,0.0597113534562738,0.615851642932478,ENSG00000213699,SLC35F6,protein_coding,2,1,26764284,26781231,p23.3,solute carrier family 35 member F6 [Source:HGNC Symbol;Acc:HGNC:26055],NA,SLC35F6,54978,NM_017877
FAM50A_SIG,FAM50A,FAM50A_SIG,FAM50A,SIG,21,-1.49471301066794,0.0628652475151117,0.066510400270827,0.050888317032047,-0.01562208323878,0.179142531619436,-0.956838714098869,5.28225715645056,5.29567041968334,5.23818500582856,-0.0574854138547813,0.452256878776803,ENSG00000071859,FAM50A,protein_coding,X,1,154444141,154450654,q28,family with sequence similarity 50 member A [Source:HGNC Symbol;Acc:HGNC:18786],NA,FAM50A,9130,NM_004699
NSRP1_SIG,NSRP1,NSRP1_SIG,NSRP1,SIG,37,1.49423795869481,0.123907634250968,0.122082048455118,0.12990598758019,0.00782393912507232,0.17927847612888,1.54893657773626,5.22552826702426,5.20781588204309,5.28372610339096,0.0759102213478666,0.206152776133061,ENSG00000126653,NSRP1,protein_coding,17,1,30115521,30186475,q11.2,nuclear speckle splicing regulatory protein 1 [Source:HGNC Symbol;Acc:HGNC:25305],NA,NSRP1,84081,NM_001261467;NM_032141
TSC22D4_TF,TSC22D4,TSC22D4_TF,TSC22D4,TF,50,-1.49302220021309,0.150342456401663,0.151460710915924,0.146668191569094,-0.00479251934682942,0.179671569020506,1.03706854535579,6.62528610568311,6.61199189329179,6.66896708925457,0.0569751959627771,0.412309534028051,ENSG00000166925,TSC22D4,protein_coding,7,-1,100463359,100479232,q22.1,TSC22 domain family member 4 [Source:HGNC Symbol;Acc:HGNC:21696],NA,TSC22D4,81628,NM_001303043;NM_030935
ESCO1_SIG,ESCO1,ESCO1_SIG,ESCO1,SIG,23,1.49231134921122,0.303169424075551,0.300281246414201,0.312659150677128,0.0123779042629269,0.179889744262987,2.57922300906457,5.38333210134734,5.35385138202087,5.48019732199145,0.126345939970586,0.0295644466754547,ENSG00000141446,ESCO1,protein_coding,18,-1,21529284,21600884,q11.2,establishment of sister chromatid cohesion N-acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24645],NA,ESCO1,114799,NM_052911
PARK7_SIG,PARK7,PARK7_SIG,PARK7,SIG,46,1.49092658745217,0.31147778769764,0.307861884125384,0.323358613720766,0.0154967295953826,0.180342673299064,1.80048756103646,6.35584915812101,6.33540604291874,6.42301939378561,0.0876133508668637,0.138059965996494,ENSG00000116288,PARK7,protein_coding,1,1,7954291,7985505,p36.23,Parkinsonism associated deglycase [Source:HGNC Symbol;Acc:HGNC:16369],Amyotrophic lateral sclerosis-parkinsonism-dementia complex;PARKINSON DISEASE 7 AUTOSOMAL RECESSIVE EARLY-ONSET;Young-onset Parkinson disease,PARK7,11315,NM_001123377;NM_007262
E2F4_TF,E2F4,E2F4_TF,E2F4,TF,168,-1.48998359932149,0.13443976571421,0.136374377023756,0.128083185697132,-0.00829119132662445,0.180642369223135,0.335161880635719,6.45635423408601,6.45273077185119,6.46825989571472,0.0155291238635326,0.806742130150703,ENSG00000205250,E2F4,protein_coding,16,1,67192155,67198918,q22.1,E2F transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:3118],NA,E2F4,1874,NM_001950
ITGA4_SIG,ITGA4,ITGA4_SIG,ITGA4,SIG,14,1.48957473823198,0.374490958968853,0.37115998790164,0.385435578189696,0.0142755902880558,0.180756039692757,0.395113025502744,8.25214663491357,8.24323825159236,8.2814170372547,0.0381787856623408,0.771299556273774,ENSG00000115232,ITGA4,protein_coding,2,1,181457202,181538940,q31.3,integrin subunit alpha 4 [Source:HGNC Symbol;Acc:HGNC:6140],NA,ITGA4,3676,NM_000885;NM_001316312
SNRPD3_SIG,SNRPD3,SNRPD3_SIG,SNRPD3,SIG,44,1.48923930519079,0.542823131496201,0.538150068421884,0.558177481597531,0.020027413175648,0.18083025654559,0.940730442159759,6.20950039240543,6.19737588480477,6.2493380602362,0.0519621754314318,0.460365839647206,ENSG00000100028,SNRPD3,protein_coding,22,1,24555958,24582052,q11.23,small nuclear ribonucleoprotein D3 polypeptide [Source:HGNC Symbol;Acc:HGNC:11160],NA,SNRPD3,6634,NM_001278656;NM_004175
INPP4B_SIG,INPP4B,INPP4B_SIG,INPP4B,SIG,65,-1.48919616945812,-0.0516372726050459,-0.0481190283942585,-0.0631972178690617,-0.0150781894748033,0.18083025654559,0.410049404990706,3.82016216212603,3.80188130945314,3.8802278209084,0.0783465114552642,0.762714312407494,ENSG00000109452,INPP4B,protein_coding,4,-1,142023160,142847432,q31.21,inositol polyphosphate-4-phosphatase type II B [Source:HGNC Symbol;Acc:HGNC:6075],NA,INPP4B,8821,NM_001101669;NM_001331040;NM_003866
SPTLC2_SIG,SPTLC2,SPTLC2_SIG,SPTLC2,SIG,5,1.48809971794989,0.460959391275033,0.457713684811021,0.471623855371071,0.01391017056005,0.18118414799662,1.61991305810808,7.55376589966125,7.51591615324261,7.67812935217964,0.162213198937037,0.185010580132412,ENSG00000100596,SPTLC2,protein_coding,14,-1,77505997,77616773,q24.3,serine palmitoyltransferase long chain base subunit 2 [Source:HGNC Symbol;Acc:HGNC:11278],Hereditary sensory and autonomic neuropathy type 1;Neuropathy hereditary sensory and autonomic type IC,SPTLC2,9517,NM_004863
WDR82_SIG,WDR82,WDR82_SIG,WDR82,SIG,69,1.48799634681944,0.343005087536734,0.3412758405658,0.348686899012661,0.00741105844686119,0.181191289893709,1.9781310074943,7.29901185920117,7.27853195911591,7.36630295948132,0.0877710003654092,0.101119157653836,ENSG00000164091,WDR82,protein_coding,3,-1,52254434,52288020,p21.2,WD repeat domain 82 [Source:HGNC Symbol;Acc:HGNC:28826],NA,WDR82,80335,NM_025222
RPL15_SIG,RPL15,RPL15_SIG,RPL15,SIG,22,1.4878534346023,1.6893712338712,1.68300321273679,1.71029473188426,0.0272915191474641,0.181206381305874,2.16415331911175,9.81958435809221,9.78810795744119,9.92300681737411,0.134898859932912,0.0711453374396047,ENSG00000174748,RPL15,protein_coding,3,1,23916545,23924374,p24.2,ribosomal protein L15 [Source:HGNC Symbol;Acc:HGNC:10306],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 12,RPL15,6138,NM_001253379;NM_001253380;NM_001253382;NM_001253383;NM_001253384;NM_002948
RNMT_SIG,RNMT,RNMT_SIG,RNMT,SIG,80,1.48778732132359,0.468156361024077,0.463843923782447,0.482325797675146,0.0184818738926991,0.181206381305874,1.27333422327483,5.69507364584034,5.67457115175867,5.76243898353728,0.087867831778608,0.305808813238903,ENSG00000101654,RNMT,protein_coding,18,1,13726660,13764558,p11.21,RNA guanine-7 methyltransferase [Source:HGNC Symbol;Acc:HGNC:10075],NA,RNMT,8731,NM_001308263;NM_003799
HYI_SIG,HYI,HYI_SIG,HYI,SIG,12,1.4871011711152,0.0151947263097996,0.012862548711509,0.0228575955613256,0.00999504684981654,0.181417254570419,0.916476741205418,3.99667813212523,3.97804111212734,4.05791405497541,0.0798729428480701,0.473111059475553,ENSG00000178922,HYI,protein_coding,1,-1,43451003,43453989,p34.2,hydroxypyruvate isomerase (putative) [Source:HGNC Symbol;Acc:HGNC:26948],NA,HYI,81888,NM_001190880;NM_001243526;NM_001330526;NM_031207
PRKAB1_SIG,PRKAB1,PRKAB1_SIG,PRKAB1,SIG,27,-1.48476354066757,0.186778921207892,0.189104342024011,0.179138252812072,-0.00996608921193892,0.182207068852414,-0.169715545071195,5.22898273587984,5.23130795153611,5.22134274158063,-0.00996520995548264,0.904856225306492,ENSG00000111725,PRKAB1,protein_coding,12,1,119667864,119681624,q24.23,protein kinase AMP-activated non-catalytic subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:9378],NA,PRKAB1,5564,NM_006253
ATP6V0A1_SIG,ATP6V0A1,ATP6V0A1_SIG,ATP6V0A1,SIG,13,-1.48466952675942,0.103413257218173,0.10587384889071,0.0953284560084081,-0.0105453928823022,0.182210937754797,-0.216663579510178,5.65242307646475,5.65726254491176,5.63652196585316,-0.0207405790586011,0.877866627909179,ENSG00000033627,ATP6V0A1,protein_coding,17,1,42458844,42522611,q21.2,ATPase H+ transporting V0 subunit a1 [Source:HGNC Symbol;Acc:HGNC:865],NA,ATP6V0A1,535,NM_001130020;NM_001130021;NM_005177
XYLT1_SIG,XYLT1,XYLT1_SIG,XYLT1,SIG,49,1.48374435160403,0.276489060373031,0.274166961792625,0.284118812851508,0.00995185105888211,0.182506617241569,-0.321588311276073,6.55938030411646,6.56729192503708,6.53338497823441,-0.0339069468026681,0.815095550921699,ENSG00000103489,XYLT1,protein_coding,16,-1,17101769,17470881,p12.3,xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:15516],DESBUQUOIS DYSPLASIA 2;Desbuquois syndrome;Pseudoxanthoma elasticum;XYLT1-CDG,XYLT1,64131,NM_022166
SLC2A13_SIG,SLC2A13,SLC2A13_SIG,SLC2A13,SIG,47,1.4832081107154,-0.0031073763473226,-0.00536719761480605,0.00431775067440872,0.00968494828921489,0.182665889279384,0.340524924533819,2.71029575762452,2.7016985987444,2.7385435653735,0.0368449666290971,0.803514089225677,ENSG00000151229,SLC2A13,protein_coding,12,-1,39755025,40106089,q12,solute carrier family 2 member 13 [Source:HGNC Symbol;Acc:HGNC:15956],NA,SLC2A13,114134,NM_052885
TSHZ1_TF,TSHZ1,TSHZ1_TF,TSHZ1,TF,53,1.48277535033418,0.395888829683841,0.393714110418721,0.403034335840665,0.00932022542194458,0.182788864155555,2.05030285765765,5.0493652407495,5.00553403905034,5.19338204633244,0.187848007282095,0.0885019013797715,ENSG00000179981,TSHZ1,protein_coding,18,1,75210755,75289950,q22.3,teashirt zinc finger homeobox 1 [Source:HGNC Symbol;Acc:HGNC:10669],Aural atresia congenital;External auditory canal aplasia/hypoplasia,TSHZ1,10194,NM_001308210;NM_005786
PLCH1_SIG,PLCH1,PLCH1_SIG,PLCH1,SIG,45,1.48065026222542,-0.0343155208977963,-0.0377854021160259,-0.0229144826093274,0.0148709195066983,0.183508111724569,0.246478400084373,1.29987974018191,1.29236419809223,1.32457366419087,0.032209466098635,0.860071476666609,ENSG00000114805,PLCH1,protein_coding,3,-1,155375580,155745067,q25.31,phospholipase C eta 1 [Source:HGNC Symbol;Acc:HGNC:29185],NA,PLCH1,23007,NM_001130960;NM_001130961;NM_001349250;NM_001349251;NM_001349252;NM_014996
PURA_TF,PURA,PURA_TF,PURA,TF,22,1.48009000127674,0.00359601604079969,0.000893185879328153,0.0124767437142062,0.0115835578348779,0.183676491616567,-0.0705310020764286,3.34501427812658,3.34672454395202,3.33939483327157,-0.0073297106804423,0.961539099638523,ENSG00000185129,PURA,protein_coding,5,1,140107777,140125619,q31.3,purine rich element binding protein A [Source:HGNC Symbol;Acc:HGNC:9701],Intellectual disability;Mental retardation autosomal dominant 31;PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation;Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,PURA,5813,NM_005859
NME8_SIG,NME8,NME8_SIG,NME8,SIG,11,-1.47996383426461,0.112556910170188,0.115448367118475,0.103056408768672,-0.0123919583498035,0.183691700837426,-1.08543631601657,2.0599391518558,2.08802678052272,1.96765122909308,-0.12037555142964,0.389348356762824,ENSG00000086288,NME8,protein_coding,7,1,37848597,37900401,p14.1,NME/NM23 family member 8 [Source:HGNC Symbol;Acc:HGNC:16473],CILIARY DYSKINESIA PRIMARY 6;Primary ciliary dyskinesia,NME8,51314,NM_016616
GNE_SIG,GNE,GNE_SIG,GNE,SIG,16,1.47963997841005,0.466582452076784,0.46400553029858,0.475049480776599,0.0110439504780193,0.18377670817816,0.592482091751994,5.24788751344551,5.2399786393771,5.27387381395598,0.0338951745788769,0.655921262948524,ENSG00000159921,GNE,protein_coding,9,-1,36214441,36277056,p13.3,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase [Source:HGNC Symbol;Acc:HGNC:23657],GNE myopathy;NONAKA MYOPATHY;SIALURIA,GNE,10020,NM_001128227;NM_001190383;NM_001190384;NM_001190388;NM_005476
PSEN1_SIG,PSEN1,PSEN1_SIG,PSEN1,SIG,59,-1.47953514451589,0.487494794478927,0.490472912709887,0.477709548862916,-0.0127633638469701,0.183784393296569,-0.368477423476384,6.85571751837921,6.86134399690488,6.83723051750916,-0.0241134793957282,0.787360192043244,ENSG00000080815,PSEN1,protein_coding,14,1,73136418,73223691,q24.2,presenilin 1 [Source:HGNC Symbol;Acc:HGNC:9508],ACNE INVERSA FAMILIAL 3;Alzheimer disease 3;Behavioral variant of frontotemporal dementia;Cardiomyopathy dilated 1u;Early-onset autosomal dominant Alzheimer disease;Familial isolated dilated cardiomyopathy;FRONTOTEMPORAL DEMENTIA;PICK DISEASE OF BRAIN;Progressive non-fluent aphasia;Semantic dementia,PSEN1,5663,NM_000021;NM_007318
SULT1A2_SIG,SULT1A2,SULT1A2_SIG,SULT1A2,SIG,21,1.47893770532776,-0.0255724112123811,-0.0270307463886166,-0.0207807384904644,0.00625000789815207,0.183966084801628,1.64869790744681,1.17684144233654,1.15078110419394,1.26246826766222,0.111687163468284,0.176796585552332,ENSG00000197165,SULT1A2,protein_coding,16,-1,28591943,28597050,p11.2,sulfotransferase family 1A member 2 [Source:HGNC Symbol;Acc:HGNC:11454],NA,SULT1A2,6799,NM_001054;NM_177528
TJP2_SIG,TJP2,TJP2_SIG,TJP2,SIG,50,-1.47834235216271,0.00561234926415334,0.00724256267191969,0.000255933781492476,-0.0069866288904271,0.184147167187067,-0.969828530952335,4.61439718134039,4.6435099241406,4.5187410264254,-0.124768897715203,0.445593806460566,ENSG00000119139,TJP2,protein_coding,9,1,69121264,69274615,q21.11,tight junction protein 2 [Source:HGNC Symbol;Acc:HGNC:11828],Autosomal dominant non-syndromic sensorineural deafness type DFNA;CHOLESTASIS PROGRESSIVE FAMILIAL INTRAHEPATIC 4;Familial hypercholanemia;HYPERCHOLANEMIA FAMILIAL;Progressive familial intrahepatic cholestasis type 4,TJP2,9414,NM_001170414;NM_001170415;NM_001170416;NM_004817;NM_201629
GNA11_SIG,GNA11,GNA11_SIG,GNA11,SIG,48,-1.47753201261851,-0.0512742786772465,-0.0493748583068695,-0.0575152313227709,-0.00814037301590152,0.184404466074958,1.29120018982057,2.66797395371363,2.63010759515678,2.79239198897185,0.162284393815067,0.298533053246981,ENSG00000088256,GNA11,protein_coding,19,1,3094362,3123999,p13.3,G protein subunit alpha 11 [Source:HGNC Symbol;Acc:HGNC:4379],Autosomal dominant hypocalcemia;Congenital Hemangioma;Familial hypocalciuric hypercalcemia type 2;Hypocalcemia autosomal dominant 2;Hypocalciuric hypercalcemia familial type II;Phakomatosis cesioflammea;Phakomatosis cesiomarmorata;Uveal melanoma,GNA11,2767,NM_002067
USP24_SIG,USP24,USP24_SIG,USP24,SIG,39,1.47743158538222,0.576431420188483,0.573783175677409,0.585132795010585,0.0113496193331756,0.184410601777406,0.108006441287989,7.27201260625895,7.2706429370564,7.27651294792448,0.00587001086808216,0.94020735102547,ENSG00000162402,USP24,protein_coding,1,-1,55066359,55215364,p32.3,ubiquitin specific peptidase 24 [Source:HGNC Symbol;Acc:HGNC:12623],NA,USP24,23358,NM_015306
SLC35C1_SIG,SLC35C1,SLC35C1_SIG,SLC35C1,SIG,83,1.47667781535237,0.195153816507294,0.189802897680939,0.212735406936747,0.0229325092558085,0.184648118233854,1.97011601880634,3.92769783935177,3.88415184565368,4.0707775329312,0.186625687277518,0.102558705661231,ENSG00000181830,SLC35C1,protein_coding,11,1,45804072,45813015,p11.2,solute carrier family 35 member C1 [Source:HGNC Symbol;Acc:HGNC:20197],Congenital disorder of glycosylation type 2C;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIc;Leukocyte adhesion deficiency type II,SLC35C1,55343,NM_001145265;NM_001145266;NM_018389
STAT5B_SIG,STAT5B,STAT5B_SIG,STAT5B,SIG,79,-1.47595825733688,0.224734197558262,0.226870480163405,0.217714983284217,-0.00915549687918781,0.184873723093687,-2.76276048829272,7.57101631209239,7.61038902929133,7.44164881272445,-0.168740216566874,0.019333799928357,ENSG00000173757,STAT5B,protein_coding,17,-1,42199168,42276707,q21.2,signal transducer and activator of transcription 5B [Source:HGNC Symbol;Acc:HGNC:11367],ACUTE PROMYELOCYTIC LEUKEMIA;GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;Laron syndrome with immunodeficiency,STAT5B,6777,NM_012448
TRIM11_SIG,TRIM11,TRIM11_SIG,TRIM11,SIG,33,-1.47556136034827,0.427556445485631,0.430712648338079,0.417186064684732,-0.0135265836533468,0.18498502407663,-0.747107888583962,5.44745814450434,5.45719761100012,5.41545704030392,-0.0417405706961941,0.564809444309299,ENSG00000154370,TRIM11,protein_coding,1,-1,228393673,228406835,q42.13,tripartite motif containing 11 [Source:HGNC Symbol;Acc:HGNC:16281],NA,TRIM11,81559,NM_145214
SLC9A3_SIG,SLC9A3,SLC9A3_SIG,SLC9A3,SIG,14,-1.47421866430066,-0.014571949047671,-0.0123525941788399,-0.0218641150452588,-0.00951152086641903,0.185432305714504,-2.12254601780898,0.265093332465392,0.289142787930574,0.186073693079797,-0.103069094850777,0.0770335160679583,ENSG00000066230,SLC9A3,protein_coding,5,-1,470458,524332,p15.33,solute carrier family 9 member A3 [Source:HGNC Symbol;Acc:HGNC:11073],Congenital sodium diarrhea;DIARRHEA 8 SECRETORY SODIUM CONGENITAL,SLC9A3,6550,NM_001284351;NM_004174
NFAT5_TF,NFAT5,NFAT5_TF,NFAT5,TF,102,1.47388535018674,0.0911768415333029,0.0887487195790618,0.0991549565258095,0.0104062369467476,0.1855212357351,1.27884907447074,6.93557316065965,6.91294285723131,7.00992987192419,0.0969870146928811,0.303572131797722,ENSG00000102908,NFAT5,protein_coding,16,1,69565094,69704666,q22.1,nuclear factor of activated T cells 5 [Source:HGNC Symbol;Acc:HGNC:7774],NA,NFAT5,10725,NM_001113178;NM_001367709;NM_006599;NM_138713;NM_138714;NM_173214;NM_173215
DCK_SIG,DCK,DCK_SIG,DCK,SIG,12,1.4734052623558,0.307936951898257,0.303496745158675,0.322526202614027,0.0190294574553518,0.185662404102938,-0.558352396299275,5.78490283304741,5.79444242837362,5.75355844840415,-0.0408839799694762,0.676143792062165,ENSG00000156136,DCK,protein_coding,4,1,70992538,71030914,q13.3,deoxycytidine kinase [Source:HGNC Symbol;Acc:HGNC:2704],NA,DCK,1633,NM_000788
PDE1C_SIG,PDE1C,PDE1C_SIG,PDE1C,SIG,25,-1.46902937879531,-0.14240702422786,-0.140092317826359,-0.150012488118505,-0.0099201702921456,0.187194303136122,0.429894442371112,0.2478209139606,0.242207512698269,0.266264946679688,0.0240574339814199,0.750582117103604,ENSG00000154678,PDE1C,protein_coding,7,-1,31751179,32299329,p14.3,phosphodiesterase 1C [Source:HGNC Symbol;Acc:HGNC:8776],Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 74,PDE1C,5137,NM_001191056;NM_001191057;NM_001191058;NM_001191059;NM_001322055;NM_001322056;NM_001322057;NM_001322058;NM_001322059;NM_005020
VAC14_SIG,VAC14,VAC14_SIG,VAC14,SIG,15,1.46757159930457,0.398386651081394,0.393921219755259,0.413058782581552,0.019137562826293,0.187686826529755,0.381308733246548,5.242330641767,5.23729064436163,5.25889063324178,0.0215999888801423,0.779718404813492,ENSG00000103043,VAC14,protein_coding,16,-1,70687439,70801160,q22.2,Vac14, PIKFYVE complex component [Source:HGNC Symbol;Acc:HGNC:25507],Childhood-onset basal ganglia degeneration syndrome;Progressive neurological disorder and regression of developmental milestones;STRIATONIGRAL DEGENERATION CHILDHOOD-ONSET;YUNIS-VARON SYNDROME,VAC14,55697,NM_001351157;NM_018052
KLF10_TF,KLF10,KLF10_TF,KLF10,TF,68,-1.46713424554662,0.0707440689119581,0.0738322407134772,0.0605972187069667,-0.0132350220065104,0.187813837842843,-1.50631996794044,8.30975432958531,8.3570903226885,8.15422178081767,-0.202868541870833,0.219882017172001,ENSG00000155090,KLF10,protein_coding,8,-1,102648784,102655725,q22.3,Kruppel like factor 10 [Source:HGNC Symbol;Acc:HGNC:11810],NA,KLF10,7071,NM_001032282;NM_005655
CSRNP1_TF,CSRNP1,CSRNP1_TF,CSRNP1,TF,223,-1.46675973726263,0.126948528636079,0.132077115580305,0.110097457247907,-0.0219796583323976,0.187891195190544,-1.15174495499568,7.6166417591492,7.65856679310248,7.47888807615986,-0.179678716942619,0.358495759549351,ENSG00000144655,CSRNP1,protein_coding,3,-1,39141855,39154562,p22.2,cysteine and serine rich nuclear protein 1 [Source:HGNC Symbol;Acc:HGNC:14300],NA,CSRNP1,64651,NM_001320559;NM_001320560;NM_033027
DHX58_SIG,DHX58,DHX58_SIG,DHX58,SIG,21,-1.46675202740944,0.338933188422364,0.342658280948074,0.326693598695032,-0.0159646822530418,0.187891195190544,0.249131776360817,4.41009485573535,4.40578860061127,4.42424397971449,0.0184553791032184,0.858440842460595,ENSG00000108771,DHX58,protein_coding,17,-1,42101404,42112714,q21.2,DExH-box helicase 58 [Source:HGNC Symbol;Acc:HGNC:29517],NA,DHX58,79132,NM_024119
HMGCL_SIG,HMGCL,HMGCL_SIG,HMGCL,SIG,48,1.46655277735382,0.330176498960363,0.323721913267535,0.351384423379658,0.0276625101121232,0.187922083218481,1.34481513077666,3.75972148939865,3.73274868879047,3.84834640568266,0.115597716892193,0.277197747279829,ENSG00000117305,HMGCL,protein_coding,1,-1,23801885,23838620,p36.11,3-hydroxy-3-methylglutaryl-CoA lyase [Source:HGNC Symbol;Acc:HGNC:5005],3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY;3-hydroxy-3-methylglutaric aciduria;3-Hydroxy-3-Methylglutaryl-Coenzyme A Lyase Deficiency,HMGCL,3155,NM_000191;NM_001166059
GPLD1_SIG,GPLD1,GPLD1_SIG,GPLD1,SIG,79,1.46649932398019,-0.0344800099427001,-0.0382017878023336,-0.0222513112610474,0.0159504765412863,0.187922083218481,-0.114906402148394,1.12573348532699,1.1277435234776,1.1191290742607,-0.00861444921689661,0.936570915658107,ENSG00000112293,GPLD1,protein_coding,6,-1,24424565,24495205,p22.3,glycosylphosphatidylinositol specific phospholipase D1 [Source:HGNC Symbol;Acc:HGNC:4459],NA,GPLD1,2822,NM_001503
NMT1_SIG,NMT1,NMT1_SIG,NMT1,SIG,77,1.46619521991696,0.325215386401811,0.319153652302247,0.345132512728951,0.0259788604267044,0.188001351105257,1.64318574920422,6.36254417414384,6.33043728793324,6.4680382288358,0.137600940902558,0.178401778552292,ENSG00000136448,NMT1,protein_coding,17,1,45051610,45109016,q21.31,N-myristoyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:7857],NA,NMT1,4836,NM_021079
RHOBTB2_SIG,RHOBTB2,RHOBTB2_SIG,RHOBTB2,SIG,43,1.46583337319169,0.158886422987039,0.15601884073694,0.168308478951651,0.0122896382147102,0.188101383391249,1.07322170387642,4.1803819920318,4.15318965492519,4.26972824252494,0.116538587599746,0.395159858432351,ENSG00000008853,RHOBTB2,protein_coding,8,1,22987417,23020199,p21.3,Rho related BTB domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18756],EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 64,RHOBTB2,23221,NM_001160036;NM_001160037;NM_015178
RNF14_SIG,RNF14,RNF14_SIG,RNF14,SIG,29,1.46538821026384,0.301325583163487,0.297529699921373,0.313797770959006,0.0162680710376328,0.18823139384928,1.17343657960844,4.31746089117205,4.29581016077674,4.3885990053281,0.09278884455136,0.348914638950335,ENSG00000013561,RNF14,protein_coding,5,1,141958328,141990292,q31.3,ring finger protein 14 [Source:HGNC Symbol;Acc:HGNC:10058],NA,RNF14,9604,NM_001201365;NM_004290;NM_183398;NM_183399;NM_183400;NM_183401
TRPV2_SIG,TRPV2,TRPV2_SIG,TRPV2,SIG,27,1.4637132049791,0.312907282750532,0.30993803348182,0.322663387490584,0.012725354008764,0.18880407516577,1.00235882714927,5.59351429092604,5.57141078857291,5.66614008437205,0.0947292957991435,0.429299102042088,ENSG00000187688,TRPV2,protein_coding,17,1,16415571,16437003,p11.2,transient receptor potential cation channel subfamily V member 2 [Source:HGNC Symbol;Acc:HGNC:18082],NA,TRPV2,51393,NM_016113
PRKCG_SIG,PRKCG,PRKCG_SIG,PRKCG,SIG,9,-1.46362299252219,-0.103561581301844,-0.100685688636673,-0.113010942915976,-0.0123252542793021,0.188806541842704,-1.19306366815725,0.35360048135023,0.364939634932703,0.31634326243639,-0.0485963724963124,0.340122070838178,ENSG00000126583,PRKCG,protein_coding,19,1,53879190,53907652,q13.42,protein kinase C gamma [Source:HGNC Symbol;Acc:HGNC:9402],SPINOCEREBELLAR ATAXIA 14;Spinocerebellar ataxia type 14,PRKCG,5582,NM_001316329;NM_002739
ZNF853_TF,ZNF853,ZNF853_TF,ZNF853,TF,255,1.46237687457771,-0.00380045938355872,-0.006157575103628,0.00394434941095461,0.0101019245145828,0.189225715201168,-0.158205887258244,2.01380148780947,2.01819987271523,1.99934965169054,-0.0188502210246867,0.911119146516106,ENSG00000236609,ZNF853,protein_coding,7,1,6615610,6624290,p22.1,zinc finger protein 853 [Source:HGNC Symbol;Acc:HGNC:21767],NA,ZNF853,54753,NM_001353546;NM_017560
GCH1_SIG,GCH1,GCH1_SIG,GCH1,SIG,13,-1.46217816526015,0.218423509693816,0.221633423346273,0.207876650550027,-0.013756772796246,0.189243786049114,2.0818927250775,4.83708675719415,4.77555014698252,5.03927847646093,0.26372832947841,0.0831559540966226,ENSG00000131979,GCH1,protein_coding,14,-1,54842008,54902826,q22.2,GTP cyclohydrolase 1 [Source:HGNC Symbol;Acc:HGNC:4193],Autosomal dominant dopa-responsive dystonia;DYSTONIA DOPA-RESPONSIVE;DYSTONIA TYPE 5;GTP CYCLOHYDROLASE 1 DEFICIENCY;GTP cyclohydrolase I deficiency;HYPERPHENYLALANINEMIA BH4-DEFICIENT B,GCH1,2643,NM_000161;NM_001024024;NM_001024070;NM_001024071
PPM1G_SIG,PPM1G,PPM1G_SIG,PPM1G,SIG,49,1.46216002312902,0.504732228473769,0.500993471761477,0.517016714814156,0.0160232430526789,0.189243786049114,1.17785094963371,7.08152005034547,7.06758217682495,7.12731592048433,0.0597337436593782,0.346751968555751,ENSG00000115241,PPM1G,protein_coding,2,-1,27381195,27409591,p23.3,protein phosphatase, Mg2+/Mn2+ dependent 1G [Source:HGNC Symbol;Acc:HGNC:9278],NA,PPM1G,5496,NM_177983
RHAG_SIG,RHAG,RHAG_SIG,RHAG,SIG,42,-1.46059094191153,-0.187391405356397,-0.176581162036332,-0.222910776265182,-0.0463296142288497,0.189780399373871,-0.574746471566569,2.18087007113519,2.21243868070549,2.07714463968989,-0.135294041015601,0.666086812703256,ENSG00000112077,RHAG,protein_coding,6,-1,49605158,49636884,p12.3,Rh associated glycoprotein [Source:HGNC Symbol;Acc:HGNC:10006],Overhydrated hereditary stomatocytosis;RH-NULL REGULATOR TYPE;Rh deficiency syndrome,RHAG,6005,NM_000324
GK5_SIG,GK5,GK5_SIG,GK5,SIG,15,-1.45962411129733,0.0844908189627763,0.0872103586782713,0.0755551884690072,-0.011655170209264,0.190100014777409,-0.308624111311161,4.22915396862001,4.23463405241575,4.21114797900544,-0.0234860734103098,0.822804191280758,ENSG00000175066,GK5,protein_coding,3,-1,142157527,142225592,q23,glycerol kinase 5 [Source:HGNC Symbol;Acc:HGNC:28635],NA,GK5,256356,NM_001039547
MTMR1_SIG,MTMR1,MTMR1_SIG,MTMR1,SIG,42,1.4595041024689,0.163302517102098,0.161242252756438,0.17007195709498,0.00882970433854126,0.190113254857953,1.4886599735757,5.0563464367883,5.03466386442255,5.12758917456148,0.092925310138929,0.225736943901644,ENSG00000063601,MTMR1,protein_coding,X,1,150692971,150765108,q28,myotubularin related protein 1 [Source:HGNC Symbol;Acc:HGNC:7449],NA,MTMR1,8776,NM_001306144;NM_001306145;NM_001353990;NM_001353991;NM_001353992;NM_001353993;NM_001353994;NM_001353995;NM_001353996;NM_003828
TXNRD1_SIG,TXNRD1,TXNRD1_SIG,TXNRD1,SIG,21,1.45636699439185,0.348500152587894,0.346545777315448,0.354921671340215,0.00837589402476748,0.191221214771856,0.483767653863385,6.74257093077222,6.73600993665692,6.76412848286533,0.0281185462084136,0.718860877996173,ENSG00000198431,TXNRD1,protein_coding,12,1,104215779,104350307,q23.3,thioredoxin reductase 1 [Source:HGNC Symbol;Acc:HGNC:12437],NA,TXNRD1,7296,NM_001093771;NM_001261445;NM_001261446;NM_003330;NM_182729;NM_182742;NM_182743
PSKH1_SIG,PSKH1,PSKH1_SIG,PSKH1,SIG,30,1.45615520692509,0.412641403083185,0.407167786826201,0.430626142213276,0.0234583553870748,0.191267856038381,-0.571004423936822,4.58750126660785,4.59810350826026,4.55266532974993,-0.0454381785103317,0.668212412924962,ENSG00000159792,PSKH1,protein_coding,16,1,67893254,67929676,q22.1,protein serine kinase H1 [Source:HGNC Symbol;Acc:HGNC:9529],NA,PSKH1,5681,NM_006742
SLC12A9_SIG,SLC12A9,SLC12A9_SIG,SLC12A9,SIG,50,-1.45587993447428,0.234571298161265,0.23918680200035,0.219406071261416,-0.0197807307389341,0.191337599620866,-1.05271366452905,5.70310212446095,5.73126250244508,5.61057516822736,-0.120687334217726,0.404725724873317,ENSG00000146828,SLC12A9,protein_coding,7,1,100826820,100867010,q22.1,solute carrier family 12 member 9 [Source:HGNC Symbol;Acc:HGNC:17435],NA,SLC12A9,56996,NM_001267812;NM_001267814;NM_001363493;NM_020246
NAA60_SIG,NAA60,NAA60_SIG,NAA60,SIG,39,-1.45467228965169,-0.116612873103197,-0.113160456366423,-0.127956528095456,-0.0147960717290329,0.191746850165096,-1.00140734602154,2.86723084810063,2.88331802847339,2.81437296973299,-0.0689450587403969,0.429795372502933,ENSG00000122390,NAA60,protein_coding,16,1,3443649,3486953,p13.3,N(alpha)-acetyltransferase 60, NatF catalytic subunit [Source:HGNC Symbol;Acc:HGNC:25875],NA,NAA60,79903,NM_001083600;NM_001083601;NM_001317093;NM_001317094;NM_001317095;NM_001317096;NM_001317097;NM_001317098;NM_024845
ZFX_TF,ZFX,ZFX_TF,ZFX,TF,32,1.45446086413789,0.168769217545784,0.16437720707229,0.183200109101551,0.0188229020292609,0.191793443966129,2.79845523018204,5.78815009234401,5.75380142864991,5.90100998733894,0.147208558689033,0.0177670777572557,ENSG00000005889,ZFX,protein_coding,X,1,24149173,24216255,p22.11,zinc finger protein X-linked [Source:HGNC Symbol;Acc:HGNC:12869],NA,ZFX,7543,NM_001178084;NM_001178085;NM_001178086;NM_001178095;NM_001330327;NM_003410
PRDX4_SIG,PRDX4,PRDX4_SIG,PRDX4,SIG,23,1.45425209376211,0.250076719102809,0.248345677387426,0.25576442759621,0.00741875020878398,0.19183235078387,-0.298070873607752,3.77883900896753,3.78564805639595,3.75646642455986,-0.0291816318360895,0.829071969601669,ENSG00000123131,PRDX4,protein_coding,X,1,23664262,23686397,p22.11,peroxiredoxin 4 [Source:HGNC Symbol;Acc:HGNC:17169],NA,PRDX4,10549,NM_006406
RNF11_SIG,RNF11,RNF11_SIG,RNF11,SIG,36,-1.45418701165453,0.36828677060195,0.374878471924573,0.346628323399047,-0.0282501485255264,0.19183235078387,-1.00386481808711,6.4880664973,6.50562408568052,6.43037727833543,-0.0752468073450921,0.428618404417819,ENSG00000123091,RNF11,protein_coding,1,1,51236273,51273447,p32.3,ring finger protein 11 [Source:HGNC Symbol;Acc:HGNC:10056],NA,RNF11,26994,NM_014372
COL6A1_SIG,COL6A1,COL6A1_SIG,COL6A1,SIG,65,1.45362108577716,-0.126718345414311,-0.128496434669526,-0.120876052147178,0.00762038252234813,0.192008211170935,3.58559949977793,2.65642187075029,2.48280695702806,3.22687087298048,0.744063915952418,0.00208984802475947,ENSG00000142156,COL6A1,protein_coding,21,1,45981737,46005050,q22.3,collagen type VI alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2211],BETHLEM MYOPATHY;Bethlem myopathy 1;COL6A1 associated myopathy;Congenital muscular dystrophy Ullrich type;ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1,COL6A1,1291,NM_001848
HDAC1_SIG,HDAC1,HDAC1_SIG,HDAC1,SIG,14,1.45321129509843,0.501853231672207,0.499178992688006,0.510640016906012,0.0114610242180056,0.192127213859182,0.406659039317302,6.80466842856645,6.80012559537272,6.81959488048872,0.019469285116002,0.764538858662139,ENSG00000116478,HDAC1,protein_coding,1,1,32292083,32333635,p35.2,histone deacetylase 1 [Source:HGNC Symbol;Acc:HGNC:4852],NA,HDAC1,3065,NM_004964
MFN1_SIG,MFN1,MFN1_SIG,MFN1,SIG,24,1.45221919297806,0.296559560884759,0.294744997472513,0.302521697810711,0.00777670033819841,0.192458904121903,1.62296122951939,4.84786919694582,4.82834879896901,4.91200764744104,0.0836588484720302,0.184156774108015,ENSG00000171109,MFN1,protein_coding,3,1,179347709,179394936,q26.33,mitofusin 1 [Source:HGNC Symbol;Acc:HGNC:18262],NA,MFN1,55669,NM_033540
LTBP1_SIG,LTBP1,LTBP1_SIG,LTBP1,SIG,78,1.45156320775232,-0.0933501789707789,-0.0964890530759236,-0.0830367354824463,0.0134523175934773,0.192668095722452,1.8173419934218,3.75300843202585,3.64368992529574,4.11219781128195,0.468507885986211,0.134198445954595,ENSG00000049323,LTBP1,protein_coding,2,1,32946953,33399509,p22.3,latent transforming growth factor beta binding protein 1 [Source:HGNC Symbol;Acc:HGNC:6714],NA,LTBP1,4052,NM_000627;NM_001166264;NM_001166265;NM_001166266;NM_206943
SRSF12_SIG,SRSF12,SRSF12_SIG,SRSF12,SIG,58,1.45103226730574,0.0392284436330789,0.0358576572291272,0.0503038846746346,0.0144462274455074,0.192831700348266,0.484888101799313,1.22966646448096,1.21880696224206,1.26534768612305,0.046540723880989,0.718278921380761,ENSG00000154548,SRSF12,protein_coding,6,-1,89095959,89118071,q15,serine and arginine rich splicing factor 12 [Source:HGNC Symbol;Acc:HGNC:21220],NA,SRSF12,135295,NM_080743
HSPA9_SIG,HSPA9,HSPA9_SIG,HSPA9,SIG,29,1.450872839196,0.369304247040442,0.366842524612107,0.377392763590688,0.0105502389785816,0.192859446785438,2.42694172226656,7.81907348546179,7.79011011077365,7.91423885943712,0.124128748663473,0.0413327212173845,ENSG00000113013,HSPA9,protein_coding,5,-1,138553756,138575724,q31.2,heat shock protein family A (Hsp70) member 9 [Source:HGNC Symbol;Acc:HGNC:5244],ANEMIA SIDEROBLASTIC 4;Autosomal recessive sideroblastic anemia;EVEN-PLUS SYNDROME,HSPA9,3313,NM_004134
PLD6_SIG,PLD6,PLD6_SIG,PLD6,SIG,6,1.44990296418134,-0.318286401831968,-0.321213840516432,-0.308667674725872,0.0125461657905601,0.193178845777735,-0.443681300823531,2.07920117449677,2.08793276104945,2.05051167582369,-0.0374210852257578,0.742573854950057,ENSG00000179598,PLD6,protein_coding,17,-1,17200995,17206333,p11.2,phospholipase D family member 6 [Source:HGNC Symbol;Acc:HGNC:30447],NA,PLD6,201164,NM_178836
ARG2_SIG,ARG2,ARG2_SIG,ARG2,SIG,48,-1.44983316067417,-0.0520056955983159,-0.0497638326143492,-0.0593718168313496,-0.0096079842170006,0.193178845777735,-0.39123777236979,1.34882228797415,1.35882743410443,1.31594823640324,-0.0428791977011867,0.773714590944342,ENSG00000081181,ARG2,protein_coding,14,1,67619920,67651708,q24.1,arginase 2 [Source:HGNC Symbol;Acc:HGNC:664],NA,ARG2,384,NM_001172
SETD2_SIG,SETD2,SETD2_SIG,SETD2,SIG,30,1.44959887171999,0.686960622727077,0.684765450039989,0.694173332984651,0.00940788294466229,0.193234049731864,3.0392983409203,7.56853480397343,7.54038768471417,7.66101819582525,0.120630511111082,0.00971186418649034,ENSG00000181555,SETD2,protein_coding,3,-1,47016429,47163967,p21.31,SET domain containing 2, histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:18420],LUSCAN-LUMISH SYNDROME;SETD2-associated Overgrowth Syndrome;SOTOS SYNDROME,SETD2,29072,NM_001349370;NM_014159
DLX2_TF,DLX2,DLX2_TF,DLX2,TF,83,1.44923028167829,-0.0104977644548861,-0.0123475067903948,-0.00442003963821465,0.00792746715218015,0.193338481094851,0.00129299225314881,0.345862133885884,0.345843932813687,0.34592193740882,7.80045951336995e-05,0.999143346039538,ENSG00000115844,DLX2,protein_coding,2,-1,172099438,172102900,q31.1,distal-less homeobox 2 [Source:HGNC Symbol;Acc:HGNC:2915],NA,DLX2,1746,NM_004405
ETHE1_SIG,ETHE1,ETHE1_SIG,ETHE1,SIG,22,1.4489517749521,0.224308610302659,0.222899866989547,0.228937338331457,0.00603747134191005,0.193409926268967,1.75820548577277,4.430991561377,4.40366454816707,4.52078031906677,0.117115770899699,0.148118043522991,ENSG00000105755,ETHE1,protein_coding,19,-1,43506719,43527230,q13.31,ETHE1, persulfide dioxygenase [Source:HGNC Symbol;Acc:HGNC:23287],ENCEPHALOPATHY ETHYLMALONIC;Ethylmalonic encephalopathy,ETHE1,23474,NM_001320867;NM_001320868;NM_001320869;NM_014297
RPL10_SIG,RPL10,RPL10_SIG,RPL10,SIG,15,1.44850853834341,1.5931996322824,1.58625349939226,1.61602264034998,0.0297691409577172,0.193541799331849,1.66573355338504,8.86768467385998,8.84257104601501,8.95020087963631,0.107629833621301,0.172165588071921,ENSG00000147403,RPL10,protein_coding,X,1,154389955,154409168,q28,ribosomal protein L10 [Source:HGNC Symbol;Acc:HGNC:10298],AUTISM SUSCEPTIBILITY TO X-LINKED 5;MENTAL RETARDATION X-LINKED SYNDROMIC 35;X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome;X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,RPL10,6134,NM_001256577;NM_001256580;NM_001303624;NM_001303625;NM_001303626;NM_006013
GSTP1_SIG,GSTP1,GSTP1_SIG,GSTP1,SIG,14,1.44664858314931,0.200868618446962,0.198536706686831,0.20853061423025,0.0099939075434182,0.194194117186853,0.293919038762455,7.90105662148858,7.89587241539096,7.91809044152363,0.0222180261326761,0.83141757125201,ENSG00000084207,GSTP1,protein_coding,11,1,67583595,67586656,q13.2,glutathione S-transferase pi 1 [Source:HGNC Symbol;Acc:HGNC:4638],NA,GSTP1,2950,NM_000852
FAAH_SIG,FAAH,FAAH_SIG,FAAH,SIG,13,-1.44637601539094,0.0166246624736869,0.0187426278297192,0.00966563344672357,-0.00907699438299552,0.194263590761566,-1.2432000789771,4.08368437905886,4.1205282454738,3.96262596083834,-0.157902284635456,0.318321565580649,ENSG00000117480,FAAH,protein_coding,1,1,46394317,46413848,p33,fatty acid amide hydrolase [Source:HGNC Symbol;Acc:HGNC:3553],POLYSUBSTANCE ABUSE SUSCEPTIBILITY TO,FAAH,2166,NM_001441
HAGH_SIG,HAGH,HAGH_SIG,HAGH,SIG,28,-1.44591900220962,0.235115271168086,0.238058890268607,0.225443379837803,-0.0126155104308039,0.194400941974388,-1.6929775634536,4.34549593707395,4.37388117691843,4.25223014901353,-0.121651027904899,0.164975965198642,ENSG00000063854,HAGH,protein_coding,16,-1,1795620,1827157,p13.3,hydroxyacylglutathione hydrolase [Source:HGNC Symbol;Acc:HGNC:4805],HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY,HAGH,3029,NM_001040427;NM_001286249;NM_005326
UBE3C_SIG,UBE3C,UBE3C_SIG,UBE3C,SIG,17,1.44554392053951,0.218683446747292,0.215834384032607,0.228044652809829,0.0122102687772212,0.194508199642257,-0.404155727765522,6.37069003457845,6.37586926120496,6.35367257566279,-0.0221966855421689,0.765814543013296,ENSG00000009335,UBE3C,protein_coding,7,1,157138916,157269370,q36.3,ubiquitin protein ligase E3C [Source:HGNC Symbol;Acc:HGNC:16803],NA,UBE3C,9690,NM_014671
CARNS1_SIG,CARNS1,CARNS1_SIG,CARNS1,SIG,31,-1.44399759877975,0.0434027743666919,0.0467308033943556,0.0324678218472257,-0.0142629815471297,0.195047167897221,0.285271674787368,1.76733726352737,1.7596831663081,1.79248644010496,0.0328032737968659,0.836615118019871,ENSG00000172508,CARNS1,protein_coding,11,1,67414968,67425607,q13.2,carnosine synthase 1 [Source:HGNC Symbol;Acc:HGNC:29268],NA,CARNS1,57571,NM_001166222;NM_020811
KCTD6_SIG,KCTD6,KCTD6_SIG,KCTD6,SIG,28,-1.44376722370918,0.130692008344212,0.132508319502589,0.124724128823828,-0.00778419067876124,0.195101280177307,-0.5043514570036,2.92451218655786,2.93316003375516,2.89609783148101,-0.0370622022741501,0.706944663099029,ENSG00000168301,KCTD6,protein_coding,3,1,58492096,58502360,p14.3,potassium channel tetramerization domain containing 6 [Source:HGNC Symbol;Acc:HGNC:22235],NA,KCTD6,200845,NM_001128214;NM_153331
BUD13_SIG,BUD13,BUD13_SIG,BUD13,SIG,22,1.44363206166042,0.42739370687318,0.423666672785419,0.439639676018679,0.0159730032332601,0.195120272568838,1.39482316863152,4.49932629096141,4.47942521094758,4.56471555386399,0.0852903429164096,0.258557984172343,ENSG00000137656,BUD13,protein_coding,11,-1,116748170,116772987,q23.3,BUD13 homolog [Source:HGNC Symbol;Acc:HGNC:28199],NA,BUD13,84811,NM_001159736;NM_032725
RLF_TF,RLF,RLF_TF,RLF,TF,266,-1.44295037710398,0.0678650704458385,0.0726055914613488,0.0522890728234476,-0.0203165186379013,0.195340993833496,-1.19183177369664,5.9977847299801,6.02243794267745,5.91678131683168,-0.105656625845764,0.340674739174393,ENSG00000117000,RLF,protein_coding,1,1,40161387,40240921,p34.2,rearranged L-myc fusion [Source:HGNC Symbol;Acc:HGNC:10025],NA,RLF,6018,NM_012421
IKZF2_TF,IKZF2,IKZF2_TF,IKZF2,TF,178,-1.44232099578424,0.0120135095726914,0.0149013518109091,0.00252488507569034,-0.0123764667352187,0.195542564519882,-3.08266336001742,4.05126311587738,4.19816520901255,3.56858480986182,-0.629580399150731,0.00867142794230777,ENSG00000030419,IKZF2,protein_coding,2,-1,212999691,213152427,q34,IKAROS family zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:13177],NA,IKZF2,22807,NM_001079526;NM_016260
PDLIM2_SIG,PDLIM2,PDLIM2_SIG,PDLIM2,SIG,54,1.44146834663377,0.231135736686935,0.228456055922764,0.239940402054927,0.0114843461321625,0.195826861686024,2.77148403265525,4.64883038487855,4.5894987734533,4.84377710813293,0.254278334679626,0.0189098794735055,ENSG00000120913,PDLIM2,protein_coding,8,1,22578279,22598025,p21.3,PDZ and LIM domain 2 [Source:HGNC Symbol;Acc:HGNC:13992],NA,PDLIM2,64236,NM_021630;NM_176871;NM_198042
EIF1_SIG,EIF1,EIF1_SIG,EIF1,SIG,86,-1.44063812843083,0.307741619285805,0.313814439471109,0.287788067248375,-0.0260263722227342,0.19608624338849,-1.42198210487956,9.64683542805566,9.67609860490872,9.55068498982419,-0.125413615084533,0.248376985642131,ENSG00000173812,EIF1,protein_coding,17,1,41688885,41692668,q21.2,eukaryotic translation initiation factor 1 [Source:HGNC Symbol;Acc:HGNC:3249],NA,EIF1,10209,NM_005801
PPP2CB_SIG,PPP2CB,PPP2CB_SIG,PPP2CB,SIG,26,1.44060005309612,0.329738410644293,0.326374125478101,0.340792490476067,0.0144183649979657,0.19608624338849,0.527972025430579,4.56165065988015,4.55325001241884,4.58925278725301,0.03600277483417,0.69358217688916,ENSG00000104695,PPP2CB,protein_coding,8,-1,30774457,30814314,p12,protein phosphatase 2 catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:9300],NA,PPP2CB,5516,NM_001009552
USP12_SIG,USP12,USP12_SIG,USP12,SIG,33,1.43959112477291,0.218150017008931,0.215203581572526,0.227831162014262,0.0126275804417358,0.196429036288887,-0.322523214642301,6.11399263632252,6.11866762271403,6.09863196675042,-0.020035655963606,0.814578206286285,ENSG00000152484,USP12,protein_coding,13,-1,27066156,27171811,q12.13,ubiquitin specific peptidase 12 [Source:HGNC Symbol;Acc:HGNC:20485],NA,USP12,219333,NM_182488
TRAF3_SIG,TRAF3,TRAF3_SIG,TRAF3,SIG,17,-1.43913525777077,0.110318129116369,0.112051430371314,0.104622996421549,-0.00742843394976537,0.196567032101208,-0.56277064340329,5.33262888631774,5.3414083489288,5.30378208059567,-0.0376262683331357,0.673267852194244,ENSG00000131323,TRAF3,protein_coding,14,1,102777476,102911500,q32.32,TNF receptor associated factor 3 [Source:HGNC Symbol;Acc:HGNC:12033],ENCEPHALOPATHY ACUTE INFECTION-INDUCED (HERPES-SPECIFIC)SUSCEPTIBILITY TO 5;Herpes simplex virus encephalitis,TRAF3,7187,NM_001199427;NM_003300;NM_145725;NM_145726
ZNF528_TF,ZNF528,ZNF528_TF,ZNF528,TF,26,1.43825613717301,0.122687001837196,0.119342656939661,0.133675563643384,0.014332906703723,0.19686222118837,0.677806058126842,3.73163025805066,3.71386921556173,3.78998796908572,0.0761187535239935,0.604584493303769,ENSG00000167555,ZNF528,protein_coding,19,1,52397849,52418412,q13.41,zinc finger protein 528 [Source:HGNC Symbol;Acc:HGNC:29384],NA,ZNF528,84436,NM_032423
CD84_SIG,CD84,CD84_SIG,CD84,SIG,22,1.43742912176305,0.245112420252662,0.243519176061818,0.250347365451152,0.0068281893893339,0.197138359929767,-1.01277613182353,6.92595578339571,6.95218205363773,6.83978375260051,-0.112398301037217,0.424347494912923,ENSG00000066294,CD84,protein_coding,1,-1,160541095,160579516,q23.3,CD84 molecule [Source:HGNC Symbol;Acc:HGNC:1704],NA,CD84,8832,NM_001184879;NM_001184881;NM_001184882;NM_001330742;NM_003874
PDGFA_SIG,PDGFA,PDGFA_SIG,PDGFA,SIG,28,1.43501478723364,-0.0582509014779571,-0.0608310575913152,-0.0497732456769232,0.0110578119143919,0.198006112605303,1.51649068229422,1.05617384936046,1.01535827093706,1.1902821784659,0.174923907528838,0.216651507739521,ENSG00000197461,PDGFA,protein_coding,7,-1,497258,520296,p22.3,platelet derived growth factor subunit A [Source:HGNC Symbol;Acc:HGNC:8799],NA,PDGFA,5154,NM_002607;NM_033023
C1RL_SIG,C1RL,C1RL_SIG,C1RL,SIG,48,1.43322173065232,0.222134389947076,0.21958494146028,0.230511149260834,0.0109262078005543,0.198644333955398,1.95512983987736,5.84844719260499,5.80644796847977,5.98644464330212,0.179996674822346,0.105376004994309,ENSG00000139178,C1RL,protein_coding,12,-1,7089587,7109238,p13.31,complement C1r subcomponent like [Source:HGNC Symbol;Acc:HGNC:21265],NA,C1RL,51279,NM_001297640;NM_001297642;NM_001297643;NM_016546
CSTF2_SIG,CSTF2,CSTF2_SIG,CSTF2,SIG,30,1.43266863406431,0.444395695026984,0.43898604982928,0.462170243533723,0.0231841937044422,0.198819794249286,1.70820753621039,3.69488659397102,3.66805028019833,3.78306305350987,0.115012773311535,0.161094531108957,ENSG00000101811,CSTF2,protein_coding,X,1,100820359,100840932,q22.1,cleavage stimulation factor subunit 2 [Source:HGNC Symbol;Acc:HGNC:2484],NA,CSTF2,1478,NM_001306206;NM_001306209;NM_001325
ISY1_SIG,ISY1,ISY1_SIG,ISY1,SIG,8,-1.4305098564573,0.333526531121956,0.336468617986814,0.323859674280279,-0.0126089437065355,0.199597121799589,-1.85755308597582,4.0575586554474,4.07149098087655,4.01178101475164,-0.0597099661249062,0.125257195770004,ENSG00000240682,ISY1,protein_coding,3,-1,129127415,129161293,q21.3,ISY1 splicing factor homolog [Source:HGNC Symbol;Acc:HGNC:29201],NA,ISY1,57461,NM_001199469;NM_020701
GPR34_SIG,GPR34,GPR34_SIG,GPR34,SIG,18,1.42965276898643,0.0409742307731479,0.038295794278695,0.0497748078263503,0.0114790135476553,0.199887334761668,1.11434666656636,1.30958545633622,1.27521275626113,1.42252432801151,0.147311571750387,0.375630317831626,ENSG00000171659,GPR34,protein_coding,X,1,41688973,41697275,p11.4,G protein-coupled receptor 34 [Source:HGNC Symbol;Acc:HGNC:4490],NA,GPR34,2857,NM_001097579;NM_005300
C1orf112_SIG,C1orf112,C1orf112_SIG,C1orf112,SIG,21,1.42903663234877,0.102216274854761,0.0971806798070109,0.118761801440226,0.0215811216332148,0.200087268305338,0.283467688356682,3.39886842695615,3.39342055573741,3.41676857524632,0.0233480195089118,0.83759209612512,ENSG00000000460,C1orf112,protein_coding,1,1,169662007,169854080,q24.2,chromosome 1 open reading frame 112 [Source:HGNC Symbol;Acc:HGNC:25565],NA,C1orf112,55732,NM_001320047;NM_001320048;NM_001320050;NM_001320051;NM_001366769;NM_018186
SUFU_SIG,SUFU,SUFU_SIG,SUFU,SIG,65,1.42793293260184,0.322038112622161,0.317136764045882,0.338142543658505,0.0210057796126234,0.200470800114798,1.63351704618635,4.48608934452041,4.4497019819366,4.60564782158152,0.155945839644921,0.181181377985622,ENSG00000107882,SUFU,protein_coding,10,1,102503987,102633535,q24.32,SUFU negative regulator of hedgehog signaling [Source:HGNC Symbol;Acc:HGNC:16466],Acrocallosal syndrome;Basal cell nevus syndrome;Desmoplastic/nodular medulloblastoma;Familial multiple meningioma;Gorlin syndrome;JOUBERT SYNDROME 32;Joubert Syndrome with Cranio-facial and Skeletal Defects;Medulloblastoma;Medulloblastoma with extensive nodularity;MENINGIOMA FAMILIAL SUSCEPTIBILITY TO;Microform holoprosencephaly,SUFU,51684,NM_001178133;NM_016169
TNRC6C_SIG,TNRC6C,TNRC6C_SIG,TNRC6C,SIG,74,-1.42694086409723,0.0856800770300765,0.0877091697362843,0.0790130581382507,-0.00869611159803356,0.200812790654587,-1.61971115420305,4.23184431865447,4.2666785620667,4.11738894744283,-0.149289614623871,0.185040924975271,ENSG00000078687,TNRC6C,protein_coding,17,1,77959240,78108835,q25.3,trinucleotide repeat containing 6C [Source:HGNC Symbol;Acc:HGNC:29318],NA,TNRC6C,57690,NM_001142640;NM_018996
ZNF391_TF,ZNF391,ZNF391_TF,ZNF391,TF,20,-1.42572462986272,-0.115773220142536,-0.113354970963624,-0.123718896016105,-0.0103639250524806,0.201239805716844,-1.54548132531741,1.63759133789748,1.68176968373572,1.49243391585753,-0.189335767878191,0.207284135937669,ENSG00000124613,ZNF391,protein_coding,6,1,27374615,27403904,p22.1,zinc finger protein 391 [Source:HGNC Symbol;Acc:HGNC:18779],NA,ZNF391,346157,NM_001076781;NM_001322288;NM_001322289;NM_001322293
ZCCHC17_SIG,ZCCHC17,ZCCHC17_SIG,ZCCHC17,SIG,11,1.4253592813341,0.326778978027432,0.322450705396674,0.34100044524278,0.0185497398461058,0.201345983181512,1.53525185380634,4.55986750551661,4.5413803719841,4.62061094426627,0.0792305722821773,0.210500018965387,ENSG00000121766,ZCCHC17,protein_coding,1,1,31296982,31364953,p35.2,zinc finger CCHC-type containing 17 [Source:HGNC Symbol;Acc:HGNC:30246],NA,ZCCHC17,51538,NM_001282566;NM_001282567;NM_001282568;NM_001282569;NM_001282570;NM_001282571;NM_001282572;NM_001282573;NM_001282574;NM_016505
ASXL2_SIG,ASXL2,ASXL2_SIG,ASXL2,SIG,34,1.42466906384603,0.459786673484734,0.456236702341271,0.471450864384683,0.0152141620434123,0.20157494607017,0.873623550505492,6.15846090928365,6.14297430147791,6.20934547778824,0.0663711763103328,0.495860808961418,ENSG00000143970,ASXL2,protein_coding,2,-1,25733753,25878516,p23.3,ASXL transcriptional regulator 2 [Source:HGNC Symbol;Acc:HGNC:23805],Developmental delay macrocephaly and dysmorphic features;SHASHI-PENA SYNDROME,ASXL2,55252,NM_018263
SREK1_SIG,SREK1,SREK1_SIG,SREK1,SIG,77,1.42409013549281,0.344754301032983,0.340729168235005,0.3579797373692,0.017250569134195,0.201762003070388,2.80953981891772,7.1621319496591,7.11253666073514,7.32508789898071,0.212551238245576,0.0173003200071135,ENSG00000153914,SREK1,protein_coding,5,1,66139971,66183615,q12.3,splicing regulatory glutamic acid and lysine rich protein 1 [Source:HGNC Symbol;Acc:HGNC:17882],NA,SREK1,140890,NM_001077199;NM_001270492;NM_001323527;NM_001323529;NM_001323533;NM_001323534;NM_001323535;NM_139168
NUDT14_SIG,NUDT14,NUDT14_SIG,NUDT14,SIG,66,1.42373013052469,-0.0357741706083998,-0.0384320841585302,-0.0270410260865428,0.0113910580719873,0.20186634784808,0.842044946416847,2.16109317789372,2.14228804917274,2.22288145797693,0.0805934088041903,0.512695285040908,ENSG00000183828,NUDT14,protein_coding,14,-1,105172938,105181323,q32.33,nudix hydrolase 14 [Source:HGNC Symbol;Acc:HGNC:20141],NA,NUDT14,256281,NM_001318380;NM_177533
COX4I1_SIG,COX4I1,COX4I1_SIG,COX4I1,SIG,40,-1.42242633662458,0.174926597749759,0.17807953049374,0.164566961590965,-0.0135125689027758,0.202328140511879,-1.30084763360079,7.82795783351376,7.84542383151713,7.77056955435981,-0.074854277157325,0.294760932368184,ENSG00000131143,COX4I1,protein_coding,16,1,85798633,85807044,q24.1,cytochrome c oxidase subunit 4I1 [Source:HGNC Symbol;Acc:HGNC:2265],NA,COX4I1,1327,NM_001318786;NM_001318788;NM_001318794;NM_001318797;NM_001318802;NM_001861
ABCF1_SIG,ABCF1,ABCF1_SIG,ABCF1,SIG,16,1.42176766615094,0.391248659399185,0.389495273176199,0.397009785560427,0.00751451238422809,0.202545929965499,0.146526071588485,6.45395249594913,6.45238362980569,6.45910734184901,0.00672371204332131,0.917839109210415,ENSG00000204574,ABCF1,protein_coding,6,1,30571393,30597179,p21.33,ATP binding cassette subfamily F member 1 [Source:HGNC Symbol;Acc:HGNC:70],NA,ABCF1,23,NM_001025091;NM_001090
EGR4_TF,EGR4,EGR4_TF,EGR4,TF,37,-1.42096463287637,0.0874024604290121,0.0903548735424508,0.0777016744848564,-0.0126531990575944,0.20281868218574,-1.47066783889731,0.303610235444256,0.320377902708178,0.248516471577082,-0.0718614311310953,0.231673252975844,ENSG00000135625,EGR4,protein_coding,2,-1,73290929,73293705,p13.2,early growth response 4 [Source:HGNC Symbol;Acc:HGNC:3241],NA,EGR4,1961,NM_001965
DDX47_SIG,DDX47,DDX47_SIG,DDX47,SIG,43,1.42047418043094,0.132855680653815,0.128808189116933,0.146154581417856,0.0173463923009227,0.202972943658713,1.65593643477606,2.79690487817644,2.76028763285955,2.91721868421765,0.156931051358103,0.174850541736545,ENSG00000213782,DDX47,protein_coding,12,1,12813316,12829981,p13.1,DEAD-box helicase 47 [Source:HGNC Symbol;Acc:HGNC:18682],NA,DDX47,51202,NM_016355;NM_201224
UGDH_SIG,UGDH,UGDH_SIG,UGDH,SIG,84,1.42034136029073,0.278420336695317,0.271948983960371,0.299683352824427,0.0277343688640563,0.202991409618586,1.11863493898919,3.4083465885145,3.3764537826275,3.51313723642893,0.136683453801432,0.373448154317251,ENSG00000109814,UGDH,protein_coding,4,-1,39498755,39528311,p14,UDP-glucose 6-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:12525],NA,UGDH,7358,NM_001184700;NM_001184701;NM_003359
UROS_SIG,UROS,UROS_SIG,UROS,SIG,26,1.41836715594145,0.235645258025458,0.232063322931513,0.247414473334137,0.0153511504026248,0.20371024278377,1.43253349482964,4.89576631127318,4.8724796440054,4.97227964658159,0.099800002576183,0.24464351414301,ENSG00000188690,UROS,protein_coding,10,-1,125784980,125823285,q26.2,uroporphyrinogen III synthase [Source:HGNC Symbol;Acc:HGNC:12592],Congenital erythropoietic porphyria;PORPHYRIA CONGENITAL ERYTHROPOIETIC,UROS,7390,NM_000375;NM_001324036;NM_001324037;NM_001324038;NM_001324039
SLC24A4_SIG,SLC24A4,SLC24A4_SIG,SLC24A4,SIG,17,-1.41807095296482,0.198638937638473,0.206029399361744,0.174355991976299,-0.0316734073854447,0.203790970232119,-0.820032985838286,3.4227299960713,3.45731205511296,3.30910323064874,-0.148208824464216,0.524216172572422,ENSG00000140090,SLC24A4,protein_coding,14,1,92322581,92501483,q32.12,solute carrier family 24 member 4 [Source:HGNC Symbol;Acc:HGNC:10978],AMELOGENESIS IMPERFECTA HYPOMATURATION TYPE IIA5;AMELOGENESIS IMPERFECTA.;Hypocalcified amelogenesis imperfecta;Hypomaturation amelogenesis imperfecta;SKIN/HAIR/EYE PIGMENTATION VARIATION IN 6,SLC24A4,123041,NM_153646;NM_153647;NM_153648
STT3A_SIG,STT3A,STT3A_SIG,STT3A,SIG,77,1.41792289325013,0.48274913815553,0.477203072786383,0.50097192436844,0.023768851582057,0.203815276565893,1.15598777259997,6.24668778819048,6.21798210089986,6.34100647500253,0.123024374102673,0.35669118426797,ENSG00000134910,STT3A,protein_coding,11,1,125591712,125625215,q24.2,STT3A, catalytic subunit of the oligosaccharyltransferase complex [Source:HGNC Symbol;Acc:HGNC:6172],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Iw;STT3A-CDG,STT3A,3703,NM_001278503;NM_001278504;NM_152713
TGFB3_SIG,TGFB3,TGFB3_SIG,TGFB3,SIG,39,1.41766998857343,0.0195966152096035,0.0169930598659618,0.0281511541958547,0.0111580943298928,0.203879534234118,1.18940599422247,2.00885510201429,1.98722979326714,2.07990968789777,0.0926798946306325,0.341803556037362,ENSG00000119699,TGFB3,protein_coding,14,-1,75958099,75982991,q24.3,transforming growth factor beta 3 [Source:HGNC Symbol;Acc:HGNC:11769],ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA FAMILIAL 1;Familial isolated arrhythmogenic ventricular dysplasia biventricular form;Familial isolated arrhythmogenic ventricular dysplasia left dominant form;Familial isolated arrhythmogenic ventricular dysplasia right dominant form;Familial thoracic aortic aneurysm and aortic dissection;Loeys-Dietz syndrome;LOEYS-DIETZ SYNDROME 5,TGFB3,7043,NM_001329938;NM_001329939;NM_003239
CES2_SIG,CES2,CES2_SIG,CES2,SIG,43,1.41757849019719,0.269969235208588,0.264530043417588,0.287840865379017,0.0233108219614297,0.203882298638036,0.355660770727703,5.23566420699575,5.22995377058074,5.25442706950224,0.024473298921503,0.794246617028691,ENSG00000172831,CES2,protein_coding,16,1,66934444,66945096,q22.1,carboxylesterase 2 [Source:HGNC Symbol;Acc:HGNC:1864],NA,CES2,8824,NM_003869;NM_198061
CTDP1_SIG,CTDP1,CTDP1_SIG,CTDP1,SIG,9,-1.41633717090014,0.25569736700166,0.257384884150684,0.250152667797726,-0.00723221635295748,0.204303096018549,-2.24207685955758,5.8668042623669,5.89958108963427,5.7591089727741,-0.14047211686017,0.0608898960984318,ENSG00000060069,CTDP1,protein_coding,18,1,79679801,79756623,q23,CTD phosphatase subunit 1 [Source:HGNC Symbol;Acc:HGNC:2498],Congenital cataracts-facial dysmorphism-neuropathy syndrome;CONGENITAL CATARACTS FACIAL DYSMORPHISM AND NEUROPATHY;CONGENITAL CATARACTS FACIAL DYSMORPHISM AND NEUROPATHY SYNDROME,CTDP1,9150,NM_001202504;NM_001318511;NM_004715;NM_048368
RCC2_SIG,RCC2,RCC2_SIG,RCC2,SIG,16,1.41630644280621,0.561410491806995,0.559384825920983,0.56806625114675,0.00868142522576701,0.204303096018549,1.35872075849179,7.84913811220994,7.82905647556918,7.91512063260102,0.0860641570318413,0.272217745513504,ENSG00000179051,RCC2,protein_coding,1,-1,17406760,17439677,p36.13,regulator of chromosome condensation 2 [Source:HGNC Symbol;Acc:HGNC:30297],NA,RCC2,55920,NM_001136204;NM_018715
HMOX2_SIG,HMOX2,HMOX2_SIG,HMOX2,SIG,16,1.41616028735238,0.289698528165184,0.285534904647142,0.303379005438751,0.0178441007916095,0.204326717038539,1.94379863838628,4.5777617444319,4.54451724061978,4.68699368552887,0.14247644490909,0.1076042342859,ENSG00000103415,HMOX2,protein_coding,16,1,4474690,4510347,p13.3,heme oxygenase 2 [Source:HGNC Symbol;Acc:HGNC:5014],NA,HMOX2,3163,NM_001127204;NM_001127205;NM_001127206;NM_001286267;NM_001286268;NM_001286269;NM_001286270;NM_001286271;NM_002134
ABCA6_SIG,ABCA6,ABCA6_SIG,ABCA6,SIG,29,-1.41597911853197,-0.0417078168293803,-0.0391846675801517,-0.0499981643625598,-0.010813496782408,0.204363704807909,1.01224810430718,0.965431152808992,0.933713304691461,1.06964693948088,0.13593363478942,0.42456484845864,ENSG00000154262,ABCA6,protein_coding,17,-1,69078702,69141895,q24.3,ATP binding cassette subfamily A member 6 [Source:HGNC Symbol;Acc:HGNC:36],NA,ABCA6,23460,NM_080284
TXNRD2_SIG,TXNRD2,TXNRD2_SIG,TXNRD2,SIG,12,1.41573112788275,0.170232410121284,0.167318398923194,0.179807018343579,0.0124886194203857,0.204426205190446,1.08723884749594,4.11837724401737,4.10442236903602,4.16422897609894,0.0598066070629173,0.388397674554406,ENSG00000184470,TXNRD2,protein_coding,22,-1,19875517,19941820,q11.21,thioredoxin reductase 2 [Source:HGNC Symbol;Acc:HGNC:18155],Familial glucocorticoid deficiency;Familial isolated dilated cardiomyopathy;GLUCOCORTICOID DEFICIENCY 5,TXNRD2,10587,NM_001282512;NM_001352300;NM_001352301;NM_001352302;NM_001352303;NM_006440
NDUFS2_SIG,NDUFS2,NDUFS2_SIG,NDUFS2,SIG,22,1.41508605858751,0.426115751444048,0.422410215194297,0.438291084836088,0.0158808696417915,0.204640366917388,0.951016707400148,6.12645630995382,6.1153230663474,6.16303696751779,0.0477139011703942,0.455109121203046,ENSG00000158864,NDUFS2,protein_coding,1,1,161197104,161214395,q23.3,NADH:ubiquinone oxidoreductase core subunit S2 [Source:HGNC Symbol;Acc:HGNC:7708],Isolated complex I deficiency;Leber hereditary optic neuropathy;Leigh syndrome with cardiomyopathy;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 6,NDUFS2,4720,NM_001166159;NM_004550
EYA3_SIG,EYA3,EYA3_SIG,EYA3,SIG,19,1.414061514544,0.503428888107479,0.498740015115632,0.518835185080691,0.0200951699650587,0.204977589364931,2.70759587632186,4.85228559768983,4.81075697434723,4.98873678867264,0.177979814325417,0.0219940372365286,ENSG00000158161,EYA3,protein_coding,1,-1,27970344,28088637,p35.3,EYA transcriptional coactivator and phosphatase 3 [Source:HGNC Symbol;Acc:HGNC:3521],NA,EYA3,2140,NM_001282560;NM_001282561;NM_001282562;NM_001990
NGDN_SIG,NGDN,NGDN_SIG,NGDN,SIG,72,1.41400680718351,0.414396817623466,0.409858436476541,0.429308641391934,0.0194502049153924,0.204977589364931,1.20998773972745,4.9906601693083,4.97494575973804,5.04229322932485,0.067347469586802,0.332602079854627,ENSG00000129460,NGDN,protein_coding,14,1,23469689,23509862,q11.2,neuroguidin [Source:HGNC Symbol;Acc:HGNC:20271],NA,NGDN,25983,NM_001042635;NM_015514
SETD1B_SIG,SETD1B,SETD1B_SIG,SETD1B,SIG,26,-1.41395104819473,0.285249191453204,0.287310503747184,0.278476308201555,-0.00883419554562971,0.204977589364931,-0.575161782291782,6.66008318735684,6.66834167993897,6.63294814030126,-0.0353935396377061,0.66582356208302,ENSG00000139718,SETD1B,protein_coding,12,1,121804180,121832584,q24.31,SET domain containing 1B, histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:29187],NA,SETD1B,23067,NM_001353345
ASH1L_SIG,ASH1L,ASH1L_SIG,ASH1L,SIG,87,1.41294494328538,0.332900049829586,0.330055435812231,0.342246638743752,0.0121912029315204,0.205330367706946,1.60923524025201,6.79240400530633,6.77146614029097,6.86119984749967,0.0897337072087011,0.187975201131766,ENSG00000116539,ASH1L,protein_coding,1,-1,155335268,155562807,q22,ASH1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:19088],Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 52,ASH1L,55870,NM_001366177;NM_018489
SLC9A6_SIG,SLC9A6,SLC9A6_SIG,SLC9A6,SIG,47,-1.41137808776007,0.355415995070259,0.35728523270476,0.349274214271181,-0.00801101843357889,0.205898669599599,1.10355403396544,4.51056335910853,4.4954644239452,4.56017414607373,0.0647097221285246,0.380762468221648,ENSG00000198689,SLC9A6,protein_coding,X,1,135973841,136047269,q26.3,solute carrier family 9 member A6 [Source:HGNC Symbol;Acc:HGNC:11079],Christianson syndrome;MENTAL RETARDATION SYNDROMIC X-LINKED CHRISTIANSON TYPE;MENTAL RETARDATION X-LINKED SYNDROMIC CHRISTIANSON TYPE,SLC9A6,10479,NM_001042537;NM_001177651;NM_001330652;NM_006359
TYW5_SIG,TYW5,TYW5_SIG,TYW5,SIG,71,1.41123871108051,0.417499345158283,0.414114865852375,0.42861977716341,0.0145049113110355,0.205919794602432,2.75885198045378,4.2961228946165,4.25586225983501,4.42840783746997,0.172545577634962,0.0195319324035802,ENSG00000162971,TYW5,protein_coding,2,-1,199928913,199955736,q33.1,tRNA-yW synthesizing protein 5 [Source:HGNC Symbol;Acc:HGNC:26754],NA,TYW5,129450,NM_001039693
NDUFB6_SIG,NDUFB6,NDUFB6_SIG,NDUFB6,SIG,17,1.41018302790942,0.130623534072649,0.126973263637369,0.142617279788569,0.0156440161512003,0.20629278502231,1.51738217824974,3.4556071808193,3.43490375397554,3.52363272616307,0.0887289721875258,0.21639233667884,ENSG00000165264,NDUFB6,protein_coding,9,-1,32553001,32573184,p21.1,NADH:ubiquinone oxidoreductase subunit B6 [Source:HGNC Symbol;Acc:HGNC:7701],NA,NDUFB6,4712,NM_001199987;NM_002493;NM_182739
AHCTF1_TF,AHCTF1,AHCTF1_TF,AHCTF1,TF,137,-1.40908358380012,0.246192522945318,0.248824270529918,0.237545352310203,-0.0112789182197147,0.206683100020486,-1.4778482602128,5.92657650375603,5.95122485365999,5.84558906835729,-0.105635785302699,0.229337682347989,ENSG00000153207,AHCTF1,protein_coding,1,-1,246839098,246931967,q44,AT-hook containing transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:24618],NA,AHCTF1,25909,NM_001323342;NM_001323343;NM_015446
SRP14_SIG,SRP14,SRP14_SIG,SRP14,SIG,21,1.40889255718929,0.15097754711532,0.149331479459965,0.156386055125773,0.00705457566580836,0.206724140650862,0.368834391283752,7.41417496021433,7.41128511100663,7.42367017903965,0.0123850680330185,0.78715059709375,ENSG00000140319,SRP14,protein_coding,15,-1,40035739,40039188,q15.1,signal recognition particle 14 [Source:HGNC Symbol;Acc:HGNC:11299],NA,SRP14,6727,NM_001309434;NM_003134
TMPRSS5_SIG,TMPRSS5,TMPRSS5_SIG,TMPRSS5,SIG,33,1.40836138557917,0.103947931401477,0.100591302690081,0.114976854310349,0.0143855516202678,0.206891430428786,3.12532707583856,0.815564007157127,0.781843191915368,0.926360971522906,0.144517779607538,0.00777909771439885,ENSG00000166682,TMPRSS5,protein_coding,11,-1,113687546,113706373,q23.2,transmembrane serine protease 5 [Source:HGNC Symbol;Acc:HGNC:14908],NA,TMPRSS5,80975,NM_001288749;NM_001288750;NM_001288751;NM_001288752;NM_030770
ZNF622_TF,ZNF622,ZNF622_TF,ZNF622,TF,101,-1.4082892212877,0.138953983479425,0.13997216087265,0.135608543473112,-0.0043636173995384,0.206891430428786,-0.323029814120211,4.72665652465039,4.73025290319551,4.71483985228786,-0.0154130509076501,0.814276472269004,ENSG00000173545,ZNF622,protein_coding,5,-1,16451519,16465800,p15.1,zinc finger protein 622 [Source:HGNC Symbol;Acc:HGNC:30958],NA,ZNF622,90441,NM_033414
CCDC17_TF,CCDC17,CCDC17_TF,CCDC17,TF,194,-1.40802756180221,-0.0573262965876974,-0.0554522665079704,-0.0634838239925146,-0.0080315574845441,0.206959701658015,-1.75714634948732,2.52310773536134,2.55249910891307,2.42653607940564,-0.125963029507435,0.148347172358223,ENSG00000159588,CCDC17,protein_coding,1,-1,45620044,45624057,p34.1,coiled-coil domain containing 17 [Source:HGNC Symbol;Acc:HGNC:26574],NA,CCDC17,149483,NM_001114938;NM_001190182
VDAC3_SIG,VDAC3,VDAC3_SIG,VDAC3,SIG,25,1.40592373379118,0.278812154428817,0.274423017796229,0.293233603364463,0.0188105855682346,0.207738504617119,1.85379181083243,6.07967501170581,6.050727793038,6.17478730161434,0.124059508576342,0.12607244167238,ENSG00000078668,VDAC3,protein_coding,8,1,42391624,42405937,p11.21,voltage dependent anion channel 3 [Source:HGNC Symbol;Acc:HGNC:12674],NA,VDAC3,7419,NM_001135694;NM_005662
SLC38A2_SIG,SLC38A2,SLC38A2_SIG,SLC38A2,SIG,35,1.40422011957539,0.184602573105371,0.182507231483175,0.191487267006874,0.00898003552369926,0.208364515604862,-0.490830546542399,7.8030192783285,7.81057178663856,7.77820389388116,-0.0323678927573968,0.714963444598015,ENSG00000134294,SLC38A2,protein_coding,12,-1,46358188,46372773,q13.11,solute carrier family 38 member 2 [Source:HGNC Symbol;Acc:HGNC:13448],NA,SLC38A2,54407,NM_001307936;NM_018976
FFAR4_SIG,FFAR4,FFAR4_SIG,FFAR4,SIG,15,-1.4040693172352,0.115124837459262,0.121632490635438,0.0937425484518279,-0.0278899421836099,0.208390187315013,1.01945841247732,0.417392796906694,0.400804269673759,0.471897957814911,0.0710936881411518,0.420812629251663,ENSG00000186188,FFAR4,protein_coding,10,1,93566665,93604480,q23.33,free fatty acid receptor 4 [Source:HGNC Symbol;Acc:HGNC:19061],BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10,FFAR4,338557,NM_001195755;NM_181745
APIP_SIG,APIP,APIP_SIG,APIP,SIG,3,1.40327425250353,0.153519595837298,0.149473197232259,0.166814905539567,0.0173417083073074,0.20866537177672,1.08480816721756,3.86145347480027,3.84768872487418,3.90668051027171,0.0589917853975277,0.389642650776134,ENSG00000149089,APIP,protein_coding,11,-1,34853094,34916379,p13,APAF1 interacting protein [Source:HGNC Symbol;Acc:HGNC:17581],NA,APIP,51074,NM_015957
CGRRF1_SIG,CGRRF1,CGRRF1_SIG,CGRRF1,SIG,40,-1.40262718667541,0.197824438329516,0.199723149947412,0.191585814442145,-0.00813733550526708,0.208883421918681,0.992821901996564,2.90806856642563,2.89438155515981,2.95304017487046,0.0586586197106488,0.434032554167602,ENSG00000100532,CGRRF1,protein_coding,14,1,54509812,54539292,q22.2,cell growth regulator with ring finger domain 1 [Source:HGNC Symbol;Acc:HGNC:15528],NA,CGRRF1,10668,NM_006568
LIN7C_SIG,LIN7C,LIN7C_SIG,LIN7C,SIG,17,1.39992263515898,0.37871974446795,0.376489903999755,0.386046363149164,0.00955645914940881,0.209901159792865,1.28727677175558,5.02845144215176,5.01248476379268,5.08091338533162,0.0684286215389429,0.299997425318815,ENSG00000148943,LIN7C,protein_coding,11,-1,27494418,27506769,p14.1,lin-7 homolog C, crumbs cell polarity complex component [Source:HGNC Symbol;Acc:HGNC:17789],NA,LIN7C,55327,NM_018362
EXOSC8_SIG,EXOSC8,EXOSC8_SIG,EXOSC8,SIG,19,1.39963255856586,0.285886248870435,0.282440098596867,0.297209314055016,0.0147692154581494,0.209981134445199,0.705842900327457,4.69195733074217,4.6824083520401,4.72333254647755,0.0409241944374542,0.588616922059967,ENSG00000120699,EXOSC8,protein_coding,13,1,36998816,37009614,q13.3,exosome component 8 [Source:HGNC Symbol;Acc:HGNC:17035],Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1C,EXOSC8,11340,NM_181503
USP4_SIG,USP4,USP4_SIG,USP4,SIG,24,1.39926316769285,0.272536684920357,0.270775820662775,0.2783223817667,0.00754656110392473,0.210092012510378,1.37962500620865,6.76031869138997,6.74784206323715,6.80131332674922,0.0534712635120735,0.264289119756977,ENSG00000114316,USP4,protein_coding,3,-1,49277831,49340712,p21.31,ubiquitin specific peptidase 4 [Source:HGNC Symbol;Acc:HGNC:12627],NA,USP4,7375;107986084,NM_001251877;NM_003363;NM_199443
ZNF79_TF,ZNF79,ZNF79_TF,ZNF79,TF,10,1.3985943497795,0.195610643902616,0.19175327697529,0.208284849520973,0.0165315725456829,0.210319591143075,1.32997674716441,2.72831909912563,2.71090353964125,2.78554165171714,0.0746381120758928,0.283034962602188,ENSG00000196152,ZNF79,protein_coding,9,1,127424374,127445372,q33.3,zinc finger protein 79 [Source:HGNC Symbol;Acc:HGNC:13153],NA,ZNF79,7633,NM_001286696;NM_001286697;NM_001286698;NM_001322260;NM_007135
AARS_SIG,AARS,AARS_SIG,AARS,SIG,25,1.39787116706405,0.555784410217165,0.549386070213837,0.576807527370957,0.02742145715712,0.210544262781625,1.25938529328936,5.67032153115408,5.63665612385698,5.78093644084454,0.144280316987558,0.311443924327101,ENSG00000090861,AARS,protein_coding,16,-1,70252295,70289543,q22.1,alanyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:20],Autosomal dominant Charcot-Marie-Tooth disease type 2N;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2N;Early-Onset epileptic encephalopathy with persistent myelination defect.;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 29;Undetermined early-onset epileptic encephalopathy,AARS,16,NM_001605
APOBEC3C_SIG,APOBEC3C,APOBEC3C_SIG,APOBEC3C,SIG,15,1.39784881465106,0.501226540959805,0.496937854264537,0.515317940101399,0.0183800858368614,0.210544262781625,0.222073309873988,6.52793937643563,6.52376858543429,6.54164340401143,0.0178748185771376,0.874456604958171,ENSG00000244509,APOBEC3C,protein_coding,22,1,39014257,39020352,q13.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3C [Source:HGNC Symbol;Acc:HGNC:17353],NA,APOBEC3C,27350,NM_014508
RASD2_SIG,RASD2,RASD2_SIG,RASD2,SIG,15,-1.39725555613457,-0.0132011805879573,-0.00876812878023611,-0.0277669222418983,-0.0189987934616621,0.2107426910062,-1.28201441489944,0.487592064724101,0.512471752331031,0.405844519729904,-0.106627232601127,0.302227508995347,ENSG00000100302,RASD2,protein_coding,22,1,35540831,35553999,q12.3,RASD family member 2 [Source:HGNC Symbol;Acc:HGNC:18229],NA,RASD2,23551,NM_014310
HELZ_SIG,HELZ,HELZ_SIG,HELZ,SIG,36,1.39665832737395,0.5246803554577,0.522949042523157,0.530368955099771,0.00741991257661419,0.21094279933955,1.78838938294005,7.30285688701584,7.2812417376618,7.37387809203627,0.0926363543744628,0.140963702213631,ENSG00000198265,HELZ,protein_coding,17,-1,67070444,67245989,q24.2,helicase with zinc finger [Source:HGNC Symbol;Acc:HGNC:16878],NA,HELZ,9931,NM_001330447;NM_014877
SLC25A35_SIG,SLC25A35,SLC25A35_SIG,SLC25A35,SIG,65,1.39608549203857,0.0324374967128583,0.0291303790416444,0.0433037404897041,0.0141733614480597,0.211133507400251,1.54628862395151,3.67493716834205,3.64541659446806,3.77193333964232,0.126516745174264,0.207020540204065,ENSG00000125434,SLC25A35,protein_coding,17,-1,8287763,8295400,p13.1,solute carrier family 25 member 35 [Source:HGNC Symbol;Acc:HGNC:31921],NA,SLC25A35,399512,NM_001320870;NM_001320871;NM_001320872;NM_001320877;NM_201520
RPS6_SIG,RPS6,RPS6_SIG,RPS6,SIG,38,1.39228339478789,1.56896459681106,1.56168652805228,1.59287825130421,0.0311917232519302,0.212589853267867,2.31111307864559,10.9804117297992,10.9415440369045,11.1081198635961,0.166575826691661,0.0527584345326882,ENSG00000137154,RPS6,protein_coding,9,-1,19375715,19380254,p22.1,ribosomal protein S6 [Source:HGNC Symbol;Acc:HGNC:10429],NA,RPS6,6194,NM_001010
MAP4K1_SIG,MAP4K1,MAP4K1_SIG,MAP4K1,SIG,67,1.3914246173511,0.100237606891395,0.0981882138756535,0.10697132680026,0.00878311292460646,0.21289401695534,2.74357022968908,5.77342730164682,5.71852204834316,5.95383027678742,0.23530822844426,0.0201996760208165,ENSG00000104814,MAP4K1,protein_coding,19,-1,38587641,38618882,q13.2,mitogen-activated protein kinase kinase kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:6863],NA,MAP4K1,11184,NM_001042600;NM_007181
GPR157_SIG,GPR157,GPR157_SIG,GPR157,SIG,25,1.3905613404298,0.0307842379336147,0.0295602545081004,0.0348058977603043,0.00524564325220379,0.213173351992904,1.43438537185266,2.08518708137878,2.05660592149355,2.17909660671598,0.122490685222426,0.244051717767979,ENSG00000180758,GPR157,protein_coding,1,-1,9100305,9129102,p36.22,G protein-coupled receptor 157 [Source:HGNC Symbol;Acc:HGNC:23687],NA,GPR157,80045,NM_024980
NSA2_SIG,NSA2,NSA2_SIG,NSA2,SIG,14,1.39054490645216,0.9856912261827,0.981582721626632,0.999190598295498,0.017607876668867,0.213173351992904,1.28796814812532,6.40727444813828,6.3920753933042,6.45721419973599,0.0651388064317908,0.299779473966458,ENSG00000164346,NSA2,protein_coding,5,1,74766991,74780113,q13.3,NSA2, ribosome biogenesis homolog [Source:HGNC Symbol;Acc:HGNC:30728],NA,NSA2,10412,NM_001271665;NM_014886
DHX8_SIG,DHX8,DHX8_SIG,DHX8,SIG,37,-1.3902740925691,0.387564301316676,0.38938917714311,0.381568280744105,-0.00782089639900425,0.213246565689199,0.0310815232491723,6.18823311557218,6.18792726864922,6.18923804117619,0.0013107725269704,0.982898302574369,ENSG00000067596,DHX8,protein_coding,17,1,43483865,43610338,q21.31,DEAH-box helicase 8 [Source:HGNC Symbol;Acc:HGNC:2749],NA,DHX8,1659,NM_001302623;NM_001322216;NM_001322217;NM_001322218;NM_001322219;NM_001322220;NM_001322221;NM_004941
RSPO4_SIG,RSPO4,RSPO4_SIG,RSPO4,SIG,7,1.38920905103594,-0.182060255723382,-0.182928670093068,-0.179206894222986,0.0037217758700827,0.213632666840919,1.43203866885177,0.243432112093597,0.231266921792504,0.283403451654332,0.0521365298618275,0.244769319895852,ENSG00000101282,RSPO4,protein_coding,20,-1,958452,1002311,p13,R-spondin 4 [Source:HGNC Symbol;Acc:HGNC:16175],Anonychia congenita;Anonychia congenita totalis;NAIL DISORDER NONSYNDROMIC CONGENITAL 4,RSPO4,343637,NM_001029871;NM_001040007
CDC14A_SIG,CDC14A,CDC14A_SIG,CDC14A,SIG,23,-1.38798471043852,0.246653741210132,0.247843228324739,0.242745426404993,-0.00509780191974637,0.214082145550904,-1.03249991164167,5.04863809559811,5.06366305960613,4.99927035671458,-0.0643927028915511,0.41447141815274,ENSG00000079335,CDC14A,protein_coding,1,1,100345001,100520277,p21.2,cell division cycle 14A [Source:HGNC Symbol;Acc:HGNC:1718],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 32 WITH OR WITHOUT IMMOTILE SPERM,CDC14A,8556,NM_001319210;NM_001319211;NM_001319212;NM_003672;NM_033312;NM_033313
THAP5_TF,THAP5,THAP5_TF,THAP5,TF,40,1.38755012282466,0.295309415716864,0.290522466328505,0.311037963707185,0.0205154973786805,0.214220234522805,0.00641889872307035,3.65450505940974,3.65439124116044,3.65487903365745,0.000487792497004562,0.996178346858977,ENSG00000177683,THAP5,protein_coding,7,-1,108554543,108569750,q31.1,THAP domain containing 5 [Source:HGNC Symbol;Acc:HGNC:23188],NA,THAP5,168451,NM_001130475;NM_001287598;NM_001287599;NM_001287601;NM_182529
SUMO1_SIG,SUMO1,SUMO1_SIG,SUMO1,SIG,32,-1.38667163235829,0.416532334999363,0.418904915820839,0.408736712300226,-0.0101682035206134,0.214533827879018,-1.28257717230186,5.75579585105678,5.76789316709941,5.71604752691672,-0.0518456401826876,0.302132831980631,ENSG00000116030,SUMO1,protein_coding,2,-1,202206180,202238608,q33.1,small ubiquitin-like modifier 1 [Source:HGNC Symbol;Acc:HGNC:12502],Cleft Lip +/- Cleft Palate;Oligodontia;OROFACIAL CLEFT 10,SUMO1,7341,NM_001005781;NM_001005782;NM_003352
RTF1_SIG,RTF1,RTF1_SIG,RTF1,SIG,18,1.38599124453539,0.372431238690892,0.369964740796769,0.380535446057296,0.0105707052605274,0.214769353378464,0.608183127398642,6.71534065307796,6.70868948036051,6.73719450629244,0.0285050259319313,0.645836524845271,ENSG00000137815,RTF1,protein_coding,15,1,41408408,41483563,q15.1,RTF1 homolog, Paf1/RNA polymerase II complex component [Source:HGNC Symbol;Acc:HGNC:28996],NA,RTF1,23168,NM_015138
ZNF317_TF,ZNF317,ZNF317_TF,ZNF317,TF,95,1.38583570963004,0.236539938649459,0.232671224330124,0.249251428555844,0.0165802042257202,0.214797305958129,1.6645031425544,6.33742548560567,6.31502019419332,6.41104287167482,0.0960226774814988,0.17250780013481,ENSG00000130803,ZNF317,protein_coding,19,1,9140397,9163424,p13.2,zinc finger protein 317 [Source:HGNC Symbol;Acc:HGNC:13507],NA,ZNF317,57693,NM_001190791;NM_020933
SPHK2_SIG,SPHK2,SPHK2_SIG,SPHK2,SIG,27,1.38558688018586,0.275275530469365,0.269965676847955,0.292722192368281,0.022756515520326,0.214862183080029,1.08288555430293,3.49077088094507,3.47479049762936,3.54327785469668,0.0684873570673168,0.390621855586667,ENSG00000063176,SPHK2,protein_coding,19,1,48619291,48630717,q13.33,sphingosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:18859],NA,SPHK2,56848,NM_001204158;NM_001204159;NM_001204160;NM_001243876;NM_020126
LPAR5_SIG,LPAR5,LPAR5_SIG,LPAR5,SIG,25,1.38514837755495,0.0536176773823097,0.051514444299861,0.060528300367498,0.00901385606763712,0.215002163258373,0.357489464001392,2.07391617876452,2.06341214997846,2.10842941620443,0.045017266225964,0.793138311544877,ENSG00000184574,LPAR5,protein_coding,12,-1,6618835,6635960,p13.31,lysophosphatidic acid receptor 5 [Source:HGNC Symbol;Acc:HGNC:13307],NA,LPAR5,57121,NM_001142961;NM_020400
RPS11_SIG,RPS11,RPS11_SIG,RPS11,SIG,19,1.38404355912773,1.8570446978215,1.85000528840923,1.88017418589039,0.0301688974811578,0.215406267179025,1.69333124002137,10.2095461140792,10.1866938641446,10.2846320781501,0.0979382140054829,0.164879555624101,ENSG00000142534,RPS11,protein_coding,19,1,49496365,49499708,q13.33,ribosomal protein S11 [Source:HGNC Symbol;Acc:HGNC:10384],NA,RPS11,6205,NM_001015
RPL41_SIG,RPL41,RPL41_SIG,RPL41,SIG,20,1.38318945264331,0.11850880887289,0.11638160565733,0.125498190866874,0.00911658520954325,0.215711391881057,0.577978920503924,5.36186564026707,5.35455013981833,5.38590228459863,0.0313521447803032,0.664132774061338,ENSG00000229117,RPL41,protein_coding,12,1,56116590,56117967,q13.2,ribosomal protein L41 [Source:HGNC Symbol;Acc:HGNC:10354],NA,RPL41,6171,NM_001035267;NM_021104
IPO8_SIG,IPO8,IPO8_SIG,IPO8,SIG,17,1.38299556536277,0.491933342053101,0.486770720862116,0.50889624025205,0.0221255193899331,0.215754637435227,2.05984295968028,5.70052521827362,5.66763439605317,5.80859506271223,0.140960666659054,0.0867736559278102,ENSG00000133704,IPO8,protein_coding,12,-1,30628988,30695869,p11.21,importin 8 [Source:HGNC Symbol;Acc:HGNC:9853],NA,IPO8,10526,NM_001190995;NM_006390
PEAK1_SIG,PEAK1,PEAK1_SIG,PEAK1,SIG,25,1.38286292372268,0.0960169835020213,0.0932872408870789,0.104986137808261,0.0116988969211816,0.215773577840875,-0.421235312549225,5.77600586843351,5.78463490942839,5.74765330516463,-0.0369816042637597,0.756198055538851,ENSG00000173517,PEAK1,protein_coding,15,-1,77100656,77420144,q24.3,pseudopodium enriched atypical kinase 1 [Source:HGNC Symbol;Acc:HGNC:29431],NA,PEAK1,79834,NM_024776
MLXIPL_TF,MLXIPL,MLXIPL_TF,MLXIPL,TF,82,-1.38201158464463,0.0170917256892329,0.0194286730544689,0.00941318434631484,-0.0100154887081541,0.21606459429683,1.20369365418605,0.614197648738385,0.585036687555843,0.710012235481022,0.12497554792518,0.33517324844181,ENSG00000009950,MLXIPL,protein_coding,7,-1,73593194,73624543,q11.23,MLX interacting protein like [Source:HGNC Symbol;Acc:HGNC:12744],WILLIAMS-BEUREN SYNDROME,MLXIPL,51085,NM_032951;NM_032952;NM_032953;NM_032954
POMK_SIG,POMK,POMK_SIG,POMK,SIG,35,1.38196027699384,0.20904455207518,0.207908560688181,0.212777095203888,0.00486853451570656,0.21606459429683,1.53658854522691,2.68888296220967,2.66458861714938,2.76870723883632,0.104118621686933,0.21015747021788,ENSG00000185900,POMK,protein_coding,8,1,43093506,43123434,p11.21,protein-O-mannose kinase [Source:HGNC Symbol;Acc:HGNC:26267],Congenital muscular dystrophy with cerebellar involvement;Limb-girdle muscular dystrophy due to POMK deficiency;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES) TYPE A 12;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 12;Walker-Warburg syndrome,POMK,84197,NM_001277971;NM_032237
GNB4_SIG,GNB4,GNB4_SIG,GNB4,SIG,18,1.38186987485854,0.288326171089021,0.287237397891268,0.291903568738781,0.00466617084751265,0.2160667703166,1.94591871423558,5.87071430705337,5.84045225032527,5.97014677915997,0.129694528834706,0.10722121873321,ENSG00000114450,GNB4,protein_coding,3,-1,179396088,179451476,q26.33,G protein subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:20731],Autosomal dominant intermediate Charcot-Marie-Tooth disease type F;Charcot-Marie-Tooth disease dominant intermediate F,GNB4,59345,NM_021629
BAG4_SIG,BAG4,BAG4_SIG,BAG4,SIG,20,-1.38137110174908,0.307221047827035,0.310293587916282,0.297125558962364,-0.0131680289539184,0.216231238907358,-0.563873187849345,5.12233848611561,5.13211275498849,5.09022303124759,-0.0418897237408949,0.672525040820075,ENSG00000156735,BAG4,protein_coding,8,1,38176533,38213301,p11.23,BCL2 associated athanogene 4 [Source:HGNC Symbol;Acc:HGNC:940],NA,BAG4,9530,NM_001204878;NM_004874
SDS_SIG,SDS,SDS_SIG,SDS,SIG,16,1.38100722707585,-0.00201327176814906,-0.0035025520322416,0.00288007767101214,0.00638262970325365,0.216342144687389,3.04199876741402,0.674932607148385,0.603680513678375,0.909046628549847,0.305366114871473,0.00964851654105409,ENSG00000135094,SDS,protein_coding,12,-1,113392445,113426301,q24.13,serine dehydratase [Source:HGNC Symbol;Acc:HGNC:10691],NA,SDS,10993,NM_006843
MAT2B_SIG,MAT2B,MAT2B_SIG,MAT2B,SIG,60,1.38089706468392,0.353185145450655,0.348945185221307,0.367116443347083,0.0181712581257759,0.216352181290859,1.37488528145801,5.81000275986511,5.77916719050632,5.91131963061541,0.13215244010909,0.266107017397595,ENSG00000038274,MAT2B,protein_coding,5,1,163503114,163519354,q34,methionine adenosyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:6905],NA,MAT2B,27430,NM_013283;NM_182796
PLK4_SIG,PLK4,PLK4_SIG,PLK4,SIG,60,-1.38070089179603,0.30573053549551,0.311266291157938,0.287541624033248,-0.0237246671246897,0.216396425697435,-0.507629775109796,4.36510275359048,4.37698826048179,4.32605037380476,-0.0509378866770362,0.705076964774403,ENSG00000142731,PLK4,protein_coding,4,1,127880893,127899224,q28.1,polo like kinase 4 [Source:HGNC Symbol;Acc:HGNC:11397],Autosomal recessive chorioretinopathy-microcephaly syndrome;Microcephaly and chorioretinopathy autosomal recessive 2;Microcephaly growth failure and retinopathy;Seckel syndrome,PLK4,10733,NM_001190799;NM_001190801;NM_014264
CXCR3_SIG,CXCR3,CXCR3_SIG,CXCR3,SIG,15,-1.38014044662723,-0.0626152813760605,-0.0587285721100781,-0.0753858975357171,-0.016657325425639,0.216585601277504,-0.138894291586167,1.55689056669674,1.56054400043075,1.54488642728501,-0.0156575731457377,0.922077104694908,ENSG00000186810,CXCR3,protein_coding,X,-1,71615916,71618511,q13.1,C-X-C motif chemokine receptor 3 [Source:HGNC Symbol;Acc:HGNC:4540],NA,CXCR3,2833,NM_001142797;NM_001504
SENP2_SIG,SENP2,SENP2_SIG,SENP2,SIG,11,-1.37990333617643,0.0521401920060336,0.0552188476622822,0.0420246091355025,-0.0131942385267796,0.216646170178672,-2.76460228223464,5.54817598787986,5.57401694394335,5.46326998938555,-0.110746954557794,0.0192420417795252,ENSG00000163904,SENP2,protein_coding,3,1,185582496,185633551,q27.2,SUMO specific peptidase 2 [Source:HGNC Symbol;Acc:HGNC:23116],NA,SENP2,59343,NM_021627
RBM44_SIG,RBM44,RBM44_SIG,RBM44,SIG,20,-1.37892885132303,0.0305189534140172,0.0352307997515736,0.0150371725906176,-0.0201936271609561,0.216971186740018,-2.22937221600041,1.89080504911891,1.93649666447332,1.74067545581155,-0.195821208661765,0.0624744671941816,ENSG00000177483,RBM44,protein_coding,2,1,237798389,237842808,q37.3,RNA binding motif protein 44 [Source:HGNC Symbol;Acc:HGNC:24756],NA,RBM44,375316,NM_001080504
IFI16_SIG,IFI16,IFI16_SIG,IFI16,SIG,51,-1.37891732007341,0.0888887834763601,0.0920016495699426,0.0786607948831603,-0.0133408546867823,0.216971186740018,-1.50757682019158,7.0690377622114,7.10639851031521,6.94628101844174,-0.160117491873471,0.219585550259462,ENSG00000163565,IFI16,protein_coding,1,1,158999968,159055155,q23.1,interferon gamma inducible protein 16 [Source:HGNC Symbol;Acc:HGNC:5395],NA,IFI16,3428,NM_001206567;NM_005531
USP10_SIG,USP10,USP10_SIG,USP10,SIG,11,1.37818573034803,0.445443161093509,0.441507472150711,0.458374710476988,0.0168672383262774,0.217228942884597,0.0656247559989233,6.28525126104864,6.28439719737618,6.28805747025816,0.00366027288197115,0.96409880783179,ENSG00000103194,USP10,protein_coding,16,1,84699978,84779922,q24.1,ubiquitin specific peptidase 10 [Source:HGNC Symbol;Acc:HGNC:12608],NA,USP10,9100,NM_001272075;NM_005153
PHF21A_SIG,PHF21A,PHF21A_SIG,PHF21A,SIG,27,-1.37742491712973,0.156064614019203,0.157899181778487,0.150036748524413,-0.00786243325407456,0.217498576386475,-0.184823307341457,6.91329573395191,6.91537255622791,6.90647188933076,-0.00890066689714888,0.895945807333929,ENSG00000135365,PHF21A,protein_coding,11,-1,45929323,46121178,p11.2,PHD finger protein 21A [Source:HGNC Symbol;Acc:HGNC:24156],Potocki-Shaffer syndrome,PHF21A,51317,NM_001101802;NM_001352025;NM_001352026;NM_001352027;NM_001352028;NM_001352029;NM_001352030;NM_001352031;NM_001352032;NM_016621
RPSA_SIG,RPSA,RPSA_SIG,RPSA,SIG,11,1.37689233472473,1.3370638226698,1.33009972093398,1.35994587123032,0.0298461502963376,0.217664556602579,1.06609865874377,7.89207035693798,7.87254987032096,7.95620909867961,0.0836592283586511,0.398588388017796,ENSG00000168028,RPSA,protein_coding,3,1,39406716,39412542,p22.1,ribosomal protein SA [Source:HGNC Symbol;Acc:HGNC:6502],ASPLENIA ISOLATED CONGENITAL;Familial isolated congenital asplenia,RPSA,3921,NM_001304288;NM_002295
TAP2_SIG,TAP2,TAP2_SIG,TAP2,SIG,46,-1.37683924374445,0.167845091343293,0.170162711483898,0.160230053738447,-0.0099326577454513,0.217664556602579,-1.42777986381453,5.75033241653401,5.77483647488443,5.66981908195407,-0.10501739293036,0.246316301739607,ENSG00000204267,TAP2,protein_coding,6,-1,32821833,32838770,p21.32,transporter 2, ATP binding cassette subfamily B member [Source:HGNC Symbol;Acc:HGNC:44],BARE LYMPHOCYTE SYNDROME TYPE I;Immunodeficiency by defective expression of HLA class 1,TAP2,6891,NM_000544;NM_001290043;NM_018833
CYP51A1_SIG,CYP51A1,CYP51A1_SIG,CYP51A1,SIG,8,1.37517766093959,0.2871851605241,0.284850742058736,0.294855392624583,0.0100046505658472,0.218294801856775,1.83427763543581,1.6517341577031,1.62837820920605,1.72847513133628,0.100096922130225,0.13023168702249,ENSG00000001630,CYP51A1,protein_coding,7,-1,92112153,92134803,q21.2,cytochrome P450 family 51 subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:2649],Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,CYP51A1,1595,NM_000786;NM_001146152
DHFRP1_SIG,DHFRP1,DHFRP1_SIG,DHFRP1,SIG,15,-1.37508213938004,0.417120736512854,0.425754903792289,0.388751329737567,-0.0370035740547221,0.218299010892021,-1.16844193624798,3.82867206459189,3.85833256615462,3.73121613088578,-0.127116435268844,0.351246157778162,ENSG00000188985,DHFRP1,processed_pseudogene,18,-1,26170726,26171284,q11.2,dihydrofolate reductase pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:2862],NA,DHFRP1,NA,NA
GTPBP4_SIG,GTPBP4,GTPBP4_SIG,GTPBP4,SIG,38,1.37439490245954,0.478833165872307,0.476623480541071,0.486093560532085,0.00947007999101409,0.218540098342127,0.358655925627667,5.6885749353655,5.68325379196125,5.70605869226519,0.0228049003039398,0.792788948170015,ENSG00000107937,GTPBP4,protein_coding,10,1,988434,1019932,p15.3,GTP binding protein 4 [Source:HGNC Symbol;Acc:HGNC:21535],NA,GTPBP4,23560,NM_012341
SGMS2_SIG,SGMS2,SGMS2_SIG,SGMS2,SIG,67,1.37345002481378,0.133184864400878,0.129916754343972,0.14392294030214,0.0140061859581676,0.218884650616279,-0.153920510141235,3.62800929296486,3.63483893073173,3.605569054588,-0.0292698761437328,0.913805273742737,ENSG00000164023,SGMS2,protein_coding,4,1,107824563,107915047,q25,sphingomyelin synthase 2 [Source:HGNC Symbol;Acc:HGNC:28395],NA,SGMS2,166929,NM_001136257;NM_001136258;NM_152621
CFI_SIG,CFI,CFI_SIG,CFI,SIG,22,-1.3724393031011,-0.0965050016741972,-0.0945363837004845,-0.102973317873539,-0.0084369341730541,0.219256017948068,-2.12969939134178,0.710062355749766,0.777263605345495,0.489258249935227,-0.288005355410268,0.0760311988660818,ENSG00000205403,CFI,protein_coding,4,-1,109740694,109802179,q25,complement factor I [Source:HGNC Symbol;Acc:HGNC:5394],Atypical hemolytic uremic syndrome with I factor anomaly;COMPLEMENT FACTOR I DEFICIENCY;De novo thrombotic microangiopathy after kidney transplantation;Familial drusen;HELLP syndrome;HEMOLYTIC UREMIC SYNDROME ATYPICAL SUSCEPTIBILITY TO 3;Immunodeficiency with factor I anomaly;MACULAR DEGENERATION AGE-RELATED 13,CFI,3426,NM_000204;NM_001318057;NM_001331035
CTRL_SIG,CTRL,CTRL_SIG,CTRL,SIG,26,-1.37218573621502,0.0474564579955063,0.0518073903644867,0.0331605373545708,-0.018646853009916,0.219323668658314,-0.394282566175364,0.267019931574319,0.269275372574644,0.259609196858963,-0.00966617571568064,0.771814498718554,ENSG00000141086,CTRL,protein_coding,16,-1,67927640,67932365,q22.1,chymotrypsin like [Source:HGNC Symbol;Acc:HGNC:2524],NA,CTRL,1506,NM_001907
SECISBP2L_SIG,SECISBP2L,SECISBP2L_SIG,SECISBP2L,SIG,39,-1.37060809589951,0.612493073750852,0.6151241685957,0.603848047832068,-0.0112761207636312,0.219899263057376,-0.777609060543434,6.36691973524548,6.37819214914091,6.32988180387479,-0.0483103452661168,0.547545866254149,ENSG00000138593,SECISBP2L,protein_coding,15,-1,48988476,49046447,q21.1,SECIS binding protein 2 like [Source:HGNC Symbol;Acc:HGNC:28997],NA,SECISBP2L,9728,NM_001193489;NM_014701
PPCDC_SIG,PPCDC,PPCDC_SIG,PPCDC,SIG,17,-1.37058336300157,0.116839287258112,0.118300330326869,0.112038717175055,-0.00626161315181416,0.219899263057376,0.847463343871902,3.85783174812284,3.84524973877647,3.8991726359752,0.0539228971987263,0.509835170906642,ENSG00000138621,PPCDC,protein_coding,15,1,75023586,75117462,q24.2,phosphopantothenoylcysteine decarboxylase [Source:HGNC Symbol;Acc:HGNC:28107],NA,PPCDC,60490,NM_001301101;NM_001301102;NM_001301103;NM_001301104;NM_001301105;NM_021823
KLHL7_SIG,KLHL7,KLHL7_SIG,KLHL7,SIG,11,1.36840894275386,0.329662150366476,0.32644973892073,0.340217216545358,0.0137674776246279,0.22074090631807,1.64676539197049,3.90397528708548,3.88197013039371,3.976277944787,0.0943078143932854,0.177351361045036,ENSG00000122550,KLHL7,protein_coding,7,1,23105758,23177914,p15.3,kelch like family member 7 [Source:HGNC Symbol;Acc:HGNC:15646],Bohring-Opitz syndrome;Cold-induced sweating syndrome;Cold-induced sweating syndrome type 1 (CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa;Crisponi/CISS1-like phenotype associated with early-onset retinitis pigmentosa;CRISPONI/COLD-INDUCED SWEATING SYNDROME 3;Retinitis pigmentosa;RETINITIS PIGMENTOSA 42,KLHL7,55975,NM_001031710;NM_001172428;NM_018846
PDAP1_SIG,PDAP1,PDAP1_SIG,PDAP1,SIG,33,1.36808711025829,0.310511827538395,0.308517800141497,0.317063631842488,0.00854583170099072,0.220818206457511,1.35259929486802,5.98242893437105,5.96787356726841,6.030253711994,0.0623801447255862,0.274447708842009,ENSG00000106244,PDAP1,protein_coding,7,-1,99392048,99408597,q22.1,PDGFA associated protein 1 [Source:HGNC Symbol;Acc:HGNC:14634],NA,PDAP1,11333,NM_014891
BUB1_SIG,BUB1,BUB1_SIG,BUB1,SIG,59,-1.36804702120653,0.2036246977059,0.21454402741489,0.167746900090648,-0.046797127324242,0.220818206457511,-1.64447486493928,4.12278360533041,4.17318707164587,3.9571722160082,-0.21601485563767,0.178038853215165,ENSG00000169679,BUB1,protein_coding,2,-1,110637698,110678114,q13,BUB1 mitotic checkpoint serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:1148],Mosaic variegated aneuploidy syndrome,BUB1,699,NM_001278616;NM_001278617;NM_004336
MTDH_SIG,MTDH,MTDH_SIG,MTDH,SIG,23,-1.36761425171248,0.443475393650542,0.445014228993905,0.438419220379492,-0.00659500861441279,0.220958492169227,0.295660845578373,8.13347125487238,8.13034481836005,8.14374383198431,0.013399013624264,0.830316387081833,ENSG00000147649,MTDH,protein_coding,8,1,97644184,97730260,q22.1,metadherin [Source:HGNC Symbol;Acc:HGNC:29608],NA,MTDH,92140,NM_178812
AKR1C1_SIG,AKR1C1,AKR1C1_SIG,AKR1C1,SIG,8,-1.36735854335239,-0.0768382997431347,-0.0746145558461419,-0.0841448868332541,-0.00953033098711215,0.221027343316585,-0.923935477253232,1.6883046689791,1.71218549662161,1.60983909243942,-0.102346404182186,0.468900271211163,ENSG00000187134,AKR1C1,protein_coding,10,1,4963253,4983283,p15.1,aldo-keto reductase family 1 member C1 [Source:HGNC Symbol;Acc:HGNC:384],NA,AKR1C1,1645,NM_001353
STAT2_SIG,STAT2,STAT2_SIG,STAT2,SIG,43,-1.3670272610007,0.471632222549566,0.476337706401474,0.456171347036152,-0.0201663593653222,0.221116538999987,-1.44391738218732,6.95883023738716,6.9870487546671,6.86611225203878,-0.120936502628323,0.240600760525876,ENSG00000170581,STAT2,protein_coding,12,-1,56341597,56360167,q13.3,signal transducer and activator of transcription 2 [Source:HGNC Symbol;Acc:HGNC:11363],IMMUNODEFICIENCY 44;Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection;Recessive gain of function causing increased interferon signalling;Viral induced severe multiorgan dysfunction associated with impaired mitochondrial fission,STAT2,6773,NM_005419;NM_198332
NR3C1_SIG,NR3C1,NR3C1_SIG,NR3C1,SIG,35,-1.36696734379006,0.189117927444165,0.190317249567868,0.18517729760914,-0.00513995195872752,0.221116538999987,-0.356092035518774,6.95877998189371,6.96345376039555,6.94342328110194,-0.0200304792936121,0.794021820823534,ENSG00000113580,NR3C1,protein_coding,5,-1,143277931,143435512,q31.3,nuclear receptor subfamily 3 group C member 1 [Source:HGNC Symbol;Acc:HGNC:7978],Glucocorticoid resistance;GLUCOCORTICOID RESISTANCE GENERALIZED,NR3C1,2908,NM_000176;NM_001018074;NM_001018075;NM_001018076;NM_001018077;NM_001020825;NM_001024094;NM_001204258;NM_001204259;NM_001204260;NM_001204261;NM_001204262;NM_001204263;NM_001204264;NM_001204265;NM_001364182;NM_001364183;NM_001364184;NM_001364185
UBE2B_SIG,UBE2B,UBE2B_SIG,UBE2B,SIG,16,-1.36643419977414,0.166238774625016,0.168696980343487,0.15816181297861,-0.0105351673648763,0.221297503084346,-1.85122798987215,5.53407593346966,5.55865468485335,5.45331717892326,-0.105337505930099,0.126626714189669,ENSG00000119048,UBE2B,protein_coding,5,1,134371179,134391992,q31.1,ubiquitin conjugating enzyme E2 B [Source:HGNC Symbol;Acc:HGNC:12473],NA,UBE2B,7320,NM_003337
NAA30_SIG,NAA30,NAA30_SIG,NAA30,SIG,56,1.36438278401736,0.397729067134846,0.394348087706557,0.408837999542085,0.0144899118355279,0.222093023073843,1.77094608234751,4.92507383893941,4.89732988997026,5.01623252840949,0.118902638439233,0.145198165979496,ENSG00000139977,NAA30,protein_coding,14,1,57390544,57415906,q22.3,N(alpha)-acetyltransferase 30, NatC catalytic subunit [Source:HGNC Symbol;Acc:HGNC:19844],NA,NAA30,122830,NM_001011713
SLIRP_SIG,SLIRP,SLIRP_SIG,SLIRP,SIG,22,1.36379832778405,0.251465013950278,0.247975761021733,0.262929702144067,0.0149539411223343,0.222295340736722,1.38344864638659,3.71286191568666,3.69637476342948,3.76703398738883,0.0706592239593563,0.262873086109826,ENSG00000119705,SLIRP,protein_coding,14,1,77708071,77761104,q24.3,SRA stem-loop interacting RNA binding protein [Source:HGNC Symbol;Acc:HGNC:20495],NA,SLIRP,81892,NM_001267863;NM_001267864;NM_031210
ZCCHC8_SIG,ZCCHC8,ZCCHC8_SIG,ZCCHC8,SIG,8,-1.3626762794394,0.619447871644716,0.622466315117403,0.609530128805888,-0.0129361863115143,0.222715936751922,-0.124552445234004,5.46905134788966,5.47072203920439,5.46356193356982,-0.00716010563456487,0.930388304182494,ENSG00000033030,ZCCHC8,protein_coding,12,-1,122471600,122501073,q24.31,zinc finger CCHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:25265],Autosomal Recessive Mental Retardation,ZCCHC8,55596,NM_001350935;NM_001350936;NM_001350937;NM_001350938;NM_017612
PAXIP1_SIG,PAXIP1,PAXIP1_SIG,PAXIP1,SIG,19,1.36160202299124,0.486178591627482,0.483505106576273,0.494962899652881,0.0114577930766076,0.223100763116233,1.4380156516989,4.80833827806561,4.79022869840237,4.8678411826734,0.0776124842710369,0.242713090141945,ENSG00000157212,PAXIP1,protein_coding,7,-1,154943687,155003084,q36.2,PAX interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:8624],NA,PAXIP1,22976,NM_007349
EEF1A1_SIG,EEF1A1,EEF1A1_SIG,EEF1A1,SIG,23,1.36148715540365,1.85257312054752,1.84561647438341,1.87543067222958,0.0298141978461691,0.223100763116233,2.15719673757566,10.9289064627795,10.8971658663344,11.0331969939561,0.13603112762171,0.0721413715616559,ENSG00000156508,EEF1A1,protein_coding,6,-1,73515750,73523797,q13,eukaryotic translation elongation factor 1 alpha 1 [Source:HGNC Symbol;Acc:HGNC:3189],NA,EEF1A1,1915,NM_001402
STAT2_TF,STAT2,STAT2_TF,STAT2,TF,202,-1.36147307054382,0.249283986301977,0.252753302753671,0.237884803674981,-0.01486849907869,0.223100763116233,-1.44391738218732,6.95883023738716,6.9870487546671,6.86611225203878,-0.120936502628323,0.240600760525876,ENSG00000170581,STAT2,protein_coding,12,-1,56341597,56360167,q13.3,signal transducer and activator of transcription 2 [Source:HGNC Symbol;Acc:HGNC:11363],IMMUNODEFICIENCY 44;Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection;Recessive gain of function causing increased interferon signalling;Viral induced severe multiorgan dysfunction associated with impaired mitochondrial fission,STAT2,6773,NM_005419;NM_198332
RPL5_SIG,RPL5,RPL5_SIG,RPL5,SIG,76,1.35979726253313,1.54330253955455,1.53620009553528,1.56663914133215,0.0304390457968777,0.223747868729401,1.83552179345259,9.70302377192795,9.67289179717048,9.80202883184535,0.129137034674871,0.12991570333944,ENSG00000122406,RPL5,protein_coding,1,1,92831983,92841924,p22.1,ribosomal protein L5 [Source:HGNC Symbol;Acc:HGNC:10360],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 6,RPL5,6125,NM_000969
PLXNB2_SIG,PLXNB2,PLXNB2_SIG,PLXNB2,SIG,82,1.35712127501328,0.264731675977475,0.261330140983105,0.275908148101831,0.014578007118726,0.224804829182135,1.55216851290999,8.18656916174372,8.14640436701499,8.31853920156668,0.17213483455169,0.205050060548602,ENSG00000196576,PLXNB2,protein_coding,22,-1,50274979,50307646,q13.33,plexin B2 [Source:HGNC Symbol;Acc:HGNC:9104],NA,PLXNB2,23654,NM_012401
CD38_SIG,CD38,CD38_SIG,CD38,SIG,15,-1.35598762411497,0.142288745589939,0.14435874306367,0.135487325319106,-0.00887141774456445,0.225233540011645,-2.79166640971921,6.50371962899869,6.59456901386707,6.20521450728828,-0.389354506578788,0.0180538608279084,ENSG00000004468,CD38,protein_coding,4,1,15778275,15853232,p15.32,CD38 molecule [Source:HGNC Symbol;Acc:HGNC:1667],NA,CD38,952,NM_001775
NCOR1_TF,NCOR1,NCOR1_TF,NCOR1,TF,87,1.35575453104535,0.344133770857349,0.341373944001916,0.353201773382342,0.0118278293804253,0.225293975028639,1.92150291292607,7.80987309275873,7.78380303453076,7.89553185550779,0.111728820977028,0.112033062893821,ENSG00000141027,NCOR1,protein_coding,17,-1,16029157,16218185,p11.2,nuclear receptor corepressor 1 [Source:HGNC Symbol;Acc:HGNC:7672],NA,NCOR1,9611,NM_001190438;NM_001190440;NM_006311
ZNF124_TF,ZNF124,ZNF124_TF,ZNF124,TF,23,1.35517333256029,0.275745375987074,0.273973306637656,0.281567889563732,0.00759458292607523,0.225496970050778,0.123309504715228,2.56526125263798,2.56308631609058,2.57240747272227,0.00932115663168346,0.931137159339734,ENSG00000196418,ZNF124,protein_coding,1,-1,247121975,247172016,q44,zinc finger protein 124 [Source:HGNC Symbol;Acc:HGNC:12907],NA,ZNF124,7678,NM_001243740;NM_001297567;NM_001297568;NM_001297569;NM_003431
EIF4E3_SIG,EIF4E3,EIF4E3_SIG,EIF4E3,SIG,8,-1.35487574520806,0.307216134374513,0.310748243869059,0.295610631749575,-0.0151376121194843,0.225583872687606,0.0119448408685939,6.24386544204518,6.24342528301464,6.24531167885981,0.00188639584516796,0.993317965635787,ENSG00000163412,EIF4E3,protein_coding,3,-1,71675414,71754773,p13,eukaryotic translation initiation factor 4E family member 3 [Source:HGNC Symbol;Acc:HGNC:31837],NA,EIF4E3,317649,NM_001134649;NM_001134650;NM_001134651;NM_001282886;NM_173359
OR7E38P_SIG,OR7E38P,OR7E38P_SIG,OR7E38P,SIG,10,-1.35441380357465,0.0102861067322498,0.0114090601581619,0.00659640261853844,-0.00481265753962358,0.225738157100173,-0.590494687066625,2.30443750925102,2.31175585584717,2.28039151329222,-0.0313643425549489,0.657123686576276,ENSG00000183444,OR7E38P,unprocessed_pseudogene,7,-1,97966090,97967074,q21.3,olfactory receptor family 7 subfamily E member 38 pseudogene [Source:HGNC Symbol;Acc:HGNC:8411],NA,OR7E38P,NA,NA
CASP8AP2_SIG,CASP8AP2,CASP8AP2_SIG,CASP8AP2,SIG,59,1.3541572170357,0.491086885209115,0.486259918357094,0.506946919151469,0.0206870007943751,0.225808311299034,1.26436494734007,5.04529030536916,5.01480830337794,5.14544545476887,0.130637151390923,0.309609552593052,ENSG00000118412,CASP8AP2,protein_coding,6,1,89829894,89874436,q15,caspase 8 associated protein 2 [Source:HGNC Symbol;Acc:HGNC:1510],NA,CASP8AP2,9994,NM_001137667;NM_001137668;NM_012115
BLNK_SIG,BLNK,BLNK_SIG,BLNK,SIG,49,-1.35283910643605,-0.0537243678536596,-0.0500789523271281,-0.0657021617265487,-0.0156232093994205,0.226314068076565,2.34051264539791,2.07574113236382,1.97894418880798,2.39378823261871,0.41484404381073,0.0497656044386687,ENSG00000095585,BLNK,protein_coding,10,-1,96191702,96271587,q24.1,B cell linker [Source:HGNC Symbol;Acc:HGNC:14211],AGAMMAGLOBULINEMIA 4 AUTOSOMAL RECESSIVE;Autosomal agammaglobulinemia,BLNK,29760,NM_001114094;NM_001258440;NM_001258441;NM_001258442;NM_013314
DYRK1A_SIG,DYRK1A,DYRK1A_SIG,DYRK1A,SIG,27,1.35076473277727,0.484561541926163,0.481177933985968,0.495679110872517,0.0145011768865494,0.22713184710104,0.963572953444722,7.45951163561109,7.44825502416195,7.49649764465825,0.0482426204962972,0.448969511545108,ENSG00000157540,DYRK1A,protein_coding,21,1,37365573,37526358,q22.13,dual specificity tyrosine phosphorylation regulated kinase 1A [Source:HGNC Symbol;Acc:HGNC:3091],DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion;Intellectual disability syndrome due to a DYRK1A point mutation;MENTAL RETARDATION AUTOSOMAL DOMINANT 7;mental retardation autosomal dominant type 7,DYRK1A,1859,NM_001347721;NM_001347722;NM_001347723;NM_001396;NM_101395;NM_130436;NM_130438
ZC3H15_TF,ZC3H15,ZC3H15_TF,ZC3H15,TF,120,1.34999271418171,0.237738875434059,0.234760972037472,0.247523415165702,0.0127624431282297,0.227414603915647,1.92589993469101,6.67393276176229,6.65240568388986,6.7446645890574,0.0922589051675456,0.111144857388944,ENSG00000065548,ZC3H15,protein_coding,2,1,186486253,186509361,q32.1,zinc finger CCCH-type containing 15 [Source:HGNC Symbol;Acc:HGNC:29528],NA,ZC3H15,55854,NM_018471
XRN2_SIG,XRN2,XRN2_SIG,XRN2,SIG,7,1.34942648692751,0.31920311959071,0.31770248818632,0.324133765633708,0.00643127744738829,0.227612736259549,-2.17823573181873,7.32946333413663,7.35047098682165,7.26043818960011,-0.0900327972215457,0.0692687554793622,ENSG00000088930,XRN2,protein_coding,20,1,21303331,21389825,p11.22,5'-3' exoribonuclease 2 [Source:HGNC Symbol;Acc:HGNC:12836],NA,XRN2,22803,NM_001317960;NM_012255
ATXN1L_SIG,ATXN1L,ATXN1L_SIG,ATXN1L,SIG,71,-1.34883274648369,0.169350333795103,0.175854480456868,0.147979566192161,-0.0278749142647072,0.227822337526859,-0.943693753322736,6.68936741053384,6.70763128275067,6.62935754467853,-0.0782737380721484,0.458900999557307,ENSG00000224470,ATXN1L,protein_coding,16,1,71845976,71885268,q22.2,ataxin 1 like [Source:HGNC Symbol;Acc:HGNC:33279],NA,ATXN1L,342371,NM_001137675
F2RL1_SIG,F2RL1,F2RL1_SIG,F2RL1,SIG,92,-1.34812774271467,0.0330846372708961,0.0367158029436351,0.021153664346182,-0.0155621385974533,0.228078011339121,0.88744290042379,2.32069549136045,2.2838588210164,2.44173026534805,0.157871444331644,0.488541969284222,ENSG00000164251,F2RL1,protein_coding,5,1,76818933,76835315,q13.3,F2R like trypsin receptor 1 [Source:HGNC Symbol;Acc:HGNC:3538],NA,F2RL1,2150,NM_005242
CCL25_SIG,CCL25,CCL25_SIG,CCL25,SIG,26,1.34486204001161,-0.042918012998015,-0.0455353610324664,-0.034318155170532,0.0112172058619343,0.229393958934371,-0.498259135869864,0.310986742962448,0.317372992655583,0.290003351113575,-0.0273696415420078,0.71073384079167,ENSG00000131142,CCL25,protein_coding,19,1,8052767,8062650,p13.2,C-C motif chemokine ligand 25 [Source:HGNC Symbol;Acc:HGNC:10624],NA,CCL25,6370,NM_001201359;NM_005624
LTB4R_SIG,LTB4R,LTB4R_SIG,LTB4R,SIG,49,-1.34462587387985,0.133167226929692,0.135480129561508,0.125567689710868,-0.00991243985064013,0.229456352839679,-0.853614501367339,6.13116026710936,6.14711339254125,6.07874285497601,-0.0683705375652427,0.506268591290565,ENSG00000213903,LTB4R,protein_coding,14,1,24311450,24318036,q12,leukotriene B4 receptor [Source:HGNC Symbol;Acc:HGNC:6713],NA,LTB4R,1241,NM_001143919;NM_181657
OMA1_SIG,OMA1,OMA1_SIG,OMA1,SIG,59,1.34427717547662,0.0762979419798242,0.0708687437122338,0.0941367362876215,0.0232679925753879,0.229565443569376,0.517179677215546,4.00135828473044,3.98884442155412,4.04247526373833,0.0536308421842078,0.699732162252646,ENSG00000162600,OMA1,protein_coding,1,-1,58415384,58546802,p32.1,OMA1 zinc metallopeptidase [Source:HGNC Symbol;Acc:HGNC:29661],NA,OMA1,115209,NM_145243
ZFYVE9_TF,ZFYVE9,ZFYVE9_TF,ZFYVE9,TF,239,1.34364428395929,-0.0612002909980451,-0.062751684352501,-0.0561028556905471,0.00664882866195404,0.229792536902079,-2.08853502762748,2.28780331358856,2.36951032485127,2.01933741943962,-0.350172905411651,0.0821425658443949,ENSG00000157077,ZFYVE9,protein_coding,1,1,52142094,52346686,p32.3,zinc finger FYVE-type containing 9 [Source:HGNC Symbol;Acc:HGNC:6775],NA,ZFYVE9,9372,NM_004799;NM_007324
PSMD14_SIG,PSMD14,PSMD14_SIG,PSMD14,SIG,36,1.34344714371523,0.449844915398284,0.447204329702835,0.458521125540473,0.0113167958376379,0.229813917441793,1.90849779747438,4.983515700504,4.95962513055525,5.06201328747847,0.102388156923216,0.11459577622583,ENSG00000115233,PSMD14,protein_coding,2,1,161308425,161411717,q24.2,proteasome 26S subunit, non-ATPase 14 [Source:HGNC Symbol;Acc:HGNC:16889],NA,PSMD14,10213,NM_005805
GDPD3_SIG,GDPD3,GDPD3_SIG,GDPD3,SIG,60,-1.34342014910801,0.0185065744733528,0.0211269276747139,0.00989684252602324,-0.0112300851486906,0.229813917441793,-1.11644073732865,2.12012500677808,2.14247467785643,2.04669037323491,-0.0957843046215182,0.374545403215678,ENSG00000102886,GDPD3,protein_coding,16,-1,30104810,30113537,p11.2,glycerophosphodiester phosphodiesterase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28638],NA,GDPD3,79153,NM_024307
ACOT8_SIG,ACOT8,ACOT8_SIG,ACOT8,SIG,8,1.34333563467029,0.469945613912559,0.467335698431294,0.478521050493857,0.0111853520625625,0.229813917441793,-0.0313251306312931,4.0904485450876,4.09074113846987,4.08948716683155,-0.00125397163831918,0.982843039240485,ENSG00000101473,ACOT8,protein_coding,20,-1,45841721,45857405,q13.12,acyl-CoA thioesterase 8 [Source:HGNC Symbol;Acc:HGNC:15919],NA,ACOT8,10005,NM_005469
LFNG_SIG,LFNG,LFNG_SIG,LFNG,SIG,30,-1.34178729517544,0.394849740332982,0.399141009349907,0.38074985642023,-0.0183911529296775,0.230421718176058,1.48490922726681,4.45689346497634,4.40534120820455,4.62627945151222,0.220938243307668,0.226964129402332,ENSG00000106003,LFNG,protein_coding,7,1,2512529,2529177,p22.3,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:6560],Autosomal recessive spondylocostal dysostosis;SPONDYLOCOSTAL DYSOSTOSIS 3 AUTOSOMAL RECESSIVE;SPONDYLOCOSTAL DYSOSTOSIS TYPE 3,LFNG,3955,NM_001040167;NM_001040168;NM_001166355;NM_002304
THUMPD1_SIG,THUMPD1,THUMPD1_SIG,THUMPD1,SIG,51,1.34109834550199,0.121249902797943,0.11916943677481,0.128085719731095,0.00891628295628414,0.230672717042209,0.453660673656219,5.9970821899892,5.9913526030402,6.0159079756788,0.0245553726386013,0.737199267146064,ENSG00000066654,THUMPD1,protein_coding,16,-1,20702816,20742084,p12.3,THUMP domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23807],NA,THUMPD1,55623,NM_001304550;NM_017736
TXNIP_SIG,TXNIP,TXNIP_SIG,TXNIP,SIG,15,-1.33960192611536,0.323503637673164,0.326069467806169,0.315073052950432,-0.0109964148557368,0.231260475947713,-0.013621914099061,10.1652356437816,10.1655975214272,10.1640466172318,-0.00155090419530865,0.992390775531278,ENSG00000265972,TXNIP,protein_coding,1,-1,145992435,145996600,q21.1,thioredoxin interacting protein [Source:HGNC Symbol;Acc:HGNC:16952],NA,TXNIP,10628,NM_001313972;NM_006472
PSMC6_SIG,PSMC6,PSMC6_SIG,PSMC6,SIG,35,1.33821097009292,0.493468931545663,0.489459609568031,0.506642418043597,0.0171828084755656,0.231805242082555,1.58967779889502,5.278001789123,5.25672233153805,5.34792000690211,0.0911976753640618,0.19357903701736,ENSG00000100519,PSMC6,protein_coding,14,1,52707178,52728590,q22.1,proteasome 26S subunit, ATPase 6 [Source:HGNC Symbol;Acc:HGNC:9553],NA,PSMC6,5706,NM_002806
RBM4_SIG,RBM4,RBM4_SIG,RBM4,SIG,34,1.33725491314902,0.31262630603032,0.309246253410852,0.32373219320857,0.0144859397977179,0.232168979414705,1.58324039780818,3.77398851030273,3.74716251568543,3.8621310640453,0.114968548359869,0.195584718336448,ENSG00000173933,RBM4,protein_coding,11,1,66638617,66668374,q13.2,RNA binding motif protein 4 [Source:HGNC Symbol;Acc:HGNC:9901],NA,RBM4,5936,NM_001198843;NM_001198844;NM_002896
ZC3HAV1_TF,ZC3HAV1,ZC3HAV1_TF,ZC3HAV1,TF,54,-1.33510452837523,0.135006523452705,0.136232350322697,0.130978806594161,-0.00525354372853557,0.233033582345211,0.264821849593511,7.66882701916673,7.66519280150216,7.68076802006461,0.0155752185624463,0.84843471621021,ENSG00000105939,ZC3HAV1,protein_coding,7,-1,139043515,139109720,q34,zinc finger CCCH-type containing, antiviral 1 [Source:HGNC Symbol;Acc:HGNC:23721],NA,ZC3HAV1,56829,NM_020119;NM_024625
ZFAND6_TF,ZFAND6,ZFAND6_TF,ZFAND6,TF,82,-1.33469681319083,0.228641518624236,0.230498156171475,0.222541138111881,-0.00795701805959446,0.233168546445351,-1.04050605346019,5.94823391861862,5.96133149186774,5.90519903508579,-0.0561324567819473,0.410653910651662,ENSG00000086666,ZFAND6,protein_coding,15,1,80059568,80138393,q25.1,zinc finger AN1-type containing 6 [Source:HGNC Symbol;Acc:HGNC:30164],NA,ZFAND6,54469,NM_001242911;NM_001242912;NM_001242913;NM_001242914;NM_001242915;NM_001242916;NM_001242917;NM_001242918;NM_001242919;NM_019006
PRMT2_SIG,PRMT2,PRMT2_SIG,PRMT2,SIG,34,1.33426250210714,0.273089762184726,0.269811860738621,0.283860009793355,0.014048149054734,0.233314724307684,1.64609086787851,6.74029702618289,6.71421332263128,6.82600062356675,0.11178730093547,0.177545242544102,ENSG00000160310,PRMT2,protein_coding,21,1,46635595,46665124,q22.3,protein arginine methyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:5186],NA,PRMT2,3275,NM_001242864;NM_001242865;NM_001242866;NM_001286676;NM_001286677;NM_001286678;NM_001535;NM_206962
SLC5A10_SIG,SLC5A10,SLC5A10_SIG,SLC5A10,SIG,63,1.33408329801501,0.0327840714824707,0.0310225650590112,0.0385718783024088,0.00754931324339746,0.233353863715259,1.24584972146564,1.33332707637932,1.29156470337238,1.47054630197354,0.178981598601153,0.317077280500103,ENSG00000154025,SLC5A10,protein_coding,17,1,18950345,19022595,p11.2,solute carrier family 5 member 10 [Source:HGNC Symbol;Acc:HGNC:23155],NA,SLC5A10,125206,NM_001042450;NM_001270648;NM_001270649;NM_001282417;NM_152351
CLK4_SIG,CLK4,CLK4_SIG,CLK4,SIG,23,1.33303772538492,0.204975879852817,0.203398771128322,0.210157808519014,0.00675903739069175,0.233756906356741,2.14766080860255,4.99447541416258,4.96306338025087,5.09768638272963,0.134623002478764,0.0734484360184214,ENSG00000113240,CLK4,protein_coding,5,-1,178602664,178630615,q35.3,CDC like kinase 4 [Source:HGNC Symbol;Acc:HGNC:13659],NA,CLK4,57396,NM_020666
MICA_SIG,MICA,MICA_SIG,MICA,SIG,2,1.33135079910924,0.173635025244889,0.171270254649558,0.181404985772402,0.0101347311228441,0.234430427001226,1.16050977280564,3.35711562245491,3.3404330878058,3.41192966487341,0.0714965770676037,0.354640090437514,ENSG00000204520,MICA,protein_coding,6,1,31399784,31415315,p21.33,MHC class I polypeptide-related sequence A [Source:HGNC Symbol;Acc:HGNC:7090],NA,MICA,100507436,NM_001177519;NM_001289152;NM_001289153;NM_001289154
BABAM1_SIG,BABAM1,BABAM1_SIG,BABAM1,SIG,44,1.3303514426312,0.0906324722286813,0.0889928266655964,0.0960198790788174,0.00702705241322101,0.234815292216799,2.18317675783287,3.45168815456349,3.43051191877163,3.52126721502244,0.0907552962508121,0.0685908708274501,ENSG00000105393,BABAM1,protein_coding,19,1,17267376,17281249,p13.11,BRISC and BRCA1 A complex member 1 [Source:HGNC Symbol;Acc:HGNC:25008],NA,BABAM1,29086,NM_001033549;NM_001288756;NM_001288757;NM_014173
GPR35_SIG,GPR35,GPR35_SIG,GPR35,SIG,21,-1.33009642713273,0.245824914536458,0.248751753092676,0.236208159280312,-0.012543593812364,0.234886537991891,-0.420030260082395,3.08469132348497,3.09604431879446,3.04738862461093,-0.048655694183532,0.756890392142468,ENSG00000178623,GPR35,protein_coding,2,1,240605430,240631259,q37.3,G protein-coupled receptor 35 [Source:HGNC Symbol;Acc:HGNC:4492],Primary sclerosing cholangitis,GPR35,2859,NM_001195381;NM_001195382;NM_005301
NDUFS6_SIG,NDUFS6,NDUFS6_SIG,NDUFS6,SIG,28,1.32856962497412,0.426394377408603,0.423796535417972,0.434930143949249,0.0111336085312777,0.235494691874454,0.609319820268912,4.92359253218661,4.91709561229016,4.94493955470351,0.027843942413349,0.645108340661128,ENSG00000145494,NDUFS6,protein_coding,5,1,1801400,1816605,p15.33,NADH:ubiquinone oxidoreductase subunit S6 [Source:HGNC Symbol;Acc:HGNC:7713],Isolated complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 9,NDUFS6,4726,NM_004553
FBXW11_SIG,FBXW11,FBXW11_SIG,FBXW11,SIG,17,1.32830583874583,0.515937609368512,0.513445837951402,0.524124858310443,0.0106790203590409,0.235569772072395,0.773999680815754,5.59856449314326,5.58875314430107,5.6308017821962,0.0420486378951378,0.549704786974795,ENSG00000072803,FBXW11,protein_coding,5,-1,171861549,172006873,q35.1,F-box and WD repeat domain containing 11 [Source:HGNC Symbol;Acc:HGNC:13607],NA,FBXW11,23291,NM_012300;NM_033644;NM_033645
RPL18_SIG,RPL18,RPL18_SIG,RPL18,SIG,41,1.32792517300342,1.98269720006498,1.97556142189061,2.00614332835222,0.0305819064616089,0.235694274537758,1.78484983244953,8.991285555874,8.96655360530249,9.0725476791804,0.105994073877907,0.141726150781838,ENSG00000063177,RPL18,protein_coding,19,-1,48615328,48619184,q13.33,ribosomal protein L18 [Source:HGNC Symbol;Acc:HGNC:10310],Blackfan-Diamond anemia,RPL18,6141,NM_000979;NM_001270490
BHLHE40_TF,BHLHE40,BHLHE40_TF,BHLHE40,TF,31,-1.32545218332196,0.24673098063165,0.252677893225631,0.227191124965713,-0.0254867682599175,0.23670487941039,-1.06343461900282,7.37167054803674,7.40996671126899,7.24584029741651,-0.164126413852476,0.399731586711026,ENSG00000134107,BHLHE40,protein_coding,3,1,4979116,4985323,p26.1,basic helix-loop-helix family member e40 [Source:HGNC Symbol;Acc:HGNC:1046],NA,BHLHE40,8553,NM_003670
HSD17B14_SIG,HSD17B14,HSD17B14_SIG,HSD17B14,SIG,58,-1.32488071288834,-0.123398814462976,-0.12112066855853,-0.130884151006156,-0.00976348244762558,0.23691073112527,-2.04171405008151,0.418436696552624,0.448281504862929,0.320375183533051,-0.127906321329877,0.0899412273755906,ENSG00000087076,HSD17B14,protein_coding,19,-1,48813018,48836510,q13.33,hydroxysteroid 17-beta dehydrogenase 14 [Source:HGNC Symbol;Acc:HGNC:23238],NA,HSD17B14,51171,NM_016246
XYLB_SIG,XYLB,XYLB_SIG,XYLB,SIG,34,-1.32476044701145,0.0769145217297155,0.0799565982171652,0.0669191275566666,-0.0130374706604984,0.236925187495045,-2.06514607703709,1.77228632242357,1.81973829507308,1.61637269800376,-0.20336559706932,0.0858437795548857,ENSG00000093217,XYLB,protein_coding,3,1,38346760,38421348,p22.2,xylulokinase [Source:HGNC Symbol;Acc:HGNC:12839],NA,XYLB,9942,NM_001349178;NM_001349179;NM_001349180;NM_005108
HAUS7_SIG,HAUS7,HAUS7_SIG,HAUS7,SIG,34,1.32453669195946,0.131000940504539,0.129433663451362,0.136150565107833,0.00671690165647097,0.236983563977756,0.391847741900708,1.374726991787,1.37071465342392,1.3879103892657,0.0171957358417788,0.77340155254641,ENSG00000213397,HAUS7,protein_coding,X,-1,153447666,153495516,q28,HAUS augmin like complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:32979],NA,HAUS7,55559,NM_017518
SOAT2_SIG,SOAT2,SOAT2_SIG,SOAT2,SIG,16,-1.32434435838428,-0.0127077038597097,-0.0104681611876975,-0.0200662012106069,-0.00959804002290933,0.237028614100433,-0.931805633126317,0.235142211858737,0.242341408748657,0.211487707791857,-0.0308537009568003,0.464830671787036,ENSG00000167780,SOAT2,protein_coding,12,1,53103486,53124535,q13.13,sterol O-acyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:11178],NA,SOAT2,8435,NM_003578
ZNF264_TF,ZNF264,ZNF264_TF,ZNF264,TF,39,1.32222356272672,0.226883073151094,0.2246451460056,0.234236262343431,0.00959111633783081,0.237893295146384,2.28540872574197,3.82837691731904,3.7961389375306,3.93430170805252,0.13816277052192,0.0556356967038402,ENSG00000083844,ZNF264,protein_coding,19,1,57191500,57222846,q13.43,zinc finger protein 264 [Source:HGNC Symbol;Acc:HGNC:13057],NA,ZNF264,9422,NM_003417
HEXA_SIG,HEXA,HEXA_SIG,HEXA,SIG,36,1.32172109794963,0.264963513449315,0.263194311185527,0.270776606601761,0.00758229541623475,0.238070459833667,-0.180251283913177,6.42329842596488,6.42579888092315,6.4150826453877,-0.0107162355354413,0.89875031745207,ENSG00000213614,HEXA,protein_coding,15,-1,72340919,72376476,q23,hexosaminidase subunit alpha [Source:HGNC Symbol;Acc:HGNC:4878],GM2-GANGLIOSIDOSIS TYPE 1;TAY-SACHS DISEASE;Tay-Sachs disease B variant adult form;Tay-Sachs disease B variant infantile form;Tay-Sachs disease B variant juvenile form;TAY-SACHS DISEASE B1 VARIANT,HEXA,3073,NM_000520;NM_001318825
CDK19_SIG,CDK19,CDK19_SIG,CDK19,SIG,41,1.32110828483379,0.354966230187093,0.351331844767464,0.366907782280159,0.0155759375126951,0.238294722732557,-0.0312626032926038,5.90876425633567,5.90927830093209,5.90707525266172,-0.00220304827037038,0.982849921654623,ENSG00000155111,CDK19,protein_coding,6,-1,110609978,110815958,q21,cyclin dependent kinase 19 [Source:HGNC Symbol;Acc:HGNC:19338],NA,CDK19,23097,NM_001300960;NM_001300963;NM_001300964;NM_015076
PDIA4_SIG,PDIA4,PDIA4_SIG,PDIA4,SIG,54,1.32070768334366,0.488912609539979,0.485715511071909,0.499417361649355,0.0137018505774459,0.238428667830759,1.57107292479217,6.70965178000711,6.67420835974577,6.82610873229437,0.151900372548608,0.199299552052091,ENSG00000155660,PDIA4,protein_coding,7,-1,149003062,149028662,q36.1,protein disulfide isomerase family A member 4 [Source:HGNC Symbol;Acc:HGNC:30167],NA,PDIA4,9601,NM_004911
PTPRS_SIG,PTPRS,PTPRS_SIG,PTPRS,SIG,30,-1.31954611723171,-0.142772830044082,-0.141345098136225,-0.147463949169899,-0.00611885103367445,0.238887279339301,-0.816868347348551,2.71849091220353,2.75488090257852,2.59892380097142,-0.155957101607101,0.525898418652221,ENSG00000105426,PTPRS,protein_coding,19,-1,5158495,5340803,p13.3,protein tyrosine phosphatase, receptor type S [Source:HGNC Symbol;Acc:HGNC:9681],NA,PTPRS,5802,NM_002850;NM_130853;NM_130854;NM_130855
SMO_SIG,SMO,SMO_SIG,SMO,SIG,77,1.31757279305146,-0.100035948326983,-0.102619566774278,-0.0915469162858725,0.011072650488405,0.239675166068402,0.45507454256426,1.74100683629262,1.72623810949061,1.7895326529278,0.0632945434371883,0.736264802871194,ENSG00000128602,SMO,protein_coding,7,1,129188633,129213545,q32.1,smoothened, frizzled class receptor [Source:HGNC Symbol;Acc:HGNC:11119],BASAL CELL CARCINOMA SUSCEPTIBILITY TO 1;Curry-Jones Syndrome,SMO,6608,NM_005631
DCLRE1B_SIG,DCLRE1B,DCLRE1B_SIG,DCLRE1B,SIG,41,-1.31744216282594,0.1897539735235,0.193911459926054,0.176093661057966,-0.0178177988680887,0.239675166068402,-1.35023217457418,4.04714395406046,4.07073618900531,3.96962661067021,-0.101109578335101,0.275363100083324,ENSG00000118655,DCLRE1B,protein_coding,1,1,113905141,113914086,p13.2,DNA cross-link repair 1B [Source:HGNC Symbol;Acc:HGNC:17641],NA,DCLRE1B,64858,NM_001319946;NM_001319947;NM_001363691;NM_022836
PHKG2_SIG,PHKG2,PHKG2_SIG,PHKG2,SIG,24,1.31743260339379,0.133397355292677,0.131592968105118,0.139326056051802,0.00773308794668428,0.239675166068402,0.217250887832182,5.01517019674524,5.0127860622043,5.02300378166548,0.0102177194611821,0.877544503971054,ENSG00000156873,PHKG2,protein_coding,16,1,30748293,30761176,p11.2,phosphorylase kinase catalytic subunit gamma 2 [Source:HGNC Symbol;Acc:HGNC:8931],Glycogen storage disease due to liver phosphorylase kinase deficiency;GLYCOGEN STORAGE DISEASE IXc,PHKG2,5261,NM_000294;NM_001172432
SLC44A5_SIG,SLC44A5,SLC44A5_SIG,SLC44A5,SIG,1,1.31735687632077,0.00326355851472969,0.00103709826970884,0.0105790707483696,0.00954197247866087,0.239675166068402,-0.650454937765737,0.51986548256289,0.537736197757326,0.461147418352599,-0.0765887794047267,0.620592284634578,ENSG00000137968,SLC44A5,protein_coding,1,-1,75202131,75611116,p31.1,solute carrier family 44 member 5 [Source:HGNC Symbol;Acc:HGNC:28524],NA,SLC44A5,204962,NM_001130058;NM_001320283;NM_001320285;NM_001320287;NM_152697
LAMTOR2_SIG,LAMTOR2,LAMTOR2_SIG,LAMTOR2,SIG,96,1.31712916740608,0.195233719142524,0.191768429063645,0.206619672258838,0.0148512431951934,0.239735642977915,2.21143290964086,4.740536671208,4.69908238885844,4.87674359892799,0.177661210069546,0.0648841019070136,ENSG00000116586,LAMTOR2,protein_coding,1,1,156054752,156058510,q22,late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 [Source:HGNC Symbol;Acc:HGNC:29796],IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN;Primary immunodeficiency syndrome due to p14 deficiency,LAMTOR2,28956,NM_001145264;NM_014017
SLC38A5_SIG,SLC38A5,SLC38A5_SIG,SLC38A5,SIG,37,1.31659398532021,0.200711621192973,0.196949151347936,0.213074022112379,0.0161248707644427,0.239927723523846,1.12311517250391,4.43457935559249,4.40422961855306,4.53429992015063,0.130070301597575,0.371319424677809,ENSG00000017483,SLC38A5,protein_coding,X,-1,48458537,48470260,p11.23,solute carrier family 38 member 5 [Source:HGNC Symbol;Acc:HGNC:18070],NA,SLC38A5,92745,NM_033518
KLHL21_SIG,KLHL21,KLHL21_SIG,KLHL21,SIG,11,-1.31581385817523,0.195404928131239,0.197028720914918,0.190069608984866,-0.00695911193005148,0.240224834291779,0.282294664742218,5.53475832502748,5.53013992499039,5.54993306800649,0.0197931430161055,0.838324189931495,ENSG00000162413,KLHL21,protein_coding,1,-1,6590724,6614607,p36.31,kelch like family member 21 [Source:HGNC Symbol;Acc:HGNC:29041],NA,KLHL21,9903,NM_001324309;NM_014851
GNB1_SIG,GNB1,GNB1_SIG,GNB1,SIG,17,-1.31475438487433,0.373254260190017,0.374508591128244,0.36913288710727,-0.00537570402097385,0.240642006826485,-2.10979642535626,8.94367510109765,8.96149134324882,8.88513601974382,-0.0763553235049966,0.0788970619432952,ENSG00000078369,GNB1,protein_coding,1,-1,1785285,1891117,p36.33,G protein subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:4396],Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome;LEUKEMIA ACUTE LYMPHOBLASTIC;MENTAL RETARDATION AUTOSOMAL DOMINANT 42;Severe Neurodevelopmental Disability Hypotonia and Seizures,GNB1,2782,NM_001282538;NM_001282539;NM_002074
RPL3_SIG,RPL3,RPL3_SIG,RPL3,SIG,53,1.31449234560748,1.5179849702815,1.51112932058738,1.5405106764193,0.0293813558319157,0.240712357861974,2.11691260769403,10.4199016286969,10.3819901531663,10.5444679054401,0.162477752273808,0.0778280995725236,ENSG00000100316,RPL3,protein_coding,22,-1,39312882,39320389,q13.1,ribosomal protein L3 [Source:HGNC Symbol;Acc:HGNC:10332],NA,RPL3,6122,NM_000967;NM_001033853
NMD3_SIG,NMD3,NMD3_SIG,NMD3,SIG,28,1.31436832233371,0.394934338689744,0.39125823810746,0.407012954888678,0.0157547167812176,0.240712357861974,0.54938983820112,5.9385280955278,5.93145491745885,5.96176853775433,0.0303136202954787,0.681063791133009,ENSG00000169251,NMD3,protein_coding,3,1,161104696,161253532,q26.1,NMD3 ribosome export adaptor [Source:HGNC Symbol;Acc:HGNC:24250],NA,NMD3,51068,NM_001320227;NM_015938
NXPH3_SIG,NXPH3,NXPH3_SIG,NXPH3,SIG,62,1.31433123961329,-0.0506541244884561,-0.05387957000922,-0.0400562320630889,0.0138233379461312,0.240712357861974,1.18885460762727,0.31700738669739,0.300695813067604,0.370602557195258,0.069906744127654,0.341967136907589,ENSG00000182575,NXPH3,protein_coding,17,1,49575858,49583827,q21.33,neurexophilin 3 [Source:HGNC Symbol;Acc:HGNC:8077],NA,NXPH3,11248,NM_007225
ZNF324_TF,ZNF324,ZNF324_TF,ZNF324,TF,18,1.31389204016067,0.122705328000913,0.121651734620062,0.126167134823709,0.00451540020364697,0.240863756394714,1.18814592570243,3.38176291523273,3.37023403046592,3.4196435366094,0.0494095061434837,0.342242931278974,ENSG00000083812,ZNF324,protein_coding,19,1,58467045,58475436,q13.43,zinc finger protein 324 [Source:HGNC Symbol;Acc:HGNC:14096],NA,ZNF324,25799,NM_014347
DR1_TF,DR1,DR1_TF,DR1,TF,66,-1.3137079314743,0.216776833591059,0.217797471887976,0.21342330775833,-0.00437416412964613,0.240905705150667,0.253890941987023,6.92895354773535,6.92658591049006,6.93673292725559,0.0101470167655231,0.855349643297566,ENSG00000117505,DR1,protein_coding,1,1,93345907,93369493,p22.1,down-regulator of transcription 1 [Source:HGNC Symbol;Acc:HGNC:3017],NA,DR1,1810,NM_001938
RPL13_SIG,RPL13,RPL13_SIG,RPL13,SIG,20,1.31330301717793,2.08290514965593,2.07571085664572,2.10654354097516,0.030832684329437,0.241042459433659,2.46466713753837,9.81623504046503,9.77625074415772,9.94761201404621,0.171361269888495,0.0381304460240978,ENSG00000167526,RPL13,protein_coding,16,1,89560657,89566828,q24.3,ribosomal protein L13 [Source:HGNC Symbol;Acc:HGNC:10303],NA,RPL13,6137,NM_000977;NM_001243130;NM_001243131;NM_033251
ZNF396_TF,ZNF396,ZNF396_TF,ZNF396,TF,72,1.31282977416402,0.150406302135764,0.148961727310679,0.155152762275332,0.00619103496465327,0.241208616573792,2.18672154071863,0.913336675327552,0.888540149351346,0.994810974963657,0.106270825612311,0.0681514260906591,ENSG00000186496,ZNF396,protein_coding,18,-1,35366694,35377337,q12.2,zinc finger protein 396 [Source:HGNC Symbol;Acc:HGNC:18824],NA,ZNF396,252884,NM_001322286;NM_001322290;NM_001322291;NM_145756
MPND_SIG,MPND,MPND_SIG,MPND,SIG,11,-1.31194090419892,0.0682271331471914,0.0699327207154265,0.0626230597087045,-0.00730966100672181,0.241553533134983,-1.05989591789896,4.04619182461168,4.06606431902011,3.98089648584113,-0.0851678331789838,0.401305014891946,ENSG00000008382,MPND,protein_coding,19,1,4343527,4360086,p13.3,MPN domain containing [Source:HGNC Symbol;Acc:HGNC:25934],NA,MPND,84954,NM_001159846;NM_001300862;NM_032868
SAMD4B_SIG,SAMD4B,SAMD4B_SIG,SAMD4B,SIG,25,1.31172717686106,0.259552430816609,0.257888270922545,0.265020384754251,0.00713211383170647,0.241599262988043,-0.4838119702582,6.26863655595148,6.27340009528184,6.25298492672315,-0.0204151685586922,0.718860877996173,ENSG00000179134,SAMD4B,protein_coding,19,1,39342396,39385710,q13.2,sterile alpha motif domain containing 4B [Source:HGNC Symbol;Acc:HGNC:25492],NA,SAMD4B,55095,NM_001303614;NM_018028
PHF11_SIG,PHF11,PHF11_SIG,PHF11,SIG,44,-1.3116617747003,0.235238207974286,0.237450493703492,0.227969269149752,-0.0094812245537399,0.241599262988043,0.73622016576891,5.58438449360514,5.57533779828625,5.61410934965294,0.0387715513666977,0.571261276563113,ENSG00000136147,PHF11,protein_coding,13,1,49495610,49528981,q14.2,PHD finger protein 11 [Source:HGNC Symbol;Acc:HGNC:17024],NA,PHF11,51131,NM_001040443;NM_001040444
PAOX_SIG,PAOX,PAOX_SIG,PAOX,SIG,78,-1.31088862783113,0.00689267808542464,0.0086751850014798,0.00103586964695768,-0.00763931535452197,0.241894731723805,-0.402007281947869,1.4956002717619,1.50356102866873,1.46944349906803,-0.0341175296006909,0.767197180456238,ENSG00000148832,PAOX,protein_coding,10,1,133379261,133391694,q26.3,polyamine oxidase [Source:HGNC Symbol;Acc:HGNC:20837],NA,PAOX,196743,NM_152911;NM_207127;NM_207128
WNT11_SIG,WNT11,WNT11_SIG,WNT11,SIG,28,-1.310268296613,-0.0682846177392604,-0.0667863242479035,-0.0732075820680042,-0.00642125782010065,0.242124620830482,-0.707368610052625,0.859171707495314,0.874208594270421,0.809764793805679,-0.0644438004647409,0.587801594004367,ENSG00000085741,WNT11,protein_coding,11,-1,76186325,76210736,q13.5,Wnt family member 11 [Source:HGNC Symbol;Acc:HGNC:12776],NA,WNT11,7481,NM_004626
SLC44A3_SIG,SLC44A3,SLC44A3_SIG,SLC44A3,SIG,20,-1.30915129159095,-0.137570786507111,-0.135795149472908,-0.143405022476635,-0.00760987300372676,0.242568790031936,-0.582700364192527,0.342865695154149,0.351867714020772,0.313287633163814,-0.0385800808569584,0.661609173685745,ENSG00000143036,SLC44A3,protein_coding,1,1,94820342,94895246,p21.3,solute carrier family 44 member 3 [Source:HGNC Symbol;Acc:HGNC:28689],NA,SLC44A3,126969,NM_001114106;NM_001258340;NM_001258341;NM_001258342;NM_001258343;NM_001301079;NM_001350223;NM_152369
ACSL5_SIG,ACSL5,ACSL5_SIG,ACSL5,SIG,19,1.3089396868135,0.449297172386432,0.445152343954995,0.462915894375441,0.0177635504204461,0.24262277048174,0.542355592831272,5.9207590364968,5.91061294113672,5.95409620696564,0.0434832658289164,0.685032545715989,ENSG00000197142,ACSL5,protein_coding,10,1,112374018,112428380,q25.2,acyl-CoA synthetase long chain family member 5 [Source:HGNC Symbol;Acc:HGNC:16526],NA,ACSL5,51703,NM_016234;NM_203379;NM_203380
FBXO25_SIG,FBXO25,FBXO25_SIG,FBXO25,SIG,51,1.30866259954528,-0.00291374799010063,-0.00482832763974989,0.0033770137158898,0.00820534135563969,0.242705008790942,0.528047272566804,3.97145435491578,3.96103577943939,4.00568681719533,0.0446510377559397,0.693556806399058,ENSG00000147364,FBXO25,protein_coding,8,1,406428,477967,p23.3,F-box protein 25 [Source:HGNC Symbol;Acc:HGNC:13596],F-BOX ONLY PROTEIN 25,FBXO25,26260,NM_012173;NM_183420;NM_183421
CXXC1_TF,CXXC1,CXXC1_TF,CXXC1,TF,76,1.30856115160431,0.141720891367829,0.139323012985066,0.14959963462548,0.0102766216404149,0.242711483925321,1.0978550365794,6.38563875856486,6.37444980272678,6.42240247060426,0.0479526678774765,0.383340297326502,ENSG00000154832,CXXC1,protein_coding,18,-1,50282343,50288304,q21.1,CXXC finger protein 1 [Source:HGNC Symbol;Acc:HGNC:24343],NA,CXXC1,30827,NM_001101654;NM_014593
SIRT2_SIG,SIRT2,SIRT2_SIG,SIRT2,SIG,36,-1.30672103619713,0.111631547465989,0.113807783693481,0.10448105700423,-0.00932672668925001,0.243468878972414,-0.19288110691313,5.60118914353495,5.60334567954952,5.5941033823442,-0.00924229720532743,0.891517144320622,ENSG00000068903,SIRT2,protein_coding,19,-1,38878555,38899862,q13.2,sirtuin 2 [Source:HGNC Symbol;Acc:HGNC:10886],NA,SIRT2,22933,NM_001193286;NM_012237;NM_030593
SIRT6_SIG,SIRT6,SIRT6_SIG,SIRT6,SIG,11,-1.30632416125707,0.159504140724253,0.161076919482629,0.154336439089591,-0.00674048039303744,0.243603105517878,0.496809754833398,4.07209713224051,4.06777259917904,4.08630631229963,0.0185337131205826,0.711439241083029,ENSG00000077463,SIRT6,protein_coding,19,-1,4174109,4182566,p13.3,sirtuin 6 [Source:HGNC Symbol;Acc:HGNC:14934],NA,SIRT6,51548,NM_001193285;NM_001321058;NM_001321059;NM_001321060;NM_001321061;NM_001321062;NM_001321063;NM_001321064;NM_016539
RNF146_SIG,RNF146,RNF146_SIG,RNF146,SIG,25,1.30614231863257,0.268986184046043,0.264723309883121,0.282992770581359,0.018269460698238,0.243644348752766,1.6134693778038,4.55284624894288,4.52157297576795,4.65560128937479,0.134028313606835,0.186820834025781,ENSG00000118518,RNF146,protein_coding,6,1,127266610,127288567,q22.33,ring finger protein 146 [Source:HGNC Symbol;Acc:HGNC:21336],NA,RNF146,81847,NM_001242844;NM_001242845;NM_001242846;NM_001242847;NM_001242848;NM_001242849;NM_001242850;NM_001242851;NM_001242852;NM_030963
ZXDA_TF,ZXDA,ZXDA_TF,ZXDA,TF,26,1.3058584037746,0.423856372020457,0.421185025682739,0.432633652844388,0.0114486271616489,0.243729758741115,2.55016705446749,2.99877377882542,2.93992925441349,3.19212007332179,0.252190818908307,0.0316052668618547,ENSG00000198205,ZXDA,protein_coding,X,-1,57906708,57910820,p11.21,zinc finger X-linked duplicated A [Source:HGNC Symbol;Acc:HGNC:13198],NA,ZXDA,7789,NM_007156
CCL28_SIG,CCL28,CCL28_SIG,CCL28,SIG,11,-1.30485178037172,-0.0922827987320876,-0.0892872571617581,-0.10212529246317,-0.0128380353014122,0.244128098467082,-0.643579705880111,3.01513207083881,3.03514237245935,2.94938393694273,-0.0857584355166222,0.624862839443758,ENSG00000151882,CCL28,protein_coding,5,-1,43376645,43412391,p12,C-C motif chemokine ligand 28 [Source:HGNC Symbol;Acc:HGNC:17700],NA,CCL28,56477,NM_001301873;NM_001301874;NM_001301875;NM_148672
NFKBIB_SIG,NFKBIB,NFKBIB_SIG,NFKBIB,SIG,24,-1.30467952918868,0.344434462886209,0.349059407387262,0.329238216668464,-0.0198211907187984,0.244165238309193,1.03044638857199,4.70617099386994,4.69149426532198,4.75439453052755,0.062900265205573,0.415518277293294,ENSG00000104825,NFKBIB,protein_coding,19,1,38899700,38908893,q13.2,NFKB inhibitor beta [Source:HGNC Symbol;Acc:HGNC:7798],NA,NFKBIB,4793,NM_001243116;NM_002503
SLC9A5_SIG,SLC9A5,SLC9A5_SIG,SLC9A5,SIG,65,-1.30346487985001,-0.00988454919528064,-0.00848838892033974,-0.0144719329558007,-0.00598354403546108,0.244654293972253,-1.22980177354304,1.02581798480465,1.04376045259169,0.966864162075802,-0.0768962905158896,0.323853061598861,ENSG00000135740,SLC9A5,protein_coding,16,1,67237683,67272191,q22.1,solute carrier family 9 member A5 [Source:HGNC Symbol;Acc:HGNC:11078],NA,SLC9A5,6553,NM_001323971;NM_001323972;NM_001323973;NM_001323974;NM_001323975;NM_004594
FES_SIG,FES,FES_SIG,FES,SIG,31,-1.30327487565039,0.326736581733076,0.330183683086585,0.315410391571547,-0.0147732915150389,0.244699179024768,-0.838792630769568,7.31841071269158,7.33693180829131,7.25755568429246,-0.0793761239988475,0.514300825930654,ENSG00000182511,FES,protein_coding,15,1,90883695,90895776,q26.1,FES proto-oncogene, tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:3657],NA,FES,2242,NM_001143783;NM_001143784;NM_001143785;NM_002005
HOPX_TF,HOPX,HOPX_TF,HOPX,TF,203,1.30314563160546,0.0258940646727846,0.023045893237615,0.0352523422454848,0.0122064490078698,0.244717707563404,0.644414161425512,3.91609462689304,3.88260522850809,4.02613122158646,0.143525993078361,0.624376738118255,ENSG00000171476,HOPX,protein_coding,4,-1,56647988,56681899,q12,HOP homeobox [Source:HGNC Symbol;Acc:HGNC:24961],NA,HOPX,84525,NM_001145459;NM_001145460;NM_032495;NM_139211;NM_139212
SPSB2_SIG,SPSB2,SPSB2_SIG,SPSB2,SIG,10,1.3010117995227,0.133477105864086,0.12828433837852,0.150539056173803,0.0222547177952831,0.245583023311684,1.33126465445587,2.58730019089603,2.56307997929456,2.66688088615802,0.10380090686346,0.282514633830729,ENSG00000111671,SPSB2,protein_coding,12,-1,6870935,6889358,p13.31,splA/ryanodine receptor domain and SOCS box containing 2 [Source:HGNC Symbol;Acc:HGNC:29522],NA,SPSB2,84727,NM_001146316;NM_001319670;NM_032641
ELK1_SIG,ELK1,ELK1_SIG,ELK1,SIG,22,1.30098060081942,0.294235414603498,0.292147707370255,0.301095024084151,0.00894731671389518,0.245583023311684,2.15387933643708,5.49798779221128,5.47388577739105,5.57718012662061,0.10329434922956,0.0725768263650101,ENSG00000126767,ELK1,protein_coding,X,-1,47635521,47650604,p11.23,ELK1, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3321],NA,ELK1,2002,NM_001114123;NM_001257168;NM_005229
HIST1H1C_SIG,HIST1H1C,HIST1H1C_SIG,HIST1H1C,SIG,36,1.30061478724875,0.0240288748608719,0.0211137121113214,0.0336072667522521,0.0124935546409308,0.245704491802212,-0.00735290056150335,5.237509190579,5.237758772349,5.23668913619185,-0.00106963615714327,0.995877610031222,ENSG00000187837,HIST1H1C,protein_coding,6,-1,26055787,26056428,p22.2,histone cluster 1 H1 family member c [Source:HGNC Symbol;Acc:HGNC:4716],NA,HIST1H1C,3006,NM_005319
DNLZ_TF,DNLZ,DNLZ_TF,DNLZ,TF,48,-1.29999598660816,0.0206964080410631,0.0226582257253019,0.0142504356499929,-0.008407790075309,0.245936127867331,-1.51110390401718,0.260473261277594,0.267945100936552,0.235922930969589,-0.0320221699669625,0.218497939705597,ENSG00000213221,DNLZ,protein_coding,9,-1,136359480,136363744,q34.3,DNL-type zinc finger [Source:HGNC Symbol;Acc:HGNC:33879],NA,DNLZ,728489,NM_001080849
GALNT10_SIG,GALNT10,GALNT10_SIG,GALNT10,SIG,23,-1.29939800728545,0.237033029172674,0.237882730230855,0.234241154267222,-0.00364157596363303,0.246158838501693,-0.349355655394994,6.06299392738696,6.06881240097148,6.04387608560924,-0.024936315362244,0.798117100035725,ENSG00000164574,GALNT10,protein_coding,5,1,154190730,154420984,q33.2,polypeptide N-acetylgalactosaminyltransferase 10 [Source:HGNC Symbol;Acc:HGNC:19873],NA,GALNT10,55568,NM_198321
PIGQ_SIG,PIGQ,PIGQ_SIG,PIGQ,SIG,20,1.29914715240315,0.243714149284556,0.240780545732928,0.25335313238276,0.0125725866498311,0.246214832385028,0.533633410003062,5.02569136460288,5.01666616049148,5.05534560668319,0.0386794461917061,0.690044964019442,ENSG00000007541,PIGQ,protein_coding,16,1,566995,584136,p13.3,phosphatidylinositol glycan anchor biosynthesis class Q [Source:HGNC Symbol;Acc:HGNC:14135],Early infantile epileptic encephalopathy;SEVERE EARLY-ONSET EPILEPSY,PIGQ,9091,NM_004204;NM_148920
C1D_SIG,C1D,C1D_SIG,C1D,SIG,5,-1.29909625853471,0.456770379827748,0.459558032470357,0.44761094971632,-0.0119470827540365,0.246214832385028,-1.36671750566486,3.41419785061716,3.42940471768201,3.36423243026123,-0.0651722874207724,0.269254986152168,ENSG00000197223,C1D,protein_coding,2,-1,68041130,68110948,p14,C1D nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:29911],NA,C1D,10438,NM_001190263;NM_001190265;NM_006333;NM_173177
SIN3B_SIG,SIN3B,SIN3B_SIG,SIN3B,SIG,94,1.29853219497331,0.148918921037368,0.146839769118102,0.155750420200668,0.00891065108256535,0.246422916544995,2.66921494672243,5.64083599428833,5.60271900842765,5.76607751925913,0.163358510831484,0.0240349385482313,ENSG00000127511,SIN3B,protein_coding,19,1,16829400,16880353,p13.11,SIN3 transcription regulator family member B [Source:HGNC Symbol;Acc:HGNC:19354],NA,SIN3B,23309,NM_001297595;NM_001297597;NM_015260
MIER2_TF,MIER2,MIER2_TF,MIER2,TF,71,1.297090783369,0.100198009389677,0.0983378284766739,0.106310032389546,0.00797220391287248,0.247014034820805,2.39710909640063,3.81895888751478,3.77956511749157,3.94839556044821,0.168830442956639,0.0441559413967548,ENSG00000105556,MIER2,protein_coding,19,-1,301444,344815,p13.3,MIER family member 2 [Source:HGNC Symbol;Acc:HGNC:29210],NA,MIER2,54531,NM_001346105;NM_017550
OAS1_SIG,OAS1,OAS1_SIG,OAS1,SIG,40,-1.29673842914714,0.36969755805871,0.374960106747944,0.352406326651228,-0.0225537800967159,0.247130079483482,-1.08710782786355,4.07932172254213,4.12482185355112,3.92982129208402,-0.195000561467106,0.388455012235743,ENSG00000089127,OAS1,protein_coding,12,1,112906783,112933222,q24.13,2'-5'-oligoadenylate synthetase 1 [Source:HGNC Symbol;Acc:HGNC:8086],Hereditary pulmonary alveolar proteinosis,OAS1,4938,NM_001032409;NM_001320151;NM_002534;NM_016816
C5_SIG,C5,C5_SIG,C5,SIG,25,1.29559912474751,-0.0053830707955583,-0.00826499193210519,0.0040860986530958,0.0123510905852009,0.247590202398449,2.11597929237323,4.04074033735659,3.98806461126764,4.21381772307743,0.225753111809795,0.0779696617293828,ENSG00000106804,C5,protein_coding,9,-1,120952335,121050276,q33.2,complement C5 [Source:HGNC Symbol;Acc:HGNC:1331],COMPLEMENT COMPONENT 5 DEFICIENCY;ECULIZUMAB POOR RESPONSE TO;Immunodeficiency due to a late component of complement deficiency,C5,727,NM_001317163;NM_001735
PIGX_SIG,PIGX,PIGX_SIG,PIGX,SIG,13,1.29497452987469,0.343221698846555,0.339570533532892,0.35521838487716,0.0156478513442675,0.247825558589554,2.6011546392087,4.45384530923849,4.41750159234492,4.57326037903165,0.155758786686724,0.0280921291110406,ENSG00000163964,PIGX,protein_coding,3,1,196639775,196736007,q29,phosphatidylinositol glycan anchor biosynthesis class X [Source:HGNC Symbol;Acc:HGNC:26046],NA,PIGX,54965,NM_001166304;NM_017861
ADAMTS7_SIG,ADAMTS7,ADAMTS7_SIG,ADAMTS7,SIG,60,1.29444568525691,-0.123961879547902,-0.125669061259984,-0.118352568208205,0.00731649305177892,0.248019129428792,-0.315857681603503,1.02041527330566,1.02981897428485,0.989517398659739,-0.0403015756251125,0.818291961076302,ENSG00000136378,ADAMTS7,protein_coding,15,-1,78759206,78811464,q25.1,ADAM metallopeptidase with thrombospondin type 1 motif 7 [Source:HGNC Symbol;Acc:HGNC:223],NA,ADAMTS7,11173,NM_014272
CYB561A3_SIG,CYB561A3,CYB561A3_SIG,CYB561A3,SIG,33,1.29322295887214,0.249425740862993,0.246910941702338,0.257688652390857,0.0107777106885192,0.248516968123673,0.239750276218441,5.63521057462061,5.63172139310826,5.64667502816117,0.0149536350529075,0.86419283675891,ENSG00000162144,CYB561A3,protein_coding,11,-1,61348745,61362299,q12.2,cytochrome b561 family member A3 [Source:HGNC Symbol;Acc:HGNC:23014],NA,CYB561A3,220002,NM_001161452;NM_001161454;NM_001300763;NM_153611
DDX11_SIG,DDX11,DDX11_SIG,DDX11,SIG,13,1.2918839370754,0.421847621893454,0.416580684076299,0.439153274721251,0.0225725906449519,0.249066580795491,1.39217269583491,5.21629467989373,5.18756433976075,5.31069436890211,0.12313002914136,0.259575617359527,ENSG00000013573,DDX11,protein_coding,12,1,31073860,31104799,p11.21,DEAD/H-box helicase 11 [Source:HGNC Symbol;Acc:HGNC:2736],WARSAW BREAKAGE SYNDROME,DDX11,1663,NM_001257144;NM_001257145;NM_004399;NM_030653;NM_152438
NPR3_SIG,NPR3,NPR3_SIG,NPR3,SIG,117,1.29144467634761,0.110046651108291,0.104920626781291,0.126889302468433,0.0219686756871421,0.249221431489608,1.43196221353036,4.86186395093661,4.76657110756031,5.17496900774446,0.408397900184152,0.244787278262743,ENSG00000113389,NPR3,protein_coding,5,1,32689070,32791724,p13.3,natriuretic peptide receptor 3 [Source:HGNC Symbol;Acc:HGNC:7945],NA,NPR3,4883,NM_000908;NM_001204375;NM_001204376;NM_001363652
SNRNP40_SIG,SNRNP40,SNRNP40_SIG,SNRNP40,SIG,35,1.28987775038034,0.445637981431373,0.443056811425701,0.454118968592867,0.0110621571671662,0.249872439483314,1.65180769513726,4.84346934906451,4.82075182258226,4.91811265036332,0.0973608277810588,0.176014561440683,ENSG00000060688,SNRNP40,protein_coding,1,-1,31259568,31296788,p35.2,small nuclear ribonucleoprotein U5 subunit 40 [Source:HGNC Symbol;Acc:HGNC:30857],NA,SNRNP40,9410,NM_004814
SLC2A5_SIG,SLC2A5,SLC2A5_SIG,SLC2A5,SIG,29,1.28947687477767,0.0315434996868884,0.0298057682767404,0.037253188605946,0.0074474203292056,0.250010713973494,0.669077889317376,5.35542594543239,5.32688682499468,5.44919734115629,0.122310516161609,0.609930588207169,ENSG00000142583,SLC2A5,protein_coding,1,-1,9035107,9088478,p36.23,solute carrier family 2 member 5 [Source:HGNC Symbol;Acc:HGNC:11010],NA,SLC2A5,6518,NM_001135585;NM_001328619;NM_001328620;NM_001328621;NM_003039
ZCCHC8_TF,ZCCHC8,ZCCHC8_TF,ZCCHC8,TF,49,-1.28911488541216,0.35406584844461,0.356668397741002,0.345514615042181,-0.0111537826988204,0.250131905650973,-0.124552445234004,5.46905134788966,5.47072203920439,5.46356193356982,-0.00716010563456487,0.930388304182494,ENSG00000033030,ZCCHC8,protein_coding,12,-1,122471600,122501073,q24.31,zinc finger CCHC-type containing 8 [Source:HGNC Symbol;Acc:HGNC:25265],Autosomal Recessive Mental Retardation,ZCCHC8,55596,NM_001350935;NM_001350936;NM_001350937;NM_001350938;NM_017612
ARHGEF28_SIG,ARHGEF28,ARHGEF28_SIG,ARHGEF28,SIG,29,-1.28748053670081,-0.149544398686945,-0.147915118399893,-0.154897748201545,-0.00698262980165164,0.25081430803788,1.22105837640918,0.542719211818867,0.52095462522086,0.614231424926604,0.0932767997057439,0.327665160721433,ENSG00000214944,ARHGEF28,protein_coding,5,1,73626158,73941993,q13.2,Rho guanine nucleotide exchange factor 28 [Source:HGNC Symbol;Acc:HGNC:30322],NA,ARHGEF28,64283,NM_001080479;NM_001177693;NM_001244364
APPL2_SIG,APPL2,APPL2_SIG,APPL2,SIG,61,1.28503039344065,0.102459295826435,0.0999055972596534,0.110850019688717,0.0109444224290639,0.251859012207056,0.813221155176799,5.13644396436693,5.12423693343345,5.17655278029122,0.0523158468577679,0.528029271395926,ENSG00000136044,APPL2,protein_coding,12,-1,105173297,105236203,q23.3,adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 [Source:HGNC Symbol;Acc:HGNC:18242],NA,APPL2,55198,NM_001251904;NM_001251905;NM_018171
SMIM13_TF,SMIM13,SMIM13_TF,SMIM13,TF,91,-1.28380861455235,0.163720945129589,0.164675738087396,0.160583768268223,-0.00409196981917214,0.252361769702269,-1.26847180235859,3.40489377504801,3.4223132930883,3.34765821577278,-0.0746550773155151,0.307849559578947,ENSG00000224531,SMIM13,protein_coding,6,1,11093834,11138733,p24.2,small integral membrane protein 13 [Source:HGNC Symbol;Acc:HGNC:27356],NA,SMIM13,221710,NM_001135575
RCHY1_SIG,RCHY1,RCHY1_SIG,RCHY1,SIG,33,1.28192790228649,0.2643311731048,0.263293947731201,0.26773919933234,0.00444525160113868,0.253157907640647,1.27864424502707,4.97908271897649,4.96388136144295,5.02903003658666,0.0651486751437103,0.303661044845295,ENSG00000163743,RCHY1,protein_coding,4,-1,75479037,75514764,q21.1,ring finger and CHY zinc finger domain containing 1 [Source:HGNC Symbol;Acc:HGNC:17479],NA,RCHY1,25898,NM_001009922;NM_001278536;NM_001278537;NM_001278538;NM_001278539;NM_015436
RPL36_SIG,RPL36,RPL36_SIG,RPL36,SIG,22,1.28173880660489,1.71261839859153,1.70663707743417,1.73227131096571,0.0256342335315413,0.253203235546497,2.93846958163548,8.24045222950635,8.19772905059956,8.38082838877151,0.183099338171957,0.0126095154724315,ENSG00000130255,RPL36,protein_coding,19,1,5674947,5691875,p13.3,ribosomal protein L36 [Source:HGNC Symbol;Acc:HGNC:13631],NA,RPL36,25873,NM_015414;NM_033643
ZNF484_TF,ZNF484,ZNF484_TF,ZNF484,TF,81,1.28026881802313,0.364969145174989,0.362601320657415,0.372749140018448,0.0101478193610334,0.253818325840372,2.16698171689268,3.25504096546765,3.2240821494928,3.35676278938504,0.132680639892245,0.0707122581695629,ENSG00000127081,ZNF484,protein_coding,9,-1,92844182,92878038,q22.31,zinc finger protein 484 [Source:HGNC Symbol;Acc:HGNC:23385],NA,ZNF484,83744,NM_001007101;NM_001261458;NM_001261459;NM_001261460;NM_001354536;NM_001354537;NM_031486
SMUG1_SIG,SMUG1,SMUG1_SIG,SMUG1,SIG,100,1.28009989218398,0.197106310381419,0.191209099653126,0.21648285991724,0.025273760264114,0.253832344320571,1.51562295814759,3.01978687741327,2.98961480520719,3.11892368609039,0.129308880883201,0.216946007428557,ENSG00000123415,SMUG1,protein_coding,12,-1,54121277,54189008,q13.13,single-strand-selective monofunctional uracil-DNA glycosylase 1 [Source:HGNC Symbol;Acc:HGNC:17148],NA,SMUG1,23583,NM_001243787;NM_001243788;NM_001243789;NM_001243790;NM_001243791;NM_001351237;NM_001351238;NM_001351239;NM_001351240;NM_001351241;NM_001351242;NM_001351243;NM_001351244;NM_001351245;NM_001351246;NM_001351247;NM_001351248;NM_001351249;NM_001351250;NM_001351251;NM_001351252;NM_001351253;NM_001351254;NM_001351255;NM_001351256;NM_001351257;NM_001351258;NM_001351260;NM_001351261;NM_001351262;NM_014311
ZNF763_TF,ZNF763,ZNF763_TF,ZNF763,TF,16,1.28000892705782,0.00459576038424005,0.00186372725302935,0.0135724406725038,0.0117087134194744,0.253832344320571,1.62900312494584,1.10495596502214,1.08549843037944,1.16888786456243,0.0833894341829958,0.182456446242951,ENSG00000197054,ZNF763,protein_coding,19,1,11965037,11980381,p13.2,zinc finger protein 763 [Source:HGNC Symbol;Acc:HGNC:27614],NA,ZNF763,284390,NM_001012753;NM_001367172;NM_001367173
UQCRQ_SIG,UQCRQ,UQCRQ_SIG,UQCRQ,SIG,27,1.27997595098046,0.299466717770959,0.297291935471009,0.306612431042225,0.00932049557121657,0.253832344320571,2.18496923581533,4.5116125367652,4.48091545682703,4.61247437084775,0.131558914020728,0.0683716170024265,ENSG00000164405,UQCRQ,protein_coding,5,1,132866630,132868847,q31.1,ubiquinol-cytochrome c reductase complex III subunit VII [Source:HGNC Symbol;Acc:HGNC:29594],Isolated complex III deficiency;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 4;Mitochondrial Respiratory Chain Complex III Deficiency UQCRQ Related,UQCRQ,27089,NM_014402
STK39_SIG,STK39,STK39_SIG,STK39,SIG,5,1.27958166928082,0.328845034575011,0.324913585583194,0.341762652690981,0.0168490671077865,0.253969101274332,1.04484674673441,3.91631340619563,3.89820509634784,3.97581213855264,0.0776070422048029,0.408697143423804,ENSG00000198648,STK39,protein_coding,2,-1,167954020,168247595,q24.3,serine/threonine kinase 39 [Source:HGNC Symbol;Acc:HGNC:17717],NA,STK39,27347,NM_013233
TEF_TF,TEF,TEF_TF,TEF,TF,158,-1.27940622000096,0.0978580978269364,0.0995177402227055,0.0924049870979807,-0.00711275312472485,0.254008439206504,0.713421989618425,2.16599833614619,2.15143453572887,2.21385082323169,0.0624162875028197,0.584046413619615,ENSG00000167074,TEF,protein_coding,22,1,41367333,41399326,q13.2,TEF, PAR bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:11722],NA,TEF,7008,NM_001145398;NM_003216
ERCC6_SIG,ERCC6,ERCC6_SIG,ERCC6,SIG,49,1.27849651695568,0.341054580302919,0.338188883585263,0.350470440946645,0.012281557361382,0.254374943376537,0.363351152722029,3.53636877355703,3.53048362807887,3.55570568012812,0.0252220520492479,0.789951984248206,ENSG00000225830,ERCC6,protein_coding,10,-1,49454470,49539538,q11.23,ERCC excision repair 6, chromatin remodeling factor [Source:HGNC Symbol;Acc:HGNC:3438],CEREBRO-OCULO-FACIO-SKELETAL SYNDROME TYPE 1;CEREBROOCULOFACIOSKELETAL SYNDROME 1;COCKAYNE SYNDROME B;Cockayne syndrome type 1;Cockayne syndrome type 2;Cockayne syndrome type 3;COCKAYNE SYNDROME TYPE B;COFS syndrome;De Sanctis-Cacchione syndrome;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED;MACULAR DEGENERATION AGE-RELATED 5;Premature ovarian failure 11;UV-sensitive syndrome;UV-SENSITIVE SYNDROME 1,ERCC6,2074;267004,NM_000124;NM_001277058;NM_001277059;NM_001346440;NM_170753
WSB1_SIG,WSB1,WSB1_SIG,WSB1,SIG,16,1.2779288157614,0.301656513343077,0.299554048683157,0.308564611511385,0.00901056282822813,0.254589229526259,0.95561537919037,7.24896328700017,7.23149634750581,7.3063546596245,0.0748583121186918,0.452665990098454,ENSG00000109046,WSB1,protein_coding,17,1,27294076,27315926,q11.1,WD repeat and SOCS box containing 1 [Source:HGNC Symbol;Acc:HGNC:19221],NA,WSB1,26118,NM_001348350;NM_015626;NM_134265
ZC3H18_TF,ZC3H18,ZC3H18_TF,ZC3H18,TF,90,1.27774530820292,0.210850623952253,0.209441499597467,0.215480603975119,0.00603910437765165,0.254632214531033,1.48930187055456,6.26851778245977,6.25191545850571,6.32306827545167,0.0711528169459657,0.225522848547572,ENSG00000158545,ZC3H18,protein_coding,16,1,88570381,88631966,q24.2,zinc finger CCCH-type containing 18 [Source:HGNC Symbol;Acc:HGNC:25091],NA,ZC3H18,124245,NM_001294340;NM_144604
PGRMC1_SIG,PGRMC1,PGRMC1_SIG,PGRMC1,SIG,12,1.27722816869273,0.116383437430057,0.115236288304817,0.120152641698701,0.00491635339388357,0.254824072774317,-0.549716756052886,5.13480898047531,5.14206532898011,5.11096669253096,-0.0310986364491468,0.680836506719499,ENSG00000101856,PGRMC1,protein_coding,X,1,119236245,119244466,q24,progesterone receptor membrane component 1 [Source:HGNC Symbol;Acc:HGNC:16090],NA,PGRMC1,10857,NM_001282621;NM_006667
ZBTB20_TF,ZBTB20,ZBTB20_TF,ZBTB20,TF,172,1.2767759499436,0.0502879152836253,0.0475993574423248,0.0591217481907553,0.0115223907484304,0.254987037435717,1.44601183894162,2.82832546224396,2.79555755418426,2.93599144586871,0.140433891684452,0.2400061654028,ENSG00000181722,ZBTB20,protein_coding,3,-1,114314501,115147271,q13.31,zinc finger and BTB domain containing 20 [Source:HGNC Symbol;Acc:HGNC:13503],Intellectual disability-cataracts-calcified pinnae-myopathy syndrome;Primrose syndrome,ZBTB20,26137,NM_001164342;NM_001164343;NM_001164344;NM_001164345;NM_001164346;NM_001164347;NM_001348800;NM_001348801;NM_001348802;NM_001348803;NM_001348804;NM_001348805;NM_015642
ARHGAP32_SIG,ARHGAP32,ARHGAP32_SIG,ARHGAP32,SIG,60,-1.27640542303775,-0.00352777232160779,-0.00105637893165343,-0.0116480648886007,-0.0105916859569472,0.255113581030573,-2.15739307136076,3.94317320892505,4.03905636127489,3.62812856548987,-0.410927795785025,0.072122474632703,ENSG00000134909,ARHGAP32,protein_coding,11,-1,128965060,129279324,q24.3,Rho GTPase activating protein 32 [Source:HGNC Symbol;Acc:HGNC:17399],NA,ARHGAP32,9743,NM_001142685;NM_014715
HSD17B10_SIG,HSD17B10,HSD17B10_SIG,HSD17B10,SIG,27,1.27614686479146,0.353225359039626,0.350449822305374,0.362344979737881,0.0118951574325073,0.255190143304999,2.48428116725419,4.86797468055299,4.83692306388342,4.97000142103872,0.133078357155293,0.0365451870145103,ENSG00000072506,HSD17B10,protein_coding,X,-1,53431258,53434373,p11.22,hydroxysteroid 17-beta dehydrogenase 10 [Source:HGNC Symbol;Acc:HGNC:4800],2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency;HSD10 disease atypical type;HSD10 disease infantile type;HSD10 disease neonatal type;HSD10 MITOCHONDRIAL DISEASE;MENTAL RETARDATION SYNDROMIC X-LINKED TYPE 10,HSD17B10,3028,NM_001037811;NM_004493
EDF1_SIG,EDF1,EDF1_SIG,EDF1,SIG,30,1.27487732001,0.256873126612032,0.255202894158238,0.262361033245925,0.00715813908768731,0.255718708451159,0.878022237992966,6.78956960537718,6.78240782963177,6.81310115425494,0.0306933246231732,0.493571824731688,ENSG00000107223,EDF1,protein_coding,9,-1,136862119,136866308,q34.3,endothelial differentiation related factor 1 [Source:HGNC Symbol;Acc:HGNC:3164],NA,EDF1,8721,NM_001281297;NM_001281298;NM_001281299;NM_003792;NM_153200
NME6_SIG,NME6,NME6_SIG,NME6,SIG,73,1.27379593892112,0.326534635325801,0.321072332208907,0.344482202709879,0.0234098705009719,0.256163740376557,2.0473298383813,3.41141709648689,3.36914805713069,3.55030108294301,0.181153025812319,0.0890117376503835,ENSG00000172113,NME6,protein_coding,3,-1,48290722,48301685,p21.31,NME/NM23 nucleoside diphosphate kinase 6 [Source:HGNC Symbol;Acc:HGNC:20567],NA,NME6,10201,NM_001308426;NM_001308427;NM_001308428;NM_001308430;NM_001308431;NM_001308433;NM_001308434;NM_001308435;NM_005793
GPR88_SIG,GPR88,GPR88_SIG,GPR88,SIG,20,-1.27330462095132,-0.103588140130785,-0.102260056970916,-0.107951841941784,-0.00569178497086841,0.256344782197138,-1.13343937227286,0.450133991885096,0.473112924463811,0.374631784840745,-0.0984811396230655,0.366609784838688,ENSG00000181656,GPR88,protein_coding,1,1,100538139,100542021,p21.2,G protein-coupled receptor 88 [Source:HGNC Symbol;Acc:HGNC:4539],Chorea childhood-onset with psychomotor retardation,GPR88,54112,NM_022049
RFPL4A_SIG,RFPL4A,RFPL4A_SIG,RFPL4A,SIG,2,-1.27208584248944,-0.147436655699903,-0.145431462451192,-0.154025147802814,-0.00859368535162222,0.256852205125129,0.833846327938132,0.437456790161963,0.417213087047799,0.503971814679933,0.086758727632135,0.51702270553215,ENSG00000223638,RFPL4A,protein_coding,19,1,55759014,55763175,q13.42,ret finger protein like 4A [Source:HGNC Symbol;Acc:HGNC:16449],NA,RFPL4A,342931,NM_001145014
TG_SIG,TG,TG_SIG,TG,SIG,22,-1.27171740635671,-0.138555705129937,-0.137262172068909,-0.142805885187601,-0.00554371311869205,0.256978400952551,-0.86896396540829,0.76901320690257,0.780597028882864,0.730952077538746,-0.0496449513441188,0.498412001590005,ENSG00000042832,TG,protein_coding,8,1,132866958,133134903,q24.22,thyroglobulin [Source:HGNC Symbol;Acc:HGNC:11764],AUTOIMMUNE THYROID DISEASE SUSCEPTIBILITY TO 3;Familial thyroid dyshormonogenesis;THYROID DYSHORMONOGENESIS 3,TG,7038,NM_003235
CHCHD1_SIG,CHCHD1,CHCHD1_SIG,CHCHD1,SIG,43,1.27133907870862,0.300693064252306,0.295939196398202,0.316312915772934,0.0203737193747324,0.257109077468204,2.72868724508674,3.22501745416505,3.18691263108896,3.35021901570076,0.163306384611798,0.0209172424742827,ENSG00000172586,CHCHD1,protein_coding,10,1,73782047,73783652,q22.2,coiled-coil-helix-coiled-coil-helix domain containing 1 [Source:HGNC Symbol;Acc:HGNC:23518],NA,CHCHD1,118487,NM_203298
GPX4_SIG,GPX4,GPX4_SIG,GPX4,SIG,31,1.27107123340906,0.130976648795485,0.129734172936663,0.135059069474468,0.00532489653780502,0.25719017184412,-0.276806900767287,6.74361934417814,6.74683429613127,6.73305593061785,-0.013778365513425,0.841631637933462,ENSG00000167468,GPX4,protein_coding,19,1,1103926,1106791,p13.3,glutathione peroxidase 4 [Source:HGNC Symbol;Acc:HGNC:4556],Spondylometaphyseal dysplasia Sedaghatian type,GPX4,2879,NM_001039847;NM_001039848;NM_001367832;NM_002085
RPS5_SIG,RPS5,RPS5_SIG,RPS5,SIG,41,1.27065327759088,1.31278689324287,1.30626115721046,1.33422859734937,0.0279674401389068,0.257338720145379,2.04054827836484,8.51480419975588,8.47838346305408,8.63447233463324,0.156088871579158,0.0901278218308288,ENSG00000083845,RPS5,protein_coding,19,1,58386400,58394806,q13.43,ribosomal protein S5 [Source:HGNC Symbol;Acc:HGNC:10426],NA,RPS5,6193,NM_001009
MST1R_SIG,MST1R,MST1R_SIG,MST1R,SIG,56,1.27027252322785,-0.0301375245484739,-0.0319535158335282,-0.0241706960404383,0.00778281979308987,0.257470602482757,-0.0668874309257286,0.748892710417125,0.750472777188248,0.743701062454866,-0.00677171473338256,0.963505344451272,ENSG00000164078,MST1R,protein_coding,3,-1,49887002,49903873,p21.31,macrophage stimulating 1 receptor [Source:HGNC Symbol;Acc:HGNC:7381],NASOPHARYNGEAL CARCINOMA SUSCEPTIBILITY TO 3,MST1R,4486,NM_001244937;NM_001318913;NM_002447
ZNF578_TF,ZNF578,ZNF578_TF,ZNF578,TF,24,-1.2700306714416,-0.0342806276365168,-0.0317593112847419,-0.0425649527923484,-0.0108056415076065,0.257540083105687,-0.96131329305038,0.770624640585233,0.788376378813625,0.712297500691945,-0.0760788781216806,0.450201886384288,ENSG00000258405,ZNF578,protein_coding,19,1,52453553,52516882,q13.41,zinc finger protein 578 [Source:HGNC Symbol;Acc:HGNC:26449],NA,ZNF578,147660,NM_001099694;NM_001366182
DARS2_SIG,DARS2,DARS2_SIG,DARS2,SIG,80,1.26939078456397,0.472458188198525,0.466378576282583,0.492434055922333,0.0260554796397503,0.257788571605973,0.807607948100991,4.19538953955246,4.17318825720546,4.2683366101212,0.0951483529157437,0.530941610001512,ENSG00000117593,DARS2,protein_coding,1,1,173824568,173858808,q25.1,aspartyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:25538],Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome;LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION,DARS2,55157,NM_001365212;NM_018122
NDOR1_SIG,NDOR1,NDOR1_SIG,NDOR1,SIG,15,1.26732309686067,0.201430200839133,0.20026166061447,0.205269690148739,0.00500802953426859,0.258680465956551,2.23091030332448,5.01377304151519,4.99103259550452,5.08849164983594,0.0974590543314156,0.0622602040910425,ENSG00000188566,NDOR1,protein_coding,9,1,137205685,137217009,q34.3,NADPH dependent diflavin oxidoreductase 1 [Source:HGNC Symbol;Acc:HGNC:29838],NA,NDOR1,27158,NM_001144026;NM_001144027;NM_001144028;NM_014434
OGG1_TF,OGG1,OGG1_TF,OGG1,TF,71,-1.26612359844153,0.16791729887124,0.170525977459986,0.159345926365358,-0.0111800510946278,0.259182292793184,-1.17691991432827,4.0944695412419,4.12096513005076,4.00741260658424,-0.113552523466514,0.347202910395788,ENSG00000114026,OGG1,protein_coding,3,1,9749944,9788219,p25.3,8-oxoguanine DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:8125],Hereditary clear cell renal cell carcinoma;RENAL CELL CARCINOMA NONPAPILLARY,OGG1,4968,NM_001354648;NM_001354649;NM_001354650;NM_001354651;NM_001354652;NM_002542;NM_016819;NM_016820;NM_016821;NM_016826;NM_016827;NM_016828;NM_016829
PEF1_SIG,PEF1,PEF1_SIG,PEF1,SIG,14,-1.26593125248123,0.0335748573898699,0.034365626934579,0.0309766146001115,-0.00338901233446748,0.259229686915643,-1.42020755267347,5.37372573992535,5.38757929558066,5.32820691420075,-0.0593723813799106,0.249034836119724,ENSG00000162517,PEF1,protein_coding,1,-1,31629866,31644896,p35.2,penta-EF-hand domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30009],NA,PEF1,553115,NM_001359651;NM_012392
ATG16L1_SIG,ATG16L1,ATG16L1_SIG,ATG16L1,SIG,35,-1.26545034334109,0.30950438724508,0.312609582167407,0.299301603928861,-0.0133079782385456,0.259407433522111,-0.893160606413842,5.17704470153908,5.18905339646651,5.13758756106323,-0.0514658354032802,0.48548365892154,ENSG00000085978,ATG16L1,protein_coding,2,1,233210051,233295674,q37.1,autophagy related 16 like 1 [Source:HGNC Symbol;Acc:HGNC:21498],INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10,ATG16L1,55054,NM_001190266;NM_001190267;NM_001363742;NM_017974;NM_030803;NM_198890
ALOX12B_SIG,ALOX12B,ALOX12B_SIG,ALOX12B,SIG,50,1.26456247551651,-0.0921023981964038,-0.094162320849669,-0.0853340809071038,0.00882823994256502,0.259769248796507,-0.371158813815701,0.284391526182746,0.287591853122198,0.273876166238833,-0.0137156868833658,0.785880365713216,ENSG00000179477,ALOX12B,protein_coding,17,-1,8072636,8087716,p13.1,arachidonate 12-lipoxygenase, 12R type [Source:HGNC Symbol;Acc:HGNC:430],Congenital nonbullous ichthyosiform erythroderma;ICHTHYOSIS CONGENITAL AUTOSOMAL RECESSIVE 2;Lamellar ichthyosis;Self-improving collodion baby,ALOX12B,242,NM_001139
USP39_SIG,USP39,USP39_SIG,USP39,SIG,31,1.2637627725348,0.34777401708559,0.346171760053178,0.35303857590637,0.0068668158531916,0.260091497658086,1.57939216419712,6.02797798338185,6.01492789588849,6.07085684228859,0.055928946400095,0.196760101978244,ENSG00000168883,USP39,protein_coding,2,1,85602856,85649283,p11.2,ubiquitin specific peptidase 39 [Source:HGNC Symbol;Acc:HGNC:20071],NA,USP39,10713,NM_001256725;NM_001256726;NM_001256727;NM_001256728;NM_006590
GPD1L_SIG,GPD1L,GPD1L_SIG,GPD1L,SIG,25,1.2634391102824,0.133941944283472,0.130813472945582,0.144221207250824,0.0134077343052426,0.260198430381306,0.930252080086612,4.34089385941208,4.32229879897132,4.40199191514601,0.0796931161746867,0.465577935908808,ENSG00000152642,GPD1L,protein_coding,3,1,32105689,32168713,p22.3,glycerol-3-phosphate dehydrogenase 1 like [Source:HGNC Symbol;Acc:HGNC:28956],Brugada syndrome;BRUGADA SYNDROME 2,GPD1L,23171,NM_015141
DZIP1_TF,DZIP1,DZIP1_TF,DZIP1,TF,161,-1.26303913804091,-0.102569921798921,-0.101612270367208,-0.105716490788836,-0.0041042204216273,0.260339949019321,-1.47894236684701,0.516378242116511,0.55463581818348,0.39067477789647,-0.16396104028701,0.228988265675214,ENSG00000134874,DZIP1,protein_coding,13,-1,95578202,95644703,q32.1,DAZ interacting zinc finger protein 1 [Source:HGNC Symbol;Acc:HGNC:20908],NA,DZIP1,22873,NM_014934;NM_198968
ZC3H12C_TF,ZC3H12C,ZC3H12C_TF,ZC3H12C,TF,214,1.26279011334307,0.0225863665552394,0.0200903887322521,0.0307874365450548,0.0106970478128028,0.260413135519166,2.23130554306912,3.86983878286886,3.7838255202664,4.15245378856269,0.368628268296292,0.0622165728120806,ENSG00000149289,ZC3H12C,protein_coding,11,1,110093392,110171841,q22.3,zinc finger CCCH-type containing 12C [Source:HGNC Symbol;Acc:HGNC:29362],NA,ZC3H12C,85463,NM_033390
ZDHHC6_TF,ZDHHC6,ZDHHC6_TF,ZDHHC6,TF,83,1.2620105311993,0.294805058908682,0.29082154932195,0.307893733265087,0.0170721839431364,0.260726779121205,1.30021281938666,5.25997216450908,5.24310320068589,5.31539875992814,0.0722955592422485,0.294974291335979,ENSG00000023041,ZDHHC6,protein_coding,10,-1,112424428,112446917,q25.2,zinc finger DHHC-type containing 6 [Source:HGNC Symbol;Acc:HGNC:19160],NA,ZDHHC6,64429,NM_001303134;NM_001351082;NM_001351083;NM_001351084;NM_001351085;NM_001351086;NM_022494
SREK1IP1_SIG,SREK1IP1,SREK1IP1_SIG,SREK1IP1,SIG,17,1.25908654303045,0.259944172273985,0.257962323972381,0.266455959550683,0.00849363557830142,0.262014950918246,-1.31799123851139,4.76041852996695,4.77663860063681,4.7071240120517,-0.0695145885851129,0.287832747716145,ENSG00000153006,SREK1IP1,protein_coding,5,-1,64718148,64768691,q12.3,SREK1 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:26716],NA,SREK1IP1,285672,NM_173829
CDK14_SIG,CDK14,CDK14_SIG,CDK14,SIG,68,1.25882129745518,0.106342197915731,0.104139772560688,0.113578738368016,0.00943896580732812,0.262095793569596,1.04634273310755,3.97290393686247,3.93936034573236,4.08311859343282,0.143758247700463,0.407915966524135,ENSG00000058091,CDK14,protein_coding,7,1,90466424,91210590,q21.13,cyclin dependent kinase 14 [Source:HGNC Symbol;Acc:HGNC:8883],NA,CDK14,5218,NM_001287135;NM_001287136;NM_001287137;NM_012395
GTDC1_SIG,GTDC1,GTDC1_SIG,GTDC1,SIG,45,1.25796541630641,-0.0157259154706223,-0.0181631560429277,-0.00771783930447617,0.0104453167384514,0.262445557894159,0.83986992967431,4.91650882896028,4.90481947488233,4.95491670664498,0.0500972317626456,0.51381496966999,ENSG00000121964,GTDC1,protein_coding,2,-1,143938068,144332568,q22.3,glycosyltransferase like domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20887],NA,GTDC1,79712,NM_001006636;NM_001164629;NM_001284233;NM_001284234;NM_001284235;NM_001284238;NM_001354350;NM_001354351;NM_001354352;NM_001354353;NM_001354354;NM_001354355;NM_001354356;NM_001354358;NM_001354360;NM_001354361;NM_001354362;NM_024659
COQ3_SIG,COQ3,COQ3_SIG,COQ3,SIG,22,1.25773210535381,0.208201579053919,0.204474167965511,0.220448786915833,0.0159746189503217,0.262511933826673,1.44255968265658,1.55978589219245,1.53831482891394,1.63033367153613,0.0920188426221856,0.241031351941463,ENSG00000132423,COQ3,protein_coding,6,-1,99369401,99394195,q16.2,coenzyme Q3, methyltransferase [Source:HGNC Symbol;Acc:HGNC:18175],NA,COQ3,51805,NM_017421
MIXL1_TF,MIXL1,MIXL1_TF,MIXL1,TF,230,-1.25740083569083,-0.0874278076113738,-0.0860175156772606,-0.0920616239663175,-0.00604410828905675,0.262622951587986,2.25246621559858,0.421870427590864,0.390844791261129,0.523811804102853,0.132967012841724,0.059659668035579,ENSG00000185155,MIXL1,protein_coding,1,1,226223618,226227054,q42.12,Mix paired-like homeobox [Source:HGNC Symbol;Acc:HGNC:13363],NA,MIXL1,83881,NM_001282402;NM_031944
RPL37A_SIG,RPL37A,RPL37A_SIG,RPL37A,SIG,76,1.25688444029326,0.48500785132188,0.480571536077889,0.499584315694996,0.019012779617107,0.262812623349477,2.32894575633416,9.40632756969747,9.37112802956793,9.52198320155164,0.150855171983709,0.0509133586892436,ENSG00000197756,RPL37A,protein_coding,2,1,216498189,216579180,q35,ribosomal protein L37a [Source:HGNC Symbol;Acc:HGNC:10348],NA,RPL37A,6168,NM_000998
ZBTB17_TF,ZBTB17,ZBTB17_TF,ZBTB17,TF,128,1.25680948343747,0.0172666405914994,0.0143169061508306,0.026958625182268,0.0126417190314374,0.262812623349477,0.368170820343015,5.62471107694627,5.62060657902101,5.63819728441498,0.0175907053939753,0.78746866737978,ENSG00000116809,ZBTB17,protein_coding,1,-1,15941869,15976132,p36.13,zinc finger and BTB domain containing 17 [Source:HGNC Symbol;Acc:HGNC:12936],NA,ZBTB17,7709,NM_001242884;NM_001287603;NM_001287604;NM_001324137;NM_001324138;NM_003443
ATP6V0C_SIG,ATP6V0C,ATP6V0C_SIG,ATP6V0C,SIG,56,-1.25629177678487,0.224465681649001,0.227697931196106,0.213845433137085,-0.0138524980590209,0.263008737184782,0.252882561892163,1.5550814111589,1.5506225194922,1.56973205520663,0.0191095357144345,0.855982657616687,ENSG00000185883,ATP6V0C,protein_coding,16,1,2513952,2520218,p13.3,ATPase H+ transporting V0 subunit c [Source:HGNC Symbol;Acc:HGNC:855],NA,ATP6V0C,527,NM_001198569;NM_001694
ZBTB10_TF,ZBTB10,ZBTB10_TF,ZBTB10,TF,92,1.25610485889008,0.320897854598806,0.317065534189114,0.333489764516366,0.0164242303272524,0.263054040225259,1.04167310283548,6.23229225390756,6.19895964536402,6.34181368197919,0.14285403661517,0.41010574804709,ENSG00000205189,ZBTB10,protein_coding,8,1,80485619,80526265,q21.13,zinc finger and BTB domain containing 10 [Source:HGNC Symbol;Acc:HGNC:30953],NA,ZBTB10,65986,NM_001105539;NM_001277145;NM_023929
COL9A2_SIG,COL9A2,COL9A2_SIG,COL9A2,SIG,38,1.25596301873259,-0.01654430426275,-0.0189193482287714,-0.00874058837439413,0.0101787598543771,0.263078788351501,0.808762840206948,4.67164605244588,4.64315736213831,4.76525174917075,0.122094387032432,0.530415867154225,ENSG00000049089,COL9A2,protein_coding,1,-1,40300489,40317813,p34.2,collagen type IX alpha 2 chain [Source:HGNC Symbol;Acc:HGNC:2218],Autosomal recessive Stickler syndrome;EPIPHYSEAL DYSPLASIA MULTIPLE 2;Multiple epiphyseal dysplasia due to collagen 9 anomaly;MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 2;Stickler syndrome type V,COL9A2,1298,NM_001852
DDX12P_SIG,DDX12P,DDX12P_SIG,DDX12P,SIG,23,1.25526355515251,0.260434080198122,0.256974528553841,0.2718011784579,0.0148266499040584,0.263357976108445,3.70786274390127,4.18205878728392,4.11237229553063,4.41102868875903,0.298656393228406,0.00143671226852867,ENSG00000214826,DDX12P,unprocessed_pseudogene,12,-1,9418673,9448229,p13.31,DEAD/H-box helicase 12, pseudogene [Source:HGNC Symbol;Acc:HGNC:2737],NA,DDX12P,NA,NA
TNK1_SIG,TNK1,TNK1_SIG,TNK1,SIG,47,-1.25468008450262,-0.113043284182535,-0.110553871469624,-0.121222783096386,-0.0106689116267622,0.263584380342454,-1.11105968797247,0.724337631601941,0.742566005662672,0.664444402545256,-0.0781216031174163,0.37725656553299,ENSG00000174292,TNK1,protein_coding,17,1,7380534,7389774,p13.1,tyrosine kinase non receptor 1 [Source:HGNC Symbol;Acc:HGNC:11940],NA,TNK1,8711,NM_001251902;NM_003985
LRRN2_SIG,LRRN2,LRRN2_SIG,LRRN2,SIG,51,-1.25402521407481,-0.0777618800933463,-0.0756542058489505,-0.0846870954677898,-0.00903288961883922,0.263843540316231,0.113861151715504,1.04429488579371,1.0405953544792,1.05645048868426,0.015855134205054,0.937028108958583,ENSG00000170382,LRRN2,protein_coding,1,-1,204617170,204685738,q32.1,leucine rich repeat neuronal 2 [Source:HGNC Symbol;Acc:HGNC:16914],NA,LRRN2,10446,NM_006338;NM_201630
AKR7A3_SIG,AKR7A3,AKR7A3_SIG,AKR7A3,SIG,45,1.25314147508283,-0.0133519985350031,-0.0152096749525243,-0.00724820459171921,0.00796147036080504,0.264207549116003,1.03506336182853,0.935369625620655,0.921423933336368,0.981191185983313,0.0597672526469452,0.413272749410257,ENSG00000162482,AKR7A3,protein_coding,1,-1,19282573,19288770,p36.13,aldo-keto reductase family 7 member A3 [Source:HGNC Symbol;Acc:HGNC:390],NA,AKR7A3,22977,NM_012067
RNGTT_SIG,RNGTT,RNGTT_SIG,RNGTT,SIG,16,1.25295025064864,0.359146087154857,0.355614305618796,0.370750512201915,0.0151362065831196,0.264254936519046,1.54902001498209,4.46761391842588,4.44371892165356,4.54612605067779,0.102407129024233,0.206149372675993,ENSG00000111880,RNGTT,protein_coding,6,-1,88609897,88963618,q15,RNA guanylyltransferase and 5'-phosphatase [Source:HGNC Symbol;Acc:HGNC:10073],NA,RNGTT,8732,NM_001286426;NM_001286428;NM_003800
ANKDD1A_SIG,ANKDD1A,ANKDD1A_SIG,ANKDD1A,SIG,14,-1.25261238926211,0.0498153765253115,0.0536873099937374,0.0370933094147693,-0.0165940005789682,0.264369428056006,-0.862032297145604,2.54294112078605,2.56596633800265,2.4672868356458,-0.0986795023568437,0.502057596725429,ENSG00000166839,ANKDD1A,protein_coding,15,1,64911902,64958691,q22.31,ankyrin repeat and death domain containing 1A [Source:HGNC Symbol;Acc:HGNC:28002],NA,ANKDD1A,348094,NM_182703
ACTR2_SIG,ACTR2,ACTR2_SIG,ACTR2,SIG,67,-1.25160058530221,0.433401190349033,0.436829827124508,0.422135669515327,-0.0146941576091808,0.264792572495772,-0.792484678524149,9.17196015586403,9.1846082614338,9.13040209470621,-0.0542061667275925,0.53915839797375,ENSG00000138071,ACTR2,protein_coding,2,1,65227753,65271253,p14,ARP2 actin related protein 2 homolog [Source:HGNC Symbol;Acc:HGNC:169],NA,ACTR2,10097,NM_001005386;NM_005722
LDB1_TF,LDB1,LDB1_TF,LDB1,TF,225,1.25108805277589,-0.0558643326416277,-0.0583250038052262,-0.047779270246947,0.0105457335582792,0.264987261445603,0.317959840603739,7.10889991560036,7.10433299044015,7.12390552684106,0.019572536400914,0.817023557316864,ENSG00000198728,LDB1,protein_coding,10,-1,102107560,102120453,q24.32,LIM domain binding 1 [Source:HGNC Symbol;Acc:HGNC:6532],NA,LDB1,8861,NM_001113407;NM_001321612;NM_003893
ZC3H7A_SIG,ZC3H7A,ZC3H7A_SIG,ZC3H7A,SIG,12,-1.24838322446799,0.326403977709448,0.328247370785784,0.320347114744345,-0.00790025604143895,0.266188757990256,-0.971355635367766,6.43090038112025,6.43992910862156,6.40123456218736,-0.0386945464342007,0.444835871056339,ENSG00000122299,ZC3H7A,protein_coding,16,-1,11750586,11797258,p13.13,zinc finger CCCH-type containing 7A [Source:HGNC Symbol;Acc:HGNC:30959],NA,ZC3H7A,29066,NM_014153
NLGN3_SIG,NLGN3,NLGN3_SIG,NLGN3,SIG,53,-1.24778406085949,-0.108847432325942,-0.105275763092931,-0.120582916948694,-0.0153071538557636,0.266423979763983,-0.856865081426096,2.18605214671737,2.20694152988528,2.1174156020228,-0.0895259278624808,0.504651709672743,ENSG00000196338,NLGN3,protein_coding,X,1,71144831,71171201,q13.1,neuroligin 3 [Source:HGNC Symbol;Acc:HGNC:14289],ASPERGER SYNDROME X-LINKED SUSCEPTIBILITY TO 1;Autism Spectrum Disorders;AUTISM SUSCEPTIBILITY TO X-LINKED 1,NLGN3,54413,NM_001166660;NM_001321276;NM_018977;NM_181303
SOCS6_SIG,SOCS6,SOCS6_SIG,SOCS6,SIG,34,1.24718299105031,0.316094727895095,0.312987399773756,0.32630452029378,0.0133171205200238,0.266660213886116,0.926052922998587,4.38169414357979,4.35949596267769,4.4546310236867,0.0951350610090111,0.467744727914267,ENSG00000170677,SOCS6,protein_coding,18,1,70289045,70330199,q22.2,suppressor of cytokine signaling 6 [Source:HGNC Symbol;Acc:HGNC:16833],NA,SOCS6,9306,NM_004232
SCGB3A1_SIG,SCGB3A1,SCGB3A1_SIG,SCGB3A1,SIG,19,1.24682081786546,-0.0681851036081474,-0.0697566925908299,-0.0630213112364765,0.00673538135435328,0.266786550023308,-0.598714112668573,0.464790664805686,0.474284917530186,0.433595262996616,-0.0406896545335694,0.65203084135768,ENSG00000161055,SCGB3A1,protein_coding,5,-1,180590105,180591499,q35.3,secretoglobin family 3A member 1 [Source:HGNC Symbol;Acc:HGNC:18384],NA,SCGB3A1,92304,NM_052863
USP6_SIG,USP6,USP6_SIG,USP6,SIG,5,1.24512156445577,0.0158675693506563,0.0140016939635023,0.0219983027655908,0.00799660880208849,0.26752937754468,-1.04077320289772,0.975862348573359,1.00994855793609,0.8638648035244,-0.146083754411685,0.41057962805665,ENSG00000129204,USP6,protein_coding,17,1,5116438,5175034,p13.2,ubiquitin specific peptidase 6 [Source:HGNC Symbol;Acc:HGNC:12629],Nodular fasciitis,USP6,9098,NM_001304284;NM_004505
CREB3L3_TF,CREB3L3,CREB3L3_TF,CREB3L3,TF,66,-1.2440191745702,-0.022563882197925,-0.02121683350594,-0.0269898993287329,-0.0057730658227929,0.267997789696134,-1.29192532835953,0.445783606287183,0.470523429800911,0.364495614742077,-0.106027815058834,0.298250893949436,ENSG00000060566,CREB3L3,protein_coding,19,1,4153631,4173054,p13.3,cAMP responsive element binding protein 3 like 3 [Source:HGNC Symbol;Acc:HGNC:18855],Hyperlipoproteinemia type 5,CREB3L3,84699,NM_001271995;NM_001271996;NM_001271997;NM_032607
NFAT5_SIG,NFAT5,NFAT5_SIG,NFAT5,SIG,32,1.24280218482843,0.207237951571437,0.204572314087392,0.2159964747333,0.0114241606459087,0.268519770930683,1.27884907447074,6.93557316065965,6.91294285723131,7.00992987192419,0.0969870146928811,0.303572131797722,ENSG00000102908,NFAT5,protein_coding,16,1,69565094,69704666,q22.1,nuclear factor of activated T cells 5 [Source:HGNC Symbol;Acc:HGNC:7774],NA,NFAT5,10725,NM_001113178;NM_001367709;NM_006599;NM_138713;NM_138714;NM_173214;NM_173215
GALNT12_SIG,GALNT12,GALNT12_SIG,GALNT12,SIG,68,1.24099514921338,-0.0832196681906899,-0.0848534403913236,-0.0778515595314651,0.0070018808598584,0.269315885467916,0.173351586178115,2.39351428989318,2.38900505023779,2.4083303630466,0.0193253128088077,0.902893856603651,ENSG00000119514,GALNT12,protein_coding,9,1,98807670,98850081,q22.33,polypeptide N-acetylgalactosaminyltransferase 12 [Source:HGNC Symbol;Acc:HGNC:19877],COLORECTAL CANCER SUSCEPTIBILITY TO 1,GALNT12,79695,NM_024642
STAT6_SIG,STAT6,STAT6_SIG,STAT6,SIG,104,1.23841794357054,0.277374140657428,0.274076331116903,0.288209800576295,0.0141334694593919,0.270471598922536,1.23107715261183,8.40529704632658,8.38285139393794,8.47904704703213,0.0961956530941936,0.323314112544126,ENSG00000166888,STAT6,protein_coding,12,-1,57095408,57132139,q13.3,signal transducer and activator of transcription 6 [Source:HGNC Symbol;Acc:HGNC:11368],Solitary fibrous tumor,STAT6,6778,NM_001178078;NM_001178079;NM_001178080;NM_001178081;NM_003153
CHAMP1_TF,CHAMP1,CHAMP1_TF,CHAMP1,TF,160,1.23805227027868,0.223004799179794,0.221567502792465,0.227727344452446,0.00615984165998176,0.270592483476072,1.75881885254938,5.30641496318063,5.28081618772386,5.39052522539574,0.109709037671871,0.14799483321122,ENSG00000198824,CHAMP1,protein_coding,13,1,114314482,114337626,q34,chromosome alignment maintaining phosphoprotein 1 [Source:HGNC Symbol;Acc:HGNC:20311],Autosomal dominant non-syndromic intellectual disability;Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 40,CHAMP1,283489,NM_001164144;NM_001164145;NM_032436
RBM42_SIG,RBM42,RBM42_SIG,RBM42,SIG,30,1.23798183967003,0.27996084879852,0.27882631227467,0.2836886116626,0.00486229938793007,0.270592483476072,0.535751920322509,5.6317390719526,5.62749280108577,5.64569110480076,0.0181983037149955,0.688832619566474,ENSG00000126254,RBM42,protein_coding,19,1,35629030,35637686,q13.12,RNA binding motif protein 42 [Source:HGNC Symbol;Acc:HGNC:28117],NA,RBM42,79171,NM_001319113;NM_024321
TPP1_SIG,TPP1,TPP1_SIG,TPP1,SIG,38,-1.23778395988581,0.486123876406316,0.489535604297006,0.474913913336907,-0.014621690960099,0.270643555996097,-1.12690211001406,9.15690523983108,9.17752724625003,9.08914721874026,-0.0883800275097624,0.369683715460095,ENSG00000166340,TPP1,protein_coding,11,-1,6612768,6619448,p15.4,tripeptidyl peptidase 1 [Source:HGNC Symbol;Acc:HGNC:2073],CEROID LIPOFUSCINOSIS NEURONAL 2;Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia;CLN2 disease;NEURONAL CEROID LIPOFUSCINOSIS TYPE 2;Spinocerebellar ataxia autosomal recessive 7,TPP1,1200,NM_000391
BIRC2_SIG,BIRC2,BIRC2_SIG,BIRC2,SIG,14,1.23668620228234,0.291235325607425,0.289983198638441,0.295349457076944,0.00536625843850314,0.2711134934905,1.12641526598803,6.29435933518222,6.28283145244842,6.33223666416471,0.0494052117162936,0.369930641076634,ENSG00000110330,BIRC2,protein_coding,11,1,102347211,102378670,q22.2,baculoviral IAP repeat containing 2 [Source:HGNC Symbol;Acc:HGNC:590],NA,BIRC2,329,NM_001166;NM_001256163;NM_001256166
SATB2_TF,SATB2,SATB2_TF,SATB2,TF,327,-1.23608584000992,0.0379083183301954,0.0403361333363503,0.0299312118814008,-0.0104049214549496,0.271352127587961,-0.260827997508433,1.4161133074442,1.42443416793743,1.38877333725216,-0.0356608306852752,0.851072932801199,ENSG00000119042,SATB2,protein_coding,2,-1,199269500,199471266,q33.1,SATB homeobox 2 [Source:HGNC Symbol;Acc:HGNC:21637],2q32q33 microdeletion syndrome;2q33.1 microdeletion syndrome;CLEFT PALATE ISOLATED;GLASS SYNDROME;Nonspecific severe ID;Syndromal Pierre Robin sequence,SATB2,23314,NM_001172509;NM_001172517;NM_015265
WTAP_SIG,WTAP,WTAP_SIG,WTAP,SIG,54,-1.23381603527357,0.276288538145178,0.281159582862724,0.260283676930383,-0.0208759059323407,0.272370111858791,-1.32606470693441,6.67472445325942,6.69468107843172,6.60915268483615,-0.0855283935955739,0.284643560907213,ENSG00000146457,WTAP,protein_coding,6,1,159725585,159756319,q25.3,WT1 associated protein [Source:HGNC Symbol;Acc:HGNC:16846],NA,WTAP,9589,NM_001270531;NM_001270532;NM_001270533;NM_004906;NM_152857;NM_152858
SLC5A5_SIG,SLC5A5,SLC5A5_SIG,SLC5A5,SIG,35,1.23278797953547,-0.087595941424754,-0.0890421093712792,-0.0828442467433138,0.00619786262796528,0.272809479222333,3.52904510762559,0.805608265853641,0.736938517353056,1.03123743949842,0.294298922145365,0.00247736708199029,ENSG00000105641,SLC5A5,protein_coding,19,1,17871945,17895174,p13.11,solute carrier family 5 member 5 [Source:HGNC Symbol;Acc:HGNC:11040],Familial thyroid dyshormonogenesis;THYROID DYSHORMONOGENESIS 1;Thyroid Hormonogenesis Defect I,SLC5A5,6528,NM_000453
SLC40A1_SIG,SLC40A1,SLC40A1_SIG,SLC40A1,SIG,77,1.23151534719717,-0.00373825092116464,-0.0061096763961883,0.00405357563962739,0.0101632520358156,0.273363869805134,1.61361194252226,5.65034994239751,5.57336720505432,5.90329322223938,0.32992601718506,0.186795279696903,ENSG00000138449,SLC40A1,protein_coding,2,-1,189560579,189583758,q32.2,solute carrier family 40 member 1 [Source:HGNC Symbol;Acc:HGNC:10909],Hemochromatosis type 4;HEMOCHROMATOSIS TYPE 4,SLC40A1,30061,NM_014585
RPS8_SIG,RPS8,RPS8_SIG,RPS8,SIG,25,1.2306331359806,1.59032436287219,1.58408059292229,1.61083960699332,0.0267590140710356,0.273735931620876,1.80673233448493,9.52229694527106,9.49464204078125,9.61316306002328,0.118521019242037,0.136613001505851,ENSG00000142937,RPS8,protein_coding,1,1,44775251,44778779,p34.1,ribosomal protein S8 [Source:HGNC Symbol;Acc:HGNC:10441],NA,RPS8,6202,NM_001012
EIF5AL1_SIG,EIF5AL1,EIF5AL1_SIG,EIF5AL1,SIG,25,1.2304857713695,0.509660146724465,0.507622237874686,0.51635613294517,0.0087338950704846,0.273763626593932,0.852496542471937,5.76572867258957,5.75447599661843,5.80270175078046,0.0482257541620311,0.506819777754294,ENSG00000253626,EIF5AL1,protein_coding,10,1,79512601,79516440,q22.3,eukaryotic translation initiation factor 5A-like 1 [Source:HGNC Symbol;Acc:HGNC:17419],NA,EIF5AL1,143244,NM_001099692
ATP2B1_SIG,ATP2B1,ATP2B1_SIG,ATP2B1,SIG,26,1.23033013325191,0.220989874074053,0.218764432025922,0.228302040803626,0.00953760877770367,0.273795205054999,1.57932219010894,6.90337586651258,6.86086749819895,7.04304621954308,0.182178721344128,0.196762740136273,ENSG00000070961,ATP2B1,protein_coding,12,-1,89588049,89709300,q21.33,ATPase plasma membrane Ca2+ transporting 1 [Source:HGNC Symbol;Acc:HGNC:814],NA,ATP2B1,490,NM_001001323;NM_001366520;NM_001366521;NM_001366522;NM_001366523;NM_001366526;NM_001366527;NM_001366530;NM_001682
RPLP1_SIG,RPLP1,RPLP1_SIG,RPLP1,SIG,31,1.2300162855795,0.431907614455824,0.428480538170765,0.443168007963876,0.0146874697931113,0.27390098085229,1.90313930486846,9.80799774718566,9.77814882411146,9.90607278014378,0.127923956032324,0.115680898410627,ENSG00000137818,RPLP1,protein_coding,15,1,69452814,69456205,q23,ribosomal protein lateral stalk subunit P1 [Source:HGNC Symbol;Acc:HGNC:10372],NA,RPLP1,6176,NM_001003;NM_213725
TYMS_SIG,TYMS,TYMS_SIG,TYMS,SIG,37,-1.22919766561752,0.508615026293032,0.518042787949772,0.477638095135173,-0.0404046928145982,0.274243648308879,-0.172581138397326,5.85837510381063,5.86414038722644,5.83943202973011,-0.0247083574963379,0.903285808127027,ENSG00000176890,TYMS,protein_coding,18,1,657653,673578,p11.32,thymidylate synthetase [Source:HGNC Symbol;Acc:HGNC:12441],5-@FLUOROURACIL TOXICITY,TYMS,7298,NM_001071;NM_001354867;NM_001354868
SCCPDH_SIG,SCCPDH,SCCPDH_SIG,SCCPDH,SIG,50,1.22910274273647,0.305887825883556,0.303144143979937,0.31490278070973,0.0117586367297927,0.274246755699228,1.51356232820525,6.05697255253523,6.02268320066548,6.16963756582153,0.14695436515605,0.217628585936981,ENSG00000143653,SCCPDH,protein_coding,1,1,246724409,246768137,q44,saccharopine dehydrogenase (putative) [Source:HGNC Symbol;Acc:HGNC:24275],NA,SCCPDH,51097,NM_016002
PPP1R10_SIG,PPP1R10,PPP1R10_SIG,PPP1R10,SIG,23,1.22863532741946,0.29654496962191,0.292127782837241,0.311058583342964,0.0189308005057231,0.274424743425268,1.25330484880414,5.44123839317316,5.40832137570737,5.54939430770363,0.141072931996268,0.314021506216895,ENSG00000204569,PPP1R10,protein_coding,6,-1,30600413,30618612,p21.33,protein phosphatase 1 regulatory subunit 10 [Source:HGNC Symbol;Acc:HGNC:9284],NA,PPP1R10,5514,NM_002714
FBXO3_SIG,FBXO3,FBXO3_SIG,FBXO3,SIG,51,-1.22644418777809,0.334993429739979,0.338103108689943,0.324775913190096,-0.013327195499847,0.275413434860312,-1.00470155683108,5.06288419247921,5.07814896656313,5.01272850620349,-0.0654204603596415,0.428215873710338,ENSG00000110429,FBXO3,protein_coding,11,-1,33740939,33774543,p13,F-box protein 3 [Source:HGNC Symbol;Acc:HGNC:13582],NA,FBXO3,26273,NM_012175;NM_033406
ZNF281_TF,ZNF281,ZNF281_TF,ZNF281,TF,98,-1.22563476594749,0.309728353667911,0.313648542084512,0.296847734584795,-0.0168008074997162,0.275753020024296,-0.753367542103387,6.03764045385528,6.05247977947069,5.98888266969038,-0.0635971097803081,0.561595647668048,ENSG00000162702,ZNF281,protein_coding,1,-1,200404940,200410056,q32.1,zinc finger protein 281 [Source:HGNC Symbol;Acc:HGNC:13075],NA,ZNF281,23528,NM_001281293;NM_001281294;NM_012482
CYP2E1_SIG,CYP2E1,CYP2E1_SIG,CYP2E1,SIG,54,1.22500391631867,-0.00203079154806009,-0.00377649738855242,0.00370509907070039,0.00748159645925283,0.276008680980828,1.53877623376548,1.49266057727514,1.4483035435615,1.63840511661995,0.190101573058446,0.209476891961404,ENSG00000130649,CYP2E1,protein_coding,10,1,133520406,133561220,q26.3,cytochrome P450 family 2 subfamily E member 1 [Source:HGNC Symbol;Acc:HGNC:2631],NA,CYP2E1,1571,NM_000773
KCNS1_SIG,KCNS1,KCNS1_SIG,KCNS1,SIG,5,1.22350605639638,-0.0696306569662959,-0.0716251246099775,-0.0630774061370562,0.00854771847292141,0.276673731636042,-1.54433537927918,0.216442628924144,0.234316077824752,0.157715582536432,-0.0766004952883202,0.207667367749509,ENSG00000124134,KCNS1,protein_coding,20,-1,45091214,45101127,q13.12,potassium voltage-gated channel modifier subfamily S member 1 [Source:HGNC Symbol;Acc:HGNC:6300],NA,KCNS1,3787,NM_001322799;NM_002251
SETX_SIG,SETX,SETX_SIG,SETX,SIG,56,-1.22325636582884,0.428963330050129,0.431126611616895,0.421855404902182,-0.00927120671471279,0.276749876015734,0.450563841080329,7.69963689881155,7.69430512914528,7.71715557057215,0.0228504414268774,0.738848571719399,ENSG00000107290,SETX,protein_coding,9,-1,132261356,132354986,q34.13,senataxin [Source:HGNC Symbol;Acc:HGNC:445],AMYOTROPHIC LATERAL SCLEROSIS 4 JUVENILE;Amyotrophic lateral sclerosis type 4;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 1;Spinocerebellar ataxia with axonal neuropathy type 2,SETX,23064,NM_001351527;NM_001351528;NM_015046
PANK4_SIG,PANK4,PANK4_SIG,PANK4,SIG,34,-1.22202303148215,0.243133326762001,0.246742899318155,0.231273302648923,-0.0154695966692322,0.27729099205278,-0.565183514519784,3.7884099936379,3.79797345037754,3.75698720720767,-0.0409862431698685,0.671761719447724,ENSG00000157881,PANK4,protein_coding,1,-1,2508531,2526628,p36.32,pantothenate kinase 4 [Source:HGNC Symbol;Acc:HGNC:19366],NA,PANK4,55229,NM_018216
RPL26_SIG,RPL26,RPL26_SIG,RPL26,SIG,29,1.22065649600487,0.576234247224224,0.571731397107626,0.591029326178759,0.0192979290711328,0.277860535847335,2.90707313869083,6.36553142834457,6.32031076988878,6.51411359184217,0.193802821953392,0.0136159085556508,ENSG00000161970,RPL26,protein_coding,17,-1,8377516,8383250,p13.1,ribosomal protein L26 [Source:HGNC Symbol;Acc:HGNC:10327],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 11,RPL26,6154,NM_000987;NM_001315530;NM_001315531
ZBTB14_TF,ZBTB14,ZBTB14_TF,ZBTB14,TF,105,1.22064264329018,0.2245036769933,0.22301157598527,0.229406294591114,0.00639471860584479,0.277860535847335,1.54404945629422,4.61446384105149,4.59465555240166,4.67954821804379,0.0848926656421308,0.20773848981457,ENSG00000198081,ZBTB14,protein_coding,18,-1,5289019,5297053,p11.31,zinc finger and BTB domain containing 14 [Source:HGNC Symbol;Acc:HGNC:12860],NA,ZBTB14,7541,NM_001143823;NM_001243702;NM_001243704;NM_003409
TPSD1_SIG,TPSD1,TPSD1_SIG,TPSD1,SIG,12,-1.22011979160308,-0.000896479443989298,0.00510688217341434,-0.0206218104726012,-0.0257286926460157,0.278066286842545,-0.852796675162276,2.37776052502085,2.42275346150517,2.22992659085809,-0.192826870647081,0.506680905903619,ENSG00000095917,TPSD1,protein_coding,16,1,1256059,1259008,p13.3,tryptase delta 1 [Source:HGNC Symbol;Acc:HGNC:14118],NA,TPSD1,23430,NM_012217
CHRM4_SIG,CHRM4,CHRM4_SIG,CHRM4,SIG,39,-1.21817179284947,0.290415231463506,0.29628810094332,0.271118660315546,-0.0251694406277746,0.278948370362128,-1.16512548573841,1.0304014967181,1.05018538912411,0.965397278812666,-0.0847881103114412,0.35262669810328,ENSG00000180720,CHRM4,protein_coding,11,-1,46385098,46386608,p11.2,cholinergic receptor muscarinic 4 [Source:HGNC Symbol;Acc:HGNC:1953],NA,CHRM4,1132,NM_000741
COMTD1_SIG,COMTD1,COMTD1_SIG,COMTD1,SIG,28,1.21741337691187,0.0382605606064984,0.0359949428960009,0.045704733083847,0.00970979018784603,0.279266585636213,1.65872399536872,2.31261476133161,2.28653244641857,2.39831379604589,0.111781349627323,0.174125737906616,ENSG00000165644,COMTD1,protein_coding,10,-1,75233969,75236030,q22.2,catechol-O-methyltransferase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:26309],NA,COMTD1,118881,NM_144589
RSRC1_SIG,RSRC1,RSRC1_SIG,RSRC1,SIG,9,1.21631443637954,0.647341428168879,0.643646591509692,0.659481605763352,0.0158350142536602,0.279747041572593,1.32285794358119,4.288675100026,4.26904818308823,4.35316354139295,0.0841153583047216,0.285935704863915,ENSG00000174891,RSRC1,protein_coding,3,1,158105855,158545730,q25.32,arginine and serine rich coiled-coil 1 [Source:HGNC Symbol;Acc:HGNC:24152],NA,RSRC1,51319,NM_001271834;NM_001271838;NM_016625
MFAP1_SIG,MFAP1,MFAP1_SIG,MFAP1,SIG,35,1.21479447755186,0.337771498827231,0.334555943658456,0.348336894381779,0.0137809507233234,0.28042868046133,1.55782896406491,4.123635324995,4.09064360590122,4.2320366877317,0.141393081830485,0.203181838406683,ENSG00000140259,MFAP1,protein_coding,15,-1,43804492,43824690,q15.3,microfibril associated protein 1 [Source:HGNC Symbol;Acc:HGNC:7032],NA,MFAP1,4236,NM_005926
YRDC_SIG,YRDC,YRDC_SIG,YRDC,SIG,37,-1.21414565561735,0.293741014919858,0.296301152691958,0.285329133668675,-0.0109720190232827,0.280695735487095,-1.71205787282086,4.59489840830185,4.62768246506964,4.48717936463625,-0.140503100433398,0.160172398201126,ENSG00000196449,YRDC,protein_coding,1,-1,37802945,37808208,p34.3,yrdC N6-threonylcarbamoyltransferase domain containing [Source:HGNC Symbol;Acc:HGNC:28905],NA,YRDC,79693,NM_024640
SLC2A1_SIG,SLC2A1,SLC2A1_SIG,SLC2A1,SIG,34,-1.21311802553927,0.141352729954196,0.144311281187282,0.13163177590263,-0.0126795052846516,0.281138502832137,0.014027907742136,5.52848787678794,5.52804015607341,5.52995895913571,0.00191880306230796,0.992240171009055,ENSG00000117394,SLC2A1,protein_coding,1,-1,42925375,42959176,p34.2,solute carrier family 2 member 1 [Source:HGNC Symbol;Acc:HGNC:11005],Childhood absence epilepsy;DYSTONIA 9;Encephalopathy due to GLUT1 deficiency;EPILEPSY IDIOPATHIC GENERALIZED SUSCEPTIBILITY TO 12;GLUT1 DEFICIENCY SYNDROME 1;GLUT1 DEFICIENCY SYNDROME 2;GLUT1 DEFICIENCY SYNDROME TYPE 1;GLUT1 DEFICIENCY SYNDROME TYPE 2;Hereditary cryohydrocytosis with reduced stomatin;Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity;Paroxysmal exertion-induced dyskinesia;STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS,SLC2A1,6513,NM_006516
EIF2S1_SIG,EIF2S1,EIF2S1_SIG,EIF2S1,SIG,80,1.21304032665765,0.551656453533981,0.547066978932358,0.566736155796456,0.0196691768640979,0.281138502832137,1.43160604913701,5.75747470958902,5.73127453367419,5.84356100188058,0.112286468206385,0.244865064534377,ENSG00000134001,EIF2S1,protein_coding,14,1,67360328,67386516,q23.3,eukaryotic translation initiation factor 2 subunit alpha [Source:HGNC Symbol;Acc:HGNC:3265],NA,EIF2S1,1965,NM_004094
P2RX4_SIG,P2RX4,P2RX4_SIG,P2RX4,SIG,42,-1.21132395863961,0.125685824408835,0.127595748270625,0.119410360291524,-0.00818538797910084,0.281916348359537,-2.20448588105018,5.57284103099475,5.61007281454169,5.45050802791197,-0.159564786629718,0.0658202464375627,ENSG00000135124,P2RX4,protein_coding,12,1,121209857,121234106,q24.31,purinergic receptor P2X 4 [Source:HGNC Symbol;Acc:HGNC:8535],NA,P2RX4,5025,NM_001256796;NM_001261397;NM_001261398;NM_002560
TRIM13_SIG,TRIM13,TRIM13_SIG,TRIM13,SIG,34,1.21039028569779,0.404979321324655,0.40183783402725,0.415301351016127,0.0134635169888766,0.282320698370879,1.47316414900271,4.64672636796724,4.6188697137077,4.73825537481998,0.119385661112281,0.23084200595365,ENSG00000204977,TRIM13,protein_coding,13,1,49995888,50020481,q14.2,tripartite motif containing 13 [Source:HGNC Symbol;Acc:HGNC:9976],NA,TRIM13,10206,NM_001007278;NM_005798;NM_052811;NM_213590
FTCD_SIG,FTCD,FTCD_SIG,FTCD,SIG,17,1.20968885491089,-0.0161664181933608,-0.0180855885225212,-0.00986057282611945,0.00822501569640187,0.282600439303099,0.929714311746317,0.429869370351348,0.418658570278618,0.466704856304604,0.0480462860259864,0.465803212093898,ENSG00000160282,FTCD,protein_coding,21,-1,46136262,46155579,q22.3,formimidoyltransferase cyclodeaminase [Source:HGNC Symbol;Acc:HGNC:3974],Formiminoglutamic aciduria;GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY,FTCD,10841,NM_001320412;NM_006657;NM_206965
PAFAH1B1_SIG,PAFAH1B1,PAFAH1B1_SIG,PAFAH1B1,SIG,36,1.20962856950069,0.410288837975812,0.407932903664353,0.418029764999174,0.0100968613348207,0.282600439303099,0.228901490998213,6.81721767945049,6.81398598374505,6.82783610819694,0.013850124451885,0.870722937065757,ENSG00000007168,PAFAH1B1,protein_coding,17,1,2593210,2685615,p13.3,platelet activating factor acetylhydrolase 1b regulatory subunit 1 [Source:HGNC Symbol;Acc:HGNC:8574],17p13.3 microduplication syndrome;LISSENCEPHALY 1;Lissencephaly due to LIS1 mutation;LISSENCEPHALY TYPE 1;Miller-Dieker syndrome;Subcortical band heterotopia,PAFAH1B1,5048,NM_000430
PSMD7_SIG,PSMD7,PSMD7_SIG,PSMD7,SIG,25,-1.20815936011392,0.17818325420278,0.179689700912355,0.173233500728464,-0.00645620018389037,0.283262051923664,-1.73520596935244,6.46657175844384,6.48239963692821,6.4145658719952,-0.0678337649330053,0.153904724105441,ENSG00000103035,PSMD7,protein_coding,16,1,74296814,74306288,q23.1,proteasome 26S subunit, non-ATPase 7 [Source:HGNC Symbol;Acc:HGNC:9565],NA,PSMD7,5713,NM_002811
IRF2_SIG,IRF2,IRF2_SIG,IRF2,SIG,108,-1.20807109079178,0.184558569474957,0.188796381511969,0.170634329924776,-0.0181620515871928,0.283262051923664,-0.788398886032741,5.15347684239507,5.17636996506844,5.07825658218255,-0.0981133828858844,0.541475801319512,ENSG00000168310,IRF2,protein_coding,4,-1,184387729,184474550,q35.1,interferon regulatory factor 2 [Source:HGNC Symbol;Acc:HGNC:6117],NA,IRF2,3660,NM_002199
MRPL20_SIG,MRPL20,MRPL20_SIG,MRPL20,SIG,17,1.20797383269489,0.38621379964552,0.382980405690238,0.396837808355734,0.0138574026654962,0.283266068413221,0.938153042169794,4.96187089090025,4.9514187520488,4.99621363284073,0.044794880791934,0.461814578957494,ENSG00000242485,MRPL20,protein_coding,1,-1,1401909,1407293,p36.33,mitochondrial ribosomal protein L20 [Source:HGNC Symbol;Acc:HGNC:14478],NA,MRPL20,55052,NM_001318485;NM_017971
UTY_SIG,UTY,UTY_SIG,UTY,SIG,23,-1.20783816054736,-0.218028031842977,-0.203829350990586,-0.264680840357975,-0.0608514893673894,0.283288523341323,-0.899892425280482,3.11715841710557,3.18045917696797,2.90917020612912,-0.271288970838856,0.481893030895138,ENSG00000183878,UTY,protein_coding,Y,-1,13248379,13480673,q11.221,ubiquitously transcribed tetratricopeptide repeat containing, Y-linked [Source:HGNC Symbol;Acc:HGNC:12638],NA,UTY,7404,NM_001258249;NM_001258250;NM_001258251;NM_001258252;NM_001258253;NM_001258254;NM_001258255;NM_001258256;NM_001258257;NM_001258258;NM_001258259;NM_001258260;NM_001258261;NM_001258262;NM_001258263;NM_001258264;NM_001258265;NM_001258266;NM_001258267;NM_001258268;NM_001258269;NM_001258270;NM_007125;NM_182659;NM_182660
AR_SIG,AR,AR_SIG,AR,SIG,65,-1.2069745483433,-0.0549861935572558,-0.0535587387975459,-0.0596764020534453,-0.00611766325589935,0.283660472961747,0.122398262913226,1.71691482172451,1.71082268278173,1.73693184967936,0.0261091668976362,0.931629468774358,ENSG00000169083,AR,protein_coding,X,1,67544032,67730619,q12,androgen receptor [Source:HGNC Symbol;Acc:HGNC:644],ANDROGEN INSENSITIVITY PARTIAL;ANDROGEN INSENSITIVITY SYNDROME;Complete androgen insensitivity syndrome;Familial hypospadias;HYPOSPADIAS 1 X-LINKED;Kennedy disease;Partial androgen insensitivity syndrome;Prostate Cancer;Spinal and Bulbar Muscular Atrophy;SPINAL AND BULBAR MUSCULAR ATROPHY X-LINKED 1,AR,367,NM_000044;NM_001011645;NM_001348061;NM_001348063;NM_001348064
CD34_SIG,CD34,CD34_SIG,CD34,SIG,142,-1.20672103968176,0.00861560842913482,0.0128618816369935,-0.00533643211097225,-0.0181983137479656,0.283739544380808,-1.20070775994577,6.05381312356643,6.15603881914719,5.71792869522963,-0.438110123917561,0.336673773763963,ENSG00000174059,CD34,protein_coding,1,-1,207880972,207911402,q32.2,CD34 molecule [Source:HGNC Symbol;Acc:HGNC:1662],NA,CD34,947,NM_001025109;NM_001773
SLC35B1_SIG,SLC35B1,SLC35B1_SIG,SLC35B1,SIG,27,-1.20646258718417,0.202422735872885,0.203892590837937,0.197593212416284,-0.00629937842165312,0.283762911566136,-0.0923987200984326,4.95254099472956,4.95357041460546,4.9491586151373,-0.00441179946816025,0.948476518716378,ENSG00000121073,SLC35B1,protein_coding,17,-1,49700934,49709014,q21.33,solute carrier family 35 member B1 [Source:HGNC Symbol;Acc:HGNC:20798],NA,SLC35B1,10237,NM_001278784;NM_005827
AMPD2_SIG,AMPD2,AMPD2_SIG,AMPD2,SIG,13,-1.20645185263523,0.196279617162085,0.198373743528338,0.189398916244394,-0.00897482728394403,0.283762911566136,-0.409127236146655,7.2578092891366,7.26412672837811,7.23705198877165,-0.0270747396064614,0.763260978260571,ENSG00000116337,AMPD2,protein_coding,1,1,109616104,109632051,p13.3,adenosine monophosphate deaminase 2 [Source:HGNC Symbol;Acc:HGNC:469],Autosomal recessive spastic paraplegia type 63;Pontocerebellar hypoplasia;Pontocerebellar hypoplasia type 9;PONTOCEREBELLAR HYPOPLASIA TYPE 9;Spastic paraplegia 63 autosomal recessive,AMPD2,271,NM_001257360;NM_001257361;NM_001308170;NM_004037;NM_139156;NM_203404
MTM1_SIG,MTM1,MTM1_SIG,MTM1,SIG,19,1.20640574219171,0.196360285918995,0.19463241779313,0.202037566903981,0.00740514911085053,0.283762911566136,-0.696256520707758,5.18665068980666,5.19480605386665,5.15985449360955,-0.0349515602571034,0.594290207354798,ENSG00000171100,MTM1,protein_coding,X,1,150568619,150673322,q28,myotubularin 1 [Source:HGNC Symbol;Acc:HGNC:7448],MYOPATHY CENTRONUCLEAR X-LINKED;MYOTUBULAR MYOPATHY X-LINKED;X-linked centronuclear myopathy;X-linked myotubular myopathy-abnormal genitalia syndrome,MTM1,4534,NM_000252
DDB2_SIG,DDB2,DDB2_SIG,DDB2,SIG,29,1.20546687461162,0.108156700380568,0.106323537857723,0.114179948669916,0.00785641081219255,0.284171410385241,2.55800432892161,5.10274734824792,5.05766587288168,5.25087219587985,0.193206322998167,0.0310094181684502,ENSG00000134574,DDB2,protein_coding,11,1,47214465,47239240,p11.2,damage specific DNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:2718],Xeroderma pigmentosum;XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP E;XERODERMA PIGMENTOSUM GROUP E DDB-NEGATIVE SUBTYPE,DDB2,1643,NM_000107;NM_001300734
IRAK3_SIG,IRAK3,IRAK3_SIG,IRAK3,SIG,39,-1.20534841320583,0.253692439273004,0.25638761906584,0.244836848525116,-0.0115507705407243,0.284185627028978,-0.381236069310625,7.8185938308892,7.82700805944101,7.79094707993327,-0.0360609795077424,0.779718404813492,ENSG00000090376,IRAK3,protein_coding,12,1,66188879,66254622,q14.3,interleukin 1 receptor associated kinase 3 [Source:HGNC Symbol;Acc:HGNC:17020],ASTHMA-RELATED TRAITS SUSCEPTIBILITY TO 5,IRAK3,11213,NM_001142523;NM_007199
DTX3L_SIG,DTX3L,DTX3L_SIG,DTX3L,SIG,33,-1.20466593259159,0.454619720875659,0.458591998035612,0.441567953064387,-0.0170240449712256,0.284471134443532,-0.539318408738978,6.13870284457343,6.14873172998246,6.10575079251518,-0.0429809374672841,0.686632119797294,ENSG00000163840,DTX3L,protein_coding,3,1,122564338,122575203,q21.1,deltex E3 ubiquitin ligase 3L [Source:HGNC Symbol;Acc:HGNC:30323],NA,DTX3L,151636,NM_138287
TLE1_SIG,TLE1,TLE1_SIG,TLE1,SIG,28,-1.20286545351154,-0.0328082343157695,-0.0307429571277739,-0.0395941450763267,-0.0088511879485527,0.285295477109974,-1.11650513507186,3.25733200959811,3.29620495939803,3.12960660311265,-0.166598356285379,0.374529597376943,ENSG00000196781,TLE1,protein_coding,9,-1,81583683,81689547,q21.32,TLE family member 1, transcriptional corepressor [Source:HGNC Symbol;Acc:HGNC:11837],NA,TLE1,7088,NM_001303103;NM_001303104;NM_005077
SLC27A2_SIG,SLC27A2,SLC27A2_SIG,SLC27A2,SIG,41,1.20139230611342,0.142585188195297,0.139753244139412,0.151890147236063,0.0121369030966513,0.285963350219678,-0.0973371120608224,3.76472059015267,3.76798717745575,3.75398751758541,-0.0139996598703397,0.945477715707723,ENSG00000140284,SLC27A2,protein_coding,15,1,50182196,50236385,q21.2,solute carrier family 27 member 2 [Source:HGNC Symbol;Acc:HGNC:10996],NA,SLC27A2,11001,NM_001159629;NM_003645
CASZ1_TF,CASZ1,CASZ1_TF,CASZ1,TF,59,1.20071904998383,0.0433884223208809,0.0415227511518236,0.0495184847334977,0.00799573358167429,0.286245569395741,0.976765388072945,4.10952106173096,4.08916715861887,4.17639817195639,0.0872310133375196,0.442320951058904,ENSG00000130940,CASZ1,protein_coding,1,-1,10636604,10796650,p36.22,castor zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:26002],NA,CASZ1,54897,NM_001079843;NM_017766
CDC26_SIG,CDC26,CDC26_SIG,CDC26,SIG,12,-1.20015798886472,0.144319969352199,0.146984486682917,0.135565126694123,-0.0114193599887941,0.286430704895169,-0.912051099941572,2.51283803529792,2.52491502604353,2.47315649427666,-0.0517585317668639,0.475595734357437,ENSG00000176386,CDC26,protein_coding,9,-1,113255835,113275572,q32,cell division cycle 26 [Source:HGNC Symbol;Acc:HGNC:17839],NA,CDC26,246184,NM_139286
MTHFD1_SIG,MTHFD1,MTHFD1_SIG,MTHFD1,SIG,48,1.20015792289457,0.575614889437369,0.570254590998295,0.593227298594325,0.0229727075960294,0.286430704895169,2.0972899982658,5.98493000955548,5.93710426334909,6.14207174709075,0.204967483741658,0.080758942055491,ENSG00000100714,MTHFD1,protein_coding,14,1,64388031,64463457,q23.3,methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 [Source:HGNC Symbol;Acc:HGNC:7432],Cervical spina bifida aperta;Cervical spina bifida cystica;Cervicothoracic spina bifida aperta;Cervicothoracic spina bifida cystica;COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUTHYPERHOMOCYSTEINEMIA;Lumbosacral spina bifida aperta;Lumbosacral spina bifida cystica;Neural tube defects folate-sensitive;Thoracolumbosacral spina bifida aperta;Thoracolumbosacral spina bifida cystica;Total spina bifida aperta;Total spina bifida cystica;Upper thoracic spina bifida aperta;Upper thoracic spina bifida cystica,MTHFD1,4522,NM_005956
SLC25A3_SIG,SLC25A3,SLC25A3_SIG,SLC25A3,SIG,40,1.1982977633153,0.48258836149757,0.479764615994757,0.491866382435384,0.0121017664406274,0.287271357961268,1.21900923090681,8.29649041560933,8.2816155735344,8.34536489671267,0.0637493231782624,0.328599006455128,ENSG00000075415,SLC25A3,protein_coding,12,1,98593591,98606379,q23.1,solute carrier family 25 member 3 [Source:HGNC Symbol;Acc:HGNC:10989],Cardiomyopathy-hypotonia-lactic acidosis syndrome;MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY,SLC25A3,5250,NM_002635;NM_005888;NM_213611
EFNA1_SIG,EFNA1,EFNA1_SIG,EFNA1,SIG,109,-1.19817443291954,-0.0250638335937595,-0.0218401191814249,-0.0356560380914301,-0.0138159189100052,0.287271357961268,-0.357937415202044,1.32792805846323,1.33820709475801,1.29415408206612,-0.0440530126918829,0.793037705870296,ENSG00000169242,EFNA1,protein_coding,1,1,155127876,155134899,q22,ephrin A1 [Source:HGNC Symbol;Acc:HGNC:3221],NA,EFNA1,1942,NM_004428;NM_182685
RBM48_SIG,RBM48,RBM48_SIG,RBM48,SIG,34,1.19815341715619,0.402492594084363,0.399777373156705,0.411414034275239,0.0116366611185333,0.287271357961268,1.65687235594219,4.10828415515236,4.08512301618056,4.18438504034542,0.0992620241648563,0.174607435338221,ENSG00000127993,RBM48,protein_coding,7,1,92528773,92540481,q21.2,RNA binding motif protein 48 [Source:HGNC Symbol;Acc:HGNC:21785],NA,RBM48,84060,NM_032120
DIAPH1_SIG,DIAPH1,DIAPH1_SIG,DIAPH1,SIG,29,-1.19786315579478,0.190027437182833,0.19222865635012,0.182794859918888,-0.00943379643123264,0.287368808765262,-1.86789791755774,8.5979927088239,8.62585471573311,8.50644611469365,-0.119408601039455,0.12301930510229,ENSG00000131504,DIAPH1,protein_coding,5,-1,141515016,141619055,q31.3,diaphanous related formin 1 [Source:HGNC Symbol;Acc:HGNC:2876],Deafness autosomal dominant 1;DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome;Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome;Seizures cortical blindness and microcephaly syndrome,DIAPH1,1729,NM_001079812;NM_001314007;NM_005219
PPP2R5B_SIG,PPP2R5B,PPP2R5B_SIG,PPP2R5B,SIG,23,-1.1977057498334,0.000522872014690503,0.0019854978661049,-0.00428289863995679,-0.00626839650606169,0.287401910509763,-0.467466382501424,3.89447327060699,3.90354912772018,3.86465259723506,-0.038896530485121,0.728714803523042,ENSG00000068971,PPP2R5B,protein_coding,11,1,64917553,64934475,q13.1,protein phosphatase 2 regulatory subunit B'beta [Source:HGNC Symbol;Acc:HGNC:9310],NA,PPP2R5B,5526,NM_006244
AGPS_SIG,AGPS,AGPS_SIG,AGPS,SIG,16,1.19722849736106,0.34652151189091,0.3447313843576,0.352403359500357,0.00767197514275647,0.2875900061922,0.703707522305468,6.54838002772478,6.53715373389339,6.58526642174221,0.0481126878488202,0.589865937260617,ENSG00000018510,AGPS,protein_coding,2,1,177392768,177559299,q31.2,alkylglycerone phosphate synthase [Source:HGNC Symbol;Acc:HGNC:327],Rhizomelic chondrodysplasia punctata type 3,AGPS,8540,NM_003659
PHF23_SIG,PHF23,PHF23_SIG,PHF23,SIG,31,1.19666394106335,0.0895213179655399,0.0855356282259455,0.10261715568135,0.0170815274554044,0.287820510906713,1.10583005775984,4.34988099468541,4.32623471639007,4.42757590908439,0.101341192694319,0.379651647161725,ENSG00000040633,PHF23,protein_coding,17,-1,7235029,7239722,p13.1,PHD finger protein 23 [Source:HGNC Symbol;Acc:HGNC:28428],NA,PHF23,79142,NM_001284517;NM_001284518;NM_024297
ZCCHC17_TF,ZCCHC17,ZCCHC17_TF,ZCCHC17,TF,110,1.19633803500913,0.255704779995283,0.252724852872319,0.265495969113594,0.0127711162412753,0.287935360260222,1.53525185380634,4.55986750551661,4.5413803719841,4.62061094426627,0.0792305722821773,0.210500018965387,ENSG00000121766,ZCCHC17,protein_coding,1,1,31296982,31364953,p35.2,zinc finger CCHC-type containing 17 [Source:HGNC Symbol;Acc:HGNC:30246],NA,ZCCHC17,51538,NM_001282566;NM_001282567;NM_001282568;NM_001282569;NM_001282570;NM_001282571;NM_001282572;NM_001282573;NM_001282574;NM_016505
SLC39A7_SIG,SLC39A7,SLC39A7_SIG,SLC39A7,SIG,23,1.19475892545058,0.241590766001102,0.240143345820792,0.246346575164976,0.00620322934418441,0.28864405798181,0.724957917365387,5.86840887074547,5.8613544389044,5.89158771822325,0.030233279318847,0.577149949266187,ENSG00000112473,SLC39A7,protein_coding,6,1,33200445,33204439,p21.32,solute carrier family 39 member 7 [Source:HGNC Symbol;Acc:HGNC:4927],NA,SLC39A7,7922,NM_001077516;NM_001288777;NM_006979
ILK_SIG,ILK,ILK_SIG,ILK,SIG,69,-1.19469989749741,0.352447125011621,0.356105823657076,0.340425686605125,-0.015680137051951,0.28864405798181,-1.01514609272288,6.45815384747405,6.47525425347555,6.40196679918342,-0.0732874542921272,0.422956782215225,ENSG00000166333,ILK,protein_coding,11,1,6603708,6610874,p15.4,integrin linked kinase [Source:HGNC Symbol;Acc:HGNC:6040],NA,ILK,3611,NM_001014794;NM_001014795;NM_001278441;NM_001278442;NM_004517
RNASEL_SIG,RNASEL,RNASEL_SIG,RNASEL,SIG,96,1.19444698533794,0.278147455264153,0.273025772504524,0.294975841474364,0.0219500689698404,0.28872363291792,0.774218218207778,4.12236263124058,4.0985920001085,4.20046613353171,0.10187413342321,0.54966352440747,ENSG00000135828,RNASEL,protein_coding,1,-1,182573634,182589256,q25.3,ribonuclease L [Source:HGNC Symbol;Acc:HGNC:10050],Familial prostate cancer;PROSTATE CANCER HEREDITARY 1,RNASEL,6041,NM_021133
CAPN14_SIG,CAPN14,CAPN14_SIG,CAPN14,SIG,52,1.19409748655492,0.0254173178519235,0.0224248367509688,0.0352497557550606,0.0128249190040919,0.288850164074315,1.26893652640896,0.94637304413689,0.922946819939717,1.02334492364189,0.100398103702168,0.307693953965625,ENSG00000214711,CAPN14,protein_coding,2,-1,31173056,31233858,p23.1,calpain 14 [Source:HGNC Symbol;Acc:HGNC:16664],NA,CAPN14,440854,NM_001145122;NM_001321270
ENTPD2_SIG,ENTPD2,ENTPD2_SIG,ENTPD2,SIG,11,1.19349767410633,-0.145927984164884,-0.147164428953441,-0.141865379859624,0.0052990490938177,0.289098443180695,0.264937100591727,0.280315833025371,0.276601586066618,0.292519787318415,0.015918201251797,0.848383722760228,ENSG00000054179,ENTPD2,protein_coding,9,-1,137048107,137054061,q34.3,ectonucleoside triphosphate diphosphohydrolase 2 [Source:HGNC Symbol;Acc:HGNC:3364],NA,ENTPD2,954,NM_001246;NM_203468
TXN_SIG,TXN,TXN_SIG,TXN,SIG,35,1.1925206819754,-0.0108872870189358,-0.0125377514552643,-0.00546433244242773,0.00707341901283664,0.289530432732016,1.03532064422536,6.16931680440352,6.15606025082596,6.21287405187266,0.0568138010467054,0.413157352644278,ENSG00000136810,TXN,protein_coding,9,-1,110243810,110256507,q31.3,thioredoxin [Source:HGNC Symbol;Acc:HGNC:12435],NA,TXN,7295,NM_001244938;NM_003329
GBGT1_SIG,GBGT1,GBGT1_SIG,GBGT1,SIG,5,1.19115138822844,0.131934954652707,0.12993418379037,0.138508916057528,0.00857473226715875,0.290154064379079,2.51798299521029,3.5271005773606,3.46226867534993,3.74011968396708,0.277851008617148,0.0339484861150584,ENSG00000148288,GBGT1,protein_coding,9,-1,133152948,133163933,q34.2,globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group) [Source:HGNC Symbol;Acc:HGNC:20460],NA,GBGT1,26301,NM_001282629;NM_001282632;NM_001288572;NM_001288573;NM_021996
BDNF_SIG,BDNF,BDNF_SIG,BDNF,SIG,17,-1.18954232934851,-0.118037238268625,-0.115087108404309,-0.127730522108518,-0.0126434137042084,0.290895682408645,-1.851948762784,0.314569414899033,0.343975533138183,0.217949312113254,-0.126026221024928,0.126444076904098,ENSG00000176697,BDNF,protein_coding,11,-1,27654893,27722058,p14.1,brain derived neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:1033],Ondine syndrome;WAGR syndrome,BDNF,627,NM_001143805;NM_001143806;NM_001143807;NM_001143808;NM_001143809;NM_001143810;NM_001143811;NM_001143812;NM_001143813;NM_001143814;NM_001143816;NM_001709;NM_170731;NM_170732;NM_170733;NM_170734;NM_170735
ZNF880_TF,ZNF880,ZNF880_TF,ZNF880,TF,16,1.18919269748676,-0.0271957953445232,-0.029995045898288,-0.0179982578107247,0.0119967880875632,0.291022853149286,2.1131835891975,3.08796816529064,3.04053093115233,3.24383336317365,0.203302432021318,0.0783706047684811,ENSG00000221923,ZNF880,protein_coding,19,1,52369917,52385795,q13.41,zinc finger protein 880 [Source:HGNC Symbol;Acc:HGNC:37249],NA,ZNF880,400713,NM_001145434
CTBP2_TF,CTBP2,CTBP2_TF,CTBP2,TF,72,1.18850736165531,0.291722855908948,0.28823650130067,0.30317802105043,0.0149415197497603,0.291314134648751,1.46504470335702,5.63037329243853,5.60091609445787,5.72716122866071,0.12624513420284,0.233715731710057,ENSG00000175029,CTBP2,protein_coding,10,-1,124984317,125161170,q26.13,C-terminal binding protein 2 [Source:HGNC Symbol;Acc:HGNC:2495],NA,CTBP2,1488,NM_001083914;NM_001290214;NM_001290215;NM_001321012;NM_001321013;NM_001321014;NM_001329;NM_022802
PIGH_SIG,PIGH,PIGH_SIG,PIGH,SIG,38,-1.18600448625785,0.165753424523489,0.168189203388694,0.157750151109245,-0.0104390522794482,0.292495665748744,-1.58527679888972,3.47712287662002,3.50274508217273,3.39293562980398,-0.109809452368752,0.194888607067971,ENSG00000100564,PIGH,protein_coding,14,-1,67581955,67600286,q24.1,phosphatidylinositol glycan anchor biosynthesis class H [Source:HGNC Symbol;Acc:HGNC:8964],GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17,PIGH,5283,NM_001363694;NM_004569
SLC6A9_SIG,SLC6A9,SLC6A9_SIG,SLC6A9,SIG,21,-1.18559869632827,-0.175370648019047,-0.167910141375187,-0.199883741277443,-0.031973599902256,0.292650797260369,0.623897840293134,1.47535053271508,1.45434642653428,1.54436402445199,0.090017597917705,0.636252530261139,ENSG00000196517,SLC6A9,protein_coding,1,-1,43991500,44031467,p34.1,solute carrier family 6 member 9 [Source:HGNC Symbol;Acc:HGNC:11056],Atypical glycine encephalopathy;Glycine Encephalopathy with Arthrogryposis;GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE;Infantile glycine encephalopathy,SLC6A9,6536,NM_001024845;NM_001261380;NM_001328626;NM_001328627;NM_001328628;NM_001328629;NM_001328630;NM_006934;NM_201649
EIF1AY_SIG,EIF1AY,EIF1AY_SIG,EIF1AY,SIG,27,-1.18523771672652,-0.0660347372785675,-0.0548231901665925,-0.102872677789343,-0.0480494876227502,0.292783337458198,-1.50593613085007,2.93847433261555,3.04224560759496,2.59751157196893,-0.444734035626027,0.219981949726725,ENSG00000198692,EIF1AY,protein_coding,Y,1,20575776,20593154,q11.223,eukaryotic translation initiation factor 1A Y-linked [Source:HGNC Symbol;Acc:HGNC:3252],NA,EIF1AY,9086,NM_001278612;NM_004681
HSD17B13_SIG,HSD17B13,HSD17B13_SIG,HSD17B13,SIG,10,1.18514966004069,0.0105546863258959,0.00883839640985097,0.0161939246214722,0.00735552821162113,0.292783337458198,1.29448286042545,1.20835732237531,1.1908088554213,1.26601657093848,0.0752077155171817,0.297258056822814,ENSG00000170509,HSD17B13,protein_coding,4,-1,87303789,87322886,q22.1,hydroxysteroid 17-beta dehydrogenase 13 [Source:HGNC Symbol;Acc:HGNC:18685],NA,HSD17B13,345275,NM_001136230;NM_178135
GPR171_SIG,GPR171,GPR171_SIG,GPR171,SIG,26,-1.18502830316115,0.0663496932367744,0.0693131397196914,0.0566126547929044,-0.0127004849267869,0.292799016992989,0.0541190393534825,0.971250904364932,0.970066793262988,0.975141555128462,0.00507476186547474,0.970066819032501,ENSG00000174946,GPR171,protein_coding,3,-1,151197832,151203201,q25.1,G protein-coupled receptor 171 [Source:HGNC Symbol;Acc:HGNC:30057],NA,GPR171,29909,NM_013308
CCL24_SIG,CCL24,CCL24_SIG,CCL24,SIG,34,-1.18450417169965,0.0201596599644381,0.0218736464774412,0.0145279899931425,-0.00734565648429883,0.293012311391587,0.119457221132351,0.500929618307498,0.498016263106208,0.510502071111736,0.0124858080055284,0.933654158626217,ENSG00000106178,CCL24,protein_coding,7,-1,75811665,75823356,q11.23,C-C motif chemokine ligand 24 [Source:HGNC Symbol;Acc:HGNC:10623],NA,CCL24,6369,NM_002991
KLHL8_SIG,KLHL8,KLHL8_SIG,KLHL8,SIG,40,-1.18415319371259,0.309072449129751,0.312924045424605,0.296417204160948,-0.0165068412636565,0.293140696703847,-0.108026491131039,4.55791075717843,4.56003979136536,4.55091535913564,-0.00912443222971948,0.94020735102547,ENSG00000145332,KLHL8,protein_coding,4,-1,87160103,87240314,q22.1,kelch like family member 8 [Source:HGNC Symbol;Acc:HGNC:18644],NA,KLHL8,57563,NM_001292003;NM_001292006;NM_001292007;NM_020803
RANBP1_SIG,RANBP1,RANBP1_SIG,RANBP1,SIG,46,1.18240874784855,0.612080494357868,0.60795566516616,0.625633504559196,0.0176778393930362,0.293953875686891,1.03843097621195,5.88132561648651,5.86395918451316,5.93838675011325,0.0744275656000905,0.411635073059874,ENSG00000099901,RANBP1,protein_coding,22,1,20115938,20127355,q11.21,RAN binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9847],NA,RANBP1,5902,NM_001278639;NM_001278640;NM_001278641;NM_002882
PRPF38B_SIG,PRPF38B,PRPF38B_SIG,PRPF38B,SIG,35,1.17889109942415,-0.0302195342365472,-0.0312940011187731,-0.0266891430520909,0.0046048580666821,0.295643247288305,0.335213952185952,6.91262981874098,6.90892361123014,6.92480735770516,0.0158837464750201,0.806737807569287,ENSG00000134186,PRPF38B,protein_coding,1,1,108692310,108702928,p13.3,pre-mRNA processing factor 38B [Source:HGNC Symbol;Acc:HGNC:25512],NA,PRPF38B,55119,NM_001349757;NM_001349758;NM_001349759;NM_001349761;NM_001349762;NM_001349763;NM_001349764;NM_001349765;NM_001349766;NM_001349767;NM_001349768;NM_001349769;NM_001349770;NM_001349771;NM_018061
PTP4A1_SIG,PTP4A1,PTP4A1_SIG,PTP4A1,SIG,39,-1.1787238083316,0.425572698033399,0.430350614974118,0.409873828085323,-0.0204767868887959,0.295681610876824,-0.385097104702636,8.09767319591824,8.10439392676264,8.07559079457236,-0.0288031321902746,0.777178910638904,ENSG00000112245,PTP4A1,protein_coding,6,1,63521746,63583377,q12,protein tyrosine phosphatase type IVA, member 1 [Source:HGNC Symbol;Acc:HGNC:9634],NA,PTP4A1,7803,NM_003463
SON_SIG,SON,SON_SIG,SON,SIG,21,1.17800881382656,0.528257916507671,0.526038134407,0.535551486267018,0.00951335186001725,0.29599054027718,1.72509796275065,9.09571107328751,9.07852056913073,9.15219415837407,0.073673589243345,0.156588296228495,ENSG00000159140,SON,protein_coding,21,1,33543038,33577514,q22.11,SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183],Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome;Intellectual Disability Congenital Malformations and Failure to Thrive;ZTTK SYNDROME,SON,6651,NM_001291411;NM_001291412;NM_032195;NM_138927
EIF3F_SIG,EIF3F,EIF3F_SIG,EIF3F,SIG,8,1.17752750642975,1.66215414823665,1.65769560757276,1.67680363898944,0.0191080314166802,0.296184133935643,1.58543138891465,7.21792259250232,7.20043462356853,7.27538306185621,0.0749484382876818,0.194870315684594,ENSG00000175390,EIF3F,protein_coding,11,1,7970251,8001862,p15.4,eukaryotic translation initiation factor 3 subunit F [Source:HGNC Symbol;Acc:HGNC:3275],NA,EIF3F,8665,NM_003754
SETD1A_SIG,SETD1A,SETD1A_SIG,SETD1A,SIG,50,1.17611747528811,0.247548787811828,0.244911036732461,0.256215684215464,0.0113046474830037,0.296837368619873,1.46417422922558,6.36270416989473,6.3423062387911,6.42972594352096,0.087419704729867,0.234003807262003,ENSG00000099381,SETD1A,protein_coding,16,1,30957754,30984664,p11.2,SET domain containing 1A, histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:29010],Intellectual disability,SETD1A,9739,NM_014712
RBM33_SIG,RBM33,RBM33_SIG,RBM33,SIG,40,1.17475252818429,0.541336077719422,0.538685723392646,0.550044384793116,0.0113586614004703,0.297466896074136,2.38681698365565,7.60151556418811,7.57453562798464,7.69016392599949,0.115628298014849,0.0450823159089538,ENSG00000184863,RBM33,protein_coding,7,1,155644451,155781485,q36.3,RNA binding motif protein 33 [Source:HGNC Symbol;Acc:HGNC:27223],NA,RBM33,155435,NM_053043
SHMT2_SIG,SHMT2,SHMT2_SIG,SHMT2,SIG,9,1.17466748361943,0.389546723102187,0.386731031634062,0.398798280783169,0.0120672491491068,0.297466896074136,0.404840861883093,6.22319227775988,6.216631024709,6.24475068064133,0.0281196559323291,0.765582190799402,ENSG00000182199,SHMT2,protein_coding,12,1,57229573,57234935,q13.3,serine hydroxymethyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:10852],NA,SHMT2,6472,NM_001166356;NM_001166357;NM_001166358;NM_001166359;NM_005412
CDC40_SIG,CDC40,CDC40_SIG,CDC40,SIG,23,-1.17250905010192,0.460351312711827,0.462030219589437,0.454834904399678,-0.00719531518975878,0.298493774455347,0.141467062968722,5.2532872571982,5.25162769805853,5.25874009437138,0.00711239631285048,0.920722293227331,ENSG00000168438,CDC40,protein_coding,6,1,110180141,110254275,q21,cell division cycle 40 [Source:HGNC Symbol;Acc:HGNC:17350],NA,CDC40,51362,NM_015891
PHF1_SIG,PHF1,PHF1_SIG,PHF1,SIG,53,-1.17189913993351,0.0707226493609667,0.0749820218359852,0.0567275683716204,-0.0182544534643646,0.298752335097365,-1.35982333472084,6.46858078613735,6.4945806110584,6.38315278996818,-0.111427821090219,0.271858070977024,ENSG00000112511,PHF1,protein_coding,6,1,33410399,33416453,p21.32,PHD finger protein 1 [Source:HGNC Symbol;Acc:HGNC:8919],NA,PHF1,5252,NM_002636;NM_024165
MMP28_SIG,MMP28,MMP28_SIG,MMP28,SIG,83,1.17107280187267,0.0466381115539344,0.0424289172210529,0.0604683215048307,0.0180394042837776,0.299118731676676,1.46837897622489,1.59595102787772,1.54429181800149,1.76568843175677,0.221396613755279,0.232481460722272,ENSG00000271447,MMP28,protein_coding,17,-1,35756249,35795707,q12,matrix metallopeptidase 28 [Source:HGNC Symbol;Acc:HGNC:14366],NA,MMP28,79148,NM_001032278;NM_024302;NM_032950
KDM5D_SIG,KDM5D,KDM5D_SIG,KDM5D,SIG,22,-1.17059218601936,-0.166556299288803,-0.151085601065767,-0.217388593450208,-0.0663029923844411,0.299313254396842,-1.00115499666049,4.09058083400202,4.18245064371694,3.78872288779586,-0.393727755921085,0.429884274157079,ENSG00000012817,KDM5D,protein_coding,Y,-1,19703865,19744939,q11.223,lysine demethylase 5D [Source:HGNC Symbol;Acc:HGNC:11115],SPERMATOGENIC FAILURE Y-LINKED 2,KDM5D,8284,NM_001146705;NM_001146706;NM_004653
RPL35A_SIG,RPL35A,RPL35A_SIG,RPL35A,SIG,23,1.17009780567583,1.67591633432551,1.67029415724558,1.69438920187386,0.0240950446282794,0.299514709515668,2.529919923387,8.82499971491685,8.78531817362306,8.95538192202504,0.170063748401983,0.0330972190062448,ENSG00000182899,RPL35A,protein_coding,3,1,197949980,197956610,q29,ribosomal protein L35a [Source:HGNC Symbol;Acc:HGNC:10345],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 5,RPL35A,6165,NM_000996;NM_001316311
CWC27_SIG,CWC27,CWC27_SIG,CWC27,SIG,19,1.16784432364637,0.522784439012355,0.519720584504128,0.532851389539388,0.01313080503526,0.300593718432939,1.26878228591338,4.80786339004183,4.79208810206845,4.85969647909723,0.0676083770287868,0.307721314835552,ENSG00000153015,CWC27,protein_coding,5,1,64768930,65018750,q12.3,CWC27 spliceosome associated protein homolog [Source:HGNC Symbol;Acc:HGNC:10664],Retinitis pigmentosa skeletal anomalies and intellectual disability;RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES,CWC27,10283,NM_001297644;NM_001297645;NM_001318000;NM_005869
ATP13A4_SIG,ATP13A4,ATP13A4_SIG,ATP13A4,SIG,10,-1.16743727859265,-0.0900226909136051,-0.0889916872273619,-0.0934102744541183,-0.00441858722675629,0.300694924480275,-1.4187037166479,0.702393373824384,0.724941413017834,0.628306959331623,-0.0966344536862113,0.249561362016347,ENSG00000127249,ATP13A4,protein_coding,3,-1,193398967,193593111,q29,ATPase 13A4 [Source:HGNC Symbol;Acc:HGNC:25422],NA,ATP13A4,84239,NM_032279
DHCR7_SIG,DHCR7,DHCR7_SIG,DHCR7,SIG,59,-1.16739279980806,0.0786638427140683,0.080908703212566,0.0712878725047189,-0.00962083070784708,0.300694924480275,-0.0146997293680616,4.64378359599004,4.64420087165051,4.64241254739133,-0.0017883242591862,0.991789489292078,ENSG00000172893,DHCR7,protein_coding,11,-1,71428193,71452868,q13.4,7-dehydrocholesterol reductase [Source:HGNC Symbol;Acc:HGNC:2860],SMITH-LEMLI-OPITZ SYNDROME,DHCR7,1717,NM_001163817;NM_001360
RRP7A_SIG,RRP7A,RRP7A_SIG,RRP7A,SIG,6,1.16737188900237,0.301916509432116,0.299749842986293,0.309035556325536,0.00928571333924377,0.300694924480275,0.32691193076313,5.28200880386654,5.27739354652879,5.29717322083342,0.0197796743046235,0.811977769987162,ENSG00000189306,RRP7A,protein_coding,22,-1,42508344,42519796,q13.2,ribosomal RNA processing 7 homolog A [Source:HGNC Symbol;Acc:HGNC:24286],NA,RRP7A,27341,NM_015703
CDC25A_SIG,CDC25A,CDC25A_SIG,CDC25A,SIG,28,-1.16682532317379,0.449098578973068,0.457596269248797,0.42117759663853,-0.0364186726102672,0.300923022970857,-0.923665155570764,3.47207794369223,3.49991740830083,3.38060541712114,-0.119311991179683,0.469031756644018,ENSG00000164045,CDC25A,protein_coding,3,-1,48157146,48188402,p21.31,cell division cycle 25A [Source:HGNC Symbol;Acc:HGNC:1725],NA,CDC25A,993,NM_001789;NM_201567
B3GNT3_SIG,B3GNT3,B3GNT3_SIG,B3GNT3,SIG,71,-1.16630954706087,-0.0569186069587795,-0.0549131860169728,-0.0635078471961441,-0.00859466117917135,0.3011358368943,-1.56895488853091,0.278287170895019,0.300162631843773,0.206410656349115,-0.0937519754946578,0.200009687813432,ENSG00000179913,B3GNT3,protein_coding,19,1,17794828,17813082,p13.11,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:13528],NA,B3GNT3,10331,NM_014256
OR52N4_SIG,OR52N4,OR52N4_SIG,OR52N4,SIG,35,1.16542991736123,0.0134916382791045,0.0115120245977828,0.0199960832320188,0.00848405863423618,0.30153073637812,0.824807823662717,0.420048582089772,0.411959027501765,0.446628547164654,0.0346695196628892,0.521765661365043,ENSG00000181074,OR52N4,protein_coding,11,1,5754243,5755905,p15.4,olfactory receptor family 52 subfamily N member 4 (gene/pseudogene) [Source:HGNC Symbol;Acc:HGNC:15230],NA,OR52N4,390072,NM_001005175
LTBP3_SIG,LTBP3,LTBP3_SIG,LTBP3,SIG,95,1.1651383012905,0.0449084902589326,0.0422289938505309,0.0537125498865384,0.0114835560360076,0.30163163437168,0.0371684720394441,5.7375743202962,5.73631892466397,5.74169919165925,0.00538026699528526,0.979764061755253,ENSG00000168056,LTBP3,protein_coding,11,-1,65538805,65558930,q13.1,latent transforming growth factor beta binding protein 3 [Source:HGNC Symbol;Acc:HGNC:6716],ACROMICRIC DYSPLASIA;Brachyolmia-amelogenesis imperfecta syndrome;DENTAL ANOMALIES AND SHORT STATURE;Geleophysic dysplasia;GELEOPHYSIC DYSPLASIA 3;Platyspondyly with amelogenesis imperfecta,LTBP3,4054,NM_001130144;NM_001164266;NM_021070
UBR1_SIG,UBR1,UBR1_SIG,UBR1,SIG,30,1.16412089472982,0.36905054128202,0.367494097347385,0.374164571352963,0.00667047400557817,0.302095950121428,-0.670311050092746,5.43760134392245,5.44634663020683,5.40886683184518,-0.0374797983616474,0.609237743366906,ENSG00000159459,UBR1,protein_coding,15,-1,42942897,43106113,q15.2,ubiquitin protein ligase E3 component n-recognin 1 [Source:HGNC Symbol;Acc:HGNC:16808],JOHANSON-BLIZZARD SYNDROME,UBR1,197131,NM_174916
IDH3B_SIG,IDH3B,IDH3B_SIG,IDH3B,SIG,16,1.1639344715145,0.386714002884321,0.385347111968087,0.391205215894804,0.0058581039267169,0.302144257818257,2.67851815555543,6.29973012074333,6.27882800946615,6.36840848636836,0.0895804769022127,0.0235630945829863,ENSG00000101365,IDH3B,protein_coding,20,-1,2658395,2664219,p13,isocitrate dehydrogenase 3 (NAD(+)) beta [Source:HGNC Symbol;Acc:HGNC:5385],Retinitis pigmentosa;RETINITIS PIGMENTOSA 46,IDH3B,3420,NM_001258384;NM_001330763;NM_006899;NM_174855
TRIM71_SIG,TRIM71,TRIM71_SIG,TRIM71,SIG,70,1.16344799294676,0.0811917889405291,0.0784695542528356,0.0901362743429508,0.0116667200901152,0.30234291712646,0.478807414600602,3.17955858111301,3.15522987397034,3.25949576172466,0.10426588775432,0.721807751907006,ENSG00000206557,TRIM71,protein_coding,3,1,32817997,32897824,p22.3,tripartite motif containing 71 [Source:HGNC Symbol;Acc:HGNC:32669],NA,TRIM71,131405,NM_001039111
GSTM5_SIG,GSTM5,GSTM5_SIG,GSTM5,SIG,15,-1.16328397732634,-0.12495583355003,-0.123315393904863,-0.130345849527006,-0.00703045562214228,0.302380016580053,0.39098581437123,1.15693443254852,1.14363499465621,1.20063258562326,0.0569975909670573,0.773770984335891,ENSG00000134201,GSTM5,protein_coding,1,1,109711780,109775428,p13.3,glutathione S-transferase mu 5 [Source:HGNC Symbol;Acc:HGNC:4637],NA,GSTM5,2949,NM_000851
REXO1_SIG,REXO1,REXO1_SIG,REXO1,SIG,35,-1.16290717918701,0.0851817938219906,0.088389094855335,0.0746435189981449,-0.0137455758571902,0.302523778172376,-1.092701131368,6.08969240397627,6.10242579941016,6.04785410469349,-0.0545716947166621,0.385723627140214,ENSG00000079313,REXO1,protein_coding,19,-1,1815248,1848483,p13.3,RNA exonuclease 1 homolog [Source:HGNC Symbol;Acc:HGNC:24616],NA,REXO1,57455,NM_020695
DDX21_SIG,DDX21,DDX21_SIG,DDX21,SIG,17,1.16238194605014,0.319595003407092,0.317343710843827,0.326992107543535,0.00964839669970858,0.302742020031104,0.284031905596624,7.81420759379106,7.81012284439849,7.82762891322376,0.0175060688252638,0.837363062379417,ENSG00000165732,DDX21,protein_coding,10,1,68956170,68985068,q22.1,DExD-box helicase 21 [Source:HGNC Symbol;Acc:HGNC:2744],NA,DDX21,9188,NM_001256910;NM_004728
RPF1_SIG,RPF1,RPF1_SIG,RPF1,SIG,30,1.16222527921203,0.439389367330439,0.437980167184777,0.44401959638047,0.00603942919569235,0.302775459420469,2.01686832276623,5.47141066627669,5.45002224711386,5.54168690066882,0.0916646535549583,0.0940973434875406,ENSG00000117133,RPF1,protein_coding,1,1,84479259,84498352,p22.3,ribosome production factor 1 homolog [Source:HGNC Symbol;Acc:HGNC:30350],NA,RPF1,80135,NM_025065
MANF_SIG,MANF,MANF_SIG,MANF,SIG,18,1.16192151847029,0.529165552534066,0.526095784782211,0.539251932290159,0.0131561475079479,0.30288268850456,2.9997324419337,5.31496514605745,5.25012847725971,5.52799991496431,0.277871437704599,0.0107671313978027,ENSG00000145050,MANF,protein_coding,3,1,51385047,51389397,p21.2,mesencephalic astrocyte derived neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:15461],NA,MANF,7873,NM_006010
SELPLG_SIG,SELPLG,SELPLG_SIG,SELPLG,SIG,74,-1.16120591338361,0.369580753693199,0.374113448488033,0.35468761365303,-0.0194258348350028,0.303196638293952,0.266936191376528,7.10665545319401,7.09756002079427,7.13654044536457,0.0389804245703056,0.84720558235677,ENSG00000110876,SELPLG,protein_coding,12,-1,108622277,108633959,q24.11,selectin P ligand [Source:HGNC Symbol;Acc:HGNC:10722],NA,SELPLG,6404,NM_001206609;NM_003006
RPL4_SIG,RPL4,RPL4_SIG,RPL4,SIG,38,1.15927804544417,1.9297846103513,1.92375478774799,1.94959688461931,0.0258420968713152,0.304120199601156,1.91122646705735,10.2394597347214,10.2131192348969,10.3260070912876,0.112887856390744,0.114051565900139,ENSG00000174444,RPL4,protein_coding,15,-1,66498015,66524532,q22.31,ribosomal protein L4 [Source:HGNC Symbol;Acc:HGNC:10353],NA,RPL4,6124,NM_000968
RNF130_SIG,RNF130,RNF130_SIG,RNF130,SIG,25,-1.1588814088238,0.143001547050379,0.144218873555071,0.139001759963533,-0.00521711359153774,0.304274435915311,-0.674742647975621,7.88432366402897,7.89390762615436,7.85283350275984,-0.0410741233945143,0.606397669068447,ENSG00000113269,RNF130,protein_coding,5,-1,179911651,180072113,q35.3,ring finger protein 130 [Source:HGNC Symbol;Acc:HGNC:18280],NA,RNF130,55819,NM_001280801;NM_018434
FADD_SIG,FADD,FADD_SIG,FADD,SIG,34,1.15778751050158,0.173207183296263,0.170482084877932,0.182161078099348,0.0116789932214162,0.304779838872577,0.949848250656701,3.83154920406334,3.81467760907882,3.88698444472676,0.0723068356479381,0.455766856592435,ENSG00000168040,FADD,protein_coding,11,1,70203163,70207390,q13.3,Fas associated via death domain [Source:HGNC Symbol;Acc:HGNC:3573],FADD-related immunodeficiency;INFECTIONS RECURRENT WITH ENCEPHALOPATHY HEPATIC DYSFUNCTION AND CARDIOVASCULAR MALFORMATIONS;Oculootodental syndrome,FADD,8772,NM_003824
HMGCR_SIG,HMGCR,HMGCR_SIG,HMGCR,SIG,14,1.15661501617496,0.278306405609607,0.276729301936966,0.283488317676855,0.00675901573988817,0.30532542982679,0.0179852486012351,5.49033232533419,5.4900351548142,5.49130874275703,0.00127358794282622,0.990072717896098,ENSG00000113161,HMGCR,protein_coding,5,1,75336329,75362101,q13.3,3-hydroxy-3-methylglutaryl-CoA reductase [Source:HGNC Symbol;Acc:HGNC:5006],NA,HMGCR,3156,NM_000859;NM_001130996;NM_001364187
C1GALT1C1_SIG,C1GALT1C1,C1GALT1C1_SIG,C1GALT1C1,SIG,58,1.15596179336384,0.400218155632897,0.395423975575868,0.415970461534562,0.0205464859586938,0.305609510740152,1.49787682328219,3.52754859391747,3.4927002897998,3.64205016458979,0.149349874789985,0.222572421799004,ENSG00000171155,C1GALT1C1,protein_coding,X,-1,120625674,120630054,q24,C1GALT1 specific chaperone 1 [Source:HGNC Symbol;Acc:HGNC:24338],TN POLYAGGLUTINATION SYNDROME,C1GALT1C1,29071,NM_001011551;NM_152692
RMND5B_SIG,RMND5B,RMND5B_SIG,RMND5B,SIG,46,-1.15517985513902,0.0464498664744349,0.0478910112703086,0.0417146764308499,-0.00617633483945887,0.305958761452632,0.65628280816549,4.09302807437269,4.07782563938726,4.14297893218196,0.0651532927947026,0.617011113208658,ENSG00000145916,RMND5B,protein_coding,5,1,178130996,178150568,q35.3,required for meiotic nuclear division 5 homolog B [Source:HGNC Symbol;Acc:HGNC:26181],NA,RMND5B,64777,NM_001288794;NM_001288795;NM_022762
IGFBP5_SIG,IGFBP5,IGFBP5_SIG,IGFBP5,SIG,14,-1.15491523696297,-0.28507394344016,-0.282846786829185,-0.292391743733362,-0.0095449569041769,0.306046862844069,0.103060077412328,0.771082362591875,0.767712326947089,0.782155336853313,0.0144430099062236,0.942852133068799,ENSG00000115461,IGFBP5,protein_coding,2,-1,216672105,216695549,q35,insulin like growth factor binding protein 5 [Source:HGNC Symbol;Acc:HGNC:5474],NA,IGFBP5,3488,NM_000599
RPS4Y1_SIG,RPS4Y1,RPS4Y1_SIG,RPS4Y1,SIG,13,-1.15469036042212,0.0634945090278715,0.0841008170170381,-0.00421193150796159,-0.0883127485249997,0.306114900701348,-0.801340864895229,4.4343870299348,4.51390927093943,4.17309966663387,-0.340809604305556,0.534402343344716,ENSG00000129824,RPS4Y1,protein_coding,Y,1,2841602,2932000,p11.2,ribosomal protein S4 Y-linked 1 [Source:HGNC Symbol;Acc:HGNC:10425],NA,RPS4Y1,6192,NM_001008
VPS8_SIG,VPS8,VPS8_SIG,VPS8,SIG,23,1.15406877551141,0.315341379748997,0.313741136961772,0.320599320335591,0.00685818337381892,0.306383435139147,1.20945739562383,5.83480033849108,5.81801181121755,5.88996264238983,0.0719508311722866,0.332840021787898,ENSG00000156931,VPS8,protein_coding,3,1,184812143,185052614,q27.2,VPS8, CORVET complex subunit [Source:HGNC Symbol;Acc:HGNC:29122],NA,VPS8,23355,NM_001009921;NM_001349292;NM_001349293;NM_001349294;NM_001349295;NM_001349296;NM_001349297;NM_001349298;NM_015303
GAA_SIG,GAA,GAA_SIG,GAA,SIG,33,-1.15244973203832,0.348020286667961,0.352487343136408,0.333342815414494,-0.0191445277219143,0.307156900064853,-0.279899163128063,6.44271612030948,6.45060529353236,6.41679455114861,-0.0338107423837561,0.839705496093293,ENSG00000171298,GAA,protein_coding,17,1,80101556,80119881,q25.3,glucosidase alpha, acid [Source:HGNC Symbol;Acc:HGNC:4065],Glycogen storage disease due to acid maltase deficiency infantile onset;Glycogen storage disease due to acid maltase deficiency late-onset;GLYCOGEN STORAGE DISEASE II;GLYCOGEN STORAGE DISEASE TYPE II,GAA,2548,NM_000152;NM_001079803;NM_001079804
DYRK3_SIG,DYRK3,DYRK3_SIG,DYRK3,SIG,65,1.15202866461764,0.0956564704771437,0.0917765303064199,0.108404845323808,0.0166283150173877,0.307324431623196,0.749702245916493,2.56986703852321,2.54689632088074,2.64534225363419,0.0984459327534504,0.563602759721381,ENSG00000143479,DYRK3,protein_coding,1,1,206635536,206684419,q32.1,dual specificity tyrosine phosphorylation regulated kinase 3 [Source:HGNC Symbol;Acc:HGNC:3094],NA,DYRK3,8444,NM_001004023;NM_003582
SNAPC2_TF,SNAPC2,SNAPC2_TF,SNAPC2,TF,200,1.15168101801356,0.135113124407735,0.133903023391595,0.139089170603622,0.00518614721202744,0.30745481581344,0.707256916316421,3.79725920344284,3.78986514468664,3.8215539679275,0.0316888232408613,0.587855126325066,ENSG00000104976,SNAPC2,protein_coding,19,1,7920338,7923250,p13.2,small nuclear RNA activating complex polypeptide 2 [Source:HGNC Symbol;Acc:HGNC:11135],NA,SNAPC2,6618,NM_003083
TCF19_SIG,TCF19,TCF19_SIG,TCF19,SIG,38,-1.15044803621148,0.420858344601868,0.429410177485313,0.392759465127694,-0.0366507123576188,0.308034137249951,-1.28107444074024,4.95832691350188,4.99244198265274,4.84623454343475,-0.146207439217997,0.302549848686826,ENSG00000137310,TCF19,protein_coding,6,1,31158547,31167159,p21.33,transcription factor 19 [Source:HGNC Symbol;Acc:HGNC:11629],NA,TCF19,6941,NM_001077511;NM_001318908;NM_007109
DOK1_SIG,DOK1,DOK1_SIG,DOK1,SIG,30,-1.15006514644108,0.123193069089144,0.126310723794589,0.112949346485538,-0.0133613773090513,0.308182581568465,-1.42798807496219,5.2976383306441,5.32601763131391,5.20439205701474,-0.121625574299169,0.246240737090203,ENSG00000115325,DOK1,protein_coding,2,1,74549026,74557554,p13.1,docking protein 1 [Source:HGNC Symbol;Acc:HGNC:2990],NA,DOK1,1796,NM_001197260;NM_001318866;NM_001318867;NM_001318868;NM_001318869;NM_001381
FBXO31_SIG,FBXO31,FBXO31_SIG,FBXO31,SIG,22,1.14872069424435,-0.0274781420900744,-0.0291917205871104,-0.0218478127426705,0.00734390784443995,0.308819426318976,2.14505247521987,4.21436359897852,4.18170306827157,4.32167677130136,0.139973703029798,0.0738099501360548,ENSG00000103264,FBXO31,protein_coding,16,-1,87326987,87392142,q24.2,F-box protein 31 [Source:HGNC Symbol;Acc:HGNC:16510],Autosomal recessive non-syndromic intellectual disability;Mental retardation autosomal recessive 45,FBXO31,79791,NM_001282683;NM_024735
TCF20_SIG,TCF20,TCF20_SIG,TCF20,SIG,34,-1.14854080914228,0.319173335273686,0.320642569587188,0.314345851100747,-0.006296718486441,0.308864918552768,-1.12840412453041,6.26239454685128,6.27611347566388,6.21731806646703,-0.0587954091968409,0.368941603413479,ENSG00000100207,TCF20,protein_coding,22,-1,42160013,42343616,q13.2,transcription factor 20 [Source:HGNC Symbol;Acc:HGNC:11631],TCF20 syndrome,TCF20,6942,NM_005650;NM_181492
INPP4A_SIG,INPP4A,INPP4A_SIG,INPP4A,SIG,82,-1.14839890607161,0.369861560229037,0.372591156660838,0.360892886238831,-0.0116982704220076,0.308891113329466,-0.206687820300027,6.00732974710025,6.0110801541591,5.99500698104973,-0.0160731731093742,0.883204229847026,ENSG00000040933,INPP4A,protein_coding,2,1,98444854,98594390,q11.2,inositol polyphosphate-4-phosphatase type I A [Source:HGNC Symbol;Acc:HGNC:6074],Autosomal Recessive Mental Retardation,INPP4A,3631,NM_001134224;NM_001134225;NM_001351424;NM_001351425;NM_001351426;NM_001351427;NM_001351428;NM_001351429;NM_001566;NM_004027
ANO10_SIG,ANO10,ANO10_SIG,ANO10,SIG,34,-1.14804012480492,0.311630903792715,0.314131562386952,0.303414454125936,-0.0107171082610158,0.309027544451557,-1.3843320735948,4.50739177156459,4.53193814338855,4.42673940700013,-0.10519873638842,0.262518597999473,ENSG00000160746,ANO10,protein_coding,3,-1,43354859,43691594,p21.33,anoctamin 10 [Source:HGNC Symbol;Acc:HGNC:25519],Adult-onset autosomal recessive cerebellar ataxia;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 10,ANO10,55129,NM_001204831;NM_001204832;NM_001204833;NM_001204834;NM_001346463;NM_001346464;NM_001346465;NM_001346466;NM_001346467;NM_001346468;NM_001346469;NM_018075
PLCB2_SIG,PLCB2,PLCB2_SIG,PLCB2,SIG,62,1.14718267284745,0.339710991750626,0.337361021137464,0.347432323765302,0.0100713026278382,0.30941763964628,0.0119183894893731,8.31156868383216,8.3112954636524,8.31246640727994,0.00117094362753886,0.993317965635787,ENSG00000137841,PLCB2,protein_coding,15,-1,40278176,40307935,q15.1,phospholipase C beta 2 [Source:HGNC Symbol;Acc:HGNC:9055],NA,PLCB2,5330,NM_001284297;NM_001284298;NM_001284299;NM_004573
PNPLA6_SIG,PNPLA6,PNPLA6_SIG,PNPLA6,SIG,30,1.14588246990786,0.278322367563917,0.27645197502812,0.284467943038681,0.00801596801056116,0.310033545807184,2.51353738487701,6.48717970251179,6.44543703905437,6.62433416815761,0.178897129103241,0.0342489408106556,ENSG00000032444,PNPLA6,protein_coding,19,1,7534004,7561764,p13.2,patatin like phospholipase domain containing 6 [Source:HGNC Symbol;Acc:HGNC:16268],Ataxia-hypogonadism-choroidal dystrophy syndrome;Autosomal recessive spastic paraplegia type 39;Boucher Neuhauser syndrome;Cerebellar ataxia-hypogonadism syndrome;Laurence-Moon syndrome;OLIVER-MCFARLANE SYNDROME;SPASTIC PARAPLEGIA 39 AUTOSOMAL RECESSIVE;Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,PNPLA6,10908,NM_001166111;NM_001166112;NM_001166113;NM_001166114;NM_006702
AKR1E2_SIG,AKR1E2,AKR1E2_SIG,AKR1E2,SIG,1,-1.14560795707942,-0.233595937592144,-0.228131986710864,-0.251548919059206,-0.0234169323483427,0.310127334295352,0.866049981663321,1.29485245698966,1.2755981106573,1.35811673779598,0.0825186271386872,0.499810278022418,ENSG00000165568,AKR1E2,protein_coding,10,1,4786629,4848062,p15.1,aldo-keto reductase family 1 member E2 [Source:HGNC Symbol;Acc:HGNC:23437],NA,AKR1E2,83592,NM_001040177;NM_001271021;NM_001271025
ADRA2A_SIG,ADRA2A,ADRA2A_SIG,ADRA2A,SIG,38,1.14538984753228,-0.0665091773755565,-0.0692401225367372,-0.0575360718459625,0.0117040506907747,0.310192396203989,0.894751149808452,1.15050615295191,1.12215887436255,1.24364721117411,0.121488336811558,0.484704908969979,ENSG00000150594,ADRA2A,protein_coding,10,1,111077163,111080907,q25.2,adrenoceptor alpha 2A [Source:HGNC Symbol;Acc:HGNC:281],NA,ADRA2A,150,NM_000681
MRPL28_SIG,MRPL28,MRPL28_SIG,MRPL28,SIG,13,-1.14295049696802,0.321197321955278,0.322348048981472,0.317416361726354,-0.00493168725511815,0.311390912705165,0.380416867660636,5.2100440714615,5.20648762892476,5.22172952551077,0.0152418965860132,0.780159014945446,ENSG00000086504,MRPL28,protein_coding,16,-1,366969,371289,p13.3,mitochondrial ribosomal protein L28 [Source:HGNC Symbol;Acc:HGNC:14484],NA,MRPL28,10573,NM_006428
POLQ_SIG,POLQ,POLQ_SIG,POLQ,SIG,26,-1.14171595782537,0.217964245265221,0.228350360251153,0.183838438882872,-0.0445119213682808,0.31197577873378,-0.664249169204668,3.78808407800617,3.8088928245492,3.7197124822219,-0.089180342327305,0.612433554866076,ENSG00000051341,POLQ,protein_coding,3,-1,121431427,121546641,q13.33,DNA polymerase theta [Source:HGNC Symbol;Acc:HGNC:9186],NA,POLQ,10721,NM_199420
FOXD2_TF,FOXD2,FOXD2_TF,FOXD2,TF,69,1.14039279647921,-0.0158842016394344,-0.0170735413071247,-0.0119763713027377,0.00509717000438704,0.312606757007172,1.3436949709203,0.470733833473973,0.457776231665595,0.513308810844356,0.0555325791787609,0.277665173814961,ENSG00000186564,FOXD2,protein_coding,1,1,47436017,47440691,p33,forkhead box D2 [Source:HGNC Symbol;Acc:HGNC:3803],NA,FOXD2,2306,NM_004474
SEMA3F_SIG,SEMA3F,SEMA3F_SIG,SEMA3F,SIG,37,1.1402528150303,-0.155676388908618,-0.157407174329352,-0.149989522526207,0.0074176518031439,0.312632051517964,0.382147974201597,1.14844947806163,1.13690855431142,1.18636965609803,0.0494611017866069,0.779226763257492,ENSG00000001617,SEMA3F,protein_coding,3,1,50155045,50189075,p21.31,semaphorin 3F [Source:HGNC Symbol;Acc:HGNC:10728],NA,SEMA3F,6405,NM_001318798;NM_001318800;NM_004186
TSEN34_SIG,TSEN34,TSEN34_SIG,TSEN34,SIG,20,1.13996100835004,-0.014309500955356,-0.0152842551078994,-0.0111067373112849,0.00417751779661441,0.312735133403361,1.29182394713552,4.71011012869738,4.69271007295496,4.76728174042246,0.0745716674674998,0.298284387024123,ENSG00000170892,TSEN34,protein_coding,19,1,54189938,54194536,q13.42,tRNA splicing endonuclease subunit 34 [Source:HGNC Symbol;Acc:HGNC:15506],Pontocerebellar hypoplasia type 2;Pontocerebellar Hypoplasia Type 2 and Type 4;PONTOCEREBELLAR HYPOPLASIA TYPE 2C,TSEN34,79042,NM_001077446;NM_001282332;NM_001282333;NM_024075
UEVLD_SIG,UEVLD,UEVLD_SIG,UEVLD,SIG,32,1.13965556273798,0.321462588122092,0.318149764696361,0.332347579378066,0.0141978146817043,0.312845223893194,2.31471418862564,3.74111149854008,3.68966033380786,3.91016532551737,0.220504991709514,0.0524020971083467,ENSG00000151116,UEVLD,protein_coding,11,-1,18529609,18588747,p15.1,UEV and lactate/malate dehyrogenase domains [Source:HGNC Symbol;Acc:HGNC:30866],NA,UEVLD,55293,NM_001040697;NM_001261382;NM_001261383;NM_001261384;NM_001261385;NM_001261386;NM_001297771;NM_018314
LSM5_SIG,LSM5,LSM5_SIG,LSM5,SIG,33,1.13923461228913,0.273921400658263,0.271771506542374,0.280985338467612,0.00921383192523796,0.313014544543259,1.16835057816191,3.9713506879431,3.95451098217213,4.026681149762,0.0721701675898672,0.351254948110541,ENSG00000106355,LSM5,protein_coding,7,-1,32485338,32495283,p14.3,LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated [Source:HGNC Symbol;Acc:HGNC:17162],NA,LSM5,23658,NM_001130710;NM_001139499;NM_012322
SNRPF_SIG,SNRPF,SNRPF_SIG,SNRPF,SIG,39,1.13899994466952,0.41232184612741,0.410138718953129,0.419494978271478,0.00935625931834892,0.3130884011461,1.77146251247841,4.60886810042586,4.58682467184923,4.68129650860622,0.0944718367569957,0.14509561601054,ENSG00000139343,SNRPF,protein_coding,12,1,95858928,95903828,q23.1,small nuclear ribonucleoprotein polypeptide F [Source:HGNC Symbol;Acc:HGNC:11162],NA,SNRPF,6636,NM_003095
ZNF641_TF,ZNF641,ZNF641_TF,ZNF641,TF,187,-1.13782121645543,0.17773248282516,0.180236291078648,0.169505684277986,-0.0107306068006619,0.313646605317852,1.0370015506891,4.90330676373121,4.88177059595763,4.97406845784437,0.0922978618867409,0.412327646881562,ENSG00000167528,ZNF641,protein_coding,12,-1,48337180,48351414,q13.11,zinc finger protein 641 [Source:HGNC Symbol;Acc:HGNC:31834],NA,ZNF641,121274,NM_001172681;NM_001172682;NM_152320
ITGB7_SIG,ITGB7,ITGB7_SIG,ITGB7,SIG,37,-1.13761933545637,0.131579246220815,0.135052101455244,0.120168436164833,-0.0148836652904115,0.313703708475327,-0.572582089284128,5.86127838465672,5.88138495304435,5.79521394566877,-0.0861710073755813,0.667298610912404,ENSG00000139626,ITGB7,protein_coding,12,-1,53191323,53207282,q13.13,integrin subunit beta 7 [Source:HGNC Symbol;Acc:HGNC:6162],NA,ITGB7,3695,NM_000889
SLC25A40_SIG,SLC25A40,SLC25A40_SIG,SLC25A40,SIG,51,-1.13482624077539,0.225736403553721,0.229230823051675,0.214254739489016,-0.0149760835626596,0.315093096671586,-0.854457376638121,4.91733143630544,4.93600463583319,4.85597663785712,-0.0800279979760702,0.505783480335208,ENSG00000075303,SLC25A40,protein_coding,7,-1,87833568,87876360,q21.12,solute carrier family 25 member 40 [Source:HGNC Symbol;Acc:HGNC:29680],NA,SLC25A40,55972,NM_018843
SLC25A5_SIG,SLC25A5,SLC25A5_SIG,SLC25A5,SIG,33,1.13464236014181,0.476637568381883,0.474544492578553,0.483514817449967,0.00897032487141495,0.315141052328782,1.4806750077814,7.77948080738732,7.75768196608272,7.85110557167386,0.0934236055911351,0.228448083678687,ENSG00000005022,SLC25A5,protein_coding,X,1,119468422,119471396,q24,solute carrier family 25 member 5 [Source:HGNC Symbol;Acc:HGNC:10991],NA,SLC25A5,292,NM_001152
ELK3_SIG,ELK3,ELK3_SIG,ELK3,SIG,77,1.13453734715162,0.199329567015725,0.197519659512901,0.205276405953575,0.0077567464406741,0.31514840076723,0.622870470679157,5.97030654381802,5.95696488613065,6.01414341907651,0.0571785329458577,0.63687970406827,ENSG00000111145,ELK3,protein_coding,12,1,96194375,96269824,q23.1,ELK3, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3325],NA,ELK3,2004,NM_001303511;NM_005230
EEF1A1P5_SIG,EEF1A1P5,EEF1A1P5_SIG,EEF1A1P5,SIG,18,1.13384691822251,1.80739047975582,1.80165993572937,1.82621941012845,0.0245594743990781,0.315457290194967,1.80094000211722,11.6379624808684,11.6105756498512,11.7279477827821,0.11737213293091,0.137980844441549,ENSG00000196205,EEF1A1P5,processed_pseudogene,9,1,133019486,133020874,q34.13,eukaryotic translation elongation factor 1 alpha 1 pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:3200],NA,EEF1A1P5,NA,NA
DUSP22_SIG,DUSP22,DUSP22_SIG,DUSP22,SIG,26,1.13357647663403,0.293765934046551,0.291304728754546,0.301852751434566,0.0105480226800205,0.315549881324537,1.24037774684962,5.69627856603975,5.67501361767562,5.76614911066475,0.0911354929891289,0.319372676849167,ENSG00000112679,DUSP22,protein_coding,6,1,291630,351355,p25.3,dual specificity phosphatase 22 [Source:HGNC Symbol;Acc:HGNC:16077],NA,DUSP22,56940,NM_001286555;NM_020185
RPL29_SIG,RPL29,RPL29_SIG,RPL29,SIG,22,1.13312124553406,1.637731582568,1.63175075262977,1.65738288093645,0.0256321283066849,0.315737741059161,2.48306064992465,8.54883867228148,8.51249732354412,8.66824596098996,0.155748637445839,0.036629672060225,ENSG00000162244,RPL29,protein_coding,3,-1,51993522,51995942,p21.2,ribosomal protein L29 [Source:HGNC Symbol;Acc:HGNC:10331],NA,RPL29,6159,NM_000992
ZNF212_TF,ZNF212,ZNF212_TF,ZNF212,TF,126,1.13292285839742,0.326766870956442,0.32512890496675,0.332148759208287,0.00701985424153725,0.31579322770142,2.35327404910226,3.81268750530514,3.77500956998204,3.93648643565248,0.161476865670434,0.0484302279929053,ENSG00000170260,ZNF212,protein_coding,7,1,149239651,149255609,q36.1,zinc finger protein 212 [Source:HGNC Symbol;Acc:HGNC:13004],NA,ZNF212,7988,NM_012256
KDM3B_SIG,KDM3B,KDM3B_SIG,KDM3B,SIG,27,1.13148434443539,0.411621468712451,0.41069750436105,0.41465735158134,0.00395984722028957,0.316488582261183,0.758655676795026,7.33770970210593,7.32984110098162,7.36356367722864,0.0337225762470217,0.55847141563939,ENSG00000120733,KDM3B,protein_coding,5,1,138352685,138437028,q31.2,lysine demethylase 3B [Source:HGNC Symbol;Acc:HGNC:1337],NA,KDM3B,51780,NM_016604
ZMAT2_TF,ZMAT2,ZMAT2_TF,ZMAT2,TF,139,1.1312484443886,0.196321468202223,0.194847129847902,0.201165722794993,0.0063185929470912,0.316563501707834,0.667146949728465,6.09438420191892,6.08582831094052,6.12249641513364,0.0366681041931117,0.610872832310146,ENSG00000146007,ZMAT2,protein_coding,5,1,140698680,140706676,q31.3,zinc finger matrin-type 2 [Source:HGNC Symbol;Acc:HGNC:26433],NA,ZMAT2,153527,NM_144723
LATS2_SIG,LATS2,LATS2_SIG,LATS2,SIG,22,1.13082193693521,0.214789963663758,0.211979493458436,0.22402436576696,0.0120448723085249,0.316736881139381,1.64036558621453,6.2133213290571,6.18029298217521,6.32184304024046,0.141550058065253,0.179299789796793,ENSG00000150457,LATS2,protein_coding,13,-1,20973036,21061586,q12.11,large tumor suppressor kinase 2 [Source:HGNC Symbol;Acc:HGNC:6515],NA,LATS2,26524,NM_014572
SLC25A32_SIG,SLC25A32,SLC25A32_SIG,SLC25A32,SIG,17,1.13000010920424,0.342946997174642,0.340874482167903,0.349756689339642,0.00888220717173949,0.317108672476014,0.287057657843115,4.73772163862865,4.7342830434333,4.7490198799848,0.0147368365514938,0.835613086968585,ENSG00000164933,SLC25A32,protein_coding,8,-1,103398635,103415189,q22.3,solute carrier family 25 member 32 [Source:HGNC Symbol;Acc:HGNC:29683],EXERCISE INTOLERANCE RIBOFLAVIN-RESPONSIVE;Multiple acyl-CoA dehydrogenase deficiency mild type,SLC25A32,81034,NM_030780
ZNF205_TF,ZNF205,ZNF205_TF,ZNF205,TF,79,1.12992081438012,-0.0884680656261961,-0.0895262534518174,-0.0849911627705833,0.00453509068123395,0.317108672476014,1.81564050196045,0.734915504346629,0.686736476549542,0.893218024251345,0.206481547701803,0.134601492078934,ENSG00000122386,ZNF205,protein_coding,16,1,3112560,3120517,p13.3,zinc finger protein 205 [Source:HGNC Symbol;Acc:HGNC:12996],NA,ZNF205,7755,NM_001042428;NM_001278158;NM_003456
ASH2L_SIG,ASH2L,ASH2L_SIG,ASH2L,SIG,21,1.12854276405436,0.525098697792542,0.52051962096906,0.540144235926841,0.0196246149577817,0.317774538328281,0.606810488428155,6.02442911462983,6.01418434233347,6.05809050931789,0.0439061669844261,0.646717455153339,ENSG00000129691,ASH2L,protein_coding,8,1,38105242,38144076,p11.23,ASH2 like, histone lysine methyltransferase complex subunit [Source:HGNC Symbol;Acc:HGNC:744],NA,ASH2L,9070,NM_001105214;NM_001261832;NM_001282272;NM_004674
KLKB1_SIG,KLKB1,KLKB1_SIG,KLKB1,SIG,33,-1.12763513754544,-0.0897305822295219,-0.0882648774264488,-0.0945464694396193,-0.0062815920131704,0.318156708056272,-1.99124728917052,0.357423169935408,0.37710665843414,0.292748850582434,-0.0843578078517057,0.0987216930100195,ENSG00000164344,KLKB1,protein_coding,4,1,186208979,186258471,q35.2,kallikrein B1 [Source:HGNC Symbol;Acc:HGNC:6371],Congenital prekallikrein deficiency;PREKALLIKREIN DEFICIENCY,KLKB1,3818,NM_000892;NM_001318394;NM_001318396
ETV3_TF,ETV3,ETV3_TF,ETV3,TF,89,-1.12762301110599,0.231188460217586,0.234780311249287,0.219386663970568,-0.0153936472787188,0.318156708056272,-0.0428399917986724,5.36865830138762,5.36948370899331,5.36594624782608,-0.00353746116723015,0.976422738246796,ENSG00000117036,ETV3,protein_coding,1,-1,157121191,157138474,q23.1,ETS variant 3 [Source:HGNC Symbol;Acc:HGNC:3492],NA,ETV3,2117,NM_001145312;NM_005240
SIK1_SIG,SIK1,SIK1_SIG,SIK1,SIG,47,-1.12617257584045,0.270875766262059,0.275606771640604,0.255331034303983,-0.0202757373366202,0.31885393238047,-0.876362965625925,5.83936909420441,5.88042087899462,5.70448465846515,-0.17593622052947,0.494461162767231,ENSG00000142178,SIK1,protein_coding,21,-1,43414483,43427189,q22.3,salt inducible kinase 1 [Source:HGNC Symbol;Acc:HGNC:11142],Early infantile epileptic encephalopathy;Early myoclonic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 30;Neonatal epilepsy spectrum;West syndrome,SIK1,150094,NM_173354
CHD1_SIG,CHD1,CHD1_SIG,CHD1,SIG,37,-1.12609627364936,0.607906059078509,0.6112104080936,0.597048912314638,-0.0141614957789618,0.31885393238047,-0.678249778417836,7.16153134999503,7.17488388264206,7.11765874272621,-0.0572251399158505,0.604339275901125,ENSG00000153922,CHD1,protein_coding,5,-1,98853985,98928957,q21.1,chromodomain helicase DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:1915],PILAROWSKI-BJORNSSON SYNDROME,CHD1,1105,NM_001270
SCAF11_SIG,SCAF11,SCAF11_SIG,SCAF11,SIG,26,1.12362297182772,0.494006331497717,0.492731396646477,0.498195403151792,0.00546400650531567,0.320091473233879,1.23732782561892,7.6998197163362,7.68835425853374,7.73749193482997,0.0491376762962279,0.320676324841262,ENSG00000139218,SCAF11,protein_coding,12,-1,45919131,45992120,q12,SR-related CTD associated factor 11 [Source:HGNC Symbol;Acc:HGNC:10784],NA,SCAF11,9169,NM_004719
RNF135_SIG,RNF135,RNF135_SIG,RNF135,SIG,36,-1.12263512118234,0.428658991128859,0.43181915097891,0.418275608764403,-0.0135435422145071,0.320558172258806,0.534650333679095,4.78172091922162,4.77205099290857,4.81349353425019,0.041442541341616,0.68941975277994,ENSG00000181481,RNF135,protein_coding,17,1,30970984,30999911,q11.2,ring finger protein 135 [Source:HGNC Symbol;Acc:HGNC:21158],MACROCEPHALY MACROSOMIA AND FACIAL DYSMORPHISM SYNDROME;Macrocephaly macrosomia facial dysmorphism syndrome;Overgrowth-macrocephaly-facial dysmorphism syndrome,RNF135,84282,NM_001184992;NM_032322;NM_197939
NSD1_SIG,NSD1,NSD1_SIG,NSD1,SIG,34,-1.12210052913699,0.224146760094577,0.225316144010234,0.220304498657419,-0.00501164535281517,0.320789146065072,0.167963037543936,7.65033942257366,7.6482847634345,7.65709044545946,0.00880568202495355,0.905775484908252,ENSG00000165671,NSD1,protein_coding,5,1,177133025,177300215,q35.3,nuclear receptor binding SET domain protein 1 [Source:HGNC Symbol;Acc:HGNC:14234],5q35 microduplication syndrome;BECKWITH-WIEDEMANN SYNDROME;Beckwith-Wiedemann syndrome due to NSD1 mutation;Deletion 5q35;LEUKEMIA ACUTE MYELOID;SOTOS SYNDROME;SOTOS SYNDROME 1;Weaver syndrome,NSD1,64324,NM_001365684;NM_022455;NM_172349
ANAPC10_SIG,ANAPC10,ANAPC10_SIG,ANAPC10,SIG,32,1.12177181215188,0.358651903726822,0.357379261670944,0.362833441910423,0.00545418023947887,0.320912944436181,1.65438458089779,2.81446385617317,2.79563116174539,2.87634270929304,0.0807115475476531,0.175262530299376,ENSG00000164162,ANAPC10,protein_coding,4,-1,144831908,145098541,q31.21,anaphase promoting complex subunit 10 [Source:HGNC Symbol;Acc:HGNC:24077],NA,ANAPC10,10393,NM_001256706;NM_001256707;NM_001256708;NM_001256709;NM_001256710;NM_001256711;NM_001256712;NM_001318367;NM_014885
TCF19_TF,TCF19,TCF19_TF,TCF19,TF,279,-1.12143512716329,0.223422667937262,0.227862181102141,0.2088356961098,-0.0190264849923411,0.320968647939126,-1.28107444074024,4.95832691350188,4.99244198265274,4.84623454343475,-0.146207439217997,0.302549848686826,ENSG00000137310,TCF19,protein_coding,6,1,31158547,31167159,p21.33,transcription factor 19 [Source:HGNC Symbol;Acc:HGNC:11629],NA,TCF19,6941,NM_001077511;NM_001318908;NM_007109
GAPVD1_SIG,GAPVD1,GAPVD1_SIG,GAPVD1,SIG,19,-1.12142579623513,0.495816109355627,0.497615958303002,0.489902319957109,-0.00771363834589355,0.320968647939126,0.64235970853558,6.36734443069625,6.36047496342695,6.38991553743822,0.0294405740112732,0.625518086272052,ENSG00000165219,GAPVD1,protein_coding,9,1,125261794,125367207,q33.3,GTPase activating protein and VPS9 domains 1 [Source:HGNC Symbol;Acc:HGNC:23375],Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis,GAPVD1,26130,NM_001282679;NM_001282680;NM_001282681;NM_001330777;NM_001330778;NM_001354293;NM_001354294;NM_001354295;NM_001354296;NM_001354297;NM_001354298;NM_001354299;NM_001354300;NM_001354301;NM_015635
ABCG1_SIG,ABCG1,ABCG1_SIG,ABCG1,SIG,60,1.12139170039415,0.0675476082270802,0.064776029100783,0.0766542253563423,0.0118781962555592,0.320968647939126,0.74975409811967,3.63185951566019,3.60522878189641,3.7193604980269,0.114131716130486,0.563594610055467,ENSG00000160179,ABCG1,protein_coding,21,1,42199689,42297244,q22.3,ATP binding cassette subfamily G member 1 [Source:HGNC Symbol;Acc:HGNC:73],NA,ABCG1,9619,NM_004915;NM_016818;NM_207174;NM_207627;NM_207628;NM_207629
ATP6V1H_SIG,ATP6V1H,ATP6V1H_SIG,ATP6V1H,SIG,23,1.12129310545522,0.28050560535701,0.279384266662741,0.284190003923892,0.00480573726115119,0.320972579223923,0.934990472826939,4.85030864354106,4.8397833100611,4.88489188211807,0.0451085720569626,0.463354264549568,ENSG00000047249,ATP6V1H,protein_coding,8,-1,53715543,53843558,q11.23,ATPase H+ transporting V1 subunit H [Source:HGNC Symbol;Acc:HGNC:18303],NA,ATP6V1H,51606,NM_015941;NM_213619;NM_213620
ASB7_SIG,ASB7,ASB7_SIG,ASB7,SIG,47,1.12044888466902,0.331066165004817,0.329698924480284,0.335558526728282,0.00585960224799836,0.321365115971137,1.65931639587025,4.82964858297466,4.81070537838271,4.89189054091964,0.0811851625369285,0.173985759353455,ENSG00000183475,ASB7,protein_coding,15,1,100602534,100651705,q26.3,ankyrin repeat and SOCS box containing 7 [Source:HGNC Symbol;Acc:HGNC:17182],NA,ASB7,140460,NM_024708;NM_198243
ASH1L_TF,ASH1L,ASH1L_TF,ASH1L,TF,164,1.11994612873266,0.248900648095867,0.246899120954439,0.255477094417705,0.00857797346326634,0.321579807967082,1.60923524025201,6.79240400530633,6.77146614029097,6.86119984749967,0.0897337072087011,0.187975201131766,ENSG00000116539,ASH1L,protein_coding,1,-1,155335268,155562807,q22,ASH1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:19088],Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 52,ASH1L,55870,NM_001366177;NM_018489
AMZ2_SIG,AMZ2,AMZ2_SIG,AMZ2,SIG,6,1.11944315826323,0.0354203688394404,0.033976091306451,0.0401658521621198,0.00618976085566887,0.321794696123254,-0.0792593223981152,5.2434805202104,5.2444059930222,5.24043968097163,-0.00396631205057585,0.956383710087432,ENSG00000196704,AMZ2,protein_coding,17,1,68247930,68257164,q24.2,archaelysin family metallopeptidase 2 [Source:HGNC Symbol;Acc:HGNC:28041],NA,AMZ2,51321,NM_001033569;NM_001033570;NM_001033571;NM_001033572;NM_001033574;NM_001289054;NM_001289056;NM_001346471;NM_001346472;NM_001346473;NM_001346474;NM_001346475;NM_001346476;NM_001346477;NM_001346478;NM_001346479;NM_001346480;NM_001346481;NM_001346482;NM_001346483;NM_001346484;NM_001346485;NM_016627
RECQL4_SIG,RECQL4,RECQL4_SIG,RECQL4,SIG,37,-1.11761253401357,0.382452534615145,0.391678028916269,0.352140196197163,-0.0395378327191069,0.322703274586146,-1.40032050187842,4.46626166879782,4.50580443966513,4.33633542166239,-0.169469018002745,0.256562384788678,ENSG00000160957,RECQL4,protein_coding,8,-1,144511288,144517845,q24.3,RecQ like helicase 4 [Source:HGNC Symbol;Acc:HGNC:9949],Baller-Gerold syndrome;RAPADILINO SYNDROME;ROTHMUND-THOMSON SYNDROME;Rothmund-Thomson syndrome type 2,RECQL4,9401,NM_004260
RPS25_SIG,RPS25,RPS25_SIG,RPS25,SIG,72,1.11680651373125,0.336377256606263,0.33355639211525,0.345645811362448,0.0120894192471979,0.323077151262839,0.581346868220156,9.24074531735713,9.23126716935449,9.27188780365153,0.0406206342970421,0.662411973602865,ENSG00000118181,RPS25,protein_coding,11,-1,119015712,119018691,q23.3,ribosomal protein S25 [Source:HGNC Symbol;Acc:HGNC:10413],NA,RPS25,6230,NM_001028
SLC25A10_SIG,SLC25A10,SLC25A10_SIG,SLC25A10,SIG,21,-1.11590446020767,0.10516361488401,0.109138587664493,0.0921029900338539,-0.0170355976306387,0.323501583295728,0.101765892770378,1.36866716777088,1.36713205493189,1.37371110995613,0.00657905502424198,0.943594131846694,ENSG00000183048,SLC25A10,protein_coding,17,1,81712236,81721016,q25.3,solute carrier family 25 member 10 [Source:HGNC Symbol;Acc:HGNC:10980],NA,SLC25A10,1468,NM_001270888;NM_001270953;NM_012140
GFI1_TF,GFI1,GFI1_TF,GFI1,TF,310,1.11513261830841,0.0776090525828165,0.0761581602330494,0.0823762703034797,0.00621811007043035,0.323858125036592,2.30550939717175,6.02560184967242,5.94695836575462,6.2840018682595,0.337043502504883,0.0533521110402954,ENSG00000162676,GFI1,protein_coding,1,-1,92473043,92486925,p22.1,growth factor independent 1 transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:4237],Autosomal dominant severe congenital neutropenia;NEUTROPENIA NONIMMUNE CHRONIC IDIOPATHIC OF ADULTS;NEUTROPENIA SEVERE CONGENITAL 2 AUTOSOMAL DOMINANT,GFI1,2672,NM_001127215;NM_001127216;NM_005263
UBA52_SIG,UBA52,UBA52_SIG,UBA52,SIG,12,-1.11385368248947,0.649228023976799,0.651881270278729,0.640510214699031,-0.0113710555796985,0.324480909179454,-1.00846869407862,8.73577283903197,8.74651233848864,8.70048591224574,-0.0460264262429088,0.426396179456097,ENSG00000221983,UBA52,protein_coding,19,1,18571730,18577550,p13.11,ubiquitin A-52 residue ribosomal protein fusion product 1 [Source:HGNC Symbol;Acc:HGNC:12458],NA,UBA52,7311,NM_001033930;NM_001321017;NM_001321018;NM_001321019;NM_001321020;NM_001321021;NM_001321022;NM_003333
CTSK_SIG,CTSK,CTSK_SIG,CTSK,SIG,31,-1.11317414552101,-0.0757265915996279,-0.0730178433950096,-0.0846267642719449,-0.0116089208769353,0.324789661136468,-0.319785789386025,2.98716967888529,2.99292477060185,2.96826009181659,-0.0246646787852617,0.816021858900589,ENSG00000143387,CTSK,protein_coding,1,-1,150796208,150808260,q21.3,cathepsin K [Source:HGNC Symbol;Acc:HGNC:2536],PYCNODYSOSTOSIS,CTSK,1513,NM_000396
ZNF185_TF,ZNF185,ZNF185_TF,ZNF185,TF,297,1.11293575370887,0.0742544428731667,0.0732040458445554,0.0777057473957465,0.00450170155119112,0.324866895573288,0.667652995831367,5.78434777570409,5.75332545751227,5.88627824976293,0.132952792250664,0.610685188272352,ENSG00000147394,ZNF185,protein_coding,X,1,152914442,152973480,q28,zinc finger protein 185 with LIM domain [Source:HGNC Symbol;Acc:HGNC:12976],NA,ZNF185,7739,NM_001178106;NM_001178107;NM_001178108;NM_001178109;NM_001178110;NM_001178113;NM_001178115;NM_007150
INPP1_SIG,INPP1,INPP1_SIG,INPP1,SIG,15,-1.11283886892456,0.328033725994292,0.330077390820875,0.321318827278376,-0.0087585635424998,0.32486983409473,-0.014949415589732,4.07006011345837,4.07031610809037,4.06921898823894,-0.00109711985143682,0.991676738738711,ENSG00000151689,INPP1,protein_coding,2,1,190343570,190371665,q32.2,inositol polyphosphate-1-phosphatase [Source:HGNC Symbol;Acc:HGNC:6071],NA,INPP1,3628,NM_001128928;NM_002194
SARNP_SIG,SARNP,SARNP_SIG,SARNP,SIG,9,1.11153083006592,0.0917376018046489,0.0889966233963501,0.100743673717631,0.011747050321281,0.325509115943329,1.71512628453111,1.20004748611005,1.18252438937739,1.25762337537448,0.075098985997088,0.159312853938643,ENSG00000205323,SARNP,protein_coding,12,-1,55752463,55817724,q13.2,SAP domain containing ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:24432],NA,SARNP,84324,NM_033082
CYBRD1_SIG,CYBRD1,CYBRD1_SIG,CYBRD1,SIG,15,1.11026961396203,0.174869815573556,0.172246065422106,0.183490708928322,0.0112446435062163,0.326124560236479,1.10279211505796,5.69983334930697,5.6703679279203,5.79664830529172,0.12628037737142,0.381141835849307,ENSG00000071967,CYBRD1,protein_coding,2,1,171522247,171558129,q31.1,cytochrome b reductase 1 [Source:HGNC Symbol;Acc:HGNC:20797],NA,CYBRD1,79901,NM_001127383;NM_001256909;NM_024843
MORC1_TF,MORC1,MORC1_TF,MORC1,TF,53,1.1095987828899,-0.0580402215820784,-0.0591959803558483,-0.0542427284682629,0.00495325188758552,0.326429679303025,0.400298104107147,0.339895151002163,0.333789424348947,0.359956824291301,0.0261673999423541,0.768075251474711,ENSG00000114487,MORC1,protein_coding,3,-1,108958239,109118142,q13.13,MORC family CW-type zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:7198],NA,MORC1,27136,NM_014429
ZNF256_TF,ZNF256,ZNF256_TF,ZNF256,TF,104,1.10870999611406,0.0698552716536349,0.0672079704261666,0.0785535471153166,0.0113455766891499,0.326849856791791,0.482758887367894,3.48808673898369,3.47289516571069,3.53800190830925,0.0651067425985632,0.719411748210125,ENSG00000152454,ZNF256,protein_coding,19,-1,57940833,57947706,q13.43,zinc finger protein 256 [Source:HGNC Symbol;Acc:HGNC:13049],NA,ZNF256,10172,NM_005773
ELF2_TF,ELF2,ELF2_TF,ELF2,TF,87,1.10779137697736,0.419651096326566,0.416792659333447,0.429043103589673,0.0122504442562265,0.327286112132616,1.34555659313389,6.18966703963252,6.17156391321136,6.24914874073062,0.0775848275192637,0.276958081863662,ENSG00000109381,ELF2,protein_coding,4,-1,139028112,139177218,q31.1,E74 like ETS transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:3317],NA,ELF2,1998,NM_001276457;NM_001276458;NM_001276459;NM_001331036;NM_006874;NM_201999
PHLPP1_SIG,PHLPP1,PHLPP1_SIG,PHLPP1,SIG,23,1.10645749822831,0.338485564003249,0.336312153289534,0.345626770634028,0.00931461734449445,0.327942075404914,0.753755142283884,5.13750825719139,5.12291844296175,5.18544621823166,0.0625277752699098,0.561428273741468,ENSG00000081913,PHLPP1,protein_coding,18,1,62715541,62980433,q21.33,PH domain and leucine rich repeat protein phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:20610],NA,PHLPP1,23239,NM_194449
MPPED1_SIG,MPPED1,MPPED1_SIG,MPPED1,SIG,18,1.10569174998952,0.0372127014469787,0.0344302122990558,0.0463551657901539,0.0119249534910981,0.328298420913748,-0.0689482173002425,0.208815517486864,0.209488856722436,0.206603117141414,-0.00288573958102279,0.962393277429387,ENSG00000186732,MPPED1,protein_coding,22,1,43411196,43507848,q13.2,metallophosphoesterase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1306],NA,MPPED1,758,NM_001044370
ENTPD4_SIG,ENTPD4,ENTPD4_SIG,ENTPD4,SIG,34,-1.105403544364,0.252293426881523,0.254093945721575,0.246377436407068,-0.00771650931450668,0.328402417960909,-0.991889052922539,6.37621016037875,6.3905520251883,6.32908689029024,-0.0614651348980527,0.434442110896327,ENSG00000197217,ENTPD4,protein_coding,8,-1,23385783,23457695,p21.3,ectonucleoside triphosphate diphosphohydrolase 4 [Source:HGNC Symbol;Acc:HGNC:14573],NA,ENTPD4,9583,NM_001128930;NM_004901
CLP1_SIG,CLP1,CLP1_SIG,CLP1,SIG,41,-1.10494133611365,0.369172089793392,0.372111482968497,0.359514083646616,-0.0125973993218812,0.328598468267196,-0.959844967502707,3.71270026997187,3.72941213778762,3.65778984714871,-0.071622290638902,0.4508996754386,ENSG00000172409,CLP1,protein_coding,11,1,57648992,57661865,q12.1,cleavage and polyadenylation factor I subunit 1 [Source:HGNC Symbol;Acc:HGNC:16999],Pontocerebellar hypoplasia type 10,CLP1,10978,NM_001142597;NM_006831
NT5C2_SIG,NT5C2,NT5C2_SIG,NT5C2,SIG,24,1.10470154017316,0.283433166452343,0.282069820052124,0.287912733195919,0.00584291314379536,0.328676905321215,0.926694819078284,7.53991189697916,7.52920012246253,7.57510772753379,0.0459076050712576,0.467439697875267,ENSG00000076685,NT5C2,protein_coding,10,-1,103088017,103193306,q24.33,5'-nucleotidase, cytosolic II [Source:HGNC Symbol;Acc:HGNC:8022],Autosomal recessive spastic paraplegia type 45;Spastic paraplegia 45 autosomal recessive,NT5C2,22978,NM_001134373;NM_001351169;NM_001351170;NM_001351171;NM_001351172;NM_001351173;NM_001351174;NM_001351175;NM_001351176;NM_001351177;NM_001351178;NM_001351179;NM_001351180;NM_001351181;NM_001351182;NM_001351183;NM_001351184;NM_001351185;NM_001351186;NM_001351187;NM_001351188;NM_001351189;NM_001351190;NM_001351191;NM_001351192;NM_001351193;NM_001351194;NM_001351195;NM_001351196;NM_001351197;NM_012229
ZMAT2_SIG,ZMAT2,ZMAT2_SIG,ZMAT2,SIG,23,1.10282992302878,0.316338419959872,0.314639668653551,0.321920031394928,0.00728036274137731,0.32961953761961,0.667146949728465,6.09438420191892,6.08582831094052,6.12249641513364,0.0366681041931117,0.610872832310146,ENSG00000146007,ZMAT2,protein_coding,5,1,140698680,140706676,q31.3,zinc finger matrin-type 2 [Source:HGNC Symbol;Acc:HGNC:26433],NA,ZMAT2,153527,NM_144723
CALR_SIG,CALR,CALR_SIG,CALR,SIG,46,1.10213118089024,0.398946065092409,0.395912609776188,0.408913132559994,0.0130005227838064,0.329941456093339,1.37771422220087,9.79606248377361,9.76418002629806,9.9008191297647,0.136639103466642,0.265016815989968,ENSG00000179218,CALR,protein_coding,19,1,12938578,12944489,p13.13,calreticulin [Source:HGNC Symbol;Acc:HGNC:1455],Essential thrombocythemia;MYELOFIBROSIS MYELOFIBROSIS WITH MYELOID METAPLASIA INCLUDED;Primary myelofibrosis;THROMBOCYTHEMIA 1,CALR,811,NM_004343
MARCH5_SIG,MARCH5,MARCH5_SIG,MARCH5,SIG,34,1.10200656942332,0.339082438437388,0.337153281103161,0.345421098249847,0.00826781714668587,0.329958958500363,0.472118254760891,5.58312606581947,5.57771769778563,5.60089641793069,0.0231787201450686,0.725832162443249,ENSG00000198060,MARCH5,protein_coding,10,1,92291167,92353964,q23.32,membrane associated ring-CH-type finger 5 [Source:HGNC Symbol;Acc:HGNC:26025],NA,MARCH5,54708,NM_017824
CRNKL1_SIG,CRNKL1,CRNKL1_SIG,CRNKL1,SIG,23,1.10132313181853,0.382856049215452,0.381516289346711,0.387258117355602,0.00574182800889188,0.330272946134839,1.57597000624698,5.1689975775022,5.15380260732549,5.2189239080828,0.0651213007573058,0.197816425379905,ENSG00000101343,CRNKL1,protein_coding,20,-1,20034368,20056046,p11.23,crooked neck pre-mRNA splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:15762],NA,CRNKL1,51340,NM_001278625;NM_001278626;NM_001278627;NM_001278628;NM_016652
RAG1_TF,RAG1,RAG1_TF,RAG1,TF,36,1.10111524712596,0.00163063221167845,-0.00042644144548445,0.0083895885137851,0.00881602995926944,0.33033464864221,0.725664036979185,1.19227484362302,1.17589888035317,1.24608158008113,0.0701826997279614,0.576678610039517,ENSG00000166349,RAG1,protein_coding,11,1,36510709,36593156,p12,recombination activating 1 [Source:HGNC Symbol;Acc:HGNC:9831],ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION SEVERE CYTOMEGALOVIRUS INFECTION AND AUTOIMMUNITY;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS;Combined immunodeficiency due to partial RAG1 deficiency;Combined immunodeficiency with granulomatosis;OMENN SYNDROME;SEVERE COMBINED IMMUNODEFICIENCY AUTOSOMAL RECESSIVE T CELL-NEGATIVE B CELL-NEGATIVE NK CELL-POSITIVE;Severe combined immunodeficiency due to complete RAG1/2 deficiency,RAG1,5896,NM_000448
ADORA2B_SIG,ADORA2B,ADORA2B_SIG,ADORA2B,SIG,17,-1.10060105280966,0.221436155018343,0.223572030267107,0.214418279200976,-0.00915375106613186,0.330558972669941,-1.2652799214391,1.73813486202073,1.76791974074945,1.64027026048351,-0.127649480265946,0.309200840231749,ENSG00000170425,ADORA2B,protein_coding,17,1,15944917,15975746,p12,adenosine A2b receptor [Source:HGNC Symbol;Acc:HGNC:264],NA,ADORA2B,136,NM_000676
AEN_SIG,AEN,AEN_SIG,AEN,SIG,16,1.1003648449438,0.133394446282529,0.132116299235432,0.137594072294421,0.00547777305898953,0.330635742902032,0.180443640293357,4.70816317867115,4.70459660880398,4.71988190823473,0.0152852994307526,0.898674492276265,ENSG00000181026,AEN,protein_coding,15,1,88621337,88632281,q26.1,apoptosis enhancing nuclease [Source:HGNC Symbol;Acc:HGNC:25722],NA,AEN,64782,NM_022767
SART3_SIG,SART3,SART3_SIG,SART3,SIG,35,1.09869490897484,0.465809102127631,0.463685546923099,0.472786497799664,0.00910095087656462,0.331474564919642,1.08119959504209,5.34222979335367,5.32633180966313,5.39446602547972,0.0681342158165962,0.391383120919482,ENSG00000075856,SART3,protein_coding,12,-1,108522214,108561400,q23.3,spliceosome associated factor 3, U4/U6 recycling protein [Source:HGNC Symbol;Acc:HGNC:16860],NA,SART3,9733,NM_014706
FZR1_SIG,FZR1,FZR1_SIG,FZR1,SIG,23,-1.09746193010181,0.395302095092944,0.397848670615796,0.386934775517858,-0.0109138950979388,0.33206918624418,0.449753304089476,5.65015717671905,5.64462854758783,5.66832267243592,0.0236941248480908,0.739210639354591,ENSG00000105325,FZR1,protein_coding,19,1,3506273,3538330,p13.3,fizzy and cell division cycle 20 related 1 [Source:HGNC Symbol;Acc:HGNC:24824],NA,FZR1,51343,NM_001136197;NM_001136198;NM_016263
CSNK1D_SIG,CSNK1D,CSNK1D_SIG,CSNK1D,SIG,27,-1.09739426343083,0.601066624067228,0.603045300299165,0.59456525930515,-0.0084800409940153,0.33206918624418,-0.793204878161548,7.23322701203803,7.24404244021791,7.19769060516132,-0.046351835056587,0.538696307338554,ENSG00000141551,CSNK1D,protein_coding,17,-1,82239023,82273731,q25.3,casein kinase 1 delta [Source:HGNC Symbol;Acc:HGNC:2452],ADVANCED SLEEP PHASE SYNDROME FAMILIAL 2;FAMILIAL ADVANCED SLEEP-PHASE SYNDROME,CSNK1D,1453,NM_001893;NM_139062
HMGXB4_TF,HMGXB4,HMGXB4_TF,HMGXB4,TF,109,-1.0972027215576,0.294551193046951,0.296296713920213,0.288815910177661,-0.00748080374255247,0.332073839326275,-0.693900812180542,5.0799777778375,5.09031539393718,5.04601132493856,-0.0443040689986115,0.595488863280596,ENSG00000100281,HMGXB4,protein_coding,22,1,35257452,35295807,q12.3,HMG-box containing 4 [Source:HGNC Symbol;Acc:HGNC:5003],NA,HMGXB4,10042,NM_001003681;NM_001362972
GLRX5_SIG,GLRX5,GLRX5_SIG,GLRX5,SIG,41,-1.09716955388618,0.342429356782558,0.345347316173932,0.332841775925188,-0.0125055402487439,0.332073839326275,-0.842188028281303,5.31499592539021,5.32941502606705,5.26761888030916,-0.061796145757885,0.512668733752696,ENSG00000182512,GLRX5,protein_coding,14,1,95533503,95544724,q32.13,glutaredoxin 5 [Source:HGNC Symbol;Acc:HGNC:20134],Adult-onset autosomal recessive sideroblastic anemia;ANEMIA SIDEROBLASTIC 3 PYRIDOXINE-REFRACTORY;Childhood-onset spasticity with hyperglycinemia;Spasticity childhood-onset with hyperglycinemia,GLRX5,51218,NM_016417
SRSF4_SIG,SRSF4,SRSF4_SIG,SRSF4,SIG,26,-1.09711038285657,0.438372566469602,0.43971497377535,0.433961799607858,-0.00575317416749166,0.332073839326275,-0.179206019601465,6.70391420792634,6.70582470718913,6.69763685320577,-0.00818785398335564,0.899528359266151,ENSG00000116350,SRSF4,protein_coding,1,-1,29147743,29181900,p35.3,serine and arginine rich splicing factor 4 [Source:HGNC Symbol;Acc:HGNC:10786],NA,SRSF4,6429,NM_005626
GPATCH3_SIG,GPATCH3,GPATCH3_SIG,GPATCH3,SIG,30,1.09652155390911,0.317149921521704,0.315721160080057,0.321844423401401,0.0061232633213439,0.332338604690308,1.33418466423941,4.18174395313985,4.16928824587384,4.22266984844248,0.0533816025686429,0.281415841424163,ENSG00000198746,GPATCH3,protein_coding,1,-1,26890488,26900467,p36.11,G-patch domain containing 3 [Source:HGNC Symbol;Acc:HGNC:25720],NA,GPATCH3,63906,NM_022078
RPS19_SIG,RPS19,RPS19_SIG,RPS19,SIG,21,1.09635423383668,1.01901795225947,1.01419338403807,1.03487010498691,0.020676720948842,0.332378884360554,1.16478199629811,9.18298635889859,9.16384180437375,9.2458898951945,0.082048090820754,0.352688877102427,ENSG00000105372,RPS19,protein_coding,19,1,41859918,41872926,q13.2,ribosomal protein S19 [Source:HGNC Symbol;Acc:HGNC:10402],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 1;RPS19-Related Diamond-Blackfan Anemia,RPS19,6223,NM_001022;NM_001321483;NM_001321484;NM_001321485
CTF1_SIG,CTF1,CTF1_SIG,CTF1,SIG,26,-1.09580500366149,-0.0757310737827126,-0.0744655278508383,-0.0798892961302996,-0.00542376827946133,0.332622680811187,-0.811366237521573,1.12443403931065,1.13933415639341,1.07547651175301,-0.063857644640405,0.529077943916963,ENSG00000150281,CTF1,protein_coding,16,1,30896607,30903560,p11.2,cardiotrophin 1 [Source:HGNC Symbol;Acc:HGNC:2499],NA,CTF1,1489,NM_001142544;NM_001330
ZNF335_TF,ZNF335,ZNF335_TF,ZNF335,TF,106,-1.09559569273373,0.0763362226484944,0.0777036078877933,0.071843385433655,-0.00586022245413834,0.332685359009054,0.872723474594973,5.84539271265441,5.83619463266751,5.87561497546854,0.0394203428010301,0.496299698738639,ENSG00000198026,ZNF335,protein_coding,20,-1,45948660,45972203,q13.12,zinc finger protein 335 [Source:HGNC Symbol;Acc:HGNC:15807],Microcephalic primordial dwarfism due to ZNF335 deficiency;MICROCEPHALY 10 PRIMARY AUTOSOMAL RECESSIVE,ZNF335,63925,NM_022095
PRPSAP1_SIG,PRPSAP1,PRPSAP1_SIG,PRPSAP1,SIG,26,1.09511111847266,0.310738325897643,0.307475228985336,0.321459930038082,0.0139847010527461,0.332894803698675,1.45344785688503,4.81930166618344,4.79483664130911,4.89968674791338,0.104850106604271,0.237454492663604,ENSG00000161542,PRPSAP1,protein_coding,17,-1,76309486,76384521,q25.1,phosphoribosyl pyrophosphate synthetase associated protein 1 [Source:HGNC Symbol;Acc:HGNC:9466],NA,PRPSAP1,5635,NM_001330503;NM_002766
PPP1R16B_SIG,PPP1R16B,PPP1R16B_SIG,PPP1R16B,SIG,68,-1.09490685713398,0.0344698960049084,0.0373741644100475,0.0249272998165945,-0.0124468645934531,0.332954815442669,-0.228094684470265,5.32498934510641,5.33579738456981,5.28947721544096,-0.0463201691288466,0.87122749175234,ENSG00000101445,PPP1R16B,protein_coding,20,1,38805697,38923024,q11.23,protein phosphatase 1 regulatory subunit 16B [Source:HGNC Symbol;Acc:HGNC:15850],NA,PPP1R16B,26051,NM_001172735;NM_015568
IL34_SIG,IL34,IL34_SIG,IL34,SIG,16,-1.09258067717603,-0.116187905891963,-0.111791802931158,-0.130632244191749,-0.0188404412605903,0.334147814241287,-2.22150158679964,0.182238123844045,0.195328550121612,0.139226723217754,-0.0561018269038587,0.0635509672120245,ENSG00000157368,IL34,protein_coding,16,1,70579895,70660682,q22.1,interleukin 34 [Source:HGNC Symbol;Acc:HGNC:28529],NA,IL34,146433,NM_001172771;NM_001172772;NM_152456
YBX1_TF,YBX1,YBX1_TF,YBX1,TF,270,1.09157212558086,0.139475803999451,0.13845061661029,0.142844276849551,0.00439366023926149,0.334638090030639,-0.634656741451701,9.02558400207273,9.03308458557349,9.00093922771309,-0.0321453578604006,0.63001584255931,ENSG00000065978,YBX1,protein_coding,1,1,42682418,42703805,p34.2,Y-box binding protein 1 [Source:HGNC Symbol;Acc:HGNC:8014],NA,YBX1,4904,NM_004559
NDST2_SIG,NDST2,NDST2_SIG,NDST2,SIG,13,-1.0913276319252,-0.109989569953792,-0.107540780387321,-0.118035592815055,-0.0104948124277339,0.334719770651745,-1.3364413605705,2.12315619169166,2.14142046528166,2.06314500703881,-0.0782754582428535,0.280445927543367,ENSG00000166507,NDST2,protein_coding,10,-1,73801911,73811798,q22.2,N-deacetylase and N-sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:7681],NA,NDST2,8509,NM_001330107;NM_003635
FLNB_SIG,FLNB,FLNB_SIG,FLNB,SIG,78,-1.0909594818154,0.0917123132765118,0.0934649492166367,0.0859536523303872,-0.00751129688624965,0.334867647585977,-1.59047513998825,7.00099929043386,7.05760484006869,6.815009627348,-0.242595212720689,0.193385365404261,ENSG00000136068,FLNB,protein_coding,3,1,58008400,58172251,p14.3,filamin B [Source:HGNC Symbol;Acc:HGNC:3755],Atelosteogenesis type 1;Atelosteogenesis type 3;Atelosteogenesis type I;ATELOSTEOGENESIS TYPE I;ATELOSTEOGENESIS TYPE III;Autosomal dominant Larsen syndrome;BOOMERANG DYSPLASIA;LARSEN SYNDROME;Spondylocarpotarsal synostosis;SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,FLNB,2317,NM_001164317;NM_001164318;NM_001164319;NM_001457
WEE1_SIG,WEE1,WEE1_SIG,WEE1,SIG,6,-1.08934901760993,0.36762937104289,0.371361290482746,0.355367350026222,-0.015993940456524,0.335681156440031,-0.628787574585483,4.6561958213345,4.66992994774726,4.61106940597831,-0.058860541768948,0.633283783169261,ENSG00000166483,WEE1,protein_coding,11,1,9573670,9593457,p15.4,WEE1 G2 checkpoint kinase [Source:HGNC Symbol;Acc:HGNC:12761],NA,WEE1,7465,NM_001143976;NM_003390
KAT5_SIG,KAT5,KAT5_SIG,KAT5,SIG,10,-1.08911435857585,0.285306775086454,0.286250265087138,0.28220673651278,-0.00404352857435782,0.335757692061924,-0.26940242094999,5.86407587262659,5.86625980609434,5.85690009123254,-0.00935971486180885,0.845757802099566,ENSG00000172977,KAT5,protein_coding,11,1,65711996,65719604,q13.1,lysine acetyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:5275],NA,KAT5,10524,NM_001206833;NM_006388;NM_182709;NM_182710
EBP_SIG,EBP,EBP_SIG,EBP,SIG,16,1.08874145337879,0.116763551734402,0.115082728426512,0.122286256888897,0.00720352846238546,0.335908377551639,2.07095008635568,4.70673120586914,4.68154312931404,4.78949202883593,0.107948899521889,0.0849000315596909,ENSG00000147155,EBP,protein_coding,X,1,48521799,48528716,p11.23,EBP, cholestenol delta-isomerase [Source:HGNC Symbol;Acc:HGNC:3133],Chondrodysplasia Punctata 2 X-Linked;CHONDRODYSPLASIA PUNCTATA 2 X-LINKED DOMINANT;Digital anomalies-intellectual disability-short stature syndrome;MEND syndrome;X-linked dominant chondrodysplasia punctata,EBP,10682,NM_006579
CCL23_SIG,CCL23,CCL23_SIG,CCL23,SIG,79,1.08832634281661,-0.0300045329379089,-0.0327435102833965,-0.0210050359455926,0.0117384743378039,0.336081742458354,1.03007135219723,1.60089578009467,1.56060392426381,1.73328330639605,0.172679382132242,0.415734819883968,ENSG00000274736,CCL23,protein_coding,17,-1,36013056,36017972,q12,C-C motif chemokine ligand 23 [Source:HGNC Symbol;Acc:HGNC:10622],NA,CCL23,6368,NM_005064;NM_145898
GSTM3_SIG,GSTM3,GSTM3_SIG,GSTM3,SIG,38,-1.08786040713304,-0.105714904758824,-0.104425432236269,-0.109951743047219,-0.00552631081095055,0.336282433591649,-0.918084410465016,1.82550326533229,1.85306301903542,1.73494978887915,-0.118113230156261,0.472220164455865,ENSG00000134202,GSTM3,protein_coding,1,-1,109733932,109741038,p13.3,glutathione S-transferase mu 3 [Source:HGNC Symbol;Acc:HGNC:4635],NA,GSTM3,2947,NM_000849
AMFR_SIG,AMFR,AMFR_SIG,AMFR,SIG,25,-1.08679109508113,0.0792817792097143,0.0804809663132972,0.0753415930122277,-0.00513937330106956,0.336807240562849,-1.29231922354091,6.19164990552605,6.20836027872486,6.13674439358708,-0.0716158851377857,0.298096875137882,ENSG00000159461,AMFR,protein_coding,16,-1,56361452,56425545,q13,autocrine motility factor receptor [Source:HGNC Symbol;Acc:HGNC:463],NA,AMFR,267,NM_001144;NM_001323511;NM_001323512
IL1B_SIG,IL1B,IL1B_SIG,IL1B,SIG,11,-1.08665491293459,0.178643112040108,0.180563787673542,0.172332320673112,-0.0082314670004295,0.336830997204026,-1.78649685993249,5.04644623977499,5.12360160890332,4.79293574121046,-0.330665867692856,0.141311517117448,ENSG00000125538,IL1B,protein_coding,2,-1,112829751,112836903,q14.1,interleukin 1 beta [Source:HGNC Symbol;Acc:HGNC:5992],GASTRIC CANCER HEREDITARY DIFFUSE,IL1B,3553,NM_000576
FOSB_TF,FOSB,FOSB_TF,FOSB,TF,85,-1.08434288461138,0.0766650213956969,0.0780286897544467,0.0721843967883762,-0.00584429296607043,0.338025081097202,-0.768209151859215,8.72998162372859,8.75830702206054,8.63691245778079,-0.121394564279743,0.553244381018,ENSG00000125740,FOSB,protein_coding,19,1,45467995,45475179,q13.32,FosB proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:3797],NA,FOSB,2354,NM_001114171;NM_006732
HIPK2_SIG,HIPK2,HIPK2_SIG,HIPK2,SIG,18,-1.08258854937243,0.298862690503222,0.301115212231554,0.29146154768156,-0.00965366454999433,0.338920996750731,-1.58539861689284,6.80891845912884,6.84522760755396,6.6896169714463,-0.155610636107654,0.194870315684594,ENSG00000064393,HIPK2,protein_coding,7,-1,139561570,139777998,q34,homeodomain interacting protein kinase 2 [Source:HGNC Symbol;Acc:HGNC:14402],NA,HIPK2,28996,NM_001113239;NM_022740
RIPK2_SIG,RIPK2,RIPK2_SIG,RIPK2,SIG,38,-1.08089977340871,0.37993056659215,0.385095493249063,0.362960093290864,-0.0221353999581984,0.339783020079949,-0.534027891143941,5.99117127196986,6.00505771122064,5.94554440014589,-0.0595133110747447,0.689797889096996,ENSG00000104312,RIPK2,protein_coding,8,1,89757806,89791064,q21.3,receptor interacting serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:10020],NA,RIPK2,8767,NM_003821
ZFY_TF,ZFY,ZFY_TF,ZFY,TF,44,-1.078908082247,-0.108224717415883,-0.100779496775925,-0.132687585232886,-0.0319080884569601,0.340810440512664,-0.512696081647905,2.77274811469398,2.805360737841,2.66559235292521,-0.139768384915789,0.702120200866987,ENSG00000067646,ZFY,protein_coding,Y,1,2935281,2982506,p11.2,zinc finger protein Y-linked [Source:HGNC Symbol;Acc:HGNC:12870],NA,ZFY,7544,NM_001145275;NM_001145276;NM_003411
USP9X_SIG,USP9X,USP9X_SIG,USP9X,SIG,47,-1.07825678534814,0.622475284982636,0.624129138507823,0.617041194828451,-0.00708794367937167,0.341113202192861,0.199597450502135,7.14415385573123,7.14150357049983,7.15286193577725,0.0113583652774167,0.887333581776222,ENSG00000124486,USP9X,protein_coding,X,1,41085445,41236579,p11.4,ubiquitin specific peptidase 9 X-linked [Source:HGNC Symbol;Acc:HGNC:12632],Mental retardation X-linked 99;MENTAL RETARDATION X-LINKED 99 SYNDROMIC FEMALE-RESTRICTED;X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability;X-linked non-syndromic intellectual disability,USP9X,8239,NM_001039590;NM_001039591
HDGF_SIG,HDGF,HDGF_SIG,HDGF,SIG,55,-1.07766385609094,0.0922028806203414,0.0939662636418276,0.0864089078354581,-0.00755735580636956,0.341384486026591,-2.4747928020981,8.65700815090771,8.68959320049407,8.54994298798112,-0.139650212512953,0.0373143796147732,ENSG00000143321,HDGF,protein_coding,1,-1,156742109,156766925,q23.1,heparin binding growth factor [Source:HGNC Symbol;Acc:HGNC:4856],NA,HDGF,3068,NM_001126050;NM_001126051;NM_001319186;NM_001319187;NM_001319188;NM_004494
MRPL16_SIG,MRPL16,MRPL16_SIG,MRPL16,SIG,9,1.07718918730926,0.382073542239527,0.380145910641306,0.388407188919398,0.00826127827809222,0.341591769806482,1.91997160070091,5.25206699466909,5.22517118394282,5.34043894419824,0.115267760255412,0.112284618389301,ENSG00000166902,MRPL16,protein_coding,11,-1,59806140,59810778,q12.1,mitochondrial ribosomal protein L16 [Source:HGNC Symbol;Acc:HGNC:14476],NA,MRPL16,54948,NM_017840
ALAD_SIG,ALAD,ALAD_SIG,ALAD,SIG,30,-1.07643229278831,0.267250389242513,0.270024408277521,0.258135755270344,-0.011888653007177,0.341952228599177,-1.05487832547609,6.32160914944016,6.34038528852019,6.25991612103434,-0.0804691674858536,0.403677014857263,ENSG00000148218,ALAD,protein_coding,9,-1,113386312,113401290,q32,aminolevulinate dehydratase [Source:HGNC Symbol;Acc:HGNC:395],Acute Hepatic Porphyria;PORPHYRIA ACUTE HEPATIC;Porphyria due to ALA dehydratase deficiency,ALAD,210,NM_000031;NM_001003945;NM_001317745
CREBRF_TF,CREBRF,CREBRF_TF,CREBRF,TF,262,-1.07536135553041,-0.0478006667077163,-0.045142059265937,-0.0565360911592768,-0.0113940318933397,0.342483449391109,-0.524959762608649,5.77094095072493,5.78143625322539,5.73645638536629,-0.0449798678591024,0.695339467202325,ENSG00000164463,CREBRF,protein_coding,5,1,173056352,173139284,q35.1,CREB3 regulatory factor [Source:HGNC Symbol;Acc:HGNC:24050],NA,CREBRF,153222,NM_001168393;NM_001168394;NM_153607
HELZ_TF,HELZ,HELZ_TF,HELZ,TF,108,1.07464981867879,0.42812854986379,0.427086386881848,0.431552799661601,0.00446641277975266,0.342819829494288,1.78838938294005,7.30285688701584,7.2812417376618,7.37387809203627,0.0926363543744628,0.140963702213631,ENSG00000198265,HELZ,protein_coding,17,-1,67070444,67245989,q24.2,helicase with zinc finger [Source:HGNC Symbol;Acc:HGNC:16878],NA,HELZ,9931,NM_001330447;NM_014877
SALL4_TF,SALL4,SALL4_TF,SALL4,TF,131,1.07299043637223,-0.0905506905049172,-0.0917510295566733,-0.0866067193348615,0.00514431022181186,0.343672096640518,-0.212586564992429,1.05866690730916,1.06543097606476,1.03644210996935,-0.0289888660954077,0.880173256280121,ENSG00000101115,SALL4,protein_coding,20,-1,51782331,51802521,q13.2,spalt like transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:15924],Acro-Renal-Ocular syndrome;DUANE-RADIAL RAY SYNDROME;IVIC SYNDROME;Okihiro syndrome due to 20q13 microdeletion;Okihiro syndrome due to a point mutation,SALL4,57167,NM_001318031;NM_020436
NOSIP_SIG,NOSIP,NOSIP_SIG,NOSIP,SIG,23,-1.07270453623624,0.158025127260529,0.160827560038626,0.148817133846784,-0.0120104261918424,0.34377740720766,-0.956646152429049,4.94487821607762,4.95686453031513,4.90549461215436,-0.0513699181607779,0.452256878776803,ENSG00000142546,NOSIP,protein_coding,19,-1,49555711,49590262,q13.33,nitric oxide synthase interacting protein [Source:HGNC Symbol;Acc:HGNC:17946],NA,NOSIP,51070,NM_001270960;NM_015953
RPS21_SIG,RPS21,RPS21_SIG,RPS21,SIG,54,1.0723137049622,0.724944537138805,0.720666218617109,0.739001869424374,0.0183356508072648,0.343939874644357,1.61318877713021,7.24508670218504,7.21308242467053,7.35024361401842,0.137161189347889,0.186877454082616,ENSG00000171858,RPS21,protein_coding,20,1,62387103,62388520,q13.33,ribosomal protein S21 [Source:HGNC Symbol;Acc:HGNC:10409],NA,RPS21,6227,NM_001024
SLC4A1AP_SIG,SLC4A1AP,SLC4A1AP_SIG,SLC4A1AP,SIG,28,1.07221127320788,0.46505664674242,0.462133483894508,0.474661324671274,0.0125278407767662,0.34394530913378,2.53929885327447,4.83151565021797,4.8020127607988,4.92845371545238,0.126440954653575,0.032420979157765,ENSG00000163798,SLC4A1AP,protein_coding,2,1,27663471,27694976,p23.3,solute carrier family 4 member 1 adaptor protein [Source:HGNC Symbol;Acc:HGNC:13813],NA,SLC4A1AP,22950,NM_018158
NRXN2_SIG,NRXN2,NRXN2_SIG,NRXN2,SIG,9,1.07154046718732,-0.0422600795148166,-0.0440534028674036,-0.0363677313563162,0.00768567151108736,0.344260343953259,0.416738558242031,4.16312273620288,4.14129305286809,4.23484883858865,0.0935557857205583,0.758959253065226,ENSG00000110076,NRXN2,protein_coding,11,-1,64606174,64723188,q13.1,neurexin 2 [Source:HGNC Symbol;Acc:HGNC:8009],Autism,NRXN2,9379,NM_015080;NM_138732;NM_138734
IGFALS_SIG,IGFALS,IGFALS_SIG,IGFALS,SIG,33,1.07090228753214,-0.0259725514194932,-0.0279833816237513,-0.0193655378912165,0.00861784373253477,0.344557762266053,0.90313943263077,0.497817335729251,0.48965851636065,0.524624885083225,0.0349663687225743,0.480184874697355,ENSG00000099769,IGFALS,protein_coding,16,-1,1790413,1794971,p13.3,insulin like growth factor binding protein acid labile subunit [Source:HGNC Symbol;Acc:HGNC:5468],Acid-labile subunit deficiency;Short stature due to primary acid-labile subunit deficiency,IGFALS,3483,NM_001146006;NM_004970
RAPGEFL1_SIG,RAPGEFL1,RAPGEFL1_SIG,RAPGEFL1,SIG,16,-1.06989920061412,-0.079190850161602,-0.0770529872770459,-0.0862152567822863,-0.00916226950524046,0.345054410880288,-2.10527996420589,2.89009566212024,2.92722352783676,2.76810410333738,-0.159119424499383,0.0796155818194915,ENSG00000108352,RAPGEFL1,protein_coding,17,1,40177010,40195656,q21.1,Rap guanine nucleotide exchange factor like 1 [Source:HGNC Symbol;Acc:HGNC:17428],NA,RAPGEFL1,51195,NM_001303533;NM_001303534;NM_016339
SEMA4D_SIG,SEMA4D,SEMA4D_SIG,SEMA4D,SIG,55,-1.0696794353284,0.294729826670635,0.296427567181967,0.289151536419116,-0.00727603076285113,0.345123850395541,2.05715641887086,7.09278459674369,7.05756100027417,7.20851927085786,0.150958270583695,0.0872280807173503,ENSG00000187764,SEMA4D,protein_coding,9,-1,89360787,89498130,q22.2,semaphorin 4D [Source:HGNC Symbol;Acc:HGNC:10732],NA,SEMA4D,10507,NM_001142287;NM_006378
C2_SIG,C2,C2_SIG,C2,SIG,31,-1.06920965073289,-0.0600341164316235,-0.0573204331653527,-0.0689505043065134,-0.0116300711411608,0.345329767963489,0.287568813535957,1.81491432066842,1.80242471770526,1.85595158754737,0.0535268698421071,0.835309074329192,ENSG00000166278,C2,protein_coding,6,1,31897785,31945672,p21.33,complement C2 [Source:HGNC Symbol;Acc:HGNC:1248],COMPLEMENT COMPONENT 2 DEFICIENCY;Immunodeficiency due to a classical component pathway complement deficiency;MACULAR DEGENERATION AGE-RELATED 14,C2,717,NM_000063;NM_001145903;NM_001178063;NM_001282457;NM_001282458;NM_001282459
NUCB2_SIG,NUCB2,NUCB2_SIG,NUCB2,SIG,89,1.06560948803784,0.182893551443602,0.180109802459536,0.192040155248391,0.0119303527888549,0.34724813196131,-0.524775202819189,8.08159422642496,8.09632451696868,8.03319470035274,-0.0631298166159393,0.695417634612811,ENSG00000070081,NUCB2,protein_coding,11,1,17208153,17349980,p15.1,nucleobindin 2 [Source:HGNC Symbol;Acc:HGNC:8044],NA,NUCB2,4925,NM_001330227;NM_001352661;NM_001352662;NM_001352663;NM_001352664;NM_001352665;NM_001352666;NM_001352667;NM_001352668;NM_001352669;NM_001352670;NM_001352671;NM_001352672;NM_005013
STX2_SIG,STX2,STX2_SIG,STX2,SIG,32,1.06396197493423,0.151999537244141,0.150202119080155,0.157905339782953,0.00770322070279793,0.348076008298197,1.10701848523426,4.32063479588207,4.29516893288611,4.40430834572592,0.109139412839809,0.379108756721958,ENSG00000111450,STX2,protein_coding,12,-1,130789600,130839266,q24.33,syntaxin 2 [Source:HGNC Symbol;Acc:HGNC:3403],NA,STX2,2054,NM_001351049;NM_001351050;NM_001351051;NM_001351052;NM_001980;NM_194356
RBL1_TF,RBL1,RBL1_TF,RBL1,TF,199,-1.0639143112903,0.232796875351647,0.235959226644721,0.222406292531546,-0.0135529341131747,0.348076008298197,-1.94192199212975,4.58158865908226,4.62272389880527,4.44643001427811,-0.176293884527157,0.107956725507739,ENSG00000080839,RBL1,protein_coding,20,-1,36996349,37095995,q11.23,RB transcriptional corepressor like 1 [Source:HGNC Symbol;Acc:HGNC:9893],NA,RBL1,5933,NM_001323281;NM_001323282;NM_002895;NM_183404
MTHFD2_SIG,MTHFD2,MTHFD2_SIG,MTHFD2,SIG,39,-1.0624323585165,0.149053215906728,0.15023583331801,0.145167472983943,-0.0050683603340672,0.348838889935505,-0.184758958585108,5.61633135079868,5.62008537324884,5.60399670560533,-0.0160886676435111,0.895945807333929,ENSG00000065911,MTHFD2,protein_coding,2,1,74198610,74217565,p13.1,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase [Source:HGNC Symbol;Acc:HGNC:7434],NA,MTHFD2,10797,NM_006636
PABPC4_SIG,PABPC4,PABPC4_SIG,PABPC4,SIG,35,-1.06224468646068,0.14005923312843,0.141553728567053,0.135148748115808,-0.00640498045124509,0.348891034940807,-1.76342083312909,7.6979389822199,7.72128215776573,7.62123997685506,-0.100042180910665,0.146940573278046,ENSG00000090621,PABPC4,protein_coding,1,-1,39560816,39576790,p34.3,poly(A) binding protein cytoplasmic 4 [Source:HGNC Symbol;Acc:HGNC:8557],NA,PABPC4,8761,NM_001135653;NM_001135654;NM_003819
IPPK_SIG,IPPK,IPPK_SIG,IPPK,SIG,17,-1.06184081310488,0.17149092500536,0.17271655730972,0.167463847433893,-0.00525270987582674,0.349062024454345,0.0150636393469347,3.38017353846864,3.38002139078453,3.38067345228787,0.000652061503346549,0.991628859641664,ENSG00000127080,IPPK,protein_coding,9,-1,92613183,92670131,q22.31,inositol-pentakisphosphate 2-kinase [Source:HGNC Symbol;Acc:HGNC:14645],NA,IPPK,64768,NM_022755
CARS_SIG,CARS,CARS_SIG,CARS,SIG,11,-1.06098426475417,0.301677597397737,0.30294593841893,0.297510191185248,-0.00543574723368191,0.349482039403878,0.578959519553815,5.43737323718558,5.43112530028042,5.45790217273109,0.0267768724506663,0.663420908234721,ENSG00000110619,CARS,protein_coding,11,-1,3000922,3057613,p15.4,cysteinyl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:1493],Inflammatory myofibroblastic tumor,CARS,833,NM_001014437;NM_001194997;NM_001751;NM_139273
TIGD7_TF,TIGD7,TIGD7_TF,TIGD7,TF,16,1.06023726516965,-0.0539446600618939,-0.0571219746260667,-0.0435049122081831,0.0136170624178836,0.349842048896844,0.814260746433725,2.63748061569151,2.61421921027252,2.7139109477825,0.0996917375099868,0.527366954624694,ENSG00000140993,TIGD7,protein_coding,16,-1,3298808,3305729,p13.3,tigger transposable element derived 7 [Source:HGNC Symbol;Acc:HGNC:18331],NA,TIGD7,91151,NM_033208
TRIB3_SIG,TRIB3,TRIB3_SIG,TRIB3,SIG,42,1.05992833031358,0.0881081704579479,0.0865014526060836,0.0933873862569306,0.00688593365084717,0.349961021188105,0.924307234367198,3.58293011050712,3.55991900203344,3.65853803834922,0.09861903631578,0.468724659472482,ENSG00000101255,TRIB3,protein_coding,20,1,362835,397559,p13,tribbles pseudokinase 3 [Source:HGNC Symbol;Acc:HGNC:16228],NA,TRIB3,57761,NM_001301188;NM_001301190;NM_001301193;NM_001301196;NM_001301201;NM_021158
TRIM36_SIG,TRIM36,TRIM36_SIG,TRIM36,SIG,35,-1.05907374030494,0.081698207980034,0.0841761406896726,0.0735564290769356,-0.0106197116127372,0.35038059753629,-0.135397758381929,1.04237188329414,1.04570499823368,1.03142021992139,-0.0142847783122847,0.92399392361929,ENSG00000152503,TRIM36,protein_coding,5,-1,115124762,115180546,q22.3,tripartite motif containing 36 [Source:HGNC Symbol;Acc:HGNC:16280],Anencephaly,TRIM36,55521,NM_001017397;NM_001017398;NM_001300752;NM_001300759;NM_018700
SEMA3B_SIG,SEMA3B,SEMA3B_SIG,SEMA3B,SIG,19,-1.05887702781204,-0.108070049717335,-0.105893280588758,-0.115222291139799,-0.00932901055104097,0.350437821238029,-1.2873550565227,1.12453904119307,1.14876456891463,1.0449408786794,-0.103823690235223,0.29998365858325,ENSG00000012171,SEMA3B,protein_coding,3,1,50267558,50277546,p21.31,semaphorin 3B [Source:HGNC Symbol;Acc:HGNC:10724],NA,SEMA3B,7869,NM_001005914;NM_001290060;NM_001290061;NM_001290062;NM_001290063;NM_004636
ADCY7_SIG,ADCY7,ADCY7_SIG,ADCY7,SIG,43,-1.05852770258975,0.365833902321031,0.368639183185984,0.356616550907616,-0.0120226322783681,0.3505791616033,0.608306856722217,7.45747095233454,7.44286482984826,7.50546249764659,0.062597667798329,0.645772576806711,ENSG00000121281,ADCY7,protein_coding,16,1,50246137,50318135,q12.1,adenylate cyclase 7 [Source:HGNC Symbol;Acc:HGNC:238],NA,ADCY7,113,NM_001114;NM_001286057
ZNF415_TF,ZNF415,ZNF415_TF,ZNF415,TF,21,1.05580224908507,-0.149985278805388,-0.152375163570498,-0.142132800291454,0.0102423632790446,0.352032154233745,1.15474743558149,1.3278778740379,1.29774766203095,1.42687714206075,0.129129480029797,0.357277660167442,ENSG00000170954,ZNF415,protein_coding,19,-1,53107879,53133077,q13.42,zinc finger protein 415 [Source:HGNC Symbol;Acc:HGNC:20636],NA,ZNF415,55786,NM_001136038;NM_001164309;NM_001330759;NM_001330766;NM_001352130;NM_001352131;NM_001352132;NM_001352133;NM_001352134;NM_001352135;NM_001352136;NM_001352137;NM_001352138;NM_001352139;NM_001352140;NM_001352141;NM_001352142;NM_001352143;NM_001352144;NM_001352146;NM_001352147;NM_001352148;NM_001352149;NM_001352150;NM_001352151;NM_018355
ACAD8_SIG,ACAD8,ACAD8_SIG,ACAD8,SIG,34,-1.05561593490986,0.0115249534523221,0.0126001544525662,0.00799215016580564,-0.00460800428676048,0.352083739820038,0.407108280388934,4.67127883348717,4.66606115290916,4.68842264110065,0.0223614881914875,0.764286157454343,ENSG00000151498,ACAD8,protein_coding,11,1,134253495,134265855,q25,acyl-CoA dehydrogenase family member 8 [Source:HGNC Symbol;Acc:HGNC:87],ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY,ACAD8,27034,NM_014384
SON_TF,SON,SON_TF,SON,TF,28,1.05416365223765,0.458329555049357,0.456540689570147,0.464207255909617,0.0076665663394695,0.352803994433749,1.72509796275065,9.09571107328751,9.07852056913073,9.15219415837407,0.073673589243345,0.156588296228495,ENSG00000159140,SON,protein_coding,21,1,33543038,33577514,q22.11,SON DNA binding protein [Source:HGNC Symbol;Acc:HGNC:11183],Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome;Intellectual Disability Congenital Malformations and Failure to Thrive;ZTTK SYNDROME,SON,6651,NM_001291411;NM_001291412;NM_032195;NM_138927
SLC25A33_SIG,SLC25A33,SLC25A33_SIG,SLC25A33,SIG,50,1.05412765826264,0.225328372435045,0.223365047642651,0.231779296752911,0.00841424911025963,0.352803994433749,1.3390639752987,3.22314935452849,3.19753334238589,3.30731625156846,0.109782909182568,0.279521175087856,ENSG00000171612,SLC25A33,protein_coding,1,1,9539465,9585173,p36.22,solute carrier family 25 member 33 [Source:HGNC Symbol;Acc:HGNC:29681],NA,SLC25A33,84275,NM_032315
ZNF793_TF,ZNF793,ZNF793_TF,ZNF793,TF,66,-1.0539626358783,-0.0390750815796719,-0.0364854075208585,-0.0475840106300586,-0.0110986031091999,0.352843842870189,-0.411520016420381,2.07169641759786,2.08585962685301,2.02516015861664,-0.0606994682363654,0.761783125825663,ENSG00000188227,ZNF793,protein_coding,19,1,37506939,37548762,q13.12,zinc finger protein 793 [Source:HGNC Symbol;Acc:HGNC:33115],NA,ZNF793,390927,NM_001013659
PCSK7_SIG,PCSK7,PCSK7_SIG,PCSK7,SIG,87,-1.05319562904097,0.0316121815032991,0.032954964604991,0.0272001798834542,-0.00575478472153677,0.353178777830163,0.363722661067148,6.25895643788015,6.25385898343429,6.27570521677369,0.0218462333394037,0.789836704884185,ENSG00000160613,PCSK7,protein_coding,11,-1,117204337,117232525,q23.3,proprotein convertase subtilisin/kexin type 7 [Source:HGNC Symbol;Acc:HGNC:8748],NA,PCSK7,9159,NM_004716
DDX3Y_SIG,DDX3Y,DDX3Y_SIG,DDX3Y,SIG,22,-1.05317157010105,-0.124776735544681,-0.111211154697205,-0.169349358329247,-0.0581382036320424,0.353178777830163,-0.979995171671661,4.55637519752295,4.65457337503976,4.23372404282486,-0.4208493322149,0.440743457666324,ENSG00000067048,DDX3Y,protein_coding,Y,1,12904108,12920478,q11.221,DEAD-box helicase 3 Y-linked [Source:HGNC Symbol;Acc:HGNC:2699],Partial chromosome Y deletion;SPERMATOGENIC FAILURE Y-LINKED 2,DDX3Y,8653,NM_001122665;NM_001302552;NM_001324195;NM_004660
GABPA_TF,GABPA,GABPA_TF,GABPA,TF,89,1.05097087390085,0.402588015229115,0.401650284808313,0.405669129468891,0.00401884466057822,0.354331744828226,-0.589041877435526,5.53153906890274,5.53850736581444,5.50864323619289,-0.0298641296215507,0.657833870729812,ENSG00000154727,GABPA,protein_coding,21,1,25734570,25772460,q21.3,GA binding protein transcription factor subunit alpha [Source:HGNC Symbol;Acc:HGNC:4071],NA,GABPA,2551,NM_001197297;NM_002040
FOXO4_TF,FOXO4,FOXO4_TF,FOXO4,TF,188,1.05090547768863,0.00753267835881624,0.00648054885302553,0.0109896753064143,0.00450912645338889,0.354331744828226,0.222153860437985,5.33472307481957,5.33194490306272,5.34385135344924,0.0119064503865172,0.874430704075615,ENSG00000184481,FOXO4,protein_coding,X,1,71096197,71103535,q13.1,forkhead box O4 [Source:HGNC Symbol;Acc:HGNC:7139],NA,FOXO4,4303,NM_001170931;NM_005938
DHX36_SIG,DHX36,DHX36_SIG,DHX36,SIG,62,1.05060458590383,0.369352829215913,0.367384911604779,0.375818844223926,0.00843393261914687,0.354447053285504,1.09851579911867,5.73170792750089,5.71594202743034,5.78351017058985,0.0675681431595133,0.383146739284929,ENSG00000174953,DHX36,protein_coding,3,-1,154272546,154324487,q25.2,DEAH-box helicase 36 [Source:HGNC Symbol;Acc:HGNC:14410],NA,DHX36,170506,NM_001114397;NM_020865
SLC35A1_SIG,SLC35A1,SLC35A1_SIG,SLC35A1,SIG,78,-1.05015698111872,0.264275088630616,0.268116900490852,0.251651992518412,-0.0164649079724406,0.354643826422887,-0.516561939319745,3.25604796738453,3.26721780398416,3.21934707570005,-0.047870728284105,0.700027109989559,ENSG00000164414,SLC35A1,protein_coding,6,1,87470623,87512336,q15,solute carrier family 35 member A1 [Source:HGNC Symbol;Acc:HGNC:11021],CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIf;Congenital Disorders of Glycosylation;SLC35A1-CDG,SLC35A1,10559,NM_001168398;NM_006416
ARID2_TF,ARID2,ARID2_TF,ARID2,TF,55,1.04956494953622,0.405097057686369,0.403133588007391,0.411548458060153,0.00841487005276224,0.354920873612335,1.44359056660297,6.35753891251884,6.33540380427032,6.43026855390686,0.094864749636538,0.240698357957851,ENSG00000189079,ARID2,protein_coding,12,1,45729706,45908040,q12,AT-rich interaction domain 2 [Source:HGNC Symbol;Acc:HGNC:18037],ARID2-Coffin-Siris like disorder;COFFIN-SIRIS SYNDROME;COFFIN-SIRIS SYNDROME 6,ARID2,196528,NM_001347839;NM_152641
VHL_SIG,VHL,VHL_SIG,VHL,SIG,30,-1.04918035234431,0.287617427280337,0.288663504483875,0.284180316468711,-0.00448318801516461,0.355036293462462,-0.0124907655055809,6.38198927516153,6.38211534971051,6.38157503021489,-0.000540319495613171,0.993034436977115,ENSG00000134086,VHL,protein_coding,3,1,10141008,10152220,p25.3,von Hippel-Lindau tumor suppressor [Source:HGNC Symbol;Acc:HGNC:12687],Chuvash erythrocytosis;ERYTHROCYTOSIS FAMILIAL 2;Hereditary pheochromocytoma-paraganglioma;Pheochromocytoma;RENAL CELL CARCINOMA NONPAPILLARY;Sporadic pheochromocytoma;Von Hippel-Lindau disease;VON HIPPEL-LINDAU SYNDROME,VHL,7428,NM_000551;NM_198156
PXK_SIG,PXK,PXK_SIG,PXK,SIG,64,-1.049147327265,0.306648338062464,0.309073232315212,0.298680828374864,-0.010392403940348,0.355036293462462,-0.760201626683223,6.47356346943041,6.48747747681762,6.42784601658675,-0.0596314602308646,0.557653914077233,ENSG00000168297,PXK,protein_coding,3,1,58332880,58426126,p14.3,PX domain containing serine/threonine kinase like [Source:HGNC Symbol;Acc:HGNC:23326],Systemic lupus erythematosus,PXK,54899,NM_001289095;NM_001289096;NM_001289098;NM_001289099;NM_001289100;NM_001289101;NM_001349488;NM_001349489;NM_001349490;NM_001349491;NM_001349492;NM_001349493;NM_001349494;NM_001349495;NM_001349496;NM_001349497;NM_001349498;NM_001349499;NM_001349500;NM_001349501;NM_001349502;NM_001349503;NM_001349504;NM_001349506;NM_001349507;NM_001349508;NM_001349509;NM_001349510;NM_001349511;NM_001349512;NM_001349513;NM_001349514;NM_001349515;NM_001349516;NM_001349517;NM_001349518;NM_001349519;NM_001349520;NM_001349521;NM_001349522;NM_001349524;NM_001349525;NM_001349526;NM_001349527;NM_001349528;NM_001349529;NM_001349530;NM_001349531;NM_001349532;NM_001349533;NM_001349534;NM_001349535;NM_001349536;NM_001349537;NM_001349538;NM_001349539;NM_001349540;NM_017771
MBD4_SIG,MBD4,MBD4_SIG,MBD4,SIG,12,-1.04907778479859,0.24334477825713,0.245666150962238,0.235717410797487,-0.00994874016475129,0.355036293462462,0.140903137455477,5.80773733448358,5.80628994920986,5.81249302895435,0.00620307974448133,0.921100767114409,ENSG00000129071,MBD4,protein_coding,3,-1,129430944,129440179,q21.3,methyl-CpG binding domain 4, DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:6919],NA,MBD4,8930,NM_001276270;NM_001276271;NM_001276272;NM_001276273;NM_003925
HBP1_SIG,HBP1,HBP1_SIG,HBP1,SIG,39,-1.04861091792975,0.629280722970992,0.631947683662055,0.62051785212893,-0.0114298315331248,0.355243938956688,-0.161832353433214,5.8939161401707,5.89698644589132,5.88382799280294,-0.0131584530883808,0.909379058034315,ENSG00000105856,HBP1,protein_coding,7,1,107168961,107202522,q22.3,HMG-box transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:23200],NA,HBP1,26959,NM_001244262;NM_012257
MRPS5_SIG,MRPS5,MRPS5_SIG,MRPS5,SIG,22,1.04803776639729,0.26972684037786,0.26701225706498,0.278646185548754,0.0116339284837741,0.355510734194007,0.42511477453933,5.63806299129378,5.63267957260476,5.65575136698629,0.0230717943815345,0.753597228594973,ENSG00000144029,MRPS5,protein_coding,2,-1,95085369,95149434,q11.1,mitochondrial ribosomal protein S5 [Source:HGNC Symbol;Acc:HGNC:14498],NA,MRPS5,64969,NM_001321995;NM_001321996;NM_001321997;NM_031902
MPP1_SIG,MPP1,MPP1_SIG,MPP1,SIG,33,-1.04636316901445,0.0442667769203278,0.0465306587767524,0.036828307963504,-0.00970235081324842,0.356390598774345,-0.418598978171698,7.20387377684872,7.2107373390807,7.18132207237222,-0.0294152667084805,0.75784065798396,ENSG00000130830,MPP1,protein_coding,X,-1,154778684,154821007,q28,membrane palmitoylated protein 1 [Source:HGNC Symbol;Acc:HGNC:7219],NA,MPP1,4354,NM_001166460;NM_001166461;NM_001166462;NM_002436
SLK_SIG,SLK,SLK_SIG,SLK,SIG,21,-1.04550776328441,0.352775262268135,0.353990855625494,0.348781169808242,-0.00520968581725241,0.356815159673397,0.910202609275615,6.97381706339764,6.96205623197451,7.0124597952165,0.0504035632419874,0.476557507285125,ENSG00000065613,SLK,protein_coding,10,1,103967140,104029233,q24.33,STE20 like kinase [Source:HGNC Symbol;Acc:HGNC:11088],NA,SLK,9748,NM_001304743;NM_014720
SARNP_TF,SARNP,SARNP_TF,SARNP,TF,51,1.04495966037771,0.172721568103693,0.170636521829603,0.179572434432845,0.00893591260324249,0.357068681352284,1.71512628453111,1.20004748611005,1.18252438937739,1.25762337537448,0.075098985997088,0.159312853938643,ENSG00000205323,SARNP,protein_coding,12,-1,55752463,55817724,q13.2,SAP domain containing ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:24432],NA,SARNP,84324,NM_033082
RPS15A_SIG,RPS15A,RPS15A_SIG,RPS15A,SIG,18,1.04467491172052,0.832024308302334,0.828240228266472,0.844457714134451,0.0162174858679797,0.357175447695082,2.34021452256105,5.51944016339226,5.48301311504461,5.63912903653452,0.15611592148991,0.0497937354020114,ENSG00000134419,RPS15A,protein_coding,16,-1,18781295,18790383,p12.3,ribosomal protein S15a [Source:HGNC Symbol;Acc:HGNC:10389],NA,RPS15A,6210,NM_001019;NM_001030009
ICMT_SIG,ICMT,ICMT_SIG,ICMT,SIG,61,1.04340255112907,0.371406180355138,0.367455280579518,0.384387708189318,0.0169324276098002,0.357823379167853,1.23914404843503,5.40208827264811,5.36985574706503,5.50799514242109,0.138139395356055,0.319937453493776,ENSG00000116237,ICMT,protein_coding,1,-1,6221193,6235972,p36.31,isoprenylcysteine carboxyl methyltransferase [Source:HGNC Symbol;Acc:HGNC:5350],NA,ICMT,23463,NM_012405
PFKL_SIG,PFKL,PFKL_SIG,PFKL,SIG,24,1.04330411105218,0.401301430554179,0.400039430293814,0.405448002838236,0.00540857254442164,0.357823379167853,1.236303286146,7.56604555689986,7.55129679233735,7.61450578331951,0.0632089909821527,0.32107422526248,ENSG00000141959,PFKL,protein_coding,21,1,44300051,44327376,q22.3,phosphofructokinase, liver type [Source:HGNC Symbol;Acc:HGNC:8876],NA,PFKL,5211,NM_001002021;NM_002626
ZNF341_TF,ZNF341,ZNF341_TF,ZNF341,TF,140,1.04323367055066,0.0360725657496462,0.0336714307713476,0.0439620092497701,0.0102905784784224,0.357823379167853,1.49003661372648,3.01770739107744,2.99718315679734,3.08514416085492,0.0879610040575754,0.225252210569595,ENSG00000131061,ZNF341,protein_coding,20,1,33731657,33792269,q11.22,zinc finger protein 341 [Source:HGNC Symbol;Acc:HGNC:15992],NA,ZNF341,84905,NM_001282933;NM_001282935;NM_032819
NDUFA12_SIG,NDUFA12,NDUFA12_SIG,NDUFA12,SIG,13,1.04194245910352,0.45082586268474,0.448838051611208,0.457357241926344,0.00851919031513589,0.358461021991524,2.01880921922263,4.86873142053966,4.84397065592803,4.95008821854929,0.106117562621264,0.0938215823816493,ENSG00000184752,NDUFA12,protein_coding,12,-1,94897055,95003748,q22,NADH:ubiquinone oxidoreductase subunit A12 [Source:HGNC Symbol;Acc:HGNC:23987],Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 23,NDUFA12,55967,NM_001258338;NM_018838
BRD4_SIG,BRD4,BRD4_SIG,BRD4,SIG,25,-1.04190530241679,0.398409389816215,0.399639081914781,0.39436897292093,-0.00527010899385104,0.358461021991524,-0.555031121293597,7.16832689050886,7.17401979590823,7.14962162991092,-0.0243981659973169,0.677830653618211,ENSG00000141867,BRD4,protein_coding,19,-1,15235519,15332545,p13.12,bromodomain containing 4 [Source:HGNC Symbol;Acc:HGNC:13575],NUT midline carcinoma,BRD4,23476,NM_001330384;NM_014299;NM_058243
ZNF432_TF,ZNF432,ZNF432_TF,ZNF432,TF,48,1.04053830128674,0.179594569996101,0.176982528721459,0.188176991327067,0.0111944626056083,0.359173160041927,1.97144639110752,3.75049859087528,3.71526652094374,3.86626110636463,0.150994585420895,0.102295382695171,ENSG00000256087,ZNF432,protein_coding,19,-1,52031378,52095738,q13.41,zinc finger protein 432 [Source:HGNC Symbol;Acc:HGNC:20810],NA,ZNF432,9668,NM_001322284;NM_001322285;NM_014650
RDM1_SIG,RDM1,RDM1_SIG,RDM1,SIG,14,-1.03951864173852,0.162009353936597,0.166929076972396,0.145844549676115,-0.0210845272962808,0.359691633908485,0.677547770518275,0.327165029344407,0.32121484924496,0.346715621099731,0.0255007718547713,0.604686938625333,ENSG00000278023,RDM1,protein_coding,17,-1,35918066,35930773,q12,RAD52 motif containing 1 [Source:HGNC Symbol;Acc:HGNC:19950],NA,RDM1,201299,NM_001034836;NM_001163120;NM_001163121;NM_001163122;NM_001163124;NM_001163125;NM_001163130;NM_001330194;NM_145654
ZMYND8_SIG,ZMYND8,ZMYND8_SIG,ZMYND8,SIG,19,1.03904776364843,0.056242962570906,0.0539164358438938,0.0638872646739463,0.00997082883005253,0.35990305369784,1.07422923136324,5.90145296510598,5.87893053093854,5.97545524879901,0.0965247178604782,0.394722479171578,ENSG00000101040,ZMYND8,protein_coding,20,-1,47209214,47356889,q13.12,zinc finger MYND-type containing 8 [Source:HGNC Symbol;Acc:HGNC:9397],NA,ZMYND8,23613,NM_001281771;NM_001281772;NM_001281773;NM_001281774;NM_001281775;NM_001281776;NM_001281777;NM_001281778;NM_001281779;NM_001281780;NM_001281781;NM_001281782;NM_001281783;NM_001281784;NM_001363714;NM_001363741;NM_012408;NM_183047;NM_183048
VIPR2_SIG,VIPR2,VIPR2_SIG,VIPR2,SIG,24,1.03889388382105,-0.0757835744992634,-0.077477365877528,-0.0702182599706794,0.0072591059068487,0.359936930603195,0.977031460866558,0.274521645955439,0.264385490035051,0.307826158265287,0.0434406682302365,0.442247910181842,ENSG00000106018,VIPR2,protein_coding,7,-1,159028175,159144867,q36.3,vasoactive intestinal peptide receptor 2 [Source:HGNC Symbol;Acc:HGNC:12695],NA,VIPR2,7434,NM_001304522;NM_001308259;NM_003382
ATAD2_SIG,ATAD2,ATAD2_SIG,ATAD2,SIG,19,-1.03879158213311,0.286607362036806,0.291537749062615,0.270407518952006,-0.0211302301106086,0.359941917918263,-0.0366761191638691,5.82354191630392,5.82432714183499,5.82096188955897,-0.00336525227601933,0.979969215794074,ENSG00000156802,ATAD2,protein_coding,8,-1,123319850,123416350,q24.13,ATPase family, AAA domain containing 2 [Source:HGNC Symbol;Acc:HGNC:30123],NA,ATAD2,29028,NM_014109
SLC46A1_SIG,SLC46A1,SLC46A1_SIG,SLC46A1,SIG,19,1.03809916493841,0.00293899511174558,0.000352367760737316,0.0114379135507727,0.0110855457900355,0.36027756579355,0.462332494818876,2.31823222368839,2.30383445260839,2.36553918580839,0.0617047331999961,0.732005206460935,ENSG00000076351,SLC46A1,protein_coding,17,-1,28394642,28407197,q11.2,solute carrier family 46 member 1 [Source:HGNC Symbol;Acc:HGNC:30521],FOLATE MALABSORPTION HEREDITARY;Hereditary folate malabsorption,SLC46A1,113235,NM_001242366;NM_080669
CKS1B_SIG,CKS1B,CKS1B_SIG,CKS1B,SIG,48,-1.03796633160703,0.32897234991732,0.3351325040852,0.308731843365714,-0.0264006607194858,0.360299661917499,-1.31246208131365,2.4095473011374,2.43430613138743,2.3281968588873,-0.106109272500125,0.290002137892233,ENSG00000173207,CKS1B,protein_coding,1,1,154974653,154979251,q21.3,CDC28 protein kinase regulatory subunit 1B [Source:HGNC Symbol;Acc:HGNC:19083],NA,CKS1B,1163,NM_001826
NDUFAB1_SIG,NDUFAB1,NDUFAB1_SIG,NDUFAB1,SIG,44,1.03555856822735,0.390756548296471,0.388588710134981,0.397879445112792,0.00929073497781081,0.361598336848655,1.62193707542184,4.26709114181754,4.24404232104616,4.34282298149495,0.0987806604487958,0.184443039359151,ENSG00000004779,NDUFAB1,protein_coding,16,-1,23581014,23596316,p12.2,NADH:ubiquinone oxidoreductase subunit AB1 [Source:HGNC Symbol;Acc:HGNC:7694],NA,NDUFAB1,4706,NM_005003
RMND5A_SIG,RMND5A,RMND5A_SIG,RMND5A,SIG,14,1.03523570491882,0.340829970079799,0.339058791893651,0.346649555548572,0.00759076365492126,0.361704716682984,0.392639738151323,6.65675564866467,6.65209029808502,6.67208465771211,0.0199943596270895,0.772863525938935,ENSG00000153561,RMND5A,protein_coding,2,1,86720291,86778041,p11.2,required for meiotic nuclear division 5 homolog A [Source:HGNC Symbol;Acc:HGNC:25850],NA,RMND5A,64795,NM_022780
PDSS1_SIG,PDSS1,PDSS1_SIG,PDSS1,SIG,20,-1.03518221464126,0.242176024259293,0.244982545736514,0.232954596548422,-0.0120279491880921,0.361704716682984,-0.252075491787594,3.04745818038316,3.05155018758389,3.03401301386647,-0.0175371737174198,0.856449209642942,ENSG00000148459,PDSS1,protein_coding,10,1,26697701,26746798,p12.1,decaprenyl diphosphate synthase subunit 1 [Source:HGNC Symbol;Acc:HGNC:17759],COENZYME Q10 DEFICIENCY PRIMARY 2;Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,PDSS1,23590,NM_001321978;NM_001321979;NM_014317
RPL32_SIG,RPL32,RPL32_SIG,RPL32,SIG,89,1.03488831993308,0.819775799629404,0.81558669659043,0.833539995328888,0.0179532987384582,0.361817319867825,1.7116098005909,9.16901976652472,9.14340112560354,9.25319530098005,0.10979417537652,0.160260640104782,ENSG00000144713,RPL32,protein_coding,3,-1,12834485,12841588,p25.2,ribosomal protein L32 [Source:HGNC Symbol;Acc:HGNC:10336],NA,RPL32,6161,NM_000994;NM_001007073;NM_001007074
CSAD_SIG,CSAD,CSAD_SIG,CSAD,SIG,125,-1.03478848947581,0.0501309062165738,0.0515603429294552,0.0454341855885347,-0.00612615734092052,0.361820878655278,-1.12595836473766,4.71020101733971,4.72863453942149,4.64963373049958,-0.0790008089219114,0.37011317994078,ENSG00000139631,CSAD,protein_coding,12,-1,53157663,53180909,q13.13,cysteine sulfinic acid decarboxylase [Source:HGNC Symbol;Acc:HGNC:18966],NA,CSAD,51380,NM_001244705;NM_001244706;NM_015989
RBBP5_SIG,RBBP5,RBBP5_SIG,RBBP5,SIG,50,1.03363441090346,0.327016347205541,0.324050300248493,0.336761930064413,0.0127116298159195,0.362417156564981,0.243354075453608,4.51677090687781,4.51267539989199,4.53022757268833,0.0175521727963348,0.861889333652704,ENSG00000117222,RBBP5,protein_coding,1,-1,205086142,205122015,q32.1,RB binding protein 5, histone lysine methyltransferase complex subunit [Source:HGNC Symbol;Acc:HGNC:9888],NA,RBBP5,5929,NM_001193272;NM_001193273;NM_005057
THUMPD3_SIG,THUMPD3,THUMPD3_SIG,THUMPD3,SIG,20,1.03314848962526,0.324564124980971,0.323514098777259,0.328014211078882,0.00450011230162297,0.362637918706619,1.84947976516651,5.1294053774439,5.11035782588044,5.19199018972383,0.0816323638433857,0.126938791734314,ENSG00000134077,THUMPD3,protein_coding,3,1,9362971,9386791,p25.3,THUMP domain containing 3 [Source:HGNC Symbol;Acc:HGNC:24493],NA,THUMPD3,25917,NM_001114092;NM_015453
TRPC4AP_SIG,TRPC4AP,TRPC4AP_SIG,TRPC4AP,SIG,14,-1.03251327918864,0.281280091835176,0.282154709900387,0.278406346763766,-0.00374836313662138,0.362942798854158,-0.440979164377431,7.05880110341411,7.06222185227143,7.04756150002577,-0.0146603522456639,0.744307522472719,ENSG00000100991,TRPC4AP,protein_coding,20,-1,35002404,35092807,q11.22,transient receptor potential cation channel subfamily C member 4 associated protein [Source:HGNC Symbol;Acc:HGNC:16181],NA,TRPC4AP,26133,NM_015638;NM_199368
TIPARP_SIG,TIPARP,TIPARP_SIG,TIPARP,SIG,25,-1.0321654106419,0.463414246992302,0.467514369547512,0.449942415739469,-0.0175719538080428,0.363085990019106,0.624866753997458,6.056509922884,6.04042094488496,6.109373707738,0.0689527628530459,0.635592419549064,ENSG00000163659,TIPARP,protein_coding,3,1,156673235,156706770,q25.31,TCDD inducible poly(ADP-ribose) polymerase [Source:HGNC Symbol;Acc:HGNC:23696],NA,TIPARP,25976,NM_001184717;NM_001184718;NM_015508
SP4_TF,SP4,SP4_TF,SP4,TF,50,1.03197345757036,0.19616636911947,0.194572066474717,0.201404792095088,0.0068327256203705,0.363141397459352,2.51669866240475,4.36982388911487,4.32615053533737,4.51332205152667,0.187171516189299,0.0340397002661759,ENSG00000105866,SP4,protein_coding,7,1,21428043,21514822,p15.3,Sp4 transcription factor [Source:HGNC Symbol;Acc:HGNC:11209],NA,SP4,6671,NM_001326542;NM_001326543;NM_003112
ZNF639_TF,ZNF639,ZNF639_TF,ZNF639,TF,303,1.03130074601732,0.270107440668249,0.267548802194395,0.278514395653768,0.0109655934593735,0.36346763591594,0.716413293423835,5.60799100667878,5.59503713964296,5.65055371265362,0.0555165730106647,0.582277359963996,ENSG00000121864,ZNF639,protein_coding,3,1,179323031,179338583,q26.33,zinc finger protein 639 [Source:HGNC Symbol;Acc:HGNC:30950],NA,ZNF639,51193,NM_001303425;NM_001303426;NM_016331
EEF1E1_SIG,EEF1E1,EEF1E1_SIG,EEF1E1,SIG,5,1.03096401712317,0.286780599774106,0.283914225046556,0.296198688164627,0.0122844631180716,0.363604655548317,0.52391399079036,2.66577565100106,2.65759919745393,2.69264114122737,0.0350419437734456,0.696006051515849,ENSG00000124802,EEF1E1,protein_coding,6,-1,8073360,8102559,p24.3,eukaryotic translation elongation factor 1 epsilon 1 [Source:HGNC Symbol;Acc:HGNC:3212],NA,EEF1E1,9521,NM_001135650;NM_004280
S1PR2_SIG,S1PR2,S1PR2_SIG,S1PR2,SIG,14,-1.03062580075964,0.199199463463422,0.201934372578426,0.19021333351412,-0.0117210390643068,0.363742539791286,-0.110785415042696,0.766732015539744,0.768195520328724,0.761923356947383,-0.00627216338134045,0.938498605384308,ENSG00000267534,S1PR2,protein_coding,19,-1,10221433,10231331,p13.2,sphingosine-1-phosphate receptor 2 [Source:HGNC Symbol;Acc:HGNC:3169],Autosomal recessive non-syndromic sensorineural deafness type DFNB;Deafness autosomal recessive 68,S1PR2,9294,NM_004230
UNC50_SIG,UNC50,UNC50_SIG,UNC50,SIG,29,1.02987295185687,0.138162802823209,0.137336509108187,0.14087776788685,0.00354125877866302,0.364114275677071,1.01956804894037,4.53501606447136,4.52460673389932,4.56921815063665,0.0446114167373243,0.420766723448308,ENSG00000115446,UNC50,protein_coding,2,1,98608579,98618515,q11.2,unc-50 inner nuclear membrane RNA binding protein [Source:HGNC Symbol;Acc:HGNC:16046],NA,UNC50,25972,NM_001330353;NM_001330354;NM_014044
SUMO2_SIG,SUMO2,SUMO2_SIG,SUMO2,SIG,12,1.02927095861475,0.217399943844303,0.215955652531885,0.222145472442245,0.00618981991036025,0.364401095214214,0.495472978176213,5.68339331330041,5.67834519525581,5.69997998687553,0.0216347916197286,0.712203796252565,ENSG00000188612,SUMO2,protein_coding,17,-1,75165586,75182959,q25.1,small ubiquitin-like modifier 2 [Source:HGNC Symbol;Acc:HGNC:11125],NA,SUMO2,6613,NM_001005849;NM_006937
LARP7_SIG,LARP7,LARP7_SIG,LARP7,SIG,12,1.02903793069886,0.259013050759858,0.257837534588241,0.262875461038029,0.00503792644978818,0.364440671035001,1.23572627153525,5.73049601082369,5.72005871200775,5.7647899926475,0.0447312806397415,0.321350761934628,ENSG00000174720,LARP7,protein_coding,4,1,112637107,112657592,q25,La ribonucleoprotein domain family member 7 [Source:HGNC Symbol;Acc:HGNC:24912],ALAZAMI SYNDROME;Microcephalic primordial dwarfism Alazami type,LARP7,51574,NM_001267039;NM_015454;NM_016648
MPPED2_SIG,MPPED2,MPPED2_SIG,MPPED2,SIG,44,-1.02895739632474,-0.0922867220216073,-0.090665992807328,-0.0976119751542393,-0.00694598234691144,0.364440671035001,-2.9283193980592,0.556532472468036,0.639116615121869,0.285184575176871,-0.353932039944998,0.0129218728890733,ENSG00000066382,MPPED2,protein_coding,11,-1,30384493,30586872,p14.1,metallophosphoesterase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:1180],NA,MPPED2,744,NM_001145399;NM_001584
HIST1H4D_SIG,HIST1H4D,HIST1H4D_SIG,HIST1H4D,SIG,20,1.02891998612442,-0.172425907269787,-0.175122900629985,-0.163564357657706,0.0115585429722791,0.364440671035001,-1.16086328986554,0.297920783868164,0.306744708661119,0.268927888119885,-0.0378168205412341,0.35452036418489,ENSG00000277157,HIST1H4D,protein_coding,6,-1,26188765,26189076,p22.2,histone cluster 1 H4 family member d [Source:HGNC Symbol;Acc:HGNC:4782],NA,HIST1H4D,8360,NM_003539
RPL7A_SIG,RPL7A,RPL7A_SIG,RPL7A,SIG,51,1.02881061066722,0.963352557501159,0.958325398177612,0.979870366707099,0.0215449685294871,0.364449574137568,1.38246911227106,8.09884609763817,8.07740337640399,8.16930075312191,0.0918973767179186,0.263219868061175,ENSG00000148303,RPL7A,protein_coding,9,1,133348218,133351426,q34.2,ribosomal protein L7a [Source:HGNC Symbol;Acc:HGNC:10364],NA,RPL7A,6130,NM_000972
RALY_SIG,RALY,RALY_SIG,RALY,SIG,15,1.0281198397046,0.439366522912823,0.438350584575991,0.442704606019557,0.00435402144356573,0.364786628451867,-0.227866335632221,7.56980524344314,7.57133165597082,7.56478988799505,-0.00654176797577057,0.871335083977823,ENSG00000125970,RALY,protein_coding,20,1,33993646,34108308,q11.22,RALY heterogeneous nuclear ribonucleoprotein [Source:HGNC Symbol;Acc:HGNC:15921],NA,RALY,22913,NM_007367;NM_016732
RBX1_SIG,RBX1,RBX1_SIG,RBX1,SIG,45,-1.02693274564544,0.0149390904907811,0.015949885740458,0.0116179060989856,-0.00433197964147241,0.365404306591539,-1.58311686092874,3.44657616453597,3.46627499715274,3.38185142879515,-0.0844235683575963,0.195603728475482,ENSG00000100387,RBX1,protein_coding,22,1,40951347,40973309,q13.2,ring-box 1 [Source:HGNC Symbol;Acc:HGNC:9928],NA,RBX1,9978,NM_014248
PIAS4_SIG,PIAS4,PIAS4_SIG,PIAS4,SIG,34,1.02436990296436,0.297480173564059,0.293193484638733,0.311565008604418,0.0183715239656851,0.36680156508325,-0.00244878055708487,4.35039297384331,4.35042978318998,4.35027202884713,-0.000157754342853612,0.998439640118049,ENSG00000105229,PIAS4,protein_coding,19,1,4007736,4039386,p13.3,protein inhibitor of activated STAT 4 [Source:HGNC Symbol;Acc:HGNC:17002],NA,PIAS4,51588,NM_015897
BAZ1B_SIG,BAZ1B,BAZ1B_SIG,BAZ1B,SIG,23,1.02419300513005,0.501911044808283,0.499245835699182,0.510668160452472,0.0114223247532898,0.36684866772332,1.13012950925112,7.02300629967391,7.00759623909486,7.07363935586224,0.0660431167673821,0.368166849708902,ENSG00000009954,BAZ1B,protein_coding,7,-1,73440406,73522293,q11.23,bromodomain adjacent to zinc finger domain 1B [Source:HGNC Symbol;Acc:HGNC:961],Williams syndrome,BAZ1B,9031,NM_032408
KHSRP_SIG,KHSRP,KHSRP_SIG,KHSRP,SIG,15,1.02354488276452,0.827568414357483,0.825542238211906,0.83422585026438,0.00868361205247465,0.367162851648483,0.716040269560781,7.72126439469587,7.71385714003921,7.74560251713917,0.0317453770999582,0.582459155344262,ENSG00000088247,KHSRP,protein_coding,19,-1,6413348,6424794,p13.3,KH-type splicing regulatory protein [Source:HGNC Symbol;Acc:HGNC:6316],NA,KHSRP,8570,NM_003685
TCEA1_SIG,TCEA1,TCEA1_SIG,TCEA1,SIG,23,1.0227846805045,0.385450269120153,0.384031299060956,0.390112599314659,0.00608130025370352,0.367540763941772,-0.753376927076558,5.57081578097235,5.57980256900491,5.54128776315109,-0.0385148058538248,0.561595647668048,ENSG00000187735,TCEA1,protein_coding,8,-1,53966552,54022456,q11.23,transcription elongation factor A1 [Source:HGNC Symbol;Acc:HGNC:11612],NA,TCEA1,6917,NM_006756;NM_201437
CHN1_SIG,CHN1,CHN1_SIG,CHN1,SIG,18,-1.02244664359627,-0.110718197184133,-0.109350303128635,-0.115212706223626,-0.0058624030949909,0.367679321581631,0.793914739087855,0.791513385715462,0.776456773059896,0.84098511301232,0.0645283399524233,0.538406115798861,ENSG00000128656,CHN1,protein_coding,2,-1,174799313,175005381,q31.1,chimerin 1 [Source:HGNC Symbol;Acc:HGNC:1943],Duane retraction syndrome;DUANE RETRACTION SYNDROME 2,CHN1,1123,NM_001025201;NM_001206602;NM_001822
E2F1_TF,E2F1,E2F1_TF,E2F1,TF,165,-1.02101187764883,0.194309836864224,0.19736488786326,0.184271812153106,-0.0130930757101535,0.36844064293753,-1.63176652077509,4.43374427991983,4.47878911462225,4.28573982304044,-0.193049291581813,0.181636333164494,ENSG00000101412,E2F1,protein_coding,20,-1,33675477,33686385,q11.22,E2F transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:3113],NA,E2F1,1869,NM_005225
LPAR1_SIG,LPAR1,LPAR1_SIG,LPAR1,SIG,27,-1.02069714435404,0.00313540133780144,0.00438271789210056,-0.000962924483467077,-0.00534564237556775,0.368523478967822,-0.191869007034398,1.55561771829409,1.56127373977691,1.53703364770766,-0.0242400920692479,0.891994459467936,ENSG00000198121,LPAR1,protein_coding,9,-1,110873263,111038458,q31.3,lysophosphatidic acid receptor 1 [Source:HGNC Symbol;Acc:HGNC:3166],NA,LPAR1,1902,NM_001351397;NM_001351398;NM_001351399;NM_001351400;NM_001351401;NM_001351402;NM_001351403;NM_001351404;NM_001351405;NM_001351406;NM_001351407;NM_001351408;NM_001351409;NM_001351410;NM_001351411;NM_001351412;NM_001351413;NM_001351414;NM_001351415;NM_001351416;NM_001351417;NM_001351418;NM_001351419;NM_001351420;NM_001401;NM_057159
ITGB5_SIG,ITGB5,ITGB5_SIG,ITGB5,SIG,18,-1.02067835804042,-0.0905781535852123,-0.088744800088358,-0.0966020293605908,-0.0078572292722327,0.368523478967822,-2.72320479562641,2.43620383001122,2.54217146493872,2.08802445810658,-0.454147006832141,0.0212043222362753,ENSG00000082781,ITGB5,protein_coding,3,-1,124761948,124901418,q21.2,integrin subunit beta 5 [Source:HGNC Symbol;Acc:HGNC:6160],NA,ITGB5,3693,NM_001354764;NM_001354765;NM_001354766;NM_002213
KATNA1_SIG,KATNA1,KATNA1_SIG,KATNA1,SIG,11,1.0191507563629,0.281284296681935,0.280605605999621,0.283514280352398,0.00290867435277675,0.369338636512751,-0.276006260039803,4.37273031120444,4.3748624726762,4.36572463779725,-0.00913783487894914,0.841975989894506,ENSG00000186625,KATNA1,protein_coding,6,-1,149594873,149648972,q25.1,katanin catalytic subunit A1 [Source:HGNC Symbol;Acc:HGNC:6216],NA,KATNA1,11104,NM_001204076;NM_007044
ABR_SIG,ABR,ABR_SIG,ABR,SIG,50,-1.01883150142517,0.16278992009152,0.165538845600733,0.153757736275534,-0.0117811093251986,0.369466857715758,0.511615430281763,6.89018400090865,6.87878139643621,6.92764970131807,0.0488683048818563,0.70285116226309,ENSG00000159842,ABR,protein_coding,17,-1,1003518,1229738,p13.3,ABR, RhoGEF and GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:81],NA,ABR,29,NM_001092;NM_001159746;NM_001256847;NM_001282149;NM_001322840;NM_001322841;NM_021962
CELF2_SIG,CELF2,CELF2_SIG,CELF2,SIG,22,1.01871886040399,0.354298912278483,0.353050857734946,0.35839966292153,0.00534880518658357,0.369477514905642,0.0906428384848594,8.41454892034597,8.4134566116334,8.41813793468727,0.00468132305386974,0.949436702822104,ENSG00000048740,CELF2,protein_coding,10,1,10798397,11336675,p14,CUGBP Elav-like family member 2 [Source:HGNC Symbol;Acc:HGNC:2550],NA,CELF2,10659,NM_001025076;NM_001025077;NM_001083591;NM_001326317;NM_001326318;NM_001326319;NM_001326320;NM_001326321;NM_001326323;NM_001326324;NM_001326325;NM_001326326;NM_001326327;NM_001326328;NM_001326329;NM_001326330;NM_001326331;NM_001326332;NM_001326333;NM_001326334;NM_001326335;NM_001326336;NM_001326337;NM_001326338;NM_001326339;NM_001326340;NM_001326341;NM_001326342;NM_001326343;NM_001326344;NM_001326345;NM_001326346;NM_001326347;NM_001326348;NM_001326349;NM_006561
GTF2B_SIG,GTF2B,GTF2B_SIG,GTF2B,SIG,35,-1.01709075749757,0.367010193858046,0.370204556247782,0.356514431720342,-0.0136901245274403,0.370351189674075,-0.467828795518494,5.30961750610032,5.31579721794229,5.28931273861957,-0.0264844793227173,0.728553915069643,ENSG00000137947,GTF2B,protein_coding,1,-1,88852633,88891944,p22.2,general transcription factor IIB [Source:HGNC Symbol;Acc:HGNC:4648],NA,GTF2B,2959,NM_001514
HS3ST3A1_SIG,HS3ST3A1,HS3ST3A1_SIG,HS3ST3A1,SIG,15,1.01692036495366,-0.105610842105374,-0.107034895126629,-0.100931810749822,0.00610308437680661,0.370394742777946,-0.729859642454341,0.288045265420617,0.294991057718314,0.265223376442471,-0.0297676812758431,0.574529742966109,ENSG00000153976,HS3ST3A1,protein_coding,17,-1,13494032,13601929,p12,heparan sulfate-glucosamine 3-sulfotransferase 3A1 [Source:HGNC Symbol;Acc:HGNC:5196],NA,HS3ST3A1,9955,NM_006042
RPL27A_SIG,RPL27A,RPL27A_SIG,RPL27A,SIG,13,1.01674907979899,1.66092814737728,1.65604428561173,1.67697512174981,0.0209308361380723,0.370438808851785,1.01971833183253,8.57762288649776,8.56363285163808,8.62359014389386,0.059957292255783,0.420719644422573,ENSG00000166441,RPL27A,protein_coding,11,1,8682788,8714759,p15.4,ribosomal protein L27a [Source:HGNC Symbol;Acc:HGNC:10329],NA,RPL27A,6157,NM_000990
SLC25A6_SIG,SLC25A6,SLC25A6_SIG,SLC25A6,SIG,17,1.01579653998924,0.73289961708686,0.731193114587678,0.738506696727027,0.00731358213934866,0.370926032308688,1.10135998153622,9.13299966431027,9.11623722354573,9.18807625539375,0.0718390318480252,0.381895597720501,ENSG00000169100,SLC25A6,protein_coding,X,-1,1386152,1392113,p22.33,solute carrier family 25 member 6 [Source:HGNC Symbol;Acc:HGNC:10992],NA,SLC25A6,293,NM_001636
UHRF1_SIG,UHRF1,UHRF1_SIG,UHRF1,SIG,23,-1.0157065939774,0.375646917788312,0.383012866207918,0.351444515838181,-0.0315683503697372,0.370926032308688,-0.856489713776719,4.35711723298259,4.38883255320483,4.25290975225238,-0.135922800952446,0.504760401003579,ENSG00000276043,UHRF1,protein_coding,19,1,4903080,4962154,p13.3,ubiquitin like with PHD and ring finger domains 1 [Source:HGNC Symbol;Acc:HGNC:12556],NA,UHRF1,29128,NM_001048201;NM_001290050;NM_001290051;NM_001290052;NM_013282
UBE2A_SIG,UBE2A,UBE2A_SIG,UBE2A,SIG,21,1.01560808318166,0.0595306916078501,0.0587086530178309,0.0622316755464848,0.00352302252865391,0.37092861392911,-1.24052422607458,6.11285871004538,6.12222722278493,6.08207645390112,-0.0401507688838158,0.319372676849167,ENSG00000077721,UBE2A,protein_coding,X,1,119574536,119591083,q24,ubiquitin conjugating enzyme E2 A [Source:HGNC Symbol;Acc:HGNC:12472],MENTAL RETARDATION X-LINKED SYNDROMIC NASCIMENTO TYPE;UBE2A-Related X-Linked Syndromic Mental Retardation;X-linked intellectual disability Nascimento type,UBE2A,7319,NM_001282161;NM_003336;NM_181762
FOXK1_TF,FOXK1,FOXK1_TF,FOXK1,TF,62,1.01527082945962,0.234086051613299,0.232712886105711,0.238597881138233,0.00588499503252272,0.371067379908096,0.933257955423305,6.250549959892,6.23721208314693,6.2943744120544,0.0571623289074745,0.464161029414981,ENSG00000164916,FOXK1,protein_coding,7,1,4682295,4771442,p22.1,forkhead box K1 [Source:HGNC Symbol;Acc:HGNC:23480],NA,FOXK1,221937,NM_001037165
BRPF1_SIG,BRPF1,BRPF1_SIG,BRPF1,SIG,13,1.0147239595531,0.344454283366331,0.342794320779439,0.349908446151835,0.00711412537239651,0.371325788065531,-0.32982948703991,6.33857553783886,6.34278220233987,6.32475364019269,-0.018028562147176,0.810253269508081,ENSG00000156983,BRPF1,protein_coding,3,1,9731729,9748018,p25.3,bromodomain and PHD finger containing 1 [Source:HGNC Symbol;Acc:HGNC:14255],BRPF1 associated syndromic intellectual disability with ptosis;INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS,BRPF1,7862,NM_001003694;NM_001319049;NM_001319050;NM_004634
TIAM2_SIG,TIAM2,TIAM2_SIG,TIAM2,SIG,15,-1.01414593601777,0.0467593297931614,0.0481884044269018,0.0420637988537288,-0.00612460557317311,0.371602081865851,-1.45289886139119,1.92826470315126,1.95520976792057,1.83973091890923,-0.115478849011334,0.237583810284778,ENSG00000146426,TIAM2,protein_coding,6,1,154832697,155257723,q25.2,T cell lymphoma invasion and metastasis 2 [Source:HGNC Symbol;Acc:HGNC:11806],NA,TIAM2,26230,NM_001010927;NM_012454
DDAH1_SIG,DDAH1,DDAH1_SIG,DDAH1,SIG,64,-1.01225684673514,-0.0806716493741764,-0.0792914286682799,-0.085206660264979,-0.00591523159669917,0.372593012085413,-0.864974118890837,1.33391764097717,1.36120524024056,1.2442583862546,-0.116946853985965,0.500431932727108,ENSG00000153904,DDAH1,protein_coding,1,-1,85318481,85578363,p22.3,dimethylarginine dimethylaminohydrolase 1 [Source:HGNC Symbol;Acc:HGNC:2715],NA,DDAH1,23576,NM_001134445;NM_001330655;NM_012137
GPD2_SIG,GPD2,GPD2_SIG,GPD2,SIG,6,-1.01222372818866,0.234772136981593,0.237282126003308,0.226525030195959,-0.0107570958073493,0.372593012085413,-0.728733350676992,5.60583761846495,5.61943322906722,5.56116632648605,-0.0582669025811694,0.575013787551286,ENSG00000115159,GPD2,protein_coding,2,1,156435290,156613735,q24.1,glycerol-3-phosphate dehydrogenase 2 [Source:HGNC Symbol;Acc:HGNC:4456],DIABETES MELLITUS NONINSULIN-DEPENDENT,GPD2,2820,NM_000408;NM_001083112
CDYL2_SIG,CDYL2,CDYL2_SIG,CDYL2,SIG,9,1.0116762440119,0.198064679445984,0.196304723743502,0.203847391039853,0.00754266729635128,0.372803599387647,-0.716160299315227,5.06364862689243,5.08291093575382,5.00035818349072,-0.082552752263103,0.582437982126894,ENSG00000166446,CDYL2,protein_coding,16,-1,80597907,80804598,q23.2,chromodomain Y like 2 [Source:HGNC Symbol;Acc:HGNC:23030],NA,CDYL2,124359,NM_152342
RAC1_SIG,RAC1,RAC1_SIG,RAC1,SIG,30,1.01166740109328,0.163878829315087,0.162068144051365,0.169828223753031,0.00776007970166653,0.372803599387647,1.41887984860193,6.64030112135957,6.62169795879404,6.70142579836057,0.0797278395665303,0.249496662150688,ENSG00000136238,RAC1,protein_coding,7,1,6374527,6403967,p22.1,Rac family small GTPase 1 [Source:HGNC Symbol;Acc:HGNC:9801],Developmental Disorders with Diverse Phenotypes;MENTAL RETARDATION AUTOSOMAL DOMINANT 48;Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,RAC1,5879,NM_006908;NM_018890
RPL31_SIG,RPL31,RPL31_SIG,RPL31,SIG,47,1.00973011299519,0.923372390275794,0.918418049183288,0.939650939579743,0.0212328903964558,0.373858964080195,1.59807590286055,8.42308363537215,8.39578858878387,8.51276735987651,0.116978771092642,0.191193556581706,ENSG00000071082,RPL31,protein_coding,2,1,101002229,101024032,q11.2,ribosomal protein L31 [Source:HGNC Symbol;Acc:HGNC:10334],NA,RPL31,6160,NM_000993;NM_001098577;NM_001099693
RPS15_SIG,RPS15,RPS15_SIG,RPS15,SIG,16,1.00934307985035,1.61475132693814,1.60979766780127,1.63102763553074,0.0212299677294721,0.374026828795342,2.04847145127843,7.89290257035501,7.8651900049833,7.98395814229062,0.118768137307325,0.0888092013149452,ENSG00000115268,RPS15,protein_coding,19,1,1438358,1440494,p13.3,ribosomal protein S15 [Source:HGNC Symbol;Acc:HGNC:10388],B-cell chronic lymphocytic leukemia,RPS15,6209,NM_001018;NM_001308226
ATP6V1G1_SIG,ATP6V1G1,ATP6V1G1_SIG,ATP6V1G1,SIG,10,1.00848708017587,0.309227105630179,0.307868463116866,0.313691216745352,0.00582275362848578,0.374457570778999,-2.28292143225699,6.58489844623186,6.60793268348065,6.50921452384298,-0.0987181596376718,0.055951514843848,ENSG00000136888,ATP6V1G1,protein_coding,9,1,114587769,114598879,q32,ATPase H+ transporting V1 subunit G1 [Source:HGNC Symbol;Acc:HGNC:864],NA,ATP6V1G1,9550,NM_004888
MDK_SIG,MDK,MDK_SIG,MDK,SIG,32,1.00840356290281,8.07654904499708e-05,-0.00241668043168132,0.00828665923459564,0.0107033396662768,0.374457570778999,1.14975305367298,3.89329344503571,3.84901909318329,4.03876631540797,0.189747222224679,0.359234041263499,ENSG00000110492,MDK,protein_coding,11,1,46380756,46383837,p11.2,midkine [Source:HGNC Symbol;Acc:HGNC:6972],NA,MDK,4192,NM_001012333;NM_001012334;NM_001270550;NM_001270551;NM_001270552;NM_002391
CASC3_SIG,CASC3,CASC3_SIG,CASC3,SIG,9,1.00782924317832,0.334313949840182,0.333234834228778,0.33785961542051,0.00462478119173255,0.37473304137352,2.64756886966438,7.22816008148563,7.20628623544189,7.30003128991506,0.0937450544731738,0.0251830868793831,ENSG00000108349,CASC3,protein_coding,17,1,40140318,40172171,q21.1,CASC3, exon junction complex subunit [Source:HGNC Symbol;Acc:HGNC:17040],NA,CASC3,22794,NM_007359
P2RX5_SIG,P2RX5,P2RX5_SIG,P2RX5,SIG,25,-1.00742328390979,-0.00277915963506274,-0.00120060267256364,-0.00796584679755981,-0.00676524412499611,0.374832942136301,-0.20928569988935,3.14659720786661,3.15309968315318,3.12523193192501,-0.0278677512281723,0.882285982590171,ENSG00000083454,P2RX5,protein_coding,17,-1,3672199,3696240,p13.2,purinergic receptor P2X 5 [Source:HGNC Symbol;Acc:HGNC:8536],NA,P2RX5,5026,NM_001204519;NM_001204520;NM_002561;NM_175080
EIF4A1_SIG,EIF4A1,EIF4A1_SIG,EIF4A1,SIG,31,1.00737939374801,0.0863449109831542,0.0846009338399207,0.0920751215966357,0.00747418775671501,0.374832942136301,1.29090603716777,5.89720304468548,5.86884684386577,5.99037341880738,0.121526574941614,0.298628515068272,ENSG00000161960,EIF4A1,protein_coding,17,1,7572706,7579006,p13.1,eukaryotic translation initiation factor 4A1 [Source:HGNC Symbol;Acc:HGNC:3282],NA,EIF4A1,1973,NM_001204510;NM_001416
PIK3CA_SIG,PIK3CA,PIK3CA_SIG,PIK3CA,SIG,29,-1.00737259073642,0.414230973345739,0.416364810289063,0.407219794817676,-0.00914501547138727,0.374832942136301,-1.12461447968072,5.74425933445477,5.76004395217771,5.69239559050797,-0.0676483616697406,0.370669365875529,ENSG00000121879,PIK3CA,protein_coding,3,1,179148114,179240093,q26.32,phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:8975],Adult hepatocellular carcinoma;Breast Cancer;CAPILLARY MALFORMATION OF THE LOWER LIP LYMPHATIC MALFORMATION OFFACE AND NECK ASYMMETRY OF FACE AND LIMBS AND PARTIAL/GENERALIZEDOVERGROWTH;CLOVES syndrome;CLOVES: CONGENITAL LIPOMATOUS OVERGROWTH VASCULAR MALFORMATIONS AND EPIDERMAL NEVI;Colorectal Cancer;Congenital lipomatous overgrowth vascular malformations and epidermal nevi;COWDEN SYNDROME;COWDEN SYNDROME 5;GASTRIC CANCER GASTRIC CANCER INTESTINAL INCLUDED;Hemihyperplasia-multiple lipomatosis syndrome;Hemimegalencephaly;Hemimegalencephaly PIK3CA;Hepatocellular Carcinoma;KERATOSIS SEBORRHEIC;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED;Lynch syndrome;MACRODACTYLY;Macrodactyly of fingers unilateral;Macrodactyly of toes unilateral;Megalencephaly-capillary malformation-polymicrogyria syndrome;Megalencephaly-Capillary malformation-Polymicrogyria syndrome somatic  3;NEVUS EPIDERMAL;OVARIAN CANCER OVARIAN CANCER EPITHELIAL INCLUDED;Segmental progressive overgrowth syndrome with fibroadipose hyperplasia,PIK3CA,5290,NM_006218
ZDHHC13_TF,ZDHHC13,ZDHHC13_TF,ZDHHC13,TF,115,-1.0069044507955,0.171405807449187,0.173062157757738,0.165963513578234,-0.00709864417950488,0.375001333119816,0.0180078572782948,3.92525681424347,3.92489074273604,3.92645962062503,0.0015688778889898,0.990072717896098,ENSG00000177054,ZDHHC13,protein_coding,11,1,19117099,19176422,p15.1,zinc finger DHHC-type containing 13 [Source:HGNC Symbol;Acc:HGNC:18413],NA,ZDHHC13,54503,NM_001001483;NM_019028
BCL2L1_SIG,BCL2L1,BCL2L1_SIG,BCL2L1,SIG,26,1.00689083714425,0.112289402181353,0.110133743852895,0.119372279546288,0.00923853569339334,0.375001333119816,2.27456001075954,5.83837280729729,5.7935152288566,5.98576199360239,0.19224676474579,0.0569059857619081,ENSG00000171552,BCL2L1,protein_coding,20,-1,31664452,31723989,q11.21,BCL2 like 1 [Source:HGNC Symbol;Acc:HGNC:992],NA,BCL2L1,598,NM_001191;NM_001317919;NM_001317920;NM_001317921;NM_001322239;NM_001322240;NM_001322242;NM_138578
GALNT5_SIG,GALNT5,GALNT5_SIG,GALNT5,SIG,36,1.00645276750545,-0.0896993690730806,-0.0914549256338478,-0.0839311118019885,0.00752381383185933,0.375198753242713,0.785611762200024,0.546276240830906,0.527259249770361,0.608760640029839,0.0815013902594782,0.542870268075954,ENSG00000136542,GALNT5,protein_coding,2,1,157257705,157318491,q24.1,polypeptide N-acetylgalactosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:4127],NA,GALNT5,11227,NM_001329868;NM_014568
RBBP6_SIG,RBBP6,RBBP6_SIG,RBBP6,SIG,43,1.00590097660076,0.449370591153449,0.446206825535388,0.459765821041365,0.0135589955059775,0.375461545659102,2.43433207902857,7.31878989446887,7.28696476364693,7.42335818145523,0.1363934178083,0.0406791987611417,ENSG00000122257,RBBP6,protein_coding,16,1,24537693,24572863,p12.1,RB binding protein 6, ubiquitin ligase [Source:HGNC Symbol;Acc:HGNC:9889],NA,RBBP6,5930,NM_006910;NM_018703;NM_032626
CDADC1_SIG,CDADC1,CDADC1_SIG,CDADC1,SIG,58,1.0054941612885,0.0413218975636503,0.0391343768676357,0.0485094655648409,0.00937508869720512,0.375630021223625,0.977459883045411,4.34084102549329,4.32476518778789,4.39366163509673,0.0688964473088349,0.442129467332408,ENSG00000102543,CDADC1,protein_coding,13,1,49247925,49293485,q14.2,cytidine and dCMP deaminase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20299],NA,CDADC1,81602,NM_001193478;NM_030911
ZNF451_TF,ZNF451,ZNF451_TF,ZNF451,TF,165,1.00541930439841,0.275187838032974,0.272413759190273,0.284302668516132,0.0118889093258588,0.375630021223625,1.02667908076175,6.59350918634929,6.57586063445131,6.65149728544267,0.0756366509913616,0.417572293590878,ENSG00000112200,ZNF451,protein_coding,6,1,57086844,57170305,p12.1,zinc finger protein 451 [Source:HGNC Symbol;Acc:HGNC:21091],NA,ZNF451,26036,NM_001031623;NM_001257273;NM_015555
MAPRE1_SIG,MAPRE1,MAPRE1_SIG,MAPRE1,SIG,26,-1.0050644487734,0.298667836796248,0.300685981798323,0.292036788932286,-0.00864919286603641,0.375779789251385,-0.723377646438181,7.68722909460376,7.69602166005605,7.65833923668908,-0.0376824233669676,0.578220252929753,ENSG00000101367,MAPRE1,protein_coding,20,1,32819954,32850405,q11.21,microtubule associated protein RP/EB family member 1 [Source:HGNC Symbol;Acc:HGNC:6890],NA,MAPRE1,22919,NM_012325
RARS2_SIG,RARS2,RARS2_SIG,RARS2,SIG,4,1.00485106263256,0.202704468982075,0.201771832839022,0.205768844880678,0.00399701204165615,0.375848281356619,0.61792279043823,4.85977849046087,4.85511361647039,4.87510593357247,0.0199923171020826,0.639677071246647,ENSG00000146282,RARS2,protein_coding,6,-1,87513938,87589987,q15,arginyl-tRNA synthetase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:21406],Pontocerebellar hypoplasia type 1;Pontocerebellar hypoplasia type 6;PONTOCEREBELLAR HYPOPLASIA TYPE 6,RARS2,57038,NM_001318785;NM_001350505;NM_001350506;NM_001350507;NM_001350508;NM_001350509;NM_001350510;NM_001350511;NM_020320
CDK11A_SIG,CDK11A,CDK11A_SIG,CDK11A,SIG,49,-1.00451254151767,0.207677565241539,0.211293520725696,0.195796568650735,-0.0154969520749615,0.375988702204735,-0.730000339944449,3.1815742698704,3.19545431530199,3.13596840630945,-0.0594859089925395,0.574461429133035,ENSG00000008128,CDK11A,protein_coding,1,-1,1702379,1724357,p36.33,cyclin dependent kinase 11A [Source:HGNC Symbol;Acc:HGNC:1730],NA,CDK11A,728642,NM_001313896;NM_001313982;NM_024011;NM_033529
DSTYK_SIG,DSTYK,DSTYK_SIG,DSTYK,SIG,14,-1.00329568925308,0.473953833023461,0.475711641921519,0.468178175215559,-0.0075334667059599,0.376634328962655,0.759867336265051,5.5550482611544,5.54487975537315,5.58845906586423,0.0435793104910811,0.557811728661288,ENSG00000133059,DSTYK,protein_coding,1,-1,205142505,205211702,q32.1,dual serine/threonine and tyrosine protein kinase [Source:HGNC Symbol;Acc:HGNC:29043],Autosomal recessive spastic paraplegia type 23;CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 1;CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT CAKUT1;Renal agenesis unilateral;SPASTIC PARAPLEGIA 23,DSTYK,25778,NM_015375;NM_199462
ZFYVE21_TF,ZFYVE21,ZFYVE21_TF,ZFYVE21,TF,125,1.00214214282053,0.205055881441957,0.202976048689376,0.211889617629009,0.00891356893963273,0.377244159493605,0.221245478005015,3.63047493584533,3.6266099696689,3.64317411042504,0.016564140756142,0.874977751632961,ENSG00000100711,ZFYVE21,protein_coding,14,1,103715730,103733668,q32.33,zinc finger FYVE-type containing 21 [Source:HGNC Symbol;Acc:HGNC:20760],NA,ZFYVE21,79038,NM_001198953;NM_024071
HIST1H4H_SIG,HIST1H4H,HIST1H4H_SIG,HIST1H4H,SIG,24,-1.00063008974298,-0.0372664353968358,-0.0359137429587746,-0.0417109962647515,-0.00579725330597695,0.378061326779395,-2.95033625144154,1.92702674699492,1.98534960918167,1.73539448552414,-0.24995512365753,0.0122294258122938,ENSG00000158406,HIST1H4H,protein_coding,6,-1,26277609,26285638,p22.2,histone cluster 1 H4 family member h [Source:HGNC Symbol;Acc:HGNC:4788],NA,HIST1H4H,8365,NM_003543
CLEC2B_SIG,CLEC2B,CLEC2B_SIG,CLEC2B,SIG,25,-1.00031682842242,-0.0301178567588353,-0.0282890233288276,-0.0361268808860036,-0.00783785755717601,0.378187600691836,-2.59021864933892,5.74564323314548,5.83603979105725,5.44862597143538,-0.387413819621868,0.0288022434611113,ENSG00000110852,CLEC2B,protein_coding,12,-1,9852984,9870136,p13.31,C-type lectin domain family 2 member B [Source:HGNC Symbol;Acc:HGNC:2053],NA,CLEC2B,9976,NM_005127
MAN2A1_SIG,MAN2A1,MAN2A1_SIG,MAN2A1,SIG,24,0.999234158543409,0.162785699435749,0.162117540587045,0.164981078510065,0.00286353792301997,0.378757999744987,0.795880357081031,5.95574054278877,5.94414456548729,5.99384161106508,0.0496970455777931,0.537567798248729,ENSG00000112893,MAN2A1,protein_coding,5,1,109689366,109869625,q21.3,mannosidase alpha class 2A member 1 [Source:HGNC Symbol;Acc:HGNC:6824],NA,MAN2A1,4124,NM_002372
GFI1B_TF,GFI1B,GFI1B_TF,GFI1B,TF,230,0.997780974872372,0.0300306661394351,0.0280943596443412,0.0363928160518864,0.00829845640754528,0.379543094998907,-0.175445410295034,3.65981150792899,3.66805755092132,3.63271736666848,-0.0353401842528335,0.901508130743866,ENSG00000165702,GFI1B,protein_coding,9,1,132944000,132991687,q34.13,growth factor independent 1B transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:4238],Alpha delta granule deficiency;Autosomal dominant macrothrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 17;GRAY PLATELET SYNDROME,GFI1B,8328,NM_001135031;NM_004188
CSNK2B_SIG,CSNK2B,CSNK2B_SIG,CSNK2B,SIG,119,0.99726507639899,0.0792007746855363,0.0782056882715903,0.082470344331359,0.00426465605976873,0.379786808437322,-0.0453787957100157,5.08853825976022,5.08901462244248,5.08697306808996,-0.00204155435252502,0.975034265618174,ENSG00000204435,CSNK2B,protein_coding,6,1,31665236,31670343,p21.33,casein kinase 2 beta [Source:HGNC Symbol;Acc:HGNC:2460],Autosomal dominant non-syndromic intellectual disability,CSNK2B,1460,NM_001282385;NM_001320
RPL35_SIG,RPL35,RPL35_SIG,RPL35,SIG,14,0.996696270458879,1.19276195366731,1.18850170911731,1.20675990004585,0.0182581909285391,0.380061218796741,1.68642517694024,7.91446492705551,7.89018615857954,7.99423802347655,0.104051864897017,0.166717435723423,ENSG00000136942,RPL35,protein_coding,9,-1,124857880,124861981,q33.3,ribosomal protein L35 [Source:HGNC Symbol;Acc:HGNC:10344],Blackfan-Diamond anemia,RPL35,11224,NM_007209
DUSP12_SIG,DUSP12,DUSP12_SIG,DUSP12,SIG,36,0.996397323688403,0.3998497180446,0.397946058096872,0.406104600729993,0.00815854263312111,0.380136083699532,1.25041822170719,4.34838898324697,4.33372335958223,4.39657603243114,0.0628526728489138,0.315305024353076,ENSG00000081721,DUSP12,protein_coding,1,1,161749758,161757238,q23.3,dual specificity phosphatase 12 [Source:HGNC Symbol;Acc:HGNC:3067],NA,DUSP12,11266,NM_007240
DGUOK_SIG,DGUOK,DGUOK_SIG,DGUOK,SIG,8,0.996377944580696,0.261825006525553,0.260375362496669,0.266588122620457,0.00621276012378805,0.380136083699532,-0.84735960352647,4.66345487946435,4.67206594647893,4.63516137355931,-0.0369045729196139,0.509880760587882,ENSG00000114956,DGUOK,protein_coding,2,1,73926826,73958961,p13.1,deoxyguanosine kinase [Source:HGNC Symbol;Acc:HGNC:2858],Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency;Early-onset familial noncirrhotic portal hypertension;MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE);Mitochondrial DNA depletion syndrome hepatocerebral form due to DGUOK deficiency;Portal hypertension noncirrhotic;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNADELETIONS AUTOSOMAL RECESSIVE 4,DGUOK,1716,NM_001318859;NM_001318860;NM_001318861;NM_001318862;NM_001318863;NM_080916;NM_080918
CD72_SIG,CD72,CD72_SIG,CD72,SIG,22,-0.99626238654495,-0.0344064954345146,-0.0329797226558689,-0.039094463135779,-0.00611474047991004,0.380148289824647,1.12259719951217,2.55395390650363,2.52827225834551,2.63833646473748,0.110064206391973,0.371608864811817,ENSG00000137101,CD72,protein_coding,9,-1,35609533,35646810,p13.3,CD72 molecule [Source:HGNC Symbol;Acc:HGNC:1696],NA,CD72,971,NM_001782
DCBLD2_SIG,DCBLD2,DCBLD2_SIG,DCBLD2,SIG,60,-0.995359195797536,-0.097160433461378,-0.0952221649852647,-0.103529029882893,-0.00830686489762846,0.380616421593715,-1.48674216467201,1.91184055918301,1.96218295794117,1.7464298204062,-0.215753137534966,0.22637664948688,ENSG00000057019,DCBLD2,protein_coding,3,-1,98795941,98901695,q12.1,discoidin, CUB and LCCL domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24627],NA,DCBLD2,131566,NM_080927
SLC35A4_SIG,SLC35A4,SLC35A4_SIG,SLC35A4,SIG,25,0.994467672551316,0.364028453810569,0.361242963282621,0.373180779830969,0.0119378165483486,0.381078127460562,0.919679071637923,5.81403799825421,5.79931689781697,5.8624073282623,0.0630904304453281,0.471339042516211,ENSG00000176087,SLC35A4,protein_coding,5,1,140564828,140569100,q31.3,solute carrier family 35 member A4 [Source:HGNC Symbol;Acc:HGNC:20753],NA,SLC35A4,113829,NM_080670
ZNF257_TF,ZNF257,ZNF257_TF,ZNF257,TF,19,0.994342652063946,-0.0958213118253696,-0.0987586214548425,-0.0861701516142442,0.0125884698405983,0.381095803565813,0.934290642622207,1.63842826570394,1.61253691784192,1.72349983725059,0.110962919408676,0.463724580516535,ENSG00000197134,ZNF257,protein_coding,19,1,22052430,22091480,p12,zinc finger protein 257 [Source:HGNC Symbol;Acc:HGNC:13498],NA,ZNF257,113835,NM_001316996;NM_001316997;NM_033468
RPS18_SIG,RPS18,RPS18_SIG,RPS18,SIG,23,0.99421648839348,1.69759505732882,1.69119803629226,1.71861384073466,0.0274158044424054,0.381114146054333,2.02298851979402,8.82866795320357,8.78956648372439,8.95714421006373,0.167577726339333,0.0931346809568431,ENSG00000231500,RPS18,protein_coding,6,1,33272075,33276511,p21.32,ribosomal protein S18 [Source:HGNC Symbol;Acc:HGNC:10401],NA,RPS18,6222,NM_022551
PIP4K2A_SIG,PIP4K2A,PIP4K2A_SIG,PIP4K2A,SIG,25,-0.993704951539818,0.337300171284598,0.339854385228396,0.328907754040689,-0.0109466311877071,0.381355849519334,-0.787771922330351,7.19672093031995,7.20974065618477,7.15394183104981,-0.0557988251349605,0.541698376774754,ENSG00000150867,PIP4K2A,protein_coding,10,-1,22534854,22714578,p12.2,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [Source:HGNC Symbol;Acc:HGNC:8997],Precursor B-cell acute lymphoblastic leukemia,PIP4K2A,5305,NM_001330062;NM_005028
LCOR_TF,LCOR,LCOR_TF,LCOR,TF,84,0.993214790314503,0.36058379638475,0.357999996290738,0.369073425265076,0.0110734289743375,0.381585238468675,2.08667750329834,6.31865708513744,6.28559972284548,6.42727413266816,0.141674409822682,0.0824447772967192,ENSG00000196233,LCOR,protein_coding,10,1,96832282,96995959,q24.1,ligand dependent nuclear receptor corepressor [Source:HGNC Symbol;Acc:HGNC:29503],NA,LCOR,84458,NM_001170765;NM_001170766;NM_001346516;NM_032440
EPHX3_SIG,EPHX3,EPHX3_SIG,EPHX3,SIG,5,-0.993017771441892,0.0158653420187733,0.0179304070491382,0.00908012834757429,-0.00885027870156379,0.381644674072521,-2.55558046016855,0.25050075504408,0.271672404828418,0.180936762895541,-0.0907356419328768,0.0311912533511645,ENSG00000105131,EPHX3,protein_coding,19,-1,15226919,15233435,p13.12,epoxide hydrolase 3 [Source:HGNC Symbol;Acc:HGNC:23760],NA,EPHX3,79852,NM_001142886;NM_024794
LRPAP1_SIG,LRPAP1,LRPAP1_SIG,LRPAP1,SIG,53,-0.992342941404469,0.275356263019971,0.277862548389726,0.267121325376493,-0.0107412230132333,0.381926791611749,0.856431199919177,6.95846632941716,6.94201689632535,7.01251446671882,0.0704975703934708,0.504773608375372,ENSG00000163956,LRPAP1,protein_coding,4,-1,3503612,3532446,p16.3,LDL receptor related protein associated protein 1 [Source:HGNC Symbol;Acc:HGNC:6701],EXTREME MYOPIA;MYOPIA 23 AUTOSOMAL RECESSIVE;Myopia 23 autosomal recessive;Rare isolated myopia,LRPAP1,4043,NM_002337
ATM_SIG,ATM,ATM_SIG,ATM,SIG,101,-0.99229237024943,0.0633761668404742,0.0650840160960683,0.0577646621435222,-0.00731935395254605,0.381926791611749,0.0187382923664724,6.65039204312867,6.64996899990749,6.65178204228397,0.0018130423764786,0.989643400026565,ENSG00000149311,ATM,protein_coding,11,1,108222484,108369102,q22.3,ATM serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:795],ATAXIA-TELANGIECTASIA;ATAXIA-TELANGIECTASIA VARIANT;B-cell chronic lymphocytic leukemia;Breast Cancer;Combined cervical dystonia;MANTLE CELL LYMPHOMA,ATM,472,NM_000051;NM_001351834;NM_001351835;NM_001351836
APBB1IP_SIG,APBB1IP,APBB1IP_SIG,APBB1IP,SIG,61,-0.992247806556084,0.40084275065371,0.404132271634559,0.390034324573781,-0.0140979470607777,0.381926791611749,-1.23069377926689,6.96706113346307,6.99157749893008,6.88650736121435,-0.105070137715723,0.323484550923552,ENSG00000077420,APBB1IP,protein_coding,10,1,26438341,26567803,p12.1,amyloid beta precursor protein binding family B member 1 interacting protein [Source:HGNC Symbol;Acc:HGNC:17379],NA,APBB1IP,54518,NM_019043
PHF3_SIG,PHF3,PHF3_SIG,PHF3,SIG,34,0.992066747833303,0.318919547617333,0.317086874046937,0.324941189348634,0.00785431530169706,0.381976994493606,1.97170995817063,7.44587606922906,7.42135936603455,7.52643095115386,0.10507158511931,0.10225845353877,ENSG00000118482,PHF3,protein_coding,6,1,63635820,63779336,q12,PHD finger protein 3 [Source:HGNC Symbol;Acc:HGNC:8921],NA,PHF3,23469,NM_001290259;NM_001290260;NM_015153
SP140L_SIG,SP140L,SP140L_SIG,SP140L,SIG,47,-0.991300274157046,0.123490044630023,0.125313393835097,0.117499040099062,-0.00781435373603526,0.382366935903612,-0.973262343861696,4.83384348641184,4.84924747785823,4.78323037165942,-0.0660171061988085,0.443900730168377,ENSG00000185404,SP140L,protein_coding,2,1,230327184,230403732,q37.1,SP140 nuclear body protein like [Source:HGNC Symbol;Acc:HGNC:25105],NA,SP140L,93349,NM_001308162;NM_001308163;NM_001352892;NM_001352893;NM_001352894;NM_138402
BRPF3_SIG,BRPF3,BRPF3_SIG,BRPF3,SIG,17,-0.991056571080769,0.0281288416139847,0.0293252192019106,0.0241978866822284,-0.00512733251968211,0.382450630165581,-1.56020892787049,5.78464999695108,5.80617993279686,5.71390877917209,-0.0922711536247611,0.202463933235054,ENSG00000096070,BRPF3,protein_coding,6,1,36196744,36232790,p21.31,bromodomain and PHD finger containing 3 [Source:HGNC Symbol;Acc:HGNC:14256],NA,BRPF3,27154,NM_015695
NCOR1_SIG,NCOR1,NCOR1_SIG,NCOR1,SIG,20,0.990967023695979,0.514975051193148,0.512224884522642,0.524011313110525,0.0117864285878822,0.382450630165581,1.92150291292607,7.80987309275873,7.78380303453076,7.89553185550779,0.111728820977028,0.112033062893821,ENSG00000141027,NCOR1,protein_coding,17,-1,16029157,16218185,p11.2,nuclear receptor corepressor 1 [Source:HGNC Symbol;Acc:HGNC:7672],NA,NCOR1,9611,NM_001190438;NM_001190440;NM_006311
HRH4_SIG,HRH4,HRH4_SIG,HRH4,SIG,35,-0.990610484351957,0.0206508663454682,0.0220964845202727,0.0159009780568247,-0.00619550646344803,0.382602745682965,0.964073162890628,0.995683648223315,0.973391402911947,1.06892959710353,0.0955381941915797,0.448800856323795,ENSG00000134489,HRH4,protein_coding,18,1,24460637,24479961,q11.2,histamine receptor H4 [Source:HGNC Symbol;Acc:HGNC:17383],NA,HRH4,59340,NM_001143828;NM_001160166;NM_021624
RAD54L_SIG,RAD54L,RAD54L_SIG,RAD54L,SIG,62,-0.989183425560612,0.249316748842212,0.257912681932384,0.221072968688788,-0.0368397132435963,0.38337694307476,-0.264150091807629,2.84604165575564,2.85417027988266,2.81933331933828,-0.0348369605443773,0.848882728270454,ENSG00000085999,RAD54L,protein_coding,1,1,46247688,46278473,p34.1,RAD54 like [Source:HGNC Symbol;Acc:HGNC:9826],Breast Cancer;Hereditary breast cancer;LYMPHOMA NON-HODGKIN FAMILIAL,RAD54L,8438,NM_001142548;NM_003579
SEC61B_SIG,SEC61B,SEC61B_SIG,SEC61B,SIG,36,-0.988947274417407,0.215700858630938,0.2181785648547,0.20755982389572,-0.0106187409589798,0.383459245618904,0.275119657859453,5.26805414879173,5.26465535634381,5.27922160969205,0.0145662533482395,0.842549981269999,ENSG00000106803,SEC61B,protein_coding,9,1,99222064,99230615,q22.33,Sec61 translocon beta subunit [Source:HGNC Symbol;Acc:HGNC:16993],NA,SEC61B,10952,NM_006808
DDX28_SIG,DDX28,DDX28_SIG,DDX28,SIG,24,0.988528645393325,0.204921391742897,0.203615745642109,0.209211371788345,0.00559562614623607,0.383647674873236,1.9378890597998,4.48638459767106,4.4590272207088,4.57627312197564,0.117245901266835,0.108692410380154,ENSG00000182810,DDX28,protein_coding,16,-1,68021274,68023442,q22.1,DEAD-box helicase 28 [Source:HGNC Symbol;Acc:HGNC:17330],NA,DDX28,55794,NM_018380
AATF_SIG,AATF,AATF_SIG,AATF,SIG,17,0.984191194714264,0.209563413957244,0.207945797899047,0.214878438148461,0.00693264024941418,0.386120339365581,0.845168937717595,6.2256013235177,6.21744189912231,6.25241086081684,0.0349689616945294,0.51101947085249,ENSG00000275700,AATF,protein_coding,17,1,36948954,37056871,q12,apoptosis antagonizing transcription factor [Source:HGNC Symbol;Acc:HGNC:19235],NA,AATF,26574,NM_012138
ZNF814_TF,ZNF814,ZNF814_TF,ZNF814,TF,64,-0.983698984765033,-0.063363605252492,-0.0619573984542638,-0.0679839990180993,-0.00602660056383551,0.386352461915374,-0.127682092163348,3.01978545532828,3.02305338586248,3.00904796928733,-0.0140054165751522,0.928360798419002,ENSG00000204514,ZNF814,protein_coding,19,-1,57848731,57889074,q13.43,zinc finger protein 814 [Source:HGNC Symbol;Acc:HGNC:33258],NA,ZNF814,730051,NM_001144989
SLC37A1_SIG,SLC37A1,SLC37A1_SIG,SLC37A1,SIG,52,0.983174292819818,0.0500054040621915,0.0473672519338569,0.0586736181981483,0.0113063662642915,0.386603639932784,-0.272047456719374,5.53081921836409,5.53700052165302,5.51050922184334,-0.026491299809681,0.84417545369512,ENSG00000160190,SLC37A1,protein_coding,21,1,42496008,42581440,q22.3,solute carrier family 37 member 1 [Source:HGNC Symbol;Acc:HGNC:11024],NA,SLC37A1,54020,NM_001320537;NM_018964
RYR1_SIG,RYR1,RYR1_SIG,RYR1,SIG,15,-0.981650949008889,-0.0229316005619511,-0.0200779738315647,-0.0323078026760778,-0.0122298288445132,0.387439039580648,2.57828188115349,1.82316663793368,1.73205324759939,2.12253920617491,0.390485958575519,0.0296179912292966,ENSG00000196218,RYR1,protein_coding,19,1,38433699,38587564,q13.2,ryanodine receptor 1 [Source:HGNC Symbol;Acc:HGNC:10483],Autosomal dominant centronuclear myopathy;Autosomal recessive centronuclear myopathy;Benign Samaritan congenital myopathy;Central core disease;CENTRAL CORE DISEASE OF MUSCLE;Congenital multicore myopathy with external ophthalmoplegia;Congenital myopathy with myasthenic-like onset;Exercise-induced malignant hyperthermia;King Denborough syndrome;Lethal multiple pterygium syndrome;Malignant hyperthermia of anesthesia;MALIGNANT HYPERTHERMIA SUSCEPTIBILITY TO 1;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;Moderate multiminicore disease with hand involvement;MYOPATHY CONGENITAL WITH FIBER-TYPE DISPROPORTION,RYR1,6261,NM_000540;NM_001042723
SRP54_SIG,SRP54,SRP54_SIG,SRP54,SIG,27,-0.981360517557235,0.45632934229526,0.458643776090829,0.448724774109819,-0.00991900198101006,0.387553480158801,-1.00816944684615,5.48101160073618,5.49568097420178,5.43281223077779,-0.0628687434239899,0.426464573393002,ENSG00000100883,SRP54,protein_coding,14,1,34981957,35029567,q13.2,signal recognition particle 54 [Source:HGNC Symbol;Acc:HGNC:11301],SHWACHMAN-DIAMOND SYNDROME;SHWACHMAN-DIAMOND SYNDROME 1;Syndromic neutropenia with Shwachman-Diamond-like features,SRP54,6729,NM_001146282;NM_003136
ZDHHC13_SIG,ZDHHC13,ZDHHC13_SIG,ZDHHC13,SIG,27,-0.981262008769183,0.235768657428031,0.23744736357268,0.230252908667041,-0.00719445490563844,0.387555599893111,0.0180078572782948,3.92525681424347,3.92489074273604,3.92645962062503,0.0015688778889898,0.990072717896098,ENSG00000177054,ZDHHC13,protein_coding,11,1,19117099,19176422,p15.1,zinc finger DHHC-type containing 13 [Source:HGNC Symbol;Acc:HGNC:18413],NA,ZDHHC13,54503,NM_001001483;NM_019028
MRPS15_SIG,MRPS15,MRPS15_SIG,MRPS15,SIG,22,-0.980587533232694,0.285858250611774,0.287273193804773,0.281209151549061,-0.00606404225571261,0.387894898189133,0.504633714322959,4.99234095327839,4.98689655000003,5.01022970690726,0.0233331569072331,0.706787619579777,ENSG00000116898,MRPS15,protein_coding,1,-1,36455718,36464384,p34.3,mitochondrial ribosomal protein S15 [Source:HGNC Symbol;Acc:HGNC:14504],NA,MRPS15,64960,NM_031280
RPL39_SIG,RPL39,RPL39_SIG,RPL39,SIG,15,0.980458995116822,0.193385762493177,0.190662658097452,0.202333105507702,0.0116704474102502,0.387914595838142,2.02787652191631,3.90120193191547,3.86976212680987,4.00450414869102,0.134742021881152,0.092275325505085,ENSG00000198918,RPL39,protein_coding,X,-1,119786504,119791630,q24,ribosomal protein L39 [Source:HGNC Symbol;Acc:HGNC:10350],NA,RPL39,6170,NM_001000
STRAP_SIG,STRAP,STRAP_SIG,STRAP,SIG,46,0.979642545681026,0.313902366342486,0.31088700654364,0.323809977110125,0.0129229705664856,0.388337239498432,0.2223614375283,6.71492703022056,6.71197683722237,6.72462052150033,0.0126436842779533,0.874299891243254,ENSG00000023734,STRAP,protein_coding,12,1,15882387,15903478,p12.3,serine/threonine kinase receptor associated protein [Source:HGNC Symbol;Acc:HGNC:30796],NA,STRAP,11171,NM_007178
CHD3_SIG,CHD3,CHD3_SIG,CHD3,SIG,59,-0.978948072833684,0.0332063743972047,0.0343782638861972,0.029355880361944,-0.00502238352425309,0.388688630501597,0.0830620758778467,8.26983425727974,8.26837865762253,8.2746169418677,0.00623828424517289,0.954149458609478,ENSG00000170004,CHD3,protein_coding,17,1,7884806,7912760,p13.1,chromodomain helicase DNA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:1918],Apraxia of speech;SNIJDERS BLOK-CAMPEAU SYNDROME,CHD3,1107,NM_001005271;NM_001005273;NM_005852
PNPO_SIG,PNPO,PNPO_SIG,PNPO,SIG,41,0.978671607666041,0.336355060411502,0.332034285688726,0.350551891643482,0.0185176059547558,0.388795055360156,0.230567481325343,3.1549531470617,3.14895569329083,3.17465906659455,0.0257033733037163,0.869791879779872,ENSG00000108439,PNPO,protein_coding,17,1,47941506,47949308,q21.32,pyridoxamine 5'-phosphate oxidase [Source:HGNC Symbol;Acc:HGNC:30260],Pyridoxal phosphate-responsive seizures;PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY,PNPO,55163,NM_018129
EIF3C_SIG,EIF3C,EIF3C_SIG,EIF3C,SIG,5,0.977439129264251,-0.0688545441401982,-0.0699716590386752,-0.0651840237594884,0.00478763527918696,0.389462370300849,1.72036057676825,4.17060898780873,4.15172411801999,4.23265927425746,0.0809351562374728,0.157766797473138,ENSG00000184110,EIF3C,protein_coding,16,1,28688558,28735730,p11.2,eukaryotic translation initiation factor 3 subunit C [Source:HGNC Symbol;Acc:HGNC:3279],NA,EIF3C,8663,NM_001037808;NM_001199142;NM_001267574;NM_001286478;NM_003752
NAA38_SIG,NAA38,NAA38_SIG,NAA38,SIG,29,0.977159829089504,0.23467549125825,0.233451301620478,0.238697828639503,0.00524652701902463,0.38957055748643,-0.394498649551072,5.20060825350007,5.2053330090421,5.1850840567191,-0.0202489523229997,0.771712174431683,ENSG00000183011,NAA38,protein_coding,17,-1,7856685,7885238,p13.1,N(alpha)-acetyltransferase 38, NatC auxiliary subunit [Source:HGNC Symbol;Acc:HGNC:28212],NA,NAA38,84316,NM_001320924;NM_001320925;NM_001330111;NM_032356
ADI1_SIG,ADI1,ADI1_SIG,ADI1,SIG,10,0.975980836945534,0.24366746980064,0.24182223913967,0.249730370543829,0.0079081314041591,0.39020720835676,1.1565022944935,5.73188661756749,5.71694626216438,5.78097635674914,0.0640300945847566,0.356500597202317,ENSG00000182551,ADI1,protein_coding,2,-1,3497366,3519531,p25.3,acireductone dioxygenase 1 [Source:HGNC Symbol;Acc:HGNC:30576],NA,ADI1,55256,NM_001306077;NM_018269
PER2_TF,PER2,PER2_TF,PER2,TF,54,0.975871319990055,0.213374354297761,0.211960639217209,0.218019418133863,0.00605877891665458,0.39021571794033,0.411823361417852,4.87628803820956,4.86983996786268,4.89747455506358,0.0276345872008986,0.761608910121991,ENSG00000132326,PER2,protein_coding,2,-1,238244044,238290102,q37.3,period circadian regulator 2 [Source:HGNC Symbol;Acc:HGNC:8846],ADVANCED SLEEP PHASE SYNDROME FAMILIAL 1;FAMILIAL ADVANCED SLEEP-PHASE SYNDROME,PER2,8864,NM_022817
FZD8_SIG,FZD8,FZD8_SIG,FZD8,SIG,32,-0.975355221426988,-0.0762925643658821,-0.0747348282953555,-0.0814108400261839,-0.00667601173082847,0.390463179802587,-1.80963747222181,0.827480856944702,0.868004947149897,0.694330274841917,-0.17367467230798,0.135947638562405,ENSG00000177283,FZD8,protein_coding,10,-1,35638249,35642278,p11.21,frizzled class receptor 8 [Source:HGNC Symbol;Acc:HGNC:4046],NA,FZD8,8325,NM_031866
NR1D2_TF,NR1D2,NR1D2_TF,NR1D2,TF,74,-0.973222896491258,0.0845702713762116,0.0869838586311573,0.0766399132528185,-0.0103439453783388,0.391661858392796,-0.242146096818208,5.17584108610445,5.18188407292349,5.15598555798472,-0.0258985149387721,0.862646084712242,ENSG00000174738,NR1D2,protein_coding,3,1,23945286,23980617,p24.2,nuclear receptor subfamily 1 group D member 2 [Source:HGNC Symbol;Acc:HGNC:7963],NA,NR1D2,9975,NM_001145425;NM_005126
ASS1_SIG,ASS1,ASS1_SIG,ASS1,SIG,37,-0.972612693298873,-0.050434898719463,-0.049033263938137,-0.0550402701438198,-0.00600700620568269,0.391965271760837,0.0573568877946539,0.759489842555135,0.757568963264171,0.765801303082587,0.00823233981841536,0.968209360548367,ENSG00000130707,ASS1,protein_coding,9,1,130444929,130501274,q34.11,argininosuccinate synthase 1 [Source:HGNC Symbol;Acc:HGNC:758],Acute neonatal citrullinemia type I;Adult-onset citrullinemia type I;CITRULLINEMIA CLASSIC;Citrullinemia Type I,ASS1,445,NM_000050;NM_054012
RPS7_SIG,RPS7,RPS7_SIG,RPS7,SIG,47,0.971967405978325,0.900923898159516,0.896238631880999,0.916318344503217,0.0200797126222185,0.392289493620737,1.67045336001257,6.84536249675291,6.81924456372746,6.93117856240795,0.111933998680489,0.170880683695529,ENSG00000171863,RPS7,protein_coding,2,1,3575205,3580920,p25.3,ribosomal protein S7 [Source:HGNC Symbol;Acc:HGNC:10440],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 8,RPS7,6201,NM_001011
GPR3_SIG,GPR3,GPR3_SIG,GPR3,SIG,35,0.971818093124468,0.0858704287554138,0.0842605417018419,0.0911600576457211,0.00689951594387917,0.392321410676954,2.39541008426516,1.23763162918074,1.18381030921067,1.4144731090824,0.230662799871734,0.0442759521099376,ENSG00000181773,GPR3,protein_coding,1,1,27392622,27395814,p36.11,G protein-coupled receptor 3 [Source:HGNC Symbol;Acc:HGNC:4484],NA,GPR3,2827,NM_005281
CCNT2_SIG,CCNT2,CCNT2_SIG,CCNT2,SIG,33,0.969803837703257,0.578198136781863,0.575649508878499,0.586572199892916,0.0109226910144171,0.393453725509324,-0.0440475136886004,6.27496529696082,6.27552503993178,6.27312614148479,-0.00239889844698924,0.975761976309625,ENSG00000082258,CCNT2,protein_coding,2,1,134918235,134959342,q21.3,cyclin T2 [Source:HGNC Symbol;Acc:HGNC:1600],NA,CCNT2,905,NM_001241;NM_001320748;NM_001320749;NM_058241
CAPN12_SIG,CAPN12,CAPN12_SIG,CAPN12,SIG,30,0.966296233897338,0.00159986149276076,0.000449601551297742,0.00537928701471067,0.00492968546341308,0.395472210406676,0.450002631683706,1.85534262592958,1.84458314839236,1.89069519498047,0.0461120465881094,0.739159612173091,ENSG00000182472,CAPN12,protein_coding,19,-1,38730187,38769904,q13.2,calpain 12 [Source:HGNC Symbol;Acc:HGNC:13249],NA,CAPN12,147968,NM_144691
MEX3D_SIG,MEX3D,MEX3D_SIG,MEX3D,SIG,48,0.965688089827244,0.0117960297761774,0.010421758591691,0.0163114922394897,0.00588973364779883,0.395776061747722,1.19765105131168,1.89593327487589,1.87164420375332,1.97574022285003,0.104096019096708,0.337980714216983,ENSG00000181588,MEX3D,protein_coding,19,-1,1554669,1568058,p13.3,mex-3 RNA binding family member D [Source:HGNC Symbol;Acc:HGNC:16734],NA,MEX3D,399664,NM_001174118;NM_203304
C1R_SIG,C1R,C1R_SIG,C1R,SIG,59,0.965195388265846,-0.0827375089377525,-0.0845151840307631,-0.0768965764892894,0.00761860754147382,0.395937573242729,2.12240704944574,2.04106983534881,1.98908060420496,2.21189159482144,0.222810990616471,0.0770508179217965,ENSG00000159403,C1R,protein_coding,12,-1,7080209,7092607,p13.31,complement C1r [Source:HGNC Symbol;Acc:HGNC:1246],EHLERS-DANLOS SYNDROME PERIODONTAL TYPE 1;Ehlers-Danlos syndrome periodontitis type;Immunodeficiency due to a classical component pathway complement deficiency;Pediatric systemic lupus erythematosus,C1R,715,NM_001354346;NM_001733
FBXO11_SIG,FBXO11,FBXO11_SIG,FBXO11,SIG,16,-0.965188240047235,0.656524292490346,0.658718851883781,0.649313597340487,-0.0094052545432945,0.395937573242729,-0.843809532767194,6.84398280451808,6.85197217305178,6.81773202219307,-0.0342401508587091,0.511764205342151,ENSG00000138081,FBXO11,protein_coding,2,-1,47789316,47905793,p16.3,F-box protein 11 [Source:HGNC Symbol;Acc:HGNC:13590],FBXO11 related intellectual disability;INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES ANDBEHAVIORAL ABNORMALITIES,FBXO11,80204,NM_001190274;NM_025133
SRP9_SIG,SRP9,SRP9_SIG,SRP9,SIG,21,0.965129339557961,0.299477779015806,0.297551045795214,0.305808473883464,0.00825742808824987,0.395937573242729,-0.182188507922912,6.20125671506271,6.20335851322818,6.19435080680473,-0.00900770642345513,0.897609094445218,ENSG00000143742,SRP9,protein_coding,1,1,225777813,225790468,q42.12,signal recognition particle 9 [Source:HGNC Symbol;Acc:HGNC:11304],NA,SRP9,6726,NM_001130440;NM_003133
PATL2_SIG,PATL2,PATL2_SIG,PATL2,SIG,44,-0.96482930807039,-0.0012581756430276,0.000447970847910661,-0.00686408554182472,-0.00731205638973541,0.396045610091133,-1.60516381012762,3.44855065889015,3.48171630020843,3.3395778374158,-0.142138462792628,0.189043646305701,ENSG00000229474,PATL2,protein_coding,15,-1,44665732,44711316,q21.1,PAT1 homolog 2 [Source:HGNC Symbol;Acc:HGNC:33630],Female infertility due to oocyte meiotic arrest;OOCYTE MATURATION DEFECT 4,PATL2,197135,NM_001145112;NM_001330283
RAPGEF4_SIG,RAPGEF4,RAPGEF4_SIG,RAPGEF4,SIG,35,-0.964697103857816,-0.0687528565100379,-0.067000793277118,-0.0745096357039175,-0.00750884242679936,0.396045610091133,-0.0259092485346362,0.601488611177744,0.601978827553391,0.599877900229189,-0.00210092732420254,0.985630994230889,ENSG00000091428,RAPGEF4,protein_coding,2,1,172735274,173052893,q31.1,Rap guanine nucleotide exchange factor 4 [Source:HGNC Symbol;Acc:HGNC:16626],NA,RAPGEF4,11069,NM_001100397;NM_001282899;NM_001282900;NM_001282901;NM_007023
CRYL1_SIG,CRYL1,CRYL1_SIG,CRYL1,SIG,16,0.964660853451354,0.207746003301832,0.206330355133805,0.212397418711062,0.00606706357725741,0.396045610091133,0.675475414056833,3.93982820745334,3.9284693309537,3.97715023023786,0.0486808992841533,0.605985628440552,ENSG00000165475,CRYL1,protein_coding,13,-1,20403666,20525873,q12.11,crystallin lambda 1 [Source:HGNC Symbol;Acc:HGNC:18246],NA,CRYL1,51084,NM_001363647;NM_015974
AURKC_SIG,AURKC,AURKC_SIG,AURKC,SIG,14,0.962307721219028,0.114314200688194,0.112621201569667,0.119876912077638,0.00725571050797088,0.397385477995407,0.413633269257254,0.870552393441842,0.866236998309742,0.884731548875885,0.0184945505661429,0.760721107599601,ENSG00000105146,AURKC,protein_coding,19,1,57230802,57235548,q13.43,aurora kinase C [Source:HGNC Symbol;Acc:HGNC:11391],Male infertility due to large-headed multiflagellar polyploid spermatozoa;SPERMATOGENIC FAILURE 5,AURKC,6795,NM_001015878;NM_001015879;NM_003160
POU2F1_TF,POU2F1,POU2F1_TF,POU2F1,TF,93,0.960424262885806,0.245786165784973,0.244269942364802,0.250768042736965,0.00649810037216281,0.398448564707619,0.728289218714138,5.729492595911,5.71785434878038,5.76773255076876,0.0498782019883767,0.575205780258679,ENSG00000143190,POU2F1,protein_coding,1,1,167220876,167427345,q24.2,POU class 2 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9212],NA,POU2F1,5451,NM_001198783;NM_001198786;NM_001365848;NM_001365849;NM_002697
GAL3ST4_SIG,GAL3ST4,GAL3ST4_SIG,GAL3ST4,SIG,48,0.960312322487205,-0.0557311412109725,-0.057299632459777,-0.0505775271077577,0.00672210535201908,0.398458293403525,-0.223752788323167,1.8843727373311,1.89009414897233,1.86557381336704,-0.024520335605296,0.873353853229497,ENSG00000197093,GAL3ST4,protein_coding,7,-1,100159244,100168617,q22.1,galactose-3-O-sulfotransferase 4 [Source:HGNC Symbol;Acc:HGNC:24145],NA,GAL3ST4,79690,NM_024637
FDX1_SIG,FDX1,FDX1_SIG,FDX1,SIG,24,0.959717811245322,0.102839777288584,0.101801978644914,0.106249687117783,0.00444770847286817,0.398755248464262,1.66794437961831,4.08583928985391,4.05996927064466,4.17084078154143,0.110871510896775,0.171510077625888,ENSG00000137714,FDX1,protein_coding,11,1,110429948,110464884,q22.3,ferredoxin 1 [Source:HGNC Symbol;Acc:HGNC:3638],NA,FDX1,2230,NM_004109
ZNF341_SIG,ZNF341,ZNF341_SIG,ZNF341,SIG,27,0.959481241743679,0.109908217139658,0.106963573688612,0.119583474193094,0.0126199005044812,0.398839172952759,1.49003661372648,3.01770739107744,2.99718315679734,3.08514416085492,0.0879610040575754,0.225252210569595,ENSG00000131061,ZNF341,protein_coding,20,1,33731657,33792269,q11.22,zinc finger protein 341 [Source:HGNC Symbol;Acc:HGNC:15992],NA,ZNF341,84905,NM_001282933;NM_001282935;NM_032819
PIGA_SIG,PIGA,PIGA_SIG,PIGA,SIG,61,-0.959134545008458,0.494934821528128,0.499750968748759,0.479110337803199,-0.0206406309455596,0.398965051569778,-1.09504396251296,4.84860475893774,4.87376323321257,4.76594120060615,-0.107822032606424,0.384668325181199,ENSG00000165195,PIGA,protein_coding,X,-1,15319451,15335580,p22.2,phosphatidylinositol glycan anchor biosynthesis class A [Source:HGNC Symbol;Acc:HGNC:8957],Ferro-cerebro-cutaneous syndrome;MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2;Multiple congenital anomalies-hypotonia-seizures syndrome type 2;Paroxysmal nocturnal hemoglobinuria;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1;West syndrome,PIGA,5277,NM_002641;NM_020473
CSF1R_SIG,CSF1R,CSF1R_SIG,CSF1R,SIG,39,-0.959078627095186,0.323124768518219,0.327579449053069,0.308487961046567,-0.0190914880065016,0.398965051569778,-0.0979584525344256,6.14597526270911,6.15091362330014,6.12974922076715,-0.0211644025329843,0.945268977595903,ENSG00000182578,CSF1R,protein_coding,5,-1,150053291,150113372,q32,colony stimulating factor 1 receptor [Source:HGNC Symbol;Acc:HGNC:2433],Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia;LEUKOENCEPHALOPATHY HEREDITARY DIFFUSE WITH SPHEROIDS,CSF1R,1436,NM_001288705;NM_001349736;NM_005211
SKOR1_TF,SKOR1,SKOR1_TF,SKOR1,TF,70,0.95840605669578,0.108669656882002,0.107251491941614,0.113329341686136,0.00607784974452276,0.399308684800724,0.378129104992862,1.0705136663038,1.0657092446031,1.08629962332037,0.0205903787172735,0.781283808023581,ENSG00000188779,SKOR1,protein_coding,15,1,67819704,67834555,q23,SKI family transcriptional corepressor 1 [Source:HGNC Symbol;Acc:HGNC:21326],NA,SKOR1,390598,NM_001258024;NM_001365915
ALG14_SIG,ALG14,ALG14_SIG,ALG14,SIG,15,0.956433546365341,0.146954231983048,0.144311612172451,0.155637125646436,0.0113255134739847,0.400427773437995,1.25951768379914,1.50463517791616,1.4876177355979,1.56054963124761,0.0729318956497119,0.311410568514177,ENSG00000172339,ALG14,protein_coding,1,-1,94974405,95072951,p21.3,ALG14, UDP-N-acetylglucosaminyltransferase subunit [Source:HGNC Symbol;Acc:HGNC:28287],Congenital myasthenic syndromes with glycosylation defect;Myasthenic syndrome congenital 15,ALG14,199857,NM_001305242;NM_144988
SPEN_TF,SPEN,SPEN_TF,SPEN,TF,59,0.954871729430857,0.460195253734392,0.458762144397754,0.464904041554776,0.00614189715702172,0.401303290756312,2.01912954679908,8.2030742727974,8.1799226119801,8.27914401548282,0.0992214035027211,0.0937586343433083,ENSG00000065526,SPEN,protein_coding,1,1,15847707,15940456,p36.21,spen family transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:17575],NA,SPEN,23013,NM_015001
SH2D2A_SIG,SH2D2A,SH2D2A_SIG,SH2D2A,SIG,24,-0.954329663730148,0.0801581107590488,0.0825588260217814,0.0722700463243558,-0.0102887796974255,0.401570036293492,0.526295279218628,2.36139261166335,2.34585239564194,2.412453321448,0.0666009258060639,0.694561358830773,ENSG00000027869,SH2D2A,protein_coding,1,-1,156806243,156816862,q23.1,SH2 domain containing 2A [Source:HGNC Symbol;Acc:HGNC:10821],NA,SH2D2A,9047,NM_001161441;NM_001161442;NM_001161443;NM_001161444;NM_003975
NCEH1_SIG,NCEH1,NCEH1_SIG,NCEH1,SIG,34,-0.954069192845182,0.203280804760403,0.205187189321444,0.197016969774128,-0.0081702195473158,0.401652408833382,-0.433147518869337,3.94629042210973,3.95844205099368,3.90636364149105,-0.0520784095026302,0.74841021863486,ENSG00000144959,NCEH1,protein_coding,3,-1,172630249,172711218,q26.31,neutral cholesterol ester hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:29260],NA,NCEH1,57552,NM_001146276;NM_001146277;NM_001146278;NM_020792
LGSN_SIG,LGSN,LGSN_SIG,LGSN,SIG,18,-0.954000316936868,-0.0348241013814406,-0.0330640001620991,-0.0406072911021341,-0.00754329094003514,0.401652408833382,-0.429364938567659,0.487610640335705,0.497280210158432,0.455839196632458,-0.0414410135259745,0.750752592700609,ENSG00000146166,LGSN,protein_coding,6,-1,63275951,63319977,q12,lengsin, lens protein with glutamine synthetase domain [Source:HGNC Symbol;Acc:HGNC:21016],NA,LGSN,51557,NM_001143940;NM_016571
SDHA_SIG,SDHA,SDHA_SIG,SDHA,SIG,20,-0.95387478574461,0.373012557592136,0.374181159134668,0.369172866809531,-0.00500829232513694,0.401670200514218,-1.74175424011072,6.45598803195876,6.47573540774501,6.39110379723252,-0.0846316105124885,0.15220583711151,ENSG00000073578,SDHA,protein_coding,5,1,218241,257082,p15.33,succinate dehydrogenase complex flavoprotein subunit A [Source:HGNC Symbol;Acc:HGNC:10680],CARDIOMYOPATHY DILATED 1GG;Familial isolated dilated cardiomyopathy;Gastrointestinal stromal tumor;Hereditary pheochromocytoma-paraganglioma;Isolated succinate-CoQ reductase deficiency;Leigh syndrome;Leigh syndrome with leukodystrophy;Mitochondrial complex II deficiency;PARAGANGLIOMAS 5,SDHA,6389,NM_001294332;NM_001330758;NM_004168
RERE_TF,RERE,RERE_TF,RERE,TF,159,-0.95351669464072,-0.0176796030382015,-0.0165117109403722,-0.021516962788212,-0.00500525184783998,0.401827035804322,-0.814242338143065,7.13425970969402,7.14641430482834,7.09432318282412,-0.0520911220042191,0.527366954624694,ENSG00000142599,RERE,protein_coding,1,-1,8352397,8817640,p36.23,arginine-glutamic acid dipeptide repeats [Source:HGNC Symbol;Acc:HGNC:9965],1p36 deletion syndrome;NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN EYE OR HEART;Phenocopy of Proximal 1p36 Deletions;RERE-related neurodevelopmental syndrome,RERE,473,NM_001042681;NM_001042682;NM_012102
SCAMP4_SIG,SCAMP4,SCAMP4_SIG,SCAMP4,SIG,30,0.951795550660496,0.324131068396636,0.322735873914258,0.328715278838735,0.00597940492447645,0.402799604642259,0.8911185091927,4.66973417774169,4.65707966702831,4.71131328437137,0.0542336173430655,0.486514717049004,ENSG00000227500,SCAMP4,protein_coding,19,1,1905372,1926013,p13.3,secretory carrier membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:30385],NA,SCAMP4,113178,NM_001329539;NM_001329540;NM_079834
EIF1AD_SIG,EIF1AD,EIF1AD_SIG,EIF1AD,SIG,23,-0.951312373650555,0.29337622417386,0.295549865103334,0.286234261119871,-0.00931560398346305,0.403031582973274,-1.41710373150232,4.72127779482906,4.74096289243937,4.65659818839517,-0.0843647040441989,0.250116070425072,ENSG00000175376,EIF1AD,protein_coding,11,-1,65996545,66002176,q13.1,eukaryotic translation initiation factor 1A domain containing [Source:HGNC Symbol;Acc:HGNC:28147],NA,EIF1AD,84285,NM_001242481;NM_001242482;NM_001242483;NM_001242484;NM_001242485;NM_001242486;NM_032325
SIAH1_SIG,SIAH1,SIAH1_SIG,SIAH1,SIG,49,0.950908093804579,0.385490805202336,0.381769469489492,0.397718051115966,0.015948581626474,0.40321635417069,1.22563118320854,4.62759418373286,4.59732450590754,4.72705169658747,0.129727190679931,0.32558055212041,ENSG00000196470,SIAH1,protein_coding,16,-1,48356364,48448402,q12.1,siah E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:10857],NA,SIAH1,6477,NM_001006610;NM_003031
HTR1F_SIG,HTR1F,HTR1F_SIG,HTR1F,SIG,99,0.950331954774798,0.0274954637840089,0.0250987291102967,0.0353704491404916,0.0102717200301947,0.403504170890923,0.162751167595505,2.2437290403133,2.23633750971855,2.2680154979818,0.0316779882632523,0.908756628872861,ENSG00000179097,HTR1F,protein_coding,3,1,87990696,87993835,p11.1,5-hydroxytryptamine receptor 1F [Source:HGNC Symbol;Acc:HGNC:5292],NA,HTR1F,3355,NM_000866;NM_001322208;NM_001322209;NM_001322210
MAP2K4_SIG,MAP2K4,MAP2K4_SIG,MAP2K4,SIG,49,-0.949649666613042,0.434385362459418,0.436966898791039,0.425903171655518,-0.011063727135521,0.403855750117829,-0.890797040360443,4.43445753730494,4.45013383380779,4.38294970593846,-0.0671841278693268,0.486637167254519,ENSG00000065559,MAP2K4,protein_coding,17,1,12020829,12143830,p12,mitogen-activated protein kinase kinase 4 [Source:HGNC Symbol;Acc:HGNC:6844],NA,MAP2K4,6416,NM_001281435;NM_003010
EIF5_SIG,EIF5,EIF5_SIG,EIF5,SIG,23,-0.948281044263555,0.423070271867023,0.425920364976715,0.413705680220894,-0.0122146847558202,0.40456876440107,-0.611117478841623,8.14341384051168,8.15171919475769,8.11612481941762,-0.0355943753400697,0.643993890040581,ENSG00000100664,EIF5,protein_coding,14,1,103333544,103345025,q32.32,eukaryotic translation initiation factor 5 [Source:HGNC Symbol;Acc:HGNC:3299],NA,EIF5,1983,NM_001969;NM_183004
ZBTB8OS_TF,ZBTB8OS,ZBTB8OS_TF,ZBTB8OS,TF,165,-0.948269496866523,-0.228604382314981,-0.226918013318663,-0.234145309017167,-0.00722729569850398,0.40456876440107,-0.167429224146799,3.82452094519102,3.82652275883722,3.8179435574964,-0.00857920134081602,0.906033824232018,ENSG00000176261,ZBTB8OS,protein_coding,1,-1,32600172,32650903,p35.1,zinc finger and BTB domain containing 8 opposite strand [Source:HGNC Symbol;Acc:HGNC:24094],NA,ZBTB8OS,339487,NM_001308135;NM_001308136;NM_001308137;NM_001308138;NM_001308139;NM_001308140;NM_001308141;NM_001330475;NM_001366257;NM_001366278;NM_178547
CDC5L_SIG,CDC5L,CDC5L_SIG,CDC5L,SIG,31,0.947816713318639,0.422609601199168,0.421493198070673,0.426277782907081,0.00478458483640788,0.404770984588253,1.43854850764208,6.30871766584458,6.29319158364606,6.35973193592541,0.0665403522793496,0.242572077373255,ENSG00000096401,CDC5L,protein_coding,6,1,44387706,44450425,p21.1,cell division cycle 5 like [Source:HGNC Symbol;Acc:HGNC:1743],NA,CDC5L,988,NM_001253
AKR7A2_SIG,AKR7A2,AKR7A2_SIG,AKR7A2,SIG,49,0.947740792195901,0.300393288344228,0.298250739363422,0.307433092138304,0.00918235277488131,0.404770984588253,0.738606464864256,4.8121223859304,4.79663354378818,4.86301429582628,0.0663807520380945,0.569929175807776,ENSG00000053371,AKR7A2,protein_coding,1,-1,19303965,19312146,p36.13,aldo-keto reductase family 7 member A2 [Source:HGNC Symbol;Acc:HGNC:389],NA,AKR7A2,8574,NM_001320979;NM_003689
EIF3H_SIG,EIF3H,EIF3H_SIG,EIF3H,SIG,11,0.947618392853901,1.54821837739017,1.54462735211004,1.56001746045348,0.0153901083434435,0.404786871369902,0.830008381189137,8.38058809351737,8.37164303053592,8.40997901474213,0.0383359842062082,0.519188616290029,ENSG00000147677,EIF3H,protein_coding,8,-1,116642130,116766925,q24.11,eukaryotic translation initiation factor 3 subunit H [Source:HGNC Symbol;Acc:HGNC:3273],NA,EIF3H,8667,NM_003756
PDE7A_SIG,PDE7A,PDE7A_SIG,PDE7A,SIG,30,0.947469190177725,0.139426987235003,0.137861051625226,0.144572204238556,0.00671115261332925,0.404818855691051,-1.33450259839524,6.92646725486982,6.95697440487679,6.82622947627548,-0.130744928601316,0.281273959122152,ENSG00000205268,PDE7A,protein_coding,8,-1,65717510,65842322,q13.1,phosphodiesterase 7A [Source:HGNC Symbol;Acc:HGNC:8791],NA,PDE7A,5150,NM_001242318;NM_002603
EIF2S2_SIG,EIF2S2,EIF2S2_SIG,EIF2S2,SIG,34,0.94667951885685,0.195333356456104,0.192814881371069,0.203608346021219,0.0107934646501503,0.405235521623046,0.18512085631721,5.28381606853122,5.28156472386792,5.29121334385348,0.00964861998555645,0.89585372059245,ENSG00000125977,EIF2S2,protein_coding,20,-1,34088309,34112243,q11.22,eukaryotic translation initiation factor 2 subunit beta [Source:HGNC Symbol;Acc:HGNC:3266],NA,EIF2S2,8894,NM_001316363;NM_001316364;NM_003908
RPL34_SIG,RPL34,RPL34_SIG,RPL34,SIG,28,0.946174030862513,1.00183723674726,0.997753530813633,1.01525512767204,0.0175015968584079,0.405481605421833,1.36978472015082,7.39520941908666,7.37253522838795,7.4697103313824,0.0971751029944458,0.268192000186743,ENSG00000109475,RPL34,protein_coding,4,1,108620566,108630412,q25,ribosomal protein L34 [Source:HGNC Symbol;Acc:HGNC:10340],NA,RPL34,6164,NM_000995;NM_001319232;NM_001319234;NM_001319235;NM_001319236;NM_033625
BST2_SIG,BST2,BST2_SIG,BST2,SIG,30,-0.944995214158851,0.187328666634947,0.188918220617291,0.182105846407248,-0.00681237421004249,0.406132702436184,-0.911199092423832,6.04404523384819,6.06891231350014,5.96233911499177,-0.106573198508376,0.476048577900117,ENSG00000130303,BST2,protein_coding,19,-1,17402939,17405630,p13.11,bone marrow stromal cell antigen 2 [Source:HGNC Symbol;Acc:HGNC:1119],NA,BST2,684,NM_004335
ODC1_SIG,ODC1,ODC1_SIG,ODC1,SIG,29,0.944435476813795,0.218969985380886,0.217541789340797,0.223662629512608,0.00612084017181166,0.406411720207783,1.39104985049731,7.03404264121625,7.00184618481681,7.13983099795726,0.137984813140447,0.259989708880265,ENSG00000115758,ODC1,protein_coding,2,-1,10439968,10448327,p25.1,ornithine decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:8109],NA,ODC1,4953,NM_001287188;NM_001287189;NM_001287190;NM_002539
ENTPD7_SIG,ENTPD7,ENTPD7_SIG,ENTPD7,SIG,36,-0.944076408381658,0.270147113312701,0.272197639358239,0.263409670591651,-0.00878796876658722,0.406570034681634,-0.313005872094928,3.85042904823556,3.85864292346528,3.82344060105219,-0.0352023224130913,0.820062156599388,ENSG00000198018,ENTPD7,protein_coding,10,1,99659509,99711241,q24.2,ectonucleoside triphosphate diphosphohydrolase 7 [Source:HGNC Symbol;Acc:HGNC:19745],NA,ENTPD7,57089,NM_001349962;NM_001349963;NM_020354
RNF123_SIG,RNF123,RNF123_SIG,RNF123,SIG,33,0.943630341477486,0.304413317481035,0.301969505281496,0.312442986136664,0.0104734808551686,0.406780757677792,-0.00703007754779897,5.59939590482406,5.59950157916547,5.59904868913086,-0.000452890034616941,0.995922627386179,ENSG00000164068,RNF123,protein_coding,3,1,49689538,49721529,p21.31,ring finger protein 123 [Source:HGNC Symbol;Acc:HGNC:21148],NA,RNF123,63891,NM_022064
KDM4C_SIG,KDM4C,KDM4C_SIG,KDM4C,SIG,4,0.941415114332873,0.220358379095857,0.21860861134555,0.226107615989721,0.00749900464417055,0.408057944188656,-1.64620294972614,5.86149612609058,5.87726163768476,5.80969515942399,-0.0675664782607628,0.17752969341454,ENSG00000107077,KDM4C,protein_coding,9,1,6720863,7175648,p24.1,lysine demethylase 4C [Source:HGNC Symbol;Acc:HGNC:17071],NA,KDM4C,23081,NM_001146695;NM_001146696;NM_001304339;NM_001304340;NM_001304341;NM_001353997;NM_001353998;NM_001353999;NM_001354000;NM_001354001;NM_015061
THRA_SIG,THRA,THRA_SIG,THRA,SIG,6,-0.938564700881064,0.0800334737772812,0.0808199850638294,0.077449222407194,-0.00337076265663535,0.409721608514839,1.95431543543845,5.6366783725472,5.60992436466045,5.72458439846083,0.114660033800384,0.105537904267494,ENSG00000126351,THRA,protein_coding,17,1,40058290,40093867,q21.1,thyroid hormone receptor alpha [Source:HGNC Symbol;Acc:HGNC:11796],HYPOTHYROIDISM CONGENITAL NONGOITROUS 6;Peripheral resistance to thyroid hormones,THRA,7067,NM_001190918;NM_001190919;NM_003250;NM_199334
EEF1D_SIG,EEF1D,EEF1D_SIG,EEF1D,SIG,14,-0.93781698310205,0.203912538704467,0.206014809521691,0.197005077447872,-0.0090097320738196,0.410115708246486,-1.42612653450829,8.26746722420729,8.28076757858518,8.22376605982277,-0.0570015187624121,0.246894180248314,ENSG00000104529,EEF1D,protein_coding,8,-1,143579697,143599541,q24.3,eukaryotic translation elongation factor 1 delta [Source:HGNC Symbol;Acc:HGNC:3211],NA,EEF1D,1936,NM_001130053;NM_001130055;NM_001130056;NM_001130057;NM_001195203;NM_001289950;NM_001317743;NM_001330646;NM_001960;NM_032378
SLC35C2_SIG,SLC35C2,SLC35C2_SIG,SLC35C2,SIG,40,-0.936618609388881,0.237939972367877,0.239965247703902,0.231285496263796,-0.00867975144010598,0.410782938258408,0.124854596051164,6.00445371356462,6.00281417910514,6.00984075536006,0.0070265762549217,0.930286123044273,ENSG00000080189,SLC35C2,protein_coding,20,-1,46345980,46364458,q13.12,solute carrier family 35 member C2 [Source:HGNC Symbol;Acc:HGNC:17117],NA,SLC35C2,51006,NM_001281457;NM_001281458;NM_001281459;NM_001281460;NM_015945;NM_173073;NM_173179
ANP32B_SIG,ANP32B,ANP32B_SIG,ANP32B,SIG,54,-0.936224104354514,0.124465440734717,0.125760229690269,0.120211134166475,-0.00554909552379327,0.410963559818404,-0.875619753029297,7.99755973461789,8.00947238080113,7.95841818287298,-0.051054197928149,0.494816960544078,ENSG00000136938,ANP32B,protein_coding,9,1,97983341,98015943,q22.33,acidic nuclear phosphoprotein 32 family member B [Source:HGNC Symbol;Acc:HGNC:16677],NA,ANP32B,10541,NM_006401
H6PD_SIG,H6PD,H6PD_SIG,H6PD,SIG,11,-0.935864065333394,0.336443247360387,0.337640084726615,0.332510781728496,-0.00512930299811863,0.411123331559934,-2.58630290943961,6.57241201574905,6.62416606573796,6.40236299435693,-0.221803071381026,0.0290665793478213,ENSG00000049239,H6PD,protein_coding,1,1,9234775,9271337,p36.22,hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:HGNC Symbol;Acc:HGNC:4795],CORTISONE REDUCTASE DEFICIENCY 1;Hyperandrogenism due to cortisone reductase deficiency,H6PD,9563,NM_001282587;NM_004285
RPL9_SIG,RPL9,RPL9_SIG,RPL9,SIG,6,0.935288137763531,0.207080181658438,0.203325571905512,0.219416756560908,0.0160911846553959,0.41141399880824,0.793365327930473,5.65646043654963,5.63629542736685,5.72271689529305,0.0864214679262005,0.538684364405969,ENSG00000163682,RPL9,protein_coding,4,-1,39452521,39458949,p14,ribosomal protein L9 [Source:HGNC Symbol;Acc:HGNC:10369],NA,RPL9,6133,NM_000661;NM_001024921
DOT1L_TF,DOT1L,DOT1L_TF,DOT1L,TF,105,0.934773102555482,0.210096749364163,0.209144395229059,0.213225912950934,0.00408151772187593,0.411667842485691,-1.78901012998318,6.75535825403411,6.7773073512126,6.68323979187622,-0.0940675593363806,0.140813155693875,ENSG00000104885,DOT1L,protein_coding,19,1,2163933,2232578,p13.3,DOT1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:24948],NA,DOT1L,84444,NM_032482
RPS3A_SIG,RPS3A,RPS3A_SIG,RPS3A,SIG,32,0.933414441353516,1.26712560231978,1.26198875391856,1.28400381849521,0.0220150645766539,0.41243375451968,1.15213234645921,8.07535949308157,8.0527992830392,8.14948589750647,0.0966866144672719,0.358357158745147,ENSG00000145425,RPS3A,protein_coding,4,1,151099624,151104642,q31.3,ribosomal protein S3A [Source:HGNC Symbol;Acc:HGNC:10421],NA,RPS3A,6189,NM_001006;NM_001267699
ROCK1_SIG,ROCK1,ROCK1_SIG,ROCK1,SIG,33,-0.933307619177636,0.480932275621793,0.481969104532982,0.477525552056456,-0.00444355247652607,0.412433867530142,-0.139630117860594,7.68799700296775,7.68952181451019,7.68298690789972,-0.00653490661047315,0.92164172951409,ENSG00000067900,ROCK1,protein_coding,18,-1,20946906,21111813,q11.1,Rho associated coiled-coil containing protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:10251],NA,ROCK1,6093,NM_005406
FUT8_SIG,FUT8,FUT8_SIG,FUT8,SIG,6,0.933221367386173,0.266560802994117,0.26508261326075,0.271417712118037,0.00633509885728702,0.412433867530142,-0.581695586779587,3.84183477354014,3.85504585470764,3.79842693541833,-0.0566189192893132,0.662237270334426,ENSG00000033170,FUT8,protein_coding,14,1,65410592,65744121,q23.3,fucosyltransferase 8 [Source:HGNC Symbol;Acc:HGNC:4019],CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION,FUT8,2530,NM_004480;NM_178155;NM_178156
C1orf52_SIG,C1orf52,C1orf52_SIG,C1orf52,SIG,11,-0.93302343011413,0.354702061103469,0.357223543469487,0.346417190472266,-0.0108063529972219,0.412495488555038,-0.34582344159122,4.64032649278205,4.64370326380626,4.62923138798823,-0.0144718758180264,0.800260838285212,ENSG00000162642,C1orf52,protein_coding,1,-1,85249953,85259672,p22.3,chromosome 1 open reading frame 52 [Source:HGNC Symbol;Acc:HGNC:24871],NA,C1orf52,148423,NM_198077
ZNF655_TF,ZNF655,ZNF655_TF,ZNF655,TF,146,0.932020534423104,0.121494102685706,0.120470799014418,0.12485638617708,0.00438558716266145,0.413046004314578,1.09997816065114,6.67863298557375,6.6643304888667,6.7256269033255,0.0612964144588054,0.382531574525269,ENSG00000197343,ZNF655,protein_coding,7,1,99558406,99576453,q22.1,zinc finger protein 655 [Source:HGNC Symbol;Acc:HGNC:30899],NA,ZNF655,79027,NM_001009958;NM_001009960;NM_001083956;NM_001085366;NM_001085367;NM_001085368;NM_001363332;NM_001363333;NM_001363334;NM_024061;NM_138494
MAP3K13_SIG,MAP3K13,MAP3K13_SIG,MAP3K13,SIG,22,0.930592307450283,-0.0627501907875048,-0.0640390363646886,-0.0585154124624721,0.00552362390221637,0.41385561049543,-0.843491230046961,2.85597315502506,2.88345597153333,2.76567247221217,-0.117783499321163,0.511906237303046,ENSG00000073803,MAP3K13,protein_coding,3,1,185282941,185489094,q27.2,mitogen-activated protein kinase kinase kinase 13 [Source:HGNC Symbol;Acc:HGNC:6852],NA,MAP3K13,9175,NM_001242314;NM_001242317;NM_004721
MAP3K11_SIG,MAP3K11,MAP3K11_SIG,MAP3K11,SIG,37,-0.930321377299583,0.199549622927401,0.201170238276014,0.194224743924816,-0.00694549435119815,0.413961703033072,0.364680674187894,6.83482401196779,6.82980787237343,6.85130561349211,0.0214977411186724,0.789296185410475,ENSG00000173327,MAP3K11,protein_coding,11,-1,65597756,65615382,q13.1,mitogen-activated protein kinase kinase kinase 11 [Source:HGNC Symbol;Acc:HGNC:6850],NA,MAP3K11,4296,NM_002419
CHAF1B_SIG,CHAF1B,CHAF1B_SIG,CHAF1B,SIG,16,-0.930213670678105,0.404574783160053,0.410125474143017,0.386336798501743,-0.0237886756412732,0.413968504043607,-0.559504444645258,3.72773365436949,3.74015285156281,3.68692772073429,-0.0532251308285181,0.675429874073992,ENSG00000159259,CHAF1B,protein_coding,21,1,36385392,36419015,q22.12,chromatin assembly factor 1 subunit B [Source:HGNC Symbol;Acc:HGNC:1911],NA,CHAF1B,8208,NM_005441
RPL18A_SIG,RPL18A,RPL18A_SIG,RPL18A,SIG,44,0.929743434276122,0.65588432743989,0.652064748695577,0.668434371885491,0.0163696231899137,0.414195879113761,1.15283718431765,6.7303247080846,6.712241742165,6.78974016753471,0.0774984253697113,0.358053699391392,ENSG00000105640,RPL18A,protein_coding,19,1,17859910,17864153,p13.11,ribosomal protein L18a [Source:HGNC Symbol;Acc:HGNC:10311],NA,RPL18A,6142,NM_000980
SPEN_SIG,SPEN,SPEN_SIG,SPEN,SIG,33,0.928182539652283,0.542649057950614,0.541012980910166,0.548024739654943,0.0070117587447772,0.415087534483191,2.01912954679908,8.2030742727974,8.1799226119801,8.27914401548282,0.0992214035027211,0.0937586343433083,ENSG00000065526,SPEN,protein_coding,1,1,15847707,15940456,p36.21,spen family transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:17575],NA,SPEN,23013,NM_015001
IFNAR2_SIG,IFNAR2,IFNAR2_SIG,IFNAR2,SIG,22,0.928044548692501,0.20811007342132,0.206188775225412,0.214422910350734,0.00823413512532267,0.415112755498794,2.00745446910907,5.44222375295971,5.40649912649657,5.55960466848146,0.153105541984894,0.0957459624719185,ENSG00000159110,IFNAR2,protein_coding,21,1,33229901,33265675,q22.11,interferon alpha and beta receptor subunit 2 [Source:HGNC Symbol;Acc:HGNC:5433],HEPATITIS B VIRUS SUSCEPTIBILITY TO;IMMUNODEFICIENCY 45;Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,IFNAR2,3455,NM_000874;NM_001289125;NM_001289126;NM_001289128;NM_207584;NM_207585
PSMA6_SIG,PSMA6,PSMA6_SIG,PSMA6,SIG,23,0.927157291328387,0.128118834537746,0.126396912783733,0.133776577443788,0.00737966466005492,0.41559466670609,0.558403958695231,4.18318292590826,4.17526701551057,4.2091923457864,0.0339253302758254,0.676137231081241,ENSG00000100902,PSMA6,protein_coding,14,1,35278633,35317493,q13.2,proteasome subunit alpha 6 [Source:HGNC Symbol;Acc:HGNC:9535],MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,PSMA6,5687,NM_001282232;NM_001282233;NM_001282234;NM_002791
LOXL2_SIG,LOXL2,LOXL2_SIG,LOXL2,SIG,27,-0.926755947579972,-0.0295636466310675,-0.0283499367940767,-0.03355155038118,-0.00520161358710338,0.415780478400321,-0.186035987869793,1.24465164829654,1.24719326275738,1.23630062935379,-0.0108926334035907,0.895403880771975,ENSG00000134013,LOXL2,protein_coding,8,-1,23297189,23425328,p21.3,lysyl oxidase like 2 [Source:HGNC Symbol;Acc:HGNC:6666],NA,LOXL2,4017,NM_002318
PRPS1_SIG,PRPS1,PRPS1_SIG,PRPS1,SIG,34,0.925501639787247,0.500407340390819,0.498466226045751,0.506785287524615,0.00831906147886383,0.416486845650463,0.432839822336121,5.33251174479543,5.32627210430957,5.35301342067752,0.0267413163679483,0.748624931519238,ENSG00000147224,PRPS1,protein_coding,X,1,107628424,107651026,q22.3,phosphoribosyl pyrophosphate synthetase 1 [Source:HGNC Symbol;Acc:HGNC:9462],Arts syndrome;CHARCOT-MARIE-TOOTH DISEASE X-LINKED RECESSIVE 5;CHARCOT-MARIE-TOOTH DISEASE X-LINKED RECESSIVE TYPE 5;DEAFNESS X-LINKED 1;DEAFNESS X-LINKED TYPE 1;Lethal ataxia with deafness and optic atrophy;Mild phosphoribosylpyrophosphate synthetase superactivity;PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY;Severe phosphoribosylpyrophosphate synthetase superactivity;X-linked Charcot-Marie-Tooth disease type 5;X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome;X-linked nonsyndromic sensorineural deafness type DFN,PRPS1,5631,NM_001204402;NM_002764
CRHBP_SIG,CRHBP,CRHBP_SIG,CRHBP,SIG,58,0.924737395648219,0.0278964744403158,0.0248127619870994,0.038028672500884,0.0132159105137847,0.416894487425582,1.5840259276265,2.2590603097245,2.19132622273193,2.48161516698579,0.290288944253863,0.195300745691761,ENSG00000145708,CRHBP,protein_coding,5,1,76953045,76981158,q13.3,corticotropin releasing hormone binding protein [Source:HGNC Symbol;Acc:HGNC:2356],NA,CRHBP,1393,NM_001882
HPRT1_SIG,HPRT1,HPRT1_SIG,HPRT1,SIG,22,0.924625334773896,0.560127730663218,0.557421262260716,0.569020412557153,0.0115991502964374,0.416903864626541,2.24675230700459,5.30944972811984,5.27530248123212,5.42164782503662,0.146345343804499,0.0603500433943124,ENSG00000165704,HPRT1,protein_coding,X,1,134460165,134520513,q26.2,hypoxanthine phosphoribosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:5157],GOUT HPRT-RELATED;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;KELLEY-SEEGMILLER SYNDROME;LESCH-NYHAN SYNDROME,HPRT1,3251,NM_000194
HDC_SIG,HDC,HDC_SIG,HDC,SIG,33,-0.923179422688237,-0.0902996494937419,-0.0877768522483113,-0.0985888404430141,-0.0108119881947029,0.417728444675429,-0.321035562380492,3.68198659757671,3.70239661027307,3.61492512728867,-0.0874714829844004,0.815387231371456,ENSG00000140287,HDC,protein_coding,15,-1,50241947,50265965,q21.2,histidine decarboxylase [Source:HGNC Symbol;Acc:HGNC:4855],GILLES DE LA TOURETTE SYNDROME,HDC,3067,NM_001306146;NM_002112
PHF1_TF,PHF1,PHF1_TF,PHF1,TF,386,-0.922751557210637,-0.132951314441173,-0.13054888217327,-0.140845020464283,-0.0102961382910126,0.417930946934847,-1.35982333472084,6.46858078613735,6.4945806110584,6.38315278996818,-0.111427821090219,0.271858070977024,ENSG00000112511,PHF1,protein_coding,6,1,33410399,33416453,p21.32,PHD finger protein 1 [Source:HGNC Symbol;Acc:HGNC:8919],NA,PHF1,5252,NM_002636;NM_024165
OXA1L_SIG,OXA1L,OXA1L_SIG,OXA1L,SIG,21,-0.922382948785688,0.434445843177519,0.435869018683201,0.42976969508742,-0.00609932359578134,0.418097239852529,0.105540898593118,7.38215501693727,7.38108723819079,7.38566343281858,0.00457619462779135,0.941364472762968,ENSG00000155463,OXA1L,protein_coding,14,1,22766522,22773041,q11.2,OXA1L, mitochondrial inner membrane protein [Source:HGNC Symbol;Acc:HGNC:8526],NA,OXA1L,5018,NM_005015
PLCXD2_SIG,PLCXD2,PLCXD2_SIG,PLCXD2,SIG,45,0.922233073602789,0.220834531439265,0.218302117088296,0.229155321449592,0.010853204361296,0.418129725178901,1.67474123875103,1.53479488766091,1.49900708803561,1.65238337214402,0.153376284108412,0.169805041928965,ENSG00000240891,PLCXD2,protein_coding,3,1,111674676,111846447,q13.2,phosphatidylinositol specific phospholipase C X domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26462],NA,PLCXD2,257068,NM_001185106;NM_153268
ETNK2_SIG,ETNK2,ETNK2_SIG,ETNK2,SIG,53,-0.921344474627448,-0.104855812906763,-0.103206024885291,-0.110276544977315,-0.00707052009202353,0.418610356872153,-0.027020324362527,0.860950725224292,0.861489050747199,0.859181941363311,-0.00230710938388809,0.985086397084391,ENSG00000143845,ETNK2,protein_coding,1,-1,204131062,204152044,q32.1,ethanolamine kinase 2 [Source:HGNC Symbol;Acc:HGNC:25575],NA,ETNK2,55224,NM_001297760;NM_001297761;NM_001297762;NM_018208
TWF1_SIG,TWF1,TWF1_SIG,TWF1,SIG,55,-0.921254155091972,0.452553342317651,0.456167535955378,0.440678134650835,-0.0154894013045426,0.418610356872153,-1.49554578870306,5.22063674507807,5.24948245671683,5.12585797826501,-0.123624478451818,0.223416776743993,ENSG00000151239,TWF1,protein_coding,12,-1,43793723,43806375,q12,twinfilin actin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9620],NA,TWF1,5756,NM_001242397;NM_002822
ZNF44_TF,ZNF44,ZNF44_TF,ZNF44,TF,53,0.920634581624404,0.0672912008893908,0.0658199747145071,0.0721252297497229,0.00630525503521579,0.418930457494627,1.63205425960294,4.16333617286986,4.13416566919471,4.25918211351677,0.12501644432206,0.181568683905694,ENSG00000197857,ZNF44,protein_coding,19,-1,12224686,12294887,p13.2,zinc finger protein 44 [Source:HGNC Symbol;Acc:HGNC:13110],NA,ZNF44,51710,NM_001164276;NM_001353549;NM_001353550;NM_001353551;NM_001353552;NM_001353553;NM_016264
ATP6V0E2_SIG,ATP6V0E2,ATP6V0E2_SIG,ATP6V0E2,SIG,63,-0.919537801675106,-0.0388015247130641,-0.0375357740479095,-0.042960419755715,-0.00542464570780553,0.419543140359195,0.0598038009626405,3.19738816497661,3.19583610885831,3.20248777793672,0.0066516690784103,0.966962199134253,ENSG00000171130,ATP6V0E2,protein_coding,7,1,149872968,149891204,q36.1,ATPase H+ transporting V0 subunit e2 [Source:HGNC Symbol;Acc:HGNC:21723],NA,ATP6V0E2,155066,NM_001100592;NM_001289990;NM_001367793;NM_145230
GSK3B_SIG,GSK3B,GSK3B_SIG,GSK3B,SIG,20,0.919292917972151,0.363302628823271,0.361608446321853,0.368869228470787,0.00726078214893408,0.419633879642899,-0.143142955734391,6.57893051719799,6.58038115237494,6.57416414447372,-0.00621700790122307,0.919766875148267,ENSG00000082701,GSK3B,protein_coding,3,-1,119821323,120094417,q13.33,glycogen synthase kinase 3 beta [Source:HGNC Symbol;Acc:HGNC:4617],NA,GSK3B,2932,NM_001146156;NM_001354596;NM_002093
ALG5_SIG,ALG5,ALG5_SIG,ALG5,SIG,20,0.918808860595398,0.268789056818593,0.267572077710634,0.272787702459033,0.00521562474839907,0.419839043964061,1.31017991736675,4.14765328702125,4.13328053084306,4.194878057321,0.0615975264779394,0.290907998392971,ENSG00000120697,ALG5,protein_coding,13,-1,36949738,37000261,q13.3,ALG5, dolichyl-phosphate beta-glucosyltransferase [Source:HGNC Symbol;Acc:HGNC:20266],NA,ALG5,29880,NM_001142364;NM_013338
CTDSPL2_SIG,CTDSPL2,CTDSPL2_SIG,CTDSPL2,SIG,45,0.918764560640452,0.390789819773216,0.389409147874086,0.395326313156072,0.00591716528198631,0.419839043964061,0.359962215431554,6.25961479731837,6.25546602064831,6.2732464920914,0.0177804714430927,0.791941981581529,ENSG00000137770,CTDSPL2,protein_coding,15,1,44427622,44529038,q15.3,CTD small phosphatase like 2 [Source:HGNC Symbol;Acc:HGNC:26936],NA,CTDSPL2,51496,NM_016396
ATG4B_SIG,ATG4B,ATG4B_SIG,ATG4B,SIG,4,0.917354631218124,0.11539683747623,0.114655379331935,0.117833057093196,0.00317767776126108,0.420644611931008,1.63136127191909,6.03106435163494,6.01829831767827,6.0730098917783,0.0547115741000325,0.181717039551926,ENSG00000168397,ATG4B,protein_coding,2,1,241637213,241673857,q37.3,autophagy related 4B cysteine peptidase [Source:HGNC Symbol;Acc:HGNC:20790],NA,ATG4B,23192,NM_013325;NM_178326
CCL3L3_SIG,CCL3L3,CCL3L1;CCL3L3_SIG,CCL3L1;CCL3L3,SIG,3,-0.917118245571175,-0.132617109269812,-0.128912299416111,-0.144790055931972,-0.0158777565158618,0.420730228082958,-0.46046367742483,0.65089744882238,0.661364604638715,0.616505365425848,-0.0448592392128669,0.73318342748835,ENSG00000276085;ENSG00000277796,CCL3L1;CCL3L3,protein_coding,17;CHR_HSCHR17_10_CTG4,-1,36194869;36194906,36196758;36196795,q12,C-C motif chemokine ligand 3 like 1 [Source:HGNC Symbol;Acc:HGNC:10628];C-C motif chemokine ligand 3 like 3 [Source:HGNC Symbol;Acc:HGNC:30554],HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUSCEPTIBILITY TO,CCL3L3,6349;414062,NM_001001437
PHF5A_TF,PHF5A,PHF5A_TF,PHF5A,TF,119,-0.915681909412128,0.208592207432601,0.209428519785657,0.205844323986847,-0.00358419579880957,0.421518026312772,-1.14463509895251,4.91517453320081,4.92649897958782,4.87796563792922,-0.0485333416585947,0.361575583917233,ENSG00000100410,PHF5A,protein_coding,22,-1,41459717,41468692,q13.2,PHD finger protein 5A [Source:HGNC Symbol;Acc:HGNC:18000],NA,PHF5A,84844,NM_032758
TRIM33_SIG,TRIM33,TRIM33_SIG,TRIM33,SIG,45,0.915576348106914,0.53421141404245,0.532643046393236,0.539364622032728,0.00672157563949215,0.421518026312772,1.49076286309503,6.67399447720818,6.65792387228809,6.72679789337417,0.0688740210860736,0.225034390262177,ENSG00000197323,TRIM33,protein_coding,1,-1,114392790,114511203,p13.2,tripartite motif containing 33 [Source:HGNC Symbol;Acc:HGNC:16290],Differentiated thyroid carcinoma,TRIM33,51592,NM_015906;NM_033020
EIF3CL_SIG,EIF3CL,EIF3CL_SIG,EIF3CL,SIG,35,0.915544837580737,-0.0351764412319948,-0.0364130003889985,-0.0311134611446968,0.00529953924430194,0.421518026312772,3.10085701767466,3.60914667843625,3.57354282991626,3.72613075214481,0.152587922228546,0.0082847536010155,ENSG00000205609,EIF3CL,protein_coding,16,-1,28379579,28403879,p12.1,eukaryotic translation initiation factor 3 subunit C like [Source:HGNC Symbol;Acc:HGNC:26347],NA,EIF3CL,728689,NM_001099661;NM_001317856;NM_001317857
HMGN5_TF,HMGN5,HMGN5_TF,HMGN5,TF,313,0.914908380111886,-0.0299878660734018,-0.0311057335467142,-0.026314872946804,0.00479086059991013,0.421849634741551,1.14320530368825,2.55230428068884,2.52020332841105,2.65777883817301,0.137575509761958,0.362288861678411,ENSG00000198157,HMGN5,protein_coding,X,-1,81113701,81201942,q21.1,high mobility group nucleosome binding domain 5 [Source:HGNC Symbol;Acc:HGNC:8013],NA,HMGN5,79366,NM_030763
SYVN1_SIG,SYVN1,SYVN1_SIG,SYVN1,SIG,11,-0.913600081313162,0.099751578932207,0.100340769681287,0.097815666470944,-0.00252510321034294,0.422594741532366,0.66600808327771,6.27269368774548,6.2659730513178,6.29477577886502,0.0288027275472295,0.611559121972121,ENSG00000162298,SYVN1,protein_coding,11,-1,65121780,65134533,q13.1,synoviolin 1 [Source:HGNC Symbol;Acc:HGNC:20738],NA,SYVN1,84447,NM_032431;NM_172230
ACSL3_SIG,ACSL3,ACSL3_SIG,ACSL3,SIG,21,-0.912808981608665,0.0880855884933763,0.088902795143109,0.0854004809299688,-0.00350231421314033,0.423022024703315,1.42818364498557,5.55639932835104,5.53602127024138,5.62335580499704,0.0873345347556639,0.24616764199795,ENSG00000123983,ACSL3,protein_coding,2,1,222860942,222944639,q36.1,acyl-CoA synthetase long chain family member 3 [Source:HGNC Symbol;Acc:HGNC:3570],NA,ACSL3,2181,NM_001354158;NM_001354159;NM_004457;NM_203372
EBF4_TF,EBF4,EBF4_TF,EBF4,TF,175,-0.912471483276511,-0.0744302496852375,-0.0734155672355015,-0.0777642063057986,-0.00434863907029717,0.423170098912326,-1.62660864812468,0.921666760800487,0.962300120225593,0.788157151260855,-0.174142968964738,0.183126813417944,ENSG00000088881,EBF4,protein_coding,20,1,2692878,2760108,p13,EBF family member 4 [Source:HGNC Symbol;Acc:HGNC:29278],NA,EBF4,57593,NM_001110514
ANXA7_SIG,ANXA7,ANXA7_SIG,ANXA7,SIG,19,0.911677924979557,0.145592138433713,0.1448418241161,0.148057456905872,0.00321563278977227,0.42359919699049,0.336073434100012,6.81288997822534,6.80964855099913,6.8235403819686,0.0138918309694692,0.806183181680232,ENSG00000138279,ANXA7,protein_coding,10,-1,73375101,73414076,q22.2,annexin A7 [Source:HGNC Symbol;Acc:HGNC:545],NA,ANXA7,310,NM_001156;NM_001320879;NM_001320880;NM_004034
YTHDF3_SIG,YTHDF3,YTHDF3_SIG,YTHDF3,SIG,21,-0.911331037689724,0.555390479643872,0.557985535013846,0.546863869142528,-0.0111216658713186,0.423753149512507,-0.0992609969506273,7.13810872948113,7.13962751958041,7.1331184191549,-0.00650910042551091,0.944590266464624,ENSG00000185728,YTHDF3,protein_coding,8,1,63168553,63212786,q12.3,YTH N6-methyladenosine RNA binding protein 3 [Source:HGNC Symbol;Acc:HGNC:26465],NA,YTHDF3,253943,NM_001277813;NM_001277814;NM_001277815;NM_001277816;NM_001277817;NM_001277818;NM_152758
HIST1H4C_SIG,HIST1H4C,HIST1H4C_SIG,HIST1H4C,SIG,26,0.911002656209115,-0.215615990168145,-0.218029272973749,-0.207686632378303,0.0103426405954466,0.423895717502258,0.984217712432756,0.650343282006934,0.635197360537687,0.700108452548746,0.0649110920110591,0.438509903558822,ENSG00000197061,HIST1H4C,protein_coding,6,1,26103876,26104310,p22.2,histone cluster 1 H4 family member c [Source:HGNC Symbol;Acc:HGNC:4787],HIST1H4C,HIST1H4C,8364,NM_003542
ZNF148_TF,ZNF148,ZNF148_TF,ZNF148,TF,91,0.90888199104322,0.416591861757004,0.415184132649004,0.421217257397574,0.00603312474857058,0.425099019280046,0.85168383680854,5.74154541164748,5.73120895101228,5.77550806802027,0.0442991170079859,0.507161166561987,ENSG00000163848,ZNF148,protein_coding,3,-1,125225561,125375354,q21.2,zinc finger protein 148 [Source:HGNC Symbol;Acc:HGNC:12933],GLOBAL DEVELOPMENTAL DELAY ABSENT OR HYPOPLASTIC CORPUS CALLOSUMAND DYSMORPHIC FACIES,ZNF148,7707,NM_001348424;NM_001348425;NM_001348426;NM_001348427;NM_001348428;NM_001348429;NM_001348430;NM_001348431;NM_001348432;NM_001348433;NM_001348434;NM_001348436;NM_021964
PDE8A_SIG,PDE8A,PDE8A_SIG,PDE8A,SIG,29,-0.908858111008509,0.136449320042145,0.137460920229226,0.133125490856022,-0.00433542937320476,0.425099019280046,-0.858903133544332,4.32092496944335,4.33577931975998,4.27211781840299,-0.0636615013569884,0.503611075818549,ENSG00000073417,PDE8A,protein_coding,15,1,84980440,85139145,q25.3,phosphodiesterase 8A [Source:HGNC Symbol;Acc:HGNC:8793],NA,PDE8A,5151,NM_001243137;NM_002605;NM_173454
ZNF333_TF,ZNF333,ZNF333_TF,ZNF333,TF,69,0.907688960056686,0.166976684382664,0.165984907427122,0.170235380093732,0.00425047266660969,0.425761259434485,0.11157675975074,5.0774130097518,5.07625437086433,5.08121996609634,0.00496559523200994,0.938167234937763,ENSG00000160961,ZNF333,protein_coding,19,1,14689801,14733746,p13.12,zinc finger protein 333 [Source:HGNC Symbol;Acc:HGNC:15624],NA,ZNF333,84449,NM_001300912;NM_001352239;NM_001352240;NM_001352241;NM_001352243;NM_001352244;NM_032433
ZFP90_TF,ZFP90,ZFP90_TF,ZFP90,TF,43,0.907542706880737,-0.029938646666749,-0.0311956831653714,-0.0258083838855611,0.00538729927981023,0.425791555897376,2.11328025364343,4.54102330773059,4.50007638987919,4.67556318067091,0.175486790791715,0.0783596410848104,ENSG00000184939,ZFP90,protein_coding,16,1,68530090,68576072,q22.1,ZFP90 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:23329],NA,ZFP90,146198,NM_001305203;NM_001305204;NM_001305206;NM_001305207;NM_001305208;NM_133458
DPM1_SIG,DPM1,DPM1_SIG,DPM1,SIG,23,-0.907292084608282,0.398508416252275,0.399502578671287,0.395241882589808,-0.00426069608147859,0.425824881075728,-1.0324602139396,4.94679290227088,4.95602603607733,4.91645546262112,-0.0395705734562072,0.414472020214058,ENSG00000000419,DPM1,protein_coding,20,-1,50934867,50958555,q13.13,dolichyl-phosphate mannosyltransferase subunit 1, catalytic [Source:HGNC Symbol;Acc:HGNC:3005],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ie;Congenital Disorders of Glycosylation;DPM1-CDG,DPM1,8813,NM_001317034;NM_001317035;NM_001317036;NM_003859
EPC2_SIG,EPC2,EPC2_SIG,EPC2,SIG,30,0.907245342696939,0.329089206575443,0.328101540274877,0.33233439584873,0.00423285557385248,0.425824881075728,-0.976707073612251,5.97201709209873,5.98195504099685,5.93936383143348,-0.0425912095633646,0.442333746261045,ENSG00000135999,EPC2,protein_coding,2,1,148644440,148787569,q23.1,enhancer of polycomb homolog 2 [Source:HGNC Symbol;Acc:HGNC:24543],NA,EPC2,26122,NM_015630
TMEM11_SIG,TMEM11,TMEM11_SIG,TMEM11,SIG,14,0.907197121373388,0.212403501081562,0.211637608403782,0.214920005594269,0.00328239719048793,0.425824881075728,1.20804247558963,4.79358878635062,4.77802924412725,4.8447129965131,0.0666837523858508,0.333233064973669,ENSG00000178307,TMEM11,protein_coding,17,-1,21197280,21214624,p11.2,transmembrane protein 11 [Source:HGNC Symbol;Acc:HGNC:16823],NA,TMEM11,8834,NM_003876
INPP5J_SIG,INPP5J,INPP5J_SIG,INPP5J,SIG,34,0.906517907268423,-0.0654318733022615,-0.0666555643329555,-0.0614111742014097,0.00524439013154579,0.426184643628271,0.653955697765586,0.451279839505894,0.438890791026168,0.491986713082135,0.053095922055967,0.61849296109293,ENSG00000185133,INPP5J,protein_coding,22,1,31122731,31134697,q12.2,inositol polyphosphate-5-phosphatase J [Source:HGNC Symbol;Acc:HGNC:8956],NA,INPP5J,27124,NM_001002837;NM_001284285;NM_001284286;NM_001284287;NM_001284288;NM_001284289
UROD_SIG,UROD,UROD_SIG,UROD,SIG,56,-0.906224177590972,0.100841220338542,0.103532682552685,0.0919978444920724,-0.0115348380606123,0.42630614551502,0.338138435309005,5.7817438978424,5.77543329142289,5.8024787475065,0.0270454560836057,0.804827050549129,ENSG00000126088,UROD,protein_coding,1,1,45010950,45015575,p34.1,uroporphyrinogen decarboxylase [Source:HGNC Symbol;Acc:HGNC:12591],Familial porphyria cutanea tarda;Hepatoerythropoietic porphyria;PORPHYRIA CUTANEA TARDA,UROD,7389,NM_000374
CENPU_SIG,CENPU,CENPU_SIG,CENPU,SIG,19,-0.904798333812209,0.530316729879635,0.533925538271261,0.518459216592865,-0.0154663216783959,0.427128185472924,0.769246173175998,5.16058706990417,5.14028127057048,5.2273061248577,0.0870248542872201,0.552625606952733,ENSG00000151725,CENPU,protein_coding,4,-1,184694085,184734130,q35.1,centromere protein U [Source:HGNC Symbol;Acc:HGNC:21348],NA,CENPU,79682,NM_024629
POMC_SIG,POMC,POMC_SIG,POMC,SIG,3,-0.904606524642766,0.00968131666622101,0.011597285542658,0.00338599035792818,-0.00821129518472969,0.427186699829391,0.874041523483205,1.04507783857841,1.02146746659208,1.12265477510491,0.101187308512836,0.495621842224498,ENSG00000115138,POMC,protein_coding,2,-1,25160853,25168903,p23.3,proopiomelanocortin [Source:HGNC Symbol;Acc:HGNC:9201],Obesity due to pro-opiomelanocortin deficiency;OBESITY EARLY-ONSET WITH ADRENAL INSUFFICIENCY AND RED HAIR;OBESITY LEANNESS INCLUDED,POMC,5443,NM_000939;NM_001035256;NM_001319204;NM_001319205
NAT1_SIG,NAT1,NAT1_SIG,NAT1,SIG,26,0.903349350087007,0.142722552209762,0.140589349375691,0.149731647235994,0.00914229786030377,0.427905138309835,0.371143169926178,2.41849079150293,2.41239122924713,2.43853221034343,0.0261409810963066,0.785880365713216,ENSG00000171428,NAT1,protein_coding,8,1,18170477,18223689,p22,N-acetyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:7645],NA,NAT1,9,NM_000662;NM_001160170;NM_001160171;NM_001160172;NM_001160173;NM_001160174;NM_001160175;NM_001160176;NM_001160179;NM_001291962
SLC4A8_SIG,SLC4A8,SLC4A8_SIG,SLC4A8,SIG,51,-0.901220912442922,0.0415395577505579,0.0427767707218028,0.0374744294164675,-0.00530234130533537,0.429146930862237,-1.35888290416084,2.63506268767776,2.66694973275611,2.5302909681346,-0.136658764621504,0.272211940623513,ENSG00000050438,SLC4A8,protein_coding,12,1,51391317,51515763,q13.13,solute carrier family 4 member 8 [Source:HGNC Symbol;Acc:HGNC:11034],NA,SLC4A8,9498,NM_001039960;NM_001258401;NM_001258402;NM_001258403;NM_001267615
RASAL3_SIG,RASAL3,RASAL3_SIG,RASAL3,SIG,67,0.901152506363255,0.22830728049372,0.226934459635731,0.232817977598542,0.00588351796281085,0.429146930862237,-0.019508780291459,6.41018343302953,6.41049878638439,6.40914727200639,-0.00135151437800486,0.9892573435761,ENSG00000105122,RASAL3,protein_coding,19,-1,15451624,15464544,p13.12,RAS protein activator like 3 [Source:HGNC Symbol;Acc:HGNC:26129],NA,RASAL3,64926,NM_022904
AGA_SIG,AGA,AGA_SIG,AGA,SIG,18,0.900590821679285,0.380436600643046,0.379015609655656,0.385105571030185,0.00608996137452895,0.429435177221419,1.01989409946689,4.29274104608571,4.27903712886449,4.33776820266969,0.0587310738051939,0.420639677716523,ENSG00000038002,AGA,protein_coding,4,-1,177430774,177442437,q34.3,aspartylglucosaminidase [Source:HGNC Symbol;Acc:HGNC:318],ASPARTYLGLUCOSAMINURIA,AGA,175,NM_000027;NM_001171988
HBP1_TF,HBP1,HBP1_TF,HBP1,TF,116,-0.899742926064426,0.357117804557377,0.359064310643519,0.350722141702908,-0.00834216894061103,0.429819614376394,-0.161832353433214,5.8939161401707,5.89698644589132,5.88382799280294,-0.0131584530883808,0.909379058034315,ENSG00000105856,HBP1,protein_coding,7,1,107168961,107202522,q22.3,HMG-box transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:23200],NA,HBP1,26959,NM_001244262;NM_012257
GTF2B_TF,GTF2B,GTF2B_TF,GTF2B,TF,91,-0.899698639397023,0.307054599362955,0.309375548759684,0.299428622773702,-0.00994692598598176,0.429819614376394,-0.467828795518494,5.30961750610032,5.31579721794229,5.28931273861957,-0.0264844793227173,0.728553915069643,ENSG00000137947,GTF2B,protein_coding,1,-1,88852633,88891944,p22.2,general transcription factor IIB [Source:HGNC Symbol;Acc:HGNC:4648],NA,GTF2B,2959,NM_001514
ISG20L2_SIG,ISG20L2,ISG20L2_SIG,ISG20L2,SIG,15,0.899679530220626,0.246461915049651,0.245447676953572,0.249794411651051,0.00434673469747815,0.429819614376394,0.00739913863122714,5.42397932898855,5.4239055061715,5.42422188967315,0.000316383501646949,0.995877610031222,ENSG00000143319,ISG20L2,protein_coding,1,-1,156721891,156728799,q23.1,interferon stimulated exonuclease gene 20 like 2 [Source:HGNC Symbol;Acc:HGNC:25745],NA,ISG20L2,81875,NM_001303095
FOLH1_SIG,FOLH1,FOLH1_SIG,FOLH1,SIG,20,-0.899282798163929,-0.0402017744035535,-0.0383898152605062,-0.0461553544449948,-0.00776553918448848,0.429998361142565,-1.34099802269294,0.299410912294889,0.317623251062754,0.239570370629047,-0.078052880433707,0.278755633443243,ENSG00000086205,FOLH1,protein_coding,11,-1,49145092,49208638,p11.12,folate hydrolase 1 [Source:HGNC Symbol;Acc:HGNC:3788],NA,FOLH1,2346,NM_001014986;NM_001193471;NM_001193472;NM_001193473;NM_001351236;NM_004476
RPP25_SIG,RPP25,RPP25_SIG,RPP25,SIG,11,0.89919691998656,0.154340355448337,0.151313317736457,0.164286336501655,0.0129730187651985,0.429998361142565,0.656332575710221,1.94838861071697,1.92902189022748,2.01202212089675,0.0830002306692682,0.617006826754823,ENSG00000178718,RPP25,protein_coding,15,-1,74954416,74957464,q24.2,ribonuclease P and MRP subunit p25 [Source:HGNC Symbol;Acc:HGNC:30361],NA,RPP25,54913,NM_017793
TAF4_TF,TAF4,TAF4_TF,TAF4,TF,108,0.897792190486237,0.297850831769573,0.295132570264623,0.306782262428694,0.0116496921640715,0.430811074451604,0.667021177378888,4.82982419159312,4.82010275889584,4.86176604188417,0.0416632829883295,0.610929505107597,ENSG00000130699,TAF4,protein_coding,20,-1,61953469,62065810,q13.33,TATA-box binding protein associated factor 4 [Source:HGNC Symbol;Acc:HGNC:11537],NA,TAF4,6874,NM_003185
MARCH8_SIG,MARCH8,MARCH8_SIG,MARCH8,SIG,45,-0.897543217554055,0.187783206661514,0.189613823844357,0.181768321632174,-0.00784550221218287,0.43090529130829,1.0246710344462,6.18086692286554,6.16299163768441,6.23960000274639,0.0766083650619845,0.418468451617047,ENSG00000165406,MARCH8,protein_coding,10,-1,45454585,45594906,q11.22,membrane associated ring-CH-type finger 8 [Source:HGNC Symbol;Acc:HGNC:23356],NA,MARCH8,220972,NM_001002266;NM_001282866;NM_145021
ZNF780A_TF,ZNF780A,ZNF780A_TF,ZNF780A,TF,114,0.896197600260799,0.181935782204237,0.179469526690992,0.190039193176325,0.010569666485333,0.431682131152652,1.52238417563348,2.35217981664753,2.31365717305529,2.478754217022,0.165097043966708,0.214616538010228,ENSG00000197782,ZNF780A,protein_coding,19,-1,40069152,40090938,q13.2,zinc finger protein 780A [Source:HGNC Symbol;Acc:HGNC:27603],NA,ZNF780A,284323,NM_001010880;NM_001142577;NM_001142578;NM_001142579
NCKIPSD_SIG,NCKIPSD,NCKIPSD_SIG,NCKIPSD,SIG,15,0.895891915790872,0.345447069823587,0.342288956328334,0.355823728450847,0.0135347721225133,0.43180249777287,0.54611241567136,3.66761217063559,3.65843129516423,3.69777790432722,0.0393466091629895,0.683099972496911,ENSG00000213672,NCKIPSD,protein_coding,3,-1,48673844,48686364,p21.31,NCK interacting protein with SH3 domain [Source:HGNC Symbol;Acc:HGNC:15486],NA,NCKIPSD,51517,NM_016453;NM_184231
ENPP5_SIG,ENPP5,ENPP5_SIG,ENPP5,SIG,38,-0.895809185754762,-0.157852646846862,-0.156383286768454,-0.162680544247348,-0.0062972574788941,0.43180249777287,2.68587141498244,0.566372990732863,0.519067347519765,0.721805818433044,0.202738470913279,0.0231801551086202,ENSG00000112796,ENPP5,protein_coding,6,-1,46159185,46170980,p21.1,ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) [Source:HGNC Symbol;Acc:HGNC:13717],NA,ENPP5,59084,NM_001290072;NM_001290073;NM_021572
JUN_SIG,JUN,JUN_SIG,JUN,SIG,59,-0.893662028780449,0.149718521904659,0.15155123341703,0.143696755506869,-0.00785447791016119,0.433080098799665,0.339946718255647,9.4691143852064,9.45629457861846,9.5112366068525,0.0549420282340397,0.803787438826121,ENSG00000177606,JUN,protein_coding,1,-1,58780788,58784327,p32.1,Jun proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6204],NA,JUN,3725,NM_002228
SUPT6H_TF,SUPT6H,SUPT6H_TF,SUPT6H,TF,135,-0.891098546154485,0.325077973254627,0.326463626705722,0.320525111915315,-0.00593851479040735,0.434620172406574,0.979529346513518,7.82456614585602,7.81361089416178,7.86056197285137,0.0469510786895942,0.440923287143298,ENSG00000109111,SUPT6H,protein_coding,17,1,28662198,28702679,q11.2,SPT6 homolog, histone chaperone [Source:HGNC Symbol;Acc:HGNC:11470],NA,SUPT6H,6830,NM_001320755;NM_003170
CIC_TF,CIC,CIC_TF,CIC,TF,128,-0.890557615468894,0.101448156218313,0.102856046037659,0.0968222325261742,-0.00603381351148532,0.434897289940117,-1.28725357309194,7.4102983708906,7.42613002082163,7.35828009254578,-0.0678499282758515,0.299997425318815,ENSG00000079432,CIC,protein_coding,19,1,42268537,42295797,q13.2,capicua transcriptional repressor [Source:HGNC Symbol;Acc:HGNC:14214],Autosomal dominant non-syndromic intellectual disability;CAPICUA DROSOPHILA HOMOLOG OF;MENTAL RETARDATION AUTOSOMAL DOMINANT 45,CIC,23152,NM_001304815;NM_015125
ACP2_SIG,ACP2,ACP2_SIG,ACP2,SIG,15,-0.890442615425678,0.251419253546802,0.253698411213764,0.24393059264107,-0.00976781857269365,0.434908045536264,-0.76297797878718,4.14696728778742,4.16172477347391,4.09847840624612,-0.0632463672277873,0.556224575875573,ENSG00000134575,ACP2,protein_coding,11,-1,47239302,47248840,p11.2,acid phosphatase 2, lysosomal [Source:HGNC Symbol;Acc:HGNC:123],ACID PHOSPHATASE DEFICIENCY,ACP2,53,NM_001302489;NM_001302490;NM_001302491;NM_001302492;NM_001357016;NM_001610
USP42_SIG,USP42,USP42_SIG,USP42,SIG,30,-0.889031970894503,0.529936431335018,0.532675300979468,0.52093728821754,-0.0117380127619279,0.435729596914048,0.376721765216102,4.82392827483308,4.81779939117607,4.84406603542037,0.0262666442442949,0.782214463500477,ENSG00000106346,USP42,protein_coding,7,1,6104884,6161564,p22.1,ubiquitin specific peptidase 42 [Source:HGNC Symbol;Acc:HGNC:20068],NA,USP42,84132,NM_032172
CBR1_SIG,CBR1,CBR1_SIG,CBR1,SIG,32,-0.887890526693811,0.0653655329320351,0.0679577554697735,0.0568482303080374,-0.0111095251617363,0.43638329944853,0.369891726735224,3.96383764688376,3.95270845761622,4.00040498304857,0.0476965254323528,0.786660420418344,ENSG00000159228,CBR1,protein_coding,21,1,36069941,36073166,q22.12,carbonyl reductase 1 [Source:HGNC Symbol;Acc:HGNC:1548],NA,CBR1,873,NM_001286789;NM_001757
P2RX7_SIG,P2RX7,P2RX7_SIG,P2RX7,SIG,41,0.88766352690601,0.235078244262599,0.231914158293942,0.245474526731045,0.0135603684371029,0.436464202214803,2.08649579562006,3.69750519824241,3.6300290441572,3.91921256166526,0.289183517508064,0.0824734253561248,ENSG00000089041,P2RX7,protein_coding,12,1,121132819,121188032,q24.31,purinergic receptor P2X 7 [Source:HGNC Symbol;Acc:HGNC:8537],B-cell chronic lymphocytic leukemia,P2RX7,5027,NM_002562
FAM32A_SIG,FAM32A,FAM32A_SIG,FAM32A,SIG,8,-0.887504888095989,0.25064129456634,0.252315790882712,0.245139378098262,-0.00717641278445098,0.436502265826065,-3.22395938093644,6.15817853097687,6.18706022094864,6.06328154964104,-0.123778671307602,0.00594219453347388,ENSG00000105058,FAM32A,protein_coding,19,1,16185380,16192046,p13.11,family with sequence similarity 32 member A [Source:HGNC Symbol;Acc:HGNC:24563],NA,FAM32A,26017,NM_014077
GABRE_SIG,GABRE,GABRE_SIG,GABRE,SIG,45,0.887306732990129,-0.110476771868256,-0.111745120568264,-0.106309340425374,0.00543578014288974,0.436565099162641,0.478834137711651,0.691421271769852,0.671813168207546,0.755847897760287,0.0840347295527409,0.721807751907006,ENSG00000102287,GABRE,protein_coding,X,-1,151953124,151974680,q28,gamma-aminobutyric acid type A receptor epsilon subunit [Source:HGNC Symbol;Acc:HGNC:4085],NA,GABRE,2564,NM_004961
CPT2_SIG,CPT2,CPT2_SIG,CPT2,SIG,31,0.887072144974578,0.103688134215758,0.100331727574653,0.114716327465102,0.0143845998904493,0.436639206012756,0.193464957804949,4.21025091429386,4.2062020017499,4.22355448408118,0.0173524823312769,0.891199710781464,ENSG00000157184,CPT2,protein_coding,1,1,53196792,53214197,p32.3,carnitine palmitoyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:2330],Acute necrotizing encephalopathy of childhood;Carnitine palmitoyl transferase II deficiency myopathic form;Carnitine palmitoyl transferase II deficiency neonatal form;Carnitine palmitoyl transferase II deficiency severe infantile form;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY INFANTILE;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY LETHAL NEONATAL;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY MYOPATHIC STRESS-INDUCED;ENCEPHALOPATHY ACUTE INFECTION-INDUCED SUSCEPTIBILITY TO 4,CPT2,1376,NM_000098;NM_001330589
FBXL3_SIG,FBXL3,FBXL3_SIG,FBXL3,SIG,31,-0.886992705243577,0.504681139516039,0.50673766120183,0.497923996834158,-0.00881366436767177,0.436639206012756,-0.596458056808517,5.95508799138455,5.96485793370179,5.92298675234221,-0.0418711813595803,0.653381189540976,ENSG00000005812,FBXL3,protein_coding,13,-1,76992598,77027195,q22.3,F-box and leucine rich repeat protein 3 [Source:HGNC Symbol;Acc:HGNC:13599],NA,FBXL3,26224,NM_012158
GPR161_SIG,GPR161,GPR161_SIG,GPR161,SIG,34,0.883865512254235,-0.0699795328649216,-0.0710784069701672,-0.0663689465191144,0.00470946045105292,0.438540270212227,-0.170390226022504,0.697306373552285,0.7001948089838,0.687815799991594,-0.0123790089922062,0.904425588930815,ENSG00000143147,GPR161,protein_coding,1,-1,168079543,168137667,q24.2,G protein-coupled receptor 161 [Source:HGNC Symbol;Acc:HGNC:23694],Pituitary stalk interruption syndrome,GPR161,23432,NM_001267609;NM_001267610;NM_001267611;NM_001267612;NM_001267613;NM_001267614;NM_001349632;NM_001349633;NM_001349634;NM_001349635;NM_153832
TRIM10_SIG,TRIM10,TRIM10_SIG,TRIM10,SIG,18,-0.883382100847961,-0.2199586046161,-0.212542809726621,-0.244324787824386,-0.031781978097765,0.438711814031987,1.0059051184005,1.46775804822674,1.42543908503551,1.60680607014075,0.181366985105241,0.427614072965267,ENSG00000204613,TRIM10,protein_coding,6,-1,30151943,30161211,p22.1,tripartite motif containing 10 [Source:HGNC Symbol;Acc:HGNC:10072],NA,TRIM10,10107,NM_006778;NM_052828
GLYATL2_SIG,GLYATL2,GLYATL2_SIG,GLYATL2,SIG,27,-0.883315550448445,0.0635951452070957,0.0657712806855149,0.0564449857780042,-0.00932629490751078,0.438711814031987,-0.587329916970663,0.348092879317153,0.356132951743384,0.321675498488106,-0.0344574532552789,0.65878399687262,ENSG00000156689,GLYATL2,protein_coding,11,-1,58834065,58904215,q12.1,glycine-N-acyltransferase like 2 [Source:HGNC Symbol;Acc:HGNC:24178],NA,GLYATL2,219970,NM_145016
IL2RG_SIG,IL2RG,IL2RG_SIG,IL2RG,SIG,36,0.883298424832811,0.0770867896875564,0.0755336275005133,0.0821900368735552,0.00665640937304173,0.438711814031987,0.119785747604821,7.15242363376297,7.14926894587668,7.16278903681795,0.0135200909412731,0.933427806766798,ENSG00000147168,IL2RG,protein_coding,X,-1,71107404,71112108,q13.1,interleukin 2 receptor subunit gamma [Source:HGNC Symbol;Acc:HGNC:6010],COMBINED IMMUNODEFICIENCY X-LINKED;OMENN SYNDROME;SEVERE COMBINED IMMUNODEFICIENCY X-LINKED;T-B+ severe combined immunodeficiency due to gamma chain deficiency,IL2RG,3561,NM_000206
LSM14A_SIG,LSM14A,LSM14A_SIG,LSM14A,SIG,24,-0.883156544441088,0.308076777502194,0.30957877354383,0.303141647651105,-0.00643712589272531,0.438727069739394,-0.810948297642262,7.83460122918535,7.84078669146276,7.81427756741669,-0.02650912404607,0.529159964816721,ENSG00000257103,LSM14A,protein_coding,19,1,34172504,34229515,q13.11,LSM14A, mRNA processing body assembly factor [Source:HGNC Symbol;Acc:HGNC:24489],NA,LSM14A,26065,NM_001114093;NM_015578
ZNF311_TF,ZNF311,ZNF311_TF,ZNF311,TF,39,-0.883078099967793,-0.0817293866945737,-0.0805605536892008,-0.0855698379979421,-0.00500928430874122,0.438727069739394,0.648892153310139,0.944264184935469,0.932914904584546,0.981554677517075,0.0486397729325285,0.621468969676112,ENSG00000197935,ZNF311,protein_coding,6,-1,28994785,29005316,p22.1,zinc finger protein 311 [Source:HGNC Symbol;Acc:HGNC:13847],NA,ZNF311,282890,NM_001010877;NM_001318534;NM_001318535;NM_001350637
PRPF3_SIG,PRPF3,PRPF3_SIG,PRPF3,SIG,20,-0.882950515863186,0.12881042082344,0.129705208094964,0.125870405502719,-0.00383480259224492,0.438745651776131,-1.42675148692778,5.98186800191763,5.99654036612244,5.93365880524467,-0.0628815608777734,0.246673714537781,ENSG00000117360,PRPF3,protein_coding,1,1,150321479,150353233,q21.2,pre-mRNA processing factor 3 [Source:HGNC Symbol;Acc:HGNC:17348],Retinitis pigmentosa;RETINITIS PIGMENTOSA 18,PRPF3,9129,NM_001350529;NM_004698
THRAP3_SIG,THRAP3,THRAP3_SIG,THRAP3,SIG,32,0.882752022758257,0.40796610061339,0.4056114149401,0.415702924968482,0.010091510028382,0.438808795375801,1.05154481722845,7.47516786059342,7.45854313407751,7.52979196200282,0.0712488279253068,0.405246709979897,ENSG00000054118,THRAP3,protein_coding,1,1,36224432,36305357,p34.3,thyroid hormone receptor associated protein 3 [Source:HGNC Symbol;Acc:HGNC:22964],NA,THRAP3,9967,NM_001321471;NM_001321473;NM_005119
PDE4D_SIG,PDE4D,PDE4D_SIG,PDE4D,SIG,22,-0.881956979232846,0.360827752257608,0.363739375467542,0.351260990282111,-0.0124783851854309,0.439246926531445,1.04915266469247,6.02817512966752,5.99605523367177,6.13371193079641,0.137656697124639,0.406471871931106,ENSG00000113448,PDE4D,protein_coding,5,-1,58969038,60522120,q12.1,phosphodiesterase 4D [Source:HGNC Symbol;Acc:HGNC:8783],Acrodysostosis;ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE;Acrodysostosis with multiple hormone resistance;PDE4D haploinsufficiency syndrome;STROKE SUSCEPTIBILITY TO 1,PDE4D,5144,NM_001104631;NM_001165899;NM_001197218;NM_001197219;NM_001197220;NM_001197221;NM_001197222;NM_001197223;NM_001349241;NM_001349242;NM_001349243;NM_001364599;NM_006203
PSMC4_SIG,PSMC4,PSMC4_SIG,PSMC4,SIG,15,-0.881592605253836,0.169460294849261,0.170704190711164,0.165373208445864,-0.00533098226530002,0.439414400565646,-0.391553899088375,5.49141411388315,5.494935458023,5.47984398313794,-0.0150914748850636,0.773530076870933,ENSG00000013275,PSMC4,protein_coding,19,1,39971005,39981441,q13.2,proteasome 26S subunit, ATPase 4 [Source:HGNC Symbol;Acc:HGNC:9551],NA,PSMC4,5704,NM_006503;NM_153001
IFIT5_SIG,IFIT5,IFIT5_SIG,IFIT5,SIG,53,-0.880728547602594,0.187109908410701,0.188660723807004,0.182014372108561,-0.00664635169844364,0.439896261068295,-0.498984365371227,4.21122821620453,4.22335791899051,4.17137347847916,-0.0519844405113537,0.710276320493696,ENSG00000152778,IFIT5,protein_coding,10,1,89414568,89420997,q23.31,interferon induced protein with tetratricopeptide repeats 5 [Source:HGNC Symbol;Acc:HGNC:13328],NA,IFIT5,24138,NM_012420
SEMA3G_SIG,SEMA3G,SEMA3G_SIG,SEMA3G,SIG,52,0.87736583467281,-0.122963389688232,-0.12404514773431,-0.119409041822548,0.00463610591176152,0.441953399137246,0.105073231086147,0.811355058506378,0.809027342034648,0.819003269770635,0.0099759277359865,0.941627582161818,ENSG00000010319,SEMA3G,protein_coding,3,-1,52433053,52445085,p21.1,semaphorin 3G [Source:HGNC Symbol;Acc:HGNC:30400],NA,SEMA3G,56920,NM_020163
HBS1L_SIG,HBS1L,HBS1L_SIG,HBS1L,SIG,31,-0.876954694815523,0.281150603363755,0.283082406574009,0.274803249958634,-0.00827915661537493,0.442150866276315,0.212416404894827,6.04923748499544,6.04647947182303,6.05829952827621,0.0118200564531881,0.880272943118689,ENSG00000112339,HBS1L,protein_coding,6,-1,134960378,135103056,q23.3,HBS1 like translational GTPase [Source:HGNC Symbol;Acc:HGNC:4834],NA,HBS1L,10767,NM_001145158;NM_001145207;NM_006620
RPL23A_SIG,RPL23A,RPL23A_SIG,RPL23A,SIG,33,0.87589411792346,0.827060857649182,0.823359848375008,0.8392213166929,0.0158614683178924,0.442758483453609,0.700563189708072,6.33997364357788,6.32954541875311,6.37423781085929,0.0446923921061842,0.591727872669037,ENSG00000198242,RPL23A,protein_coding,17,1,28719985,28724359,q11.2,ribosomal protein L23a [Source:HGNC Symbol;Acc:HGNC:10317],NA,RPL23A,6147,NM_000984
EDEM3_SIG,EDEM3,EDEM3_SIG,EDEM3,SIG,54,0.875187952791364,0.276859293597885,0.27422729162252,0.285507300088371,0.0112800084658509,0.443142540157628,1.38838186388615,6.00639667979576,5.97398387896196,6.11289588253541,0.138912003573457,0.260909714560487,ENSG00000116406,EDEM3,protein_coding,1,-1,184690237,184754907,q25.3,ER degradation enhancing alpha-mannosidase like protein 3 [Source:HGNC Symbol;Acc:HGNC:16787],NA,EDEM3,80267,NM_001319960;NM_025191
SNRNP25_SIG,SNRNP25,SNRNP25_SIG,SNRNP25,SIG,22,-0.874824217784646,0.346716144267973,0.348967023646418,0.339320397738795,-0.00964662590762253,0.443310288430687,-0.43967665313623,3.77609263525993,3.78386547196702,3.75055331465091,-0.033312157316116,0.744951690159735,ENSG00000161981,SNRNP25,protein_coding,16,1,53010,57669,p13.3,small nuclear ribonucleoprotein U11/U12 subunit 25 [Source:HGNC Symbol;Acc:HGNC:14161],NA,SNRNP25,79622,NM_024571
ITPKB_SIG,ITPKB,ITPKB_SIG,ITPKB,SIG,45,-0.87208740447762,0.191811679665304,0.193411713573001,0.186554425397153,-0.00685728817584843,0.444979867404424,-0.433242704368356,6.38130680798623,6.38864323538629,6.35720140367177,-0.0314418317145186,0.748369275391443,ENSG00000143772,ITPKB,protein_coding,1,-1,226631690,226739323,q42.12,inositol-trisphosphate 3-kinase B [Source:HGNC Symbol;Acc:HGNC:6179],NA,ITPKB,3707,NM_002221
COL14A1_SIG,COL14A1,COL14A1_SIG,COL14A1,SIG,38,-0.871763746127271,-0.0157846049281062,-0.0140528127589721,-0.0214747791981181,-0.00742196643914618,0.44512254148632,-2.27525189669849,1.19447173478097,1.27402075762218,0.93309637401697,-0.340924383605215,0.0568276694426646,ENSG00000187955,COL14A1,protein_coding,8,1,120059780,120373573,q24.12,collagen type XIV alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2191],Punctate palmoplantar keratoderma type 1,COL14A1,7373,NM_021110
RABGGTA_SIG,RABGGTA,RABGGTA_SIG,RABGGTA,SIG,33,0.869734754811617,0.22134269592481,0.219718716749126,0.226678627502055,0.00695991075292844,0.446346682666641,1.71877512131122,5.0341272507103,5.01639591917224,5.09238734004965,0.0759914208774034,0.15819738852114,ENSG00000100949,RABGGTA,protein_coding,14,-1,24265538,24271739,q12,Rab geranylgeranyltransferase subunit alpha [Source:HGNC Symbol;Acc:HGNC:9795],NA,RABGGTA,5875,NM_004581;NM_182836
AMZ2P1_SIG,AMZ2P1,AMZ2P1_SIG,AMZ2P1,SIG,21,0.868150603861357,0.0625477766479936,0.0615647203318579,0.0657778188295826,0.00421309849772454,0.447290040821753,1.10407299845605,3.44125618542688,3.42465245964043,3.49581128443951,0.0711588247990834,0.380491709095261,ENSG00000214174,AMZ2P1,transcribed_unprocessed_pseudogene,17,-1,64966550,64975576,q24.1,archaelysin family metallopeptidase 2 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:26491],NA,AMZ2P1,NA,NA
PDIA3_SIG,PDIA3,PDIA3_SIG,PDIA3,SIG,35,-0.867633150045807,0.24291995364028,0.244143429731514,0.23889996076908,-0.00524346896243447,0.447556202308076,-0.520599040091818,8.04932456949823,8.05564260239972,8.02856531853618,-0.0270772838635408,0.697860856768841,ENSG00000167004,PDIA3,protein_coding,15,1,43746410,43773278,q15.3,protein disulfide isomerase family A member 3 [Source:HGNC Symbol;Acc:HGNC:4606],NA,PDIA3,2923,NM_005313
GBE1_SIG,GBE1,GBE1_SIG,GBE1,SIG,45,0.86680291650568,0.262080969692683,0.260497612835698,0.267283427937062,0.00678581510136426,0.448021330976989,0.477047913402259,5.30330829012517,5.2944097295754,5.33254641764583,0.0381366880704261,0.72298483463359,ENSG00000114480,GBE1,protein_coding,3,-1,81489703,81761645,p12.2,1,4-alpha-glucan branching enzyme 1 [Source:HGNC Symbol;Acc:HGNC:4180],Adult polyglucosan body disease;Glycogen storage disease due to glycogen branching enzyme deficiency adult neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency childhood combined hepatic and myopathic form;Glycogen storage disease due to glycogen branching enzyme deficiency childhood neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency congenital neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency fatal perinatal neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency non progressive hepatic form;Glycogen storage disease due to glycogen branching enzyme deficiency progressive hepatic form;GLYCOGEN STORAGE DISEASE IV;POLYGLUCOSAN BODY NEUROPATHY ADULT FORM,GBE1,2632,NM_000158
ACAA2_SIG,ACAA2,ACAA2_SIG,ACAA2,SIG,5,0.866345376880423,0.156747030359632,0.155263648239086,0.16162100018428,0.00635735194519407,0.448182425209501,0.0534737727205572,4.73041039875548,4.72938247306036,4.73378786889658,0.00440539583621914,0.970442676160901,ENSG00000167315,ACAA2,protein_coding,18,-1,49782164,49813953,q21.1,acetyl-CoA acyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:83],NA,ACAA2,10449,NM_006111
SKAP2_SIG,SKAP2,SKAP2_SIG,SKAP2,SIG,36,-0.866254794905248,0.432625373405896,0.434405657259775,0.426775869314581,-0.00762978794519373,0.448182425209501,-0.830371715722557,6.39036241337758,6.42099923822553,6.28969856030571,-0.131300677919819,0.51903610181512,ENSG00000005020,SKAP2,protein_coding,7,-1,26667068,26995239,p15.2,src kinase associated phosphoprotein 2 [Source:HGNC Symbol;Acc:HGNC:15687],NA,SKAP2,8935,NM_001303468;NM_003930
UHRF1_TF,UHRF1,UHRF1_TF,UHRF1,TF,191,-0.866253606149724,0.225901247115104,0.229040404027957,0.215586874401444,-0.0134535296265132,0.448182425209501,-0.856489713776719,4.35711723298259,4.38883255320483,4.25290975225238,-0.135922800952446,0.504760401003579,ENSG00000276043,UHRF1,protein_coding,19,1,4903080,4962154,p13.3,ubiquitin like with PHD and ring finger domains 1 [Source:HGNC Symbol;Acc:HGNC:12556],NA,UHRF1,29128,NM_001048201;NM_001290050;NM_001290051;NM_001290052;NM_013282
PSMC1_SIG,PSMC1,PSMC1_SIG,PSMC1,SIG,4,-0.862872184799433,0.26828396755771,0.271449929604132,0.25788152083375,-0.0135684087703817,0.450163630114342,0.558236326440241,3.76977098256832,3.76302484363081,3.79193686764871,0.0289120240179023,0.676201996666054,ENSG00000100764,PSMC1,protein_coding,14,1,90256527,90275429,q32.11,proteasome 26S subunit, ATPase 1 [Source:HGNC Symbol;Acc:HGNC:9547],NA,PSMC1,5700,NM_001330212;NM_002802
UBP1_TF,UBP1,UBP1_TF,UBP1,TF,199,0.862854537889746,0.103010255234491,0.10201923635347,0.106266460129275,0.00424722377580447,0.450163630114342,0.710559864157755,6.89279720366199,6.88525429059395,6.91758106088554,0.0323267702915809,0.585705595345077,ENSG00000153560,UBP1,protein_coding,3,-1,33388336,33441371,p22.3,upstream binding protein 1 [Source:HGNC Symbol;Acc:HGNC:12507],NA,UBP1,7342,NM_001128160;NM_001128161;NM_014517
ZNF646_TF,ZNF646,ZNF646_TF,ZNF646,TF,31,0.86284629080851,0.368381639704059,0.366762829480041,0.373700587582974,0.00693775810293326,0.450163630114342,2.17745898519574,5.5686247052754,5.53652921386019,5.67408131992536,0.137552106065175,0.069366851952296,ENSG00000167395,ZNF646,protein_coding,16,1,31074422,31084196,p11.2,zinc finger protein 646 [Source:HGNC Symbol;Acc:HGNC:29004],NA,ZNF646,9726,NM_014699
HNRNPH3_SIG,HNRNPH3,HNRNPH3_SIG,HNRNPH3,SIG,14,0.861690165574199,0.473212308545827,0.471736269655427,0.478062150614284,0.00632588095885749,0.450838070443518,-2.12974421861036,8.01869688511972,8.03952291993806,7.95026848500232,-0.089254434935742,0.0760303426691724,ENSG00000096746,HNRNPH3,protein_coding,10,1,68331174,68343191,q21.3,heterogeneous nuclear ribonucleoprotein H3 [Source:HGNC Symbol;Acc:HGNC:5043],NA,HNRNPH3,3189,NM_001322434;NM_001322436;NM_001322437;NM_001322438;NM_001322439;NM_001322440;NM_001322441;NM_001322442;NM_001322443;NM_001322444;NM_001322445;NM_001322446;NM_001322447;NM_001322448;NM_001322449;NM_001322450;NM_001322451;NM_001322452;NM_001322453;NM_012207;NM_021644
B3GNT5_SIG,B3GNT5,B3GNT5_SIG,B3GNT5,SIG,12,-0.861483627636264,0.26899933422548,0.271883694965932,0.259522148935422,-0.0123615460305102,0.450906789056199,0.253932776401886,5.83231852717994,5.82471664070118,5.85729615418158,0.0325795134803978,0.855349643297566,ENSG00000176597,B3GNT5,protein_coding,3,1,183253253,183298504,q27.1,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:15684],NA,B3GNT5,84002,NM_032047
DUSP28_SIG,DUSP28,DUSP28_SIG,DUSP28,SIG,21,-0.86134212760996,0.263639154261418,0.265463361291822,0.257645331161518,-0.00781803013030417,0.450934004731535,-1.15055242290247,3.16246745922739,3.1748976369971,3.12162544655551,-0.0532721904415849,0.358974852872028,ENSG00000188542,DUSP28,protein_coding,2,1,240560054,240564014,q37.3,dual specificity phosphatase 28 [Source:HGNC Symbol;Acc:HGNC:33237],NA,DUSP28,285193,NM_001033575
RPL7_SIG,RPL7,RPL7_SIG,RPL7,SIG,16,0.860927705571482,1.36237209222656,1.35870820185364,1.37441058916616,0.0157023873125227,0.451135414927789,1.50863113020433,6.59829666215962,6.57236930881823,6.6834865374242,0.111117228605977,0.219247671747429,ENSG00000147604,RPL7,protein_coding,8,-1,73290242,73295789,q21.11,ribosomal protein L7 [Source:HGNC Symbol;Acc:HGNC:10363],NA,RPL7,6129,NM_000971;NM_001363737
NDUFB8_SIG,NDUFB8,NDUFB8_SIG,NDUFB8,SIG,12,0.86038585318377,0.162727001774396,0.161599994845849,0.16643002453962,0.00483002969377143,0.451418226603987,2.2224241525183,2.42766668376303,2.40630886628793,2.49784236975266,0.091533503464727,0.0634272238435327,ENSG00000166136,NDUFB8,protein_coding,10,-1,100523740,100530000,q24.31,NADH:ubiquinone oxidoreductase subunit B8 [Source:HGNC Symbol;Acc:HGNC:7703],Leigh syndrome with cardiomyopathy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 32,NDUFB8,4714,NM_001284367;NM_001284368;NM_005004
GMPPA_SIG,GMPPA,GMPPA_SIG,GMPPA,SIG,65,0.86020900890651,0.206114026728697,0.203637430278546,0.214251415064907,0.0106139847863608,0.451468012926363,0.755215584819877,4.4901369435278,4.47914426926922,4.52625573037741,0.0471114611081872,0.560581458076224,ENSG00000144591,GMPPA,protein_coding,2,1,219498867,219506989,q35,GDP-mannose pyrophosphorylase A [Source:HGNC Symbol;Acc:HGNC:22923],Alacrima achalasia and mental retardation syndrome;Glycosylation Disorder Characterized by Intellectual Disability and Autonomic Dysfunction;Triple A syndrome,GMPPA,29926,NM_013335;NM_205847
U2AF1L4_SIG,U2AF1L4,U2AF1L4_SIG,U2AF1L4,SIG,21,0.860008820163069,0.182892586061686,0.181024460933287,0.189030711483567,0.00800625055027953,0.451482446644284,0.676594066345511,3.75700455523399,3.74614910355759,3.79267246788503,0.0465233643274413,0.605260663034934,ENSG00000161265,U2AF1L4,protein_coding,19,-1,35742464,35745445,q13.12,U2 small nuclear RNA auxiliary factor 1 like 4 [Source:HGNC Symbol;Acc:HGNC:23020],NA,U2AF1L4,199746,NM_001040425;NM_144987
NDUFA9_SIG,NDUFA9,NDUFA9_SIG,NDUFA9,SIG,18,0.859988674509276,0.156386397228006,0.15554985603768,0.159135032567646,0.00358517652996615,0.451482446644284,1.82089921445914,2.64035331627249,2.62249039262836,2.69904577967461,0.0765553870462504,0.133395019881094,ENSG00000139180,NDUFA9,protein_coding,12,1,4649095,4694317,p13.32,NADH:ubiquinone oxidoreductase subunit A9 [Source:HGNC Symbol;Acc:HGNC:7693],Leigh syndrome;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 26,NDUFA9,4704,NM_005002
WDR76_SIG,WDR76,WDR76_SIG,WDR76,SIG,21,-0.859761576292945,0.322120159840351,0.328691463188017,0.300528734555162,-0.0281627286328553,0.451564328836793,-1.38760188953606,4.07014627370685,4.10343660633097,3.96076375222762,-0.142672854103351,0.261212896520522,ENSG00000092470,WDR76,protein_coding,15,1,43826980,43868412,q15.3,WD repeat domain 76 [Source:HGNC Symbol;Acc:HGNC:25773],NA,WDR76,79968,NM_001167941;NM_024908
HIST1H1E_SIG,HIST1H1E,HIST1H1E_SIG,HIST1H1E,SIG,52,0.858965852026084,-0.120616560827066,-0.122558920224606,-0.114234522806577,0.00832439741802894,0.452009401132064,0.636546701721186,2.53717967375608,2.51542185394631,2.60866965313107,0.0932477991847694,0.628935143465214,ENSG00000168298,HIST1H1E,protein_coding,6,1,26156354,26157107,p22.2,histone cluster 1 H1 family member e [Source:HGNC Symbol;Acc:HGNC:4718],Childhood overgrowth;RAHMAN SYNDROME,HIST1H1E,3008,NM_005321
CDKN2A_SIG,CDKN2A,CDKN2A_SIG,CDKN2A,SIG,19,-0.858615700127684,-0.0370422307929687,-0.0354297150696315,-0.0423404967410769,-0.00691078167144529,0.452153310343293,0.963838447626528,2.5983646281365,2.56339618878628,2.71326092885865,0.14986474007237,0.448899855757569,ENSG00000147889,CDKN2A,protein_coding,9,-1,21967753,21995301,p21.3,cyclin dependent kinase inhibitor 2A [Source:HGNC Symbol;Acc:HGNC:1787],Familial atypical multiple mole melanoma syndrome;Familial melanoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;MELANOMA-ASTROCYTOMA SYNDROME;Melanoma-pancreatic cancer syndrome;Melanoma and neural system tumor syndrome;MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 2;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia,CDKN2A,1029,NM_000077;NM_001195132;NM_058195;NM_058197
LDLR_SIG,LDLR,LDLR_SIG,LDLR,SIG,29,-0.858542836867947,0.0959931619367073,0.0972977377555261,0.091706698532017,-0.00559103922350916,0.452153310343293,0.296465763656989,5.35632602761533,5.34627471323705,5.38935177485824,0.0430770616211955,0.829917331573793,ENSG00000130164,LDLR,protein_coding,19,1,11089362,11133816,p13.2,low density lipoprotein receptor [Source:HGNC Symbol;Acc:HGNC:6547],Homozygous familial hypercholesterolemia;HYPERCHOLESTEROLEMIA FAMILIAL,LDLR,3949,NM_000527;NM_001195798;NM_001195799;NM_001195800;NM_001195803
CTDNEP1_SIG,CTDNEP1,CTDNEP1_SIG,CTDNEP1,SIG,31,-0.857952427577467,0.214113594985451,0.21500959860289,0.211169583099577,-0.00384001550331356,0.452448311413945,-0.208971901703065,6.29792731036393,6.29960885524647,6.29240223432129,-0.00720662092518411,0.882463318043022,ENSG00000175826,CTDNEP1,protein_coding,17,-1,7243591,7252491,p13.1,CTD nuclear envelope phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:19085],NA,CTDNEP1,23399,NM_001143775;NM_015343
GNMT_SIG,GNMT,GNMT_SIG,GNMT,SIG,14,0.857883411353306,0.0613540652393053,0.0601634018739231,0.0652662448684181,0.00510284299449504,0.452448311413945,1.03331122443652,1.85677057937409,1.84116302937683,1.90805252936505,0.0668894999882179,0.414019727311374,ENSG00000124713,GNMT,protein_coding,6,1,42960754,42963880,p21.1,glycine N-methyltransferase [Source:HGNC Symbol;Acc:HGNC:4415],GLYCINE N-METHYLTRANSFERASE DEFICIENCY;Hypermethioninemia due to glycine N-methyltransferase deficiency,GNMT,27232;107080644,NM_001318856;NM_001318865;NM_018960
FRRS1_SIG,FRRS1,FRRS1_SIG,FRRS1,SIG,21,0.855507851796805,0.158090815480034,0.157345168622968,0.160540798010394,0.00319562938742609,0.453904670804672,0.557651534708055,2.23490167101026,2.22320373864674,2.27333773449042,0.0501339958436761,0.676461852955987,ENSG00000156869,FRRS1,protein_coding,1,-1,99708632,99766631,p21.2,ferric chelate reductase 1 [Source:HGNC Symbol;Acc:HGNC:27622],NA,FRRS1,391059,NM_001013660;NM_001361041
ASL_SIG,ASL,ASL_SIG,ASL,SIG,52,0.855380545378622,0.118876676266297,0.117057456896611,0.124854111338124,0.00779665444151333,0.453922793885585,1.44847934079437,3.76094423954584,3.73695455060473,3.83976750320946,0.102812952604725,0.239141591639253,ENSG00000126522,ASL,protein_coding,7,1,66075798,66093558,q11.21,argininosuccinate lyase [Source:HGNC Symbol;Acc:HGNC:746],Argininosuccinate Lyase Deficiency;ARGININOSUCCINIC ACIDURIA,ASL,435,NM_000048;NM_001024943;NM_001024944;NM_001024946
RFWD3_SIG,RFWD3,RFWD3_SIG,RFWD3,SIG,25,-0.854038604733887,0.339819536253376,0.341591592989016,0.333997064121988,-0.00759452886702764,0.454719020310755,0.0317786749188924,6.04439358401326,6.04391673175076,6.04596038430432,0.00204365255356091,0.982782100174725,ENSG00000168411,RFWD3,protein_coding,16,-1,74621399,74666877,q23.1,ring finger and WD repeat domain 3 [Source:HGNC Symbol;Acc:HGNC:25539],Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP W,RFWD3,55159,NM_018124
NAPSA_SIG,NAPSA,NAPSA_SIG,NAPSA,SIG,42,0.853189592098341,0.0595044261551826,0.0572327144165523,0.0669686218678251,0.00973590745127288,0.455199823094799,1.07485540496786,0.875959459137142,0.861151003243069,0.924615814217668,0.0634648109745992,0.394454962718052,ENSG00000131400,NAPSA,protein_coding,19,-1,50358477,50365830,q13.33,napsin A aspartic peptidase [Source:HGNC Symbol;Acc:HGNC:13395],NA,NAPSA,9476,NM_004851
CRY2_TF,CRY2,CRY2_TF,CRY2,TF,73,-0.85293158569434,0.408129476376791,0.410442125698367,0.400530771463041,-0.00991135423532602,0.455301740808714,0.0202947327117408,5.01385342640646,5.01348956191083,5.01504898117781,0.0015594192669779,0.988831001234215,ENSG00000121671,CRY2,protein_coding,11,1,45847118,45883248,p11.2,cryptochrome circadian regulator 2 [Source:HGNC Symbol;Acc:HGNC:2385],NA,CRY2,1408,NM_001127457;NM_021117
PEX2_SIG,PEX2,PEX2_SIG,PEX2,SIG,27,-0.852094777238908,0.322095489455968,0.32271677798625,0.320054112856468,-0.00266266512978196,0.455775010306098,0.520065081860285,4.87762424714898,4.87155890767772,4.89755321969739,0.025994312019666,0.698085211685447,ENSG00000164751,PEX2,protein_coding,8,-1,76980258,77001044,q21.13,peroxisomal biogenesis factor 2 [Source:HGNC Symbol;Acc:HGNC:9717],Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 5B;PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 5;Zellweger Syndrome,PEX2,5828,NM_000318;NM_001079867;NM_001172086;NM_001172087
HYAL2_SIG,HYAL2,HYAL2_SIG,HYAL2,SIG,25,0.850809470829494,0.170433016609153,0.168920628837889,0.175402290714734,0.00648166187684448,0.45653656574229,0.36723129378343,2.89441516340558,2.88593834763463,2.92226755808157,0.0363292104469376,0.787861590226793,ENSG00000068001,HYAL2,protein_coding,3,-1,50317790,50322782,p21.31,hyaluronidase 2 [Source:HGNC Symbol;Acc:HGNC:5321],Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,HYAL2,8692,NM_003773;NM_033158
DDX3X_SIG,DDX3X,DDX3X_SIG,DDX3X,SIG,18,-0.850482984489909,0.45334220998978,0.456085172491931,0.444329618911285,-0.011755553580647,0.456682582455286,-1.09534340612146,9.4253218514594,9.44037718086888,9.37585434054253,-0.0645228403263544,0.384507533776069,ENSG00000215301,DDX3X,protein_coding,X,1,41333284,41364472,p11.4,DEAD-box helicase 3 X-linked [Source:HGNC Symbol;Acc:HGNC:2745],Intellectual diability;MENTAL RETARDATION X-LINKED 102;Precursor T-cell acute lymphoblastic leukemia;Toriello-Carey syndrome;X-linked intellectual disability-hypotonia-movement disorder syndrome,DDX3X,1654,NM_001193416;NM_001193417;NM_001356;NM_001363819
AHR_SIG,AHR,AHR_SIG,AHR,SIG,41,0.850044763500129,0.136341143594629,0.13475408721544,0.141555757411962,0.00680167019652226,0.456850383176749,2.33420375458517,7.12393554364097,7.03947702590899,7.4014421019032,0.361965075994215,0.0504414018666365,ENSG00000106546,AHR,protein_coding,7,1,16916359,17346152,p21.1,aryl hydrocarbon receptor [Source:HGNC Symbol;Acc:HGNC:348],Retinitis pigmentosa,AHR,196,NM_001621
STAMBPL1_SIG,STAMBPL1,STAMBPL1_SIG,STAMBPL1,SIG,47,0.850023434371037,0.10271559376798,0.101113168425971,0.107980705606009,0.00686753718003802,0.456850383176749,-0.021709874004846,2.70530398015026,2.70577205019112,2.70376603573028,-0.00200601446084775,0.987957260315668,ENSG00000138134,STAMBPL1,protein_coding,10,1,88879734,88975153,q23.31,STAM binding protein like 1 [Source:HGNC Symbol;Acc:HGNC:24105],NA,STAMBPL1,57559,NM_020799
ZFPL1_SIG,ZFPL1,ZFPL1_SIG,ZFPL1,SIG,9,0.847528994018605,0.125235272739552,0.124416066342372,0.127926950901714,0.00351088455934168,0.458381639503377,1.65865757653144,4.83276725084523,4.81999497749856,4.87473329184145,0.0547383143428971,0.174125966180138,ENSG00000162300,ZFPL1,protein_coding,11,1,65084210,65088398,q13.1,zinc finger protein like 1 [Source:HGNC Symbol;Acc:HGNC:12868],NA,ZFPL1,7542,NM_006782
PRIM2_SIG,PRIM2,PRIM2_SIG,PRIM2,SIG,47,0.84744396972773,0.284107434930435,0.280571748940366,0.295724688897805,0.0151529399574397,0.458381639503377,1.00900894963469,3.03832000053767,3.02162729706485,3.09316745480551,0.0715401577406563,0.426188185800154,ENSG00000146143,PRIM2,protein_coding,6,1,57314805,57646850,p11.2,DNA primase subunit 2 [Source:HGNC Symbol;Acc:HGNC:9370],NA,PRIM2,5558,NM_000947;NM_001282487;NM_001282488
TPSB2_SIG,TPSB2,TPSB2_SIG,TPSB2,SIG,9,0.847267266194962,0.0447649650028679,0.0391616249478462,0.063175939469368,0.0240143145215218,0.458431469476407,-0.22668692431295,3.16500555542073,3.17812354933912,3.12190357540318,-0.0562199739359418,0.871929214080146,ENSG00000197253,TPSB2,protein_coding,16,-1,1227272,1230184,p13.3,tryptase beta 2 (gene/pseudogene) [Source:HGNC Symbol;Acc:HGNC:14120],NA,TPSB2,64499,NM_024164
ZNF695_TF,ZNF695,ZNF695_TF,ZNF695,TF,104,-0.847101535426779,0.0218881575945108,0.0233185182110164,0.0171884012831353,-0.00613011692788104,0.458474238934957,1.38893834087358,0.934601937628721,0.911460194073248,1.01063909502527,0.0991789009520266,0.260750361165642,ENSG00000197472,ZNF695,protein_coding,1,-1,246945547,247008093,q44,zinc finger protein 695 [Source:HGNC Symbol;Acc:HGNC:30954],NA,ZNF695,57116,NM_001204221;NM_020394
EPC1_SIG,EPC1,EPC1_SIG,EPC1,SIG,45,0.846925072590395,0.367501666373902,0.365766547830064,0.373202770160798,0.00743622233073419,0.458523920153767,0.222708078215114,6.47965050184644,6.47722849811528,6.48760851410595,0.0103800159906732,0.874135453461514,ENSG00000120616,EPC1,protein_coding,10,-1,32267751,32378798,p11.22,enhancer of polycomb homolog 1 [Source:HGNC Symbol;Acc:HGNC:19876],NA,EPC1,80314,NM_001272004;NM_001272019;NM_001282391;NM_025209
RPS12_SIG,RPS12,RPS12_SIG,RPS12,SIG,12,0.846183759757914,0.909916564583275,0.90612141972003,0.922386326276797,0.0162649065567679,0.458897690191099,1.42539934553138,8.01092192101751,7.98172964401048,8.10683940261202,0.125109758601538,0.247161703187462,ENSG00000112306,RPS12,protein_coding,6,1,132814569,132817564,q23.2,ribosomal protein S12 [Source:HGNC Symbol;Acc:HGNC:10385],NA,RPS12,6206,NM_001016
AKAP8_TF,AKAP8,AKAP8_TF,AKAP8,TF,82,0.846080337180275,0.265838414365519,0.264397192474007,0.270573857723342,0.00617666524933477,0.458897690191099,0.211931527508362,5.89112893691568,5.88893432049228,5.89833981944971,0.00940549895743825,0.88061048855594,ENSG00000105127,AKAP8,protein_coding,19,-1,15353385,15379798,p13.12,A-kinase anchoring protein 8 [Source:HGNC Symbol;Acc:HGNC:378],NA,AKAP8,10270,NM_005858
PGM2_SIG,PGM2,PGM2_SIG,PGM2,SIG,27,0.846046684242725,0.333016631355743,0.329685510533068,0.343961742630245,0.0142762320971769,0.458897690191099,1.27306005521924,5.42819500162001,5.40452310224485,5.50597409956694,0.101450997322085,0.30588049652958,ENSG00000169299,PGM2,protein_coding,4,1,37826660,37862937,p14,phosphoglucomutase 2 [Source:HGNC Symbol;Acc:HGNC:8906],NA,PGM2,55276,NM_018290
ACVR2A_SIG,ACVR2A,ACVR2A_SIG,ACVR2A,SIG,74,-0.84577648063563,-0.00336563251463207,-0.00164859658621419,-0.00900732199371937,-0.00735872540750517,0.45900775414509,-2.66847487446475,1.7140528479488,1.79190036749682,1.45826814086245,-0.333632226634368,0.0240777494655312,ENSG00000121989,ACVR2A,protein_coding,2,1,147844517,147930826,q22.3,activin A receptor type 2A [Source:HGNC Symbol;Acc:HGNC:173],NA,ACVR2A,92,NM_001278579;NM_001278580;NM_001616
PARP10_SIG,PARP10,PARP10_SIG,PARP10,SIG,35,0.845468681715602,0.348361926278365,0.346300973185368,0.355133629298212,0.00883265611284419,0.459142041660517,0.056884691004231,6.5431531421107,6.54204234048013,6.54680291889688,0.00476057841675563,0.968418900877384,ENSG00000178685,PARP10,protein_coding,8,-1,143977153,144012772,q24.3,poly(ADP-ribose) polymerase family member 10 [Source:HGNC Symbol;Acc:HGNC:25895],NA,PARP10,84875,NM_001317895;NM_032789
PPARGC1B_SIG,PPARGC1B,PPARGC1B_SIG,PPARGC1B,SIG,32,0.843241135866884,0.128061235226813,0.12637488701385,0.133602093640833,0.00722720662698231,0.460513989824823,1.90314619380591,4.35098376955248,4.30331902628545,4.50759649742988,0.204277471144428,0.115680898410627,ENSG00000155846,PPARGC1B,protein_coding,5,1,149730298,149855022,q32,PPARG coactivator 1 beta [Source:HGNC Symbol;Acc:HGNC:30022],OBESITY LEANNESS INCLUDED,PPARGC1B,133522,NM_001172698;NM_001172699;NM_133263
COPS3_SIG,COPS3,COPS3_SIG,COPS3,SIG,44,-0.837555438417971,0.325407109316802,0.326915801474241,0.320449977942359,-0.00646582353188199,0.464126633132598,-0.517984384345235,6.05300433705392,6.05943472467679,6.03187592057876,-0.0275588040980352,0.699339495970268,ENSG00000141030,COPS3,protein_coding,17,-1,17246616,17281273,p11.2,COP9 signalosome subunit 3 [Source:HGNC Symbol;Acc:HGNC:2239],NA,COPS3,8533,NM_001199125;NM_001316354;NM_001316355;NM_001316356;NM_001316357;NM_001316358;NM_003653
FUCA2_SIG,FUCA2,FUCA2_SIG,FUCA2,SIG,56,0.836899854399012,0.0468460524638509,0.0448312578455074,0.0534660919241225,0.00863483407861518,0.464423976847634,1.2658070363617,5.37658495540384,5.35350477314331,5.45241983997414,0.0989150668308208,0.308975329915932,ENSG00000001036,FUCA2,protein_coding,6,-1,143494811,143511690,q24.2,alpha-L-fucosidase 2 [Source:HGNC Symbol;Acc:HGNC:4008],NA,FUCA2,2519,NM_032020
MAST2_SIG,MAST2,MAST2_SIG,MAST2,SIG,13,0.836897363263143,0.0930146025078605,0.0916259947223951,0.0975771709458184,0.0059511762234234,0.464423976847634,3.47473874614398,4.98179189679336,4.92949468901267,5.15362557950135,0.224130890488684,0.00289841774505283,ENSG00000086015,MAST2,protein_coding,1,1,45786987,46036122,p34.1,microtubule associated serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:19035],NA,MAST2,23139,NM_001319245;NM_001324320;NM_001324321;NM_015112
IRF5_TF,IRF5,IRF5_TF,IRF5,TF,400,-0.835803389268264,0.180389530873671,0.182315754844319,0.174060509255827,-0.00825524558849145,0.465068879305545,0.216298466108167,6.19654426722838,6.19087099611886,6.21518501515967,0.0243140190408145,0.878045944076609,ENSG00000128604,IRF5,protein_coding,7,1,128937457,128950038,q32.1,interferon regulatory factor 5 [Source:HGNC Symbol;Acc:HGNC:6120],Diffuse cutaneous systemic sclerosis;INFLAMMATORY BOWEL DISEASE 14;Limited cutaneous systemic sclerosis;Primary biliary cholangitis;Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 10,IRF5,3663,NM_001098627;NM_001098629;NM_001098630;NM_001242452;NM_001347928;NM_001364314;NM_032643
SPEF2_SIG,SPEF2,SPEF2_SIG,SPEF2,SIG,8,0.835416876812873,0.0124369442609632,0.0110798807034531,0.0168958673784963,0.00581598667504315,0.46522913125704,-0.631565414242358,3.09470872636008,3.11060285974818,3.04248514522777,-0.0681177145204059,0.631802622881501,ENSG00000152582,SPEF2,protein_coding,5,1,35617844,35814611,p13.2,sperm flagellar 2 [Source:HGNC Symbol;Acc:HGNC:26293],NA,SPEF2,79925,NM_024867;NM_144722
AK4_SIG,AK4,AK4_SIG,AK4,SIG,19,-0.835356913144849,-0.0421870480919693,-0.0407709167291582,-0.0468400511412055,-0.00606913441204733,0.46522913125704,-0.492719055170533,2.62011968665986,2.63854255367852,2.55958740931285,-0.0789551443656629,0.713790885487896,ENSG00000162433,AK4,protein_coding,1,1,65147549,65232145,p31.3,adenylate kinase 4 [Source:HGNC Symbol;Acc:HGNC:363],NA,AK4,205,NM_001005353;NM_001330616;NM_013410;NM_203464
DGKG_SIG,DGKG,DGKG_SIG,DGKG,SIG,34,-0.835096679175048,0.309068096606469,0.31076453782418,0.303494075462558,-0.00727046236162227,0.465333274538824,-0.378659925119161,4.61273207697782,4.62265305956299,4.58013456276941,-0.0425184967935825,0.781152564705688,ENSG00000058866,DGKG,protein_coding,3,-1,186105668,186362234,q27.3,diacylglycerol kinase gamma [Source:HGNC Symbol;Acc:HGNC:2853],NA,DGKG,1608,NM_001080744;NM_001080745;NM_001346
CDK16_SIG,CDK16,CDK16_SIG,CDK16,SIG,34,-0.834468541385739,0.372495389097895,0.375102624567313,0.363928758269806,-0.0111738662975069,0.465676253029509,0.0827753044886331,6.2771683000794,6.27610757733632,6.28065353194951,0.00454595461319224,0.954254364597966,ENSG00000102225,CDK16,protein_coding,X,1,47217860,47229997,p11.3,cyclin dependent kinase 16 [Source:HGNC Symbol;Acc:HGNC:8749],Intellectual disability,CDK16,5127,NM_001170460;NM_006201;NM_033018
G3BP2_SIG,G3BP2,G3BP2_SIG,G3BP2,SIG,13,0.833451254269907,0.435019951825045,0.434142060041002,0.437904453401189,0.00376239336018692,0.466272146049065,1.26027561584558,7.44843804053654,7.43512825550383,7.4921701913583,0.0570419358544719,0.311123327732725,ENSG00000138757,G3BP2,protein_coding,4,-1,75642782,75724525,q21.1,G3BP stress granule assembly factor 2 [Source:HGNC Symbol;Acc:HGNC:30291],NA,G3BP2,9908,NM_012297;NM_203504;NM_203505
ZFP91_TF,ZFP91,ZFP91_TF,ZFP91,TF,166,0.833274805980484,0.27084882035294,0.269149794892186,0.276431332581134,0.00728153768894892,0.466321930024253,-0.111845693313725,7.06817721676005,7.0697446757127,7.06302699448706,-0.0067176812256405,0.938077611823677,ENSG00000186660,ZFP91,protein_coding,11,1,58579063,58621550,q12.1,ZFP91 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:14983],NA,ZFP91,80829,NM_001197051;NM_053023
RPS6KA1_SIG,RPS6KA1,RPS6KA1_SIG,RPS6KA1,SIG,39,-0.832081425932188,0.412512051798278,0.415193589941228,0.403701283614301,-0.0114923063269267,0.466943873940485,1.28841945091974,7.24255817435533,7.22067468303428,7.3144610744102,0.0937863913759208,0.299561272213023,ENSG00000117676,RPS6KA1,protein_coding,1,1,26529761,26575030,p36.11,ribosomal protein S6 kinase A1 [Source:HGNC Symbol;Acc:HGNC:10430],NA,RPS6KA1,6195,NM_001006665;NM_001330441;NM_002953
ARID3B_TF,ARID3B,ARID3B_TF,ARID3B,TF,82,-0.831970742611,-0.0325550922338025,-0.0307227413615852,-0.038575673671088,-0.00785293230950288,0.466943873940485,3.6205098335284,4.9571953627089,4.87699662343698,5.22070550603092,0.343708882593947,0.00187611203446265,ENSG00000179361,ARID3B,protein_coding,15,1,74541177,74598131,q24.1,AT-rich interaction domain 3B [Source:HGNC Symbol;Acc:HGNC:14350],NA,ARID3B,10620,NM_001307939;NM_006465
RPL13A_SIG,RPL13A,RPL13A_SIG,RPL13A,SIG,24,0.831966257493529,1.64798566649105,1.6438001958019,1.66173792732684,0.0179377315249435,0.466943873940485,1.35474924464695,8.94555508675126,8.92489966904539,9.01342288778483,0.0885232187394376,0.273703172175264,ENSG00000142541,RPL13A,protein_coding,19,1,49487554,49492308,q13.33,ribosomal protein L13a [Source:HGNC Symbol;Acc:HGNC:10304],NA,RPL13A,23521,NM_001270491;NM_012423
RELA_SIG,RELA,RELA_SIG,RELA,SIG,31,0.83191850454288,0.244766482249422,0.242309836349435,0.252838318777953,0.0105284824285187,0.466943873940485,0.113105490331375,6.90612072677544,6.90479384899123,6.91048046806645,0.00568661907521837,0.93742302319635,ENSG00000173039,RELA,protein_coding,11,-1,65653597,65663090,q13.1,RELA proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9955],Ependymoma,RELA,5970,NM_001145138;NM_001243984;NM_001243985;NM_021975
STAU1_SIG,STAU1,STAU1_SIG,STAU1,SIG,21,-0.830667285519979,0.197904588965105,0.198940705725613,0.194500205323436,-0.00444050040217683,0.46769269738395,0.497469516599599,6.6190619020582,6.6143717393201,6.63447243676911,0.0201006974490135,0.711158859380329,ENSG00000124214,STAU1,protein_coding,20,-1,49113339,49188367,q13.13,staufen double-stranded RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:11370],NA,STAU1,6780,NM_001037328;NM_001319134;NM_001319135;NM_001322927;NM_001322928;NM_001322929;NM_001322930;NM_001322931;NM_001322932;NM_001322933;NM_004602;NM_017452;NM_017453;NM_017454
CAMKK1_SIG,CAMKK1,CAMKK1_SIG,CAMKK1,SIG,17,-0.830490769618965,0.156435920446446,0.158012205396005,0.151256698469324,-0.00675550692668065,0.467742552034278,0.794340011288764,3.89766660575786,3.88067146142993,3.95350779426393,0.0728363328340071,0.53827237222499,ENSG00000004660,CAMKK1,protein_coding,17,-1,3860315,3894891,p13.2,calcium/calmodulin dependent protein kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:1469],NA,CAMKK1,84254,NM_032294;NM_172206;NM_172207
RPL14_SIG,RPL14,RPL14_SIG,RPL14,SIG,11,0.83017896840239,1.15456986874556,1.15132291307299,1.16523843738398,0.0139155243109844,0.467826865470392,2.12495014754581,8.24522541192263,8.21452351093471,8.34610308659722,0.13157957566251,0.0766943973521097,ENSG00000188846,RPL14,protein_coding,3,1,40457292,40468587,p22.1,ribosomal protein L14 [Source:HGNC Symbol;Acc:HGNC:10305],NA,RPL14,9045,NM_001034996;NM_003973
MTO1_SIG,MTO1,MTO1_SIG,MTO1,SIG,19,0.830161412387633,0.307762903553737,0.305795882475475,0.314225972810882,0.00843009033540709,0.467826865470392,1.0631983031784,4.91001254013245,4.89541074269985,4.95798987455387,0.0625791318540224,0.399758012111373,ENSG00000135297,MTO1,protein_coding,6,1,73461578,73509236,q13,mitochondrial tRNA translation optimization 1 [Source:HGNC Symbol;Acc:HGNC:19261],COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10;Infantile hypertrophic cardiomyopathy and lactic acidosis;Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,MTO1,25821,NM_001123226;NM_012123;NM_133645
NCOR2_SIG,NCOR2,NCOR2_SIG,NCOR2,SIG,71,0.830032651766308,0.251113790219748,0.250146032404834,0.254293565897322,0.00414753349248858,0.467845655744788,0.879254516702511,8.0049779750948,7.99332878623998,8.04325388133207,0.0499250950920835,0.492899828130478,ENSG00000196498,NCOR2,protein_coding,12,-1,124324415,124567589,q24.31,nuclear receptor corepressor 2 [Source:HGNC Symbol;Acc:HGNC:7673],NA,NCOR2,9612,NM_001077261;NM_001206654;NM_006312
SORBS1_SIG,SORBS1,SORBS1_SIG,SORBS1,SIG,58,0.829001750304087,-0.0215500538673573,-0.0238132974132593,-0.0141136822165364,0.00969961519672283,0.468451640030937,-0.309819719924238,2.10105593605738,2.11044896300213,2.07019313323892,-0.0402558297632142,0.822108157670347,ENSG00000095637,SORBS1,protein_coding,10,-1,95311771,95561414,q24.1,sorbin and SH3 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:14565],NA,SORBS1,10580,NM_001034954;NM_001034955;NM_001034956;NM_001034957;NM_001290294;NM_001290295;NM_001290296;NM_001290297;NM_001290298;NM_006434;NM_015385;NM_024991
EIF3L_SIG,EIF3L,EIF3L_SIG,EIF3L,SIG,14,0.828893735096277,1.65648092171539,1.65324244016956,1.66712164679456,0.0138792066250074,0.468456911541533,1.12392757889651,8.93762842957895,8.92162111374857,8.99022389587876,0.0686027821301884,0.370968022900316,ENSG00000100129,EIF3L,protein_coding,22,1,37848868,37889407,q13.1,eukaryotic translation initiation factor 3 subunit L [Source:HGNC Symbol;Acc:HGNC:18138],NA,EIF3L,51386,NM_001242923;NM_016091
ZNF586_TF,ZNF586,ZNF586_TF,ZNF586,TF,65,0.82854182744168,0.0556974496493716,0.0542911845169515,0.0603180350844664,0.00602685056751497,0.468620993679549,1.09258608779544,4.60411318082875,4.58480418853484,4.66755701265158,0.0827528241167331,0.385757144135904,ENSG00000083828,ZNF586,protein_coding,19,1,57769655,57819939,q13.43,zinc finger protein 586 [Source:HGNC Symbol;Acc:HGNC:25949],NA,ZNF586,54807,NM_001077426;NM_001204814;NM_017652
SNRNP27_SIG,SNRNP27,SNRNP27_SIG,SNRNP27,SIG,41,0.827364669707,0.262048100138829,0.261311106105353,0.264469651963109,0.00315854585775643,0.469322762515256,0.71509646049286,4.80633774484303,4.79982979074321,4.82772102259958,0.0278912318563683,0.583057275636887,ENSG00000124380,SNRNP27,protein_coding,2,1,69893956,69905575,p13.3,small nuclear ribonucleoprotein U4/U6.U5 subunit 27 [Source:HGNC Symbol;Acc:HGNC:30240],NA,SNRNP27,11017,NM_006857
ACE_SIG,ACE,ACE_SIG,ACE,SIG,50,-0.826409725516469,0.0027175874502805,0.00433645560107131,-0.00260155075946073,-0.00693800636053206,0.469880150419612,-1.11666862557564,1.65612181336315,1.69394586448466,1.53184278824961,-0.162103076235057,0.374454083957809,ENSG00000159640,ACE,protein_coding,17,1,63477061,63498380,q23.3,angiotensin I converting enzyme [Source:HGNC Symbol;Acc:HGNC:2707],HEMORRHAGE INTRACEREBRAL SUSCEPTIBILITY TO;MICROVASCULAR COMPLICATIONS OF DIABETES SUSCEPTIBILITY TO 3;Renal tubular dysgenesis of genetic origin,ACE,1636,NM_000789;NM_001178057;NM_152830
GPBP1_TF,GPBP1,GPBP1_TF,GPBP1,TF,58,0.826204681385058,0.369710178495628,0.368713232089019,0.372985859545914,0.00427262745689495,0.469948649955183,0.760845804071256,6.78356157373053,6.77605203689731,6.8082357661825,0.0321837292851875,0.557386956408448,ENSG00000062194,GPBP1,protein_coding,5,1,57173948,57264679,q11.2,GC-rich promoter binding protein 1 [Source:HGNC Symbol;Acc:HGNC:29520],NA,GPBP1,65056,NM_001127235;NM_001127236;NM_001203246;NM_001331037;NM_022913
FEN1_SIG,FEN1,FEN1_SIG,FEN1,SIG,57,-0.824769993426076,0.406839412618911,0.411800073561909,0.390540098091918,-0.0212599754699906,0.470819540145771,-0.704294117215324,4.71895533907341,4.73771678903034,4.65731057492922,-0.080406214101119,0.589513371230492,ENSG00000168496,FEN1,protein_coding,11,1,61792911,61797238,q12.2,flap structure-specific endonuclease 1 [Source:HGNC Symbol;Acc:HGNC:3650],NA,FEN1,2237,NM_004111
RNF138_SIG,RNF138,RNF138_SIG,RNF138,SIG,39,-0.82424353087299,0.39762990904472,0.400493531452315,0.388220863991194,-0.012272667461121,0.471097949122699,-0.587339160954421,6.44058458964223,6.44845848408009,6.41471322220356,-0.0337452618765246,0.65878399687262,ENSG00000134758,RNF138,protein_coding,18,1,32091874,32131561,q12.1,ring finger protein 138 [Source:HGNC Symbol;Acc:HGNC:17765],NA,RNF138,51444,NM_001191324;NM_016271;NM_198128
UBE2N_SIG,UBE2N,UBE2N_SIG,UBE2N,SIG,20,0.824016141735443,0.25530693354213,0.254455074811848,0.258105897941627,0.00365082312977901,0.471156148596521,1.85248534436139,6.41570957178183,6.39792977306664,6.47412891041744,0.0761991373508009,0.12633568284116,ENSG00000177889,UBE2N,protein_coding,12,-1,93405673,93441947,q22,ubiquitin conjugating enzyme E2 N [Source:HGNC Symbol;Acc:HGNC:12492],NA,UBE2N,7334,NM_003348
GNPTG_SIG,GNPTG,GNPTG_SIG,GNPTG,SIG,19,-0.823954236592801,0.265509216281994,0.266559702668685,0.262057618154294,-0.00450208451439173,0.471156148596521,-0.301817147628592,5.64020119107467,5.64317051329531,5.63044484663543,-0.0127256666598798,0.826761676827152,ENSG00000090581,GNPTG,protein_coding,16,1,1351931,1364113,p13.3,N-acetylglucosamine-1-phosphate transferase subunit gamma [Source:HGNC Symbol;Acc:HGNC:23026],MUCOLIPIDOSIS III GAMMA;MUCOLIPIDOSIS TYPE III COMPLEMENTATION GROUP C;Mucolipidosis Type III Gamma,GNPTG,84572,NM_032520
CXCL2_SIG,CXCL2,CXCL2_SIG,CXCL2,SIG,33,-0.823389336429553,0.170780176060748,0.173302305453097,0.162493179485884,-0.0108091259672131,0.471448126903561,-0.00539882275729623,4.01153980314718,4.01180436351516,4.01067053336669,-0.00113383014847008,0.996652507749455,ENSG00000081041,CXCL2,protein_coding,4,-1,74097040,74099196,q13.3,C-X-C motif chemokine ligand 2 [Source:HGNC Symbol;Acc:HGNC:4603],NA,CXCL2,2920,NM_002089
HGS_SIG,HGS,HGS_SIG,HGS,SIG,15,-0.823307012128272,0.234995303066767,0.235703434915921,0.232668584133832,-0.0030348507820893,0.471448126903561,-0.117104619899539,6.78720050231356,6.78812365988735,6.78416727028537,-0.00395638960198758,0.935154883789814,ENSG00000185359,HGS,protein_coding,17,1,81683326,81703138,q25.3,hepatocyte growth factor-regulated tyrosine kinase substrate [Source:HGNC Symbol;Acc:HGNC:4897],NA,HGS,9146,NM_004712
PPM1D_SIG,PPM1D,PPM1D_SIG,PPM1D,SIG,10,0.822662132410436,0.351060409732411,0.350072934344101,0.35430497172257,0.00423203737846907,0.47180404676455,0.837859391534531,4.872871944186,4.86230276834606,4.90759923623151,0.0452964678854455,0.514712107839832,ENSG00000170836,PPM1D,protein_coding,17,1,60600183,60666280,q23.2,protein phosphatase, Mg2+/Mn2+ dependent 1D [Source:HGNC Symbol;Acc:HGNC:9277],Breast Cancer;Hereditary breast cancer;INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD;PPM1D syndrome,PPM1D,8493,NM_003620
GMPS_SIG,GMPS,GMPS_SIG,GMPS,SIG,25,0.820996813989952,0.56597506475058,0.563921739416895,0.572721705132686,0.00879996571579086,0.472827445936013,1.30341794956806,6.42051257014264,6.40377343579752,6.47551258299088,0.0717391471933552,0.293644695690373,ENSG00000163655,GMPS,protein_coding,3,1,155870650,155944020,q25.31,guanine monophosphate synthase [Source:HGNC Symbol;Acc:HGNC:4378],NA,GMPS,8833,NM_003875
DNAJC8_SIG,DNAJC8,DNAJC8_SIG,DNAJC8,SIG,32,0.820650316977361,0.288447765610311,0.286942241645625,0.293394487208562,0.00645224556293634,0.472988603512182,1.29348004925808,6.32421255477402,6.3118587480322,6.36480363406859,0.0529448860363953,0.297651676402386,ENSG00000126698,DNAJC8,protein_coding,1,-1,28199456,28233029,p35.3,DnaJ heat shock protein family (Hsp40) member C8 [Source:HGNC Symbol;Acc:HGNC:15470],NA,DNAJC8,22826,NM_014280
MRPL13_SIG,MRPL13,MRPL13_SIG,MRPL13,SIG,24,0.820062038798313,0.324098754760367,0.322556727402884,0.329165416077813,0.00660868867492938,0.473308030889955,0.41437768619803,3.50608247371024,3.50029125527708,3.52511076284778,0.0248195075707081,0.760371510005571,ENSG00000172172,MRPL13,protein_coding,8,-1,120380761,120445402,q24.12,mitochondrial ribosomal protein L13 [Source:HGNC Symbol;Acc:HGNC:14278],NA,MRPL13,28998,NM_014078
USP38_SIG,USP38,USP38_SIG,USP38,SIG,32,-0.818070294489898,0.388643868704054,0.390502576529899,0.382536685847705,-0.00796589068219348,0.474547083883412,-0.154212430192443,5.79384117303809,5.79586124558658,5.78720379180734,-0.00865745377924749,0.913607279915426,ENSG00000170185,USP38,protein_coding,4,1,143184917,143223830,q31.21,ubiquitin specific peptidase 38 [Source:HGNC Symbol;Acc:HGNC:20067],NA,USP38,84640,NM_001290325;NM_001290326;NM_032557
CD44_SIG,CD44,CD44_SIG,CD44,SIG,30,-0.816576057328461,0.0706870177082746,0.0716211910425515,0.0676175910385076,-0.00400360000404389,0.47543660149439,-2.44984192424191,9.80016199809407,9.85167308676464,9.63091127817646,-0.220761808588188,0.0393660583777837,ENSG00000026508,CD44,protein_coding,11,1,35138870,35232402,p13,CD44 molecule (Indian blood group) [Source:HGNC Symbol;Acc:HGNC:1681],BLOOD GROUP INDIAN SYSTEM,CD44,960,NM_000610;NM_001001389;NM_001001390;NM_001001391;NM_001001392;NM_001202555;NM_001202556;NM_001202557
RPN1_SIG,RPN1,RPN1_SIG,RPN1,SIG,31,0.816513396261411,0.417701453483749,0.416099557292167,0.422964826684661,0.00686526939249444,0.47543660149439,-0.387350925705196,7.65663006140706,7.66143329773261,7.64084799919455,-0.0205852985380605,0.775929708679085,ENSG00000163902,RPN1,protein_coding,3,-1,128619969,128681075,q21.3,ribophorin I [Source:HGNC Symbol;Acc:HGNC:10381],Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2),RPN1,6184,NM_002950
CYP21A2_SIG,CYP21A2,CYP21A2_SIG,CYP21A2,SIG,5,-0.815393138230161,-0.118579642860002,-0.117580737087337,-0.121861761827329,-0.00428102473999182,0.476106104723638,-2.66374056839073,0.192448208040254,0.206428474899956,0.146513045501233,-0.0599154293987239,0.0243417644606593,ENSG00000231852,CYP21A2,protein_coding,6,1,32038265,32041670,p21.33,cytochrome P450 family 21 subfamily A member 2 [Source:HGNC Symbol;Acc:HGNC:2600],ADRENAL HYPERPLASIA CONGENITAL DUE TO 21-HYDROXYLASE DEFICIENCY;Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency salt wasting form;Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency simple virilizing form,CYP21A2,1589,NM_000500;NM_001128590
COX6A1_SIG,COX6A1,COX6A1_SIG,COX6A1,SIG,19,-0.814485596622208,0.158641039888822,0.159742556059792,0.155021772469922,-0.00472078358986966,0.476636302719185,-0.272715317243411,3.57786539959566,3.58059816161107,3.56888632440217,-0.0117118372088995,0.843901653134821,ENSG00000111775,COX6A1,protein_coding,12,1,120438090,120440737,q24.31,cytochrome c oxidase subunit 6A1 [Source:HGNC Symbol;Acc:HGNC:2277],Autosomal recessive intermediate Charcot-Marie-Tooth disease type D;Charcot-Marie-Tooth disease recessive intermediate d,COX6A1,1337,NM_004373
ATG4A_SIG,ATG4A,ATG4A_SIG,ATG4A,SIG,22,0.814383799882206,0.340287197895015,0.337430813140753,0.349672462087591,0.0122416489468388,0.476637181640254,0.339751129718904,3.66817281830531,3.66385911843715,3.6823464035864,0.0184872851492508,0.803843951762527,ENSG00000101844,ATG4A,protein_coding,X,1,108091668,108154671,q22.3,autophagy related 4A cysteine peptidase [Source:HGNC Symbol;Acc:HGNC:16489],NA,ATG4A,115201,NM_001321287;NM_001321288;NM_001321289;NM_001321290;NM_052936;NM_178270;NM_178271
B3GNT9_SIG,B3GNT9,B3GNT9_SIG,B3GNT9,SIG,29,-0.81419906546266,0.0359248205525803,0.0374932197014292,0.0307715090635052,-0.00672171063792395,0.476692561411316,-0.729806799928984,1.55392053979334,1.56698354798493,1.5109992271638,-0.0559843208211373,0.574529742966109,ENSG00000237172,B3GNT9,protein_coding,16,-1,67148104,67150998,q22.1,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 [Source:HGNC Symbol;Acc:HGNC:28714],NA,B3GNT9,84752,NM_033309
DDX39B_SIG,DDX39B,DDX39B_SIG,DDX39B,SIG,52,0.813230900091239,0.217165452496379,0.215536398010794,0.222518060091871,0.0069816620810778,0.47726289778626,0.898334150030689,7.95309941761294,7.94182449774253,7.9901455829014,0.048321085158867,0.482840927668236,ENSG00000198563,DDX39B,protein_coding,6,-1,31530219,31542448,p21.33,DExD-box helicase 39B [Source:HGNC Symbol;Acc:HGNC:13917],NA,DDX39B,7919,NM_004640;NM_080598
GFPT1_SIG,GFPT1,GFPT1_SIG,GFPT1,SIG,27,0.811324380422124,0.405737592914884,0.404345145395684,0.410312777620826,0.00596763222514216,0.478451195109914,1.64387436095191,5.212982046693,5.19277719683633,5.27936941050778,0.086592213671442,0.178245572807808,ENSG00000198380,GFPT1,protein_coding,2,-1,69319769,69387254,p13.3,glutamine--fructose-6-phosphate transaminase 1 [Source:HGNC Symbol;Acc:HGNC:4241],Congenital myasthenic syndromes with glycosylation defect;MYASTHENIC SYNDROME CONGENITAL 12;MYASTHENIC SYNDROME CONGENITAL 4C ASSOCIATED WITH ACETYLCHOLINERECEPTOR DEFICIENCY,GFPT1,2673,NM_001244710;NM_002056
RPL38_SIG,RPL38,RPL38_SIG,RPL38,SIG,30,0.811198985651325,1.66716159619288,1.66305956272435,1.68063970616091,0.0175801434365651,0.478467531586597,1.68200971937267,8.57831167902738,8.55633682315383,8.65051477689765,0.0941779537438236,0.167960555904796,ENSG00000172809,RPL38,protein_coding,17,1,74203582,74210655,q25.1,ribosomal protein L38 [Source:HGNC Symbol;Acc:HGNC:10349],NA,RPL38,6169,NM_000999;NM_001035258
PRKD2_SIG,PRKD2,PRKD2_SIG,PRKD2,SIG,77,-0.810738498561963,0.0917834940557228,0.0934228733245734,0.0863969621723563,-0.00702591115221703,0.478704524960201,-0.401225824631118,6.0891624162087,6.09557635107928,6.06808805877679,-0.0274882923024818,0.767542129771218,ENSG00000105287,PRKD2,protein_coding,19,-1,46674275,46717127,q13.32,protein kinase D2 [Source:HGNC Symbol;Acc:HGNC:17293],NA,PRKD2,25865,NM_001079880;NM_001079881;NM_001079882;NM_016457
PSMA2_SIG,PSMA2,PSMA2_SIG,PSMA2,SIG,28,0.810289285522592,0.225352875991098,0.224595934890579,0.227839968178519,0.00324403328794037,0.478934139448604,1.87918873123159,2.7126172574161,2.68546382792429,2.8018356686035,0.116371840679209,0.120580016302869,ENSG00000106588,PSMA2,protein_coding,7,-1,42916861,42932185,p14.1,proteasome subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:9531],NA,PSMA2,5683,NM_002787
TRIM69_SIG,TRIM69,TRIM69_SIG,TRIM69,SIG,59,-0.808953226848357,0.303996569515629,0.307013890168623,0.294082515941505,-0.0129313742271172,0.479748324749952,-1.7236960172658,3.94195029490823,3.98987601162238,3.78448008284744,-0.205395928774939,0.156967772082203,ENSG00000185880,TRIM69,protein_coding,15,1,44728988,44767829,q21.1,tripartite motif containing 69 [Source:HGNC Symbol;Acc:HGNC:17857],NA,TRIM69,140691,NM_001301144;NM_001301145;NM_001301146;NM_080745;NM_182985
VNN1_SIG,VNN1,VNN1_SIG,VNN1,SIG,23,-0.808132698761856,0.104919520115577,0.106501171484982,0.0997226656161006,-0.00677850586888158,0.48022307535469,-0.178811141944582,4.20142559282396,4.2110989186282,4.1696418080386,-0.0414571105895999,0.899729563684832,ENSG00000112299,VNN1,protein_coding,6,-1,132680849,132714055,q23.2,vanin 1 [Source:HGNC Symbol;Acc:HGNC:12705],NA,VNN1,8876,NM_004666
MGMT_SIG,MGMT,MGMT_SIG,MGMT,SIG,14,-0.807864024974696,-0.00257587788735016,-0.00111814316034516,-0.00736557770465228,-0.00624743454430708,0.480333890700709,0.0327946500388659,3.38627319632171,3.38537906899004,3.38921104326864,0.00383197427859892,0.982187846849696,ENSG00000170430,MGMT,protein_coding,10,1,129467190,129770983,q26.3,O-6-methylguanine-DNA methyltransferase [Source:HGNC Symbol;Acc:HGNC:7059],Familial melanoma;Giant cell glioblastoma;Gliosarcoma,MGMT,4255,NM_002412
GXYLT1_SIG,GXYLT1,GXYLT1_SIG,GXYLT1,SIG,5,0.807620390807834,0.359361265492318,0.357117568638064,0.366733412299153,0.00961584366108837,0.480428193033386,1.40231295245143,4.79562274631643,4.77437068345394,4.86545095286459,0.0910802694106455,0.255722585456192,ENSG00000151233,GXYLT1,protein_coding,12,-1,42081845,42144874,q12,glucoside xylosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:27482],NA,GXYLT1,283464,NM_001099650;NM_173601
PLD1_SIG,PLD1,PLD1_SIG,PLD1,SIG,52,0.805206372621632,0.172066195724133,0.170478905050352,0.17728157936656,0.00680267431620843,0.481955816970508,-0.336684676488849,5.22643700153831,5.23511636787093,5.19791908358829,-0.037197284282641,0.805756126802871,ENSG00000075651,PLD1,protein_coding,3,-1,171600404,171810950,q26.31,phospholipase D1 [Source:HGNC Symbol;Acc:HGNC:9067],CARDIAC VALVULAR DEFECT DEVELOPMENTAL,PLD1,5337,NM_001130081;NM_002662
RPS27A_SIG,RPS27A,RPS27A_SIG,RPS27A,SIG,32,0.804501769620914,1.27327085538503,1.26888669875547,1.28767594145355,0.0187892426980753,0.482354976858659,1.49753092587187,7.15911683215123,7.13537169250824,7.23713657669246,0.101764884184216,0.222705396876101,ENSG00000143947,RPS27A,protein_coding,2,1,55231903,55235853,p16.1,ribosomal protein S27a [Source:HGNC Symbol;Acc:HGNC:10417],NA,RPS27A,6233,NM_001135592;NM_001177413;NM_002954
GTF2E2_SIG,GTF2E2,GTF2E2_SIG,GTF2E2,SIG,16,0.801437124866467,0.447385302766388,0.444733124348056,0.456099603283765,0.0113664789357085,0.484317037593052,0.720204070396931,4.09901938564073,4.08939899528294,4.13062923967347,0.041230244390534,0.58018577966343,ENSG00000197265,GTF2E2,protein_coding,8,-1,30578318,30658236,p12,general transcription factor IIE subunit 2 [Source:HGNC Symbol;Acc:HGNC:4651],DNA Repair-Proficient Trichothiodystrophy;Trichothiodystrophy;Trichothiodystrophy 6 nonphotosensitive,GTF2E2,2961,NM_001348353;NM_002095
GALNT6_SIG,GALNT6,GALNT6_SIG,GALNT6,SIG,5,0.801002511477706,0.0962140561070389,0.0949496086798879,0.100368669081963,0.00541906040207558,0.484538167235919,0.407398439584098,4.76030082616771,4.75166356471391,4.78868039951592,0.0370168348020191,0.764149936685913,ENSG00000139629,GALNT6,protein_coding,12,-1,51351247,51392867,q13.13,polypeptide N-acetylgalactosaminyltransferase 6 [Source:HGNC Symbol;Acc:HGNC:4128],NA,GALNT6,11226,NM_007210
SLC25A27_SIG,SLC25A27,SLC25A27_SIG,SLC25A27,SIG,90,-0.80006376384145,-0.128324129394987,-0.127154231878747,-0.132168078376916,-0.0050138464981688,0.485093682122922,0.364642884015269,0.74251135985645,0.733603136880391,0.771781235349216,0.0381780984688246,0.789296185410475,ENSG00000153291,SLC25A27,protein_coding,6,1,46652915,46678190,p12.3,solute carrier family 25 member 27 [Source:HGNC Symbol;Acc:HGNC:21065],NA,SLC25A27,9481,NM_001204051;NM_001204052;NM_004277
ZFP69_TF,ZFP69,ZFP69_TF,ZFP69,TF,56,0.799699842050004,0.114533829945525,0.112851355117828,0.120061961522244,0.00721060640441594,0.485268058920343,1.07163044353002,2.78598061129158,2.76629239210737,2.85067047432541,0.0843780822180381,0.39599731244099,ENSG00000187815,ZFP69,protein_coding,1,1,40477290,40496343,p34.2,ZFP69 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:24708],NA,ZFP69,339559,NM_001320178;NM_001320179;NM_198494
RPS9_SIG,RPS9,RPS9_SIG,RPS9,SIG,9,0.798459448471732,0.791862715208888,0.789291914502823,0.800309631814528,0.0110177173117045,0.485970786164304,0.627563001134862,9.39252609168363,9.38399070552215,9.4205709319285,0.036580226406354,0.634077098263855,ENSG00000170889,RPS9,protein_coding,19,1,54200809,54249003,q13.42,ribosomal protein S9 [Source:HGNC Symbol;Acc:HGNC:10442],NA,RPS9,6203,NM_001013;NM_001321701;NM_001321702;NM_001321704;NM_001321705;NM_001321706
SUPT6H_SIG,SUPT6H,SUPT6H_SIG,SUPT6H,SIG,46,-0.798438834827086,0.468739293464807,0.470038157511007,0.464471597313005,-0.00556656019800201,0.485970786164304,0.979529346513518,7.82456614585602,7.81361089416178,7.86056197285137,0.0469510786895942,0.440923287143298,ENSG00000109111,SUPT6H,protein_coding,17,1,28662198,28702679,q11.2,SPT6 homolog, histone chaperone [Source:HGNC Symbol;Acc:HGNC:11470],NA,SUPT6H,6830,NM_001320755;NM_003170
DHFR_SIG,DHFR,DHFR_SIG,DHFR,SIG,13,-0.797123186277514,0.375734520723971,0.380402502901481,0.360396864997866,-0.0200056379036153,0.486777498338304,-0.710536133412494,5.15947617095801,5.17886142010107,5.0957817809165,-0.0830796391845753,0.585705595345077,ENSG00000228716,DHFR,protein_coding,5,-1,80626226,80654983,q14.1,dihydrofolate reductase [Source:HGNC Symbol;Acc:HGNC:2861],Constitutional megaloblastic anemia with severe neurologic disease;Megaloblastic anemia due to dihydrofolate reductase deficiency,DHFR,1719,NM_000791;NM_001290354;NM_001290357
RNASEH2A_SIG,RNASEH2A,RNASEH2A_SIG,RNASEH2A,SIG,93,0.796839938996314,0.308355834758214,0.304825295713658,0.319956177333186,0.0151308816195279,0.486898495982548,1.44544159070434,3.94192420053319,3.90719974733427,4.0560188324725,0.148819085138233,0.240184433032217,ENSG00000104889,RNASEH2A,protein_coding,19,1,12806556,12815201,p13.13,ribonuclease H2 subunit A [Source:HGNC Symbol;Acc:HGNC:18518],Aicardi-Goutieres syndrome;AICARDI-GOUTIERES SYNDROME 4,RNASEH2A,10535,NM_006397
ITGB1BP2_SIG,ITGB1BP2,ITGB1BP2_SIG,ITGB1BP2,SIG,17,-0.796455688539483,0.0406682404119623,0.0417415491167605,0.0371416546676251,-0.0045998944491355,0.487086637240911,-0.980527273955125,1.38205112075145,1.39408284141914,1.34251832427189,-0.0515645171472455,0.440467594327458,ENSG00000147166,ITGB1BP2,protein_coding,X,1,71301750,71305371,q13.1,integrin subunit beta 1 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:6154],NA,ITGB1BP2,26548,NM_001303277;NM_012278
JOSD2_SIG,JOSD2,JOSD2_SIG,JOSD2,SIG,68,-0.796009606708093,0.100978229939109,0.102808525158492,0.0949644027897086,-0.00784412236878382,0.487315912198711,0.436797935456541,2.56654877297781,2.5590354855177,2.59123528891817,0.0321998034004668,0.746421063073753,ENSG00000161677,JOSD2,protein_coding,19,-1,50505998,50511353,q13.33,Josephin domain containing 2 [Source:HGNC Symbol;Acc:HGNC:28853],NA,JOSD2,126119,NM_001270639;NM_001270640;NM_001270641;NM_001270686;NM_138334
RCL1_SIG,RCL1,RCL1_SIG,RCL1,SIG,36,0.795043273793011,0.185937936946298,0.183880166563284,0.192699182490484,0.0088190159272,0.48789126402268,1.13579749958856,4.17467241027283,4.15194164036416,4.24935922568702,0.0974175853228524,0.365473824063715,ENSG00000120158,RCL1,protein_coding,9,1,4792944,4885917,p24.1,RNA terminal phosphate cyclase like 1 [Source:HGNC Symbol;Acc:HGNC:17687],NA,RCL1,10171,NM_001286699;NM_001286700;NM_001286701;NM_005772
SEC61A1_SIG,SEC61A1,SEC61A1_SIG,SEC61A1,SIG,28,0.794633082006573,0.352257484923954,0.351302827431931,0.355394216683459,0.00409138925152767,0.488096816570626,2.17183696294088,7.980962021566,7.96110135482386,8.04621849800448,0.0851171431806232,0.0700662209821551,ENSG00000058262,SEC61A1,protein_coding,3,1,128051641,128071683,q21.3,Sec61 translocon alpha 1 subunit [Source:HGNC Symbol;Acc:HGNC:18276],Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia;HYPERURICEMIC NEPHROPATHY FAMILIAL JUVENILE 4,SEC61A1,29927,NM_013336
PREB_TF,PREB,PREB_TF,PREB,TF,524,0.793704732298234,0.185572054296948,0.183261837673878,0.193162766058461,0.00990092838458248,0.48864731581472,1.02645964661296,5.10351500007543,5.07953644076598,5.18230169494935,0.102765254183377,0.417672958509459,ENSG00000138073,PREB,protein_coding,2,-1,27130756,27134666,p23.3,prolactin regulatory element binding [Source:HGNC Symbol;Acc:HGNC:9356],NA,PREB,10113,NM_001330484;NM_001330485;NM_001330486;NM_001330487;NM_013388
NEURL1_SIG,NEURL1,NEURL1_SIG,NEURL1,SIG,10,-0.792957510226258,0.107501467968776,0.108644672916933,0.103745223139119,-0.00489944977781327,0.489077461638207,-2.74684290794002,1.6732671282189,1.75301793027973,1.41122877859046,-0.341789151689265,0.0200517550204577,ENSG00000107954,NEURL1,protein_coding,10,1,103493979,103592552,q24.33,neuralized E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:7761],NA,NEURL1,9148,NM_004210
JMJD1C_SIG,JMJD1C,JMJD1C_SIG,JMJD1C,SIG,8,-0.792753604822283,0.56900632779983,0.571362112483072,0.561265892412037,-0.0100962200710351,0.489145796656317,-1.77771380515592,7.73814180012597,7.76882419915032,7.63732820333166,-0.131495995818656,0.143505583814567,ENSG00000171988,JMJD1C,protein_coding,10,-1,63167221,63521850,q21.3,jumonji domain containing 1C [Source:HGNC Symbol;Acc:HGNC:12313],22q11.2 Deletion Syndrome;Germinoma of the central nervous system,JMJD1C,221037,NM_001282948;NM_001318153;NM_001318154;NM_001322252;NM_001322254;NM_001322258;NM_032776
YME1L1_SIG,YME1L1,YME1L1_SIG,YME1L1,SIG,22,-0.792434981568926,0.396760014972125,0.397474191596071,0.394413434636304,-0.00306075695976727,0.489290554842189,-0.271889602166956,7.48583375283711,7.48777486331229,7.47945581841866,-0.00831904489362763,0.844226433731797,ENSG00000136758,YME1L1,protein_coding,10,-1,27110112,27155266,p12.1,YME1 like 1 ATPase [Source:HGNC Symbol;Acc:HGNC:12843],OPTIC ATROPHY 11,YME1L1,10730,NM_001253866;NM_014263;NM_139312
UHMK1_SIG,UHMK1,UHMK1_SIG,UHMK1,SIG,44,-0.792279342311871,0.289217676771397,0.289979767403714,0.286713664693786,-0.00326610270992812,0.489326743434907,-0.379910561208094,7.2078951619007,7.21256520367494,7.19255073892822,-0.0200144647467192,0.780462021618539,ENSG00000152332,UHMK1,protein_coding,1,1,162497251,162529631,q23.3,U2AF homology motif kinase 1 [Source:HGNC Symbol;Acc:HGNC:19683],NA,UHMK1,127933,NM_001184763;NM_144624;NM_175866
ARHGAP11A_SIG,ARHGAP11A,ARHGAP11A_SIG,ARHGAP11A,SIG,18,-0.792042809970429,0.221940092091161,0.226694526232472,0.206318379912565,-0.0203761463199076,0.489416824903184,1.87928562418724,5.05109371806989,5.00288422903724,5.20949632489147,0.206612095854234,0.120573816919356,ENSG00000198826,ARHGAP11A,protein_coding,15,1,32615144,32639941,q13.3,Rho GTPase activating protein 11A [Source:HGNC Symbol;Acc:HGNC:15783],NA,ARHGAP11A,9824,NM_001286479;NM_001286480;NM_014783;NM_199357
CUL3_SIG,CUL3,CUL3_SIG,CUL3,SIG,14,-0.791820361415967,0.504339767347061,0.505212168928373,0.501473305008465,-0.00373886391990859,0.489497527871578,-1.42476144608223,6.48467001967128,6.49732934242787,6.44307510204249,-0.0542542403853829,0.247376328456324,ENSG00000036257,CUL3,protein_coding,2,-1,224470150,224585397,q36.2,cullin 3 [Source:HGNC Symbol;Acc:HGNC:2553],CUL3 associated autism spectrum disorder;Pseudohypoaldosteronism type 2E;PSEUDOHYPOALDOSTERONISM TYPE IIE,CUL3,8452,NM_001257197;NM_001257198;NM_003590
ARID5A_TF,ARID5A,ARID5A_TF,ARID5A,TF,140,-0.790832177497759,-0.00157068849235938,0.000555404974562592,-0.00855642416938872,-0.00911182914395132,0.490088569048129,-0.542908152961952,5.99393229923206,6.00727497905353,5.95009206553295,-0.0571829135205782,0.684833640017704,ENSG00000196843,ARID5A,protein_coding,2,1,96536743,96552634,q11.2,AT-rich interaction domain 5A [Source:HGNC Symbol;Acc:HGNC:17361],NA,ARID5A,10865,NM_001319085;NM_001319087;NM_001319092;NM_001319093;NM_001319094;NM_001319096;NM_212481
DHRS13_SIG,DHRS13,DHRS13_SIG,DHRS13,SIG,30,-0.790595828417587,0.006703340118091,0.00840415002679292,0.00111496470378471,-0.00728918532300833,0.49017856655541,0.17546232543582,3.60075129717716,3.59756179601892,3.61123108669708,0.0136692906781516,0.901508130743866,ENSG00000167536,DHRS13,protein_coding,17,-1,28897781,28903079,q11.2,dehydrogenase/reductase 13 [Source:HGNC Symbol;Acc:HGNC:28326],NA,DHRS13,147015,NM_144683
SLC25A24_SIG,SLC25A24,SLC25A24_SIG,SLC25A24,SIG,26,-0.788648871520223,0.499086572561864,0.501240358566228,0.492009847118954,-0.00923051144727317,0.491347295134287,-0.0287384629144184,5.68895883820169,5.68952490226428,5.6870989134246,-0.00242598883967751,0.983962826063344,ENSG00000085491,SLC25A24,protein_coding,1,-1,108134043,108200849,p13.3,solute carrier family 25 member 24 [Source:HGNC Symbol;Acc:HGNC:20662],FONTAINE PROGEROID SYNDROME;Gorlin-Chaudhry-Moss syndrome;Gorlin-Chaudhry-Moss syndrome (GCMS);  Syndrome with Hypertrichosis Progeroid Appearance and Mitochondrial Dysfunction;Progeroid syndrome Petty type,SLC25A24,29957,NM_013386;NM_213651
PSMB4_SIG,PSMB4,PSMB4_SIG,PSMB4,SIG,20,0.788641132374037,0.14009564249962,0.139051349312012,0.143526891544619,0.00447554223260672,0.491347295134287,0.907499814564603,7.03496200347219,7.0281019845811,7.05750206554292,0.0294000809618202,0.477981570136167,ENSG00000159377,PSMB4,protein_coding,1,1,151399560,151401937,q21.3,proteasome subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:9541],PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3,PSMB4,5692,NM_002796
HYAL3_SIG,HYAL3,HYAL3_SIG,HYAL3,SIG,61,-0.787255750023163,0.13067204594482,0.132317963699523,0.125264030465083,-0.0070539332344398,0.492204768935142,-1.36688594963765,4.04106407098988,4.08502930193684,3.89660688359271,-0.188422418344138,0.269209143714791,ENSG00000186792,HYAL3,protein_coding,3,-1,50292831,50299405,p21.31,hyaluronidase 3 [Source:HGNC Symbol;Acc:HGNC:5322],NA,HYAL3,8372,NM_001200029;NM_001200030;NM_001200031;NM_001200032;NM_003549
DUSP11_SIG,DUSP11,DUSP11_SIG,DUSP11,SIG,33,0.786877420988663,0.377032654242079,0.375868434937367,0.380857946243275,0.0049895113059081,0.492389748320899,1.83943990300936,4.19129056083618,4.17002849077142,4.2611516481918,0.0911231574203849,0.12899480394023,ENSG00000144048,DUSP11,protein_coding,2,-1,73762184,73780157,p13.1,dual specificity phosphatase 11 [Source:HGNC Symbol;Acc:HGNC:3066],NA,DUSP11,8446,NM_003584
NAA50_SIG,NAA50,NAA50_SIG,NAA50,SIG,43,-0.785577164967447,0.274459623612683,0.275405894814451,0.271350446806876,-0.00405544800757535,0.493165706494281,0.256374642746257,6.97459086172302,6.97092061365391,6.98665024823583,0.0157296345819215,0.853937613883405,ENSG00000121579,NAA50,protein_coding,3,-1,113716458,113746300,q13.31,N(alpha)-acetyltransferase 50, NatE catalytic subunit [Source:HGNC Symbol;Acc:HGNC:29533],NA,NAA50,80218,NM_001308445;NM_025146
MAEA_SIG,MAEA,MAEA_SIG,MAEA,SIG,32,-0.785513688659041,0.259835233939116,0.26113961907863,0.255549397052143,-0.00559022202648688,0.493165706494281,0.16742667373183,5.88608045340664,5.88406500529791,5.8927026400496,0.00863763475168611,0.906033824232018,ENSG00000090316,MAEA,protein_coding,4,1,1289887,1340147,p16.3,macrophage erythroblast attacher [Source:HGNC Symbol;Acc:HGNC:13731],NA,MAEA,10296,NM_001017405;NM_001297430;NM_001297431;NM_001297432;NM_001297433;NM_005882
PRPF18_SIG,PRPF18,PRPF18_SIG,PRPF18,SIG,11,-0.785149097744028,0.186721134661164,0.187412857346905,0.184448331550875,-0.00296452579602982,0.493341633689429,-0.887115600641597,3.57834353213763,3.58606191414449,3.55298313411511,-0.0330787800293716,0.488714626716172,ENSG00000165630,PRPF18,protein_coding,10,1,13586939,13630859,p13,pre-mRNA processing factor 18 [Source:HGNC Symbol;Acc:HGNC:17351],NA,PRPF18,8559,NM_003675
INO80_SIG,INO80,INO80_SIG,INO80,SIG,24,0.784680543571851,0.357284064536153,0.35628117616404,0.36057926918738,0.00429809302334018,0.49358713843243,0.563542717560011,6.1356377131169,6.13042498850377,6.15276523684574,0.0223402483419654,0.672719959485789,ENSG00000128908,INO80,protein_coding,15,-1,40978880,41116354,q15.1,INO80 complex subunit [Source:HGNC Symbol;Acc:HGNC:26956],NA,INO80,54617,NM_017553
DHX16_SIG,DHX16,DHX16_SIG,DHX16,SIG,34,0.784575422368871,0.236298592035613,0.233251917933843,0.246309092655715,0.0130571747218717,0.493589506305619,1.24049007478672,5.38814894029811,5.37234295185541,5.44008290232411,0.0677399504686969,0.319372676849167,ENSG00000204560,DHX16,protein_coding,6,-1,30653119,30673006,p21.33,DEAH-box helicase 16 [Source:HGNC Symbol;Acc:HGNC:2739],NA,DHX16,8449,NM_001164239;NM_003587
RPS14_SIG,RPS14,RPS14_SIG,RPS14,SIG,20,0.781429375262979,1.09024638689123,1.08647277199759,1.10264540725606,0.0161726352584768,0.49562868213082,1.21674805182788,8.69172580905357,8.67029488289955,8.76214170927393,0.0918468263743755,0.329632143843875,ENSG00000164587,RPS14,protein_coding,5,-1,150442635,150449739,q33.1,ribosomal protein S14 [Source:HGNC Symbol;Acc:HGNC:10387],CHROMOSOME 5q DELETION SYNDROME;Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality,RPS14,6208,NM_001025070;NM_001025071;NM_005617
DNTTIP1_SIG,DNTTIP1,DNTTIP1_SIG,DNTTIP1,SIG,23,-0.781028024907117,-0.0218770831985916,-0.0201991452274965,-0.0273903079607611,-0.00719116273326459,0.495765545496519,0.141992836653617,5.00753993029616,5.00560173040416,5.01390830136985,0.00830657096568291,0.920375053654569,ENSG00000101457,DNTTIP1,protein_coding,20,1,45791954,45811427,q13.12,deoxynucleotidyltransferase terminal interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:16160],NA,DNTTIP1,116092,NM_052951
AGO1_SIG,AGO1,AGO1_SIG,AGO1,SIG,24,0.781021797598539,0.296886601518137,0.296111314578334,0.299433972891776,0.00332265831344276,0.495765545496519,0.223857093606491,6.98445158871321,6.98186799844622,6.9929405281619,0.0110725297156868,0.873308299954963,ENSG00000092847,AGO1,protein_coding,1,1,35869808,35930532,p34.3,argonaute RISC catalytic component 1 [Source:HGNC Symbol;Acc:HGNC:3262],NA,AGO1,26523,NM_001317122;NM_001317123;NM_012199
GPR150_SIG,GPR150,GPR150_SIG,GPR150,SIG,6,0.780207271412156,0.10468558220631,0.103521601675646,0.108510089664206,0.00498848798856062,0.496243662531896,1.27055473046704,0.371051672136235,0.359805703643088,0.408002711470863,0.0481970078277752,0.306973214269961,ENSG00000178015,GPR150,protein_coding,5,1,95620087,95622142,q15,G protein-coupled receptor 150 [Source:HGNC Symbol;Acc:HGNC:23628],NA,GPR150,285601,NM_199243
TRAP1_SIG,TRAP1,TRAP1_SIG,TRAP1,SIG,20,0.779622718838749,0.219951232504621,0.21827585155644,0.225456055620071,0.0071802040636305,0.496567629851863,1.03991124249825,5.5089041123632,5.48858895901217,5.57565390194513,0.0870649429329583,0.410984925576771,ENSG00000126602,TRAP1,protein_coding,16,-1,3651639,3717553,p13.3,TNF receptor associated protein 1 [Source:HGNC Symbol;Acc:HGNC:16264],NA,TRAP1,10131,NM_001272049;NM_016292
USP7_SIG,USP7,USP7_SIG,USP7,SIG,5,0.77842462633653,0.282901186096274,0.281474481329054,0.287588930331427,0.0061144490023727,0.497303706282626,-0.0522166155579974,7.80649332147402,7.80694827560132,7.8049984721986,-0.00194980340272553,0.971113196595729,ENSG00000187555,USP7,protein_coding,16,-1,8892097,8964514,p13.2,ubiquitin specific peptidase 7 [Source:HGNC Symbol;Acc:HGNC:12630],16p13.2 microdeletion syndrome;Intellectual disability autism epilepsy aggressive behaviour hypotonia and hypogonadism,USP7,7874,NM_001286457;NM_001286458;NM_001321858;NM_003470
LPIN2_SIG,LPIN2,LPIN2_SIG,LPIN2,SIG,48,-0.777994088281137,0.296762104850377,0.297808943663467,0.293322491607369,-0.0044864520560977,0.497524504647692,0.367694972779871,5.90791886978654,5.90186688523629,5.92780396188022,0.0259370766439212,0.787628863357831,ENSG00000101577,LPIN2,protein_coding,18,-1,2916994,3013315,p11.31,lipin 2 [Source:HGNC Symbol;Acc:HGNC:14450],MAJEED SYNDROME,LPIN2,9663,NM_014646
NDUFB10_SIG,NDUFB10,NDUFB10_SIG,NDUFB10,SIG,26,0.777732337838006,0.360308215754123,0.358760747147451,0.365392755461762,0.00663200831431144,0.497631926325494,1.7438802150408,5.59516411134891,5.57672282022289,5.65575692504871,0.0790341048258184,0.151673663299412,ENSG00000140990,NDUFB10,protein_coding,16,1,1959538,1961975,p13.3,NADH:ubiquinone oxidoreductase subunit B10 [Source:HGNC Symbol;Acc:HGNC:7696],Isolated complex I deficiency,NDUFB10,4716,NM_004548
HGD_SIG,HGD,HGD_SIG,HGD,SIG,42,-0.77586019890839,-0.100216796872984,-0.0991616292368042,-0.103683776249002,-0.00452214701219718,0.498822094161001,-0.0104533634929047,0.640854803394195,0.641024910335295,0.640295880587722,-0.00072902974757326,0.994157579539531,ENSG00000113924,HGD,protein_coding,3,-1,120628172,120682269,q13.33,homogentisate 1,2-dioxygenase [Source:HGNC Symbol;Acc:HGNC:4892],Alkaptonuria,HGD,3081,NM_000187
CRK_SIG,CRK,CRK_SIG,CRK,SIG,28,-0.775456879765797,0.309381416296625,0.311209987536548,0.303373253651164,-0.00783673388538365,0.499024853814736,0.801514654206984,4.83733419422713,4.8242076693571,4.88046420451435,0.0562565351572469,0.534321307351812,ENSG00000167193,CRK,protein_coding,17,-1,1420689,1463162,p13.3,CRK proto-oncogene, adaptor protein [Source:HGNC Symbol;Acc:HGNC:2362],NA,CRK,1398,NM_005206;NM_016823
NDST3_SIG,NDST3,NDST3_SIG,NDST3,SIG,55,0.775023792074596,-0.0609799217231524,-0.0618963867085288,-0.0579686796283441,0.00392770708018454,0.499247677148203,-0.519924899389642,0.923432862616654,0.941556118286487,0.863885022558633,-0.0776710957278539,0.698127541573692,ENSG00000164100,NDST3,protein_coding,4,1,118033618,118258634,q26,N-deacetylase and N-sulfotransferase 3 [Source:HGNC Symbol;Acc:HGNC:7682],NA,NDST3,9348,NM_004784
ANXA2_SIG,ANXA2,ANXA2_SIG,ANXA2,SIG,59,-0.774692445554147,0.260041281320981,0.2634828659065,0.24873321768285,-0.0147496482236493,0.499402052456533,-0.146511686390172,6.52929689560707,6.5350122385254,6.51051791173256,-0.0244943267928387,0.917839109210415,ENSG00000182718,ANXA2,protein_coding,15,-1,60347134,60402883,q22.2,annexin A2 [Source:HGNC Symbol;Acc:HGNC:537],NA,ANXA2,302,NM_001002857;NM_001002858;NM_001136015;NM_004039
CNDP2_SIG,CNDP2,CNDP2_SIG,CNDP2,SIG,30,0.773733319407161,0.152670224828522,0.150665264655167,0.159257951112402,0.00859268645723534,0.499979153551965,1.7308834156011,6.41654511887509,6.38077378889704,6.53407948880295,0.153305699905907,0.155068970609417,ENSG00000133313,CNDP2,protein_coding,18,1,74495816,74523454,q22.3,carnosine dipeptidase 2 [Source:HGNC Symbol;Acc:HGNC:24437],NA,CNDP2,55748,NM_001168499;NM_018235
PINK1_SIG,PINK1,PINK1_SIG,PINK1,SIG,27,-0.773518606388964,0.256886171833054,0.258572584978687,0.251345100068833,-0.00722748490985432,0.500055049541204,0.106583096359239,5.12931344157066,5.12741061988162,5.13556556997749,0.00815495009586455,0.94095404137309,ENSG00000158828,PINK1,protein_coding,1,1,20633458,20651511,p36.12,PTEN induced kinase 1 [Source:HGNC Symbol;Acc:HGNC:14581],PARKINSON DISEASE 6 AUTOSOMAL RECESSIVE EARLY-ONSET;Young-onset Parkinson disease,PINK1,65018,NM_032409
PRKAG1_SIG,PRKAG1,PRKAG1_SIG,PRKAG1,SIG,11,0.772347641154609,0.435034552795411,0.433339882517879,0.440602755135874,0.0072628726179954,0.500775265825798,1.35487593027664,5.34853255444528,5.33508529211075,5.39271641640161,0.0576311242908601,0.273658895934647,ENSG00000181929,PRKAG1,protein_coding,12,-1,49002274,49018825,q13.12,protein kinase AMP-activated non-catalytic subunit gamma 1 [Source:HGNC Symbol;Acc:HGNC:9385],NA,PRKAG1,5571,NM_001206709;NM_001206710;NM_002733
BRIP1_SIG,BRIP1,BRIP1_SIG,BRIP1,SIG,31,-0.77144761811301,0.429093461276113,0.433665619715715,0.414070654974563,-0.0195949647411527,0.501313250322089,-0.114191481133907,3.6003450825171,3.60338132411849,3.59036886011252,-0.0130124640059726,0.936859074538339,ENSG00000136492,BRIP1,protein_coding,17,-1,61681266,61863521,q23.2,BRCA1 interacting protein C-terminal helicase 1 [Source:HGNC Symbol;Acc:HGNC:20473],Breast Cancer;Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP J;Hereditary breast and ovarian cancer syndrome,BRIP1,83990,NM_032043
TCF7L1_TF,TCF7L1,TCF7L1_TF,TCF7L1,TF,97,-0.771201763708017,-0.0551830646650122,-0.0541408321340693,-0.0586075429809675,-0.00446671084689834,0.501371524906018,-0.700699630198017,0.455335715828859,0.463002121973516,0.430146095639271,-0.0328560263342449,0.591655355757601,ENSG00000152284,TCF7L1,protein_coding,2,1,85133392,85310387,p11.2,transcription factor 7 like 1 [Source:HGNC Symbol;Acc:HGNC:11640],NA,TCF7L1,83439,NM_031283
HNRNPUL1_SIG,HNRNPUL1,HNRNPUL1_SIG,HNRNPUL1,SIG,15,0.771156981276997,0.402170317464749,0.401304373875471,0.405015560686663,0.00371118681119247,0.501371524906018,0.652481459434667,9.0419487167364,9.03622594430757,9.0607521118597,0.0245261675521302,0.619519043528908,ENSG00000105323,HNRNPUL1,protein_coding,19,1,41262496,41307598,q13.2,heterogeneous nuclear ribonucleoprotein U like 1 [Source:HGNC Symbol;Acc:HGNC:17011],NA,HNRNPUL1,11100,NM_001301016;NM_001321208;NM_001321211;NM_007040;NM_144732
SIAH2_SIG,SIAH2,SIAH2_SIG,SIAH2,SIG,22,-0.770563310386408,0.162612474631852,0.164125699703631,0.157640449396007,-0.00648525030762451,0.501703073354337,-0.954996023500558,5.74870843319453,5.76346620170083,5.70021862238811,-0.0632475793127209,0.453004368784367,ENSG00000181788,SIAH2,protein_coding,3,-1,150741125,150763477,q25.1,siah E3 ubiquitin protein ligase 2 [Source:HGNC Symbol;Acc:HGNC:10858],NA,SIAH2,6478,NM_005067
ASNA1_SIG,ASNA1,ASNA1_SIG,ASNA1,SIG,19,0.769842045861706,0.375657308519748,0.374010331763628,0.381068803575572,0.00705847181194372,0.50212082048292,-0.612392399241444,5.46469165057077,5.47178430895661,5.44138720158871,-0.0303971073679018,0.643224510209405,ENSG00000198356,ASNA1,protein_coding,19,1,12737139,12748323,p13.13,arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) [Source:HGNC Symbol;Acc:HGNC:752],NA,ASNA1,439,NM_004317
HAS1_SIG,HAS1,HAS1_SIG,HAS1,SIG,16,-0.768965658982687,-0.0381298747441968,-0.0345783364939245,-0.0497992147093773,-0.0152208782154528,0.502643462578751,-1.67196375781634,0.366282913847774,0.401143910879047,0.251739637887879,-0.149404272991168,0.17056294190023,ENSG00000105509,HAS1,protein_coding,19,-1,51713112,51723994,q13.41,hyaluronan synthase 1 [Source:HGNC Symbol;Acc:HGNC:4818],NA,HAS1,3036,NM_001297436;NM_001523
LHPP_SIG,LHPP,LHPP_SIG,LHPP,SIG,12,0.76750883722652,0.259458765029376,0.258446186120441,0.262785810015875,0.00433962389543385,0.503558593614168,1.26103438466809,3.87868301973081,3.85512885236941,3.95607528391826,0.10094643154885,0.310835800067898,ENSG00000107902,LHPP,protein_coding,10,1,124461823,124617888,q26.13,phospholysine phosphohistidine inorganic pyrophosphate phosphatase [Source:HGNC Symbol;Acc:HGNC:30042],NA,LHPP,64077,NM_001167880;NM_001318331;NM_001318332;NM_022126
HMGA2_TF,HMGA2,HMGA2_TF,HMGA2,TF,77,-0.767069004808416,-0.0836235111146308,-0.0824557610584202,-0.0874604041564655,-0.00500464309804515,0.503731846533884,-1.05588406008786,1.17681565460809,1.22091264981532,1.03192552749861,-0.188987122316712,0.403181925322734,ENSG00000149948,HMGA2,protein_coding,12,1,65824131,65966295,q14.3,high mobility group AT-hook 2 [Source:HGNC Symbol;Acc:HGNC:5009],12q14 microdeletion syndrome;Dedifferentiated liposarcoma;LEIOMYOMA UTERINE;Pleomorphic salivary gland adenoma;Well-differentiated liposarcoma,HMGA2,8091,NM_001300918;NM_001300919;NM_001330190;NM_003483;NM_003484
ZCCHC7_SIG,ZCCHC7,ZCCHC7_SIG,ZCCHC7,SIG,10,0.767017261039893,0.198259309604861,0.196656860514018,0.20352449947477,0.00686763896075206,0.503731846533884,1.1094750391639,4.55925764711903,4.54140616830198,4.61791250608931,0.0765063377873228,0.377990827317175,ENSG00000147905,ZCCHC7,protein_coding,9,1,37120539,37358149,p13.2,zinc finger CCHC-type containing 7 [Source:HGNC Symbol;Acc:HGNC:26209],NA,ZCCHC7,84186,NM_001289119;NM_001289120;NM_001289121;NM_032226
MED8_SIG,MED8,MED8_SIG,MED8,SIG,53,-0.766939148958301,0.289202943616774,0.291215288290737,0.282590953973752,-0.00862433431698471,0.503731846533884,-0.343893982346177,4.38892588881767,4.3939094266332,4.37255140742378,-0.0213580192094182,0.801351774523166,ENSG00000159479,MED8,protein_coding,1,-1,43383917,43389808,p34.2,mediator complex subunit 8 [Source:HGNC Symbol;Acc:HGNC:19971],NA,MED8,112950,NM_001001653;NM_052877;NM_201542
SLC7A2_SIG,SLC7A2,SLC7A2_SIG,SLC7A2,SIG,62,-0.766843475499335,-0.170809005874447,-0.169873173330724,-0.173883884232395,-0.00401071090167149,0.503731846533884,-0.760725385309656,0.845818371643964,0.871957749703683,0.759931843733458,-0.112025905970225,0.557415801848098,ENSG00000003989,SLC7A2,protein_coding,8,1,17497088,17570573,p22,solute carrier family 7 member 2 [Source:HGNC Symbol;Acc:HGNC:11060],NA,SLC7A2,6542,NM_001008539;NM_001164771;NM_003046
TPSAB1_SIG,TPSAB1,TPSAB1_SIG,TPSAB1,SIG,25,0.766433070219759,-0.018930091220765,-0.0214973991936813,-0.0104946507383255,0.0110027484553557,0.503940138993273,0.604838816278129,4.05483244475934,4.01802801037371,4.17576130059783,0.157733290224127,0.648139210731318,ENSG00000172236,TPSAB1,protein_coding,16,1,1240705,1242554,p13.3,tryptase alpha/beta 1 [Source:HGNC Symbol;Acc:HGNC:12019],NA,TPSAB1,7177,NM_003294
LPCAT3_SIG,LPCAT3,LPCAT3_SIG,LPCAT3,SIG,20,0.766305739621802,0.293598097216488,0.292401847639194,0.297528631541883,0.00512678390268893,0.503957089116737,-0.192880513812735,5.71606726637202,5.71936047250672,5.70524673192943,-0.0141137405772912,0.891517144320622,ENSG00000111684,LPCAT3,protein_coding,12,-1,6976185,7018477,p13.31,lysophosphatidylcholine acyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:30244],NA,LPCAT3,10162,NM_005768
SRF_TF,SRF,SRF_TF,SRF,TF,41,-0.764988844944889,0.136566807560809,0.137358371427409,0.133965954856266,-0.00339241657114304,0.504745603445676,-2.60267651865795,6.48056244670994,6.50470714534033,6.40122986549577,-0.103477279844563,0.0279936902329136,ENSG00000112658,SRF,protein_coding,6,1,43171269,43181506,p21.1,serum response factor [Source:HGNC Symbol;Acc:HGNC:11291],NA,SRF,6722,NM_001292001;NM_003131
DDX19B_SIG,DDX19B,DDX19B_SIG,DDX19B,SIG,21,0.764935150976252,0.417004756125351,0.415901022840872,0.420631308345779,0.00473028550490665,0.504745603445676,2.29145047827301,4.31080502511526,4.28496019043463,4.39572376763736,0.110763577202735,0.054932432626946,ENSG00000157349,DDX19B,protein_coding,16,1,70289663,70335283,q22.1,DEAD-box helicase 19B [Source:HGNC Symbol;Acc:HGNC:2742],NA,DDX19B,11269,NM_001014449;NM_001014451;NM_001257172;NM_001257173;NM_001257174;NM_001257175;NM_001363938;NM_007242
ATP8A2_SIG,ATP8A2,ATP8A2_SIG,ATP8A2,SIG,35,0.764282170580264,-0.13577447945747,-0.136837697438316,-0.132281048948978,0.00455664848933755,0.505072627563142,0.846598856600459,0.714599029548677,0.696782208187774,0.773140014020212,0.0763578058324375,0.510368213526941,ENSG00000132932,ATP8A2,protein_coding,13,1,25371974,26025851,q12.13,ATPase phospholipid transporting 8A2 [Source:HGNC Symbol;Acc:HGNC:13533],Cerebellar ataxia mental retardation and dysequilibrium syndrome 4;Dysequilibrium syndrome,ATP8A2,51761,NM_001313741;NM_016529
NOTCH1_TF,NOTCH1,NOTCH1_TF,NOTCH1,TF,256,-0.764247182857028,0.0972510601228033,0.0981954369455465,0.0941481077052185,-0.00404732924032799,0.505072627563142,0.213344246686021,7.3274344745996,7.3230362729722,7.34188570851821,0.0188494355460163,0.879710862267333,ENSG00000148400,NOTCH1,protein_coding,9,-1,136494433,136546048,q34.3,notch 1 [Source:HGNC Symbol;Acc:HGNC:7881],Adams-Oliver syndrome;Adams-Oliver syndrome 5;Adams Oliver syndrome;AORTIC VALVE DISEASE 1;Familial bicuspid aortic valve;LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION,NOTCH1,4851,NM_017617
GEN1_SIG,GEN1,GEN1_SIG,GEN1,SIG,16,0.763744928802893,0.383281771676171,0.38152624109114,0.389049943598417,0.00752370250727686,0.505343280755638,0.686453295264311,4.3503339388448,4.33891706960731,4.38784650919656,0.0489294395892532,0.599891304762125,ENSG00000178295,GEN1,protein_coding,2,1,17753858,17788946,p24.2,GEN1, Holliday junction 5' flap endonuclease [Source:HGNC Symbol;Acc:HGNC:26881],NA,GEN1,348654,NM_001130009;NM_182625
G2E3_SIG,G2E3,G2E3_SIG,G2E3,SIG,36,0.762504898110625,0.381558865513984,0.380525309831257,0.384954834185802,0.00442952435454512,0.506113608693893,-1.59853411913773,4.38730667369276,4.40799059667717,4.31934521245827,-0.088645384218898,0.191074593183819,ENSG00000092140,G2E3,protein_coding,14,1,30559158,30620064,q12,G2/M-phase specific E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:20338],NA,G2E3,55632,NM_001308097;NM_017769
SSH1_SIG,SSH1,SSH1_SIG,SSH1,SIG,29,0.762082859370495,0.308606347650795,0.30753760828542,0.312117919851315,0.00458031156589575,0.506330148767615,1.96007414375791,6.5832124563807,6.55583806854888,6.67315687354239,0.117318804993503,0.104423341612794,ENSG00000084112,SSH1,protein_coding,12,-1,108778191,108857590,q24.11,slingshot protein phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:30579],NA,SSH1,54434,NM_001161330;NM_001161331;NM_018984
ACY3_SIG,ACY3,ACY3_SIG,ACY3,SIG,67,0.761822075967346,0.0456083375492719,0.0437045886916094,0.0518635123673062,0.00815892367569678,0.506437455819694,-0.130352067591493,2.63058086532354,2.63698747319205,2.60953058232704,-0.0274568908650036,0.926932636802952,ENSG00000132744,ACY3,protein_coding,11,-1,67642555,67650730,q13.2,aminoacylase 3 [Source:HGNC Symbol;Acc:HGNC:24104],NA,ACY3,91703,NM_080658
CC2D1B_SIG,CC2D1B,CC2D1B_SIG,CC2D1B,SIG,32,0.761392002643838,0.299717012144209,0.298646778642504,0.303233493649814,0.00458671500731027,0.506659485816264,0.366316446417004,5.46566730125668,5.46165866866253,5.47883852263745,0.0171798539749241,0.788424608710971,ENSG00000154222,CC2D1B,protein_coding,1,-1,52345723,52366193,p32.3,coiled-coil and C2 domain containing 1B [Source:HGNC Symbol;Acc:HGNC:29386],NA,CC2D1B,200014,NM_001330585;NM_032449
FAM120A_SIG,FAM120A,FAM120A_SIG,FAM120A,SIG,54,-0.759951825767692,0.416426058849311,0.419045280986144,0.407820043256858,-0.0112252377292866,0.507566472273447,1.01520757836448,7.75693947525869,7.74344798611696,7.80126865386721,0.0578206677502493,0.422942070692027,ENSG00000048828,FAM120A,protein_coding,9,1,93451685,93566112,q22.31,family with sequence similarity 120A [Source:HGNC Symbol;Acc:HGNC:13247],NA,FAM120A,23196,NM_001286722;NM_001286723;NM_001286724;NM_014612
ZRSR2_TF,ZRSR2,ZRSR2_TF,ZRSR2,TF,135,0.757860955794127,-0.013289954905634,-0.0139695200419077,-0.011057098029306,0.00291242201260174,0.508916196271127,0.0151927768559862,4.48894123766743,4.488761811878,4.489530779547,0.000768967669002563,0.991628859641664,ENSG00000169249,ZRSR2,protein_coding,X,1,15790472,15823260,p22.2,zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 [Source:HGNC Symbol;Acc:HGNC:23019],NA,ZRSR2,8233,NM_005089
GPR83_SIG,GPR83,GPR83_SIG,GPR83,SIG,25,-0.757189286380268,0.0178962082780492,0.0186190083666893,0.015521293701089,-0.00309771466560013,0.509302839429397,-1.84349756728365,0.333184767764501,0.344815545859455,0.294969354023936,-0.0498461918355192,0.128172385713194,ENSG00000123901,GPR83,protein_coding,11,-1,94377316,94401419,q21,G protein-coupled receptor 83 [Source:HGNC Symbol;Acc:HGNC:4523],NA,GPR83,10888,NM_001330345;NM_016540
TLK2_SIG,TLK2,TLK2_SIG,TLK2,SIG,26,0.755337812507539,0.482773179494246,0.481165812737075,0.488054527410667,0.00688871467359247,0.510492022086814,0.0343561027351139,5.23061208123765,5.23025792673538,5.23177573174511,0.00151780500972982,0.981402908635362,ENSG00000146872,TLK2,protein_coding,17,1,62458658,62615481,q23.2,tousled like kinase 2 [Source:HGNC Symbol;Acc:HGNC:11842],MENTAL RETARDATION AUTOSOMAL DOMINANT 57;TLK2 syndrome,TLK2,11011,NM_001284333;NM_001284363;NM_001330418;NM_006852
DTL_SIG,DTL,DTL_SIG,DTL,SIG,28,-0.753926187313489,0.399351736042398,0.404683415157059,0.381833361808513,-0.0228500533485468,0.511383028087445,-0.318386010852844,4.38096585543235,4.39103135449182,4.3478935013798,-0.0431378531120172,0.816788466827364,ENSG00000143476,DTL,protein_coding,1,1,212035553,212107400,q32.3,denticleless E3 ubiquitin protein ligase homolog [Source:HGNC Symbol;Acc:HGNC:30288],NA,DTL,51514,NM_001286229;NM_001286230;NM_016448
INPP5D_SIG,INPP5D,INPP5D_SIG,INPP5D,SIG,21,-0.753208818359619,0.357862633706817,0.359370314316144,0.352908825990459,-0.00646148832568507,0.511801669061042,-2.63920856520915,8.30955735899567,8.34159775078004,8.2042817859899,-0.137315964790139,0.0256938940793949,ENSG00000168918,INPP5D,protein_coding,2,1,233059967,233207903,q37.1,inositol polyphosphate-5-phosphatase D [Source:HGNC Symbol;Acc:HGNC:6079],NA,INPP5D,3635,NM_001017915;NM_005541
ZNF33A_TF,ZNF33A,ZNF33A_TF,ZNF33A,TF,105,0.753012373216377,0.0211932928906802,0.0204441210845825,0.0236548573964297,0.00321073631184728,0.511865462778714,0.936495131265543,6.15347156031427,6.13829968476465,6.20332200854873,0.0650223237840795,0.462636146679846,ENSG00000189180,ZNF33A,protein_coding,10,1,38010650,38065088,p11.1,zinc finger protein 33A [Source:HGNC Symbol;Acc:HGNC:13096],NA,ZNF33A,7581,NM_001278170;NM_001278171;NM_001278173;NM_001278174;NM_001278175;NM_001278176;NM_001278177;NM_001278178;NM_001278179;NM_001324175;NM_001324176;NM_001324177;NM_001324178;NM_006954;NM_006974
EFNB1_SIG,EFNB1,EFNB1_SIG,EFNB1,SIG,42,0.752189326755264,-0.00373929978546335,-0.00544729865187877,0.00187269648990161,0.0073199951417803,0.512356293857915,2.954792802229,3.35331787368048,3.27074777495765,3.62461962662692,0.353871851669267,0.0121002879440589,ENSG00000090776,EFNB1,protein_coding,X,1,68829021,68842160,q13.1,ephrin B1 [Source:HGNC Symbol;Acc:HGNC:3226],Craniofrontonasal dysplasia;CRANIOFRONTONASAL SYNDROME,EFNB1,1947,NM_004429
PHF21A_TF,PHF21A,PHF21A_TF,PHF21A,TF,152,-0.751169669436033,0.017279183524816,0.0180473096094757,0.0147553406752198,-0.0032919689342559,0.512981436266932,-0.184823307341457,6.91329573395191,6.91537255622791,6.90647188933076,-0.00890066689714888,0.895945807333929,ENSG00000135365,PHF21A,protein_coding,11,-1,45929323,46121178,p11.2,PHD finger protein 21A [Source:HGNC Symbol;Acc:HGNC:24156],Potocki-Shaffer syndrome,PHF21A,51317,NM_001101802;NM_001352025;NM_001352026;NM_001352027;NM_001352028;NM_001352029;NM_001352030;NM_001352031;NM_001352032;NM_016621
CDKN1B_SIG,CDKN1B,CDKN1B_SIG,CDKN1B,SIG,23,-0.750176909460645,0.193622382455122,0.194490483821235,0.190770049395036,-0.00372043442619889,0.513581480271154,0.622604385487295,6.58239665930952,6.57078494123414,6.62054944727148,0.0497645060373354,0.637001066484061,ENSG00000111276,CDKN1B,protein_coding,12,1,12715058,12722369,p13.1,cyclin dependent kinase inhibitor 1B [Source:HGNC Symbol;Acc:HGNC:1785],Multiple endocrine neoplasia type 1;Multiple endocrine neoplasia type 4;MULTIPLE ENDOCRINE NEOPLASIA TYPE IV,CDKN1B,1027,NM_004064
PRKY_SIG,PRKY,PRKY_SIG,PRKY,SIG,25,-0.75008437932546,-0.0858024604388047,-0.080350937778109,-0.103714606323948,-0.0233636685458388,0.513581480271154,-0.620016737525569,3.44557940729298,3.4879123649517,3.30648540355718,-0.18142696139452,0.638599364214525,ENSG00000099725,PRKY,protein_coding,Y,1,7273972,7381548,p11.2,protein kinase Y-linked (pseudogene) [Source:HGNC Symbol;Acc:HGNC:9444],NA,PRKY,NA,NA
COX5A_SIG,COX5A,COX5A_SIG,COX5A,SIG,41,0.749837216768857,0.388298748021197,0.386964741786661,0.392681911363243,0.00571716957658149,0.513679915471158,0.946814323332405,5.83466037009485,5.82277617495963,5.87370843982487,0.0509322648652388,0.457423209387656,ENSG00000178741,COX5A,protein_coding,15,-1,74919791,74938083,q24.2,cytochrome c oxidase subunit 5A [Source:HGNC Symbol;Acc:HGNC:2267],Isolated cytochrome C oxidase deficiency,COX5A,9377,NM_004255
TSEN54_SIG,TSEN54,TSEN54_SIG,TSEN54,SIG,56,-0.749581503976063,0.0808494039620201,0.0822347011298777,0.0762977132676308,-0.00593698786224683,0.513784190867116,-0.830919438759549,4.37497757942624,4.3917762086187,4.31978208350816,-0.0719941251105399,0.518698765638399,ENSG00000182173,TSEN54,protein_coding,17,1,75516060,75524735,q25.1,tRNA splicing endonuclease subunit 54 [Source:HGNC Symbol;Acc:HGNC:27561],Pontocerebellar hypoplasia type 1;Pontocerebellar hypoplasia type 2;Pontocerebellar Hypoplasia Type 2 and Type 4;PONTOCEREBELLAR HYPOPLASIA TYPE 2A;Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA TYPE 4;Pontocerebellar hypoplasia type 5;PONTOCEREBELLAR HYPOPLASIA TYPE 5,TSEN54,283989,NM_207346
ZFYVE26_TF,ZFYVE26,ZFYVE26_TF,ZFYVE26,TF,83,0.749465743647701,0.330949074561007,0.330286239004896,0.333126962816802,0.00284072381190596,0.5137929478417,0.0699368915403738,5.5965649123124,5.59582723299336,5.59898871578925,0.00316148279589162,0.961728752013953,ENSG00000072121,ZFYVE26,protein_coding,14,-1,67727374,67816590,q24.1,zinc finger FYVE-type containing 26 [Source:HGNC Symbol;Acc:HGNC:20761],Autosomal recessive spastic paraplegia type 15;SPASTIC PARAPLEGIA 15 AUTOSOMAL RECESSIVE;SPASTIC PARAPLEGIA AUTOSOMAL RECESSIVE TYPE 15,ZFYVE26,23503,NM_015346
ITGB1_SIG,ITGB1,ITGB1_SIG,ITGB1,SIG,30,-0.74934015679521,0.139127380412651,0.140273156284167,0.135362688263385,-0.0049104680207813,0.513808415623486,-1.74354554889532,7.81191382706458,7.83915184282952,7.72241748955118,-0.116734353278344,0.151745505137872,ENSG00000150093,ITGB1,protein_coding,10,-1,32900318,33005792,p11.22,integrin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6153],NA,ITGB1,3688,NM_002211;NM_033668;NM_133376
ZNF503_TF,ZNF503,ZNF503_TF,ZNF503,TF,145,-0.748980148571425,0.0112273326092424,0.0124928977880533,0.00706904702172059,-0.00542385076633273,0.513983881570157,-1.12314617103157,3.15927641219283,3.20810987902776,2.99882359259236,-0.2092862864354,0.371319424677809,ENSG00000165655,ZNF503,protein_coding,10,-1,75397830,75401764,q22.2,zinc finger protein 503 [Source:HGNC Symbol;Acc:HGNC:23589],NA,ZNF503,84858,NM_032772
ABHD11_SIG,ABHD11,ABHD11_SIG,ABHD11,SIG,47,0.748362297137684,-0.00991886824457112,-0.0116866997667283,-0.00411027895748323,0.00757642080924508,0.514335401541626,1.3258439614971,2.74023052706879,2.7163628864851,2.81865277470089,0.102289888215789,0.284696195241633,ENSG00000106077,ABHD11,protein_coding,7,-1,73736094,73738867,q11.23,abhydrolase domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16407],NA,ABHD11,83451,NM_001145364;NM_001301058;NM_001321382;NM_001321383;NM_148912;NM_148913
RAD54B_SIG,RAD54B,RAD54B_SIG,RAD54B,SIG,27,0.74820671743613,0.206185730352872,0.202653698309133,0.217790978496584,0.0151372801874511,0.51437133784531,1.90960371225621,1.118237608962,1.09388477275642,1.19825407078032,0.104369298023902,0.114356494862882,ENSG00000197275,RAD54B,protein_coding,8,-1,94371960,94475115,q22.1,RAD54 homolog B [Source:HGNC Symbol;Acc:HGNC:17228],LYMPHOMA NON-HODGKIN FAMILIAL,RAD54B,25788,NM_001205262;NM_012415
MRPL54_SIG,MRPL54,MRPL54_SIG,MRPL54,SIG,21,0.746557453533792,0.285254267228424,0.284203355358143,0.288707263373633,0.00450390801549057,0.515427677380573,0.341170443387846,4.30206977342604,4.29826243460135,4.31457960099288,0.0163171663915246,0.803058736373293,ENSG00000183617,MRPL54,protein_coding,19,1,3762682,3768575,p13.3,mitochondrial ribosomal protein L54 [Source:HGNC Symbol;Acc:HGNC:16685],NA,MRPL54,116541,NM_172251
DUSP7_SIG,DUSP7,DUSP7_SIG,DUSP7,SIG,32,-0.746244127871923,0.165203369141519,0.166453354905768,0.161096273058984,-0.00535708184678411,0.515571425391486,-1.07404116919523,4.68397896736191,4.71186476510878,4.59235420333647,-0.119510561772314,0.394816004679356,ENSG00000164086,DUSP7,protein_coding,3,-1,52048919,52056571,p21.2,dual specificity phosphatase 7 [Source:HGNC Symbol;Acc:HGNC:3073],NA,DUSP7,1849,NM_001947
TOX4_TF,TOX4,TOX4_TF,TOX4,TF,90,-0.744815185358656,0.123544460567465,0.124036429737291,0.121927990438038,-0.00210843929925323,0.516478201468531,-1.2963390161971,6.50064868033081,6.51207882373925,6.46309249484591,-0.0489863288933394,0.296547275193505,ENSG00000092203,TOX4,protein_coding,14,1,21476597,21499175,q11.2,TOX high mobility group box family member 4 [Source:HGNC Symbol;Acc:HGNC:20161],NA,TOX4,9878,NM_001303523;NM_014828
BCLAF1_TF,BCLAF1,BCLAF1_TF,BCLAF1,TF,173,0.743894214549925,0.28723167151349,0.285009161303276,0.294534205061336,0.00952504375805928,0.517037946120593,1.51823363938966,8.57934259889672,8.5565604211305,8.65419832584289,0.0976379047123963,0.216048491122209,ENSG00000029363,BCLAF1,protein_coding,6,-1,136256627,136289851,q23.3,BCL2 associated transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:16863],NA,BCLAF1,9774,NM_001077440;NM_001077441;NM_001301038;NM_001363659;NM_014739
MAFF_TF,MAFF,MAFF_TF,MAFF,TF,90,-0.7433770392757,0.182950814113145,0.185724189614427,0.173838294608935,-0.0118858950054922,0.517321420467313,-0.164541647384734,4.88500290359114,4.89304676431483,4.85857307549904,-0.0344736888157869,0.907783295396224,ENSG00000185022,MAFF,protein_coding,22,1,38200767,38216507,q13.1,MAF bZIP transcription factor F [Source:HGNC Symbol;Acc:HGNC:6780],NA,MAFF,23764,NM_001161572;NM_001161573;NM_001161574;NM_012323
BAMBI_SIG,BAMBI,BAMBI_SIG,BAMBI,SIG,27,-0.74064418802268,-0.0749592221388564,-0.0736156584704787,-0.0793737884778117,-0.00575813000733306,0.519123810549359,-0.924849471109765,1.89876828404797,1.93534113892312,1.77860033231533,-0.156740806607791,0.468408128037591,ENSG00000095739,BAMBI,protein_coding,10,1,28677510,28682932,p12.1,BMP and activin membrane bound inhibitor [Source:HGNC Symbol;Acc:HGNC:30251],NA,BAMBI,25805,NM_012342
TERT_SIG,TERT,TERT_SIG,TERT,SIG,15,0.739889200091232,0.0365941847608063,0.0350887540398462,0.041540599986818,0.00645184594697177,0.519570987682238,-0.801720782543753,0.729677619932609,0.746989253747694,0.672796537397329,-0.0741927163503645,0.534229708728635,ENSG00000164362,TERT,protein_coding,5,-1,1253147,1295069,p15.33,telomerase reverse transcriptase [Source:HGNC Symbol;Acc:HGNC:11730],APLASTIC ANEMIA APLASTIC ANEMIA SUSCEPTIBILITY TO INCLUDED;Clear cell sarcoma of kidney;Dyskeratosis congenita;DYSKERATOSIS CONGENITA AUTOSOMAL DOMINANT 1;DYSKERATOSIS CONGENITA AUTOSOMAL DOMINANT 2;DYSKERATOSIS CONGENITA AUTOSOMAL RECESSIVE 4;Familial melanoma;HOYERAAL-HREIDARSSON SYNDROME;Idiopathic aplastic anemia;Idiopathic pulmonary fibrosis;LEUKEMIA ACUTE MYELOID;MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 9;Pulmonary fibrosis and/or bone marrow failure telomere-related 1;PULMONARY FIBROSIS IDIOPATHIC,TERT,7015,NM_001193376;NM_198253
MSANTD1_TF,MSANTD1,MSANTD1_TF,MSANTD1,TF,184,-0.73875283568308,-0.0442528647715299,-0.043701876625558,-0.0460632543940092,-0.00236137776845114,0.520280240314796,-0.800054268929571,0.583711323529883,0.590543757136345,0.561261898822937,-0.029281858313408,0.535152955646638,ENSG00000188981,MSANTD1,protein_coding,4,1,3244369,3271738,p16.3,Myb/SANT DNA binding domain containing 1 [Source:HGNC Symbol;Acc:HGNC:33741],NA,MSANTD1,345222,NM_001042690;NM_001330620
ADCY9_SIG,ADCY9,ADCY9_SIG,ADCY9,SIG,88,-0.737198534868056,0.0863016724928242,0.0882135154928815,0.0800199026354932,-0.0081936128573884,0.52127725636385,-0.470129193777761,4.27936139060959,4.29940413979555,4.21350664328428,-0.0858974965112732,0.727038675111833,ENSG00000162104,ADCY9,protein_coding,16,-1,3953387,4116442,p13.3,adenylate cyclase 9 [Source:HGNC Symbol;Acc:HGNC:240],NA,ADCY9,115,NM_001116
GNL1_SIG,GNL1,GNL1_SIG,GNL1,SIG,40,0.736501948065514,0.169617722020946,0.167795415602817,0.175605300251939,0.00780988464912159,0.521685107158831,0.345051028328609,5.9147712620417,5.90931479537804,5.93269965250802,0.0233848571299803,0.800719961942309,ENSG00000204590,GNL1,protein_coding,6,-1,30541377,30557174,p21.33,G protein nucleolar 1 (putative) [Source:HGNC Symbol;Acc:HGNC:4413],NA,GNL1,2794,NM_005275
ZNF672_TF,ZNF672,ZNF672_TF,ZNF672,TF,165,0.735773386419091,0.205204877435661,0.203305171724931,0.211446767628056,0.00814159590312508,0.522115093088216,-0.650871926558117,5.03790028773417,5.04885548609229,5.00190463598606,-0.0469508501062218,0.62036622574494,ENSG00000171161,ZNF672,protein_coding,1,1,248838210,248849517,q44,zinc finger protein 672 [Source:HGNC Symbol;Acc:HGNC:26179],NA,ZNF672,79894,NM_024836
FECH_SIG,FECH,FECH_SIG,FECH,SIG,22,-0.735456968217374,0.222301042563523,0.224507007091159,0.215052873401288,-0.00945413368987132,0.522261576637209,-0.435493811817176,5.33385176877641,5.34476762845755,5.29798537268121,-0.0467822557763417,0.747229287461054,ENSG00000066926,FECH,protein_coding,18,-1,57544389,57586702,q21.31,ferrochelatase [Source:HGNC Symbol;Acc:HGNC:3647],Autosomal erythropoietic protoporphyria;PROTOPORPHYRIA ERYTHROPOIETIC 1,FECH,2235,NM_000140;NM_001012515
LIPA_SIG,LIPA,LIPA_SIG,LIPA,SIG,33,0.733157601614241,0.311179857937038,0.309747920279513,0.315884795954621,0.00613687567510865,0.523767706258943,1.14368477421838,6.76415270983272,6.73957523524512,6.84490726919199,0.105332033946874,0.36207201132577,ENSG00000107798,LIPA,protein_coding,10,-1,89213569,89414557,q23.31,lipase A, lysosomal acid type [Source:HGNC Symbol;Acc:HGNC:6617],Cholesteryl ester storage disease;Lysosomal acid lipase deficiency;WOLMAN DISEASE,LIPA,3988,NM_000235;NM_001127605;NM_001288979
LACTB2_SIG,LACTB2,LACTB2_SIG,LACTB2,SIG,40,0.732991643865719,0.133976290239972,0.130393175634544,0.145749381086379,0.0153562054518352,0.523767706258943,0.0338157671681959,2.6926250571662,2.69169650572623,2.69567601189753,0.00397950617129513,0.981750928740782,ENSG00000147592,LACTB2,protein_coding,8,-1,70635318,70669185,q13.3,lactamase beta 2 [Source:HGNC Symbol;Acc:HGNC:18512],NA,LACTB2,51110,NM_016027
TGM5_SIG,TGM5,TGM5_SIG,TGM5,SIG,45,-0.73295903553966,0.0172106799679129,0.0188233486434304,0.011911911462641,-0.00691143718078931,0.523767706258943,-1.17584278403943,1.15662747967805,1.19880563409582,1.01804211516251,-0.18076351893331,0.347805225878816,ENSG00000104055,TGM5,protein_coding,15,-1,43232595,43266857,q15.2,transglutaminase 5 [Source:HGNC Symbol;Acc:HGNC:11781],Acral peeling skin syndrome;PEELING SKIN SYNDROME 2,TGM5,9333,NM_004245;NM_201631
SMOX_SIG,SMOX,SMOX_SIG,SMOX,SIG,20,0.731609478461323,0.0170275718708076,0.0148242450097232,0.0242670744143705,0.00944282940464715,0.524626625875908,0.0699387297008623,4.39628100525804,4.39371999644209,4.40469574851044,0.010975752068349,0.961728752013953,ENSG00000088826,SMOX,protein_coding,20,1,4120980,4187747,p13,spermine oxidase [Source:HGNC Symbol;Acc:HGNC:15862],NA,SMOX,54498,NM_001270691;NM_175839;NM_175840;NM_175841;NM_175842
DNMT1_SIG,DNMT1,DNMT1_SIG,DNMT1,SIG,23,-0.730771686300475,0.608087875703858,0.611953359545875,0.595387000222944,-0.0165663593229316,0.52513302944182,-0.855536881942557,7.22714198938698,7.24083410163984,7.18215362055613,-0.0586804810837149,0.50525619907043,ENSG00000130816,DNMT1,protein_coding,19,-1,10133345,10231286,p13.2,DNA methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:2976],Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome;CEREBELLAR ATAXIA DEAFNESS AND NARCOLEPSY AUTOSOMAL DOMINANT;Hereditary sensory neuropathy-deafness-dementia syndrome;NEUROPATHY HEREDITARY SENSORY TYPE IE,DNMT1,1786,NM_001130823;NM_001318730;NM_001318731;NM_001379
TNFSF13_SIG,TNFSF13,TNFSF13_SIG,TNFSF13,SIG,47,0.72957297991304,0.467992757281919,0.465415217129352,0.476461817783208,0.0110466006538561,0.525888842870617,2.29976767825958,3.46227767284862,3.41079336436293,3.63144040073016,0.220647036367221,0.053959447477103,ENSG00000161955,TNFSF13,protein_coding,17,1,7558292,7561608,p13.1,TNF superfamily member 13 [Source:HGNC Symbol;Acc:HGNC:11928],NA,TNFSF13,8741,NM_001198622;NM_001198623;NM_001198624;NM_003808;NM_172087;NM_172088
TAF12_TF,TAF12,TAF12_TF,TAF12,TF,144,0.729102759011776,-0.016459856164272,-0.0182463217223655,-0.0105900407591077,0.00765628096325784,0.526141885848496,1.17188547598958,4.7283956367564,4.70966343334397,4.78994430511152,0.0802808717675544,0.349594979467734,ENSG00000120656,TAF12,protein_coding,1,-1,28589323,28643085,p35.3,TATA-box binding protein associated factor 12 [Source:HGNC Symbol;Acc:HGNC:11545],NA,TAF12,6883,NM_001135218;NM_005644
RPS20_SIG,RPS20,RPS20_SIG,RPS20,SIG,21,0.728576573232971,1.32019435242545,1.3171521289732,1.33019022948281,0.0130381005096049,0.52643363410818,0.733789517114751,9.70466288873397,9.69439725246991,9.73839283645874,0.0439955839888223,0.572565790240085,ENSG00000008988,RPS20,protein_coding,8,-1,56067295,56074581,q12.1,ribosomal protein S20 [Source:HGNC Symbol;Acc:HGNC:10405],Familial colorectal cancer Type X,RPS20,6224,NM_001023;NM_001146227
CPSF2_SIG,CPSF2,CPSF2_SIG,CPSF2,SIG,103,0.727670740025973,0.370437053907741,0.367492760269562,0.380111161576045,0.0126184013064834,0.526932236231963,0.826204880003077,5.61274685101462,5.59395773225086,5.67448252695269,0.0805247947018284,0.520971539274154,ENSG00000165934,CPSF2,protein_coding,14,1,92121937,92172145,q32.12,cleavage and polyadenylation specific factor 2 [Source:HGNC Symbol;Acc:HGNC:2325],NA,CPSF2,53981,NM_001322270;NM_001322271;NM_001322272;NM_017437
GMFB_SIG,GMFB,GMFB_SIG,GMFB,SIG,23,-0.72764728893533,0.533128659977171,0.534685917558893,0.528011956494369,-0.00667396106452424,0.526932236231963,1.79888710342127,5.83173140013367,5.80664339781376,5.91416340775625,0.107520009942492,0.138452995092789,ENSG00000197045,GMFB,protein_coding,14,-1,54474484,54489026,q22.2,glia maturation factor beta [Source:HGNC Symbol;Acc:HGNC:4373],NA,GMFB,2764,NM_004124
CRY1_TF,CRY1,CRY1_TF,CRY1,TF,139,-0.727073884129565,0.00501810647368813,0.00583640433865644,0.00232941348879226,-0.00350699084986415,0.527256786182314,-1.34163782215955,4.13393888302802,4.16930843001534,4.01772465721253,-0.151583772802817,0.278490615871018,ENSG00000008405,CRY1,protein_coding,12,-1,106991364,107093549,q23.3,cryptochrome circadian regulator 1 [Source:HGNC Symbol;Acc:HGNC:2384],DELAYED SLEEP PHASE DISORDER SUSCEPTIBILITY TO,CRY1,1407,NM_004075
BLM_SIG,BLM,BLM_SIG,BLM,SIG,52,0.726165292270451,0.268351247106613,0.265233350096749,0.278595765853307,0.0133624157565575,0.52781323107102,1.52438103816706,4.48923867356424,4.45529480323577,4.6007685332149,0.145473729979124,0.213935985107049,ENSG00000197299,BLM,protein_coding,15,1,90717346,90816166,q26.1,BLM RecQ like helicase [Source:HGNC Symbol;Acc:HGNC:1058],Bloom syndrome,BLM,641,NM_000057;NM_001287246;NM_001287247;NM_001287248
ENOX2_SIG,ENOX2,ENOX2_SIG,ENOX2,SIG,30,0.725562832565746,0.37579836108658,0.373315856752766,0.383955161040543,0.0106393042877766,0.528158102438443,0.206248948198828,3.845327057755,3.84115861044325,3.85902338463646,0.017864774193212,0.883361995210387,ENSG00000165675,ENOX2,protein_coding,X,-1,130623369,130903317,q26.1,ecto-NOX disulfide-thiol exchanger 2 [Source:HGNC Symbol;Acc:HGNC:2259],NA,ENOX2,10495,NM_001281736;NM_006375;NM_182314
TRNAU1AP_SIG,TRNAU1AP,TRNAU1AP_SIG,TRNAU1AP,SIG,8,0.72513766972379,0.409356308235402,0.408252207798353,0.412984066814279,0.00473185901592588,0.52838036124231,0.740424675806857,4.11344492619473,4.10607670695959,4.13765478939591,0.0315780824363188,0.568747296098417,ENSG00000180098,TRNAU1AP,protein_coding,1,1,28553085,28578545,p35.3,tRNA selenocysteine 1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:30813],NA,TRNAU1AP,54952,NM_017846
ZNF487_TF,ZNF487,ZNF487_TF,ZNF487,TF,87,-0.724250746239807,0.0956369738558887,0.0966043862542965,0.0924583331182628,-0.00414605313603365,0.528922306197072,1.4195113775331,2.81810124806878,2.79823779281021,2.88336688677553,0.0851290939653247,0.249272012327884,ENSG00000243660,ZNF487,protein_coding,10,1,43436841,43483181,q11.21,zinc finger protein 487 [Source:HGNC Symbol;Acc:HGNC:23488],NA,ZNF487,642819,NM_001355444;NM_001355445;NM_001355446;NM_001355447;NM_001355448;NM_001355449;NM_001355450
ERI2_SIG,ERI2,ERI2_SIG,ERI2,SIG,46,0.722352325424993,0.28911481502246,0.285937166355568,0.299555660642247,0.0136184942866788,0.530165439520403,0.141388168945027,3.65019500799226,3.6463236264815,3.66291526152761,0.0165916350461118,0.920745120675269,ENSG00000196678,ERI2,protein_coding,16,-1,20780193,20900349,p12.3,ERI1 exoribonuclease family member 2 [Source:HGNC Symbol;Acc:HGNC:30541],NA,ERI2,112479,NM_001142725;NM_080663
FAM13A_SIG,FAM13A,FAM13A_SIG,FAM13A,SIG,39,-0.720337053032811,0.0740752346702098,0.0751862056005012,0.0704249016135378,-0.00476130398696329,0.531440549339059,0.237547972319305,4.01965969393949,4.01371493376098,4.03919247738315,0.0254775436221612,0.865317013601681,ENSG00000138640,FAM13A,protein_coding,4,-1,88725955,89111398,q22.1,family with sequence similarity 13 member A [Source:HGNC Symbol;Acc:HGNC:19367],Idiopathic pulmonary fibrosis,FAM13A,10144,NM_001015045;NM_001265578;NM_001265579;NM_001265580;NM_014883
C19orf66_SIG,C19orf66,C19orf66_SIG,C19orf66,SIG,61,0.720305738907389,0.146254222041997,0.145002675202832,0.150366447370682,0.0053637721678505,0.531440549339059,-0.225708072654863,5.72659174873704,5.73019938832421,5.71473807580776,-0.0154613125164449,0.872307006536242,ENSG00000130813,C19orf66,protein_coding,19,1,10086122,10093252,p13.2,chromosome 19 open reading frame 66 [Source:HGNC Symbol;Acc:HGNC:25649],NA,C19orf66,55337,NM_001308277;NM_018381
SGK3_SIG,SGK3,SGK3_SIG,SGK3,SIG,12,0.720150149294543,0.229711968017947,0.228509507299469,0.23366291037866,0.00515340307919173,0.531476214958653,0.771487566077882,4.15658284049056,4.14543291789739,4.19321830043954,0.0477853825421581,0.551294980722574,ENSG00000104205,SGK3,protein_coding,8,1,66667596,66862022,q13.1,serum/glucocorticoid regulated kinase family member 3 [Source:HGNC Symbol;Acc:HGNC:10812],NA,SGK3,23678;100533105,NM_001033578;NM_001204173;NM_013257;NM_170709
ADIPOR2_SIG,ADIPOR2,ADIPOR2_SIG,ADIPOR2,SIG,15,-0.719162110148237,0.200107301996234,0.200996451502736,0.197185810760585,-0.0038106407421506,0.532089800445694,-1.42338285655281,6.43820807926711,6.45939122654086,6.36860630965338,-0.0907849168874781,0.247853981844694,ENSG00000006831,ADIPOR2,protein_coding,12,1,1688574,1788674,p13.33,adiponectin receptor 2 [Source:HGNC Symbol;Acc:HGNC:24041],NA,ADIPOR2,79602,NM_024551
RPL23_SIG,RPL23,RPL23_SIG,RPL23,SIG,27,0.718042087404864,1.17689662909935,1.17358316890771,1.18778371258619,0.0142005436784846,0.532795418814131,0.827168903549665,8.61659731575999,8.60513349525966,8.65426415454679,0.049130659287126,0.520536337077813,ENSG00000125691,RPL23,protein_coding,17,-1,38847860,38853764,q12,ribosomal protein L23 [Source:HGNC Symbol;Acc:HGNC:10316],NA,RPL23,9349,NM_000978
SYF2_SIG,SYF2,SYF2_SIG,SYF2,SIG,30,-0.716749542832911,0.0297356688141342,0.0315286163884603,0.0238445553556342,-0.00768406103282594,0.533621445664889,-0.360112966363855,6.44077409698434,6.445430480772,6.42547455025346,-0.0199559305185444,0.791871397349932,ENSG00000117614,SYF2,protein_coding,1,-1,25222276,25232502,p36.11,SYF2 pre-mRNA splicing factor [Source:HGNC Symbol;Acc:HGNC:19824],NA,SYF2,25949,NM_015484;NM_207170
RAET1E_SIG,RAET1E,RAET1E_SIG,RAET1E,SIG,7,0.715657268399344,0.013836237983857,0.0128614356526077,0.0170391599293905,0.0041777242767829,0.534308700640282,1.28517972510414,0.338715891804242,0.319799732059715,0.400868988107689,0.0810692560479741,0.300993851482348,ENSG00000164520,RAET1E,protein_coding,6,-1,149883375,149898102,q25.1,retinoic acid early transcript 1E [Source:HGNC Symbol;Acc:HGNC:16793],NA,RAET1E,135250,NM_001243325;NM_001243327;NM_001243328;NM_139165
CHAF1A_SIG,CHAF1A,CHAF1A_SIG,CHAF1A,SIG,29,-0.714972052290567,0.544090283301685,0.54897611145271,0.528036847948316,-0.0209392635043945,0.534712945512651,0.334433895083395,5.4849507093825,5.47907359354499,5.50426123284861,0.0251876393036187,0.807304210657452,ENSG00000167670,CHAF1A,protein_coding,19,1,4402640,4445018,p13.3,chromatin assembly factor 1 subunit A [Source:HGNC Symbol;Acc:HGNC:1910],NA,CHAF1A,10036,NM_005483
ABT1_SIG,ABT1,ABT1_SIG,ABT1,SIG,35,0.713730240308694,0.262559597985607,0.261539837281435,0.265910240299314,0.00437040301787869,0.53544928896341,0.617874669351486,4.83261318173243,4.82585716361512,4.85481152697505,0.0289543633599338,0.639681495913501,ENSG00000146109,ABT1,protein_coding,6,1,26596953,26600739,p22.2,activator of basal transcription 1 [Source:HGNC Symbol;Acc:HGNC:17369],NA,ABT1,29777,NM_013375
SLCO4A1_SIG,SLCO4A1,SLCO4A1_SIG,SLCO4A1,SIG,14,-0.71370571858584,0.14745334322172,0.148319554472996,0.144607220538954,-0.00371233393404215,0.53544928896341,-1.00077610122139,3.28855751404834,3.31744167001324,3.19365243016368,-0.123789239849555,0.430035039658392,ENSG00000101187,SLCO4A1,protein_coding,20,1,62642503,62685785,q13.33,solute carrier organic anion transporter family member 4A1 [Source:HGNC Symbol;Acc:HGNC:10953],NA,SLCO4A1,28231,NM_016354
MIER3_TF,MIER3,MIER3_TF,MIER3,TF,91,0.713588263479996,0.514201375594927,0.512412098098144,0.520080430227213,0.00766833212906865,0.535458319159279,0.688789952940923,4.98329245771153,4.97085972824603,5.02414285452674,0.0532831262807169,0.598737040483724,ENSG00000155545,MIER3,protein_coding,5,-1,56919602,56971675,q11.2,MIER family member 3 [Source:HGNC Symbol;Acc:HGNC:26678],NA,MIER3,166968,NM_001297598;NM_001297599;NM_152622
TRAF1_SIG,TRAF1,TRAF1_SIG,TRAF1,SIG,22,-0.71147423167118,-0.0163905180288927,-0.0147388520072118,-0.0218174206715584,-0.0070785686643466,0.536859007216397,-1.29986330885825,4.43005693094005,4.46207117112548,4.32486728461649,-0.137203886508986,0.295078089128357,ENSG00000056558,TRAF1,protein_coding,9,-1,120902393,120929173,q33.2,TNF receptor associated factor 1 [Source:HGNC Symbol;Acc:HGNC:12031],NA,TRAF1,7185,NM_001190945;NM_001190947;NM_005658
MALAT1_SIG,MALAT1,MALAT1_SIG,MALAT1,SIG,43,0.710161615969546,0.112105378308799,0.110957490778546,0.115877008765347,0.00491951798680052,0.53765088369889,0.5129854165656,11.0756622039616,11.0640318117414,11.1138763498282,0.0498445380867948,0.702068765749059,ENSG00000251562,MALAT1,lincRNA,11,1,65497688,65506516,q13.1,metastasis associated lung adenocarcinoma transcript 1 [Source:HGNC Symbol;Acc:HGNC:29665],NA,MALAT1,NA,NA
TRIM35_SIG,TRIM35,TRIM35_SIG,TRIM35,SIG,10,0.710130076732532,0.0645664780111499,0.0625053473070437,0.0713387646103562,0.00883341730331246,0.53765088369889,0.430076002407504,4.65663474676104,4.64937355063421,4.68049296260636,0.0311194119721591,0.750516468331831,ENSG00000104228,TRIM35,protein_coding,8,-1,27284886,27311272,p21.2,tripartite motif containing 35 [Source:HGNC Symbol;Acc:HGNC:16285],NA,TRIM35,23087,NM_001304495;NM_001362813;NM_171982
CWC15_SIG,CWC15,CWC15_SIG,CWC15,SIG,24,0.709398775680506,0.323649483057393,0.322483413930021,0.327480853047331,0.00499743911730925,0.538031109191778,0.552017832767931,5.37965050942387,5.37454022298053,5.39644145059484,0.0219012276143129,0.679383966068109,ENSG00000150316,CWC15,protein_coding,11,-1,94962620,94973586,q21,CWC15 spliceosome associated protein homolog [Source:HGNC Symbol;Acc:HGNC:26939],NA,CWC15,51503,NM_016403
RNF139_SIG,RNF139,RNF139_SIG,RNF139,SIG,36,-0.70937607326499,0.501985912876739,0.504136367315294,0.494920134007202,-0.00921623330809227,0.538031109191778,-0.775836135295053,6.62601139788613,6.64076425492765,6.57753772474971,-0.06322653017794,0.548676650565482,ENSG00000170881,RNF139,protein_coding,8,1,124474738,124487914,q24.13,ring finger protein 139 [Source:HGNC Symbol;Acc:HGNC:17023],Hereditary clear cell renal cell carcinoma;RENAL CELL CARCINOMA NONPAPILLARY,RNF139,11236,NM_007218
MPHOSPH6_SIG,MPHOSPH6,MPHOSPH6_SIG,MPHOSPH6,SIG,11,0.708101141238355,0.221694416082992,0.219576563292373,0.228653075252169,0.00907651195979504,0.538848445777262,1.45090526179118,3.57690648765765,3.54986970794635,3.66574162099479,0.115871913048431,0.238314910488686,ENSG00000135698,MPHOSPH6,protein_coding,16,-1,82147798,82170224,q23.3,M-phase phosphoprotein 6 [Source:HGNC Symbol;Acc:HGNC:7214],NA,MPHOSPH6,10200,NM_005792
CA3_SIG,CA3,CA3_SIG,CA3,SIG,47,0.707771122233295,-0.0462069615243432,-0.047886963872793,-0.0406869538080082,0.0072000100647846,0.539005856504045,-0.0572459571289259,0.739658695921958,0.740681480747173,0.736298117210536,-0.00438336353663766,0.968255998548188,ENSG00000164879,CA3,protein_coding,8,1,85373436,85449040,q21.2,carbonic anhydrase 3 [Source:HGNC Symbol;Acc:HGNC:1374],NA,CA3,761,NM_005181
CLTC_SIG,CLTC,CLTC_SIG,CLTC,SIG,26,-0.706628518148515,0.404654370647373,0.405592828453965,0.401570866425711,-0.00402196202825397,0.539731316018125,-0.756816990193088,8.07143004895304,8.0805520872322,8.04145763746436,-0.0390944497678412,0.559599333615867,ENSG00000141367,CLTC,protein_coding,17,1,59619689,59696956,q23.1,clathrin heavy chain [Source:HGNC Symbol;Acc:HGNC:2092],Autosomal dominant non-syndromic intellectual disability;Epilepsy and intellectual disability;Inflammatory myofibroblastic tumor;MENTAL RETARDATION AUTOSOMAL DOMINANT 56;MiT family translocation renal cell carcinoma;Overgrowth intellectual disability;Undetermined early-onset epileptic encephalopathy,CLTC,1213,NM_001288653;NM_004859
F2R_SIG,F2R,F2R_SIG,F2R,SIG,34,0.706077232255828,0.039648818371433,0.0376556198179194,0.0461978993329778,0.00854227951505848,0.54004355257106,1.11385768484333,4.12065643181142,4.07760721327907,4.262103864132,0.184496650852937,0.375834223199468,ENSG00000181104,F2R,protein_coding,5,1,76716126,76735770,q13.3,coagulation factor II thrombin receptor [Source:HGNC Symbol;Acc:HGNC:3537],NA,F2R,2149,NM_001311313;NM_001992
ZNF706_TF,ZNF706,ZNF706_TF,ZNF706,TF,59,0.705434190158206,0.229143475679817,0.228083716229807,0.232625542444134,0.00454182621432675,0.54042004964819,0.977357777150393,6.19753534139793,6.18456185138099,6.24016252288215,0.055600671501165,0.442129467332408,ENSG00000120963,ZNF706,protein_coding,8,-1,101177878,101206193,q22.3,zinc finger protein 706 [Source:HGNC Symbol;Acc:HGNC:24992],NA,ZNF706,51123,NM_001042510;NM_001267708;NM_001267709;NM_016096
CREBL2_SIG,CREBL2,CREBL2_SIG,CREBL2,SIG,55,-0.705209418313974,0.316502410756532,0.319305337182621,0.307292795356523,-0.0120125418260989,0.540503955651509,0.804002899239113,4.6328268346797,4.61421275730913,4.69398737461154,0.0797746173024042,0.532857390935521,ENSG00000111269,CREBL2,protein_coding,12,1,12611827,12645108,p13.1,cAMP responsive element binding protein like 2 [Source:HGNC Symbol;Acc:HGNC:2350],NA,CREBL2,1389,NM_001310
PRDM4_TF,PRDM4,PRDM4_TF,PRDM4,TF,49,-0.704745214983806,0.225438934117673,0.226068466869963,0.22337046936015,-0.00269799750981278,0.540755404004088,-0.554055679665134,5.60922396082644,5.61555853431007,5.58841036223738,-0.0271481720726953,0.678299092458497,ENSG00000110851,PRDM4,protein_coding,12,-1,107732871,107761272,q23.3,PR/SET domain 4 [Source:HGNC Symbol;Acc:HGNC:9348],NA,PRDM4,11108,NM_012406
DUSP5_SIG,DUSP5,DUSP5_SIG,DUSP5,SIG,36,-0.704018077171809,0.404692931457993,0.407952460524409,0.393983050239767,-0.0139694102846426,0.541190944377772,1.06113669681744,4.59242692979207,4.54904818840546,4.73495708006236,0.1859088916569,0.400716923629537,ENSG00000138166,DUSP5,protein_coding,10,1,110497907,110511533,q25.2,dual specificity phosphatase 5 [Source:HGNC Symbol;Acc:HGNC:3071],NA,DUSP5,1847,NM_004419
IL13_SIG,IL13,IL13_SIG,IL13,SIG,21,-0.702245541254819,0.0444591171891151,0.0459339591628459,0.0396132078468567,-0.00632075131598927,0.54235901726533,-1.34746666076414,0.363648529472143,0.379891544919761,0.310278621572827,-0.0696129233469344,0.276321925734133,ENSG00000169194,IL13,protein_coding,5,1,132656263,132661110,q31.1,interleukin 13 [Source:HGNC Symbol;Acc:HGNC:5973],Allergic rhinitis;ASTHMA SUSCEPTIBILITY TO,IL13,3596,NM_001354991;NM_001354992;NM_001354993;NM_002188
FHIT_SIG,FHIT,FHIT_SIG,FHIT,SIG,24,-0.701390875623382,-0.0342589393660692,-0.0334031131028744,-0.0370709399451376,-0.0036678268422633,0.542825636291802,-1.12958325424855,2.64095534851576,2.66382620316163,2.56580825467934,-0.0980179484822902,0.368371235758731,ENSG00000189283,FHIT,protein_coding,3,-1,59747277,61251459,p14.2,fragile histidine triad [Source:HGNC Symbol;Acc:HGNC:3701],Hereditary clear cell renal cell carcinoma,FHIT,2272,NM_001166243;NM_001320899;NM_001320900;NM_001354589;NM_001354590;NM_002012
PODXL_SIG,PODXL,PODXL_SIG,PODXL,SIG,39,-0.701369856005416,-0.152754244350268,-0.151708754030379,-0.156189426829905,-0.0044806727995267,0.542825636291802,1.004766417441,1.7685451026161,1.74220108051451,1.85510403237848,0.112902951863965,0.428206443766773,ENSG00000128567,PODXL,protein_coding,7,-1,131500262,131558217,q32.3,podocalyxin like [Source:HGNC Symbol;Acc:HGNC:9171],Atypical juvenile parkinsonism;Young-onset Parkinson disease,PODXL,5420,NM_001018111;NM_005397
TMF1_TF,TMF1,TMF1_TF,TMF1,TF,102,0.700540017656534,0.367283650815276,0.366336067962238,0.370397137332399,0.00406106937016111,0.543333898617122,1.64053867433139,6.43256408440309,6.41287495798071,6.49725692836232,0.0843819703816102,0.179251464882552,ENSG00000144747,TMF1,protein_coding,3,-1,69019827,69052339,p14.1,TATA element modulatory factor 1 [Source:HGNC Symbol;Acc:HGNC:11870],NA,TMF1,7110,NM_001363879;NM_007114
COL5A1_SIG,COL5A1,COL5A1_SIG,COL5A1,SIG,45,-0.699362835071838,-0.0924285417313068,-0.0913991129527684,-0.0958109505750757,-0.00441183762230742,0.544086125306118,-0.964083047488135,2.27255045293617,2.32054724145074,2.11484671924543,-0.205700522205312,0.448800856323795,ENSG00000130635,COL5A1,protein_coding,9,1,134641774,134844843,q34.3,collagen type V alpha 1 chain [Source:HGNC Symbol;Acc:HGNC:2209],EHLERS-DANLOS SYNDROME CLASSIC TYPE 1;Ehlers-Danlos syndrome type 1;Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome vascular type,COL5A1,1289,NM_000093;NM_001278074
FH_SIG,FH,FH_SIG,FH,SIG,37,0.698158707173375,0.452766828150096,0.450775566772177,0.459309544106116,0.0085339773339392,0.544857753676098,1.57437285811937,5.13063822846102,5.10461145941316,5.21615475533257,0.111543295919412,0.198315818653118,ENSG00000091483,FH,protein_coding,1,-1,241497603,241519761,q43,fumarate hydratase [Source:HGNC Symbol;Acc:HGNC:3700],FUMARASE DEFICIENCY;Fumaric aciduria;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER;Hereditary pheochromocytoma-paraganglioma,FH,2271,NM_000143
PPP1R11_SIG,PPP1R11,PPP1R11_SIG,PPP1R11,SIG,67,-0.696092620783665,0.269694960049441,0.272375917379726,0.260886100249932,-0.0114898171297943,0.546235909683959,-1.84395702924061,5.92143464628817,5.94654820139514,5.83891867950812,-0.107629521887027,0.128084865520728,ENSG00000204619,PPP1R11,protein_coding,6,1,30066709,30070333,p22.1,protein phosphatase 1 regulatory inhibitor subunit 11 [Source:HGNC Symbol;Acc:HGNC:9285],NA,PPP1R11,6992,NM_021959
POLR2L_SIG,POLR2L,POLR2L_SIG,POLR2L,SIG,28,0.695690842137631,0.15431759353516,0.153029848206216,0.158548756758834,0.00551890855261763,0.546419798160902,1.1334698956908,5.11530683957901,5.09865110997821,5.17003280826736,0.0713816982891533,0.366609784838688,ENSG00000177700,POLR2L,protein_coding,11,-1,837356,842529,p15.5,RNA polymerase II subunit L [Source:HGNC Symbol;Acc:HGNC:9199],NA,POLR2L,5441,NM_021128
TRAK1_SIG,TRAK1,TRAK1_SIG,TRAK1,SIG,45,0.695620589566695,0.305385136112014,0.304444455194397,0.308475944841325,0.00403148964692729,0.546419798160902,-0.881112928651727,6.68867573636105,6.69735687792295,6.6601519855148,-0.037204892408143,0.4918155468002,ENSG00000182606,TRAK1,protein_coding,3,1,42013802,42225890,p22.1,trafficking kinesin protein 1 [Source:HGNC Symbol;Acc:HGNC:29947],EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 68;Undetermined early-onset epileptic encephalopathy,TRAK1,22906,NM_001042646;NM_001265608;NM_001265609;NM_001265610;NM_001349245;NM_001349246;NM_001349247;NM_001349248;NM_001349249;NM_014965
TRIM38_SIG,TRIM38,TRIM38_SIG,TRIM38,SIG,52,-0.695401957936558,0.256814078948533,0.257863462542762,0.253366104281779,-0.00449735826098288,0.54649951892274,1.8004926441147,6.26494884828596,6.23825253917137,6.3526652925196,0.114412753348232,0.138059965996494,ENSG00000112343,TRIM38,protein_coding,6,1,25962802,25991231,p22.2,tripartite motif containing 38 [Source:HGNC Symbol;Acc:HGNC:10059],NA,TRIM38,10475,NM_006355
EIF4G3_SIG,EIF4G3,EIF4G3_SIG,EIF4G3,SIG,5,0.694378449002869,0.429961782908128,0.428130525664297,0.435978770995003,0.0078482453307057,0.547145514156773,-0.36217347612963,7.0513467633347,7.05660963806378,7.03405446065345,-0.022555177410336,0.79073128928605,ENSG00000075151,EIF4G3,protein_coding,1,-1,20806292,21176888,p36.12,eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298],NA,EIF4G3,8672,NM_001198801;NM_001198802;NM_001198803;NM_003760
ATF5_TF,ATF5,ATF5_TF,ATF5,TF,47,0.693787341912334,-0.0102532519589207,-0.0108980892452456,-0.00813450087528174,0.00276358836996378,0.547487414877105,0.936357522512178,4.38884629183474,4.37199209604011,4.44422436373139,0.0722322676912787,0.462663148072769,ENSG00000169136,ATF5,protein_coding,19,1,49928702,49933935,q13.33,activating transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:790],NA,ATF5,22809,NM_001193646;NM_001290746;NM_012068
ADARB2_SIG,ADARB2,ADARB2_SIG,ADARB2,SIG,21,-0.693255338568091,0.00839328774093038,0.0093859088989794,0.00513181822162648,-0.00425409067735308,0.54778777744164,-1.54861659385183,1.14766288655191,1.19311581385052,0.998317553999335,-0.194798259851181,0.206268108116522,ENSG00000185736,ADARB2,protein_coding,10,-1,1177313,1737525,p15.3,adenosine deaminase, RNA specific B2 (inactive) [Source:HGNC Symbol;Acc:HGNC:227],NA,ADARB2,105,NM_018702
CTDSPL_SIG,CTDSPL,CTDSPL_SIG,CTDSPL,SIG,90,-0.693035467717741,-0.0397849498663487,-0.0384874909154669,-0.0440480292763889,-0.00556053836092205,0.547868394899053,-0.53415287250636,3.3519582192785,3.37078988704418,3.290082739477,-0.0807071475671816,0.689732477340354,ENSG00000144677,CTDSPL,protein_coding,3,1,37861880,37984469,p22.2,CTD small phosphatase like [Source:HGNC Symbol;Acc:HGNC:16890],NA,CTDSPL,10217,NM_001008392;NM_005808
ABAT_SIG,ABAT,ABAT_SIG,ABAT,SIG,63,-0.692735440226871,0.172335005930796,0.173851930309604,0.167350825828999,-0.00650110448060521,0.548005456369873,-0.594199786033498,3.727912148945,3.74070447984694,3.68588020455289,-0.0548242752940493,0.654865166911852,ENSG00000183044,ABAT,protein_coding,16,1,8674596,8784575,p13.2,4-aminobutyrate aminotransferase [Source:HGNC Symbol;Acc:HGNC:23],GABA-TRANSAMINASE DEFICIENCY;Gamma-aminobutyric acid transaminase deficiency,ABAT,18,NM_000663;NM_001127448;NM_020686
ANAPC11_SIG,ANAPC11,ANAPC11_SIG,ANAPC11,SIG,52,-0.6913328413947,0.271830534882854,0.272975735993621,0.26806773123319,-0.00490800476043148,0.548919273775506,-0.760483840308723,4.19863391183494,4.20903299720239,4.16446548848474,-0.0445675087176499,0.557514498275253,ENSG00000141552,ANAPC11,protein_coding,17,1,81890790,81900991,q25.3,anaphase promoting complex subunit 11 [Source:HGNC Symbol;Acc:HGNC:14452],NA,ANAPC11,51529,NM_001002244;NM_001002245;NM_001002246;NM_001002247;NM_001002248;NM_001002249;NM_001289414;NM_001289415;NM_001289416;NM_001289417;NM_001289418;NM_001289419;NM_001289420;NM_016476
TPI1_SIG,TPI1,TPI1_SIG,TPI1,SIG,34,-0.690526511890938,0.286974779005663,0.288089041745033,0.283313630004878,-0.00477541174015539,0.549413313090219,0.795867512292193,7.56896228251374,7.55781939146434,7.6055746388189,0.0477552473545514,0.537567798248729,ENSG00000111669,TPI1,protein_coding,12,1,6867119,6870948,p13.31,triosephosphate isomerase 1 [Source:HGNC Symbol;Acc:HGNC:12009],TRIOSEPHOSPHATE ISOMERASE DEFICIENCY,TPI1,7167,NM_000365;NM_001159287;NM_001258026
NACC1_SIG,NACC1,NACC1_SIG,NACC1,SIG,26,-0.690282185414798,0.191986170141211,0.192746545401846,0.189487794284838,-0.00325875111700872,0.549511202207482,0.0343722369909762,5.94039280877416,5.94000861660191,5.941655154483,0.00164653788108711,0.981402908635362,ENSG00000160877,NACC1,protein_coding,19,1,13116862,13141147,p13.13,nucleus accumbens associated 1 [Source:HGNC Symbol;Acc:HGNC:20967],Infantile Epilepsy Cataracts and Profound Developmental Delay;NEURODEVELOPMENTAL DISORDER WITH EPILEPSY CATARACTS FEEDINGDIFFICULTIES AND DELAYED BRAIN MYELINATION;Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,NACC1,112939,NM_052876
PABPN1L_SIG,PABPN1L,PABPN1L_SIG,PABPN1L,SIG,20,-0.688283579253001,-0.0728299453637649,-0.0709045030800789,-0.0791563985815903,-0.0082518955015116,0.550837753188404,-1.18517952074904,0.646992175471045,0.663310362916559,0.593375273864355,-0.0699350890522046,0.34340166864307,ENSG00000205022,PABPN1L,protein_coding,16,-1,88863333,88866660,q24.3,poly(A) binding protein nuclear 1 like, cytoplasmic [Source:HGNC Symbol;Acc:HGNC:37237],NA,PABPN1L,390748,NM_001080487;NM_001294328
SDC4_SIG,SDC4,SDC4_SIG,SDC4,SIG,39,-0.688190780603635,-0.0256679408742469,-0.0244398236655934,-0.0297031831312515,-0.00526335946565812,0.550837753188404,-0.595344230628409,3.30700144722051,3.33208094152864,3.22459739449381,-0.107483547034832,0.654127901278892,ENSG00000124145,SDC4,protein_coding,20,-1,45325288,45348424,q13.12,syndecan 4 [Source:HGNC Symbol;Acc:HGNC:10661],NA,SDC4,6385,NM_002999
TAF5L_TF,TAF5L,TAF5L_TF,TAF5L,TF,89,0.68752303817592,0.240295730596375,0.239586950709197,0.242624578797106,0.00303762808790937,0.551234631706763,-0.541188126869523,5.39353325719613,5.39904648240557,5.3754183743651,-0.0236281080404694,0.685689257380986,ENSG00000135801,TAF5L,protein_coding,1,-1,229593111,229626047,q42.13,TATA-box binding protein associated factor 5 like [Source:HGNC Symbol;Acc:HGNC:17304],NA,TAF5L,27097,NM_001025247;NM_014409
IDH3G_SIG,IDH3G,IDH3G_SIG,IDH3G,SIG,14,0.684076936670534,0.0940252915005002,0.0932603487334646,0.0965386748779027,0.00327832614443816,0.553596016401599,2.84229822759519,5.94996922849495,5.92903667884256,6.01874760592423,0.0897109270816649,0.0159996787669691,ENSG00000067829,IDH3G,protein_coding,X,-1,153785766,153794523,q28,isocitrate dehydrogenase 3 (NAD(+)) gamma [Source:HGNC Symbol;Acc:HGNC:5386],NA,IDH3G,3421,NM_004135;NM_174869
SCAF8_SIG,SCAF8,SCAF8_SIG,SCAF8,SIG,83,0.68310706448887,0.587039238775513,0.585744487259081,0.591293422329504,0.00554893507042219,0.554207656388861,1.77340187869346,6.64847548572022,6.62809218074934,6.71544920205313,0.0873570213037871,0.144608227650134,ENSG00000213079,SCAF8,protein_coding,6,1,154733325,154834244,q25.2,SR-related CTD associated factor 8 [Source:HGNC Symbol;Acc:HGNC:20959],NA,SCAF8,22828,NM_001286188;NM_001286189;NM_001286194;NM_001286199;NM_014892
TSNAX_SIG,TSNAX,TSNAX_SIG,TSNAX,SIG,13,-0.682934036714305,0.503871013407085,0.505427299516364,0.498757501905168,-0.00666979761119602,0.554255211141725,-1.86545015481006,5.09826400706926,5.12363724619458,5.01489479280035,-0.108742453394227,0.123549587670236,ENSG00000116918,TSNAX,protein_coding,1,1,231528655,231566524,q42.2,translin associated factor X [Source:HGNC Symbol;Acc:HGNC:12380],NA,TSNAX,7257,NM_005999
MSRB2_SIG,MSRB2,MSRB2_SIG,MSRB2,SIG,26,-0.682825442615386,0.215849479920756,0.217522883923176,0.210351152484231,-0.0071717314389452,0.554257145770373,-0.904296385690045,3.37498600383939,3.39194245540134,3.31927194870727,-0.0726705066940715,0.479512249352571,ENSG00000148450,MSRB2,protein_coding,10,1,23095579,23122013,p12.2,methionine sulfoxide reductase B2 [Source:HGNC Symbol;Acc:HGNC:17061],NA,MSRB2,22921,NM_012228
DLST_SIG,DLST,DLST_SIG,DLST,SIG,30,0.680782221672462,0.497014757849012,0.495426927654455,0.502231914202554,0.00680498654809838,0.555568633067613,1.22965149879904,6.50887461494004,6.49471811826551,6.55538881829922,0.0606707000337145,0.323894402199908,ENSG00000119689,DLST,protein_coding,14,1,74881891,74903743,q24.3,dihydrolipoamide S-succinyltransferase [Source:HGNC Symbol;Acc:HGNC:2911],NA,DLST,1743,NM_001244883;NM_001933
MANBA_SIG,MANBA,MANBA_SIG,MANBA,SIG,30,0.680762363512344,0.244923076314337,0.243531206126893,0.249496364073084,0.00596515794619142,0.555568633067613,0.523225363396955,6.74120050753542,6.73370055881314,6.76584319619435,0.0321426373812138,0.69634935649475,ENSG00000109323,MANBA,protein_coding,4,-1,102630770,102760994,q24,mannosidase beta [Source:HGNC Symbol;Acc:HGNC:6831],BETA-MANNOSIDOSIS;LYSOSOMAL BETA-MANNOSIDOSIS;MANNOSIDOSIS BETA A LYSOSOMAL,MANBA,4126,NM_005908
SUZ12_SIG,SUZ12,SUZ12_SIG,SUZ12,SIG,17,0.679958007946671,0.0865777446425596,0.0852416184895421,0.0909678734310456,0.00572625494150356,0.556058155257973,0.151585513990586,6.68862399600598,6.6869910787857,6.69398929544406,0.00699821665836002,0.91513841853344,ENSG00000178691,SUZ12,protein_coding,17,1,31937007,32001038,q11.2,SUZ12, polycomb repressive complex 2 subunit [Source:HGNC Symbol;Acc:HGNC:17101],Endometrial stromal sarcoma;Weaver syndrome,SUZ12,23512,NM_001321207;NM_015355
IL5RA_SIG,IL5RA,IL5RA_SIG,IL5RA,SIG,12,0.67985993043801,-0.124744707233561,-0.126904973775398,-0.117646688596095,0.00925828517930266,0.556058155257973,0.405340907286707,1.59886957789449,1.58410276267939,1.64738911360126,0.0632863509218716,0.76532144834079,ENSG00000091181,IL5RA,protein_coding,3,-1,3066326,3126613,p26.2,interleukin 5 receptor subunit alpha [Source:HGNC Symbol;Acc:HGNC:6017],NA,IL5RA,3568,NM_000564;NM_001243099;NM_175724;NM_175725;NM_175726;NM_175727;NM_175728
VEGFC_SIG,VEGFC,VEGFC_SIG,VEGFC,SIG,15,-0.679223167139614,-0.147744276482883,-0.145394005824064,-0.155466594361859,-0.0100725885377944,0.556434561731375,-0.136530012526616,0.424919718286142,0.427272620216446,0.417188754800859,-0.010083865415587,0.923176015956119,ENSG00000150630,VEGFC,protein_coding,4,-1,176683538,176792922,q34.3,vascular endothelial growth factor C [Source:HGNC Symbol;Acc:HGNC:12682],LYMPHATIC MALFORMATION 4;Milroy Disease,VEGFC,7424,NM_005429
ARAF_SIG,ARAF,ARAF_SIG,ARAF,SIG,12,-0.678030906870145,0.343760691989924,0.34458859558388,0.341040437324065,-0.00354815825981551,0.55720525928141,0.944652157701315,6.4915440990704,6.48488384406038,6.51342779410331,0.0285439500429262,0.458410321364742,ENSG00000078061,ARAF,protein_coding,X,1,47561100,47571920,p11.3,A-Raf proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:646],NA,ARAF,369,NM_001256196;NM_001256197;NM_001654
RPL30_SIG,RPL30,RPL30_SIG,RPL30,SIG,29,0.677824963592948,1.44839307700028,1.44528717011155,1.45859819963469,0.0133110295231372,0.557276143195207,0.461333835482439,9.81271230923169,9.80616540612754,9.83422356228819,0.0280581561606591,0.732692706262394,ENSG00000156482,RPL30,protein_coding,8,-1,98024851,98046469,q22.2,ribosomal protein L30 [Source:HGNC Symbol;Acc:HGNC:10333],NA,RPL30,6156,NM_000989
SBDS_SIG,SBDS,SBDS_SIG,SBDS,SIG,70,-0.677525772723957,0.406590775577122,0.409360366783573,0.397490690184499,-0.011869676599074,0.55741321482883,-0.332869936764504,6.5224019503765,6.53052284460693,6.49571901219077,-0.0348038324161567,0.808285539122282,ENSG00000126524,SBDS,protein_coding,7,-1,66987680,66995587,q11.21,SBDS, ribosome maturation factor [Source:HGNC Symbol;Acc:HGNC:19440],APLASTIC ANEMIA APLASTIC ANEMIA SUSCEPTIBILITY TO INCLUDED;Idiopathic aplastic anemia;SHWACHMAN-DIAMOND SYNDROME;SHWACHMAN-DIAMOND SYNDROME 1,SBDS,51119,NM_016038
RIN3_SIG,RIN3,RIN3_SIG,RIN3,SIG,24,-0.675476630232426,0.218153855695948,0.219304108414991,0.214374453904807,-0.00492965451018384,0.558793254466339,-0.978392990543303,7.54255165453926,7.55876360138065,7.48928382920326,-0.0694797721773944,0.441575480030252,ENSG00000100599,RIN3,protein_coding,14,1,92513781,92688994,q32.12,Ras and Rab interactor 3 [Source:HGNC Symbol;Acc:HGNC:18751],NA,RIN3,79890,NM_001319987;NM_024832
ROBO4_SIG,ROBO4,ROBO4_SIG,ROBO4,SIG,75,-0.673848339310747,0.00625365019265278,0.0083370224617634,-0.000591715834424957,-0.00892873829618841,0.559875505272241,-1.39687280449383,2.28892282320376,2.35511407806659,2.07143727151162,-0.283676806554968,0.257722285808174,ENSG00000154133,ROBO4,protein_coding,11,-1,124883691,124898500,q24.2,roundabout guidance receptor 4 [Source:HGNC Symbol;Acc:HGNC:17985],NA,ROBO4,54538,NM_001301088;NM_019055
UBR7_SIG,UBR7,UBR7_SIG,UBR7,SIG,40,0.673475170245735,0.499925625644295,0.497367737059863,0.508330116707428,0.0109623796475641,0.560044660108472,0.318561257456823,5.35797376282294,5.35348202356132,5.37273233468258,0.0192503111212597,0.81672163123197,ENSG00000012963,UBR7,protein_coding,14,1,93207241,93229215,q32.12,ubiquitin protein ligase E3 component n-recognin 7 (putative) [Source:HGNC Symbol;Acc:HGNC:20344],Autosomal Recessive Mental Retardation,UBR7,55148,NM_175748
DLC1_SIG,DLC1,DLC1_SIG,DLC1,SIG,66,0.673397998541072,0.0328872035549255,0.0315722300387787,0.0372078308222651,0.00563560078348643,0.560044660108472,-0.269661968082269,3.74195870409542,3.75521337195228,3.69840765256575,-0.0568057193865269,0.845590044817068,ENSG00000164741,DLC1,protein_coding,8,-1,13083361,13604610,p22,DLC1 Rho GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:2897],Colorectal Cancer,DLC1,10395,NM_001164271;NM_001316668;NM_001348081;NM_001348082;NM_001348083;NM_001348084;NM_006094;NM_024767;NM_182643
BCLAF1_SIG,BCLAF1,BCLAF1_SIG,BCLAF1,SIG,72,0.671975921568,0.549782597655849,0.547322026760755,0.557867330596871,0.0105453038361152,0.560981091267929,1.51823363938966,8.57934259889672,8.5565604211305,8.65419832584289,0.0976379047123963,0.216048491122209,ENSG00000029363,BCLAF1,protein_coding,6,-1,136256627,136289851,q23.3,BCL2 associated transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:16863],NA,BCLAF1,9774,NM_001077440;NM_001077441;NM_001301038;NM_001363659;NM_014739
USP36_SIG,USP36,USP36_SIG,USP36,SIG,46,0.67138535634701,0.374324185125265,0.372308497701988,0.380947158087464,0.00863866038547632,0.561325882657307,1.57279559448538,6.56480592732443,6.53182575148623,6.67316936222135,0.141343610735124,0.19879327066786,ENSG00000055483,USP36,protein_coding,17,-1,78787381,78841441,q25.3,ubiquitin specific peptidase 36 [Source:HGNC Symbol;Acc:HGNC:20062],NA,USP36,57602,NM_001321291
RPS13_SIG,RPS13,RPS13_SIG,RPS13,SIG,23,0.671169637705016,1.52925145061626,1.5257992678401,1.54059433688079,0.0147950690406969,0.561403751877639,0.966913926072227,7.98121326647861,7.96757918715405,8.02601095568787,0.0584317685338201,0.447256959278738,ENSG00000110700,RPS13,protein_coding,11,-1,17074388,17077715,p15.1,ribosomal protein S13 [Source:HGNC Symbol;Acc:HGNC:10386],NA,RPS13,6207,NM_001017
ZNF135_TF,ZNF135,ZNF135_TF,ZNF135,TF,57,-0.670642840543929,-0.126798898021958,-0.124970722217279,-0.132805761380189,-0.00783503916291006,0.561703194864664,-0.323347637247221,2.03259819192089,2.0446294435773,1.99306693647839,-0.0515625070989119,0.814130630527596,ENSG00000176293,ZNF135,protein_coding,19,1,58059239,58086310,q13.43,zinc finger protein 135 [Source:HGNC Symbol;Acc:HGNC:12919],NA,ZNF135,7694,NM_001164527;NM_001164529;NM_001164530;NM_001289401;NM_001289402;NM_003436;NM_007134
MEF2C_SIG,MEF2C,MEF2C_SIG,MEF2C,SIG,109,0.669425313551868,0.14759956977897,0.146302814347115,0.151860337626495,0.00555752327937971,0.562494949774301,0.0382431192496586,6.26134724956545,6.25991373962138,6.26605735366741,0.00614361404603597,0.97914076003819,ENSG00000081189,MEF2C,protein_coding,5,-1,88717117,88904257,q14.3,myocyte enhancer factor 2C [Source:HGNC Symbol;Acc:HGNC:6996],5q14.3 microdeletion syndrome;MENTAL RETARDATION-STEREOTYPIC MOVEMENTS-EPILEPSY AND/OR CEREBRAL MALFORMATIONS;MENTAL RETARDATION AUTOSOMAL DOMINANT 20,MEF2C,4208,NM_001131005;NM_001193347;NM_001193348;NM_001193349;NM_001193350;NM_001308002;NM_001363581;NM_001364333;NM_001364334;NM_001364335;NM_001364336;NM_001364337;NM_001364345;NM_001364346;NM_001364347;NM_001364356;NM_002397
ATF3_TF,ATF3,ATF3_TF,ATF3,TF,50,0.668236978420093,0.136746220902695,0.135123303808509,0.142078662783592,0.00695535897508249,0.563266375526796,2.21300813240234,5.6628553819976,5.56189574220287,5.99457991275171,0.432684170548835,0.0646781857146719,ENSG00000162772,ATF3,protein_coding,1,1,212565334,212620777,q32.3,activating transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:785],NA,ATF3,467,NM_001030287;NM_001040619;NM_001206484;NM_001206486;NM_001206488;NM_001674
USP9Y_SIG,USP9Y,USP9Y_SIG,USP9Y,SIG,38,-0.667338020635526,0.00777746847822103,0.0124090716283575,-0.00744065615794166,-0.019849727786299,0.563831736692676,-0.659070676090208,3.14317406083122,3.19087947819268,2.98642768950069,-0.204451788691985,0.615339458946269,ENSG00000114374,USP9Y,protein_coding,Y,1,12537650,12860839,q11.221,ubiquitin specific peptidase 9 Y-linked [Source:HGNC Symbol;Acc:HGNC:12633],Partial chromosome Y deletion;SPERMATOGENIC FAILURE Y-LINKED 2,USP9Y,8287,NM_004654
PTPN2_SIG,PTPN2,PTPN2_SIG,PTPN2,SIG,20,0.66641675686582,0.0920303952226106,0.0911456058747556,0.0949375602227053,0.00379195434794978,0.564413256002335,1.58112666146633,5.87695025007731,5.86170392145287,5.92704532984331,0.0653414083904398,0.196253882419942,ENSG00000175354,PTPN2,protein_coding,18,-1,12785478,12929643,p11.21,protein tyrosine phosphatase, non-receptor type 2 [Source:HGNC Symbol;Acc:HGNC:9650],Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis,PTPN2,5771,NM_001207013;NM_001308287;NM_002828;NM_080422;NM_080423
YTHDC2_SIG,YTHDC2,YTHDC2_SIG,YTHDC2,SIG,30,0.664984365033326,0.24913976562096,0.248309505495569,0.251867763175815,0.00355825768024672,0.565360192460955,0.433671663392181,5.43423406582115,5.42880550714371,5.45207075861846,0.0232652514747453,0.748181123171207,ENSG00000047188,YTHDC2,protein_coding,5,1,113513694,113595285,q22.2,YTH domain containing 2 [Source:HGNC Symbol;Acc:HGNC:24721],NA,YTHDC2,64848,NM_001345975;NM_001345976;NM_022828
TRIO_SIG,TRIO,TRIO_SIG,TRIO,SIG,42,0.664502976958989,0.191189128746472,0.190352039997393,0.193939563207732,0.00358752321033931,0.565627957450267,0.734077769328642,6.60105924125677,6.58107626591019,6.6667175888241,0.0856413229139069,0.572410544554571,ENSG00000038382,TRIO,protein_coding,5,1,14143342,14532128,p15.2,trio Rho guanine nucleotide exchange factor [Source:HGNC Symbol;Acc:HGNC:12303],Intellectual disability;MENTAL RETARDATION AUTOSOMAL DOMINANT 44;Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,TRIO,7204,NM_007118
SLC35A2_SIG,SLC35A2,SLC35A2_SIG,SLC35A2,SIG,13,-0.662649721858526,0.0670578739755433,0.0679132282902727,0.0642474240842894,-0.00366580420598321,0.566871127947967,-0.716971412468141,3.89557462576624,3.9064972883904,3.859685877144,-0.0468114112464,0.581979278662297,ENSG00000102100,SLC35A2,protein_coding,X,-1,48903180,48911958,p11.23,solute carrier family 35 member A2 [Source:HGNC Symbol;Acc:HGNC:11022],Congenital Disorder of Glycosylation;CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIm;Isolated focal cortical dysplasia type Ia;SLC35A2-CDG,SLC35A2,7355,NM_001032289;NM_001042498;NM_001282647;NM_001282648;NM_001282649;NM_001282650;NM_001282651;NM_005660
JARID2_TF,JARID2,JARID2_TF,JARID2,TF,84,-0.662550918682108,0.309178618393314,0.310386692985296,0.305209230448229,-0.00517746253706693,0.566871127947967,-1.80594274778114,7.33774593546945,7.37127840581314,7.22756781862589,-0.143710587187254,0.136769936643925,ENSG00000008083,JARID2,protein_coding,6,1,15246069,15522042,p22.3,jumonji and AT-rich interaction domain containing 2 [Source:HGNC Symbol;Acc:HGNC:6196],NA,JARID2,3720,NM_001267040;NM_004973
ZNF711_TF,ZNF711,ZNF711_TF,ZNF711,TF,240,0.662333847200049,-0.0963929893441837,-0.0973894725083891,-0.0931188303760802,0.00427064213230885,0.566889982031806,0.257456274297347,3.06113780127319,3.0455986933854,3.11219487004735,0.0665961766619522,0.853283704624168,ENSG00000147180,ZNF711,protein_coding,X,1,85244032,85273362,q21.1,zinc finger protein 711 [Source:HGNC Symbol;Acc:HGNC:13128],MENTAL RETARDATION X-LINKED 97;MENTAL RETARDATION X-LINKED ZNF711-RELATED;X-linked non-syndromic intellectual disability,ZNF711,7552,NM_001330574;NM_021998
PHTF2_TF,PHTF2,PHTF2_TF,PHTF2,TF,125,-0.662310975834304,0.12182511080978,0.122403849515695,0.119923540776057,-0.00248030873963839,0.566889982031806,2.70313260707246,5.03994581276165,5.00448675994262,5.15645412916703,0.151967369224415,0.0222347041716913,ENSG00000006576,PHTF2,protein_coding,7,1,77798792,77957503,q11.23,putative homeodomain transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:13411],NA,PHTF2,57157,NM_001127357;NM_001127358;NM_001127359;NM_001127360;NM_001366081;NM_001366082;NM_001366086;NM_001366088;NM_001366089;NM_020432
KHDRBS2_SIG,KHDRBS2,KHDRBS2_SIG,KHDRBS2,SIG,19,-0.661702872607453,-0.0540954951320042,-0.0533273584408241,-0.0566193728315959,-0.00329201439077186,0.56724863661439,4.01443168851124,0.68860781450989,0.609629426449959,0.948108232421091,0.338478805971132,0.000542166741373619,ENSG00000112232,KHDRBS2,protein_coding,6,-1,61679961,62286225,q11.1,KH RNA binding domain containing, signal transduction associated 2 [Source:HGNC Symbol;Acc:HGNC:18114],NA,KHDRBS2,202559,NM_001350622;NM_152688
PDCD4_SIG,PDCD4,PDCD4_SIG,PDCD4,SIG,18,0.660816778451842,0.340071200959467,0.339167845274591,0.343039369638345,0.00387152436375371,0.567806354581891,-1.507125632798,7.55363244274914,7.57514910896612,7.48293482517905,-0.0922142837870758,0.219708913364849,ENSG00000150593,PDCD4,protein_coding,10,1,110871795,110900006,q25.2,programmed cell death 4 [Source:HGNC Symbol;Acc:HGNC:8763],NA,PDCD4,27250,NM_001199492;NM_014456;NM_145341
POLD3_SIG,POLD3,POLD3_SIG,POLD3,SIG,46,-0.659625893766772,0.26285111267515,0.265431346756279,0.254373200694301,-0.0110581460619777,0.568582601992314,0.277581425462673,4.82320582882779,4.81766834852369,4.84140040696983,0.0237320584461427,0.841229434343393,ENSG00000077514,POLD3,protein_coding,11,1,74493851,74669117,q13.4,DNA polymerase delta 3, accessory subunit [Source:HGNC Symbol;Acc:HGNC:20932],NA,POLD3,10714,NM_001363597;NM_006591
GALNT11_SIG,GALNT11,GALNT11_SIG,GALNT11,SIG,18,0.659512972187787,0.273215626200795,0.272474473637174,0.275650841766978,0.00317636812980407,0.568586906319497,1.05626168264327,4.81101520717073,4.79348028472616,4.86862995234576,0.0751496676196002,0.40299182330764,ENSG00000178234,GALNT11,protein_coding,7,1,152025674,152122340,q36.1,polypeptide N-acetylgalactosaminyltransferase 11 [Source:HGNC Symbol;Acc:HGNC:19875],NA,GALNT11,63917,NM_001304514;NM_022087
MCM4_SIG,MCM4,MCM4_SIG,MCM4,SIG,53,-0.659404659362102,0.626965194569713,0.631157864560747,0.613189278884888,-0.0179685856758587,0.568587914529645,-0.439688087039821,6.8796141867705,6.89204372119996,6.83877428793087,-0.0532694332690832,0.744951690159735,ENSG00000104738,MCM4,protein_coding,8,1,47960185,47978160,q11.21,minichromosome maintenance complex component 4 [Source:HGNC Symbol;Acc:HGNC:6947],IMMUNODEFICIENCY 54;Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,MCM4,4173,NM_005914;NM_182746
PCBP4_SIG,PCBP4,PCBP4_SIG,PCBP4,SIG,75,0.65914089103698,-0.051756354426551,-0.0525899893181967,-0.049017268354001,0.00357272096419554,0.568698066747444,1.18397756011711,2.34492577909946,2.31341977350431,2.44844551176926,0.13502573826495,0.343920029135954,ENSG00000090097,PCBP4,protein_coding,3,-1,51957454,51974016,p21.2,poly(rC) binding protein 4 [Source:HGNC Symbol;Acc:HGNC:8652],NA,PCBP4,57060,NM_001174100;NM_020418;NM_033008;NM_033010
ZNF800_TF,ZNF800,ZNF800_TF,ZNF800,TF,101,-0.659037067250591,0.366997461912778,0.369102505291009,0.360080890812877,-0.00902161447813276,0.568698066747444,-0.125331133597285,5.80087743835607,5.80312639235655,5.7934880180688,-0.00963837428774991,0.929947065152284,ENSG00000048405,ZNF800,protein_coding,7,-1,127346790,127431924,q31.33,zinc finger protein 800 [Source:HGNC Symbol;Acc:HGNC:27267],NA,ZNF800,168850,NM_176814
CHEK1_SIG,CHEK1,CHEK1_SIG,CHEK1,SIG,34,-0.658762936653222,0.503719513329943,0.506982485189194,0.492998320078118,-0.0139841651110759,0.568817845093103,0.181812058566164,4.32653989273371,4.32202327353957,4.34138021294305,0.0193569394034795,0.897795334875789,ENSG00000149554,CHEK1,protein_coding,11,1,125625136,125676255,q24.2,checkpoint kinase 1 [Source:HGNC Symbol;Acc:HGNC:1925],NA,CHEK1,1111,NM_001114121;NM_001114122;NM_001244846;NM_001274;NM_001330427;NM_001330428
KCTD21_SIG,KCTD21,KCTD21_SIG,KCTD21,SIG,92,-0.658184683105678,0.222595548660201,0.225019199067823,0.214632125892301,-0.0103870731755215,0.569155487784778,0.502939002706721,2.62674648231258,2.61389273007588,2.66898023966174,0.055087509585854,0.707695176576601,ENSG00000188997,KCTD21,protein_coding,11,-1,78171249,78188626,q14.1,potassium channel tetramerization domain containing 21 [Source:HGNC Symbol;Acc:HGNC:27452],NA,KCTD21,283219,NM_001029859
RRP36_SIG,RRP36,RRP36_SIG,RRP36,SIG,26,0.657163055324595,0.349844189174518,0.348134659024813,0.355461216809261,0.00732655778444745,0.569810968474243,0.39948668133121,4.7975000124129,4.79308599883064,4.81200319989745,0.0189172010668078,0.768516469981843,ENSG00000124541,RRP36,protein_coding,6,1,43021623,43034156,p21.1,ribosomal RNA processing 36 [Source:HGNC Symbol;Acc:HGNC:21374],NA,RRP36,88745,NM_001329704;NM_033112
CHD2_SIG,CHD2,CHD2_SIG,CHD2,SIG,90,-0.656444536112385,0.244003009218877,0.246045857371797,0.237290793859284,-0.00875506351251245,0.570249396507878,-0.542912192468105,8.09330086158164,8.10238485336097,8.06345346002097,-0.0389313933400005,0.684833640017704,ENSG00000173575,CHD2,protein_coding,15,1,92900189,93027996,q26.1,chromodomain helicase DNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:1917],Epileptic encephalopathy;Epileptic encephalopathy childhood-onset;Lennox-Gastaut syndrome;Myoclonic-astastic epilepsy,CHD2,1106,NM_001042572;NM_001271
NPEPL1_SIG,NPEPL1,NPEPL1_SIG,NPEPL1,SIG,46,-0.655732375662339,0.0901088666531138,0.0911963310026882,0.0865357695045125,-0.00466056149817562,0.57068338842932,0.511372181749242,4.42251583534294,4.41407365438941,4.45025442990455,0.0361807755151345,0.70297665471064,ENSG00000215440,NPEPL1,protein_coding,20,1,58689131,58719238,q13.32,aminopeptidase like 1 [Source:HGNC Symbol;Acc:HGNC:16244],NA,NPEPL1,79716,NM_001204872;NM_001204873;NM_024663
XIAP_SIG,XIAP,XIAP_SIG,XIAP,SIG,38,-0.655462541092754,0.426628975102392,0.427389474981165,0.424130189786421,-0.0032592851947441,0.570800164099756,0.576532873635439,5.29414519888079,5.28793802857391,5.31454018703195,0.0266021584580453,0.664952805341943,ENSG00000101966,XIAP,protein_coding,X,1,123859724,123913979,q25,X-linked inhibitor of apoptosis [Source:HGNC Symbol;Acc:HGNC:592],LYMPHOPROLIFERATIVE SYNDROME X-LINKED 1;LYMPHOPROLIFERATIVE SYNDROME X-LINKED 2;X-linked lymphoproliferative disease,XIAP,331,NM_001167;NM_001204401
UCP2_SIG,UCP2,UCP2_SIG,UCP2,SIG,11,-0.654324492832071,0.420540346120744,0.422977375804275,0.412532962874855,-0.0104444129294197,0.571539938626274,0.035108373718777,7.23124381261388,7.23047299334628,7.23377650449313,0.0033035111468463,0.980995406111906,ENSG00000175567,UCP2,protein_coding,11,-1,73974672,73982843,q13.4,uncoupling protein 2 [Source:HGNC Symbol;Acc:HGNC:12518],BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4;Hyperinsulinism due to UCP2 deficiency,UCP2,7351,NM_003355
ST6GAL1_SIG,ST6GAL1,ST6GAL1_SIG,ST6GAL1,SIG,56,0.65382895662125,0.248433500091075,0.246489274923154,0.254821668499958,0.00833239357680333,0.571818765607325,-0.221194843518219,6.04831422320456,6.05422658091219,6.02888790502237,-0.0253386758898176,0.874978928818249,ENSG00000073849,ST6GAL1,protein_coding,3,1,186930502,187078553,q27.3,ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10860],NA,ST6GAL1,6480,NM_001353916;NM_003032;NM_173216;NM_173217
DNAJB2_SIG,DNAJB2,DNAJB2_SIG,DNAJB2,SIG,27,-0.653509609177762,0.0975615172438767,0.0982608290186824,0.0952637785552293,-0.00299705046345307,0.571967303740381,0.396727124178865,5.0921713899709,5.08632225094645,5.11138998962269,0.0250677386762373,0.770368618787339,ENSG00000135924,DNAJB2,protein_coding,2,1,219279267,219286900,q35,DnaJ heat shock protein family (Hsp40) member B2 [Source:HGNC Symbol;Acc:HGNC:5228],DNAJB2-related Charcot-Marie-Tooth disease type 2;SPINAL MUSCULAR ATROPHY DISTAL AUTOSOMAL RECESSIVE 5;Young adult-onset distal hereditary motor neuropathy,DNAJB2,3300,NM_001039550;NM_006736
MRPS24_SIG,MRPS24,MRPS24_SIG,MRPS24,SIG,2,-0.653407820599432,-0.153771888219563,-0.152735497136786,-0.15717717320583,-0.00444167606904384,0.571967303740381,-0.144722611344125,0.702257134371972,0.70327765591535,0.698903992158014,-0.00437366375733591,0.918764493671838,ENSG00000062582,MRPS24,protein_coding,7,-1,43866558,43869893,p13,mitochondrial ribosomal protein S24 [Source:HGNC Symbol;Acc:HGNC:14510],NA,MRPS24,64951,NM_032014
IL9R_SIG,IL9R,IL9R_SIG,IL9R,SIG,7,0.652526939181321,-0.027868745835807,-0.0291691934545791,-0.0235958465169841,0.00557334693759499,0.572522902447463,0.140827990122791,0.860960726710826,0.857706978170478,0.87165161477197,0.0139446366014921,0.921113400401473,ENSG00000124334,IL9R,protein_coding,X,1,155997581,156010817,q28,interleukin 9 receptor [Source:HGNC Symbol;Acc:HGNC:6030],NA,IL9R,3581,NM_002186;NM_176786
DGKE_SIG,DGKE,DGKE_SIG,DGKE,SIG,49,0.650839434944911,0.0893644567996041,0.0880618904231884,0.0936443177506845,0.00558242732749608,0.573658456753552,-0.149078369633379,4.5849209108227,4.58824848408562,4.57398745581599,-0.0142610282696259,0.916748137951292,ENSG00000153933,DGKE,protein_coding,17,1,56834107,56869567,q22,diacylglycerol kinase epsilon [Source:HGNC Symbol;Acc:HGNC:2852],Atypical hemolytic-uremic syndrome with DGKE deficiency;Immunoglobulin-mediated membranoproliferative glomerulonephritis;NEPHROTIC SYNDROME TYPE 7,DGKE,8526,NM_003647
OPRL1_SIG,OPRL1,OPRL1_SIG,OPRL1,SIG,68,-0.650403539550094,0.342086800185543,0.344183139166175,0.33519882924918,-0.00898430991699528,0.573894736739622,0.275541958681351,3.4976930702704,3.49041522269147,3.52160599802971,0.0311907753382382,0.842320026901766,ENSG00000125510,OPRL1,protein_coding,20,1,64080082,64100643,q13.33,opioid related nociceptin receptor 1 [Source:HGNC Symbol;Acc:HGNC:8155],NA,OPRL1,4987,NM_000913;NM_001200019;NM_001318853;NM_001318854;NM_001318855;NM_182647
ZNF608_TF,ZNF608,ZNF608_TF,ZNF608,TF,188,-0.645406683041939,-0.0106114277655988,-0.0096259497696074,-0.0138494268952848,-0.00422347712567751,0.577415820518914,0.974882085405396,2.97288573117636,2.92983765601856,3.11432940669485,0.184491750676291,0.443211462016202,ENSG00000168916,ZNF608,protein_coding,5,-1,124636913,124748807,q23.2,zinc finger protein 608 [Source:HGNC Symbol;Acc:HGNC:29238],NA,ZNF608,57507,NM_020747
ARNT_TF,ARNT,ARNT_TF,ARNT,TF,118,0.644292393597391,0.333688469938158,0.332122690772072,0.338833172912439,0.0067104821403668,0.57814211251525,0.293541323949399,6.49761701804558,6.49372149686768,6.51041658763011,0.0166950907624317,0.8316742715163,ENSG00000143437,ARNT,protein_coding,1,-1,150809713,150876708,q21.3,aryl hydrocarbon receptor nuclear translocator [Source:HGNC Symbol;Acc:HGNC:700],NA,ARNT,405,NM_001197325;NM_001286035;NM_001286036;NM_001350224;NM_001350225;NM_001350226;NM_001668;NM_178427
ZCWPW2_SIG,ZCWPW2,ZCWPW2_SIG,ZCWPW2,SIG,2,0.643361887361257,0.0235538517632789,0.0219315611380176,0.0288842352462804,0.00695267410826281,0.578736084673987,-0.430718467467574,0.68315818824954,0.686647416275214,0.671693581879468,-0.0149538343957458,0.750101657269885,ENSG00000206559,ZCWPW2,protein_coding,3,1,28348721,28538122,p24.1,zinc finger CW-type and PWWP domain containing 2 [Source:HGNC Symbol;Acc:HGNC:23574],NA,ZCWPW2,152098,NM_001040432;NM_001324169;NM_001324170
ZNF276_TF,ZNF276,ZNF276_TF,ZNF276,TF,108,0.642903220338836,0.107773056164034,0.106968357441002,0.110417066253997,0.0034487088129951,0.578989518334229,1.25478280251219,6.30872447548083,6.29221438097992,6.36297192884094,0.070757547861022,0.313362186008259,ENSG00000158805,ZNF276,protein_coding,16,1,89720400,89740925,q24.3,zinc finger protein 276 [Source:HGNC Symbol;Acc:HGNC:23330],NA,ZNF276,92822,NM_001113525;NM_152287
HDAC7_SIG,HDAC7,HDAC7_SIG,HDAC7,SIG,73,-0.642722816076655,0.060375754436454,0.0616328416924409,0.0562453248810684,-0.00538751681137262,0.579042025317695,-0.454634320669616,6.91805203708654,6.9250532499313,6.89504805202519,-0.0300051979061119,0.736514333926497,ENSG00000061273,HDAC7,protein_coding,12,-1,47782722,47833132,q13.11,histone deacetylase 7 [Source:HGNC Symbol;Acc:HGNC:14067],NA,HDAC7,51564,NM_001098416;NM_001308090;NM_015401
AKR1C2_SIG,AKR1C2,AKR1C2_SIG,AKR1C2,SIG,7,0.642178139050919,-0.0594445263190058,-0.0607745875603756,-0.0550743250973619,0.00570026246301385,0.579308982842555,-0.904319245748794,0.728553071020451,0.745201713233159,0.673850389464413,-0.0713513237687453,0.479512249352571,ENSG00000151632,AKR1C2,protein_coding,10,-1,4987400,5018031,p15.1,aldo-keto reductase family 1 member C2 [Source:HGNC Symbol;Acc:HGNC:385],46XY disorder of sex development due to testicular 1720-desmolase deficiency;46XY SEX REVERSAL 8,AKR1C2,1646,NM_001135241;NM_001321027;NM_001354;NM_205845
MAST1_SIG,MAST1,MAST1_SIG,MAST1,SIG,25,-0.642137757434003,-0.123687759325468,-0.122460967513376,-0.127718646708058,-0.00525767919468162,0.579308982842555,-0.177136476658109,0.908204987292151,0.911786432540597,0.89643738147583,-0.015349051064767,0.900456549445066,ENSG00000105613,MAST1,protein_coding,19,1,12833951,12874952,p13.13,microtubule associated serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:19034],NA,MAST1,22983,NM_014975
MAX_TF,MAX,MAX_TF,MAX,TF,147,0.640632455745804,0.0422180758652074,0.041321935092324,0.0451625384046814,0.00384060331235746,0.580253005963101,-0.208584143223077,6.95796624418668,6.96071490315348,6.94893493615291,-0.0117799670005683,0.882619958933894,ENSG00000125952,MAX,protein_coding,14,-1,65006174,65102695,q23.3,MYC associated factor X [Source:HGNC Symbol;Acc:HGNC:6913],Hereditary pheochromocytoma-paraganglioma;Pheochromocytoma,MAX,4149,NM_001271068;NM_001271069;NM_001320415;NM_002382;NM_145112;NM_145113;NM_145114;NM_197957
PLXNA2_SIG,PLXNA2,PLXNA2_SIG,PLXNA2,SIG,4,0.64054028864832,0.0642061568716194,0.0631995883860567,0.0675134533241825,0.00431386493812588,0.580253005963101,2.53817477764033,2.31178042534084,2.235204452094,2.56338719458046,0.328182742486464,0.0325003813882343,ENSG00000076356,PLXNA2,protein_coding,1,-1,208022242,208244384,q32.2,plexin A2 [Source:HGNC Symbol;Acc:HGNC:9100],NA,PLXNA2,5362,NM_025179
SLC7A5_SIG,SLC7A5,SLC7A5_SIG,SLC7A5,SIG,44,0.640440652005711,-0.0255457218363055,-0.0270608800031669,-0.0205673450023324,0.00649353500083459,0.580253005963101,-0.334100861783349,6.70830065479679,6.71955652470457,6.67131708224264,-0.048239442461929,0.807463046927743,ENSG00000103257,SLC7A5,protein_coding,16,-1,87830023,87869507,q24.2,solute carrier family 7 member 5 [Source:HGNC Symbol;Acc:HGNC:11063],NA,SLC7A5,8140,NM_003486
SEMA4F_SIG,SEMA4F,SEMA4F_SIG,SEMA4F,SIG,101,0.640397696318252,-0.103948185998929,-0.104871682673976,-0.100913839780919,0.00395784289305654,0.580253005963101,0.106191783570206,1.51338083393111,1.51111734452729,1.52081801340081,0.00970066887351141,0.941079930681085,ENSG00000135622,SEMA4F,protein_coding,2,1,74654228,74683853,p13.1,ssemaphorin 4F [Source:HGNC Symbol;Acc:HGNC:10734],NA,SEMA4F,10505,NM_001271661;NM_001271662;NM_004263
HYKK_SIG,HYKK,HYKK_SIG,HYKK,SIG,43,-0.640292312924028,-0.125887646663318,-0.124906787673594,-0.129110469058125,-0.00420368138453133,0.580253005963101,-0.447492413107568,0.264756033718057,0.268125590965277,0.253684631334333,-0.0144409596309445,0.740366699505169,ENSG00000188266,HYKK,protein_coding,15,1,78507564,78537372,q25.1,hydroxylysine kinase [Source:HGNC Symbol;Acc:HGNC:34403],NA,HYKK,123688,NM_001013619;NM_001083612
RPS17_SIG,RPS17,RPS17_SIG,RPS17,SIG,11,0.640103704780433,0.51971127316614,0.5182343138692,0.524564139427515,0.00632982555831504,0.580311432960222,1.39894376079627,5.15440218183139,5.10616293218729,5.31290257351915,0.206739641331867,0.25702122876371,ENSG00000182774,RPS17,protein_coding,15,-1,82536750,82540564,q25.2,ribosomal protein S17 [Source:HGNC Symbol;Acc:HGNC:10397],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 4,RPS17,6218,NM_001021
DTX2_SIG,DTX2,DTX2_SIG,DTX2,SIG,37,-0.63988971655808,0.21514958324934,0.21719326298274,0.208434635553883,-0.00875862742885762,0.580350757394082,-0.0550736696983493,3.67752145829001,3.67854139686683,3.67417023153762,-0.00437116532921375,0.969494861340597,ENSG00000091073,DTX2,protein_coding,7,1,76461676,76505995,q11.23,deltex E3 ubiquitin ligase 2 [Source:HGNC Symbol;Acc:HGNC:15973],NA,DTX2,113878,NM_001102594;NM_001102595;NM_001102596;NM_020892
EED_SIG,EED,EED_SIG,EED,SIG,18,-0.639833797477099,0.195462520744272,0.196099485151209,0.193369637692909,-0.00272984745829938,0.580350757394082,1.69682256397596,3.66470462040513,3.64327336679946,3.73512159653805,0.0918482297385821,0.163985982661168,ENSG00000074266,EED,protein_coding,11,1,86244753,86278813,q14.2,embryonic ectoderm development [Source:HGNC Symbol;Acc:HGNC:3188],Cohen-Gibson syndrome;Weaver-like overgrowth syndrome;Weaver syndrome,EED,8726,NM_001308007;NM_001330334;NM_003797
IRF2BP2_SIG,IRF2BP2,IRF2BP2_SIG,IRF2BP2,SIG,31,0.639650220342174,0.320597775662985,0.318947427881191,0.326020346946025,0.00707291906483408,0.580405552975733,0.424573081262894,9.28894865528337,9.28085495565231,9.31554223978541,0.0346872841330939,0.753910725238499,ENSG00000168264,IRF2BP2,protein_coding,1,-1,234604269,234609525,q42.3,interferon regulatory factor 2 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:21729],IMMUNODEFICIENCY COMMON VARIABLE 14,IRF2BP2,359948,NM_001077397;NM_182972
SLC1A5_SIG,SLC1A5,SLC1A5_SIG,SLC1A5,SIG,9,0.638459037305103,0.277726870580104,0.275442966722476,0.285231126112312,0.00978815938983695,0.581188540625331,1.07099046081615,6.0242821147907,5.99949846467738,6.10571410802017,0.106215643342795,0.396243449587603,ENSG00000105281,SLC1A5,protein_coding,19,-1,46774883,46788594,q13.32,solute carrier family 1 member 5 [Source:HGNC Symbol;Acc:HGNC:10943],NA,SLC1A5,6510,NM_001145144;NM_001145145;NM_005628
MKLN1_SIG,MKLN1,MKLN1_SIG,MKLN1,SIG,35,0.638231173361204,0.439013924596815,0.43790331283804,0.442663077518504,0.00475976468046368,0.5812753417748,0.543087594640051,6.11980751233127,6.11314221347535,6.14170778000075,0.0285655665254073,0.684794464355424,ENSG00000128585,MKLN1,protein_coding,7,1,131110096,131496632,q32.3,muskelin 1 [Source:HGNC Symbol;Acc:HGNC:7109],NA,MKLN1,4289,NM_001145354;NM_001321316;NM_013255
DDO_SIG,DDO,DDO_SIG,DDO,SIG,25,-0.635825506823339,0.0183805214786277,0.0195532055056748,0.0145274168183303,-0.00502578868734439,0.582937664855264,1.38255562913899,1.95804223254327,1.91498895067886,2.09950301581204,0.184514065133182,0.263196168042397,ENSG00000203797,DDO,protein_coding,6,-1,110391771,110415575,q21,D-aspartate oxidase [Source:HGNC Symbol;Acc:HGNC:2727],NA,DDO,8528,NM_003649;NM_004032
LIF_SIG,LIF,LIF_SIG,LIF,SIG,17,-0.635172220816947,0.0213967596286572,0.0235345287315886,0.014372661147597,-0.00916186758399162,0.583332512769431,0.686068212284361,1.72590737807181,1.70052469486444,1.80930762289605,0.108782928031618,0.600078555974087,ENSG00000128342,LIF,protein_coding,22,-1,30240453,30246759,q12.2,LIF, interleukin 6 family cytokine [Source:HGNC Symbol;Acc:HGNC:6596],NA,LIF,3976,NM_001257135;NM_002309
DUSP15_SIG,DUSP15,DUSP15_SIG,DUSP15,SIG,21,0.634739630027322,-0.113007930418656,-0.114116050984244,-0.10936696284601,0.00474908813823321,0.583567600903767,0.770538200471355,0.497241363958719,0.484471535631379,0.539199371319979,0.0547278356885995,0.551817881454993,ENSG00000149599,DUSP15,protein_coding,20,-1,31847637,31870747,q11.21,dual specificity phosphatase 15 [Source:HGNC Symbol;Acc:HGNC:16236],NA,DUSP15,128853,NM_001012644;NM_001320478;NM_001320479;NM_080611;NM_177991
RNF169_SIG,RNF169,RNF169_SIG,RNF169,SIG,26,-0.634203313095411,0.38480657025592,0.385777076522534,0.381617763951331,-0.00415931257120388,0.583877848983807,0.732233091254755,6.36898210717885,6.36056263486764,6.39664608762995,0.0360834527623083,0.573304957768933,ENSG00000166439,RNF169,protein_coding,11,1,74748849,74842413,q13.4,ring finger protein 169 [Source:HGNC Symbol;Acc:HGNC:26961],NA,RNF169,254225,NM_001098638
CYCS_SIG,CYCS,CYCS_SIG,CYCS,SIG,19,0.633180569547078,0.264094279159605,0.263326726418951,0.266616238164611,0.00328951174566006,0.584540641269847,0.357590697815469,5.82450636275232,5.81936699923542,5.84139284287928,0.0220258436438591,0.79309314463558,ENSG00000172115,CYCS,protein_coding,7,-1,25120091,25125361,p15.3,cytochrome c, somatic [Source:HGNC Symbol;Acc:HGNC:19986],Autosomal thrombocytopenia with normal platelets;Thrombocytopenia 4,CYCS,54205,NM_018947
SLC4A7_SIG,SLC4A7,SLC4A7_SIG,SLC4A7,SIG,45,0.632870836020773,-0.0210380596896961,-0.0218755068634345,-0.0182864475474128,0.00358905931602164,0.584686815933959,-0.939411029282446,4.49349894931518,4.5220922343733,4.3995495841242,-0.122542650249101,0.461118388653653,ENSG00000033867,SLC4A7,protein_coding,3,-1,27372721,27484420,p24.1,solute carrier family 4 member 7 [Source:HGNC Symbol;Acc:HGNC:11033],NA,SLC4A7,9497,NM_001258379;NM_001258380;NM_001321103;NM_001321104;NM_001321105;NM_001321106;NM_001321107;NM_001321108;NM_003615
UNC5C_SIG,UNC5C,UNC5C_SIG,UNC5C,SIG,36,-0.631715049356446,-0.10510441122115,-0.104076192415281,-0.108482844440431,-0.00440665202515003,0.585446433193445,-1.40748546076769,0.575035804960533,0.622517422495653,0.419024775916566,-0.203492646579088,0.253753537448465,ENSG00000182168,UNC5C,protein_coding,4,-1,95162504,95549206,q22.3,unc-5 netrin receptor C [Source:HGNC Symbol;Acc:HGNC:12569],NA,UNC5C,8633,NM_003728
GPR19_SIG,GPR19,GPR19_SIG,GPR19,SIG,14,-0.631314018120075,-0.0116194711797725,-0.0110413457395148,-0.0135190261977622,-0.00247768045824753,0.585632622473219,-0.686042798710541,0.499275816570333,0.50497318976539,0.480555876072287,-0.0244173136931032,0.600078555974087,ENSG00000183150,GPR19,protein_coding,12,-1,12660890,12696207,p13.1,G protein-coupled receptor 19 [Source:HGNC Symbol;Acc:HGNC:4473],NA,GPR19,2842,NM_006143
RELA_TF,RELA,RELA_TF,RELA,TF,172,0.631242085599837,-0.0271438400118747,-0.0286529267174017,-0.0221854122651432,0.00646751445225854,0.585632622473219,0.113105490331375,6.90612072677544,6.90479384899123,6.91048046806645,0.00568661907521837,0.93742302319635,ENSG00000173039,RELA,protein_coding,11,-1,65653597,65663090,q13.1,RELA proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9955],Ependymoma,RELA,5970,NM_001145138;NM_001243984;NM_001243985;NM_021975
CD180_SIG,CD180,CD180_SIG,CD180,SIG,54,0.630801398230656,0.152060053925061,0.149854966507078,0.159305341155576,0.00945037464849745,0.585873834953639,1.24226186752392,3.87632279007512,3.81149448012775,4.08933009418793,0.277835614060184,0.318663600553571,ENSG00000134061,CD180,protein_coding,5,-1,67179613,67196799,q12.3,CD180 molecule [Source:HGNC Symbol;Acc:HGNC:6726],NA,CD180,4064,NM_005582
PAK2_SIG,PAK2,PAK2_SIG,PAK2,SIG,50,-0.630134140946634,0.649544984047003,0.651388003823355,0.643489347638988,-0.00789865618436738,0.58621482143106,-0.318950737498078,7.78532854686821,7.78967903971671,7.771034070366,-0.0186449693507056,0.816550032202677,ENSG00000180370,PAK2,protein_coding,3,1,196739857,196832647,q29,p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591],NA,PAK2,5062,NM_002577
TAOK1_SIG,TAOK1,TAOK1_SIG,TAOK1,SIG,45,0.63011506527126,0.426445785732606,0.425280067459787,0.430276002914727,0.00499593545494063,0.58621482143106,1.0468934709526,7.26067635959712,7.2443411516458,7.31434918572291,0.0700080340771078,0.407595330974053,ENSG00000160551,TAOK1,protein_coding,17,1,29390464,29551904,q11.2,TAO kinase 1 [Source:HGNC Symbol;Acc:HGNC:29259],NA,TAOK1,57551,NM_020791;NM_025142
BUD31_TF,BUD31,BUD31_TF,BUD31,TF,77,-0.629620410265961,0.158861006702057,0.159751358065428,0.155935566508125,-0.00381579155730279,0.586495245981542,-0.417581340925303,5.70675517676983,5.71166493025774,5.69062312959526,-0.0210418006624842,0.758456652338172,ENSG00000106245,BUD31,protein_coding,7,1,99408641,99419616,q22.1,BUD31 homolog [Source:HGNC Symbol;Acc:HGNC:29629],NA,BUD31,8896,NM_003910
SMPD4_SIG,SMPD4,SMPD4_SIG,SMPD4,SIG,53,0.628875960739559,0.406023635386428,0.404859774492797,0.409847749751216,0.00498797525841842,0.586908307821273,0.846470386736397,6.15210572037605,6.14219266562758,6.18467718597817,0.0424845203505885,0.510390457968322,ENSG00000136699,SMPD4,protein_coding,2,-1,130151392,130182750,q21.1,sphingomyelin phosphodiesterase 4 [Source:HGNC Symbol;Acc:HGNC:32949],NA,SMPD4,55627,NM_001171083;NM_017751;NM_017951
TFRC_SIG,TFRC,TFRC_SIG,TFRC,SIG,33,-0.628834860934101,0.0816491308870647,0.0833811896483714,0.0759580806713427,-0.00742310897702883,0.586908307821273,0.145215984793982,7.6884770560188,7.68419239877697,7.70255521552766,0.0183628167506917,0.918447572946878,ENSG00000072274,TFRC,protein_coding,3,-1,196027183,196082096,q29,transferrin receptor [Source:HGNC Symbol;Acc:HGNC:11763],Combined immunodeficiency;Combined immunodeficiency due to TFRC deficiency;Immunodeficiency 46,TFRC,7037,NM_001128148;NM_001313965;NM_001313966;NM_003234
PCDHGA9_SIG,PCDHGA9,PCDHGA9_SIG,PCDHGA9,SIG,23,0.62845647851293,-0.0853174582738783,-0.0863383992507674,-0.0819629379212427,0.00437546132952471,0.587104414554983,0.224202578907297,0.381313444227011,0.379096185560168,0.388598722703779,0.00950253714361098,0.873144727899101,ENSG00000261934,PCDHGA9,protein_coding,5,1,141402932,141512979,q31.3,protocadherin gamma subfamily A, 9 [Source:HGNC Symbol;Acc:HGNC:8707],NA,PCDHGA9,56107,NM_018921;NM_032089
ARID5B_TF,ARID5B,ARID5B_TF,ARID5B,TF,209,-0.625162353722807,0.00838767665857431,0.00929259370315791,0.00541437779779966,-0.00387821590535813,0.589419133507562,0.469333042299177,4.96622186469707,4.95163045095068,5.01416508129234,0.0625346303416635,0.727485651869446,ENSG00000150347,ARID5B,protein_coding,10,1,61901684,62096944,q21.2,AT-rich interaction domain 5B [Source:HGNC Symbol;Acc:HGNC:17362],NA,ARID5B,84159,NM_001244638;NM_032199
SUCLG2_SIG,SUCLG2,SUCLG2_SIG,SUCLG2,SIG,60,0.624005676569563,-0.0323355025723225,-0.0336506908308395,-0.0280141697229094,0.00563652110793023,0.590181711380847,1.58981589721632,4.33110239190294,4.27421684294697,4.51801205275828,0.243795209811315,0.19356915512076,ENSG00000172340,SUCLG2,protein_coding,3,-1,67360460,67654614,p14.1,succinate-CoA ligase GDP-forming beta subunit [Source:HGNC Symbol;Acc:HGNC:11450],NA,SUCLG2,8801,NM_001177599;NM_003848
MED11_SIG,MED11,MED11_SIG,MED11,SIG,34,0.623352053895781,0.205595069413327,0.202800518439819,0.21477716546914,0.0119766470293205,0.590578462854348,1.06290033456134,2.68781421546621,2.66780969486109,2.75354335459732,0.0857336597362282,0.399872773698267,ENSG00000161920,MED11,protein_coding,17,1,4731428,4733607,p13.2,mediator complex subunit 11 [Source:HGNC Symbol;Acc:HGNC:32687],NA,MED11,400569,NM_001001683;NM_001305000
ZNF774_TF,ZNF774,ZNF774_TF,ZNF774,TF,21,0.623059696497607,-0.0334544551438105,-0.034259813833781,-0.0308082765910502,0.00345153724273064,0.590712295336786,-1.01988356040529,0.59061802298633,0.602338049793196,0.552109363478058,-0.0502286863151375,0.420639677716523,ENSG00000196391,ZNF774,protein_coding,15,1,90352245,90369146,q26.1,zinc finger protein 774 [Source:HGNC Symbol;Acc:HGNC:33108],NA,ZNF774,342132,NM_001004309
PAFAH2_SIG,PAFAH2,PAFAH2_SIG,PAFAH2,SIG,28,-0.621108140994528,0.217239288676773,0.218586123694528,0.212813973618434,-0.0057721500760944,0.592054598958099,-0.455569363694189,3.53831833799006,3.54718461026014,3.50918630053121,-0.0379983097289287,0.735934155071505,ENSG00000158006,PAFAH2,protein_coding,1,-1,25959767,25998117,p36.11,platelet activating factor acetylhydrolase 2 [Source:HGNC Symbol;Acc:HGNC:8579],NA,PAFAH2,5051,NM_000437
YBX1_SIG,YBX1,YBX1_SIG,YBX1,SIG,59,-0.619929730195183,0.0298546037048579,0.0305870019183818,0.0274481524318509,-0.00313884948653085,0.592834389156253,-0.634656741451701,9.02558400207273,9.03308458557349,9.00093922771309,-0.0321453578604006,0.63001584255931,ENSG00000065978,YBX1,protein_coding,1,1,42682418,42703805,p34.2,Y-box binding protein 1 [Source:HGNC Symbol;Acc:HGNC:8014],NA,YBX1,4904,NM_004559
GDI1_SIG,GDI1,GDI1_SIG,GDI1,SIG,24,-0.619243168736041,-0.208798780214527,-0.207930210607033,-0.211652651782007,-0.00372244117497357,0.593255804386813,-0.425001146153886,6.69084917345723,6.69541872469416,6.67583493367875,-0.0195837910154105,0.753597228594973,ENSG00000203879,GDI1,protein_coding,X,1,154436913,154443467,q28,GDP dissociation inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:4226],MENTAL RETARDATION X-LINKED 41;MENTAL RETARDATION X-LINKED TYPE 41;MENTAL RETARDATION X-LINKED TYPE 48;X-linked non-syndromic intellectual disability,GDI1,2664,NM_001493
ASB8_SIG,ASB8,ASB8_SIG,ASB8,SIG,34,-0.619027005661936,0.322821566272137,0.323504458146552,0.320577778684774,-0.00292667946177874,0.593334175975298,0.270159375455981,4.93281699035104,4.92991334855509,4.94235752768057,0.0124441791254793,0.845298344132624,ENSG00000177981,ASB8,protein_coding,12,-1,48147789,48181213,q13.11,ankyrin repeat and SOCS box containing 8 [Source:HGNC Symbol;Acc:HGNC:17183],NA,ASB8,140461,NM_001319296;NM_001319297;NM_001319298;NM_001319299;NM_001319300;NM_001319301;NM_024095
ATG5_SIG,ATG5,ATG5_SIG,ATG5,SIG,37,-0.618885077610006,-0.0512941865133277,-0.0506432894994425,-0.0534328481303793,-0.00278955863093673,0.593358404235956,-0.490380179869833,4.60185866400554,4.60601453728777,4.58820365179249,-0.0178108854952795,0.715292835796367,ENSG00000057663,ATG5,protein_coding,6,-1,106045423,106325791,q21,autophagy related 5 [Source:HGNC Symbol;Acc:HGNC:589],SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 25,ATG5,9474,NM_001286106;NM_001286107;NM_001286108;NM_001286111;NM_004849
ARID4B_SIG,ARID4B,ARID4B_SIG,ARID4B,SIG,24,-0.617150490777929,0.404966726215993,0.406128590941351,0.401149170689815,-0.00497942025153617,0.594486173796567,-0.742347414225267,6.55216783101032,6.56113451042991,6.52270588434594,-0.0384286260839712,0.567703681639221,ENSG00000054267,ARID4B,protein_coding,1,-1,235131634,235328219,q42.3,AT-rich interaction domain 4B [Source:HGNC Symbol;Acc:HGNC:15550],NA,ARID4B,51742,NM_001206794;NM_016374;NM_031371
RBM7_SIG,RBM7,RBM7_SIG,RBM7,SIG,24,-0.617052693751419,0.63763071932659,0.640113374979254,0.629473422182122,-0.0106399527971327,0.594486173796567,-1.55962768831096,4.89768682339395,4.92023974531325,4.8235843656591,-0.0966553796541545,0.202644865725233,ENSG00000076053,RBM7,protein_coding,11,1,114400030,114414203,q23.2,RNA binding motif protein 7 [Source:HGNC Symbol;Acc:HGNC:9904],NA,RBM7,10179,NM_001286045;NM_001286046;NM_001286047;NM_001286048;NM_016090
REXO2_SIG,REXO2,REXO2_SIG,REXO2,SIG,60,0.617013124154443,0.0561652585048726,0.0547240184995785,0.0609007613794104,0.00617674287983195,0.594486173796567,0.284990371952449,4.11766250835609,4.11136344088566,4.13835944433038,0.026996003444725,0.836800270912958,ENSG00000076043,REXO2,protein_coding,11,1,114439386,114450279,q23.2,RNA exonuclease 2 [Source:HGNC Symbol;Acc:HGNC:17851],NA,REXO2,25996,NM_015523
AMY1B_SIG,AMY1B,AMY1B_SIG,AMY1B,SIG,2,-0.615390676853006,-0.0509724901413205,-0.0498597691011583,-0.0546285735589965,-0.00476880445783839,0.595591419409155,-0.0618969822057389,0.248743754945107,0.24909345734689,0.247594732767822,-0.00149872457906805,0.965913726337104,ENSG00000174876,AMY1B,protein_coding,1,-1,103687415,103696680,p21.1,amylase, alpha 1B (salivary) [Source:HGNC Symbol;Acc:HGNC:475],NA,AMY1B,277,NM_001008218
IRAK1_SIG,IRAK1,IRAK1_SIG,IRAK1,SIG,32,-0.614930805868817,0.1474008884575,0.148108990640306,0.14507426699971,-0.00303472364059579,0.595847837986865,-1.08951989688614,7.50364939320067,7.51840523676016,7.45516590721948,-0.0632393295406723,0.387247544501955,ENSG00000184216,IRAK1,protein_coding,X,-1,154010506,154019902,q28,interleukin 1 receptor associated kinase 1 [Source:HGNC Symbol;Acc:HGNC:6112],Pediatric systemic lupus erythematosus;Systemic lupus erythematosus,IRAK1,3654,NM_001025242;NM_001025243;NM_001569
MUL1_SIG,MUL1,MUL1_SIG,MUL1,SIG,20,-0.614801691812791,0.284521255875189,0.285697758535165,0.280655604278127,-0.00504215425703767,0.595862611118768,0.51486307160973,4.66946848335115,4.66366367348546,4.68854143005269,0.0248777565672347,0.701000901215527,ENSG00000090432,MUL1,protein_coding,1,-1,20499448,20508151,p36.12,mitochondrial E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:25762],NA,MUL1,79594,NM_024544
BTD_SIG,BTD,BTD_SIG,BTD,SIG,5,0.614664510721103,0.329357994717864,0.327968346063468,0.333923983153738,0.00595563709026989,0.595883281177312,2.16411012227753,3.21238687434262,3.18229313038089,3.31126631878831,0.128973188407417,0.0711458021548869,ENSG00000169814,BTD,protein_coding,3,1,15601341,15647640,p25.1,biotinidase [Source:HGNC Symbol;Acc:HGNC:1122],BIOTINIDASE DEFICIENCY,BTD,686,NM_000060;NM_001281723;NM_001281724;NM_001281725;NM_001281726;NM_001323582
ALDH9A1_SIG,ALDH9A1,ALDH9A1_SIG,ALDH9A1,SIG,46,0.613506816764619,0.238086618862595,0.236810388341401,0.242279947717949,0.00546955937654777,0.596649690123919,1.82013268558246,5.39757783458057,5.370502437743,5.48653985276117,0.11603741501817,0.133598978788976,ENSG00000143149,ALDH9A1,protein_coding,1,-1,165662216,165698863,q24.1,aldehyde dehydrogenase 9 family member A1 [Source:HGNC Symbol;Acc:HGNC:412],NA,ALDH9A1,223,NM_000696
PGM1_SIG,PGM1,PGM1_SIG,PGM1,SIG,45,-0.611846025302912,0.137748219649134,0.138627465610688,0.134859268632597,-0.00376819697809123,0.597784515852683,-0.107092542869851,5.16801987756166,5.1706218532586,5.15947052884314,-0.0111513244154562,0.940665525010429,ENSG00000079739,PGM1,protein_coding,1,1,63593411,63660245,p31.3,phosphoglucomutase 1 [Source:HGNC Symbol;Acc:HGNC:8905],CONGENITAL DISORDER OF GLYCOSYLATION TYPE It;PGM1-CDG,PGM1,5236,NM_001172818;NM_001172819;NM_002633
NT5C3B_SIG,NT5C3B,NT5C3B_SIG,NT5C3B,SIG,35,0.611629211789779,-0.0780450303977336,-0.0789361955114827,-0.0751169164525578,0.00381927905892509,0.597825959534215,1.74523375672602,3.33804143266321,3.29545872318881,3.47795604950766,0.182497326318854,0.151376280730508,ENSG00000141698,NT5C3B,protein_coding,17,-1,41825181,41836263,q21.2,5'-nucleotidase, cytosolic IIIB [Source:HGNC Symbol;Acc:HGNC:28300],NA,NT5C3B,115024,NM_052935
RNF38_SIG,RNF38,RNF38_SIG,RNF38,SIG,14,-0.61157129864618,0.671809465810409,0.673903514256776,0.664929020915205,-0.00897449334157085,0.597825959534215,-1.06410292995169,6.8269428002926,6.84014739134599,6.78355628683146,-0.0565911045145348,0.399528696030874,ENSG00000137075,RNF38,protein_coding,9,-1,36336396,36487548,p13.2,ring finger protein 38 [Source:HGNC Symbol;Acc:HGNC:18052],NA,RNF38,152006,NM_022781;NM_194328;NM_194329;NM_194330;NM_194332
ARID4A_TF,ARID4A,ARID4A_TF,ARID4A,TF,146,-0.610704717451723,0.16715310039038,0.168301166820937,0.163380882118553,-0.00492028470238375,0.598380237149242,0.580282815569627,6.25148229171009,6.24391023278083,6.27636191390623,0.0324516811253942,0.662950337117487,ENSG00000032219,ARID4A,protein_coding,14,1,58298385,58373887,q23.1,AT-rich interaction domain 4A [Source:HGNC Symbol;Acc:HGNC:9885],NA,ARID4A,5926,NM_002892;NM_023000;NM_023001
MAP2K2_SIG,MAP2K2,MAP2K2_SIG,MAP2K2,SIG,14,-0.610412482540186,0.129987244290645,0.13052790789967,0.128210778146706,-0.00231712975296358,0.598514280726852,0.385268768300623,6.36484762402609,6.36147282497578,6.37593624947713,0.0144634245013488,0.777075517271099,ENSG00000126934,MAP2K2,protein_coding,19,-1,4090321,4124129,p13.3,mitogen-activated protein kinase kinase 2 [Source:HGNC Symbol;Acc:HGNC:6842],CARDIOFACIOCUTANEOUS SYNDROME;CARDIOFACIOCUTANEOUS SYNDROME 4;Neurofibromatosis-Noonan syndrome,MAP2K2,5605,NM_030662
DCP1A_SIG,DCP1A,DCP1A_SIG,DCP1A,SIG,104,0.609630024338578,0.360155823044318,0.358119282824799,0.366847312337024,0.00872802951222511,0.599007177286008,1.19577616541038,5.75796941832969,5.73519929609122,5.83278553425611,0.0975862381648939,0.338963202384619,ENSG00000272886,DCP1A,protein_coding,3,-1,53283429,53347586,p21.1,decapping mRNA 1A [Source:HGNC Symbol;Acc:HGNC:18714],NA,DCP1A,55802,NM_001290204;NM_001290205;NM_001290206;NM_001290207;NM_018403
DDOST_SIG,DDOST,DDOST_SIG,DDOST,SIG,58,0.609341235293854,0.335288489168774,0.33414796105599,0.339035938682207,0.00488797762621689,0.599138718810541,-0.523089927721135,7.95875481090396,7.96562340868117,7.93618656106454,-0.0294368476166317,0.69642323820865,ENSG00000244038,DDOST,protein_coding,1,-1,20651767,20661544,p36.12,dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit [Source:HGNC Symbol;Acc:HGNC:2728],CONGENITAL DISORDER OF GLYCOSYLATION TYPE Ir;DDOST-CDG,DDOST,1650,NM_005216
GLIS2_TF,GLIS2,GLIS2_TF,GLIS2,TF,91,-0.60906306086015,-0.0795041869538817,-0.079043265327214,-0.0810186437272183,-0.00197537840000433,0.59919920710247,1.14129039061,0.502497866750576,0.482657640468762,0.567687181676538,0.0850295412077763,0.36301874265502,ENSG00000126603,GLIS2,protein_coding,16,1,4314761,4339597,p13.3,GLIS family zinc finger 2 [Source:HGNC Symbol;Acc:HGNC:29450],Acute megakaryoblastic leukemia without Down syndrome;Juvenile nephronophthisis;Nephronophthisis 7,GLIS2,84662,NM_001318918;NM_032575
NAA20_SIG,NAA20,NAA20_SIG,NAA20,SIG,27,0.609040375773254,0.321062004557467,0.319441038336604,0.326388036426018,0.00694699808941356,0.59919920710247,0.0561099780181855,4.79344156004509,4.79267411088889,4.79596317870117,0.00328906781228793,0.968872803993975,ENSG00000173418,NAA20,protein_coding,20,1,20017116,20033655,p11.23,N(alpha)-acetyltransferase 20, NatB catalytic subunit [Source:HGNC Symbol;Acc:HGNC:15908],NA,NAA20,51126,NM_016100;NM_181527;NM_181528
ANP32A_SIG,ANP32A,ANP32A_SIG,ANP32A,SIG,20,0.607959383701374,0.282583434676536,0.281304118184358,0.286786903150837,0.00548278496647961,0.599910878049426,0.564532733866983,7.88624099533936,7.87961724575594,7.90800474397061,0.028387498214668,0.672101786104468,ENSG00000140350,ANP32A,protein_coding,15,-1,68778535,68820897,q23,acidic nuclear phosphoprotein 32 family member A [Source:HGNC Symbol;Acc:HGNC:13233],NA,ANP32A,8125,NM_006305
SCNN1A_SIG,SCNN1A,SCNN1A_SIG,SCNN1A,SIG,19,-0.606547952394853,0.118009116744795,0.118645198921518,0.115919132449847,-0.00272606647167113,0.600865070119372,0.226162818657543,1.26480395040278,1.2615624469462,1.27545460461725,0.0138921576710502,0.872053061544246,ENSG00000111319,SCNN1A,protein_coding,12,-1,6346843,6377730,p13.31,sodium channel epithelial 1 alpha subunit [Source:HGNC Symbol;Acc:HGNC:10599],BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2;Generalized pseudohypoaldosteronism type 1;Idiopathic bronchiectasis;LIDDLE SYNDROME 3;PSEUDOHYPOALDOSTERONISM TYPE I AUTOSOMAL RECESSIVE,SCNN1A,6337,NM_001038;NM_001159575;NM_001159576
NDUFB3_SIG,NDUFB3,NDUFB3_SIG,NDUFB3,SIG,79,-0.605390694580402,0.0265178500931629,0.0286675851708303,0.0194544348379699,-0.00921315033286049,0.601633461920961,-0.656729252604874,3.89476473069678,3.90678998814108,3.85525317052263,-0.0515368176184556,0.61676858017669,ENSG00000119013,NDUFB3,protein_coding,2,1,201071433,201085750,q33.1,NADH:ubiquinone oxidoreductase subunit B3 [Source:HGNC Symbol;Acc:HGNC:7698],Isolated complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 25,NDUFB3,4709,NM_001257102;NM_002491
CYP20A1_SIG,CYP20A1,CYP20A1_SIG,CYP20A1,SIG,34,0.605148261309514,-0.0822591396842528,-0.0830076317855542,-0.0797998084942627,0.00320782329129166,0.601731093557633,2.32503554927388,3.47990137553957,3.45573161713292,3.55931629601857,0.103584678885651,0.0512799224147744,ENSG00000119004,CYP20A1,protein_coding,2,1,203238940,203305611,q33.2,cytochrome P450 family 20 subfamily A member 1 [Source:HGNC Symbol;Acc:HGNC:20576],NA,CYP20A1,57404,NM_177538
ARID4A_SIG,ARID4A,ARID4A_SIG,ARID4A,SIG,21,-0.604884386102951,0.554266907873011,0.555793484507956,0.549251013215337,-0.00654247129261862,0.601844451840879,0.580282815569627,6.25148229171009,6.24391023278083,6.27636191390623,0.0324516811253942,0.662950337117487,ENSG00000032219,ARID4A,protein_coding,14,1,58298385,58373887,q23.1,AT-rich interaction domain 4A [Source:HGNC Symbol;Acc:HGNC:9885],NA,ARID4A,5926,NM_002892;NM_023000;NM_023001
PHF19_TF,PHF19,PHF19_TF,PHF19,TF,98,0.602252644659034,0.109879614477701,0.109000993651779,0.112766511477162,0.00376551782538339,0.603695820509795,-2.38973029653178,5.98827985705155,6.01963518933344,5.88525519383963,-0.134379995493803,0.044788755730261,ENSG00000119403,PHF19,protein_coding,9,-1,120855651,120894896,q33.2,PHD finger protein 19 [Source:HGNC Symbol;Acc:HGNC:24566],NA,PHF19,26147,NM_001009936;NM_001286840;NM_001286842;NM_001286843;NM_015651
PABPC3_SIG,PABPC3,PABPC3_SIG,PABPC3,SIG,61,0.602075325207188,0.114843983229727,0.113494277147876,0.119278731784381,0.005784454636505,0.603745648221718,-0.177187886233931,5.80377981123244,5.80602313092929,5.79640890365706,-0.00961422727222515,0.900456549445066,ENSG00000151846,PABPC3,protein_coding,13,1,25095868,25099254,q12.13,poly(A) binding protein cytoplasmic 3 [Source:HGNC Symbol;Acc:HGNC:8556],NA,PABPC3,5042,NM_030979
SMU1_SIG,SMU1,SMU1_SIG,SMU1,SIG,19,0.601708834664096,0.520201673486711,0.519546826277611,0.52235331431661,0.00280648803899901,0.603934427539195,-0.703875533254056,5.87289602370854,5.87820329451578,5.85545784819905,-0.022745446316728,0.58976940098921,ENSG00000122692,SMU1,protein_coding,9,-1,33041765,33076674,p21.1,SMU1, DNA replication regulator and spliceosomal factor [Source:HGNC Symbol;Acc:HGNC:18247],NA,SMU1,55234,NM_018225
HLF_TF,HLF,HLF_TF,HLF,TF,206,0.601145932044298,-0.0617546943711455,-0.0626468102463184,-0.0588234564955776,0.00382335375074069,0.604267514930355,4.24368976401334,1.1003736739534,0.959613007043652,1.56287300808543,0.603260001041774,0.000247231353118175,ENSG00000108924,HLF,protein_coding,17,1,55264960,55325187,q22,HLF, PAR bZIP transcription factor [Source:HGNC Symbol;Acc:HGNC:4977],Precursor B-cell acute lymphoblastic leukemia,HLF,3131,NM_001330375;NM_002126
STMN1_SIG,STMN1,STMN1_SIG,STMN1,SIG,32,0.600472587504297,0.328459642852742,0.326247041726479,0.335729617981894,0.00948257625541484,0.604681816570497,1.16764299622191,7.05923215876032,7.02515806880231,7.17118988290806,0.146031814105749,0.351512126277953,ENSG00000117632,STMN1,protein_coding,1,-1,25884181,25906991,p36.11,stathmin 1 [Source:HGNC Symbol;Acc:HGNC:6510],NA,STMN1,3925,NM_001145454;NM_005563;NM_203399;NM_203401
SNW1_SIG,SNW1,SNW1_SIG,SNW1,SIG,24,0.599754144395323,0.386031478956865,0.385491051678865,0.387807168584578,0.00231611690571275,0.60512936112115,-0.601934266823875,6.64803085760584,6.65338755493907,6.63043028065378,-0.0229572742852922,0.649894171975811,ENSG00000100603,SNW1,protein_coding,14,-1,77717599,77761207,q24.3,SNW domain containing 1 [Source:HGNC Symbol;Acc:HGNC:16696],NA,SNW1,22938,NM_001318844;NM_012245
PRDX3_SIG,PRDX3,PRDX3_SIG,PRDX3,SIG,56,0.599531950180643,0.326559118060631,0.325166387655828,0.331135232247841,0.00596884459201338,0.605151021155686,1.36381118727742,5.6469079622316,5.61564602721454,5.74962574871622,0.133979721501682,0.270278538489477,ENSG00000165672,PRDX3,protein_coding,10,-1,119167720,119178812,q26.11,peroxiredoxin 3 [Source:HGNC Symbol;Acc:HGNC:9354],NA,PRDX3,10935,NM_001302272;NM_006793
MGRN1_SIG,MGRN1,MGRN1_SIG,MGRN1,SIG,28,0.599505534499917,0.229146075692699,0.228655193385235,0.230758974702936,0.00210378131770124,0.605151021155686,1.43296744774723,7.02952164181796,7.01409973413601,7.0801936242015,0.0660938900654883,0.244529076114655,ENSG00000102858,MGRN1,protein_coding,16,1,4616493,4690974,p13.3,mahogunin ring finger 1 [Source:HGNC Symbol;Acc:HGNC:20254],NA,MGRN1,23295,NM_001142289;NM_001142290;NM_001142291;NM_015246
PGGT1B_SIG,PGGT1B,PGGT1B_SIG,PGGT1B,SIG,39,0.59891656140335,0.112573531164787,0.112120357699673,0.11406252969302,0.00194217199334776,0.605503439163018,1.59452498856583,4.269433351129,4.24904434719901,4.33642579261325,0.0873814454142393,0.192219508483359,ENSG00000164219,PGGT1B,protein_coding,5,-1,115204012,115262877,q22.3,protein geranylgeranyltransferase type I subunit beta [Source:HGNC Symbol;Acc:HGNC:8895],NA,PGGT1B,5229,NM_005023
A4GALT_SIG,A4GALT,A4GALT_SIG,A4GALT,SIG,24,-0.598601958020363,-0.241112531038286,-0.238976889451017,-0.248129639110741,-0.00915274965972422,0.605654168461938,1.77247343217652,1.41167111344946,1.34495430754983,1.63088347569108,0.285929168141242,0.144861485373956,ENSG00000128274,A4GALT,protein_coding,22,-1,42692121,42721298,q13.2,alpha 1,4-galactosyltransferase (P blood group) [Source:HGNC Symbol;Acc:HGNC:18149],BLOOD GROUP P1PK SYSTEM P(1) PHENOTYPE INCLUDED,A4GALT,53947,NM_001318038;NM_017436
FOXRED2_SIG,FOXRED2,FOXRED2_SIG,FOXRED2,SIG,16,0.598172982233427,0.503312883779373,0.500881747026445,0.511300904538994,0.010419157512549,0.605889001361474,1.59734926135889,4.04183248416121,3.99380897862408,4.19962400235462,0.205815023730541,0.191381833274146,ENSG00000100350,FOXRED2,protein_coding,22,-1,36487190,36507101,q12.3,FAD dependent oxidoreductase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26264],NA,FOXRED2,80020,NM_001102371;NM_024955
ZBTB8OS_SIG,ZBTB8OS,ZBTB8OS_SIG,ZBTB8OS,SIG,16,-0.597086613013137,0.221512281414939,0.222814671939827,0.217232998261733,-0.00558167367809435,0.60660741750191,-0.167429224146799,3.82452094519102,3.82652275883722,3.8179435574964,-0.00857920134081602,0.906033824232018,ENSG00000176261,ZBTB8OS,protein_coding,1,-1,32600172,32650903,p35.1,zinc finger and BTB domain containing 8 opposite strand [Source:HGNC Symbol;Acc:HGNC:24094],NA,ZBTB8OS,339487,NM_001308135;NM_001308136;NM_001308137;NM_001308138;NM_001308139;NM_001308140;NM_001308141;NM_001330475;NM_001366257;NM_001366278;NM_178547
EPHB3_SIG,EPHB3,EPHB3_SIG,EPHB3,SIG,19,-0.596639159825048,0.144610269588974,0.146445933135635,0.138578803649944,-0.0078671294856909,0.606855942850979,0.294453455320969,1.26456746934121,1.25536748092634,1.29479600270434,0.0394285217779947,0.831077987702029,ENSG00000182580,EPHB3,protein_coding,3,1,184561785,184582408,q27.1,EPH receptor B3 [Source:HGNC Symbol;Acc:HGNC:3394],NA,EPHB3,2049,NM_004443
COLEC12_SIG,COLEC12,COLEC12_SIG,COLEC12,SIG,36,0.596335222768002,-0.0348795051841422,-0.0355809781847461,-0.0325746653250151,0.00300631285973105,0.606920692376996,-3.18027343296856,0.766739531681521,0.852971594421727,0.483405611249414,-0.369565983172314,0.00670286886754009,ENSG00000158270,COLEC12,protein_coding,18,-1,316737,500722,p11.32,collectin subfamily member 12 [Source:HGNC Symbol;Acc:HGNC:16016],NA,COLEC12,81035,NM_130386
SUPT5H_SIG,SUPT5H,SUPT5H_SIG,SUPT5H,SIG,17,0.596331795643826,0.499201518907227,0.497972674204934,0.503239151500479,0.00526647729554534,0.606920692376996,0.695242867807505,7.32954032622881,7.32417210315319,7.34717877347728,0.0230066703240936,0.59487515306752,ENSG00000196235,SUPT5H,protein_coding,19,1,39436156,39476670,q13.2,SPT5 homolog, DSIF elongation factor subunit [Source:HGNC Symbol;Acc:HGNC:11469],NA,SUPT5H,6829,NM_001111020;NM_001130824;NM_001130825;NM_001319990;NM_001319991;NM_003169
RNF217_SIG,RNF217,RNF217_SIG,RNF217,SIG,53,-0.595283042195958,-0.0487931289515713,-0.0478715421516954,-0.0518211998654494,-0.00394965771375384,0.607611777019252,-2.82386263076997,4.17353870849011,4.30824601796815,3.73092897734797,-0.577317040620183,0.0167142732723513,ENSG00000146373,RNF217,protein_coding,6,1,124962545,125092633,q22.31,ring finger protein 217 [Source:HGNC Symbol;Acc:HGNC:21487],NA,RNF217,154214,NM_001286398;NM_152553
KDM5A_TF,KDM5A,KDM5A_TF,KDM5A,TF,136,-0.594883225431792,0.430032123906558,0.43079131159162,0.427537650084209,-0.00325366150741164,0.607825320110883,0.0157668708988897,6.99677953223117,6.99660603984632,6.99734957863851,0.000743538792186804,0.991484635002324,ENSG00000073614,KDM5A,protein_coding,12,-1,280129,389454,p13.33,lysine demethylase 5A [Source:HGNC Symbol;Acc:HGNC:9886],Autosomal Recessive Mental Retardation,KDM5A,5927,NM_001042603
ZNF213_TF,ZNF213,ZNF213_TF,ZNF213,TF,56,0.594660604720175,0.271079361601286,0.269262978025173,0.277047479065654,0.00778450104048092,0.607908417802313,0.608379702815782,4.12113901938252,4.11216329906507,4.15063067185414,0.0384673727890751,0.645748757811394,ENSG00000085644,ZNF213,protein_coding,16,1,3129777,3142805,p13.3,zinc finger protein 213 [Source:HGNC Symbol;Acc:HGNC:13005],NA,ZNF213,7760,NM_001134655;NM_004220
LAG3_SIG,LAG3,LAG3_SIG,LAG3,SIG,50,0.594362864989385,-7.91248466291528e-05,-0.00147513805867587,0.00450777570723865,0.00598291376591463,0.608046818941235,-1.34584662685591,2.04652707039905,2.09079933953166,1.90106104324901,-0.189738296282652,0.276869300101376,ENSG00000089692,LAG3,protein_coding,12,1,6772512,6778455,p13.31,lymphocyte activating 3 [Source:HGNC Symbol;Acc:HGNC:6476],NA,LAG3,3902,NM_002286
GPBP1L1_TF,GPBP1L1,GPBP1L1_TF,GPBP1L1,TF,60,0.592834830069233,0.345990805906382,0.345161784922442,0.34871473199647,0.00355294707402781,0.609091376330772,1.05720398912456,7.25133598360092,7.24136360353919,7.28410237523232,0.0427387716931317,0.40264007263031,ENSG00000159592,GPBP1L1,protein_coding,1,-1,45627304,45688113,p34.1,GC-rich promoter binding protein 1 like 1 [Source:HGNC Symbol;Acc:HGNC:28843],NA,GPBP1L1,60313,NM_021639
TAF3_SIG,TAF3,TAF3_SIG,TAF3,SIG,18,0.592488240490318,0.158883257860359,0.158263573807162,0.160919362606575,0.00265578879941291,0.609265815944303,1.28748358969875,4.64235893860019,4.62826848059533,4.688656157759,0.0603876771636687,0.299935711337442,ENSG00000165632,TAF3,protein_coding,10,1,7818505,8016631,p14,TATA-box binding protein associated factor 3 [Source:HGNC Symbol;Acc:HGNC:17303],NA,TAF3,83860,NM_031923
FAR2_SIG,FAR2,FAR2_SIG,FAR2,SIG,38,-0.592359052463358,0.382398999469714,0.383858550065506,0.377603333226397,-0.00625521683910899,0.609280066659134,0.589608838306803,5.10156741387177,5.08534039802652,5.15488475164906,0.0695443536225405,0.657520135065987,ENSG00000064763,FAR2,protein_coding,12,1,29149103,29340980,p11.22,fatty acyl-CoA reductase 2 [Source:HGNC Symbol;Acc:HGNC:25531],NA,FAR2,55711,NM_001271783;NM_001271784;NM_018099
IGFLR1_SIG,IGFLR1,IGFLR1_SIG,IGFLR1,SIG,18,-0.590756324058392,0.240645107338725,0.242452745509033,0.234705724779139,-0.00774702072989392,0.610380459532791,-0.38122844126066,1.86005178264643,1.86649860513911,1.83886936588479,-0.0276292392543186,0.779718404813492,ENSG00000126246,IGFLR1,protein_coding,19,-1,35738801,35742453,q13.12,IGF like family receptor 1 [Source:HGNC Symbol;Acc:HGNC:23620],NA,IGFLR1,79713,NM_001346003;NM_001346004;NM_001346005;NM_001346006;NM_024660
SLC3A2_SIG,SLC3A2,SLC3A2_SIG,SLC3A2,SIG,32,-0.588272117700101,0.169671545804584,0.170396046745542,0.167291042712865,-0.00310500403267723,0.612132392098553,0.838009310667695,6.79779693614138,6.78442440454994,6.84173525422753,0.0573108496775924,0.514687847173655,ENSG00000168003,SLC3A2,protein_coding,11,1,62856102,62888875,q12.3,solute carrier family 3 member 2 [Source:HGNC Symbol;Acc:HGNC:11026],NA,SLC3A2,6520,NM_001012662;NM_001012664;NM_001013251;NM_002394
WNK1_SIG,WNK1,WNK1_SIG,WNK1,SIG,26,-0.587311161837201,0.201290119333214,0.201840386286916,0.19948209934248,-0.00235828694443691,0.612760784908768,-1.45049912424146,8.35271343297224,8.37405222829849,8.28260024832886,-0.091451979969623,0.23843078132333,ENSG00000060237,WNK1,protein_coding,12,1,752579,911452,p13.33,WNK lysine deficient protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:14540],Hereditary sensory and autonomic neuropathy type 2;NEUROPATHY HEREDITARY SENSORY AND AUTONOMIC TYPE IIA;Pseudohypoaldosteronism type 2C;PSEUDOHYPOALDOSTERONISM TYPE IIC,WNK1,65125,NM_001184985;NM_014823;NM_018979;NM_213655
AMZ1_SIG,AMZ1,AMZ1_SIG,AMZ1,SIG,34,-0.585413742248026,0.00838642215924154,0.00956360054475393,0.00451855032112937,-0.00504505022362466,0.614081681829399,0.644006375246255,0.554480063207051,0.543030576368711,0.59209980567588,0.0490692293071693,0.624595977072789,ENSG00000174945,AMZ1,protein_coding,7,1,2679522,2775500,p22.3,archaelysin family metallopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:22231],NA,AMZ1,155185,NM_001284355;NM_001321766;NM_133463
PTS_SIG,PTS,PTS_SIG,PTS,SIG,27,-0.58251038564192,0.350222844695269,0.35262100471263,0.342343176066799,-0.0102778286458304,0.616148562935248,0.456739275260711,3.44090166663424,3.43309258779675,3.46656006852885,0.0334674807321004,0.735345108943989,ENSG00000150787,PTS,protein_coding,11,1,112226367,112269955,q23.1,6-pyruvoyltetrahydropterin synthase [Source:HGNC Symbol;Acc:HGNC:9689],6-pyruvoyl-tetrahydropterin synthase deficiency;6-Pyruvoyltetrahydropterin Synthase Deficiency;HYPERPHENYLALANINEMIA BH4-DEFICIENT A,PTS,5805,NM_000317
ZBTB43_TF,ZBTB43,ZBTB43_TF,ZBTB43,TF,122,-0.58206355364396,0.190238205100227,0.192502982968585,0.182796792104191,-0.00970619086439407,0.616393247407754,-0.158222508264928,5.71913761955194,5.7234929491434,5.70482725089428,-0.0186656982491202,0.911119146516106,ENSG00000169155,ZBTB43,protein_coding,9,1,126805006,126838210,q33.3,zinc finger and BTB domain containing 43 [Source:HGNC Symbol;Acc:HGNC:17908],NA,ZBTB43,23099,NM_001135776;NM_014007
TALDO1_SIG,TALDO1,TALDO1_SIG,TALDO1,SIG,41,0.581959114407878,0.187341829534554,0.18609553281931,0.19143680445607,0.00534127163675989,0.616393247407754,1.30785120341752,8.33178394168472,8.31038266832099,8.4021024113084,0.0917197429874043,0.291842465462521,ENSG00000177156,TALDO1,protein_coding,11,1,747415,765012,p15.5,transaldolase 1 [Source:HGNC Symbol;Acc:HGNC:11559],TRANSALDOLASE DEFICIENCY,TALDO1,6888,NM_006755
HSP90B1_SIG,HSP90B1,HSP90B1_SIG,HSP90B1,SIG,32,-0.581414223282851,0.484175866713026,0.485267015338716,0.480590664085758,-0.00467635125295771,0.616715032365213,-0.0488904591027018,9.14528906636866,9.14607028860164,9.14272219331741,-0.00334809528423124,0.972936941456647,ENSG00000166598,HSP90B1,protein_coding,12,1,103930107,103953645,q23.3,heat shock protein 90 beta family member 1 [Source:HGNC Symbol;Acc:HGNC:12028],NA,HSP90B1,7184,NM_003299
TIGD3_TF,TIGD3,TIGD3_TF,TIGD3,TF,24,-0.580391460006406,-0.000268389664845312,0.00031120588171687,-0.00217277503212105,-0.002483980913838,0.617390970102644,1.89249768231507,1.21167179478223,1.17990635843604,1.31604394277685,0.136137584340813,0.117782447756173,ENSG00000173825,TIGD3,protein_coding,11,1,65354751,65357613,q13.1,tigger transposable element derived 3 [Source:HGNC Symbol;Acc:HGNC:18334],NA,TIGD3,220359,NM_145719
WWP1_SIG,WWP1,WWP1_SIG,WWP1,SIG,17,0.579330057433663,0.065294158020949,0.0644235251839159,0.0681548087712006,0.00373128358728455,0.618095828150909,-0.262586505421232,5.21212546525567,5.21579716063706,5.20006132328823,-0.0157358373488324,0.850002640884212,ENSG00000123124,WWP1,protein_coding,8,1,86342738,86478420,q21.3,WW domain containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:17004],NA,WWP1,11059,NM_007013
PIGC_SIG,PIGC,PIGC_SIG,PIGC,SIG,8,0.579106921546548,0.259781104542885,0.258899252483732,0.262678618451533,0.00377936596780151,0.618179280226665,-0.541515698981034,4.78149974052622,4.78699352324611,4.76344874016087,-0.0235447830852406,0.685532145782221,ENSG00000135845,PIGC,protein_coding,1,-1,172370189,172444086,q24.3,phosphatidylinositol glycan anchor biosynthesis class C [Source:HGNC Symbol;Acc:HGNC:8960],Autosomal recessive non-syndromic intellectual disability;GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16,PIGC,5279,NM_002642;NM_153747
UFL1_SIG,UFL1,UFL1_SIG,UFL1,SIG,25,0.578315433897239,0.512702611083202,0.511960471686762,0.515141069100075,0.00318059741331311,0.618684216833891,2.05983574754811,5.48645072025545,5.46338830325877,5.56222723324456,0.098838929985785,0.0867736559278102,ENSG00000014123,UFL1,protein_coding,6,1,96521595,96555276,q16.1,UFM1 specific ligase 1 [Source:HGNC Symbol;Acc:HGNC:23039],NA,UFL1,23376,NM_015323
RNF4_SIG,RNF4,RNF4_SIG,RNF4,SIG,33,-0.577847885563991,0.418214145833469,0.419123873188106,0.415225041668233,-0.00389883151987288,0.61894896223634,0.379968493404242,6.18747362639953,6.18312106662223,6.20177489423922,0.0186538276169886,0.780452233187039,ENSG00000063978,RNF4,protein_coding,4,1,2462220,2625320,p16.3,ring finger protein 4 [Source:HGNC Symbol;Acc:HGNC:10067],NA,RNF4,6047,NM_001185009;NM_001185010;NM_002938
TEX14_SIG,TEX14,TEX14_SIG,TEX14,SIG,16,-0.577493207721265,-0.093222725549395,-0.0913501232609165,-0.0993755616401102,-0.00802543837919391,0.619129993170247,-0.95756829013592,0.984583358327448,1.00648730904077,0.912613234555097,-0.0938740744856746,0.45192504896413,ENSG00000121101,TEX14,protein_coding,17,-1,58556678,58692055,q22,testis expressed 14, intercellular bridge forming factor [Source:HGNC Symbol;Acc:HGNC:11737],SPERMATOGENIC FAILURE 23,TEX14,56155,NM_001201457;NM_031272;NM_198393
FIG4_SIG,FIG4,FIG4_SIG,FIG4,SIG,70,-0.577240337198336,0.336880164574715,0.33850746003579,0.331533336631184,-0.00697412340460593,0.619235498966417,-1.01998655654178,4.82671302424442,4.8476156518809,4.75803296201026,-0.0895826898706372,0.420639677716523,ENSG00000112367,FIG4,protein_coding,6,1,109691312,109825428,q21,FIG4 phosphoinositide 5-phosphatase [Source:HGNC Symbol;Acc:HGNC:16873],Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 11;Bilateral parasagittal parieto-occipital polymicrogyria;CHARCOT-MARIE-TOOTH DISEASE TYPE 4J;CLEIDOCRANIAL DYSPLASIA WITH MICROGNATHIA ABSENT THUMBS AND DISTAL APHALANGIA YUNIS-VARON SYNDROME;Polymicrogyria bilateral temporooccipital;YUNIS-VARON SYNDROME,FIG4,9896,NM_014845
HMGB1_SIG,HMGB1,HMGB1_SIG,HMGB1,SIG,34,-0.573766710353889,0.292146089519718,0.293284922562922,0.288404209520619,-0.00488071304230277,0.621732667987897,-1.63007093573259,8.06892093652818,8.09113408993024,7.99593486106427,-0.0951992288659699,0.182142091177895,ENSG00000189403,HMGB1,protein_coding,13,-1,30456704,30617597,q12.3,high mobility group box 1 [Source:HGNC Symbol;Acc:HGNC:4983],NA,HMGB1,3146,NM_001313892;NM_001313893;NM_002128
ZNF385D_TF,ZNF385D,ZNF385D_TF,ZNF385D,TF,228,-0.573072726413365,-0.0362008546311226,-0.0353155295830574,-0.0391097797890512,-0.00379425020599393,0.622166113635199,-3.21982501792169,0.950331320242326,1.06117921594063,0.586116805805026,-0.475062410135608,0.00601000425386647,ENSG00000151789,ZNF385D,protein_coding,3,-1,21412218,22373321,p24.3,zinc finger protein 385D [Source:HGNC Symbol;Acc:HGNC:26191],NA,ZNF385D,79750,NM_024697
VRK2_SIG,VRK2,VRK2_SIG,VRK2,SIG,6,0.572290532923188,0.402692668747844,0.40211651708384,0.404585738500998,0.00246922141715798,0.622665249159451,1.65416207782417,4.95132972528799,4.93621214953516,5.00100175990443,0.0647896103692692,0.175302140511003,ENSG00000028116,VRK2,protein_coding,2,1,57907629,58159920,p16.1,VRK serine/threonine kinase 2 [Source:HGNC Symbol;Acc:HGNC:12719],NA,VRK2,7444,NM_001130480;NM_001130481;NM_001130482;NM_001130483;NM_001288836;NM_001288837;NM_001288838;NM_001288839;NM_006296
DCUN1D1_SIG,DCUN1D1,DCUN1D1_SIG,DCUN1D1,SIG,44,0.572139483681009,0.523017048710087,0.521727917741598,0.527252764749407,0.00552484700780933,0.622695069111776,1.91677567752297,5.65060819134355,5.627241727677,5.72738371481937,0.100141987142374,0.112911039858179,ENSG00000043093,DCUN1D1,protein_coding,3,-1,182938074,182985953,q26.33,defective in cullin neddylation 1 domain containing 1 [Source:HGNC Symbol;Acc:HGNC:18184],NA,DCUN1D1,54165,NM_001308101;NM_020640
RPL19_SIG,RPL19,RPL19_SIG,RPL19,SIG,48,0.571790162725686,0.916284225819647,0.913862003175711,0.92424295736401,0.0103809541882993,0.622872339870554,1.17845177566951,9.51384472265698,9.49745373321476,9.5677008308243,0.0702470976095365,0.346492406820757,ENSG00000108298,RPL19,protein_coding,17,1,39200283,39204732,q12,ribosomal protein L19 [Source:HGNC Symbol;Acc:HGNC:10312],NA,RPL19,6143,NM_000981;NM_001330200
ABCA10_SIG,ABCA10,ABCA10_SIG,ABCA10,SIG,46,0.57149029435824,-0.0422586050102176,-0.0429362071073423,-0.0400321981196652,0.00290400898767702,0.623012835036177,1.00994261650139,0.687147611819244,0.674950059067241,0.727225285147255,0.0522752260800143,0.425789452600614,ENSG00000154263,ABCA10,protein_coding,17,-1,69147214,69244846,q24.3,ATP binding cassette subfamily A member 10 [Source:HGNC Symbol;Acc:HGNC:30],NA,ABCA10,10349,NM_080282
JUND_TF,JUND,JUND_TF,JUND,TF,89,0.56999741085322,0.0605006347902394,0.0590299116446444,0.0653330108400517,0.0063030991954074,0.624002975923128,0.39630229972757,8.74304974579679,8.73345204234826,8.7745850571277,0.0411330147794421,0.770568638848691,ENSG00000130522,JUND,protein_coding,19,-1,18279760,18281622,p13.11,JunD proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6206],NA,JUND,3727,NM_001286968;NM_005354
ATP13A3_SIG,ATP13A3,ATP13A3_SIG,ATP13A3,SIG,17,-0.569937405574105,0.317670321531694,0.318577953785199,0.314688101270176,-0.003889852515023,0.624002975923128,-0.819082258800889,6.59479227058746,6.61043271284326,6.54340224603269,-0.0670304668105731,0.524701156669508,ENSG00000133657,ATP13A3,protein_coding,3,-1,194402672,194498364,q29,ATPase 13A3 [Source:HGNC Symbol;Acc:HGNC:24113],NA,ATP13A3,79572,NM_024524
PDP1_SIG,PDP1,PDP1_SIG,PDP1,SIG,39,-0.568137783623342,0.104665129109682,0.105408952032173,0.102221139507211,-0.00318781252496256,0.62526014459536,1.62130885039291,4.99808866970263,4.96913603044883,5.09321877010798,0.124082739659146,0.184622980298351,ENSG00000164951,PDP1,protein_coding,8,1,93857807,93926068,q22.1,pyruvate dehyrogenase phosphatase catalytic subunit 1 [Source:HGNC Symbol;Acc:HGNC:9279],Pyruvate dehydrogenase phosphatase deficiency,PDP1,54704,NM_001161779;NM_001161780;NM_001161781;NM_018444
ZNF778_TF,ZNF778,ZNF778_TF,ZNF778,TF,36,-0.566958800185257,0.355287044422055,0.355818664648109,0.353540292250734,-0.00227837239737531,0.626055727032873,0.876299713201744,2.73132116964926,2.72053273114959,2.76676889614816,0.0462361649985761,0.494477682812112,ENSG00000170100,ZNF778,protein_coding,16,1,89217703,89237071,q24.3,zinc finger protein 778 [Source:HGNC Symbol;Acc:HGNC:26479],NA,ZNF778,197320,NM_001201407;NM_182531
GP6_SIG,GP6,GP6_SIG,GP6,SIG,40,-0.563244570767162,-0.142665195305995,-0.140582711161909,-0.149507643207991,-0.0089249320460823,0.628743491362468,-0.14304211260686,0.979804189954565,0.983973577860765,0.966104772548478,-0.0178688053122872,0.91980773177325,ENSG00000088053,GP6,protein_coding,19,-1,55013705,55038264,q13.42,glycoprotein VI platelet [Source:HGNC Symbol;Acc:HGNC:14388],Bleeding diathesis due to glycoprotein VI deficiency;BLEEDING DISORDER PLATELET-TYPE 11,GP6,51206,NM_001083899;NM_001256017;NM_016363
SNRPC_SIG,SNRPC,SNRPC_SIG,SNRPC,SIG,53,0.562795212580183,0.361698254039781,0.360800050977181,0.36464949267404,0.00384944169685912,0.628995818969552,0.517208693477455,5.67049298339036,5.66460110273727,5.68985201982193,0.0252509170846516,0.699732162252646,ENSG00000124562,SNRPC,protein_coding,6,1,34757505,34773857,p21.31,small nuclear ribonucleoprotein polypeptide C [Source:HGNC Symbol;Acc:HGNC:11157],NA,SNRPC,6631,NM_003093
RRM1_SIG,RRM1,RRM1_SIG,RRM1,SIG,53,-0.561274305285713,0.398723214793914,0.401891535538267,0.388313018062469,-0.013578517475798,0.630048762429896,-0.18125615984105,5.68765658736719,5.69159695223644,5.67470967422539,-0.0168872780110513,0.898129293131336,ENSG00000167325,RRM1,protein_coding,11,1,4094707,4138932,p15.4,ribonucleotide reductase catalytic subunit M1 [Source:HGNC Symbol;Acc:HGNC:10451],NA,RRM1,6240,NM_001033;NM_001318064;NM_001318065;NM_001330193
FLI1_TF,FLI1,FLI1_TF,FLI1,TF,92,0.560889439995215,0.235902950938878,0.234391505854475,0.240869127644774,0.00647762179029905,0.630253017554489,0.39965883420029,7.49568842565056,7.48596446178635,7.52763859263299,0.0416741308466467,0.768412626300446,ENSG00000151702,FLI1,protein_coding,11,1,128686535,128813267,q24.3,Fli-1 proto-oncogene, ETS transcription factor [Source:HGNC Symbol;Acc:HGNC:3749],Bleeding disorder platelet-type 21;Ewing sarcoma;Extraskeletal Ewing sarcoma;Isolated delta-storage pool disease;Jacobsen syndrome;Paris-Trousseau thrombocytopenia;Peripheral primitive neuroectodermal tumor,FLI1,2313,NM_001167681;NM_001271010;NM_001271012;NM_002017
RC3H1_TF,RC3H1,RC3H1_TF,RC3H1,TF,70,-0.559855730925368,0.128979304712191,0.129718493407409,0.126550541856477,-0.00316795155093146,0.630903288852787,-0.353916507353045,7.01811282797131,7.02149036709513,7.00701519942158,-0.014475167673556,0.795163604251732,ENSG00000135870,RC3H1,protein_coding,1,-1,173931214,174022297,q25.1,ring finger and CCCH-type domains 1 [Source:HGNC Symbol;Acc:HGNC:29434],NA,RC3H1,149041,NM_001300850;NM_001300851;NM_001300852;NM_172071
ZFP69B_TF,ZFP69B,ZFP69B_TF,ZFP69B,TF,19,0.559718006174681,0.078157533368609,0.0771879409994092,0.0813433368674085,0.00415539586799932,0.630903288852787,0.952211723835712,1.73067883445008,1.71743262003854,1.77420211037374,0.0567694903352019,0.45448697735313,ENSG00000187801,ZFP69B,protein_coding,1,1,40450102,40463718,p34.2,ZFP69 zinc finger protein B [Source:HGNC Symbol;Acc:HGNC:28053],NA,ZFP69B,65243,NM_023070
NEU4_SIG,NEU4,NEU4_SIG,NEU4,SIG,33,0.559646087756709,0.031488483067916,0.0292577997076423,0.0388178712516725,0.00956007154403009,0.630903288852787,1.52703944403907,2.62966076498603,2.54623188340061,2.9037842330524,0.357552349651786,0.213184359383547,ENSG00000204099,NEU4,protein_coding,2,1,241808825,241817413,q37.3,neuraminidase 4 [Source:HGNC Symbol;Acc:HGNC:21328],NA,NEU4,129807,NM_001167599;NM_001167600;NM_001167601;NM_001167602;NM_080741
SELP_SIG,SELP,SELP_SIG,SELP,SIG,29,-0.559573122906528,-0.0259821705527024,-0.0242065374198661,-0.0318163937034505,-0.00760985628358433,0.630903288852787,-2.48330232460951,2.41197261933142,2.5133143890536,2.07899251881568,-0.434321870237921,0.0366141772898228,ENSG00000174175,SELP,protein_coding,1,-1,169588849,169630193,q24.2,selectin P [Source:HGNC Symbol;Acc:HGNC:10721],NA,SELP,6403,NM_003005
CDK12_SIG,CDK12,CDK12_SIG,CDK12,SIG,36,0.559366234701146,0.658096447121936,0.656662963320017,0.662806465328242,0.00614350200822449,0.630974512826626,1.78738828426974,7.09060480396905,7.07072339338871,7.15592943873303,0.0852060453443241,0.141157712042759,ENSG00000167258,CDK12,protein_coding,17,1,39461511,39564907,q12,cyclin dependent kinase 12 [Source:HGNC Symbol;Acc:HGNC:24224],NA,CDK12,51755,NM_015083;NM_016507
PRDM2_SIG,PRDM2,PRDM2_SIG,PRDM2,SIG,22,0.559095724167898,0.423287639941887,0.421736759162832,0.428383391073065,0.00664663191023274,0.631093298143163,3.47220795844022,7.17362738282103,7.10915796154377,7.38545548130346,0.276297519759696,0.00292008297507881,ENSG00000116731,PRDM2,protein_coding,1,1,13700198,13825079,p36.21,PR/SET domain 2 [Source:HGNC Symbol;Acc:HGNC:9347],NA,PRDM2,7799,NM_001007257;NM_001135610;NM_012231;NM_015866
SQSTM1_SIG,SQSTM1,SQSTM1_SIG,SQSTM1,SIG,16,-0.558870715190333,0.276175435532847,0.277536836553793,0.271702260749737,-0.00583457580405666,0.631178066118144,1.80636764077439,7.5028425006684,7.47208748522976,7.60389469425249,0.13180720902273,0.136666075860038,ENSG00000161011,SQSTM1,protein_coding,5,1,179806398,179838078,q35.3,sequestosome 1 [Source:HGNC Symbol;Acc:HGNC:11280],Amyotrophic lateral sclerosis;Behavioral variant of frontotemporal dementia;Frontotemporal dementia and/or amyotrophic lateral sclerosis 3;Frontotemporal dementia with motor neuron disease;MYOPATHY DISTAL WITH RIMMED VACUOLES;NEURODEGENERATION WITH ATAXIA DYSTONIA AND GAZE PALSY CHILDHOOD-ONSET;PAGET DISEASE OF BONE 3,SQSTM1,8878,NM_001142298;NM_001142299;NM_003900
VPS29_SIG,VPS29,VPS29_SIG,VPS29,SIG,26,0.55775023183856,0.0765395544694995,0.0756310491576439,0.0795246433513106,0.00389359419366667,0.631932435194579,-0.113835784398405,6.21921968018501,6.22057092832576,6.21477986486543,-0.0057910634603299,0.937028108958583,ENSG00000111237,VPS29,protein_coding,12,-1,110491097,110502117,q24.11,VPS29, retromer complex component [Source:HGNC Symbol;Acc:HGNC:14340],NA,VPS29,51699,NM_001282150;NM_001282151;NM_016226;NM_057180
HNMT_SIG,HNMT,HNMT_SIG,HNMT,SIG,64,-0.557183570450136,-0.115921591845561,-0.114057129989973,-0.122047680799633,-0.00799055080965993,0.6322727576183,2.42824717941279,2.45387194726837,2.33564330319095,2.84233749209418,0.506694188903223,0.041235842840054,ENSG00000150540,HNMT,protein_coding,2,1,137964020,138016364,q22.1,histamine N-methyltransferase [Source:HGNC Symbol;Acc:HGNC:5028],ASTHMA SUSCEPTIBILITY TO;Autosomal recessive non-syndromic intellectual disability;Mental retardation autosomal recessive 51,HNMT,3176,NM_001024074;NM_001024075;NM_006895
JARID2_SIG,JARID2,JARID2_SIG,JARID2,SIG,27,-0.556628185913274,0.464141538817569,0.465223818519844,0.460585476938662,-0.00463834158118194,0.632604686331807,-1.80594274778114,7.33774593546945,7.37127840581314,7.22756781862589,-0.143710587187254,0.136769936643925,ENSG00000008083,JARID2,protein_coding,6,1,15246069,15522042,p22.3,jumonji and AT-rich interaction domain containing 2 [Source:HGNC Symbol;Acc:HGNC:6196],NA,JARID2,3720,NM_001267040;NM_004973
EZH1_SIG,EZH1,EZH1_SIG,EZH1,SIG,65,0.553849093106551,0.171630080742259,0.170801027618172,0.174354112435685,0.00355308481751231,0.634524620362383,-0.190154294489094,5.83790561941023,5.84059660676452,5.82906380381756,-0.0115328029469595,0.893106360005036,ENSG00000108799,EZH1,protein_coding,17,-1,42700275,42745049,q21.2,enhancer of zeste 1 polycomb repressive complex 2 subunit [Source:HGNC Symbol;Acc:HGNC:3526],NA,EZH1,2145,NM_001321079;NM_001321081;NM_001321082;NM_001991
ING3_SIG,ING3,ING3_SIG,ING3,SIG,27,-0.553840199806849,0.375376907684919,0.376659869357088,0.371161462190652,-0.00549840716643542,0.634524620362383,-0.211308423168513,4.93787561317932,4.94100226948284,4.92760231389635,-0.0133999555864836,0.880902003422889,ENSG00000071243,ING3,protein_coding,7,1,120950763,120977216,q31.31,inhibitor of growth family member 3 [Source:HGNC Symbol;Acc:HGNC:14587],NA,ING3,54556,NM_019071;NM_198267
UQCRH_SIG,UQCRH,UQCRH_SIG,UQCRH,SIG,27,-0.553224133952285,0.172582118969119,0.173386827991075,0.169938075039832,-0.00344875295124324,0.634902361761693,-0.972626347078634,5.72302803618254,5.73412649585164,5.68656166869836,-0.0475648271532753,0.444194749904455,ENSG00000173660,UQCRH,protein_coding,1,1,46303698,46316776,p33,ubiquinol-cytochrome c reductase hinge protein [Source:HGNC Symbol;Acc:HGNC:12590],NA,UQCRH,7388,NM_001297565;NM_001297566;NM_006004
ENDOU_SIG,ENDOU,ENDOU_SIG,ENDOU,SIG,35,-0.552243716977043,0.0211400002373649,0.0223065565197853,0.0173070295951268,-0.00499952692465849,0.63555326695737,-0.460565624878024,0.475729925929197,0.482522993731251,0.453409846008164,-0.0291131477230867,0.733173257515672,ENSG00000111405,ENDOU,protein_coding,12,-1,47709734,47725567,q13.11,endonuclease, poly(U) specific [Source:HGNC Symbol;Acc:HGNC:14369],NA,ENDOU,8909,NM_001172439;NM_001172440;NM_006025
TNRC6B_SIG,TNRC6B,TNRC6B_SIG,TNRC6B,SIG,79,0.551050849969241,0.2409099745286,0.240083642642985,0.243625065009906,0.00354142236692066,0.636363734528151,0.470434737309512,6.83103871431653,6.82298520562825,6.85750024286376,0.034515037235516,0.726915496451292,ENSG00000100354,TNRC6B,protein_coding,22,1,40044817,40335808,q13.1,trinucleotide repeat containing 6B [Source:HGNC Symbol;Acc:HGNC:29190],NA,TNRC6B,23112,NM_001024843;NM_001162501;NM_015088
RPN2_SIG,RPN2,RPN2_SIG,RPN2,SIG,55,0.549959614545149,0.442461235884452,0.441303536692902,0.446265104656688,0.00496156796378549,0.637098310603014,0.353762642721783,8.04983453646556,8.04517585628075,8.06514162850138,0.0199657722206349,0.795252082837187,ENSG00000118705,RPN2,protein_coding,20,1,37178410,37241619,q11.23,ribophorin II [Source:HGNC Symbol;Acc:HGNC:10382],NA,RPN2,6185,NM_001135771;NM_001324299;NM_001324301;NM_001324302;NM_001324303;NM_001324304;NM_001324305;NM_001324306;NM_002951
CASP8_SIG,CASP8,CASP8_SIG,CASP8,SIG,24,-0.548163437499407,0.315434479604025,0.316408408090407,0.312234428863054,-0.00417397922735348,0.6383625151424,1.32194907295084,6.74720319939533,6.72471805914058,6.82108294594668,0.0963648868060992,0.286285305248983,ENSG00000064012,CASP8,protein_coding,2,1,201233443,201287711,q33.1,caspase 8 [Source:HGNC Symbol;Acc:HGNC:1509],Adult hepatocellular carcinoma;Autoimmune lymphoproliferative syndrome with recurrent viral infections;Breast Cancer;CASPASE 8 DEFICIENCY;Hepatocellular Carcinoma;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED,CASP8,841,NM_001080124;NM_001080125;NM_001228;NM_033355;NM_033356;NM_033358
PIWIL4_SIG,PIWIL4,PIWIL4_SIG,PIWIL4,SIG,93,-0.547702748035921,0.184075016372694,0.18562773907212,0.178973213217437,-0.00665452585468299,0.638624233185528,-0.915270583323008,5.01463231059931,5.04393150159364,4.91836354018937,-0.125567961404274,0.4737527467318,ENSG00000134627,PIWIL4,protein_coding,11,1,94543840,94621421,q21,piwi like RNA-mediated gene silencing 4 [Source:HGNC Symbol;Acc:HGNC:18444],NA,PIWIL4,143689,NM_152431
ZNF502_TF,ZNF502,ZNF502_TF,ZNF502,TF,14,0.547498963490038,-0.0653344301956288,-0.0661644029793447,-0.0626073767634195,0.00355702621592528,0.638692992873995,0.616755966096418,1.53327393128238,1.51752295694702,1.58502713267,0.0675041757229821,0.640427156929633,ENSG00000196653,ZNF502,protein_coding,3,1,44712643,44723831,p21.31,zinc finger protein 502 [Source:HGNC Symbol;Acc:HGNC:23718],NA,ZNF502,91392,NM_001134440;NM_001134441;NM_001134442;NM_001282880;NM_033210
KLHL22_SIG,KLHL22,KLHL22_SIG,KLHL22,SIG,10,-0.546480050194797,0.149933620464851,0.150891466698074,0.146786411412834,-0.00410505528524025,0.639374124124408,-0.455649353526745,3.91357219380891,3.92042243909864,3.89106424499978,-0.0293581940988653,0.735934155071505,ENSG00000099910,KLHL22,protein_coding,22,-1,20441519,20495844,q11.21,kelch like family member 22 [Source:HGNC Symbol;Acc:HGNC:25888],NA,KLHL22,84861,NM_032775
ASCL2_TF,ASCL2,ASCL2_TF,ASCL2,TF,83,0.545344281637508,0.000707917598661776,-7.1086664502054e-05,0.0032675030347715,0.0033385896992735,0.640143350045655,1.02644557486933,2.068430178033,2.03944515178284,2.16366669285495,0.124221541072109,0.417672958509459,ENSG00000183734,ASCL2,protein_coding,11,-1,2268495,2270952,p15.5,achaete-scute family bHLH transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:739],NA,ASCL2,430,NM_005170
PTH2R_SIG,PTH2R,PTH2R_SIG,PTH2R,SIG,56,0.545197622369754,-0.0565532845549222,-0.0573632089826407,-0.0538921042924188,0.00347110469022197,0.640169134550676,0.507358791247996,2.80203620430477,2.78012041133759,2.87404523833977,0.0939248270021764,0.705189289811174,ENSG00000144407,PTH2R,protein_coding,2,1,208359714,208854503,q34,parathyroid hormone 2 receptor [Source:HGNC Symbol;Acc:HGNC:9609],NA,PTH2R,5746,NM_001309516;NM_005048
RPL27_SIG,RPL27,RPL27_SIG,RPL27,SIG,27,0.543333025230217,1.16317059785893,1.16085685016267,1.17077291171804,0.00991606155537293,0.641486924688521,0.929234976065135,8.87472092813307,8.86166906881703,8.91760560874288,0.0559365399258488,0.466077373532587,ENSG00000131469,RPL27,protein_coding,17,1,42998273,43002959,q21.31,ribosomal protein L27 [Source:HGNC Symbol;Acc:HGNC:10328],Blackfan-Diamond anemia;Diamond-Blackfan anemia 16,RPL27,6155,NM_000988;NM_001349921;NM_001349922
GATAD2A_TF,GATAD2A,GATAD2A_TF,GATAD2A,TF,106,-0.542071081192137,0.040048265089194,0.0407584791866044,0.0377147044834169,-0.00304377470318757,0.642352016398689,-0.0677740228026296,7.16395996830136,7.16463076206784,7.16175593164006,-0.00287483042778097,0.963044884847551,ENSG00000167491,GATAD2A,protein_coding,19,1,19385826,19508931,p13.11,GATA zinc finger domain containing 2A [Source:HGNC Symbol;Acc:HGNC:29989],NA,GATAD2A,54815,NM_001300946;NM_001359631;NM_017660
UBE2E3_SIG,UBE2E3,UBE2E3_SIG,UBE2E3,SIG,14,0.541069189242511,0.0130976017947227,0.0124204781737074,0.015322436549487,0.00290195837577946,0.643021659423167,-0.573155158682351,4.84598682105007,4.85876254182143,4.80400945280131,-0.0547530890201272,0.666876234300653,ENSG00000170035,UBE2E3,protein_coding,2,1,180967248,181076585,q31.3,ubiquitin conjugating enzyme E2 E3 [Source:HGNC Symbol;Acc:HGNC:12479],NA,UBE2E3,10477,NM_001278554;NM_001278555;NM_006357;NM_182678
ICAM5_SIG,ICAM5,ICAM5_SIG,ICAM5,SIG,41,0.540763764195531,0.0352135805489177,0.033732031547538,0.040081527267737,0.00634949572019914,0.643166879151168,-0.63585650598344,2.33946216294301,2.36502571173341,2.25546764548881,-0.109558066244599,0.62934238851322,ENSG00000105376,ICAM5,protein_coding,19,1,10289952,10296778,p13.2,intercellular adhesion molecule 5 [Source:HGNC Symbol;Acc:HGNC:5348],NA,ICAM5,7087,NM_003259
GPR63_SIG,GPR63,GPR63_SIG,GPR63,SIG,55,-0.540542159121253,-0.131162956574293,-0.130387566612298,-0.133710666449422,-0.00332309983712368,0.643248967340381,0.410021038920544,0.523420471622421,0.515655633872927,0.548933509942189,0.0332778760692624,0.762714312407494,ENSG00000112218,GPR63,protein_coding,6,-1,96794125,96837477,q16.1,G protein-coupled receptor 63 [Source:HGNC Symbol;Acc:HGNC:13302],NA,GPR63,81491,NM_001143957;NM_030784
PDE3A_SIG,PDE3A,PDE3A_SIG,PDE3A,SIG,37,0.54019070148804,-0.00292090211678624,-0.00420247999251694,0.00128999661775749,0.00549247661027447,0.643428855799806,-1.18295267847308,1.21754842633149,1.2569970249367,1.08793160234293,-0.169065422593764,0.344289184938901,ENSG00000172572,PDE3A,protein_coding,12,1,20369245,20684381,p12.2,phosphodiesterase 3A [Source:HGNC Symbol;Acc:HGNC:8778],Brachydactyly-arterial hypertension syndrome;HYPERTENSION AND BRACHYDACTYLY SYNDROME,PDE3A,5139,NM_000921;NM_001244683
COX6C_SIG,COX6C,COX6C_SIG,COX6C,SIG,26,0.540002893861168,0.223849166842289,0.223113057515192,0.226267811774181,0.00315475425898971,0.643485483686086,0.217566725034161,5.7633461742917,5.76063515436134,5.77225381120572,0.0116186568443791,0.877353919299275,ENSG00000164919,COX6C,protein_coding,8,-1,99873200,99893707,q22.2,cytochrome c oxidase subunit 6C [Source:HGNC Symbol;Acc:HGNC:2285],NA,COX6C,1345,NM_004374
MATN1_SIG,MATN1,MATN1_SIG,MATN1,SIG,54,-0.537924512031182,-0.00843125581131175,-0.00689335946545191,-0.0134843438048512,-0.00659098433939931,0.644966736813267,-1.89576225668838,0.743383849101223,0.778389306955956,0.628365916149955,-0.150023390806001,0.117178519751134,ENSG00000162510,MATN1,protein_coding,1,-1,30711277,30723585,p35.2,matrilin 1 [Source:HGNC Symbol;Acc:HGNC:6907],NA,MATN1,4146,NM_002379
ZNF354A_TF,ZNF354A,ZNF354A_TF,ZNF354A,TF,37,-0.536851681670573,0.00540709615482505,0.00630678377066623,0.00245097970277545,-0.00385580406789066,0.645690698875518,0.57243901352507,3.76569463079189,3.7556853392502,3.79858230300028,0.0428969637500712,0.667343877385579,ENSG00000169131,ZNF354A,protein_coding,5,-1,178711512,178730659,q35.3,zinc finger protein 354A [Source:HGNC Symbol;Acc:HGNC:11628],NA,ZNF354A,6940,NM_001324339;NM_005649
IKZF5_TF,IKZF5,IKZF5_TF,IKZF5,TF,208,-0.535921077566077,0.223615885299437,0.225229459644111,0.218314141024081,-0.00691531862002976,0.646307616998783,-0.0623392245980774,5.58649005689495,5.58752810460753,5.58307932869649,-0.00444877591103505,0.965879444307668,ENSG00000095574,IKZF5,protein_coding,10,-1,122990806,123008817,q26.13,IKAROS family zinc finger 5 [Source:HGNC Symbol;Acc:HGNC:14283],NA,IKZF5,64376,NM_001271840
SRSF3_SIG,SRSF3,SRSF3_SIG,SRSF3,SIG,23,0.535224584394669,0.489790875231433,0.488994102720944,0.492408842051612,0.00341473933066841,0.64674802352987,1.41641235990639,8.31489685408901,8.3000672474426,8.36362270449864,0.0635554570560402,0.250363309803418,ENSG00000112081,SRSF3,protein_coding,6,1,36594353,36605600,p21.31,serine and arginine rich splicing factor 3 [Source:HGNC Symbol;Acc:HGNC:10785],NA,SRSF3,6428,NM_003017
IDH2_SIG,IDH2,IDH2_SIG,IDH2,SIG,31,0.533966984975833,0.573301250865756,0.571939337175696,0.577776110133098,0.00583677295740211,0.647612153335148,0.753791439591283,7.2695854841259,7.25822345317984,7.30691787152012,0.0486944183402817,0.561428273741468,ENSG00000182054,IDH2,protein_coding,15,-1,90083045,90102504,q26.1,isocitrate dehydrogenase (NADP(+)) 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:5383],Anaplastic astrocytoma;Anaplastic oligoastrocytoma;Anaplastic oligodendroglioma;D-2-hydroxyglutaric aciduria;D-2-hydroxyglutaric aciduria 2;Enchondromatosis;Fibrillary astrocytoma;Gemistocytic astrocytoma;Maffucci syndrome;Oligoastrocytoma;Oligodendroglioma;Protoplasmic astrocytoma,IDH2,3418,NM_001289910;NM_001290114;NM_002168
PNO1_SIG,PNO1,PNO1_SIG,PNO1,SIG,21,0.533680817633331,0.350853105569878,0.35001394045572,0.35361036237354,0.00359642191782081,0.647742932347266,0.821971186718652,3.75966755663261,3.74966473626861,3.79253396640004,0.04286923013143,0.523307558336345,ENSG00000115946,PNO1,protein_coding,2,1,68157888,68176238,p14,partner of NOB1 homolog [Source:HGNC Symbol;Acc:HGNC:32790],NA,PNO1,56902,NM_001329916;NM_001329917;NM_020143
ABCC5_SIG,ABCC5,ABCC5_SIG,ABCC5,SIG,11,0.532425268984828,0.216845533758611,0.215479016653942,0.221335518531096,0.00585650187715399,0.648569715319586,1.24286858163644,5.44569688779161,5.41737435047848,5.53875665324903,0.121382302770557,0.318441154058554,ENSG00000114770,ABCC5,protein_coding,3,-1,183919934,184017939,q27.1,ATP binding cassette subfamily C member 5 [Source:HGNC Symbol;Acc:HGNC:56],NA,ABCC5,10057,NM_001023587;NM_001320032;NM_005688
RCE1_SIG,RCE1,RCE1_SIG,RCE1,SIG,28,0.532360157773434,0.245611036172656,0.244944802028486,0.247800091217785,0.00285528918929907,0.648569715319586,1.20730087580968,4.43036227064689,4.418277528223,4.47006928146821,0.0517917532452089,0.333518933192355,ENSG00000173653,RCE1,protein_coding,11,1,66842835,66846546,q13.2,Ras converting CAAX endopeptidase 1 [Source:HGNC Symbol;Acc:HGNC:13721],NA,RCE1,9986,NM_001032279;NM_005133
RNF103_SIG,RNF103,RNF103_SIG,RNF103,SIG,127,-0.532068643290095,0.182365064156583,0.184258921484832,0.176142390078051,-0.00811653140678097,0.648704541397248,0.148266644794631,5.39940241945082,5.39600063716943,5.41057970408965,0.0145790669202198,0.916876893851693,ENSG00000239305,RNF103,protein_coding,2,-1,86603398,86623866,p11.2,ring finger protein 103 [Source:HGNC Symbol;Acc:HGNC:12859],NA,RNF103,7844,NM_001198951;NM_001198952;NM_005667
ELMSAN1_TF,ELMSAN1,ELMSAN1_TF,ELMSAN1,TF,49,0.531779558194847,0.336087331794069,0.334997648201907,0.339667720739746,0.00467007253783974,0.648837530701222,1.32590401262152,7.12687396566934,7.09979729653013,7.21584016426963,0.116042867739503,0.284687141063365,ENSG00000156030,ELMSAN1,protein_coding,14,-1,73715122,73790285,q24.3,ELM2 and Myb/SANT domain containing 1 [Source:HGNC Symbol;Acc:HGNC:19853],NA,ELMSAN1,91748,NM_001043318;NM_194278
POLA1_SIG,POLA1,POLA1_SIG,POLA1,SIG,47,0.531620638365626,0.640376488980639,0.637697945135344,0.649177418758037,0.0114794736226934,0.648872178538909,0.887571378508425,4.86664673153673,4.84845507765082,4.92641930859044,0.0779642309396253,0.488507616269935,ENSG00000101868,POLA1,protein_coding,X,1,24693919,24996986,p22.11,DNA polymerase alpha 1, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9173],Pigmentary disorder reticulate with systemic manifestations X-linked;X-linked reticulate pigmentary disorder,POLA1,5422,NM_001330360;NM_016937
NTNG2_SIG,NTNG2,NTNG2_SIG,NTNG2,SIG,77,0.530013787161604,0.0266500531993468,0.0256651479426748,0.0298861704712691,0.00422102252859433,0.650001072586034,-0.407585233087013,4.67256585562289,4.6906740647334,4.61306745425981,-0.0776066104735831,0.764115297274318,ENSG00000196358,NTNG2,protein_coding,9,1,132161676,132244526,q34.13,netrin G2 [Source:HGNC Symbol;Acc:HGNC:14288],NA,NTNG2,84628,NM_032536
ZNF414_TF,ZNF414,ZNF414_TF,ZNF414,TF,95,0.529589099586421,0.0384468697947577,0.037956587274832,0.0400577980745134,0.00210121079968131,0.650236601169644,-0.00557003922786572,4.01197467823943,4.01203096746153,4.01178972793826,-0.000241239523267841,0.996603130947838,ENSG00000133250,ZNF414,protein_coding,19,-1,8509678,8514167,p13.2,zinc finger protein 414 [Source:HGNC Symbol;Acc:HGNC:20630],NA,ZNF414,84330,NM_001146175;NM_032370
RNF6_SIG,RNF6,RNF6_SIG,RNF6,SIG,41,0.529321743738124,0.314474706412814,0.313804136546431,0.316678007402355,0.00287387085592401,0.650353176755811,0.0702281965414111,6.00209443674119,6.00132527625031,6.00462167835408,0.00329640210377233,0.961698834713097,ENSG00000127870,RNF6,protein_coding,13,-1,26132115,26222314,q12.13,ring finger protein 6 [Source:HGNC Symbol;Acc:HGNC:10069],ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA SUSCEPTIBILITY TO INCLUDED;Squamous cell carcinoma of the esophagus,RNF6,6049,NM_005977;NM_183043;NM_183044;NM_183045
SLC39A11_SIG,SLC39A11,SLC39A11_SIG,SLC39A11,SIG,70,0.52911038910289,0.277545882042681,0.276028000316052,0.282533207715893,0.00650520739984122,0.650427408049729,1.85526379513304,4.67963881223325,4.63105683105941,4.83926532180445,0.208208490745048,0.125724293008511,ENSG00000133195,SLC39A11,protein_coding,17,-1,72645949,73092712,q25.1,solute carrier family 39 member 11 [Source:HGNC Symbol;Acc:HGNC:14463],NA,SLC39A11,201266,NM_001159770;NM_001352691;NM_001352692;NM_001352693;NM_139177
ZCCHC2_TF,ZCCHC2,ZCCHC2_TF,ZCCHC2,TF,109,-0.528835133236747,-0.015933365319246,-0.0150350401980356,-0.0188850050032232,-0.00384996480518767,0.650549952213084,0.956660684272209,5.85172118768738,5.83356740661667,5.91136932549114,0.0778019188744618,0.452256878776803,ENSG00000141664,ZCCHC2,protein_coding,18,1,62523007,62587709,q21.33,zinc finger CCHC-type containing 2 [Source:HGNC Symbol;Acc:HGNC:22916],NA,ZCCHC2,54877,NM_017742
ADORA3_SIG,ADORA3,ADORA3_SIG,ADORA3,SIG,14,0.526181980753207,0.103579860188136,0.10258376931789,0.10685273019037,0.00426896087247989,0.652471561969591,1.25587300398638,1.6285492258729,1.59955964196468,1.72380071585706,0.124241073892381,0.312893554195832,ENSG00000282608,ADORA3,protein_coding,1,-1,111499429,111503760,p13.2,adenosine A3 receptor [Source:HGNC Symbol;Acc:HGNC:268],NA,ADORA3,140,NM_000677;NM_001302678
FEM1B_SIG,FEM1B,FEM1B_SIG,FEM1B,SIG,34,0.524513958187614,0.284082257482839,0.283487738888977,0.286035675719814,0.00254793683083705,0.653648925537608,-0.357759954107347,6.68433037398921,6.68842849757621,6.67086511077481,-0.0175633868014015,0.793037705870296,ENSG00000169018,FEM1B,protein_coding,15,1,68277745,68295862,q23,fem-1 homolog B [Source:HGNC Symbol;Acc:HGNC:3649],NA,FEM1B,10116,NM_015322
CELSR1_SIG,CELSR1,CELSR1_SIG,CELSR1,SIG,41,0.523965244327653,-0.0522999400000659,-0.0528404510169183,-0.0505239752304081,0.00231647578651028,0.653978696032772,-1.03685413126903,2.59497559533952,2.63373647533244,2.46761841821991,-0.166118057112539,0.412397324063325,ENSG00000075275,CELSR1,protein_coding,22,-1,46360834,46537170,q13.31,cadherin EGF LAG seven-pass G-type receptor 1 [Source:HGNC Symbol;Acc:HGNC:1850],NA,CELSR1,9620,NM_014246
GJC2_SIG,GJC2,GJC2_SIG,GJC2,SIG,59,0.523078752327362,-0.0335133533944114,-0.0347545268733564,-0.029435211963592,0.00531931490976444,0.654564508473957,1.16738225012973,0.712971995818858,0.693452066748981,0.777108905619883,0.0836568388709029,0.35158759107816,ENSG00000198835,GJC2,protein_coding,1,1,228149930,228159826,q42.13,gap junction protein gamma 2 [Source:HGNC Symbol;Acc:HGNC:17494],Autosomal recessive spastic paraplegia type 44;LEUKODYSTROPHY HYPOMYELINATING 2;LYMPHATIC MALFORMATION 3;Lymphedema hereditary ic;Milroy Disease;Pelizaeus-Merzbacher-like disease due to GJC2 mutation;Spastic paraplegia 44;SPASTIC PARAPLEGIA 44 AUTOSOMAL RECESSIVE,GJC2,57165,NM_020435
POU5F2_TF,POU5F2,POU5F2_TF,POU5F2,TF,163,0.522316409302825,-0.0266432720207333,-0.027277654189343,-0.0245588734667299,0.00271878072261307,0.655040109058516,0.356913103147974,0.345942912021768,0.342812065991758,0.356229977548942,0.0134179115571832,0.793460166282853,ENSG00000248483,POU5F2,protein_coding,5,-1,93733220,93741637,q15,POU domain class 5, transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:26367],NA,POU5F2,134187,NM_153216
SRRM1_SIG,SRRM1,SRRM1_SIG,SRRM1,SIG,12,0.522224254715546,0.562386958451453,0.561526015015063,0.565215772599591,0.00368975758452775,0.655040109058516,1.38929797556009,7.45435555702955,7.44074917127405,7.49906225308334,0.0583130818092929,0.260631568461664,ENSG00000133226,SRRM1,protein_coding,1,1,24631716,24673281,p36.11,serine and arginine repetitive matrix 1 [Source:HGNC Symbol;Acc:HGNC:16638],NA,SRRM1,10250,NM_001303448;NM_001303449;NM_001366566;NM_001366582;NM_001366588;NM_001366589;NM_001366599;NM_005839
BUD31_SIG,BUD31,BUD31_SIG,BUD31,SIG,28,-0.522013504837768,0.270372397005411,0.27120370310819,0.267640962667708,-0.00356274044048269,0.655113784520606,-0.417581340925303,5.70675517676983,5.71166493025774,5.69062312959526,-0.0210418006624842,0.758456652338172,ENSG00000106245,BUD31,protein_coding,7,1,99408641,99419616,q22.1,BUD31 homolog [Source:HGNC Symbol;Acc:HGNC:29629],NA,BUD31,8896,NM_003910
TPK1_SIG,TPK1,TPK1_SIG,TPK1,SIG,22,0.521059468616943,0.112617023035087,0.111097994385518,0.117608117169384,0.00651012278386527,0.655751048887301,-0.445868355952841,2.88531817511592,2.89495158738088,2.85366553481678,-0.0412860525640982,0.74147293890529,ENSG00000196511,TPK1,protein_coding,7,-1,144451941,144836395,q35,thiamin pyrophosphokinase 1 [Source:HGNC Symbol;Acc:HGNC:17358],Childhood encephalopathy due to thiamine pyrophosphokinase deficiency;THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE),TPK1,27010,NM_001042482;NM_001350879;NM_001350880;NM_001350881;NM_001350882;NM_001350883;NM_001350884;NM_001350885;NM_001350886;NM_001350887;NM_001350889;NM_001350893;NM_001350894;NM_001350895;NM_022445
IRF2BPL_SIG,IRF2BPL,IRF2BPL_SIG,IRF2BPL,SIG,22,-0.520669549318377,0.31761936109099,0.318625137719369,0.314314666454887,-0.00431047126448162,0.655960592086196,1.16879035939833,5.49499773169894,5.47131230139117,5.57282128842446,0.10150898703329,0.351131879102595,ENSG00000119669,IRF2BPL,protein_coding,14,-1,77024543,77028708,q24.3,interferon regulatory factor 2 binding protein like [Source:HGNC Symbol;Acc:HGNC:14282],NEURODEVELOPMENTAL DISORDER WITH REGRESSION ABNORMAL MOVEMENTS LOSSOF SPEECH AND SEIZURES,IRF2BPL,64207,NM_024496
UBR3_SIG,UBR3,UBR3_SIG,UBR3,SIG,26,-0.520416491620614,0.276829729833986,0.277331156241243,0.275182185924429,-0.00214897031681434,0.656066334807852,-0.997581533350056,5.45521791572859,5.46738054733056,5.41525498332211,-0.0521255640084526,0.431719637211873,ENSG00000144357,UBR3,protein_coding,2,1,169827458,170084131,q31.1,ubiquitin protein ligase E3 component n-recognin 3 [Source:HGNC Symbol;Acc:HGNC:30467],NA,UBR3,130507,NM_172070
METTL7B_SIG,METTL7B,METTL7B_SIG,METTL7B,SIG,34,-0.517604069052198,-0.0343358766701246,-0.0328804347549622,-0.0391180429628008,-0.00623760820783846,0.658114499149871,0.318858907335779,2.01210295732653,1.99787640626557,2.05884733938397,0.0609709331183984,0.816550032202677,ENSG00000170439,METTL7B,protein_coding,12,1,55681678,55684611,q13.2,methyltransferase like 7B [Source:HGNC Symbol;Acc:HGNC:28276],NA,METTL7B,196410,NM_152637
ADNP2_TF,ADNP2,ADNP2_TF,ADNP2,TF,177,-0.515608853113283,0.146082659258456,0.147753036632718,0.140594276457311,-0.00715876017540769,0.659543916401666,-0.641955240112054,5.88609343058316,5.90244885082951,5.83235419263087,-0.0700946581986352,0.625734815822787,ENSG00000101544,ADNP2,protein_coding,18,1,80109262,80147523,q23,ADNP homeobox 2 [Source:HGNC Symbol;Acc:HGNC:23803],NA,ADNP2,22850,NM_014913
ZNF677_TF,ZNF677,ZNF677_TF,ZNF677,TF,30,0.512524199880192,-0.0766832233259698,-0.0780664492945846,-0.0721383380005213,0.00592811129406332,0.661726925108151,1.31719721153278,2.78991745661148,2.74933688012748,2.92325363648744,0.173916756359961,0.288163512553339,ENSG00000197928,ZNF677,protein_coding,19,-1,53235381,53254898,q13.42,zinc finger protein 677 [Source:HGNC Symbol;Acc:HGNC:28730],NA,ZNF677,342926,NM_001317998;NM_182609
AKR1B1_SIG,AKR1B1,AKR1B1_SIG,AKR1B1,SIG,31,0.512510785081625,0.105228412649031,0.104450137110253,0.107785603705013,0.00333546659476013,0.661726925108151,0.0467062135296526,4.44148501583493,4.4403059510048,4.44535908599106,0.00505313498625691,0.974395580261785,ENSG00000085662,AKR1B1,protein_coding,7,-1,134442356,134459284,q33,aldo-keto reductase family 1 member B [Source:HGNC Symbol;Acc:HGNC:381],NA,AKR1B1,231,NM_001346142;NM_001628
MBD4_TF,MBD4,MBD4_TF,MBD4,TF,39,-0.510868038392068,0.146064141771932,0.147068391969082,0.142764462552726,-0.00430392941635654,0.662890782437383,0.140903137455477,5.80773733448358,5.80628994920986,5.81249302895435,0.00620307974448133,0.921100767114409,ENSG00000129071,MBD4,protein_coding,3,-1,129430944,129440179,q21.3,methyl-CpG binding domain 4, DNA glycosylase [Source:HGNC Symbol;Acc:HGNC:6919],NA,MBD4,8930,NM_001276270;NM_001276271;NM_001276272;NM_001276273;NM_003925
TFR2_SIG,TFR2,TFR2_SIG,TFR2,SIG,22,0.508863098373785,0.0126422007148166,0.0109979467086636,0.0180447495921766,0.00704680288351306,0.664331482350703,1.23337739389929,3.9600480956439,3.90544064126901,4.13947258858996,0.234031947320942,0.322397284932314,ENSG00000106327,TFR2,protein_coding,7,-1,100620416,100642779,q22.1,transferrin receptor 2 [Source:HGNC Symbol;Acc:HGNC:11762],Hemochromatosis type 3;HEMOCHROMATOSIS TYPE 3,TFR2,7036,NM_001206855;NM_003227
PSMB1_SIG,PSMB1,PSMB1_SIG,PSMB1,SIG,48,0.506021387279837,0.432881241171199,0.43209334935414,0.435470028570107,0.00337667921596709,0.666411989982993,0.404176321368048,6.28766215500498,6.28385698713334,6.30016484944039,0.0163078623070536,0.765814543013296,ENSG00000008018,PSMB1,protein_coding,6,-1,170535120,170553307,q27,proteasome subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:9537],NA,PSMB1,5689,NM_002793
GP1BA_SIG,GP1BA,GP1BA_SIG,GP1BA,SIG,29,-0.505631226082458,-0.202753300140382,-0.20065784043364,-0.209638382033962,-0.00898054160032211,0.666622360149027,0.0573647894912932,1.81371019813431,1.81134722713677,1.82147424569768,0.0101270185609095,0.968209360548367,ENSG00000185245,GP1BA,protein_coding,17,1,4932277,4935023,p13.2,glycoprotein Ib platelet subunit alpha [Source:HGNC Symbol;Acc:HGNC:4439],BERNARD-SOULIER SYNDROME;BERNARD-SOULIER SYNDROME TYPE A2 AUTOSOMAL DOMINANT;Fetal and neonatal alloimmune thrombocytopenia;NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY SUSCEPTIBILITY TO;Pseudo von Willebrand disease,GP1BA,2811,NM_000173
CHRNA10_SIG,CHRNA10,CHRNA10_SIG,CHRNA10,SIG,45,-0.505267587839737,-0.0846940139786223,-0.0838723346962144,-0.0873938173351057,-0.00352148263889121,0.666812484618579,-0.366599704159517,0.870628281148802,0.874915193726021,0.856542711252227,-0.0183724824737944,0.788256717952105,ENSG00000129749,CHRNA10,protein_coding,11,-1,3665587,3671384,p15.4,cholinergic receptor nicotinic alpha 10 subunit [Source:HGNC Symbol;Acc:HGNC:13800],NA,CHRNA10,57053,NM_001303034;NM_001303035;NM_020402
PTPRG_SIG,PTPRG,PTPRG_SIG,PTPRG,SIG,37,0.505130869044833,-0.118050826152106,-0.118835913247159,-0.115471254268359,0.00336465897880017,0.666829368056222,1.62626422658707,0.814833969183792,0.759458695707855,0.996781296319013,0.237322600611158,0.183185215353513,ENSG00000144724,PTPRG,protein_coding,3,1,61561569,62297609,p14.2,protein tyrosine phosphatase, receptor type G [Source:HGNC Symbol;Acc:HGNC:9671],NA,PTPRG,5793,NM_002841
HSDL2_SIG,HSDL2,HSDL2_SIG,HSDL2,SIG,19,0.504910867895817,0.295851288061673,0.294335605463334,0.300831388027645,0.00649578256431034,0.666830972310071,1.10875306151407,5.10894130251731,5.08657202019986,5.18244037298894,0.0958683527890836,0.378288414211312,ENSG00000119471,HSDL2,protein_coding,9,1,112380080,112472405,q32,hydroxysteroid dehydrogenase like 2 [Source:HGNC Symbol;Acc:HGNC:18572],NA,HSDL2,84263,NM_001195822;NM_032303
TNK2_SIG,TNK2,TNK2_SIG,TNK2,SIG,66,-0.504537703486345,0.173017204356716,0.173721087241839,0.170704446305596,-0.00301664093624287,0.666830972310071,0.246972385784667,7.11775704843053,7.11425819496838,7.12925328123474,0.0149950862663645,0.859904437683104,ENSG00000061938,TNK2,protein_coding,3,-1,195863365,195909009,q29,tyrosine kinase non receptor 2 [Source:HGNC Symbol;Acc:HGNC:19297],Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,TNK2,10188,NM_001010938;NM_001308046;NM_005781
TOP1_SIG,TOP1,TOP1_SIG,TOP1,SIG,18,-0.504515892466422,0.326286092120615,0.32696342222538,0.324060578919246,-0.00290284330613422,0.666830972310071,-0.679356040509443,6.78396817469889,6.79497448853321,6.7478045721004,-0.047169916432809,0.603841116793397,ENSG00000198900,TOP1,protein_coding,20,1,41028822,41124487,q12,DNA topoisomerase I [Source:HGNC Symbol;Acc:HGNC:11986],NA,TOP1,7150,NM_003286
APOBEC3G_SIG,APOBEC3G,APOBEC3G_SIG,APOBEC3G,SIG,48,-0.504463910917834,0.183770356869354,0.18507656343462,0.179478535297766,-0.00559802813685374,0.666830972310071,-0.277174199989907,5.03010954594186,5.03487817534704,5.01444119218198,-0.020436983165064,0.841486714635604,ENSG00000239713,APOBEC3G,protein_coding,22,1,39077067,39087743,q13.1,apolipoprotein B mRNA editing enzyme catalytic subunit 3G [Source:HGNC Symbol;Acc:HGNC:17357],NA,APOBEC3G,60489,NM_001349436;NM_001349437;NM_021822
PTK6_SIG,PTK6,PTK6_SIG,PTK6,SIG,41,-0.504442920921443,0.023215666668459,0.0249201139147086,0.0176153400022105,-0.00730477391249791,0.666830972310071,-0.0309865445018789,1.35216482472626,1.3531055627027,1.34907382851795,-0.00403173418475018,0.982898302574369,ENSG00000101213,PTK6,protein_coding,20,-1,63528001,63537376,q13.33,protein tyrosine kinase 6 [Source:HGNC Symbol;Acc:HGNC:9617],NA,PTK6,5753,NM_001256358;NM_005975
DICER1_SIG,DICER1,DICER1_SIG,DICER1,SIG,45,0.504441279355869,0.326140298057756,0.325557834321798,0.328054107475905,0.00249627315410696,0.666830972310071,1.18366844588726,7.02943949212803,7.01234236566325,7.08561576479805,0.0732733991347977,0.343986434257242,ENSG00000100697,DICER1,protein_coding,14,-1,95086228,95158010,q32.13,dicer 1, ribonuclease III [Source:HGNC Symbol;Acc:HGNC:17098],Familial multinodular goiter;Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome;Goiter multinodular 1 with or without sertoli-leydig cell tumors;Gynandroblastoma;Maligant granulosa cell tumor of the ovary;Malignant Sertoli-Leydig cell tumor of the ovary;PLEUROPULMONARY BLASTOMA;Pleuropulmonary blastoma familial tumor susceptibility syndrome;Rhabdomyosarcoma embryonal 2,DICER1,23405,NM_001195573;NM_001271282;NM_001291628;NM_030621;NM_177438
LSM10_SIG,LSM10,LSM10_SIG,LSM10,SIG,33,-0.504262663606094,0.318708562433145,0.320378043554262,0.313223124463761,-0.00715491909050116,0.66687985014361,1.66347338918057,4.16902801713655,4.14464006878678,4.24915984742865,0.104519778641865,0.172813520926361,ENSG00000181817,LSM10,protein_coding,1,-1,36391238,36397908,p34.3,LSM10, U7 small nuclear RNA associated [Source:HGNC Symbol;Acc:HGNC:17562],NA,LSM10,84967,NM_032881
TWF2_SIG,TWF2,TWF2_SIG,TWF2,SIG,31,0.503280267739914,0.386211137609208,0.385283567618428,0.389258867578917,0.0039752999604891,0.667542144656243,2.74698625931121,4.12281588037047,4.08205319123348,4.256750430392,0.174697239158517,0.0200491842485815,ENSG00000247596,TWF2,protein_coding,3,-1,52228612,52239158,p21.2,twinfilin actin binding protein 2 [Source:HGNC Symbol;Acc:HGNC:9621],NA,TWF2,11344,NM_007284
STAT6_TF,STAT6,STAT6_TF,STAT6,TF,355,0.502638127797963,0.225351166358081,0.224238187604806,0.229008096547411,0.00476990894260477,0.667944840116539,1.23107715261183,8.40529704632658,8.38285139393794,8.47904704703213,0.0961956530941936,0.323314112544126,ENSG00000166888,STAT6,protein_coding,12,-1,57095408,57132139,q13.3,signal transducer and activator of transcription 6 [Source:HGNC Symbol;Acc:HGNC:11368],Solitary fibrous tumor,STAT6,6778,NM_001178078;NM_001178079;NM_001178080;NM_001178081;NM_003153
SH2D1A_SIG,SH2D1A,SH2D1A_SIG,SH2D1A,SIG,18,0.500964543186554,0.0517470893686412,0.0503208781585511,0.0564332119160803,0.00611233375752937,0.669135416264392,1.22797546556779,3.39945452573534,3.34356123667434,3.58310390407864,0.2395426674043,0.32459331221247,ENSG00000183918,SH2D1A,protein_coding,X,1,124227868,124373197,q25,SH2 domain containing 1A [Source:HGNC Symbol;Acc:HGNC:10820],LYMPHOPROLIFERATIVE SYNDROME X-LINKED 1;X-linked lymphoproliferative disease,SH2D1A,4068,NM_001114937;NM_002351
TNFSF9_SIG,TNFSF9,TNFSF9_SIG,TNFSF9,SIG,60,0.500350523185259,0.0130205779961563,0.012192156200412,0.0157425353250304,0.00355037912461853,0.669516879461955,2.66101478957815,2.45038156898862,2.34979278192773,2.78088758361728,0.431094801689551,0.0244822995011137,ENSG00000125657,TNFSF9,protein_coding,19,1,6531026,6535924,p13.3,TNF superfamily member 9 [Source:HGNC Symbol;Acc:HGNC:11939],NA,TNFSF9,8744,NM_003811
DYRK2_SIG,DYRK2,DYRK2_SIG,DYRK2,SIG,82,0.498863124790161,0.210978336272538,0.210143873612837,0.213720142154411,0.00357626854157407,0.670566035508062,0.811528888809577,5.85498042813977,5.83993017053319,5.90443127456137,0.0645011040281834,0.5289888984872,ENSG00000127334,DYRK2,protein_coding,12,1,67648338,67665406,q15,dual specificity tyrosine phosphorylation regulated kinase 2 [Source:HGNC Symbol;Acc:HGNC:3093],NA,DYRK2,8445,NM_003583;NM_006482
RICTOR_SIG,RICTOR,RICTOR_SIG,RICTOR,SIG,101,-0.498410385484971,0.342936370890381,0.344257168335024,0.338596607857982,-0.00566056047704168,0.670824370521996,-0.953862964305672,6.79785242349678,6.81683589503068,6.73547815988541,-0.0813577351452696,0.453663163487948,ENSG00000164327,RICTOR,protein_coding,5,-1,38937920,39074399,p13.1,RPTOR independent companion of MTOR complex 2 [Source:HGNC Symbol;Acc:HGNC:28611],NA,RICTOR,253260,NM_001285439;NM_001285440;NM_152756
FAAH2_SIG,FAAH2,FAAH2_SIG,FAAH2,SIG,24,-0.498050734364016,0.0578125397634599,0.0589376812455139,0.0541156463224254,-0.00482203492308844,0.671011527962279,-1.33093971388803,0.628374849194773,0.646423820505646,0.569071086316189,-0.0773527341894571,0.282622295986885,ENSG00000165591,FAAH2,protein_coding,X,1,57286706,57489196,p11.21,fatty acid amide hydrolase 2 [Source:HGNC Symbol;Acc:HGNC:26440],NA,FAAH2,158584,NM_001353840;NM_001353841;NM_174912
MINPP1_SIG,MINPP1,MINPP1_SIG,MINPP1,SIG,31,-0.497683521309341,0.164975059906307,0.166477492819135,0.160038494621303,-0.00643899819783186,0.671204468696826,-0.289758546656609,3.58004671547135,3.58917948488181,3.55003904455125,-0.0391404403305598,0.834012299068768,ENSG00000107789,MINPP1,protein_coding,10,1,87504875,87553461,q23.2,multiple inositol-polyphosphate phosphatase 1 [Source:HGNC Symbol;Acc:HGNC:7102],Familial papillary or follicular thyroid carcinoma;THYROID CANCER NONMEDULLARY 2,MINPP1,9562,NM_001178117;NM_001178118;NM_004897
PTPN6_SIG,PTPN6,PTPN6_SIG,PTPN6,SIG,35,0.495740943885717,0.294083526112506,0.293044044359938,0.297498966156657,0.00445492179671958,0.67260271888741,-0.750298572048434,8.73138841679778,8.74470786175827,8.68762452621333,-0.0570833355449435,0.563309644339096,ENSG00000111679,PTPN6,protein_coding,12,1,6946468,6961316,p13.31,protein tyrosine phosphatase, non-receptor type 6 [Source:HGNC Symbol;Acc:HGNC:9658],NA,PTPN6,5777,NM_002831;NM_080548;NM_080549
HIPK3_SIG,HIPK3,HIPK3_SIG,HIPK3,SIG,46,-0.494914133341253,0.35313741527958,0.354260624289871,0.349446871388622,-0.00481375290124948,0.673147555824029,0.53955570920691,7.70759729512282,7.69941461207221,7.73448325371766,0.035068641645447,0.68654651951341,ENSG00000110422,HIPK3,protein_coding,11,1,33256672,33357023,p13,homeodomain interacting protein kinase 3 [Source:HGNC Symbol;Acc:HGNC:4915],NA,HIPK3,10114,NM_001048200;NM_001278162;NM_001278163;NM_005734
ISCA1_SIG,ISCA1,ISCA1_SIG,ISCA1,SIG,49,0.493917826391944,0.238674543952383,0.237330681372136,0.243090092430336,0.00575941105820009,0.673822318907884,0.524706634905406,4.95293781658765,4.94313592322399,4.98514403763969,0.0420081144157071,0.695437602197665,ENSG00000135070,ISCA1,protein_coding,9,-1,86264546,86283102,q21.33,iron-sulfur cluster assembly 1 [Source:HGNC Symbol;Acc:HGNC:28660],MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5,ISCA1,81689,NM_030940
ARHGAP25_SIG,ARHGAP25,ARHGAP25_SIG,ARHGAP25,SIG,73,-0.492257595498909,0.171785889147625,0.17243876164326,0.169640736661965,-0.00279802498129534,0.675006038671407,2.35033035966237,6.67023505431836,6.62596982135431,6.81567796262879,0.189708141274477,0.0487146619361474,ENSG00000163219,ARHGAP25,protein_coding,2,1,68679601,68826833,p13.3,Rho GTPase activating protein 25 [Source:HGNC Symbol;Acc:HGNC:28951],NA,ARHGAP25,9938,NM_001007231;NM_001166276;NM_001166277;NM_001364819;NM_014882
RNF167_SIG,RNF167,RNF167_SIG,RNF167,SIG,16,-0.492120738760753,0.267524410621983,0.268557251610263,0.26413079023192,-0.00442646137834285,0.675022589032409,-1.13466339821536,6.50173377328959,6.51542869672214,6.45673616772552,-0.0586925289966205,0.366014654218157,ENSG00000108523,RNF167,protein_coding,17,1,4940008,4945222,p13.2,ring finger protein 167 [Source:HGNC Symbol;Acc:HGNC:24544],NA,RNF167,26001,NM_001320356;NM_001320357;NM_001320358;NM_001320359;NM_001320360;NM_001320361;NM_001320362;NM_001320363;NM_001320364;NM_001320365;NM_015528
UBE2Q1_SIG,UBE2Q1,UBE2Q1_SIG,UBE2Q1,SIG,25,0.491866390531143,0.237543894319612,0.237242315988796,0.238534794549435,0.00129247856063834,0.675129180489761,0.801322975917426,6.68535563597771,6.6795452316621,6.70444696444328,0.0249017327811769,0.534402343344716,ENSG00000160714,UBE2Q1,protein_coding,1,-1,154548577,154559028,q21.3,ubiquitin conjugating enzyme E2 Q1 [Source:HGNC Symbol;Acc:HGNC:15698],NA,UBE2Q1,55585,NM_017582
SEC63_SIG,SEC63,SEC63_SIG,SEC63,SIG,12,-0.491402313670973,0.0448386505759309,0.0454419982504649,0.042856222502462,-0.002585775748003,0.675361808164256,-1.2351000642627,6.95377254067647,6.96489468392843,6.91722835570572,-0.0476663282227063,0.321618229492034,ENSG00000025796,SEC63,protein_coding,6,-1,107867756,107958208,q21,SEC63 homolog, protein translocation regulator [Source:HGNC Symbol;Acc:HGNC:21082],Isolated polycystic liver disease;POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS,SEC63,11231,NM_007214
KMT2E_SIG,KMT2E,KMT2E_SIG,KMT2E,SIG,33,0.491332307373864,0.449460594727115,0.448509951112239,0.452584138033136,0.00407418692089735,0.675361808164256,-0.906815483167561,7.90368350175621,7.91753536900787,7.85817022364363,-0.0593651453642395,0.478302305769698,ENSG00000005483,KMT2E,protein_coding,7,1,105014179,105114361,q22.3,lysine methyltransferase 2E [Source:HGNC Symbol;Acc:HGNC:18541],Intellectual disability,KMT2E,55904,NM_018682;NM_182931
FOXN3_TF,FOXN3,FOXN3_TF,FOXN3,TF,183,-0.490163239759403,0.0608252278285015,0.0615334400578939,0.0584982447890694,-0.00303519526882455,0.676169548669127,-1.40835777327425,7.6338092907979,7.65161181504412,7.5753152825603,-0.0762965324838208,0.253412706382368,ENSG00000053254,FOXN3,protein_coding,14,-1,89124871,89619149,q32.11,forkhead box N3 [Source:HGNC Symbol;Acc:HGNC:1928],NA,FOXN3,1112,NM_001085471;NM_005197
PLK2_SIG,PLK2,PLK2_SIG,PLK2,SIG,16,-0.488980628266311,0.0228415780289179,0.0235596505679805,0.0204821968291406,-0.00307745373883978,0.676987980212125,0.0192178335544553,3.79939514061273,3.79878520396662,3.80139921816422,0.00261401419760087,0.989433178183349,ENSG00000145632,PLK2,protein_coding,5,-1,58453982,58460139,q11.2,polo like kinase 2 [Source:HGNC Symbol;Acc:HGNC:19699],NA,PLK2,10769,NM_001252226;NM_006622
RNF168_SIG,RNF168,RNF168_SIG,RNF168,SIG,24,0.488620277353966,0.332321074678025,0.330668172354947,0.337752039453854,0.00708386709890651,0.677175855662244,1.53092249943233,5.91963493216582,5.88966121385519,6.01812000661503,0.128458792759847,0.211924239514274,ENSG00000163961,RNF168,protein_coding,3,-1,196468783,196503768,q29,ring finger protein 168 [Source:HGNC Symbol;Acc:HGNC:26661],RIDDLE syndrome,RNF168,165918,NM_152617
ZBED1_TF,ZBED1,ZBED1_TF,ZBED1,TF,59,0.488503729581216,0.0896652551381665,0.0892635213204789,0.0909852376819975,0.00172171636151843,0.677176716729599,0.630818393756294,6.01628081113415,6.00610163596829,6.04972667239342,0.0436250364251327,0.632091676247801,ENSG00000214717,ZBED1,protein_coding,X,-1,2486414,2500976,p22.33,zinc finger BED-type containing 1 [Source:HGNC Symbol;Acc:HGNC:447],NA,ZBED1,9189,NM_001171135;NM_001171136;NM_004729
DPM3_SIG,DPM3,DPM3_SIG,DPM3,SIG,5,0.487647550636892,0.272525960727864,0.271513818868163,0.275851569695455,0.00433775082729199,0.677744957855136,-1.40881875239131,3.10118422578326,3.11811423930046,3.04555703851247,-0.07255720078799,0.253230707737607,ENSG00000179085,DPM3,protein_coding,1,-1,155139891,155140595,q22,dolichyl-phosphate mannosyltransferase subunit 3 [Source:HGNC Symbol;Acc:HGNC:3007],Congenital disorder of glycosylation type 1O;DPM3-CDG;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE) TYPE C 15,DPM3,54344,NM_018973;NM_153741
SREBF1_SIG,SREBF1,SREBF1_SIG,SREBF1,SIG,13,0.486849249651559,-0.0671277896016438,-0.0680004281148772,-0.0642605487724485,0.0037398793424287,0.678268906056312,0.676600332459569,5.9092016677206,5.8965006107451,5.95093371206867,0.0544331013235721,0.605260663034934,ENSG00000072310,SREBF1,protein_coding,17,-1,17810399,17837002,p11.2,sterol regulatory element binding transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:11289],NA,SREBF1,6720,NM_001005291;NM_001321096;NM_004176
GNAI1_SIG,GNAI1,GNAI1_SIG,GNAI1,SIG,54,-0.486370201720338,0.0459356641153985,0.0476817860580706,0.0401984063037615,-0.00748337975430899,0.678547903019876,-0.489130161072386,3.76965438502922,3.79502987608681,3.68627777155427,-0.108752104532537,0.715875838526093,ENSG00000127955,GNAI1,protein_coding,7,1,79768028,80226181,q21.11,G protein subunit alpha i1 [Source:HGNC Symbol;Acc:HGNC:4384],GNAI1 syndrome,GNAI1,2770,NM_001256414;NM_002069
ZNF25_TF,ZNF25,ZNF25_TF,ZNF25,TF,65,0.485727441578419,0.221118127142058,0.220438328282346,0.223351751966826,0.00291342368447996,0.67895258309,0.361286181794611,4.29197838589898,4.28720932455729,4.30764815887879,0.0204388343214995,0.791195003912413,ENSG00000175395,ZNF25,protein_coding,10,-1,37949573,37976647,p11.21,zinc finger protein 25 [Source:HGNC Symbol;Acc:HGNC:13043],NA,ZNF25,219749,NM_001329647;NM_001329648;NM_001329649;NM_001329650;NM_001329651;NM_001329652;NM_001329653;NM_001329654;NM_001329655;NM_001329656;NM_001329657;NM_001329658;NM_001329659;NM_001329660;NM_001329661;NM_001329662;NM_001329663;NM_001329664;NM_145011
NEK7_SIG,NEK7,NEK7_SIG,NEK7,SIG,13,0.485159677329365,0.480581098597005,0.479393292727539,0.484483889310966,0.00509059658342651,0.679299730685076,-0.751727992063054,5.60480628649426,5.61772560735032,5.5623570893958,-0.0553685179545153,0.562515716254661,ENSG00000151414,NEK7,protein_coding,1,1,198156994,198322420,q31.3,NIMA related kinase 7 [Source:HGNC Symbol;Acc:HGNC:13386],NA,NEK7,140609,NM_133494
MAGT1_SIG,MAGT1,MAGT1_SIG,MAGT1,SIG,42,0.484744479703852,0.315977257725411,0.315392192875236,0.3178996136617,0.00250742078646456,0.679529758713235,0.326437894640305,6.11340220700558,6.10909368292839,6.12755878611633,0.018465103187938,0.812239063790715,ENSG00000102158,MAGT1,protein_coding,X,-1,77826364,77895593,q21.1,magnesium transporter 1 [Source:HGNC Symbol;Acc:HGNC:28880],Immunodeficiency X-Linked with magnesium defect Epstein-Barr virus infection and neoplasia;MENTAL RETARDATION X-LINKED TYPE 95;X-linked immunodeficiency with magnesium defect Epstein-Barr virus infection and neoplasia,MAGT1,84061,NM_032121
ERH_SIG,ERH,ERH_SIG,ERH,SIG,32,-0.484329894268103,0.423443041580707,0.42436582539608,0.420411037615908,-0.00395478778017191,0.679759320716973,-0.347772560221048,5.75812386833369,5.76229404649294,5.74442185438188,-0.0178721921110528,0.798999768117689,ENSG00000100632,ERH,protein_coding,14,-1,69380128,69398299,q24.1,ERH, mRNA splicing and mitosis factor [Source:HGNC Symbol;Acc:HGNC:3447],NA,ERH,2079,NM_004450
CALM2_SIG,CALM2,CALM2_SIG,CALM2,SIG,14,0.483254539546006,0.383195680441685,0.38194214756903,0.387314431308982,0.00537228373995227,0.680496394725572,1.80523046109063,7.01152809173361,6.97978002283802,7.11584317524768,0.13606315240966,0.136973075418718,ENSG00000143933,CALM2,protein_coding,2,-1,47160083,47176601,p21,calmodulin 2 [Source:HGNC Symbol;Acc:HGNC:1445],Brugada syndrome;Catecholaminergic polymorphic ventricular tachycardia;LONG QT SYNDROME 15;Romano-Ward syndrome,CALM2,805,NM_001305624;NM_001305625;NM_001305626;NM_001743
COL9A3_SIG,COL9A3,COL9A3_SIG,COL9A3,SIG,17,-0.479811617280866,0.107429601900394,0.108183308834284,0.104953136260469,-0.0032301725738145,0.683054165163381,-0.0350241622419892,1.91134720380233,1.91243750833628,1.90776477461935,-0.0046727337169274,0.980995406111906,ENSG00000092758,COL9A3,protein_coding,20,1,62816244,62841159,q13.33,collagen type IX alpha 3 chain [Source:HGNC Symbol;Acc:HGNC:2219],Autosomal recessive Stickler syndrome;EPIPHYSEAL DYSPLASIA MULTIPLE 3;INTERVERTEBRAL DISC DISEASE;Multiple epiphyseal dysplasia due to collagen 9 anomaly;MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 3;Stickler syndrome,COL9A3,1299,NM_001853
RNF44_SIG,RNF44,RNF44_SIG,RNF44,SIG,29,-0.479395243790916,0.0345920278003877,0.0350848208174573,0.032972850744302,-0.0021119700731552,0.68314791855506,-1.43277583525672,7.28445616523023,7.3003303375002,7.23229817062888,-0.068032166871321,0.244550690144853,ENSG00000146083,RNF44,protein_coding,5,-1,176526712,176538025,q35.2,ring finger protein 44 [Source:HGNC Symbol;Acc:HGNC:19180],NA,RNF44,22838,NM_014901
CTAGE1_SIG,CTAGE1,CTAGE1_SIG,CTAGE1,SIG,4,-0.479346962098626,0.0366124156025277,0.0371585189745808,0.0348180759514962,-0.00234044302308446,0.68314791855506,-0.488280243391974,1.4659258997794,1.46937126123,1.45460542644171,-0.0147658347882859,0.716357576871878,ENSG00000212710,CTAGE1,protein_coding,18,-1,22413601,22417915,q11.2,cutaneous T cell lymphoma-associated antigen 1 [Source:HGNC Symbol;Acc:HGNC:24346],NA,CTAGE1,64693,NM_172241
TP53BP2_SIG,TP53BP2,TP53BP2_SIG,TP53BP2,SIG,51,0.479341957858431,0.0618316845820289,0.060659723299471,0.0656824145104332,0.00502269121096202,0.68314791855506,-0.294295652972388,6.63026443574805,6.63477955698302,6.61542903740458,-0.0193505195784427,0.831169025802116,ENSG00000143514,TP53BP2,protein_coding,1,-1,223779893,223845954,q41,tumor protein p53 binding protein 2 [Source:HGNC Symbol;Acc:HGNC:12000],NA,TP53BP2,7159,NM_001031685;NM_005426
ACBD3_SIG,ACBD3,ACBD3_SIG,ACBD3,SIG,29,-0.477832051294831,0.386411311549306,0.386939063369599,0.384677269854058,-0.00226179351554111,0.684220484449633,0.483027316541621,5.79250455256637,5.78756901533998,5.80872131773878,0.0211523023987922,0.719317864465567,ENSG00000182827,ACBD3,protein_coding,1,-1,226144679,226186741,q42.12,acyl-CoA binding domain containing 3 [Source:HGNC Symbol;Acc:HGNC:15453],NA,ACBD3,64746,NM_022735
LAMP2_SIG,LAMP2,LAMP2_SIG,LAMP2,SIG,37,0.475997741655351,0.366055998119142,0.365338685251661,0.368412883255151,0.00307419800348973,0.685543462181579,0.923792623088083,7.73972776793345,7.72578978540851,7.78552399622966,0.0597342108211521,0.468971295555648,ENSG00000005893,LAMP2,protein_coding,X,-1,120427827,120469365,q24,lysosomal associated membrane protein 2 [Source:HGNC Symbol;Acc:HGNC:6501],Danon disease;Glycogen storage disease due to LAMP-2 deficiency,LAMP2,3920,NM_001122606;NM_002294;NM_013995
RHEB_SIG,RHEB,RHEB_SIG,RHEB,SIG,39,-0.475410502337814,0.00401460524300868,0.00469830287364744,0.00176817017090989,-0.00293013270273762,0.685906339855384,-0.826518969036653,4.6355836342947,4.64600617919913,4.60133812960871,-0.0446680495904283,0.520831701525217,ENSG00000106615,RHEB,protein_coding,7,-1,151466012,151520120,q36.1,Ras homolog, mTORC1 binding [Source:HGNC Symbol;Acc:HGNC:10011],NA,RHEB,6009,NM_005614
SIX5_TF,SIX5,SIX5_TF,SIX5,TF,172,-0.472613040217719,-0.0637100342581983,-0.0633290634036114,-0.0649617956375552,-0.00163273223394377,0.687944202792299,-0.0376351796312518,1.12168989283445,1.12256660355111,1.11880927190827,-0.00375733164284039,0.97953023842949,ENSG00000177045,SIX5,protein_coding,19,-1,45764785,45769252,q13.32,SIX homeobox 5 [Source:HGNC Symbol;Acc:HGNC:10891],BOR syndrome;BRANCHIOOTORENAL SYNDROME 2;branchiootorenal syndrome type 2,SIX5,147912,NM_175875
CRKL_SIG,CRKL,CRKL_SIG,CRKL,SIG,30,0.472347028642616,0.361615954549206,0.361033561042964,0.363529533212572,0.00249597216960807,0.687944202792299,0.0620455707955999,6.99327061420642,6.99263653428194,6.99535401967257,0.0027174853906232,0.965879444307668,ENSG00000099942,CRKL,protein_coding,22,1,20917407,20953747,q11.21,CRK like proto-oncogene, adaptor protein [Source:HGNC Symbol;Acc:HGNC:2363],Bladder exstrophy plus;Distal 22q11.2 microdeletion syndrome,CRKL,1399,NM_005207
SNAI1_TF,SNAI1,SNAI1_TF,SNAI1,TF,157,0.472314313973219,-0.00407256707208091,-0.00445699723222634,-0.00280943940303163,0.00164755782919462,0.687944202792299,1.56621157999932,2.74133292337046,2.68732262460757,2.91879533359137,0.231472708983796,0.200799781647566,ENSG00000124216,SNAI1,protein_coding,20,1,49982980,49988886,q13.13,snail family transcriptional repressor 1 [Source:HGNC Symbol;Acc:HGNC:11128],NA,SNAI1,6615,NM_005985
CLCN5_SIG,CLCN5,CLCN5_SIG,CLCN5,SIG,17,0.472301408293234,0.0575982742880107,0.0561494264149768,0.0623587744422649,0.00620934802728814,0.687944202792299,3.550923643103,3.35552254360468,3.26235361929496,3.66164900919376,0.399295389898802,0.00231800846388187,ENSG00000171365,CLCN5,protein_coding,X,1,49922596,50099235,p11.23,chloride voltage-gated channel 5 [Source:HGNC Symbol;Acc:HGNC:2023],Dent disease 1;Dent disease type 1;HYPOPHOSPHATEMIC RICKETS X-LINKED RECESSIVE;NEPHROLITHIASIS X-LINKED RECESSIVE WITH RENAL FAILURE;PROTEINURIA LOW MOLECULAR WEIGHT WITH HYPERCALCIURIA AND NEPHROCALCINOSIS,CLCN5,1184,NM_000084;NM_001127898;NM_001127899;NM_001272102;NM_001282163
HERC6_SIG,HERC6,HERC6_SIG,HERC6,SIG,17,-0.471889486848884,0.313243599643293,0.314237403818186,0.309978243068644,-0.00425916074954179,0.688172121090395,1.70383862977317,3.87964890385687,3.84413672913493,3.99633176365753,0.152195034522601,0.162185513886709,ENSG00000138642,HERC6,protein_coding,4,1,88378739,88443111,q22.1,HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 [Source:HGNC Symbol;Acc:HGNC:26072],NA,HERC6,55008,NM_001165136;NM_017912
CXCL3_SIG,CXCL3,CXCL3_SIG,CXCL3,SIG,51,0.471527327333644,-0.00201458691133733,-0.00318647852495147,0.0018359141048234,0.00502239262977487,0.688361665720018,0.385285997200807,2.89025176280337,2.87203508417618,2.95010656400701,0.078071479830828,0.777075517271099,ENSG00000163734,CXCL3,protein_coding,4,-1,74036589,74038807,q13.3,C-X-C motif chemokine ligand 3 [Source:HGNC Symbol;Acc:HGNC:4604],NA,CXCL3,2921,NM_002090
RHOT1_SIG,RHOT1,RHOT1_SIG,RHOT1,SIG,13,-0.470887163412996,0.165915336735269,0.167282208165346,0.161424187750728,-0.00585802041461858,0.688765623416811,-0.318492600599131,5.81008603937489,5.81396546241321,5.79733936367754,-0.0166260987356708,0.816739387217353,ENSG00000126858,RHOT1,protein_coding,17,1,32142454,32253374,q11.2,ras homolog family member T1 [Source:HGNC Symbol;Acc:HGNC:21168],NA,RHOT1,55288,NM_001033566;NM_001033567;NM_001033568;NM_001288754;NM_001288755;NM_001288758;NM_018307
RIPK3_SIG,RIPK3,RIPK3_SIG,RIPK3,SIG,55,0.470598189624929,0.254393674436176,0.253395087188197,0.257674746822393,0.00427965963419622,0.688898722663179,0.71973534053217,3.7825211908994,3.7684133766496,3.82887543772018,0.0604620610705812,0.580415863007013,ENSG00000129465,RIPK3,protein_coding,14,-1,24336025,24340022,q12,receptor interacting serine/threonine kinase 3 [Source:HGNC Symbol;Acc:HGNC:10021],NA,RIPK3,11035,NM_006871
ABCC10_SIG,ABCC10,ABCC10_SIG,ABCC10,SIG,57,0.470278555659073,0.266304083515905,0.265318516700134,0.26954237448201,0.0042238577818763,0.689055466601744,1.459227342738,4.64421557088506,4.62138248098763,4.71923858054807,0.0978560995604462,0.235563183074243,ENSG00000124574,ABCC10,protein_coding,6,1,43427366,43450427,p21.1,ATP binding cassette subfamily C member 10 [Source:HGNC Symbol;Acc:HGNC:52],NA,ABCC10,89845,NM_001198934;NM_001350518;NM_033450
PPIL1_SIG,PPIL1,PPIL1_SIG,PPIL1,SIG,55,0.469733144176205,0.311222666995769,0.309184967543134,0.317917965197287,0.00873299765415352,0.689308246718232,0.261134850652609,3.56353390279471,3.55682432683239,3.5855796523852,0.0287553255528094,0.850922885156135,ENSG00000137168,PPIL1,protein_coding,6,-1,36854827,36874803,p21.2,peptidylprolyl isomerase like 1 [Source:HGNC Symbol;Acc:HGNC:9260],NA,PPIL1,51645,NM_016059
ZNF211_TF,ZNF211,ZNF211_TF,ZNF211,TF,22,-0.46971797612043,0.0977001410402225,0.0982903285332849,0.0957609535630172,-0.00252937497026789,0.689308246718232,0.369417638136824,4.33443874817691,4.32926984125827,4.35142229948098,0.0221524582227088,0.786859851695792,ENSG00000121417,ZNF211,protein_coding,19,1,57630395,57644041,q13.43,zinc finger protein 211 [Source:HGNC Symbol;Acc:HGNC:13003],NA,ZNF211,10520,NM_001265597;NM_001265598;NM_001265599;NM_001265600;NM_001322306;NM_006385;NM_198855
SLC16A2_SIG,SLC16A2,SLC16A2_SIG,SLC16A2,SIG,85,-0.46817626251923,-0.147608612454638,-0.146789422414631,-0.150300236871804,-0.00351081445717384,0.690407901565741,-0.491152016613583,0.721078797677729,0.736607950449315,0.670054438571091,-0.0665535118782242,0.714846305758934,ENSG00000147100,SLC16A2,protein_coding,X,1,74421493,74533917,q13.2,solute carrier family 16 member 2 [Source:HGNC Symbol;Acc:HGNC:10923],ALLAN-HERNDON-DUDLEY SYNDROME;MCT8 (SLC16A2)-Specific Thyroid Hormone Cell Transporter Deficiency,SLC16A2,6567,NM_006517
HIC1_TF,HIC1,HIC1_TF,HIC1,TF,42,-0.467804161775637,0.180441281076896,0.181305586617681,0.177601420014316,-0.00370416660336498,0.690555979135203,0.376311070130986,2.69173516985297,2.678223550909,2.73613048924028,0.0579069383312761,0.782476615641976,ENSG00000177374,HIC1,protein_coding,17,1,2054154,2063241,p13.3,HIC ZBTB transcriptional repressor 1 [Source:HGNC Symbol;Acc:HGNC:4909],Miller-Dieker syndrome,HIC1,3090,NM_001098202;NM_006497
LRR1_SIG,LRR1,LRR1_SIG,LRR1,SIG,9,-0.467751316212576,0.217353847390996,0.21877737827371,0.212676531633505,-0.00610084664020457,0.690555979135203,0.09515742996631,3.50507237426506,3.50390977391392,3.5088923468474,0.00498257293348869,0.946657190493028,ENSG00000165501,LRR1,protein_coding,14,1,49598761,49614672,q21.3,leucine rich repeat protein 1 [Source:HGNC Symbol;Acc:HGNC:19742],NA,LRR1,122769,NM_152329;NM_203467
PER2_SIG,PER2,PER2_SIG,PER2,SIG,11,0.467588590029393,0.329941400216508,0.328977061814114,0.333109940681516,0.00413287886740195,0.690591623032309,0.411823361417852,4.87628803820956,4.86983996786268,4.89747455506358,0.0276345872008986,0.761608910121991,ENSG00000132326,PER2,protein_coding,2,-1,238244044,238290102,q37.3,period circadian regulator 2 [Source:HGNC Symbol;Acc:HGNC:8846],ADVANCED SLEEP PHASE SYNDROME FAMILIAL 1;FAMILIAL ADVANCED SLEEP-PHASE SYNDROME,PER2,8864,NM_022817
RDH5_SIG,RDH5,RDH5_SIG,RDH5,SIG,29,-0.466170903567104,0.0368531349769833,0.0373887398135049,0.0350932905141267,-0.00229544929937809,0.69159595709619,-1.70567265257949,1.08500344330604,1.10877344073386,1.00690202318604,-0.101871417547827,0.161713657650982,ENSG00000135437,RDH5,protein_coding,12,1,55720367,55724705,q13.2,retinol dehydrogenase 5 [Source:HGNC Symbol;Acc:HGNC:9940],FUNDUS ALBIPUNCTATUS;FUNDUS ALBIPUNCTATUS RETINITIS PUNCTATA ALBESCENS INCLUDED;RETINITIS PUNCTATA ALBESCENS,RDH5,5959,NM_001199771;NM_002905
IRF5_SIG,IRF5,IRF5_SIG,IRF5,SIG,46,-0.465986035147377,0.232667015611522,0.234191826010395,0.227656924300939,-0.00653490170945569,0.691628798222895,0.216298466108167,6.19654426722838,6.19087099611886,6.21518501515967,0.0243140190408145,0.878045944076609,ENSG00000128604,IRF5,protein_coding,7,1,128937457,128950038,q32.1,interferon regulatory factor 5 [Source:HGNC Symbol;Acc:HGNC:6120],Diffuse cutaneous systemic sclerosis;INFLAMMATORY BOWEL DISEASE 14;Limited cutaneous systemic sclerosis;Primary biliary cholangitis;Systemic lupus erythematosus;SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO 10,IRF5,3663,NM_001098627;NM_001098629;NM_001098630;NM_001242452;NM_001347928;NM_001364314;NM_032643
CCDC59_SIG,CCDC59,CCDC59_SIG,CCDC59,SIG,39,-0.465895116755285,0.152941160722584,0.154485791094568,0.147865946643209,-0.00661984445135961,0.691628798222895,-0.558663602662618,5.55205254471966,5.56063329883415,5.52385863834349,-0.0367746604906687,0.675998801640372,ENSG00000133773,CCDC59,protein_coding,12,-1,82223681,82358805,q21.31,coiled-coil domain containing 59 [Source:HGNC Symbol;Acc:HGNC:25005],NA,CCDC59,29080,NM_014167
SYDE1_SIG,SYDE1,SYDE1_SIG,SYDE1,SIG,66,0.464436857080544,-0.1441768755259,-0.145066083067865,-0.1412551936023,0.00381088946556537,0.692664808662124,-0.165034544105252,0.521761738292685,0.525082246844533,0.510851495908039,-0.0142307509364946,0.907502643007812,ENSG00000105137,SYDE1,protein_coding,19,1,15107401,15114985,p13.12,synapse defective Rho GTPase homolog 1 [Source:HGNC Symbol;Acc:HGNC:25824],NA,SYDE1,85360,NM_001300910;NM_033025
PJA2_SIG,PJA2,PJA2_SIG,PJA2,SIG,30,-0.463156508442326,0.389102254649314,0.389640255740185,0.387334536779309,-0.00230571896087606,0.693563817872124,1.60654531398439,7.69727621181632,7.67819476588297,7.7599723913116,0.0817776254286314,0.188710203458131,ENSG00000198961,PJA2,protein_coding,5,-1,109334713,109409974,q21.3,praja ring finger ubiquitin ligase 2 [Source:HGNC Symbol;Acc:HGNC:17481],NA,PJA2,9867,NM_014819
KDM5A_SIG,KDM5A,KDM5A_SIG,KDM5A,SIG,44,-0.462723752481422,0.493858354867484,0.494576177576259,0.491499794538649,-0.00307638303760966,0.693807990315124,0.0157668708988897,6.99677953223117,6.99660603984632,6.99734957863851,0.000743538792186804,0.991484635002324,ENSG00000073614,KDM5A,protein_coding,12,-1,280129,389454,p13.33,lysine demethylase 5A [Source:HGNC Symbol;Acc:HGNC:9886],Autosomal Recessive Mental Retardation,KDM5A,5927,NM_001042603
ZBTB11_TF,ZBTB11,ZBTB11_TF,ZBTB11,TF,73,0.462223701832638,0.281478748030965,0.28080533638651,0.283691386291316,0.00288604990480643,0.694104179263489,0.372569532175784,5.99767116630883,5.99281411094902,6.01363006249103,0.0208159515420084,0.784987412081233,ENSG00000066422,ZBTB11,protein_coding,3,-1,101648889,101677495,q12.3,zinc finger and BTB domain containing 11 [Source:HGNC Symbol;Acc:HGNC:16740],NA,ZBTB11,27107,NM_014415
DCAF5_SIG,DCAF5,DCAF5_SIG,DCAF5,SIG,37,-0.461888175784913,0.181969364206323,0.18250028391961,0.180224913719807,-0.00227537019980271,0.694273206950735,-1.87926525009972,6.62621698125792,6.64523206118346,6.56373886150257,-0.0814931996808966,0.120573816919356,ENSG00000139990,DCAF5,protein_coding,14,-1,69050881,69153150,q24.1,DDB1 and CUL4 associated factor 5 [Source:HGNC Symbol;Acc:HGNC:20224],NA,DCAF5,8816,NM_001284206;NM_001284207;NM_001284208;NM_003861
ZDHHC17_SIG,ZDHHC17,ZDHHC17_SIG,ZDHHC17,SIG,24,-0.460508079049348,0.195576330070101,0.196126170417762,0.193769711784931,-0.00235645863283086,0.695249842531496,-0.824467674339417,5.96465638811665,5.97417057843025,5.93339547708622,-0.0407751013440292,0.521907971948857,ENSG00000186908,ZDHHC17,protein_coding,12,1,76763588,76853696,q21.2,zinc finger DHHC-type containing 17 [Source:HGNC Symbol;Acc:HGNC:18412],NA,ZDHHC17,23390,NM_001359626;NM_015336
SMURF1_SIG,SMURF1,SMURF1_SIG,SMURF1,SIG,53,-0.460317587500137,0.255272404831534,0.256753703897906,0.250405279327743,-0.00634842457016245,0.695306722803094,-0.333612026482866,5.36681418234104,5.37427853686019,5.34228844606383,-0.031990090796363,0.807789123778848,ENSG00000198742,SMURF1,protein_coding,7,-1,99027438,99144100,q22.1,SMAD specific E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:16807],NA,SMURF1,57154,NM_001199847;NM_020429;NM_181349
TNFRSF10B_SIG,TNFRSF10B,TNFRSF10B_SIG,TNFRSF10B,SIG,15,0.459814088998883,0.121335160374765,0.120747463411416,0.123266164682913,0.00251870127149665,0.695605658246081,0.120548019705706,5.87853117416821,5.87604899425797,5.886686908159,0.0106379139010375,0.932889069128368,ENSG00000120889,TNFRSF10B,protein_coding,8,-1,23020133,23069031,p21.3,TNF receptor superfamily member 10b [Source:HGNC Symbol;Acc:HGNC:11905],SQUAMOUS CELL CARCINOMA HEAD AND NECK;Squamous cell carcinoma of salivary glands;Squamous cell carcinoma of the hypopharynx;Squamous cell carcinoma of the larynx;Squamous cell carcinoma of the lip;Squamous cell carcinoma of the nasal cavity and paranasal sinuses;Squamous cell carcinoma of the oral cavity;Squamous cell carcinoma of the oropharynx,TNFRSF10B,8795,NM_003842;NM_147187
CYB5R1_SIG,CYB5R1,CYB5R1_SIG,CYB5R1,SIG,21,0.458740200998442,0.115431802977976,0.114751971316492,0.117665535579993,0.00291356426350092,0.696345838516863,0.812544849464526,4.58214787403929,4.57052258286975,4.62034525931062,0.0498226764408766,0.528454959013313,ENSG00000159348,CYB5R1,protein_coding,1,-1,202961873,202967275,q32.1,cytochrome b5 reductase 1 [Source:HGNC Symbol;Acc:HGNC:13397],NA,CYB5R1,51706,NM_016243
SRGAP1_SIG,SRGAP1,SRGAP1_SIG,SRGAP1,SIG,56,-0.458122486270106,-0.0470884831695494,-0.0460608571982067,-0.050464968503961,-0.0044041113057544,0.696721606370246,-0.425729164276058,1.38227679784309,1.39593915309945,1.33738620200075,-0.0585529510987011,0.753297575935635,ENSG00000196935,SRGAP1,protein_coding,12,1,63844700,64162217,q14.2,SLIT-ROBO Rho GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:17382],THYROID CANCER NONMEDULLARY 2,SRGAP1,57522,NM_001346201;NM_020762
U2AF1_SIG,U2AF1,U2AF1_SIG,U2AF1,SIG,58,-0.458020439023987,0.0464646392103104,0.0481010509455743,0.0410878577944432,-0.00701319315113109,0.696721606370246,0.388152954708551,7.64825991640252,7.64139133325911,7.67082811815945,0.0294367849003452,0.775534386244631,ENSG00000160201,U2AF1,protein_coding,21,-1,43092956,43107587,q22.3,U2 small nuclear RNA auxiliary factor 1 [Source:HGNC Symbol;Acc:HGNC:12453],NA,U2AF1,7307,NM_001025203;NM_001025204;NM_006758
RNF6_TF,RNF6,RNF6_TF,RNF6,TF,65,0.457811894475467,0.303621290590844,0.303109120290327,0.305304135863973,0.00219501557364626,0.696792394036252,0.0702281965414111,6.00209443674119,6.00132527625031,6.00462167835408,0.00329640210377233,0.961698834713097,ENSG00000127870,RNF6,protein_coding,13,-1,26132115,26222314,q12.13,ring finger protein 6 [Source:HGNC Symbol;Acc:HGNC:10069],ESOPHAGEAL CANCER ESOPHAGEAL SQUAMOUS CELL CARCINOMA SUSCEPTIBILITY TO INCLUDED;Squamous cell carcinoma of the esophagus,RNF6,6049,NM_005977;NM_183043;NM_183044;NM_183045
MAP2K7_SIG,MAP2K7,MAP2K7_SIG,MAP2K7,SIG,23,-0.457411362988733,0.322801179351631,0.323312311095555,0.321121746478739,-0.00219056461681568,0.697011718869458,1.88823354310711,5.72640043668279,5.71213965893755,5.77325727784572,0.061117618908174,0.118701558531348,ENSG00000076984,MAP2K7,protein_coding,19,1,7903843,7914478,p13.2,mitogen-activated protein kinase kinase 7 [Source:HGNC Symbol;Acc:HGNC:6847],NA,MAP2K7,5609,NM_001297555;NM_001297556;NM_145185
BZW1_SIG,BZW1,BZW1_SIG,BZW1,SIG,40,-0.45456589812411,0.243687228404002,0.244700795143993,0.240356937686889,-0.00434385745710386,0.699123925871961,0.133628032146619,6.9408593272168,6.93917124780144,6.94640587386726,0.00723462606581749,0.924963355864691,ENSG00000082153,BZW1,protein_coding,2,1,200810594,200827338,q33.1,basic leucine zipper and W2 domains 1 [Source:HGNC Symbol;Acc:HGNC:18380],NA,BZW1,9689,NM_001207067;NM_001207068;NM_001207069;NM_001321688;NM_001321690;NM_001321691;NM_001321693;NM_001321694;NM_014670
TATDN3_SIG,TATDN3,TATDN3_SIG,TATDN3,SIG,12,-0.451982714839304,0.278105181528843,0.278629649250784,0.276381930442466,-0.00224771880831775,0.701035037962253,0.652401955866861,3.72802071803468,3.71989240963789,3.7547280170527,0.0348356074148181,0.619519043528908,ENSG00000203705,TATDN3,protein_coding,1,1,212791828,212816830,q32.3,TatD DNase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:27010],NA,TATDN3,128387,NM_001042552;NM_001042553;NM_001146169;NM_001146170;NM_001146171
HIST1H1B_SIG,HIST1H1B,HIST1H1B_SIG,HIST1H1B,SIG,24,0.451737805440644,-0.233701407943986,-0.234951276161138,-0.229594698087628,0.00535657807351019,0.701122610985398,0.0721823287751903,0.865228551190258,0.863508804551403,0.870879147289354,0.00737034273795098,0.96058583085454,ENSG00000184357,HIST1H1B,protein_coding,6,-1,27866849,27867529,p22.1,histone cluster 1 H1 family member b [Source:HGNC Symbol;Acc:HGNC:4719],NA,HIST1H1B,3009,NM_005322
POLE2_SIG,POLE2,POLE2_SIG,POLE2,SIG,39,-0.451634872083101,0.389692114322542,0.392180357348976,0.381516458664257,-0.010663898684719,0.701122610985398,-0.598677203690866,2.91083142537155,2.92541826894722,2.86290322505149,-0.0625150438957384,0.65203084135768,ENSG00000100479,POLE2,protein_coding,14,-1,49643555,49688422,q21.3,DNA polymerase epsilon 2, accessory subunit [Source:HGNC Symbol;Acc:HGNC:9178],NA,POLE2,5427,NM_001197330;NM_001197331;NM_001348384;NM_001348385;NM_002692
ZBTB21_TF,ZBTB21,ZBTB21_TF,ZBTB21,TF,119,0.451012449793825,0.312480273729509,0.310795899985675,0.318014644602107,0.00721874461643214,0.701514165301185,2.03036714837908,5.31250633011143,5.25852857752823,5.48986180288479,0.23133322535656,0.0918498700185503,ENSG00000173276,ZBTB21,protein_coding,21,-1,41986831,42010387,q22.3,zinc finger and BTB domain containing 21 [Source:HGNC Symbol;Acc:HGNC:13083],NA,ZBTB21,49854,NM_001098402;NM_001098403;NM_001320729;NM_001320731;NM_020727
ECHDC1_SIG,ECHDC1,ECHDC1_SIG,ECHDC1,SIG,75,0.450521829958291,0.350879790125099,0.349144492895756,0.356581481021513,0.00743698812575799,0.701737885321378,0.497707054723649,4.91529387580203,4.90438167288247,4.95114825682345,0.0467665839409798,0.711002201427177,ENSG00000093144,ECHDC1,protein_coding,6,-1,127288712,127343609,q22.33,ethylmalonyl-CoA decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:21489],NA,ECHDC1,55862,NM_001002030;NM_001105544;NM_001105545;NM_001139510;NM_018479
NKAP_SIG,NKAP,NKAP_SIG,NKAP,SIG,10,0.45048897928792,0.308762892058494,0.308005545816102,0.311251315426351,0.00324576961024911,0.701737885321378,0.658517230870717,3.7893778605272,3.78338201219322,3.80907850505313,0.0256964928599115,0.615670832677837,ENSG00000101882,NKAP,protein_coding,X,-1,119920672,119943751,q24,NFKB activating protein [Source:HGNC Symbol;Acc:HGNC:29873],NA,NKAP,79576,NM_024528
POLR2E_SIG,POLR2E,POLR2E_SIG,POLR2E,SIG,17,0.449988300591095,0.443853021579093,0.443040193093363,0.446523743746493,0.0034835506531291,0.702035037235536,0.191188919764389,6.2096825868606,6.20761144433388,6.21648776944839,0.00887632511451293,0.892459297589599,ENSG00000099817,POLR2E,protein_coding,19,-1,1086574,1095380,p13.3,RNA polymerase II subunit E [Source:HGNC Symbol;Acc:HGNC:9192],NA,POLR2E,5434,NM_001316323;NM_001316324;NM_002695
DDX6_SIG,DDX6,DDX6_SIG,DDX6,SIG,28,-0.449545310962912,0.537592775286667,0.53842132966222,0.534870382338421,-0.00355094732379938,0.70228745577215,-0.663010249431725,7.72273558221111,7.73182588996622,7.69286742815859,-0.0389584618076304,0.613035502141488,ENSG00000110367,DDX6,protein_coding,11,-1,118747763,118791164,q23.3,DEAD-box helicase 6 [Source:HGNC Symbol;Acc:HGNC:2747],Intellectual disability,DDX6,1656,NM_001257191;NM_004397
ZNF274_TF,ZNF274,ZNF274_TF,ZNF274,TF,27,0.448175207579219,0.156617791163223,0.155796729606505,0.159315564849581,0.00351883524307594,0.703259137773544,-1.04764975854973,5.24682664766908,5.26453699944599,5.18863549183064,-0.0759015076153481,0.407255923600452,ENSG00000171606,ZNF274,protein_coding,19,1,58183029,58213562,q13.43,zinc finger protein 274 [Source:HGNC Symbol;Acc:HGNC:13068],NA,ZNF274,10782,NM_001278734;NM_016324;NM_016325;NM_133502
NDUFAF5_SIG,NDUFAF5,NDUFAF5_SIG,NDUFAF5,SIG,38,-0.446699364101002,0.202334688876001,0.204069644903712,0.196634119070665,-0.00743552583304747,0.704313312808413,0.230614576321746,3.30895836162585,3.30475276716367,3.32277674343014,0.0180239762664735,0.869791879779872,ENSG00000101247,NDUFAF5,protein_coding,20,1,13785007,13821580,p12.1,NADH:ubiquinone oxidoreductase complex assembly factor 5 [Source:HGNC Symbol;Acc:HGNC:15899],Isolated complex I deficiency;Leigh syndrome with leukodystrophy,NDUFAF5,79133,NM_001039375;NM_001352403;NM_001352406;NM_001352407;NM_024120
PLBD2_SIG,PLBD2,PLBD2_SIG,PLBD2,SIG,25,0.446341738548354,0.213080002806954,0.212188204459337,0.216010197377696,0.00382199291835955,0.704499565840198,2.51622860896997,4.81688967819937,4.76539091678113,4.98609989428787,0.220708977506741,0.0340697292076628,ENSG00000151176,PLBD2,protein_coding,12,1,113358566,113391629,q24.13,phospholipase B domain containing 2 [Source:HGNC Symbol;Acc:HGNC:27283],NA,PLBD2,196463,NM_001159727;NM_173542
VEZF1_TF,VEZF1,VEZF1_TF,VEZF1,TF,48,-0.445509924847559,0.447902397871573,0.448495068198759,0.44595505251082,-0.00254001568793831,0.705054025629832,-1.50566837235453,6.58379858228361,6.59979458675529,6.53124028187667,-0.0685543048786243,0.220048318696899,ENSG00000136451,VEZF1,protein_coding,17,-1,57971547,57988259,q22,vascular endothelial zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:12949],NA,VEZF1,7716,NM_001330393;NM_007146
RNF111_SIG,RNF111,RNF111_SIG,RNF111,SIG,56,-0.443634832807577,0.367817361464145,0.368455565330541,0.365720405903129,-0.00273515942741221,0.706381427520033,0.462387743782226,5.37560136864153,5.3694147232887,5.39592891765796,0.0265141943692528,0.732005206460935,ENSG00000157450,RNF111,protein_coding,15,1,58865175,59097419,q22.1,ring finger protein 111 [Source:HGNC Symbol;Acc:HGNC:17384],NA,RNF111,54778,NM_001270528;NM_001270529;NM_001270530;NM_001330331;NM_017610
LIPC_SIG,LIPC,LIPC_SIG,LIPC,SIG,17,0.443565482775428,0.103571154047641,0.102786251926016,0.106150118161549,0.00336386623553242,0.706381427520033,0.55130527016707,1.09601956941047,1.08388613230041,1.1358865770578,0.0520004447573874,0.679737361749786,ENSG00000166035,LIPC,protein_coding,15,1,58410569,58569844,q21.3,lipase C, hepatic type [Source:HGNC Symbol;Acc:HGNC:6619],DIABETES MELLITUS NONINSULIN-DEPENDENT;HEPATIC LIPASE DEFICIENCY;HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12;Hyperlipidemia due to hepatic triacylglycerol lipase deficiency,LIPC,3990,NM_000236
EZH2_SIG,EZH2,EZH2_SIG,EZH2,SIG,14,0.443094306864347,0.274656633645237,0.273710432721629,0.277765579537091,0.00405514681546197,0.706655943128684,0.173241919877207,5.48136838241075,5.47819822953321,5.49178459900838,0.0135863694751741,0.9029076797077,ENSG00000106462,EZH2,protein_coding,7,-1,148807383,148884321,q36.1,enhancer of zeste 2 polycomb repressive complex 2 subunit [Source:HGNC Symbol;Acc:HGNC:3527],Weaver syndrome;WEAVER SYNDROME 2,EZH2,2146,NM_001203247;NM_001203248;NM_001203249;NM_004456;NM_152998
GLB1_SIG,GLB1,GLB1_SIG,GLB1,SIG,74,0.442279841310762,0.414831684996645,0.413516833115671,0.419151912605559,0.00563507948988762,0.707197283002822,0.216775299992094,6.13872356152465,6.13489192147301,6.15131323598002,0.01642131450701,0.877837876976775,ENSG00000170266,GLB1,protein_coding,3,-1,32996609,33097202,p22.3,galactosidase beta 1 [Source:HGNC Symbol;Acc:HGNC:4298],GM1-GANGLIOSIDOSIS TYPE 1;GM1-GANGLIOSIDOSIS TYPE I;GM1-GANGLIOSIDOSIS TYPE II;GM1-GANGLIOSIDOSIS TYPE III;GM1 gangliosidosis type 1;GM1 gangliosidosis type 2;GM1 gangliosidosis type 3;Mucopolysaccharidosis type 4B;MUCOPOLYSACCHARIDOSIS TYPE IVB,GLB1,2720,NM_000404;NM_001079811;NM_001135602;NM_001317040
SLC29A1_SIG,SLC29A1,SLC29A1_SIG,SLC29A1,SIG,18,0.442004920739445,0.115281888834039,0.114097818581899,0.119172405376786,0.00507458679488735,0.70731927523704,2.58869756190657,5.45479863880814,5.38431951698711,5.6863728962201,0.302053379232982,0.0289145611702553,ENSG00000112759,SLC29A1,protein_coding,6,1,44219505,44234151,p21.1,solute carrier family 29 member 1 (Augustine blood group) [Source:HGNC Symbol;Acc:HGNC:11003],NA,SLC29A1,2030,NM_001078175;NM_001078177;NM_001304462;NM_001304463;NM_001304465;NM_001304466
YTHDF1_SIG,YTHDF1,YTHDF1_SIG,YTHDF1,SIG,30,0.440677093104365,0.351808553808566,0.35111464446963,0.3540885416365,0.00297389716686934,0.708259864100234,-0.811195971918097,6.09270527585992,6.09982189136523,6.0693221106282,-0.0304997807370367,0.529141035252605,ENSG00000149658,YTHDF1,protein_coding,20,-1,63195429,63216139,q13.33,YTH N6-methyladenosine RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:15867],NA,YTHDF1,54915,NM_017798
XRCC5_SIG,XRCC5,XRCC5_SIG,XRCC5,SIG,26,0.439207452054938,0.482116186472761,0.480886102335732,0.486157891494428,0.00527178915869554,0.709311147939747,0.208661322531921,8.28942208812849,8.2871289764907,8.29695659779551,0.0098276213048098,0.882619958933894,ENSG00000079246,XRCC5,protein_coding,2,1,216107464,216206303,q35,X-ray repair cross complementing 5 [Source:HGNC Symbol;Acc:HGNC:12833],NA,XRCC5,7520,NM_021141
SRRT_SIG,SRRT,SRRT_SIG,SRRT,SIG,18,0.438950148710605,0.276714259284463,0.276216208645933,0.278350711382491,0.00213450273655868,0.709419401199095,-0.481245794443899,7.39193452690737,7.39689443734851,7.37563767831508,-0.0212567590334274,0.720332069590757,ENSG00000087087,SRRT,protein_coding,7,1,100875103,100888664,q22.1,serrate, RNA effector molecule [Source:HGNC Symbol;Acc:HGNC:24101],NA,SRRT,51593,NM_001128852;NM_001128853;NM_001128854;NM_015908
POP4_SIG,POP4,POP4_SIG,POP4,SIG,34,0.43880784919035,0.333136773673462,0.331921033578546,0.337131348271044,0.0052103146924983,0.709438175370011,0.399083733726287,4.35445386274749,4.3499428094662,4.36927589495746,0.0193330854912598,0.768772307937923,ENSG00000105171,POP4,protein_coding,19,1,29606283,29617237,q12,POP4 homolog, ribonuclease P/MRP subunit [Source:HGNC Symbol;Acc:HGNC:30081],NA,POP4,10775,NM_006627
PLCB3_SIG,PLCB3,PLCB3_SIG,PLCB3,SIG,43,0.436739042244406,0.0825696994607331,0.0816735586858345,0.0855141620068288,0.00384060332099426,0.710915974920726,1.27932429339298,5.10804203249613,5.08286768420611,5.19075774830617,0.107890064100053,0.303359487837202,ENSG00000149782,PLCB3,protein_coding,11,1,64251523,64269150,q13.1,phospholipase C beta 3 [Source:HGNC Symbol;Acc:HGNC:9056],NA,PLCB3,5331,NM_000932;NM_001184883;NM_001316314
CD59_SIG,CD59,CD59_SIG,CD59,SIG,115,0.4365806129597,-0.0465503672194394,-0.0474711172112399,-0.0435250458178093,0.00394607139343046,0.710915974920726,2.29681358048442,5.26186891552863,5.16242502227871,5.58861313620694,0.426188113928228,0.0542982034268783,ENSG00000085063,CD59,protein_coding,11,-1,33703010,33736491,p13,CD59 molecule (CD59 blood group) [Source:HGNC Symbol;Acc:HGNC:1689],HEMOLYTIC ANEMIA CD59-MEDIATED WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY;Primary CD59 deficiency,CD59,966,NM_000611;NM_001127223;NM_001127225;NM_001127226;NM_001127227;NM_203329;NM_203330;NM_203331
SLC7A11_SIG,SLC7A11,SLC7A11_SIG,SLC7A11,SIG,18,-0.436523805874852,0.104896865844461,0.10585172517266,0.101759470908952,-0.00409225426370853,0.710915974920726,-0.506533817256579,2.03258488253445,2.05083290790487,1.97262708488879,-0.0782058230160742,0.705571550974417,ENSG00000151012,SLC7A11,protein_coding,4,-1,138164097,138242349,q28.3,solute carrier family 7 member 11 [Source:HGNC Symbol;Acc:HGNC:11059],NA,SLC7A11,23657,NM_014331
ALKBH5_SIG,ALKBH5,ALKBH5_SIG,ALKBH5,SIG,16,-0.436435912297684,0.127997878842377,0.12832607407838,0.126919523066939,-0.00140655101144105,0.710915974920726,0.959253015159604,6.7106872482445,6.700751800292,6.74333229151701,0.0425804912250083,0.451219028541167,ENSG00000091542,ALKBH5,protein_coding,17,1,18183078,18209954,p11.2,alkB homolog 5, RNA demethylase [Source:HGNC Symbol;Acc:HGNC:25996],NA,ALKBH5,54890,NM_017758
DOT1L_SIG,DOT1L,DOT1L_SIG,DOT1L,SIG,10,-0.435995314945302,0.359808134314356,0.360280887898072,0.358254801110716,-0.00202608678735587,0.71116685662276,-1.78901012998318,6.75535825403411,6.7773073512126,6.68323979187622,-0.0940675593363806,0.140813155693875,ENSG00000104885,DOT1L,protein_coding,19,1,2163933,2232578,p13.3,DOT1 like histone lysine methyltransferase [Source:HGNC Symbol;Acc:HGNC:24948],NA,DOT1L,84444,NM_032482
CNOT6L_SIG,CNOT6L,CNOT6L_SIG,CNOT6L,SIG,48,-0.434984934541867,0.390209952802367,0.39076863467479,0.388374283792977,-0.00239435088181342,0.711861363589539,0.300021474112508,6.55561145084639,6.55088317782593,6.57114720505646,0.0202640272305262,0.827813653796868,ENSG00000138767,CNOT6L,protein_coding,4,-1,77713387,77819615,q21.1,CCR4-NOT transcription complex subunit 6 like [Source:HGNC Symbol;Acc:HGNC:18042],NA,CNOT6L,246175,NM_001286790;NM_001365007;NM_144571
CRLS1_SIG,CRLS1,CRLS1_SIG,CRLS1,SIG,21,0.434462233838038,0.189829031346334,0.188448944507831,0.194363602387133,0.00591465787930216,0.712176212095844,0.352645371916965,4.82573262108435,4.82042958278604,4.84315688977881,0.0227273069927705,0.795942816955819,ENSG00000088766,CRLS1,protein_coding,20,1,6006090,6040053,p12.3,cardiolipin synthase 1 [Source:HGNC Symbol;Acc:HGNC:16148],NA,CRLS1,54675,NM_001127458;NM_001323561;NM_001323562;NM_001323563;NM_001323564;NM_019095
CCNT1_SIG,CCNT1,CCNT1_SIG,CCNT1,SIG,75,0.432928044332552,0.404177192099016,0.402431154155916,0.409914173912058,0.00748301975614176,0.713279025428801,0.0249444280853646,6.20979765912824,6.20932341833319,6.21135587888342,0.00203246055023415,0.986231658084353,ENSG00000129315,CCNT1,protein_coding,12,-1,48688458,48716998,q13.12,cyclin T1 [Source:HGNC Symbol;Acc:HGNC:1599],NA,CCNT1,904,NM_001240;NM_001277842
UQCR10_SIG,UQCR10,UQCR10_SIG,UQCR10,SIG,44,0.432722993566202,0.0996690966169852,0.0984607285515393,0.103639448832021,0.00517872028048201,0.713321012874486,0.215784872169907,4.92147640193385,4.91842750543607,4.93149420471225,0.0130666992761839,0.878312703525988,ENSG00000184076,UQCR10,protein_coding,22,1,29767369,29770413,q12.2,ubiquinol-cytochrome c reductase, complex III subunit X [Source:HGNC Symbol;Acc:HGNC:30863],NA,UQCR10,29796,NM_001003684;NM_013387
CWC22_SIG,CWC22,CWC22_SIG,CWC22,SIG,15,0.432637157413843,0.516890715054221,0.516005155719183,0.519800410012205,0.00379525429302238,0.713321012874486,0.319880515323904,4.92388155279901,4.91971883927812,4.93755904008192,0.0178402008037982,0.815982556001354,ENSG00000163510,CWC22,protein_coding,2,-1,179944876,180007297,q31.3,CWC22 spliceosome associated protein homolog [Source:HGNC Symbol;Acc:HGNC:29322],NA,CWC22,57703,NM_020943
SMAD3_SIG,SMAD3,SMAD3_SIG,SMAD3,SIG,32,-0.432443378497548,0.225560831428546,0.226172148280681,0.223552218914388,-0.00261992936629294,0.713379663794016,-1.64450895989865,6.151227744384,6.19133366869618,6.0194511359297,-0.171882532766481,0.178038853215165,ENSG00000166949,SMAD3,protein_coding,15,1,67063763,67195169,q22.33,SMAD family member 3 [Source:HGNC Symbol;Acc:HGNC:6769],Aneurysm - osteoarthritis syndrome;Familial thoracic aortic aneurysm and aortic dissection;LOEYS-DIETZ SYNDROME 3;SMAD3-Related Loeys-Dietz Syndrome,SMAD3,4088,NM_001145102;NM_001145103;NM_001145104;NM_005902
LONRF2_SIG,LONRF2,LONRF2_SIG,LONRF2,SIG,13,0.431563947043798,-0.0710743151152352,-0.0720530342991979,-0.067858523510786,0.00419451078841195,0.713972514726698,1.5987413901725,0.66649761762187,0.630132677574287,0.785982420635357,0.15584974306107,0.191023571775607,ENSG00000170500,LONRF2,protein_coding,2,-1,100273291,100322733,q11.2,LON peptidase N-terminal domain and ring finger 2 [Source:HGNC Symbol;Acc:HGNC:24788],NA,LONRF2,164832,NM_198461
BRCA1_SIG,BRCA1,BRCA1_SIG,BRCA1,SIG,63,-0.430572551825821,0.267664225487358,0.269961982487437,0.260114452487099,-0.00984753000033744,0.714652741840389,0.438429632168311,4.78848476856417,4.77524155943696,4.83199816998213,0.0567566105451699,0.745529224798279,ENSG00000012048,BRCA1,protein_coding,17,-1,43044295,43170245,q21.31,BRCA1, DNA repair associated [Source:HGNC Symbol;Acc:HGNC:1100],BREAST-OVARIAN CANCER FAMILIAL SUSCEPTIBILITY TO 1;Breast Cancer;Familial pancreatic carcinoma;Familial prostate cancer;Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP S;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Hereditary site-specific ovarian cancer syndrome;Intellectual disability;PANCREATIC CANCER SUSCEPTIBILITY TO 4;Primary peritoneal carcinoma,BRCA1,672,NM_007294;NM_007297;NM_007298;NM_007299;NM_007300
GLRX2_SIG,GLRX2,GLRX2_SIG,GLRX2,SIG,13,0.42993625364805,0.194094416567882,0.193039012346647,0.197562173294796,0.00452316094814908,0.715056276660383,2.36236837920163,2.26313039375284,2.23466099930354,2.35667268980056,0.12201169049702,0.0474688278340146,ENSG00000023572,GLRX2,protein_coding,1,-1,193090866,193106114,q31.2,glutaredoxin 2 [Source:HGNC Symbol;Acc:HGNC:16065],NA,GLRX2,51022,NM_001243399;NM_001319291;NM_016066;NM_197962
PLCB4_SIG,PLCB4,PLCB4_SIG,PLCB4,SIG,134,0.428773687912225,-0.0862290832299938,-0.0869616688647757,-0.0838220161442818,0.00313965272049382,0.715870213599153,-1.11966567382058,1.39676533913415,1.44302286165059,1.24477633658015,-0.19824652507044,0.372917212073045,ENSG00000101333,PLCB4,protein_coding,20,1,9068763,9481242,p12.3,phospholipase C beta 4 [Source:HGNC Symbol;Acc:HGNC:9059],Auriculocondylar syndrome;AURICULOCONDYLAR SYNDROME 2,PLCB4,5332,NM_000933;NM_001172646;NM_182797
ZNF14_TF,ZNF14,ZNF14_TF,ZNF14,TF,33,0.427936227761048,0.313512207118532,0.312107334711394,0.318128216456269,0.00602088174487464,0.716430777953808,0.8068763602076,2.63369938436414,2.61291652735519,2.70198591453642,0.0890693871812358,0.531261447959814,ENSG00000105708,ZNF14,protein_coding,19,-1,19710472,19733112,p13.11,zinc finger protein 14 [Source:HGNC Symbol;Acc:HGNC:12924],NA,ZNF14,7561,NM_021030
ZGLP1_TF,ZGLP1,ZGLP1_TF,ZGLP1,TF,98,0.427474357989431,0.0667223683356553,0.0659876602834731,0.0691364090785398,0.0031487487950669,0.716698411294254,0.252645969001862,0.983411960806689,0.980430774894853,0.99320728594558,0.0127765110507273,0.856098018112971,ENSG00000220201,ZGLP1,protein_coding,19,-1,10304803,10309880,p13.2,zinc finger, GATA-like protein 1 [Source:HGNC Symbol;Acc:HGNC:37245],NA,ZGLP1,100125288,NM_001103167
PSMC3_SIG,PSMC3,PSMC3_SIG,PSMC3,SIG,37,0.42721605959604,0.55153297074069,0.55068734308982,0.554311461593548,0.00362411850372817,0.716807237405695,0.882136231951952,5.82118160496129,5.81181416282747,5.85196034340095,0.0401461805734814,0.491207666866022,ENSG00000165916,PSMC3,protein_coding,11,-1,47418769,47426473,p11.2,proteasome 26S subunit, ATPase 3 [Source:HGNC Symbol;Acc:HGNC:9549],NA,PSMC3,5702,NM_002804
HMGA2_SIG,HMGA2,HMGA2_SIG,HMGA2,SIG,66,-0.424244997258678,-0.0646910367566024,-0.0637918873772808,-0.0676453847172306,-0.00385349733994997,0.719033417641494,-1.05588406008786,1.17681565460809,1.22091264981532,1.03192552749861,-0.188987122316712,0.403181925322734,ENSG00000149948,HMGA2,protein_coding,12,1,65824131,65966295,q14.3,high mobility group AT-hook 2 [Source:HGNC Symbol;Acc:HGNC:5009],12q14 microdeletion syndrome;Dedifferentiated liposarcoma;LEIOMYOMA UTERINE;Pleomorphic salivary gland adenoma;Well-differentiated liposarcoma,HMGA2,8091,NM_001300918;NM_001300919;NM_001330190;NM_003483;NM_003484
F2RL3_SIG,F2RL3,F2RL3_SIG,F2RL3,SIG,12,0.422301121393817,0.0165945366534434,0.0153760070622503,0.0205982767387924,0.00522226967654209,0.720459016585112,0.0595418881488378,0.720258607061383,0.718757412855036,0.725191102310805,0.00643368945576865,0.967074329423253,ENSG00000127533,F2RL3,protein_coding,19,1,16888860,16892606,p13.11,F2R like thrombin or trypsin receptor 3 [Source:HGNC Symbol;Acc:HGNC:3540],NA,F2RL3,9002,NM_003950
ZNF746_TF,ZNF746,ZNF746_TF,ZNF746,TF,58,0.419367404811928,0.248971427420005,0.248212836798357,0.251463939462563,0.00325110266420563,0.722659758720599,1.68576756695974,5.80949697090805,5.78588617822365,5.88707528972823,0.101189111504587,0.166866935506939,ENSG00000181220,ZNF746,protein_coding,7,-1,149472696,149497817,q36.1,zinc finger protein 746 [Source:HGNC Symbol;Acc:HGNC:21948],NA,ZNF746,155061,NM_001163474;NM_001363517;NM_152557
STK38L_SIG,STK38L,STK38L_SIG,STK38L,SIG,15,0.419208044626339,0.452851459904484,0.452192969557112,0.455015071045848,0.00282210148873582,0.722691047073276,0.147134131034715,5.71395127000716,5.71186602336711,5.72080279468162,0.0089367713145014,0.917622324169539,ENSG00000211455,STK38L,protein_coding,12,1,27243968,27325959,p11.23,serine/threonine kinase 38 like [Source:HGNC Symbol;Acc:HGNC:17848],NA,STK38L,23012,NM_015000
SENP1_SIG,SENP1,SENP1_SIG,SENP1,SIG,31,-0.418185064149178,0.335795734920756,0.336366162895366,0.333921471575611,-0.00244469131975475,0.723350252195399,-0.161139150788345,4.8372876020894,4.83902201967709,4.83158880144411,-0.00743321823298269,0.909707362313999,ENSG00000079387,SENP1,protein_coding,12,-1,48042897,48106079,q13.11,SUMO specific peptidase 1 [Source:HGNC Symbol;Acc:HGNC:17927],NA,SENP1,29843,NM_001267594;NM_001267595
SUV39H1_SIG,SUV39H1,SUV39H1_SIG,SUV39H1,SIG,19,-0.418126716842523,0.590518960044397,0.591715906338599,0.586586136506305,-0.00512976983229377,0.723350252195399,-0.866281052055735,4.29820709637621,4.31056449265197,4.25760422289873,-0.0529602697532416,0.499726871821677,ENSG00000101945,SUV39H1,protein_coding,X,1,48695554,48709012,p11.23,suppressor of variegation 3-9 homolog 1 [Source:HGNC Symbol;Acc:HGNC:11479],NA,SUV39H1,6839,NM_001282166;NM_003173
SULT1A1_SIG,SULT1A1,SULT1A1_SIG,SULT1A1,SIG,10,0.417892354849456,0.196076338367266,0.195444773292279,0.198151480756508,0.00270670746422845,0.723352100343703,0.709060609826338,5.15871736069484,5.1411129407378,5.21656045483941,0.0754475141016037,0.586670810457062,ENSG00000196502,SULT1A1,protein_coding,16,-1,28605196,28623625,p11.2,sulfotransferase family 1A member 1 [Source:HGNC Symbol;Acc:HGNC:11453],NA,SULT1A1,6817,NM_001055;NM_177529;NM_177530;NM_177534;NM_177536
HK2_SIG,HK2,HK2_SIG,HK2,SIG,23,0.417778781577242,0.0757014339912216,0.0751599672413525,0.0774805390265058,0.00232057178515329,0.723352100343703,0.835232577972445,6.34255379729051,6.32156339021998,6.41152227766511,0.0899588874451247,0.516316512157269,ENSG00000159399,HK2,protein_coding,2,1,74833981,74893359,p12,hexokinase 2 [Source:HGNC Symbol;Acc:HGNC:4923],NA,HK2,3099,NM_000189
NDUFB7_SIG,NDUFB7,NDUFB7_SIG,NDUFB7,SIG,19,0.417748610519332,0.501187360454921,0.500454463429489,0.50359545068134,0.00314098725185103,0.723352100343703,0.810930782936231,5.04728360015446,5.03785258248605,5.0782712296364,0.0404186471503544,0.529159964816721,ENSG00000099795,NDUFB7,protein_coding,19,-1,14566078,14572066,p13.12,NADH:ubiquinone oxidoreductase subunit B7 [Source:HGNC Symbol;Acc:HGNC:7702],NA,NDUFB7,4713,NM_004146
SPPL3_SIG,SPPL3,SPPL3_SIG,SPPL3,SIG,47,0.417646718733634,0.216985728465876,0.216572498888393,0.218343482791892,0.00177098390349865,0.723352100343703,1.64344564147959,5.46675522779767,5.44790069655961,5.52870583043703,0.0808051338774255,0.178361511140333,ENSG00000157837,SPPL3,protein_coding,12,-1,120762510,120904358,q24.31,signal peptide peptidase like 3 [Source:HGNC Symbol;Acc:HGNC:30424],NA,SPPL3,121665,NM_139015
MLNR_SIG,MLNR,MLNR_SIG,MLNR,SIG,46,-0.415930046799959,0.0229724065090016,0.0237595763404686,0.0203859913484672,-0.00337358499200148,0.724601855954805,0.865787876189173,0.721117154510679,0.706903080761065,0.767820539687983,0.0609174589269181,0.499939559269572,ENSG00000102539,MLNR,protein_coding,13,1,49220338,49222377,q14.2,motilin receptor [Source:HGNC Symbol;Acc:HGNC:4495],NA,MLNR,2862,NM_001507
FMO5_SIG,FMO5,FMO5_SIG,FMO5,SIG,26,0.415807142101037,0.202531689413083,0.201857391277,0.204747240431639,0.00288984915463845,0.72460450889966,0.0148712295836792,2.79424165122407,2.79394653854292,2.79521130717641,0.00126476863348963,0.991695759383633,ENSG00000131781,FMO5,protein_coding,1,-1,147175351,147243050,q21.1,flavin containing monooxygenase 5 [Source:HGNC Symbol;Acc:HGNC:3773],NA,FMO5,2330,NM_001144829;NM_001144830;NM_001461
F8_SIG,F8,F8_SIG,F8,SIG,11,-0.41541120732792,0.136483093688603,0.137228391611871,0.134034257655006,-0.00319413395686542,0.724778363637056,-0.182736069314878,2.86044554936942,2.86363866559558,2.84995388176916,-0.0136847838264236,0.897283331796659,ENSG00000185010,F8,protein_coding,X,-1,154835788,155026940,q28,coagulation factor VIII [Source:HGNC Symbol;Acc:HGNC:3546],HEMOPHILIA A;Mild hemophilia A;Moderately severe hemophilia A;Severe hemophilia A;Symptomatic form of hemophilia A in female carriers,F8,2157,NM_000132;NM_019863
RSU1_SIG,RSU1,RSU1_SIG,RSU1,SIG,11,-0.415345962225408,0.631309659401953,0.632012979922196,0.628998749121152,-0.00301423080104394,0.724778363637056,-0.917647554294538,6.44771776895375,6.46327093590964,6.39661450609868,-0.0666564298109611,0.472466905547072,ENSG00000148484,RSU1,protein_coding,10,-1,16590611,16817463,p13,Ras suppressor protein 1 [Source:HGNC Symbol;Acc:HGNC:10464],NA,RSU1,6251,NM_012425;NM_152724
KLF8_TF,KLF8,KLF8_TF,KLF8,TF,190,-0.414797786258676,-0.054807394297626,-0.0544012117995966,-0.0561419939340086,-0.00174078213441207,0.725113826490252,0.12438399423887,2.17633108221237,2.1728638967248,2.18772326310012,0.0148593663753274,0.93046910633589,ENSG00000102349,KLF8,protein_coding,X,1,56232356,56291531,p11.21,Kruppel like factor 8 [Source:HGNC Symbol;Acc:HGNC:6351],NONSYNDROMIC MENTAL RETARDATION,KLF8,11279,NM_001159296;NM_001324099;NM_001324100;NM_001324102;NM_001324104;NM_001324105;NM_007250
PRKAG2_SIG,PRKAG2,PRKAG2_SIG,PRKAG2,SIG,29,-0.4137160341993,0.113531376750416,0.114222674688108,0.111259969240857,-0.00296270544725067,0.725866992284732,1.07738422460676,5.19617882863168,5.17816581382217,5.25536444872009,0.0771986348979237,0.393305106713075,ENSG00000106617,PRKAG2,protein_coding,7,-1,151556124,151877125,q36.1,protein kinase AMP-activated non-catalytic subunit gamma 2 [Source:HGNC Symbol;Acc:HGNC:9386],CARDIOMYOPATHY FAMILIAL HYPERTROPHIC 6;Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease;GLYCOGEN STORAGE DISEASE OF HEART LETHAL CONGENITAL;WOLFF-PARKINSON-WHITE SYNDROME,PRKAG2,51422,NM_001040633;NM_001304527;NM_001304531;NM_001363698;NM_016203;NM_024429
CMAS_SIG,CMAS,CMAS_SIG,CMAS,SIG,16,-0.413232009559446,0.309516543393758,0.310682961378318,0.305684027158778,-0.00499893421953939,0.726152289357761,-0.0675403081850423,4.65622879182639,4.65734954173039,4.65254632785607,-0.00480321387432526,0.963148056293808,ENSG00000111726,CMAS,protein_coding,12,1,22046218,22065674,p12.1,cytidine monophosphate N-acetylneuraminic acid synthetase [Source:HGNC Symbol;Acc:HGNC:18290],NA,CMAS,55907,NM_018686
DNASE1L2_SIG,DNASE1L2,DNASE1L2_SIG,DNASE1L2,SIG,11,0.412556148628399,-0.0712254561172805,-0.0719748311795678,-0.0687632237697648,0.00321160740980317,0.726587805024865,-1.05373410263137,0.755232841712304,0.769073690658304,0.709755766604018,-0.0593179240542855,0.404198649577654,ENSG00000167968,DNASE1L2,protein_coding,16,1,2235816,2238711,p13.3,deoxyribonuclease 1 like 2 [Source:HGNC Symbol;Acc:HGNC:2958],NA,DNASE1L2,1775,NM_001301680;NM_001374
GALNT4_SIG,GALNT4,GALNT4_SIG,GALNT4,SIG,32,0.412096837172472,0.0565995849404673,0.0562665662428112,0.0576937892327659,0.00142722298995472,0.726853763459651,3.37615489283794,0.895458380683799,0.866143679542331,0.991778113005767,0.125634433463436,0.00387593740825754,ENSG00000257594,GALNT4,protein_coding,12,-1,89519412,89524796,q21.33,polypeptide N-acetylgalactosaminyltransferase 4 [Source:HGNC Symbol;Acc:HGNC:4126],NA,GALNT4,8693,NM_003774
ME2_SIG,ME2,ME2_SIG,ME2,SIG,37,0.411574871977626,0.240702052121589,0.239325987602329,0.245223406970586,0.00589741936825618,0.727168790553876,-0.320603383088252,6.40493263657039,6.41027419528544,6.38738180079236,-0.0228923944930878,0.815502366405243,ENSG00000082212,ME2,protein_coding,18,1,50879080,50954257,q21.2,malic enzyme 2 [Source:HGNC Symbol;Acc:HGNC:6984],NA,ME2,4200,NM_001168335;NM_002396
EDEM2_SIG,EDEM2,EDEM2_SIG,EDEM2,SIG,23,0.410658505679683,0.317712911453317,0.316860060372656,0.320515136432633,0.00365507605997761,0.727792766907041,-0.555748761783908,5.45811049933187,5.46519195478256,5.43484285999391,-0.0303490947886456,0.677517263089451,ENSG00000088298,EDEM2,protein_coding,20,-1,35115364,35147336,q11.22,ER degradation enhancing alpha-mannosidase like protein 2 [Source:HGNC Symbol;Acc:HGNC:15877],NA,EDEM2,55741;111089941,NM_001145025;NM_001355008;NM_018217
L3MBTL3_TF,L3MBTL3,L3MBTL3_TF,L3MBTL3,TF,118,0.408823548669375,0.00485739670769983,0.004508785397193,0.0060028338707937,0.00149404847360057,0.729136775331877,1.19502017177978,4.40815186575558,4.38481026436188,4.48484569890632,0.10003543454444,0.339286314951908,ENSG00000198945,L3MBTL3,protein_coding,6,1,130013699,130141451,q23.1,L3MBTL3, histone methyl-lysine binding protein [Source:HGNC Symbol;Acc:HGNC:23035],NA,L3MBTL3,84456,NM_001007102;NM_001346550;NM_001346551;NM_032438
RPS27_SIG,RPS27,RPS27_SIG,RPS27,SIG,45,0.407739774293145,0.384728898324153,0.383518876454681,0.388704684466701,0.00518580801202003,0.729892409810845,0.469742069893707,5.59307933727701,5.58471877939413,5.62054974174932,0.0358309623551864,0.727225321935708,ENSG00000177954,RPS27,protein_coding,1,1,153990755,153992155,q21.3,ribosomal protein S27 [Source:HGNC Symbol;Acc:HGNC:10416],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 17,RPS27,6232,NM_001030;NM_001349946;NM_001349947
TRIM23_SIG,TRIM23,TRIM23_SIG,TRIM23,SIG,44,0.405296159688175,0.40766955203168,0.407004258559571,0.409855516297181,0.00285125773760999,0.731715128676232,0.382763656864503,2.86856978375374,2.86317503044201,2.88629540177799,0.0231203713359855,0.778833698983421,ENSG00000113595,TRIM23,protein_coding,5,-1,65589690,65625975,q12.3,tripartite motif containing 23 [Source:HGNC Symbol;Acc:HGNC:660],NA,TRIM23,373,NM_001656;NM_033227;NM_033228
MTRF1L_SIG,MTRF1L,MTRF1L_SIG,MTRF1L,SIG,3,0.403864073001894,0.226064581432119,0.224976674529037,0.229639132685099,0.00466245815606201,0.732744913281636,1.3902839382427,3.32657081109254,3.31125069154359,3.37690834675338,0.0656576552097871,0.260265945560873,ENSG00000112031,MTRF1L,protein_coding,6,-1,152987362,153002709,q25.2,mitochondrial translational release factor 1 like [Source:HGNC Symbol;Acc:HGNC:21051],NA,MTRF1L,54516,NM_001114184;NM_001301047;NM_001301870;NM_001301871;NM_019041
RPA3_SIG,RPA3,RPA3_SIG,RPA3,SIG,21,-0.403068051099687,0.116386687206944,0.117945421170613,0.111265132754887,-0.00668028841572627,0.733275516247507,0.921655317402853,2.87931658892175,2.86405765793833,2.92945307643869,0.0653954185003559,0.470223366641867,ENSG00000106399,RPA3,protein_coding,7,-1,7636518,7718607,p21.3,replication protein A3 [Source:HGNC Symbol;Acc:HGNC:10291],NA,RPA3,6119,NM_002947
PPP3CA_SIG,PPP3CA,PPP3CA_SIG,PPP3CA,SIG,8,0.402801051708103,0.403157297302912,0.40202757741293,0.406869234084281,0.00484165667135091,0.733390705561583,-0.696840783927221,6.41406811457928,6.42447560367527,6.37987207897813,-0.0446035246971404,0.5940339407529,ENSG00000138814,PPP3CA,protein_coding,4,-1,101023409,101348278,q24,protein phosphatase 3 catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9314],Autosomal dominant non-syndromic intellectual disability;EPILEPTIC ENCEPHALOPATHY INFANTILE OR EARLY CHILDHOOD 1;Severe Neurodevelopmental Disease with Seizures;Undetermined early-onset epileptic encephalopathy,PPP3CA,5530,NM_000944;NM_001130691;NM_001130692
RPS28_SIG,RPS28,RPS28_SIG,RPS28,SIG,6,-0.402144199153487,0.205828837941868,0.207492437393981,0.200362725456353,-0.00712971193762776,0.733812050921187,-0.222361777998107,3.90012188929169,3.90730848482796,3.87650878967251,-0.0307996951554474,0.874299891243254,ENSG00000233927,RPS28,protein_coding,19,1,8321158,8323340,p13.2,ribosomal protein S28 [Source:HGNC Symbol;Acc:HGNC:10418],Blackfan-Diamond anemia;DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS,RPS28,6234,NM_001031
ZNF841_TF,ZNF841,ZNF841_TF,ZNF841,TF,30,-0.401770702409116,-0.0393847250571952,-0.0386228696622744,-0.0418879642119351,-0.00326509454966066,0.73401086146925,0.397826272454022,3.75206355907718,3.74278016327624,3.78256614528026,0.0397859820040245,0.769654866680792,ENSG00000197608,ZNF841,protein_coding,19,-1,52064466,52095765,q13.41,zinc finger protein 841 [Source:HGNC Symbol;Acc:HGNC:27611],NA,ZNF841,284371,NM_001136499;NM_001321349;NM_001352298;NM_001352299
KPNA2_SIG,KPNA2,KPNA2_SIG,KPNA2,SIG,43,-0.401479804831228,0.134856034942714,0.135660989881145,0.132211183002154,-0.00344980687899167,0.734144790495789,-0.296784327102761,6.11801009341159,6.12374931464468,6.09915265221715,-0.0245966624275234,0.829781320012022,ENSG00000182481,KPNA2,protein_coding,17,1,68035708,68046854,q24.2,karyopherin subunit alpha 2 [Source:HGNC Symbol;Acc:HGNC:6395],NA,KPNA2,3838,NM_001320611;NM_002266
EPHA1_SIG,EPHA1,EPHA1_SIG,EPHA1,SIG,5,0.400967675282529,0.101915428082753,0.101235127467343,0.104150701533384,0.0029155740660408,0.734452472566202,-0.29556275218348,2.05510283540338,2.06240101150201,2.03112311393645,-0.031277897565559,0.830335598864984,ENSG00000146904,EPHA1,protein_coding,7,-1,143390289,143408856,q35,EPH receptor A1 [Source:HGNC Symbol;Acc:HGNC:3385],NA,EPHA1,2041,NM_005232
CYC1_SIG,CYC1,CYC1_SIG,CYC1,SIG,28,0.398951288435329,0.171372230100566,0.170756727098607,0.173394597107002,0.00263787000839523,0.735942135763294,0.597536885975331,6.13117249295103,6.12326319465029,6.15716018736776,0.0338969927174694,0.652798110499016,ENSG00000179091,CYC1,protein_coding,8,1,144095039,144097525,q24.3,cytochrome c1 [Source:HGNC Symbol;Acc:HGNC:2579],Isolated complex III deficiency;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 6,CYC1,1537,NM_001916
VAV2_SIG,VAV2,VAV2_SIG,VAV2,SIG,47,-0.396201235571111,0.0511046411406605,0.0521285050474084,0.0477405168756315,-0.00438798817177678,0.738009817756427,0.810567337024993,3.68942872519665,3.66487937569704,3.77009087355253,0.105211497855493,0.529388328146721,ENSG00000160293,VAV2,protein_coding,9,-1,133761894,133992604,q34.2,vav guanine nucleotide exchange factor 2 [Source:HGNC Symbol;Acc:HGNC:12658],NA,VAV2,7410,NM_001134398;NM_003371
S100A10_SIG,S100A10,S100A10_SIG,S100A10,SIG,52,0.394674680015509,0.211194339508268,0.210160193136084,0.214592249016871,0.00443205588078677,0.739111948331878,-0.905840435228821,6.69538912390557,6.73844310869297,6.55392603103266,-0.184517077660308,0.478886019551563,ENSG00000197747,S100A10,protein_coding,1,-1,151982915,151993859,q21.3,S100 calcium binding protein A10 [Source:HGNC Symbol;Acc:HGNC:10487],NA,S100A10,6281,NM_002966
HDGF_TF,HDGF,HDGF_TF,HDGF,TF,342,-0.394559026673648,0.0810891271088952,0.0816829167650757,0.0791381039528735,-0.0025448128122023,0.739111948331878,-2.4747928020981,8.65700815090771,8.68959320049407,8.54994298798112,-0.139650212512953,0.0373143796147732,ENSG00000143321,HDGF,protein_coding,1,-1,156742109,156766925,q23.1,heparin binding growth factor [Source:HGNC Symbol;Acc:HGNC:4856],NA,HDGF,3068,NM_001126050;NM_001126051;NM_001319186;NM_001319187;NM_001319188;NM_004494
CPVL_SIG,CPVL,CPVL_SIG,CPVL,SIG,9,-0.393841060010738,0.253489616498142,0.255031457126695,0.24842356871861,-0.00660788840808449,0.739581925477948,1.25068521674953,5.27746339876882,5.21298524789284,5.48932018021847,0.276334932325624,0.315221315681142,ENSG00000106066,CPVL,protein_coding,7,-1,28995235,29195451,p14.3,carboxypeptidase, vitellogenic like [Source:HGNC Symbol;Acc:HGNC:14399],NA,CPVL,54504,NM_001348052;NM_001348054;NM_019029;NM_031311
PPIG_SIG,PPIG,PPIG_SIG,PPIG,SIG,24,-0.393507062414572,0.34002932534938,0.34042562528356,0.338727196994215,-0.00169842828934485,0.739749665208225,-0.489683531333828,6.43446042498935,6.44017654252444,6.41567889594547,-0.0244976465789683,0.715606543843871,ENSG00000138398,PPIG,protein_coding,2,1,169584344,169641406,q31.1,peptidylprolyl isomerase G [Source:HGNC Symbol;Acc:HGNC:14650],NA,PPIG,9360,NM_004792
RAPGEF3_SIG,RAPGEF3,RAPGEF3_SIG,RAPGEF3,SIG,38,0.393321528821512,0.0144002365988525,0.0131907901896384,0.0183741319434135,0.00518334175377509,0.739800531272229,-0.747857032679276,3.1506830592166,3.17400479062729,3.07405451315291,-0.0999502774743763,0.564515604507751,ENSG00000079337,RAPGEF3,protein_coding,12,-1,47734363,47771040,q13.11,Rap guanine nucleotide exchange factor 3 [Source:HGNC Symbol;Acc:HGNC:16629],NA,RAPGEF3,10411,NM_001098531;NM_001098532;NM_006105
ZNF200_TF,ZNF200,ZNF200_TF,ZNF200,TF,104,-0.392556230456656,0.252438512875572,0.253313015418176,0.249565147378444,-0.0037478680397316,0.740307776311235,-0.793195281453345,2.64980421968402,2.66582682478446,2.59715851721114,-0.0686683075733239,0.538696307338554,ENSG00000010539,ZNF200,protein_coding,16,-1,3222325,3236221,p13.3,zinc finger protein 200 [Source:HGNC Symbol;Acc:HGNC:12993],NA,ZNF200,7752,NM_001145446;NM_001145447;NM_001145448;NM_003454;NM_198087;NM_198088
PHKG1_SIG,PHKG1,PHKG1_SIG,PHKG1,SIG,38,0.392262687089144,0.130989479013707,0.129929441971069,0.134472457868089,0.00454301589702001,0.740443642340942,0.719303546720057,1.3149584210024,1.30384437892462,1.35147598782942,0.0476316089047991,0.580680538099011,ENSG00000164776,PHKG1,protein_coding,7,-1,56080283,56092996,p11.2,phosphorylase kinase catalytic subunit gamma 1 [Source:HGNC Symbol;Acc:HGNC:8930],Glycogen storage disease due to muscle phosphorylase kinase deficiency,PHKG1,5260,NM_001258459;NM_001258460;NM_006213
GRIN3B_SIG,GRIN3B,GRIN3B_SIG,GRIN3B,SIG,9,-0.392039072879453,-0.0267235338643573,-0.0262249924170082,-0.0283615986199326,-0.00213660620292438,0.740506191396265,-1.00656710621698,0.450308741870854,0.462477104756301,0.410326978104386,-0.052150126651916,0.427289194847431,ENSG00000116032,GRIN3B,protein_coding,19,1,1000419,1009732,p13.3,glutamate ionotropic receptor NMDA type subunit 3B [Source:HGNC Symbol;Acc:HGNC:16768],NA,GRIN3B,116444,NM_138690
PANX2_SIG,PANX2,PANX2_SIG,PANX2,SIG,16,0.391941298831054,-0.0191638455387984,-0.0200895043407429,-0.0161223951895521,0.00396710915119071,0.740506191396265,0.856560973645571,3.22055640422968,3.19143801264139,3.31623111944833,0.124793106806944,0.504738113457267,ENSG00000073150,PANX2,protein_coding,22,1,50170731,50180294,q13.33,pannexin 2 [Source:HGNC Symbol;Acc:HGNC:8600],NA,PANX2,56666,NM_001160300;NM_052839
MOCOS_SIG,MOCOS,MOCOS_SIG,MOCOS,SIG,31,0.391727934201628,-0.0552099881962535,-0.0557939835080901,-0.0532911464573618,0.0025028370507284,0.740578923605061,0.545527222670789,0.481742229383607,0.47196799240195,0.513857579466193,0.0418895870642425,0.683429958565742,ENSG00000075643,MOCOS,protein_coding,18,1,36187497,36272157,q12.2,molybdenum cofactor sulfurase [Source:HGNC Symbol;Acc:HGNC:18234],XANTHINURIA TYPE II,MOCOS,55034,NM_017947
MMP14_SIG,MMP14,MMP14_SIG,MMP14,SIG,93,-0.3912272956655,-0.0497181727525214,-0.0491816807777567,-0.0514809320981771,-0.00229925132042029,0.740849878081667,-0.987035698884654,3.26716899557614,3.32218149509142,3.08641364002595,-0.235767855065467,0.437211741607585,ENSG00000157227,MMP14,protein_coding,14,1,22836560,22849027,q11.2,matrix metallopeptidase 14 [Source:HGNC Symbol;Acc:HGNC:7160],Nodulosis-arthropathy-osteolysis syndrome;TORG-WINCHESTER SYNDROME;Winchester syndrome,MMP14,4323,NM_004995
BACE2_SIG,BACE2,BACE2_SIG,BACE2,SIG,39,-0.391034118986064,-0.121623244923701,-0.121237491493818,-0.122890720479031,-0.0016532289852134,0.740849878081667,0.826256768688848,1.99096669189666,1.9593454510801,2.09486505457961,0.13551960349951,0.520963104606869,ENSG00000182240,BACE2,protein_coding,21,1,41167801,41282530,q22.2,beta-secretase 2 [Source:HGNC Symbol;Acc:HGNC:934],NA,BACE2,25825,NM_012105;NM_138991;NM_138992
TCN2_SIG,TCN2,TCN2_SIG,TCN2,SIG,44,0.391020770465974,0.235829948766646,0.23477358985297,0.239300842340151,0.00452725248718137,0.740849878081667,1.98391676849125,3.82933455543223,3.75503057067003,4.07347621965085,0.318445648980817,0.100017932593233,ENSG00000185339,TCN2,protein_coding,22,1,30606838,30627278,q12.2,transcobalamin 2 [Source:HGNC Symbol;Acc:HGNC:11653],Transcobalamin deficiency;TRANSCOBALAMIN II DEFICIENCY,TCN2,6948,NM_000355;NM_001184726
MRPL28_TF,MRPL28,MRPL28_TF,MRPL28,TF,104,0.390856709618702,0.188050214145857,0.187719230661952,0.189137731307259,0.00141850064530744,0.740883787376285,0.380416867660636,5.2100440714615,5.20648762892476,5.22172952551077,0.0152418965860132,0.780159014945446,ENSG00000086504,MRPL28,protein_coding,16,-1,366969,371289,p13.3,mitochondrial ribosomal protein L28 [Source:HGNC Symbol;Acc:HGNC:14484],NA,MRPL28,10573,NM_006428
POLE3_SIG,POLE3,POLE3_SIG,POLE3,SIG,26,-0.389762333270684,0.224930805887414,0.225502420953875,0.223052642097611,-0.00244977885626452,0.741556060101127,0.0692034740375494,6.77931810397984,6.77840069947224,6.78233243307626,0.00393173360402355,0.962272185813353,ENSG00000148229,POLE3,protein_coding,9,-1,113407235,113410675,q32,DNA polymerase epsilon 3, accessory subunit [Source:HGNC Symbol;Acc:HGNC:13546],NA,POLE3,54107,NM_001278255;NM_017443
ZC3H6_TF,ZC3H6,ZC3H6_TF,ZC3H6,TF,50,0.389760542083708,0.230184280582021,0.229541409210366,0.232296572231745,0.00275516302137955,0.741556060101127,0.318092394606366,3.89662112656658,3.89012947716297,3.91795083174989,0.0278213545869232,0.816953043153369,ENSG00000188177,ZC3H6,protein_coding,2,1,112275597,112340063,q14.1,zinc finger CCCH-type containing 6 [Source:HGNC Symbol;Acc:HGNC:24762],NA,ZC3H6,376940,NM_198581
KMT2B_SIG,KMT2B,KMT2B_SIG,KMT2B,SIG,87,-0.389385054017595,0.0153039354071775,0.0160957134271624,0.0127023790557986,-0.00339333437136386,0.741613270447332,-0.338834957865582,2.04113716520558,2.04622112379609,2.02443272983673,-0.0217883939593624,0.804445384921962,ENSG00000272333,KMT2B,protein_coding,19,1,35718019,35738878,q13.12,lysine methyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:15840],Complex early-onset dystonia;DYSTONIA 28 CHILDHOOD-ONSET,KMT2B,9757,NM_014727
PLCG2_SIG,PLCG2,PLCG2_SIG,PLCG2,SIG,28,-0.389359253320675,0.23904816744697,0.240037133067315,0.23579870898012,-0.0042384240871951,0.741613270447332,0.0911743013450328,6.27358307894054,6.27205479004553,6.27860459959557,0.00654980955004183,0.949149460605271,ENSG00000197943,PLCG2,protein_coding,16,1,81739097,81962685,q23.3,phospholipase C gamma 2 [Source:HGNC Symbol;Acc:HGNC:9066],Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation;Autoinflammation antibody deficiency and immune dysregulation plcg2-associated;FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3;PLCG2-associated antibody deficiency and immune dysregulation,PLCG2,5336,NM_002661
HIST1H1D_SIG,HIST1H1D,HIST1H1D_SIG,HIST1H1D,SIG,21,-0.389324773186072,-0.186179447382982,-0.185260949122277,-0.189197370239581,-0.00393642111730397,0.741613270447332,-2.31259679271276,1.53652179008081,1.61047911602999,1.29351914767639,-0.3169599683536,0.0526069024917687,ENSG00000124575,HIST1H1D,protein_coding,6,-1,26234268,26234933,p22.2,histone cluster 1 H1 family member d [Source:HGNC Symbol;Acc:HGNC:4717],NA,HIST1H1D,3007,NM_005320
SPR_SIG,SPR,SPR_SIG,SPR,SIG,45,-0.389027650389489,-0.120270978888393,-0.119464007530915,-0.122922456205823,-0.00345844867490832,0.741751850374382,-0.939571080713217,1.04182462533335,1.06076530277522,0.979590970881495,-0.0811743318937274,0.461062980798021,ENSG00000116096,SPR,protein_coding,2,1,72887382,72892158,p13.2,sepiapterin reductase [Source:HGNC Symbol;Acc:HGNC:11257],Dopa-responsive dystonia due to sepiapterin reductase deficiency;DYSTONIA DOPA-RESPONSIVE DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY,SPR,6697,NM_003124
DENND4A_TF,DENND4A,DENND4A_TF,DENND4A,TF,99,0.388741155976093,0.23866404342587,0.238332919305764,0.239752022677649,0.00141910337188465,0.741882057939213,1.29988303087868,6.34165759523868,6.32242005197798,6.40486666595243,0.0824466139744544,0.295078089128357,ENSG00000174485,DENND4A,protein_coding,15,-1,65658046,65792293,q22.31,DENN domain containing 4A [Source:HGNC Symbol;Acc:HGNC:24321],NA,DENND4A,10260,NM_001144823;NM_001320835;NM_005848
ARHGAP21_SIG,ARHGAP21,ARHGAP21_SIG,ARHGAP21,SIG,54,-0.388464916096069,0.0373558062479596,0.0379887209921561,0.0352762292313139,-0.00271249176084232,0.742004187742487,0.523811612177256,5.28863405877652,5.26781772685044,5.35703057796221,0.0892128511117757,0.696017943445331,ENSG00000107863,ARHGAP21,protein_coding,10,-1,24583609,24723887,p12.1,Rho GTPase activating protein 21 [Source:HGNC Symbol;Acc:HGNC:23725],NA,ARHGAP21,57584,NM_001367448;NM_001367454;NM_020824
SREBF1_TF,SREBF1,SREBF1_TF,SREBF1,TF,83,0.387684784445162,-0.0464353603386597,-0.0468591102519619,-0.0450430391949528,0.00181607105700923,0.742514684895603,0.676600332459569,5.9092016677206,5.8965006107451,5.95093371206867,0.0544331013235721,0.605260663034934,ENSG00000072310,SREBF1,protein_coding,17,-1,17810399,17837002,p11.2,sterol regulatory element binding transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:11289],NA,SREBF1,6720,NM_001005291;NM_001321096;NM_004176
RBCK1_TF,RBCK1,RBCK1_TF,RBCK1,TF,156,0.387574081847324,0.232991220258036,0.232338846708096,0.235134733350697,0.00279588664260045,0.742514684895603,0.392768854940234,6.35633884130284,6.35168778755205,6.37162087505543,0.0199330875033806,0.772832712453413,ENSG00000125826,RBCK1,protein_coding,20,1,407498,430966,p13,RANBP2-type and C3HC4-type zinc finger containing 1 [Source:HGNC Symbol;Acc:HGNC:15864],Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis;POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY;Polyglucosan body myopathy type 1,RBCK1,10616,NM_001323956;NM_001323958;NM_001323960;NM_006462;NM_031229
TRA2B_SIG,TRA2B,TRA2B_SIG,TRA2B,SIG,39,0.386710238209547,0.252440829807081,0.251630894283845,0.255102046526287,0.00347115224244198,0.74309926161762,0.843633519550061,8.7961394875848,8.78224214940776,8.84180217016648,0.0595600207587223,0.511837678433168,ENSG00000136527,TRA2B,protein_coding,3,-1,185914558,185938103,q27.2,transformer 2 beta homolog [Source:HGNC Symbol;Acc:HGNC:10781],NA,TRA2B,6434,NM_001243879;NM_004593
PROK2_SIG,PROK2,PROK2_SIG,PROK2,SIG,21,-0.385321121395382,0.0784420068672696,0.0792758534842401,0.0757022251257952,-0.00357362835844506,0.74400368042496,0.0450970426525603,4.37414894890273,4.37191838384081,4.38147794839188,0.00955956455107282,0.9752182576139,ENSG00000163421,PROK2,protein_coding,3,-1,71771655,71785206,p13,prokineticin 2 [Source:HGNC Symbol;Acc:HGNC:18455],HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA;Kallmann Syndrome;Normosmic congenital hypogonadotropic hypogonadism,PROK2,60675,NM_001126128;NM_021935
SPTBN1_SIG,SPTBN1,SPTBN1_SIG,SPTBN1,SIG,38,0.38531905070184,0.111306972813946,0.110262902114633,0.114737490825975,0.00447458871134207,0.74400368042496,-0.0604328817797852,7.85003283502761,7.85161181594979,7.84484475485473,-0.00676706109505884,0.966539412719707,ENSG00000115306,SPTBN1,protein_coding,2,1,54456317,54671446,p16.2,spectrin beta, non-erythrocytic 1 [Source:HGNC Symbol;Acc:HGNC:11275],NA,SPTBN1,6711,NM_003128;NM_178313
EIF4E2_SIG,EIF4E2,EIF4E2_SIG,EIF4E2,SIG,38,-0.385116723332459,0.270601152372953,0.271573582012542,0.267406026414303,-0.00416755559823977,0.744053322408789,-0.587356509882825,6.017969067356,6.02470044963457,5.99585166844072,-0.028848781193849,0.65878399687262,ENSG00000135930,EIF4E2,protein_coding,2,1,232550674,232583644,q37.1,eukaryotic translation initiation factor 4E family member 2 [Source:HGNC Symbol;Acc:HGNC:3293],NA,EIF4E2,9470,NM_001276336;NM_001276337;NM_001282958;NM_001330201;NM_001330202;NM_001330203;NM_004846
ME3_SIG,ME3,ME3_SIG,ME3,SIG,48,-0.385013559696566,0.0612578385411858,0.0621376868045436,0.0583669085330101,-0.0037707782715333,0.744053322408789,-0.0707072302410416,3.57830640707996,3.58068075548039,3.5705049766214,-0.0101757788589878,0.961439092128504,ENSG00000151376,ME3,protein_coding,11,-1,86441108,86672636,q14.2,malic enzyme 3 [Source:HGNC Symbol;Acc:HGNC:6985],NA,ME3,10873,NM_001014811;NM_001161586;NM_001351934;NM_006680
MEF2C_TF,MEF2C,MEF2C_TF,MEF2C,TF,347,0.384775872594603,0.0695603188081859,0.0690244069389812,0.0713211720927157,0.00229676515373455,0.744145011714023,0.0382431192496586,6.26134724956545,6.25991373962138,6.26605735366741,0.00614361404603597,0.97914076003819,ENSG00000081189,MEF2C,protein_coding,5,-1,88717117,88904257,q14.3,myocyte enhancer factor 2C [Source:HGNC Symbol;Acc:HGNC:6996],5q14.3 microdeletion syndrome;MENTAL RETARDATION-STEREOTYPIC MOVEMENTS-EPILEPSY AND/OR CEREBRAL MALFORMATIONS;MENTAL RETARDATION AUTOSOMAL DOMINANT 20,MEF2C,4208,NM_001131005;NM_001193347;NM_001193348;NM_001193349;NM_001193350;NM_001308002;NM_001363581;NM_001364333;NM_001364334;NM_001364335;NM_001364336;NM_001364337;NM_001364345;NM_001364346;NM_001364347;NM_001364356;NM_002397
HNRNPCL1_SIG,HNRNPCL1,HNRNPCL1_SIG,HNRNPCL1,SIG,109,0.384360231082363,-0.0375983335833036,-0.0379876933793375,-0.0363190085391923,0.0016686848401451,0.744376784827129,0.794173143066748,0.443267067223118,0.438882435181756,0.45767371535902,0.0187912801772638,0.538305663789662,ENSG00000179172,HNRNPCL1,protein_coding,1,-1,12847408,12848725,p36.21,heterogeneous nuclear ribonucleoprotein C-like 1 [Source:HGNC Symbol;Acc:HGNC:29295],NA,HNRNPCL1,343069,NM_001013631
CBLB_SIG,CBLB,CBLB_SIG,CBLB,SIG,48,0.384149565720362,0.220601177788143,0.219930093938311,0.222806167580446,0.00287607364213413,0.744447184127254,0.659179304682902,5.11553464810559,5.10406329823927,5.15322622623778,0.0491629279985134,0.615320314833042,ENSG00000114423,CBLB,protein_coding,3,-1,105655461,105869552,q13.11,Cbl proto-oncogene B [Source:HGNC Symbol;Acc:HGNC:1542],NA,CBLB,868,NM_001321786;NM_001321788;NM_001321789;NM_001321790;NM_001321791;NM_001321793;NM_001321794;NM_001321795;NM_001321796;NM_001321797;NM_001321798;NM_001321799;NM_001321806;NM_001321807;NM_001321808;NM_001321811;NM_001321813;NM_001321816;NM_001321820;NM_001321822;NM_170662
TSC22D3_TF,TSC22D3,TSC22D3_TF,TSC22D3,TF,48,0.383253672063681,0.202466244769527,0.202042986786414,0.203856949571184,0.00181396278477024,0.745057046196982,-0.405496770704311,9.18955848707042,9.20089928901261,9.15229585211748,-0.0486034368951386,0.765230934591186,ENSG00000157514,TSC22D3,protein_coding,X,-1,107713221,107777342,q22.3,TSC22 domain family member 3 [Source:HGNC Symbol;Acc:HGNC:3051],NA,TSC22D3,1831,NM_001015881;NM_001318468;NM_001318470;NM_004089;NM_198057
THNSL2_SIG,THNSL2,THNSL2_SIG,THNSL2,SIG,24,-0.382990290824701,-0.12124316845044,-0.12078951874011,-0.12273373178438,-0.00194421304427035,0.745168916791711,-0.401061246346295,1.10350182127057,1.11574894389333,1.06326127551006,-0.0524876683832742,0.767636144765535,ENSG00000144115,THNSL2,protein_coding,2,1,88170295,88186636,p11.2,threonine synthase like 2 [Source:HGNC Symbol;Acc:HGNC:25602],NA,THNSL2,55258,NM_001244676;NM_001244678;NM_018271
PKN2_SIG,PKN2,PKN2_SIG,PKN2,SIG,30,0.382544242789334,0.458341502438614,0.457520377842816,0.461039483253379,0.00351910541056344,0.745424605844736,0.270825177866862,6.10783566843116,6.10450470068879,6.11878027672751,0.0142755760387187,0.844907225653467,ENSG00000065243,PKN2,protein_coding,1,1,88684222,88836255,p22.2,protein kinase N2 [Source:HGNC Symbol;Acc:HGNC:9406],NA,PKN2,5586,NM_001320707;NM_001320708;NM_001320709;NM_006256
AKAP8_SIG,AKAP8,AKAP8_SIG,AKAP8,SIG,29,0.381172381018045,0.395145910226514,0.394398106814607,0.39760297857992,0.00320487176531278,0.746409431775282,0.211931527508362,5.89112893691568,5.88893432049228,5.89833981944971,0.00940549895743825,0.88061048855594,ENSG00000105127,AKAP8,protein_coding,19,-1,15353385,15379798,p13.12,A-kinase anchoring protein 8 [Source:HGNC Symbol;Acc:HGNC:378],NA,AKAP8,10270,NM_005858
AHRR_SIG,AHRR,AHRR_SIG,AHRR,SIG,7,0.380638696185039,-0.181386766361141,-0.181913861046561,-0.179654883823331,0.0022589772232299,0.746734176458561,0.951342195253646,1.0073549362584,0.982898796500932,1.08771082403294,0.104812027532012,0.454942105865318,ENSG00000063438,AHRR,protein_coding,5,1,321759,435110,p15.33,aryl-hydrocarbon receptor repressor [Source:HGNC Symbol;Acc:HGNC:346],NA,AHRR,NA,NA
TP73_TF,TP73,TP73_TF,TP73,TF,133,-0.380178649750871,0.0289893903341298,0.029523814428044,0.0272334254541258,-0.00229038897391822,0.747000909855054,2.1038526123537,1.54573224387078,1.47826270085954,1.76741788519344,0.2891551843339,0.07980954368099,ENSG00000078900,TP73,protein_coding,1,1,3652516,3736201,p36.32,tumor protein p73 [Source:HGNC Symbol;Acc:HGNC:12003],Small cell lung cancer,TP73,7161,NM_001126240;NM_001126241;NM_001126242;NM_001204184;NM_001204185;NM_001204186;NM_001204187;NM_001204188;NM_001204189;NM_001204190;NM_001204191;NM_001204192;NM_005427
NXF3_SIG,NXF3,NXF3_SIG,NXF3,SIG,34,0.3783908610263,0.0212537407759148,0.0203381837768263,0.0242619994872056,0.00392381571037912,0.748313951970549,-2.2190916510611,2.19310653739121,2.29422832064238,1.86084924956596,-0.433379071076414,0.063864711008013,ENSG00000147206,NXF3,protein_coding,X,-1,103075810,103093143,q22.1,nuclear RNA export factor 3 [Source:HGNC Symbol;Acc:HGNC:8073],NA,NXF3,56000,NM_022052
SLC37A4_SIG,SLC37A4,SLC37A4_SIG,SLC37A4,SIG,12,0.37703955611192,0.429239547821674,0.427683726470546,0.434351532261094,0.00666780579054831,0.749283397958683,0.761898042369093,4.16009895437796,4.14438708655671,4.2117236629335,0.0673365763767979,0.556785552800545,ENSG00000137700,SLC37A4,protein_coding,11,-1,119024114,119030906,q23.3,solute carrier family 37 member 4 [Source:HGNC Symbol;Acc:HGNC:4061],Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib;GLYCOGEN STORAGE DISEASE Ib;GLYCOGEN STORAGE DISEASE Ic,SLC37A4,2542,NM_001164277;NM_001164278;NM_001164279;NM_001164280;NM_001467
ZNF136_TF,ZNF136,ZNF136_TF,ZNF136,TF,123,0.376617171387202,0.311358271234727,0.310340786852605,0.314701434204557,0.00436064735195198,0.749520497533242,0.276832584344749,3.94276596137691,3.93739867963679,3.96040131566588,0.023002636029088,0.841631637933462,ENSG00000196646,ZNF136,protein_coding,19,1,12163064,12189871,p13.2,zinc finger protein 136 [Source:HGNC Symbol;Acc:HGNC:12920],NA,ZNF136,7695,NM_001348013;NM_001348014;NM_003437
GTF2H2_SIG,GTF2H2,GTF2H2_SIG,GTF2H2,SIG,4,-0.37624871792059,-0.137756722654858,-0.136972377552608,-0.140333856562252,-0.00336147900964458,0.749715060242744,1.25367418701729,2.78138043305721,2.75944915132122,2.85344035876117,0.0939912074399415,0.313861811024215,ENSG00000145736,GTF2H2,protein_coding,5,-1,71032670,71067689,q13.2,general transcription factor IIH subunit 2 [Source:HGNC Symbol;Acc:HGNC:4656],NA,GTF2H2,2966;728340,NM_001515
ICK_SIG,ICK,ICK_SIG,ICK,SIG,21,-0.373090761266425,0.177598931400633,0.178201018416164,0.175620645492458,-0.00258037292370673,0.752110512234721,-2.68965825800177,4.2859479434256,4.34194626434032,4.10195346042008,-0.239992803920242,0.0229865118836901,ENSG00000112144,ICK,protein_coding,6,-1,53001279,53061802,p12.1,intestinal cell kinase [Source:HGNC Symbol;Acc:HGNC:21219],Endocrine-cerebro-osteodysplasia syndrome;ENDOCRINE-CEREBROOSTEODYSPLASIA;EPILEPSY JUVENILE MYOCLONIC SUSCEPTIBILITY TO 10;Juvenile myoclonic epilepsy,ICK,22858,NM_014920;NM_016513
ASIC3_SIG,ASIC3,ASIC3_SIG,ASIC3,SIG,63,0.372255699607321,-0.0589631633776224,-0.0594138457435349,-0.0574823498896243,0.00193149585391048,0.75267345582152,0.357750798536111,1.5584784973414,1.55127893058131,1.58213421669597,0.0308552861146528,0.793037705870296,ENSG00000213199,ASIC3,protein_coding,7,1,151048292,151052756,q36.1,acid sensing ion channel subunit 3 [Source:HGNC Symbol;Acc:HGNC:101],NA,ASIC3,9311,NM_004769;NM_020321;NM_020322
RPL8_SIG,RPL8,RPL8_SIG,RPL8,SIG,11,0.372047090204063,0.936998813691423,0.936022189526423,0.940207721662134,0.00418553213571054,0.752741812527434,0.615287230469986,9.94387639090638,9.93611864659436,9.96936612221731,0.0332474756229466,0.64131462240783,ENSG00000161016,RPL8,protein_coding,8,-1,144789765,144792587,q24.3,ribosomal protein L8 [Source:HGNC Symbol;Acc:HGNC:10368],NA,RPL8,6132,NM_000973;NM_001317771;NM_001317782;NM_033301
FRG1_SIG,FRG1,FRG1_SIG,FRG1,SIG,17,0.371590665777766,0.367935742664357,0.367489686009024,0.369401357389021,0.00191167137999665,0.753005816021413,-0.145603490666678,4.99562940696535,4.99696709562218,4.99123414423576,-0.00573295138642141,0.918256027735939,ENSG00000109536,FRG1,protein_coding,4,1,189940870,189963202,q35.2,FSHD region gene 1 [Source:HGNC Symbol;Acc:HGNC:3954],Facioscapulohumeral dystrophy;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1,FRG1,2483,NM_004477
GPSM2_SIG,GPSM2,GPSM2_SIG,GPSM2,SIG,31,0.371155748952528,0.152001814786323,0.151160208794791,0.154767091615642,0.0036068828208502,0.753252831259164,-0.670838521917816,4.60585461507776,4.62457362398167,4.54434930010779,-0.0802243238738819,0.608926141637086,ENSG00000121957,GPSM2,protein_coding,1,1,108875350,108934545,p13.3,G protein signaling modulator 2 [Source:HGNC Symbol;Acc:HGNC:29501],Autosomal recessive non-syndromic sensorineural deafness type DFNB;CHUDLEY-MCCULLOUGH SYNDROME,GPSM2,29899,NM_001321038;NM_001321039;NM_013296
NFYA_TF,NFYA,NFYA_TF,NFYA,TF,53,-0.370886693832404,0.0379431062139007,0.0384376611127681,0.0363181401176221,-0.00211952099514605,0.753354659634274,-0.624910011760384,5.87633951150103,5.88597200877933,5.84468987758659,-0.0412821311927473,0.635591748984941,ENSG00000001167,NFYA,protein_coding,6,1,41072945,41099976,p21.1,nuclear transcription factor Y subunit alpha [Source:HGNC Symbol;Acc:HGNC:7804],NA,NFYA,4800,NM_002505;NM_021705
FBXO44_SIG,FBXO44,FBXO44_SIG,FBXO44,SIG,79,0.370744597486038,0.0246678566821714,0.0241052114941314,0.0265165480143028,0.00241133652017135,0.753354659634274,0.973286608478494,3.32521309250532,3.30074360614374,3.40561283340766,0.104869227263922,0.443900730168377,ENSG00000132879,FBXO44,protein_coding,1,1,11654375,11663327,p36.22,F-box protein 44 [Source:HGNC Symbol;Acc:HGNC:24847],NA,FBXO44,93611,NM_001014765;NM_001304790;NM_001304791;NM_001330355;NM_033182;NM_183412;NM_183413
ZNF829_TF,ZNF829,ZNF829_TF,ZNF829,TF,28,0.370660557184159,-0.0704901664147596,-0.0711742990780417,-0.0682423019496902,0.00293199712835147,0.753354659634274,0.760246849469489,2.31514677305128,2.29890937986809,2.36849820779602,0.0695888279279306,0.557650661019641,ENSG00000185869,ZNF829,protein_coding,19,-1,36888124,36916291,q13.12,zinc finger protein 829 [Source:HGNC Symbol;Acc:HGNC:34032],NA,ZNF829,374899,NM_001037232;NM_001171979
DLL1_SIG,DLL1,DLL1_SIG,DLL1,SIG,29,0.370169005961743,0.0118131016895873,0.011149039614015,0.0139950199378965,0.00284598032388166,0.753646332080994,0.882525275338384,1.48789642878639,1.46099004664533,1.57630311296416,0.115313066318821,0.491073966254993,ENSG00000198719,DLL1,protein_coding,6,-1,170282206,170306565,q27,delta like canonical Notch ligand 1 [Source:HGNC Symbol;Acc:HGNC:2908],Alobar holoprosencephaly;Lobar holoprosencephaly;Microform holoprosencephaly;Midline interhemispheric variant of holoprosencephaly;Semilobar holoprosencephaly;Septopreoptic holoprosencephaly,DLL1,28514,NM_005618
JADE1_SIG,JADE1,JADE1_SIG,JADE1,SIG,47,0.366880752409747,0.096744043003989,0.0961721287083446,0.0986231899753919,0.00245106126704715,0.756147125945067,0.429419963762463,5.967026448091,5.96119142598149,5.98619866359371,0.0250072376122246,0.750752592700609,ENSG00000077684,JADE1,protein_coding,4,1,128809700,128875224,q28.2,jade family PHD finger 1 [Source:HGNC Symbol;Acc:HGNC:30027],NA,JADE1,79960,NM_001287437;NM_001287439;NM_001287440;NM_001287441;NM_001287442;NM_001287443;NM_024900;NM_199320
CPOX_SIG,CPOX,CPOX_SIG,CPOX,SIG,43,-0.36605392454907,0.201042098962666,0.202220365890943,0.197170650484042,-0.00504971540690165,0.756703910116295,0.0245391316350857,4.27307965828727,4.2724591591621,4.27511844112713,0.00265928196503134,0.986452444957619,ENSG00000080819,CPOX,protein_coding,3,-1,98579446,98593723,q11.2,coproporphyrinogen oxidase [Source:HGNC Symbol;Acc:HGNC:2321],COPROPORPHYRIA HEREDITARY;Hereditary coproporphyria,CPOX,1371,NM_000097
TRADD_SIG,TRADD,TRADD_SIG,TRADD,SIG,67,-0.36566763034838,0.224524561477787,0.225367471732266,0.221754999213073,-0.00361247251919333,0.756912497838693,0.629764305093338,3.79659216551003,3.78384307430567,3.83848203661008,0.0546389623044144,0.632651655855608,ENSG00000102871,TRADD,protein_coding,16,-1,67154185,67159909,q22.1,TNFRSF1A associated via death domain [Source:HGNC Symbol;Acc:HGNC:12030],NA,TRADD,8717,NM_001323552;NM_003789
MBOAT1_SIG,MBOAT1,MBOAT1_SIG,MBOAT1,SIG,16,0.365220681469743,0.0723956033657522,0.0719286468844177,0.0739298889472799,0.00200124206286231,0.757169021573012,-0.583601882141449,4.81478932181784,4.82436914822231,4.78331274934602,-0.0410563988762923,0.661200159249275,ENSG00000172197,MBOAT1,protein_coding,6,-1,20102145,20212399,p22.3,membrane bound O-acyltransferase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21579],NA,MBOAT1,154141,NM_001080480
SMC1A_SIG,SMC1A,SMC1A_SIG,SMC1A,SIG,13,0.364803625761629,0.631720835359568,0.63003822286297,0.63724941927696,0.00721119641399,0.757401906525902,0.506422000694483,7.42911327001607,7.41910479252966,7.46199826747142,0.0428934749417607,0.705626361200847,ENSG00000072501,SMC1A,protein_coding,X,-1,53374149,53422728,p11.22,structural maintenance of chromosomes 1A [Source:HGNC Symbol;Acc:HGNC:11111],Cornelia de Lange syndrome;CORNELIA DE LANGE SYNDROME 2;CORNELIA DE LANGE SYNDROME TYPE 2;Epileptic encephalopathy;Wiedemann-Steiner syndrome,SMC1A,8243,NM_001281463;NM_006306
SLC23A2_SIG,SLC23A2,SLC23A2_SIG,SLC23A2,SIG,37,0.363515525821554,0.333245410541751,0.332781835851649,0.334768584523512,0.00198674867186298,0.758322127943811,1.89498353252429,5.74856905807641,5.72088886282075,5.83951827105929,0.118629408238544,0.117283062249559,ENSG00000089057,SLC23A2,protein_coding,20,-1,4852356,5010293,p13,solute carrier family 23 member 2 [Source:HGNC Symbol;Acc:HGNC:10973],NA,SLC23A2,9962,NM_005116;NM_203327
NEU1_SIG,NEU1,NEU1_SIG,NEU1,SIG,8,0.363295352655088,0.103121834843601,0.102610393432328,0.104802285194926,0.00219189176259736,0.758322127943811,-0.439485638190141,5.51878115831048,5.524455347538,5.50013739370578,-0.0243179538322149,0.745034204698099,ENSG00000204386,NEU1,protein_coding,6,-1,31857659,31862906,p21.33,neuraminidase 1 [Source:HGNC Symbol;Acc:HGNC:7758],Congenital sialidosis type 2;Juvenile sialidosis type 2;NEURAMINIDASE DEFICIENCY;Sialidosis;Sialidosis type 1,NEU1,4758,NM_000434
OTUD5_SIG,OTUD5,OTUD5_SIG,OTUD5,SIG,59,0.363272137509025,0.104752032806555,0.104167895793014,0.106671340136759,0.00250344434374445,0.758322127943811,0.626520268156208,6.4650517650307,6.45920604629646,6.48425912658605,0.0250530802895917,0.634694973082311,ENSG00000068308,OTUD5,protein_coding,X,-1,48922028,48958386,p11.23,OTU deubiquitinase 5 [Source:HGNC Symbol;Acc:HGNC:25402],NA,OTUD5,55593,NM_001136157;NM_001136158;NM_001136159;NM_017602
SRI_SIG,SRI,SRI_SIG,SRI,SIG,25,-0.358426141870055,0.15255149632934,0.152972210096645,0.151169151093906,-0.00180305900273957,0.76203538259331,0.89124596430219,5.50202043709524,5.49136285979681,5.5370381910758,0.0456753312789865,0.486461936677125,ENSG00000075142,SRI,protein_coding,7,-1,88205118,88226993,q21.12,sorcin [Source:HGNC Symbol;Acc:HGNC:11292],NA,SRI,6717,NM_001256891;NM_001256892;NM_003130;NM_198901
ACAA1_SIG,ACAA1,ACAA1_SIG,ACAA1,SIG,18,-0.358333776842255,0.374089884878426,0.374947789459325,0.371271055541188,-0.00367673391813673,0.76203538259331,0.102177531565558,6.24199017724961,6.24072303089173,6.24615365813977,0.00543062724804064,0.943359481427938,ENSG00000060971,ACAA1,protein_coding,3,-1,38103129,38137242,p22.2,acetyl-CoA acyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:82],NA,ACAA1,30,NM_001130410;NM_001607
ZNF775_TF,ZNF775,ZNF775_TF,ZNF775,TF,137,0.358164031116281,0.0932439408989881,0.0925745535977281,0.0954433563174137,0.00286880271968562,0.762072460444228,1.52924794121208,3.84940022382871,3.81756191772882,3.95401180101408,0.136449883285266,0.212465733794014,ENSG00000196456,ZNF775,protein_coding,7,1,150379330,150398630,q36.1,zinc finger protein 775 [Source:HGNC Symbol;Acc:HGNC:28501],NA,ZNF775,285971,NM_173680
XRCC6_SIG,XRCC6,XRCC6_SIG,XRCC6,SIG,18,0.357795996156443,0.563585730947027,0.562890100791162,0.565871372887726,0.00298127209656359,0.762266537239574,0.201126536235114,7.86540810887965,7.86338925117629,7.87204149847642,0.00865224730013111,0.886310318589187,ENSG00000196419,XRCC6,protein_coding,22,1,41621119,41664048,q13.2,X-ray repair cross complementing 6 [Source:HGNC Symbol;Acc:HGNC:4055],NA,XRCC6,2547,NM_001288976;NM_001288977;NM_001288978;NM_001469
PYCARD_SIG,PYCARD,PYCARD_SIG,PYCARD,SIG,107,0.357507147595314,0.291726922052863,0.290617181042111,0.295373213945334,0.00475603290322303,0.762397903535064,1.63142977996562,5.65768590176011,5.61591214205581,5.79494254078854,0.179030398732735,0.181717039551926,ENSG00000103490,PYCARD,protein_coding,16,-1,31201486,31203450,p11.2,PYD and CARD domain containing [Source:HGNC Symbol;Acc:HGNC:16608],NA,PYCARD,29108,NM_013258;NM_145182
PIK3R1_SIG,PIK3R1,PIK3R1_SIG,PIK3R1,SIG,26,0.355876579822106,0.414416587876327,0.413388071931497,0.417795997409338,0.0044079254778405,0.763501846370609,0.926120761149257,8.05049891134947,8.03004307009994,8.11771096116934,0.0876678910693994,0.467725234224502,ENSG00000145675,PIK3R1,protein_coding,5,1,68215756,68301821,q13.1,phosphoinositide-3-kinase regulatory subunit 1 [Source:HGNC Symbol;Acc:HGNC:8979],Activated PI3K-delta syndrome;AGAMMAGLOBULINEMIA 7 AUTOSOMAL RECESSIVE;Autosomal agammaglobulinemia;Immunodeficiency 36;SHORT syndrome,PIK3R1,5295,NM_001242466;NM_181504;NM_181523;NM_181524
CLCN3_SIG,CLCN3,CLCN3_SIG,CLCN3,SIG,26,-0.355867136404885,0.329579899823551,0.330671879948852,0.32599196512613,-0.00467991482272262,0.763501846370609,-0.788204816139677,4.9330355882079,4.95285334033088,4.86792011694666,-0.084933223384227,0.541577512289965,ENSG00000109572,CLCN3,protein_coding,4,1,169612633,169723673,q33,chloride voltage-gated channel 3 [Source:HGNC Symbol;Acc:HGNC:2021],NA,CLCN3,1182,NM_001243372;NM_001243374;NM_001829;NM_173872
NUDT22_SIG,NUDT22,NUDT22_SIG,NUDT22,SIG,43,0.35562085763407,0.247923041694909,0.247280117137068,0.250035508099242,0.00275539096217383,0.763599445993658,0.378332612475599,4.4684187670831,4.46396404328375,4.48305571670951,0.019091673425761,0.78119214551522,ENSG00000149761,NUDT22,protein_coding,11,1,64225941,64230686,q13.1,nudix hydrolase 22 [Source:HGNC Symbol;Acc:HGNC:28189],NA,NUDT22,84304,NM_001128612;NM_001128613;NM_001271831;NM_032344
GPR27_SIG,GPR27,GPR27_SIG,GPR27,SIG,17,-0.355471057979438,0.113001502234058,0.113636139515502,0.110916265452173,-0.00271987406332843,0.763620629536877,2.3774491349389,4.227269123536,4.11983217181252,4.58027625062744,0.460444078814926,0.0460353757655191,ENSG00000170837,GPR27,protein_coding,3,1,71754050,71756496,p13,G protein-coupled receptor 27 [Source:HGNC Symbol;Acc:HGNC:4482],NA,GPR27,2850,NM_018971
ZBTB1_TF,ZBTB1,ZBTB1_TF,ZBTB1,TF,51,0.355345059179987,0.358726833183268,0.357834739117937,0.361657999397925,0.00382326027998799,0.763622966309601,1.86418505519202,6.55408253670956,6.52376148817667,6.65370883903193,0.129947350855261,0.123805359698308,ENSG00000126804,ZBTB1,protein_coding,14,1,64503712,64533690,q23.3,zinc finger and BTB domain containing 1 [Source:HGNC Symbol;Acc:HGNC:20259],NA,ZBTB1,22890,NM_001123329;NM_014950
SETD3_SIG,SETD3,SETD3_SIG,SETD3,SIG,28,-0.355127476090302,0.397419209333111,0.398342285815407,0.394386243748427,-0.00395604206697967,0.763697826585854,-0.630664655411172,6.16938732152257,6.17721396278571,6.14367121451508,-0.0335427482706363,0.632112620895529,ENSG00000183576,SETD3,protein_coding,14,-1,99397748,99480889,q32.2,SET domain containing 3, actin histidine methyltransferase [Source:HGNC Symbol;Acc:HGNC:20493],NA,SETD3,84193,NM_032233;NM_199123
PRKAR1A_SIG,PRKAR1A,PRKAR1A_SIG,PRKAR1A,SIG,61,0.354741875317935,0.334427527047103,0.3331072793683,0.338765483706025,0.00565820433772537,0.763905722765054,0.795317546002672,7.46967464690824,7.45230297808533,7.52675298732638,0.0744500092410476,0.537856440151056,ENSG00000108946,PRKAR1A,protein_coding,17,1,68511780,68551319,q24.2,protein kinase cAMP-dependent type I regulatory subunit alpha [Source:HGNC Symbol;Acc:HGNC:9388],Acrodysostosis;ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE;Acrodysostosis with multiple hormone resistance;ACUTE PROMYELOCYTIC LEUKEMIA;Carney complex;Carney complex type 1;Familial atrial myxoma;MYXOMA INTRACARDIAC;PIGMENTED NODULAR ADRENOCORTICAL DISEASE PRIMARY 1;Primary pigmented nodular adrenocortical disease,PRKAR1A,5573,NM_001276289;NM_001276290;NM_001278433;NM_002734;NM_212471;NM_212472
SLC2A9_SIG,SLC2A9,SLC2A9_SIG,SLC2A9,SIG,81,0.353993918672918,0.0527370240151765,0.0515353113698666,0.0566855084211946,0.00515019705132795,0.764390202389725,1.47682190848839,3.03116497260254,2.98450797209388,3.18446654570244,0.199958573608561,0.229569408064808,ENSG00000109667,SLC2A9,protein_coding,4,-1,9771153,10054936,p16.1,solute carrier family 2 member 9 [Source:HGNC Symbol;Acc:HGNC:13446],Hereditary renal hypouricemia;HYPOURICEMIA RENAL 2,SLC2A9,56606,NM_001001290;NM_020041
KMT2C_SIG,KMT2C,KMT2C_SIG,KMT2C,SIG,36,0.35388389171261,0.529391905043817,0.528798024935772,0.531343225398821,0.00254520046304923,0.764390202389725,0.939199700864895,7.86411729749893,7.84944589010169,7.91232335037558,0.0628774602738903,0.461208721275086,ENSG00000055609,KMT2C,protein_coding,7,-1,152134922,152436005,q36.1,lysine methyltransferase 2C [Source:HGNC Symbol;Acc:HGNC:13726],Intellectual disability;KLEEFSTRA SYNDROME 2;Kleefstra syndrome due to a point mutation,KMT2C,58508,NM_170606
SNX17_SIG,SNX17,SNX17_SIG,SNX17,SIG,47,0.353301010401384,0.381564225468622,0.380806586576643,0.384053610399409,0.00324702382276543,0.764754297320048,0.726679915791544,6.3927646386592,6.38305032286577,6.42468310483761,0.04163278197184,0.576097877705888,ENSG00000115234,SNX17,protein_coding,2,1,27370496,27377535,p23.3,sorting nexin 17 [Source:HGNC Symbol;Acc:HGNC:14979],NA,SNX17,9784,NM_001267059;NM_001267060;NM_001267061;NM_014748
SNRPA1_SIG,SNRPA1,SNRPA1_SIG,SNRPA1,SIG,76,0.352927586972227,0.330057502045801,0.328763014859326,0.334310817087077,0.00554780222775064,0.764952506169772,1.08792275294878,4.82710853109754,4.80367424721435,4.90410689242803,0.100432645213674,0.388021699070487,ENSG00000131876,SNRPA1,protein_coding,15,-1,101281510,101295282,q26.3,small nuclear ribonucleoprotein polypeptide A' [Source:HGNC Symbol;Acc:HGNC:11152],NA,SNRPA1,6627,NM_003090
ING2_SIG,ING2,ING2_SIG,ING2,SIG,20,0.352682724686321,0.0166921319027619,0.016228030351228,0.0182170370006589,0.00198900664943091,0.76504889011405,0.143854958635741,4.37447566506531,4.37252981682835,4.38086916641532,0.00833934958696686,0.919343011738244,ENSG00000168556,ING2,protein_coding,4,1,183505058,183512429,q35.1,inhibitor of growth family member 2 [Source:HGNC Symbol;Acc:HGNC:6063],NA,ING2,3622,NM_001291959;NM_001564
TNFRSF1A_SIG,TNFRSF1A,TNFRSF1A_SIG,TNFRSF1A,SIG,30,0.351078711337883,0.100750228976332,0.0997664949868471,0.103982497798926,0.00421600281207915,0.766221827750387,0.650179612992156,6.88637575675471,6.87292894172717,6.93055814898804,0.0576292072608737,0.620708201245377,ENSG00000067182,TNFRSF1A,protein_coding,12,-1,6328757,6342114,p13.31,TNF receptor superfamily member 1A [Source:HGNC Symbol;Acc:HGNC:11916],Intermittent hydrarthrosis;MULTIPLE SCLEROSIS SUSCEPTIBILITY TO 5;PERIODIC FEVER FAMILIAL AUTOSOMAL DOMINANT;Tumor necrosis factor receptor 1 associated periodic syndrome,TNFRSF1A,7132,NM_001065;NM_001346091;NM_001346092
FBXL14_SIG,FBXL14,FBXL14_SIG,FBXL14,SIG,42,-0.350049858283213,0.161240437836602,0.161583742528582,0.160112436705813,-0.00147130582276931,0.766939345813743,-0.449383530322601,4.01606619919427,4.02265830194875,3.99440643300097,-0.0282518689477847,0.73933585950022,ENSG00000171823,FBXL14,protein_coding,12,-1,1565993,1594581,p13.33,F-box and leucine rich repeat protein 14 [Source:HGNC Symbol;Acc:HGNC:28624],NA,FBXL14,144699,NM_152441
PHF8_SIG,PHF8,PHF8_SIG,PHF8,SIG,39,0.349491093768446,0.359679510386943,0.359180144766955,0.361320283138329,0.00214013837137416,0.767284393340532,0.00233035016868893,5.81082642765244,5.8108039276838,5.81090035612084,9.64284370416388e-05,0.998446695263715,ENSG00000172943,PHF8,protein_coding,X,-1,53936676,54048958,p11.22,PHD finger protein 8 [Source:HGNC Symbol;Acc:HGNC:20672],MENTAL RETARDATION SYNDROMIC X-LINKED SIDERIUS TYPE;SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME;X-linked intellectual disability Siderius type,PHF8,23133,NM_001184896;NM_001184897;NM_001184898;NM_015107
LAMA3_SIG,LAMA3,LAMA3_SIG,LAMA3,SIG,35,0.348332627667642,0.000747671195708017,0.00012186798033885,0.00280388176049243,0.0026820137801535,0.768104791805914,1.15490286815211,1.25439991006608,1.21467877019883,1.38491222677275,0.170233456573925,0.357240542571868,ENSG00000053747,LAMA3,protein_coding,18,1,23689443,23956222,q11.2,laminin subunit alpha 3 [Source:HGNC Symbol;Acc:HGNC:6483],EPIDERMOLYSIS BULLOSA JUNCTIONAL HERLITZ TYPE;EPIDERMOLYSIS BULLOSA JUNCTIONAL NON-HERLITZ TYPE;Junctional epidermolysis bullosa generalized intermediate;Junctional epidermolysis bullosa generalized severe;LARYNGOONYCHOCUTANEOUS SYNDROME;LOC syndrome,LAMA3,3909,NM_000227;NM_001127717;NM_001127718;NM_198129
ZRANB1_TF,ZRANB1,ZRANB1_TF,ZRANB1,TF,314,0.347455393157206,0.0599636751183287,0.0591856593557263,0.0625200126240226,0.00333435326829635,0.768702360212768,-1.15964556988161,6.05950393475587,6.07449420873554,6.01025017739409,-0.0642440313414515,0.354988806994445,ENSG00000019995,ZRANB1,protein_coding,10,1,124942123,124988189,q26.13,zinc finger RANBP2-type containing 1 [Source:HGNC Symbol;Acc:HGNC:18224],NA,ZRANB1,54764,NM_017580
AFF4_SIG,AFF4,AFF4_SIG,AFF4,SIG,38,0.346815280811873,0.525478893886521,0.524270313007365,0.529449945346602,0.00517963233923704,0.769111955260076,1.41983829460209,7.15305574432253,7.1291340126319,7.23165571987745,0.102521707245551,0.24915454078296,ENSG00000072364,AFF4,protein_coding,5,-1,132875395,132963634,q31.1,AF4/FMR2 family member 4 [Source:HGNC Symbol;Acc:HGNC:17869],CHOPS SYNDROME;Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome;Cornelia de Lange-like syndrome,AFF4,27125,NM_014423
SLC27A3_SIG,SLC27A3,SLC27A3_SIG,SLC27A3,SIG,42,-0.346441587850339,0.11546544598841,0.116554151353328,0.111888271217962,-0.00466588013536656,0.769310291929029,1.29965980005071,4.86430165210998,4.83137009697167,4.97250533327871,0.141135236307036,0.295110535527661,ENSG00000143554,SLC27A3,protein_coding,1,1,153774354,153780157,q21.3,solute carrier family 27 member 3 [Source:HGNC Symbol;Acc:HGNC:10997],NA,SLC27A3,11000,NM_001317929;NM_024330
RNF7_SIG,RNF7,RNF7_SIG,RNF7,SIG,31,-0.34594782474753,0.395823125883794,0.396501044943301,0.393595677545415,-0.00290536739788529,0.769603828093919,0.944665341969456,5.00139155740626,4.99038327138994,5.03756164003131,0.0471783686413678,0.458410321364742,ENSG00000114125,RNF7,protein_coding,3,1,141738249,141747560,q23,ring finger protein 7 [Source:HGNC Symbol;Acc:HGNC:10070],NA,RNF7,9616,NM_001201370;NM_014245;NM_183237
CDK20_SIG,CDK20,CDK20_SIG,CDK20,SIG,59,0.34477529743213,-0.103418089308698,-0.104026597318805,-0.101418705846918,0.00260789147188716,0.770435691565214,0.957676277914517,1.74116748143251,1.71355979742766,1.83187844316273,0.118318645735078,0.451911284332808,ENSG00000156345,CDK20,protein_coding,9,-1,87966441,87974753,q22.1,cyclin dependent kinase 20 [Source:HGNC Symbol;Acc:HGNC:21420],NA,CDK20,23552,NM_001039803;NM_001170639;NM_001170640;NM_012119;NM_178432
PCTP_SIG,PCTP,PCTP_SIG,PCTP,SIG,15,0.342344990283198,0.226191992919292,0.225433903267063,0.228682858919472,0.00324895565240824,0.772198875404217,-0.778249550824486,4.74001754929355,4.75460329171405,4.69209296705478,-0.062510324659268,0.547132584894993,ENSG00000141179,PCTP,protein_coding,17,1,55750979,55842830,q22,phosphatidylcholine transfer protein [Source:HGNC Symbol;Acc:HGNC:8752],NA,PCTP,58488,NM_001102402;NM_001330377;NM_001330378;NM_021213
LLPH_SIG,LLPH,LLPH_SIG,LLPH,SIG,29,-0.342305547022807,0.329707473737397,0.330132995508151,0.328309330776349,-0.00182366473180248,0.772198875404217,0.441535998564032,3.95320131006738,3.94865790945097,3.96812962637845,0.0194717169274802,0.744008087748539,ENSG00000139233,LLPH,protein_coding,12,-1,66116555,66130750,q14.3,LLP homolog, long-term synaptic facilitation factor [Source:HGNC Symbol;Acc:HGNC:28229],NA,LLPH,84298,NM_032338
TRIM22_TF,TRIM22,TRIM22_TF,TRIM22,TF,160,0.339883763792788,0.150501263824793,0.150117266408394,0.151762969621533,0.00164570321313826,0.774023239762035,2.01811071958852,7.23629702440828,7.19323497209115,7.37778662487887,0.184551652787726,0.0939059480159381,ENSG00000132274,TRIM22,protein_coding,11,1,5689697,5737089,p15.4,tripartite motif containing 22 [Source:HGNC Symbol;Acc:HGNC:16379],NA,TRIM22,10346,NM_001199573;NM_006074
CTSA_SIG,CTSA,CTSA_SIG,CTSA,SIG,37,-0.339561712584825,0.328418081810641,0.329041815477108,0.326368671192248,-0.00267314428486076,0.774180489945284,-2.42406097831932,8.12741773170079,8.18371366748999,7.94244537125055,-0.241268296239444,0.041597782857313,ENSG00000064601,CTSA,protein_coding,20,1,45890144,45898820,q13.12,cathepsin A [Source:HGNC Symbol;Acc:HGNC:9251],GALACTOSIALIDOSIS,CTSA,5476,NM_000308;NM_001127695;NM_001167594
SLC23A3_SIG,SLC23A3,SLC23A3_SIG,SLC23A3,SIG,18,-0.339070249940406,-0.180487558761848,-0.179852972887654,-0.1825726266342,-0.00271965374654512,0.77439373710209,-1.02123809818769,0.828214814106999,0.841174658244087,0.785632469085137,-0.0555421891589497,0.42008706802755,ENSG00000213901,SLC23A3,protein_coding,2,-1,219161465,219170095,q35,solute carrier family 23 member 3 [Source:HGNC Symbol;Acc:HGNC:20601],NA,SLC23A3,151295,NM_001144889;NM_001144890;NM_144712
PHF19_SIG,PHF19,PHF19_SIG,PHF19,SIG,7,0.339045060306667,0.092771168939801,0.0922184480578106,0.0945872518377695,0.00236880377995888,0.77439373710209,-2.38973029653178,5.98827985705155,6.01963518933344,5.88525519383963,-0.134379995493803,0.044788755730261,ENSG00000119403,PHF19,protein_coding,9,-1,120855651,120894896,q33.2,PHD finger protein 19 [Source:HGNC Symbol;Acc:HGNC:24566],NA,PHF19,26147,NM_001009936;NM_001286840;NM_001286842;NM_001286843;NM_015651
CHRM3_SIG,CHRM3,CHRM3_SIG,CHRM3,SIG,68,-0.338919758914675,-0.10791067130464,-0.10730716254584,-0.109893628654984,-0.00258646610914458,0.774394711584766,-1.77591773260334,0.530868046531361,0.573687574957698,0.390175310273399,-0.183512264684299,0.143988412468314,ENSG00000133019,CHRM3,protein_coding,1,1,239386565,239915452,q43,cholinergic receptor muscarinic 3 [Source:HGNC Symbol;Acc:HGNC:1952],Prune belly syndrome,CHRM3,1131,NM_000740;NM_001347716
DDX24_SIG,DDX24,DDX24_SIG,DDX24,SIG,45,0.337183040171261,0.356061472576908,0.354842287666187,0.360067365854989,0.00522507818880215,0.775675532917077,1.18159232640501,7.48226033941588,7.46422393358963,7.54152281570215,0.0772988821125154,0.344941876724002,ENSG00000089737,DDX24,protein_coding,14,-1,94048287,94081212,q32.12,DEAD-box helicase 24 [Source:HGNC Symbol;Acc:HGNC:13266],NA,DDX24,57062,NM_020414
IQGAP2_SIG,IQGAP2,IQGAP2_SIG,IQGAP2,SIG,24,-0.336830601990557,0.423956409554505,0.424765301123634,0.421298622970222,-0.00346667815341186,0.775856847235599,1.06433698004455,7.64001487312837,7.61797052408559,7.71244630569748,0.0944757816118873,0.399454253908188,ENSG00000145703,IQGAP2,protein_coding,5,1,76403285,76708132,q13.3,IQ motif containing GTPase activating protein 2 [Source:HGNC Symbol;Acc:HGNC:6111],NA,IQGAP2,10788,NM_001285460;NM_001285461;NM_001285462;NM_006633
NOTCH1_SIG,NOTCH1,NOTCH1_SIG,NOTCH1,SIG,68,-0.33374843925363,0.23220477993006,0.232685191804889,0.230626283769907,-0.00205890803498118,0.778207736167408,0.213344246686021,7.3274344745996,7.3230362729722,7.34188570851821,0.0188494355460163,0.879710862267333,ENSG00000148400,NOTCH1,protein_coding,9,-1,136494433,136546048,q34.3,notch 1 [Source:HGNC Symbol;Acc:HGNC:7881],Adams-Oliver syndrome;Adams-Oliver syndrome 5;Adams Oliver syndrome;AORTIC VALVE DISEASE 1;Familial bicuspid aortic valve;LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION,NOTCH1,4851,NM_017617
ZFP91_SIG,ZFP91,ZFP91_SIG,ZFP91,SIG,66,0.331680536505163,0.322212657808069,0.321318602522683,0.325150268031479,0.00383166550879656,0.779702277261292,-0.111845693313725,7.06817721676005,7.0697446757127,7.06302699448706,-0.0067176812256405,0.938077611823677,ENSG00000186660,ZFP91,protein_coding,11,1,58579063,58621550,q12.1,ZFP91 zinc finger protein [Source:HGNC Symbol;Acc:HGNC:14983],NA,ZFP91,80829,NM_001197051;NM_053023
EEA1_TF,EEA1,EEA1_TF,EEA1,TF,187,-0.331620245424837,0.272977451815321,0.273861423062999,0.270072974858665,-0.00378844820433324,0.779702277261292,0.229245260983244,5.39503474817014,5.39005155802303,5.41140808722495,0.0213565292019212,0.87061998328927,ENSG00000102189,EEA1,protein_coding,12,-1,92770637,92929331,q22,early endosome antigen 1 [Source:HGNC Symbol;Acc:HGNC:3185],NA,EEA1,8411,NM_003566
SLC25A16_SIG,SLC25A16,SLC25A16_SIG,SLC25A16,SIG,24,0.33109123398008,0.235811280232265,0.235508023365946,0.236807695650171,0.00129967228422548,0.780023979289646,-0.246022468078382,4.1790951531218,4.18157868003637,4.17093499325965,-0.0106436867767153,0.860327688645957,ENSG00000122912,SLC25A16,protein_coding,10,-1,68477998,68527523,q21.3,solute carrier family 25 member 16 [Source:HGNC Symbol;Acc:HGNC:10986],NA,SLC25A16,8034,NM_001324312;NM_001324313;NM_001324314;NM_001324315;NM_001324317;NM_152707
RHBDL3_SIG,RHBDL3,RHBDL3_SIG,RHBDL3,SIG,38,0.328567929474179,-0.0740671488408085,-0.0744411097604646,-0.0728384201047958,0.00160268965566876,0.78193285730275,-1.66829324123362,0.893872396665035,0.94348875571248,0.730847216937713,-0.212641538774767,0.171412075753905,ENSG00000141314,RHBDL3,protein_coding,17,1,32265832,32324659,q11.2,rhomboid like 3 [Source:HGNC Symbol;Acc:HGNC:16502],NA,RHBDL3,162494,NM_001330181;NM_138328
KDM4B_SIG,KDM4B,KDM4B_SIG,KDM4B,SIG,19,-0.328065348113995,0.286873439720587,0.287261770726689,0.285597494986253,-0.0016642757404354,0.782233575303309,-1.55425455307791,6.30385664988126,6.32287817685629,6.2413573469633,-0.081520829892991,0.204385721377947,ENSG00000127663,KDM4B,protein_coding,19,1,4969113,5153598,p13.3,lysine demethylase 4B [Source:HGNC Symbol;Acc:HGNC:29136],NA,KDM4B,23030,NM_015015
RNF19A_SIG,RNF19A,RNF19A_SIG,RNF19A,SIG,27,-0.327062021756128,0.537738099953037,0.538840356198188,0.534116400861826,-0.00472395533636212,0.782933000910785,-0.851743503792249,6.47422302179193,6.48785798555174,6.42942242658113,-0.0584355589706112,0.507161166561987,ENSG00000034677,RNF19A,protein_coding,8,-1,100257060,100336218,q22.2,ring finger protein 19A, RBR E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:13432],NA,RNF19A,25897,NM_001280539;NM_001353837;NM_001353838;NM_015435;NM_183419
HM13_SIG,HM13,HM13_SIG,HM13,SIG,24,0.324956446938074,0.214538397344968,0.213725984931508,0.217207752417764,0.00348176748625564,0.784510581544594,1.76118872893838,6.85107682301038,6.82854190070736,6.92512013914889,0.0965782384415242,0.147457153500915,ENSG00000101294,HM13,protein_coding,20,1,31514410,31577923,q11.21,histocompatibility minor 13 [Source:HGNC Symbol;Acc:HGNC:16435],NA,HM13,81502,NM_030789;NM_178580;NM_178581;NM_178582
TMX1_SIG,TMX1,TMX1_SIG,TMX1,SIG,41,0.322987826289781,0.369842743439247,0.368957487805562,0.372751440521355,0.00379395271579266,0.785979731211458,-0.322290223710915,5.52692980084779,5.53263567377644,5.50818193265365,-0.0244537411227928,0.814653952229785,ENSG00000139921,TMX1,protein_coding,14,1,51240162,51257655,q22.1,thioredoxin related transmembrane protein 1 [Source:HGNC Symbol;Acc:HGNC:15487],NA,TMX1,81542,NM_030755
IL11_SIG,IL11,IL11_SIG,IL11,SIG,10,0.320666664990107,0.111365412267805,0.110214960234727,0.115145468947922,0.00493050871319487,0.787612478077487,-0.535327995554561,0.298812888795627,0.307232072847077,0.271149855483719,-0.036082217363358,0.688998048004355,ENSG00000095752,IL11,protein_coding,19,-1,55364382,55370463,q13.42,interleukin 11 [Source:HGNC Symbol;Acc:HGNC:5966],Craniosynostosis and dental anomalies,IL11,3589,NM_000641;NM_001267718
PCK2_SIG,PCK2,PCK2_SIG,PCK2,SIG,11,0.320611131807736,0.3159010074092,0.31524040324818,0.318071563938268,0.00283116069008833,0.787612478077487,0.0606438913368706,4.10984164746561,4.10860332701242,4.11391041466895,0.00530708765653186,0.966454708296124,ENSG00000100889,PCK2,protein_coding,14,1,24094053,24110598,q11.2,phosphoenolpyruvate carboxykinase 2, mitochondrial [Source:HGNC Symbol;Acc:HGNC:8725],Phosphoenolpyruvate carboxykinase deficiency;PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY MITOCHONDRIAL,PCK2,5106,NM_001018073;NM_001291556;NM_001308054;NM_004563
BRAF_SIG,BRAF,BRAF_SIG,BRAF,SIG,31,0.320564010171285,0.430924402751581,0.430318151615687,0.432916370769518,0.00259821915383084,0.787612478077487,1.34939865052725,6.21546228772664,6.1957528138553,6.2802219875896,0.0844691737342949,0.275657031770273,ENSG00000157764,BRAF,protein_coding,7,-1,140719327,140924928,q34,B-Raf proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:1097],CARDIOFACIOCUTANEOUS SYNDROME;CARDIOFACIOCUTANEOUS SYNDROME 1;Classic hairy cell leukemia;Craniopharyngioma;Differentiated thyroid carcinoma;Hashimoto-Pritzker syndrome;LEOPARD SYNDROME 3;LEOPARD SYNDROME TYPE 3;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED;Noonan Syndrome;NOONAN SYNDROME 1;NOONAN SYNDROME 7;NOONAN SYNDROME TYPE 7;Noonan syndrome with multiple lentigines;Pilomyxoid astrocytoma,BRAF,673,NM_001354609;NM_004333
VCPIP1_SIG,VCPIP1,VCPIP1_SIG,VCPIP1,SIG,29,-0.320300162910298,0.421922524818129,0.42277941624891,0.419107024402704,-0.0036723918462059,0.787722860354094,-0.0965379244676207,6.54745430583196,6.54902140349178,6.54230527066397,-0.00671613282780987,0.945915954082397,ENSG00000175073,VCPIP1,protein_coding,8,-1,66628487,66667231,q13.1,valosin containing protein interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:30897],NA,VCPIP1,80124,NM_025054
MFNG_SIG,MFNG,MFNG_SIG,MFNG,SIG,20,0.319510635012565,0.402376451497026,0.401914580938925,0.403894026187928,0.00197944524900297,0.788252454736467,-0.229729027974531,6.44655707275392,6.45074406491354,6.4327998128009,-0.0179442521126471,0.870363302629774,ENSG00000100060,MFNG,protein_coding,22,-1,37469063,37486401,q13.1,MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7038],NA,MFNG,4242,NM_001166343;NM_002405
RAB40C_SIG,RAB40C,RAB40C_SIG,RAB40C,SIG,30,0.319289130064601,0.335412794141508,0.334699133421479,0.337757679364463,0.00305854594298398,0.788329030112158,0.258800011252102,4.81315078837598,4.80937045171979,4.82557189453202,0.0162014428122354,0.852453020072268,ENSG00000197562,RAB40C,protein_coding,16,1,589357,629272,p13.3,RAB40C, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:18285],NA,RAB40C,57799,NM_001172663;NM_001172664;NM_001172665;NM_001172666;NM_021168
PPP3CB_SIG,PPP3CB,PPP3CB_SIG,PPP3CB,SIG,24,-0.318673111181015,0.46074981307974,0.461835197332137,0.457183550536151,-0.00465164679598598,0.788631909267557,-1.15284089864449,5.80568815816632,5.82078521643545,5.75608353813918,-0.0647016782962685,0.358053699391392,ENSG00000107758,PPP3CB,protein_coding,10,-1,73436428,73496024,q22.2,protein phosphatase 3 catalytic subunit beta [Source:HGNC Symbol;Acc:HGNC:9315],NA,PPP3CB,5532,NM_001142353;NM_001142354;NM_001289968;NM_001289969;NM_021132
ZNF662_TF,ZNF662,ZNF662_TF,ZNF662,TF,127,0.318658332961862,-0.0282805979728623,-0.0289801071309288,-0.0259822107392152,0.00299789639171346,0.788631909267557,-1.78580601516562,2.70861133661628,2.7755699542088,2.48860445024084,-0.286965503967968,0.141489525022884,ENSG00000182983,ZNF662,protein_coding,3,1,42905731,42917641,p22.1,zinc finger protein 662 [Source:HGNC Symbol;Acc:HGNC:31930],NA,ZNF662,389114,NM_001134656;NM_207404
EIF4B_SIG,EIF4B,EIF4B_SIG,EIF4B,SIG,9,0.317367329401285,1.47809188510284,1.47686825230187,1.48211239287746,0.00524414057559157,0.789561440138214,-0.432377926940131,9.35142390171953,9.35733132573075,9.33201379425411,-0.0253175314766417,0.748965765880092,ENSG00000063046,EIF4B,protein_coding,12,1,53006158,53042209,q13.13,eukaryotic translation initiation factor 4B [Source:HGNC Symbol;Acc:HGNC:3285],NA,EIF4B,1975,NM_001300821;NM_001330654;NM_001417
SMARCA1_SIG,SMARCA1,SMARCA1_SIG,SMARCA1,SIG,34,0.315084894281485,-0.129428584261047,-0.12983879504264,-0.128080748835814,0.00175804620682632,0.791282360200448,2.02876179854635,1.02912563696881,0.966462193075056,1.23501980976257,0.268557616687517,0.092106038128241,ENSG00000102038,SMARCA1,protein_coding,X,-1,129446501,129523500,q26.1,SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 [Source:HGNC Symbol;Acc:HGNC:11097],NA,SMARCA1,6594,NM_001282874;NM_001282875;NM_003069
CDK15_SIG,CDK15,CDK15_SIG,CDK15,SIG,41,-0.314336269316504,-0.0791239702497867,-0.0783398860108089,-0.0817002470349993,-0.0033603610241904,0.791779490697386,-1.68874687977404,0.777640373738299,0.821743341542448,0.632730622381809,-0.189012719160639,0.166091809558715,ENSG00000138395,CDK15,protein_coding,2,1,201790461,201895550,q33.1,cyclin dependent kinase 15 [Source:HGNC Symbol;Acc:HGNC:14434],NA,CDK15,65061,NM_001261435;NM_001261436;NM_001366386;NM_139158
RLIM_SIG,RLIM,RLIM_SIG,RLIM,SIG,68,0.313537788814184,0.554663801751008,0.553592313290307,0.558184406693312,0.00459209340300572,0.792316437609889,0.928542923688967,6.46649055736539,6.4500408706788,6.52053952790703,0.0704986572282289,0.466389379416455,ENSG00000131263,RLIM,protein_coding,X,-1,74585217,74614617,q13.2,ring finger protein, LIM domain interacting [Source:HGNC Symbol;Acc:HGNC:13429],Intellectual disability;Non-specific syndromic intellectual disability;TONNE-KALSCHEUER SYNDROME,RLIM,51132,NM_016120;NM_183353
PNP_SIG,PNP,PNP_SIG,PNP,SIG,35,0.312447617799194,0.11744128802099,0.116653941000313,0.120028285374645,0.00337434437433259,0.793086318769923,0.65238255165605,6.7533042296151,6.73790034266783,6.80391700101327,0.0660166583454399,0.619519043528908,ENSG00000198805,PNP,protein_coding,14,1,20468954,20477094,q11.2,purine nucleoside phosphorylase [Source:HGNC Symbol;Acc:HGNC:7892],PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY,PNP,4860,NM_000270
ITGA2B_SIG,ITGA2B,ITGA2B_SIG,ITGA2B,SIG,36,-0.312182542633424,-0.0641446819058755,-0.0632651338452585,-0.0670346255336168,-0.00376949168835848,0.793197387581029,0.400472024409064,4.84223091869663,4.82151405052458,4.91030062840479,0.0887865778802181,0.767971742617551,ENSG00000005961,ITGA2B,protein_coding,17,-1,44372180,44389505,q21.31,integrin subunit alpha 2b [Source:HGNC Symbol;Acc:HGNC:6138],Autosomal dominant macrothrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 16;Fetal and neonatal alloimmune thrombocytopenia;GLANZMANN THROMBASTHENIA,ITGA2B,3674,NM_000419
CANX_SIG,CANX,CANX_SIG,CANX,SIG,38,0.311443675778044,0.338367797918207,0.337741922104106,0.340424247021684,0.00268232491757864,0.793686773763904,0.917319940577707,9.66897408383653,9.65646303180411,9.71008182622877,0.0536187944246649,0.472638358652627,ENSG00000127022,CANX,protein_coding,5,1,179678628,179731641,q35.3,calnexin [Source:HGNC Symbol;Acc:HGNC:1473],NA,CANX,821,NM_001024649;NM_001363993;NM_001363994;NM_001363996;NM_001363997;NM_001363998;NM_001363999;NM_001364000;NM_001364001;NM_001746
DNTTIP1_TF,DNTTIP1,DNTTIP1_TF,DNTTIP1,TF,85,-0.309047040044161,0.00180107925979422,0.00233237451558246,5.53948479185732e-05,-0.0022769796676638,0.795500298165606,0.141992836653617,5.00753993029616,5.00560173040416,5.01390830136985,0.00830657096568291,0.920375053654569,ENSG00000101457,DNTTIP1,protein_coding,20,1,45791954,45811427,q13.12,deoxynucleotidyltransferase terminal interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:16160],NA,DNTTIP1,116092,NM_052951
MRPL44_SIG,MRPL44,MRPL44_SIG,MRPL44,SIG,22,0.308921061187936,0.322858676483648,0.322286161233542,0.324739798019708,0.00245363678616556,0.795500298165606,1.47710036087279,4.98233418027315,4.96498609526166,5.0393350310252,0.0743489357635436,0.229485371178598,ENSG00000135900,MRPL44,protein_coding,2,1,223957463,223967714,q36.1,mitochondrial ribosomal protein L44 [Source:HGNC Symbol;Acc:HGNC:16650],Combined oxidative phosphorylation deficiency 16;Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,MRPL44,65080,NM_022915
KL_SIG,KL,KL_SIG,KL,SIG,30,-0.308563460483084,-0.092077970694776,-0.0916573140842059,-0.0934601281295065,-0.00180281404530056,0.795685161440626,-1.28898839733414,0.638092524460635,0.663142072477532,0.555786866690831,-0.107355205786701,0.299375952574952,ENSG00000133116,KL,protein_coding,13,1,33016423,33066143,q13.1,klotho [Source:HGNC Symbol;Acc:HGNC:6344],Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome;TUMORAL CALCINOSIS HYPERPHOSPHATEMIC FAMILIAL 3,KL,9365,NM_004795
MAN2A2_SIG,MAN2A2,MAN2A2_SIG,MAN2A2,SIG,20,-0.306244915904087,0.0150479957333576,0.0154511456250399,0.0137233603749729,-0.00172778525006708,0.797437210376286,-0.948253551727205,8.24815049232229,8.26060231175257,8.20723737133706,-0.0533649404155075,0.456660637968906,ENSG00000196547,MAN2A2,protein_coding,15,1,90902218,90922584,q26.1,mannosidase alpha class 2A member 2 [Source:HGNC Symbol;Acc:HGNC:6825],NA,MAN2A2,4122,NM_001320977;NM_006122
ATP2B2_SIG,ATP2B2,ATP2B2_SIG,ATP2B2,SIG,30,0.302397666967074,0.0341445292245336,0.0335865993926007,0.0359777272437416,0.00239112785114091,0.800302467732349,-0.814638002363519,0.328438085044978,0.340517704345726,0.288747907342522,-0.0517697970032034,0.527196570301238,ENSG00000157087,ATP2B2,protein_coding,3,-1,10324023,10708007,p25.3,ATPase plasma membrane Ca2+ transporting 2 [Source:HGNC Symbol;Acc:HGNC:815],Autosomal recessive non-syndromic sensorineural deafness type DFNB;DEAFNESS AUTOSOMAL RECESSIVE 12,ATP2B2,491,NM_001001331;NM_001330611;NM_001353564;NM_001683
JUN_TF,JUN,JUN_TF,JUN,TF,89,-0.302345452720404,0.0705518271620649,0.071031690797868,0.0689751323587116,-0.00205655843915624,0.800302467732349,0.339946718255647,9.4691143852064,9.45629457861846,9.5112366068525,0.0549420282340397,0.803787438826121,ENSG00000177606,JUN,protein_coding,1,-1,58780788,58784327,p32.1,Jun proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6204],NA,JUN,3725,NM_002228
POLD1_SIG,POLD1,POLD1_SIG,POLD1,SIG,31,0.302282631172308,0.499837379614491,0.498384558208191,0.504610935663765,0.00622637745557438,0.800302467732349,-0.330615996997112,5.51442174002816,5.52121507084992,5.49210079589953,-0.0291142749503894,0.809889891295686,ENSG00000062822,POLD1,protein_coding,19,1,50384204,50418016,q13.33,DNA polymerase delta 1, catalytic subunit [Source:HGNC Symbol;Acc:HGNC:9175],COLORECTAL CANCER SUSCEPTIBILITY TO 10;Mandibular hypoplasia-deafness-progeroid syndrome;Mandibular hypoplasia deafness progeroid features and lipodystrophy syndrome;Polymerase proofreading-related adenomatous polyposis;SUBCUTANEOUS LIPODYSTROPHY DEAFNESS MANDIBULAR HYPOPLASIA AND MALE HYPOGONADISM,POLD1,5424,NM_001256849;NM_001308632;NM_002691
RNF10_SIG,RNF10,RNF10_SIG,RNF10,SIG,19,-0.301765499919702,0.157896387266101,0.158660264204093,0.155386505898415,-0.00327375830567766,0.800614827452246,-0.666452019160186,7.79390067903082,7.80225358845264,7.76645540521628,-0.0357981832363557,0.611276465928471,ENSG00000022840,RNF10,protein_coding,12,1,120533480,120577588,q24.31,ring finger protein 10 [Source:HGNC Symbol;Acc:HGNC:10055],NA,RNF10,9921,NM_001330474;NM_014868
MRPS6_SIG,MRPS6,MRPS6_SIG,MRPS6,SIG,7,-0.30133494229521,0.135122676549127,0.135910973192903,0.132532559005294,-0.00337841418760883,0.800857901175215,-0.383185331430881,4.12236081457344,4.1289202985601,4.10080822433157,-0.0281120742285303,0.778607580724921,ENSG00000243927,MRPS6,protein_coding,21,1,34073224,34143034,q22.11,mitochondrial ribosomal protein S6 [Source:HGNC Symbol;Acc:HGNC:14051],NA,MRPS6,64968,NM_032476
XAB2_SIG,XAB2,XAB2_SIG,XAB2,SIG,39,0.301111998113581,0.383244630167316,0.382543434554375,0.385548558609834,0.0030051240554594,0.800934844081463,1.5349080750189,6.12323003153632,6.10844678752737,6.17180354756572,0.0633567600383485,0.210580271815718,ENSG00000076924,XAB2,protein_coding,19,-1,7619525,7629545,p13.2,XPA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:14089],NA,XAB2,56949,NM_020196
ROBO3_SIG,ROBO3,ROBO3_SIG,ROBO3,SIG,51,0.299877216414908,0.000415773674351469,-0.000141227734567097,0.00224592116079819,0.00238714889536523,0.801821412091173,-0.758709751808403,3.6191884928315,3.6473853908413,3.52654154222788,-0.120843848613413,0.558461567432117,ENSG00000154134,ROBO3,protein_coding,11,1,124865432,124881471,q24.2,roundabout guidance receptor 3 [Source:HGNC Symbol;Acc:HGNC:13433],Familial Horizontal Gaze Palsy with Progressive Scoliosis;GAZE PALSY FAMILIAL HORIZONTAL WITH PROGRESSIVE SCOLIOSIS 1;Horizontal gaze palsy with progressive scoliosis,ROBO3,64221,NM_022370
TUBA1B_SIG,TUBA1B,TUBA1B_SIG,TUBA1B,SIG,32,-0.299430480166232,0.385841714728565,0.386698105118366,0.383027860590645,-0.00367024452772112,0.802077383760498,-0.253052686769641,9.2575417041694,9.26259280105798,9.24094524296405,-0.0216475580939352,0.855922224186735,ENSG00000123416,TUBA1B,protein_coding,12,-1,49127782,49131397,q13.12,tubulin alpha 1b [Source:HGNC Symbol;Acc:HGNC:18809],NA,TUBA1B,10376,NM_006082
GPR12_SIG,GPR12,GPR12_SIG,GPR12,SIG,44,-0.298857765844035,2.02733410661612e-05,0.000490826612775231,-0.00152583026597793,-0.00201665687875325,0.802434159791819,-0.394345739627498,0.839759846566649,0.852231427163105,0.798781796035435,-0.0534496311276697,0.771800207292079,ENSG00000132975,GPR12,protein_coding,13,-1,26755200,26760786,q12.13,G protein-coupled receptor 12 [Source:HGNC Symbol;Acc:HGNC:4466],NA,GPR12,2835,NM_005288
CBLL1_SIG,CBLL1,CBLL1_SIG,CBLL1,SIG,26,0.298067359641466,0.367804553735354,0.367388209741132,0.36917254114494,0.0017843314038071,0.802965161333046,0.663447042822691,5.6835983571924,5.67425823777993,5.71428732097622,0.0400290831962974,0.612794789842647,ENSG00000105879,CBLL1,protein_coding,7,1,107743949,107761667,q22.3,Cbl proto-oncogene like 1 [Source:HGNC Symbol;Acc:HGNC:21225],NA,CBLL1,79872,NM_001284291;NM_024814
RNF181_SIG,RNF181,RNF181_SIG,RNF181,SIG,18,0.297724875171054,0.156000729190218,0.155706694294812,0.156966843846551,0.00126014955173916,0.803137640773802,0.820858171070772,5.09006187537532,5.08211524509121,5.11617223202312,0.0340569869319128,0.523835308580561,ENSG00000168894,RNF181,protein_coding,2,1,85595725,85597613,p11.2,ring finger protein 181 [Source:HGNC Symbol;Acc:HGNC:28037],NA,RNF181,51255,NM_016494
SLC22A18_SIG,SLC22A18,SLC22A18_SIG,SLC22A18,SIG,16,-0.297559898768387,0.188068512400202,0.188664771219382,0.186109376280038,-0.00255539493934351,0.803168035781865,1.8947913883539,3.45140222752372,3.40663049059677,3.59850936314085,0.19187887254408,0.117324092406433,ENSG00000110628,SLC22A18,protein_coding,11,1,2899721,2925246,p15.4,solute carrier family 22 member 18 [Source:HGNC Symbol;Acc:HGNC:10964],Breast Cancer;embryonal rhabdomyosarcoma;Hereditary breast cancer;LUNG CANCER ALVEOLAR CELL CARCINOMA INCLUDED;RHABDOMYOSARCOMA EMBRYONAL 1,SLC22A18,5002,NM_001315501;NM_001315502;NM_002555;NM_183233
MAPK6_SIG,MAPK6,MAPK6_SIG,MAPK6,SIG,40,-0.296631315043367,0.394079649167016,0.395051774671295,0.390885522510101,-0.00416625216119402,0.803809589172885,0.493783614222251,6.363393267544,6.35446576696265,6.39272648373987,0.0382607167772236,0.713035537194382,ENSG00000069956,MAPK6,protein_coding,15,1,51952106,52067375,q21.2,mitogen-activated protein kinase 6 [Source:HGNC Symbol;Acc:HGNC:6879],NA,MAPK6,5597,NM_002748
GNRH1_SIG,GNRH1,GNRH1_SIG,GNRH1,SIG,27,0.295825803043569,0.170350607465988,0.16987165355063,0.171924313187879,0.00205265963724936,0.804352659436396,1.61293450841344,1.3766647773138,1.35522164152406,1.44712079490866,0.0918991533845997,0.186952632268542,ENSG00000147437,GNRH1,protein_coding,8,-1,25419258,25424654,p21.2,gonadotropin releasing hormone 1 [Source:HGNC Symbol;Acc:HGNC:4419],Hypogonadotropic hypogonadism 7 with or without anosmia;Normosmic congenital hypogonadotropic hypogonadism,GNRH1,2796,NM_000825;NM_001083111
DCAF12_SIG,DCAF12,DCAF12_SIG,DCAF12,SIG,28,0.295585140612085,0.268479421724782,0.267415859892737,0.271973982030072,0.00455812213733435,0.80444354917349,-0.0544994759732423,5.12564603959011,5.12723794434264,5.12041549540321,-0.00682244893942393,0.969872602764823,ENSG00000198876,DCAF12,protein_coding,9,-1,34086387,34127399,p13.3,DDB1 and CUL4 associated factor 12 [Source:HGNC Symbol;Acc:HGNC:19911],NA,DCAF12,25853,NM_015397
AGT_SIG,AGT,AGT_SIG,AGT,SIG,14,-0.295196005360649,-0.0329798212447282,-0.0324155715467616,-0.034833784538047,-0.00241821299128555,0.804652193329487,-2.31453061509142,0.378768156296387,0.431583093706038,0.205233361950392,-0.226349731755646,0.0524159789370815,ENSG00000135744,AGT,protein_coding,1,-1,230702523,230714122,q42.2,angiotensinogen [Source:HGNC Symbol;Acc:HGNC:333],HYPERTENSION ESSENTIAL;Renal tubular dysgenesis of genetic origin,AGT,183,NM_000029
ZNF229_TF,ZNF229,ZNF229_TF,ZNF229,TF,21,-0.29507021726566,-0.11490298604264,-0.114111451836708,-0.117503741290703,-0.0033922894539954,0.804652193329487,-0.36077628124792,1.23580671395099,1.24666079680452,1.20014329886082,-0.0465174979436958,0.791500507484291,ENSG00000278318,ZNF229,protein_coding,19,-1,44417519,44448578,q13.31,zinc finger protein 229 [Source:HGNC Symbol;Acc:HGNC:13022],NA,ZNF229,7772,NM_001278510;NM_014518
NT5DC2_SIG,NT5DC2,NT5DC2_SIG,NT5DC2,SIG,17,0.29405842340545,0.00307545606843028,0.00254261932299923,0.00482620537484659,0.00228358605184751,0.80529905828548,2.93635014762723,4.39590561038208,4.30162923317335,4.7056708497822,0.404041616608853,0.0126761660090982,ENSG00000168268,NT5DC2,protein_coding,3,-1,52524385,52535054,p21.1,5'-nucleotidase domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25717],NA,NT5DC2,64943,NM_001134231;NM_022908
AFF4_TF,AFF4,AFF4_TF,AFF4,TF,147,0.294007736302932,0.3356712748858,0.334839854607659,0.338403084371121,0.00356322976346196,0.80529905828548,1.41983829460209,7.15305574432253,7.1291340126319,7.23165571987745,0.102521707245551,0.24915454078296,ENSG00000072364,AFF4,protein_coding,5,-1,132875395,132963634,q31.1,AF4/FMR2 family member 4 [Source:HGNC Symbol;Acc:HGNC:17869],CHOPS SYNDROME;Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome;Cornelia de Lange-like syndrome,AFF4,27125,NM_014423
RBFOX3_SIG,RBFOX3,RBFOX3_SIG,RBFOX3,SIG,34,0.293625786353846,-0.0328408793471786,-0.0333393163461045,-0.0312031577792794,0.00213615856682519,0.805502965458609,0.447625542739725,0.428945315618173,0.41844342216255,0.463451536972362,0.0450081148098119,0.740331336336844,ENSG00000167281,RBFOX3,protein_coding,17,-1,79089345,79516148,q25.3,RNA binding fox-1 homolog 3 [Source:HGNC Symbol;Acc:HGNC:27097],NA,RBFOX3,146713,NM_001082575;NM_001350451;NM_001350453
HCN2_SIG,HCN2,HCN2_SIG,HCN2,SIG,6,0.292615496308661,0.124264685627282,0.123817341682425,0.125734530017525,0.00191718833509912,0.80620984962915,-0.494517540197986,0.897224685776229,0.904925917284859,0.871920639390732,-0.0330052778941266,0.712684596928566,ENSG00000099822,HCN2,protein_coding,19,1,589881,617159,p13.3,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 [Source:HGNC Symbol;Acc:HGNC:4846],NA,HCN2,610,NM_001194
PTMA_SIG,PTMA,PTMA_SIG,PTMA,SIG,25,-0.291477232733748,0.403586133508655,0.404048347519435,0.40206743033038,-0.0019809171890545,0.80701926726003,-1.25188468124904,10.2230337906913,10.2397318181635,10.1681688432827,-0.0715629748807771,0.314714493548109,ENSG00000187514,PTMA,protein_coding,2,1,231706895,231713541,q37.1,prothymosin alpha [Source:HGNC Symbol;Acc:HGNC:9623],NA,PTMA,5757,NM_001099285;NM_002823
OGDH_SIG,OGDH,OGDH_SIG,OGDH,SIG,52,-0.286957486047036,0.37567839467747,0.37659352560128,0.372671535927807,-0.00392198967347338,0.810538389089794,0.342576367797433,6.72405365919005,6.71636179672159,6.74932692158641,0.0329651248648117,0.802168868447218,ENSG00000105953,OGDH,protein_coding,7,1,44606572,44709066,p13,oxoglutarate dehydrogenase [Source:HGNC Symbol;Acc:HGNC:8124],ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY;Oxoglutaric aciduria,OGDH,4967,NM_001003941;NM_001165036;NM_002541
HERC1_SIG,HERC1,HERC1_SIG,HERC1,SIG,34,-0.286057172135915,0.503154503364432,0.503607052301064,0.501667556858355,-0.00193949544270901,0.811157752100029,-0.494920009783451,7.3370532840019,7.34498258138244,7.31099987832299,-0.0339827030594463,0.712508643360322,ENSG00000103657,HERC1,protein_coding,15,-1,63608618,63833948,q22.31,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 [Source:HGNC Symbol;Acc:HGNC:4867],MACROCEPHALY DYSMORPHIC FACIES AND PSYCHOMOTOR RETARDATION;Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,HERC1,8925,NM_003922
SLC16A13_SIG,SLC16A13,SLC16A13_SIG,SLC16A13,SIG,37,0.283293801797992,0.191836228891162,0.190709314878563,0.195538946361129,0.00482963148256625,0.813271540077607,-0.152017731104434,1.62450152713585,1.62784365201975,1.61352025966018,-0.0143233923595654,0.91486706812632,ENSG00000174327,SLC16A13,protein_coding,17,1,7036075,7040121,p13.1,solute carrier family 16 member 13 [Source:HGNC Symbol;Acc:HGNC:31037],NA,SLC16A13,201232,NM_201566
MKNK1_SIG,MKNK1,MKNK1_SIG,MKNK1,SIG,28,-0.282351919767341,0.128368257809699,0.128845645997346,0.126799696621716,-0.00204594937563043,0.813924510258552,2.82160946187572,6.05105158588403,6.01068676193703,6.18367886456701,0.172992102629985,0.01680621974599,ENSG00000079277,MKNK1,protein_coding,1,-1,46557408,46616843,p33,MAP kinase interacting serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:7110],NA,MKNK1,8569,NM_001135553;NM_003684;NM_198973
PDHA1_SIG,PDHA1,PDHA1_SIG,PDHA1,SIG,33,-0.282046282886908,0.184840539982902,0.185499747232483,0.182674573305708,-0.00282517392677551,0.814048985641569,0.709369270449009,6.28185075233405,6.27219115670838,6.31358942367554,0.0413982669671586,0.586498901815558,ENSG00000131828,PDHA1,protein_coding,X,1,19343893,19361705,p22.12,pyruvate dehydrogenase E1 alpha 1 subunit [Source:HGNC Symbol;Acc:HGNC:8806],Intellectual disabiltiy;Leigh syndrome with leukodystrophy;PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY;Pyruvate Dehydrogenase E1-Alpha Deficiency in females;X-linked Leigh syndrome,PDHA1,5160,NM_000284;NM_001173454;NM_001173455;NM_001173456
AHR_TF,AHR,AHR_TF,AHR,TF,125,0.281940517065182,0.111109365953252,0.110736066523282,0.112335921223154,0.0015998546998717,0.814048985641569,2.33420375458517,7.12393554364097,7.03947702590899,7.4014421019032,0.361965075994215,0.0504414018666365,ENSG00000106546,AHR,protein_coding,7,1,16916359,17346152,p21.1,aryl hydrocarbon receptor [Source:HGNC Symbol;Acc:HGNC:348],Retinitis pigmentosa,AHR,196,NM_001621
EPCAM_SIG,EPCAM,EPCAM_SIG,EPCAM,SIG,12,0.281730715737364,-0.118636310198444,-0.119127962769094,-0.117020880323453,0.00210708244564011,0.814114503447711,1.39469461609855,1.22425928650176,1.1715414111213,1.39747516275184,0.225933751630536,0.258601515849652,ENSG00000119888,EPCAM,protein_coding,2,1,47345158,47387601,p21,epithelial cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:11529],COLORECTAL CANCER HEREDITARY NONPOLYPOSIS TYPE 8;Congenital tufting enteropathy;DIARRHEA 5 WITH TUFTING ENTEROPATHY CONGENITAL;Lynch syndrome,EPCAM,4072,NM_002354
EIF1B_SIG,EIF1B,EIF1B_SIG,EIF1B,SIG,14,-0.281397455178836,-0.0533886262985604,-0.0525390211604231,-0.0561801860381543,-0.00364116487773121,0.814279058780009,0.469763535893464,6.15730711183655,6.14943426930325,6.1831750230174,0.0337407537141514,0.727225321935708,ENSG00000114784,EIF1B,protein_coding,3,1,40309707,40312424,p22.1,eukaryotic translation initiation factor 1B [Source:HGNC Symbol;Acc:HGNC:30792],NA,EIF1B,10289,NM_005875
TPCN2_SIG,TPCN2,TPCN2_SIG,TPCN2,SIG,17,0.280950053275125,0.0421445884963298,0.0415763671674903,0.0440116014339454,0.00243523426645524,0.814489281622931,0.128038670773708,5.02138530680854,5.01928580210824,5.02828367939524,0.00899787728700652,0.92819519466288,ENSG00000162341,TPCN2,protein_coding,11,1,69048932,69162440,q13.3,two pore segment channel 2 [Source:HGNC Symbol;Acc:HGNC:20820],SKIN/HAIR/EYE PIGMENTATION VARIATION IN 10,TPCN2,219931,NM_139075
EIF3K_SIG,EIF3K,EIF3K_SIG,EIF3K,SIG,30,0.280879077116406,0.574078108829664,0.573651536439341,0.575479703826438,0.00182816738709688,0.814489281622931,0.467213404105721,6.93049602572133,6.92601812502811,6.94520912799907,0.0191910029709588,0.728848141446628,ENSG00000178982,EIF3K,protein_coding,19,1,38619082,38636955,q13.2,eukaryotic translation initiation factor 3 subunit K [Source:HGNC Symbol;Acc:HGNC:24656],NA,EIF3K,27335,NM_001300992;NM_001308393;NM_013234
KHDRBS3_SIG,KHDRBS3,KHDRBS3_SIG,KHDRBS3,SIG,51,-0.280453165196192,-0.120018125635896,-0.119530976341906,-0.121618759030436,-0.00208778268852981,0.814728112003766,-0.86787719239955,1.31232668688197,1.34226220158973,1.21396713855645,-0.128295063033288,0.499055052349411,ENSG00000131773,KHDRBS3,protein_coding,8,1,135457456,135656722,q24.23,KH RNA binding domain containing, signal transduction associated 3 [Source:HGNC Symbol;Acc:HGNC:18117],NA,KHDRBS3,10656,NM_006558
TUBB4B_SIG,TUBB4B,TUBB4B_SIG,TUBB4B,SIG,35,-0.28021721687561,-0.0110003073616865,-0.0106471412742385,-0.0121607102204441,-0.00151356894620556,0.814814545955452,-0.683300378874004,7.48234390219273,7.4961052217763,7.43712813784674,-0.0589770839295606,0.60154514017241,ENSG00000188229,TUBB4B,protein_coding,9,1,137241287,137243707,q34.3,tubulin beta 4B class IVb [Source:HGNC Symbol;Acc:HGNC:20771],LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS,TUBB4B,10383,NM_006088
DPEP2_SIG,DPEP2,DPEP2_SIG,DPEP2,SIG,49,0.279671774207394,0.127603856698505,0.127096703256882,0.129270218006695,0.00217351474981311,0.815149216896849,1.83811493095086,5.17894127425855,5.13660328320856,5.31805181627995,0.181448533071394,0.129277486287308,ENSG00000167261,DPEP2,protein_coding,16,-1,67987394,68000586,q22.1,dipeptidase 2 [Source:HGNC Symbol;Acc:HGNC:23028],NA,DPEP2,64174,NM_001324159;NM_022355
FANCG_SIG,FANCG,FANCG_SIG,FANCG,SIG,54,0.277389851018411,0.390261739592699,0.388900376669741,0.394734789196705,0.005834412526964,0.816831774151655,1.47594298687347,4.57211430313954,4.54719351349971,4.65399689767041,0.106803384170707,0.229863229757872,ENSG00000221829,FANCG,protein_coding,9,-1,35073835,35080016,p13.3,FA complementation group G [Source:HGNC Symbol;Acc:HGNC:3588],Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP G,FANCG,2189,NM_004629
CERS4_SIG,CERS4,CERS4_SIG,CERS4,SIG,67,0.277317966048972,-0.044538431117229,-0.0449621232103642,-0.0431462999540706,0.00181582325629368,0.816831774151655,0.0384362360238074,3.34259824213401,3.34114744963149,3.34736513178515,0.00621768215366059,0.979028553118907,ENSG00000090661,CERS4,protein_coding,19,1,8206736,8262421,p13.2,ceramide synthase 4 [Source:HGNC Symbol;Acc:HGNC:23747],NA,CERS4,79603,NM_024552
RGS14_SIG,RGS14,RGS14_SIG,RGS14,SIG,88,0.277046756236114,0.246156189981909,0.245355699146671,0.248786374154837,0.00343067500816575,0.816946358934415,2.14518866382115,5.99353277025087,5.94120357914754,6.16547154101896,0.224267961871427,0.0738072002983943,ENSG00000169220,RGS14,protein_coding,5,1,177357924,177372596,q35.3,regulator of G protein signaling 14 [Source:HGNC Symbol;Acc:HGNC:9996],NA,RGS14,10636,NM_001366617;NM_006480
RNF4_TF,RNF4,RNF4_TF,RNF4,TF,93,-0.275956289681158,0.365050046051206,0.365413055661616,0.36385730018843,-0.00155575547318589,0.817718360184915,0.379968493404242,6.18747362639953,6.18312106662223,6.20177489423922,0.0186538276169886,0.780452233187039,ENSG00000063978,RNF4,protein_coding,4,1,2462220,2625320,p16.3,ring finger protein 4 [Source:HGNC Symbol;Acc:HGNC:10067],NA,RNF4,6047,NM_001185009;NM_001185010;NM_002938
AAK1_SIG,AAK1,AAK1_SIG,AAK1,SIG,34,0.275556778995056,0.0611603136822387,0.0608375843238372,0.062220710145558,0.00138312582172082,0.817863134457776,0.66486557030431,5.2661597406494,5.25427017819072,5.30522544587078,0.0509552676800541,0.612173228603781,ENSG00000115977,AAK1,protein_coding,2,-1,69457997,69674349,p13.3,AP2 associated kinase 1 [Source:HGNC Symbol;Acc:HGNC:19679],NA,AAK1,22848,NM_014911
ITGA9_SIG,ITGA9,ITGA9_SIG,ITGA9,SIG,65,0.275518877677742,0.120446074521277,0.119465719270629,0.123667241773403,0.00420152250277375,0.817863134457776,-0.203120029264564,5.37601008395492,5.3864205188963,5.34180436914753,-0.0446161497487667,0.885247598590547,ENSG00000144668,ITGA9,protein_coding,3,1,37452115,37823507,p22.2,integrin subunit alpha 9 [Source:HGNC Symbol;Acc:HGNC:6145],NA,ITGA9,3680,NM_002207
MR1_SIG,MR1,MR1_SIG,MR1,SIG,35,0.275142479005566,0.431057223358602,0.430259408141098,0.433678616216115,0.00341920807501793,0.818062045810416,0.289801226690169,5.7007217015038,5.69592126321445,5.71649457016879,0.0205733069543408,0.834012299068768,ENSG00000153029,MR1,protein_coding,1,1,181033425,181061938,q25.3,major histocompatibility complex, class I-related [Source:HGNC Symbol;Acc:HGNC:4975],NA,MR1,3140,NM_001194999;NM_001195000;NM_001195035;NM_001310213;NM_001531
PSMD4_SIG,PSMD4,PSMD4_SIG,PSMD4,SIG,27,0.274914356379162,0.222329236068738,0.221658243618137,0.224533925549282,0.00287568193114513,0.818141961176488,0.148242900522183,5.9694968040599,5.96792215539596,5.97467064966998,0.00674849427401542,0.916876893851693,ENSG00000159352,PSMD4,protein_coding,1,1,151254703,151267479,q21.3,proteasome 26S subunit, non-ATPase 4 [Source:HGNC Symbol;Acc:HGNC:9561],NA,PSMD4,5710,NM_001330692;NM_002810
CFB_SIG,CFB,CFB_SIG,CFB,SIG,11,0.27412474903733,-0.0641202660679883,-0.0650701218217783,-0.0609993114483927,0.00407081037338545,0.81867240177816,0.696351503247556,0.345627547754497,0.335254220151706,0.379711338449383,0.0444571182976779,0.594249327509438,ENSG00000243649,CFB,protein_coding,6,1,31945650,31952084,p21.33,complement factor B [Source:HGNC Symbol;Acc:HGNC:1037],Atypical hemolytic uremic syndrome with B factor anomaly;COMPLEMENT FACTOR B DEFICIENCY;HEMOLYTIC UREMIC SYNDROME ATYPICAL SUSCEPTIBILITY TO 4;MACULAR DEGENERATION AGE-RELATED 14,CFB,629,NM_001710
ID1_TF,ID1,ID1_TF,ID1,TF,76,0.2733640658723,0.0693653173081723,0.0689753684025262,0.0706465779981525,0.00167120959562638,0.819179633342606,4.19580088567331,2.56847182562609,2.42230422718806,3.0487367919225,0.626432564734445,0.000292353433854343,ENSG00000125968,ID1,protein_coding,20,1,31605283,31606515,q11.21,inhibitor of DNA binding 1, HLH protein [Source:HGNC Symbol;Acc:HGNC:5360],NA,ID1,3397,NM_002165;NM_181353
STK32B_SIG,STK32B,STK32B_SIG,STK32B,SIG,59,-0.272766392539587,0.080076073546699,0.0809957542166143,0.0770542656312629,-0.00394148858535124,0.819531862559183,-0.0419660880327678,2.98751482064374,2.98935336077648,2.98147390306472,-0.00787945771176624,0.976877545668769,ENSG00000152953,STK32B,protein_coding,4,1,5051480,5500994,p16.2,serine/threonine kinase 32B [Source:HGNC Symbol;Acc:HGNC:14217],NA,STK32B,55351,NM_001306082;NM_001345969;NM_018401
GNA14_SIG,GNA14,GNA14_SIG,GNA14,SIG,43,-0.272667841805756,-0.0589986146820601,-0.0583151203709916,-0.0612443817041423,-0.00292926133315084,0.819531862559183,-0.952593691078355,0.6624275338019,0.682602752971469,0.59613752795903,-0.0864652250124383,0.454361473589445,ENSG00000156049,GNA14,protein_coding,9,-1,77423079,77648322,q21.2,G protein subunit alpha 14 [Source:HGNC Symbol;Acc:HGNC:4382],Congenital vascular tumours;Kaposiform hemangioendothelioma;Tufted angioma,GNA14,9630,NM_004297
CD200_SIG,CD200,CD200_SIG,CD200,SIG,56,-0.272094300607662,0.0670675301544436,0.0679208310735667,0.0642638271344678,-0.00365700393909898,0.819888851696242,1.85953163025814,3.00721021937057,2.91495025993415,3.31035008609027,0.395399826156128,0.124870209050053,ENSG00000091972,CD200,protein_coding,3,1,112332347,112362812,q13.2,CD200 molecule [Source:HGNC Symbol;Acc:HGNC:7203],NA,CD200,4345,NM_001004196;NM_001318826;NM_001318828;NM_001318830;NM_001365853;NM_001365854;NM_001365855;NM_005944
RBCK1_SIG,RBCK1,RBCK1_SIG,RBCK1,SIG,43,0.271669919187303,0.306614622364799,0.306068146114511,0.308410187187174,0.00234204107266294,0.820126120874233,0.392768854940234,6.35633884130284,6.35168778755205,6.37162087505543,0.0199330875033806,0.772832712453413,ENSG00000125826,RBCK1,protein_coding,20,1,407498,430966,p13,RANBP2-type and C3HC4-type zinc finger containing 1 [Source:HGNC Symbol;Acc:HGNC:15864],Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis;POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY;Polyglucosan body myopathy type 1,RBCK1,10616,NM_001323956;NM_001323958;NM_001323960;NM_006462;NM_031229
PCBP2_SIG,PCBP2,PCBP2_SIG,PCBP2,SIG,67,-0.270988579645423,0.3398909483278,0.340711001066102,0.337196489330524,-0.00351451173557772,0.820507968663995,-0.45039184343735,7.5762915353632,7.58256827499921,7.55566796227348,-0.0269003127257239,0.738952364666964,ENSG00000197111,PCBP2,protein_coding,12,1,53452102,53481162,q13.13,poly(rC) binding protein 2 [Source:HGNC Symbol;Acc:HGNC:8648],NA,PCBP2,5094,NM_001098620;NM_001128911;NM_001128912;NM_001128913;NM_001128914;NM_005016;NM_031989
EXOSC9_SIG,EXOSC9,EXOSC9_SIG,EXOSC9,SIG,26,-0.270936587449319,0.48043263720956,0.480903069722461,0.478886930381458,-0.00201613934100323,0.820507968663995,-0.0157335344219161,5.20008138388992,5.20024756167652,5.19953537116249,-0.000712190514029538,0.991484635002324,ENSG00000123737,EXOSC9,protein_coding,4,1,121801317,121817021,q27,exosome component 9 [Source:HGNC Symbol;Acc:HGNC:9137],Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1D,EXOSC9,5393,NM_001034194;NM_005033
ATP6V1A_SIG,ATP6V1A,ATP6V1A_SIG,ATP6V1A,SIG,37,-0.27050316243407,0.402861967671034,0.403386523571859,0.401138426854039,-0.00224809671782056,0.820752434150048,1.34147386674151,6.27910203940268,6.25456964770749,6.3597084692583,0.105138821550812,0.278535244107906,ENSG00000114573,ATP6V1A,protein_coding,3,1,113747033,113812056,q13.31,ATPase H+ transporting V1 subunit A [Source:HGNC Symbol;Acc:HGNC:851],Autosomal recessive cutis laxa type 2 classic type;CUTIS LAXA AUTOSOMAL RECESSIVE TYPE IID;EPILEPTIC ENCEPHALOPATHY INFANTILE OR EARLY CHILDHOOD 3;Undetermined early-onset epileptic encephalopathy,ATP6V1A,523,NM_001690
RBM39_SIG,RBM39,RBM39_SIG,RBM39,SIG,58,0.269232871497519,0.527679356647406,0.526812510057662,0.530527566870851,0.00371505681318895,0.821668485074198,1.05710655733925,8.72651415775722,8.71179855458,8.7748654253395,0.0630668707594958,0.40267726532618,ENSG00000131051,RBM39,protein_coding,20,-1,35701347,35742312,q11.22,RNA binding motif protein 39 [Source:HGNC Symbol;Acc:HGNC:15923],NA,RBM39,9584,NM_001242599;NM_001242600;NM_001323422;NM_001323423;NM_001323424;NM_004902;NM_184234
DGKQ_SIG,DGKQ,DGKQ_SIG,DGKQ,SIG,30,0.267565180767604,0.0831802831676553,0.0828886697694765,0.084138441475957,0.00124977170648053,0.822903699105251,1.06584436500911,5.02655552274042,5.00939185200592,5.08295044086806,0.0735585888621415,0.398711958398857,ENSG00000145214,DGKQ,protein_coding,4,-1,958887,986895,p16.3,diacylglycerol kinase theta [Source:HGNC Symbol;Acc:HGNC:2856],NA,DGKQ,1609,NM_001347
PABPC1_SIG,PABPC1,PABPC1_SIG,PABPC1,SIG,7,0.266372172595853,0.825459676670915,0.824840798892833,0.82749313222747,0.00265233333463708,0.82375556342316,-0.245875500798868,11.6099157275917,11.6128352832733,11.6003229017805,-0.0125123814928703,0.860408944689228,ENSG00000070756,PABPC1,protein_coding,8,-1,100685816,100722809,q22.3,poly(A) binding protein cytoplasmic 1 [Source:HGNC Symbol;Acc:HGNC:8554],NA,PABPC1,26986,NM_002568
PI4K2B_SIG,PI4K2B,PI4K2B_SIG,PI4K2B,SIG,11,0.266246084598914,0.272285463241726,0.271578400711733,0.274608668697418,0.0030302679856855,0.82375556342316,0.84282991787119,4.69143333204488,4.68097108925658,4.72580927263501,0.0448381833784285,0.512294390162659,ENSG00000038210,PI4K2B,protein_coding,4,1,25234033,25279204,p15.2,phosphatidylinositol 4-kinase type 2 beta [Source:HGNC Symbol;Acc:HGNC:18215],NA,PI4K2B,55300,NM_018323
ETF1_SIG,ETF1,ETF1_SIG,ETF1,SIG,57,-0.266106457616127,0.360733097589103,0.361590109770279,0.357917200422381,-0.0036729093478986,0.823764009388108,0.751530000836776,7.25568068526837,7.24265090369246,7.29849282473206,0.0558419210395947,0.562602576510775,ENSG00000120705,ETF1,protein_coding,5,-1,138506095,138543236,q31.2,eukaryotic translation termination factor 1 [Source:HGNC Symbol;Acc:HGNC:3477],NA,ETF1,2107,NM_001256302;NM_001282185;NM_001291974;NM_001291975;NM_001364160;NM_004730
ASB6_SIG,ASB6,ASB6_SIG,ASB6,SIG,14,-0.265712225460526,0.222324580286498,0.222798920338772,0.220766034400455,-0.00203288593831711,0.823976864503464,1.3199948364849,4.82710298604962,4.81357875158373,4.87153975643753,0.0579610048537927,0.286997422214632,ENSG00000148331,ASB6,protein_coding,9,-1,129634604,129642169,q34.11,ankyrin repeat and SOCS box containing 6 [Source:HGNC Symbol;Acc:HGNC:17181],NA,ASB6,140459,NM_001202403;NM_017873;NM_177999
MGAT5_SIG,MGAT5,MGAT5_SIG,MGAT5,SIG,44,-0.265331016800634,0.125368959728773,0.125629090694801,0.124514243697538,-0.00111484699726289,0.824161121557216,1.04133694613616,6.19284230484242,6.17638355932765,6.24692104010525,0.0705374807776007,0.410271135839483,ENSG00000152127,MGAT5,protein_coding,2,1,134119983,134454621,q21.2,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:7049],NA,MGAT5,4249,NM_002410
PEPD_SIG,PEPD,PEPD_SIG,PEPD,SIG,32,0.265224448386357,0.228516153539788,0.228072845984955,0.229972735505669,0.00189988952071419,0.824161121557216,0.243723933759037,4.92719128671173,4.92258516505785,4.94232568643165,0.0197405213737997,0.861704432317375,ENSG00000124299,PEPD,protein_coding,19,-1,33386950,33521895,q13.11,peptidase D [Source:HGNC Symbol;Acc:HGNC:8840],PROLIDASE DEFICIENCY,PEPD,5184,NM_000285;NM_001166056;NM_001166057
ZFYVE1_TF,ZFYVE1,ZFYVE1_TF,ZFYVE1,TF,61,0.264102495124016,0.372273248559567,0.371949969695991,0.373335450539887,0.00138548084389547,0.824958156042881,0.718205398604051,4.79343993982742,4.78511496397705,4.82079343190719,0.0356784679301379,0.58120283644561,ENSG00000165861,ZFYVE1,protein_coding,14,-1,72969451,73027131,q24.2,zinc finger FYVE-type containing 1 [Source:HGNC Symbol;Acc:HGNC:13180],NA,ZFYVE1,53349,NM_001281734;NM_001281735;NM_021260;NM_178441
MRPL14_SIG,MRPL14,MRPL14_SIG,MRPL14,SIG,26,-0.262223450900831,0.189628140756171,0.190153888442667,0.18790068407197,-0.00225320437069618,0.826293510096259,-1.39297544210853,3.49543326328633,3.51651644031017,3.42615996735089,-0.0903564729592808,0.259302368841307,ENSG00000180992,MRPL14,protein_coding,6,-1,44113451,44127452,p21.1,mitochondrial ribosomal protein L14 [Source:HGNC Symbol;Acc:HGNC:14279],NA,MRPL14,64928,NM_001318767;NM_001318768;NM_001318769;NM_001318770;NM_032111
SLU7_SIG,SLU7,SLU7_SIG,SLU7,SIG,27,-0.262180963023189,0.490167365739706,0.490585043088,0.488794997309599,-0.00179004577840087,0.826293510096259,1.4596147537641,6.49901585984411,6.48152711138614,6.55647889049173,0.0749517791055964,0.235490326620924,ENSG00000164609,SLU7,protein_coding,5,-1,160401641,160421711,q33.3,SLU7 homolog, splicing factor [Source:HGNC Symbol;Acc:HGNC:16939],NA,SLU7,10569,NM_001364517;NM_001364520;NM_001364521;NM_001364523;NM_006425
SMC3_SIG,SMC3,SMC3_SIG,SMC3,SIG,37,0.261613890841474,0.47567428987325,0.475209457862137,0.477201595052622,0.00199213719048511,0.826638359842332,0.961864698193093,6.82277679741136,6.81087019148034,6.86189850261327,0.0510283111329253,0.449883778301752,ENSG00000108055,SMC3,protein_coding,10,1,110567691,110604636,q25.2,structural maintenance of chromosomes 3 [Source:HGNC Symbol;Acc:HGNC:2468],Cornelia de Lange syndrome;CORNELIA DE LANGE SYNDROME 3;CORNELIA DE LANGE SYNDROME TYPE 3,SMC3,9126,NM_005445
SF3B2_SIG,SF3B2,SF3B2_SIG,SF3B2,SIG,21,0.261492787450509,0.454290575784548,0.454070124182814,0.455014916761675,0.000944792578861166,0.826638359842332,1.76906535311928,8.10521503584264,8.09351686991139,8.1436518667596,0.0501349968482075,0.145663687892224,ENSG00000087365,SF3B2,protein_coding,11,1,66050729,66069308,q13.1,splicing factor 3b subunit 2 [Source:HGNC Symbol;Acc:HGNC:10769],NA,SF3B2,10992,NM_006842
LSM1_SIG,LSM1,LSM1_SIG,LSM1,SIG,20,-0.259956363331525,0.197516137976711,0.197780264084926,0.196648295049718,-0.00113196903520776,0.827768380830829,0.31614570303425,4.61751246532643,4.61449497087486,4.62742708995304,0.0129321190781822,0.818136278871563,ENSG00000175324,LSM1,protein_coding,8,-1,38163335,38176730,p11.23,LSM1 homolog, mRNA degradation associated [Source:HGNC Symbol;Acc:HGNC:20472],NA,LSM1,27257,NM_014462
PTEN_SIG,PTEN,PTEN_SIG,PTEN,SIG,16,0.259821816872616,0.45640632765152,0.455764024440612,0.458516752487361,0.00275272804674856,0.827772416565816,-0.71826496421152,7.42609169586224,7.43596112382384,7.39366357541701,-0.0422975484068263,0.58120283644561,ENSG00000171862,PTEN,protein_coding,10,1,87863625,87971930,q23.31,phosphatase and tensin homolog [Source:HGNC Symbol;Acc:HGNC:9588],Activated PI3K-delta syndrome;Bannayan-Riley-Ruvalcaba syndrome;Bannayan-Zonana syndrome;COWDEN DISEASE;COWDEN SYNDROME;COWDEN SYNDROME 1;GLIOMA SUSCEPTIBILITY 2;Hereditary breast and ovarian cancer syndrome;Juvenile polyposis of infancy;LHERMITTE-DUCLOS DISEASE;Macrocephaly-intellectual disability-autism syndrome;MACROCEPHALY/AUTISM SYNDROME;MENINGIOMA FAMILIAL SUSCEPTIBILITY TO;Prostate Cancer;Proteus-like syndrome;Proteus syndrome;Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome;Squamous cell carcinoma of salivary glands;Squamous cell carcinoma of the hypopharynx;Squamous cell carcinoma of the larynx;Squamous cell carcinoma of the lip;Squamous cell carcinoma of the nasal cavity and paranasal sinuses;Squamous cell carcinoma of the oral cavity;Squamous cell carcinoma of the oropharynx;VACTERL association with hydrocephalus,PTEN,5728,NM_000314;NM_001304717;NM_001304718
NMNAT3_SIG,NMNAT3,NMNAT3_SIG,NMNAT3,SIG,11,-0.259307282018784,0.108712457436178,0.109299205315834,0.10678457154588,-0.00251463376995433,0.828081649440843,-0.817101680849449,3.03197666279328,3.0568582825974,2.95022276915116,-0.10663551344624,0.525758277483501,ENSG00000163864,NMNAT3,protein_coding,3,-1,139560180,139678017,q23,nicotinamide nucleotide adenylyltransferase 3 [Source:HGNC Symbol;Acc:HGNC:20989],NA,NMNAT3,349565,NM_001200047;NM_001320510;NM_001320511;NM_001320512;NM_001320513;NM_178177
TRAF6_SIG,TRAF6,TRAF6_SIG,TRAF6,SIG,84,-0.258691408337038,0.568308992105362,0.569283572195525,0.565106800380542,-0.00417677181498243,0.828472257509844,0.288549697586916,5.25157816628402,5.2465679593517,5.26804027477593,0.0214723154242281,0.834814175611311,ENSG00000175104,TRAF6,protein_coding,11,-1,36483769,36510272,p12,TNF receptor associated factor 6 [Source:HGNC Symbol;Acc:HGNC:12036],Autosomal dominant hypohidrotic ectodermal dysplasia,TRAF6,7189,NM_004620;NM_145803
ZRANB1_SIG,ZRANB1,ZRANB1_SIG,ZRANB1,SIG,37,-0.25720077902118,0.217965846633083,0.218612316623857,0.21584173094911,-0.00277058567474669,0.829565582833296,-1.15964556988161,6.05950393475587,6.07449420873554,6.01025017739409,-0.0642440313414515,0.354988806994445,ENSG00000019995,ZRANB1,protein_coding,10,1,124942123,124988189,q26.13,zinc finger RANBP2-type containing 1 [Source:HGNC Symbol;Acc:HGNC:18224],NA,ZRANB1,54764,NM_017580
ZNF75D_TF,ZNF75D,ZNF75D_TF,ZNF75D,TF,80,-0.256031644655255,0.136306098852268,0.136743832743379,0.134867830352905,-0.00187600239047364,0.830400734246798,1.8423199905476,4.45665720443215,4.43069875516105,4.54194925203719,0.111250496876135,0.128421778847472,ENSG00000186376,ZNF75D,protein_coding,X,-1,135248920,135344109,q26.3,zinc finger protein 75D [Source:HGNC Symbol;Acc:HGNC:13145],NA,ZNF75D,7626,NM_001185063;NM_007131
GRIN2D_SIG,GRIN2D,GRIN2D_SIG,GRIN2D,SIG,30,0.254870239716162,-0.0899651579329389,-0.0903488680811494,-0.0887043960173901,0.00164447206375925,0.831229744763987,-0.53835539743854,0.781540183139214,0.794634474662351,0.738516082420335,-0.0561183922420156,0.687230734866233,ENSG00000105464,GRIN2D,protein_coding,19,1,48394875,48444931,q13.33,glutamate ionotropic receptor NMDA type subunit 2D [Source:HGNC Symbol;Acc:HGNC:4588],EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 46;Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers;Undetermined early-onset epileptic encephalopathy,GRIN2D,2906,NM_000836
IRAK4_SIG,IRAK4,IRAK4_SIG,IRAK4,SIG,52,0.253942525763574,0.362975192845312,0.362472264112844,0.364627672966279,0.00215540885343554,0.831870974906829,0.787897917901941,5.66745098637208,5.6574073729471,5.70045143048273,0.0430440575356307,0.541635521647935,ENSG00000198001,IRAK4,protein_coding,12,1,43758944,43789543,q12,interleukin 1 receptor associated kinase 4 [Source:HGNC Symbol;Acc:HGNC:17967],Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency;INVASIVE PNEUMOCOCCAL DISEASE RECURRENT ISOLATED 1;IRAK4 DEFICIENCY,IRAK4,51135,NM_001114182;NM_001145256;NM_001145257;NM_001145258;NM_001351338;NM_001351339;NM_001351340;NM_001351341;NM_001351342;NM_001351343;NM_001351344;NM_001351345;NM_016123
SPSB4_SIG,SPSB4,SPSB4_SIG,SPSB4,SIG,24,-0.253510615990507,-0.0830888254353809,-0.0827279017270319,-0.0842747176199562,-0.00154681589292447,0.832113669278462,2.23790226373681,0.462293274549192,0.418059165704315,0.607633917896644,0.189574752192328,0.0614299009127316,ENSG00000175093,SPSB4,protein_coding,3,1,141051347,141148611,q23,splA/ryanodine receptor domain and SOCS box containing 4 [Source:HGNC Symbol;Acc:HGNC:30630],NA,SPSB4,92369,NM_080862
THOC5_SIG,THOC5,THOC5_SIG,THOC5,SIG,4,0.252920581955414,0.524194618603515,0.523938112091272,0.525037425715168,0.00109931362389594,0.832483440839539,0.130625810532103,5.37999005020149,5.37888559282136,5.38361898159336,0.00473338877200823,0.926837714187419,ENSG00000100296,THOC5,protein_coding,22,-1,29505879,29555216,q12.2,THO complex 5 [Source:HGNC Symbol;Acc:HGNC:19074],NA,THOC5,8563,NM_001002877;NM_001002878;NM_001002879;NM_003678
GCLC_SIG,GCLC,GCLC_SIG,GCLC,SIG,9,0.252669361296881,0.144713598626676,0.144250702772459,0.146234542147677,0.00198383937521815,0.832580852277801,1.60778030106896,5.49477373967583,5.46781381683852,5.58335634328413,0.115542526445613,0.188430670667319,ENSG00000001084,GCLC,protein_coding,6,-1,53497341,53616970,p12.1,glutamate-cysteine ligase catalytic subunit [Source:HGNC Symbol;Acc:HGNC:4311],GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY HEMOLYTIC ANEMIA DUE TO;Glutamate-cysteine ligase deficiency;MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED,GCLC,2729,NM_001197115;NM_001498
SF3B5_SIG,SF3B5,SF3B5_SIG,SF3B5,SIG,37,0.251484108622477,0.322258935666553,0.321923207776787,0.323362041590068,0.00143883381328087,0.833429036296519,0.81237831593868,5.83277780245033,5.82428673242079,5.86067703254737,0.0363903001265788,0.528546796608024,ENSG00000169976,SF3B5,protein_coding,6,-1,144094881,144095573,q24.2,splicing factor 3b subunit 5 [Source:HGNC Symbol;Acc:HGNC:21083],NA,SF3B5,83443,NM_031287
YTHDC1_SIG,YTHDC1,YTHDC1_SIG,YTHDC1,SIG,48,0.250396635444706,0.539223139056745,0.538632714417458,0.541163105728689,0.00253039131123064,0.834198673471931,0.465789636369773,7.07807713136756,7.07223307421667,7.09727903343478,0.0250459592181044,0.729762945212257,ENSG00000083896,YTHDC1,protein_coding,4,-1,68310387,68350089,q13.2,YTH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30626],NA,YTHDC1,91746,NM_001031732;NM_001330698;NM_133370
BRPF1_TF,BRPF1,BRPF1_TF,BRPF1,TF,28,-0.24898050160413,0.247401379874648,0.247644202555251,0.246603533924094,-0.00104066863115624,0.835226230569998,-0.32982948703991,6.33857553783886,6.34278220233987,6.32475364019269,-0.018028562147176,0.810253269508081,ENSG00000156983,BRPF1,protein_coding,3,1,9731729,9748018,p25.3,bromodomain and PHD finger containing 1 [Source:HGNC Symbol;Acc:HGNC:14255],BRPF1 associated syndromic intellectual disability with ptosis;INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS,BRPF1,7862,NM_001003694;NM_001319049;NM_001319050;NM_004634
ATXN7_SIG,ATXN7,ATXN7_SIG,ATXN7,SIG,28,0.248858166387117,0.459183335039947,0.458498231306169,0.461434390165217,0.00293615885904794,0.835226230569998,-0.0492114573330712,6.51648697852367,6.51715582696368,6.51428933364935,-0.00286649331432532,0.972821812242386,ENSG00000163635,ATXN7,protein_coding,3,1,63898399,64003453,p14.1,ataxin 7 [Source:HGNC Symbol;Acc:HGNC:10560],SPINOCEREBELLAR ATAXIA 7;Spinocerebellar ataxia type 7,ATXN7,6314,NM_001128149;NM_001177387
KNTC1_TF,KNTC1,KNTC1_TF,KNTC1,TF,229,0.247954311936416,0.223978236437309,0.223255311162609,0.226353562339895,0.00309825117728582,0.835848254346881,0.297940243831463,5.84629734123985,5.84029229253951,5.86602821554096,0.0257359230014503,0.829140614603345,ENSG00000184445,KNTC1,protein_coding,12,1,122527246,122626396,q24.31,kinetochore associated 1 [Source:HGNC Symbol;Acc:HGNC:17255],NA,KNTC1,9735,NM_014708
TLR9_SIG,TLR9,TLR9_SIG,TLR9,SIG,23,-0.247296144732591,0.0389520885725197,0.0392811504992162,0.0378708850990883,-0.001410265400128,0.836272687494512,-0.863036867874229,0.222771960141552,0.227092900378738,0.208574585076512,-0.0185183153022258,0.501552310069274,ENSG00000239732,TLR9,protein_coding,3,-1,52221080,52226163,p21.2,toll like receptor 9 [Source:HGNC Symbol;Acc:HGNC:15633],NA,TLR9,54106,NM_017442
CLASRP_SIG,CLASRP,CLASRP_SIG,CLASRP,SIG,21,0.246994534706933,0.136809018544397,0.136389868371089,0.138186226256692,0.0017963578856033,0.836380930555656,-0.146742637913437,6.56090006552691,6.56229837986714,6.55630560412332,-0.00599277574381485,0.917734639473516,ENSG00000104859,CLASRP,protein_coding,19,1,45039045,45070956,q13.32,CLK4 associating serine/arginine rich protein [Source:HGNC Symbol;Acc:HGNC:17731],NA,CLASRP,11129,NM_001278439;NM_007056
USP16_SIG,USP16,USP16_SIG,USP16,SIG,40,-0.246900669213455,0.441897388902003,0.442550255570412,0.439752255562948,-0.00279800000746418,0.836380930555656,-0.378409323979168,5.86794390786695,5.87337033190028,5.85011422890028,-0.0232561029999996,0.78119214551522,ENSG00000156256,USP16,protein_coding,21,1,29024629,29054488,q21.3,ubiquitin specific peptidase 16 [Source:HGNC Symbol;Acc:HGNC:12614],NA,USP16,10600,NM_001001992;NM_001032410;NM_006447
DAB2IP_SIG,DAB2IP,DAB2IP_SIG,DAB2IP,SIG,58,0.246529970165526,-0.12078665404667,-0.121069185153072,-0.119858337554209,0.00121084759886332,0.836574116739777,1.33789183577234,1.00491328391454,0.973774775337406,1.10722552638229,0.13345075104488,0.2799605127937,ENSG00000136848,DAB2IP,protein_coding,9,1,121567057,121785530,q33.2,DAB2 interacting protein [Source:HGNC Symbol;Acc:HGNC:17294],NA,DAB2IP,153090,NM_032552;NM_138709
BAP1_SIG,BAP1,BAP1_SIG,BAP1,SIG,23,-0.246143248259667,0.405518205006798,0.405968635522018,0.404038219028217,-0.00193041649380072,0.83668073083496,0.254935614142536,6.77184048149295,6.76973215068316,6.77876785415371,0.00903570347054843,0.854926891774044,ENSG00000163930,BAP1,protein_coding,3,-1,52401008,52410008,p21.1,BRCA1 associated protein 1 [Source:HGNC Symbol;Acc:HGNC:950],BAP1-related tumor predisposition syndrome;Familial melanoma;TUMOR PREDISPOSITION SYNDROME;Uveal melanoma,BAP1,8314,NM_004656
USP47_SIG,USP47,USP47_SIG,USP47,SIG,46,0.246136450917835,0.568410000386089,0.56806423692806,0.569546080319616,0.00148184339155614,0.83668073083496,0.668244444433481,6.5081229567997,6.50122306329792,6.53079403544842,0.029570972150503,0.610380555577226,ENSG00000170242,USP47,protein_coding,11,1,11841423,11959323,p15.3,ubiquitin specific peptidase 47 [Source:HGNC Symbol;Acc:HGNC:20076],NA,USP47,55031,NM_001282659;NM_001330208;NM_017944
ATP8B3_SIG,ATP8B3,ATP8B3_SIG,ATP8B3,SIG,41,0.245621220657722,0.0937477356639744,0.0930798298012792,0.095942283498544,0.00286245369726478,0.836990059119335,-0.523486506064016,3.59452843703418,3.60776572138829,3.55103450272784,-0.0567312186604458,0.696174103992722,ENSG00000130270,ATP8B3,protein_coding,19,-1,1782075,1812276,p13.3,ATPase phospholipid transporting 8B3 [Source:HGNC Symbol;Acc:HGNC:13535],NA,ATP8B3,148229,NM_001178002;NM_138813
PLD3_SIG,PLD3,PLD3_SIG,PLD3,SIG,48,-0.244729839958779,0.166131309853372,0.166679984543363,0.164328521586258,-0.00235146295710566,0.837601788995516,-0.473168633414232,6.94599682010727,6.95912332706009,6.90286686869085,-0.0562564583692461,0.725260694889909,ENSG00000105223,PLD3,protein_coding,19,1,40348456,40380439,q13.2,phospholipase D family member 3 [Source:HGNC Symbol;Acc:HGNC:17158],SPINOCEREBELLAR ATAXIA 46,PLD3,23646,NM_001031696;NM_001291311;NM_012268
ZCCHC14_TF,ZCCHC14,ZCCHC14_TF,ZCCHC14,TF,161,-0.243913390038456,-0.035039218695938,-0.0348124569479545,-0.0357842930107408,-0.000971836062786406,0.83815326939481,1.84948612090952,4.03227833532575,3.99160537031623,4.16591807749989,0.174312707183662,0.126938791734314,ENSG00000140948,ZCCHC14,protein_coding,16,-1,87406246,87492045,q24.2,zinc finger CCHC-type containing 14 [Source:HGNC Symbol;Acc:HGNC:24134],NA,ZCCHC14,23174,NM_015144
STS_SIG,STS,STS_SIG,STS,SIG,62,-0.243349364048817,0.234304998568459,0.235125851633885,0.231607909924919,-0.00351794170896597,0.838501759209895,0.116965708812167,3.8238312801015,3.82042210369712,3.8350328597159,0.0146107560187855,0.935226173413158,ENSG00000101846,STS,protein_coding,X,1,7219456,7354810,p22.31,steroid sulfatase [Source:HGNC Symbol;Acc:HGNC:11425],ICHTHYOSIS X-LINKED;Recessive X-linked ichthyosis;Syndromic recessive X-linked ichthyosis,STS,412,NM_000351;NM_001320750;NM_001320751;NM_001320752;NM_001320753;NM_001320754
CLK3_SIG,CLK3,CLK3_SIG,CLK3,SIG,33,-0.241897839945757,0.189409087758413,0.190256986112857,0.186623136022382,-0.00363385009047427,0.839533739589703,0.149140218261165,6.87835020904811,6.87653704436526,6.8843077501489,0.007770705783641,0.916748137951292,ENSG00000179335,CLK3,protein_coding,15,1,74598500,74645414,q24.1,CDC like kinase 3 [Source:HGNC Symbol;Acc:HGNC:2071],NA,CLK3,1198,NM_001130028;NM_003992
BRWD3_SIG,BRWD3,BRWD3_SIG,BRWD3,SIG,41,-0.241804639040457,0.131127712080878,0.13148427502053,0.129956148136307,-0.00152812688422317,0.839533739589703,-0.722345473860948,6.07693833585141,6.08584822098638,6.04766299897935,-0.0381852220070354,0.578782884921266,ENSG00000165288,BRWD3,protein_coding,X,-1,80670854,80809688,q21.1,bromodomain and WD repeat domain containing 3 [Source:HGNC Symbol;Acc:HGNC:17342],MENTAL RETARDATION X-LINKED 93;MENTAL RETARDATION X-LINKED TYPE 93,BRWD3,254065,NM_153252
AK1_SIG,AK1,AK1_SIG,AK1,SIG,53,0.241623110878425,-0.035288362637624,-0.0356894309867439,-0.0339705666333728,0.00171886435337103,0.839574559413649,-0.117664696602913,1.17333147332654,1.1752823735957,1.16692137244213,-0.00836100115357438,0.934781613928543,ENSG00000106992,AK1,protein_coding,9,-1,127866486,127877675,q34.11,adenylate kinase 1 [Source:HGNC Symbol;Acc:HGNC:361],ADENYLATE KINASE DEFICIENCY HEMOLYTIC ANEMIA DUE TO;Hemolytic anemia due to adenylate kinase deficiency,AK1,203,NM_000476;NM_001318121;NM_001318122
TIMP2_SIG,TIMP2,TIMP2_SIG,TIMP2,SIG,32,-0.241248023369549,0.401868142032832,0.402468330877351,0.399896092972271,-0.00257223790507937,0.839771016252289,1.6781395502235,7.252329542559,7.21293998838978,7.38175236340069,0.168812375010907,0.168835683125518,ENSG00000035862,TIMP2,protein_coding,17,-1,78852977,78925387,q25.3,TIMP metallopeptidase inhibitor 2 [Source:HGNC Symbol;Acc:HGNC:11821],NA,TIMP2,7077,NM_003255
SP6_TF,SP6,SP6_TF,SP6,TF,81,0.239173320607572,-0.08795850366138,-0.0884324435059534,-0.0864012727434959,0.00203117076245748,0.841334373223773,-1.06711033239899,0.351169589814878,0.365330077400019,0.3046422734637,-0.0606878039363192,0.398025059038862,ENSG00000189120,SP6,protein_coding,17,-1,47844908,47855874,q21.32,Sp6 transcription factor [Source:HGNC Symbol;Acc:HGNC:14530],NA,SP6,80320,NM_001258248;NM_199262
COPS2_SIG,COPS2,COPS2_SIG,COPS2,SIG,48,-0.237527591414628,0.401102671640004,0.401851656731795,0.398641720624121,-0.00320993610767335,0.84255298309998,0.47420176761754,6.30898286712186,6.30229184245879,6.33096766244337,0.0286758199845822,0.724792733189862,ENSG00000166200,COPS2,protein_coding,15,-1,49106068,49155661,q21.1,COP9 signalosome subunit 2 [Source:HGNC Symbol;Acc:HGNC:30747],NA,COPS2,9318,NM_001143887;NM_004236
LYAR_SIG,LYAR,LYAR_SIG,LYAR,SIG,16,0.236759201806109,0.0903760637441846,0.0897159902650285,0.0925448766042691,0.00282888633924047,0.84306575598678,-1.78629595168761,4.45173726712602,4.48636129667604,4.33797259860451,-0.148388698071537,0.141361759319685,ENSG00000145220,LYAR,protein_coding,4,-1,4267701,4290154,p16.3,Ly1 antibody reactive [Source:HGNC Symbol;Acc:HGNC:26021],NA,LYAR,55646,NM_001145725;NM_017816
DDX5_SIG,DDX5,DDX5_SIG,DDX5,SIG,26,0.236608080731063,0.326796849384906,0.326385012497352,0.328150027729726,0.00176501523237391,0.843081818484937,1.01236714421508,10.4554732356245,10.4433190026461,10.4954085725534,0.0520895699072863,0.424537964407511,ENSG00000108654,DDX5,protein_coding,17,-1,64499616,64508199,q23.3,DEAD-box helicase 5 [Source:HGNC Symbol;Acc:HGNC:2746],NA,DDX5,1655,NM_001320595;NM_001320596;NM_001320597;NM_004396
CKB_SIG,CKB,CKB_SIG,CKB,SIG,50,-0.236180411162803,-0.0796469897487532,-0.0793044692231109,-0.0807724143330067,-0.00146794510989589,0.843320381390008,1.04466077048741,3.04552293063933,3.00765807559608,3.16993602578142,0.162277950185341,0.408722305961145,ENSG00000166165,CKB,protein_coding,14,-1,103519667,103522833,q32.33,creatine kinase B [Source:HGNC Symbol;Acc:HGNC:1991],NA,CKB,1152,NM_001823
ALOX15B_SIG,ALOX15B,ALOX15B_SIG,ALOX15B,SIG,6,0.235861182645652,-0.131063634982183,-0.131338409922483,-0.130160803035485,0.00117760688699795,0.843471672298241,0.718229196258653,0.553611750853235,0.532934197133533,0.621552284503683,0.08861808737015,0.58120283644561,ENSG00000179593,ALOX15B,protein_coding,17,1,8039034,8049134,p13.1,arachidonate 15-lipoxygenase, type B [Source:HGNC Symbol;Acc:HGNC:434],NA,ALOX15B,247,NM_001039130;NM_001039131;NM_001141
L3MBTL3_SIG,L3MBTL3,L3MBTL3_SIG,L3MBTL3,SIG,38,0.235542067942161,0.0488345244211867,0.0485910564262404,0.049634490690296,0.00104343426405549,0.84355750773244,1.19502017177978,4.40815186575558,4.38481026436188,4.48484569890632,0.10003543454444,0.339286314951908,ENSG00000198945,L3MBTL3,protein_coding,6,1,130013699,130141451,q23.1,L3MBTL3, histone methyl-lysine binding protein [Source:HGNC Symbol;Acc:HGNC:23035],NA,L3MBTL3,84456,NM_001007102;NM_001346550;NM_001346551;NM_032438
ATP6AP1_SIG,ATP6AP1,ATP6AP1_SIG,ATP6AP1,SIG,45,0.235492093705061,0.326435560898762,0.326152879161449,0.327364372321361,0.00121149315991221,0.84355750773244,-0.774289512125695,7.4164133627934,7.42497138722029,7.38829413967649,-0.0366772475437964,0.549640871385056,ENSG00000071553,ATP6AP1,protein_coding,X,1,154428645,154436516,q28,ATPase H+ transporting accessory protein 1 [Source:HGNC Symbol;Acc:HGNC:868],IMMUNODEFICIENCY 47,ATP6AP1,537,NM_001183
ATF4_TF,ATF4,ATF4_TF,ATF4,TF,172,-0.235112200212547,-0.112597277364081,-0.11192918291673,-0.114792444833949,-0.00286326191721934,0.843757551617805,-0.915527092738699,8.75585203581741,8.7697439411225,8.71020720410066,-0.0595367370218441,0.473630202732977,ENSG00000128272,ATF4,protein_coding,22,1,39519695,39522685,q13.1,activating transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:786],NA,ATF4,468,NM_001675;NM_182810
ZMAT5_SIG,ZMAT5,ZMAT5_SIG,ZMAT5,SIG,19,0.234931299784569,0.105491472052935,0.104613344940326,0.108376746851508,0.00376340191118123,0.843797514801644,-0.202975866765123,3.65568496173245,3.65840073878282,3.64676169428123,-0.0116390445015911,0.885284681593413,ENSG00000100319,ZMAT5,protein_coding,22,-1,29730956,29767011,q12.2,zinc finger matrin-type 5 [Source:HGNC Symbol;Acc:HGNC:28046],NA,ZMAT5,55954,NM_001003692;NM_001318129;NM_019103
FOSL1_TF,FOSL1,FOSL1_TF,FOSL1,TF,65,-0.234497578133393,0.00854436188679925,0.00901929822356928,0.00698385678026914,-0.00203544144330001,0.844040812714166,0.424439653046895,3.97700584617684,3.96173020876524,4.02719722624352,0.0654670174782774,0.753982922451586,ENSG00000175592,FOSL1,protein_coding,11,-1,65892049,65900573,q13.1,FOS like 1, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:13718],NA,FOSL1,8061,NM_001300844;NM_001300855;NM_001300856;NM_001300857;NM_005438
KDM3A_SIG,KDM3A,KDM3A_SIG,KDM3A,SIG,80,0.233322340195283,0.472882297733451,0.472110378557018,0.475418603598875,0.00330822504185735,0.844880525880642,0.0290984029962173,6.88638593835845,6.88584860579795,6.88815145962868,0.00230285383072734,0.983894865132955,ENSG00000115548,KDM3A,protein_coding,2,1,86440647,86492716,p11.2,lysine demethylase 3A [Source:HGNC Symbol;Acc:HGNC:20815],NA,KDM3A,55818,NM_001146688;NM_018433
FAU_SIG,FAU,FAU_SIG,FAU,SIG,29,-0.232611740940323,0.542205255137098,0.542931382768745,0.539819407204545,-0.00311197556419986,0.845346487197119,-0.327970108528465,7.42442383911678,7.42803927189605,7.4125445599849,-0.0154947119111527,0.811439560891509,ENSG00000149806,FAU,protein_coding,11,-1,65120630,65122177,q13.1,FAU, ubiquitin like and ribosomal protein S30 fusion [Source:HGNC Symbol;Acc:HGNC:3597],NA,FAU,2197,NM_001997
ABHD6_SIG,ABHD6,ABHD6_SIG,ABHD6,SIG,27,-0.232398364731479,0.13153141593008,0.13229946942838,0.129007811578523,-0.00329165784985761,0.84541244002043,-0.137738648287095,2.03081329470111,2.03400103015071,2.02033930679529,-0.0136617233554256,0.922555483013741,ENSG00000163686,ABHD6,protein_coding,3,1,58237506,58295693,p14.3,abhydrolase domain containing 6 [Source:HGNC Symbol;Acc:HGNC:21398],NA,ABHD6,57406,NM_001320126;NM_020676
ABCF3_SIG,ABCF3,ABCF3_SIG,ABCF3,SIG,12,-0.231317528066267,0.325900432862301,0.326259682992636,0.324720039576915,-0.00153964341572154,0.846176182634603,1.55738824535209,5.5978588191567,5.58406223293594,5.64319045959636,0.059128226660424,0.203314418841156,ENSG00000161204,ABCF3,protein_coding,3,1,184186023,184194012,q27.1,ATP binding cassette subfamily F member 3 [Source:HGNC Symbol;Acc:HGNC:72],NA,ABCF3,55324,NM_001351298;NM_001351299;NM_001351300;NM_018358
CDC7_SIG,CDC7,CDC7_SIG,CDC7,SIG,33,-0.231184399608421,0.433693014398311,0.435024642061385,0.429317666362497,-0.00570697569888875,0.846177513314131,-0.171941076157011,4.18626419481192,4.18976873311735,4.17474928323693,-0.0150194498804153,0.903609937143515,ENSG00000097046,CDC7,protein_coding,1,1,91500851,91525764,p22.1,cell division cycle 7 [Source:HGNC Symbol;Acc:HGNC:1745],NA,CDC7,8317,NM_001134419;NM_001134420;NM_003503
ICOSLG_SIG,ICOSLG,ICOSLG_SIG,ICOSLG,SIG,35,0.229774760070255,0.22136610953551,0.220775667413487,0.223306133650729,0.00253046623724199,0.847205751811106,1.92537866105651,4.5044050394777,4.43038346312876,4.74761879033852,0.317235327209762,0.111227060547691,ENSG00000160223,ICOSLG,protein_coding,21,-1,44217014,44240966,q22.3,inducible T cell costimulator ligand [Source:HGNC Symbol;Acc:HGNC:17087],NA,ICOSLG,23308,NM_001283050;NM_001283051;NM_001283052;NM_015259
KDM6A_SIG,KDM6A,KDM6A_SIG,KDM6A,SIG,17,0.228695445786938,0.34143046260051,0.340447072676458,0.344661600922397,0.00421452824593882,0.847968284860828,-1.66919113600116,6.03656596795756,6.0616976430352,5.95399046413104,-0.107707178904159,0.171200085447967,ENSG00000147050,KDM6A,protein_coding,X,1,44873177,45112602,p11.3,lysine demethylase 6A [Source:HGNC Symbol;Acc:HGNC:12637],Kabuki syndrome;KABUKI SYNDROME 1;KABUKI SYNDROME 2,KDM6A,7403,NM_001291415;NM_001291416;NM_001291417;NM_001291418;NM_001291421;NM_021140
ZNRF3_SIG,ZNRF3,ZNRF3_SIG,ZNRF3,SIG,10,0.227901018358855,-0.0639714477115412,-0.064411117032885,-0.0625268199414117,0.00188429709147325,0.848501578909574,0.0491918095713979,1.71546084236954,1.71438156020367,1.71900705520026,0.00462549499659211,0.972821812242386,ENSG00000183579,ZNRF3,protein_coding,22,1,28883592,29057487,q12.1,zinc and ring finger 3 [Source:HGNC Symbol;Acc:HGNC:18126],NA,ZNRF3,84133,NM_001206998;NM_032173
CDK2_SIG,CDK2,CDK2_SIG,CDK2,SIG,24,0.22655810241487,0.525697262226774,0.524776340604239,0.528723147557959,0.00394680695371942,0.849476289583962,0.0547623583260728,5.32100840717845,5.32002388164901,5.32424327677521,0.00421939512620537,0.96970329985314,ENSG00000123374,CDK2,protein_coding,12,1,55966781,55972789,q13.2,cyclin dependent kinase 2 [Source:HGNC Symbol;Acc:HGNC:1771],NA,CDK2,1017,NM_001290230;NM_001798;NM_052827
RNF26_SIG,RNF26,RNF26_SIG,RNF26,SIG,13,-0.226381661603469,0.332087665300111,0.332351061046512,0.331222222133365,-0.00112883891314694,0.849512181523683,-1.67019747909065,5.2143257853452,5.23518439285978,5.14579036065442,-0.0893940322053624,0.170935735222388,ENSG00000173456,RNF26,protein_coding,11,1,119334527,119337313,q23.3,ring finger protein 26 [Source:HGNC Symbol;Acc:HGNC:14646],NA,RNF26,79102,NM_032015
LY6G6C_SIG,LY6G6C,LY6G6C_SIG,LY6G6C,SIG,25,-0.225678514876978,0.148781573689327,0.149365345417241,0.146863466583325,-0.00250187883391639,0.849971952808085,-1.00833862810055,0.90649808309331,0.926444801381028,0.840958865862236,-0.0854859355187915,0.42645572428358,ENSG00000204421,LY6G6C,protein_coding,6,-1,31718648,31721746,p21.33,lymphocyte antigen 6 family member G6C [Source:HGNC Symbol;Acc:HGNC:13936],NA,LY6G6C,80740,NM_025261
HIVEP1_TF,HIVEP1,HIVEP1_TF,HIVEP1,TF,66,0.225212041930372,0.308832008998791,0.308438757906066,0.310124119732031,0.00168536182596541,0.850162746280204,1.90432151210052,5.6219220837613,5.58752184606832,5.73495143618107,0.147429590112749,0.115460697038412,ENSG00000095951,HIVEP1,protein_coding,6,1,12008762,12164999,p24.1,human immunodeficiency virus type I enhancer binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4920],NA,HIVEP1,3096,NM_002114
ARNT_SIG,ARNT,ARNT_SIG,ARNT,SIG,6,0.225177630954475,0.831298134725793,0.830632513027687,0.833485177448142,0.00285266442045544,0.850162746280204,0.293541323949399,6.49761701804558,6.49372149686768,6.51041658763011,0.0166950907624317,0.8316742715163,ENSG00000143437,ARNT,protein_coding,1,-1,150809713,150876708,q21.3,aryl hydrocarbon receptor nuclear translocator [Source:HGNC Symbol;Acc:HGNC:700],NA,ARNT,405,NM_001197325;NM_001286035;NM_001286036;NM_001350224;NM_001350225;NM_001350226;NM_001668;NM_178427
KHNYN_SIG,KHNYN,KHNYN_SIG,KHNYN,SIG,30,0.225031267242996,0.158827217948385,0.158539934020615,0.159771150853917,0.0012312168333023,0.850174377391077,-0.104543943178845,6.96999847655183,6.97122812584364,6.9659582003073,-0.00526992553633137,0.941809654700081,ENSG00000100441,KHNYN,protein_coding,14,1,24429286,24441843,q12,KH and NYN domain containing [Source:HGNC Symbol;Acc:HGNC:20166],NA,KHNYN,23351,NM_001290256;NM_001290257;NM_015299
NUDT16_SIG,NUDT16,NUDT16_SIG,NUDT16,SIG,58,-0.224238145056343,0.247597239825376,0.248340787440387,0.245154154804629,-0.00318663263575789,0.850706409957448,0.794886039859785,5.84859856233304,5.83065988593877,5.90753992762851,0.0768800416897476,0.537989679024885,ENSG00000198585,NUDT16,protein_coding,3,1,131381671,131388830,q22.1,nudix hydrolase 16 [Source:HGNC Symbol;Acc:HGNC:26442],NA,NUDT16,131870,NM_001171905;NM_001171906;NM_152395
PTH1R_SIG,PTH1R,PTH1R_SIG,PTH1R,SIG,38,0.223518095430316,-0.0598547535460382,-0.0602385798722697,-0.0585936099027064,0.00164496996956337,0.851179620033807,-1.27563107302503,0.39235544098409,0.417086097799883,0.311097568589342,-0.10598852921054,0.304844254648857,ENSG00000160801,PTH1R,protein_coding,3,1,46877721,46903799,p21.31,parathyroid hormone 1 receptor [Source:HGNC Symbol;Acc:HGNC:9608],Blomstrand lethal chondrodysplasia;Chondrodysplasia Blomstrand type;Eiken skeletal dysplasia;EIKEN SYNDROME;Enchondromatosis;FAILURE OF TOOTH ERUPTION PRIMARY;JANSEN METAPHYSEAL CHONDRODYSPLASIA;Metaphyseal chondrodysplasia Jansen type;PRIMARY FAILURE OF TOOTH ERUPTION,PTH1R,5745,NM_000316;NM_001184744
GPR85_SIG,GPR85,GPR85_SIG,GPR85,SIG,18,-0.223224896060586,-0.02418538564745,-0.0236807172298923,-0.0258435818765685,-0.00216286464667633,0.85130931583727,-0.655413259593133,0.882483130728499,0.901750604985469,0.81917571531274,-0.082574889672729,0.617524580529173,ENSG00000164604,GPR85,protein_coding,7,-1,113078331,113087778,q31.1,G protein-coupled receptor 85 [Source:HGNC Symbol;Acc:HGNC:4536],NA,GPR85,54329,NM_001146265;NM_001146266;NM_001146267;NM_018970
CLEC11A_SIG,CLEC11A,CLEC11A_SIG,CLEC11A,SIG,58,-0.223074147772241,0.050711361677394,0.0511325570445015,0.0493274340426122,-0.00180512300188949,0.851324377409081,-0.846511120070056,6.59635640036925,6.64574160611526,6.43409072434662,-0.211650881768645,0.510390457968322,ENSG00000105472,CLEC11A,protein_coding,19,1,50723364,50725718,q13.33,C-type lectin domain containing 11A [Source:HGNC Symbol;Acc:HGNC:10576],NA,CLEC11A,6320,NM_002975
LRRK1_SIG,LRRK1,LRRK1_SIG,LRRK1,SIG,52,-0.221532828747883,0.167531679792542,0.167867453493227,0.166428423347432,-0.00143903014579544,0.852458357172842,1.54105231926019,5.80836122912577,5.77075975875102,5.93190891749994,0.161149158748924,0.208693000768911,ENSG00000154237,LRRK1,protein_coding,15,1,100919327,101078257,q26.3,leucine rich repeat kinase 1 [Source:HGNC Symbol;Acc:HGNC:18608],Osteosclerotic metaphyseal dysplasia,LRRK1,79705,NM_024652
UGGT1_SIG,UGGT1,UGGT1_SIG,UGGT1,SIG,29,-0.22125069805366,0.414594677505467,0.415262783977559,0.412399470525737,-0.00286331345182261,0.852579041851175,-0.286924127252452,7.24358066939751,7.24789453514405,7.22940653908747,-0.0184879960565743,0.835683956794244,ENSG00000136731,UGGT1,protein_coding,2,1,128091200,128195677,q14.3,UDP-glucose glycoprotein glucosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:15663],NA,UGGT1,56886,NM_020120
WDTC1_SIG,WDTC1,WDTC1_SIG,WDTC1,SIG,17,-0.219606137108125,0.500546337379328,0.501014091404642,0.499009431296153,-0.00200466010848837,0.853796182571256,-1.23164586852426,6.84030199114278,6.85666853915894,6.78652619051822,-0.0701423486407249,0.323099780732509,ENSG00000142784,WDTC1,protein_coding,1,1,27234632,27308636,p36.11,WD and tetratricopeptide repeats 1 [Source:HGNC Symbol;Acc:HGNC:29175],NA,WDTC1,23038,NM_001276252;NM_015023
CHST1_SIG,CHST1,CHST1_SIG,CHST1,SIG,11,-0.218922625287696,-0.0371624036087904,-0.036841635917848,-0.0382163545933153,-0.00137471867546727,0.85423983708375,2.00723926013248,0.355537750697627,0.323840749326589,0.45968504091675,0.135844291590161,0.0957590848071437,ENSG00000175264,CHST1,protein_coding,11,-1,45647689,45665622,p11.2,carbohydrate sulfotransferase 1 [Source:HGNC Symbol;Acc:HGNC:1969],NA,CHST1,8534,NM_003654
BRD2_SIG,BRD2,BRD2_SIG,BRD2,SIG,23,0.217984753569231,0.335839896448381,0.33543535208562,0.337169113640309,0.00173376155468873,0.854888216461297,1.19130320965637,9.04651706388315,9.03343215074753,9.08951034990016,0.0560781991526245,0.340846748524967,ENSG00000204256,BRD2,protein_coding,6,1,32968594,32981505,p21.32,bromodomain containing 2 [Source:HGNC Symbol;Acc:HGNC:1103],NA,BRD2,6046,NM_001113182;NM_001199455;NM_001199456;NM_001291986;NM_005104
PPP2R2A_SIG,PPP2R2A,PPP2R2A_SIG,PPP2R2A,SIG,27,-0.217155911930137,0.348880230256994,0.349126216223378,0.348071990653161,-0.00105422557021693,0.855448813703179,0.470633076499377,5.44031958158819,5.43494867777157,5.45796683698565,0.0230181592140833,0.726790353946684,ENSG00000221914,PPP2R2A,protein_coding,8,1,26291508,26372680,p21.2,protein phosphatase 2 regulatory subunit Balpha [Source:HGNC Symbol;Acc:HGNC:9304],NA,PPP2R2A,5520,NM_001177591;NM_002717
SHMT1_SIG,SHMT1,SHMT1_SIG,SHMT1,SIG,7,0.216810052843805,0.329666719759904,0.328638299121701,0.333045816142572,0.00440751702087065,0.855620569209677,1.70306034808474,3.95009732557799,3.91393561825882,4.06891436391242,0.154978745653604,0.162361197830667,ENSG00000176974,SHMT1,protein_coding,17,-1,18327860,18363563,p11.2,serine hydroxymethyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:10850],NA,SHMT1,6470,NM_001281786;NM_004169;NM_148918
PPP1CC_SIG,PPP1CC,PPP1CC_SIG,PPP1CC,SIG,35,-0.216522934138401,0.212455345759227,0.212723301398232,0.211574920088211,-0.00114838131002017,0.855725192251591,0.685016117344976,7.33287066890332,7.32558386212484,7.35681303403259,0.0312291719077482,0.600579074611781,ENSG00000186298,PPP1CC,protein_coding,12,-1,110719680,110742939,q24.11,protein phosphatase 1 catalytic subunit gamma [Source:HGNC Symbol;Acc:HGNC:9283],NA,PPP1CC,5501,NM_001244974;NM_002710
ZNF486_TF,ZNF486,ZNF486_TF,ZNF486,TF,12,-0.2163315341592,-0.0441263991536386,-0.04368164435699,-0.0455877363426266,-0.00190609198563666,0.855725192251591,0.149598196978984,2.74065333311888,2.73524336777852,2.75842893352289,0.0231855657443631,0.916477394765526,ENSG00000256229,ZNF486,protein_coding,19,1,20167214,20200488,p12,zinc finger protein 486 [Source:HGNC Symbol;Acc:HGNC:20807],NA,ZNF486,90649,NM_052852
TNFRSF10D_SIG,TNFRSF10D,TNFRSF10D_SIG,TNFRSF10D,SIG,12,0.216282531392395,0.138469339516719,0.13829460403468,0.139043470386274,0.000748866351594537,0.855725192251591,1.08176105451171,4.61692091013092,4.59254726529729,4.6970057431557,0.104458477858403,0.391201557312983,ENSG00000173530,TNFRSF10D,protein_coding,8,-1,23135588,23164027,p21.3,TNF receptor superfamily member 10d [Source:HGNC Symbol;Acc:HGNC:11907],NA,TNFRSF10D,8793,NM_003840
ZNF552_TF,ZNF552,ZNF552_TF,ZNF552,TF,49,-0.215838898552083,0.0903123262590584,0.090574170639905,0.0894519804362771,-0.00112219020362795,0.855975564829571,0.404325837647234,3.01607373718815,3.01121543408149,3.03203673311005,0.0208212990285569,0.765780335535661,ENSG00000178935,ZNF552,protein_coding,19,-1,57803841,57814913,q13.43,zinc finger protein 552 [Source:HGNC Symbol;Acc:HGNC:26135],NA,ZNF552,79818,NM_024762
LPCAT2_SIG,LPCAT2,LPCAT2_SIG,LPCAT2,SIG,41,0.215524980030401,0.187258666553334,0.186885401298486,0.188485109533549,0.00159970823506266,0.856121523573688,1.49861762894685,6.18378467893472,6.13920796592636,6.33025102167648,0.191043055750118,0.222333996662111,ENSG00000087253,LPCAT2,protein_coding,16,1,55509072,55586666,q12.2,lysophosphatidylcholine acyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:26032],NA,LPCAT2,54947,NM_017839
HENMT1_SIG,HENMT1,HENMT1_SIG,HENMT1,SIG,21,-0.215130752999082,-0.0117774073162926,-0.0113674329172663,-0.0131244660559504,-0.00175703313868392,0.856332086064898,-0.440195561846772,4.57551244625834,4.58862175433175,4.53243900544572,-0.056182748886026,0.744675162197562,ENSG00000162639,HENMT1,protein_coding,1,-1,108648290,108661526,p13.3,HEN methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:26400],NA,HENMT1,113802,NM_001102592;NM_144584
KMT2D_SIG,KMT2D,KMT2D_SIG,KMT2D,SIG,35,0.21386113529105,0.276558680100525,0.276262229134783,0.27753273327368,0.00127050413889776,0.85724708058037,0.40704162613787,8.35383376648088,8.34803071051242,8.37290095037726,0.0248702398648443,0.764299664338669,ENSG00000167548,KMT2D,protein_coding,12,-1,49018975,49059774,q13.12,lysine methyltransferase 2D [Source:HGNC Symbol;Acc:HGNC:7133],Kabuki syndrome;KABUKI SYNDROME 1,KMT2D,8085,NM_003482
ACACB_SIG,ACACB,ACACB_SIG,ACACB,SIG,4,0.213558339434953,-0.00923931477808611,-0.009543917883278,-0.00823847600388421,0.0013054418793937,0.857383982552754,1.42834067880653,4.19984117551171,4.16557535364206,4.31242887594054,0.146853522298484,0.246147004326209,ENSG00000076555,ACACB,protein_coding,12,1,109116595,109268226,q24.11,acetyl-CoA carboxylase beta [Source:HGNC Symbol;Acc:HGNC:85],NA,ACACB,32,NM_001093
CUL2_SIG,CUL2,CUL2_SIG,CUL2,SIG,37,-0.212990429589056,0.427567343528325,0.42780995059106,0.426770206036481,-0.00103974455457922,0.857734213182787,-0.584659590814479,4.99114048748115,4.99694720356498,4.9720612774914,-0.0248859260735809,0.66049595780003,ENSG00000108094,CUL2,protein_coding,10,-1,35008551,35090642,p11.21,cullin 2 [Source:HGNC Symbol;Acc:HGNC:2552],NA,CUL2,8453,NM_001198777;NM_001198778;NM_001198779;NM_001324375;NM_001324376;NM_003591
WBP4_SIG,WBP4,WBP4_SIG,WBP4,SIG,18,0.211767687907564,0.228828169769163,0.228569583381037,0.229677810758718,0.00110822737768116,0.858611428720044,0.378564815576743,4.28134863408586,4.27752957804067,4.29389696109149,0.0163673830508193,0.781176533505183,ENSG00000120688,WBP4,protein_coding,13,1,41061509,41084006,q14.11,WW domain binding protein 4 [Source:HGNC Symbol;Acc:HGNC:12739],NA,WBP4,11193,NM_007187
ANXA4_SIG,ANXA4,ANXA4_SIG,ANXA4,SIG,26,0.211557220735322,0.413171836056157,0.412664046385935,0.414840287829744,0.00217624144380906,0.858673910939378,1.37097970361646,5.57035703354825,5.53894566498663,5.67356581596499,0.134620150978356,0.267698477013227,ENSG00000196975,ANXA4,protein_coding,2,1,69644425,69827112,p13.3,annexin A4 [Source:HGNC Symbol;Acc:HGNC:542],NA,ANXA4,307,NM_001153;NM_001320698;NM_001320700;NM_001320702
GLS2_SIG,GLS2,GLS2_SIG,GLS2,SIG,49,-0.211081133142053,-0.0669260215208281,-0.0665730174407827,-0.0680858920695486,-0.00151287462876575,0.858950146422535,0.989734361379977,0.366019046354896,0.357737860170949,0.39322865810215,0.0354907979312006,0.435710405489821,ENSG00000135423,GLS2,protein_coding,12,-1,56470944,56488414,q13.3,glutaminase 2 [Source:HGNC Symbol;Acc:HGNC:29570],NA,GLS2,27165,NM_001280796;NM_001280797;NM_001280798;NM_013267
P2RY8_SIG,P2RY8,P2RY8_SIG,P2RY8,SIG,19,0.209165956974676,0.359941196189284,0.359527985694362,0.361298887815458,0.00177090212109578,0.860384655441405,0.286594626659984,7.4377712984696,7.43096238362393,7.46014344724823,0.0291810636243009,0.83581548258169,ENSG00000182162,P2RY8,protein_coding,X,-1,1462581,1537185,p22.33,P2Y receptor family member 8 [Source:HGNC Symbol;Acc:HGNC:15524],NA,P2RY8,286530,NM_178129
CA11_SIG,CA11,CA11_SIG,CA11,SIG,66,-0.208640362775994,-0.0217239935215626,-0.0213460061089391,-0.0229659521630397,-0.00161994605410059,0.860700654210706,1.05702892122943,1.82640308938121,1.8060006956048,1.89343952607512,0.0874388304703259,0.402701936112972,ENSG00000063180,CA11,protein_coding,19,-1,48637946,48646187,q13.33,carbonic anhydrase 11 [Source:HGNC Symbol;Acc:HGNC:1370],NA,CA11,770,NM_001217
TDP1_SIG,TDP1,TDP1_SIG,TDP1,SIG,17,0.207388045509699,0.328799714483191,0.328058767032337,0.331234256107427,0.00317548907508911,0.86160166585419,0.112047660235962,4.65855358651196,4.65693976539256,4.66385614161859,0.00691637622603306,0.9379756995248,ENSG00000042088,TDP1,protein_coding,14,1,89954939,90044768,q32.11,tyrosyl-DNA phosphodiesterase 1 [Source:HGNC Symbol;Acc:HGNC:18884],Spinocerebellar ataxia autosomal recessive with axonal neuropathy;Spinocerebellar ataxia with axonal neuropathy type 1,TDP1,55775,NM_001008744;NM_001330205;NM_018319
KAT7_SIG,KAT7,KAT7_SIG,KAT7,SIG,35,0.206683297857392,0.699374574504487,0.698671783354758,0.701683745425023,0.00301196207026439,0.862061829006733,1.20717967783026,6.57764085665364,6.56031274471238,6.6345760816035,0.0742633368911187,0.333544536770972,ENSG00000136504,KAT7,protein_coding,17,1,49788681,49835026,q21.33,lysine acetyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:17016],NA,KAT7,11143,NM_001199155;NM_001199156;NM_001199157;NM_001199158;NM_001346706;NM_007067
SRSF10_SIG,SRSF10,SRSF10_SIG,SRSF10,SIG,2,-0.20650181643329,0.200275539872849,0.20061791967305,0.199150577672191,-0.00146734200085907,0.862100680231495,0.711273587277795,2.8978388635578,2.88444024192278,2.94186290607285,0.0574226641500669,0.585302093847598,ENSG00000188529,SRSF10,protein_coding,1,-1,23964804,23980927,p36.11,serine and arginine rich splicing factor 10 [Source:HGNC Symbol;Acc:HGNC:16713],NA,SRSF10,10772,NM_001191005;NM_001191006;NM_001191007;NM_001191009;NM_001300936;NM_001300937;NM_006625;NM_054016
ATP6V1G2_SIG,ATP6V1G2,ATP6V1G2_SIG,ATP6V1G2,SIG,27,0.205802999357901,0.0332665272575207,0.0329402611299928,0.0343385445336836,0.00139828340369088,0.862555996160492,0.455762594179797,0.890693378778448,0.884746815695027,0.910232086052544,0.0254852703575166,0.735893644953631,ENSG00000213760,ATP6V1G2,protein_coding,6,-1,31544462,31548427,p21.33,ATPase H+ transporting V1 subunit G2 [Source:HGNC Symbol;Acc:HGNC:862],NA,ATP6V1G2,534,NM_001204078;NM_130463;NM_138282
RANBP2_SIG,RANBP2,RANBP2_SIG,RANBP2,SIG,42,0.204611503320124,0.555329026766157,0.554951922859834,0.55656808245836,0.00161615959852539,0.863407948104898,1.83781515396782,7.68961105703225,7.65583578164476,7.80058696187686,0.144751180232094,0.129352870068404,ENSG00000153201,RANBP2,protein_coding,2,1,108719482,108785809,q13,RAN binding protein 2 [Source:HGNC Symbol;Acc:HGNC:9848],ACUTE NECROTIZING ENCEPHALOPATHY 1 SUSCEPTIBILITY TO;Acute necrotizing encephalopathy of childhood;ENCEPHALOPATHY ACUTE INFECTION-INDUCED SUSCEPTIBILITY TO 3;Familial acute necrotizing encephalopathy;Inflammatory myofibroblastic tumor,RANBP2,5903,NM_006267
ZMPSTE24_SIG,ZMPSTE24,ZMPSTE24_SIG,ZMPSTE24,SIG,51,0.204473998448277,0.434727279846259,0.434100799452596,0.436785715425437,0.00268491597284159,0.86341127445799,0.551661825654931,5.08082828184569,5.07151731449336,5.11142146028904,0.0399041457956749,0.679486470943662,ENSG00000084073,ZMPSTE24,protein_coding,1,1,40258236,40294180,p34.2,zinc metallopeptidase STE24 [Source:HGNC Symbol;Acc:HGNC:12877],HUTCHINSON-GILFORD PROGERIA SYNDROME;Lethal Restrictive Dermopathy ZMPSTE24-Related;MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY;Restrictive dermopathy;RESTRICTIVE DERMOPATHY LETHAL,ZMPSTE24,10269,NM_005857
PPP2CA_SIG,PPP2CA,PPP2CA_SIG,PPP2CA,SIG,35,-0.204292062237538,0.547617855768516,0.548178641504422,0.545775274064822,-0.0024033674395998,0.863450370979408,0.444408752520485,7.05227089270929,7.04657563653933,7.07098387726774,0.0244082407284161,0.742114459005636,ENSG00000113575,PPP2CA,protein_coding,5,-1,134194332,134226073,q31.1,protein phosphatase 2 catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9299],NA,PPP2CA,5515,NM_001355019;NM_002715
RBM3_SIG,RBM3,RBM3_SIG,RBM3,SIG,25,-0.20064095451896,0.375547267321746,0.376060692746172,0.373860298070062,-0.0022003946761094,0.866282949971675,-1.26408987091328,8.38734652711887,8.40818197264232,8.31888720611327,-0.0892947665290525,0.309712490340136,ENSG00000102317,RBM3,protein_coding,X,1,48574449,48581162,p11.23,RNA binding motif protein 3 [Source:HGNC Symbol;Acc:HGNC:9900],NA,RBM3,5935,NM_006743
ANKHD1_SIG,ANKHD1,ANKHD1_SIG,ANKHD1,SIG,62,0.199784820778264,0.0549891602630595,0.054507081345533,0.0565731338492177,0.00206605250368481,0.86686485765988,1.00484211176867,2.47850349899054,2.46345285679001,2.52795560907797,0.0645027522879539,0.428182375017764,ENSG00000131503,ANKHD1,protein_coding,5,1,140401814,140539856,q31.3,ankyrin repeat and KH domain containing 1 [Source:HGNC Symbol;Acc:HGNC:24714],NA,ANKHD1,54882,NM_001197030;NM_017747;NM_017978;NM_024668
CHRAC1_SIG,CHRAC1,CHRAC1_SIG,CHRAC1,SIG,28,-0.197911327570457,0.121733213750015,0.121900340251327,0.121184083817135,-0.000716256434191539,0.868266394859709,-0.380857118419084,5.67193822751369,5.67597052392964,5.6586892535756,-0.0172812703540357,0.779896010524926,ENSG00000104472,CHRAC1,protein_coding,8,1,140511311,140517154,q24.3,chromatin accessibility complex subunit 1 [Source:HGNC Symbol;Acc:HGNC:13544],NA,CHRAC1,54108,NM_017444
GFOD1_SIG,GFOD1,GFOD1_SIG,GFOD1,SIG,13,0.195856492789236,0.0707849972889607,0.0703830356195168,0.0721057284885623,0.00172269286904549,0.869814297936684,0.766701123034656,4.93412393399436,4.91180416763383,5.00746030917897,0.0956561415451329,0.554183245796307,ENSG00000145990,GFOD1,protein_coding,6,-1,13357830,13487662,p23,glucose-fructose oxidoreductase domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21096],NA,GFOD1,54438,NM_001242628;NM_001242629;NM_001242630;NM_018988
SRSF9_SIG,SRSF9,SRSF9_SIG,SRSF9,SIG,14,0.194101801066509,0.28025335591229,0.279991583690535,0.281113464640915,0.00112188095038023,0.8711205144843,-0.717314194767271,6.83247791622322,6.83764691979147,6.8154940473561,-0.0221528724353729,0.581750599296634,ENSG00000111786,SRSF9,protein_coding,12,-1,120461672,120469748,q24.31,serine and arginine rich splicing factor 9 [Source:HGNC Symbol;Acc:HGNC:10791],NA,SRSF9,8683,NM_003769
YEATS4_TF,YEATS4,YEATS4_TF,YEATS4,TF,324,-0.193515063666141,0.208389143780137,0.208802759992741,0.20703011908158,-0.00177264091116124,0.871485242074099,0.309981912851291,4.51591715139906,4.51130740419461,4.53106346364224,0.0197560594476237,0.822052368013114,ENSG00000127337,YEATS4,protein_coding,12,1,69359710,69390870,q15,YEATS domain containing 4 [Source:HGNC Symbol;Acc:HGNC:24859],NA,YEATS4,8089,NM_001300950;NM_006530
CD79B_SIG,CD79B,CD79B_SIG,CD79B,SIG,52,0.192848393832472,0.119893689207982,0.119576664848566,0.120935340674632,0.00135867582606528,0.871842686145221,1.26835406785852,3.79009341183245,3.75105301304321,3.91836900785423,0.167315994811025,0.307870101753838,ENSG00000007312,CD79B,protein_coding,17,-1,63928740,63932354,q23.3,CD79b molecule [Source:HGNC Symbol;Acc:HGNC:1699],AGAMMAGLOBULINEMIA 6 AUTOSOMAL RECESSIVE;Autosomal agammaglobulinemia,CD79B,974,NM_000626;NM_001039933;NM_001329050;NM_021602
KCND1_SIG,KCND1,KCND1_SIG,KCND1,SIG,35,-0.192802951484831,-0.0182899900729825,-0.0180619354042855,-0.0190393125558441,-0.000977377151558708,0.871842686145221,0.944727923954197,2.83076460414166,2.81463275637861,2.88376924679167,0.0691364904130584,0.458410321364742,ENSG00000102057,KCND1,protein_coding,X,-1,48961378,48971844,p11.23,potassium voltage-gated channel subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:6237],NA,KCND1,3750,NM_004979
GSTO2_SIG,GSTO2,GSTO2_SIG,GSTO2,SIG,76,-0.192512569553865,-0.0928859830766548,-0.0926307188480071,-0.0937247083993541,-0.00109398955134681,0.871968437445366,-0.474136682127014,0.957280981557853,0.96519665055619,0.931272354849031,-0.0339242957071586,0.724809468863114,ENSG00000065621,GSTO2,protein_coding,10,1,104268873,104304950,q25.1,glutathione S-transferase omega 2 [Source:HGNC Symbol;Acc:HGNC:23064],NA,GSTO2,119391,NM_001191013;NM_001191014;NM_001191015;NM_183239
ACOX1_SIG,ACOX1,ACOX1_SIG,ACOX1,SIG,43,0.192116709084606,0.425950941741056,0.425521897086108,0.42736065989303,0.0018387628069225,0.872179181345097,0.90680001898247,5.51022701521616,5.49720538949727,5.55301235686393,0.0558069673666609,0.478302305769698,ENSG00000161533,ACOX1,protein_coding,17,-1,75941507,75979177,q25.1,acyl-CoA oxidase 1 [Source:HGNC Symbol;Acc:HGNC:119],ADRENOLEUKODYSTROPHY PSEUDONEONATAL;PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY,ACOX1,51,NM_001185039;NM_004035;NM_007292
MMP11_SIG,MMP11,MMP11_SIG,MMP11,SIG,49,0.191931786883885,-0.0184570408733774,-0.0188077506286782,-0.0173047088202461,0.00150304180843206,0.872219900732705,0.535955225348621,0.869284971459062,0.859370735824518,0.901860317115423,0.0424895812909049,0.688704233822925,ENSG00000099953,MMP11,protein_coding,22,1,23768226,23784316,q11.23,matrix metallopeptidase 11 [Source:HGNC Symbol;Acc:HGNC:7157],NA,MMP11,4320,NM_005940
LDHA_SIG,LDHA,LDHA_SIG,LDHA,SIG,35,0.190744993756076,0.116487841053773,0.116272603453805,0.11719505031081,0.000922446857004708,0.873068018642003,-0.00747356762087298,8.97739599606449,8.9774999780098,8.97705434110134,-0.000445636908461087,0.995872785685275,ENSG00000134333,LDHA,protein_coding,11,1,18394560,18408425,p15.1,lactate dehydrogenase A [Source:HGNC Symbol;Acc:HGNC:6535],Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI,LDHA,3939,NM_001135239;NM_001165414;NM_001165415;NM_001165416;NM_005566
BTAF1_SIG,BTAF1,BTAF1_SIG,BTAF1,SIG,27,-0.190310761004692,0.308658917206349,0.309006907134367,0.307515521728577,-0.00149138540579003,0.87328226862861,-0.488270610832198,7.17483928735534,7.18187534099843,7.15172082538517,-0.0301545156132691,0.716357576871878,ENSG00000095564,BTAF1,protein_coding,10,1,91923770,92030325,q23.32,B-TFIID TATA-box binding protein associated factor 1 [Source:HGNC Symbol;Acc:HGNC:17307],NA,BTAF1,9044,NM_003972
ATMIN_TF,ATMIN,ATMIN_TF,ATMIN,TF,74,-0.190210130983944,0.197397524028002,0.197544575188218,0.196914355930151,-0.000630219258066605,0.87328226862861,0.767339686215219,6.06407980485631,6.05545406632475,6.09242151717431,0.0369674508495522,0.553860190187666,ENSG00000166454,ATMIN,protein_coding,16,1,81035842,81047350,q23.2,ATM interactor [Source:HGNC Symbol;Acc:HGNC:29034],NA,ATMIN,23300,NM_001300728;NM_015251
MED10_SIG,MED10,MED10_SIG,MED10,SIG,27,-0.188737388674931,0.134564526888617,0.134878270418488,0.133533655290469,-0.00134461512801812,0.874360715441873,0.0456424922447305,4.6239312172294,4.62346848727788,4.62545161564154,0.00198312836365839,0.974908009681773,ENSG00000133398,MED10,protein_coding,5,-1,6371874,6378571,p15.31,mediator complex subunit 10 [Source:HGNC Symbol;Acc:HGNC:28760],NA,MED10,84246,NM_032286
NKX3-1_TF,NKX3-1,NKX3-1_TF,NKX3-1,TF,93,0.187731139104566,-0.098266394739825,-0.0985089354195676,-0.097469475363528,0.00103946005603966,0.875032800139787,0.168676950079443,1.47908282887773,1.47428711897611,1.49484016141165,0.0205530424355394,0.905420297608645,ENSG00000167034,NKX3-1,protein_coding,8,-1,23678697,23682938,p21.2,NK3 homeobox 1 [Source:HGNC Symbol;Acc:HGNC:7838],NA,NKX3-1,4824,NM_001256339;NM_006167
SHH_SIG,SHH,SHH_SIG,SHH,SIG,24,-0.187634131347124,-0.0361091399062271,-0.0358515051354009,-0.0369556541532273,-0.00110414901782656,0.875032800139787,0.494481889500386,0.304520046326063,0.297690246224961,0.326960818086826,0.0292705718618654,0.712684596928566,ENSG00000164690,SHH,protein_coding,7,-1,155799980,155812463,q36.3,sonic hedgehog signaling molecule [Source:HGNC Symbol;Acc:HGNC:10848],Acquired schizencephaly;Alobar holoprosencephaly;Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome;Colobomatous microphthalmia;HOLOPROSENCEPHALY 3;HOLOPROSENCEPHALY TYPE 3;Hypoplastic tibiae-postaxial polydactyly syndrome;Lobar holoprosencephaly;Microform holoprosencephaly;MICROPHTHALMIA ISOLATED WITH COLOBOMA 5;microphthalmia isolated with coloboma type 5;Midline interhemispheric variant of holoprosencephaly;Polydactyly of a triphalangeal thumb;Radial hemimelia;Schizencephaly;Semilobar holoprosencephaly;Septopreoptic holoprosencephaly;SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR;Syndactyly type 4;TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME,SHH,6469,NM_000193;NM_001310462
ELOVL1_SIG,ELOVL1,ELOVL1_SIG,ELOVL1,SIG,35,-0.185825921160189,0.28124157707963,0.281795817407494,0.279420501716649,-0.00237531569084561,0.876381622220439,0.156294354954911,5.66094549213536,5.6587601643302,5.66812585492374,0.00936569059354136,0.912147925771279,ENSG00000066322,ELOVL1,protein_coding,1,-1,43363398,43368074,p34.2,ELOVL fatty acid elongase 1 [Source:HGNC Symbol;Acc:HGNC:14418],NA,ELOVL1,64834,NM_001256399;NM_001256401;NM_001256402;NM_022821
GPR52_SIG,GPR52,GPR52_SIG,GPR52,SIG,32,-0.185204629904137,-0.116998084289843,-0.116681129118456,-0.118039508424401,-0.00135837930594463,0.876773704934832,0.193999244361147,0.245052389680193,0.243942009328174,0.248700782265396,0.00475877293722184,0.890923565101935,ENSG00000203737,GPR52,protein_coding,1,1,174448111,174449198,q25.1,G protein-coupled receptor 52 [Source:HGNC Symbol;Acc:HGNC:4508],NA,GPR52,9293,NM_005684
KAT7_TF,KAT7,KAT7_TF,KAT7,TF,69,0.184373799266227,0.454543389964357,0.453967793795177,0.456434634520231,0.00246684072505384,0.877334661911331,1.20717967783026,6.57764085665364,6.56031274471238,6.6345760816035,0.0742633368911187,0.333544536770972,ENSG00000136504,KAT7,protein_coding,17,1,49788681,49835026,q21.33,lysine acetyltransferase 7 [Source:HGNC Symbol;Acc:HGNC:17016],NA,KAT7,11143,NM_001199155;NM_001199156;NM_001199157;NM_001199158;NM_001346706;NM_007067
DCLK2_SIG,DCLK2,DCLK2_SIG,DCLK2,SIG,51,0.183959773290111,-0.118948207020514,-0.119230367202703,-0.118021109279036,0.00120925792366709,0.877371377235052,1.62060988655297,1.01873364490483,0.969762589188643,1.17963854225802,0.20987595306938,0.184801284748861,ENSG00000170390,DCLK2,protein_coding,4,1,150078445,150257438,q31.23,doublecortin like kinase 2 [Source:HGNC Symbol;Acc:HGNC:19002],NA,DCLK2,166614,NM_001040260;NM_001040261
DECR1_SIG,DECR1,DECR1_SIG,DECR1,SIG,8,0.183860534629142,0.305588081645682,0.305201621891288,0.30685787798155,0.00165625609026248,0.877371377235052,-0.660956580935278,5.34666414709068,5.3563705843567,5.31477156750233,-0.0415990168543746,0.614203432004053,ENSG00000104325,DECR1,protein_coding,8,1,90001405,90053633,q21.3,2,4-dienoyl-CoA reductase 1 [Source:HGNC Symbol;Acc:HGNC:2753],NA,DECR1,1666,NM_001330575;NM_001359
AMH_SIG,AMH,AMH_SIG,AMH,SIG,14,0.183796566411104,-0.092571150780654,-0.0927470692012951,-0.0919931331128336,0.000753936088461538,0.877371377235052,-0.615656802008634,0.820871132036893,0.831498151782214,0.785953781445126,-0.0455443703370883,0.641090849774427,ENSG00000104899,AMH,protein_coding,19,1,2249309,2252073,p13.3,anti-Mullerian hormone [Source:HGNC Symbol;Acc:HGNC:464],Persistent Mullerian duct syndrome;PERSISTENT MULLERIAN DUCT SYNDROME TYPES I AND II,AMH,268,NM_000479
ZC3HAV1_SIG,ZC3HAV1,ZC3HAV1_SIG,ZC3HAV1,SIG,13,-0.183788287539139,0.178403061044752,0.178657475086496,0.177567129193306,-0.0010903458931905,0.877371377235052,0.264821849593511,7.66882701916673,7.66519280150216,7.68076802006461,0.0155752185624463,0.84843471621021,ENSG00000105939,ZC3HAV1,protein_coding,7,-1,139043515,139109720,q34,zinc finger CCCH-type containing, antiviral 1 [Source:HGNC Symbol;Acc:HGNC:23721],NA,ZC3HAV1,56829,NM_020119;NM_024625
BMP2K_SIG,BMP2K,BMP2K_SIG,BMP2K,SIG,20,0.183452392608937,0.150749018812407,0.150351770258675,0.152054264060384,0.00170249380170931,0.877533263256977,-1.0389195458682,6.20226647000765,6.22462641348464,6.12879808429753,-0.0958283291871034,0.411446210804072,ENSG00000138756,BMP2K,protein_coding,4,1,78776342,78916372,q21.21,BMP2 inducible kinase [Source:HGNC Symbol;Acc:HGNC:18041],NA,BMP2K,55589,NM_017593;NM_198892
SLC2A10_SIG,SLC2A10,SLC2A10_SIG,SLC2A10,SIG,79,0.183231233033334,-0.138785718300333,-0.139038030180922,-0.137956693549826,0.00108133663109662,0.877602681962929,-0.561222564414828,0.99083501655824,1.00539499748139,0.942995079239309,-0.0623999182420833,0.674173423925289,ENSG00000197496,SLC2A10,protein_coding,20,1,46709649,46736347,q13.12,solute carrier family 2 member 10 [Source:HGNC Symbol;Acc:HGNC:13444],ARTERIAL TORTUOSITY SYNDROME,SLC2A10,81031,NM_030777
SSU72_SIG,SSU72,SSU72_SIG,SSU72,SIG,14,-0.182714520938765,0.127364972621701,0.127670450725404,0.126361258852392,-0.00130919187301215,0.877910205498232,0.465826668251257,6.14419699042954,6.1385120627435,6.16287603854079,0.024363975797285,0.729762945212257,ENSG00000160075,SSU72,protein_coding,1,-1,1541673,1574863,p36.33,SSU72 homolog, RNA polymerase II CTD phosphatase [Source:HGNC Symbol;Acc:HGNC:25016],NA,SSU72,29101,NM_014188
LONRF1_SIG,LONRF1,LONRF1_SIG,LONRF1,SIG,10,-0.182065564062537,0.260404026795571,0.260806684865706,0.25908100742227,-0.00172567744343603,0.878227817164605,0.114535717338467,4.7002711738198,4.69831801462756,4.70668869688004,0.00837068225248242,0.936746955632805,ENSG00000154359,LONRF1,protein_coding,8,-1,12721906,12756073,p23.1,LON peptidase N-terminal domain and ring finger 1 [Source:HGNC Symbol;Acc:HGNC:26302],NA,LONRF1,91694,NM_001329976;NM_152271
UBE2L3_SIG,UBE2L3,UBE2L3_SIG,UBE2L3,SIG,23,0.182050165892422,0.374971957180228,0.374549788455597,0.376359082989727,0.00180929453412932,0.878227817164605,0.642846072453459,6.30487941619615,6.29745265030689,6.32928164697517,0.0318289966682848,0.625237507705227,ENSG00000185651,UBE2L3,protein_coding,22,1,21549447,21624034,q11.21,ubiquitin conjugating enzyme E2 L3 [Source:HGNC Symbol;Acc:HGNC:12488],Systemic lupus erythematosus,UBE2L3,7332,NM_001256355;NM_001256356;NM_003347
NAAA_SIG,NAAA,NAAA_SIG,NAAA,SIG,41,-0.181650125065627,0.357079980395615,0.357668703773145,0.35514560358373,-0.00252310018941521,0.878363374032997,2.85087172624949,5.27053754491179,5.19233321088157,5.52749464243967,0.335161431558106,0.0156603180896498,ENSG00000138744,NAAA,protein_coding,4,-1,75913660,75941013,q21.1,N-acylethanolamine acid amidase [Source:HGNC Symbol;Acc:HGNC:736],NA,NAAA,27163,NM_001042402;NM_014435
WDHD1_TF,WDHD1,WDHD1_TF,WDHD1,TF,503,0.181611721461883,0.274028519556305,0.273457628268143,0.275904305217409,0.00244667694926585,0.878363374032997,0.513073678699831,3.89910605934454,3.8851696668123,3.94489706337904,0.0597273965667368,0.70206368654939,ENSG00000198554,WDHD1,protein_coding,14,-1,54938949,55027105,q22.3,WD repeat and HMG-box DNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:23170],NA,WDHD1,11169,NM_001008396;NM_007086
C8G_SIG,C8G,C8G_SIG,C8G,SIG,8,0.179971300259112,-0.142937644435521,-0.14311313934085,-0.142361018318011,0.000752121022838408,0.879575885335456,1.03464456128035,0.581402778154641,0.574643953295076,0.603610345550355,0.0289663922552783,0.413374954963624,ENSG00000176919,C8G,protein_coding,9,1,136945185,136946975,q34.3,complement C8 gamma chain [Source:HGNC Symbol;Acc:HGNC:1354],Immunodeficiency due to a late component of complement deficiency,C8G,733,NM_000606
HSF2_TF,HSF2,HSF2_TF,HSF2,TF,108,0.179431406764153,0.196440069804928,0.195951143740803,0.198046541158481,0.00209539741767817,0.879901856005715,-1.37563238850715,4.2773003883222,4.30376427996324,4.19034760150165,-0.113416678461594,0.26586498446354,ENSG00000025156,HSF2,protein_coding,6,1,122399546,122433119,q22.31,heat shock transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:5225],NA,HSF2,3298,NM_001135564;NM_004506
PIP5KL1_SIG,PIP5KL1,PIP5KL1_SIG,PIP5KL1,SIG,21,0.177190913303371,-0.0871324486460366,-0.0872900516387445,-0.0866146102414252,0.000675441397319193,0.88159789701607,-0.808293178342918,0.696643702569698,0.706141458411874,0.665436790516836,-0.0407046678950371,0.53060871677655,ENSG00000167103,PIP5KL1,protein_coding,9,-1,127920881,127930785,q34.11,phosphatidylinositol-4-phosphate 5-kinase like 1 [Source:HGNC Symbol;Acc:HGNC:28711],NA,PIP5KL1,138429,NM_001135219;NM_173492
DMGDH_SIG,DMGDH,DMGDH_SIG,DMGDH,SIG,20,-0.175526620964726,-0.00791035581021902,-0.00768279506763302,-0.00865805539300156,-0.000975260325368493,0.882829838855894,0.663800045730093,0.344883153223727,0.339471526258481,0.362664213252392,0.0231926869939107,0.612632204763499,ENSG00000132837,DMGDH,protein_coding,5,-1,78997606,79236038,q14.1,dimethylglycine dehydrogenase [Source:HGNC Symbol;Acc:HGNC:24475],DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY,DMGDH,29958,NM_013391
IL12RB2_SIG,IL12RB2,IL12RB2_SIG,IL12RB2,SIG,74,0.174961330577673,-0.0457965259469384,-0.0462329764827691,-0.0443624741863517,0.00187050229641738,0.883176096048678,-3.30540384131812,1.8694302874892,2.02475548585567,1.35907606428508,-0.665679421570595,0.00473410465258507,ENSG00000081985,IL12RB2,protein_coding,1,1,67307364,67397090,p31.3,interleukin 12 receptor subunit beta 2 [Source:HGNC Symbol;Acc:HGNC:5972],NA,IL12RB2,3595,NM_001258214;NM_001258215;NM_001258216;NM_001319233;NM_001559
NFRKB_TF,NFRKB,NFRKB_TF,NFRKB,TF,28,0.17377951040361,0.332637212342526,0.332425797873118,0.333331859884869,0.00090606201175171,0.88401918859708,-0.428458768765921,5.82287113549355,5.82861584750608,5.80399565316666,-0.0246201943394216,0.751396153007976,ENSG00000170322,NFRKB,protein_coding,11,-1,129863636,129895590,q24.3,nuclear factor related to kappaB binding protein [Source:HGNC Symbol;Acc:HGNC:7802],NA,NFRKB,4798,NM_001143835;NM_006165
NAIF1_TF,NAIF1,NAIF1_TF,NAIF1,TF,102,0.172443931197362,0.106651331276454,0.106511863951409,0.107109581058745,0.000597717107336784,0.884986204436254,0.483521426977934,3.61040550581423,3.60505620182568,3.627981790348,0.0229255885223175,0.718988751870427,ENSG00000171169,NAIF1,protein_coding,9,-1,128061233,128068206,q34.11,nuclear apoptosis inducing factor 1 [Source:HGNC Symbol;Acc:HGNC:25446],NA,NAIF1,203245,NM_197956
H1FX_SIG,H1FX,H1FX_SIG,H1FX,SIG,25,0.172171003308039,0.254956392590324,0.254404746249404,0.256768944853346,0.00236419860394177,0.885012797967695,-0.12601086685663,8.97769985673824,8.98118156612548,8.96625995446588,-0.0149216116596021,0.9295173724989,ENSG00000184897,H1FX,protein_coding,3,-1,129314771,129316286,q21.3,H1 histone family member X [Source:HGNC Symbol;Acc:HGNC:4722],NA,H1FX,8971,NM_006026
KIDINS220_SIG,KIDINS220,KIDINS220_SIG,KIDINS220,SIG,33,-0.172139175220887,0.344978986328983,0.345418354045116,0.343535349547404,-0.00188300449771243,0.885012797967695,-0.343620907133154,7.13323051993621,7.13779006860051,7.11824914575353,-0.0195409228469837,0.801499988980606,ENSG00000134313,KIDINS220,protein_coding,2,-1,8721081,8837630,p25.1,kinase D interacting substrate 220 [Source:HGNC Symbol;Acc:HGNC:29508],Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome;SPASTIC PARAPLEGIA INTELLECTUAL DISABILITY NYSTAGMUS AND OBESITY,KIDINS220,57498,NM_001348729;NM_001348731;NM_001348732;NM_001348734;NM_001348735;NM_001348736;NM_001348738;NM_001348739;NM_001348740;NM_001348741;NM_001348742;NM_001348743;NM_001348745;NM_020738
NDUFA4_SIG,NDUFA4,NDUFA4_SIG,NDUFA4,SIG,33,0.171245089769898,0.30808065011663,0.307788923451091,0.309039180589117,0.00125025713802565,0.88562381383143,0.958359713223041,5.3372389281518,5.32487731106979,5.37785566999272,0.052978358922929,0.451647210507873,ENSG00000189043,NDUFA4,protein_coding,7,-1,10931943,10940153,p21.3,NDUFA4, mitochondrial complex associated [Source:HGNC Symbol;Acc:HGNC:7687],Leigh syndrome with leukodystrophy,NDUFA4,4697,NM_002489
RB1_TF,RB1,RB1_TF,RB1,TF,48,0.170586255751153,0.354113108226008,0.353809020109304,0.35511225489518,0.00130323478587624,0.886045193199809,-1.15049083070313,6.4388241345699,6.46245682932053,6.3611738518178,-0.101282977502733,0.358982340598198,ENSG00000139687,RB1,protein_coding,13,1,48303726,48599436,q14.2,RB transcriptional corepressor 1 [Source:HGNC Symbol;Acc:HGNC:9884],Bladder Cancer;Hereditary retinoblastoma;Monosomy 13q14;Non-hereditary retinoblastoma;OSTEOGENIC SARCOMA;OSTEOSARCOMA;RETINOBLASTOMA;Small cell cancer of the lung;Small cell lung cancer,RB1,5925,NM_000321
PSMB10_SIG,PSMB10,PSMB10_SIG,PSMB10,SIG,34,0.170408572395954,0.256416855905175,0.256095454840134,0.257472887976025,0.00137743313589141,0.886078783475701,-0.166698221000633,4.69042239765752,4.69300361622423,4.68194125093831,-0.0110623652859198,0.906466858840013,ENSG00000205220,PSMB10,protein_coding,16,-1,67934506,67936864,q22.1,proteasome subunit beta 10 [Source:HGNC Symbol;Acc:HGNC:9538],NA,PSMB10,5699,NM_002801
MTMR4_SIG,MTMR4,MTMR4_SIG,MTMR4,SIG,10,-0.170228233488794,0.244617811148919,0.244867771514505,0.243796512804849,-0.00107125870965568,0.886114509518821,-1.25458102515149,6.02037737383202,6.03721030824726,5.96506916075339,-0.0721411474938699,0.313451237742517,ENSG00000108389,MTMR4,protein_coding,17,-1,58489529,58517905,q22,myotubularin related protein 4 [Source:HGNC Symbol;Acc:HGNC:7452],NA,MTMR4,9110,NM_004687
NUP98_SIG,NUP98,NUP98_SIG,NUP98,SIG,40,-0.169889213287153,0.498181404788519,0.498436981524151,0.497341652657156,-0.00109532886699521,0.886278080273976,-1.49470859029344,7.37841954049839,7.39778853324592,7.31477856432793,-0.0830099689179872,0.223675081834857,ENSG00000110713,NUP98,protein_coding,11,-1,3671083,3797792,p15.4,nucleoporin 98 [Source:HGNC Symbol;Acc:HGNC:8068],NA,NUP98,4928,NM_001365126;NM_005387;NM_016320;NM_139131;NM_139132
KMT2B_TF,KMT2B,KMT2B_TF,KMT2B,TF,231,-0.169268981291365,0.040738062287203,0.0410172795388372,0.0398206341746907,-0.00119664536414657,0.886668191364146,-0.338834957865582,2.04113716520558,2.04622112379609,2.02443272983673,-0.0217883939593624,0.804445384921962,ENSG00000272333,KMT2B,protein_coding,19,1,35718019,35738878,q13.12,lysine methyltransferase 2B [Source:HGNC Symbol;Acc:HGNC:15840],Complex early-onset dystonia;DYSTONIA 28 CHILDHOOD-ONSET,KMT2B,9757,NM_014727
SP1_TF,SP1,SP1_TF,SP1,TF,99,-0.168014887913421,0.161353464932231,0.161497464340623,0.160880324018943,-0.000617140321679814,0.887568973943144,0.0916766794941927,7.77909544631741,7.77819125800088,7.78206635078602,0.00387509278514664,0.948893704539373,ENSG00000185591,SP1,protein_coding,12,1,53380176,53416446,q13.13,Sp1 transcription factor [Source:HGNC Symbol;Acc:HGNC:11205],NA,SP1,6667,NM_001251825;NM_003109;NM_138473
PHEX_SIG,PHEX,PHEX_SIG,PHEX,SIG,14,0.167819467198213,0.00241847952747973,0.00216013684180695,0.00326731978040459,0.00110718293859761,0.887579990441555,0.456770572653187,0.480448321508938,0.473903328688487,0.50195329791899,0.0280499692305032,0.735345108943989,ENSG00000102174,PHEX,protein_coding,X,1,22032325,22251310,p22.11,phosphate regulating endopeptidase homolog X-linked [Source:HGNC Symbol;Acc:HGNC:8918],HYPOPHOSPHATEMIC RICKETS X-LINKED DOMINANT;X-Linked Hypophosphatemia,PHEX,5251,NM_000444;NM_001282754
NDUFS5_SIG,NDUFS5,NDUFS5_SIG,NDUFS5,SIG,17,0.167728868030162,0.239929697236885,0.239710342570818,0.240650433996817,0.000940091425998784,0.887579990441555,0.888671135978922,5.71944923578226,5.70807852182752,5.7568101530621,0.0487316312345793,0.487903687703784,ENSG00000168653,NDUFS5,protein_coding,1,1,39026318,39034636,p34.3,NADH:ubiquinone oxidoreductase subunit S5 [Source:HGNC Symbol;Acc:HGNC:7712],NA,NDUFS5,4725,NM_001184979;NM_004552
F13A1_SIG,F13A1,F13A1_SIG,F13A1,SIG,17,0.167137335205056,0.0819122113646471,0.0816978741226586,0.0826164623026092,0.000918588179950453,0.887946810001699,1.34274011571596,6.27023813522853,6.19072099995506,6.53150872255565,0.340787722600591,0.278068986660539,ENSG00000124491,F13A1,protein_coding,6,-1,6144085,6321013,p25.1,coagulation factor XIII A chain [Source:HGNC Symbol;Acc:HGNC:3531],Congenital factor XIII deficiency;FACTOR XIII A SUBUNIT DEFICIENCY OF;MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED;THROMBOPHILIA DUE TO THROMBIN DEFECT,F13A1,2162,NM_000129
HCCS_SIG,HCCS,HCCS_SIG,HCCS,SIG,26,-0.165956403243486,0.266436830971618,0.266693811392659,0.265592466731053,-0.00110134466160638,0.888788407869584,0.977355927654075,3.83975167884657,3.82849116171051,3.87675052086508,0.048259359154577,0.442129467332408,ENSG00000004961,HCCS,protein_coding,X,1,11111301,11123086,p22.2,holocytochrome c synthase [Source:HGNC Symbol;Acc:HGNC:4837],LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1;MICROPHTHALMIA SYNDROMIC TYPE 7;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME,HCCS,3052,NM_001122608;NM_001171991;NM_005333
SDHC_SIG,SDHC,SDHC_SIG,SDHC,SIG,30,0.165455012409839,0.20669509677271,0.206329564430351,0.20789613161189,0.00156656718153913,0.88908250830353,0.601650048341868,4.42373138781378,4.41443877958216,4.45426424343197,0.0398254638498017,0.650085080459031,ENSG00000143252,SDHC,protein_coding,1,1,161314257,161375340,q23.3,succinate dehydrogenase complex subunit C [Source:HGNC Symbol;Acc:HGNC:10682],Carney-Stratakis syndrome;COWDEN SYNDROME;Gastrointestinal stromal tumor;Hereditary pheochromocytoma-paraganglioma;PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA;Paragangliomas 3,SDHC,6391,NM_001035511;NM_001035512;NM_001035513;NM_001278172;NM_003001
RBM15_SIG,RBM15,RBM15_SIG,RBM15,SIG,50,-0.162539844273396,0.511334928209991,0.512026750182061,0.509061798873189,-0.00296495130887133,0.891321439011587,1.99901185854418,5.70547874894682,5.6707548292345,5.81957162800156,0.148816798767059,0.0972391631095677,ENSG00000162775,RBM15,protein_coding,1,1,110338506,110346681,p13.3,RNA binding motif protein 15 [Source:HGNC Symbol;Acc:HGNC:14959],Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),RBM15,64783,NM_001201545;NM_022768
ZIK1_TF,ZIK1,ZIK1_TF,ZIK1,TF,23,0.16229778533953,0.015342418829411,0.0149402714999389,0.0166637600548194,0.00172348855488062,0.891406398966019,0.136950387319004,2.91072169576742,2.90700493701212,2.92293390310625,0.0159289660941293,0.923041179083176,ENSG00000171649,ZIK1,protein_coding,19,1,57578456,57593890,q13.43,zinc finger protein interacting with K protein 1 [Source:HGNC Symbol;Acc:HGNC:33104],NA,ZIK1,284307,NM_001010879;NM_001321145;NM_001321146;NM_001321147
ACBD5_SIG,ACBD5,ACBD5_SIG,ACBD5,SIG,30,0.160782715997992,0.2449332237129,0.244795633579841,0.245385305578666,0.000589671998824303,0.892517191991381,0.436903186174769,4.92116587333705,4.91683419557221,4.9353985288501,0.0185643332778894,0.746386643038787,ENSG00000107897,ACBD5,protein_coding,10,-1,27195214,27242130,p12.1,acyl-CoA binding domain containing 5 [Source:HGNC Symbol;Acc:HGNC:23338],NA,ACBD5,91452,NM_001042473;NM_001271512;NM_001301251;NM_001301252;NM_001301253;NM_001301254;NM_001352568;NM_001352569;NM_001352570;NM_001352571;NM_001352572;NM_001352573;NM_001352574;NM_001352575;NM_001352576;NM_001352577;NM_001352578;NM_001352579;NM_001352580;NM_001352581;NM_001352582;NM_001352583;NM_001352584;NM_001352585;NM_001352586;NM_001352587;NM_001352588;NM_145698
NUDT8_SIG,NUDT8,NUDT8_SIG,NUDT8,SIG,32,-0.159879134634191,0.122230990411574,0.122521602415668,0.12127612239812,-0.00124548001754792,0.893135159679773,0.380522213208183,1.8903017681311,1.88183627418672,1.9181169625198,0.0362806883330841,0.780110202138605,ENSG00000167799,NUDT8,protein_coding,11,-1,67627938,67629937,q13.2,nudix hydrolase 8 [Source:HGNC Symbol;Acc:HGNC:8055],NA,NUDT8,254552,NM_001243750;NM_181843
GLA_SIG,GLA,GLA_SIG,GLA,SIG,34,-0.159617667203064,0.054269756651519,0.0545259436253232,0.0534279994518766,-0.00109794417344652,0.893235588645468,-2.18738977870379,5.57033485362485,5.60156141380647,5.4677332987424,-0.133828115064064,0.0680514200858863,ENSG00000102393,GLA,protein_coding,X,-1,101397803,101408012,q22.1,galactosidase alpha [Source:HGNC Symbol;Acc:HGNC:4296],FABRY DISEASE,GLA,2717,NM_000169
NDUFB1_SIG,NDUFB1,NDUFB1_SIG,NDUFB1,SIG,21,-0.158962641774655,0.161654593828933,0.161987809658249,0.160559741818324,-0.00142806783992486,0.893653144936173,0.716075791277784,4.22515823942688,4.21568719857618,4.2562773736506,0.0405901750744206,0.582459155344262,ENSG00000183648,NDUFB1,protein_coding,14,-1,92116122,92121917,q32.12,NADH:ubiquinone oxidoreductase subunit B1 [Source:HGNC Symbol;Acc:HGNC:7695],NA,NDUFB1,4707,NM_004545
SF1_SIG,SF1,SF1_SIG,SF1,SIG,60,-0.158674238330366,0.23661366842158,0.237171290788458,0.234781480644693,-0.00238981014376542,0.893775220887634,0.366760901662586,8.95180723946373,8.94762827072729,8.96553813674062,0.0179098660133247,0.788210948975399,ENSG00000168066,SF1,protein_coding,11,-1,64764606,64778786,q13.1,splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:12950],NA,SF1,7536,NM_001178030;NM_001178031;NM_001346363;NM_001346364;NM_001346409;NM_001346410;NM_004630;NM_201995;NM_201997;NM_201998
TIMP1_SIG,TIMP1,TIMP1_SIG,TIMP1,SIG,30,0.158492883125884,0.0806238991210503,0.0802611439269318,0.0818158090445825,0.00155466511765072,0.893811025409871,-0.630678749881654,6.71826632959357,6.73584833265983,6.66049689094728,-0.0753514417125477,0.632112620895529,ENSG00000102265,TIMP1,protein_coding,X,1,47582408,47586789,p11.3,TIMP metallopeptidase inhibitor 1 [Source:HGNC Symbol;Acc:HGNC:11820],NA,TIMP1,7076,NM_003254
ATP1B3_SIG,ATP1B3,ATP1B3_SIG,ATP1B3,SIG,37,-0.157316718281366,0.173476137719352,0.173662050862386,0.172865280249386,-0.000796770612999621,0.894579182708289,1.57263973262137,6.11933272171681,6.09631882162995,6.19494982200223,0.0986310003722873,0.198810423902649,ENSG00000069849,ATP1B3,protein_coding,3,1,141876124,141926549,q23,ATPase Na+/K+ transporting subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:806],NA,ATP1B3,483,NM_001679
RPS16_SIG,RPS16,RPS16_SIG,RPS16,SIG,42,0.15726554947196,0.491256387668748,0.490770055914895,0.492854334859976,0.00208427894508112,0.894579182708289,0.693462341984099,8.15314386926275,8.14269358026403,8.18748053311571,0.0447869528516803,0.595792804112517,ENSG00000105193,RPS16,protein_coding,19,-1,39433137,39435949,q13.2,ribosomal protein S16 [Source:HGNC Symbol;Acc:HGNC:10396],NA,RPS16,6217,NM_001020;NM_001321111
ATG4D_SIG,ATG4D,ATG4D_SIG,ATG4D,SIG,32,-0.156166613428097,0.234121674532318,0.234581915512104,0.232609454170166,-0.00197246134193773,0.895354166792067,0.594648114716628,4.61353341338808,4.60397266406339,4.64494730402636,0.0409746399629725,0.654645699231989,ENSG00000130734,ATG4D,protein_coding,19,1,10543895,10553418,p13.2,autophagy related 4D cysteine peptidase [Source:HGNC Symbol;Acc:HGNC:20789],NA,ATG4D,84971,NM_001281504;NM_032885
CRABP1_SIG,CRABP1,CRABP1_SIG,CRABP1,SIG,15,0.153941757937675,-0.146773300153794,-0.146920284901523,-0.146290350268398,0.000629934633125021,0.897036408855716,-0.1380261530103,0.531534340259885,0.534953945025034,0.520298496031538,-0.0146554489934958,0.922530188805532,ENSG00000166426,CRABP1,protein_coding,15,1,78340353,78348225,q25.1,cellular retinoic acid binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2338],NA,CRABP1,1381,NM_004378
PRIM1_SIG,PRIM1,PRIM1_SIG,PRIM1,SIG,48,-0.152624071013858,0.497975864631664,0.498822954380755,0.495192569741795,-0.00363038463895976,0.897925819099476,0.0893119525071754,3.79281189290391,3.79083517449094,3.79930682483222,0.00847165034128084,0.950178370846345,ENSG00000198056,PRIM1,protein_coding,12,-1,56731580,56752373,q13.3,DNA primase subunit 1 [Source:HGNC Symbol;Acc:HGNC:9369],NA,PRIM1,5557,NM_000946
ATP7A_SIG,ATP7A,ATP7A_SIG,ATP7A,SIG,51,-0.152563371481406,0.303511206633986,0.303769246176719,0.302663362422147,-0.00110588375457208,0.897925819099476,0.22099355849158,4.17085003097484,4.16639407037535,4.18549104437317,0.0190969739978273,0.875104515744665,ENSG00000165240,ATP7A,protein_coding,X,1,77910656,78050395,q21.1,ATPase copper transporting alpha [Source:HGNC Symbol;Acc:HGNC:869],MENKES DISEASE;Occipital horn syndrome;Spinal muscular atrophy distal X-linked 3;X-linked distal spinal muscular atrophy type 3,ATP7A,538,NM_000052;NM_001282224
RBM17_SIG,RBM17,RBM17_SIG,RBM17,SIG,20,-0.152291256712887,0.299088760343437,0.29931284094718,0.298352495502566,-0.000960345444614397,0.898034353536796,3.27962634807988,6.92912402737897,6.90049067215219,7.02320505169554,0.122714379543354,0.0050895884899934,ENSG00000134453,RBM17,protein_coding,10,1,6089034,6117457,p15.1,RNA binding motif protein 17 [Source:HGNC Symbol;Acc:HGNC:16944],NA,RBM17,84991,NM_001145547;NM_032905
HELLS_SIG,HELLS,HELLS_SIG,HELLS,SIG,14,-0.148534833727099,0.272328857359998,0.272956648364637,0.270266115487615,-0.00269053287702153,0.900951045475443,0.670272380916153,4.3720870559621,4.35450102053084,4.42986974380766,0.0753687232768244,0.609237743366906,ENSG00000119969,HELLS,protein_coding,10,1,94501434,94613905,q23.33,helicase, lymphoid specific [Source:HGNC Symbol;Acc:HGNC:4861],ICF syndrome;IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME4,HELLS,3070,NM_001289067;NM_001289068;NM_001289069;NM_001289070;NM_001289071;NM_001289072;NM_001289073;NM_001289074;NM_001289075;NM_018063
HNRNPL_SIG,HNRNPL,HNRNPL_SIG,HNRNPL,SIG,88,0.146918115606706,0.331667618239315,0.331132725372312,0.333425123373751,0.0022923980014386,0.902143295433297,0.395092356595275,7.25406742479216,7.24907648291022,7.27046623383282,0.021389750922604,0.771299556273774,ENSG00000104824,HNRNPL,protein_coding,19,-1,38836388,38852347,q13.2,heterogeneous nuclear ribonucleoprotein L [Source:HGNC Symbol;Acc:HGNC:5045],NA,HNRNPL,3191,NM_001005335;NM_001533
DNMT1_TF,DNMT1,DNMT1_TF,DNMT1,TF,249,-0.146027390259148,0.334610592229185,0.334988153353551,0.333370034249124,-0.00161811910442653,0.902750192358345,-0.855536881942557,7.22714198938698,7.24083410163984,7.18215362055613,-0.0586804810837149,0.50525619907043,ENSG00000130816,DNMT1,protein_coding,19,-1,10133345,10231286,p13.2,DNA methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:2976],Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome;CEREBELLAR ATAXIA DEAFNESS AND NARCOLEPSY AUTOSOMAL DOMINANT;Hereditary sensory neuropathy-deafness-dementia syndrome;NEUROPATHY HEREDITARY SENSORY TYPE IE,DNMT1,1786,NM_001130823;NM_001318730;NM_001318731;NM_001379
UIMC1_SIG,UIMC1,UIMC1_SIG,UIMC1,SIG,17,-0.142712482642853,0.291247555018444,0.291537608284468,0.290294522858649,-0.00124308542581884,0.905311904571362,1.99031679902451,5.71714621016338,5.69216483761237,5.79922786283097,0.107063025218595,0.0988592588330363,ENSG00000087206,UIMC1,protein_coding,5,-1,176905005,177022633,q35.2,ubiquitin interaction motif containing 1 [Source:HGNC Symbol;Acc:HGNC:30298],NA,UIMC1,51720,NM_001199297;NM_001199298;NM_001317961;NM_016290
GMEB1_TF,GMEB1,GMEB1_TF,GMEB1,TF,42,-0.14022055660565,0.329958820949327,0.33010771337321,0.32946960298514,-0.000638110388070087,0.907210288083206,-1.53497608036305,5.02222185587058,5.03656074404618,4.97510836615076,-0.061452377895418,0.210580271815718,ENSG00000162419,GMEB1,protein_coding,1,1,28668732,28719353,p35.3,glucocorticoid modulatory element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:4370],NA,GMEB1,10691,NM_001319674;NM_006582;NM_024482
EIF4H_SIG,EIF4H,EIF4H_SIG,EIF4H,SIG,46,-0.137924042928753,0.474586461091239,0.474884810289546,0.473606170868228,-0.00127863942131863,0.908951228068804,1.74440670414478,7.95685988251753,7.93476430812769,8.02945962694129,0.0946953188135993,0.151526974118096,ENSG00000106682,EIF4H,protein_coding,7,1,74174245,74197101,q11.23,eukaryotic translation initiation factor 4H [Source:HGNC Symbol;Acc:HGNC:12741],NA,EIF4H,7458,NM_022170;NM_031992
MEF2D_TF,MEF2D,MEF2D_TF,MEF2D,TF,88,0.137743068088935,0.0201945627107442,0.0199863942758971,0.0208785447109562,0.000892150435059207,0.908985243345485,-1.40893993811228,7.86904950160683,7.89792089094271,7.77418636521751,-0.1237345257252,0.253208929635391,ENSG00000116604,MEF2D,protein_coding,1,-1,156463727,156500779,q22,myocyte enhancer factor 2D [Source:HGNC Symbol;Acc:HGNC:6997],NA,MEF2D,4209,NM_001271629;NM_005920
ZNF350_TF,ZNF350,ZNF350_TF,ZNF350,TF,108,0.136692433781222,0.20100933653098,0.200659053439063,0.202160266690138,0.0015012132510752,0.909720875612025,-0.372194723773744,4.35222472595136,4.35755063524644,4.33472530969608,-0.0228253255503663,0.785258088407906,ENSG00000256683,ZNF350,protein_coding,19,-1,51964340,51986856,q13.41,zinc finger protein 350 [Source:HGNC Symbol;Acc:HGNC:16656],NA,ZNF350,59348,NM_021632
SPTLC1_SIG,SPTLC1,SPTLC1_SIG,SPTLC1,SIG,19,-0.136476269363071,0.596777716471832,0.597252390850001,0.595218072086419,-0.00203431876358224,0.909783201497834,-0.289087796561381,5.54664640713885,5.55021295249274,5.53492775811892,-0.0152851943738189,0.834408863616975,ENSG00000090054,SPTLC1,protein_coding,9,-1,92000087,92115413,q22.31,serine palmitoyltransferase long chain base subunit 1 [Source:HGNC Symbol;Acc:HGNC:11277],Hereditary sensory and autonomic neuropathy type 1;NEUROPATHY HEREDITARY SENSORY AND AUTONOMIC TYPE IA,SPTLC1,10558,NM_001281303;NM_006415;NM_178324
ATF1_SIG,ATF1,ATF1_SIG,ATF1,SIG,39,-0.1359899706436,0.327158398687081,0.327624565188473,0.325626708753937,-0.00199785643453594,0.910063431620629,-1.29064816741808,4.49055371511983,4.51535150651723,4.40907525767125,-0.106276248845978,0.298724572158293,ENSG00000123268,ATF1,protein_coding,12,1,50763710,50821162,q13.12,activating transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:783],Melanoma of soft tissue,ATF1,466,NM_005171
DYNC1LI1_SIG,DYNC1LI1,DYNC1LI1_SIG,DYNC1LI1,SIG,8,-0.134686146795614,0.201319057012423,0.201416466907315,0.200998995929207,-0.000417470978107989,0.910946291335616,0.807136755180726,5.60609155913074,5.59975785262359,5.6269023090828,0.0271444564592106,0.531159881656421,ENSG00000144635,DYNC1LI1,protein_coding,3,-1,32525974,32570858,p22.3,dynein cytoplasmic 1 light intermediate chain 1 [Source:HGNC Symbol;Acc:HGNC:18745],NA,DYNC1LI1,51143,NM_001329135;NM_016141
KCNIP3_TF,KCNIP3,KCNIP3_TF,KCNIP3,TF,142,0.134504745614754,-0.092680714819493,-0.0928291897438302,-0.0921928686395277,0.00063632110430234,0.910946291335616,-1.39792810795088,0.511315269501597,0.536925263744706,0.427168145559951,-0.109757118184755,0.257380033532336,ENSG00000115041,KCNIP3,protein_coding,2,1,95297327,95386077,q11.1,potassium voltage-gated channel interacting protein 3 [Source:HGNC Symbol;Acc:HGNC:15523],NA,KCNIP3,30818,NM_001034914;NM_013434
PRDM4_SIG,PRDM4,PRDM4_SIG,PRDM4,SIG,24,-0.134478471193721,0.262607562495816,0.262748876600095,0.262143244724613,-0.000605631875481688,0.910946291335616,-0.554055679665134,5.60922396082644,5.61555853431007,5.58841036223738,-0.0271481720726953,0.678299092458497,ENSG00000110851,PRDM4,protein_coding,12,-1,107732871,107761272,q23.3,PR/SET domain 4 [Source:HGNC Symbol;Acc:HGNC:9348],NA,PRDM4,11108,NM_012406
HNRNPF_SIG,HNRNPF,HNRNPF_SIG,HNRNPF,SIG,28,0.13320091554725,0.37555667533003,0.375155987966792,0.376873219523526,0.00171723155673334,0.911864547965253,-0.117473762871951,7.9063489075727,7.90817743992258,7.90034087270881,-0.00783656721377216,0.934895433890649,ENSG00000169813,HNRNPF,protein_coding,10,-1,43385617,43409166,q11.21,heterogeneous nuclear ribonucleoprotein F [Source:HGNC Symbol;Acc:HGNC:5039],NA,HNRNPF,3185,NM_001098204;NM_001098205;NM_001098206;NM_001098207;NM_001098208;NM_004966
ZACN_SIG,ZACN,ZACN_SIG,ZACN,SIG,25,0.132862460313333,-0.107032487237821,-0.107169453233099,-0.106582456110477,0.000586997122622774,0.912025278454261,0.580621966356172,0.258478317815889,0.255363589228209,0.268712426032551,0.0133488368043424,0.66278043300179,ENSG00000186919,ZACN,protein_coding,17,1,76071961,76083666,q25.1,zinc activated ion channel [Source:HGNC Symbol;Acc:HGNC:29504],NA,ZACN,353174,NM_180990
SPCS2_SIG,SPCS2,SPCS2_SIG,SPCS2,SIG,33,0.13110405226237,0.282082370719512,0.281896260294712,0.282693876400997,0.000797616106285332,0.913331257659588,0.415559724051166,3.1799742092121,3.17459649655943,3.19764383649945,0.023047339940022,0.759774696147011,ENSG00000118363,SPCS2,protein_coding,11,1,74949247,74979033,q13.4,signal peptidase complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:28962],NA,SPCS2,9789,NM_014752
MST1L_SIG,MST1L,MST1L_SIG,MST1L,SIG,6,0.130926803526264,-0.121289669225193,-0.121513292351312,-0.120554907525085,0.000958384826226687,0.913361820511628,0.799036402973109,1.06405321188633,1.04929724675062,1.11253709733227,0.0632398505816527,0.535690722569946,ENSG00000186715,MST1L,transcribed_unprocessed_pseudogene,1,-1,16754910,16770237,p36.13,macrophage stimulating 1 like [Source:HGNC Symbol;Acc:HGNC:7390],NA,MST1L,11223,NM_001271733
CNKSR1_SIG,CNKSR1,CNKSR1_SIG,CNKSR1,SIG,50,-0.130625340128522,-0.0782500934568769,-0.0780544613664051,-0.078892884611284,-0.000838423244878983,0.913492555802061,-0.833244187113837,1.32857571542179,1.34319993739858,1.28052470035516,-0.0626752370434205,0.51739877765909,ENSG00000142675,CNKSR1,protein_coding,1,1,26177484,26189884,p36.11,connector enhancer of kinase suppressor of Ras 1 [Source:HGNC Symbol;Acc:HGNC:19700],Autosomal Recessive Mental Retardation,CNKSR1,10256,NM_001297647;NM_001297648;NM_006314
RC3H1_SIG,RC3H1,RC3H1_SIG,RC3H1,SIG,26,-0.130234402845046,0.244369266385091,0.244589630644809,0.243645212388876,-0.000944418255932204,0.9136954223634,-0.353916507353045,7.01811282797131,7.02149036709513,7.00701519942158,-0.014475167673556,0.795163604251732,ENSG00000135870,RC3H1,protein_coding,1,-1,173931214,174022297,q25.1,ring finger and CCCH-type domains 1 [Source:HGNC Symbol;Acc:HGNC:29434],NA,RC3H1,149041,NM_001300850;NM_001300851;NM_001300852;NM_172071
UQCRC1_SIG,UQCRC1,UQCRC1_SIG,UQCRC1,SIG,46,0.129347365846712,0.255641223969104,0.255398182310283,0.256439789419517,0.00104160710923345,0.914298307979558,1.53740131625162,6.59679768084792,6.57732229879614,6.6607882218752,0.0834659230790668,0.209871737649157,ENSG00000010256,UQCRC1,protein_coding,3,-1,48599002,48610976,p21.31,ubiquinol-cytochrome c reductase core protein 1 [Source:HGNC Symbol;Acc:HGNC:12585],NA,UQCRC1,7384,NM_003365
RAE1_SIG,RAE1,RAE1_SIG,RAE1,SIG,27,-0.128483846299256,0.433056458628381,0.433328082053906,0.432163981658798,-0.00116410039510729,0.914882162548946,1.04888524379592,5.09479905111764,5.08273051724436,5.13445280527268,0.0517222880283218,0.406617363181352,ENSG00000101146,RAE1,protein_coding,20,1,57351223,57379211,q13.31,ribonucleic acid export 1 [Source:HGNC Symbol;Acc:HGNC:9828],NA,RAE1,8480,NM_001015885;NM_003610
SCYL1_SIG,SCYL1,SCYL1_SIG,SCYL1,SIG,31,0.127991052085964,0.137364320661814,0.137246876071371,0.137750210030412,0.00050333395904159,0.915164209569513,-0.89206456729477,6.00064149357656,6.00824347459441,5.9756635559465,-0.0325799186479064,0.486028067965962,ENSG00000142186,SCYL1,protein_coding,11,1,65525077,65538704,q13.1,SCY1 like pseudokinase 1 [Source:HGNC Symbol;Acc:HGNC:14372],Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome;Episodes of Liver Failure Peripheral Neuropathy Cerebellar Atrophy and Ataxia;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE 21,SCYL1,57410,NM_001048218;NM_020680
ZFAND2B_TF,ZFAND2B,ZFAND2B_TF,ZFAND2B,TF,96,-0.127854938506482,0.0160511740175436,0.0161742007397429,0.0156469433588887,-0.00052725738085429,0.915164209569513,-1.10409237465707,5.02188799838425,5.033080895061,4.98511133787492,-0.0479695571860832,0.380491709095261,ENSG00000158552,ZFAND2B,protein_coding,2,1,219195237,219209651,q35,zinc finger AN1-type containing 2B [Source:HGNC Symbol;Acc:HGNC:25206],NA,ZFAND2B,130617,NM_001270998;NM_001270999;NM_138802
SIRT1_SIG,SIRT1,SIRT1_SIG,SIRT1,SIG,29,-0.127238282008637,0.350381997255309,0.350562616867561,0.349788532815056,-0.000774084052504575,0.915548840586036,0.304141046356606,5.22257398695643,5.21879780689156,5.23498143574101,0.0161836288494497,0.825351365872258,ENSG00000096717,SIRT1,protein_coding,10,1,67884656,67918390,q21.3,sirtuin 1 [Source:HGNC Symbol;Acc:HGNC:14929],NA,SIRT1,23411,NM_001142498;NM_001314049;NM_012238
CNR2_SIG,CNR2,CNR2_SIG,CNR2,SIG,18,-0.125986201668075,-0.0282151967913628,-0.0279845995562653,-0.0289728734209691,-0.000988273864703608,0.916445720126442,2.51570814268131,1.89384584149864,1.82529984971676,2.11906838592481,0.293768536208051,0.0341107894008973,ENSG00000188822,CNR2,protein_coding,1,-1,23870515,23913362,p36.11,cannabinoid receptor 2 [Source:HGNC Symbol;Acc:HGNC:2160],NA,CNR2,1269,NM_001841
NCK2_SIG,NCK2,NCK2_SIG,NCK2,SIG,19,-0.123703661964693,0.211737451612168,0.211937470496652,0.211080246706003,-0.00085722379064912,0.918173450743327,-2.04308711295932,5.66758190781368,5.69971614635934,5.56199798116364,-0.137718165195696,0.0896954652843975,ENSG00000071051,NCK2,protein_coding,2,1,105744912,105894274,q12.2,NCK adaptor protein 2 [Source:HGNC Symbol;Acc:HGNC:7665],NA,NCK2,8440,NM_001004720;NM_001004722;NM_003581
MAP3K1_SIG,MAP3K1,MAP3K1_SIG,MAP3K1,SIG,29,0.12200251357203,0.12575363216226,0.125534962117463,0.126472119452306,0.000937157334843189,0.919432383686405,0.644763957910519,6.95695897033432,6.9438130432883,7.00015273062838,0.0563396873400767,0.624136979817812,ENSG00000095015,MAP3K1,protein_coding,5,1,56815549,56896152,q11.2,mitogen-activated protein kinase kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:6848],46XY complete gonadal dysgenesis;46XY partial gonadal dysgenesis;46XY SEX REVERSAL 6,MAP3K1,4214,NM_005921
TAF5_TF,TAF5,TAF5_TF,TAF5,TF,189,0.121762447758901,0.176336495848558,0.176064385948732,0.1772305712337,0.00116618528496797,0.919512975141069,-0.345544248734498,2.96221235088258,2.96812410413783,2.94278801875816,-0.0253360853796757,0.800414144301413,ENSG00000148835,TAF5,protein_coding,10,1,103367976,103389065,q24.33,TATA-box binding protein associated factor 5 [Source:HGNC Symbol;Acc:HGNC:11539],NA,TAF5,6877,NM_006951;NM_139052
KCNH4_SIG,KCNH4,KCNH4_SIG,KCNH4,SIG,11,0.120778550441131,-0.0492271755996389,-0.0493528042920392,-0.0488143956103233,0.000538408681715912,0.920193346676856,0.776033424779107,0.875365400717134,0.861017645789589,0.922508024050497,0.0614903782609077,0.548560769184827,ENSG00000089558,KCNH4,protein_coding,17,-1,42156891,42181142,q21.2,potassium voltage-gated channel subfamily H member 4 [Source:HGNC Symbol;Acc:HGNC:6253],NA,KCNH4,23415,NM_012285
MARCH7_SIG,MARCH7,MARCH7_SIG,MARCH7,SIG,34,0.117724316453588,0.412373191048969,0.412076688937711,0.413347412271674,0.00127072333396321,0.922537092515551,-0.56684536787604,7.01396204637378,7.02294112854438,6.98445934781323,-0.0384817807311516,0.670762365029504,ENSG00000136536,MARCH7,protein_coding,2,1,159712457,159771027,q24.2,membrane associated ring-CH-type finger 7 [Source:HGNC Symbol;Acc:HGNC:17393],NA,MARCH7,64844,NM_001282805;NM_001282806;NM_001282807;NM_022826
FBXO7_SIG,FBXO7,FBXO7_SIG,FBXO7,SIG,46,-0.117591548859832,0.349865144792295,0.35017299845554,0.348853625613063,-0.00131937284247649,0.922537092515551,-0.757971289061756,7.50023657683758,7.5110079898443,7.46484479124407,-0.0461631986002205,0.558920957034116,ENSG00000100225,FBXO7,protein_coding,22,1,32474676,32498829,q12.3,F-box protein 7 [Source:HGNC Symbol;Acc:HGNC:13586],PARKINSON DISEASE 15 AUTOSOMAL RECESSIVE EARLY-ONSET;Parkinsonian-pyramidal syndrome,FBXO7,25793,NM_001033024;NM_001257990;NM_012179
HSD17B12_SIG,HSD17B12,HSD17B12_SIG,HSD17B12,SIG,5,-0.11726174033733,0.586335024796543,0.586538518956497,0.585666401128125,-0.000872117828371757,0.922689736389809,2.52275131354552,5.75925442556867,5.71454912608987,5.90614326671331,0.191594140623432,0.0336389196557932,ENSG00000149084,HSD17B12,protein_coding,11,1,43680680,43856617,p11.2,hydroxysteroid 17-beta dehydrogenase 12 [Source:HGNC Symbol;Acc:HGNC:18646],NA,HSD17B12,51144,NM_016142
IL1RL1_SIG,IL1RL1,IL1RL1_SIG,IL1RL1,SIG,23,-0.116605832154409,-0.0429906509493779,-0.0427077361101208,-0.0439202282783656,-0.00121249216824471,0.923105313860723,0.795268665500875,2.54624994074924,2.50779401491576,2.67260512563067,0.164811110714902,0.537858502982635,ENSG00000115602,IL1RL1,protein_coding,2,1,102311502,102352037,q12.1,interleukin 1 receptor like 1 [Source:HGNC Symbol;Acc:HGNC:5998],NA,IL1RL1,9173,NM_001282408;NM_003856;NM_016232
UBR2_SIG,UBR2,UBR2_SIG,UBR2,SIG,74,-0.11640246323323,0.316535271421386,0.316684135673668,0.316046146021032,-0.000637989652636514,0.923131758187831,-0.694975331979218,6.56805939946078,6.57604183095562,6.54183141026345,-0.0342104206921743,0.594980416767968,ENSG00000024048,UBR2,protein_coding,6,1,42564062,42693504,p21.1,ubiquitin protein ligase E3 component n-recognin 2 [Source:HGNC Symbol;Acc:HGNC:21289],NA,UBR2,23304,NM_001184801;NM_001363705;NM_015255
CTDSP2_SIG,CTDSP2,CTDSP2_SIG,CTDSP2,SIG,44,-0.116291845794577,0.203222264689207,0.203399100939715,0.202641231294679,-0.000757869645036906,0.923131758187831,0.00143878891547513,7.86569359549742,7.86567388562684,7.86575835650076,8.44708739117406e-05,0.999070752425435,ENSG00000175215,CTDSP2,protein_coding,12,-1,57819927,57846729,q14.1,CTD small phosphatase 2 [Source:HGNC Symbol;Acc:HGNC:17077],NA,CTDSP2,10106,NM_005730
FASTKD5_SIG,FASTKD5,FASTKD5_SIG,FASTKD5,SIG,61,-0.114091543860864,0.459102211859236,0.459537941531312,0.457670528650985,-0.00186741288032757,0.924792374838226,0.454679224486213,5.46933862794484,5.45998900409041,5.50005882060939,0.0400698165189794,0.736514266982035,ENSG00000215251,FASTKD5,protein_coding,20,-1,3146519,3159865,p13,FAST kinase domains 5 [Source:HGNC Symbol;Acc:HGNC:25790],NA,FASTKD5,60493,NM_021826
SCP2_SIG,SCP2,SCP2_SIG,SCP2,SIG,30,-0.113818660858218,0.409063815765709,0.409302929040633,0.408278157862385,-0.00102477117824812,0.924898858882288,0.0978136738306212,6.20286359500161,6.20149398787116,6.20736373271595,0.00586974484479524,0.945301968638978,ENSG00000116171,SCP2,protein_coding,1,1,52927276,53051698,p32.3,sterol carrier protein 2 [Source:HGNC Symbol;Acc:HGNC:10606],Leukoencephalopathy-dystonia-motor neuropathy syndrome;LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY,SCP2,6342,NM_001007098;NM_001007099;NM_001007100;NM_001007250;NM_001193599;NM_001193600;NM_001193617;NM_001330587;NM_002979
ZNF805_TF,ZNF805,ZNF805_TF,ZNF805,TF,123,0.113375003735881,0.258368413518395,0.257980032133887,0.259644523781776,0.00166449164788846,0.92514300065815,0.860764631385289,3.21373379621534,3.19537641562282,3.27405090387647,0.0786744882536538,0.502684713628812,ENSG00000204524,ZNF805,protein_coding,19,1,57240632,57262728,q13.43,zinc finger protein 805 [Source:HGNC Symbol;Acc:HGNC:23272],NA,ZNF805,390980,NM_001023563;NM_001145078
DUT_SIG,DUT,DUT_SIG,DUT,SIG,27,0.110697545797563,0.293666136322356,0.293263897448368,0.29498777833689,0.00172388088852239,0.927188089383149,0.26238775475946,5.75278589121473,5.74826460221629,5.76764155506675,0.0193769528504646,0.850047177398279,ENSG00000128951,DUT,protein_coding,15,1,48331011,48343373,q21.1,deoxyuridine triphosphatase [Source:HGNC Symbol;Acc:HGNC:3078],NA,DUT,1854,NM_001025248;NM_001025249;NM_001330286;NM_001948
RPLP2_SIG,RPLP2,RPLP2_SIG,RPLP2,SIG,17,-0.110267675897794,1.35181996769042,1.3522565110221,1.35038561102919,-0.00187089999290993,0.927420898954164,-0.249808525436677,8.69421977729409,8.6976929034723,8.68280807699426,-0.0148848264780364,0.857961760311809,ENSG00000177600,RPLP2,protein_coding,11,1,809965,812880,p15.5,ribosomal protein lateral stalk subunit P2 [Source:HGNC Symbol;Acc:HGNC:10377],NA,RPLP2,6181,NM_001004
KHSRPP1_SIG,KHSRPP1,KHSRPP1_SIG,KHSRPP1,SIG,18,0.11004600076734,0.0983179919711896,0.0981751751423873,0.0987872472658255,0.000612072123438108,0.927485818313215,0.910033081046674,2.30903636174938,2.299660606543,2.33984241457033,0.0401818080273292,0.47663690065766,ENSG00000229835,KHSRPP1,processed_pseudogene,9,1,21695176,21696943,p21.3,KH-type splicing regulatory protein pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:39198],NA,KHSRPP1,NA,NA
AQP1_SIG,AQP1,AQP1_SIG,AQP1,SIG,18,-0.109720399532533,-0.0333891230238625,-0.0330709539304633,-0.0344345357593173,-0.00136358182885415,0.927634504048708,0.956578627770991,2.31868304910145,2.27492654300177,2.46245442628613,0.187527883284358,0.452256878776803,ENSG00000240583,AQP1,protein_coding,7,1,30911694,30925517,p14.3,aquaporin 1 (Colton blood group) [Source:HGNC Symbol;Acc:HGNC:633],BLOOD GROUP COLTON SYSTEM,AQP1,358,NM_001329872;NM_198098
MC1R_SIG,MC1R,MC1R_SIG,MC1R,SIG,52,-0.109176671373345,0.0761132919898558,0.0762528690255714,0.0756546817296473,-0.000598187295924221,0.9279589891319,-0.557937668451445,1.78573262336036,1.79543755043894,1.75384500581648,-0.0415925446224532,0.676302219619528,ENSG00000258839,MC1R,protein_coding,16,1,89912119,89920977,q24.3,melanocortin 1 receptor [Source:HGNC Symbol;Acc:HGNC:6929],ALBINISM OCULOCUTANEOUS TYPE II;Familial melanoma;Increased analgesia from kappa-opioid receptor agonist female-specific;Large congenital melanocytic nevus;MELANOMA CUTANEOUS MALIGNANT SUSCEPTIBILITY TO 5;Oculocutaneous albinism type 2;SKIN/HAIR/EYE PIGMENTATION VARIATION IN 2,MC1R,4157,NM_002386
BRD1_SIG,BRD1,BRD1_SIG,BRD1,SIG,36,-0.109012967242356,0.402513626179829,0.402726726376312,0.401813439819957,-0.000913286556355301,0.927977115244363,0.857942041844469,6.38406647902975,6.37304812658411,6.42026963706544,0.0472215104813377,0.504096107923921,ENSG00000100425,BRD1,protein_coding,22,-1,49773283,49827512,q13.33,bromodomain containing 1 [Source:HGNC Symbol;Acc:HGNC:1102],NA,BRD1,23774,NM_001304808;NM_001304809;NM_001349940;NM_001349941;NM_001349942
ITGA10_SIG,ITGA10,ITGA10_SIG,ITGA10,SIG,30,0.108826098358921,0.0189523154255262,0.0187645785837141,0.0195691650486229,0.000804586464908818,0.928013908103068,-0.0485118895877698,1.04698527254256,1.04776194101413,1.04443336185028,-0.00332857916385051,0.973154723067578,ENSG00000143127,ITGA10,protein_coding,1,-1,145891208,145910111,q21.1,integrin subunit alpha 10 [Source:HGNC Symbol;Acc:HGNC:6135],NA,ITGA10,8515,NM_001303040;NM_001303041;NM_003637
COA1_SIG,COA1,COA1_SIG,COA1,SIG,13,-0.108410169488296,0.0859745959130107,0.086089672430165,0.0855964873566465,-0.000493185073518597,0.928235281683132,-0.0620709197149307,4.83409488667732,4.83472880338643,4.83201201749024,-0.00271678589618588,0.965879444307668,ENSG00000106603,COA1,protein_coding,7,-1,43608456,43729717,p13,cytochrome c oxidase assembly factor 1 homolog [Source:HGNC Symbol;Acc:HGNC:21868],NA,COA1,55744,NM_001321197;NM_001321198;NM_001321199;NM_001321200;NM_001321201;NM_001321202;NM_001321203;NM_001321204;NM_001321205;NM_001350924;NM_001350925;NM_001350926;NM_001350927;NM_001350928;NM_018224
TDRKH_SIG,TDRKH,TDRKH_SIG,TDRKH,SIG,29,-0.10735383953735,-0.078844133873606,-0.0787192203335201,-0.0792545640767454,-0.000535343743225215,0.928972663812787,0.31534146696804,1.96812509866512,1.96025123333356,1.99399637046879,0.0337451371352279,0.818562322302179,ENSG00000182134,TDRKH,protein_coding,1,-1,151770107,151791416,q21.3,tudor and KH domain containing [Source:HGNC Symbol;Acc:HGNC:11713],NA,TDRKH,11022,NM_001083963;NM_001083964;NM_001083965;NM_006862
BAZ2A_TF,BAZ2A,BAZ2A_TF,BAZ2A,TF,224,0.106570495154736,0.145590782860444,0.145392906364339,0.146240948490503,0.000848042126164267,0.929426416879629,0.73136809076862,8.38454353396805,8.37525009974998,8.41507910354171,0.0398290037917252,0.573802136202481,ENSG00000076108,BAZ2A,protein_coding,12,-1,56595596,56636816,q13.3,bromodomain adjacent to zinc finger domain 2A [Source:HGNC Symbol;Acc:HGNC:962],NA,BAZ2A,11176,NM_001300905;NM_001351156;NM_013449
CDYL_SIG,CDYL,CDYL_SIG,CDYL,SIG,17,0.106507978923257,0.350521828419964,0.35036311690188,0.351043309122242,0.000680192220362223,0.929426416879629,0.128551596304173,4.83458705552746,4.83288008273972,4.84019568040144,0.00731559766172393,0.9278937071366,ENSG00000153046,CDYL,protein_coding,6,1,4706159,4955551,p25.1,chromodomain Y like [Source:HGNC Symbol;Acc:HGNC:1811],NA,CDYL,9425,NM_001143970;NM_001143971;NM_004824
MAGOH_SIG,MAGOH,MAGOH_SIG,MAGOH,SIG,26,-0.105957822731781,0.239383963360143,0.239490238025585,0.239034775173693,-0.000455462851892428,0.929755734555162,0.101050791517305,5.33163720655497,5.33069037072374,5.33474823857187,0.00405786784813247,0.943836237636676,ENSG00000162385,MAGOH,protein_coding,1,-1,53226900,53238518,p32.3,mago homolog, exon junction complex subunit [Source:HGNC Symbol;Acc:HGNC:6815],NA,MAGOH,4116,NM_002370
SLC38A1_SIG,SLC38A1,SLC38A1_SIG,SLC38A1,SIG,73,0.10568960111699,0.118239486434817,0.117938823017121,0.119227380521532,0.00128855750441083,0.929857868855462,0.834305253087231,7.34852717380586,7.31678624265049,7.4528188047449,0.136032562094411,0.516786690096501,ENSG00000111371,SLC38A1,protein_coding,12,-1,46183063,46270017,q13.11,solute carrier family 38 member 1 [Source:HGNC Symbol;Acc:HGNC:13447],NA,SLC38A1,81539,NM_001077484;NM_001278387;NM_001278388;NM_001278389;NM_001278390;NM_030674
MPP3_SIG,MPP3,MPP3_SIG,MPP3,SIG,31,0.103388772237498,-0.0302548476291564,-0.0304169754028818,-0.0297221420869157,0.000694833315966106,0.931597462725508,2.60240680040941,1.17507430239848,1.11361154339976,1.37702336767998,0.26341182428022,0.0280049168311936,ENSG00000161647,MPP3,protein_coding,17,-1,43800799,43833170,q21.31,membrane palmitoylated protein 3 [Source:HGNC Symbol;Acc:HGNC:7221],NA,MPP3,4356,NM_001330233;NM_001353080;NM_001932
BCAS2_SIG,BCAS2,BCAS2_SIG,BCAS2,SIG,32,0.102963326280031,0.401057367364382,0.400811070150636,0.401866629638117,0.00105555948748014,0.931826067495855,-0.0339885090355089,4.74531926706351,4.74576808388398,4.74384458322482,-0.00192350065916186,0.981655315240402,ENSG00000116752,BCAS2,protein_coding,1,-1,114567557,114581629,p13.2,BCAS2, pre-mRNA processing factor [Source:HGNC Symbol;Acc:HGNC:975],NA,BCAS2,10286,NM_005872
NDUFV2_SIG,NDUFV2,NDUFV2_SIG,NDUFV2,SIG,104,-0.102567501110661,0.156191008808714,0.156635485051645,0.154730586867656,-0.00190489818398918,0.93203076988425,2.06096338725619,3.7062055446205,3.63454538314346,3.94166036090221,0.307114977758753,0.0865699004481759,ENSG00000178127,NDUFV2,protein_coding,18,1,9102630,9134345,p11.22,NADH:ubiquinone oxidoreductase core subunit V2 [Source:HGNC Symbol;Acc:HGNC:7717],Isolated complex I deficiency;Leigh syndrome with leukodystrophy;MITOCHONDRIAL COMPLEX I DEFICIENCY NUCLEAR TYPE 7,NDUFV2,4729,NM_021074
ZNF410_TF,ZNF410,ZNF410_TF,ZNF410,TF,186,-0.101074100208554,0.0835685620438205,0.0838351979308189,0.0826924727008257,-0.00114272522999336,0.933119576062753,0.140578458046052,1.74675662698495,1.74461803734686,1.75378342151012,0.00916538416326346,0.92124130992949,ENSG00000119725,ZNF410,protein_coding,14,1,73886617,73932511,q24.3,zinc finger protein 410 [Source:HGNC Symbol;Acc:HGNC:20144],NA,ZNF410,57862,NM_001242924;NM_001242926;NM_001242927;NM_001242928;NM_021188
ETV4_TF,ETV4,ETV4_TF,ETV4,TF,88,0.0999999819990134,-0.0593287321532725,-0.0593920765812159,-0.0591206004614585,0.000271476119757217,0.933870527216312,-1.27209212649478,0.302633222123403,0.320000496514097,0.24556932055398,-0.0744311759601168,0.306311639077186,ENSG00000175832,ETV4,protein_coding,17,-1,43527844,43579620,q21.31,ETS variant 4 [Source:HGNC Symbol;Acc:HGNC:3493],Ewing sarcoma,ETV4,2118,NM_001079675;NM_001261437;NM_001261438;NM_001261439;NM_001986
PAFAH1B2_SIG,PAFAH1B2,PAFAH1B2_SIG,PAFAH1B2,SIG,17,0.0988577342474902,0.332668422092857,0.33250778937499,0.333196215308704,0.000688425933713447,0.934676270026412,0.909742186744653,6.29716848296856,6.28454773119235,6.33863666737614,0.0540889361837947,0.476756185578768,ENSG00000168092,PAFAH1B2,protein_coding,11,1,117144284,117176894,q23.3,platelet activating factor acetylhydrolase 1b catalytic subunit 2 [Source:HGNC Symbol;Acc:HGNC:8575],NA,PAFAH1B2,5049,NM_001184746;NM_001184747;NM_001184748;NM_001309431;NM_002572
MBTPS1_SIG,MBTPS1,MBTPS1_SIG,MBTPS1,SIG,25,-0.0986243794924921,0.263552621268876,0.263684074242332,0.26312070435609,-0.000563369886241978,0.934749786314335,-0.786958745492585,7.11776366188237,7.12675411302322,7.08822360813389,-0.038530504889331,0.542136678794437,ENSG00000140943,MBTPS1,protein_coding,16,-1,84053761,84116942,q24.1,membrane bound transcription factor peptidase, site 1 [Source:HGNC Symbol;Acc:HGNC:15456],NA,MBTPS1,8720,NM_003791
TUBB_SIG,TUBB,TUBB_SIG,TUBB,SIG,28,-0.0982976332397791,0.552508409278725,0.552959850330621,0.551025102965351,-0.00193474736527019,0.93489850731467,0.341434191602839,9.35203678066317,9.34494081556316,9.37535209456319,0.0304112790000258,0.802884688547986,ENSG00000196230,TUBB,protein_coding,6,1,30720352,30725426,p21.33,tubulin beta class I [Source:HGNC Symbol;Acc:HGNC:20778],Circumferential Skin Creases Kunze Type;Cortical dysplasia complex with other brain malformations 6;Multiple benign circumferential skin creases on limbs;SKIN CREASES CONGENITAL SYMMETRIC CIRCUMFERENTIAL 1,TUBB,203068,NM_001293212;NM_001293213;NM_001293214;NM_001293215;NM_001293216;NM_178014
ARCN1_SIG,ARCN1,ARCN1_SIG,ARCN1,SIG,38,0.0978615461996614,0.588268891503215,0.588012598589871,0.589110996789914,0.00109839820004249,0.93513525736993,0.513496969552306,6.85890417570534,6.85010221007982,6.88782491990345,0.0377227098236298,0.701792756612899,ENSG00000095139,ARCN1,protein_coding,11,1,118572390,118603033,q23.3,archain 1 [Source:HGNC Symbol;Acc:HGNC:649],Microcephalic dwarfism;SHORT STATURE RHIZOMELIC WITH MICROCEPHALY MICROGNATHIA AND DEVELOPMENTAL DELAY,ARCN1,372,NM_001142281;NM_001655
UBE4A_SIG,UBE4A,UBE4A_SIG,UBE4A,SIG,40,0.0943048656456332,0.401599990263596,0.4013849543912,0.402306536701468,0.000921582310267592,0.937885308449906,0.296667491439458,6.3926586860459,6.3884994903999,6.40632461459704,0.0178251241971382,0.829799217084887,ENSG00000110344,UBE4A,protein_coding,11,1,118359585,118399211,q23.3,ubiquitination factor E4A [Source:HGNC Symbol;Acc:HGNC:12499],NA,UBE4A,9354,NM_001204077;NM_004788
ATP6V1D_SIG,ATP6V1D,ATP6V1D_SIG,ATP6V1D,SIG,34,0.0930708717093396,0.0732597557274079,0.0730096276911401,0.0740816049894307,0.00107197729829083,0.938725650690628,-0.242561152534221,4.1627898414738,4.16659359268365,4.15029180178432,-0.0163017908993305,0.862390201503976,ENSG00000100554,ATP6V1D,protein_coding,14,-1,67294371,67360265,q23.3,ATPase H+ transporting V1 subunit D [Source:HGNC Symbol;Acc:HGNC:13527],NA,ATP6V1D,51382,NM_015994
DNA2_SIG,DNA2,DNA2_SIG,DNA2,SIG,29,0.0929764488371993,0.31192692278048,0.31144863361162,0.313498444335305,0.0020498107236859,0.938725650690628,0.429461605484714,3.16864196476784,3.16049412441993,3.19541344019668,0.0349193157767486,0.750752592700609,ENSG00000138346,DNA2,protein_coding,10,-1,68414064,68472121,q21.3,DNA replication helicase/nuclease 2 [Source:HGNC Symbol;Acc:HGNC:2939],DNA2-related mitochondrial DNA deletion syndrome;PRIMORDIAL DWARFISM SECKEL SYNDROME 8;Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant 6;Seckel syndrome 8,DNA2,1763,NM_001080449
ICAM4_SIG,ICAM4,ICAM4_SIG,ICAM4,SIG,18,0.0912329574301676,-0.0143358041117117,-0.0144870207938787,-0.0138389492988771,0.000648071495001724,0.940014992935272,0.492553567201146,3.02474237816569,3.01092642986289,3.0701376368749,0.0592112070120118,0.713889189554421,ENSG00000105371,ICAM4,protein_coding,19,1,10286955,10288522,p13.2,intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) [Source:HGNC Symbol;Acc:HGNC:5347],BLOOD GROUP SYSTEM LANDSTEINER-WIENER,ICAM4,3386,NM_001039132;NM_001544
PSMB7_SIG,PSMB7,PSMB7_SIG,PSMB7,SIG,33,0.0895072232913716,0.209784999431172,0.209644836635387,0.21024553433161,0.000600697696223241,0.941289939802769,-0.940713295854905,6.22543696996828,6.23488914967897,6.19437980806175,-0.0405093416172174,0.460365839647206,ENSG00000136930,PSMB7,protein_coding,9,-1,124353465,124415444,q33.3,proteasome subunit beta 7 [Source:HGNC Symbol;Acc:HGNC:9544],NA,PSMB7,5695,NM_002799
ARIH1_SIG,ARIH1,ARIH1_SIG,ARIH1,SIG,44,0.0893095860305626,0.546519875348745,0.546342651760777,0.547102181423494,0.000759529662716819,0.941333973378021,-0.382240985127382,6.54828050556299,6.55238574279023,6.53479186895922,-0.0175938738310161,0.779188081626022,ENSG00000166233,ARIH1,protein_coding,15,1,72474330,72602987,q24.1,ariadne RBR E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:689],NA,ARIH1,25820,NM_005744
POP7_SIG,POP7,POP7_SIG,POP7,SIG,43,0.0888827975481663,0.131372583596164,0.131220613143211,0.131871915084437,0.000651301941226225,0.941562540448291,1.06041725054482,3.55345216802633,3.53821955654778,3.60350217717014,0.0652826206223581,0.401073431632716,ENSG00000172336,POP7,protein_coding,7,1,100706121,100707486,q22.1,POP7 homolog, ribonuclease P/MRP subunit [Source:HGNC Symbol;Acc:HGNC:19949],NA,POP7,10248,NM_005837
SLBP_SIG,SLBP,SLBP_SIG,SLBP,SIG,40,0.0884629747090301,0.253840931000776,0.253688970688155,0.254340229170816,0.000651258482660843,0.941785455454413,1.03869975330895,6.09786372531937,6.08435104953493,6.14226251718253,0.0579114676475987,0.411537354275066,ENSG00000163950,SLBP,protein_coding,4,-1,1692731,1712344,p16.3,stem-loop binding protein [Source:HGNC Symbol;Acc:HGNC:10904],NA,SLBP,7884,NM_001306074;NM_001306075;NM_006527
DDT_SIG,DDT,DDT_SIG,DDT,SIG,8,0.0867927851170828,0.321896705850498,0.32175772947242,0.322353342521324,0.000595613048904246,0.943015175403867,0.349637747462779,3.93037190848408,3.92624587659612,3.94392887040166,0.0176829938055388,0.797924984557056,ENSG00000099977,DDT,protein_coding,22,-1,23971365,23979828,q11.23,D-dopachrome tautomerase [Source:HGNC Symbol;Acc:HGNC:2732],NA,DDT,1652;100037417,NM_001084392;NM_001355
NSF_SIG,NSF,NSF_SIG,NSF,SIG,95,0.0850562955832375,0.366096144061121,0.365766643402762,0.367178789081445,0.00141214567868359,0.944206551311962,-0.00262831155098831,4.84783397472086,4.84789291301324,4.84764032033161,-0.000252592681638482,0.998383809204718,ENSG00000073969,NSF,protein_coding,17,1,46590669,46757464,q21.31,N-ethylmaleimide sensitive factor, vesicle fusing ATPase [Source:HGNC Symbol;Acc:HGNC:8016],NA,NSF,4905,NM_006178
ZBTB24_TF,ZBTB24,ZBTB24_TF,ZBTB24,TF,38,0.0850267257060708,0.110713528087746,0.110657549899148,0.110897456421711,0.000239906522562972,0.944206551311962,0.401517162003327,5.02114459983143,5.01665662818664,5.0358907923786,0.0192341641919568,0.767449247750061,ENSG00000112365,ZBTB24,protein_coding,6,-1,109462594,109483237,q21,zinc finger and BTB domain containing 24 [Source:HGNC Symbol;Acc:HGNC:21143],ICF syndrome;IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2,ZBTB24,9841,NM_014797
ZNF791_TF,ZNF791,ZNF791_TF,ZNF791,TF,45,-0.0842335059152473,0.222376391250487,0.222604312520826,0.221627507076518,-0.000976805444307663,0.944699160603546,0.156566453737771,4.6893258330269,4.68699196978514,4.69699424082125,0.0100022710361145,0.912007747787197,ENSG00000173875,ZNF791,protein_coding,19,1,12610918,12633840,p13.13,zinc finger protein 791 [Source:HGNC Symbol;Acc:HGNC:26895],NA,ZNF791,163049,NM_153358
LARP4B_SIG,LARP4B,LARP4B_SIG,LARP4B,SIG,53,0.0841281288871374,0.361310601735487,0.361049082971233,0.362169877675178,0.0011207947039453,0.944699160603546,-0.17067224385044,6.58331205644804,6.58634203469644,6.57335641363186,-0.0129856210645852,0.904313508789797,ENSG00000107929,LARP4B,protein_coding,10,-1,806914,931705,p15.3,La ribonucleoprotein domain family member 4B [Source:HGNC Symbol;Acc:HGNC:28987],NA,LARP4B,23185,NM_001351277;NM_015155
EDARADD_SIG,EDARADD,EDARADD_SIG,EDARADD,SIG,27,0.0837123029434332,-0.0765742148113345,-0.0767064044383612,-0.0761398774653895,0.000566526972971596,0.944918449969731,0.522146256090363,0.638322395247661,0.630181783645874,0.665070119082103,0.0348883354362284,0.696883934087068,ENSG00000186197,EDARADD,protein_coding,1,1,236348257,236502915,q42.3,EDAR associated death domain [Source:HGNC Symbol;Acc:HGNC:14341],Autosomal dominant hypohidrotic ectodermal dysplasia;Autosomal recessive hypohidrotic ectodermal dysplasia;ECTODERMAL DYSPLASIA 10A HYPOHIDROTIC/HAIR/NAIL TYPE AUTOSOMAL DOMINANT;ECTODERMAL DYSPLASIA 10B HYPOHIDROTIC/HAIR/TOOTH TYPE AUTOSOMALRECESSIVE;ECTODERMAL DYSPLASIA 11A HYPOHIDROTIC/HAIR/TOOTH TYPE AUTOSOMAL DOMINANT;ECTODERMAL DYSPLASIA 11B HYPOHIDROTIC/HAIR/TOOTH TYPE AUTOSOMALRECESSIVE;Oligodontia,EDARADD,128178,NM_080738;NM_145861
NAGPA_SIG,NAGPA,NAGPA_SIG,NAGPA,SIG,31,-0.0808082098438431,0.328046472995703,0.32821482901852,0.327493303206447,-0.000721525812073078,0.947140793963966,-0.416976769088889,4.51380174384992,4.52079925047441,4.49080993636946,-0.029989314104948,0.75883588741517,ENSG00000103174,NAGPA,protein_coding,16,-1,5024844,5034141,p13.3,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase [Source:HGNC Symbol;Acc:HGNC:17378],NA,NAGPA,51172,NM_016256
CDK17_SIG,CDK17,CDK17_SIG,CDK17,SIG,77,-0.079049861950067,0.430993401004336,0.43120926380632,0.430284137512104,-0.000925126294215248,0.948440647352864,0.0627114907094665,5.46614183982591,5.46496049578373,5.47002339882163,0.00506290303789394,0.965770312321904,ENSG00000059758,CDK17,protein_coding,12,-1,96278261,96400480,q23.1,cyclin dependent kinase 17 [Source:HGNC Symbol;Acc:HGNC:8750],NA,CDK17,5128,NM_001170464;NM_002595
NEURL1B_SIG,NEURL1B,NEURL1B_SIG,NEURL1B,SIG,21,-0.0772177855719504,0.00893637388301854,0.0090509496452639,0.00855991066421236,-0.000491038981051434,0.949799740766465,0.623501948293709,3.24674636929116,3.22059240025316,3.33268083898744,0.112088438734285,0.636463263833516,ENSG00000214357,NEURL1B,protein_coding,5,1,172641266,172691540,q35.1,neuralized E3 ubiquitin protein ligase 1B [Source:HGNC Symbol;Acc:HGNC:35422],NA,NEURL1B,54492,NM_001142651;NM_001308177;NM_001308178
PLAA_SIG,PLAA,PLAA_SIG,PLAA,SIG,10,0.0765516871374337,0.438855005629284,0.438691432895382,0.439392458897818,0.000701026002435762,0.950219971765182,0.398639832889707,5.72871529095695,5.72481906026835,5.7415171917909,0.0166981315225536,0.769061779353334,ENSG00000137055,PLAA,protein_coding,9,-1,26903372,26947242,p21.2,phospholipase A2 activating protein [Source:HGNC Symbol;Acc:HGNC:9043],Lethal Infantile Epileptic Encephalopathy;NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY SPASTICITY AND BRAIN ANOMALIES,PLAA,9373,NM_001031689;NM_001321546
USPL1_SIG,USPL1,USPL1_SIG,USPL1,SIG,29,0.0753023940012157,0.530912406099446,0.530697804874125,0.531617524411215,0.000919719537090283,0.951109618626995,0.565110687106558,5.3499114272872,5.34128458709868,5.37825675933517,0.0369721722364877,0.67177831236546,ENSG00000132952,USPL1,protein_coding,13,1,30617693,30660770,q12.3,ubiquitin specific peptidase like 1 [Source:HGNC Symbol;Acc:HGNC:20294],NA,USPL1,10208,NM_001321532;NM_001321533;NM_001321534;NM_005800
BECN1_SIG,BECN1,BECN1_SIG,BECN1,SIG,37,-0.0747152001945941,0.13184520780156,0.13190424720834,0.131651221179283,-0.000253026029056452,0.95146614752876,-0.160010017752789,6.24356298422834,6.24491584267044,6.23911787791857,-0.00579796475187321,0.9102609652149,ENSG00000126581,BECN1,protein_coding,17,-1,42810134,42833350,q21.31,beclin 1 [Source:HGNC Symbol;Acc:HGNC:1034],NA,BECN1,8678,NM_001313998;NM_001313999;NM_001314000;NM_003766
NLGN2_SIG,NLGN2,NLGN2_SIG,NLGN2,SIG,35,0.0737141639817159,-0.132413769422199,-0.132502003145007,-0.132123858618685,0.000378144526321837,0.95215572733126,-0.268598293040967,2.53645004499954,2.54461659400959,2.50961709825224,-0.0349994957573547,0.846190479445738,ENSG00000169992,NLGN2,protein_coding,17,1,7404874,7419860,p13.1,neuroligin 2 [Source:HGNC Symbol;Acc:HGNC:14290],NA,NLGN2,57555,NM_020795
RNF31_SIG,RNF31,RNF31_SIG,RNF31,SIG,35,0.072339786903558,0.406044282774817,0.405950915128466,0.406351062184255,0.000400147055788742,0.953145708233976,0.370532397014402,4.95924608807807,4.95540542392346,4.97186541315749,0.0164599892340309,0.786284923956329,ENSG00000092098,RNF31,protein_coding,14,1,24146683,24160660,q12,ring finger protein 31 [Source:HGNC Symbol;Acc:HGNC:16031],Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,RNF31,55072,NM_001310332;NM_017999
ZNF292_TF,ZNF292,ZNF292_TF,ZNF292,TF,146,0.0710778467856273,0.306558571329543,0.306410829763541,0.30704400790355,0.000633178140009066,0.954045055783531,-0.0498397586963548,6.85071287596169,6.85156727558244,6.84790556292208,-0.00366171266035679,0.972476833709268,ENSG00000188994,ZNF292,protein_coding,6,1,87152833,87265943,q14.3,zinc finger protein 292 [Source:HGNC Symbol;Acc:HGNC:18410],NA,ZNF292,23036,NM_001351444;NM_015021
SRF_SIG,SRF,SRF_SIG,SRF,SIG,17,0.0694840672298282,0.201791520427741,0.201705704089779,0.202073488395329,0.000367784305550307,0.955211368936868,-2.60267651865795,6.48056244670994,6.50470714534033,6.40122986549577,-0.103477279844563,0.0279936902329136,ENSG00000112658,SRF,protein_coding,6,1,43171269,43181506,p21.1,serum response factor [Source:HGNC Symbol;Acc:HGNC:11291],NA,SRF,6722,NM_001292001;NM_003131
FBXW2_SIG,FBXW2,FBXW2_SIG,FBXW2,SIG,35,0.0687905270704235,0.318518853941525,0.318437522099066,0.318786087138176,0.000348565039109587,0.955627527097444,-0.0220329262690535,6.73602411838392,6.73625561044339,6.7352635016171,-0.00099210882628247,0.987741663596856,ENSG00000119402,FBXW2,protein_coding,9,-1,120751978,120793416,q33.2,F-box and WD repeat domain containing 2 [Source:HGNC Symbol;Acc:HGNC:13608],NA,FBXW2,26190,NM_012164
DTNA_SIG,DTNA,DTNA_SIG,DTNA,SIG,55,-0.0686772339551832,-0.0679420843242584,-0.0677698184118985,-0.0685081008934406,-0.000738282481541972,0.955627527097444,-0.301354570136868,1.26303414226853,1.27486363842175,1.22416579776508,-0.0506978406566724,0.827026173765777,ENSG00000134769,DTNA,protein_coding,18,1,34493290,34891844,q12.1,dystrobrevin alpha [Source:HGNC Symbol;Acc:HGNC:3057],Left ventricular noncompaction;LEFT VENTRICULAR NONCOMPACTION 1,DTNA,1837,NM_001128175;NM_001198938;NM_001198939;NM_001198940;NM_001198941;NM_001198942;NM_001198943;NM_001198944;NM_001198945;NM_001390;NM_001391;NM_001392;NM_032975;NM_032978;NM_032979;NM_032980;NM_032981
LSM3_SIG,LSM3,LSM3_SIG,LSM3,SIG,26,0.0673309432707408,0.368806992784015,0.368707255334328,0.369134701547276,0.00042744621294845,0.956594271386607,0.817904463915387,5.20414819386793,5.19584452666459,5.23143167182174,0.0355871451571472,0.525263376760386,ENSG00000170860,LSM3,protein_coding,3,1,14178817,14201122,p25.1,LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated [Source:HGNC Symbol;Acc:HGNC:17874],NA,LSM3,27258,NM_014463
HYAL1_SIG,HYAL1,HYAL1_SIG,HYAL1,SIG,19,-0.0671298639190401,-0.128255490644861,-0.128177878115349,-0.128510503241831,-0.000332625126482634,0.956639365305194,-1.15888387814811,0.456759890350216,0.468043811691244,0.419684148801124,-0.0483596628901206,0.355391471899895,ENSG00000114378,HYAL1,protein_coding,3,-1,50299890,50312381,p21.31,hyaluronidase 1 [Source:HGNC Symbol;Acc:HGNC:5320],Hyaluronidase deficiency;MUCOPOLYSACCHARIDOSIS TYPE 9;MUCOPOLYSACCHARIDOSIS TYPE IX,HYAL1,3373,NM_033159;NM_153281;NM_153282;NM_153283;NM_153285
ABHD3_SIG,ABHD3,ABHD3_SIG,ABHD3,SIG,19,-0.0661720413276635,0.255498963078218,0.255618214837476,0.255107135869228,-0.000511078968248076,0.957293302023535,0.803161503365176,4.5413550619722,4.52731497046291,4.58748679121699,0.0601718207540848,0.533383456369941,ENSG00000158201,ABHD3,protein_coding,18,-1,21650901,21704780,q11.2,abhydrolase domain containing 3 [Source:HGNC Symbol;Acc:HGNC:18718],NA,ABHD3,171586,NM_001308256;NM_001308257;NM_138340
SLC35E1_SIG,SLC35E1,SLC35E1_SIG,SLC35E1,SIG,26,-0.0643407078350307,0.200692922192251,0.200785691487714,0.20038810879287,-0.000397582694843682,0.958649923330638,0.0268439121284439,5.78745991220184,5.7871311850157,5.78854001581343,0.00140883079772817,0.985141196293274,ENSG00000127526,SLC35E1,protein_coding,19,-1,16549831,16572415,p13.11,solute carrier family 35 member E1 [Source:HGNC Symbol;Acc:HGNC:20803],NA,SLC35E1,79939,NM_024881
IMPA2_SIG,IMPA2,IMPA2_SIG,IMPA2,SIG,24,-0.0640357814003914,0.243058423645893,0.243203156456931,0.242582872981054,-0.000620283475876689,0.958778326988511,0.683826075564037,5.57662953925267,5.56176959571736,5.62545506801154,0.0636854722941756,0.601301311886676,ENSG00000141401,IMPA2,protein_coding,18,1,11981025,12030877,p11.21,inositol monophosphatase 2 [Source:HGNC Symbol;Acc:HGNC:6051],NA,IMPA2,3613,NM_014214
MAN2B1_SIG,MAN2B1,MAN2B1_SIG,MAN2B1,SIG,36,0.0636590338406002,0.297260331377637,0.29710424274849,0.297773194016265,0.000668951267774818,0.958964478727448,0.573476781436174,7.68990452368111,7.67980343830512,7.72309380420222,0.0432903658970947,0.666791791526478,ENSG00000104774,MAN2B1,protein_coding,19,-1,12646511,12666742,p13.13,mannosidase alpha class 2B member 1 [Source:HGNC Symbol;Acc:HGNC:6826],Alpha-mannosidosis adult form;Alpha-mannosidosis infantile form;LYSOSOMAL ALPHA-MANNOSIDOSIS;MANNOSIDOSIS ALPHA B LYSOSOMAL,MAN2B1,4125,NM_000528;NM_001173498
SF3B4_SIG,SF3B4,SF3B4_SIG,SF3B4,SIG,19,-0.0630256361829014,0.24134996097833,0.241416514019234,0.241131286701071,-0.000285227318162716,0.959334153759149,-0.519555701208471,6.15462497091087,6.15875566001824,6.14105270670095,-0.0177029533172908,0.698354650344223,ENSG00000143368,SF3B4,protein_coding,1,-1,149923317,149927803,q21.2,splicing factor 3b subunit 4 [Source:HGNC Symbol;Acc:HGNC:10771],ACROFACIAL DYSOSTOSIS 1 NAGER TYPE;Acrofacial dysostosis Rodriguez type;Nager syndrome,SF3B4,10262,NM_005850
RAPGEF2_SIG,RAPGEF2,RAPGEF2_SIG,RAPGEF2,SIG,17,-0.0627421197394178,0.0133548369012399,0.0134929387173106,0.012901073791293,-0.000591864926017713,0.959334153759149,1.77567734176589,6.31779870653454,6.27841931403931,6.44718813901885,0.168768824979541,0.144006181048555,ENSG00000109756,RAPGEF2,protein_coding,4,1,159103013,159360174,q32.1,Rap guanine nucleotide exchange factor 2 [Source:HGNC Symbol;Acc:HGNC:16854],EPILEPSY FAMILIAL ADULT MYOCLONIC 7,RAPGEF2,9693,NM_001351724;NM_001351725;NM_001351726;NM_001351727;NM_001351728;NM_014247
CRIM1_SIG,CRIM1,CRIM1_SIG,CRIM1,SIG,66,0.0626650220117503,-0.0292933541914177,-0.0294652627810518,-0.0287285116826199,0.000736751098431795,0.959334153759149,0.39749036161405,3.490245320715,3.47314774592807,3.54642306644348,0.0732753205154163,0.769855672335136,ENSG00000150938,CRIM1,protein_coding,2,1,36355778,36551135,p22.2,cysteine rich transmembrane BMP regulator 1 [Source:HGNC Symbol;Acc:HGNC:2359],Colobomatous macrophthalmia-microcornea syndrome;Colobomatous macrophthalmia with microcornea syndrome,CRIM1,51232,NM_016441
RNPEP_SIG,RNPEP,RNPEP_SIG,RNPEP,SIG,43,0.0626178456393749,0.251756776821606,0.251567416371693,0.252378961157035,0.000811544785341838,0.959334153759149,0.510965777959269,6.24998016276476,6.24086202093982,6.27993977161811,0.0390777506782874,0.703089336262346,ENSG00000176393,RNPEP,protein_coding,1,1,201982372,202006147,q32.1,arginyl aminopeptidase [Source:HGNC Symbol;Acc:HGNC:10078],NA,RNPEP,6051,NM_001319182;NM_001319183;NM_001319184;NM_020216
DCTN6_SIG,DCTN6,DCTN6_SIG,DCTN6,SIG,24,-0.0624122470900537,0.443742444627482,0.44386326138042,0.443345475296399,-0.000517786084021618,0.959382547183326,-0.313577890417269,3.87850399833988,3.88295512561422,3.86387886586702,-0.0190762597471989,0.819745814629318,ENSG00000104671,DCTN6,protein_coding,8,1,30156319,30183639,p12,dynactin subunit 6 [Source:HGNC Symbol;Acc:HGNC:16964],NA,DCTN6,10671,NM_006571
PDE12_SIG,PDE12,PDE12_SIG,PDE12,SIG,25,0.0612023038942006,0.386402294570305,0.386310077352952,0.386705293998751,0.000395216645798865,0.960238359511882,0.443484332924978,5.16606382853354,5.16064587365013,5.18386568029334,0.0232198066432117,0.742666185028575,ENSG00000174840,PDE12,protein_coding,3,1,57556274,57566848,p14.3,phosphodiesterase 12 [Source:HGNC Symbol;Acc:HGNC:25386],NA,PDE12,201626,NM_001322177;NM_177966
GPX7_SIG,GPX7,GPX7_SIG,GPX7,SIG,18,-0.0605443626086696,0.154179698710715,0.154283049982535,0.15384011596045,-0.000442934022084032,0.960650276447058,-0.881748158870638,4.59196730781042,4.6109988410549,4.52943512715001,-0.081563713904889,0.49139665466007,ENSG00000116157,GPX7,protein_coding,1,1,52602371,52609051,p32.3,glutathione peroxidase 7 [Source:HGNC Symbol;Acc:HGNC:4559],NA,GPX7,2882,NM_015696
ZNF628_TF,ZNF628,ZNF628_TF,ZNF628,TF,47,-0.0592602669894006,0.302809285815642,0.302912136404034,0.302471348168069,-0.000440788235964748,0.961565444362498,0.474704711019815,3.77301639607147,3.76669401709582,3.79378992699147,0.0270959098956526,0.724564654006776,ENSG00000197483,ZNF628,protein_coding,19,1,55476617,55484487,q13.42,zinc finger protein 628 [Source:HGNC Symbol;Acc:HGNC:28054],NA,ZNF628,89887,NM_033113
SLC3A1_SIG,SLC3A1,SLC3A1_SIG,SLC3A1,SIG,18,0.0570783034504745,-0.0789956799964599,-0.0790837160792948,-0.0787064185814309,0.000377297497863831,0.963202211963011,-1.73038470072317,0.323199702062988,0.336604849669267,0.279154217070927,-0.0574506325983404,0.155184687523998,ENSG00000138079,SLC3A1,protein_coding,2,1,44275458,44321494,p21,solute carrier family 3 member 1 [Source:HGNC Symbol;Acc:HGNC:11025],2p21 microdeletion syndrome;Atypical hypotonia - cystinuria syndrome;CYSTINURIA;Cystinuria type A;HYPOTONIA-CYSTINURIA SYNDROME,SLC3A1,6519,NM_000341
OVOL1_TF,OVOL1,OVOL1_TF,OVOL1,TF,60,-0.0561965859847335,-0.0474185594773626,-0.0473696665368907,-0.0475792077103415,-0.000209541173450597,0.963793616988838,-1.35454748673761,0.330777970054053,0.355947800849072,0.248077097441851,-0.107870703407221,0.273784774358249,ENSG00000172818,OVOL1,protein_coding,11,1,65787063,65797214,q13.1,ovo like transcriptional repressor 1 [Source:HGNC Symbol;Acc:HGNC:8525],NA,OVOL1,5017,NM_004561
B3GNT2_SIG,B3GNT2,B3GNT2_SIG,B3GNT2,SIG,19,0.0555798432902805,0.277252156983974,0.277127329217494,0.277662305359552,0.000534976142058373,0.964171942049747,-1.82753012747571,6.35674528740775,6.3954593500533,6.22954193871524,-0.165917411338064,0.131851113261059,ENSG00000170340,B3GNT2,protein_coding,2,1,62196115,62224731,p15,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:15629],NA,B3GNT2,10678,NM_001319075;NM_006577
SUB1_SIG,SUB1,SUB1_SIG,SUB1,SIG,16,0.0551460583952612,0.384227102226251,0.384110412727652,0.384610510578789,0.000500097851136828,0.964369684083177,1.13492527755229,7.53216280765978,7.51815774741287,7.57817943418534,0.0600216867724727,0.365880914713537,ENSG00000113387,SUB1,protein_coding,5,1,32531633,32604079,p13.3,SUB1 homolog, transcriptional regulator [Source:HGNC Symbol;Acc:HGNC:19985],NA,SUB1,10923,NM_006713
MAP4K2_SIG,MAP4K2,MAP4K2_SIG,MAP4K2,SIG,28,0.0550416011675863,0.070458294006903,0.0703865101164755,0.0706941553611645,0.000307645244688867,0.964369684083177,-0.30956173124907,6.10040810026182,6.10479008692927,6.08601014406878,-0.0187799428604834,0.82224309072435,ENSG00000168067,MAP4K2,protein_coding,11,-1,64784918,64803241,q13.1,mitogen-activated protein kinase kinase kinase kinase 2 [Source:HGNC Symbol;Acc:HGNC:6864],NA,MAP4K2,5871,NM_001307990;NM_004579
ABCA5_SIG,ABCA5,ABCA5_SIG,ABCA5,SIG,90,0.0542493600400153,-0.0831535295853231,-0.0832171065029032,-0.0829446339989883,0.000272472503914926,0.964879581960323,0.894814733830914,3.7159814175109,3.68859152277249,3.80597678593709,0.117385263164596,0.484688218308762,ENSG00000154265,ABCA5,protein_coding,17,-1,69244311,69327244,q24.3,ATP binding cassette subfamily A member 5 [Source:HGNC Symbol;Acc:HGNC:35],Gingival fibromatosis-hypertrichosis syndrome;HYPERTRICHOSIS CONGENITAL GENERALIZED WITH OR WITHOUT GINGIVALHYPERPLASIA,ABCA5,23461,NM_018672;NM_172232
SARS_SIG,SARS,SARS_SIG,SARS,SIG,37,0.054107532941894,0.322041977507349,0.321905720613485,0.322489678730046,0.000583958116560327,0.964879581960323,1.34085003197824,6.10127308987867,6.08387800759705,6.15842836023255,0.0745503526354926,0.278811168832758,ENSG00000031698,SARS,protein_coding,1,1,109213918,109238182,p13.3,seryl-tRNA synthetase [Source:HGNC Symbol;Acc:HGNC:10537],Autosomal recessive non-syndromic intellectual disability;NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY ATAXIA AND SEIZURES,SARS,6301,NM_001330669;NM_006513
DNM3_SIG,DNM3,DNM3_SIG,DNM3,SIG,45,-0.053968535980782,-0.0713739542257266,-0.0712344629137077,-0.0718322828223604,-0.000597819908652692,0.964879581960323,-1.25422548399721,1.79915238232131,1.83809245174625,1.67120643992507,-0.166886011821189,0.313603304818331,ENSG00000197959,DNM3,protein_coding,1,1,171841498,172418466,q24.3,dynamin 3 [Source:HGNC Symbol;Acc:HGNC:29125],NA,DNM3,26052,NM_001136127;NM_001278252;NM_001350204;NM_001350205;NM_001350206;NM_015569
BRAP_SIG,BRAP,BRAP_SIG,BRAP,SIG,36,-0.0531117445515994,0.444090915617645,0.444169195882065,0.443833709034551,-0.00033548684751481,0.965450378431795,1.75131068792194,5.47258680893682,5.45543242843596,5.52895120201109,0.0735187735751292,0.149881123344997,ENSG00000089234,BRAP,protein_coding,12,-1,111642146,111685956,q24.12,BRCA1 associated protein [Source:HGNC Symbol;Acc:HGNC:1099],NA,BRAP,8315,NM_006768
DKK2_SIG,DKK2,DKK2_SIG,DKK2,SIG,20,-0.0523422613842401,0.0293654753039863,0.029516868395345,0.0288680408609507,-0.000648827534394459,0.96595094197635,-0.786070875706994,0.584283069281735,0.603664563820161,0.520601015798333,-0.0830635480218287,0.542562146680582,ENSG00000155011,DKK2,protein_coding,4,-1,106921802,107283806,q25,dickkopf WNT signaling pathway inhibitor 2 [Source:HGNC Symbol;Acc:HGNC:2892],NA,DKK2,27123,NM_014421
ATF1_TF,ATF1,ATF1_TF,ATF1,TF,142,-0.0519734174688448,0.159165770942008,0.159307307826227,0.158700721179575,-0.000606586646652283,0.9661296485123,-1.29064816741808,4.49055371511983,4.51535150651723,4.40907525767125,-0.106276248845978,0.298724572158293,ENSG00000123268,ATF1,protein_coding,12,1,50763710,50821162,q13.12,activating transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:783],Melanoma of soft tissue,ATF1,466,NM_005171
GLI1_TF,GLI1,GLI1_TF,GLI1,TF,69,0.0492594902426968,-0.0425858985789716,-0.0426398471744066,-0.0424086389082565,0.000231208266150011,0.968191592559889,1.35268295700261,0.334798603660749,0.325493223622512,0.365373423786383,0.0398802001638712,0.274431815274593,ENSG00000111087,GLI1,protein_coding,12,1,57459785,57472268,q13.3,GLI family zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:4317],ELLIS-VAN CREVELD SYNDROME;POLYDACTYLY POSTAXIAL TYPE A8,GLI1,2735,NM_001160045;NM_001167609;NM_005269
GXYLT2_SIG,GXYLT2,GXYLT2_SIG,GXYLT2,SIG,36,-0.0489225804547547,-0.0401013914870077,-0.0399953065194347,-0.0404499563804617,-0.00045464986102697,0.968234713855329,0.109665335369566,1.01999434500056,1.01633246071726,1.03202625050283,0.0156937897855631,0.939158935066642,ENSG00000172986,GXYLT2,protein_coding,3,1,72888073,72998138,p13,glucoside xylosyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:33383],NA,GXYLT2,727936,NM_001080393
UBR4_SIG,UBR4,UBR4_SIG,UBR4,SIG,15,-0.048912505837778,0.46345184283472,0.463520988585115,0.463224649654849,-0.00029633893026589,0.968234713855329,-0.538309241820678,8.28127227968127,8.28868255341276,8.25692423742068,-0.0317583159920788,0.68723279104063,ENSG00000127481,UBR4,protein_coding,1,-1,19074510,19210266,p36.13,ubiquitin protein ligase E3 component n-recognin 4 [Source:HGNC Symbol;Acc:HGNC:30313],NA,UBR4,23352,NM_020765
KCNIP3_SIG,KCNIP3,KCNIP3_SIG,KCNIP3,SIG,63,0.0464127357051565,-0.0959145938122264,-0.0959797152676443,-0.0957006233158533,0.000279091951791185,0.970124021532549,-1.39792810795088,0.511315269501597,0.536925263744706,0.427168145559951,-0.109757118184755,0.257380033532336,ENSG00000115041,KCNIP3,protein_coding,2,1,95297327,95386077,q11.1,potassium voltage-gated channel interacting protein 3 [Source:HGNC Symbol;Acc:HGNC:15523],NA,KCNIP3,30818,NM_001034914;NM_013434
TNFRSF12A_SIG,TNFRSF12A,TNFRSF12A_SIG,TNFRSF12A,SIG,8,-0.0459385081297113,0.0596704149879742,0.0597905050263383,0.0592758334333495,-0.000514671592988964,0.970386806277401,-1.33927888681585,2.15745530280886,2.20029979910233,2.01668052927317,-0.183619269829158,0.279450773789905,ENSG00000006327,TNFRSF12A,protein_coding,16,1,3018445,3022383,p13.3,TNF receptor superfamily member 12A [Source:HGNC Symbol;Acc:HGNC:18152],NA,TNFRSF12A,51330,NM_016639
HEXIM2_SIG,HEXIM2,HEXIM2_SIG,HEXIM2,SIG,24,-0.04425565874455,0.0494742429909033,0.0496150848856638,0.0490114767652618,-0.000603608120401852,0.971619815869635,-0.679161702721995,1.54252198990532,1.55327864347943,1.50717869959038,-0.0460999438890572,0.603938992887995,ENSG00000168517,HEXIM2,protein_coding,17,1,45160700,45170040,q21.31,HEXIM P-TEFb complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:28591],NA,HEXIM2,124790,NM_001303436;NM_001303437;NM_001303438;NM_001303439;NM_001303440;NM_001303441;NM_001303442;NM_001303443;NM_001303444;NM_144608
TANK_SIG,TANK,TANK_SIG,TANK,SIG,42,-0.0415451414277276,0.127759638747173,0.127829182226001,0.127531138745312,-0.000298043480688772,0.973677637319345,-0.142376918261683,6.03281596435025,6.03482426414177,6.02621726503525,-0.00860699910651954,0.920227528958143,ENSG00000136560,TANK,protein_coding,2,1,161136908,161236221,q24.2,TRAF family member associated NFKB activator [Source:HGNC Symbol;Acc:HGNC:11562],NA,TANK,10010,NM_001199135;NM_004180;NM_133484
TRIM9_SIG,TRIM9,TRIM9_SIG,TRIM9,SIG,31,0.0409007874640512,-0.0655559640921307,-0.0656133290384712,-0.0653674792684401,0.000245849770031174,0.974076542222383,-0.420790816735016,1.26167025920434,1.27193272300101,1.22795073530101,-0.0439819876999987,0.756378497903549,ENSG00000100505,TRIM9,protein_coding,14,-1,50975262,51096061,q22.1,tripartite motif containing 9 [Source:HGNC Symbol;Acc:HGNC:16288],NA,TRIM9,114088,NM_015163;NM_052978
PPTC7_SIG,PPTC7,PPTC7_SIG,PPTC7,SIG,58,-0.0406577088787693,0.502065092292646,0.502207298166437,0.501597844421618,-0.000609453744818251,0.974153277246219,1.23509027158997,6.73086501176204,6.70865799998335,6.80383090760633,0.095172907622989,0.321618229492034,ENSG00000196850,PPTC7,protein_coding,12,-1,110533245,110583318,q24.11,PTC7 protein phosphatase homolog [Source:HGNC Symbol;Acc:HGNC:30695],NA,PPTC7,160760,NM_139283
MSRB2_TF,MSRB2,MSRB2_TF,MSRB2,TF,167,-0.039877388432508,0.106890041431624,0.1069790151408,0.106597699244332,-0.000381315896468449,0.974661169587328,-0.904296385690045,3.37498600383939,3.39194245540134,3.31927194870727,-0.0726705066940715,0.479512249352571,ENSG00000148450,MSRB2,protein_coding,10,1,23095579,23122013,p12.2,methionine sulfoxide reductase B2 [Source:HGNC Symbol;Acc:HGNC:17061],NA,MSRB2,22921,NM_012228
PDK1_SIG,PDK1,PDK1_SIG,PDK1,SIG,11,0.0393781835821875,0.141096138690495,0.140994668999089,0.141429539105116,0.00043487010602733,0.974843495410065,-0.41169335737499,5.62619897389702,5.63557755672568,5.59538363031717,-0.0401939264085102,0.761678240975235,ENSG00000152256,PDK1,protein_coding,2,1,172555373,172608669,q31.1,pyruvate dehydrogenase kinase 1 [Source:HGNC Symbol;Acc:HGNC:8809],NA,PDK1,5163,NM_001278549;NM_002610
PHF12_SIG,PHF12,PHF12_SIG,PHF12,SIG,36,0.0392950098176852,0.160534096791061,0.160423893953717,0.160896191828048,0.000472297874331219,0.974843495410065,0.402456028076741,7.17675588964787,7.17107650825806,7.19541671421441,0.0243402059563512,0.76701570481099,ENSG00000109118,PHF12,protein_coding,17,-1,28905250,28951771,q11.2,PHD finger protein 12 [Source:HGNC Symbol;Acc:HGNC:20816],NA,PHF12,57649,NM_001033561;NM_001290131;NM_020889
ADAMTS2_SIG,ADAMTS2,ADAMTS2_SIG,ADAMTS2,SIG,49,-0.0390964203784195,0.0224735373721619,0.0225534430635536,0.0222109901004467,-0.000342452963106964,0.974843495410065,-0.22004646704532,1.8029468719,1.81536862268837,1.76213254788106,-0.0532360748073105,0.875764714123106,ENSG00000087116,ADAMTS2,protein_coding,5,-1,179110853,179345461,q35.3,ADAM metallopeptidase with thrombospondin type 1 motif 2 [Source:HGNC Symbol;Acc:HGNC:218],Ehlers-Danlos syndrome dermatosparaxis type,ADAMTS2,9509,NM_014244;NM_021599
TRAIP_SIG,TRAIP,TRAIP_SIG,TRAIP,SIG,35,-0.039059879196243,0.374059543179415,0.374251369808677,0.373429255683268,-0.000822114125408742,0.974843495410065,0.751636959116929,2.61257920936384,2.59879510606413,2.65786983449145,0.0590747284273215,0.562553188174994,ENSG00000183763,TRAIP,protein_coding,3,-1,49828601,49856574,p21.31,TRAF interacting protein [Source:HGNC Symbol;Acc:HGNC:30764],Primordial Dwarfism;Seckel syndrome;Seckel syndrome 9,TRAIP,10293,NM_005879
ZNF331_TF,ZNF331,ZNF331_TF,ZNF331,TF,130,-0.0388694602588167,-0.0706362467214061,-0.0705495149033544,-0.0709212226950048,-0.000371707791650357,0.974877856146995,1.05883101450527,4.60419551009081,4.5718538593882,4.71046093382795,0.138607074439745,0.40183124909473,ENSG00000130844,ZNF331,protein_coding,19,1,53519527,53580269,q13.42,zinc finger protein 331 [Source:HGNC Symbol;Acc:HGNC:15489],NA,ZNF331,55422,NM_001079906;NM_001079907;NM_001253798;NM_001253799;NM_001253800;NM_001253801;NM_001317113;NM_001317114;NM_001317115;NM_001317116;NM_001317117;NM_001317118;NM_001317119;NM_001317120;NM_001317121;NM_018555
CLK1_SIG,CLK1,CLK1_SIG,CLK1,SIG,56,-0.0367546055980819,0.358729512770304,0.358840940142562,0.358363394261457,-0.000477545881104806,0.976455724032045,0.527903189788545,7.76207012629892,7.75114841026648,7.79795576469121,0.0468073544247261,0.693602381744183,ENSG00000013441,CLK1,protein_coding,2,-1,200853009,200864744,q33.1,CDC like kinase 1 [Source:HGNC Symbol;Acc:HGNC:2068],NA,CLK1,1195,NM_001162407;NM_004071
SEC24A_SIG,SEC24A,SEC24A_SIG,SEC24A,SIG,19,-0.0364790298275715,0.195555904247164,0.195603017059541,0.195401105006497,-0.000201912053043916,0.976558189708968,0.174924044477851,5.38001874950683,5.37759314036614,5.38798860811195,0.0103954677458064,0.901832862960187,ENSG00000113615,SEC24A,protein_coding,5,1,134648785,134727909,q31.1,SEC24 homolog A, COPII coat complex component [Source:HGNC Symbol;Acc:HGNC:10703],NA,SEC24A,10802,NM_001252231;NM_021982
EIF4G2_SIG,EIF4G2,EIF4G2_SIG,EIF4G2,SIG,19,-0.0354584260656381,0.375424436947483,0.375491733394078,0.375203320051526,-0.000288413342552224,0.977258086879005,0.0966547758762065,10.0120756270074,10.0110005697699,10.0156079579306,0.00460738816067513,0.945863301760215,ENSG00000110321,EIF4G2,protein_coding,11,-1,10797050,10808940,p15.4,eukaryotic translation initiation factor 4 gamma 2 [Source:HGNC Symbol;Acc:HGNC:3297],NA,EIF4G2,1982,NM_001042559;NM_001172705;NM_001418
LYPLA1_SIG,LYPLA1,LYPLA1_SIG,LYPLA1,SIG,22,-0.0350662366310933,0.390092316098605,0.390117486054693,0.390009614814316,-0.000107871240377531,0.977403264782303,-0.0671243575069347,6.36932241040808,6.37011476109969,6.36671897242136,-0.00339578867832386,0.963356308397464,ENSG00000120992,LYPLA1,protein_coding,8,-1,54046367,54102017,q11.23,lysophospholipase 1 [Source:HGNC Symbol;Acc:HGNC:6737],NA,LYPLA1,10434,NM_001279356;NM_001279357;NM_001279358;NM_001279359;NM_001279360;NM_006330
HDAC3_SIG,HDAC3,HDAC3_SIG,HDAC3,SIG,50,-0.0349814954979966,0.189887970377188,0.18992768076348,0.189757493393655,-0.000170187369825631,0.977403264782303,1.48456311686256,5.92815730731251,5.91185032169195,5.98173740292291,0.069887081230954,0.22706624050832,ENSG00000171720,HDAC3,protein_coding,5,-1,141620876,141636849,q31.3,histone deacetylase 3 [Source:HGNC Symbol;Acc:HGNC:4854],NA,HDAC3,8841,NM_001355039;NM_001355040;NM_001355041;NM_003883
SART1_SIG,SART1,SART1_SIG,SART1,SIG,22,-0.0341519375197966,0.346756653633308,0.346785078656434,0.346663257128752,-0.000121821527681799,0.97794969027633,1.13646983944603,6.87005277410053,6.86174267888205,6.89735737267554,0.0356146937934936,0.365186363184958,ENSG00000175467,SART1,protein_coding,11,1,65961728,65980137,q13.1,spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP [Source:HGNC Symbol;Acc:HGNC:10538],NA,SART1,9092,NM_005146
RHBDL1_SIG,RHBDL1,RHBDL1_SIG,RHBDL1,SIG,20,0.0332243589783939,-0.00564214952746948,-0.0057009932130329,-0.00544880598918969,0.00025218722384315,0.978574575631683,-1.54218348287522,1.19526963980961,1.21877232571284,1.11804652898472,-0.100725796728116,0.208304682821629,ENSG00000103269,RHBDL1,protein_coding,16,1,675666,678268,p13.3,rhomboid like 1 [Source:HGNC Symbol;Acc:HGNC:10007],NA,RHBDL1,9028,NM_001278720;NM_001278721;NM_001318733
RSRC2_SIG,RSRC2,RSRC2_SIG,RSRC2,SIG,63,0.0330357013328511,0.473244441240205,0.473129627016686,0.473621687974623,0.000492060957936326,0.978607070788327,1.01476504617274,7.31762023091682,7.30119636300135,7.37158436835334,0.0703880053519904,0.423154031576,ENSG00000111011,RSRC2,protein_coding,12,-1,122503454,122527000,q24.31,arginine and serine rich coiled-coil 2 [Source:HGNC Symbol;Acc:HGNC:30559],NA,RSRC2,65117,NM_023012
ZMAT5_TF,ZMAT5,ZMAT5_TF,ZMAT5,TF,73,0.032417544579633,0.172098753286563,0.172003473252263,0.172411816256405,0.00040834300414223,0.978842313146299,-0.202975866765123,3.65568496173245,3.65840073878282,3.64676169428123,-0.0116390445015911,0.885284681593413,ENSG00000100319,ZMAT5,protein_coding,22,-1,29730956,29767011,q12.2,zinc finger matrin-type 5 [Source:HGNC Symbol;Acc:HGNC:28046],NA,ZMAT5,55954,NM_001003692;NM_001318129;NM_019103
STRN4_SIG,STRN4,STRN4_SIG,STRN4,SIG,31,-0.0323194591027507,0.27367614625663,0.273725518723392,0.27351392243727,-0.000211596286121857,0.978842313146299,1.29627665826373,6.80779598592833,6.79678366835567,6.84397931509562,0.0471956467399535,0.296560194418508,ENSG00000090372,STRN4,protein_coding,19,-1,46719511,46746994,q13.32,striatin 4 [Source:HGNC Symbol;Acc:HGNC:15721],NA,STRN4,29888,NM_001039877;NM_013403
WBP11_SIG,WBP11,WBP11_SIG,WBP11,SIG,27,-0.0322977463488892,0.156767601917451,0.156859015688188,0.15646724238503,-0.000391773303158385,0.978842313146299,-1.09754785082096,7.08659990539825,7.10084814271992,7.03978426848419,-0.0610638742357265,0.383422440679674,ENSG00000084463,WBP11,protein_coding,12,-1,14784582,14803486,p12.3,WW domain binding protein 11 [Source:HGNC Symbol;Acc:HGNC:16461],NA,WBP11,51729,NM_016312
TRIP12_SIG,TRIP12,TRIP12_SIG,TRIP12,SIG,24,0.0310919066141918,0.465099827925477,0.465065142307416,0.465213794956251,0.000148652648835569,0.979689691120987,1.19933197218863,8.02338019053659,8.01222005346962,8.06004921232803,0.0478291588584093,0.337304917043205,ENSG00000153827,TRIP12,protein_coding,2,-1,229763838,229923239,q36.3,thyroid hormone receptor interactor 12 [Source:HGNC Symbol;Acc:HGNC:12306],MENTAL RETARDATION AUTOSOMAL DOMINANT 49;TRIP12-related intellectual disability with/without autism spectrum disorder,TRIP12,9320,NM_001284214;NM_001284215;NM_001284216;NM_001348315;NM_001348316;NM_001348317;NM_001348318;NM_001348319;NM_001348320;NM_001348321;NM_001348322;NM_001348323;NM_001348324;NM_001348325;NM_001348326;NM_001348327;NM_001348328;NM_001348329;NM_001348330;NM_001348331;NM_001348332;NM_001348333;NM_001348334;NM_001348335;NM_001348336;NM_004238
EGF_SIG,EGF,EGF_SIG,EGF,SIG,64,-0.0303620519540423,-0.0378789889778809,-0.0377986423777627,-0.0381429849496977,-0.00034434257193497,0.980155588076086,-0.314383999435757,0.96225339512929,0.970544228328091,0.935012086047516,-0.0355321422805753,0.819236079966496,ENSG00000138798,EGF,protein_coding,4,1,109912884,110013755,q25,epidermal growth factor [Source:HGNC Symbol;Acc:HGNC:3229],Adult hepatocellular carcinoma;Familial primary hypomagnesemia with normocalciuria and normocalcemia;HYPOMAGNESEMIA 4 RENAL,EGF,1950,NM_001178130;NM_001178131;NM_001357021;NM_001963
PRRC2C_SIG,PRRC2C,PRRC2C_SIG,PRRC2C,SIG,27,0.0297926062919194,0.565692640881319,0.565638322558261,0.565871115371364,0.000232792813103198,0.980492895334296,0.827762122443991,8.7954447949357,8.78662359214445,8.82442874696408,0.0378051548196207,0.520232787489346,ENSG00000117523,PRRC2C,protein_coding,1,1,171485551,171593511,q24.3,proline rich coiled-coil 2C [Source:HGNC Symbol;Acc:HGNC:24903],NA,PRRC2C,23215,NM_015172
NUBP1_SIG,NUBP1,NUBP1_SIG,NUBP1,SIG,25,0.0291807996524549,0.19611984280874,0.196079948164052,0.196250925212715,0.000170977048662783,0.980864056649465,0.670088529516278,4.35873490029719,4.35133620444799,4.38304490094457,0.0317086964965725,0.609311466176885,ENSG00000103274,NUBP1,protein_coding,16,1,10743786,10769351,p13.13,nucleotide binding protein 1 [Source:HGNC Symbol;Acc:HGNC:8041],NA,NUBP1,4682,NM_001278506;NM_001323594;NM_001323595;NM_001323596;NM_001323597;NM_002484
USP30_SIG,USP30,USP30_SIG,USP30,SIG,39,0.0289775547167031,0.220550953106035,0.22045304124417,0.220872663509306,0.000419622265136401,0.980907943849861,-0.174900044885277,4.50384470253978,4.50664669110134,4.49463816869468,-0.0120085224066512,0.901832862960187,ENSG00000135093,USP30,protein_coding,12,1,109023089,109088023,q24.11,ubiquitin specific peptidase 30 [Source:HGNC Symbol;Acc:HGNC:20065],NA,USP30,84749,NM_001301175;NM_032663
CERS4_TF,CERS4,CERS4_TF,CERS4,TF,210,0.0270540463059033,-0.0422116700818445,-0.0422406071449099,-0.0421165911603441,0.000124015984565656,0.982329345036794,0.0384362360238074,3.34259824213401,3.34114744963149,3.34736513178515,0.00621768215366059,0.979028553118907,ENSG00000090661,CERS4,protein_coding,19,1,8206736,8262421,p13.2,ceramide synthase 4 [Source:HGNC Symbol;Acc:HGNC:23747],NA,CERS4,79603,NM_024552
ASRGL1_SIG,ASRGL1,ASRGL1_SIG,ASRGL1,SIG,29,-0.0268403748396093,0.0653011400197082,0.0653545387454956,0.0651256870635496,-0.000228851681946119,0.982381402166992,0.347051432409443,3.61390158346804,3.60209255917929,3.6527026632739,0.0506101040946119,0.799479003725179,ENSG00000162174,ASRGL1,protein_coding,11,1,62337448,62393412,q12.3,asparaginase like 1 [Source:HGNC Symbol;Acc:HGNC:16448],NA,ASRGL1,80150,NM_001083926;NM_025080
CA8_SIG,CA8,CA8_SIG,CA8,SIG,22,-0.0266022185377887,-0.0235336087349026,-0.0234958785719631,-0.0236575792702754,-0.000161700698312213,0.982453050165641,1.63818995255502,1.39300250868364,1.33643534851234,1.57886603496078,0.24243068644844,0.179868120329724,ENSG00000178538,CA8,protein_coding,8,-1,60185412,60281400,q12.1,carbonic anhydrase 8 [Source:HGNC Symbol;Acc:HGNC:1382],CEREBELLAR ATAXIA MENTAL RETARDATION AND DYSEQUILIBRIUM SYNDROME TYPE 3;CEREBELLAR ATAXIA MENTAL RETARDATION AND DYSEQUILIBRIUM SYNDROME3;Dysequilibrium syndrome,CA8,767,NM_001321837;NM_001321838;NM_001321839;NM_004056
CTNNB1_TF,CTNNB1,CTNNB1_TF,CTNNB1,TF,88,0.025998743828058,0.265370411024006,0.265327534251636,0.265511291847506,0.000183757595870222,0.982817122975171,0.679072669065399,7.77557013909592,7.76493993082572,7.81049796626942,0.0455580354436941,0.603962857290899,ENSG00000168036,CTNNB1,protein_coding,3,1,41194741,41260096,p22.1,catenin beta 1 [Source:HGNC Symbol;Acc:HGNC:2514],Adult hepatocellular carcinoma;Colorectal Cancer;Craniopharyngioma;Desmoid tumor;EXUDATIVE VITREORETINOPATHY 7;Familial exudative vitreoretinopathy;Hepatocellular Carcinoma;Medulloblastoma;MENTAL RETARDATION AUTOSOMAL DOMINANT 19;OVARIAN CANCER OVARIAN CANCER EPITHELIAL INCLUDED;Pediatric hepatocellular carcinoma;Pilomatrixoma;Severe intellectual disability-progressive spastic diplegia syndrome,CTNNB1,1499,NM_001098209;NM_001098210;NM_001330729;NM_001904
UAP1_SIG,UAP1,UAP1_SIG,UAP1,SIG,42,-0.0258117894613422,0.0421120132749921,0.0421664222543103,0.0419332409143751,-0.00023318133993524,0.982847721953686,0.588367047724453,4.67810154611506,4.66590241909859,4.7181843920263,0.0522819729277088,0.658199174147557,ENSG00000117143,UAP1,protein_coding,1,1,162561506,162599842,q23.3,UDP-N-acetylglucosamine pyrophosphorylase 1 [Source:HGNC Symbol;Acc:HGNC:12457],NA,UAP1,6675,NM_001324113;NM_001324114;NM_001324115;NM_001324116;NM_001324117;NM_003115
CENPB_TF,CENPB,CENPB_TF,CENPB,TF,313,0.024765252982956,0.145665679797098,0.145631478952574,0.145778054000533,0.000146575047959833,0.983566268879745,0.729620990607549,5.95954341659268,5.95008354669815,5.99062584624614,0.0405422995479913,0.57462345611915,ENSG00000125817,CENPB,protein_coding,20,-1,3783851,3786740,p13,centromere protein B [Source:HGNC Symbol;Acc:HGNC:1852],NA,CENPB,1059,NM_001810
KLHL12_SIG,KLHL12,KLHL12_SIG,KLHL12,SIG,18,-0.0234975016179372,0.26203886698466,0.262083103246295,0.261893519267861,-0.000189583978434181,0.984461695178589,0.823626217176042,5.04070588063329,5.03080220604198,5.07324652571901,0.0424443196770305,0.522340161690252,ENSG00000117153,KLHL12,protein_coding,1,-1,202891116,202928636,q32.1,kelch like family member 12 [Source:HGNC Symbol;Acc:HGNC:19360],NA,KLHL12,59349,NM_001303051;NM_001303109;NM_021633
COQ2_SIG,COQ2,COQ2_SIG,COQ2,SIG,12,-0.0221890451401343,0.189937769494384,0.190010974627919,0.189697238341342,-0.000313736286576897,0.985389507049696,-0.40555201143306,4.16916250170658,4.17558352255357,4.14806486178075,-0.0275186607728228,0.765223017082516,ENSG00000173085,COQ2,protein_coding,4,-1,83261536,83284914,q21.23,coenzyme Q2, polyprenyltransferase [Source:HGNC Symbol;Acc:HGNC:25223],Coenzyme Q10 deficiency;COENZYME Q10 DEFICIENCY PRIMARY 1;Leigh syndrome with nephrotic syndrome;MULTIPLE SYSTEM ATROPHY 1 SUSCEPTIBILITY TO;Multiple system atrophy cerebellar type;Multiple system atrophy parkinsonian type,COQ2,27235,NM_001358921;NM_015697
BTAF1_TF,BTAF1,BTAF1_TF,BTAF1,TF,109,-0.0218509251728708,0.196524181040432,0.196560293564823,0.196405525603146,-0.000154767961676453,0.985480415325352,-0.488270610832198,7.17483928735534,7.18187534099843,7.15172082538517,-0.0301545156132691,0.716357576871878,ENSG00000095564,BTAF1,protein_coding,10,1,91923770,92030325,q23.32,B-TFIID TATA-box binding protein associated factor 1 [Source:HGNC Symbol;Acc:HGNC:17307],NA,BTAF1,9044,NM_003972
DNTTIP2_SIG,DNTTIP2,DNTTIP2_SIG,DNTTIP2,SIG,46,0.021777209285802,0.412233676661941,0.412161182220057,0.412471872685275,0.000310690465218693,0.985480415325352,0.44552871214506,6.5980197583813,6.59185288721778,6.61828233506144,0.0264294478436636,0.741493396751446,ENSG00000067334,DNTTIP2,protein_coding,1,-1,93866284,93879918,p22.1,deoxynucleotidyltransferase terminal interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:24013],NA,DNTTIP2,30836,NM_014597
ILKAP_SIG,ILKAP,ILKAP_SIG,ILKAP,SIG,25,-0.0215597351315939,0.290789725026032,0.290842459141183,0.290616455790535,-0.000226003350648161,0.985535098123579,0.532540116287635,5.06392581261119,5.05653354126523,5.08821470417651,0.0316811629112833,0.690678598838258,ENSG00000132323,ILKAP,protein_coding,2,-1,238170402,238203708,q37.3,ILK associated serine/threonine phosphatase [Source:HGNC Symbol;Acc:HGNC:15566],NA,ILKAP,80895,NM_030768
USP28_SIG,USP28,USP28_SIG,USP28,SIG,24,0.0212688818049727,0.199672200377947,0.199613377429625,0.199865475779576,0.000252098349951514,0.985648459171015,0.378845303631416,4.13401135942988,4.12601391992617,4.16028866065636,0.0342747407301989,0.781114158053931,ENSG00000048028,USP28,protein_coding,11,-1,113797874,113875570,q23.2,ubiquitin specific peptidase 28 [Source:HGNC Symbol;Acc:HGNC:12625],NA,USP28,57646,NM_001301029;NM_001346252;NM_001346253;NM_001346254;NM_001346255;NM_001346257;NM_001346258;NM_001346259;NM_001346260;NM_001346261;NM_001346262;NM_001346263;NM_001346264;NM_001346265;NM_001346267;NM_001346268;NM_001346269;NM_001346270;NM_001346271;NM_001346272;NM_001346273;NM_020886
TRIM22_SIG,TRIM22,TRIM22_SIG,TRIM22,SIG,50,0.0195910702405914,0.20683713746587,0.206808384451748,0.206931611655131,0.000123227203383692,0.986871010584594,2.01811071958852,7.23629702440828,7.19323497209115,7.37778662487887,0.184551652787726,0.0939059480159381,ENSG00000132274,TRIM22,protein_coding,11,1,5689697,5737089,p15.4,tripartite motif containing 22 [Source:HGNC Symbol;Acc:HGNC:16379],NA,TRIM22,10346,NM_001199573;NM_006074
PSMB6_SIG,PSMB6,PSMB6_SIG,PSMB6,SIG,22,0.0187085240711164,0.375499743284449,0.375473839155679,0.375584856850409,0.000111017694730046,0.987457351458703,1.21534922985918,5.4248710540002,5.41214713203475,5.46667822617236,0.0545310941376106,0.330268124005645,ENSG00000142507,PSMB6,protein_coding,17,1,4796144,4798502,p13.2,proteasome subunit beta 6 [Source:HGNC Symbol;Acc:HGNC:9543],NA,PSMB6,5694,NM_001270481;NM_002798
LHX6_TF,LHX6,LHX6_TF,LHX6,TF,185,0.018525153173135,-0.00160933639307998,-0.00163947124244996,-0.00151032188800718,0.000129149354442807,0.987484511037933,-0.509170301828833,1.09410375660125,1.11143504872713,1.03715808247335,-0.0742769662537722,0.704045164504363,ENSG00000106852,LHX6,protein_coding,9,-1,122202577,122229626,q33.2,LIM homeobox 6 [Source:HGNC Symbol;Acc:HGNC:21735],NA,LHX6,26468,NM_001242333;NM_001242334;NM_001242335;NM_001348190;NM_014368;NM_199160
CCR9_SIG,CCR9,CCR9_SIG,CCR9,SIG,19,-0.0181363658256206,-0.0412063916464278,-0.0411756292662086,-0.0413074680385765,-0.000131838772367858,0.987634522575742,-0.273123317587185,0.383627598049779,0.38708949058509,0.372252808290901,-0.0148366822941884,0.843750639965939,ENSG00000173585,CCR9,protein_coding,3,1,45886504,45903175,p21.31,C-C motif chemokine receptor 9 [Source:HGNC Symbol;Acc:HGNC:1610],NA,CCR9,10803,NM_001256369;NM_006641;NM_031200
HMGB1_TF,HMGB1,HMGB1_TF,HMGB1,TF,207,0.0180386824584652,0.11228437439993,0.112257758656655,0.112371826127834,0.000114067471179597,0.987634522575742,-1.63007093573259,8.06892093652818,8.09113408993024,7.99593486106427,-0.0951992288659699,0.182142091177895,ENSG00000189403,HMGB1,protein_coding,13,-1,30456704,30617597,q12.3,high mobility group box 1 [Source:HGNC Symbol;Acc:HGNC:4983],NA,HMGB1,3146,NM_001313892;NM_001313893;NM_002128
HES4_TF,HES4,HES4_TF,HES4,TF,60,0.0174614941032835,-0.00213252969672846,-0.0021557062498672,-0.0020563781649869,9.93280848802958e-05,0.987976432454012,0.224495924042751,1.02536849379237,1.01983568834014,1.04354771170684,0.0237120233667061,0.872943038605397,ENSG00000188290,HES4,protein_coding,1,-1,998962,1000172,p36.33,hes family bHLH transcription factor 4 [Source:HGNC Symbol;Acc:HGNC:24149],NA,HES4,57801,NM_001142467;NM_021170
MORF4L1_SIG,MORF4L1,MORF4L1_SIG,MORF4L1,SIG,30,0.015680540366659,0.525289308166046,0.525243436863574,0.525440028159884,0.000196591296310009,0.989280344587024,-1.0105371723105,6.35292082093819,6.36445742530485,6.315014835162,-0.0494425901428555,0.425452219143065,ENSG00000185787,MORF4L1,protein_coding,15,1,78810487,78898133,q25.1,mortality factor 4 like 1 [Source:HGNC Symbol;Acc:HGNC:16989],NA,MORF4L1,10933,NM_001265603;NM_001265604;NM_001265605;NM_006791;NM_206839
SENP5_SIG,SENP5,SENP5_SIG,SENP5,SIG,28,0.0153642232441793,0.689868835127715,0.689821491773452,0.690024391863151,0.000202900089699076,0.989413517569357,-0.206703078791482,5.58798807385822,5.5905496887841,5.57957133910176,-0.010978349682337,0.883204229847026,ENSG00000119231,SENP5,protein_coding,3,1,196867856,196934714,q29,SUMO specific peptidase 5 [Source:HGNC Symbol;Acc:HGNC:28407],NA,SENP5,205564,NM_001308045;NM_152699
SLC43A3_SIG,SLC43A3,SLC43A3_SIG,SLC43A3,SIG,15,-0.0145700371139744,0.287607456983381,0.287654889856118,0.287451606115818,-0.000203283740299672,0.989928501222692,0.169468446320919,4.93537903243479,4.93191701798313,4.94675422277595,0.0148372047928237,0.904949917151922,ENSG00000134802,SLC43A3,protein_coding,11,-1,57406954,57427580,q12.1,solute carrier family 43 member 3 [Source:HGNC Symbol;Acc:HGNC:17466],NA,SLC43A3,29015,NM_001278201;NM_001278206;NM_014096;NM_017611;NM_199329
RIPK1_SIG,RIPK1,RIPK1_SIG,RIPK1,SIG,27,-0.0133532135863849,0.452045839062108,0.452061150374269,0.451995530465009,-6.56199092594492e-05,0.99078104163781,0.665798959793382,5.74912394699676,5.74139884114707,5.77450643764572,0.0331075964986482,0.611656056708631,ENSG00000137275,RIPK1,protein_coding,6,1,3063991,3115187,p25.2,receptor interacting serine/threonine kinase 1 [Source:HGNC Symbol;Acc:HGNC:10019],IMMUNODEFICIENCY 57,RIPK1,8737,NM_001317061;NM_001354930;NM_001354931;NM_001354932;NM_001354933;NM_001354934;NM_003804
BAZ2A_SIG,BAZ2A,BAZ2A_SIG,BAZ2A,SIG,53,0.0119751175050397,0.382363570646597,0.382340150514876,0.382440522507967,0.000100371993091049,0.991762230359921,0.73136809076862,8.38454353396805,8.37525009974998,8.41507910354171,0.0398290037917252,0.573802136202481,ENSG00000076108,BAZ2A,protein_coding,12,-1,56595596,56636816,q13.3,bromodomain adjacent to zinc finger domain 2A [Source:HGNC Symbol;Acc:HGNC:962],NA,BAZ2A,11176,NM_001300905;NM_001351156;NM_013449
EME1_SIG,EME1,EME1_SIG,EME1,SIG,31,0.0110005788561288,0.119935849276022,0.119866571476945,0.120163476330129,0.000296904853183464,0.992420837542763,0.0272783211047495,2.5038097330365,2.50317658473248,2.50589007746399,0.00271349273151629,0.984922645441573,ENSG00000154920,EME1,protein_coding,17,1,50373220,50381483,q21.33,essential meiotic structure-specific endonuclease 1 [Source:HGNC Symbol;Acc:HGNC:24965],NA,EME1,146956,NM_001166131;NM_152463
TGM1_SIG,TGM1,TGM1_SIG,TGM1,SIG,12,-0.0105232259237641,-0.0607789551825023,-0.0607596438465534,-0.0608424067149055,-8.27628683519261e-05,0.992682186667235,0.480465720193244,1.04394788739234,1.03682504172578,1.06735152315387,0.0305264814280874,0.720857466335951,ENSG00000092295,TGM1,protein_coding,14,-1,24249114,24264432,q12,transglutaminase 1 [Source:HGNC Symbol;Acc:HGNC:11777],Acral self-healing collodion baby;Bathing suit ichthyosis;Congenital nonbullous ichthyosiform erythroderma;ICHTHYOSIS CONGENITAL AUTOSOMAL RECESSIVE 1;Lamellar ichthyosis;Self-improving collodion baby,TGM1,7051,NM_000359
SNRPB2_SIG,SNRPB2,SNRPB2_SIG,SNRPB2,SIG,14,0.0103529680359755,0.366181342140306,0.3661713151862,0.366214287846655,4.29726604554881e-05,0.992698224092719,-0.625682230395691,5.25450648988774,5.25970058866827,5.23744016532316,-0.0222604233451067,0.635152926529261,ENSG00000125870,SNRPB2,protein_coding,20,1,16729961,16742564,p12.1,small nuclear ribonucleoprotein polypeptide B2 [Source:HGNC Symbol;Acc:HGNC:11155],NA,SNRPB2,6629,NM_003092;NM_198220
TPMT_SIG,TPMT,TPMT_SIG,TPMT,SIG,14,-0.0100135530908815,0.268299899792305,0.268327203886426,0.268210186340192,-0.000117017546233785,0.992849332931004,-0.325805830843258,4.55604713930408,4.56077197753125,4.54052267084336,-0.0202493066878899,0.812605688006137,ENSG00000137364,TPMT,protein_coding,6,-1,18128311,18155077,p22.3,thiopurine S-methyltransferase [Source:HGNC Symbol;Acc:HGNC:12014],Azathioprine or 6-mercatopurine toxicity or dose selection;Cisplatin toxicity;THIOPURINES POOR METABOLISM OF 1,TPMT,7172,NM_000367;NM_001346817;NM_001346818
CARD11_SIG,CARD11,CARD11_SIG,CARD11,SIG,83,-0.00957102335638797,0.00654738050866153,0.00657311364725581,0.006462828767566,-0.000110284879689665,0.993082735698749,1.9940138433687,4.51152924569708,4.43935477883468,4.74867392253067,0.309319143695989,0.09818706171845,ENSG00000198286,CARD11,protein_coding,7,-1,2906141,3043945,p22.2,caspase recruitment domain family member 11 [Source:HGNC Symbol;Acc:HGNC:16393],B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY;BENTA disease;IMMUNODEFICIENCY 11;IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS;Persistent polyclonal B-cell lymphocytosis;Severe combined immunodeficiency due to CARD11 deficiency,CARD11,84433,NM_001324281;NM_032415
ZNF668_TF,ZNF668,ZNF668_TF,ZNF668,TF,53,0.00917505760192515,0.13400727003996,0.133996683160708,0.134042055500358,4.53723396501505e-05,0.993278910026159,0.946394030651887,3.98359760488356,3.97027745408962,4.02736381463508,0.0570863605454633,0.457628318479954,ENSG00000167394,ZNF668,protein_coding,16,-1,31060843,31074240,p11.2,zinc finger protein 668 [Source:HGNC Symbol;Acc:HGNC:25821],NA,ZNF668,79759,NM_001172668;NM_001172669;NM_001172670;NM_024706
DTYMK_SIG,DTYMK,DTYMK_SIG,DTYMK,SIG,48,-0.00757282682153989,0.23568410467842,0.235715212271932,0.235581894014026,-0.000133318257905986,0.994437931021567,0.742231869642681,3.80490513218152,3.79079559119472,3.85126505256672,0.0604694613720009,0.567759636207712,ENSG00000168393,DTYMK,protein_coding,2,-1,241675747,241686944,q37.3,deoxythymidylate kinase [Source:HGNC Symbol;Acc:HGNC:3061],NA,DTYMK,1841,NM_001165031;NM_001320902;NM_001320903;NM_001320904;NM_001320905;NM_012145
RBM34_SIG,RBM34,RBM34_SIG,RBM34,SIG,88,0.00653413719742421,0.195811614510659,0.195787717523129,0.195890133183972,0.000102415660842977,0.995146892780079,0.628448912373774,2.0373267191178,2.0251308057868,2.07739900577681,0.0522681999900146,0.633515845487232,ENSG00000188739,RBM34,protein_coding,1,-1,235131183,235161283,q42.3,RNA binding motif protein 34 [Source:HGNC Symbol;Acc:HGNC:28965],NA,RBM34,23029,NM_001346738;NM_015014
KLK14_SIG,KLK14,KLK14_SIG,KLK14,SIG,23,-0.00620875779930994,0.00322626541446182,0.00323354903231405,0.00320233352723307,-3.12155050810812e-05,0.99528642209994,-1.01151598986691,0.320176364435382,0.326988877309502,0.297792393563274,-0.0291964837462287,0.424966026174946,ENSG00000129437,KLK14,protein_coding,19,-1,51077495,51084245,q13.41,kallikrein related peptidase 14 [Source:HGNC Symbol;Acc:HGNC:6362],NA,KLK14,43847,NM_001311182;NM_022046
SRP19_SIG,SRP19,SRP19_SIG,SRP19,SIG,74,0.00303473329472428,0.032741454569474,0.0327383599348105,0.0327516226547972,1.32627199866349e-05,0.997699059211277,1.2584577159526,3.00189021722651,2.98689747869269,3.05115207240906,0.0642545937163751,0.311759216558538,ENSG00000153037,SRP19,protein_coding,5,1,112861188,112898371,q22.2,signal recognition particle 19 [Source:HGNC Symbol;Acc:HGNC:11300],NA,SRP19,6728,NM_001204193;NM_001204194;NM_001204196;NM_001204199;NM_003135
MDM2_SIG,MDM2,MDM2_SIG,MDM2,SIG,28,0.00251889534508322,0.271496507737256,0.271493084139758,0.271507756700462,1.46725607045799e-05,0.997990214419173,0.654590346641924,6.39813505353787,6.38631426589697,6.43697478435798,0.0506605184610072,0.618098089163453,ENSG00000135679,MDM2,protein_coding,12,1,68808177,68850686,q15,MDM2 proto-oncogene [Source:HGNC Symbol;Acc:HGNC:6973],Accelerated tumor formation susceptibility to;Dedifferentiated liposarcoma;Li-Fraumeni syndrome;Well-differentiated liposarcoma,MDM2,4193,NM_001145337;NM_001145339;NM_001145340;NM_001278462;NM_002392
